ID,DOI,Type,PublishedDate,Source,ScrapDate,title_words,abstract_sentences,abstract_words,abstract_length,abstract_wc,abstract_kw,abstract_kw_sum,abstract_sentiment
DOI:10.1016/j.kint.2020.05.006,10.1016/j.kint.2020.05.006,Kidney International,2020-05-16 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['acute', 'kidney', 'injury', 'patient', 'hospitalize', 'covid-19']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.therap.2020.05.009,10.1016/j.therap.2020.05.009,Therapies,2020-05-20 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['renin-angiotensin-aldosterone', 'system', 'covid-19', 'infection']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.enfcli.2020.05.016,10.1016/j.enfcli.2020.05.016,Enfermería Clínica,2020-05-23 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['cuidados', 'enfermeros', 'en', 'el', 'paciente', 'adulto', 'ingresado', 'en', 'unidades', 'de', 'hospitalizacin', 'por', 'covid-19']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.ando.2020.04.005,10.1016/j.ando.2020.04.005,Annales d'Endocrinologie,2020-04-21 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['renin-angiotensin-aldosterone', 'system', 'covid-19', 'infection']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jamda.2020.04.017,10.1016/j.jamda.2020.04.017,Journal of the American Medical Directors Association,2020-04-23 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['geriatrician', '', 'frontline', 'specialist', 'treatment', 'covid-19', 'patients']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jviscsurg.2020.04.018,10.1016/j.jviscsurg.2020.04.018,Journal of Visceral Surgery,2020-04-30 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['endocrine', 'surgery', 'covid-19', 'epidemic', '', 'expert', 'guideline', 'afce']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jtcvs.2020.04.059,10.1016/j.jtcvs.2020.04.059,The Journal of Thoracic and Cardiovascular Surgery,2020-04-27 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['adult', 'cardiac', 'surgery', 'covid-19', 'pandemic', '', 'aggressive', 'infection', 'mitigation', 'strategies', 'necessary', 'operating', 'room', 'surgical', 'recovery']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.neurol.2020.04.004,10.1016/j.neurol.2020.04.004,Revue Neurologique,2020-04-20 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['guidance', 'care', 'neuromuscular', 'patient', 'covid-19', 'pandemic', 'outbreak', 'french', 'rare', 'health', 'care', 'neuromuscular', 'diseases', 'network']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.fertnstert.2020.04.025,10.1016/j.fertnstert.2020.04.025,Fertility and Sterility,2020-04-16 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['prior', 'novel', 'coronaviruses', '', 'covid-19', '', 'human', 'reproduction', '', 'known', '']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.ultrasmedbio.2020.04.026,10.1016/j.ultrasmedbio.2020.04.026,Ultrasound in Medicine & Biology,2020-05-03 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['lung', 'ultrasound', 'children', 'covid-19', '', 'preliminary', 'findings']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.cgh.2020.05.030,10.1016/j.cgh.2020.05.030,Clinical Gastroenterology and Hepatology,2020-05-22 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['plans', 'reactivate', 'gastroenterology', 'practices', 'following', 'covid-19', 'pandemic', '', 'survey', 'north', 'american', 'centers']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jchirv.2020.04.015,10.1016/j.jchirv.2020.04.015,Journal de Chirurgie Viscérale,2020-04-30 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['chirurgie', 'endocrinienne', 'au', 'cours', 'au', 'dcours', 'de', 'l', '', 'pidmie', 'de', 'covid-19', '', 'recommandations', 'de', 'l', '', 'afce']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jaci.2020.05.003,10.1016/j.jaci.2020.05.003,Journal of Allergy and Clinical Immunology,2020-05-11 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['longitudinal', 'hematologic', 'immunologic', 'variation', 'associate', 'progression', 'covid-19', 'patient', 'china']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.athoracsur.2020.05.002,10.1016/j.athoracsur.2020.05.002,The Annals of Thoracic Surgery,2020-05-12 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['ramping', 'delivery', 'cardiac', 'surgery', 'covid-19', 'pandemic', '', 'guidance', 'statement', 'society', 'thoracic', 'surgeons', 'covid-19', 'task', 'force']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.athoracsur.2020.04.007,10.1016/j.athoracsur.2020.04.007,The Annals of Thoracic Surgery,2020-04-27 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['adult', 'cardiac', 'surgery', 'covid-19', 'pandemic', '', 'aggressive', 'infection', 'mitigation', 'strategies', 'necessary', 'operating', 'room', 'surgical', 'recovery']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.thromres.2020.04.024,10.1016/j.thromres.2020.04.024,Thrombosis Research,2020-04-23 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['venous', 'arterial', 'thromboembolic', 'complication', 'covid-19', 'patient', 'admit', 'academic', 'hospital', 'milan', '', 'italy']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.ekir.2020.04.001,10.1016/j.ekir.2020.04.001,Kidney International Reports,2020-04-04 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['management', 'patients', 'dialysis', 'kidney', 'transplantation', 'sars-cov-2', '', 'covid-19', '', 'pandemic', 'brescia', '', 'italy']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.psym.2020.05.007,10.1016/j.psym.2020.05.007,Psychosomatics,2020-05-19 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['case', 'report', 'covid-19', 'associated', 'hyperactive', 'icu', 'delirium', 'proposed', 'pathophysiology', 'treatment']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jse.2020.05.003,10.1016/j.jse.2020.05.003,Journal of Shoulder and Elbow Surgery,2020-05-20 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['impact', 'covid-19', 'shoulder', 'elbow', 'trauma', '', 'italian', 'survey']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.therap.2020.04.004,10.1016/j.therap.2020.04.004,Therapies,2020-04-23 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,['therapcovid-19'],['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.medcli.2020.05.005,10.1016/j.medcli.2020.05.005,Medicina Clínica,2020-05-19 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['mortalidad', 'por', 'covid-19', 'en', 'pacientes', 'con', 'cncer', 'en', 'un', 'hospital', 'de', 'madrid', 'durante', 'la', 'primeras', '3', 'semanas', 'de', 'epidemia']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.adro.2020.04.028,10.1016/j.adro.2020.04.028,Advances in Radiation Oncology,2020-05-20 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['extent', 'prior', 'lung', 'irradiation', 'mortality', 'covid-19', 'patient', 'cancer', 'history']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.tipsro.2020.05.003,10.1016/j.tipsro.2020.05.003,Technical Innovations & Patient Support in Radiation Oncology,2020-05-22 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['meeting', 'challenge', 'impose', 'covid-19', '', 'guidance', 'document', 'estro', 'radiation', 'therapist', 'committee', '', 'rttc', '']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.jchirv.2020.04.009,10.1016/j.jchirv.2020.04.009,Journal de Chirurgie Viscérale,2020-04-18 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['gestion', 'de', 'l', '', 'pidmie', 'de', 'la', 'covid-19', 'par', 'le', 'tablissements', 'public', 'de', 'sant', '', 'analyse', 'de', 'la', 'fdration', 'hospitalire', 'de', 'france']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
DOI:10.1016/j.mmcr.2020.05.001,10.1016/j.mmcr.2020.05.001,Medical Mycology Case Reports,2020-05-11 00:00:00,ELSEVIER,2020-05-23 22:13:35.057884,"['invasive', 'pulmonary', 'aspergillosis', 'complicate', 'covid-19', 'icu', '-', 'case', 'report']",['N/A ( Too many request )'],"['na', '', 'request', '']",4,"{'': 2, 'na': 1, 'request': 1}",{},0,0.0
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-05-20 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA Health Canada jointly chair fourth global regulatory workshop Tuesday 19 May , umbrella International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'The participant identify priority area cooperation observational research COVID-19 : pregnancy research , medicine use clinical practice , monitor vaccine safety effectiveness .']","['ema', 'health', 'canada', 'jointly', 'chair', 'fourth', 'global', 'regulatory', 'workshop', 'tuesday', '19', '', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'participant', 'identify', 'priority', 'area', 'cooperation', 'observational', 'research', 'covid-19', '', 'pregnancy', 'research', '', 'medicine', 'clinical', 'practice', '', 'monitor', 'vaccine', 'safety', 'effectiveness', '']",43,"{'': 8, 'regulatory': 2, 'research': 2, 'ema': 1, 'health': 1, 'canada': 1, 'jointly': 1, 'chair': 1, 'fourth': 1, 'global': 1, 'workshop': 1, 'tuesday': 1, '19': 1, 'umbrella': 1, 'international': 1, 'coalition': 1, 'medicines': 1, 'authorities': 1, 'icmra': 1, 'participant': 1}",{'safety': 1},1,0.4215
URL:emas-governance-during-covid-19-pandemic,,Update,2020-05-19 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['EMA decide continue hold committee working-party meet virtually end August 2020 .', 'Stakeholder event plan end August either postpone hold virtually .']","['ema', 'decide', 'continue', 'hold', 'committee', 'working-party', 'meet', 'virtually', 'end', 'august', '2020', '', 'stakeholder', 'event', 'plan', 'end', 'august', 'either', 'postpone', 'hold', 'virtually', '']",22,"{'hold': 2, 'virtually': 2, 'end': 2, 'august': 2, '': 2, 'ema': 1, 'decide': 1, 'continue': 1, 'committee': 1, 'working-party': 1, 'meet': 1, '2020': 1, 'stakeholder': 1, 'event': 1, 'plan': 1, 'either': 1, 'postpone': 1}",{},0,-0.2263
URL:emas-governance-during-covid-19-pandemic,,Update,2020-05-19 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']",['EMA announce essential work combat COVID-19 pandemic would continue Agency ’ closure 21 22 May .'],"['ema', 'announce', 'essential', 'work', 'combat', 'covid-19', 'pandemic', 'continue', 'agency', '', 'closure', '21', '22', '']",14,"{'': 2, 'ema': 1, 'announce': 1, 'essential': 1, 'work': 1, 'combat': 1, 'covid-19': 1, 'pandemic': 1, 'continue': 1, 'agency': 1, 'closure': 1, '21': 1, '22': 1}",{},0,-0.34
URL:emas-governance-during-covid-19-pandemic,,Update,2020-05-18 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['EMA ’ Executive Director , Guido Rasi , attend European Parliament ’ Committee Environment , Public Health Food Safety ( ENVI ) Monday , 18 May , respond question EMA ’ response COVID-19 .', 'This follow statement committee Tuesday , 12 May .', 'A record session available European Parliament ’ website .']","['ema', '', 'executive', 'director', '', 'guido', 'rasi', '', 'attend', 'european', 'parliament', '', 'committee', 'environment', '', 'public', 'health', 'food', 'safety', '', 'envi', '', 'monday', '', '18', '', 'respond', 'question', 'ema', '', 'response', 'covid-19', '', 'follow', 'statement', 'committee', 'tuesday', '', '12', '', 'record', 'session', 'available', 'european', 'parliament', '', 'website', '']",48,"{'': 15, 'ema': 2, 'european': 2, 'parliament': 2, 'committee': 2, 'executive': 1, 'director': 1, 'guido': 1, 'rasi': 1, 'attend': 1, 'environment': 1, 'public': 1, 'health': 1, 'food': 1, 'safety': 1, 'envi': 1, 'monday': 1, '18': 1, 'respond': 1, 'question': 1}",{'safety': 1},1,0.4215
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-05-18 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA participate third bi-weekly global regulator ’ meet COVID-19-related policy approach regulatory flexibility Thursday 14 May , umbrella International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'Participants discuss COVID-19 clinical-trial management , focus particular use master protocol help generate robust evidence need regulatory decision , measure mitigate medicine-supply issue .']","['ema', 'participate', 'third', 'bi-weekly', 'global', 'regulator', '', 'meet', 'covid-19-related', 'policy', 'approach', 'regulatory', 'flexibility', 'thursday', '14', '', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'participants', 'discuss', 'covid-19', 'clinical-trial', 'management', '', 'focus', 'particular', 'master', 'protocol', 'help', 'generate', 'robust', 'evidence', 'regulatory', 'decision', '', 'measure', 'mitigate', 'medicine-supply', 'issue', '']",48,"{'': 8, 'regulatory': 3, 'ema': 1, 'participate': 1, 'third': 1, 'bi-weekly': 1, 'global': 1, 'regulator': 1, 'meet': 1, 'covid-19-related': 1, 'policy': 1, 'approach': 1, 'flexibility': 1, 'thursday': 1, '14': 1, 'umbrella': 1, 'international': 1, 'coalition': 1, 'medicines': 1, 'authorities': 1}",{},0,0.7579
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-05-15 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA provide update measure EU authority put place support continue availability medicine pandemic , follow meet EU Executive Steering Group Shortages Medicines Caused Major Events .']","['ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', '', 'follow', 'meet', 'eu', 'executive', 'steering', 'group', 'shortages', 'medicines', 'caused', 'major', 'events', '']",26,"{'eu': 2, '': 2, 'ema': 1, 'provide': 1, 'update': 1, 'measure': 1, 'authority': 1, 'put': 1, 'place': 1, 'support': 1, 'continue': 1, 'availability': 1, 'medicine': 1, 'pandemic': 1, 'follow': 1, 'meet': 1, 'executive': 1, 'steering': 1, 'group': 1, 'shortages': 1}",{},0,0.34
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-05-15 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['Members EMA staff scientific committee publish article set concrete action stakeholder involve COVID-19 clinical trial take order generate conclusive evidence need enable rapid development approval potential treatment vaccine COVID-19 .', 'The article available via open access website Clinical Pharmacology & Therapeutics .']","['members', 'ema', 'staff', 'scientific', 'committee', 'publish', 'article', 'set', 'concrete', 'action', 'stakeholder', 'involve', 'covid-19', 'clinical', 'trial', 'order', 'generate', 'conclusive', 'evidence', 'enable', 'rapid', 'development', 'approval', 'potential', 'treatment', 'vaccine', 'covid-19', '', 'article', 'available', 'via', 'open', 'access', 'website', 'clinical', 'pharmacology', '', 'therapeutics', '']",39,"{'': 3, 'article': 2, 'covid-19': 2, 'clinical': 2, 'members': 1, 'ema': 1, 'staff': 1, 'scientific': 1, 'committee': 1, 'publish': 1, 'set': 1, 'concrete': 1, 'action': 1, 'stakeholder': 1, 'involve': 1, 'trial': 1, 'order': 1, 'generate': 1, 'conclusive': 1, 'evidence': 1}",{},0,0.4767
URL:treatments-vaccines-covid-19,,Update,2020-05-14 00:00:00,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']","['EMA hold virtual press brief explain effort expedite development approval COVID-19 treatment vaccine , role ensure continue availability crucial medicine EU pandemic , publication reliable information patient healthcare professional .', 'The press brief feature Noël Wathion , EMA ’ Deputy Executive Director , Marco Cavaleri , EMA ’ Head Biological Health Threats Vaccines Strategy .', 'A record brief available .']","['ema', 'hold', 'virtual', 'press', 'brief', 'explain', 'effort', 'expedite', 'development', 'approval', 'covid-19', 'treatment', 'vaccine', '', 'role', 'ensure', 'continue', 'availability', 'crucial', 'medicine', 'eu', 'pandemic', '', 'publication', 'reliable', 'information', 'patient', 'healthcare', 'professional', '', 'press', 'brief', 'feature', 'nol', 'wathion', '', 'ema', '', 'deputy', 'executive', 'director', '', 'marco', 'cavaleri', '', 'ema', '', 'head', 'biological', 'health', 'threats', 'vaccines', 'strategy', '', 'record', 'brief', 'available', '']",58,"{'': 10, 'ema': 3, 'brief': 3, 'press': 2, 'hold': 1, 'virtual': 1, 'explain': 1, 'effort': 1, 'expedite': 1, 'development': 1, 'approval': 1, 'covid-19': 1, 'treatment': 1, 'vaccine': 1, 'role': 1, 'ensure': 1, 'continue': 1, 'availability': 1, 'crucial': 1, 'medicine': 1}",{},0,0.4404
URL:fees-payable-european-medicines-agency,,Update,2020-05-14 00:00:00,EMA,2020-05-23 22:13:35.057884,"['fees', 'payable', 'european', 'medicines', 'agency']","['EMA announce waive fee on-site inspection manufacture site blood establishment inspect remotely pandemic remote inspection could confirm compliance good manufacture practice ( GMP ) standard .', 'For detail , see decision EMA ’ Executive Director .']","['ema', 'announce', 'waive', 'fee', 'on-site', 'inspection', 'manufacture', 'site', 'blood', 'establishment', 'inspect', 'remotely', 'pandemic', 'remote', 'inspection', 'confirm', 'compliance', 'manufacture', 'practice', '', 'gmp', '', 'standard', '', 'detail', '', 'decision', 'ema', '', 'executive', 'director', '']",32,"{'': 6, 'ema': 2, 'inspection': 2, 'manufacture': 2, 'announce': 1, 'waive': 1, 'fee': 1, 'on-site': 1, 'site': 1, 'blood': 1, 'establishment': 1, 'inspect': 1, 'remotely': 1, 'pandemic': 1, 'remote': 1, 'confirm': 1, 'compliance': 1, 'practice': 1, 'gmp': 1, 'standard': 1}",{},0,0.4404
URL:treatments-vaccines-covid-19,,Update,2020-05-14 00:00:00,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']",['EMA give update state contact developer around:115 potential COVID-19 treatment ; 33 potential COVID-19 vaccine .'],"['ema', 'give', 'update', 'state', 'contact', 'developer', 'around115', 'potential', 'covid-19', 'treatment', '', '33', 'potential', 'covid-19', 'vaccine', '']",16,"{'potential': 2, 'covid-19': 2, '': 2, 'ema': 1, 'give': 1, 'update': 1, 'state': 1, 'contact': 1, 'developer': 1, 'around115': 1, 'treatment': 1, '33': 1, 'vaccine': 1}",{},0,0.0
URL:emas-governance-during-covid-19-pandemic,,Update,2020-05-13 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['EMA ’ Executive Director , Guido Rasi , brief European Parliament ’ Committee Environment , Public Health Food Safety ( ENVI ) EMA ’ response COVID-19 Tuesday , 12 May .', 'He explain EMA ’ effort expedite development approval COVID-19 treatment vaccine , role ensure continue availability crucial medicine EU pandemic , publication reliable information patient healthcare professional .', 'A record session available European Parliament ’ website .']","['ema', '', 'executive', 'director', '', 'guido', 'rasi', '', 'brief', 'european', 'parliament', '', 'committee', 'environment', '', 'public', 'health', 'food', 'safety', '', 'envi', '', 'ema', '', 'response', 'covid-19', 'tuesday', '', '12', '', 'explain', 'ema', '', 'effort', 'expedite', 'development', 'approval', 'covid-19', 'treatment', 'vaccine', '', 'role', 'ensure', 'continue', 'availability', 'crucial', 'medicine', 'eu', 'pandemic', '', 'publication', 'reliable', 'information', 'patient', 'healthcare', 'professional', '', 'record', 'session', 'available', 'european', 'parliament', '', 'website', '']",65,"{'': 16, 'ema': 3, 'european': 2, 'parliament': 2, 'covid-19': 2, 'executive': 1, 'director': 1, 'guido': 1, 'rasi': 1, 'brief': 1, 'committee': 1, 'environment': 1, 'public': 1, 'health': 1, 'food': 1, 'safety': 1, 'envi': 1, 'response': 1, 'tuesday': 1, '12': 1}",{'safety': 1},1,0.8176
URL:treatments-vaccines-covid-19,,Update,2020-05-11 00:00:00,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']","['EMA ’ CHMP recommend extend compassionate use investigational medicine remdesivir group patient Europe , base preliminary result study medicine .', 'The update recommendation cover hospitalise patient require supplemental oxygen , non-invasive ventilation , high-flow oxygen device ECMO ( extracorporeal membrane oxygenation ) , addition invasive mechanical ventilation .']","['ema', '', 'chmp', 'recommend', 'extend', 'compassionate', 'investigational', 'medicine', 'remdesivir', 'group', 'patient', 'europe', '', 'base', 'preliminary', 'result', 'study', 'medicine', '', 'update', 'recommendation', 'cover', 'hospitalise', 'patient', 'require', 'supplemental', 'oxygen', '', 'non-invasive', 'ventilation', '', 'high-flow', 'oxygen', 'device', 'ecmo', '', 'extracorporeal', 'membrane', 'oxygenation', '', '', 'addition', 'invasive', 'mechanical', 'ventilation', '']",46,"{'': 9, 'medicine': 2, 'patient': 2, 'oxygen': 2, 'ventilation': 2, 'ema': 1, 'chmp': 1, 'recommend': 1, 'extend': 1, 'compassionate': 1, 'investigational': 1, 'remdesivir': 1, 'group': 1, 'europe': 1, 'base': 1, 'preliminary': 1, 'result': 1, 'study': 1, 'update': 1, 'recommendation': 1}",{},0,0.7506
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-05-08 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA provide update measure EU authority put place support continue availability medicine pandemic , follow meet EU Executive Steering Group Shortages Medicines Caused Major Events .']","['ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', '', 'follow', 'meet', 'eu', 'executive', 'steering', 'group', 'shortages', 'medicines', 'caused', 'major', 'events', '']",26,"{'eu': 2, '': 2, 'ema': 1, 'provide': 1, 'update': 1, 'measure': 1, 'authority': 1, 'put': 1, 'place': 1, 'support': 1, 'continue': 1, 'availability': 1, 'medicine': 1, 'pandemic': 1, 'follow': 1, 'meet': 1, 'executive': 1, 'steering': 1, 'group': 1, 'shortages': 1}",{},0,0.34
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-05-07 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA update eSubmission Gateway user interface allow applicant flag submission relate COVID-19 .', 'The aim help EMA rapidly identify prioritise COVID-19-related submission .', 'More information , include update user guide release note available eSubmission website .']","['ema', 'update', 'esubmission', 'gateway', 'user', 'interface', 'allow', 'applicant', 'flag', 'submission', 'relate', 'covid-19', '', 'aim', 'help', 'ema', 'rapidly', 'identify', 'prioritise', 'covid-19-related', 'submission', '', 'information', '', 'include', 'update', 'user', 'guide', 'release', 'note', 'available', 'esubmission', 'website', '']",34,"{'': 4, 'ema': 2, 'update': 2, 'esubmission': 2, 'user': 2, 'submission': 2, 'gateway': 1, 'interface': 1, 'allow': 1, 'applicant': 1, 'flag': 1, 'relate': 1, 'covid-19': 1, 'aim': 1, 'help': 1, 'rapidly': 1, 'identify': 1, 'prioritise': 1, 'covid-19-related': 1, 'information': 1}",{},0,0.5574
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-05-05 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA chair second bi-weekly global regulator ’ meet COVID-19-related policy approach regulatory flexibility Thursday 30 April , umbrella International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'Participants focus development medicine vaccine development COVID-19 , stress need alignment regulatory requirement help speed development , evaluation availability .']","['ema', 'chair', 'second', 'bi-weekly', 'global', 'regulator', '', 'meet', 'covid-19-related', 'policy', 'approach', 'regulatory', 'flexibility', 'thursday', '30', 'april', '', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'participants', 'focus', 'development', 'medicine', 'vaccine', 'development', 'covid-19', '', 'stress', 'alignment', 'regulatory', 'requirement', 'help', 'speed', 'development', '', 'evaluation', 'availability', '']",46,"{'': 8, 'regulatory': 3, 'development': 3, 'ema': 1, 'chair': 1, 'second': 1, 'bi-weekly': 1, 'global': 1, 'regulator': 1, 'meet': 1, 'covid-19-related': 1, 'policy': 1, 'approach': 1, 'flexibility': 1, 'thursday': 1, '30': 1, 'april': 1, 'umbrella': 1, 'international': 1, 'coalition': 1}",{},0,0.3182
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-05-04 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA publish guidance developer rapid review procedure put place speed development approval COVID-19 treatment vaccine .', 'The rapid procedure accelerate every step regulatory pathway ensure robust evidence efficacy , safety quality generate support scientific regulatory decision .', 'As procedure require developer submit well-prepared dossier , EMA encourage contact Agency soon possible discus strategy evidence-generation , email proposal 2019-ncov @ ema.europa.eu .']","['ema', 'publish', 'guidance', 'developer', 'rapid', 'review', 'procedure', 'put', 'place', 'speed', 'development', 'approval', 'covid-19', 'treatment', 'vaccine', '', 'rapid', 'procedure', 'accelerate', 'every', 'step', 'regulatory', 'pathway', 'ensure', 'robust', 'evidence', 'efficacy', '', 'safety', 'quality', 'generate', 'support', 'scientific', 'regulatory', 'decision', '', 'procedure', 'require', 'developer', 'submit', 'well-prepared', 'dossier', '', 'ema', 'encourage', 'contact', 'agency', 'soon', 'possible', 'discus', 'strategy', 'evidence-generation', '', 'email', 'proposal', '2019-ncov', '', 'emaeuropaeu', '']",59,"{'': 7, 'procedure': 3, 'ema': 2, 'developer': 2, 'rapid': 2, 'regulatory': 2, 'publish': 1, 'guidance': 1, 'review': 1, 'put': 1, 'place': 1, 'speed': 1, 'development': 1, 'approval': 1, 'covid-19': 1, 'treatment': 1, 'vaccine': 1, 'accelerate': 1, 'every': 1, 'step': 1}",{'safety': 1},1,0.9423
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-05-04 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA update guidance market authorisation holder submit COVID-19-related individual case safety report ( ICSR ) EudraVigilance .', 'The update guidance follow implementation version 23.0 Medical Dictionary Regulatory Activities ( MedDRA ) contain additional COVID-19-related term EudraVigilance Monday , 4 May .']","['ema', 'update', 'guidance', 'market', 'authorisation', 'holder', 'submit', 'covid-19-related', 'individual', 'case', 'safety', 'report', '', 'icsr', '', 'eudravigilance', '', 'update', 'guidance', 'follow', 'implementation', 'version', '230', 'medical', 'dictionary', 'regulatory', 'activities', '', 'meddra', '', 'contain', 'additional', 'covid-19-related', 'term', 'eudravigilance', 'monday', '', '4', '']",39,"{'': 7, 'update': 2, 'guidance': 2, 'covid-19-related': 2, 'eudravigilance': 2, 'ema': 1, 'market': 1, 'authorisation': 1, 'holder': 1, 'submit': 1, 'individual': 1, 'case': 1, 'safety': 1, 'report': 1, 'icsr': 1, 'follow': 1, 'implementation': 1, 'version': 1, '230': 1, 'medical': 1}",{'safety': 1},1,0.4215
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-05-04 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA , European Commission national competent authority publish question answer regulatory expectation medicinal product veterinary use COVID-19 pandemic .', 'This guidance pharmaceutical company responsible veterinary medicine set adaptation regulatory framework place address challenge arise COVID-19 pandemic .', 'It cover market authorisation procedure , pharmacovigilance good-manufacturing-practice ( GMP ) certificate , inspection veterinary medicine .']","['ema', '', 'european', 'commission', 'national', 'competent', 'authority', 'publish', 'question', 'answer', 'regulatory', 'expectation', 'medicinal', 'product', 'veterinary', 'covid-19', 'pandemic', '', 'guidance', 'pharmaceutical', 'company', 'responsible', 'veterinary', 'medicine', 'set', 'adaptation', 'regulatory', 'framework', 'place', 'address', 'challenge', 'arise', 'covid-19', 'pandemic', '', 'cover', 'market', 'authorisation', 'procedure', '', 'pharmacovigilance', 'good-manufacturing-practice', '', 'gmp', '', 'certificate', '', 'inspection', 'veterinary', 'medicine', '']",51,"{'': 8, 'veterinary': 3, 'regulatory': 2, 'covid-19': 2, 'pandemic': 2, 'medicine': 2, 'ema': 1, 'european': 1, 'commission': 1, 'national': 1, 'competent': 1, 'authority': 1, 'publish': 1, 'question': 1, 'answer': 1, 'expectation': 1, 'medicinal': 1, 'product': 1, 'guidance': 1, 'pharmaceutical': 1}",{},0,0.6369
URL:treatments-vaccines-covid-19,,Update,2020-04-30 00:00:00,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']","['EMA announce human medicine committee ( CHMP ) start roll review data use investigational antiviral medicine remdesivir treatment COVID-19 .', 'This mean CHMP assess data become available roll basis development still ongoing .', ""This one Agency 's regulatory tool speed evaluation promise investigational treatment public health emergency .""]","['ema', 'announce', 'human', 'medicine', 'committee', '', 'chmp', '', 'start', 'roll', 'review', 'data', 'investigational', 'antiviral', 'medicine', 'remdesivir', 'treatment', 'covid-19', '', 'mean', 'chmp', 'assess', 'data', 'become', 'available', 'roll', 'basis', 'development', 'still', 'ongoing', '', 'one', 'agency', 'regulatory', 'tool', 'speed', 'evaluation', 'promise', 'investigational', 'treatment', 'public', 'health', 'emergency', '']",44,"{'': 5, 'medicine': 2, 'chmp': 2, 'roll': 2, 'data': 2, 'investigational': 2, 'treatment': 2, 'ema': 1, 'announce': 1, 'human': 1, 'committee': 1, 'start': 1, 'review': 1, 'antiviral': 1, 'remdesivir': 1, 'covid-19': 1, 'mean': 1, 'assess': 1, 'become': 1, 'available': 1}",{},0,-0.0772
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-30 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA provide update measure EU authority put place support continue availability medicine pandemic , follow meet EU Executive Steering Group Shortages Medicines Caused Major Events .']","['ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', '', 'follow', 'meet', 'eu', 'executive', 'steering', 'group', 'shortages', 'medicines', 'caused', 'major', 'events', '']",26,"{'eu': 2, '': 2, 'ema': 1, 'provide': 1, 'update': 1, 'measure': 1, 'authority': 1, 'put': 1, 'place': 1, 'support': 1, 'continue': 1, 'availability': 1, 'medicine': 1, 'pandemic': 1, 'follow': 1, 'meet': 1, 'executive': 1, 'steering': 1, 'group': 1, 'shortages': 1}",{},0,0.34
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-04-28 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA , European Commission Heads Medicines Agencies update Guidance management clinical trial COVID-19 ( coronavirus ) pandemic .', 'The update guidance include recommendation simple flexible measure sponsor take manage clinical trial COVID-19 pandemic , give impact European health system society general .']","['ema', '', 'european', 'commission', 'heads', 'medicines', 'agencies', 'update', 'guidance', 'management', 'clinical', 'trial', 'covid-19', '', 'coronavirus', '', 'pandemic', '', 'update', 'guidance', 'include', 'recommendation', 'simple', 'flexible', 'measure', 'sponsor', 'manage', 'clinical', 'trial', 'covid-19', 'pandemic', '', 'give', 'impact', 'european', 'health', 'system', 'society', 'general', '']",40,"{'': 6, 'european': 2, 'update': 2, 'guidance': 2, 'clinical': 2, 'trial': 2, 'covid-19': 2, 'pandemic': 2, 'ema': 1, 'commission': 1, 'heads': 1, 'medicines': 1, 'agencies': 1, 'management': 1, 'coronavirus': 1, 'include': 1, 'recommendation': 1, 'simple': 1, 'flexible': 1, 'measure': 1}",{},0,0.2263
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-04-28 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA endorse joint statement member International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'The statement commit international regulator strengthen global collaboration facilitate rapid development , approval roll-out safe effective medicine COVID-19 .']","['ema', 'endorse', 'joint', 'statement', 'member', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'statement', 'commit', 'international', 'regulator', 'strengthen', 'global', 'collaboration', 'facilitate', 'rapid', 'development', '', 'approval', 'roll-out', 'safe', 'effective', 'medicine', 'covid-19', '']",32,"{'': 5, 'statement': 2, 'international': 2, 'ema': 1, 'endorse': 1, 'joint': 1, 'member': 1, 'coalition': 1, 'medicines': 1, 'regulatory': 1, 'authorities': 1, 'icmra': 1, 'commit': 1, 'regulator': 1, 'strengthen': 1, 'global': 1, 'collaboration': 1, 'facilitate': 1, 'rapid': 1, 'development': 1}",{},0,0.9313
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-24 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA provide update measure EU authority put place support continue availability medicine pandemic , follow meet EU Executive Steering Group Shortages Medicines Caused Major Events .', 'This include development guidance pharmaceutical company responsible veterinary medicine adaptation regulatory framework address COVID-19-related challenge .']","['ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', '', 'follow', 'meet', 'eu', 'executive', 'steering', 'group', 'shortages', 'medicines', 'caused', 'major', 'events', '', 'include', 'development', 'guidance', 'pharmaceutical', 'company', 'responsible', 'veterinary', 'medicine', 'adaptation', 'regulatory', 'framework', 'address', 'covid-19-related', 'challenge', '']",41,"{'': 3, 'eu': 2, 'medicine': 2, 'ema': 1, 'provide': 1, 'update': 1, 'measure': 1, 'authority': 1, 'put': 1, 'place': 1, 'support': 1, 'continue': 1, 'availability': 1, 'pandemic': 1, 'follow': 1, 'meet': 1, 'executive': 1, 'steering': 1, 'group': 1, 'shortages': 1}",{},0,0.6124
URL:public-health-advice-during-covid-19-pandemic,,Update,2020-04-24 00:00:00,EMA,2020-05-23 22:13:35.057884,"['public-health', 'advice', 'covid-19', 'pandemic']","['EMA national competent authority remind patient suspect confirm COVID-19 report suspect side effect experience medicine , include medicine take treat COVID-19 pre-existing condition .', 'Healthcare professional treat COVID-19 patient also report suspect side effect patient experience .', 'These report help regulator understand medicine act patient COVID-19 , complement knowledge generate clinical trial study .']","['ema', 'national', 'competent', 'authority', 'remind', 'patient', 'suspect', 'confirm', 'covid-19', 'report', 'suspect', 'side', 'effect', 'experience', 'medicine', '', 'include', 'medicine', 'treat', 'covid-19', 'pre-existing', 'condition', '', 'healthcare', 'professional', 'treat', 'covid-19', 'patient', 'report', 'suspect', 'side', 'effect', 'patient', 'experience', '', 'report', 'help', 'regulator', 'understand', 'medicine', 'act', 'patient', 'covid-19', '', 'complement', 'knowledge', 'generate', 'clinical', 'trial', 'study', '']",51,"{'': 5, 'patient': 4, 'covid-19': 4, 'suspect': 3, 'report': 3, 'medicine': 3, 'side': 2, 'effect': 2, 'experience': 2, 'treat': 2, 'ema': 1, 'national': 1, 'competent': 1, 'authority': 1, 'remind': 1, 'confirm': 1, 'include': 1, 'pre-existing': 1, 'condition': 1, 'healthcare': 1}",{},0,0.6249
URL:emas-governance-during-covid-19-pandemic,,Update,2020-04-23 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']",['EMA announce essential work combat COVID-19 pandemic would continue Agency ’ closure 27 April 1 May 2020 .'],"['ema', 'announce', 'essential', 'work', 'combat', 'covid-19', 'pandemic', 'continue', 'agency', '', 'closure', '27', 'april', '1', '2020', '']",16,"{'': 2, 'ema': 1, 'announce': 1, 'essential': 1, 'work': 1, 'combat': 1, 'covid-19': 1, 'pandemic': 1, 'continue': 1, 'agency': 1, 'closure': 1, '27': 1, 'april': 1, '1': 1, '2020': 1}",{},0,-0.34
URL:public-health-advice-during-covid-19-pandemic,,Update,2020-04-23 00:00:00,EMA,2020-05-23 22:13:35.057884,"['public-health', 'advice', 'covid-19', 'pandemic']","['EMA remind patient healthcare professional chloroquine hydroxychloroquine medicine know potentially cause certain side effect , include heart rhythm problem .', 'Healthcare professional carefully consider possibility heart rhythm problem treat COVID-19 patient medicine , particularly patient pre-existing heart problem higher do , exercise extra caution combine treatment medicine azithromycin similar effect heart .']","['ema', 'remind', 'patient', 'healthcare', 'professional', 'hydroxychloroquine', 'hydroxychloroquine', 'medicine', 'potentially', 'cause', 'certain', 'side', 'effect', '', 'include', 'heart', 'rhythm', 'problem', '', 'healthcare', 'professional', 'carefully', 'consider', 'possibility', 'heart', 'rhythm', 'problem', 'treat', 'covid-19', 'patient', 'medicine', '', 'particularly', 'patient', 'pre-existing', 'heart', 'problem', 'higher', '', 'exercise', 'extra', 'caution', 'combine', 'treatment', 'medicine', 'azithromycin', 'similar', 'effect', 'heart', '']",50,"{'': 5, 'heart': 4, 'patient': 3, 'medicine': 3, 'problem': 3, 'healthcare': 2, 'professional': 2, 'hydroxychloroquine': 2, 'effect': 2, 'rhythm': 2, 'ema': 1, 'remind': 1, 'potentially': 1, 'cause': 1, 'certain': 1, 'side': 1, 'include': 1, 'carefully': 1, 'consider': 1, 'possibility': 1}",{'hydroxychloroquine': 2},2,-0.4215
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-04-21 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA participate global regulator ’ meet COVID-19-related policy approach regulatory flexibility Thursday , 16 April , umbrella International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'Participants discuss high-level policy issue regulatory challenge relate rapid development potential COVID-19 treatment vaccine continue availability medicine pandemic , particular use intensive care .', 'The meet first series bi-weekly meet organise ICMRA allow medicine regulator worldwide exchange information build synergy expedite COVID-19 medicine vaccine development approval avoid medicine shortage .', 'EMA chair every meet .']","['ema', 'participate', 'global', 'regulator', '', 'meet', 'covid-19-related', 'policy', 'approach', 'regulatory', 'flexibility', 'thursday', '', '16', 'april', '', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'participants', 'discuss', 'high-level', 'policy', 'issue', 'regulatory', 'challenge', 'relate', 'rapid', 'development', 'potential', 'covid-19', 'treatment', 'vaccine', 'continue', 'availability', 'medicine', 'pandemic', '', 'particular', 'intensive', 'care', '', 'meet', 'first', 'series', 'bi-weekly', 'meet', 'organise', 'icmra', 'allow', 'medicine', 'regulator', 'worldwide', 'exchange', 'information', 'build', 'synergy', 'expedite', 'covid-19', 'medicine', 'vaccine', 'development', 'approval', 'avoid', 'medicine', 'shortage', '', 'ema', 'chair', 'every', 'meet', '']",79,"{'': 10, 'meet': 4, 'medicine': 4, 'regulatory': 3, 'ema': 2, 'regulator': 2, 'policy': 2, 'icmra': 2, 'development': 2, 'covid-19': 2, 'vaccine': 2, 'participate': 1, 'global': 1, 'covid-19-related': 1, 'approach': 1, 'flexibility': 1, 'thursday': 1, '16': 1, 'april': 1, 'umbrella': 1}",{},0,0.7717
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-21 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA announce launch , together EU Member States pharmaceutical industry , enhance fast-track monitor system help prevent mitigate supply issue crucial medicine use treat COVID-19 patient .', 'Initially , system focus medicine use intensive care , greatest demand , extend broader range medicine .', 'The monitor system , involve pharmaceutical company appoint industry single point contact ( iSPOC ) , set EU Executive Steering Group Shortages Medicines Caused Major Events cooperation pharmaceutical company EU .']","['ema', 'announce', 'launch', '', 'together', 'eu', 'member', 'states', 'pharmaceutical', 'industry', '', 'enhance', 'fast-track', 'monitor', 'system', 'help', 'prevent', 'mitigate', 'supply', 'issue', 'crucial', 'medicine', 'treat', 'covid-19', 'patient', '', 'initially', '', 'system', 'focus', 'medicine', 'intensive', 'care', '', 'greatest', 'demand', '', 'extend', 'broader', 'range', 'medicine', '', 'monitor', 'system', '', 'involve', 'pharmaceutical', 'company', 'appoint', 'industry', 'single', 'point', 'contact', '', 'ispoc', '', '', 'set', 'eu', 'executive', 'steering', 'group', 'shortages', 'medicines', 'caused', 'major', 'events', 'cooperation', 'pharmaceutical', 'company', 'eu', '']",72,"{'': 12, 'eu': 3, 'pharmaceutical': 3, 'system': 3, 'medicine': 3, 'industry': 2, 'monitor': 2, 'company': 2, 'ema': 1, 'announce': 1, 'launch': 1, 'together': 1, 'member': 1, 'states': 1, 'enhance': 1, 'fast-track': 1, 'help': 1, 'prevent': 1, 'mitigate': 1, 'supply': 1}",{},0,0.91
URL:emas-governance-during-covid-19-pandemic,,Update,2020-04-21 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['EMA decide continue hold committee working-party meet virtually end May 2020 .', 'Stakeholder event plan May either postpone hold virtually .', 'Most EMA staff also continue work remotely end May .']","['ema', 'decide', 'continue', 'hold', 'committee', 'working-party', 'meet', 'virtually', 'end', '2020', '', 'stakeholder', 'event', 'plan', 'either', 'postpone', 'hold', 'virtually', '', 'ema', 'staff', 'continue', 'work', 'remotely', 'end', '']",26,"{'': 3, 'ema': 2, 'continue': 2, 'hold': 2, 'virtually': 2, 'end': 2, 'decide': 1, 'committee': 1, 'working-party': 1, 'meet': 1, '2020': 1, 'stakeholder': 1, 'event': 1, 'plan': 1, 'either': 1, 'postpone': 1, 'staff': 1, 'work': 1, 'remotely': 1}",{},0,-0.2263
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-04-20 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['The European Commission , EMA Heads Medicine Agencies update guidance pharmaceutical company adaptation regulatory framework address COVID-19 challenge cover good manufacture practice ( GMP ) good distribution practice ( GDP ) inspection , submission individual case safety report ( ICSRs ) EudraVigilance .', 'EMA publish additional guidance qualify person pharmcovigilance ( QPPV ) market authorisation holder submit COVID-19-related ICSRs EudraVigilance , include use correct Medical Dictionary Regulatory Activities ( MedDRA ) term free-text field .']","['european', 'commission', '', 'ema', 'heads', 'medicine', 'agencies', 'update', 'guidance', 'pharmaceutical', 'company', 'adaptation', 'regulatory', 'framework', 'address', 'covid-19', 'challenge', 'cover', 'manufacture', 'practice', '', 'gmp', '', 'distribution', 'practice', '', 'gdp', '', 'inspection', '', 'submission', 'individual', 'case', 'safety', 'report', '', 'icsrs', '', 'eudravigilance', '', 'ema', 'publish', 'additional', 'guidance', 'qualify', 'person', 'pharmcovigilance', '', 'qppv', '', 'market', 'authorisation', 'holder', 'submit', 'covid-19-related', 'icsrs', 'eudravigilance', '', 'include', 'correct', 'medical', 'dictionary', 'regulatory', 'activities', '', 'meddra', '', 'term', 'free-text', 'field', '']",71,"{'': 15, 'ema': 2, 'guidance': 2, 'regulatory': 2, 'practice': 2, 'icsrs': 2, 'eudravigilance': 2, 'european': 1, 'commission': 1, 'heads': 1, 'medicine': 1, 'agencies': 1, 'update': 1, 'pharmaceutical': 1, 'company': 1, 'adaptation': 1, 'framework': 1, 'address': 1, 'covid-19': 1, 'challenge': 1}",{'safety': 1},1,0.836
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-20 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA provide update measure EU authority put place support continue availability medicine pandemic , follow meet EU Executive Steering Group Shortages Medicines Caused Major Events .', 'The update cover progress make set enhance monitor system supply issue crucial medicine treatment COVID-19 plan update guidance pharmaceutical company adaptation regulatory framework address COVID-19-related challenge .']","['ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', '', 'follow', 'meet', 'eu', 'executive', 'steering', 'group', 'shortages', 'medicines', 'caused', 'major', 'events', '', 'update', 'cover', 'progress', 'set', 'enhance', 'monitor', 'system', 'supply', 'issue', 'crucial', 'medicine', 'treatment', 'covid-19', 'plan', 'update', 'guidance', 'pharmaceutical', 'company', 'adaptation', 'regulatory', 'framework', 'address', 'covid-19-related', 'challenge', '']",51,"{'update': 3, '': 3, 'eu': 2, 'medicine': 2, 'ema': 1, 'provide': 1, 'measure': 1, 'authority': 1, 'put': 1, 'place': 1, 'support': 1, 'continue': 1, 'availability': 1, 'pandemic': 1, 'follow': 1, 'meet': 1, 'executive': 1, 'steering': 1, 'group': 1, 'shortages': 1}",{},0,0.6705
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-04-16 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['The International Coalition Medicines Regulatory Authorities publish report summarise third global regulatory workshop use observational study real-world data generate robust evidence safety efficacy COVID-19 vaccine treatment .', 'The report provide snapshot ongoing plan observational study , platform registry various country region around world .', 'EMA co-chaired meet Health Canada .']","['international', 'coalition', 'medicines', 'regulatory', 'authorities', 'publish', 'report', 'summarise', 'third', 'global', 'regulatory', 'workshop', 'observational', 'study', 'real-world', 'data', 'generate', 'robust', 'evidence', 'safety', 'efficacy', 'covid-19', 'vaccine', 'treatment', '', 'report', 'provide', 'snapshot', 'ongoing', 'plan', 'observational', 'study', '', 'platform', 'registry', 'various', 'country', 'region', 'around', 'world', '', 'ema', 'co-chaired', 'meet', 'health', 'canada', '']",47,"{'': 4, 'regulatory': 2, 'report': 2, 'observational': 2, 'study': 2, 'international': 1, 'coalition': 1, 'medicines': 1, 'authorities': 1, 'publish': 1, 'summarise': 1, 'third': 1, 'global': 1, 'workshop': 1, 'real-world': 1, 'data': 1, 'generate': 1, 'robust': 1, 'evidence': 1, 'safety': 1}",{'safety': 1},1,0.6369
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-10 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA , European Commission European medicine regulatory network publish guidance company adaptation regulatory framework address challenge arise COVID-19 pandemic , particular focus crucial medicine use COVID-19 patient .']","['ema', '', 'european', 'commission', 'european', 'medicine', 'regulatory', 'network', 'publish', 'guidance', 'company', 'adaptation', 'regulatory', 'framework', 'address', 'challenge', 'arise', 'covid-19', 'pandemic', '', 'particular', 'focus', 'crucial', 'medicine', 'covid-19', 'patient', '']",27,"{'': 3, 'european': 2, 'medicine': 2, 'regulatory': 2, 'covid-19': 2, 'ema': 1, 'commission': 1, 'network': 1, 'publish': 1, 'guidance': 1, 'company': 1, 'adaptation': 1, 'framework': 1, 'address': 1, 'challenge': 1, 'arise': 1, 'pandemic': 1, 'particular': 1, 'focus': 1, 'crucial': 1}",{},0,0.0772
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-10 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA provide update measure EU authority put place support continue availability medicine pandemic .', 'This cover enhance monitor system supply issue crucial medicine treatment COVID-19 guidance currently development regulatory rule could apply greater flexibility help secure continue supply .']","['ema', 'provide', 'update', 'measure', 'eu', 'authority', 'put', 'place', 'support', 'continue', 'availability', 'medicine', 'pandemic', '', 'cover', 'enhance', 'monitor', 'system', 'supply', 'issue', 'crucial', 'medicine', 'treatment', 'covid-19', 'guidance', 'currently', 'development', 'regulatory', 'rule', 'apply', 'greater', 'flexibility', 'help', 'secure', 'continue', 'supply', '']",37,"{'continue': 2, 'medicine': 2, '': 2, 'supply': 2, 'ema': 1, 'provide': 1, 'update': 1, 'measure': 1, 'eu': 1, 'authority': 1, 'put': 1, 'place': 1, 'support': 1, 'availability': 1, 'pandemic': 1, 'cover': 1, 'enhance': 1, 'monitor': 1, 'system': 1, 'issue': 1}",{},0,0.9001
URL:emas-governance-during-covid-19-pandemic,,Update,2020-04-09 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['EMA publish mandate COVID-19 EMA pandemic Task Force ( COVID-ETF ) .', 'The Task Force help EU Member States European Commission take quick coordinate regulatory action development , authorisation safety monitor treatment vaccine intend treatment prevention COVID-19 .']","['ema', 'publish', 'mandate', 'covid-19', 'ema', 'pandemic', 'task', 'force', '', 'covid-etf', '', '', 'task', 'force', 'help', 'eu', 'member', 'states', 'european', 'commission', 'quick', 'coordinate', 'regulatory', 'action', 'development', '', 'authorisation', 'safety', 'monitor', 'treatment', 'vaccine', 'intend', 'treatment', 'prevention', 'covid-19', '']",36,"{'': 5, 'ema': 2, 'covid-19': 2, 'task': 2, 'force': 2, 'treatment': 2, 'publish': 1, 'mandate': 1, 'pandemic': 1, 'covid-etf': 1, 'help': 1, 'eu': 1, 'member': 1, 'states': 1, 'european': 1, 'commission': 1, 'quick': 1, 'coordinate': 1, 'regulatory': 1, 'action': 1}",{'safety': 1},1,0.6705
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-04-09 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['The International Coalition Medicines Regulatory Authorities publish report summarise second global regulatory workshop COVID-19 medicine development hold Thursday 2 April .', 'The report stress need robust evidence show potential treatment work .', 'EMA co-chaired meet .']","['international', 'coalition', 'medicines', 'regulatory', 'authorities', 'publish', 'report', 'summarise', 'second', 'global', 'regulatory', 'workshop', 'covid-19', 'medicine', 'development', 'hold', 'thursday', '2', 'april', '', 'report', 'stress', 'robust', 'evidence', 'show', 'potential', 'treatment', 'work', '', 'ema', 'co-chaired', 'meet', '']",33,"{'': 3, 'regulatory': 2, 'report': 2, 'international': 1, 'coalition': 1, 'medicines': 1, 'authorities': 1, 'publish': 1, 'summarise': 1, 'second': 1, 'global': 1, 'workshop': 1, 'covid-19': 1, 'medicine': 1, 'development': 1, 'hold': 1, 'thursday': 1, '2': 1, 'april': 1, 'stress': 1}",{},0,-0.1027
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-04-07 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA Health Canada jointly chair third global regulatory workshop Monday 6 April umbrella International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'The participant discuss data generate clinical practice treatment COVID-19 could complement evidence clinical trial potential COVID-19 treatment vaccine .']","['ema', 'health', 'canada', 'jointly', 'chair', 'third', 'global', 'regulatory', 'workshop', 'monday', '6', 'april', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'participant', 'discuss', 'data', 'generate', 'clinical', 'practice', 'treatment', 'covid-19', 'complement', 'evidence', 'clinical', 'trial', 'potential', 'covid-19', 'treatment', 'vaccine', '']",39,"{'': 4, 'regulatory': 2, 'clinical': 2, 'treatment': 2, 'covid-19': 2, 'ema': 1, 'health': 1, 'canada': 1, 'jointly': 1, 'chair': 1, 'third': 1, 'global': 1, 'workshop': 1, 'monday': 1, '6': 1, 'april': 1, 'umbrella': 1, 'international': 1, 'coalition': 1, 'medicines': 1}",{},0,0.0
URL:emas-governance-during-covid-19-pandemic,,Update,2020-04-07 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']",['EMA announce essential work combat COVID-19 pandemic would continue Agency ’ Easter break 9 13 April 2020 .'],"['ema', 'announce', 'essential', 'work', 'combat', 'covid-19', 'pandemic', 'continue', 'agency', '', 'easter', 'break', '9', '13', 'april', '2020', '']",17,"{'': 2, 'ema': 1, 'announce': 1, 'essential': 1, 'work': 1, 'combat': 1, 'covid-19': 1, 'pandemic': 1, 'continue': 1, 'agency': 1, 'easter': 1, 'break': 1, '9': 1, '13': 1, 'april': 1, '2020': 1}",{},0,-0.34
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-04-06 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['EMA announce new EU-level measure help prevent mitigate supply issue medicine use treat COVID-19 patient .', 'These include enhance coordination pharmaceutical industry monitor supply issue regulatory action support company increase available supply critical medicine .', ""During extraordinary health crisis , EMA act central EU coordinator , support Member States ' activity prevent mitigate supply issue .""]","['ema', 'announce', 'new', 'eu-level', 'measure', 'help', 'prevent', 'mitigate', 'supply', 'issue', 'medicine', 'treat', 'covid-19', 'patient', '', 'include', 'enhance', 'coordination', 'pharmaceutical', 'industry', 'monitor', 'supply', 'issue', 'regulatory', 'action', 'support', 'company', 'increase', 'available', 'supply', 'critical', 'medicine', '', 'extraordinary', 'health', 'crisis', '', 'ema', 'act', 'central', 'eu', 'coordinator', '', 'support', 'member', 'states', '', 'activity', 'prevent', 'mitigate', 'supply', 'issue', '']",53,"{'': 6, 'supply': 4, 'issue': 3, 'ema': 2, 'prevent': 2, 'mitigate': 2, 'medicine': 2, 'support': 2, 'announce': 1, 'new': 1, 'eu-level': 1, 'measure': 1, 'help': 1, 'treat': 1, 'covid-19': 1, 'patient': 1, 'include': 1, 'enhance': 1, 'coordination': 1, 'pharmaceutical': 1}",{},0,0.7096
URL:treatments-vaccines-covid-19,,Update,2020-04-03 00:00:00,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']","['EMA ’ human medicine committee ( CHMP ) give recommendation investigational antiviral medicine remdesivir use compassionate use programme across Europe treat COVID-19 patient eligible inclusion clinical trial .', 'These recommendation aim ensure harmonise approach across EU Member States .', 'They also explain group patient may benefit treatment provide preliminary information medicine ’ safety .']","['ema', '', 'human', 'medicine', 'committee', '', 'chmp', '', 'give', 'recommendation', 'investigational', 'antiviral', 'medicine', 'remdesivir', 'compassionate', 'programme', 'across', 'europe', 'treat', 'covid-19', 'patient', 'eligible', 'inclusion', 'clinical', 'trial', '', 'recommendation', 'aim', 'ensure', 'harmonise', 'approach', 'across', 'eu', 'member', 'states', '', 'explain', 'group', 'patient', 'benefit', 'treatment', 'provide', 'preliminary', 'information', 'medicine', '', 'safety', '']",48,"{'': 7, 'medicine': 3, 'recommendation': 2, 'across': 2, 'patient': 2, 'ema': 1, 'human': 1, 'committee': 1, 'chmp': 1, 'give': 1, 'investigational': 1, 'antiviral': 1, 'remdesivir': 1, 'compassionate': 1, 'programme': 1, 'europe': 1, 'treat': 1, 'covid-19': 1, 'eligible': 1, 'inclusion': 1}",{'safety': 1},1,0.9442
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-04-03 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['EMA Japanese Pharmaceuticals Medical Devices Agency ( PMDA ) jointly chair second global regulatory workshop Thursday 2 April umbrella International Coalition Medicines Regulatory Authorities ( ICMRA ) .', 'The participant discuss progress make development potential COVID-19 treatment reaffirm need large clinical trial generate conclusive evidence treatment work .', 'ICMRA publish summary report meet shortly .']","['ema', 'japanese', 'pharmaceuticals', 'medical', 'devices', 'agency', '', 'pmda', '', 'jointly', 'chair', 'second', 'global', 'regulatory', 'workshop', 'thursday', '2', 'april', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '', '', 'participant', 'discuss', 'progress', 'development', 'potential', 'covid-19', 'treatment', 'reaffirm', 'large', 'clinical', 'trial', 'generate', 'conclusive', 'evidence', 'treatment', 'work', '', 'icmra', 'publish', 'summary', 'report', 'meet', 'shortly', '']",52,"{'': 7, 'regulatory': 2, 'icmra': 2, 'treatment': 2, 'ema': 1, 'japanese': 1, 'pharmaceuticals': 1, 'medical': 1, 'devices': 1, 'agency': 1, 'pmda': 1, 'jointly': 1, 'chair': 1, 'second': 1, 'global': 1, 'workshop': 1, 'thursday': 1, '2': 1, 'april': 1, 'umbrella': 1}",{},0,0.4215
URL:public-health-advice-during-covid-19-pandemic,,Update,2020-04-01 00:00:00,EMA,2020-05-23 22:13:35.057884,"['public-health', 'advice', 'covid-19', 'pandemic']","['EMA advise patient healthcare professional use chloroquine hydroxychloroquine medicine authorise indication part clinical trial national emergency use programme treatment COVID-19 .', 'This ensure patient safety best use available supply .']","['ema', 'advise', 'patient', 'healthcare', 'professional', 'hydroxychloroquine', 'hydroxychloroquine', 'medicine', 'authorise', 'indication', 'part', 'clinical', 'trial', 'national', 'emergency', 'programme', 'treatment', 'covid-19', '', 'ensure', 'patient', 'safety', 'best', 'available', 'supply', '']",26,"{'patient': 2, 'hydroxychloroquine': 2, '': 2, 'ema': 1, 'advise': 1, 'healthcare': 1, 'professional': 1, 'medicine': 1, 'authorise': 1, 'indication': 1, 'part': 1, 'clinical': 1, 'trial': 1, 'national': 1, 'emergency': 1, 'programme': 1, 'treatment': 1, 'covid-19': 1, 'ensure': 1, 'safety': 1}","{'hydroxychloroquine': 2, 'safety': 1}",3,0.7906
URL:treatments-vaccines-covid-19,,Update,,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']","['EMA announce hold discussion developer around 40 potential treatment dozen vaccine COVID-19 .', 'No potential COVID-19 treatment demonstrate efficacy base preliminary data available .', 'EMA welcome launch large clinical trial test promise treatment generate conclusive evidence .', 'Two vaccine already enter phase I clinical trial .', 'EMA estimate might take least year vaccine ready approval available sufficient quantity enable widespread use .']","['ema', 'announce', 'hold', 'discussion', 'developer', 'around', '40', 'potential', 'treatment', 'dozen', 'vaccine', 'covid-19', '', 'potential', 'covid-19', 'treatment', 'demonstrate', 'efficacy', 'base', 'preliminary', 'data', 'available', '', 'ema', 'welcome', 'launch', 'large', 'clinical', 'trial', 'test', 'promise', 'treatment', 'generate', 'conclusive', 'evidence', '', 'two', 'vaccine', 'already', 'enter', 'phase', 'clinical', 'trial', '', 'ema', 'estimate', 'least', 'year', 'vaccine', 'ready', 'approval', 'available', 'sufficient', 'quantity', 'enable', 'widespread', '']",57,"{'': 5, 'ema': 3, 'treatment': 3, 'vaccine': 3, 'potential': 2, 'covid-19': 2, 'available': 2, 'clinical': 2, 'trial': 2, 'announce': 1, 'hold': 1, 'discussion': 1, 'developer': 1, 'around': 1, '40': 1, 'dozen': 1, 'demonstrate': 1, 'efficacy': 1, 'base': 1, 'preliminary': 1}",{},0,0.4767
URL:certification-medicinal-products,,Update,2020-03-30 00:00:00,EMA,2020-05-23 22:13:35.057884,"['certification', 'medicinal', 'product']","['EMA start issue certificate sign authenticate electronically place paper certificate .', 'This apply ongoing future request certificate COVID-19 pandemic .']","['ema', 'start', 'issue', 'certificate', 'sign', 'authenticate', 'electronically', 'place', 'paper', 'certificate', '', 'apply', 'ongoing', 'future', 'request', 'certificate', 'covid-19', 'pandemic', '']",19,"{'certificate': 3, '': 2, 'ema': 1, 'start': 1, 'issue': 1, 'sign': 1, 'authenticate': 1, 'electronically': 1, 'place': 1, 'paper': 1, 'apply': 1, 'ongoing': 1, 'future': 1, 'request': 1, 'covid-19': 1, 'pandemic': 1}",{},0,0.0
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-03-27 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA , European Commission Heads Medicines Agencies update Guidance management clinical trial COVID-19 ( coronavirus ) pandemic cover safety report , distribution in-vitro diagnostics , medical device audit .', 'The update guidance also incorporate change section , particular communicate authority , inform consent distribution investigational medicine .']","['ema', '', 'european', 'commission', 'heads', 'medicines', 'agencies', 'update', 'guidance', 'management', 'clinical', 'trial', 'covid-19', '', 'coronavirus', '', 'pandemic', 'cover', 'safety', 'report', '', 'distribution', 'in-vitro', 'diagnostics', '', 'medical', 'device', 'audit', '', 'update', 'guidance', 'incorporate', 'change', 'section', '', 'particular', 'communicate', 'authority', '', 'inform', 'consent', 'distribution', 'investigational', 'medicine', '']",45,"{'': 9, 'update': 2, 'guidance': 2, 'distribution': 2, 'ema': 1, 'european': 1, 'commission': 1, 'heads': 1, 'medicines': 1, 'agencies': 1, 'management': 1, 'clinical': 1, 'trial': 1, 'covid-19': 1, 'coronavirus': 1, 'pandemic': 1, 'cover': 1, 'safety': 1, 'report': 1, 'in-vitro': 1}",{'safety': 1},1,0.6124
URL:public-health-advice-during-covid-19-pandemic,,Update,2020-03-27 00:00:00,EMA,2020-05-23 22:13:35.057884,"['public-health', 'advice', 'covid-19', 'pandemic']","['EMA advise patient healthcare professional angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARBs , sartan medicine ) continue use treat high blood pressure , heart failure kidney disease COVID-19 pandemic .', 'There currently evidence clinical epidemiological study establish link medicine worsen COVID-19 .', 'Patients take medicine interrupt treatment without speak doctor pharmacist first .', 'EMA keep information new COVID-19-related treatment recommendation date .']","['ema', 'advise', 'patient', 'healthcare', 'professional', 'angiotensin', 'convert', 'enzyme', '', 'ace', '', 'inhibitor', 'angiotensin', 'receptor', 'blocker', '', 'arbs', '', 'sartan', 'medicine', '', 'continue', 'treat', 'high', 'blood', 'pressure', '', 'heart', 'failure', 'kidney', 'disease', 'covid-19', 'pandemic', '', 'currently', 'evidence', 'clinical', 'epidemiological', 'study', 'establish', 'link', 'medicine', 'worsen', 'covid-19', '', 'patients', 'medicine', 'interrupt', 'treatment', 'without', 'speak', 'doctor', 'pharmacist', 'first', '', 'ema', 'keep', 'information', 'new', 'covid-19-related', 'treatment', 'recommendation', 'date', '']",64,"{'': 10, 'medicine': 3, 'ema': 2, 'angiotensin': 2, 'covid-19': 2, 'treatment': 2, 'advise': 1, 'patient': 1, 'healthcare': 1, 'professional': 1, 'convert': 1, 'enzyme': 1, 'ace': 1, 'inhibitor': 1, 'receptor': 1, 'blocker': 1, 'arbs': 1, 'sartan': 1, 'continue': 1, 'treat': 1}",{},0,-0.8316
URL:treatments-vaccines-covid-19,,Update,2020-03-27 00:00:00,EMA,2020-05-23 22:13:35.057884,"['treatments', 'vaccine', 'covid-19']","['EMA European Network Centres Pharmacoepidemiology Pharmacovigilance ( ENCePP ) encourage researcher register pharmacoepidemiological study relate COVID-19 pandemic EU PAS Register .', 'They also upload make study protocol public , description data collect plan collect .', 'This facilitate collaboration speed design observational study others .', 'Researchers include ‘ COVID-19 ’ study title allow easy retrieval COVID-19-related study via ‘ Title Study ’ search filter .']","['ema', 'european', 'network', 'centres', 'pharmacoepidemiology', 'pharmacovigilance', '', 'encepp', '', 'encourage', 'researcher', 'register', 'pharmacoepidemiological', 'study', 'relate', 'covid-19', 'pandemic', 'eu', 'pas', 'register', '', 'upload', 'study', 'protocol', 'public', '', 'description', 'data', 'collect', 'plan', 'collect', '', 'facilitate', 'collaboration', 'speed', 'design', 'observational', 'study', 'others', '', 'researchers', 'include', '', 'covid-19', '', 'study', 'title', 'allow', 'retrieval', 'covid-19-related', 'study', 'via', '', 'title', 'study', '', 'search', 'filter', '']",59,"{'': 11, 'study': 6, 'register': 2, 'covid-19': 2, 'collect': 2, 'title': 2, 'ema': 1, 'european': 1, 'network': 1, 'centres': 1, 'pharmacoepidemiology': 1, 'pharmacovigilance': 1, 'encepp': 1, 'encourage': 1, 'researcher': 1, 'pharmacoepidemiological': 1, 'relate': 1, 'pandemic': 1, 'eu': 1, 'pas': 1}",{},0,0.5106
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-03-25 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA publish guidance action sponsor ongoing clinical trial affect COVID-19 pandemic take help ensure integrity study interpretation study result safeguard safety trial participant first priority .', 'This complement good clinical practice guidance sponsor adjust management clinical trial participant pandemic .']","['ema', 'publish', 'guidance', 'action', 'sponsor', 'ongoing', 'clinical', 'trial', 'affect', 'covid-19', 'pandemic', 'help', 'ensure', 'integrity', 'study', 'interpretation', 'study', 'result', 'safeguard', 'safety', 'trial', 'participant', 'first', 'priority', '', 'complement', 'clinical', 'practice', 'guidance', 'sponsor', 'adjust', 'management', 'clinical', 'trial', 'participant', 'pandemic', '']",37,"{'clinical': 3, 'trial': 3, 'guidance': 2, 'sponsor': 2, 'pandemic': 2, 'study': 2, 'participant': 2, '': 2, 'ema': 1, 'publish': 1, 'action': 1, 'ongoing': 1, 'affect': 1, 'covid-19': 1, 'help': 1, 'ensure': 1, 'integrity': 1, 'interpretation': 1, 'result': 1, 'safeguard': 1}",{'safety': 1},1,0.9349
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-03-24 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['The International Coalition Medicines Regulatory Authorities publish summary report first global regulatory workshop COVID-19 vaccine development co-chaired EMA .', 'The report focus pre-clinical data requirement theoretical risk vaccine COVID-19 enhance disease prior start first-in-human clinical trial .']","['international', 'coalition', 'medicines', 'regulatory', 'authorities', 'publish', 'summary', 'report', 'first', 'global', 'regulatory', 'workshop', 'covid-19', 'vaccine', 'development', 'co-chaired', 'ema', '', 'report', 'focus', 'pre-clinical', 'data', 'requirement', 'theoretical', 'risk', 'vaccine', 'covid-19', 'enhance', 'disease', 'prior', 'start', 'first-in-human', 'clinical', 'trial', '']",35,"{'regulatory': 2, 'report': 2, 'covid-19': 2, 'vaccine': 2, '': 2, 'international': 1, 'coalition': 1, 'medicines': 1, 'authorities': 1, 'publish': 1, 'summary': 1, 'first': 1, 'global': 1, 'workshop': 1, 'development': 1, 'co-chaired': 1, 'ema': 1, 'focus': 1, 'pre-clinical': 1, 'data': 1}",{},0,-0.2732
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-03-24 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['Some Member States experience medicine shortage due increase demand medicine .', 'This either medicine use treat COVID-19 patient patient request usual supply .', 'In order prevent unnecessary strain supply chain , patient receive usual supply medicine .', ""For information ongoing medicine shortage EU , patient healthcare professional check relevant national shortage register EMA's shortage catalogue .""]","['member', 'states', 'experience', 'medicine', 'shortage', 'due', 'increase', 'demand', 'medicine', '', 'either', 'medicine', 'treat', 'covid-19', 'patient', 'patient', 'request', 'usual', 'supply', '', 'order', 'prevent', 'unnecessary', 'strain', 'supply', 'chain', '', 'patient', 'receive', 'usual', 'supply', 'medicine', '', 'information', 'ongoing', 'medicine', 'shortage', 'eu', '', 'patient', 'healthcare', 'professional', 'check', 'relevant', 'national', 'shortage', 'register', 'emas', 'shortage', 'catalogue', '']",51,"{'': 6, 'medicine': 5, 'shortage': 4, 'patient': 4, 'supply': 3, 'usual': 2, 'member': 1, 'states': 1, 'experience': 1, 'due': 1, 'increase': 1, 'demand': 1, 'either': 1, 'treat': 1, 'covid-19': 1, 'request': 1, 'order': 1, 'prevent': 1, 'unnecessary': 1, 'strain': 1}",{},0,0.34
URL:buying-medicines-online,,Update,2020-03-24 00:00:00,EMA,2020-05-23 22:13:35.057884,"['buying', 'medicine', 'online']","['EMA urge patient beware potential falsify medicine sell unregistered website vendor .', 'These vendor may exploit fear COVID-19 pandemic claim product prevent cure COVID-19 .', 'They may also appear provide easy access medicine otherwise readily available .', 'Patients stay safe buy medicine online follow EU advice .']","['ema', 'urge', 'patient', 'beware', 'potential', 'falsify', 'medicine', 'sell', 'unregistered', 'website', 'vendor', '', 'vendor', 'exploit', 'fear', 'covid-19', 'pandemic', 'claim', 'product', 'prevent', 'cure', 'covid-19', '', 'appear', 'provide', 'access', 'medicine', 'otherwise', 'readily', 'available', '', 'patients', 'stay', 'safe', 'buy', 'medicine', 'online', 'follow', 'eu', 'advice', '']",41,"{'': 4, 'medicine': 3, 'vendor': 2, 'covid-19': 2, 'ema': 1, 'urge': 1, 'patient': 1, 'beware': 1, 'potential': 1, 'falsify': 1, 'sell': 1, 'unregistered': 1, 'website': 1, 'exploit': 1, 'fear': 1, 'pandemic': 1, 'claim': 1, 'product': 1, 'prevent': 1, 'cure': 1}",{},0,-0.5574
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-03-20 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['The European Commission , EMA Head Medicines Agencies provide guidance sponsor adjust management clinical trial participant COVID-19 pandemic .', 'It cover deal extraordinary situation pandemic present include specific advice clinical trial COVID-19 treatment .']","['european', 'commission', '', 'ema', 'head', 'medicines', 'agencies', 'provide', 'guidance', 'sponsor', 'adjust', 'management', 'clinical', 'trial', 'participant', 'covid-19', 'pandemic', '', 'cover', 'deal', 'extraordinary', 'situation', 'pandemic', 'present', 'include', 'specific', 'advice', 'clinical', 'trial', 'covid-19', 'treatment', '']",32,"{'': 3, 'clinical': 2, 'trial': 2, 'covid-19': 2, 'pandemic': 2, 'european': 1, 'commission': 1, 'ema': 1, 'head': 1, 'medicines': 1, 'agencies': 1, 'provide': 1, 'guidance': 1, 'sponsor': 1, 'adjust': 1, 'management': 1, 'participant': 1, 'cover': 1, 'deal': 1, 'extraordinary': 1}",{},0,0.0
URL:emas-governance-during-covid-19-pandemic,,Update,2020-03-20 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']",['EMA ’ first Management Board meet 2020 take place virtually reduce one half hour allow EMA Member States continue focus resource response pandemic .'],"['ema', '', 'first', 'management', 'board', 'meet', '2020', 'place', 'virtually', 'reduce', 'one', 'half', 'hour', 'allow', 'ema', 'member', 'states', 'continue', 'focus', 'resource', 'response', 'pandemic', '']",23,"{'ema': 2, '': 2, 'first': 1, 'management': 1, 'board': 1, 'meet': 1, '2020': 1, 'place': 1, 'virtually': 1, 'reduce': 1, 'one': 1, 'half': 1, 'hour': 1, 'allow': 1, 'member': 1, 'states': 1, 'continue': 1, 'focus': 1, 'resource': 1, 'response': 1}",{},0,0.2263
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-03-19 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","[""EMA 's Committee Medicinal Products Human Use ( CHMP ) urge EU research community prioritise large randomise control clinical study likely generate conclusive evidence need enable rapid development approval potential COVID-19 treatment ."", 'They also emphasise need include EU country trial .', 'EMA currently engage stakeholder support conduct clinical trial across Europe .']","['ema', 'committee', 'medicinal', 'products', 'human', '', 'chmp', '', 'urge', 'eu', 'research', 'community', 'prioritise', 'large', 'randomise', 'control', 'clinical', 'study', 'likely', 'generate', 'conclusive', 'evidence', 'enable', 'rapid', 'development', 'approval', 'potential', 'covid-19', 'treatment', '', 'emphasise', 'include', 'eu', 'country', 'trial', '', 'ema', 'currently', 'engage', 'stakeholder', 'support', 'conduct', 'clinical', 'trial', 'across', 'europe', '']",47,"{'': 5, 'ema': 2, 'eu': 2, 'clinical': 2, 'trial': 2, 'committee': 1, 'medicinal': 1, 'products': 1, 'human': 1, 'chmp': 1, 'urge': 1, 'research': 1, 'community': 1, 'prioritise': 1, 'large': 1, 'randomise': 1, 'control': 1, 'study': 1, 'likely': 1, 'generate': 1}",{},0,0.802
URL:international-coalition-medicines-regulatory-authorities-icmra,,Update,2020-03-18 00:00:00,EMA,2020-05-23 22:13:35.057884,"['international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'icmra', '']","['The first global regulatory workshop COVID-19 convene umbrella International Coalition Medicines Regulatory Authorities .', 'Co-chaired EMA US Food Drug Administration , bring together delegate 17 country expert World Health Organization European Commission discus development vaccine COVID-19 .']","['first', 'global', 'regulatory', 'workshop', 'covid-19', 'convene', 'umbrella', 'international', 'coalition', 'medicines', 'regulatory', 'authorities', '', 'co-chaired', 'ema', 'us', 'food', 'drug', 'administration', '', 'bring', 'together', 'delegate', '17', 'country', 'expert', 'world', 'health', 'organization', 'european', 'commission', 'discus', 'development', 'vaccine', 'covid-19', '']",36,"{'': 3, 'regulatory': 2, 'covid-19': 2, 'first': 1, 'global': 1, 'workshop': 1, 'convene': 1, 'umbrella': 1, 'international': 1, 'coalition': 1, 'medicines': 1, 'authorities': 1, 'co-chaired': 1, 'ema': 1, 'us': 1, 'food': 1, 'drug': 1, 'administration': 1, 'bring': 1, 'together': 1}",{},0,0.0
URL:public-health-advice-during-covid-19-pandemic,,Update,2020-03-18 00:00:00,EMA,2020-05-23 22:13:35.057884,"['public-health', 'advice', 'covid-19', 'pandemic']","['EMA advise patient healthcare professional currently scientific evidence establish link ibuprofen worsen COVID 19 .', 'However , EMA call study , ready support .', 'Patients healthcare professional consider available option treat coronavirus symptom , include paracetamol NSAIDs , line product information national guideline .']","['ema', 'advise', 'patient', 'healthcare', 'professional', 'currently', 'scientific', 'evidence', 'establish', 'link', 'ibuprofen', 'worsen', 'covid', '19', '', 'however', '', 'ema', 'call', 'study', '', 'ready', 'support', '', 'patients', 'healthcare', 'professional', 'consider', 'available', 'option', 'treat', 'coronavirus', 'symptom', '', 'include', 'paracetamol', 'nsaids', '', 'product', 'information', 'national', 'guideline', '']",43,"{'': 7, 'ema': 2, 'healthcare': 2, 'professional': 2, 'advise': 1, 'patient': 1, 'currently': 1, 'scientific': 1, 'evidence': 1, 'establish': 1, 'link': 1, 'ibuprofen': 1, 'worsen': 1, 'covid': 1, '19': 1, 'however': 1, 'call': 1, 'study': 1, 'ready': 1, 'support': 1}",{},0,0.5574
URL:emas-governance-during-covid-19-pandemic,,Update,2020-03-18 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","[""EMA announce participate observer European Commission 's advisory panel COVID-19 ."", 'Chaired Commission President Ursula von der Leyen co-chaired Stella Kyriakides , Commissioner Health Food Safety , panel European scientific expert formulate EU guideline science-based coordinate risk-management measure .']","['ema', 'announce', 'participate', 'observer', 'european', 'commission', 'advisory', 'panel', 'covid-19', '', 'chaired', 'commission', 'president', 'ursula', 'von', 'der', 'leyen', 'co-chaired', 'stella', 'kyriakides', '', 'commissioner', 'health', 'food', 'safety', '', 'panel', 'european', 'scientific', 'expert', 'formulate', 'eu', 'guideline', 'science-based', 'coordinate', 'risk-management', 'measure', '']",38,"{'': 4, 'european': 2, 'commission': 2, 'panel': 2, 'ema': 1, 'announce': 1, 'participate': 1, 'observer': 1, 'advisory': 1, 'covid-19': 1, 'chaired': 1, 'president': 1, 'ursula': 1, 'von': 1, 'der': 1, 'leyen': 1, 'co-chaired': 1, 'stella': 1, 'kyriakides': 1, 'commissioner': 1}",{'safety': 1},1,0.4215
URL:emas-governance-during-covid-19-pandemic,,Update,2020-03-17 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['As 16 March 2020 , EMA staff work remotely .', 'This expect last end April 2020 .']","['16', 'march', '2020', '', 'ema', 'staff', 'work', 'remotely', '', 'expect', 'last', 'end', 'april', '2020', '']",15,"{'': 3, '2020': 2, '16': 1, 'march': 1, 'ema': 1, 'staff': 1, 'work': 1, 'remotely': 1, 'expect': 1, 'last': 1, 'end': 1, 'april': 1}",{},0,0.0
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-03-13 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","['EMA provide full fee waiver scientific advice potential vaccine treatment COVID-19 .', 'Developers potential therapeutic vaccine COVID-19 invite contact Agency soon possible information propose development , email 2019-ncov @ ema.europa.eu .']","['ema', 'provide', 'full', 'fee', 'waiver', 'scientific', 'advice', 'potential', 'vaccine', 'treatment', 'covid-19', '', 'developers', 'potential', 'therapeutic', 'vaccine', 'covid-19', 'invite', 'contact', 'agency', 'soon', 'possible', 'information', 'propose', 'development', '', 'email', '2019-ncov', '', 'emaeuropaeu', '']",31,"{'': 4, 'potential': 2, 'vaccine': 2, 'covid-19': 2, 'ema': 1, 'provide': 1, 'full': 1, 'fee': 1, 'waiver': 1, 'scientific': 1, 'advice': 1, 'treatment': 1, 'developers': 1, 'therapeutic': 1, 'invite': 1, 'contact': 1, 'agency': 1, 'soon': 1, 'possible': 1, 'information': 1}",{},0,0.1531
URL:emas-governance-during-covid-19-pandemic,,Update,2020-03-11 00:00:00,EMA,2020-05-23 22:13:35.057884,"['ema', '', 'governance', 'covid-19', 'pandemic']","['EMA announce hold committee work party meet virtually end April 2020 .', 'Other EMA-hosted stakeholder event either hold virtually postpone later 2020 .', 'EMA also initiate business continuity plan effective management COVID-19 crisis .', 'These measure impact EMA ’ core activity .']","['ema', 'announce', 'hold', 'committee', 'work', 'party', 'meet', 'virtually', 'end', 'april', '2020', '', 'ema-hosted', 'stakeholder', 'event', 'either', 'hold', 'virtually', 'postpone', 'later', '2020', '', 'ema', 'initiate', 'business', 'continuity', 'plan', 'effective', 'management', 'covid-19', 'crisis', '', 'measure', 'impact', 'ema', '', 'core', 'activity', '']",39,"{'': 5, 'ema': 3, 'hold': 2, 'virtually': 2, '2020': 2, 'announce': 1, 'committee': 1, 'work': 1, 'party': 1, 'meet': 1, 'end': 1, 'april': 1, 'ema-hosted': 1, 'stakeholder': 1, 'event': 1, 'either': 1, 'postpone': 1, 'later': 1, 'initiate': 1, 'business': 1}",{},0,-0.0516
URL:availability-medicines-during-covid-19-pandemic,,Update,2020-03-10 00:00:00,EMA,2020-05-23 22:13:35.057884,"['availability', 'medicine', 'covid-19', 'pandemic']","['The European medicine regulatory network take measure monitor potential impact outbreak COVID-19 human veterinary medicine supply chain EU .', 'This include work pharmaceutical industry association , company manufacturer EU ass resilience supply chain .']","['european', 'medicine', 'regulatory', 'network', 'measure', 'monitor', 'potential', 'impact', 'outbreak', 'covid-19', 'human', 'veterinary', 'medicine', 'supply', 'chain', 'eu', '', 'include', 'work', 'pharmaceutical', 'industry', 'association', '', 'company', 'manufacturer', 'eu', 'ass', 'resilience', 'supply', 'chain', '']",31,"{'': 3, 'medicine': 2, 'supply': 2, 'chain': 2, 'eu': 2, 'european': 1, 'regulatory': 1, 'network': 1, 'measure': 1, 'monitor': 1, 'potential': 1, 'impact': 1, 'outbreak': 1, 'covid-19': 1, 'human': 1, 'veterinary': 1, 'include': 1, 'work': 1, 'pharmaceutical': 1, 'industry': 1}",{},0,-0.5423
URL:guidance-medicine-developers-companies-covid-19,,Update,2020-02-04 00:00:00,EMA,2020-05-23 22:13:35.057884,"['guidance', 'medicine', 'developer', 'company', 'covid-19']","[""EMA encourage developer potential vaccine treatment novel coronavirus disease ( COVID-19 ) make use Agency's regulatory mechanism speed development approval contact EMA soon possible discus strategy evidence-generation , email 2019-ncov @ ema.europa.eu ."", 'EMA activate plan manage emerge health threat .']","['ema', 'encourage', 'developer', 'potential', 'vaccine', 'treatment', 'novel', 'coronavirus', 'disease', '', 'covid-19', '', 'agencys', 'regulatory', 'mechanism', 'speed', 'development', 'approval', 'contact', 'ema', 'soon', 'possible', 'discus', 'strategy', 'evidence-generation', '', 'email', '2019-ncov', '', 'emaeuropaeu', '', 'ema', 'activate', 'plan', 'manage', 'emerge', 'health', 'threat', '']",39,"{'': 6, 'ema': 3, 'encourage': 1, 'developer': 1, 'potential': 1, 'vaccine': 1, 'treatment': 1, 'novel': 1, 'coronavirus': 1, 'disease': 1, 'covid-19': 1, 'agencys': 1, 'regulatory': 1, 'mechanism': 1, 'speed': 1, 'development': 1, 'approval': 1, 'contact': 1, 'soon': 1, 'possible': 1}",{},0,0.6486
DOI:10.1016/S0140-6736(20)31180-6,10.1016/S0140-6736(20)31180-6,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['hydroxychloroquine', 'hydroxychloroquine', 'without', 'macrolide', 'treatment', 'covid-19', '', 'multinational', 'registry', 'analysis']","['BackgroundHydroxychloroquine chloroquine , often combination second-generation macrolide , widely use treatment COVID-19 , despite conclusive evidence benefit .', 'Although generally safe use approve indication autoimmune disease malaria , safety benefit treatment regimen poorly evaluate COVID-19.MethodsWe multinational registry analysis use hydroxychloroquine chloroquine without macrolide treatment COVID-19 .', 'The registry comprise data 671 hospital six continent .', 'We include patient hospitalise Dec 20 , 2019 , April 14 , 2020 , positive laboratory find SARS-CoV-2 .', 'Patients receive one treatment interest within 48 h diagnosis include one four treatment group ( chloroquine alone , chloroquine macrolide , hydroxychloroquine alone , hydroxychloroquine macrolide ) , patient receive none treatment form control group .', 'Patients one treatment interest initiate 48 h diagnosis mechanical ventilation , well patient receive remdesivir , exclude .', 'The main outcome interest in-hospital mortality occurrence de-novo ventricular arrhythmia ( non-sustained sustain ventricular tachycardia ventricular fibrillation ) .Findings96 032 patient ( mean age 53·8 year , 46·3 % woman ) COVID-19 hospitalise study period meet inclusion criterion .', 'Of , 14 888 patient treatment group ( 1868 receive chloroquine , 3783 receive chloroquine macrolide , 3016 receive hydroxychloroquine , 6221 receive hydroxychloroquine macrolide ) 81 144 patient control group .', '10 698 ( 11·1 % ) patient die hospital .', 'After control multiple confound factor ( age , sex , race ethnicity , body-mass index , underlie cardiovascular disease risk factor , diabetes , underlie lung disease , smoke , immunosuppressed condition , baseline disease severity ) , compare mortality control group ( 9·3 % ) , hydroxychloroquine ( 18·0 % ; hazard ratio 1·335 , 95 % CI 1·223–1·457 ) , hydroxychloroquine macrolide ( 23·8 % ; 1·447 , 1·368–1·531 ) , chloroquine ( 16·4 % ; 1·365 , 1·218–1·531 ) , chloroquine macrolide ( 22·2 % ; 1·368 , 1·273–1·469 ) independently associate increase risk in-hospital mortality .', 'Compared control group ( 0·3 % ) , hydroxychloroquine ( 6·1 % ; 2·369 , 1·935–2·900 ) , hydroxychloroquine macrolide ( 8·1 % ; 5·106 , 4·106–5·983 ) , chloroquine ( 4·3 % ; 3·561 , 2·760–4·596 ) , chloroquine macrolide ( 6·5 % ; 4·011 , 3·344–4·812 ) independently associate increase risk de-novo ventricular arrhythmia hospitalisation.InterpretationWe unable confirm benefit hydroxychloroquine chloroquine , use alone macrolide , in-hospital outcome COVID-19 .', ""Each drug regimen associate decrease in-hospital survival increase frequency ventricular arrhythmia use treatment COVID-19.FundingWilliam Harvey Distinguished Chair Advanced Cardiovascular Medicine Brigham Women 's Hospital ."", 'Hydroxychloroquine chloroquine , often combination second-generation macrolide , widely use treatment COVID-19 , despite conclusive evidence benefit .', 'Although generally safe use approve indication autoimmune disease malaria , safety benefit treatment regimen poorly evaluate COVID-19 .', 'We multinational registry analysis use hydroxychloroquine chloroquine without macrolide treatment COVID-19 .', 'The registry comprise data 671 hospital six continent .', 'We include patient hospitalise Dec 20 , 2019 , April 14 , 2020 , positive laboratory find SARS-CoV-2 .', 'Patients receive one treatment interest within 48 h diagnosis include one four treatment group ( chloroquine alone , chloroquine macrolide , hydroxychloroquine alone , hydroxychloroquine macrolide ) , patient receive none treatment form control group .', 'Patients one treatment interest initiate 48 h diagnosis mechanical ventilation , well patient receive remdesivir , exclude .', 'The main outcome interest in-hospital mortality occurrence de-novo ventricular arrhythmia ( non-sustained sustain ventricular tachycardia ventricular fibrillation ) .', '96 032 patient ( mean age 53·8 year , 46·3 % woman ) COVID-19 hospitalise study period meet inclusion criterion .', 'Of , 14 888 patient treatment group ( 1868 receive chloroquine , 3783 receive chloroquine macrolide , 3016 receive hydroxychloroquine , 6221 receive hydroxychloroquine macrolide ) 81 144 patient control group .', '10 698 ( 11·1 % ) patient die hospital .', 'After control multiple confound factor ( age , sex , race ethnicity , body-mass index , underlie cardiovascular disease risk factor , diabetes , underlie lung disease , smoke , immunosuppressed condition , baseline disease severity ) , compare mortality control group ( 9·3 % ) , hydroxychloroquine ( 18·0 % ; hazard ratio 1·335 , 95 % CI 1·223–1·457 ) , hydroxychloroquine macrolide ( 23·8 % ; 1·447 , 1·368–1·531 ) , chloroquine ( 16·4 % ; 1·365 , 1·218–1·531 ) , chloroquine macrolide ( 22·2 % ; 1·368 , 1·273–1·469 ) independently associate increase risk in-hospital mortality .', 'Compared control group ( 0·3 % ) , hydroxychloroquine ( 6·1 % ; 2·369 , 1·935–2·900 ) , hydroxychloroquine macrolide ( 8·1 % ; 5·106 , 4·106–5·983 ) , chloroquine ( 4·3 % ; 3·561 , 2·760–4·596 ) , chloroquine macrolide ( 6·5 % ; 4·011 , 3·344–4·812 ) independently associate increase risk de-novo ventricular arrhythmia hospitalisation .', 'We unable confirm benefit hydroxychloroquine chloroquine , use alone macrolide , in-hospital outcome COVID-19 .', 'Each drug regimen associate decrease in-hospital survival increase frequency ventricular arrhythmia use treatment COVID-19 .', ""William Harvey Distinguished Chair Advanced Cardiovascular Medicine Brigham Women 's Hospital ."", 'The absence effective treatment severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection lead clinician redirect drug know effective medical condition treatment COVID-19 .', 'Key among repurposed therapeutic agent antimalarial drug chloroquine analogue hydroxychloroquine , use treatment autoimmune disease , systemic lupus erythematosus rheumatoid arthritis.1Principi N Esposito S Chloroquine hydroxychloroquine prophylaxis COVID-19.Lancet Infect Dis .', '2020 ; ( publish online April 17 . )', 'urlplaceholder Scholar , 2Perricone C Triggianese P Bartoloni E et al.The anti-viral facet anti-rheumatic drug : lesson COVID-19.J Autoimmun .', '2020 ; ( publish online April 17 .', ') DOI:10.1016/j.jaut.2020.102468Google Scholar These drug show laboratory condition antiviral property well immunomodulatory effects.3Liu J Cao R Xu M et al.Hydroxychloroquine , le toxic derivative chloroquine , effective inhibit SARS-CoV-2 infection vitro.Cell Discov .', '2020 ; 6 : 16Google Scholar , 4Devaux CA Rolain JM Colson P Raoult D New insight antiviral effect chloroquine coronavirus : expect COVID-19 ? .Int J Antimicrob Agents .', '2020 ; ( publish online March 12 .', ') DOI:10.1016/j.ijantimicag.2020.105938Google Scholar However , use class drug COVID-19 base small number anecdotal experience show variable response uncontrolled observational analysis , small , open-label , randomise trial largely inconclusive.5Tang W Cao Z Han M et al.Hydroxychloroquine patient mainly mild moderate COVID-19 : open-label , randomize , control trial.medRxiv .', '2020 ; ( publish online May 7 . )', '( preprint ) .DOI : 10.1101/2020.04.10.20060558Google Scholar , 6Chen J Liu D Liu L et al.A pilot study hydroxychloroquine treatment patient moderate COVID-19.J Zhejiang Univ ( Med Sci ) .', '2020 ; 49 : 215-219Google Scholar The combination hydroxychloroquine second-generation macrolide , azithromycin ( clarithromycin ) , also advocate , despite limit evidence effectiveness.7Gautret P Lagier JC Parola P et al.Hydroxychloroquine azithromycin treatment COVID-19 : result open-label non-randomized clinical trial.Int J Antimicrob Agents .', '2020 ; ( publish online March 20 .', ') DOI:10.1016/j.ijantimicag.2020.105949Google Scholar Previous study show treatment chloroquine , hydroxychloroquine , either drug combine macrolide cardiovascular adverse effect prolongation QT interval , could mechanism predispose ventricular arrhythmias.8Ray WA Murray KT Hall K Arbogast PG Stein CM Azithromycin risk cardiovascular death.N Engl J Med .', '2012 ; 366 : 1881-1890Google Scholar , 9Giudicessi JR Noseworthy PA Friedman PA Ackerman MJ Urgent guidance navigate circumvent QTc-prolonging torsadogenic potential possible pharmacotherapies coronavirus disease 19 ( COVID-19 ) .Mayo Clin Proc .', '2020 ; ( publish online April 7 .', ') DOI:10.1016/j.mayocp.2020.03.024Google Scholar Research contextEvidence studyWe search MEDLINE ( via PubMed ) article publish April 21 , 2020 , use key word “ novel coronavirus ” , “ 2019-nCoV ” , “ COVID-19 ” , “ SARS-CoV-2 ” , “ therapy ” , “ hydroxychloroquine ” , “ chloroquine ” , “ macrolide ” .', 'Moreover , screen preprint server , Medrxiv , relevant article consult web page organisation US National Institutes Health WHO .', 'Hydroxychloroquine chloroquine ( use without macrolide ) widely advocate treatment COVID-19 base in-vitro evidence antiviral effect severe acute respiratory syndrome coronavirus 2 .', 'Their use base small uncontrolled study absence evidence randomise control trial .', 'Concerns raise drug combination macrolides could result electrical instability predispose patient ventricular arrhythmia .', 'Whether drug improve outcome associate harm COVID-19 remain unknown.Added value studyIn absence report randomise trial , urgent need evaluate real-world evidence relate outcome use hydroxychloroquine chloroquine ( use without macrolides ) COVID-19 .', 'Using international , observational registry across six continent , assess 96 032 patient COVID-19 , 14 888 treat hydroxychloroquine , chloroquine , combination macrolide .', 'After control age , sex , race ethnicity , underlie comorbidities , disease severity baseline , use four regimen associate increase hazard de-novo ventricular arrythmia death hospital .', 'This study provide real-world evidence use therapeutic regimen include large number patient across world .', 'Thus , knowledge , find provide comprehensive evidence use hydroxychloroquine chloroquine ( without macrolide ) treatment COVID-19.Implications available evidenceWe find evidence benefit hydroxychloroquine chloroquine use either alone macrolide .', 'Previous evidence derive either small anecdotal study inconclusive small randomise trial .', 'Our study include large number patient across multiple geographic region provide robust real-world evidence date usefulness treatment regimen .', 'Although observational study fully account unmeasured confound factor , find suggest absence therapeutic benefit also potential harm use hydroxychloroquine chloroquine drug regimen ( without macrolide ) hospitalise patient COVID-19 .', 'Evidence study We search MEDLINE ( via PubMed ) article publish April 21 , 2020 , use key word “ novel coronavirus ” , “ 2019-nCoV ” , “ COVID-19 ” , “ SARS-CoV-2 ” , “ therapy ” , “ hydroxychloroquine ” , “ chloroquine ” , “ macrolide ” .', 'Moreover , screen preprint server , Medrxiv , relevant article consult web page organisation US National Institutes Health WHO .', 'Hydroxychloroquine chloroquine ( use without macrolide ) widely advocate treatment COVID-19 base in-vitro evidence antiviral effect severe acute respiratory syndrome coronavirus 2 .', 'Their use base small uncontrolled study absence evidence randomise control trial .', 'Concerns raise drug combination macrolides could result electrical instability predispose patient ventricular arrhythmia .', 'Whether drug improve outcome associate harm COVID-19 remain unknown .', 'Added value study In absence report randomise trial , urgent need evaluate real-world evidence relate outcome use hydroxychloroquine chloroquine ( use without macrolides ) COVID-19 .', 'Using international , observational registry across six continent , assess 96 032 patient COVID-19 , 14 888 treat hydroxychloroquine , chloroquine , combination macrolide .', 'After control age , sex , race ethnicity , underlie comorbidities , disease severity baseline , use four regimen associate increase hazard de-novo ventricular arrythmia death hospital .', 'This study provide real-world evidence use therapeutic regimen include large number patient across world .', 'Thus , knowledge , find provide comprehensive evidence use hydroxychloroquine chloroquine ( without macrolide ) treatment COVID-19 .', 'Implications available evidence We find evidence benefit hydroxychloroquine chloroquine use either alone macrolide .', 'Previous evidence derive either small anecdotal study inconclusive small randomise trial .', 'Our study include large number patient across multiple geographic region provide robust real-world evidence date usefulness treatment regimen .', 'Although observational study fully account unmeasured confound factor , find suggest absence therapeutic benefit also potential harm use hydroxychloroquine chloroquine drug regimen ( without macrolide ) hospitalise patient COVID-19 .', 'Although several multicentre randomise control trial underway , press need provide accurate clinical guidance use chloroquine hydroxychloroquine along macrolides widespread , often little regard potential risk .', 'Some country stockpile drug , result shortage medication need approve clinical indications.10Peschken CA Possible consequence shortage hydroxychloroquine patient systemic lupus erythematosus amid COVID-19 pandemic.J Rheumatol .', '2020 ; ( publish online April 8 .', ') DOI:10.3899/jrheum.200395Google Scholar The purpose study evaluate use chloroquine hydroxychloroquine alone combination macrolide treatment COVID-19 use large multinational registry ass real-world application .', 'Principally , seek analyse association treatment regimen in-hospital death .', 'Secondarily , aim evaluate occurrence de-novo clinically significant ventricular arrhythmia .', 'We multinational registry analysis use hydroxychloroquine chloroquine without macrolide treatment COVID-19 .', 'The registry comprise 671 hospital locate six continent ( appendix p 3 ) .', 'The Surgical Outcomes Collaborative ( Surgisphere Corporation , Chicago , IL , USA ) consist de-identified data obtain automate data extraction inpatient outpatient electronic health record , supply chain database , financial record .', 'The registry us cloud-based health-care data analytics platform include specific module data acquisition , data warehouse , data analytics , data report .', 'A manual data entry process use quality assurance validation ensure key miss value keep minimum .', 'The Surgical Outcomes Collaborative ( hereafter refer Collaborative ) ensure compliance US Food Drug Administration ( FDA ) guidance real-world evidence .', 'Real-world data collect automate data transfer capture 100 % data health-care entity regular , predetermine interval , thus reduce impact selection bias miss value , ensure data current , reliable , relevant .', 'Verifiable source documentation element include electronic inpatient outpatient medical record , accordance FDA guidance relevance real-world data , data acquisition perform use standardise Health Level Seven-compliant data dictionary , data collect prospective ongoing basis .', 'The validation procedure registry refer standard operate procedure place four ISO 9001:2015 ISO 27001:2013 certify feature registry : data acquisition , data warehouse , data analytics , data report .', 'The standardise Health Level Seven-compliant data dictionary use Collaborative serf focal point data acquisition warehouse .', 'Once data dictionary harmonise electronic health record data , data acquisition complete use automate interface expedite data transfer improve data integrity .', 'Collection 100 % sample health-care entity validate financial record external database minimise selection bias .', 'To reduce risk inadvertent protect health information disclosure , information strip storage cloud-based data warehouse .', 'The Collaborative intend minimise effect information bias selection bias capture all-comer data consecutive patient enrolment capture 100 % data within electronic system , ensure result remain generalisable larger population .', 'The Collaborative compliant US Agency Healthcare Research Quality guideline registry .', 'With onset COVID-19 crisis , registry use collect data hospital USA ( select match epidemiological characteristic US population ) internationally , achieve representation diverse population across six continent .', 'Data collect variety urban rural hospital , academic community hospital , for-profit non-profit hospital .', 'The data collection analysis deem exempt ethic review .', 'We include patient hospitalise Dec 20 , 2019 , April 14 , 2020 , hospital participate registry PCR-confirmed COVID-19 infection , clinical outcome either hospital discharge death hospitalisation record .', 'A positive laboratory find SARS-CoV-2 define positive result high-throughput sequence reverse transcription-quantitative PCR assay nasal pharyngeal swab specimen , find use classify patient positive COVID-19 .', 'COVID-19 diagnose , site , basis WHO guidance.11WHOClinical management severe acute respiratory infection ( SARI ) novel COVID-19 disease suspect : interim guidance .', 'urlplaceholder March 13 , 2020Date access : April 24 , 2020Google Scholar Patients record test database , negative test , include study .', 'Only one positive test necessary patient include analysis .', 'Patients receive either hydroxychloroquine chloroquine analogue-based treatment ( without second-generation macrolide ) include treatment group .', 'Patients receive treatment regimen start 48 h COVID-19 diagnosis exclude .', 'We also exclude data patient treatment initiate mechanical ventilation receive therapy antiviral remdesivir .', 'These specific exclusion criterion establish avoid enrolment patient treatment might start non-uniform time course COVID-19 illness exclude individual drug regimen might use critical phase illness , could skew interpretation result .', 'Thus , define four distinct treatment group , patient start therapy within 48 h establish COVID-19 diagnosis : chloroquine alone , chloroquine macrolide , hydroxychloroquine alone , hydroxychloroquine macrolide .', 'All include patient serve control population .', 'Patient demographic , include age , body-mass index ( BMI ) , sex , race ethnicity , continent origin obtain .', 'Underlying comorbidities ( base International Classification Diseases , tenth revision , clinical modification code ) present either inpatient outpatient electronic health record collect , include cardiovascular disease ( include coronary artery disease , congestive heart failure , history cardiac arrhythmia ) , current previous history smoke , history hypertension , diabetes , hyperlipidaemia , chronic obstructive pulmonary disease ( COPD ) , presence immunosuppressed condition ( steroid use , pre-existing immunological condition , current chemotherapy individual cancer ) .', 'We collect data use medication baseline , include cardiac medication ( angiotensin convert enzyme [ ACE ] inhibitor , angiotensin receptor blocker , statin ) use antiviral therapy drug regimen evaluate .', 'The initiation hydroxychloroquine chloroquine hospital admission record , include time initiation .', 'The use second-generation macrolides , specifically azithromycin clarithromycin , similarly record .', 'A quick sepsis-related organ failure assessment ( qSOFA ) calculate start therapy ( include score calculation mental status , respiratory rate , systolic blood pressure ) oxygen saturation ( SPO2 ) room air record , measure disease severity .', 'The primary outcome interest association use treatment regimen contain chloroquine hydroxychloroquine ( without second-generation macrolide ) initiate early COVID-19 diagnosis endpoint in-hospital mortality .', 'The secondary outcome interest association treatment regimen occurrence clinically significant ventricular arrhythmia ( define first occurrence non-sustained [ least 6 sec ] sustain ventricular tachycardia ventricular fibrillation ) hospitalisation .', 'We also analyse rate progression mechanical ventilation use total intensive care unit length stay ( day ) patient group .', 'For primary analysis in-hospital mortality , control confound factor , include demographic variable , comorbidities , disease severity presentation , medication use ( cardiac medication antiviral therapy ) .', 'Categorical variable show frequency percentage , continuous variable mean SDs .', ""Comparison continuous data group do use unpaired t-test categorical data compare use Fisher 's exact test ."", 'A p value le 0·05 consider significant .', ""Multiple imputation miss value possible disease drug variable , code indicate data miss ; patient 's electronic health record include information clinical characteristic , assume characteristic present ."", 'Cox proportional hazard regression analysis do evaluate effect age , sex , race ethnicity ( use white race reference group ) , comorbidities ( BMI , presence coronary artery disease , presence congestive heart failure , history cardiac arrhythmia , diabetes , COPD , current smoker , history hypertension , immunocompromised state , history hyperlipidaemia ) , medication ( cardiac medication , antiviral , treatment regimen interest ) , severity illness score ( qSOFA < 1 SPO2 < 94 % ) risk clinically significant ventricular arrhythmia ( use time admission first occurrence , event occur , time discharge ) mortality ( use time admission inpatient mortality discharge ) .', 'Age BMI treat continuous variable data treat categorical variable model .', 'From model , hazard ratio ( HRs ) 95 % CIs estimate include variable determine effect risk in-hospital mortality ( primary endpoint ) subsequent mechanical ventilation death ( composite endpoint ) .', 'Independence survival time ( time first arrhythmia ventricular arrhythmia analysis ) confirm .', 'Proportionality predictor hazard validate evaluation Schoenfeld residual , find p > 0·05 thus confirm proportionality .', 'To minimise effect confound factor , propensity score match analysis do individually four treatment group compare control group receive form therapy .', 'For treatment group , separate match control identify use exact propensity-score match criterion calliper 0·001 .', 'This method use provide close approximation demographic , comorbidities , disease severity , baseline medication patient .', 'The propensity score base follow variable : age , BMI , gender , race ethnicity , comorbidities , use ACE inhibitor , use statin , use angiotensin receptor blocker , treatment antiviral , qSOFA score le 1 , SPO2 le 94 % room air .', 'The patient well match , standardise mean difference estimate le 10 % match parameter .', 'Additional analysis do examine robustness estimate initially obtain .', 'Individual analysis continent origin sex-adjusted analysis use Cox proportional hazard model perform .', 'A tipping-point analysis ( analysis show effect size prevalence unmeasured confounder could shift upper boundary CI towards null ) also do .', 'All statistical analysis do R version 3.6.3 SPSS version 26 .', 'The funder study role study design , data collection , data analysis , data interpretation , write report .', 'The correspond author co-author ANP full access data study final responsibility decision submit publication .', '96 032 hospitalise patient 671 hospital diagnose COVID-19 Dec 20 , 2019 , April 14 , 2020 meet inclusion criterion study ( figure 1 ) .', 'All include patient complete hospital course ( discharge die ) April 21 , 2020 .', 'Patients hospitalise study period without complete course unable analyse .', 'The study cohort include 63 315 ( 65·9 % ) patient North America , 16 574 ( 17·3 % ) Europe , 7555 ( 7·9 % ) Asia , 4402 ( 4·6 % ) Africa , 3577 ( 3·7 % ) South America , 609 ( 0·6 % ) Australia ( detail number hospital per continent present appendix , p 3 ) .', 'The mean age 53·8 year ( SD 17·6 ) , 44 426 ( 46·3 % ) woman , mean BMI 27·6 kg/m2 ( SD 5·5 ; 29 510 [ 30·7 % ] obese BMI ≥30 kg/m2 ) , 64 220 ( 66·9 % ) white , 9054 ( 9·4 % ) black , 5978 ( 6·2 % ) Hispanic , 13 519 ( 14·1 % ) Asian origin ( appendix p 4 ) .', 'In term comorbidities , 30 198 ( 31·4 % ) hyperlipidaemia , 25 810 ( 26·9 % ) hypertension , 13 260 ( 13·8 % ) diabetes , 3177 ( 3·3 % ) COPD , 2868 ( 3·0 % ) underlie immunosuppressed condition , 16 553 ( 17·2 % ) former smoker , 9488 ( 9·9 % ) current smoker .', 'In term pre-existing cardiovascular disease , 12 137 ( 12·6 % ) coronary artery disease , 2368 ( 2·5 % ) history congestive heart failure , 3381 ( 3·5 % ) history arrhythmia .', 'The mean length stay hospital 9·1 day ( SD 6·4 ) , overall in-hospital mortality 10 698 ( 11·1 % ) 96 032 .', 'The use antiviral record 38 927 ( 40·5 % ) patient treatment COVID-19 .', 'The common antiviral lopinavir ritonavir ( 12 304 [ 31·6 % ] ) , ribavirin ( 7904 [ 20·3 % ] ) , oseltamivir ( 5101 [ 13·1 % ] ) .', 'Combination therapy one antiviral regimen use 6782 ( 17·4 % ) patients.Figure 1Study profileView Large Image Figure ViewerDownload Hi-res image Download ( PPT ) The treatment group include 1868 patient give chloroquine alone , 3016 give hydroxychloroquine alone , 3783 give chloroquine macrolide 6221 give hydroxychloroquine macrolide .', 'The median time hospitalisation diagnosis COVID-19 2 day ( IQR 1–4 ) .', 'The mean daily dose duration various drug regimen follow : chloroquine alone , 765 mg ( SD 308 ) 6·6 day ( 2·4 ) ; hydroxychloroquine alone , 596 mg ( 126 ) 4·2 day ( 1·9 ) ; chloroquine macrolide , 790 mg ( 320 ) 6·8 day ( 2·5 ) ; hydroxychloroquine macrolide , 597 mg ( 128 ) 4·3 day ( 2·0 ) .', 'Additional detail study cohort provide appendix ( pp 4–5 ) .', 'Demographic variable comorbidities compare among survivor non-survivors ( table 1 ) .', 'Non-survivors older , likely obese , likely men , likely black Hispanic , diabetes , hyperlipidaemia , coronary artery disease , congestive heart failure , history arrhythmia .', 'Non-survivors also likely COPD report current smoking.Table 1Demographics comorbidities patient survival non-survival hospitalisationSurvivors ( n=85 334 ) Non-survivors ( n=10 698 ) p valueAge , years53·1 ( 17·5 ) 60·0 ( 17·6 ) < 0·0001BMI , kg/m227·0 ( 5·1 ) 31·8 ( 6·4 ) < 0·0001Obese , BMI > 30 kg/m222 992 ( 26·9 % ) 6518 ( 60·9 % ) < 0·0001SexFemale40 169 ( 47·1 % ) 4257 ( 39·8 % ) < 0·0001Male45 165 ( 52·9 % ) 6441 ( 60·2 % ) < 0·0001Race ethnicityWhite57 503 ( 67·4 % ) 6717 ( 62·8 % ) < 0·0001Black7219 ( 8·5 % ) 1835 ( 17·2 % ) < 0·0001Hispanic4948 ( 5·8 % ) 1030 ( 9·6 % ) < 0·0001Asian12 657 ( 14·8 % ) 862 ( 8·1 % ) < 0·0001Native American1023 ( 1·2 % ) 56 ( 0·5 % ) < 0·0001Other1984 ( 2·3 % ) 198 ( 1·9 % ) 0·0019Comorbidities baselineCoronary artery disease9777 ( 11·5 % ) 2360 ( 22·1 % ) < 0·0001Congestive heart failure1828 ( 2·1 % ) 540 ( 5·0 % ) < 0·0001Arrhythmia2700 ( 3·2 % ) 681 ( 6·4 % ) < 0·0001Diabetes10 963 ( 12·8 % ) 2297 ( 21·5 % ) < 0·0001Hypertension21 948 ( 25·7 % ) 3862 ( 36·1 % ) < 0·0001Hyperlipidaemia26 480 ( 31·0 % ) 3718 ( 34·8 % ) < 0·0001COPD2603 ( 3·1 % ) 574 ( 5·4 % ) < 0·0001Current smoker7972 ( 9·3 % ) 1516 ( 14·2 % ) < 0·0001Former smoker14 681 ( 17·2 % ) 1872 ( 17·5 % ) 0·45Immunocompromised2406 ( 2·8 % ) 462 ( 4·3 % ) < 0·0001MedicationsACE inhibitor7521 ( 8·8 % ) 428 ( 4·0 % ) < 0·0001Statin8506 ( 10·0 % ) 739 ( 6·9 % ) < 0·0001Angiotensin receptor blocker5190 ( 6·1 % ) 659 ( 6·2 % ) 0·75Antiviral35 189 ( 41·2 % ) 3738 ( 34·9 % ) < 0·0001Disease severityqSOFA < 171 457 ( 83·7 % ) 7911 ( 73·9 % ) < 0·0001SPO2 < 94 % 7188 ( 8·4 % ) 2129 ( 19·9 % ) < 0·0001Treatment groupChloroquine alone1561 ( 1·8 % ) 307 ( 2·9 % ) < 0·0001Chloroquine macrolide * * Macrolides include azithromycin clarithromycin.2944 ( 3·4 % ) 839 ( 7·8 % ) < 0·0001Hydroxychloroquine alone2473 ( 2·9 % ) 543 ( 5·1 % ) < 0·0001Hydroxychloroquine macrolide * * Macrolides include azithromycin clarithromycin.4742 ( 5·6 % ) 1479 ( 13·8 % ) < 0·0001OutcomesDe-novo ventricular arrhythmia839 ( 1·0 % ) 400 ( 3·7 % ) < 0·0001Non-ICU length stay , days9·0 ( 6·2 ) 9·8 ( 7·4 ) < 0·0001ICU length stay , days2·1 ( 3·7 ) 9·4 ( 10·6 ) < 0·0001Total length stay , days11·1 ( 7·3 ) 19·2 ( 14·4 ) < 0·0001Mechanical ventilation4821 ( 5·6 % ) 4533 ( 42·4 % ) < 0·0001Data mean ( SD ) n ( % ) .', 'BMI=body-mass index .', 'COPD=chronic obstructive pulmonary disease .', 'ACE=angiotensin-converting enzyme .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation .', 'ICU=intensive care unit .', '* Macrolides include azithromycin clarithromycin .', 'Open table new tab Data mean ( SD ) n ( % ) .', 'BMI=body-mass index .', 'COPD=chronic obstructive pulmonary disease .', 'ACE=angiotensin-converting enzyme .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation .', 'ICU=intensive care unit .', 'The distribution demographic , comorbidities , outcome four treatment group show table 2 .', 'No significant between-group difference find among baseline characteristic comorbidities .', 'Ventricular arrhythmia common treatment group compare control population .', 'Mortality higher treatment group compare control population ( p < 0·0001 ; appendix pp 15–18 ) .Table 2Patient demographic characteristic treatment groupControl group ( n=81 144 ) Chloroquine ( n=1868 ) Chloroquine macrolide * * Macrolides include clarithromycin azithromycin .', '( n=3783 ) Hydroxychloroquine ( n=3016 ) Hydroxychloroquine macrolide * * Macrolides include clarithromycin azithromycin .', '( n=6221 ) Age , years53·6 ( 17·6 ) 55·1 ( 18·0 ) 54·9 ( 17·7 ) 55·1 ( 17·9 ) 55·2 ( 17·7 ) BMI , kg/m227·4 ( 5·4 ) 27·8 ( 6·1 ) 28·2 ( 5·8 ) 28·4 ( 5.9 ) 28·5 ( 5·9 ) SexFemale37 716 ( 46·5 % ) 845 ( 45·2 % ) 1718 ( 45·4 % ) 1388 ( 46·0 % ) 2759 ( 44·3 % ) Male43 428 ( 53·5 % ) 1023 ( 54·8 % ) 2065 ( 54·6 % ) 1628 ( 54·0 % ) 3462 ( 55·7 % ) Race ethnicityWhite54 403 ( 67·1 % ) 1201 ( 64·3 % ) 2418 ( 63·9 % ) 2074 ( 68·8 % ) 4124 ( 66·3 % ) Black7519 ( 9·3 % ) 203 ( 10·9 % ) 369 ( 9·8 % ) 287 ( 9·5 % ) 676 ( 10·9 % ) Hispanic4943 ( 6·1 % ) 108 ( 5·8 % ) 273 ( 7·2 % ) 194 ( 6·4 % ) 460 ( 7·4 % ) Asian11 504 ( 14·2 % ) 301 ( 16·1 % ) 603 ( 15·9 % ) 366 ( 12·1 % ) 745 ( 12·0 % ) Native American922 ( 1·1 % ) 19 ( 1·0 % ) 37 ( 1·0 % ) 33 ( 1·1 % ) 68 ( 1·1 % ) Other1853 ( 2·3 % ) 36 ( 1·9 % ) 83 ( 2·2 % ) 62 ( 2·1 % ) 148 ( 2·4 % ) ComorbiditiesCoronary artery disease10 076 ( 12·4 % ) 284 ( 15·2 % ) 515 ( 13·6 % ) 421 ( 14·0 % ) 841 ( 13·5 % ) Congestive heart failure1949 ( 2·4 % ) 50 ( 2·7 % ) 103 ( 2·7 % ) 78 ( 2·6 % ) 188 ( 3·0 % ) Arrhythmia2861 ( 3·5 % ) 63 ( 3·4 % ) 126 ( 3·3 % ) 108 ( 3·6 % ) 223 ( 3·6 % ) Diabetes11 058 ( 13·6 % ) 258 ( 13·8 % ) 584 ( 15·4 % ) 447 ( 14·8 % ) 913 ( 14·7 % ) Hypertension21 437 ( 26·4 % ) 560 ( 30·0 % ) 1095 ( 28·9 % ) 891 ( 29·5 % ) 1827 ( 29·4 % ) Hyperlipidaemia25 538 ( 31·5 % ) 607 ( 32·5 % ) 1164 ( 30·8 % ) 941 ( 31·2 % ) 1948 ( 31·3 % ) COPD2647 ( 3·3 % ) 55 ( 2·9 % ) 144 ( 3·8 % ) 111 ( 3·7 % ) 220 ( 3·5 % ) Current smoker7884 ( 9·7 % ) 190 ( 10·2 % ) 428 ( 11·3 % ) 342 ( 11·3 % ) 644 ( 10·4 % ) Former smoker14 049 ( 17·3 % ) 321 ( 17·2 % ) 648 ( 17·1 % ) 509 ( 16·9 % ) 1026 ( 16·5 % ) Immunocompromised2416 ( 3·0 % ) 53 ( 2·8 % ) 122 ( 3·2 % ) 90 ( 3·0 % ) 187 ( 3·0 % ) Baseline disease severityqSOFA < 167 316 ( 83·0 % ) 1530 ( 81·9 % ) 3051 ( 80·7 % ) 2477 ( 82·1 % ) 4994 ( 80·3 % ) SPO2 < 94 % 7721 ( 9·5 % ) 209 ( 11·2 % ) 413 ( 10·9 % ) 323 ( 10·7 % ) 651 ( 10·5 % ) OutcomesDe-novo ventricular arrhythmia226 ( 0·3 % ) 81 ( 4·3 % ) 246 ( 6·5 % ) 184 ( 6·1 % ) 502 ( 8·1 % ) Non-ICU length stay , days9·1 ( 6·4 ) 8·8 ( 6·2 ) 9·0 ( 6·6 ) 8·9 ( 6·2 ) 9·1 ( 6·7 ) ICU length stay , days2·6 ( 5·0 ) 4·3 ( 6·8 ) 4·9 ( 8·1 ) 4·3 ( 6·8 ) 4·7 ( 7·8 ) Total length stay , days11·7 ( 8·4 ) 13·2 ( 9·1 ) 13·8 ( 11·0 ) 13·2 ( 9·3 ) 13·8 ( 10·7 ) Mechanical ventilation6278 ( 7·7 % ) 403 ( 21·6 % ) 814 ( 21·5 % ) 616 ( 20·4 % ) 1243 ( 20·0 % ) Mortality7530 ( 9·3 % ) 307 ( 16·4 % ) 839 ( 22·2 % ) 543 ( 18·0 % ) 1479 ( 23·8 % ) Ventilator mortality10 703 ( 13·2 % ) 531 ( 28·4 % ) 1288 ( 34·0 % ) 877 ( 29·1 % ) 2120 ( 34·1 % ) Data mean ( SD ) n ( % ) .', 'BMI=body-mass index .', 'COPD=chronic obstructive pulmonary disease .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation .', 'ICU=intensive care unit .', '* Macrolides include clarithromycin azithromycin .', 'Open table new tab Data mean ( SD ) n ( % ) .', 'BMI=body-mass index .', 'COPD=chronic obstructive pulmonary disease .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation .', 'ICU=intensive care unit .', 'Independent predictor in-hospital mortality show figure 2 .', 'Age , BMI , black race Hispanic ethnicity ( versus white race ) , coronary artery disease , congestive heart failure , history arrhythmia , diabetes , hypertension , hyperlipidaemia , COPD , current smoker , immunosuppressed condition associate higher risk in-hospital death .', 'Female sex , ethnicity Asian origin , use ACE inhibitor ( angiotensin receptor blocker ) , use statin associate reduce in-hospital mortality risk .', 'Compared control group ( 9·3 % ) , hydroxychloroquine alone ( 18·0 % ; HR 1·335 , 95 % CI 1·223–1·457 ) , hydroxychloroquine macrolide ( 23·8 % ; 1·447 , 1·368–1·531 ) , chloroquine alone ( 16·4 % ; 1·365 , 1·218–1·531 ) , chloroquine macrolide ( 22·2 % ; 1·368 , 1·273–1·469 ) independently associate increase risk in-hospital mortality .', 'The multivariable Cox regression analysis continent show appendix ( pp 6–11 ) , well data sex-adjusted multivariable logistic regression analysis ( pp 12–13 ) separate Cox regression analysis combine endpoint mechanical ventilation mortality ( p 14 ) .Figure 2Independent predictor in-hospital mortalityShow full captionAge BMI continuous variable .', 'The 95 % CIs adjust multiple test use infer definitive effect .', 'ACE=angiotensin-converting enzyme .', 'BMI=body mass index .', 'COPD=chronic obstructive pulmonary disease .', 'HR=hazard ratio .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Age BMI continuous variable .', 'The 95 % CIs adjust multiple test use infer definitive effect .', 'ACE=angiotensin-converting enzyme .', 'BMI=body mass index .', 'COPD=chronic obstructive pulmonary disease .', 'HR=hazard ratio .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation .', 'Independent predictor ventricular arrythmia show figure 3 .', 'Coronary artery disease , congestive heart failure , history cardiac arrhythmia , COPD independently associate increase risk de-novo ventricular arrhythmia hospitalisation .', 'Compared control group ( 0·3 % ) , hydroxychloroquine alone ( 6·1 % ; HR 2·369 , 95 % CI 1·935–2·900 ) , hydroxychloroquine macrolide ( 8·1 % ; 5·106 , 4·106–5·983 ) , chloroquine alone ( 4·3 % ; 3·561 , 2·760–4·596 ) , chloroquine macrolide ( 6·5 % ; 4·011 , 3·344–4·812 ) independently associate increase risk de-novo ventricular arrhythmia hospitalisation.Figure 3Independent predictor ventricular arrhythmia hospitalisationShow full captionAge BMI continuous variable .', 'The 95 % CIs adjust multiple test use infer definitive effect .', 'ACE=angiotensin-converting enzyme .', 'BMI=body mass index .', 'COPD=chronic obstructive pulmonary disease .', 'HR=hazard ratio .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Age BMI continuous variable .', 'The 95 % CIs adjust multiple test use infer definitive effect .', 'ACE=angiotensin-converting enzyme .', 'BMI=body mass index .', 'COPD=chronic obstructive pulmonary disease .', 'HR=hazard ratio .', 'qSOFA=quick sepsis-related organ failure assessment .', 'SPO2=oxygen saturation .', 'Analyses use propensity score match treatment group show appendix ( pp 15–18 ) .', 'The result indicate association drug regimen mortality , need mechanical ventilation , length stay , occurrence de-novo ventricular arrhythmia consistent primary analysis .', 'A tip point analysis do ass effect unmeasured confounder find significance hydroxychloroquine chloroquine ( appendix pp 19–20 ) .', 'For chloroquine , hydroxychloroquine , chloroquine macrolide , hypothetical unobserved binary confounder prevalence 50 % expose population would need HR 1·5 tip analysis non-significance 5 % level .', 'For comparison observe confounders study , congestive heart failure ( HR 1·756 ) leave model , would need prevalence approximately 30 % population lead confound analysis .', 'Similarly , hydroxychloroquine macrolide , hypothetical unobserved binary confounder prevalence 37 % expose population would need HR 2·0 tip analysis non-significance 5 % level .', 'Again , congestive heart failure ( HR 1·756 ) would need prevalence approximately 50 % population lead confound analysis , adjust Cox proportional hazard model .', 'In large multinational real-world analysis , observe benefit hydroxychloroquine chloroquine ( use alone combination macrolide ) in-hospital outcome , initiate early diagnosis COVID-19 .', 'Each drug regimen chloroquine hydroxychloroquine alone combination macrolide associate increase hazard clinically significant occurrence ventricular arrhythmia increase risk in-hospital death COVID-19 .', 'The use hydroxychloroquine chloroquine COVID-19 base widespread publicity small , uncontrolled study , suggest combination hydroxychloroquine macrolide azithromycin successful clear viral replication.7Gautret P Lagier JC Parola P et al.Hydroxychloroquine azithromycin treatment COVID-19 : result open-label non-randomized clinical trial.Int J Antimicrob Agents .', '2020 ; ( publish online March 20 .', ') DOI:10.1016/j.ijantimicag.2020.105949Google Scholar On March 28 , 2020 , FDA issue emergency use authorisation drug patient clinical trial access unavailable.12US Food Drug AdministrationEmergency use authorization : coronavirus disease 2019 ( COVID-19 ) EUA information .', 'urlplaceholder # covidtherapeuticsDate access : May 15 , 2020Google Scholar Other country , China , issue guideline allow use chloroquine COVID-19.13Gao J Tian Z Yang X Breakthrough : chloroquine phosphate show apparent efficacy treatment COVID-19 associate pneumonia clinical studies.Biosci Trends .', '2020 ; 14 : 72-73Google Scholar Several country stockpile drug , shortage approve indication , autoimmune disease rheumatoid arthritis , encountered.10Peschken CA Possible consequence shortage hydroxychloroquine patient systemic lupus erythematosus amid COVID-19 pandemic.J Rheumatol .', '2020 ; ( publish online April 8 .', ') DOI:10.3899/jrheum.200395Google Scholar A retrospective observational review 368 men COVID-19 treat US Veterans Affairs hospital raise concern use hydroxychloroquine associate greater hazard death ; however , baseline characteristic among group analyse dissimilar possibility bias rule out.14Magagnoli J Narendran S Pereira F et al.Outcomes hydroxychloroquine usage United States veteran hospitalize COVID-19.medRxiv .', '2020 ; ( publish online April 23 . )', '( preprint ) .DOI : 10.1101/2020.04.16.20065920Google Scholar Another observational study 181 patient France report use hydroxychloroquine dose 600 mg per day associate measurable clinical benefit patient COVID-19 pneumonia.15Mahevas M Tran V-T Roumier M et al.No evidence clinical efficacy hydroxychloroquine patient hospitalise COVID-19 infection oxygen requiremenr : result study use routinely collect data emulate target trial.medRxiv .', '2020 ; ( publish online April 14 . )', '( preprint ) .DOI : 10.1101/2020.04.10.20060699Google Scholar Our large-scale , international , real-world analysis support absence clinical benefit chloroquine hydroxychloroquine point potential harm hospitalise patient COVID-19 .', 'Chloroquine hydroxychloroquine associate concern cardiovascular toxicity , particularly know relationship electrical instability , characterise QT interval prolongation ( time take ventricular depolarisation repolarisation ) .', 'This mechanism relate blockade hERG potassium channel,16Traebert M Dumotier B Meister L Hoffmann P Dominguez-Estevez M Suter W Inhibition hERG K+ current antimalarial drug stably transfected HEK293 cells.Eur J Pharmacol .', '2004 ; 484 : 41-48Google Scholar lengthen ventricular repolarisation duration ventricular action potential .', 'Under specific condition , early after-depolarisations trigger ventricular arrhythmias.9Giudicessi JR Noseworthy PA Friedman PA Ackerman MJ Urgent guidance navigate circumvent QTc-prolonging torsadogenic potential possible pharmacotherapies coronavirus disease 19 ( COVID-19 ) .Mayo Clin Proc .', '2020 ; ( publish online April 7 .', ') DOI:10.1016/j.mayocp.2020.03.024Google Scholar Such propensity arrhythmia provocation often see individual structural cardiovascular disease , cardiac injury report occur high frequency COVID-19 illness.17Shi S Qin M Shen B et al.Association cardiac injury mortality hospitalize patient COVID-19 Wuhan , China.JAMA Cardiol .', '2020 ; ( publish online March 25 .', ') DOI:10.1001/jamacardio.2020.0950Google Scholar , 18Guo T Fan Y Chen M et al.Cardiovascular implication fatal outcome patient coronavirus disease 2019 ( COVID-19 ) .JAMA Cardiol .', '2020 ; ( publish online March 27 .', "") DOI:10.1001/jamacardio.2020.1017Google Scholar Furthermore , individual cardiovascular disease represent vulnerable population experience worse outcome COVID-19.19Bonow RO Fonarow GC O'Gara PT Yancy CW Association coronavirus disease 2019 ( COVID-19 ) myocardial injury mortality.JAMA Cardiol ."", '2020 ; ( publish online March 27 .', ') DOI:10.1001/jamacardio.2020.1105Google Scholar , 20Mehra MR Desai SS Kuy S Henry TD Patel AN Cardiovascular disease , drug therapy , mortality COVID-19.N Engl J Med .', '2020 ; ( publish online May 1 .', ') DOI:10.1056/NEJMoa2007621Google Scholar Pathological study point derangement vascular endothelium diffuse endotheliitis note across multiple organ COVID-19.21Varga Z Flammer AJ Steiger P et al.Endothelial cell infection endotheliitis COVID-19.Lancet .', '2020 ; 395 : 1417-1418Google Scholar Whether patient underlie cardiovascular disease experience de-novo cardiovascular injury greater predilection ventricular arrhythmia chloroquine analogue remain uncertain plausible .', 'COVID-19 exemplify initial viral replication follow enhance systemic inflammation.22Siddiqi HK Mehra MR COVID-19 illness native immunosuppressed state : clinical-therapeutic stag proposal.J Heart Lung Transplant .', '2020 ; 39 : 405-407Google Scholar The use chloroquine hydroxychloroquine combination macrolide design use antimicrobial property synergistic manner.23Nakornchai S Konthiang P Activity azithromycin erythromycin combination antimalarial drug multidrug-resistant Plasmodium falciparum vitro.Acta Trop .', '2006 ; 100 : 185-191Google Scholar Macrolides , azithromycin clarithromycin , antibiotic immunomodulatory anti-inflammatory effects.24Lee N Wong CK Chan MCW et al.Anti-inflammatory effect adjunctive macrolide treatment adult hospitalize influenza : randomize control trial.Antiviral Res .', '2017 ; 144 : 48-56Google Scholar However , drug prolong QT interval increase risk sudden cardiac death.8Ray WA Murray KT Hall K Arbogast PG Stein CM Azithromycin risk cardiovascular death.N Engl J Med .', '2012 ; 366 : 1881-1890Google Scholar , 9Giudicessi JR Noseworthy PA Friedman PA Ackerman MJ Urgent guidance navigate circumvent QTc-prolonging torsadogenic potential possible pharmacotherapies coronavirus disease 19 ( COVID-19 ) .Mayo Clin Proc .', '2020 ; ( publish online April 7 .', ') DOI:10.1016/j.mayocp.2020.03.024Google Scholar In preliminary analysis , Borba colleagues25Borba MGS Val FFA Sampaio VS et al.Effect high v low do chloroquine diphosphate adjunctive therapy patient hospitalize severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection : randomize clinical trial.JAMA Netw Open .', '2020 ; 3e208857Google Scholar report double-blind , randomise trial 81 adult patient hospitalise severe COVID-19 tertiary care facility Brazil .', 'This study suggest higher dose chloroquine represent safety hazard , especially take concurrently azithromycin oseltamivir .', 'In another cohort study 90 patient COVID-19 pneumonia , Mercuro colleagues26Mercuro NJ Yen CF Shim DJ et al.Risk QT interval prolongation associate use hydroxychloroquine without concomitant azithromycin among hospitalize patient test positive coronavirus disease 2019 ( COVID-19 ) .JAMA Cardiol .', '2020 ; ( publish online May 1 .', ') DOI:10.1001/jamacardio.2020.1834Google Scholar find concomitant use macrolide associate greater change correct QT interval .', 'Our study examine QT interval instead directly analyse risk clinically significant ventricular arrythmias .', 'We show independent association use either hydroxychloroquine chloroquine occurrence de-novo ventricular arrhythmia .', 'We also note hazard de-novo ventricular arrhythmia increase drug use combination macrolide .', 'In analysis , dominate patient North America , note higher BMI emerge risk marker worse in-hospital survival .', 'Obesity know risk factor cardiac arrhythmia sudden cardiac death.27Lavie CJ Arena R Alpert MA Milani RV Ventura HO Management cardiovascular disease patient obesity.Nat Rev Cardiol .', '2018 ; 15 : 45-56Google Scholar , 28Sanchis-Gomar F Lavie CJ Mehra MR Henry BM Lippi G Obesity outcome COVID-19 : epidemic pandemic collide.Mayo Clin Proc .', '2020 ; ( publish online May 19 .', ') DOI:10.1016/j.mayocp.2020.05.006Google Scholar The commonly report arrhythmia atrial fibrillation ventricular tachycardia .', 'Although age , race , BMI predictive increase risk death COVID-19 analysis , find associate increase risk ventricular arrhythmia multivariable regression analysis .', 'The variable find independently predictive ventricular arrhythmia four treatment regimen , along underlie cardiovascular disease COPD .', 'Thus , presence cardiovascular comorbidity study population could partially explain observe risk increase cardiovascular toxicity use chloroquine hydroxychloroquine , especially use combination macrolides .', 'In investigation , consistent previous find smaller cohort 8910 patients,20Mehra MR Desai SS Kuy S Henry TD Patel AN Cardiovascular disease , drug therapy , mortality COVID-19.N Engl J Med .', '2020 ; ( publish online May 1 .', ') DOI:10.1056/NEJMoa2007621Google Scholar find woman patient treat ACE inhibitor ( angiotensin receptor blocker ) statin lower mortality COVID-19 .', 'These find imply drug stabilise cardiovascular function improve endothelial cell dysfunction might improve prognosis , independent use cardiotoxic drug combinations.21Varga Z Flammer AJ Steiger P et al.Endothelial cell infection endotheliitis COVID-19.Lancet .', '2020 ; 395 : 1417-1418Google Scholar Our study several limitation .', 'The association decrease survival hydroxychloroquine chloroquine treatment regimen interpret cautiously .', 'Due observational study design , exclude possibility unmeasured confound factor , although reassuringly note consistency primary analysis propensity score match analysis .', 'Nevertheless , cause-and-effect relationship drug therapy survival infer .', 'These data apply use treatment regimen use ambulatory , out-of-hospital set .', 'Randomised clinical trial require conclusion reach regard benefit harm agent COVID-19 patient .', 'We also note although evaluate relationship drug treatment regimen occurrence ventricular arrhythmia , measure QT interval , stratify arrhythmia pattern ( torsade de point ) .', 'We also establish association increase risk in-hospital death use drug regimen link directly cardiovascular risk , conduct drug dose-response analysis observe risk .', 'Even limitation suggest conservative interpretation find , believe absence observe benefit could still represent reasonable explanation .', 'In summary , multinational , observational , real-world study patient COVID-19 require hospitalisation find use regimen contain hydroxychloroquine chloroquine ( without macrolide ) associate evidence benefit , instead associate increase risk ventricular arrhythmia greater hazard in-hospital death COVID-19 .', 'These find suggest drug regimen use outside clinical trial urgent confirmation randomise clinical trial need .', 'Contributors The study conceive design MRM ANP .', 'Acquisition data statistical analysis data supervise perform SSD .', 'MRM draft manuscript author participate critical revision manuscript important intellectual content .', 'MRM ANP supervise study .', 'All author approve final manuscript responsible decision submit publication .', 'Declaration interest MRM report personal fee Abbott , Medtronic , Janssen , Mesoblast , Portola , Bayer , Baim Institute Clinical Research , NupulseCV , FineHeart , Leviticus , Roivant , Triple Gene .', 'SSD founder Surgisphere Corporation .', 'FR pay time spend committee member clinical trial , advisory board , form consult , lecture presentation ; payment make directly University Zurich personal payment receive relation trial activity .', 'ANP declare compete interest .', 'Acknowledgments The development maintenance Surgical Outcomes Collaborative database fund Surgisphere Corporation ( Chicago , IL , USA ) .', ""This study support William Harvey Distinguished Chair Advanced Cardiovascular Medicine Brigham Women 's Hospital ( Boston , MA , USA ) ."", 'We acknowledge Jide Olayinka ( Surgisphere ) helpful statistical review manuscript .', 'Download .pdf ( .6 MB ) Help pdf file Supplementary appendix Chloroquine hydroxychloroquine COVID-19 : might hazardous ? Full-TextPDF']","['backgroundhydroxychloroquine', 'hydroxychloroquine', '', 'often', 'combination', 'second-generation', 'macrolide', '', 'widely', 'treatment', 'covid-19', '', 'despite', 'conclusive', 'evidence', 'benefit', '', 'although', 'generally', 'safe', 'approve', 'indication', 'autoimmune', 'disease', 'malaria', '', 'safety', 'benefit', 'treatment', 'regimen', 'poorly', 'evaluate', 'covid-19methodswe', 'multinational', 'registry', 'analysis', 'hydroxychloroquine', 'hydroxychloroquine', 'without', 'macrolide', 'treatment', 'covid-19', '', 'registry', 'comprise', 'data', '671', 'hospital', 'six', 'continent', '', 'include', 'patient', 'hospitalise', 'dec', '20', '', '2019', '', 'april', '14', '', '2020', '', 'positive', 'laboratory', 'find', 'sars-cov-2', '', 'patients', 'receive', 'one', 'treatment', 'interest', 'within', '48', 'h', 'diagnosis', 'include', 'one', 'four', 'treatment', 'group', '', 'hydroxychloroquine', 'alone', '', 'hydroxychloroquine', 'macrolide', '', 'hydroxychloroquine', 'alone', '', 'hydroxychloroquine', 'macrolide', '', '', 'patient', 'receive', 'none', 'treatment', 'form', 'control', 'group', '', 'patients', 'one', 'treatment', 'interest', 'initiate', '48', 'h', 'diagnosis', 'mechanical', 'ventilation', '', 'well', 'patient', 'receive', 'remdesivir', '', 'exclude', '', 'main', 'outcome', 'interest', 'in-hospital', 'mortality', 'occurrence', 'de-novo', 'ventricular', 'arrhythmia', '', 'non-sustained', 'sustain', 'ventricular', 'tachycardia', 'ventricular', 'fibrillation', '', 'findings96', '032', 'patient', '', 'mean', 'age', '538', 'year', '', '463', '', 'woman', '', 'covid-19', 'hospitalise', 'study', 'period', 'meet', 'inclusion', 'criterion', '', '', '14', '888', 'patient', 'treatment', 'group', '', '1868', 'receive', 'hydroxychloroquine', '', '3783', 'receive', 'hydroxychloroquine', 'macrolide', '', '3016', 'receive', 'hydroxychloroquine', '', '6221', 'receive', 'hydroxychloroquine', 'macrolide', '', '81', '144', 'patient', 'control', 'group', '', '10', '698', '', '111', '', '', 'patient', 'die', 'hospital', '', 'control', 'multiple', 'confound', 'factor', '', 'age', '', 'sex', '', 'race', 'ethnicity', '', 'body-mass', 'index', '', 'underlie', 'cardiovascular', 'disease', 'risk', 'factor', '', 'diabetes', '', 'underlie', 'lung', 'disease', '', 'smoke', '', 'immunosuppressed', 'condition', '', 'baseline', 'disease', 'severity', '', '', 'compare', 'mortality', 'control', 'group', '', '93', '', '', '', 'hydroxychloroquine', '', '180', '', '', 'hazard', 'ratio', '1335', '', '95', '', 'ci', '12231457', '', '', 'hydroxychloroquine', 'macrolide', '', '238', '', '', '1447', '', '13681531', '', '', 'hydroxychloroquine', '', '164', '', '', '1365', '', '12181531', '', '', 'hydroxychloroquine', 'macrolide', '', '222', '', '', '1368', '', '12731469', '', 'independently', 'associate', 'increase', 'risk', 'in-hospital', 'mortality', '', 'compared', 'control', 'group', '', '03', '', '', '', 'hydroxychloroquine', '', '61', '', '', '2369', '', '19352900', '', '', 'hydroxychloroquine', 'macrolide', '', '81', '', '', '5106', '', '41065983', '', '', 'hydroxychloroquine', '', '43', '', '', '3561', '', '27604596', '', '', 'hydroxychloroquine', 'macrolide', '', '65', '', '', '4011', '', '33444812', '', 'independently', 'associate', 'increase', 'risk', 'de-novo', 'ventricular', 'arrhythmia', 'hospitalisationinterpretationwe', 'unable', 'confirm', 'benefit', 'hydroxychloroquine', 'hydroxychloroquine', '', 'alone', 'macrolide', '', 'in-hospital', 'outcome', 'covid-19', '', 'drug', 'regimen', 'associate', 'decrease', 'in-hospital', 'survival', 'increase', 'frequency', 'ventricular', 'arrhythmia', 'treatment', 'covid-19fundingwilliam', 'harvey', 'distinguished', 'chair', 'advanced', 'cardiovascular', 'medicine', 'brigham', 'women', 'hospital', '', 'hydroxychloroquine', 'hydroxychloroquine', '', 'often', 'combination', 'second-generation', 'macrolide', '', 'widely', 'treatment', 'covid-19', '', 'despite', 'conclusive', 'evidence', 'benefit', '', 'although', 'generally', 'safe', 'approve', 'indication', 'autoimmune', 'disease', 'malaria', '', 'safety', 'benefit', 'treatment', 'regimen', 'poorly', 'evaluate', 'covid-19', '', 'multinational', 'registry', 'analysis', 'hydroxychloroquine', 'hydroxychloroquine', 'without', 'macrolide', 'treatment', 'covid-19', '', 'registry', 'comprise', 'data', '671', 'hospital', 'six', 'continent', '', 'include', 'patient', 'hospitalise', 'dec', '20', '', '2019', '', 'april', '14', '', '2020', '', 'positive', 'laboratory', 'find', 'sars-cov-2', '', 'patients', 'receive', 'one', 'treatment', 'interest', 'within', '48', 'h', 'diagnosis', 'include', 'one', 'four', 'treatment', 'group', '', 'hydroxychloroquine', 'alone', '', 'hydroxychloroquine', 'macrolide', '', 'hydroxychloroquine', 'alone', '', 'hydroxychloroquine', 'macrolide', '', '', 'patient', 'receive', 'none', 'treatment', 'form', 'control', 'group', '', 'patients', 'one', 'treatment', 'interest', 'initiate', '48', 'h', 'diagnosis', 'mechanical', 'ventilation', '', 'well', 'patient', 'receive', 'remdesivir', '', 'exclude', '', 'main', 'outcome', 'interest', 'in-hospital', 'mortality', 'occurrence', 'de-novo', 'ventricular', 'arrhythmia', '', 'non-sustained', 'sustain', 'ventricular', 'tachycardia', 'ventricular', 'fibrillation', '', '', '96', '032', 'patient', '', 'mean', 'age', '538', 'year', '', '463', '', 'woman', '', 'covid-19', 'hospitalise', 'study', 'period', 'meet', 'inclusion', 'criterion', '', '', '14', '888', 'patient', 'treatment', 'group', '', '1868', 'receive', 'hydroxychloroquine', '', '3783', 'receive', 'hydroxychloroquine', 'macrolide', '', '3016', 'receive', 'hydroxychloroquine', '', '6221', 'receive', 'hydroxychloroquine', 'macrolide', '', '81', '144', 'patient', 'control', 'group', '', '10', '698', '', '111', '', '', 'patient', 'die', 'hospital', '', 'control', 'multiple', 'confound', 'factor', '', 'age', '', 'sex', '', 'race', 'ethnicity', '', 'body-mass', 'index', '', 'underlie', 'cardiovascular', 'disease', 'risk', 'factor', '', 'diabetes', '', 'underlie', 'lung', 'disease', '', 'smoke', '', 'immunosuppressed', 'condition', '', 'baseline', 'disease', 'severity', '', '', 'compare', 'mortality', 'control', 'group', '', '93', '', '', '', 'hydroxychloroquine', '', '180', '', '', 'hazard', 'ratio', '1335', '', '95', '', 'ci', '12231457', '', '', 'hydroxychloroquine', 'macrolide', '', '238', '', '', '1447', '', '13681531', '', '', 'hydroxychloroquine', '', '164', '', '', '1365', '', '12181531', '', '', 'hydroxychloroquine', 'macrolide', '', '222', '', '', '1368', '', '12731469', '', 'independently', 'associate', 'increase', 'risk', 'in-hospital', 'mortality', '', 'compared', 'control', 'group', '', '03', '', '', '', 'hydroxychloroquine', '', '61', '', '', '2369', '', '19352900', '', '', 'hydroxychloroquine', 'macrolide', '', '81', '', '', '5106', '', '41065983', '', '', 'hydroxychloroquine', '', '43', '', '', '3561', '', '27604596', '', '', 'hydroxychloroquine', 'macrolide', '', '65', '', '', '4011', '', '33444812', '', 'independently', 'associate', 'increase', 'risk', 'de-novo', 'ventricular', 'arrhythmia', 'hospitalisation', '', 'unable', 'confirm', 'benefit', 'hydroxychloroquine', 'hydroxychloroquine', '', 'alone', 'macrolide', '', 'in-hospital', 'outcome', 'covid-19', '', 'drug', 'regimen', 'associate', 'decrease', 'in-hospital', 'survival', 'increase', 'frequency', 'ventricular', 'arrhythmia', 'treatment', 'covid-19', '', 'william', 'harvey', 'distinguished', 'chair', 'advanced', 'cardiovascular', 'medicine', 'brigham', 'women', 'hospital', '', 'absence', 'effective', 'treatment', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', 'lead', 'clinician', 'redirect', 'drug', 'effective', 'medical', 'condition', 'treatment', 'covid-19', '', 'key', 'among', 'repurposed', 'therapeutic', 'agent', 'antimalarial', 'drug', 'hydroxychloroquine', 'analogue', 'hydroxychloroquine', '', 'treatment', 'autoimmune', 'disease', '', 'systemic', 'lupus', 'erythematosus', 'arthritis', 'arthritis1principi', 'n', 'esposito', 'hydroxychloroquine', 'hydroxychloroquine', 'prophylaxis', 'covid-19lancet', 'infect', 'dis', '', '2020', '', '', 'publish', 'online', 'april', '17', '', '', 'urlplaceholder', '', '2perricone', 'c', 'triggianese', 'p', 'bartoloni', 'e', 'althe', 'anti-viral', 'facet', 'anti-rheumatic', 'drug', '', 'lesson', 'covid-19j', 'autoimmun', '', '2020', '', '', 'publish', 'online', 'april', '17', '', '', 'doi101016jjaut2020102468google', 'drug', 'show', 'laboratory', 'condition', 'antiviral', 'property', 'well', 'immunomodulatory', 'effects3liu', 'j', 'cao', 'r', 'xu', 'alhydroxychloroquine', '', 'le', 'toxic', 'derivative', 'hydroxychloroquine', '', 'effective', 'inhibit', 'sars-cov-2', 'infection', 'vitrocell', 'discov', '', '2020', '', '6', '', '16google', '', '4devaux', 'ca', 'rolain', 'jm', 'colson', 'p', 'raoult', 'new', 'insight', 'antiviral', 'effect', 'hydroxychloroquine', 'coronavirus', '', 'expect', 'covid-19', '', 'int', 'j', 'antimicrob', 'agents', '', '2020', '', '', 'publish', 'online', 'march', '12', '', '', 'doi101016jijantimicag2020105938google', 'however', '', 'class', 'drug', 'covid-19', 'base', 'small', 'number', 'anecdotal', 'experience', 'show', 'variable', 'response', 'uncontrolled', 'observational', 'analysis', '', 'small', '', 'open-label', '', 'randomise', 'trial', 'largely', 'inconclusive5tang', 'w', 'cao', 'z', 'han', 'alhydroxychloroquine', 'patient', 'mainly', 'mild', 'moderate', 'covid-19', '', 'open-label', '', 'randomize', '', 'control', 'trialmedrxiv', '', '2020', '', '', 'publish', 'online', '7', '', '', '', 'preprint', '', 'doi', '', '1011012020041020060558google', '', '6chen', 'j', 'liu', 'liu', 'l', 'ala', 'pilot', 'study', 'hydroxychloroquine', 'treatment', 'patient', 'moderate', 'covid-19j', 'zhejiang', 'univ', '', 'med', 'sci', '', '', '2020', '', '49', '', '215-219google', 'combination', 'hydroxychloroquine', 'second-generation', 'macrolide', '', 'azithromycin', '', 'clarithromycin', '', '', 'advocate', '', 'despite', 'limit', 'evidence', 'effectiveness7gautret', 'p', 'lagier', 'jc', 'parola', 'p', 'alhydroxychloroquine', 'azithromycin', 'treatment', 'covid-19', '', 'result', 'open-label', 'non-randomized', 'clinical', 'trialint', 'j', 'antimicrob', 'agents', '', '2020', '', '', 'publish', 'online', 'march', '20', '', '', 'doi101016jijantimicag2020105949google', 'previous', 'study', 'show', 'treatment', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'either', 'drug', 'combine', 'macrolide', 'cardiovascular', 'adverse', 'effect', 'prolongation', 'qt', 'interval', '', 'mechanism', 'predispose', 'ventricular', 'arrhythmias8ray', 'wa', 'murray', 'kt', 'hall', 'k', 'arbogast', 'pg', 'stein', 'cm', 'azithromycin', 'risk', 'cardiovascular', 'deathn', 'engl', 'j', 'med', '', '2012', '', '366', '', '1881-1890google', '', '9giudicessi', 'jr', 'noseworthy', 'pa', 'friedman', 'pa', 'ackerman', 'mj', 'urgent', 'guidance', 'navigate', 'circumvent', 'qtc-prolonging', 'torsadogenic', 'potential', 'possible', 'pharmacotherapies', 'coronavirus', 'disease', '19', '', 'covid-19', '', 'mayo', 'clin', 'proc', '', '2020', '', '', 'publish', 'online', 'april', '7', '', '', 'doi101016jmayocp202003024google', 'research', 'contextevidence', 'studywe', 'search', 'medline', '', 'via', '', 'article', 'publish', 'april', '21', '', '2020', '', 'key', 'word', '', 'novel', 'coronavirus', '', '', '', '2019-ncov', '', '', '', 'covid-19', '', '', '', 'sars-cov-2', '', '', '', 'therapy', '', '', '', 'hydroxychloroquine', '', '', '', 'hydroxychloroquine', '', '', '', 'macrolide', '', '', 'moreover', '', 'screen', 'preprint', 'server', '', 'medrxiv', '', 'relevant', 'article', 'consult', 'web', 'page', 'organisation', 'us', 'national', 'institutes', 'health', '', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', 'widely', 'advocate', 'treatment', 'covid-19', 'base', 'in-vitro', 'evidence', 'antiviral', 'effect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'base', 'small', 'uncontrolled', 'study', 'absence', 'evidence', 'randomise', 'control', 'trial', '', 'concerns', 'raise', 'drug', 'combination', 'macrolides', 'result', 'electrical', 'instability', 'predispose', 'patient', 'ventricular', 'arrhythmia', '', 'whether', 'drug', 'improve', 'outcome', 'associate', 'harm', 'covid-19', 'remain', 'unknownadded', 'value', 'studyin', 'absence', 'report', 'randomise', 'trial', '', 'urgent', 'evaluate', 'real-world', 'evidence', 'relate', 'outcome', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolides', '', 'covid-19', '', 'using', 'international', '', 'observational', 'registry', 'across', 'six', 'continent', '', 'assess', '96', '032', 'patient', 'covid-19', '', '14', '888', 'treat', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'combination', 'macrolide', '', 'control', 'age', '', 'sex', '', 'race', 'ethnicity', '', 'underlie', 'comorbidities', '', 'disease', 'severity', 'baseline', '', 'four', 'regimen', 'associate', 'increase', 'hazard', 'de-novo', 'ventricular', 'arrythmia', 'death', 'hospital', '', 'study', 'provide', 'real-world', 'evidence', 'therapeutic', 'regimen', 'include', 'large', 'number', 'patient', 'across', 'world', '', 'thus', '', 'knowledge', '', 'find', 'provide', 'comprehensive', 'evidence', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', 'treatment', 'covid-19implications', 'available', 'evidencewe', 'find', 'evidence', 'benefit', 'hydroxychloroquine', 'hydroxychloroquine', 'either', 'alone', 'macrolide', '', 'previous', 'evidence', 'derive', 'either', 'small', 'anecdotal', 'study', 'inconclusive', 'small', 'randomise', 'trial', '', 'study', 'include', 'large', 'number', 'patient', 'across', 'multiple', 'geographic', 'region', 'provide', 'robust', 'real-world', 'evidence', 'date', 'usefulness', 'treatment', 'regimen', '', 'although', 'observational', 'study', 'fully', 'account', 'unmeasured', 'confound', 'factor', '', 'find', 'suggest', 'absence', 'therapeutic', 'benefit', 'potential', 'harm', 'hydroxychloroquine', 'hydroxychloroquine', 'drug', 'regimen', '', 'without', 'macrolide', '', 'hospitalise', 'patient', 'covid-19', '', 'evidence', 'study', 'search', 'medline', '', 'via', '', 'article', 'publish', 'april', '21', '', '2020', '', 'key', 'word', '', 'novel', 'coronavirus', '', '', '', '2019-ncov', '', '', '', 'covid-19', '', '', '', 'sars-cov-2', '', '', '', 'therapy', '', '', '', 'hydroxychloroquine', '', '', '', 'hydroxychloroquine', '', '', '', 'macrolide', '', '', 'moreover', '', 'screen', 'preprint', 'server', '', 'medrxiv', '', 'relevant', 'article', 'consult', 'web', 'page', 'organisation', 'us', 'national', 'institutes', 'health', '', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', 'widely', 'advocate', 'treatment', 'covid-19', 'base', 'in-vitro', 'evidence', 'antiviral', 'effect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'base', 'small', 'uncontrolled', 'study', 'absence', 'evidence', 'randomise', 'control', 'trial', '', 'concerns', 'raise', 'drug', 'combination', 'macrolides', 'result', 'electrical', 'instability', 'predispose', 'patient', 'ventricular', 'arrhythmia', '', 'whether', 'drug', 'improve', 'outcome', 'associate', 'harm', 'covid-19', 'remain', 'unknown', '', 'added', 'value', 'study', 'absence', 'report', 'randomise', 'trial', '', 'urgent', 'evaluate', 'real-world', 'evidence', 'relate', 'outcome', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolides', '', 'covid-19', '', 'using', 'international', '', 'observational', 'registry', 'across', 'six', 'continent', '', 'assess', '96', '032', 'patient', 'covid-19', '', '14', '888', 'treat', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'combination', 'macrolide', '', 'control', 'age', '', 'sex', '', 'race', 'ethnicity', '', 'underlie', 'comorbidities', '', 'disease', 'severity', 'baseline', '', 'four', 'regimen', 'associate', 'increase', 'hazard', 'de-novo', 'ventricular', 'arrythmia', 'death', 'hospital', '', 'study', 'provide', 'real-world', 'evidence', 'therapeutic', 'regimen', 'include', 'large', 'number', 'patient', 'across', 'world', '', 'thus', '', 'knowledge', '', 'find', 'provide', 'comprehensive', 'evidence', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', 'treatment', 'covid-19', '', 'implications', 'available', 'evidence', 'find', 'evidence', 'benefit', 'hydroxychloroquine', 'hydroxychloroquine', 'either', 'alone', 'macrolide', '', 'previous', 'evidence', 'derive', 'either', 'small', 'anecdotal', 'study', 'inconclusive', 'small', 'randomise', 'trial', '', 'study', 'include', 'large', 'number', 'patient', 'across', 'multiple', 'geographic', 'region', 'provide', 'robust', 'real-world', 'evidence', 'date', 'usefulness', 'treatment', 'regimen', '', 'although', 'observational', 'study', 'fully', 'account', 'unmeasured', 'confound', 'factor', '', 'find', 'suggest', 'absence', 'therapeutic', 'benefit', 'potential', 'harm', 'hydroxychloroquine', 'hydroxychloroquine', 'drug', 'regimen', '', 'without', 'macrolide', '', 'hospitalise', 'patient', 'covid-19', '', 'although', 'several', 'multicentre', 'randomise', 'control', 'trial', 'underway', '', 'press', 'provide', 'accurate', 'clinical', 'guidance', 'hydroxychloroquine', 'hydroxychloroquine', 'along', 'macrolides', 'widespread', '', 'often', 'little', 'regard', 'potential', 'risk', '', 'country', 'stockpile', 'drug', '', 'result', 'shortage', 'medication', 'approve', 'clinical', 'indications10peschken', 'ca', 'possible', 'consequence', 'shortage', 'hydroxychloroquine', 'patient', 'systemic', 'lupus', 'erythematosus', 'amid', 'covid-19', 'pandemicj', 'rheumatol', '', '2020', '', '', 'publish', 'online', 'april', '8', '', '', 'doi103899jrheum200395google', 'purpose', 'study', 'evaluate', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'macrolide', 'treatment', 'covid-19', 'large', 'multinational', 'registry', 'ass', 'real-world', 'application', '', 'principally', '', 'seek', 'analyse', 'association', 'treatment', 'regimen', 'in-hospital', 'death', '', 'secondarily', '', 'aim', 'evaluate', 'occurrence', 'de-novo', 'clinically', 'significant', 'ventricular', 'arrhythmia', '', 'multinational', 'registry', 'analysis', 'hydroxychloroquine', 'hydroxychloroquine', 'without', 'macrolide', 'treatment', 'covid-19', '', 'registry', 'comprise', '671', 'hospital', 'locate', 'six', 'continent', '', 'appendix', 'p', '3', '', '', 'surgical', 'outcomes', 'collaborative', '', 'surgisphere', 'corporation', '', 'chicago', '', 'il', '', 'usa', '', 'consist', 'de-identified', 'data', 'obtain', 'automate', 'data', 'extraction', 'inpatient', 'outpatient', 'electronic', 'health', 'record', '', 'supply', 'chain', 'database', '', 'financial', 'record', '', 'registry', 'us', 'cloud-based', 'health-care', 'data', 'analytics', 'platform', 'include', 'specific', 'module', 'data', 'acquisition', '', 'data', 'warehouse', '', 'data', 'analytics', '', 'data', 'report', '', 'manual', 'data', 'entry', 'process', 'quality', 'assurance', 'validation', 'ensure', 'key', 'miss', 'value', 'keep', 'minimum', '', 'surgical', 'outcomes', 'collaborative', '', 'hereafter', 'refer', 'collaborative', '', 'ensure', 'compliance', 'us', 'food', 'drug', 'administration', '', 'fda', '', 'guidance', 'real-world', 'evidence', '', 'real-world', 'data', 'collect', 'automate', 'data', 'transfer', 'capture', '100', '', 'data', 'health-care', 'entity', 'regular', '', 'predetermine', 'interval', '', 'thus', 'reduce', 'impact', 'selection', 'bias', 'miss', 'value', '', 'ensure', 'data', 'current', '', 'reliable', '', 'relevant', '', 'verifiable', 'source', 'documentation', 'element', 'include', 'electronic', 'inpatient', 'outpatient', 'medical', 'record', '', 'accordance', 'fda', 'guidance', 'relevance', 'real-world', 'data', '', 'data', 'acquisition', 'perform', 'standardise', 'health', 'level', 'seven-compliant', 'data', 'dictionary', '', 'data', 'collect', 'prospective', 'ongoing', 'basis', '', 'validation', 'procedure', 'registry', 'refer', 'standard', 'operate', 'procedure', 'place', 'four', 'iso', '90012015', 'iso', '270012013', 'certify', 'feature', 'registry', '', 'data', 'acquisition', '', 'data', 'warehouse', '', 'data', 'analytics', '', 'data', 'report', '', 'standardise', 'health', 'level', 'seven-compliant', 'data', 'dictionary', 'collaborative', 'serf', 'focal', 'point', 'data', 'acquisition', 'warehouse', '', 'data', 'dictionary', 'harmonise', 'electronic', 'health', 'record', 'data', '', 'data', 'acquisition', 'complete', 'automate', 'interface', 'expedite', 'data', 'transfer', 'improve', 'data', 'integrity', '', 'collection', '100', '', 'sample', 'health-care', 'entity', 'validate', 'financial', 'record', 'external', 'database', 'minimise', 'selection', 'bias', '', 'reduce', 'risk', 'inadvertent', 'protect', 'health', 'information', 'disclosure', '', 'information', 'strip', 'storage', 'cloud-based', 'data', 'warehouse', '', 'collaborative', 'intend', 'minimise', 'effect', 'information', 'bias', 'selection', 'bias', 'capture', 'all-comer', 'data', 'consecutive', 'patient', 'enrolment', 'capture', '100', '', 'data', 'within', 'electronic', 'system', '', 'ensure', 'result', 'remain', 'generalisable', 'larger', 'population', '', 'collaborative', 'compliant', 'us', 'agency', 'healthcare', 'research', 'quality', 'guideline', 'registry', '', 'onset', 'covid-19', 'crisis', '', 'registry', 'collect', 'data', 'hospital', 'usa', '', 'select', 'match', 'epidemiological', 'characteristic', 'us', 'population', '', 'internationally', '', 'achieve', 'representation', 'diverse', 'population', 'across', 'six', 'continent', '', 'data', 'collect', 'variety', 'urban', 'rural', 'hospital', '', 'academic', 'community', 'hospital', '', 'for-profit', 'non-profit', 'hospital', '', 'data', 'collection', 'analysis', 'deem', 'exempt', 'ethic', 'review', '', 'include', 'patient', 'hospitalise', 'dec', '20', '', '2019', '', 'april', '14', '', '2020', '', 'hospital', 'participate', 'registry', 'pcr-confirmed', 'covid-19', 'infection', '', 'clinical', 'outcome', 'either', 'hospital', 'discharge', 'death', 'hospitalisation', 'record', '', 'positive', 'laboratory', 'find', 'sars-cov-2', 'define', 'positive', 'result', 'high-throughput', 'sequence', 'reverse', 'transcription-quantitative', 'pcr', 'assay', 'nasal', 'pharyngeal', 'swab', 'specimen', '', 'find', 'classify', 'patient', 'positive', 'covid-19', '', 'covid-19', 'diagnose', '', 'site', '', 'basis', 'guidance11whoclinical', 'management', 'severe', 'acute', 'respiratory', 'infection', '', 'sari', '', 'novel', 'covid-19', 'disease', 'suspect', '', 'interim', 'guidance', '', 'urlplaceholder', 'march', '13', '', '2020date', 'access', '', 'april', '24', '', '2020google', 'patients', 'record', 'test', 'database', '', 'negative', 'test', '', 'include', 'study', '', 'one', 'positive', 'test', 'necessary', 'patient', 'include', 'analysis', '', 'patients', 'receive', 'either', 'hydroxychloroquine', 'hydroxychloroquine', 'analogue-based', 'treatment', '', 'without', 'second-generation', 'macrolide', '', 'include', 'treatment', 'group', '', 'patients', 'receive', 'treatment', 'regimen', 'start', '48', 'h', 'covid-19', 'diagnosis', 'exclude', '', 'exclude', 'data', 'patient', 'treatment', 'initiate', 'mechanical', 'ventilation', 'receive', 'therapy', 'antiviral', 'remdesivir', '', 'specific', 'exclusion', 'criterion', 'establish', 'avoid', 'enrolment', 'patient', 'treatment', 'start', 'non-uniform', 'time', 'course', 'covid-19', 'illness', 'exclude', 'individual', 'drug', 'regimen', 'critical', 'phase', 'illness', '', 'skew', 'interpretation', 'result', '', 'thus', '', 'define', 'four', 'distinct', 'treatment', 'group', '', 'patient', 'start', 'therapy', 'within', '48', 'h', 'establish', 'covid-19', 'diagnosis', '', 'hydroxychloroquine', 'alone', '', 'hydroxychloroquine', 'macrolide', '', 'hydroxychloroquine', 'alone', '', 'hydroxychloroquine', 'macrolide', '', 'include', 'patient', 'serve', 'control', 'population', '', 'patient', 'demographic', '', 'include', 'age', '', 'body-mass', 'index', '', 'bmi', '', '', 'sex', '', 'race', 'ethnicity', '', 'continent', 'origin', 'obtain', '', 'underlying', 'comorbidities', '', 'base', 'international', 'classification', 'diseases', '', 'tenth', 'revision', '', 'clinical', 'modification', 'code', '', 'present', 'either', 'inpatient', 'outpatient', 'electronic', 'health', 'record', 'collect', '', 'include', 'cardiovascular', 'disease', '', 'include', 'coronary', 'artery', 'disease', '', 'congestive', 'heart', 'failure', '', 'history', 'cardiac', 'arrhythmia', '', '', 'current', 'previous', 'history', 'smoke', '', 'history', 'hypertension', '', 'diabetes', '', 'hyperlipidaemia', '', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', '', 'presence', 'immunosuppressed', 'condition', '', 'steroid', '', 'pre-existing', 'immunological', 'condition', '', 'current', 'chemotherapy', 'individual', 'cancer', '', '', 'collect', 'data', 'medication', 'baseline', '', 'include', 'cardiac', 'medication', '', 'angiotensin', 'convert', 'enzyme', '', 'ace', '', 'inhibitor', '', 'angiotensin', 'receptor', 'blocker', '', 'statin', '', 'antiviral', 'therapy', 'drug', 'regimen', 'evaluate', '', 'initiation', 'hydroxychloroquine', 'hydroxychloroquine', 'hospital', 'admission', 'record', '', 'include', 'time', 'initiation', '', 'second-generation', 'macrolides', '', 'specifically', 'azithromycin', 'clarithromycin', '', 'similarly', 'record', '', 'quick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'qsofa', '', 'calculate', 'start', 'therapy', '', 'include', 'score', 'calculation', 'mental', 'status', '', 'respiratory', 'rate', '', 'systolic', 'blood', 'pressure', '', 'oxygen', 'saturation', '', 'spo2', '', 'room', 'air', 'record', '', 'measure', 'disease', 'severity', '', 'primary', 'outcome', 'interest', 'association', 'treatment', 'regimen', 'contain', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'second-generation', 'macrolide', '', 'initiate', 'early', 'covid-19', 'diagnosis', 'endpoint', 'in-hospital', 'mortality', '', 'secondary', 'outcome', 'interest', 'association', 'treatment', 'regimen', 'occurrence', 'clinically', 'significant', 'ventricular', 'arrhythmia', '', 'define', 'first', 'occurrence', 'non-sustained', '', 'least', '6', 'sec', '', 'sustain', 'ventricular', 'tachycardia', 'ventricular', 'fibrillation', '', 'hospitalisation', '', 'analyse', 'rate', 'progression', 'mechanical', 'ventilation', 'total', 'intensive', 'care', 'unit', 'length', 'stay', '', 'day', '', 'patient', 'group', '', 'primary', 'analysis', 'in-hospital', 'mortality', '', 'control', 'confound', 'factor', '', 'include', 'demographic', 'variable', '', 'comorbidities', '', 'disease', 'severity', 'presentation', '', 'medication', '', 'cardiac', 'medication', 'antiviral', 'therapy', '', '', 'categorical', 'variable', 'show', 'frequency', 'percentage', '', 'continuous', 'variable', 'mean', 'sds', '', 'comparison', 'continuous', 'data', 'group', 'unpaired', 't-test', 'categorical', 'data', 'compare', 'fisher', 'exact', 'test', '', 'p', 'value', 'le', '005', 'consider', 'significant', '', 'multiple', 'imputation', 'miss', 'value', 'possible', 'disease', 'drug', 'variable', '', 'code', 'indicate', 'data', 'miss', '', 'patient', 'electronic', 'health', 'record', 'include', 'information', 'clinical', 'characteristic', '', 'assume', 'characteristic', 'present', '', 'cox', 'proportional', 'hazard', 'regression', 'analysis', 'evaluate', 'effect', 'age', '', 'sex', '', 'race', 'ethnicity', '', 'white', 'race', 'reference', 'group', '', '', 'comorbidities', '', 'bmi', '', 'presence', 'coronary', 'artery', 'disease', '', 'presence', 'congestive', 'heart', 'failure', '', 'history', 'cardiac', 'arrhythmia', '', 'diabetes', '', 'copd', '', 'current', 'smoker', '', 'history', 'hypertension', '', 'immunocompromised', 'state', '', 'history', 'hyperlipidaemia', '', '', 'medication', '', 'cardiac', 'medication', '', 'antiviral', '', 'treatment', 'regimen', 'interest', '', '', 'severity', 'illness', 'score', '', 'qsofa', '', '1', 'spo2', '', '94', '', '', 'risk', 'clinically', 'significant', 'ventricular', 'arrhythmia', '', 'time', 'admission', 'first', 'occurrence', '', 'event', 'occur', '', 'time', 'discharge', '', 'mortality', '', 'time', 'admission', 'inpatient', 'mortality', 'discharge', '', '', 'age', 'bmi', 'treat', 'continuous', 'variable', 'data', 'treat', 'categorical', 'variable', 'model', '', 'model', '', 'hazard', 'ratio', '', 'hrs', '', '95', '', 'cis', 'estimate', 'include', 'variable', 'determine', 'effect', 'risk', 'in-hospital', 'mortality', '', 'primary', 'endpoint', '', 'subsequent', 'mechanical', 'ventilation', 'death', '', 'composite', 'endpoint', '', '', 'independence', 'survival', 'time', '', 'time', 'first', 'arrhythmia', 'ventricular', 'arrhythmia', 'analysis', '', 'confirm', '', 'proportionality', 'predictor', 'hazard', 'validate', 'evaluation', 'schoenfeld', 'residual', '', 'find', 'p', '', '005', 'thus', 'confirm', 'proportionality', '', 'minimise', 'effect', 'confound', 'factor', '', 'propensity', 'score', 'match', 'analysis', 'individually', 'four', 'treatment', 'group', 'compare', 'control', 'group', 'receive', 'form', 'therapy', '', 'treatment', 'group', '', 'separate', 'match', 'control', 'identify', 'exact', 'propensity-score', 'match', 'criterion', 'calliper', '0001', '', 'method', 'provide', 'close', 'approximation', 'demographic', '', 'comorbidities', '', 'disease', 'severity', '', 'baseline', 'medication', 'patient', '', 'propensity', 'score', 'base', 'follow', 'variable', '', 'age', '', 'bmi', '', 'gender', '', 'race', 'ethnicity', '', 'comorbidities', '', 'ace', 'inhibitor', '', 'statin', '', 'angiotensin', 'receptor', 'blocker', '', 'treatment', 'antiviral', '', 'qsofa', 'score', 'le', '1', '', 'spo2', 'le', '94', '', 'room', 'air', '', 'patient', 'well', 'match', '', 'standardise', 'mean', 'difference', 'estimate', 'le', '10', '', 'match', 'parameter', '', 'additional', 'analysis', 'examine', 'robustness', 'estimate', 'initially', 'obtain', '', 'individual', 'analysis', 'continent', 'origin', 'sex-adjusted', 'analysis', 'cox', 'proportional', 'hazard', 'model', 'perform', '', 'tipping-point', 'analysis', '', 'analysis', 'show', 'effect', 'size', 'prevalence', 'unmeasured', 'confounder', 'shift', 'upper', 'boundary', 'ci', 'towards', 'null', '', '', 'statistical', 'analysis', 'r', 'version', '363', 'spss', 'version', '26', '', 'funder', 'study', 'role', 'study', 'design', '', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'correspond', 'author', 'co-author', 'anp', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', '96', '032', 'hospitalise', 'patient', '671', 'hospital', 'diagnose', 'covid-19', 'dec', '20', '', '2019', '', 'april', '14', '', '2020', 'meet', 'inclusion', 'criterion', 'study', '', 'figure', '1', '', '', 'include', 'patient', 'complete', 'hospital', 'course', '', 'discharge', 'die', '', 'april', '21', '', '2020', '', 'patients', 'hospitalise', 'study', 'period', 'without', 'complete', 'course', 'unable', 'analyse', '', 'study', 'cohort', 'include', '63', '315', '', '659', '', '', 'patient', 'north', 'america', '', '16', '574', '', '173', '', '', 'europe', '', '7555', '', '79', '', '', 'asia', '', '4402', '', '46', '', '', 'africa', '', '3577', '', '37', '', '', 'south', 'america', '', '609', '', '06', '', '', 'australia', '', 'detail', 'number', 'hospital', 'per', 'continent', 'present', 'appendix', '', 'p', '3', '', '', 'mean', 'age', '538', 'year', '', 'sd', '176', '', '', '44', '426', '', '463', '', '', 'woman', '', 'mean', 'bmi', '276', 'kgm2', '', 'sd', '55', '', '29', '510', '', '307', '', '', 'obese', 'bmi', '30', 'kgm2', '', '', '64', '220', '', '669', '', '', 'white', '', '9054', '', '94', '', '', 'black', '', '5978', '', '62', '', '', 'hispanic', '', '13', '519', '', '141', '', '', 'asian', 'origin', '', 'appendix', 'p', '4', '', '', 'term', 'comorbidities', '', '30', '198', '', '314', '', '', 'hyperlipidaemia', '', '25', '810', '', '269', '', '', 'hypertension', '', '13', '260', '', '138', '', '', 'diabetes', '', '3177', '', '33', '', '', 'copd', '', '2868', '', '30', '', '', 'underlie', 'immunosuppressed', 'condition', '', '16', '553', '', '172', '', '', 'former', 'smoker', '', '9488', '', '99', '', '', 'current', 'smoker', '', 'term', 'pre-existing', 'cardiovascular', 'disease', '', '12', '137', '', '126', '', '', 'coronary', 'artery', 'disease', '', '2368', '', '25', '', '', 'history', 'congestive', 'heart', 'failure', '', '3381', '', '35', '', '', 'history', 'arrhythmia', '', 'mean', 'length', 'stay', 'hospital', '91', 'day', '', 'sd', '64', '', '', 'overall', 'in-hospital', 'mortality', '10', '698', '', '111', '', '', '96', '032', '', 'antiviral', 'record', '38', '927', '', '405', '', '', 'patient', 'treatment', 'covid-19', '', 'common', 'antiviral', 'lopinavir', 'ritonavir', '', '12', '304', '', '316', '', '', '', '', 'ribavirin', '', '7904', '', '203', '', '', '', '', 'oseltamivir', '', '5101', '', '131', '', '', '', '', 'combination', 'therapy', 'one', 'antiviral', 'regimen', '6782', '', '174', '', '', 'patientsfigure', '1study', 'profileview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'treatment', 'group', 'include', '1868', 'patient', 'give', 'hydroxychloroquine', 'alone', '', '3016', 'give', 'hydroxychloroquine', 'alone', '', '3783', 'give', 'hydroxychloroquine', 'macrolide', '6221', 'give', 'hydroxychloroquine', 'macrolide', '', 'median', 'time', 'hospitalisation', 'diagnosis', 'covid-19', '2', 'day', '', 'iqr', '14', '', '', 'mean', 'daily', 'dose', 'duration', 'various', 'drug', 'regimen', 'follow', '', 'hydroxychloroquine', 'alone', '', '765', 'mg', '', 'sd', '308', '', '66', 'day', '', '24', '', '', 'hydroxychloroquine', 'alone', '', '596', 'mg', '', '126', '', '42', 'day', '', '19', '', '', 'hydroxychloroquine', 'macrolide', '', '790', 'mg', '', '320', '', '68', 'day', '', '25', '', '', 'hydroxychloroquine', 'macrolide', '', '597', 'mg', '', '128', '', '43', 'day', '', '20', '', '', 'additional', 'detail', 'study', 'cohort', 'provide', 'appendix', '', 'pp', '45', '', '', 'demographic', 'variable', 'comorbidities', 'compare', 'among', 'survivor', 'non-survivors', '', 'table', '1', '', '', 'non-survivors', 'older', '', 'likely', 'obese', '', 'likely', 'men', '', 'likely', 'black', 'hispanic', '', 'diabetes', '', 'hyperlipidaemia', '', 'coronary', 'artery', 'disease', '', 'congestive', 'heart', 'failure', '', 'history', 'arrhythmia', '', 'non-survivors', 'likely', 'copd', 'report', 'current', 'smokingtable', '1demographics', 'comorbidities', 'patient', 'survival', 'non-survival', 'hospitalisationsurvivors', '', 'n85', '334', '', 'non-survivors', '', 'n10', '698', '', 'p', 'valueage', '', 'years531', '', '175', '', '600', '', '176', '', '', '00001bmi', '', 'kgm2270', '', '51', '', '318', '', '64', '', '', '00001obese', '', 'bmi', '', '30', 'kgm222', '992', '', '269', '', '', '6518', '', '609', '', '', '', '00001sexfemale40', '169', '', '471', '', '', '4257', '', '398', '', '', '', '00001male45', '165', '', '529', '', '', '6441', '', '602', '', '', '', '00001race', 'ethnicitywhite57', '503', '', '674', '', '', '6717', '', '628', '', '', '', '00001black7219', '', '85', '', '', '1835', '', '172', '', '', '', '00001hispanic4948', '', '58', '', '', '1030', '', '96', '', '', '', '00001asian12', '657', '', '148', '', '', '862', '', '81', '', '', '', '00001native', 'american1023', '', '12', '', '', '56', '', '05', '', '', '', '00001other1984', '', '23', '', '', '198', '', '19', '', '', '00019comorbidities', 'baselinecoronary', 'artery', 'disease9777', '', '115', '', '', '2360', '', '221', '', '', '', '00001congestive', 'heart', 'failure1828', '', '21', '', '', '540', '', '50', '', '', '', '00001arrhythmia2700', '', '32', '', '', '681', '', '64', '', '', '', '00001diabetes10', '963', '', '128', '', '', '2297', '', '215', '', '', '', '00001hypertension21', '948', '', '257', '', '', '3862', '', '361', '', '', '', '00001hyperlipidaemia26', '480', '', '310', '', '', '3718', '', '348', '', '', '', '00001copd2603', '', '31', '', '', '574', '', '54', '', '', '', '00001current', 'smoker7972', '', '93', '', '', '1516', '', '142', '', '', '', '00001former', 'smoker14', '681', '', '172', '', '', '1872', '', '175', '', '', '045immunocompromised2406', '', '28', '', '', '462', '', '43', '', '', '', '00001medicationsace', 'inhibitor7521', '', '88', '', '', '428', '', '40', '', '', '', '00001statin8506', '', '100', '', '', '739', '', '69', '', '', '', '00001angiotensin', 'receptor', 'blocker5190', '', '61', '', '', '659', '', '62', '', '', '075antiviral35', '189', '', '412', '', '', '3738', '', '349', '', '', '', '00001disease', 'severityqsofa', '', '171', '457', '', '837', '', '', '7911', '', '739', '', '', '', '00001spo2', '', '94', '', '7188', '', '84', '', '', '2129', '', '199', '', '', '', '00001treatment', 'groupchloroquine', 'alone1561', '', '18', '', '', '307', '', '29', '', '', '', '00001chloroquine', 'macrolide', '', '', 'macrolides', 'include', 'azithromycin', 'clarithromycin2944', '', '34', '', '', '839', '', '78', '', '', '', '00001hydroxychloroquine', 'alone2473', '', '29', '', '', '543', '', '51', '', '', '', '00001hydroxychloroquine', 'macrolide', '', '', 'macrolides', 'include', 'azithromycin', 'clarithromycin4742', '', '56', '', '', '1479', '', '138', '', '', '', '00001outcomesde-novo', 'ventricular', 'arrhythmia839', '', '10', '', '', '400', '', '37', '', '', '', '00001non-icu', 'length', 'stay', '', 'days90', '', '62', '', '98', '', '74', '', '', '00001icu', 'length', 'stay', '', 'days21', '', '37', '', '94', '', '106', '', '', '00001total', 'length', 'stay', '', 'days111', '', '73', '', '192', '', '144', '', '', '00001mechanical', 'ventilation4821', '', '56', '', '', '4533', '', '424', '', '', '', '00001data', 'mean', '', 'sd', '', 'n', '', '', '', '', 'bmibody-mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'aceangiotensin-converting', 'enzyme', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturation', '', 'icuintensive', 'care', 'unit', '', '', 'macrolides', 'include', 'azithromycin', 'clarithromycin', '', 'open', 'table', 'new', 'tab', 'data', 'mean', '', 'sd', '', 'n', '', '', '', '', 'bmibody-mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'aceangiotensin-converting', 'enzyme', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturation', '', 'icuintensive', 'care', 'unit', '', 'distribution', 'demographic', '', 'comorbidities', '', 'outcome', 'four', 'treatment', 'group', 'show', 'table', '2', '', 'significant', 'between-group', 'difference', 'find', 'among', 'baseline', 'characteristic', 'comorbidities', '', 'ventricular', 'arrhythmia', 'common', 'treatment', 'group', 'compare', 'control', 'population', '', 'mortality', 'higher', 'treatment', 'group', 'compare', 'control', 'population', '', 'p', '', '00001', '', 'appendix', 'pp', '1518', '', 'table', '2patient', 'demographic', 'characteristic', 'treatment', 'groupcontrol', 'group', '', 'n81', '144', '', 'hydroxychloroquine', '', 'n1868', '', 'hydroxychloroquine', 'macrolide', '', '', 'macrolides', 'include', 'clarithromycin', 'azithromycin', '', '', 'n3783', '', 'hydroxychloroquine', '', 'n3016', '', 'hydroxychloroquine', 'macrolide', '', '', 'macrolides', 'include', 'clarithromycin', 'azithromycin', '', '', 'n6221', '', 'age', '', 'years536', '', '176', '', '551', '', '180', '', '549', '', '177', '', '551', '', '179', '', '552', '', '177', '', 'bmi', '', 'kgm2274', '', '54', '', '278', '', '61', '', '282', '', '58', '', '284', '', '59', '', '285', '', '59', '', 'sexfemale37', '716', '', '465', '', '', '845', '', '452', '', '', '1718', '', '454', '', '', '1388', '', '460', '', '', '2759', '', '443', '', '', 'male43', '428', '', '535', '', '', '1023', '', '548', '', '', '2065', '', '546', '', '', '1628', '', '540', '', '', '3462', '', '557', '', '', 'race', 'ethnicitywhite54', '403', '', '671', '', '', '1201', '', '643', '', '', '2418', '', '639', '', '', '2074', '', '688', '', '', '4124', '', '663', '', '', 'black7519', '', '93', '', '', '203', '', '109', '', '', '369', '', '98', '', '', '287', '', '95', '', '', '676', '', '109', '', '', 'hispanic4943', '', '61', '', '', '108', '', '58', '', '', '273', '', '72', '', '', '194', '', '64', '', '', '460', '', '74', '', '', 'asian11', '504', '', '142', '', '', '301', '', '161', '', '', '603', '', '159', '', '', '366', '', '121', '', '', '745', '', '120', '', '', 'native', 'american922', '', '11', '', '', '19', '', '10', '', '', '37', '', '10', '', '', '33', '', '11', '', '', '68', '', '11', '', '', 'other1853', '', '23', '', '', '36', '', '19', '', '', '83', '', '22', '', '', '62', '', '21', '', '', '148', '', '24', '', '', 'comorbiditiescoronary', 'artery', 'disease10', '076', '', '124', '', '', '284', '', '152', '', '', '515', '', '136', '', '', '421', '', '140', '', '', '841', '', '135', '', '', 'congestive', 'heart', 'failure1949', '', '24', '', '', '50', '', '27', '', '', '103', '', '27', '', '', '78', '', '26', '', '', '188', '', '30', '', '', 'arrhythmia2861', '', '35', '', '', '63', '', '34', '', '', '126', '', '33', '', '', '108', '', '36', '', '', '223', '', '36', '', '', 'diabetes11', '058', '', '136', '', '', '258', '', '138', '', '', '584', '', '154', '', '', '447', '', '148', '', '', '913', '', '147', '', '', 'hypertension21', '437', '', '264', '', '', '560', '', '300', '', '', '1095', '', '289', '', '', '891', '', '295', '', '', '1827', '', '294', '', '', 'hyperlipidaemia25', '538', '', '315', '', '', '607', '', '325', '', '', '1164', '', '308', '', '', '941', '', '312', '', '', '1948', '', '313', '', '', 'copd2647', '', '33', '', '', '55', '', '29', '', '', '144', '', '38', '', '', '111', '', '37', '', '', '220', '', '35', '', '', 'current', 'smoker7884', '', '97', '', '', '190', '', '102', '', '', '428', '', '113', '', '', '342', '', '113', '', '', '644', '', '104', '', '', 'former', 'smoker14', '049', '', '173', '', '', '321', '', '172', '', '', '648', '', '171', '', '', '509', '', '169', '', '', '1026', '', '165', '', '', 'immunocompromised2416', '', '30', '', '', '53', '', '28', '', '', '122', '', '32', '', '', '90', '', '30', '', '', '187', '', '30', '', '', 'baseline', 'disease', 'severityqsofa', '', '167', '316', '', '830', '', '', '1530', '', '819', '', '', '3051', '', '807', '', '', '2477', '', '821', '', '', '4994', '', '803', '', '', 'spo2', '', '94', '', '7721', '', '95', '', '', '209', '', '112', '', '', '413', '', '109', '', '', '323', '', '107', '', '', '651', '', '105', '', '', 'outcomesde-novo', 'ventricular', 'arrhythmia226', '', '03', '', '', '81', '', '43', '', '', '246', '', '65', '', '', '184', '', '61', '', '', '502', '', '81', '', '', 'non-icu', 'length', 'stay', '', 'days91', '', '64', '', '88', '', '62', '', '90', '', '66', '', '89', '', '62', '', '91', '', '67', '', 'icu', 'length', 'stay', '', 'days26', '', '50', '', '43', '', '68', '', '49', '', '81', '', '43', '', '68', '', '47', '', '78', '', 'total', 'length', 'stay', '', 'days117', '', '84', '', '132', '', '91', '', '138', '', '110', '', '132', '', '93', '', '138', '', '107', '', 'mechanical', 'ventilation6278', '', '77', '', '', '403', '', '216', '', '', '814', '', '215', '', '', '616', '', '204', '', '', '1243', '', '200', '', '', 'mortality7530', '', '93', '', '', '307', '', '164', '', '', '839', '', '222', '', '', '543', '', '180', '', '', '1479', '', '238', '', '', 'ventilator', 'mortality10', '703', '', '132', '', '', '531', '', '284', '', '', '1288', '', '340', '', '', '877', '', '291', '', '', '2120', '', '341', '', '', 'data', 'mean', '', 'sd', '', 'n', '', '', '', '', 'bmibody-mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturation', '', 'icuintensive', 'care', 'unit', '', '', 'macrolides', 'include', 'clarithromycin', 'azithromycin', '', 'open', 'table', 'new', 'tab', 'data', 'mean', '', 'sd', '', 'n', '', '', '', '', 'bmibody-mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturation', '', 'icuintensive', 'care', 'unit', '', 'independent', 'predictor', 'in-hospital', 'mortality', 'show', 'figure', '2', '', 'age', '', 'bmi', '', 'black', 'race', 'hispanic', 'ethnicity', '', 'versus', 'white', 'race', '', '', 'coronary', 'artery', 'disease', '', 'congestive', 'heart', 'failure', '', 'history', 'arrhythmia', '', 'diabetes', '', 'hypertension', '', 'hyperlipidaemia', '', 'copd', '', 'current', 'smoker', '', 'immunosuppressed', 'condition', 'associate', 'higher', 'risk', 'in-hospital', 'death', '', 'female', 'sex', '', 'ethnicity', 'asian', 'origin', '', 'ace', 'inhibitor', '', 'angiotensin', 'receptor', 'blocker', '', '', 'statin', 'associate', 'reduce', 'in-hospital', 'mortality', 'risk', '', 'compared', 'control', 'group', '', '93', '', '', '', 'hydroxychloroquine', 'alone', '', '180', '', '', 'hr', '1335', '', '95', '', 'ci', '12231457', '', '', 'hydroxychloroquine', 'macrolide', '', '238', '', '', '1447', '', '13681531', '', '', 'hydroxychloroquine', 'alone', '', '164', '', '', '1365', '', '12181531', '', '', 'hydroxychloroquine', 'macrolide', '', '222', '', '', '1368', '', '12731469', '', 'independently', 'associate', 'increase', 'risk', 'in-hospital', 'mortality', '', 'multivariable', 'cox', 'regression', 'analysis', 'continent', 'show', 'appendix', '', 'pp', '611', '', '', 'well', 'data', 'sex-adjusted', 'multivariable', 'logistic', 'regression', 'analysis', '', 'pp', '1213', '', 'separate', 'cox', 'regression', 'analysis', 'combine', 'endpoint', 'mechanical', 'ventilation', 'mortality', '', 'p', '14', '', 'figure', '2independent', 'predictor', 'in-hospital', 'mortalityshow', 'full', 'captionage', 'bmi', 'continuous', 'variable', '', '95', '', 'cis', 'adjust', 'multiple', 'test', 'infer', 'definitive', 'effect', '', 'aceangiotensin-converting', 'enzyme', '', 'bmibody', 'mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'hrhazard', 'ratio', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturationview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'age', 'bmi', 'continuous', 'variable', '', '95', '', 'cis', 'adjust', 'multiple', 'test', 'infer', 'definitive', 'effect', '', 'aceangiotensin-converting', 'enzyme', '', 'bmibody', 'mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'hrhazard', 'ratio', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturation', '', 'independent', 'predictor', 'ventricular', 'arrythmia', 'show', 'figure', '3', '', 'coronary', 'artery', 'disease', '', 'congestive', 'heart', 'failure', '', 'history', 'cardiac', 'arrhythmia', '', 'copd', 'independently', 'associate', 'increase', 'risk', 'de-novo', 'ventricular', 'arrhythmia', 'hospitalisation', '', 'compared', 'control', 'group', '', '03', '', '', '', 'hydroxychloroquine', 'alone', '', '61', '', '', 'hr', '2369', '', '95', '', 'ci', '19352900', '', '', 'hydroxychloroquine', 'macrolide', '', '81', '', '', '5106', '', '41065983', '', '', 'hydroxychloroquine', 'alone', '', '43', '', '', '3561', '', '27604596', '', '', 'hydroxychloroquine', 'macrolide', '', '65', '', '', '4011', '', '33444812', '', 'independently', 'associate', 'increase', 'risk', 'de-novo', 'ventricular', 'arrhythmia', 'hospitalisationfigure', '3independent', 'predictor', 'ventricular', 'arrhythmia', 'hospitalisationshow', 'full', 'captionage', 'bmi', 'continuous', 'variable', '', '95', '', 'cis', 'adjust', 'multiple', 'test', 'infer', 'definitive', 'effect', '', 'aceangiotensin-converting', 'enzyme', '', 'bmibody', 'mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'hrhazard', 'ratio', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturationview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'age', 'bmi', 'continuous', 'variable', '', '95', '', 'cis', 'adjust', 'multiple', 'test', 'infer', 'definitive', 'effect', '', 'aceangiotensin-converting', 'enzyme', '', 'bmibody', 'mass', 'index', '', 'copdchronic', 'obstructive', 'pulmonary', 'disease', '', 'hrhazard', 'ratio', '', 'qsofaquick', 'sepsis-related', 'organ', 'failure', 'assessment', '', 'spo2oxygen', 'saturation', '', 'analyses', 'propensity', 'score', 'match', 'treatment', 'group', 'show', 'appendix', '', 'pp', '1518', '', '', 'result', 'indicate', 'association', 'drug', 'regimen', 'mortality', '', 'mechanical', 'ventilation', '', 'length', 'stay', '', 'occurrence', 'de-novo', 'ventricular', 'arrhythmia', 'consistent', 'primary', 'analysis', '', 'tip', 'point', 'analysis', 'ass', 'effect', 'unmeasured', 'confounder', 'find', 'significance', 'hydroxychloroquine', 'hydroxychloroquine', '', 'appendix', 'pp', '1920', '', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'hydroxychloroquine', 'macrolide', '', 'hypothetical', 'unobserved', 'binary', 'confounder', 'prevalence', '50', '', 'expose', 'population', 'hr', '15', 'tip', 'analysis', 'non-significance', '5', '', 'level', '', 'comparison', 'observe', 'confounders', 'study', '', 'congestive', 'heart', 'failure', '', 'hr', '1756', '', 'leave', 'model', '', 'prevalence', 'approximately', '30', '', 'population', 'lead', 'confound', 'analysis', '', 'similarly', '', 'hydroxychloroquine', 'macrolide', '', 'hypothetical', 'unobserved', 'binary', 'confounder', 'prevalence', '37', '', 'expose', 'population', 'hr', '20', 'tip', 'analysis', 'non-significance', '5', '', 'level', '', '', 'congestive', 'heart', 'failure', '', 'hr', '1756', '', 'prevalence', 'approximately', '50', '', 'population', 'lead', 'confound', 'analysis', '', 'adjust', 'cox', 'proportional', 'hazard', 'model', '', 'large', 'multinational', 'real-world', 'analysis', '', 'observe', 'benefit', 'hydroxychloroquine', 'hydroxychloroquine', '', 'alone', 'combination', 'macrolide', '', 'in-hospital', 'outcome', '', 'initiate', 'early', 'diagnosis', 'covid-19', '', 'drug', 'regimen', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'macrolide', 'associate', 'increase', 'hazard', 'clinically', 'significant', 'occurrence', 'ventricular', 'arrhythmia', 'increase', 'risk', 'in-hospital', 'death', 'covid-19', '', 'hydroxychloroquine', 'hydroxychloroquine', 'covid-19', 'base', 'widespread', 'publicity', 'small', '', 'uncontrolled', 'study', '', 'suggest', 'combination', 'hydroxychloroquine', 'macrolide', 'azithromycin', 'successful', 'clear', 'viral', 'replication7gautret', 'p', 'lagier', 'jc', 'parola', 'p', 'alhydroxychloroquine', 'azithromycin', 'treatment', 'covid-19', '', 'result', 'open-label', 'non-randomized', 'clinical', 'trialint', 'j', 'antimicrob', 'agents', '', '2020', '', '', 'publish', 'online', 'march', '20', '', '', 'doi101016jijantimicag2020105949google', 'march', '28', '', '2020', '', 'fda', 'issue', 'emergency', 'authorisation', 'drug', 'patient', 'clinical', 'trial', 'access', 'unavailable12us', 'food', 'drug', 'administrationemergency', 'authorization', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'eua', 'information', '', 'urlplaceholder', '', 'covidtherapeuticsdate', 'access', '', '15', '', '2020google', 'country', '', 'china', '', 'issue', 'guideline', 'allow', 'hydroxychloroquine', 'covid-1913gao', 'j', 'tian', 'z', 'yang', 'x', 'breakthrough', '', 'hydroxychloroquine', 'phosphate', 'show', 'apparent', 'efficacy', 'treatment', 'covid-19', 'associate', 'pneumonia', 'clinical', 'studiesbiosci', 'trends', '', '2020', '', '14', '', '72-73google', 'several', 'country', 'stockpile', 'drug', '', 'shortage', 'approve', 'indication', '', 'autoimmune', 'disease', 'arthritis', 'arthritis', '', 'encountered10peschken', 'ca', 'possible', 'consequence', 'shortage', 'hydroxychloroquine', 'patient', 'systemic', 'lupus', 'erythematosus', 'amid', 'covid-19', 'pandemicj', 'rheumatol', '', '2020', '', '', 'publish', 'online', 'april', '8', '', '', 'doi103899jrheum200395google', 'retrospective', 'observational', 'review', '368', 'men', 'covid-19', 'treat', 'us', 'veterans', 'affairs', 'hospital', 'raise', 'concern', 'hydroxychloroquine', 'associate', 'greater', 'hazard', 'death', '', 'however', '', 'baseline', 'characteristic', 'among', 'group', 'analyse', 'dissimilar', 'possibility', 'bias', 'rule', 'out14magagnoli', 'j', 'narendran', 'pereira', 'f', 'aloutcomes', 'hydroxychloroquine', 'usage', 'united', 'states', 'veteran', 'hospitalize', 'covid-19medrxiv', '', '2020', '', '', 'publish', 'online', 'april', '23', '', '', '', 'preprint', '', 'doi', '', '1011012020041620065920google', 'another', 'observational', 'study', '181', 'patient', 'france', 'report', 'hydroxychloroquine', 'dose', '600', 'mg', 'per', 'day', 'associate', 'measurable', 'clinical', 'benefit', 'patient', 'covid-19', 'pneumonia15mahevas', 'tran', 'v-t', 'roumier', 'alno', 'evidence', 'clinical', 'efficacy', 'hydroxychloroquine', 'patient', 'hospitalise', 'covid-19', 'infection', 'oxygen', 'requiremenr', '', 'result', 'study', 'routinely', 'collect', 'data', 'emulate', 'target', 'trialmedrxiv', '', '2020', '', '', 'publish', 'online', 'april', '14', '', '', '', 'preprint', '', 'doi', '', '1011012020041020060699google', 'large-scale', '', 'international', '', 'real-world', 'analysis', 'support', 'absence', 'clinical', 'benefit', 'hydroxychloroquine', 'hydroxychloroquine', 'point', 'potential', 'harm', 'hospitalise', 'patient', 'covid-19', '', 'hydroxychloroquine', 'hydroxychloroquine', 'associate', 'concern', 'cardiovascular', 'toxicity', '', 'particularly', 'relationship', 'electrical', 'instability', '', 'characterise', 'qt', 'interval', 'prolongation', '', 'time', 'ventricular', 'depolarisation', 'repolarisation', '', '', 'mechanism', 'relate', 'blockade', 'herg', 'potassium', 'channel16traebert', 'dumotier', 'b', 'meister', 'l', 'hoffmann', 'p', 'dominguez-estevez', 'suter', 'w', 'inhibition', 'herg', 'k', 'current', 'antimalarial', 'drug', 'stably', 'transfected', 'hek293', 'cellseur', 'j', 'pharmacol', '', '2004', '', '484', '', '41-48google', 'lengthen', 'ventricular', 'repolarisation', 'duration', 'ventricular', 'action', 'potential', '', 'specific', 'condition', '', 'early', 'after-depolarisations', 'trigger', 'ventricular', 'arrhythmias9giudicessi', 'jr', 'noseworthy', 'pa', 'friedman', 'pa', 'ackerman', 'mj', 'urgent', 'guidance', 'navigate', 'circumvent', 'qtc-prolonging', 'torsadogenic', 'potential', 'possible', 'pharmacotherapies', 'coronavirus', 'disease', '19', '', 'covid-19', '', 'mayo', 'clin', 'proc', '', '2020', '', '', 'publish', 'online', 'april', '7', '', '', 'doi101016jmayocp202003024google', 'propensity', 'arrhythmia', 'provocation', 'often', 'individual', 'structural', 'cardiovascular', 'disease', '', 'cardiac', 'injury', 'report', 'occur', 'high', 'frequency', 'covid-19', 'illness17shi', 'qin', 'shen', 'b', 'alassociation', 'cardiac', 'injury', 'mortality', 'hospitalize', 'patient', 'covid-19', 'wuhan', '', 'chinajama', 'cardiol', '', '2020', '', '', 'publish', 'online', 'march', '25', '', '', 'doi101001jamacardio20200950google', '', '18guo', 'fan', 'chen', 'alcardiovascular', 'implication', 'fatal', 'outcome', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'jama', 'cardiol', '', '2020', '', '', 'publish', 'online', 'march', '27', '', '', 'doi101001jamacardio20201017google', 'furthermore', '', 'individual', 'cardiovascular', 'disease', 'represent', 'vulnerable', 'population', 'experience', 'worse', 'outcome', 'covid-1919bonow', 'ro', 'fonarow', 'gc', 'ogara', 'pt', 'yancy', 'cw', 'association', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'myocardial', 'injury', 'mortalityjama', 'cardiol', '', '2020', '', '', 'publish', 'online', 'march', '27', '', '', 'doi101001jamacardio20201105google', '', '20mehra', 'mr', 'desai', 'ss', 'kuy', 'henry', 'td', 'patel', 'cardiovascular', 'disease', '', 'drug', 'therapy', '', 'mortality', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', '1', '', '', 'doi101056nejmoa2007621google', 'pathological', 'study', 'point', 'derangement', 'vascular', 'endothelium', 'diffuse', 'endotheliitis', 'note', 'across', 'multiple', 'organ', 'covid-1921varga', 'z', 'flammer', 'aj', 'steiger', 'p', 'alendothelial', 'cell', 'infection', 'endotheliitis', 'covid-19lancet', '', '2020', '', '395', '', '1417-1418google', 'whether', 'patient', 'underlie', 'cardiovascular', 'disease', 'experience', 'de-novo', 'cardiovascular', 'injury', 'greater', 'predilection', 'ventricular', 'arrhythmia', 'hydroxychloroquine', 'analogue', 'remain', 'uncertain', 'plausible', '', 'covid-19', 'exemplify', 'initial', 'viral', 'replication', 'follow', 'enhance', 'systemic', 'inflammation22siddiqi', 'hk', 'mehra', 'mr', 'covid-19', 'illness', 'native', 'immunosuppressed', 'state', '', 'clinical-therapeutic', 'stag', 'proposalj', 'heart', 'lung', 'transplant', '', '2020', '', '39', '', '405-407google', 'hydroxychloroquine', 'hydroxychloroquine', 'combination', 'macrolide', 'design', 'antimicrobial', 'property', 'synergistic', 'manner23nakornchai', 'konthiang', 'p', 'activity', 'azithromycin', 'erythromycin', 'combination', 'antimalarial', 'drug', 'multidrug-resistant', 'plasmodium', 'falciparum', 'vitroacta', 'trop', '', '2006', '', '100', '', '185-191google', 'macrolides', '', 'azithromycin', 'clarithromycin', '', 'antibiotic', 'immunomodulatory', 'anti-inflammatory', 'effects24lee', 'n', 'wong', 'ck', 'chan', 'mcw', 'alanti-inflammatory', 'effect', 'adjunctive', 'macrolide', 'treatment', 'adult', 'hospitalize', 'influenza', '', 'randomize', 'control', 'trialantiviral', 'res', '', '2017', '', '144', '', '48-56google', 'however', '', 'drug', 'prolong', 'qt', 'interval', 'increase', 'risk', 'sudden', 'cardiac', 'death8ray', 'wa', 'murray', 'kt', 'hall', 'k', 'arbogast', 'pg', 'stein', 'cm', 'azithromycin', 'risk', 'cardiovascular', 'deathn', 'engl', 'j', 'med', '', '2012', '', '366', '', '1881-1890google', '', '9giudicessi', 'jr', 'noseworthy', 'pa', 'friedman', 'pa', 'ackerman', 'mj', 'urgent', 'guidance', 'navigate', 'circumvent', 'qtc-prolonging', 'torsadogenic', 'potential', 'possible', 'pharmacotherapies', 'coronavirus', 'disease', '19', '', 'covid-19', '', 'mayo', 'clin', 'proc', '', '2020', '', '', 'publish', 'online', 'april', '7', '', '', 'doi101016jmayocp202003024google', 'preliminary', 'analysis', '', 'borba', 'colleagues25borba', 'mgs', 'val', 'ffa', 'sampaio', 'aleffect', 'high', 'v', 'low', 'hydroxychloroquine', 'diphosphate', 'adjunctive', 'therapy', 'patient', 'hospitalize', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', '', 'randomize', 'clinical', 'trialjama', 'netw', 'open', '', '2020', '', '3e208857google', 'report', 'double-blind', '', 'randomise', 'trial', '81', 'adult', 'patient', 'hospitalise', 'severe', 'covid-19', 'tertiary', 'care', 'facility', 'brazil', '', 'study', 'suggest', 'higher', 'dose', 'hydroxychloroquine', 'represent', 'safety', 'hazard', '', 'especially', 'concurrently', 'azithromycin', 'oseltamivir', '', 'another', 'cohort', 'study', '90', 'patient', 'covid-19', 'pneumonia', '', 'mercuro', 'colleagues26mercuro', 'nj', 'yen', 'cf', 'shim', 'dj', 'alrisk', 'qt', 'interval', 'prolongation', 'associate', 'hydroxychloroquine', 'without', 'concomitant', 'azithromycin', 'among', 'hospitalize', 'patient', 'test', 'positive', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'jama', 'cardiol', '', '2020', '', '', 'publish', 'online', '1', '', '', 'doi101001jamacardio20201834google', 'find', 'concomitant', 'macrolide', 'associate', 'greater', 'change', 'correct', 'qt', 'interval', '', 'study', 'examine', 'qt', 'interval', 'instead', 'directly', 'analyse', 'risk', 'clinically', 'significant', 'ventricular', 'arrythmias', '', 'show', 'independent', 'association', 'either', 'hydroxychloroquine', 'hydroxychloroquine', 'occurrence', 'de-novo', 'ventricular', 'arrhythmia', '', 'note', 'hazard', 'de-novo', 'ventricular', 'arrhythmia', 'increase', 'drug', 'combination', 'macrolide', '', 'analysis', '', 'dominate', 'patient', 'north', 'america', '', 'note', 'higher', 'bmi', 'emerge', 'risk', 'marker', 'worse', 'in-hospital', 'survival', '', 'obesity', 'risk', 'factor', 'cardiac', 'arrhythmia', 'sudden', 'cardiac', 'death27lavie', 'cj', 'arena', 'r', 'alpert', 'milani', 'rv', 'ventura', 'ho', 'management', 'cardiovascular', 'disease', 'patient', 'obesitynat', 'rev', 'cardiol', '', '2018', '', '15', '', '45-56google', '', '28sanchis-gomar', 'f', 'lavie', 'cj', 'mehra', 'mr', 'henry', 'bm', 'lippi', 'g', 'obesity', 'outcome', 'covid-19', '', 'epidemic', 'pandemic', 'collidemayo', 'clin', 'proc', '', '2020', '', '', 'publish', 'online', '19', '', '', 'doi101016jmayocp202005006google', 'commonly', 'report', 'arrhythmia', 'atrial', 'fibrillation', 'ventricular', 'tachycardia', '', 'although', 'age', '', 'race', '', 'bmi', 'predictive', 'increase', 'risk', 'death', 'covid-19', 'analysis', '', 'find', 'associate', 'increase', 'risk', 'ventricular', 'arrhythmia', 'multivariable', 'regression', 'analysis', '', 'variable', 'find', 'independently', 'predictive', 'ventricular', 'arrhythmia', 'four', 'treatment', 'regimen', '', 'along', 'underlie', 'cardiovascular', 'disease', 'copd', '', 'thus', '', 'presence', 'cardiovascular', 'comorbidity', 'study', 'population', 'partially', 'explain', 'observe', 'risk', 'increase', 'cardiovascular', 'toxicity', 'hydroxychloroquine', 'hydroxychloroquine', '', 'especially', 'combination', 'macrolides', '', 'investigation', '', 'consistent', 'previous', 'find', 'smaller', 'cohort', '8910', 'patients20mehra', 'mr', 'desai', 'ss', 'kuy', 'henry', 'td', 'patel', 'cardiovascular', 'disease', '', 'drug', 'therapy', '', 'mortality', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', '1', '', '', 'doi101056nejmoa2007621google', 'find', 'woman', 'patient', 'treat', 'ace', 'inhibitor', '', 'angiotensin', 'receptor', 'blocker', '', 'statin', 'lower', 'mortality', 'covid-19', '', 'find', 'imply', 'drug', 'stabilise', 'cardiovascular', 'function', 'improve', 'endothelial', 'cell', 'dysfunction', 'improve', 'prognosis', '', 'independent', 'cardiotoxic', 'drug', 'combinations21varga', 'z', 'flammer', 'aj', 'steiger', 'p', 'alendothelial', 'cell', 'infection', 'endotheliitis', 'covid-19lancet', '', '2020', '', '395', '', '1417-1418google', 'study', 'several', 'limitation', '', 'association', 'decrease', 'survival', 'hydroxychloroquine', 'hydroxychloroquine', 'treatment', 'regimen', 'interpret', 'cautiously', '', 'due', 'observational', 'study', 'design', '', 'exclude', 'possibility', 'unmeasured', 'confound', 'factor', '', 'although', 'reassuringly', 'note', 'consistency', 'primary', 'analysis', 'propensity', 'score', 'match', 'analysis', '', 'nevertheless', '', 'cause-and-effect', 'relationship', 'drug', 'therapy', 'survival', 'infer', '', 'data', 'apply', 'treatment', 'regimen', 'ambulatory', '', 'out-of-hospital', 'set', '', 'randomised', 'clinical', 'trial', 'require', 'conclusion', 'reach', 'regard', 'benefit', 'harm', 'agent', 'covid-19', 'patient', '', 'note', 'although', 'evaluate', 'relationship', 'drug', 'treatment', 'regimen', 'occurrence', 'ventricular', 'arrhythmia', '', 'measure', 'qt', 'interval', '', 'stratify', 'arrhythmia', 'pattern', '', 'torsade', 'de', 'point', '', '', 'establish', 'association', 'increase', 'risk', 'in-hospital', 'death', 'drug', 'regimen', 'link', 'directly', 'cardiovascular', 'risk', '', 'conduct', 'drug', 'dose-response', 'analysis', 'observe', 'risk', '', 'limitation', 'suggest', 'conservative', 'interpretation', 'find', '', 'believe', 'absence', 'observe', 'benefit', 'still', 'represent', 'reasonable', 'explanation', '', 'summary', '', 'multinational', '', 'observational', '', 'real-world', 'study', 'patient', 'covid-19', 'require', 'hospitalisation', 'find', 'regimen', 'contain', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', 'associate', 'evidence', 'benefit', '', 'instead', 'associate', 'increase', 'risk', 'ventricular', 'arrhythmia', 'greater', 'hazard', 'in-hospital', 'death', 'covid-19', '', 'find', 'suggest', 'drug', 'regimen', 'outside', 'clinical', 'trial', 'urgent', 'confirmation', 'randomise', 'clinical', 'trial', '', 'contributors', 'study', 'conceive', 'design', 'mrm', 'anp', '', 'acquisition', 'data', 'statistical', 'analysis', 'data', 'supervise', 'perform', 'ssd', '', 'mrm', 'draft', 'manuscript', 'author', 'participate', 'critical', 'revision', 'manuscript', 'important', 'intellectual', 'content', '', 'mrm', 'anp', 'supervise', 'study', '', 'author', 'approve', 'final', 'manuscript', 'responsible', 'decision', 'submit', 'publication', '', 'declaration', 'interest', 'mrm', 'report', 'personal', 'fee', 'abbott', '', 'medtronic', '', 'janssen', '', 'mesoblast', '', 'portola', '', 'bayer', '', 'baim', 'institute', 'clinical', 'research', '', 'nupulsecv', '', 'fineheart', '', 'leviticus', '', 'roivant', '', 'triple', 'gene', '', 'ssd', 'founder', 'surgisphere', 'corporation', '', 'fr', 'pay', 'time', 'spend', 'committee', 'member', 'clinical', 'trial', '', 'advisory', 'board', '', 'form', 'consult', '', 'lecture', 'presentation', '', 'payment', 'directly', 'university', 'zurich', 'personal', 'payment', 'receive', 'relation', 'trial', 'activity', '', 'anp', 'declare', 'compete', 'interest', '', 'acknowledgments', 'development', 'maintenance', 'surgical', 'outcomes', 'collaborative', 'database', 'fund', 'surgisphere', 'corporation', '', 'chicago', '', 'il', '', 'usa', '', '', 'study', 'support', 'william', 'harvey', 'distinguished', 'chair', 'advanced', 'cardiovascular', 'medicine', 'brigham', 'women', 'hospital', '', 'boston', '', '', 'usa', '', '', 'acknowledge', 'jide', 'olayinka', '', 'surgisphere', '', 'helpful', 'statistical', 'review', 'manuscript', '', 'download', 'pdf', '', '6', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'hydroxychloroquine', 'hydroxychloroquine', 'covid-19', '', 'hazardous', '', 'full-textpdf']",7234,"{'': 2077, 'hydroxychloroquine': 158, 'covid-19': 73, 'macrolide': 64, 'patient': 64, 'treatment': 59, 'data': 53, 'disease': 49, 'ventricular': 43, 'study': 40, 'drug': 38, 'analysis': 36, 'arrhythmia': 36, '2020': 35, 'include': 33, 'regimen': 30, 'group': 29, 'risk': 29, 'control': 25, 'associate': 25}","{'hydroxychloroquine': 158, 'infection': 8, 'sars-cov-2': 8, 'safety': 3, 'arthritis': 3}",180,0.1877
DOI:10.1016/S0140-6736(20)31174-0,10.1016/S0140-6736(20)31174-0,Comment,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['hydroxychloroquine', 'hydroxychloroquine', 'covid-19', '', 'hazardous', '']","['The 4-aminoquinoline antimalarial chloroquine hydroxychloroquine promote sometimes use treatment COVID-19 , alone combine azithromycin , base immunomodulatory antiviral property , despite absence methodologically appropriate proof efficacy .', 'The global community await result ongoing , well power randomise control trial show effect chloroquine hydroxychloroquine COVID-19 clinical outcome .', 'These drug , however , might associate cardiac toxicity .', 'Macrolides1Mason JW Antimicrobials QT prolongation.J Antimicrob Chemother .', '2017 ; 72 : 1272-1274Google Scholar 4-aminoquinolines2White NJ Cardiotoxicity antimalarial drugs.Lancet Infect Dis .', '2007 ; 7 : 549-558Google Scholar prolong ventricular repolarisation , evidence QT interval prolongation correct heart rate ( QTc ) electrocardiogram .', 'QTc prolongation associate specific ventricular arrhythmia call torsade de point , , although often self-terminating , degenerate ventricular tachycardia fibrillation , lead death .', 'Torsade de point rare event , estimate annual crude incidence 3·2 per million population ; incidence almost double woman compare men increase age.3Sarganas G Garbe E Klimpel A Hering RC Bronder E Haverkamp W Epidemiology symptomatic drug-induced long QT syndrome torsade de point Germany.Europace .', '2014 ; 16 : 101-108Google Scholar Drug-induced torsade de point mostly occur presence several risk factor , include high drug concentration , simultaneous exposure multiple QTc-prolonging drug , coronary heart disease , heart failure , hypokalaemia , bradycardia , congenital long-QT syndrome , among others.4Vlachos K Georgopoulos S Efremidis M Sideris A Letsas KP An update risk factor drug-induced arrhythmias.Expert Rev Clin Pharmacol .', '2016 ; 9 : 117-127Google Scholar In The Lancet , Mandeep Mehra colleagues5Mehra MR Desai SS Ruschitzka F Patel AN Hydroxychloroquine chloroquine without macrolide treatment COVID-19 : multinational registry analysis.Lancet .', '2020 ; ( publish online May 22 . )', 'urlplaceholder Scholar report largest observational study publish date effect chloroquine hydroxychloroquine , without macrolide , 96 032 hospitalise patient ( mean age 53·8 year , 46·3 % woman ) test positive severe acute respiratory syndrome coronavirus 2 .', 'Verified data international registry comprise 671 hospital six continent use compare patient COVID-19 receive chloroquine ( n=1868 ) , hydroxychloroquine ( n=3016 ) , chloroquine macrolide ( n=3783 ) , hydroxychloroquine macrolide ( n=6221 ) within 48 h COVID-19 diagnosis , 81 144 control receive drug .', 'The primary outcome in-hospital mortality occurrence de-novo non-sustained sustain ventricular tachycardia ventricular fibrillation also analyse .', 'A Cox proportional hazard model account many confound variable , include age , sex , ethnicity , comorbidities , medication , COVID-19 severity , show significant increase risk in-hospital mortality four treatment regimen compare control group ( hazard ratio [ HRs ] 1·335 [ 95 % CI 1·223–1·457 ] 1·447 [ 1·368–1·531 ] ) .', 'Analyses use propensity score match treatment group support result .', 'The increase risk in-hospital mortality similar men ( 1·293 [ 1·178–1·420 ] 1·408 [ 1·309–1·513 ] ) woman ( 1·338 [ 1·169–1·531 ] 1·494 [ 1·334–1·672 ] ) .', 'The incidence repetitive ventricular arrhythmia range 4·3 % 8·1 % patient treat 4-aminoquinoline , compare 0·3 % control group ( p < 0·0001 ) .', 'Despite limitation inherent observational nature study , Mehra colleague commend provide result well design control study effect chloroquine hydroxychloroquine , without macrolide , large sample hospitalise patient COVID-19 .', 'Their result indicate absence benefit 4-aminoquinoline-based treatment population suggest could even harmful .', 'It tempt attribute increase risk in-hospital death higher observe incidence drug-induced ventricular arrhythmia , give drug know prolong QTc provoke torsade de point .', 'However , relationship death ventricular tachycardia study cause death ( ie , arrhythmic v non-arrhythmic ) adjudicate .', 'Although ventricular arrhythmia might detect , number death treatment group much greater number patient ventricular arrhythmia .', 'The risk death associate 4-aminoquinolines alone combine macrolide similar , whereas would expect combination two QTc-prolonging drug would increase proarrhythmic potential.6Frommeyer G Fischer C Ellermann C et al.Additive proarrhythmic effect combine treatment QT-prolonging agents.Cardiovasc Toxicol .', '2018 ; 18 : 84-90Google Scholar The HRs death similar men woman , whereas woman higher sensitivity drug-induced QTc prolongation7Darpo B Karnad DR Badilini F et al.Are woman susceptible men drug-induced QT prolongation ?', 'Concentration-QTc model phase 1 study oral rac-sotalol.Br J Clin Pharmacol .', '2014 ; 77 : 522-531Google Scholar higher risk drug-induced torsade de pointes3Sarganas G Garbe E Klimpel A Hering RC Bronder E Haverkamp W Epidemiology symptomatic drug-induced long QT syndrome torsade de point Germany.Europace .', '2014 ; 16 : 101-108Google Scholar men .', 'The study therefore suggest increase risk death 4-aminoquinolines due proarrhythmic mechanism .', 'Another hypothesis explain increase risk death 4-aminoquinolines antiviral immunomodulatory property could worsen COVID-19 severity patient .', 'Nevertheless , increase incidence ventricular arrhythmia intrigue .', 'Chloroquine,8Vicente J Zusterzeel R Johannesen L et al.Assessment multi-ion channel block phase I randomize study design : result CiPA phase I ECG biomarker validation study.Clin Pharmacol Ther .', '2019 ; 105 : 943-953Google Scholar hydroxychloroquine,9Ten Broeke R Mestrom E Woo L Kreeftenberg H Early treatment intravenous lipid emulsion potentially lethal hydroxychloroquine intoxication.Neth J Med .', '2016 ; 74 : 210-214Google Scholar azithromycin10Yang Z Prinsen JK Bersell KR et al.Azithromycin cause novel proarrhythmic syndrome.Circ Arrhythm Electrophysiol .', '2017 ; 10e003560Google Scholar sodium channel block property might contribute proarrhythmia11Roden DM Anderson ME Proarrhythmia.Handb Exp Pharmacol .', '2006 ; 171 : 73-97Google Scholar heart failure context myocardial injury hypoxia present COVID-19.12Guo T Fan Y Chen M et al.Cardiovascular implication fatal outcome patient coronavirus disease 2019 ( COVID-19 ) .JAMA Cardiol .', '2020 ; ( publish online March 27 .', ') DOI:10.1001/jamacardio.2020.1017Google Scholar This hypothesis remain test .', ""View Large Image Copyright © 2020 Associated Press View Large Image Copyright © 2020 Associated Press The find Mehra colleague ' study add preliminary report suggest regimen chloroquine hydroxychloroquine , alone azithromycin , useful could harmful hospitalise patient COVID-19 ."", 'We declare compete interest .', 'Hydroxychloroquine chloroquine without macrolide treatment COVID-19 : multinational registry analysisFull-TextPDF']","['4-aminoquinoline', 'antimalarial', 'hydroxychloroquine', 'hydroxychloroquine', 'promote', 'sometimes', 'treatment', 'covid-19', '', 'alone', 'combine', 'azithromycin', '', 'base', 'immunomodulatory', 'antiviral', 'property', '', 'despite', 'absence', 'methodologically', 'appropriate', 'proof', 'efficacy', '', 'global', 'community', 'await', 'result', 'ongoing', '', 'well', 'power', 'randomise', 'control', 'trial', 'show', 'effect', 'hydroxychloroquine', 'hydroxychloroquine', 'covid-19', 'clinical', 'outcome', '', 'drug', '', 'however', '', 'associate', 'cardiac', 'toxicity', '', 'macrolides1mason', 'jw', 'antimicrobials', 'qt', 'prolongationj', 'antimicrob', 'chemother', '', '2017', '', '72', '', '1272-1274google', '4-aminoquinolines2white', 'nj', 'cardiotoxicity', 'antimalarial', 'drugslancet', 'infect', 'dis', '', '2007', '', '7', '', '549-558google', 'prolong', 'ventricular', 'repolarisation', '', 'evidence', 'qt', 'interval', 'prolongation', 'correct', 'heart', 'rate', '', 'qtc', '', 'electrocardiogram', '', 'qtc', 'prolongation', 'associate', 'specific', 'ventricular', 'arrhythmia', 'call', 'torsade', 'de', 'point', '', '', 'although', 'often', 'self-terminating', '', 'degenerate', 'ventricular', 'tachycardia', 'fibrillation', '', 'lead', 'death', '', 'torsade', 'de', 'point', 'rare', 'event', '', 'estimate', 'annual', 'crude', 'incidence', '32', 'per', 'million', 'population', '', 'incidence', 'almost', 'double', 'woman', 'compare', 'men', 'increase', 'age3sarganas', 'g', 'garbe', 'e', 'klimpel', 'hering', 'rc', 'bronder', 'e', 'haverkamp', 'w', 'epidemiology', 'symptomatic', 'drug-induced', 'long', 'qt', 'syndrome', 'torsade', 'de', 'point', 'germanyeuropace', '', '2014', '', '16', '', '101-108google', 'drug-induced', 'torsade', 'de', 'point', 'mostly', 'occur', 'presence', 'several', 'risk', 'factor', '', 'include', 'high', 'drug', 'concentration', '', 'simultaneous', 'exposure', 'multiple', 'qtc-prolonging', 'drug', '', 'coronary', 'heart', 'disease', '', 'heart', 'failure', '', 'hypokalaemia', '', 'bradycardia', '', 'congenital', 'long-qt', 'syndrome', '', 'among', 'others4vlachos', 'k', 'georgopoulos', 'efremidis', 'sideris', 'letsas', 'kp', 'update', 'risk', 'factor', 'drug-induced', 'arrhythmiasexpert', 'rev', 'clin', 'pharmacol', '', '2016', '', '9', '', '117-127google', 'lancet', '', 'mandeep', 'mehra', 'colleagues5mehra', 'mr', 'desai', 'ss', 'ruschitzka', 'f', 'patel', 'hydroxychloroquine', 'hydroxychloroquine', 'without', 'macrolide', 'treatment', 'covid-19', '', 'multinational', 'registry', 'analysislancet', '', '2020', '', '', 'publish', 'online', '22', '', '', 'urlplaceholder', 'report', 'largest', 'observational', 'study', 'publish', 'date', 'effect', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', '96', '032', 'hospitalise', 'patient', '', 'mean', 'age', '538', 'year', '', '463', '', 'woman', '', 'test', 'positive', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'verified', 'data', 'international', 'registry', 'comprise', '671', 'hospital', 'six', 'continent', 'compare', 'patient', 'covid-19', 'receive', 'hydroxychloroquine', '', 'n1868', '', '', 'hydroxychloroquine', '', 'n3016', '', '', 'hydroxychloroquine', 'macrolide', '', 'n3783', '', '', 'hydroxychloroquine', 'macrolide', '', 'n6221', '', 'within', '48', 'h', 'covid-19', 'diagnosis', '', '81', '144', 'control', 'receive', 'drug', '', 'primary', 'outcome', 'in-hospital', 'mortality', 'occurrence', 'de-novo', 'non-sustained', 'sustain', 'ventricular', 'tachycardia', 'ventricular', 'fibrillation', 'analyse', '', 'cox', 'proportional', 'hazard', 'model', 'account', 'confound', 'variable', '', 'include', 'age', '', 'sex', '', 'ethnicity', '', 'comorbidities', '', 'medication', '', 'covid-19', 'severity', '', 'show', 'significant', 'increase', 'risk', 'in-hospital', 'mortality', 'four', 'treatment', 'regimen', 'compare', 'control', 'group', '', 'hazard', 'ratio', '', 'hrs', '', '1335', '', '95', '', 'ci', '12231457', '', '1447', '', '13681531', '', '', '', 'analyses', 'propensity', 'score', 'match', 'treatment', 'group', 'support', 'result', '', 'increase', 'risk', 'in-hospital', 'mortality', 'similar', 'men', '', '1293', '', '11781420', '', '1408', '', '13091513', '', '', 'woman', '', '1338', '', '11691531', '', '1494', '', '13341672', '', '', '', 'incidence', 'repetitive', 'ventricular', 'arrhythmia', 'range', '43', '', '81', '', 'patient', 'treat', '4-aminoquinoline', '', 'compare', '03', '', 'control', 'group', '', 'p', '', '00001', '', '', 'despite', 'limitation', 'inherent', 'observational', 'nature', 'study', '', 'mehra', 'colleague', 'commend', 'provide', 'result', 'well', 'design', 'control', 'study', 'effect', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'macrolide', '', 'large', 'sample', 'hospitalise', 'patient', 'covid-19', '', 'result', 'indicate', 'absence', 'benefit', '4-aminoquinoline-based', 'treatment', 'population', 'suggest', 'harmful', '', 'tempt', 'attribute', 'increase', 'risk', 'in-hospital', 'death', 'higher', 'observe', 'incidence', 'drug-induced', 'ventricular', 'arrhythmia', '', 'give', 'drug', 'prolong', 'qtc', 'provoke', 'torsade', 'de', 'point', '', 'however', '', 'relationship', 'death', 'ventricular', 'tachycardia', 'study', 'cause', 'death', '', 'ie', '', 'arrhythmic', 'v', 'non-arrhythmic', '', 'adjudicate', '', 'although', 'ventricular', 'arrhythmia', 'detect', '', 'number', 'death', 'treatment', 'group', 'much', 'greater', 'number', 'patient', 'ventricular', 'arrhythmia', '', 'risk', 'death', 'associate', '4-aminoquinolines', 'alone', 'combine', 'macrolide', 'similar', '', 'whereas', 'expect', 'combination', 'two', 'qtc-prolonging', 'drug', 'increase', 'proarrhythmic', 'potential6frommeyer', 'g', 'fischer', 'c', 'ellermann', 'c', 'aladditive', 'proarrhythmic', 'effect', 'combine', 'treatment', 'qt-prolonging', 'agentscardiovasc', 'toxicol', '', '2018', '', '18', '', '84-90google', 'hrs', 'death', 'similar', 'men', 'woman', '', 'whereas', 'woman', 'higher', 'sensitivity', 'drug-induced', 'qtc', 'prolongation7darpo', 'b', 'karnad', 'dr', 'badilini', 'f', 'alare', 'woman', 'susceptible', 'men', 'drug-induced', 'qt', 'prolongation', '', 'concentration-qtc', 'model', 'phase', '1', 'study', 'oral', 'rac-sotalolbr', 'j', 'clin', 'pharmacol', '', '2014', '', '77', '', '522-531google', 'higher', 'risk', 'drug-induced', 'torsade', 'de', 'pointes3sarganas', 'g', 'garbe', 'e', 'klimpel', 'hering', 'rc', 'bronder', 'e', 'haverkamp', 'w', 'epidemiology', 'symptomatic', 'drug-induced', 'long', 'qt', 'syndrome', 'torsade', 'de', 'point', 'germanyeuropace', '', '2014', '', '16', '', '101-108google', 'men', '', 'study', 'therefore', 'suggest', 'increase', 'risk', 'death', '4-aminoquinolines', 'due', 'proarrhythmic', 'mechanism', '', 'another', 'hypothesis', 'explain', 'increase', 'risk', 'death', '4-aminoquinolines', 'antiviral', 'immunomodulatory', 'property', 'worsen', 'covid-19', 'severity', 'patient', '', 'nevertheless', '', 'increase', 'incidence', 'ventricular', 'arrhythmia', 'intrigue', '', 'chloroquine8vicente', 'j', 'zusterzeel', 'r', 'johannesen', 'l', 'alassessment', 'multi-ion', 'channel', 'block', 'phase', 'randomize', 'study', 'design', '', 'result', 'cipa', 'phase', 'ecg', 'biomarker', 'validation', 'studyclin', 'pharmacol', 'ther', '', '2019', '', '105', '', '943-953google', 'hydroxychloroquine9ten', 'broeke', 'r', 'mestrom', 'e', 'woo', 'l', 'kreeftenberg', 'h', 'early', 'treatment', 'intravenous', 'lipid', 'emulsion', 'potentially', 'lethal', 'hydroxychloroquine', 'intoxicationneth', 'j', 'med', '', '2016', '', '74', '', '210-214google', 'azithromycin10yang', 'z', 'prinsen', 'jk', 'bersell', 'kr', 'alazithromycin', 'cause', 'novel', 'proarrhythmic', 'syndromecirc', 'arrhythm', 'electrophysiol', '', '2017', '', '10e003560google', 'sodium', 'channel', 'block', 'property', 'contribute', 'proarrhythmia11roden', 'dm', 'anderson', 'proarrhythmiahandb', 'exp', 'pharmacol', '', '2006', '', '171', '', '73-97google', 'heart', 'failure', 'context', 'myocardial', 'injury', 'hypoxia', 'present', 'covid-1912guo', 'fan', 'chen', 'alcardiovascular', 'implication', 'fatal', 'outcome', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'jama', 'cardiol', '', '2020', '', '', 'publish', 'online', 'march', '27', '', '', 'doi101001jamacardio20201017google', 'hypothesis', 'remain', 'test', '', 'view', 'large', 'image', 'copyright', '', '2020', 'associated', 'press', 'view', 'large', 'image', 'copyright', '', '2020', 'associated', 'press', 'find', 'mehra', 'colleague', '', 'study', 'add', 'preliminary', 'report', 'suggest', 'regimen', 'hydroxychloroquine', 'hydroxychloroquine', '', 'alone', 'azithromycin', '', 'useful', 'harmful', 'hospitalise', 'patient', 'covid-19', '', 'declare', 'compete', 'interest', '', 'hydroxychloroquine', 'hydroxychloroquine', 'without', 'macrolide', 'treatment', 'covid-19', '', 'multinational', 'registry', 'analysisfull-textpdf']",889,"{'': 166, 'hydroxychloroquine': 19, 'covid-19': 11, 'ventricular': 11, 'treatment': 9, 'death': 9, 'risk': 9, 'increase': 8, 'drug-induced': 8, 'study': 8, 'patient': 8, 'torsade': 7, 'de': 7, 'macrolide': 7, 'drug': 6, 'arrhythmia': 6, 'point': 6, 'woman': 6, 'result': 5, 'control': 5}",{'hydroxychloroquine': 19},19,0.4767
DOI:10.1016/S0140-6736(20)31207-1,10.1016/S0140-6736(20)31207-1,Perspectives,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['history', 'medical', 'mask', 'rise', 'throwaway', 'culture']","['The shortage face mask COVID-19 pandemic become symbol fragility modern medicine public health .', 'Several explanation advance situation , panic public hoard mask offshoring manufacture disruption global trade .', 'The history medicine suggest another factor could consider : progressive replacement reusable face mask disposable one since 1960s .', 'Medicine transform consumer culture—what Life Magazine enthusiastically name “ Throwaway Living ” 1955 .', 'The history medical mask illuminate vulnerability create .', 'Covering nose mouth part traditional sanitary practice contagious disease early modern Europe .', ""This protection primarily neutralise so-called miasma air perfume spice hold mask , plague doctor ' bird-like mask ."", 'Such practice , however , become marginal 18th century .', 'Face mask , use today health care community , largely trace back historically recent period new understand contagion base germ theory apply surgery .', 'In 1867 , British surgeon Joseph Lister postulate wind disease cause germ microscopically small live entity Louis Pasteur recently describe .', 'Lister suggest eliminate germ use antiseptic substance .', 'But 1880s , new generation surgeon devise strategy asepsis aim stop germ enter wind first place .', 'This risky strategy .', ""Hands , instrument , even operator 's exhalation suspect ."", 'Johann Mikulicz , head surgery department University Breslau ( Wroclaw , Poland ) start work local bacteriologist Carl Flügge , show experimentally respiratory droplet carry culturable bacteria .', 'In response find , Mikulicz start wear face mask 1897 , describe “ piece gauze tie two string cap , sweep across face cover nose mouth beard ” .', 'In Paris , surgeon Paul Berger also begin wear mask operate room year .', 'The face mask stand strategy infection control focus keep germ away , oppose kill chemical .', 'Such narrowly target strategy uncontroversial .', 'The physician Alexander Fraenkel Berlin , example , sceptical “ whole surgical costume bonnet , mouth mask veil , devise slogan total wind sterility ” .', 'However , mask become increasingly widespread .', 'A study 1000 photograph surgeon operate room US European hospital 1863 1969 indicate 1923 two-thirds wear mask 1935 use mask .', 'It mainly use mask cover mouth nose ( beard ) Manchurian plague 1910–11 influenza pandemic 1918–19 turn face mask mean protect medical worker patient infectious disease outside operate room .', 'During 1918–19 influenza pandemic , wear mask become mandatory police force , medical worker , even resident US city , although use often controversial .', 'Yet city like San Francisco , decline death influenza partly attribute mandatory mask-wearing policy .', 'At point , rationale wear mask move beyond original use operate theatre : also protect wearer infection .', 'Meanwhile , mask continue develop medicine .', 'Although medical practitioner agree general function mask , first decade 20th century attempt determine efficient type mask patent various design .', 'Masks usually make several layer cotton gauze , sometimes additional layer impervious material , hold metal frame .', 'Their main goal prevent respiratory droplet transmit wearer , Mikulicz Flügge suggest operate theatre .', 'Most mask washable metal part could sterilise “ thus permit use mask long time ” , one US inventor explain , medical mask patent 1919 .', 'Red Cross worker fold reusable mask influenza pandemic , Boston , MA , USA , March , 1919View Large Image Copyright © 2020 Courtesy National Archives ( 165-WW-269B-37 ) Red Cross worker fold reusable mask influenza pandemic , Boston , MA , USA , March , 1919View Large Image Copyright © 2020 Courtesy National Archives ( 165-WW-269B-37 ) Medical researcher test compare filter efficiency reusable mask experiment involve culture bacteria nebulised though mask spread infectious volunteer wear mask experimental chamber , well observational study clinical set .', 'They find mask vary greatly extent filter bacteria .', 'But use properly , mask consider offer protection infection .', 'Medical mask start replace disposable paper mask 1930s increasingly make synthetic material single use 1960s .', 'By early 1960s , advertisement new kind filter mask make non-woven synthetic fibre nurse surgery journal .', 'These filter mask disposable .', 'Advertisements highlight performance , comfort , convenience .', 'Unlike traditional medical mask , cup-shaped respirator mask fit snugly face design filter incoming , outgo , air , well prevent spread droplet like traditional mask .', 'These mask could use synthetic fabric would deteriorate sterilisation .', 'The substitution reusable mask part broader transformation hospital care towards hospital administrator 1969 call “ total disposable system ” include syrinx , needle , tray , surgical instrument .', 'In part , disposability suppose reduce risk compromise precarious state sterility .', 'However , another reason switch disposable mask desire reduce labour cost , facilitate management supply , respond increase demand disposable aggressive market campaign create among health-care worker .', 'Disposables convenient , advantage apparent anyone “ see staff disentangle tape reassemble autoclave linen mask ” , British medical researcher put 1980 .', 'Industry-sponsored study find new synthetic mask superior traditional reusable cotton mask .', 'More frequently , however , reusable mask omit comparative study .', 'In 1975 , one last study include industrially manufacture cotton mask , author conclude reusable mask , make four-ply cotton muslin , superior popular disposable paper mask new synthetic respirator .', 'He note “ cotton fabric may effective synthetic fabric incorporate good mask design ” .', 'Some study suggest wash reusable mask might increase bacterial filter efficiency , perhaps tighten fibre .', 'In absence commercial cotton mask , recent study compare artisanal homemade mask industrially produce disposable mask , find latter superior .', 'These result extent reinforce idea reusable mask potentially unsafe , partly discourage research well design industrially manufacture reusable mask .', 'During COVID-19 pandemic , health authority country recommend citizen wear mask public certain circumstance .', 'In context , number grassroots initiative emerge , typical participatory age , help people sew cloth mask home personal use community supply nearby hospital .', 'These improvise mask typically overlook design element crucial efficiency earlier cotton mask .', 'Yet public response enthusiastic place , least measure number people view instructional video .', 'The home production reusable mask use community offer last resort solution comfort many , unlikely contribute marginally solve shortage personal protective equipment globally .', 'As health-care worker hospital , set experiment method sanitise disposable mask , even though design reuse .', 'Such approach far cry carefully design , manufacture , test reusable mask use 1970s .', 'Reusable mask essential part medical arsenal .', 'However , industrial production research development reusable mask largely halt transition towards disposable mask 1960s .', 'Disposable mask respirator certainly remain essential part medical personal protective equipment future , since posse specific filtration quality design health-care situation .', 'To avoid shortage mask next pandemic , one look beyond creation large stockpile disposable face mask consider risk throwaway consumer culture apply life-saving device .', 'Perhaps one day might possible say protective face mask medical researcher write 1918 : “ A mask may repeatedly wash use indefinitely . ”']","['shortage', 'face', 'mask', 'covid-19', 'pandemic', 'become', 'symbol', 'fragility', 'modern', 'medicine', 'public', 'health', '', 'several', 'explanation', 'advance', 'situation', '', 'panic', 'public', 'hoard', 'mask', 'offshoring', 'manufacture', 'disruption', 'global', 'trade', '', 'history', 'medicine', 'suggest', 'another', 'factor', 'consider', '', 'progressive', 'replacement', 'reusable', 'face', 'mask', 'disposable', 'one', 'since', '1960s', '', 'medicine', 'transform', 'consumer', 'culturewhat', 'life', 'magazine', 'enthusiastically', 'name', '', 'throwaway', 'living', '', '1955', '', 'history', 'medical', 'mask', 'illuminate', 'vulnerability', 'create', '', 'covering', 'nose', 'mouth', 'part', 'traditional', 'sanitary', 'practice', 'contagious', 'disease', 'early', 'modern', 'europe', '', 'protection', 'primarily', 'neutralise', 'so-called', 'miasma', 'air', 'perfume', 'spice', 'hold', 'mask', '', 'plague', 'doctor', '', 'bird-like', 'mask', '', 'practice', '', 'however', '', 'become', 'marginal', '18th', 'century', '', 'face', 'mask', '', 'today', 'health', 'care', 'community', '', 'largely', 'trace', 'back', 'historically', 'recent', 'period', 'new', 'understand', 'contagion', 'base', 'germ', 'theory', 'apply', 'surgery', '', '1867', '', 'british', 'surgeon', 'joseph', 'lister', 'postulate', 'wind', 'disease', 'cause', 'germ', 'microscopically', 'small', 'live', 'entity', 'louis', 'pasteur', 'recently', 'describe', '', 'lister', 'suggest', 'eliminate', 'germ', 'antiseptic', 'substance', '', '1880s', '', 'new', 'generation', 'surgeon', 'devise', 'strategy', 'asepsis', 'aim', 'stop', 'germ', 'enter', 'wind', 'first', 'place', '', 'risky', 'strategy', '', 'hands', '', 'instrument', '', 'operator', 'exhalation', 'suspect', '', 'johann', 'mikulicz', '', 'head', 'surgery', 'department', 'university', 'breslau', '', 'wroclaw', '', 'poland', '', 'start', 'work', 'local', 'bacteriologist', 'carl', 'flgge', '', 'show', 'experimentally', 'respiratory', 'droplet', 'carry', 'culturable', 'bacteria', '', 'response', 'find', '', 'mikulicz', 'start', 'wear', 'face', 'mask', '1897', '', 'describe', '', 'piece', 'gauze', 'tie', 'two', 'string', 'cap', '', 'sweep', 'across', 'face', 'cover', 'nose', 'mouth', 'beard', '', '', 'paris', '', 'surgeon', 'paul', 'berger', 'begin', 'wear', 'mask', 'operate', 'room', 'year', '', 'face', 'mask', 'stand', 'strategy', 'infection', 'control', 'focus', 'keep', 'germ', 'away', '', 'oppose', 'kill', 'chemical', '', 'narrowly', 'target', 'strategy', 'uncontroversial', '', 'physician', 'alexander', 'fraenkel', 'berlin', '', 'example', '', 'sceptical', '', 'whole', 'surgical', 'costume', 'bonnet', '', 'mouth', 'mask', 'veil', '', 'devise', 'slogan', 'total', 'wind', 'sterility', '', '', 'however', '', 'mask', 'become', 'increasingly', 'widespread', '', 'study', '1000', 'photograph', 'surgeon', 'operate', 'room', 'us', 'european', 'hospital', '1863', '1969', 'indicate', '1923', 'two-thirds', 'wear', 'mask', '1935', 'mask', '', 'mainly', 'mask', 'cover', 'mouth', 'nose', '', 'beard', '', 'manchurian', 'plague', '191011', 'influenza', 'pandemic', '191819', 'turn', 'face', 'mask', 'mean', 'protect', 'medical', 'worker', 'patient', 'infectious', 'disease', 'outside', 'operate', 'room', '', '191819', 'influenza', 'pandemic', '', 'wear', 'mask', 'become', 'mandatory', 'police', 'force', '', 'medical', 'worker', '', 'resident', 'us', 'city', '', 'although', 'often', 'controversial', '', 'yet', 'city', 'like', 'san', 'francisco', '', 'decline', 'death', 'influenza', 'partly', 'attribute', 'mandatory', 'mask-wearing', 'policy', '', 'point', '', 'rationale', 'wear', 'mask', 'move', 'beyond', 'original', 'operate', 'theatre', '', 'protect', 'wearer', 'infection', '', 'meanwhile', '', 'mask', 'continue', 'develop', 'medicine', '', 'although', 'medical', 'practitioner', 'agree', 'general', 'function', 'mask', '', 'first', 'decade', '20th', 'century', 'attempt', 'determine', 'efficient', 'type', 'mask', 'patent', 'various', 'design', '', 'masks', 'usually', 'several', 'layer', 'cotton', 'gauze', '', 'sometimes', 'additional', 'layer', 'impervious', 'material', '', 'hold', 'metal', 'frame', '', 'main', 'goal', 'prevent', 'respiratory', 'droplet', 'transmit', 'wearer', '', 'mikulicz', 'flgge', 'suggest', 'operate', 'theatre', '', 'mask', 'washable', 'metal', 'part', 'sterilise', '', 'thus', 'permit', 'mask', 'long', 'time', '', '', 'one', 'us', 'inventor', 'explain', '', 'medical', 'mask', 'patent', '1919', '', 'red', 'cross', 'worker', 'fold', 'reusable', 'mask', 'influenza', 'pandemic', '', 'boston', '', '', 'usa', '', 'march', '', '1919view', 'large', 'image', 'copyright', '', '2020', 'courtesy', 'national', 'archives', '', '165-ww-269b-37', '', 'red', 'cross', 'worker', 'fold', 'reusable', 'mask', 'influenza', 'pandemic', '', 'boston', '', '', 'usa', '', 'march', '', '1919view', 'large', 'image', 'copyright', '', '2020', 'courtesy', 'national', 'archives', '', '165-ww-269b-37', '', 'medical', 'researcher', 'test', 'compare', 'filter', 'efficiency', 'reusable', 'mask', 'experiment', 'involve', 'culture', 'bacteria', 'nebulised', 'though', 'mask', 'spread', 'infectious', 'volunteer', 'wear', 'mask', 'experimental', 'chamber', '', 'well', 'observational', 'study', 'clinical', 'set', '', 'find', 'mask', 'vary', 'greatly', 'extent', 'filter', 'bacteria', '', 'properly', '', 'mask', 'consider', 'offer', 'protection', 'infection', '', 'medical', 'mask', 'start', 'replace', 'disposable', 'paper', 'mask', '1930s', 'increasingly', 'synthetic', 'material', 'single', '1960s', '', 'early', '1960s', '', 'advertisement', 'new', 'kind', 'filter', 'mask', 'non-woven', 'synthetic', 'fibre', 'nurse', 'surgery', 'journal', '', 'filter', 'mask', 'disposable', '', 'advertisements', 'highlight', 'performance', '', 'comfort', '', 'convenience', '', 'unlike', 'traditional', 'medical', 'mask', '', 'cup-shaped', 'respirator', 'mask', 'fit', 'snugly', 'face', 'design', 'filter', 'incoming', '', 'outgo', '', 'air', '', 'well', 'prevent', 'spread', 'droplet', 'like', 'traditional', 'mask', '', 'mask', 'synthetic', 'fabric', 'deteriorate', 'sterilisation', '', 'substitution', 'reusable', 'mask', 'part', 'broader', 'transformation', 'hospital', 'care', 'towards', 'hospital', 'administrator', '1969', 'call', '', 'total', 'disposable', 'system', '', 'include', 'syrinx', '', 'needle', '', 'tray', '', 'surgical', 'instrument', '', 'part', '', 'disposability', 'suppose', 'reduce', 'risk', 'compromise', 'precarious', 'state', 'sterility', '', 'however', '', 'another', 'reason', 'switch', 'disposable', 'mask', 'desire', 'reduce', 'labour', 'cost', '', 'facilitate', 'management', 'supply', '', 'respond', 'increase', 'demand', 'disposable', 'aggressive', 'market', 'campaign', 'create', 'among', 'health-care', 'worker', '', 'disposables', 'convenient', '', 'advantage', 'apparent', 'anyone', '', 'staff', 'disentangle', 'tape', 'reassemble', 'autoclave', 'linen', 'mask', '', '', 'british', 'medical', 'researcher', 'put', '1980', '', 'industry-sponsored', 'study', 'find', 'new', 'synthetic', 'mask', 'superior', 'traditional', 'reusable', 'cotton', 'mask', '', 'frequently', '', 'however', '', 'reusable', 'mask', 'omit', 'comparative', 'study', '', '1975', '', 'one', 'last', 'study', 'include', 'industrially', 'manufacture', 'cotton', 'mask', '', 'author', 'conclude', 'reusable', 'mask', '', 'four-ply', 'cotton', 'muslin', '', 'superior', 'popular', 'disposable', 'paper', 'mask', 'new', 'synthetic', 'respirator', '', 'note', '', 'cotton', 'fabric', 'effective', 'synthetic', 'fabric', 'incorporate', 'mask', 'design', '', '', 'study', 'suggest', 'wash', 'reusable', 'mask', 'increase', 'bacterial', 'filter', 'efficiency', '', 'perhaps', 'tighten', 'fibre', '', 'absence', 'commercial', 'cotton', 'mask', '', 'recent', 'study', 'compare', 'artisanal', 'homemade', 'mask', 'industrially', 'produce', 'disposable', 'mask', '', 'find', 'latter', 'superior', '', 'result', 'extent', 'reinforce', 'idea', 'reusable', 'mask', 'potentially', 'unsafe', '', 'partly', 'discourage', 'research', 'well', 'design', 'industrially', 'manufacture', 'reusable', 'mask', '', 'covid-19', 'pandemic', '', 'health', 'authority', 'country', 'recommend', 'citizen', 'wear', 'mask', 'public', 'certain', 'circumstance', '', 'context', '', 'number', 'grassroots', 'initiative', 'emerge', '', 'typical', 'participatory', 'age', '', 'help', 'people', 'sew', 'cloth', 'mask', 'home', 'personal', 'community', 'supply', 'nearby', 'hospital', '', 'improvise', 'mask', 'typically', 'overlook', 'design', 'element', 'crucial', 'efficiency', 'earlier', 'cotton', 'mask', '', 'yet', 'public', 'response', 'enthusiastic', 'place', '', 'least', 'measure', 'number', 'people', 'view', 'instructional', 'video', '', 'home', 'production', 'reusable', 'mask', 'community', 'offer', 'last', 'resort', 'solution', 'comfort', '', 'unlikely', 'contribute', 'marginally', 'solve', 'shortage', 'personal', 'protective', 'equipment', 'globally', '', 'health-care', 'worker', 'hospital', '', 'set', 'experiment', 'method', 'sanitise', 'disposable', 'mask', '', 'though', 'design', 'reuse', '', 'approach', 'far', 'cry', 'carefully', 'design', '', 'manufacture', '', 'test', 'reusable', 'mask', '1970s', '', 'reusable', 'mask', 'essential', 'part', 'medical', 'arsenal', '', 'however', '', 'industrial', 'production', 'research', 'development', 'reusable', 'mask', 'largely', 'halt', 'transition', 'towards', 'disposable', 'mask', '1960s', '', 'disposable', 'mask', 'respirator', 'certainly', 'remain', 'essential', 'part', 'medical', 'personal', 'protective', 'equipment', 'future', '', 'since', 'posse', 'specific', 'filtration', 'quality', 'design', 'health-care', 'situation', '', 'avoid', 'shortage', 'mask', 'next', 'pandemic', '', 'one', 'look', 'beyond', 'creation', 'large', 'stockpile', 'disposable', 'face', 'mask', 'consider', 'risk', 'throwaway', 'consumer', 'culture', 'apply', 'life-saving', 'device', '', 'perhaps', 'one', 'day', 'possible', 'protective', 'face', 'mask', 'medical', 'researcher', 'write', '1918', '', '', 'mask', 'repeatedly', 'wash', 'indefinitely', '', '']",1063,"{'': 180, 'mask': 70, 'reusable': 15, 'disposable': 12, 'medical': 12, 'face': 10, 'design': 8, 'pandemic': 7, 'wear': 7, 'study': 7, 'cotton': 7, 'part': 6, 'worker': 6, 'filter': 6, 'synthetic': 6, 'one': 5, 'however': 5, 'new': 5, 'germ': 5, 'operate': 5}",{'infection': 3},3,-0.7783
DOI:10.1016/S0140-6736(20)31202-2,10.1016/S0140-6736(20)31202-2,Perspectives,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['compassion', 'time', 'covid-19']","['The verdict success global response COVID-19 pandemic remain write , consequence disease indisputable rapidly come focus .', 'In many country , effort contain COVID-19 result economic recession , push million job , create previously unprecedented unemployment many country worldwide .', 'In addition million people infect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , hundred thousand died—and die—from COVID-19 .', 'An anticipate wave mental behavioural problem begin documented—compounded social economic stressor uncertainties—that likely present population health burden month year come .', 'COVID-19 also trigger enormous display pro-social behaviour neighbour come aid isolate containment effort support front-line worker , include doctor , nurse , health-care personnel , whose responsibility keep risk infection .', 'In public conversation pandemic , admirable empathy evident affect die COVID-19 .', 'In way , pandemic bring population together , generate understand health interlink could risk .', 'That understand make possible , perhaps unprecedented way , empathise disease wish well clear sense could also u .', 'Infectious disease always paradigmatic example disease show health interlink .', 'We take vaccination make sure child vaccinate protect social good .', 'This impulse laudable , indeed , useful .', 'It help , example , ensure pandemic enormous number people worldwide follow guidance order physically distance relatively little demonstrable social disturbance .', 'In fact , opposite quickly become true : many country social norm shift encourage physical distance , cast opprobrium may flaunt physical distance norm expectation .', 'Public apology prominent figure find flaunt guideline become feature national medium coverage .', 'And yet , worth reflect extent response COVID-19 pandemic inform understand together , virus discriminate , result benefit u comply physical distance guideline protect others .', 'Our empathy , capacity envision could affect , powerful tool public health arsenal .', 'But , large part , hard notice empathy inform , often , appreciation personal risk .', 'We feel regret feel terrible suffer , small part imagine suffer .', 'But true suffer ?', 'Is true COVID-19 discriminate ?', 'Evidence emerge effect COVID-19 , far indiscriminate , follow deeply entrench pattern health inequity , mirror burden disease near universal .', 'Those resource , money , power , often majority racial ethnic group , better able physically distance , work home , retain employment .', 'Those group lower risk become infect die COVID-19 , probably reflect combination factor , include better access health care lower underlie burden morbidity predispose worse COVID-19 outcome .', 'It turn COVID-19 discriminate , already vulnerable—for example , unstably house , people low income , poorer education , individual le access reliable nutritious food—are likely become infect virus die COVID-19 .', 'And empathy fail .', 'Empathy context health largely predicate appreciate risk disease imagine get disease .', 'When imagine also infect , will take step necessary protect ourselves—and others—from disease .', ""And force powerful contribute dramatic change live shutdown large part world 's economy , inform fear novel disease need protect others around u ."", 'View Large Image Copyright © 2020 Hossein Fatemi/Panos Pictures View Large Image Copyright © 2020 Hossein Fatemi/Panos Pictures But effort contribute health divide ?', 'What effort also result economic consequence inevitably go bear principally vulnerable marginalise begin ?', 'What effort therefore go result long-term widen health inequity , consign many people worse mental physical health year come ?', 'How account eventuality factor think ?', 'This call ultimately compassion animate force behind think health , think go inform decision make contain novel threat like COVID-19 .', 'Compassion extend beyond empathy .', 'It motivate action may harm .', 'Compassion motivate action phenomenon observe unjust , worthy world would like live .', 'Martin Luther King Jr speak often compassion , enjoin u see compassion ultimately motivate “ [ fling ] coin beggar ” “ see edifice produce beggar need restructure ” .', 'Compassion push u understand structure world , ask structure better , may suffer others suffer world .', 'What would world look like ?', 'It would one ground principle justice equitable distribution resource .', 'An approach health root compassion would help u see beyond , place good others first .', 'A world root compassion would embrace health public good .', 'This mean treat health way park , education , post office , fire station , environment—in essence , crucial piece global common support collective investment benefit .', 'I recognise might seem theoretical , approach would concrete implication approach health shape action , time crisis , time .', 'In respect , current overwhelm investment doctor medicine push vision health private commodity , something buy sell , particularly country like USA access universal health care .', 'But buy—health care—can help u become sick .', 'And buy time COVID-19 largely approach bludgeon epidemic submission , inform strict prioritisation biological imperative viral transmission .', 'But focus always , importantly , build world resilient challenge .', 'Our focus health state sick begin , ground approach balance health action .', 'We must recognise unless invest preventive condition health—like safe house , good school , liveable wage , gender equity , clean air , drinkable water , equal economy—any action take future pandemic likely widen entrench health gap .', 'And situation unacceptable u .', 'Would approach COVID-19 different accustom see health lens compassion ?', 'I would argue yes .', 'First , would long invest condition make people healthy , aim remove underlie disproportionate burden preventable illness accrue vulnerable population worldwide .', 'Second , response COVID-19 would inform equal part effort contain spread mitigate consequence effort bring disproportionate harm remove decision make around pandemic .', 'Third , response would recognise global difference characterise world put burden disease squarely country fewer resource , often drive condition century cross-national injustice , would push u redouble effort everything power help country , perhaps .', 'Surely moment call careful reflection reinvestment compassion foundational approach health .', 'Calling attention compassion way sentimental .', 'It point tangible good , without health impossible .', 'In sense , COVID-19 show u healthy person healthy world .', 'And healthy people healthy world strengthen immeasurably compassion heart health .']","['verdict', 'success', 'global', 'response', 'covid-19', 'pandemic', 'remain', 'write', '', 'consequence', 'disease', 'indisputable', 'rapidly', 'focus', '', 'country', '', 'effort', 'contain', 'covid-19', 'result', 'economic', 'recession', '', 'push', 'million', 'job', '', 'create', 'previously', 'unprecedented', 'unemployment', 'country', 'worldwide', '', 'addition', 'million', 'people', 'infect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'hundred', 'thousand', 'diedand', 'diefrom', 'covid-19', '', 'anticipate', 'wave', 'mental', 'behavioural', 'problem', 'begin', 'documentedcompounded', 'social', 'economic', 'stressor', 'uncertaintiesthat', 'likely', 'present', 'population', 'health', 'burden', 'month', 'year', '', 'covid-19', 'trigger', 'enormous', 'display', 'pro-social', 'behaviour', 'neighbour', 'aid', 'isolate', 'containment', 'effort', 'support', 'front-line', 'worker', '', 'include', 'doctor', '', 'nurse', '', 'health-care', 'personnel', '', 'whose', 'responsibility', 'keep', 'risk', 'infection', '', 'public', 'conversation', 'pandemic', '', 'admirable', 'empathy', 'evident', 'affect', 'die', 'covid-19', '', 'way', '', 'pandemic', 'bring', 'population', 'together', '', 'generate', 'understand', 'health', 'interlink', 'risk', '', 'understand', 'possible', '', 'perhaps', 'unprecedented', 'way', '', 'empathise', 'disease', 'wish', 'well', 'clear', 'sense', 'u', '', 'infectious', 'disease', 'always', 'paradigmatic', 'example', 'disease', 'show', 'health', 'interlink', '', 'vaccination', 'sure', 'child', 'vaccinate', 'protect', 'social', '', 'impulse', 'laudable', '', 'indeed', '', 'useful', '', 'help', '', 'example', '', 'ensure', 'pandemic', 'enormous', 'number', 'people', 'worldwide', 'follow', 'guidance', 'order', 'physically', 'distance', 'relatively', 'little', 'demonstrable', 'social', 'disturbance', '', 'fact', '', 'opposite', 'quickly', 'become', 'true', '', 'country', 'social', 'norm', 'shift', 'encourage', 'physical', 'distance', '', 'cast', 'opprobrium', 'flaunt', 'physical', 'distance', 'norm', 'expectation', '', 'public', 'apology', 'prominent', 'figure', 'find', 'flaunt', 'guideline', 'become', 'feature', 'national', 'medium', 'coverage', '', 'yet', '', 'worth', 'reflect', 'extent', 'response', 'covid-19', 'pandemic', 'inform', 'understand', 'together', '', 'virus', 'discriminate', '', 'result', 'benefit', 'u', 'comply', 'physical', 'distance', 'guideline', 'protect', 'others', '', 'empathy', '', 'capacity', 'envision', 'affect', '', 'powerful', 'tool', 'public', 'health', 'arsenal', '', '', 'large', 'part', '', 'hard', 'notice', 'empathy', 'inform', '', 'often', '', 'appreciation', 'personal', 'risk', '', 'feel', 'regret', 'feel', 'terrible', 'suffer', '', 'small', 'part', 'imagine', 'suffer', '', 'true', 'suffer', '', 'true', 'covid-19', 'discriminate', '', 'evidence', 'emerge', 'effect', 'covid-19', '', 'far', 'indiscriminate', '', 'follow', 'deeply', 'entrench', 'pattern', 'health', 'inequity', '', 'mirror', 'burden', 'disease', 'near', 'universal', '', 'resource', '', 'money', '', 'power', '', 'often', 'majority', 'racial', 'ethnic', 'group', '', 'better', 'able', 'physically', 'distance', '', 'work', 'home', '', 'retain', 'employment', '', 'group', 'lower', 'risk', 'become', 'infect', 'die', 'covid-19', '', 'probably', 'reflect', 'combination', 'factor', '', 'include', 'better', 'access', 'health', 'care', 'lower', 'underlie', 'burden', 'morbidity', 'predispose', 'worse', 'covid-19', 'outcome', '', 'turn', 'covid-19', 'discriminate', '', 'already', 'vulnerablefor', 'example', '', 'unstably', 'house', '', 'people', 'low', 'income', '', 'poorer', 'education', '', 'individual', 'le', 'access', 'reliable', 'nutritious', 'foodare', 'likely', 'become', 'infect', 'virus', 'die', 'covid-19', '', 'empathy', 'fail', '', 'empathy', 'context', 'health', 'largely', 'predicate', 'appreciate', 'risk', 'disease', 'imagine', 'disease', '', 'imagine', 'infect', '', 'step', 'necessary', 'protect', 'ourselvesand', 'othersfrom', 'disease', '', 'force', 'powerful', 'contribute', 'dramatic', 'change', 'live', 'shutdown', 'large', 'part', 'world', 'economy', '', 'inform', 'fear', 'novel', 'disease', 'protect', 'others', 'around', 'u', '', 'view', 'large', 'image', 'copyright', '', '2020', 'hossein', 'fatemipanos', 'pictures', 'view', 'large', 'image', 'copyright', '', '2020', 'hossein', 'fatemipanos', 'pictures', 'effort', 'contribute', 'health', 'divide', '', 'effort', 'result', 'economic', 'consequence', 'inevitably', 'bear', 'principally', 'vulnerable', 'marginalise', 'begin', '', 'effort', 'therefore', 'result', 'long-term', 'widen', 'health', 'inequity', '', 'consign', 'people', 'worse', 'mental', 'physical', 'health', 'year', '', 'account', 'eventuality', 'factor', '', 'call', 'ultimately', 'compassion', 'animate', 'force', 'behind', 'health', '', 'inform', 'decision', 'contain', 'novel', 'threat', 'like', 'covid-19', '', 'compassion', 'extend', 'beyond', 'empathy', '', 'motivate', 'action', 'harm', '', 'compassion', 'motivate', 'action', 'phenomenon', 'observe', 'unjust', '', 'worthy', 'world', 'like', 'live', '', 'martin', 'luther', 'king', 'jr', 'speak', 'often', 'compassion', '', 'enjoin', 'u', 'compassion', 'ultimately', 'motivate', '', '', 'fling', '', 'coin', 'beggar', '', '', 'edifice', 'produce', 'beggar', 'restructure', '', '', 'compassion', 'push', 'u', 'understand', 'structure', 'world', '', 'ask', 'structure', 'better', '', 'suffer', 'others', 'suffer', 'world', '', 'world', 'look', 'like', '', 'one', 'ground', 'principle', 'justice', 'equitable', 'distribution', 'resource', '', 'approach', 'health', 'root', 'compassion', 'help', 'u', 'beyond', '', 'place', 'others', 'first', '', 'world', 'root', 'compassion', 'embrace', 'health', 'public', '', 'mean', 'treat', 'health', 'way', 'park', '', 'education', '', 'post', 'office', '', 'fire', 'station', '', 'environmentin', 'essence', '', 'crucial', 'piece', 'global', 'common', 'support', 'collective', 'investment', 'benefit', '', 'recognise', 'theoretical', '', 'approach', 'concrete', 'implication', 'approach', 'health', 'shape', 'action', '', 'time', 'crisis', '', 'time', '', 'respect', '', 'current', 'overwhelm', 'investment', 'doctor', 'medicine', 'push', 'vision', 'health', 'private', 'commodity', '', 'something', 'buy', 'sell', '', 'particularly', 'country', 'like', 'usa', 'access', 'universal', 'health', 'care', '', 'buyhealth', 'carecan', 'help', 'u', 'become', 'sick', '', 'buy', 'time', 'covid-19', 'largely', 'approach', 'bludgeon', 'epidemic', 'submission', '', 'inform', 'strict', 'prioritisation', 'biological', 'imperative', 'viral', 'transmission', '', 'focus', 'always', '', 'importantly', '', 'build', 'world', 'resilient', 'challenge', '', 'focus', 'health', 'state', 'sick', 'begin', '', 'ground', 'approach', 'balance', 'health', 'action', '', 'must', 'recognise', 'unless', 'invest', 'preventive', 'condition', 'healthlike', 'safe', 'house', '', 'school', '', 'liveable', 'wage', '', 'gender', 'equity', '', 'clean', 'air', '', 'drinkable', 'water', '', 'equal', 'economyany', 'action', 'future', 'pandemic', 'likely', 'widen', 'entrench', 'health', 'gap', '', 'situation', 'unacceptable', 'u', '', 'approach', 'covid-19', 'different', 'accustom', 'health', 'lens', 'compassion', '', 'argue', 'yes', '', 'first', '', 'long', 'invest', 'condition', 'people', 'healthy', '', 'aim', 'remove', 'underlie', 'disproportionate', 'burden', 'preventable', 'illness', 'accrue', 'vulnerable', 'population', 'worldwide', '', 'second', '', 'response', 'covid-19', 'inform', 'equal', 'part', 'effort', 'contain', 'spread', 'mitigate', 'consequence', 'effort', 'bring', 'disproportionate', 'harm', 'remove', 'decision', 'around', 'pandemic', '', 'third', '', 'response', 'recognise', 'global', 'difference', 'characterise', 'world', 'put', 'burden', 'disease', 'squarely', 'country', 'fewer', 'resource', '', 'often', 'drive', 'condition', 'century', 'cross-national', 'injustice', '', 'push', 'u', 'redouble', 'effort', 'everything', 'power', 'help', 'country', '', 'perhaps', '', 'surely', 'moment', 'call', 'careful', 'reflection', 'reinvestment', 'compassion', 'foundational', 'approach', 'health', '', 'calling', 'attention', 'compassion', 'way', 'sentimental', '', 'point', 'tangible', '', 'without', 'health', 'impossible', '', 'sense', '', 'covid-19', 'show', 'u', 'healthy', 'person', 'healthy', 'world', '', 'healthy', 'people', 'healthy', 'world', 'strengthen', 'immeasurably', 'compassion', 'heart', 'health', '']",888,"{'': 157, 'health': 24, 'covid-19': 17, 'compassion': 12, 'disease': 10, 'u': 10, 'world': 10, 'effort': 8, 'pandemic': 7, 'approach': 7, 'country': 6, 'people': 6, 'empathy': 6, 'inform': 6, 'burden': 5, 'risk': 5, 'distance': 5, 'become': 5, 'suffer': 5, 'action': 5}","{'infection': 1, 'sars-cov-2': 1}",2,-0.2263
DOI:10.1016/S2352-3026(20)30176-9,10.1016/S2352-3026(20)30176-9,In Focus,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['following-up', 'allogeneic', 'transplantation', 'recipient', 'covid-19', 'pandemic']","['After allogeneic transplantation , comprehensive clinical follow-up recommend early detection post-transplantation infection common complication endocrine disease metabolic syndrome , ensure patient enjoy quality life .', 'Long-term follow-up rely combination primary disease monitor , graft-versus-host disease ( GVHD ) surveillance treatment , long-term complication , secondary malignancy surveillance .', 'The pandemic coronavirus disease 2019 ( COVID-19 ) start spread around world Feb 2020 , present unexpected challenge transplantation service .', 'In Italy , first positive patient identify Feb 21 , 2020 , Apr 23 , 2020 190 000 people diagnose 25 000 die .', 'Northern Italy , stem cell transplantation programme locate , rapidly overwhelm .', 'When first patient COVID-19 diagnose , face dilemma minimise risk infection ensure delivery essential clinical care onco-haematological patient receive transplantation curative intent high risk develop clinically significant COVID-19 disease .', 'Could use telemedicine follow-up patient transplantation pandemic ?', 'Telemedicine facilitate interaction patient , caregiver , health-care provider , could use manage transplantation recipient , generally frail multiple comorbidities ?', 'Italy privilege national health system ( Servizio Sanitario Nazionale ) since 1978 , rely three fundamental principle : universality , solidarity , uniformity .', 'Even though much discuss potential benefit telemedicine country past decade , little implement far .', 'However , COVID-19 pandemic urgently push need rethink classic model in-person consultation .', 'Within 48 hour first COVID-19 diagnosis Italy , physician long-term follow clinic organise telephone consultation transplantation recipient , prioritise contact basis time transplantation know individual post-transplantation complication .', 'The first plan telephone call focus area urgent intervention : assessment sign symptom infection , GVHD , sign organ damage .', 'The suggestion infection GVHD symptom investigate closed-ended question aim identify warn sign : “ dry mouth difficulty swallow dry food past 4 week ? ” , address potential oral GVHD ; “ notice dry cough past two week ? ” , address concern infection .', 'When visual examination require ( ie , onset skin rash ) , voice-only call replace video consultation .', ""The consultation summarise patient ' electronic medical record ."", 'We start risk versus benefit approach , patient le 3 month follow-up since transplantation suspect COVID-19 assess in-person visit ( figure ) .', 'All patient suspect COVID-19 test severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) nasopharyngeal swab manage dedicate COVID-multidisciplinary team positive , transplant physician negative .', 'Patients 3 month follow-up transplantation COVID-19 symptom attend via teleconsultation show sign transplantation-related complication , organ toxicity GVHD assess in-person.FigurePatient distribution decision-making flow-chartShow full captionBlue pathway=classic long-term follow-up ; red pathway=COVID-19 dedicate follow-up .', '* Of five COVID-19-positive patient , three hospitalise two followed-up via teleconsultation .', '†All COVID-19-negative patient evaluate in-person visit.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Blue pathway=classic long-term follow-up ; red pathway=COVID-19 dedicate follow-up .', '* Of five COVID-19-positive patient , three hospitalise two followed-up via teleconsultation .', '†All COVID-19-negative patient evaluate in-person visit .', 'Between Feb 24 Mar 31 , 2020 , contact 236 ( 51 % ) 465 adult patient receive allogeneic transplantation Jan 1999 Jan 2020 centre , apply decision-making criterion ( figure ) decide whether in-person visit require .', '14 ( 6 % ) patient follow-up le 3 month transplantation , 15 ( 6 % ) 3–6 month , 81 ( 34 % ) 6–24 month , 126 ( 53 % ) 24 month follow-up .', '50 ( 40 % ) 126 patient 24 month follow-up receive immunosuppressive therapy chronic GVHD , high risk complication infection .', '21 ( 42 % ) 50 patient chronic GVHD evaluate in-person 29 ( 58 % ) could see via teleconsultations .', 'Of 81 patient 6–24 month follow-up , 24 ( 30 % ) still immunosuppressive therapy chronic GVHD 21 receive in-person visit long-term follow-up clinic .', 'All patient 24 month follow-up receive clinical evaluation since outbreak start ( 75 [ 68 % ] 110 patient in-person visit 35 [ 32 % ] teleconsultation ) .', 'Only 20 ( 4 % ) 465 patient receive transplantation report fever respiratory symptom suggestive COVID-19 ; 17 ( 85 % ) 20 test 5 ( 25 % ) confirm COVID-19 case .', 'These patient treat dedicate multidisciplinary team full clinical resolution .', 'The remain 229 ( 49 % ) 465 patients—all post-transplantation follow-up 2 years—were contact e-mail provide disease-specific information explain re-organising visit teleconsultations long-term follow-up clinic .', 'Our next step send email survey patient ask feedback preference teleconsultations in-person visit .', 'We also prepare standarised telephone questionnaire address possible complication post-transplantation , include physical function quality life , special section effect isolation physical distance measure pandemic .', 'The medical emergency around COVID-19 allow team discus important aspect teleconsultations , medical liability economic compensation consultation .', 'The complete definition legal financial framework kind programme next challenge .', 'The widespread use internet connection , smartphones , device facilitate access e-Health technology .', 'The sponsorship government agency would crucial success e-Health programme level ; among multidisciplinary hospital team , patient , caregiver , community health provider .', 'But ultimately , health care provider guide patient virtuous use tool promote equitable personalise medicine .', 'Our experience show feasibility use telemedicine maintain long-term follow-up programme transplantation patient .', 'Physicians involve experience felt confident management patient use teleconsultations , patients—reassured leave alone quarantine—provided positive feedback telemedicine approach .', 'This framework develop necessity context COVID-19 could foster post pandemic-era integrate model care transplantation .', 'Similar teleconsultation programme might useful manage patient undergo intensive treatment future , acute leukemia lymphoma .', ""For follow-up allogeneic transplantation see Hematology Am Soc Hematol Educ Program 2019 ; 1 : 626–29 Biol Blood Marrow Transplant 2012 ; 18 : 348–71For effect pandemic Northern Italy see urlplaceholder ( access April 23 , 2020 ) For telemedicine 's role emergency see JAMA Intern Med 2018 ; 178 : 745–46 N Engl J Med 2020 ; 382 : 1679–81 For follow-up allogeneic transplantation see Hematology Am Soc Hematol Educ Program 2019 ; 1 : 626–29 Biol Blood Marrow Transplant 2012 ; 18 : 348–71 For effect pandemic Northern Italy see urlplaceholder ( access April 23 , 2020 ) For telemedicine 's role emergency see JAMA Intern Med 2018 ; 178 : 745–46 N Engl J Med 2020 ; 382 : 1679–81 The author declare compete interest""]","['allogeneic', 'transplantation', '', 'comprehensive', 'clinical', 'follow-up', 'recommend', 'early', 'detection', 'post-transplantation', 'infection', 'common', 'complication', 'endocrine', 'disease', 'metabolic', 'syndrome', '', 'ensure', 'patient', 'enjoy', 'quality', 'life', '', 'long-term', 'follow-up', 'rely', 'combination', 'primary', 'disease', 'monitor', '', 'graft-versus-host', 'disease', '', 'gvhd', '', 'surveillance', 'treatment', '', 'long-term', 'complication', '', 'secondary', 'malignancy', 'surveillance', '', 'pandemic', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'start', 'spread', 'around', 'world', 'feb', '2020', '', 'present', 'unexpected', 'challenge', 'transplantation', 'service', '', 'italy', '', 'first', 'positive', 'patient', 'identify', 'feb', '21', '', '2020', '', 'apr', '23', '', '2020', '190', '000', 'people', 'diagnose', '25', '000', 'die', '', 'northern', 'italy', '', 'stem', 'cell', 'transplantation', 'programme', 'locate', '', 'rapidly', 'overwhelm', '', 'first', 'patient', 'covid-19', 'diagnose', '', 'face', 'dilemma', 'minimise', 'risk', 'infection', 'ensure', 'delivery', 'essential', 'clinical', 'care', 'onco-haematological', 'patient', 'receive', 'transplantation', 'curative', 'intent', 'high', 'risk', 'develop', 'clinically', 'significant', 'covid-19', 'disease', '', 'telemedicine', 'follow-up', 'patient', 'transplantation', 'pandemic', '', 'telemedicine', 'facilitate', 'interaction', 'patient', '', 'caregiver', '', 'health-care', 'provider', '', 'manage', 'transplantation', 'recipient', '', 'generally', 'frail', 'multiple', 'comorbidities', '', 'italy', 'privilege', 'national', 'health', 'system', '', 'servizio', 'sanitario', 'nazionale', '', 'since', '1978', '', 'rely', 'three', 'fundamental', 'principle', '', 'universality', '', 'solidarity', '', 'uniformity', '', 'though', 'much', 'discuss', 'potential', 'benefit', 'telemedicine', 'country', 'past', 'decade', '', 'little', 'implement', 'far', '', 'however', '', 'covid-19', 'pandemic', 'urgently', 'push', 'rethink', 'classic', 'model', 'in-person', 'consultation', '', 'within', '48', 'hour', 'first', 'covid-19', 'diagnosis', 'italy', '', 'physician', 'long-term', 'follow', 'clinic', 'organise', 'telephone', 'consultation', 'transplantation', 'recipient', '', 'prioritise', 'contact', 'basis', 'time', 'transplantation', 'individual', 'post-transplantation', 'complication', '', 'first', 'plan', 'telephone', 'call', 'focus', 'area', 'urgent', 'intervention', '', 'assessment', 'sign', 'symptom', 'infection', '', 'gvhd', '', 'sign', 'organ', 'damage', '', 'suggestion', 'infection', 'gvhd', 'symptom', 'investigate', 'closed-ended', 'question', 'aim', 'identify', 'warn', 'sign', '', '', 'dry', 'mouth', 'difficulty', 'swallow', 'dry', 'food', 'past', '4', 'week', '', '', '', 'address', 'potential', 'oral', 'gvhd', '', '', 'notice', 'dry', 'cough', 'past', 'two', 'week', '', '', '', 'address', 'concern', 'infection', '', 'visual', 'examination', 'require', '', 'ie', '', 'onset', 'skin', 'rash', '', '', 'voice-only', 'call', 'replace', 'video', 'consultation', '', 'consultation', 'summarise', 'patient', '', 'electronic', 'medical', 'record', '', 'start', 'risk', 'versus', 'benefit', 'approach', '', 'patient', 'le', '3', 'month', 'follow-up', 'since', 'transplantation', 'suspect', 'covid-19', 'assess', 'in-person', 'visit', '', 'figure', '', '', 'patient', 'suspect', 'covid-19', 'test', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'nasopharyngeal', 'swab', 'manage', 'dedicate', 'covid-multidisciplinary', 'team', 'positive', '', 'transplant', 'physician', 'negative', '', 'patients', '3', 'month', 'follow-up', 'transplantation', 'covid-19', 'symptom', 'attend', 'via', 'teleconsultation', 'show', 'sign', 'transplantation-related', 'complication', '', 'organ', 'toxicity', 'gvhd', 'assess', 'in-personfigurepatient', 'distribution', 'decision-making', 'flow-chartshow', 'full', 'captionblue', 'pathwayclassic', 'long-term', 'follow-up', '', 'red', 'pathwaycovid-19', 'dedicate', 'follow-up', '', '', 'five', 'covid-19-positive', 'patient', '', 'three', 'hospitalise', 'two', 'followed-up', 'via', 'teleconsultation', '', 'covid-19-negative', 'patient', 'evaluate', 'in-person', 'visitview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'blue', 'pathwayclassic', 'long-term', 'follow-up', '', 'red', 'pathwaycovid-19', 'dedicate', 'follow-up', '', '', 'five', 'covid-19-positive', 'patient', '', 'three', 'hospitalise', 'two', 'followed-up', 'via', 'teleconsultation', '', 'covid-19-negative', 'patient', 'evaluate', 'in-person', 'visit', '', 'feb', '24', 'mar', '31', '', '2020', '', 'contact', '236', '', '51', '', '', '465', 'adult', 'patient', 'receive', 'allogeneic', 'transplantation', 'jan', '1999', 'jan', '2020', 'centre', '', 'apply', 'decision-making', 'criterion', '', 'figure', '', 'decide', 'whether', 'in-person', 'visit', 'require', '', '14', '', '6', '', '', 'patient', 'follow-up', 'le', '3', 'month', 'transplantation', '', '15', '', '6', '', '', '36', 'month', '', '81', '', '34', '', '', '624', 'month', '', '126', '', '53', '', '', '24', 'month', 'follow-up', '', '50', '', '40', '', '', '126', 'patient', '24', 'month', 'follow-up', 'receive', 'immunosuppressive', 'therapy', 'chronic', 'gvhd', '', 'high', 'risk', 'complication', 'infection', '', '21', '', '42', '', '', '50', 'patient', 'chronic', 'gvhd', 'evaluate', 'in-person', '29', '', '58', '', '', 'via', 'teleconsultations', '', '81', 'patient', '624', 'month', 'follow-up', '', '24', '', '30', '', '', 'still', 'immunosuppressive', 'therapy', 'chronic', 'gvhd', '21', 'receive', 'in-person', 'visit', 'long-term', 'follow-up', 'clinic', '', 'patient', '24', 'month', 'follow-up', 'receive', 'clinical', 'evaluation', 'since', 'outbreak', 'start', '', '75', '', '68', '', '', '110', 'patient', 'in-person', 'visit', '35', '', '32', '', '', 'teleconsultation', '', '', '20', '', '4', '', '', '465', 'patient', 'receive', 'transplantation', 'report', 'fever', 'respiratory', 'symptom', 'suggestive', 'covid-19', '', '17', '', '85', '', '', '20', 'test', '5', '', '25', '', '', 'confirm', 'covid-19', 'case', '', 'patient', 'treat', 'dedicate', 'multidisciplinary', 'team', 'full', 'clinical', 'resolution', '', 'remain', '229', '', '49', '', '', '465', 'patientsall', 'post-transplantation', 'follow-up', '2', 'yearswere', 'contact', 'e-mail', 'provide', 'disease-specific', 'information', 'explain', 're-organising', 'visit', 'teleconsultations', 'long-term', 'follow-up', 'clinic', '', 'next', 'step', 'send', 'email', 'survey', 'patient', 'ask', 'feedback', 'preference', 'teleconsultations', 'in-person', 'visit', '', 'prepare', 'standarised', 'telephone', 'questionnaire', 'address', 'possible', 'complication', 'post-transplantation', '', 'include', 'physical', 'function', 'quality', 'life', '', 'special', 'section', 'effect', 'isolation', 'physical', 'distance', 'measure', 'pandemic', '', 'medical', 'emergency', 'around', 'covid-19', 'allow', 'team', 'discus', 'important', 'aspect', 'teleconsultations', '', 'medical', 'liability', 'economic', 'compensation', 'consultation', '', 'complete', 'definition', 'legal', 'financial', 'framework', 'kind', 'programme', 'next', 'challenge', '', 'widespread', 'internet', 'connection', '', 'smartphones', '', 'device', 'facilitate', 'access', 'e-health', 'technology', '', 'sponsorship', 'government', 'agency', 'crucial', 'success', 'e-health', 'programme', 'level', '', 'among', 'multidisciplinary', 'hospital', 'team', '', 'patient', '', 'caregiver', '', 'community', 'health', 'provider', '', 'ultimately', '', 'health', 'care', 'provider', 'guide', 'patient', 'virtuous', 'tool', 'promote', 'equitable', 'personalise', 'medicine', '', 'experience', 'show', 'feasibility', 'telemedicine', 'maintain', 'long-term', 'follow-up', 'programme', 'transplantation', 'patient', '', 'physicians', 'involve', 'experience', 'felt', 'confident', 'management', 'patient', 'teleconsultations', '', 'patientsreassured', 'leave', 'alone', 'quarantineprovided', 'positive', 'feedback', 'telemedicine', 'approach', '', 'framework', 'develop', 'necessity', 'context', 'covid-19', 'foster', 'post', 'pandemic-era', 'integrate', 'model', 'care', 'transplantation', '', 'similar', 'teleconsultation', 'programme', 'useful', 'manage', 'patient', 'undergo', 'intensive', 'treatment', 'future', '', 'acute', 'leukemia', 'lymphoma', '', 'follow-up', 'allogeneic', 'transplantation', 'hematology', 'soc', 'hematol', 'educ', 'program', '2019', '', '1', '', '62629', 'biol', 'blood', 'marrow', 'transplant', '2012', '', '18', '', '34871for', 'effect', 'pandemic', 'northern', 'italy', 'urlplaceholder', '', 'access', 'april', '23', '', '2020', '', 'telemedicine', 'role', 'emergency', 'jama', 'intern', 'med', '2018', '', '178', '', '74546', 'n', 'engl', 'j', 'med', '2020', '', '382', '', '167981', 'follow-up', 'allogeneic', 'transplantation', 'hematology', 'soc', 'hematol', 'educ', 'program', '2019', '', '1', '', '62629', 'biol', 'blood', 'marrow', 'transplant', '2012', '', '18', '', '34871', 'effect', 'pandemic', 'northern', 'italy', 'urlplaceholder', '', 'access', 'april', '23', '', '2020', '', 'telemedicine', 'role', 'emergency', 'jama', 'intern', 'med', '2018', '', '178', '', '74546', 'n', 'engl', 'j', 'med', '2020', '', '382', '', '167981', 'author', 'declare', 'compete', 'interest']",971,"{'': 199, 'patient': 28, 'follow-up': 20, 'transplantation': 17, 'covid-19': 12, '2020': 9, 'in-person': 9, 'month': 9, 'long-term': 8, 'gvhd': 8, 'telemedicine': 7, 'visit': 7, 'infection': 6, 'complication': 6, 'pandemic': 6, 'italy': 6, 'receive': 6, 'disease': 5, 'programme': 5, 'consultation': 5}","{'infection': 6, 'sars-cov-2': 1}",7,0.8625
DOI:10.1016/S1473-3099(20)30430-8,10.1016/S1473-3099(20)30430-8,Correspondence,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['hydroxychloroquine', 'prophylaxis', 'high-risk', 'covid-19', 'contact', 'india', '', 'prudent', 'approach']","['We read interest Correspondence Sahaj Rathi colleagues1Rathi S Ish P Kalantri A Kalantri S Hydroxychloroquine prophylaxis COVID-19 contact India.Lancet Infect Dis .', '2020 ; ( publish online April 17 . )', 'urlplaceholder Scholar hydroxychloroquine prophylaxis COVID-19 contact India .', 'The author see decision Indian Council Medical Research , Ministry Health Family Welfare , recommend chemoprophylaxis hydroxychloroquine select group contact high risk abandonment scientific reason desperate time .', 'We present counterview issue .', 'The safety concern raise Rathi colleague include haemolysis individual glucose-6-phosphate dehydrogenase deficiency QTc prolongation .', 'The prevalence glucose-6-phosphate dehydrogenase deficiency India range 0 % 10 % , heterogenous distribution incomplete penetrance.2Kumar P Yadav U Rai V Prevalence glucose-6-phosphate dehydrogenase deficiency India : update meta-analysis.Egypt J Med Hum Genet .', '2016 ; 17 : 295-302Google Scholar Haemolysis clinically significant hydroxychloroquine administer usual therapeutic do individual WHO class II III glucose-6-phosphate dehydrogenase deficiency , safety hydroxychloroquine well establish prolong use .', 'Furthermore , routine electrocardiogram QTc interval essential hydroxychloroquine initiation clinical practice recommend guideline .', 'Decades experience drug autoimmune disorder enough allay fear .', 'Concerns raise regard lack data efficacy hydroxychloroquine severe acute respiratory syndrome coronavirus 2 .', 'A paucity data expect first wave pandemic cause novel virus .', 'Hydroxychloroquine show in-vitro activity virus .', 'Recently publish human trials,4Gautret P Lagier J-C Parola P Hoang VT Meddeb L Mailhe M et al.Hydroxychloroquine azithromycin treatment COVID-19 : result open-label non-randomized clinical trial.Int J Antimicrob Agents .', '2020 ; ( publish online March 20 .', ') DOI:10.1016/j.ijantimicag.2020.105949Google Scholar along unpublished data,5Chen Z Hu J Zhang Z et al.Efficacy hydroxychloroquine patient COVID-19 : result randomize clinical trial.medRxiv .', '2020 ; ( publish online April 10 . )', '( preprint ) .DOI : 10.1101/2020.03.22.20040758v3Google Scholar suggest could decrease duration viral shed symptom give early .', 'A study South Korea show efficacy hydroxychloroquine post-exposure prophylaxis.6Lee SH Son H Peck KR Can post-exposure prophylaxis COVID-19 consider outbreak response strategy long-term care hospital ? .Int J Antimicrob Agents .', '2020 ; ( publish online April 17 .', ') DOI:10.1016/j.ijantimicag.2020.105988Google Scholar Historically , many drug use treatment infectious disease also use prophylaxis .', 'The pharmacokinetics hydroxychloroquine , long half-life high lung concentration ( 500-times blood concentration ) , ideally suit use agent prophylaxis.7Liu J Cao R Xu M et al.Hydroxychloroquine , le toxic derivative chloroquine , effective inhibit SARS-CoV-2 infection vitro.Cell Discov .', '2020 ; 6 : 16Google Scholar The criticism make Rathi colleague overlook fact prophylactic hydroxychloroquine would target individual high risk rather general population .', 'Projection adverse event population level cause unjustified alarm .', 'The advisory Indian Council Medical Research include section key consideration address concern , ignore Rathi colleague .', 'In addition , argument shortage drug tenable .', 'Production ramp Government India supply hydroxychloroquine 50 country , receive widespread appreciation .', 'We midst once-in-a-generation pandemic , give scale morbidity mortality .', 'The frontline health-care worker great risk infection ; Italy , 20 % respond health-care worker infected.8The LancetCOVID-19 : protect health-care workers.Lancet .', '2020 ; 395 : 922Google Scholar A wide variety therapeutic intervention try COVID-19 patient , without evidence follow prudent approach .', 'We believe hydroxychloroquine prophylaxis select group high-risk contact prudent approach consider risk–benefit analysis .', 'Implemented envisage recommendation document Indian Council Medical Research , evidence generate future recommendation .', 'We declare compete interest .']","['read', 'interest', 'correspondence', 'sahaj', 'rathi', 'colleagues1rathi', 'ish', 'p', 'kalantri', 'kalantri', 'hydroxychloroquine', 'prophylaxis', 'covid-19', 'contact', 'indialancet', 'infect', 'dis', '', '2020', '', '', 'publish', 'online', 'april', '17', '', '', 'urlplaceholder', 'hydroxychloroquine', 'prophylaxis', 'covid-19', 'contact', 'india', '', 'author', 'decision', 'indian', 'council', 'medical', 'research', '', 'ministry', 'health', 'family', 'welfare', '', 'recommend', 'chemoprophylaxis', 'hydroxychloroquine', 'select', 'group', 'contact', 'high', 'risk', 'abandonment', 'scientific', 'reason', 'desperate', 'time', '', 'present', 'counterview', 'issue', '', 'safety', 'concern', 'raise', 'rathi', 'colleague', 'include', 'haemolysis', 'individual', 'glucose-6-phosphate', 'dehydrogenase', 'deficiency', 'qtc', 'prolongation', '', 'prevalence', 'glucose-6-phosphate', 'dehydrogenase', 'deficiency', 'india', 'range', '0', '', '10', '', '', 'heterogenous', 'distribution', 'incomplete', 'penetrance2kumar', 'p', 'yadav', 'u', 'rai', 'v', 'prevalence', 'glucose-6-phosphate', 'dehydrogenase', 'deficiency', 'india', '', 'update', 'meta-analysisegypt', 'j', 'med', 'hum', 'genet', '', '2016', '', '17', '', '295-302google', 'haemolysis', 'clinically', 'significant', 'hydroxychloroquine', 'administer', 'usual', 'therapeutic', 'individual', 'class', 'ii', 'iii', 'glucose-6-phosphate', 'dehydrogenase', 'deficiency', '', 'safety', 'hydroxychloroquine', 'well', 'establish', 'prolong', '', 'furthermore', '', 'routine', 'electrocardiogram', 'qtc', 'interval', 'essential', 'hydroxychloroquine', 'initiation', 'clinical', 'practice', 'recommend', 'guideline', '', 'decades', 'experience', 'drug', 'autoimmune', 'disorder', 'enough', 'allay', 'fear', '', 'concerns', 'raise', 'regard', 'data', 'efficacy', 'hydroxychloroquine', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'paucity', 'data', 'expect', 'first', 'wave', 'pandemic', 'cause', 'novel', 'virus', '', 'hydroxychloroquine', 'show', 'in-vitro', 'activity', 'virus', '', 'recently', 'publish', 'human', 'trials4gautret', 'p', 'lagier', 'j-c', 'parola', 'p', 'hoang', 'vt', 'meddeb', 'l', 'mailhe', 'alhydroxychloroquine', 'azithromycin', 'treatment', 'covid-19', '', 'result', 'open-label', 'non-randomized', 'clinical', 'trialint', 'j', 'antimicrob', 'agents', '', '2020', '', '', 'publish', 'online', 'march', '20', '', '', 'doi101016jijantimicag2020105949google', 'along', 'unpublished', 'data5chen', 'z', 'hu', 'j', 'zhang', 'z', 'alefficacy', 'hydroxychloroquine', 'patient', 'covid-19', '', 'result', 'randomize', 'clinical', 'trialmedrxiv', '', '2020', '', '', 'publish', 'online', 'april', '10', '', '', '', 'preprint', '', 'doi', '', '1011012020032220040758v3google', 'suggest', 'decrease', 'duration', 'viral', 'shed', 'symptom', 'give', 'early', '', 'study', 'south', 'korea', 'show', 'efficacy', 'hydroxychloroquine', 'post-exposure', 'prophylaxis6lee', 'sh', 'son', 'h', 'peck', 'kr', 'post-exposure', 'prophylaxis', 'covid-19', 'consider', 'outbreak', 'response', 'strategy', 'long-term', 'care', 'hospital', '', 'int', 'j', 'antimicrob', 'agents', '', '2020', '', '', 'publish', 'online', 'april', '17', '', '', 'doi101016jijantimicag2020105988google', 'historically', '', 'drug', 'treatment', 'infectious', 'disease', 'prophylaxis', '', 'pharmacokinetics', 'hydroxychloroquine', '', 'long', 'half-life', 'high', 'lung', 'concentration', '', '500-times', 'blood', 'concentration', '', '', 'ideally', 'suit', 'agent', 'prophylaxis7liu', 'j', 'cao', 'r', 'xu', 'alhydroxychloroquine', '', 'le', 'toxic', 'derivative', 'hydroxychloroquine', '', 'effective', 'inhibit', 'sars-cov-2', 'infection', 'vitrocell', 'discov', '', '2020', '', '6', '', '16google', 'criticism', 'rathi', 'colleague', 'overlook', 'fact', 'prophylactic', 'hydroxychloroquine', 'target', 'individual', 'high', 'risk', 'general', 'population', '', 'projection', 'adverse', 'event', 'population', 'level', 'cause', 'unjustified', 'alarm', '', 'advisory', 'indian', 'council', 'medical', 'research', 'include', 'section', 'key', 'consideration', 'address', 'concern', '', 'ignore', 'rathi', 'colleague', '', 'addition', '', 'argument', 'shortage', 'drug', 'tenable', '', 'production', 'ramp', 'government', 'india', 'supply', 'hydroxychloroquine', '50', 'country', '', 'receive', 'widespread', 'appreciation', '', 'midst', 'once-in-a-generation', 'pandemic', '', 'give', 'scale', 'morbidity', 'mortality', '', 'frontline', 'health-care', 'worker', 'great', 'risk', 'infection', '', 'italy', '', '20', '', 'respond', 'health-care', 'worker', 'infected8the', 'lancetcovid-19', '', 'protect', 'health-care', 'workerslancet', '', '2020', '', '395', '', '922google', 'wide', 'variety', 'therapeutic', 'intervention', 'covid-19', 'patient', '', 'without', 'evidence', 'follow', 'prudent', 'approach', '', 'believe', 'hydroxychloroquine', 'prophylaxis', 'select', 'group', 'high-risk', 'contact', 'prudent', 'approach', 'consider', 'riskbenefit', 'analysis', '', 'implemented', 'envisage', 'recommendation', 'document', 'indian', 'council', 'medical', 'research', '', 'evidence', 'generate', 'future', 'recommendation', '', 'declare', 'compete', 'interest', '']",495,"{'': 82, 'hydroxychloroquine': 15, 'covid-19': 6, '2020': 6, 'prophylaxis': 5, 'publish': 5, 'j': 5, 'rathi': 4, 'p': 4, 'contact': 4, 'online': 4, 'india': 4, 'glucose-6-phosphate': 4, 'dehydrogenase': 4, 'deficiency': 4, 'april': 3, '17': 3, 'indian': 3, 'council': 3, 'medical': 3}","{'hydroxychloroquine': 15, 'infection': 2, 'sars-cov-2': 1, 'safety': 2}",20,0.4588
DOI:10.1016/S0140-6736(20)31181-8,10.1016/S0140-6736(20)31181-8,Correspondence,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['detection', 'sars-cov-2', 'human', 'breastmilk']","['It remain unclear whether severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) shed breastmilk transmit child breastfeed .', 'Recent investigation find evidence SARS-CoV-2 human breastmilk , sample size small.1Lackey KA Pace RM Williams JE et al.SARS-CoV-2 human milk : evidence ? .medRxiv .', '2020 ; ( publish online April 20 . )', '( preprint ) .DOI : 10.1101/2020.04.07.20056812Google Scholar , 2Yang N Che S Zhang J et al.Breastfeeding infant bear mother COVID-19 : rapid review.medRxiv .', '2020 ; ( publish April 19 . )', '( preprint ) .DOI : 10.1101/2020.04.13.20064378Google Scholar , 3Chen L Li Q Zheng D Jiang H et al.Clinical characteristic pregnant woman Covid-19 Wuhan , China.N Engl J Med .', '2020 ; ( publish April 17 .', ') DOI:10.1056/NEJMc2009226CrossrefGoogle Scholar We examine milk two nurse mother infect SARS-CoV-2 .', 'Both mother inform study give inform consent .', 'Ethical approval case study waive Ethics Committee Ulm University sample anonymised .', 'Clinical data timecourse infection two mother show figure 1 .', 'After feed nipple disinfection , milk collect pump store sterile container 4°C −20°C analysis .', 'We determine viral load use RT-qPCR SARS-CoV-2 N ORF1b-nsp14 genes4Chu DKW Pan Y Cheng SMS et al.Molecular diagnosis novel coronavirus ( 2019-nCoV ) cause outbreak pneumonia.Clin Chem .', '2020 ; 66 : 549-555CrossrefPubMedScopus ( 39 ) Google Scholar whole skim milk ( obtain removal lipid fraction ) .', 'Further detail sample storage process provide appendix .', 'Following admission delivery ( day 0 ) , four sample Mother 1 test negative ( figure 2 ) .', 'By contrast , SARS-CoV-2 RNA detect milk Mother 2 day 10 ( leave right breast ) , 12 , 13 .', 'Samples take subsequently negative ( figure 2 ) .', 'Ct value SARS-CoV-2 N peak 29·8 30·4 whole milk skim milk , respectively , correspond 1·32 × 105 copy per mL 9·48 × 104 copy per mL ( mean isolation ) .', 'Since milk component might affect RNA isolation quantification , viral RNA recovery rate milk spike serial dilution SARS-CoV-2 stock determine .', 'We observe 89·2 % reduce recovery rate whole milk 51·5 % skim milk ( appendix ) , suggest actual viral load whole milk Mother 2 could even higher detected.Figure 1Timecourse SARS-CoV-2 infection two mother newborn childrenShow full captionAfter delivery , Mother 1 develop mild COVID-19 symptom test positive SARS-CoV-2 .', 'Following spatial isolation Mother 1 newborn ( Newborn 1 ) , Newborn 1 subsequently test positive develop respiratory problem , Mother 1 Newborn 1 recover .', 'Mother 2 admit hospital room Mother 1 Newborn 1 .', 'Upon delivery , Mother 2 Newborn 2 bring back room Mother 1 Newborn 1 , stay room Mother 1 test positive SARS-CoV-2 isolate .', 'Mother 2 Newborn 2 discharge day 4 .', 'Mother 2 develop mild COVID-19 symptom shortly thereafter begin wear surgical mask time day .', 'Mother 2 test positive SARS-CoV-2 day 8 .', '3 day later , Newborn 2 test positive SARS-CoV-2 readmitted hospital newborn icterus severe breathe problem .', 'The child receive ultraviolet therapy ventilation therapy .', 'Newborn 2 test positive RSV SARS-CoV-2 later timepoints .', 'Mother 1 test positive SARS-CoV-2 day 22 , 13 day first diagnose .', 'RT-qPCR analysis breastmilk sample mother reveal SARS-CoV-2 RNA milk Mother 2 day 10–13 ( red bottle ) , whereas sample Mother 1 negative ( white bottle ) .', 'Dark shade indicate time first SARS-CoV-2 positive oropharyngeal nasopharyngeal swab .', 'Brackets indicate duration COVID-19 symptom .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'RSV=respiratory syncytial virus.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Figure 2Detection SARS-CoV-2 breastmilk infect motherShow full captionSARS-CoV-2 RNA isolate whole skim breastmilk obtain different timepoints analyse RT-qPCR , use primer set target SARS-CoV-2 N ORF1b gene .', 'Samples viral RNA standard run duplicate , isolation RT-qPCR repeat two independent assay .', 'RNA breastmilk Mother 2 day 25 isolate analyse RT-qPCR SARS-CoV-2 N. Symbols baseline indicate amplification ( Ct > 36·5 amplification one replicate ) .', 'Blue dash line denote quantification threshold N ( 160 copy per reaction ; Ct 34·2 ) red dot line ORF1b ( 32 copy per reaction ; Ct 35·9 ) .', 'Values line baseline indicate amplification replicate , reliable quantification .', 'Values show represent mean ( SD ) duplicate .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'Ct=cycle threshold.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) After delivery , Mother 1 develop mild COVID-19 symptom test positive SARS-CoV-2 .', 'Following spatial isolation Mother 1 newborn ( Newborn 1 ) , Newborn 1 subsequently test positive develop respiratory problem , Mother 1 Newborn 1 recover .', 'Mother 2 admit hospital room Mother 1 Newborn 1 .', 'Upon delivery , Mother 2 Newborn 2 bring back room Mother 1 Newborn 1 , stay room Mother 1 test positive SARS-CoV-2 isolate .', 'Mother 2 Newborn 2 discharge day 4 .', 'Mother 2 develop mild COVID-19 symptom shortly thereafter begin wear surgical mask time day .', 'Mother 2 test positive SARS-CoV-2 day 8 .', '3 day later , Newborn 2 test positive SARS-CoV-2 readmitted hospital newborn icterus severe breathe problem .', 'The child receive ultraviolet therapy ventilation therapy .', 'Newborn 2 test positive RSV SARS-CoV-2 later timepoints .', 'Mother 1 test positive SARS-CoV-2 day 22 , 13 day first diagnose .', 'RT-qPCR analysis breastmilk sample mother reveal SARS-CoV-2 RNA milk Mother 2 day 10–13 ( red bottle ) , whereas sample Mother 1 negative ( white bottle ) .', 'Dark shade indicate time first SARS-CoV-2 positive oropharyngeal nasopharyngeal swab .', 'Brackets indicate duration COVID-19 symptom .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'RSV=respiratory syncytial virus .', 'SARS-CoV-2 RNA isolate whole skim breastmilk obtain different timepoints analyse RT-qPCR , use primer set target SARS-CoV-2 N ORF1b gene .', 'Samples viral RNA standard run duplicate , isolation RT-qPCR repeat two independent assay .', 'RNA breastmilk Mother 2 day 25 isolate analyse RT-qPCR SARS-CoV-2 N. Symbols baseline indicate amplification ( Ct > 36·5 amplification one replicate ) .', 'Blue dash line denote quantification threshold N ( 160 copy per reaction ; Ct 34·2 ) red dot line ORF1b ( 32 copy per reaction ; Ct 35·9 ) .', 'Values line baseline indicate amplification replicate , reliable quantification .', 'Values show represent mean ( SD ) duplicate .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'Ct=cycle threshold .', 'We detect SARS-CoV-2 RNA milk sample Mother 2 4 consecutive day .', 'Detection viral RNA milk Mother 2 coincide mild COVID-19 symptom SARS-CoV-2 positive diagnostic test newborn ( Newborn 2 ) .', 'Mother 2 wear surgical mask since onset symptom follow safety precaution handle feed neonate ( include proper hand breast disinfection , strict wash , sterilisation milk pump tube ) .', 'However , whether Newborn 2 infect breastfeed mode transmission remain unclear .', 'Further study milk sample lactate woman possible virus transmission via breastfeed need develop recommendation whether mother COVID-19 breastfeed .', 'We declare compete interest .', 'RG , CC , JAM contribute equally .', ""This work support EU 's Horizon 2020 research innovation programme ( Fight-nCoV , 101003555 JM ) German Research Foundation ( CRC 1279 SS , FK , JM ; MU 4485/1-1 JAM ) Download .pdf ( .26 MB ) Help pdf file Supplementary appendix""]","['remain', 'unclear', 'whether', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'shed', 'breastmilk', 'transmit', 'child', 'breastfeed', '', 'recent', 'investigation', 'find', 'evidence', 'sars-cov-2', 'human', 'breastmilk', '', 'sample', 'size', 'small1lackey', 'ka', 'pace', 'rm', 'williams', 'je', 'alsars-cov-2', 'human', 'milk', '', 'evidence', '', 'medrxiv', '', '2020', '', '', 'publish', 'online', 'april', '20', '', '', '', 'preprint', '', 'doi', '', '1011012020040720056812google', '', '2yang', 'n', 'che', 'zhang', 'j', 'albreastfeeding', 'infant', 'bear', 'mother', 'covid-19', '', 'rapid', 'reviewmedrxiv', '', '2020', '', '', 'publish', 'april', '19', '', '', '', 'preprint', '', 'doi', '', '1011012020041320064378google', '', '3chen', 'l', 'li', 'q', 'zheng', 'jiang', 'h', 'alclinical', 'characteristic', 'pregnant', 'woman', 'covid-19', 'wuhan', '', 'chinan', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'april', '17', '', '', 'doi101056nejmc2009226crossrefgoogle', 'examine', 'milk', 'two', 'nurse', 'mother', 'infect', 'sars-cov-2', '', 'mother', 'inform', 'study', 'give', 'inform', 'consent', '', 'ethical', 'approval', 'case', 'study', 'waive', 'ethics', 'committee', 'ulm', 'university', 'sample', 'anonymised', '', 'clinical', 'data', 'timecourse', 'infection', 'two', 'mother', 'show', 'figure', '1', '', 'feed', 'nipple', 'disinfection', '', 'milk', 'collect', 'pump', 'store', 'sterile', 'container', '4c', '20c', 'analysis', '', 'determine', 'viral', 'load', 'rt-qpcr', 'sars-cov-2', 'n', 'orf1b-nsp14', 'genes4chu', 'dkw', 'pan', 'cheng', 'sms', 'almolecular', 'diagnosis', 'novel', 'coronavirus', '', '2019-ncov', '', 'cause', 'outbreak', 'pneumoniaclin', 'chem', '', '2020', '', '66', '', '549-555crossrefpubmedscopus', '', '39', '', 'whole', 'skim', 'milk', '', 'obtain', 'removal', 'lipid', 'fraction', '', '', 'detail', 'sample', 'storage', 'process', 'provide', 'appendix', '', 'following', 'admission', 'delivery', '', 'day', '0', '', '', 'four', 'sample', 'mother', '1', 'test', 'negative', '', 'figure', '2', '', '', 'contrast', '', 'sars-cov-2', 'rna', 'detect', 'milk', 'mother', '2', 'day', '10', '', 'leave', 'breast', '', '', '12', '', '13', '', 'samples', 'subsequently', 'negative', '', 'figure', '2', '', '', 'ct', 'value', 'sars-cov-2', 'n', 'peak', '298', '304', 'whole', 'milk', 'skim', 'milk', '', 'respectively', '', 'correspond', '132', '', '105', 'copy', 'per', 'ml', '948', '', '104', 'copy', 'per', 'ml', '', 'mean', 'isolation', '', '', 'since', 'milk', 'component', 'affect', 'rna', 'isolation', 'quantification', '', 'viral', 'rna', 'recovery', 'rate', 'milk', 'spike', 'serial', 'dilution', 'sars-cov-2', 'stock', 'determine', '', 'observe', '892', '', 'reduce', 'recovery', 'rate', 'whole', 'milk', '515', '', 'skim', 'milk', '', 'appendix', '', '', 'suggest', 'actual', 'viral', 'load', 'whole', 'milk', 'mother', '2', 'higher', 'detectedfigure', '1timecourse', 'sars-cov-2', 'infection', 'two', 'mother', 'newborn', 'childrenshow', 'full', 'captionafter', 'delivery', '', 'mother', '1', 'develop', 'mild', 'covid-19', 'symptom', 'test', 'positive', 'sars-cov-2', '', 'following', 'spatial', 'isolation', 'mother', '1', 'newborn', '', 'newborn', '1', '', '', 'newborn', '1', 'subsequently', 'test', 'positive', 'develop', 'respiratory', 'problem', '', 'mother', '1', 'newborn', '1', 'recover', '', 'mother', '2', 'admit', 'hospital', 'room', 'mother', '1', 'newborn', '1', '', 'upon', 'delivery', '', 'mother', '2', 'newborn', '2', 'bring', 'back', 'room', 'mother', '1', 'newborn', '1', '', 'stay', 'room', 'mother', '1', 'test', 'positive', 'sars-cov-2', 'isolate', '', 'mother', '2', 'newborn', '2', 'discharge', 'day', '4', '', 'mother', '2', 'develop', 'mild', 'covid-19', 'symptom', 'shortly', 'thereafter', 'begin', 'wear', 'surgical', 'mask', 'time', 'day', '', 'mother', '2', 'test', 'positive', 'sars-cov-2', 'day', '8', '', '3', 'day', 'later', '', 'newborn', '2', 'test', 'positive', 'sars-cov-2', 'readmitted', 'hospital', 'newborn', 'icterus', 'severe', 'breathe', 'problem', '', 'child', 'receive', 'ultraviolet', 'therapy', 'ventilation', 'therapy', '', 'newborn', '2', 'test', 'positive', 'rsv', 'sars-cov-2', 'later', 'timepoints', '', 'mother', '1', 'test', 'positive', 'sars-cov-2', 'day', '22', '', '13', 'day', 'first', 'diagnose', '', 'rt-qpcr', 'analysis', 'breastmilk', 'sample', 'mother', 'reveal', 'sars-cov-2', 'rna', 'milk', 'mother', '2', 'day', '1013', '', 'red', 'bottle', '', '', 'whereas', 'sample', 'mother', '1', 'negative', '', 'white', 'bottle', '', '', 'dark', 'shade', 'indicate', 'time', 'first', 'sars-cov-2', 'positive', 'oropharyngeal', 'nasopharyngeal', 'swab', '', 'brackets', 'indicate', 'duration', 'covid-19', 'symptom', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'rsvrespiratory', 'syncytial', 'virusview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'figure', '2detection', 'sars-cov-2', 'breastmilk', 'infect', 'mothershow', 'full', 'captionsars-cov-2', 'rna', 'isolate', 'whole', 'skim', 'breastmilk', 'obtain', 'different', 'timepoints', 'analyse', 'rt-qpcr', '', 'primer', 'set', 'target', 'sars-cov-2', 'n', 'orf1b', 'gene', '', 'samples', 'viral', 'rna', 'standard', 'duplicate', '', 'isolation', 'rt-qpcr', 'repeat', 'two', 'independent', 'assay', '', 'rna', 'breastmilk', 'mother', '2', 'day', '25', 'isolate', 'analyse', 'rt-qpcr', 'sars-cov-2', 'n', 'symbols', 'baseline', 'indicate', 'amplification', '', 'ct', '', '365', 'amplification', 'one', 'replicate', '', '', 'blue', 'dash', 'denote', 'quantification', 'threshold', 'n', '', '160', 'copy', 'per', 'reaction', '', 'ct', '342', '', 'red', 'dot', 'orf1b', '', '32', 'copy', 'per', 'reaction', '', 'ct', '359', '', '', 'values', 'baseline', 'indicate', 'amplification', 'replicate', '', 'reliable', 'quantification', '', 'values', 'show', 'represent', 'mean', '', 'sd', '', 'duplicate', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'ctcycle', 'thresholdview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'delivery', '', 'mother', '1', 'develop', 'mild', 'covid-19', 'symptom', 'test', 'positive', 'sars-cov-2', '', 'following', 'spatial', 'isolation', 'mother', '1', 'newborn', '', 'newborn', '1', '', '', 'newborn', '1', 'subsequently', 'test', 'positive', 'develop', 'respiratory', 'problem', '', 'mother', '1', 'newborn', '1', 'recover', '', 'mother', '2', 'admit', 'hospital', 'room', 'mother', '1', 'newborn', '1', '', 'upon', 'delivery', '', 'mother', '2', 'newborn', '2', 'bring', 'back', 'room', 'mother', '1', 'newborn', '1', '', 'stay', 'room', 'mother', '1', 'test', 'positive', 'sars-cov-2', 'isolate', '', 'mother', '2', 'newborn', '2', 'discharge', 'day', '4', '', 'mother', '2', 'develop', 'mild', 'covid-19', 'symptom', 'shortly', 'thereafter', 'begin', 'wear', 'surgical', 'mask', 'time', 'day', '', 'mother', '2', 'test', 'positive', 'sars-cov-2', 'day', '8', '', '3', 'day', 'later', '', 'newborn', '2', 'test', 'positive', 'sars-cov-2', 'readmitted', 'hospital', 'newborn', 'icterus', 'severe', 'breathe', 'problem', '', 'child', 'receive', 'ultraviolet', 'therapy', 'ventilation', 'therapy', '', 'newborn', '2', 'test', 'positive', 'rsv', 'sars-cov-2', 'later', 'timepoints', '', 'mother', '1', 'test', 'positive', 'sars-cov-2', 'day', '22', '', '13', 'day', 'first', 'diagnose', '', 'rt-qpcr', 'analysis', 'breastmilk', 'sample', 'mother', 'reveal', 'sars-cov-2', 'rna', 'milk', 'mother', '2', 'day', '1013', '', 'red', 'bottle', '', '', 'whereas', 'sample', 'mother', '1', 'negative', '', 'white', 'bottle', '', '', 'dark', 'shade', 'indicate', 'time', 'first', 'sars-cov-2', 'positive', 'oropharyngeal', 'nasopharyngeal', 'swab', '', 'brackets', 'indicate', 'duration', 'covid-19', 'symptom', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'rsvrespiratory', 'syncytial', 'virus', '', 'sars-cov-2', 'rna', 'isolate', 'whole', 'skim', 'breastmilk', 'obtain', 'different', 'timepoints', 'analyse', 'rt-qpcr', '', 'primer', 'set', 'target', 'sars-cov-2', 'n', 'orf1b', 'gene', '', 'samples', 'viral', 'rna', 'standard', 'duplicate', '', 'isolation', 'rt-qpcr', 'repeat', 'two', 'independent', 'assay', '', 'rna', 'breastmilk', 'mother', '2', 'day', '25', 'isolate', 'analyse', 'rt-qpcr', 'sars-cov-2', 'n', 'symbols', 'baseline', 'indicate', 'amplification', '', 'ct', '', '365', 'amplification', 'one', 'replicate', '', '', 'blue', 'dash', 'denote', 'quantification', 'threshold', 'n', '', '160', 'copy', 'per', 'reaction', '', 'ct', '342', '', 'red', 'dot', 'orf1b', '', '32', 'copy', 'per', 'reaction', '', 'ct', '359', '', '', 'values', 'baseline', 'indicate', 'amplification', 'replicate', '', 'reliable', 'quantification', '', 'values', 'show', 'represent', 'mean', '', 'sd', '', 'duplicate', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'ctcycle', 'threshold', '', 'detect', 'sars-cov-2', 'rna', 'milk', 'sample', 'mother', '2', '4', 'consecutive', 'day', '', 'detection', 'viral', 'rna', 'milk', 'mother', '2', 'coincide', 'mild', 'covid-19', 'symptom', 'sars-cov-2', 'positive', 'diagnostic', 'test', 'newborn', '', 'newborn', '2', '', '', 'mother', '2', 'wear', 'surgical', 'mask', 'since', 'onset', 'symptom', 'follow', 'safety', 'precaution', 'handle', 'feed', 'neonate', '', 'include', 'proper', 'hand', 'breast', 'disinfection', '', 'strict', 'wash', '', 'sterilisation', 'milk', 'pump', 'tube', '', '', 'however', '', 'whether', 'newborn', '2', 'infect', 'breastfeed', 'mode', 'transmission', 'remain', 'unclear', '', 'study', 'milk', 'sample', 'lactate', 'woman', 'possible', 'virus', 'transmission', 'via', 'breastfeed', 'develop', 'recommendation', 'whether', 'mother', 'covid-19', 'breastfeed', '', 'declare', 'compete', 'interest', '', 'rg', '', 'cc', '', 'jam', 'contribute', 'equally', '', 'work', 'support', 'eu', 'horizon', '2020', 'research', 'innovation', 'programme', '', 'fight-ncov', '', '101003555', 'jm', '', 'german', 'research', 'foundation', '', 'crc', '1279', 'ss', '', 'fk', '', 'jm', '', 'mu', '44851-1', 'jam', '', 'download', 'pdf', '', '26', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix']",1152,"{'': 209, 'mother': 44, '2': 36, 'sars-cov-2': 32, '1': 28, 'newborn': 26, 'day': 19, 'milk': 18, 'positive': 17, 'test': 16, 'rna': 13, 'sample': 10, 'covid-19': 10, 'breastmilk': 9, 'n': 9, 'rt-qpcr': 9, 'symptom': 8, 'indicate': 8, 'respiratory': 7, 'ct': 7}","{'infection': 2, 'sars-cov-2': 32, 'safety': 1}",35,-0.5574
DOI:10.1016/S0140-6736(20)31198-3,10.1016/S0140-6736(20)31198-3,World Report,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['mexican', 'president', 'lpez', 'obrador', 'draw', 'doctor', '', 'ire']","['President López Obrador later apologise comment denounce Mexican medical association amid COVID-19 pandemic .', 'David Agren report Mexico City .', ""Mexican President Andrés Manuel López Obrador set defend country 's coronavirus czsar Hugo López-Gatell May 8 , morning press conference ."", 'He describe López-Gatell “ honest ” “ humanistic ” , “ position favour people , favour mercantilism , unfortunately also come predominate neoliberal period everything relate health ” .', 'López Obrador , commonly know AMLO , refer three decade take office .', 'He say past doctor “ look enrich ” , ask patient “ asset ” , rather “ ( condition ) ” .', ""“ That 's not…Dr López-Gatell ” , say ."", 'Doctors quickly denounce comment , come medical staff stop wear uniform public .', 'Health worker physically assail people consider COVID-19 risk .', 'Some bleach throw .', '“ Many u risk life treat COVID-19 president make remark appropriate president much le time ” , say Asisclo de Jesús Villagómez , former president Mexican College Critical Care Medicine .', 'More 40 medical association issue statement May 10 urge AMLO apologise .', 'It unprecedented rebuke profession careful public pronouncement .', ""Mexico 's Health Secretariat respond interview request The Lancet ."", 'AMLO apologise May 11 , say speak physician .', ""His response accusation former health secretary shortcoming government 's response raise accusation corruption past administration ."", 'However , physician report routinely pay pocket supply .', 'Georgina Magaña , neurointensivist Mexico City , say saw early story COVID-19 start purchase personal protective equipment ( PPE ) .', 'What subsequently arrive “ augment ” personal supply , say .', 'Staff protest outside public hospital , , lack PPE .', 'Anti-graft group Mexicans Against Corruption Impunity find 219 hospital report shortages—ranging disposable gown N95 mask hand gel—as May 14 .', 'Mexico implement “ safe-distancing ” campaign , shut school university , close non-essential business .', 'The government urge people “ stay home ” , although quarantine strictly enforce .', ""Mexico 's response rely heavily model sentinel surveillance—which report respiratory disease information 475 site across country—rather widespread test ."", ""“ I n't think test must ” , López-Gatell tell CNN May 16 ."", '“ We use test carefully plan manner. ” Mexico do 0·4 test per 1000 people , rank last among member Organisation Economic Co-operation Development .', '“ Mexico reserve PCR serious patient ” , say Xavier Tello , physician health-care consultant .', '“ Contacts test , identify , traced. ” Foreign medium outlet allege Mexico undercounting COVID-19 death .', 'López-Gatell deny hide death figure project true death rate eight time higher officially confirm figures—not unusual occurrence pandemic , say .', 'Mexico start reopen stage May 18 , begin 324 municipality COVID-19 case report past 28 day .', 'Public health expert ask , however , test occur municipality .', '“ They know [ municipality open ] sample scheme ” , say Malaquías López-Cervantes , public health professor National Autonomous University Mexico .', 'He say sentinel surveillance could provide national picture , one state local level .', 'The Health Secretariat record 51 633 COVID-19 case 5322 death May 18 .', '“ We able flatten curve ” , López-Gatell say May 16 .', 'The pandemic “ lengthen , serious case overwhelm hospital capacity ” .', 'Even controversial comment COVID-19 approach , AMLO remain popular , accord polls—and retain support many physician .', ""Esther Zurita , general practitioner private practice , say people take president 's comment context ."", 'She back COVID-19 response .', '“ Dr López-Gatell good job communicate strategy…It would extremely arrogant judge result prematurely . ”']","['president', 'lpez', 'obrador', 'later', 'apologise', 'comment', 'denounce', 'mexican', 'medical', 'association', 'amid', 'covid-19', 'pandemic', '', 'david', 'agren', 'report', 'mexico', 'city', '', 'mexican', 'president', 'andrs', 'manuel', 'lpez', 'obrador', 'set', 'defend', 'country', 'coronavirus', 'czsar', 'hugo', 'lpez-gatell', '8', '', 'morning', 'press', 'conference', '', 'describe', 'lpez-gatell', '', 'honest', '', '', 'humanistic', '', '', '', 'position', 'favour', 'people', '', 'favour', 'mercantilism', '', 'unfortunately', 'predominate', 'neoliberal', 'period', 'everything', 'relate', 'health', '', '', 'lpez', 'obrador', '', 'commonly', 'amlo', '', 'refer', 'three', 'decade', 'office', '', 'past', 'doctor', '', 'look', 'enrich', '', '', 'ask', 'patient', '', 'asset', '', '', '', '', 'condition', '', '', '', '', 'notdr', 'lpez-gatell', '', '', '', 'doctors', 'quickly', 'denounce', 'comment', '', 'medical', 'staff', 'stop', 'wear', 'uniform', 'public', '', 'health', 'worker', 'physically', 'assail', 'people', 'consider', 'covid-19', 'risk', '', 'bleach', 'throw', '', '', 'u', 'risk', 'life', 'treat', 'covid-19', 'president', 'remark', 'appropriate', 'president', 'much', 'le', 'time', '', '', 'asisclo', 'de', 'jess', 'villagmez', '', 'former', 'president', 'mexican', 'college', 'critical', 'care', 'medicine', '', '40', 'medical', 'association', 'issue', 'statement', '10', 'urge', 'amlo', 'apologise', '', 'unprecedented', 'rebuke', 'profession', 'careful', 'public', 'pronouncement', '', 'mexico', 'health', 'secretariat', 'respond', 'interview', 'request', 'lancet', '', 'amlo', 'apologise', '11', '', 'speak', 'physician', '', 'response', 'accusation', 'former', 'health', 'secretary', 'shortcoming', 'government', 'response', 'raise', 'accusation', 'corruption', 'past', 'administration', '', 'however', '', 'physician', 'report', 'routinely', 'pay', 'pocket', 'supply', '', 'georgina', 'magaa', '', 'neurointensivist', 'mexico', 'city', '', 'saw', 'early', 'story', 'covid-19', 'start', 'purchase', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'subsequently', 'arrive', '', 'augment', '', 'personal', 'supply', '', '', 'staff', 'protest', 'outside', 'public', 'hospital', '', '', 'ppe', '', 'anti-graft', 'group', 'mexicans', 'corruption', 'impunity', 'find', '219', 'hospital', 'report', 'shortagesranging', 'disposable', 'gown', 'n95', 'mask', 'hand', 'gelas', '14', '', 'mexico', 'implement', '', 'safe-distancing', '', 'campaign', '', 'shut', 'school', 'university', '', 'close', 'non-essential', 'business', '', 'government', 'urge', 'people', '', 'stay', 'home', '', '', 'although', 'quarantine', 'strictly', 'enforce', '', 'mexico', 'response', 'rely', 'heavily', 'model', 'sentinel', 'surveillancewhich', 'report', 'respiratory', 'disease', 'information', '475', 'site', 'across', 'countryrather', 'widespread', 'test', '', '', 'nt', 'test', 'must', '', '', 'lpez-gatell', 'tell', 'cnn', '16', '', '', 'test', 'carefully', 'plan', 'manner', '', 'mexico', '04', 'test', 'per', '1000', 'people', '', 'rank', 'last', 'among', 'member', 'organisation', 'economic', 'co-operation', 'development', '', '', 'mexico', 'reserve', 'pcr', 'serious', 'patient', '', '', 'xavier', 'tello', '', 'physician', 'health-care', 'consultant', '', '', 'contacts', 'test', '', 'identify', '', 'traced', '', 'foreign', 'medium', 'outlet', 'allege', 'mexico', 'undercounting', 'covid-19', 'death', '', 'lpez-gatell', 'deny', 'hide', 'death', 'figure', 'project', 'true', 'death', 'rate', 'eight', 'time', 'higher', 'officially', 'confirm', 'figuresnot', 'unusual', 'occurrence', 'pandemic', '', '', 'mexico', 'start', 'reopen', 'stage', '18', '', 'begin', '324', 'municipality', 'covid-19', 'case', 'report', 'past', '28', 'day', '', 'public', 'health', 'expert', 'ask', '', 'however', '', 'test', 'occur', 'municipality', '', '', '', 'municipality', 'open', '', 'sample', 'scheme', '', '', 'malaquas', 'lpez-cervantes', '', 'public', 'health', 'professor', 'national', 'autonomous', 'university', 'mexico', '', 'sentinel', 'surveillance', 'provide', 'national', 'picture', '', 'one', 'state', 'local', 'level', '', 'health', 'secretariat', 'record', '51', '633', 'covid-19', 'case', '5322', 'death', '18', '', '', 'able', 'flatten', 'curve', '', '', 'lpez-gatell', '16', '', 'pandemic', '', 'lengthen', '', 'serious', 'case', 'overwhelm', 'hospital', 'capacity', '', '', 'controversial', 'comment', 'covid-19', 'approach', '', 'amlo', 'remain', 'popular', '', 'accord', 'pollsand', 'retain', 'support', 'physician', '', 'esther', 'zurita', '', 'general', 'practitioner', 'private', 'practice', '', 'people', 'president', 'comment', 'context', '', 'back', 'covid-19', 'response', '', '', 'dr', 'lpez-gatell', 'job', 'communicate', 'strategyit', 'extremely', 'arrogant', 'judge', 'result', 'prematurely', '', '']",529,"{'': 125, 'mexico': 10, 'covid-19': 9, 'lpez-gatell': 7, 'health': 7, 'president': 6, 'test': 6, 'report': 5, 'people': 5, 'public': 5, 'comment': 4, 'amlo': 4, 'physician': 4, 'response': 4, 'death': 4, 'lpez': 3, 'obrador': 3, 'apologise': 3, 'mexican': 3, 'medical': 3}",{},0,0.0516
DOI:10.1016/S0140-6736(20)31139-9,10.1016/S0140-6736(20)31139-9,Perspectives,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['stereotype', 'threat']","['Among disturb statistic emerge COVID-19 pandemic disproportionate impact term death severe illness ethnic minority UK USA .', 'On April 7 , 2020 , report US city Chicago , black population roughly 30 % , nearly 70 % COVID-19 death demographic .', 'A report release UK Intensive Care National Audit Research Centre April 17 , 2020 , show 34 % patient UK receive advance respiratory support non-white , despite non-white population nationally 14 % .', 'That day , UK Government announce review impact COVID-19 black , Asian , minority ethnic community .', 'On May 7 , 2020 , provisional analysis UK Office National Statistics NHS England data suggest , adjustment age , sociodemographic characteristic , measure self-reported health disability , black people almost twice likely white people COVID-19-related death .', ""We n't yet full picture pandemic ."", 'Even , tease apart local demographic infection pattern seem likely explain least portion disparity see date .', '44 % National Health Service medical staff , front line virus exposure , non-white .', 'In London , one worst affect region UK , white British people minority accord 2011 Census .', 'Socioeconomic factor may well account disparity , might racism health care .', 'However , far speculative explanation also offer : medical researcher raise possibility innate genetic difference racial group cause virus hit harder others .', 'View Large Image Copyright © 2020 Photo Neil Hall/Pool/Getty Images View Large Image Copyright © 2020 Photo Neil Hall/Pool/Getty Images Such speculation run risk forget demographic category recognise socially fact much biological mean betray wider problem medicine come race .', 'It become routine medical research clinical practice categorise people race ethnicity .', 'While doubt important identify demographic group might disadvantage unequal treatment spot environmental social pattern affect disease prevalence , category also sometimes use guide research , diagnosis , treatment way necessarily useful .', 'At worst , may reinforce damage myth biological difference group .', 'In make case possibility innate biological health difference group COVID-19 crisis , least one researcher point already-recognised increase risk hypertension among black people Afro-Caribbean descent UK USA .', 'Hypertension example health condition unambiguously racialised .', 'It widely accept UK National Institute Health Care Excellence guideline recommend black patient younger 55 year hypertension give calcium-channel blocker instead angiotensin-converting enzyme inhibitor ( ACE ) inhibitor , give non-black patient 55 year .', 'What justify distinction treatment basis race ?', 'When epidemiologist Jay Kaufman , McGill University Canada , cardiologist global expert hypertension Richard Cooper , Loyola University Chicago USA , analyse study claim see racial difference response ACE inhibitor , find evidence black white patient significantly advantage different prescription .', 'Their conclusion benefit assign ACE inhibitor accord race “ point view individual patient , meaningfully better assign flip coin ” .', ""Kaufman Cooper 's research affirm long know population geneticist ."", 'Humans highly homogeneous specie , even closest evolutionary cousin , chimpanzee .', 'By far greatest source human genetic variation group difference , individual difference .', 'This perhaps , effort pour research prove long-held hypothesis racial difference see hypertension genetic basis , scientist find anything consistent DNA support .', 'More pertinently , talk race talk group socially define .', 'In USA , instance , someone may one grandparent African ancestry categorise black base appearance .', 'It make little sense conduct research around assumption socially define group could exhibit genetic difference another socially define group group biologically define begin .', 'To defy logic .', 'It similarly defy logic assume non-white people UK , diverse geographical ancestry , genetically different white people group innately affect COVID-19 .', 'We need look history understand race construct little ground ever biology .', ""One reason counter-assumptions persist racial category loom presence social cultural life ca n't imagine n't firmer biological basis ."", 'This say group-level difference exist—for example , certain genetic condition run families—and indeed , research dismiss yield useful insight .', 'But must also remember variation see , fuzzy marginal , reliable guide treatment one patient .', 'Very often , environmental social factor play rather biological one .', 'In case hypertension , one dominant risk factor diet , particularly salt consumption .', 'Alongside know social risk factor physical inactivity obesity , research look hypertension black Americans suggest might also association stress , possibly include stress associate racial discrimination .', 'Yet , time , I see health researcher erroneously invoke social category though biological one .', 'At conference diversity clinical trial hold London , UK , I saw employee major pharmaceutical company repeatedly refer “ Latino ” “ ancestral ” group .', 'Anyone familiar history Americas know socially define group people cultural tie Latin America comprise individual hugely diverse ancestry .', ""Even stretch ca n't consider genetically similar group purpose scientific research ."", 'Incidents like make wonder whether well intentioned misguide medical researcher keep race science alive .', 'The temptation group people perceive common trait know sphere life stereotype .', 'I would argue medicine also dangerous habit racial stereotype .', 'This tendency treat people social group similar , enter biological essentialism , easily gloss complexity breadth individual difference .', ""One possible reason race keep reintroduce health research one blue-sky goal personalise medicine precise every person 's biological profile perfectly understand , avoid adverse drug reaction unnecessary death ."", ""In greyer real world n't necessary data , doctor researcher instead turn social category proxy ."", 'They work assumption certain group share certain health trait average , allow roughly gauge medical requirement patient belong group .', 'It feel like useful step road personalise medicine , might argue .', 'In view , fudge .', ""Our social category enormous power society , dictate live treat others , n't mean significance underneath skin ."", 'When gap see group , must therefore careful diagnose cause clear evidence .', 'Casual speculation help nobody .', 'The UK Confidential Enquiry Maternal Deaths find 2018 black woman five time likely white woman die pregnancy childbirth .', 'Similar mortality rate see USA , among black woman also minority .', ""Some wonder whether might something black woman 's body way vulnerable le able withstand pregnancy ."", 'It fall health professional work minority woman , brilliant Florida-based midwife Jennie Joseph , show on-the-ground work pregnant woman , simply improve standard care , mortality rate drastically improve .', ""It group people different , Joseph 's work prof , group treat ."", 'It racism kill , race .', 'Scientists finally investigate damage effect conscious unconscious bias patient , reveal disturb truth racism , sexism , form prejudice medicine .', 'A review gender difference treatment chronic pain 2018 show woman tend take le seriously men , easily dismiss over-sensitive hysterical .', 'A 2020 study uncover racial disparity dementia care UK , Asian dementia patient le likely prescribe anti-dementia drug white patient .', 'These easy fact confront doctor medical researcher believe best patient .', 'But persistent habit essentialising large group people medicine , I would argue , need interrogate .', 'Medical research help maintain myth .', 'If race use research variable diagnostic tool , reason need clearly articulate justify , avoid reliance stereotype rather fact .', ""Angela Saini author Superior : The Return Race Science ( 2019 ) Inferior : How Science Got Women Wrong New Research That 's Rewriting Story ( 2017 )""]","['among', 'disturb', 'statistic', 'emerge', 'covid-19', 'pandemic', 'disproportionate', 'impact', 'term', 'death', 'severe', 'illness', 'ethnic', 'minority', 'uk', 'usa', '', 'april', '7', '', '2020', '', 'report', 'us', 'city', 'chicago', '', 'black', 'population', 'roughly', '30', '', '', 'nearly', '70', '', 'covid-19', 'death', 'demographic', '', 'report', 'release', 'uk', 'intensive', 'care', 'national', 'audit', 'research', 'centre', 'april', '17', '', '2020', '', 'show', '34', '', 'patient', 'uk', 'receive', 'advance', 'respiratory', 'support', 'non-white', '', 'despite', 'non-white', 'population', 'nationally', '14', '', '', 'day', '', 'uk', 'government', 'announce', 'review', 'impact', 'covid-19', 'black', '', 'asian', '', 'minority', 'ethnic', 'community', '', '7', '', '2020', '', 'provisional', 'analysis', 'uk', 'office', 'national', 'statistics', 'nhs', 'england', 'data', 'suggest', '', 'adjustment', 'age', '', 'sociodemographic', 'characteristic', '', 'measure', 'self-reported', 'health', 'disability', '', 'black', 'people', 'almost', 'twice', 'likely', 'white', 'people', 'covid-19-related', 'death', '', 'nt', 'yet', 'full', 'picture', 'pandemic', '', '', 'tease', 'apart', 'local', 'demographic', 'infection', 'pattern', 'likely', 'explain', 'least', 'portion', 'disparity', 'date', '', '44', '', 'national', 'health', 'service', 'medical', 'staff', '', 'front', 'virus', 'exposure', '', 'non-white', '', 'london', '', 'one', 'worst', 'affect', 'region', 'uk', '', 'white', 'british', 'people', 'minority', 'accord', '2011', 'census', '', 'socioeconomic', 'factor', 'well', 'account', 'disparity', '', 'racism', 'health', 'care', '', 'however', '', 'far', 'speculative', 'explanation', 'offer', '', 'medical', 'researcher', 'raise', 'possibility', 'innate', 'genetic', 'difference', 'racial', 'group', 'cause', 'virus', 'hit', 'harder', 'others', '', 'view', 'large', 'image', 'copyright', '', '2020', 'photo', 'neil', 'hallpoolgetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'photo', 'neil', 'hallpoolgetty', 'images', 'speculation', 'risk', 'forget', 'demographic', 'category', 'recognise', 'socially', 'fact', 'much', 'biological', 'mean', 'betray', 'wider', 'problem', 'medicine', 'race', '', 'become', 'routine', 'medical', 'research', 'clinical', 'practice', 'categorise', 'people', 'race', 'ethnicity', '', 'doubt', 'important', 'identify', 'demographic', 'group', 'disadvantage', 'unequal', 'treatment', 'spot', 'environmental', 'social', 'pattern', 'affect', 'disease', 'prevalence', '', 'category', 'sometimes', 'guide', 'research', '', 'diagnosis', '', 'treatment', 'way', 'necessarily', 'useful', '', 'worst', '', 'reinforce', 'damage', 'myth', 'biological', 'difference', 'group', '', 'case', 'possibility', 'innate', 'biological', 'health', 'difference', 'group', 'covid-19', 'crisis', '', 'least', 'one', 'researcher', 'point', 'already-recognised', 'increase', 'risk', 'hypertension', 'among', 'black', 'people', 'afro-caribbean', 'descent', 'uk', 'usa', '', 'hypertension', 'example', 'health', 'condition', 'unambiguously', 'racialised', '', 'widely', 'accept', 'uk', 'national', 'institute', 'health', 'care', 'excellence', 'guideline', 'recommend', 'black', 'patient', 'younger', '55', 'year', 'hypertension', 'give', 'calcium-channel', 'blocker', 'instead', 'angiotensin-converting', 'enzyme', 'inhibitor', '', 'ace', '', 'inhibitor', '', 'give', 'non-black', 'patient', '55', 'year', '', 'justify', 'distinction', 'treatment', 'basis', 'race', '', 'epidemiologist', 'jay', 'kaufman', '', 'mcgill', 'university', 'canada', '', 'cardiologist', 'global', 'expert', 'hypertension', 'richard', 'cooper', '', 'loyola', 'university', 'chicago', 'usa', '', 'analyse', 'study', 'claim', 'racial', 'difference', 'response', 'ace', 'inhibitor', '', 'find', 'evidence', 'black', 'white', 'patient', 'significantly', 'advantage', 'different', 'prescription', '', 'conclusion', 'benefit', 'assign', 'ace', 'inhibitor', 'accord', 'race', '', 'point', 'view', 'individual', 'patient', '', 'meaningfully', 'better', 'assign', 'flip', 'coin', '', '', 'kaufman', 'cooper', 'research', 'affirm', 'long', 'population', 'geneticist', '', 'humans', 'highly', 'homogeneous', 'specie', '', 'closest', 'evolutionary', 'cousin', '', 'chimpanzee', '', 'far', 'greatest', 'source', 'human', 'genetic', 'variation', 'group', 'difference', '', 'individual', 'difference', '', 'perhaps', '', 'effort', 'pour', 'research', 'prove', 'long-held', 'hypothesis', 'racial', 'difference', 'hypertension', 'genetic', 'basis', '', 'scientist', 'find', 'anything', 'consistent', 'dna', 'support', '', 'pertinently', '', 'talk', 'race', 'talk', 'group', 'socially', 'define', '', 'usa', '', 'instance', '', 'someone', 'one', 'grandparent', 'african', 'ancestry', 'categorise', 'black', 'base', 'appearance', '', 'little', 'sense', 'conduct', 'research', 'around', 'assumption', 'socially', 'define', 'group', 'exhibit', 'genetic', 'difference', 'another', 'socially', 'define', 'group', 'group', 'biologically', 'define', 'begin', '', 'defy', 'logic', '', 'similarly', 'defy', 'logic', 'assume', 'non-white', 'people', 'uk', '', 'diverse', 'geographical', 'ancestry', '', 'genetically', 'different', 'white', 'people', 'group', 'innately', 'affect', 'covid-19', '', 'look', 'history', 'understand', 'race', 'construct', 'little', 'ground', 'ever', 'biology', '', 'one', 'reason', 'counter-assumptions', 'persist', 'racial', 'category', 'loom', 'presence', 'social', 'cultural', 'life', 'ca', 'nt', 'imagine', 'nt', 'firmer', 'biological', 'basis', '', 'group-level', 'difference', 'existfor', 'example', '', 'certain', 'genetic', 'condition', 'familiesand', 'indeed', '', 'research', 'dismiss', 'yield', 'useful', 'insight', '', 'must', 'remember', 'variation', '', 'fuzzy', 'marginal', '', 'reliable', 'guide', 'treatment', 'one', 'patient', '', 'often', '', 'environmental', 'social', 'factor', 'play', 'biological', 'one', '', 'case', 'hypertension', '', 'one', 'dominant', 'risk', 'factor', 'diet', '', 'particularly', 'salt', 'consumption', '', 'alongside', 'social', 'risk', 'factor', 'physical', 'inactivity', 'obesity', '', 'research', 'look', 'hypertension', 'black', 'americans', 'suggest', 'association', 'stress', '', 'possibly', 'include', 'stress', 'associate', 'racial', 'discrimination', '', 'yet', '', 'time', '', 'health', 'researcher', 'erroneously', 'invoke', 'social', 'category', 'though', 'biological', 'one', '', 'conference', 'diversity', 'clinical', 'trial', 'hold', 'london', '', 'uk', '', 'saw', 'employee', 'major', 'pharmaceutical', 'company', 'repeatedly', 'refer', '', 'latino', '', '', 'ancestral', '', 'group', '', 'anyone', 'familiar', 'history', 'americas', 'socially', 'define', 'group', 'people', 'cultural', 'tie', 'latin', 'america', 'comprise', 'individual', 'hugely', 'diverse', 'ancestry', '', 'stretch', 'ca', 'nt', 'consider', 'genetically', 'similar', 'group', 'purpose', 'scientific', 'research', '', 'incidents', 'like', 'wonder', 'whether', 'well', 'intentioned', 'misguide', 'medical', 'researcher', 'keep', 'race', 'science', 'alive', '', 'temptation', 'group', 'people', 'perceive', 'common', 'trait', 'sphere', 'life', 'stereotype', '', 'argue', 'medicine', 'dangerous', 'habit', 'racial', 'stereotype', '', 'tendency', 'treat', 'people', 'social', 'group', 'similar', '', 'enter', 'biological', 'essentialism', '', 'gloss', 'complexity', 'breadth', 'individual', 'difference', '', 'one', 'possible', 'reason', 'race', 'keep', 'reintroduce', 'health', 'research', 'one', 'blue-sky', 'goal', 'personalise', 'medicine', 'precise', 'every', 'person', 'biological', 'profile', 'perfectly', 'understand', '', 'avoid', 'adverse', 'drug', 'reaction', 'unnecessary', 'death', '', 'greyer', 'real', 'world', 'nt', 'necessary', 'data', '', 'doctor', 'researcher', 'instead', 'turn', 'social', 'category', 'proxy', '', 'work', 'assumption', 'certain', 'group', 'share', 'certain', 'health', 'trait', 'average', '', 'allow', 'roughly', 'gauge', 'medical', 'requirement', 'patient', 'belong', 'group', '', 'feel', 'like', 'useful', 'step', 'road', 'personalise', 'medicine', '', 'argue', '', 'view', '', 'fudge', '', 'social', 'category', 'enormous', 'power', 'society', '', 'dictate', 'live', 'treat', 'others', '', 'nt', 'mean', 'significance', 'underneath', 'skin', '', 'gap', 'group', '', 'must', 'therefore', 'careful', 'diagnose', 'cause', 'clear', 'evidence', '', 'casual', 'speculation', 'help', 'nobody', '', 'uk', 'confidential', 'enquiry', 'maternal', 'deaths', 'find', '2018', 'black', 'woman', 'five', 'time', 'likely', 'white', 'woman', 'die', 'pregnancy', 'childbirth', '', 'similar', 'mortality', 'rate', 'usa', '', 'among', 'black', 'woman', 'minority', '', 'wonder', 'whether', 'something', 'black', 'woman', 'body', 'way', 'vulnerable', 'le', 'able', 'withstand', 'pregnancy', '', 'fall', 'health', 'professional', 'work', 'minority', 'woman', '', 'brilliant', 'florida-based', 'midwife', 'jennie', 'joseph', '', 'show', 'on-the-ground', 'work', 'pregnant', 'woman', '', 'simply', 'improve', 'standard', 'care', '', 'mortality', 'rate', 'drastically', 'improve', '', 'group', 'people', 'different', '', 'joseph', 'work', 'prof', '', 'group', 'treat', '', 'racism', 'kill', '', 'race', '', 'scientists', 'finally', 'investigate', 'damage', 'effect', 'conscious', 'unconscious', 'bias', 'patient', '', 'reveal', 'disturb', 'truth', 'racism', '', 'sexism', '', 'form', 'prejudice', 'medicine', '', 'review', 'gender', 'difference', 'treatment', 'chronic', 'pain', '2018', 'show', 'woman', 'tend', 'le', 'seriously', 'men', '', 'dismiss', 'over-sensitive', 'hysterical', '', '2020', 'study', 'uncover', 'racial', 'disparity', 'dementia', 'care', 'uk', '', 'asian', 'dementia', 'patient', 'le', 'likely', 'prescribe', 'anti-dementia', 'drug', 'white', 'patient', '', 'fact', 'confront', 'doctor', 'medical', 'researcher', 'believe', 'best', 'patient', '', 'persistent', 'habit', 'essentialising', 'large', 'group', 'people', 'medicine', '', 'argue', '', 'interrogate', '', 'medical', 'research', 'help', 'maintain', 'myth', '', 'race', 'research', 'variable', 'diagnostic', 'tool', '', 'reason', 'clearly', 'articulate', 'justify', '', 'avoid', 'reliance', 'stereotype', 'fact', '', 'angela', 'saini', 'author', 'superior', '', 'return', 'race', 'science', '', '2019', '', 'inferior', '', 'science', 'got', 'women', 'wrong', 'new', 'research', 'rewriting', 'story', '', '2017', '']",1084,"{'': 173, 'group': 21, 'research': 13, 'uk': 12, 'people': 12, 'black': 11, 'patient': 11, 'difference': 11, 'race': 11, 'health': 10, 'one': 10, 'biological': 8, 'social': 8, 'medical': 7, 'racial': 7, 'hypertension': 7, 'woman': 7, '2020': 6, 'white': 6, 'nt': 6}",{'infection': 1},1,-0.872
DOI:10.1016/S0140-6736(20)31138-7,10.1016/S0140-6736(20)31138-7,Perspectives,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['helena', 'legido-quigley', '', 'proponent', 'health', 'system', 'strengthen']","['View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) As Associate Professor Health Systems Saw Swee Hock School Public Health National University Singapore , Helena Legido-Quigley able observe first-hand country respond first COVID-19 outbreak earlier year .', '“ It strike well Singapore prepare , legacy SARS era , dedicate infectious disease hospital 6 month supply personal protective equipment ventilator .', 'The public health response fast efficient good governance effective health-risk communication ” , say .', ""But Singapore 's second wave COVID-19 among migrant worker expose wider inequality ."", ""Highlighting value heart global health vision , Legido-Quigley say : “ We job properly global health address circumstance vulnerable population , especially among million people make world 's migrant population. ” Before COVID-19 pandemic , analysis health system implication prevention management key health area include antimicrobial resistance , non-communicable disease , mental health research priority ."", 'The pandemic understandably refocus work team Singapore .', 'As result , collaborate public health colleague internationally build in-country profile pandemic response .', '“ This crucial help u establish best practice , learn adapt influence ability health system respond appropriate public health strategy future outbreak public health emergency ” , explain .', ""Legido-Quigley 's career journey owe much parent , instill value education five daughter family life Barcelona , Spain ."", 'She study sociology university Barcelona Reading , UK , follow master social policy University Edinburgh .', ""But time volunteer HIV/AIDS hospice South Africa around turn millennium heighten Legido-Quigley 's desire work academic health policy arena ."", '“ It difficult transform experience , try help die mother child , era access antiretroviral therapy ” , say .', 'She move London 2002 PhD London School Hygiene & Tropical Medicine ( LSHTM ) , work extensively European health system project Martin McKee , Professor European Public Health .', ""This include analysis health system impact Spain 's austerity programme ."", ""Having spend COVID-19 lockdown back native country , impact Spain 's austerity measure evident ."", '“ Any country deplete public health infrastructure go struggle respond pandemic , sober message future global health security ” , say .', ""The latter part time LSHTM spend work school 's Director Peter Piot , focus policy implication public health research , highlight contribution 2015 Defeating AIDS—Advancing Global Health 2018 Future Health sub-Saharan Africa Lancet Commissions ."", ""Legido-Quigley 's engage care personality immediately apparent McKee , comment : “ The first thing strike Helena concern others ."", 'These include people research , many margin society , colleague , especially junior staff .', ""I 'm sure help fit easily different culture Europe Asia ."", 'But Helena also extremely talented researcher become role model others , especially young female health service researcher .', 'I feel extremely privilege doctoral student , continue work ever since. ” With current position share Saw Swee Hock School Public Health Singapore LSHTM , Legido-Quigley collaborate multidisciplinary team academic research health , social , economic impact COVID-19 Asia Europe .', '“ We plan one project WHO Europe , include focus pandemic greatest impact , encompass effect vulnerable population ” , explain .', 'Her priority consolidation professional passion : mentor younger generation public health researcher contribute woman science global health agenda ; currently help establish network female scientist Asia part wider global advocacy movement improve gender equality throughout scientific community .', ""Legido-Quigley recently appoint Editor-in-Chief Elsevier 's new Journal Migration Health , plan special issue later year dedicate migrant health impact COVID-19 ."", '“ This incredibly excite , health migrant passion , journal main focus important component global health ” , say .', 'Further ahead , see new dialogue global health governance priority , light COVID-19 pandemic .', '“ How redefine global health architecture enormous implication health system worldwide resilient future public health emergency ” , say .', 'Through membership Council World Economic Forum , Legido-Quigley prime position exert grow influence global health wider sustainable development arena .']","['view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'associate', 'professor', 'health', 'systems', 'saw', 'swee', 'hock', 'school', 'public', 'health', 'national', 'university', 'singapore', '', 'helena', 'legido-quigley', 'able', 'observe', 'first-hand', 'country', 'respond', 'first', 'covid-19', 'outbreak', 'earlier', 'year', '', '', 'strike', 'well', 'singapore', 'prepare', '', 'legacy', 'sars', 'era', '', 'dedicate', 'infectious', 'disease', 'hospital', '6', 'month', 'supply', 'personal', 'protective', 'equipment', 'ventilator', '', 'public', 'health', 'response', 'fast', 'efficient', 'governance', 'effective', 'health-risk', 'communication', '', '', '', 'singapore', 'second', 'wave', 'covid-19', 'among', 'migrant', 'worker', 'expose', 'wider', 'inequality', '', 'highlighting', 'value', 'heart', 'global', 'health', 'vision', '', 'legido-quigley', '', '', 'job', 'properly', 'global', 'health', 'address', 'circumstance', 'vulnerable', 'population', '', 'especially', 'among', 'million', 'people', 'world', 'migrant', 'population', '', 'covid-19', 'pandemic', '', 'analysis', 'health', 'system', 'implication', 'prevention', 'management', 'key', 'health', 'area', 'include', 'antimicrobial', 'resistance', '', 'non-communicable', 'disease', '', 'mental', 'health', 'research', 'priority', '', 'pandemic', 'understandably', 'refocus', 'work', 'team', 'singapore', '', 'result', '', 'collaborate', 'public', 'health', 'colleague', 'internationally', 'build', 'in-country', 'profile', 'pandemic', 'response', '', '', 'crucial', 'help', 'u', 'establish', 'best', 'practice', '', 'learn', 'adapt', 'influence', 'ability', 'health', 'system', 'respond', 'appropriate', 'public', 'health', 'strategy', 'future', 'outbreak', 'public', 'health', 'emergency', '', '', 'explain', '', 'legido-quigley', 'career', 'journey', 'owe', 'much', 'parent', '', 'instill', 'value', 'education', 'five', 'daughter', 'family', 'life', 'barcelona', '', 'spain', '', 'study', 'sociology', 'university', 'barcelona', 'reading', '', 'uk', '', 'follow', 'master', 'social', 'policy', 'university', 'edinburgh', '', 'time', 'volunteer', 'hivaids', 'hospice', 'south', 'africa', 'around', 'turn', 'millennium', 'heighten', 'legido-quigley', 'desire', 'work', 'academic', 'health', 'policy', 'arena', '', '', 'difficult', 'transform', 'experience', '', 'help', 'die', 'mother', 'child', '', 'era', 'access', 'antiretroviral', 'therapy', '', '', '', 'move', 'london', '2002', 'phd', 'london', 'school', 'hygiene', '', 'tropical', 'medicine', '', 'lshtm', '', '', 'work', 'extensively', 'european', 'health', 'system', 'project', 'martin', 'mckee', '', 'professor', 'european', 'public', 'health', '', 'include', 'analysis', 'health', 'system', 'impact', 'spain', 'austerity', 'programme', '', 'spend', 'covid-19', 'lockdown', 'back', 'native', 'country', '', 'impact', 'spain', 'austerity', 'measure', 'evident', '', '', 'country', 'deplete', 'public', 'health', 'infrastructure', 'struggle', 'respond', 'pandemic', '', 'sober', 'message', 'future', 'global', 'health', 'security', '', '', '', 'latter', 'part', 'time', 'lshtm', 'spend', 'work', 'school', 'director', 'peter', 'piot', '', 'focus', 'policy', 'implication', 'public', 'health', 'research', '', 'highlight', 'contribution', '2015', 'defeating', 'aidsadvancing', 'global', 'health', '2018', 'future', 'health', 'sub-saharan', 'africa', 'lancet', 'commissions', '', 'legido-quigley', 'engage', 'care', 'personality', 'immediately', 'apparent', 'mckee', '', 'comment', '', '', 'first', 'thing', 'strike', 'helena', 'concern', 'others', '', 'include', 'people', 'research', '', 'margin', 'society', '', 'colleague', '', 'especially', 'junior', 'staff', '', 'sure', 'help', 'fit', 'different', 'culture', 'europe', 'asia', '', 'helena', 'extremely', 'talented', 'researcher', 'become', 'role', 'model', 'others', '', 'especially', 'young', 'female', 'health', 'service', 'researcher', '', 'feel', 'extremely', 'privilege', 'doctoral', 'student', '', 'continue', 'work', 'ever', 'since', '', 'current', 'position', 'share', 'saw', 'swee', 'hock', 'school', 'public', 'health', 'singapore', 'lshtm', '', 'legido-quigley', 'collaborate', 'multidisciplinary', 'team', 'academic', 'research', 'health', '', 'social', '', 'economic', 'impact', 'covid-19', 'asia', 'europe', '', '', 'plan', 'one', 'project', 'europe', '', 'include', 'focus', 'pandemic', 'greatest', 'impact', '', 'encompass', 'effect', 'vulnerable', 'population', '', '', 'explain', '', 'priority', 'consolidation', 'professional', 'passion', '', 'mentor', 'younger', 'generation', 'public', 'health', 'researcher', 'contribute', 'woman', 'science', 'global', 'health', 'agenda', '', 'currently', 'help', 'establish', 'network', 'female', 'scientist', 'asia', 'part', 'wider', 'global', 'advocacy', 'movement', 'improve', 'gender', 'equality', 'throughout', 'scientific', 'community', '', 'legido-quigley', 'recently', 'appoint', 'editor-in-chief', 'elsevier', 'new', 'journal', 'migration', 'health', '', 'plan', 'special', 'issue', 'later', 'year', 'dedicate', 'migrant', 'health', 'impact', 'covid-19', '', '', 'incredibly', 'excite', '', 'health', 'migrant', 'passion', '', 'journal', 'main', 'focus', 'important', 'component', 'global', 'health', '', '', '', 'ahead', '', 'new', 'dialogue', 'global', 'health', 'governance', 'priority', '', 'light', 'covid-19', 'pandemic', '', '', 'redefine', 'global', 'health', 'architecture', 'enormous', 'implication', 'health', 'system', 'worldwide', 'resilient', 'future', 'public', 'health', 'emergency', '', '', '', 'membership', 'council', 'world', 'economic', 'forum', '', 'legido-quigley', 'prime', 'position', 'exert', 'grow', 'influence', 'global', 'health', 'wider', 'sustainable', 'development', 'arena', '']",603,"{'': 104, 'health': 35, 'public': 11, 'global': 10, 'legido-quigley': 8, 'covid-19': 7, 'pandemic': 6, 'singapore': 5, 'system': 5, 'work': 5, 'impact': 5, 'image': 4, 'school': 4, 'migrant': 4, 'include': 4, 'research': 4, 'help': 4, 'future': 4, 'university': 3, 'helena': 3}",{},0,0.8555
DOI:10.1016/S0140-6736(20)31199-5,10.1016/S0140-6736(20)31199-5,World Report,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['england', 'wales', '20', '000', 'excess', 'death', 'care', 'home']","['PPE shortage , lack test , vulnerable population see care home England Wales become hotspot COVID-19 epidemic .', 'Talha Burki report .', 'On May 15 , 2020 , UK Office National Statistics ( ONS ) release provisional figure death involve COVID-19 care sector England Wales .', 'From March 2 May 1 , 2020 , COVID-19 confirm suspect death 12 526 individual live care home two nation .', 'Worrying figure , capture official notification ; take account excess mortality , situation appear even worse .', 'In average year , care sector England Wales see roughly 20 000 fewer death March April record 2020 .', 'Once COVID-19 enter care home , move quickly .', 'By time first patient display symptom , half resident might already infect .', 'Care home find difficult obtain adequate quantity personal protective equipment reasonable time , provider tend prioritise National Health Service .', ""A survey Alzheimer 's Society find almost half care home confident supply personal protective equipment ; one facility say start tap bag staff member ' hand , foot , hair ."", 'There also difficulty get hold enough test .', '“ People try isolate resident manage outbreak without know virus ; incredibly difficult task ” , say Adam Gordon , professor care older people ( University Nottingham , Nottingham , UK ) .', 'According report Sky News , home pressure receive patient COVID-19 hospital .', 'Until mid-April , official advice state “ negative test require prior transfers/admissions care home ” .', 'It April 28 government stipulate resident staff test virus .', '“ You situation care home force bring people probably virus , mean test , tool keep people safe ” , point Adelina Comas-Herrera , research fellow London School Economics Political Science , London , UK .', '“ It toxic combination. ” The sector already face staff crisis .', 'Pay care home worker tend hover around minimum wage , despite perform similar job nurse .', 'If work , get pay .', 'That make choose self-isolate costly decision .', 'The ONS note 9039 12 526 death involve COVID-19 March April occur within care home , 3444 death occur within hospital .', 'Gordon surprise disparity .', '“ This group people frail often multiple morbidity ” , say .', '“ Many patient care home feel come end life ; make conscious decision go hospital receive care within residential facility , even mean palliative care ” .', ""In vast majority register case , care home resident die COVID-19 least one underlie condition , commonly dementia Alzheimer 's disease ."", 'This hardly surprise ; around 80 % resident kind cognitive impairment .', 'Patients may deteriorate quickly time get hospital ; COVID-19 kill soon initial appearance symptom .', ""Comas-Herrera point even majority year 's excess death care home directly attributable infection SARS-CoV-2 , mean consequence pandemic ."", '“ COVID-19 hugely disruptive ; affect aspect care ” , say .', 'Isolating resident may mitigate spread virus , associate morbidity .', 'Care home build communal live staff accordingly .', 'The lack supervision place isolate resident increase risk injury , particularly fall , mental health might suffer .', 'People dementia often stop eat depress , hasten death .', 'Besides , small task persuade people dementia stay room maintain physical distance .', 'No-one want see caregiver resort restrain sedate resident .', 'England Wales far country struggle epidemic COVID-19 within care sector .', 'The French death toll much smaller ( 12 511 ) .', 'Care home resident represent around third total number report death COVID-19 England Wales , line several country similar income level .', '“ Even nation do well control overall epidemic , Germany Norway , see high proportion death among people long-term care ” , say Gordon .']","['ppe', 'shortage', '', 'test', '', 'vulnerable', 'population', 'care', 'home', 'england', 'wales', 'become', 'hotspot', 'covid-19', 'epidemic', '', 'talha', 'burki', 'report', '', '15', '', '2020', '', 'uk', 'office', 'national', 'statistics', '', 'ons', '', 'release', 'provisional', 'figure', 'death', 'involve', 'covid-19', 'care', 'sector', 'england', 'wales', '', 'march', '2', '1', '', '2020', '', 'covid-19', 'confirm', 'suspect', 'death', '12', '526', 'individual', 'live', 'care', 'home', 'two', 'nation', '', 'worrying', 'figure', '', 'capture', 'official', 'notification', '', 'account', 'excess', 'mortality', '', 'situation', 'appear', 'worse', '', 'average', 'year', '', 'care', 'sector', 'england', 'wales', 'roughly', '20', '000', 'fewer', 'death', 'march', 'april', 'record', '2020', '', 'covid-19', 'enter', 'care', 'home', '', 'move', 'quickly', '', 'time', 'first', 'patient', 'display', 'symptom', '', 'half', 'resident', 'already', 'infect', '', 'care', 'home', 'find', 'difficult', 'obtain', 'adequate', 'quantity', 'personal', 'protective', 'equipment', 'reasonable', 'time', '', 'provider', 'tend', 'prioritise', 'national', 'health', 'service', '', 'survey', 'alzheimer', 'society', 'find', 'almost', 'half', 'care', 'home', 'confident', 'supply', 'personal', 'protective', 'equipment', '', 'one', 'facility', 'start', 'tap', 'bag', 'staff', 'member', '', 'hand', '', 'foot', '', 'hair', '', 'difficulty', 'hold', 'enough', 'test', '', '', 'people', 'isolate', 'resident', 'manage', 'outbreak', 'without', 'virus', '', 'incredibly', 'difficult', 'task', '', '', 'adam', 'gordon', '', 'professor', 'care', 'older', 'people', '', 'university', 'nottingham', '', 'nottingham', '', 'uk', '', '', 'according', 'report', 'sky', 'news', '', 'home', 'pressure', 'receive', 'patient', 'covid-19', 'hospital', '', 'mid-april', '', 'official', 'advice', 'state', '', 'negative', 'test', 'require', 'prior', 'transfersadmissions', 'care', 'home', '', '', 'april', '28', 'government', 'stipulate', 'resident', 'staff', 'test', 'virus', '', '', 'situation', 'care', 'home', 'force', 'bring', 'people', 'probably', 'virus', '', 'mean', 'test', '', 'tool', 'keep', 'people', 'safe', '', '', 'point', 'adelina', 'comas-herrera', '', 'research', 'fellow', 'london', 'school', 'economics', 'political', 'science', '', 'london', '', 'uk', '', '', 'toxic', 'combination', '', 'sector', 'already', 'face', 'staff', 'crisis', '', 'pay', 'care', 'home', 'worker', 'tend', 'hover', 'around', 'minimum', 'wage', '', 'despite', 'perform', 'similar', 'job', 'nurse', '', 'work', '', 'pay', '', 'choose', 'self-isolate', 'costly', 'decision', '', 'ons', 'note', '9039', '12', '526', 'death', 'involve', 'covid-19', 'march', 'april', 'occur', 'within', 'care', 'home', '', '3444', 'death', 'occur', 'within', 'hospital', '', 'gordon', 'surprise', 'disparity', '', '', 'group', 'people', 'frail', 'often', 'multiple', 'morbidity', '', '', '', '', 'patient', 'care', 'home', 'feel', 'end', 'life', '', 'conscious', 'decision', 'hospital', 'receive', 'care', 'within', 'residential', 'facility', '', 'mean', 'palliative', 'care', '', '', 'vast', 'majority', 'register', 'case', '', 'care', 'home', 'resident', 'die', 'covid-19', 'least', 'one', 'underlie', 'condition', '', 'commonly', 'dementia', 'alzheimer', 'disease', '', 'hardly', 'surprise', '', 'around', '80', '', 'resident', 'kind', 'cognitive', 'impairment', '', 'patients', 'deteriorate', 'quickly', 'time', 'hospital', '', 'covid-19', 'kill', 'soon', 'initial', 'appearance', 'symptom', '', 'comas-herrera', 'point', 'majority', 'year', 'excess', 'death', 'care', 'home', 'directly', 'attributable', 'infection', 'sars-cov-2', '', 'mean', 'consequence', 'pandemic', '', '', 'covid-19', 'hugely', 'disruptive', '', 'affect', 'aspect', 'care', '', '', '', 'isolating', 'resident', 'mitigate', 'spread', 'virus', '', 'associate', 'morbidity', '', 'care', 'home', 'build', 'communal', 'live', 'staff', 'accordingly', '', 'supervision', 'place', 'isolate', 'resident', 'increase', 'risk', 'injury', '', 'particularly', 'fall', '', 'mental', 'health', 'suffer', '', 'people', 'dementia', 'often', 'stop', 'eat', 'depress', '', 'hasten', 'death', '', 'besides', '', 'small', 'task', 'persuade', 'people', 'dementia', 'stay', 'room', 'maintain', 'physical', 'distance', '', 'no-one', 'caregiver', 'resort', 'restrain', 'sedate', 'resident', '', 'england', 'wales', 'far', 'country', 'struggle', 'epidemic', 'covid-19', 'within', 'care', 'sector', '', 'french', 'death', 'toll', 'much', 'smaller', '', '12', '511', '', '', 'care', 'home', 'resident', 'represent', 'around', 'third', 'total', 'number', 'report', 'death', 'covid-19', 'england', 'wales', '', 'several', 'country', 'similar', 'income', 'level', '', '', 'nation', 'well', 'control', 'overall', 'epidemic', '', 'germany', 'norway', '', 'high', 'proportion', 'death', 'among', 'people', 'long-term', 'care', '', '', 'gordon', '']",554,"{'': 114, 'care': 22, 'home': 15, 'covid-19': 11, 'death': 10, 'resident': 9, 'people': 8, 'test': 5, 'england': 5, 'wales': 5, 'sector': 4, 'staff': 4, 'virus': 4, 'hospital': 4, 'within': 4, 'epidemic': 3, 'report': 3, '2020': 3, 'uk': 3, 'march': 3}","{'infection': 1, 'sars-cov-2': 1}",2,-0.4019
DOI:10.1016/S0140-6736(20)31200-9,10.1016/S0140-6736(20)31200-9,Editorial,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['plight', 'essential', 'worker', 'covid-19', 'pandemic']","['The COVID-19 pandemic vividly highlight much society depend upon essential worker .', 'Praise heroic work do health-care worker save life worldwide dangerous , exhaust condition everywhere .', 'But worker often leave unprotected government system fail supply enough personal protective equipment ( PPE ) , supply , resource job .', 'In April alone , estimate 27 COVID-19-related health worker death USA , 106 UK , 180 Russia , ten thousand infection .', 'The actual number probably much higher .', 'But essential work extend beyond health care .', 'Although people able shift job home , million worker job do home—not custodial staff orderly hospital , also teacher child-care worker , grocery clerk supermarket worker , delivery people , factory farm worker , restaurant staff , often without adequate PPE .', 'These people leave home help maintain semblance normality others , great risk family .', 'What constitute essential worker USA vary state , black Latino Americans make large part essential workforce disproportionately affect COVID-19 .', 'In New York City , 60 % COVID-19 death black Latino population .', 'Meat process plant become hotspot transmission , 700 new case Texas plant May 16 .', '81 employee Walmart Massachusetts test positive COVID-19 May 2 .', 'Those would rather quit job expose dangerous work situation face daunt prospect USA .', '36 million people file unemployment past 2 month quit job ( even one unsafe ) would disqualify worker unemployment insurance benefit .', 'In UK , 33 % ( 10·6 million people ) total workforce deem key worker accord Office National Statistics .', 'Despite government plan pay furlough worker 80 % salary , many low-wage worker cleaner , migrant seasonal worker , student labourer might eligible .', 'Transport staff particularly hard hit .', 'In New York City , 120 employee Metropolitan Transportation Authority ( MTA ) die due COVID-19 , nearly 4000 test positive .', 'The MTA change guidance advise wear face mask US Centers Disease Control Prevention ( CDC ) WHO shift guidance , expose public , even adequate PPE , present danger .', 'At least 28 London bus driver die due COVID-19 , UK railway worker , Belly Mujinga , die spat passenger claim COVID-19 , leave behind 11-year-old daughter .', ""The International Labour Organization report 2·7 billion people—81 % world 's workforce—had affect lockdown measure ."", '61 % worker informal sector , 90 % low-income middle-income country , social protection measure often inadequate , lack access health-care support economic protection .', 'Informal migrant worker likely fall crack ensure safety must priority .', 'Some US state consider reopen restaurant , bar , gym , swim pool , without viable system place test , trace , isolate people , CDC draft plan lift lockdown water Trump administration .', ""In Germany , infection rate rise lockdown restriction begin ease UK Boris Johnson 's vague , amorphous plan end lockdown cause confusion anger many ."", 'Gifted 2-month lockdown chance lay groundwork stag , successful reopen , many western leader instead prevaricate , shift blame , appear grasp danger lift lockdown without robust test mitigation strategy place .', 'The rush towards premature , ill-advised end lockdown risk second wave infection could surpass first , essential worker never get chance isolate consider health first wave face greatest risk life .', 'When pandemic end , allow return status quo ante .', 'We must ensure essential worker job safely , adequate health care pay sick leave safeguard health beyond extraordinary pandemic .', 'Essential worker that—essential—and protect health , protect health wellbeing u .', 'For COVID-19 crisis informal migrant worker see urlplaceholder For COVID-19 crisis informal migrant worker see urlplaceholder View Large Image Copyright © 2020 Niccolo Guasti/Getty Images View Large Image Copyright © 2020 Niccolo Guasti/Getty Images']","['covid-19', 'pandemic', 'vividly', 'highlight', 'much', 'society', 'depend', 'upon', 'essential', 'worker', '', 'praise', 'heroic', 'work', 'health-care', 'worker', 'save', 'life', 'worldwide', 'dangerous', '', 'exhaust', 'condition', 'everywhere', '', 'worker', 'often', 'leave', 'unprotected', 'government', 'system', 'fail', 'supply', 'enough', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'supply', '', 'resource', 'job', '', 'april', 'alone', '', 'estimate', '27', 'covid-19-related', 'health', 'worker', 'death', 'usa', '', '106', 'uk', '', '180', 'russia', '', 'ten', 'thousand', 'infection', '', 'actual', 'number', 'probably', 'much', 'higher', '', 'essential', 'work', 'extend', 'beyond', 'health', 'care', '', 'although', 'people', 'able', 'shift', 'job', 'home', '', 'million', 'worker', 'job', 'homenot', 'custodial', 'staff', 'orderly', 'hospital', '', 'teacher', 'child-care', 'worker', '', 'grocery', 'clerk', 'supermarket', 'worker', '', 'delivery', 'people', '', 'factory', 'farm', 'worker', '', 'restaurant', 'staff', '', 'often', 'without', 'adequate', 'ppe', '', 'people', 'leave', 'home', 'help', 'maintain', 'semblance', 'normality', 'others', '', 'great', 'risk', 'family', '', 'constitute', 'essential', 'worker', 'usa', 'vary', 'state', '', 'black', 'latino', 'americans', 'large', 'part', 'essential', 'workforce', 'disproportionately', 'affect', 'covid-19', '', 'new', 'york', 'city', '', '60', '', 'covid-19', 'death', 'black', 'latino', 'population', '', 'meat', 'process', 'plant', 'become', 'hotspot', 'transmission', '', '700', 'new', 'case', 'texas', 'plant', '16', '', '81', 'employee', 'walmart', 'massachusetts', 'test', 'positive', 'covid-19', '2', '', 'quit', 'job', 'expose', 'dangerous', 'work', 'situation', 'face', 'daunt', 'prospect', 'usa', '', '36', 'million', 'people', 'file', 'unemployment', 'past', '2', 'month', 'quit', 'job', '', 'one', 'unsafe', '', 'disqualify', 'worker', 'unemployment', 'insurance', 'benefit', '', 'uk', '', '33', '', '', '106', 'million', 'people', '', 'total', 'workforce', 'deem', 'key', 'worker', 'accord', 'office', 'national', 'statistics', '', 'despite', 'government', 'plan', 'pay', 'furlough', 'worker', '80', '', 'salary', '', 'low-wage', 'worker', 'cleaner', '', 'migrant', 'seasonal', 'worker', '', 'student', 'labourer', 'eligible', '', 'transport', 'staff', 'particularly', 'hard', 'hit', '', 'new', 'york', 'city', '', '120', 'employee', 'metropolitan', 'transportation', 'authority', '', 'mta', '', 'die', 'due', 'covid-19', '', 'nearly', '4000', 'test', 'positive', '', 'mta', 'change', 'guidance', 'advise', 'wear', 'face', 'mask', 'us', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'shift', 'guidance', '', 'expose', 'public', '', 'adequate', 'ppe', '', 'present', 'danger', '', 'least', '28', 'london', 'bus', 'driver', 'die', 'due', 'covid-19', '', 'uk', 'railway', 'worker', '', 'belly', 'mujinga', '', 'die', 'spat', 'passenger', 'claim', 'covid-19', '', 'leave', 'behind', '11-year-old', 'daughter', '', 'international', 'labour', 'organization', 'report', '27', 'billion', 'people81', '', 'world', 'workforcehad', 'affect', 'lockdown', 'measure', '', '61', '', 'worker', 'informal', 'sector', '', '90', '', 'low-income', 'middle-income', 'country', '', 'social', 'protection', 'measure', 'often', 'inadequate', '', 'access', 'health-care', 'support', 'economic', 'protection', '', 'informal', 'migrant', 'worker', 'likely', 'fall', 'crack', 'ensure', 'safety', 'must', 'priority', '', 'us', 'state', 'consider', 'reopen', 'restaurant', '', 'bar', '', 'gym', '', 'swim', 'pool', '', 'without', 'viable', 'system', 'place', 'test', '', 'trace', '', 'isolate', 'people', '', 'cdc', 'draft', 'plan', 'lift', 'lockdown', 'water', 'trump', 'administration', '', 'germany', '', 'infection', 'rate', 'rise', 'lockdown', 'restriction', 'begin', 'ease', 'uk', 'boris', 'johnson', 'vague', '', 'amorphous', 'plan', 'end', 'lockdown', 'cause', 'confusion', 'anger', '', 'gifted', '2-month', 'lockdown', 'chance', 'lay', 'groundwork', 'stag', '', 'successful', 'reopen', '', 'western', 'leader', 'instead', 'prevaricate', '', 'shift', 'blame', '', 'appear', 'grasp', 'danger', 'lift', 'lockdown', 'without', 'robust', 'test', 'mitigation', 'strategy', 'place', '', 'rush', 'towards', 'premature', '', 'ill-advised', 'end', 'lockdown', 'risk', 'second', 'wave', 'infection', 'surpass', 'first', '', 'essential', 'worker', 'never', 'chance', 'isolate', 'consider', 'health', 'first', 'wave', 'face', 'greatest', 'risk', 'life', '', 'pandemic', 'end', '', 'allow', 'return', 'status', 'quo', 'ante', '', 'must', 'ensure', 'essential', 'worker', 'job', 'safely', '', 'adequate', 'health', 'care', 'pay', 'sick', 'leave', 'safeguard', 'health', 'beyond', 'extraordinary', 'pandemic', '', 'essential', 'worker', 'thatessentialand', 'protect', 'health', '', 'protect', 'health', 'wellbeing', 'u', '', 'covid-19', 'crisis', 'informal', 'migrant', 'worker', 'urlplaceholder', 'covid-19', 'crisis', 'informal', 'migrant', 'worker', 'urlplaceholder', 'view', 'large', 'image', 'copyright', '', '2020', 'niccolo', 'guastigetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'niccolo', 'guastigetty', 'images']",571,"{'': 100, 'worker': 22, 'covid-19': 9, 'essential': 7, 'health': 7, 'lockdown': 7, 'job': 6, 'people': 6, 'leave': 4, 'uk': 4, 'test': 4, 'migrant': 4, 'informal': 4, 'pandemic': 3, 'work': 3, 'often': 3, 'ppe': 3, 'usa': 3, 'infection': 3, 'shift': 3}","{'infection': 3, 'safety': 1}",4,0.3182
DOI:10.1016/S0140-6736(20)31206-X,10.1016/S0140-6736(20)31206-X,Comment,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['offline', '', 'health', 'unhappy', 'time', 'covid-19']","['It tragedy anyone hop see COVID-19 become catalyst international solidarity .', ""On first day first-ever virtual World Health Assembly , hold worst acute global health crisis since WHO 's creation 1948 , Alex Azar , US Secretary Health Human Services , damage credibility US Government constructive member international community ."", '“ We must frank ” , begin .', 'What follow astonish series unsubstantiated allegation .', '“ There failure organisation ” , Azar state .', 'He argue WHO conspire member state ( mean China ) “ apparent attempt conceal outbreak ” .', ""He accuse WHO unjustly block Taiwan 's participation World Health Assembly ."", 'And say “ WHO must change. ” It must transparent accountable .', 'Earlier , WHO Director-General Tedros Adhanom Ghebreyesus give forceful defence agency .', 'He accept “ lesson learn ” , argue WHO stand “ shoulder-to-shoulder country ” .', 'The agency act quickly , Tedros say .', 'He promise initiate “ independent evaluation ” global response .', '“ The world must never same. ” There need new plan , procedure , institution .', 'What matter strengthen exist mechanism , especially national public health capacity specify 2005 International Health Regulations .', 'Investing health prerequisite development .', 'To protect world future pandemic , Tedros call member state support stronger WHO .', 'In speech follow , country repeatedly back WHO Director-General .', 'China stress act timely , open , transparent , responsible manner .', 'Some country go , denounce unilateral coercive action US Government .', 'View Large Image Copyright © 2020 Mandel Ngan/AFP/Getty Images View Large Image Copyright © 2020 Mandel Ngan/AFP/Getty Images That Monday .', ""Overnight , President Trump write explosive letter WHO 's Director-General ."", 'He claim “ repeat misstep organization respond pandemic extremely costly world…if World Health Organization commit major substantive improvement within next 30 day , I make temporary freeze United States fund World Health Organization permanent reconsider membership organization .', ""I allow American taxpayer dollar continue finance organization , present state , clearly serve America 's interests. ” But basis accusation dubious best ."", ""In letter , President Trump report result review administration conduct WHO 's response COVID-19 pandemic ."", 'He write “ know follow ” .', 'The first allegation make WHO “ consistently ignore credible report virus spread Wuhan early December 2019 even earlier , include report Lancet medical journal .', ""The World Health Organization fail independently investigate credible report conflict directly Chinese government 's official account , even come source within Wuhan itself. ” This statement factually incorrect ."", 'View Large Image Copyright © 2020 Fabrice Coffrini/AFP/Getty Images View Large Image Copyright © 2020 Fabrice Coffrini/AFP/Getty Images The Lancet publish report December , 2019 , refer virus outbreak Wuhan anywhere else China .', 'The first report journal publish Jan 24 , 2020 .', 'In paper Chaolin Huang colleague , first 41 patient Wuhan COVID-19 describe .', 'The scientist physician lead study Chinese institution .', 'They work u closely , collaboratively , quickly make information new epidemic outbreak disease fully freely available international audience .', 'A second paper , Jasper Fuk-Woo Chan colleague , also publish Jan 24 , describe first scientific evidence confirm person-to-person transmission new virus .', 'This report include scientist physician Hong Kong mainland China .', ""The allegation level WHO President Trump 's letter serious damage effort strengthen international cooperation control pandemic ."", 'It essential review global response base factually accurate account take place December January .', ""It regrettable President Trump 's letter fell short standard ."", 'He retract letter , correct record , withdraw allegation WHO .', 'View Large Image Copyright © 2020 Noel Celis/AFP/Getty Images View Large Image Copyright © 2020 Noel Celis/AFP/Getty Images']","['tragedy', 'anyone', 'hop', 'covid-19', 'become', 'catalyst', 'international', 'solidarity', '', 'first', 'day', 'first-ever', 'virtual', 'world', 'health', 'assembly', '', 'hold', 'worst', 'acute', 'global', 'health', 'crisis', 'since', 'creation', '1948', '', 'alex', 'azar', '', 'us', 'secretary', 'health', 'human', 'services', '', 'damage', 'credibility', 'us', 'government', 'constructive', 'member', 'international', 'community', '', '', 'must', 'frank', '', '', 'begin', '', 'follow', 'astonish', 'series', 'unsubstantiated', 'allegation', '', '', 'failure', 'organisation', '', '', 'azar', 'state', '', 'argue', 'conspire', 'member', 'state', '', 'mean', 'china', '', '', 'apparent', 'attempt', 'conceal', 'outbreak', '', '', 'accuse', 'unjustly', 'block', 'taiwan', 'participation', 'world', 'health', 'assembly', '', '', 'must', 'change', '', 'must', 'transparent', 'accountable', '', 'earlier', '', 'director-general', 'tedros', 'adhanom', 'ghebreyesus', 'give', 'forceful', 'defence', 'agency', '', 'accept', '', 'lesson', 'learn', '', '', 'argue', 'stand', '', 'shoulder-to-shoulder', 'country', '', '', 'agency', 'act', 'quickly', '', 'tedros', '', 'promise', 'initiate', '', 'independent', 'evaluation', '', 'global', 'response', '', '', 'world', 'must', 'never', '', 'new', 'plan', '', 'procedure', '', 'institution', '', 'matter', 'strengthen', 'exist', 'mechanism', '', 'especially', 'national', 'public', 'health', 'capacity', 'specify', '2005', 'international', 'health', 'regulations', '', 'investing', 'health', 'prerequisite', 'development', '', 'protect', 'world', 'future', 'pandemic', '', 'tedros', 'call', 'member', 'state', 'support', 'stronger', '', 'speech', 'follow', '', 'country', 'repeatedly', 'back', 'director-general', '', 'china', 'stress', 'act', 'timely', '', 'open', '', 'transparent', '', 'responsible', 'manner', '', 'country', '', 'denounce', 'unilateral', 'coercive', 'action', 'us', 'government', '', 'view', 'large', 'image', 'copyright', '', '2020', 'mandel', 'nganafpgetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'mandel', 'nganafpgetty', 'images', 'monday', '', 'overnight', '', 'president', 'trump', 'write', 'explosive', 'letter', 'director-general', '', 'claim', '', 'repeat', 'misstep', 'organization', 'respond', 'pandemic', 'extremely', 'costly', 'worldif', 'world', 'health', 'organization', 'commit', 'major', 'substantive', 'improvement', 'within', 'next', '30', 'day', '', 'temporary', 'freeze', 'united', 'states', 'fund', 'world', 'health', 'organization', 'permanent', 'reconsider', 'membership', 'organization', '', 'allow', 'american', 'taxpayer', 'dollar', 'continue', 'finance', 'organization', '', 'present', 'state', '', 'clearly', 'serve', 'america', 'interests', '', 'basis', 'accusation', 'dubious', 'best', '', 'letter', '', 'president', 'trump', 'report', 'result', 'review', 'administration', 'conduct', 'response', 'covid-19', 'pandemic', '', 'write', '', 'follow', '', '', 'first', 'allegation', '', 'consistently', 'ignore', 'credible', 'report', 'virus', 'spread', 'wuhan', 'early', 'december', '2019', 'earlier', '', 'include', 'report', 'lancet', 'medical', 'journal', '', 'world', 'health', 'organization', 'fail', 'independently', 'investigate', 'credible', 'report', 'conflict', 'directly', 'chinese', 'government', 'official', 'account', '', 'source', 'within', 'wuhan', '', 'statement', 'factually', 'incorrect', '', 'view', 'large', 'image', 'copyright', '', '2020', 'fabrice', 'coffriniafpgetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'fabrice', 'coffriniafpgetty', 'images', 'lancet', 'publish', 'report', 'december', '', '2019', '', 'refer', 'virus', 'outbreak', 'wuhan', 'anywhere', 'else', 'china', '', 'first', 'report', 'journal', 'publish', 'jan', '24', '', '2020', '', 'paper', 'chaolin', 'huang', 'colleague', '', 'first', '41', 'patient', 'wuhan', 'covid-19', 'describe', '', 'scientist', 'physician', 'lead', 'study', 'chinese', 'institution', '', 'work', 'u', 'closely', '', 'collaboratively', '', 'quickly', 'information', 'new', 'epidemic', 'outbreak', 'disease', 'fully', 'freely', 'available', 'international', 'audience', '', 'second', 'paper', '', 'jasper', 'fuk-woo', 'chan', 'colleague', '', 'publish', 'jan', '24', '', 'describe', 'first', 'scientific', 'evidence', 'confirm', 'person-to-person', 'transmission', 'new', 'virus', '', 'report', 'include', 'scientist', 'physician', 'hong', 'kong', 'mainland', 'china', '', 'allegation', 'level', 'president', 'trump', 'letter', 'serious', 'damage', 'effort', 'strengthen', 'international', 'cooperation', 'control', 'pandemic', '', 'essential', 'review', 'global', 'response', 'base', 'factually', 'accurate', 'account', 'place', 'december', 'january', '', 'regrettable', 'president', 'trump', 'letter', 'fell', 'short', 'standard', '', 'retract', 'letter', '', 'correct', 'record', '', 'withdraw', 'allegation', '', 'view', 'large', 'image', 'copyright', '', '2020', 'noel', 'celisafpgetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'noel', 'celisafpgetty', 'images']",529,"{'': 104, 'health': 10, 'world': 7, '2020': 7, 'report': 7, 'view': 6, 'large': 6, 'image': 6, 'copyright': 6, 'images': 6, 'organization': 6, 'international': 5, 'first': 5, 'letter': 5, 'must': 4, 'allegation': 4, 'state': 4, 'china': 4, 'pandemic': 4, 'president': 4}",{},0,-0.926
DOI:10.1016/S2214-109X(20)30228-X,10.1016/S2214-109X(20)30228-X,Editorial,2020-05-23 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['food', 'insecurity', 'sting', 'tail', 'covid-19']","['On April 29 , UNICEF publish discussion paper compare probable downstream effect COVID-19 develop develop country .', 'High-income upper-middle-income country bear brunt death associate COVID-19 far , see diminish mortality rate .', 'Countries across world ease lockdown restriction .', 'But , UNICEF paper outline , population least affect disease , food insecurity , hunger , malnutrition already prevalent critical problem , worst might yet come .', 'The Global Nutrition Report launch month , bleak headline find one nine people hungry malnourish .', ""In 2018 , almost quarter world 's child younger 5 year , 149·0 million child , stunt 7·3 % ( 49·5 million child ) waste ."", 'Progress past year minimal remain far 2025 global nutrition target : reduce childhood stunt fewer 100 million child childhood waste 5 % le .', 'Now , light current global event , tackle malnutrition expect become harder still .', 'On April 20 , 2020 Global Report Food Crises publish , describe factor lead perfect storm food crisis sub-Saharan Africa .', 'According report , arm conflict remain key driver food insecurity region , disrupt agriculture trade , block supply chain , prompt mass population displacement .', 'Exacerbating situation since last June , unusually heavy rain facilitate development locust swarm , devastate crop across east Africa .', 'Movement restriction response COVID-19 crisis delay delivery pesticide station staff address problem .', 'Moreover , report indicate , farmer grow crop , lockdown restriction regularly prevent transport produce livestock market , rice import sub-Saharan Africa intend compensate shortfall disrupt stop , drive price staple food .', 'Finally , wage loss result government-imposed shelter-in-place order restrict purchase power many family already borderline poverty : African Union study project 20 million job could lose region due COVID-19 crisis .', 'The Global Report Food Crises estimate 135 million people food insecure 2019 , recent World Food Programme ( WFP ) projection indicate , economic effect supply chain disruption associate COVID-19 , number could double 2020 , 265 million people .', ""In announce projection , WFP Executive Director David Beasley warn : “ n't prepare act now—to secure access , avoid fund shortfall disruption trade—we could face multiple famine biblical proportion within short months. ” Women , particularly , child could bear brunt effect food insecurity , well COVID-19-associated health system disruption ."", 'In Article The Lancet Global Health , Timothy Roberton colleague estimate effect disruption maternal under-5 child death 118 low-income middle-income country .', 'They find even small reduction coverage use maternal child health service could lead 42 240 additional child death 2030 additional maternal death per month , worst-case scenario disruption potentially result excess 1 157 000 child death 56 700 maternal death 6 month .', 'These indirect effect reach far beyond disease , long-term social economic consequence individual society .', 'How prepare impend humanitarian disaster ?', 'In March , UN set US $ 2 billion COVID-19 Global Humanitarian Response Plan , enable agency WHO , UNICEF , WFP provide food , water sanitation , vaccination , well COVID-19 test material medical equipment , vulnerable community .', 'At time write , receive 46 % require amount .', 'Fully fund appeal urgent priority donor , even struggle economic shock .', 'Additionally , restriction transport trade consider wider context potentially devastate effect food supply chain .', 'To paraphrase David Beasley , leader acutely alert potential infectious disease pandemic compound pandemic undernutrition .', 'Early estimate indirect effect COVID-19 pandemic maternal child mortality low-income middle-income country : model studyFull-TextPDFOpen Access']","['april', '29', '', 'unicef', 'publish', 'discussion', 'paper', 'compare', 'probable', 'downstream', 'effect', 'covid-19', 'develop', 'develop', 'country', '', 'high-income', 'upper-middle-income', 'country', 'bear', 'brunt', 'death', 'associate', 'covid-19', 'far', '', 'diminish', 'mortality', 'rate', '', 'countries', 'across', 'world', 'ease', 'lockdown', 'restriction', '', '', 'unicef', 'paper', 'outline', '', 'population', 'least', 'affect', 'disease', '', 'food', 'insecurity', '', 'hunger', '', 'malnutrition', 'already', 'prevalent', 'critical', 'problem', '', 'worst', 'yet', '', 'global', 'nutrition', 'report', 'launch', 'month', '', 'bleak', 'headline', 'find', 'one', 'nine', 'people', 'hungry', 'malnourish', '', '2018', '', 'almost', 'quarter', 'world', 'child', 'younger', '5', 'year', '', '1490', 'million', 'child', '', 'stunt', '73', '', '', '495', 'million', 'child', '', 'waste', '', 'progress', 'past', 'year', 'minimal', 'remain', 'far', '2025', 'global', 'nutrition', 'target', '', 'reduce', 'childhood', 'stunt', 'fewer', '100', 'million', 'child', 'childhood', 'waste', '5', '', 'le', '', '', 'light', 'current', 'global', 'event', '', 'tackle', 'malnutrition', 'expect', 'become', 'harder', 'still', '', 'april', '20', '', '2020', 'global', 'report', 'food', 'crises', 'publish', '', 'describe', 'factor', 'lead', 'perfect', 'storm', 'food', 'crisis', 'sub-saharan', 'africa', '', 'according', 'report', '', 'arm', 'conflict', 'remain', 'key', 'driver', 'food', 'insecurity', 'region', '', 'disrupt', 'agriculture', 'trade', '', 'block', 'supply', 'chain', '', 'prompt', 'mass', 'population', 'displacement', '', 'exacerbating', 'situation', 'since', 'last', 'june', '', 'unusually', 'heavy', 'rain', 'facilitate', 'development', 'locust', 'swarm', '', 'devastate', 'crop', 'across', 'east', 'africa', '', 'movement', 'restriction', 'response', 'covid-19', 'crisis', 'delay', 'delivery', 'pesticide', 'station', 'staff', 'address', 'problem', '', 'moreover', '', 'report', 'indicate', '', 'farmer', 'grow', 'crop', '', 'lockdown', 'restriction', 'regularly', 'prevent', 'transport', 'produce', 'livestock', 'market', '', 'rice', 'import', 'sub-saharan', 'africa', 'intend', 'compensate', 'shortfall', 'disrupt', 'stop', '', 'drive', 'price', 'staple', 'food', '', 'finally', '', 'wage', 'loss', 'result', 'government-imposed', 'shelter-in-place', 'order', 'restrict', 'purchase', 'power', 'family', 'already', 'borderline', 'poverty', '', 'african', 'union', 'study', 'project', '20', 'million', 'job', 'lose', 'region', 'due', 'covid-19', 'crisis', '', 'global', 'report', 'food', 'crises', 'estimate', '135', 'million', 'people', 'food', 'insecure', '2019', '', 'recent', 'world', 'food', 'programme', '', 'wfp', '', 'projection', 'indicate', '', 'economic', 'effect', 'supply', 'chain', 'disruption', 'associate', 'covid-19', '', 'number', 'double', '2020', '', '265', 'million', 'people', '', 'announce', 'projection', '', 'wfp', 'executive', 'director', 'david', 'beasley', 'warn', '', '', 'nt', 'prepare', 'act', 'nowto', 'secure', 'access', '', 'avoid', 'fund', 'shortfall', 'disruption', 'tradewe', 'face', 'multiple', 'famine', 'biblical', 'proportion', 'within', 'short', 'months', '', 'women', '', 'particularly', '', 'child', 'bear', 'brunt', 'effect', 'food', 'insecurity', '', 'well', 'covid-19-associated', 'health', 'system', 'disruption', '', 'article', 'lancet', 'global', 'health', '', 'timothy', 'roberton', 'colleague', 'estimate', 'effect', 'disruption', 'maternal', 'under-5', 'child', 'death', '118', 'low-income', 'middle-income', 'country', '', 'find', 'small', 'reduction', 'coverage', 'maternal', 'child', 'health', 'service', 'lead', '42', '240', 'additional', 'child', 'death', '2030', 'additional', 'maternal', 'death', 'per', 'month', '', 'worst-case', 'scenario', 'disruption', 'potentially', 'result', 'excess', '1', '157', '000', 'child', 'death', '56', '700', 'maternal', 'death', '6', 'month', '', 'indirect', 'effect', 'reach', 'far', 'beyond', 'disease', '', 'long-term', 'social', 'economic', 'consequence', 'individual', 'society', '', 'prepare', 'impend', 'humanitarian', 'disaster', '', 'march', '', 'un', 'set', 'us', '', '2', 'billion', 'covid-19', 'global', 'humanitarian', 'response', 'plan', '', 'enable', 'agency', '', 'unicef', '', 'wfp', 'provide', 'food', '', 'water', 'sanitation', '', 'vaccination', '', 'well', 'covid-19', 'test', 'material', 'medical', 'equipment', '', 'vulnerable', 'community', '', 'time', 'write', '', 'receive', '46', '', 'require', 'amount', '', 'fully', 'fund', 'appeal', 'urgent', 'priority', 'donor', '', 'struggle', 'economic', 'shock', '', 'additionally', '', 'restriction', 'transport', 'trade', 'consider', 'wider', 'context', 'potentially', 'devastate', 'effect', 'food', 'supply', 'chain', '', 'paraphrase', 'david', 'beasley', '', 'leader', 'acutely', 'alert', 'potential', 'infectious', 'disease', 'pandemic', 'compound', 'pandemic', 'undernutrition', '', 'early', 'estimate', 'indirect', 'effect', 'covid-19', 'pandemic', 'maternal', 'child', 'mortality', 'low-income', 'middle-income', 'country', '', 'model', 'studyfull-textpdfopen', 'access']",546,"{'': 91, 'food': 11, 'child': 10, 'covid-19': 8, 'effect': 7, 'global': 7, 'death': 6, 'million': 6, 'report': 5, 'disruption': 5, 'maternal': 5, 'country': 4, 'restriction': 4, 'unicef': 3, 'far': 3, 'world': 3, 'disease': 3, 'insecurity': 3, 'month': 3, 'people': 3}",{},0,-0.5423
DOI:10.1016/S2352-3018(20)30143-0,10.1016/S2352-3018(20)30143-0,Editorial,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['lockdown', 'fear', 'key', 'population']","[""With much world 's population COVID-19 lockdown , curfew , travel restriction , access HIV test treatment service significant concern people HIV provide care ."", 'Interruptions supply chain subsequent stock-outs antiretrovirals closure sexual health clinic counsel service already affect HIV response country .', 'Correspondence issue describe drug shortage affect HIV response Indonesia .', 'Many government non-governmental organisation ( NGOs ) respond innovative strategy counter lockdown , include multimonth dispense antiretrovirals , online clinic support network , postal test sexually transmit infection .', 'However , worry report country region abuse right key population affect HIV/AIDS pretext COVID-19 regulation .', 'In Egypt , Human Rights Watch ( HRW ) report people HIV afraid collect antiretroviral prescription since government infectious disease hospital , centre HIV treatment , designate COVID-19 centre .', 'Provision HIV service trust NGOs resist government multimonth prescribe encourage .', 'Also widely report medium plight 19 young people stay shelter lesbian , gay , bisexual , transgender , intersex ( LGBTI ) people Kampala , Uganda , arrest , beat , question sexual behaviour .', ""They charge disobey COVID-19 regulation social distance detain Uganda 's anti-homosexuality law ."", 'After 50 day detention , charge drop 19 people release mount pressure human right group .', 'Some detain HIV access medication detention .', 'UNAIDS report crackdown sex worker , include home raid , compulsory COVID-19 test , arrest , threaten deportation migrant sex worker .', ""Criminalised jurisdiction , lockdown social distance decimate livelihood , police harassment criminal penalty endanger sex worker ' health ."", 'Many government-led social protection scheme exclude sex worker .', 'Transgender population also impact lack societal care many country .', 'Since lockdown , report murder transgender people Puerto Rico .', 'And HRW report transgender people ( hijra ) Bangladesh , poorly provision best time , little access food medication doubt equitable distribution emergency resource group .', 'Homeless population severely affected—for example , Minsk , Belarus , number homeless shelter reduce 11 three , reduce support available group , live HIV .', 'Some government take advantage COVID-19 emergency pas law blatantly penalise key population .', 'Hungary pass law remove right people change gender name conform gender identity ; Poland fast-tracked update criminal law increase penalty HIV exposure , non-disclosure , transmission .', 'UNAIDS European Parliament rightly condemn abuse emergency power two country .', 'Discrimination LGBTI community South Korea threaten COVID-19 response .', ""Lauded approach contain COVID-19 pandemic , country 's track trace people link outbreak gay nightclub Seoul lead anti-gay backlash , country already entrench homophobic attitude ."", 'Concerns affect get test COVID-19 fear out .', 'The COVID-19 crisis exacerbate previous inequality key population affect HIV , emergency law increase stigma discrimination .', 'As HIV epidemic , human rights-based approach key combat COVID-19 epidemic , many lesson learn HIV experience .', 'Countries must take effective proportionate response COVID-19 , unacceptable vulnerable society leave behind , case , target criminalise government agency .', 'Indeed , infringement right , abuse , stigmatisation , criminalisation nothing alienate already vulnerable population engagement service crucial .', 'COVID-19 must become cover roll back hard right fight HIV .', 'Evolving ART crisis people live HIV IndonesiaFull-TextPDF']","['much', 'world', 'population', 'covid-19', 'lockdown', '', 'curfew', '', 'travel', 'restriction', '', 'access', 'hiv', 'test', 'treatment', 'service', 'significant', 'concern', 'people', 'hiv', 'provide', 'care', '', 'interruptions', 'supply', 'chain', 'subsequent', 'stock-outs', 'antiretrovirals', 'closure', 'sexual', 'health', 'clinic', 'counsel', 'service', 'already', 'affect', 'hiv', 'response', 'country', '', 'correspondence', 'issue', 'describe', 'drug', 'shortage', 'affect', 'hiv', 'response', 'indonesia', '', 'government', 'non-governmental', 'organisation', '', 'ngos', '', 'respond', 'innovative', 'strategy', 'counter', 'lockdown', '', 'include', 'multimonth', 'dispense', 'antiretrovirals', '', 'online', 'clinic', 'support', 'network', '', 'postal', 'test', 'sexually', 'transmit', 'infection', '', 'however', '', 'worry', 'report', 'country', 'region', 'abuse', 'key', 'population', 'affect', 'hivaids', 'pretext', 'covid-19', 'regulation', '', 'egypt', '', 'human', 'rights', 'watch', '', 'hrw', '', 'report', 'people', 'hiv', 'afraid', 'collect', 'antiretroviral', 'prescription', 'since', 'government', 'infectious', 'disease', 'hospital', '', 'centre', 'hiv', 'treatment', '', 'designate', 'covid-19', 'centre', '', 'provision', 'hiv', 'service', 'trust', 'ngos', 'resist', 'government', 'multimonth', 'prescribe', 'encourage', '', 'widely', 'report', 'medium', 'plight', '19', 'young', 'people', 'stay', 'shelter', 'lesbian', '', 'gay', '', 'bisexual', '', 'transgender', '', 'intersex', '', 'lgbti', '', 'people', 'kampala', '', 'uganda', '', 'arrest', '', 'beat', '', 'question', 'sexual', 'behaviour', '', 'charge', 'disobey', 'covid-19', 'regulation', 'social', 'distance', 'detain', 'uganda', 'anti-homosexuality', 'law', '', '50', 'day', 'detention', '', 'charge', 'drop', '19', 'people', 'release', 'mount', 'pressure', 'human', 'group', '', 'detain', 'hiv', 'access', 'medication', 'detention', '', 'unaids', 'report', 'crackdown', 'sex', 'worker', '', 'include', 'home', 'raid', '', 'compulsory', 'covid-19', 'test', '', 'arrest', '', 'threaten', 'deportation', 'migrant', 'sex', 'worker', '', 'criminalised', 'jurisdiction', '', 'lockdown', 'social', 'distance', 'decimate', 'livelihood', '', 'police', 'harassment', 'criminal', 'penalty', 'endanger', 'sex', 'worker', '', 'health', '', 'government-led', 'social', 'protection', 'scheme', 'exclude', 'sex', 'worker', '', 'transgender', 'population', 'impact', 'societal', 'care', 'country', '', 'since', 'lockdown', '', 'report', 'murder', 'transgender', 'people', 'puerto', 'rico', '', 'hrw', 'report', 'transgender', 'people', '', 'hijra', '', 'bangladesh', '', 'poorly', 'provision', 'best', 'time', '', 'little', 'access', 'food', 'medication', 'doubt', 'equitable', 'distribution', 'emergency', 'resource', 'group', '', 'homeless', 'population', 'severely', 'affectedfor', 'example', '', 'minsk', '', 'belarus', '', 'number', 'homeless', 'shelter', 'reduce', '11', 'three', '', 'reduce', 'support', 'available', 'group', '', 'live', 'hiv', '', 'government', 'advantage', 'covid-19', 'emergency', 'pas', 'law', 'blatantly', 'penalise', 'key', 'population', '', 'hungary', 'pass', 'law', 'remove', 'people', 'change', 'gender', 'name', 'conform', 'gender', 'identity', '', 'poland', 'fast-tracked', 'update', 'criminal', 'law', 'increase', 'penalty', 'hiv', 'exposure', '', 'non-disclosure', '', 'transmission', '', 'unaids', 'european', 'parliament', 'rightly', 'condemn', 'abuse', 'emergency', 'power', 'two', 'country', '', 'discrimination', 'lgbti', 'community', 'south', 'korea', 'threaten', 'covid-19', 'response', '', 'lauded', 'approach', 'contain', 'covid-19', 'pandemic', '', 'country', 'track', 'trace', 'people', 'link', 'outbreak', 'gay', 'nightclub', 'seoul', 'lead', 'anti-gay', 'backlash', '', 'country', 'already', 'entrench', 'homophobic', 'attitude', '', 'concerns', 'affect', 'test', 'covid-19', 'fear', '', 'covid-19', 'crisis', 'exacerbate', 'previous', 'inequality', 'key', 'population', 'affect', 'hiv', '', 'emergency', 'law', 'increase', 'stigma', 'discrimination', '', 'hiv', 'epidemic', '', 'human', 'rights-based', 'approach', 'key', 'combat', 'covid-19', 'epidemic', '', 'lesson', 'learn', 'hiv', 'experience', '', 'countries', 'must', 'effective', 'proportionate', 'response', 'covid-19', '', 'unacceptable', 'vulnerable', 'society', 'leave', 'behind', '', 'case', '', 'target', 'criminalise', 'government', 'agency', '', 'indeed', '', 'infringement', '', 'abuse', '', 'stigmatisation', '', 'criminalisation', 'nothing', 'alienate', 'already', 'vulnerable', 'population', 'engagement', 'service', 'crucial', '', 'covid-19', 'must', 'become', 'cover', 'roll', 'back', 'hard', 'fight', 'hiv', '', 'evolving', 'art', 'crisis', 'people', 'live', 'hiv', 'indonesiafull-textpdf']",490,"{'': 86, 'hiv': 15, 'covid-19': 13, 'people': 10, 'population': 7, 'country': 6, 'report': 6, 'affect': 5, 'government': 5, 'law': 5, 'lockdown': 4, 'test': 4, 'service': 4, 'response': 4, 'key': 4, 'transgender': 4, 'sex': 4, 'worker': 4, 'emergency': 4, 'access': 3}",{'infection': 1},1,-0.2023
DOI:10.1016/S1470-2045(20)30287-4,10.1016/S1470-2045(20)30287-4,News,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['covid-19', '', 'consequence', 'higher', 'education']","['The COVID-19 pandemic already cost UK university estimate £790 million .', 'The shutdown mean accommodation , cater , conference income evaporate .', 'A similar situation evolve USA .', 'In 2017 fiscal year , US higher education sector earn US $ 44·6 billion so-called auxiliary revenue , bookstore , hall residence , summer camp .', 'The figure year likely nearer $ 30 billion .', 'Meanwhile , Australia expect higher education sector lose somewhere region AUS $ 3–4·6 billion 2019–20 academic year .', 'Universities worldwide force rapidly scale online teach , typically entail unexpected expenditure .', 'They find money continue pay staff , well deep-cleaning facility mothball research project .', 'Yet , sizeable loss current academic year , could easily dwarf expect next year .', 'The economic downturn force thousand youngster defer enter university .', 'More 20 million Americans lose job April 2020 alone .', 'Students outside UK EU contribute £6·9 billion yearly fee British university .', 'Encouraged successive government , wish bolster commercial education , institution come rely money , represent third total income tuition fee .', 'A collapse international student market , seem inevitable , would serious consequence .', 'Australia similarly expose .', 'Its higher education sector host 300 000 student overseas .', 'Terry Hartle ( Vice-President American Council Education , Washington , DC , USA ) expect international enrolment US university college fall least quarter 2020–21 .', 'Prospective student might also put physical distance requirement likely prevail university campus foreseeable future .', 'Much depend dynamic pandemic .', '“ We really handle happen come September ” , say Hartle .', '“ Very school USA certain able open time. ” The shift online learn look set continue least advent successful vaccine COVID-19 .', 'This situation raise question whether institution justify fee structure predicate model face-to-face contact .', '“ Students generally report university much tuition—place also really important ” , say Simon Marginson ( Professor Higher Education University Oxford , Oxford , UK ) .', '“ If student go miss half usually constitute student experience , really receive value money ? ” Furthermore , online learn substitute laboratory work .', 'Moreover , recession diminish prospect graduate employment .', '“ You downgrade student experience downgrade value degree ; I think go difficult university sustain level fee ” , say Marginson .', 'It could easily add perfect storm : weaken domestic international demand couple pressure decrease fee .', '“ Without action , university force make huge cut , job lose , vital research halt ” , spokesperson Universities UK , umbrella group represent 137 institution , tell The Lancet Oncology .', '“ Pretty much every university country look voluntary redundancy ” , add Malcolm Reed ( Dean Brighton Sussex Medical School , Brighton , UK , Co-Chair Medical Schools Council , London , UK ) .', '“ A lot staff short-term contract likely go , fund PhDs look precarious impact charity ; pool future researcher go shallower. ” Prestigious research institution , Harvard ( Cambridge , MA , USA ) Oxford ( UK ) university , well place weather come storm .', 'But place fall lower league table vulnerable , especially international student fee form big part income .', '“ For part , medical school high-quality research ring-fenced change ” , say Marginson .', '“ Medicine life science strong UK system ; I confident survive thing go ” .', 'Much depend depth downturn .', ""Reed point medical school integrate within university 's wider economy ."", '“ If university threat , medical school ” , say .', 'Clinical placement UK medical student penultimate year suspend since March .', 'Reed hope able restart September , lose grind recover .', 'But delay would problematic .', '“ There simple answer deal student miss 6 month clinical experience ” , say Reed .', '“ It would real threat graduate time next year ” .', 'As The Lancet Oncology go press , number confirm case COVID-19 worldwide approach 5 million .', ""In absence substantial financial support , many world 's college university unlikely survive pandemic ."", 'Others shut large project sell property .', '“ This epochal event ” , say Hartle .', '“ It go leave huge impression education sector. ” View Large Image Copyright © 2020 Ruth Swan/Shutterstock.com View Large Image Copyright © 2020 Ruth Swan/Shutterstock.com']","['covid-19', 'pandemic', 'already', 'cost', 'uk', 'university', 'estimate', '790', 'million', '', 'shutdown', 'mean', 'accommodation', '', 'cater', '', 'conference', 'income', 'evaporate', '', 'similar', 'situation', 'evolve', 'usa', '', '2017', 'fiscal', 'year', '', 'us', 'higher', 'education', 'sector', 'earn', 'us', '', '446', 'billion', 'so-called', 'auxiliary', 'revenue', '', 'bookstore', '', 'hall', 'residence', '', 'summer', 'camp', '', 'figure', 'year', 'likely', 'nearer', '', '30', 'billion', '', 'meanwhile', '', 'australia', 'expect', 'higher', 'education', 'sector', 'lose', 'somewhere', 'region', 'aus', '', '346', 'billion', '201920', 'academic', 'year', '', 'universities', 'worldwide', 'force', 'rapidly', 'scale', 'online', 'teach', '', 'typically', 'entail', 'unexpected', 'expenditure', '', 'find', 'money', 'continue', 'pay', 'staff', '', 'well', 'deep-cleaning', 'facility', 'mothball', 'research', 'project', '', 'yet', '', 'sizeable', 'loss', 'current', 'academic', 'year', '', 'dwarf', 'expect', 'next', 'year', '', 'economic', 'downturn', 'force', 'thousand', 'youngster', 'defer', 'enter', 'university', '', '20', 'million', 'americans', 'lose', 'job', 'april', '2020', 'alone', '', 'students', 'outside', 'uk', 'eu', 'contribute', '69', 'billion', 'yearly', 'fee', 'british', 'university', '', 'encouraged', 'successive', 'government', '', 'wish', 'bolster', 'commercial', 'education', '', 'institution', 'rely', 'money', '', 'represent', 'third', 'total', 'income', 'tuition', 'fee', '', 'collapse', 'international', 'student', 'market', '', 'inevitable', '', 'serious', 'consequence', '', 'australia', 'similarly', 'expose', '', 'higher', 'education', 'sector', 'host', '300', '000', 'student', 'overseas', '', 'terry', 'hartle', '', 'vice-president', 'american', 'council', 'education', '', 'washington', '', 'dc', '', 'usa', '', 'expect', 'international', 'enrolment', 'us', 'university', 'college', 'fall', 'least', 'quarter', '202021', '', 'prospective', 'student', 'put', 'physical', 'distance', 'requirement', 'likely', 'prevail', 'university', 'campus', 'foreseeable', 'future', '', 'much', 'depend', 'dynamic', 'pandemic', '', '', 'really', 'handle', 'happen', 'september', '', '', 'hartle', '', '', 'school', 'usa', 'certain', 'able', 'open', 'time', '', 'shift', 'online', 'learn', 'look', 'set', 'continue', 'least', 'advent', 'successful', 'vaccine', 'covid-19', '', 'situation', 'raise', 'question', 'whether', 'institution', 'justify', 'fee', 'structure', 'predicate', 'model', 'face-to-face', 'contact', '', '', 'students', 'generally', 'report', 'university', 'much', 'tuitionplace', 'really', 'important', '', '', 'simon', 'marginson', '', 'professor', 'higher', 'education', 'university', 'oxford', '', 'oxford', '', 'uk', '', '', '', 'student', 'miss', 'half', 'usually', 'constitute', 'student', 'experience', '', 'really', 'receive', 'value', 'money', '', '', 'furthermore', '', 'online', 'learn', 'substitute', 'laboratory', 'work', '', 'moreover', '', 'recession', 'diminish', 'prospect', 'graduate', 'employment', '', '', 'downgrade', 'student', 'experience', 'downgrade', 'value', 'degree', '', 'difficult', 'university', 'sustain', 'level', 'fee', '', '', 'marginson', '', 'add', 'perfect', 'storm', '', 'weaken', 'domestic', 'international', 'demand', 'couple', 'pressure', 'decrease', 'fee', '', '', 'without', 'action', '', 'university', 'force', 'huge', 'cut', '', 'job', 'lose', '', 'vital', 'research', 'halt', '', '', 'spokesperson', 'universities', 'uk', '', 'umbrella', 'group', 'represent', '137', 'institution', '', 'tell', 'lancet', 'oncology', '', '', 'pretty', 'much', 'every', 'university', 'country', 'look', 'voluntary', 'redundancy', '', '', 'add', 'malcolm', 'reed', '', 'dean', 'brighton', 'sussex', 'medical', 'school', '', 'brighton', '', 'uk', '', 'co-chair', 'medical', 'schools', 'council', '', 'london', '', 'uk', '', '', '', 'staff', 'short-term', 'contract', 'likely', '', 'fund', 'phds', 'look', 'precarious', 'impact', 'charity', '', 'pool', 'future', 'researcher', 'shallower', '', 'prestigious', 'research', 'institution', '', 'harvard', '', 'cambridge', '', '', 'usa', '', 'oxford', '', 'uk', '', 'university', '', 'well', 'place', 'weather', 'storm', '', 'place', 'fall', 'lower', 'league', 'table', 'vulnerable', '', 'especially', 'international', 'student', 'fee', 'form', 'big', 'part', 'income', '', '', 'part', '', 'medical', 'school', 'high-quality', 'research', 'ring-fenced', 'change', '', '', 'marginson', '', '', 'medicine', 'life', 'science', 'strong', 'uk', 'system', '', 'confident', 'survive', 'thing', '', '', 'much', 'depend', 'depth', 'downturn', '', 'reed', 'point', 'medical', 'school', 'integrate', 'within', 'university', 'wider', 'economy', '', '', 'university', 'threat', '', 'medical', 'school', '', '', '', 'clinical', 'placement', 'uk', 'medical', 'student', 'penultimate', 'year', 'suspend', 'since', 'march', '', 'reed', 'hope', 'able', 'restart', 'september', '', 'lose', 'grind', 'recover', '', 'delay', 'problematic', '', '', 'simple', 'answer', 'deal', 'student', 'miss', '6', 'month', 'clinical', 'experience', '', '', 'reed', '', '', 'real', 'threat', 'graduate', 'time', 'next', 'year', '', '', 'lancet', 'oncology', 'press', '', 'number', 'confirm', 'case', 'covid-19', 'worldwide', 'approach', '5', 'million', '', 'absence', 'substantial', 'financial', 'support', '', 'world', 'college', 'university', 'unlikely', 'survive', 'pandemic', '', 'others', 'shut', 'large', 'project', 'sell', 'property', '', '', 'epochal', 'event', '', '', 'hartle', '', '', 'leave', 'huge', 'impression', 'education', 'sector', '', 'view', 'large', 'image', 'copyright', '', '2020', 'ruth', 'swanshutterstockcom', 'view', 'large', 'image', 'copyright', '', '2020', 'ruth', 'swanshutterstockcom']",640,"{'': 149, 'university': 14, 'uk': 9, 'student': 9, 'year': 7, 'education': 7, 'fee': 6, 'medical': 6, 'school': 5, 'usa': 4, 'higher': 4, 'sector': 4, 'billion': 4, 'lose': 4, 'research': 4, 'institution': 4, 'international': 4, 'much': 4, 'reed': 4, 'covid-19': 3}",{},0,0.0
DOI:10.1016/S2665-9913(20)30160-0,10.1016/S2665-9913(20)30160-0,Comment,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['anakinra', 'covid-19', '', 'important', 'consideration', 'clinical', 'trial']","['The COVID-19 pandemic cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) cause 320 000 death May 19 , 2020 .', 'COVID-19 death primarily cause acute respiratory distress syndrome ( ARDS ) cytokine storm syndrome—ie , state hyperinflammation lead multiorgan failure.1Tay MZ Poh CM Renia L MacAry PA Ng LFP The trinity COVID-19 : immunity , inflammation intervention.Nat Rev Immunol .', '2020 ; ( publish online April 28 .', ') DOI:10.1038/s41577-020-0311-8CrossrefScopus ( 0 ) Google Scholar A recent Lancet letter2Mehta P McAuley DF Brown M et al.COVID-19 : consider cytokine storm syndrome immunosuppression.Lancet .', '2020 ; 395 : 1033-1034SummaryFull TextFull Text PDFPubMedScopus ( 122 ) Google Scholar suggest screen patient COVID-19 hyperinflammation treat immunosuppressive drug could improve mortality .', 'Cytokine storm complicate macrophage activation syndrome associate rheumatic disease share considerable biochemical overlap hyperinflammation observe patient COVID-19.1Tay MZ Poh CM Renia L MacAry PA Ng LFP The trinity COVID-19 : immunity , inflammation intervention.Nat Rev Immunol .', '2020 ; ( publish online April 28 .', "") DOI:10.1038/s41577-020-0311-8CrossrefScopus ( 0 ) Google Scholar , 3McGonagle D Sharif K O'Regan A Bridgewood C The role cytokine include interleukin-6 COVID-19 induce pneumonia macrophage activation syndrome-like disease.Autoimmun Rev ."", '2020 ; ( publish online April 3 .', ') DOI:10.1016/j.autrev.2020.102537CrossrefScopus ( 5 ) Google Scholar At time write , ten ongoing clinical trial COVID-19 drug anakinra ( table ) .', 'Anakinra inhibit proinflammatory cytokine interleukin ( IL ) -1α IL-1β use success treat macrophage activation syndrome cause various inflammatory conditions,4Monteagudo LA Boothby A Gertner E Continuous intravenous anakinra infusion calm cytokine storm macrophage activation syndrome.ACR Open Rheumatol .', '2020 ; ( publish April 8 .', ') DOI:10.1002/acr2.11135CrossrefGoogle Scholar , 5Sonmez HE Demir S Bilginer Y Ozen S Anakinra treatment macrophage activation syndrome : single center experience systemic review literature.Clin Rheumatol .', '2018 ; 37 : 3329-3335CrossrefPubMedScopus ( 0 ) Google Scholar several small study patient COVID-19.6Aouba A Baldolli A Geffray L et al.Targeting inflammatory cascade anakinra moderate severe COVID-19 pneumonia : case series.Ann Rheum Dis .', '2020 ; ( publish online May 6 .', ') DOI:10.1136/annrheumdis-2020-217706CrossrefGoogle Scholar , 7Cavalli G De Luca G Campochiaro C et al.Interleukin-1 blockade high-dose anakinra patient COVID-19 , acute respiratory distress syndrome , hyperinflammation : retrospective cohort study.Lancet Rheumatology .', '2020 ; ( publish online May 7 . )', 'urlplaceholder TextFull Text PDFGoogle Scholar Here support rationale target hyperinflammation COVID-19 anakinra comment different aspect use , patient selection , dose , outcome measures.TableAnakinra trial COVID-19PopulationInterventionControlOutcome ( primary ) Targeted recruitment ( receive anakinra ) Completion dateCountryNCT043640092020-001734-36Confirmed SARS-CoV-2 ; patient respiratory symptom requirement oxygen therapy ; CRP > 50 mg/LIntravenous : 200 mg twice day day 1–3 ; 100 mg twice day day 4–10SOCTreatment success day 14 ( patient alive require IMV EMCO ) 240 ( 120 ) September , 2020FranceNCT043573662020-001466-11Confirmed SARS-CoV-2 ; x-ray CT confirmation lower respiratory tract infection ; plasma soluble urokinase plaminogen activator receptor ≥6 ng/mLSubcutaneous : 100 mg day day 1–10 antibiotic ( trimethoprim–sulfamethoxazole ) NonePatients develop serious respiratory failure day 14100 ( 100 ) April , 2022GreeceNCT043240212020-001167-93Confirmed SARS-CoV-2 ; presence respiratory distress ( PaO2/FiO2 < 300 mm Hg , respiratory rate ≥30 breath per min , peripheral oxygen saturation < 93 % ) ; hyperinflammation ( lymphocyte count < 1000 cell per μL two follow : ferritin > 500 ng/mL , LDH > 300 U/L , D-dimer > 1000 ng/mL ) Intravenous : 100 mg every 4 h day 1–15 ( comparator group : emapalumab [ anti-IFNγ mAb ] ) SOCTreatment success day 15 ( proportion patient require IMV EMCO ) 54 ( 18 ) September , 2020ItalyNCT043397122020-001-039-29Confirmed SARS-CoV-2 ; organ dysfunction define presence total SOFA score ≥2 involvement lower respiratory tract ; macrophage activation syndromeIntravenous : 200 mg three time day day 1–7SOCChange SOFA score ; improvement lung involvement measurement ; increase PaO2/FiO2 ratio ( day 8 ) 40 ( 20 ) April , 2022GreeceNCT04362111NAConfirmed SARS-CoV-2 ; hyperferritinaemia > 700 ng/mL ; fever > 38°C ; two follow : increase D-dimers > 500 ng/mL thrombocytopenia < 130 000 mm3 , leukopenia ( white blood cell count < 3500 mm3 ) lymphopenia ( < 1000 mm3 ) , elevate AST ALT > 2 time upper limit normal , elevate LDH > 2 time upper limit normalSubcutaneous : 100 mg every 4 h day 1–5PlaceboNo increase oxygen requirement increase respiratory support measures20 ( 10 ) December , 2020USANCT043306382020-001-500-41Confirmed COVID-19 diagnosis ; PaO2/FiO2 < 350 mm Hg ( room air ) PaO2/FiO2 < 280 mm Hg ( supplemental oxygen ) require high flow IMV ; cytokine release syndrome define follow : ferritin > 1000 μg/L rise last 24 h , ferritin > 2000 μg/L high flow IMV patient , lymphopenia ( < 800 cell per μL ) , two follow : ferritin > 700 μL , increase LDH > 300 IU/L , D-dimers > 1000 ng/mL , CRP > 70 mg/mL ; chest x-ray CT bilateral infiltratesSubcutaneous : 100 mg day day 1–28 ( comparator group : without siltuximab ; without tocilizumab ) SOC2 point improvement six category ordinal scale discharge hospital342 ( 171 ) December , 2020BelgiumNCT043415842020-001-246-18Patients CORIMUNO-19 cohort ; CRP > 25 mg/L ; patient either group 1 : require > 3 L/min oxygen , WHO progression scale 5 , NIV high flow ; group 2 : respiratory failure IMV NIV high flow , WHO progression scale ≥6 , do-not-resuscitate orderIntravenous : 200 mg twice day day 1–3 ; 100 mg twice day day 4 ; 100 mg day day 5SOCSurvival without need ventilator use day 14 ; WHO progression scale ≤5 day 4 ; cumulative incidence successful tracheal extubation withdrawal NIV high flow day 14 ; decrease least 1 point WHO progression scale day 4240 ( 120 ) December , 2020FranceNCT027357072015-002340-14 ( REMAP-CAP ) Suspected confirm COVID-19 ; admission ICU symptom , sign , consistent lower respiratory tract infection , radiological evidence new onset consolidation ; 48 h ICU admission , receive organ support one follow : NIV , IMV , vasopressor ionotropes alone combinationIntravenous : 300 mg bolus ; 100 mg every 4 hSOCAll-cause mortality ( day 90 ) ; day alive outside ICU ( day 21 ) 7100 ( unspecified ) December , 2023GlobalNCT043662322020-001963-10Confirmed SARS-CoV-2 ; hypoxic pneumonia ( include arterial oxygen saturation < 90 mm Hg ) ; CRP > 150 mg/L ; acute respiratory distress syndrome ( include IMV PaO2/FiO2 < 300 mm Hg ) Intravenous : 300 mg day day 1–5 ( dose taper ) without ruxolitinibSOCAt least three parameter meet ( include CRP , ferritin , ) : CRP decrease > 50 % , ferritinaemia decrease > 1/3 , serum creatine decrease > 1/3 , AST ALT decrease > 50 % , eosinophil > 50 mm3 , lymphocyte > 1000 mm350 ( 25 ) August , 2020FranceNA2020-001636-95Suspected confirm COVID-19 ; receive organ support one follow : NIV , IMV , vasopressor inotropes alone combinationSubcutaneous : 100 mg twice day ; intravenous : 100 mg every 4 hNAPlasma IL-1 receptor antagonist IL-6 day 1–730 ( 30 ) September , 2020UKSARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'CRP=C-reactive protein .', 'SOC=standard care .', 'IMV=invasive mechanical ventilation .', 'EMCO=extracorporeal membrane oxygenation .', 'NA=not applicable .', 'LDH=lactose dehydrogenase .', 'SOFA=sequential organ failure assessment .', 'AST=aspartate aminotransferase .', 'ALT=alanine aminotransferase .', 'NIV=non-invasive ventilation .', 'ICU=intensive care unit .', 'IL=interleukin .', 'Open table new tab SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'CRP=C-reactive protein .', 'SOC=standard care .', 'IMV=invasive mechanical ventilation .', 'EMCO=extracorporeal membrane oxygenation .', 'NA=not applicable .', 'LDH=lactose dehydrogenase .', 'SOFA=sequential organ failure assessment .', 'AST=aspartate aminotransferase .', 'ALT=alanine aminotransferase .', 'NIV=non-invasive ventilation .', 'ICU=intensive care unit .', 'IL=interleukin .', 'Anakinra immunosuppressive drug carry theoretical risk harm wrong patient group potentially target beneficial inflammation ; however , positive effect might also miss correct patient group ascertain .', 'It important , therefore , target treatment individual consider hyperinflammation .', 'Diagnostic criterion patient group poorly develop consensus , see inclusion criterion list ongoing anakinra trial ( table ) .', 'Although serum ferritin IL-6 concentration highly specific hyperinflammation show associate need ventilation patient COVID-19,8Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; 395 : 1054-1062SummaryFull TextFull Text PDFPubMedScopus ( 401 ) Google Scholar routinely measure clinical set , shortcoming highly relevant give requirement identify many patient possible might benefit .', 'We suggest pragmatic approach patient selection base identify patient progressive disease evidence increase inflammation .', 'Therefore , propose use worsen lymphopenia , marker disease progression severity COVID-19 , increase C-reactive protein evidence worsen inflammation .', 'The dose route administration anakinra especially relevant give short plasma half-life , intravenous subcutaneous route considered.6Aouba A Baldolli A Geffray L et al.Targeting inflammatory cascade anakinra moderate severe COVID-19 pneumonia : case series.Ann Rheum Dis .', '2020 ; ( publish online May 6 .', ') DOI:10.1136/annrheumdis-2020-217706CrossrefGoogle Scholar , 7Cavalli G De Luca G Campochiaro C et al.Interleukin-1 blockade high-dose anakinra patient COVID-19 , acute respiratory distress syndrome , hyperinflammation : retrospective cohort study.Lancet Rheumatology .', '2020 ; ( publish online May 7 . )', ""urlplaceholder TextFull Text PDFGoogle Scholar While short half-life beneficial limit drug 's duration action case adverse event , also lead large peak–trough fluctuation intravenous formulation ."", 'Variation dose need minimise ensure constant adequate bioavailability , avoid detrimental rebound increase inflammation .', 'Pharmacokinetic study various disease state show subcutaneous anakinra might ensure adequate consistent plasma concentration , bioavailability range 80–95 % .9Yang BB Baughman S Sullivan JT Pharmacokinetics anakinra subject different level renal function.Clin Pharmacol Ther .', '2003 ; 74 : 85-94CrossrefPubMedScopus ( 57 ) Google Scholar , 10Yang BB Gozzi P Sullivan JT Pharmacokinetics anakinra subject heavier vs. lighter body weights.Clin Transl Sci .', '2019 ; 12 : 371-378CrossrefPubMedScopus ( 0 ) Google Scholar Concerns raise regard suitability subcutaneous drug administration patient intensive care susceptible development peripheral oedema poor skin perfusion .', 'Repeated subcutaneous injection might also lead patient discomfort .', 'However , downside weigh considerable benefit subcutaneous administration context pandemic , include easy administration health-care professional , increase cost-effectiveness need infusion pump equivalent , reduce fluid load .', 'Reduced fluid load important current guideline management severe ARDS recommend negative fluid balance 0·5–1·0 L per day,11Matthay MA Aldrich JM Gotts JE Treatment severe acute respiratory distress syndrome COVID-19.Lancet Respir Med .', '2020 ; 8 : 433-434SummaryFull TextFull Text PDFPubMedScopus ( 9 ) Google Scholar commonly adopt mode intravenous anakinra result infusion minimum 400 mL fluid .', 'Another important consideration choice record success ( otherwise ) intervention .', 'It rare single trial provide definitive answer , core set outcome report trial give intervention important allow systematic reviewer combine result similar patient populations.12Williamson PR Altman DG Bagley H et al.The COMET handbook : version 1·0.Trials .', '2017 ; 18 : 280CrossrefPubMedScopus ( 0 ) Google Scholar Of ten identify trial ( table ) , six trial consider patient severe condition .', 'These trial dominate REMAP-CAP trial ( NCT02735707 ) , open-ended recruitment target 7100 patient .', 'The five trial total fewer 400 participant receive anakinra , outcome common .', 'Some trial focus effectiveness ( clinical ) others efficacy ( biomarker ) endpoint .', 'The four trial include patient le severe disease hospitalise , total recruitment around 250 participant .', 'These trial similar mix effectiveness efficacy endpoint , mortality commonly report outcome .', 'Only five trial explicitly mention ferritin outcome , regard important parameter assess hyperinflammation , trial report data different way preclude pool .', 'Even without clinical heterogeneity inherent range eligibility criterion dose regimen study ( table ) , power meaningful meta-analysis low .', 'Anakinra highly plausible drug candidate COVID-19 , encourage trialists consider patient selection , dose , outcome measure , , importantly , ensure collection core outcome measure current future trial .', 'AK , AV , JG , HP , SH fund National Institute Health Research Efficacy Mechanism Evaluation Programme Ref : 14/209/07 .', 'Swedish Orphan Biovitrum provide investigational medicinal product public-funded , peer-reviewed trial AK , AV , JG , HP , SH coinvestigators .', 'All author declare compete interest .']","['covid-19', 'pandemic', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'cause', '320', '000', 'death', '19', '', '2020', '', 'covid-19', 'death', 'primarily', 'cause', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'cytokine', 'storm', 'syndromeie', '', 'state', 'hyperinflammation', 'lead', 'multiorgan', 'failure1tay', 'mz', 'poh', 'cm', 'renia', 'l', 'macary', 'pa', 'ng', 'lfp', 'trinity', 'covid-19', '', 'immunity', '', 'inflammation', 'interventionnat', 'rev', 'immunol', '', '2020', '', '', 'publish', 'online', 'april', '28', '', '', 'doi101038s41577-020-0311-8crossrefscopus', '', '0', '', 'recent', 'lancet', 'letter2mehta', 'p', 'mcauley', 'df', 'brown', 'alcovid-19', '', 'consider', 'cytokine', 'storm', 'syndrome', 'immunosuppressionlancet', '', '2020', '', '395', '', '1033-1034summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '122', '', 'suggest', 'screen', 'patient', 'covid-19', 'hyperinflammation', 'treat', 'immunosuppressive', 'drug', 'improve', 'mortality', '', 'cytokine', 'storm', 'complicate', 'macrophage', 'activation', 'syndrome', 'associate', 'rheumatic', 'disease', 'share', 'considerable', 'biochemical', 'overlap', 'hyperinflammation', 'observe', 'patient', 'covid-191tay', 'mz', 'poh', 'cm', 'renia', 'l', 'macary', 'pa', 'ng', 'lfp', 'trinity', 'covid-19', '', 'immunity', '', 'inflammation', 'interventionnat', 'rev', 'immunol', '', '2020', '', '', 'publish', 'online', 'april', '28', '', '', 'doi101038s41577-020-0311-8crossrefscopus', '', '0', '', '', '3mcgonagle', 'sharif', 'k', 'oregan', 'bridgewood', 'c', 'role', 'cytokine', 'include', 'interleukin-6', 'covid-19', 'induce', 'pneumonia', 'macrophage', 'activation', 'syndrome-like', 'diseaseautoimmun', 'rev', '', '2020', '', '', 'publish', 'online', 'april', '3', '', '', 'doi101016jautrev2020102537crossrefscopus', '', '5', '', 'time', 'write', '', 'ten', 'ongoing', 'clinical', 'trial', 'covid-19', 'drug', 'anakinra', '', 'table', '', '', 'anakinra', 'inhibit', 'proinflammatory', 'cytokine', 'interleukin', '', 'il', '', '-1', 'il-inhibitor', 'success', 'treat', 'macrophage', 'activation', 'syndrome', 'cause', 'various', 'inflammatory', 'conditions4monteagudo', 'la', 'boothby', 'gertner', 'e', 'continuous', 'intravenous', 'anakinra', 'infusion', 'calm', 'cytokine', 'storm', 'macrophage', 'activation', 'syndromeacr', 'open', 'rheumatol', '', '2020', '', '', 'publish', 'april', '8', '', '', 'doi101002acr211135crossrefgoogle', '', '5sonmez', 'demir', 'bilginer', 'ozen', 'anakinra', 'treatment', 'macrophage', 'activation', 'syndrome', '', 'single', 'center', 'experience', 'systemic', 'review', 'literatureclin', 'rheumatol', '', '2018', '', '37', '', '3329-3335crossrefpubmedscopus', '', '0', '', 'several', 'small', 'study', 'patient', 'covid-196aouba', 'baldolli', 'geffray', 'l', 'altargeting', 'inflammatory', 'cascade', 'anakinra', 'moderate', 'severe', 'covid-19', 'pneumonia', '', 'case', 'seriesann', 'rheum', 'dis', '', '2020', '', '', 'publish', 'online', '6', '', '', 'doi101136annrheumdis-2020-217706crossrefgoogle', '', '7cavalli', 'g', 'de', 'luca', 'g', 'campochiaro', 'c', 'alinterleukin-1', 'blockade', 'high-dose', 'anakinra', 'patient', 'covid-19', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'hyperinflammation', '', 'retrospective', 'cohort', 'studylancet', 'rheumatology', '', '2020', '', '', 'publish', 'online', '7', '', '', 'urlplaceholder', 'textfull', 'text', 'pdfgoogle', 'support', 'rationale', 'target', 'hyperinflammation', 'covid-19', 'anakinra', 'comment', 'different', 'aspect', '', 'patient', 'selection', '', 'dose', '', 'outcome', 'measurestableanakinra', 'trial', 'covid-19populationinterventioncontroloutcome', '', 'primary', '', 'targeted', 'recruitment', '', 'receive', 'anakinra', '', 'completion', 'datecountrynct043640092020-001734-36confirmed', 'sars-cov-2', '', 'patient', 'respiratory', 'symptom', 'requirement', 'oxygen', 'therapy', '', 'crp', '', '50', 'mglintravenous', '', '200', 'mg', 'twice', 'day', 'day', '13', '', '100', 'mg', 'twice', 'day', 'day', '410soctreatment', 'success', 'day', '14', '', 'patient', 'alive', 'require', 'imv', 'emco', '', '240', '', '120', '', 'september', '', '2020francenct043573662020-001466-11confirmed', 'sars-cov-2', '', 'x-ray', 'ct', 'confirmation', 'lower', 'respiratory', 'tract', 'infection', '', 'plasma', 'soluble', 'urokinase', 'plaminogen', 'activator', 'receptor', '6', 'ngmlsubcutaneous', '', '100', 'mg', 'day', 'day', '110', 'antibiotic', '', 'trimethoprimsulfamethoxazole', '', 'nonepatients', 'develop', 'serious', 'respiratory', 'failure', 'day', '14100', '', '100', '', 'april', '', '2022greecenct043240212020-001167-93confirmed', 'sars-cov-2', '', 'presence', 'respiratory', 'distress', '', 'pao2fio2', '', '300', 'mm', 'hg', '', 'respiratory', 'rate', '30', 'breath', 'per', 'min', '', 'peripheral', 'oxygen', 'saturation', '', '93', '', '', '', 'hyperinflammation', '', 'lymphocyte', 'count', '', '1000', 'cell', 'per', 'l', 'two', 'follow', '', 'ferritin', '', '500', 'ngml', '', 'ldh', '', '300', 'ul', '', 'd-dimer', '', '1000', 'ngml', '', 'intravenous', '', '100', 'mg', 'every', '4', 'h', 'day', '115', '', 'comparator', 'group', '', 'emapalumab', '', 'anti-ifn', 'mab', '', '', 'soctreatment', 'success', 'day', '15', '', 'proportion', 'patient', 'require', 'imv', 'emco', '', '54', '', '18', '', 'september', '', '2020italynct043397122020-001-039-29confirmed', 'sars-cov-2', '', 'organ', 'dysfunction', 'define', 'presence', 'total', 'sofa', 'score', '2', 'involvement', 'lower', 'respiratory', 'tract', '', 'macrophage', 'activation', 'syndromeintravenous', '', '200', 'mg', 'three', 'time', 'day', 'day', '17socchange', 'sofa', 'score', '', 'improvement', 'lung', 'involvement', 'measurement', '', 'increase', 'pao2fio2', 'ratio', '', 'day', '8', '', '40', '', '20', '', 'april', '', '2022greecenct04362111naconfirmed', 'sars-cov-2', '', 'hyperferritinaemia', '', '700', 'ngml', '', 'fever', '', '38c', '', 'two', 'follow', '', 'increase', 'd-dimers', '', '500', 'ngml', 'thrombocytopenia', '', '130', '000', 'mm3', '', 'leukopenia', '', 'white', 'blood', 'cell', 'count', '', '3500', 'mm3', '', 'lymphopenia', '', '', '1000', 'mm3', '', '', 'elevate', 'ast', 'alt', '', '2', 'time', 'upper', 'limit', 'normal', '', 'elevate', 'ldh', '', '2', 'time', 'upper', 'limit', 'normalsubcutaneous', '', '100', 'mg', 'every', '4', 'h', 'day', '15placebono', 'increase', 'oxygen', 'requirement', 'increase', 'respiratory', 'support', 'measures20', '', '10', '', 'december', '', '2020usanct043306382020-001-500-41confirmed', 'covid-19', 'diagnosis', '', 'pao2fio2', '', '350', 'mm', 'hg', '', 'room', 'air', '', 'pao2fio2', '', '280', 'mm', 'hg', '', 'supplemental', 'oxygen', '', 'require', 'high', 'flow', 'imv', '', 'cytokine', 'release', 'syndrome', 'define', 'follow', '', 'ferritin', '', '1000', 'gl', 'rise', 'last', '24', 'h', '', 'ferritin', '', '2000', 'gl', 'high', 'flow', 'imv', 'patient', '', 'lymphopenia', '', '', '800', 'cell', 'per', 'l', '', '', 'two', 'follow', '', 'ferritin', '', '700', 'l', '', 'increase', 'ldh', '', '300', 'iul', '', 'd-dimers', '', '1000', 'ngml', '', 'crp', '', '70', 'mgml', '', 'chest', 'x-ray', 'ct', 'bilateral', 'infiltratessubcutaneous', '', '100', 'mg', 'day', 'day', '128', '', 'comparator', 'group', '', 'without', 'siltuximab', '', 'without', 'tocilizumab', '', 'soc2', 'point', 'improvement', 'six', 'category', 'ordinal', 'scale', 'discharge', 'hospital342', '', '171', '', 'december', '', '2020belgiumnct043415842020-001-246-18patients', 'corimuno-19', 'cohort', '', 'crp', '', '25', 'mgl', '', 'patient', 'either', 'group', '1', '', 'require', '', '3', 'lmin', 'oxygen', '', 'progression', 'scale', '5', '', 'niv', 'high', 'flow', '', 'group', '2', '', 'respiratory', 'failure', 'imv', 'niv', 'high', 'flow', '', 'progression', 'scale', '6', '', 'do-not-resuscitate', 'orderintravenous', '', '200', 'mg', 'twice', 'day', 'day', '13', '', '100', 'mg', 'twice', 'day', 'day', '4', '', '100', 'mg', 'day', 'day', '5socsurvival', 'without', 'ventilator', 'day', '14', '', 'progression', 'scale', '5', 'day', '4', '', 'cumulative', 'incidence', 'successful', 'tracheal', 'extubation', 'withdrawal', 'niv', 'high', 'flow', 'day', '14', '', 'decrease', 'least', '1', 'point', 'progression', 'scale', 'day', '4240', '', '120', '', 'december', '', '2020francenct027357072015-002340-14', '', 'remap-cap', '', 'suspected', 'confirm', 'covid-19', '', 'admission', 'icu', 'symptom', '', 'sign', '', 'consistent', 'lower', 'respiratory', 'tract', 'infection', '', 'radiological', 'evidence', 'new', 'onset', 'consolidation', '', '48', 'h', 'icu', 'admission', '', 'receive', 'organ', 'support', 'one', 'follow', '', 'niv', '', 'imv', '', 'vasopressor', 'ionotropes', 'alone', 'combinationintravenous', '', '300', 'mg', 'bolus', '', '100', 'mg', 'every', '4', 'hsocall-cause', 'mortality', '', 'day', '90', '', '', 'day', 'alive', 'outside', 'icu', '', 'day', '21', '', '7100', '', 'unspecified', '', 'december', '', '2023globalnct043662322020-001963-10confirmed', 'sars-cov-2', '', 'hypoxic', 'pneumonia', '', 'include', 'arterial', 'oxygen', 'saturation', '', '90', 'mm', 'hg', '', '', 'crp', '', '150', 'mgl', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'include', 'imv', 'pao2fio2', '', '300', 'mm', 'hg', '', 'intravenous', '', '300', 'mg', 'day', 'day', '15', '', 'dose', 'taper', '', 'without', 'ruxolitinibsocat', 'least', 'three', 'parameter', 'meet', '', 'include', 'crp', '', 'ferritin', '', '', '', 'crp', 'decrease', '', '50', '', '', 'ferritinaemia', 'decrease', '', '13', '', 'serum', 'creatine', 'decrease', '', '13', '', 'ast', 'alt', 'decrease', '', '50', '', '', 'eosinophil', '', '50', 'mm3', '', 'lymphocyte', '', '1000', 'mm350', '', '25', '', 'august', '', '2020francena2020-001636-95suspected', 'confirm', 'covid-19', '', 'receive', 'organ', 'support', 'one', 'follow', '', 'niv', '', 'imv', '', 'vasopressor', 'inotropes', 'alone', 'combinationsubcutaneous', '', '100', 'mg', 'twice', 'day', '', 'intravenous', '', '100', 'mg', 'every', '4', 'hnaplasma', 'il-inhibitor', 'receptor', 'antagonist', 'il-inhibitor', 'day', '1730', '', '30', '', 'september', '', '2020uksars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'crpc-reactive', 'protein', '', 'socstandard', 'care', '', 'imvinvasive', 'mechanical', 'ventilation', '', 'emcoextracorporeal', 'membrane', 'oxygenation', '', 'nanot', 'applicable', '', 'ldhlactose', 'dehydrogenase', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'astaspartate', 'aminotransferase', '', 'altalanine', 'aminotransferase', '', 'nivnon-invasive', 'ventilation', '', 'icuintensive', 'care', 'unit', '', 'ilinterleukin', '', 'open', 'table', 'new', 'tab', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'crpc-reactive', 'protein', '', 'socstandard', 'care', '', 'imvinvasive', 'mechanical', 'ventilation', '', 'emcoextracorporeal', 'membrane', 'oxygenation', '', 'nanot', 'applicable', '', 'ldhlactose', 'dehydrogenase', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'astaspartate', 'aminotransferase', '', 'altalanine', 'aminotransferase', '', 'nivnon-invasive', 'ventilation', '', 'icuintensive', 'care', 'unit', '', 'ilinterleukin', '', 'anakinra', 'immunosuppressive', 'drug', 'carry', 'theoretical', 'risk', 'harm', 'wrong', 'patient', 'group', 'potentially', 'target', 'beneficial', 'inflammation', '', 'however', '', 'positive', 'effect', 'miss', 'correct', 'patient', 'group', 'ascertain', '', 'important', '', 'therefore', '', 'target', 'treatment', 'individual', 'consider', 'hyperinflammation', '', 'diagnostic', 'criterion', 'patient', 'group', 'poorly', 'develop', 'consensus', '', 'inclusion', 'criterion', 'list', 'ongoing', 'anakinra', 'trial', '', 'table', '', '', 'although', 'serum', 'ferritin', 'il-inhibitor', 'concentration', 'highly', 'specific', 'hyperinflammation', 'show', 'associate', 'ventilation', 'patient', 'covid-198zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '395', '', '1054-1062summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '401', '', 'routinely', 'measure', 'clinical', 'set', '', 'shortcoming', 'highly', 'relevant', 'give', 'requirement', 'identify', 'patient', 'possible', 'benefit', '', 'suggest', 'pragmatic', 'approach', 'patient', 'selection', 'base', 'identify', 'patient', 'progressive', 'disease', 'evidence', 'increase', 'inflammation', '', 'therefore', '', 'propose', 'worsen', 'lymphopenia', '', 'marker', 'disease', 'progression', 'severity', 'covid-19', '', 'increase', 'c-reactive', 'protein', 'evidence', 'worsen', 'inflammation', '', 'dose', 'route', 'administration', 'anakinra', 'especially', 'relevant', 'give', 'short', 'plasma', 'half-life', '', 'intravenous', 'subcutaneous', 'route', 'considered6aouba', 'baldolli', 'geffray', 'l', 'altargeting', 'inflammatory', 'cascade', 'anakinra', 'moderate', 'severe', 'covid-19', 'pneumonia', '', 'case', 'seriesann', 'rheum', 'dis', '', '2020', '', '', 'publish', 'online', '6', '', '', 'doi101136annrheumdis-2020-217706crossrefgoogle', '', '7cavalli', 'g', 'de', 'luca', 'g', 'campochiaro', 'c', 'alinterleukin-1', 'blockade', 'high-dose', 'anakinra', 'patient', 'covid-19', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'hyperinflammation', '', 'retrospective', 'cohort', 'studylancet', 'rheumatology', '', '2020', '', '', 'publish', 'online', '7', '', '', 'urlplaceholder', 'textfull', 'text', 'pdfgoogle', 'short', 'half-life', 'beneficial', 'limit', 'drug', 'duration', 'action', 'case', 'adverse', 'event', '', 'lead', 'large', 'peaktrough', 'fluctuation', 'intravenous', 'formulation', '', 'variation', 'dose', 'minimise', 'ensure', 'constant', 'adequate', 'bioavailability', '', 'avoid', 'detrimental', 'rebound', 'increase', 'inflammation', '', 'pharmacokinetic', 'study', 'various', 'disease', 'state', 'show', 'subcutaneous', 'anakinra', 'ensure', 'adequate', 'consistent', 'plasma', 'concentration', '', 'bioavailability', 'range', '8095', '', '9yang', 'bb', 'baughman', 'sullivan', 'jt', 'pharmacokinetics', 'anakinra', 'different', 'level', 'renal', 'functionclin', 'pharmacol', 'ther', '', '2003', '', '74', '', '85-94crossrefpubmedscopus', '', '57', '', '', '10yang', 'bb', 'gozzi', 'p', 'sullivan', 'jt', 'pharmacokinetics', 'anakinra', 'heavier', 'lighter', 'body', 'weightsclin', 'transl', 'sci', '', '2019', '', '12', '', '371-378crossrefpubmedscopus', '', '0', '', 'concerns', 'raise', 'regard', 'suitability', 'subcutaneous', 'drug', 'administration', 'patient', 'intensive', 'care', 'susceptible', 'development', 'peripheral', 'oedema', 'poor', 'skin', 'perfusion', '', 'repeated', 'subcutaneous', 'injection', 'lead', 'patient', 'discomfort', '', 'however', '', 'downside', 'weigh', 'considerable', 'benefit', 'subcutaneous', 'administration', 'context', 'pandemic', '', 'include', 'administration', 'health-care', 'professional', '', 'increase', 'cost-effectiveness', 'infusion', 'pump', 'equivalent', '', 'reduce', 'fluid', 'load', '', 'reduced', 'fluid', 'load', 'important', 'current', 'guideline', 'management', 'severe', 'ards', 'recommend', 'negative', 'fluid', 'balance', '0510', 'l', 'per', 'day11matthay', 'aldrich', 'jm', 'gotts', 'je', 'treatment', 'severe', 'acute', 'respiratory', 'distress', 'syndrome', 'covid-19lancet', 'respir', 'med', '', '2020', '', '8', '', '433-434summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '9', '', 'commonly', 'adopt', 'mode', 'intravenous', 'anakinra', 'result', 'infusion', 'minimum', '400', 'ml', 'fluid', '', 'another', 'important', 'consideration', 'choice', 'record', 'success', '', 'otherwise', '', 'intervention', '', 'rare', 'single', 'trial', 'provide', 'definitive', 'answer', '', 'core', 'set', 'outcome', 'report', 'trial', 'give', 'intervention', 'important', 'allow', 'systematic', 'reviewer', 'combine', 'result', 'similar', 'patient', 'populations12williamson', 'pr', 'altman', 'dg', 'bagley', 'h', 'althe', 'comet', 'handbook', '', 'version', '10trials', '', '2017', '', '18', '', '280crossrefpubmedscopus', '', '0', '', 'ten', 'identify', 'trial', '', 'table', '', '', 'six', 'trial', 'consider', 'patient', 'severe', 'condition', '', 'trial', 'dominate', 'remap-cap', 'trial', '', 'nct02735707', '', '', 'open-ended', 'recruitment', 'target', '7100', 'patient', '', 'five', 'trial', 'total', 'fewer', '400', 'participant', 'receive', 'anakinra', '', 'outcome', 'common', '', 'trial', 'focus', 'effectiveness', '', 'clinical', '', 'others', 'efficacy', '', 'biomarker', '', 'endpoint', '', 'four', 'trial', 'include', 'patient', 'le', 'severe', 'disease', 'hospitalise', '', 'total', 'recruitment', 'around', '250', 'participant', '', 'trial', 'similar', 'mix', 'effectiveness', 'efficacy', 'endpoint', '', 'mortality', 'commonly', 'report', 'outcome', '', 'five', 'trial', 'explicitly', 'mention', 'ferritin', 'outcome', '', 'regard', 'important', 'parameter', 'assess', 'hyperinflammation', '', 'trial', 'report', 'data', 'different', 'way', 'preclude', 'pool', '', 'without', 'clinical', 'heterogeneity', 'inherent', 'range', 'eligibility', 'criterion', 'dose', 'regimen', 'study', '', 'table', '', '', 'power', 'meaningful', 'meta-analysis', 'low', '', 'anakinra', 'highly', 'plausible', 'drug', 'candidate', 'covid-19', '', 'encourage', 'trialists', 'consider', 'patient', 'selection', '', 'dose', '', 'outcome', 'measure', '', '', 'importantly', '', 'ensure', 'collection', 'core', 'outcome', 'measure', 'current', 'future', 'trial', '', 'ak', '', 'av', '', 'jg', '', 'hp', '', 'sh', 'fund', 'national', 'institute', 'health', 'research', 'efficacy', 'mechanism', 'evaluation', 'programme', 'ref', '', '1420907', '', 'swedish', 'orphan', 'biovitrum', 'provide', 'investigational', 'medicinal', 'product', 'public-funded', '', 'peer-reviewed', 'trial', 'ak', '', 'av', '', 'jg', '', 'hp', '', 'sh', 'coinvestigators', '', 'author', 'declare', 'compete', 'interest', '']",1891,"{'': 431, 'day': 33, 'patient': 25, 'anakinra': 19, 'covid-19': 18, 'respiratory': 17, 'trial': 17, 'mg': 15, 'syndrome': 13, '2020': 12, '100': 11, 'hyperinflammation': 10, 'increase': 9, 'acute': 8, 'l': 8, 'publish': 8, 'imv': 8, 'severe': 7, '2': 7, 'sars-cov-2': 7}","{'tocilizumab': 1, 'infection': 2, 'sars-cov-2': 7, 'il-inhibitor': 4}",14,-0.93
DOI:10.1016/S2213-2600(20)30238-1,10.1016/S2213-2600(20)30238-1,Correspondence,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['organoids', 'human', 'airway', 'study', 'infectivity', 'cytopathy', 'sars-cov-2']","['Studies infectious disease limit lack model recapitulate normal cellular physiology pathology .', 'Developments organotypic model pave road towards study viral infection host–virus interaction .', 'For example , human intestinal organoids efficiently use study many virus , rotavirus , norovirus , enterovirus 71 , human adenovirus.1Ramani S Crawford SE Blutt SE Estes MK Human organoid culture : transformative new tool human virus studies.Curr Opin Virol .', '2018 ; 29 : 79-86CrossrefPubMedScopus ( 14 ) Google Scholar Mammalian airway organoids complex three-dimensional structure characterise different cellular composition design mimic lung structure .', 'Early research attempt develop organoids different progenitor cell , include basal cell , secretory cell , alveolar epithelial cells.2Barkauskas CE Chung MI Fioret B Gao X Katsura H Hogan BLM Lung organoids : current us future promise.Development .', '2017 ; 144 : 986-997CrossrefPubMedScopus ( 64 ) Google Scholar In past 5 year , scientist able generate mature lung organoids contain basal , ciliated , club cell .', 'These organoids use study disease cystic fibrosis lung tumour , infections.3Sachs N Papaspyropoulos A Zomer-van Ommen DD et al.Long-term expand human airway organoids disease modeling.EMBO J .', '2019 ; 38 : 1-20CrossrefScopus ( 0 ) Google Scholar One study4Hui KPY Ching RHH Chan SKH et al.Tropism , replication competence , innate immune response influenza virus : analysis human airway organoids ex-vivo bronchus cultures.Lancet Respir Med .', '2018 ; 6 : 846-854SummaryFull TextFull Text PDFPubMedScopus ( 11 ) Google Scholar use airway organoids look viral replication , tissue tropism , immune response many human influenza A avian virus .', 'Fortunately , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , virus responsible COVID-19 , isolate propagate early pandemic use numerous in-vitro model , Vero cell , Huh7 cell , human airway epithelial cell .', 'This isolation enhance SARS-CoV-2 isolate propagate TMPRSS2-expressing VeroE6 cell , indicate vital role TMPRSS2 serine protease virus infectivity.5Matsuyama S Nao N Shirato K et al.Enhanced isolation SARS-CoV-2 TMPRSS2-expressing cells.Proc Natl Acad Sci USA .', '2020 ; 117 : 7001-7003CrossrefPubMedScopus ( 8 ) Google Scholar Thus , in-vitro model effective study virus propagation , poorly recapitulate respiratory tract histology function .', 'We recommend use human airway organoids model study SARS-CoV-2 replication kinetics , tropism , host response ( figure ) .', 'Airway organoids generate use healthy lung tissue derive patient undergo surgical resection , SARS-CoV-2 obtain clinical specimen patient test positive .', 'After airway organoid infect SARS-CoV-2 , immunofluorescence electron scan microscope could use study cytopathic effect viral particle different cell type .', 'Furthermore , whole-genome sequence real-time quantitative PCR could determine viral replication kinetics genetic alteration , transcriptomic profile could reveal differential expression gene relate viral infection .', 'Additionally , flow cytometry enable detection quantification different cell type SARS-CoV-2 infection.FigureCo-culture airway organoidsShow full captionCo-culture airway organoids SARS-CoV-2 could use study viral replication , tropism , pathogenicity addition structural change ( A ) ; study immune response cytokine release , recapitulate pathological condition cytokine release syndrome , develop immunomodulatory drug ( B ) ; tool antiviral drug discovery development ( C ) .', 'Created use BioRender.com.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Co-culture airway organoids SARS-CoV-2 could use study viral replication , tropism , pathogenicity addition structural change ( A ) ; study immune response cytokine release , recapitulate pathological condition cytokine release syndrome , develop immunomodulatory drug ( B ) ; tool antiviral drug discovery development ( C ) .', 'Created use BioRender.com .', 'Angiotensin convert enzyme 2 TMPRSS2 serine protease highly express human airway epithelium airway organoids,6Zhou J Li C Sachs N et al.Differentiated human airway organoids ass infectivity emerge influenza virus.Proc Natl Acad Sci USA .', '2018 ; 115 : 6822-6827CrossrefPubMedScopus ( 18 ) Google Scholar , 7Oudit GY Imai Y Kuba K Scholey JW Penninger JM The role ACE2 pulmonary diseases—relevance nephrologist.Nephrol Dial Transplant .', '2009 ; 24 : 1362-1365CrossrefPubMedScopus ( 8 ) Google Scholar make model use airway organoids suitable study viral infectivity , since protein think facilitate infection cell .', 'Airway organoids could also use co-culture model culture different immune cell .', 'This co-culture model would enable study immunological response SARS-CoV-2 .', 'Moreover , genomic transcriptomic profile could reveal signal pathway involve immune response .', 'It also possible detect secrete cytokine response SARS-CoV-2 infection hence provide model recapitulate cytokine release syndrome see patient COVID-19.8Shi Y Wang Y Shao C et al.COVID-19 infection : perspective immune responses.Cell Death Differ .', '2020 ; 27 : 1451-1454CrossrefPubMedScopus ( 11 ) Google Scholar Moreover , co-culture model could use explore activity immunomodulatory drug .', 'Airway organoids could also use discover effective antiviral drug treat COVID-19 .', 'The potential activity drug candidate could predict several laboratory method : real-time quantitative PCR ass viral load , immunofluorescence electron microscopy identify number cell infect .', 'Additionally , microarray analysis identify molecular mechanism investigational drug possible cellular target .', 'Models use airway organoids could invaluable learn SARS-CoV-2 infectivity , replication kinetics , host–virus interaction , understand key help fight current pandemic .', 'We declare compete interest .']","['studies', 'infectious', 'disease', 'limit', 'model', 'recapitulate', 'normal', 'cellular', 'physiology', 'pathology', '', 'developments', 'organotypic', 'model', 'pave', 'road', 'towards', 'study', 'viral', 'infection', 'hostvirus', 'interaction', '', 'example', '', 'human', 'intestinal', 'organoids', 'efficiently', 'study', 'virus', '', 'rotavirus', '', 'norovirus', '', 'enterovirus', '71', '', 'human', 'adenovirus1ramani', 'crawford', 'se', 'blutt', 'se', 'estes', 'mk', 'human', 'organoid', 'culture', '', 'transformative', 'new', 'tool', 'human', 'virus', 'studiescurr', 'opin', 'virol', '', '2018', '', '29', '', '79-86crossrefpubmedscopus', '', '14', '', 'mammalian', 'airway', 'organoids', 'complex', 'three-dimensional', 'structure', 'characterise', 'different', 'cellular', 'composition', 'design', 'mimic', 'lung', 'structure', '', 'early', 'research', 'attempt', 'develop', 'organoids', 'different', 'progenitor', 'cell', '', 'include', 'basal', 'cell', '', 'secretory', 'cell', '', 'alveolar', 'epithelial', 'cells2barkauskas', 'ce', 'chung', 'mi', 'fioret', 'b', 'gao', 'x', 'katsura', 'h', 'hogan', 'blm', 'lung', 'organoids', '', 'current', 'us', 'future', 'promisedevelopment', '', '2017', '', '144', '', '986-997crossrefpubmedscopus', '', '64', '', 'past', '5', 'year', '', 'scientist', 'able', 'generate', 'mature', 'lung', 'organoids', 'contain', 'basal', '', 'ciliated', '', 'club', 'cell', '', 'organoids', 'study', 'disease', 'cystic', 'fibrosis', 'lung', 'tumour', '', 'infections3sachs', 'n', 'papaspyropoulos', 'zomer-van', 'ommen', 'dd', 'allong-term', 'expand', 'human', 'airway', 'organoids', 'disease', 'modelingembo', 'j', '', '2019', '', '38', '', '1-20crossrefscopus', '', '0', '', 'one', 'study4hui', 'kpy', 'ching', 'rhh', 'chan', 'skh', 'altropism', '', 'replication', 'competence', '', 'innate', 'immune', 'response', 'influenza', 'virus', '', 'analysis', 'human', 'airway', 'organoids', 'ex-vivo', 'bronchus', 'cultureslancet', 'respir', 'med', '', '2018', '', '6', '', '846-854summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '11', '', 'airway', 'organoids', 'look', 'viral', 'replication', '', 'tissue', 'tropism', '', 'immune', 'response', 'human', 'influenza', 'avian', 'virus', '', 'fortunately', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'virus', 'responsible', 'covid-19', '', 'isolate', 'propagate', 'early', 'pandemic', 'numerous', 'in-vitro', 'model', '', 'vero', 'cell', '', 'huh7', 'cell', '', 'human', 'airway', 'epithelial', 'cell', '', 'isolation', 'enhance', 'sars-cov-2', 'isolate', 'propagate', 'tmprss2-expressing', 'veroe6', 'cell', '', 'indicate', 'vital', 'role', 'tmprss2', 'serine', 'protease', 'virus', 'infectivity5matsuyama', 'nao', 'n', 'shirato', 'k', 'alenhanced', 'isolation', 'sars-cov-2', 'tmprss2-expressing', 'cellsproc', 'natl', 'acad', 'sci', 'usa', '', '2020', '', '117', '', '7001-7003crossrefpubmedscopus', '', '8', '', 'thus', '', 'in-vitro', 'model', 'effective', 'study', 'virus', 'propagation', '', 'poorly', 'recapitulate', 'respiratory', 'tract', 'histology', 'function', '', 'recommend', 'human', 'airway', 'organoids', 'model', 'study', 'sars-cov-2', 'replication', 'kinetics', '', 'tropism', '', 'host', 'response', '', 'figure', '', '', 'airway', 'organoids', 'generate', 'healthy', 'lung', 'tissue', 'derive', 'patient', 'undergo', 'surgical', 'resection', '', 'sars-cov-2', 'obtain', 'clinical', 'specimen', 'patient', 'test', 'positive', '', 'airway', 'organoid', 'infect', 'sars-cov-2', '', 'immunofluorescence', 'electron', 'scan', 'microscope', 'study', 'cytopathic', 'effect', 'viral', 'particle', 'different', 'cell', 'type', '', 'furthermore', '', 'whole-genome', 'sequence', 'real-time', 'quantitative', 'pcr', 'determine', 'viral', 'replication', 'kinetics', 'genetic', 'alteration', '', 'transcriptomic', 'profile', 'reveal', 'differential', 'expression', 'gene', 'relate', 'viral', 'infection', '', 'additionally', '', 'flow', 'cytometry', 'enable', 'detection', 'quantification', 'different', 'cell', 'type', 'sars-cov-2', 'infectionfigureco-culture', 'airway', 'organoidsshow', 'full', 'captionco-culture', 'airway', 'organoids', 'sars-cov-2', 'study', 'viral', 'replication', '', 'tropism', '', 'pathogenicity', 'addition', 'structural', 'change', '', '', '', 'study', 'immune', 'response', 'cytokine', 'release', '', 'recapitulate', 'pathological', 'condition', 'cytokine', 'release', 'syndrome', '', 'develop', 'immunomodulatory', 'drug', '', 'b', '', '', 'tool', 'antiviral', 'drug', 'discovery', 'development', '', 'c', '', '', 'created', 'biorendercomview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'co-culture', 'airway', 'organoids', 'sars-cov-2', 'study', 'viral', 'replication', '', 'tropism', '', 'pathogenicity', 'addition', 'structural', 'change', '', '', '', 'study', 'immune', 'response', 'cytokine', 'release', '', 'recapitulate', 'pathological', 'condition', 'cytokine', 'release', 'syndrome', '', 'develop', 'immunomodulatory', 'drug', '', 'b', '', '', 'tool', 'antiviral', 'drug', 'discovery', 'development', '', 'c', '', '', 'created', 'biorendercom', '', 'angiotensin', 'convert', 'enzyme', '2', 'tmprss2', 'serine', 'protease', 'highly', 'express', 'human', 'airway', 'epithelium', 'airway', 'organoids6zhou', 'j', 'li', 'c', 'sachs', 'n', 'aldifferentiated', 'human', 'airway', 'organoids', 'ass', 'infectivity', 'emerge', 'influenza', 'virusproc', 'natl', 'acad', 'sci', 'usa', '', '2018', '', '115', '', '6822-6827crossrefpubmedscopus', '', '18', '', '', '7oudit', 'gy', 'imai', 'kuba', 'k', 'scholey', 'jw', 'penninger', 'jm', 'role', 'ace2', 'pulmonary', 'diseasesrelevance', 'nephrologistnephrol', 'dial', 'transplant', '', '2009', '', '24', '', '1362-1365crossrefpubmedscopus', '', '8', '', 'model', 'airway', 'organoids', 'suitable', 'study', 'viral', 'infectivity', '', 'since', 'protein', 'facilitate', 'infection', 'cell', '', 'airway', 'organoids', 'co-culture', 'model', 'culture', 'different', 'immune', 'cell', '', 'co-culture', 'model', 'enable', 'study', 'immunological', 'response', 'sars-cov-2', '', 'moreover', '', 'genomic', 'transcriptomic', 'profile', 'reveal', 'signal', 'pathway', 'involve', 'immune', 'response', '', 'possible', 'detect', 'secrete', 'cytokine', 'response', 'sars-cov-2', 'infection', 'hence', 'provide', 'model', 'recapitulate', 'cytokine', 'release', 'syndrome', 'patient', 'covid-198shi', 'wang', 'shao', 'c', 'alcovid-19', 'infection', '', 'perspective', 'immune', 'responsescell', 'death', 'differ', '', '2020', '', '27', '', '1451-1454crossrefpubmedscopus', '', '11', '', 'moreover', '', 'co-culture', 'model', 'explore', 'activity', 'immunomodulatory', 'drug', '', 'airway', 'organoids', 'discover', 'effective', 'antiviral', 'drug', 'treat', 'covid-19', '', 'potential', 'activity', 'drug', 'candidate', 'predict', 'several', 'laboratory', 'method', '', 'real-time', 'quantitative', 'pcr', 'ass', 'viral', 'load', '', 'immunofluorescence', 'electron', 'microscopy', 'identify', 'number', 'cell', 'infect', '', 'additionally', '', 'microarray', 'analysis', 'identify', 'molecular', 'mechanism', 'investigational', 'drug', 'possible', 'cellular', 'target', '', 'models', 'airway', 'organoids', 'invaluable', 'learn', 'sars-cov-2', 'infectivity', '', 'replication', 'kinetics', '', 'hostvirus', 'interaction', '', 'understand', 'key', 'help', 'fight', 'current', 'pandemic', '', 'declare', 'compete', 'interest', '']",751,"{'': 140, 'organoids': 18, 'airway': 18, 'cell': 13, 'study': 12, 'sars-cov-2': 12, 'human': 11, 'model': 10, 'viral': 9, 'response': 8, 'drug': 8, 'virus': 7, 'replication': 7, 'immune': 7, 'cytokine': 6, 'recapitulate': 5, 'infection': 5, 'different': 5, 'lung': 5, 'release': 5}","{'infection': 5, 'sars-cov-2': 12}",17,0.1027
DOI:10.1016/S2213-2600(20)30236-8,10.1016/S2213-2600(20)30236-8,Comment,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['novel', 'virus', '', 'old', 'data', '', 'basic', 'principle', '', 'save', 'life', 'avoid', 'harm', 'amid', 'unknown']","['The 2013–16 west African Ebola epidemic stagger case fatality rate 30–70 % , yet surprisingly dozen Americans Europeans medically evacuate region die , case fatality rate Europe USA estimate mere 10 % .1Centers Disease Control Prevention2014–2016 Ebola outbreak west Africa .', 'urlplaceholder access : April 16 , 2020Google Scholar Every American receive experimental antiviral medication convalescent plasma , efficacy ethic therapy occupy national headline headspace .', 'However , randomise clinical trial therapy since fail show benefit.2van Griensven J Edwards T de Lamballerie X et al.Evaluation convalescent plasma Ebola virus disease Guinea.N Engl J Med .', '2016 ; 374 : 33-42CrossrefPubMedScopus ( 137 ) Google Scholar , 3The PREVAIL II Writing GroupA randomize , control trial ZMapp Ebola virus infection.N Engl J Med .', '2016 ; 375 : 1448-1456CrossrefPubMedScopus ( 191 ) Google Scholar Why , , many Americans survive due preferential access experimental therapy ?', 'The likely answer Americans survive due preferential access unproven therapy prove one .', '5 year later , world face another , much larger , pandemic , worry medical community learn recent experience .', 'To clear , search effective new therapy COVID-19 highly important .', 'At time , must remain cognisant odds stack candidate .', 'Medications decrease mortality difficult come , leave numerous disease without direct remedy .', 'Influenza provide important perspective .', 'Scientists search cure since 1918 influenza pandemic , 100 year later best medicine influenza merely shorten duration symptom day best.4Jefferson T Jones MA Doshi P et al.Neuraminidase inhibitor prevent treat influenza adult children.Cochrane Database Syst Rev .', '2014 ; 4CD008965PubMedGoogle Scholar None show reduce mortality .', ""Influenza unique ; sepsis subject decade research result much advance understand syndrome 's pathobiology ."", 'However , hundred therapeutic candidate biological plausibility , stem cell vitamin C , consistently improve patient outcome .', 'Of course , lack target therapy mean patient 1918 influenza would fare better today , someone sepsis better 2020 Surviving Sepsis campaign 2002 .', ""Just like Americans evacuate home Ebola epidemic , access modern medicine 's supportive care toolbox—frequent laboratory assessment correction metabolic derangement , precise haemodynamic monitor support , lung protective mechanical ventilation , dialysis , among others—would save countless life ."", 'Although everyday intervention receive attention novel therapeutic strategy COVID-19 pandemic , value inform decade evidence .', 'As influenza , Ebola , sepsis , timely delivery standard supportive care probably save patient COVID-19 month ahead unproven , potentially dangerous , pharmacological therapy formally trialled individually try today .', 'Hydroxychloroquine , example , widely use early pandemic basis report potential benefit .', 'More recent assessment call use question even suggest harm .', ""Rather ruminate innovative therapeutic might help give patient , collective mental energy better spend guarantee delivery evidence-based care COVID-19 's main killer ."", 'In 2000 , ARDS Network discover use small tidal volume reduce absolute mortality 9 % —the first intervention show improve outcome since acute respiratory distress syndrome ( ARDS ) first describe 33 year earlier.5The Acute Respiratory Distress Syndrome NetworkVentilation lower tidal volume compare traditional tidal volume acute lung injury acute respiratory distress syndrome.N Engl J Med .', '2000 ; 342 : 1301-1308CrossrefPubMedScopus ( 7881 ) Google Scholar Subsequent trial show additional 17 % absolute risk reduction patient moderate severe ARDS manage prone position.6Guérin C Reignier J Richard J-C et al.Prone position severe acute respiratory distress syndrome.N Engl J Med .', '2013 ; 368 : 2159-2168CrossrefPubMedScopus ( 1122 ) Google Scholar Furthermore , conservative fluid management strategy decrease duration mechanical ventilation onset organ dysfunction.7The National Heart , Lung , Blood Institute Acute Respiratory Distress Syndrome ( ARDS ) Clinical Trials NetworkComparison two fluid-management strategy acute lung injury.N Engl J Med .', '2006 ; 354 : 2564-2575CrossrefPubMedScopus ( 2068 ) Google Scholar Other strategy show prevent ARDS , include conservative use blood product , early identification treatment sepsis , default use lung protective ventilation , intensivist involvement .', 'Despite decade data agreed-upon standard care ARDS , many suggested—via journal article , medical blog , news site , social media—that several standard abandon patient respiratory failure COVID-19 .', 'It argue COVID-19 cause form ARDS different claim traditional typical ARDS therefore treat differently .', 'The evidence support claim poor absent .', 'For example , common refrain patient ARDS COVID-19 higher lung compliance worse oxygenation traditional ARDS .', 'However , publish compliance data patient ARDS COVID-19 largely consistent data ARDS trial predate pandemic .', 'Furthermore , publish preprint tissue analysis available biopsy autopsy specimen show diffuse alveolar damage typically see ARDS cause .', 'Similarly , much attention pay presence extensive pulmonary microthrombosis patient ARDS COVID-19 , observation make ARDS 30 year ago .', 'It certainly possible , perhaps even likely , ARDS COVID-19 unique feature , ARDS pneumonia , pancreatitis , gastric aspiration probably unique feature .', 'By definition ARDS syndrome , disease .', 'While disentangle subtypes ARDS active promise field , bulk clinical trial data date come patient ARDS vary cause , include viral pneumonia .', 'In absence evidence contrary , prove therapy ARDS ( low tidal volume ventilation , prone position , conservative fluid strategy ) remain standard care patient ARDS , include patient COVID-19 .', 'As clinician care patient die COVID-19 , yearn novel therapy novel disease .', 'We also recognise appreciate scientific value expert observation .', 'Indeed , crucial identify aspect management truly equipoise thus indication rigorous study .', 'Prompt collection data must prioritise arm appropriate evidence fight inevitable second surge arrive .', 'History tell u pandemic justification abandon basic principle evidence-based medicine .', 'In fact , adhere value never important .', 'View Large Image Copyright © 2020 TEK Image/Science Photo Library View Large Image Copyright © 2020 TEK Image/Science Photo Library We declare compete interest .']","['201316', 'west', 'african', 'ebola', 'epidemic', 'stagger', 'case', 'fatality', 'rate', '3070', '', '', 'yet', 'surprisingly', 'dozen', 'americans', 'europeans', 'medically', 'evacuate', 'region', 'die', '', 'case', 'fatality', 'rate', 'europe', 'usa', 'estimate', 'mere', '10', '', '1centers', 'disease', 'control', 'prevention20142016', 'ebola', 'outbreak', 'west', 'africa', '', 'urlplaceholder', 'access', '', 'april', '16', '', '2020google', 'every', 'american', 'receive', 'experimental', 'antiviral', 'medication', 'convalescent', 'plasma', '', 'efficacy', 'ethic', 'therapy', 'occupy', 'national', 'headline', 'headspace', '', 'however', '', 'randomise', 'clinical', 'trial', 'therapy', 'since', 'fail', 'show', 'benefit2van', 'griensven', 'j', 'edwards', 'de', 'lamballerie', 'x', 'alevaluation', 'convalescent', 'plasma', 'ebola', 'virus', 'disease', 'guinean', 'engl', 'j', 'med', '', '2016', '', '374', '', '33-42crossrefpubmedscopus', '', '137', '', '', '3the', 'prevail', 'ii', 'writing', 'groupa', 'randomize', '', 'control', 'trial', 'zmapp', 'ebola', 'virus', 'infectionn', 'engl', 'j', 'med', '', '2016', '', '375', '', '1448-1456crossrefpubmedscopus', '', '191', '', '', '', 'americans', 'survive', 'due', 'preferential', 'access', 'experimental', 'therapy', '', 'likely', 'answer', 'americans', 'survive', 'due', 'preferential', 'access', 'unproven', 'therapy', 'prove', 'one', '', '5', 'year', 'later', '', 'world', 'face', 'another', '', 'much', 'larger', '', 'pandemic', '', 'worry', 'medical', 'community', 'learn', 'recent', 'experience', '', 'clear', '', 'search', 'effective', 'new', 'therapy', 'covid-19', 'highly', 'important', '', 'time', '', 'must', 'remain', 'cognisant', 'odds', 'stack', 'candidate', '', 'medications', 'decrease', 'mortality', 'difficult', '', 'leave', 'numerous', 'disease', 'without', 'direct', 'remedy', '', 'influenza', 'provide', 'important', 'perspective', '', 'scientists', 'search', 'cure', 'since', '1918', 'influenza', 'pandemic', '', '100', 'year', 'later', 'best', 'medicine', 'influenza', 'merely', 'shorten', 'duration', 'symptom', 'day', 'best4jefferson', 'jones', 'doshi', 'p', 'alneuraminidase', 'inhibitor', 'prevent', 'treat', 'influenza', 'adult', 'childrencochrane', 'database', 'syst', 'rev', '', '2014', '', '4cd008965pubmedgoogle', 'none', 'show', 'reduce', 'mortality', '', 'influenza', 'unique', '', 'sepsis', 'decade', 'research', 'result', 'much', 'advance', 'understand', 'syndrome', 'pathobiology', '', 'however', '', 'hundred', 'therapeutic', 'candidate', 'biological', 'plausibility', '', 'stem', 'cell', 'vitamin', 'c', '', 'consistently', 'improve', 'patient', 'outcome', '', 'course', '', 'target', 'therapy', 'mean', 'patient', '1918', 'influenza', 'fare', 'better', 'today', '', 'someone', 'sepsis', 'better', '2020', 'surviving', 'sepsis', 'campaign', '2002', '', 'like', 'americans', 'evacuate', 'home', 'ebola', 'epidemic', '', 'access', 'modern', 'medicine', 'supportive', 'care', 'toolboxfrequent', 'laboratory', 'assessment', 'correction', 'metabolic', 'derangement', '', 'precise', 'haemodynamic', 'monitor', 'support', '', 'lung', 'protective', 'mechanical', 'ventilation', '', 'dialysis', '', 'among', 'otherswould', 'save', 'countless', 'life', '', 'although', 'everyday', 'intervention', 'receive', 'attention', 'novel', 'therapeutic', 'strategy', 'covid-19', 'pandemic', '', 'value', 'inform', 'decade', 'evidence', '', 'influenza', '', 'ebola', '', 'sepsis', '', 'timely', 'delivery', 'standard', 'supportive', 'care', 'probably', 'save', 'patient', 'covid-19', 'month', 'ahead', 'unproven', '', 'potentially', 'dangerous', '', 'pharmacological', 'therapy', 'formally', 'trialled', 'individually', 'today', '', 'hydroxychloroquine', '', 'example', '', 'widely', 'early', 'pandemic', 'basis', 'report', 'potential', 'benefit', '', 'recent', 'assessment', 'call', 'question', 'suggest', 'harm', '', 'ruminate', 'innovative', 'therapeutic', 'help', 'give', 'patient', '', 'collective', 'mental', 'energy', 'better', 'spend', 'guarantee', 'delivery', 'evidence-based', 'care', 'covid-19', 'main', 'killer', '', '2000', '', 'ards', 'network', 'discover', 'small', 'tidal', 'volume', 'reduce', 'absolute', 'mortality', '9', '', 'first', 'intervention', 'show', 'improve', 'outcome', 'since', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'first', 'describe', '33', 'year', 'earlier5the', 'acute', 'respiratory', 'distress', 'syndrome', 'networkventilation', 'lower', 'tidal', 'volume', 'compare', 'traditional', 'tidal', 'volume', 'acute', 'lung', 'injury', 'acute', 'respiratory', 'distress', 'syndromen', 'engl', 'j', 'med', '', '2000', '', '342', '', '1301-1308crossrefpubmedscopus', '', '7881', '', 'subsequent', 'trial', 'show', 'additional', '17', '', 'absolute', 'risk', 'reduction', 'patient', 'moderate', 'severe', 'ards', 'manage', 'prone', 'position6gurin', 'c', 'reignier', 'j', 'richard', 'j-c', 'alprone', 'position', 'severe', 'acute', 'respiratory', 'distress', 'syndromen', 'engl', 'j', 'med', '', '2013', '', '368', '', '2159-2168crossrefpubmedscopus', '', '1122', '', 'furthermore', '', 'conservative', 'fluid', 'management', 'strategy', 'decrease', 'duration', 'mechanical', 'ventilation', 'onset', 'organ', 'dysfunction7the', 'national', 'heart', '', 'lung', '', 'blood', 'institute', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'clinical', 'trials', 'networkcomparison', 'two', 'fluid-management', 'strategy', 'acute', 'lung', 'injuryn', 'engl', 'j', 'med', '', '2006', '', '354', '', '2564-2575crossrefpubmedscopus', '', '2068', '', 'strategy', 'show', 'prevent', 'ards', '', 'include', 'conservative', 'blood', 'product', '', 'early', 'identification', 'treatment', 'sepsis', '', 'default', 'lung', 'protective', 'ventilation', '', 'intensivist', 'involvement', '', 'despite', 'decade', 'data', 'agreed-upon', 'standard', 'care', 'ards', '', 'suggestedvia', 'journal', 'article', '', 'medical', 'blog', '', 'news', 'site', '', 'social', 'mediathat', 'several', 'standard', 'abandon', 'patient', 'respiratory', 'failure', 'covid-19', '', 'argue', 'covid-19', 'cause', 'form', 'ards', 'different', 'claim', 'traditional', 'typical', 'ards', 'therefore', 'treat', 'differently', '', 'evidence', 'support', 'claim', 'poor', 'absent', '', 'example', '', 'common', 'refrain', 'patient', 'ards', 'covid-19', 'higher', 'lung', 'compliance', 'worse', 'oxygenation', 'traditional', 'ards', '', 'however', '', 'publish', 'compliance', 'data', 'patient', 'ards', 'covid-19', 'largely', 'consistent', 'data', 'ards', 'trial', 'predate', 'pandemic', '', 'furthermore', '', 'publish', 'preprint', 'tissue', 'analysis', 'available', 'biopsy', 'autopsy', 'specimen', 'show', 'diffuse', 'alveolar', 'damage', 'typically', 'ards', 'cause', '', 'similarly', '', 'much', 'attention', 'pay', 'presence', 'extensive', 'pulmonary', 'microthrombosis', 'patient', 'ards', 'covid-19', '', 'observation', 'ards', '30', 'year', 'ago', '', 'certainly', 'possible', '', 'perhaps', 'likely', '', 'ards', 'covid-19', 'unique', 'feature', '', 'ards', 'pneumonia', '', 'pancreatitis', '', 'gastric', 'aspiration', 'probably', 'unique', 'feature', '', 'definition', 'ards', 'syndrome', '', 'disease', '', 'disentangle', 'subtypes', 'ards', 'active', 'promise', 'field', '', 'bulk', 'clinical', 'trial', 'data', 'date', 'patient', 'ards', 'vary', 'cause', '', 'include', 'viral', 'pneumonia', '', 'absence', 'evidence', 'contrary', '', 'prove', 'therapy', 'ards', '', 'low', 'tidal', 'volume', 'ventilation', '', 'prone', 'position', '', 'conservative', 'fluid', 'strategy', '', 'remain', 'standard', 'care', 'patient', 'ards', '', 'include', 'patient', 'covid-19', '', 'clinician', 'care', 'patient', 'die', 'covid-19', '', 'yearn', 'novel', 'therapy', 'novel', 'disease', '', 'recognise', 'appreciate', 'scientific', 'value', 'expert', 'observation', '', 'indeed', '', 'crucial', 'identify', 'aspect', 'management', 'truly', 'equipoise', 'thus', 'indication', 'rigorous', 'study', '', 'prompt', 'collection', 'data', 'must', 'prioritise', 'arm', 'appropriate', 'evidence', 'fight', 'inevitable', 'second', 'surge', 'arrive', '', 'history', 'tell', 'u', 'pandemic', 'justification', 'abandon', 'basic', 'principle', 'evidence-based', 'medicine', '', 'fact', '', 'adhere', 'value', 'never', 'important', '', 'view', 'large', 'image', 'copyright', '', '2020', 'tek', 'imagescience', 'photo', 'library', 'view', 'large', 'image', 'copyright', '', '2020', 'tek', 'imagescience', 'photo', 'library', 'declare', 'compete', 'interest', '']",874,"{'': 147, 'ards': 22, 'patient': 13, 'covid-19': 12, 'therapy': 9, 'j': 7, 'influenza': 7, 'acute': 7, 'ebola': 6, 'show': 6, 'pandemic': 6, 'care': 6, 'lung': 6, 'respiratory': 6, 'disease': 5, 'trial': 5, 'engl': 5, 'med': 5, 'sepsis': 5, 'syndrome': 5}",{'hydroxychloroquine': 1},1,-0.9451
DOI:10.1016/S2215-0366(20)30141-3,10.1016/S2215-0366(20)30141-3,Correspondence,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['covid-19', '', 'unemployment', '', 'suicide']","['The COVID-19 pandemic lead introduction strong restrictive measure substantial effect global economy , include increase unemployment rate worldwide.1International Labor OrganizationAlmost 25 million job could lose worldwide result COVID-19 , say ILO .', 'urlplaceholder March 18 , 2020Date access : March 24 , 2020Google Scholar In previous study,2Nordt C Warnke I Seifritz E Kawohl W Modelling suicide unemployment : longitudinal analysis cover 63 country , 2000–11.Lancet Psychiatry .', '2015 ; 2 : 239-245SummaryFull TextFull Text PDFPubMedScopus ( 82 ) Google Scholar model effect unemployment suicide basis global public data 63 country , observe suicide risk elevate 20–30 % associate unemployment 2000–11 ( include 2008 economic crisis ) .', 'We use model predict effect currently expect rise unemployment rate suicide rate .', 'Close 800 000 people die suicide every year.3WHOSuicide prevention .', ""urlplaceholder # tab=tab_1Date access : March 24 , 2020Google Scholar We use core model 's estimate ( intercept , sex , age group , unemployment ) 2Nordt C Warnke I Seifritz E Kawohl W Modelling suicide unemployment : longitudinal analysis cover 63 country , 2000–11.Lancet Psychiatry ."", '2015 ; 2 : 239-245SummaryFull TextFull Text PDFPubMedScopus ( 82 ) Google Scholar describe non-linear connection unemployment suicide .', 'We apply overall estimate World Bank Open Data ( ie , worldwide number labour force 2019 , unemployment rate [ model estimate International Labour Organization ] 2019 , male female population 2018 four age group ) .', 'Because model predict 671 301 suicide data , instead 800 000 , add correction term 0·17 address difference space ( 194 v 63 country ) time ( 2020 v 2000 ) .', ""The expect number job loss due COVID-19 take International Labour Organization 's press release March 18 , 2020,1International Labor OrganizationAlmost 25 million job could lose worldwide result COVID-19 , say ILO ."", 'urlplaceholder March 18 , 2020Date access : March 24 , 2020Google Scholar report decline 24·7 million job high scenario 5·3 million job lose low scenario .', 'In high scenario , worldwide unemployment rate would increase 4·936 % 5·644 % , would associate increase suicide 9570 per year .', 'In low scenario , unemployment would increase 5·088 % , associate increase 2135 suicide .', 'According WHO , suicide population accompany 20 suicide attempts.3WHOSuicide prevention .', 'urlplaceholder # tab=tab_1Date access : March 24 , 2020Google Scholar Thus , number mentally distress people might seek help mental health service expect increase context COVID-19 pandemic .', 'Data economic crisis 2008 show increase suicide precede actual rise unemployment rate.2Nordt C Warnke I Seifritz E Kawohl W Modelling suicide unemployment : longitudinal analysis cover 63 country , 2000–11.Lancet Psychiatry .', '2015 ; 2 : 239-245SummaryFull TextFull Text PDFPubMedScopus ( 82 ) Google Scholar We therefore expect extra burden mental health system , medical community prepare challenge .', 'Mental health provider also raise awareness politics society rise unemployment associate increase number suicide .', 'The downsize economy focus medical system COVID-19 pandemic lead unintended long-term problem vulnerable group fringe society .', 'It important various service , hotlines psychiatric service , remain able respond appropriately .', 'We declare compete interest .']","['covid-19', 'pandemic', 'lead', 'strong', 'restrictive', 'measure', 'substantial', 'effect', 'global', 'economy', '', 'include', 'increase', 'unemployment', 'rate', 'worldwide1international', 'labor', 'organizationalmost', '25', 'million', 'job', 'lose', 'worldwide', 'result', 'covid-19', '', 'ilo', '', 'urlplaceholder', 'march', '18', '', '2020date', 'access', '', 'march', '24', '', '2020google', 'previous', 'study2nordt', 'c', 'warnke', 'seifritz', 'e', 'kawohl', 'w', 'modelling', 'suicide', 'unemployment', '', 'longitudinal', 'analysis', 'cover', '63', 'country', '', '200011lancet', 'psychiatry', '', '2015', '', '2', '', '239-245summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '82', '', 'model', 'effect', 'unemployment', 'suicide', 'basis', 'global', 'public', 'data', '63', 'country', '', 'observe', 'suicide', 'risk', 'elevate', '2030', '', 'associate', 'unemployment', '200011', '', 'include', '2008', 'economic', 'crisis', '', '', 'model', 'predict', 'effect', 'currently', 'expect', 'rise', 'unemployment', 'rate', 'suicide', 'rate', '', 'close', '800', '000', 'people', 'die', 'suicide', 'every', 'year3whosuicide', 'prevention', '', 'urlplaceholder', '', 'tabtab1date', 'access', '', 'march', '24', '', '2020google', 'core', 'model', 'estimate', '', 'intercept', '', 'sex', '', 'age', 'group', '', 'unemployment', '', '2nordt', 'c', 'warnke', 'seifritz', 'e', 'kawohl', 'w', 'modelling', 'suicide', 'unemployment', '', 'longitudinal', 'analysis', 'cover', '63', 'country', '', '200011lancet', 'psychiatry', '', '2015', '', '2', '', '239-245summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '82', '', 'describe', 'non-linear', 'connection', 'unemployment', 'suicide', '', 'apply', 'overall', 'estimate', 'world', 'bank', 'open', 'data', '', 'ie', '', 'worldwide', 'number', 'labour', 'force', '2019', '', 'unemployment', 'rate', '', 'model', 'estimate', 'international', 'labour', 'organization', '', '2019', '', 'male', 'female', 'population', '2018', 'four', 'age', 'group', '', '', 'model', 'predict', '671', '301', 'suicide', 'data', '', 'instead', '800', '000', '', 'add', 'correction', 'term', '017', 'address', 'difference', 'space', '', '194', 'v', '63', 'country', '', 'time', '', '2020', 'v', '2000', '', '', 'expect', 'number', 'job', 'loss', 'due', 'covid-19', 'international', 'labour', 'organization', 'press', 'release', 'march', '18', '', '20201international', 'labor', 'organizationalmost', '25', 'million', 'job', 'lose', 'worldwide', 'result', 'covid-19', '', 'ilo', '', 'urlplaceholder', 'march', '18', '', '2020date', 'access', '', 'march', '24', '', '2020google', 'report', 'decline', '247', 'million', 'job', 'high', 'scenario', '53', 'million', 'job', 'lose', 'low', 'scenario', '', 'high', 'scenario', '', 'worldwide', 'unemployment', 'rate', 'increase', '4936', '', '5644', '', '', 'associate', 'increase', 'suicide', '9570', 'per', 'year', '', 'low', 'scenario', '', 'unemployment', 'increase', '5088', '', '', 'associate', 'increase', '2135', 'suicide', '', 'according', '', 'suicide', 'population', 'accompany', '20', 'suicide', 'attempts3whosuicide', 'prevention', '', 'urlplaceholder', '', 'tabtab1date', 'access', '', 'march', '24', '', '2020google', 'thus', '', 'number', 'mentally', 'distress', 'people', 'seek', 'help', 'mental', 'health', 'service', 'expect', 'increase', 'context', 'covid-19', 'pandemic', '', 'data', 'economic', 'crisis', '2008', 'show', 'increase', 'suicide', 'precede', 'actual', 'rise', 'unemployment', 'rate2nordt', 'c', 'warnke', 'seifritz', 'e', 'kawohl', 'w', 'modelling', 'suicide', 'unemployment', '', 'longitudinal', 'analysis', 'cover', '63', 'country', '', '200011lancet', 'psychiatry', '', '2015', '', '2', '', '239-245summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '82', '', 'therefore', 'expect', 'extra', 'burden', 'mental', 'health', 'system', '', 'medical', 'community', 'prepare', 'challenge', '', 'mental', 'health', 'provider', 'raise', 'awareness', 'politics', 'society', 'rise', 'unemployment', 'associate', 'increase', 'number', 'suicide', '', 'downsize', 'economy', 'focus', 'medical', 'system', 'covid-19', 'pandemic', 'lead', 'unintended', 'long-term', 'problem', 'vulnerable', 'group', 'fringe', 'society', '', 'important', 'various', 'service', '', 'hotlines', 'psychiatric', 'service', '', 'remain', 'able', 'respond', 'appropriately', '', 'declare', 'compete', 'interest', '']",467,"{'': 89, 'suicide': 15, 'unemployment': 14, 'increase': 8, 'march': 7, 'covid-19': 6, 'rate': 5, 'job': 5, '63': 5, 'country': 5, 'model': 5, 'million': 4, 'worldwide': 4, 'urlplaceholder': 4, 'access': 4, '24': 4, '2020google': 4, 'data': 4, 'associate': 4, 'expect': 4}",{},0,-0.981
DOI:10.1016/S2215-0366(20)30142-5,10.1016/S2215-0366(20)30142-5,Correspondence,2020-05-21 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['suicide', 'prevention', 'covid-19', 'outbreak']","[""Publications mental health psychosocial consideration COVID-19 outbreak1Inter-Agency Standing CommitteeInterim brief note address mental health psychosocial aspect COVID-19 outbreak ( develop IASC 's reference group mental health psychosocial support ) ."", 'urlplaceholder March 17 , 2020Date access : March 24 , 2020Google Scholar , 2WHOMental health psychosocial consideration COVID-19 outbreak .', 'urlplaceholder March 12 , 2020Date access : March 24 , 2020Google Scholar psychological effect quarantine3Brooks S Webster R Smith L et al.The psychological impact quarantine reduce : rapid review evidence.Lancet .', '2020 ; 395 : 912-920SummaryFull TextFull Text PDFPubMedScopus ( 41 ) Google Scholar provide important information recommendation .', 'These important publication translate field three level suicide prevention : primary , secondary , tertiary .', 'These publication include section urgent mental health issue depression2WHOMental health psychosocial consideration COVID-19 outbreak .', ""urlplaceholder March 12 , 2020Date access : March 24 , 2020Google Scholar severe psychiatric conditions,1Inter-Agency Standing CommitteeInterim brief note address mental health psychosocial aspect COVID-19 outbreak ( develop IASC 's reference group mental health psychosocial support ) ."", 'urlplaceholder March 17 , 2020Date access : March 24 , 2020Google Scholar directly address specific recommendation suicide prevention need .', 'The COVID-19 outbreak emotionally challenge everyone , especially individual already risk ( eg , suffer depression ) .', 'During follow COVID-19 outbreak outcome isolation quarantine , might see increase suicide ideation behaviour among at-risk populations.4Chan S Chiu F Lam C Leung P Conwell Y Elderly suicide 2003 SARS epidemic Hong Kong.Int J Geriatr Psychiatry .', '2006 ; 21 : 113-118CrossrefPubMedScopus ( 19 ) Google Scholar Whether increase short long term ( ) remain unclear , mental health community prepare use challenge period advance suicide prevention .', 'First , people currently able past talk depression , anxiety , suicide ideation .', 'It appear share experience negative emotion carry le stigma use .', 'Moreover , death become topic age readily talk , might easier people mental health provider ask directly suicide risk .', 'Second , people understand importance social support time crisis tend agree save life .', 'Finally , people risk suicide get psychological help online , might accessible various reason ( eg , reduce stigma removal transportation time barrier ) .', 'The medical community need make sure online provider ass suicide risk provide specific suicide prevention interventions.5Stanley B Brown G Safety plan intervention : brief intervention mitigate suicide risk.Cogn Behav Pract .', '2012 ; 19 : 256-264CrossrefScopus ( 280 ) Google Scholar Mental health provider directly convey every patient case severe crisis , hurt .', 'It always priority mental health provider reinforce patient always hope several solution problem .', 'The challenge COVID-19 outbreak might bring opportunity advance field suicide prevention thus save life .', 'These suicide prevention effort integrate overall reaction programme deal COVID-19 crisis .', 'I declare compete interest .']","['publications', 'mental', 'health', 'psychosocial', 'consideration', 'covid-19', 'outbreak1inter-agency', 'standing', 'committeeinterim', 'brief', 'note', 'address', 'mental', 'health', 'psychosocial', 'aspect', 'covid-19', 'outbreak', '', 'develop', 'iasc', 'reference', 'group', 'mental', 'health', 'psychosocial', 'support', '', '', 'urlplaceholder', 'march', '17', '', '2020date', 'access', '', 'march', '24', '', '2020google', '', '2whomental', 'health', 'psychosocial', 'consideration', 'covid-19', 'outbreak', '', 'urlplaceholder', 'march', '12', '', '2020date', 'access', '', 'march', '24', '', '2020google', 'psychological', 'effect', 'quarantine3brooks', 'webster', 'r', 'smith', 'l', 'althe', 'psychological', 'impact', 'quarantine', 'reduce', '', 'rapid', 'review', 'evidencelancet', '', '2020', '', '395', '', '912-920summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '41', '', 'provide', 'important', 'information', 'recommendation', '', 'important', 'publication', 'translate', 'field', 'three', 'level', 'suicide', 'prevention', '', 'primary', '', 'secondary', '', 'tertiary', '', 'publication', 'include', 'section', 'urgent', 'mental', 'health', 'issue', 'depression2whomental', 'health', 'psychosocial', 'consideration', 'covid-19', 'outbreak', '', 'urlplaceholder', 'march', '12', '', '2020date', 'access', '', 'march', '24', '', '2020google', 'severe', 'psychiatric', 'conditions1inter-agency', 'standing', 'committeeinterim', 'brief', 'note', 'address', 'mental', 'health', 'psychosocial', 'aspect', 'covid-19', 'outbreak', '', 'develop', 'iasc', 'reference', 'group', 'mental', 'health', 'psychosocial', 'support', '', '', 'urlplaceholder', 'march', '17', '', '2020date', 'access', '', 'march', '24', '', '2020google', 'directly', 'address', 'specific', 'recommendation', 'suicide', 'prevention', '', 'covid-19', 'outbreak', 'emotionally', 'challenge', 'everyone', '', 'especially', 'individual', 'already', 'risk', '', 'eg', '', 'suffer', 'depression', '', '', 'follow', 'covid-19', 'outbreak', 'outcome', 'isolation', 'quarantine', '', 'increase', 'suicide', 'ideation', 'behaviour', 'among', 'at-risk', 'populations4chan', 'chiu', 'f', 'lam', 'c', 'leung', 'p', 'conwell', 'elderly', 'suicide', '2003', 'sars', 'epidemic', 'hong', 'kongint', 'j', 'geriatr', 'psychiatry', '', '2006', '', '21', '', '113-118crossrefpubmedscopus', '', '19', '', 'whether', 'increase', 'short', 'long', 'term', '', '', 'remain', 'unclear', '', 'mental', 'health', 'community', 'prepare', 'challenge', 'period', 'advance', 'suicide', 'prevention', '', 'first', '', 'people', 'currently', 'able', 'past', 'talk', 'depression', '', 'anxiety', '', 'suicide', 'ideation', '', 'appear', 'share', 'experience', 'negative', 'emotion', 'carry', 'le', 'stigma', '', 'moreover', '', 'death', 'become', 'topic', 'age', 'readily', 'talk', '', 'easier', 'people', 'mental', 'health', 'provider', 'ask', 'directly', 'suicide', 'risk', '', 'second', '', 'people', 'understand', 'importance', 'social', 'support', 'time', 'crisis', 'tend', 'agree', 'save', 'life', '', 'finally', '', 'people', 'risk', 'suicide', 'psychological', 'help', 'online', '', 'accessible', 'various', 'reason', '', 'eg', '', 'reduce', 'stigma', 'removal', 'transportation', 'time', 'barrier', '', '', 'medical', 'community', 'sure', 'online', 'provider', 'ass', 'suicide', 'risk', 'provide', 'specific', 'suicide', 'prevention', 'interventions5stanley', 'b', 'brown', 'g', 'safety', 'plan', 'intervention', '', 'brief', 'intervention', 'mitigate', 'suicide', 'riskcogn', 'behav', 'pract', '', '2012', '', '19', '', '256-264crossrefscopus', '', '280', '', 'mental', 'health', 'provider', 'directly', 'convey', 'every', 'patient', 'case', 'severe', 'crisis', '', 'hurt', '', 'always', 'priority', 'mental', 'health', 'provider', 'reinforce', 'patient', 'always', 'hope', 'several', 'solution', 'problem', '', 'challenge', 'covid-19', 'outbreak', 'bring', 'opportunity', 'advance', 'field', 'suicide', 'prevention', 'thus', 'save', 'life', '', 'suicide', 'prevention', 'effort', 'integrate', 'overall', 'reaction', 'programme', 'deal', 'covid-19', 'crisis', '', 'declare', 'compete', 'interest', '']",421,"{'': 76, 'suicide': 13, 'health': 12, 'mental': 10, 'covid-19': 9, 'march': 8, 'psychosocial': 7, 'outbreak': 7, 'prevention': 6, 'urlplaceholder': 4, '2020date': 4, 'access': 4, '24': 4, '2020google': 4, 'risk': 4, 'people': 4, 'provider': 4, 'consideration': 3, 'brief': 3, 'address': 3}",{'safety': 1},1,0.4019
DOI:10.1016/S0140-6736(20)31191-0,10.1016/S0140-6736(20)31191-0,Comment,2020-05-20 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['attacks', 'health-care', 'personnel', 'must', 'stop', '', 'especially', 'world', 'fight', 'covid-19']","['Physicians , nurse , front-line health-care worker celebrate many country hero work COVID-19 pandemic .', 'Yet everyone appreciate effort contribution .', 'Since begin pandemic , headline also capture story health-care personnel face attack travel health-care facility .', 'Nurses doctor pelt egg physically assault Mexico.1Semple K “ Afraid nurse ” : health worker attack.The New York Times .', 'April 27 , 2020 ; Google Scholar In Philippines , nurse reportedly attack men pour bleach face , damage vision.2The EconomistHealth worker become unexpected target COVID-19.The Economist .', 'May 11 , 2020 ; Google Scholar Across India , report describe health-care worker beat , stone , spat , threaten , evict homes.3Withnall A Coronavirus : India pas new law attack healthcare workers.The Independent .', 'April 23 , 2020 ; Google Scholar These example among many across numerous country , include USA Australia.2The EconomistHealth worker become unexpected target COVID-19.The Economist .', 'May 11 , 2020 ; Google Scholar Sadly , violence health-care personnel new phenomenon .', 'Before COVID-19 pandemic , attack increasingly document clinic hospital worldwide.3Withnall A Coronavirus : India pas new law attack healthcare workers.The Independent .', 'April 23 , 2020 ; Google Scholar , 4WHOViolence health worker .', 'urlplaceholder 2020Date access : May 3 , 2020Google Scholar Attacks health-care worker health-care facility also occur deplorable tactic war defy international humanitarian human right law .', 'In May , 2020 , arm attack hospital maternity ward Kabul , Afghanistan , kill least 24 civilian , include two infants.5BBC NewsAfghan attack : maternity ward death toll climb 24.BBC News .', 'May 13 , 2020 ; Google Scholar And midst humanitarian emergency thousand people displace opposition-held area northwest Syria , Syrian Government continue bomb health-care facility region.6Physicians Human RightsIllegal attack health care Syria .', 'Physicians Human Rights .', 'urlplaceholder # /enDate : 2020Date access : May 16 , 2020Google Scholar Acts violence context must condemn .', 'What make current attack specifically horrify health-care personnel respond crisis deeply affect society .', 'Governmental failure country adequately provide manage resource pandemic mean health-care personnel risk life daily care COVID-19 patient without adequate personal protective equipment safety measure workplaces.7Horton R Coronavirus greatest global science policy failure generation.The Guardian .', 'April 9 , 2020 ; Google Scholar As result , thousand health-care worker worldwide contract severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) thus perceive public health hazard themselves.8Mantovani C 90 000 healthcare worker infect COVID-19 : nurse group.Reuters World News .', 'May 6 , 2020 ; Google Scholar This situation generate violence place , essentially perform professional duty .', 'This response likely exacerbate already unprecedented COVID-19-related stress burnout health-care worker family experience pandemic .', 'With COVID-19 pandemic tax health-care system almost every country , assault health-care worker assault u .', 'We depend health wellbeing continue provide care individual , family , community without COVID-19 .', 'The reason people attack abuse health-care personnel health emergency many , local context vary .', 'In set COVID-19 pandemic , fear , panic , misinformation SARS-CoV-2 spread , misplace anger likely driver .', 'A government leader respond announce swift , case , draconian punishment attack health-care workers.9The Economic TimesCabinet okay ordinance protect frontline workers.The Economic Times .', 'April 22 , 2020 ; Google Scholar Yet threat retribution address cause violence alone unlikely curtail attack .', 'Effective response must address root cause .', 'We recommend follow action take immediately .', 'First , collect data incidence type attack health-care personnel , include context COVID-19 pandemic , country fully understand scope problem design intervention prevent respond attack .', 'National international body WHO must engage coordinate global effort .', 'And initiative must incorporate lesson learn previous effort document violence health-care personnel , attack lead polio vaccination campaign care patient Ebola virus disease.10Burke J Ebola health worker kill injure rebel attack Congo.The Guardian .', 'Nov 28 , 2019 ; Google Scholar Data attack specific COVID-19 systematically gather include WHO Surveillance System Attacks Healthcare .', 'Global support member state community effort essential achieve robust surveillance system .', 'National data collect ministry health occupational health safety body .', 'Mechanisms analyse , share , widely disseminate information violence health-care personnel need develop expand , follow example report Safeguarding Health Conflict Coalition11Safeguarding Health Conflict CoalitionImpunity remain : attack health care 23 country conflict .', 'urlplaceholder May , 2019Date access : May 3 , 2020Google Scholar data gather Insecurity Insight,12Insecurity InsightAttacks health care .', 'urlplaceholder 2020Date access : May 16 , 2020Google Scholar among others .', 'View Large Image Copyright © 2020 Jose Luis Gonzales/Reuters View Large Image Copyright © 2020 Jose Luis Gonzales/Reuters Second , attack health-care personnel must prevent condemn .', 'Partnerships prevention violence must forge .', 'Local state government must partner civil society , community-based group , medium organisation highlight problem attack health-care worker engage community prevention , bystander intervention , report .', 'The Health Care Danger team International Committee Red Cross , example , recently publish checklist prevent violence health-care worker COVID-19 response , include recommendation communication collaboration.13International Committee Red CrossSafer COVID-19 response : checklist health-care service .', 'urlplaceholder May , 2020Date access : May 16 , 2020Google Scholar Third , misinformation disinformation COVID-19 must counter .', 'Widespread misinformation disinformation COVID-19 , include conspiracy theory , contribute demonisation certain group health-care workers.14Beaumont P Borger J Boffey D Malicious force create “ perfect storm ” coronavirus disinformation.The Guardian .', 'April 24 , 2020 ; Google Scholar Governments , international collaborative body , social medium company must refine expand effective public information campaign keep member public inform educate correct misinformation .', 'These include clear concise information SARS-CoV-2 spread science behind response measure .', 'In face high level community distrust many place , active engagement key trust community stakeholder organisation information campaign also essential success .', 'Fourth , accountability need .', 'We must demand strong yet responsible enforcement action perpetrator attack local national government .', 'Violence health-care personnel meet swift response law enforcement legal system .', 'Local law enforcement authority must fully investigate report incident , objective , evidence-based process .', 'Full accountability crime must ensure perpetrator must hold accountable .', 'Fifth , state local government invest health security measure protect health-care worker part COVID-19 emergency budget .', 'Funding protection health-care personnel health facility need .', 'Finally , health professional association , society , organisation specialty discipline unite speak forcefully act discrimination , intimidation , violence health-care workers.15International Council NursesICN call government action stop attack nurse time mental health wellbeing already threat COVID-19 pandemic .', 'urlplaceholder April 29 , 2020Date access : May 3 , 2020Google Scholar They must immediately condemn violence occur participate initiative aim respond eliminate violence .', 'These action must take .', 'By protect health-care personnel , protect valuable asset fight COVID-19 : doctor , nurse , emergency medical technician , medical respiratory technician , laboratory worker , many others front line .', 'We declare compete interest .', 'We thank Susannah Sirkin Physicians Human Rights , Erica Burton International Council Nurses , Erin Downey , visit scientist Harvard Humanitarian Initiative , input Comment .']","['physicians', '', 'nurse', '', 'front-line', 'health-care', 'worker', 'celebrate', 'country', 'hero', 'work', 'covid-19', 'pandemic', '', 'yet', 'everyone', 'appreciate', 'effort', 'contribution', '', 'since', 'begin', 'pandemic', '', 'headline', 'capture', 'story', 'health-care', 'personnel', 'face', 'attack', 'travel', 'health-care', 'facility', '', 'nurses', 'doctor', 'pelt', 'egg', 'physically', 'assault', 'mexico1semple', 'k', '', 'afraid', 'nurse', '', '', 'health', 'worker', 'attackthe', 'new', 'york', 'times', '', 'april', '27', '', '2020', '', 'philippines', '', 'nurse', 'reportedly', 'attack', 'men', 'pour', 'bleach', 'face', '', 'damage', 'vision2the', 'economisthealth', 'worker', 'become', 'unexpected', 'target', 'covid-19the', 'economist', '', '11', '', '2020', '', 'across', 'india', '', 'report', 'describe', 'health-care', 'worker', 'beat', '', 'stone', '', 'spat', '', 'threaten', '', 'evict', 'homes3withnall', 'coronavirus', '', 'india', 'pas', 'new', 'law', 'attack', 'healthcare', 'workersthe', 'independent', '', 'april', '23', '', '2020', '', 'example', 'among', 'across', 'numerous', 'country', '', 'include', 'usa', 'australia2the', 'economisthealth', 'worker', 'become', 'unexpected', 'target', 'covid-19the', 'economist', '', '11', '', '2020', '', 'sadly', '', 'violence', 'health-care', 'personnel', 'new', 'phenomenon', '', 'covid-19', 'pandemic', '', 'attack', 'increasingly', 'document', 'clinic', 'hospital', 'worldwide3withnall', 'coronavirus', '', 'india', 'pas', 'new', 'law', 'attack', 'healthcare', 'workersthe', 'independent', '', 'april', '23', '', '2020', '', '', '4whoviolence', 'health', 'worker', '', 'urlplaceholder', '2020date', 'access', '', '3', '', '2020google', 'attacks', 'health-care', 'worker', 'health-care', 'facility', 'occur', 'deplorable', 'tactic', 'war', 'defy', 'international', 'humanitarian', 'human', 'law', '', '', '2020', '', 'arm', 'attack', 'hospital', 'maternity', 'ward', 'kabul', '', 'afghanistan', '', 'kill', 'least', '24', 'civilian', '', 'include', 'two', 'infants5bbc', 'newsafghan', 'attack', '', 'maternity', 'ward', 'death', 'toll', 'climb', '24bbc', 'news', '', '13', '', '2020', '', 'midst', 'humanitarian', 'emergency', 'thousand', 'people', 'displace', 'opposition-held', 'area', 'northwest', 'syria', '', 'syrian', 'government', 'continue', 'bomb', 'health-care', 'facility', 'region6physicians', 'human', 'rightsillegal', 'attack', 'health', 'care', 'syria', '', 'physicians', 'human', 'rights', '', 'urlplaceholder', '', 'endate', '', '2020date', 'access', '', '16', '', '2020google', 'acts', 'violence', 'context', 'must', 'condemn', '', 'current', 'attack', 'specifically', 'horrify', 'health-care', 'personnel', 'respond', 'crisis', 'deeply', 'affect', 'society', '', 'governmental', 'failure', 'country', 'adequately', 'provide', 'manage', 'resource', 'pandemic', 'mean', 'health-care', 'personnel', 'risk', 'life', 'daily', 'care', 'covid-19', 'patient', 'without', 'adequate', 'personal', 'protective', 'equipment', 'safety', 'measure', 'workplaces7horton', 'r', 'coronavirus', 'greatest', 'global', 'science', 'policy', 'failure', 'generationthe', 'guardian', '', 'april', '9', '', '2020', '', 'result', '', 'thousand', 'health-care', 'worker', 'worldwide', 'contract', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'thus', 'perceive', 'public', 'health', 'hazard', 'themselves8mantovani', 'c', '90', '000', 'healthcare', 'worker', 'infect', 'covid-19', '', 'nurse', 'groupreuters', 'world', 'news', '', '6', '', '2020', '', 'situation', 'generate', 'violence', 'place', '', 'essentially', 'perform', 'professional', 'duty', '', 'response', 'likely', 'exacerbate', 'already', 'unprecedented', 'covid-19-related', 'stress', 'burnout', 'health-care', 'worker', 'family', 'experience', 'pandemic', '', 'covid-19', 'pandemic', 'tax', 'health-care', 'system', 'almost', 'every', 'country', '', 'assault', 'health-care', 'worker', 'assault', 'u', '', 'depend', 'health', 'wellbeing', 'continue', 'provide', 'care', 'individual', '', 'family', '', 'community', 'without', 'covid-19', '', 'reason', 'people', 'attack', 'abuse', 'health-care', 'personnel', 'health', 'emergency', '', 'local', 'context', 'vary', '', 'set', 'covid-19', 'pandemic', '', 'fear', '', 'panic', '', 'misinformation', 'sars-cov-2', 'spread', '', 'misplace', 'anger', 'likely', 'driver', '', 'government', 'leader', 'respond', 'announce', 'swift', '', 'case', '', 'draconian', 'punishment', 'attack', 'health-care', 'workers9the', 'economic', 'timescabinet', 'okay', 'ordinance', 'protect', 'frontline', 'workersthe', 'economic', 'times', '', 'april', '22', '', '2020', '', 'yet', 'threat', 'retribution', 'address', 'cause', 'violence', 'alone', 'unlikely', 'curtail', 'attack', '', 'effective', 'response', 'must', 'address', 'root', 'cause', '', 'recommend', 'follow', 'action', 'immediately', '', 'first', '', 'collect', 'data', 'incidence', 'type', 'attack', 'health-care', 'personnel', '', 'include', 'context', 'covid-19', 'pandemic', '', 'country', 'fully', 'understand', 'scope', 'problem', 'design', 'intervention', 'prevent', 'respond', 'attack', '', 'national', 'international', 'body', 'must', 'engage', 'coordinate', 'global', 'effort', '', 'initiative', 'must', 'incorporate', 'lesson', 'learn', 'previous', 'effort', 'document', 'violence', 'health-care', 'personnel', '', 'attack', 'lead', 'polio', 'vaccination', 'campaign', 'care', 'patient', 'ebola', 'virus', 'disease10burke', 'j', 'ebola', 'health', 'worker', 'kill', 'injure', 'rebel', 'attack', 'congothe', 'guardian', '', 'nov', '28', '', '2019', '', 'data', 'attack', 'specific', 'covid-19', 'systematically', 'gather', 'include', 'surveillance', 'system', 'attacks', 'healthcare', '', 'global', 'support', 'member', 'state', 'community', 'effort', 'essential', 'achieve', 'robust', 'surveillance', 'system', '', 'national', 'data', 'collect', 'ministry', 'health', 'occupational', 'health', 'safety', 'body', '', 'mechanisms', 'analyse', '', 'share', '', 'widely', 'disseminate', 'information', 'violence', 'health-care', 'personnel', 'develop', 'expand', '', 'follow', 'example', 'report', 'safeguarding', 'health', 'conflict', 'coalition11safeguarding', 'health', 'conflict', 'coalitionimpunity', 'remain', '', 'attack', 'health', 'care', '23', 'country', 'conflict', '', 'urlplaceholder', '', '2019date', 'access', '', '3', '', '2020google', 'data', 'gather', 'insecurity', 'insight12insecurity', 'insightattacks', 'health', 'care', '', 'urlplaceholder', '2020date', 'access', '', '16', '', '2020google', 'among', 'others', '', 'view', 'large', 'image', 'copyright', '', '2020', 'jose', 'luis', 'gonzalesreuters', 'view', 'large', 'image', 'copyright', '', '2020', 'jose', 'luis', 'gonzalesreuters', 'second', '', 'attack', 'health-care', 'personnel', 'must', 'prevent', 'condemn', '', 'partnerships', 'prevention', 'violence', 'must', 'forge', '', 'local', 'state', 'government', 'must', 'partner', 'civil', 'society', '', 'community-based', 'group', '', 'medium', 'organisation', 'highlight', 'problem', 'attack', 'health-care', 'worker', 'engage', 'community', 'prevention', '', 'bystander', 'intervention', '', 'report', '', 'health', 'care', 'danger', 'team', 'international', 'committee', 'red', 'cross', '', 'example', '', 'recently', 'publish', 'checklist', 'prevent', 'violence', 'health-care', 'worker', 'covid-19', 'response', '', 'include', 'recommendation', 'communication', 'collaboration13international', 'committee', 'red', 'crosssafer', 'covid-19', 'response', '', 'checklist', 'health-care', 'service', '', 'urlplaceholder', '', '2020date', 'access', '', '16', '', '2020google', 'third', '', 'misinformation', 'disinformation', 'covid-19', 'must', 'counter', '', 'widespread', 'misinformation', 'disinformation', 'covid-19', '', 'include', 'conspiracy', 'theory', '', 'contribute', 'demonisation', 'certain', 'group', 'health-care', 'workers14beaumont', 'p', 'borger', 'j', 'boffey', 'malicious', 'force', 'create', '', 'perfect', 'storm', '', 'coronavirus', 'disinformationthe', 'guardian', '', 'april', '24', '', '2020', '', 'governments', '', 'international', 'collaborative', 'body', '', 'social', 'medium', 'company', 'must', 'refine', 'expand', 'effective', 'public', 'information', 'campaign', 'keep', 'member', 'public', 'inform', 'educate', 'correct', 'misinformation', '', 'include', 'clear', 'concise', 'information', 'sars-cov-2', 'spread', 'science', 'behind', 'response', 'measure', '', 'face', 'high', 'level', 'community', 'distrust', 'place', '', 'active', 'engagement', 'key', 'trust', 'community', 'stakeholder', 'organisation', 'information', 'campaign', 'essential', 'success', '', 'fourth', '', 'accountability', '', 'must', 'demand', 'strong', 'yet', 'responsible', 'enforcement', 'action', 'perpetrator', 'attack', 'local', 'national', 'government', '', 'violence', 'health-care', 'personnel', 'meet', 'swift', 'response', 'law', 'enforcement', 'legal', 'system', '', 'local', 'law', 'enforcement', 'authority', 'must', 'fully', 'investigate', 'report', 'incident', '', 'objective', '', 'evidence-based', 'process', '', 'full', 'accountability', 'crime', 'must', 'ensure', 'perpetrator', 'must', 'hold', 'accountable', '', 'fifth', '', 'state', 'local', 'government', 'invest', 'health', 'security', 'measure', 'protect', 'health-care', 'worker', 'part', 'covid-19', 'emergency', 'budget', '', 'funding', 'protection', 'health-care', 'personnel', 'health', 'facility', '', 'finally', '', 'health', 'professional', 'association', '', 'society', '', 'organisation', 'specialty', 'discipline', 'unite', 'speak', 'forcefully', 'act', 'discrimination', '', 'intimidation', '', 'violence', 'health-care', 'workers15international', 'council', 'nursesicn', 'call', 'government', 'action', 'stop', 'attack', 'nurse', 'time', 'mental', 'health', 'wellbeing', 'already', 'threat', 'covid-19', 'pandemic', '', 'urlplaceholder', 'april', '29', '', '2020date', 'access', '', '3', '', '2020google', 'must', 'immediately', 'condemn', 'violence', 'occur', 'participate', 'initiative', 'aim', 'respond', 'eliminate', 'violence', '', 'action', 'must', '', 'protect', 'health-care', 'personnel', '', 'protect', 'valuable', 'asset', 'fight', 'covid-19', '', 'doctor', '', 'nurse', '', 'emergency', 'medical', 'technician', '', 'medical', 'respiratory', 'technician', '', 'laboratory', 'worker', '', 'others', 'front', '', 'declare', 'compete', 'interest', '', 'susannah', 'sirkin', 'physicians', 'human', 'rights', '', 'erica', 'burton', 'international', 'council', 'nurses', '', 'erin', 'downey', '', 'visit', 'scientist', 'harvard', 'humanitarian', 'initiative', '', 'input', 'comment', '']",1066,"{'': 186, 'health-care': 29, 'attack': 22, 'health': 18, 'worker': 16, 'covid-19': 16, 'must': 15, '2020': 13, 'personnel': 12, 'violence': 12, 'pandemic': 9, 'april': 7, 'include': 7, 'care': 7, 'nurse': 6, 'country': 6, 'urlplaceholder': 6, 'access': 6, '2020google': 6, 'government': 6}","{'sars-cov-2': 3, 'safety': 2}",5,0.7845
DOI:10.1016/S2213-8587(20)30183-2,10.1016/S2213-8587(20)30183-2,In Focus,2020-05-20 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['vitamin-d', 'covid-19', '', 'deficient', 'risk', 'poorer', 'outcome', '']","['Despite difficulty compare data across nation , mortality COVID-19 clearly higher country others .', 'Many factor could role disparity , include difference proportion elderly people population , general health , accessibility quality healthcare , socioeconomic status .', 'One mostly overlook factor could influence outcome COVID-19 relative vitamin D status population .', 'Because people advise stay home much possible , government health agency Great Britain recommend people take vitamin D supplement summer autumn pandemic .', 'Vitamin D supplementation could especially important older people high risk poor outcome COVID-19 vitamin D deficiency .', 'Vitamin D well-characterised role calcium phosphate balance , affect bone growth turnover .', 'Low vitamin D status also associate non-communicable disease increase susceptibility infectious disease ; notably , upper respiratory tract infection .', 'However , whether low vitamin D level cause consequence disease remain point heat debate .', 'Intervention trial rarely show benefit vitamin D supplementation treatment preventive measure .', 'However , one important exception general trend upper respiratory tract infection : 2017 meta-analysis individual patient data 11 321 participant 25 randomise control trial show vitamin D supplementation protect acute respiratory tract infection patient low ( < 25 nmol/L ) serum 25-hydroxyvitamin D concentration ( marker vitamin D status ) gain benefit .', 'A grow body circumstantial evidence also specifically link outcome COVID-19 vitamin D status .', 'SARS-CoV-2 , virus responsible COVID-19 , emerge start spread Northern hemisphere end 2019 ( winter ) , level 25-hydroxyvitamin D nadir .', 'Also , nation northern hemisphere bear much burden case mortality .', 'In cross-sectional analysis across Europe , COVID-19 mortality significantly associate vitamin D status different population .', 'The low mortality rate Nordic country exception trend towards poorer outcome northerly latitude , population country relatively vitamin D sufficient owe widespread fortification food .', 'Italy Spain also exception , prevalence vitamin D deficiency population surprisingly common .', 'Additionally , black minority ethnic people—who likely vitamin D deficiency darker skin—seem worse affect white people COVID-19 .', 'For example , data UK Office National Statistics show black people England Wales four time likely die COVID-19 white people .', 'A role vitamin D response COVID-19 infection could twofold .', 'First , vitamin D support production antimicrobial peptide respiratory epithelium , thus make infection virus development COVID-19 symptom le likely .', 'Second , vitamin D might help reduce inflammatory response infection SARS-CoV-2 .', 'Deregulation response , especially renin–angiotensin system , characteristic COVID-19 degree overactivation associate poorer prognosis .', 'Vitamin D know interact protein pathway—angiotensin-converting enzyme 2 ( ACE2 ) —which also exploit SARS-CoV-2 entry receptor .', 'While SARS-CoV-2 downregulates expression ACE2 , vitamin D promote expression gene .', 'Rose Anne Kenny ( Trinity College Dublin , University Dublin , Ireland ) lead cross-sectional study mortality vitamin D status lead investigator Irish Longitudinal Study Ageing ( TILDA ) .', 'She adamant recommendation public health body population take vitamin D supplement pandemic .', '“ The circumstantial evidence strong ” , proclaim regard potential effect COVID-19 outcome .', ""Adding , “ n't randomise control trial evidence , long want wait context crisis ?"", 'We know vitamin D important musculoskeletal function , people take anyway ” .', 'Kenny recommend , least , vitamin D supplement give care home resident unless extremely good reason .', 'Adrian Martineau ( Institute Population Health Sciences , Barts The London , Queen Mary University London , UK ) , lead author 2017 meta-analysis join colleague university around UK launch COVIDENCE UK , study investigate diet lifestyle factor might influence transmission SARS-CoV-2 , severity COVID-19 symptom , speed recovery , long-term effect .', 'They aim recruit least 12 000 people obtain interim result summer .', ""Despite enthusiasm study , Martineau pragmatic : “ At best vitamin D deficiency one many factor involve determine outcome COVID-19 , 's problem could correct safely cheaply ; downside speak , good reason think might benefit ” ."", 'View Large Image Copyright © 2020 Shutterstock View Large Image Copyright © 2020 Shutterstock']","['despite', 'difficulty', 'compare', 'data', 'across', 'nation', '', 'mortality', 'covid-19', 'clearly', 'higher', 'country', 'others', '', 'factor', 'role', 'disparity', '', 'include', 'difference', 'proportion', 'elderly', 'people', 'population', '', 'general', 'health', '', 'accessibility', 'quality', 'healthcare', '', 'socioeconomic', 'status', '', 'one', 'mostly', 'overlook', 'factor', 'influence', 'outcome', 'covid-19', 'relative', 'vitamin', 'status', 'population', '', 'people', 'advise', 'stay', 'home', 'much', 'possible', '', 'government', 'health', 'agency', 'great', 'britain', 'recommend', 'people', 'vitamin', 'supplement', 'summer', 'autumn', 'pandemic', '', 'vitamin', 'supplementation', 'especially', 'important', 'older', 'people', 'high', 'risk', 'poor', 'outcome', 'covid-19', 'vitamin', 'deficiency', '', 'vitamin', 'well-characterised', 'role', 'calcium', 'phosphate', 'balance', '', 'affect', 'bone', 'growth', 'turnover', '', 'low', 'vitamin', 'status', 'associate', 'non-communicable', 'disease', 'increase', 'susceptibility', 'infectious', 'disease', '', 'notably', '', 'upper', 'respiratory', 'tract', 'infection', '', 'however', '', 'whether', 'low', 'vitamin', 'level', 'cause', 'consequence', 'disease', 'remain', 'point', 'heat', 'debate', '', 'intervention', 'trial', 'rarely', 'show', 'benefit', 'vitamin', 'supplementation', 'treatment', 'preventive', 'measure', '', 'however', '', 'one', 'important', 'exception', 'general', 'trend', 'upper', 'respiratory', 'tract', 'infection', '', '2017', 'meta-analysis', 'individual', 'patient', 'data', '11', '321', 'participant', '25', 'randomise', 'control', 'trial', 'show', 'vitamin', 'supplementation', 'protect', 'acute', 'respiratory', 'tract', 'infection', 'patient', 'low', '', '', '25', 'nmoll', '', 'serum', '25-hydroxyvitamin', 'concentration', '', 'marker', 'vitamin', 'status', '', 'gain', 'benefit', '', 'grow', 'body', 'circumstantial', 'evidence', 'specifically', 'link', 'outcome', 'covid-19', 'vitamin', 'status', '', 'sars-cov-2', '', 'virus', 'responsible', 'covid-19', '', 'emerge', 'start', 'spread', 'northern', 'hemisphere', 'end', '2019', '', 'winter', '', '', 'level', '25-hydroxyvitamin', 'nadir', '', '', 'nation', 'northern', 'hemisphere', 'bear', 'much', 'burden', 'case', 'mortality', '', 'cross-sectional', 'analysis', 'across', 'europe', '', 'covid-19', 'mortality', 'significantly', 'associate', 'vitamin', 'status', 'different', 'population', '', 'low', 'mortality', 'rate', 'nordic', 'country', 'exception', 'trend', 'towards', 'poorer', 'outcome', 'northerly', 'latitude', '', 'population', 'country', 'relatively', 'vitamin', 'sufficient', 'owe', 'widespread', 'fortification', 'food', '', 'italy', 'spain', 'exception', '', 'prevalence', 'vitamin', 'deficiency', 'population', 'surprisingly', 'common', '', 'additionally', '', 'black', 'minority', 'ethnic', 'peoplewho', 'likely', 'vitamin', 'deficiency', 'darker', 'skinseem', 'worse', 'affect', 'white', 'people', 'covid-19', '', 'example', '', 'data', 'uk', 'office', 'national', 'statistics', 'show', 'black', 'people', 'england', 'wales', 'four', 'time', 'likely', 'die', 'covid-19', 'white', 'people', '', 'role', 'vitamin', 'response', 'covid-19', 'infection', 'twofold', '', 'first', '', 'vitamin', 'support', 'production', 'antimicrobial', 'peptide', 'respiratory', 'epithelium', '', 'thus', 'infection', 'virus', 'development', 'covid-19', 'symptom', 'le', 'likely', '', 'second', '', 'vitamin', 'help', 'reduce', 'inflammatory', 'response', 'infection', 'sars-cov-2', '', 'deregulation', 'response', '', 'especially', 'reninangiotensin', 'system', '', 'characteristic', 'covid-19', 'degree', 'overactivation', 'associate', 'poorer', 'prognosis', '', 'vitamin', 'interact', 'protein', 'pathwayangiotensin-converting', 'enzyme', '2', '', 'ace2', '', 'exploit', 'sars-cov-2', 'entry', 'receptor', '', 'sars-cov-2', 'downregulates', 'expression', 'ace2', '', 'vitamin', 'promote', 'expression', 'gene', '', 'rose', 'anne', 'kenny', '', 'trinity', 'college', 'dublin', '', 'university', 'dublin', '', 'ireland', '', 'lead', 'cross-sectional', 'study', 'mortality', 'vitamin', 'status', 'lead', 'investigator', 'irish', 'longitudinal', 'study', 'ageing', '', 'tilda', '', '', 'adamant', 'recommendation', 'public', 'health', 'body', 'population', 'vitamin', 'supplement', 'pandemic', '', '', 'circumstantial', 'evidence', 'strong', '', '', 'proclaim', 'regard', 'potential', 'effect', 'covid-19', 'outcome', '', 'adding', '', '', 'nt', 'randomise', 'control', 'trial', 'evidence', '', 'long', 'wait', 'context', 'crisis', '', 'vitamin', 'important', 'musculoskeletal', 'function', '', 'people', 'anyway', '', '', 'kenny', 'recommend', '', 'least', '', 'vitamin', 'supplement', 'give', 'care', 'home', 'resident', 'unless', 'extremely', 'reason', '', 'adrian', 'martineau', '', 'institute', 'population', 'health', 'sciences', '', 'barts', 'london', '', 'queen', 'mary', 'university', 'london', '', 'uk', '', '', 'lead', 'author', '2017', 'meta-analysis', 'join', 'colleague', 'university', 'around', 'uk', 'launch', 'covidence', 'uk', '', 'study', 'investigate', 'diet', 'lifestyle', 'factor', 'influence', 'transmission', 'sars-cov-2', '', 'severity', 'covid-19', 'symptom', '', 'speed', 'recovery', '', 'long-term', 'effect', '', 'aim', 'recruit', 'least', '12', '000', 'people', 'obtain', 'interim', 'result', 'summer', '', 'despite', 'enthusiasm', 'study', '', 'martineau', 'pragmatic', '', '', 'best', 'vitamin', 'deficiency', 'one', 'factor', 'involve', 'determine', 'outcome', 'covid-19', '', 'problem', 'correct', 'safely', 'cheaply', '', 'downside', 'speak', '', 'reason', 'benefit', '', '', 'view', 'large', 'image', 'copyright', '', '2020', 'shutterstock', 'view', 'large', 'image', 'copyright', '', '2020', 'shutterstock']",584,"{'': 104, 'vitamin': 25, 'covid-19': 14, 'people': 9, 'population': 7, 'status': 7, 'outcome': 6, 'infection': 6, 'mortality': 5, 'sars-cov-2': 5, 'factor': 4, 'health': 4, 'deficiency': 4, 'low': 4, 'respiratory': 4, 'uk': 4, 'study': 4, 'data': 3, 'country': 3, 'role': 3}","{'infection': 6, 'sars-cov-2': 5}",11,0.7128
DOI:10.1016/S0140-6736(20)31208-3,10.1016/S0140-6736(20)31208-3,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['safety', '', 'tolerability', '', 'immunogenicity', 'recombinant', 'adenovirus', 'type-5', 'vectored', 'covid-19', 'vaccine', '', 'dose-escalation', '', 'open-label', '', 'non-randomised', '', 'first-in-human', 'trial']","['BackgroundA vaccine protect COVID-19 urgently need .', 'We aim ass safety , tolerability , immunogenicity recombinant adenovirus type-5 ( Ad5 ) vectored COVID-19 vaccine express spike glycoprotein severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) strain.MethodsWe dose-escalation , single-centre , open-label , non-randomised , phase 1 trial Ad5 vectored COVID-19 vaccine Wuhan , China .', 'Healthy adult age 18 60 year sequentially enrol allocate one three dose group ( 5 × 1010 , 1 × 1011 , 1·5 × 1011 viral particle ) receive intramuscular injection vaccine .', 'The primary outcome adverse event 7 day post-vaccination .', 'Safety assess 28 day post-vaccination .', 'Specific antibody measure ELISA , neutralise antibody response induce vaccination detect SARS-CoV-2 virus neutralisation pseudovirus neutralisation test .', 'T-cell response assess enzyme-linked immunospot flow-cytometry assay .', 'This study register ClinicalTrials.gov , NCT04313127.FindingsBetween March 16 March 27 , 2020 , screen 195 individual eligibility .', 'Of , 108 participant ( 51 % male , 49 % female ; mean age 36·3 year ) recruit receive low dose ( n=36 ) , middle dose ( n=36 ) , high dose ( n=36 ) vaccine .', 'All enrol participant include analysis .', 'At least one adverse reaction within first 7 day vaccination report 30 ( 83 % ) participant low dose group , 30 ( 83 % ) participant middle dose group , 27 ( 75 % ) participant high dose group .', 'The common injection site adverse reaction pain , report 58 ( 54 % ) vaccine recipient , commonly report systematic adverse reaction fever ( 50 [ 46 % ] ) , fatigue ( 47 [ 44 % ] ) , headache ( 42 [ 39 % ] ) , muscle pain ( 18 [ 17 % ] .', 'Most adverse reaction report dose group mild moderate severity .', 'No serious adverse event note within 28 day post-vaccination .', 'ELISA antibody neutralise antibody increase significantly day 14 , peak 28 day post-vaccination .', 'Specific T-cell response peak day 14 post-vaccination.InterpretationThe Ad5 vectored COVID-19 vaccine tolerable immunogenic 28 day post-vaccination .', 'Humoral response SARS-CoV-2 peak day 28 post-vaccination healthy adult , rapid specific T-cell response note day 14 post-vaccination .', 'Our find suggest Ad5 vectored COVID-19 vaccine warrant investigation.FundingNational Key R & D Program China , National Science Technology Major Project , CanSino Biologics .', 'A vaccine protect COVID-19 urgently need .', 'We aim ass safety , tolerability , immunogenicity recombinant adenovirus type-5 ( Ad5 ) vectored COVID-19 vaccine express spike glycoprotein severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) strain .', 'We dose-escalation , single-centre , open-label , non-randomised , phase 1 trial Ad5 vectored COVID-19 vaccine Wuhan , China .', 'Healthy adult age 18 60 year sequentially enrol allocate one three dose group ( 5 × 1010 , 1 × 1011 , 1·5 × 1011 viral particle ) receive intramuscular injection vaccine .', 'The primary outcome adverse event 7 day post-vaccination .', 'Safety assess 28 day post-vaccination .', 'Specific antibody measure ELISA , neutralise antibody response induce vaccination detect SARS-CoV-2 virus neutralisation pseudovirus neutralisation test .', 'T-cell response assess enzyme-linked immunospot flow-cytometry assay .', 'This study register ClinicalTrials.gov , NCT04313127 .', 'Between March 16 March 27 , 2020 , screen 195 individual eligibility .', 'Of , 108 participant ( 51 % male , 49 % female ; mean age 36·3 year ) recruit receive low dose ( n=36 ) , middle dose ( n=36 ) , high dose ( n=36 ) vaccine .', 'All enrol participant include analysis .', 'At least one adverse reaction within first 7 day vaccination report 30 ( 83 % ) participant low dose group , 30 ( 83 % ) participant middle dose group , 27 ( 75 % ) participant high dose group .', 'The common injection site adverse reaction pain , report 58 ( 54 % ) vaccine recipient , commonly report systematic adverse reaction fever ( 50 [ 46 % ] ) , fatigue ( 47 [ 44 % ] ) , headache ( 42 [ 39 % ] ) , muscle pain ( 18 [ 17 % ] .', 'Most adverse reaction report dose group mild moderate severity .', 'No serious adverse event note within 28 day post-vaccination .', 'ELISA antibody neutralise antibody increase significantly day 14 , peak 28 day post-vaccination .', 'Specific T-cell response peak day 14 post-vaccination .', 'The Ad5 vectored COVID-19 vaccine tolerable immunogenic 28 day post-vaccination .', 'Humoral response SARS-CoV-2 peak day 28 post-vaccination healthy adult , rapid specific T-cell response note day 14 post-vaccination .', 'Our find suggest Ad5 vectored COVID-19 vaccine warrant investigation .', 'National Key R & D Program China , National Science Technology Major Project , CanSino Biologics .', 'Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) first report January , 2020 .', 'The virus highly transmissible human spread rapidly , cause COVID-19 pandemic.1Zhu N Zhang D Wang W et al.A novel coronavirus patient pneumonia China , 2019.N Engl J Med .', '2020 ; 382 : 727-733Google Scholar , 2Li Q Guan X Wu P et al.Early transmission dynamic Wuhan , China , novel coronavirus-infected pneumonia.N Engl J Med .', '2020 ; 382 : 1199-1207Google Scholar Patients infect SARS-CoV-2 , especially older patient pre-existing respiratory cardiovascular condition greater risk severe complication , include severe pneumonia , acute respiratory distress syndrome , multiple organ failure , case , death.3Grein J Ohmagari N Shin D et al.Compassionate use remdesivir patient severe Covid-19.N Engl J Med .', '2020 ; ( publish online April 10 .', ') DOI:10.1056/NEJMoa2007016NEJMoa2007016Google Scholar , 4Weiss P Murdoch DR Clinical course mortality risk severe COVID-19.Lancet .', '2020 ; 395 : 1014-1015Google Scholar By May 20 , 2020 , SARS-CoV-2 infect 4·7 million people across 215 country territory kill 316 000 worldwide.5WHOCoronavirus disease ( COVID-2019 ) situation report .', 'urlplaceholder 2020Date access : May 5 , 2020Google Scholar In absence effective prevention measure , current management control epidemic enforcement quarantine , isolation , physical distancing.6Cowling BJ Ali ST Ng TWY et al.Impact assessment non-pharmaceutical intervention coronavirus disease 2019 influenza Hong Kong : observational study.Lancet Public Health .', '2020 ; 5 : e279-e288Google Scholar , 7Gudbjartsson DF Helgason A Jonsson H et al.Spread SARS-CoV-2 Icelandic population.N Engl J Med .', '2020 ; ( publish online April 14 .', ') DOI:10.1056/NEJMoa2006100Google Scholar Effective vaccine COVID-19 urgently need reduce enormous burden mortality morbidity associate SARS-CoV-2 infection.8Amanat F Krammer F SARS-CoV-2 vaccine : status report.Immunity .', '2020 ; 52 : 583-589Google Scholar There 100 candidate vaccine development worldwide,9WHODRAFT landscape COVID-19 candidate vaccines–30 April 2020. urlplaceholder 2020Date access : May 5 , 2020Google Scholar among least eight start soon start clinical trial .', ""These include Moderna 's mRNA COVID-19 vaccine CanSino 's non-replicating adenovirus type-5 ( Ad5 ) vectored COVID-19 vaccine , enter phase 1 clinical trial March 16 , 2020 ; Inovio Pharmaceuticals ' DNA vaccine COVID-19 , enter trial April 3 , 2020 ; three inactive COVID-19 vaccine manufacture Sinovac , Wuhan Institute Biological Products , Beijing Institute Biological Products enter clinical trial April , 2020 , successively ; University Oxford 's non-replicating chimpanzee adenovirus vectored vaccine ChAdOx1 nCoV-19 , BioNTech 's mRNA COVID-19 vaccine also start trial recent month ."", 'Research contextEvidence studyWe search PubMed May 8 , 2020 , clinical trial report term “ COVID-19 ” “ SARS-CoV-2 ” , “ vaccine ” , “ clinical trial ” date language restriction ; data human clinical trial COVID-19 vaccine report thus far , knowledge .', 'We also search ClinicalTrials.gov registry unpublished trial COVID-19 vaccine , May 6 , 2020 .', ""In addition adenovirus type-5 ( Ad5 ) vectored COVID-19 vaccine report , seven candidate COVID-19 vaccine ongoing clinical trial , include Moderna 's mRNA COVID-19 vaccine , Inovio Pharmaceuticals ' DNA vaccine , Sinovac , Wuhan Beijing Institute Biological Products ' inactive COVID-19 vaccine , University Oxford 's chimpanzee adenovirus-vectored vaccine , BioNTech 's mRNA COVID-19 vaccine.Added value studyThis first-in-human trial show Ad5 vectored COVID-19 vaccine tolerable immunogenic healthy adult ."", 'One dose vaccine dose concentration ( 5 × 1010 , 1 × 1011 , 1·5 × 1011 viral particle ) test induce specific antibody T-cell response participant .', 'Rapid specific T-cell response note day 14 specific humoral response severe acute respiratory syndrome coronavirus 2 peak day 28 post-vaccination .', 'Although find high dose vaccine tend immunogenic middle dose low dose vaccine , also associate higher reactogenicity .', 'Severe fever , fatigue , dyspnoea , muscle pain , joint pain report recipient high dose group.Implications available evidenceMany vaccine candidate rapid development , include recombinant-protein base vaccine , replicate non-replicating viral vector-based vaccine , DNA vaccine , mRNA vaccine ( mostly focus spike glycoprotein receptor bind domain ) , live attenuate vaccine , inactivate virus vaccine .', 'All vaccine platform advantage disadvantage , soon predict successful .', 'Our study suggest potential investigation Ad5 vectored COVID-19 vaccine prevention COVID-19 .', 'Evidence study We search PubMed May 8 , 2020 , clinical trial report term “ COVID-19 ” “ SARS-CoV-2 ” , “ vaccine ” , “ clinical trial ” date language restriction ; data human clinical trial COVID-19 vaccine report thus far , knowledge .', 'We also search ClinicalTrials.gov registry unpublished trial COVID-19 vaccine , May 6 , 2020 .', ""In addition adenovirus type-5 ( Ad5 ) vectored COVID-19 vaccine report , seven candidate COVID-19 vaccine ongoing clinical trial , include Moderna 's mRNA COVID-19 vaccine , Inovio Pharmaceuticals ' DNA vaccine , Sinovac , Wuhan Beijing Institute Biological Products ' inactive COVID-19 vaccine , University Oxford 's chimpanzee adenovirus-vectored vaccine , BioNTech 's mRNA COVID-19 vaccine ."", 'Added value study This first-in-human trial show Ad5 vectored COVID-19 vaccine tolerable immunogenic healthy adult .', 'One dose vaccine dose concentration ( 5 × 1010 , 1 × 1011 , 1·5 × 1011 viral particle ) test induce specific antibody T-cell response participant .', 'Rapid specific T-cell response note day 14 specific humoral response severe acute respiratory syndrome coronavirus 2 peak day 28 post-vaccination .', 'Although find high dose vaccine tend immunogenic middle dose low dose vaccine , also associate higher reactogenicity .', 'Severe fever , fatigue , dyspnoea , muscle pain , joint pain report recipient high dose group .', 'Implications available evidence Many vaccine candidate rapid development , include recombinant-protein base vaccine , replicate non-replicating viral vector-based vaccine , DNA vaccine , mRNA vaccine ( mostly focus spike glycoprotein receptor bind domain ) , live attenuate vaccine , inactivate virus vaccine .', 'All vaccine platform advantage disadvantage , soon predict successful .', 'Our study suggest potential investigation Ad5 vectored COVID-19 vaccine prevention COVID-19 .', ""Here , report preliminary assessment 28 day post-vaccination safety , tolerability , immunogenicity CanSino 's non-replicating Ad5 vectored COVID-19 vaccine healthy adult China ."", 'We single-centre , open-label , non-randomised , dose-escalation phase 1 trial Ad5 vectored COVID-19 vaccine candidate rehabilitation centre Wuhan , Hubei province , China .', 'Eligible participant healthy adult age 18 60 year , SARS-CoV-2 infection , confirm negative result serum specific IgM IgG antibody commercial SARS-CoV-2 rapid test kit ( Jinwofu , Beijing , China ) , negative nucleic acid SARS-CoV-2 pharyngeal swab sputum anal swab detect nucleic acid diagnostic kit ( PCR-fluorescence probe , Sansure Biotech , Changsha , China ) , clear chest CT image evidence lesion lung time screen .', 'Exclusion criterion history seizure mental illness ; allergy ingredient include vaccine ; acute febrile disease day enrolment ; receipt blood product past 4 month ; receipt research medicine vaccine past month ; unable comply study schedule .', 'Further detail outline protocol.10Zhu F-C Guan X-H Wang W et al.Protocol .', 'A single-center , open-label , dose-escalating phase I clinical trial recombinant novel coronavirus vaccine ( adenovirus type 5 vector ) healthy adult age 18 60 year China .', 'urlplaceholder 2020Date access : May 20 , 2020Google Scholar Participants sequentially enrol receive single intramuscular injection dose-escalating manner : first group participant allocate receive low dose , follow minimum 3 day proceed recruit participant receive middle dose , safety observation 3 day , last group participant recruit allocate receive high dose .', 'The administration higher dose injection new enrolment pause criterion pause dose escalation meet .', 'The protocol inform consent approve institutional review board Jiangsu Provincial Center Disease Control Prevention .', 'Written inform consent participant obtain screen .', 'This study undertake Jiangsu Provincial Center Disease Control Prevention , Hubei Provincial Center Disease Control Prevention , Tongji Hospital , Tongji Medical College , Huazhong University Science Technology accordance Declaration Helsinki Good Clinical Practice .', 'The Ad5 vectored COVID-19 vaccine develop Beijing Institute Biotechnology ( Beijing , China ) CanSino Biologics ( Tianjin , China ) .', 'The vaccine replication defective Ad5 vectored vaccine express spike glycoprotein SARS-CoV-2 .', 'We clone optimise full-length spike gene base Wuhan-Hu-1 ( GenBank accession number YP_009724390 ) tissue plasminogen activator signal peptide gene E1 E3 delete Ad5 vector , construct Ad5 vectored COVID-19 vaccine use Admax system Microbix Biosystem ( Toronto , ON , Canada ) .', 'The Ad5 vectored COVID-19 vaccine manufacture liquid formulation contain 5 × 1010 viral particle per 0·5 mL vial .', 'A single shoot allocate intramuscularly arm participant low dose group , one vial Ad5 vectored COVID-19 vaccine ( 5 × 1010 viral particle per 0·5 mL ) .', 'The participant middle dose group receive one shoot intramuscularly arm two vial Ad5 vectored COVID-19 vaccine ( 1 × 1011 viral particle per mL ) .', 'Participants high dose group receive double-shot regimen one vial Ad5 vectored COVID-19 vaccine one arm two vial Ad5 vectored COVID-19 vaccine arm ( 1·5 × 1011 viral particle per 1·5 mL ) .', 'Adverse event self-reported participant , verify investigator daily first 14 day vaccination .', 'Subsequently , adverse event record participant diary card follow week .', 'Laboratory safety test include white blood cell count , lymphocyte count , neutrophil , platelet , haemoglobin , alanine aminotransferase , aspartate aminotransferase , total bilirubin , fast blood glucose , creatinine measure day 7 ass toxic effect post-vaccination .', 'We grade adverse event abnormal change laboratory test accord scale issue China State Food Drug Administration ( version 2019 ) .11National Medical Products Administration urlplaceholder 2019Date access : May 20 , 2020Google Scholar Blood sample take participant serology test schedule site visit vaccination , day 14 28 vaccination .', 'We assess bind antibody response receptor bind domain ( RBD ) spike glycoprotein ELISA kit manufacture Beijing Wantai BioPharm ( Beijing , China ) .', 'A dilution 1:40 positivity cutoff value ELISA .', 'We also measure neutralise antibody response induce vaccination use live SARS-CoV-2 virus neutralisation ( virus strain SARS-CoV-2/human/CHN/Wuhan_IME-BJ01/2020 , GenBank number MT291831.1 ) pseudovirus neutralisation test ( vesicular stomatitis virus pseudovirus system express spike glycoprotein ) .12Nie J Li Q Wu J et al.Establishment validation pseudovirus neutralization assay SARS-CoV-2.Emerg Microbes Infect .', '2020 ; 9 : 680-686Google Scholar Peripheral blood mononuclear cell isolate whole blood vaccination day 14 28 post-vaccination .', 'Specific T-cell response quantify interferon ( IFN ) γ enzyme-linked immunospot ( ELISpot ) assay use fresh peripheral blood mononuclear cell stimulate overlap spike glycoprotein peptide pool 12–24 h detection , express number spot-forming cell per 100 000 cell .', 'All measurement subtract unstimulated control value , minus value correct zero .', 'The result consider positive least two-time increase number IFNγ secrete T cell post-vaccination .', 'We also assess CD4+ CD8+ T-cell response vaccination accord secretion IFNγ , interleukin-2 ( IL-2 ) , tumour necrosis factor α ( TNFα ) , measure intracellular cytokine stain assay peripheral blood mononuclear cell stimulation overlap spike glycoprotein peptide pool 6 h detect flow cytometry .', 'Similar method measure T-cell response intracellular cytokine stain assay report previously.13Ewer K Rampling T Venkatraman N et al.A monovalent chimpanzee adenovirus Ebola vaccine boost MVA.N Engl J Med .', '2016 ; 374 : 1635-1646Google Scholar , 14De Santis O Audran R Pothin E et al.Safety immunogenicity chimpanzee adenovirus-vectored Ebola vaccine healthy adult : randomise , double-blind , placebo-controlled , dose-finding , phase 1/2a study.Lancet Infect Dis .', '2016 ; 16 : 311-320Google Scholar The pre-vaccination post-vaccination anti-Ad5 neutralise antibody titre detect serum neutralisation assay.15Sprangers MC Lakhai W Koudstaal W et al.Quantifying adenovirus-neutralizing antibody luciferase transgene detection : address preexist immunity vaccine gene therapy vectors.J Clin Microbiol .', '2003 ; 41 : 5046-5052Google Scholar We analyse outcome intention-to-treat cohort .', 'The primary endpoint safety occurrence adverse reaction within 7 day vaccination .', 'Any abnormal change laboratory measure 7 day post-vaccination , adverse event within 28 day across treatment group also analyse secondary safety endpoint .', 'The specific ELISA antibody titre RBD spike glycoprotein , neutralise antibody amount live SARS-CoV-2 pseudovirus measure humoral immunogenicity endpoint .', 'We define positive antibody response ( seroconversion ) least four-fold increase post-vaccination titre baseline .', 'ELISpot IFNγ positive T-cell response measure intracellular cytokine stain assay compare across group endpoint cell-mediated response .', 'Stratified analysis immune response do base pre-existing Ad5 neutralise antibody titre among participant low negative ( ≤1:200 ) high ( > 1:200 ) .', 'The sample size determine basis statistical power calculation ; however , minimum sample size 20–30 participant pilot vaccine trial recommend National Medical Products Administration , China .', 'We assess number proportion participant adverse reaction post-vaccination compare safety profile across dose group .', 'The antibody SARS-CoV-2 present geometric mean titre 95 % CIs cellular response show proportion positive responder .', ""We use χ2 test Fisher 's exact test analyse categorical data , ANOVA analyse log transform antibody titre , Wilcoxon rank-sum test data normally distribute ."", 'When overall difference across three group significant , pairwise comparison make difference group estimate 95 % CIs .', 'Multivariable analysis use establish possible effect immunogenicity safety profile vaccine candidate .', 'Hypothesis test two-sided α value 0·05 .', 'Statistical analysis do statistician use SAS ( version 9.4 ) GraphPad Prism 8·0·1 .', 'SPICE ( version 6.0 ) use analysis data multicolour flow cytometry experiment .', 'An independent data safety monitor committee , one independent statistician , one clinician , one epidemiologist , establish start trial .', 'Safety data first 3 day post-vaccination assess review committee ensure sufficient hold time dose escalation .', 'This study register ClinicalTrials.gov , NCT04313127 .', 'The sponsor study participate study design , role data collection , data analysis , data interpretation , write report .', 'All author full access data study final responsibility decision submit publication .', 'Between March 16 March 27 , 2020 , screen 195 individual eligibility .', 'Of , 108 sequentially enrol assign receive low dose ( n=36 [ 33 % ] ) , middle dose ( n=36 [ 33 % ] ) , high dose ( n=36 [ 33 % ] ) Ad5 vectored COVID-19 vaccine ( appendix p 2 ) .', 'All participant complete vaccination schedule visit within 28 day .', 'Baseline characteristic participant similar across treatment group ( table 1 ) .Table 1Baseline characteristicsLow dose group ( n=36 ) Middle dose group ( n=36 ) High dose group ( n=36 ) Age , years18–299 ( 25 % ) 12 ( 33 % ) 10 ( 28 % ) 30–3913 ( 36 % ) 14 ( 39 % ) 15 ( 42 % ) 40–498 ( 22 % ) 3 ( 8 % ) 7 ( 19 % ) 50–606 ( 17 % ) 7 ( 19 % ) 4 ( 11 % ) Mean age , years37·2 ( 10·7 ) 36·3 ( 11·5 ) 35·5 ( 10·1 ) SexMale18 ( 50 % ) 19 ( 53 % ) 18 ( 50 % ) Female18 ( 50 % ) 17 ( 47 % ) 18 ( 50 % ) Mean body-mass index , kg/m223·3 ( 2·7 ) 23·9 ( 2·7 ) 24·1 ( 3·1 ) Underlying disease * * Seven participant hypertension , chronic bronchitis , gout , carrier hepatitis B virus.Yes1 ( 3 % ) 2 ( 6 % ) 4 ( 11 % ) No35 ( 97 % ) 34 ( 94 % ) 32 ( 89 % ) Pre-existing adenovirus type-5 neutralise antibodyMean GMT168·9 ( 13·9 ) 149·5 ( 10·5 ) 115·0 ( 13·4 ) ≤200 , titre16 ( 44 % ) 17 ( 47 % ) 20 ( 56 % ) > 200 , titre20 ( 56 % ) 19 ( 53 % ) 16 ( 44 % ) Data n ( % ) mean ( SD ) .', 'GMT=geometric mean titre .', '* Seven participant hypertension , chronic bronchitis , gout , carrier hepatitis B virus .', 'Open table new tab Data n ( % ) mean ( SD ) .', 'GMT=geometric mean titre .', '87 ( 81 % ) 108 participant report least one adverse reaction within first 7 day vaccination : 30 ( 83 % ) low dose group , 30 ( 83 % ) middle dose group , 27 ( 75 % ) high dose group ( table 2 ) .', 'No significant difference overall number adverse reaction across treatment group observe .', 'The common injection site adverse reaction pain , report 58 ( 54 % ) vaccine recipient .', 'Pain report 17 ( 47 % ) participant low dose group , 20 ( 56 % ) participant middle dose group , 21 ( 58 % ) participant high dose group .', 'The commonly report systematic adverse reaction overall fever ( 50 [ 46 % ] ) , fatigue ( 47 [ 44 % ] ) , headache ( 42 [ 39 % ] ) , muscle pain ( 18 [ 17 % ] ) .', 'Fever report 15 ( 42 % ) participant low dose group , 15 ( 42 % ) participant middle dose group , 20 ( 56 % ) participant high dose group .', 'Headache report 14 ( 39 % ) participant low dose group , 11 ( 31 % ) participant middle dose group , 17 ( 47 % ) participant high dose group .', 'Muscle pain report seven ( 19 % ) participant low dose group , three ( 8 % ) participant middle dose group , eight ( 22 % ) participant high dose group .', 'Most adverse reaction mild moderate severity .', 'Nine participant ( two [ 6 % ] low dose group , two [ 6 % ] middle dose group , five [ 14 % ] high dose group ) episode severe fever ( grade 3 ) axillary temperature greater 38·5°C .', 'Of , one ( 3 % ) high dose group report severe fever along severe symptom fatigue , dyspnoea , muscle pain .', 'One participant high dose group report severe fatigue joint pain ( appendix p 3 ) .', 'These reaction occur within 24 h post-vaccination , persist 48 h. We find significant difference incidence adverse reaction overall adverse event among dose group .', 'High pre-existing Ad5 immunity ( titre > 1:200 v ≤1:200 ) associate significantly fewer occurrence fever post-vaccination ( odds ratio 0·3 , 95 % CI 0·1–0·6 ; appendix p 4 ) .', 'No serious adverse event report within 28 day .', 'At day 7 vaccination , nine ( 8 % ) participant mild moderate total bilirubin increase , ten ( 9 % ) alanine aminotransferase increase , four ( 4 % ) fast hyperglycaemia ( appendix p 5 ) , instance consider clinically significant.Table 2Adverse reaction within 7 day overall adverse event within 28 day vaccinationLow dose group ( n=36 ) Middle dose group ( n=36 ) High dose group ( n=36 ) Total ( N=108 ) All adverse reaction within 0–7 daysAny30 ( 83 % ) 30 ( 83 % ) 27 ( 75 % ) 87 ( 81 % ) Grade 32 ( 6 % ) 2 ( 6 % ) 6 ( 17 % ) 10 ( 9 % ) Injection site adverse reaction within 0–7 daysPain17 ( 47 % ) 20 ( 56 % ) 21 ( 58 % ) 58 ( 54 % ) Induration2 ( 6 % ) 1 ( 3 % ) 1 ( 3 % ) 4 ( 4 % ) Redness2 ( 6 % ) 1 ( 3 % ) 1 ( 3 % ) 4 ( 4 % ) Swelling4 ( 11 % ) 4 ( 11 % ) 08 ( 7 % ) Itch2 ( 6 % ) 3 ( 8 % ) 05 ( 5 % ) Muscular weakness001 ( 3 % ) 1 ( 1 % ) Systemic adverse reaction within 0–7 daysFever15 ( 42 % ) 15 ( 42 % ) 20 ( 56 % ) 50 ( 46 % ) Grade 3 fever2 ( 6 % ) 2 ( 6 % ) 5 ( 14 % ) 9 ( 8 % ) Headache14 ( 39 % ) 11 ( 31 % ) 17 ( 47 % ) 42 ( 39 % ) Fatigue17 ( 47 % ) 14 ( 39 % ) 16 ( 44 % ) 47 ( 44 % ) Grade 3 fatigue002 ( 6 % ) 2 ( 2 % ) Vomiting1 ( 3 % ) 01 ( 3 % ) 2 ( 2 % ) Diarrhoea3 ( 8 % ) 4 ( 11 % ) 5 ( 14 % ) 12 ( 11 % ) Muscle pain7 ( 19 % ) 3 ( 8 % ) 8 ( 22 % ) 18 ( 17 % ) Grade 3 muscle pain001 ( 3 % ) 1 ( 1 % ) Joint pain2 ( 6 % ) 2 ( 6 % ) 5 ( 14 % ) 9 ( 8 % ) Grade 3 joint pain001 ( 3 % ) 1 ( 1 % ) Throat pain1 ( 3 % ) 3 ( 8 % ) 4 ( 11 % ) 8 ( 7 % ) Cough1 ( 3 % ) 2 ( 6 % ) 3 ( 8 % ) 6 ( 6 % ) Nausea2 ( 6 % ) 1 ( 3 % ) 3 ( 8 % ) 6 ( 6 % ) Functional GI disorder1 ( 3 % ) 001 ( 1 % ) Dyspnoea002 ( 6 % ) 2 ( 2 % ) Grade 3 dyspnoea001 ( 3 % ) 1 ( 1 % ) Appetite impaired6 ( 17 % ) 5 ( 14 % ) 6 ( 17 % ) 17 ( 16 % ) Dizziness1 ( 3 % ) 01 ( 3 % ) 2 ( 2 % ) Mucosal abnormality001 ( 3 % ) 1 ( 1 % ) Pruritus1 ( 3 % ) 1 ( 3 % ) 1 ( 3 % ) 3 ( 3 % ) Overall adverse event within 0–28 daysAny31 ( 86 % ) 30 ( 83 % ) 27 ( 75 % ) 88 ( 81 % ) Grade 32 ( 6 % ) 2 ( 6 % ) 6 ( 17 % ) 10 ( 9 % ) Data n ( % ) .', 'Any refer participant grade adverse reaction event .', 'Adverse reaction event grade accord scale issue China State Food Drug Administration .', 'Grade 3=severe ( ie , prevent activity ) .', 'GI=gastrointestinal .', 'Open table new tab Data n ( % ) .', 'Any refer participant grade adverse reaction event .', 'Adverse reaction event grade accord scale issue China State Food Drug Administration .', 'Grade 3=severe ( ie , prevent activity ) .', 'GI=gastrointestinal .', 'Rapid bind antibody response RBD observe three dose group day 14 ( table 3 ) .', 'At day 28 , recipient high dose group tend higher bind antibody geometric mean titre 1445·8 ( 95 % CI 935·5–2234·5 ) , follow 806·0 ( 528·2–1229·9 ) middle dose group , 615·8 ( 405·4–935·5 ) low dose group ( high dose v low dose 1611·5 , 531·5–2691·5 ) .', 'At least four-fold increase anti-RBD antibody note 35 ( 97 % ) 36 participant low dose group , 34 ( 94 % ) 36 middle dose group , 36 ( 100 % ) 36 high dose group .', 'Neutralising antibody live SARS-CoV-2 negative day 0 , increase moderately day 14 , peak 28 day post-vaccination .', 'Neutralising antibody titre geometric mean titre 34·0 ( 95 % CI 22·6–50·1 ) note high dose group , significantly higher compare 16·2 ( 10·4–25·2 ) middle dose group 14·5 ( 9·6–21·8 ) low dose group , estimate difference 27·7 ( 1·0–54·4 ) high dose group middle dose group 33·2 ( 6·5–59·9 ) high dose group low dose group day 28 .', 'Meanwhile , 18 ( 50 % ) participant low dose group , 18 ( 50 % ) middle dose group , 27 ( 75 % ) high dose group least four-fold increase neutralise antibody titre day 28 .', 'Similar pattern bind antibody spike glycoprotein neutralise antibody titre pseudovirus post-vaccination across dose group also note ( appendix p 6 ) .', 'The association ELISA antibody RBD neutralise antibody titre live virus show moderate positive correlation 0·749 , ELISA antibody spike glycoprotein neutralise antibody titre live virus 0·753 , peak antibody response ( p < 0·0001 ) .', 'The neutralise antibody titre measure use pseudovirus also correlate well measure live SARS-CoV-2 ( appendix p 7 ) .Table 3Specific antibody response receptor bind domain , neutralise antibody live SARS-CoV-2Day 14Day 28Low dose group ( n=36 ) Middle dose group ( n=36 ) High dose group ( n=36 ) p valueLow dose group ( n=36 ) Middle dose group ( n=36 ) High dose group ( n=36 ) p valueELISA antibody receptor bind domainGMT76·5 ( 44·3–132·0 ) 91·2 ( 55·9–148·7 ) 132·6 ( 80·7–218·0 ) 0·29615·8 ( 405·4–935·5 ) 806·0 ( 528·2–1229·9 ) 1445·8 ( 935·5–2234·5 ) 0·016≥4-fold increase16 ( 44 % ) 18 ( 50 % ) 22 ( 61 % ) 0·3535 ( 97 % ) 34 ( 94 % ) 36 ( 100 % ) 0·77Neutralising antibody live SARS-CoV-2GMT8·2 ( 5·8–11·5 ) 9·6 ( 6·6–14·1 ) 12·7 ( 8·5–19·0 ) 0·2414·5 ( 9·6–21·8 ) 16·2 ( 10·4–25·2 ) 34·0 ( 22·6–50·1 ) 0·0082≥4-fold increase10 ( 28 % ) 11 ( 31 % ) 15 ( 42 % ) 0·4218 ( 50 % ) 18 ( 50 % ) 27 ( 75 % ) 0·046Data mean ( 95 % CI ) n ( % ) .', 'The p value result comparison across three dose group .', 'If difference significant across three group , difference group estimate 95 % CIs .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'GMT=geometric mean titre .', 'Open table new tab Data mean ( 95 % CI ) n ( % ) .', 'The p value result comparison across three dose group .', 'If difference significant across three group , difference group estimate 95 % CIs .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'GMT=geometric mean titre .', 'Before vaccination , 20 ( 56 % ) participant low dose group , 19 ( 53 % ) participant middle dose group , 16 ( 44 % ) participant high dose group high pre-existing Ad5 neutralise antibody titre ( > 1:200 ) .', 'Only five ( 25 % ) participant 20 low dose group , seven ( 37 % ) participant 19 middle dose group , ten ( 63 % ) participant 16 high dose group , high pre-existing Ad5 immunity , least four-fold increase neutralise antibody titre day 28 post-vaccination ( appendix pp 8–10 ) .', 'Multivariable analysis show high pre-existing Ad5 neutralise antibody titre compromise seroconversion neutralise antibody post-vaccination , regardless vaccine do , recipient age 45–60 year seem lower seroconversion neutralise antibody compare younger recipient ( appendix p 11 ) .', 'The Ad5 neutralise antibody significantly boost post-vaccination ( appendix p 12 ) .', 'ELISpot response baseline undetectable spot-forming cell level detection assay participant , peak day 14 post-vaccination .', 'The proportion positive responder range 83–97 % across dose group , mean number spot-forming cell per 100 000 cell 20·8 ( 95 % CI 12·7–34·0 ) low dose group , 40·8 ( 27·6–60·3 ) middle dose group , 58·0 ( 39·1–85·9 ) high dose group ( figure 1 ) .', 'T-cell response high dose group significantly higher low dose group ( p < 0·0010 ) , significant compare middle dose group .', 'A slight decrease T-cell response across dose group note day 28 .', 'High level baseline Ad5 neutralise antibody titre reduce peak post-vaccination T-cell response dose group , particularly low dose group .', 'Despite effect high pre-existing Ad5 immunity , positive responder identify 15 ( 75 % ) 20 participant low dose group , 18 ( 95 % ) 19 participant middle dose group , 15 ( 94 % ) 16 participant high dose group day 14 , 12 ( 60 % ) 20 participant low dose group , 16 ( 84 % ) 19 participant middle dose group , 16 ( 100 % ) 16 participant high dose group day 28.Figure 1Specific T-cell response measure ELISpotShow full caption ( A ) The number specific T cell secretion IFNγ day 0 , 14 , 28 participant , stratify pre-existing Ad5 neutralise antibody titre .', '( B ) The proportion positive ELISpot responder day 14 28 post-vaccination participant , stratify pre-existing Ad5 neutralise antibody titre .', 'IFN=interferon .', 'PBMCs=peripheral blood mononuclear cell .', 'Ad5=adenovirus type-5 .', 'ELISpot=enzyme-linked immunospot.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) The number specific T cell secretion IFNγ day 0 , 14 , 28 participant , stratify pre-existing Ad5 neutralise antibody titre .', '( B ) The proportion positive ELISpot responder day 14 28 post-vaccination participant , stratify pre-existing Ad5 neutralise antibody titre .', 'IFN=interferon .', 'PBMCs=peripheral blood mononuclear cell .', 'Ad5=adenovirus type-5 .', 'ELISpot=enzyme-linked immunospot .', 'IFNγ detect CD4+ CD8+ T cell vaccination day 14 28 , dose group ( figure 2 , appendix p 13 ) .', 'The TNFα expression CD4+ T cell tend significantly lower low dose group high dose ( p < 0·0001 ) middle dose group ( p=0·0032 ) , day 14 .', 'The TNFα expression CD8+ T cell show overall p value le 0·0001 across three group day 14 .', 'And TNFα expression CD8+ T cell tend higher high dose group middle dose group ( p=0·016 ) low dose group ( p < 0·0001 ) .', 'The p value pairwise comparison group .', 'Amounts IL-2 detect CD4+ T cell higher detect CD8+ cell .', 'The proportion polyfunctional phenotype detect memory CD4+ T cell higher CD8+ T cell .', 'Higher proportion polyfunctional phenotype note higher vaccine do .', 'We also note pre-existing Ad5 neutralise antibody negative effect pattern T-cell response ( appendix pp 14–16 ) .', 'A post-hoc analysis show 28 ( 78 % ) participant low dose group , 33 ( 92 % ) participant middle dose group , 36 ( 100 % ) participant high dose group show either positive T-cell response spike glycoprotein seroconversion neutralise antibody live SARS-CoV-2 , day 28 post-vaccination ( appendix p 17 ) .Figure 2Flow cytometry intracellular cytokine stain vaccinationShow full caption ( A ) Percentage cell secrete IFNγ , TNFα , IL-2 CD4+ T cell .', '( B ) Percentage cell secrete IFNγ , TNFα , IL-2 CD8+ T cell .', '( C ) The proportion CD4+ T cell CD8+ T cell produce combination IFNγ , TNFα , IL-2 .', 'The analysis 108 participant , 36 dose group .', 'IFN=interferon .', 'TNF=tumour necrosis factor .', 'IL=interleukin.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Percentage cell secrete IFNγ , TNFα , IL-2 CD4+ T cell .', '( B ) Percentage cell secrete IFNγ , TNFα , IL-2 CD8+ T cell .', '( C ) The proportion CD4+ T cell CD8+ T cell produce combination IFNγ , TNFα , IL-2 .', 'The analysis 108 participant , 36 dose group .', 'IFN=interferon .', 'TNF=tumour necrosis factor .', 'IL=interleukin .', 'To exclude possible SARS-CoV-2 exposure study period , test serum antibody nucleocapsid protein SARS-CoV-2 participant day 28 use special IgG/IgM rapid test kit ( Vazyme Biotech , number CD101 , Nanjing , China ) , none participant positive .', 'To knowledge , first report first-in-human clinical trial novel Ad5 vectored COVID-19 vaccine .', 'The Ad5 vectored COVID-19 vaccine tolerate healthy adult three dose group .', 'The common adverse reaction fever , fatigue , headache , muscle pain significant difference incidence adverse reaction across group .', 'Most adverse event report mild moderate severity .', 'We notice higher reactogenicity profile high dose 1·5 × 1011 viral particle , present severe fever , fatigue , muscle pain , joint pain , might associate viraemia cause Ad5 vector infection .', 'However , severe adverse reaction transient self-limiting .', 'Additionally , abnormal change laboratory measurement clinically significant consider relate vaccine .', 'The profile adverse event report trial similar another Ad5 vector-based Ebola vaccine express glycoprotein.16Zhu FC Hou LH Li JX et al.Safety immunogenicity novel recombinant adenovirus type-5 vector-based Ebola vaccine healthy adult China : preliminary report randomise , double-blind , placebo-controlled , phase 1 trial.Lancet .', '2015 ; 385 : 2272-2279Google Scholar To accelerate process clinical evaluation candidate COVID-19 vaccine , select do phase 2 study mainly basis safety profile candidate vaccine show participant within 7 day 14 day post-vaccination .', 'We choose low dose ( 5 × 1010 viral particle ) middle dose ( 1 × 1011 viral particle ) assess phase 2 clinical trial .', 'The Ad5 vectored COVID-19 vaccine immunogenic , induce humoral T-cell response rapidly participant .', 'Onset detectable immune response rapid , T-cell response peak day 14 vaccination antibody peak day 28 .', 'The antibody response vaccine high dose group slightly greater middle dose low dose group .', 'A single dose Ad5 vectored COVID-19 vaccine able elicit four-fold increase bind antibody RBD 94–100 % participant , four-fold increase live virus 50–75 % participant .', 'Despite difference magnitude antibody measure different method , strong positive correlation bind antibody neutralise antibody titre live virus .', 'High proportion participant positive T-cell response note across dose group post-vaccination .', 'The activation CD4+ T cell CD8+ T cell observe vaccine recipient , particularly antigen-specific CD4+ T cell CD8+ T cell .', 'However , specific antibody response T-cell response induce vaccination partly diminish presence high pre-existing anti-Ad5 immunity .', 'Currently , correlate protection vaccine COVID-19 unknown , role specific antibody T cell build effective protection yet define .', 'Therefore , unable predict protection Ad5 vectored COVID-19 vaccine basis vaccine-elicited immune response study .', 'However , previous study investigate SARS Middle East respiratory syndrome ( MERS ) find increase specific antibody temporary , decline quickly patient recovery , whereas specific CD4+ CD8+ T-cell response play essential role immunity.17Zhao J Zhao J Perlman S T cell response require protection clinical disease virus clearance severe acute respiratory syndrome coronavirus-infected mice.J Virol .', '2010 ; 84 : 9318-9325Google Scholar , 18Channappanavar R Fett C Zhao J Meyerholz DK Perlman S Virus-specific memory CD8 T cell provide substantial protection lethal severe acute respiratory syndrome coronavirus infection.J Virol .', '2014 ; 88 : 11034-11044Google Scholar A similar rapid decline specific antibody amount patient COVID-19 recovery also noted,19Wang X Guo X Xin Q et al.Neutralizing antibody response SARS-CoV-2 COVID-19 inpatient convalescent patients.medRxiv .', '2020 ; ( DOI : 2020.04.15.20065623 ( preprint ) ) Google Scholar , 20Wu F Wang A Liu M et al.Neutralizing antibody response SARS-CoV-2 COVID-19 recover patient cohort implications.medRxiv .', '2020 ; ( DOI : 2020.03.30.20047365 ( preprint ) ) Google Scholar suggest specific cellular humoral immunity potentially important successful COVID-19 vaccine .', 'Here , report data within 28 day vaccination , go follow vaccine recipient least 6 month , data obtain .', 'This study do Wuhan , Hubei province , centre COVID-19 epidemic China.21Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513Google Scholar People live city Wuhan much higher risk SARS-CoV-2 infection compare live city outside Hubei province , even though initiate trial , city already begin lockdown implement mandatory home isolation resident .', 'Therefore , serological screen , nucleic acid test , chest CT exclude participant previously expose SARS-CoV-2 recruitment .', 'In addition , arrange participant study stay designate hotel 14 day post-vaccination .', 'This arrangement facilitate observation adverse event immunisation participant , reduce risk SARS-CoV-2 exposure follow 2 week .', 'These measure allow study do successfully without interference circulation SARS-CoV-2 , especially important absence placebo control .', 'Interpretation result study limit small size cohort , short duration follow-up , absence randomise control group .', 'As first-in-human study Ad5 vectored COVID-19 vaccine , design measure vaccine efficacy .', 'However , preclinical study , seven eight ferret protect detectable virus copy challenge SARS-CoV-2 nasal drip 21 day immunisation vaccine , whereas one eight ferret control group negative virus copy ( Wei C , unpublished ) .', 'We aim evaluate safety tolerability candidate vaccine healthy adult , interference underlie disease medicine .', 'However , result study indicate older age could negative effect vaccine-elicited response SARS-CoV-2 .', 'In trial , participant older 60 year 16 % participant older 50 year , provide limit information capability generate potent cellular humoral response older population .', 'Since age also identify independent risk factor severe disease associate SARS-CoV-2 infection,4Weiss P Murdoch DR Clinical course mortality risk severe COVID-19.Lancet .', '2020 ; 395 : 1014-1015Google Scholar , 22Ye G Pan Z Pan Y et al.Clinical characteristic severe acute respiratory syndrome coronavirus 2 reactivation.J Infect .', '2020 ; 80 : e14-e17Google Scholar possibility even lower immune response might find older population , go include participant older 60 year phase 2 study consider population important target population COVID-19 vaccine .', 'Additionally , experience vaccine candidate SARS MERS raise concern antibody-dependent enhancement participant infect circulate SARS-CoV-2 post-vaccination.23Lurie N Saville M Hatchett R Halton J Developing Covid-19 vaccine pandemic speed.N Engl J Med .', '2020 ; ( NEJMp2005630 .', ') Google Scholar However , study statistically power measure safety outcome , especially concern around immunopathology antibody-dependent enhancement event associate full-length spike glycoprotein vaccine antigen.24Cao X COVID-19 : immunopathology implication therapy.Nat Rev Immunol .', '2020 ; 20 : 269-270Google Scholar Our study find pre-existing Ad5 immunity could slow rapid immune response SARS-CoV-2 also lower peak response , particularly humoral immunity .', 'The high pre-existing Ad5 immunity might also negative effect persistence vaccine-elicited immune response .', 'In previous study , heterologous prime-boost combination homologous prime-boost regimen Ad5 vectored vaccine show able induce strong durable immunogenic response population high pre-existing Ad5 immunity.25Venkatraman N Ndiaye BP Bowyer G et al.Safety immunogenicity heterologous prime-boost Ebola virus vaccine regimen healthy adult United Kingdom Senegal.J Infect Dis .', '2019 ; 219 : 1187-1197Google Scholar , 26Dolzhikova IV Zubkova OV Tukhvatulin AI et al.Safety immunogenicity GamEvac-Combi , heterologous VSV- Ad5-vectored Ebola vaccine : open phase I/II trial healthy adult Russia.Hum Vaccin Immunother .', '2017 ; 13 : 613-620Google Scholar , 27Shukarev G Callendret B Luhn K Douoguih M A two-dose heterologous prime-boost vaccine regimen elicit sustain immune response Ebola Zaire could support preventive strategy future outbreaks.Hum Vaccin Immunother .', '2017 ; 13 : 266-270Google Scholar Nevertheless , limit information available effect multiple do candidate Ad5 vectored COVID-19 vaccine human , warrant investigation .', 'Over past decade , vaccine industry clinical research centre ask provide urgent response epidemic emerge infectious disease , H1N1 influenza , Ebola virus , Zika , MERS , SARS-CoV-2.23Lurie N Saville M Hatchett R Halton J Developing Covid-19 vaccine pandemic speed.N Engl J Med .', '2020 ; ( NEJMp2005630 .', ') Google Scholar The risk COVID-19 cause SARS-CoV-2 ongoing , make need effective vaccine even urgent.28Richardson S Hirsch JS Narasimhan M et al.Presenting characteristic , comorbidities , outcome among 5700 patient hospitalize COVID-19 New York City area.JAMA .', '2020 ; ( publish online April 22 .', ') DOI:10.1001/jama.2020.6775Google Scholar We start development candidate vaccine January , 2020 , SARS-CoV-2 first isolate sequence .', 'The full-length spike glycoprotein select vaccine antigen , mainly basis previous experience SARS MERS vaccine .', 'Previous find suggest vaccine express full-length spike glycoprotein induce good immune response protective efficacy.29Yong CY Ong HK Yeap SK Ho KL Tan WS Recent advance vaccine development Middle East respiratory syndrome-coronavirus.Front Microbiol .', '2019 ; 101781Google Scholar Although RBD comprise critical neutralise domain coronaviruses , neutralise epitope locate outside RBD also identified.30Duan J Yan X Guo X et al.A human SARS-CoV neutralize antibody epitope S2 protein.Biochem Biophys Res Commun .', '2005 ; 333 : 186-193Google Scholar , 31Wang Q Zhang L Kuwahara K et al.Immunodominant SARS coronavirus epitope human elicit enhance neutralize effect infection non-human primates.ACS Infect Dis .', '2016 ; 2 : 361-376Google Scholar The full-length spike choose viral vectored , mRNA , DNA COVID-19 vaccine development.9WHODRAFT landscape COVID-19 candidate vaccines–30 April 2020. urlplaceholder 2020Date access : May 5 , 2020Google Scholar The Ad5 vector vaccine platform highly efficient well establish vaccine antigen delivery system .', 'In addition candidate Ad5 vectored COVID-19 vaccine , several Ad5-based vaccine COVID-19 list WHO draft landscape COVID-19 candidate vaccine , include Ad5 S ( GREVAXTM platform ) USA , Oral Ad5 S ( Stabilitech Biopharma ) UK.9WHODRAFT landscape COVID-19 candidate vaccines–30 April 2020. urlplaceholder 2020Date access : May 5 , 2020Google Scholar However , aside pre-existing anti-Ad5 immunity , concern increase risk HIV-1 acquisition associate Ad5 activate CD4+ T cells.32Gray GE Moodie Z Metch B et al.Recombinant adenovirus type 5 HIV gag/pol/nef vaccine South Africa : unblinded , long-term follow-up phase 2b HVTN 503/Phambili study.Lancet Infect Dis .', '2014 ; 14 : 388-396Google Scholar Although association HIV-1 acquisition risk Ad5 vectored vaccine controversial mechanism unclear , potential risk take account study viral vector delivery platform .', 'We plan monitor participant upcoming phase 2 phase 3 study ass indication acquisition .', 'In conclusion , find Ad5 vectored COVID-19 vaccine tolerable immunogenic healthy adult .', 'Specific humoral response SARS-CoV-2 peak day 28 post-vaccination , rapid , specific T-cell response note day 14 one shoot vaccine .', 'There potential investigation Ad5 vectored COVID-19 vaccine control COVID-19 outbreak .', 'An ongoing phase 2 trial China ( NCT04341389 ) provide information safety immunogenicity Ad5 vectored COVID-19 vaccine .', 'Contributors F-CZ Y-HL co-first author .', 'F-CZ , WW , WC joint correspond author .', 'F-CZ principal investigator trial .', 'X-HG WW work co-principal investigator trial .', 'F-CZ , WC , X-HG , L-HH , Y-HL , W-JW , J-XL , S-YJ design trial study protocol .', 'J-XL draft manuscript .', 'WC contribute critical review revision manuscript .', 'F-CZ , W-JW , J-XL , S-YJ contribute data interpretation revision manuscript .', 'X-WW responsible statistical analysis .', 'J-JX B-SW contribute study supervision .', 'WW , W-JW , ZW , LeW , S-YJ , H-DJ lead participate site work , include recruitment , follow-up , data collection .', 'Y-HL , TJ , YH , LiW , S-BX responsible laboratory analysis .', 'W-JW , J-XL , S-YJ contribute literature search .', 'J-BG S-PW monitor trial .', 'Declaration interest WC report grant National Key R & D Program China ( 2020YFC10841400 ) , grant National Science Technology Major Project ( 2016ZX10004001 , 2018ZX09201005 ) .', 'J-BG employee CanSino Biologics .', 'All author declare compete interest .', 'We support data share individual participant data .', 'The individual participant data underlie result report Article , de-identification ( text , table , figure , appendix ) share .', 'Individual participant data available begin 3 month end 1 year publication .', 'Supporting clinical document include study protocol , statistical analysis plan , inform consent form available immediately follow publication least 1 year .', 'Researchers provide scientifically sound proposal allow access individual participant data .', 'Proposals direct [ email protect ] [ email protect ] .', 'These proposal review approve sponsor , investigator , collaborator basis scientific merit .', 'To gain access , data requester need sign data access agreement .', 'Acknowledgments We thank Peng Deng , Qiong Li , Xiaoai Qian Hubei Provincial Center Disease Control Prevention participant recruitment sample collection .', 'We thank Miao Xu Jingjing Liu National Institute Food Drug Control ( China ) , Yansong Sun , Sen Zhang , Yuchang Li Beijing Institute Microbiology Epidemiology , Feng Wang , Hongyan Hou , Hanxiong Guan , Bo Liu Tongji Hospital laboratory analysis .', ""We thank Ke Zhang Academy Military Medical Sciences , Kun Liu General Hospital Central Theater Command , Changlong Fu Wuhan Rest Center , Chinese People 's Armed Police Force management clinical trial site ."", 'Download .pdf ( 1.78 MB ) Help pdf file Supplementary appendix']","['backgrounda', 'vaccine', 'protect', 'covid-19', 'urgently', '', 'aim', 'ass', 'safety', '', 'tolerability', '', 'immunogenicity', 'recombinant', 'adenovirus', 'type-5', '', 'ad5', '', 'vectored', 'covid-19', 'vaccine', 'express', 'spike', 'glycoprotein', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'strainmethodswe', 'dose-escalation', '', 'single-centre', '', 'open-label', '', 'non-randomised', '', 'phase', '1', 'trial', 'ad5', 'vectored', 'covid-19', 'vaccine', 'wuhan', '', 'china', '', 'healthy', 'adult', 'age', '18', '60', 'year', 'sequentially', 'enrol', 'allocate', 'one', 'three', 'dose', 'group', '', '5', '', '1010', '', '1', '', '1011', '', '15', '', '1011', 'viral', 'particle', '', 'receive', 'intramuscular', 'injection', 'vaccine', '', 'primary', 'outcome', 'adverse', 'event', '7', 'day', 'post-vaccination', '', 'safety', 'assess', '28', 'day', 'post-vaccination', '', 'specific', 'antibody', 'measure', 'elisa', '', 'neutralise', 'antibody', 'response', 'induce', 'vaccination', 'detect', 'sars-cov-2', 'virus', 'neutralisation', 'pseudovirus', 'neutralisation', 'test', '', 't-cell', 'response', 'assess', 'enzyme-linked', 'immunospot', 'flow-cytometry', 'assay', '', 'study', 'register', 'clinicaltrialsgov', '', 'nct04313127findingsbetween', 'march', '16', 'march', '27', '', '2020', '', 'screen', '195', 'individual', 'eligibility', '', '', '108', 'participant', '', '51', '', 'male', '', '49', '', 'female', '', 'mean', 'age', '363', 'year', '', 'recruit', 'receive', 'low', 'dose', '', 'n36', '', '', 'middle', 'dose', '', 'n36', '', '', 'high', 'dose', '', 'n36', '', 'vaccine', '', 'enrol', 'participant', 'include', 'analysis', '', 'least', 'one', 'adverse', 'reaction', 'within', 'first', '7', 'day', 'vaccination', 'report', '30', '', '83', '', '', 'participant', 'low', 'dose', 'group', '', '30', '', '83', '', '', 'participant', 'middle', 'dose', 'group', '', '27', '', '75', '', '', 'participant', 'high', 'dose', 'group', '', 'common', 'injection', 'site', 'adverse', 'reaction', 'pain', '', 'report', '58', '', '54', '', '', 'vaccine', 'recipient', '', 'commonly', 'report', 'systematic', 'adverse', 'reaction', 'fever', '', '50', '', '46', '', '', '', '', 'fatigue', '', '47', '', '44', '', '', '', '', 'headache', '', '42', '', '39', '', '', '', '', 'muscle', 'pain', '', '18', '', '17', '', '', '', 'adverse', 'reaction', 'report', 'dose', 'group', 'mild', 'moderate', 'severity', '', 'serious', 'adverse', 'event', 'note', 'within', '28', 'day', 'post-vaccination', '', 'elisa', 'antibody', 'neutralise', 'antibody', 'increase', 'significantly', 'day', '14', '', 'peak', '28', 'day', 'post-vaccination', '', 'specific', 't-cell', 'response', 'peak', 'day', '14', 'post-vaccinationinterpretationthe', 'ad5', 'vectored', 'covid-19', 'vaccine', 'tolerable', 'immunogenic', '28', 'day', 'post-vaccination', '', 'humoral', 'response', 'sars-cov-2', 'peak', 'day', '28', 'post-vaccination', 'healthy', 'adult', '', 'rapid', 'specific', 't-cell', 'response', 'note', 'day', '14', 'post-vaccination', '', 'find', 'suggest', 'ad5', 'vectored', 'covid-19', 'vaccine', 'warrant', 'investigationfundingnational', 'key', 'r', '', 'program', 'china', '', 'national', 'science', 'technology', 'major', 'project', '', 'cansino', 'biologics', '', 'vaccine', 'protect', 'covid-19', 'urgently', '', 'aim', 'ass', 'safety', '', 'tolerability', '', 'immunogenicity', 'recombinant', 'adenovirus', 'type-5', '', 'ad5', '', 'vectored', 'covid-19', 'vaccine', 'express', 'spike', 'glycoprotein', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'strain', '', 'dose-escalation', '', 'single-centre', '', 'open-label', '', 'non-randomised', '', 'phase', '1', 'trial', 'ad5', 'vectored', 'covid-19', 'vaccine', 'wuhan', '', 'china', '', 'healthy', 'adult', 'age', '18', '60', 'year', 'sequentially', 'enrol', 'allocate', 'one', 'three', 'dose', 'group', '', '5', '', '1010', '', '1', '', '1011', '', '15', '', '1011', 'viral', 'particle', '', 'receive', 'intramuscular', 'injection', 'vaccine', '', 'primary', 'outcome', 'adverse', 'event', '7', 'day', 'post-vaccination', '', 'safety', 'assess', '28', 'day', 'post-vaccination', '', 'specific', 'antibody', 'measure', 'elisa', '', 'neutralise', 'antibody', 'response', 'induce', 'vaccination', 'detect', 'sars-cov-2', 'virus', 'neutralisation', 'pseudovirus', 'neutralisation', 'test', '', 't-cell', 'response', 'assess', 'enzyme-linked', 'immunospot', 'flow-cytometry', 'assay', '', 'study', 'register', 'clinicaltrialsgov', '', 'nct04313127', '', 'march', '16', 'march', '27', '', '2020', '', 'screen', '195', 'individual', 'eligibility', '', '', '108', 'participant', '', '51', '', 'male', '', '49', '', 'female', '', 'mean', 'age', '363', 'year', '', 'recruit', 'receive', 'low', 'dose', '', 'n36', '', '', 'middle', 'dose', '', 'n36', '', '', 'high', 'dose', '', 'n36', '', 'vaccine', '', 'enrol', 'participant', 'include', 'analysis', '', 'least', 'one', 'adverse', 'reaction', 'within', 'first', '7', 'day', 'vaccination', 'report', '30', '', '83', '', '', 'participant', 'low', 'dose', 'group', '', '30', '', '83', '', '', 'participant', 'middle', 'dose', 'group', '', '27', '', '75', '', '', 'participant', 'high', 'dose', 'group', '', 'common', 'injection', 'site', 'adverse', 'reaction', 'pain', '', 'report', '58', '', '54', '', '', 'vaccine', 'recipient', '', 'commonly', 'report', 'systematic', 'adverse', 'reaction', 'fever', '', '50', '', '46', '', '', '', '', 'fatigue', '', '47', '', '44', '', '', '', '', 'headache', '', '42', '', '39', '', '', '', '', 'muscle', 'pain', '', '18', '', '17', '', '', '', 'adverse', 'reaction', 'report', 'dose', 'group', 'mild', 'moderate', 'severity', '', 'serious', 'adverse', 'event', 'note', 'within', '28', 'day', 'post-vaccination', '', 'elisa', 'antibody', 'neutralise', 'antibody', 'increase', 'significantly', 'day', '14', '', 'peak', '28', 'day', 'post-vaccination', '', 'specific', 't-cell', 'response', 'peak', 'day', '14', 'post-vaccination', '', 'ad5', 'vectored', 'covid-19', 'vaccine', 'tolerable', 'immunogenic', '28', 'day', 'post-vaccination', '', 'humoral', 'response', 'sars-cov-2', 'peak', 'day', '28', 'post-vaccination', 'healthy', 'adult', '', 'rapid', 'specific', 't-cell', 'response', 'note', 'day', '14', 'post-vaccination', '', 'find', 'suggest', 'ad5', 'vectored', 'covid-19', 'vaccine', 'warrant', 'investigation', '', 'national', 'key', 'r', '', 'program', 'china', '', 'national', 'science', 'technology', 'major', 'project', '', 'cansino', 'biologics', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'first', 'report', 'january', '', '2020', '', 'virus', 'highly', 'transmissible', 'human', 'spread', 'rapidly', '', 'cause', 'covid-19', 'pandemic1zhu', 'n', 'zhang', 'wang', 'w', 'ala', 'novel', 'coronavirus', 'patient', 'pneumonia', 'china', '', '2019n', 'engl', 'j', 'med', '', '2020', '', '382', '', '727-733google', '', '2li', 'q', 'guan', 'x', 'wu', 'p', 'alearly', 'transmission', 'dynamic', 'wuhan', '', 'china', '', 'novel', 'coronavirus-infected', 'pneumonian', 'engl', 'j', 'med', '', '2020', '', '382', '', '1199-1207google', 'patients', 'infect', 'sars-cov-2', '', 'especially', 'older', 'patient', 'pre-existing', 'respiratory', 'cardiovascular', 'condition', 'greater', 'risk', 'severe', 'complication', '', 'include', 'severe', 'pneumonia', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'multiple', 'organ', 'failure', '', 'case', '', 'death3grein', 'j', 'ohmagari', 'n', 'shin', 'alcompassionate', 'remdesivir', 'patient', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'april', '10', '', '', 'doi101056nejmoa2007016nejmoa2007016google', '', '4weiss', 'p', 'murdoch', 'dr', 'clinical', 'course', 'mortality', 'risk', 'severe', 'covid-19lancet', '', '2020', '', '395', '', '1014-1015google', '20', '', '2020', '', 'sars-cov-2', 'infect', '47', 'million', 'people', 'across', '215', 'country', 'territory', 'kill', '316', '000', 'worldwide5whocoronavirus', 'disease', '', 'covid-2019', '', 'situation', 'report', '', 'urlplaceholder', '2020date', 'access', '', '5', '', '2020google', 'absence', 'effective', 'prevention', 'measure', '', 'current', 'management', 'control', 'epidemic', 'enforcement', 'quarantine', '', 'isolation', '', 'physical', 'distancing6cowling', 'bj', 'ali', 'st', 'ng', 'twy', 'alimpact', 'assessment', 'non-pharmaceutical', 'intervention', 'coronavirus', 'disease', '2019', 'influenza', 'hong', 'kong', '', 'observational', 'studylancet', 'public', 'health', '', '2020', '', '5', '', 'e279-e288google', '', '7gudbjartsson', 'df', 'helgason', 'jonsson', 'h', 'alspread', 'sars-cov-2', 'icelandic', 'populationn', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'april', '14', '', '', 'doi101056nejmoa2006100google', 'effective', 'vaccine', 'covid-19', 'urgently', 'reduce', 'enormous', 'burden', 'mortality', 'morbidity', 'associate', 'sars-cov-2', 'infection8amanat', 'f', 'krammer', 'f', 'sars-cov-2', 'vaccine', '', 'status', 'reportimmunity', '', '2020', '', '52', '', '583-589google', '100', 'candidate', 'vaccine', 'development', 'worldwide9whodraft', 'landscape', 'covid-19', 'candidate', 'vaccines30', 'april', '2020', 'urlplaceholder', '2020date', 'access', '', '5', '', '2020google', 'among', 'least', 'eight', 'start', 'soon', 'start', 'clinical', 'trial', '', 'include', 'moderna', 'mrna', 'covid-19', 'vaccine', 'cansino', 'non-replicating', 'adenovirus', 'type-5', '', 'ad5', '', 'vectored', 'covid-19', 'vaccine', '', 'enter', 'phase', '1', 'clinical', 'trial', 'march', '16', '', '2020', '', 'inovio', 'pharmaceuticals', '', 'dna', 'vaccine', 'covid-19', '', 'enter', 'trial', 'april', '3', '', '2020', '', 'three', 'inactive', 'covid-19', 'vaccine', 'manufacture', 'sinovac', '', 'wuhan', 'institute', 'biological', 'products', '', 'beijing', 'institute', 'biological', 'products', 'enter', 'clinical', 'trial', 'april', '', '2020', '', 'successively', '', 'university', 'oxford', 'non-replicating', 'chimpanzee', 'adenovirus', 'vectored', 'vaccine', 'chadox1', 'ncov-19', '', 'biontech', 'mrna', 'covid-19', 'vaccine', 'start', 'trial', 'recent', 'month', '', 'research', 'contextevidence', 'studywe', 'search', '8', '', '2020', '', 'clinical', 'trial', 'report', 'term', '', 'covid-19', '', '', 'sars-cov-2', '', '', '', 'vaccine', '', '', '', 'clinical', 'trial', '', 'date', 'language', 'restriction', '', 'data', 'human', 'clinical', 'trial', 'covid-19', 'vaccine', 'report', 'thus', 'far', '', 'knowledge', '', 'search', 'clinicaltrialsgov', 'registry', 'unpublished', 'trial', 'covid-19', 'vaccine', '', '6', '', '2020', '', 'addition', 'adenovirus', 'type-5', '', 'ad5', '', 'vectored', 'covid-19', 'vaccine', 'report', '', 'seven', 'candidate', 'covid-19', 'vaccine', 'ongoing', 'clinical', 'trial', '', 'include', 'moderna', 'mrna', 'covid-19', 'vaccine', '', 'inovio', 'pharmaceuticals', '', 'dna', 'vaccine', '', 'sinovac', '', 'wuhan', 'beijing', 'institute', 'biological', 'products', '', 'inactive', 'covid-19', 'vaccine', '', 'university', 'oxford', 'chimpanzee', 'adenovirus-vectored', 'vaccine', '', 'biontech', 'mrna', 'covid-19', 'vaccineadded', 'value', 'studythis', 'first-in-human', 'trial', 'show', 'ad5', 'vectored', 'covid-19', 'vaccine', 'tolerable', 'immunogenic', 'healthy', 'adult', '', 'one', 'dose', 'vaccine', 'dose', 'concentration', '', '5', '', '1010', '', '1', '', '1011', '', '15', '', '1011', 'viral', 'particle', '', 'test', 'induce', 'specific', 'antibody', 't-cell', 'response', 'participant', '', 'rapid', 'specific', 't-cell', 'response', 'note', 'day', '14', 'specific', 'humoral', 'response', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'peak', 'day', '28', 'post-vaccination', '', 'although', 'find', 'high', 'dose', 'vaccine', 'tend', 'immunogenic', 'middle', 'dose', 'low', 'dose', 'vaccine', '', 'associate', 'higher', 'reactogenicity', '', 'severe', 'fever', '', 'fatigue', '', 'dyspnoea', '', 'muscle', 'pain', '', 'joint', 'pain', 'report', 'recipient', 'high', 'dose', 'groupimplications', 'available', 'evidencemany', 'vaccine', 'candidate', 'rapid', 'development', '', 'include', 'recombinant-protein', 'base', 'vaccine', '', 'replicate', 'non-replicating', 'viral', 'vector-based', 'vaccine', '', 'dna', 'vaccine', '', 'mrna', 'vaccine', '', 'mostly', 'focus', 'spike', 'glycoprotein', 'receptor', 'bind', 'domain', '', '', 'live', 'attenuate', 'vaccine', '', 'inactivate', 'virus', 'vaccine', '', 'vaccine', 'platform', 'advantage', 'disadvantage', '', 'soon', 'predict', 'successful', '', 'study', 'suggest', 'potential', 'investigation', 'ad5', 'vectored', 'covid-19', 'vaccine', 'prevention', 'covid-19', '', 'evidence', 'study', 'search', '8', '', '2020', '', 'clinical', 'trial', 'report', 'term', '', 'covid-19', '', '', 'sars-cov-2', '', '', '', 'vaccine', '', '', '', 'clinical', 'trial', '', 'date', 'language', 'restriction', '', 'data', 'human', 'clinical', 'trial', 'covid-19', 'vaccine', 'report', 'thus', 'far', '', 'knowledge', '', 'search', 'clinicaltrialsgov', 'registry', 'unpublished', 'trial', 'covid-19', 'vaccine', '', '6', '', '2020', '', 'addition', 'adenovirus', 'type-5', '', 'ad5', '', 'vectored', 'covid-19', 'vaccine', 'report', '', 'seven', 'candidate', 'covid-19', 'vaccine', 'ongoing', 'clinical', 'trial', '', 'include', 'moderna', 'mrna', 'covid-19', 'vaccine', '', 'inovio', 'pharmaceuticals', '', 'dna', 'vaccine', '', 'sinovac', '', 'wuhan', 'beijing', 'institute', 'biological', 'products', '', 'inactive', 'covid-19', 'vaccine', '', 'university', 'oxford', 'chimpanzee', 'adenovirus-vectored', 'vaccine', '', 'biontech', 'mrna', 'covid-19', 'vaccine', '', 'added', 'value', 'study', 'first-in-human', 'trial', 'show', 'ad5', 'vectored', 'covid-19', 'vaccine', 'tolerable', 'immunogenic', 'healthy', 'adult', '', 'one', 'dose', 'vaccine', 'dose', 'concentration', '', '5', '', '1010', '', '1', '', '1011', '', '15', '', '1011', 'viral', 'particle', '', 'test', 'induce', 'specific', 'antibody', 't-cell', 'response', 'participant', '', 'rapid', 'specific', 't-cell', 'response', 'note', 'day', '14', 'specific', 'humoral', 'response', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'peak', 'day', '28', 'post-vaccination', '', 'although', 'find', 'high', 'dose', 'vaccine', 'tend', 'immunogenic', 'middle', 'dose', 'low', 'dose', 'vaccine', '', 'associate', 'higher', 'reactogenicity', '', 'severe', 'fever', '', 'fatigue', '', 'dyspnoea', '', 'muscle', 'pain', '', 'joint', 'pain', 'report', 'recipient', 'high', 'dose', 'group', '', 'implications', 'available', 'evidence', 'vaccine', 'candidate', 'rapid', 'development', '', 'include', 'recombinant-protein', 'base', 'vaccine', '', 'replicate', 'non-replicating', 'viral', 'vector-based', 'vaccine', '', 'dna', 'vaccine', '', 'mrna', 'vaccine', '', 'mostly', 'focus', 'spike', 'glycoprotein', 'receptor', 'bind', 'domain', '', '', 'live', 'attenuate', 'vaccine', '', 'inactivate', 'virus', 'vaccine', '', 'vaccine', 'platform', 'advantage', 'disadvantage', '', 'soon', 'predict', 'successful', '', 'study', 'suggest', 'potential', 'investigation', 'ad5', 'vectored', 'covid-19', 'vaccine', 'prevention', 'covid-19', '', '', 'report', 'preliminary', 'assessment', '28', 'day', 'post-vaccination', 'safety', '', 'tolerability', '', 'immunogenicity', 'cansino', 'non-replicating', 'ad5', 'vectored', 'covid-19', 'vaccine', 'healthy', 'adult', 'china', '', 'single-centre', '', 'open-label', '', 'non-randomised', '', 'dose-escalation', 'phase', '1', 'trial', 'ad5', 'vectored', 'covid-19', 'vaccine', 'candidate', 'rehabilitation', 'centre', 'wuhan', '', 'hubei', 'province', '', 'china', '', 'eligible', 'participant', 'healthy', 'adult', 'age', '18', '60', 'year', '', 'sars-cov-2', 'infection', '', 'confirm', 'negative', 'result', 'serum', 'specific', 'igm', 'igg', 'antibody', 'commercial', 'sars-cov-2', 'rapid', 'test', 'kit', '', 'jinwofu', '', 'beijing', '', 'china', '', '', 'negative', 'nucleic', 'acid', 'sars-cov-2', 'pharyngeal', 'swab', 'sputum', 'anal', 'swab', 'detect', 'nucleic', 'acid', 'diagnostic', 'kit', '', 'pcr-fluorescence', 'probe', '', 'sansure', 'biotech', '', 'changsha', '', 'china', '', '', 'clear', 'chest', 'ct', 'image', 'evidence', 'lesion', 'lung', 'time', 'screen', '', 'exclusion', 'criterion', 'history', 'seizure', 'mental', 'illness', '', 'allergy', 'ingredient', 'include', 'vaccine', '', 'acute', 'febrile', 'disease', 'day', 'enrolment', '', 'receipt', 'blood', 'product', 'past', '4', 'month', '', 'receipt', 'research', 'medicine', 'vaccine', 'past', 'month', '', 'unable', 'comply', 'study', 'schedule', '', 'detail', 'outline', 'protocol10zhu', 'f-c', 'guan', 'x-h', 'wang', 'w', 'alprotocol', '', 'single-center', '', 'open-label', '', 'dose-escalating', 'phase', 'clinical', 'trial', 'recombinant', 'novel', 'coronavirus', 'vaccine', '', 'adenovirus', 'type', '5', 'vector', '', 'healthy', 'adult', 'age', '18', '60', 'year', 'china', '', 'urlplaceholder', '2020date', 'access', '', '20', '', '2020google', 'participants', 'sequentially', 'enrol', 'receive', 'single', 'intramuscular', 'injection', 'dose-escalating', 'manner', '', 'first', 'group', 'participant', 'allocate', 'receive', 'low', 'dose', '', 'follow', 'minimum', '3', 'day', 'proceed', 'recruit', 'participant', 'receive', 'middle', 'dose', '', 'safety', 'observation', '3', 'day', '', 'last', 'group', 'participant', 'recruit', 'allocate', 'receive', 'high', 'dose', '', 'administration', 'higher', 'dose', 'injection', 'new', 'enrolment', 'pause', 'criterion', 'pause', 'dose', 'escalation', 'meet', '', 'protocol', 'inform', 'consent', 'approve', 'institutional', 'review', 'board', 'jiangsu', 'provincial', 'center', 'disease', 'control', 'prevention', '', 'written', 'inform', 'consent', 'participant', 'obtain', 'screen', '', 'study', 'undertake', 'jiangsu', 'provincial', 'center', 'disease', 'control', 'prevention', '', 'hubei', 'provincial', 'center', 'disease', 'control', 'prevention', '', 'tongji', 'hospital', '', 'tongji', 'medical', 'college', '', 'huazhong', 'university', 'science', 'technology', 'accordance', 'declaration', 'helsinki', 'clinical', 'practice', '', 'ad5', 'vectored', 'covid-19', 'vaccine', 'develop', 'beijing', 'institute', 'biotechnology', '', 'beijing', '', 'china', '', 'cansino', 'biologics', '', 'tianjin', '', 'china', '', '', 'vaccine', 'replication', 'defective', 'ad5', 'vectored', 'vaccine', 'express', 'spike', 'glycoprotein', 'sars-cov-2', '', 'clone', 'optimise', 'full-length', 'spike', 'gene', 'base', 'wuhan-hu-1', '', 'genbank', 'accession', 'number', 'yp009724390', '', 'tissue', 'plasminogen', 'activator', 'signal', 'peptide', 'gene', 'e1', 'e3', 'delete', 'ad5', 'vector', '', 'construct', 'ad5', 'vectored', 'covid-19', 'vaccine', 'admax', 'system', 'microbix', 'biosystem', '', 'toronto', '', '', 'canada', '', '', 'ad5', 'vectored', 'covid-19', 'vaccine', 'manufacture', 'liquid', 'formulation', 'contain', '5', '', '1010', 'viral', 'particle', 'per', '05', 'ml', 'vial', '', 'single', 'shoot', 'allocate', 'intramuscularly', 'arm', 'participant', 'low', 'dose', 'group', '', 'one', 'vial', 'ad5', 'vectored', 'covid-19', 'vaccine', '', '5', '', '1010', 'viral', 'particle', 'per', '05', 'ml', '', '', 'participant', 'middle', 'dose', 'group', 'receive', 'one', 'shoot', 'intramuscularly', 'arm', 'two', 'vial', 'ad5', 'vectored', 'covid-19', 'vaccine', '', '1', '', '1011', 'viral', 'particle', 'per', 'ml', '', '', 'participants', 'high', 'dose', 'group', 'receive', 'double-shot', 'regimen', 'one', 'vial', 'ad5', 'vectored', 'covid-19', 'vaccine', 'one', 'arm', 'two', 'vial', 'ad5', 'vectored', 'covid-19', 'vaccine', 'arm', '', '15', '', '1011', 'viral', 'particle', 'per', '15', 'ml', '', '', 'adverse', 'event', 'self-reported', 'participant', '', 'verify', 'investigator', 'daily', 'first', '14', 'day', 'vaccination', '', 'subsequently', '', 'adverse', 'event', 'record', 'participant', 'diary', 'card', 'follow', 'week', '', 'laboratory', 'safety', 'test', 'include', 'white', 'blood', 'cell', 'count', '', 'lymphocyte', 'count', '', 'neutrophil', '', 'platelet', '', 'haemoglobin', '', 'alanine', 'aminotransferase', '', 'aspartate', 'aminotransferase', '', 'total', 'bilirubin', '', 'fast', 'blood', 'glucose', '', 'creatinine', 'measure', 'day', '7', 'ass', 'toxic', 'effect', 'post-vaccination', '', 'grade', 'adverse', 'event', 'abnormal', 'change', 'laboratory', 'test', 'accord', 'scale', 'issue', 'china', 'state', 'food', 'drug', 'administration', '', 'version', '2019', '', '11national', 'medical', 'products', 'administration', 'urlplaceholder', '2019date', 'access', '', '20', '', '2020google', 'blood', 'sample', 'participant', 'serology', 'test', 'schedule', 'site', 'visit', 'vaccination', '', 'day', '14', '28', 'vaccination', '', 'assess', 'bind', 'antibody', 'response', 'receptor', 'bind', 'domain', '', 'rbd', '', 'spike', 'glycoprotein', 'elisa', 'kit', 'manufacture', 'beijing', 'wantai', 'biopharm', '', 'beijing', '', 'china', '', '', 'dilution', '140', 'positivity', 'cutoff', 'value', 'elisa', '', 'measure', 'neutralise', 'antibody', 'response', 'induce', 'vaccination', 'live', 'sars-cov-2', 'virus', 'neutralisation', '', 'virus', 'strain', 'sars-cov-2humanchnwuhanime-bj012020', '', 'genbank', 'number', 'mt2918311', '', 'pseudovirus', 'neutralisation', 'test', '', 'vesicular', 'stomatitis', 'virus', 'pseudovirus', 'system', 'express', 'spike', 'glycoprotein', '', '12nie', 'j', 'li', 'q', 'wu', 'j', 'alestablishment', 'validation', 'pseudovirus', 'neutralization', 'assay', 'sars-cov-2emerg', 'microbes', 'infect', '', '2020', '', '9', '', '680-686google', 'peripheral', 'blood', 'mononuclear', 'cell', 'isolate', 'whole', 'blood', 'vaccination', 'day', '14', '28', 'post-vaccination', '', 'specific', 't-cell', 'response', 'quantify', 'interferon', '', 'ifn', '', '', 'enzyme-linked', 'immunospot', '', 'elispot', '', 'assay', 'fresh', 'peripheral', 'blood', 'mononuclear', 'cell', 'stimulate', 'overlap', 'spike', 'glycoprotein', 'peptide', 'pool', '1224', 'h', 'detection', '', 'express', 'number', 'spot-forming', 'cell', 'per', '100', '000', 'cell', '', 'measurement', 'subtract', 'unstimulated', 'control', 'value', '', 'minus', 'value', 'correct', 'zero', '', 'result', 'consider', 'positive', 'least', 'two-time', 'increase', 'number', 'ifn', 'secrete', 'cell', 'post-vaccination', '', 'assess', 'cd4', 'cd8', 't-cell', 'response', 'vaccination', 'accord', 'secretion', 'ifn', '', 'interleukin-2', '', 'il-2', '', '', 'tumour', 'necrosis', 'factor', '', '', 'certolizumab', '', '', 'measure', 'intracellular', 'cytokine', 'stain', 'assay', 'peripheral', 'blood', 'mononuclear', 'cell', 'stimulation', 'overlap', 'spike', 'glycoprotein', 'peptide', 'pool', '6', 'h', 'detect', 'flow', 'cytometry', '', 'similar', 'method', 'measure', 't-cell', 'response', 'intracellular', 'cytokine', 'stain', 'assay', 'report', 'previously13ewer', 'k', 'rampling', 'venkatraman', 'n', 'ala', 'monovalent', 'chimpanzee', 'adenovirus', 'ebola', 'vaccine', 'boost', 'mvan', 'engl', 'j', 'med', '', '2016', '', '374', '', '1635-1646google', '', '14de', 'santis', 'audran', 'r', 'pothin', 'e', 'alsafety', 'immunogenicity', 'chimpanzee', 'adenovirus-vectored', 'ebola', 'vaccine', 'healthy', 'adult', '', 'randomise', '', 'double-blind', '', 'placebo-controlled', '', 'dose-finding', '', 'phase', '12a', 'studylancet', 'infect', 'dis', '', '2016', '', '16', '', '311-320google', 'pre-vaccination', 'post-vaccination', 'anti-ad5', 'neutralise', 'antibody', 'titre', 'detect', 'serum', 'neutralisation', 'assay15sprangers', 'mc', 'lakhai', 'w', 'koudstaal', 'w', 'alquantifying', 'adenovirus-neutralizing', 'antibody', 'luciferase', 'transgene', 'detection', '', 'address', 'preexist', 'immunity', 'vaccine', 'gene', 'therapy', 'vectorsj', 'clin', 'microbiol', '', '2003', '', '41', '', '5046-5052google', 'analyse', 'outcome', 'intention-to-treat', 'cohort', '', 'primary', 'endpoint', 'safety', 'occurrence', 'adverse', 'reaction', 'within', '7', 'day', 'vaccination', '', 'abnormal', 'change', 'laboratory', 'measure', '7', 'day', 'post-vaccination', '', 'adverse', 'event', 'within', '28', 'day', 'across', 'treatment', 'group', 'analyse', 'secondary', 'safety', 'endpoint', '', 'specific', 'elisa', 'antibody', 'titre', 'rbd', 'spike', 'glycoprotein', '', 'neutralise', 'antibody', 'amount', 'live', 'sars-cov-2', 'pseudovirus', 'measure', 'humoral', 'immunogenicity', 'endpoint', '', 'define', 'positive', 'antibody', 'response', '', 'seroconversion', '', 'least', 'four-fold', 'increase', 'post-vaccination', 'titre', 'baseline', '', 'elispot', 'ifn', 'positive', 't-cell', 'response', 'measure', 'intracellular', 'cytokine', 'stain', 'assay', 'compare', 'across', 'group', 'endpoint', 'cell-mediated', 'response', '', 'stratified', 'analysis', 'immune', 'response', 'base', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', 'among', 'participant', 'low', 'negative', '', '1200', '', 'high', '', '', '1200', '', '', 'sample', 'size', 'determine', 'basis', 'statistical', 'power', 'calculation', '', 'however', '', 'minimum', 'sample', 'size', '2030', 'participant', 'pilot', 'vaccine', 'trial', 'recommend', 'national', 'medical', 'products', 'administration', '', 'china', '', 'assess', 'number', 'proportion', 'participant', 'adverse', 'reaction', 'post-vaccination', 'compare', 'safety', 'profile', 'across', 'dose', 'group', '', 'antibody', 'sars-cov-2', 'present', 'geometric', 'mean', 'titre', '95', '', 'cis', 'cellular', 'response', 'show', 'proportion', 'positive', 'responder', '', '2', 'test', 'fisher', 'exact', 'test', 'analyse', 'categorical', 'data', '', 'anova', 'analyse', 'log', 'transform', 'antibody', 'titre', '', 'wilcoxon', 'rank-sum', 'test', 'data', 'normally', 'distribute', '', 'overall', 'difference', 'across', 'three', 'group', 'significant', '', 'pairwise', 'comparison', 'difference', 'group', 'estimate', '95', '', 'cis', '', 'multivariable', 'analysis', 'establish', 'possible', 'effect', 'immunogenicity', 'safety', 'profile', 'vaccine', 'candidate', '', 'hypothesis', 'test', 'two-sided', '', 'value', '005', '', 'statistical', 'analysis', 'statistician', 'sas', '', 'version', '94', '', 'graphpad', 'prism', '801', '', 'spice', '', 'version', '60', '', 'analysis', 'data', 'multicolour', 'flow', 'cytometry', 'experiment', '', 'independent', 'data', 'safety', 'monitor', 'committee', '', 'one', 'independent', 'statistician', '', 'one', 'clinician', '', 'one', 'epidemiologist', '', 'establish', 'start', 'trial', '', 'safety', 'data', 'first', '3', 'day', 'post-vaccination', 'assess', 'review', 'committee', 'ensure', 'sufficient', 'hold', 'time', 'dose', 'escalation', '', 'study', 'register', 'clinicaltrialsgov', '', 'nct04313127', '', 'sponsor', 'study', 'participate', 'study', 'design', '', 'role', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'author', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', 'march', '16', 'march', '27', '', '2020', '', 'screen', '195', 'individual', 'eligibility', '', '', '108', 'sequentially', 'enrol', 'assign', 'receive', 'low', 'dose', '', 'n36', '', '33', '', '', '', '', 'middle', 'dose', '', 'n36', '', '33', '', '', '', '', 'high', 'dose', '', 'n36', '', '33', '', '', '', 'ad5', 'vectored', 'covid-19', 'vaccine', '', 'appendix', 'p', '2', '', '', 'participant', 'complete', 'vaccination', 'schedule', 'visit', 'within', '28', 'day', '', 'baseline', 'characteristic', 'participant', 'similar', 'across', 'treatment', 'group', '', 'table', '1', '', 'table', '1baseline', 'characteristicslow', 'dose', 'group', '', 'n36', '', 'middle', 'dose', 'group', '', 'n36', '', 'high', 'dose', 'group', '', 'n36', '', 'age', '', 'years18299', '', '25', '', '', '12', '', '33', '', '', '10', '', '28', '', '', '303913', '', '36', '', '', '14', '', '39', '', '', '15', '', '42', '', '', '40498', '', '22', '', '', '3', '', '8', '', '', '7', '', '19', '', '', '50606', '', '17', '', '', '7', '', '19', '', '', '4', '', '11', '', '', 'mean', 'age', '', 'years372', '', '107', '', '363', '', '115', '', '355', '', '101', '', 'sexmale18', '', '50', '', '', '19', '', '53', '', '', '18', '', '50', '', '', 'female18', '', '50', '', '', '17', '', '47', '', '', '18', '', '50', '', '', 'mean', 'body-mass', 'index', '', 'kgm2233', '', '27', '', '239', '', '27', '', '241', '', '31', '', 'underlying', 'disease', '', '', 'seven', 'participant', 'hypertension', '', 'chronic', 'bronchitis', '', 'gout', '', 'carrier', 'hepatitis', 'b', 'virusyes1', '', '3', '', '', '2', '', '6', '', '', '4', '', '11', '', '', 'no35', '', '97', '', '', '34', '', '94', '', '', '32', '', '89', '', '', 'pre-existing', 'adenovirus', 'type-5', 'neutralise', 'antibodymean', 'gmt1689', '', '139', '', '1495', '', '105', '', '1150', '', '134', '', '200', '', 'titre16', '', '44', '', '', '17', '', '47', '', '', '20', '', '56', '', '', '', '200', '', 'titre20', '', '56', '', '', '19', '', '53', '', '', '16', '', '44', '', '', 'data', 'n', '', '', '', 'mean', '', 'sd', '', '', 'gmtgeometric', 'mean', 'titre', '', '', 'seven', 'participant', 'hypertension', '', 'chronic', 'bronchitis', '', 'gout', '', 'carrier', 'hepatitis', 'b', 'virus', '', 'open', 'table', 'new', 'tab', 'data', 'n', '', '', '', 'mean', '', 'sd', '', '', 'gmtgeometric', 'mean', 'titre', '', '87', '', '81', '', '', '108', 'participant', 'report', 'least', 'one', 'adverse', 'reaction', 'within', 'first', '7', 'day', 'vaccination', '', '30', '', '83', '', '', 'low', 'dose', 'group', '', '30', '', '83', '', '', 'middle', 'dose', 'group', '', '27', '', '75', '', '', 'high', 'dose', 'group', '', 'table', '2', '', '', 'significant', 'difference', 'overall', 'number', 'adverse', 'reaction', 'across', 'treatment', 'group', 'observe', '', 'common', 'injection', 'site', 'adverse', 'reaction', 'pain', '', 'report', '58', '', '54', '', '', 'vaccine', 'recipient', '', 'pain', 'report', '17', '', '47', '', '', 'participant', 'low', 'dose', 'group', '', '20', '', '56', '', '', 'participant', 'middle', 'dose', 'group', '', '21', '', '58', '', '', 'participant', 'high', 'dose', 'group', '', 'commonly', 'report', 'systematic', 'adverse', 'reaction', 'overall', 'fever', '', '50', '', '46', '', '', '', '', 'fatigue', '', '47', '', '44', '', '', '', '', 'headache', '', '42', '', '39', '', '', '', '', 'muscle', 'pain', '', '18', '', '17', '', '', '', '', 'fever', 'report', '15', '', '42', '', '', 'participant', 'low', 'dose', 'group', '', '15', '', '42', '', '', 'participant', 'middle', 'dose', 'group', '', '20', '', '56', '', '', 'participant', 'high', 'dose', 'group', '', 'headache', 'report', '14', '', '39', '', '', 'participant', 'low', 'dose', 'group', '', '11', '', '31', '', '', 'participant', 'middle', 'dose', 'group', '', '17', '', '47', '', '', 'participant', 'high', 'dose', 'group', '', 'muscle', 'pain', 'report', 'seven', '', '19', '', '', 'participant', 'low', 'dose', 'group', '', 'three', '', '8', '', '', 'participant', 'middle', 'dose', 'group', '', 'eight', '', '22', '', '', 'participant', 'high', 'dose', 'group', '', 'adverse', 'reaction', 'mild', 'moderate', 'severity', '', 'nine', 'participant', '', 'two', '', '6', '', '', 'low', 'dose', 'group', '', 'two', '', '6', '', '', 'middle', 'dose', 'group', '', 'five', '', '14', '', '', 'high', 'dose', 'group', '', 'episode', 'severe', 'fever', '', 'grade', '3', '', 'axillary', 'temperature', 'greater', '385c', '', '', 'one', '', '3', '', '', 'high', 'dose', 'group', 'report', 'severe', 'fever', 'along', 'severe', 'symptom', 'fatigue', '', 'dyspnoea', '', 'muscle', 'pain', '', 'one', 'participant', 'high', 'dose', 'group', 'report', 'severe', 'fatigue', 'joint', 'pain', '', 'appendix', 'p', '3', '', '', 'reaction', 'occur', 'within', '24', 'h', 'post-vaccination', '', 'persist', '48', 'h', 'find', 'significant', 'difference', 'incidence', 'adverse', 'reaction', 'overall', 'adverse', 'event', 'among', 'dose', 'group', '', 'high', 'pre-existing', 'ad5', 'immunity', '', 'titre', '', '1200', 'v', '1200', '', 'associate', 'significantly', 'fewer', 'occurrence', 'fever', 'post-vaccination', '', 'odds', 'ratio', '03', '', '95', '', 'ci', '0106', '', 'appendix', 'p', '4', '', '', 'serious', 'adverse', 'event', 'report', 'within', '28', 'day', '', 'day', '7', 'vaccination', '', 'nine', '', '8', '', '', 'participant', 'mild', 'moderate', 'total', 'bilirubin', 'increase', '', 'ten', '', '9', '', '', 'alanine', 'aminotransferase', 'increase', '', 'four', '', '4', '', '', 'fast', 'hyperglycaemia', '', 'appendix', 'p', '5', '', '', 'instance', 'consider', 'clinically', 'significanttable', '2adverse', 'reaction', 'within', '7', 'day', 'overall', 'adverse', 'event', 'within', '28', 'day', 'vaccinationlow', 'dose', 'group', '', 'n36', '', 'middle', 'dose', 'group', '', 'n36', '', 'high', 'dose', 'group', '', 'n36', '', 'total', '', 'n108', '', 'adverse', 'reaction', 'within', '07', 'daysany30', '', '83', '', '', '30', '', '83', '', '', '27', '', '75', '', '', '87', '', '81', '', '', 'grade', '32', '', '6', '', '', '2', '', '6', '', '', '6', '', '17', '', '', '10', '', '9', '', '', 'injection', 'site', 'adverse', 'reaction', 'within', '07', 'dayspain17', '', '47', '', '', '20', '', '56', '', '', '21', '', '58', '', '', '58', '', '54', '', '', 'induration2', '', '6', '', '', '1', '', '3', '', '', '1', '', '3', '', '', '4', '', '4', '', '', 'redness2', '', '6', '', '', '1', '', '3', '', '', '1', '', '3', '', '', '4', '', '4', '', '', 'swelling4', '', '11', '', '', '4', '', '11', '', '', '08', '', '7', '', '', 'itch2', '', '6', '', '', '3', '', '8', '', '', '05', '', '5', '', '', 'muscular', 'weakness001', '', '3', '', '', '1', '', '1', '', '', 'systemic', 'adverse', 'reaction', 'within', '07', 'daysfever15', '', '42', '', '', '15', '', '42', '', '', '20', '', '56', '', '', '50', '', '46', '', '', 'grade', '3', 'fever2', '', '6', '', '', '2', '', '6', '', '', '5', '', '14', '', '', '9', '', '8', '', '', 'headache14', '', '39', '', '', '11', '', '31', '', '', '17', '', '47', '', '', '42', '', '39', '', '', 'fatigue17', '', '47', '', '', '14', '', '39', '', '', '16', '', '44', '', '', '47', '', '44', '', '', 'grade', '3', 'fatigue002', '', '6', '', '', '2', '', '2', '', '', 'vomiting1', '', '3', '', '', '01', '', '3', '', '', '2', '', '2', '', '', 'diarrhoea3', '', '8', '', '', '4', '', '11', '', '', '5', '', '14', '', '', '12', '', '11', '', '', 'muscle', 'pain7', '', '19', '', '', '3', '', '8', '', '', '8', '', '22', '', '', '18', '', '17', '', '', 'grade', '3', 'muscle', 'pain001', '', '3', '', '', '1', '', '1', '', '', 'joint', 'pain2', '', '6', '', '', '2', '', '6', '', '', '5', '', '14', '', '', '9', '', '8', '', '', 'grade', '3', 'joint', 'pain001', '', '3', '', '', '1', '', '1', '', '', 'throat', 'pain1', '', '3', '', '', '3', '', '8', '', '', '4', '', '11', '', '', '8', '', '7', '', '', 'cough1', '', '3', '', '', '2', '', '6', '', '', '3', '', '8', '', '', '6', '', '6', '', '', 'nausea2', '', '6', '', '', '1', '', '3', '', '', '3', '', '8', '', '', '6', '', '6', '', '', 'functional', 'gi', 'disorder1', '', '3', '', '', '001', '', '1', '', '', 'dyspnoea002', '', '6', '', '', '2', '', '2', '', '', 'grade', '3', 'dyspnoea001', '', '3', '', '', '1', '', '1', '', '', 'appetite', 'impaired6', '', '17', '', '', '5', '', '14', '', '', '6', '', '17', '', '', '17', '', '16', '', '', 'dizziness1', '', '3', '', '', '01', '', '3', '', '', '2', '', '2', '', '', 'mucosal', 'abnormality001', '', '3', '', '', '1', '', '1', '', '', 'pruritus1', '', '3', '', '', '1', '', '3', '', '', '1', '', '3', '', '', '3', '', '3', '', '', 'overall', 'adverse', 'event', 'within', '028', 'daysany31', '', '86', '', '', '30', '', '83', '', '', '27', '', '75', '', '', '88', '', '81', '', '', 'grade', '32', '', '6', '', '', '2', '', '6', '', '', '6', '', '17', '', '', '10', '', '9', '', '', 'data', 'n', '', '', '', '', 'refer', 'participant', 'grade', 'adverse', 'reaction', 'event', '', 'adverse', 'reaction', 'event', 'grade', 'accord', 'scale', 'issue', 'china', 'state', 'food', 'drug', 'administration', '', 'grade', '3severe', '', 'ie', '', 'prevent', 'activity', '', '', 'gigastrointestinal', '', 'open', 'table', 'new', 'tab', 'data', 'n', '', '', '', '', 'refer', 'participant', 'grade', 'adverse', 'reaction', 'event', '', 'adverse', 'reaction', 'event', 'grade', 'accord', 'scale', 'issue', 'china', 'state', 'food', 'drug', 'administration', '', 'grade', '3severe', '', 'ie', '', 'prevent', 'activity', '', '', 'gigastrointestinal', '', 'rapid', 'bind', 'antibody', 'response', 'rbd', 'observe', 'three', 'dose', 'group', 'day', '14', '', 'table', '3', '', '', 'day', '28', '', 'recipient', 'high', 'dose', 'group', 'tend', 'higher', 'bind', 'antibody', 'geometric', 'mean', 'titre', '14458', '', '95', '', 'ci', '935522345', '', '', 'follow', '8060', '', '528212299', '', 'middle', 'dose', 'group', '', '6158', '', '40549355', '', 'low', 'dose', 'group', '', 'high', 'dose', 'v', 'low', 'dose', '16115', '', '531526915', '', '', 'least', 'four-fold', 'increase', 'anti-rbd', 'antibody', 'note', '35', '', '97', '', '', '36', 'participant', 'low', 'dose', 'group', '', '34', '', '94', '', '', '36', 'middle', 'dose', 'group', '', '36', '', '100', '', '', '36', 'high', 'dose', 'group', '', 'neutralising', 'antibody', 'live', 'sars-cov-2', 'negative', 'day', '0', '', 'increase', 'moderately', 'day', '14', '', 'peak', '28', 'day', 'post-vaccination', '', 'neutralising', 'antibody', 'titre', 'geometric', 'mean', 'titre', '340', '', '95', '', 'ci', '226501', '', 'note', 'high', 'dose', 'group', '', 'significantly', 'higher', 'compare', '162', '', '104252', '', 'middle', 'dose', 'group', '145', '', '96218', '', 'low', 'dose', 'group', '', 'estimate', 'difference', '277', '', '10544', '', 'high', 'dose', 'group', 'middle', 'dose', 'group', '332', '', '65599', '', 'high', 'dose', 'group', 'low', 'dose', 'group', 'day', '28', '', 'meanwhile', '', '18', '', '50', '', '', 'participant', 'low', 'dose', 'group', '', '18', '', '50', '', '', 'middle', 'dose', 'group', '', '27', '', '75', '', '', 'high', 'dose', 'group', 'least', 'four-fold', 'increase', 'neutralise', 'antibody', 'titre', 'day', '28', '', 'similar', 'pattern', 'bind', 'antibody', 'spike', 'glycoprotein', 'neutralise', 'antibody', 'titre', 'pseudovirus', 'post-vaccination', 'across', 'dose', 'group', 'note', '', 'appendix', 'p', '6', '', '', 'association', 'elisa', 'antibody', 'rbd', 'neutralise', 'antibody', 'titre', 'live', 'virus', 'show', 'moderate', 'positive', 'correlation', '0749', '', 'elisa', 'antibody', 'spike', 'glycoprotein', 'neutralise', 'antibody', 'titre', 'live', 'virus', '0753', '', 'peak', 'antibody', 'response', '', 'p', '', '00001', '', '', 'neutralise', 'antibody', 'titre', 'measure', 'pseudovirus', 'correlate', 'well', 'measure', 'live', 'sars-cov-2', '', 'appendix', 'p', '7', '', 'table', '3specific', 'antibody', 'response', 'receptor', 'bind', 'domain', '', 'neutralise', 'antibody', 'live', 'sars-cov-2day', '14day', '28low', 'dose', 'group', '', 'n36', '', 'middle', 'dose', 'group', '', 'n36', '', 'high', 'dose', 'group', '', 'n36', '', 'p', 'valuelow', 'dose', 'group', '', 'n36', '', 'middle', 'dose', 'group', '', 'n36', '', 'high', 'dose', 'group', '', 'n36', '', 'p', 'valueelisa', 'antibody', 'receptor', 'bind', 'domaingmt765', '', '4431320', '', '912', '', '5591487', '', '1326', '', '8072180', '', '0296158', '', '40549355', '', '8060', '', '528212299', '', '14458', '', '935522345', '', '00164-fold', 'increase16', '', '44', '', '', '18', '', '50', '', '', '22', '', '61', '', '', '03535', '', '97', '', '', '34', '', '94', '', '', '36', '', '100', '', '', '077neutralising', 'antibody', 'live', 'sars-cov-2gmt82', '', '58115', '', '96', '', '66141', '', '127', '', '85190', '', '024145', '', '96218', '', '162', '', '104252', '', '340', '', '226501', '', '000824-fold', 'increase10', '', '28', '', '', '11', '', '31', '', '', '15', '', '42', '', '', '04218', '', '50', '', '', '18', '', '50', '', '', '27', '', '75', '', '', '0046data', 'mean', '', '95', '', 'ci', '', 'n', '', '', '', '', 'p', 'value', 'result', 'comparison', 'across', 'three', 'dose', 'group', '', 'difference', 'significant', 'across', 'three', 'group', '', 'difference', 'group', 'estimate', '95', '', 'cis', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'gmtgeometric', 'mean', 'titre', '', 'open', 'table', 'new', 'tab', 'data', 'mean', '', '95', '', 'ci', '', 'n', '', '', '', '', 'p', 'value', 'result', 'comparison', 'across', 'three', 'dose', 'group', '', 'difference', 'significant', 'across', 'three', 'group', '', 'difference', 'group', 'estimate', '95', '', 'cis', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'gmtgeometric', 'mean', 'titre', '', 'vaccination', '', '20', '', '56', '', '', 'participant', 'low', 'dose', 'group', '', '19', '', '53', '', '', 'participant', 'middle', 'dose', 'group', '', '16', '', '44', '', '', 'participant', 'high', 'dose', 'group', 'high', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', '', '', '1200', '', '', 'five', '', '25', '', '', 'participant', '20', 'low', 'dose', 'group', '', 'seven', '', '37', '', '', 'participant', '19', 'middle', 'dose', 'group', '', 'ten', '', '63', '', '', 'participant', '16', 'high', 'dose', 'group', '', 'high', 'pre-existing', 'ad5', 'immunity', '', 'least', 'four-fold', 'increase', 'neutralise', 'antibody', 'titre', 'day', '28', 'post-vaccination', '', 'appendix', 'pp', '810', '', '', 'multivariable', 'analysis', 'show', 'high', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', 'compromise', 'seroconversion', 'neutralise', 'antibody', 'post-vaccination', '', 'regardless', 'vaccine', '', 'recipient', 'age', '4560', 'year', 'lower', 'seroconversion', 'neutralise', 'antibody', 'compare', 'younger', 'recipient', '', 'appendix', 'p', '11', '', '', 'ad5', 'neutralise', 'antibody', 'significantly', 'boost', 'post-vaccination', '', 'appendix', 'p', '12', '', '', 'elispot', 'response', 'baseline', 'undetectable', 'spot-forming', 'cell', 'level', 'detection', 'assay', 'participant', '', 'peak', 'day', '14', 'post-vaccination', '', 'proportion', 'positive', 'responder', 'range', '8397', '', 'across', 'dose', 'group', '', 'mean', 'number', 'spot-forming', 'cell', 'per', '100', '000', 'cell', '208', '', '95', '', 'ci', '127340', '', 'low', 'dose', 'group', '', '408', '', '276603', '', 'middle', 'dose', 'group', '', '580', '', '391859', '', 'high', 'dose', 'group', '', 'figure', '1', '', '', 't-cell', 'response', 'high', 'dose', 'group', 'significantly', 'higher', 'low', 'dose', 'group', '', 'p', '', '00010', '', '', 'significant', 'compare', 'middle', 'dose', 'group', '', 'slight', 'decrease', 't-cell', 'response', 'across', 'dose', 'group', 'note', 'day', '28', '', 'high', 'level', 'baseline', 'ad5', 'neutralise', 'antibody', 'titre', 'reduce', 'peak', 'post-vaccination', 't-cell', 'response', 'dose', 'group', '', 'particularly', 'low', 'dose', 'group', '', 'despite', 'effect', 'high', 'pre-existing', 'ad5', 'immunity', '', 'positive', 'responder', 'identify', '15', '', '75', '', '', '20', 'participant', 'low', 'dose', 'group', '', '18', '', '95', '', '', '19', 'participant', 'middle', 'dose', 'group', '', '15', '', '94', '', '', '16', 'participant', 'high', 'dose', 'group', 'day', '14', '', '12', '', '60', '', '', '20', 'participant', 'low', 'dose', 'group', '', '16', '', '84', '', '', '19', 'participant', 'middle', 'dose', 'group', '', '16', '', '100', '', '', '16', 'participant', 'high', 'dose', 'group', 'day', '28figure', '1specific', 't-cell', 'response', 'measure', 'elispotshow', 'full', 'caption', '', '', 'number', 'specific', 'cell', 'secretion', 'ifn', 'day', '0', '', '14', '', '28', 'participant', '', 'stratify', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', '', '', 'b', '', 'proportion', 'positive', 'elispot', 'responder', 'day', '14', '28', 'post-vaccination', 'participant', '', 'stratify', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', '', 'ifninterferon', '', 'pbmcsperipheral', 'blood', 'mononuclear', 'cell', '', 'ad5adenovirus', 'type-5', '', 'elispotenzyme-linked', 'immunospotview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'number', 'specific', 'cell', 'secretion', 'ifn', 'day', '0', '', '14', '', '28', 'participant', '', 'stratify', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', '', '', 'b', '', 'proportion', 'positive', 'elispot', 'responder', 'day', '14', '28', 'post-vaccination', 'participant', '', 'stratify', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'titre', '', 'ifninterferon', '', 'pbmcsperipheral', 'blood', 'mononuclear', 'cell', '', 'ad5adenovirus', 'type-5', '', 'elispotenzyme-linked', 'immunospot', '', 'ifn', 'detect', 'cd4', 'cd8', 'cell', 'vaccination', 'day', '14', '28', '', 'dose', 'group', '', 'figure', '2', '', 'appendix', 'p', '13', '', '', 'certolizumab', 'expression', 'cd4', 'cell', 'tend', 'significantly', 'lower', 'low', 'dose', 'group', 'high', 'dose', '', 'p', '', '00001', '', 'middle', 'dose', 'group', '', 'p00032', '', '', 'day', '14', '', 'certolizumab', 'expression', 'cd8', 'cell', 'show', 'overall', 'p', 'value', 'le', '00001', 'across', 'three', 'group', 'day', '14', '', 'certolizumab', 'expression', 'cd8', 'cell', 'tend', 'higher', 'high', 'dose', 'group', 'middle', 'dose', 'group', '', 'p0016', '', 'low', 'dose', 'group', '', 'p', '', '00001', '', '', 'p', 'value', 'pairwise', 'comparison', 'group', '', 'amounts', 'il-2', 'detect', 'cd4', 'cell', 'higher', 'detect', 'cd8', 'cell', '', 'proportion', 'polyfunctional', 'phenotype', 'detect', 'memory', 'cd4', 'cell', 'higher', 'cd8', 'cell', '', 'higher', 'proportion', 'polyfunctional', 'phenotype', 'note', 'higher', 'vaccine', '', 'note', 'pre-existing', 'ad5', 'neutralise', 'antibody', 'negative', 'effect', 'pattern', 't-cell', 'response', '', 'appendix', 'pp', '1416', '', '', 'post-hoc', 'analysis', 'show', '28', '', '78', '', '', 'participant', 'low', 'dose', 'group', '', '33', '', '92', '', '', 'participant', 'middle', 'dose', 'group', '', '36', '', '100', '', '', 'participant', 'high', 'dose', 'group', 'show', 'either', 'positive', 't-cell', 'response', 'spike', 'glycoprotein', 'seroconversion', 'neutralise', 'antibody', 'live', 'sars-cov-2', '', 'day', '28', 'post-vaccination', '', 'appendix', 'p', '17', '', 'figure', '2flow', 'cytometry', 'intracellular', 'cytokine', 'stain', 'vaccinationshow', 'full', 'caption', '', '', 'percentage', 'cell', 'secrete', 'ifn', '', 'certolizumab', '', 'il-2', 'cd4', 'cell', '', '', 'b', '', 'percentage', 'cell', 'secrete', 'ifn', '', 'certolizumab', '', 'il-2', 'cd8', 'cell', '', '', 'c', '', 'proportion', 'cd4', 'cell', 'cd8', 'cell', 'produce', 'combination', 'ifn', '', 'certolizumab', '', 'il-2', '', 'analysis', '108', 'participant', '', '36', 'dose', 'group', '', 'ifninterferon', '', 'tnftumour', 'necrosis', 'factor', '', 'ilinterleukinview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'percentage', 'cell', 'secrete', 'ifn', '', 'certolizumab', '', 'il-2', 'cd4', 'cell', '', '', 'b', '', 'percentage', 'cell', 'secrete', 'ifn', '', 'certolizumab', '', 'il-2', 'cd8', 'cell', '', '', 'c', '', 'proportion', 'cd4', 'cell', 'cd8', 'cell', 'produce', 'combination', 'ifn', '', 'certolizumab', '', 'il-2', '', 'analysis', '108', 'participant', '', '36', 'dose', 'group', '', 'ifninterferon', '', 'tnftumour', 'necrosis', 'factor', '', 'ilinterleukin', '', 'exclude', 'possible', 'sars-cov-2', 'exposure', 'study', 'period', '', 'test', 'serum', 'antibody', 'nucleocapsid', 'protein', 'sars-cov-2', 'participant', 'day', '28', 'special', 'iggigm', 'rapid', 'test', 'kit', '', 'vazyme', 'biotech', '', 'number', 'cd101', '', 'nanjing', '', 'china', '', '', 'none', 'participant', 'positive', '', 'knowledge', '', 'first', 'report', 'first-in-human', 'clinical', 'trial', 'novel', 'ad5', 'vectored', 'covid-19', 'vaccine', '', 'ad5', 'vectored', 'covid-19', 'vaccine', 'tolerate', 'healthy', 'adult', 'three', 'dose', 'group', '', 'common', 'adverse', 'reaction', 'fever', '', 'fatigue', '', 'headache', '', 'muscle', 'pain', 'significant', 'difference', 'incidence', 'adverse', 'reaction', 'across', 'group', '', 'adverse', 'event', 'report', 'mild', 'moderate', 'severity', '', 'notice', 'higher', 'reactogenicity', 'profile', 'high', 'dose', '15', '', '1011', 'viral', 'particle', '', 'present', 'severe', 'fever', '', 'fatigue', '', 'muscle', 'pain', '', 'joint', 'pain', '', 'associate', 'viraemia', 'cause', 'ad5', 'vector', 'infection', '', 'however', '', 'severe', 'adverse', 'reaction', 'transient', 'self-limiting', '', 'additionally', '', 'abnormal', 'change', 'laboratory', 'measurement', 'clinically', 'significant', 'consider', 'relate', 'vaccine', '', 'profile', 'adverse', 'event', 'report', 'trial', 'similar', 'another', 'ad5', 'vector-based', 'ebola', 'vaccine', 'express', 'glycoprotein16zhu', 'fc', 'hou', 'lh', 'li', 'jx', 'alsafety', 'immunogenicity', 'novel', 'recombinant', 'adenovirus', 'type-5', 'vector-based', 'ebola', 'vaccine', 'healthy', 'adult', 'china', '', 'preliminary', 'report', 'randomise', '', 'double-blind', '', 'placebo-controlled', '', 'phase', '1', 'triallancet', '', '2015', '', '385', '', '2272-2279google', 'accelerate', 'process', 'clinical', 'evaluation', 'candidate', 'covid-19', 'vaccine', '', 'select', 'phase', '2', 'study', 'mainly', 'basis', 'safety', 'profile', 'candidate', 'vaccine', 'show', 'participant', 'within', '7', 'day', '14', 'day', 'post-vaccination', '', 'choose', 'low', 'dose', '', '5', '', '1010', 'viral', 'particle', '', 'middle', 'dose', '', '1', '', '1011', 'viral', 'particle', '', 'assess', 'phase', '2', 'clinical', 'trial', '', 'ad5', 'vectored', 'covid-19', 'vaccine', 'immunogenic', '', 'induce', 'humoral', 't-cell', 'response', 'rapidly', 'participant', '', 'onset', 'detectable', 'immune', 'response', 'rapid', '', 't-cell', 'response', 'peak', 'day', '14', 'vaccination', 'antibody', 'peak', 'day', '28', '', 'antibody', 'response', 'vaccine', 'high', 'dose', 'group', 'slightly', 'greater', 'middle', 'dose', 'low', 'dose', 'group', '', 'single', 'dose', 'ad5', 'vectored', 'covid-19', 'vaccine', 'able', 'elicit', 'four-fold', 'increase', 'bind', 'antibody', 'rbd', '94100', '', 'participant', '', 'four-fold', 'increase', 'live', 'virus', '5075', '', 'participant', '', 'despite', 'difference', 'magnitude', 'antibody', 'measure', 'different', 'method', '', 'strong', 'positive', 'correlation', 'bind', 'antibody', 'neutralise', 'antibody', 'titre', 'live', 'virus', '', 'high', 'proportion', 'participant', 'positive', 't-cell', 'response', 'note', 'across', 'dose', 'group', 'post-vaccination', '', 'activation', 'cd4', 'cell', 'cd8', 'cell', 'observe', 'vaccine', 'recipient', '', 'particularly', 'antigen-specific', 'cd4', 'cell', 'cd8', 'cell', '', 'however', '', 'specific', 'antibody', 'response', 't-cell', 'response', 'induce', 'vaccination', 'partly', 'diminish', 'presence', 'high', 'pre-existing', 'anti-ad5', 'immunity', '', 'currently', '', 'correlate', 'protection', 'vaccine', 'covid-19', 'unknown', '', 'role', 'specific', 'antibody', 'cell', 'build', 'effective', 'protection', 'yet', 'define', '', 'therefore', '', 'unable', 'predict', 'protection', 'ad5', 'vectored', 'covid-19', 'vaccine', 'basis', 'vaccine-elicited', 'immune', 'response', 'study', '', 'however', '', 'previous', 'study', 'investigate', 'sars', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'find', 'increase', 'specific', 'antibody', 'temporary', '', 'decline', 'quickly', 'patient', 'recovery', '', 'whereas', 'specific', 'cd4', 'cd8', 't-cell', 'response', 'play', 'essential', 'role', 'immunity17zhao', 'j', 'zhao', 'j', 'perlman', 'cell', 'response', 'require', 'protection', 'clinical', 'disease', 'virus', 'clearance', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus-infected', 'micej', 'virol', '', '2010', '', '84', '', '9318-9325google', '', '18channappanavar', 'r', 'fett', 'c', 'zhao', 'j', 'meyerholz', 'dk', 'perlman', 'virus-specific', 'memory', 'cd8', 'cell', 'provide', 'substantial', 'protection', 'lethal', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'infectionj', 'virol', '', '2014', '', '88', '', '11034-11044google', 'similar', 'rapid', 'decline', 'specific', 'antibody', 'amount', 'patient', 'covid-19', 'recovery', 'noted19wang', 'x', 'guo', 'x', 'xin', 'q', 'alneutralizing', 'antibody', 'response', 'sars-cov-2', 'covid-19', 'inpatient', 'convalescent', 'patientsmedrxiv', '', '2020', '', '', 'doi', '', '2020041520065623', '', 'preprint', '', '', '', '20wu', 'f', 'wang', 'liu', 'alneutralizing', 'antibody', 'response', 'sars-cov-2', 'covid-19', 'recover', 'patient', 'cohort', 'implicationsmedrxiv', '', '2020', '', '', 'doi', '', '2020033020047365', '', 'preprint', '', '', 'suggest', 'specific', 'cellular', 'humoral', 'immunity', 'potentially', 'important', 'successful', 'covid-19', 'vaccine', '', '', 'report', 'data', 'within', '28', 'day', 'vaccination', '', 'follow', 'vaccine', 'recipient', 'least', '6', 'month', '', 'data', 'obtain', '', 'study', 'wuhan', '', 'hubei', 'province', '', 'centre', 'covid-19', 'epidemic', 'china21chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513google', 'people', 'live', 'city', 'wuhan', 'much', 'higher', 'risk', 'sars-cov-2', 'infection', 'compare', 'live', 'city', 'outside', 'hubei', 'province', '', 'though', 'initiate', 'trial', '', 'city', 'already', 'begin', 'lockdown', 'implement', 'mandatory', 'home', 'isolation', 'resident', '', 'therefore', '', 'serological', 'screen', '', 'nucleic', 'acid', 'test', '', 'chest', 'ct', 'exclude', 'participant', 'previously', 'expose', 'sars-cov-2', 'recruitment', '', 'addition', '', 'arrange', 'participant', 'study', 'stay', 'designate', 'hotel', '14', 'day', 'post-vaccination', '', 'arrangement', 'facilitate', 'observation', 'adverse', 'event', 'immunisation', 'participant', '', 'reduce', 'risk', 'sars-cov-2', 'exposure', 'follow', '2', 'week', '', 'measure', 'allow', 'study', 'successfully', 'without', 'interference', 'circulation', 'sars-cov-2', '', 'especially', 'important', 'absence', 'placebo', 'control', '', 'interpretation', 'result', 'study', 'limit', 'small', 'size', 'cohort', '', 'short', 'duration', 'follow-up', '', 'absence', 'randomise', 'control', 'group', '', 'first-in-human', 'study', 'ad5', 'vectored', 'covid-19', 'vaccine', '', 'design', 'measure', 'vaccine', 'efficacy', '', 'however', '', 'preclinical', 'study', '', 'seven', 'eight', 'ferret', 'protect', 'detectable', 'virus', 'copy', 'challenge', 'sars-cov-2', 'nasal', 'drip', '21', 'day', 'immunisation', 'vaccine', '', 'whereas', 'one', 'eight', 'ferret', 'control', 'group', 'negative', 'virus', 'copy', '', 'wei', 'c', '', 'unpublished', '', '', 'aim', 'evaluate', 'safety', 'tolerability', 'candidate', 'vaccine', 'healthy', 'adult', '', 'interference', 'underlie', 'disease', 'medicine', '', 'however', '', 'result', 'study', 'indicate', 'older', 'age', 'negative', 'effect', 'vaccine-elicited', 'response', 'sars-cov-2', '', 'trial', '', 'participant', 'older', '60', 'year', '16', '', 'participant', 'older', '50', 'year', '', 'provide', 'limit', 'information', 'capability', 'generate', 'potent', 'cellular', 'humoral', 'response', 'older', 'population', '', 'since', 'age', 'identify', 'independent', 'risk', 'factor', 'severe', 'disease', 'associate', 'sars-cov-2', 'infection4weiss', 'p', 'murdoch', 'dr', 'clinical', 'course', 'mortality', 'risk', 'severe', 'covid-19lancet', '', '2020', '', '395', '', '1014-1015google', '', '22ye', 'g', 'pan', 'z', 'pan', 'alclinical', 'characteristic', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'reactivationj', 'infect', '', '2020', '', '80', '', 'e14-e17google', 'possibility', 'lower', 'immune', 'response', 'find', 'older', 'population', '', 'include', 'participant', 'older', '60', 'year', 'phase', '2', 'study', 'consider', 'population', 'important', 'target', 'population', 'covid-19', 'vaccine', '', 'additionally', '', 'experience', 'vaccine', 'candidate', 'sars', 'mers', 'raise', 'concern', 'antibody-dependent', 'enhancement', 'participant', 'infect', 'circulate', 'sars-cov-2', 'post-vaccination23lurie', 'n', 'saville', 'hatchett', 'r', 'halton', 'j', 'developing', 'covid-19', 'vaccine', 'pandemic', 'speedn', 'engl', 'j', 'med', '', '2020', '', '', 'nejmp2005630', '', '', 'however', '', 'study', 'statistically', 'power', 'measure', 'safety', 'outcome', '', 'especially', 'concern', 'around', 'immunopathology', 'antibody-dependent', 'enhancement', 'event', 'associate', 'full-length', 'spike', 'glycoprotein', 'vaccine', 'antigen24cao', 'x', 'covid-19', '', 'immunopathology', 'implication', 'therapynat', 'rev', 'immunol', '', '2020', '', '20', '', '269-270google', 'study', 'find', 'pre-existing', 'ad5', 'immunity', 'slow', 'rapid', 'immune', 'response', 'sars-cov-2', 'lower', 'peak', 'response', '', 'particularly', 'humoral', 'immunity', '', 'high', 'pre-existing', 'ad5', 'immunity', 'negative', 'effect', 'persistence', 'vaccine-elicited', 'immune', 'response', '', 'previous', 'study', '', 'heterologous', 'prime-boost', 'combination', 'homologous', 'prime-boost', 'regimen', 'ad5', 'vectored', 'vaccine', 'show', 'able', 'induce', 'strong', 'durable', 'immunogenic', 'response', 'population', 'high', 'pre-existing', 'ad5', 'immunity25venkatraman', 'n', 'ndiaye', 'bp', 'bowyer', 'g', 'alsafety', 'immunogenicity', 'heterologous', 'prime-boost', 'ebola', 'virus', 'vaccine', 'regimen', 'healthy', 'adult', 'united', 'kingdom', 'senegalj', 'infect', 'dis', '', '2019', '', '219', '', '1187-1197google', '', '26dolzhikova', 'iv', 'zubkova', 'ov', 'tukhvatulin', 'ai', 'alsafety', 'immunogenicity', 'gamevac-combi', '', 'heterologous', 'vsv-', 'ad5-vectored', 'ebola', 'vaccine', '', 'open', 'phase', 'iii', 'trial', 'healthy', 'adult', 'russiahum', 'vaccin', 'immunother', '', '2017', '', '13', '', '613-620google', '', '27shukarev', 'g', 'callendret', 'b', 'luhn', 'k', 'douoguih', 'two-dose', 'heterologous', 'prime-boost', 'vaccine', 'regimen', 'elicit', 'sustain', 'immune', 'response', 'ebola', 'zaire', 'support', 'preventive', 'strategy', 'future', 'outbreakshum', 'vaccin', 'immunother', '', '2017', '', '13', '', '266-270google', 'nevertheless', '', 'limit', 'information', 'available', 'effect', 'multiple', 'candidate', 'ad5', 'vectored', 'covid-19', 'vaccine', 'human', '', 'warrant', 'investigation', '', 'past', 'decade', '', 'vaccine', 'industry', 'clinical', 'research', 'centre', 'ask', 'provide', 'urgent', 'response', 'epidemic', 'emerge', 'infectious', 'disease', '', 'h1n1', 'influenza', '', 'ebola', 'virus', '', 'zika', '', 'mers', '', 'sars-cov-223lurie', 'n', 'saville', 'hatchett', 'r', 'halton', 'j', 'developing', 'covid-19', 'vaccine', 'pandemic', 'speedn', 'engl', 'j', 'med', '', '2020', '', '', 'nejmp2005630', '', '', 'risk', 'covid-19', 'cause', 'sars-cov-2', 'ongoing', '', 'effective', 'vaccine', 'urgent28richardson', 'hirsch', 'js', 'narasimhan', 'alpresenting', 'characteristic', '', 'comorbidities', '', 'outcome', 'among', '5700', 'patient', 'hospitalize', 'covid-19', 'new', 'york', 'city', 'areajama', '', '2020', '', '', 'publish', 'online', 'april', '22', '', '', 'doi101001jama20206775google', 'start', 'development', 'candidate', 'vaccine', 'january', '', '2020', '', 'sars-cov-2', 'first', 'isolate', 'sequence', '', 'full-length', 'spike', 'glycoprotein', 'select', 'vaccine', 'antigen', '', 'mainly', 'basis', 'previous', 'experience', 'sars', 'mers', 'vaccine', '', 'previous', 'find', 'suggest', 'vaccine', 'express', 'full-length', 'spike', 'glycoprotein', 'induce', 'immune', 'response', 'protective', 'efficacy29yong', 'cy', 'ong', 'hk', 'yeap', 'sk', 'ho', 'kl', 'tan', 'ws', 'recent', 'advance', 'vaccine', 'development', 'middle', 'east', 'respiratory', 'syndrome-coronavirusfront', 'microbiol', '', '2019', '', '101781google', 'although', 'rbd', 'comprise', 'critical', 'neutralise', 'domain', 'coronaviruses', '', 'neutralise', 'epitope', 'locate', 'outside', 'rbd', 'identified30duan', 'j', 'yan', 'x', 'guo', 'x', 'ala', 'human', 'sars-cov', 'neutralize', 'antibody', 'epitope', 's2', 'proteinbiochem', 'biophys', 'res', 'commun', '', '2005', '', '333', '', '186-193google', '', '31wang', 'q', 'zhang', 'l', 'kuwahara', 'k', 'alimmunodominant', 'sars', 'coronavirus', 'epitope', 'human', 'elicit', 'enhance', 'neutralize', 'effect', 'infection', 'non-human', 'primatesacs', 'infect', 'dis', '', '2016', '', '2', '', '361-376google', 'full-length', 'spike', 'choose', 'viral', 'vectored', '', 'mrna', '', 'dna', 'covid-19', 'vaccine', 'development9whodraft', 'landscape', 'covid-19', 'candidate', 'vaccines30', 'april', '2020', 'urlplaceholder', '2020date', 'access', '', '5', '', '2020google', 'ad5', 'vector', 'vaccine', 'platform', 'highly', 'efficient', 'well', 'establish', 'vaccine', 'antigen', 'delivery', 'system', '', 'addition', 'candidate', 'ad5', 'vectored', 'covid-19', 'vaccine', '', 'several', 'ad5-based', 'vaccine', 'covid-19', 'list', 'draft', 'landscape', 'covid-19', 'candidate', 'vaccine', '', 'include', 'ad5', '', 'grevaxtm', 'platform', '', 'usa', '', 'oral', 'ad5', '', 'stabilitech', 'biopharma', '', 'uk9whodraft', 'landscape', 'covid-19', 'candidate', 'vaccines30', 'april', '2020', 'urlplaceholder', '2020date', 'access', '', '5', '', '2020google', 'however', '', 'aside', 'pre-existing', 'anti-ad5', 'immunity', '', 'concern', 'increase', 'risk', 'hiv-1', 'acquisition', 'associate', 'ad5', 'activate', 'cd4', 'cells32gray', 'ge', 'moodie', 'z', 'metch', 'b', 'alrecombinant', 'adenovirus', 'type', '5', 'hiv', 'gagpolnef', 'vaccine', 'south', 'africa', '', 'unblinded', '', 'long-term', 'follow-up', 'phase', '2b', 'hvtn', '503phambili', 'studylancet', 'infect', 'dis', '', '2014', '', '14', '', '388-396google', 'although', 'association', 'hiv-1', 'acquisition', 'risk', 'ad5', 'vectored', 'vaccine', 'controversial', 'mechanism', 'unclear', '', 'potential', 'risk', 'account', 'study', 'viral', 'vector', 'delivery', 'platform', '', 'plan', 'monitor', 'participant', 'upcoming', 'phase', '2', 'phase', '3', 'study', 'ass', 'indication', 'acquisition', '', 'conclusion', '', 'find', 'ad5', 'vectored', 'covid-19', 'vaccine', 'tolerable', 'immunogenic', 'healthy', 'adult', '', 'specific', 'humoral', 'response', 'sars-cov-2', 'peak', 'day', '28', 'post-vaccination', '', 'rapid', '', 'specific', 't-cell', 'response', 'note', 'day', '14', 'one', 'shoot', 'vaccine', '', 'potential', 'investigation', 'ad5', 'vectored', 'covid-19', 'vaccine', 'control', 'covid-19', 'outbreak', '', 'ongoing', 'phase', '2', 'trial', 'china', '', 'nct04341389', '', 'provide', 'information', 'safety', 'immunogenicity', 'ad5', 'vectored', 'covid-19', 'vaccine', '', 'contributors', 'f-cz', 'y-hl', 'co-first', 'author', '', 'f-cz', '', 'ww', '', 'wc', 'joint', 'correspond', 'author', '', 'f-cz', 'principal', 'investigator', 'trial', '', 'x-hg', 'ww', 'work', 'co-principal', 'investigator', 'trial', '', 'f-cz', '', 'wc', '', 'x-hg', '', 'l-hh', '', 'y-hl', '', 'w-jw', '', 'j-xl', '', 's-yj', 'design', 'trial', 'study', 'protocol', '', 'j-xl', 'draft', 'manuscript', '', 'wc', 'contribute', 'critical', 'review', 'revision', 'manuscript', '', 'f-cz', '', 'w-jw', '', 'j-xl', '', 's-yj', 'contribute', 'data', 'interpretation', 'revision', 'manuscript', '', 'x-ww', 'responsible', 'statistical', 'analysis', '', 'j-jx', 'b-sw', 'contribute', 'study', 'supervision', '', 'ww', '', 'w-jw', '', 'zw', '', 'lew', '', 's-yj', '', 'h-dj', 'lead', 'participate', 'site', 'work', '', 'include', 'recruitment', '', 'follow-up', '', 'data', 'collection', '', 'y-hl', '', 'tj', '', 'yh', '', 'liw', '', 's-bx', 'responsible', 'laboratory', 'analysis', '', 'w-jw', '', 'j-xl', '', 's-yj', 'contribute', 'literature', 'search', '', 'j-bg', 's-pw', 'monitor', 'trial', '', 'declaration', 'interest', 'wc', 'report', 'grant', 'national', 'key', 'r', '', 'program', 'china', '', '2020yfc10841400', '', '', 'grant', 'national', 'science', 'technology', 'major', 'project', '', '2016zx10004001', '', '2018zx09201005', '', '', 'j-bg', 'employee', 'cansino', 'biologics', '', 'author', 'declare', 'compete', 'interest', '', 'support', 'data', 'share', 'individual', 'participant', 'data', '', 'individual', 'participant', 'data', 'underlie', 'result', 'report', 'article', '', 'de-identification', '', 'text', '', 'table', '', 'figure', '', 'appendix', '', 'share', '', 'individual', 'participant', 'data', 'available', 'begin', '3', 'month', 'end', '1', 'year', 'publication', '', 'supporting', 'clinical', 'document', 'include', 'study', 'protocol', '', 'statistical', 'analysis', 'plan', '', 'inform', 'consent', 'form', 'available', 'immediately', 'follow', 'publication', 'least', '1', 'year', '', 'researchers', 'provide', 'scientifically', 'sound', 'proposal', 'allow', 'access', 'individual', 'participant', 'data', '', 'proposals', 'direct', '', 'email', 'protect', '', '', 'email', 'protect', '', '', 'proposal', 'review', 'approve', 'sponsor', '', 'investigator', '', 'collaborator', 'basis', 'scientific', 'merit', '', 'gain', 'access', '', 'data', 'requester', 'sign', 'data', 'access', 'agreement', '', 'acknowledgments', 'peng', 'deng', '', 'qiong', 'li', '', 'xiaoai', 'qian', 'hubei', 'provincial', 'center', 'disease', 'control', 'prevention', 'participant', 'recruitment', 'sample', 'collection', '', 'miao', 'xu', 'jingjing', 'liu', 'national', 'institute', 'food', 'drug', 'control', '', 'china', '', '', 'yansong', 'sun', '', 'sen', 'zhang', '', 'yuchang', 'li', 'beijing', 'institute', 'microbiology', 'epidemiology', '', 'feng', 'wang', '', 'hongyan', 'hou', '', 'hanxiong', 'guan', '', 'bo', 'liu', 'tongji', 'hospital', 'laboratory', 'analysis', '', 'ke', 'zhang', 'academy', 'military', 'medical', 'sciences', '', 'kun', 'liu', 'general', 'hospital', 'central', 'theater', 'command', '', 'changlong', 'fu', 'wuhan', 'rest', 'center', '', 'chinese', 'people', 'armed', 'police', 'force', 'management', 'clinical', 'trial', 'site', '', 'download', 'pdf', '', '178', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix']",7654,"{'': 1960, 'vaccine': 141, 'dose': 139, 'group': 122, 'participant': 91, 'covid-19': 80, 'day': 72, 'antibody': 66, 'ad5': 62, 'response': 60, 'high': 52, '3': 44, 'post-vaccination': 42, 'vectored': 41, 'adverse': 41, 'cell': 41, 'sars-cov-2': 40, '28': 38, 'report': 38, 'middle': 37}","{'certolizumab': 10, 'infection': 4, 'sars-cov-2': 40, 'safety': 17}",71,0.25
DOI:10.1016/S0140-6736(20)31022-9,10.1016/S0140-6736(20)31022-9,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['remdesivir', 'adult', 'severe', 'covid-19', '', 'randomise', '', 'double-blind', '', 'placebo-controlled', '', 'multicentre', 'trial']","['BackgroundNo specific antiviral drug prove effective treatment patient severe coronavirus disease 2019 ( COVID-19 ) .', 'Remdesivir ( GS-5734 ) , nucleoside analogue prodrug , inhibitory effect pathogenic animal human coronaviruses , include severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) vitro , inhibit Middle East respiratory syndrome coronavirus , SARS-CoV-1 , SARS-CoV-2 replication animal models.MethodsWe randomise , double-blind , placebo-controlled , multicentre trial ten hospital Hubei , China .', 'Eligible patient adult ( age ≥18 year ) admit hospital laboratory-confirmed SARS-CoV-2 infection , interval symptom onset enrolment 12 day le , oxygen saturation 94 % le room air ratio arterial oxygen partial pressure fractional inspire oxygen 300 mm Hg le , radiologically confirm pneumonia .', 'Patients randomly assign 2:1 ratio intravenous remdesivir ( 200 mg day 1 follow 100 mg day 2–10 single daily infusion ) volume placebo infusion 10 day .', 'Patients permit concomitant use lopinavir–ritonavir , interferon , corticosteroid .', 'The primary endpoint time clinical improvement day 28 , define time ( day ) randomisation point decline two level six-point ordinal scale clinical status ( 1=discharged 6=death ) discharge alive hospital , whichever come first .', 'Primary analysis do intention-to-treat ( ITT ) population safety analysis do patient start assign treatment .', 'This trial register ClinicalTrials.gov , NCT04257656.FindingsBetween Feb 6 , 2020 , March 12 , 2020 , 237 patient enrol randomly assign treatment group ( 158 remdesivir 79 placebo ) ; one patient placebo group withdraw randomisation include ITT population .', 'Remdesivir use associate difference time clinical improvement ( hazard ratio 1·23 [ 95 % CI 0·87–1·75 ] ) .', 'Although statistically significant , patient receive remdesivir numerically faster time clinical improvement receive placebo among patient symptom duration 10 day le ( hazard ratio 1·52 [ 0·95–2·43 ] ) .', 'Adverse event report 102 ( 66 % ) 155 remdesivir recipient versus 50 ( 64 % ) 78 placebo recipient .', 'Remdesivir stop early adverse event 18 ( 12 % ) patient versus four ( 5 % ) patient stop placebo early.InterpretationIn study adult patient admit hospital severe COVID-19 , remdesivir associate statistically significant clinical benefit .', 'However , numerical reduction time clinical improvement treat earlier require confirmation larger studies.FundingChinese Academy Medical Sciences Emergency Project COVID-19 , National Key Research Development Program China , Beijing Science Technology Project .', 'No specific antiviral drug prove effective treatment patient severe coronavirus disease 2019 ( COVID-19 ) .', 'Remdesivir ( GS-5734 ) , nucleoside analogue prodrug , inhibitory effect pathogenic animal human coronaviruses , include severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) vitro , inhibit Middle East respiratory syndrome coronavirus , SARS-CoV-1 , SARS-CoV-2 replication animal model .', 'We randomise , double-blind , placebo-controlled , multicentre trial ten hospital Hubei , China .', 'Eligible patient adult ( age ≥18 year ) admit hospital laboratory-confirmed SARS-CoV-2 infection , interval symptom onset enrolment 12 day le , oxygen saturation 94 % le room air ratio arterial oxygen partial pressure fractional inspire oxygen 300 mm Hg le , radiologically confirm pneumonia .', 'Patients randomly assign 2:1 ratio intravenous remdesivir ( 200 mg day 1 follow 100 mg day 2–10 single daily infusion ) volume placebo infusion 10 day .', 'Patients permit concomitant use lopinavir–ritonavir , interferon , corticosteroid .', 'The primary endpoint time clinical improvement day 28 , define time ( day ) randomisation point decline two level six-point ordinal scale clinical status ( 1=discharged 6=death ) discharge alive hospital , whichever come first .', 'Primary analysis do intention-to-treat ( ITT ) population safety analysis do patient start assign treatment .', 'This trial register ClinicalTrials.gov , NCT04257656 .', 'Between Feb 6 , 2020 , March 12 , 2020 , 237 patient enrol randomly assign treatment group ( 158 remdesivir 79 placebo ) ; one patient placebo group withdraw randomisation include ITT population .', 'Remdesivir use associate difference time clinical improvement ( hazard ratio 1·23 [ 95 % CI 0·87–1·75 ] ) .', 'Although statistically significant , patient receive remdesivir numerically faster time clinical improvement receive placebo among patient symptom duration 10 day le ( hazard ratio 1·52 [ 0·95–2·43 ] ) .', 'Adverse event report 102 ( 66 % ) 155 remdesivir recipient versus 50 ( 64 % ) 78 placebo recipient .', 'Remdesivir stop early adverse event 18 ( 12 % ) patient versus four ( 5 % ) patient stop placebo early .', 'In study adult patient admit hospital severe COVID-19 , remdesivir associate statistically significant clinical benefit .', 'However , numerical reduction time clinical improvement treat earlier require confirmation larger study .', 'Chinese Academy Medical Sciences Emergency Project COVID-19 , National Key Research Development Program China , Beijing Science Technology Project .', 'The ongoing pandemic severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection lead 4 692 797 case 195 920 death globally April 25 , 2020.1Johns Hopkins University MedicineCOVID-19 map .', 'Johns Hopkins Coronavirus Resource Centre .', 'urlplaceholder access : April 25 , 2020Google Scholar Although infection self-limited , 15 % infect adult develop severe pneumonia require treatment supplemental oxygen additional 5 % progress critical illness hypoxaemic respiratory failure , acute respiratory distress syndrome , multiorgan failure necessitate ventilatory support , often several weeks.2Wu Z McGoogan JM Characteristics important lesson coronavirus disease 2019 ( COVID-19 ) outbreak China : summary report 72 314 case Chinese Center Disease Control Prevention.JAMA .', '2020 ; ( publish online Feb 24 .', ') DOI:10.1001/jama.2020.2648Google Scholar , 3Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513Google Scholar , 4Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; 395 : 1054-1062Google Scholar At least half patient coronavirus disease 2019 ( COVID-19 ) require invasive mechanical ventilation die hospital,4Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; 395 : 1054-1062Google Scholar , 5Bhatraju PK Ghassemieh BJ Nichols M et al.Covid-19 critically ill patient Seattle region–case series.N Engl J Med .', '2020 ; ( publish online March 30 .', ') DOI:10.1056/NEJMoa2004500Google Scholar associate burden health-care system , especially intensive care unit , overwhelm several affect country .', 'Although several approve drug investigational agent show antiviral activity SARS-CoV-2 vitro,6Wang M Cao R Zhang L et al.Remdesivir chloroquine effectively inhibit recently emerge novel coronavirus ( 2019-nCoV ) vitro.Cell Res .', '2020 ; 30 : 2-71Google Scholar , 7Liu J Cao R Xu M et al.Hydroxychloroquine , le toxic derivative chloroquine , effective inhibit SARS-CoV-2 infection vitro.Cell Discov .', '2020 ; 6 : 16Google Scholar present antiviral therapy prove effectiveness treat severely ill patient COVID-19 .', 'A multicentre , open-label , randomise control trial ( RCT ) hydroxychloroquine involve 150 adult admit hospital COVID-19 report significant effect drug accelerate viral clearance.8Tang W Cao Zhu Han M et al.Hydroxychloroquine patient COVID-19 : open-label , randomize , control trial.medRxiv .', '2020 ; ( publish online April 14 . )', '( preprint ) .DOI : 10.1101/2020.04.10.20060558Google Scholar An RCT enrol patient within 12 day symptom onset find favipiravir superior arbidol term clinical recovery rate day 7 patient mild illness ( 62 [ 56 % ] 111 arbidol v 70 [ 71 % ] 98 favipiravir ) , critical illness ( 0 v 1 [ 6 % ] ) .9Chen C Huang J Cheng Z et al.Favipiravir versus arbidol COVID-19 : randomize clinical trial.medRxiv .', '2020 ; ( publish online April 15 . )', '( preprint ) .DOI : 10.1101/2020.03.17.20037432Google Scholar In severe illness , one uncontrolled study five patient give convalescent plasma suggest possible benefit , although patient already detectable anti-SARS-CoV-2 neutralise antibody receipt plasma.10Shen C Wang Z Zhao F et al.Treatment 5 critically ill patient COVID-19 convalescent plasma.JAMA .', '2020 ; ( publish online March 27 .', ') DOI:10.1001/jama.2020.4783Google Scholar An open-label RCT oral lopinavir–ritonavir find significant effect primary outcome measure time clinical improvement evidence reduction viral RNA titre compare control.11Cao B Wang Y Wen D et al.A trial lopinavir–ritonavir adult hospitalize severe Covid-19.N Engl J Med .', '2020 ; ( publish online March 18 .', ') DOI:10.1056/NEJMoa2001282Google Scholar However , per-protocol analysis suggest possible reduction time clinical improvement ( difference 1 day ) , particularly treat within 12 day symptom onset .', 'Further study lopinavir–ritonavir drug ongoing .', 'Research contextEvidence studyWe search PubMed , April 10 , 2020 , publish clinical trial assess effect remdesivir among patient laboratory-confirmed coronavirus disease 2019 ( COVID-19 ) .', 'The search term use ( “ COVID-19 ” “ 2019-nCoV ” “ SARS-CoV-2 ” ) AND “ remdesivir ” AND ( “ clinical trial ” “ randomize control trial ” ) .', 'We identify publish clinical trial effect remdesivir patient COVID-19.Added value studyOur study first randomise , double-blind , placebo-controlled clinical trial assess effect intravenous remdesivir adult admit hospital severe COVID-19 .', 'The study terminate attain prespecified sample size .', 'In intention-to-treat population , primary endpoint time clinical improvement significantly different group , numerically shorter remdesivir group control group , particularly treat within 10 day symptom onset .', 'The duration invasive mechanical ventilation , although also significantly different group , numerically shorter remdesivir recipient placebo recipients.Implications available evidenceNo statistically significant benefit observe remdesivir treatment beyond standard care treatment .', 'Our trial attain predetermine sample size outbreak COVID-19 bring control China .', 'Future study remdesivir , include earlier treatment patient COVID-19 higher-dose regimen combination antiviral SARS-CoV-2 neutralise antibody severe COVID-19 need better understand potential effectiveness .', 'Evidence study We search PubMed , April 10 , 2020 , publish clinical trial assess effect remdesivir among patient laboratory-confirmed coronavirus disease 2019 ( COVID-19 ) .', 'The search term use ( “ COVID-19 ” “ 2019-nCoV ” “ SARS-CoV-2 ” ) AND “ remdesivir ” AND ( “ clinical trial ” “ randomize control trial ” ) .', 'We identify publish clinical trial effect remdesivir patient COVID-19 .', 'Added value study Our study first randomise , double-blind , placebo-controlled clinical trial assess effect intravenous remdesivir adult admit hospital severe COVID-19 .', 'The study terminate attain prespecified sample size .', 'In intention-to-treat population , primary endpoint time clinical improvement significantly different group , numerically shorter remdesivir group control group , particularly treat within 10 day symptom onset .', 'The duration invasive mechanical ventilation , although also significantly different group , numerically shorter remdesivir recipient placebo recipient .', 'Implications available evidence No statistically significant benefit observe remdesivir treatment beyond standard care treatment .', 'Our trial attain predetermine sample size outbreak COVID-19 bring control China .', 'Future study remdesivir , include earlier treatment patient COVID-19 higher-dose regimen combination antiviral SARS-CoV-2 neutralise antibody severe COVID-19 need better understand potential effectiveness .', 'Remdesivir ( also GS-5734 ) monophosphoramidate prodrug adenosine analogue broad antiviral spectrum include filovirus , paramyxovirus , pneumoviruses , coronaviruses.12Lo MK Jordan R Arvey A et al.GS-5734 parent nucleoside analog inhibit filo- , pneumo- , paramyxoviruses.Sci Rep. 2017 ; 743395Google Scholar , 13Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar In vitro , remdesivir inhibit human animal coronaviruses test date , include SARS-CoV-2,13Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar , 14Warren TK Jordan R Lo MK et al.Therapeutic efficacy small molecule GS-5734 Ebola virus rhesus monkeys.Nature .', '2016 ; 531 : 381-385Google Scholar , 15Brown AJ Won JJ Graham RL et al.Broad spectrum antiviral remdesivir inhibit human endemic zoonotic deltacoronaviruses highly divergent RNA dependent RNA polymerase.Antiviral Res .', '2019 ; 169104541Google Scholar show antiviral clinical effect animal model SARS-CoV-1 Middle East respiratory syndrome ( MERS ) -CoV infections.13Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar , 16Sheahan TP Sims AC Leist SR et al.Comparative therapeutic efficacy remdesivir combination lopinavir , ritonavir , interferon beta MERS-CoV.Nat Commun .', '2020 ; 11 : 222Google Scholar , 17de Wit E Feldmann F Cronin J et al.Prophylactic therapeutic remdesivir ( GS-5734 ) treatment rhesus macaque model MERS-CoV infection.Proc Natl Acad Sci USA .', '2020 ; 117 : 6771-6776Google Scholar In lethal murine model MERS , remdesivir superior regimen combine interferon beta lopinavir–ritonavir.16Sheahan TP Sims AC Leist SR et al.Comparative therapeutic efficacy remdesivir combination lopinavir , ritonavir , interferon beta MERS-CoV.Nat Commun .', '2020 ; 11 : 222Google Scholar Remdesivir potent inhibitor SARS-CoV-2 replication human nasal bronchial airway epithelial cells.18Pizzorno A Padey B Julien T et al.Characterization treatment SARS-CoV-2 nasal bronchial human airway epithelia.bioRxiv .', '2020 ; ( publish online April 2 . )', '( preprint ) .DOI : 10.1101/2020.03.31.017889Google Scholar In non-lethal rhesus macaque model SARS-CoV-2 infection , early remdesivir administration show exert significant antiviral clinical effect ( reduce pulmonary infiltrate virus titre bronchoalveolar lavage v vehicle ) .19Williamson BN Feldmann F Schwarz B et al.Clinical benefit remdesivir rhesus macaque infect SARS-CoV-2.bioRxiv .', '2020 ; ( publish online April 22 . )', '( preprint ) .DOI : 10.1101/2020.04.15.043166Google Scholar Intravenous remdesivir study treatment Ebola virus disease , adequately tolerate le effective several monoclonal antibody therapeutics,20Mulangu S Dodd LE Davey Jr , RT et al.A randomize , control trial Ebola virus disease therapeutics.N Engl J Med .', '2019 ; 381 : 2293-2303Google Scholar use basis individual compassionate use past several month patient COVID-19 countries.21Grein J Ohmagari N Shin D et al.Compassionate use remdesivir patient severe Covid-19.N Engl J Med .', '2020 ; ( publish online April 10 .', ') DOI:10.1056/NEJMoa2007016Google Scholar Case study report benefit severely ill patient COVID-19.5Bhatraju PK Ghassemieh BJ Nichols M et al.Covid-19 critically ill patient Seattle region–case series.N Engl J Med .', '2020 ; ( publish online March 30 .', ') DOI:10.1056/NEJMoa2004500Google Scholar , 21Grein J Ohmagari N Shin D et al.Compassionate use remdesivir patient severe Covid-19.N Engl J Med .', '2020 ; ( publish online April 10 .', ') DOI:10.1056/NEJMoa2007016Google Scholar , 22Holshue ML DeBolt C Lindquist S et al.First case 2019 novel coronavirus United States.N Engl J Med .', '2020 ; 382 : 929-936Google Scholar However , clinical antiviral efficacy remdesivir COVID-19 remain establish .', 'Here , report result placebo-controlled randomise trial remdesivir patient severe COVID-19 .', 'This investigator-initiated , individually randomise , placebo-controlled , double-blind trial ass effectiveness safety intravenous remdesivir adult ( age ≥18 year ) admit hospital severe COVID-19 .', 'The trial do ten hospital Wuhan , Hubei , China ) .', 'Ethical approval obtain institutional review board participate hospital .', 'Written inform consent obtain patient , legal representative unable provide consent .', 'The trial do accordance principle Declaration Helsinki International Conference Harmonization–Good Clinical Practice guideline .', 'The protocol available online .', 'Eligible patient men non-pregnant woman COVID-19 age least 18 year RT-PCR positive SARS-CoV-2 , pneumonia confirm chest image , oxygen saturation 94 % lower room air ratio arterial oxygen partial pressure fractional inspire oxygen 300 mm Hg le , within 12 day symptom onset .', 'Eligible patient child-bearing age ( men woman ) agree take effective contraceptive measure ( include hormonal contraception , barrier method , abstinence ) study period least 7 day last study drug administration .', 'Exclusion criterion include pregnancy breast feed ; hepatic cirrhosis ; alanine aminotransferase aspartate aminotransferase five time upper limit normal ; know severe renal impairment ( estimate glomerular filtration rate < 30 mL/min per 1·73 m2 ) receipt continuous renal replacement therapy , haemodialysis , peritoneal dialysis ; possibility transfer non-study hospital within 72 h ; enrolment investigational treatment study COVID-19 30 day screen .', 'The use treatment , include lopinavir–ritonavir , permit .', 'Eligible patient randomly assign ( 2:1 ) either remdesivir group placebo group .', 'Randomisation stratify accord level respiratory support follow : ( 1 ) oxygen support oxygen support nasal duct mask ; ( 2 ) high-flow oxygen , non-invasive ventilation , invasive ventilation , extracorporeal membrane oxygenation .', 'The permute block ( 30 patient per block ) randomisation sequence , include stratification , prepare statistician involve trial use SAS software , version 9.4 .', 'Eligible patient allocate receive medication individually number pack , accord sequential order randomisation centre ( Jin Yin-tan Hospital central pharmacy ) .', 'Envelopes prepare emergency unmask .', 'Patients receive either intravenous remdesivir ( 200 mg day 1 follow 100 mg day 2–10 single daily infusion ) volume placebo infusion total 10 day ( provide Gilead Sciences , Foster City , CA , USA ) .', 'Patients assess daily train nurse use diary card capture data six-category ordinal scale safety day 0 28 death .', 'Other clinical data record use WHO–International Severe Acute Respiratory Emerging Infections Consortium ( ISARIC ) case record form .', 'The safety assessment include daily monitor adverse event , clinical laboratory test ( day 1 , 3 , 7 , 10 ) , 12-lead electrocardiogram ( day 1 14 ) , daily vital sign measurement .', 'Clinical data record paper case record form double enter electronic database validate trial staff .', 'Nasopharyngeal oropharyngeal swab , expectorate sputum available , faecal anal swab specimen collect day 1 , 3 , 5 , 7 , 10 , 14 , 21 , 28 viral RNA detection quantification .', 'The trial monitor contract research organisation ( Hangzhou Tigermed Consulting ) .', ""Virological test do Teddy Clinical Research Laboratory ( Tigermed–DI'AN , Hangzhou , China ) use quantitative real-time RT-PCR ."", 'RNA extract clinical sample MagNA Pure 96 system ( Roche , Rotkreuz , Switzerland ) , detect quantify Cobas z480 qPCR ( Roche ) , use LightMix Modular SARS-CoV-2 assay ( TIB MOBIOL , Berlin , Germany ) .', 'At baseline , upper ( nasopharyngeal oropharyngeal swab ) lower respiratory tract specimen test detection E-gene , RNA-dependent RNA polymerase gene , N-gene , sample subsequent visit quantitatively qualitative assess E-gene .', 'The primary clinical endpoint time clinical improvement within 28 day randomisation .', ""Clinical improvement define two-point reduction patient ' admission status six-point ordinal scale , live discharge hospital , whichever come first ."", 'The six-point scale follow : death=6 ; hospital admission extracorporeal membrane oxygenation mechanical ventilation=5 ; hospital admission non-invasive ventilation high-flow oxygen therapy=4 ; hospital admission oxygen therapy ( require high-flow non-invasive ventilation ) =3 ; hospital admission require oxygen therapy=2 ; discharge reach discharge criterion ( define clinical recovery—ie , normalisation pyrexia , respiratory rate < 24 breath per minute , saturation peripheral oxygen > 94 % room air , relief cough , maintain least 72 h ) =1 .', 'The six-point scale modify seven-point scale use previous COVID-19 lopinavir–ritonavir RCT11Cao B Wang Y Wen D et al.A trial lopinavir–ritonavir adult hospitalize severe Covid-19.N Engl J Med .', '2020 ; ( publish online March 18 .', ') DOI:10.1056/NEJMoa2001282Google Scholar combine two outpatient stratum one .', 'Secondary outcome proportion patient category six-point scale day 7 , 14 , 28 randomisation ; all-cause mortality day 28 ; frequency invasive mechanical ventilation ; duration oxygen therapy ; duration hospital admission ; proportion patient nosocomial infection .', 'Virological measure include proportion patient viral RNA detect viral RNA load ( measure quantitative RT-PCR ) .', 'Safety outcome include treatment-emergent adverse event , serious adverse event , premature discontinuation study drug .', 'The original design require total 325 event across group , would provide 80 % power one-sided type I error 2·5 % hazard ratio ( HR ) compare remdesivir placebo 1·4 , correspond change time clinical improvement 6 day assume time clinical improvement 21 day placebo .', 'One interim analysis use triangular boundaries23Whitehead J Stratton I Group sequential clinical trial triangular continuation regions.Biometrics .', '1983 ; 39 : 227-236Google Scholar 2:1 allocation ratio remdesivir placebo account original design .', 'Assuming 80 % event rate within 28 day across group dropout rate 10 % imply 453 patient recruit trial ( 151 placebo 302 remdesivir ) .', 'The possibility interim analysis enrolment 240 patient include design request independent data safety monitor board .', 'The primary efficacy analysis do intention-to-treat ( ITT ) basis randomly assign patient .', 'Time clinical improvement assess patient reach day 28 ; clinical improvement day 28 death day 28 consider right censor day 28 .', 'Time clinical improvement portray Kaplan-Meier plot compare log-rank test .', 'The HR 95 % CI clinical improvement HR 95 % CI clinical deterioration calculate Cox proportional hazard model .', 'Other analysis include subgroup analysis receive treatment 10 day le v 10 day symptom onset , time clinical deterioration ( define one category increase death ) , viral RNA load entry .', 'The difference continuous variable group calculate use Hodges-Lehmann estimation .', ""We present adverse event data patient ' actual treatment exposure , cod use Medical Dictionary Regulatory Activities ."", 'Statistical analysis do use SAS software , version 9.4 .', 'This trial register ClinicalTrials.gov , NCT04257656 .', 'Between Feb 6 , 2020 , March 12 , 2020 , 255 patient screen , 237 eligible ( figure 1 ) .', '158 patient assign receive remdesivir 79 receive placebo ; one patient placebo group withdraw previously write inform consent randomisation , 158 78 patient include ITT population .', 'No patient enrol March 12 , control outbreak Wuhan basis termination criterion specify protocol , data safety monitor board recommend study terminate data analyse March 29 .', 'At stage , interim analysis abandon .', 'When assumption stay , actual enrolment 236 participant , statistical power reduce 80 % 58 % .Figure 1Trial profileView Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Three patient remdesivir group start assign treatment include safety analysis ( figure 1 ) .', 'The median age study patient 65 year ( IQR 56–71 ) ; sex distribution 89 ( 56 % ) men versus 69 ( 44 % ) woman remdesivir group 51 ( 65 % ) versus 27 ( 35 % ) placebo group ( table 1 ) .', 'The common comorbidity hypertension , follow diabetes coronary heart disease .', 'Lopinavir–ritonavir co-administered 42 ( 18 % ) patient baseline .', 'Most patient category 3 six-point ordinal scale clinical status baseline .', 'Some imbalance exist enrolment group , include patient hypertension , diabetes , coronary artery disease remdesivir group placebo group .', 'More patient control group remdesivir group symptomatic 10 day le time start remdesivir placebo treatment , higher proportion remdesivir recipient respiratory rate 24 breath per min .', 'No major difference symptom , sign , laboratory result , disease severity , treatment observe group baseline.Table 1Baseline patient characteristicsRemdesivir group ( n=158 ) Placebo group ( n=78 ) Age , years66·0 ( 57·0–73·0 ) 64·0 ( 53·0–70·0 ) SexMen89 ( 56 % ) 51 ( 65 % ) Women69 ( 44 % ) 27 ( 35 % ) Any comorbidities112 ( 71 % ) 55 ( 71 % ) Hypertension72 ( 46 % ) 30 ( 38 % ) Diabetes40 ( 25 % ) 16 ( 21 % ) Coronary heart disease15 ( 9 % ) 2 ( 3 % ) Body temperature , °C36·8 ( 36·5–37·2 ) 36·8 ( 36·5–37·2 ) Fever56 ( 35 % ) 31 ( 40 % ) Respiratory rate > 24 breath per min36 ( 23 % ) 11 ( 14 % ) White blood cell count , × 109 per LMedian6·2 ( 4·4–8·3 ) 6·4 ( 4·5–8·3 ) 4–10108/155 ( 70 % ) 58 ( 74 % ) < 427/155 ( 17 % ) 12 ( 15 % ) > 1020/155 ( 13 % ) 8 ( 10 % ) Lymphocyte count , × 109 per L0·8 ( 0·6–1·1 ) 0·7 ( 0·6–1·2 ) ≥1·049/155 ( 32 % ) 23 ( 29 % ) < 1·0106/155 ( 68 % ) 55 ( 71 % ) Platelet count , × 109 per L183·0 ( 144·0–235·0 ) 194·5 ( 141·0–266·0 ) ≥100148/155 ( 95 % ) 75 ( 96 % ) < 1007/155 ( 5 % ) 3 ( 4 % ) Serum creatinine , μmol/L68·0 ( 56·0–82·0 ) 71·3 ( 56·0–88·7 ) ≤133151/154 ( 98 % ) 76 ( 97 % ) > 1333/154 ( 2 % ) 2 ( 3 % ) Aspartate aminotransferase , U/L31·0 ( 22·0–44·0 ) 33·0 ( 24·0–48·0 ) ≤40109/155 ( 70 % ) 49 ( 63 % ) > 4046/155 ( 30 % ) 29 ( 37 % ) Alanine aminotransferase , U/L26·0 ( 18·0–42·0 ) 26·0 ( 20·0–43·0 ) ≤50130/155 ( 84 % ) 66 ( 85 % ) > 5025/155 ( 16 % ) 12 ( 15 % ) Lactate dehydrogenase , U/L339·0 ( 247·0–441·5 ) 329·0 ( 249·0–411·0 ) ≤24536/148 ( 24 % ) 17/75 ( 23 % ) > 245112/148 ( 76 % ) 58/75 ( 77 % ) Creatine kinase , U/L75·9 ( 47·0–131·1 ) 75·0 ( 47·0–158·0 ) ≤185118/141 ( 84 % ) 54/67 ( 81 % ) > 18523/141 ( 16 % ) 13/67 ( 19 % ) National Early Warning Score 2 level day 15·0 ( 3·0–7·0 ) 4·0 ( 3·0–6·0 ) Six-category scale day 12—hospital admission , require supplemental oxygen03 ( 4 % ) 3—hospital admission , require supplemental oxygen129 ( 82 % ) 65 ( 83 % ) 4—hospital admission , require high-flow nasal cannula non-invasive mechanical ventilation28 ( 18 % ) 9 ( 12 % ) 5—hospital admission , require extracorporeal membrane oxygenation invasive mechanical ventilation01 ( 1 % ) 6—death1 ( 1 % ) 0Baseline viral load nasopharyngeal oropharyngeal swab , log10 copy per mL4·7 ( 0·3 ) 4·7 ( 0·4 ) Receiving interferon alfa-2b baseline29 ( 18 % ) 15 ( 19 % ) Receiving lopinavir–ritonavir baseline27 ( 17 % ) 15 ( 19 % ) Antibiotic treatment baseline121 ( 77 % ) 63 ( 81 % ) Corticosteroids therapy baseline60 ( 38 % ) 31 ( 40 % ) Data median ( IQR ) , n ( % ) , n/N ( % ) , mean ( SE ) .', 'Open table new tab Data median ( IQR ) , n ( % ) , n/N ( % ) , mean ( SE ) .', 'Median time symptom onset start study treatment 10 day ( IQR 9–12 ) .', 'No important difference apparent group treatment receive ( include lopinavir–ritonavir corticosteroid ; table 2 ) .', 'During hospital stay , 155 ( 66 % ) patient receive corticosteroid , median time symptom onset corticosteroid therapy 8·0 day ( 6·0–11·0 ) ; 91 ( 39 % ) patient receive corticosteroid enrolment.Table 2Treatments receive enrolmentRemdesivir group ( n=158 ) Placebo group ( n=78 ) Time symptom onset start study treatment , day * * Three patient start treatment include time symptom onset start study treatment subgroup analyses.11 ( 9–12 ) 10 ( 9–12 ) Early ( ≤10 day symptom onset ) 71/155 ( 46 % ) 47 ( 60 % ) Late ( > 10 day symptom onset ) 84/155 ( 54 % ) 31 ( 40 % ) Receiving injection interferon alfa-2b46 ( 29 % ) 30 ( 38 % ) Receiving lopinavir–ritonavir44 ( 28 % ) 23 ( 29 % ) Vasopressors25 ( 16 % ) 13 ( 17 % ) Renal replacement therapy3 ( 2 % ) 3 ( 4 % ) Highest oxygen therapy supportNon-invasive mechanical ventilation14 ( 9 % ) 3 ( 4 % ) Invasive mechanical ventilation11 ( 7 % ) 10 ( 13 % ) Extracorporeal membrane oxygenation mechanical ventilation2 ( 1 % ) 0Antibiotic142 ( 90 % ) 73 ( 94 % ) Corticosteroids therapy102 ( 65 % ) 53 ( 68 % ) Time symptom onset corticosteroid therapy , days9 ( 7–11 ) 8 ( 6–10 ) Duration corticosteroid therapy , days9 ( 5–15 ) 10 ( 6–16 ) Data median ( IQR ) n ( % ) .', '* Three patient start treatment include time symptom onset start study treatment subgroup analysis .', 'Open table new tab Data median ( IQR ) n ( % ) .', 'Final follow-up April 10 , 2020 .', 'In ITT population , time clinical improvement remdesivir group significantly different control group ( median 21·0 day [ IQR 13·0–28·0 ] remdesivir group v 23·0 day [ 15·0–28·0 ] ; HR 1·23 [ 95 % CI 0·87–1·75 ] ; table 3 , figure 2 ) .Table 3Outcomes intention-to-treat populationRemdesivir group ( n=158 ) Placebo group ( n=78 ) Difference * * Differences express rate difference Hodges-Lehmann estimator 95 % CI.Time clinical improvement21·0 ( 13·0 28·0 ) 23·0 ( 15·0 28·0 ) 1·23 ( 0·87 1·75 ) †† Hazard ratio 95 % CI estimate Cox proportional risk model.Day 28 mortality22 ( 14 % ) 10 ( 13 % ) 1·1 % ( −8·1 10·3 ) Early ( ≤10 day symptom onset ) 8/71 ( 11 % ) 7/47 ( 15 % ) −3·6 % ( −16·2 8·9 ) Late ( > 10 day symptom onset ) 12/84 ( 14 % ) 3/31 ( 10 % ) 4·6 % ( −8·2 17·4 ) Clinical improvement ratesDay 74 ( 3 % ) 2 ( 3 % ) 0·0 % ( −4·3 4·2 ) Day 1442 ( 27 % ) 18 ( 23 % ) 3·5 % ( −8·1 15·1 ) Day 28103 ( 65 % ) 45 ( 58 % ) 7·5 % ( −5·7 20·7 ) Duration invasive mechanical ventilation , days7·0 ( 4·0 16·0 ) 15·5 ( 6·0 21·0 ) −4·0 ( −14·0 2·0 ) Duration invasive mechanical ventilation survivor , days‡‡ Three patient group survivor ten patient remdesivir group seven patient placebo group non-survivors.19·0 ( 5·0 42·0 ) 42·0 ( 17·0 46·0 ) −12·0 ( −41·0 25·0 ) Duration invasive mechanical ventilation non-survivors , days‡‡ Three patient group survivor ten patient remdesivir group seven patient placebo group non-survivors.7·0 ( 2·0 11·0 ) 8·0 ( 5·0 16·0 ) −2·5 ( −11·0 3·0 ) Duration oxygen support , days19·0 ( 11·0 30·0 ) 21·0 ( 14·0 30·5 ) −2·0 ( −6·0 1·0 ) Duration hospital stay , days25·0 ( 16·0 38·0 ) 24·0 ( 18·0 36·0 ) 0·0 ( −4·0 4·0 ) Time random group assignment discharge , days21·0 ( 12·0 31·0 ) 21·0 ( 13·5 28·5 ) 0·0 ( −3·0 3·0 ) Time random group assignment death , days9·5 ( 6·0 18·5 ) 11·0 ( 7·0 18·0 ) −1·0 ( −7·0 5·0 ) Six-category scale day 71—discharge ( alive ) 4/154 ( 3 % ) 2/77 ( 3 % ) OR 0·69 ( 0·41 1·17 ) §§ Calculated ordinal logistic regression model.2—hospital admission , require supplemental oxygen21/154 ( 14 % ) 16/77 ( 21 % ) .. 3—hospital admission , require supplemental oxygen87/154 ( 56 % ) 43/77 ( 56 % ) .. 4—hospital admission , require high-flow nasal cannula non-invasive mechanical ventilation26/154 ( 17 % ) 8/77 ( 10 % ) .. 5—hospital admission , require extracorporeal membrane oxygenation invasive mechanical ventilation6/154 ( 4 % ) 4/77 ( 5 % ) .. 6—death10/154 ( 6 % ) 4/77 ( 5 % ) .. Six-category scale day 141—discharge ( alive ) 39/153 ( 25 % ) 18/78 ( 23 % ) OR 1·25 ( 0·76 2·04 ) §§ Calculated ordinal logistic regression model.2—hospital admission , require supplemental oxygen21/153 ( 14 % ) 10/78 ( 13 % ) .. 3—hospital admission , require supplemental oxygen61/153 ( 40 % ) 28/78 ( 36 % ) .. 4—hospital admission , require high-flow nasal cannula non-invasive mechanical ventilation13/153 ( 8 % ) 8/78 ( 10 % ) .. 5—hospital admission , require extracorporeal membrane oxygenation invasive mechanical ventilation4/153 ( 3 % ) 7/78 ( 9 % ) .. 6—death15/153 ( 10 % ) 7/78 ( 9 % ) .. Six-category scale day 281—discharge ( alive ) 92/150 ( 61 % ) 45/77 ( 58 % ) OR 1·15 ( 0·67 1·96 ) §§ Calculated ordinal logistic regression model.2—hospital admission , require supplemental oxygen14/150 ( 9 % ) 4/77 ( 5 % ) .. 3—hospital admission , require supplemental oxygen18/150 ( 12 % ) 13/77 ( 17 % ) .. 4—hospital admission , require high-flow nasal cannula non-invasive mechanical ventilation2/150 ( 1 % ) 2/77 ( 3 % ) .. 5—hospital admission , require extracorporeal membrane oxygenation invasive mechanical ventilation2/150 ( 1 % ) 3/77 ( 4 % ) .. 6—death22/150 ( 15 % ) 10/77 ( 13 % ) .. Data median ( IQR ) , n ( % ) , n/N ( % ) .', 'Clinical improvement ( event ) define decline two category modify seven-category ordinal scale clinical status , hospital discharge .', 'OR=odds ratio .', '* Differences express rate difference Hodges-Lehmann estimator 95 % CI.† Hazard ratio 95 % CI estimate Cox proportional risk model.‡ Three patient group survivor ten patient remdesivir group seven patient placebo group non-survivors.§ Calculated ordinal logistic regression model .', 'Open table new tab Figure 2Time clinical improvement intention-to-treat populationShow full captionAdjusted hazard ratio randomisation stratification 1·25 ( 95 % CI 0·88–1·78 ) .', '* Including death day 28 right censor day 28 , number patient without clinical improvement still include number risk.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Data median ( IQR ) , n ( % ) , n/N ( % ) .', 'Clinical improvement ( event ) define decline two category modify seven-category ordinal scale clinical status , hospital discharge .', 'OR=odds ratio .', 'Adjusted hazard ratio randomisation stratification 1·25 ( 95 % CI 0·88–1·78 ) .', '* Including death day 28 right censor day 28 , number patient without clinical improvement still include number risk .', 'Results time clinical improvement similar per-protocol population ( median 21·0 day [ IQR 13·0–28·0 ] remdesivir group v 23·0 day [ 15·0–28·0 ] placebo group HR 1·27 [ 95 % CI 0·89–1·80 ] ; appendix pp 2–3 , 5 ) .', 'Although statistically significant , patient receive remdesivir placebo within 10 day symptom onset ITT population , receive remdesivir numerically faster time clinical improvement receive placebo ( median 18·0 day [ IQR 12·0–28·0 ] v 23·0 day [ 15·0–28·0 ] ; HR 1·52 [ 0·95–2·43 ] ; appendix p 6 ) .', 'If clinical improvement define one , instead two , category decline , HR 1·34 95 % CI 0·96–1·86 ( appendix p 7 ) .', 'For time clinical deterioration , define one-category increase death , HR 0·95 95 % CI 0·55–1·64 ( appendix p 8 ) .', '28-day mortality similar two group ( 22 [ 14 % ] die remdesivir group v 10 ( 13 % ) placebo group ; difference 1·1 % [ 95 % CI −8·1 10·3 ] ) .', 'In patient use remdesivir within 10 day symptom onset , 28-day mortality significantly different group , although numerically higher placebo group ; contrast , group patient late use , remdesivir patient numerically higher 28-day mortality , although significant difference .', 'Clinical improvement rate day 14 day 28 also significantly different group , numerically higher remdesivir group placebo group .', 'For patient assign remdesivir group , duration invasive mechanical ventilation significantly different , numerically shorter assign control group ; however , number patient invasive mechanical ventilation small .', 'No significant difference observe two group length oxygen support , hospital length stay , day randomisation discharge , day randomisation death distribution six-category scale day 7 , day 14 , day 28 ( table 3 ; appendix p 9 ) .', 'Of 236 patient ( 158 remdesivir group 78 placebo group ) RT-PCR positive enrolment , 37 ( 19 % ) 196 data available undetectable viral RNA nasopharyngeal oropharyngeal swab take baseline .', 'The mean baseline viral load nasopharyngeal oropharyngeal swab 4·7 log10 copy per mL ( SE 0·3 ) remdesivir group 4·7 log10 copy per mL ( 0·4 ) control group ( table 1 ) .', 'Viral load decrease time similarly group ( figure 3A ) .', 'No difference viral load observe stratify interval symptom onset start study treatment ( appendix p 10 ) .', 'In subset patient expectorate sputum could obtain ( 103 patient ) , mean viral RNA load enrolment nearly 1-log higher remdesivir group placebo group enrolment ( figure 3B ) .', 'When adjust baseline sputum viral load enrolment , remdesivir group show significant difference day 5 placebo , slightly rapid decline load ( p=0·0672 ) .Figure 3Viral load quantitative PCR upper respiratory tract specimen ( A ) lower respiratory tract specimen ( B ) Show full captionData mean ( SE ) .', 'Results le lower limit quantification PCR assay greater limit qualitative detection impute half actual value ; result patient viral-negative RNA impute 0 log10 copy per mL.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Data mean ( SE ) .', 'Results le lower limit quantification PCR assay greater limit qualitative detection impute half actual value ; result patient viral-negative RNA impute 0 log10 copy per mL .', 'The cumulative rate undetectable viral RNA nasopharyngeal oropharyngeal swab day 28 153 ( 78 % ) 196 patient , negative proportion similar among patient receive remdesivir receive placebo ( appendix p 4 ) .', 'Adverse event report 102 ( 66 % ) 155 patient remdesivir group 50 ( 64 % ) 78 control group ( table 4 ) .', 'The common adverse event remdesivir group constipation , hypoalbuminaemia , hypokalaemia , anaemia , thrombocytopenia , increase total bilirubin ; placebo group , common hypoalbuminaemia , constipation , anaemia , hypokalaemia , increase aspartate aminotransferase , increase blood lipid , increase total bilirubin .', '28 ( 18 % ) serious adverse event report remdesivir group 20 ( 26 % ) report control group .', 'More patient remdesivir group placebo group discontinue study drug adverse event serious adverse event ( 18 [ 12 % ] remdesivir group v four [ 5 % ] placebo group ) , among seven ( 5 % ) due respiratory failure acute respiratory distress syndrome remdesivir group .', 'All death observation period judge site investigator unrelated intervention ) .Table 4Summary adverse event safety population occur one participantRemdesivir group ( n=155 ) Placebo group ( n=78 ) Any gradeGrade 3 4Any gradeGrade 3 4Adverse event ( ≥2 % patient treatment group ) Any102 ( 66 % ) 13 ( 8 % ) 50 ( 64 % ) 11 ( 14 % ) Hypoalbuminaemia20 ( 13 % ) 012 ( 15 % ) 1 ( 1 % ) Hypokalaemia18 ( 12 % ) 2 ( 1 % ) 11 ( 14 % ) 1 ( 1 % ) Increased blood glucose11 ( 7 % ) 06 ( 8 % ) 0Anaemia18 ( 12 % ) 1 ( 1 % ) 12 ( 15 % ) 2 ( 3 % ) Rash11 ( 7 % ) 02 ( 3 % ) 0Thrombocytopenia16 ( 10 % ) 4 ( 3 % ) 5 ( 6 % ) 3 ( 4 % ) Increased total bilirubin15 ( 10 % ) 1 ( 1 % ) 7 ( 9 % ) 0Increased blood lipids10 ( 6 % ) 08 ( 10 % ) 0Increased white blood cell count11 ( 7 % ) 06 ( 8 % ) 0Hyperlipidaemia10 ( 6 % ) 08 ( 10 % ) 0Increased blood urea nitrogen10 ( 6 % ) 05 ( 6 % ) 0Increased neutrophil10 ( 6 % ) 04 ( 5 % ) 0Aspartate aminotransferase increased7 ( 5 % ) 09 ( 12 % ) 0Constipation21 ( 14 % ) 012 ( 15 % ) 0Nausea8 ( 5 % ) 02 ( 3 % ) 0Diarrhoea5 ( 3 % ) 02 ( 3 % ) 0Vomiting4 ( 3 % ) 02 ( 3 % ) 0Reduced serum sodium4 ( 3 % ) 02 ( 3 % ) 0Increased serum potassium4 ( 3 % ) 2 ( 1 % ) 1 ( 1 % ) 0Serious adverse eventsAny28 ( 18 % ) 9 ( 6 % ) 20 ( 26 % ) 10 ( 13 % ) Respiratory failure acute respiratory distress syndrome16 ( 10 % ) 4 ( 3 % ) 6 ( 8 % ) 4 ( 5 % ) Cardiopulmonary failure8 ( 5 % ) 07 ( 9 % ) 1 ( 1 % ) Pulmonary embolism1 ( 1 % ) 1 ( 1 % ) 1 ( 1 % ) 1 ( 1 % ) Recurrence COVID-191 ( 1 % ) 000Cardiac arrest1 ( 1 % ) 000Acute coronary syndrome001 ( 1 % ) 1 ( 1 % ) Tachycardia001 ( 1 % ) 0Septic shock1 ( 1 % ) 01 ( 1 % ) 1 ( 1 % ) Lung abscess001 ( 1 % ) 1 ( 1 % ) Sepsis001 ( 1 % ) 1 ( 1 % ) Bronchitis001 ( 1 % ) 1 ( 1 % ) Thrombocytopenia1 ( 1 % ) 1 ( 1 % ) 00Increased D-dimer001 ( 1 % ) 1 ( 1 % ) Haemorrhage lower digestive tract1 ( 1 % ) 1 ( 1 % ) 00Ileus001 ( 1 % ) 0Deep vein thrombosis1 ( 1 % ) 1 ( 1 % ) 1 ( 1 % ) 1 ( 1 % ) Acute kidney injury1 ( 1 % ) 000Diabetic ketoacidosis001 ( 1 % ) 1 ( 1 % ) Multiple organ dysfunction syndrome1 ( 1 % ) 02 ( 3 % ) 0Events lead drug discontinuationAny18 ( 12 % ) 3 ( 2 % ) 4 ( 5 % ) 1 ( 1 % ) Respiratory failure acute respiratory distress syndrome7 ( 5 % ) 1 ( 1 % ) 1 ( 1 % ) 0Secondary infection4 ( 3 % ) 07 ( 9 % ) 2 ( 3 % ) Cardiopulmonary failure3 ( 2 % ) 01 ( 1 % ) 0Nausea1 ( 1 % ) 000Vomiting1 ( 1 % ) 000Ileus001 ( 1 % ) 0Increased alanine aminotransferase2 ( 1 % ) 1 ( 1 % ) 00Rash2 ( 1 % ) 000Poor appetite1 ( 1 % ) 000Increased total bilirubin1 ( 1 % ) 000Acute kidney injury1 ( 1 % ) 1 ( 1 % ) 00Seizure001 ( 1 % ) 0Aggravated schizophrenia001 ( 1 % ) 1 ( 1 % ) Aggravated depression001 ( 1 % ) 1 ( 1 % ) Data n ( % ) include event report antiviral treatment .', 'Some patient one adverse event .', '36 patient discontinue drug , 22 adverse event 14 patient reason ( eg , hospital discharge early death ) .', 'COVID-19=coronavirus disease 2019 .', 'Open table new tab Data n ( % ) include event report antiviral treatment .', 'Some patient one adverse event .', '36 patient discontinue drug , 22 adverse event 14 patient reason ( eg , hospital discharge early death ) .', 'COVID-19=coronavirus disease 2019 .', 'Our trial find intravenous remdesivir significantly improve time clinical improvement , mortality , time clearance virus patient serious COVID-19 compare placebo .', 'Compared previous study compassionate use remdesivir,21Grein J Ohmagari N Shin D et al.Compassionate use remdesivir patient severe Covid-19.N Engl J Med .', '2020 ; ( publish online April 10 .', ') DOI:10.1056/NEJMoa2007016Google Scholar study population le ill ( eg , time enrolment , 0·4 % invasive mechanical ventilation extracorporeal membrane oxygenation v 64 % previous study ) treat somewhat earlier disease course ( median 10 day v 12 day ) .', 'Such difference might expect favour remdesivir , provide greater effect study population , result meet expectation .', 'However , study reach target enrolment stringent public health measure use Wuhan lead mark reduction new patient presentation mid-March , restriction hospital bed availability result patient enrol later course disease .', 'Consequently , could adequately ass whether earlier remdesivir treatment might provide clinical benefit .', 'However , among patient treat within 10 day symptom onset , remdesivir significant factor associate numerical reduction 5 day median time clinical improvement .', 'Ongoing control clinical trial expect confirm refute find .', 'In one murine model SARS , remdesivir treatment start 2 day infection , virus replication lung airway epithelial damage already peak , significantly reduce SARS-CoV-1 lung titre decrease disease severity mortality.13Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar A need early treatment find non-human primate model SARS MERS virus replication short-lived lung pathology appear develop rapidly human infections.17de Wit E Feldmann F Cronin J et al.Prophylactic therapeutic remdesivir ( GS-5734 ) treatment rhesus macaque model MERS-CoV infection.Proc Natl Acad Sci USA .', '2020 ; 117 : 6771-6776Google Scholar , 19Williamson BN Feldmann F Schwarz B et al.Clinical benefit remdesivir rhesus macaque infect SARS-CoV-2.bioRxiv .', '2020 ; ( publish online April 22 . )', '( preprint ) .DOI : 10.1101/2020.04.15.043166Google Scholar Such find argue test remdesivir earlier COVID-19 .', 'Remdesivir result significant reduction SARS-CoV-2 RNA load detectability upper respiratory tract sputum specimen study despite show strong antiviral effect preclinical model infection coronaviruses .', 'In African green monkey kidney Vero E6 cell , remdesivir inhibit SARS-CoV-2 50 % effective concentration ( EC50 ) 0·46 μg/mL EC90 1·06 μg/mL.6Wang M Cao R Zhang L et al.Remdesivir chloroquine effectively inhibit recently emerge novel coronavirus ( 2019-nCoV ) vitro.Cell Res .', '2020 ; 30 : 2-71Google Scholar In human nasal bronchial airway epithelial cell , fix 20 μM ( 12·1 μg/mL ) concentration reduce estimate intracellular viral titre 7·0 log10 50 % tissue culture infective dose per mL 48 h.18Pizzorno A Padey B Julien T et al.Characterization treatment SARS-CoV-2 nasal bronchial human airway epithelia.bioRxiv .', '2020 ; ( publish online April 2 . )', '( preprint ) .DOI : 10.1101/2020.03.31.017889Google Scholar In human airway epithelial cell , EC50 remdesivir 0·042 μg/mL SARS-CoV 0·045 μg/mL MERS-CoV.13Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar In murine model MERS , subcutaneous remdesivir show significant antiviral clinical effect dose regimen maintain plasma concentration greater 1 μM ( 0·60 μg/mL ) throughout dose interval.13Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar In rhesus macaque , 5 mg/kg dose , report roughly equivalent 100-mg daily dose human , effective treatment MERS-CoV infection reduce pulmonary virus replication start 12 h infection.18Pizzorno A Padey B Julien T et al.Characterization treatment SARS-CoV-2 nasal bronchial human airway epithelia.bioRxiv .', '2020 ; ( publish online April 2 . )', '( preprint ) .DOI : 10.1101/2020.03.31.017889Google Scholar Healthy adult volunteer receive do similar trial ( 200 mg day 1 , 100 mg day 2–4 ) mean peak plasma concentration 5·4 μg/mL ( percentage coefficient variation 20·3 ) day 1 2·6 μg/mL ( 12·7 ) day 5.24Gilead Sciences .', ""Investigator 's brochure remdesivir , 5th edition ."", 'Feb 21 , 2020.Google Scholar Doses 150 mg/day 14 day adequately tolerate healthy adult , daily dose regimen 150 mg 3 day follow 225 mg 11 day appear generally well tolerate one patient Ebola meningoencephalitis.25Jacobs M Rodger A Bell DJ et al.Late Ebola virus relapse cause meningoencephalitis : case report.Lancet .', '2016 ; 388 : 498-503Google Scholar However , pharmacokinetics remdesivir severely ill patient , particularly concentration active nucleotide metabolite ( GS-441524 ) triphosphate respiratory tract cell treat patient , unknown .', 'Studies higher-dose regimen safety data ( eg , 150–200 mg daily do ) warrant consideration severe COVID-19 .', 'Our study find remdesivir adequately tolerate new safety concern identify .', 'The overall proportion patient serious adverse event tend lower remdesivir recipient placebo recipient .', 'However , higher proportion remdesivir recipient placebo recipient dose prematurely stop investigator adverse event include gastrointestinal symptom ( anorexia , nausea , vomit ) , aminotransferase bilirubin increase , worsen cardiopulmonary status .', 'Limitations study include insufficient power detect assume difference clinical outcome , initiation treatment quite late COVID-19 , absence data infectious virus recovery possible emergence reduce susceptibility remdesivir .', 'Of note , non-human primate , inhibitory effect remdesivir infectious SARS-CoV-2 recovery bronchoalveolar lavage much greater control , viral RNA detection upper lower respiratory tract specimen consistently decrease versus controls.19Williamson BN Feldmann F Schwarz B et al.Clinical benefit remdesivir rhesus macaque infect SARS-CoV-2.bioRxiv .', '2020 ; ( publish online April 22 . )', '( preprint ) .DOI : 10.1101/2020.04.15.043166Google Scholar Coronaviruses partially resistant inhibition remdesivir ( six-times increase EC50 ) obtain serial vitro passage , virus remain susceptible higher remdesivir concentration show impair fitness.26Agostini ML Andres EL Sims AC et al.Coronavirus susceptibility antiviral remdesivir ( GS-5734 ) mediate viral polymerase proofread exoribonuclease.MBio .', '2018 ; 9 : e00221-e00318Google Scholar The frequent use corticosteroid patient group might promote viral replication , observe SARS27Lee N Allen Chan KC Hui DS et al.Effects early corticosteroid treatment plasma SARS-associated coronavirus RNA concentration adult patients.J Clin Virol .', '2004 ; 31 : 304-309Google Scholar MERS,28Arabi YM Mandourah Y Al-Hameed F et al.Corticosteroid therapy critically ill patient Middle East respiratory syndrome.Am J Respir Crit Care Med .', '2018 ; 197 : 757-767Google Scholar although study report prolongation detection viral RNA , infectious virus .', 'Furthermore , answer whether longer treatment course higher dose remdesivir would beneficial patient severe COVID-19 .', 'In summary , find dose regimen intravenous remdesivir adequately tolerate provide significant clinical antiviral effect seriously ill patient COVID-19 .', 'However , could exclude clinically meaningful difference saw numerical reduction clinical parameter .', 'Ongoing study larger sample size continue inform understand effect remdesivir COVID-19 .', 'Furthermore , strategy enhance antiviral potency remdesivir ( eg , higher-dose regimen , combination antiviral , SARS-CoV-2 neutralise antibody ) mitigate immunopathological host response contribute COVID-19 severity ( eg , inhibitor IL-6 , IL-1 , TNFα ) require rigorous study patient severe COVID-19 .', 'Contributors BC , CW , YeW full access data study take responsibility integrity data accuracy data analysis .', 'CW BC decide publish paper .', 'BC , CW , YeW , PWH , TJ , FGH provide input trial design .', 'BC , CW , YeW , FGH , PWH responsible acquisition , analysis , interpretation data .', 'YeW , FGH , PWH , GF draft manuscript .', 'BC , CW , PWH , FGH , GF , TJ , XG critically revise manuscript .', 'YeW contribute statistical analysis .', 'GF give valuable suggestion data analysis .', 'All author contribute conduct trial .', 'Declaration interest FGH serve non-compensated consultant Gilead Sciences respiratory antiviral programme , outside submit work .', 'All author declare compete interest .', 'After approval Human Genetic Resources Administration China , trial data share qualify researcher submit proposal valuable research question .', 'A contract sign .', 'Acknowledgments We thank Gilead Sciences provide study drug Huyen Cao Anu Osinusi advice regard safe use remdesivir .', 'We thank Joe Yao Ella Lin statistical consultation .', 'We also thank member international data safety monitor board ( Jieming Qu [ chair ] , Weichung Joe Shih , Robert Fowler , Rory Collins , Chen Yao ) , independent statistician ( Xiaoyan Yan Bin Shan ) , academic secretary ( Lingling Gao Junkai Lai ) , eDMC system provider ( Tai Xie , Rong Ran , Peng Zhang , Emily Wang ) service .', 'Roche Diagnostics ( Shanghai ) provide instrument SARS-CoV-2 assay detection ; SMO assistance provide Shanghai MedKey Med-Tech Development , Clinplus , Hangzhou SIMO , MEDPISON .', 'This work support Chinese Academy Medical Sciences Emergency Project COVID-19 ( 2020HY320001 ) ; Major Projects National Science Technology New Drug Creation Development ( 2020ZX09201012 ) ; National Key Research Development Program China ( 2018YFC1200102 ) ; Beijing Science Technology Project ( Z19110700660000 ) .', 'TJ fund National Institutes Health Research ( NIHR ) Senior Research Fellowship ( 2015-08-001 ) .', 'PH fund Wellcome Trust UK Department International Development [ 215091/Z/18/Z ] , Bill & Melinda Gates Foundation [ OPP1209135 ] , NIHR [ 200907 ] .', 'Download .pdf ( .62 MB ) Help pdf file Supplementary appendix Remdesivir COVID-19 : challenge underpowered studiesFull-TextPDF']","['backgroundno', 'specific', 'antiviral', 'drug', 'prove', 'effective', 'treatment', 'patient', 'severe', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'remdesivir', '', 'gs-5734', '', '', 'nucleoside', 'analogue', 'prodrug', '', 'inhibitory', 'effect', 'pathogenic', 'animal', 'human', 'coronaviruses', '', 'include', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'vitro', '', 'inhibit', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov-1', '', 'sars-cov-2', 'replication', 'animal', 'modelsmethodswe', 'randomise', '', 'double-blind', '', 'placebo-controlled', '', 'multicentre', 'trial', 'ten', 'hospital', 'hubei', '', 'china', '', 'eligible', 'patient', 'adult', '', 'age', '18', 'year', '', 'admit', 'hospital', 'laboratory-confirmed', 'sars-cov-2', 'infection', '', 'interval', 'symptom', 'onset', 'enrolment', '12', 'day', 'le', '', 'oxygen', 'saturation', '94', '', 'le', 'room', 'air', 'ratio', 'arterial', 'oxygen', 'partial', 'pressure', 'fractional', 'inspire', 'oxygen', '300', 'mm', 'hg', 'le', '', 'radiologically', 'confirm', 'pneumonia', '', 'patients', 'randomly', 'assign', '21', 'ratio', 'intravenous', 'remdesivir', '', '200', 'mg', 'day', '1', 'follow', '100', 'mg', 'day', '210', 'single', 'daily', 'infusion', '', 'volume', 'placebo', 'infusion', '10', 'day', '', 'patients', 'permit', 'concomitant', 'lopinavirritonavir', '', 'interferon', '', 'corticosteroid', '', 'primary', 'endpoint', 'time', 'clinical', 'improvement', 'day', '28', '', 'define', 'time', '', 'day', '', 'randomisation', 'point', 'decline', 'two', 'level', 'six-point', 'ordinal', 'scale', 'clinical', 'status', '', '1discharged', '6death', '', 'discharge', 'alive', 'hospital', '', 'whichever', 'first', '', 'primary', 'analysis', 'intention-to-treat', '', 'itt', '', 'population', 'safety', 'analysis', 'patient', 'start', 'assign', 'treatment', '', 'trial', 'register', 'clinicaltrialsgov', '', 'nct04257656findingsbetween', 'feb', '6', '', '2020', '', 'march', '12', '', '2020', '', '237', 'patient', 'enrol', 'randomly', 'assign', 'treatment', 'group', '', '158', 'remdesivir', '79', 'placebo', '', '', 'one', 'patient', 'placebo', 'group', 'withdraw', 'randomisation', 'include', 'itt', 'population', '', 'remdesivir', 'associate', 'difference', 'time', 'clinical', 'improvement', '', 'hazard', 'ratio', '123', '', '95', '', 'ci', '087175', '', '', '', 'although', 'statistically', 'significant', '', 'patient', 'receive', 'remdesivir', 'numerically', 'faster', 'time', 'clinical', 'improvement', 'receive', 'placebo', 'among', 'patient', 'symptom', 'duration', '10', 'day', 'le', '', 'hazard', 'ratio', '152', '', '095243', '', '', '', 'adverse', 'event', 'report', '102', '', '66', '', '', '155', 'remdesivir', 'recipient', 'versus', '50', '', '64', '', '', '78', 'placebo', 'recipient', '', 'remdesivir', 'stop', 'early', 'adverse', 'event', '18', '', '12', '', '', 'patient', 'versus', 'four', '', '5', '', '', 'patient', 'stop', 'placebo', 'earlyinterpretationin', 'study', 'adult', 'patient', 'admit', 'hospital', 'severe', 'covid-19', '', 'remdesivir', 'associate', 'statistically', 'significant', 'clinical', 'benefit', '', 'however', '', 'numerical', 'reduction', 'time', 'clinical', 'improvement', 'treat', 'earlier', 'require', 'confirmation', 'larger', 'studiesfundingchinese', 'academy', 'medical', 'sciences', 'emergency', 'project', 'covid-19', '', 'national', 'key', 'research', 'development', 'program', 'china', '', 'beijing', 'science', 'technology', 'project', '', 'specific', 'antiviral', 'drug', 'prove', 'effective', 'treatment', 'patient', 'severe', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'remdesivir', '', 'gs-5734', '', '', 'nucleoside', 'analogue', 'prodrug', '', 'inhibitory', 'effect', 'pathogenic', 'animal', 'human', 'coronaviruses', '', 'include', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'vitro', '', 'inhibit', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov-1', '', 'sars-cov-2', 'replication', 'animal', 'model', '', 'randomise', '', 'double-blind', '', 'placebo-controlled', '', 'multicentre', 'trial', 'ten', 'hospital', 'hubei', '', 'china', '', 'eligible', 'patient', 'adult', '', 'age', '18', 'year', '', 'admit', 'hospital', 'laboratory-confirmed', 'sars-cov-2', 'infection', '', 'interval', 'symptom', 'onset', 'enrolment', '12', 'day', 'le', '', 'oxygen', 'saturation', '94', '', 'le', 'room', 'air', 'ratio', 'arterial', 'oxygen', 'partial', 'pressure', 'fractional', 'inspire', 'oxygen', '300', 'mm', 'hg', 'le', '', 'radiologically', 'confirm', 'pneumonia', '', 'patients', 'randomly', 'assign', '21', 'ratio', 'intravenous', 'remdesivir', '', '200', 'mg', 'day', '1', 'follow', '100', 'mg', 'day', '210', 'single', 'daily', 'infusion', '', 'volume', 'placebo', 'infusion', '10', 'day', '', 'patients', 'permit', 'concomitant', 'lopinavirritonavir', '', 'interferon', '', 'corticosteroid', '', 'primary', 'endpoint', 'time', 'clinical', 'improvement', 'day', '28', '', 'define', 'time', '', 'day', '', 'randomisation', 'point', 'decline', 'two', 'level', 'six-point', 'ordinal', 'scale', 'clinical', 'status', '', '1discharged', '6death', '', 'discharge', 'alive', 'hospital', '', 'whichever', 'first', '', 'primary', 'analysis', 'intention-to-treat', '', 'itt', '', 'population', 'safety', 'analysis', 'patient', 'start', 'assign', 'treatment', '', 'trial', 'register', 'clinicaltrialsgov', '', 'nct04257656', '', 'feb', '6', '', '2020', '', 'march', '12', '', '2020', '', '237', 'patient', 'enrol', 'randomly', 'assign', 'treatment', 'group', '', '158', 'remdesivir', '79', 'placebo', '', '', 'one', 'patient', 'placebo', 'group', 'withdraw', 'randomisation', 'include', 'itt', 'population', '', 'remdesivir', 'associate', 'difference', 'time', 'clinical', 'improvement', '', 'hazard', 'ratio', '123', '', '95', '', 'ci', '087175', '', '', '', 'although', 'statistically', 'significant', '', 'patient', 'receive', 'remdesivir', 'numerically', 'faster', 'time', 'clinical', 'improvement', 'receive', 'placebo', 'among', 'patient', 'symptom', 'duration', '10', 'day', 'le', '', 'hazard', 'ratio', '152', '', '095243', '', '', '', 'adverse', 'event', 'report', '102', '', '66', '', '', '155', 'remdesivir', 'recipient', 'versus', '50', '', '64', '', '', '78', 'placebo', 'recipient', '', 'remdesivir', 'stop', 'early', 'adverse', 'event', '18', '', '12', '', '', 'patient', 'versus', 'four', '', '5', '', '', 'patient', 'stop', 'placebo', 'early', '', 'study', 'adult', 'patient', 'admit', 'hospital', 'severe', 'covid-19', '', 'remdesivir', 'associate', 'statistically', 'significant', 'clinical', 'benefit', '', 'however', '', 'numerical', 'reduction', 'time', 'clinical', 'improvement', 'treat', 'earlier', 'require', 'confirmation', 'larger', 'study', '', 'chinese', 'academy', 'medical', 'sciences', 'emergency', 'project', 'covid-19', '', 'national', 'key', 'research', 'development', 'program', 'china', '', 'beijing', 'science', 'technology', 'project', '', 'ongoing', 'pandemic', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', 'lead', '4', '692', '797', 'case', '195', '920', 'death', 'globally', 'april', '25', '', '20201johns', 'hopkins', 'university', 'medicinecovid-19', 'map', '', 'johns', 'hopkins', 'coronavirus', 'resource', 'centre', '', 'urlplaceholder', 'access', '', 'april', '25', '', '2020google', 'although', 'infection', 'self-limited', '', '15', '', 'infect', 'adult', 'develop', 'severe', 'pneumonia', 'require', 'treatment', 'supplemental', 'oxygen', 'additional', '5', '', 'progress', 'critical', 'illness', 'hypoxaemic', 'respiratory', 'failure', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'multiorgan', 'failure', 'necessitate', 'ventilatory', 'support', '', 'often', 'several', 'weeks2wu', 'z', 'mcgoogan', 'jm', 'characteristics', 'important', 'lesson', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'outbreak', 'china', '', 'summary', 'report', '72', '314', 'case', 'chinese', 'center', 'disease', 'control', 'preventionjama', '', '2020', '', '', 'publish', 'online', 'feb', '24', '', '', 'doi101001jama20202648google', '', '3chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513google', '', '4zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '395', '', '1054-1062google', 'least', 'half', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'require', 'invasive', 'mechanical', 'ventilation', 'die', 'hospital4zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '395', '', '1054-1062google', '', '5bhatraju', 'pk', 'ghassemieh', 'bj', 'nichols', 'alcovid-19', 'critically', 'ill', 'patient', 'seattle', 'regioncase', 'seriesn', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'march', '30', '', '', 'doi101056nejmoa2004500google', 'associate', 'burden', 'health-care', 'system', '', 'especially', 'intensive', 'care', 'unit', '', 'overwhelm', 'several', 'affect', 'country', '', 'although', 'several', 'approve', 'drug', 'investigational', 'agent', 'show', 'antiviral', 'activity', 'sars-cov-2', 'vitro6wang', 'cao', 'r', 'zhang', 'l', 'alremdesivir', 'hydroxychloroquine', 'effectively', 'inhibit', 'recently', 'emerge', 'novel', 'coronavirus', '', '2019-ncov', '', 'vitrocell', 'res', '', '2020', '', '30', '', '2-71google', '', '7liu', 'j', 'cao', 'r', 'xu', 'alhydroxychloroquine', '', 'le', 'toxic', 'derivative', 'hydroxychloroquine', '', 'effective', 'inhibit', 'sars-cov-2', 'infection', 'vitrocell', 'discov', '', '2020', '', '6', '', '16google', 'present', 'antiviral', 'therapy', 'prove', 'effectiveness', 'treat', 'severely', 'ill', 'patient', 'covid-19', '', 'multicentre', '', 'open-label', '', 'randomise', 'control', 'trial', '', 'rct', '', 'hydroxychloroquine', 'involve', '150', 'adult', 'admit', 'hospital', 'covid-19', 'report', 'significant', 'effect', 'drug', 'accelerate', 'viral', 'clearance8tang', 'w', 'cao', 'zhu', 'han', 'alhydroxychloroquine', 'patient', 'covid-19', '', 'open-label', '', 'randomize', '', 'control', 'trialmedrxiv', '', '2020', '', '', 'publish', 'online', 'april', '14', '', '', '', 'preprint', '', 'doi', '', '1011012020041020060558google', 'rct', 'enrol', 'patient', 'within', '12', 'day', 'symptom', 'onset', 'find', 'favipiravir', 'superior', 'arbidol', 'term', 'clinical', 'recovery', 'rate', 'day', '7', 'patient', 'mild', 'illness', '', '62', '', '56', '', '', '111', 'arbidol', 'v', '70', '', '71', '', '', '98', 'favipiravir', '', '', 'critical', 'illness', '', '0', 'v', '1', '', '6', '', '', '', '9chen', 'c', 'huang', 'j', 'cheng', 'z', 'alfavipiravir', 'versus', 'arbidol', 'covid-19', '', 'randomize', 'clinical', 'trialmedrxiv', '', '2020', '', '', 'publish', 'online', 'april', '15', '', '', '', 'preprint', '', 'doi', '', '1011012020031720037432google', 'severe', 'illness', '', 'one', 'uncontrolled', 'study', 'five', 'patient', 'give', 'convalescent', 'plasma', 'suggest', 'possible', 'benefit', '', 'although', 'patient', 'already', 'detectable', 'anti-sars-cov-2', 'neutralise', 'antibody', 'receipt', 'plasma10shen', 'c', 'wang', 'z', 'zhao', 'f', 'altreatment', '5', 'critically', 'ill', 'patient', 'covid-19', 'convalescent', 'plasmajama', '', '2020', '', '', 'publish', 'online', 'march', '27', '', '', 'doi101001jama20204783google', 'open-label', 'rct', 'oral', 'lopinavirritonavir', 'find', 'significant', 'effect', 'primary', 'outcome', 'measure', 'time', 'clinical', 'improvement', 'evidence', 'reduction', 'viral', 'rna', 'titre', 'compare', 'control11cao', 'b', 'wang', 'wen', 'ala', 'trial', 'lopinavirritonavir', 'adult', 'hospitalize', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'march', '18', '', '', 'doi101056nejmoa2001282google', 'however', '', 'per-protocol', 'analysis', 'suggest', 'possible', 'reduction', 'time', 'clinical', 'improvement', '', 'difference', '1', 'day', '', '', 'particularly', 'treat', 'within', '12', 'day', 'symptom', 'onset', '', 'study', 'lopinavirritonavir', 'drug', 'ongoing', '', 'research', 'contextevidence', 'studywe', 'search', '', 'april', '10', '', '2020', '', 'publish', 'clinical', 'trial', 'assess', 'effect', 'remdesivir', 'among', 'patient', 'laboratory-confirmed', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'search', 'term', '', '', 'covid-19', '', '', '2019-ncov', '', '', 'sars-cov-2', '', '', '', 'remdesivir', '', '', '', 'clinical', 'trial', '', '', 'randomize', 'control', 'trial', '', '', '', 'identify', 'publish', 'clinical', 'trial', 'effect', 'remdesivir', 'patient', 'covid-19added', 'value', 'studyour', 'study', 'first', 'randomise', '', 'double-blind', '', 'placebo-controlled', 'clinical', 'trial', 'assess', 'effect', 'intravenous', 'remdesivir', 'adult', 'admit', 'hospital', 'severe', 'covid-19', '', 'study', 'terminate', 'attain', 'prespecified', 'sample', 'size', '', 'intention-to-treat', 'population', '', 'primary', 'endpoint', 'time', 'clinical', 'improvement', 'significantly', 'different', 'group', '', 'numerically', 'shorter', 'remdesivir', 'group', 'control', 'group', '', 'particularly', 'treat', 'within', '10', 'day', 'symptom', 'onset', '', 'duration', 'invasive', 'mechanical', 'ventilation', '', 'although', 'significantly', 'different', 'group', '', 'numerically', 'shorter', 'remdesivir', 'recipient', 'placebo', 'recipientsimplications', 'available', 'evidenceno', 'statistically', 'significant', 'benefit', 'observe', 'remdesivir', 'treatment', 'beyond', 'standard', 'care', 'treatment', '', 'trial', 'attain', 'predetermine', 'sample', 'size', 'outbreak', 'covid-19', 'bring', 'control', 'china', '', 'future', 'study', 'remdesivir', '', 'include', 'earlier', 'treatment', 'patient', 'covid-19', 'higher-dose', 'regimen', 'combination', 'antiviral', 'sars-cov-2', 'neutralise', 'antibody', 'severe', 'covid-19', 'better', 'understand', 'potential', 'effectiveness', '', 'evidence', 'study', 'search', '', 'april', '10', '', '2020', '', 'publish', 'clinical', 'trial', 'assess', 'effect', 'remdesivir', 'among', 'patient', 'laboratory-confirmed', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'search', 'term', '', '', 'covid-19', '', '', '2019-ncov', '', '', 'sars-cov-2', '', '', '', 'remdesivir', '', '', '', 'clinical', 'trial', '', '', 'randomize', 'control', 'trial', '', '', '', 'identify', 'publish', 'clinical', 'trial', 'effect', 'remdesivir', 'patient', 'covid-19', '', 'added', 'value', 'study', 'study', 'first', 'randomise', '', 'double-blind', '', 'placebo-controlled', 'clinical', 'trial', 'assess', 'effect', 'intravenous', 'remdesivir', 'adult', 'admit', 'hospital', 'severe', 'covid-19', '', 'study', 'terminate', 'attain', 'prespecified', 'sample', 'size', '', 'intention-to-treat', 'population', '', 'primary', 'endpoint', 'time', 'clinical', 'improvement', 'significantly', 'different', 'group', '', 'numerically', 'shorter', 'remdesivir', 'group', 'control', 'group', '', 'particularly', 'treat', 'within', '10', 'day', 'symptom', 'onset', '', 'duration', 'invasive', 'mechanical', 'ventilation', '', 'although', 'significantly', 'different', 'group', '', 'numerically', 'shorter', 'remdesivir', 'recipient', 'placebo', 'recipient', '', 'implications', 'available', 'evidence', 'statistically', 'significant', 'benefit', 'observe', 'remdesivir', 'treatment', 'beyond', 'standard', 'care', 'treatment', '', 'trial', 'attain', 'predetermine', 'sample', 'size', 'outbreak', 'covid-19', 'bring', 'control', 'china', '', 'future', 'study', 'remdesivir', '', 'include', 'earlier', 'treatment', 'patient', 'covid-19', 'higher-dose', 'regimen', 'combination', 'antiviral', 'sars-cov-2', 'neutralise', 'antibody', 'severe', 'covid-19', 'better', 'understand', 'potential', 'effectiveness', '', 'remdesivir', '', 'gs-5734', '', 'monophosphoramidate', 'prodrug', 'adenosine', 'analogue', 'broad', 'antiviral', 'spectrum', 'include', 'filovirus', '', 'paramyxovirus', '', 'pneumoviruses', '', 'coronaviruses12lo', 'mk', 'jordan', 'r', 'arvey', 'algs-5734', 'parent', 'nucleoside', 'analog', 'inhibit', 'filo-', '', 'pneumo-', '', 'paramyxovirusessci', 'rep', '2017', '', '743395google', '', '13sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', 'vitro', '', 'remdesivir', 'inhibit', 'human', 'animal', 'coronaviruses', 'test', 'date', '', 'include', 'sars-cov-213sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', '', '14warren', 'tk', 'jordan', 'r', 'lo', 'mk', 'altherapeutic', 'efficacy', 'small', 'molecule', 'gs-5734', 'ebola', 'virus', 'rhesus', 'monkeysnature', '', '2016', '', '531', '', '381-385google', '', '15brown', 'aj', 'jj', 'graham', 'rl', 'albroad', 'spectrum', 'antiviral', 'remdesivir', 'inhibit', 'human', 'endemic', 'zoonotic', 'deltacoronaviruses', 'highly', 'divergent', 'rna', 'dependent', 'rna', 'polymeraseantiviral', 'res', '', '2019', '', '169104541google', 'show', 'antiviral', 'clinical', 'effect', 'animal', 'model', 'sars-cov-1', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '-cov', 'infections13sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', '', '16sheahan', 'tp', 'sims', 'ac', 'leist', 'sr', 'alcomparative', 'therapeutic', 'efficacy', 'remdesivir', 'combination', 'lopinavir', '', 'ritonavir', '', 'interferon', 'beta', 'mers-covnat', 'commun', '', '2020', '', '11', '', '222google', '', '17de', 'wit', 'e', 'feldmann', 'f', 'cronin', 'j', 'alprophylactic', 'therapeutic', 'remdesivir', '', 'gs-5734', '', 'treatment', 'rhesus', 'macaque', 'model', 'mers-cov', 'infectionproc', 'natl', 'acad', 'sci', 'usa', '', '2020', '', '117', '', '6771-6776google', 'lethal', 'murine', 'model', 'mers', '', 'remdesivir', 'superior', 'regimen', 'combine', 'interferon', 'beta', 'lopinavirritonavir16sheahan', 'tp', 'sims', 'ac', 'leist', 'sr', 'alcomparative', 'therapeutic', 'efficacy', 'remdesivir', 'combination', 'lopinavir', '', 'ritonavir', '', 'interferon', 'beta', 'mers-covnat', 'commun', '', '2020', '', '11', '', '222google', 'remdesivir', 'potent', 'inhibitor', 'sars-cov-2', 'replication', 'human', 'nasal', 'bronchial', 'airway', 'epithelial', 'cells18pizzorno', 'padey', 'b', 'julien', 'alcharacterization', 'treatment', 'sars-cov-2', 'nasal', 'bronchial', 'human', 'airway', 'epitheliabiorxiv', '', '2020', '', '', 'publish', 'online', 'april', '2', '', '', '', 'preprint', '', 'doi', '', '10110120200331017889google', 'non-lethal', 'rhesus', 'macaque', 'model', 'sars-cov-2', 'infection', '', 'early', 'remdesivir', 'administration', 'show', 'exert', 'significant', 'antiviral', 'clinical', 'effect', '', 'reduce', 'pulmonary', 'infiltrate', 'virus', 'titre', 'bronchoalveolar', 'lavage', 'v', 'vehicle', '', '19williamson', 'bn', 'feldmann', 'f', 'schwarz', 'b', 'alclinical', 'benefit', 'remdesivir', 'rhesus', 'macaque', 'infect', 'sars-cov-2biorxiv', '', '2020', '', '', 'publish', 'online', 'april', '22', '', '', '', 'preprint', '', 'doi', '', '10110120200415043166google', 'intravenous', 'remdesivir', 'study', 'treatment', 'ebola', 'virus', 'disease', '', 'adequately', 'tolerate', 'le', 'effective', 'several', 'monoclonal', 'antibody', 'therapeutics20mulangu', 'dodd', 'le', 'davey', 'jr', '', 'rt', 'ala', 'randomize', '', 'control', 'trial', 'ebola', 'virus', 'disease', 'therapeuticsn', 'engl', 'j', 'med', '', '2019', '', '381', '', '2293-2303google', 'basis', 'individual', 'compassionate', 'past', 'several', 'month', 'patient', 'covid-19', 'countries21grein', 'j', 'ohmagari', 'n', 'shin', 'alcompassionate', 'remdesivir', 'patient', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'april', '10', '', '', 'doi101056nejmoa2007016google', 'case', 'study', 'report', 'benefit', 'severely', 'ill', 'patient', 'covid-195bhatraju', 'pk', 'ghassemieh', 'bj', 'nichols', 'alcovid-19', 'critically', 'ill', 'patient', 'seattle', 'regioncase', 'seriesn', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'march', '30', '', '', 'doi101056nejmoa2004500google', '', '21grein', 'j', 'ohmagari', 'n', 'shin', 'alcompassionate', 'remdesivir', 'patient', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'april', '10', '', '', 'doi101056nejmoa2007016google', '', '22holshue', 'ml', 'debolt', 'c', 'lindquist', 'alfirst', 'case', '2019', 'novel', 'coronavirus', 'united', 'statesn', 'engl', 'j', 'med', '', '2020', '', '382', '', '929-936google', 'however', '', 'clinical', 'antiviral', 'efficacy', 'remdesivir', 'covid-19', 'remain', 'establish', '', '', 'report', 'result', 'placebo-controlled', 'randomise', 'trial', 'remdesivir', 'patient', 'severe', 'covid-19', '', 'investigator-initiated', '', 'individually', 'randomise', '', 'placebo-controlled', '', 'double-blind', 'trial', 'ass', 'effectiveness', 'safety', 'intravenous', 'remdesivir', 'adult', '', 'age', '18', 'year', '', 'admit', 'hospital', 'severe', 'covid-19', '', 'trial', 'ten', 'hospital', 'wuhan', '', 'hubei', '', 'china', '', '', 'ethical', 'approval', 'obtain', 'institutional', 'review', 'board', 'participate', 'hospital', '', 'written', 'inform', 'consent', 'obtain', 'patient', '', 'legal', 'representative', 'unable', 'provide', 'consent', '', 'trial', 'accordance', 'principle', 'declaration', 'helsinki', 'international', 'conference', 'harmonizationgood', 'clinical', 'practice', 'guideline', '', 'protocol', 'available', 'online', '', 'eligible', 'patient', 'men', 'non-pregnant', 'woman', 'covid-19', 'age', 'least', '18', 'year', 'rt-pcr', 'positive', 'sars-cov-2', '', 'pneumonia', 'confirm', 'chest', 'image', '', 'oxygen', 'saturation', '94', '', 'lower', 'room', 'air', 'ratio', 'arterial', 'oxygen', 'partial', 'pressure', 'fractional', 'inspire', 'oxygen', '300', 'mm', 'hg', 'le', '', 'within', '12', 'day', 'symptom', 'onset', '', 'eligible', 'patient', 'child-bearing', 'age', '', 'men', 'woman', '', 'agree', 'effective', 'contraceptive', 'measure', '', 'include', 'hormonal', 'contraception', '', 'barrier', 'method', '', 'abstinence', '', 'study', 'period', 'least', '7', 'day', 'last', 'study', 'drug', 'administration', '', 'exclusion', 'criterion', 'include', 'pregnancy', 'breast', 'feed', '', 'hepatic', 'cirrhosis', '', 'alanine', 'aminotransferase', 'aspartate', 'aminotransferase', 'five', 'time', 'upper', 'limit', 'normal', '', 'severe', 'renal', 'impairment', '', 'estimate', 'glomerular', 'filtration', 'rate', '', '30', 'mlmin', 'per', '173', 'm2', '', 'receipt', 'continuous', 'renal', 'replacement', 'therapy', '', 'haemodialysis', '', 'peritoneal', 'dialysis', '', 'possibility', 'transfer', 'non-study', 'hospital', 'within', '72', 'h', '', 'enrolment', 'investigational', 'treatment', 'study', 'covid-19', '30', 'day', 'screen', '', 'treatment', '', 'include', 'lopinavirritonavir', '', 'permit', '', 'eligible', 'patient', 'randomly', 'assign', '', '21', '', 'either', 'remdesivir', 'group', 'placebo', 'group', '', 'randomisation', 'stratify', 'accord', 'level', 'respiratory', 'support', 'follow', '', '', '1', '', 'oxygen', 'support', 'oxygen', 'support', 'nasal', 'duct', 'mask', '', '', '2', '', 'high-flow', 'oxygen', '', 'non-invasive', 'ventilation', '', 'invasive', 'ventilation', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'permute', 'block', '', '30', 'patient', 'per', 'block', '', 'randomisation', 'sequence', '', 'include', 'stratification', '', 'prepare', 'statistician', 'involve', 'trial', 'sas', 'software', '', 'version', '94', '', 'eligible', 'patient', 'allocate', 'receive', 'medication', 'individually', 'number', 'pack', '', 'accord', 'sequential', 'order', 'randomisation', 'centre', '', 'jin', 'yin-tan', 'hospital', 'central', 'pharmacy', '', '', 'envelopes', 'prepare', 'emergency', 'unmask', '', 'patients', 'receive', 'either', 'intravenous', 'remdesivir', '', '200', 'mg', 'day', '1', 'follow', '100', 'mg', 'day', '210', 'single', 'daily', 'infusion', '', 'volume', 'placebo', 'infusion', 'total', '10', 'day', '', 'provide', 'gilead', 'sciences', '', 'foster', 'city', '', 'ca', '', 'usa', '', '', 'patients', 'assess', 'daily', 'train', 'nurse', 'diary', 'card', 'capture', 'data', 'six-category', 'ordinal', 'scale', 'safety', 'day', '0', '28', 'death', '', 'clinical', 'data', 'record', 'whointernational', 'severe', 'acute', 'respiratory', 'emerging', 'infections', 'consortium', '', 'isaric', '', 'case', 'record', 'form', '', 'safety', 'assessment', 'include', 'daily', 'monitor', 'adverse', 'event', '', 'clinical', 'laboratory', 'test', '', 'day', '1', '', '3', '', '7', '', '10', '', '', '12-lead', 'electrocardiogram', '', 'day', '1', '14', '', '', 'daily', 'vital', 'sign', 'measurement', '', 'clinical', 'data', 'record', 'paper', 'case', 'record', 'form', 'double', 'enter', 'electronic', 'database', 'validate', 'trial', 'staff', '', 'nasopharyngeal', 'oropharyngeal', 'swab', '', 'expectorate', 'sputum', 'available', '', 'faecal', 'anal', 'swab', 'specimen', 'collect', 'day', '1', '', '3', '', '5', '', '7', '', '10', '', '14', '', '21', '', '28', 'viral', 'rna', 'detection', 'quantification', '', 'trial', 'monitor', 'contract', 'research', 'organisation', '', 'hangzhou', 'tigermed', 'consulting', '', '', 'virological', 'test', 'teddy', 'clinical', 'research', 'laboratory', '', 'tigermeddian', '', 'hangzhou', '', 'china', '', 'quantitative', 'real-time', 'rt-pcr', '', 'rna', 'extract', 'clinical', 'sample', 'magna', 'pure', '96', 'system', '', 'roche', '', 'rotkreuz', '', 'switzerland', '', '', 'detect', 'quantify', 'cobas', 'z480', 'qpcr', '', 'roche', '', '', 'lightmix', 'modular', 'sars-cov-2', 'assay', '', 'tib', 'mobiol', '', 'berlin', '', 'germany', '', '', 'baseline', '', 'upper', '', 'nasopharyngeal', 'oropharyngeal', 'swab', '', 'lower', 'respiratory', 'tract', 'specimen', 'test', 'detection', 'e-gene', '', 'rna-dependent', 'rna', 'polymerase', 'gene', '', 'n-gene', '', 'sample', 'subsequent', 'visit', 'quantitatively', 'qualitative', 'assess', 'e-gene', '', 'primary', 'clinical', 'endpoint', 'time', 'clinical', 'improvement', 'within', '28', 'day', 'randomisation', '', 'clinical', 'improvement', 'define', 'two-point', 'reduction', 'patient', '', 'admission', 'status', 'six-point', 'ordinal', 'scale', '', 'live', 'discharge', 'hospital', '', 'whichever', 'first', '', 'six-point', 'scale', 'follow', '', 'death6', '', 'hospital', 'admission', 'extracorporeal', 'membrane', 'oxygenation', 'mechanical', 'ventilation5', '', 'hospital', 'admission', 'non-invasive', 'ventilation', 'high-flow', 'oxygen', 'therapy4', '', 'hospital', 'admission', 'oxygen', 'therapy', '', 'require', 'high-flow', 'non-invasive', 'ventilation', '', '3', '', 'hospital', 'admission', 'require', 'oxygen', 'therapy2', '', 'discharge', 'reach', 'discharge', 'criterion', '', 'define', 'clinical', 'recoveryie', '', 'normalisation', 'pyrexia', '', 'respiratory', 'rate', '', '24', 'breath', 'per', 'minute', '', 'saturation', 'peripheral', 'oxygen', '', '94', '', 'room', 'air', '', 'relief', 'cough', '', 'maintain', 'least', '72', 'h', '', '1', '', 'six-point', 'scale', 'modify', 'seven-point', 'scale', 'previous', 'covid-19', 'lopinavirritonavir', 'rct11cao', 'b', 'wang', 'wen', 'ala', 'trial', 'lopinavirritonavir', 'adult', 'hospitalize', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'march', '18', '', '', 'doi101056nejmoa2001282google', 'combine', 'two', 'outpatient', 'stratum', 'one', '', 'secondary', 'outcome', 'proportion', 'patient', 'category', 'six-point', 'scale', 'day', '7', '', '14', '', '28', 'randomisation', '', 'all-cause', 'mortality', 'day', '28', '', 'frequency', 'invasive', 'mechanical', 'ventilation', '', 'duration', 'oxygen', 'therapy', '', 'duration', 'hospital', 'admission', '', 'proportion', 'patient', 'nosocomial', 'infection', '', 'virological', 'measure', 'include', 'proportion', 'patient', 'viral', 'rna', 'detect', 'viral', 'rna', 'load', '', 'measure', 'quantitative', 'rt-pcr', '', '', 'safety', 'outcome', 'include', 'treatment-emergent', 'adverse', 'event', '', 'serious', 'adverse', 'event', '', 'premature', 'discontinuation', 'study', 'drug', '', 'original', 'design', 'require', 'total', '325', 'event', 'across', 'group', '', 'provide', '80', '', 'power', 'one-sided', 'type', 'error', '25', '', 'hazard', 'ratio', '', 'hr', '', 'compare', 'remdesivir', 'placebo', '14', '', 'correspond', 'change', 'time', 'clinical', 'improvement', '6', 'day', 'assume', 'time', 'clinical', 'improvement', '21', 'day', 'placebo', '', 'one', 'interim', 'analysis', 'triangular', 'boundaries23whitehead', 'j', 'stratton', 'group', 'sequential', 'clinical', 'trial', 'triangular', 'continuation', 'regionsbiometrics', '', '1983', '', '39', '', '227-236google', '21', 'allocation', 'ratio', 'remdesivir', 'placebo', 'account', 'original', 'design', '', 'assuming', '80', '', 'event', 'rate', 'within', '28', 'day', 'across', 'group', 'dropout', 'rate', '10', '', 'imply', '453', 'patient', 'recruit', 'trial', '', '151', 'placebo', '302', 'remdesivir', '', '', 'possibility', 'interim', 'analysis', 'enrolment', '240', 'patient', 'include', 'design', 'request', 'independent', 'data', 'safety', 'monitor', 'board', '', 'primary', 'efficacy', 'analysis', 'intention-to-treat', '', 'itt', '', 'basis', 'randomly', 'assign', 'patient', '', 'time', 'clinical', 'improvement', 'assess', 'patient', 'reach', 'day', '28', '', 'clinical', 'improvement', 'day', '28', 'death', 'day', '28', 'consider', 'censor', 'day', '28', '', 'time', 'clinical', 'improvement', 'portray', 'kaplan-meier', 'plot', 'compare', 'log-rank', 'test', '', 'hr', '95', '', 'ci', 'clinical', 'improvement', 'hr', '95', '', 'ci', 'clinical', 'deterioration', 'calculate', 'cox', 'proportional', 'hazard', 'model', '', 'analysis', 'include', 'subgroup', 'analysis', 'receive', 'treatment', '10', 'day', 'le', 'v', '10', 'day', 'symptom', 'onset', '', 'time', 'clinical', 'deterioration', '', 'define', 'one', 'category', 'increase', 'death', '', '', 'viral', 'rna', 'load', 'entry', '', 'difference', 'continuous', 'variable', 'group', 'calculate', 'hodges-lehmann', 'estimation', '', 'present', 'adverse', 'event', 'data', 'patient', '', 'actual', 'treatment', 'exposure', '', 'cod', 'medical', 'dictionary', 'regulatory', 'activities', '', 'statistical', 'analysis', 'sas', 'software', '', 'version', '94', '', 'trial', 'register', 'clinicaltrialsgov', '', 'nct04257656', '', 'feb', '6', '', '2020', '', 'march', '12', '', '2020', '', '255', 'patient', 'screen', '', '237', 'eligible', '', 'figure', '1', '', '', '158', 'patient', 'assign', 'receive', 'remdesivir', '79', 'receive', 'placebo', '', 'one', 'patient', 'placebo', 'group', 'withdraw', 'previously', 'write', 'inform', 'consent', 'randomisation', '', '158', '78', 'patient', 'include', 'itt', 'population', '', 'patient', 'enrol', 'march', '12', '', 'control', 'outbreak', 'wuhan', 'basis', 'termination', 'criterion', 'specify', 'protocol', '', 'data', 'safety', 'monitor', 'board', 'recommend', 'study', 'terminate', 'data', 'analyse', 'march', '29', '', 'stage', '', 'interim', 'analysis', 'abandon', '', 'assumption', 'stay', '', 'actual', 'enrolment', '236', 'participant', '', 'statistical', 'power', 'reduce', '80', '', '58', '', 'figure', '1trial', 'profileview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'three', 'patient', 'remdesivir', 'group', 'start', 'assign', 'treatment', 'include', 'safety', 'analysis', '', 'figure', '1', '', '', 'median', 'age', 'study', 'patient', '65', 'year', '', 'iqr', '5671', '', '', 'sex', 'distribution', '89', '', '56', '', '', 'men', 'versus', '69', '', '44', '', '', 'woman', 'remdesivir', 'group', '51', '', '65', '', '', 'versus', '27', '', '35', '', '', 'placebo', 'group', '', 'table', '1', '', '', 'common', 'comorbidity', 'hypertension', '', 'follow', 'diabetes', 'coronary', 'heart', 'disease', '', 'lopinavirritonavir', 'co-administered', '42', '', '18', '', '', 'patient', 'baseline', '', 'patient', 'category', '3', 'six-point', 'ordinal', 'scale', 'clinical', 'status', 'baseline', '', 'imbalance', 'exist', 'enrolment', 'group', '', 'include', 'patient', 'hypertension', '', 'diabetes', '', 'coronary', 'artery', 'disease', 'remdesivir', 'group', 'placebo', 'group', '', 'patient', 'control', 'group', 'remdesivir', 'group', 'symptomatic', '10', 'day', 'le', 'time', 'start', 'remdesivir', 'placebo', 'treatment', '', 'higher', 'proportion', 'remdesivir', 'recipient', 'respiratory', 'rate', '24', 'breath', 'per', 'min', '', 'major', 'difference', 'symptom', '', 'sign', '', 'laboratory', 'result', '', 'disease', 'severity', '', 'treatment', 'observe', 'group', 'baselinetable', '1baseline', 'patient', 'characteristicsremdesivir', 'group', '', 'n158', '', 'placebo', 'group', '', 'n78', '', 'age', '', 'years660', '', '570730', '', '640', '', '530700', '', 'sexmen89', '', '56', '', '', '51', '', '65', '', '', 'women69', '', '44', '', '', '27', '', '35', '', '', 'comorbidities112', '', '71', '', '', '55', '', '71', '', '', 'hypertension72', '', '46', '', '', '30', '', '38', '', '', 'diabetes40', '', '25', '', '', '16', '', '21', '', '', 'coronary', 'heart', 'disease15', '', '9', '', '', '2', '', '3', '', '', 'body', 'temperature', '', 'c368', '', '365372', '', '368', '', '365372', '', 'fever56', '', '35', '', '', '31', '', '40', '', '', 'respiratory', 'rate', '', '24', 'breath', 'per', 'min36', '', '23', '', '', '11', '', '14', '', '', 'white', 'blood', 'cell', 'count', '', '', '109', 'per', 'lmedian62', '', '4483', '', '64', '', '4583', '', '410108155', '', '70', '', '', '58', '', '74', '', '', '', '427155', '', '17', '', '', '12', '', '15', '', '', '', '1020155', '', '13', '', '', '8', '', '10', '', '', 'lymphocyte', 'count', '', '', '109', 'per', 'l08', '', '0611', '', '07', '', '0612', '', '1049155', '', '32', '', '', '23', '', '29', '', '', '', '10106155', '', '68', '', '', '55', '', '71', '', '', 'platelet', 'count', '', '', '109', 'per', 'l1830', '', '14402350', '', '1945', '', '14102660', '', '100148155', '', '95', '', '', '75', '', '96', '', '', '', '1007155', '', '5', '', '', '3', '', '4', '', '', 'serum', 'creatinine', '', 'moll680', '', '560820', '', '713', '', '560887', '', '133151154', '', '98', '', '', '76', '', '97', '', '', '', '1333154', '', '2', '', '', '2', '', '3', '', '', 'aspartate', 'aminotransferase', '', 'ul310', '', '220440', '', '330', '', '240480', '', '40109155', '', '70', '', '', '49', '', '63', '', '', '', '4046155', '', '30', '', '', '29', '', '37', '', '', 'alanine', 'aminotransferase', '', 'ul260', '', '180420', '', '260', '', '200430', '', '50130155', '', '84', '', '', '66', '', '85', '', '', '', '5025155', '', '16', '', '', '12', '', '15', '', '', 'lactate', 'dehydrogenase', '', 'ul3390', '', '24704415', '', '3290', '', '24904110', '', '24536148', '', '24', '', '', '1775', '', '23', '', '', '', '245112148', '', '76', '', '', '5875', '', '77', '', '', 'creatine', 'kinase', '', 'ul759', '', '4701311', '', '750', '', '4701580', '', '185118141', '', '84', '', '', '5467', '', '81', '', '', '', '18523141', '', '16', '', '', '1367', '', '19', '', '', 'national', 'early', 'warning', 'score', '2', 'level', 'day', '150', '', '3070', '', '40', '', '3060', '', 'six-category', 'scale', 'day', '12hospital', 'admission', '', 'require', 'supplemental', 'oxygen03', '', '4', '', '', '3hospital', 'admission', '', 'require', 'supplemental', 'oxygen129', '', '82', '', '', '65', '', '83', '', '', '4hospital', 'admission', '', 'require', 'high-flow', 'nasal', 'cannula', 'non-invasive', 'mechanical', 'ventilation28', '', '18', '', '', '9', '', '12', '', '', '5hospital', 'admission', '', 'require', 'extracorporeal', 'membrane', 'oxygenation', 'invasive', 'mechanical', 'ventilation01', '', '1', '', '', '6death1', '', '1', '', '', '0baseline', 'viral', 'load', 'nasopharyngeal', 'oropharyngeal', 'swab', '', 'log10', 'copy', 'per', 'ml47', '', '03', '', '47', '', '04', '', 'receiving', 'interferon', 'alfa-2b', 'baseline29', '', '18', '', '', '15', '', '19', '', '', 'receiving', 'lopinavirritonavir', 'baseline27', '', '17', '', '', '15', '', '19', '', '', 'antibiotic', 'treatment', 'baseline121', '', '77', '', '', '63', '', '81', '', '', 'corticosteroids', 'therapy', 'baseline60', '', '38', '', '', '31', '', '40', '', '', 'data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'mean', '', 'se', '', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'mean', '', 'se', '', '', 'median', 'time', 'symptom', 'onset', 'start', 'study', 'treatment', '10', 'day', '', 'iqr', '912', '', '', 'important', 'difference', 'apparent', 'group', 'treatment', 'receive', '', 'include', 'lopinavirritonavir', 'corticosteroid', '', 'table', '2', '', '', 'hospital', 'stay', '', '155', '', '66', '', '', 'patient', 'receive', 'corticosteroid', '', 'median', 'time', 'symptom', 'onset', 'corticosteroid', 'therapy', '80', 'day', '', '60110', '', '', '91', '', '39', '', '', 'patient', 'receive', 'corticosteroid', 'enrolmenttable', '2treatments', 'receive', 'enrolmentremdesivir', 'group', '', 'n158', '', 'placebo', 'group', '', 'n78', '', 'time', 'symptom', 'onset', 'start', 'study', 'treatment', '', 'day', '', '', 'three', 'patient', 'start', 'treatment', 'include', 'time', 'symptom', 'onset', 'start', 'study', 'treatment', 'subgroup', 'analyses11', '', '912', '', '10', '', '912', '', 'early', '', '10', 'day', 'symptom', 'onset', '', '71155', '', '46', '', '', '47', '', '60', '', '', 'late', '', '', '10', 'day', 'symptom', 'onset', '', '84155', '', '54', '', '', '31', '', '40', '', '', 'receiving', 'injection', 'interferon', 'alfa-2b46', '', '29', '', '', '30', '', '38', '', '', 'receiving', 'lopinavirritonavir44', '', '28', '', '', '23', '', '29', '', '', 'vasopressors25', '', '16', '', '', '13', '', '17', '', '', 'renal', 'replacement', 'therapy3', '', '2', '', '', '3', '', '4', '', '', 'highest', 'oxygen', 'therapy', 'supportnon-invasive', 'mechanical', 'ventilation14', '', '9', '', '', '3', '', '4', '', '', 'invasive', 'mechanical', 'ventilation11', '', '7', '', '', '10', '', '13', '', '', 'extracorporeal', 'membrane', 'oxygenation', 'mechanical', 'ventilation2', '', '1', '', '', '0antibiotic142', '', '90', '', '', '73', '', '94', '', '', 'corticosteroids', 'therapy102', '', '65', '', '', '53', '', '68', '', '', 'time', 'symptom', 'onset', 'corticosteroid', 'therapy', '', 'days9', '', '711', '', '8', '', '610', '', 'duration', 'corticosteroid', 'therapy', '', 'days9', '', '515', '', '10', '', '616', '', 'data', 'median', '', 'iqr', '', 'n', '', '', '', '', '', 'three', 'patient', 'start', 'treatment', 'include', 'time', 'symptom', 'onset', 'start', 'study', 'treatment', 'subgroup', 'analysis', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'final', 'follow-up', 'april', '10', '', '2020', '', 'itt', 'population', '', 'time', 'clinical', 'improvement', 'remdesivir', 'group', 'significantly', 'different', 'control', 'group', '', 'median', '210', 'day', '', 'iqr', '130280', '', 'remdesivir', 'group', 'v', '230', 'day', '', '150280', '', '', 'hr', '123', '', '95', '', 'ci', '087175', '', '', 'table', '3', '', 'figure', '2', '', 'table', '3outcomes', 'intention-to-treat', 'populationremdesivir', 'group', '', 'n158', '', 'placebo', 'group', '', 'n78', '', 'difference', '', '', 'differences', 'express', 'rate', 'difference', 'hodges-lehmann', 'estimator', '95', '', 'citime', 'clinical', 'improvement210', '', '130', '280', '', '230', '', '150', '280', '', '123', '', '087', '175', '', '', 'hazard', 'ratio', '95', '', 'ci', 'estimate', 'cox', 'proportional', 'risk', 'modelday', '28', 'mortality22', '', '14', '', '', '10', '', '13', '', '', '11', '', '', '81', '103', '', 'early', '', '10', 'day', 'symptom', 'onset', '', '871', '', '11', '', '', '747', '', '15', '', '', '36', '', '', '162', '89', '', 'late', '', '', '10', 'day', 'symptom', 'onset', '', '1284', '', '14', '', '', '331', '', '10', '', '', '46', '', '', '82', '174', '', 'clinical', 'improvement', 'ratesday', '74', '', '3', '', '', '2', '', '3', '', '', '00', '', '', '43', '42', '', 'day', '1442', '', '27', '', '', '18', '', '23', '', '', '35', '', '', '81', '151', '', 'day', '28103', '', '65', '', '', '45', '', '58', '', '', '75', '', '', '57', '207', '', 'duration', 'invasive', 'mechanical', 'ventilation', '', 'days70', '', '40', '160', '', '155', '', '60', '210', '', '40', '', '140', '20', '', 'duration', 'invasive', 'mechanical', 'ventilation', 'survivor', '', 'days', 'three', 'patient', 'group', 'survivor', 'ten', 'patient', 'remdesivir', 'group', 'seven', 'patient', 'placebo', 'group', 'non-survivors190', '', '50', '420', '', '420', '', '170', '460', '', '120', '', '410', '250', '', 'duration', 'invasive', 'mechanical', 'ventilation', 'non-survivors', '', 'days', 'three', 'patient', 'group', 'survivor', 'ten', 'patient', 'remdesivir', 'group', 'seven', 'patient', 'placebo', 'group', 'non-survivors70', '', '20', '110', '', '80', '', '50', '160', '', '25', '', '110', '30', '', 'duration', 'oxygen', 'support', '', 'days190', '', '110', '300', '', '210', '', '140', '305', '', '20', '', '60', '10', '', 'duration', 'hospital', 'stay', '', 'days250', '', '160', '380', '', '240', '', '180', '360', '', '00', '', '40', '40', '', 'time', 'random', 'group', 'assignment', 'discharge', '', 'days210', '', '120', '310', '', '210', '', '135', '285', '', '00', '', '30', '30', '', 'time', 'random', 'group', 'assignment', 'death', '', 'days95', '', '60', '185', '', '110', '', '70', '180', '', '10', '', '70', '50', '', 'six-category', 'scale', 'day', '71discharge', '', 'alive', '', '4154', '', '3', '', '', '277', '', '3', '', '', '069', '', '041', '117', '', '', 'calculated', 'ordinal', 'logistic', 'regression', 'model2hospital', 'admission', '', 'require', 'supplemental', 'oxygen21154', '', '14', '', '', '1677', '', '21', '', '', '', '3hospital', 'admission', '', 'require', 'supplemental', 'oxygen87154', '', '56', '', '', '4377', '', '56', '', '', '', '4hospital', 'admission', '', 'require', 'high-flow', 'nasal', 'cannula', 'non-invasive', 'mechanical', 'ventilation26154', '', '17', '', '', '877', '', '10', '', '', '', '5hospital', 'admission', '', 'require', 'extracorporeal', 'membrane', 'oxygenation', 'invasive', 'mechanical', 'ventilation6154', '', '4', '', '', '477', '', '5', '', '', '', '6death10154', '', '6', '', '', '477', '', '5', '', '', '', 'six-category', 'scale', 'day', '141discharge', '', 'alive', '', '39153', '', '25', '', '', '1878', '', '23', '', '', '125', '', '076', '204', '', '', 'calculated', 'ordinal', 'logistic', 'regression', 'model2hospital', 'admission', '', 'require', 'supplemental', 'oxygen21153', '', '14', '', '', '1078', '', '13', '', '', '', '3hospital', 'admission', '', 'require', 'supplemental', 'oxygen61153', '', '40', '', '', '2878', '', '36', '', '', '', '4hospital', 'admission', '', 'require', 'high-flow', 'nasal', 'cannula', 'non-invasive', 'mechanical', 'ventilation13153', '', '8', '', '', '878', '', '10', '', '', '', '5hospital', 'admission', '', 'require', 'extracorporeal', 'membrane', 'oxygenation', 'invasive', 'mechanical', 'ventilation4153', '', '3', '', '', '778', '', '9', '', '', '', '6death15153', '', '10', '', '', '778', '', '9', '', '', '', 'six-category', 'scale', 'day', '281discharge', '', 'alive', '', '92150', '', '61', '', '', '4577', '', '58', '', '', '115', '', '067', '196', '', '', 'calculated', 'ordinal', 'logistic', 'regression', 'model2hospital', 'admission', '', 'require', 'supplemental', 'oxygen14150', '', '9', '', '', '477', '', '5', '', '', '', '3hospital', 'admission', '', 'require', 'supplemental', 'oxygen18150', '', '12', '', '', '1377', '', '17', '', '', '', '4hospital', 'admission', '', 'require', 'high-flow', 'nasal', 'cannula', 'non-invasive', 'mechanical', 'ventilation2150', '', '1', '', '', '277', '', '3', '', '', '', '5hospital', 'admission', '', 'require', 'extracorporeal', 'membrane', 'oxygenation', 'invasive', 'mechanical', 'ventilation2150', '', '1', '', '', '377', '', '4', '', '', '', '6death22150', '', '15', '', '', '1077', '', '13', '', '', '', 'data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'clinical', 'improvement', '', 'event', '', 'define', 'decline', 'two', 'category', 'modify', 'seven-category', 'ordinal', 'scale', 'clinical', 'status', '', 'hospital', 'discharge', '', 'orodds', 'ratio', '', '', 'differences', 'express', 'rate', 'difference', 'hodges-lehmann', 'estimator', '95', '', 'ci', 'hazard', 'ratio', '95', '', 'ci', 'estimate', 'cox', 'proportional', 'risk', 'model', 'three', 'patient', 'group', 'survivor', 'ten', 'patient', 'remdesivir', 'group', 'seven', 'patient', 'placebo', 'group', 'non-survivors', 'calculated', 'ordinal', 'logistic', 'regression', 'model', '', 'open', 'table', 'new', 'tab', 'figure', '2time', 'clinical', 'improvement', 'intention-to-treat', 'populationshow', 'full', 'captionadjusted', 'hazard', 'ratio', 'randomisation', 'stratification', '125', '', '95', '', 'ci', '088178', '', '', '', 'including', 'death', 'day', '28', 'censor', 'day', '28', '', 'number', 'patient', 'without', 'clinical', 'improvement', 'still', 'include', 'number', 'riskview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'clinical', 'improvement', '', 'event', '', 'define', 'decline', 'two', 'category', 'modify', 'seven-category', 'ordinal', 'scale', 'clinical', 'status', '', 'hospital', 'discharge', '', 'orodds', 'ratio', '', 'adjusted', 'hazard', 'ratio', 'randomisation', 'stratification', '125', '', '95', '', 'ci', '088178', '', '', '', 'including', 'death', 'day', '28', 'censor', 'day', '28', '', 'number', 'patient', 'without', 'clinical', 'improvement', 'still', 'include', 'number', 'risk', '', 'results', 'time', 'clinical', 'improvement', 'similar', 'per-protocol', 'population', '', 'median', '210', 'day', '', 'iqr', '130280', '', 'remdesivir', 'group', 'v', '230', 'day', '', '150280', '', 'placebo', 'group', 'hr', '127', '', '95', '', 'ci', '089180', '', '', 'appendix', 'pp', '23', '', '5', '', '', 'although', 'statistically', 'significant', '', 'patient', 'receive', 'remdesivir', 'placebo', 'within', '10', 'day', 'symptom', 'onset', 'itt', 'population', '', 'receive', 'remdesivir', 'numerically', 'faster', 'time', 'clinical', 'improvement', 'receive', 'placebo', '', 'median', '180', 'day', '', 'iqr', '120280', '', 'v', '230', 'day', '', '150280', '', '', 'hr', '152', '', '095243', '', '', 'appendix', 'p', '6', '', '', 'clinical', 'improvement', 'define', 'one', '', 'instead', 'two', '', 'category', 'decline', '', 'hr', '134', '95', '', 'ci', '096186', '', 'appendix', 'p', '7', '', '', 'time', 'clinical', 'deterioration', '', 'define', 'one-category', 'increase', 'death', '', 'hr', '095', '95', '', 'ci', '055164', '', 'appendix', 'p', '8', '', '', '28-day', 'mortality', 'similar', 'two', 'group', '', '22', '', '14', '', '', 'die', 'remdesivir', 'group', 'v', '10', '', '13', '', '', 'placebo', 'group', '', 'difference', '11', '', '', '95', '', 'ci', '81', '103', '', '', '', 'patient', 'remdesivir', 'within', '10', 'day', 'symptom', 'onset', '', '28-day', 'mortality', 'significantly', 'different', 'group', '', 'although', 'numerically', 'higher', 'placebo', 'group', '', 'contrast', '', 'group', 'patient', 'late', '', 'remdesivir', 'patient', 'numerically', 'higher', '28-day', 'mortality', '', 'although', 'significant', 'difference', '', 'clinical', 'improvement', 'rate', 'day', '14', 'day', '28', 'significantly', 'different', 'group', '', 'numerically', 'higher', 'remdesivir', 'group', 'placebo', 'group', '', 'patient', 'assign', 'remdesivir', 'group', '', 'duration', 'invasive', 'mechanical', 'ventilation', 'significantly', 'different', '', 'numerically', 'shorter', 'assign', 'control', 'group', '', 'however', '', 'number', 'patient', 'invasive', 'mechanical', 'ventilation', 'small', '', 'significant', 'difference', 'observe', 'two', 'group', 'length', 'oxygen', 'support', '', 'hospital', 'length', 'stay', '', 'day', 'randomisation', 'discharge', '', 'day', 'randomisation', 'death', 'distribution', 'six-category', 'scale', 'day', '7', '', 'day', '14', '', 'day', '28', '', 'table', '3', '', 'appendix', 'p', '9', '', '', '236', 'patient', '', '158', 'remdesivir', 'group', '78', 'placebo', 'group', '', 'rt-pcr', 'positive', 'enrolment', '', '37', '', '19', '', '', '196', 'data', 'available', 'undetectable', 'viral', 'rna', 'nasopharyngeal', 'oropharyngeal', 'swab', 'baseline', '', 'mean', 'baseline', 'viral', 'load', 'nasopharyngeal', 'oropharyngeal', 'swab', '47', 'log10', 'copy', 'per', 'ml', '', 'se', '03', '', 'remdesivir', 'group', '47', 'log10', 'copy', 'per', 'ml', '', '04', '', 'control', 'group', '', 'table', '1', '', '', 'viral', 'load', 'decrease', 'time', 'similarly', 'group', '', 'figure', '3a', '', '', 'difference', 'viral', 'load', 'observe', 'stratify', 'interval', 'symptom', 'onset', 'start', 'study', 'treatment', '', 'appendix', 'p', '10', '', '', 'subset', 'patient', 'expectorate', 'sputum', 'obtain', '', '103', 'patient', '', '', 'mean', 'viral', 'rna', 'load', 'enrolment', 'nearly', '1-log', 'higher', 'remdesivir', 'group', 'placebo', 'group', 'enrolment', '', 'figure', '3b', '', '', 'adjust', 'baseline', 'sputum', 'viral', 'load', 'enrolment', '', 'remdesivir', 'group', 'show', 'significant', 'difference', 'day', '5', 'placebo', '', 'slightly', 'rapid', 'decline', 'load', '', 'p00672', '', 'figure', '3viral', 'load', 'quantitative', 'pcr', 'upper', 'respiratory', 'tract', 'specimen', '', '', 'lower', 'respiratory', 'tract', 'specimen', '', 'b', '', 'show', 'full', 'captiondata', 'mean', '', 'se', '', '', 'results', 'le', 'lower', 'limit', 'quantification', 'pcr', 'assay', 'greater', 'limit', 'qualitative', 'detection', 'impute', 'half', 'actual', 'value', '', 'result', 'patient', 'viral-negative', 'rna', 'impute', '0', 'log10', 'copy', 'per', 'mlview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'data', 'mean', '', 'se', '', '', 'results', 'le', 'lower', 'limit', 'quantification', 'pcr', 'assay', 'greater', 'limit', 'qualitative', 'detection', 'impute', 'half', 'actual', 'value', '', 'result', 'patient', 'viral-negative', 'rna', 'impute', '0', 'log10', 'copy', 'per', 'ml', '', 'cumulative', 'rate', 'undetectable', 'viral', 'rna', 'nasopharyngeal', 'oropharyngeal', 'swab', 'day', '28', '153', '', '78', '', '', '196', 'patient', '', 'negative', 'proportion', 'similar', 'among', 'patient', 'receive', 'remdesivir', 'receive', 'placebo', '', 'appendix', 'p', '4', '', '', 'adverse', 'event', 'report', '102', '', '66', '', '', '155', 'patient', 'remdesivir', 'group', '50', '', '64', '', '', '78', 'control', 'group', '', 'table', '4', '', '', 'common', 'adverse', 'event', 'remdesivir', 'group', 'constipation', '', 'hypoalbuminaemia', '', 'hypokalaemia', '', 'anaemia', '', 'thrombocytopenia', '', 'increase', 'total', 'bilirubin', '', 'placebo', 'group', '', 'common', 'hypoalbuminaemia', '', 'constipation', '', 'anaemia', '', 'hypokalaemia', '', 'increase', 'aspartate', 'aminotransferase', '', 'increase', 'blood', 'lipid', '', 'increase', 'total', 'bilirubin', '', '28', '', '18', '', '', 'serious', 'adverse', 'event', 'report', 'remdesivir', 'group', '20', '', '26', '', '', 'report', 'control', 'group', '', 'patient', 'remdesivir', 'group', 'placebo', 'group', 'discontinue', 'study', 'drug', 'adverse', 'event', 'serious', 'adverse', 'event', '', '18', '', '12', '', '', 'remdesivir', 'group', 'v', 'four', '', '5', '', '', 'placebo', 'group', '', '', 'among', 'seven', '', '5', '', '', 'due', 'respiratory', 'failure', 'acute', 'respiratory', 'distress', 'syndrome', 'remdesivir', 'group', '', 'death', 'observation', 'period', 'judge', 'site', 'investigator', 'unrelated', 'intervention', '', 'table', '4summary', 'adverse', 'event', 'safety', 'population', 'occur', 'one', 'participantremdesivir', 'group', '', 'n155', '', 'placebo', 'group', '', 'n78', '', 'gradegrade', '3', '4any', 'gradegrade', '3', '4adverse', 'event', '', '2', '', 'patient', 'treatment', 'group', '', 'any102', '', '66', '', '', '13', '', '8', '', '', '50', '', '64', '', '', '11', '', '14', '', '', 'hypoalbuminaemia20', '', '13', '', '', '012', '', '15', '', '', '1', '', '1', '', '', 'hypokalaemia18', '', '12', '', '', '2', '', '1', '', '', '11', '', '14', '', '', '1', '', '1', '', '', 'increased', 'blood', 'glucose11', '', '7', '', '', '06', '', '8', '', '', '0anaemia18', '', '12', '', '', '1', '', '1', '', '', '12', '', '15', '', '', '2', '', '3', '', '', 'rash11', '', '7', '', '', '02', '', '3', '', '', '0thrombocytopenia16', '', '10', '', '', '4', '', '3', '', '', '5', '', '6', '', '', '3', '', '4', '', '', 'increased', 'total', 'bilirubin15', '', '10', '', '', '1', '', '1', '', '', '7', '', '9', '', '', '0increased', 'blood', 'lipids10', '', '6', '', '', '08', '', '10', '', '', '0increased', 'white', 'blood', 'cell', 'count11', '', '7', '', '', '06', '', '8', '', '', '0hyperlipidaemia10', '', '6', '', '', '08', '', '10', '', '', '0increased', 'blood', 'urea', 'nitrogen10', '', '6', '', '', '05', '', '6', '', '', '0increased', 'neutrophil10', '', '6', '', '', '04', '', '5', '', '', '0aspartate', 'aminotransferase', 'increased7', '', '5', '', '', '09', '', '12', '', '', '0constipation21', '', '14', '', '', '012', '', '15', '', '', '0nausea8', '', '5', '', '', '02', '', '3', '', '', '0diarrhoea5', '', '3', '', '', '02', '', '3', '', '', '0vomiting4', '', '3', '', '', '02', '', '3', '', '', '0reduced', 'serum', 'sodium4', '', '3', '', '', '02', '', '3', '', '', '0increased', 'serum', 'potassium4', '', '3', '', '', '2', '', '1', '', '', '1', '', '1', '', '', '0serious', 'adverse', 'eventsany28', '', '18', '', '', '9', '', '6', '', '', '20', '', '26', '', '', '10', '', '13', '', '', 'respiratory', 'failure', 'acute', 'respiratory', 'distress', 'syndrome16', '', '10', '', '', '4', '', '3', '', '', '6', '', '8', '', '', '4', '', '5', '', '', 'cardiopulmonary', 'failure8', '', '5', '', '', '07', '', '9', '', '', '1', '', '1', '', '', 'pulmonary', 'embolism1', '', '1', '', '', '1', '', '1', '', '', '1', '', '1', '', '', '1', '', '1', '', '', 'recurrence', 'covid-191', '', '1', '', '', '000cardiac', 'arrest1', '', '1', '', '', '000acute', 'coronary', 'syndrome001', '', '1', '', '', '1', '', '1', '', '', 'tachycardia001', '', '1', '', '', '0septic', 'shock1', '', '1', '', '', '01', '', '1', '', '', '1', '', '1', '', '', 'lung', 'abscess001', '', '1', '', '', '1', '', '1', '', '', 'sepsis001', '', '1', '', '', '1', '', '1', '', '', 'bronchitis001', '', '1', '', '', '1', '', '1', '', '', 'thrombocytopenia1', '', '1', '', '', '1', '', '1', '', '', '00increased', 'd-dimer001', '', '1', '', '', '1', '', '1', '', '', 'haemorrhage', 'lower', 'digestive', 'tract1', '', '1', '', '', '1', '', '1', '', '', '00ileus001', '', '1', '', '', '0deep', 'vein', 'thrombosis1', '', '1', '', '', '1', '', '1', '', '', '1', '', '1', '', '', '1', '', '1', '', '', 'acute', 'kidney', 'injury1', '', '1', '', '', '000diabetic', 'ketoacidosis001', '', '1', '', '', '1', '', '1', '', '', 'multiple', 'organ', 'dysfunction', 'syndrome1', '', '1', '', '', '02', '', '3', '', '', '0events', 'lead', 'drug', 'discontinuationany18', '', '12', '', '', '3', '', '2', '', '', '4', '', '5', '', '', '1', '', '1', '', '', 'respiratory', 'failure', 'acute', 'respiratory', 'distress', 'syndrome7', '', '5', '', '', '1', '', '1', '', '', '1', '', '1', '', '', '0secondary', 'infection4', '', '3', '', '', '07', '', '9', '', '', '2', '', '3', '', '', 'cardiopulmonary', 'failure3', '', '2', '', '', '01', '', '1', '', '', '0nausea1', '', '1', '', '', '000vomiting1', '', '1', '', '', '000ileus001', '', '1', '', '', '0increased', 'alanine', 'aminotransferase2', '', '1', '', '', '1', '', '1', '', '', '00rash2', '', '1', '', '', '000poor', 'appetite1', '', '1', '', '', '000increased', 'total', 'bilirubin1', '', '1', '', '', '000acute', 'kidney', 'injury1', '', '1', '', '', '1', '', '1', '', '', '00seizure001', '', '1', '', '', '0aggravated', 'schizophrenia001', '', '1', '', '', '1', '', '1', '', '', 'aggravated', 'depression001', '', '1', '', '', '1', '', '1', '', '', 'data', 'n', '', '', '', 'include', 'event', 'report', 'antiviral', 'treatment', '', 'patient', 'one', 'adverse', 'event', '', '36', 'patient', 'discontinue', 'drug', '', '22', 'adverse', 'event', '14', 'patient', 'reason', '', 'eg', '', 'hospital', 'discharge', 'early', 'death', '', '', 'covid-19coronavirus', 'disease', '2019', '', 'open', 'table', 'new', 'tab', 'data', 'n', '', '', '', 'include', 'event', 'report', 'antiviral', 'treatment', '', 'patient', 'one', 'adverse', 'event', '', '36', 'patient', 'discontinue', 'drug', '', '22', 'adverse', 'event', '14', 'patient', 'reason', '', 'eg', '', 'hospital', 'discharge', 'early', 'death', '', '', 'covid-19coronavirus', 'disease', '2019', '', 'trial', 'find', 'intravenous', 'remdesivir', 'significantly', 'improve', 'time', 'clinical', 'improvement', '', 'mortality', '', 'time', 'clearance', 'virus', 'patient', 'serious', 'covid-19', 'compare', 'placebo', '', 'compared', 'previous', 'study', 'compassionate', 'remdesivir21grein', 'j', 'ohmagari', 'n', 'shin', 'alcompassionate', 'remdesivir', 'patient', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'april', '10', '', '', 'doi101056nejmoa2007016google', 'study', 'population', 'le', 'ill', '', 'eg', '', 'time', 'enrolment', '', '04', '', 'invasive', 'mechanical', 'ventilation', 'extracorporeal', 'membrane', 'oxygenation', 'v', '64', '', 'previous', 'study', '', 'treat', 'somewhat', 'earlier', 'disease', 'course', '', 'median', '10', 'day', 'v', '12', 'day', '', '', 'difference', 'expect', 'favour', 'remdesivir', '', 'provide', 'greater', 'effect', 'study', 'population', '', 'result', 'meet', 'expectation', '', 'however', '', 'study', 'reach', 'target', 'enrolment', 'stringent', 'public', 'health', 'measure', 'wuhan', 'lead', 'mark', 'reduction', 'new', 'patient', 'presentation', 'mid-march', '', 'restriction', 'hospital', 'bed', 'availability', 'result', 'patient', 'enrol', 'later', 'course', 'disease', '', 'consequently', '', 'adequately', 'ass', 'whether', 'earlier', 'remdesivir', 'treatment', 'provide', 'clinical', 'benefit', '', 'however', '', 'among', 'patient', 'treat', 'within', '10', 'day', 'symptom', 'onset', '', 'remdesivir', 'significant', 'factor', 'associate', 'numerical', 'reduction', '5', 'day', 'median', 'time', 'clinical', 'improvement', '', 'ongoing', 'control', 'clinical', 'trial', 'expect', 'confirm', 'refute', 'find', '', 'one', 'murine', 'model', 'sars', '', 'remdesivir', 'treatment', 'start', '2', 'day', 'infection', '', 'virus', 'replication', 'lung', 'airway', 'epithelial', 'damage', 'already', 'peak', '', 'significantly', 'reduce', 'sars-cov-1', 'lung', 'titre', 'decrease', 'disease', 'severity', 'mortality13sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', 'early', 'treatment', 'find', 'non-human', 'primate', 'model', 'sars', 'mers', 'virus', 'replication', 'short-lived', 'lung', 'pathology', 'appear', 'develop', 'rapidly', 'human', 'infections17de', 'wit', 'e', 'feldmann', 'f', 'cronin', 'j', 'alprophylactic', 'therapeutic', 'remdesivir', '', 'gs-5734', '', 'treatment', 'rhesus', 'macaque', 'model', 'mers-cov', 'infectionproc', 'natl', 'acad', 'sci', 'usa', '', '2020', '', '117', '', '6771-6776google', '', '19williamson', 'bn', 'feldmann', 'f', 'schwarz', 'b', 'alclinical', 'benefit', 'remdesivir', 'rhesus', 'macaque', 'infect', 'sars-cov-2biorxiv', '', '2020', '', '', 'publish', 'online', 'april', '22', '', '', '', 'preprint', '', 'doi', '', '10110120200415043166google', 'find', 'argue', 'test', 'remdesivir', 'earlier', 'covid-19', '', 'remdesivir', 'result', 'significant', 'reduction', 'sars-cov-2', 'rna', 'load', 'detectability', 'upper', 'respiratory', 'tract', 'sputum', 'specimen', 'study', 'despite', 'show', 'strong', 'antiviral', 'effect', 'preclinical', 'model', 'infection', 'coronaviruses', '', 'african', 'green', 'monkey', 'kidney', 'vero', 'e6', 'cell', '', 'remdesivir', 'inhibit', 'sars-cov-2', '50', '', 'effective', 'concentration', '', 'ec50', '', '046', 'gml', 'ec90', '106', 'gml6wang', 'cao', 'r', 'zhang', 'l', 'alremdesivir', 'hydroxychloroquine', 'effectively', 'inhibit', 'recently', 'emerge', 'novel', 'coronavirus', '', '2019-ncov', '', 'vitrocell', 'res', '', '2020', '', '30', '', '2-71google', 'human', 'nasal', 'bronchial', 'airway', 'epithelial', 'cell', '', 'fix', '20', '', '121', 'gml', '', 'concentration', 'reduce', 'estimate', 'intracellular', 'viral', 'titre', '70', 'log10', '50', '', 'tissue', 'culture', 'infective', 'dose', 'per', 'ml', '48', 'h18pizzorno', 'padey', 'b', 'julien', 'alcharacterization', 'treatment', 'sars-cov-2', 'nasal', 'bronchial', 'human', 'airway', 'epitheliabiorxiv', '', '2020', '', '', 'publish', 'online', 'april', '2', '', '', '', 'preprint', '', 'doi', '', '10110120200331017889google', 'human', 'airway', 'epithelial', 'cell', '', 'ec50', 'remdesivir', '0042', 'gml', 'sars-cov', '0045', 'gml', 'mers-cov13sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', 'murine', 'model', 'mers', '', 'subcutaneous', 'remdesivir', 'show', 'significant', 'antiviral', 'clinical', 'effect', 'dose', 'regimen', 'maintain', 'plasma', 'concentration', 'greater', '1', '', '060', 'gml', '', 'throughout', 'dose', 'interval13sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', 'rhesus', 'macaque', '', '5', 'mgkg', 'dose', '', 'report', 'roughly', 'equivalent', '100-mg', 'daily', 'dose', 'human', '', 'effective', 'treatment', 'mers-cov', 'infection', 'reduce', 'pulmonary', 'virus', 'replication', 'start', '12', 'h', 'infection18pizzorno', 'padey', 'b', 'julien', 'alcharacterization', 'treatment', 'sars-cov-2', 'nasal', 'bronchial', 'human', 'airway', 'epitheliabiorxiv', '', '2020', '', '', 'publish', 'online', 'april', '2', '', '', '', 'preprint', '', 'doi', '', '10110120200331017889google', 'healthy', 'adult', 'volunteer', 'receive', 'similar', 'trial', '', '200', 'mg', 'day', '1', '', '100', 'mg', 'day', '24', '', 'mean', 'peak', 'plasma', 'concentration', '54', 'gml', '', 'percentage', 'coefficient', 'variation', '203', '', 'day', '1', '26', 'gml', '', '127', '', 'day', '524gilead', 'sciences', '', 'investigator', 'brochure', 'remdesivir', '', '5th', 'edition', '', 'feb', '21', '', '2020google', 'doses', '150', 'mgday', '14', 'day', 'adequately', 'tolerate', 'healthy', 'adult', '', 'daily', 'dose', 'regimen', '150', 'mg', '3', 'day', 'follow', '225', 'mg', '11', 'day', 'appear', 'generally', 'well', 'tolerate', 'one', 'patient', 'ebola', 'meningoencephalitis25jacobs', 'rodger', 'bell', 'dj', 'allate', 'ebola', 'virus', 'relapse', 'cause', 'meningoencephalitis', '', 'case', 'reportlancet', '', '2016', '', '388', '', '498-503google', 'however', '', 'pharmacokinetics', 'remdesivir', 'severely', 'ill', 'patient', '', 'particularly', 'concentration', 'active', 'nucleotide', 'metabolite', '', 'gs-441524', '', 'triphosphate', 'respiratory', 'tract', 'cell', 'treat', 'patient', '', 'unknown', '', 'studies', 'higher-dose', 'regimen', 'safety', 'data', '', 'eg', '', '150200', 'mg', 'daily', '', 'warrant', 'consideration', 'severe', 'covid-19', '', 'study', 'find', 'remdesivir', 'adequately', 'tolerate', 'new', 'safety', 'concern', 'identify', '', 'overall', 'proportion', 'patient', 'serious', 'adverse', 'event', 'tend', 'lower', 'remdesivir', 'recipient', 'placebo', 'recipient', '', 'however', '', 'higher', 'proportion', 'remdesivir', 'recipient', 'placebo', 'recipient', 'dose', 'prematurely', 'stop', 'investigator', 'adverse', 'event', 'include', 'gastrointestinal', 'symptom', '', 'anorexia', '', 'nausea', '', 'vomit', '', '', 'aminotransferase', 'bilirubin', 'increase', '', 'worsen', 'cardiopulmonary', 'status', '', 'limitations', 'study', 'include', 'insufficient', 'power', 'detect', 'assume', 'difference', 'clinical', 'outcome', '', 'initiation', 'treatment', 'quite', 'late', 'covid-19', '', 'absence', 'data', 'infectious', 'virus', 'recovery', 'possible', 'emergence', 'reduce', 'susceptibility', 'remdesivir', '', 'note', '', 'non-human', 'primate', '', 'inhibitory', 'effect', 'remdesivir', 'infectious', 'sars-cov-2', 'recovery', 'bronchoalveolar', 'lavage', 'much', 'greater', 'control', '', 'viral', 'rna', 'detection', 'upper', 'lower', 'respiratory', 'tract', 'specimen', 'consistently', 'decrease', 'versus', 'controls19williamson', 'bn', 'feldmann', 'f', 'schwarz', 'b', 'alclinical', 'benefit', 'remdesivir', 'rhesus', 'macaque', 'infect', 'sars-cov-2biorxiv', '', '2020', '', '', 'publish', 'online', 'april', '22', '', '', '', 'preprint', '', 'doi', '', '10110120200415043166google', 'coronaviruses', 'partially', 'resistant', 'inhibition', 'remdesivir', '', 'six-times', 'increase', 'ec50', '', 'obtain', 'serial', 'vitro', 'passage', '', 'virus', 'remain', 'susceptible', 'higher', 'remdesivir', 'concentration', 'show', 'impair', 'fitness26agostini', 'ml', 'andres', 'el', 'sims', 'ac', 'alcoronavirus', 'susceptibility', 'antiviral', 'remdesivir', '', 'gs-5734', '', 'mediate', 'viral', 'polymerase', 'proofread', 'exoribonucleasembio', '', '2018', '', '9', '', 'e00221-e00318google', 'frequent', 'corticosteroid', 'patient', 'group', 'promote', 'viral', 'replication', '', 'observe', 'sars27lee', 'n', 'allen', 'chan', 'kc', 'hui', 'ds', 'aleffects', 'early', 'corticosteroid', 'treatment', 'plasma', 'sars-associated', 'coronavirus', 'rna', 'concentration', 'adult', 'patientsj', 'clin', 'virol', '', '2004', '', '31', '', '304-309google', 'mers28arabi', 'ym', 'mandourah', 'al-hameed', 'f', 'alcorticosteroid', 'therapy', 'critically', 'ill', 'patient', 'middle', 'east', 'respiratory', 'syndromeam', 'j', 'respir', 'crit', 'care', 'med', '', '2018', '', '197', '', '757-767google', 'although', 'study', 'report', 'prolongation', 'detection', 'viral', 'rna', '', 'infectious', 'virus', '', 'furthermore', '', 'answer', 'whether', 'longer', 'treatment', 'course', 'higher', 'dose', 'remdesivir', 'beneficial', 'patient', 'severe', 'covid-19', '', 'summary', '', 'find', 'dose', 'regimen', 'intravenous', 'remdesivir', 'adequately', 'tolerate', 'provide', 'significant', 'clinical', 'antiviral', 'effect', 'seriously', 'ill', 'patient', 'covid-19', '', 'however', '', 'exclude', 'clinically', 'meaningful', 'difference', 'saw', 'numerical', 'reduction', 'clinical', 'parameter', '', 'ongoing', 'study', 'larger', 'sample', 'size', 'continue', 'inform', 'understand', 'effect', 'remdesivir', 'covid-19', '', 'furthermore', '', 'strategy', 'enhance', 'antiviral', 'potency', 'remdesivir', '', 'eg', '', 'higher-dose', 'regimen', '', 'combination', 'antiviral', '', 'sars-cov-2', 'neutralise', 'antibody', '', 'mitigate', 'immunopathological', 'host', 'response', 'contribute', 'covid-19', 'severity', '', 'eg', '', 'inhibitor', 'il-inhibitor', '', 'il-inhibitor', '', 'certolizumab', '', 'require', 'rigorous', 'study', 'patient', 'severe', 'covid-19', '', 'contributors', 'bc', '', 'cw', '', 'yew', 'full', 'access', 'data', 'study', 'responsibility', 'integrity', 'data', 'accuracy', 'data', 'analysis', '', 'cw', 'bc', 'decide', 'publish', 'paper', '', 'bc', '', 'cw', '', 'yew', '', 'pwh', '', 'tj', '', 'fgh', 'provide', 'input', 'trial', 'design', '', 'bc', '', 'cw', '', 'yew', '', 'fgh', '', 'pwh', 'responsible', 'acquisition', '', 'analysis', '', 'interpretation', 'data', '', 'yew', '', 'fgh', '', 'pwh', '', 'gf', 'draft', 'manuscript', '', 'bc', '', 'cw', '', 'pwh', '', 'fgh', '', 'gf', '', 'tj', '', 'xg', 'critically', 'revise', 'manuscript', '', 'yew', 'contribute', 'statistical', 'analysis', '', 'gf', 'give', 'valuable', 'suggestion', 'data', 'analysis', '', 'author', 'contribute', 'conduct', 'trial', '', 'declaration', 'interest', 'fgh', 'serve', 'non-compensated', 'consultant', 'gilead', 'sciences', 'respiratory', 'antiviral', 'programme', '', 'outside', 'submit', 'work', '', 'author', 'declare', 'compete', 'interest', '', 'approval', 'human', 'genetic', 'resources', 'administration', 'china', '', 'trial', 'data', 'share', 'qualify', 'researcher', 'submit', 'proposal', 'valuable', 'research', 'question', '', 'contract', 'sign', '', 'acknowledgments', 'gilead', 'sciences', 'provide', 'study', 'drug', 'huyen', 'cao', 'anu', 'osinusi', 'advice', 'regard', 'safe', 'remdesivir', '', 'joe', 'yao', 'ella', 'lin', 'statistical', 'consultation', '', 'member', 'international', 'data', 'safety', 'monitor', 'board', '', 'jieming', 'qu', '', 'chair', '', '', 'weichung', 'joe', 'shih', '', 'robert', 'fowler', '', 'rory', 'collins', '', 'chen', 'yao', '', '', 'independent', 'statistician', '', 'xiaoyan', 'yan', 'bin', '', '', 'academic', 'secretary', '', 'lingling', 'gao', 'junkai', 'lai', '', '', 'edmc', 'system', 'provider', '', 'tai', 'xie', '', 'rong', 'ran', '', 'peng', 'zhang', '', 'emily', 'wang', '', 'service', '', 'roche', 'diagnostics', '', 'shanghai', '', 'provide', 'instrument', 'sars-cov-2', 'assay', 'detection', '', 'smo', 'assistance', 'provide', 'shanghai', 'medkey', 'med-tech', 'development', '', 'clinplus', '', 'hangzhou', 'simo', '', 'medpison', '', 'work', 'support', 'chinese', 'academy', 'medical', 'sciences', 'emergency', 'project', 'covid-19', '', '2020hy320001', '', '', 'major', 'projects', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', '', '2020zx09201012', '', '', 'national', 'key', 'research', 'development', 'program', 'china', '', '2018yfc1200102', '', '', 'beijing', 'science', 'technology', 'project', '', 'z19110700660000', '', '', 'tj', 'fund', 'national', 'institutes', 'health', 'research', '', 'nihr', '', 'senior', 'research', 'fellowship', '', '2015-08-001', '', '', 'ph', 'fund', 'wellcome', 'trust', 'uk', 'department', 'international', 'development', '', '215091z18z', '', '', 'bill', '', 'melinda', 'gates', 'foundation', '', 'opp1209135', '', '', 'nihr', '', '200907', '', '', 'download', 'pdf', '', '62', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'remdesivir', 'covid-19', '', 'challenge', 'underpowered', 'studiesfull-textpdf']",8265,"{'': 2327, 'patient': 119, 'remdesivir': 114, '1': 110, 'day': 90, 'group': 86, 'clinical': 73, 'placebo': 48, '10': 47, 'covid-19': 46, 'treatment': 45, 'study': 40, 'time': 39, '2020': 37, '3': 37, 'trial': 36, 'improvement': 33, 'hospital': 30, 'include': 29, 'respiratory': 27}","{'certolizumab': 1, 'hydroxychloroquine': 4, 'infection': 10, 'sars-cov-2': 25, 'vitro': 4, 'safety': 13, 'il-inhibitor': 2}",59,-0.34
DOI:10.1016/S0140-6736(20)31140-5,10.1016/S0140-6736(20)31140-5,Editorial,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['reviving', 'us', 'cdc']","['The COVID-19 pandemic continue worsen USA 1·3 million case estimate death toll 80 684 May 12 .', 'States initially hardest hit , New York New Jersey , decelerate rate infection death implementation 2 month lockdown .', 'However , emergence new outbreak Minnesota , stay-at-home order set lift mid-May , Iowa , enact restriction movement commerce , prompt point new question inconsistent incoherent national response COVID-19 crisis .', ""The US Centers Disease Control Prevention ( CDC ) , flagship agency nation 's public health , see role minimise become ineffective nominal adviser response contain spread virus ."", ""The strain relationship CDC federal government lay bare , accord The Washington Post , Deborah Birx , head US COVID-19 Task Force former director CDC 's Global HIV/AIDS Division , cast doubt CDC 's COVID-19 mortality case data reportedly say : “ There nothing CDC I trust ” ."", 'This unhelpful statement , also shock indictment agency regard gold standard global disease detection control .', ""How agency first point contact many national health authority face public health threat become ill-prepared protect public 's health ?"", 'In decade follow found 1946 , CDC become national pillar public health globally respect .', 'It train cadre apply epidemiologist deploy USA abroad .', 'CDC scientist help discover new virus develop accurate test .', 'CDC support instrumental help WHO eradicate smallpox .', ""However , fund CDC long time subject conservative politics increasingly erode agency 's ability mount effective , evidence-based public health response ."", 'In 1980s , Reagan administration resist provide sufficient budget CDC need fight HIV/AIDS crisis .', 'The George W Bush administration put restriction global domestic HIV prevention reproductive health program .', ""The Trump administration chip away CDC 's capacity combat infectious disease ."", 'CDC staff China cut back last remain CDC officer recall home China CDC July , 2019 , leave intelligence vacuum COVID-19 begin emerge .', ""In press conference Feb 25 , Nancy Messonnier , director CDC 's National Center Immunization Respiratory Diseases , warn US citizen prepare major disruption movement everyday life ."", 'Messonnier subsequently longer appear White House brief COVID-19 .', 'More recently , Trump administration question guideline CDC provide .', ""These action undermine CDC 's leadership work COVID-19 pandemic ."", 'There doubt CDC make mistake , especially test early stage pandemic .', 'The agency convince contain virus retain control diagnostic test severe acute respiratory syndrome coronavirus 2 , follow admission Feb 12 CDC develop faulty test kit .', 'The USA still nowhere near able provide basic surveillance laboratory test infrastructure need combat COVID-19 pandemic .', 'But punish agency marginalise hobble solution .', 'The Administration obsess magic bullets—vaccines , new medicine , hope virus simply disappear .', 'But steadfast reliance basic public health principle , like test , trace , isolate , see emergency bring end , require effective national public health agency .', ""The CDC need director provide leadership without threat silence technical capacity lead today 's complicate effort ."", ""The Trump administration 's erosion CDC harm global cooperation science public health , try defunding WHO ."", 'A strong CDC need respond public health threat , domestic international , help prevent next inevitable pandemic .', 'Americans must put president White House come January , 2021 , understand public health guide partisan politics .', ""For CDC 's advice question see urlplaceholder For CDC 's advice question see urlplaceholder View Large Image Copyright © 2020 Alex Wong/Getty Images View Large Image Copyright © 2020 Alex Wong/Getty Images""]","['covid-19', 'pandemic', 'continue', 'worsen', 'usa', '13', 'million', 'case', 'estimate', 'death', 'toll', '80', '684', '12', '', 'states', 'initially', 'hardest', 'hit', '', 'new', 'york', 'new', 'jersey', '', 'decelerate', 'rate', 'infection', 'death', 'implementation', '2', 'month', 'lockdown', '', 'however', '', 'emergence', 'new', 'outbreak', 'minnesota', '', 'stay-at-home', 'order', 'set', 'lift', 'mid-may', '', 'iowa', '', 'enact', 'restriction', 'movement', 'commerce', '', 'prompt', 'point', 'new', 'question', 'inconsistent', 'incoherent', 'national', 'response', 'covid-19', 'crisis', '', 'us', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', '', 'flagship', 'agency', 'nation', 'public', 'health', '', 'role', 'minimise', 'become', 'ineffective', 'nominal', 'adviser', 'response', 'contain', 'spread', 'virus', '', 'strain', 'relationship', 'cdc', 'federal', 'government', 'lay', 'bare', '', 'accord', 'washington', 'post', '', 'deborah', 'birx', '', 'head', 'us', 'covid-19', 'task', 'force', 'former', 'director', 'cdc', 'global', 'hivaids', 'division', '', 'cast', 'doubt', 'cdc', 'covid-19', 'mortality', 'case', 'data', 'reportedly', '', '', 'nothing', 'cdc', 'trust', '', '', 'unhelpful', 'statement', '', 'shock', 'indictment', 'agency', 'regard', 'gold', 'standard', 'global', 'disease', 'detection', 'control', '', 'agency', 'first', 'point', 'contact', 'national', 'health', 'authority', 'face', 'public', 'health', 'threat', 'become', 'ill-prepared', 'protect', 'public', 'health', '', 'decade', 'follow', 'found', '1946', '', 'cdc', 'become', 'national', 'pillar', 'public', 'health', 'globally', 'respect', '', 'train', 'cadre', 'apply', 'epidemiologist', 'deploy', 'usa', 'abroad', '', 'cdc', 'scientist', 'help', 'discover', 'new', 'virus', 'develop', 'accurate', 'test', '', 'cdc', 'support', 'instrumental', 'help', 'eradicate', 'smallpox', '', 'however', '', 'fund', 'cdc', 'long', 'time', 'conservative', 'politics', 'increasingly', 'erode', 'agency', 'ability', 'mount', 'effective', '', 'evidence-based', 'public', 'health', 'response', '', '1980s', '', 'reagan', 'administration', 'resist', 'provide', 'sufficient', 'budget', 'cdc', 'fight', 'hivaids', 'crisis', '', 'george', 'w', 'bush', 'administration', 'put', 'restriction', 'global', 'domestic', 'hiv', 'prevention', 'reproductive', 'health', 'program', '', 'trump', 'administration', 'chip', 'away', 'cdc', 'capacity', 'combat', 'infectious', 'disease', '', 'cdc', 'staff', 'china', 'cut', 'back', 'last', 'remain', 'cdc', 'officer', 'recall', 'home', 'china', 'cdc', 'july', '', '2019', '', 'leave', 'intelligence', 'vacuum', 'covid-19', 'begin', 'emerge', '', 'press', 'conference', 'feb', '25', '', 'nancy', 'messonnier', '', 'director', 'cdc', 'national', 'center', 'immunization', 'respiratory', 'diseases', '', 'warn', 'us', 'citizen', 'prepare', 'major', 'disruption', 'movement', 'everyday', 'life', '', 'messonnier', 'subsequently', 'longer', 'appear', 'white', 'house', 'brief', 'covid-19', '', 'recently', '', 'trump', 'administration', 'question', 'guideline', 'cdc', 'provide', '', 'action', 'undermine', 'cdc', 'leadership', 'work', 'covid-19', 'pandemic', '', 'doubt', 'cdc', 'mistake', '', 'especially', 'test', 'early', 'stage', 'pandemic', '', 'agency', 'convince', 'contain', 'virus', 'retain', 'control', 'diagnostic', 'test', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'follow', 'admission', 'feb', '12', 'cdc', 'develop', 'faulty', 'test', 'kit', '', 'usa', 'still', 'nowhere', 'near', 'able', 'provide', 'basic', 'surveillance', 'laboratory', 'test', 'infrastructure', 'combat', 'covid-19', 'pandemic', '', 'punish', 'agency', 'marginalise', 'hobble', 'solution', '', 'administration', 'obsess', 'magic', 'bulletsvaccines', '', 'new', 'medicine', '', 'hope', 'virus', 'simply', 'disappear', '', 'steadfast', 'reliance', 'basic', 'public', 'health', 'principle', '', 'like', 'test', '', 'trace', '', 'isolate', '', 'emergency', 'bring', 'end', '', 'require', 'effective', 'national', 'public', 'health', 'agency', '', 'cdc', 'director', 'provide', 'leadership', 'without', 'threat', 'silence', 'technical', 'capacity', 'lead', 'today', 'complicate', 'effort', '', 'trump', 'administration', 'erosion', 'cdc', 'harm', 'global', 'cooperation', 'science', 'public', 'health', '', 'defunding', '', 'strong', 'cdc', 'respond', 'public', 'health', 'threat', '', 'domestic', 'international', '', 'help', 'prevent', 'next', 'inevitable', 'pandemic', '', 'americans', 'must', 'put', 'president', 'white', 'house', 'january', '', '2021', '', 'understand', 'public', 'health', 'guide', 'partisan', 'politics', '', 'cdc', 'advice', 'question', 'urlplaceholder', 'cdc', 'advice', 'question', 'urlplaceholder', 'view', 'large', 'image', 'copyright', '', '2020', 'alex', 'wonggetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'alex', 'wonggetty', 'images']",516,"{'': 75, 'cdc': 24, 'health': 12, 'public': 10, 'covid-19': 8, 'agency': 7, 'new': 6, 'test': 6, 'administration': 6, 'pandemic': 5, 'national': 5, 'question': 4, 'virus': 4, 'global': 4, 'provide': 4, 'usa': 3, 'response': 3, 'us': 3, 'disease': 3, 'control': 3}",{'infection': 1},1,-0.9538
DOI:10.1016/S0140-6736(20)31095-3,10.1016/S0140-6736(20)31095-3,Editorial,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['covid-19', 'brazil', '', '', '', '']","['The coronavirus disease 2019 ( COVID-19 ) pandemic reach Latin America later continent .', 'The first case record Brazil Feb 25 , 2020 .', 'But , Brazil case death Latin America ( 105 222 case 7288 death May 4 ) , probably substantial underestimate .', 'Even worryingly , double rate death estimate 5 day recent study Imperial College ( London , UK ) , analyse active transmission rate COVID-19 48 country , show Brazil country highest rate transmission ( R0 2·81 ) .', 'Large city São Paulo Rio de Janeiro main hotspot concern early sign infection move inland smaller city inadequate provision intensive care bed ventilator .', ""Yet , perhaps biggest threat Brazil 's COVID-19 response president , Jair Bolsonaro ."", 'When ask journalist last week rapidly increase number COVID-19 case , respond : “ So ?', 'What want ? ” He continue sow confusion openly flout discourage sensible measure physical distance lockdown bring state governor city mayor also lose two important influential minister past 3 week .', ""First , April 16 , Luiz Henrique Mandetta , respect well like Health Minister , sack television interview , strongly criticise Bolsonaro 's action call unity , else risk leave 210 million Brazilians utterly confuse ."", ""Then April 24 , follow removal head Brazil 's federal police Bolsonaro , Justice Minister Sérgio Moro , one powerful figure right-wing government appoint Bolsonaro combat corruption , announce resignation ."", ""Such disarray heart administration deadly distraction middle public health emergency also stark sign Brazil 's leadership lose moral compass , ever one ."", 'Even without vacuum political action federal level , Brazil would difficult time combat COVID-19 .', 'About 13 million Brazilians live favelas , often three people per room little access clean water .', 'Physical distance hygiene recommendation near impossible follow environments—many favelas organise implement measure best possible .', 'Brazil large informal employment sector many source income longer option .', 'The Indigenous population severe threat even COVID-19 outbreak government ignore even encourage illegal mine log Amazon rainforest .', 'These logger miner risk bring COVID-19 remote population .', 'An open letter May 3 global coalition artist , celebrity , scientist , intellectual , organise Brazilian photojournalist Sebastião Salgado , warn impend genocide .', 'What health science community civil society country know activism outspoken opposition injustice inequity health constitutional right ?', 'Many scientific organisation , Brazilian Academy Sciences ABRASCO , long-opposed Bolsonaro severe cut science budget general demolition social security public service .', 'In context COVID-19 , many organisation launch manifesto aim public—such Pact Life Brazil—and write statement plea government official call unity join solution .', 'Pot-banging balcony protest presidential announcement happen frequently .', 'There much research go , basic science epidemiology , rapid production personal protective equipment , respirator , test kit .', 'These hopeful action .', 'Yet , leadership highest level government crucial quickly avert worst outcome pandemic , evident country .', 'In 2009 Brazil Series , author conclude : “ The challenge ultimately political , require continuous engagement Brazilian society whole secure right health Brazilian people. ” Brazil country must come together give clear answer “ So ? ” President .', 'He need drastically change course must next go .', 'View Large Image Copyright © 2020 Bruna Prado/Getty Images View Large Image Copyright © 2020 Bruna Prado/Getty Images Download .pdf ( .25 MB ) Help pdf file Portuguese translation full text']","['coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'reach', 'latin', 'america', 'later', 'continent', '', 'first', 'case', 'record', 'brazil', 'feb', '25', '', '2020', '', '', 'brazil', 'case', 'death', 'latin', 'america', '', '105', '222', 'case', '7288', 'death', '4', '', '', 'probably', 'substantial', 'underestimate', '', 'worryingly', '', 'double', 'rate', 'death', 'estimate', '5', 'day', 'recent', 'study', 'imperial', 'college', '', 'london', '', 'uk', '', '', 'analyse', 'active', 'transmission', 'rate', 'covid-19', '48', 'country', '', 'show', 'brazil', 'country', 'highest', 'rate', 'transmission', '', 'r0', '281', '', '', 'large', 'city', 'paulo', 'rio', 'de', 'janeiro', 'main', 'hotspot', 'concern', 'early', 'sign', 'infection', 'move', 'inland', 'smaller', 'city', 'inadequate', 'provision', 'intensive', 'care', 'bed', 'ventilator', '', 'yet', '', 'perhaps', 'biggest', 'threat', 'brazil', 'covid-19', 'response', 'president', '', 'jair', 'bolsonaro', '', 'ask', 'journalist', 'last', 'week', 'rapidly', 'increase', 'number', 'covid-19', 'case', '', 'respond', '', '', '', '', '', 'continue', 'sow', 'confusion', 'openly', 'flout', 'discourage', 'sensible', 'measure', 'physical', 'distance', 'lockdown', 'bring', 'state', 'governor', 'city', 'mayor', 'lose', 'two', 'important', 'influential', 'minister', 'past', '3', 'week', '', 'first', '', 'april', '16', '', 'luiz', 'henrique', 'mandetta', '', 'respect', 'well', 'like', 'health', 'minister', '', 'sack', 'television', 'interview', '', 'strongly', 'criticise', 'bolsonaro', 'action', 'call', 'unity', '', 'else', 'risk', 'leave', '210', 'million', 'brazilians', 'utterly', 'confuse', '', 'april', '24', '', 'follow', 'removal', 'head', 'brazil', 'federal', 'police', 'bolsonaro', '', 'justice', 'minister', 'srgio', 'moro', '', 'one', 'powerful', 'figure', 'right-wing', 'government', 'appoint', 'bolsonaro', 'combat', 'corruption', '', 'announce', 'resignation', '', 'disarray', 'heart', 'administration', 'deadly', 'distraction', 'middle', 'public', 'health', 'emergency', 'stark', 'sign', 'brazil', 'leadership', 'lose', 'moral', 'compass', '', 'ever', 'one', '', 'without', 'vacuum', 'political', 'action', 'federal', 'level', '', 'brazil', 'difficult', 'time', 'combat', 'covid-19', '', '13', 'million', 'brazilians', 'live', 'favelas', '', 'often', 'three', 'people', 'per', 'room', 'little', 'access', 'clean', 'water', '', 'physical', 'distance', 'hygiene', 'recommendation', 'near', 'impossible', 'follow', 'environmentsmany', 'favelas', 'organise', 'implement', 'measure', 'best', 'possible', '', 'brazil', 'large', 'informal', 'employment', 'sector', 'source', 'income', 'longer', 'option', '', 'indigenous', 'population', 'severe', 'threat', 'covid-19', 'outbreak', 'government', 'ignore', 'encourage', 'illegal', 'mine', 'log', 'amazon', 'rainforest', '', 'logger', 'miner', 'risk', 'bring', 'covid-19', 'remote', 'population', '', 'open', 'letter', '3', 'global', 'coalition', 'artist', '', 'celebrity', '', 'scientist', '', 'intellectual', '', 'organise', 'brazilian', 'photojournalist', 'sebastio', 'salgado', '', 'warn', 'impend', 'genocide', '', 'health', 'science', 'community', 'civil', 'society', 'country', 'activism', 'outspoken', 'opposition', 'injustice', 'inequity', 'health', 'constitutional', '', 'scientific', 'organisation', '', 'brazilian', 'academy', 'sciences', 'abrasco', '', 'long-opposed', 'bolsonaro', 'severe', 'cut', 'science', 'budget', 'general', 'demolition', 'social', 'security', 'public', 'service', '', 'context', 'covid-19', '', 'organisation', 'launch', 'manifesto', 'aim', 'publicsuch', 'pact', 'life', 'braziland', 'write', 'statement', 'plea', 'government', 'official', 'call', 'unity', 'join', 'solution', '', 'pot-banging', 'balcony', 'protest', 'presidential', 'announcement', 'happen', 'frequently', '', 'much', 'research', '', 'basic', 'science', 'epidemiology', '', 'rapid', 'production', 'personal', 'protective', 'equipment', '', 'respirator', '', 'test', 'kit', '', 'hopeful', 'action', '', 'yet', '', 'leadership', 'highest', 'level', 'government', 'crucial', 'quickly', 'avert', 'worst', 'outcome', 'pandemic', '', 'evident', 'country', '', '2009', 'brazil', 'series', '', 'author', 'conclude', '', '', 'challenge', 'ultimately', 'political', '', 'require', 'continuous', 'engagement', 'brazilian', 'society', 'whole', 'secure', 'health', 'brazilian', 'people', '', 'brazil', 'country', 'must', 'together', 'give', 'clear', 'answer', '', '', '', 'president', '', 'drastically', 'change', 'course', 'must', 'next', '', 'view', 'large', 'image', 'copyright', '', '2020', 'bruna', 'pradogetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'bruna', 'pradogetty', 'images', 'download', 'pdf', '', '25', 'mb', '', 'help', 'pdf', 'file', 'portuguese', 'translation', 'full', 'text']",512,"{'': 88, 'brazil': 10, 'covid-19': 8, 'country': 5, 'bolsonaro': 5, 'health': 5, 'case': 4, 'large': 4, 'government': 4, 'brazilian': 4, '2020': 3, 'death': 3, 'rate': 3, 'city': 3, 'minister': 3, 'action': 3, 'science': 3, 'pandemic': 2, 'latin': 2, 'america': 2}",{'infection': 1},1,-0.8442
DOI:10.1016/S0140-6736(20)31103-X,10.1016/S0140-6736(20)31103-X,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['outbreak', 'severe', 'kawasaki-like', 'disease', 'italian', 'epicentre', 'sars-cov-2', 'epidemic', '', 'observational', 'cohort', 'study']","['BackgroundThe Bergamo province , extensively affect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) epidemic , natural observatory virus manifestation general population .', 'In past month record outbreak Kawasaki disease ; aim evaluate incidence feature patient Kawasaki-like disease diagnose SARS-CoV-2 epidemic.MethodsAll patient diagnose Kawasaki-like disease centre past 5 year divide accord symptomatic presentation ( group 1 ) ( group 2 ) begin SARS-CoV-2 epidemic .', 'Kawasaki- like presentation manage Kawasaki disease accord American Heart Association indication .', 'Kawasaki disease shock syndrome ( KDSS ) define presence circulatory dysfunction , macrophage activation syndrome ( MAS ) Paediatric Rheumatology International Trials Organisation criterion .', 'Current previous infection seek reverse-transcriptase quantitative PCR nasopharyngeal oropharyngeal swab , serological qualitative test detect SARS-CoV-2 IgM IgG , respectively.FindingsGroup 1 comprise 19 patient ( seven boy , 12 girl ; age 3·0 year [ SD 2·5 ] ) diagnose Jan 1 , 2015 , Feb 17 , 2020 .', 'Group 2 include ten patient ( seven boy , three girl ; age 7·5 year [ SD 3·5 ] ) diagnose Feb 18 April 20 , 2020 ; eight ten positive IgG IgM , .', 'The two group differ disease incidence ( group 1 v group 2 , 0·3 v ten per month ) , mean age ( 3·0 v 7·5 year ) , cardiac involvement ( two 19 v six ten ) , KDSS ( zero 19 v five ten ) , MAS ( zero 19 v five ten ) , need adjunctive steroid treatment ( three 19 v eight ten ; p < 0·01 ) .InterpretationIn past month find 30-fold increase incidence Kawasaki-like disease .', 'Children diagnose SARS-CoV-2 epidemic begin show evidence immune response virus , older , higher rate cardiac involvement , feature MAS .', 'The SARS-CoV-2 epidemic associate high incidence severe form Kawasaki disease .', 'A similar outbreak Kawasaki-like disease expect country involve SARS-CoV-2 epidemic.FundingNone .', 'The Bergamo province , extensively affect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) epidemic , natural observatory virus manifestation general population .', 'In past month record outbreak Kawasaki disease ; aim evaluate incidence feature patient Kawasaki-like disease diagnose SARS-CoV-2 epidemic .', 'All patient diagnose Kawasaki-like disease centre past 5 year divide accord symptomatic presentation ( group 1 ) ( group 2 ) begin SARS-CoV-2 epidemic .', 'Kawasaki- like presentation manage Kawasaki disease accord American Heart Association indication .', 'Kawasaki disease shock syndrome ( KDSS ) define presence circulatory dysfunction , macrophage activation syndrome ( MAS ) Paediatric Rheumatology International Trials Organisation criterion .', 'Current previous infection seek reverse-transcriptase quantitative PCR nasopharyngeal oropharyngeal swab , serological qualitative test detect SARS-CoV-2 IgM IgG , respectively .', 'Group 1 comprise 19 patient ( seven boy , 12 girl ; age 3·0 year [ SD 2·5 ] ) diagnose Jan 1 , 2015 , Feb 17 , 2020 .', 'Group 2 include ten patient ( seven boy , three girl ; age 7·5 year [ SD 3·5 ] ) diagnose Feb 18 April 20 , 2020 ; eight ten positive IgG IgM , .', 'The two group differ disease incidence ( group 1 v group 2 , 0·3 v ten per month ) , mean age ( 3·0 v 7·5 year ) , cardiac involvement ( two 19 v six ten ) , KDSS ( zero 19 v five ten ) , MAS ( zero 19 v five ten ) , need adjunctive steroid treatment ( three 19 v eight ten ; p < 0·01 ) .', 'In past month find 30-fold increase incidence Kawasaki-like disease .', 'Children diagnose SARS-CoV-2 epidemic begin show evidence immune response virus , older , higher rate cardiac involvement , feature MAS .', 'The SARS-CoV-2 epidemic associate high incidence severe form Kawasaki disease .', 'A similar outbreak Kawasaki-like disease expect country involve SARS-CoV-2 epidemic .', 'None .', 'The epidemic severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , cause COVID-19 , rapidly spread worldwide .', 'Italy first European country affect , outbreak estimate start February , 2020 .', ""Currently , Italy report 132 547 COVID-19-positive case , 51 534 Lombardy.1Ministero della SaluteNuovo coronavirus : cosa c ' è da sapere ."", 'urlplaceholder access : April 15 , 2020Google Scholar It estimate least 10 % Italian population—ie , approximately 1 million people—have expose virus.2Flaxman S Mishra S Gandy A et al.Estimating number infection impact nonpharmaceutical intervention COVID-19 11 European country .', 'urlplaceholder access : March 30 , 2020Google Scholar The city Bergamo highest rate infection death Italy , make province Bergamo natural epidemiological set SARS-CoV-2 infection appear earlier evident .', 'In adult , COVID-19 typically characterise severe interstitial pneumonia hyperactivation inflammatory cascade.3Zhu N Zhang D Wang W et al.A novel coronavirus patient pneumonia China , 2019.N Engl J Med .', '2020 ; 382 : 727-733Google Scholar , 4Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar In child , respiratory involvement appear benign course , almost fatality report age group.5Yonker LM Shen K Kinane TB Lessons unfold pediatric case COVID-19 disease cause SARS-CoV-2 infection.Pediatr Pulmonol .', '2020 ; 55 : 1085-1086Google Scholar , 6Dong Y Mo X Hu Y et al.Epidemiology COVID-19 among child China.Pediatrics .', '2020 ; ( publish online March 16 .', "") DOI:10.1542/peds.2020-0702Google Scholar , 7Nicastro E Mazza A Gervasoni A Di Giorgio A D'Antiga L A pediatric emergency department protocol avoid intra-hospital dispersal SARS-CoV-2 outbreak Bergamo , Italy.J Pediatr ."", '2020 ; ( publish online April 21 .', ') DOI:10.1016/j.jpeds.2020.04.026Google Scholar Nonetheless , respiratory tract seem system susceptible SARS-CoV-2 infection.8Xiao F Tang M Zheng X Liu Y Li X Shan H Evidence gastrointestinal infection SARS-CoV-2.Gastroenterology .', '2020 ; 158 : 1831-1833Google Scholar Increasing evidence suggest tissue damage COVID-19 mostly mediate host innate immunity.9Henderson LA Canna SW Schulert GS et al.On alert cytokine storm : immunopathology COVID-19.Arthritis Rheumatol .', '2020 ; ( publish online April 15 .', "") DOI:10.1002/art.41285Google Scholar , 10D'Antiga L Coronaviruses immunosuppressed patient ."", 'The fact third epidemic.Liver Transpl .', '2020 ; ( publish online March 20 .', ') DOI:10.1002/lt.25756Google Scholar This disease characterise cytokine storm resemble macrophage activation see viral-induced haemophagocytic lymphohistiocytosis.11Mehta P McAuley DF Brown M Sanchez E Tattersall RS Manson JJ COVID-19 : consider cytokine storm syndrome immunosuppression.Lancet .', '2020 ; 395 : 1033-1034Google Scholar Kawasaki disease acute usually self-limiting vasculitis medium calibre vessel , almost exclusively affect children.12Kawasaki T Kosaki F Okawa S Shigematsu I Yanagawa H A new infantile acute febrile mucocutaneous lymph node syndrome ( MLNS ) prevail Japan.Pediatrics .', '1974 ; 54 : 271-276Google Scholar , 13Kato H Sugimura T Akagi T et al.Long-term consequence Kawasaki disease .', 'A 10- 21-year follow-up study 594 patients.Circulation .', '1996 ; 94 : 1379-1385Google Scholar In acute phase disease , patient Kawasaki disease might haemodynamic instability , condition know Kawasaki disease shock syndrome ( KDSS ) .14Kanegaye JT Wilder MS Molkara D et al.Recognition Kawasaki disease shock syndrome.Pediatrics .', '2009 ; 123 : e783-e789Google Scholar Other patient Kawasaki disease might fulfil criterion macrophage activation syndrome ( MAS ) , resemble secondary haemophagocytic lymphohistiocytosis.15Wang W Gong F Zhu W Fu S Zhang Q Macrophage activation syndrome Kawasaki disease : common think ? .Semin Arthritis Rheum .', '2015 ; 44 : 405-410Google Scholar The cause Kawasaki disease remain unknown ; however , earlier evidence16Rowley AH Is Kawasaki disease infectious disorder ? .Int J Rheum Dis .', '2018 ; 21 : 20-25Google Scholar suggest infectious agent trigger cascade cause illness .', 'Research contextEvidence studyKawasaki disease acute self-limiting vasculitis specific predilection coronary artery affect previously healthy young infant child .', 'Despite half century pass since Kawasaki disease first report Japan , cause condition remain unknown .', 'We PubMed database search identify study investigate cause pathogenesis Kawasaki disease use term “ Kawasaki disease ” , “ etiology ” , “ pathogenesis ” , “ intravenous immunoglobulin ” , “ corticosteroid ” , “ macrophage activation syndrome ( MAS ) ” , “ KD shock syndrome ” .', 'All relevant article evaluate .', 'The accept pathogenetic hypothesis support aberrant response immune system one unidentified pathogen genetically predispose subject .', 'An infectious trigger , however , identified.Added value studyShortly spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) region ( Bergamo , Italy ) , find 30-fold increase incidence Kawasaki disease .', 'Children diagnose SARS-CoV-2 epidemic begin show evidence immune response virus , older , higher rate cardiac involvement , feature MAS .', 'We therefore show SARS-CoV-2 might cause severe form Kawasaki-like disease.Implications available evidenceOutbreaks Kawasaki-like disease might occur country affect SARS-CoV-2 pandemic , might present outside classic Kawasaki disease phenotype .', 'This condition might serious require prompt aggressive management .', 'Future research cause Kawasaki disease similar syndrome focus immune response viral trigger .', 'Evidence study Kawasaki disease acute self-limiting vasculitis specific predilection coronary artery affect previously healthy young infant child .', 'Despite half century pass since Kawasaki disease first report Japan , cause condition remain unknown .', 'We PubMed database search identify study investigate cause pathogenesis Kawasaki disease use term “ Kawasaki disease ” , “ etiology ” , “ pathogenesis ” , “ intravenous immunoglobulin ” , “ corticosteroid ” , “ macrophage activation syndrome ( MAS ) ” , “ KD shock syndrome ” .', 'All relevant article evaluate .', 'The accept pathogenetic hypothesis support aberrant response immune system one unidentified pathogen genetically predispose subject .', 'An infectious trigger , however , identify .', 'Added value study Shortly spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) region ( Bergamo , Italy ) , find 30-fold increase incidence Kawasaki disease .', 'Children diagnose SARS-CoV-2 epidemic begin show evidence immune response virus , older , higher rate cardiac involvement , feature MAS .', 'We therefore show SARS-CoV-2 might cause severe form Kawasaki-like disease .', 'Implications available evidence Outbreaks Kawasaki-like disease might occur country affect SARS-CoV-2 pandemic , might present outside classic Kawasaki disease phenotype .', 'This condition might serious require prompt aggressive management .', 'Future research cause Kawasaki disease similar syndrome focus immune response viral trigger .', 'The aim study describe incidence feature new case Kawasaki-like presentation admit unit SARS-CoV-2 epidemic .', 'We retrospectively review note patient diagnose Kawasaki disease admit General Paediatric Unit Hospital Papa Giovanni XXIII ( Bergamo , Italy ) , Jan 1 , 2015 , April 20 , 2020 .', 'Our unit tertiary paediatric referral centre approximately 1300 paediatric admission per year , serve province approximately 1 million people , host largest Italian paediatric liver transplant programme largest paediatric intensive care unit northern Italy ( 16 bed ) .', 'In general paediatric unit , paediatric consultant fully train paediatric subspecialties .', 'Patients Kawasaki-like presentation define accord 2017 criterion American Heart Association , include classic type ( fever ≥5 day plus four clinical criterion , include bilateral bulbar non-exudative conjunctivitis , change lip oral cavity , non-suppurative laterocervical lymphadenopathy , polymorphic rash , erythema palm sol , firm induration hand foot , ) incomplete type .', 'In incomplete type ( fever ≥5 day plus two three aforementioned clinical criterion ) , value erythrocyte sedimentation rate ( ESR ) C-reactive protein ( CRP ) , , take additional diagnostic criterion association presence anaemia , thrombocytosis 7 day fever , hypoalbuminaemia , hypertransaminasaemia , leucocytosis , sterile pyuria , echocardiogram show coronary aneurysm cardiac dysfunction ( ie , leave ventricular function depression , mitral valve regurgitation , pericardial effusion ) .17McCrindle BW Rowley AH Newburger JW et al.Diagnosis , treatment , long-term management Kawasaki disease : scientific statement health professional American Heart Association.Circulation .', '2017 ; 135 : e927-e999Google Scholar All patient diagnose manage LV , charge paediatric rheumatology Paediatric Department since 2010 .', 'KDSS define Kawasaki disease accompany systolic arterial hypotension , decrease basal systolic blood pressure least 20 % , appearance sign peripheral hypoperfusion.14Kanegaye JT Wilder MS Molkara D et al.Recognition Kawasaki disease shock syndrome.Pediatrics .', '2009 ; 123 : e783-e789Google Scholar Ejection fraction , concentration troponin I pro-B-type natriuretic peptide ( proBNP ) measure use indirect sign myocarditis heart failure .', 'MAS define use Paediatric Rheumatology International Trials Organisation criteria18Ravelli A Minoia F Davì S et al.2016 Classification criterion macrophage activation syndrome complicate systemic juvenile idiopathic arthritis : European League Against Rheumatism/American College Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Ann Rheum Dis .', '2016 ; 75 : 481-489Google Scholar classification MAS systemic juvenile idiopathic arthritis .', 'The MAS criterion validate systemic juvenile idiopathic arthritis , commonly use systemic autoinflammatory disease Kawasaki disease paediatric systemic lupus erythematosus.19García-Pavón S Yamazaki-Nakashimada MA Báez M Borjas-Aguilar KL Murata C Kawasaki disease complicate macrophage activation syndrome : systematic review.J Pediatr Hematol Oncol .', '2017 ; 39 : 445-451Google Scholar We divide patient two group accord date presentation : group 1 , present 5 year precede local SARS-CoV-2 epidemic ( ie , Jan 1 , 2015 , Feb 17 , 2020 ) ; group 2 , present thereafter ( ie , Feb 18 April 20 , 2020 ) .', 'Data obtain hospital medical record , include demographic data , present symptom history previous treatment , contact confirm suspect case COVID-19 , vital sign , laboratory data , include white blood cell count , lymphocyte count , ESR , CRP , procalcitonin , ferritin , fibrinogen , proBNP , troponin I , natural killer ( NK ) activity , concentration interleukin 6 ( IL-6 ) .', 'Electrocardiogram echocardiogram do child .', 'Patients caregiver nasopharyngeal oropharyngeal swab sample , test SARS-CoV-2 nucleic acid use reverse-transcriptase quantitative PCR assay ; patient positive nasopharyngeal oropharyngeal swab sample test consider confirm case SARS-CoV-2 infection .', 'The patient diagnose recently test qualitative detection SARS-CoV-2 antibody ( IgM IgG ) lateral flow chromatographic immunoassay ( NADAL COVID-19 IgG/IgM Test , Nal Von Minden , Moers , Germany ) .', 'Positivity IgM IgG , , consider consistent earlier infection SARS-CoV-2 .', 'Risk resistance intravenous immunoglobulin treatment ascertain accord Kobayashi score.20Kobayashi T Saji T Otani T et al.Efficacy immunoglobulin plus prednisolone prevention coronary artery abnormality severe Kawasaki disease ( RAISE study ) : randomise , open-label , blinded-endpoints trial.Lancet .', '2012 ; 379 : 1613-1620Google Scholar All patient administer intravenous immunoglobulin 2 g/kg .', 'According RAISE study,20Kobayashi T Saji T Otani T et al.Efficacy immunoglobulin plus prednisolone prevention coronary artery abnormality severe Kawasaki disease ( RAISE study ) : randomise , open-label , blinded-endpoints trial.Lancet .', '2012 ; 379 : 1613-1620Google Scholar base risk stratification , patient also treat aspirin 50–80 mg/kg per day ( Kobayashi score < 5 ) 5 day aspirin 30 mg/kg per day plus methylprednisolone 2 mg/kg per day 5 day ( Kobayashi score ≥5 ) , follow taper methylprednisolone 2 week .', 'Aspirin maintain 48 h defervescence , continue antiplatelet dose 3–5 mg/kg per day 8 weeks.20Kobayashi T Saji T Otani T et al.Efficacy immunoglobulin plus prednisolone prevention coronary artery abnormality severe Kawasaki disease ( RAISE study ) : randomise , open-label , blinded-endpoints trial.Lancet .', '2012 ; 379 : 1613-1620Google Scholar The schedule patient risk intravenous immunglobulin resistance adopt also patient KDSS MAS .', 'Response treatment define normalisation vital sign , CRP , blood test , resolution symptom sign .', ""The Student 's test , χ2 method , Fisher 's exact test do appropriate statistical analysis compare continuous categorical variable ."", 'A p value < 0·05 choose cutoff significance .', 'Data analyse SPSS ( version 20.0 ) GraphPad Prism ( version 5.00 Mac ) .', 'The study approve Bergamo Ethics Committee ( registration number 37/20 , 25/03/2020 ) .', 'There fund source study .', 'The correspond author full access data study final responsibility decision submit publication .', 'Between Feb 18 April 20 , 2020 , ten patient ( age 7·5 year [ SD 3·5 ] ; seven boy , three girl ) , diagnose Kawasaki disease ( incidence ten per month ) , comprise group 2 .', 'Admission hospital occur , average , day 6 fever ( range 4–8 ) .', 'Five ( 50 % ) patient present classic form disease , five ( 50 % ) present incomplete form .', 'Patients present classic form non-exudative conjunctivitis , hand foot anomaly ( ie , erythema firm induration , ) , polymorphic rash .', 'Four ( 80 % ) five patient associate change lip oral cavity , ; patient 7 also laterocervical lymphadenopathy ( table 1 ) .Table 1Clinical laboratory feature ten patient Kawasaki-like disease present 1 month SARS-CoV-2 epidemic ( group 2 ) Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Date onsetMarch 17 , 2020March 27 , 2020March 28 , 2020April 3 , 2020April 3 , 2020April 4 , 2020April 6 , 2020April 10 , 2020April 11 , 2020April 14 , 2020Age , years8·27·02·97·77·516·05·09·25·55·5SexMaleMaleFemaleFemaleFemaleMaleMaleMaleMaleMaleType Kawasaki diseaseIncompleteIncompleteClassicIncompleteIncompleteClassicClassicIncompleteClassicClassicOther symptom .. Diarrhoea , meningeal sign .. Diarrhoea , meningeal signsDiarrhoeaDiarrhoeaMeningeal signsDiarrhoeaMeningeal signsDiarrhoea , drowsinessESR , mm/h .. 603910897 .. 51848154Lymphocytes , × 109 per L80310609709304507901870860420460Blood culture .. SterileSterileSterileSterileSterileSterileSterileSterileSterileChest x-rayPneumoniaPneumoniaPneumoniaNormalNormalNormalNormalPneumoniaNormalPneumoniaEchocardiographyAbnormalNormalNormalAbnormalAbnormalAbnormalNormalAbnormalNormalAbnormalAneurism > 4 mmNoNoNoNoNoNo > 4 mmNoNoEjection fraction48 % > 55 % > 55 % 25 % 30 % > 55 % > 55 % 40 % > 55 % 45 % Mitral valve regurgitationYesNoNoYesYesNoNoYesNoNoPericardial effusionYesNoNoYesYesYesNoNoNoNoKobayashi ≥5Yes ( 6 ) Yes ( 6 ) No ( 4 ) Yes ( 6 ) Yes ( 6 ) No ( 3 ) No ( 2 ) Yes ( 6 ) Yes ( 6 ) Yes ( 6 ) < 12 monthsNoNoNoNoNoNoNoNoNoNoKawasaki disease sign day 4NoNoNoNoNoNoNoNoNoNoCRP ≥10 mg/dLYes ( 0·9 ) Yes ( 31·1 ) Yes ( 15·2 ) Yes ( 48·0 ) Yes ( 52·5 ) No ( 7·3 ) Yes ( 24·0 ) Yes ( 24·2 ) Yes ( 24·6 ) Yes ( 12·2 ) Neutrophils ≥80 % Yes ( 80·0 ) Yes ( 89·7 ) No ( 77·3 ) Yes ( 90·0 ) Yes ( 90·5 ) No ( 79·4 ) No ( 77·9 ) Yes ( 91·9 ) Yes ( 85·5 ) Yes ( 83·0 ) Platelets ≤300 × 109 per LYes ( 119 ) Yes ( 121 ) Yes ( 66 ) Yes ( 142 ) Yes ( 113 ) Yes ( 121 ) Yes ( 138 ) Yes ( 192 ) Yes ( 151 ) Yes ( 142 ) Sodium ≤133 mEq/LYes ( 131 ) Yes ( 130 ) Yes ( 132 ) Yes ( 128 ) Yes ( 129 ) No ( 135 ) No ( 135 ) Yes ( 133 ) Yes ( 133 ) Yes ( 122 ) ALT ≥100 U/LNo ( 32 ) No ( 79 ) No ( 46 ) No ( 82 ) No ( 78 ) Yes ( 733 ) No ( 41 ) No ( 63 ) No ( 20 ) No ( 20 ) MAS18Ravelli A Minoia F Davì S et al.2016 Classification criterion macrophage activation syndrome complicate systemic juvenile idiopathic arthritis : European League Against Rheumatism/American College Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Ann Rheum Dis .', '2016 ; 75 : 481-489Google Scholar .. YesYesYesYesYesNoNoNoNoFerritin > 684 ng/mL .. Yes ( 1183 ) Yes ( 893 ) Yes ( 1972 ) Yes ( 3213 ) Yes ( 2027 ) No ( 199 ) No ( 449 ) No ( 307 ) No ( 341 ) Platelets ≤181 × 109 per LYes ( 119 ) Yes ( 121 ) Yes ( 66 ) Yes ( 142 ) Yes ( 113 ) Yes ( 121 ) Yes ( 138 ) No ( 192 ) Yes ( 151 ) Yes ( 142 ) AST > 48 IU/LNo ( 30 ) Yes ( 120 ) Yes ( 63 ) Yes ( 174 ) Yes ( 89 ) Yes ( 237 ) Yes ( 50 ) Yes ( 51 ) No ( 29 ) No ( 30 ) Triglycerides ≥156 mg/dL−Yes ( 434 ) Yes ( 367 ) Yes ( 263 ) Yes ( 198 ) .. Yes ( 161 ) Yes ( 200 ) Yes ( 171 ) No ( 121 ) Fibrinogen ≤360 mg/dLNo ( 465 ) No ( 599 ) No ( 506 ) No ( 924 ) No ( 759 ) Yes ( 313 ) No ( 637 ) No ( 759 ) No ( 759 ) No ( 489 ) KDSS14Kanegaye JT Wilder MS Molkara D et al.Recognition Kawasaki disease shock syndrome.Pediatrics .', '2009 ; 123 : e783-e789Google ScholarNoNoNoYesYesYesNoYesNoYesHypotensionNoNoNoYesYesYesNoYesNoYesSBP ≤20 % basalNoNoNoNoNoNoNoNoNoNoPeripheral hypoperfusionNoNoNoYesYesNoNoYesNoYesCPK , nv 461–71 IU/L1684762478911979405940Troponin I , nv ≤53 ng/L111188−200355749061236 < 323proBNP , nv 1–00 ng/L18709521519207216651083472957139927Nasal swab respiratory pathogensNegativeNegativeNegativeNegativeNegativeNegativeNegativeNegativeNegativeNegativeNasal swab SARS-CoV-2NegativePositiveNegativeNegativePositiveNegativeNegativeNegativeNegativeNegativeSerology SARS-CoV-2 ( IgG , IgM ) Negative , negativePositive , negativePositive , negativePositive , positivePositive , positiveNegative , negative * * Test do shortly high-dose IVIG.Positive , negativePositive , negativePositive , positivePositive , negativeSerology ( day onset ) 3018161111108746Contact suspect confirm caseNoYesNoNoYesNoYesNoYesYesCaregiver nasal swab SARS-CoV-2 .. PositiveNegativeNegativeNegativeNegativePositiveNegativeNegativePositiveTreatmentIVIG plus aspirinIVIG plus mPDNIVIG plus mPDNIVIG plus mPDNIVIG plus mPDNIVIG plus mPDNIVIG plus aspirinIVIG plus mPDNIVIG plus mPDNIVIG plus mPDNInotropesNoNoNoYesYesNoNoNoNoNoResponseYesYesYesYesYesYesYesYesYesYesESR=erythrocyte sedimentation rate .', 'CRP=C-reactive protein .', 'MAS=Macrophage Activation Syndrome .', 'ALT=alanine aminotransferase .', 'AST=aspartate aminotransferase .', 'KDSS=Kawasaki disease shock syndrome .', 'SBP=systolic blood pressure .', 'CPK=creatine phosphokinase .', 'BNP=B-type natriuretic peptide .', 'nv=normal value .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'IVIG=intravenous immunoglobulin .', 'mPDN=methylprednisolone .', '* Test do shortly high-dose IVIG .', 'Open table new tab ESR=erythrocyte sedimentation rate .', 'CRP=C-reactive protein .', 'MAS=Macrophage Activation Syndrome .', 'ALT=alanine aminotransferase .', 'AST=aspartate aminotransferase .', 'KDSS=Kawasaki disease shock syndrome .', 'SBP=systolic blood pressure .', 'CPK=creatine phosphokinase .', 'BNP=B-type natriuretic peptide .', 'nv=normal value .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'IVIG=intravenous immunoglobulin .', 'mPDN=methylprednisolone .', 'In group 2 , five ( 50 % ) ten patient diagnose incomplete Kawasaki disease , present three fewer clinical criterion associate additional laboratory criterion ( n=1 ) abnormal echocardiography ( n=4 ) .', 'Two ( 20 % ) patient bulbar non-exudative conjunctivitis ; change lip oral cavity , ; polymorphic rash .', 'One ( 10 % ) patient bulbar non-exudative conjunctivitis polymorphic rash .', 'In two ( 20 % ) patient , echocardiography detect leave coronary aneurysm ( > 4 mm ) , reduce ejection fraction ( 48 % 40 % ) , mitral valve regurgitation ; patient 1 also pericardial effusion .', 'Patient 2 meet diagnosis four additional laboratory criterion ( ie , hypoalbuminaemia , hypertransaminasaemia , leucocytosis , sterile pyuria ) .', 'Patients 4 5 diagnose incomplete Kawasaki disease , present non-exudative conjunctivitis associate change lip oral cavity ( patient 4 ) , polymorphic rash ( patient 5 ) .', 'In patient , echocardiography reveal leave ventricular function depression , mitral valve regurgitation , pericardial effusion ; also require inotropic support .', 'Patient 4 underlie diagnosis congenital adrenal hyperplasia .', 'Chest x-ray , do patient group 2 , positive five ( 50 % ) patient minimal mono bilateral infiltrate .', 'Patients 1 10 chest CT confirm bibasilar pulmonary thicken .', 'Patients 2 7 , meningeal sign , electroencephalogram show slow wave pattern ; patient 7 lumbar puncture reveal normal cerebrospinal fluid absence SARS-CoV-2 cerebrospinal fluid .', 'Five ( 50 % ) ten patient group 2 meet criterion KDSS hypotension clinical sign hypoperfusion .', 'Two ( 20 % ) patient diarrhoea meningeal sign , four ( 40 % ) diarrhoea , two ( 20 % ) meningeal sign ( table 1 ) .', 'Mean ESR 72 mm/h ( SD 24 ) , mean CRP 25 mg/dL ( SD 15·3 ) , mean ferritin 1176 ng/mL ( SD 1032 ) .', 'Full blood count show mean white cell count 10·8 × 109 per L ( SD 6·1 ) , increase neutrophil percentage eight patient ( 84·5 % [ SD 5·7 ] ) , lymphopenia eight patient ( 0·86 × 109 per L [ SD 0·40 ] ) , thrombocytopenia eight patient ( 130 × 109 per L [ 32 ] ) .', 'Hyponatraemia ( ≤133 mEq/L ) observe eight patient ( 131 mEq/L [ SD 4 ] ) slight increase transaminase record seven patient ( aspartate aminotransferase 87 U/L [ SD 70 ] ; alanine aminotransferase 119 U/L [ 217 ] ) .', 'Hypertriglyceridaemia show seven ( 87 % ) eight test patient group 2 ( 239 mg/dL [ SD 108 ] ) ; fibrinogen high nine ( 90 % ) ten patient ( 621 mg/dL [ 182 ] ) , D-dimer eight ( 80 % ) ten patient ( 3798 ng/mL [ SD 1318 ] ) .', 'Laboratory criterion predict intravenous immunoglobulin-resistance seven ( 70 % ) ten patient .', 'MAS diagnose five ( 50 % ) ten patient .', 'Troponin I elevate five ( 55 % ) nine test patient ( 1004 ng/L [ SD 1862 ] ) , creatine phosphokinase one ( 10 % ) ten patient ( 85 IU/L [ 64 ] ) , proBNP ten patient ( 1255 ng/L [ 929 ] ; Table 1 , Table 2 ) .Table 2Comparison patient Kawasaki-like disease present SARS-CoV-2 epidemicGroup 1Group 2p valueTime presentationUntil February , 2020March–April , 2020NANumber patients1910NAAge onset , years3·0 ( 2·5 ) 7·5 ( 3·5 ) 0·00035Incidence0·3 per month10 per month < 0·00001SexNANA0·13Female123NAMale77NAIncomplete Kawasaki disease6/19 ( 31 % ) 5/10 ( 50 % ) 0·43CRP , mg/dL16·3 ( 8·0 ) 25 ( 15·3 ) 0·05ESR , mm/h82 ( 29 ) 72 ( 24 ) 0·38White cell count , × 109 per L19·4 ( 6·4 ) 10·8 ( 6·1 ) 0·0017Neutrophils71·9 % ( 17·2 ) 84·5 % ( 5·7 ) 0·034Lymphocytes , × 109 per L3·0 ( 1·8 ) 0·86 ( 0·4 ) 0·0012Haemoglobin , g/dL10·8 ( 2·0 ) 11 ( 1·2 ) 0·79Platelets , × 109 per L457 ( 96 ) 130 ( 32 ) < 0·00001Albumin , g/dLl3·3 ( 0·5 ) 3·2 ( 0·3 ) 0·55Sodium , mEq/L134·7 ( 1·6 ) 130·8 ( 3·9 ) 0·0011AST , U/L120 ( 218 ) 87 ( 70 ) 0·64ALT , U/L92 ( 122 ) 119 ( 217 ) 0·67Ferritin , ng/mL187 ( 89 ) 1176 ( 1032 ) 0·011Triglycerides , mg/dL .. 239 ( 108 ) .. Fibrinogen , mg/dL543 ( 300 ) 621 ( 182 ) 0·51D-dimer , ng/mL3244 ( 943 ) 3798 ( 1318 ) 0·52CPK , IU/L61 ( 28 ) 85 ( 64 ) 0·19Troponin I , ng/L .. 1004 ( 1862 ) .. proBNP , ng/L .. 1255 ( 929 ) .. Kobayashi score ≥52/19 ( 10 % ) 7/10 ( 70 % ) 0·0021MAS18Ravelli A Minoia F Davì S et al.2016 Classification criterion macrophage activation syndrome complicate systemic juvenile idiopathic arthritis : European League Against Rheumatism/American College Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Ann Rheum Dis .', '2016 ; 75 : 481-489Google Scholar0/10 ( 0 % ) 5/10 ( 50 % ) 0·021KDSS14Kanegaye JT Wilder MS Molkara D et al.Recognition Kawasaki disease shock syndrome.Pediatrics .', '2009 ; 123 : e783-e789Google Scholar0/10 ( 0 % ) 5/10 ( 50 % ) 0·021Abnormal echocardiography2/19 ( 10 % ) 6/10 ( 60 % ) 0·0089Adjunctive steroid treatment4/19 ( 16 % ) 8/10 ( 80 % ) 0·0045Inotropes treatment0/19 ( 0 % ) 2/10 ( 20 % ) 0·11Response treatment19/19 ( 100 % ) 10/10 ( 100 % ) 1Data mean ( SD ) n/N ( % ) , unless otherwise state .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'NA=not applicable .', 'CRP=C-reactive protein .', 'ESR=erythrocyte sedimentation rate .', 'AST=aspartate aminotransferase .', 'ALT=alanine aminotransferase .', 'CPK=creatine phosphokinase .', 'BNP=B-type natriuretic peptide .', 'MAS=Macrophage Activation Syndrome .', 'KDSS=Kawasaki disease shock syndrome .', 'Open table new tab Data mean ( SD ) n/N ( % ) , unless otherwise state .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'NA=not applicable .', 'CRP=C-reactive protein .', 'ESR=erythrocyte sedimentation rate .', 'AST=aspartate aminotransferase .', 'ALT=alanine aminotransferase .', 'CPK=creatine phosphokinase .', 'BNP=B-type natriuretic peptide .', 'MAS=Macrophage Activation Syndrome .', 'KDSS=Kawasaki disease shock syndrome .', 'For four ( 40 % ) ten patient group 2 , IL-6 increase ( 177·1 pg/mL [ SD 137·4 ] , normal value ( nv ) < 3·4 ) .', 'NK count measure four ( 40 % ) patient , reduce ( 62 [ SD 35 ] ; nv 200–600 × 109 per L ) .', 'Blood culture sterile patient .', 'Nasopharyngeal oropharyngeal swab sample SARS-CoV-2 , available Feb 24 , 2020 , positive two ( 20 % ) ten patient group 2 ( table 1 ) .', 'All patient test least twice .', 'Serology SARS-CoV-2 antibody , available April 13 , 2020 , investigate patient group 2 ; eight ( 80 % ) ten patient IgG positive , three also IgM positive .', 'Patient 6 , negative serology , test shortly infusion high-dose intravenous immunoglobulin ( table 1 ) .', 'On April 14 , 2020 , 31 health-care personnel Paediatric Department , Hospital Papa Giovanni XXIII ( Bergamo , Italy ) serology test .', 'Nine ( 29 % ) 31 IgG positive , three ( 10 % ) also IgM positive , correspond expect rate exposure local heath-care personnel SARS-CoV-2 infection .', 'In addition , two patient group 1 diagnose start epidemic contact test SARS-CoV-2 antibody , negative .', 'To date , patient group 2 discharge , treatment aspirin antiplatelet dose ongoing , follow-up echocardiogram schedule 8 week .', 'From Jan 1 , 2015 , start epidemic Feb 17 , 2020 , 19 child diagnose Kawasaki disease ( incidence 0·3 per month ; mean age 3 year [ SD 2·5 ] ; seven boy , 12 girl ) ; patient comprise group 1 .', 'Admission hospital occur , average , day 6 fever ( range 4–11 day ) .', '13 ( 68 % ) 19 patient present classic form disease , six ( 31 % ) 19 incomplete form .', 'None patient hypotension , clinical sign hypoperfusion , atypical symptom .', 'Laboratory criterion predict intravenous immunoglobulin resistance two ( 10 % ) 19 patient .', 'MAS diagnose patient .', 'A full comparison clinical biochemical characteristic two group provide table 2 .', 'All patient include favourable outcome .', 'Patients group 1 conclude treatment follow-up period , recover completely residual coronary artery aneurism .', 'Group 1 comprise 19 patient diagnose 5 year , whereas group 2 include ten patient diagnose 1 month ( incidence 0·3 per month v ten per month ; p < 0·0001 ; table 2 ; figure ) .', 'To rule possible effect number referral emergency department different period , calculate incidence correct number patient see emergency department .', 'We find past 5 year , January , 2015 , December , 2019 , 98 572 patient evaluate , mean 1642 ( SD 280 ) per month , compare 283 patient per month study period—approximately six-fold lower .', 'With figure , incidence Kawasaki disease group 1 0·019 % ( 95 % CI −0·002 0·0019 ) , compare 3·5 % ( −3·5 3·6 ) group 2 ( odds ratio 184 ; p < 0·0001 ; figure ) .', 'To rule possible effect change geographical catchment area prepandemic ( group 1 ) versus pandemic ( group 2 ) period , review place residence patient Kawasaki disease draw referral map , show one come Bergamo province ( appendix p 1 ) .FigureIncidence Kawasaki disease study period past 5 yearsShow full caption ( A ) Frequency Kawasaki disease paediatric emergency department Hospital Papa Giovanni XXIII Bergamo , Italy , past 5 year , case severity .', '( B ) Number patient present paediatric emergency department severe acute respiratory syndrome coronavirus 2 epidemic , date presentation ten patient Kawasaki-like disease ( indicate asterisk ) .View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Frequency Kawasaki disease paediatric emergency department Hospital Papa Giovanni XXIII Bergamo , Italy , past 5 year , case severity .', '( B ) Number patient present paediatric emergency department severe acute respiratory syndrome coronavirus 2 epidemic , date presentation ten patient Kawasaki-like disease ( indicate asterisk ) .', 'The average age onset 3·0 year ( SD 2·5 ) group 1 versus 7·5 year ( 3·5 ) group 2 ( p=0·0003 ) .', 'In group 1 , 14 19 patient white , versus eight ten patient group 2 .', 'The mean body-mass index patient group 1 15·93 kg/m2 ( SD 1·72 ) versus 19·11 kg/m2 ( SD 3·21 ) group 2 ( p=0·0016 ) .', 'Two patient test group 1 negative serology SARS-CoV-2 versus eight ten positive patient group 2 ( one two negative patient test high-dose intravenous immunoglobulin ) ; five ( 50 % ) ten patient contact confirm COVID-19 case .', 'Group 2 significantly lower white cell count , lymphocyte count , platelet count compare group 1 ( table 2 ) .', 'Group 2 also differ significantly group 1 increase rate marker severity .', 'An abnormal echocardiogram record six ( 60 % ) ten patient group 2 versus two ( 10 % ) 19 patient group 1 ( p=0·0089 ) ; fulfilment criterion KDSS MAS find five ( 50 % ) ten patient group 2 , none patient group 1 ( p=0·021 ) .', 'Seven ( 70 % ) patient group 2 meet criterion Kobayashi score 5 , compare two ( 10 % ) 19 patient group 1 ( p=0·0021 ) .', 'Adjunctive steroid treatment require four ( 16 % ) 19 patient group 1 versus eight ( 80 % ) ten patient group 2 ( p=0·0045 ; table 2 ) .', 'Despite half century pass since Tomisaku Kawasaki first report 50 case Japan,12Kawasaki T Kosaki F Okawa S Shigematsu I Yanagawa H A new infantile acute febrile mucocutaneous lymph node syndrome ( MLNS ) prevail Japan.Pediatrics .', '1974 ; 54 : 271-276Google Scholar cause Kawasaki disease remain unknown .', 'The accept hypothesis support aberrant response immune system one unidentified pathogen genetically predispose patient ; 21Shulman ST Rowley AH Kawasaki disease : insight pathogenesis approach treatment.Nat Rev Rheumatol .', '2015 ; 11 : 475-482Google Scholar , 22Nakamura Y Kawasaki disease : epidemiology lesson it.Int J Rheum Dis .', '2018 ; 21 : 16-19Google Scholar , 23Nakamura Y Yashiro M Uehara R et al.Epidemiologic feature Kawasaki disease Japan : result 2009-2010 nationwide survey.J Epidemiol .', '2012 ; 22 : 216-221Google Scholar however , search infectious trigger disappointing.24Yim D Curtis N Cheung M Burgner D Update Kawasaki disease : epidemiology , aetiology pathogenesis.J Paediatr Child Health .', '2013 ; 49 : 704-708Google Scholar In Japan , three epidemic record 1979 , 1982 , 1986 , highest Kawasaki disease incidence see January , potentially suggest factor winter month may trigger Kawasaki disease.25Makino N Nakamura Y Yashiro M et al.Descriptive epidemiology Kawasaki disease Japan , 2011–2012 : result 22nd nationwide survey.J Epidemiol .', '2015 ; 25 : 239-245Google Scholar , 26Onouchi Y The genetics Kawasaki disease.Int J Rheum Dis .', '2018 ; 21 : 26-30Google Scholar In 2010 , incidence Kawasaki disease Japan 239·6 per 100 000 child younger 5 year , compare 20·8 per 100 000 USA.27Holman RC Belay ED Christensen KY Folkema AM Steiner CA Schonberger LB Hospitalizations Kawasaki syndrome among child United States , 1997–2007.Pediatr Infect Dis J .', '2010 ; 29 : 483-488Google Scholar A 2-year retrospective survey do northeastern Italy calculate incidence 14·7 case per 100 000 child younger 5 years.28Marchesi A Tarissi de Jacobis I Rigante D et al.Kawasaki disease : guideline Italian Society Pediatrics , part I - definition , epidemiology , etiopathogenesis , clinical expression management acute phase.Ital J Pediatr .', '2018 ; 44 : 102Google Scholar We report high number Kawasaki-like disease case Bergamo province follow SARS-CoV-2 epidemic , monthly incidence least 30 time greater monthly incidence previous 5 year , clear start point first case COVID-19 diagnose area .', 'Group 2 , diagnose SARS-CoV-2 appear , show evidence seroconversion virus majority patient .', 'In past 20 year , virus coronavirus family propose possibly implicate pathogenesis Kawasaki disease .', 'In 2005 , group New Haven ( CT , USA ) 29Esper F Shapiro ED Weibel C Ferguson D Landry ML Kahn JS Association novel human coronavirus Kawasaki disease.J Infect Dis .', '2005 ; 191 : 499-502Google Scholar identify novel human coronavirus , designate New Haven coronavirus ( HCoV-NH ) , respiratory secretion eight 11 child Kawasaki disease versus one 22 control test RT-PCR .', 'A serological test do .', 'This report follow commentary express mix sense interest scepticism.30McIntosh K Coronaviruses limelight.J Infect Dis .', '2005 ; 191 : 489-491Google Scholar The argument association express group Japan , retrospective study31Ebihara T Endo R Ma X Ishiguro N Kikuta H Lack association New Haven coronavirus Kawasaki disease.J Infect Dis .', '2005 ; 192 : 351-352Google Scholar , 32Esper F Shapiro ED Landry ML Kahn JS Reply van der Hoek Berkhout , Ebihara et al. , Belay et al.J Infect Dis .', '2005 ; 192 : 353Google Scholar , 33Turnier JL Anderson MS Heizer HR Jone PN Glodé MP Dominguez SR Concurrent respiratory virus Kawasaki disease.Pediatrics .', '2015 ; 136 : e609-e614Google Scholar nasopharyngeal swab sample 19 child Kawasaki disease 208 control respiratory tract infection , find RNA sequence HCoV-NH five ( 2 % ) 208 control versus zero 19 child Kawasaki disease .', 'Another group Japan explore association two different coronaviruses ( HCoV-NL63 HCoV-229E ) Kawasaki disease serological test .', 'The immunofluorescence assay detect difference HCoV-NL63 antibody positivity patient control , whereas HCoV-229E antibody positivity higher patient Kawasaki disease.34Shirato K Imada Y Kawase M Nakagaki K Matsuyama S Taguchi F Possible involvement infection human coronavirus 229E , NL63 , Kawasaki disease.J Med Virol .', '2014 ; 86 : 2146-2153Google Scholar Given pathogenesis disease , serology test seem reliable tool RT-PCR detect cause infection .', 'This suggest coronavirus family might represent one trigger Kawasaki disease , SARS-CoV-2 particularly virulent strain able elicit powerful immune response host .', 'In study , clinical biochemical feature patient Kawasaki disease diagnose COVID-19 pandemic appear differ historical cohort patient ; therefore , classify patient Kawasaki-like disease .', 'From clinical perspective , older , respiratory gastrointestinal involvement , meningeal sign , sign cardiovascular involvement .', 'From biochemical perspective , leucopenia mark lymphopenia , thrombocytopenia , increase ferritin , well marker myocarditis .', 'Similar clinical feature share patient COVID-19.4Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar Additionally , patient severe disease course , resistance intravenous immunoglobulin need adjunctive steroid , biochemical evidence MAS , clinical sign keep KDSS .', ""The proinflammatory effect SARS-CoV-2 report adult severe respiratory complication COVID-19.35McGonagle D Sharif K O'Regan A Bridgewood C The role cytokine include interleukin-6 COVID-19 induce pneumonia macrophage activation syndrome-like disease.Autoimmun Rev ."", '2020 ; ( publish online April 3 .', ') DOI:10.1016/j.autrev.2020.102537Google Scholar , 36Molloy EJ Bearer CF COVID-19 child alter inflammatory responses.Pediatr Res .', '2020 ; ( publish online April 3 .', ') DOI:10.1038/s41390-020-0881-yGoogle Scholar Many patient constellation feature classify term cytokine storm , fever , lymphopenia , elevate transaminase , lactate dehydrogenase , D-dimer , ferritin , keep MAS.11Mehta P McAuley DF Brown M Sanchez E Tattersall RS Manson JJ COVID-19 : consider cytokine storm syndrome immunosuppression.Lancet .', ""2020 ; 395 : 1033-1034Google Scholar , 35McGonagle D Sharif K O'Regan A Bridgewood C The role cytokine include interleukin-6 COVID-19 induce pneumonia macrophage activation syndrome-like disease.Autoimmun Rev ."", '2020 ; ( publish online April 3 .', ') DOI:10.1016/j.autrev.2020.102537Google Scholar , 37Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; 395 : 1054-1062Google Scholar Likewise , MAS form cytokine storm , might affect patient Kawasaki disease.9Henderson LA Canna SW Schulert GS et al.On alert cytokine storm : immunopathology COVID-19.Arthritis Rheumatol .', '2020 ; ( publish online April 15 .', ') DOI:10.1002/art.41285Google Scholar , 15Wang W Gong F Zhu W Fu S Zhang Q Macrophage activation syndrome Kawasaki disease : common think ? .Semin Arthritis Rheum .', '2015 ; 44 : 405-410Google Scholar All element support need start adjunctive steroid .', 'In experience , treatment effective safe , consider physician treat patient Kawasaki-like presentation context COVID-19 pandemic .', 'Evidence contact virus confirm presence antibody SARS-CoV-2 eight ten patient group 2 .', 'It possible remain two patient , negative serology , confound factor play role .', 'One patient test infusion high-dose immunoglobulin .', 'Additionally , qualitative antibody test report sensitivity 95 % specificity 85–90 % compare PCR test nasal swab .', 'It also possible patient represent usual presentation Kawasaki disease outside SARS-CoV-2 epidemic , see previous year .', 'Only two patient group 2 present positive nasopharyngeal oropharyngeal swab sample SARS-CoV-2 .', 'This find positivity IgG antibody suggest late onset disease compare primary infection , due host immune response .', 'This might reason , past , active viral infection could show disease .', 'All result consideration support hypothesis immune response SARS-CoV-2 responsible Kawasaki-like disease susceptible patient .', 'We believe find important implication public health .', 'The association SARS-CoV-2 Kawasaki-like disease take account come consider social reintegration policy paediatric population .', 'However , Kawasaki-like disease describe remain rare condition , probably affect one 1000 child expose SARS-CoV-2 .', 'This estimate base limit data case series region .', 'This study limitation relatively small case series , require confirmation larger group .', 'Genetic study investigate susceptibility patient develop disease trigger effect SARS-CoV-2 do .', 'Nonetheless , report strong association outbreak Kawasaki-like disease SARS-CoV-2 epidemic Bergamo province Italy .', 'Patients diagnose Kawasaki-like disease viral spread reveal severe course , include KDSS MAS , require adjunctive steroid treatment .', 'A similar outbreak Kawasaki-like disease expect country affect SARS-CoV-2 pandemic .', ""Contributors LV LD ' A make substantial contribution conception design work ."", 'LV AM draft work .', ""LV , AM , AG , LM , MR , MC , EB , LD ' A give final approval Article publish ."", ""LV , AM , AG , LM , MR , MC , EB , LD ' A agree accountable aspect work ensure question relate accuracy integrity part work appropriately investigate resolve ."", 'AM , AG , LM , MR , MC , EB acquire , analyse , interpret data Article .', 'AG , LM , MR , MC , EB revise Article critically important intellectual content .', ""LD ' A prepare final draft critically revise Article important intellectual content ."", 'Declaration interest We declare compete interest financial support study .', ""Acknowledgments We thank Giulia Quattrocchi Angela Amoroso help retrieve patient ' data file note ."", 'Download .pdf ( .22 MB ) Help pdf file Supplementary appendix Kawasaki-like disease : emerge complication COVID-19 pandemicFull-TextPDF']","['backgroundthe', 'bergamo', 'province', '', 'extensively', 'affect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'epidemic', '', 'natural', 'observatory', 'virus', 'manifestation', 'general', 'population', '', 'past', 'month', 'record', 'outbreak', 'kawasaki', 'disease', '', 'aim', 'evaluate', 'incidence', 'feature', 'patient', 'kawasaki-like', 'disease', 'diagnose', 'sars-cov-2', 'epidemicmethodsall', 'patient', 'diagnose', 'kawasaki-like', 'disease', 'centre', 'past', '5', 'year', 'divide', 'accord', 'symptomatic', 'presentation', '', 'group', '1', '', '', 'group', '2', '', 'begin', 'sars-cov-2', 'epidemic', '', 'kawasaki-', 'like', 'presentation', 'manage', 'kawasaki', 'disease', 'accord', 'american', 'heart', 'association', 'indication', '', 'kawasaki', 'disease', 'shock', 'syndrome', '', 'kdss', '', 'define', 'presence', 'circulatory', 'dysfunction', '', 'macrophage', 'activation', 'syndrome', '', 'mas', '', 'paediatric', 'rheumatology', 'international', 'trials', 'organisation', 'criterion', '', 'current', 'previous', 'infection', 'seek', 'reverse-transcriptase', 'quantitative', 'pcr', 'nasopharyngeal', 'oropharyngeal', 'swab', '', 'serological', 'qualitative', 'test', 'detect', 'sars-cov-2', 'igm', 'igg', '', 'respectivelyfindingsgroup', '1', 'comprise', '19', 'patient', '', 'seven', 'boy', '', '12', 'girl', '', 'age', '30', 'year', '', 'sd', '25', '', '', 'diagnose', 'jan', '1', '', '2015', '', 'feb', '17', '', '2020', '', 'group', '2', 'include', 'ten', 'patient', '', 'seven', 'boy', '', 'three', 'girl', '', 'age', '75', 'year', '', 'sd', '35', '', '', 'diagnose', 'feb', '18', 'april', '20', '', '2020', '', 'eight', 'ten', 'positive', 'igg', 'igm', '', '', 'two', 'group', 'differ', 'disease', 'incidence', '', 'group', '1', 'v', 'group', '2', '', '03', 'v', 'ten', 'per', 'month', '', '', 'mean', 'age', '', '30', 'v', '75', 'year', '', '', 'cardiac', 'involvement', '', 'two', '19', 'v', 'six', 'ten', '', '', 'kdss', '', 'zero', '19', 'v', 'five', 'ten', '', '', 'mas', '', 'zero', '19', 'v', 'five', 'ten', '', '', 'adjunctive', 'steroid', 'treatment', '', 'three', '19', 'v', 'eight', 'ten', '', 'p', '', '001', '', 'interpretationin', 'past', 'month', 'find', '30-fold', 'increase', 'incidence', 'kawasaki-like', 'disease', '', 'children', 'diagnose', 'sars-cov-2', 'epidemic', 'begin', 'show', 'evidence', 'immune', 'response', 'virus', '', 'older', '', 'higher', 'rate', 'cardiac', 'involvement', '', 'feature', 'mas', '', 'sars-cov-2', 'epidemic', 'associate', 'high', 'incidence', 'severe', 'form', 'kawasaki', 'disease', '', 'similar', 'outbreak', 'kawasaki-like', 'disease', 'expect', 'country', 'involve', 'sars-cov-2', 'epidemicfundingnone', '', 'bergamo', 'province', '', 'extensively', 'affect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'epidemic', '', 'natural', 'observatory', 'virus', 'manifestation', 'general', 'population', '', 'past', 'month', 'record', 'outbreak', 'kawasaki', 'disease', '', 'aim', 'evaluate', 'incidence', 'feature', 'patient', 'kawasaki-like', 'disease', 'diagnose', 'sars-cov-2', 'epidemic', '', 'patient', 'diagnose', 'kawasaki-like', 'disease', 'centre', 'past', '5', 'year', 'divide', 'accord', 'symptomatic', 'presentation', '', 'group', '1', '', '', 'group', '2', '', 'begin', 'sars-cov-2', 'epidemic', '', 'kawasaki-', 'like', 'presentation', 'manage', 'kawasaki', 'disease', 'accord', 'american', 'heart', 'association', 'indication', '', 'kawasaki', 'disease', 'shock', 'syndrome', '', 'kdss', '', 'define', 'presence', 'circulatory', 'dysfunction', '', 'macrophage', 'activation', 'syndrome', '', 'mas', '', 'paediatric', 'rheumatology', 'international', 'trials', 'organisation', 'criterion', '', 'current', 'previous', 'infection', 'seek', 'reverse-transcriptase', 'quantitative', 'pcr', 'nasopharyngeal', 'oropharyngeal', 'swab', '', 'serological', 'qualitative', 'test', 'detect', 'sars-cov-2', 'igm', 'igg', '', 'respectively', '', 'group', '1', 'comprise', '19', 'patient', '', 'seven', 'boy', '', '12', 'girl', '', 'age', '30', 'year', '', 'sd', '25', '', '', 'diagnose', 'jan', '1', '', '2015', '', 'feb', '17', '', '2020', '', 'group', '2', 'include', 'ten', 'patient', '', 'seven', 'boy', '', 'three', 'girl', '', 'age', '75', 'year', '', 'sd', '35', '', '', 'diagnose', 'feb', '18', 'april', '20', '', '2020', '', 'eight', 'ten', 'positive', 'igg', 'igm', '', '', 'two', 'group', 'differ', 'disease', 'incidence', '', 'group', '1', 'v', 'group', '2', '', '03', 'v', 'ten', 'per', 'month', '', '', 'mean', 'age', '', '30', 'v', '75', 'year', '', '', 'cardiac', 'involvement', '', 'two', '19', 'v', 'six', 'ten', '', '', 'kdss', '', 'zero', '19', 'v', 'five', 'ten', '', '', 'mas', '', 'zero', '19', 'v', 'five', 'ten', '', '', 'adjunctive', 'steroid', 'treatment', '', 'three', '19', 'v', 'eight', 'ten', '', 'p', '', '001', '', '', 'past', 'month', 'find', '30-fold', 'increase', 'incidence', 'kawasaki-like', 'disease', '', 'children', 'diagnose', 'sars-cov-2', 'epidemic', 'begin', 'show', 'evidence', 'immune', 'response', 'virus', '', 'older', '', 'higher', 'rate', 'cardiac', 'involvement', '', 'feature', 'mas', '', 'sars-cov-2', 'epidemic', 'associate', 'high', 'incidence', 'severe', 'form', 'kawasaki', 'disease', '', 'similar', 'outbreak', 'kawasaki-like', 'disease', 'expect', 'country', 'involve', 'sars-cov-2', 'epidemic', '', 'none', '', 'epidemic', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'cause', 'covid-19', '', 'rapidly', 'spread', 'worldwide', '', 'italy', 'first', 'european', 'country', 'affect', '', 'outbreak', 'estimate', 'start', 'february', '', '2020', '', 'currently', '', 'italy', 'report', '132', '547', 'covid-19-positive', 'case', '', '51', '534', 'lombardy1ministero', 'della', 'salutenuovo', 'coronavirus', '', 'cosa', 'c', '', '', 'da', 'sapere', '', 'urlplaceholder', 'access', '', 'april', '15', '', '2020google', 'estimate', 'least', '10', '', 'italian', 'populationie', '', 'approximately', '1', 'million', 'peoplehave', 'expose', 'virus2flaxman', 'mishra', 'gandy', 'alestimating', 'number', 'infection', 'impact', 'nonpharmaceutical', 'intervention', 'covid-19', '11', 'european', 'country', '', 'urlplaceholder', 'access', '', 'march', '30', '', '2020google', 'city', 'bergamo', 'highest', 'rate', 'infection', 'death', 'italy', '', 'province', 'bergamo', 'natural', 'epidemiological', 'set', 'sars-cov-2', 'infection', 'appear', 'earlier', 'evident', '', 'adult', '', 'covid-19', 'typically', 'characterise', 'severe', 'interstitial', 'pneumonia', 'hyperactivation', 'inflammatory', 'cascade3zhu', 'n', 'zhang', 'wang', 'w', 'ala', 'novel', 'coronavirus', 'patient', 'pneumonia', 'china', '', '2019n', 'engl', 'j', 'med', '', '2020', '', '382', '', '727-733google', '', '4huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'child', '', 'respiratory', 'involvement', 'appear', 'benign', 'course', '', 'almost', 'fatality', 'report', 'age', 'group5yonker', 'lm', 'shen', 'k', 'kinane', 'tb', 'lessons', 'unfold', 'pediatric', 'case', 'covid-19', 'disease', 'cause', 'sars-cov-2', 'infectionpediatr', 'pulmonol', '', '2020', '', '55', '', '1085-1086google', '', '6dong', 'mo', 'x', 'hu', 'alepidemiology', 'covid-19', 'among', 'child', 'chinapediatrics', '', '2020', '', '', 'publish', 'online', 'march', '16', '', '', 'doi101542peds2020-0702google', '', '7nicastro', 'e', 'mazza', 'gervasoni', 'di', 'giorgio', 'dantiga', 'l', 'pediatric', 'emergency', 'department', 'protocol', 'avoid', 'intra-hospital', 'dispersal', 'sars-cov-2', 'outbreak', 'bergamo', '', 'italyj', 'pediatr', '', '2020', '', '', 'publish', 'online', 'april', '21', '', '', 'doi101016jjpeds202004026google', 'nonetheless', '', 'respiratory', 'tract', 'system', 'susceptible', 'sars-cov-2', 'infection8xiao', 'f', 'tang', 'zheng', 'x', 'liu', 'li', 'x', 'h', 'evidence', 'gastrointestinal', 'infection', 'sars-cov-2gastroenterology', '', '2020', '', '158', '', '1831-1833google', 'increasing', 'evidence', 'suggest', 'tissue', 'damage', 'covid-19', 'mostly', 'mediate', 'host', 'innate', 'immunity9henderson', 'la', 'canna', 'sw', 'schulert', 'gs', 'alon', 'alert', 'cytokine', 'storm', '', 'immunopathology', 'covid-19arthritis', 'rheumatol', '', '2020', '', '', 'publish', 'online', 'april', '15', '', '', 'doi101002art41285google', '', '10dantiga', 'l', 'coronaviruses', 'immunosuppressed', 'patient', '', 'fact', 'third', 'epidemicliver', 'transpl', '', '2020', '', '', 'publish', 'online', 'march', '20', '', '', 'doi101002lt25756google', 'disease', 'characterise', 'cytokine', 'storm', 'resemble', 'macrophage', 'activation', 'viral-induced', 'haemophagocytic', 'lymphohistiocytosis11mehta', 'p', 'mcauley', 'df', 'brown', 'sanchez', 'e', 'tattersall', 'rs', 'manson', 'jj', 'covid-19', '', 'consider', 'cytokine', 'storm', 'syndrome', 'immunosuppressionlancet', '', '2020', '', '395', '', '1033-1034google', 'kawasaki', 'disease', 'acute', 'usually', 'self-limiting', 'vasculitis', 'medium', 'calibre', 'vessel', '', 'almost', 'exclusively', 'affect', 'children12kawasaki', 'kosaki', 'f', 'okawa', 'shigematsu', 'yanagawa', 'h', 'new', 'infantile', 'acute', 'febrile', 'mucocutaneous', 'lymph', 'node', 'syndrome', '', 'mlns', '', 'prevail', 'japanpediatrics', '', '1974', '', '54', '', '271-276google', '', '13kato', 'h', 'sugimura', 'akagi', 'allong-term', 'consequence', 'kawasaki', 'disease', '', '10-', '21-year', 'follow-up', 'study', '594', 'patientscirculation', '', '1996', '', '94', '', '1379-1385google', 'acute', 'phase', 'disease', '', 'patient', 'kawasaki', 'disease', 'haemodynamic', 'instability', '', 'condition', 'kawasaki', 'disease', 'shock', 'syndrome', '', 'kdss', '', '14kanegaye', 'jt', 'wilder', 'ms', 'molkara', 'alrecognition', 'kawasaki', 'disease', 'shock', 'syndromepediatrics', '', '2009', '', '123', '', 'e783-e789google', 'patient', 'kawasaki', 'disease', 'fulfil', 'criterion', 'macrophage', 'activation', 'syndrome', '', 'mas', '', '', 'resemble', 'secondary', 'haemophagocytic', 'lymphohistiocytosis15wang', 'w', 'gong', 'f', 'zhu', 'w', 'fu', 'zhang', 'q', 'macrophage', 'activation', 'syndrome', 'kawasaki', 'disease', '', 'common', '', 'semin', 'arthritis', 'rheum', '', '2015', '', '44', '', '405-410google', 'cause', 'kawasaki', 'disease', 'remain', 'unknown', '', 'however', '', 'earlier', 'evidence16rowley', 'ah', 'kawasaki', 'disease', 'infectious', 'disorder', '', 'int', 'j', 'rheum', 'dis', '', '2018', '', '21', '', '20-25google', 'suggest', 'infectious', 'agent', 'trigger', 'cascade', 'cause', 'illness', '', 'research', 'contextevidence', 'studykawasaki', 'disease', 'acute', 'self-limiting', 'vasculitis', 'specific', 'predilection', 'coronary', 'artery', 'affect', 'previously', 'healthy', 'young', 'infant', 'child', '', 'despite', 'half', 'century', 'pass', 'since', 'kawasaki', 'disease', 'first', 'report', 'japan', '', 'cause', 'condition', 'remain', 'unknown', '', 'database', 'search', 'identify', 'study', 'investigate', 'cause', 'pathogenesis', 'kawasaki', 'disease', 'term', '', 'kawasaki', 'disease', '', '', '', 'etiology', '', '', '', 'pathogenesis', '', '', '', 'intravenous', 'immunoglobulin', '', '', '', 'corticosteroid', '', '', '', 'macrophage', 'activation', 'syndrome', '', 'mas', '', '', '', '', 'kd', 'shock', 'syndrome', '', '', 'relevant', 'article', 'evaluate', '', 'accept', 'pathogenetic', 'hypothesis', 'support', 'aberrant', 'response', 'immune', 'system', 'one', 'unidentified', 'pathogen', 'genetically', 'predispose', '', 'infectious', 'trigger', '', 'however', '', 'identifiedadded', 'value', 'studyshortly', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'region', '', 'bergamo', '', 'italy', '', '', 'find', '30-fold', 'increase', 'incidence', 'kawasaki', 'disease', '', 'children', 'diagnose', 'sars-cov-2', 'epidemic', 'begin', 'show', 'evidence', 'immune', 'response', 'virus', '', 'older', '', 'higher', 'rate', 'cardiac', 'involvement', '', 'feature', 'mas', '', 'therefore', 'show', 'sars-cov-2', 'cause', 'severe', 'form', 'kawasaki-like', 'diseaseimplications', 'available', 'evidenceoutbreaks', 'kawasaki-like', 'disease', 'occur', 'country', 'affect', 'sars-cov-2', 'pandemic', '', 'present', 'outside', 'classic', 'kawasaki', 'disease', 'phenotype', '', 'condition', 'serious', 'require', 'prompt', 'aggressive', 'management', '', 'future', 'research', 'cause', 'kawasaki', 'disease', 'similar', 'syndrome', 'focus', 'immune', 'response', 'viral', 'trigger', '', 'evidence', 'study', 'kawasaki', 'disease', 'acute', 'self-limiting', 'vasculitis', 'specific', 'predilection', 'coronary', 'artery', 'affect', 'previously', 'healthy', 'young', 'infant', 'child', '', 'despite', 'half', 'century', 'pass', 'since', 'kawasaki', 'disease', 'first', 'report', 'japan', '', 'cause', 'condition', 'remain', 'unknown', '', 'database', 'search', 'identify', 'study', 'investigate', 'cause', 'pathogenesis', 'kawasaki', 'disease', 'term', '', 'kawasaki', 'disease', '', '', '', 'etiology', '', '', '', 'pathogenesis', '', '', '', 'intravenous', 'immunoglobulin', '', '', '', 'corticosteroid', '', '', '', 'macrophage', 'activation', 'syndrome', '', 'mas', '', '', '', '', 'kd', 'shock', 'syndrome', '', '', 'relevant', 'article', 'evaluate', '', 'accept', 'pathogenetic', 'hypothesis', 'support', 'aberrant', 'response', 'immune', 'system', 'one', 'unidentified', 'pathogen', 'genetically', 'predispose', '', 'infectious', 'trigger', '', 'however', '', 'identify', '', 'added', 'value', 'study', 'shortly', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'region', '', 'bergamo', '', 'italy', '', '', 'find', '30-fold', 'increase', 'incidence', 'kawasaki', 'disease', '', 'children', 'diagnose', 'sars-cov-2', 'epidemic', 'begin', 'show', 'evidence', 'immune', 'response', 'virus', '', 'older', '', 'higher', 'rate', 'cardiac', 'involvement', '', 'feature', 'mas', '', 'therefore', 'show', 'sars-cov-2', 'cause', 'severe', 'form', 'kawasaki-like', 'disease', '', 'implications', 'available', 'evidence', 'outbreaks', 'kawasaki-like', 'disease', 'occur', 'country', 'affect', 'sars-cov-2', 'pandemic', '', 'present', 'outside', 'classic', 'kawasaki', 'disease', 'phenotype', '', 'condition', 'serious', 'require', 'prompt', 'aggressive', 'management', '', 'future', 'research', 'cause', 'kawasaki', 'disease', 'similar', 'syndrome', 'focus', 'immune', 'response', 'viral', 'trigger', '', 'aim', 'study', 'describe', 'incidence', 'feature', 'new', 'case', 'kawasaki-like', 'presentation', 'admit', 'unit', 'sars-cov-2', 'epidemic', '', 'retrospectively', 'review', 'note', 'patient', 'diagnose', 'kawasaki', 'disease', 'admit', 'general', 'paediatric', 'unit', 'hospital', 'papa', 'giovanni', 'xxiii', '', 'bergamo', '', 'italy', '', '', 'jan', '1', '', '2015', '', 'april', '20', '', '2020', '', 'unit', 'tertiary', 'paediatric', 'referral', 'centre', 'approximately', '1300', 'paediatric', 'admission', 'per', 'year', '', 'serve', 'province', 'approximately', '1', 'million', 'people', '', 'host', 'largest', 'italian', 'paediatric', 'liver', 'transplant', 'programme', 'largest', 'paediatric', 'intensive', 'care', 'unit', 'northern', 'italy', '', '16', 'bed', '', '', 'general', 'paediatric', 'unit', '', 'paediatric', 'consultant', 'fully', 'train', 'paediatric', 'subspecialties', '', 'patients', 'kawasaki-like', 'presentation', 'define', 'accord', '2017', 'criterion', 'american', 'heart', 'association', '', 'include', 'classic', 'type', '', 'fever', '5', 'day', 'plus', 'four', 'clinical', 'criterion', '', 'include', 'bilateral', 'bulbar', 'non-exudative', 'conjunctivitis', '', 'change', 'lip', 'oral', 'cavity', '', 'non-suppurative', 'laterocervical', 'lymphadenopathy', '', 'polymorphic', 'rash', '', 'erythema', 'palm', 'sol', '', 'firm', 'induration', 'hand', 'foot', '', '', 'incomplete', 'type', '', 'incomplete', 'type', '', 'fever', '5', 'day', 'plus', 'two', 'three', 'aforementioned', 'clinical', 'criterion', '', '', 'value', 'erythrocyte', 'sedimentation', 'rate', '', 'esr', '', 'c-reactive', 'protein', '', 'crp', '', '', '', 'additional', 'diagnostic', 'criterion', 'association', 'presence', 'anaemia', '', 'thrombocytosis', '7', 'day', 'fever', '', 'hypoalbuminaemia', '', 'hypertransaminasaemia', '', 'leucocytosis', '', 'sterile', 'pyuria', '', 'echocardiogram', 'show', 'coronary', 'aneurysm', 'cardiac', 'dysfunction', '', 'ie', '', 'leave', 'ventricular', 'function', 'depression', '', 'mitral', 'valve', 'regurgitation', '', 'pericardial', 'effusion', '', '17mccrindle', 'bw', 'rowley', 'ah', 'newburger', 'jw', 'aldiagnosis', '', 'treatment', '', 'long-term', 'management', 'kawasaki', 'disease', '', 'scientific', 'statement', 'health', 'professional', 'american', 'heart', 'associationcirculation', '', '2017', '', '135', '', 'e927-e999google', 'patient', 'diagnose', 'manage', 'lv', '', 'charge', 'paediatric', 'rheumatology', 'paediatric', 'department', 'since', '2010', '', 'kdss', 'define', 'kawasaki', 'disease', 'accompany', 'systolic', 'arterial', 'hypotension', '', 'decrease', 'basal', 'systolic', 'blood', 'pressure', 'least', '20', '', '', 'appearance', 'sign', 'peripheral', 'hypoperfusion14kanegaye', 'jt', 'wilder', 'ms', 'molkara', 'alrecognition', 'kawasaki', 'disease', 'shock', 'syndromepediatrics', '', '2009', '', '123', '', 'e783-e789google', 'ejection', 'fraction', '', 'concentration', 'troponin', 'pro-b-type', 'natriuretic', 'peptide', '', 'probnp', '', 'measure', 'indirect', 'sign', 'myocarditis', 'heart', 'failure', '', 'mas', 'define', 'paediatric', 'rheumatology', 'international', 'trials', 'organisation', 'criteria18ravelli', 'minoia', 'f', 'dav', 'al2016', 'classification', 'criterion', 'macrophage', 'activation', 'syndrome', 'complicate', 'systemic', 'juvenile', 'idiopathic', 'arthritis', '', 'european', 'league', 'rheumatismamerican', 'college', 'rheumatologypaediatric', 'rheumatology', 'international', 'trials', 'organisation', 'collaborative', 'initiativeann', 'rheum', 'dis', '', '2016', '', '75', '', '481-489google', 'classification', 'mas', 'systemic', 'juvenile', 'idiopathic', 'arthritis', '', 'mas', 'criterion', 'validate', 'systemic', 'juvenile', 'idiopathic', 'arthritis', '', 'commonly', 'systemic', 'autoinflammatory', 'disease', 'kawasaki', 'disease', 'paediatric', 'systemic', 'lupus', 'erythematosus19garca-pavn', 'yamazaki-nakashimada', 'bez', 'borjas-aguilar', 'kl', 'murata', 'c', 'kawasaki', 'disease', 'complicate', 'macrophage', 'activation', 'syndrome', '', 'systematic', 'reviewj', 'pediatr', 'hematol', 'oncol', '', '2017', '', '39', '', '445-451google', 'divide', 'patient', 'two', 'group', 'accord', 'date', 'presentation', '', 'group', '1', '', 'present', '5', 'year', 'precede', 'local', 'sars-cov-2', 'epidemic', '', 'ie', '', 'jan', '1', '', '2015', '', 'feb', '17', '', '2020', '', '', 'group', '2', '', 'present', 'thereafter', '', 'ie', '', 'feb', '18', 'april', '20', '', '2020', '', '', 'data', 'obtain', 'hospital', 'medical', 'record', '', 'include', 'demographic', 'data', '', 'present', 'symptom', 'history', 'previous', 'treatment', '', 'contact', 'confirm', 'suspect', 'case', 'covid-19', '', 'vital', 'sign', '', 'laboratory', 'data', '', 'include', 'white', 'blood', 'cell', 'count', '', 'lymphocyte', 'count', '', 'esr', '', 'crp', '', 'procalcitonin', '', 'ferritin', '', 'fibrinogen', '', 'probnp', '', 'troponin', '', 'natural', 'killer', '', 'nk', '', 'activity', '', 'concentration', 'interleukin', '6', '', 'il-inhibitor', '', '', 'electrocardiogram', 'echocardiogram', 'child', '', 'patients', 'caregiver', 'nasopharyngeal', 'oropharyngeal', 'swab', 'sample', '', 'test', 'sars-cov-2', 'nucleic', 'acid', 'reverse-transcriptase', 'quantitative', 'pcr', 'assay', '', 'patient', 'positive', 'nasopharyngeal', 'oropharyngeal', 'swab', 'sample', 'test', 'consider', 'confirm', 'case', 'sars-cov-2', 'infection', '', 'patient', 'diagnose', 'recently', 'test', 'qualitative', 'detection', 'sars-cov-2', 'antibody', '', 'igm', 'igg', '', 'lateral', 'flow', 'chromatographic', 'immunoassay', '', 'nadal', 'covid-19', 'iggigm', 'test', '', 'nal', 'von', 'minden', '', 'moers', '', 'germany', '', '', 'positivity', 'igm', 'igg', '', '', 'consider', 'consistent', 'earlier', 'infection', 'sars-cov-2', '', 'risk', 'resistance', 'intravenous', 'immunoglobulin', 'treatment', 'ascertain', 'accord', 'kobayashi', 'score20kobayashi', 'saji', 'otani', 'alefficacy', 'immunoglobulin', 'plus', 'prednisolone', 'prevention', 'coronary', 'artery', 'abnormality', 'severe', 'kawasaki', 'disease', '', 'raise', 'study', '', '', 'randomise', '', 'open-label', '', 'blinded-endpoints', 'triallancet', '', '2012', '', '379', '', '1613-1620google', 'patient', 'administer', 'intravenous', 'immunoglobulin', '2', 'gkg', '', 'according', 'raise', 'study20kobayashi', 'saji', 'otani', 'alefficacy', 'immunoglobulin', 'plus', 'prednisolone', 'prevention', 'coronary', 'artery', 'abnormality', 'severe', 'kawasaki', 'disease', '', 'raise', 'study', '', '', 'randomise', '', 'open-label', '', 'blinded-endpoints', 'triallancet', '', '2012', '', '379', '', '1613-1620google', 'base', 'risk', 'stratification', '', 'patient', 'treat', 'aspirin', '5080', 'mgkg', 'per', 'day', '', 'kobayashi', 'score', '', '5', '', '5', 'day', 'aspirin', '30', 'mgkg', 'per', 'day', 'plus', 'methylprednisolone', '2', 'mgkg', 'per', 'day', '5', 'day', '', 'kobayashi', 'score', '5', '', '', 'follow', 'taper', 'methylprednisolone', '2', 'week', '', 'aspirin', 'maintain', '48', 'h', 'defervescence', '', 'continue', 'antiplatelet', 'dose', '35', 'mgkg', 'per', 'day', '8', 'weeks20kobayashi', 'saji', 'otani', 'alefficacy', 'immunoglobulin', 'plus', 'prednisolone', 'prevention', 'coronary', 'artery', 'abnormality', 'severe', 'kawasaki', 'disease', '', 'raise', 'study', '', '', 'randomise', '', 'open-label', '', 'blinded-endpoints', 'triallancet', '', '2012', '', '379', '', '1613-1620google', 'schedule', 'patient', 'risk', 'intravenous', 'immunglobulin', 'resistance', 'adopt', 'patient', 'kdss', 'mas', '', 'response', 'treatment', 'define', 'normalisation', 'vital', 'sign', '', 'crp', '', 'blood', 'test', '', 'resolution', 'symptom', 'sign', '', 'student', 'test', '', '2', 'method', '', 'fisher', 'exact', 'test', 'appropriate', 'statistical', 'analysis', 'compare', 'continuous', 'categorical', 'variable', '', 'p', 'value', '', '005', 'choose', 'cutoff', 'significance', '', 'data', 'analyse', 'spss', '', 'version', '200', '', 'graphpad', 'prism', '', 'version', '500', 'mac', '', '', 'study', 'approve', 'bergamo', 'ethics', 'committee', '', 'registration', 'number', '3720', '', '25032020', '', '', 'fund', 'source', 'study', '', 'correspond', 'author', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', 'feb', '18', 'april', '20', '', '2020', '', 'ten', 'patient', '', 'age', '75', 'year', '', 'sd', '35', '', '', 'seven', 'boy', '', 'three', 'girl', '', '', 'diagnose', 'kawasaki', 'disease', '', 'incidence', 'ten', 'per', 'month', '', '', 'comprise', 'group', '2', '', 'admission', 'hospital', 'occur', '', 'average', '', 'day', '6', 'fever', '', 'range', '48', '', '', 'five', '', '50', '', '', 'patient', 'present', 'classic', 'form', 'disease', '', 'five', '', '50', '', '', 'present', 'incomplete', 'form', '', 'patients', 'present', 'classic', 'form', 'non-exudative', 'conjunctivitis', '', 'hand', 'foot', 'anomaly', '', 'ie', '', 'erythema', 'firm', 'induration', '', '', '', 'polymorphic', 'rash', '', 'four', '', '80', '', '', 'five', 'patient', 'associate', 'change', 'lip', 'oral', 'cavity', '', '', 'patient', '7', 'laterocervical', 'lymphadenopathy', '', 'table', '1', '', 'table', '1clinical', 'laboratory', 'feature', 'ten', 'patient', 'kawasaki-like', 'disease', 'present', '1', 'month', 'sars-cov-2', 'epidemic', '', 'group', '2', '', 'patient', '1patient', '2patient', '3patient', '4patient', '5patient', '6patient', '7patient', '8patient', '9patient', '10date', 'onsetmarch', '17', '', '2020march', '27', '', '2020march', '28', '', '2020april', '3', '', '2020april', '3', '', '2020april', '4', '', '2020april', '6', '', '2020april', '10', '', '2020april', '11', '', '2020april', '14', '', '2020age', '', 'years827029777516050925555sexmalemalefemalefemalefemalemalemalemalemalemaletype', 'kawasaki', 'diseaseincompleteincompleteclassicincompleteincompleteclassicclassicincompleteclassicclassicother', 'symptom', '', 'diarrhoea', '', 'meningeal', 'sign', '', 'diarrhoea', '', 'meningeal', 'signsdiarrhoeadiarrhoeameningeal', 'signsdiarrhoeameningeal', 'signsdiarrhoea', '', 'drowsinessesr', '', 'mmh', '', '603910897', '', '51848154lymphocytes', '', '', '109', 'per', 'l80310609709304507901870860420460blood', 'culture', '', 'sterilesterilesterilesterilesterilesterilesterilesterilesterilechest', 'x-raypneumoniapneumoniapneumonianormalnormalnormalnormalpneumonianormalpneumoniaechocardiographyabnormalnormalnormalabnormalabnormalabnormalnormalabnormalnormalabnormalaneurism', '', '4', 'mmnononononono', '', '4', 'mmnonoejection', 'fraction48', '', '', '55', '', '', '55', '', '25', '', '30', '', '', '55', '', '', '55', '', '40', '', '', '55', '', '45', '', 'mitral', 'valve', 'regurgitationyesnonoyesyesnonoyesnonopericardial', 'effusionyesnonoyesyesyesnonononokobayashi', '5yes', '', '6', '', 'yes', '', '6', '', '', '4', '', 'yes', '', '6', '', 'yes', '', '6', '', '', '3', '', '', '2', '', 'yes', '', '6', '', 'yes', '', '6', '', 'yes', '', '6', '', '', '12', 'monthsnonononononononononokawasaki', 'disease', 'sign', 'day', '4nonononononononononocrp', '10', 'mgdlyes', '', '09', '', 'yes', '', '311', '', 'yes', '', '152', '', 'yes', '', '480', '', 'yes', '', '525', '', '', '73', '', 'yes', '', '240', '', 'yes', '', '242', '', 'yes', '', '246', '', 'yes', '', '122', '', 'neutrophils', '80', '', 'yes', '', '800', '', 'yes', '', '897', '', '', '773', '', 'yes', '', '900', '', 'yes', '', '905', '', '', '794', '', '', '779', '', 'yes', '', '919', '', 'yes', '', '855', '', 'yes', '', '830', '', 'platelets', '300', '', '109', 'per', 'lyes', '', '119', '', 'yes', '', '121', '', 'yes', '', '66', '', 'yes', '', '142', '', 'yes', '', '113', '', 'yes', '', '121', '', 'yes', '', '138', '', 'yes', '', '192', '', 'yes', '', '151', '', 'yes', '', '142', '', 'sodium', '133', 'meqlyes', '', '131', '', 'yes', '', '130', '', 'yes', '', '132', '', 'yes', '', '128', '', 'yes', '', '129', '', '', '135', '', '', '135', '', 'yes', '', '133', '', 'yes', '', '133', '', 'yes', '', '122', '', 'alt', '100', 'ulno', '', '32', '', '', '79', '', '', '46', '', '', '82', '', '', '78', '', 'yes', '', '733', '', '', '41', '', '', '63', '', '', '20', '', '', '20', '', 'mas18ravelli', 'minoia', 'f', 'dav', 'al2016', 'classification', 'criterion', 'macrophage', 'activation', 'syndrome', 'complicate', 'systemic', 'juvenile', 'idiopathic', 'arthritis', '', 'european', 'league', 'rheumatismamerican', 'college', 'rheumatologypaediatric', 'rheumatology', 'international', 'trials', 'organisation', 'collaborative', 'initiativeann', 'rheum', 'dis', '', '2016', '', '75', '', '481-489google', '', 'yesyesyesyesyesnonononoferritin', '', '684', 'ngml', '', 'yes', '', '1183', '', 'yes', '', '893', '', 'yes', '', '1972', '', 'yes', '', '3213', '', 'yes', '', '2027', '', '', '199', '', '', '449', '', '', '307', '', '', '341', '', 'platelets', '181', '', '109', 'per', 'lyes', '', '119', '', 'yes', '', '121', '', 'yes', '', '66', '', 'yes', '', '142', '', 'yes', '', '113', '', 'yes', '', '121', '', 'yes', '', '138', '', '', '192', '', 'yes', '', '151', '', 'yes', '', '142', '', 'ast', '', '48', 'iulno', '', '30', '', 'yes', '', '120', '', 'yes', '', '63', '', 'yes', '', '174', '', 'yes', '', '89', '', 'yes', '', '237', '', 'yes', '', '50', '', 'yes', '', '51', '', '', '29', '', '', '30', '', 'triglycerides', '156', 'mgdlyes', '', '434', '', 'yes', '', '367', '', 'yes', '', '263', '', 'yes', '', '198', '', '', 'yes', '', '161', '', 'yes', '', '200', '', 'yes', '', '171', '', '', '121', '', 'fibrinogen', '360', 'mgdlno', '', '465', '', '', '599', '', '', '506', '', '', '924', '', '', '759', '', 'yes', '', '313', '', '', '637', '', '', '759', '', '', '759', '', '', '489', '', 'kdss14kanegaye', 'jt', 'wilder', 'ms', 'molkara', 'alrecognition', 'kawasaki', 'disease', 'shock', 'syndromepediatrics', '', '2009', '', '123', '', 'e783-e789google', 'scholarnononoyesyesyesnoyesnoyeshypotensionnononoyesyesyesnoyesnoyessbp', '20', '', 'basalnonononononononononoperipheral', 'hypoperfusionnononoyesyesnonoyesnoyescpk', '', 'nv', '46171', 'iul1684762478911979405940troponin', '', 'nv', '53', 'ngl111188200355749061236', '', '323probnp', '', 'nv', '100', 'ngl18709521519207216651083472957139927nasal', 'swab', 'respiratory', 'pathogensnegativenegativenegativenegativenegativenegativenegativenegativenegativenegativenasal', 'swab', 'sars-cov-2negativepositivenegativenegativepositivenegativenegativenegativenegativenegativeserology', 'sars-cov-2', '', 'igg', '', 'igm', '', 'negative', '', 'negativepositive', '', 'negativepositive', '', 'negativepositive', '', 'positivepositive', '', 'positivenegative', '', 'negative', '', '', 'test', 'shortly', 'high-dose', 'ivigpositive', '', 'negativepositive', '', 'negativepositive', '', 'positivepositive', '', 'negativeserology', '', 'day', 'onset', '', '3018161111108746contact', 'suspect', 'confirm', 'casenoyesnonoyesnoyesnoyesyescaregiver', 'nasal', 'swab', 'sars-cov-2', '', 'positivenegativenegativenegativenegativepositivenegativenegativepositivetreatmentivig', 'plus', 'aspirinivig', 'plus', 'mpdnivig', 'plus', 'mpdnivig', 'plus', 'mpdnivig', 'plus', 'mpdnivig', 'plus', 'mpdnivig', 'plus', 'aspirinivig', 'plus', 'mpdnivig', 'plus', 'mpdnivig', 'plus', 'mpdninotropesnononoyesyesnononononoresponseyesyesyesyesyesyesyesyesyesyesesrerythrocyte', 'sedimentation', 'rate', '', 'crpc-reactive', 'protein', '', 'masmacrophage', 'activation', 'syndrome', '', 'altalanine', 'aminotransferase', '', 'astaspartate', 'aminotransferase', '', 'kdsskawasaki', 'disease', 'shock', 'syndrome', '', 'sbpsystolic', 'blood', 'pressure', '', 'cpkcreatine', 'phosphokinase', '', 'bnpb-type', 'natriuretic', 'peptide', '', 'nvnormal', 'value', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'ivigintravenous', 'immunoglobulin', '', 'mpdnmethylprednisolone', '', '', 'test', 'shortly', 'high-dose', 'ivig', '', 'open', 'table', 'new', 'tab', 'esrerythrocyte', 'sedimentation', 'rate', '', 'crpc-reactive', 'protein', '', 'masmacrophage', 'activation', 'syndrome', '', 'altalanine', 'aminotransferase', '', 'astaspartate', 'aminotransferase', '', 'kdsskawasaki', 'disease', 'shock', 'syndrome', '', 'sbpsystolic', 'blood', 'pressure', '', 'cpkcreatine', 'phosphokinase', '', 'bnpb-type', 'natriuretic', 'peptide', '', 'nvnormal', 'value', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'ivigintravenous', 'immunoglobulin', '', 'mpdnmethylprednisolone', '', 'group', '2', '', 'five', '', '50', '', '', 'ten', 'patient', 'diagnose', 'incomplete', 'kawasaki', 'disease', '', 'present', 'three', 'fewer', 'clinical', 'criterion', 'associate', 'additional', 'laboratory', 'criterion', '', 'n1', '', 'abnormal', 'echocardiography', '', 'n4', '', '', 'two', '', '20', '', '', 'patient', 'bulbar', 'non-exudative', 'conjunctivitis', '', 'change', 'lip', 'oral', 'cavity', '', '', 'polymorphic', 'rash', '', 'one', '', '10', '', '', 'patient', 'bulbar', 'non-exudative', 'conjunctivitis', 'polymorphic', 'rash', '', 'two', '', '20', '', '', 'patient', '', 'echocardiography', 'detect', 'leave', 'coronary', 'aneurysm', '', '', '4', 'mm', '', '', 'reduce', 'ejection', 'fraction', '', '48', '', '40', '', '', '', 'mitral', 'valve', 'regurgitation', '', 'patient', '1', 'pericardial', 'effusion', '', 'patient', '2', 'meet', 'diagnosis', 'four', 'additional', 'laboratory', 'criterion', '', 'ie', '', 'hypoalbuminaemia', '', 'hypertransaminasaemia', '', 'leucocytosis', '', 'sterile', 'pyuria', '', '', 'patients', '4', '5', 'diagnose', 'incomplete', 'kawasaki', 'disease', '', 'present', 'non-exudative', 'conjunctivitis', 'associate', 'change', 'lip', 'oral', 'cavity', '', 'patient', '4', '', '', 'polymorphic', 'rash', '', 'patient', '5', '', '', 'patient', '', 'echocardiography', 'reveal', 'leave', 'ventricular', 'function', 'depression', '', 'mitral', 'valve', 'regurgitation', '', 'pericardial', 'effusion', '', 'require', 'inotropic', 'support', '', 'patient', '4', 'underlie', 'diagnosis', 'congenital', 'adrenal', 'hyperplasia', '', 'chest', 'x-ray', '', 'patient', 'group', '2', '', 'positive', 'five', '', '50', '', '', 'patient', 'minimal', 'mono', 'bilateral', 'infiltrate', '', 'patients', '1', '10', 'chest', 'ct', 'confirm', 'bibasilar', 'pulmonary', 'thicken', '', 'patients', '2', '7', '', 'meningeal', 'sign', '', 'electroencephalogram', 'show', 'slow', 'wave', 'pattern', '', 'patient', '7', 'lumbar', 'puncture', 'reveal', 'normal', 'cerebrospinal', 'fluid', 'absence', 'sars-cov-2', 'cerebrospinal', 'fluid', '', 'five', '', '50', '', '', 'ten', 'patient', 'group', '2', 'meet', 'criterion', 'kdss', 'hypotension', 'clinical', 'sign', 'hypoperfusion', '', 'two', '', '20', '', '', 'patient', 'diarrhoea', 'meningeal', 'sign', '', 'four', '', '40', '', '', 'diarrhoea', '', 'two', '', '20', '', '', 'meningeal', 'sign', '', 'table', '1', '', '', 'mean', 'esr', '72', 'mmh', '', 'sd', '24', '', '', 'mean', 'crp', '25', 'mgdl', '', 'sd', '153', '', '', 'mean', 'ferritin', '1176', 'ngml', '', 'sd', '1032', '', '', 'full', 'blood', 'count', 'show', 'mean', 'white', 'cell', 'count', '108', '', '109', 'per', 'l', '', 'sd', '61', '', '', 'increase', 'neutrophil', 'percentage', 'eight', 'patient', '', '845', '', '', 'sd', '57', '', '', '', 'lymphopenia', 'eight', 'patient', '', '086', '', '109', 'per', 'l', '', 'sd', '040', '', '', '', 'thrombocytopenia', 'eight', 'patient', '', '130', '', '109', 'per', 'l', '', '32', '', '', '', 'hyponatraemia', '', '133', 'meql', '', 'observe', 'eight', 'patient', '', '131', 'meql', '', 'sd', '4', '', '', 'slight', 'increase', 'transaminase', 'record', 'seven', 'patient', '', 'aspartate', 'aminotransferase', '87', 'ul', '', 'sd', '70', '', '', 'alanine', 'aminotransferase', '119', 'ul', '', '217', '', '', '', 'hypertriglyceridaemia', 'show', 'seven', '', '87', '', '', 'eight', 'test', 'patient', 'group', '2', '', '239', 'mgdl', '', 'sd', '108', '', '', '', 'fibrinogen', 'high', 'nine', '', '90', '', '', 'ten', 'patient', '', '621', 'mgdl', '', '182', '', '', '', 'd-dimer', 'eight', '', '80', '', '', 'ten', 'patient', '', '3798', 'ngml', '', 'sd', '1318', '', '', '', 'laboratory', 'criterion', 'predict', 'intravenous', 'immunoglobulin-resistance', 'seven', '', '70', '', '', 'ten', 'patient', '', 'mas', 'diagnose', 'five', '', '50', '', '', 'ten', 'patient', '', 'troponin', 'elevate', 'five', '', '55', '', '', 'nine', 'test', 'patient', '', '1004', 'ngl', '', 'sd', '1862', '', '', '', 'creatine', 'phosphokinase', 'one', '', '10', '', '', 'ten', 'patient', '', '85', 'iul', '', '64', '', '', '', 'probnp', 'ten', 'patient', '', '1255', 'ngl', '', '929', '', '', 'table', '1', '', 'table', '2', '', 'table', '2comparison', 'patient', 'kawasaki-like', 'disease', 'present', 'sars-cov-2', 'epidemicgroup', '1group', '2p', 'valuetime', 'presentationuntil', 'february', '', '2020marchapril', '', '2020nanumber', 'patients1910naage', 'onset', '', 'years30', '', '25', '', '75', '', '35', '', '000035incidence03', 'per', 'month10', 'per', 'month', '', '000001sexnana013female123namale77naincomplete', 'kawasaki', 'disease619', '', '31', '', '', '510', '', '50', '', '', '043crp', '', 'mgdl163', '', '80', '', '25', '', '153', '', '005esr', '', 'mmh82', '', '29', '', '72', '', '24', '', '038white', 'cell', 'count', '', '', '109', 'per', 'l194', '', '64', '', '108', '', '61', '', '00017neutrophils719', '', '', '172', '', '845', '', '', '57', '', '0034lymphocytes', '', '', '109', 'per', 'l30', '', '18', '', '086', '', '04', '', '00012haemoglobin', '', 'gdl108', '', '20', '', '11', '', '12', '', '079platelets', '', '', '109', 'per', 'l457', '', '96', '', '130', '', '32', '', '', '000001albumin', '', 'gdll33', '', '05', '', '32', '', '03', '', '055sodium', '', 'meql1347', '', '16', '', '1308', '', '39', '', '00011ast', '', 'ul120', '', '218', '', '87', '', '70', '', '064alt', '', 'ul92', '', '122', '', '119', '', '217', '', '067ferritin', '', 'ngml187', '', '89', '', '1176', '', '1032', '', '0011triglycerides', '', 'mgdl', '', '239', '', '108', '', '', 'fibrinogen', '', 'mgdl543', '', '300', '', '621', '', '182', '', '051d-dimer', '', 'ngml3244', '', '943', '', '3798', '', '1318', '', '052cpk', '', 'iul61', '', '28', '', '85', '', '64', '', '019troponin', '', 'ngl', '', '1004', '', '1862', '', '', 'probnp', '', 'ngl', '', '1255', '', '929', '', '', 'kobayashi', 'score', '5219', '', '10', '', '', '710', '', '70', '', '', '00021mas18ravelli', 'minoia', 'f', 'dav', 'al2016', 'classification', 'criterion', 'macrophage', 'activation', 'syndrome', 'complicate', 'systemic', 'juvenile', 'idiopathic', 'arthritis', '', 'european', 'league', 'rheumatismamerican', 'college', 'rheumatologypaediatric', 'rheumatology', 'international', 'trials', 'organisation', 'collaborative', 'initiativeann', 'rheum', 'dis', '', '2016', '', '75', '', '481-489google', 'scholar010', '', '0', '', '', '510', '', '50', '', '', '0021kdss14kanegaye', 'jt', 'wilder', 'ms', 'molkara', 'alrecognition', 'kawasaki', 'disease', 'shock', 'syndromepediatrics', '', '2009', '', '123', '', 'e783-e789google', 'scholar010', '', '0', '', '', '510', '', '50', '', '', '0021abnormal', 'echocardiography219', '', '10', '', '', '610', '', '60', '', '', '00089adjunctive', 'steroid', 'treatment419', '', '16', '', '', '810', '', '80', '', '', '00045inotropes', 'treatment019', '', '0', '', '', '210', '', '20', '', '', '011response', 'treatment1919', '', '100', '', '', '1010', '', '100', '', '', '1data', 'mean', '', 'sd', '', 'nn', '', '', '', '', 'unless', 'otherwise', 'state', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'nanot', 'applicable', '', 'crpc-reactive', 'protein', '', 'esrerythrocyte', 'sedimentation', 'rate', '', 'astaspartate', 'aminotransferase', '', 'altalanine', 'aminotransferase', '', 'cpkcreatine', 'phosphokinase', '', 'bnpb-type', 'natriuretic', 'peptide', '', 'masmacrophage', 'activation', 'syndrome', '', 'kdsskawasaki', 'disease', 'shock', 'syndrome', '', 'open', 'table', 'new', 'tab', 'data', 'mean', '', 'sd', '', 'nn', '', '', '', '', 'unless', 'otherwise', 'state', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'nanot', 'applicable', '', 'crpc-reactive', 'protein', '', 'esrerythrocyte', 'sedimentation', 'rate', '', 'astaspartate', 'aminotransferase', '', 'altalanine', 'aminotransferase', '', 'cpkcreatine', 'phosphokinase', '', 'bnpb-type', 'natriuretic', 'peptide', '', 'masmacrophage', 'activation', 'syndrome', '', 'kdsskawasaki', 'disease', 'shock', 'syndrome', '', 'four', '', '40', '', '', 'ten', 'patient', 'group', '2', '', 'il-inhibitor', 'increase', '', '1771', 'pgml', '', 'sd', '1374', '', '', 'normal', 'value', '', 'nv', '', '', '34', '', '', 'nk', 'count', 'measure', 'four', '', '40', '', '', 'patient', '', 'reduce', '', '62', '', 'sd', '35', '', '', 'nv', '200600', '', '109', 'per', 'l', '', '', 'blood', 'culture', 'sterile', 'patient', '', 'nasopharyngeal', 'oropharyngeal', 'swab', 'sample', 'sars-cov-2', '', 'available', 'feb', '24', '', '2020', '', 'positive', 'two', '', '20', '', '', 'ten', 'patient', 'group', '2', '', 'table', '1', '', '', 'patient', 'test', 'least', 'twice', '', 'serology', 'sars-cov-2', 'antibody', '', 'available', 'april', '13', '', '2020', '', 'investigate', 'patient', 'group', '2', '', 'eight', '', '80', '', '', 'ten', 'patient', 'igg', 'positive', '', 'three', 'igm', 'positive', '', 'patient', '6', '', 'negative', 'serology', '', 'test', 'shortly', 'infusion', 'high-dose', 'intravenous', 'immunoglobulin', '', 'table', '1', '', '', 'april', '14', '', '2020', '', '31', 'health-care', 'personnel', 'paediatric', 'department', '', 'hospital', 'papa', 'giovanni', 'xxiii', '', 'bergamo', '', 'italy', '', 'serology', 'test', '', 'nine', '', '29', '', '', '31', 'igg', 'positive', '', 'three', '', '10', '', '', 'igm', 'positive', '', 'correspond', 'expect', 'rate', 'exposure', 'local', 'heath-care', 'personnel', 'sars-cov-2', 'infection', '', 'addition', '', 'two', 'patient', 'group', '1', 'diagnose', 'start', 'epidemic', 'contact', 'test', 'sars-cov-2', 'antibody', '', 'negative', '', 'date', '', 'patient', 'group', '2', 'discharge', '', 'treatment', 'aspirin', 'antiplatelet', 'dose', 'ongoing', '', 'follow-up', 'echocardiogram', 'schedule', '8', 'week', '', 'jan', '1', '', '2015', '', 'start', 'epidemic', 'feb', '17', '', '2020', '', '19', 'child', 'diagnose', 'kawasaki', 'disease', '', 'incidence', '03', 'per', 'month', '', 'mean', 'age', '3', 'year', '', 'sd', '25', '', '', 'seven', 'boy', '', '12', 'girl', '', '', 'patient', 'comprise', 'group', '1', '', 'admission', 'hospital', 'occur', '', 'average', '', 'day', '6', 'fever', '', 'range', '411', 'day', '', '', '13', '', '68', '', '', '19', 'patient', 'present', 'classic', 'form', 'disease', '', 'six', '', '31', '', '', '19', 'incomplete', 'form', '', 'none', 'patient', 'hypotension', '', 'clinical', 'sign', 'hypoperfusion', '', 'atypical', 'symptom', '', 'laboratory', 'criterion', 'predict', 'intravenous', 'immunoglobulin', 'resistance', 'two', '', '10', '', '', '19', 'patient', '', 'mas', 'diagnose', 'patient', '', 'full', 'comparison', 'clinical', 'biochemical', 'characteristic', 'two', 'group', 'provide', 'table', '2', '', 'patient', 'include', 'favourable', 'outcome', '', 'patients', 'group', '1', 'conclude', 'treatment', 'follow-up', 'period', '', 'recover', 'completely', 'residual', 'coronary', 'artery', 'aneurism', '', 'group', '1', 'comprise', '19', 'patient', 'diagnose', '5', 'year', '', 'whereas', 'group', '2', 'include', 'ten', 'patient', 'diagnose', '1', 'month', '', 'incidence', '03', 'per', 'month', 'v', 'ten', 'per', 'month', '', 'p', '', '00001', '', 'table', '2', '', 'figure', '', '', 'rule', 'possible', 'effect', 'number', 'referral', 'emergency', 'department', 'different', 'period', '', 'calculate', 'incidence', 'correct', 'number', 'patient', 'emergency', 'department', '', 'find', 'past', '5', 'year', '', 'january', '', '2015', '', 'december', '', '2019', '', '98', '572', 'patient', 'evaluate', '', 'mean', '1642', '', 'sd', '280', '', 'per', 'month', '', 'compare', '283', 'patient', 'per', 'month', 'study', 'periodapproximately', 'six-fold', 'lower', '', 'figure', '', 'incidence', 'kawasaki', 'disease', 'group', '1', '0019', '', '', '95', '', 'ci', '0002', '00019', '', '', 'compare', '35', '', '', '35', '36', '', 'group', '2', '', 'odds', 'ratio', '184', '', 'p', '', '00001', '', 'figure', '', '', 'rule', 'possible', 'effect', 'change', 'geographical', 'catchment', 'area', 'prepandemic', '', 'group', '1', '', 'versus', 'pandemic', '', 'group', '2', '', 'period', '', 'review', 'place', 'residence', 'patient', 'kawasaki', 'disease', 'draw', 'referral', 'map', '', 'show', 'one', 'bergamo', 'province', '', 'appendix', 'p', '1', '', 'figureincidence', 'kawasaki', 'disease', 'study', 'period', 'past', '5', 'yearsshow', 'full', 'caption', '', '', 'frequency', 'kawasaki', 'disease', 'paediatric', 'emergency', 'department', 'hospital', 'papa', 'giovanni', 'xxiii', 'bergamo', '', 'italy', '', 'past', '5', 'year', '', 'case', 'severity', '', '', 'b', '', 'number', 'patient', 'present', 'paediatric', 'emergency', 'department', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'epidemic', '', 'date', 'presentation', 'ten', 'patient', 'kawasaki-like', 'disease', '', 'indicate', 'asterisk', '', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'frequency', 'kawasaki', 'disease', 'paediatric', 'emergency', 'department', 'hospital', 'papa', 'giovanni', 'xxiii', 'bergamo', '', 'italy', '', 'past', '5', 'year', '', 'case', 'severity', '', '', 'b', '', 'number', 'patient', 'present', 'paediatric', 'emergency', 'department', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'epidemic', '', 'date', 'presentation', 'ten', 'patient', 'kawasaki-like', 'disease', '', 'indicate', 'asterisk', '', '', 'average', 'age', 'onset', '30', 'year', '', 'sd', '25', '', 'group', '1', 'versus', '75', 'year', '', '35', '', 'group', '2', '', 'p00003', '', '', 'group', '1', '', '14', '19', 'patient', 'white', '', 'versus', 'eight', 'ten', 'patient', 'group', '2', '', 'mean', 'body-mass', 'index', 'patient', 'group', '1', '1593', 'kgm2', '', 'sd', '172', '', 'versus', '1911', 'kgm2', '', 'sd', '321', '', 'group', '2', '', 'p00016', '', '', 'two', 'patient', 'test', 'group', '1', 'negative', 'serology', 'sars-cov-2', 'versus', 'eight', 'ten', 'positive', 'patient', 'group', '2', '', 'one', 'two', 'negative', 'patient', 'test', 'high-dose', 'intravenous', 'immunoglobulin', '', '', 'five', '', '50', '', '', 'ten', 'patient', 'contact', 'confirm', 'covid-19', 'case', '', 'group', '2', 'significantly', 'lower', 'white', 'cell', 'count', '', 'lymphocyte', 'count', '', 'platelet', 'count', 'compare', 'group', '1', '', 'table', '2', '', '', 'group', '2', 'differ', 'significantly', 'group', '1', 'increase', 'rate', 'marker', 'severity', '', 'abnormal', 'echocardiogram', 'record', 'six', '', '60', '', '', 'ten', 'patient', 'group', '2', 'versus', 'two', '', '10', '', '', '19', 'patient', 'group', '1', '', 'p00089', '', '', 'fulfilment', 'criterion', 'kdss', 'mas', 'find', 'five', '', '50', '', '', 'ten', 'patient', 'group', '2', '', 'none', 'patient', 'group', '1', '', 'p0021', '', '', 'seven', '', '70', '', '', 'patient', 'group', '2', 'meet', 'criterion', 'kobayashi', 'score', '5', '', 'compare', 'two', '', '10', '', '', '19', 'patient', 'group', '1', '', 'p00021', '', '', 'adjunctive', 'steroid', 'treatment', 'require', 'four', '', '16', '', '', '19', 'patient', 'group', '1', 'versus', 'eight', '', '80', '', '', 'ten', 'patient', 'group', '2', '', 'p00045', '', 'table', '2', '', '', 'despite', 'half', 'century', 'pass', 'since', 'tomisaku', 'kawasaki', 'first', 'report', '50', 'case', 'japan12kawasaki', 'kosaki', 'f', 'okawa', 'shigematsu', 'yanagawa', 'h', 'new', 'infantile', 'acute', 'febrile', 'mucocutaneous', 'lymph', 'node', 'syndrome', '', 'mlns', '', 'prevail', 'japanpediatrics', '', '1974', '', '54', '', '271-276google', 'cause', 'kawasaki', 'disease', 'remain', 'unknown', '', 'accept', 'hypothesis', 'support', 'aberrant', 'response', 'immune', 'system', 'one', 'unidentified', 'pathogen', 'genetically', 'predispose', 'patient', '', '21shulman', 'st', 'rowley', 'ah', 'kawasaki', 'disease', '', 'insight', 'pathogenesis', 'approach', 'treatmentnat', 'rev', 'rheumatol', '', '2015', '', '11', '', '475-482google', '', '22nakamura', 'kawasaki', 'disease', '', 'epidemiology', 'lesson', 'itint', 'j', 'rheum', 'dis', '', '2018', '', '21', '', '16-19google', '', '23nakamura', 'yashiro', 'uehara', 'r', 'alepidemiologic', 'feature', 'kawasaki', 'disease', 'japan', '', 'result', '2009-2010', 'nationwide', 'surveyj', 'epidemiol', '', '2012', '', '22', '', '216-221google', 'however', '', 'search', 'infectious', 'trigger', 'disappointing24yim', 'curtis', 'n', 'cheung', 'burgner', 'update', 'kawasaki', 'disease', '', 'epidemiology', '', 'aetiology', 'pathogenesisj', 'paediatr', 'child', 'health', '', '2013', '', '49', '', '704-708google', 'japan', '', 'three', 'epidemic', 'record', '1979', '', '1982', '', '1986', '', 'highest', 'kawasaki', 'disease', 'incidence', 'january', '', 'potentially', 'suggest', 'factor', 'winter', 'month', 'trigger', 'kawasaki', 'disease25makino', 'n', 'nakamura', 'yashiro', 'aldescriptive', 'epidemiology', 'kawasaki', 'disease', 'japan', '', '20112012', '', 'result', '22nd', 'nationwide', 'surveyj', 'epidemiol', '', '2015', '', '25', '', '239-245google', '', '26onouchi', 'genetics', 'kawasaki', 'diseaseint', 'j', 'rheum', 'dis', '', '2018', '', '21', '', '26-30google', '2010', '', 'incidence', 'kawasaki', 'disease', 'japan', '2396', 'per', '100', '000', 'child', 'younger', '5', 'year', '', 'compare', '208', 'per', '100', '000', 'usa27holman', 'rc', 'belay', 'ed', 'christensen', 'ky', 'folkema', 'steiner', 'ca', 'schonberger', 'lb', 'hospitalizations', 'kawasaki', 'syndrome', 'among', 'child', 'united', 'states', '', '19972007pediatr', 'infect', 'dis', 'j', '', '2010', '', '29', '', '483-488google', '2-year', 'retrospective', 'survey', 'northeastern', 'italy', 'calculate', 'incidence', '147', 'case', 'per', '100', '000', 'child', 'younger', '5', 'years28marchesi', 'tarissi', 'de', 'jacobis', 'rigante', 'alkawasaki', 'disease', '', 'guideline', 'italian', 'society', 'pediatrics', '', 'part', '-', 'definition', '', 'epidemiology', '', 'etiopathogenesis', '', 'clinical', 'expression', 'management', 'acute', 'phaseital', 'j', 'pediatr', '', '2018', '', '44', '', '102google', 'report', 'high', 'number', 'kawasaki-like', 'disease', 'case', 'bergamo', 'province', 'follow', 'sars-cov-2', 'epidemic', '', 'monthly', 'incidence', 'least', '30', 'time', 'greater', 'monthly', 'incidence', 'previous', '5', 'year', '', 'clear', 'start', 'point', 'first', 'case', 'covid-19', 'diagnose', 'area', '', 'group', '2', '', 'diagnose', 'sars-cov-2', 'appear', '', 'show', 'evidence', 'seroconversion', 'virus', 'majority', 'patient', '', 'past', '20', 'year', '', 'virus', 'coronavirus', 'family', 'propose', 'possibly', 'implicate', 'pathogenesis', 'kawasaki', 'disease', '', '2005', '', 'group', 'new', '', 'ct', '', 'usa', '', '29esper', 'f', 'shapiro', 'ed', 'weibel', 'c', 'ferguson', 'landry', 'ml', 'kahn', 'js', 'association', 'novel', 'human', 'coronavirus', 'kawasaki', 'diseasej', 'infect', 'dis', '', '2005', '', '191', '', '499-502google', 'identify', 'novel', 'human', 'coronavirus', '', 'designate', 'new', 'coronavirus', '', 'hcov-nh', '', '', 'respiratory', 'secretion', 'eight', '11', 'child', 'kawasaki', 'disease', 'versus', 'one', '22', 'control', 'test', 'rt-pcr', '', 'serological', 'test', '', 'report', 'follow', 'commentary', 'express', 'mix', 'sense', 'interest', 'scepticism30mcintosh', 'k', 'coronaviruses', 'limelightj', 'infect', 'dis', '', '2005', '', '191', '', '489-491google', 'argument', 'association', 'express', 'group', 'japan', '', 'retrospective', 'study31ebihara', 'endo', 'r', 'x', 'ishiguro', 'n', 'kikuta', 'h', 'association', 'new', 'coronavirus', 'kawasaki', 'diseasej', 'infect', 'dis', '', '2005', '', '192', '', '351-352google', '', '32esper', 'f', 'shapiro', 'ed', 'landry', 'ml', 'kahn', 'js', 'reply', 'van', 'der', 'hoek', 'berkhout', '', 'ebihara', 'al', '', 'belay', 'alj', 'infect', 'dis', '', '2005', '', '192', '', '353google', '', '33turnier', 'jl', 'anderson', 'ms', 'heizer', 'hr', 'jone', 'pn', 'glod', 'mp', 'dominguez', 'sr', 'concurrent', 'respiratory', 'virus', 'kawasaki', 'diseasepediatrics', '', '2015', '', '136', '', 'e609-e614google', 'nasopharyngeal', 'swab', 'sample', '19', 'child', 'kawasaki', 'disease', '208', 'control', 'respiratory', 'tract', 'infection', '', 'find', 'rna', 'sequence', 'hcov-nh', 'five', '', '2', '', '', '208', 'control', 'versus', 'zero', '19', 'child', 'kawasaki', 'disease', '', 'another', 'group', 'japan', 'explore', 'association', 'two', 'different', 'coronaviruses', '', 'hcov-nl63', 'hcov-229e', '', 'kawasaki', 'disease', 'serological', 'test', '', 'immunofluorescence', 'assay', 'detect', 'difference', 'hcov-nl63', 'antibody', 'positivity', 'patient', 'control', '', 'whereas', 'hcov-229e', 'antibody', 'positivity', 'higher', 'patient', 'kawasaki', 'disease34shirato', 'k', 'imada', 'kawase', 'nakagaki', 'k', 'matsuyama', 'taguchi', 'f', 'possible', 'involvement', 'infection', 'human', 'coronavirus', '229e', '', 'nl63', '', 'kawasaki', 'diseasej', 'med', 'virol', '', '2014', '', '86', '', '2146-2153google', 'given', 'pathogenesis', 'disease', '', 'serology', 'test', 'reliable', 'tool', 'rt-pcr', 'detect', 'cause', 'infection', '', 'suggest', 'coronavirus', 'family', 'represent', 'one', 'trigger', 'kawasaki', 'disease', '', 'sars-cov-2', 'particularly', 'virulent', 'strain', 'able', 'elicit', 'powerful', 'immune', 'response', 'host', '', 'study', '', 'clinical', 'biochemical', 'feature', 'patient', 'kawasaki', 'disease', 'diagnose', 'covid-19', 'pandemic', 'appear', 'differ', 'historical', 'cohort', 'patient', '', 'therefore', '', 'classify', 'patient', 'kawasaki-like', 'disease', '', 'clinical', 'perspective', '', 'older', '', 'respiratory', 'gastrointestinal', 'involvement', '', 'meningeal', 'sign', '', 'sign', 'cardiovascular', 'involvement', '', 'biochemical', 'perspective', '', 'leucopenia', 'mark', 'lymphopenia', '', 'thrombocytopenia', '', 'increase', 'ferritin', '', 'well', 'marker', 'myocarditis', '', 'similar', 'clinical', 'feature', 'share', 'patient', 'covid-194huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'additionally', '', 'patient', 'severe', 'disease', 'course', '', 'resistance', 'intravenous', 'immunoglobulin', 'adjunctive', 'steroid', '', 'biochemical', 'evidence', 'mas', '', 'clinical', 'sign', 'keep', 'kdss', '', 'proinflammatory', 'effect', 'sars-cov-2', 'report', 'adult', 'severe', 'respiratory', 'complication', 'covid-1935mcgonagle', 'sharif', 'k', 'oregan', 'bridgewood', 'c', 'role', 'cytokine', 'include', 'interleukin-6', 'covid-19', 'induce', 'pneumonia', 'macrophage', 'activation', 'syndrome-like', 'diseaseautoimmun', 'rev', '', '2020', '', '', 'publish', 'online', 'april', '3', '', '', 'doi101016jautrev2020102537google', '', '36molloy', 'ej', 'bearer', 'cf', 'covid-19', 'child', 'alter', 'inflammatory', 'responsespediatr', 'res', '', '2020', '', '', 'publish', 'online', 'april', '3', '', '', 'doi101038s41390-020-0881-ygoogle', 'patient', 'constellation', 'feature', 'classify', 'term', 'cytokine', 'storm', '', 'fever', '', 'lymphopenia', '', 'elevate', 'transaminase', '', 'lactate', 'dehydrogenase', '', 'd-dimer', '', 'ferritin', '', 'keep', 'mas11mehta', 'p', 'mcauley', 'df', 'brown', 'sanchez', 'e', 'tattersall', 'rs', 'manson', 'jj', 'covid-19', '', 'consider', 'cytokine', 'storm', 'syndrome', 'immunosuppressionlancet', '', '2020', '', '395', '', '1033-1034google', '', '35mcgonagle', 'sharif', 'k', 'oregan', 'bridgewood', 'c', 'role', 'cytokine', 'include', 'interleukin-6', 'covid-19', 'induce', 'pneumonia', 'macrophage', 'activation', 'syndrome-like', 'diseaseautoimmun', 'rev', '', '2020', '', '', 'publish', 'online', 'april', '3', '', '', 'doi101016jautrev2020102537google', '', '37zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '395', '', '1054-1062google', 'likewise', '', 'mas', 'form', 'cytokine', 'storm', '', 'affect', 'patient', 'kawasaki', 'disease9henderson', 'la', 'canna', 'sw', 'schulert', 'gs', 'alon', 'alert', 'cytokine', 'storm', '', 'immunopathology', 'covid-19arthritis', 'rheumatol', '', '2020', '', '', 'publish', 'online', 'april', '15', '', '', 'doi101002art41285google', '', '15wang', 'w', 'gong', 'f', 'zhu', 'w', 'fu', 'zhang', 'q', 'macrophage', 'activation', 'syndrome', 'kawasaki', 'disease', '', 'common', '', 'semin', 'arthritis', 'rheum', '', '2015', '', '44', '', '405-410google', 'element', 'support', 'start', 'adjunctive', 'steroid', '', 'experience', '', 'treatment', 'effective', 'safe', '', 'consider', 'physician', 'treat', 'patient', 'kawasaki-like', 'presentation', 'context', 'covid-19', 'pandemic', '', 'evidence', 'contact', 'virus', 'confirm', 'presence', 'antibody', 'sars-cov-2', 'eight', 'ten', 'patient', 'group', '2', '', 'possible', 'remain', 'two', 'patient', '', 'negative', 'serology', '', 'confound', 'factor', 'play', 'role', '', 'one', 'patient', 'test', 'infusion', 'high-dose', 'immunoglobulin', '', 'additionally', '', 'qualitative', 'antibody', 'test', 'report', 'sensitivity', '95', '', 'specificity', '8590', '', 'compare', 'pcr', 'test', 'nasal', 'swab', '', 'possible', 'patient', 'represent', 'usual', 'presentation', 'kawasaki', 'disease', 'outside', 'sars-cov-2', 'epidemic', '', 'previous', 'year', '', 'two', 'patient', 'group', '2', 'present', 'positive', 'nasopharyngeal', 'oropharyngeal', 'swab', 'sample', 'sars-cov-2', '', 'find', 'positivity', 'igg', 'antibody', 'suggest', 'late', 'onset', 'disease', 'compare', 'primary', 'infection', '', 'due', 'host', 'immune', 'response', '', 'reason', '', 'past', '', 'active', 'viral', 'infection', 'show', 'disease', '', 'result', 'consideration', 'support', 'hypothesis', 'immune', 'response', 'sars-cov-2', 'responsible', 'kawasaki-like', 'disease', 'susceptible', 'patient', '', 'believe', 'find', 'important', 'implication', 'public', 'health', '', 'association', 'sars-cov-2', 'kawasaki-like', 'disease', 'account', 'consider', 'social', 'reintegration', 'policy', 'paediatric', 'population', '', 'however', '', 'kawasaki-like', 'disease', 'describe', 'remain', 'rare', 'condition', '', 'probably', 'affect', 'one', '1000', 'child', 'expose', 'sars-cov-2', '', 'estimate', 'base', 'limit', 'data', 'case', 'series', 'region', '', 'study', 'limitation', 'relatively', 'small', 'case', 'series', '', 'require', 'confirmation', 'larger', 'group', '', 'genetic', 'study', 'investigate', 'susceptibility', 'patient', 'develop', 'disease', 'trigger', 'effect', 'sars-cov-2', '', 'nonetheless', '', 'report', 'strong', 'association', 'outbreak', 'kawasaki-like', 'disease', 'sars-cov-2', 'epidemic', 'bergamo', 'province', 'italy', '', 'patients', 'diagnose', 'kawasaki-like', 'disease', 'viral', 'spread', 'reveal', 'severe', 'course', '', 'include', 'kdss', 'mas', '', 'require', 'adjunctive', 'steroid', 'treatment', '', 'similar', 'outbreak', 'kawasaki-like', 'disease', 'expect', 'country', 'affect', 'sars-cov-2', 'pandemic', '', 'contributors', 'lv', 'ld', '', 'substantial', 'contribution', 'conception', 'design', 'work', '', 'lv', 'draft', 'work', '', 'lv', '', '', 'ag', '', 'lm', '', 'mr', '', 'mc', '', 'eb', '', 'ld', '', 'give', 'final', 'approval', 'article', 'publish', '', 'lv', '', '', 'ag', '', 'lm', '', 'mr', '', 'mc', '', 'eb', '', 'ld', '', 'agree', 'accountable', 'aspect', 'work', 'ensure', 'question', 'relate', 'accuracy', 'integrity', 'part', 'work', 'appropriately', 'investigate', 'resolve', '', '', 'ag', '', 'lm', '', 'mr', '', 'mc', '', 'eb', 'acquire', '', 'analyse', '', 'interpret', 'data', 'article', '', 'ag', '', 'lm', '', 'mr', '', 'mc', '', 'eb', 'revise', 'article', 'critically', 'important', 'intellectual', 'content', '', 'ld', '', 'prepare', 'final', 'draft', 'critically', 'revise', 'article', 'important', 'intellectual', 'content', '', 'declaration', 'interest', 'declare', 'compete', 'interest', 'financial', 'support', 'study', '', 'acknowledgments', 'giulia', 'quattrocchi', 'angela', 'amoroso', 'help', 'retrieve', 'patient', '', 'data', 'file', 'note', '', 'download', 'pdf', '', '22', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'kawasaki-like', 'disease', '', 'emerge', 'complication', 'covid-19', 'pandemicfull-textpdf']",6628,"{'': 1759, 'patient': 119, 'disease': 111, 'kawasaki': 79, 'yes': 65, 'group': 63, '2': 57, 'sars-cov-2': 56, 'syndrome': 42, '1': 40, 'ten': 39, '2020': 29, 'kawasaki-like': 28, 'diagnose': 28, 'per': 28, 'test': 26, 'sd': 25, 'epidemic': 24, 'coronavirus': 22, 'year': 22}","{'infection': 14, 'sars-cov-2': 56, 'arthritis': 7, 'il-inhibitor': 2}",79,0.34
DOI:10.1016/S0140-6736(20)30937-5,10.1016/S0140-6736(20)30937-5,Correspondence,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['endothelial', 'cell', 'infection', 'endotheliitis', 'covid-19']","['Cardiovascular complication rapidly emerge key threat coronavirus disease 2019 ( COVID-19 ) addition respiratory disease .', 'The mechanism underlie disproportionate effect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection patient cardiovascular comorbidities , however , remain incompletely understood.1Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; 395 : 1054-1062Google Scholar , 2Horton R Offline : COVID-19—bewilderment candour.Lancet .', '2020 ; 3951178Google Scholar SARS-CoV-2 infect host use angiotensin convert enzyme 2 ( ACE2 ) receptor , express several organ , include lung , heart , kidney , intestine .', 'ACE2 receptor also express endothelial cells.3Ferrario CM Jessup J Chappell MC et al.Effect angiotensin-converting enzyme inhibition angiotensin II receptor blocker cardiac angiotensin-converting enzyme 2.Circulation .', '2005 ; 111 : 2605-2610Google Scholar Whether vascular derangement COVID-19 due endothelial cell involvement virus currently unknown .', 'Intriguingly , SARS-CoV-2 directly infect engineer human blood vessel organoids vitro.4Monteil V KH Prado P Hagelkrüys A et al.Inhibition SARS-CoV-2 infection engineer human tissue use clinical-grade soluble human ACE2.Cell .', '2020 ; ( publish online press . )', 'urlplaceholder access : April 17 , 2020Google Scholar Here demonstrate endothelial cell involvement across vascular bed different organ series patient COVID-19 ( case detail provide appendix ) .', 'Patient 1 male renal transplant recipient , age 71 year , coronary artery disease arterial hypertension .', ""The patient 's condition deteriorate follow COVID-19 diagnosis , require mechanical ventilation ."", 'Multisystem organ failure occur , patient die day 8 .', 'Post-mortem analysis transplant kidney electron microscopy reveal viral inclusion structure endothelial cell ( figure A , B ) .', 'In histological analysis , find accumulation inflammatory cell associate endothelium , well apoptotic body , heart , small bowel ( figure C ) lung ( figure D ) .', 'An accumulation mononuclear cell find lung , small lung vessel appear congested.FigurePathology endothelial cell dysfunction COVID-19Show full caption ( A , B ) Electron microscopy kidney tissue show viral inclusion body peritubular space viral particle endothelial cell glomerular capillary loop .', 'Aggregates viral particle ( arrow ) appear dense circular surface lucid centre .', 'The asterisk panel B mark peritubular space consistent capillary contain viral particle .', 'The inset panel B show glomerular basement membrane endothelial cell viral particle ( arrow ; 150 nm diameter ) .', '( C ) Small bowel resection specimen patient 3 , stain haematoxylin eosin .', 'Arrows point dominant mononuclear cell infiltrate within intima along lumen many vessel .', 'The inset panel C show immunohistochemical stain caspase 3 small bowel specimen serial section tissue describe panel D. Staining pattern consistent apoptosis endothelial cell mononuclear cell observe haematoxylin-eosin-stained section , indicate apoptosis induce substantial proportion cell .', '( D ) Post-mortem lung specimen stain haematoxylin eosin show thicken lung septum , include large arterial vessel mononuclear neutrophilic infiltration ( arrow upper inset ) .', 'The lower inset show immunohistochemical stain caspase 3 lung specimen ; stain pattern consistent apoptosis endothelial cell mononuclear cell observe haematoxylin-eosin-stained section .', 'COVID-19=coronavirus disease 2019.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A , B ) Electron microscopy kidney tissue show viral inclusion body peritubular space viral particle endothelial cell glomerular capillary loop .', 'Aggregates viral particle ( arrow ) appear dense circular surface lucid centre .', 'The asterisk panel B mark peritubular space consistent capillary contain viral particle .', 'The inset panel B show glomerular basement membrane endothelial cell viral particle ( arrow ; 150 nm diameter ) .', '( C ) Small bowel resection specimen patient 3 , stain haematoxylin eosin .', 'Arrows point dominant mononuclear cell infiltrate within intima along lumen many vessel .', 'The inset panel C show immunohistochemical stain caspase 3 small bowel specimen serial section tissue describe panel D. Staining pattern consistent apoptosis endothelial cell mononuclear cell observe haematoxylin-eosin-stained section , indicate apoptosis induce substantial proportion cell .', '( D ) Post-mortem lung specimen stain haematoxylin eosin show thicken lung septum , include large arterial vessel mononuclear neutrophilic infiltration ( arrow upper inset ) .', 'The lower inset show immunohistochemical stain caspase 3 lung specimen ; stain pattern consistent apoptosis endothelial cell mononuclear cell observe haematoxylin-eosin-stained section .', 'COVID-19=coronavirus disease 2019 .', 'Patient 2 woman , age 58 year , diabetes , arterial hypertension , obesity .', 'She develop progressive respiratory failure due COVID-19 subsequently develop multi-organ failure need renal replacement therapy .', 'On day 16 , mesenteric ischaemia prompt removal necrotic small intestine .', 'Circulatory failure occur set right heart failure consequent ST-segment elevation myocardial infarction , cardiac arrest result death .', 'Post-mortem histology reveal lymphocytic endotheliitis lung , heart , kidney , liver well liver cell necrosis .', 'We find histological evidence myocardial infarction sign lymphocytic myocarditis .', 'Histology small intestine show endotheliitis ( endothelialitis ) submucosal vessel .', 'Patient 3 man , age 69 year , hypertension develop respiratory failure result COVID-19 require mechanical ventilation .', 'Echocardiography show reduce leave ventricular ejection fraction .', 'Circulatory collapse ensue mesenteric ischaemia , small intestine resection perform , patient survive .', 'Histology small intestine resection reveal prominent endotheliitis submucosal vessel apoptotic body ( figure C ) .', 'We find evidence direct viral infection endothelial cell diffuse endothelial inflammation .', 'Although virus us ACE2 receptor express pneumocytes epithelial alveolar line infect host , thereby cause lung injury , ACE2 receptor also widely express endothelial cell , traverse multiple organs.3Ferrario CM Jessup J Chappell MC et al.Effect angiotensin-converting enzyme inhibition angiotensin II receptor blocker cardiac angiotensin-converting enzyme 2.Circulation .', '2005 ; 111 : 2605-2610Google Scholar Recruitment immune cell , either direct viral infection endothelium immune-mediated , result widespread endothelial dysfunction associate apoptosis ( figure D ) .', 'The vascular endothelium active paracrine , endocrine , autocrine organ indispensable regulation vascular tone maintenance vascular homoeostasis.5Flammer AJ Anderson T Celermajer DS et al.The assessment endothelial function : research clinical practice.Circulation .', '2012 ; 126 : 753-767Google Scholar Endothelial dysfunction principal determinant microvascular dysfunction shift vascular equilibrium towards vasoconstriction subsequent organ ischaemia , inflammation associate tissue oedema , pro-coagulant state.6Bonetti PO Lerman LO Lerman A Endothelial dysfunction - marker atherosclerotic risk.Arterioscl Throm Vas .', '2003 ; 23 : 168-175Google Scholar Our find show presence viral element within endothelial cell accumulation inflammatory cell , evidence endothelial inflammatory cell death .', 'These find suggest SARS-CoV-2 infection facilitate induction endotheliitis several organ direct consequence viral involvement ( note presence viral body ) host inflammatory response .', 'In addition , induction apoptosis pyroptosis might important role endothelial cell injury patient COVID-19 .', 'COVID-19-endotheliitis could explain systemic impair microcirculatory function different vascular bed clinical sequela patient COVID-19 .', 'This hypothesis provide rationale therapy stabilise endothelium tackle viral replication , particularly anti-inflammatory anti-cytokine drug , ACE inhibitor , statins.7Anderson TJ Meredith IT Yeung AC Frei B Selwyn AP Ganz P The effect cholesterol-lowering antioxidant therapy endothelium-dependent coronary vasomotion.N Engl J Med .', '1995 ; 332 : 488-493Google Scholar , 8Taddei S Virdis A Ghiadoni L Mattei P Salvetti A Effects angiotensin convert enzyme inhibition endothelium-dependent vasodilatation essential hypertensive patients.J Hypertens .', '1998 ; 16 : 447-456Google Scholar , 9Flammer AJ Sudano I Hermann F et al.Angiotensin-converting enzyme inhibition improve vascular function rheumatoid arthritis.Circulation .', '2008 ; 117 : 2262-2269Google Scholar , 10Hurlimann D Forster A Noll G et al.Anti-tumor necrosis factor-alpha treatment improve endothelial function patient rheumatoid arthritis.Circulation .', '2002 ; 106 : 2184-2187Google Scholar , 11Feldmann M Maini RN Woody JN et al.Trials anti-tumour necrosis factor therapy COVID-19 urgently needed.Lancet .', '2020 ; ( publish online April 9 . )', 'urlplaceholder TextFull Text PDFGoogle Scholar This strategy could particularly relevant vulnerable patient pre-existing endothelial dysfunction , associate male sex , smoke , hypertension , diabetes , obesity , establish cardiovascular disease , associate adverse outcome COVID-19 .', 'ZV AJF contribute equally first author , RAS , FR , HM contribute equally last author .', 'AJF report fee Alnylam , Amgen , AstraZeneca , Fresenius , Imedos Systems , Novartis , Pfizer , Roche , Vifor , Zoll , unrelated Correspondence .', 'MRM report consult relationship Abbott , Medtronic , Janssen , Mesoblast , Portola , Bayer , NupulseCV , FineHeart , Leviticus , Baim Institute Clinical Research , Riovant , Triple Gene , unrelated Correspondence .', 'FR pay time spend committee member clinical trial , advisory board , form consult lecture presentation .', 'These payment make directly University Zurich personal payment receive relation trial activity .', 'All author declare compete interest .', ""Download .pdf ( 1.83 MB ) Help pdf file Supplementary appendix Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort studyFull-TextPDFElectron microscopy SARS-CoV-2 : challenge task – Authors ' replyFull-TextPDFElectron microscopy SARS-CoV-2 : challenge taskFull-TextPDF""]","['cardiovascular', 'complication', 'rapidly', 'emerge', 'key', 'threat', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'addition', 'respiratory', 'disease', '', 'mechanism', 'underlie', 'disproportionate', 'effect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', 'patient', 'cardiovascular', 'comorbidities', '', 'however', '', 'remain', 'incompletely', 'understood1zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '395', '', '1054-1062google', '', '2horton', 'r', 'offline', '', 'covid-19bewilderment', 'candourlancet', '', '2020', '', '3951178google', 'sars-cov-2', 'infect', 'host', 'angiotensin', 'convert', 'enzyme', '2', '', 'ace2', '', 'receptor', '', 'express', 'several', 'organ', '', 'include', 'lung', '', 'heart', '', 'kidney', '', 'intestine', '', 'ace2', 'receptor', 'express', 'endothelial', 'cells3ferrario', 'cm', 'jessup', 'j', 'chappell', 'mc', 'aleffect', 'angiotensin-converting', 'enzyme', 'inhibition', 'angiotensin', 'ii', 'receptor', 'blocker', 'cardiac', 'angiotensin-converting', 'enzyme', '2circulation', '', '2005', '', '111', '', '2605-2610google', 'whether', 'vascular', 'derangement', 'covid-19', 'due', 'endothelial', 'cell', 'involvement', 'virus', 'currently', 'unknown', '', 'intriguingly', '', 'sars-cov-2', 'directly', 'infect', 'engineer', 'human', 'blood', 'vessel', 'organoids', 'vitro4monteil', 'v', 'kh', 'prado', 'p', 'hagelkrys', 'alinhibition', 'sars-cov-2', 'infection', 'engineer', 'human', 'tissue', 'clinical-grade', 'soluble', 'human', 'ace2cell', '', '2020', '', '', 'publish', 'online', 'press', '', '', 'urlplaceholder', 'access', '', 'april', '17', '', '2020google', 'demonstrate', 'endothelial', 'cell', 'involvement', 'across', 'vascular', 'bed', 'different', 'organ', 'series', 'patient', 'covid-19', '', 'case', 'detail', 'provide', 'appendix', '', '', 'patient', '1', 'male', 'renal', 'transplant', 'recipient', '', 'age', '71', 'year', '', 'coronary', 'artery', 'disease', 'arterial', 'hypertension', '', 'patient', 'condition', 'deteriorate', 'follow', 'covid-19', 'diagnosis', '', 'require', 'mechanical', 'ventilation', '', 'multisystem', 'organ', 'failure', 'occur', '', 'patient', 'die', 'day', '8', '', 'post-mortem', 'analysis', 'transplant', 'kidney', 'electron', 'microscopy', 'reveal', 'viral', 'inclusion', 'structure', 'endothelial', 'cell', '', 'figure', '', 'b', '', '', 'histological', 'analysis', '', 'find', 'accumulation', 'inflammatory', 'cell', 'associate', 'endothelium', '', 'well', 'apoptotic', 'body', '', 'heart', '', 'small', 'bowel', '', 'figure', 'c', '', 'lung', '', 'figure', '', '', 'accumulation', 'mononuclear', 'cell', 'find', 'lung', '', 'small', 'lung', 'vessel', 'appear', 'congestedfigurepathology', 'endothelial', 'cell', 'dysfunction', 'covid-19show', 'full', 'caption', '', '', 'b', '', 'electron', 'microscopy', 'kidney', 'tissue', 'show', 'viral', 'inclusion', 'body', 'peritubular', 'space', 'viral', 'particle', 'endothelial', 'cell', 'glomerular', 'capillary', 'loop', '', 'aggregates', 'viral', 'particle', '', 'arrow', '', 'appear', 'dense', 'circular', 'surface', 'lucid', 'centre', '', 'asterisk', 'panel', 'b', 'mark', 'peritubular', 'space', 'consistent', 'capillary', 'contain', 'viral', 'particle', '', 'inset', 'panel', 'b', 'show', 'glomerular', 'basement', 'membrane', 'endothelial', 'cell', 'viral', 'particle', '', 'arrow', '', '150', 'nm', 'diameter', '', '', '', 'c', '', 'small', 'bowel', 'resection', 'specimen', 'patient', '3', '', 'stain', 'haematoxylin', 'eosin', '', 'arrows', 'point', 'dominant', 'mononuclear', 'cell', 'infiltrate', 'within', 'intima', 'along', 'lumen', 'vessel', '', 'inset', 'panel', 'c', 'show', 'immunohistochemical', 'stain', 'caspase', '3', 'small', 'bowel', 'specimen', 'serial', 'section', 'tissue', 'describe', 'panel', 'staining', 'pattern', 'consistent', 'apoptosis', 'endothelial', 'cell', 'mononuclear', 'cell', 'observe', 'haematoxylin-eosin-stained', 'section', '', 'indicate', 'apoptosis', 'induce', 'substantial', 'proportion', 'cell', '', '', '', 'post-mortem', 'lung', 'specimen', 'stain', 'haematoxylin', 'eosin', 'show', 'thicken', 'lung', 'septum', '', 'include', 'large', 'arterial', 'vessel', 'mononuclear', 'neutrophilic', 'infiltration', '', 'arrow', 'upper', 'inset', '', '', 'lower', 'inset', 'show', 'immunohistochemical', 'stain', 'caspase', '3', 'lung', 'specimen', '', 'stain', 'pattern', 'consistent', 'apoptosis', 'endothelial', 'cell', 'mononuclear', 'cell', 'observe', 'haematoxylin-eosin-stained', 'section', '', 'covid-19coronavirus', 'disease', '2019view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'b', '', 'electron', 'microscopy', 'kidney', 'tissue', 'show', 'viral', 'inclusion', 'body', 'peritubular', 'space', 'viral', 'particle', 'endothelial', 'cell', 'glomerular', 'capillary', 'loop', '', 'aggregates', 'viral', 'particle', '', 'arrow', '', 'appear', 'dense', 'circular', 'surface', 'lucid', 'centre', '', 'asterisk', 'panel', 'b', 'mark', 'peritubular', 'space', 'consistent', 'capillary', 'contain', 'viral', 'particle', '', 'inset', 'panel', 'b', 'show', 'glomerular', 'basement', 'membrane', 'endothelial', 'cell', 'viral', 'particle', '', 'arrow', '', '150', 'nm', 'diameter', '', '', '', 'c', '', 'small', 'bowel', 'resection', 'specimen', 'patient', '3', '', 'stain', 'haematoxylin', 'eosin', '', 'arrows', 'point', 'dominant', 'mononuclear', 'cell', 'infiltrate', 'within', 'intima', 'along', 'lumen', 'vessel', '', 'inset', 'panel', 'c', 'show', 'immunohistochemical', 'stain', 'caspase', '3', 'small', 'bowel', 'specimen', 'serial', 'section', 'tissue', 'describe', 'panel', 'staining', 'pattern', 'consistent', 'apoptosis', 'endothelial', 'cell', 'mononuclear', 'cell', 'observe', 'haematoxylin-eosin-stained', 'section', '', 'indicate', 'apoptosis', 'induce', 'substantial', 'proportion', 'cell', '', '', '', 'post-mortem', 'lung', 'specimen', 'stain', 'haematoxylin', 'eosin', 'show', 'thicken', 'lung', 'septum', '', 'include', 'large', 'arterial', 'vessel', 'mononuclear', 'neutrophilic', 'infiltration', '', 'arrow', 'upper', 'inset', '', '', 'lower', 'inset', 'show', 'immunohistochemical', 'stain', 'caspase', '3', 'lung', 'specimen', '', 'stain', 'pattern', 'consistent', 'apoptosis', 'endothelial', 'cell', 'mononuclear', 'cell', 'observe', 'haematoxylin-eosin-stained', 'section', '', 'covid-19coronavirus', 'disease', '2019', '', 'patient', '2', 'woman', '', 'age', '58', 'year', '', 'diabetes', '', 'arterial', 'hypertension', '', 'obesity', '', 'develop', 'progressive', 'respiratory', 'failure', 'due', 'covid-19', 'subsequently', 'develop', 'multi-organ', 'failure', 'renal', 'replacement', 'therapy', '', 'day', '16', '', 'mesenteric', 'ischaemia', 'prompt', 'removal', 'necrotic', 'small', 'intestine', '', 'circulatory', 'failure', 'occur', 'set', 'heart', 'failure', 'consequent', 'st-segment', 'elevation', 'myocardial', 'infarction', '', 'cardiac', 'arrest', 'result', 'death', '', 'post-mortem', 'histology', 'reveal', 'lymphocytic', 'endotheliitis', 'lung', '', 'heart', '', 'kidney', '', 'liver', 'well', 'liver', 'cell', 'necrosis', '', 'find', 'histological', 'evidence', 'myocardial', 'infarction', 'sign', 'lymphocytic', 'myocarditis', '', 'histology', 'small', 'intestine', 'show', 'endotheliitis', '', 'endothelialitis', '', 'submucosal', 'vessel', '', 'patient', '3', 'man', '', 'age', '69', 'year', '', 'hypertension', 'develop', 'respiratory', 'failure', 'result', 'covid-19', 'require', 'mechanical', 'ventilation', '', 'echocardiography', 'show', 'reduce', 'leave', 'ventricular', 'ejection', 'fraction', '', 'circulatory', 'collapse', 'ensue', 'mesenteric', 'ischaemia', '', 'small', 'intestine', 'resection', 'perform', '', 'patient', 'survive', '', 'histology', 'small', 'intestine', 'resection', 'reveal', 'prominent', 'endotheliitis', 'submucosal', 'vessel', 'apoptotic', 'body', '', 'figure', 'c', '', '', 'find', 'evidence', 'direct', 'viral', 'infection', 'endothelial', 'cell', 'diffuse', 'endothelial', 'inflammation', '', 'although', 'virus', 'us', 'ace2', 'receptor', 'express', 'pneumocytes', 'epithelial', 'alveolar', 'infect', 'host', '', 'thereby', 'cause', 'lung', 'injury', '', 'ace2', 'receptor', 'widely', 'express', 'endothelial', 'cell', '', 'traverse', 'multiple', 'organs3ferrario', 'cm', 'jessup', 'j', 'chappell', 'mc', 'aleffect', 'angiotensin-converting', 'enzyme', 'inhibition', 'angiotensin', 'ii', 'receptor', 'blocker', 'cardiac', 'angiotensin-converting', 'enzyme', '2circulation', '', '2005', '', '111', '', '2605-2610google', 'recruitment', 'immune', 'cell', '', 'either', 'direct', 'viral', 'infection', 'endothelium', 'immune-mediated', '', 'result', 'widespread', 'endothelial', 'dysfunction', 'associate', 'apoptosis', '', 'figure', '', '', 'vascular', 'endothelium', 'active', 'paracrine', '', 'endocrine', '', 'autocrine', 'organ', 'indispensable', 'regulation', 'vascular', 'tone', 'maintenance', 'vascular', 'homoeostasis5flammer', 'aj', 'anderson', 'celermajer', 'ds', 'althe', 'assessment', 'endothelial', 'function', '', 'research', 'clinical', 'practicecirculation', '', '2012', '', '126', '', '753-767google', 'endothelial', 'dysfunction', 'principal', 'determinant', 'microvascular', 'dysfunction', 'shift', 'vascular', 'equilibrium', 'towards', 'vasoconstriction', 'subsequent', 'organ', 'ischaemia', '', 'inflammation', 'associate', 'tissue', 'oedema', '', 'pro-coagulant', 'state6bonetti', 'po', 'lerman', 'lo', 'lerman', 'endothelial', 'dysfunction', '-', 'marker', 'atherosclerotic', 'riskarterioscl', 'throm', 'vas', '', '2003', '', '23', '', '168-175google', 'find', 'show', 'presence', 'viral', 'element', 'within', 'endothelial', 'cell', 'accumulation', 'inflammatory', 'cell', '', 'evidence', 'endothelial', 'inflammatory', 'cell', 'death', '', 'find', 'suggest', 'sars-cov-2', 'infection', 'facilitate', 'induction', 'endotheliitis', 'several', 'organ', 'direct', 'consequence', 'viral', 'involvement', '', 'note', 'presence', 'viral', 'body', '', 'host', 'inflammatory', 'response', '', 'addition', '', 'induction', 'apoptosis', 'pyroptosis', 'important', 'role', 'endothelial', 'cell', 'injury', 'patient', 'covid-19', '', 'covid-19-endotheliitis', 'explain', 'systemic', 'impair', 'microcirculatory', 'function', 'different', 'vascular', 'bed', 'clinical', 'sequela', 'patient', 'covid-19', '', 'hypothesis', 'provide', 'rationale', 'therapy', 'stabilise', 'endothelium', 'tackle', 'viral', 'replication', '', 'particularly', 'anti-inflammatory', 'anti-cytokine', 'drug', '', 'ace', 'inhibitor', '', 'statins7anderson', 'tj', 'meredith', 'yeung', 'ac', 'frei', 'b', 'selwyn', 'ap', 'ganz', 'p', 'effect', 'cholesterol-lowering', 'antioxidant', 'therapy', 'endothelium-dependent', 'coronary', 'vasomotionn', 'engl', 'j', 'med', '', '1995', '', '332', '', '488-493google', '', '8taddei', 'virdis', 'ghiadoni', 'l', 'mattei', 'p', 'salvetti', 'effects', 'angiotensin', 'convert', 'enzyme', 'inhibition', 'endothelium-dependent', 'vasodilatation', 'essential', 'hypertensive', 'patientsj', 'hypertens', '', '1998', '', '16', '', '447-456google', '', '9flammer', 'aj', 'sudano', 'hermann', 'f', 'alangiotensin-converting', 'enzyme', 'inhibition', 'improve', 'vascular', 'function', 'arthritis', 'arthritiscirculation', '', '2008', '', '117', '', '2262-2269google', '', '10hurlimann', 'forster', 'noll', 'g', 'alanti-tumor', 'necrosis', 'factor-alpha', 'treatment', 'improve', 'endothelial', 'function', 'patient', 'arthritis', 'arthritiscirculation', '', '2002', '', '106', '', '2184-2187google', '', '11feldmann', 'maini', 'rn', 'woody', 'jn', 'altrials', 'anti-tumour', 'necrosis', 'factor', 'therapy', 'covid-19', 'urgently', 'neededlancet', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'urlplaceholder', 'textfull', 'text', 'pdfgoogle', 'strategy', 'particularly', 'relevant', 'vulnerable', 'patient', 'pre-existing', 'endothelial', 'dysfunction', '', 'associate', 'male', 'sex', '', 'smoke', '', 'hypertension', '', 'diabetes', '', 'obesity', '', 'establish', 'cardiovascular', 'disease', '', 'associate', 'adverse', 'outcome', 'covid-19', '', 'zv', 'ajf', 'contribute', 'equally', 'first', 'author', '', 'ras', '', 'fr', '', 'hm', 'contribute', 'equally', 'last', 'author', '', 'ajf', 'report', 'fee', 'alnylam', '', 'amgen', '', 'astrazeneca', '', 'fresenius', '', 'imedos', 'systems', '', 'novartis', '', 'pfizer', '', 'roche', '', 'vifor', '', 'zoll', '', 'unrelated', 'correspondence', '', 'mrm', 'report', 'consult', 'relationship', 'abbott', '', 'medtronic', '', 'janssen', '', 'mesoblast', '', 'portola', '', 'bayer', '', 'nupulsecv', '', 'fineheart', '', 'leviticus', '', 'baim', 'institute', 'clinical', 'research', '', 'riovant', '', 'triple', 'gene', '', 'unrelated', 'correspondence', '', 'fr', 'pay', 'time', 'spend', 'committee', 'member', 'clinical', 'trial', '', 'advisory', 'board', '', 'form', 'consult', 'lecture', 'presentation', '', 'payment', 'directly', 'university', 'zurich', 'personal', 'payment', 'receive', 'relation', 'trial', 'activity', '', 'author', 'declare', 'compete', 'interest', '', 'download', 'pdf', '', '183', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'clinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studyfull-textpdfelectron', 'microscopy', 'sars-cov-2', '', 'challenge', 'task', '', 'authors', '', 'replyfull-textpdfelectron', 'microscopy', 'sars-cov-2', '', 'challenge', 'taskfull-textpdf']",1363,"{'': 249, 'cell': 30, 'endothelial': 25, 'viral': 17, 'patient': 14, 'show': 13, 'covid-19': 12, 'lung': 12, 'small': 10, 'stain': 10, 'mononuclear': 9, 'vascular': 8, 'vessel': 8, 'b': 8, 'particle': 8, 'panel': 8, 'inset': 8, 'specimen': 8, 'apoptosis': 8, 'sars-cov-2': 7}","{'infection': 5, 'sars-cov-2': 7, 'arthritis': 2}",14,-0.8225
DOI:10.1016/S0140-6736(14)61202-2,10.1016/S0140-6736(14)61202-2,Obituary,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['ciro', 'de', 'quadros']","['View Large Image Copyright © 2014 Sabin Vaccine Institute View Large Image Copyright © 2014 Sabin Vaccine Institute Public health physician rid Latin America polio .', 'He bear Rio Pardo , Brazil , Jan 30 , 1940 , die Washington , DC , USA , May 28 , 2014 , age 74 year .', 'The last case polio Latin America detect 1991 small Peruvian town Pichanaki .', '3 year later , Pan American Health Organization ( PAHO ) declare disease eradicate within region .', 'If one man say deserve personal credit achievement , Ciro de Quadros .', 'A physician train public health , join PAHO 1977 advise matter relate immunisation , implement Expanded Programme Immunization Latin America .', '“ At time vaccine coverage rate 5 20 % ” , say Donald Henderson , Professor Medicine Public Health University Pittsburgh .', '“ What Ciro amazing. ” He persuade country join become hemisphere-wide effort .', '“ Within 5 6 year except Haiti well 80 % coverage. ” de Quadros also create fund buy vaccine behalf PAHO member , one largest ever bulk purchase scheme public sector .', 'Countries able buy vaccine quantity would otherwise unaffordable .', 'It 1985 de Quadros put forward programme eliminate polio Americas , ambition Henderson admit view scepticism .', 'But succeeded—and manage something similar indigenous measles .', ""Henderson attribute de Quadros 's success way job ."", '“ He travel extensively , talk staff , talk minister .', 'He persuade programme .', ""He could help , yes—but programme. ” de Quadros train Catholic School Medicine Porto Alegre , master 's degree public health , 1967 join Brazilian public health service work health centre Amazon region ."", 'He become involve smallpox campaign , three colleague , begin test value surveillance containment strategy alternative prove unaffordable policy mass vaccination .', 'Over next 8 month identify 100 case smallpox , vaccinate contact , succeed break chain transmission .', ""On strength achievement de Quadros become chief epidemiologist WHO 's smallpox eradication programme Ethiopia ."", '“ He take smallpox field something like ten Ethiopian health officer dozen US Peace Corps people ” , recall Henderson .', ""“ Ethiopia 's big place road terrible ."", ""He work difficult condition , within 12 month 'd turn 600 cases. ” Among Peace Corps volunteer Peter Carrasco , Director Secretariat International Association Immunization Managers base Sabin Vaccine Institute Washington , DC ."", 'Two previous Peace Corps group deal location accessible road .', '“ When Ciro I hook look hardest part Ethiopia get ” , Carrasco recall .', 'There way could job foot , start use helicopter highland camel desert area .', 'It success Ethiopian smallpox project de Quadros join PAHO head Expanded Programme Immunization .', 'Between 1994 1998 spend 4 year special adviser vaccine Director-General WHO , continue work PAHO retirement 2002 .', 'Even , maintain lifelong connection vaccination appointment Vice-President Sabin Vaccine Institute Washington .', ""Throughout de Quadros 's life , Henderson think , tell something could n't do , want ."", 'And usually succeed .', '“ His work marvellous illustration community involvement accomplish task ” , say Henderson .', '“ He understand management ” , add Carrasco .', 'He use smallpox experience build Expanded Programme Immunization rid Latin America polio .', '“ He show doubter , many , polio could eradicate .', 'He practical clear insight ” , say Carrasco .', ""Despite de Quadros 's many award medal , “ earth ” , note Carrasco ."", '“ He kind man could sit ordinary health worker , beer , motivate guy better job. ” de Quadros survive wife , two daughter , two stepson .']","['view', 'large', 'image', 'copyright', '', '2014', 'sabin', 'vaccine', 'institute', 'view', 'large', 'image', 'copyright', '', '2014', 'sabin', 'vaccine', 'institute', 'public', 'health', 'physician', 'rid', 'latin', 'america', 'polio', '', 'bear', 'rio', 'pardo', '', 'brazil', '', 'jan', '30', '', '1940', '', 'die', 'washington', '', 'dc', '', 'usa', '', '28', '', '2014', '', 'age', '74', 'year', '', 'last', 'case', 'polio', 'latin', 'america', 'detect', '1991', 'small', 'peruvian', 'town', 'pichanaki', '', '3', 'year', 'later', '', 'pan', 'american', 'health', 'organization', '', 'paho', '', 'declare', 'disease', 'eradicate', 'within', 'region', '', 'one', 'man', 'deserve', 'personal', 'credit', 'achievement', '', 'ciro', 'de', 'quadros', '', 'physician', 'train', 'public', 'health', '', 'join', 'paho', '1977', 'advise', 'matter', 'relate', 'immunisation', '', 'implement', 'expanded', 'programme', 'immunization', 'latin', 'america', '', '', 'time', 'vaccine', 'coverage', 'rate', '5', '20', '', '', '', 'donald', 'henderson', '', 'professor', 'medicine', 'public', 'health', 'university', 'pittsburgh', '', '', 'ciro', 'amazing', '', 'persuade', 'country', 'join', 'become', 'hemisphere-wide', 'effort', '', '', 'within', '5', '6', 'year', 'except', 'haiti', 'well', '80', '', 'coverage', '', 'de', 'quadros', 'create', 'fund', 'buy', 'vaccine', 'behalf', 'paho', 'member', '', 'one', 'largest', 'ever', 'bulk', 'purchase', 'scheme', 'public', 'sector', '', 'countries', 'able', 'buy', 'vaccine', 'quantity', 'otherwise', 'unaffordable', '', '1985', 'de', 'quadros', 'put', 'forward', 'programme', 'eliminate', 'polio', 'americas', '', 'ambition', 'henderson', 'admit', 'view', 'scepticism', '', 'succeededand', 'manage', 'something', 'similar', 'indigenous', 'measles', '', 'henderson', 'attribute', 'de', 'quadros', 'success', 'way', 'job', '', '', 'travel', 'extensively', '', 'talk', 'staff', '', 'talk', 'minister', '', 'persuade', 'programme', '', 'help', '', 'yesbut', 'programme', '', 'de', 'quadros', 'train', 'catholic', 'school', 'medicine', 'porto', 'alegre', '', 'master', 'degree', 'public', 'health', '', '1967', 'join', 'brazilian', 'public', 'health', 'service', 'work', 'health', 'centre', 'amazon', 'region', '', 'become', 'involve', 'smallpox', 'campaign', '', 'three', 'colleague', '', 'begin', 'test', 'value', 'surveillance', 'containment', 'strategy', 'alternative', 'prove', 'unaffordable', 'policy', 'mass', 'vaccination', '', 'next', '8', 'month', 'identify', '100', 'case', 'smallpox', '', 'vaccinate', 'contact', '', 'succeed', 'break', 'chain', 'transmission', '', 'strength', 'achievement', 'de', 'quadros', 'become', 'chief', 'epidemiologist', 'smallpox', 'eradication', 'programme', 'ethiopia', '', '', 'smallpox', 'field', 'something', 'like', 'ten', 'ethiopian', 'health', 'officer', 'dozen', 'us', 'peace', 'corps', 'people', '', '', 'recall', 'henderson', '', '', 'ethiopia', 'big', 'place', 'road', 'terrible', '', 'work', 'difficult', 'condition', '', 'within', '12', 'month', 'turn', '600', 'cases', '', 'among', 'peace', 'corps', 'volunteer', 'peter', 'carrasco', '', 'director', 'secretariat', 'international', 'association', 'immunization', 'managers', 'base', 'sabin', 'vaccine', 'institute', 'washington', '', 'dc', '', 'two', 'previous', 'peace', 'corps', 'group', 'deal', 'location', 'accessible', 'road', '', '', 'ciro', 'hook', 'look', 'hardest', 'part', 'ethiopia', '', '', 'carrasco', 'recall', '', 'way', 'job', 'foot', '', 'start', 'helicopter', 'highland', 'camel', 'desert', 'area', '', 'success', 'ethiopian', 'smallpox', 'project', 'de', 'quadros', 'join', 'paho', 'head', 'expanded', 'programme', 'immunization', '', '1994', '1998', 'spend', '4', 'year', 'special', 'adviser', 'vaccine', 'director-general', '', 'continue', 'work', 'paho', 'retirement', '2002', '', '', 'maintain', 'lifelong', 'connection', 'vaccination', 'appointment', 'vice-president', 'sabin', 'vaccine', 'institute', 'washington', '', 'throughout', 'de', 'quadros', 'life', '', 'henderson', '', 'tell', 'something', 'nt', '', '', 'usually', 'succeed', '', '', 'work', 'marvellous', 'illustration', 'community', 'involvement', 'accomplish', 'task', '', '', 'henderson', '', '', 'understand', 'management', '', '', 'add', 'carrasco', '', 'smallpox', 'experience', 'build', 'expanded', 'programme', 'immunization', 'rid', 'latin', 'america', 'polio', '', '', 'show', 'doubter', '', '', 'polio', 'eradicate', '', 'practical', 'clear', 'insight', '', '', 'carrasco', '', 'despite', 'de', 'quadros', 'award', 'medal', '', '', 'earth', '', '', 'note', 'carrasco', '', '', 'kind', 'man', 'sit', 'ordinary', 'health', 'worker', '', 'beer', '', 'motivate', 'guy', 'better', 'job', '', 'de', 'quadros', 'survive', 'wife', '', 'two', 'daughter', '', 'two', 'stepson', '']",538,"{'': 115, 'de': 10, 'quadros': 10, 'health': 9, 'vaccine': 8, 'programme': 7, 'public': 6, 'henderson': 6, 'smallpox': 6, 'polio': 5, 'paho': 5, 'carrasco': 5, 'sabin': 4, 'institute': 4, 'latin': 4, 'america': 4, 'year': 4, 'join': 4, 'immunization': 4, 'work': 4}",{},0,-0.5994
DOI:10.1016/S0140-6736(20)31042-4,10.1016/S0140-6736(20)31042-4,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['triple', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'treatment', 'patient', 'admit', 'hospital', 'covid-19', '', 'open-label', '', 'randomise', '', 'phase', '2', 'trial']","['BackgroundEffective antiviral therapy important tackle coronavirus disease 2019 ( COVID-19 ) pandemic .', 'We assess efficacy safety combine interferon beta-1b , lopinavir–ritonavir , ribavirin treat patient COVID-19.MethodsThis multicentre , prospective , open-label , randomise , phase 2 trial adult COVID-19 admit six hospital Hong Kong .', 'Patients randomly assign ( 2:1 ) 14-day combination lopinavir 400 mg ritonavir 100 mg every 12 h , ribavirin 400 mg every 12 h , three do 8 million international unit interferon beta-1b alternate day ( combination group ) 14 day lopinavir 400 mg ritonavir 100 mg every 12 h ( control group ) .', 'The primary endpoint time provide nasopharyngeal swab negative severe acute respiratory syndrome coronavirus 2 RT-PCR , do intention-to-treat population .', 'The study register ClinicalTrials.gov , NCT04276688.FindingsBetween Feb 10 March 20 , 2020 , 127 patient recruit ; 86 randomly assign combination group 41 assign control group .', 'The median number day symptom onset start study treatment 5 day ( IQR 3–7 ) .', 'The combination group significantly shorter median time start study treatment negative nasopharyngeal swab ( 7 day [ IQR 5–11 ] ) control group ( 12 day [ 8–15 ] ; hazard ratio 4·37 [ 95 % CI 1·86–10·24 ] , p=0·0010 ) .', 'Adverse event include self-limited nausea diarrhoea difference two group .', 'One patient control group discontinue lopinavir–ritonavir biochemical hepatitis .', 'No patient die study.InterpretationEarly triple antiviral therapy safe superior lopinavir–ritonavir alone alleviate symptom shorten duration viral shed hospital stay patient mild moderate COVID-19 .', 'Future clinical study double antiviral therapy interferon beta-1b backbone warranted.FundingThe Shaw-Foundation , Richard Carol Yu , May Tam Mak Mei Yin , Sanming Project Medicine .', 'Effective antiviral therapy important tackle coronavirus disease 2019 ( COVID-19 ) pandemic .', 'We assess efficacy safety combine interferon beta-1b , lopinavir–ritonavir , ribavirin treat patient COVID-19 .', 'This multicentre , prospective , open-label , randomise , phase 2 trial adult COVID-19 admit six hospital Hong Kong .', 'Patients randomly assign ( 2:1 ) 14-day combination lopinavir 400 mg ritonavir 100 mg every 12 h , ribavirin 400 mg every 12 h , three do 8 million international unit interferon beta-1b alternate day ( combination group ) 14 day lopinavir 400 mg ritonavir 100 mg every 12 h ( control group ) .', 'The primary endpoint time provide nasopharyngeal swab negative severe acute respiratory syndrome coronavirus 2 RT-PCR , do intention-to-treat population .', 'The study register ClinicalTrials.gov , NCT04276688 .', 'Between Feb 10 March 20 , 2020 , 127 patient recruit ; 86 randomly assign combination group 41 assign control group .', 'The median number day symptom onset start study treatment 5 day ( IQR 3–7 ) .', 'The combination group significantly shorter median time start study treatment negative nasopharyngeal swab ( 7 day [ IQR 5–11 ] ) control group ( 12 day [ 8–15 ] ; hazard ratio 4·37 [ 95 % CI 1·86–10·24 ] , p=0·0010 ) .', 'Adverse event include self-limited nausea diarrhoea difference two group .', 'One patient control group discontinue lopinavir–ritonavir biochemical hepatitis .', 'No patient die study .', 'Early triple antiviral therapy safe superior lopinavir–ritonavir alone alleviate symptom shorten duration viral shed hospital stay patient mild moderate COVID-19 .', 'Future clinical study double antiviral therapy interferon beta-1b backbone warrant .', 'The Shaw-Foundation , Richard Carol Yu , May Tam Mak Mei Yin , Sanming Project Medicine .', 'The coronavirus disease 2019 ( COVID-19 ) pandemic cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) affect 3 million patient 200 000 death 230 countries.1WHOCoronavirus disease 2019 ( COVID-19 ) situation report–107 .', 'urlplaceholder May 6 , 2020Date access : May 6 , 2020Google Scholar COVID-19 spread quickly person person,2Chan JF Yuan S Kok KH et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; 395 : 514-523Google Scholar primarily acute viral pneumonia lead respiratory failure report autopsy study animal models,3Yao XH Li TY He ZC et al.A pathological report three COVID-19 case minimally invasive autopsies.Zhonghua Bing Li Xue Za Zhi .', '2020 ; 49 ( Chinese ) .', ': E009Google Scholar , 4Chan JF Zhang AJ Yuan S et al.Simulation clinical pathological manifestation coronavirus disease 2019 ( COVID-19 ) golden syrian hamster model : implication disease pathogenesis tansmissibility.Clin Infect Dis .', '2020 ; ( publised online March 26 . )', 'urlplaceholder Scholar although cytokine storm extrapulmonary involvement occasionally reported.3Yao XH Li TY He ZC et al.A pathological report three COVID-19 case minimally invasive autopsies.Zhonghua Bing Li Xue Za Zhi .', '2020 ; 49 ( Chinese ) .', ': E009Google Scholar , 4Chan JF Zhang AJ Yuan S et al.Simulation clinical pathological manifestation coronavirus disease 2019 ( COVID-19 ) golden syrian hamster model : implication disease pathogenesis tansmissibility.Clin Infect Dis .', '2020 ; ( publised online March 26 . )', 'urlplaceholder Scholar Besides respiratory intensive care support extent extracorporeal membrane oxygenation , specific antiviral treatment recommend insufficient evidence randomise trial .', 'Many repurposed drug show in-vitro activity close relative SARS-CoV-2 , beta-coronaviruses .', 'Lopinavir many interferon , particularly interferon beta , show modest activity vitro SARS-CoV Middle East respiratory syndrome ( MERS ) -CoV , use synergistically ribavirin.5Chen F Chan KH Jiang Y et al.In vitro susceptibility 10 clinical isolate SARS coronavirus select antiviral compounds.J Clin Virol .', '2004 ; 31 : 69-75Google Scholar , 6Chan JF Chan KH Kao RY et al.Broad-spectrum antiviral emerge Middle East respiratory syndrome coronavirus.J Infect .', '2013 ; 67 : 606-616Google Scholar In 2003 , open-label trial use historical control , show combination lopinavir–ritonavir ribavirin reduce mortality need intensive respiratory support patient SARS admit hospital.7Chu CM Cheng VC Hung IF et al.Role lopinavir/ritonavir treatment SARS : initial virological clinical findings.Thorax .', '2004 ; 59 : 252-256Google Scholar Moreover , lopinavir–ritonavir interferon beta-1b show reduce viral load improve lung pathology common marmoset model.8Chan JF Yao Y Yeung ML et al.Treatment lopinavir/ritonavir interferon-β1b improve outcome MERS-CoV infection nonhuman primate model common marmoset.J Infect Dis .', '2015 ; 212 : 1904-1913Google Scholar However viral load SARS MERS peak around day 7–10 symptom onset , whereas viral load COVID-19 peak time presentation , similar influenza.9To KK-W Tsang OT-Y Leung W-S et al.Temporal profile viral load posterior oropharyngeal saliva sample serum antibody response infection SARS-CoV-2 : observational cohort study.Lancet Infect Dis .', '2020 ; ( publish online March 23 . )', 'urlplaceholder Scholar , 10Cheng VC Tang BS Wu AK Chu CM Yuen KY Medical treatment viral pneumonia include SARS immunocompetent adult.J Infect .', '2004 ; 49 : 262-273Google Scholar Experience treatment patient influenza admit hospital suggest combination multiple antiviral drug effective single drug treatment set patient high viral load presentation.11Dunning J Baillie JK Cao B Hayden FG Antiviral combination severe influenza.Lancet Infect Dis .', '2014 ; 14 : 1259-1270Google Scholar , 12Hung IFN To KKW Chan JFW et al.Efficacy clarithromycin-naproxen-oseltamivir combination treatment patient hospitalize influenza A ( H3N2 ) infection : open-label randomize , control , phase IIb/III trial.Chest .', '2017 ; 151 : 1069-1080Google Scholar Therefore , phase 2 randomise trial establish whether combination three modestly active drug SARS-CoV-2 improve viral load profile clinical parameter adult COVID-19 require hospital admission .', 'Research contextEvidence studyWe search PubMed March 30 , 2020 , use term “ Covid-19 ” , “ interferon beta 1b ” , “ lopinavir/ ritonavir ” , “ treatment ” , “ hospitalize ” , “ patient ” , “ phase 2 ” , “ trial ” article English publish date search .', 'Our search show randomise control trial assess combination interferon beta-1b , lopinavir–ritonavir , ribavirin treatment patient coronavirus disease 2019 ( COVID-19 ) .Added value studyThis first randomise control trial triple combination interferon beta-1b , lopinavir–ritonavir , ribavirin , compare single-drug lopinavir–ritonavir treatment patient admit hospital COVID-19 .', 'Treatment triple combination effectively suppress viral load clinical specimen , include nasopharyngeal swab , throat saliva , posterior oropharyngeal saliva , stool patient 8 day treatment commencement , significantly shorter time take control group , treat lopinavir–ritonavir alone .', 'The triple combination also alleviate symptom completely within 4 days—a significantly shorter time control .', 'The triple combination also suppress IL-6 level .', 'The clinical virological efficacy result shorter hospital stay facilitate infection control .', 'This treatment regimen also show safe , minor self-limiting gastrointestinal adverse event diarrhoea vomit .', 'Increased liver enzyme uncommon , resolve upon stop medications.Implications available evidenceThis study show early treatment triple combination antiviral therapy interferon beta-1b , lopinavir–ritonavir , ribavirin safe highly effective shorten duration virus shed , decrease cytokine response , alleviate symptom , facilitate discharge patient mild moderate COVID-19 .', 'Furthermore , triple antiviral therapy rapidly render viral load negative specimen , thereby reduce infectiousness patient .', 'Evidence study We search PubMed March 30 , 2020 , use term “ Covid-19 ” , “ interferon beta 1b ” , “ lopinavir/ ritonavir ” , “ treatment ” , “ hospitalize ” , “ patient ” , “ phase 2 ” , “ trial ” article English publish date search .', 'Our search show randomise control trial assess combination interferon beta-1b , lopinavir–ritonavir , ribavirin treatment patient coronavirus disease 2019 ( COVID-19 ) .', 'Added value study This first randomise control trial triple combination interferon beta-1b , lopinavir–ritonavir , ribavirin , compare single-drug lopinavir–ritonavir treatment patient admit hospital COVID-19 .', 'Treatment triple combination effectively suppress viral load clinical specimen , include nasopharyngeal swab , throat saliva , posterior oropharyngeal saliva , stool patient 8 day treatment commencement , significantly shorter time take control group , treat lopinavir–ritonavir alone .', 'The triple combination also alleviate symptom completely within 4 days—a significantly shorter time control .', 'The triple combination also suppress IL-6 level .', 'The clinical virological efficacy result shorter hospital stay facilitate infection control .', 'This treatment regimen also show safe , minor self-limiting gastrointestinal adverse event diarrhoea vomit .', 'Increased liver enzyme uncommon , resolve upon stop medication .', 'Implications available evidence This study show early treatment triple combination antiviral therapy interferon beta-1b , lopinavir–ritonavir , ribavirin safe highly effective shorten duration virus shed , decrease cytokine response , alleviate symptom , facilitate discharge patient mild moderate COVID-19 .', 'Furthermore , triple antiviral therapy rapidly render viral load negative specimen , thereby reduce infectiousness patient .', 'This phase 2 , multicentre , open-label , randomise trial .', 'Adult patient age least 18 year admit hospital Feb 10 , 2020 , virologically confirm COVID-19 , recruit Queen Mary Hospital , Pamela Youde Nethersole Hospital , Ruttonjee Hospital , United Christian Hospital , Queen Elizabeth Hospital , Tuen Mun Hospital Hong Kong .', 'These six major public hospital position across five seven hospital cluster , serve 75 % 7·5 million population .', 'Public health ordinance Hong Kong require patient test positive COVID-19 admit hospital .', 'Eligibility criterion study age least 18 year , national early warn score 2 ( NEWS2 ) least 1 , symptom duration 14 day le upon recruitment ( appendix pp 9–10 ) .', 'The institutional review board University Hong Kong Hospital Authority approve study ( UW20–074 ) .', 'All patient give write consent participation study .', 'Patients randomly assign either triple combination lopinavir–ritonavir , ribavirin , interferon beta-1b group control group ( lopinavir–ritonavir ) , ratio 2:1 , simple randomisation stratification .', 'Randomised treatment open-label .', 'Patients assign serial number study coordinator .', 'Each serial number link computer-generated randomisation list assign antiviral treatment regimen .', 'The study medication dispense hospital pharmacy patient medical ward nurse .', 'In combination group , patient recruit treat le 7 day symptom onset receive triple combination 14 day oral lopinavir–ritonavir ( lopinavir 400 mg ritonavir 100 mg ) every 12 h ( via nasogastric tube intubate patient ) , ribavirin 400 mg every 12 h , subcutaneous injection one three do interferon beta-1b 1 mL ( 8 million international unit [ IU ] ) alternate day depend day drug commencement ( commence day 1–2 symptom onset , patient receive three do interferon beta-1b ; commence day 3–4 , patient receive two do ; commence day 5–6 , patient receive one dose ) .', 'For recruit treat day 7 14 , interferon beta-1b injection omit avoid proinflammatory effect .', 'Patients assign control group receive oral lopinavir–ritonavir ( lopinavir 400 mg ritonavir 100 mg ) every 12 h 14 day .', 'For patient history prolong QTc syndrome , find prolong QTc le 480 m , first-degree heart block bundle branch block , bradycardia upon ECG examination , develop increase alanine transaminase three time upper limit normal ( ULN ) , lopinavir–ritonavir treatment reduce per day .', 'Lopinavir–ritonavir would stop alanine transaminase level exceed six time ULN .', 'The randomisation window symptom onset extend 10 14 day trial commencement know incubation period could go beyond 14 day .', 'Because placebo group generally accept Chinese culture , previous study show interferon beta-1b lopinavir–ritonavir active SARS-CoV MERS-CoV , lopinavir–ritonavir use control group whereas interferon beta-1b , lopinavir–ritonavir , ribavirin use combination group patient admit le 7 day symptom onset .', 'The intervention treatment start within 48 h hospital admission .', 'Standard care include oxygen , non-invasive invasive ventilatory support , extracorporeal membrane oxygenation support , dialysis support , antimicrobial treatment secondary bacterial infection indicate clinically .', 'Stress do corticosteroid ( 50 mg hydrocortisone every 8 h intravenously , taper 7 day ) give patient develop oxygen desaturation require oxygen support .', 'Non-invasive invasive ventilatory support beyond day 7 symptom onset discretion consultant .', 'Clinical find include history physical examination , laboratory radiological investigation result enter predesigned database .', 'Chest radiograph ECG take baseline regular interval monitor patient progress detect early cardiac rhythm change .', 'Patients underlie cardiac condition put cardiac monitor .', ""High-resolution CT do consultant ' discretion ."", 'All patient follow infectious disease clinic within 30 day discharge .', 'Initial diagnosis SARS-CoV-2 infection make upon admission .', 'All recruit patient laboratory confirm SARS-CoV-2 infection RT-PCR nasopharyngeal swab .', 'Daily nasopharyngeal swab , posterior oropharyngeal saliva , throat swab , stool rectal swab , urine available , obtain discharge , quantification viral load genetic mutation test ( appendix pp 20–23 ) .', 'Complete blood count , liver renal function test , lactate dehydrogenase , creatine kinase , C-reactive protein , erythrocyte sedimentation rate , cytokine profile regularly check discharge ( appendix p 21 ) .', 'Blood urine sample bacterial culture take clinically indicate .', ""The nasopharyngeal swab upon admission assess BioFire FilmArray Respiratory Panel 2 plus ( bioMérieux , Marcy l'Etoile , France ) ."", 'Methods assay quantitative RT-PCR , serum cytokine profile , nanopore sequence nsp5 mutation appendix ( pp 20–23 ) .', 'The primary endpoint time achieve negative RT-PCR result SARS-CoV-2 nasopharyngeal swab sample .', 'Secondary clinical endpoint time resolution symptom define NEWS2 0 maintain 24 h ; daily NEWS2 sequential organ failure assessment ( SOFA ) score ; length hospital stay ; 30-day mortality .', 'Other virological endpoint include time achieve negative SARS-CoV-2 RT-PCR clinical sample , include nasopharyngeal swab , posterior oropharyngeal saliva , throat swab , stool , urine ; daily viral load change first 7 day ; emergence amino acid mutation nsp5 gene encode 3C-like protease .', 'The serum cytokine response also measure .', 'Safety endpoint frequency duration adverse event .', 'It important note COVID-19 new disease cause SARS-CoV-2 , phylogenetically closest 2003 SARS-CoV .', 'At time study design mid-January , 2020 , insufficient information mortality COVID-19 .', 'Thus , base sample size calculation find lopinavir–ritonavir treatment trial 2003 SARS-CoV.7Chu CM Cheng VC Hung IF et al.Role lopinavir/ritonavir treatment SARS : initial virological clinical findings.Thorax .', '2004 ; 59 : 252-256Google Scholar The current study design basis estimate difference 26·4 % 21-day mortality acute respiratory distress syndrome rate patient severe SARS-CoV-2 infection , treat lopinavir–ritonavir ( 2·4 % ) versus historical control without antiviral treatment ( 28·8 % ) .', 'The necessary sample size calculate 30 patient per group detect difference two-sided α level 0·05 , 80 % power .', 'The protocol propose recruit least 35 patient per group allow 17 % dropout rate .', 'The primary endpoint assess intention-to-treat population randomise patient .', 'Safety assess patient receive least one dose assign drug .', 'Categorical variable compare use χ2 test continuous variable compare use Mann-Whitney U test , intention-to-treat subgroup analysis .', 'For viral load , specimen undetectable viral load assign value 1 log10 copy per mL purpose statistical analysis .', 'Hazard ratio ( HRs ) 95 % CIs calculate Cox proportional hazard model .', 'Factors significant univariable analysis ( p < 0·10 ) assess mean multivariable analysis Cox proportional hazard model identify independent factor negative nasopharyngeal swab RT-PCR day 7 treatment .', 'A p value le 0·05 consider statistically significant .', 'Statistical analysis perform use SPSS , version 26.0 PRISM , version 8 .', 'The study register ClinicalTrials.gov , NCT04276688 .', 'The funders role study design , data collection , data analysis , data interpretation , write report .', 'The correspond author full access data study final responsibility decision submit publication .', 'Between Feb 10 March 20 , 2020 , 144 patient screen , 127 patient recruit ( figure 1 ) .', 'The number patient screen account 80 % confirm COVID-19 case Hong Kong period .', 'Nine patient fulfil inclusion criterion ( four second-degree third-degree cardiac arrhythmia , two severe depression , three pregnancy ) eight patient decline treatment regimen .', 'One patient control group require discontinuation lopinavir–ritonavir alanine transaminase six time greater ULN 1 week treatment .', 'The median age 52 year ( IQR 32–62 ) ; 68 ( 54 % ) patient men versus 59 ( 46 % ) woman ( table 1 ) .', '51 ( 40 % ) patient underlie disease .', ""The median time hospital admission symptom onset 5 day ( IQR 3–7 ) .Figure 1Trial profileView Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Table 1Baseline demographic study populationCombination group ( n=86 ) Control group ( n=41 ) Age51·0 ( 31·0–61·3 ) 52·0 ( 33·5–62·5 ) SexMen45 ( 52 % ) 23 ( 56 % ) Women41 ( 48 % ) 18 ( 44 % ) Time symptom onset start treatment , days5 ( 4–7 ) 4 ( 3–8 ) Underlying diseasesDiabetes11 ( 13 % ) 6 ( 15 % ) Hypertension23 ( 27 % ) 13 ( 32 % ) Coronary artery disease5 ( 6 % ) 5 ( 12 % ) Cerebrovascular disease1 ( 1 % ) 1 ( 2 % ) Hyperlipidaemia18 ( 21 % ) 11 ( 27 % ) Thyroid disease3 ( 3 % ) 1 ( 2 % ) Obstructive sleep apnoea1 ( 1 % ) 1 ( 2 % ) Crohn 's disease1 ( 1 % ) 0Epilepsy1 ( 1 % ) 0Tuberculosis2 ( 2 % ) 0Chronic hepatitis B2 ( 2 % ) 1 ( 2 % ) Chronic hepatitis C01 ( 2 % ) Malignancy1 ( 1 % ) 1 ( 2 % ) Smoker6 ( 7 % ) 1 ( 2 % ) Symptoms signsFever70 ( 81 % ) 32 ( 78 % ) Chills13 ( 15 % ) 6 ( 15 % ) Cough45 ( 52 % ) 23 ( 56 % ) Sputum29 ( 34 % ) 13 ( 32 % ) Shortness breath7 ( 8 % ) 7 ( 17 % ) Sore throat16 ( 19 % ) 10 ( 24 % ) Myalgia10 ( 12 % ) 8 ( 20 % ) Malaise19 ( 22 % ) 5 ( 12 % ) Nausea vomiting1 ( 1 % ) 0Diarrhoea17 ( 20 % ) 7 ( 17 % ) Rhinorrhoea14 ( 16 % ) 10 ( 24 % ) Anosmia4 ( 5 % ) 1 ( 2 % ) Headache3 ( 3 % ) 3 ( 7 % ) Chest tightness2 ( 2 % ) 0Anorexia1 ( 1 % ) 0Baseline laboratory find ( normal range ) Haemoglobin ( 11·5–14·8 g/dL ) 13·4 ( 12·7–14·9 ) 13·5 ( 12·7–14·8 ) White cell count ( 3·89–9·93 × 109 per L ) 4·9 ( 3·7–6·2 ) 5·4 ( 4·6–6·4 ) Neutrophils ( 2·01–7·42 × 109 per L ) 3·4 ( 2·4–4·3 ) 3·5 ( 2·9–4·5 ) Lymphocytes ( 1·06–3·61 × 109 per L ) 1·0 ( 0·8–1·5 ) 1·3 ( 0·9–1·6 ) Platelets ( 154–371 × 109 per L ) 195·0 ( 171·8–260·0 ) 192·0 ( 160·5–244·5 ) Alanine aminotransferase ( 8–45 U/L ) 23·0 ( 15·0–33·3 ) 26·0 ( 14·5–43·0 ) Alkaline phosphatase ( 42–110 U/L ) 58·0 ( 48·0–75·0 ) 65·0 ( 52·5–75·0 ) Lactate dehydrogenase ( 143–280 U/L ) 194·0 ( 159·8–249·0 ) 167·5 ( 142·0–200·0 ) Bilirubin ( 4–23 μmol/L ) 7·9 ( 5·5–9·0 ) 7·5 ( 6·0–10·8 ) Creatinine ( 49–82 μmol/L ) 75·5 ( 65·0–92·0 ) 76·0 ( 62·5–96·0 ) Urea ( 2·9–8·0 mmol/L ) 4·0 ( 2·9–4·8 ) 3·7 ( 2·7–4·6 ) Creatine kinase ( 22–198 U/L ) 79·0 ( 50·0–151·0 ) 90·5 ( 54·5–141·5 ) C-reactive protein ( < 0·76 mg/dL ) 3·0 ( 2·0–9·2 ) 3·0 ( 1·5–7·2 ) Erythrocyte sedimentation rate ( < 12 mm/h ) 19·0 ( 11·0–48·0 ) 19·0 ( 9·8–37·8 ) Baseline radiological find ( % ) Abnormal chest x-ray64 ( 74 % ) 32 ( 78 % ) Right upper zone infiltrate00 ( 0 % ) Right middle zone infiltrate4 ( 5 % ) 6 ( 15 % ) Right lower zone infiltrate38 ( 44 % ) 18 ( 44 % ) Left upper zone infiltrate1 ( 1 % ) 0Left middle zone infiltrate7 ( 8 % ) 7 ( 17 % ) Left lower zone infiltrate27 ( 31 % ) 10 ( 24 % ) High-resolution CT ( perform 22 patient ) 14 ( 16 % ) 6 ( 15 % ) Data n ( % ) median ( IQR ) ."", 'In combination group 52 patient treat triple combination interferon beta-1b , lopinavir–ritonavir , ribavirin 34 patient treat lopinavir–ritonavir ribavirin ; control group , 41 patient treat lopinavir–ritonavir .', 'U/L=units per L. Open table new tab Data n ( % ) median ( IQR ) .', 'In combination group 52 patient treat triple combination interferon beta-1b , lopinavir–ritonavir , ribavirin 34 patient treat lopinavir–ritonavir ribavirin ; control group , 41 patient treat lopinavir–ritonavir .', 'U/L=units per L. Among 127 patient , 86 randomly assign combination group 41 patient assign control group .', 'Within combination group , 52 patient admit hospital le 7 day symptom onset receive lopinavir–ritonavir , ribavirin , interferon beta-1b regimen , 34 patient admit 7 day symptom onset receive lopinavir–ritonavir ribavirin regimen .', 'The median number do interferon beta-1b receive two .', 'Median time symptom onset start treatment 5 day ( 4–7 ) combination group 4 day ( 3–8 ) control group ( table 1 ) .', 'The age , sex , baseline demographic group similar .', 'Fever unproductive cough common present sign symptom .', 'Both diarrhoea anosmia infrequent .', 'Most patient lymphopenia increase C-reactive protein erythrocyte sedimentation rate upon presentation .', 'One patient combination group concomitant rhinovirus infection upon presentation .', 'Disease severity upon presentation mild base NEWS2 SOFA score ( table 2 ) .Table 2Clinical , viral load , cytokine profile concomitant treatmentsCombination group ( n=86 ) Control group ( n=41 ) p valueNEWS2Baseline2 ( 1–2 ) 2 ( 2–2 ) 0·52Day 11 ( 1–2 ) 2 ( 2–2 ) < 0·0001Day 21·0 ( 0·0–2·0 ) 2·0 ( 1·5–3·0 ) < 0·0001Day 30 ( 0–1 ) 2 ( 1–3 ) < 0·0001Day 40 ( 0–1 ) 2 ( 1–2 ) < 0·0001Day 50 ( 0–1 ) 2 ( 1–2 ) < 0·0001Day 60·0 ( 0·0–1·0 ) 1·5 ( 1·0–2·0 ) < 0·0001Day 70·0 ( 0·0–1·0 ) 1·0 ( 0·8–2·0 ) 0·0010Time NEWS2 0 , days4 ( 3–8 ) 8 ( 7–9 ) < 0·0001SOFA scoreBaseline0 ( 0–1 ) 0 ( 0–1 ) 0·38Day 10 ( 0–1 ) 0 ( 1–1 ) 0·21Day 20 ( 0–2 ) 1 ( 0–2 ) 0·025Day 30 ( 0–2 ) 1 ( 0–2 ) 0·010Day 40·0 ( 0·0–1·3 ) 1·0 ( 0·0–2·0 ) 0·012Day 50 ( 0–1 ) 1 ( 0–2 ) 0·010Day 60 ( 0–1 ) 1 ( 0–2 ) 0·035Day 70 ( 0–1 ) 1 ( 0–2 ) 0·028Time SOFA score 0 , days3·0 ( 1·0–8·0 ) 8·0 ( 6·5–9·0 ) 0·041Duration hospital stay , days9·0 ( 7·0–13·0 ) 14·5 ( 9·3–16·0 ) 0·01630-day mortality0 ( 0 ) 0 ( 0 ) 1·00Time negative viral load , daysNasopharyngeal swab7 ( 5–11 ) 12 ( 8–15 ) 0·0010Posterior oropharyngeal saliva6·0 ( 3·0–8·0 ) 8·0 ( 5·3–10·8 ) 0·044Throat swab4·5 ( 1·3–6·8 ) 7·0 ( 3·0–12·0 ) 0·039Stool5 ( 2–5 ) 7 ( 4–8 ) 0·030All specimens8 ( 6–12 ) 13 ( 8–15 ) 0·0010Virological find ( RT-PCR ) , log10 copy per mLNasopharyngeal swab ( baseline ) 6·4 ( 4·5–8·0 ) 6·4 ( 3·9–7·7 ) 0·70Posterior oropharyngeal saliva ( baseline ) * * Stress-dose steroid hydrocortisone 50 mg every 8 h intravenously , taper 5–7 days.5·2 ( 3·8–7·0 ) 5·3 ( 4·3–7·1 ) 0·54Throat swab ( baseline ) 4·6 ( 2·9–6·1 ) 4·5 ( 3·7–5·7 ) 0·85Stool ( baseline ) 3·3 ( 2·7–5·3 ) 3·8 ( 2·6–7·3 ) 0·53Cytokine concentration , log10 pg/mLIL-6 ( baseline ) 1·4 ( 1·0–1·4 ) 1·4 ( 1·0–1·6 ) 0·43TNFα ( baseline ) 1 ( 1–1 ) 1 ( 1–1 ) 1·00Concomitant treatmentsOxygen therapy12 ( 14 % ) 5 ( 12 % ) 0·72Non-invasive ventilator support3 ( 3 % ) 2 ( 5 % ) 0·75Ventilator support01 ( 2 % ) 0·15Antibiotics44 ( 51 % ) 25 ( 61 % ) 0·33Amoxicillin–clavulanate29 ( 34 % ) 21 ( 51 % ) 0·080Azithromycin7 ( 8 % ) 4 ( 10 % ) 0·76Ceftriaxone12 ( 14 % ) 8 ( 20 % ) 0·42Doxycycline13 ( 15 % ) 8 ( 20 % ) 0·53Levofloxacin11 ( 13 % ) 3 ( 7 % ) 0·36Piperacillin–tazobactam5 ( 6 % ) 00·12Corticosteroid ( stress dose ) * * Stress-dose steroid hydrocortisone 50 mg every 8 h intravenously , taper 5–7 days.6 ( 7 % ) 2 ( 5 % ) 0·65Data median ( IQR ) n ( % ) .', 'NEWS2=national early warn score 2 .', 'SOFA=sequential organ failure assessment .', '* Stress-dose steroid hydrocortisone 50 mg every 8 h intravenously , taper 5–7 day .', 'Open table new tab Data median ( IQR ) n ( % ) .', 'NEWS2=national early warn score 2 .', 'SOFA=sequential organ failure assessment .', 'For primary endpoint time start study treatment negative nasopharyngeal swab , combination group significantly shorter median time ( 7 day [ IQR 5–11 ] ) control group ( 12 day [ 8–15 ] ; HR 4·37 [ 95 % CI 1·86–10·24 ] , p=0·0010 ; table 2 ) .', 'Clinical improvement significantly better combination group , significantly shorter time complete alleviation symptom , define NEWS2 0 ( 4 day [ IQR 3–8 ] combination group v 8 day [ 7–9 ] control group ; HR 3·92 [ 95 % CI 1·66–9·23 ] , p < 0·0001 ) SOFA score 0 ( 3·0 day [ 1·0–8·0 ] v 8·0 day [ 6·5–9·0 ] ; HR 1·89 [ 1·03–3·49 ] , p=0·041 ; table 2 ) .', 'A similar pattern observe daily NEWS2 ( p < 0·0001 ; figure 2A ) daily SOFA score treatment ( p < 0·05 except day 1 [ p=0·21 ] ; table 2 ) .', 'The significantly better clinical virological response also reflect shorter median hospital stay combination group control group ( 9·0 day [ 7·0–13·0 ] v 14·5 day [ 9·3–16·0 ] ; HR 2·72 [ 1·2–6·13 ] , p=0·016 ) .Figure 2Outcomes timeShow full caption ( A ) National early warn score 2 ; ( B ) nasopharyngeal swab viral load ; ( C ) posterior oropharyngeal saliva viral load ; ( D ) throat swab viral load ; ( E ) stool viral load ; ( F ) serum IL-6 cytokine concentration ( first 60 recruit patient ) .', 'Data point median error bar IQRs.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) National early warn score 2 ; ( B ) nasopharyngeal swab viral load ; ( C ) posterior oropharyngeal saliva viral load ; ( D ) throat swab viral load ; ( E ) stool viral load ; ( F ) serum IL-6 cytokine concentration ( first 60 recruit patient ) .', 'Data point median error bar IQRs .', 'For virological outcome , combination treatment associate significantly shorter time negative viral load specimen assess individually ( nasopharyngeal swab , posterior oropharyngeal saliva , throat swab , stool sample ) well specimen combine ( table 2 ) .', 'All urine sample test negative viral load .', 'All patient SARS-CoV-2 positive baseline nasopharyngeal swab .', 'With regard clinical sample , 108 ( 85 % ) patient provide posterior oropharyngeal saliva sample , 99 ( 78 % ) provide throat swab , 36 ( 28 % ) provide stool sample , 83 ( 65 % ) provide urine sample .', 'The baseline viral load specimen similar combination group control group ( table 2 ) .', 'The nasopharyngeal swab viral load significantly lower combination group control group day 1 day 7 treatment ( figure 2B ) .', 'Similar result find posterior oropharyngeal saliva , throat swab , stool specimen treatment ( figure 2C–E ) .', 'Post-hoc subgroup comparison 76 patient start treatment le 7 day onset symptom show better clinical virological outcome combination group ( 52 patient , receive lopinavir–ritonavir , ribavirin , interferon beta-1b ) control group ( 24 patient ; table 3 ) across measure variable except stool sample .', 'However , significant difference treatment group measure outcome 51 patient treat 7 day symptom onset ( 34 combination group [ receive lopinavir–ritonavir ribavirin ] 17 control group ; appendix p 31 ) .Table 3Subgroup analysis clinical , viral load , cytokine profileStarted treatment < 7 day symptom onsetStarted treatment ≥7 day symptom onsetCombination group ( interferon beta-1b ; n=52 ) Control group ( n=24 ) p valueCombination group ( without interferon beta-1b ; n=34 ) Control group ( n=17 ) p valueNEWS2Baseline2 ( 1–2 ) 2 ( 2–2 ) 0·112 ( 1–2 ) 2 ( 1–2 ) 0·49Day 11 ( 1–1 ) 2 ( 2–2 ) < 0·00012 ( 1–2 ) 2 ( 1–2 ) 0·71Day 21·0 ( 0·0–1·0 ) 2·0 ( 1·5–3·0 ) < 0·00011·5 ( 1·0–2·0 ) 2·0 ( 1·0–2·8 ) 0·41Day 30·0 ( 0·0–1·0 ) 2·0 ( 1·0–3·0 ) < 0·00011·0 ( 1·0–2·0 ) 2·0 ( 0·3–2·8 ) 0·16Day 40·0 ( 0·0–0·0 ) 2·0 ( 1·0–2·5 ) < 0·00011·0 ( 1·0–2·0 ) 2·0 ( 0·3–2·0 ) 0·37Day 50 ( 0–0·5 ) 2 ( 1–2 ) < 0·00011 ( 0–1 ) 2 ( 0–2 ) 0·040Day 60 ( 0–0·3 ) 1 ( 1–2 ) < 0·00011 ( 0–1 ) 1 ( 0–2 ) 0·14Day 70 ( 0–0 ) 1 ( 0–2 ) < 0·00011 ( 0–1 ) 1 ( 0–1 ) 0·68Time NEWS2 0 , days4·0 ( 3·0–5·0 ) 8·0 ( 6·5–9·0 ) < 0·00016·0 ( 5·0–10·8 ) 8·0 ( 5·5–8·0 ) 0·90SOFA scoreBaseline0 ( 0–1 ) 0 ( 0–1 ) 0·991 ( 0–1 ) 0 ( 0–1 ) 0·17Day 10·0 ( 0·0–1·0 ) 1·0 ( 0·0–1·0 ) 0·0301·0 ( 0·0–2·0 ) 1·0 ( 0·0–1·5 ) 0·67Day 20 ( 0–1 ) 1 ( 0–2 ) 0·00601 ( 0–2 ) 1 ( 0–2 ) 0·72Day 30 ( 0–1 ) 1 ( 0–2 ) 0·00501 ( 0–2 ) 1 ( 0–3 ) 0·49Day 40 ( 0–1 ) 1 ( 0–2 ) 0·00601 ( 0–2 ) 1 ( 0–3 ) 0·48Day 50·0 ( 0·0–0·8 ) 1·0 ( 0·0–2·0 ) 0·00301·0 ( 0·0–2·0 ) 1·0 ( 0·0–3·0 ) 0·55Day 60·0 ( 0·0–0·0 ) 0·5 ( 0·0–2·0 ) 0·00101·0 ( 0·0–2·0 ) 1·0 ( 0·0–2·0 ) 0·88Day 70·0 ( 0·0–0·0 ) 0·5 ( 0·0–2·0 ) < 0·00011·0 ( 0·0–2·0 ) 1·0 ( 0·0–2·0 ) 0·88Time SOFA score 0 , days3 ( 1–5 ) 7 ( 1–9 ) 0·00108 ( 1–8 ) 8 ( 1–9 ) 0·23Duration hospital stay , days8 ( 6–12·5 ) 15 ( 9–16 ) 0·003013 ( 8–15 ) 13·5 ( 12·3–21·8 ) 0·09030-day mortality0 ( 0 ) 0 ( 0 ) 1·000 ( 0 ) 0 ( 0 ) 1·00Time negative viral load , daysNasopharyngeal swab6·5 ( 4·0–8·0 ) 12·5 ( 8·0–14·8 ) < 0·000110·5 ( 8·0–12·3 ) 12·0 ( 8·0–17·0 ) 0·10Posterior oropharyngeal saliva6·0 ( 2·0–7·0 ) 8·5 ( 5·3–11·8 ) < 0·00018·0 ( 6·0–9·0 ) 8·0 ( 5·3–9·0 ) 0·79Throat swab4·0 ( 1·0–6·0 ) 8·0 ( 3·3–12·8 ) 0·00105·0 ( 1·5–8·0 ) 4·5 ( 2·0–9·0 ) 0·52Stool4·5 ( 2·0–5·0 ) 6·0 ( 3·0–7·0 ) 0·0705·0 ( 2·0–10·0 ) 7·0 ( 5·5–8·5 ) 0·14All specimens7·0 ( 4·0–9·0 ) 13·0 ( 8·0–14·0 ) < 0·000112·0 ( 7·8–14·0 ) 12·0 ( 12·0–19·0 ) 0·080Virological find ( RT-PCR ) , log10 copy per mLNasopharyngeal swab ( baseline ) 7 ( 5·2–8·4 ) 6·1 ( 4·3–7·7 ) 0·295·5 ( 3·8–7·3 ) 6·6 ( 3·8–8 ) 0·65Posterior oropharyngeal saliva ( baseline ) 5·4 ( 3·9–7·3 ) 5·3 ( 3·9–7·5 ) 0·864·8 ( 3·8–6·2 ) 5·4 ( 4·9–6·8 ) 0·30Throat swab ( baseline ) 4·8 ( 3·2–6·9 ) 4·4 ( 3·5–6·1 ) 0·814·5 ( 1·0–5·6 ) 5·0 ( 4·0–5·5 ) 0·52Stool ( baseline ) 3·2 ( 1·9–6·2 ) 3·2 ( 2·9–5·6 ) 0·853·3 ( 2·8–3·9 ) 5·6 ( 1·9–7·4 ) 0·48Cytokine concentration , log10 pg/mLIL-6 ( baseline ) 1·4 ( 1–1·5 ) 1·4 ( 1·4–1·6 ) 0·131·4 ( 1–1·4 ) 1 ( 1–1·6 ) 0·45TNFα ( baseline ) 1 ( 1–1 ) 1 ( 1–1 ) 0·871 ( 1–1 ) 1 ( 1–1 ) 0·82Data median ( IQR ) .', 'NEWS2=national early warn score 2 .', 'SOFA=sequential organ failure assessment .', 'Open table new tab Data median ( IQR ) .', 'NEWS2=national early warn score 2 .', 'SOFA=sequential organ failure assessment .', '17 ( 13 % ) 127 patient develop oxygen desaturation require oxygen treatment ( table 2 ) .', 'Six ( 5 % ) patient admit intensive care unit , five require non-invasive ventilator support one 96-year-old female patient past medical history coronary artery disease require intubation ventilator support .', 'She control group successfully extubated 10 day intensive care .', '69 ( 54 % ) patient receive concomitant antibiotic .', 'Eight ( 6 % ) patient give stress do corticosteroid second week symptom onset .', 'The serum cytokine profile analyse first 84 recruit patient .', 'The IL-6 concentration combination group significantly lower control group day 2 , 6 , 8 ( figure 2F ) .', 'TNFα concentration IL-10 concentration significantly different group .', 'No significant nsp5 mutation identify serial nasopharyngeal swab sample .', 'Multivariable analysis show combination group normal baseline chest x-ray independently associate day 7 negative nasopharyngeal swab viral load .', 'Of two , combination group significant independent factor ( HR 4·27 [ 95 % CI 1·82–10·02 ] , p=0·0010 ; appendix p 30 ) .', 'Adverse event report 41 ( 48 % ) 86 patient combination group 20 ( 49 % ) 41 patient control group .', 'The common adverse event diarrhoea ( 52 [ 41 % ] 127 patient ) , fever ( 48 [ 38 % ] patient ) , nausea ( 43 [ 34 % ] ) raise alanine transaminase level ( 18 [ 14 % ] ; table 4 ) .', 'These side-effects mostly resolve within 3 day drug initiation .', 'Sinus bradycardia report four ( 3 % ) patient .', 'There difference incidence adverse event duration nausea diarrhoea treatment group .', 'The peak median alanine transaminase concentration 38·0 unit per L ( 24·5–62·5 ) peak median bilirubin 22·0 μmol/L ( 17·0–32·5 ) , patient .', 'No serious adverse event report combination group .', 'One patient control group serious adverse event impair hepatic enzyme require discontinuation treatment .', 'No patient die study.Table 4Adverse event study populationCombination group ( n=86 ) Control group ( n=41 ) p valueAdverse eventsNausea30 ( 35 % ) 13 ( 32 % ) 0·87Diarrhoea34 ( 40 % ) 18 ( 44 % ) 0·54Increased alanine aminotransferase11 ( 13 % ) 7 ( 17 % ) 0·32Hyperbilirubinaemia4 ( 5 % ) 3 ( 7 % ) 0·54Sinus bradycardia3 ( 4 % ) 1 ( 2 % ) 0·77Fever32 ( 37 % ) 16 ( 39 % ) 0·73Serious adverse events01 ( 2 % ) 0·15Duration nausea , days2 ( 1–2 ) 2 ( 1–2 ) 0·80Duration diarrhoea , days3 ( 3–3 ) 3 ( 3–3 ) 0·88 Open table new tab In multicentre randomise open-label phase 2 trial patient COVID-19 , show triple combination injectable interferon ( interferon beta-1b ) , oral protease inhibitor ( lopinavir–ritonavir ) , oral nucleoside analogue ( ribavirin ) , give within 7 day symptom onset , effective suppress shed SARS-CoV-2 , nasopharyngeal swab , clinical specimen , compare lopinavir–ritonavir alone .', 'Furthermore , significant reduction duration RT-PCR positivity viral load associate clinical improvement show significant reduction NEWS2 duration hospital stay .', 'Most patient treat triple combination RT-PCR negative specimen day 8 .', 'The side-effects generally mild self-limiting .', 'Specific highly active antiviral drug always need novel emerge infectious disease development new antiviral take year approval clinical use .', 'Therefore , drug repurposing test exist broad-spectrum antiviral drug use treat viral infection feasible approach pandemic .', 'Many drug show in-vitro activity betacoronaviruses , include remdesivir , favipiravir , nitazoxanide , camostat mesilate , interferon , lopinavir–ritonavir , ribavirin , chloroquine , hydroxychloroquine , convalescent plasma contain neutralise antibodies.5Chen F Chan KH Jiang Y et al.In vitro susceptibility 10 clinical isolate SARS coronavirus select antiviral compounds.J Clin Virol .', '2004 ; 31 : 69-75Google Scholar , 6Chan JF Chan KH Kao RY et al.Broad-spectrum antiviral emerge Middle East respiratory syndrome coronavirus.J Infect .', '2013 ; 67 : 606-616Google Scholar , 7Chu CM Cheng VC Hung IF et al.Role lopinavir/ritonavir treatment SARS : initial virological clinical findings.Thorax .', '2004 ; 59 : 252-256Google Scholar , 8Chan JF Yao Y Yeung ML et al.Treatment lopinavir/ritonavir interferon-β1b improve outcome MERS-CoV infection nonhuman primate model common marmoset.J Infect Dis .', '2015 ; 212 : 1904-1913Google Scholar , 13Agostini ML Andres EL Sims AC et al.Coronavirus susceptibility antiviral remdesivir ( GS-5734 ) mediate viral polymerase proofread exoribonulcease.MBio .', '2018 ; 9 : e00221-e00318Google Scholar , 14Li G De Clercq E Therapeutic option 2019 novel coronavirus ( 2019-nCoV ) .Nat Rev Drug Discov .', '2020 ; 19 : 149-150Google Scholar , 15Wang M Cao R Zhang L et al.Remdesivir chloroquine effectively inhibit recently emerge novel coronavirus ( 2019-nCoV ) vitro.Cell Res .', '2020 ; 30 : 269-271Google Scholar , 16Rossignol JF Nitazoxanide , new drug candidate treatment Middle East respiratory syndrome coronavirus.J Infect Public Health .', '2016 ; 9 : 227-230Google Scholar , 17Beigel JH Nam HH Adams PL et al.Advances respiratory virus therapeutic - meet report 6th isirv Antiviral Group conference.Antiviral Res .', '2019 ; 167 : 45-67Google Scholar , 18Sheahan TP Sims AC Leist SR et al.Comparative therapeutic efficacy remdesivir combination lopinavir , ritonavir , interferon beta MERS-CoV.Nat Commun .', '2020 ; 11 : 222Google Scholar , 19Mair-Jenkins J Saavedra-Campos M Baillie JK et al.The effectiveness convalescent plasma hyperimmune immunoglobulin treatment severe acute respiratory infection viral etiology : systematic review exploratory meta-analysis.J Infect Dis .', '2015 ; 211 : 80-90Google Scholar , 20Cunningham AC Goh HP Koh D Treatment COVID-19 : old trick new challenges.Crit Care .', '2020 ; 24 : 91Google Scholar , 21Dong L Hu S Gao J Discovering drug treat coronavirus disease 2019 ( COVID-19 ) .Drug Discov Ther .', '2020 ; 14 : 58-60Google Scholar These drug know pharmacokinetic pharmacodynamic property , side-effects , dose regimen .', 'As expect , lopinavir–ritonavir alone show similar effect placebo reduce viral load treatment initiate median 13 day symptom onset , despite improvement symptoms.22Cao B Wang Y Wen D et al.A trial lopinavir-ritonavir adult hospitalize severe Covid-19.N Engl J Med .', '2020 ; ( publish online March 18 .', ') DOI:10.1056/NEJMoa2001282Google Scholar Up , two open-label non-randomised trial report .', ""One trial use combination oral hydroxychloroquine azithromycin 20 patient COVID-19 show combination might reduce viral load significantly day 6 treatment , compare 16 control another hospital , could due chance combination plan priori addition azithromycin physician 's discretion.23Gautret P Lagier JC Parola P et al.Hydroxychloroquine azithromycin treatment COVID-19 : result open-label non-randomized clinical trial.Int J Antimicrob Agents ."", '2020 ; ( publish online March 20 .', ') DOI:10.1016/j.ijantimicag.2020.105949Google Scholar A small retrospective analysis show viral load negative day 7 post-treatment 75 % patient COVID-19 treat arbidol lopinavir–ritonavir ( 16 patient ) versus 35 % patient treat lopinavir–ritonavir alone ( 17 patient ) .24Deng L Li C Zeng Q et al.Arbidol combine LPV/r versus LPV/r alone Corona Virus Disease 2019 : retrospective cohort study.J Infect .', '2020 ; ( publish March 11 .', ') DOI:10.1016/j.jinf.2020.03.002Google Scholar Under Hong Kong Special Administrative Region public health ordinance , patient COVID-19 must stay hospital nasopharyngeal swab viral load negative 2 consecutive day .', 'Thus , patient admit hospital within 7 day symptom onset , allow recruitment clinical trial early course COVID-19 .', 'With memory 2003 SARS pandemic , patient COVID-19 Hong Kong accept antiviral treatment , explain high recruitment rate .', 'Despite open-label study , patient enrol consecutively without bias .', 'Our case demographic proportion patient underlie disease similar report cohort China .', 'The low crude mortality rate Hong Kong ( four [ 0·4 % ] 1041 case ) could explain highly vigilant infection control measure , efficient contact trace , early hospital admission treatment .', 'Early treatment triple combination modestly active antiviral appropriate treatment COVID-19 viral load SARS-CoV-2 peak around time symptom onset .', 'This unlike situation SARS MERS antiviral treatment time suppress viral load peak around day 7–10 symptom onset .', 'The viral load profile COVID-19 similar influenza , high viral load time initiation anti-influenza treatment .', 'The emergence resistant influenza virus quasispecies treatment well report single-drug treatment amantadine , baloxavir marboxil , oseltamivir set severe influenza disease cause H5N1 , H7N9 , immunosuppressed hosts.11Dunning J Baillie JK Cao B Hayden FG Antiviral combination severe influenza.Lancet Infect Dis .', '2014 ; 14 : 1259-1270Google Scholar , 17Beigel JH Nam HH Adams PL et al.Advances respiratory virus therapeutic - meet report 6th isirv Antiviral Group conference.Antiviral Res .', '2019 ; 167 : 45-67Google Scholar , 25Hayden FG Sugaya N Hirotsu N et al.Baloxavir marboxil uncomplicated influenza adult adolescents.N Engl J Med .', '2018 ; 379 : 913-923Google Scholar Thus , antiviral combination consider reasonable option improve outcome severe influenza .', 'Indeed , previously show combination naproxen clarithromycin , weak anti-influenza virus activity vitro individually , combine oseltamivir improve morbidity mortality shorten duration hospital stay patient influenza A/H3N2 pneumonia.12Hung IFN To KKW Chan JFW et al.Efficacy clarithromycin-naproxen-oseltamivir combination treatment patient hospitalize influenza A ( H3N2 ) infection : open-label randomize , control , phase IIb/III trial.Chest .', '2017 ; 151 : 1069-1080Google Scholar Furthermore , previously show combination lopinavir–ritonavir ribavirin significantly reduce mortality respiratory failure patient 2003 SARS outbreak.7Chu CM Cheng VC Hung IF et al.Role lopinavir/ritonavir treatment SARS : initial virological clinical findings.Thorax .', '2004 ; 59 : 252-256Google Scholar Thus , hypothesise triple combination modest antiviral drug might rapidly suppress high initial viral load , improve clinical parameter , reduce risk health-care worker reduce duration quantity virus shed treat patient .', 'An in-vitro study cell culture-based assay show 50 % effective concentration ( EC50 ) lopinavir SARS-CoV 17 μM MERS-CoV 8 μM , whereas peak serum lopinavir concentration 15 μM half-life 7·4–10·8 h oral dose 400 mg lopinavir 100 mg ritonavir.26de Wilde AH Jochmans D Posthuma CC et al.Screening FDA-approved compound library identify four small-molecule inhibitor Middle East respiratory syndrome coronavirus replication cell culture.Antimicrob Agents Chemother .', '2014 ; 58 : 4875-4884Google Scholar The EC50 interferon beta-1b 0·12 IU/mL SARS-CoV 17·6 IU/mL MERS-CoV,6Chan JF Chan KH Kao RY et al.Broad-spectrum antiviral emerge Middle East respiratory syndrome coronavirus.J Infect .', '2013 ; 67 : 606-616Google Scholar , 27Tan EL Ooi EE Lin CY et al.Inhibition SARS coronavirus infection vitro clinically approve antiviral drugs.Emerg Infect Dis .', '2004 ; 10 : 581-586Google Scholar whereas peak serum level 20 IU/mL half-life 2–5 h single subcutaneous dose 8 million IU .', 'Notably , maintenance high serum interferon beta-1b level essential antiviral status expose cell induce .', 'The EC50 ribavirin SARS-CoV-2 109 μM,15Wang M Cao R Zhang L et al.Remdesivir chloroquine effectively inhibit recently emerge novel coronavirus ( 2019-nCoV ) vitro.Cell Res .', ""2020 ; 30 : 269-271Google Scholar greatly exceed drug 's serum concentration usual oral dose ."", 'Nevertheless , synergistic activity interferon lower dose ribavirin show checkerboard assay .', 'However , combine ribavirin interferon ( alfa-2a , alfa-2b , beta-1a ) improve outcome critically ill patient MERS.28Arabi YM Shalhoub S Mandourah Y et al.Ribavirin interferon therapy critically ill patient Middle East Respiratory Syndrome : multicentre observational study.Clin Infect Dis .', '2020 ; 70 : 1837-1844Google Scholar Thus , repurposing triple combination modestly active lopinavir–ritonavir , interferon beta-1b , ribavirin treatment novel pandemic virus reasonable therapeutic approach .', 'Furthermore , SARS-CoV-2 significantly induce type I , II , III interferon ex-vivo infect human lung tissue compare 2003 SARS-CoV.29Chu H Chan JF-W Wang Y et al.Comparative replication immune activation profile SARS-CoV-2 SARS-CoV human lung : ex vivo study implication pathogenesis COVID-19.Clin Infect Dis .', '2020 ; ( publish online April 9 .', ') DOI:10.1093/cid/ciaa410Google Scholar Thus , use interferon beta-1b treatment jump-start improve antiviral response patient would logical approach .', 'Additionally , interferon beta-1b show decrease virus-induced lung fibrosis mouse model , might improve outcome patient COVID-19 complicate acute respiratory distress syndrome.30Luckhardt TR Commes SM Trujillo G et al.TLR9-induced interferon β associate protection gammaherpesvirus-induced exacerbation lung fibrosis.Fibrogenesis Tissue Repair .', '2011 ; 4 : 18Google Scholar Despite concern major side-effects arise combination three drug , significant difference incidence adverse event treatment group report cohort 127 patient .', 'No haemolysis occur short duration low dose ribavirin .', 'We use triple combination patient start treatment 7 day symptom onset concern proinflammatory side-effects interferon beta-1b , despite three do use patient .', 'Liver dysfunction observe 14 % patient mild self-limiting , except one patient control group , biochemical hepatitis warrant discontinuation lopinavir–ritonavir treatment .', 'Our study several limitation .', 'This trial open label , without placebo group , confound subgroup omit interferon beta-1b within combination group , depend time symptom onset .', 'A subsequent phase 3 trial interferon beta-1b backbone treatment placebo control group consider , subgroup comparison suggest interferon beta-1b appear key component combination treatment .', 'Our absence critically ill patient allow generalisation find severe case .', 'Triple antiviral therapy interferon beta-1b , lopinavir–ritonavir , ribavirin safe superior lopinavir–ritonavir alone shorten virus shed , alleviate symptom , facilitate discharge patient mild moderate COVID-19 .', 'Contributors IF-NH , K-CL , EY-KT , JC , W-SL , Y-YN , T-CW , K-YY responsible design , analyse , write manuscript .', 'IF-NH , K-CL , EY-KT , RL , TW-HC , M-YC , Y-YN , JL , ART , H-PS , VC , AK-LW , K-MS , W-LL , DCL , SS , PY , RLi , KF , AY , T-CW , JW-MC , W-WY , W-MiC , AK-WL , VC-CC , T-LQ , C-SL responsible recruitment clinical care patient .', 'IFN-H , JF-WC , KK-WT , K-YY responsible analyse write manuscript .', 'CC-YY , RRZ , AY-FF , EY-WY , K-HL , AW-HC , W-MuC , AC-KN , JDI , RLe , KF , DCL , AK-LW , VC-CC , T-LQ , K-HC responsible laboratory analysis .', 'All author review approve final version manuscript .', 'Declaration interest We declare compete interest .', 'Qualified researcher request access deidentified participant data anonymised clinical study report , inform consent form , relate document include study protocol underlie Article submission proposal valuable research question correspond author , provide necessary data protection agency ethical committee approval compliance relevant registration .', 'A contract also sign .', 'Acknowledgments This study partly support Consultancy Service Enhancing Laboratory Surveillance Emerging Infectious Diseases Research Capability Antimicrobial Resistance Department Health Hong Kong ; Theme-Based Research Scheme ( T11/707/15 ) Research Grants Council , Hong Kong ; Sanming Project Medicine Shenzhen , China ( SZSM201911014 ) ; Health Medical Research Fund , Hong Kong ; High Level-Hospital Program , Health Commission Guangdong Province , China ; donation Richard Yu Carol Yu , Shaw Foundation Hong Kong , Michael Seak-Kan Tong , May Tam Mak Mei Yin , Respiratory Viral Research Foundation Limited , Hui Ming , Hui Hoy , Chow Sin Lan Charity Fund Limited , Chan Yin Chuen Memorial Charitable Foundation , Marina Man-Wai Lee , Hong Kong Hainan Commercial Association South China Microbiology Research Fund , Jessie & George Ho Charitable Foundation .', 'Download .pdf ( 1.14 MB ) Help pdf file Supplementary appendix Interferon beta-1b COVID-19Full-TextPDF']","['backgroundeffective', 'antiviral', 'therapy', 'important', 'tackle', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', '', 'assess', 'efficacy', 'safety', 'combine', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'treat', 'patient', 'covid-19methodsthis', 'multicentre', '', 'prospective', '', 'open-label', '', 'randomise', '', 'phase', '2', 'trial', 'adult', 'covid-19', 'admit', 'six', 'hospital', 'hong', 'kong', '', 'patients', 'randomly', 'assign', '', '21', '', '14-day', 'combination', 'lopinavir', '400', 'mg', 'ritonavir', '100', 'mg', 'every', '12', 'h', '', 'ribavirin', '400', 'mg', 'every', '12', 'h', '', 'three', '8', 'million', 'international', 'unit', 'interferon', 'beta-1b', 'alternate', 'day', '', 'combination', 'group', '', '14', 'day', 'lopinavir', '400', 'mg', 'ritonavir', '100', 'mg', 'every', '12', 'h', '', 'control', 'group', '', '', 'primary', 'endpoint', 'time', 'provide', 'nasopharyngeal', 'swab', 'negative', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'rt-pcr', '', 'intention-to-treat', 'population', '', 'study', 'register', 'clinicaltrialsgov', '', 'nct04276688findingsbetween', 'feb', '10', 'march', '20', '', '2020', '', '127', 'patient', 'recruit', '', '86', 'randomly', 'assign', 'combination', 'group', '41', 'assign', 'control', 'group', '', 'median', 'number', 'day', 'symptom', 'onset', 'start', 'study', 'treatment', '5', 'day', '', 'iqr', '37', '', '', 'combination', 'group', 'significantly', 'shorter', 'median', 'time', 'start', 'study', 'treatment', 'negative', 'nasopharyngeal', 'swab', '', '7', 'day', '', 'iqr', '511', '', '', 'control', 'group', '', '12', 'day', '', '815', '', '', 'hazard', 'ratio', '437', '', '95', '', 'ci', '1861024', '', '', 'p00010', '', '', 'adverse', 'event', 'include', 'self-limited', 'nausea', 'diarrhoea', 'difference', 'two', 'group', '', 'one', 'patient', 'control', 'group', 'discontinue', 'lopinavirritonavir', 'biochemical', 'hepatitis', '', 'patient', 'die', 'studyinterpretationearly', 'triple', 'antiviral', 'therapy', 'safe', 'superior', 'lopinavirritonavir', 'alone', 'alleviate', 'symptom', 'shorten', 'duration', 'viral', 'shed', 'hospital', 'stay', 'patient', 'mild', 'moderate', 'covid-19', '', 'future', 'clinical', 'study', 'double', 'antiviral', 'therapy', 'interferon', 'beta-1b', 'backbone', 'warrantedfundingthe', 'shaw-foundation', '', 'richard', 'carol', 'yu', '', 'tam', 'mak', 'mei', 'yin', '', 'sanming', 'project', 'medicine', '', 'effective', 'antiviral', 'therapy', 'important', 'tackle', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', '', 'assess', 'efficacy', 'safety', 'combine', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'treat', 'patient', 'covid-19', '', 'multicentre', '', 'prospective', '', 'open-label', '', 'randomise', '', 'phase', '2', 'trial', 'adult', 'covid-19', 'admit', 'six', 'hospital', 'hong', 'kong', '', 'patients', 'randomly', 'assign', '', '21', '', '14-day', 'combination', 'lopinavir', '400', 'mg', 'ritonavir', '100', 'mg', 'every', '12', 'h', '', 'ribavirin', '400', 'mg', 'every', '12', 'h', '', 'three', '8', 'million', 'international', 'unit', 'interferon', 'beta-1b', 'alternate', 'day', '', 'combination', 'group', '', '14', 'day', 'lopinavir', '400', 'mg', 'ritonavir', '100', 'mg', 'every', '12', 'h', '', 'control', 'group', '', '', 'primary', 'endpoint', 'time', 'provide', 'nasopharyngeal', 'swab', 'negative', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'rt-pcr', '', 'intention-to-treat', 'population', '', 'study', 'register', 'clinicaltrialsgov', '', 'nct04276688', '', 'feb', '10', 'march', '20', '', '2020', '', '127', 'patient', 'recruit', '', '86', 'randomly', 'assign', 'combination', 'group', '41', 'assign', 'control', 'group', '', 'median', 'number', 'day', 'symptom', 'onset', 'start', 'study', 'treatment', '5', 'day', '', 'iqr', '37', '', '', 'combination', 'group', 'significantly', 'shorter', 'median', 'time', 'start', 'study', 'treatment', 'negative', 'nasopharyngeal', 'swab', '', '7', 'day', '', 'iqr', '511', '', '', 'control', 'group', '', '12', 'day', '', '815', '', '', 'hazard', 'ratio', '437', '', '95', '', 'ci', '1861024', '', '', 'p00010', '', '', 'adverse', 'event', 'include', 'self-limited', 'nausea', 'diarrhoea', 'difference', 'two', 'group', '', 'one', 'patient', 'control', 'group', 'discontinue', 'lopinavirritonavir', 'biochemical', 'hepatitis', '', 'patient', 'die', 'study', '', 'early', 'triple', 'antiviral', 'therapy', 'safe', 'superior', 'lopinavirritonavir', 'alone', 'alleviate', 'symptom', 'shorten', 'duration', 'viral', 'shed', 'hospital', 'stay', 'patient', 'mild', 'moderate', 'covid-19', '', 'future', 'clinical', 'study', 'double', 'antiviral', 'therapy', 'interferon', 'beta-1b', 'backbone', 'warrant', '', 'shaw-foundation', '', 'richard', 'carol', 'yu', '', 'tam', 'mak', 'mei', 'yin', '', 'sanming', 'project', 'medicine', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'affect', '3', 'million', 'patient', '200', '000', 'death', '230', 'countries1whocoronavirus', 'disease', '2019', '', 'covid-19', '', 'situation', 'report107', '', 'urlplaceholder', '6', '', '2020date', 'access', '', '6', '', '2020google', 'covid-19', 'spread', 'quickly', 'person', 'person2chan', 'jf', 'yuan', 'kok', 'kh', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '395', '', '514-523google', 'primarily', 'acute', 'viral', 'pneumonia', 'lead', 'respiratory', 'failure', 'report', 'autopsy', 'study', 'animal', 'models3yao', 'xh', 'li', 'ty', 'zc', 'ala', 'pathological', 'report', 'three', 'covid-19', 'case', 'minimally', 'invasive', 'autopsieszhonghua', 'bing', 'li', 'xue', 'za', 'zhi', '', '2020', '', '49', '', 'chinese', '', '', '', 'e009google', '', '4chan', 'jf', 'zhang', 'aj', 'yuan', 'alsimulation', 'clinical', 'pathological', 'manifestation', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'golden', 'syrian', 'hamster', 'model', '', 'implication', 'disease', 'pathogenesis', 'tansmissibilityclin', 'infect', 'dis', '', '2020', '', '', 'publised', 'online', 'march', '26', '', '', 'urlplaceholder', 'although', 'cytokine', 'storm', 'extrapulmonary', 'involvement', 'occasionally', 'reported3yao', 'xh', 'li', 'ty', 'zc', 'ala', 'pathological', 'report', 'three', 'covid-19', 'case', 'minimally', 'invasive', 'autopsieszhonghua', 'bing', 'li', 'xue', 'za', 'zhi', '', '2020', '', '49', '', 'chinese', '', '', '', 'e009google', '', '4chan', 'jf', 'zhang', 'aj', 'yuan', 'alsimulation', 'clinical', 'pathological', 'manifestation', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'golden', 'syrian', 'hamster', 'model', '', 'implication', 'disease', 'pathogenesis', 'tansmissibilityclin', 'infect', 'dis', '', '2020', '', '', 'publised', 'online', 'march', '26', '', '', 'urlplaceholder', 'besides', 'respiratory', 'intensive', 'care', 'support', 'extent', 'extracorporeal', 'membrane', 'oxygenation', '', 'specific', 'antiviral', 'treatment', 'recommend', 'insufficient', 'evidence', 'randomise', 'trial', '', 'repurposed', 'drug', 'show', 'in-vitro', 'activity', 'close', 'relative', 'sars-cov-2', '', 'beta-coronaviruses', '', 'lopinavir', 'interferon', '', 'particularly', 'interferon', 'beta', '', 'show', 'modest', 'activity', 'vitro', 'sars-cov', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '-cov', '', 'synergistically', 'ribavirin5chen', 'f', 'chan', 'kh', 'jiang', 'alin', 'vitro', 'susceptibility', '10', 'clinical', 'isolate', 'sars', 'coronavirus', 'select', 'antiviral', 'compoundsj', 'clin', 'virol', '', '2004', '', '31', '', '69-75google', '', '6chan', 'jf', 'chan', 'kh', 'kao', 'ry', 'albroad-spectrum', 'antiviral', 'emerge', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirusj', 'infect', '', '2013', '', '67', '', '606-616google', '2003', '', 'open-label', 'trial', 'historical', 'control', '', 'show', 'combination', 'lopinavirritonavir', 'ribavirin', 'reduce', 'mortality', 'intensive', 'respiratory', 'support', 'patient', 'sars', 'admit', 'hospital7chu', 'cm', 'cheng', 'vc', 'hung', 'alrole', 'lopinavirritonavir', 'treatment', 'sars', '', 'initial', 'virological', 'clinical', 'findingsthorax', '', '2004', '', '59', '', '252-256google', 'moreover', '', 'lopinavirritonavir', 'interferon', 'beta-1b', 'show', 'reduce', 'viral', 'load', 'improve', 'lung', 'pathology', 'common', 'marmoset', 'model8chan', 'jf', 'yao', 'yeung', 'ml', 'altreatment', 'lopinavirritonavir', 'interferon-1b', 'improve', 'outcome', 'mers-cov', 'infection', 'nonhuman', 'primate', 'model', 'common', 'marmosetj', 'infect', 'dis', '', '2015', '', '212', '', '1904-1913google', 'however', 'viral', 'load', 'sars', 'mers', 'peak', 'around', 'day', '710', 'symptom', 'onset', '', 'whereas', 'viral', 'load', 'covid-19', 'peak', 'time', 'presentation', '', 'similar', 'influenza9to', 'kk-w', 'tsang', 'ot-y', 'leung', 'w-s', 'altemporal', 'profile', 'viral', 'load', 'posterior', 'oropharyngeal', 'saliva', 'sample', 'serum', 'antibody', 'response', 'infection', 'sars-cov-2', '', 'observational', 'cohort', 'studylancet', 'infect', 'dis', '', '2020', '', '', 'publish', 'online', 'march', '23', '', '', 'urlplaceholder', '', '10cheng', 'vc', 'tang', 'bs', 'wu', 'ak', 'chu', 'cm', 'yuen', 'ky', 'medical', 'treatment', 'viral', 'pneumonia', 'include', 'sars', 'immunocompetent', 'adultj', 'infect', '', '2004', '', '49', '', '262-273google', 'experience', 'treatment', 'patient', 'influenza', 'admit', 'hospital', 'suggest', 'combination', 'multiple', 'antiviral', 'drug', 'effective', 'single', 'drug', 'treatment', 'set', 'patient', 'high', 'viral', 'load', 'presentation11dunning', 'j', 'baillie', 'jk', 'cao', 'b', 'hayden', 'fg', 'antiviral', 'combination', 'severe', 'influenzalancet', 'infect', 'dis', '', '2014', '', '14', '', '1259-1270google', '', '12hung', 'ifn', 'kkw', 'chan', 'jfw', 'alefficacy', 'clarithromycin-naproxen-oseltamivir', 'combination', 'treatment', 'patient', 'hospitalize', 'influenza', '', 'h3n2', '', 'infection', '', 'open-label', 'randomize', '', 'control', '', 'phase', 'iibiii', 'trialchest', '', '2017', '', '151', '', '1069-1080google', 'therefore', '', 'phase', '2', 'randomise', 'trial', 'establish', 'whether', 'combination', 'three', 'modestly', 'active', 'drug', 'sars-cov-2', 'improve', 'viral', 'load', 'profile', 'clinical', 'parameter', 'adult', 'covid-19', 'require', 'hospital', 'admission', '', 'research', 'contextevidence', 'studywe', 'search', 'march', '30', '', '2020', '', 'term', '', 'covid-19', '', '', '', 'interferon', 'beta', '1b', '', '', '', 'lopinavir', 'ritonavir', '', '', '', 'treatment', '', '', '', 'hospitalize', '', '', '', 'patient', '', '', '', 'phase', '2', '', '', '', 'trial', '', 'article', 'english', 'publish', 'date', 'search', '', 'search', 'show', 'randomise', 'control', 'trial', 'assess', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'treatment', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'added', 'value', 'studythis', 'first', 'randomise', 'control', 'trial', 'triple', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', '', 'compare', 'single-drug', 'lopinavirritonavir', 'treatment', 'patient', 'admit', 'hospital', 'covid-19', '', 'treatment', 'triple', 'combination', 'effectively', 'suppress', 'viral', 'load', 'clinical', 'specimen', '', 'include', 'nasopharyngeal', 'swab', '', 'throat', 'saliva', '', 'posterior', 'oropharyngeal', 'saliva', '', 'stool', 'patient', '8', 'day', 'treatment', 'commencement', '', 'significantly', 'shorter', 'time', 'control', 'group', '', 'treat', 'lopinavirritonavir', 'alone', '', 'triple', 'combination', 'alleviate', 'symptom', 'completely', 'within', '4', 'daysa', 'significantly', 'shorter', 'time', 'control', '', 'triple', 'combination', 'suppress', 'il-inhibitor', 'level', '', 'clinical', 'virological', 'efficacy', 'result', 'shorter', 'hospital', 'stay', 'facilitate', 'infection', 'control', '', 'treatment', 'regimen', 'show', 'safe', '', 'minor', 'self-limiting', 'gastrointestinal', 'adverse', 'event', 'diarrhoea', 'vomit', '', 'increased', 'liver', 'enzyme', 'uncommon', '', 'resolve', 'upon', 'stop', 'medicationsimplications', 'available', 'evidencethis', 'study', 'show', 'early', 'treatment', 'triple', 'combination', 'antiviral', 'therapy', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'safe', 'highly', 'effective', 'shorten', 'duration', 'virus', 'shed', '', 'decrease', 'cytokine', 'response', '', 'alleviate', 'symptom', '', 'facilitate', 'discharge', 'patient', 'mild', 'moderate', 'covid-19', '', 'furthermore', '', 'triple', 'antiviral', 'therapy', 'rapidly', 'render', 'viral', 'load', 'negative', 'specimen', '', 'thereby', 'reduce', 'infectiousness', 'patient', '', 'evidence', 'study', 'search', 'march', '30', '', '2020', '', 'term', '', 'covid-19', '', '', '', 'interferon', 'beta', '1b', '', '', '', 'lopinavir', 'ritonavir', '', '', '', 'treatment', '', '', '', 'hospitalize', '', '', '', 'patient', '', '', '', 'phase', '2', '', '', '', 'trial', '', 'article', 'english', 'publish', 'date', 'search', '', 'search', 'show', 'randomise', 'control', 'trial', 'assess', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'treatment', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'added', 'value', 'study', 'first', 'randomise', 'control', 'trial', 'triple', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', '', 'compare', 'single-drug', 'lopinavirritonavir', 'treatment', 'patient', 'admit', 'hospital', 'covid-19', '', 'treatment', 'triple', 'combination', 'effectively', 'suppress', 'viral', 'load', 'clinical', 'specimen', '', 'include', 'nasopharyngeal', 'swab', '', 'throat', 'saliva', '', 'posterior', 'oropharyngeal', 'saliva', '', 'stool', 'patient', '8', 'day', 'treatment', 'commencement', '', 'significantly', 'shorter', 'time', 'control', 'group', '', 'treat', 'lopinavirritonavir', 'alone', '', 'triple', 'combination', 'alleviate', 'symptom', 'completely', 'within', '4', 'daysa', 'significantly', 'shorter', 'time', 'control', '', 'triple', 'combination', 'suppress', 'il-inhibitor', 'level', '', 'clinical', 'virological', 'efficacy', 'result', 'shorter', 'hospital', 'stay', 'facilitate', 'infection', 'control', '', 'treatment', 'regimen', 'show', 'safe', '', 'minor', 'self-limiting', 'gastrointestinal', 'adverse', 'event', 'diarrhoea', 'vomit', '', 'increased', 'liver', 'enzyme', 'uncommon', '', 'resolve', 'upon', 'stop', 'medication', '', 'implications', 'available', 'evidence', 'study', 'show', 'early', 'treatment', 'triple', 'combination', 'antiviral', 'therapy', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'safe', 'highly', 'effective', 'shorten', 'duration', 'virus', 'shed', '', 'decrease', 'cytokine', 'response', '', 'alleviate', 'symptom', '', 'facilitate', 'discharge', 'patient', 'mild', 'moderate', 'covid-19', '', 'furthermore', '', 'triple', 'antiviral', 'therapy', 'rapidly', 'render', 'viral', 'load', 'negative', 'specimen', '', 'thereby', 'reduce', 'infectiousness', 'patient', '', 'phase', '2', '', 'multicentre', '', 'open-label', '', 'randomise', 'trial', '', 'adult', 'patient', 'age', 'least', '18', 'year', 'admit', 'hospital', 'feb', '10', '', '2020', '', 'virologically', 'confirm', 'covid-19', '', 'recruit', 'queen', 'mary', 'hospital', '', 'pamela', 'youde', 'nethersole', 'hospital', '', 'ruttonjee', 'hospital', '', 'united', 'christian', 'hospital', '', 'queen', 'elizabeth', 'hospital', '', 'tuen', 'mun', 'hospital', 'hong', 'kong', '', 'six', 'major', 'public', 'hospital', 'position', 'across', 'five', 'seven', 'hospital', 'cluster', '', 'serve', '75', '', '75', 'million', 'population', '', 'public', 'health', 'ordinance', 'hong', 'kong', 'require', 'patient', 'test', 'positive', 'covid-19', 'admit', 'hospital', '', 'eligibility', 'criterion', 'study', 'age', 'least', '18', 'year', '', 'national', 'early', 'warn', 'score', '2', '', 'news2', '', 'least', '1', '', 'symptom', 'duration', '14', 'day', 'le', 'upon', 'recruitment', '', 'appendix', 'pp', '910', '', '', 'institutional', 'review', 'board', 'university', 'hong', 'kong', 'hospital', 'authority', 'approve', 'study', '', 'uw20074', '', '', 'patient', 'give', 'write', 'consent', 'participation', 'study', '', 'patients', 'randomly', 'assign', 'either', 'triple', 'combination', 'lopinavirritonavir', '', 'ribavirin', '', 'interferon', 'beta-1b', 'group', 'control', 'group', '', 'lopinavirritonavir', '', '', 'ratio', '21', '', 'simple', 'randomisation', 'stratification', '', 'randomised', 'treatment', 'open-label', '', 'patients', 'assign', 'serial', 'number', 'study', 'coordinator', '', 'serial', 'number', 'link', 'computer-generated', 'randomisation', 'list', 'assign', 'antiviral', 'treatment', 'regimen', '', 'study', 'medication', 'dispense', 'hospital', 'pharmacy', 'patient', 'medical', 'ward', 'nurse', '', 'combination', 'group', '', 'patient', 'recruit', 'treat', 'le', '7', 'day', 'symptom', 'onset', 'receive', 'triple', 'combination', '14', 'day', 'oral', 'lopinavirritonavir', '', 'lopinavir', '400', 'mg', 'ritonavir', '100', 'mg', '', 'every', '12', 'h', '', 'via', 'nasogastric', 'tube', 'intubate', 'patient', '', '', 'ribavirin', '400', 'mg', 'every', '12', 'h', '', 'subcutaneous', 'injection', 'one', 'three', 'interferon', 'beta-1b', '1', 'ml', '', '8', 'million', 'international', 'unit', '', 'iu', '', '', 'alternate', 'day', 'depend', 'day', 'drug', 'commencement', '', 'commence', 'day', '12', 'symptom', 'onset', '', 'patient', 'receive', 'three', 'interferon', 'beta-1b', '', 'commence', 'day', '34', '', 'patient', 'receive', 'two', '', 'commence', 'day', '56', '', 'patient', 'receive', 'one', 'dose', '', '', 'recruit', 'treat', 'day', '7', '14', '', 'interferon', 'beta-1b', 'injection', 'omit', 'avoid', 'proinflammatory', 'effect', '', 'patients', 'assign', 'control', 'group', 'receive', 'oral', 'lopinavirritonavir', '', 'lopinavir', '400', 'mg', 'ritonavir', '100', 'mg', '', 'every', '12', 'h', '14', 'day', '', 'patient', 'history', 'prolong', 'qtc', 'syndrome', '', 'find', 'prolong', 'qtc', 'le', '480', '', 'first-degree', 'heart', 'block', 'bundle', 'branch', 'block', '', 'bradycardia', 'upon', 'ecg', 'examination', '', 'develop', 'increase', 'alanine', 'transaminase', 'three', 'time', 'upper', 'limit', 'normal', '', 'uln', '', '', 'lopinavirritonavir', 'treatment', 'reduce', 'per', 'day', '', 'lopinavirritonavir', 'stop', 'alanine', 'transaminase', 'level', 'exceed', 'six', 'time', 'uln', '', 'randomisation', 'window', 'symptom', 'onset', 'extend', '10', '14', 'day', 'trial', 'commencement', 'incubation', 'period', 'beyond', '14', 'day', '', 'placebo', 'group', 'generally', 'accept', 'chinese', 'culture', '', 'previous', 'study', 'show', 'interferon', 'beta-1b', 'lopinavirritonavir', 'active', 'sars-cov', 'mers-cov', '', 'lopinavirritonavir', 'control', 'group', 'whereas', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'combination', 'group', 'patient', 'admit', 'le', '7', 'day', 'symptom', 'onset', '', 'intervention', 'treatment', 'start', 'within', '48', 'h', 'hospital', 'admission', '', 'standard', 'care', 'include', 'oxygen', '', 'non-invasive', 'invasive', 'ventilatory', 'support', '', 'extracorporeal', 'membrane', 'oxygenation', 'support', '', 'dialysis', 'support', '', 'antimicrobial', 'treatment', 'secondary', 'bacterial', 'infection', 'indicate', 'clinically', '', 'stress', 'corticosteroid', '', '50', 'mg', 'hydrocortisone', 'every', '8', 'h', 'intravenously', '', 'taper', '7', 'day', '', 'give', 'patient', 'develop', 'oxygen', 'desaturation', 'require', 'oxygen', 'support', '', 'non-invasive', 'invasive', 'ventilatory', 'support', 'beyond', 'day', '7', 'symptom', 'onset', 'discretion', 'consultant', '', 'clinical', 'find', 'include', 'history', 'physical', 'examination', '', 'laboratory', 'radiological', 'investigation', 'result', 'enter', 'predesigned', 'database', '', 'chest', 'radiograph', 'ecg', 'baseline', 'regular', 'interval', 'monitor', 'patient', 'progress', 'detect', 'early', 'cardiac', 'rhythm', 'change', '', 'patients', 'underlie', 'cardiac', 'condition', 'put', 'cardiac', 'monitor', '', 'high-resolution', 'ct', 'consultant', '', 'discretion', '', 'patient', 'follow', 'infectious', 'disease', 'clinic', 'within', '30', 'day', 'discharge', '', 'initial', 'diagnosis', 'sars-cov-2', 'infection', 'upon', 'admission', '', 'recruit', 'patient', 'laboratory', 'confirm', 'sars-cov-2', 'infection', 'rt-pcr', 'nasopharyngeal', 'swab', '', 'daily', 'nasopharyngeal', 'swab', '', 'posterior', 'oropharyngeal', 'saliva', '', 'throat', 'swab', '', 'stool', 'rectal', 'swab', '', 'urine', 'available', '', 'obtain', 'discharge', '', 'quantification', 'viral', 'load', 'genetic', 'mutation', 'test', '', 'appendix', 'pp', '2023', '', '', 'complete', 'blood', 'count', '', 'liver', 'renal', 'function', 'test', '', 'lactate', 'dehydrogenase', '', 'creatine', 'kinase', '', 'c-reactive', 'protein', '', 'erythrocyte', 'sedimentation', 'rate', '', 'cytokine', 'profile', 'regularly', 'check', 'discharge', '', 'appendix', 'p', '21', '', '', 'blood', 'urine', 'sample', 'bacterial', 'culture', 'clinically', 'indicate', '', 'nasopharyngeal', 'swab', 'upon', 'admission', 'assess', 'biofire', 'filmarray', 'respiratory', 'panel', '2', 'plus', '', 'biomrieux', '', 'marcy', 'letoile', '', 'france', '', '', 'methods', 'assay', 'quantitative', 'rt-pcr', '', 'serum', 'cytokine', 'profile', '', 'nanopore', 'sequence', 'nsp5', 'mutation', 'appendix', '', 'pp', '2023', '', '', 'primary', 'endpoint', 'time', 'achieve', 'negative', 'rt-pcr', 'result', 'sars-cov-2', 'nasopharyngeal', 'swab', 'sample', '', 'secondary', 'clinical', 'endpoint', 'time', 'resolution', 'symptom', 'define', 'news2', '0', 'maintain', '24', 'h', '', 'daily', 'news2', 'sequential', 'organ', 'failure', 'assessment', '', 'sofa', '', 'score', '', 'length', 'hospital', 'stay', '', '30-day', 'mortality', '', 'virological', 'endpoint', 'include', 'time', 'achieve', 'negative', 'sars-cov-2', 'rt-pcr', 'clinical', 'sample', '', 'include', 'nasopharyngeal', 'swab', '', 'posterior', 'oropharyngeal', 'saliva', '', 'throat', 'swab', '', 'stool', '', 'urine', '', 'daily', 'viral', 'load', 'change', 'first', '7', 'day', '', 'emergence', 'amino', 'acid', 'mutation', 'nsp5', 'gene', 'encode', '3c-like', 'protease', '', 'serum', 'cytokine', 'response', 'measure', '', 'safety', 'endpoint', 'frequency', 'duration', 'adverse', 'event', '', 'important', 'note', 'covid-19', 'new', 'disease', 'cause', 'sars-cov-2', '', 'phylogenetically', 'closest', '2003', 'sars-cov', '', 'time', 'study', 'design', 'mid-january', '', '2020', '', 'insufficient', 'information', 'mortality', 'covid-19', '', 'thus', '', 'base', 'sample', 'size', 'calculation', 'find', 'lopinavirritonavir', 'treatment', 'trial', '2003', 'sars-cov7chu', 'cm', 'cheng', 'vc', 'hung', 'alrole', 'lopinavirritonavir', 'treatment', 'sars', '', 'initial', 'virological', 'clinical', 'findingsthorax', '', '2004', '', '59', '', '252-256google', 'current', 'study', 'design', 'basis', 'estimate', 'difference', '264', '', '21-day', 'mortality', 'acute', 'respiratory', 'distress', 'syndrome', 'rate', 'patient', 'severe', 'sars-cov-2', 'infection', '', 'treat', 'lopinavirritonavir', '', '24', '', '', 'versus', 'historical', 'control', 'without', 'antiviral', 'treatment', '', '288', '', '', '', 'necessary', 'sample', 'size', 'calculate', '30', 'patient', 'per', 'group', 'detect', 'difference', 'two-sided', '', 'level', '005', '', '80', '', 'power', '', 'protocol', 'propose', 'recruit', 'least', '35', 'patient', 'per', 'group', 'allow', '17', '', 'dropout', 'rate', '', 'primary', 'endpoint', 'assess', 'intention-to-treat', 'population', 'randomise', 'patient', '', 'safety', 'assess', 'patient', 'receive', 'least', 'one', 'dose', 'assign', 'drug', '', 'categorical', 'variable', 'compare', '2', 'test', 'continuous', 'variable', 'compare', 'mann-whitney', 'u', 'test', '', 'intention-to-treat', 'subgroup', 'analysis', '', 'viral', 'load', '', 'specimen', 'undetectable', 'viral', 'load', 'assign', 'value', '1', 'log10', 'copy', 'per', 'ml', 'purpose', 'statistical', 'analysis', '', 'hazard', 'ratio', '', 'hrs', '', '95', '', 'cis', 'calculate', 'cox', 'proportional', 'hazard', 'model', '', 'factors', 'significant', 'univariable', 'analysis', '', 'p', '', '010', '', 'assess', 'mean', 'multivariable', 'analysis', 'cox', 'proportional', 'hazard', 'model', 'identify', 'independent', 'factor', 'negative', 'nasopharyngeal', 'swab', 'rt-pcr', 'day', '7', 'treatment', '', 'p', 'value', 'le', '005', 'consider', 'statistically', 'significant', '', 'statistical', 'analysis', 'perform', 'spss', '', 'version', '260', 'prism', '', 'version', '8', '', 'study', 'register', 'clinicaltrialsgov', '', 'nct04276688', '', 'funders', 'role', 'study', 'design', '', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'correspond', 'author', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', 'feb', '10', 'march', '20', '', '2020', '', '144', 'patient', 'screen', '', '127', 'patient', 'recruit', '', 'figure', '1', '', '', 'number', 'patient', 'screen', 'account', '80', '', 'confirm', 'covid-19', 'case', 'hong', 'kong', 'period', '', 'nine', 'patient', 'fulfil', 'inclusion', 'criterion', '', 'four', 'second-degree', 'third-degree', 'cardiac', 'arrhythmia', '', 'two', 'severe', 'depression', '', 'three', 'pregnancy', '', 'eight', 'patient', 'decline', 'treatment', 'regimen', '', 'one', 'patient', 'control', 'group', 'require', 'discontinuation', 'lopinavirritonavir', 'alanine', 'transaminase', 'six', 'time', 'greater', 'uln', '1', 'week', 'treatment', '', 'median', 'age', '52', 'year', '', 'iqr', '3262', '', '', '68', '', '54', '', '', 'patient', 'men', 'versus', '59', '', '46', '', '', 'woman', '', 'table', '1', '', '', '51', '', '40', '', '', 'patient', 'underlie', 'disease', '', 'median', 'time', 'hospital', 'admission', 'symptom', 'onset', '5', 'day', '', 'iqr', '37', '', 'figure', '1trial', 'profileview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'table', '1baseline', 'demographic', 'study', 'populationcombination', 'group', '', 'n86', '', 'control', 'group', '', 'n41', '', 'age510', '', '310613', '', '520', '', '335625', '', 'sexmen45', '', '52', '', '', '23', '', '56', '', '', 'women41', '', '48', '', '', '18', '', '44', '', '', 'time', 'symptom', 'onset', 'start', 'treatment', '', 'days5', '', '47', '', '4', '', '38', '', 'underlying', 'diseasesdiabetes11', '', '13', '', '', '6', '', '15', '', '', 'hypertension23', '', '27', '', '', '13', '', '32', '', '', 'coronary', 'artery', 'disease5', '', '6', '', '', '5', '', '12', '', '', 'cerebrovascular', 'disease1', '', '1', '', '', '1', '', '2', '', '', 'hyperlipidaemia18', '', '21', '', '', '11', '', '27', '', '', 'thyroid', 'disease3', '', '3', '', '', '1', '', '2', '', '', 'obstructive', 'sleep', 'apnoea1', '', '1', '', '', '1', '', '2', '', '', 'crohn', 'disease1', '', '1', '', '', '0epilepsy1', '', '1', '', '', '0tuberculosis2', '', '2', '', '', '0chronic', 'hepatitis', 'b2', '', '2', '', '', '1', '', '2', '', '', 'chronic', 'hepatitis', 'c01', '', '2', '', '', 'malignancy1', '', '1', '', '', '1', '', '2', '', '', 'smoker6', '', '7', '', '', '1', '', '2', '', '', 'symptoms', 'signsfever70', '', '81', '', '', '32', '', '78', '', '', 'chills13', '', '15', '', '', '6', '', '15', '', '', 'cough45', '', '52', '', '', '23', '', '56', '', '', 'sputum29', '', '34', '', '', '13', '', '32', '', '', 'shortness', 'breath7', '', '8', '', '', '7', '', '17', '', '', 'sore', 'throat16', '', '19', '', '', '10', '', '24', '', '', 'myalgia10', '', '12', '', '', '8', '', '20', '', '', 'malaise19', '', '22', '', '', '5', '', '12', '', '', 'nausea', 'vomiting1', '', '1', '', '', '0diarrhoea17', '', '20', '', '', '7', '', '17', '', '', 'rhinorrhoea14', '', '16', '', '', '10', '', '24', '', '', 'anosmia4', '', '5', '', '', '1', '', '2', '', '', 'headache3', '', '3', '', '', '3', '', '7', '', '', 'chest', 'tightness2', '', '2', '', '', '0anorexia1', '', '1', '', '', '0baseline', 'laboratory', 'find', '', 'normal', 'range', '', 'haemoglobin', '', '115148', 'gdl', '', '134', '', '127149', '', '135', '', '127148', '', 'white', 'cell', 'count', '', '389993', '', '109', 'per', 'l', '', '49', '', '3762', '', '54', '', '4664', '', 'neutrophils', '', '201742', '', '109', 'per', 'l', '', '34', '', '2443', '', '35', '', '2945', '', 'lymphocytes', '', '106361', '', '109', 'per', 'l', '', '10', '', '0815', '', '13', '', '0916', '', 'platelets', '', '154371', '', '109', 'per', 'l', '', '1950', '', '17182600', '', '1920', '', '16052445', '', 'alanine', 'aminotransferase', '', '845', 'ul', '', '230', '', '150333', '', '260', '', '145430', '', 'alkaline', 'phosphatase', '', '42110', 'ul', '', '580', '', '480750', '', '650', '', '525750', '', 'lactate', 'dehydrogenase', '', '143280', 'ul', '', '1940', '', '15982490', '', '1675', '', '14202000', '', 'bilirubin', '', '423', 'moll', '', '79', '', '5590', '', '75', '', '60108', '', 'creatinine', '', '4982', 'moll', '', '755', '', '650920', '', '760', '', '625960', '', 'urea', '', '2980', 'mmoll', '', '40', '', '2948', '', '37', '', '2746', '', 'creatine', 'kinase', '', '22198', 'ul', '', '790', '', '5001510', '', '905', '', '5451415', '', 'c-reactive', 'protein', '', '', '076', 'mgdl', '', '30', '', '2092', '', '30', '', '1572', '', 'erythrocyte', 'sedimentation', 'rate', '', '', '12', 'mmh', '', '190', '', '110480', '', '190', '', '98378', '', 'baseline', 'radiological', 'find', '', '', '', 'abnormal', 'chest', 'x-ray64', '', '74', '', '', '32', '', '78', '', '', 'upper', 'zone', 'infiltrate00', '', '0', '', '', 'middle', 'zone', 'infiltrate4', '', '5', '', '', '6', '', '15', '', '', 'lower', 'zone', 'infiltrate38', '', '44', '', '', '18', '', '44', '', '', 'left', 'upper', 'zone', 'infiltrate1', '', '1', '', '', '0left', 'middle', 'zone', 'infiltrate7', '', '8', '', '', '7', '', '17', '', '', 'left', 'lower', 'zone', 'infiltrate27', '', '31', '', '', '10', '', '24', '', '', 'high-resolution', 'ct', '', 'perform', '22', 'patient', '', '14', '', '16', '', '', '6', '', '15', '', '', 'data', 'n', '', '', '', 'median', '', 'iqr', '', '', 'combination', 'group', '52', 'patient', 'treat', 'triple', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', '34', 'patient', 'treat', 'lopinavirritonavir', 'ribavirin', '', 'control', 'group', '', '41', 'patient', 'treat', 'lopinavirritonavir', '', 'ulunits', 'per', 'l', 'open', 'table', 'new', 'tab', 'data', 'n', '', '', '', 'median', '', 'iqr', '', '', 'combination', 'group', '52', 'patient', 'treat', 'triple', 'combination', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', '34', 'patient', 'treat', 'lopinavirritonavir', 'ribavirin', '', 'control', 'group', '', '41', 'patient', 'treat', 'lopinavirritonavir', '', 'ulunits', 'per', 'l', 'among', '127', 'patient', '', '86', 'randomly', 'assign', 'combination', 'group', '41', 'patient', 'assign', 'control', 'group', '', 'within', 'combination', 'group', '', '52', 'patient', 'admit', 'hospital', 'le', '7', 'day', 'symptom', 'onset', 'receive', 'lopinavirritonavir', '', 'ribavirin', '', 'interferon', 'beta-1b', 'regimen', '', '34', 'patient', 'admit', '7', 'day', 'symptom', 'onset', 'receive', 'lopinavirritonavir', 'ribavirin', 'regimen', '', 'median', 'number', 'interferon', 'beta-1b', 'receive', 'two', '', 'median', 'time', 'symptom', 'onset', 'start', 'treatment', '5', 'day', '', '47', '', 'combination', 'group', '4', 'day', '', '38', '', 'control', 'group', '', 'table', '1', '', '', 'age', '', 'sex', '', 'baseline', 'demographic', 'group', 'similar', '', 'fever', 'unproductive', 'cough', 'common', 'present', 'sign', 'symptom', '', 'diarrhoea', 'anosmia', 'infrequent', '', 'patient', 'lymphopenia', 'increase', 'c-reactive', 'protein', 'erythrocyte', 'sedimentation', 'rate', 'upon', 'presentation', '', 'one', 'patient', 'combination', 'group', 'concomitant', 'rhinovirus', 'infection', 'upon', 'presentation', '', 'disease', 'severity', 'upon', 'presentation', 'mild', 'base', 'news2', 'sofa', 'score', '', 'table', '2', '', 'table', '2clinical', '', 'viral', 'load', '', 'cytokine', 'profile', 'concomitant', 'treatmentscombination', 'group', '', 'n86', '', 'control', 'group', '', 'n41', '', 'p', 'valuenews2baseline2', '', '12', '', '2', '', '22', '', '052day', '11', '', '12', '', '2', '', '22', '', '', '00001day', '210', '', '0020', '', '20', '', '1530', '', '', '00001day', '30', '', '01', '', '2', '', '13', '', '', '00001day', '40', '', '01', '', '2', '', '12', '', '', '00001day', '50', '', '01', '', '2', '', '12', '', '', '00001day', '600', '', '0010', '', '15', '', '1020', '', '', '00001day', '700', '', '0010', '', '10', '', '0820', '', '00010time', 'news2', '0', '', 'days4', '', '38', '', '8', '', '79', '', '', '00001sofa', 'scorebaseline0', '', '01', '', '0', '', '01', '', '038day', '10', '', '01', '', '0', '', '11', '', '021day', '20', '', '02', '', '1', '', '02', '', '0025day', '30', '', '02', '', '1', '', '02', '', '0010day', '400', '', '0013', '', '10', '', '0020', '', '0012day', '50', '', '01', '', '1', '', '02', '', '0010day', '60', '', '01', '', '1', '', '02', '', '0035day', '70', '', '01', '', '1', '', '02', '', '0028time', 'sofa', 'score', '0', '', 'days30', '', '1080', '', '80', '', '6590', '', '0041duration', 'hospital', 'stay', '', 'days90', '', '70130', '', '145', '', '93160', '', '001630-day', 'mortality0', '', '0', '', '0', '', '0', '', '100time', 'negative', 'viral', 'load', '', 'daysnasopharyngeal', 'swab7', '', '511', '', '12', '', '815', '', '00010posterior', 'oropharyngeal', 'saliva60', '', '3080', '', '80', '', '53108', '', '0044throat', 'swab45', '', '1368', '', '70', '', '30120', '', '0039stool5', '', '25', '', '7', '', '48', '', '0030all', 'specimens8', '', '612', '', '13', '', '815', '', '00010virological', 'find', '', 'rt-pcr', '', '', 'log10', 'copy', 'per', 'mlnasopharyngeal', 'swab', '', 'baseline', '', '64', '', '4580', '', '64', '', '3977', '', '070posterior', 'oropharyngeal', 'saliva', '', 'baseline', '', '', '', 'stress-dose', 'steroid', 'hydrocortisone', '50', 'mg', 'every', '8', 'h', 'intravenously', '', 'taper', '57', 'days52', '', '3870', '', '53', '', '4371', '', '054throat', 'swab', '', 'baseline', '', '46', '', '2961', '', '45', '', '3757', '', '085stool', '', 'baseline', '', '33', '', '2753', '', '38', '', '2673', '', '053cytokine', 'concentration', '', 'log10', 'pgmlil-6', '', 'baseline', '', '14', '', '1014', '', '14', '', '1016', '', '043tnf', '', 'baseline', '', '1', '', '11', '', '1', '', '11', '', '100concomitant', 'treatmentsoxygen', 'therapy12', '', '14', '', '', '5', '', '12', '', '', '072non-invasive', 'ventilator', 'support3', '', '3', '', '', '2', '', '5', '', '', '075ventilator', 'support01', '', '2', '', '', '015antibiotics44', '', '51', '', '', '25', '', '61', '', '', '033amoxicillinclavulanate29', '', '34', '', '', '21', '', '51', '', '', '0080azithromycin7', '', '8', '', '', '4', '', '10', '', '', '076ceftriaxone12', '', '14', '', '', '8', '', '20', '', '', '042doxycycline13', '', '15', '', '', '8', '', '20', '', '', '053levofloxacin11', '', '13', '', '', '3', '', '7', '', '', '036piperacillintazobactam5', '', '6', '', '', '0012corticosteroid', '', 'stress', 'dose', '', '', '', 'stress-dose', 'steroid', 'hydrocortisone', '50', 'mg', 'every', '8', 'h', 'intravenously', '', 'taper', '57', 'days6', '', '7', '', '', '2', '', '5', '', '', '065data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'news2national', 'early', 'warn', 'score', '2', '', 'sofasequential', 'organ', 'failure', 'assessment', '', '', 'stress-dose', 'steroid', 'hydrocortisone', '50', 'mg', 'every', '8', 'h', 'intravenously', '', 'taper', '57', 'day', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'news2national', 'early', 'warn', 'score', '2', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'primary', 'endpoint', 'time', 'start', 'study', 'treatment', 'negative', 'nasopharyngeal', 'swab', '', 'combination', 'group', 'significantly', 'shorter', 'median', 'time', '', '7', 'day', '', 'iqr', '511', '', '', 'control', 'group', '', '12', 'day', '', '815', '', '', 'hr', '437', '', '95', '', 'ci', '1861024', '', '', 'p00010', '', 'table', '2', '', '', 'clinical', 'improvement', 'significantly', 'better', 'combination', 'group', '', 'significantly', 'shorter', 'time', 'complete', 'alleviation', 'symptom', '', 'define', 'news2', '0', '', '4', 'day', '', 'iqr', '38', '', 'combination', 'group', 'v', '8', 'day', '', '79', '', 'control', 'group', '', 'hr', '392', '', '95', '', 'ci', '166923', '', '', 'p', '', '00001', '', 'sofa', 'score', '0', '', '30', 'day', '', '1080', '', 'v', '80', 'day', '', '6590', '', '', 'hr', '189', '', '103349', '', '', 'p0041', '', 'table', '2', '', '', 'similar', 'pattern', 'observe', 'daily', 'news2', '', 'p', '', '00001', '', 'figure', '2a', '', 'daily', 'sofa', 'score', 'treatment', '', 'p', '', '005', 'except', 'day', '1', '', 'p021', '', '', 'table', '2', '', '', 'significantly', 'better', 'clinical', 'virological', 'response', 'reflect', 'shorter', 'median', 'hospital', 'stay', 'combination', 'group', 'control', 'group', '', '90', 'day', '', '70130', '', 'v', '145', 'day', '', '93160', '', '', 'hr', '272', '', '12613', '', '', 'p0016', '', 'figure', '2outcomes', 'timeshow', 'full', 'caption', '', '', 'national', 'early', 'warn', 'score', '2', '', '', 'b', '', 'nasopharyngeal', 'swab', 'viral', 'load', '', '', 'c', '', 'posterior', 'oropharyngeal', 'saliva', 'viral', 'load', '', '', '', 'throat', 'swab', 'viral', 'load', '', '', 'e', '', 'stool', 'viral', 'load', '', '', 'f', '', 'serum', 'il-inhibitor', 'cytokine', 'concentration', '', 'first', '60', 'recruit', 'patient', '', '', 'data', 'point', 'median', 'error', 'bar', 'iqrsview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'national', 'early', 'warn', 'score', '2', '', '', 'b', '', 'nasopharyngeal', 'swab', 'viral', 'load', '', '', 'c', '', 'posterior', 'oropharyngeal', 'saliva', 'viral', 'load', '', '', '', 'throat', 'swab', 'viral', 'load', '', '', 'e', '', 'stool', 'viral', 'load', '', '', 'f', '', 'serum', 'il-inhibitor', 'cytokine', 'concentration', '', 'first', '60', 'recruit', 'patient', '', '', 'data', 'point', 'median', 'error', 'bar', 'iqrs', '', 'virological', 'outcome', '', 'combination', 'treatment', 'associate', 'significantly', 'shorter', 'time', 'negative', 'viral', 'load', 'specimen', 'assess', 'individually', '', 'nasopharyngeal', 'swab', '', 'posterior', 'oropharyngeal', 'saliva', '', 'throat', 'swab', '', 'stool', 'sample', '', 'well', 'specimen', 'combine', '', 'table', '2', '', '', 'urine', 'sample', 'test', 'negative', 'viral', 'load', '', 'patient', 'sars-cov-2', 'positive', 'baseline', 'nasopharyngeal', 'swab', '', 'regard', 'clinical', 'sample', '', '108', '', '85', '', '', 'patient', 'provide', 'posterior', 'oropharyngeal', 'saliva', 'sample', '', '99', '', '78', '', '', 'provide', 'throat', 'swab', '', '36', '', '28', '', '', 'provide', 'stool', 'sample', '', '83', '', '65', '', '', 'provide', 'urine', 'sample', '', 'baseline', 'viral', 'load', 'specimen', 'similar', 'combination', 'group', 'control', 'group', '', 'table', '2', '', '', 'nasopharyngeal', 'swab', 'viral', 'load', 'significantly', 'lower', 'combination', 'group', 'control', 'group', 'day', '1', 'day', '7', 'treatment', '', 'figure', '2b', '', '', 'similar', 'result', 'find', 'posterior', 'oropharyngeal', 'saliva', '', 'throat', 'swab', '', 'stool', 'specimen', 'treatment', '', 'figure', '2ce', '', '', 'post-hoc', 'subgroup', 'comparison', '76', 'patient', 'start', 'treatment', 'le', '7', 'day', 'onset', 'symptom', 'show', 'better', 'clinical', 'virological', 'outcome', 'combination', 'group', '', '52', 'patient', '', 'receive', 'lopinavirritonavir', '', 'ribavirin', '', 'interferon', 'beta-1b', '', 'control', 'group', '', '24', 'patient', '', 'table', '3', '', 'across', 'measure', 'variable', 'except', 'stool', 'sample', '', 'however', '', 'significant', 'difference', 'treatment', 'group', 'measure', 'outcome', '51', 'patient', 'treat', '7', 'day', 'symptom', 'onset', '', '34', 'combination', 'group', '', 'receive', 'lopinavirritonavir', 'ribavirin', '', '17', 'control', 'group', '', 'appendix', 'p', '31', '', 'table', '3subgroup', 'analysis', 'clinical', '', 'viral', 'load', '', 'cytokine', 'profilestarted', 'treatment', '', '7', 'day', 'symptom', 'onsetstarted', 'treatment', '7', 'day', 'symptom', 'onsetcombination', 'group', '', 'interferon', 'beta-1b', '', 'n52', '', 'control', 'group', '', 'n24', '', 'p', 'valuecombination', 'group', '', 'without', 'interferon', 'beta-1b', '', 'n34', '', 'control', 'group', '', 'n17', '', 'p', 'valuenews2baseline2', '', '12', '', '2', '', '22', '', '0112', '', '12', '', '2', '', '12', '', '049day', '11', '', '11', '', '2', '', '22', '', '', '000012', '', '12', '', '2', '', '12', '', '071day', '210', '', '0010', '', '20', '', '1530', '', '', '0000115', '', '1020', '', '20', '', '1028', '', '041day', '300', '', '0010', '', '20', '', '1030', '', '', '0000110', '', '1020', '', '20', '', '0328', '', '016day', '400', '', '0000', '', '20', '', '1025', '', '', '0000110', '', '1020', '', '20', '', '0320', '', '037day', '50', '', '005', '', '2', '', '12', '', '', '000011', '', '01', '', '2', '', '02', '', '0040day', '60', '', '003', '', '1', '', '12', '', '', '000011', '', '01', '', '1', '', '02', '', '014day', '70', '', '00', '', '1', '', '02', '', '', '000011', '', '01', '', '1', '', '01', '', '068time', 'news2', '0', '', 'days40', '', '3050', '', '80', '', '6590', '', '', '0000160', '', '50108', '', '80', '', '5580', '', '090sofa', 'scorebaseline0', '', '01', '', '0', '', '01', '', '0991', '', '01', '', '0', '', '01', '', '017day', '100', '', '0010', '', '10', '', '0010', '', '003010', '', '0020', '', '10', '', '0015', '', '067day', '20', '', '01', '', '1', '', '02', '', '000601', '', '02', '', '1', '', '02', '', '072day', '30', '', '01', '', '1', '', '02', '', '000501', '', '02', '', '1', '', '03', '', '049day', '40', '', '01', '', '1', '', '02', '', '000601', '', '02', '', '1', '', '03', '', '048day', '500', '', '0008', '', '10', '', '0020', '', '0003010', '', '0020', '', '10', '', '0030', '', '055day', '600', '', '0000', '', '05', '', '0020', '', '0001010', '', '0020', '', '10', '', '0020', '', '088day', '700', '', '0000', '', '05', '', '0020', '', '', '0000110', '', '0020', '', '10', '', '0020', '', '088time', 'sofa', 'score', '0', '', 'days3', '', '15', '', '7', '', '19', '', '000108', '', '18', '', '8', '', '19', '', '023duration', 'hospital', 'stay', '', 'days8', '', '6125', '', '15', '', '916', '', '0003013', '', '815', '', '135', '', '123218', '', '009030-day', 'mortality0', '', '0', '', '0', '', '0', '', '1000', '', '0', '', '0', '', '0', '', '100time', 'negative', 'viral', 'load', '', 'daysnasopharyngeal', 'swab65', '', '4080', '', '125', '', '80148', '', '', '00001105', '', '80123', '', '120', '', '80170', '', '010posterior', 'oropharyngeal', 'saliva60', '', '2070', '', '85', '', '53118', '', '', '0000180', '', '6090', '', '80', '', '5390', '', '079throat', 'swab40', '', '1060', '', '80', '', '33128', '', '0001050', '', '1580', '', '45', '', '2090', '', '052stool45', '', '2050', '', '60', '', '3070', '', '007050', '', '20100', '', '70', '', '5585', '', '014all', 'specimens70', '', '4090', '', '130', '', '80140', '', '', '00001120', '', '78140', '', '120', '', '120190', '', '0080virological', 'find', '', 'rt-pcr', '', '', 'log10', 'copy', 'per', 'mlnasopharyngeal', 'swab', '', 'baseline', '', '7', '', '5284', '', '61', '', '4377', '', '02955', '', '3873', '', '66', '', '388', '', '065posterior', 'oropharyngeal', 'saliva', '', 'baseline', '', '54', '', '3973', '', '53', '', '3975', '', '08648', '', '3862', '', '54', '', '4968', '', '030throat', 'swab', '', 'baseline', '', '48', '', '3269', '', '44', '', '3561', '', '08145', '', '1056', '', '50', '', '4055', '', '052stool', '', 'baseline', '', '32', '', '1962', '', '32', '', '2956', '', '08533', '', '2839', '', '56', '', '1974', '', '048cytokine', 'concentration', '', 'log10', 'pgmlil-6', '', 'baseline', '', '14', '', '115', '', '14', '', '1416', '', '01314', '', '114', '', '1', '', '116', '', '045tnf', '', 'baseline', '', '1', '', '11', '', '1', '', '11', '', '0871', '', '11', '', '1', '', '11', '', '082data', 'median', '', 'iqr', '', '', 'news2national', 'early', 'warn', 'score', '2', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', '', 'news2national', 'early', 'warn', 'score', '2', '', 'sofasequential', 'organ', 'failure', 'assessment', '', '17', '', '13', '', '', '127', 'patient', 'develop', 'oxygen', 'desaturation', 'require', 'oxygen', 'treatment', '', 'table', '2', '', '', 'six', '', '5', '', '', 'patient', 'admit', 'intensive', 'care', 'unit', '', 'five', 'require', 'non-invasive', 'ventilator', 'support', 'one', '96-year-old', 'female', 'patient', 'past', 'medical', 'history', 'coronary', 'artery', 'disease', 'require', 'intubation', 'ventilator', 'support', '', 'control', 'group', 'successfully', 'extubated', '10', 'day', 'intensive', 'care', '', '69', '', '54', '', '', 'patient', 'receive', 'concomitant', 'antibiotic', '', 'eight', '', '6', '', '', 'patient', 'give', 'stress', 'corticosteroid', 'second', 'week', 'symptom', 'onset', '', 'serum', 'cytokine', 'profile', 'analyse', 'first', '84', 'recruit', 'patient', '', 'il-inhibitor', 'concentration', 'combination', 'group', 'significantly', 'lower', 'control', 'group', 'day', '2', '', '6', '', '8', '', 'figure', '2f', '', '', 'certolizumab', 'concentration', 'il-10', 'concentration', 'significantly', 'different', 'group', '', 'significant', 'nsp5', 'mutation', 'identify', 'serial', 'nasopharyngeal', 'swab', 'sample', '', 'multivariable', 'analysis', 'show', 'combination', 'group', 'normal', 'baseline', 'chest', 'x-ray', 'independently', 'associate', 'day', '7', 'negative', 'nasopharyngeal', 'swab', 'viral', 'load', '', 'two', '', 'combination', 'group', 'significant', 'independent', 'factor', '', 'hr', '427', '', '95', '', 'ci', '1821002', '', '', 'p00010', '', 'appendix', 'p', '30', '', '', 'adverse', 'event', 'report', '41', '', '48', '', '', '86', 'patient', 'combination', 'group', '20', '', '49', '', '', '41', 'patient', 'control', 'group', '', 'common', 'adverse', 'event', 'diarrhoea', '', '52', '', '41', '', '', '127', 'patient', '', '', 'fever', '', '48', '', '38', '', '', 'patient', '', '', 'nausea', '', '43', '', '34', '', '', '', 'raise', 'alanine', 'transaminase', 'level', '', '18', '', '14', '', '', '', 'table', '4', '', '', 'side-effects', 'mostly', 'resolve', 'within', '3', 'day', 'drug', 'initiation', '', 'sinus', 'bradycardia', 'report', 'four', '', '3', '', '', 'patient', '', 'difference', 'incidence', 'adverse', 'event', 'duration', 'nausea', 'diarrhoea', 'treatment', 'group', '', 'peak', 'median', 'alanine', 'transaminase', 'concentration', '380', 'unit', 'per', 'l', '', '245625', '', 'peak', 'median', 'bilirubin', '220', 'moll', '', '170325', '', '', 'patient', '', 'serious', 'adverse', 'event', 'report', 'combination', 'group', '', 'one', 'patient', 'control', 'group', 'serious', 'adverse', 'event', 'impair', 'hepatic', 'enzyme', 'require', 'discontinuation', 'treatment', '', 'patient', 'die', 'studytable', '4adverse', 'event', 'study', 'populationcombination', 'group', '', 'n86', '', 'control', 'group', '', 'n41', '', 'p', 'valueadverse', 'eventsnausea30', '', '35', '', '', '13', '', '32', '', '', '087diarrhoea34', '', '40', '', '', '18', '', '44', '', '', '054increased', 'alanine', 'aminotransferase11', '', '13', '', '', '7', '', '17', '', '', '032hyperbilirubinaemia4', '', '5', '', '', '3', '', '7', '', '', '054sinus', 'bradycardia3', '', '4', '', '', '1', '', '2', '', '', '077fever32', '', '37', '', '', '16', '', '39', '', '', '073serious', 'adverse', 'events01', '', '2', '', '', '015duration', 'nausea', '', 'days2', '', '12', '', '2', '', '12', '', '080duration', 'diarrhoea', '', 'days3', '', '33', '', '3', '', '33', '', '088', 'open', 'table', 'new', 'tab', 'multicentre', 'randomise', 'open-label', 'phase', '2', 'trial', 'patient', 'covid-19', '', 'show', 'triple', 'combination', 'injectable', 'interferon', '', 'interferon', 'beta-1b', '', '', 'oral', 'protease', 'inhibitor', '', 'lopinavirritonavir', '', '', 'oral', 'nucleoside', 'analogue', '', 'ribavirin', '', '', 'give', 'within', '7', 'day', 'symptom', 'onset', '', 'effective', 'suppress', 'shed', 'sars-cov-2', '', 'nasopharyngeal', 'swab', '', 'clinical', 'specimen', '', 'compare', 'lopinavirritonavir', 'alone', '', 'furthermore', '', 'significant', 'reduction', 'duration', 'rt-pcr', 'positivity', 'viral', 'load', 'associate', 'clinical', 'improvement', 'show', 'significant', 'reduction', 'news2', 'duration', 'hospital', 'stay', '', 'patient', 'treat', 'triple', 'combination', 'rt-pcr', 'negative', 'specimen', 'day', '8', '', 'side-effects', 'generally', 'mild', 'self-limiting', '', 'specific', 'highly', 'active', 'antiviral', 'drug', 'always', 'novel', 'emerge', 'infectious', 'disease', 'development', 'new', 'antiviral', 'year', 'approval', 'clinical', '', 'therefore', '', 'drug', 'repurposing', 'test', 'exist', 'broad-spectrum', 'antiviral', 'drug', 'treat', 'viral', 'infection', 'feasible', 'approach', 'pandemic', '', 'drug', 'show', 'in-vitro', 'activity', 'betacoronaviruses', '', 'include', 'remdesivir', '', 'favipiravir', '', 'nitazoxanide', '', 'camostat', 'mesilate', '', 'interferon', '', 'lopinavirritonavir', '', 'ribavirin', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'convalescent', 'plasma', 'contain', 'neutralise', 'antibodies5chen', 'f', 'chan', 'kh', 'jiang', 'alin', 'vitro', 'susceptibility', '10', 'clinical', 'isolate', 'sars', 'coronavirus', 'select', 'antiviral', 'compoundsj', 'clin', 'virol', '', '2004', '', '31', '', '69-75google', '', '6chan', 'jf', 'chan', 'kh', 'kao', 'ry', 'albroad-spectrum', 'antiviral', 'emerge', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirusj', 'infect', '', '2013', '', '67', '', '606-616google', '', '7chu', 'cm', 'cheng', 'vc', 'hung', 'alrole', 'lopinavirritonavir', 'treatment', 'sars', '', 'initial', 'virological', 'clinical', 'findingsthorax', '', '2004', '', '59', '', '252-256google', '', '8chan', 'jf', 'yao', 'yeung', 'ml', 'altreatment', 'lopinavirritonavir', 'interferon-1b', 'improve', 'outcome', 'mers-cov', 'infection', 'nonhuman', 'primate', 'model', 'common', 'marmosetj', 'infect', 'dis', '', '2015', '', '212', '', '1904-1913google', '', '13agostini', 'ml', 'andres', 'el', 'sims', 'ac', 'alcoronavirus', 'susceptibility', 'antiviral', 'remdesivir', '', 'gs-5734', '', 'mediate', 'viral', 'polymerase', 'proofread', 'exoribonulceasembio', '', '2018', '', '9', '', 'e00221-e00318google', '', '14li', 'g', 'de', 'clercq', 'e', 'therapeutic', 'option', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', 'nat', 'rev', 'drug', 'discov', '', '2020', '', '19', '', '149-150google', '', '15wang', 'cao', 'r', 'zhang', 'l', 'alremdesivir', 'hydroxychloroquine', 'effectively', 'inhibit', 'recently', 'emerge', 'novel', 'coronavirus', '', '2019-ncov', '', 'vitrocell', 'res', '', '2020', '', '30', '', '269-271google', '', '16rossignol', 'jf', 'nitazoxanide', '', 'new', 'drug', 'candidate', 'treatment', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirusj', 'infect', 'public', 'health', '', '2016', '', '9', '', '227-230google', '', '17beigel', 'jh', 'nam', 'hh', 'adams', 'pl', 'aladvances', 'respiratory', 'virus', 'therapeutic', '-', 'meet', 'report', '6th', 'isirv', 'antiviral', 'group', 'conferenceantiviral', 'res', '', '2019', '', '167', '', '45-67google', '', '18sheahan', 'tp', 'sims', 'ac', 'leist', 'sr', 'alcomparative', 'therapeutic', 'efficacy', 'remdesivir', 'combination', 'lopinavir', '', 'ritonavir', '', 'interferon', 'beta', 'mers-covnat', 'commun', '', '2020', '', '11', '', '222google', '', '19mair-jenkins', 'j', 'saavedra-campos', 'baillie', 'jk', 'althe', 'effectiveness', 'convalescent', 'plasma', 'hyperimmune', 'immunoglobulin', 'treatment', 'severe', 'acute', 'respiratory', 'infection', 'viral', 'etiology', '', 'systematic', 'review', 'exploratory', 'meta-analysisj', 'infect', 'dis', '', '2015', '', '211', '', '80-90google', '', '20cunningham', 'ac', 'goh', 'hp', 'koh', 'treatment', 'covid-19', '', 'old', 'trick', 'new', 'challengescrit', 'care', '', '2020', '', '24', '', '91google', '', '21dong', 'l', 'hu', 'gao', 'j', 'discovering', 'drug', 'treat', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'drug', 'discov', 'ther', '', '2020', '', '14', '', '58-60google', 'drug', 'pharmacokinetic', 'pharmacodynamic', 'property', '', 'side-effects', '', 'dose', 'regimen', '', 'expect', '', 'lopinavirritonavir', 'alone', 'show', 'similar', 'effect', 'placebo', 'reduce', 'viral', 'load', 'treatment', 'initiate', 'median', '13', 'day', 'symptom', 'onset', '', 'despite', 'improvement', 'symptoms22cao', 'b', 'wang', 'wen', 'ala', 'trial', 'lopinavir-ritonavir', 'adult', 'hospitalize', 'severe', 'covid-19n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'march', '18', '', '', 'doi101056nejmoa2001282google', '', 'two', 'open-label', 'non-randomised', 'trial', 'report', '', 'one', 'trial', 'combination', 'oral', 'hydroxychloroquine', 'azithromycin', '20', 'patient', 'covid-19', 'show', 'combination', 'reduce', 'viral', 'load', 'significantly', 'day', '6', 'treatment', '', 'compare', '16', 'control', 'another', 'hospital', '', 'due', 'chance', 'combination', 'plan', 'priori', 'addition', 'azithromycin', 'physician', 'discretion23gautret', 'p', 'lagier', 'jc', 'parola', 'p', 'alhydroxychloroquine', 'azithromycin', 'treatment', 'covid-19', '', 'result', 'open-label', 'non-randomized', 'clinical', 'trialint', 'j', 'antimicrob', 'agents', '', '2020', '', '', 'publish', 'online', 'march', '20', '', '', 'doi101016jijantimicag2020105949google', 'small', 'retrospective', 'analysis', 'show', 'viral', 'load', 'negative', 'day', '7', 'post-treatment', '75', '', 'patient', 'covid-19', 'treat', 'arbidol', 'lopinavirritonavir', '', '16', 'patient', '', 'versus', '35', '', 'patient', 'treat', 'lopinavirritonavir', 'alone', '', '17', 'patient', '', '24deng', 'l', 'li', 'c', 'zeng', 'q', 'alarbidol', 'combine', 'lpvr', 'versus', 'lpvr', 'alone', 'corona', 'virus', 'disease', '2019', '', 'retrospective', 'cohort', 'studyj', 'infect', '', '2020', '', '', 'publish', 'march', '11', '', '', 'doi101016jjinf202003002google', 'hong', 'kong', 'special', 'administrative', 'region', 'public', 'health', 'ordinance', '', 'patient', 'covid-19', 'must', 'stay', 'hospital', 'nasopharyngeal', 'swab', 'viral', 'load', 'negative', '2', 'consecutive', 'day', '', 'thus', '', 'patient', 'admit', 'hospital', 'within', '7', 'day', 'symptom', 'onset', '', 'allow', 'recruitment', 'clinical', 'trial', 'early', 'course', 'covid-19', '', 'memory', '2003', 'sars', 'pandemic', '', 'patient', 'covid-19', 'hong', 'kong', 'accept', 'antiviral', 'treatment', '', 'explain', 'high', 'recruitment', 'rate', '', 'despite', 'open-label', 'study', '', 'patient', 'enrol', 'consecutively', 'without', 'bias', '', 'case', 'demographic', 'proportion', 'patient', 'underlie', 'disease', 'similar', 'report', 'cohort', 'china', '', 'low', 'crude', 'mortality', 'rate', 'hong', 'kong', '', 'four', '', '04', '', '', '1041', 'case', '', 'explain', 'highly', 'vigilant', 'infection', 'control', 'measure', '', 'efficient', 'contact', 'trace', '', 'early', 'hospital', 'admission', 'treatment', '', 'early', 'treatment', 'triple', 'combination', 'modestly', 'active', 'antiviral', 'appropriate', 'treatment', 'covid-19', 'viral', 'load', 'sars-cov-2', 'peak', 'around', 'time', 'symptom', 'onset', '', 'unlike', 'situation', 'sars', 'mers', 'antiviral', 'treatment', 'time', 'suppress', 'viral', 'load', 'peak', 'around', 'day', '710', 'symptom', 'onset', '', 'viral', 'load', 'profile', 'covid-19', 'similar', 'influenza', '', 'high', 'viral', 'load', 'time', 'initiation', 'anti-influenza', 'treatment', '', 'emergence', 'resistant', 'influenza', 'virus', 'quasispecies', 'treatment', 'well', 'report', 'single-drug', 'treatment', 'amantadine', '', 'baloxavir', 'marboxil', '', 'oseltamivir', 'set', 'severe', 'influenza', 'disease', 'cause', 'h5n1', '', 'h7n9', '', 'immunosuppressed', 'hosts11dunning', 'j', 'baillie', 'jk', 'cao', 'b', 'hayden', 'fg', 'antiviral', 'combination', 'severe', 'influenzalancet', 'infect', 'dis', '', '2014', '', '14', '', '1259-1270google', '', '17beigel', 'jh', 'nam', 'hh', 'adams', 'pl', 'aladvances', 'respiratory', 'virus', 'therapeutic', '-', 'meet', 'report', '6th', 'isirv', 'antiviral', 'group', 'conferenceantiviral', 'res', '', '2019', '', '167', '', '45-67google', '', '25hayden', 'fg', 'sugaya', 'n', 'hirotsu', 'n', 'albaloxavir', 'marboxil', 'uncomplicated', 'influenza', 'adult', 'adolescentsn', 'engl', 'j', 'med', '', '2018', '', '379', '', '913-923google', 'thus', '', 'antiviral', 'combination', 'consider', 'reasonable', 'option', 'improve', 'outcome', 'severe', 'influenza', '', 'indeed', '', 'previously', 'show', 'combination', 'naproxen', 'clarithromycin', '', 'weak', 'anti-influenza', 'virus', 'activity', 'vitro', 'individually', '', 'combine', 'oseltamivir', 'improve', 'morbidity', 'mortality', 'shorten', 'duration', 'hospital', 'stay', 'patient', 'influenza', 'ah3n2', 'pneumonia12hung', 'ifn', 'kkw', 'chan', 'jfw', 'alefficacy', 'clarithromycin-naproxen-oseltamivir', 'combination', 'treatment', 'patient', 'hospitalize', 'influenza', '', 'h3n2', '', 'infection', '', 'open-label', 'randomize', '', 'control', '', 'phase', 'iibiii', 'trialchest', '', '2017', '', '151', '', '1069-1080google', 'furthermore', '', 'previously', 'show', 'combination', 'lopinavirritonavir', 'ribavirin', 'significantly', 'reduce', 'mortality', 'respiratory', 'failure', 'patient', '2003', 'sars', 'outbreak7chu', 'cm', 'cheng', 'vc', 'hung', 'alrole', 'lopinavirritonavir', 'treatment', 'sars', '', 'initial', 'virological', 'clinical', 'findingsthorax', '', '2004', '', '59', '', '252-256google', 'thus', '', 'hypothesise', 'triple', 'combination', 'modest', 'antiviral', 'drug', 'rapidly', 'suppress', 'high', 'initial', 'viral', 'load', '', 'improve', 'clinical', 'parameter', '', 'reduce', 'risk', 'health-care', 'worker', 'reduce', 'duration', 'quantity', 'virus', 'shed', 'treat', 'patient', '', 'in-vitro', 'study', 'cell', 'culture-based', 'assay', 'show', '50', '', 'effective', 'concentration', '', 'ec50', '', 'lopinavir', 'sars-cov', '17', 'mers-cov', '8', '', 'whereas', 'peak', 'serum', 'lopinavir', 'concentration', '15', 'half-life', '74108', 'h', 'oral', 'dose', '400', 'mg', 'lopinavir', '100', 'mg', 'ritonavir26de', 'wilde', 'ah', 'jochmans', 'posthuma', 'cc', 'alscreening', 'fda-approved', 'compound', 'library', 'identify', 'four', 'small-molecule', 'inhibitor', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'replication', 'cell', 'cultureantimicrob', 'agents', 'chemother', '', '2014', '', '58', '', '4875-4884google', 'ec50', 'interferon', 'beta-1b', '012', 'iuml', 'sars-cov', '176', 'iuml', 'mers-cov6chan', 'jf', 'chan', 'kh', 'kao', 'ry', 'albroad-spectrum', 'antiviral', 'emerge', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirusj', 'infect', '', '2013', '', '67', '', '606-616google', '', '27tan', 'el', 'ooi', 'ee', 'lin', 'cy', 'alinhibition', 'sars', 'coronavirus', 'infection', 'vitro', 'clinically', 'approve', 'antiviral', 'drugsemerg', 'infect', 'dis', '', '2004', '', '10', '', '581-586google', 'whereas', 'peak', 'serum', 'level', '20', 'iuml', 'half-life', '25', 'h', 'single', 'subcutaneous', 'dose', '8', 'million', 'iu', '', 'notably', '', 'maintenance', 'high', 'serum', 'interferon', 'beta-1b', 'level', 'essential', 'antiviral', 'status', 'expose', 'cell', 'induce', '', 'ec50', 'ribavirin', 'sars-cov-2', '109', 'm15wang', 'cao', 'r', 'zhang', 'l', 'alremdesivir', 'hydroxychloroquine', 'effectively', 'inhibit', 'recently', 'emerge', 'novel', 'coronavirus', '', '2019-ncov', '', 'vitrocell', 'res', '', '2020', '', '30', '', '269-271google', 'greatly', 'exceed', 'drug', 'serum', 'concentration', 'usual', 'oral', 'dose', '', 'nevertheless', '', 'synergistic', 'activity', 'interferon', 'lower', 'dose', 'ribavirin', 'show', 'checkerboard', 'assay', '', 'however', '', 'combine', 'ribavirin', 'interferon', '', 'alfa-2a', '', 'alfa-2b', '', 'beta-1a', '', 'improve', 'outcome', 'critically', 'ill', 'patient', 'mers28arabi', 'ym', 'shalhoub', 'mandourah', 'alribavirin', 'interferon', 'therapy', 'critically', 'ill', 'patient', 'middle', 'east', 'respiratory', 'syndrome', '', 'multicentre', 'observational', 'studyclin', 'infect', 'dis', '', '2020', '', '70', '', '1837-1844google', 'thus', '', 'repurposing', 'triple', 'combination', 'modestly', 'active', 'lopinavirritonavir', '', 'interferon', 'beta-1b', '', 'ribavirin', 'treatment', 'novel', 'pandemic', 'virus', 'reasonable', 'therapeutic', 'approach', '', 'furthermore', '', 'sars-cov-2', 'significantly', 'induce', 'type', '', 'ii', '', 'iii', 'interferon', 'ex-vivo', 'infect', 'human', 'lung', 'tissue', 'compare', '2003', 'sars-cov29chu', 'h', 'chan', 'jf-w', 'wang', 'alcomparative', 'replication', 'immune', 'activation', 'profile', 'sars-cov-2', 'sars-cov', 'human', 'lung', '', 'ex', 'vivo', 'study', 'implication', 'pathogenesis', 'covid-19clin', 'infect', 'dis', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'doi101093cidciaa410google', 'thus', '', 'interferon', 'beta-1b', 'treatment', 'jump-start', 'improve', 'antiviral', 'response', 'patient', 'logical', 'approach', '', 'additionally', '', 'interferon', 'beta-1b', 'show', 'decrease', 'virus-induced', 'lung', 'fibrosis', 'mouse', 'model', '', 'improve', 'outcome', 'patient', 'covid-19', 'complicate', 'acute', 'respiratory', 'distress', 'syndrome30luckhardt', 'tr', 'commes', 'sm', 'trujillo', 'g', 'altlr9-induced', 'interferon', '', 'associate', 'protection', 'gammaherpesvirus-induced', 'exacerbation', 'lung', 'fibrosisfibrogenesis', 'tissue', 'repair', '', '2011', '', '4', '', '18google', 'despite', 'concern', 'major', 'side-effects', 'arise', 'combination', 'three', 'drug', '', 'significant', 'difference', 'incidence', 'adverse', 'event', 'treatment', 'group', 'report', 'cohort', '127', 'patient', '', 'haemolysis', 'occur', 'short', 'duration', 'low', 'dose', 'ribavirin', '', 'triple', 'combination', 'patient', 'start', 'treatment', '7', 'day', 'symptom', 'onset', 'concern', 'proinflammatory', 'side-effects', 'interferon', 'beta-1b', '', 'despite', 'three', 'patient', '', 'liver', 'dysfunction', 'observe', '14', '', 'patient', 'mild', 'self-limiting', '', 'except', 'one', 'patient', 'control', 'group', '', 'biochemical', 'hepatitis', 'warrant', 'discontinuation', 'lopinavirritonavir', 'treatment', '', 'study', 'several', 'limitation', '', 'trial', 'open', 'label', '', 'without', 'placebo', 'group', '', 'confound', 'subgroup', 'omit', 'interferon', 'beta-1b', 'within', 'combination', 'group', '', 'depend', 'time', 'symptom', 'onset', '', 'subsequent', 'phase', '3', 'trial', 'interferon', 'beta-1b', 'backbone', 'treatment', 'placebo', 'control', 'group', 'consider', '', 'subgroup', 'comparison', 'suggest', 'interferon', 'beta-1b', 'appear', 'key', 'component', 'combination', 'treatment', '', 'absence', 'critically', 'ill', 'patient', 'allow', 'generalisation', 'find', 'severe', 'case', '', 'triple', 'antiviral', 'therapy', 'interferon', 'beta-1b', '', 'lopinavirritonavir', '', 'ribavirin', 'safe', 'superior', 'lopinavirritonavir', 'alone', 'shorten', 'virus', 'shed', '', 'alleviate', 'symptom', '', 'facilitate', 'discharge', 'patient', 'mild', 'moderate', 'covid-19', '', 'contributors', 'if-nh', '', 'k-cl', '', 'ey-kt', '', 'jc', '', 'w-sl', '', 'y-yn', '', 't-cw', '', 'k-yy', 'responsible', 'design', '', 'analyse', '', 'write', 'manuscript', '', 'if-nh', '', 'k-cl', '', 'ey-kt', '', 'rl', '', 'tw-hc', '', 'm-yc', '', 'y-yn', '', 'jl', '', 'art', '', 'h-ps', '', 'vc', '', 'ak-lw', '', 'k-ms', '', 'w-ll', '', 'dcl', '', 'ss', '', 'py', '', 'rli', '', 'kf', '', 'ay', '', 't-cw', '', 'jw-mc', '', 'w-wy', '', 'w-mic', '', 'ak-wl', '', 'vc-cc', '', 't-lq', '', 'c-sl', 'responsible', 'recruitment', 'clinical', 'care', 'patient', '', 'ifn-h', '', 'jf-wc', '', 'kk-wt', '', 'k-yy', 'responsible', 'analyse', 'write', 'manuscript', '', 'cc-yy', '', 'rrz', '', 'ay-ff', '', 'ey-wy', '', 'k-hl', '', 'aw-hc', '', 'w-muc', '', 'ac-kn', '', 'jdi', '', 'rle', '', 'kf', '', 'dcl', '', 'ak-lw', '', 'vc-cc', '', 't-lq', '', 'k-hc', 'responsible', 'laboratory', 'analysis', '', 'author', 'review', 'approve', 'final', 'version', 'manuscript', '', 'declaration', 'interest', 'declare', 'compete', 'interest', '', 'qualified', 'researcher', 'request', 'access', 'deidentified', 'participant', 'data', 'anonymised', 'clinical', 'study', 'report', '', 'inform', 'consent', 'form', '', 'relate', 'document', 'include', 'study', 'protocol', 'underlie', 'article', 'submission', 'proposal', 'valuable', 'research', 'question', 'correspond', 'author', '', 'provide', 'necessary', 'data', 'protection', 'agency', 'ethical', 'committee', 'approval', 'compliance', 'relevant', 'registration', '', 'contract', 'sign', '', 'acknowledgments', 'study', 'partly', 'support', 'consultancy', 'service', 'enhancing', 'laboratory', 'surveillance', 'emerging', 'infectious', 'diseases', 'research', 'capability', 'antimicrobial', 'resistance', 'department', 'health', 'hong', 'kong', '', 'theme-based', 'research', 'scheme', '', 't1170715', '', 'research', 'grants', 'council', '', 'hong', 'kong', '', 'sanming', 'project', 'medicine', 'shenzhen', '', 'china', '', 'szsm201911014', '', '', 'health', 'medical', 'research', 'fund', '', 'hong', 'kong', '', 'high', 'level-hospital', 'program', '', 'health', 'commission', 'guangdong', 'province', '', 'china', '', 'donation', 'richard', 'yu', 'carol', 'yu', '', 'shaw', 'foundation', 'hong', 'kong', '', 'michael', 'seak-kan', 'tong', '', 'tam', 'mak', 'mei', 'yin', '', 'respiratory', 'viral', 'research', 'foundation', 'limited', '', 'hui', 'ming', '', 'hui', 'hoy', '', 'chow', 'sin', 'lan', 'charity', 'fund', 'limited', '', 'chan', 'yin', 'chuen', 'memorial', 'charitable', 'foundation', '', 'marina', 'man-wai', 'lee', '', 'hong', 'kong', 'hainan', 'commercial', 'association', 'south', 'china', 'microbiology', 'research', 'fund', '', 'jessie', '', 'george', 'ho', 'charitable', 'foundation', '', 'download', 'pdf', '', '114', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'interferon', 'beta-1b', 'covid-19full-textpdf']",7788,"{'': 2109, 'patient': 118, 'group': 83, 'treatment': 73, 'combination': 69, 'day': 68, 'lopinavirritonavir': 57, '2': 56, 'interferon': 50, 'control': 50, 'viral': 49, '1': 46, 'covid-19': 42, 'load': 41, 'beta-1b': 38, 'antiviral': 36, 'study': 36, 'symptom': 36, 'hospital': 35, 'swab': 34}","{'certolizumab': 1, 'hydroxychloroquine': 5, 'infection': 16, 'sars-cov-2': 16, 'vitro': 5, 'safety': 4, 'crohn': 1, 'il-inhibitor': 5}",53,0.7964
DOI:10.1016/S0140-6736(20)30460-8,10.1016/S0140-6736(20)30460-8,Rapid Review,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['psychological', 'impact', 'quarantine', 'reduce', '', 'rapid', 'review', 'evidence']","['The December , 2019 coronavirus disease outbreak see many country ask people potentially come contact infection isolate home dedicate quarantine facility .', 'Decisions apply quarantine base best available evidence .', 'We Review psychological impact quarantine use three electronic database .', 'Of 3166 paper find , 24 include Review .', 'Most review study report negative psychological effect include post-traumatic stress symptom , confusion , anger .', 'Stressors include longer quarantine duration , infection fear , frustration , boredom , inadequate supply , inadequate information , financial loss , stigma .', 'Some researcher suggest long-lasting effect .', 'In situation quarantine deem necessary , official quarantine individual longer require , provide clear rationale quarantine information protocol , ensure sufficient supply provide .', 'Appeals altruism remind public benefit quarantine wider society favourable .', 'The December , 2019 coronavirus disease outbreak see many country ask people potentially come contact infection isolate home dedicate quarantine facility .', 'Decisions apply quarantine base best available evidence .', 'We Review psychological impact quarantine use three electronic database .', 'Of 3166 paper find , 24 include Review .', 'Most review study report negative psychological effect include post-traumatic stress symptom , confusion , anger .', 'Stressors include longer quarantine duration , infection fear , frustration , boredom , inadequate supply , inadequate information , financial loss , stigma .', 'Some researcher suggest long-lasting effect .', 'In situation quarantine deem necessary , official quarantine individual longer require , provide clear rationale quarantine information protocol , ensure sufficient supply provide .', 'Appeals altruism remind public benefit quarantine wider society favourable .', 'Quarantine separation restriction movement people potentially expose contagious disease ascertain become unwell , reduce risk infect others.1Centers Disease Control PreventionQuarantine isolation .', 'urlplaceholder 2017Google Scholar This definition differ isolation , separation people diagnose contagious disease people sick ; however , two term often use interchangeably , especially communication public.2Manuell M-E Cukor J Mother Nature versus human nature : public compliance evacuation quarantine.Disasters .', '2011 ; 35 : 417-442CrossrefPubMedScopus ( 8 ) Google Scholar The word quarantine first use Venice , Italy 1127 regard leprosy widely use response Black Death , although 300 year later UK properly begin impose quarantine response plague.3Newman K Shutt : bubonic plague quarantine early modern England.J Sol Hist .', '2012 ; 45 : 809-834CrossrefPubMedScopus ( 8 ) Google Scholar Most recently , quarantine use coronavirus disease 2019 ( COVID-19 ) outbreak .', 'This outbreak see entire city China effectively place mass quarantine , many thousand foreign national return home China ask self-isolate home state-run facilities.4Public Health EnglandNovel coronavirus ( 2019-nCoV ) – need know .', 'urlplaceholder 2020Google Scholar There precedent measure .', 'Citywide quarantine also impose area China Canada 2003 outbreak severe acute respiratory syndrome ( SARS ) , whereas entire village many west African country quarantine 2014 Ebola outbreak .', 'Key messages•Information key ; people quarantine need understand situation•Effective rapid communication essential•Supplies ( general medical ) need provided•The quarantine period short duration change unless extreme circumstances•Most adverse effect come imposition restriction liberty ; voluntary quarantine associate le distress fewer long-term complications•Public health official emphasise altruistic choice self-isolating •Information key ; people quarantine need understand situation•Effective rapid communication essential•Supplies ( general medical ) need provided•The quarantine period short duration change unless extreme circumstances•Most adverse effect come imposition restriction liberty ; voluntary quarantine associate le distress fewer long-term complications•Public health official emphasise altruistic choice self-isolating Quarantine often unpleasant experience undergo .', 'Separation love one , loss freedom , uncertainty disease status , boredom , occasion , create dramatic effect .', 'Suicide reported,5Barbisch D Koenig KL Shih FY Is case quarantine ?', 'Perspectives SARS Ebola.Disaster Med Public Health Prep .', '2015 ; 9 : 547-553CrossrefPubMedScopus ( 26 ) Google Scholar substantial anger generate , lawsuit brought6Miles SH Kaci Hickox : public health politics fear .', 'urlplaceholder 2014Google Scholar follow imposition quarantine previous outbreak .', 'The potential benefit mandatory mass quarantine need weigh carefully possible psychological costs.7Rubin GJ Wessely S The psychological effect quarantine city.BMJ .', '2020 ; 368 : m313CrossrefPubMedScopus ( 6 ) Google Scholar Successful use quarantine public health measure require u reduce , far possible , negative effect associate .', 'Given develop situation coronavirus , policy maker urgently need evidence synthesis produce guidance public .', 'In circumstance , rapid review recommend WHO.8WHORapid review strengthen health policy system : practical guide .', 'urlplaceholder 2017Google Scholar We undertake Review evidence psychological impact quarantine explore likely effect mental health psychological wellbeing , factor contribute , mitigate , effect .', 'Of 3166 paper find , 24 include Review ( figure ) .', 'The characteristic study meet inclusion criterion present table .', 'These study do across ten country include people SARS ( 11 study ) , Ebola ( five ) , 2009 2010 H1N1 influenza pandemic ( three ) , Middle East respiratory syndrome ( two ) , equine influenza ( one ) .', 'One study relate H1N1 SARS.FigureScreening profileView Large Image Figure ViewerDownload Hi-res image Download ( PPT ) TableStudy characteristicsCountryDesignParticipantsQuarantine periodMeasuresBai et al ( 2004 ) 9Bai Y Lin C-C Lin C-Y Chen J-Y Chue C-M Chou P Survey stress reaction among health care worker involve SARS outbreak.Psychiatr Serv .', ""2004 ; 55 : 1055-1057CrossrefPubMedScopus ( 39 ) Google ScholarTaiwanCross-sectional338 hospital staff9 day contact suspect SARS casesStudy-specific survey ; SARS-related stress survey compose acute stress disorder criterion accord DSM-IV relate emotional behavioural changesBlendon et al ( 2004 ) 10Blendon RJ Benson JM DesRoches CM Raleigh E Taylor-Clark K The public 's response severe acute respiratory syndrome Toronto United States.Clin Infect Dis ."", ""2004 ; 38 : 925-931CrossrefPubMedScopus ( 91 ) Google ScholarCanadaCross-sectional501 Canadian residentsLength unclear ; exposure SARSStudy-specific surveyBraunack-Mayer et al ( 2013 ) 11Braunack-Mayer A Tooher R Collins JE Street JM Marshall H Understanding school community 's response school closure H1N1 2009 influenza pandemic.BMC Public Health ."", '2013 ; 13 : 344CrossrefPubMedScopus ( 5 ) Google ScholarAustraliaQualitative56 school community membersLength unclear ; H1N1 influenzaInterviewCaleo et al ( 2018 ) 12Caleo G Duncombe J Jephcott F et al.The factor affect household transmission dynamic community compliance Ebola control measure : mixed-methods study rural village Sierra Leone.BMC Public Health .', '2018 ; 18 : 248CrossrefPubMedScopus ( 6 ) Google ScholarSierra LeoneMixed methods1161 resident rural village ; 20 take part interview studyLength unclear ; entire village restrict movement EbolaInterviewCava et al ( 2005 ) 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google ScholarCanadaQualitative21 Toronto residents5–10 day SARS contactInterviewDesclaux et al ( 2017 ) 14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google ScholarSenegalQualitative70 Ebola contact cases21 day Ebola contactInterviewDiGiovanni et al ( 2004 ) 15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google ScholarCanadaMixed methods1509 Toronto residentsDuration quarantine difference incubation period SARS ( take 10 day ) time elapse since exposure SARS patientInterviews , focus group , telephone pollsHawryluck et al ( 2004 ) 16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google ScholarCanadaCross-sectional129 Toronto residentsMedian 10 day potential SARS exposureIES-R ass post-traumatic stress CES-D ass depressionJeong et al ( 2016 ) 17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', '2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google ScholarSouth KoreaLongitudinal1656 resident four region Korea2 week contact MERS patientsGAD-7 ass anxiety STAXI-2 ass angerLee et al ( 2005 ) 18Lee S Chan LY Chau AM Kwok KP Kleinman A The experience SARS-related stigma Amoy Gardens.Soc Sci Med .', '2005 ; 61 : 2038-2046CrossrefPubMedScopus ( 31 ) Google ScholarHong Kong ( Special Administrative Region , China ) Mixed methods903 resident Amoy Gardens ( first officially recognise site community outbreak SARS Hong Kong ) take survey ; 856 diagnose SARS ; 2 interviewedLength unclear ; resident SARS outbreak siteStudy-specific surveyLiu et al ( 2012 ) 19Liu X Kakade M Fuller CJ et al.Depression exposure stressful event : lesson learn severe acute respiratory syndrome epidemic.Compr Psychiatry .', ""2012 ; 53 : 15-23CrossrefPubMedScopus ( 6 ) Google ScholarChinaCross-sectional549 hospital employee ; 104 ( 19 % ) quarantinedLength unclear ; home work quarantine potential SARS contactCES-D ass depressive symptom IES-R ass post-traumatic stress symptomsMarjanovic et al ( 2007 ) 20Marjanovic Z Greenglass ER Coffey S The relevance psychosocial variable work condition predict nurse ' cop strategy SARS crisis : online questionnaire survey.Int J Nurs Stud ."", '2007 ; 44 : 991-998CrossrefPubMedScopus ( 17 ) Google ScholarCanadaCross-sectional333 nursesLength unclear ; SARS exposureMBI-GS ass burnout ; STAXI-2 ass anger ; six study-specific question ass avoidance behaviourMaunder et al ( 2003 ) 21Maunder R Hunter J Vincent L et al.The immediate psychological occupational impact 2003 SARS outbreak teach hospital.CMAJ .', '2003 ; 168 : 1245-1251PubMedGoogle ScholarCanadaObservationalHealth-care worker ( sample size unavailable ) 10 day voluntary quarantine potential SARS contactObservations health-care staffMihashi et al ( 2009 ) 22Mihashi M Otsubo Y Yinjuan X Nagatomi K Hoshiko M Ishitake T Predictive factor psychological disorder development recovery follow SARS outbreak.Health Psychol .', '2009 ; 28 : 91-100CrossrefPubMedScopus ( 5 ) Google ScholarChinaRetrospective cross-sectional187 print company worker , university faculty member family , non-medicine studentsLength unclear ; citywide isolation SARSGHQ-30 ass psychological disordersPan et al ( 2005 ) 23Pan PJD Chang S-H Yu Y-Y A support group home-quarantined college student expose SARS : learn practice.J Spec Group Work .', '2005 ; 30 : 363-374CrossrefScopus ( 4 ) Google ScholarTaiwanObservational12 college studentsLength unclear ; ask limit interaction outside home potential SARS contactObservations support group home-quarantined studentsPellecchia et al ( 2015 ) 24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google ScholarLiberiaQualitative432 ( focus group ) 30 ( interview ) resident neighbourhood incidence Ebola21 day neighbourhood epidemiological incidence EbolaInterviews focus groupsReynolds et al ( 2008 ) 25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google ScholarCanadaCross-sectional1057 close contact potential SARS casesMean 8·3 day ; range 2–30 day contact potential SARS casesIES-7 ass post-traumatic stress symptomsRobertson et al ( 2004 ) 26Robertson E Hershenfield K Grace SL Stewart DE The psychosocial effect quarantine follow exposure SARS : qualitative study Toronto health care workers.Can J Psychiatry .', '2004 ; 49 : 403-407CrossrefPubMedScopus ( 34 ) Google ScholarCanadaQualitative10 health-care workers10 day home quarantine , continually wear mask presence others , require attend work travel vehicle wear mask , SARS exposureInterviewsSprang Silman ( 2013 ) 27Sprang G Silman M Posttraumatic stress disorder parent youth health-related disasters.Disaster Med Public Health Prep .', ""2013 ; 7 : 105-110CrossrefPubMedScopus ( 7 ) Google ScholarUSA CanadaCross-sectional398 parentsLength unclear ; live area severely affect H1N1 SARSPTSD-RI Parent Version PCL-CTaylor et al ( 2008 ) 28Taylor MR Agho KE Stevens GJ Raphael B Factors influence psychological distress disease epidemic : data Australia 's first outbreak equine influenza.BMC Public Health ."", '2008 ; 8 : 347CrossrefPubMedScopus ( 27 ) Google ScholarAustraliaCross-sectional2760 horse owner involve horse industrySeveral week equine influenzaK10 ass distressWang et al ( 2011 ) 29Wang Y Xu B Zhao G Cao R He X Fu S Is quarantine relate immediate negative psychological consequence 2009 H1N1 epidemic ? .Gen Hosp Psychiatry .', '2011 ; 33 : 75-77CrossrefPubMedScopus ( 4 ) Google ScholarChinaCross-sectional419 undergraduates7 day ; non-suspected H1N1 influenza casesSRQ-20 ass general mental health IES-R ass post-traumatic stressWester Giesecke ( 2019 ) 30Wester M Giesecke J Ebola healthcare worker stigma.Scand J Public Health .', '2019 ; 47 : 99-104CrossrefPubMedScopus ( 2 ) Google ScholarSwedenQualitative12 : six health-care worker work west Africa Ebola outbreak one close contact them3 week work west Africa Ebola crisisInterviewWilken et al ( 2017 ) 31Wilken JA Pordell P Goode B et al.Knowledge , attitude , practice among member household actively monitor quarantine prevent transmission Ebola virus disease–Margibi County , Liberia : February–March 2015.Prehosp Disaster Med .', '2017 ; 32 : 673-678CrossrefPubMedScopus ( 3 ) Google ScholarLiberiaQualitative16 resident village quarantined21 day live village someone die EbolaInterviewWu et al ( 2008 , 2009 ) 32Wu P Liu X Fang Y et al.Alcohol abuse/dependence symptom among hospital employee expose SARS outbreak.Alcohol Alcohol .', '2008 ; 43 : 706-712CrossrefPubMedScopus ( 9 ) Google Scholar , 33Wu P Fang Y Guan Z et al.The psychological impact SARS epidemic hospital employee China : exposure , risk perception , altruistic acceptance risk.Can J Psychiatry .', '2009 ; 54 : 302-311CrossrefPubMedScopus ( 33 ) Google ScholarChinaCross-sectional549 hospital employeesLength unclear ; either SARS diagnosis , suspect SARS , direct contact SARS patients7 question adapt NHSDA ass alcohol dependence abuse ; IES-R ass post-traumatic stress symptom ; CES-D ass depressionYoon et al ( 2016 ) 34Yoon MK Kim SY Ko HS Lee MS System effectiveness detection , brief intervention refer treatment people post-traumatic emotional distress MERS : case report community-based proactive intervention South Korea.Int J Ment Health Syst .', '2016 ; 10 : 51CrossrefPubMedScopus ( 3 ) Google ScholarSouth KoreaPsychological evaluation professionals6231 Korean residentsLength unclear ; place quarantine MERSQuestions ‘ last 2 week quarantine , feel depress hopelessness ?', 'Do feel loss interest part life ? ’ SARS=severe acute respiratory syndrome .', 'DSM-IV=Diagnostic Statistical Manual Mental Disorders-IV .', 'IES-R=Impact Event Scale-Revised .', 'CES-D=Center Epidemiologic Studies Depression scale .', 'MERS=Middle East respiratory syndrome-related coronavirus .', 'GAD-7=Generalised Anxiety Disorder-7 .', 'STAXI-2=State-Trait Anger Expression Inventory .', 'MBI-GS= Maslach Burnout Inventory-General Survey .', 'GHQ-30=General Health Questionnaire-30 .', 'IES-7=International Education Standard-7 .', 'PTSD-RI=Post-Traumatic Stress Disorder Reaction Index .', 'PCL-C=PTSD Checklist-Civilian version .', 'K10= Kessler 10 Psychological Distress Scale .', 'SRQ-20=Self-Reporting Questionnaire-20 .', 'NHSDA=National Household Survey Drug Abuse .', 'Open table new tab SARS=severe acute respiratory syndrome .', 'DSM-IV=Diagnostic Statistical Manual Mental Disorders-IV .', 'IES-R=Impact Event Scale-Revised .', 'CES-D=Center Epidemiologic Studies Depression scale .', 'MERS=Middle East respiratory syndrome-related coronavirus .', 'GAD-7=Generalised Anxiety Disorder-7 .', 'STAXI-2=State-Trait Anger Expression Inventory .', 'MBI-GS= Maslach Burnout Inventory-General Survey .', 'GHQ-30=General Health Questionnaire-30 .', 'IES-7=International Education Standard-7 .', 'PTSD-RI=Post-Traumatic Stress Disorder Reaction Index .', 'PCL-C=PTSD Checklist-Civilian version .', 'K10= Kessler 10 Psychological Distress Scale .', 'SRQ-20=Self-Reporting Questionnaire-20 .', 'NHSDA=National Household Survey Drug Abuse .', 'Five study compare psychological outcome people quarantine quarantined.9Bai Y Lin C-C Lin C-Y Chen J-Y Chue C-M Chou P Survey stress reaction among health care worker involve SARS outbreak.Psychiatr Serv .', '2004 ; 55 : 1055-1057CrossrefPubMedScopus ( 39 ) Google Scholar , 19Liu X Kakade M Fuller CJ et al.Depression exposure stressful event : lesson learn severe acute respiratory syndrome epidemic.Compr Psychiatry .', '2012 ; 53 : 15-23CrossrefPubMedScopus ( 6 ) Google Scholar , 27Sprang G Silman M Posttraumatic stress disorder parent youth health-related disasters.Disaster Med Public Health Prep .', ""2013 ; 7 : 105-110CrossrefPubMedScopus ( 7 ) Google Scholar , 28Taylor MR Agho KE Stevens GJ Raphael B Factors influence psychological distress disease epidemic : data Australia 's first outbreak equine influenza.BMC Public Health ."", '2008 ; 8 : 347CrossrefPubMedScopus ( 27 ) Google Scholar , 33Wu P Fang Y Guan Z et al.The psychological impact SARS epidemic hospital employee China : exposure , risk perception , altruistic acceptance risk.Can J Psychiatry .', '2009 ; 54 : 302-311CrossrefPubMedScopus ( 33 ) Google Scholar A study9Bai Y Lin C-C Lin C-Y Chen J-Y Chue C-M Chou P Survey stress reaction among health care worker involve SARS outbreak.Psychiatr Serv .', '2004 ; 55 : 1055-1057CrossrefPubMedScopus ( 39 ) Google Scholar hospital staff might come contact SARS find immediately quarantine period ( 9 day ) end , quarantine factor predictive symptom acute stress disorder .', 'In study , quarantine staff significantly likely report exhaustion , detachment others , anxiety deal febrile patient , irritability , insomnia , poor concentration indecisiveness , deteriorate work performance , reluctance work consideration resignation .', 'In another study,33Wu P Fang Y Guan Z et al.The psychological impact SARS epidemic hospital employee China : exposure , risk perception , altruistic acceptance risk.Can J Psychiatry .', '2009 ; 54 : 302-311CrossrefPubMedScopus ( 33 ) Google Scholar effect quarantine predictor post-traumatic stress symptom hospital employee even 3 year later .', ""Approximately 34 % ( 938 2760 ) horse owner quarantine several week equine influenza outbreak report high psychological distress outbreak , compare around 12 % Australian general population.28Taylor MR Agho KE Stevens GJ Raphael B Factors influence psychological distress disease epidemic : data Australia 's first outbreak equine influenza.BMC Public Health ."", '2008 ; 8 : 347CrossrefPubMedScopus ( 27 ) Google Scholar A study27Sprang G Silman M Posttraumatic stress disorder parent youth health-related disasters.Disaster Med Public Health Prep .', '2013 ; 7 : 105-110CrossrefPubMedScopus ( 7 ) Google Scholar compare post-traumatic stress symptom parent child quarantine quarantine find mean post-traumatic stress score four time higher child quarantine quarantine .', '28 % ( 27 98 ) parent quarantine study report sufficient symptom warrant diagnosis trauma-related mental health disorder , compare 6 % ( 17 299 ) parent quarantine .', 'Another study19Liu X Kakade M Fuller CJ et al.Depression exposure stressful event : lesson learn severe acute respiratory syndrome epidemic.Compr Psychiatry .', '2012 ; 53 : 15-23CrossrefPubMedScopus ( 6 ) Google Scholar hospital staff examine symptom depression 3 year quarantine find 9 % ( 48 549 ) whole sample report high depressive symptom .', 'In group high depressive symptom , nearly 60 % ( 29 48 ) quarantine 15 % ( 63 424 ) group low depressive symptom quarantine .', 'All quantitative study survey quarantine generally report high prevalence symptom psychological distress disorder .', 'Studies report general psychological symptoms,22Mihashi M Otsubo Y Yinjuan X Nagatomi K Hoshiko M Ishitake T Predictive factor psychological disorder development recovery follow SARS outbreak.Health Psychol .', '2009 ; 28 : 91-100CrossrefPubMedScopus ( 5 ) Google Scholar emotional disturbance,34Yoon MK Kim SY Ko HS Lee MS System effectiveness detection , brief intervention refer treatment people post-traumatic emotional distress MERS : case report community-based proactive intervention South Korea.Int J Ment Health Syst .', '2016 ; 10 : 51CrossrefPubMedScopus ( 3 ) Google Scholar depression,16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar stress,15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar low mood,18Lee S Chan LY Chau AM Kwok KP Kleinman A The experience SARS-related stigma Amoy Gardens.Soc Sci Med .', '2005 ; 61 : 2038-2046CrossrefPubMedScopus ( 31 ) Google Scholar irritability,18Lee S Chan LY Chau AM Kwok KP Kleinman A The experience SARS-related stigma Amoy Gardens.Soc Sci Med .', '2005 ; 61 : 2038-2046CrossrefPubMedScopus ( 31 ) Google Scholar insomnia,18Lee S Chan LY Chau AM Kwok KP Kleinman A The experience SARS-related stigma Amoy Gardens.Soc Sci Med .', '2005 ; 61 : 2038-2046CrossrefPubMedScopus ( 31 ) Google Scholar post-traumatic stress symptoms25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', ""2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar ( rat Weiss Marmar 's Impact Event Scale–Revised35Weiss DS Marmar CR The impact event scale – revised.in : Wilson JP Keane TM Assessing psychological trauma PTSD ."", ""Guildford Press , New York1997 : 399-411Google Scholar ) , anger,20Marjanovic Z Greenglass ER Coffey S The relevance psychosocial variable work condition predict nurse ' cop strategy SARS crisis : online questionnaire survey.Int J Nurs Stud ."", '2007 ; 44 : 991-998CrossrefPubMedScopus ( 17 ) Google Scholar emotional exhaustion.21Maunder R Hunter J Vincent L et al.The immediate psychological occupational impact 2003 SARS outbreak teach hospital.CMAJ .', '2003 ; 168 : 1245-1251PubMedGoogle Scholar Low mood ( 660 [ 73 % ] 903 ) irritability ( 512 [ 57 % ] 903 ) stand high prevalence.18Lee S Chan LY Chau AM Kwok KP Kleinman A The experience SARS-related stigma Amoy Gardens.Soc Sci Med .', '2005 ; 61 : 2038-2046CrossrefPubMedScopus ( 31 ) Google Scholar People quarantine close contact potentially SARS25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar report various negative response quarantine period : 20 % ( 230 1057 ) report fear , 18 % ( 187 ) report nervousness , 18 % ( 186 ) report sadness , 10 % ( 101 ) report guilt .', 'Few report positive feel : 5 % ( 48 ) report feel happiness 4 % ( 43 ) report feel relief .', ""Qualitative study also identify range psychological response quarantine , confusion,11Braunack-Mayer A Tooher R Collins JE Street JM Marshall H Understanding school community 's response school closure H1N1 2009 influenza pandemic.BMC Public Health ."", '2013 ; 13 : 344CrossrefPubMedScopus ( 5 ) Google Scholar , 12Caleo G Duncombe J Jephcott F et al.The factor affect household transmission dynamic community compliance Ebola control measure : mixed-methods study rural village Sierra Leone.BMC Public Health .', '2018 ; 18 : 248CrossrefPubMedScopus ( 6 ) Google Scholar , 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar , 23Pan PJD Chang S-H Yu Y-Y A support group home-quarantined college student expose SARS : learn practice.J Spec Group Work .', '2005 ; 30 : 363-374CrossrefScopus ( 4 ) Google Scholar fear,12Caleo G Duncombe J Jephcott F et al.The factor affect household transmission dynamic community compliance Ebola control measure : mixed-methods study rural village Sierra Leone.BMC Public Health .', '2018 ; 18 : 248CrossrefPubMedScopus ( 6 ) Google Scholar , 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar , 14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar , 15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar , 23Pan PJD Chang S-H Yu Y-Y A support group home-quarantined college student expose SARS : learn practice.J Spec Group Work .', '2005 ; 30 : 363-374CrossrefScopus ( 4 ) Google Scholar , 24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google Scholar anger,12Caleo G Duncombe J Jephcott F et al.The factor affect household transmission dynamic community compliance Ebola control measure : mixed-methods study rural village Sierra Leone.BMC Public Health .', '2018 ; 18 : 248CrossrefPubMedScopus ( 6 ) Google Scholar , 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar grief,29Wang Y Xu B Zhao G Cao R He X Fu S Is quarantine relate immediate negative psychological consequence 2009 H1N1 epidemic ? .Gen Hosp Psychiatry .', '2011 ; 33 : 75-77CrossrefPubMedScopus ( 4 ) Google Scholar numbness,23Pan PJD Chang S-H Yu Y-Y A support group home-quarantined college student expose SARS : learn practice.J Spec Group Work .', '2005 ; 30 : 363-374CrossrefScopus ( 4 ) Google Scholar anxiety-induced insomnia.14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar , 15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar One study compare undergraduate quarantine quarantine immediately quarantine period find significant difference group term post-traumatic stress symptom general mental health problems.29Wang Y Xu B Zhao G Cao R He X Fu S Is quarantine relate immediate negative psychological consequence 2009 H1N1 epidemic ? .Gen Hosp Psychiatry .', '2011 ; 33 : 75-77CrossrefPubMedScopus ( 4 ) Google Scholar However , entire study population undergraduate student ( generally young , perhaps fewer responsibility adult employ full-time ) thus possible conclusion generalise wider population .', 'Only one study17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', '2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar compare psychological outcome quarantine later outcome find quarantine , 7 % ( 126 1656 ) show anxiety symptom 17 % ( 275 ) show feel anger , whereas 4–6 month quarantine symptom reduce 3 % ( anxiety ) 6 % ( anger ) .', 'Two study report longer-term effect quarantine .', '3 year SARS outbreak , alcohol abuse dependency symptom positively associate quarantine health-care workers.32Wu P Liu X Fang Y et al.Alcohol abuse/dependence symptom among hospital employee expose SARS outbreak.Alcohol Alcohol .', '2008 ; 43 : 706-712CrossrefPubMedScopus ( 9 ) Google Scholar In multivariate analysis,32Wu P Liu X Fang Y et al.Alcohol abuse/dependence symptom among hospital employee expose SARS outbreak.Alcohol Alcohol .', '2008 ; 43 : 706-712CrossrefPubMedScopus ( 9 ) Google Scholar control demographic factor , quarantine work high-risk location two type exposure significantly associate outcome ( quarantine : unadjusted mean ratio 0·45 ; 95 % CI 1·02–2·65 ) .', 'After quarantine , many participant continue engage avoidance behaviour .', ""For health-care workers,20Marjanovic Z Greenglass ER Coffey S The relevance psychosocial variable work condition predict nurse ' cop strategy SARS crisis : online questionnaire survey.Int J Nurs Stud ."", '2007 ; 44 : 991-998CrossrefPubMedScopus ( 17 ) Google Scholar quarantine significantly positively associate avoidance behaviour , minimise direct contact patient report work .', 'A study25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar people quarantine potential SARS contact note 54 % ( 524 1057 ) people quarantine avoid people cough sneeze , 26 % ( 255 ) avoid crowd enclose place , 21 % ( 204 ) avoid public space week follow quarantine period .', 'A qualitative study13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar report several participant describe long-term behavioural change quarantine period , vigilant handwash avoidance crowd , , return normality delay many month .', 'There mix evidence whether participant characteristic demographic predictor psychological impact quarantine .', ""A study28Taylor MR Agho KE Stevens GJ Raphael B Factors influence psychological distress disease epidemic : data Australia 's first outbreak equine influenza.BMC Public Health ."", '2008 ; 8 : 347CrossrefPubMedScopus ( 27 ) Google Scholar horse owner quarantine equine influenza identify several characteristic associate negative psychological impact : younger age ( 16–24 year ) , lower level formal educational qualification , female gender , one child oppose child ( although three child appear somewhat protective ) .', 'However , another study16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar suggest demographic factor marital status , age , education , live adult , child associate psychological outcome .', 'Having history psychiatric illness associate experience anxiety anger 4–6 month release quarantine.17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', '2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar Health-care workers25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar quarantine severe symptom post-traumatic stress member general public quarantine , score significantly higher dimension .', 'Health-care worker also felt greater stigmatisation general public , exhibit avoidance behaviour quarantine , report greater lose income , consistently affect psychologically : report substantially anger , annoyance , fear , frustration , guilt , helplessness , isolation , loneliness , nervousness , sadness , worry , le happy .', 'Health-care worker also substantially likely think SARS concern infect others .', 'Conversely , one study16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar suggest health-care worker status associate psychological outcome .', 'Three study show longer duration quarantine associate poorer mental health specifically , post-traumatic stress symptoms,16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar , 25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', ""2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar avoidance behaviour , anger.20Marjanovic Z Greenglass ER Coffey S The relevance psychosocial variable work condition predict nurse ' cop strategy SARS crisis : online questionnaire survey.Int J Nurs Stud ."", '2007 ; 44 : 991-998CrossrefPubMedScopus ( 17 ) Google Scholar Although duration quarantine always clear , one study16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar show quarantine 10 day show significantly higher post-traumatic stress symptom quarantine le 10 day .', 'Participants eight study report fear health fear infect others9Bai Y Lin C-C Lin C-Y Chen J-Y Chue C-M Chou P Survey stress reaction among health care worker involve SARS outbreak.Psychiatr Serv .', '2004 ; 55 : 1055-1057CrossrefPubMedScopus ( 39 ) Google Scholar , 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar , 14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar , 16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar , 17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', '2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar , 21Maunder R Hunter J Vincent L et al.The immediate psychological occupational impact 2003 SARS outbreak teach hospital.CMAJ .', '2003 ; 168 : 1245-1251PubMedGoogle Scholar , 25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar , 26Robertson E Hershenfield K Grace SL Stewart DE The psychosocial effect quarantine follow exposure SARS : qualitative study Toronto health care workers.Can J Psychiatry .', '2004 ; 49 : 403-407CrossrefPubMedScopus ( 34 ) Google Scholar likely fear infect family member quarantined.9Bai Y Lin C-C Lin C-Y Chen J-Y Chue C-M Chou P Survey stress reaction among health care worker involve SARS outbreak.Psychiatr Serv .', '2004 ; 55 : 1055-1057CrossrefPubMedScopus ( 39 ) Google Scholar They also become particularly worry experience physical symptom potentially relate infection14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar fear symptom could reflect infection continue relate psychological outcome several month later.17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', ""2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar Conversely , one study11Braunack-Mayer A Tooher R Collins JE Street JM Marshall H Understanding school community 's response school closure H1N1 2009 influenza pandemic.BMC Public Health ."", '2013 ; 13 : 344CrossrefPubMedScopus ( 5 ) Google Scholar find although participant extremely concern become infect transmit virus others , concern tend pregnant woman young child .', ""Confinement , loss usual routine , reduce social physical contact others frequently show cause boredom , frustration , sense isolation rest world , distress participants.10Blendon RJ Benson JM DesRoches CM Raleigh E Taylor-Clark K The public 's response severe acute respiratory syndrome Toronto United States.Clin Infect Dis ."", ""2004 ; 38 : 925-931CrossrefPubMedScopus ( 91 ) Google Scholar , 11Braunack-Mayer A Tooher R Collins JE Street JM Marshall H Understanding school community 's response school closure H1N1 2009 influenza pandemic.BMC Public Health ."", '2013 ; 13 : 344CrossrefPubMedScopus ( 5 ) Google Scholar , 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar , 14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar , 15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar , 16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar , 25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar , 26Robertson E Hershenfield K Grace SL Stewart DE The psychosocial effect quarantine follow exposure SARS : qualitative study Toronto health care workers.Can J Psychiatry .', '2004 ; 49 : 403-407CrossrefPubMedScopus ( 34 ) Google Scholar , 31Wilken JA Pordell P Goode B et al.Knowledge , attitude , practice among member household actively monitor quarantine prevent transmission Ebola virus disease–Margibi County , Liberia : February–March 2015.Prehosp Disaster Med .', '2017 ; 32 : 673-678CrossrefPubMedScopus ( 3 ) Google Scholar This frustration exacerbate able take part usual day-to-day activity , shop basic necessities16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar take part social network activity via telephone internet.17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', ""2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar Having inadequate basic supply ( eg , food , water , clothe , accommodation ) quarantine source frustration10Blendon RJ Benson JM DesRoches CM Raleigh E Taylor-Clark K The public 's response severe acute respiratory syndrome Toronto United States.Clin Infect Dis ."", '2004 ; 38 : 925-931CrossrefPubMedScopus ( 91 ) Google Scholar , 31Wilken JA Pordell P Goode B et al.Knowledge , attitude , practice among member household actively monitor quarantine prevent transmission Ebola virus disease–Margibi County , Liberia : February–March 2015.Prehosp Disaster Med .', '2017 ; 32 : 673-678CrossrefPubMedScopus ( 3 ) Google Scholar continue associate anxiety anger 4–6 month release.17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', ""2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar Being unable get regular medical care prescription also appear problem participants.10Blendon RJ Benson JM DesRoches CM Raleigh E Taylor-Clark K The public 's response severe acute respiratory syndrome Toronto United States.Clin Infect Dis ."", '2004 ; 38 : 925-931CrossrefPubMedScopus ( 91 ) Google Scholar Four study find supply public health authority insufficient .', 'Participants report receive mask thermometer late ; 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar food , water , item intermittently distribute ; 24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google Scholar food supply take long time arrive.12Caleo G Duncombe J Jephcott F et al.The factor affect household transmission dynamic community compliance Ebola control measure : mixed-methods study rural village Sierra Leone.BMC Public Health .', '2018 ; 18 : 248CrossrefPubMedScopus ( 6 ) Google Scholar Although quarantine Toronto SARS outbreak praise public health authority deliver kit medical supply begin quarantine period , receive grocery routine supply need daily living.15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', ""2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar Many participant cite poor information public health authority stressor , report insufficient clear guideline action take confusion purpose quarantine.11Braunack-Mayer A Tooher R Collins JE Street JM Marshall H Understanding school community 's response school closure H1N1 2009 influenza pandemic.BMC Public Health ."", '2013 ; 13 : 344CrossrefPubMedScopus ( 5 ) Google Scholar , 12Caleo G Duncombe J Jephcott F et al.The factor affect household transmission dynamic community compliance Ebola control measure : mixed-methods study rural village Sierra Leone.BMC Public Health .', '2018 ; 18 : 248CrossrefPubMedScopus ( 6 ) Google Scholar , 13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar , 15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar , 24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google Scholar , 26Robertson E Hershenfield K Grace SL Stewart DE The psychosocial effect quarantine follow exposure SARS : qualitative study Toronto health care workers.Can J Psychiatry .', '2004 ; 49 : 403-407CrossrefPubMedScopus ( 34 ) Google Scholar After Toronto SARS epidemic , participant perceive confusion stem difference style , approach , content various public health message poor coordination multiple jurisdiction level government involved.15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar Lack clarity different level risk , particular , lead participant fear worst.14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", ""2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar Participants also report perceive lack transparency health government official severity pandemic.11Braunack-Mayer A Tooher R Collins JE Street JM Marshall H Understanding school community 's response school closure H1N1 2009 influenza pandemic.BMC Public Health ."", '2013 ; 13 : 344CrossrefPubMedScopus ( 5 ) Google Scholar Perhaps relate lack clear guideline rationale , perceive difficulty comply quarantine protocol significant predictor post-traumatic stress symptom one study.25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar Financial loss problem quarantine , people unable work interrupt professional activity advance plan ; effect appear long last .', 'In review study , financial loss result quarantine create serious socioeconomic distress24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google Scholar find risk factor symptom psychological disorders22Mihashi M Otsubo Y Yinjuan X Nagatomi K Hoshiko M Ishitake T Predictive factor psychological disorder development recovery follow SARS outbreak.Health Psychol .', '2009 ; 28 : 91-100CrossrefPubMedScopus ( 5 ) Google Scholar anger anxiety several month quarantine.17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', ""2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar One study28Taylor MR Agho KE Stevens GJ Raphael B Factors influence psychological distress disease epidemic : data Australia 's first outbreak equine influenza.BMC Public Health ."", '2008 ; 8 : 347CrossrefPubMedScopus ( 27 ) Google Scholar find respondent quarantine equine influenza , whose principal source income horse-related industry , twice likely high distress whose income industry .', 'This find probably link economic effect could also relate disruption social network loss leisure activity .', 'Notably , study exceptional occupation exposure confound .', 'A study14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar people quarantine potential Ebola contact find , although participant receive financial assistance , felt amount insufficient come late ; many felt wrong assistance receive cover ongoing professional expense .', 'Many become dependent family provide financially quarantine often hard accept could cause conflict .', 'In one study,13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar none quarantine Toronto SARS report much financial hardship employer government compensate , reimbursement slow arrive cause le financially well-off struggle .', 'Potentially relate financial loss , participant combine annual household income le CAN $ 40 000 show significantly higher amount post-traumatic stress depressive symptoms.16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar These symptom probably lower income likely affect temporary loss income higher income .', 'People quarantine lower household income might require additional level support , along lose earn quarantine ( ie , self-employed people unable work salaried staff unable take pay leave ) .', 'Financial reimbursement provide possible programme develop provide financial support throughout quarantine period .', 'Where appropriate , employer might also wish consider proactive approach allow employee work home wish , avoid financial loss stave boredom , mindful staff situation might productive might benefit remote social support colleagues.2Manuell M-E Cukor J Mother Nature versus human nature : public compliance evacuation quarantine.Disasters .', '2011 ; 35 : 417-442CrossrefPubMedScopus ( 8 ) Google Scholar Stigma others major theme throughout literature , often continue time quarantine , even containment outbreak .', 'In comparison health-care worker quarantine versus quarantined,9Bai Y Lin C-C Lin C-Y Chen J-Y Chue C-M Chou P Survey stress reaction among health care worker involve SARS outbreak.Psychiatr Serv .', '2004 ; 55 : 1055-1057CrossrefPubMedScopus ( 39 ) Google Scholar quarantine participant significantly likely report stigmatisation rejection people local neighbourhood , suggest stigma specifically surround people quarantine .', 'Participants several study report others treat differently : avoid , withdraw social invitation , treat fear suspicion , make critical comments.13Cava MA Fay KE Beanlands HJ McCay EA Wignall R The experience quarantine individual affect SARS Toronto.Public Health Nurs .', '2005 ; 22 : 398-406CrossrefPubMedScopus ( 18 ) Google Scholar , 14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar , 15DiGiovanni C Conley J Chiu D Zaborski J Factors influence compliance quarantine Toronto 2003 SARS outbreak.Biosecur Bioterror .', '2004 ; 2 : 265-272CrossrefPubMedScopus ( 40 ) Google Scholar , 16Hawryluck L Gold WL Robinson S Pogorski S Galea S Styra R SARS control psychological effect quarantine , Toronto , Canada.Emerg Infect Dis .', '2004 ; 10 : 1206-1212CrossrefPubMedScopus ( 93 ) Google Scholar , 18Lee S Chan LY Chau AM Kwok KP Kleinman A The experience SARS-related stigma Amoy Gardens.Soc Sci Med .', '2005 ; 61 : 2038-2046CrossrefPubMedScopus ( 31 ) Google Scholar , 21Maunder R Hunter J Vincent L et al.The immediate psychological occupational impact 2003 SARS outbreak teach hospital.CMAJ .', '2003 ; 168 : 1245-1251PubMedGoogle Scholar , 23Pan PJD Chang S-H Yu Y-Y A support group home-quarantined college student expose SARS : learn practice.J Spec Group Work .', '2005 ; 30 : 363-374CrossrefScopus ( 4 ) Google Scholar , 24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google Scholar , 25Reynolds DL Garay JR Deamond SL Moran MK Gold W Styra R Understanding , compliance psychological impact SARS quarantine experience.Epidemiol Infect .', '2008 ; 136 : 997-1007CrossrefPubMedScopus ( 18 ) Google Scholar , 26Robertson E Hershenfield K Grace SL Stewart DE The psychosocial effect quarantine follow exposure SARS : qualitative study Toronto health care workers.Can J Psychiatry .', '2004 ; 49 : 403-407CrossrefPubMedScopus ( 34 ) Google Scholar , 30Wester M Giesecke J Ebola healthcare worker stigma.Scand J Public Health .', '2019 ; 47 : 99-104CrossrefPubMedScopus ( 2 ) Google Scholar , 31Wilken JA Pordell P Goode B et al.Knowledge , attitude , practice among member household actively monitor quarantine prevent transmission Ebola virus disease–Margibi County , Liberia : February–March 2015.Prehosp Disaster Med .', '2017 ; 32 : 673-678CrossrefPubMedScopus ( 3 ) Google Scholar Several health-care worker involve Ebola outbreak Senegal report quarantine lead family consider job risky , create intra-household tension.14Desclaux A Badji D Ndione AG Sow K Accepted monitor endure quarantine ?', ""Ebola contact ' perception Senegal.Soc Sci Med ."", '2017 ; 178 : 38-45CrossrefPubMedScopus ( 5 ) Google Scholar In study , three participant report unable resume job surveillance end employer express fear contagion .', 'Those quarantine Ebola epidemic Liberia report stigma could lead disenfranchisement minority group community family quarantine often say belong different ethnic group , tribe , religion perceive dangerous different.24Pellecchia U Crestani R Decroo T Van den Bergh R Al-Kourdi Y Social consequence Ebola containment measure Liberia.PLoS One .', '2015 ; 10 : e0143036CrossrefPubMedScopus ( 23 ) Google Scholar Perhaps stigma , quarantine lead participant study keep easily treatable , non-Ebola illness secret avoid seek help .', 'General education disease rationale quarantine public health information provide general public beneficial reduce stigmatisation , whereas detail information target school workplace might also useful .', 'It might also medium report contribute stigmatise attitude general public ; medium powerful influence public attitude dramatic headline fear monger show contribute stigmatise attitude past ( eg , SARS outbreak ) .36Person B Sy F Holton K et al.Fear stigma : epidemic within SARS outbreak.Emerg Infect Dis .', '2004 ; 10 : 358-363CrossrefPubMedScopus ( 70 ) Google Scholar This issue highlight need public health official provide rapid , clear message deliver effectively entire affect population promote accurate understand situation .', 'During major infectious disease outbreak , quarantine necessary preventive measure .', 'However , Review suggest quarantine often associate negative psychological effect .', 'During period quarantine negative psychological effect unsurprising , yet evidence psychological effect quarantine still detect month year later—albeit small number studies17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', '2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar , 19Liu X Kakade M Fuller CJ et al.Depression exposure stressful event : lesson learn severe acute respiratory syndrome epidemic.Compr Psychiatry .', '2012 ; 53 : 15-23CrossrefPubMedScopus ( 6 ) Google Scholar— trouble suggest need ensure effective mitigation measure put place part quarantine plan process .', 'In regard , result provide strong evidence particular demographic factor risk factor poor psychological outcome quarantine therefore require specific attention .', 'However , history mental illness examine risk factor one study .', 'Previous literature suggest psychiatric history associate psychological distress experience disaster-related trauma37Alvarez J Hunt M Risk resilience canine search rescue handler 9/11.J Trauma Stress .', '2005 ; 18 : 497-505CrossrefPubMedScopus ( 40 ) Google Scholar , 38Cukor J Wyka K Jayasinghe N et al.Prevalence predictor posttraumatic stress symptom utility worker deploy World Trade Center follow attack September 11 , 2001.Depress Anxiety .', '2011 ; 28 : 210-217CrossrefPubMedScopus ( 34 ) Google Scholar likely people pre-existing poor mental health would need extra support quarantine .', 'There also appear high prevalence psychological distress quarantine health-care worker , although mix evidence whether group higher risk distress non-health-care worker quarantine .', 'For health-care worker , support manager essential facilitate return work39Brooks SK Dunn R Amlôt R Rubin GJ Greenberg N A systematic , thematic review social occupational factor associate psychological outcome healthcare employee infectious disease outbreak.J Occup Environ Med .', '2018 ; 60 : 248-257CrossrefPubMedScopus ( 3 ) Google Scholar manager aware potential risk staff quarantine prepare early intervention .', 'Longer quarantine associate poorer psychological outcome , perhaps unsurprisingly , stand reason stressor report participant could effect longer experience .', 'Restricting length quarantine scientifically reasonable give know duration incubation period , adopt overly precautionary approach , would minimise effect people .', 'Evidence elsewhere also emphasis importance authority adhere recommend length quarantine , extend .', 'For people already quarantine , extension , matter small , likely exacerbate sense frustration demoralisation.40Rona RJ Fear NT Hull L et al.Mental health consequence overstretch UK arm force : first phase cohort study.BMJ .', '2007 ; 335 : 603CrossrefPubMedScopus ( 100 ) Google Scholar Imposing cordon indefinitely whole city clear time limit ( see Wuhan , China ) might detrimental strictly apply quarantine procedure limit period incubation .', 'People quarantine often fear infect infect others .', 'They also often catastrophic appraisal physical symptom experience quarantine period .', 'This fear common occurrence people expose worry infectious disease,41Rubin GJ Harper S Williams PD et al.How support staff deploy overseas humanitarian work : qualitative analysis responder view 2014/15 West African Ebola outbreak.Eur J Psychotraumatol .', '2016 ; 7 : 30933CrossrefPubMedScopus ( 8 ) Google Scholar might exacerbate often inadequate information participant report receive public health official leave unclear nature risk face quarantine .', 'Ensuring quarantine good understand disease question , reason quarantine , priority .', 'Officials also need ensure quarantine household enough supply basic need , importantly , must provide rapidly possible .', 'Coordination provision supply ideally occur advance , conservation reallocation plan establish ensure resource run , unfortunately reported.2Manuell M-E Cukor J Mother Nature versus human nature : public compliance evacuation quarantine.Disasters .', '2011 ; 35 : 417-442CrossrefPubMedScopus ( 8 ) Google Scholar Boredom isolation cause distress ; people quarantine advise stave boredom provide practical advice cop stress management technique .', 'Having work mobile phone necessity , luxury , step long flight enter quarantine probably welcome charger adaptor anything else.17Jeong H Yim HW Song Y-J et al.Mental health status people isolate due Middle East respiratory syndrome.Epidemiol Health .', '2016 ; 38 : e2016048CrossrefPubMedScopus ( 12 ) Google Scholar Activating social network , albeit remotely , key priority , inability associate immediate anxiety , longer- term distress.2Manuell M-E Cukor J Mother Nature versus human nature : public compliance evacuation quarantine.Disasters .', '2011 ; 35 : 417-442CrossrefPubMedScopus ( 8 ) Google Scholar , 42Rubin GJ Brewin CR Greenberg N Simpson J Wessely S Psychological behavioural reaction bomb London 7 July 2005 : cross sectional survey representative sample Londoners.BMJ .', '2005 ; 331 : 606CrossrefPubMedScopus ( 154 ) Google Scholar One study21Maunder R Hunter J Vincent L et al.The immediate psychological occupational impact 2003 SARS outbreak teach hospital.CMAJ .', '2003 ; 168 : 1245-1251PubMedGoogle Scholar suggest telephone support line , staff psychiatric nurse , set specifically quarantine could effective term provide social network .', ""The ability communicate one 's family friend also essential ."", 'Particularly , social medium could play important part communication far away , allow people quarantine update love one situation reassure well .', 'Therefore , provide quarantine mobile phone , cord outlet charge device , robust WiFi network internet access allow communicate directly love one could reduce feel isolation , stress , panic.2Manuell M-E Cukor J Mother Nature versus human nature : public compliance evacuation quarantine.Disasters .', '2011 ; 35 : 417-442CrossrefPubMedScopus ( 8 ) Google Scholar Although possible achieve enforce quarantine , could difficult case widespread home quarantine ; country impose censor social medium message application could also present difficulty ensure line communication quarantine love one .', 'It also important public health official maintain clear line communication people quarantine experience symptom .', 'A phone line online service specifically set quarantine staff health-care worker provide instruction event develop illness symptom , would help reassure people care become ill .', 'This service would show quarantine forget health need important wider public .', 'The benefit resource study , likely reassurance could subsequently decrease feel fear , worry , anger .', 'There evidence suggest support group specifically people quarantine home disease outbreak helpful .', 'One study23Pan PJD Chang S-H Yu Y-Y A support group home-quarantined college student expose SARS : learn practice.J Spec Group Work .', '2005 ; 30 : 363-374CrossrefScopus ( 4 ) Google Scholar find group feel connect others situation could validate , empower experience provide people support might find receive people .', 'Health-care worker often quarantine Review suggest , like general public , negatively affect stigmatise attitude others .', 'None study include Review focus perception colleague , would interest aspect explore .', 'It also possible health-care worker quarantine might concern cause workplace understaffed cause extra work colleagues21Maunder R Hunter J Vincent L et al.The immediate psychological occupational impact 2003 SARS outbreak teach hospital.CMAJ .', ""2003 ; 168 : 1245-1251PubMedGoogle Scholar colleague ' perception could particularly important ."", 'Being separate team use work close contact might add feel isolation health-care worker quarantine .', 'Therefore , essential feel support immediate colleague .', 'During infectious disease outbreak , organisational support find protective mental health health-care staff general39Brooks SK Dunn R Amlôt R Rubin GJ Greenberg N A systematic , thematic review social occupational factor associate psychological outcome healthcare employee infectious disease outbreak.J Occup Environ Med .', '2018 ; 60 : 248-257CrossrefPubMedScopus ( 3 ) Google Scholar manager take step ensure staff member supportive colleague quarantine .', 'Perhaps difficulty design appropriate study , research find test whether mandatory versus voluntary quarantine differential effect wellbeing .', ""In context , however , feel others benefit one 's situation make stressful situation easier bear seem likely also true home-based quarantine ."", 'Reinforcing quarantine help keep others safe , include particularly vulnerable ( young , old , pre-existing serious medical condition ) , health authority genuinely grateful , help reduce mental health effect adherence quarantined.19Liu X Kakade M Fuller CJ et al.Depression exposure stressful event : lesson learn severe acute respiratory syndrome epidemic.Compr Psychiatry .', '2012 ; 53 : 15-23CrossrefPubMedScopus ( 6 ) Google Scholar , 33Wu P Fang Y Guan Z et al.The psychological impact SARS epidemic hospital employee China : exposure , risk perception , altruistic acceptance risk.Can J Psychiatry .', '2009 ; 54 : 302-311CrossrefPubMedScopus ( 33 ) Google Scholar Notably , altruism limit people ask quarantine without adequate information keep people live safe .', ""It unacceptable ask people self-quarantine benefit community 's health , might put love one risk ."", 'Quarantine one several public health measure prevent spread infectious disease show Review , considerable psychological impact affect .', 'As , question whether public health measure prevent need impose quarantine ( social distance , cancellation mass gather , school closure ) might favourable .', 'Future research need establish effectiveness measure .', 'The strength limitation Review must consider .', 'Because time constraint Review give ongoing coronavirus outbreak , review literature undergo formal quality appraisal .', 'Additionally , Review limit peer-reviewed publication explore potentially relevant grey literature .', 'The recommendation make apply primarily small group people dedicate facility extent self-isolation .', 'Although anticipate many risk factor poor psychosocial outcome would larger containment process ( entire town city ) , likely distinct difference situation mean information present Review apply situation cautiously .', 'Furthermore , potential cultural difference need consider .', 'Although Review predict exactly happen provide recommendation work every future population quarantine , provide overview key issue could rectify future .', 'There also several limitation review literature , must point : one study follow participant time , sample size generally small , study directly compare participant quarantine quarantine , conclusion base certain study population ( eg , student ) might generalisable wider public , heterogeneity outcome measure across study make difficult make direct comparison study .', 'It also worth point minority study assess symptom post-traumatic stress use measure design measure post-traumatic stress disorder , despite quarantine qualify trauma diagnosis post-traumatic stress disorder Diagnostic Statistical Manual Mental Disorders 5.43American Psychiatric AssociationDiagnostic statistical manual mental disorder : DSM-5 .', 'American Psychiatric Association , Arlington , VA2013CrossrefGoogle Scholar Strengths Review include hand-searching reference list identify paper find initial search , contact author send full-texts paper available full online , multiple researcher carry screen improve rigour Review .', 'Overall , Review suggest psychological impact quarantine wide-ranging , substantial , long last .', 'This suggest quarantine use ; psychological effect use quarantine allow disease spread might worse.44Hull HF SARS control psychological effect quarantine , Toronto , Canada.Emerging Infectious Diseases .', '2005 ; 11 : 354-355CrossrefPubMedGoogle Scholar However , deprive people liberty wider public good often contentious need handle carefully .', 'If quarantine essential , result suggest official take every measure ensure experience tolerable possible people .', 'This achieve : tell people happen , explain long continue , provide meaningful activity quarantine , provide clear communication , ensure basic supply ( food , water , medical supply ) available , reinforce sense altruism people , rightly , feel .', 'Health official charge implement quarantine , definition employment usually reasonable job security , also remember everyone situation .', 'If quarantine experience negative , result Review suggest long-term consequence affect people quarantine also health-care system administer quarantine politician public health official mandate .', 'Our search strategy design inform Review second review publish elsewhere relate adherence quarantine .', 'We search Medline , PsycINFO , Web Science .', 'The full list search term find appendix .', 'In brief , use combination term relate quarantine ( eg , “ quarantine ” “ patient isolation ” ) psychological outcome ( eg , “ psych ” “ stigma ” ) .', 'For study include Review , report primary research , publish peer-reviewed journal , write English Italian ( language speak current author ) , include participant ask enter quarantine outside hospital environment least 24 hour , include data prevalence mental illness psychological wellbeing , factor associate mental illness psychological wellbeing ( ie , predictor psychological wellbeing quarantine ) .', 'The initial search yield 3166 paper , 24 include relevant data include Review .', 'The screen process illustrate figure .', 'Our search strategy design inform Review second review publish elsewhere relate adherence quarantine .', 'We search Medline , PsycINFO , Web Science .', 'The full list search term find appendix .', 'In brief , use combination term relate quarantine ( eg , “ quarantine ” “ patient isolation ” ) psychological outcome ( eg , “ psych ” “ stigma ” ) .', 'For study include Review , report primary research , publish peer-reviewed journal , write English Italian ( language speak current author ) , include participant ask enter quarantine outside hospital environment least 24 hour , include data prevalence mental illness psychological wellbeing , factor associate mental illness psychological wellbeing ( ie , predictor psychological wellbeing quarantine ) .', 'The initial search yield 3166 paper , 24 include relevant data include Review .', 'The screen process illustrate figure .', 'Contributors GJR design search strategy input SKB , RKW , LES .', 'SKB , RKW , LES , LW carry literature search screen , discrepancy discuss GJR SW. SKB carry data extraction .', 'SKB write first draft review input RKW , LES , LW , SW , NG , GJR .', 'Declaration interest We declare compete interest .', ""Acknowledgments The research fund National Institute Health Research ( NIHR ) Health Protection Research Unit Emergency Preparedness Response King 's College London , partnership Public Health England , collaboration University East Anglia Newcastle University ."", 'The view express author ( ) necessarily National Health Service , NIHR , Department Health Social Care , Public Health England .', 'Editorial note : Lancet Group take neutral position respect territorial claim publish table .', 'Download .pdf ( .08 MB ) Help pdf file Supplementary appendix']","['december', '', '2019', 'coronavirus', 'disease', 'outbreak', 'country', 'ask', 'people', 'potentially', 'contact', 'infection', 'isolate', 'home', 'dedicate', 'quarantine', 'facility', '', 'decisions', 'apply', 'quarantine', 'base', 'best', 'available', 'evidence', '', 'review', 'psychological', 'impact', 'quarantine', 'three', 'electronic', 'database', '', '3166', 'paper', 'find', '', '24', 'include', 'review', '', 'review', 'study', 'report', 'negative', 'psychological', 'effect', 'include', 'post-traumatic', 'stress', 'symptom', '', 'confusion', '', 'anger', '', 'stressors', 'include', 'longer', 'quarantine', 'duration', '', 'infection', 'fear', '', 'frustration', '', 'boredom', '', 'inadequate', 'supply', '', 'inadequate', 'information', '', 'financial', 'loss', '', 'stigma', '', 'researcher', 'suggest', 'long-lasting', 'effect', '', 'situation', 'quarantine', 'deem', 'necessary', '', 'official', 'quarantine', 'individual', 'longer', 'require', '', 'provide', 'clear', 'rationale', 'quarantine', 'information', 'protocol', '', 'ensure', 'sufficient', 'supply', 'provide', '', 'appeals', 'altruism', 'remind', 'public', 'benefit', 'quarantine', 'wider', 'society', 'favourable', '', 'december', '', '2019', 'coronavirus', 'disease', 'outbreak', 'country', 'ask', 'people', 'potentially', 'contact', 'infection', 'isolate', 'home', 'dedicate', 'quarantine', 'facility', '', 'decisions', 'apply', 'quarantine', 'base', 'best', 'available', 'evidence', '', 'review', 'psychological', 'impact', 'quarantine', 'three', 'electronic', 'database', '', '3166', 'paper', 'find', '', '24', 'include', 'review', '', 'review', 'study', 'report', 'negative', 'psychological', 'effect', 'include', 'post-traumatic', 'stress', 'symptom', '', 'confusion', '', 'anger', '', 'stressors', 'include', 'longer', 'quarantine', 'duration', '', 'infection', 'fear', '', 'frustration', '', 'boredom', '', 'inadequate', 'supply', '', 'inadequate', 'information', '', 'financial', 'loss', '', 'stigma', '', 'researcher', 'suggest', 'long-lasting', 'effect', '', 'situation', 'quarantine', 'deem', 'necessary', '', 'official', 'quarantine', 'individual', 'longer', 'require', '', 'provide', 'clear', 'rationale', 'quarantine', 'information', 'protocol', '', 'ensure', 'sufficient', 'supply', 'provide', '', 'appeals', 'altruism', 'remind', 'public', 'benefit', 'quarantine', 'wider', 'society', 'favourable', '', 'quarantine', 'separation', 'restriction', 'movement', 'people', 'potentially', 'expose', 'contagious', 'disease', 'ascertain', 'become', 'unwell', '', 'reduce', 'risk', 'infect', 'others1centers', 'disease', 'control', 'preventionquarantine', 'isolation', '', 'urlplaceholder', '2017google', 'definition', 'differ', 'isolation', '', 'separation', 'people', 'diagnose', 'contagious', 'disease', 'people', 'sick', '', 'however', '', 'two', 'term', 'often', 'interchangeably', '', 'especially', 'communication', 'public2manuell', 'm-e', 'cukor', 'j', 'mother', 'nature', 'versus', 'human', 'nature', '', 'public', 'compliance', 'evacuation', 'quarantinedisasters', '', '2011', '', '35', '', '417-442crossrefpubmedscopus', '', '8', '', 'word', 'quarantine', 'first', 'venice', '', 'italy', '1127', 'regard', 'leprosy', 'widely', 'response', 'black', 'death', '', 'although', '300', 'year', 'later', 'uk', 'properly', 'begin', 'impose', 'quarantine', 'response', 'plague3newman', 'k', 'shutt', '', 'bubonic', 'plague', 'quarantine', 'early', 'modern', 'englandj', 'sol', 'hist', '', '2012', '', '45', '', '809-834crossrefpubmedscopus', '', '8', '', 'recently', '', 'quarantine', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'outbreak', '', 'outbreak', 'entire', 'city', 'china', 'effectively', 'place', 'mass', 'quarantine', '', 'thousand', 'foreign', 'national', 'return', 'home', 'china', 'ask', 'self-isolate', 'home', 'state-run', 'facilities4public', 'health', 'englandnovel', 'coronavirus', '', '2019-ncov', '', '', '', 'urlplaceholder', '2020google', 'precedent', 'measure', '', 'citywide', 'quarantine', 'impose', 'area', 'china', 'canada', '2003', 'outbreak', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', 'whereas', 'entire', 'village', 'west', 'african', 'country', 'quarantine', '2014', 'ebola', 'outbreak', '', 'key', 'messagesinformation', 'key', '', 'people', 'quarantine', 'understand', 'situationeffective', 'rapid', 'communication', 'essentialsupplies', '', 'general', 'medical', '', 'providedthe', 'quarantine', 'period', 'short', 'duration', 'change', 'unless', 'extreme', 'circumstancesmost', 'adverse', 'effect', 'imposition', 'restriction', 'liberty', '', 'voluntary', 'quarantine', 'associate', 'le', 'distress', 'fewer', 'long-term', 'complicationspublic', 'health', 'official', 'emphasise', 'altruistic', 'choice', 'self-isolating', 'information', 'key', '', 'people', 'quarantine', 'understand', 'situationeffective', 'rapid', 'communication', 'essentialsupplies', '', 'general', 'medical', '', 'providedthe', 'quarantine', 'period', 'short', 'duration', 'change', 'unless', 'extreme', 'circumstancesmost', 'adverse', 'effect', 'imposition', 'restriction', 'liberty', '', 'voluntary', 'quarantine', 'associate', 'le', 'distress', 'fewer', 'long-term', 'complicationspublic', 'health', 'official', 'emphasise', 'altruistic', 'choice', 'self-isolating', 'quarantine', 'often', 'unpleasant', 'experience', 'undergo', '', 'separation', 'love', 'one', '', 'loss', 'freedom', '', 'uncertainty', 'disease', 'status', '', 'boredom', '', 'occasion', '', 'create', 'dramatic', 'effect', '', 'suicide', 'reported5barbisch', 'koenig', 'kl', 'shih', 'fy', 'case', 'quarantine', '', 'perspectives', 'sars', 'eboladisaster', 'med', 'public', 'health', 'prep', '', '2015', '', '9', '', '547-553crossrefpubmedscopus', '', '26', '', 'substantial', 'anger', 'generate', '', 'lawsuit', 'brought6miles', 'sh', 'kaci', 'hickox', '', 'public', 'health', 'politics', 'fear', '', 'urlplaceholder', '2014google', 'follow', 'imposition', 'quarantine', 'previous', 'outbreak', '', 'potential', 'benefit', 'mandatory', 'mass', 'quarantine', 'weigh', 'carefully', 'possible', 'psychological', 'costs7rubin', 'gj', 'wessely', 'psychological', 'effect', 'quarantine', 'citybmj', '', '2020', '', '368', '', 'm313crossrefpubmedscopus', '', '6', '', 'successful', 'quarantine', 'public', 'health', 'measure', 'require', 'u', 'reduce', '', 'far', 'possible', '', 'negative', 'effect', 'associate', '', 'given', 'develop', 'situation', 'coronavirus', '', 'policy', 'maker', 'urgently', 'evidence', 'synthesis', 'produce', 'guidance', 'public', '', 'circumstance', '', 'rapid', 'review', 'recommend', 'who8whorapid', 'review', 'strengthen', 'health', 'policy', 'system', '', 'practical', 'guide', '', 'urlplaceholder', '2017google', 'undertake', 'review', 'evidence', 'psychological', 'impact', 'quarantine', 'explore', 'likely', 'effect', 'mental', 'health', 'psychological', 'wellbeing', '', 'factor', 'contribute', '', 'mitigate', '', 'effect', '', '3166', 'paper', 'find', '', '24', 'include', 'review', '', 'figure', '', '', 'characteristic', 'study', 'meet', 'inclusion', 'criterion', 'present', 'table', '', 'study', 'across', 'ten', 'country', 'include', 'people', 'sars', '', '11', 'study', '', '', 'ebola', '', 'five', '', '', '2009', '2010', 'h1n1', 'influenza', 'pandemic', '', 'three', '', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'two', '', '', 'equine', 'influenza', '', 'one', '', '', 'one', 'study', 'relate', 'h1n1', 'sarsfigurescreening', 'profileview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'tablestudy', 'characteristicscountrydesignparticipantsquarantine', 'periodmeasuresbai', 'al', '', '2004', '', '9bai', 'lin', 'c-c', 'lin', 'c-y', 'chen', 'j-y', 'chue', 'c-m', 'chou', 'p', 'survey', 'stress', 'reaction', 'among', 'health', 'care', 'worker', 'involve', 'sars', 'outbreakpsychiatr', 'serv', '', '2004', '', '55', '', '1055-1057crossrefpubmedscopus', '', '39', '', 'scholartaiwancross-sectional338', 'hospital', 'staff9', 'day', 'contact', 'suspect', 'sars', 'casesstudy-specific', 'survey', '', 'sars-related', 'stress', 'survey', 'compose', 'acute', 'stress', 'disorder', 'criterion', 'accord', 'dsm-iv', 'relate', 'emotional', 'behavioural', 'changesblendon', 'al', '', '2004', '', '10blendon', 'rj', 'benson', 'jm', 'desroches', 'cm', 'raleigh', 'e', 'taylor-clark', 'k', 'public', 'response', 'severe', 'acute', 'respiratory', 'syndrome', 'toronto', 'united', 'statesclin', 'infect', 'dis', '', '2004', '', '38', '', '925-931crossrefpubmedscopus', '', '91', '', 'scholarcanadacross-sectional501', 'canadian', 'residentslength', 'unclear', '', 'exposure', 'sarsstudy-specific', 'surveybraunack-mayer', 'al', '', '2013', '', '11braunack-mayer', 'tooher', 'r', 'collins', 'je', 'street', 'jm', 'marshall', 'h', 'understanding', 'school', 'community', 'response', 'school', 'closure', 'h1n1', '2009', 'influenza', 'pandemicbmc', 'public', 'health', '', '2013', '', '13', '', '344crossrefpubmedscopus', '', '5', '', 'scholaraustraliaqualitative56', 'school', 'community', 'memberslength', 'unclear', '', 'h1n1', 'influenzainterviewcaleo', 'al', '', '2018', '', '12caleo', 'g', 'duncombe', 'j', 'jephcott', 'f', 'althe', 'factor', 'affect', 'household', 'transmission', 'dynamic', 'community', 'compliance', 'ebola', 'control', 'measure', '', 'mixed-methods', 'study', 'rural', 'village', 'sierra', 'leonebmc', 'public', 'health', '', '2018', '', '18', '', '248crossrefpubmedscopus', '', '6', '', 'scholarsierra', 'leonemixed', 'methods1161', 'resident', 'rural', 'village', '', '20', 'part', 'interview', 'studylength', 'unclear', '', 'entire', 'village', 'restrict', 'movement', 'ebolainterviewcava', 'al', '', '2005', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', 'scholarcanadaqualitative21', 'toronto', 'residents510', 'day', 'sars', 'contactinterviewdesclaux', 'al', '', '2017', '', '14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', 'scholarsenegalqualitative70', 'ebola', 'contact', 'cases21', 'day', 'ebola', 'contactinterviewdigiovanni', 'al', '', '2004', '', '15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', 'scholarcanadamixed', 'methods1509', 'toronto', 'residentsduration', 'quarantine', 'difference', 'incubation', 'period', 'sars', '', '10', 'day', '', 'time', 'elapse', 'since', 'exposure', 'sars', 'patientinterviews', '', 'focus', 'group', '', 'telephone', 'pollshawryluck', 'al', '', '2004', '', '16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'scholarcanadacross-sectional129', 'toronto', 'residentsmedian', '10', 'day', 'potential', 'sars', 'exposureies-r', 'ass', 'post-traumatic', 'stress', 'ces-d', 'ass', 'depressionjeong', 'al', '', '2016', '', '17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'scholarsouth', 'korealongitudinal1656', 'resident', 'four', 'region', 'korea2', 'week', 'contact', 'mers', 'patientsgad-7', 'ass', 'anxiety', 'staxi-2', 'ass', 'angerlee', 'al', '', '2005', '', '18lee', 'chan', 'ly', 'chau', 'kwok', 'kp', 'kleinman', 'experience', 'sars-related', 'stigma', 'amoy', 'gardenssoc', 'sci', 'med', '', '2005', '', '61', '', '2038-2046crossrefpubmedscopus', '', '31', '', 'scholarhong', 'kong', '', 'special', 'administrative', 'region', '', 'china', '', 'mixed', 'methods903', 'resident', 'amoy', 'gardens', '', 'first', 'officially', 'recognise', 'site', 'community', 'outbreak', 'sars', 'hong', 'kong', '', 'survey', '', '856', 'diagnose', 'sars', '', '2', 'interviewedlength', 'unclear', '', 'resident', 'sars', 'outbreak', 'sitestudy-specific', 'surveyliu', 'al', '', '2012', '', '19liu', 'x', 'kakade', 'fuller', 'cj', 'aldepression', 'exposure', 'stressful', 'event', '', 'lesson', 'learn', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemiccompr', 'psychiatry', '', '2012', '', '53', '', '15-23crossrefpubmedscopus', '', '6', '', 'scholarchinacross-sectional549', 'hospital', 'employee', '', '104', '', '19', '', '', 'quarantinedlength', 'unclear', '', 'home', 'work', 'quarantine', 'potential', 'sars', 'contactces-d', 'ass', 'depressive', 'symptom', 'ies-r', 'ass', 'post-traumatic', 'stress', 'symptomsmarjanovic', 'al', '', '2007', '', '20marjanovic', 'z', 'greenglass', 'er', 'coffey', 'relevance', 'psychosocial', 'variable', 'work', 'condition', 'predict', 'nurse', '', 'cop', 'strategy', 'sars', 'crisis', '', 'online', 'questionnaire', 'surveyint', 'j', 'nurs', 'stud', '', '2007', '', '44', '', '991-998crossrefpubmedscopus', '', '17', '', 'scholarcanadacross-sectional333', 'nurseslength', 'unclear', '', 'sars', 'exposurembi-gs', 'ass', 'burnout', '', 'staxi-2', 'ass', 'anger', '', 'six', 'study-specific', 'question', 'ass', 'avoidance', 'behaviourmaunder', 'al', '', '2003', '', '21maunder', 'r', 'hunter', 'j', 'vincent', 'l', 'althe', 'immediate', 'psychological', 'occupational', 'impact', '2003', 'sars', 'outbreak', 'teach', 'hospitalcmaj', '', '2003', '', '168', '', '1245-1251pubmedgoogle', 'scholarcanadaobservationalhealth-care', 'worker', '', 'sample', 'size', 'unavailable', '', '10', 'day', 'voluntary', 'quarantine', 'potential', 'sars', 'contactobservations', 'health-care', 'staffmihashi', 'al', '', '2009', '', '22mihashi', 'otsubo', 'yinjuan', 'x', 'nagatomi', 'k', 'hoshiko', 'ishitake', 'predictive', 'factor', 'psychological', 'disorder', 'development', 'recovery', 'follow', 'sars', 'outbreakhealth', 'psychol', '', '2009', '', '28', '', '91-100crossrefpubmedscopus', '', '5', '', 'scholarchinaretrospective', 'cross-sectional187', 'print', 'company', 'worker', '', 'university', 'faculty', 'member', 'family', '', 'non-medicine', 'studentslength', 'unclear', '', 'citywide', 'isolation', 'sarsghq-30', 'ass', 'psychological', 'disorderspan', 'al', '', '2005', '', '23pan', 'pjd', 'chang', 's-h', 'yu', 'y-y', 'support', 'group', 'home-quarantined', 'college', 'student', 'expose', 'sars', '', 'learn', 'practicej', 'spec', 'group', 'work', '', '2005', '', '30', '', '363-374crossrefscopus', '', '4', '', 'scholartaiwanobservational12', 'college', 'studentslength', 'unclear', '', 'ask', 'limit', 'interaction', 'outside', 'home', 'potential', 'sars', 'contactobservations', 'support', 'group', 'home-quarantined', 'studentspellecchia', 'al', '', '2015', '', '24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', 'scholarliberiaqualitative432', '', 'focus', 'group', '', '30', '', 'interview', '', 'resident', 'neighbourhood', 'incidence', 'ebola21', 'day', 'neighbourhood', 'epidemiological', 'incidence', 'ebolainterviews', 'focus', 'groupsreynolds', 'al', '', '2008', '', '25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', 'scholarcanadacross-sectional1057', 'close', 'contact', 'potential', 'sars', 'casesmean', '83', 'day', '', 'range', '230', 'day', 'contact', 'potential', 'sars', 'casesies-7', 'ass', 'post-traumatic', 'stress', 'symptomsrobertson', 'al', '', '2004', '', '26robertson', 'e', 'hershenfield', 'k', 'grace', 'sl', 'stewart', 'de', 'psychosocial', 'effect', 'quarantine', 'follow', 'exposure', 'sars', '', 'qualitative', 'study', 'toronto', 'health', 'care', 'workerscan', 'j', 'psychiatry', '', '2004', '', '49', '', '403-407crossrefpubmedscopus', '', '34', '', 'scholarcanadaqualitative10', 'health-care', 'workers10', 'day', 'home', 'quarantine', '', 'continually', 'wear', 'mask', 'presence', 'others', '', 'require', 'attend', 'work', 'travel', 'vehicle', 'wear', 'mask', '', 'sars', 'exposureinterviewssprang', 'silman', '', '2013', '', '27sprang', 'g', 'silman', 'posttraumatic', 'stress', 'disorder', 'parent', 'youth', 'health-related', 'disastersdisaster', 'med', 'public', 'health', 'prep', '', '2013', '', '7', '', '105-110crossrefpubmedscopus', '', '7', '', 'scholarusa', 'canadacross-sectional398', 'parentslength', 'unclear', '', 'live', 'area', 'severely', 'affect', 'h1n1', 'sarsptsd-ri', 'parent', 'version', 'pcl-ctaylor', 'al', '', '2008', '', '28taylor', 'mr', 'agho', 'ke', 'stevens', 'gj', 'raphael', 'b', 'factors', 'influence', 'psychological', 'distress', 'disease', 'epidemic', '', 'data', 'australia', 'first', 'outbreak', 'equine', 'influenzabmc', 'public', 'health', '', '2008', '', '8', '', '347crossrefpubmedscopus', '', '27', '', 'scholaraustraliacross-sectional2760', 'horse', 'owner', 'involve', 'horse', 'industryseveral', 'week', 'equine', 'influenzak10', 'ass', 'distresswang', 'al', '', '2011', '', '29wang', 'xu', 'b', 'zhao', 'g', 'cao', 'r', 'x', 'fu', 'quarantine', 'relate', 'immediate', 'negative', 'psychological', 'consequence', '2009', 'h1n1', 'epidemic', '', 'gen', 'hosp', 'psychiatry', '', '2011', '', '33', '', '75-77crossrefpubmedscopus', '', '4', '', 'scholarchinacross-sectional419', 'undergraduates7', 'day', '', 'non-suspected', 'h1n1', 'influenza', 'casessrq-20', 'ass', 'general', 'mental', 'health', 'ies-r', 'ass', 'post-traumatic', 'stresswester', 'giesecke', '', '2019', '', '30wester', 'giesecke', 'j', 'ebola', 'healthcare', 'worker', 'stigmascand', 'j', 'public', 'health', '', '2019', '', '47', '', '99-104crossrefpubmedscopus', '', '2', '', 'scholarswedenqualitative12', '', 'six', 'health-care', 'worker', 'work', 'west', 'africa', 'ebola', 'outbreak', 'one', 'close', 'contact', 'them3', 'week', 'work', 'west', 'africa', 'ebola', 'crisisinterviewwilken', 'al', '', '2017', '', '31wilken', 'ja', 'pordell', 'p', 'goode', 'b', 'alknowledge', '', 'attitude', '', 'practice', 'among', 'member', 'household', 'actively', 'monitor', 'quarantine', 'prevent', 'transmission', 'ebola', 'virus', 'diseasemargibi', 'county', '', 'liberia', '', 'februarymarch', '2015prehosp', 'disaster', 'med', '', '2017', '', '32', '', '673-678crossrefpubmedscopus', '', '3', '', 'scholarliberiaqualitative16', 'resident', 'village', 'quarantined21', 'day', 'live', 'village', 'someone', 'die', 'ebolainterviewwu', 'al', '', '2008', '', '2009', '', '32wu', 'p', 'liu', 'x', 'fang', 'alalcohol', 'abusedependence', 'symptom', 'among', 'hospital', 'employee', 'expose', 'sars', 'outbreakalcohol', 'alcohol', '', '2008', '', '43', '', '706-712crossrefpubmedscopus', '', '9', '', '', '33wu', 'p', 'fang', 'guan', 'z', 'althe', 'psychological', 'impact', 'sars', 'epidemic', 'hospital', 'employee', 'china', '', 'exposure', '', 'risk', 'perception', '', 'altruistic', 'acceptance', 'riskcan', 'j', 'psychiatry', '', '2009', '', '54', '', '302-311crossrefpubmedscopus', '', '33', '', 'scholarchinacross-sectional549', 'hospital', 'employeeslength', 'unclear', '', 'either', 'sars', 'diagnosis', '', 'suspect', 'sars', '', 'direct', 'contact', 'sars', 'patients7', 'question', 'adapt', 'nhsda', 'ass', 'alcohol', 'dependence', 'abuse', '', 'ies-r', 'ass', 'post-traumatic', 'stress', 'symptom', '', 'ces-d', 'ass', 'depressionyoon', 'al', '', '2016', '', '34yoon', 'mk', 'kim', 'sy', 'ko', 'hs', 'lee', 'ms', 'system', 'effectiveness', 'detection', '', 'brief', 'intervention', 'refer', 'treatment', 'people', 'post-traumatic', 'emotional', 'distress', 'mers', '', 'case', 'report', 'community-based', 'proactive', 'intervention', 'south', 'koreaint', 'j', 'ment', 'health', 'syst', '', '2016', '', '10', '', '51crossrefpubmedscopus', '', '3', '', 'scholarsouth', 'koreapsychological', 'evaluation', 'professionals6231', 'korean', 'residentslength', 'unclear', '', 'place', 'quarantine', 'mersquestions', '', 'last', '2', 'week', 'quarantine', '', 'feel', 'depress', 'hopelessness', '', 'feel', 'loss', 'interest', 'part', 'life', '', '', 'sarssevere', 'acute', 'respiratory', 'syndrome', '', 'dsm-ivdiagnostic', 'statistical', 'manual', 'mental', 'disorders-iv', '', 'ies-rimpact', 'event', 'scale-revised', '', 'ces-dcenter', 'epidemiologic', 'studies', 'depression', 'scale', '', 'mersmiddle', 'east', 'respiratory', 'syndrome-related', 'coronavirus', '', 'gad-7generalised', 'anxiety', 'disorder-7', '', 'staxi-2state-trait', 'anger', 'expression', 'inventory', '', 'mbi-gs', 'maslach', 'burnout', 'inventory-general', 'survey', '', 'ghq-30general', 'health', 'questionnaire-30', '', 'ies-7international', 'education', 'standard-7', '', 'ptsd-ripost-traumatic', 'stress', 'disorder', 'reaction', 'index', '', 'pcl-cptsd', 'checklist-civilian', 'version', '', 'k10', 'kessler', '10', 'psychological', 'distress', 'scale', '', 'srq-20self-reporting', 'questionnaire-20', '', 'nhsdanational', 'household', 'survey', 'drug', 'abuse', '', 'open', 'table', 'new', 'tab', 'sarssevere', 'acute', 'respiratory', 'syndrome', '', 'dsm-ivdiagnostic', 'statistical', 'manual', 'mental', 'disorders-iv', '', 'ies-rimpact', 'event', 'scale-revised', '', 'ces-dcenter', 'epidemiologic', 'studies', 'depression', 'scale', '', 'mersmiddle', 'east', 'respiratory', 'syndrome-related', 'coronavirus', '', 'gad-7generalised', 'anxiety', 'disorder-7', '', 'staxi-2state-trait', 'anger', 'expression', 'inventory', '', 'mbi-gs', 'maslach', 'burnout', 'inventory-general', 'survey', '', 'ghq-30general', 'health', 'questionnaire-30', '', 'ies-7international', 'education', 'standard-7', '', 'ptsd-ripost-traumatic', 'stress', 'disorder', 'reaction', 'index', '', 'pcl-cptsd', 'checklist-civilian', 'version', '', 'k10', 'kessler', '10', 'psychological', 'distress', 'scale', '', 'srq-20self-reporting', 'questionnaire-20', '', 'nhsdanational', 'household', 'survey', 'drug', 'abuse', '', 'five', 'study', 'compare', 'psychological', 'outcome', 'people', 'quarantine', 'quarantined9bai', 'lin', 'c-c', 'lin', 'c-y', 'chen', 'j-y', 'chue', 'c-m', 'chou', 'p', 'survey', 'stress', 'reaction', 'among', 'health', 'care', 'worker', 'involve', 'sars', 'outbreakpsychiatr', 'serv', '', '2004', '', '55', '', '1055-1057crossrefpubmedscopus', '', '39', '', '', '19liu', 'x', 'kakade', 'fuller', 'cj', 'aldepression', 'exposure', 'stressful', 'event', '', 'lesson', 'learn', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemiccompr', 'psychiatry', '', '2012', '', '53', '', '15-23crossrefpubmedscopus', '', '6', '', '', '27sprang', 'g', 'silman', 'posttraumatic', 'stress', 'disorder', 'parent', 'youth', 'health-related', 'disastersdisaster', 'med', 'public', 'health', 'prep', '', '2013', '', '7', '', '105-110crossrefpubmedscopus', '', '7', '', '', '28taylor', 'mr', 'agho', 'ke', 'stevens', 'gj', 'raphael', 'b', 'factors', 'influence', 'psychological', 'distress', 'disease', 'epidemic', '', 'data', 'australia', 'first', 'outbreak', 'equine', 'influenzabmc', 'public', 'health', '', '2008', '', '8', '', '347crossrefpubmedscopus', '', '27', '', '', '33wu', 'p', 'fang', 'guan', 'z', 'althe', 'psychological', 'impact', 'sars', 'epidemic', 'hospital', 'employee', 'china', '', 'exposure', '', 'risk', 'perception', '', 'altruistic', 'acceptance', 'riskcan', 'j', 'psychiatry', '', '2009', '', '54', '', '302-311crossrefpubmedscopus', '', '33', '', 'study9bai', 'lin', 'c-c', 'lin', 'c-y', 'chen', 'j-y', 'chue', 'c-m', 'chou', 'p', 'survey', 'stress', 'reaction', 'among', 'health', 'care', 'worker', 'involve', 'sars', 'outbreakpsychiatr', 'serv', '', '2004', '', '55', '', '1055-1057crossrefpubmedscopus', '', '39', '', 'hospital', 'staff', 'contact', 'sars', 'find', 'immediately', 'quarantine', 'period', '', '9', 'day', '', 'end', '', 'quarantine', 'factor', 'predictive', 'symptom', 'acute', 'stress', 'disorder', '', 'study', '', 'quarantine', 'staff', 'significantly', 'likely', 'report', 'exhaustion', '', 'detachment', 'others', '', 'anxiety', 'deal', 'febrile', 'patient', '', 'irritability', '', 'insomnia', '', 'poor', 'concentration', 'indecisiveness', '', 'deteriorate', 'work', 'performance', '', 'reluctance', 'work', 'consideration', 'resignation', '', 'another', 'study33wu', 'p', 'fang', 'guan', 'z', 'althe', 'psychological', 'impact', 'sars', 'epidemic', 'hospital', 'employee', 'china', '', 'exposure', '', 'risk', 'perception', '', 'altruistic', 'acceptance', 'riskcan', 'j', 'psychiatry', '', '2009', '', '54', '', '302-311crossrefpubmedscopus', '', '33', '', 'effect', 'quarantine', 'predictor', 'post-traumatic', 'stress', 'symptom', 'hospital', 'employee', '3', 'year', 'later', '', 'approximately', '34', '', '', '938', '2760', '', 'horse', 'owner', 'quarantine', 'several', 'week', 'equine', 'influenza', 'outbreak', 'report', 'high', 'psychological', 'distress', 'outbreak', '', 'compare', 'around', '12', '', 'australian', 'general', 'population28taylor', 'mr', 'agho', 'ke', 'stevens', 'gj', 'raphael', 'b', 'factors', 'influence', 'psychological', 'distress', 'disease', 'epidemic', '', 'data', 'australia', 'first', 'outbreak', 'equine', 'influenzabmc', 'public', 'health', '', '2008', '', '8', '', '347crossrefpubmedscopus', '', '27', '', 'study27sprang', 'g', 'silman', 'posttraumatic', 'stress', 'disorder', 'parent', 'youth', 'health-related', 'disastersdisaster', 'med', 'public', 'health', 'prep', '', '2013', '', '7', '', '105-110crossrefpubmedscopus', '', '7', '', 'compare', 'post-traumatic', 'stress', 'symptom', 'parent', 'child', 'quarantine', 'quarantine', 'find', 'mean', 'post-traumatic', 'stress', 'score', 'four', 'time', 'higher', 'child', 'quarantine', 'quarantine', '', '28', '', '', '27', '98', '', 'parent', 'quarantine', 'study', 'report', 'sufficient', 'symptom', 'warrant', 'diagnosis', 'trauma-related', 'mental', 'health', 'disorder', '', 'compare', '6', '', '', '17', '299', '', 'parent', 'quarantine', '', 'another', 'study19liu', 'x', 'kakade', 'fuller', 'cj', 'aldepression', 'exposure', 'stressful', 'event', '', 'lesson', 'learn', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemiccompr', 'psychiatry', '', '2012', '', '53', '', '15-23crossrefpubmedscopus', '', '6', '', 'hospital', 'staff', 'examine', 'symptom', 'depression', '3', 'year', 'quarantine', 'find', '9', '', '', '48', '549', '', 'whole', 'sample', 'report', 'high', 'depressive', 'symptom', '', 'group', 'high', 'depressive', 'symptom', '', 'nearly', '60', '', '', '29', '48', '', 'quarantine', '15', '', '', '63', '424', '', 'group', 'low', 'depressive', 'symptom', 'quarantine', '', 'quantitative', 'study', 'survey', 'quarantine', 'generally', 'report', 'high', 'prevalence', 'symptom', 'psychological', 'distress', 'disorder', '', 'studies', 'report', 'general', 'psychological', 'symptoms22mihashi', 'otsubo', 'yinjuan', 'x', 'nagatomi', 'k', 'hoshiko', 'ishitake', 'predictive', 'factor', 'psychological', 'disorder', 'development', 'recovery', 'follow', 'sars', 'outbreakhealth', 'psychol', '', '2009', '', '28', '', '91-100crossrefpubmedscopus', '', '5', '', 'emotional', 'disturbance34yoon', 'mk', 'kim', 'sy', 'ko', 'hs', 'lee', 'ms', 'system', 'effectiveness', 'detection', '', 'brief', 'intervention', 'refer', 'treatment', 'people', 'post-traumatic', 'emotional', 'distress', 'mers', '', 'case', 'report', 'community-based', 'proactive', 'intervention', 'south', 'koreaint', 'j', 'ment', 'health', 'syst', '', '2016', '', '10', '', '51crossrefpubmedscopus', '', '3', '', 'depression16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'stress15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', 'low', 'mood18lee', 'chan', 'ly', 'chau', 'kwok', 'kp', 'kleinman', 'experience', 'sars-related', 'stigma', 'amoy', 'gardenssoc', 'sci', 'med', '', '2005', '', '61', '', '2038-2046crossrefpubmedscopus', '', '31', '', 'irritability18lee', 'chan', 'ly', 'chau', 'kwok', 'kp', 'kleinman', 'experience', 'sars-related', 'stigma', 'amoy', 'gardenssoc', 'sci', 'med', '', '2005', '', '61', '', '2038-2046crossrefpubmedscopus', '', '31', '', 'insomnia18lee', 'chan', 'ly', 'chau', 'kwok', 'kp', 'kleinman', 'experience', 'sars-related', 'stigma', 'amoy', 'gardenssoc', 'sci', 'med', '', '2005', '', '61', '', '2038-2046crossrefpubmedscopus', '', '31', '', 'post-traumatic', 'stress', 'symptoms25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', '', 'rat', 'weiss', 'marmar', 'impact', 'event', 'scalerevised35weiss', 'ds', 'marmar', 'cr', 'impact', 'event', 'scale', '', 'revisedin', '', 'wilson', 'jp', 'keane', 'tm', 'assessing', 'psychological', 'trauma', 'ptsd', '', 'guildford', 'press', '', 'new', 'york1997', '', '399-411google', '', '', 'anger20marjanovic', 'z', 'greenglass', 'er', 'coffey', 'relevance', 'psychosocial', 'variable', 'work', 'condition', 'predict', 'nurse', '', 'cop', 'strategy', 'sars', 'crisis', '', 'online', 'questionnaire', 'surveyint', 'j', 'nurs', 'stud', '', '2007', '', '44', '', '991-998crossrefpubmedscopus', '', '17', '', 'emotional', 'exhaustion21maunder', 'r', 'hunter', 'j', 'vincent', 'l', 'althe', 'immediate', 'psychological', 'occupational', 'impact', '2003', 'sars', 'outbreak', 'teach', 'hospitalcmaj', '', '2003', '', '168', '', '1245-1251pubmedgoogle', 'low', 'mood', '', '660', '', '73', '', '', '903', '', 'irritability', '', '512', '', '57', '', '', '903', '', 'stand', 'high', 'prevalence18lee', 'chan', 'ly', 'chau', 'kwok', 'kp', 'kleinman', 'experience', 'sars-related', 'stigma', 'amoy', 'gardenssoc', 'sci', 'med', '', '2005', '', '61', '', '2038-2046crossrefpubmedscopus', '', '31', '', 'people', 'quarantine', 'close', 'contact', 'potentially', 'sars25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', 'report', 'various', 'negative', 'response', 'quarantine', 'period', '', '20', '', '', '230', '1057', '', 'report', 'fear', '', '18', '', '', '187', '', 'report', 'nervousness', '', '18', '', '', '186', '', 'report', 'sadness', '', '10', '', '', '101', '', 'report', 'guilt', '', 'report', 'positive', 'feel', '', '5', '', '', '48', '', 'report', 'feel', 'happiness', '4', '', '', '43', '', 'report', 'feel', 'relief', '', 'qualitative', 'study', 'identify', 'range', 'psychological', 'response', 'quarantine', '', 'confusion11braunack-mayer', 'tooher', 'r', 'collins', 'je', 'street', 'jm', 'marshall', 'h', 'understanding', 'school', 'community', 'response', 'school', 'closure', 'h1n1', '2009', 'influenza', 'pandemicbmc', 'public', 'health', '', '2013', '', '13', '', '344crossrefpubmedscopus', '', '5', '', '', '12caleo', 'g', 'duncombe', 'j', 'jephcott', 'f', 'althe', 'factor', 'affect', 'household', 'transmission', 'dynamic', 'community', 'compliance', 'ebola', 'control', 'measure', '', 'mixed-methods', 'study', 'rural', 'village', 'sierra', 'leonebmc', 'public', 'health', '', '2018', '', '18', '', '248crossrefpubmedscopus', '', '6', '', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', '', '23pan', 'pjd', 'chang', 's-h', 'yu', 'y-y', 'support', 'group', 'home-quarantined', 'college', 'student', 'expose', 'sars', '', 'learn', 'practicej', 'spec', 'group', 'work', '', '2005', '', '30', '', '363-374crossrefscopus', '', '4', '', 'fear12caleo', 'g', 'duncombe', 'j', 'jephcott', 'f', 'althe', 'factor', 'affect', 'household', 'transmission', 'dynamic', 'community', 'compliance', 'ebola', 'control', 'measure', '', 'mixed-methods', 'study', 'rural', 'village', 'sierra', 'leonebmc', 'public', 'health', '', '2018', '', '18', '', '248crossrefpubmedscopus', '', '6', '', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', '', '14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', '', '15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', '', '23pan', 'pjd', 'chang', 's-h', 'yu', 'y-y', 'support', 'group', 'home-quarantined', 'college', 'student', 'expose', 'sars', '', 'learn', 'practicej', 'spec', 'group', 'work', '', '2005', '', '30', '', '363-374crossrefscopus', '', '4', '', '', '24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', 'anger12caleo', 'g', 'duncombe', 'j', 'jephcott', 'f', 'althe', 'factor', 'affect', 'household', 'transmission', 'dynamic', 'community', 'compliance', 'ebola', 'control', 'measure', '', 'mixed-methods', 'study', 'rural', 'village', 'sierra', 'leonebmc', 'public', 'health', '', '2018', '', '18', '', '248crossrefpubmedscopus', '', '6', '', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', 'grief29wang', 'xu', 'b', 'zhao', 'g', 'cao', 'r', 'x', 'fu', 'quarantine', 'relate', 'immediate', 'negative', 'psychological', 'consequence', '2009', 'h1n1', 'epidemic', '', 'gen', 'hosp', 'psychiatry', '', '2011', '', '33', '', '75-77crossrefpubmedscopus', '', '4', '', 'numbness23pan', 'pjd', 'chang', 's-h', 'yu', 'y-y', 'support', 'group', 'home-quarantined', 'college', 'student', 'expose', 'sars', '', 'learn', 'practicej', 'spec', 'group', 'work', '', '2005', '', '30', '', '363-374crossrefscopus', '', '4', '', 'anxiety-induced', 'insomnia14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', '', '15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', 'one', 'study', 'compare', 'undergraduate', 'quarantine', 'quarantine', 'immediately', 'quarantine', 'period', 'find', 'significant', 'difference', 'group', 'term', 'post-traumatic', 'stress', 'symptom', 'general', 'mental', 'health', 'problems29wang', 'xu', 'b', 'zhao', 'g', 'cao', 'r', 'x', 'fu', 'quarantine', 'relate', 'immediate', 'negative', 'psychological', 'consequence', '2009', 'h1n1', 'epidemic', '', 'gen', 'hosp', 'psychiatry', '', '2011', '', '33', '', '75-77crossrefpubmedscopus', '', '4', '', 'however', '', 'entire', 'study', 'population', 'undergraduate', 'student', '', 'generally', 'young', '', 'perhaps', 'fewer', 'responsibility', 'adult', 'employ', 'full-time', '', 'thus', 'possible', 'conclusion', 'generalise', 'wider', 'population', '', 'one', 'study17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'compare', 'psychological', 'outcome', 'quarantine', 'later', 'outcome', 'find', 'quarantine', '', '7', '', '', '126', '1656', '', 'show', 'anxiety', 'symptom', '17', '', '', '275', '', 'show', 'feel', 'anger', '', 'whereas', '46', 'month', 'quarantine', 'symptom', 'reduce', '3', '', '', 'anxiety', '', '6', '', '', 'anger', '', '', 'two', 'study', 'report', 'longer-term', 'effect', 'quarantine', '', '3', 'year', 'sars', 'outbreak', '', 'alcohol', 'abuse', 'dependency', 'symptom', 'positively', 'associate', 'quarantine', 'health-care', 'workers32wu', 'p', 'liu', 'x', 'fang', 'alalcohol', 'abusedependence', 'symptom', 'among', 'hospital', 'employee', 'expose', 'sars', 'outbreakalcohol', 'alcohol', '', '2008', '', '43', '', '706-712crossrefpubmedscopus', '', '9', '', 'multivariate', 'analysis32wu', 'p', 'liu', 'x', 'fang', 'alalcohol', 'abusedependence', 'symptom', 'among', 'hospital', 'employee', 'expose', 'sars', 'outbreakalcohol', 'alcohol', '', '2008', '', '43', '', '706-712crossrefpubmedscopus', '', '9', '', 'control', 'demographic', 'factor', '', 'quarantine', 'work', 'high-risk', 'location', 'two', 'type', 'exposure', 'significantly', 'associate', 'outcome', '', 'quarantine', '', 'unadjusted', 'mean', 'ratio', '045', '', '95', '', 'ci', '102265', '', '', 'quarantine', '', 'participant', 'continue', 'engage', 'avoidance', 'behaviour', '', 'health-care', 'workers20marjanovic', 'z', 'greenglass', 'er', 'coffey', 'relevance', 'psychosocial', 'variable', 'work', 'condition', 'predict', 'nurse', '', 'cop', 'strategy', 'sars', 'crisis', '', 'online', 'questionnaire', 'surveyint', 'j', 'nurs', 'stud', '', '2007', '', '44', '', '991-998crossrefpubmedscopus', '', '17', '', 'quarantine', 'significantly', 'positively', 'associate', 'avoidance', 'behaviour', '', 'minimise', 'direct', 'contact', 'patient', 'report', 'work', '', 'study25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', 'people', 'quarantine', 'potential', 'sars', 'contact', 'note', '54', '', '', '524', '1057', '', 'people', 'quarantine', 'avoid', 'people', 'cough', 'sneeze', '', '26', '', '', '255', '', 'avoid', 'crowd', 'enclose', 'place', '', '21', '', '', '204', '', 'avoid', 'public', 'space', 'week', 'follow', 'quarantine', 'period', '', 'qualitative', 'study13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', 'report', 'several', 'participant', 'describe', 'long-term', 'behavioural', 'change', 'quarantine', 'period', '', 'vigilant', 'handwash', 'avoidance', 'crowd', '', '', 'return', 'normality', 'delay', 'month', '', 'mix', 'evidence', 'whether', 'participant', 'characteristic', 'demographic', 'predictor', 'psychological', 'impact', 'quarantine', '', 'study28taylor', 'mr', 'agho', 'ke', 'stevens', 'gj', 'raphael', 'b', 'factors', 'influence', 'psychological', 'distress', 'disease', 'epidemic', '', 'data', 'australia', 'first', 'outbreak', 'equine', 'influenzabmc', 'public', 'health', '', '2008', '', '8', '', '347crossrefpubmedscopus', '', '27', '', 'horse', 'owner', 'quarantine', 'equine', 'influenza', 'identify', 'several', 'characteristic', 'associate', 'negative', 'psychological', 'impact', '', 'younger', 'age', '', '1624', 'year', '', '', 'lower', 'level', 'formal', 'educational', 'qualification', '', 'female', 'gender', '', 'one', 'child', 'oppose', 'child', '', 'although', 'three', 'child', 'appear', 'somewhat', 'protective', '', '', 'however', '', 'another', 'study16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'suggest', 'demographic', 'factor', 'marital', 'status', '', 'age', '', 'education', '', 'live', 'adult', '', 'child', 'associate', 'psychological', 'outcome', '', 'history', 'psychiatric', 'illness', 'associate', 'experience', 'anxiety', 'anger', '46', 'month', 'release', 'quarantine17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'health-care', 'workers25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', 'quarantine', 'severe', 'symptom', 'post-traumatic', 'stress', 'member', 'general', 'public', 'quarantine', '', 'score', 'significantly', 'higher', 'dimension', '', 'health-care', 'worker', 'felt', 'greater', 'stigmatisation', 'general', 'public', '', 'exhibit', 'avoidance', 'behaviour', 'quarantine', '', 'report', 'greater', 'lose', 'income', '', 'consistently', 'affect', 'psychologically', '', 'report', 'substantially', 'anger', '', 'annoyance', '', 'fear', '', 'frustration', '', 'guilt', '', 'helplessness', '', 'isolation', '', 'loneliness', '', 'nervousness', '', 'sadness', '', 'worry', '', 'le', 'happy', '', 'health-care', 'worker', 'substantially', 'likely', 'sars', 'concern', 'infect', 'others', '', 'conversely', '', 'one', 'study16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'suggest', 'health-care', 'worker', 'status', 'associate', 'psychological', 'outcome', '', 'three', 'study', 'show', 'longer', 'duration', 'quarantine', 'associate', 'poorer', 'mental', 'health', 'specifically', '', 'post-traumatic', 'stress', 'symptoms16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', '', '25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', 'avoidance', 'behaviour', '', 'anger20marjanovic', 'z', 'greenglass', 'er', 'coffey', 'relevance', 'psychosocial', 'variable', 'work', 'condition', 'predict', 'nurse', '', 'cop', 'strategy', 'sars', 'crisis', '', 'online', 'questionnaire', 'surveyint', 'j', 'nurs', 'stud', '', '2007', '', '44', '', '991-998crossrefpubmedscopus', '', '17', '', 'although', 'duration', 'quarantine', 'always', 'clear', '', 'one', 'study16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'show', 'quarantine', '10', 'day', 'show', 'significantly', 'higher', 'post-traumatic', 'stress', 'symptom', 'quarantine', 'le', '10', 'day', '', 'participants', 'eight', 'study', 'report', 'fear', 'health', 'fear', 'infect', 'others9bai', 'lin', 'c-c', 'lin', 'c-y', 'chen', 'j-y', 'chue', 'c-m', 'chou', 'p', 'survey', 'stress', 'reaction', 'among', 'health', 'care', 'worker', 'involve', 'sars', 'outbreakpsychiatr', 'serv', '', '2004', '', '55', '', '1055-1057crossrefpubmedscopus', '', '39', '', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', '', '14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', '', '16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', '', '17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', '', '21maunder', 'r', 'hunter', 'j', 'vincent', 'l', 'althe', 'immediate', 'psychological', 'occupational', 'impact', '2003', 'sars', 'outbreak', 'teach', 'hospitalcmaj', '', '2003', '', '168', '', '1245-1251pubmedgoogle', '', '25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', '', '26robertson', 'e', 'hershenfield', 'k', 'grace', 'sl', 'stewart', 'de', 'psychosocial', 'effect', 'quarantine', 'follow', 'exposure', 'sars', '', 'qualitative', 'study', 'toronto', 'health', 'care', 'workerscan', 'j', 'psychiatry', '', '2004', '', '49', '', '403-407crossrefpubmedscopus', '', '34', '', 'likely', 'fear', 'infect', 'family', 'member', 'quarantined9bai', 'lin', 'c-c', 'lin', 'c-y', 'chen', 'j-y', 'chue', 'c-m', 'chou', 'p', 'survey', 'stress', 'reaction', 'among', 'health', 'care', 'worker', 'involve', 'sars', 'outbreakpsychiatr', 'serv', '', '2004', '', '55', '', '1055-1057crossrefpubmedscopus', '', '39', '', 'become', 'particularly', 'worry', 'experience', 'physical', 'symptom', 'potentially', 'relate', 'infection14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', 'fear', 'symptom', 'reflect', 'infection', 'continue', 'relate', 'psychological', 'outcome', 'several', 'month', 'later17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'conversely', '', 'one', 'study11braunack-mayer', 'tooher', 'r', 'collins', 'je', 'street', 'jm', 'marshall', 'h', 'understanding', 'school', 'community', 'response', 'school', 'closure', 'h1n1', '2009', 'influenza', 'pandemicbmc', 'public', 'health', '', '2013', '', '13', '', '344crossrefpubmedscopus', '', '5', '', 'find', 'although', 'participant', 'extremely', 'concern', 'become', 'infect', 'transmit', 'virus', 'others', '', 'concern', 'tend', 'pregnant', 'woman', 'young', 'child', '', 'confinement', '', 'loss', 'usual', 'routine', '', 'reduce', 'social', 'physical', 'contact', 'others', 'frequently', 'show', 'cause', 'boredom', '', 'frustration', '', 'sense', 'isolation', 'rest', 'world', '', 'distress', 'participants10blendon', 'rj', 'benson', 'jm', 'desroches', 'cm', 'raleigh', 'e', 'taylor-clark', 'k', 'public', 'response', 'severe', 'acute', 'respiratory', 'syndrome', 'toronto', 'united', 'statesclin', 'infect', 'dis', '', '2004', '', '38', '', '925-931crossrefpubmedscopus', '', '91', '', '', '11braunack-mayer', 'tooher', 'r', 'collins', 'je', 'street', 'jm', 'marshall', 'h', 'understanding', 'school', 'community', 'response', 'school', 'closure', 'h1n1', '2009', 'influenza', 'pandemicbmc', 'public', 'health', '', '2013', '', '13', '', '344crossrefpubmedscopus', '', '5', '', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', '', '14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', '', '15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', '', '16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', '', '25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', '', '26robertson', 'e', 'hershenfield', 'k', 'grace', 'sl', 'stewart', 'de', 'psychosocial', 'effect', 'quarantine', 'follow', 'exposure', 'sars', '', 'qualitative', 'study', 'toronto', 'health', 'care', 'workerscan', 'j', 'psychiatry', '', '2004', '', '49', '', '403-407crossrefpubmedscopus', '', '34', '', '', '31wilken', 'ja', 'pordell', 'p', 'goode', 'b', 'alknowledge', '', 'attitude', '', 'practice', 'among', 'member', 'household', 'actively', 'monitor', 'quarantine', 'prevent', 'transmission', 'ebola', 'virus', 'diseasemargibi', 'county', '', 'liberia', '', 'februarymarch', '2015prehosp', 'disaster', 'med', '', '2017', '', '32', '', '673-678crossrefpubmedscopus', '', '3', '', 'frustration', 'exacerbate', 'able', 'part', 'usual', 'day-to-day', 'activity', '', 'shop', 'basic', 'necessities16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'part', 'social', 'network', 'activity', 'via', 'telephone', 'internet17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'inadequate', 'basic', 'supply', '', 'eg', '', 'food', '', 'water', '', 'clothe', '', 'accommodation', '', 'quarantine', 'source', 'frustration10blendon', 'rj', 'benson', 'jm', 'desroches', 'cm', 'raleigh', 'e', 'taylor-clark', 'k', 'public', 'response', 'severe', 'acute', 'respiratory', 'syndrome', 'toronto', 'united', 'statesclin', 'infect', 'dis', '', '2004', '', '38', '', '925-931crossrefpubmedscopus', '', '91', '', '', '31wilken', 'ja', 'pordell', 'p', 'goode', 'b', 'alknowledge', '', 'attitude', '', 'practice', 'among', 'member', 'household', 'actively', 'monitor', 'quarantine', 'prevent', 'transmission', 'ebola', 'virus', 'diseasemargibi', 'county', '', 'liberia', '', 'februarymarch', '2015prehosp', 'disaster', 'med', '', '2017', '', '32', '', '673-678crossrefpubmedscopus', '', '3', '', 'continue', 'associate', 'anxiety', 'anger', '46', 'month', 'release17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'unable', 'regular', 'medical', 'care', 'prescription', 'appear', 'problem', 'participants10blendon', 'rj', 'benson', 'jm', 'desroches', 'cm', 'raleigh', 'e', 'taylor-clark', 'k', 'public', 'response', 'severe', 'acute', 'respiratory', 'syndrome', 'toronto', 'united', 'statesclin', 'infect', 'dis', '', '2004', '', '38', '', '925-931crossrefpubmedscopus', '', '91', '', 'four', 'study', 'find', 'supply', 'public', 'health', 'authority', 'insufficient', '', 'participants', 'report', 'receive', 'mask', 'thermometer', 'late', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', 'food', '', 'water', '', 'item', 'intermittently', 'distribute', '', '24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', 'food', 'supply', 'long', 'time', 'arrive12caleo', 'g', 'duncombe', 'j', 'jephcott', 'f', 'althe', 'factor', 'affect', 'household', 'transmission', 'dynamic', 'community', 'compliance', 'ebola', 'control', 'measure', '', 'mixed-methods', 'study', 'rural', 'village', 'sierra', 'leonebmc', 'public', 'health', '', '2018', '', '18', '', '248crossrefpubmedscopus', '', '6', '', 'although', 'quarantine', 'toronto', 'sars', 'outbreak', 'praise', 'public', 'health', 'authority', 'deliver', 'kit', 'medical', 'supply', 'begin', 'quarantine', 'period', '', 'receive', 'grocery', 'routine', 'supply', 'daily', 'living15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', 'participant', 'cite', 'poor', 'information', 'public', 'health', 'authority', 'stressor', '', 'report', 'insufficient', 'clear', 'guideline', 'action', 'confusion', 'purpose', 'quarantine11braunack-mayer', 'tooher', 'r', 'collins', 'je', 'street', 'jm', 'marshall', 'h', 'understanding', 'school', 'community', 'response', 'school', 'closure', 'h1n1', '2009', 'influenza', 'pandemicbmc', 'public', 'health', '', '2013', '', '13', '', '344crossrefpubmedscopus', '', '5', '', '', '12caleo', 'g', 'duncombe', 'j', 'jephcott', 'f', 'althe', 'factor', 'affect', 'household', 'transmission', 'dynamic', 'community', 'compliance', 'ebola', 'control', 'measure', '', 'mixed-methods', 'study', 'rural', 'village', 'sierra', 'leonebmc', 'public', 'health', '', '2018', '', '18', '', '248crossrefpubmedscopus', '', '6', '', '', '13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', '', '15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', '', '24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', '', '26robertson', 'e', 'hershenfield', 'k', 'grace', 'sl', 'stewart', 'de', 'psychosocial', 'effect', 'quarantine', 'follow', 'exposure', 'sars', '', 'qualitative', 'study', 'toronto', 'health', 'care', 'workerscan', 'j', 'psychiatry', '', '2004', '', '49', '', '403-407crossrefpubmedscopus', '', '34', '', 'toronto', 'sars', 'epidemic', '', 'participant', 'perceive', 'confusion', 'stem', 'difference', 'style', '', 'approach', '', 'content', 'various', 'public', 'health', 'message', 'poor', 'coordination', 'multiple', 'jurisdiction', 'level', 'government', 'involved15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', 'clarity', 'different', 'level', 'risk', '', 'particular', '', 'lead', 'participant', 'fear', 'worst14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', 'participants', 'report', 'perceive', 'transparency', 'health', 'government', 'official', 'severity', 'pandemic11braunack-mayer', 'tooher', 'r', 'collins', 'je', 'street', 'jm', 'marshall', 'h', 'understanding', 'school', 'community', 'response', 'school', 'closure', 'h1n1', '2009', 'influenza', 'pandemicbmc', 'public', 'health', '', '2013', '', '13', '', '344crossrefpubmedscopus', '', '5', '', 'perhaps', 'relate', 'clear', 'guideline', 'rationale', '', 'perceive', 'difficulty', 'comply', 'quarantine', 'protocol', 'significant', 'predictor', 'post-traumatic', 'stress', 'symptom', 'one', 'study25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', 'financial', 'loss', 'problem', 'quarantine', '', 'people', 'unable', 'work', 'interrupt', 'professional', 'activity', 'advance', 'plan', '', 'effect', 'appear', 'long', 'last', '', 'review', 'study', '', 'financial', 'loss', 'result', 'quarantine', 'create', 'serious', 'socioeconomic', 'distress24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', 'find', 'risk', 'factor', 'symptom', 'psychological', 'disorders22mihashi', 'otsubo', 'yinjuan', 'x', 'nagatomi', 'k', 'hoshiko', 'ishitake', 'predictive', 'factor', 'psychological', 'disorder', 'development', 'recovery', 'follow', 'sars', 'outbreakhealth', 'psychol', '', '2009', '', '28', '', '91-100crossrefpubmedscopus', '', '5', '', 'anger', 'anxiety', 'several', 'month', 'quarantine17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'one', 'study28taylor', 'mr', 'agho', 'ke', 'stevens', 'gj', 'raphael', 'b', 'factors', 'influence', 'psychological', 'distress', 'disease', 'epidemic', '', 'data', 'australia', 'first', 'outbreak', 'equine', 'influenzabmc', 'public', 'health', '', '2008', '', '8', '', '347crossrefpubmedscopus', '', '27', '', 'find', 'respondent', 'quarantine', 'equine', 'influenza', '', 'whose', 'principal', 'source', 'income', 'horse-related', 'industry', '', 'twice', 'likely', 'high', 'distress', 'whose', 'income', 'industry', '', 'find', 'probably', 'link', 'economic', 'effect', 'relate', 'disruption', 'social', 'network', 'loss', 'leisure', 'activity', '', 'notably', '', 'study', 'exceptional', 'occupation', 'exposure', 'confound', '', 'study14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', 'people', 'quarantine', 'potential', 'ebola', 'contact', 'find', '', 'although', 'participant', 'receive', 'financial', 'assistance', '', 'felt', 'amount', 'insufficient', 'late', '', 'felt', 'wrong', 'assistance', 'receive', 'cover', 'ongoing', 'professional', 'expense', '', 'become', 'dependent', 'family', 'provide', 'financially', 'quarantine', 'often', 'hard', 'accept', 'cause', 'conflict', '', 'one', 'study13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', 'none', 'quarantine', 'toronto', 'sars', 'report', 'much', 'financial', 'hardship', 'employer', 'government', 'compensate', '', 'reimbursement', 'slow', 'arrive', 'cause', 'le', 'financially', 'well-off', 'struggle', '', 'potentially', 'relate', 'financial', 'loss', '', 'participant', 'combine', 'annual', 'household', 'income', 'le', '', '40', '000', 'show', 'significantly', 'higher', 'amount', 'post-traumatic', 'stress', 'depressive', 'symptoms16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', 'symptom', 'probably', 'lower', 'income', 'likely', 'affect', 'temporary', 'loss', 'income', 'higher', 'income', '', 'people', 'quarantine', 'lower', 'household', 'income', 'require', 'additional', 'level', 'support', '', 'along', 'lose', 'earn', 'quarantine', '', 'ie', '', 'self-employed', 'people', 'unable', 'work', 'salaried', 'staff', 'unable', 'pay', 'leave', '', '', 'financial', 'reimbursement', 'provide', 'possible', 'programme', 'develop', 'provide', 'financial', 'support', 'throughout', 'quarantine', 'period', '', 'appropriate', '', 'employer', 'wish', 'consider', 'proactive', 'approach', 'allow', 'employee', 'work', 'home', 'wish', '', 'avoid', 'financial', 'loss', 'stave', 'boredom', '', 'mindful', 'staff', 'situation', 'productive', 'benefit', 'remote', 'social', 'support', 'colleagues2manuell', 'm-e', 'cukor', 'j', 'mother', 'nature', 'versus', 'human', 'nature', '', 'public', 'compliance', 'evacuation', 'quarantinedisasters', '', '2011', '', '35', '', '417-442crossrefpubmedscopus', '', '8', '', 'stigma', 'others', 'major', 'theme', 'throughout', 'literature', '', 'often', 'continue', 'time', 'quarantine', '', 'containment', 'outbreak', '', 'comparison', 'health-care', 'worker', 'quarantine', 'versus', 'quarantined9bai', 'lin', 'c-c', 'lin', 'c-y', 'chen', 'j-y', 'chue', 'c-m', 'chou', 'p', 'survey', 'stress', 'reaction', 'among', 'health', 'care', 'worker', 'involve', 'sars', 'outbreakpsychiatr', 'serv', '', '2004', '', '55', '', '1055-1057crossrefpubmedscopus', '', '39', '', 'quarantine', 'participant', 'significantly', 'likely', 'report', 'stigmatisation', 'rejection', 'people', 'local', 'neighbourhood', '', 'suggest', 'stigma', 'specifically', 'surround', 'people', 'quarantine', '', 'participants', 'several', 'study', 'report', 'others', 'treat', 'differently', '', 'avoid', '', 'withdraw', 'social', 'invitation', '', 'treat', 'fear', 'suspicion', '', 'critical', 'comments13cava', 'fay', 'ke', 'beanlands', 'hj', 'mccay', 'ea', 'wignall', 'r', 'experience', 'quarantine', 'individual', 'affect', 'sars', 'torontopublic', 'health', 'nurs', '', '2005', '', '22', '', '398-406crossrefpubmedscopus', '', '18', '', '', '14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', '', '15digiovanni', 'c', 'conley', 'j', 'chiu', 'zaborski', 'j', 'factors', 'influence', 'compliance', 'quarantine', 'toronto', '2003', 'sars', 'outbreakbiosecur', 'bioterror', '', '2004', '', '2', '', '265-272crossrefpubmedscopus', '', '40', '', '', '16hawryluck', 'l', 'gold', 'wl', 'robinson', 'pogorski', 'galea', 'styra', 'r', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerg', 'infect', 'dis', '', '2004', '', '10', '', '1206-1212crossrefpubmedscopus', '', '93', '', '', '18lee', 'chan', 'ly', 'chau', 'kwok', 'kp', 'kleinman', 'experience', 'sars-related', 'stigma', 'amoy', 'gardenssoc', 'sci', 'med', '', '2005', '', '61', '', '2038-2046crossrefpubmedscopus', '', '31', '', '', '21maunder', 'r', 'hunter', 'j', 'vincent', 'l', 'althe', 'immediate', 'psychological', 'occupational', 'impact', '2003', 'sars', 'outbreak', 'teach', 'hospitalcmaj', '', '2003', '', '168', '', '1245-1251pubmedgoogle', '', '23pan', 'pjd', 'chang', 's-h', 'yu', 'y-y', 'support', 'group', 'home-quarantined', 'college', 'student', 'expose', 'sars', '', 'learn', 'practicej', 'spec', 'group', 'work', '', '2005', '', '30', '', '363-374crossrefscopus', '', '4', '', '', '24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', '', '25reynolds', 'dl', 'garay', 'jr', 'deamond', 'sl', 'moran', 'mk', 'gold', 'w', 'styra', 'r', 'understanding', '', 'compliance', 'psychological', 'impact', 'sars', 'quarantine', 'experienceepidemiol', 'infect', '', '2008', '', '136', '', '997-1007crossrefpubmedscopus', '', '18', '', '', '26robertson', 'e', 'hershenfield', 'k', 'grace', 'sl', 'stewart', 'de', 'psychosocial', 'effect', 'quarantine', 'follow', 'exposure', 'sars', '', 'qualitative', 'study', 'toronto', 'health', 'care', 'workerscan', 'j', 'psychiatry', '', '2004', '', '49', '', '403-407crossrefpubmedscopus', '', '34', '', '', '30wester', 'giesecke', 'j', 'ebola', 'healthcare', 'worker', 'stigmascand', 'j', 'public', 'health', '', '2019', '', '47', '', '99-104crossrefpubmedscopus', '', '2', '', '', '31wilken', 'ja', 'pordell', 'p', 'goode', 'b', 'alknowledge', '', 'attitude', '', 'practice', 'among', 'member', 'household', 'actively', 'monitor', 'quarantine', 'prevent', 'transmission', 'ebola', 'virus', 'diseasemargibi', 'county', '', 'liberia', '', 'februarymarch', '2015prehosp', 'disaster', 'med', '', '2017', '', '32', '', '673-678crossrefpubmedscopus', '', '3', '', 'several', 'health-care', 'worker', 'involve', 'ebola', 'outbreak', 'senegal', 'report', 'quarantine', 'lead', 'family', 'consider', 'job', 'risky', '', 'create', 'intra-household', 'tension14desclaux', 'badji', 'ndione', 'ag', 'sow', 'k', 'accepted', 'monitor', 'endure', 'quarantine', '', 'ebola', 'contact', '', 'perception', 'senegalsoc', 'sci', 'med', '', '2017', '', '178', '', '38-45crossrefpubmedscopus', '', '5', '', 'study', '', 'three', 'participant', 'report', 'unable', 'resume', 'job', 'surveillance', 'end', 'employer', 'express', 'fear', 'contagion', '', 'quarantine', 'ebola', 'epidemic', 'liberia', 'report', 'stigma', 'lead', 'disenfranchisement', 'minority', 'group', 'community', 'family', 'quarantine', 'often', 'belong', 'different', 'ethnic', 'group', '', 'tribe', '', 'religion', 'perceive', 'dangerous', 'different24pellecchia', 'u', 'crestani', 'r', 'decroo', 'van', 'den', 'bergh', 'r', 'al-kourdi', 'social', 'consequence', 'ebola', 'containment', 'measure', 'liberiaplos', 'one', '', '2015', '', '10', '', 'e0143036crossrefpubmedscopus', '', '23', '', 'perhaps', 'stigma', '', 'quarantine', 'lead', 'participant', 'study', 'keep', 'treatable', '', 'non-ebola', 'illness', 'secret', 'avoid', 'seek', 'help', '', 'general', 'education', 'disease', 'rationale', 'quarantine', 'public', 'health', 'information', 'provide', 'general', 'public', 'beneficial', 'reduce', 'stigmatisation', '', 'whereas', 'detail', 'information', 'target', 'school', 'workplace', 'useful', '', 'medium', 'report', 'contribute', 'stigmatise', 'attitude', 'general', 'public', '', 'medium', 'powerful', 'influence', 'public', 'attitude', 'dramatic', 'headline', 'fear', 'monger', 'show', 'contribute', 'stigmatise', 'attitude', 'past', '', 'eg', '', 'sars', 'outbreak', '', '36person', 'b', 'sy', 'f', 'holton', 'k', 'alfear', 'stigma', '', 'epidemic', 'within', 'sars', 'outbreakemerg', 'infect', 'dis', '', '2004', '', '10', '', '358-363crossrefpubmedscopus', '', '70', '', 'issue', 'highlight', 'public', 'health', 'official', 'provide', 'rapid', '', 'clear', 'message', 'deliver', 'effectively', 'entire', 'affect', 'population', 'promote', 'accurate', 'understand', 'situation', '', 'major', 'infectious', 'disease', 'outbreak', '', 'quarantine', 'necessary', 'preventive', 'measure', '', 'however', '', 'review', 'suggest', 'quarantine', 'often', 'associate', 'negative', 'psychological', 'effect', '', 'period', 'quarantine', 'negative', 'psychological', 'effect', 'unsurprising', '', 'yet', 'evidence', 'psychological', 'effect', 'quarantine', 'still', 'detect', 'month', 'year', 'lateralbeit', 'small', 'number', 'studies17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', '', '19liu', 'x', 'kakade', 'fuller', 'cj', 'aldepression', 'exposure', 'stressful', 'event', '', 'lesson', 'learn', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemiccompr', 'psychiatry', '', '2012', '', '53', '', '15-23crossrefpubmedscopus', '', '6', '', 'trouble', 'suggest', 'ensure', 'effective', 'mitigation', 'measure', 'put', 'place', 'part', 'quarantine', 'plan', 'process', '', 'regard', '', 'result', 'provide', 'strong', 'evidence', 'particular', 'demographic', 'factor', 'risk', 'factor', 'poor', 'psychological', 'outcome', 'quarantine', 'therefore', 'require', 'specific', 'attention', '', 'however', '', 'history', 'mental', 'illness', 'examine', 'risk', 'factor', 'one', 'study', '', 'previous', 'literature', 'suggest', 'psychiatric', 'history', 'associate', 'psychological', 'distress', 'experience', 'disaster-related', 'trauma37alvarez', 'j', 'hunt', 'risk', 'resilience', 'canine', 'search', 'rescue', 'handler', '911j', 'trauma', 'stress', '', '2005', '', '18', '', '497-505crossrefpubmedscopus', '', '40', '', '', '38cukor', 'j', 'wyka', 'k', 'jayasinghe', 'n', 'alprevalence', 'predictor', 'posttraumatic', 'stress', 'symptom', 'utility', 'worker', 'deploy', 'world', 'trade', 'center', 'follow', 'attack', 'september', '11', '', '2001depress', 'anxiety', '', '2011', '', '28', '', '210-217crossrefpubmedscopus', '', '34', '', 'likely', 'people', 'pre-existing', 'poor', 'mental', 'health', 'extra', 'support', 'quarantine', '', 'appear', 'high', 'prevalence', 'psychological', 'distress', 'quarantine', 'health-care', 'worker', '', 'although', 'mix', 'evidence', 'whether', 'group', 'higher', 'risk', 'distress', 'non-health-care', 'worker', 'quarantine', '', 'health-care', 'worker', '', 'support', 'manager', 'essential', 'facilitate', 'return', 'work39brooks', 'sk', 'dunn', 'r', 'amlt', 'r', 'rubin', 'gj', 'greenberg', 'n', 'systematic', '', 'thematic', 'review', 'social', 'occupational', 'factor', 'associate', 'psychological', 'outcome', 'healthcare', 'employee', 'infectious', 'disease', 'outbreakj', 'occup', 'environ', 'med', '', '2018', '', '60', '', '248-257crossrefpubmedscopus', '', '3', '', 'manager', 'aware', 'potential', 'risk', 'staff', 'quarantine', 'prepare', 'early', 'intervention', '', 'longer', 'quarantine', 'associate', 'poorer', 'psychological', 'outcome', '', 'perhaps', 'unsurprisingly', '', 'stand', 'reason', 'stressor', 'report', 'participant', 'effect', 'longer', 'experience', '', 'restricting', 'length', 'quarantine', 'scientifically', 'reasonable', 'give', 'duration', 'incubation', 'period', '', 'adopt', 'overly', 'precautionary', 'approach', '', 'minimise', 'effect', 'people', '', 'evidence', 'elsewhere', 'emphasis', 'importance', 'authority', 'adhere', 'recommend', 'length', 'quarantine', '', 'extend', '', 'people', 'already', 'quarantine', '', 'extension', '', 'matter', 'small', '', 'likely', 'exacerbate', 'sense', 'frustration', 'demoralisation40rona', 'rj', 'fear', 'nt', 'hull', 'l', 'almental', 'health', 'consequence', 'overstretch', 'uk', 'arm', 'force', '', 'first', 'phase', 'cohort', 'studybmj', '', '2007', '', '335', '', '603crossrefpubmedscopus', '', '100', '', 'imposing', 'cordon', 'indefinitely', 'whole', 'city', 'clear', 'time', 'limit', '', 'wuhan', '', 'china', '', 'detrimental', 'strictly', 'apply', 'quarantine', 'procedure', 'limit', 'period', 'incubation', '', 'people', 'quarantine', 'often', 'fear', 'infect', 'infect', 'others', '', 'often', 'catastrophic', 'appraisal', 'physical', 'symptom', 'experience', 'quarantine', 'period', '', 'fear', 'common', 'occurrence', 'people', 'expose', 'worry', 'infectious', 'disease41rubin', 'gj', 'harper', 'williams', 'pd', 'alhow', 'support', 'staff', 'deploy', 'overseas', 'humanitarian', 'work', '', 'qualitative', 'analysis', 'responder', 'view', '201415', 'west', 'african', 'ebola', 'outbreakeur', 'j', 'psychotraumatol', '', '2016', '', '7', '', '30933crossrefpubmedscopus', '', '8', '', 'exacerbate', 'often', 'inadequate', 'information', 'participant', 'report', 'receive', 'public', 'health', 'official', 'leave', 'unclear', 'nature', 'risk', 'face', 'quarantine', '', 'ensuring', 'quarantine', 'understand', 'disease', 'question', '', 'reason', 'quarantine', '', 'priority', '', 'officials', 'ensure', 'quarantine', 'household', 'enough', 'supply', 'basic', '', 'importantly', '', 'must', 'provide', 'rapidly', 'possible', '', 'coordination', 'provision', 'supply', 'ideally', 'occur', 'advance', '', 'conservation', 'reallocation', 'plan', 'establish', 'ensure', 'resource', '', 'unfortunately', 'reported2manuell', 'm-e', 'cukor', 'j', 'mother', 'nature', 'versus', 'human', 'nature', '', 'public', 'compliance', 'evacuation', 'quarantinedisasters', '', '2011', '', '35', '', '417-442crossrefpubmedscopus', '', '8', '', 'boredom', 'isolation', 'cause', 'distress', '', 'people', 'quarantine', 'advise', 'stave', 'boredom', 'provide', 'practical', 'advice', 'cop', 'stress', 'management', 'technique', '', 'work', 'mobile', 'phone', 'necessity', '', 'luxury', '', 'step', 'long', 'flight', 'enter', 'quarantine', 'probably', 'welcome', 'charger', 'adaptor', 'anything', 'else17jeong', 'h', 'yim', 'hw', 'song', 'y-j', 'almental', 'health', 'status', 'people', 'isolate', 'due', 'middle', 'east', 'respiratory', 'syndromeepidemiol', 'health', '', '2016', '', '38', '', 'e2016048crossrefpubmedscopus', '', '12', '', 'activating', 'social', 'network', '', 'albeit', 'remotely', '', 'key', 'priority', '', 'inability', 'associate', 'immediate', 'anxiety', '', 'longer-', 'term', 'distress2manuell', 'm-e', 'cukor', 'j', 'mother', 'nature', 'versus', 'human', 'nature', '', 'public', 'compliance', 'evacuation', 'quarantinedisasters', '', '2011', '', '35', '', '417-442crossrefpubmedscopus', '', '8', '', '', '42rubin', 'gj', 'brewin', 'cr', 'greenberg', 'n', 'simpson', 'j', 'wessely', 'psychological', 'behavioural', 'reaction', 'bomb', 'london', '7', 'july', '2005', '', 'cross', 'sectional', 'survey', 'representative', 'sample', 'londonersbmj', '', '2005', '', '331', '', '606crossrefpubmedscopus', '', '154', '', 'one', 'study21maunder', 'r', 'hunter', 'j', 'vincent', 'l', 'althe', 'immediate', 'psychological', 'occupational', 'impact', '2003', 'sars', 'outbreak', 'teach', 'hospitalcmaj', '', '2003', '', '168', '', '1245-1251pubmedgoogle', 'suggest', 'telephone', 'support', '', 'staff', 'psychiatric', 'nurse', '', 'set', 'specifically', 'quarantine', 'effective', 'term', 'provide', 'social', 'network', '', 'ability', 'communicate', 'one', 'family', 'friend', 'essential', '', 'particularly', '', 'social', 'medium', 'play', 'important', 'part', 'communication', 'far', 'away', '', 'allow', 'people', 'quarantine', 'update', 'love', 'one', 'situation', 'reassure', 'well', '', 'therefore', '', 'provide', 'quarantine', 'mobile', 'phone', '', 'cord', 'outlet', 'charge', 'device', '', 'robust', 'wifi', 'network', 'internet', 'access', 'allow', 'communicate', 'directly', 'love', 'one', 'reduce', 'feel', 'isolation', '', 'stress', '', 'panic2manuell', 'm-e', 'cukor', 'j', 'mother', 'nature', 'versus', 'human', 'nature', '', 'public', 'compliance', 'evacuation', 'quarantinedisasters', '', '2011', '', '35', '', '417-442crossrefpubmedscopus', '', '8', '', 'although', 'possible', 'achieve', 'enforce', 'quarantine', '', 'difficult', 'case', 'widespread', 'home', 'quarantine', '', 'country', 'impose', 'censor', 'social', 'medium', 'message', 'application', 'present', 'difficulty', 'ensure', 'communication', 'quarantine', 'love', 'one', '', 'important', 'public', 'health', 'official', 'maintain', 'clear', 'communication', 'people', 'quarantine', 'experience', 'symptom', '', 'phone', 'online', 'service', 'specifically', 'set', 'quarantine', 'staff', 'health-care', 'worker', 'provide', 'instruction', 'event', 'develop', 'illness', 'symptom', '', 'help', 'reassure', 'people', 'care', 'become', 'ill', '', 'service', 'show', 'quarantine', 'forget', 'health', 'important', 'wider', 'public', '', 'benefit', 'resource', 'study', '', 'likely', 'reassurance', 'subsequently', 'decrease', 'feel', 'fear', '', 'worry', '', 'anger', '', 'evidence', 'suggest', 'support', 'group', 'specifically', 'people', 'quarantine', 'home', 'disease', 'outbreak', 'helpful', '', 'one', 'study23pan', 'pjd', 'chang', 's-h', 'yu', 'y-y', 'support', 'group', 'home-quarantined', 'college', 'student', 'expose', 'sars', '', 'learn', 'practicej', 'spec', 'group', 'work', '', '2005', '', '30', '', '363-374crossrefscopus', '', '4', '', 'find', 'group', 'feel', 'connect', 'others', 'situation', 'validate', '', 'empower', 'experience', 'provide', 'people', 'support', 'find', 'receive', 'people', '', 'health-care', 'worker', 'often', 'quarantine', 'review', 'suggest', '', 'like', 'general', 'public', '', 'negatively', 'affect', 'stigmatise', 'attitude', 'others', '', 'none', 'study', 'include', 'review', 'focus', 'perception', 'colleague', '', 'interest', 'aspect', 'explore', '', 'possible', 'health-care', 'worker', 'quarantine', 'concern', 'cause', 'workplace', 'understaffed', 'cause', 'extra', 'work', 'colleagues21maunder', 'r', 'hunter', 'j', 'vincent', 'l', 'althe', 'immediate', 'psychological', 'occupational', 'impact', '2003', 'sars', 'outbreak', 'teach', 'hospitalcmaj', '', '2003', '', '168', '', '1245-1251pubmedgoogle', 'colleague', '', 'perception', 'particularly', 'important', '', 'separate', 'team', 'work', 'close', 'contact', 'add', 'feel', 'isolation', 'health-care', 'worker', 'quarantine', '', 'therefore', '', 'essential', 'feel', 'support', 'immediate', 'colleague', '', 'infectious', 'disease', 'outbreak', '', 'organisational', 'support', 'find', 'protective', 'mental', 'health', 'health-care', 'staff', 'general39brooks', 'sk', 'dunn', 'r', 'amlt', 'r', 'rubin', 'gj', 'greenberg', 'n', 'systematic', '', 'thematic', 'review', 'social', 'occupational', 'factor', 'associate', 'psychological', 'outcome', 'healthcare', 'employee', 'infectious', 'disease', 'outbreakj', 'occup', 'environ', 'med', '', '2018', '', '60', '', '248-257crossrefpubmedscopus', '', '3', '', 'manager', 'step', 'ensure', 'staff', 'member', 'supportive', 'colleague', 'quarantine', '', 'perhaps', 'difficulty', 'design', 'appropriate', 'study', '', 'research', 'find', 'test', 'whether', 'mandatory', 'versus', 'voluntary', 'quarantine', 'differential', 'effect', 'wellbeing', '', 'context', '', 'however', '', 'feel', 'others', 'benefit', 'one', 'situation', 'stressful', 'situation', 'easier', 'bear', 'likely', 'true', 'home-based', 'quarantine', '', 'reinforcing', 'quarantine', 'help', 'keep', 'others', 'safe', '', 'include', 'particularly', 'vulnerable', '', 'young', '', 'old', '', 'pre-existing', 'serious', 'medical', 'condition', '', '', 'health', 'authority', 'genuinely', 'grateful', '', 'help', 'reduce', 'mental', 'health', 'effect', 'adherence', 'quarantined19liu', 'x', 'kakade', 'fuller', 'cj', 'aldepression', 'exposure', 'stressful', 'event', '', 'lesson', 'learn', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemiccompr', 'psychiatry', '', '2012', '', '53', '', '15-23crossrefpubmedscopus', '', '6', '', '', '33wu', 'p', 'fang', 'guan', 'z', 'althe', 'psychological', 'impact', 'sars', 'epidemic', 'hospital', 'employee', 'china', '', 'exposure', '', 'risk', 'perception', '', 'altruistic', 'acceptance', 'riskcan', 'j', 'psychiatry', '', '2009', '', '54', '', '302-311crossrefpubmedscopus', '', '33', '', 'notably', '', 'altruism', 'limit', 'people', 'ask', 'quarantine', 'without', 'adequate', 'information', 'keep', 'people', 'live', 'safe', '', 'unacceptable', 'ask', 'people', 'self-quarantine', 'benefit', 'community', 'health', '', 'put', 'love', 'one', 'risk', '', 'quarantine', 'one', 'several', 'public', 'health', 'measure', 'prevent', 'spread', 'infectious', 'disease', 'show', 'review', '', 'considerable', 'psychological', 'impact', 'affect', '', '', 'question', 'whether', 'public', 'health', 'measure', 'prevent', 'impose', 'quarantine', '', 'social', 'distance', '', 'cancellation', 'mass', 'gather', '', 'school', 'closure', '', 'favourable', '', 'future', 'research', 'establish', 'effectiveness', 'measure', '', 'strength', 'limitation', 'review', 'must', 'consider', '', 'time', 'constraint', 'review', 'give', 'ongoing', 'coronavirus', 'outbreak', '', 'review', 'literature', 'undergo', 'formal', 'quality', 'appraisal', '', 'additionally', '', 'review', 'limit', 'peer-reviewed', 'publication', 'explore', 'potentially', 'relevant', 'grey', 'literature', '', 'recommendation', 'apply', 'primarily', 'small', 'group', 'people', 'dedicate', 'facility', 'extent', 'self-isolation', '', 'although', 'anticipate', 'risk', 'factor', 'poor', 'psychosocial', 'outcome', 'larger', 'containment', 'process', '', 'entire', 'town', 'city', '', '', 'likely', 'distinct', 'difference', 'situation', 'mean', 'information', 'present', 'review', 'apply', 'situation', 'cautiously', '', 'furthermore', '', 'potential', 'cultural', 'difference', 'consider', '', 'although', 'review', 'predict', 'exactly', 'happen', 'provide', 'recommendation', 'work', 'every', 'future', 'population', 'quarantine', '', 'provide', 'overview', 'key', 'issue', 'rectify', 'future', '', 'several', 'limitation', 'review', 'literature', '', 'must', 'point', '', 'one', 'study', 'follow', 'participant', 'time', '', 'sample', 'size', 'generally', 'small', '', 'study', 'directly', 'compare', 'participant', 'quarantine', 'quarantine', '', 'conclusion', 'base', 'certain', 'study', 'population', '', 'eg', '', 'student', '', 'generalisable', 'wider', 'public', '', 'heterogeneity', 'outcome', 'measure', 'across', 'study', 'difficult', 'direct', 'comparison', 'study', '', 'worth', 'point', 'minority', 'study', 'assess', 'symptom', 'post-traumatic', 'stress', 'measure', 'design', 'measure', 'post-traumatic', 'stress', 'disorder', '', 'despite', 'quarantine', 'qualify', 'trauma', 'diagnosis', 'post-traumatic', 'stress', 'disorder', 'diagnostic', 'statistical', 'manual', 'mental', 'disorders', '543american', 'psychiatric', 'associationdiagnostic', 'statistical', 'manual', 'mental', 'disorder', '', 'dsm-5', '', 'american', 'psychiatric', 'association', '', 'arlington', '', 'va2013crossrefgoogle', 'strengths', 'review', 'include', 'hand-searching', 'reference', 'list', 'identify', 'paper', 'find', 'initial', 'search', '', 'contact', 'author', 'send', 'full-texts', 'paper', 'available', 'full', 'online', '', 'multiple', 'researcher', 'carry', 'screen', 'improve', 'rigour', 'review', '', 'overall', '', 'review', 'suggest', 'psychological', 'impact', 'quarantine', 'wide-ranging', '', 'substantial', '', 'long', 'last', '', 'suggest', 'quarantine', '', 'psychological', 'effect', 'quarantine', 'allow', 'disease', 'spread', 'worse44hull', 'hf', 'sars', 'control', 'psychological', 'effect', 'quarantine', '', 'toronto', '', 'canadaemerging', 'infectious', 'diseases', '', '2005', '', '11', '', '354-355crossrefpubmedgoogle', 'however', '', 'deprive', 'people', 'liberty', 'wider', 'public', 'often', 'contentious', 'handle', 'carefully', '', 'quarantine', 'essential', '', 'result', 'suggest', 'official', 'every', 'measure', 'ensure', 'experience', 'tolerable', 'possible', 'people', '', 'achieve', '', 'tell', 'people', 'happen', '', 'explain', 'long', 'continue', '', 'provide', 'meaningful', 'activity', 'quarantine', '', 'provide', 'clear', 'communication', '', 'ensure', 'basic', 'supply', '', 'food', '', 'water', '', 'medical', 'supply', '', 'available', '', 'reinforce', 'sense', 'altruism', 'people', '', 'rightly', '', 'feel', '', 'health', 'official', 'charge', 'implement', 'quarantine', '', 'definition', 'employment', 'usually', 'reasonable', 'job', 'security', '', 'remember', 'everyone', 'situation', '', 'quarantine', 'experience', 'negative', '', 'result', 'review', 'suggest', 'long-term', 'consequence', 'affect', 'people', 'quarantine', 'health-care', 'system', 'administer', 'quarantine', 'politician', 'public', 'health', 'official', 'mandate', '', 'search', 'strategy', 'design', 'inform', 'review', 'second', 'review', 'publish', 'elsewhere', 'relate', 'adherence', 'quarantine', '', 'search', 'medline', '', 'psycinfo', '', 'web', 'science', '', 'full', 'list', 'search', 'term', 'find', 'appendix', '', 'brief', '', 'combination', 'term', 'relate', 'quarantine', '', 'eg', '', '', 'quarantine', '', '', 'patient', 'isolation', '', '', 'psychological', 'outcome', '', 'eg', '', '', 'psych', '', '', 'stigma', '', '', '', 'study', 'include', 'review', '', 'report', 'primary', 'research', '', 'publish', 'peer-reviewed', 'journal', '', 'write', 'english', 'italian', '', 'language', 'speak', 'current', 'author', '', '', 'include', 'participant', 'ask', 'enter', 'quarantine', 'outside', 'hospital', 'environment', 'least', '24', 'hour', '', 'include', 'data', 'prevalence', 'mental', 'illness', 'psychological', 'wellbeing', '', 'factor', 'associate', 'mental', 'illness', 'psychological', 'wellbeing', '', 'ie', '', 'predictor', 'psychological', 'wellbeing', 'quarantine', '', '', 'initial', 'search', 'yield', '3166', 'paper', '', '24', 'include', 'relevant', 'data', 'include', 'review', '', 'screen', 'process', 'illustrate', 'figure', '', 'search', 'strategy', 'design', 'inform', 'review', 'second', 'review', 'publish', 'elsewhere', 'relate', 'adherence', 'quarantine', '', 'search', 'medline', '', 'psycinfo', '', 'web', 'science', '', 'full', 'list', 'search', 'term', 'find', 'appendix', '', 'brief', '', 'combination', 'term', 'relate', 'quarantine', '', 'eg', '', '', 'quarantine', '', '', 'patient', 'isolation', '', '', 'psychological', 'outcome', '', 'eg', '', '', 'psych', '', '', 'stigma', '', '', '', 'study', 'include', 'review', '', 'report', 'primary', 'research', '', 'publish', 'peer-reviewed', 'journal', '', 'write', 'english', 'italian', '', 'language', 'speak', 'current', 'author', '', '', 'include', 'participant', 'ask', 'enter', 'quarantine', 'outside', 'hospital', 'environment', 'least', '24', 'hour', '', 'include', 'data', 'prevalence', 'mental', 'illness', 'psychological', 'wellbeing', '', 'factor', 'associate', 'mental', 'illness', 'psychological', 'wellbeing', '', 'ie', '', 'predictor', 'psychological', 'wellbeing', 'quarantine', '', '', 'initial', 'search', 'yield', '3166', 'paper', '', '24', 'include', 'relevant', 'data', 'include', 'review', '', 'screen', 'process', 'illustrate', 'figure', '', 'contributors', 'gjr', 'design', 'search', 'strategy', 'input', 'skb', '', 'rkw', '', 'les', '', 'skb', '', 'rkw', '', 'les', '', 'lw', 'carry', 'literature', 'search', 'screen', '', 'discrepancy', 'discuss', 'gjr', 'sw', 'skb', 'carry', 'data', 'extraction', '', 'skb', 'write', 'first', 'draft', 'review', 'input', 'rkw', '', 'les', '', 'lw', '', 'sw', '', 'ng', '', 'gjr', '', 'declaration', 'interest', 'declare', 'compete', 'interest', '', 'acknowledgments', 'research', 'fund', 'national', 'institute', 'health', 'research', '', 'nihr', '', 'health', 'protection', 'research', 'unit', 'emergency', 'preparedness', 'response', 'king', 'college', 'london', '', 'partnership', 'public', 'health', 'england', '', 'collaboration', 'university', 'east', 'anglia', 'newcastle', 'university', '', 'view', 'express', 'author', '', '', 'necessarily', 'national', 'health', 'service', '', 'nihr', '', 'department', 'health', 'social', 'care', '', 'public', 'health', 'england', '', 'editorial', 'note', '', 'lancet', 'group', 'neutral', 'position', 'respect', 'territorial', 'claim', 'publish', 'table', '', 'download', 'pdf', '', '08', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix']",9176,"{'': 1801, 'quarantine': 239, 'sars': 109, 'health': 107, 'psychological': 88, 'r': 65, 'public': 60, 'j': 58, 'people': 52, 'study': 45, '2004': 41, 'effect': 40, 'ebola': 39, 'report': 38, 'review': 37, 'stress': 37, 'toronto': 36, 'infect': 33, 'outbreak': 32, 'symptom': 32}",{'infection': 5},5,0.5267
DOI:10.1016/S0140-6736(20)31097-7,10.1016/S0140-6736(20)31097-7,World Report,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['new', 'zealand', 'eliminate', 'covid-19']","['An aggressive approach enable New Zealand end community transmission SARS-CoV-2 .', 'Sophie Cousins report .', 'New Zealand record first day new case coronavirus disease 2019 ( COVID-19 ) early week , month strict lockdown begin .', 'At time publication , New Zealand record fewer 1500 confirm case COVID-19 , 20 death .', 'On March 23 , month country record first case , New Zealand commit elimination strategy .', 'A day later , Prime Minister Jacinda Ardern announce strict national lockdown 102 case zero death .', 'Her swift decision make international praise , include WHO .', ""New Zealand 's decision pursue elimination approach vastly different approach usual pandemic plan , historically base mitigation model focus delay arrival virus , follow range measure flatten curve case death ."", ""Michael Baker , professor University Otago 's department public health Wellington , advise New Zealand Government response , say implement full lockdown—involving closure school non-essential workplace , ban social gather , severe travel restrictions—enabled country consider elimination ."", '“ I think right decision ; go hard ” , say .', '“ The two biggest benefit pursue elimination strategy case death get business back run .', 'The alternative stick virus stick mitigation suppression .', 'Suppression pretty grim. ” While strategy critic , Baker , evidence overwhelm elimination could achieve .', 'Baker say full lockdown allow country get key system run effectively manage border , contact trace , test , surveillance .', 'Since Jan 22 , 150 000 people test country 5 million .', 'Testing focus people symptom , trace close contact casual contact .', 'However , widespread test introduce .', 'The Ministry Health discussion district arrange test specific community higher risk acquire virus age residential care health-care worker .', 'Testing sample sewerage also consider monitor control elimination .', 'The response also one place science , leadership , careful language forefront .', ""Siouxsie Wiles , associate professor head Bioluminescent Superbugs Lab University Auckland , say one country 's key success way COVID-19 frame general population ."", '“ In country , people talk war battle , put people negative fearful frame mind ” , say .', '“ The official response guide principle stigmatise unite COVID-19. ” Ardern regularly appear social medium , smile share part personal life lockdown without underplay seriousness situation , help build public trust .', 'Baker agree language crucial part response .', 'He say country communicate concept elimination important go forward .', 'Wiles agree .', ""“ We n't want public feel like lie ."", 'Elimination everyone mean go .', 'But epidemiological term , mean bring case zero near zero geographical location .', 'We still see cases…but case people arrive overseas. ” Travellers abroad quarantine part effort prevent transmission New Zealand .', 'As New Zealand eas restriction economy slowly reopen , discussion open border ensure everyone protect , particularly susceptible population .', 'Australia , similar success New Zealand publicly float idea elimination , discussion neighbour reopen travel two country .', 'Baker envision , time , small number country region reach agreement enable travel specific control measure place .', 'Officials plead vigilance breach shutdown rule continue rise .', 'When country loosen restriction last week , fast-food outlet run food people flock huge number get burger fry .', '“ We nearly .', 'We finish line yet ” , Wiles say .', ""“ We wo n't see successful week yet . ”""]","['aggressive', 'approach', 'enable', 'new', 'zealand', 'end', 'community', 'transmission', 'sars-cov-2', '', 'sophie', 'cousins', 'report', '', 'new', 'zealand', 'record', 'first', 'day', 'new', 'case', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'early', 'week', '', 'month', 'strict', 'lockdown', 'begin', '', 'time', 'publication', '', 'new', 'zealand', 'record', 'fewer', '1500', 'confirm', 'case', 'covid-19', '', '20', 'death', '', 'march', '23', '', 'month', 'country', 'record', 'first', 'case', '', 'new', 'zealand', 'commit', 'elimination', 'strategy', '', 'day', 'later', '', 'prime', 'minister', 'jacinda', 'ardern', 'announce', 'strict', 'national', 'lockdown', '102', 'case', 'zero', 'death', '', 'swift', 'decision', 'international', 'praise', '', 'include', '', 'new', 'zealand', 'decision', 'pursue', 'elimination', 'approach', 'vastly', 'different', 'approach', 'usual', 'pandemic', 'plan', '', 'historically', 'base', 'mitigation', 'model', 'focus', 'delay', 'arrival', 'virus', '', 'follow', 'range', 'measure', 'flatten', 'curve', 'case', 'death', '', 'michael', 'baker', '', 'professor', 'university', 'otago', 'department', 'public', 'health', 'wellington', '', 'advise', 'new', 'zealand', 'government', 'response', '', 'implement', 'full', 'lockdowninvolving', 'closure', 'school', 'non-essential', 'workplace', '', 'ban', 'social', 'gather', '', 'severe', 'travel', 'restrictionsenabled', 'country', 'consider', 'elimination', '', '', 'decision', '', 'hard', '', '', '', '', 'two', 'biggest', 'benefit', 'pursue', 'elimination', 'strategy', 'case', 'death', 'business', 'back', '', 'alternative', 'stick', 'virus', 'stick', 'mitigation', 'suppression', '', 'suppression', 'pretty', 'grim', '', 'strategy', 'critic', '', 'baker', '', 'evidence', 'overwhelm', 'elimination', 'achieve', '', 'baker', 'full', 'lockdown', 'allow', 'country', 'key', 'system', 'effectively', 'manage', 'border', '', 'contact', 'trace', '', 'test', '', 'surveillance', '', 'since', 'jan', '22', '', '150', '000', 'people', 'test', 'country', '5', 'million', '', 'testing', 'focus', 'people', 'symptom', '', 'trace', 'close', 'contact', 'casual', 'contact', '', 'however', '', 'widespread', 'test', 'introduce', '', 'ministry', 'health', 'discussion', 'district', 'arrange', 'test', 'specific', 'community', 'higher', 'risk', 'acquire', 'virus', 'age', 'residential', 'care', 'health-care', 'worker', '', 'testing', 'sample', 'sewerage', 'consider', 'monitor', 'control', 'elimination', '', 'response', 'one', 'place', 'science', '', 'leadership', '', 'careful', 'language', 'forefront', '', 'siouxsie', 'wiles', '', 'associate', 'professor', 'head', 'bioluminescent', 'superbugs', 'lab', 'university', 'auckland', '', 'one', 'country', 'key', 'success', 'way', 'covid-19', 'frame', 'general', 'population', '', '', 'country', '', 'people', 'talk', 'war', 'battle', '', 'put', 'people', 'negative', 'fearful', 'frame', 'mind', '', '', '', '', 'official', 'response', 'guide', 'principle', 'stigmatise', 'unite', 'covid-19', '', 'ardern', 'regularly', 'appear', 'social', 'medium', '', 'smile', 'share', 'part', 'personal', 'life', 'lockdown', 'without', 'underplay', 'seriousness', 'situation', '', 'help', 'build', 'public', 'trust', '', 'baker', 'agree', 'language', 'crucial', 'part', 'response', '', 'country', 'communicate', 'concept', 'elimination', 'important', 'forward', '', 'wiles', 'agree', '', '', 'nt', 'public', 'feel', 'like', 'lie', '', 'elimination', 'everyone', 'mean', '', 'epidemiological', 'term', '', 'mean', 'bring', 'case', 'zero', 'near', 'zero', 'geographical', 'location', '', 'still', 'casesbut', 'case', 'people', 'arrive', 'overseas', '', 'travellers', 'abroad', 'quarantine', 'part', 'effort', 'prevent', 'transmission', 'new', 'zealand', '', 'new', 'zealand', 'eas', 'restriction', 'economy', 'slowly', 'reopen', '', 'discussion', 'open', 'border', 'ensure', 'everyone', 'protect', '', 'particularly', 'susceptible', 'population', '', 'australia', '', 'similar', 'success', 'new', 'zealand', 'publicly', 'float', 'idea', 'elimination', '', 'discussion', 'neighbour', 'reopen', 'travel', 'two', 'country', '', 'baker', 'envision', '', 'time', '', 'small', 'number', 'country', 'region', 'reach', 'agreement', 'enable', 'travel', 'specific', 'control', 'measure', 'place', '', 'officials', 'plead', 'vigilance', 'breach', 'shutdown', 'rule', 'continue', 'rise', '', 'country', 'loosen', 'restriction', 'last', 'week', '', 'fast-food', 'outlet', 'food', 'people', 'flock', 'huge', 'number', 'burger', 'fry', '', '', 'nearly', '', 'finish', 'yet', '', '', 'wiles', '', '', 'wo', 'nt', 'successful', 'week', 'yet', '', '']",502,"{'': 96, 'new': 10, 'country': 10, 'zealand': 9, 'elimination': 9, 'case': 8, 'people': 6, 'baker': 5, 'covid-19': 4, 'lockdown': 4, 'death': 4, 'response': 4, 'test': 4, 'approach': 3, 'record': 3, 'week': 3, 'strategy': 3, 'zero': 3, 'decision': 3, 'virus': 3}",{'sars-cov-2': 1},1,-0.1531
DOI:10.1016/S0140-6736(20)31035-7,10.1016/S0140-6736(20)31035-7,Correspondence,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['invisible', 'pandemic']","[""Many country ( member press medium ) marvel Sweden 's relax strategy face coronavirus disease 2019 ( COVID-19 ) pandemic : school workplace remain open , police officer check one 's errand street ."", 'Severe critic describe Sweden sacrifice ( elderly ) citizen quickly reach herd immunity.1Henley J Swedish PM warn ‘ Russian roulette-style ’ Covid-19 strategy .', 'urlplaceholder March 23 , 2020Date access : May 1 , 2020Google Scholar The death toll surpass three closest neighbour , Denmark , Norway , Finland , mortality remain lower UK , Spain , Belgium.2European Centre Disease Prevention Control urlplaceholder May 1 , 2020Date access : May 1 , 2020Google Scholar It become clear hard lockdown protect old frail people live care homes—a population lockdown design protect.3BBCCoronavirus : Hard prevent care home death , say Chris Whitty .', ""urlplaceholder April 22 , 2020Date access : May 1 , 2020Google Scholar Neither decrease mortality COVID-19 , evident compare UK 's experience European country ."", 'PCR test straightforward assumption indicate , April 29 , 2020 , half million people Stockholm county , Sweden , 20–25 % population , infect ( Hansson D , Swedish Public Health Agency , personal communication ) .', '98–99 % people probably unaware uncertain infection ; either symptom severe , severe enough go hospital get test , symptom .', 'Serology test support assumptions.4Hedberg K Var femte anställd på Danderyds sjukhus har haft smittan .', 'urlplaceholder April 27 , 2020Date access : May 1 , 2020Google Scholar These fact lead follow conclusion .', 'Everyone expose severe acute respiratory syndrome coronavirus 2 , people become infect .', 'COVID-19 spread like wildfire country , see it—it almost always spread younger people weak symptom people also mild symptom .', 'This real pandemic , go beneath surface , probably peak many European country .', 'There little prevent spread : lockdown might delay severe case , restriction ease , case reappear .', 'I expect count number death COVID-19 country 1 year , figure similar , regardless measure take .', 'Measures flatten curve might effect , lockdown push severe case future —it prevent .', 'Admittedly , country manage slow spread overburden health-care system , , yes , effective drug save life might soon develop , pandemic swift , drug develop , test , market quickly .', 'Much hope put vaccine , take time , unclear protective immunological response infection , certain vaccine effective .', 'In summary , COVID-19 disease highly infectious spread rapidly society .', 'It often quite symptomless might pas unnoticed , also cause severe disease , even death , proportion population , important task stop spread , futile , concentrate give unfortunate victim optimal care .', 'I declare compete interest .']","['country', '', 'member', 'press', 'medium', '', 'marvel', 'sweden', 'relax', 'strategy', 'face', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', '', 'school', 'workplace', 'remain', 'open', '', 'police', 'officer', 'check', 'one', 'errand', 'street', '', 'severe', 'critic', 'describe', 'sweden', 'sacrifice', '', 'elderly', '', 'citizen', 'quickly', 'reach', 'herd', 'immunity1henley', 'j', 'swedish', 'pm', 'warn', '', 'russian', 'roulette-style', '', 'covid-19', 'strategy', '', 'urlplaceholder', 'march', '23', '', '2020date', 'access', '', '1', '', '2020google', 'death', 'toll', 'surpass', 'three', 'closest', 'neighbour', '', 'denmark', '', 'norway', '', 'finland', '', 'mortality', 'remain', 'lower', 'uk', '', 'spain', '', 'belgium2european', 'centre', 'disease', 'prevention', 'control', 'urlplaceholder', '1', '', '2020date', 'access', '', '1', '', '2020google', 'become', 'clear', 'hard', 'lockdown', 'protect', 'old', 'frail', 'people', 'live', 'care', 'homesa', 'population', 'lockdown', 'design', 'protect3bbccoronavirus', '', 'hard', 'prevent', 'care', 'home', 'death', '', 'chris', 'whitty', '', 'urlplaceholder', 'april', '22', '', '2020date', 'access', '', '1', '', '2020google', 'neither', 'decrease', 'mortality', 'covid-19', '', 'evident', 'compare', 'uk', 'experience', 'european', 'country', '', 'pcr', 'test', 'straightforward', 'assumption', 'indicate', '', 'april', '29', '', '2020', '', 'half', 'million', 'people', 'stockholm', 'county', '', 'sweden', '', '2025', '', 'population', '', 'infect', '', 'hansson', '', 'swedish', 'public', 'health', 'agency', '', 'personal', 'communication', '', '', '9899', '', 'people', 'probably', 'unaware', 'uncertain', 'infection', '', 'either', 'symptom', 'severe', '', 'severe', 'enough', 'hospital', 'test', '', 'symptom', '', 'serology', 'test', 'support', 'assumptions4hedberg', 'k', 'var', 'femte', 'anstlld', 'p', 'danderyds', 'sjukhus', 'har', 'haft', 'smittan', '', 'urlplaceholder', 'april', '27', '', '2020date', 'access', '', '1', '', '2020google', 'fact', 'lead', 'follow', 'conclusion', '', 'everyone', 'expose', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'people', 'become', 'infect', '', 'covid-19', 'spread', 'like', 'wildfire', 'country', '', 'itit', 'almost', 'always', 'spread', 'younger', 'people', 'weak', 'symptom', 'people', 'mild', 'symptom', '', 'real', 'pandemic', '', 'beneath', 'surface', '', 'probably', 'peak', 'european', 'country', '', 'little', 'prevent', 'spread', '', 'lockdown', 'delay', 'severe', 'case', '', 'restriction', 'ease', '', 'case', 'reappear', '', 'expect', 'count', 'number', 'death', 'covid-19', 'country', '1', 'year', '', 'figure', 'similar', '', 'regardless', 'measure', '', 'measures', 'flatten', 'curve', 'effect', '', 'lockdown', 'push', 'severe', 'case', 'future', 'prevent', '', 'admittedly', '', 'country', 'manage', 'slow', 'spread', 'overburden', 'health-care', 'system', '', '', 'yes', '', 'effective', 'drug', 'save', 'life', 'soon', 'develop', '', 'pandemic', 'swift', '', 'drug', 'develop', '', 'test', '', 'market', 'quickly', '', 'much', 'hope', 'put', 'vaccine', '', 'time', '', 'unclear', 'protective', 'immunological', 'response', 'infection', '', 'certain', 'vaccine', 'effective', '', 'summary', '', 'covid-19', 'disease', 'highly', 'infectious', 'spread', 'rapidly', 'society', '', 'often', 'quite', 'symptomless', 'pas', 'unnoticed', '', 'cause', 'severe', 'disease', '', 'death', '', 'proportion', 'population', '', 'important', 'task', 'stop', 'spread', '', 'futile', '', 'concentrate', 'give', 'unfortunate', 'victim', 'optimal', 'care', '', 'declare', 'compete', 'interest', '']",406,"{'': 93, 'severe': 7, 'country': 6, 'covid-19': 6, '1': 6, 'people': 6, 'spread': 6, 'disease': 4, 'urlplaceholder': 4, '2020date': 4, 'access': 4, '2020google': 4, 'death': 4, 'lockdown': 4, 'test': 4, 'symptom': 4, 'sweden': 3, 'pandemic': 3, 'care': 3, 'population': 3}",{'infection': 2},2,0.1531
DOI:10.1016/S0140-6736(20)31094-1,10.1016/S0140-6736(20)31094-1,Correspondence,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['hyperinflammatory', 'shock', 'child', 'covid-19', 'pandemic']","['South Thames Retrieval Service London , UK , provide paediatric intensive care support retrieval 2 million child South East England .', 'During period 10 day mid-April , 2020 , note unprecedented cluster eight child hyperinflammatory shock , show feature similar atypical Kawasaki disease , Kawasaki disease shock syndrome,1Zhang M-M Shi L Lin Y Liu Y Clinical analysis Kawasaki disease shock syndrome.Chin Med J ( Engl ) .', '2017 ; 130 : 2891-2892CrossrefPubMedScopus ( 1 ) Google Scholar toxic shock syndrome ( typical number one two child per week ) .', 'This case cluster form basis national alert .', 'All child previously fit well .', 'Six child Afro-Caribbean descent , five child boy .', 'All child except one well 75th centile weight .', 'Four child know family exposure coronavirus disease 2019 ( COVID-19 ) .', 'Demographics , clinical find , image find , treatment , outcome cluster eight child show table.TableDemographics , clinical find , image find , treatment , outcome PICUAge ; weight ; BMI ; comorbiditiesClinical presentationOrgan supportPharmacological treatmentImaging resultsLaboratory resultsMicrobiology resultsPICU length stay ; outcomeInitialPICU referralPatient 1 ( male , AfroCaribbean ) 14 year ; 95 kg ; BMI 33 kg/m2 ; comorbidities4 day > 40°C ; 3 day non-bloody diarrhoea ; abdominal pain ; headacheBP 80/40 mmHg ; HR 120 beats/min ; RR 40 breath per min ; work breathe ; SatO2 99 % NCO2MV , RRT , VA-ECMODopamine , noradrenaline , argipressin , adrenaline milrinone , hydroxicortisone , IVIG , ceftriaxone , clindamycinRV dysfunction/elevate RVSP ; ileitis , GB oedema dilate biliary tree , ascites , bilateral basal lung consolidation diffuse nodulesFerritin 4220 μg/L ; D-dimers 13·4 mg/L ; troponin 675 ng/L ; proBNP > 35 000 ; CRP 556 mg/L ; procalcitonin > 100 μg/L ; albumin 20 g/L ; platelet 123 × 109SARS-CoV-2 positive ( post mortem ) 6 day ; demise ( right MCA ACA ischaemic infarction ) Patient 2 ( male , AfroCaribbean ) 8 year ; 30 kg ; BMI 18 kg/m2 ; comorbidities5 day > 39°C ; non-bloody diarrhoea ; abdominal pain ; conjunctivitis ; rashBP 81/37 mmHg ; HR 165 beats/min ; RR 40 breaths/min ; SVIAMVNoradrenaline , adrenaline , IVIG , infliximab , methylprednisolone , ceftriaxone , clindamycinMild biventricular dysfunction , severely dilate coronary ; ascites , pleural effusionsFerritin 277 μg/L ; D-dimers 4·8 mg/L ; troponin 25 ng/L ; CRP 295 mg/L ; procalcitonin 8·4 μg/L ; albumin 18 g/L ; platelet 61 × 109SARS-CoV-2 negative ; likely COVID-19 exposure mother4 day ; alivePatient 3 ( male , Middle-Eastern ) 4 year ; 18 kg ; BMI 17 kg/m2 ; comorbidities4 day > 39°C ; diarrhoea vomit ; abdominal pain ; rash ; conjunctivitisBP 90/30 mmHg ; HR 170 beats/min ; RR 35 breaths/min ; SVIAMVNoradrenaline , adrenaline , IVIG ceftriaxone , clindamycinAscites , pleural effusionsFerritin 574 μg/L ; D-dimers 11·7 mg/L ; tropinin 45 ng/L ; CRP 322 mg/L ; procalcitonin 10·3 μg/L ; albumin 22 g/L ; platelet 103 × 109Adenovirus positive ; HERV positive4 day ; alivePatient 4 ( female , AfroCaribbean ) 13 year ; 64 kg ; BMI 33 kg/m2 ; comorbidities5 day > 39°C ; non-bloody diarrhoea ; abdominal pain ; conjunctivitisBP 77/41 mmHg ; HR 127 beats/min ; RR 24 breaths/min ; SVIAHFNCNoradrenaline , milrinone , IVIG , ceftriaxone , clindamycinModerate-severe LV dysfunction ; ascitesFerritin 631 μg/L ; D-dimers 3·4 mg/L ; troponin 250 ng/L ; proBNP 13427 ng/L ; CRP 307 mg/L ; procalcitonin 12·1 μg/L ; albumin 21 g/L ; platelet 146 × 109SARS-CoV-2 negative5 day ; alivePatient 5 ( male , Asian ) 6 year ; 22 kg ; BMI 14 kg/m2 ; autism , ADHD4 day > 39°C ; odynophagia ; rash ; conjunctivitisBP 85/43 mmHg ; HR 150 beats/min ; RR 50 breaths/min ; SVIANIVMilrinone , IVIG , methylprednisolone , aspirin , ceftriaxoneDilated LV , AVVR , pericoronary hyperechogenicityFerritin 550 μg/L ; D-dimers 11·1 mg/L ; troponin 47 ng/L ; NT-proBNP 7004 ng/L ; CRP 183 mg/L ; albumin 24 g/L ; platelet 165 × 109SARS-CoV-2 positive ; likely COVID-19 exposure father4 day ; alivePatient 6 ( female , AfroCaribbean ) 6 year ; 26 kg ; BMI 15 kg/m2 ; comorbidities5 day > 39°C ; myalgia ; 3 day diarrhoea vomit ; conjunctivitisBP 77/46 mmHg ; HR 120 beats/min ; RR 40 breaths/min ; SVIANIVDopamine , noradrenaline , milrinone , IVIG , methylprednisolone , aspirin , ceftriaxone , clindamycinMild LV systolic impairmentFerritin 1023 μg/L ; D-dimers 9·9 mg/L ; troponin 45 ng/L ; NT-proBNP 9376 ng/L ; CRP mg/L 169 ; procalcitonin 11·6 μg/L ; albumin 25 g/L ; platelet 158SARS-CoV-2 negative ; confirm COVID-19 exposure grandfather3 day ; alivePatient 7 ( male , AfroCaribbean12 year ; 50kg ; BMI 20 kg/m2 ; alopecia areata , hayfever4 day > 39°C ; 2 day diarrhoea vomit ; abdominal pain ; rash ; odynophagia ; headacheBP 80/48 mmHg ; HR 125 beats/min ; RR 47 breaths/min ; SatO2 98 % ; HFNC FiO2 0.35MVNoradrenaline , adrenaline , milrinone , IVIG , methylprednisolone , heparin , ceftriaxone , clindamycin , metronidazoleSevere biventricular impairment ; ileitis , ascites , pleural effusionsFerritin 958 μg/L ; D-dimer 24·5 mg/L ; troponin 813 ng/L ; NT-proBNP > 35 000 ng/L ; CRP 251 mg/L ; procalcitonin 71·5 μg/L ; albumin 24 g/L ; platelet 273 × 109SARS-CoV-2 negative4 day ; alivePatient 8 ( female , AfroCaribbean ) 8 year ; 50 kg ; BMI 25 kg/m2 ; comorbidities4 day > 39°C ; odynophagia ; 2 day diarrhoea vomit ; abdominal painBP 82/41 mmHg ; HR 130 beats/min ; RR 35 breaths/min ; SatO2 97 % NCO2MVDopamine , noradrenaline , milrinone , IVIG , aspirin , ceftriaxone , clindamycinModerate LV dysfunctionFerritin 460 μg/L ; D-dimers 4·3 mg/L ; troponin 120 ng/L ; CRP 347 mg/L ; procalcitonin 7·42 μg/L ; albumin 22 g/L ; platelet 296 × 109SARS-CoV-2 negative ; likely COVID-19 exposure parent7 day ; aliveACA= anterior cerebral artery .', 'ADHD=attention deficit hyperactivity disorder .', 'AVR=atrioventricular valve regurgitation .', 'BMI=body mass index .', 'BP=blood pressure .', 'COVID-19=coronavirus disease 2019 .', 'CRP=C-reactive protein .', 'FiO2=fraction inspire oxygen .', 'HERV=human endogenous retrovirus .', 'HFNC=high-flow nasal canula .', 'HR=heart rate .', 'IVIG=human intravenous immunoglobulin .', 'LV=left ventricle .', 'MCA=middle cerebral artery .', 'MV=mechanical ventilation via endotracheal tube .', 'NIV=non-invasive ventilation .', 'PICU=paediatric intensive care unit .', 'RA=room air .', 'RR=respiratory rate .', 'RRT=renal replacement therapy .', 'RV=right ventricle .', 'RVSP=right ventricular systolic pressure .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'SatO2=oxygen saturation .', 'SVIA=self-ventilating air .', 'VA-ECMO=veno-arterial extracorporeal membrane oxygenation .', 'Open table new tab ACA= anterior cerebral artery .', 'ADHD=attention deficit hyperactivity disorder .', 'AVR=atrioventricular valve regurgitation .', 'BMI=body mass index .', 'BP=blood pressure .', 'COVID-19=coronavirus disease 2019 .', 'CRP=C-reactive protein .', 'FiO2=fraction inspire oxygen .', 'HERV=human endogenous retrovirus .', 'HFNC=high-flow nasal canula .', 'HR=heart rate .', 'IVIG=human intravenous immunoglobulin .', 'LV=left ventricle .', 'MCA=middle cerebral artery .', 'MV=mechanical ventilation via endotracheal tube .', 'NIV=non-invasive ventilation .', 'PICU=paediatric intensive care unit .', 'RA=room air .', 'RR=respiratory rate .', 'RRT=renal replacement therapy .', 'RV=right ventricle .', 'RVSP=right ventricular systolic pressure .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'SatO2=oxygen saturation .', 'SVIA=self-ventilating air .', 'VA-ECMO=veno-arterial extracorporeal membrane oxygenation .', 'Clinical presentation similar , unrelenting fever ( 38–40°C ) , variable rash , conjunctivitis , peripheral oedema , generalise extremity pain significant gastrointestinal symptom .', 'All progress warm , vasoplegic shock , refractory volume resuscitation eventually require noradrenaline milrinone haemodynamic support .', 'Most child significant respiratory involvement , although seven child require mechanical ventilation cardiovascular stabilisation .', 'Other notable feature ( besides persistent fever rash ) include development small pleural , pericardial , ascitic effusion , suggestive diffuse inflammatory process .', 'All child test negative severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) broncho-alveolar lavage nasopharyngeal aspirate .', 'Despite critically unwell , laboratory evidence infection inflammation3Li Y Zou L Wu J et al.Kawasaki disease shock syndrome : clinical characteristic possible use IL-6 , IL-10 IFN- biomarkers early recognition.Pediatr Rheumatol Online J .', '2019 ; 17 : 1CrossrefPubMedScopus ( 2 ) Google Scholar include elevate concentration C-reactive protein , procalcitonin , ferritin , triglyceride , D-dimers , pathological organism identify seven child .', 'Adenovirus enterovirus isolate one child .', 'Baseline electrocardiogram non-specific ; however , common echocardiographic find echo-bright coronary vessel ( appendix ) , progress giant coronary aneurysm one patient within week discharge paediatric intensive care ( appendix ) .', 'One child develop arrhythmia refractory shock , require extracorporeal life support , die large cerebrovascular infarct .', 'The myocardial involvement2Liu P Blet A Smyth D Li H The science underlie COVID-19 : implication cardiovascular system.Circulation .', '2020 ; ( publish online April 15 .', ') DOI:10.1161/CIRCULATIONAHA.120.047549CrossrefGoogle Scholar syndrome evidence elevate cardiac enzyme course illness .', 'All child give intravenous immunoglobulin ( 2 g/kg ) first 24 h , antibiotic cover include ceftriaxone clindamycin .', 'Subsequently , six child give 50 mg/kg aspirin .', 'All child discharge PICU 4–6 day .', 'Since discharge , two child test positive SARS-CoV-2 ( include child die , SARS-CoV-2 detect post mortem ) .', 'All child receive ongoing surveillance coronary abnormality .', 'We suggest clinical picture represent new phenomenon affect previously asymptomatic child SARS-CoV-2 infection manifest hyperinflammatory syndrome multiorgan involvement similar Kawasaki disease shock syndrome .', 'The multifaceted nature disease course underline need multispecialty input ( intensive care , cardiology , infectious disease , immunology , rheumatology ) .', 'The intention Correspondence bring subset child attention wider paediatric community optimise early recognition management .', ""As Correspondence go press , 1 week initial submission , Evelina London Children 's Hospital paediatric intensive care unit manage 20 child similar clinical presentation , first ten test positive antibody ( include original eight child cohort describe ) ."", 'We declare compete interest .', 'Download .pdf ( .11 MB ) Help pdf file Supplementary appendix']","['south', 'thames', 'retrieval', 'service', 'london', '', 'uk', '', 'provide', 'paediatric', 'intensive', 'care', 'support', 'retrieval', '2', 'million', 'child', 'south', 'east', 'england', '', 'period', '10', 'day', 'mid-april', '', '2020', '', 'note', 'unprecedented', 'cluster', 'eight', 'child', 'hyperinflammatory', 'shock', '', 'show', 'feature', 'similar', 'atypical', 'kawasaki', 'disease', '', 'kawasaki', 'disease', 'shock', 'syndrome1zhang', 'm-m', 'shi', 'l', 'lin', 'liu', 'clinical', 'analysis', 'kawasaki', 'disease', 'shock', 'syndromechin', 'med', 'j', '', 'engl', '', '', '2017', '', '130', '', '2891-2892crossrefpubmedscopus', '', '1', '', 'toxic', 'shock', 'syndrome', '', 'typical', 'number', 'one', 'two', 'child', 'per', 'week', '', '', 'case', 'cluster', 'form', 'basis', 'national', 'alert', '', 'child', 'previously', 'fit', 'well', '', 'six', 'child', 'afro-caribbean', 'descent', '', 'five', 'child', 'boy', '', 'child', 'except', 'one', 'well', '75th', 'centile', 'weight', '', 'four', 'child', 'family', 'exposure', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'demographics', '', 'clinical', 'find', '', 'image', 'find', '', 'treatment', '', 'outcome', 'cluster', 'eight', 'child', 'show', 'tabletabledemographics', '', 'clinical', 'find', '', 'image', 'find', '', 'treatment', '', 'outcome', 'picuage', '', 'weight', '', 'bmi', '', 'comorbiditiesclinical', 'presentationorgan', 'supportpharmacological', 'treatmentimaging', 'resultslaboratory', 'resultsmicrobiology', 'resultspicu', 'length', 'stay', '', 'outcomeinitialpicu', 'referralpatient', '1', '', 'male', '', 'afrocaribbean', '', '14', 'year', '', '95', 'kg', '', 'bmi', '33', 'kgm2', '', 'comorbidities4', 'day', '', '40c', '', '3', 'day', 'non-bloody', 'diarrhoea', '', 'abdominal', 'pain', '', 'headachebp', '8040', 'mmhg', '', 'hr', '120', 'beatsmin', '', 'rr', '40', 'breath', 'per', 'min', '', 'work', 'breathe', '', 'sato2', '99', '', 'nco2mv', '', 'rrt', '', 'va-ecmodopamine', '', 'noradrenaline', '', 'argipressin', '', 'adrenaline', 'milrinone', '', 'hydroxicortisone', '', 'ivig', '', 'ceftriaxone', '', 'clindamycinrv', 'dysfunctionelevate', 'rvsp', '', 'ileitis', '', 'gb', 'oedema', 'dilate', 'biliary', 'tree', '', 'ascites', '', 'bilateral', 'basal', 'lung', 'consolidation', 'diffuse', 'nodulesferritin', '4220', 'gl', '', 'd-dimers', '134', 'mgl', '', 'troponin', '675', 'ngl', '', 'probnp', '', '35', '000', '', 'crp', '556', 'mgl', '', 'procalcitonin', '', '100', 'gl', '', 'albumin', '20', 'gl', '', 'platelet', '123', '', '109sars-cov-2', 'positive', '', 'post', 'mortem', '', '6', 'day', '', 'demise', '', 'mca', 'aca', 'ischaemic', 'infarction', '', 'patient', '2', '', 'male', '', 'afrocaribbean', '', '8', 'year', '', '30', 'kg', '', 'bmi', '18', 'kgm2', '', 'comorbidities5', 'day', '', '39c', '', 'non-bloody', 'diarrhoea', '', 'abdominal', 'pain', '', 'conjunctivitis', '', 'rashbp', '8137', 'mmhg', '', 'hr', '165', 'beatsmin', '', 'rr', '40', 'breathsmin', '', 'sviamvnoradrenaline', '', 'adrenaline', '', 'ivig', '', 'infliximab', '', 'methylprednisolone', '', 'ceftriaxone', '', 'clindamycinmild', 'biventricular', 'dysfunction', '', 'severely', 'dilate', 'coronary', '', 'ascites', '', 'pleural', 'effusionsferritin', '277', 'gl', '', 'd-dimers', '48', 'mgl', '', 'troponin', '25', 'ngl', '', 'crp', '295', 'mgl', '', 'procalcitonin', '84', 'gl', '', 'albumin', '18', 'gl', '', 'platelet', '61', '', '109sars-cov-2', 'negative', '', 'likely', 'covid-19', 'exposure', 'mother4', 'day', '', 'alivepatient', '3', '', 'male', '', 'middle-eastern', '', '4', 'year', '', '18', 'kg', '', 'bmi', '17', 'kgm2', '', 'comorbidities4', 'day', '', '39c', '', 'diarrhoea', 'vomit', '', 'abdominal', 'pain', '', 'rash', '', 'conjunctivitisbp', '9030', 'mmhg', '', 'hr', '170', 'beatsmin', '', 'rr', '35', 'breathsmin', '', 'sviamvnoradrenaline', '', 'adrenaline', '', 'ivig', 'ceftriaxone', '', 'clindamycinascites', '', 'pleural', 'effusionsferritin', '574', 'gl', '', 'd-dimers', '117', 'mgl', '', 'tropinin', '45', 'ngl', '', 'crp', '322', 'mgl', '', 'procalcitonin', '103', 'gl', '', 'albumin', '22', 'gl', '', 'platelet', '103', '', '109adenovirus', 'positive', '', 'herv', 'positive4', 'day', '', 'alivepatient', '4', '', 'female', '', 'afrocaribbean', '', '13', 'year', '', '64', 'kg', '', 'bmi', '33', 'kgm2', '', 'comorbidities5', 'day', '', '39c', '', 'non-bloody', 'diarrhoea', '', 'abdominal', 'pain', '', 'conjunctivitisbp', '7741', 'mmhg', '', 'hr', '127', 'beatsmin', '', 'rr', '24', 'breathsmin', '', 'sviahfncnoradrenaline', '', 'milrinone', '', 'ivig', '', 'ceftriaxone', '', 'clindamycinmoderate-severe', 'lv', 'dysfunction', '', 'ascitesferritin', '631', 'gl', '', 'd-dimers', '34', 'mgl', '', 'troponin', '250', 'ngl', '', 'probnp', '13427', 'ngl', '', 'crp', '307', 'mgl', '', 'procalcitonin', '121', 'gl', '', 'albumin', '21', 'gl', '', 'platelet', '146', '', '109sars-cov-2', 'negative5', 'day', '', 'alivepatient', '5', '', 'male', '', 'asian', '', '6', 'year', '', '22', 'kg', '', 'bmi', '14', 'kgm2', '', 'autism', '', 'adhd4', 'day', '', '39c', '', 'odynophagia', '', 'rash', '', 'conjunctivitisbp', '8543', 'mmhg', '', 'hr', '150', 'beatsmin', '', 'rr', '50', 'breathsmin', '', 'svianivmilrinone', '', 'ivig', '', 'methylprednisolone', '', 'aspirin', '', 'ceftriaxonedilated', 'lv', '', 'avvr', '', 'pericoronary', 'hyperechogenicityferritin', '550', 'gl', '', 'd-dimers', '111', 'mgl', '', 'troponin', '47', 'ngl', '', 'nt-probnp', '7004', 'ngl', '', 'crp', '183', 'mgl', '', 'albumin', '24', 'gl', '', 'platelet', '165', '', '109sars-cov-2', 'positive', '', 'likely', 'covid-19', 'exposure', 'father4', 'day', '', 'alivepatient', '6', '', 'female', '', 'afrocaribbean', '', '6', 'year', '', '26', 'kg', '', 'bmi', '15', 'kgm2', '', 'comorbidities5', 'day', '', '39c', '', 'myalgia', '', '3', 'day', 'diarrhoea', 'vomit', '', 'conjunctivitisbp', '7746', 'mmhg', '', 'hr', '120', 'beatsmin', '', 'rr', '40', 'breathsmin', '', 'svianivdopamine', '', 'noradrenaline', '', 'milrinone', '', 'ivig', '', 'methylprednisolone', '', 'aspirin', '', 'ceftriaxone', '', 'clindamycinmild', 'lv', 'systolic', 'impairmentferritin', '1023', 'gl', '', 'd-dimers', '99', 'mgl', '', 'troponin', '45', 'ngl', '', 'nt-probnp', '9376', 'ngl', '', 'crp', 'mgl', '169', '', 'procalcitonin', '116', 'gl', '', 'albumin', '25', 'gl', '', 'platelet', '158sars-cov-2', 'negative', '', 'confirm', 'covid-19', 'exposure', 'grandfather3', 'day', '', 'alivepatient', '7', '', 'male', '', 'afrocaribbean12', 'year', '', '50kg', '', 'bmi', '20', 'kgm2', '', 'alopecia', 'areata', '', 'hayfever4', 'day', '', '39c', '', '2', 'day', 'diarrhoea', 'vomit', '', 'abdominal', 'pain', '', 'rash', '', 'odynophagia', '', 'headachebp', '8048', 'mmhg', '', 'hr', '125', 'beatsmin', '', 'rr', '47', 'breathsmin', '', 'sato2', '98', '', '', 'hfnc', 'fio2', '035mvnoradrenaline', '', 'adrenaline', '', 'milrinone', '', 'ivig', '', 'methylprednisolone', '', 'heparin', '', 'ceftriaxone', '', 'clindamycin', '', 'metronidazolesevere', 'biventricular', 'impairment', '', 'ileitis', '', 'ascites', '', 'pleural', 'effusionsferritin', '958', 'gl', '', 'd-dimer', '245', 'mgl', '', 'troponin', '813', 'ngl', '', 'nt-probnp', '', '35', '000', 'ngl', '', 'crp', '251', 'mgl', '', 'procalcitonin', '715', 'gl', '', 'albumin', '24', 'gl', '', 'platelet', '273', '', '109sars-cov-2', 'negative4', 'day', '', 'alivepatient', '8', '', 'female', '', 'afrocaribbean', '', '8', 'year', '', '50', 'kg', '', 'bmi', '25', 'kgm2', '', 'comorbidities4', 'day', '', '39c', '', 'odynophagia', '', '2', 'day', 'diarrhoea', 'vomit', '', 'abdominal', 'painbp', '8241', 'mmhg', '', 'hr', '130', 'beatsmin', '', 'rr', '35', 'breathsmin', '', 'sato2', '97', '', 'nco2mvdopamine', '', 'noradrenaline', '', 'milrinone', '', 'ivig', '', 'aspirin', '', 'ceftriaxone', '', 'clindamycinmoderate', 'lv', 'dysfunctionferritin', '460', 'gl', '', 'd-dimers', '43', 'mgl', '', 'troponin', '120', 'ngl', '', 'crp', '347', 'mgl', '', 'procalcitonin', '742', 'gl', '', 'albumin', '22', 'gl', '', 'platelet', '296', '', '109sars-cov-2', 'negative', '', 'likely', 'covid-19', 'exposure', 'parent7', 'day', '', 'aliveaca', 'anterior', 'cerebral', 'artery', '', 'adhdattention', 'deficit', 'hyperactivity', 'disorder', '', 'avratrioventricular', 'valve', 'regurgitation', '', 'bmibody', 'mass', 'index', '', 'bpblood', 'pressure', '', 'covid-19coronavirus', 'disease', '2019', '', 'crpc-reactive', 'protein', '', 'fio2fraction', 'inspire', 'oxygen', '', 'hervhuman', 'endogenous', 'retrovirus', '', 'hfnchigh-flow', 'nasal', 'canula', '', 'hrheart', 'rate', '', 'ivighuman', 'intravenous', 'immunoglobulin', '', 'lvleft', 'ventricle', '', 'mcamiddle', 'cerebral', 'artery', '', 'mvmechanical', 'ventilation', 'via', 'endotracheal', 'tube', '', 'nivnon-invasive', 'ventilation', '', 'picupaediatric', 'intensive', 'care', 'unit', '', 'raroom', 'air', '', 'rrrespiratory', 'rate', '', 'rrtrenal', 'replacement', 'therapy', '', 'rvright', 'ventricle', '', 'rvspright', 'ventricular', 'systolic', 'pressure', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sato2oxygen', 'saturation', '', 'sviaself-ventilating', 'air', '', 'va-ecmoveno-arterial', 'extracorporeal', 'membrane', 'oxygenation', '', 'open', 'table', 'new', 'tab', 'aca', 'anterior', 'cerebral', 'artery', '', 'adhdattention', 'deficit', 'hyperactivity', 'disorder', '', 'avratrioventricular', 'valve', 'regurgitation', '', 'bmibody', 'mass', 'index', '', 'bpblood', 'pressure', '', 'covid-19coronavirus', 'disease', '2019', '', 'crpc-reactive', 'protein', '', 'fio2fraction', 'inspire', 'oxygen', '', 'hervhuman', 'endogenous', 'retrovirus', '', 'hfnchigh-flow', 'nasal', 'canula', '', 'hrheart', 'rate', '', 'ivighuman', 'intravenous', 'immunoglobulin', '', 'lvleft', 'ventricle', '', 'mcamiddle', 'cerebral', 'artery', '', 'mvmechanical', 'ventilation', 'via', 'endotracheal', 'tube', '', 'nivnon-invasive', 'ventilation', '', 'picupaediatric', 'intensive', 'care', 'unit', '', 'raroom', 'air', '', 'rrrespiratory', 'rate', '', 'rrtrenal', 'replacement', 'therapy', '', 'rvright', 'ventricle', '', 'rvspright', 'ventricular', 'systolic', 'pressure', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sato2oxygen', 'saturation', '', 'sviaself-ventilating', 'air', '', 'va-ecmoveno-arterial', 'extracorporeal', 'membrane', 'oxygenation', '', 'clinical', 'presentation', 'similar', '', 'unrelenting', 'fever', '', '3840c', '', '', 'variable', 'rash', '', 'conjunctivitis', '', 'peripheral', 'oedema', '', 'generalise', 'extremity', 'pain', 'significant', 'gastrointestinal', 'symptom', '', 'progress', 'warm', '', 'vasoplegic', 'shock', '', 'refractory', 'volume', 'resuscitation', 'eventually', 'require', 'noradrenaline', 'milrinone', 'haemodynamic', 'support', '', 'child', 'significant', 'respiratory', 'involvement', '', 'although', 'seven', 'child', 'require', 'mechanical', 'ventilation', 'cardiovascular', 'stabilisation', '', 'notable', 'feature', '', 'besides', 'persistent', 'fever', 'rash', '', 'include', 'development', 'small', 'pleural', '', 'pericardial', '', 'ascitic', 'effusion', '', 'suggestive', 'diffuse', 'inflammatory', 'process', '', 'child', 'test', 'negative', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'broncho-alveolar', 'lavage', 'nasopharyngeal', 'aspirate', '', 'despite', 'critically', 'unwell', '', 'laboratory', 'evidence', 'infection', 'inflammation3li', 'zou', 'l', 'wu', 'j', 'alkawasaki', 'disease', 'shock', 'syndrome', '', 'clinical', 'characteristic', 'possible', 'il-inhibitor', '', 'il-10', 'ifn-', 'biomarkers', 'early', 'recognitionpediatr', 'rheumatol', 'online', 'j', '', '2019', '', '17', '', '1crossrefpubmedscopus', '', '2', '', 'include', 'elevate', 'concentration', 'c-reactive', 'protein', '', 'procalcitonin', '', 'ferritin', '', 'triglyceride', '', 'd-dimers', '', 'pathological', 'organism', 'identify', 'seven', 'child', '', 'adenovirus', 'enterovirus', 'isolate', 'one', 'child', '', 'baseline', 'electrocardiogram', 'non-specific', '', 'however', '', 'common', 'echocardiographic', 'find', 'echo-bright', 'coronary', 'vessel', '', 'appendix', '', '', 'progress', 'giant', 'coronary', 'aneurysm', 'one', 'patient', 'within', 'week', 'discharge', 'paediatric', 'intensive', 'care', '', 'appendix', '', '', 'one', 'child', 'develop', 'arrhythmia', 'refractory', 'shock', '', 'require', 'extracorporeal', 'life', 'support', '', 'die', 'large', 'cerebrovascular', 'infarct', '', 'myocardial', 'involvement2liu', 'p', 'blet', 'smyth', 'li', 'h', 'science', 'underlie', 'covid-19', '', 'implication', 'cardiovascular', 'systemcirculation', '', '2020', '', '', 'publish', 'online', 'april', '15', '', '', 'doi101161circulationaha120047549crossrefgoogle', 'syndrome', 'evidence', 'elevate', 'cardiac', 'enzyme', 'course', 'illness', '', 'child', 'give', 'intravenous', 'immunoglobulin', '', '2', 'gkg', '', 'first', '24', 'h', '', 'antibiotic', 'cover', 'include', 'ceftriaxone', 'clindamycin', '', 'subsequently', '', 'six', 'child', 'give', '50', 'mgkg', 'aspirin', '', 'child', 'discharge', 'picu', '46', 'day', '', 'since', 'discharge', '', 'two', 'child', 'test', 'positive', 'sars-cov-2', '', 'include', 'child', 'die', '', 'sars-cov-2', 'detect', 'post', 'mortem', '', '', 'child', 'receive', 'ongoing', 'surveillance', 'coronary', 'abnormality', '', 'suggest', 'clinical', 'picture', 'represent', 'new', 'phenomenon', 'affect', 'previously', 'asymptomatic', 'child', 'sars-cov-2', 'infection', 'manifest', 'hyperinflammatory', 'syndrome', 'multiorgan', 'involvement', 'similar', 'kawasaki', 'disease', 'shock', 'syndrome', '', 'multifaceted', 'nature', 'disease', 'course', 'underline', 'multispecialty', 'input', '', 'intensive', 'care', '', 'cardiology', '', 'infectious', 'disease', '', 'immunology', '', 'rheumatology', '', '', 'intention', 'correspondence', 'bring', 'subset', 'child', 'attention', 'wider', 'paediatric', 'community', 'optimise', 'early', 'recognition', 'management', '', 'correspondence', 'press', '', '1', 'week', 'initial', 'submission', '', 'evelina', 'london', 'children', 'hospital', 'paediatric', 'intensive', 'care', 'unit', 'manage', '20', 'child', 'similar', 'clinical', 'presentation', '', 'first', 'ten', 'test', 'positive', 'antibody', '', 'include', 'original', 'eight', 'child', 'cohort', 'describe', '', '', 'declare', 'compete', 'interest', '', 'download', 'pdf', '', '11', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix']",1597,"{'': 429, 'child': 25, 'gl': 23, 'day': 22, 'mgl': 16, 'ngl': 12, 'disease': 10, '2': 9, 'bmi': 9, 'shock': 8, 'syndrome': 8, 'year': 8, 'kgm2': 8, 'mmhg': 8, 'hr': 8, 'beatsmin': 8, 'rr': 8, 'ivig': 8, 'ceftriaxone': 8, 'd-dimers': 8}","{'infliximab': 1, 'infection': 2, 'sars-cov-2': 4, 'il-inhibitor': 1}",8,-0.4939
DOI:10.1016/S0140-6736(20)30628-0,10.1016/S0140-6736(20)30628-0,Correspondence,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['covid-19', '', 'consider', 'cytokine', 'storm', 'syndrome', 'immunosuppression']","['As March 12 , 2020 , coronavirus disease 2019 ( COVID-19 ) confirm 125 048 people worldwide , carry mortality approximately 3·7 % ,1WHOCoronavirus disease 2019 ( COVID-19 ) situation report – 52. urlplaceholder March 12 , 2020Date access : March 13 , 2020Google Scholar compare mortality rate le 1 % influenza .', 'There urgent need effective treatment .', 'Current focus development novel therapeutic , include antiviral vaccine .', 'Accumulating evidence suggest subgroup patient severe COVID-19 might cytokine storm syndrome .', 'We recommend identification treatment hyperinflammation use exist , approve therapy prove safety profile address immediate need reduce rise mortality .', 'Current management COVID-19 supportive , respiratory failure acute respiratory distress syndrome ( ARDS ) lead cause mortality.2Ruan Q Yang K Wang W Jiang L Song J Clinical predictor mortality due COVID-19 base analysis data 150 patient Wuhan , China.Intensive Care Med .', '2020 ; ( publish online March 3 .', ') DOI:10.1007/s00134-020-05991-xGoogle Scholar Secondary haemophagocytic lymphohistiocytosis ( sHLH ) under-recognised , hyperinflammatory syndrome characterise fulminant fatal hypercytokinaemia multiorgan failure .', 'In adult , sHLH commonly trigger viral infections3Ramos-Casals M Brito-Zeron P Lopez-Guillermo A Khamashta MA Bosch X Adult haemophagocytic syndrome.Lancet .', '2014 ; 383 : 1503-1516Google Scholar occur 3·7–4·3 % sepsis cases.4Karakike E Giamarellos-Bourboulis EJ Macrophage activation-like syndrome : distinct entity lead early death sepsis.Front Immunol .', '2019 ; 10 : 55Google Scholar Cardinal feature sHLH include unremitting fever , cytopenia , hyperferritinaemia ; pulmonary involvement ( include ARDS ) occur approximately 50 % patients.5Seguin A Galicier L Boutboul D Lemiale V Azoulay E Pulmonary involvement patient hemophagocytic lymphohistiocytosis.Chest .', '2016 ; 149 : 1294-1301Google Scholar A cytokine profile resemble sHLH associate COVID-19 disease severity , characterise increase interleukin ( IL ) -2 , IL-7 , granulocyte-colony stimulate factor , interferon-γ inducible protein 10 , monocyte chemoattractant protein 1 , macrophage inflammatory protein 1-α , tumour necrosis factor-α.6Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar Predictors fatality recent retrospective , multicentre study 150 confirm COVID-19 case Wuhan , China , include elevate ferritin ( mean 1297·6 ng/ml non-survivors v 614·0 ng/ml survivor ; p < 0·001 ) IL-6 ( p < 0·0001 ) ,2Ruan Q Yang K Wang W Jiang L Song J Clinical predictor mortality due COVID-19 base analysis data 150 patient Wuhan , China.Intensive Care Med .', '2020 ; ( publish online March 3 .', ') DOI:10.1007/s00134-020-05991-xGoogle Scholar suggest mortality might due virally drive hyperinflammation .', 'As previous pandemic ( severe acute respiratory syndrome Middle East respiratory syndrome ) , corticosteroid routinely recommend might exacerbate COVID-19-associated lung injury.7Russell CD Millar JE Baillie JK Clinical evidence support corticosteroid treatment 2019-nCoV lung injury.Lancet .', '2020 ; 395 : 473-475Google Scholar However , hyperinflammation , immunosuppression likely beneficial .', 'Re-analysis data phase 3 randomise control trial IL-1 blockade ( anakinra ) sepsis , show significant survival benefit patient hyperinflammation , without increase adverse events.8Shakoory B Carcillo JA Chatham WW et al.Interleukin-1 receptor blockade associate reduce mortality sepsis patient feature macrophage activation syndrome : reanalysis prior phase iii trial.Crit Care Med .', '2016 ; 44 : 275-281Google Scholar A multicentre , randomise control trial tocilizumab ( IL-6 receptor blockade , license cytokine release syndrome ) , approve patient COVID-19 pneumonia elevate IL-6 China ( ChiCTR2000029765 ) .9Chinese Clinical Trial RegistryA multicenter , randomize control trial efficacy safety tocilizumab treatment new coronavirus pneumonia ( COVID-19 ) .', 'urlplaceholder Feb 13 , 2020Date access : March 6 , 2020Google Scholar Janus kinase ( JAK ) inhibition could affect inflammation cellular viral entry COVID-19.10Richardson P Griffin I Tucker C et al.Baricitinib potential treatment 2019-nCoV acute respiratory disease.Lancet .', '2020 ; 395 : e30-e31Google Scholar All patient severe COVID-19 screen hyperinflammation use laboratory trend ( eg , increase ferritin , decrease platelet count , erythrocyte sedimentation rate ) HScore11Fardet L Galicier L Lambotte O et al.Development validation HScore , score diagnosis reactive hemophagocytic syndrome.Arthritis Rheumatol .', '2014 ; 66 : 2613-2620Google Scholar ( table ) identify subgroup patient immunosuppression could improve mortality .', 'Therapeutic option include steroid , intravenous immunoglobulin , selective cytokine blockade ( eg , anakinra tocilizumab ) JAK inhibition.TableHScore secondary HLH , clinical parameterNumber pointsTemperature < 38·4°C038·4–39·4°C33 > 39·4°C49OrganomegalyNone0Hepatomegaly splenomegaly23Hepatomegaly splenomegaly38Number cytopenia * * Defined either haemoglobin concentration 9·2 g/dL le ( ≤5·71 mmol/L ) , white blood cell count 5000 white blood cell per mm3 le , platelet count 110 000 platelet per mm3 le , criterion combined.One lineage0Two lineages24Three lineages34Triglycerides ( mmol/L ) < 1·5 mmol/L01·5–4·0 mmol/L44 > 4·0 mmol/L64Fibrinogen ( g/L ) > 2·5 g/L0≤2·5 g/L30Ferritin ng/ml < 2000 ng/ml02000–6000 ng/ml35 > 6000 ng/ml50Serum aspartate aminotransferase < 30 IU/L0≥30 IU/L19Haemophagocytosis bone marrow aspirateNo0Yes35Known immunosuppression†† HIV positive receive longterm immunosuppressive therapy ( ie , glucocorticoid , cyclosporine , azathioprine ) .No0Yes18The Hscore11Fardet L Galicier L Lambotte O et al.Development validation HScore , score diagnosis reactive hemophagocytic syndrome.Arthritis Rheumatol .', '2014 ; 66 : 2613-2620Google Scholar generate probability presence secondary HLH .', 'HScores greater 169 93 % sensitive 86 % specific HLH .', 'Note bone marrow haemophagocytosis mandatory diagnosis HLH .', 'HScores calculate use online HScore calculator.11Fardet L Galicier L Lambotte O et al.Development validation HScore , score diagnosis reactive hemophagocytic syndrome.Arthritis Rheumatol .', '2014 ; 66 : 2613-2620Google Scholar HLH=haemophagocytic lymphohistiocytosis .', '* Defined either haemoglobin concentration 9·2 g/dL le ( ≤5·71 mmol/L ) , white blood cell count 5000 white blood cell per mm3 le , platelet count 110 000 platelet per mm3 le , criterion combined.† HIV positive receive longterm immunosuppressive therapy ( ie , glucocorticoid , cyclosporine , azathioprine ) .', 'Open table new tab The Hscore11Fardet L Galicier L Lambotte O et al.Development validation HScore , score diagnosis reactive hemophagocytic syndrome.Arthritis Rheumatol .', '2014 ; 66 : 2613-2620Google Scholar generate probability presence secondary HLH .', 'HScores greater 169 93 % sensitive 86 % specific HLH .', 'Note bone marrow haemophagocytosis mandatory diagnosis HLH .', 'HScores calculate use online HScore calculator.11Fardet L Galicier L Lambotte O et al.Development validation HScore , score diagnosis reactive hemophagocytic syndrome.Arthritis Rheumatol .', '2014 ; 66 : 2613-2620Google Scholar HLH=haemophagocytic lymphohistiocytosis .', 'PM clinical train fellow within Experimental Medicine Initiative Explore New Therapies network receive project fund unrelated Correspondence .', 'PM also receive co-funding National Institute Health Research ( NIHR ) University College London Hospitals Biomedical Research Centre .', 'DFM chair NIHR Medical Research Council fund committee COVID-19 therapeutic vaccine .', 'DFM report personal fee consultancy ARDS GlaxoSmithKline , Boehringer Ingelheim , Bayer ; addition , institution receive fund grant UK NIHR , Wellcome Trust , Innovate UK , others , unrelated Correspondence .', 'DFM also patent issue institution treatment ARDS .', 'DFM Director Research Intensive Care Society NIHR Efficacy Mechanism Evaluation Programme Director .', 'All author declare compete interest .']","['march', '12', '', '2020', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'confirm', '125', '048', 'people', 'worldwide', '', 'carry', 'mortality', 'approximately', '37', '', '1whocoronavirus', 'disease', '2019', '', 'covid-19', '', 'situation', 'report', '', '52', 'urlplaceholder', 'march', '12', '', '2020date', 'access', '', 'march', '13', '', '2020google', 'compare', 'mortality', 'rate', 'le', '1', '', 'influenza', '', 'urgent', 'effective', 'treatment', '', 'current', 'focus', 'development', 'novel', 'therapeutic', '', 'include', 'antiviral', 'vaccine', '', 'accumulating', 'evidence', 'suggest', 'subgroup', 'patient', 'severe', 'covid-19', 'cytokine', 'storm', 'syndrome', '', 'recommend', 'identification', 'treatment', 'hyperinflammation', 'exist', '', 'approve', 'therapy', 'prove', 'safety', 'profile', 'address', 'immediate', 'reduce', 'rise', 'mortality', '', 'current', 'management', 'covid-19', 'supportive', '', 'respiratory', 'failure', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'lead', 'cause', 'mortality2ruan', 'q', 'yang', 'k', 'wang', 'w', 'jiang', 'l', 'song', 'j', 'clinical', 'predictor', 'mortality', 'due', 'covid-19', 'base', 'analysis', 'data', '150', 'patient', 'wuhan', '', 'chinaintensive', 'care', 'med', '', '2020', '', '', 'publish', 'online', 'march', '3', '', '', 'doi101007s00134-020-05991-xgoogle', 'secondary', 'haemophagocytic', 'lymphohistiocytosis', '', 'shlh', '', 'under-recognised', '', 'hyperinflammatory', 'syndrome', 'characterise', 'fulminant', 'fatal', 'hypercytokinaemia', 'multiorgan', 'failure', '', 'adult', '', 'shlh', 'commonly', 'trigger', 'viral', 'infections3ramos-casals', 'brito-zeron', 'p', 'lopez-guillermo', 'khamashta', 'bosch', 'x', 'adult', 'haemophagocytic', 'syndromelancet', '', '2014', '', '383', '', '1503-1516google', 'occur', '3743', '', 'sepsis', 'cases4karakike', 'e', 'giamarellos-bourboulis', 'ej', 'macrophage', 'activation-like', 'syndrome', '', 'distinct', 'entity', 'lead', 'early', 'death', 'sepsisfront', 'immunol', '', '2019', '', '10', '', '55google', 'cardinal', 'feature', 'shlh', 'include', 'unremitting', 'fever', '', 'cytopenia', '', 'hyperferritinaemia', '', 'pulmonary', 'involvement', '', 'include', 'ards', '', 'occur', 'approximately', '50', '', 'patients5seguin', 'galicier', 'l', 'boutboul', 'lemiale', 'v', 'azoulay', 'e', 'pulmonary', 'involvement', 'patient', 'hemophagocytic', 'lymphohistiocytosischest', '', '2016', '', '149', '', '1294-1301google', 'cytokine', 'profile', 'resemble', 'shlh', 'associate', 'covid-19', 'disease', 'severity', '', 'characterise', 'increase', 'interleukin', '', 'il', '', '-2', '', 'il-7', '', 'granulocyte-colony', 'stimulate', 'factor', '', 'interferon-', 'inducible', 'protein', '10', '', 'monocyte', 'chemoattractant', 'protein', '1', '', 'macrophage', 'inflammatory', 'protein', '1-', '', 'tumour', 'necrosis', 'factor-6huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'predictors', 'fatality', 'recent', 'retrospective', '', 'multicentre', 'study', '150', 'confirm', 'covid-19', 'case', 'wuhan', '', 'china', '', 'include', 'elevate', 'ferritin', '', 'mean', '12976', 'ngml', 'non-survivors', 'v', '6140', 'ngml', 'survivor', '', 'p', '', '0001', '', 'il-inhibitor', '', 'p', '', '00001', '', '2ruan', 'q', 'yang', 'k', 'wang', 'w', 'jiang', 'l', 'song', 'j', 'clinical', 'predictor', 'mortality', 'due', 'covid-19', 'base', 'analysis', 'data', '150', 'patient', 'wuhan', '', 'chinaintensive', 'care', 'med', '', '2020', '', '', 'publish', 'online', 'march', '3', '', '', 'doi101007s00134-020-05991-xgoogle', 'suggest', 'mortality', 'due', 'virally', 'drive', 'hyperinflammation', '', 'previous', 'pandemic', '', 'severe', 'acute', 'respiratory', 'syndrome', 'middle', 'east', 'respiratory', 'syndrome', '', '', 'corticosteroid', 'routinely', 'recommend', 'exacerbate', 'covid-19-associated', 'lung', 'injury7russell', 'cd', 'millar', 'je', 'baillie', 'jk', 'clinical', 'evidence', 'support', 'corticosteroid', 'treatment', '2019-ncov', 'lung', 'injurylancet', '', '2020', '', '395', '', '473-475google', 'however', '', 'hyperinflammation', '', 'immunosuppression', 'likely', 'beneficial', '', 're-analysis', 'data', 'phase', '3', 'randomise', 'control', 'trial', 'il-inhibitor', 'blockade', '', 'anakinra', '', 'sepsis', '', 'show', 'significant', 'survival', 'benefit', 'patient', 'hyperinflammation', '', 'without', 'increase', 'adverse', 'events8shakoory', 'b', 'carcillo', 'ja', 'chatham', 'ww', 'alinterleukin-1', 'receptor', 'blockade', 'associate', 'reduce', 'mortality', 'sepsis', 'patient', 'feature', 'macrophage', 'activation', 'syndrome', '', 'reanalysis', 'prior', 'phase', 'iii', 'trialcrit', 'care', 'med', '', '2016', '', '44', '', '275-281google', 'multicentre', '', 'randomise', 'control', 'trial', 'tocilizumab', '', 'il-inhibitor', 'receptor', 'blockade', '', 'license', 'cytokine', 'release', 'syndrome', '', '', 'approve', 'patient', 'covid-19', 'pneumonia', 'elevate', 'il-inhibitor', 'china', '', 'chictr2000029765', '', '9chinese', 'clinical', 'trial', 'registrya', 'multicenter', '', 'randomize', 'control', 'trial', 'efficacy', 'safety', 'tocilizumab', 'treatment', 'new', 'coronavirus', 'pneumonia', '', 'covid-19', '', '', 'urlplaceholder', 'feb', '13', '', '2020date', 'access', '', 'march', '6', '', '2020google', 'janus', 'kinase', '', 'jak', '', 'inhibition', 'affect', 'inflammation', 'cellular', 'viral', 'entry', 'covid-1910richardson', 'p', 'griffin', 'tucker', 'c', 'albaricitinib', 'potential', 'treatment', '2019-ncov', 'acute', 'respiratory', 'diseaselancet', '', '2020', '', '395', '', 'e30-e31google', 'patient', 'severe', 'covid-19', 'screen', 'hyperinflammation', 'laboratory', 'trend', '', 'eg', '', 'increase', 'ferritin', '', 'decrease', 'platelet', 'count', '', 'erythrocyte', 'sedimentation', 'rate', '', 'hscore11fardet', 'l', 'galicier', 'l', 'lambotte', 'aldevelopment', 'validation', 'hscore', '', 'score', 'diagnosis', 'reactive', 'hemophagocytic', 'syndromearthritis', 'rheumatol', '', '2014', '', '66', '', '2613-2620google', '', 'table', '', 'identify', 'subgroup', 'patient', 'immunosuppression', 'improve', 'mortality', '', 'therapeutic', 'option', 'include', 'steroid', '', 'intravenous', 'immunoglobulin', '', 'selective', 'cytokine', 'blockade', '', 'eg', '', 'anakinra', 'tocilizumab', '', 'jak', 'inhibitiontablehscore', 'secondary', 'hlh', '', 'clinical', 'parameternumber', 'pointstemperature', '', '384c0384394c33', '', '394c49organomegalynone0hepatomegaly', 'splenomegaly23hepatomegaly', 'splenomegaly38number', 'cytopenia', '', '', 'defined', 'either', 'haemoglobin', 'concentration', '92', 'gdl', 'le', '', '571', 'mmoll', '', '', 'white', 'blood', 'cell', 'count', '5000', 'white', 'blood', 'cell', 'per', 'mm3', 'le', '', 'platelet', 'count', '110', '000', 'platelet', 'per', 'mm3', 'le', '', 'criterion', 'combinedone', 'lineage0two', 'lineages24three', 'lineages34triglycerides', '', 'mmoll', '', '', '15', 'mmoll01540', 'mmoll44', '', '40', 'mmoll64fibrinogen', '', 'gl', '', '', '25', 'gl025', 'gl30ferritin', 'ngml', '', '2000', 'ngml020006000', 'ngml35', '', '6000', 'ngml50serum', 'aspartate', 'aminotransferase', '', '30', 'iul030', 'iul19haemophagocytosis', 'bone', 'marrow', 'aspirateno0yes35known', 'immunosuppression', 'hiv', 'positive', 'receive', 'longterm', 'immunosuppressive', 'therapy', '', 'ie', '', 'glucocorticoid', '', 'cyclosporine', '', 'azathioprine', '', 'no0yes18the', 'hscore11fardet', 'l', 'galicier', 'l', 'lambotte', 'aldevelopment', 'validation', 'hscore', '', 'score', 'diagnosis', 'reactive', 'hemophagocytic', 'syndromearthritis', 'rheumatol', '', '2014', '', '66', '', '2613-2620google', 'generate', 'probability', 'presence', 'secondary', 'hlh', '', 'hscores', 'greater', '169', '93', '', 'sensitive', '86', '', 'specific', 'hlh', '', 'note', 'bone', 'marrow', 'haemophagocytosis', 'mandatory', 'diagnosis', 'hlh', '', 'hscores', 'calculate', 'online', 'hscore', 'calculator11fardet', 'l', 'galicier', 'l', 'lambotte', 'aldevelopment', 'validation', 'hscore', '', 'score', 'diagnosis', 'reactive', 'hemophagocytic', 'syndromearthritis', 'rheumatol', '', '2014', '', '66', '', '2613-2620google', 'hlhhaemophagocytic', 'lymphohistiocytosis', '', '', 'defined', 'either', 'haemoglobin', 'concentration', '92', 'gdl', 'le', '', '571', 'mmoll', '', '', 'white', 'blood', 'cell', 'count', '5000', 'white', 'blood', 'cell', 'per', 'mm3', 'le', '', 'platelet', 'count', '110', '000', 'platelet', 'per', 'mm3', 'le', '', 'criterion', 'combined', 'hiv', 'positive', 'receive', 'longterm', 'immunosuppressive', 'therapy', '', 'ie', '', 'glucocorticoid', '', 'cyclosporine', '', 'azathioprine', '', '', 'open', 'table', 'new', 'tab', 'hscore11fardet', 'l', 'galicier', 'l', 'lambotte', 'aldevelopment', 'validation', 'hscore', '', 'score', 'diagnosis', 'reactive', 'hemophagocytic', 'syndromearthritis', 'rheumatol', '', '2014', '', '66', '', '2613-2620google', 'generate', 'probability', 'presence', 'secondary', 'hlh', '', 'hscores', 'greater', '169', '93', '', 'sensitive', '86', '', 'specific', 'hlh', '', 'note', 'bone', 'marrow', 'haemophagocytosis', 'mandatory', 'diagnosis', 'hlh', '', 'hscores', 'calculate', 'online', 'hscore', 'calculator11fardet', 'l', 'galicier', 'l', 'lambotte', 'aldevelopment', 'validation', 'hscore', '', 'score', 'diagnosis', 'reactive', 'hemophagocytic', 'syndromearthritis', 'rheumatol', '', '2014', '', '66', '', '2613-2620google', 'hlhhaemophagocytic', 'lymphohistiocytosis', '', 'pm', 'clinical', 'train', 'fellow', 'within', 'experimental', 'medicine', 'initiative', 'explore', 'new', 'therapies', 'network', 'receive', 'project', 'fund', 'unrelated', 'correspondence', '', 'pm', 'receive', 'co-funding', 'national', 'institute', 'health', 'research', '', 'nihr', '', 'university', 'college', 'london', 'hospitals', 'biomedical', 'research', 'centre', '', 'dfm', 'chair', 'nihr', 'medical', 'research', 'council', 'fund', 'committee', 'covid-19', 'therapeutic', 'vaccine', '', 'dfm', 'report', 'personal', 'fee', 'consultancy', 'ards', 'glaxosmithkline', '', 'boehringer', 'ingelheim', '', 'bayer', '', 'addition', '', 'institution', 'receive', 'fund', 'grant', 'uk', 'nihr', '', 'wellcome', 'trust', '', 'innovate', 'uk', '', 'others', '', 'unrelated', 'correspondence', '', 'dfm', 'patent', 'issue', 'institution', 'treatment', 'ards', '', 'dfm', 'director', 'research', 'intensive', 'care', 'society', 'nihr', 'efficacy', 'mechanism', 'evaluation', 'programme', 'director', '', 'author', 'declare', 'compete', 'interest', '']",1066,"{'': 216, 'l': 13, 'covid-19': 12, 'patient': 10, 'mortality': 8, 'syndrome': 8, 'le': 7, 'hscore': 7, 'diagnosis': 7, 'hlh': 7, 'march': 6, '2020': 6, 'treatment': 6, 'clinical': 6, '2014': 6, 'galicier': 6, 'hemophagocytic': 6, 'include': 5, 'hyperinflammation': 5, 'respiratory': 5}","{'tocilizumab': 3, 'azathioprine': 2, 'safety': 2, 'il-inhibitor': 4, 'jak': 2}",13,0.7351
DOI:10.1016/S0140-6736(20)30183-5,10.1016/S0140-6736(20)30183-5,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['clinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'china']","['BackgroundA recent cluster pneumonia case Wuhan , China , cause novel betacoronavirus , 2019 novel coronavirus ( 2019-nCoV ) .', 'We report epidemiological , clinical , laboratory , radiological characteristic treatment clinical outcome patients.MethodsAll patient suspect 2019-nCoV admit designate hospital Wuhan .', 'We prospectively collect analyse data patient laboratory-confirmed 2019-nCoV infection real-time RT-PCR next-generation sequence .', 'Data obtain standardise data collection form share WHO International Severe Acute Respiratory Emerging Infection Consortium electronic medical record .', 'Researchers also directly communicate patient family ascertain epidemiological symptom data .', 'Outcomes also compare patient admit intensive care unit ( ICU ) not.FindingsBy Jan 2 , 2020 , 41 admit hospital patient identify laboratory-confirmed 2019-nCoV infection .', 'Most infect patient men ( 30 [ 73 % ] 41 ) ; le half underlie disease ( 13 [ 32 % ] ) , include diabetes ( eight [ 20 % ] ) , hypertension ( six [ 15 % ] ) , cardiovascular disease ( six [ 15 % ] ) .', 'Median age 49·0 year ( IQR 41·0–58·0 ) .', '27 ( 66 % ) 41 patient expose Huanan seafood market .', 'One family cluster find .', 'Common symptom onset illness fever ( 40 [ 98 % ] 41 patient ) , cough ( 31 [ 76 % ] ) , myalgia fatigue ( 18 [ 44 % ] ) ; le common symptom sputum production ( 11 [ 28 % ] 39 ) , headache ( three [ 8 % ] 38 ) , haemoptysis ( two [ 5 % ] 39 ) , diarrhoea ( one [ 3 % ] 38 ) .', 'Dyspnoea develop 22 ( 55 % ) 40 patient ( median time illness onset dyspnoea 8·0 day [ IQR 5·0–13·0 ] ) .', '26 ( 63 % ) 41 patient lymphopenia .', 'All 41 patient pneumonia abnormal find chest CT .', 'Complications include acute respiratory distress syndrome ( 12 [ 29 % ] ) , RNAaemia ( six [ 15 % ] ) , acute cardiac injury ( five [ 12 % ] ) secondary infection ( four [ 10 % ] ) .', '13 ( 32 % ) patient admit ICU six ( 15 % ) die .', 'Compared non-ICU patient , ICU patient higher plasma level IL2 , IL7 , IL10 , GSCF , IP10 , MCP1 , MIP1A , TNFα.InterpretationThe 2019-nCoV infection cause cluster severe respiratory illness similar severe acute respiratory syndrome coronavirus associate ICU admission high mortality .', 'Major gap knowledge origin , epidemiology , duration human transmission , clinical spectrum disease need fulfilment future studies.FundingMinistry Science Technology , Chinese Academy Medical Sciences , National Natural Science Foundation China , Beijing Municipal Science Technology Commission .', 'A recent cluster pneumonia case Wuhan , China , cause novel betacoronavirus , 2019 novel coronavirus ( 2019-nCoV ) .', 'We report epidemiological , clinical , laboratory , radiological characteristic treatment clinical outcome patient .', 'All patient suspect 2019-nCoV admit designate hospital Wuhan .', 'We prospectively collect analyse data patient laboratory-confirmed 2019-nCoV infection real-time RT-PCR next-generation sequence .', 'Data obtain standardise data collection form share WHO International Severe Acute Respiratory Emerging Infection Consortium electronic medical record .', 'Researchers also directly communicate patient family ascertain epidemiological symptom data .', 'Outcomes also compare patient admit intensive care unit ( ICU ) .', 'By Jan 2 , 2020 , 41 admit hospital patient identify laboratory-confirmed 2019-nCoV infection .', 'Most infect patient men ( 30 [ 73 % ] 41 ) ; le half underlie disease ( 13 [ 32 % ] ) , include diabetes ( eight [ 20 % ] ) , hypertension ( six [ 15 % ] ) , cardiovascular disease ( six [ 15 % ] ) .', 'Median age 49·0 year ( IQR 41·0–58·0 ) .', '27 ( 66 % ) 41 patient expose Huanan seafood market .', 'One family cluster find .', 'Common symptom onset illness fever ( 40 [ 98 % ] 41 patient ) , cough ( 31 [ 76 % ] ) , myalgia fatigue ( 18 [ 44 % ] ) ; le common symptom sputum production ( 11 [ 28 % ] 39 ) , headache ( three [ 8 % ] 38 ) , haemoptysis ( two [ 5 % ] 39 ) , diarrhoea ( one [ 3 % ] 38 ) .', 'Dyspnoea develop 22 ( 55 % ) 40 patient ( median time illness onset dyspnoea 8·0 day [ IQR 5·0–13·0 ] ) .', '26 ( 63 % ) 41 patient lymphopenia .', 'All 41 patient pneumonia abnormal find chest CT .', 'Complications include acute respiratory distress syndrome ( 12 [ 29 % ] ) , RNAaemia ( six [ 15 % ] ) , acute cardiac injury ( five [ 12 % ] ) secondary infection ( four [ 10 % ] ) .', '13 ( 32 % ) patient admit ICU six ( 15 % ) die .', 'Compared non-ICU patient , ICU patient higher plasma level IL2 , IL7 , IL10 , GSCF , IP10 , MCP1 , MIP1A , TNFα .', 'The 2019-nCoV infection cause cluster severe respiratory illness similar severe acute respiratory syndrome coronavirus associate ICU admission high mortality .', 'Major gap knowledge origin , epidemiology , duration human transmission , clinical spectrum disease need fulfilment future study .', 'Ministry Science Technology , Chinese Academy Medical Sciences , National Natural Science Foundation China , Beijing Municipal Science Technology Commission .', 'Coronaviruses envelop non-segmented positive-sense RNA virus belong family Coronaviridae order Nidovirales broadly distribute human mammals.1Richman DD Whitley RJ Hayden FG Clinical virology.4th edn .', 'ASM Press , Washington2016Google Scholar Although human coronavirus infection mild , epidemic two betacoronaviruses , severe acute respiratory syndrome coronavirus ( SARS-CoV ) 2Ksiazek TG Erdman D Goldsmith CS et al.A novel coronavirus associate severe acute respiratory syndrome.N Engl J Med .', '2003 ; 348 : 1953-1966Google Scholar , 3Kuiken T Fouchier RAM Schutten M et al.Newly discover coronavirus primary cause severe acute respiratory syndrome.Lancet .', '2003 ; 362 : 263-270Google Scholar , 4Drosten C Günther S Preiser W et al.Identification novel coronavirus patient severe acute respiratory syndrome.N Engl J Med .', '2003 ; 348 : 1967-1976Google Scholar Middle East respiratory syndrome coronavirus ( MERS-CoV ) ,5de Groot RJ Baker SC Baric RS et al.Middle East respiratory syndrome coronavirus ( MERS-CoV ) : announcement Coronavirus Study Group.J Virol .', '2013 ; 87 : 7790-7792Google Scholar , 6Zaki AM van Boheemen S Bestebroer TM Osterhaus ADME Fouchier RAM Isolation novel coronavirus man pneumonia Saudi Arabia.N Engl J Med .', '2012 ; 367 : 1814-1820Google Scholar cause 10 000 cumulative case past two decade , mortality rate 10 % SARS-CoV 37 % MERS-CoV.7WHOSummary probable SARS case onset illness 1 November 2002 31 July 2003. urlplaceholder Dec 31 , 2003Date access : January 19 , 2020Google Scholar , 8WHOMiddle East respiratory syndrome coronavirus ( MERS-CoV ) .', 'urlplaceholder November , 2019Date access : January 19 , 2020Google Scholar The coronaviruses already identify might tip iceberg , potentially novel severe zoonotic event reveal .', 'In December , 2019 , series pneumonia case unknown cause emerge Wuhan , Hubei , China , clinical presentation greatly resemble viral pneumonia.9WHONovel coronavirus – China .', 'urlplaceholder Jan 12 , 2020Date access : January 19 , 2020Google Scholar Deep sequence analysis lower respiratory tract sample indicate novel coronavirus , name 2019 novel coronavirus ( 2019-nCoV ) .', 'Thus far , 800 confirm case , include health-care worker , identify Wuhan , several export case confirm province China , Thailand , Japan , South Korea , USA.10WHONovel coronavirus – Thailand ( ex-China ) .', 'urlplaceholder Jan 14 , 2020Date access : January 19 , 2020Google Scholar , 11WHONovel coronavirus – Japan ( ex-China ) .', 'urlplaceholder Jan 17 , 2020Date access : January 19 , 2020Google Scholar , 12WHONovel coronavirus – Republic Korea ( ex-China ) .', 'urlplaceholder Jan 21 , 2020Date access : January 23 , 2020Google Scholar , 13CDCFirst travel-related case 2019 novel coronavirus detect United States .', 'urlplaceholder Jan 21 , 2020Date access : January 23 , 2020Google Scholar Research contextEvidence studyHuman coronaviruses , include hCoV-229E , OC43 , NL63 , HKU1 , cause mild respiratory disease .', 'Fatal coronavirus infection emerge past two decade severe acute respiratory syndrome coronavirus ( SARS-CoV ) Middle East respiratory syndrome coronavirus .', 'We search PubMed China National Knowledge Infrastructure database article publish Jan 11 , 2020 , use keywords “ novel coronovirus ” , “ 2019 novel coronavirus ” , “ 2019-nCoV ” .', 'No publish work human infection cause 2019 novel coronavirus ( 2019-nCoV ) could identified.Added value studyWe report epidemiological , clinical , laboratory , radiological characteristic , treatment , clinical outcome 41 laboratory-confirmed case infect 2019-nCoV .', '27 ( 66 % ) 41 patient history direct exposure Huanan seafood market .', 'The median age patient 49·0 year ( IQR 41·0–58·0 ) , 13 ( 32 % ) patient underlie disease .', 'All patient pneumonia .', 'A third patient admit intensive care unit , six die .', 'High concentration cytokine record plasma critically ill patient infect 2019-nCoV.Implications available evidence2019-nCoV cause cluster fatal pneumonia clinical presentation greatly resemble SARS-CoV .', 'Patients infect 2019-nCoV might develop acute respiratory distress syndrome , high likelihood admission intensive care , might die .', 'The cytokine storm could associate disease severity .', 'More effort make know whole spectrum pathophysiology new disease .', 'Evidence study Human coronaviruses , include hCoV-229E , OC43 , NL63 , HKU1 , cause mild respiratory disease .', 'Fatal coronavirus infection emerge past two decade severe acute respiratory syndrome coronavirus ( SARS-CoV ) Middle East respiratory syndrome coronavirus .', 'We search PubMed China National Knowledge Infrastructure database article publish Jan 11 , 2020 , use keywords “ novel coronovirus ” , “ 2019 novel coronavirus ” , “ 2019-nCoV ” .', 'No publish work human infection cause 2019 novel coronavirus ( 2019-nCoV ) could identify .', 'Added value study We report epidemiological , clinical , laboratory , radiological characteristic , treatment , clinical outcome 41 laboratory-confirmed case infect 2019-nCoV .', '27 ( 66 % ) 41 patient history direct exposure Huanan seafood market .', 'The median age patient 49·0 year ( IQR 41·0–58·0 ) , 13 ( 32 % ) patient underlie disease .', 'All patient pneumonia .', 'A third patient admit intensive care unit , six die .', 'High concentration cytokine record plasma critically ill patient infect 2019-nCoV .', 'Implications available evidence 2019-nCoV cause cluster fatal pneumonia clinical presentation greatly resemble SARS-CoV .', 'Patients infect 2019-nCoV might develop acute respiratory distress syndrome , high likelihood admission intensive care , might die .', 'The cytokine storm could associate disease severity .', 'More effort make know whole spectrum pathophysiology new disease .', 'We aim describe epidemiological , clinical , laboratory , radiological characteristic , treatment , outcome patient confirm 2019-nCoV infection , compare clinical feature intensive care unit ( ICU ) non-ICU patient .', 'We hope study find inform global community emergence novel coronavirus clinical feature .', 'Following pneumonia case unknown cause report Wuhan consider share history exposure Huanan seafood market across patient , epidemiological alert release local health authority Dec 31 , 2019 , market shut Jan 1 , 2020 .', 'Meanwhile , 59 suspect case fever dry cough transfer designate hospital start Dec 31 , 2019 .', 'An expert team physician , epidemiologist , virologist , government official soon form alert .', 'Since cause unknown onset emerge infection , diagnosis pneumonia unknown cause Wuhan base clinical characteristic , chest image , rule common bacterial viral pathogen cause pneumonia .', 'Suspected patient isolate use airborne precaution designate hospital , Jin Yin-tan Hospital ( Wuhan , China ) , fit-tested N95 mask airborne precaution aerosol-generating procedure take .', 'This study approve National Health Commission China Ethics Commission Jin Yin-tan Hospital ( KY-2020-01.01 ) .', 'Written inform consent waive Ethics Commission designate hospital emerge infectious disease .', 'Local centre disease control prevention collect respiratory , blood , faeces specimen , ship designate authoritative laboratory detect pathogen ( NHC Key Laboratory Systems Biology Pathogens Christophe Mérieux Laboratory , Beijing , China ) .', 'A novel coronavirus , name 2019-nCoV , isolate lower respiratory tract specimen diagnostic test virus develop soon that.14Tan W Zhao X Ma X et al.A novel coronavirus genome identify cluster pneumonia case — Wuhan , China 2019−2020 .', 'urlplaceholder access : January 23 , 2020Google Scholar Of 59 suspect case , 41 patient confirm infect 2019-nCoV .', 'The presence 2019-nCoV respiratory specimen detect next-generation sequence real-time RT-PCR method .', 'The primer probe target envelope gene CoV use sequence follow : forward primer 5′-ACTTCTTTTTCTTGCTTTCGTGGT-3′ ; reverse primer 5′-GCAGCAGTACGCACACAATC-3′ ; probe 5′CY5-CTAGTTACACTAGCCATCCTTACTGC-3′BHQ1 .', 'Conditions amplification 50°C 15 min , 95°C 3 min , follow 45 cycle 95°C 15 60°C 30 s. Initial investigation include complete blood count , coagulation profile , serum biochemical test ( include renal liver function , creatine kinase , lactate dehydrogenase , electrolyte ) .', 'Respiratory specimen , include nasal pharyngeal swab , bronchoalveolar lavage fluid , sputum , bronchial aspirate test common virus , include influenza , avian influenza , respiratory syncytial virus , adenovirus , parainfluenza virus , SARS-CoV MERS-CoV use real-time RT-PCR assay approve China Food Drug Administration .', 'Routine bacterial fungal examination also perform .', 'Given emergence 2019-nCoV pneumonia case influenza season , antibiotic ( orally intravenously ) oseltamivir ( orally 75 mg twice daily ) empirically administer .', 'Corticosteroid therapy ( methylprednisolone 40–120 mg per day ) give combine regimen severe community-acquired pneumonia diagnose physician designate hospital .', 'Oxygen support ( eg , nasal cannula invasive mechanical ventilation ) administer patient accord severity hypoxaemia .', 'Repeated test 2019-nCoV do patient confirm 2019-nCoV infection show viral clearance hospital discharge discontinuation isolation .', 'We review clinical chart , nurse record , laboratory find , chest x-ray patient laboratory-confirmed 2019-nCoV infection report local health authority .', 'The admission data patient Dec 16 , 2019 , Jan 2 , 2020 .', 'Epidemiological , clinical , laboratory , radiological characteristic treatment outcome data obtain standardise data collection form ( modify case record form severe acute respiratory infection clinical characterisation share WHO International Severe Acute Respiratory Emerging Infection Consortium ) electronic medical record .', 'Two researcher also independently review data collection form double check data collect .', 'To ascertain epidemiological symptom data , available electronic medical record , researcher also directly communicate patient family ascertain epidemiological symptom data .', ""To characterise effect coronavirus production cytokine chemokines acute phase illness , plasma cytokine chemokines ( IL1B , IL1RA , IL2 , IL4 , IL5 , IL6 , IL7 , IL8 ( also know CXCL8 ) , IL9 , IL10 , IL12p70 , IL13 , IL15 , IL17A , Eotaxin ( also know CCL11 ) , basic FGF2 , GCSF ( CSF3 ) , GMCSF ( CSF2 ) , IFNγ , IP10 ( CXCL10 ) , MCP1 ( CCL2 ) , MIP1A ( CCL3 ) , MIP1B ( CCL4 ) , PDGFB , RANTES ( CCL5 ) , TNFα , VEGFA measure use Human Cytokine Standard 27-Plex Assays panel Bio-Plex 200 system ( Bio-Rad , Hercules , CA , USA ) patient accord manufacturer 's instruction ."", 'The plasma sample four healthy adult use control cross-comparison .', 'The median time transfer designate hospital blood sample collection 4 day ( IQR 2–5 ) .', 'Each 80 μL plasma sample patient contact add 240 μL Trizol LS ( 10296028 ; Thermo Fisher Scientific , Carlsbad , CA , USA ) Biosafety Level 3 laboratory .', ""Total RNA extract Direct-zol RNA Miniprep kit ( R2050 ; Zymo research , Irvine , CA , USA ) accord manufacturer 's instruction 50 μL elution obtain sample ."", '5 μL RNA use real-time RT-PCR , target NP gene use AgPath-ID One-Step RT-PCR Reagent ( AM1005 ; Thermo Fisher Scientific ) .', 'The final reaction mix concentration primer 500 nM probe 200 nM .', 'Real-time RT-PCR perform use follow condition : 50°C 15 min 95°C 3 min , 50 cycle amplification 95°C 10 60°C 45 s. Since perform test detect infectious virus blood , avoid term viraemia use RNAaemia instead .', 'RNAaemia define positive result real-time RT-PCR plasma sample .', 'Acute respiratory distress syndrome ( ARDS ) shock define accord interim guidance WHO novel coronavirus.9WHONovel coronavirus – China .', 'urlplaceholder Jan 12 , 2020Date access : January 19 , 2020Google Scholar Hypoxaemia define arterial oxygen tension ( PaO2 ) inspiratory oxygen fraction ( FIO2 ) le 300 mm Hg.15Sanz F Gimeno C Lloret T et al.Relationship presence hypoxemia inflammatory response measure C-reactive protein bacteremic pneumococcal pneumonia.Eur Respir J .', '2011 ; 38 : 2492Google Scholar Acute kidney injury identify classify basis highest serum creatinine level urine output criterion accord kidney disease improve global outcome classification.16Kidney disease : improve global outcome ( KDIGO ) acute kidney injury work groupKDIGO clinical practice guideline acute kidney injury .', 'urlplaceholder March , 2012Date access : January 23 , 2020Google Scholar Secondary infection diagnose patient clinical symptom sign nosocomial pneumonia bacteraemia , combine positive culture new pathogen lower respiratory tract specimen ( include sputum , transtracheal aspirate , bronchoalveolar lavage fluid , blood sample take ≥48 h admission ) .17Garner JS Jarvis WR Emori TG Horan TC Hughes JM CDC definition nosocomial infection , 1988.Am J Infect Control .', '1988 ; 16 : 128-140Google Scholar Cardiac injury follow definition use previous study H7N9 patients.18Gao C Wang Y Gu X et al.Association cardiac injury mortality hospitalize patient infect avian influenza A ( H7N9 ) virus.Crit Care Med .', '2020 ; ( publish online Jan 20 ) DOI:10.1097/CCM.0000000000004207Google Scholar In brief , cardiac injury diagnose serum level cardiac biomarkers ( eg , troponin I ) 99th percentile upper reference limit , new abnormality show electrocardiography echocardiography .', ""Continuous variable express median ( IQR ) compare Mann-Whitney U test ; categorical variable express number ( % ) compare χ2 test Fisher 's exact test ICU care ICU care group ."", 'Boxplots draw describe plasma cytokine chemokine concentration .', 'A two-sided α le 0·05 consider statistically significant .', 'Statistical analysis do use SAS software , version 9.4 , unless otherwise indicate .', 'The funder study role study design , data collection , data analysis , data interpretation , write report .', 'The correspond author full access data study final responsibility decision submit publication .', 'By Jan 2 , 2020 , 41 admit hospital patient identify laboratory-confirmed 2019-nCoV infection Wuhan .', '20 [ 49 % ] ) 2019-nCoV-infected patient age 25–49 year , 14 ( 34 % ) age 50–64 year ( figure 1A ) .', 'The median age patient 49·0 year ( IQR 41·0–58·0 ; table 1 ) .', 'In cohort first 41 patient Jan 2 , child adolescent infect .', 'Of 41 patient , 13 ( 32 % ) admit ICU require high-flow nasal cannula higher-level oxygen support measure correct hypoxaemia .', 'Most infect patient men ( 30 [ 73 % ] ) ; le half underlie disease ( 13 [ 32 % ] ) , include diabetes ( eight [ 20 % ] ) , hypertension ( six [ 15 % ] ) , cardiovascular disease ( six [ 15 % ] ) .Figure 1Date illness onset age distribution patient laboratory-confirmed 2019-nCoV infectionShow full caption ( A ) Number hospital admission age group .', '( B ) Distribution symptom onset date laboratory-confirmed case .', 'The Wuhan local health authority issue epidemiological alert Dec 30 , 2019 , close Huanan seafood market 2 day later.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Table 1Demographics baseline characteristic patient infect 2019-nCoVAll patient ( n=41 ) ICU care ( n=13 ) No ICU care ( n=28 ) p valueCharacteristicsAge , years49·0 ( 41·0–58·0 ) 49·0 ( 41·0–61·0 ) 49·0 ( 41·0–57·5 ) 0·60Sex ...... 0·24Men30 ( 73 % ) 11 ( 85 % ) 19 ( 68 % ) .. Women11 ( 27 % ) 2 ( 15 % ) 9 ( 32 % ) .. Huanan seafood market exposure27 ( 66 % ) 9 ( 69 % ) 18 ( 64 % ) 0·75Current smoking3 ( 7 % ) 03 ( 11 % ) 0·31Any comorbidity13 ( 32 % ) 5 ( 38 % ) 8 ( 29 % ) 0·53Diabetes8 ( 20 % ) 1 ( 8 % ) 7 ( 25 % ) 0·16Hypertension6 ( 15 % ) 2 ( 15 % ) 4 ( 14 % ) 0·93Cardiovascular disease6 ( 15 % ) 3 ( 23 % ) 3 ( 11 % ) 0·32Chronic obstructive pulmonary disease1 ( 2 % ) 1 ( 8 % ) 00·14Malignancy1 ( 2 % ) 01 ( 4 % ) 0·49Chronic liver disease1 ( 2 % ) 01 ( 4 % ) 0·68Signs symptomsFever40 ( 98 % ) 13 ( 100 % ) 27 ( 96 % ) 0·68Highest temperature , °C ...... 0·037 < 37·31 ( 2 % ) 01 ( 4 % ) .. 37·3–38·08 ( 20 % ) 3 ( 23 % ) 5 ( 18 % ) .. 38·1–39·018 ( 44 % ) 7 ( 54 % ) 11 ( 39 % ) .. > 39·014 ( 34 % ) 3 ( 23 % ) 11 ( 39 % ) .. Cough31 ( 76 % ) 11 ( 85 % ) 20 ( 71 % ) 0·35Myalgia fatigue18 ( 44 % ) 7 ( 54 % ) 11 ( 39 % ) 0·38Sputum production11/39 ( 28 % ) 5 ( 38 % ) 6/26 ( 23 % ) 0·32Headache3/38 ( 8 % ) 03/25 ( 12 % ) 0·10Haemoptysis2/39 ( 5 % ) 1 ( 8 % ) 1/26 ( 4 % ) 0·46Diarrhoea1/38 ( 3 % ) 01/25 ( 4 % ) 0·66Dyspnoea22/40 ( 55 % ) 12 ( 92 % ) 10/27 ( 37 % ) 0·0010Days illness onset dyspnoea8·0 ( 5·0–13·0 ) 8·0 ( 6·0–17·0 ) 6·5 ( 2·0–10·0 ) 0·22Days first admission transfer5·0 ( 1·0–8·0 ) 8·0 ( 5·0–14·0 ) 1·0 ( 1·0–6·5 ) 0·0023Systolic pressure , mm Hg125·0 ( 119·0–135·0 ) 145·0 ( 123·0–167·0 ) 122·0 ( 118·5–129·5 ) 0·018Respiratory rate > 24 breath per min12 ( 29 % ) 8 ( 62 % ) 4 ( 14 % ) 0·0023Data median ( IQR ) , n ( % ) , n/N ( % ) , N total number patient available data .', ""p value compare ICU care ICU care χ2 test , Fisher 's exact test , Mann-Whitney U test ."", '2019-nCoV=2019 novel coronavirus .', 'ICU=intensive care unit .', 'Open table new tab ( A ) Number hospital admission age group .', '( B ) Distribution symptom onset date laboratory-confirmed case .', 'The Wuhan local health authority issue epidemiological alert Dec 30 , 2019 , close Huanan seafood market 2 day later .', 'Data median ( IQR ) , n ( % ) , n/N ( % ) , N total number patient available data .', ""p value compare ICU care ICU care χ2 test , Fisher 's exact test , Mann-Whitney U test ."", '2019-nCoV=2019 novel coronavirus .', 'ICU=intensive care unit .', '27 ( 66 % ) patient direct exposure Huanan seafood market ( figure 1B ) .', 'Market exposure similar patient ICU care ( nine [ 69 % ] ) non-ICU care ( 18 [ 64 % ] ) .', 'The symptom onset date first patient identify Dec 1 , 2019 .', 'None family member develop fever respiratory symptom .', 'No epidemiological link find first patient later case .', 'The first fatal case , continuous exposure market , admit hospital 7-day history fever , cough , dyspnoea .', '5 day illness onset , wife , 53-year-old woman know history exposure market , also present pneumonia hospitalise isolation ward .', 'The common symptom onset illness fever ( 40 [ 98 % ] 41 patient ) , cough ( 31 [ 76 % ] ) , myalgia fatigue ( 18 [ 44 % ] ) ; le common symptom sputum production ( 11 [ 28 % ] 39 ) , headache ( three [ 8 % ] 38 ) , haemoptysis ( two [ 5 % ] 39 ) , diarrhoea ( one [ 3 % ] 38 ; table 1 ) .', 'More half patient ( 22 [ 55 % ] 40 ) develop dyspnoea .', 'The median duration illness onset dyspnoea 8·0 day ( IQR 5·0–13·0 ) .', 'The median time onset symptom first hospital admission 7·0 day ( 4·0–8·0 ) , shortness breath 8·0 day ( 5·0–13·0 ) , ARDS 9·0 day ( 8·0–14·0 ) , mechanical ventilation 10·5 day ( 7·0–14·0 ) , ICU admission 10·5 day ( 8·0–17·0 ; figure 2 ) .Figure 2Timeline 2019-nCoV case onset illnessView Large Image Figure ViewerDownload Hi-res image Download ( PPT ) The blood count patient admission show leucopenia ( white blood cell count le 4 × 109/L ; ten [ 25 % ] 40 patient ) lymphopenia ( lymphocyte count < 1·0 × 109/L ; 26 [ 63 % ] patient ; table 2 ) .', 'Prothrombin time D-dimer level admission higher ICU patient ( median prothrombin time 12·2 [ IQR 11·2–13·4 ] ; median D-dimer level 2·4 mg/L [ 0·6–14·4 ] ) non-ICU patient ( median prothrombin time 10·7 [ 9·8–12·1 ] , p=0·012 ; median D-dimer level 0·5 mg/L [ 0·3–0·8 ] , p=0·0042 ) .', 'Levels aspartate aminotransferase increase 15 ( 37 % ) 41 patient , include eight ( 62 % ) 13 ICU patient seven ( 25 % ) 28 non-ICU patient .', 'Hypersensitive troponin I ( hs-cTnI ) increase substantially five patient , diagnosis virus-related cardiac injury made.Table 2Laboratory find patient infect 2019-nCoV admission hospitalAll patient ( n=41 ) ICU care ( n=13 ) No ICU care ( n=28 ) p valueWhite blood cell count , × 109/L6·2 ( 4·1–10·5 ) 11·3 ( 5·8–12·1 ) 5·7 ( 3·1–7·6 ) 0·011 < 410/40 ( 25 % ) 1/13 ( 8 % ) 9/27 ( 33 % ) 0·0414–1018/40 ( 45 % ) 5/13 ( 38 % ) 13/27 ( 48 % ) .. > 1012/40 ( 30 % ) 7/13 ( 54 % ) 5/27 ( 19 % ) .. Neutrophil count , × 109/L5·0 ( 3·3–8·9 ) 10·6 ( 5·0–11·8 ) 4·4 ( 2·0–6·1 ) 0·00069Lymphocyte count , × 109/L0·8 ( 0·6–1·1 ) 0·4 ( 0·2–0·8 ) 1·0 ( 0·7–1·1 ) 0·0041 < 1·026/41 ( 63 % ) 11/13 ( 85 % ) 15/28 ( 54 % ) 0·045≥1·015/41 ( 37 % ) 2/13 ( 15 % ) 13/28 ( 46 % ) .. Haemoglobin , g/L126·0 ( 118·0–140·0 ) 122·0 ( 111·0–128·0 ) 130·5 ( 120·0–140·0 ) 0·20Platelet count , × 109/L164·5 ( 131·5–263·0 ) 196·0 ( 165·0–263·0 ) 149·0 ( 131·0–263·0 ) 0·45 < 1002/40 ( 5 % ) 1/13 ( 8 % ) 1/27 ( 4 % ) 0·45≥10038/40 ( 95 % ) 12/13 ( 92 % ) 26/27 ( 96 % ) .. Prothrombin time , s11·1 ( 10·1–12·4 ) 12·2 ( 11·2–13·4 ) 10·7 ( 9·8–12·1 ) 0·012Activated partial thromboplastin time , s27·0 ( 24·2–34·1 ) 26·2 ( 22·5–33·9 ) 27·7 ( 24·8–34·1 ) 0·57D-dimer , mg/L0·5 ( 0·3–1·3 ) 2·4 ( 0·6–14·4 ) 0·5 ( 0·3–0·8 ) 0·0042Albumin , g/L31·4 ( 28·9–36·0 ) 27·9 ( 26·3–30·9 ) 34·7 ( 30·2–36·5 ) 0·00066Alanine aminotransferase , U/L32·0 ( 21·0–50·0 ) 49·0 ( 29·0–115·0 ) 27·0 ( 19·5–40·0 ) 0·038Aspartate aminotransferase , U/L34·0 ( 26·0–48·0 ) 44·0 ( 30·0–70·0 ) 34·0 ( 24·0–40·5 ) 0·10≤4026/41 ( 63 % ) 5/13 ( 38 % ) 21/28 ( 75 % ) 0·025 > 4015/41 ( 37 % ) 8/13 ( 62 % ) 7/28 ( 25 % ) .. Total bilirubin , mmol/L11·7 ( 9·5–13·9 ) 14·0 ( 11·9–32·9 ) 10·8 ( 9·4–12·3 ) 0·011Potassium , mmol/L4·2 ( 3·8–4·8 ) 4·6 ( 4·0–5·0 ) 4·1 ( 3·8–4·6 ) 0·27Sodium , mmol/L139·0 ( 137·0–140·0 ) 138·0 ( 137·0–139·0 ) 139·0 ( 137·5–140·5 ) 0·26Creatinine , μmol/L74·2 ( 57·5–85·7 ) 79·0 ( 53·1–92·7 ) 73·3 ( 57·5–84·7 ) 0·84≤13337/41 ( 90 % ) 11/13 ( 85 % ) 26/28 ( 93 % ) 0·42 > 1334/41 ( 10 % ) 2/13 ( 15 % ) 2/28 ( 7 % ) .. Creatine kinase , U/L132·5 ( 62·0–219·0 ) 132·0 ( 82·0–493·0 ) 133·0 ( 61·0–189·0 ) 0·31≤18527/40 ( 68 % ) 7/13 ( 54 % ) 20/27 ( 74 % ) 0·21 > 18513/40 ( 33 % ) 6/13 ( 46 % ) 7/27 ( 26 % ) .. Lactate dehydrogenase , U/L286·0 ( 242·0–408·0 ) 400·0 ( 323·0–578·0 ) 281·0 ( 233·0–357·0 ) 0·0044≤24511/40 ( 28 % ) 1/13 ( 8 % ) 10/27 ( 37 % ) 0·036 > 24529/40 ( 73 % ) 12/13 ( 92 % ) 17/27 ( 63 % ) .. Hypersensitive troponin I , pg/mL3·4 ( 1·1–9·1 ) 3·3 ( 3·0–163·0 ) 3·5 ( 0·7–5·4 ) 0·075 > 28 ( 99th percentile ) 5/41 ( 12 % ) 4/13 ( 31 % ) 1/28 ( 4 % ) 0·017Procalcitonin , ng/mL0·1 ( 0·1–0·1 ) 0·1 ( 0·1–0·4 ) 0·1 ( 0·1–0·1 ) 0·031 < 0·127/39 ( 69 % ) 6/12 ( 50 % ) 21/27 ( 78 % ) 0·029≥0·1 < 0·257/39 ( 18 % ) 3/12 ( 25 % ) 4/27 ( 15 % ) .. ≥0·25 < 0·52/39 ( 5 % ) 0/122/27 ( 7 % ) .. ≥0·53/39 ( 8 % ) 3/12 ( 25 % ) * * Complicated typical secondary infection first hospitalisation.0/27 .. Bilateral involvement chest radiographs40/41 ( 98 % ) 13/13 ( 100 % ) 27/28 ( 96 % ) 0·68Cycle threshold respiratory tract32·2 ( 31·0–34·5 ) 31·1 ( 30·0–33·5 ) 32·2 ( 31·1–34·7 ) 0·39Data median ( IQR ) n/N ( % ) , N total number patient available data .', ""p value compare ICU care ICU care χ2 , Fisher 's exact test , Mann-Whitney U test ."", '2019-nCoV=2019 novel coronavirus .', 'ICU=intensive care unit .', '* Complicated typical secondary infection first hospitalisation .', 'Open table new tab Data median ( IQR ) n/N ( % ) , N total number patient available data .', ""p value compare ICU care ICU care χ2 , Fisher 's exact test , Mann-Whitney U test ."", '2019-nCoV=2019 novel coronavirus .', 'ICU=intensive care unit .', 'Most patient normal serum level procalcitonin admission ( procalcitonin < 0·1 ng/mL ; 27 [ 69 % ] patient ; table 2 ) .', 'Four ICU patient develop secondary infection .', 'Three four patient secondary infection procalcitonin greater 0·5 ng/mL ( 0·69 ng/mL , 1·46 ng/mL , 6·48 ng/mL ) .', 'On admission , abnormality chest CT image detect among patient .', 'Of 41 patient , 40 ( 98 % ) bilateral involvement ( table 2 ) .', 'The typical find chest CT image ICU patient admission bilateral multiple lobular subsegmental area consolidation ( figure 3A ) .', 'The representative chest CT find non-ICU patient show bilateral ground-glass opacity subsegmental area consolidation ( figure 3B ) .', 'Later chest CT image show bilateral ground-glass opacity , whereas consolidation resolve ( figure 3C ) .Figure 3Chest CT imagesShow full caption ( A ) Transverse chest CT image 40-year-old man show bilateral multiple lobular subsegmental area consolidation day 15 symptom onset .', 'Transverse chest CT image 53-year-old woman show bilateral ground-glass opacity subsegmental area consolidation day 8 symptom onset ( B ) , bilateral ground-glass opacity day 12 symptom onset ( C ) .View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Transverse chest CT image 40-year-old man show bilateral multiple lobular subsegmental area consolidation day 15 symptom onset .', 'Transverse chest CT image 53-year-old woman show bilateral ground-glass opacity subsegmental area consolidation day 8 symptom onset ( B ) , bilateral ground-glass opacity day 12 symptom onset ( C ) .', 'Initial plasma IL1B , IL1RA , IL7 , IL8 , IL9 , IL10 , basic FGF , GCSF , GMCSF , IFNγ , IP10 , MCP1 , MIP1A , MIP1B , PDGF , TNFα , VEGF concentration higher ICU patient non-ICU patient healthy adult ( appendix pp 6–7 ) .', 'Plasma level IL5 , IL12p70 , IL15 , Eotaxin , RANTES similar healthy adult patient infect 2019-nCoV .', 'Further comparison ICU non-ICU patient show plasma concentration IL2 , IL7 , IL10 , GCSF , IP10 , MCP1 , MIP1A , TNFα higher ICU patient non-ICU patient .', 'All patient pneumonia .', 'Common complication include ARDS ( 12 [ 29 % ] 41 patient ) , follow RNAaemia ( six [ 15 % ] patient ) , acute cardiac injury ( five [ 12 % ] patient ) , secondary infection ( four [ 10 % ] patient ; table 3 ) .', 'Invasive mechanical ventilation require four ( 10 % ) patient , two ( 5 % ) refractory hypoxaemia receive extracorporeal membrane oxygenation salvage therapy .', 'All patient administer empirical antibiotic treatment , 38 ( 93 % ) patient receive antiviral therapy ( oseltamivir ) .', 'Additionally , nine ( 22 % ) patient give systematic corticosteroid .', 'A comparison clinical feature patient receive receive systematic corticosteroid appendix ( pp 1–5 ) .Table 3Treatments outcome patient infect 2019-nCoVAll patient ( n=41 ) ICU care ( n=13 ) No ICU care ( n=28 ) p valueDuration illness onset first admission7·0 ( 4·0–8·0 ) 7·0 ( 4·0–8·0 ) 7·0 ( 4·0–8·5 ) 0·87ComplicationsAcute respiratory distress syndrome12 ( 29 % ) 11 ( 85 % ) 1 ( 4 % ) < 0·0001RNAaemia6 ( 15 % ) 2 ( 15 % ) 4 ( 14 % ) 0·93Cycle threshold RNAaemia35·1 ( 34·7–35·1 ) 35·1 ( 35·1–35·1 ) 34·8 ( 34·1–35·4 ) 0·35Acute cardiac injury * * Defined blood level hypersensitive troponin I 99th percentile upper reference limit ( > 28 pg/mL ) new abnormality show electrocardiography echocardiography.5 ( 12 % ) 4 ( 31 % ) 1 ( 4 % ) 0·017Acute kidney injury3 ( 7 % ) 3 ( 23 % ) 00·027Secondary infection4 ( 10 % ) 4 ( 31 % ) 00·0014Shock3 ( 7 % ) 3 ( 23 % ) 00·027TreatmentAntiviral therapy38 ( 93 % ) 12 ( 92 % ) 26 ( 93 % ) 0·46Antibiotic therapy41 ( 100 % ) 13 ( 100 % ) 28 ( 100 % ) NAUse corticosteroid9 ( 22 % ) 6 ( 46 % ) 3 ( 11 % ) 0·013Continuous renal replacement therapy3 ( 7 % ) 3 ( 23 % ) 00·027Oxygen support ...... < 0·0001Nasal cannula27 ( 66 % ) 1 ( 8 % ) 26 ( 93 % ) .. Non-invasive ventilation high-flow nasal cannula10 ( 24 % ) 8 ( 62 % ) 2 ( 7 % ) .. Invasive mechanical ventilation2 ( 5 % ) 2 ( 15 % ) 0 .. Invasive mechanical ventilation ECMO2 ( 5 % ) 2 ( 15 % ) 0 .. Prognosis ...... 0·014Hospitalisation7 ( 17 % ) 1 ( 8 % ) 6 ( 21 % ) .. Discharge28 ( 68 % ) 7 ( 54 % ) 21 ( 75 % ) .. Death6 ( 15 % ) 5 ( 38 % ) 1 ( 4 % ) .. Data median ( IQR ) n ( % ) .', 'p value compare ICU care ICU care .', '2019-nCoV=2019 novel coronavirus .', 'ICU=intensive care unit .', 'NA=not applicable .', 'ECMO=extracorporeal membrane oxygenation .', '* Defined blood level hypersensitive troponin I 99th percentile upper reference limit ( > 28 pg/mL ) new abnormality show electrocardiography echocardiography .', 'Open table new tab Data median ( IQR ) n ( % ) .', 'p value compare ICU care ICU care .', '2019-nCoV=2019 novel coronavirus .', 'ICU=intensive care unit .', 'NA=not applicable .', 'ECMO=extracorporeal membrane oxygenation .', 'As Jan 22 , 2020 , 28 ( 68 % ) 41 patient discharge six ( 15 % ) patient die .', 'Fitness discharge base abatement fever least 10 day , improvement chest radiographic evidence viral clearance respiratory sample upper respiratory tract .', 'We report cohort 41 patient laboratory-confirmed 2019-nCoV infection .', 'Patients serious , sometimes fatal , pneumonia admit designate hospital Wuhan , China , Jan 2 , 2020 .', 'Clinical presentation greatly resemble SARS-CoV .', 'Patients severe illness develop ARDS require ICU admission oxygen therapy .', 'The time hospital admission ARDS short 2 day .', 'At stage , mortality rate high 2019-nCoV , six ( 15 % ) 41 patient cohort die .', 'The number death rise quickly .', 'As Jan 24 , 2020 , 835 laboratory-confirmed 2019-nCoV infection report China , 25 fatal case .', 'Reports release export case many province China , country ; health-care worker also infect Wuhan .', 'Taken together , evidence far indicate human transmission 2019-nCoV .', 'We concern 2019-nCoV could acquire ability efficient human transmission.19Perlman S Netland J Coronaviruses post-SARS : update replication pathogenesis.Nat Rev Microbiol .', '2009 ; 7 : 439-450Google Scholar Airborne precaution , fit-tested N95 respirator , personal protective equipment strongly recommend .', 'To prevent spread disease health-care set care patient infect 2019-nCoV , onset fever respiratory symptom closely monitor among health-care worker .', 'Testing respiratory specimen do immediately diagnosis suspect .', 'Serum antibody test among health-care worker exposure 2019-nCoV identification asymptomatic infection .', 'Similarities clinical feature 2019-nCoV previous betacoronavirus infection note .', 'In cohort , patient present fever , dry cough , dyspnoea , bilateral ground-glass opacity chest CT scan .', 'These feature 2019-nCoV infection bear resemblance SARS-CoV MERS-CoV infections.20Lee N Hui D Wu A et al.A major outbreak severe acute respiratory syndrome Hong Kong.N Engl J Med .', '2003 ; 348 : 1986-1994Google Scholar , 21Assiri A Al-Tawfiq JA Al-Rabeeah AA et al.Epidemiological , demographic , clinical characteristic 47 case Middle East respiratory syndrome coronavirus disease Saudi Arabia : descriptive study.Lancet Infect Dis .', '2013 ; 13 : 752-761Google Scholar However , patient 2019-nCoV infection prominent upper respiratory tract sign symptom ( eg , rhinorrhoea , sneeze , sore throat ) , indicate target cell might locate lower airway .', 'Furthermore , 2019-nCoV patient rarely develop intestinal sign symptom ( eg , diarrhoea ) , whereas 20–25 % patient MERS-CoV SARS-CoV infection diarrhoea.21Assiri A Al-Tawfiq JA Al-Rabeeah AA et al.Epidemiological , demographic , clinical characteristic 47 case Middle East respiratory syndrome coronavirus disease Saudi Arabia : descriptive study.Lancet Infect Dis .', '2013 ; 13 : 752-761Google Scholar Faecal urine sample test exclude potential alternative route transmission unknown stage .', 'The pathophysiology unusually high pathogenicity SARS-CoV MERS-CoV completely understand .', 'Early study show increase amount proinflammatory cytokine serum ( eg , IL1B , IL6 , IL12 , IFNγ , IP10 , MCP1 ) associate pulmonary inflammation extensive lung damage SARS patients.22Wong CK Lam CWK Wu AKL et al.Plasma inflammatory cytokine chemokines severe acute respiratory syndrome.Clin Exp Immunol .', '2004 ; 136 : 95-103Google Scholar MERS-CoV infection also report induce increase concentration proinflammatory cytokine ( IFNγ , TNFα , IL15 , IL17 ) .23Mahallawi WH Khabour OF Zhang Q Makhdoum HM Suliman BA MERS-CoV infection human associate pro-inflammatory Th1 Th17 cytokine profile.Cytokine .', '2018 ; 104 : 8-13Google Scholar We note patient infect 2019-nCoV also high amount IL1B , IFNγ , IP10 , MCP1 , probably lead activate T-helper-1 ( Th1 ) cell response .', 'Moreover , patient require ICU admission higher concentration GCSF , IP10 , MCP1 , MIP1A , TNFα require ICU admission , suggest cytokine storm associate disease severity .', 'However , 2019-nCoV infection also initiate increase secretion T-helper-2 ( Th2 ) cytokine ( eg , IL4 IL10 ) suppress inflammation , differ SARS-CoV infection.22Wong CK Lam CWK Wu AKL et al.Plasma inflammatory cytokine chemokines severe acute respiratory syndrome.Clin Exp Immunol .', '2004 ; 136 : 95-103Google Scholar Further study necessary characterise Th1 Th2 response 2019-nCoV infection elucidate pathogenesis .', 'Autopsy biopsy study would key understand disease .', 'In view high amount cytokine induce SARS-CoV,22Wong CK Lam CWK Wu AKL et al.Plasma inflammatory cytokine chemokines severe acute respiratory syndrome.Clin Exp Immunol .', '2004 ; 136 : 95-103Google Scholar , 24He L Ding Y Zhang Q et al.Expression elevate level pro-inflammatory cytokine SARS-CoV-infected ACE2+ cell SARS patient : relation acute lung injury pathogenesis SARS.J Pathol .', '2006 ; 210 : 288-297Google Scholar MERS-CoV,25Faure E Poissy J Goffard A et al.Distinct immune response two MERS-CoV-infected patient : go bench bedside ? .PLoS One .', '2014 ; 9e88716Google Scholar , 26Falzarano D de Wit E Rasmussen AL et al.Treatment interferon-α2b ribavirin improve outcome MERS-CoV-infected rhesus macaques.Nat Med .', '2013 ; 19 : 1313-1317Google Scholar 2019-nCoV infection , corticosteroid use frequently treatment patient severe illness , possible benefit reduce inflammatory-induced lung injury .', 'However , current evidence patient SARS MERS suggest receive corticosteroid effect mortality , rather delay viral clearance.27Stockman LJ Bellamy R Garner P SARS : systematic review treatment effects.PLoS Med .', '2006 ; 3 : e343Google Scholar , 28Lansbury L Rodrigo C Leonardi-Bee J Nguyen-Van-Tam J Lim WS Corticosteroids adjunctive therapy treatment influenza.Cochrane Database Syst Rev .', '2019 ; 2 : CD010406Google Scholar , 29Arabi YM Mandourah Y Al-Hameed F et al.Corticosteroid therapy critically ill patient Middle East respiratory syndrome.Am J Respir Crit Care Med .', '2018 ; 197 : 757-767Google Scholar Therefore , corticosteroid routinely give systemically , accord WHO interim guidance.30WHOClinical management severe acute respiratory infection novel coronavirus ( nCoV ) infection suspect .', 'urlplaceholder Jan 11 , 2020Date access : January 19 , 2020Google Scholar Among cohort 41 laboratory-confirmed patient 2019-nCoV infection , corticosteroid give non-ICU case , low-to-moderate dose corticosteroid give le half severely ill patient ARDS .', 'Further evidence urgently need ass whether systematic corticosteroid treatment beneficial harmful patient infect 2019-nCoV .', 'No antiviral treatment coronavirus infection prove effective .', 'In historical control study,31Chu CM Role lopinavir/ritonavir treatment SARS : initial virological clinical findings.Thorax .', '2004 ; 59 : 252-256Google Scholar combination lopinavir ritonavir among SARS-CoV patient associate substantial clinical benefit ( fewer adverse clinical outcome ) .', 'Arabi colleague initiate placebo-controlled trial interferon beta-1b , lopinavir , ritonavir among patient MERS infection Saudi Arabia.32Arabi YM Alothman A Balkhy HH et al.Treatment Middle East respiratory syndrome combination lopinavir-ritonavir interferon-β1b ( MIRACLE trial ) : study protocol randomize control trial.Trials .', '2018 ; 19 : 81Google Scholar Preclinical evidence show potent efficacy remdesivir ( broad-spectrum antiviral nucleotide prodrug ) treat MERS-CoV SARS-CoV infections.33Sheahan TP Sims AC Graham RL et al.Broad-spectrum antiviral GS-5734 inhibit epidemic zoonotic coronaviruses.Sci Transl Med .', '2017 ; 9eaal3653Google Scholar , 34Sheahan TP Sims AC Leist SR et al.Comparative therapeutic efficacy remdesivir combination lopinavir , ritonavir , interferon beta MERS-CoV.Nat Commun .', '2020 ; 11 : 222Google Scholar As 2019-nCoV emerge virus , effective treatment develop disease result virus .', 'Since combination lopinavir ritonavir already available designate hospital , randomise control trial initiate quickly ass efficacy safety combine use lopinavir ritonavir patient hospitalise 2019-nCoV infection .', 'Our study limitation .', 'First , 41 patient , diagnosis confirm lower respiratory tract specimen pair nasopharyngeal swab obtain investigate difference viral RNA detection rate upper lower respiratory tract specimen .', 'Serological detection do look 2019-nCoV antibody rise 18 patient undetectable viral RNA .', 'Second , limit number case , difficult ass host risk factor disease severity mortality multivariable-adjusted method .', 'This modest-sized case series patient admit hospital ; collection standardise data larger cohort would help define clinical presentation , natural history , risk factor .', 'Further study outpatient , primary care , community set need get full picture spectrum clinical severity .', 'At time , find statistical test p value interpret caution , non-significant p value necessarily rule difference ICU non-ICU patient .', 'Third , since causative pathogen identify , kinetics viral load antibody titre available .', 'Finally , potential exposure bias study might account paediatric adolescent patient report cohort .', 'More effort make answer question future study .', 'Both SARS-CoV MERS-CoV believe originate bat , infection transmit directly human market civet dromedary camel , respectively.35Cui J Li F Shi Z-L Origin evolution pathogenic coronaviruses.Nat Rev Microbiol .', '2019 ; 17 : 181-192Google Scholar Extensive research SARS-CoV MERS-CoV drive discovery many SARS-like MERS-like coronaviruses bat .', 'In 2013 , Ge colleagues36Ge X-Y Li J-L Yang X-L et al.Isolation characterization bat SARS-like coronavirus us ACE2 receptor.Nature .', '2013 ; 503 : 535-538Google Scholar report whole genome sequence SARS-like coronavirus bat ability use human ACE2 receptor , thus replication potential human cells.37Wang M Hu Z Bats animal reservoir SARS coronavirus : hypothesis prove 10 year virus hunting.Virol Sin .', '2013 ; 28 : 315-317Google Scholar 2019-nCoV still need study deeply case become global health threat .', 'Reliable quick pathogen test feasible differential diagnosis base clinical description crucial clinician first contact suspect patient .', 'Because pandemic potential 2019-nCoV , careful surveillance essential monitor future host adaption , viral evolution , infectivity , transmissibility , pathogenicity .', 'This online publication correct .', 'The correct version first appear thelancet.com January 30 , 2020 This online publication correct .', 'The correct version first appear thelancet.com January 30 , 2020 Contributors BC JW idea design study full access data study take responsibility integrity data accuracy data analysis .', 'YWa , GF , XG , JiXu , HL , BC contribute write report .', 'BC contribute critical revision report .', 'YWa , GF , XG , JiXu , HL contribute statistical analysis .', 'All author contribute data acquisition , data analysis , data interpretation , review approve final version .', 'Declaration interest All author declare compete interest .', 'The data support find study available correspond author reasonable request .', 'Participant data without name identifier make available approval correspond author National Health Commission .', 'After publication study find , data available others request .', 'The research team provide email address communication data approve share others .', 'The proposal detail description study objective statistical analysis plan need evaluation reasonability request data .', 'The correspond author National Health Commission make decision base material .', 'Additional material may also require process .', 'Acknowledgments This work fund Special Project Emergency Ministry Science Technology ( 2020YFC0841300 ) Chinese Academy Medical Sciences ( CAMS ) Innovation Fund Medical Sciences ( CIFMS 2018-I2M-1-003 ) , National Science Grant Distinguished Young Scholars ( 81425001/H0104 ) , National Key Research Development Program China ( 2018YFC1200102 ) , The Beijing Science Technology Project ( Z19110700660000 ) , CAMS Innovation Fund Medical Sciences ( 2016-I2M-1-014 ) , National Mega-projects Infectious Diseases China ( 2017ZX10103004 2018ZX10305409 ) .', 'We acknowledge health-care worker involve diagnosis treatment patient Wuhan ; thank Chinese National Health Commission coordinate data collection patient 2019-nCoV infection ; thank WHO International Severe Acute Respiratory Emerging Infections Consortium ( ISARIC ) share data collection template publicly website ; thank Prof Chen Wang Prof George F Gao guidance study design interpretation result .', ""Download .pdf ( .25 MB ) Help pdf file Supplementary appendix Data share outbreak : best practice exemplifiedFull-TextPDFA novel coronavirus outbreak global health concernFull-TextPDFDepartment ErrorFull-TextPDFFull spectrum COVID-19 severity still depictedFull-TextPDFThe first 2019 novel coronavirus case NepalFull-TextPDFTherapeutic triage strategy 2019 novel coronavirus disease fever clinicsFull-TextPDFFull spectrum COVID-19 severity still depict – Authors ' replyFull-TextPDFThe many estimate COVID-19 case fatality rateFull-TextPDF""]","['backgrounda', 'recent', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'china', '', 'cause', 'novel', 'betacoronavirus', '', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'report', 'epidemiological', '', 'clinical', '', 'laboratory', '', 'radiological', 'characteristic', 'treatment', 'clinical', 'outcome', 'patientsmethodsall', 'patient', 'suspect', '2019-ncov', 'admit', 'designate', 'hospital', 'wuhan', '', 'prospectively', 'collect', 'analyse', 'data', 'patient', 'laboratory-confirmed', '2019-ncov', 'infection', 'real-time', 'rt-pcr', 'next-generation', 'sequence', '', 'data', 'obtain', 'standardise', 'data', 'collection', 'form', 'share', 'international', 'severe', 'acute', 'respiratory', 'emerging', 'infection', 'consortium', 'electronic', 'medical', 'record', '', 'researchers', 'directly', 'communicate', 'patient', 'family', 'ascertain', 'epidemiological', 'symptom', 'data', '', 'outcomes', 'compare', 'patient', 'admit', 'intensive', 'care', 'unit', '', 'icu', '', 'notfindingsby', 'jan', '2', '', '2020', '', '41', 'admit', 'hospital', 'patient', 'identify', 'laboratory-confirmed', '2019-ncov', 'infection', '', 'infect', 'patient', 'men', '', '30', '', '73', '', '', '41', '', '', 'le', 'half', 'underlie', 'disease', '', '13', '', '32', '', '', '', '', 'include', 'diabetes', '', 'eight', '', '20', '', '', '', '', 'hypertension', '', 'six', '', '15', '', '', '', '', 'cardiovascular', 'disease', '', 'six', '', '15', '', '', '', '', 'median', 'age', '490', 'year', '', 'iqr', '410580', '', '', '27', '', '66', '', '', '41', 'patient', 'expose', 'huanan', 'seafood', 'market', '', 'one', 'family', 'cluster', 'find', '', 'common', 'symptom', 'onset', 'illness', 'fever', '', '40', '', '98', '', '', '41', 'patient', '', '', 'cough', '', '31', '', '76', '', '', '', '', 'myalgia', 'fatigue', '', '18', '', '44', '', '', '', '', 'le', 'common', 'symptom', 'sputum', 'production', '', '11', '', '28', '', '', '39', '', '', 'headache', '', 'three', '', '8', '', '', '38', '', '', 'haemoptysis', '', 'two', '', '5', '', '', '39', '', '', 'diarrhoea', '', 'one', '', '3', '', '', '38', '', '', 'dyspnoea', 'develop', '22', '', '55', '', '', '40', 'patient', '', 'median', 'time', 'illness', 'onset', 'dyspnoea', '80', 'day', '', 'iqr', '50130', '', '', '', '26', '', '63', '', '', '41', 'patient', 'lymphopenia', '', '41', 'patient', 'pneumonia', 'abnormal', 'find', 'chest', 'ct', '', 'complications', 'include', 'acute', 'respiratory', 'distress', 'syndrome', '', '12', '', '29', '', '', '', '', 'rnaaemia', '', 'six', '', '15', '', '', '', '', 'acute', 'cardiac', 'injury', '', 'five', '', '12', '', '', '', 'secondary', 'infection', '', 'four', '', '10', '', '', '', '', '13', '', '32', '', '', 'patient', 'admit', 'icu', 'six', '', '15', '', '', 'die', '', 'compared', 'non-icu', 'patient', '', 'icu', 'patient', 'higher', 'plasma', 'level', 'il2', '', 'il7', '', 'il10', '', 'gscf', '', 'ip10', '', 'mcp1', '', 'mip1a', '', 'tnfinterpretationthe', '2019-ncov', 'infection', 'cause', 'cluster', 'severe', 'respiratory', 'illness', 'similar', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'associate', 'icu', 'admission', 'high', 'mortality', '', 'major', 'gap', 'knowledge', 'origin', '', 'epidemiology', '', 'duration', 'human', 'transmission', '', 'clinical', 'spectrum', 'disease', 'fulfilment', 'future', 'studiesfundingministry', 'science', 'technology', '', 'chinese', 'academy', 'medical', 'sciences', '', 'national', 'natural', 'science', 'foundation', 'china', '', 'beijing', 'municipal', 'science', 'technology', 'commission', '', 'recent', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'china', '', 'cause', 'novel', 'betacoronavirus', '', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'report', 'epidemiological', '', 'clinical', '', 'laboratory', '', 'radiological', 'characteristic', 'treatment', 'clinical', 'outcome', 'patient', '', 'patient', 'suspect', '2019-ncov', 'admit', 'designate', 'hospital', 'wuhan', '', 'prospectively', 'collect', 'analyse', 'data', 'patient', 'laboratory-confirmed', '2019-ncov', 'infection', 'real-time', 'rt-pcr', 'next-generation', 'sequence', '', 'data', 'obtain', 'standardise', 'data', 'collection', 'form', 'share', 'international', 'severe', 'acute', 'respiratory', 'emerging', 'infection', 'consortium', 'electronic', 'medical', 'record', '', 'researchers', 'directly', 'communicate', 'patient', 'family', 'ascertain', 'epidemiological', 'symptom', 'data', '', 'outcomes', 'compare', 'patient', 'admit', 'intensive', 'care', 'unit', '', 'icu', '', '', 'jan', '2', '', '2020', '', '41', 'admit', 'hospital', 'patient', 'identify', 'laboratory-confirmed', '2019-ncov', 'infection', '', 'infect', 'patient', 'men', '', '30', '', '73', '', '', '41', '', '', 'le', 'half', 'underlie', 'disease', '', '13', '', '32', '', '', '', '', 'include', 'diabetes', '', 'eight', '', '20', '', '', '', '', 'hypertension', '', 'six', '', '15', '', '', '', '', 'cardiovascular', 'disease', '', 'six', '', '15', '', '', '', '', 'median', 'age', '490', 'year', '', 'iqr', '410580', '', '', '27', '', '66', '', '', '41', 'patient', 'expose', 'huanan', 'seafood', 'market', '', 'one', 'family', 'cluster', 'find', '', 'common', 'symptom', 'onset', 'illness', 'fever', '', '40', '', '98', '', '', '41', 'patient', '', '', 'cough', '', '31', '', '76', '', '', '', '', 'myalgia', 'fatigue', '', '18', '', '44', '', '', '', '', 'le', 'common', 'symptom', 'sputum', 'production', '', '11', '', '28', '', '', '39', '', '', 'headache', '', 'three', '', '8', '', '', '38', '', '', 'haemoptysis', '', 'two', '', '5', '', '', '39', '', '', 'diarrhoea', '', 'one', '', '3', '', '', '38', '', '', 'dyspnoea', 'develop', '22', '', '55', '', '', '40', 'patient', '', 'median', 'time', 'illness', 'onset', 'dyspnoea', '80', 'day', '', 'iqr', '50130', '', '', '', '26', '', '63', '', '', '41', 'patient', 'lymphopenia', '', '41', 'patient', 'pneumonia', 'abnormal', 'find', 'chest', 'ct', '', 'complications', 'include', 'acute', 'respiratory', 'distress', 'syndrome', '', '12', '', '29', '', '', '', '', 'rnaaemia', '', 'six', '', '15', '', '', '', '', 'acute', 'cardiac', 'injury', '', 'five', '', '12', '', '', '', 'secondary', 'infection', '', 'four', '', '10', '', '', '', '', '13', '', '32', '', '', 'patient', 'admit', 'icu', 'six', '', '15', '', '', 'die', '', 'compared', 'non-icu', 'patient', '', 'icu', 'patient', 'higher', 'plasma', 'level', 'il2', '', 'il7', '', 'il10', '', 'gscf', '', 'ip10', '', 'mcp1', '', 'mip1a', '', 'certolizumab', '', '2019-ncov', 'infection', 'cause', 'cluster', 'severe', 'respiratory', 'illness', 'similar', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'associate', 'icu', 'admission', 'high', 'mortality', '', 'major', 'gap', 'knowledge', 'origin', '', 'epidemiology', '', 'duration', 'human', 'transmission', '', 'clinical', 'spectrum', 'disease', 'fulfilment', 'future', 'study', '', 'ministry', 'science', 'technology', '', 'chinese', 'academy', 'medical', 'sciences', '', 'national', 'natural', 'science', 'foundation', 'china', '', 'beijing', 'municipal', 'science', 'technology', 'commission', '', 'coronaviruses', 'envelop', 'non-segmented', 'positive-sense', 'rna', 'virus', 'belong', 'family', 'coronaviridae', 'order', 'nidovirales', 'broadly', 'distribute', 'human', 'mammals1richman', 'dd', 'whitley', 'rj', 'hayden', 'fg', 'clinical', 'virology4th', 'edn', '', 'asm', 'press', '', 'washington2016google', 'although', 'human', 'coronavirus', 'infection', 'mild', '', 'epidemic', 'two', 'betacoronaviruses', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', '2ksiazek', 'tg', 'erdman', 'goldsmith', 'cs', 'ala', 'novel', 'coronavirus', 'associate', 'severe', 'acute', 'respiratory', 'syndromen', 'engl', 'j', 'med', '', '2003', '', '348', '', '1953-1966google', '', '3kuiken', 'fouchier', 'ram', 'schutten', 'alnewly', 'discover', 'coronavirus', 'primary', 'cause', 'severe', 'acute', 'respiratory', 'syndromelancet', '', '2003', '', '362', '', '263-270google', '', '4drosten', 'c', 'gnther', 'preiser', 'w', 'alidentification', 'novel', 'coronavirus', 'patient', 'severe', 'acute', 'respiratory', 'syndromen', 'engl', 'j', 'med', '', '2003', '', '348', '', '1967-1976google', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', '5de', 'groot', 'rj', 'baker', 'sc', 'baric', 'rs', 'almiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', '', 'announcement', 'coronavirus', 'study', 'groupj', 'virol', '', '2013', '', '87', '', '7790-7792google', '', '6zaki', 'van', 'boheemen', 'bestebroer', 'tm', 'osterhaus', 'adme', 'fouchier', 'ram', 'isolation', 'novel', 'coronavirus', 'man', 'pneumonia', 'saudi', 'arabian', 'engl', 'j', 'med', '', '2012', '', '367', '', '1814-1820google', 'cause', '10', '000', 'cumulative', 'case', 'past', 'two', 'decade', '', 'mortality', 'rate', '10', '', 'sars-cov', '37', '', 'mers-cov7whosummary', 'probable', 'sars', 'case', 'onset', 'illness', '1', 'november', '2002', '31', 'july', '2003', 'urlplaceholder', 'dec', '31', '', '2003date', 'access', '', 'january', '19', '', '2020google', '', '8whomiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', '', 'urlplaceholder', 'november', '', '2019date', 'access', '', 'january', '19', '', '2020google', 'coronaviruses', 'already', 'identify', 'tip', 'iceberg', '', 'potentially', 'novel', 'severe', 'zoonotic', 'event', 'reveal', '', 'december', '', '2019', '', 'series', 'pneumonia', 'case', 'unknown', 'cause', 'emerge', 'wuhan', '', 'hubei', '', 'china', '', 'clinical', 'presentation', 'greatly', 'resemble', 'viral', 'pneumonia9whonovel', 'coronavirus', '', 'china', '', 'urlplaceholder', 'jan', '12', '', '2020date', 'access', '', 'january', '19', '', '2020google', 'deep', 'sequence', 'analysis', 'lower', 'respiratory', 'tract', 'sample', 'indicate', 'novel', 'coronavirus', '', 'name', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'thus', 'far', '', '800', 'confirm', 'case', '', 'include', 'health-care', 'worker', '', 'identify', 'wuhan', '', 'several', 'export', 'case', 'confirm', 'province', 'china', '', 'thailand', '', 'japan', '', 'south', 'korea', '', 'usa10whonovel', 'coronavirus', '', 'thailand', '', 'ex-china', '', '', 'urlplaceholder', 'jan', '14', '', '2020date', 'access', '', 'january', '19', '', '2020google', '', '11whonovel', 'coronavirus', '', 'japan', '', 'ex-china', '', '', 'urlplaceholder', 'jan', '17', '', '2020date', 'access', '', 'january', '19', '', '2020google', '', '12whonovel', 'coronavirus', '', 'republic', 'korea', '', 'ex-china', '', '', 'urlplaceholder', 'jan', '21', '', '2020date', 'access', '', 'january', '23', '', '2020google', '', '13cdcfirst', 'travel-related', 'case', '2019', 'novel', 'coronavirus', 'detect', 'united', 'states', '', 'urlplaceholder', 'jan', '21', '', '2020date', 'access', '', 'january', '23', '', '2020google', 'research', 'contextevidence', 'studyhuman', 'coronaviruses', '', 'include', 'hcov-229e', '', 'oc43', '', 'nl63', '', 'hku1', '', 'cause', 'mild', 'respiratory', 'disease', '', 'fatal', 'coronavirus', 'infection', 'emerge', 'past', 'two', 'decade', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'search', 'china', 'national', 'knowledge', 'infrastructure', 'database', 'article', 'publish', 'jan', '11', '', '2020', '', 'keywords', '', 'novel', 'coronovirus', '', '', '', '2019', 'novel', 'coronavirus', '', '', '', '2019-ncov', '', '', 'publish', 'work', 'human', 'infection', 'cause', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', 'identifiedadded', 'value', 'studywe', 'report', 'epidemiological', '', 'clinical', '', 'laboratory', '', 'radiological', 'characteristic', '', 'treatment', '', 'clinical', 'outcome', '41', 'laboratory-confirmed', 'case', 'infect', '2019-ncov', '', '27', '', '66', '', '', '41', 'patient', 'history', 'direct', 'exposure', 'huanan', 'seafood', 'market', '', 'median', 'age', 'patient', '490', 'year', '', 'iqr', '410580', '', '', '13', '', '32', '', '', 'patient', 'underlie', 'disease', '', 'patient', 'pneumonia', '', 'third', 'patient', 'admit', 'intensive', 'care', 'unit', '', 'six', 'die', '', 'high', 'concentration', 'cytokine', 'record', 'plasma', 'critically', 'ill', 'patient', 'infect', '2019-ncovimplications', 'available', 'evidence2019-ncov', 'cause', 'cluster', 'fatal', 'pneumonia', 'clinical', 'presentation', 'greatly', 'resemble', 'sars-cov', '', 'patients', 'infect', '2019-ncov', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', '', 'high', 'likelihood', 'admission', 'intensive', 'care', '', 'die', '', 'cytokine', 'storm', 'associate', 'disease', 'severity', '', 'effort', 'whole', 'spectrum', 'pathophysiology', 'new', 'disease', '', 'evidence', 'study', 'human', 'coronaviruses', '', 'include', 'hcov-229e', '', 'oc43', '', 'nl63', '', 'hku1', '', 'cause', 'mild', 'respiratory', 'disease', '', 'fatal', 'coronavirus', 'infection', 'emerge', 'past', 'two', 'decade', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'search', 'china', 'national', 'knowledge', 'infrastructure', 'database', 'article', 'publish', 'jan', '11', '', '2020', '', 'keywords', '', 'novel', 'coronovirus', '', '', '', '2019', 'novel', 'coronavirus', '', '', '', '2019-ncov', '', '', 'publish', 'work', 'human', 'infection', 'cause', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', 'identify', '', 'added', 'value', 'study', 'report', 'epidemiological', '', 'clinical', '', 'laboratory', '', 'radiological', 'characteristic', '', 'treatment', '', 'clinical', 'outcome', '41', 'laboratory-confirmed', 'case', 'infect', '2019-ncov', '', '27', '', '66', '', '', '41', 'patient', 'history', 'direct', 'exposure', 'huanan', 'seafood', 'market', '', 'median', 'age', 'patient', '490', 'year', '', 'iqr', '410580', '', '', '13', '', '32', '', '', 'patient', 'underlie', 'disease', '', 'patient', 'pneumonia', '', 'third', 'patient', 'admit', 'intensive', 'care', 'unit', '', 'six', 'die', '', 'high', 'concentration', 'cytokine', 'record', 'plasma', 'critically', 'ill', 'patient', 'infect', '2019-ncov', '', 'implications', 'available', 'evidence', '2019-ncov', 'cause', 'cluster', 'fatal', 'pneumonia', 'clinical', 'presentation', 'greatly', 'resemble', 'sars-cov', '', 'patients', 'infect', '2019-ncov', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', '', 'high', 'likelihood', 'admission', 'intensive', 'care', '', 'die', '', 'cytokine', 'storm', 'associate', 'disease', 'severity', '', 'effort', 'whole', 'spectrum', 'pathophysiology', 'new', 'disease', '', 'aim', 'describe', 'epidemiological', '', 'clinical', '', 'laboratory', '', 'radiological', 'characteristic', '', 'treatment', '', 'outcome', 'patient', 'confirm', '2019-ncov', 'infection', '', 'compare', 'clinical', 'feature', 'intensive', 'care', 'unit', '', 'icu', '', 'non-icu', 'patient', '', 'hope', 'study', 'find', 'inform', 'global', 'community', 'emergence', 'novel', 'coronavirus', 'clinical', 'feature', '', 'following', 'pneumonia', 'case', 'unknown', 'cause', 'report', 'wuhan', 'consider', 'share', 'history', 'exposure', 'huanan', 'seafood', 'market', 'across', 'patient', '', 'epidemiological', 'alert', 'release', 'local', 'health', 'authority', 'dec', '31', '', '2019', '', 'market', 'shut', 'jan', '1', '', '2020', '', 'meanwhile', '', '59', 'suspect', 'case', 'fever', 'dry', 'cough', 'transfer', 'designate', 'hospital', 'start', 'dec', '31', '', '2019', '', 'expert', 'team', 'physician', '', 'epidemiologist', '', 'virologist', '', 'government', 'official', 'soon', 'form', 'alert', '', 'since', 'cause', 'unknown', 'onset', 'emerge', 'infection', '', 'diagnosis', 'pneumonia', 'unknown', 'cause', 'wuhan', 'base', 'clinical', 'characteristic', '', 'chest', 'image', '', 'rule', 'common', 'bacterial', 'viral', 'pathogen', 'cause', 'pneumonia', '', 'suspected', 'patient', 'isolate', 'airborne', 'precaution', 'designate', 'hospital', '', 'jin', 'yin-tan', 'hospital', '', 'wuhan', '', 'china', '', '', 'fit-tested', 'n95', 'mask', 'airborne', 'precaution', 'aerosol-generating', 'procedure', '', 'study', 'approve', 'national', 'health', 'commission', 'china', 'ethics', 'commission', 'jin', 'yin-tan', 'hospital', '', 'ky-2020-0101', '', '', 'written', 'inform', 'consent', 'waive', 'ethics', 'commission', 'designate', 'hospital', 'emerge', 'infectious', 'disease', '', 'local', 'centre', 'disease', 'control', 'prevention', 'collect', 'respiratory', '', 'blood', '', 'faeces', 'specimen', '', 'ship', 'designate', 'authoritative', 'laboratory', 'detect', 'pathogen', '', 'nhc', 'key', 'laboratory', 'systems', 'biology', 'pathogens', 'christophe', 'mrieux', 'laboratory', '', 'beijing', '', 'china', '', '', 'novel', 'coronavirus', '', 'name', '2019-ncov', '', 'isolate', 'lower', 'respiratory', 'tract', 'specimen', 'diagnostic', 'test', 'virus', 'develop', 'soon', 'that14tan', 'w', 'zhao', 'x', 'x', 'ala', 'novel', 'coronavirus', 'genome', 'identify', 'cluster', 'pneumonia', 'case', '', 'wuhan', '', 'china', '20192020', '', 'urlplaceholder', 'access', '', 'january', '23', '', '2020google', '59', 'suspect', 'case', '', '41', 'patient', 'confirm', 'infect', '2019-ncov', '', 'presence', '2019-ncov', 'respiratory', 'specimen', 'detect', 'next-generation', 'sequence', 'real-time', 'rt-pcr', 'method', '', 'primer', 'probe', 'target', 'envelope', 'gene', 'cov', 'sequence', 'follow', '', 'forward', 'primer', '5-acttctttttcttgctttcgtggt-3', '', 'reverse', 'primer', '5-gcagcagtacgcacacaatc-3', '', 'probe', '5cy5-ctagttacactagccatccttactgc-3bhq1', '', 'conditions', 'amplification', '50c', '15', 'min', '', '95c', '3', 'min', '', 'follow', '45', 'cycle', '95c', '15', '60c', '30', 'initial', 'investigation', 'include', 'complete', 'blood', 'count', '', 'coagulation', 'profile', '', 'serum', 'biochemical', 'test', '', 'include', 'renal', 'liver', 'function', '', 'creatine', 'kinase', '', 'lactate', 'dehydrogenase', '', 'electrolyte', '', '', 'respiratory', 'specimen', '', 'include', 'nasal', 'pharyngeal', 'swab', '', 'bronchoalveolar', 'lavage', 'fluid', '', 'sputum', '', 'bronchial', 'aspirate', 'test', 'common', 'virus', '', 'include', 'influenza', '', 'avian', 'influenza', '', 'respiratory', 'syncytial', 'virus', '', 'adenovirus', '', 'parainfluenza', 'virus', '', 'sars-cov', 'mers-cov', 'real-time', 'rt-pcr', 'assay', 'approve', 'china', 'food', 'drug', 'administration', '', 'routine', 'bacterial', 'fungal', 'examination', 'perform', '', 'given', 'emergence', '2019-ncov', 'pneumonia', 'case', 'influenza', 'season', '', 'antibiotic', '', 'orally', 'intravenously', '', 'oseltamivir', '', 'orally', '75', 'mg', 'twice', 'daily', '', 'empirically', 'administer', '', 'corticosteroid', 'therapy', '', 'methylprednisolone', '40120', 'mg', 'per', 'day', '', 'give', 'combine', 'regimen', 'severe', 'community-acquired', 'pneumonia', 'diagnose', 'physician', 'designate', 'hospital', '', 'oxygen', 'support', '', 'eg', '', 'nasal', 'cannula', 'invasive', 'mechanical', 'ventilation', '', 'administer', 'patient', 'accord', 'severity', 'hypoxaemia', '', 'repeated', 'test', '2019-ncov', 'patient', 'confirm', '2019-ncov', 'infection', 'show', 'viral', 'clearance', 'hospital', 'discharge', 'discontinuation', 'isolation', '', 'review', 'clinical', 'chart', '', 'nurse', 'record', '', 'laboratory', 'find', '', 'chest', 'x-ray', 'patient', 'laboratory-confirmed', '2019-ncov', 'infection', 'report', 'local', 'health', 'authority', '', 'admission', 'data', 'patient', 'dec', '16', '', '2019', '', 'jan', '2', '', '2020', '', 'epidemiological', '', 'clinical', '', 'laboratory', '', 'radiological', 'characteristic', 'treatment', 'outcome', 'data', 'obtain', 'standardise', 'data', 'collection', 'form', '', 'modify', 'case', 'record', 'form', 'severe', 'acute', 'respiratory', 'infection', 'clinical', 'characterisation', 'share', 'international', 'severe', 'acute', 'respiratory', 'emerging', 'infection', 'consortium', '', 'electronic', 'medical', 'record', '', 'two', 'researcher', 'independently', 'review', 'data', 'collection', 'form', 'double', 'check', 'data', 'collect', '', 'ascertain', 'epidemiological', 'symptom', 'data', '', 'available', 'electronic', 'medical', 'record', '', 'researcher', 'directly', 'communicate', 'patient', 'family', 'ascertain', 'epidemiological', 'symptom', 'data', '', 'characterise', 'effect', 'coronavirus', 'production', 'cytokine', 'chemokines', 'acute', 'phase', 'illness', '', 'plasma', 'cytokine', 'chemokines', '', 'il1b', '', 'il1ra', '', 'il2', '', 'il4', '', 'il5', '', 'il6', '', 'il7', '', 'il8', '', 'cxcl8', '', '', 'il9', '', 'il10', '', 'il12p70', '', 'il13', '', 'il15', '', 'il17a', '', 'eotaxin', '', 'ccl11', '', '', 'basic', 'fgf2', '', 'gcsf', '', 'csf3', '', '', 'gmcsf', '', 'csf2', '', '', 'ifn', '', 'ip10', '', 'cxcl10', '', '', 'mcp1', '', 'ccl2', '', '', 'mip1a', '', 'ccl3', '', '', 'mip1b', '', 'ccl4', '', '', 'pdgfb', '', 'rantes', '', 'ccl5', '', '', 'certolizumab', '', 'vegfa', 'measure', 'human', 'cytokine', 'standard', '27-plex', 'assays', 'panel', 'bio-plex', '200', 'system', '', 'bio-rad', '', 'hercules', '', 'ca', '', 'usa', '', 'patient', 'accord', 'manufacturer', 'instruction', '', 'plasma', 'sample', 'four', 'healthy', 'adult', 'control', 'cross-comparison', '', 'median', 'time', 'transfer', 'designate', 'hospital', 'blood', 'sample', 'collection', '4', 'day', '', 'iqr', '25', '', '', '80', 'l', 'plasma', 'sample', 'patient', 'contact', 'add', '240', 'l', 'trizol', 'ls', '', '10296028', '', 'thermo', 'fisher', 'scientific', '', 'carlsbad', '', 'ca', '', 'usa', '', 'biosafety', 'level', '3', 'laboratory', '', 'total', 'rna', 'extract', 'direct-zol', 'rna', 'miniprep', 'kit', '', 'r2050', '', 'zymo', 'research', '', 'irvine', '', 'ca', '', 'usa', '', 'accord', 'manufacturer', 'instruction', '50', 'l', 'elution', 'obtain', 'sample', '', '5', 'l', 'rna', 'real-time', 'rt-pcr', '', 'target', 'np', 'gene', 'agpath-id', 'one-step', 'rt-pcr', 'reagent', '', 'am1005', '', 'thermo', 'fisher', 'scientific', '', '', 'final', 'reaction', 'mix', 'concentration', 'primer', '500', 'nm', 'probe', '200', 'nm', '', 'real-time', 'rt-pcr', 'perform', 'follow', 'condition', '', '50c', '15', 'min', '95c', '3', 'min', '', '50', 'cycle', 'amplification', '95c', '10', '60c', '45', 'since', 'perform', 'test', 'detect', 'infectious', 'virus', 'blood', '', 'avoid', 'term', 'viraemia', 'rnaaemia', 'instead', '', 'rnaaemia', 'define', 'positive', 'result', 'real-time', 'rt-pcr', 'plasma', 'sample', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'shock', 'define', 'accord', 'interim', 'guidance', 'novel', 'coronavirus9whonovel', 'coronavirus', '', 'china', '', 'urlplaceholder', 'jan', '12', '', '2020date', 'access', '', 'january', '19', '', '2020google', 'hypoxaemia', 'define', 'arterial', 'oxygen', 'tension', '', 'pao2', '', 'inspiratory', 'oxygen', 'fraction', '', 'fio2', '', 'le', '300', 'mm', 'hg15sanz', 'f', 'gimeno', 'c', 'lloret', 'alrelationship', 'presence', 'hypoxemia', 'inflammatory', 'response', 'measure', 'c-reactive', 'protein', 'bacteremic', 'pneumococcal', 'pneumoniaeur', 'respir', 'j', '', '2011', '', '38', '', '2492google', 'acute', 'kidney', 'injury', 'identify', 'classify', 'basis', 'highest', 'serum', 'creatinine', 'level', 'urine', 'output', 'criterion', 'accord', 'kidney', 'disease', 'improve', 'global', 'outcome', 'classification16kidney', 'disease', '', 'improve', 'global', 'outcome', '', 'kdigo', '', 'acute', 'kidney', 'injury', 'work', 'groupkdigo', 'clinical', 'practice', 'guideline', 'acute', 'kidney', 'injury', '', 'urlplaceholder', 'march', '', '2012date', 'access', '', 'january', '23', '', '2020google', 'secondary', 'infection', 'diagnose', 'patient', 'clinical', 'symptom', 'sign', 'nosocomial', 'pneumonia', 'bacteraemia', '', 'combine', 'positive', 'culture', 'new', 'pathogen', 'lower', 'respiratory', 'tract', 'specimen', '', 'include', 'sputum', '', 'transtracheal', 'aspirate', '', 'bronchoalveolar', 'lavage', 'fluid', '', 'blood', 'sample', '48', 'h', 'admission', '', '17garner', 'js', 'jarvis', 'wr', 'emori', 'tg', 'horan', 'tc', 'hughes', 'jm', 'cdc', 'definition', 'nosocomial', 'infection', '', '1988am', 'j', 'infect', 'control', '', '1988', '', '16', '', '128-140google', 'cardiac', 'injury', 'follow', 'definition', 'previous', 'study', 'h7n9', 'patients18gao', 'c', 'wang', 'gu', 'x', 'alassociation', 'cardiac', 'injury', 'mortality', 'hospitalize', 'patient', 'infect', 'avian', 'influenza', '', 'h7n9', '', 'viruscrit', 'care', 'med', '', '2020', '', '', 'publish', 'online', 'jan', '20', '', 'doi101097ccm0000000000004207google', 'brief', '', 'cardiac', 'injury', 'diagnose', 'serum', 'level', 'cardiac', 'biomarkers', '', 'eg', '', 'troponin', '', '99th', 'percentile', 'upper', 'reference', 'limit', '', 'new', 'abnormality', 'show', 'electrocardiography', 'echocardiography', '', 'continuous', 'variable', 'express', 'median', '', 'iqr', '', 'compare', 'mann-whitney', 'u', 'test', '', 'categorical', 'variable', 'express', 'number', '', '', '', 'compare', '2', 'test', 'fisher', 'exact', 'test', 'icu', 'care', 'icu', 'care', 'group', '', 'boxplots', 'draw', 'describe', 'plasma', 'cytokine', 'chemokine', 'concentration', '', 'two-sided', '', 'le', '005', 'consider', 'statistically', 'significant', '', 'statistical', 'analysis', 'sas', 'software', '', 'version', '94', '', 'unless', 'otherwise', 'indicate', '', 'funder', 'study', 'role', 'study', 'design', '', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'correspond', 'author', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', 'jan', '2', '', '2020', '', '41', 'admit', 'hospital', 'patient', 'identify', 'laboratory-confirmed', '2019-ncov', 'infection', 'wuhan', '', '20', '', '49', '', '', '', '2019-ncov-infected', 'patient', 'age', '2549', 'year', '', '14', '', '34', '', '', 'age', '5064', 'year', '', 'figure', '1a', '', '', 'median', 'age', 'patient', '490', 'year', '', 'iqr', '410580', '', 'table', '1', '', '', 'cohort', 'first', '41', 'patient', 'jan', '2', '', 'child', 'adolescent', 'infect', '', '41', 'patient', '', '13', '', '32', '', '', 'admit', 'icu', 'require', 'high-flow', 'nasal', 'cannula', 'higher-level', 'oxygen', 'support', 'measure', 'correct', 'hypoxaemia', '', 'infect', 'patient', 'men', '', '30', '', '73', '', '', '', '', 'le', 'half', 'underlie', 'disease', '', '13', '', '32', '', '', '', '', 'include', 'diabetes', '', 'eight', '', '20', '', '', '', '', 'hypertension', '', 'six', '', '15', '', '', '', '', 'cardiovascular', 'disease', '', 'six', '', '15', '', '', '', 'figure', '1date', 'illness', 'onset', 'age', 'distribution', 'patient', 'laboratory-confirmed', '2019-ncov', 'infectionshow', 'full', 'caption', '', '', 'number', 'hospital', 'admission', 'age', 'group', '', '', 'b', '', 'distribution', 'symptom', 'onset', 'date', 'laboratory-confirmed', 'case', '', 'wuhan', 'local', 'health', 'authority', 'issue', 'epidemiological', 'alert', 'dec', '30', '', '2019', '', 'close', 'huanan', 'seafood', 'market', '2', 'day', 'laterview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'table', '1demographics', 'baseline', 'characteristic', 'patient', 'infect', '2019-ncovall', 'patient', '', 'n41', '', 'icu', 'care', '', 'n13', '', 'icu', 'care', '', 'n28', '', 'p', 'valuecharacteristicsage', '', 'years490', '', '410580', '', '490', '', '410610', '', '490', '', '410575', '', '060sex', '', '024men30', '', '73', '', '', '11', '', '85', '', '', '19', '', '68', '', '', '', 'women11', '', '27', '', '', '2', '', '15', '', '', '9', '', '32', '', '', '', 'huanan', 'seafood', 'market', 'exposure27', '', '66', '', '', '9', '', '69', '', '', '18', '', '64', '', '', '075current', 'smoking3', '', '7', '', '', '03', '', '11', '', '', '031any', 'comorbidity13', '', '32', '', '', '5', '', '38', '', '', '8', '', '29', '', '', '053diabetes8', '', '20', '', '', '1', '', '8', '', '', '7', '', '25', '', '', '016hypertension6', '', '15', '', '', '2', '', '15', '', '', '4', '', '14', '', '', '093cardiovascular', 'disease6', '', '15', '', '', '3', '', '23', '', '', '3', '', '11', '', '', '032chronic', 'obstructive', 'pulmonary', 'disease1', '', '2', '', '', '1', '', '8', '', '', '0014malignancy1', '', '2', '', '', '01', '', '4', '', '', '049chronic', 'liver', 'disease1', '', '2', '', '', '01', '', '4', '', '', '068signs', 'symptomsfever40', '', '98', '', '', '13', '', '100', '', '', '27', '', '96', '', '', '068highest', 'temperature', '', 'c', '', '0037', '', '3731', '', '2', '', '', '01', '', '4', '', '', '', '3733808', '', '20', '', '', '3', '', '23', '', '', '5', '', '18', '', '', '', '38139018', '', '44', '', '', '7', '', '54', '', '', '11', '', '39', '', '', '', '', '39014', '', '34', '', '', '3', '', '23', '', '', '11', '', '39', '', '', '', 'cough31', '', '76', '', '', '11', '', '85', '', '', '20', '', '71', '', '', '035myalgia', 'fatigue18', '', '44', '', '', '7', '', '54', '', '', '11', '', '39', '', '', '038sputum', 'production1139', '', '28', '', '', '5', '', '38', '', '', '626', '', '23', '', '', '032headache338', '', '8', '', '', '0325', '', '12', '', '', '010haemoptysis239', '', '5', '', '', '1', '', '8', '', '', '126', '', '4', '', '', '046diarrhoea138', '', '3', '', '', '0125', '', '4', '', '', '066dyspnoea2240', '', '55', '', '', '12', '', '92', '', '', '1027', '', '37', '', '', '00010days', 'illness', 'onset', 'dyspnoea80', '', '50130', '', '80', '', '60170', '', '65', '', '20100', '', '022days', 'first', 'admission', 'transfer50', '', '1080', '', '80', '', '50140', '', '10', '', '1065', '', '00023systolic', 'pressure', '', 'mm', 'hg1250', '', '11901350', '', '1450', '', '12301670', '', '1220', '', '11851295', '', '0018respiratory', 'rate', '', '24', 'breath', 'per', 'min12', '', '29', '', '', '8', '', '62', '', '', '4', '', '14', '', '', '00023data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'n', 'total', 'number', 'patient', 'available', 'data', '', 'p', 'value', 'compare', 'icu', 'care', 'icu', 'care', '2', 'test', '', 'fisher', 'exact', 'test', '', 'mann-whitney', 'u', 'test', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'icuintensive', 'care', 'unit', '', 'open', 'table', 'new', 'tab', '', '', 'number', 'hospital', 'admission', 'age', 'group', '', '', 'b', '', 'distribution', 'symptom', 'onset', 'date', 'laboratory-confirmed', 'case', '', 'wuhan', 'local', 'health', 'authority', 'issue', 'epidemiological', 'alert', 'dec', '30', '', '2019', '', 'close', 'huanan', 'seafood', 'market', '2', 'day', 'later', '', 'data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'n', 'total', 'number', 'patient', 'available', 'data', '', 'p', 'value', 'compare', 'icu', 'care', 'icu', 'care', '2', 'test', '', 'fisher', 'exact', 'test', '', 'mann-whitney', 'u', 'test', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'icuintensive', 'care', 'unit', '', '27', '', '66', '', '', 'patient', 'direct', 'exposure', 'huanan', 'seafood', 'market', '', 'figure', '1b', '', '', 'market', 'exposure', 'similar', 'patient', 'icu', 'care', '', 'nine', '', '69', '', '', '', 'non-icu', 'care', '', '18', '', '64', '', '', '', '', 'symptom', 'onset', 'date', 'first', 'patient', 'identify', 'dec', '1', '', '2019', '', 'none', 'family', 'member', 'develop', 'fever', 'respiratory', 'symptom', '', 'epidemiological', 'link', 'find', 'first', 'patient', 'later', 'case', '', 'first', 'fatal', 'case', '', 'continuous', 'exposure', 'market', '', 'admit', 'hospital', '7-day', 'history', 'fever', '', 'cough', '', 'dyspnoea', '', '5', 'day', 'illness', 'onset', '', 'wife', '', '53-year-old', 'woman', 'history', 'exposure', 'market', '', 'present', 'pneumonia', 'hospitalise', 'isolation', 'ward', '', 'common', 'symptom', 'onset', 'illness', 'fever', '', '40', '', '98', '', '', '41', 'patient', '', '', 'cough', '', '31', '', '76', '', '', '', '', 'myalgia', 'fatigue', '', '18', '', '44', '', '', '', '', 'le', 'common', 'symptom', 'sputum', 'production', '', '11', '', '28', '', '', '39', '', '', 'headache', '', 'three', '', '8', '', '', '38', '', '', 'haemoptysis', '', 'two', '', '5', '', '', '39', '', '', 'diarrhoea', '', 'one', '', '3', '', '', '38', '', 'table', '1', '', '', 'half', 'patient', '', '22', '', '55', '', '', '40', '', 'develop', 'dyspnoea', '', 'median', 'duration', 'illness', 'onset', 'dyspnoea', '80', 'day', '', 'iqr', '50130', '', '', 'median', 'time', 'onset', 'symptom', 'first', 'hospital', 'admission', '70', 'day', '', '4080', '', '', 'shortness', 'breath', '80', 'day', '', '50130', '', '', 'ards', '90', 'day', '', '80140', '', '', 'mechanical', 'ventilation', '105', 'day', '', '70140', '', '', 'icu', 'admission', '105', 'day', '', '80170', '', 'figure', '2', '', 'figure', '2timeline', '2019-ncov', 'case', 'onset', 'illnessview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'blood', 'count', 'patient', 'admission', 'show', 'leucopenia', '', 'white', 'blood', 'cell', 'count', 'le', '4', '', '109l', '', 'ten', '', '25', '', '', '40', 'patient', '', 'lymphopenia', '', 'lymphocyte', 'count', '', '10', '', '109l', '', '26', '', '63', '', '', 'patient', '', 'table', '2', '', '', 'prothrombin', 'time', 'd-dimer', 'level', 'admission', 'higher', 'icu', 'patient', '', 'median', 'prothrombin', 'time', '122', '', 'iqr', '112134', '', '', 'median', 'd-dimer', 'level', '24', 'mgl', '', '06144', '', '', 'non-icu', 'patient', '', 'median', 'prothrombin', 'time', '107', '', '98121', '', '', 'p0012', '', 'median', 'd-dimer', 'level', '05', 'mgl', '', '0308', '', '', 'p00042', '', '', 'levels', 'aspartate', 'aminotransferase', 'increase', '15', '', '37', '', '', '41', 'patient', '', 'include', 'eight', '', '62', '', '', '13', 'icu', 'patient', 'seven', '', '25', '', '', '28', 'non-icu', 'patient', '', 'hypersensitive', 'troponin', '', 'hs-ctni', '', 'increase', 'substantially', 'five', 'patient', '', 'diagnosis', 'virus-related', 'cardiac', 'injury', 'madetable', '2laboratory', 'find', 'patient', 'infect', '2019-ncov', 'admission', 'hospitalall', 'patient', '', 'n41', '', 'icu', 'care', '', 'n13', '', 'icu', 'care', '', 'n28', '', 'p', 'valuewhite', 'blood', 'cell', 'count', '', '', '109l62', '', '41105', '', '113', '', '58121', '', '57', '', '3176', '', '0011', '', '41040', '', '25', '', '', '113', '', '8', '', '', '927', '', '33', '', '', '00414101840', '', '45', '', '', '513', '', '38', '', '', '1327', '', '48', '', '', '', '', '101240', '', '30', '', '', '713', '', '54', '', '', '527', '', '19', '', '', '', 'neutrophil', 'count', '', '', '109l50', '', '3389', '', '106', '', '50118', '', '44', '', '2061', '', '000069lymphocyte', 'count', '', '', '109l08', '', '0611', '', '04', '', '0208', '', '10', '', '0711', '', '00041', '', '102641', '', '63', '', '', '1113', '', '85', '', '', '1528', '', '54', '', '', '0045101541', '', '37', '', '', '213', '', '15', '', '', '1328', '', '46', '', '', '', 'haemoglobin', '', 'gl1260', '', '11801400', '', '1220', '', '11101280', '', '1305', '', '12001400', '', '020platelet', 'count', '', '', '109l1645', '', '13152630', '', '1960', '', '16502630', '', '1490', '', '13102630', '', '045', '', '100240', '', '5', '', '', '113', '', '8', '', '', '127', '', '4', '', '', '0451003840', '', '95', '', '', '1213', '', '92', '', '', '2627', '', '96', '', '', '', 'prothrombin', 'time', '', 's111', '', '101124', '', '122', '', '112134', '', '107', '', '98121', '', '0012activated', 'partial', 'thromboplastin', 'time', '', 's270', '', '242341', '', '262', '', '225339', '', '277', '', '248341', '', '057d-dimer', '', 'mgl05', '', '0313', '', '24', '', '06144', '', '05', '', '0308', '', '00042albumin', '', 'gl314', '', '289360', '', '279', '', '263309', '', '347', '', '302365', '', '000066alanine', 'aminotransferase', '', 'ul320', '', '210500', '', '490', '', '2901150', '', '270', '', '195400', '', '0038aspartate', 'aminotransferase', '', 'ul340', '', '260480', '', '440', '', '300700', '', '340', '', '240405', '', '010402641', '', '63', '', '', '513', '', '38', '', '', '2128', '', '75', '', '', '0025', '', '401541', '', '37', '', '', '813', '', '62', '', '', '728', '', '25', '', '', '', 'total', 'bilirubin', '', 'mmoll117', '', '95139', '', '140', '', '119329', '', '108', '', '94123', '', '0011potassium', '', 'mmoll42', '', '3848', '', '46', '', '4050', '', '41', '', '3846', '', '027sodium', '', 'mmoll1390', '', '13701400', '', '1380', '', '13701390', '', '1390', '', '13751405', '', '026creatinine', '', 'moll742', '', '575857', '', '790', '', '531927', '', '733', '', '575847', '', '0841333741', '', '90', '', '', '1113', '', '85', '', '', '2628', '', '93', '', '', '042', '', '133441', '', '10', '', '', '213', '', '15', '', '', '228', '', '7', '', '', '', 'creatine', 'kinase', '', 'ul1325', '', '6202190', '', '1320', '', '8204930', '', '1330', '', '6101890', '', '0311852740', '', '68', '', '', '713', '', '54', '', '', '2027', '', '74', '', '', '021', '', '1851340', '', '33', '', '', '613', '', '46', '', '', '727', '', '26', '', '', '', 'lactate', 'dehydrogenase', '', 'ul2860', '', '24204080', '', '4000', '', '32305780', '', '2810', '', '23303570', '', '000442451140', '', '28', '', '', '113', '', '8', '', '', '1027', '', '37', '', '', '0036', '', '2452940', '', '73', '', '', '1213', '', '92', '', '', '1727', '', '63', '', '', '', 'hypersensitive', 'troponin', '', 'pgml34', '', '1191', '', '33', '', '301630', '', '35', '', '0754', '', '0075', '', '28', '', '99th', 'percentile', '', '541', '', '12', '', '', '413', '', '31', '', '', '128', '', '4', '', '', '0017procalcitonin', '', 'ngml01', '', '0101', '', '01', '', '0104', '', '01', '', '0101', '', '0031', '', '012739', '', '69', '', '', '612', '', '50', '', '', '2127', '', '78', '', '', '002901', '', '025739', '', '18', '', '', '312', '', '25', '', '', '427', '', '15', '', '', '', '025', '', '05239', '', '5', '', '', '012227', '', '7', '', '', '', '05339', '', '8', '', '', '312', '', '25', '', '', '', '', 'complicated', 'typical', 'secondary', 'infection', 'first', 'hospitalisation027', '', 'bilateral', 'involvement', 'chest', 'radiographs4041', '', '98', '', '', '1313', '', '100', '', '', '2728', '', '96', '', '', '068cycle', 'threshold', 'respiratory', 'tract322', '', '310345', '', '311', '', '300335', '', '322', '', '311347', '', '039data', 'median', '', 'iqr', '', 'nn', '', '', '', '', 'n', 'total', 'number', 'patient', 'available', 'data', '', 'p', 'value', 'compare', 'icu', 'care', 'icu', 'care', '2', '', 'fisher', 'exact', 'test', '', 'mann-whitney', 'u', 'test', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'icuintensive', 'care', 'unit', '', '', 'complicated', 'typical', 'secondary', 'infection', 'first', 'hospitalisation', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', 'nn', '', '', '', '', 'n', 'total', 'number', 'patient', 'available', 'data', '', 'p', 'value', 'compare', 'icu', 'care', 'icu', 'care', '2', '', 'fisher', 'exact', 'test', '', 'mann-whitney', 'u', 'test', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'icuintensive', 'care', 'unit', '', 'patient', 'normal', 'serum', 'level', 'procalcitonin', 'admission', '', 'procalcitonin', '', '01', 'ngml', '', '27', '', '69', '', '', 'patient', '', 'table', '2', '', '', 'four', 'icu', 'patient', 'develop', 'secondary', 'infection', '', 'three', 'four', 'patient', 'secondary', 'infection', 'procalcitonin', 'greater', '05', 'ngml', '', '069', 'ngml', '', '146', 'ngml', '', '648', 'ngml', '', '', 'admission', '', 'abnormality', 'chest', 'ct', 'image', 'detect', 'among', 'patient', '', '41', 'patient', '', '40', '', '98', '', '', 'bilateral', 'involvement', '', 'table', '2', '', '', 'typical', 'find', 'chest', 'ct', 'image', 'icu', 'patient', 'admission', 'bilateral', 'multiple', 'lobular', 'subsegmental', 'area', 'consolidation', '', 'figure', '3a', '', '', 'representative', 'chest', 'ct', 'find', 'non-icu', 'patient', 'show', 'bilateral', 'ground-glass', 'opacity', 'subsegmental', 'area', 'consolidation', '', 'figure', '3b', '', '', 'later', 'chest', 'ct', 'image', 'show', 'bilateral', 'ground-glass', 'opacity', '', 'whereas', 'consolidation', 'resolve', '', 'figure', '3c', '', 'figure', '3chest', 'ct', 'imagesshow', 'full', 'caption', '', '', 'transverse', 'chest', 'ct', 'image', '40-year-old', 'man', 'show', 'bilateral', 'multiple', 'lobular', 'subsegmental', 'area', 'consolidation', 'day', '15', 'symptom', 'onset', '', 'transverse', 'chest', 'ct', 'image', '53-year-old', 'woman', 'show', 'bilateral', 'ground-glass', 'opacity', 'subsegmental', 'area', 'consolidation', 'day', '8', 'symptom', 'onset', '', 'b', '', '', 'bilateral', 'ground-glass', 'opacity', 'day', '12', 'symptom', 'onset', '', 'c', '', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'transverse', 'chest', 'ct', 'image', '40-year-old', 'man', 'show', 'bilateral', 'multiple', 'lobular', 'subsegmental', 'area', 'consolidation', 'day', '15', 'symptom', 'onset', '', 'transverse', 'chest', 'ct', 'image', '53-year-old', 'woman', 'show', 'bilateral', 'ground-glass', 'opacity', 'subsegmental', 'area', 'consolidation', 'day', '8', 'symptom', 'onset', '', 'b', '', '', 'bilateral', 'ground-glass', 'opacity', 'day', '12', 'symptom', 'onset', '', 'c', '', '', 'initial', 'plasma', 'il1b', '', 'il1ra', '', 'il7', '', 'il8', '', 'il9', '', 'il10', '', 'basic', 'fgf', '', 'gcsf', '', 'gmcsf', '', 'ifn', '', 'ip10', '', 'mcp1', '', 'mip1a', '', 'mip1b', '', 'pdgf', '', 'certolizumab', '', 'vegf', 'concentration', 'higher', 'icu', 'patient', 'non-icu', 'patient', 'healthy', 'adult', '', 'appendix', 'pp', '67', '', '', 'plasma', 'level', 'il5', '', 'il12p70', '', 'il15', '', 'eotaxin', '', 'rantes', 'similar', 'healthy', 'adult', 'patient', 'infect', '2019-ncov', '', 'comparison', 'icu', 'non-icu', 'patient', 'show', 'plasma', 'concentration', 'il2', '', 'il7', '', 'il10', '', 'gcsf', '', 'ip10', '', 'mcp1', '', 'mip1a', '', 'certolizumab', 'higher', 'icu', 'patient', 'non-icu', 'patient', '', 'patient', 'pneumonia', '', 'common', 'complication', 'include', 'ards', '', '12', '', '29', '', '', '41', 'patient', '', '', 'follow', 'rnaaemia', '', 'six', '', '15', '', '', 'patient', '', '', 'acute', 'cardiac', 'injury', '', 'five', '', '12', '', '', 'patient', '', '', 'secondary', 'infection', '', 'four', '', '10', '', '', 'patient', '', 'table', '3', '', '', 'invasive', 'mechanical', 'ventilation', 'require', 'four', '', '10', '', '', 'patient', '', 'two', '', '5', '', '', 'refractory', 'hypoxaemia', 'receive', 'extracorporeal', 'membrane', 'oxygenation', 'salvage', 'therapy', '', 'patient', 'administer', 'empirical', 'antibiotic', 'treatment', '', '38', '', '93', '', '', 'patient', 'receive', 'antiviral', 'therapy', '', 'oseltamivir', '', '', 'additionally', '', 'nine', '', '22', '', '', 'patient', 'give', 'systematic', 'corticosteroid', '', 'comparison', 'clinical', 'feature', 'patient', 'receive', 'receive', 'systematic', 'corticosteroid', 'appendix', '', 'pp', '15', '', 'table', '3treatments', 'outcome', 'patient', 'infect', '2019-ncovall', 'patient', '', 'n41', '', 'icu', 'care', '', 'n13', '', 'icu', 'care', '', 'n28', '', 'p', 'valueduration', 'illness', 'onset', 'first', 'admission70', '', '4080', '', '70', '', '4080', '', '70', '', '4085', '', '087complicationsacute', 'respiratory', 'distress', 'syndrome12', '', '29', '', '', '11', '', '85', '', '', '1', '', '4', '', '', '', '00001rnaaemia6', '', '15', '', '', '2', '', '15', '', '', '4', '', '14', '', '', '093cycle', 'threshold', 'rnaaemia351', '', '347351', '', '351', '', '351351', '', '348', '', '341354', '', '035acute', 'cardiac', 'injury', '', '', 'defined', 'blood', 'level', 'hypersensitive', 'troponin', '99th', 'percentile', 'upper', 'reference', 'limit', '', '', '28', 'pgml', '', 'new', 'abnormality', 'show', 'electrocardiography', 'echocardiography5', '', '12', '', '', '4', '', '31', '', '', '1', '', '4', '', '', '0017acute', 'kidney', 'injury3', '', '7', '', '', '3', '', '23', '', '', '00027secondary', 'infection4', '', '10', '', '', '4', '', '31', '', '', '000014shock3', '', '7', '', '', '3', '', '23', '', '', '00027treatmentantiviral', 'therapy38', '', '93', '', '', '12', '', '92', '', '', '26', '', '93', '', '', '046antibiotic', 'therapy41', '', '100', '', '', '13', '', '100', '', '', '28', '', '100', '', '', 'nause', 'corticosteroid9', '', '22', '', '', '6', '', '46', '', '', '3', '', '11', '', '', '0013continuous', 'renal', 'replacement', 'therapy3', '', '7', '', '', '3', '', '23', '', '', '00027oxygen', 'support', '', '', '00001nasal', 'cannula27', '', '66', '', '', '1', '', '8', '', '', '26', '', '93', '', '', '', 'non-invasive', 'ventilation', 'high-flow', 'nasal', 'cannula10', '', '24', '', '', '8', '', '62', '', '', '2', '', '7', '', '', '', 'invasive', 'mechanical', 'ventilation2', '', '5', '', '', '2', '', '15', '', '', '0', '', 'invasive', 'mechanical', 'ventilation', 'ecmo2', '', '5', '', '', '2', '', '15', '', '', '0', '', 'prognosis', '', '0014hospitalisation7', '', '17', '', '', '1', '', '8', '', '', '6', '', '21', '', '', '', 'discharge28', '', '68', '', '', '7', '', '54', '', '', '21', '', '75', '', '', '', 'death6', '', '15', '', '', '5', '', '38', '', '', '1', '', '4', '', '', '', 'data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'p', 'value', 'compare', 'icu', 'care', 'icu', 'care', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'icuintensive', 'care', 'unit', '', 'nanot', 'applicable', '', 'ecmoextracorporeal', 'membrane', 'oxygenation', '', '', 'defined', 'blood', 'level', 'hypersensitive', 'troponin', '99th', 'percentile', 'upper', 'reference', 'limit', '', '', '28', 'pgml', '', 'new', 'abnormality', 'show', 'electrocardiography', 'echocardiography', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'p', 'value', 'compare', 'icu', 'care', 'icu', 'care', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'icuintensive', 'care', 'unit', '', 'nanot', 'applicable', '', 'ecmoextracorporeal', 'membrane', 'oxygenation', '', 'jan', '22', '', '2020', '', '28', '', '68', '', '', '41', 'patient', 'discharge', 'six', '', '15', '', '', 'patient', 'die', '', 'fitness', 'discharge', 'base', 'abatement', 'fever', 'least', '10', 'day', '', 'improvement', 'chest', 'radiographic', 'evidence', 'viral', 'clearance', 'respiratory', 'sample', 'upper', 'respiratory', 'tract', '', 'report', 'cohort', '41', 'patient', 'laboratory-confirmed', '2019-ncov', 'infection', '', 'patients', 'serious', '', 'sometimes', 'fatal', '', 'pneumonia', 'admit', 'designate', 'hospital', 'wuhan', '', 'china', '', 'jan', '2', '', '2020', '', 'clinical', 'presentation', 'greatly', 'resemble', 'sars-cov', '', 'patients', 'severe', 'illness', 'develop', 'ards', 'require', 'icu', 'admission', 'oxygen', 'therapy', '', 'time', 'hospital', 'admission', 'ards', 'short', '2', 'day', '', 'stage', '', 'mortality', 'rate', 'high', '2019-ncov', '', 'six', '', '15', '', '', '41', 'patient', 'cohort', 'die', '', 'number', 'death', 'rise', 'quickly', '', 'jan', '24', '', '2020', '', '835', 'laboratory-confirmed', '2019-ncov', 'infection', 'report', 'china', '', '25', 'fatal', 'case', '', 'reports', 'release', 'export', 'case', 'province', 'china', '', 'country', '', 'health-care', 'worker', 'infect', 'wuhan', '', 'taken', 'together', '', 'evidence', 'far', 'indicate', 'human', 'transmission', '2019-ncov', '', 'concern', '2019-ncov', 'acquire', 'ability', 'efficient', 'human', 'transmission19perlman', 'netland', 'j', 'coronaviruses', 'post-sars', '', 'update', 'replication', 'pathogenesisnat', 'rev', 'microbiol', '', '2009', '', '7', '', '439-450google', 'airborne', 'precaution', '', 'fit-tested', 'n95', 'respirator', '', 'personal', 'protective', 'equipment', 'strongly', 'recommend', '', 'prevent', 'spread', 'disease', 'health-care', 'set', 'care', 'patient', 'infect', '2019-ncov', '', 'onset', 'fever', 'respiratory', 'symptom', 'closely', 'monitor', 'among', 'health-care', 'worker', '', 'testing', 'respiratory', 'specimen', 'immediately', 'diagnosis', 'suspect', '', 'serum', 'antibody', 'test', 'among', 'health-care', 'worker', 'exposure', '2019-ncov', 'identification', 'asymptomatic', 'infection', '', 'similarities', 'clinical', 'feature', '2019-ncov', 'previous', 'betacoronavirus', 'infection', 'note', '', 'cohort', '', 'patient', 'present', 'fever', '', 'dry', 'cough', '', 'dyspnoea', '', 'bilateral', 'ground-glass', 'opacity', 'chest', 'ct', 'scan', '', 'feature', '2019-ncov', 'infection', 'bear', 'resemblance', 'sars-cov', 'mers-cov', 'infections20lee', 'n', 'hui', 'wu', 'ala', 'major', 'outbreak', 'severe', 'acute', 'respiratory', 'syndrome', 'hong', 'kongn', 'engl', 'j', 'med', '', '2003', '', '348', '', '1986-1994google', '', '21assiri', 'al-tawfiq', 'ja', 'al-rabeeah', 'aa', 'alepidemiological', '', 'demographic', '', 'clinical', 'characteristic', '47', 'case', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'disease', 'saudi', 'arabia', '', 'descriptive', 'studylancet', 'infect', 'dis', '', '2013', '', '13', '', '752-761google', 'however', '', 'patient', '2019-ncov', 'infection', 'prominent', 'upper', 'respiratory', 'tract', 'sign', 'symptom', '', 'eg', '', 'rhinorrhoea', '', 'sneeze', '', 'sore', 'throat', '', '', 'indicate', 'target', 'cell', 'locate', 'lower', 'airway', '', 'furthermore', '', '2019-ncov', 'patient', 'rarely', 'develop', 'intestinal', 'sign', 'symptom', '', 'eg', '', 'diarrhoea', '', '', 'whereas', '2025', '', 'patient', 'mers-cov', 'sars-cov', 'infection', 'diarrhoea21assiri', 'al-tawfiq', 'ja', 'al-rabeeah', 'aa', 'alepidemiological', '', 'demographic', '', 'clinical', 'characteristic', '47', 'case', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'disease', 'saudi', 'arabia', '', 'descriptive', 'studylancet', 'infect', 'dis', '', '2013', '', '13', '', '752-761google', 'faecal', 'urine', 'sample', 'test', 'exclude', 'potential', 'alternative', 'route', 'transmission', 'unknown', 'stage', '', 'pathophysiology', 'unusually', 'high', 'pathogenicity', 'sars-cov', 'mers-cov', 'completely', 'understand', '', 'early', 'study', 'show', 'increase', 'amount', 'proinflammatory', 'cytokine', 'serum', '', 'eg', '', 'il1b', '', 'il6', '', 'il12', '', 'ifn', '', 'ip10', '', 'mcp1', '', 'associate', 'pulmonary', 'inflammation', 'extensive', 'lung', 'damage', 'sars', 'patients22wong', 'ck', 'lam', 'cwk', 'wu', 'akl', 'alplasma', 'inflammatory', 'cytokine', 'chemokines', 'severe', 'acute', 'respiratory', 'syndromeclin', 'exp', 'immunol', '', '2004', '', '136', '', '95-103google', 'mers-cov', 'infection', 'report', 'induce', 'increase', 'concentration', 'proinflammatory', 'cytokine', '', 'ifn', '', 'certolizumab', '', 'il15', '', 'il17', '', '23mahallawi', 'wh', 'khabour', 'zhang', 'q', 'makhdoum', 'hm', 'suliman', 'ba', 'mers-cov', 'infection', 'human', 'associate', 'pro-inflammatory', 'th1', 'th17', 'cytokine', 'profilecytokine', '', '2018', '', '104', '', '8-13google', 'note', 'patient', 'infect', '2019-ncov', 'high', 'amount', 'il1b', '', 'ifn', '', 'ip10', '', 'mcp1', '', 'probably', 'lead', 'activate', 't-helper-1', '', 'th1', '', 'cell', 'response', '', 'moreover', '', 'patient', 'require', 'icu', 'admission', 'higher', 'concentration', 'gcsf', '', 'ip10', '', 'mcp1', '', 'mip1a', '', 'certolizumab', 'require', 'icu', 'admission', '', 'suggest', 'cytokine', 'storm', 'associate', 'disease', 'severity', '', 'however', '', '2019-ncov', 'infection', 'initiate', 'increase', 'secretion', 't-helper-2', '', 'th2', '', 'cytokine', '', 'eg', '', 'il4', 'il10', '', 'suppress', 'inflammation', '', 'differ', 'sars-cov', 'infection22wong', 'ck', 'lam', 'cwk', 'wu', 'akl', 'alplasma', 'inflammatory', 'cytokine', 'chemokines', 'severe', 'acute', 'respiratory', 'syndromeclin', 'exp', 'immunol', '', '2004', '', '136', '', '95-103google', 'study', 'necessary', 'characterise', 'th1', 'th2', 'response', '2019-ncov', 'infection', 'elucidate', 'pathogenesis', '', 'autopsy', 'biopsy', 'study', 'key', 'understand', 'disease', '', 'view', 'high', 'amount', 'cytokine', 'induce', 'sars-cov22wong', 'ck', 'lam', 'cwk', 'wu', 'akl', 'alplasma', 'inflammatory', 'cytokine', 'chemokines', 'severe', 'acute', 'respiratory', 'syndromeclin', 'exp', 'immunol', '', '2004', '', '136', '', '95-103google', '', '24he', 'l', 'ding', 'zhang', 'q', 'alexpression', 'elevate', 'level', 'pro-inflammatory', 'cytokine', 'sars-cov-infected', 'ace2', 'cell', 'sars', 'patient', '', 'relation', 'acute', 'lung', 'injury', 'pathogenesis', 'sarsj', 'pathol', '', '2006', '', '210', '', '288-297google', 'mers-cov25faure', 'e', 'poissy', 'j', 'goffard', 'aldistinct', 'immune', 'response', 'two', 'mers-cov-infected', 'patient', '', 'bench', 'bedside', '', 'plos', 'one', '', '2014', '', '9e88716google', '', '26falzarano', 'de', 'wit', 'e', 'rasmussen', 'al', 'altreatment', 'interferon-2b', 'ribavirin', 'improve', 'outcome', 'mers-cov-infected', 'rhesus', 'macaquesnat', 'med', '', '2013', '', '19', '', '1313-1317google', '2019-ncov', 'infection', '', 'corticosteroid', 'frequently', 'treatment', 'patient', 'severe', 'illness', '', 'possible', 'benefit', 'reduce', 'inflammatory-induced', 'lung', 'injury', '', 'however', '', 'current', 'evidence', 'patient', 'sars', 'mers', 'suggest', 'receive', 'corticosteroid', 'effect', 'mortality', '', 'delay', 'viral', 'clearance27stockman', 'lj', 'bellamy', 'r', 'garner', 'p', 'sars', '', 'systematic', 'review', 'treatment', 'effectsplos', 'med', '', '2006', '', '3', '', 'e343google', '', '28lansbury', 'l', 'rodrigo', 'c', 'leonardi-bee', 'j', 'nguyen-van-tam', 'j', 'lim', 'ws', 'corticosteroids', 'adjunctive', 'therapy', 'treatment', 'influenzacochrane', 'database', 'syst', 'rev', '', '2019', '', '2', '', 'cd010406google', '', '29arabi', 'ym', 'mandourah', 'al-hameed', 'f', 'alcorticosteroid', 'therapy', 'critically', 'ill', 'patient', 'middle', 'east', 'respiratory', 'syndromeam', 'j', 'respir', 'crit', 'care', 'med', '', '2018', '', '197', '', '757-767google', 'therefore', '', 'corticosteroid', 'routinely', 'give', 'systemically', '', 'accord', 'interim', 'guidance30whoclinical', 'management', 'severe', 'acute', 'respiratory', 'infection', 'novel', 'coronavirus', '', 'ncov', '', 'infection', 'suspect', '', 'urlplaceholder', 'jan', '11', '', '2020date', 'access', '', 'january', '19', '', '2020google', 'among', 'cohort', '41', 'laboratory-confirmed', 'patient', '2019-ncov', 'infection', '', 'corticosteroid', 'give', 'non-icu', 'case', '', 'low-to-moderate', 'dose', 'corticosteroid', 'give', 'le', 'half', 'severely', 'ill', 'patient', 'ards', '', 'evidence', 'urgently', 'ass', 'whether', 'systematic', 'corticosteroid', 'treatment', 'beneficial', 'harmful', 'patient', 'infect', '2019-ncov', '', 'antiviral', 'treatment', 'coronavirus', 'infection', 'prove', 'effective', '', 'historical', 'control', 'study31chu', 'cm', 'role', 'lopinavirritonavir', 'treatment', 'sars', '', 'initial', 'virological', 'clinical', 'findingsthorax', '', '2004', '', '59', '', '252-256google', 'combination', 'lopinavir', 'ritonavir', 'among', 'sars-cov', 'patient', 'associate', 'substantial', 'clinical', 'benefit', '', 'fewer', 'adverse', 'clinical', 'outcome', '', '', 'arabi', 'colleague', 'initiate', 'placebo-controlled', 'trial', 'interferon', 'beta-1b', '', 'lopinavir', '', 'ritonavir', 'among', 'patient', 'mers', 'infection', 'saudi', 'arabia32arabi', 'ym', 'alothman', 'balkhy', 'hh', 'altreatment', 'middle', 'east', 'respiratory', 'syndrome', 'combination', 'lopinavir-ritonavir', 'interferon-1b', '', 'miracle', 'trial', '', '', 'study', 'protocol', 'randomize', 'control', 'trialtrials', '', '2018', '', '19', '', '81google', 'preclinical', 'evidence', 'show', 'potent', 'efficacy', 'remdesivir', '', 'broad-spectrum', 'antiviral', 'nucleotide', 'prodrug', '', 'treat', 'mers-cov', 'sars-cov', 'infections33sheahan', 'tp', 'sims', 'ac', 'graham', 'rl', 'albroad-spectrum', 'antiviral', 'gs-5734', 'inhibit', 'epidemic', 'zoonotic', 'coronavirusessci', 'transl', 'med', '', '2017', '', '9eaal3653google', '', '34sheahan', 'tp', 'sims', 'ac', 'leist', 'sr', 'alcomparative', 'therapeutic', 'efficacy', 'remdesivir', 'combination', 'lopinavir', '', 'ritonavir', '', 'interferon', 'beta', 'mers-covnat', 'commun', '', '2020', '', '11', '', '222google', '2019-ncov', 'emerge', 'virus', '', 'effective', 'treatment', 'develop', 'disease', 'result', 'virus', '', 'since', 'combination', 'lopinavir', 'ritonavir', 'already', 'available', 'designate', 'hospital', '', 'randomise', 'control', 'trial', 'initiate', 'quickly', 'ass', 'efficacy', 'safety', 'combine', 'lopinavir', 'ritonavir', 'patient', 'hospitalise', '2019-ncov', 'infection', '', 'study', 'limitation', '', 'first', '', '41', 'patient', '', 'diagnosis', 'confirm', 'lower', 'respiratory', 'tract', 'specimen', 'pair', 'nasopharyngeal', 'swab', 'obtain', 'investigate', 'difference', 'viral', 'rna', 'detection', 'rate', 'upper', 'lower', 'respiratory', 'tract', 'specimen', '', 'serological', 'detection', 'look', '2019-ncov', 'antibody', 'rise', '18', 'patient', 'undetectable', 'viral', 'rna', '', 'second', '', 'limit', 'number', 'case', '', 'difficult', 'ass', 'host', 'risk', 'factor', 'disease', 'severity', 'mortality', 'multivariable-adjusted', 'method', '', 'modest-sized', 'case', 'series', 'patient', 'admit', 'hospital', '', 'collection', 'standardise', 'data', 'larger', 'cohort', 'help', 'define', 'clinical', 'presentation', '', 'natural', 'history', '', 'risk', 'factor', '', 'study', 'outpatient', '', 'primary', 'care', '', 'community', 'set', 'full', 'picture', 'spectrum', 'clinical', 'severity', '', 'time', '', 'find', 'statistical', 'test', 'p', 'value', 'interpret', 'caution', '', 'non-significant', 'p', 'value', 'necessarily', 'rule', 'difference', 'icu', 'non-icu', 'patient', '', 'third', '', 'since', 'causative', 'pathogen', 'identify', '', 'kinetics', 'viral', 'load', 'antibody', 'titre', 'available', '', 'finally', '', 'potential', 'exposure', 'bias', 'study', 'account', 'paediatric', 'adolescent', 'patient', 'report', 'cohort', '', 'effort', 'answer', 'question', 'future', 'study', '', 'sars-cov', 'mers-cov', 'believe', 'originate', 'bat', '', 'infection', 'transmit', 'directly', 'human', 'market', 'civet', 'dromedary', 'camel', '', 'respectively35cui', 'j', 'li', 'f', 'shi', 'z-l', 'origin', 'evolution', 'pathogenic', 'coronavirusesnat', 'rev', 'microbiol', '', '2019', '', '17', '', '181-192google', 'extensive', 'research', 'sars-cov', 'mers-cov', 'drive', 'discovery', 'sars-like', 'mers-like', 'coronaviruses', 'bat', '', '2013', '', 'ge', 'colleagues36ge', 'x-y', 'li', 'j-l', 'yang', 'x-l', 'alisolation', 'characterization', 'bat', 'sars-like', 'coronavirus', 'us', 'ace2', 'receptornature', '', '2013', '', '503', '', '535-538google', 'report', 'whole', 'genome', 'sequence', 'sars-like', 'coronavirus', 'bat', 'ability', 'human', 'ace2', 'receptor', '', 'thus', 'replication', 'potential', 'human', 'cells37wang', 'hu', 'z', 'bats', 'animal', 'reservoir', 'sars', 'coronavirus', '', 'hypothesis', 'prove', '10', 'year', 'virus', 'huntingvirol', 'sin', '', '2013', '', '28', '', '315-317google', '2019-ncov', 'still', 'study', 'deeply', 'case', 'become', 'global', 'health', 'threat', '', 'reliable', 'quick', 'pathogen', 'test', 'feasible', 'differential', 'diagnosis', 'base', 'clinical', 'description', 'crucial', 'clinician', 'first', 'contact', 'suspect', 'patient', '', 'pandemic', 'potential', '2019-ncov', '', 'careful', 'surveillance', 'essential', 'monitor', 'future', 'host', 'adaption', '', 'viral', 'evolution', '', 'infectivity', '', 'transmissibility', '', 'pathogenicity', '', 'online', 'publication', 'correct', '', 'correct', 'version', 'first', 'appear', 'thelancetcom', 'january', '30', '', '2020', 'online', 'publication', 'correct', '', 'correct', 'version', 'first', 'appear', 'thelancetcom', 'january', '30', '', '2020', 'contributors', 'bc', 'jw', 'idea', 'design', 'study', 'full', 'access', 'data', 'study', 'responsibility', 'integrity', 'data', 'accuracy', 'data', 'analysis', '', 'ywa', '', 'gf', '', 'xg', '', 'jixu', '', 'hl', '', 'bc', 'contribute', 'write', 'report', '', 'bc', 'contribute', 'critical', 'revision', 'report', '', 'ywa', '', 'gf', '', 'xg', '', 'jixu', '', 'hl', 'contribute', 'statistical', 'analysis', '', 'author', 'contribute', 'data', 'acquisition', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'review', 'approve', 'final', 'version', '', 'declaration', 'interest', 'author', 'declare', 'compete', 'interest', '', 'data', 'support', 'find', 'study', 'available', 'correspond', 'author', 'reasonable', 'request', '', 'participant', 'data', 'without', 'name', 'identifier', 'available', 'approval', 'correspond', 'author', 'national', 'health', 'commission', '', 'publication', 'study', 'find', '', 'data', 'available', 'others', 'request', '', 'research', 'team', 'provide', 'email', 'address', 'communication', 'data', 'approve', 'share', 'others', '', 'proposal', 'detail', 'description', 'study', 'objective', 'statistical', 'analysis', 'plan', 'evaluation', 'reasonability', 'request', 'data', '', 'correspond', 'author', 'national', 'health', 'commission', 'decision', 'base', 'material', '', 'additional', 'material', 'require', 'process', '', 'acknowledgments', 'work', 'fund', 'special', 'project', 'emergency', 'ministry', 'science', 'technology', '', '2020yfc0841300', '', 'chinese', 'academy', 'medical', 'sciences', '', 'cams', '', 'innovation', 'fund', 'medical', 'sciences', '', 'cifms', '2018-i2m-1-003', '', '', 'national', 'science', 'grant', 'distinguished', 'young', 'scholars', '', '81425001h0104', '', '', 'national', 'key', 'research', 'development', 'program', 'china', '', '2018yfc1200102', '', '', 'beijing', 'science', 'technology', 'project', '', 'z19110700660000', '', '', 'cams', 'innovation', 'fund', 'medical', 'sciences', '', '2016-i2m-1-014', '', '', 'national', 'mega-projects', 'infectious', 'diseases', 'china', '', '2017zx10103004', '2018zx10305409', '', '', 'acknowledge', 'health-care', 'worker', 'involve', 'diagnosis', 'treatment', 'patient', 'wuhan', '', 'chinese', 'national', 'health', 'commission', 'coordinate', 'data', 'collection', 'patient', '2019-ncov', 'infection', '', 'international', 'severe', 'acute', 'respiratory', 'emerging', 'infections', 'consortium', '', 'isaric', '', 'share', 'data', 'collection', 'template', 'publicly', 'website', '', 'prof', 'chen', 'wang', 'prof', 'george', 'f', 'gao', 'guidance', 'study', 'design', 'interpretation', 'result', '', 'download', 'pdf', '', '25', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'data', 'share', 'outbreak', '', 'best', 'practice', 'exemplifiedfull-textpdfa', 'novel', 'coronavirus', 'outbreak', 'global', 'health', 'concernfull-textpdfdepartment', 'errorfull-textpdffull', 'spectrum', 'covid-19', 'severity', 'still', 'depictedfull-textpdfthe', 'first', '2019', 'novel', 'coronavirus', 'case', 'nepalfull-textpdftherapeutic', 'triage', 'strategy', '2019', 'novel', 'coronavirus', 'disease', 'fever', 'clinicsfull-textpdffull', 'spectrum', 'covid-19', 'severity', 'still', 'depict', '', 'authors', '', 'replyfull-textpdfthe', 'estimate', 'covid-19', 'case', 'fatality', 'ratefull-textpdf']",7502,"{'': 2287, 'patient': 142, '2019-ncov': 57, 'respiratory': 53, 'coronavirus': 52, 'infection': 49, 'icu': 43, 'data': 42, 'care': 39, 'clinical': 34, '15': 32, 'case': 31, 'novel': 31, 'acute': 31, '41': 30, '2': 29, 'disease': 28, 'symptom': 25, 'study': 25, 'severe': 24}","{'certolizumab': 6, 'infection': 49, 'safety': 1}",56,0.4939
DOI:10.1016/S1473-3099(20)30243-7,10.1016/S1473-3099(20)30243-7,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['estimates', 'severity', 'coronavirus', 'disease', '2019', '', 'model-based', 'analysis']","['BackgroundIn face rapidly change data , range case fatality ratio estimate coronavirus disease 2019 ( COVID-19 ) produce differ substantially magnitude .', 'We aim provide robust estimate , account censor ascertainment biases.MethodsWe collect individual-case data patient die COVID-19 Hubei , mainland China ( report national provincial health commission Feb 8 , 2020 ) , case outside mainland China ( government ministry health website medium report 37 country , well Hong Kong Macau , Feb 25 , 2020 ) .', 'These individual-case data use estimate time onset symptom outcome ( death discharge hospital ) .', 'We next obtain age-stratified estimate case fatality ratio relate aggregate distribution case observe cumulative death China , assume constant attack rate age adjust demography age-based location-based under-ascertainment .', 'We also estimate case fatality ratio individual line-list data 1334 case identify outside mainland China .', 'Using data prevalence PCR-confirmed case international resident repatriate China , obtain age-stratified estimate infection fatality ratio .', 'Furthermore , data age-stratified severity subset 3665 case China use estimate proportion infect individual likely require hospitalisation.FindingsUsing data 24 death occur mainland China 165 recovery outside China , estimate mean duration onset symptom death 17·8 day ( 95 % credible interval [ CrI ] 16·9–19·2 ) hospital discharge 24·7 day ( 22·9–28·1 ) .', 'In laboratory confirm clinically diagnose case mainland China ( n=70 117 ) , estimate crude case fatality ratio ( adjust censor ) 3·67 % ( 95 % CrI 3·56–3·80 ) .', 'However , adjust demography under-ascertainment , obtain best estimate case fatality ratio China 1·38 % ( 1·23–1·53 ) , substantially higher ratio older age group ( 0·32 % [ 0·27–0·38 ] age < 60 year v 6·4 % [ 5·7–7·2 ] age ≥60 year ) , 13·4 % ( 11·2–15·9 ) age 80 year older .', 'Estimates case fatality ratio international case stratify age consistent China ( parametric estimate 1·4 % [ 0·4–3·5 ] age < 60 year [ n=360 ] 4·5 % [ 1·8–11·1 ] age ≥60 year [ n=151 ] ) .', 'Our estimate overall infection fatality ratio China 0·66 % ( 0·39–1·33 ) , increase profile age .', 'Similarly , estimate proportion infect individual likely hospitalise increase age maximum 18·4 % ( 11·0–37·6 ) age 80 year older.InterpretationThese early estimate give indication fatality ratio across spectrum COVID-19 disease show strong age gradient risk death.FundingUK Medical Research Council .', 'In face rapidly change data , range case fatality ratio estimate coronavirus disease 2019 ( COVID-19 ) produce differ substantially magnitude .', 'We aim provide robust estimate , account censor ascertainment bias .', 'We collect individual-case data patient die COVID-19 Hubei , mainland China ( report national provincial health commission Feb 8 , 2020 ) , case outside mainland China ( government ministry health website medium report 37 country , well Hong Kong Macau , Feb 25 , 2020 ) .', 'These individual-case data use estimate time onset symptom outcome ( death discharge hospital ) .', 'We next obtain age-stratified estimate case fatality ratio relate aggregate distribution case observe cumulative death China , assume constant attack rate age adjust demography age-based location-based under-ascertainment .', 'We also estimate case fatality ratio individual line-list data 1334 case identify outside mainland China .', 'Using data prevalence PCR-confirmed case international resident repatriate China , obtain age-stratified estimate infection fatality ratio .', 'Furthermore , data age-stratified severity subset 3665 case China use estimate proportion infect individual likely require hospitalisation .', 'Using data 24 death occur mainland China 165 recovery outside China , estimate mean duration onset symptom death 17·8 day ( 95 % credible interval [ CrI ] 16·9–19·2 ) hospital discharge 24·7 day ( 22·9–28·1 ) .', 'In laboratory confirm clinically diagnose case mainland China ( n=70 117 ) , estimate crude case fatality ratio ( adjust censor ) 3·67 % ( 95 % CrI 3·56–3·80 ) .', 'However , adjust demography under-ascertainment , obtain best estimate case fatality ratio China 1·38 % ( 1·23–1·53 ) , substantially higher ratio older age group ( 0·32 % [ 0·27–0·38 ] age < 60 year v 6·4 % [ 5·7–7·2 ] age ≥60 year ) , 13·4 % ( 11·2–15·9 ) age 80 year older .', 'Estimates case fatality ratio international case stratify age consistent China ( parametric estimate 1·4 % [ 0·4–3·5 ] age < 60 year [ n=360 ] 4·5 % [ 1·8–11·1 ] age ≥60 year [ n=151 ] ) .', 'Our estimate overall infection fatality ratio China 0·66 % ( 0·39–1·33 ) , increase profile age .', 'Similarly , estimate proportion infect individual likely hospitalise increase age maximum 18·4 % ( 11·0–37·6 ) age 80 year older .', 'These early estimate give indication fatality ratio across spectrum COVID-19 disease show strong age gradient risk death .', 'UK Medical Research Council .', 'As March 25 , 2020 , 414 179 case 18 440 death due coronavirus disease 2019 ( COVID-19 ) , cause novel severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , report worldwide.1WHOCoronavirus disease 2019 ( COVID-19 ) situation report—43 .', 'urlplaceholder March 3 , 2020Date access : March 5 , 2020Google Scholar The epidemic begin mainland China , geographical focus city Wuhan , Hubei .', 'However , Feb 26 , 2020 , rate increase case become greater rest world inside China .', 'Substantial outbreak occur Italy ( 69 176 case ) , USA ( 51 914 case ) , Iran ( 24 811 case ) , geographical expansion epidemic continue .', 'Clinical study hospitalise patient show , onset COVID-19 , patient frequently show symptom associate viral pneumonia , commonly fever , cough , sore throat , myalgia , fatigue.2Chan JFW Yuan S Kok KH et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; 395 : 514-523Google Scholar , 3Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513Google Scholar , 4Guan WJ Ni ZY Hu Y et al.Clinical characteristic coronavirus disease 2019 China.N Engl J Med .', '2020 ; ( publish online Feb 28 .', ') DOI:10.1056/NEJMoa2002032Google Scholar , 5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar , 6Li Q Guan X Wu P et al.Early transmission dynamic Wuhan , China , novel coronavirus-infected pneumonia.N Engl J Med .', '2020 ; ( publish online Jan 29 .', ') DOI:10.1056/NEJMoa2001316Google Scholar The case definition adopt China elsewhere include stratification case severe ( define tachypnoea [ ≥30 breath per min ] , oxygen saturation ≤93 % rest , PaO2/FiO2 ratio < 300 mm Hg ) critical ( respiratory failure require mechanical ventilation , septic shock , organ dysfunction failure require intensive care ) .7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristic outbreak 2019 novel coronavirus disease ( COVID-19 ) China.Zhonghua Liu Xing Bing Xue Za Zhi .', '2020 ; 41 ( Chinese ) .', ': 145-151Google Scholar According report WHO–China Joint Mission COVID-19 , 80 % 55 924 patient laboratory-confirmed COVID-19 China Feb 20 , 2020 , mild-to-moderate disease , include non-pneumonia pneumonia case , 13·8 % develop severe disease 6·1 % develop critical stage require intensive care.8WHOReport WHO-China Joint Mission coronavirus disease 2019 ( COVID-19 ) .', 'urlplaceholder Feb 28 , 2020Date access : March 26 , 2020Google Scholar In study clinical progression 1099 patients,4Guan WJ Ni ZY Hu Y et al.Clinical characteristic coronavirus disease 2019 China.N Engl J Med .', '2020 ; ( publish online Feb 28 .', ') DOI:10.1056/NEJMoa2002032Google Scholar highest risk severe disease death include people age 60 year underlie condition , include hypertension , diabetes , cardiovascular disease , chronic respiratory disease , cancer .', 'Research contextEvidence studyWe search PubMed , medRxiv , bioRxiv , arXiv , SSRN , Research Square , Virological , Wellcome Open Research peer-reviewed article , preprints , research report severity coronavirus disease 2019 ( COVID-19 ) , use search term “ coronavirus ” , “ 2019-nCoV ” , similar term , “ fatality ” , March 6 , 2020 .', 'Several study estimate case fatality ratio ( percentage individual symptomatic confirm disease die disease ) infection fatality ratio ( percentage infect individual die disease , include mild disease ) COVID-19 use range different statistical model method .', 'Studies do solely hospitalise patient report highest fatality ratio ( 8–28 % ) , represent outcome severely ill patient .', 'Estimates population-level case fatality ratio case report range 2–8 % .', 'Estimates infection fatality ratio average across age-groups range 0·2 % 1·6 % , estimate infection fatality ratio oldest age group ( ≥80 year ) range 8 % 36 % .', 'None identify study adjust difference denominator population obtain estimate could apply across population .', 'No study estimate proportion infect individual require hospitalisation.Added value studyBy synthesise data across range surveillance set , obtain estimate age-stratified case fatality ratio infection fatality ratio take account different denominator population datasets .', 'Our underlie assumption , attack rate ( ie , probability become infect ) vary substantially age , consistent previous study respiratory infection .', 'Under assumption , difference age pattern among case Wuhan versus elsewhere China would probably due under-ascertainment case , give different surveillance system place .', 'Our result consistent hypothesis , case Wuhan see older individual , would identify attendance hospital , whereas case elsewhere China younger overall , would explain policy test travel history Wuhan .', 'After correct bias , find estimate case fatality ratio China consistent obtain early international case .', 'Our age-stratified estimate infection fatality ratio apply demography give estimate infection fatality ratio older younger population .', 'These estimate combine estimate infection attack rate ( approximately 80 % unmitigated epidemic ) give rough projection scale .', 'Similarly , estimate proportion infection require hospitalisation combine infection attack rate forecast health-care requirements.Implications available evidenceOur estimate case fatality ratio COVID-19 , although lower crude estimate make date , substantially higher recent influenza pandemic ( eg , H1N1 influenza 2009 ) .', 'With rapid geographical spread observe date , COVID-19 therefore represent major global health threat come week month .', 'Our estimate proportion infect individual require hospitalisation , combine likely infection attack rate ( around 50–80 % ) , show even advance health-care system likely overwhelm .', 'These estimate therefore crucial enable country around world best prepare global pandemic continue unfold .', 'Evidence study We search PubMed , medRxiv , bioRxiv , arXiv , SSRN , Research Square , Virological , Wellcome Open Research peer-reviewed article , preprints , research report severity coronavirus disease 2019 ( COVID-19 ) , use search term “ coronavirus ” , “ 2019-nCoV ” , similar term , “ fatality ” , March 6 , 2020 .', 'Several study estimate case fatality ratio ( percentage individual symptomatic confirm disease die disease ) infection fatality ratio ( percentage infect individual die disease , include mild disease ) COVID-19 use range different statistical model method .', 'Studies do solely hospitalise patient report highest fatality ratio ( 8–28 % ) , represent outcome severely ill patient .', 'Estimates population-level case fatality ratio case report range 2–8 % .', 'Estimates infection fatality ratio average across age-groups range 0·2 % 1·6 % , estimate infection fatality ratio oldest age group ( ≥80 year ) range 8 % 36 % .', 'None identify study adjust difference denominator population obtain estimate could apply across population .', 'No study estimate proportion infect individual require hospitalisation .', 'Added value study By synthesise data across range surveillance set , obtain estimate age-stratified case fatality ratio infection fatality ratio take account different denominator population datasets .', 'Our underlie assumption , attack rate ( ie , probability become infect ) vary substantially age , consistent previous study respiratory infection .', 'Under assumption , difference age pattern among case Wuhan versus elsewhere China would probably due under-ascertainment case , give different surveillance system place .', 'Our result consistent hypothesis , case Wuhan see older individual , would identify attendance hospital , whereas case elsewhere China younger overall , would explain policy test travel history Wuhan .', 'After correct bias , find estimate case fatality ratio China consistent obtain early international case .', 'Our age-stratified estimate infection fatality ratio apply demography give estimate infection fatality ratio older younger population .', 'These estimate combine estimate infection attack rate ( approximately 80 % unmitigated epidemic ) give rough projection scale .', 'Similarly , estimate proportion infection require hospitalisation combine infection attack rate forecast health-care requirement .', 'Implications available evidence Our estimate case fatality ratio COVID-19 , although lower crude estimate make date , substantially higher recent influenza pandemic ( eg , H1N1 influenza 2009 ) .', 'With rapid geographical spread observe date , COVID-19 therefore represent major global health threat come week month .', 'Our estimate proportion infect individual require hospitalisation , combine likely infection attack rate ( around 50–80 % ) , show even advance health-care system likely overwhelm .', 'These estimate therefore crucial enable country around world best prepare global pandemic continue unfold .', 'Assessing severity COVID-19 crucial determine appropriateness mitigation strategy enable plan health-care need epidemic unfold .', 'However , crude case fatality ratio obtain divide number death number case misleading.9Garske T Legrand J Donnelly CA et al.Assessing severity novel influenza A/H1N1 pandemic.BMJ .', '2009 ; 339b2840Google Scholar , 10Lipsitch M Donnelly CA Fraser C et al.Potential bias estimate absolute relative case-fatality risk outbreaks.PLoS Negl Trop Dis .', '2015 ; 9e0003846Google Scholar First , period 2–3 week person develop symptom , case subsequently detect report , observation final clinical outcome .', 'During grow epidemic , final clinical outcome report case typically unknown .', 'Simply divide cumulative report number death cumulative number report case therefore underestimate true case fatality ratio early epidemic.9Garske T Legrand J Donnelly CA et al.Assessing severity novel influenza A/H1N1 pandemic.BMJ .', '2009 ; 339b2840Google Scholar , 10Lipsitch M Donnelly CA Fraser C et al.Potential bias estimate absolute relative case-fatality risk outbreaks.PLoS Negl Trop Dis .', '2015 ; 9e0003846Google Scholar , 11Ghani AC Donnelly CA Cox DR et al.Methods estimate case fatality ratio novel , emerge infectious disease.Am J Epidemiol .', '2005 ; 162 : 479-486Google Scholar This effect observe past epidemic respiratory pathogen , include severe acute respiratory syndrome ( SARS ) 12Donnelly CA Ghani AC Leung GM et al.Epidemiological determinant spread causal agent severe acute respiratory syndrome Hong Kong.Lancet .', '2003 ; 361 : 1761-1766Google Scholar H1N19Garske T Legrand J Donnelly CA et al.Assessing severity novel influenza A/H1N1 pandemic.BMJ .', '2009 ; 339b2840Google Scholar influenza , widely recognise .', 'Thus , many estimate case fatality ratio obtain date COVID-19 correct effect.13Jung S Akhmetzhanov AR Hayashi K et al.Real-time estimation risk death novel coronavirus ( COVID-19 ) infection : inference use export cases.J Clin Med .', '2020 ; 9 : E523Google Scholar , 14Mizumoto K Kagaya K Chowell G Yoshida-Nakaadachi-cho U Early epidemiological assessment transmission potential virulence 2019 novel coronavirus Wuhan City : China , January–February , 2020.medRxiv .', '2020 ; ( publish online March 13 . )', '( preprint ) .DOI : 10.1101/2020.02.12.20022434Google Scholar , 15Famulare M 2019-nCoV : preliminary estimate confirmed-case-fatality-ratio infection-fatality-ratio , initial pandemic risk assessment .', 'urlplaceholder Feb 19 , 2020Date access : March 26 , 2020Google Scholar , 16Wu P Hao X Lau EHY et al.Real-time tentative assessment epidemiological characteristic novel coronavirus infection Wuhan , China , 22 January 2020.Euro Surveill .', '2020 ; 25 : 1-6Google Scholar Additionally , however , exponential growth phase epidemic , observe time lag onset symptom outcome ( recovery death ) censor , naive estimate observe time symptom onset outcome provide bias estimate actual distribution .', 'Ignoring effect tend bias estimate case fatality ratio downwards early growth phase epidemic .', 'Second , surveillance newly emerge pathogen typically bias towards detect clinically severe case , especially start epidemic diagnostic capacity low ( figure 1 ) .', 'Estimates case fatality ratio thus bias upwards extent clinically milder disease determined.9Garske T Legrand J Donnelly CA et al.Assessing severity novel influenza A/H1N1 pandemic.BMJ .', '2009 ; 339b2840Google Scholar Data epicentre outbreak Wuhan primarily obtain hospital surveillance , thus , likely represent patient moderate severe illness , atypical pneumonia acute respiratory distress use define suspect case eligible testing.7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristic outbreak 2019 novel coronavirus disease ( COVID-19 ) China.Zhonghua Liu Xing Bing Xue Za Zhi .', '2020 ; 41 ( Chinese ) .', ': 145-151Google Scholar In individual , clinical outcome likely severe , estimate case fatality ratio higher .', 'Elsewhere mainland China rest world , country administrative region alert risk infection import via travel initially institute surveillance COVID-19 broader set clinical criterion define suspect case .', 'These criterion typically include combination symptom ( eg , cough fever ) combine recent travel history affect region ( Wuhan , Hubei province ) 2Chan JFW Yuan S Kok KH et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; 395 : 514-523Google Scholar , 17Xu XW Wu XX Jiang XG et al.Clinical find group patient infect 2019 novel coronavirus ( SARS-Cov-2 ) outside Wuhan , China : retrospective case series.BMJ .', '2020 ; 368 : m606Google Scholar .', 'Such surveillance likely detect clinically mild case , initially restrict test travel history link , might miss symptomatic cases.Figure 1Spectrum COVID-19 casesShow full captionAt top pyramid , meet WHO case criterion severe critical case likely identify hospital set , present atypical viral pneumonia .', 'These case identify mainland China among categorise internationally local transmission .', 'Many case likely symptomatic ( ie , fever , cough , myalgia ) , might require hospitalisation .', 'These case identify link international travel high-risk area contact-tracing contact confirm case .', 'They might also identify population surveillance , example , influenza-like illness .', 'The bottom part pyramid represent mild ( possibly asymptomatic ) case .', 'These case might identify contact trace subsequently via serological testing.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) At top pyramid , meet WHO case criterion severe critical case likely identify hospital set , present atypical viral pneumonia .', 'These case identify mainland China among categorise internationally local transmission .', 'Many case likely symptomatic ( ie , fever , cough , myalgia ) , might require hospitalisation .', 'These case identify link international travel high-risk area contact-tracing contact confirm case .', 'They might also identify population surveillance , example , influenza-like illness .', 'The bottom part pyramid represent mild ( possibly asymptomatic ) case .', 'These case might identify contact trace subsequently via serological test .', 'Here attempt adjust bias data source obtain estimate case fatality ratio ( proportion case eventually lead death ) infection fatality ratio ( proportion infection eventually lead death ) use individual-level case report data aggregate case death count mainland China , Hong Kong Macau , international case report .', 'By adjust underlie demography potential under-ascertainment different level severity pyramid ( figure 1 ) , estimate broadly applicable across range set inform health plan detail case data accrue .', 'We identify information characteristic 48 patient die COVID-19 Hubei , report National Health Commission Hubei Province Health Commission website Feb 8 , 2020 .', 'We record follow data element , available : sex , age , date symptom onset , date hospitalisation , date death .', 'Of 48 case , neither date symptom onset date report available 13 case .', 'We also remove eight case onset Jan 1 , 2020 , death Jan 21 , 2020 , three death Jan 28 , 2020 , date consistent reliable report onset death set , respectively , consider onset-to-death time ( include early onset create bias towards long onset-to-death time , reflect under-ascertainment death early ) .', 'This leave 24 death , use estimate onset-to-death distribution .', 'We collate data 2010 case report 37 country two special administrative region China ( Hong Kong Macau ) , government ministry health website medium report , Feb 25 , 2020 .', 'We record follow information available : country administrative region case detect , whether infection acquire China abroad , date travel , date symptom onset , date hospitalisation , date confirmation , date recovery , date death .', 'We use data 165 recover individual report recovery date report impute onset date estimate onset-to-recovery distribution , exclude 26 recovery without appropriate information date recovery , report , locality .', 'We use data 1334 international case obtain estimate case fatality ratio , include case without date report .', 'Data 70 117 PCR-confirmed clinically diagnose case date onset Wuhan elsewhere China Jan 1 Feb 11 , 2020 , extract WHO–China Joint Mission report.8WHOReport WHO-China Joint Mission coronavirus disease 2019 ( COVID-19 ) .', 'urlplaceholder Feb 28 , 2020Date access : March 26 , 2020Google Scholar Over period total 1023 death report across China , data available disaggregated 10-year age band 0–9 year 70–79 year old , age band age 80 year older.7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristic outbreak 2019 novel coronavirus disease ( COVID-19 ) China.Zhonghua Liu Xing Bing Xue Za Zhi .', '2020 ; 41 ( Chinese ) .', ': 145-151Google Scholar Using collate data daily report death obtain day National Health Commission regional website , estimate 74 % death occur Wuhan remainder outside Wuhan .', 'Additionally , recent available cumulative estimate ( March 3 , 2020 ) 80 304 confirm case 2946 death within China extract WHO COVID-19 Situation Report ( number 43 ) .1WHOCoronavirus disease 2019 ( COVID-19 ) situation report—43 .', 'urlplaceholder March 3 , 2020Date access : March 5 , 2020Google Scholar An earlier ( withdraw ) preprint subset case Jan 26 , 2020 report age distribution case categorise severity 3665 cases.18Yang Y Lu Q Liu M et al.Epidemiological clinical feature 2019 novel coronavirus outbreak China.medRxiv .', '2020 ; ( publish online Feb 21 . )', '( preprint ; withdraw ) .DOI : 10.1101/2020.02.10.20021675Google Scholar Under China case definition , severe case define tachypnoea ( ≥30 breath per min ) oxygen saturation 93 % higher rest , PaO2/FiO2 ratio le 300 mm Hg.7Novel Coronavirus Pneumonia Emergency Response Epidemiology TeamThe epidemiological characteristic outbreak 2019 novel coronavirus disease ( COVID-19 ) China.Zhonghua Liu Xing Bing Xue Za Zhi .', '2020 ; 41 ( Chinese ) .', ': 145-151Google Scholar Assuming severe case require hospitalisation ( oppose patient hospitalise China , hospitalise reduce onward transmission ) , use proportion severe case age patient estimate proportion case infection require hospitalisation .', 'Data infection prevalence repatriate expatriate return home country obtain government ministry health website medium report .', 'To match incidence report Wuhan Jan 30 , 2020 , use data six flight depart Jan 30 Feb 1 , 2020 , inclusive .', 'In early February 2020 cruise liner name Diamond Princess quarantine disembark passenger test positive virus .', 'Subsequently 3711 passenger board test next month .', 'We extract data age passenger onboard Feb 5 , 2020 , date positive test report , available 657 712 PCR-confirmed case , date ten death among case report Japan Ministry Health , Labour Welfare19Government JapanMinistry Health , Labour Welfare .', 'urlplaceholder 2020Date access : March 26 , 2020Google Scholar international medium .', 'Age-stratified population data 2018 obtain National Bureau Statistics China.20National Bureau Statistics ChinaChina statistical yearbook .', 'urlplaceholder 2018Date access : February 14 , 2020Google Scholar According data , population Wuhan 2018 approximately 11 million people .', 'All analysis do R software ( version 3.6.2 ) , Bayesian Marko-Chain Monte Carlo via package drjacoby ( version 1.0.0 ) .21Verity R Winskill P drjacoby .', 'urlplaceholder access : March 26 , 2020Google Scholar Data code available online GitHub .', 'In estimate time interval symptom onset outcome , necessary account fact , grow epidemic , higher proportion case infect recently ( appendix p 7 ) .', 'Therefore , re-parameterised gamma model account exponential growth use growth rate 0·14 per day , obtain early case onset data ( appendix p 6 ) .', 'Using Bayesian method , fit gamma distribution data time onset death onset recovery , conditional observe final outcome .', 'Missing onset date impute basis date report , available .', 'Estimates distribution time onset-to-death use project expect cumulative number death give onset observe Wuhan outside Wuhan , assume uniform attack rate across age group .', 'Using age-distribution population , obtain estimate expect number infection age group .', 'Under-ascertainment estimate outside Wuhan compare number observe case age expect distribution , assume perfect ascertainment 50–59 age group group highest number detect case relative population size .', 'We also sensitivity analysis assume differential attack rate age ( appendix p 9 ) .', 'For Wuhan , add scale account under-ascertainment compare outside Wuhan .', 'These step give u expect age-distribution case .', 'For give onset-to-death distribution , obtain model estimate cumulative number death age age-dependent case fatality ratio ( fit relative case fatality ratio oldest age group , represent highest crude case fatality ratio ) .', 'This estimate compare observe death age use Poisson likelihood .', 'These data jointly fit alongside recent age-aggregated cumulative death case mainland China .', 'Given number observe case death drop substantially follow peak late January , ratio current cumulative case current number death , correct under-ascertainment , provide good estimate final case fatality ratio.11Ghani AC Donnelly CA Cox DR et al.Methods estimate case fatality ratio novel , emerge infectious disease.Am J Epidemiol .', '2005 ; 162 : 479-486Google Scholar To estimate infection fatality ratio fit data infection prevalence international Wuhan resident repatriate home country .', 'Our age-stratified case fatality ratio infection fatality ratio model jointly fit case data infection prevalence data use Bayesian method , use previous estimate onset-to-death distribution prior .', 'Full mathematical detail provide appendix ( p 8 ) .', 'Assuming uniform attack rate age group , use demography-adjusted under-ascertainment rate calculate obtain estimate proportion infect individual would require hospitalisation .', 'To independently validate infection fatality ratio estimate , analyse data outbreak Diamond Princess cruise liner take date report positive test proxy onset date .', 'We calculate expect proportion death observe March 25 , 2020 , give onset time estimate onset-to-death distribution ( appendix p 13 ) .', 'We use parametric non-parametric methods11Ghani AC Donnelly CA Cox DR et al.Methods estimate case fatality ratio novel , emerge infectious disease.Am J Epidemiol .', '2005 ; 162 : 479-486Google Scholar , 22Griffin J Ghani A CASEFAT : Stata module estimate case fatality ratio new infectious disease .', 'Boston College Economics .', 'urlplaceholder May 7 , 2009Date access : March 26 , 2020Google Scholar estimate case fatality ratio case report outside mainland China use individual-level data .', 'Cases outcome unknown treat censor observation .', 'For parametric non-parametric analysis , miss onset date multiply impute use information onset-to-report distribution , unreported recovery impute use onset-to-outcome distribution country summary data .', 'The parametric model fit data use Bayesian method ( appendix p 12 ) .', 'The funder study role study design , data collection , data analysis , data interpretation , write report .', 'The correspond author full access data study final responsibility decision submit publication .', 'In subset 24 death COVID-19 occur mainland China early epidemic , correction bias introduce growth epidemic , estimate mean time onset death 18·8 day ( 95 % credible interval [ CrI ] 15·7–49·7 ; figure 2 ) coefficient variation 0·45 ( 95 % CrI 0·29–0·54 ) .', 'With small number observation data give early epidemic , could rule many death occur longer time onset death , hence high upper limit credible interval .', 'However , give epidemic China since decline , posterior estimate mean time onset death , inform analysis aggregate data China , precise ( mean 17·8 day [ 16·9–19·2 ] ; figure 2 ) .Figure 2Onset-to-death onset-to-recovery distributionsShow full caption ( A ) Onset-to-death data 24 case mainland China early epidemic .', '( B ) Onset-to-recovery data 169 case outside mainland China .', 'Red line show best fit ( posterior mode ) gamma distribution , uncorrected epidemic growth , bias towards shorter duration .', 'Blue line show distribution correct epidemic growth .', 'The black line ( panel A ) show posterior estimate onset-to-death distribution follow fit aggregate case data.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Onset-to-death data 24 case mainland China early epidemic .', '( B ) Onset-to-recovery data 169 case outside mainland China .', 'Red line show best fit ( posterior mode ) gamma distribution , uncorrected epidemic growth , bias towards shorter duration .', 'Blue line show distribution correct epidemic growth .', 'The black line ( panel A ) show posterior estimate onset-to-death distribution follow fit aggregate case data .', 'Using data outcome 169 case report outside mainland China , estimate mean onset-to-recovery time 24·7 day ( 95 % CrI 22·9–28·1 ) coefficient variation 0·35 ( 0·31–0·39 ; figure 2 ) .', 'Both onset-to-outcome estimate consistent separate study China.23Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; ( publish online March 11 . )', 'urlplaceholder Scholar Case fatality ratio estimate aggregate data case death mainland China ( table 1 ) .', 'A large proportion case , include early epidemic , report Wuhan , local health system quickly overwhelm .', 'As result , age distribution case report Wuhan differ rest China ( figure 3A ) .', 'Reported case Wuhan frequent older age group , perhaps reflect higher severity ( therefore prioritisation hospitalisation Wuhan ) , case outside Wuhan might also show bias term relationship age travel .', 'Adjusting difference underlie demography assume overall difference attack rate age , estimate high under-ascertainment case younger age group inside outside Wuhan ( figure 3C , D ) .', 'Furthermore , estimate higher level under-ascertainment overall Wuhan compare outside Wuhan ( figure 3C ) .', 'Accounting under-ascertainment , estimate highest case fatality ratio ( 13·4 % [ 11·2–15·9 % ] ) 80 year older age group ( figure 3B , table 1 ) , lower case fatality ratio associate lower age group , lowest 0–9 year age group ( 0·00260 % [ 0·000312–0·0382 ] ) .Table 1Estimates case fatality ratio infection fatality ratio obtain aggregate time series case mainland ChinaDeathsLaboratory-confirmed case * * Values include clinically diagnose case include estimates.Case fatality ratioInfection fatality ratio†† Obtained combine estimate case fatality ratio information infection prevalence obtain return home repatriation flights.CrudeAdjusted censoringAdjusted censor , demography , under-ascertainment‡‡ Accounts underlie demography Wuhan elsewhere China correct under-ascertainment.Overall102344 6722·29 % ( 2·15–2·43 ) 3·67 % ( 3·56–3·80 ) 1·38 % ( 1·23–1·53 ) 0·657 % ( 0·389–1·33 ) Age group , years0–904160·000 % ( 0·000–0·883 ) 0·0954 % ( 0·0110–1·34 ) 0·00260 % ( 0·000312–0·0382 ) 0·00161 % ( 0·000185–0·0249 ) 10–1915490·182 % ( 0·00461–1·01 ) 0·352 % ( 0·0663–1·74 ) 0·0148 % ( 0·00288–0·0759 ) 0·00695 % ( 0·00149–0·0502 ) 20–29736190·193 % ( 0·0778–0·398 ) 0·296 % ( 0·158–0·662 ) 0·0600 % ( 0·0317–0·132 ) 0·0309 % ( 0·0138–0·0923 ) 30–391876000·237 % ( 0·140–0·374 ) 0·348 % ( 0·241–0·577 ) 0·146 % ( 0·103–0·255 ) 0·0844 % ( 0·0408–0·185 ) 40–493885710·443 % ( 0·314–0·608 ) 0·711 % ( 0·521–0·966 ) 0·295 % ( 0·221–0·422 ) 0·161 % ( 0·0764–0·323 ) 50–5913010 0081·30 % ( 1·09–1·54 ) 2·06 % ( 1·74–2·43 ) 1·25 % ( 1·03–1·55 ) 0·595 % ( 0·344–1·28 ) 60–6930985833·60 % ( 3·22–4·02 ) 5·79 % ( 5·20–6·34 ) 3·99 % ( 3·41–4·55 ) 1·93 % ( 1·11–3·89 ) 70–7931239187·96 % ( 7·13–8·86 ) 12·7 % ( 11·5–13·9 ) 8·61 % ( 7·48–9·99 ) 4·28 % ( 2·45–8·44 ) ≥80208140814·8 % ( 13·0–16·7 ) 23·3 % ( 20·3–26·7 ) 13·4 % ( 11·2–15·9 ) 7·80 % ( 3·80–13·3 ) Age category ( binary ) , year < 6019430 7630·631 % ( 0·545–0·726 ) 1·01 % ( 0·900–1·17 ) 0·318 % ( 0·274–0·378 ) 0·145 % ( 0·0883–0·317 ) ≥6082913 9095·96 % ( 5·57–6·37 ) 9·49 % ( 9·11–9·95 ) 6·38 % ( 5·70–7·17 ) 3·28 % ( 1·82–6·18 ) Crude case fatality ratio present mean ( 95 % confidence interval ) .', 'All fatality ratio present posterior mode ( 95 % credible interval ) .', 'Estimates show three significant figure .', 'Cases death aggregate number report Jan 1 Feb 11 , 2020.8WHOReport WHO-China Joint Mission coronavirus disease 2019 ( COVID-19 ) .', 'urlplaceholder Feb 28 , 2020Date access : March 26 , 2020Google Scholar Crude case fatality ratio calculate number death divide number laboratory-confirmed case .', 'Our estimate also include clinically diagnose case ( scale 1·31 apply across age-groups , breakdown age report clinically diagnose case ) , give larger denominator thus lower case fatality ratio laboratory-confirmed case include .', '* Values include clinically diagnose case include estimates.† Obtained combine estimate case fatality ratio information infection prevalence obtain return home repatriation flights.‡ Accounts underlie demography Wuhan elsewhere China correct under-ascertainment .', 'Open table new tab Figure 3Estimates case fatality ratio age , obtain aggregate data mainland ChinaShow full caption ( A ) Age-distribution case Wuhan elsewhere China .', '( B ) Estimates case fatality ratio age group , adjust demography under-ascertainment .', 'Boxes represent median ( central horizontal line ) IQR , vertical line represent 1·5 × IQR , individual point represent estimate outside range .', '( C ) Estimated proportion case ascertain rest China Wuhan relative 50–59 year age group elsewhere China .', 'Error bar represent 95 % CrIs.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Crude case fatality ratio present mean ( 95 % confidence interval ) .', 'All fatality ratio present posterior mode ( 95 % credible interval ) .', 'Estimates show three significant figure .', 'Cases death aggregate number report Jan 1 Feb 11 , 2020.8WHOReport WHO-China Joint Mission coronavirus disease 2019 ( COVID-19 ) .', 'urlplaceholder Feb 28 , 2020Date access : March 26 , 2020Google Scholar Crude case fatality ratio calculate number death divide number laboratory-confirmed case .', 'Our estimate also include clinically diagnose case ( scale 1·31 apply across age-groups , breakdown age report clinically diagnose case ) , give larger denominator thus lower case fatality ratio laboratory-confirmed case include .', '( A ) Age-distribution case Wuhan elsewhere China .', '( B ) Estimates case fatality ratio age group , adjust demography under-ascertainment .', 'Boxes represent median ( central horizontal line ) IQR , vertical line represent 1·5 × IQR , individual point represent estimate outside range .', '( C ) Estimated proportion case ascertain rest China Wuhan relative 50–59 year age group elsewhere China .', 'Error bar represent 95 % CrIs .', 'In case report outside mainland China , estimate overall modal case fatality ratio 2·7 % ( 95 % CrI 1·4–4·7 ) use parametric model ( table 2 ) .', 'In report travel mainland China ( would therefore detect surveillance system ) , estimate overall modal case fatality ratio 1·1 % ( 0·4–4·1 ) , without report travel China ( therefore detect either contact trace hospital surveillance ) , estimate case fatality ratio 3·6 % ( 1·9–7·2 ) use parametric model .', 'The estimate case fatality ratio lower age 60 year age ( 1·4 % [ 0·4–3·5 ] ) compare age 60 year ( 4·5 % [ 1·8–11·1 ] ) .', 'Similar estimate obtain use non-parametric method ( table 2 ) .Table 2Estimates case fatality ratio obtain individual-level data case identify outside mainland ChinaParametricNon-parametricnCase fatality rationCase fatality ratioOverall5852·7 % ( 1·4–4·7 ) 13344·1 % ( 2·1–7·8 ) Travel versus local transmissionTravellers mainland China2031·1 % ( 0·4–4·1 ) 2082·4 % ( 0·6–8·5 ) Local transmission3823·6 % ( 1·9–7·2 ) 3873·8 % ( 1·7–8·2 ) Age group , year < 603601·4 % ( 0·4–3·5 ) 4491·5 % ( 0·6–3·9 ) ≥601514·5 % ( 1·8–11·1 ) 18112·8 % ( 4·1–33·5 ) Parametric estimate present posterior mode ( 95 % credible interval ) , obtain use gamma-distributed estimate onset-to-death onset-to-recovery .', 'Non-parametric estimate present maximum likelihood estimate ( 95 % confidence interval ) obtain use modify Kaplan-Meier method.11Ghani AC Donnelly CA Cox DR et al.Methods estimate case fatality ratio novel , emerge infectious disease.Am J Epidemiol .', '2005 ; 162 : 479-486Google Scholar , 23Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; ( publish online March 11 . )', 'urlplaceholder Scholar Note due miss data age travel status , number stratify analysis lower overall analysis .', 'In addition , parametric method require correction epidemic growth rate , estimate therefore obtain subset data travel local transmission age know .', 'Open table new tab Parametric estimate present posterior mode ( 95 % credible interval ) , obtain use gamma-distributed estimate onset-to-death onset-to-recovery .', 'Non-parametric estimate present maximum likelihood estimate ( 95 % confidence interval ) obtain use modify Kaplan-Meier method.11Ghani AC Donnelly CA Cox DR et al.Methods estimate case fatality ratio novel , emerge infectious disease.Am J Epidemiol .', '2005 ; 162 : 479-486Google Scholar , 23Zhou F Yu T Du R et al.Clinical course risk factor mortality adult inpatient COVID-19 Wuhan , China : retrospective cohort study.Lancet .', '2020 ; ( publish online March 11 . )', 'urlplaceholder Scholar Note due miss data age travel status , number stratify analysis lower overall analysis .', 'In addition , parametric method require correction epidemic growth rate , estimate therefore obtain subset data travel local transmission age know .', 'In international Wuhan resident repatriate six flight , estimate prevalence infection 0·87 % ( 95 % CI 0·32–1·9 ; six 689 ) .', 'Adjusting demography under-ascertainment , estimate infection fatality ratio 0·66 % ( 95 % CrI 0·39–1·33 ) .', 'As case fatality ratio , strongly age-dependent , estimate rise steeply age 50 year upwards ( table 1 ) .', 'The demography-adjusted under-ascertainment-adjusted proportion infect individual require hospitalisation range 1·1 % 20–29 year age group 18·4 % 80 year older ( table 3 ) .', 'Using age-stratified infection fatality ratio estimate , estimate infection fatality ratio Diamond Princess population 2·9 % .', 'Given delay onset symptom death , would expect 97 % death occur March 25 , 2020 , give estimate current infection fatality ratio 2·8 % , compare empirical estimate 1·4 % ( 95 % CI 0·7–2·6 ; ten 712 ) .Table 3Estimates proportion infection would lead hospitalisation , obtain subset case report mainland China18Yang Y Lu Q Liu M et al.Epidemiological clinical feature 2019 novel coronavirus outbreak China.medRxiv .', '2020 ; ( publish online Feb 21 . )', '( preprint ; withdraw ) .DOI : 10.1101/2020.02.10.20021675Google ScholarSevere casesAll casesProportion infect individual hospitalised0–9 years0130·00 % ( 0·00–0·00 ) 10–19 years1500·0408 % ( 0·0243–0·0832 ) 20–29 years494371·04 % ( 0·622–2·13 ) 30–39 years1247333·43 % ( 2·04–7·00 ) 40–49 years1547434·25 % ( 2·53–8·68 ) 50–59 years2227908·16 % ( 4·86–16·7 ) 60–69 years20156011·8 % ( 7·01–24·0 ) 70–79 years13326316·6 % ( 9·87–33·8 ) ≥80 years517618·4 % ( 11·0–37·6 ) Proportions infect individual hospitalise present posterior mode ( 95 % credible interval ) adjust under-ascertainment correct demography .', 'Estimates show three signficant figure .', 'We assume , base severity classification UK context , case define severe would hospitalise .', 'Open table new tab Proportions infect individual hospitalise present posterior mode ( 95 % credible interval ) adjust under-ascertainment correct demography .', 'Estimates show three signficant figure .', 'We assume , base severity classification UK context , case define severe would hospitalise .', 'From extensive analysis data different region world , best estimate current time case fatality ratio COVID-19 China 1·38 % ( 95 % CrI 1·23–1·53 ) .', 'Although value remain lower estimate coronaviruses , include SARS24Lau EHY Hsiung CA Cowling BJ et al.A comparative epidemiologic analysis SARS Hong Kong , Beijing Taiwan.BMC Infect Dis .', '2010 ; 10 : 50Google Scholar Middle East respiratory syndrome ( MERS ) ,25Lessler J Salje H Van Kerkhove MD et al.Estimating severity subclinical burden middle east respiratory syndrome coronavirus infection Kingdom Saudi Arabia.Am J Epidemiol .', '2016 ; 183 : 657-663Google Scholar substantially higher estimate 2009 H1N1 influenza pandemic.26Riley S Kwok KO Wu KM et al.Epidemiological characteristic 2009 ( H1N1 ) pandemic influenza base pair serum longitudinal community cohort study.PLoS Med .', '2011 ; 8e1000442Google Scholar , 27Kwok KO Riley S Perera RAPM et al.Relative incidence individual-level severity seasonal influenza A H3N2 compare 2009 pandemic H1N1.BMC Infect Dis .', '2017 ; 17 : 337Google Scholar Our estimate infection fatality ratio 0·66 % China inform PCR test international Wuhan resident return repatriation flight .', 'This value consistent infection fatality ratio observe passenger Diamond Princess cruise ship March 5 , 2020 , although slightly upper 95 % confidence limit age-adjusted infection fatality ratio observe March 25 ( 712 confirm case , 601 discharge , ten die , 11 remain critical condition ) .', 'This difference might due repatriation flight data slightly underestimate milder infection , due cruise passenger better outcome potentially higher-than-average quality health care .', 'Our estimate probability require hospitalisation assume severe case require hospitalisation .', 'This assumption clearly different pattern hospitalisation occur China , hospitalisation also use ensure case isolation .', 'Mortality also expect vary underlie health specific population , give risk associate COVID-19 heavily influence presence underlie comorbidities .', 'Our estimate case fatality ratio substantially lower crude case fatality ratio obtain China base case death observe date , currently 3·67 % , well many estimate currently literature .', 'The principle reason difference crude estimate take account severity case .', 'For example , various estimate make patient population range generally milder symptom ( example international traveller detect screen travel history ) 13Jung S Akhmetzhanov AR Hayashi K et al.Real-time estimation risk death novel coronavirus ( COVID-19 ) infection : inference use export cases.J Clin Med .', '2020 ; 9 : E523Google Scholar identify hospital setting.14Mizumoto K Kagaya K Chowell G Yoshida-Nakaadachi-cho U Early epidemiological assessment transmission potential virulence 2019 novel coronavirus Wuhan City : China , January–February , 2020.medRxiv .', '2020 ; ( publish online March 13 . )', '( preprint ) .DOI : 10.1101/2020.02.12.20022434Google Scholar , 15Famulare M 2019-nCoV : preliminary estimate confirmed-case-fatality-ratio infection-fatality-ratio , initial pandemic risk assessment .', 'urlplaceholder Feb 19 , 2020Date access : March 26 , 2020Google Scholar It clear data emerge China case fatality ratio increase substantially age .', 'Our result suggest low fatality ratio age 20 year .', 'As case age group , remain unclear whether reflect low risk death difference susceptibility , although early result indicate young people lower risk infection adults.28Bi Q Wu Y Mei S et al.Epidemiology transmission COVID-19 Shenzhen China : analysis 391 case 1,286 close contacts.medRxiv .', '2020 ; ( publish online March 19 . )', '( preprint ) .DOI : 10.1101/2020.03.03.20028423Google Scholar Serological test age group crucial come week understand significance age group drive population transmission .', 'The estimate increase severity age clearly reflect case report , mean age tend range 50–60 year .', 'Different surveillance system pick different age case mix , find milder symptom detect history travel younger average detect hospital surveillance .', 'Our correction surveillance bias therefore allow u obtain estimate apply different case mix demographic population structure .', 'However , note correction applicable assumption uniform infection attack rate ( ie , exposure ) across population .', 'We also assume perfect case ascertainment outside Wuhan age group case relative population size ( 50–59-year-olds ) ; however , many case miss , case fatality ratio infection fatality ratio estimate might lower .', 'In absence random population survey infection prevalence , adjustment case fatality ratio infection fatality ratio rely repatriation flight data , age specific .', 'The report proportion infect individual asymptomatic Diamond Princess vary considerably age , support approach , future larger representative population prevalence survey seroprevalence survey inform estimate .', 'Much data inform global estimate case fatality ratio present early outbreak Wuhan .', 'Given health system city quickly overwhelm , estimate suggest substantial under-ascertainment case younger age group ( estimate milder disease ) comparison elsewhere mainland China .', 'This under-ascertainment main factor drive difference estimate crude case fatality ratio China ( 3·67 % ) best estimate overall case fatality ratio ( 1·38 % ) .', 'The case fatality ratio likely strongly influence availability health-care facility .', 'However surprisingly , although health-care availability Wuhan stretch , estimate international case similar magnitude , suggest relatively little difference health outcome .', 'Finally , clinical knowledge new disease accrue , possible outcome improve .', 'It therefore important revise estimate epidemic unfold .', 'The world currently experience early stage global pandemic .', 'Although China succeed contain disease spread 2 month , containment unlikely achievable country .', 'Thus , much world experience large community epidemic COVID-19 come week month .', 'Our estimate underlie infection fatality ratio virus inform assessment health effect likely experience different country , thus decision around appropriate mitigation policy adopt .', 'This online publication correct .', 'The first correct version first appear thelancet.com/infection April 15 , 2020 second May 4 , 2020 This online publication correct .', 'The first correct version first appear thelancet.com/infection April 15 , 2020 second May 4 , 2020 Contributors NMF ACG conceive study input RV , LCO , ID , PW , CW .', 'RV , LCO , ID lead analysis individual-case data international case estimation onset-to-outcome distribution , input CAD , ACG , NMF .', 'RV , PW , CW , PGTW lead analysis China data , input ACG NMF .', 'NI coordinate management team , include data collation process .', 'NI GC-D undertake extraction international case data .', 'HT undertake extraction flight repatriation data , input NI AD .', 'HF lead extraction China mainland data national regional website input HW , YW , XX .', 'JTG develop code non-parametric model .', 'ACG produce first draft manuscript .', 'All author contribute final draft .', 'Declaration interest LCO report grant WHO outside submit work .', 'CAD report grant UK Medical Research Council National Institute Health Research conduct study .', 'NMF report grant UK Medical Research Council UK National Institute Health Research conduct study , grant Gavi , Vaccine Alliance , Janssen Pharmaceuticals , Bill Melinda Gates Foundation outside submit work .', 'All author declare compete interest .', 'All data code use study available GitHub repository .', 'Acknowledgments This work support centre fund UK Medical Research Council ( MRC ) concordat UK Department International Development , National Institute Health Research Health Protection Research Unit Modelling Methodology , Abdul Latif Jameel Foundation .', ""We grateful input follow volunteer hackathon participant MRC Centre Imperial College London : Kylie Ainslie , Sumali Bajaj , Lorenzo Cattarino , Joseph Challenger , Giovanni Charles , Georgina Charnley , Paula Christen , Constance Ciavarella , Victoria Cox , Zulma Cucunubá , Joshua D'Aeth , Tamsin Dewé , Lorna Dunning , Oliver Eales , Keith Fraser , Tini Garske , Lily Geidelberg , Nan Hong , Samuel Horsfield , Min J Kwun , David Jørgensen , Mara Kont , Alice Ledda , Xiang Li , Alessandra Lochen , Tara Mangal , Ruth McCabe , Kevin McRae-McKee , Kate Mitchell , Andria Mousa , Rebecca Nash , Daniela Olivera , Saskia Ricks , Nora Schmit , Ellie Sherrard-Smith , Janetta Skarp , Isaac Stopard , Juliette Unwin , Juan Vesga , Caroline Walters , Lilith Whittles ."", 'Download .pdf ( .32 MB ) Help pdf file Supplementary appendix Likelihood survival coronavirus disease 2019Full-TextPDFOpen AccessCorrection Lancet Infect Dis 2020 ; publish online March 30. urlplaceholder Lancet Infect Dis 2020 ; publish online March 30. urlplaceholder AccessProtecting worker age 60–69 year COVID-19Full-TextPDF']","['backgroundin', 'face', 'rapidly', 'change', 'data', '', 'range', 'case', 'fatality', 'ratio', 'estimate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'produce', 'differ', 'substantially', 'magnitude', '', 'aim', 'provide', 'robust', 'estimate', '', 'account', 'censor', 'ascertainment', 'biasesmethodswe', 'collect', 'individual-case', 'data', 'patient', 'die', 'covid-19', 'hubei', '', 'mainland', 'china', '', 'report', 'national', 'provincial', 'health', 'commission', 'feb', '8', '', '2020', '', '', 'case', 'outside', 'mainland', 'china', '', 'government', 'ministry', 'health', 'website', 'medium', 'report', '37', 'country', '', 'well', 'hong', 'kong', 'macau', '', 'feb', '25', '', '2020', '', '', 'individual-case', 'data', 'estimate', 'time', 'onset', 'symptom', 'outcome', '', 'death', 'discharge', 'hospital', '', '', 'next', 'obtain', 'age-stratified', 'estimate', 'case', 'fatality', 'ratio', 'relate', 'aggregate', 'distribution', 'case', 'observe', 'cumulative', 'death', 'china', '', 'assume', 'constant', 'attack', 'rate', 'age', 'adjust', 'demography', 'age-based', 'location-based', 'under-ascertainment', '', 'estimate', 'case', 'fatality', 'ratio', 'individual', 'line-list', 'data', '1334', 'case', 'identify', 'outside', 'mainland', 'china', '', 'using', 'data', 'prevalence', 'pcr-confirmed', 'case', 'international', 'resident', 'repatriate', 'china', '', 'obtain', 'age-stratified', 'estimate', 'infection', 'fatality', 'ratio', '', 'furthermore', '', 'data', 'age-stratified', 'severity', 'subset', '3665', 'case', 'china', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'require', 'hospitalisationfindingsusing', 'data', '24', 'death', 'occur', 'mainland', 'china', '165', 'recovery', 'outside', 'china', '', 'estimate', 'mean', 'duration', 'onset', 'symptom', 'death', '178', 'day', '', '95', '', 'credible', 'interval', '', 'cri', '', '169192', '', 'hospital', 'discharge', '247', 'day', '', '229281', '', '', 'laboratory', 'confirm', 'clinically', 'diagnose', 'case', 'mainland', 'china', '', 'n70', '117', '', '', 'estimate', 'crude', 'case', 'fatality', 'ratio', '', 'adjust', 'censor', '', '367', '', '', '95', '', 'cri', '356380', '', '', 'however', '', 'adjust', 'demography', 'under-ascertainment', '', 'obtain', 'best', 'estimate', 'case', 'fatality', 'ratio', 'china', '138', '', '', '123153', '', '', 'substantially', 'higher', 'ratio', 'older', 'age', 'group', '', '032', '', '', '027038', '', 'age', '', '60', 'year', 'v', '64', '', '', '5772', '', 'age', '60', 'year', '', '', '134', '', '', '112159', '', 'age', '80', 'year', 'older', '', 'estimates', 'case', 'fatality', 'ratio', 'international', 'case', 'stratify', 'age', 'consistent', 'china', '', 'parametric', 'estimate', '14', '', '', '0435', '', 'age', '', '60', 'year', '', 'n360', '', '45', '', '', '18111', '', 'age', '60', 'year', '', 'n151', '', '', '', 'estimate', 'overall', 'infection', 'fatality', 'ratio', 'china', '066', '', '', '039133', '', '', 'increase', 'profile', 'age', '', 'similarly', '', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'hospitalise', 'increase', 'age', 'maximum', '184', '', '', '110376', '', 'age', '80', 'year', 'olderinterpretationthese', 'early', 'estimate', 'give', 'indication', 'fatality', 'ratio', 'across', 'spectrum', 'covid-19', 'disease', 'show', 'strong', 'age', 'gradient', 'risk', 'deathfundinguk', 'medical', 'research', 'council', '', 'face', 'rapidly', 'change', 'data', '', 'range', 'case', 'fatality', 'ratio', 'estimate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'produce', 'differ', 'substantially', 'magnitude', '', 'aim', 'provide', 'robust', 'estimate', '', 'account', 'censor', 'ascertainment', 'bias', '', 'collect', 'individual-case', 'data', 'patient', 'die', 'covid-19', 'hubei', '', 'mainland', 'china', '', 'report', 'national', 'provincial', 'health', 'commission', 'feb', '8', '', '2020', '', '', 'case', 'outside', 'mainland', 'china', '', 'government', 'ministry', 'health', 'website', 'medium', 'report', '37', 'country', '', 'well', 'hong', 'kong', 'macau', '', 'feb', '25', '', '2020', '', '', 'individual-case', 'data', 'estimate', 'time', 'onset', 'symptom', 'outcome', '', 'death', 'discharge', 'hospital', '', '', 'next', 'obtain', 'age-stratified', 'estimate', 'case', 'fatality', 'ratio', 'relate', 'aggregate', 'distribution', 'case', 'observe', 'cumulative', 'death', 'china', '', 'assume', 'constant', 'attack', 'rate', 'age', 'adjust', 'demography', 'age-based', 'location-based', 'under-ascertainment', '', 'estimate', 'case', 'fatality', 'ratio', 'individual', 'line-list', 'data', '1334', 'case', 'identify', 'outside', 'mainland', 'china', '', 'using', 'data', 'prevalence', 'pcr-confirmed', 'case', 'international', 'resident', 'repatriate', 'china', '', 'obtain', 'age-stratified', 'estimate', 'infection', 'fatality', 'ratio', '', 'furthermore', '', 'data', 'age-stratified', 'severity', 'subset', '3665', 'case', 'china', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'require', 'hospitalisation', '', 'using', 'data', '24', 'death', 'occur', 'mainland', 'china', '165', 'recovery', 'outside', 'china', '', 'estimate', 'mean', 'duration', 'onset', 'symptom', 'death', '178', 'day', '', '95', '', 'credible', 'interval', '', 'cri', '', '169192', '', 'hospital', 'discharge', '247', 'day', '', '229281', '', '', 'laboratory', 'confirm', 'clinically', 'diagnose', 'case', 'mainland', 'china', '', 'n70', '117', '', '', 'estimate', 'crude', 'case', 'fatality', 'ratio', '', 'adjust', 'censor', '', '367', '', '', '95', '', 'cri', '356380', '', '', 'however', '', 'adjust', 'demography', 'under-ascertainment', '', 'obtain', 'best', 'estimate', 'case', 'fatality', 'ratio', 'china', '138', '', '', '123153', '', '', 'substantially', 'higher', 'ratio', 'older', 'age', 'group', '', '032', '', '', '027038', '', 'age', '', '60', 'year', 'v', '64', '', '', '5772', '', 'age', '60', 'year', '', '', '134', '', '', '112159', '', 'age', '80', 'year', 'older', '', 'estimates', 'case', 'fatality', 'ratio', 'international', 'case', 'stratify', 'age', 'consistent', 'china', '', 'parametric', 'estimate', '14', '', '', '0435', '', 'age', '', '60', 'year', '', 'n360', '', '45', '', '', '18111', '', 'age', '60', 'year', '', 'n151', '', '', '', 'estimate', 'overall', 'infection', 'fatality', 'ratio', 'china', '066', '', '', '039133', '', '', 'increase', 'profile', 'age', '', 'similarly', '', 'estimate', 'proportion', 'infect', 'individual', 'likely', 'hospitalise', 'increase', 'age', 'maximum', '184', '', '', '110376', '', 'age', '80', 'year', 'older', '', 'early', 'estimate', 'give', 'indication', 'fatality', 'ratio', 'across', 'spectrum', 'covid-19', 'disease', 'show', 'strong', 'age', 'gradient', 'risk', 'death', '', 'uk', 'medical', 'research', 'council', '', 'march', '25', '', '2020', '', '414', '179', 'case', '18', '440', 'death', 'due', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cause', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'report', 'worldwide1whocoronavirus', 'disease', '2019', '', 'covid-19', '', 'situation', 'report43', '', 'urlplaceholder', 'march', '3', '', '2020date', 'access', '', 'march', '5', '', '2020google', 'epidemic', 'begin', 'mainland', 'china', '', 'geographical', 'focus', 'city', 'wuhan', '', 'hubei', '', 'however', '', 'feb', '26', '', '2020', '', 'rate', 'increase', 'case', 'become', 'greater', 'rest', 'world', 'inside', 'china', '', 'substantial', 'outbreak', 'occur', 'italy', '', '69', '176', 'case', '', '', 'usa', '', '51', '914', 'case', '', '', 'iran', '', '24', '811', 'case', '', '', 'geographical', 'expansion', 'epidemic', 'continue', '', 'clinical', 'study', 'hospitalise', 'patient', 'show', '', 'onset', 'covid-19', '', 'patient', 'frequently', 'show', 'symptom', 'associate', 'viral', 'pneumonia', '', 'commonly', 'fever', '', 'cough', '', 'sore', 'throat', '', 'myalgia', '', 'fatigue2chan', 'jfw', 'yuan', 'kok', 'kh', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '395', '', '514-523google', '', '3chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513google', '', '4guan', 'wj', 'ni', 'zy', 'hu', 'alclinical', 'characteristic', 'coronavirus', 'disease', '2019', 'chinan', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'feb', '28', '', '', 'doi101056nejmoa2002032google', '', '5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', '', '6li', 'q', 'guan', 'x', 'wu', 'p', 'alearly', 'transmission', 'dynamic', 'wuhan', '', 'china', '', 'novel', 'coronavirus-infected', 'pneumonian', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'jan', '29', '', '', 'doi101056nejmoa2001316google', 'case', 'definition', 'adopt', 'china', 'elsewhere', 'include', 'stratification', 'case', 'severe', '', 'define', 'tachypnoea', '', '30', 'breath', 'per', 'min', '', '', 'oxygen', 'saturation', '93', '', 'rest', '', 'pao2fio2', 'ratio', '', '300', 'mm', 'hg', '', 'critical', '', 'respiratory', 'failure', 'require', 'mechanical', 'ventilation', '', 'septic', 'shock', '', 'organ', 'dysfunction', 'failure', 'require', 'intensive', 'care', '', '7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', '', 'covid-19', '', 'chinazhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '', '2020', '', '41', '', 'chinese', '', '', '', '145-151google', 'according', 'report', 'whochina', 'joint', 'mission', 'covid-19', '', '80', '', '55', '924', 'patient', 'laboratory-confirmed', 'covid-19', 'china', 'feb', '20', '', '2020', '', 'mild-to-moderate', 'disease', '', 'include', 'non-pneumonia', 'pneumonia', 'case', '', '138', '', 'develop', 'severe', 'disease', '61', '', 'develop', 'critical', 'stage', 'require', 'intensive', 'care8whoreport', 'who-china', 'joint', 'mission', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'urlplaceholder', 'feb', '28', '', '2020date', 'access', '', 'march', '26', '', '2020google', 'study', 'clinical', 'progression', '1099', 'patients4guan', 'wj', 'ni', 'zy', 'hu', 'alclinical', 'characteristic', 'coronavirus', 'disease', '2019', 'chinan', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'feb', '28', '', '', 'doi101056nejmoa2002032google', 'highest', 'risk', 'severe', 'disease', 'death', 'include', 'people', 'age', '60', 'year', 'underlie', 'condition', '', 'include', 'hypertension', '', 'diabetes', '', 'cardiovascular', 'disease', '', 'chronic', 'respiratory', 'disease', '', 'cancer', '', 'research', 'contextevidence', 'studywe', 'search', '', 'medrxiv', '', 'biorxiv', '', 'arxiv', '', 'ssrn', '', 'research', 'square', '', 'virological', '', 'wellcome', 'open', 'research', 'peer-reviewed', 'article', '', 'preprints', '', 'research', 'report', 'severity', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'search', 'term', '', 'coronavirus', '', '', '', '2019-ncov', '', '', 'similar', 'term', '', '', 'fatality', '', '', 'march', '6', '', '2020', '', 'several', 'study', 'estimate', 'case', 'fatality', 'ratio', '', 'percentage', 'individual', 'symptomatic', 'confirm', 'disease', 'die', 'disease', '', 'infection', 'fatality', 'ratio', '', 'percentage', 'infect', 'individual', 'die', 'disease', '', 'include', 'mild', 'disease', '', 'covid-19', 'range', 'different', 'statistical', 'model', 'method', '', 'studies', 'solely', 'hospitalise', 'patient', 'report', 'highest', 'fatality', 'ratio', '', '828', '', '', '', 'represent', 'outcome', 'severely', 'ill', 'patient', '', 'estimates', 'population-level', 'case', 'fatality', 'ratio', 'case', 'report', 'range', '28', '', '', 'estimates', 'infection', 'fatality', 'ratio', 'average', 'across', 'age-groups', 'range', '02', '', '16', '', '', 'estimate', 'infection', 'fatality', 'ratio', 'oldest', 'age', 'group', '', '80', 'year', '', 'range', '8', '', '36', '', '', 'none', 'identify', 'study', 'adjust', 'difference', 'denominator', 'population', 'obtain', 'estimate', 'apply', 'across', 'population', '', 'study', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisationadded', 'value', 'studyby', 'synthesise', 'data', 'across', 'range', 'surveillance', 'set', '', 'obtain', 'estimate', 'age-stratified', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'account', 'different', 'denominator', 'population', 'datasets', '', 'underlie', 'assumption', '', 'attack', 'rate', '', 'ie', '', 'probability', 'become', 'infect', '', 'vary', 'substantially', 'age', '', 'consistent', 'previous', 'study', 'respiratory', 'infection', '', 'assumption', '', 'difference', 'age', 'pattern', 'among', 'case', 'wuhan', 'versus', 'elsewhere', 'china', 'probably', 'due', 'under-ascertainment', 'case', '', 'give', 'different', 'surveillance', 'system', 'place', '', 'result', 'consistent', 'hypothesis', '', 'case', 'wuhan', 'older', 'individual', '', 'identify', 'attendance', 'hospital', '', 'whereas', 'case', 'elsewhere', 'china', 'younger', 'overall', '', 'explain', 'policy', 'test', 'travel', 'history', 'wuhan', '', 'correct', 'bias', '', 'find', 'estimate', 'case', 'fatality', 'ratio', 'china', 'consistent', 'obtain', 'early', 'international', 'case', '', 'age-stratified', 'estimate', 'infection', 'fatality', 'ratio', 'apply', 'demography', 'give', 'estimate', 'infection', 'fatality', 'ratio', 'older', 'younger', 'population', '', 'estimate', 'combine', 'estimate', 'infection', 'attack', 'rate', '', 'approximately', '80', '', 'unmitigated', 'epidemic', '', 'give', 'rough', 'projection', 'scale', '', 'similarly', '', 'estimate', 'proportion', 'infection', 'require', 'hospitalisation', 'combine', 'infection', 'attack', 'rate', 'forecast', 'health-care', 'requirementsimplications', 'available', 'evidenceour', 'estimate', 'case', 'fatality', 'ratio', 'covid-19', '', 'although', 'lower', 'crude', 'estimate', 'date', '', 'substantially', 'higher', 'recent', 'influenza', 'pandemic', '', 'eg', '', 'h1n1', 'influenza', '2009', '', '', 'rapid', 'geographical', 'spread', 'observe', 'date', '', 'covid-19', 'therefore', 'represent', 'major', 'global', 'health', 'threat', 'week', 'month', '', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', '', 'combine', 'likely', 'infection', 'attack', 'rate', '', 'around', '5080', '', '', '', 'show', 'advance', 'health-care', 'system', 'likely', 'overwhelm', '', 'estimate', 'therefore', 'crucial', 'enable', 'country', 'around', 'world', 'best', 'prepare', 'global', 'pandemic', 'continue', 'unfold', '', 'evidence', 'study', 'search', '', 'medrxiv', '', 'biorxiv', '', 'arxiv', '', 'ssrn', '', 'research', 'square', '', 'virological', '', 'wellcome', 'open', 'research', 'peer-reviewed', 'article', '', 'preprints', '', 'research', 'report', 'severity', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'search', 'term', '', 'coronavirus', '', '', '', '2019-ncov', '', '', 'similar', 'term', '', '', 'fatality', '', '', 'march', '6', '', '2020', '', 'several', 'study', 'estimate', 'case', 'fatality', 'ratio', '', 'percentage', 'individual', 'symptomatic', 'confirm', 'disease', 'die', 'disease', '', 'infection', 'fatality', 'ratio', '', 'percentage', 'infect', 'individual', 'die', 'disease', '', 'include', 'mild', 'disease', '', 'covid-19', 'range', 'different', 'statistical', 'model', 'method', '', 'studies', 'solely', 'hospitalise', 'patient', 'report', 'highest', 'fatality', 'ratio', '', '828', '', '', '', 'represent', 'outcome', 'severely', 'ill', 'patient', '', 'estimates', 'population-level', 'case', 'fatality', 'ratio', 'case', 'report', 'range', '28', '', '', 'estimates', 'infection', 'fatality', 'ratio', 'average', 'across', 'age-groups', 'range', '02', '', '16', '', '', 'estimate', 'infection', 'fatality', 'ratio', 'oldest', 'age', 'group', '', '80', 'year', '', 'range', '8', '', '36', '', '', 'none', 'identify', 'study', 'adjust', 'difference', 'denominator', 'population', 'obtain', 'estimate', 'apply', 'across', 'population', '', 'study', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', '', 'added', 'value', 'study', 'synthesise', 'data', 'across', 'range', 'surveillance', 'set', '', 'obtain', 'estimate', 'age-stratified', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'account', 'different', 'denominator', 'population', 'datasets', '', 'underlie', 'assumption', '', 'attack', 'rate', '', 'ie', '', 'probability', 'become', 'infect', '', 'vary', 'substantially', 'age', '', 'consistent', 'previous', 'study', 'respiratory', 'infection', '', 'assumption', '', 'difference', 'age', 'pattern', 'among', 'case', 'wuhan', 'versus', 'elsewhere', 'china', 'probably', 'due', 'under-ascertainment', 'case', '', 'give', 'different', 'surveillance', 'system', 'place', '', 'result', 'consistent', 'hypothesis', '', 'case', 'wuhan', 'older', 'individual', '', 'identify', 'attendance', 'hospital', '', 'whereas', 'case', 'elsewhere', 'china', 'younger', 'overall', '', 'explain', 'policy', 'test', 'travel', 'history', 'wuhan', '', 'correct', 'bias', '', 'find', 'estimate', 'case', 'fatality', 'ratio', 'china', 'consistent', 'obtain', 'early', 'international', 'case', '', 'age-stratified', 'estimate', 'infection', 'fatality', 'ratio', 'apply', 'demography', 'give', 'estimate', 'infection', 'fatality', 'ratio', 'older', 'younger', 'population', '', 'estimate', 'combine', 'estimate', 'infection', 'attack', 'rate', '', 'approximately', '80', '', 'unmitigated', 'epidemic', '', 'give', 'rough', 'projection', 'scale', '', 'similarly', '', 'estimate', 'proportion', 'infection', 'require', 'hospitalisation', 'combine', 'infection', 'attack', 'rate', 'forecast', 'health-care', 'requirement', '', 'implications', 'available', 'evidence', 'estimate', 'case', 'fatality', 'ratio', 'covid-19', '', 'although', 'lower', 'crude', 'estimate', 'date', '', 'substantially', 'higher', 'recent', 'influenza', 'pandemic', '', 'eg', '', 'h1n1', 'influenza', '2009', '', '', 'rapid', 'geographical', 'spread', 'observe', 'date', '', 'covid-19', 'therefore', 'represent', 'major', 'global', 'health', 'threat', 'week', 'month', '', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', '', 'combine', 'likely', 'infection', 'attack', 'rate', '', 'around', '5080', '', '', '', 'show', 'advance', 'health-care', 'system', 'likely', 'overwhelm', '', 'estimate', 'therefore', 'crucial', 'enable', 'country', 'around', 'world', 'best', 'prepare', 'global', 'pandemic', 'continue', 'unfold', '', 'assessing', 'severity', 'covid-19', 'crucial', 'determine', 'appropriateness', 'mitigation', 'strategy', 'enable', 'plan', 'health-care', 'epidemic', 'unfold', '', 'however', '', 'crude', 'case', 'fatality', 'ratio', 'obtain', 'divide', 'number', 'death', 'number', 'case', 'misleading9garske', 'legrand', 'j', 'donnelly', 'ca', 'alassessing', 'severity', 'novel', 'influenza', 'ah1n1', 'pandemicbmj', '', '2009', '', '339b2840google', '', '10lipsitch', 'donnelly', 'ca', 'fraser', 'c', 'alpotential', 'bias', 'estimate', 'absolute', 'relative', 'case-fatality', 'risk', 'outbreaksplos', 'negl', 'trop', 'dis', '', '2015', '', '9e0003846google', 'first', '', 'period', '23', 'week', 'person', 'develop', 'symptom', '', 'case', 'subsequently', 'detect', 'report', '', 'observation', 'final', 'clinical', 'outcome', '', 'grow', 'epidemic', '', 'final', 'clinical', 'outcome', 'report', 'case', 'typically', 'unknown', '', 'simply', 'divide', 'cumulative', 'report', 'number', 'death', 'cumulative', 'number', 'report', 'case', 'therefore', 'underestimate', 'true', 'case', 'fatality', 'ratio', 'early', 'epidemic9garske', 'legrand', 'j', 'donnelly', 'ca', 'alassessing', 'severity', 'novel', 'influenza', 'ah1n1', 'pandemicbmj', '', '2009', '', '339b2840google', '', '10lipsitch', 'donnelly', 'ca', 'fraser', 'c', 'alpotential', 'bias', 'estimate', 'absolute', 'relative', 'case-fatality', 'risk', 'outbreaksplos', 'negl', 'trop', 'dis', '', '2015', '', '9e0003846google', '', '11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'almethods', 'estimate', 'case', 'fatality', 'ratio', 'novel', '', 'emerge', 'infectious', 'diseaseam', 'j', 'epidemiol', '', '2005', '', '162', '', '479-486google', 'effect', 'observe', 'past', 'epidemic', 'respiratory', 'pathogen', '', 'include', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '12donnelly', 'ca', 'ghani', 'ac', 'leung', 'gm', 'alepidemiological', 'determinant', 'spread', 'causal', 'agent', 'severe', 'acute', 'respiratory', 'syndrome', 'hong', 'konglancet', '', '2003', '', '361', '', '1761-1766google', 'h1n19garske', 'legrand', 'j', 'donnelly', 'ca', 'alassessing', 'severity', 'novel', 'influenza', 'ah1n1', 'pandemicbmj', '', '2009', '', '339b2840google', 'influenza', '', 'widely', 'recognise', '', 'thus', '', 'estimate', 'case', 'fatality', 'ratio', 'obtain', 'date', 'covid-19', 'correct', 'effect13jung', 'akhmetzhanov', 'ar', 'hayashi', 'k', 'alreal-time', 'estimation', 'risk', 'death', 'novel', 'coronavirus', '', 'covid-19', '', 'infection', '', 'inference', 'export', 'casesj', 'clin', 'med', '', '2020', '', '9', '', 'e523google', '', '14mizumoto', 'k', 'kagaya', 'k', 'chowell', 'g', 'yoshida-nakaadachi-cho', 'u', 'early', 'epidemiological', 'assessment', 'transmission', 'potential', 'virulence', '2019', 'novel', 'coronavirus', 'wuhan', 'city', '', 'china', '', 'januaryfebruary', '', '2020medrxiv', '', '2020', '', '', 'publish', 'online', 'march', '13', '', '', '', 'preprint', '', 'doi', '', '1011012020021220022434google', '', '15famulare', '2019-ncov', '', 'preliminary', 'estimate', 'confirmed-case-fatality-ratio', 'infection-fatality-ratio', '', 'initial', 'pandemic', 'risk', 'assessment', '', 'urlplaceholder', 'feb', '19', '', '2020date', 'access', '', 'march', '26', '', '2020google', '', '16wu', 'p', 'hao', 'x', 'lau', 'ehy', 'alreal-time', 'tentative', 'assessment', 'epidemiological', 'characteristic', 'novel', 'coronavirus', 'infection', 'wuhan', '', 'china', '', '22', 'january', '2020euro', 'surveill', '', '2020', '', '25', '', '1-6google', 'additionally', '', 'however', '', 'exponential', 'growth', 'phase', 'epidemic', '', 'observe', 'time', 'lag', 'onset', 'symptom', 'outcome', '', 'recovery', 'death', '', 'censor', '', 'naive', 'estimate', 'observe', 'time', 'symptom', 'onset', 'outcome', 'provide', 'bias', 'estimate', 'actual', 'distribution', '', 'ignoring', 'effect', 'tend', 'bias', 'estimate', 'case', 'fatality', 'ratio', 'downwards', 'early', 'growth', 'phase', 'epidemic', '', 'second', '', 'surveillance', 'newly', 'emerge', 'pathogen', 'typically', 'bias', 'towards', 'detect', 'clinically', 'severe', 'case', '', 'especially', 'start', 'epidemic', 'diagnostic', 'capacity', 'low', '', 'figure', '1', '', '', 'estimates', 'case', 'fatality', 'ratio', 'thus', 'bias', 'upwards', 'extent', 'clinically', 'milder', 'disease', 'determined9garske', 'legrand', 'j', 'donnelly', 'ca', 'alassessing', 'severity', 'novel', 'influenza', 'ah1n1', 'pandemicbmj', '', '2009', '', '339b2840google', 'data', 'epicentre', 'outbreak', 'wuhan', 'primarily', 'obtain', 'hospital', 'surveillance', '', 'thus', '', 'likely', 'represent', 'patient', 'moderate', 'severe', 'illness', '', 'atypical', 'pneumonia', 'acute', 'respiratory', 'distress', 'define', 'suspect', 'case', 'eligible', 'testing7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', '', 'covid-19', '', 'chinazhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '', '2020', '', '41', '', 'chinese', '', '', '', '145-151google', 'individual', '', 'clinical', 'outcome', 'likely', 'severe', '', 'estimate', 'case', 'fatality', 'ratio', 'higher', '', 'elsewhere', 'mainland', 'china', 'rest', 'world', '', 'country', 'administrative', 'region', 'alert', 'risk', 'infection', 'import', 'via', 'travel', 'initially', 'institute', 'surveillance', 'covid-19', 'broader', 'set', 'clinical', 'criterion', 'define', 'suspect', 'case', '', 'criterion', 'typically', 'include', 'combination', 'symptom', '', 'eg', '', 'cough', 'fever', '', 'combine', 'recent', 'travel', 'history', 'affect', 'region', '', 'wuhan', '', 'hubei', 'province', '', '2chan', 'jfw', 'yuan', 'kok', 'kh', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '395', '', '514-523google', '', '17xu', 'xw', 'wu', 'xx', 'jiang', 'xg', 'alclinical', 'find', 'group', 'patient', 'infect', '2019', 'novel', 'coronavirus', '', 'sars-cov-2', '', 'outside', 'wuhan', '', 'china', '', 'retrospective', 'case', 'seriesbmj', '', '2020', '', '368', '', 'm606google', '', 'surveillance', 'likely', 'detect', 'clinically', 'mild', 'case', '', 'initially', 'restrict', 'test', 'travel', 'history', 'link', '', 'miss', 'symptomatic', 'casesfigure', '1spectrum', 'covid-19', 'casesshow', 'full', 'captionat', 'top', 'pyramid', '', 'meet', 'case', 'criterion', 'severe', 'critical', 'case', 'likely', 'identify', 'hospital', 'set', '', 'present', 'atypical', 'viral', 'pneumonia', '', 'case', 'identify', 'mainland', 'china', 'among', 'categorise', 'internationally', 'local', 'transmission', '', 'case', 'likely', 'symptomatic', '', 'ie', '', 'fever', '', 'cough', '', 'myalgia', '', '', 'require', 'hospitalisation', '', 'case', 'identify', 'link', 'international', 'travel', 'high-risk', 'area', 'contact-tracing', 'contact', 'confirm', 'case', '', 'identify', 'population', 'surveillance', '', 'example', '', 'influenza-like', 'illness', '', 'bottom', 'part', 'pyramid', 'represent', 'mild', '', 'possibly', 'asymptomatic', '', 'case', '', 'case', 'identify', 'contact', 'trace', 'subsequently', 'via', 'serological', 'testingview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'top', 'pyramid', '', 'meet', 'case', 'criterion', 'severe', 'critical', 'case', 'likely', 'identify', 'hospital', 'set', '', 'present', 'atypical', 'viral', 'pneumonia', '', 'case', 'identify', 'mainland', 'china', 'among', 'categorise', 'internationally', 'local', 'transmission', '', 'case', 'likely', 'symptomatic', '', 'ie', '', 'fever', '', 'cough', '', 'myalgia', '', '', 'require', 'hospitalisation', '', 'case', 'identify', 'link', 'international', 'travel', 'high-risk', 'area', 'contact-tracing', 'contact', 'confirm', 'case', '', 'identify', 'population', 'surveillance', '', 'example', '', 'influenza-like', 'illness', '', 'bottom', 'part', 'pyramid', 'represent', 'mild', '', 'possibly', 'asymptomatic', '', 'case', '', 'case', 'identify', 'contact', 'trace', 'subsequently', 'via', 'serological', 'test', '', 'attempt', 'adjust', 'bias', 'data', 'source', 'obtain', 'estimate', 'case', 'fatality', 'ratio', '', 'proportion', 'case', 'eventually', 'lead', 'death', '', 'infection', 'fatality', 'ratio', '', 'proportion', 'infection', 'eventually', 'lead', 'death', '', 'individual-level', 'case', 'report', 'data', 'aggregate', 'case', 'death', 'count', 'mainland', 'china', '', 'hong', 'kong', 'macau', '', 'international', 'case', 'report', '', 'adjust', 'underlie', 'demography', 'potential', 'under-ascertainment', 'different', 'level', 'severity', 'pyramid', '', 'figure', '1', '', '', 'estimate', 'broadly', 'applicable', 'across', 'range', 'set', 'inform', 'health', 'plan', 'detail', 'case', 'data', 'accrue', '', 'identify', 'information', 'characteristic', '48', 'patient', 'die', 'covid-19', 'hubei', '', 'report', 'national', 'health', 'commission', 'hubei', 'province', 'health', 'commission', 'website', 'feb', '8', '', '2020', '', 'record', 'follow', 'data', 'element', '', 'available', '', 'sex', '', 'age', '', 'date', 'symptom', 'onset', '', 'date', 'hospitalisation', '', 'date', 'death', '', '48', 'case', '', 'neither', 'date', 'symptom', 'onset', 'date', 'report', 'available', '13', 'case', '', 'remove', 'eight', 'case', 'onset', 'jan', '1', '', '2020', '', 'death', 'jan', '21', '', '2020', '', 'three', 'death', 'jan', '28', '', '2020', '', 'date', 'consistent', 'reliable', 'report', 'onset', 'death', 'set', '', 'respectively', '', 'consider', 'onset-to-death', 'time', '', 'include', 'early', 'onset', 'create', 'bias', 'towards', 'long', 'onset-to-death', 'time', '', 'reflect', 'under-ascertainment', 'death', 'early', '', '', 'leave', '24', 'death', '', 'estimate', 'onset-to-death', 'distribution', '', 'collate', 'data', '2010', 'case', 'report', '37', 'country', 'two', 'special', 'administrative', 'region', 'china', '', 'hong', 'kong', 'macau', '', '', 'government', 'ministry', 'health', 'website', 'medium', 'report', '', 'feb', '25', '', '2020', '', 'record', 'follow', 'information', 'available', '', 'country', 'administrative', 'region', 'case', 'detect', '', 'whether', 'infection', 'acquire', 'china', 'abroad', '', 'date', 'travel', '', 'date', 'symptom', 'onset', '', 'date', 'hospitalisation', '', 'date', 'confirmation', '', 'date', 'recovery', '', 'date', 'death', '', 'data', '165', 'recover', 'individual', 'report', 'recovery', 'date', 'report', 'impute', 'onset', 'date', 'estimate', 'onset-to-recovery', 'distribution', '', 'exclude', '26', 'recovery', 'without', 'appropriate', 'information', 'date', 'recovery', '', 'report', '', 'locality', '', 'data', '1334', 'international', 'case', 'obtain', 'estimate', 'case', 'fatality', 'ratio', '', 'include', 'case', 'without', 'date', 'report', '', 'data', '70', '117', 'pcr-confirmed', 'clinically', 'diagnose', 'case', 'date', 'onset', 'wuhan', 'elsewhere', 'china', 'jan', '1', 'feb', '11', '', '2020', '', 'extract', 'whochina', 'joint', 'mission', 'report8whoreport', 'who-china', 'joint', 'mission', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'urlplaceholder', 'feb', '28', '', '2020date', 'access', '', 'march', '26', '', '2020google', 'period', 'total', '1023', 'death', 'report', 'across', 'china', '', 'data', 'available', 'disaggregated', '10-year', 'age', 'band', '09', 'year', '7079', 'year', 'old', '', 'age', 'band', 'age', '80', 'year', 'older7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', '', 'covid-19', '', 'chinazhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '', '2020', '', '41', '', 'chinese', '', '', '', '145-151google', 'using', 'collate', 'data', 'daily', 'report', 'death', 'obtain', 'day', 'national', 'health', 'commission', 'regional', 'website', '', 'estimate', '74', '', 'death', 'occur', 'wuhan', 'remainder', 'outside', 'wuhan', '', 'additionally', '', 'recent', 'available', 'cumulative', 'estimate', '', 'march', '3', '', '2020', '', '80', '304', 'confirm', 'case', '2946', 'death', 'within', 'china', 'extract', 'covid-19', 'situation', 'report', '', 'number', '43', '', '1whocoronavirus', 'disease', '2019', '', 'covid-19', '', 'situation', 'report43', '', 'urlplaceholder', 'march', '3', '', '2020date', 'access', '', 'march', '5', '', '2020google', 'earlier', '', 'withdraw', '', 'preprint', 'subset', 'case', 'jan', '26', '', '2020', 'report', 'age', 'distribution', 'case', 'categorise', 'severity', '3665', 'cases18yang', 'lu', 'q', 'liu', 'alepidemiological', 'clinical', 'feature', '2019', 'novel', 'coronavirus', 'outbreak', 'chinamedrxiv', '', '2020', '', '', 'publish', 'online', 'feb', '21', '', '', '', 'preprint', '', 'withdraw', '', 'doi', '', '1011012020021020021675google', 'china', 'case', 'definition', '', 'severe', 'case', 'define', 'tachypnoea', '', '30', 'breath', 'per', 'min', '', 'oxygen', 'saturation', '93', '', 'higher', 'rest', '', 'pao2fio2', 'ratio', 'le', '300', 'mm', 'hg7novel', 'coronavirus', 'pneumonia', 'emergency', 'response', 'epidemiology', 'teamthe', 'epidemiological', 'characteristic', 'outbreak', '2019', 'novel', 'coronavirus', 'disease', '', 'covid-19', '', 'chinazhonghua', 'liu', 'xing', 'bing', 'xue', 'za', 'zhi', '', '2020', '', '41', '', 'chinese', '', '', '', '145-151google', 'assuming', 'severe', 'case', 'require', 'hospitalisation', '', 'oppose', 'patient', 'hospitalise', 'china', '', 'hospitalise', 'reduce', 'onward', 'transmission', '', '', 'proportion', 'severe', 'case', 'age', 'patient', 'estimate', 'proportion', 'case', 'infection', 'require', 'hospitalisation', '', 'data', 'infection', 'prevalence', 'repatriate', 'expatriate', 'return', 'home', 'country', 'obtain', 'government', 'ministry', 'health', 'website', 'medium', 'report', '', 'match', 'incidence', 'report', 'wuhan', 'jan', '30', '', '2020', '', 'data', 'six', 'flight', 'depart', 'jan', '30', 'feb', '1', '', '2020', '', 'inclusive', '', 'early', 'february', '2020', 'cruise', 'liner', 'name', 'diamond', 'princess', 'quarantine', 'disembark', 'passenger', 'test', 'positive', 'virus', '', 'subsequently', '3711', 'passenger', 'board', 'test', 'next', 'month', '', 'extract', 'data', 'age', 'passenger', 'onboard', 'feb', '5', '', '2020', '', 'date', 'positive', 'test', 'report', '', 'available', '657', '712', 'pcr-confirmed', 'case', '', 'date', 'ten', 'death', 'among', 'case', 'report', 'japan', 'ministry', 'health', '', 'labour', 'welfare19government', 'japanministry', 'health', '', 'labour', 'welfare', '', 'urlplaceholder', '2020date', 'access', '', 'march', '26', '', '2020google', 'international', 'medium', '', 'age-stratified', 'population', 'data', '2018', 'obtain', 'national', 'bureau', 'statistics', 'china20national', 'bureau', 'statistics', 'chinachina', 'statistical', 'yearbook', '', 'urlplaceholder', '2018date', 'access', '', 'february', '14', '', '2020google', 'according', 'data', '', 'population', 'wuhan', '2018', 'approximately', '11', 'million', 'people', '', 'analysis', 'r', 'software', '', 'version', '362', '', '', 'bayesian', 'marko-chain', 'monte', 'carlo', 'via', 'package', 'drjacoby', '', 'version', '100', '', '21verity', 'r', 'winskill', 'p', 'drjacoby', '', 'urlplaceholder', 'access', '', 'march', '26', '', '2020google', 'data', 'code', 'available', 'online', 'github', '', 'estimate', 'time', 'interval', 'symptom', 'onset', 'outcome', '', 'necessary', 'account', 'fact', '', 'grow', 'epidemic', '', 'higher', 'proportion', 'case', 'infect', 'recently', '', 'appendix', 'p', '7', '', '', 'therefore', '', 're-parameterised', 'gamma', 'model', 'account', 'exponential', 'growth', 'growth', 'rate', '014', 'per', 'day', '', 'obtain', 'early', 'case', 'onset', 'data', '', 'appendix', 'p', '6', '', '', 'using', 'bayesian', 'method', '', 'fit', 'gamma', 'distribution', 'data', 'time', 'onset', 'death', 'onset', 'recovery', '', 'conditional', 'observe', 'final', 'outcome', '', 'missing', 'onset', 'date', 'impute', 'basis', 'date', 'report', '', 'available', '', 'estimates', 'distribution', 'time', 'onset-to-death', 'project', 'expect', 'cumulative', 'number', 'death', 'give', 'onset', 'observe', 'wuhan', 'outside', 'wuhan', '', 'assume', 'uniform', 'attack', 'rate', 'across', 'age', 'group', '', 'using', 'age-distribution', 'population', '', 'obtain', 'estimate', 'expect', 'number', 'infection', 'age', 'group', '', 'under-ascertainment', 'estimate', 'outside', 'wuhan', 'compare', 'number', 'observe', 'case', 'age', 'expect', 'distribution', '', 'assume', 'perfect', 'ascertainment', '5059', 'age', 'group', 'group', 'highest', 'number', 'detect', 'case', 'relative', 'population', 'size', '', 'sensitivity', 'analysis', 'assume', 'differential', 'attack', 'rate', 'age', '', 'appendix', 'p', '9', '', '', 'wuhan', '', 'add', 'scale', 'account', 'under-ascertainment', 'compare', 'outside', 'wuhan', '', 'step', 'give', 'u', 'expect', 'age-distribution', 'case', '', 'give', 'onset-to-death', 'distribution', '', 'obtain', 'model', 'estimate', 'cumulative', 'number', 'death', 'age', 'age-dependent', 'case', 'fatality', 'ratio', '', 'fit', 'relative', 'case', 'fatality', 'ratio', 'oldest', 'age', 'group', '', 'represent', 'highest', 'crude', 'case', 'fatality', 'ratio', '', '', 'estimate', 'compare', 'observe', 'death', 'age', 'poisson', 'likelihood', '', 'data', 'jointly', 'fit', 'alongside', 'recent', 'age-aggregated', 'cumulative', 'death', 'case', 'mainland', 'china', '', 'given', 'number', 'observe', 'case', 'death', 'drop', 'substantially', 'follow', 'peak', 'late', 'january', '', 'ratio', 'current', 'cumulative', 'case', 'current', 'number', 'death', '', 'correct', 'under-ascertainment', '', 'provide', 'estimate', 'final', 'case', 'fatality', 'ratio11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'almethods', 'estimate', 'case', 'fatality', 'ratio', 'novel', '', 'emerge', 'infectious', 'diseaseam', 'j', 'epidemiol', '', '2005', '', '162', '', '479-486google', 'estimate', 'infection', 'fatality', 'ratio', 'fit', 'data', 'infection', 'prevalence', 'international', 'wuhan', 'resident', 'repatriate', 'home', 'country', '', 'age-stratified', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'model', 'jointly', 'fit', 'case', 'data', 'infection', 'prevalence', 'data', 'bayesian', 'method', '', 'previous', 'estimate', 'onset-to-death', 'distribution', 'prior', '', 'full', 'mathematical', 'detail', 'provide', 'appendix', '', 'p', '8', '', '', 'assuming', 'uniform', 'attack', 'rate', 'age', 'group', '', 'demography-adjusted', 'under-ascertainment', 'rate', 'calculate', 'obtain', 'estimate', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', '', 'independently', 'validate', 'infection', 'fatality', 'ratio', 'estimate', '', 'analyse', 'data', 'outbreak', 'diamond', 'princess', 'cruise', 'liner', 'date', 'report', 'positive', 'test', 'proxy', 'onset', 'date', '', 'calculate', 'expect', 'proportion', 'death', 'observe', 'march', '25', '', '2020', '', 'give', 'onset', 'time', 'estimate', 'onset-to-death', 'distribution', '', 'appendix', 'p', '13', '', '', 'parametric', 'non-parametric', 'methods11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'almethods', 'estimate', 'case', 'fatality', 'ratio', 'novel', '', 'emerge', 'infectious', 'diseaseam', 'j', 'epidemiol', '', '2005', '', '162', '', '479-486google', '', '22griffin', 'j', 'ghani', 'casefat', '', 'stata', 'module', 'estimate', 'case', 'fatality', 'ratio', 'new', 'infectious', 'disease', '', 'boston', 'college', 'economics', '', 'urlplaceholder', '7', '', '2009date', 'access', '', 'march', '26', '', '2020google', 'estimate', 'case', 'fatality', 'ratio', 'case', 'report', 'outside', 'mainland', 'china', 'individual-level', 'data', '', 'cases', 'outcome', 'unknown', 'treat', 'censor', 'observation', '', 'parametric', 'non-parametric', 'analysis', '', 'miss', 'onset', 'date', 'multiply', 'impute', 'information', 'onset-to-report', 'distribution', '', 'unreported', 'recovery', 'impute', 'onset-to-outcome', 'distribution', 'country', 'summary', 'data', '', 'parametric', 'model', 'fit', 'data', 'bayesian', 'method', '', 'appendix', 'p', '12', '', '', 'funder', 'study', 'role', 'study', 'design', '', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'correspond', 'author', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', 'subset', '24', 'death', 'covid-19', 'occur', 'mainland', 'china', 'early', 'epidemic', '', 'correction', 'bias', 'introduce', 'growth', 'epidemic', '', 'estimate', 'mean', 'time', 'onset', 'death', '188', 'day', '', '95', '', 'credible', 'interval', '', 'cri', '', '157497', '', 'figure', '2', '', 'coefficient', 'variation', '045', '', '95', '', 'cri', '029054', '', '', 'small', 'number', 'observation', 'data', 'give', 'early', 'epidemic', '', 'rule', 'death', 'occur', 'longer', 'time', 'onset', 'death', '', 'hence', 'high', 'upper', 'limit', 'credible', 'interval', '', 'however', '', 'give', 'epidemic', 'china', 'since', 'decline', '', 'posterior', 'estimate', 'mean', 'time', 'onset', 'death', '', 'inform', 'analysis', 'aggregate', 'data', 'china', '', 'precise', '', 'mean', '178', 'day', '', '169192', '', '', 'figure', '2', '', 'figure', '2onset-to-death', 'onset-to-recovery', 'distributionsshow', 'full', 'caption', '', '', 'onset-to-death', 'data', '24', 'case', 'mainland', 'china', 'early', 'epidemic', '', '', 'b', '', 'onset-to-recovery', 'data', '169', 'case', 'outside', 'mainland', 'china', '', 'red', 'show', 'best', 'fit', '', 'posterior', 'mode', '', 'gamma', 'distribution', '', 'uncorrected', 'epidemic', 'growth', '', 'bias', 'towards', 'shorter', 'duration', '', 'blue', 'show', 'distribution', 'correct', 'epidemic', 'growth', '', 'black', '', 'panel', '', 'show', 'posterior', 'estimate', 'onset-to-death', 'distribution', 'follow', 'fit', 'aggregate', 'case', 'dataview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'onset-to-death', 'data', '24', 'case', 'mainland', 'china', 'early', 'epidemic', '', '', 'b', '', 'onset-to-recovery', 'data', '169', 'case', 'outside', 'mainland', 'china', '', 'red', 'show', 'best', 'fit', '', 'posterior', 'mode', '', 'gamma', 'distribution', '', 'uncorrected', 'epidemic', 'growth', '', 'bias', 'towards', 'shorter', 'duration', '', 'blue', 'show', 'distribution', 'correct', 'epidemic', 'growth', '', 'black', '', 'panel', '', 'show', 'posterior', 'estimate', 'onset-to-death', 'distribution', 'follow', 'fit', 'aggregate', 'case', 'data', '', 'using', 'data', 'outcome', '169', 'case', 'report', 'outside', 'mainland', 'china', '', 'estimate', 'mean', 'onset-to-recovery', 'time', '247', 'day', '', '95', '', 'cri', '229281', '', 'coefficient', 'variation', '035', '', '031039', '', 'figure', '2', '', '', 'onset-to-outcome', 'estimate', 'consistent', 'separate', 'study', 'china23zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '', 'publish', 'online', 'march', '11', '', '', 'urlplaceholder', 'case', 'fatality', 'ratio', 'estimate', 'aggregate', 'data', 'case', 'death', 'mainland', 'china', '', 'table', '1', '', '', 'large', 'proportion', 'case', '', 'include', 'early', 'epidemic', '', 'report', 'wuhan', '', 'local', 'health', 'system', 'quickly', 'overwhelm', '', 'result', '', 'age', 'distribution', 'case', 'report', 'wuhan', 'differ', 'rest', 'china', '', 'figure', '3a', '', '', 'reported', 'case', 'wuhan', 'frequent', 'older', 'age', 'group', '', 'perhaps', 'reflect', 'higher', 'severity', '', 'therefore', 'prioritisation', 'hospitalisation', 'wuhan', '', '', 'case', 'outside', 'wuhan', 'show', 'bias', 'term', 'relationship', 'age', 'travel', '', 'adjusting', 'difference', 'underlie', 'demography', 'assume', 'overall', 'difference', 'attack', 'rate', 'age', '', 'estimate', 'high', 'under-ascertainment', 'case', 'younger', 'age', 'group', 'inside', 'outside', 'wuhan', '', 'figure', '3c', '', '', '', 'furthermore', '', 'estimate', 'higher', 'level', 'under-ascertainment', 'overall', 'wuhan', 'compare', 'outside', 'wuhan', '', 'figure', '3c', '', '', 'accounting', 'under-ascertainment', '', 'estimate', 'highest', 'case', 'fatality', 'ratio', '', '134', '', '', '112159', '', '', '', '80', 'year', 'older', 'age', 'group', '', 'figure', '3b', '', 'table', '1', '', '', 'lower', 'case', 'fatality', 'ratio', 'associate', 'lower', 'age', 'group', '', 'lowest', '09', 'year', 'age', 'group', '', '000260', '', '', '000031200382', '', '', 'table', '1estimates', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'obtain', 'aggregate', 'time', 'series', 'case', 'mainland', 'chinadeathslaboratory-confirmed', 'case', '', '', 'values', 'include', 'clinically', 'diagnose', 'case', 'include', 'estimatescase', 'fatality', 'ratioinfection', 'fatality', 'ratio', 'obtained', 'combine', 'estimate', 'case', 'fatality', 'ratio', 'information', 'infection', 'prevalence', 'obtain', 'return', 'home', 'repatriation', 'flightscrudeadjusted', 'censoringadjusted', 'censor', '', 'demography', '', 'under-ascertainment', 'accounts', 'underlie', 'demography', 'wuhan', 'elsewhere', 'china', 'correct', 'under-ascertainmentoverall102344', '672229', '', '', '215243', '', '367', '', '', '356380', '', '138', '', '', '123153', '', '0657', '', '', '0389133', '', 'age', 'group', '', 'years0904160000', '', '', '00000883', '', '00954', '', '', '00110134', '', '000260', '', '', '000031200382', '', '000161', '', '', '000018500249', '', '101915490182', '', '', '000461101', '', '0352', '', '', '00663174', '', '00148', '', '', '00028800759', '', '000695', '', '', '00014900502', '', '2029736190193', '', '', '007780398', '', '0296', '', '', '01580662', '', '00600', '', '', '003170132', '', '00309', '', '', '0013800923', '', '30391876000237', '', '', '01400374', '', '0348', '', '', '02410577', '', '0146', '', '', '01030255', '', '00844', '', '', '004080185', '', '40493885710443', '', '', '03140608', '', '0711', '', '', '05210966', '', '0295', '', '', '02210422', '', '0161', '', '', '007640323', '', '505913010', '008130', '', '', '109154', '', '206', '', '', '174243', '', '125', '', '', '103155', '', '0595', '', '', '0344128', '', '60693098583360', '', '', '322402', '', '579', '', '', '520634', '', '399', '', '', '341455', '', '193', '', '', '111389', '', '70793123918796', '', '', '713886', '', '127', '', '', '115139', '', '861', '', '', '748999', '', '428', '', '', '245844', '', '802081408148', '', '', '130167', '', '233', '', '', '203267', '', '134', '', '', '112159', '', '780', '', '', '380133', '', 'age', 'category', '', 'binary', '', '', 'year', '', '6019430', '7630631', '', '', '05450726', '', '101', '', '', '0900117', '', '0318', '', '', '02740378', '', '0145', '', '', '008830317', '', '6082913', '909596', '', '', '557637', '', '949', '', '', '911995', '', '638', '', '', '570717', '', '328', '', '', '182618', '', 'crude', 'case', 'fatality', 'ratio', 'present', 'mean', '', '95', '', 'confidence', 'interval', '', '', 'fatality', 'ratio', 'present', 'posterior', 'mode', '', '95', '', 'credible', 'interval', '', '', 'estimates', 'show', 'three', 'significant', 'figure', '', 'cases', 'death', 'aggregate', 'number', 'report', 'jan', '1', 'feb', '11', '', '20208whoreport', 'who-china', 'joint', 'mission', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'urlplaceholder', 'feb', '28', '', '2020date', 'access', '', 'march', '26', '', '2020google', 'crude', 'case', 'fatality', 'ratio', 'calculate', 'number', 'death', 'divide', 'number', 'laboratory-confirmed', 'case', '', 'estimate', 'include', 'clinically', 'diagnose', 'case', '', 'scale', '131', 'apply', 'across', 'age-groups', '', 'breakdown', 'age', 'report', 'clinically', 'diagnose', 'case', '', '', 'give', 'larger', 'denominator', 'thus', 'lower', 'case', 'fatality', 'ratio', 'laboratory-confirmed', 'case', 'include', '', '', 'values', 'include', 'clinically', 'diagnose', 'case', 'include', 'estimates', 'obtained', 'combine', 'estimate', 'case', 'fatality', 'ratio', 'information', 'infection', 'prevalence', 'obtain', 'return', 'home', 'repatriation', 'flights', 'accounts', 'underlie', 'demography', 'wuhan', 'elsewhere', 'china', 'correct', 'under-ascertainment', '', 'open', 'table', 'new', 'tab', 'figure', '3estimates', 'case', 'fatality', 'ratio', 'age', '', 'obtain', 'aggregate', 'data', 'mainland', 'chinashow', 'full', 'caption', '', '', 'age-distribution', 'case', 'wuhan', 'elsewhere', 'china', '', '', 'b', '', 'estimates', 'case', 'fatality', 'ratio', 'age', 'group', '', 'adjust', 'demography', 'under-ascertainment', '', 'boxes', 'represent', 'median', '', 'central', 'horizontal', '', 'iqr', '', 'vertical', 'represent', '15', '', 'iqr', '', 'individual', 'point', 'represent', 'estimate', 'outside', 'range', '', '', 'c', '', 'estimated', 'proportion', 'case', 'ascertain', 'rest', 'china', 'wuhan', 'relative', '5059', 'year', 'age', 'group', 'elsewhere', 'china', '', 'error', 'bar', 'represent', '95', '', 'crisview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'crude', 'case', 'fatality', 'ratio', 'present', 'mean', '', '95', '', 'confidence', 'interval', '', '', 'fatality', 'ratio', 'present', 'posterior', 'mode', '', '95', '', 'credible', 'interval', '', '', 'estimates', 'show', 'three', 'significant', 'figure', '', 'cases', 'death', 'aggregate', 'number', 'report', 'jan', '1', 'feb', '11', '', '20208whoreport', 'who-china', 'joint', 'mission', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'urlplaceholder', 'feb', '28', '', '2020date', 'access', '', 'march', '26', '', '2020google', 'crude', 'case', 'fatality', 'ratio', 'calculate', 'number', 'death', 'divide', 'number', 'laboratory-confirmed', 'case', '', 'estimate', 'include', 'clinically', 'diagnose', 'case', '', 'scale', '131', 'apply', 'across', 'age-groups', '', 'breakdown', 'age', 'report', 'clinically', 'diagnose', 'case', '', '', 'give', 'larger', 'denominator', 'thus', 'lower', 'case', 'fatality', 'ratio', 'laboratory-confirmed', 'case', 'include', '', '', '', 'age-distribution', 'case', 'wuhan', 'elsewhere', 'china', '', '', 'b', '', 'estimates', 'case', 'fatality', 'ratio', 'age', 'group', '', 'adjust', 'demography', 'under-ascertainment', '', 'boxes', 'represent', 'median', '', 'central', 'horizontal', '', 'iqr', '', 'vertical', 'represent', '15', '', 'iqr', '', 'individual', 'point', 'represent', 'estimate', 'outside', 'range', '', '', 'c', '', 'estimated', 'proportion', 'case', 'ascertain', 'rest', 'china', 'wuhan', 'relative', '5059', 'year', 'age', 'group', 'elsewhere', 'china', '', 'error', 'bar', 'represent', '95', '', 'cris', '', 'case', 'report', 'outside', 'mainland', 'china', '', 'estimate', 'overall', 'modal', 'case', 'fatality', 'ratio', '27', '', '', '95', '', 'cri', '1447', '', 'parametric', 'model', '', 'table', '2', '', '', 'report', 'travel', 'mainland', 'china', '', 'therefore', 'detect', 'surveillance', 'system', '', '', 'estimate', 'overall', 'modal', 'case', 'fatality', 'ratio', '11', '', '', '0441', '', '', 'without', 'report', 'travel', 'china', '', 'therefore', 'detect', 'either', 'contact', 'trace', 'hospital', 'surveillance', '', '', 'estimate', 'case', 'fatality', 'ratio', '36', '', '', '1972', '', 'parametric', 'model', '', 'estimate', 'case', 'fatality', 'ratio', 'lower', 'age', '60', 'year', 'age', '', '14', '', '', '0435', '', '', 'compare', 'age', '60', 'year', '', '45', '', '', '18111', '', '', '', 'similar', 'estimate', 'obtain', 'non-parametric', 'method', '', 'table', '2', '', 'table', '2estimates', 'case', 'fatality', 'ratio', 'obtain', 'individual-level', 'data', 'case', 'identify', 'outside', 'mainland', 'chinaparametricnon-parametricncase', 'fatality', 'rationcase', 'fatality', 'ratiooverall58527', '', '', '1447', '', '133441', '', '', '2178', '', 'travel', 'versus', 'local', 'transmissiontravellers', 'mainland', 'china20311', '', '', '0441', '', '20824', '', '', '0685', '', 'local', 'transmission38236', '', '', '1972', '', '38738', '', '', '1782', '', 'age', 'group', '', 'year', '', '6036014', '', '', '0435', '', '44915', '', '', '0639', '', '6015145', '', '', '18111', '', '181128', '', '', '41335', '', 'parametric', 'estimate', 'present', 'posterior', 'mode', '', '95', '', 'credible', 'interval', '', '', 'obtain', 'gamma-distributed', 'estimate', 'onset-to-death', 'onset-to-recovery', '', 'non-parametric', 'estimate', 'present', 'maximum', 'likelihood', 'estimate', '', '95', '', 'confidence', 'interval', '', 'obtain', 'modify', 'kaplan-meier', 'method11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'almethods', 'estimate', 'case', 'fatality', 'ratio', 'novel', '', 'emerge', 'infectious', 'diseaseam', 'j', 'epidemiol', '', '2005', '', '162', '', '479-486google', '', '23zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '', 'publish', 'online', 'march', '11', '', '', 'urlplaceholder', 'note', 'due', 'miss', 'data', 'age', 'travel', 'status', '', 'number', 'stratify', 'analysis', 'lower', 'overall', 'analysis', '', 'addition', '', 'parametric', 'method', 'require', 'correction', 'epidemic', 'growth', 'rate', '', 'estimate', 'therefore', 'obtain', 'subset', 'data', 'travel', 'local', 'transmission', 'age', '', 'open', 'table', 'new', 'tab', 'parametric', 'estimate', 'present', 'posterior', 'mode', '', '95', '', 'credible', 'interval', '', '', 'obtain', 'gamma-distributed', 'estimate', 'onset-to-death', 'onset-to-recovery', '', 'non-parametric', 'estimate', 'present', 'maximum', 'likelihood', 'estimate', '', '95', '', 'confidence', 'interval', '', 'obtain', 'modify', 'kaplan-meier', 'method11ghani', 'ac', 'donnelly', 'ca', 'cox', 'dr', 'almethods', 'estimate', 'case', 'fatality', 'ratio', 'novel', '', 'emerge', 'infectious', 'diseaseam', 'j', 'epidemiol', '', '2005', '', '162', '', '479-486google', '', '23zhou', 'f', 'yu', 'du', 'r', 'alclinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'studylancet', '', '2020', '', '', 'publish', 'online', 'march', '11', '', '', 'urlplaceholder', 'note', 'due', 'miss', 'data', 'age', 'travel', 'status', '', 'number', 'stratify', 'analysis', 'lower', 'overall', 'analysis', '', 'addition', '', 'parametric', 'method', 'require', 'correction', 'epidemic', 'growth', 'rate', '', 'estimate', 'therefore', 'obtain', 'subset', 'data', 'travel', 'local', 'transmission', 'age', '', 'international', 'wuhan', 'resident', 'repatriate', 'six', 'flight', '', 'estimate', 'prevalence', 'infection', '087', '', '', '95', '', 'ci', '03219', '', 'six', '689', '', '', 'adjusting', 'demography', 'under-ascertainment', '', 'estimate', 'infection', 'fatality', 'ratio', '066', '', '', '95', '', 'cri', '039133', '', '', 'case', 'fatality', 'ratio', '', 'strongly', 'age-dependent', '', 'estimate', 'rise', 'steeply', 'age', '50', 'year', 'upwards', '', 'table', '1', '', '', 'demography-adjusted', 'under-ascertainment-adjusted', 'proportion', 'infect', 'individual', 'require', 'hospitalisation', 'range', '11', '', '2029', 'year', 'age', 'group', '184', '', '80', 'year', 'older', '', 'table', '3', '', '', 'using', 'age-stratified', 'infection', 'fatality', 'ratio', 'estimate', '', 'estimate', 'infection', 'fatality', 'ratio', 'diamond', 'princess', 'population', '29', '', '', 'given', 'delay', 'onset', 'symptom', 'death', '', 'expect', '97', '', 'death', 'occur', 'march', '25', '', '2020', '', 'give', 'estimate', 'current', 'infection', 'fatality', 'ratio', '28', '', '', 'compare', 'empirical', 'estimate', '14', '', '', '95', '', 'ci', '0726', '', 'ten', '712', '', 'table', '3estimates', 'proportion', 'infection', 'lead', 'hospitalisation', '', 'obtain', 'subset', 'case', 'report', 'mainland', 'china18yang', 'lu', 'q', 'liu', 'alepidemiological', 'clinical', 'feature', '2019', 'novel', 'coronavirus', 'outbreak', 'chinamedrxiv', '', '2020', '', '', 'publish', 'online', 'feb', '21', '', '', '', 'preprint', '', 'withdraw', '', 'doi', '', '1011012020021020021675google', 'scholarsevere', 'casesall', 'casesproportion', 'infect', 'individual', 'hospitalised09', 'years013000', '', '', '000000', '', '1019', 'years15000408', '', '', '0024300832', '', '2029', 'years49437104', '', '', '0622213', '', '3039', 'years124733343', '', '', '204700', '', '4049', 'years154743425', '', '', '253868', '', '5059', 'years222790816', '', '', '486167', '', '6069', 'years201560118', '', '', '701240', '', '7079', 'years133263166', '', '', '987338', '', '80', 'years5176184', '', '', '110376', '', 'proportions', 'infect', 'individual', 'hospitalise', 'present', 'posterior', 'mode', '', '95', '', 'credible', 'interval', '', 'adjust', 'under-ascertainment', 'correct', 'demography', '', 'estimates', 'show', 'three', 'signficant', 'figure', '', 'assume', '', 'base', 'severity', 'classification', 'uk', 'context', '', 'case', 'define', 'severe', 'hospitalise', '', 'open', 'table', 'new', 'tab', 'proportions', 'infect', 'individual', 'hospitalise', 'present', 'posterior', 'mode', '', '95', '', 'credible', 'interval', '', 'adjust', 'under-ascertainment', 'correct', 'demography', '', 'estimates', 'show', 'three', 'signficant', 'figure', '', 'assume', '', 'base', 'severity', 'classification', 'uk', 'context', '', 'case', 'define', 'severe', 'hospitalise', '', 'extensive', 'analysis', 'data', 'different', 'region', 'world', '', 'best', 'estimate', 'current', 'time', 'case', 'fatality', 'ratio', 'covid-19', 'china', '138', '', '', '95', '', 'cri', '123153', '', '', 'although', 'value', 'remain', 'lower', 'estimate', 'coronaviruses', '', 'include', 'sars24lau', 'ehy', 'hsiung', 'ca', 'cowling', 'bj', 'ala', 'comparative', 'epidemiologic', 'analysis', 'sars', 'hong', 'kong', '', 'beijing', 'taiwanbmc', 'infect', 'dis', '', '2010', '', '10', '', '50google', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '25lessler', 'j', 'salje', 'h', 'van', 'kerkhove', 'md', 'alestimating', 'severity', 'subclinical', 'burden', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'kingdom', 'saudi', 'arabiaam', 'j', 'epidemiol', '', '2016', '', '183', '', '657-663google', 'substantially', 'higher', 'estimate', '2009', 'h1n1', 'influenza', 'pandemic26riley', 'kwok', 'ko', 'wu', 'km', 'alepidemiological', 'characteristic', '2009', '', 'h1n1', '', 'pandemic', 'influenza', 'base', 'pair', 'serum', 'longitudinal', 'community', 'cohort', 'studyplos', 'med', '', '2011', '', '8e1000442google', '', '27kwok', 'ko', 'riley', 'perera', 'rapm', 'alrelative', 'incidence', 'individual-level', 'severity', 'seasonal', 'influenza', 'h3n2', 'compare', '2009', 'pandemic', 'h1n1bmc', 'infect', 'dis', '', '2017', '', '17', '', '337google', 'estimate', 'infection', 'fatality', 'ratio', '066', '', 'china', 'inform', 'pcr', 'test', 'international', 'wuhan', 'resident', 'return', 'repatriation', 'flight', '', 'value', 'consistent', 'infection', 'fatality', 'ratio', 'observe', 'passenger', 'diamond', 'princess', 'cruise', 'ship', 'march', '5', '', '2020', '', 'although', 'slightly', 'upper', '95', '', 'confidence', 'limit', 'age-adjusted', 'infection', 'fatality', 'ratio', 'observe', 'march', '25', '', '712', 'confirm', 'case', '', '601', 'discharge', '', 'ten', 'die', '', '11', 'remain', 'critical', 'condition', '', '', 'difference', 'due', 'repatriation', 'flight', 'data', 'slightly', 'underestimate', 'milder', 'infection', '', 'due', 'cruise', 'passenger', 'better', 'outcome', 'potentially', 'higher-than-average', 'quality', 'health', 'care', '', 'estimate', 'probability', 'require', 'hospitalisation', 'assume', 'severe', 'case', 'require', 'hospitalisation', '', 'assumption', 'clearly', 'different', 'pattern', 'hospitalisation', 'occur', 'china', '', 'hospitalisation', 'ensure', 'case', 'isolation', '', 'mortality', 'expect', 'vary', 'underlie', 'health', 'specific', 'population', '', 'give', 'risk', 'associate', 'covid-19', 'heavily', 'influence', 'presence', 'underlie', 'comorbidities', '', 'estimate', 'case', 'fatality', 'ratio', 'substantially', 'lower', 'crude', 'case', 'fatality', 'ratio', 'obtain', 'china', 'base', 'case', 'death', 'observe', 'date', '', 'currently', '367', '', '', 'well', 'estimate', 'currently', 'literature', '', 'principle', 'reason', 'difference', 'crude', 'estimate', 'account', 'severity', 'case', '', 'example', '', 'various', 'estimate', 'patient', 'population', 'range', 'generally', 'milder', 'symptom', '', 'example', 'international', 'traveller', 'detect', 'screen', 'travel', 'history', '', '13jung', 'akhmetzhanov', 'ar', 'hayashi', 'k', 'alreal-time', 'estimation', 'risk', 'death', 'novel', 'coronavirus', '', 'covid-19', '', 'infection', '', 'inference', 'export', 'casesj', 'clin', 'med', '', '2020', '', '9', '', 'e523google', 'identify', 'hospital', 'setting14mizumoto', 'k', 'kagaya', 'k', 'chowell', 'g', 'yoshida-nakaadachi-cho', 'u', 'early', 'epidemiological', 'assessment', 'transmission', 'potential', 'virulence', '2019', 'novel', 'coronavirus', 'wuhan', 'city', '', 'china', '', 'januaryfebruary', '', '2020medrxiv', '', '2020', '', '', 'publish', 'online', 'march', '13', '', '', '', 'preprint', '', 'doi', '', '1011012020021220022434google', '', '15famulare', '2019-ncov', '', 'preliminary', 'estimate', 'confirmed-case-fatality-ratio', 'infection-fatality-ratio', '', 'initial', 'pandemic', 'risk', 'assessment', '', 'urlplaceholder', 'feb', '19', '', '2020date', 'access', '', 'march', '26', '', '2020google', 'clear', 'data', 'emerge', 'china', 'case', 'fatality', 'ratio', 'increase', 'substantially', 'age', '', 'result', 'suggest', 'low', 'fatality', 'ratio', 'age', '20', 'year', '', 'case', 'age', 'group', '', 'remain', 'unclear', 'whether', 'reflect', 'low', 'risk', 'death', 'difference', 'susceptibility', '', 'although', 'early', 'result', 'indicate', 'young', 'people', 'lower', 'risk', 'infection', 'adults28bi', 'q', 'wu', 'mei', 'alepidemiology', 'transmission', 'covid-19', 'shenzhen', 'china', '', 'analysis', '391', 'case', '1286', 'close', 'contactsmedrxiv', '', '2020', '', '', 'publish', 'online', 'march', '19', '', '', '', 'preprint', '', 'doi', '', '1011012020030320028423google', 'serological', 'test', 'age', 'group', 'crucial', 'week', 'understand', 'significance', 'age', 'group', 'drive', 'population', 'transmission', '', 'estimate', 'increase', 'severity', 'age', 'clearly', 'reflect', 'case', 'report', '', 'mean', 'age', 'tend', 'range', '5060', 'year', '', 'different', 'surveillance', 'system', 'pick', 'different', 'age', 'case', 'mix', '', 'find', 'milder', 'symptom', 'detect', 'history', 'travel', 'younger', 'average', 'detect', 'hospital', 'surveillance', '', 'correction', 'surveillance', 'bias', 'therefore', 'allow', 'u', 'obtain', 'estimate', 'apply', 'different', 'case', 'mix', 'demographic', 'population', 'structure', '', 'however', '', 'note', 'correction', 'applicable', 'assumption', 'uniform', 'infection', 'attack', 'rate', '', 'ie', '', 'exposure', '', 'across', 'population', '', 'assume', 'perfect', 'case', 'ascertainment', 'outside', 'wuhan', 'age', 'group', 'case', 'relative', 'population', 'size', '', '5059-year-olds', '', '', 'however', '', 'case', 'miss', '', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'estimate', 'lower', '', 'absence', 'random', 'population', 'survey', 'infection', 'prevalence', '', 'adjustment', 'case', 'fatality', 'ratio', 'infection', 'fatality', 'ratio', 'rely', 'repatriation', 'flight', 'data', '', 'age', 'specific', '', 'report', 'proportion', 'infect', 'individual', 'asymptomatic', 'diamond', 'princess', 'vary', 'considerably', 'age', '', 'support', 'approach', '', 'future', 'larger', 'representative', 'population', 'prevalence', 'survey', 'seroprevalence', 'survey', 'inform', 'estimate', '', 'much', 'data', 'inform', 'global', 'estimate', 'case', 'fatality', 'ratio', 'present', 'early', 'outbreak', 'wuhan', '', 'given', 'health', 'system', 'city', 'quickly', 'overwhelm', '', 'estimate', 'suggest', 'substantial', 'under-ascertainment', 'case', 'younger', 'age', 'group', '', 'estimate', 'milder', 'disease', '', 'comparison', 'elsewhere', 'mainland', 'china', '', 'under-ascertainment', 'main', 'factor', 'drive', 'difference', 'estimate', 'crude', 'case', 'fatality', 'ratio', 'china', '', '367', '', '', 'best', 'estimate', 'overall', 'case', 'fatality', 'ratio', '', '138', '', '', '', 'case', 'fatality', 'ratio', 'likely', 'strongly', 'influence', 'availability', 'health-care', 'facility', '', 'however', 'surprisingly', '', 'although', 'health-care', 'availability', 'wuhan', 'stretch', '', 'estimate', 'international', 'case', 'similar', 'magnitude', '', 'suggest', 'relatively', 'little', 'difference', 'health', 'outcome', '', 'finally', '', 'clinical', 'knowledge', 'new', 'disease', 'accrue', '', 'possible', 'outcome', 'improve', '', 'therefore', 'important', 'revise', 'estimate', 'epidemic', 'unfold', '', 'world', 'currently', 'experience', 'early', 'stage', 'global', 'pandemic', '', 'although', 'china', 'succeed', 'contain', 'disease', 'spread', '2', 'month', '', 'containment', 'unlikely', 'achievable', 'country', '', 'thus', '', 'much', 'world', 'experience', 'large', 'community', 'epidemic', 'covid-19', 'week', 'month', '', 'estimate', 'underlie', 'infection', 'fatality', 'ratio', 'virus', 'inform', 'assessment', 'health', 'effect', 'likely', 'experience', 'different', 'country', '', 'thus', 'decision', 'around', 'appropriate', 'mitigation', 'policy', 'adopt', '', 'online', 'publication', 'correct', '', 'first', 'correct', 'version', 'first', 'appear', 'thelancetcominfection', 'april', '15', '', '2020', 'second', '4', '', '2020', 'online', 'publication', 'correct', '', 'first', 'correct', 'version', 'first', 'appear', 'thelancetcominfection', 'april', '15', '', '2020', 'second', '4', '', '2020', 'contributors', 'nmf', 'acg', 'conceive', 'study', 'input', 'rv', '', 'lco', '', 'id', '', 'pw', '', 'cw', '', 'rv', '', 'lco', '', 'id', 'lead', 'analysis', 'individual-case', 'data', 'international', 'case', 'estimation', 'onset-to-outcome', 'distribution', '', 'input', 'cad', '', 'acg', '', 'nmf', '', 'rv', '', 'pw', '', 'cw', '', 'pgtw', 'lead', 'analysis', 'china', 'data', '', 'input', 'acg', 'nmf', '', 'ni', 'coordinate', 'management', 'team', '', 'include', 'data', 'collation', 'process', '', 'ni', 'gc-d', 'undertake', 'extraction', 'international', 'case', 'data', '', 'ht', 'undertake', 'extraction', 'flight', 'repatriation', 'data', '', 'input', 'ni', 'ad', '', 'hf', 'lead', 'extraction', 'china', 'mainland', 'data', 'national', 'regional', 'website', 'input', 'hw', '', 'yw', '', 'xx', '', 'jtg', 'develop', 'code', 'non-parametric', 'model', '', 'acg', 'produce', 'first', 'draft', 'manuscript', '', 'author', 'contribute', 'final', 'draft', '', 'declaration', 'interest', 'lco', 'report', 'grant', 'outside', 'submit', 'work', '', 'cad', 'report', 'grant', 'uk', 'medical', 'research', 'council', 'national', 'institute', 'health', 'research', 'conduct', 'study', '', 'nmf', 'report', 'grant', 'uk', 'medical', 'research', 'council', 'uk', 'national', 'institute', 'health', 'research', 'conduct', 'study', '', 'grant', 'gavi', '', 'vaccine', 'alliance', '', 'janssen', 'pharmaceuticals', '', 'bill', 'melinda', 'gates', 'foundation', 'outside', 'submit', 'work', '', 'author', 'declare', 'compete', 'interest', '', 'data', 'code', 'study', 'available', 'github', 'repository', '', 'acknowledgments', 'work', 'support', 'centre', 'fund', 'uk', 'medical', 'research', 'council', '', 'mrc', '', 'concordat', 'uk', 'department', 'international', 'development', '', 'national', 'institute', 'health', 'research', 'health', 'protection', 'research', 'unit', 'modelling', 'methodology', '', 'abdul', 'latif', 'jameel', 'foundation', '', 'grateful', 'input', 'follow', 'volunteer', 'hackathon', 'participant', 'mrc', 'centre', 'imperial', 'college', 'london', '', 'kylie', 'ainslie', '', 'sumali', 'bajaj', '', 'lorenzo', 'cattarino', '', 'joseph', 'challenger', '', 'giovanni', 'charles', '', 'georgina', 'charnley', '', 'paula', 'christen', '', 'constance', 'ciavarella', '', 'victoria', 'cox', '', 'zulma', 'cucunub', '', 'joshua', 'daeth', '', 'tamsin', 'dew', '', 'lorna', 'dunning', '', 'oliver', 'eales', '', 'keith', 'fraser', '', 'tini', 'garske', '', 'lily', 'geidelberg', '', 'nan', 'hong', '', 'samuel', 'horsfield', '', 'min', 'j', 'kwun', '', 'david', 'jrgensen', '', 'mara', 'kont', '', 'alice', 'ledda', '', 'xiang', 'li', '', 'alessandra', 'lochen', '', 'tara', 'mangal', '', 'ruth', 'mccabe', '', 'kevin', 'mcrae-mckee', '', 'kate', 'mitchell', '', 'andria', 'mousa', '', 'rebecca', 'nash', '', 'daniela', 'olivera', '', 'saskia', 'ricks', '', 'nora', 'schmit', '', 'ellie', 'sherrard-smith', '', 'janetta', 'skarp', '', 'isaac', 'stopard', '', 'juliette', 'unwin', '', 'juan', 'vesga', '', 'caroline', 'walters', '', 'lilith', 'whittles', '', 'download', 'pdf', '', '32', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'likelihood', 'survival', 'coronavirus', 'disease', '2019full-textpdfopen', 'accesscorrection', 'lancet', 'infect', 'dis', '2020', '', 'publish', 'online', 'march', '30', 'urlplaceholder', 'lancet', 'infect', 'dis', '2020', '', 'publish', 'online', 'march', '30', 'urlplaceholder', 'accessprotecting', 'worker', 'age', '6069', 'year', 'covid-19full-textpdf']",7469,"{'': 1642, 'case': 217, 'estimate': 152, 'fatality': 117, 'ratio': 116, 'china': 88, 'age': 87, 'data': 74, 'infection': 61, 'report': 55, '2020': 53, 'death': 53, 'wuhan': 49, 'covid-19': 44, 'obtain': 39, 'disease': 38, 'coronavirus': 36, 'mainland': 33, 'year': 32, 'date': 30}","{'infection': 61, 'sars-cov-2': 2}",63,-0.9153
DOI:10.1016/S0140-6736(20)30566-3,10.1016/S0140-6736(20)30566-3,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['clinical', 'course', 'risk', 'factor', 'mortality', 'adult', 'inpatient', 'covid-19', 'wuhan', '', 'china', '', 'retrospective', 'cohort', 'study']","['BackgroundSince December , 2019 , Wuhan , China , experience outbreak coronavirus disease 2019 ( COVID-19 ) , cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'Epidemiological clinical characteristic patient COVID-19 report risk factor mortality detail clinical course illness , include viral shed , well described.MethodsIn retrospective , multicentre cohort study , include adult inpatient ( ≥18 year old ) laboratory-confirmed COVID-19 Jinyintan Hospital Wuhan Pulmonary Hospital ( Wuhan , China ) discharge die Jan 31 , 2020 .', 'Demographic , clinical , treatment , laboratory data , include serial sample viral RNA detection , extract electronic medical record compare survivor non-survivors .', 'We use univariable multivariable logistic regression method explore risk factor associate in-hospital death.Findings191 patient ( 135 Jinyintan Hospital 56 Wuhan Pulmonary Hospital ) include study , 137 discharge 54 die hospital .', '91 ( 48 % ) patient comorbidity , hypertension common ( 58 [ 30 % ] patient ) , follow diabetes ( 36 [ 19 % ] patient ) coronary heart disease ( 15 [ 8 % ] patient ) .', 'Multivariable regression show increase odds in-hospital death associate older age ( odds ratio 1·10 , 95 % CI 1·03–1·17 , per year increase ; p=0·0043 ) , higher Sequential Organ Failure Assessment ( SOFA ) score ( 5·65 , 2·61–12·23 ; p < 0·0001 ) , d-dimer greater 1 μg/mL ( 18·42 , 2·64–128·55 ; p=0·0033 ) admission .', 'Median duration viral shed 20·0 day ( IQR 17·0–24·0 ) survivor , SARS-CoV-2 detectable death non-survivors .', 'The longest observe duration viral shed survivor 37 days.InterpretationThe potential risk factor older age , high SOFA score , d-dimer greater 1 μg/mL could help clinician identify patient poor prognosis early stage .', 'Prolonged viral shed provide rationale strategy isolation infect patient optimal antiviral intervention future.FundingChinese Academy Medical Sciences Innovation Fund Medical Sciences ; National Science Grant Distinguished Young Scholars ; National Key Research Development Program China ; The Beijing Science Technology Project ; Major Projects National Science Technology New Drug Creation Development .', 'Since December , 2019 , Wuhan , China , experience outbreak coronavirus disease 2019 ( COVID-19 ) , cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'Epidemiological clinical characteristic patient COVID-19 report risk factor mortality detail clinical course illness , include viral shed , well describe .', 'In retrospective , multicentre cohort study , include adult inpatient ( ≥18 year old ) laboratory-confirmed COVID-19 Jinyintan Hospital Wuhan Pulmonary Hospital ( Wuhan , China ) discharge die Jan 31 , 2020 .', 'Demographic , clinical , treatment , laboratory data , include serial sample viral RNA detection , extract electronic medical record compare survivor non-survivors .', 'We use univariable multivariable logistic regression method explore risk factor associate in-hospital death .', '191 patient ( 135 Jinyintan Hospital 56 Wuhan Pulmonary Hospital ) include study , 137 discharge 54 die hospital .', '91 ( 48 % ) patient comorbidity , hypertension common ( 58 [ 30 % ] patient ) , follow diabetes ( 36 [ 19 % ] patient ) coronary heart disease ( 15 [ 8 % ] patient ) .', 'Multivariable regression show increase odds in-hospital death associate older age ( odds ratio 1·10 , 95 % CI 1·03–1·17 , per year increase ; p=0·0043 ) , higher Sequential Organ Failure Assessment ( SOFA ) score ( 5·65 , 2·61–12·23 ; p < 0·0001 ) , d-dimer greater 1 μg/mL ( 18·42 , 2·64–128·55 ; p=0·0033 ) admission .', 'Median duration viral shed 20·0 day ( IQR 17·0–24·0 ) survivor , SARS-CoV-2 detectable death non-survivors .', 'The longest observe duration viral shed survivor 37 day .', 'The potential risk factor older age , high SOFA score , d-dimer greater 1 μg/mL could help clinician identify patient poor prognosis early stage .', 'Prolonged viral shed provide rationale strategy isolation infect patient optimal antiviral intervention future .', 'Chinese Academy Medical Sciences Innovation Fund Medical Sciences ; National Science Grant Distinguished Young Scholars ; National Key Research Development Program China ; The Beijing Science Technology Project ; Major Projects National Science Technology New Drug Creation Development .', 'In December , 2019 , Wuhan city , capital Hubei province China , become centre outbreak pneumonia unknown cause .', 'By Jan 7 , 2020 , Chinese scientist isolate novel coronavirus , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ; previously know 2019-nCoV ) , patient virus-infected pneumonia,1Phelan AL Katz R Gostin LO The novel coronavirus originate Wuhan , China : challenge global health governance.JAMA .', '2020 ; ( publish online Jan 30 .', ') DOI:10.1001/jama.2020.1097Google Scholar , 2Gorbalenya AE Baker SC Baric RS et al.Severe acute respiratory syndrome-related coronavirus : specie viruses—a statement Coronavirus Study Group.bioRxiv .', '2020 ; ( publish online Feb 11 . )', '( preprint ) .DOI:10.1101/2020.02.07.937862Google Scholar later designate coronavirus disease 2019 ( COVID-19 ) February , 2020 , WHO.3Chan JWM Ng CK Chan YH et al.Short term outcome risk factor adverse clinical outcome adult severe acute respiratory syndrome ( SARS ) .Thorax .', '2003 ; 58 : 686-689Google Scholar Although outbreak likely start zoonotic transmission event associate large seafood market also trade live wild animal , soon become clear efficient person-to-person transmission also occurring.4Li Q Guan X Wu P et al.Early transmission dynamic Wuhan , China , novel coronavirus-infected pneumonia.N Engl J Med .', '2020 ; ( publish online Jan 29 .', ') DOI:10.1056/NEJMoa2001316Google Scholar The clinical spectrum SARS-CoV-2 infection appear wide , encompass asymptomatic infection , mild upper respiratory tract illness , severe viral pneumonia respiratory failure even death , many patient hospitalise pneumonia Wuhan.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar , 6Wang D Hu B Hu C et al.Clinical characteristic 138 hospitalize patient 2019 novel coronavirus-infected pneumonia Wuhan , China.JAMA .', '2020 ; ( publish online Feb 7 .', ') DOI:10.1001/jama.2020.1585Google Scholar , 7Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513Google Scholar Although case series publish , many patient series remain hospitalise time publication .', 'To knowledge , previous study do among patient definite outcome .', 'The estimation risk factor severe disease death earlier case series therefore robust .', 'Additionally , detail clinical virological course illness yet well describe .', 'Here , present detail patient admit two designate hospital Wuhan—Jinyintan Hospital Wuhan Pulmonary Hospital—with laboratory-confirmed COVID-19 definite clinical outcome ( death discharge ) Jan 31 , 2020 .', 'We aim explore risk factor in-hospital death patient describe clinical course symptom , viral shed , temporal change laboratory find hospitalisation .', 'Research contextEvidence studyWe search PubMed Feb 23 , 2020 , article document risk factor mortality viral shed patient coronavirus disease 2019 ( COVID-19 ) , result infection severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , use search term ( “ novel coronavirus ” OR “ SARS-CoV-2 ” OR “ COVID-19 ” ) AND ( “ death ” OR “ mortality ” OR “ viral shed ” ) language time restriction .', 'Age , comorbidities , lymphocytopenia elevate alanine aminotransferase , d-dimer , creatine kinase , high-sensitivity cardiac troponin I , prothrombin time , disease severity report associate intensive care unit admission .', 'However , publish work find risk factor mortality adult patient COVID-19 .', 'One study compare sensitivity SARS-CoV-2 RNA detection throat nasopharyngeal swab 17 patient COVID-19.Added value studyIn retrospective cohort study adult inpatient two hospital Wuhan , China , find increase odds in-hospital death associate older age ( odds ratio 1·10 , 95 % CI 1·03–1·17 ; p=0·0043 ) , higher Sequential Organ Failure Assessment ( SOFA ) score ( 5·65 , 2·61–12·23 ; p < 0·0001 ) , d-dimer level greater 1·0 μg/mL ( 18·42 , 2·64–128·55 ; p=0·0033 ) admission .', 'Duration viral shed range 8 37 day .', 'The median duration viral shed 20·0 day ( IQR 17·0–24·0 ) survivor , continue death fatal cases.Implications available evidenceOlder age , elevate d-dimer level , high SOFA score could help clinician identify early stage patient COVID-19 poor prognosis .', 'Prolonged viral shed provide rationale strategy isolation infect patient optimal antiviral intervention future .', 'Evidence study We search PubMed Feb 23 , 2020 , article document risk factor mortality viral shed patient coronavirus disease 2019 ( COVID-19 ) , result infection severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , use search term ( “ novel coronavirus ” OR “ SARS-CoV-2 ” OR “ COVID-19 ” ) AND ( “ death ” OR “ mortality ” OR “ viral shed ” ) language time restriction .', 'Age , comorbidities , lymphocytopenia elevate alanine aminotransferase , d-dimer , creatine kinase , high-sensitivity cardiac troponin I , prothrombin time , disease severity report associate intensive care unit admission .', 'However , publish work find risk factor mortality adult patient COVID-19 .', 'One study compare sensitivity SARS-CoV-2 RNA detection throat nasopharyngeal swab 17 patient COVID-19 .', 'Added value study In retrospective cohort study adult inpatient two hospital Wuhan , China , find increase odds in-hospital death associate older age ( odds ratio 1·10 , 95 % CI 1·03–1·17 ; p=0·0043 ) , higher Sequential Organ Failure Assessment ( SOFA ) score ( 5·65 , 2·61–12·23 ; p < 0·0001 ) , d-dimer level greater 1·0 μg/mL ( 18·42 , 2·64–128·55 ; p=0·0033 ) admission .', 'Duration viral shed range 8 37 day .', 'The median duration viral shed 20·0 day ( IQR 17·0–24·0 ) survivor , continue death fatal case .', 'Implications available evidence Older age , elevate d-dimer level , high SOFA score could help clinician identify early stage patient COVID-19 poor prognosis .', 'Prolonged viral shed provide rationale strategy isolation infect patient optimal antiviral intervention future .', 'This retrospective cohort study include two cohort adult inpatient ( ≥18 year old ) Jinyintan Hospital Wuhan Pulmonary Hospital ( Wuhan , China ) .', 'All adult patient diagnose COVID-19 accord WHO interim guidance screen , die discharge Dec 29 , 2019 ( ie , first patient admit ) , Jan 31 , 2020 , include study .', 'Since two hospital designate hospital transfer patient COVID-19 hospital Wuhan Feb 1 , 2020 , study enrol adult inpatient hospitalise COVID-19 definite outcome ( dead discharge ) early stage outbreak .', 'Before Jan 11 , 2020 , SARS-CoV-2 RNA detection result available electronic medical record , data study obtain retrospectively ; therefore , study include 29 41 patient originally report on.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar The study approve Research Ethics Commission Jinyintan Hospital ( KY-2020–01.01 ) requirement inform consent waive Ethics Commission describe previously.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar Epidemiological , demographic , clinical , laboratory , treatment , outcome data extract electronic medical record use standardise data collection form , modify version WHO/International Severe Acute Respiratory Emerging Infection Consortium case record form severe acute respiratory infection .', 'All data check two physician ( FZ ZL ) third researcher ( GF ) adjudicate difference interpretation two primary reviewer .', 'Methods laboratory confirmation SARS-CoV-2 infection describe elsewhere.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar Briefly , four institutions—the Chinese Center Disease Control Prevention , Chinese Academy Medical Science , Academy Military Medical Sciences , Wuhan Institute Virology , Chinese Academy Sciences—were responsible SARS-CoV-2 detection respiratory specimen next-generation sequence real-time RT-PCR method .', 'From Jan 11 , 2020 , SARS-CoV-2 RNA detect local Centers Disease Control Prevention , local health institution , Jingyintan Hospital Wuhan Pulmonary Hospital .', 'Throat-swab specimen obtain SARS-CoV-2 PCR re-examination every day clinical remission symptom , include fever , cough , dyspnoea , qualitative data available .', 'The criterion discharge absence fever least 3 day , substantial improvement lung chest CT , clinical remission respiratory symptom , two throat-swab sample negative SARS-CoV-2 RNA obtain least 24 h apart .', 'Routine blood examination complete blood count , coagulation profile , serum biochemical test ( include renal liver function , creatine kinase , lactate dehydrogenase , electrolyte ) , myocardial enzyme , interleukin-6 ( IL-6 ) , serum ferritin , procalcitonin .', 'Chest radiograph CT scan also do inpatient .', 'Frequency examination determine treat physician .', 'Fever define axillary temperature least 37·3°C .', 'Sepsis septic shock define accord 2016 Third International Consensus Definition Sepsis Septic Shock.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar Secondary infection diagnose patient show clinical symptom sign pneumonia bacteraemia positive culture new pathogen obtain lower respiratory tract specimen ( qualify sputum , endotracheal aspirate , bronchoalveolar lavage fluid ) blood sample admission.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar Ventilator-associated pneumonia diagnose accord guideline treatment hospital-acquired ventilator-associated pneumonia.8Kalil AC Metersky ML Klompas M et al.Management adult hospital-acquired ventilator-associated pneumonia : 2016 clinical practice guideline Infectious Diseases Society America American Thoracic Society.Clin Infect Dis .', '2016 ; 63 : e61-e111Google Scholar Acute kidney injury diagnose accord KDIGO clinical practice guidelines9Khwaja A KDIGO clinical practice guideline acute kidney injury.Nephron Clin Pract .', '2012 ; 120 : c179-c184Google Scholar acute respiratory distress syndrome ( ARDS ) diagnose accord Berlin Definition.10Ranieri VM Rubenfeld GD Thompson BT et al.Acute respiratory distress syndrome : Berlin Definition.JAMA .', '2012 ; 307 : 2526-2533Google Scholar Acute cardiac injury diagnose serum level cardiac biomarkers ( eg , high-sensitivity cardiac troponin I ) 99th percentile upper reference limit , new abnormality show electrocardiography echocardiography.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', ""2020 ; 395 : 497-506Google Scholar The illness severity COVID-19 define accord Chinese management guideline COVID-19 ( version 6.0 ) .11National Health Commission People 's Republic ChinaChinese management guideline COVID-19 ( version 6.0 ) ."", 'urlplaceholder Feb 19 , 2020Google Scholar Coagulopathy define 3-second extension prothrombin time 5-second extension activate partial thromboplastin time .', 'Hypoproteinaemia define blood albumin le 25 g/L .', 'Exposure history define exposure people confirm SARS-CoV-2 infection Wuhan seafood market .', 'Continuous categorical variable present median ( IQR ) n ( % ) , respectively .', ""We use Mann-Whitney U test , χ2 test , Fisher 's exact test compare difference survivor non-survivors appropriate ."", 'To explore risk factor associate in-hospital death , univariable multivariable logistic regression model use .', 'Considering total number death ( n=54 ) study avoid overfitting model , five variable choose multivariable analysis basis previous find clinical constraint .', 'Previous study show blood level d-dimer Sequential Organ Failure Assessment ( SOFA ) score higher critically ill fatal case , whereas lymphopenia cardiovascular disease le commonly observe non-critical survive patient SARS-COV-2 infection.5Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; 395 : 497-506Google Scholar , 6Wang D Hu B Hu C et al.Clinical characteristic 138 hospitalize patient 2019 novel coronavirus-infected pneumonia Wuhan , China.JAMA .', '2020 ; ( publish online Feb 7 .', ') DOI:10.1001/jama.2020.1585Google Scholar , 12Yang X Yu Y Xu J et al.Clinical course outcome critically ill patient SARS-CoV-2 pneumonia Wuhan , China : single-centered , retrospective , observational study.Lancet Respir Med .', '2020 ; ( publish online Feb 24 ) urlplaceholder Scholar Similar risk factor , include older age , report associate adverse clinical outcome adult SARS Middle East respiratory syndrome ( MERS ) .3Chan JWM Ng CK Chan YH et al.Short term outcome risk factor adverse clinical outcome adult severe acute respiratory syndrome ( SARS ) .Thorax .', '2003 ; 58 : 686-689Google Scholar , 13Arabi YM Balkhy HH Hayden FG et al.Middle East respiratory syndrome.N Engl J Med .', '2017 ; 376 : 584-594Google Scholar Some laboratory find , include alanine aminotransferase ( ALT ) , lactate dehydrogenase , high-sensitivity cardiac troponin I , creatine kinase , d-dimer , serum ferritin , IL-6 , might unavailable emergency circumstance .', 'Therefore , choose lymphocyte count , d-dimer , SOFA score , coronary heart disease , age five variable multivariable logistic regression model .', 'We exclude variable univariable analysis between-group difference significant , accuracy unconfirmed ( eg , exposure , self-reported ) , number event small calculate odds ratio , colinearity SOFA score .', 'We compare patient characteristic two hospital use generalise linear model adjust possible difference patient ’ characteristic treatment two study centre .', 'A two-sided α le 0·05 consider statistically significant .', 'Statistical analysis do use SAS software ( version 9.4 ) , unless otherwise indicate .', 'The funder study role study design , data collection , data analysis , data interpretation , write report .', 'The correspond author ( BC HC ) full access data study final responsibility decision submit publication .', '813 adult patient hospitalise Jinyintan Hospital Wuhan Pulmonary Hospital COVID-19 Jan 31 , 2020 .', 'After exclude 613 patient still hospitalise confirm SARS-CoV-2 RNA detection Jan 31 , 2020 , nine inpatient without available key information medical record , include 191 inpatient ( 135 Jinyintan Hospital 56 Wuhan Pulmonary Hospital ) final analysis .', '54 patient die hospitalisation 137 discharge .', 'The median age 191 patient 56·0 year ( IQR 46·0–67·0 ) , range 18 year 87 year , patient male ( table 1 ) .', 'Comorbidities present nearly half patient , hypertension common comorbidity , follow diabetes coronary heart disease ( table 1 ) .', 'The common symptom admission fever cough , follow sputum production fatigue ( table 1 ) .', 'Lymphocytopenia occur 77 ( 40 % ) patient .', '181 ( 95 % ) patient receive antibiotic 41 ( 21 % ) receive antiviral ( lopinavir/ritonavir ; table 2 ) .', 'Systematic corticosteroid intravenous immunoglobulin use differ significantly non-survivors survivor ( table 2 ) .', 'The comparison characteristic , treatment , outcome patient two hospital show appendix ( pp 2–4 ) .Table 1Demographic , clinical , laboratory , radiographic find patient admissionTotal ( n=191 ) Non-survivor ( n=54 ) Survivor ( n=137 ) p valueDemographics clinical characteristicsAge , years56·0 ( 46·0–67·0 ) 69·0 ( 63·0–76·0 ) 52·0 ( 45·0–58·0 ) < 0·0001Sex ...... 0·15Female72 ( 38 % ) 16 ( 30 % ) 56 ( 41 % ) .. Male119 ( 62 % ) 38 ( 70 % ) 81 ( 59 % ) .. Exposure history73 ( 38 % ) 14 ( 26 % ) 59 ( 43 % ) 0·028Current smoker11 ( 6 % ) 5 ( 9 % ) 6 ( 4 % ) 0·21Comorbidity91 ( 48 % ) 36 ( 67 % ) 55 ( 40 % ) 0·0010Hypertension58 ( 30 % ) 26 ( 48 % ) 32 ( 23 % ) 0·0008Diabetes36 ( 19 % ) 17 ( 31 % ) 19 ( 14 % ) 0·0051Coronary heart disease15 ( 8 % ) 13 ( 24 % ) 2 ( 1 % ) < 0·0001Chronic obstructive lung disease6 ( 3 % ) 4 ( 7 % ) 2 ( 1 % ) 0·047Carcinoma2 ( 1 % ) 02 ( 1 % ) 0·37Chronic kidney disease2 ( 1 % ) 2 ( 4 % ) 00·024Other22 ( 12 % ) 11 ( 20 % ) 11 ( 8 % ) 0·016Respiratory rate > 24 breath per min56 ( 29 % ) 34 ( 63 % ) 22 ( 16 % ) < 0·0001Pulse ≥125 beat per min2 ( 1 % ) 2 ( 4 % ) 00·024Systolic blood pressure < 90 mm Hg1 ( 1 % ) 01 ( 1 % ) 0·53Fever ( temperature ≥37·3°C ) 180 ( 94 % ) 51 ( 94 % ) 129 ( 94 % ) 0·94Cough151 ( 79 % ) 39 ( 72 % ) 112 ( 82 % ) 0·15Sputum44 ( 23 % ) 14 ( 26 % ) 30 ( 22 % ) 0·55Myalgia29 ( 15 % ) 8 ( 15 % ) 21 ( 15 % ) 0·93Fatigue44 ( 23 % ) 15 ( 28 % ) 29 ( 21 % ) 0·33Diarrhoea9 ( 5 % ) 2 ( 4 % ) 7 ( 5 % ) 0·67Nausea vomiting7 ( 4 % ) 3 ( 6 % ) 4 ( 3 % ) 0·40SOFA score2·0 ( 1·0–4·0 ) 4·5 ( 4·0–6·0 ) 1·0 ( 1·0–2·0 ) < 0·0001qSOFA score1·0 ( 0·0–1·0 ) 1·0 ( 1·0–1·0 ) 0·0 ( 0·0–1·0 ) < 0·0001CURB-65 score0·0 ( 0·0–2·0 ) 2·0 ( 1·0–3·0 ) 0·0 ( 0·0–1·0 ) < 0·00010–1141/188 ( 75 % ) 16 ( 30 % ) 125/134 ( 93 % ) < 0·0001 * * χ2 test compare subcategories.232/188 ( 17 % ) 23 ( 43 % ) 9/134 ( 7 % ) .. 3–515/188 ( 8 % ) 15 ( 28 % ) 0/134 .. Disease severity status ...... < 0·0001General72 ( 38 % ) 072 ( 53 % ) .. Severe66 ( 35 % ) 12 ( 22 % ) 54 ( 39 % ) .. Critical53 ( 28 % ) 42 ( 78 % ) 11 ( 8 % ) .. Time illness onset hospital admission , days11·0 ( 8·0–14·0 ) 11·0 ( 8·0–15·0 ) 11·0 ( 8·0–13·0 ) 0·53Laboratory findingsWhite blood cell count , × 109 per L6·2 ( 4·5–9·5 ) 9·8 ( 6·9–13·9 ) 5·2 ( 4·3–7·7 ) < 0·0001 < 432 ( 17 % ) 5 ( 9 % ) 27 ( 20 % ) < 0·0001 * * χ2 test compare subcategories.4–10119 ( 62 % ) 24 ( 44 % ) 95 ( 69 % ) .. > 1040 ( 21 % ) 25 ( 46 % ) 15 ( 11 % ) .. Lymphocyte count , × 109 per L1·0 ( 0·6–1·3 ) 0·6 ( 0·5–0·8 ) 1·1 ( 0·8–1·5 ) < 0·0001 < 0·877 ( 40 % ) 41 ( 76 % ) 36 ( 26 % ) < 0·0001Haemoglobin , g/L128·0 ( 119·0–140·0 ) 126·0 ( 115·0–138·0 ) 128·0 ( 120·0–140·0 ) 0·30Anaemia29 ( 15 % ) 14 ( 26 % ) 15 ( 11 % ) 0·0094Platelet count , × 109 per L206·0 ( 155·0–262·0 ) 165·5 ( 107·0–229·0 ) 220·0 ( 168·0–271·0 ) < 0·0001 < 10013 ( 7 % ) 11 ( 20 % ) 2 ( 1 % ) < 0·0001Albumin , g/L32·3 ( 29·1–35·8 ) 29·1 ( 26·5–31·3 ) 33·6 ( 30·6–36·4 ) < 0·0001ALT , U/L30·0 ( 17·0–46·0 ) 40·0 ( 24·0–51·0 ) 27·0 ( 15·0–40·0 ) 0·0050 > 4059/189 ( 31 % ) 26 ( 48 % ) 33/135 ( 24 % ) 0·0015Creatinine > 133 μmol/L8/186 ( 4 % ) 5 ( 9 % ) 3/132 ( 2 % ) 0·045Lactate dehydrogenase , U/L300·0 ( 234·0–407·0 ) 521·0 ( 363·0–669·0 ) 253·5 ( 219·0–318·0 ) < 0·0001 > 245123/184 ( 67 % ) 53 ( 98 % ) 70/130 ( 54 % ) < 0·0001Creatine kinase , U/L21·5 ( 13·0–72·4 ) 39·0 ( 19·5–151·0 ) 18·0 ( 12·5–52·1 ) 0·0010 > 18522/168 ( 13 % ) 11/52 ( 21 % ) 11/116 ( 9 % ) 0·038High-sensitivity cardiac troponin I , pg/mL4·1 ( 2·0–14·1 ) 22·2 ( 5·6–83·1 ) 3·0 ( 1·1–5·5 ) < 0·0001 > 2824/145 ( 17 % ) 23/50 ( 46 % ) 1/95 ( 1 % ) < 0·0001Prothrombin time , s11·6 ( 10·6–13·0 ) 12·1 ( 11·2–13·7 ) 11·4 ( 10·4–12·6 ) 0·0004 < 16171/182 ( 94 % ) 47 ( 87 % ) 124/128 ( 97 % ) 0·016 * * χ2 test compare subcategories.≥1611/182 ( 6 % ) 7 ( 13 % ) 4/128 ( 3 % ) .. D-dimer , μg/mL0·8 ( 0·4–3·2 ) 5·2 ( 1·5–21·1 ) 0·6 ( 0·3–1·0 ) < 0·0001≤0·555/172 ( 32 % ) 4 ( 7 % ) 51/118 ( 43 % ) < 0·0001 * * χ2 test compare subcategories. > 0·5 ≤145/172 ( 26 % ) 6 ( 11 % ) 39/118 ( 33 % ) .. > 172/172 ( 42 % ) 44 ( 81 % ) 28/118 ( 24 % ) .. Serum ferritin , μg/L722·0 ( 377·2–1435·3 ) 1435·3 ( 728·9–2000·0 ) 503·2 ( 264·0–921·5 ) < 0·0001 > 300102/128 ( 80 % ) 44/46 ( 96 % ) 58/82 ( 71 % ) 0·0008IL-6 , pg/mL7·4 ( 5·3–10·8 ) 11·0 ( 7·5–14·4 ) 6·3 ( 5·0–7·9 ) < 0·0001Procalcitonin , ng/mL0·1 ( 0·1–0·1 ) 0·1 ( 0·1–0·5 ) 0·1 ( 0·1–0·1 ) < 0·0001 < 0·1114/164 ( 70 % ) 19/51 ( 37 % ) 95/113 ( 84 % ) < 0·0001 * * χ2 test compare subcategories.≥0·1 < 0·2530/164 ( 18 % ) 16/51 ( 31 % ) 14/113 ( 12 % ) .. ≥0·25 < 0·56/164 ( 4 % ) 3/51 ( 6 % ) 3/113 ( 3 % ) .. ≥0·514/164 ( 9 % ) 13/51 ( 25 % ) 1/113 ( 1 % ) .. Imaging featuresConsolidation112 ( 59 % ) 40 ( 74 % ) 72 ( 53 % ) 0·0065Ground-glass opacity136 ( 71 % ) 44 ( 81 % ) 92 ( 67 % ) 0·049Bilateral pulmonary infiltration143 ( 75 % ) 45 ( 83 % ) 98 ( 72 % ) 0·090Data median ( IQR ) , n ( % ) , n/N ( % ) .', ""p value calculate Mann-Whitney U test , χ2 test , Fisher 's exact test , appropriate ."", 'SOFA=Sequential Organ Failure Assessment .', 'qSOFA=Quick SOFA .', 'ALT=alanine aminotransferase .', 'IL-6=interleukin-6 .', '* χ2 test compare subcategories .', 'Open table new tab Table 2Treatments outcomesTotal ( n=191 ) Non-survivor ( n=54 ) Survivor ( n=137 ) p valueTreatments * * Ordered escalate scale respiratory support.Antibiotics181 ( 95 % ) 53 ( 98 % ) 128 ( 93 % ) 0·15Antiviral treatment41 ( 21 % ) 12 ( 22 % ) 29 ( 21 % ) 0·87Corticosteroids57 ( 30 % ) 26 ( 48 % ) 31 ( 23 % ) 0·0005Intravenous immunoglobin46 ( 24 % ) 36 ( 67 % ) 10 ( 7 % ) < 0·0001High-flow nasal cannula oxygen therapy41 ( 21 % ) 33 ( 61 % ) 8 ( 6 % ) < 0·0001Non-invasive mechanical ventilation26 ( 14 % ) 24 ( 44 % ) 2 ( 1 % ) < 0·0001Invasive mechanical ventilation32 ( 17 % ) 31 ( 57 % ) 1 ( 1 % ) < 0·0001ECMO3 ( 2 % ) 3 ( 6 % ) 00·0054Renal replacement therapy10 ( 5 % ) 10 ( 19 % ) 0 < 0·0001OutcomesSepsis112 ( 59 % ) 54 ( 100 % ) 58 ( 42 % ) < 0·0001Respiratory failure103 ( 54 % ) 53 ( 98 % ) 50 ( 36 % ) < 0·0001ARDS59 ( 31 % ) 50 ( 93 % ) 9 ( 7 % ) < 0·0001Heart failure44 ( 23 % ) 28 ( 52 % ) 16 ( 12 % ) < 0·0001Septic shock38 ( 20 % ) 38 ( 70 % ) 0 < 0·0001Coagulopathy37 ( 19 % ) 27 ( 50 % ) 10 ( 7 % ) < 0·0001Acute cardiac injury33 ( 17 % ) 32 ( 59 % ) 1 ( 1 % ) < 0·0001Acute kidney injury28 ( 15 % ) 27 ( 50 % ) 1 ( 1 % ) < 0·0001Secondary infection28 ( 15 % ) 27 ( 50 % ) 1 ( 1 % ) < 0·0001Hypoproteinaemia22 ( 12 % ) 20 ( 37 % ) 2 ( 1 % ) < 0·0001Acidosis17 ( 9 % ) 16 ( 30 % ) 1 ( 1 % ) < 0·0001ICU admission50 ( 26 % ) 39 ( 72 % ) 11 ( 8 % ) < 0·0001ICU length stay , days8·0 ( 4·0–12·0 ) 8·0 ( 4·0–12·0 ) 7·0 ( 2·0–9·0 ) 0·41Hospital length stay , days11·0 ( 7·0–14·0 ) 7·5 ( 5·0–11·0 ) 12·0 ( 9·0–15·0 ) < 0·0001Time illness onset fever , days1·0 ( 1·0–1·0 ) 1·0 ( 1·0–1·0 ) 1·0 ( 1·0–1·0 ) 0·16Time illness onset cough , days1·0 ( 1·0–3·0 ) 1·0 ( 1·0–1·0 ) 1·0 ( 1·0–4·0 ) 0·30Time illness onset dyspnoea , days7·0 ( 4·0–9·0 ) 7·0 ( 4·0–10·0 ) 7·0 ( 4·0–9·0 ) 0·51Time illness onset sepsis , days9·0 ( 7·0–13·0 ) 10·0 ( 7·0–14·0 ) 9·0 ( 7·0–12·0 ) 0·22Time illness onset ARDS , days12·0 ( 8·0–15·0 ) 12·0 ( 8·0–15·0 ) 10·0 ( 8·0–13·0 ) 0·65Time illness onset ICU admission , days12·0 ( 8·0–15·0 ) 12·0 ( 8·0–15·0 ) 11·5 ( 8·0–14·0 ) 0·88Time illness onset corticosteroid treatment , days12·0 ( 10·0–16·0 ) 13·0 ( 10·0–17·0 ) 12·0 ( 10·0–15·0 ) 0·55Time illness onset death discharge , days21·0 ( 17·0–25·0 ) 18·5 ( 15·0–22·0 ) 22·0 ( 18·0–25·0 ) 0·0003Duration viral shed COVID-19 onset , days20·0 ( 16·0–23·0 ) 18·5 ( 15·0–22·0 ) †† Detectable death.20·0 ( 17·0–24·0 ) 0·024Data median ( IQR ) n ( % ) .', ""p value calculate Mann-Whitney U test , χ2 test , Fisher 's exact test , appropriate ."", 'ECMO=extracorporeal membrane oxygenation .', 'ARDS=acute respiratory distress syndrome .', 'ICU=intensive care unit .', 'COVID-19=coronavirus disease 2019 .', '* Ordered escalate scale respiratory support.† Detectable death .', 'Open table new tab Data median ( IQR ) , n ( % ) , n/N ( % ) .', ""p value calculate Mann-Whitney U test , χ2 test , Fisher 's exact test , appropriate ."", 'SOFA=Sequential Organ Failure Assessment .', 'qSOFA=Quick SOFA .', 'ALT=alanine aminotransferase .', 'IL-6=interleukin-6 .', 'Data median ( IQR ) n ( % ) .', ""p value calculate Mann-Whitney U test , χ2 test , Fisher 's exact test , appropriate ."", 'ECMO=extracorporeal membrane oxygenation .', 'ARDS=acute respiratory distress syndrome .', 'ICU=intensive care unit .', 'COVID-19=coronavirus disease 2019 .', 'The median time illness onset ( ie , admission ) discharge 22·0 day ( IQR 18·0–25·0 ) , whereas median time death 18·5 day ( 15·0–22·0 ; table 2 ) .', '32 patient require invasive mechanical ventilation , 31 ( 97 % ) die .', 'The median time illness onset invasive mechanical ventilation 14·5 day ( 12·0–19·0 ) .', 'Extracorporeal membrane oxygenation use three patient , none survive .', 'Sepsis frequently observe complication , follow respiratory failure , ARDS , heart failure , septic shock ( table 2 ) .', 'Half non-survivors experience secondary infection , ventilator-associated pneumonia occur ten ( 31 % ) 32 patient require invasive mechanical ventilation .', 'The frequency complication higher non-survivors survivor ( table 2 ) .', 'In univariable analysis , odds in-hospital death higher patient diabetes coronary heart disease ( table 3 ) .', 'Age , lymphopenia , leucocytosis , elevate ALT , lactate dehydrogenase , high-sensitivity cardiac troponin I , creatine kinase , d-dimer , serum ferritin , IL-6 , prothrombin time , creatinine , procalcitonin also associate death ( table 3 ) .Table 3Risk factor associate in-hospital deathUnivariable OR ( 95 % CI ) p valueMultivariable OR ( 95 % CI ) p valueDemographics clinical characteristicsAge , year * * Per 1 unit increase.1·14 ( 1·09–1·18 ) < 0·00011·10 ( 1·03–1·17 ) 0·0043Female sex ( v male ) 0·61 ( 0·31–1·20 ) 0·15 .... Current smoker ( v non-smoker ) 2·23 ( 0·65–7·63 ) 0·20 .... Comorbidity present ( v present ) Chronic obstructive lung disease5·40 ( 0·96–30·40 ) 0·056 .... Coronary heart disease21·40 ( 4·64–98·76 ) < 0·00012·14 ( 0·26–17·79 ) 0·48Diabetes2·85 ( 1·35–6·05 ) 0·0062 .... Hypertension3·05 ( 1·57–5·92 ) 0·0010 .... Respiratory rate , breath per min≤241 ( ref ) ...... > 248·89 ( 4·34–18·19 ) < 0·0001 .... SOFA score6·14 ( 3·48–10·85 ) < 0·00015·65 ( 2·61–12·23 ) < 0·0001qSOFA score12·00 ( 5·06–28·43 ) < 0·0001 .... Laboratory findingsWhite blood cell count , × 109 per L < 40·73 ( 0·26–2·10 ) 0·56 .... 4–101 ( ref ) ...... > 106·60 ( 3·02–14·41 ) < 0·0001 .... Lymphocyte count , × 109 per L * * Per 1 unit increase.0·02 ( 0·01–0·08 ) < 0·00010·19 ( 0·02–1·62 ) 0·13ALT , U/L≤401 ( ref ) ...... > 402·87 ( 1·48–5·57 ) 0·0018 .... Creatinine , μmol/L≤1331 ( ref ) ...... > 1334·39 ( 1·01–19·06 ) 0·048 .... Lactate dehydrogenase , U/L≤2451 ( ref ) ...... > 24545·43 ( 6·10–338·44 ) 0·0002 .... Creatine kinase , U/L≤1851 ( ref ) ...... > 1852·56 ( 1·03–6·36 ) 0·043 .... High-sensitivity cardiac troponin I , pg/mL≤281 ( ref ) ...... > 2880·07 ( 10·34–620·36 ) < 0·0001 .... D-dimer , μg/mL≤0·51 ( ref ) .. 1 ( ref ) .. > 0·51·96 ( 0·52–7·43 ) 0·322·14 ( 0·21–21·39 ) 0·52 > 120·04 ( 6·52–61·56 ) < 0·000118·42 ( 2·64–128·55 ) 0·0033Prothrombin time , < 161 ( ref ) ...... ≥164·62 ( 1·29–16·50 ) 0·019 .... Serum ferritin , μg/L≤3001 ( ref ) ...... > 3009·10 ( 2·04–40·58 ) 0·0038 .... IL-6 , pg/mL * * Per 1 unit increase.1·12 ( 1·03–1·23 ) 0·0080 .... Procalcitonin , ng/mL * * Per 1 unit increase.13·75 ( 1·81–104·40 ) 0·011 .... OR=odds ratio .', 'SOFA=Sequential Organ Failure Assessment .', 'qSOFA=Quick SOFA .', 'ALT=alanine aminotransferase .', 'IL-6=interleukin-6 .', '* Per 1 unit increase .', 'Open table new tab OR=odds ratio .', 'SOFA=Sequential Organ Failure Assessment .', 'qSOFA=Quick SOFA .', 'ALT=alanine aminotransferase .', 'IL-6=interleukin-6 .', 'We include 171 patient complete data variable ( 53 non-survivors 118 survivor ) multivariable logistic regression model .', 'We find older age , higher SOFA score , d-dimer greater 1 μg/mL admission associate increase odds death ( table 3 ) .', 'When adjust study centre , generalise linear model show similar result ( appendix p 5 ) .', 'For survivor , median duration viral shed 20·0 day ( IQR 17·0–24·0 ) illness onset , virus continuously detectable death non-survivors ( table 2 ; figure 1 ) .', 'The shortest observe duration viral shed among survivor 8 day , whereas longest 37 day .', 'Among 29 patient receive lopinavir/ritonavir discharge , median time illness onset initiation antiviral treatment 14·0 day ( IQR 10·0–17·0 ) median duration viral shed 22·0 day ( 18·0–24·0 ) .', 'The median duration viral shed 19·0 day ( 17·0–22·0 ) patient severe disease status 24·0 day ( 22·0–30·0 ) patient critical disease status.Figure 1Clinical course major symptom outcome duration viral shed illness onset patient hospitalise COVID-19Show full captionFigure show median duration symptom onset complication outcome .', 'ICU=intensive care unit .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'ARDS=acute respiratory distress syndrome .', 'COVID-19=coronavirus disease 2019.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Figure show median duration symptom onset complication outcome .', 'ICU=intensive care unit .', 'SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'ARDS=acute respiratory distress syndrome .', 'COVID-19=coronavirus disease 2019 .', 'Major laboratory marker track illness onset ( figure 2 ) .', 'Baseline lymphocyte count significantly higher survivor non-survivors ; survivor , lymphocyte count lowest day 7 illness onset improve hospitalisation , whereas severe lymphopenia observe death non-survivors .', 'Levels d-dimer , high-sensitivity cardiac troponin I , serum ferritin , lactate dehydrogenase , IL-6 clearly elevate non-survivors compare survivor throughout clinical course , increase illness deterioration ( figure 2 ) .', 'In non-survivors , high-sensitivity cardiac troponin I increase rapidly day 16 disease onset , whereas lactate dehydrogenase increase survivor non-survivors early stage illness , decrease day 13 survivors.Figure 2Temporal change laboratory marker illness onset patient hospitalise COVID-19Show full captionFigure show temporal change d-dimer ( A ) , lymphocyte ( B ) , IL-6 ( C ) , serum ferritin ( D ) , high-sensitivity cardiac troponin I ( E ) , lactate dehydrogenase ( F ) .', 'Differences survivor non-survivors significant timepoints show , except day 4 illness onset d-dimer , IL-6 , high-sensitivity cardiac troponin I .', 'For serum ferritin ( D ) , median value day 16 exceed upper limit detection , indicate dash line .', 'COVID-19=coronavirus disease 2019 .', 'IL-6=interleukin-6.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Figure show temporal change d-dimer ( A ) , lymphocyte ( B ) , IL-6 ( C ) , serum ferritin ( D ) , high-sensitivity cardiac troponin I ( E ) , lactate dehydrogenase ( F ) .', 'Differences survivor non-survivors significant timepoints show , except day 4 illness onset d-dimer , IL-6 , high-sensitivity cardiac troponin I .', 'For serum ferritin ( D ) , median value day 16 exceed upper limit detection , indicate dash line .', 'COVID-19=coronavirus disease 2019 .', 'IL-6=interleukin-6 .', 'Median time illness onset dyspnoea similar survivor non-survivors , median duration dyspnoea 13·0 day ( 9·0–16·5 ) survivor ( table 2 ; figure 1 ) .', 'In survivor , median duration fever 12·0 day ( 8·0–13·0 ) cough persist 19·0 day ( IQR 12·0–23·0 ; figure 1 ) .', '62 ( 45 % ) survivor still cough discharge 39 ( 72 % ) non-survivors still cough time death .', 'The dynamic profile fever , cough , dyspnoea show appendix ( p 6 ) .', 'Sepsis develop median 9·0 day ( 7·0–13·0 ) illness onset among patient , follow ARDS ( 12·0 day [ 8·0–15·0 ] ) , acute cardiac injury ( 15·0 day [ 10·0–17·0 ] ) , acute kidney injury ( 15·0 day [ 13·0–19·5 ] ) , secondary infection ( 17·0 day [ 13·0–19·0 ] ) .', 'The initiation time duration systematic corticosteroid use also similar two group .', 'Among non-survivors , median time illness onset 10·0 day ( 7·0–14·0 ) sepsis , 12·0 day ( 8·0–15·0 ) ARDS , 14·5 day ( 9·5–17·0 ) acute cardiac injury , 17·0 day ( 13·0–19·0 ) secondary infection ( figure 1 ; table 2 ) .', 'Among survivor , secondary infection , acute kidney injury , acute cardiac injury observe one patient , occur 9 day ( acute kidney injury ) , 14 day ( secondary infection ) , 21 day ( acute cardiac injury ) illness onset .', 'The median time dyspnoea intubation 10·0 day ( IQR 5·0–12·5 ) patient receive invasive mechanical ventilation time invasive mechanical ventilation occurrence ventilator-associated pneumonia 8·0 day ( 2·0–9·0 ; figure 1 ) .', 'This retrospective cohort study identify several risk factor death adult Wuhan hospitalise COVID-19 .', 'In particular , older age , d-dimer level greater 1 μg/mL , higher SOFA score admission associate higher odds in-hospital death .', 'Additionally , elevate level blood IL-6 , high-sensitivity cardiac troponin I , lactate dehydrogenase lymphopenia commonly see severe COVID-19 illness .', 'Sustained viral detection throat sample observe survivor non-survivors .', 'Previously , older age report important independent predictor mortality SARS MERS.14Choi KW Chau TN Tsang O et al.Outcomes prognostic factor 267 patient severe acute respiratory syndrome Hong Kong.Ann Intern Med .', '2003 ; 139 : 715-723Google Scholar , 15Hong K-H Choi J-P Hong S-H et al.Predictors mortality Middle East respiratory syndrome ( MERS ) .Thorax .', '2018 ; 73 : 286-289Google Scholar The current study confirm increase age associate death patient COVID-19 .', 'Previous study macaque inoculate SARS-CoV find older macaque stronger host innate response virus infection younger adult , increase differential expression gene associate inflammation , whereas expression type I interferon beta reduced.16Smits SL de Lang A van den Brand JMA et al.Exacerbated innate host response SARS-CoV age non-human primates.PLoS Pathog .', '2010 ; 6 : e1000756-eGoogle Scholar The age-dependent defect T-cell B-cell function excess production type 2 cytokine could lead deficiency control viral replication prolong proinflammatory response , potentially lead poor outcome.17Opal SM Girard TD Ely EW The immunopathogenesis sepsis elderly patients.Clin Infect Dis .', '2005 ; 41 : S504-S512Google Scholar SOFA score good diagnostic marker sepsis septic shock , reflect state degree multi-organ dysfunction.18Singer M Deutschman CS Seymour CW et al.The Third International Consensus Definitions Sepsis Septic Shock ( Sepsis-3 ) .JAMA .', '2016 ; 315 : 801-810Google Scholar , 19Ferreira FL Bota DP Bross A Mélot C Vincent JL Serial evaluation SOFA score predict outcome critically ill patients.JAMA .', '2001 ; 286 : 1754-1758Google Scholar Although bacterial infection usually regard lead cause sepsis , viral infection also cause sepsis syndrome .', 'Previously , determine sepsis occur nearly 40 % adult community-acquired pneumonia due viral infection.20Zhou F Wang Y Liu Y et al.Disease severity clinical outcome community-acquired pneumonia cause non-influenza respiratory virus adult : multicentre prospective registry study CAP-China Network.Eur Respir J .', '2019 ; 54 : 1802406Google Scholar In current study , find half patient develop sepsis .', 'Additionally , find 70 % patient white blood cell count 10·0 × 109 per L procalcitonin 0·25 ng/mL , bacterial pathogen detect patient admission .', 'Sepsis common complication , might directly cause SARS-CoV-2 infection , research need investigate pathogenesis sepsis COVID-19 illness .', 'Cardiac complication , include new worsen heart failure , new worsen arrhythmia , myocardial infarction common patient pneumonia .', 'Cardiac arrest occur 3 % inpatient pneumonia.21Marrie TJ Shariatzadeh MR Community-acquired pneumonia require admission intensive care unit : descriptive study.Medicine ( Baltimore ) .', '2007 ; 86 : 103-111Google Scholar Risk factor cardiac event pneumonia include older age , pre-existing cardiovascular disease , greater severity pneumonia presentation.22Corrales-Medina VF Musher DM Shachkina S Chirinos JA Acute pneumonia cardiovascular system.Lancet .', '2013 ; 381 : 496-505Google Scholar Coronary heart disease also find associate acute cardiac event poor outcome influenza respiratory viral infections.22Corrales-Medina VF Musher DM Shachkina S Chirinos JA Acute pneumonia cardiovascular system.Lancet .', '2013 ; 381 : 496-505Google Scholar , 23Udell JA Zawi R Bhatt DL et al.Association influenza vaccination cardiovascular outcome high-risk patient : meta-analysis.JAMA .', '2013 ; 310 : 1711-1720Google Scholar , 24Blackburn R Zhao H Pebody R Hayward A Warren-Gash C Laboratory-confirmed respiratory infection predictor hospital admission myocardial infarction stroke : time-series analysis English data 2004–2015.Clin Infect Dis .', '2018 ; 67 : 8-17Google Scholar In study , increase high-sensitivity cardiac troponin I hospitalisation find half die .', 'The first autopsy 53-year-old woman chronic renal failure Jinyintan Hospital show acute myocardial infarction ( data publish ; personal communication pathologist Chinese Academy Science ) .', 'About 90 % inpatient pneumonia increase coagulation activity , mark increase d-dimer concentrations.25Milbrandt EB Reade MC Lee M et al.Prevalence significance coagulation abnormality community-acquired pneumonia.Mol Med .', '2009 ; 15 : 438-445Google Scholar In study , find d-dimer greater 1 μg/mL associate fatal outcome COVID-19 .', 'High level d-dimer report association 28-day mortality patient infection sepsis identify emergency department.26Rodelo JR De la Rosa G Valencia ML et al.D-dimer significant prognostic factor patient suspect infection sepsis.Am J Emerg Med .', '2012 ; 30 : 1991-1999Google Scholar Contributory mechanism include systemic pro-inflammatory cytokine response mediator atherosclerosis directly contribute plaque rupture local inflammation , induction procoagulant factor , haemodynamic change , predispose ischaemia thrombosis.27Smeeth L Thomas SL Hall AJ Hubbard R Farrington P Vallance P Risk myocardial infarction stroke acute infection vaccination.N Engl J Med .', '2004 ; 351 : 2611-2618Google Scholar , 28Corrales-Medina VF Musher DM Wells GA Chirinos JA Chen L Fine MJ Cardiac complication patient community-acquired pneumonia : incidence , time , risk factor , association short-term mortality.Circulation .', '2012 ; 125 : 773-781Google Scholar , 29Davidson JA Warren-Gash C Cardiovascular complication acute respiratory infection : current research future directions.Expert Rev Anti Infect Ther .', '2019 ; 17 : 939-942Google Scholar In addition , angiotensin convert enzyme 2 , receptor SARS-CoV-2 , express myocytes vascular endothelial cells,30Gallagher PE Ferrario CM Tallant EA Regulation ACE2 cardiac myocytes fibroblasts.Am J Physiol Heart Circ Physiol .', '2008 ; 295 : H2373-H2479Google Scholar , 31Mendoza-Torres E Oyarzún A Mondaca-Ruff D et al.ACE2 vasoactive peptide : novel player cardiovascular/renal remodel hypertension.Ther Adv Cardiovasc Dis .', '2015 ; 9 : 217-237Google Scholar least theoretical potential possibility direct cardiac involvement virus .', 'Of note , interstitial mononuclear inflammatory infiltrate heart tissue document fatal case COVID-19 , although viral detection study reported.32Xu Z Shi L Wang Y et al.Pathological find COVID-19 associate acute respiratory distress syndrome.Lancet Respir Med .', '2020 ; ( publish online Feb 18 ) urlplaceholder Scholar The level duration infectious virus replication important factor assess risk transmission guide decision regard isolation patient .', 'Because coronavirus RNA detection sensitive virus isolation , study use qualitative quantitative viral RNA test potential marker infectious coronavirus .', 'For SARS-CoV , viral RNA detect respiratory specimen third patient long 4 week disease onset.33Xu D Zhang Z Jin L et al.Persistent shed viable SARS-CoV urine stool SARS patient convalescent phase.Eur J Clin Microbiol Infect Dis .', '2005 ; 24 : 165-171Google Scholar Similarly , duration MERS-CoV RNA detection lower respiratory specimans persist least 3 weeks,34Corman VM Albarrak AM Omrani AS et al.Viral shed antibody response 37 patient Middle East Respiratory Syndrome coronavirus infection.Clin Infect Dis .', '2016 ; 62 : 477-483Google Scholar , 35Oh MD Park WB Choe PG et al.Viral load kinetics MERS coronavirus infection.N Engl J Med .', '2016 ; 375 : 1303-1405Google Scholar whereas duration SARS-CoV-2 RNA detection well characterise .', 'In current study , find detectable SARS-CoV-2 RNA persist median 20 day survivor sustain death non-survivors .', 'This important implication patient isolation decision make guidance around length antiviral treatment .', 'In severe influenza virus infection , prolong viral shed associate fatal outcome delay antiviral treatment independent risk factor prolong virus detection.36Wang Y Guo Q Yan Z et al.Factors associate prolong viral shed patient avian influenza A ( H7N9 ) virus infection.J Infect Dis .', '2018 ; 217 : 1708-1717Google Scholar Similarly , effective antiviral treatment might improve outcome COVID-19 , although observe shorten viral shed duration lopinavir/ritonavir treatment current study .', 'Randomised clinical trial lopinavir/ritonavir ( ChiCTR2000029308 ) intravenous remdesivir ( NCT04257656 , NCT04252664 ) treatment COVID-19 currently progress .', 'Our study limitation .', 'First , due retrospective study design , laboratory test do patient , include lactate dehydrogenase , IL-6 , serum ferritin .', 'Therefore , role might underestimate predict in-hospital death .', 'Second , patient sometimes transfer late illness two include hospital .', 'Lack effective antiviral , inadequate adherence standard supportive therapy , high-dose corticosteroid use might also contribute poor clinical outcome patient .', 'Third , estimate duration viral shed limit frequency respiratory specimen collection , lack quantitative viral RNA detection , relatively low positive rate SARS-CoV-2 RNA detection throat-swabs.37Zou L Ruan F Huang M et al.SARS-CoV-2 viral load upper respiratory specimen infect patients.N Engl J Med .', '2020 ; ( publish online Feb 19 .', ') DOI:10.1056/NEJMc2001737Google Scholar Fourth , exclude patient still hospital Jan 31 , 2020 , thus relatively severe disease earlier stage , case fatality ratio study reflect true mortality COVID-19 .', 'Last least , interpretation find might limit sample size .', 'However , include adult patient two designate hospital COVID-19 , believe study population representative case diagnose treat Wuhan .', 'To best knowledge , largest retrospective cohort study among patient COVID-19 experience definite outcome .', 'We find older age , higher SOFA score , elevate d-dimer admission risk factor death adult patient COVID-19 .', 'The prolong viral shed provide rationale test novel coronavirus antiviral intervention effort improve outcome .', 'This online publication correct .', 'The correct version first appear thelancet.com March 12 , 2020 This online publication correct .', 'The correct version first appear thelancet.com March 12 , 2020 Contributors BC HC idea design study full access data study take responsibility integrity data accuracy data analysis .', 'BC , FZ , GF , ZL , JXi , YL draft paper .', 'BC , FZ , RD , GF , ZL , XG , HL , YWa analysis , author critically revise manuscript important intellectual content give final approval version publish .', 'FZ , RD , GF , ZL , YL , BS , LG , YWe , XW , JXu , ST , YZ collect data .', 'All author agree accountable aspect work ensure question relate accuracy integrity part work appropriately investigate resolve .', 'Declaration interest We declare compete interest .', 'Acknowledgments This study receive follow fund : Chinese Academy Medical Sciences Innovation Fund Medical Sciences ( CIFMS 2018-I2M-1–003 ) ; National Science Grant Distinguished Young Scholars ( 81425001/H0104 ) ; National Key Research Development Program China ( 2018YFC1200100 , 2018YFC1200102 ) ; The Beijing Science Technology Project ( Z19110700660000 ) ; Major Projects National Science Technology New Drug Creation Development ( 2020ZX09201001 ) .', 'We acknowledge health-care worker involve diagnosis treatment patient Wuhan ; thank Chen Wang ( Peking Union Medical College , Beijing , China ) , Peter W Horby ( University Oxford , Oxford , UK ) , Frederick G Hayden ( University Virginia School Medicine , Charlottesville , VA , USA ) guidance study design interpretation result , review manuscript .', 'Download .pdf ( .53 MB ) Help pdf file Supplementary appendix Department ErrorFull-TextPDFDepartment ErrorFull-TextPDFCOVID-19 cytokine storm : interplay inflammation coagulationFull-TextPDFEndothelial cell infection endotheliitis COVID-19Full-TextPDF']","['backgroundsince', 'december', '', '2019', '', 'wuhan', '', 'china', '', 'experience', 'outbreak', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'epidemiological', 'clinical', 'characteristic', 'patient', 'covid-19', 'report', 'risk', 'factor', 'mortality', 'detail', 'clinical', 'course', 'illness', '', 'include', 'viral', 'shed', '', 'well', 'describedmethodsin', 'retrospective', '', 'multicentre', 'cohort', 'study', '', 'include', 'adult', 'inpatient', '', '18', 'year', 'old', '', 'laboratory-confirmed', 'covid-19', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', '', 'wuhan', '', 'china', '', 'discharge', 'die', 'jan', '31', '', '2020', '', 'demographic', '', 'clinical', '', 'treatment', '', 'laboratory', 'data', '', 'include', 'serial', 'sample', 'viral', 'rna', 'detection', '', 'extract', 'electronic', 'medical', 'record', 'compare', 'survivor', 'non-survivors', '', 'univariable', 'multivariable', 'logistic', 'regression', 'method', 'explore', 'risk', 'factor', 'associate', 'in-hospital', 'deathfindings191', 'patient', '', '135', 'jinyintan', 'hospital', '56', 'wuhan', 'pulmonary', 'hospital', '', 'include', 'study', '', '137', 'discharge', '54', 'die', 'hospital', '', '91', '', '48', '', '', 'patient', 'comorbidity', '', 'hypertension', 'common', '', '58', '', '30', '', '', 'patient', '', '', 'follow', 'diabetes', '', '36', '', '19', '', '', 'patient', '', 'coronary', 'heart', 'disease', '', '15', '', '8', '', '', 'patient', '', '', 'multivariable', 'regression', 'show', 'increase', 'odds', 'in-hospital', 'death', 'associate', 'older', 'age', '', 'odds', 'ratio', '110', '', '95', '', 'ci', '103117', '', 'per', 'year', 'increase', '', 'p00043', '', '', 'higher', 'sequential', 'organ', 'failure', 'assessment', '', 'sofa', '', 'score', '', '565', '', '2611223', '', 'p', '', '00001', '', '', 'd-dimer', 'greater', '1', 'gml', '', '1842', '', '26412855', '', 'p00033', '', 'admission', '', 'median', 'duration', 'viral', 'shed', '200', 'day', '', 'iqr', '170240', '', 'survivor', '', 'sars-cov-2', 'detectable', 'death', 'non-survivors', '', 'longest', 'observe', 'duration', 'viral', 'shed', 'survivor', '37', 'daysinterpretationthe', 'potential', 'risk', 'factor', 'older', 'age', '', 'high', 'sofa', 'score', '', 'd-dimer', 'greater', '1', 'gml', 'help', 'clinician', 'identify', 'patient', 'poor', 'prognosis', 'early', 'stage', '', 'prolonged', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'futurefundingchinese', 'academy', 'medical', 'sciences', 'innovation', 'fund', 'medical', 'sciences', '', 'national', 'science', 'grant', 'distinguished', 'young', 'scholars', '', 'national', 'key', 'research', 'development', 'program', 'china', '', 'beijing', 'science', 'technology', 'project', '', 'major', 'projects', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', '', 'since', 'december', '', '2019', '', 'wuhan', '', 'china', '', 'experience', 'outbreak', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'epidemiological', 'clinical', 'characteristic', 'patient', 'covid-19', 'report', 'risk', 'factor', 'mortality', 'detail', 'clinical', 'course', 'illness', '', 'include', 'viral', 'shed', '', 'well', 'describe', '', 'retrospective', '', 'multicentre', 'cohort', 'study', '', 'include', 'adult', 'inpatient', '', '18', 'year', 'old', '', 'laboratory-confirmed', 'covid-19', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', '', 'wuhan', '', 'china', '', 'discharge', 'die', 'jan', '31', '', '2020', '', 'demographic', '', 'clinical', '', 'treatment', '', 'laboratory', 'data', '', 'include', 'serial', 'sample', 'viral', 'rna', 'detection', '', 'extract', 'electronic', 'medical', 'record', 'compare', 'survivor', 'non-survivors', '', 'univariable', 'multivariable', 'logistic', 'regression', 'method', 'explore', 'risk', 'factor', 'associate', 'in-hospital', 'death', '', '191', 'patient', '', '135', 'jinyintan', 'hospital', '56', 'wuhan', 'pulmonary', 'hospital', '', 'include', 'study', '', '137', 'discharge', '54', 'die', 'hospital', '', '91', '', '48', '', '', 'patient', 'comorbidity', '', 'hypertension', 'common', '', '58', '', '30', '', '', 'patient', '', '', 'follow', 'diabetes', '', '36', '', '19', '', '', 'patient', '', 'coronary', 'heart', 'disease', '', '15', '', '8', '', '', 'patient', '', '', 'multivariable', 'regression', 'show', 'increase', 'odds', 'in-hospital', 'death', 'associate', 'older', 'age', '', 'odds', 'ratio', '110', '', '95', '', 'ci', '103117', '', 'per', 'year', 'increase', '', 'p00043', '', '', 'higher', 'sequential', 'organ', 'failure', 'assessment', '', 'sofa', '', 'score', '', '565', '', '2611223', '', 'p', '', '00001', '', '', 'd-dimer', 'greater', '1', 'gml', '', '1842', '', '26412855', '', 'p00033', '', 'admission', '', 'median', 'duration', 'viral', 'shed', '200', 'day', '', 'iqr', '170240', '', 'survivor', '', 'sars-cov-2', 'detectable', 'death', 'non-survivors', '', 'longest', 'observe', 'duration', 'viral', 'shed', 'survivor', '37', 'day', '', 'potential', 'risk', 'factor', 'older', 'age', '', 'high', 'sofa', 'score', '', 'd-dimer', 'greater', '1', 'gml', 'help', 'clinician', 'identify', 'patient', 'poor', 'prognosis', 'early', 'stage', '', 'prolonged', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', '', 'chinese', 'academy', 'medical', 'sciences', 'innovation', 'fund', 'medical', 'sciences', '', 'national', 'science', 'grant', 'distinguished', 'young', 'scholars', '', 'national', 'key', 'research', 'development', 'program', 'china', '', 'beijing', 'science', 'technology', 'project', '', 'major', 'projects', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', '', 'december', '', '2019', '', 'wuhan', 'city', '', 'capital', 'hubei', 'province', 'china', '', 'become', 'centre', 'outbreak', 'pneumonia', 'unknown', 'cause', '', 'jan', '7', '', '2020', '', 'chinese', 'scientist', 'isolate', 'novel', 'coronavirus', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'previously', '2019-ncov', '', '', 'patient', 'virus-infected', 'pneumonia1phelan', 'al', 'katz', 'r', 'gostin', 'lo', 'novel', 'coronavirus', 'originate', 'wuhan', '', 'china', '', 'challenge', 'global', 'health', 'governancejama', '', '2020', '', '', 'publish', 'online', 'jan', '30', '', '', 'doi101001jama20201097google', '', '2gorbalenya', 'ae', 'baker', 'sc', 'baric', 'rs', 'alsevere', 'acute', 'respiratory', 'syndrome-related', 'coronavirus', '', 'specie', 'virusesa', 'statement', 'coronavirus', 'study', 'groupbiorxiv', '', '2020', '', '', 'publish', 'online', 'feb', '11', '', '', '', 'preprint', '', 'doi10110120200207937862google', 'later', 'designate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'february', '', '2020', '', 'who3chan', 'jwm', 'ng', 'ck', 'chan', 'yh', 'alshort', 'term', 'outcome', 'risk', 'factor', 'adverse', 'clinical', 'outcome', 'adult', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'thorax', '', '2003', '', '58', '', '686-689google', 'although', 'outbreak', 'likely', 'start', 'zoonotic', 'transmission', 'event', 'associate', 'large', 'seafood', 'market', 'trade', 'live', 'wild', 'animal', '', 'soon', 'become', 'clear', 'efficient', 'person-to-person', 'transmission', 'occurring4li', 'q', 'guan', 'x', 'wu', 'p', 'alearly', 'transmission', 'dynamic', 'wuhan', '', 'china', '', 'novel', 'coronavirus-infected', 'pneumonian', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'jan', '29', '', '', 'doi101056nejmoa2001316google', 'clinical', 'spectrum', 'sars-cov-2', 'infection', 'appear', 'wide', '', 'encompass', 'asymptomatic', 'infection', '', 'mild', 'upper', 'respiratory', 'tract', 'illness', '', 'severe', 'viral', 'pneumonia', 'respiratory', 'failure', 'death', '', 'patient', 'hospitalise', 'pneumonia', 'wuhan5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', '', '6wang', 'hu', 'b', 'hu', 'c', 'alclinical', 'characteristic', '138', 'hospitalize', 'patient', '2019', 'novel', 'coronavirus-infected', 'pneumonia', 'wuhan', '', 'chinajama', '', '2020', '', '', 'publish', 'online', 'feb', '7', '', '', 'doi101001jama20201585google', '', '7chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513google', 'although', 'case', 'series', 'publish', '', 'patient', 'series', 'remain', 'hospitalise', 'time', 'publication', '', 'knowledge', '', 'previous', 'study', 'among', 'patient', 'definite', 'outcome', '', 'estimation', 'risk', 'factor', 'severe', 'disease', 'death', 'earlier', 'case', 'series', 'therefore', 'robust', '', 'additionally', '', 'detail', 'clinical', 'virological', 'course', 'illness', 'yet', 'well', 'describe', '', '', 'present', 'detail', 'patient', 'admit', 'two', 'designate', 'hospital', 'wuhanjinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospitalwith', 'laboratory-confirmed', 'covid-19', 'definite', 'clinical', 'outcome', '', 'death', 'discharge', '', 'jan', '31', '', '2020', '', 'aim', 'explore', 'risk', 'factor', 'in-hospital', 'death', 'patient', 'describe', 'clinical', 'course', 'symptom', '', 'viral', 'shed', '', 'temporal', 'change', 'laboratory', 'find', 'hospitalisation', '', 'research', 'contextevidence', 'studywe', 'search', 'feb', '23', '', '2020', '', 'article', 'document', 'risk', 'factor', 'mortality', 'viral', 'shed', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'result', 'infection', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'search', 'term', '', '', 'novel', 'coronavirus', '', '', 'sars-cov-2', '', '', 'covid-19', '', '', '', '', 'death', '', '', 'mortality', '', '', 'viral', 'shed', '', '', 'language', 'time', 'restriction', '', 'age', '', 'comorbidities', '', 'lymphocytopenia', 'elevate', 'alanine', 'aminotransferase', '', 'd-dimer', '', 'creatine', 'kinase', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'prothrombin', 'time', '', 'disease', 'severity', 'report', 'associate', 'intensive', 'care', 'unit', 'admission', '', 'however', '', 'publish', 'work', 'find', 'risk', 'factor', 'mortality', 'adult', 'patient', 'covid-19', '', 'one', 'study', 'compare', 'sensitivity', 'sars-cov-2', 'rna', 'detection', 'throat', 'nasopharyngeal', 'swab', '17', 'patient', 'covid-19added', 'value', 'studyin', 'retrospective', 'cohort', 'study', 'adult', 'inpatient', 'two', 'hospital', 'wuhan', '', 'china', '', 'find', 'increase', 'odds', 'in-hospital', 'death', 'associate', 'older', 'age', '', 'odds', 'ratio', '110', '', '95', '', 'ci', '103117', '', 'p00043', '', '', 'higher', 'sequential', 'organ', 'failure', 'assessment', '', 'sofa', '', 'score', '', '565', '', '2611223', '', 'p', '', '00001', '', '', 'd-dimer', 'level', 'greater', '10', 'gml', '', '1842', '', '26412855', '', 'p00033', '', 'admission', '', 'duration', 'viral', 'shed', 'range', '8', '37', 'day', '', 'median', 'duration', 'viral', 'shed', '200', 'day', '', 'iqr', '170240', '', 'survivor', '', 'continue', 'death', 'fatal', 'casesimplications', 'available', 'evidenceolder', 'age', '', 'elevate', 'd-dimer', 'level', '', 'high', 'sofa', 'score', 'help', 'clinician', 'identify', 'early', 'stage', 'patient', 'covid-19', 'poor', 'prognosis', '', 'prolonged', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', '', 'evidence', 'study', 'search', 'feb', '23', '', '2020', '', 'article', 'document', 'risk', 'factor', 'mortality', 'viral', 'shed', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'result', 'infection', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'search', 'term', '', '', 'novel', 'coronavirus', '', '', 'sars-cov-2', '', '', 'covid-19', '', '', '', '', 'death', '', '', 'mortality', '', '', 'viral', 'shed', '', '', 'language', 'time', 'restriction', '', 'age', '', 'comorbidities', '', 'lymphocytopenia', 'elevate', 'alanine', 'aminotransferase', '', 'd-dimer', '', 'creatine', 'kinase', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'prothrombin', 'time', '', 'disease', 'severity', 'report', 'associate', 'intensive', 'care', 'unit', 'admission', '', 'however', '', 'publish', 'work', 'find', 'risk', 'factor', 'mortality', 'adult', 'patient', 'covid-19', '', 'one', 'study', 'compare', 'sensitivity', 'sars-cov-2', 'rna', 'detection', 'throat', 'nasopharyngeal', 'swab', '17', 'patient', 'covid-19', '', 'added', 'value', 'study', 'retrospective', 'cohort', 'study', 'adult', 'inpatient', 'two', 'hospital', 'wuhan', '', 'china', '', 'find', 'increase', 'odds', 'in-hospital', 'death', 'associate', 'older', 'age', '', 'odds', 'ratio', '110', '', '95', '', 'ci', '103117', '', 'p00043', '', '', 'higher', 'sequential', 'organ', 'failure', 'assessment', '', 'sofa', '', 'score', '', '565', '', '2611223', '', 'p', '', '00001', '', '', 'd-dimer', 'level', 'greater', '10', 'gml', '', '1842', '', '26412855', '', 'p00033', '', 'admission', '', 'duration', 'viral', 'shed', 'range', '8', '37', 'day', '', 'median', 'duration', 'viral', 'shed', '200', 'day', '', 'iqr', '170240', '', 'survivor', '', 'continue', 'death', 'fatal', 'case', '', 'implications', 'available', 'evidence', 'older', 'age', '', 'elevate', 'd-dimer', 'level', '', 'high', 'sofa', 'score', 'help', 'clinician', 'identify', 'early', 'stage', 'patient', 'covid-19', 'poor', 'prognosis', '', 'prolonged', 'viral', 'shed', 'provide', 'rationale', 'strategy', 'isolation', 'infect', 'patient', 'optimal', 'antiviral', 'intervention', 'future', '', 'retrospective', 'cohort', 'study', 'include', 'two', 'cohort', 'adult', 'inpatient', '', '18', 'year', 'old', '', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', '', 'wuhan', '', 'china', '', '', 'adult', 'patient', 'diagnose', 'covid-19', 'accord', 'interim', 'guidance', 'screen', '', 'die', 'discharge', 'dec', '29', '', '2019', '', 'ie', '', 'first', 'patient', 'admit', '', '', 'jan', '31', '', '2020', '', 'include', 'study', '', 'since', 'two', 'hospital', 'designate', 'hospital', 'transfer', 'patient', 'covid-19', 'hospital', 'wuhan', 'feb', '1', '', '2020', '', 'study', 'enrol', 'adult', 'inpatient', 'hospitalise', 'covid-19', 'definite', 'outcome', '', 'dead', 'discharge', '', 'early', 'stage', 'outbreak', '', 'jan', '11', '', '2020', '', 'sars-cov-2', 'rna', 'detection', 'result', 'available', 'electronic', 'medical', 'record', '', 'data', 'study', 'obtain', 'retrospectively', '', 'therefore', '', 'study', 'include', '29', '41', 'patient', 'originally', 'report', 'on5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'study', 'approve', 'research', 'ethics', 'commission', 'jinyintan', 'hospital', '', 'ky-20200101', '', 'requirement', 'inform', 'consent', 'waive', 'ethics', 'commission', 'describe', 'previously5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'epidemiological', '', 'demographic', '', 'clinical', '', 'laboratory', '', 'treatment', '', 'outcome', 'data', 'extract', 'electronic', 'medical', 'record', 'standardise', 'data', 'collection', 'form', '', 'modify', 'version', 'whointernational', 'severe', 'acute', 'respiratory', 'emerging', 'infection', 'consortium', 'case', 'record', 'form', 'severe', 'acute', 'respiratory', 'infection', '', 'data', 'check', 'two', 'physician', '', 'fz', 'zl', '', 'third', 'researcher', '', 'gf', '', 'adjudicate', 'difference', 'interpretation', 'two', 'primary', 'reviewer', '', 'methods', 'laboratory', 'confirmation', 'sars-cov-2', 'infection', 'describe', 'elsewhere5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'briefly', '', 'four', 'institutionsthe', 'chinese', 'center', 'disease', 'control', 'prevention', '', 'chinese', 'academy', 'medical', 'science', '', 'academy', 'military', 'medical', 'sciences', '', 'wuhan', 'institute', 'virology', '', 'chinese', 'academy', 'scienceswere', 'responsible', 'sars-cov-2', 'detection', 'respiratory', 'specimen', 'next-generation', 'sequence', 'real-time', 'rt-pcr', 'method', '', 'jan', '11', '', '2020', '', 'sars-cov-2', 'rna', 'detect', 'local', 'centers', 'disease', 'control', 'prevention', '', 'local', 'health', 'institution', '', 'jingyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', '', 'throat-swab', 'specimen', 'obtain', 'sars-cov-2', 'pcr', 're-examination', 'every', 'day', 'clinical', 'remission', 'symptom', '', 'include', 'fever', '', 'cough', '', 'dyspnoea', '', 'qualitative', 'data', 'available', '', 'criterion', 'discharge', 'absence', 'fever', 'least', '3', 'day', '', 'substantial', 'improvement', 'lung', 'chest', 'ct', '', 'clinical', 'remission', 'respiratory', 'symptom', '', 'two', 'throat-swab', 'sample', 'negative', 'sars-cov-2', 'rna', 'obtain', 'least', '24', 'h', 'apart', '', 'routine', 'blood', 'examination', 'complete', 'blood', 'count', '', 'coagulation', 'profile', '', 'serum', 'biochemical', 'test', '', 'include', 'renal', 'liver', 'function', '', 'creatine', 'kinase', '', 'lactate', 'dehydrogenase', '', 'electrolyte', '', '', 'myocardial', 'enzyme', '', 'interleukin-6', '', 'il-inhibitor', '', '', 'serum', 'ferritin', '', 'procalcitonin', '', 'chest', 'radiograph', 'ct', 'scan', 'inpatient', '', 'frequency', 'examination', 'determine', 'treat', 'physician', '', 'fever', 'define', 'axillary', 'temperature', 'least', '373c', '', 'sepsis', 'septic', 'shock', 'define', 'accord', '2016', 'third', 'international', 'consensus', 'definition', 'sepsis', 'septic', 'shock5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'secondary', 'infection', 'diagnose', 'patient', 'show', 'clinical', 'symptom', 'sign', 'pneumonia', 'bacteraemia', 'positive', 'culture', 'new', 'pathogen', 'obtain', 'lower', 'respiratory', 'tract', 'specimen', '', 'qualify', 'sputum', '', 'endotracheal', 'aspirate', '', 'bronchoalveolar', 'lavage', 'fluid', '', 'blood', 'sample', 'admission5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'ventilator-associated', 'pneumonia', 'diagnose', 'accord', 'guideline', 'treatment', 'hospital-acquired', 'ventilator-associated', 'pneumonia8kalil', 'ac', 'metersky', 'ml', 'klompas', 'almanagement', 'adult', 'hospital-acquired', 'ventilator-associated', 'pneumonia', '', '2016', 'clinical', 'practice', 'guideline', 'infectious', 'diseases', 'society', 'america', 'american', 'thoracic', 'societyclin', 'infect', 'dis', '', '2016', '', '63', '', 'e61-e111google', 'acute', 'kidney', 'injury', 'diagnose', 'accord', 'kdigo', 'clinical', 'practice', 'guidelines9khwaja', 'kdigo', 'clinical', 'practice', 'guideline', 'acute', 'kidney', 'injurynephron', 'clin', 'pract', '', '2012', '', '120', '', 'c179-c184google', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'diagnose', 'accord', 'berlin', 'definition10ranieri', 'vm', 'rubenfeld', 'gd', 'thompson', 'bt', 'alacute', 'respiratory', 'distress', 'syndrome', '', 'berlin', 'definitionjama', '', '2012', '', '307', '', '2526-2533google', 'acute', 'cardiac', 'injury', 'diagnose', 'serum', 'level', 'cardiac', 'biomarkers', '', 'eg', '', 'high-sensitivity', 'cardiac', 'troponin', '', '99th', 'percentile', 'upper', 'reference', 'limit', '', 'new', 'abnormality', 'show', 'electrocardiography', 'echocardiography5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', 'illness', 'severity', 'covid-19', 'define', 'accord', 'chinese', 'management', 'guideline', 'covid-19', '', 'version', '60', '', '11national', 'health', 'commission', 'people', 'republic', 'chinachinese', 'management', 'guideline', 'covid-19', '', 'version', '60', '', '', 'urlplaceholder', 'feb', '19', '', '2020google', 'coagulopathy', 'define', '3-second', 'extension', 'prothrombin', 'time', '5-second', 'extension', 'activate', 'partial', 'thromboplastin', 'time', '', 'hypoproteinaemia', 'define', 'blood', 'albumin', 'le', '25', 'gl', '', 'exposure', 'history', 'define', 'exposure', 'people', 'confirm', 'sars-cov-2', 'infection', 'wuhan', 'seafood', 'market', '', 'continuous', 'categorical', 'variable', 'present', 'median', '', 'iqr', '', 'n', '', '', '', '', 'respectively', '', 'mann-whitney', 'u', 'test', '', '2', 'test', '', 'fisher', 'exact', 'test', 'compare', 'difference', 'survivor', 'non-survivors', 'appropriate', '', 'explore', 'risk', 'factor', 'associate', 'in-hospital', 'death', '', 'univariable', 'multivariable', 'logistic', 'regression', 'model', '', 'considering', 'total', 'number', 'death', '', 'n54', '', 'study', 'avoid', 'overfitting', 'model', '', 'five', 'variable', 'choose', 'multivariable', 'analysis', 'basis', 'previous', 'find', 'clinical', 'constraint', '', 'previous', 'study', 'show', 'blood', 'level', 'd-dimer', 'sequential', 'organ', 'failure', 'assessment', '', 'sofa', '', 'score', 'higher', 'critically', 'ill', 'fatal', 'case', '', 'whereas', 'lymphopenia', 'cardiovascular', 'disease', 'le', 'commonly', 'observe', 'non-critical', 'survive', 'patient', 'sars-cov-2', 'infection5huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '395', '', '497-506google', '', '6wang', 'hu', 'b', 'hu', 'c', 'alclinical', 'characteristic', '138', 'hospitalize', 'patient', '2019', 'novel', 'coronavirus-infected', 'pneumonia', 'wuhan', '', 'chinajama', '', '2020', '', '', 'publish', 'online', 'feb', '7', '', '', 'doi101001jama20201585google', '', '12yang', 'x', 'yu', 'xu', 'j', 'alclinical', 'course', 'outcome', 'critically', 'ill', 'patient', 'sars-cov-2', 'pneumonia', 'wuhan', '', 'china', '', 'single-centered', '', 'retrospective', '', 'observational', 'studylancet', 'respir', 'med', '', '2020', '', '', 'publish', 'online', 'feb', '24', '', 'urlplaceholder', 'similar', 'risk', 'factor', '', 'include', 'older', 'age', '', 'report', 'associate', 'adverse', 'clinical', 'outcome', 'adult', 'sars', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '3chan', 'jwm', 'ng', 'ck', 'chan', 'yh', 'alshort', 'term', 'outcome', 'risk', 'factor', 'adverse', 'clinical', 'outcome', 'adult', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'thorax', '', '2003', '', '58', '', '686-689google', '', '13arabi', 'ym', 'balkhy', 'hh', 'hayden', 'fg', 'almiddle', 'east', 'respiratory', 'syndromen', 'engl', 'j', 'med', '', '2017', '', '376', '', '584-594google', 'laboratory', 'find', '', 'include', 'alanine', 'aminotransferase', '', 'alt', '', '', 'lactate', 'dehydrogenase', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'creatine', 'kinase', '', 'd-dimer', '', 'serum', 'ferritin', '', 'il-inhibitor', '', 'unavailable', 'emergency', 'circumstance', '', 'therefore', '', 'choose', 'lymphocyte', 'count', '', 'd-dimer', '', 'sofa', 'score', '', 'coronary', 'heart', 'disease', '', 'age', 'five', 'variable', 'multivariable', 'logistic', 'regression', 'model', '', 'exclude', 'variable', 'univariable', 'analysis', 'between-group', 'difference', 'significant', '', 'accuracy', 'unconfirmed', '', 'eg', '', 'exposure', '', 'self-reported', '', '', 'number', 'event', 'small', 'calculate', 'odds', 'ratio', '', 'colinearity', 'sofa', 'score', '', 'compare', 'patient', 'characteristic', 'two', 'hospital', 'generalise', 'linear', 'model', 'adjust', 'possible', 'difference', 'patient', '', 'characteristic', 'treatment', 'two', 'study', 'centre', '', 'two-sided', '', 'le', '005', 'consider', 'statistically', 'significant', '', 'statistical', 'analysis', 'sas', 'software', '', 'version', '94', '', '', 'unless', 'otherwise', 'indicate', '', 'funder', 'study', 'role', 'study', 'design', '', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'correspond', 'author', '', 'bc', 'hc', '', 'full', 'access', 'data', 'study', 'final', 'responsibility', 'decision', 'submit', 'publication', '', '813', 'adult', 'patient', 'hospitalise', 'jinyintan', 'hospital', 'wuhan', 'pulmonary', 'hospital', 'covid-19', 'jan', '31', '', '2020', '', 'exclude', '613', 'patient', 'still', 'hospitalise', 'confirm', 'sars-cov-2', 'rna', 'detection', 'jan', '31', '', '2020', '', 'nine', 'inpatient', 'without', 'available', 'key', 'information', 'medical', 'record', '', 'include', '191', 'inpatient', '', '135', 'jinyintan', 'hospital', '56', 'wuhan', 'pulmonary', 'hospital', '', 'final', 'analysis', '', '54', 'patient', 'die', 'hospitalisation', '137', 'discharge', '', 'median', 'age', '191', 'patient', '560', 'year', '', 'iqr', '460670', '', '', 'range', '18', 'year', '87', 'year', '', 'patient', 'male', '', 'table', '1', '', '', 'comorbidities', 'present', 'nearly', 'half', 'patient', '', 'hypertension', 'common', 'comorbidity', '', 'follow', 'diabetes', 'coronary', 'heart', 'disease', '', 'table', '1', '', '', 'common', 'symptom', 'admission', 'fever', 'cough', '', 'follow', 'sputum', 'production', 'fatigue', '', 'table', '1', '', '', 'lymphocytopenia', 'occur', '77', '', '40', '', '', 'patient', '', '181', '', '95', '', '', 'patient', 'receive', 'antibiotic', '41', '', '21', '', '', 'receive', 'antiviral', '', 'lopinavirritonavir', '', 'table', '2', '', '', 'systematic', 'corticosteroid', 'intravenous', 'immunoglobulin', 'differ', 'significantly', 'non-survivors', 'survivor', '', 'table', '2', '', '', 'comparison', 'characteristic', '', 'treatment', '', 'outcome', 'patient', 'two', 'hospital', 'show', 'appendix', '', 'pp', '24', '', 'table', '1demographic', '', 'clinical', '', 'laboratory', '', 'radiographic', 'find', 'patient', 'admissiontotal', '', 'n191', '', 'non-survivor', '', 'n54', '', 'survivor', '', 'n137', '', 'p', 'valuedemographics', 'clinical', 'characteristicsage', '', 'years560', '', '460670', '', '690', '', '630760', '', '520', '', '450580', '', '', '00001sex', '', '015female72', '', '38', '', '', '16', '', '30', '', '', '56', '', '41', '', '', '', 'male119', '', '62', '', '', '38', '', '70', '', '', '81', '', '59', '', '', '', 'exposure', 'history73', '', '38', '', '', '14', '', '26', '', '', '59', '', '43', '', '', '0028current', 'smoker11', '', '6', '', '', '5', '', '9', '', '', '6', '', '4', '', '', '021comorbidity91', '', '48', '', '', '36', '', '67', '', '', '55', '', '40', '', '', '00010hypertension58', '', '30', '', '', '26', '', '48', '', '', '32', '', '23', '', '', '00008diabetes36', '', '19', '', '', '17', '', '31', '', '', '19', '', '14', '', '', '00051coronary', 'heart', 'disease15', '', '8', '', '', '13', '', '24', '', '', '2', '', '1', '', '', '', '00001chronic', 'obstructive', 'lung', 'disease6', '', '3', '', '', '4', '', '7', '', '', '2', '', '1', '', '', '0047carcinoma2', '', '1', '', '', '02', '', '1', '', '', '037chronic', 'kidney', 'disease2', '', '1', '', '', '2', '', '4', '', '', '00024other22', '', '12', '', '', '11', '', '20', '', '', '11', '', '8', '', '', '0016respiratory', 'rate', '', '24', 'breath', 'per', 'min56', '', '29', '', '', '34', '', '63', '', '', '22', '', '16', '', '', '', '00001pulse', '125', 'beat', 'per', 'min2', '', '1', '', '', '2', '', '4', '', '', '00024systolic', 'blood', 'pressure', '', '90', 'mm', 'hg1', '', '1', '', '', '01', '', '1', '', '', '053fever', '', 'temperature', '373c', '', '180', '', '94', '', '', '51', '', '94', '', '', '129', '', '94', '', '', '094cough151', '', '79', '', '', '39', '', '72', '', '', '112', '', '82', '', '', '015sputum44', '', '23', '', '', '14', '', '26', '', '', '30', '', '22', '', '', '055myalgia29', '', '15', '', '', '8', '', '15', '', '', '21', '', '15', '', '', '093fatigue44', '', '23', '', '', '15', '', '28', '', '', '29', '', '21', '', '', '033diarrhoea9', '', '5', '', '', '2', '', '4', '', '', '7', '', '5', '', '', '067nausea', 'vomiting7', '', '4', '', '', '3', '', '6', '', '', '4', '', '3', '', '', '040sofa', 'score20', '', '1040', '', '45', '', '4060', '', '10', '', '1020', '', '', '00001qsofa', 'score10', '', '0010', '', '10', '', '1010', '', '00', '', '0010', '', '', '00001curb-65', 'score00', '', '0020', '', '20', '', '1030', '', '00', '', '0010', '', '', '0000101141188', '', '75', '', '', '16', '', '30', '', '', '125134', '', '93', '', '', '', '00001', '', '', '2', 'test', 'compare', 'subcategories232188', '', '17', '', '', '23', '', '43', '', '', '9134', '', '7', '', '', '', '3515188', '', '8', '', '', '15', '', '28', '', '', '0134', '', 'disease', 'severity', 'status', '', '', '00001general72', '', '38', '', '', '072', '', '53', '', '', '', 'severe66', '', '35', '', '', '12', '', '22', '', '', '54', '', '39', '', '', '', 'critical53', '', '28', '', '', '42', '', '78', '', '', '11', '', '8', '', '', '', 'time', 'illness', 'onset', 'hospital', 'admission', '', 'days110', '', '80140', '', '110', '', '80150', '', '110', '', '80130', '', '053laboratory', 'findingswhite', 'blood', 'cell', 'count', '', '', '109', 'per', 'l62', '', '4595', '', '98', '', '69139', '', '52', '', '4377', '', '', '00001', '', '432', '', '17', '', '', '5', '', '9', '', '', '27', '', '20', '', '', '', '00001', '', '', '2', 'test', 'compare', 'subcategories410119', '', '62', '', '', '24', '', '44', '', '', '95', '', '69', '', '', '', '', '1040', '', '21', '', '', '25', '', '46', '', '', '15', '', '11', '', '', '', 'lymphocyte', 'count', '', '', '109', 'per', 'l10', '', '0613', '', '06', '', '0508', '', '11', '', '0815', '', '', '00001', '', '0877', '', '40', '', '', '41', '', '76', '', '', '36', '', '26', '', '', '', '00001haemoglobin', '', 'gl1280', '', '11901400', '', '1260', '', '11501380', '', '1280', '', '12001400', '', '030anaemia29', '', '15', '', '', '14', '', '26', '', '', '15', '', '11', '', '', '00094platelet', 'count', '', '', '109', 'per', 'l2060', '', '15502620', '', '1655', '', '10702290', '', '2200', '', '16802710', '', '', '00001', '', '10013', '', '7', '', '', '11', '', '20', '', '', '2', '', '1', '', '', '', '00001albumin', '', 'gl323', '', '291358', '', '291', '', '265313', '', '336', '', '306364', '', '', '00001alt', '', 'ul300', '', '170460', '', '400', '', '240510', '', '270', '', '150400', '', '00050', '', '4059189', '', '31', '', '', '26', '', '48', '', '', '33135', '', '24', '', '', '00015creatinine', '', '133', 'moll8186', '', '4', '', '', '5', '', '9', '', '', '3132', '', '2', '', '', '0045lactate', 'dehydrogenase', '', 'ul3000', '', '23404070', '', '5210', '', '36306690', '', '2535', '', '21903180', '', '', '00001', '', '245123184', '', '67', '', '', '53', '', '98', '', '', '70130', '', '54', '', '', '', '00001creatine', 'kinase', '', 'ul215', '', '130724', '', '390', '', '1951510', '', '180', '', '125521', '', '00010', '', '18522168', '', '13', '', '', '1152', '', '21', '', '', '11116', '', '9', '', '', '0038high-sensitivity', 'cardiac', 'troponin', '', 'pgml41', '', '20141', '', '222', '', '56831', '', '30', '', '1155', '', '', '00001', '', '2824145', '', '17', '', '', '2350', '', '46', '', '', '195', '', '1', '', '', '', '00001prothrombin', 'time', '', 's116', '', '106130', '', '121', '', '112137', '', '114', '', '104126', '', '00004', '', '16171182', '', '94', '', '', '47', '', '87', '', '', '124128', '', '97', '', '', '0016', '', '', '2', 'test', 'compare', 'subcategories1611182', '', '6', '', '', '7', '', '13', '', '', '4128', '', '3', '', '', '', 'd-dimer', '', 'gml08', '', '0432', '', '52', '', '15211', '', '06', '', '0310', '', '', '000010555172', '', '32', '', '', '4', '', '7', '', '', '51118', '', '43', '', '', '', '00001', '', '', '2', 'test', 'compare', 'subcategories', '', '05', '145172', '', '26', '', '', '6', '', '11', '', '', '39118', '', '33', '', '', '', '', '172172', '', '42', '', '', '44', '', '81', '', '', '28118', '', '24', '', '', '', 'serum', 'ferritin', '', 'gl7220', '', '377214353', '', '14353', '', '728920000', '', '5032', '', '26409215', '', '', '00001', '', '300102128', '', '80', '', '', '4446', '', '96', '', '', '5882', '', '71', '', '', '00008il-6', '', 'pgml74', '', '53108', '', '110', '', '75144', '', '63', '', '5079', '', '', '00001procalcitonin', '', 'ngml01', '', '0101', '', '01', '', '0105', '', '01', '', '0101', '', '', '00001', '', '01114164', '', '70', '', '', '1951', '', '37', '', '', '95113', '', '84', '', '', '', '00001', '', '', '2', 'test', 'compare', 'subcategories01', '', '02530164', '', '18', '', '', '1651', '', '31', '', '', '14113', '', '12', '', '', '', '025', '', '056164', '', '4', '', '', '351', '', '6', '', '', '3113', '', '3', '', '', '', '0514164', '', '9', '', '', '1351', '', '25', '', '', '1113', '', '1', '', '', '', 'imaging', 'featuresconsolidation112', '', '59', '', '', '40', '', '74', '', '', '72', '', '53', '', '', '00065ground-glass', 'opacity136', '', '71', '', '', '44', '', '81', '', '', '92', '', '67', '', '', '0049bilateral', 'pulmonary', 'infiltration143', '', '75', '', '', '45', '', '83', '', '', '98', '', '72', '', '', '0090data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'p', 'value', 'calculate', 'mann-whitney', 'u', 'test', '', '2', 'test', '', 'fisher', 'exact', 'test', '', 'appropriate', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'qsofaquick', 'sofa', '', 'altalanine', 'aminotransferase', '', 'il-6interleukin-6', '', '', '2', 'test', 'compare', 'subcategories', '', 'open', 'table', 'new', 'tab', 'table', '2treatments', 'outcomestotal', '', 'n191', '', 'non-survivor', '', 'n54', '', 'survivor', '', 'n137', '', 'p', 'valuetreatments', '', '', 'ordered', 'escalate', 'scale', 'respiratory', 'supportantibiotics181', '', '95', '', '', '53', '', '98', '', '', '128', '', '93', '', '', '015antiviral', 'treatment41', '', '21', '', '', '12', '', '22', '', '', '29', '', '21', '', '', '087corticosteroids57', '', '30', '', '', '26', '', '48', '', '', '31', '', '23', '', '', '00005intravenous', 'immunoglobin46', '', '24', '', '', '36', '', '67', '', '', '10', '', '7', '', '', '', '00001high-flow', 'nasal', 'cannula', 'oxygen', 'therapy41', '', '21', '', '', '33', '', '61', '', '', '8', '', '6', '', '', '', '00001non-invasive', 'mechanical', 'ventilation26', '', '14', '', '', '24', '', '44', '', '', '2', '', '1', '', '', '', '00001invasive', 'mechanical', 'ventilation32', '', '17', '', '', '31', '', '57', '', '', '1', '', '1', '', '', '', '00001ecmo3', '', '2', '', '', '3', '', '6', '', '', '000054renal', 'replacement', 'therapy10', '', '5', '', '', '10', '', '19', '', '', '0', '', '00001outcomessepsis112', '', '59', '', '', '54', '', '100', '', '', '58', '', '42', '', '', '', '00001respiratory', 'failure103', '', '54', '', '', '53', '', '98', '', '', '50', '', '36', '', '', '', '00001ards59', '', '31', '', '', '50', '', '93', '', '', '9', '', '7', '', '', '', '00001heart', 'failure44', '', '23', '', '', '28', '', '52', '', '', '16', '', '12', '', '', '', '00001septic', 'shock38', '', '20', '', '', '38', '', '70', '', '', '0', '', '00001coagulopathy37', '', '19', '', '', '27', '', '50', '', '', '10', '', '7', '', '', '', '00001acute', 'cardiac', 'injury33', '', '17', '', '', '32', '', '59', '', '', '1', '', '1', '', '', '', '00001acute', 'kidney', 'injury28', '', '15', '', '', '27', '', '50', '', '', '1', '', '1', '', '', '', '00001secondary', 'infection28', '', '15', '', '', '27', '', '50', '', '', '1', '', '1', '', '', '', '00001hypoproteinaemia22', '', '12', '', '', '20', '', '37', '', '', '2', '', '1', '', '', '', '00001acidosis17', '', '9', '', '', '16', '', '30', '', '', '1', '', '1', '', '', '', '00001icu', 'admission50', '', '26', '', '', '39', '', '72', '', '', '11', '', '8', '', '', '', '00001icu', 'length', 'stay', '', 'days80', '', '40120', '', '80', '', '40120', '', '70', '', '2090', '', '041hospital', 'length', 'stay', '', 'days110', '', '70140', '', '75', '', '50110', '', '120', '', '90150', '', '', '00001time', 'illness', 'onset', 'fever', '', 'days10', '', '1010', '', '10', '', '1010', '', '10', '', '1010', '', '016time', 'illness', 'onset', 'cough', '', 'days10', '', '1030', '', '10', '', '1010', '', '10', '', '1040', '', '030time', 'illness', 'onset', 'dyspnoea', '', 'days70', '', '4090', '', '70', '', '40100', '', '70', '', '4090', '', '051time', 'illness', 'onset', 'sepsis', '', 'days90', '', '70130', '', '100', '', '70140', '', '90', '', '70120', '', '022time', 'illness', 'onset', 'ards', '', 'days120', '', '80150', '', '120', '', '80150', '', '100', '', '80130', '', '065time', 'illness', 'onset', 'icu', 'admission', '', 'days120', '', '80150', '', '120', '', '80150', '', '115', '', '80140', '', '088time', 'illness', 'onset', 'corticosteroid', 'treatment', '', 'days120', '', '100160', '', '130', '', '100170', '', '120', '', '100150', '', '055time', 'illness', 'onset', 'death', 'discharge', '', 'days210', '', '170250', '', '185', '', '150220', '', '220', '', '180250', '', '00003duration', 'viral', 'shed', 'covid-19', 'onset', '', 'days200', '', '160230', '', '185', '', '150220', '', '', 'detectable', 'death200', '', '170240', '', '0024data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'p', 'value', 'calculate', 'mann-whitney', 'u', 'test', '', '2', 'test', '', 'fisher', 'exact', 'test', '', 'appropriate', '', 'ecmoextracorporeal', 'membrane', 'oxygenation', '', 'ardsacute', 'respiratory', 'distress', 'syndrome', '', 'icuintensive', 'care', 'unit', '', 'covid-19coronavirus', 'disease', '2019', '', '', 'ordered', 'escalate', 'scale', 'respiratory', 'support', 'detectable', 'death', '', 'open', 'table', 'new', 'tab', 'data', 'median', '', 'iqr', '', '', 'n', '', '', '', '', 'nn', '', '', '', '', 'p', 'value', 'calculate', 'mann-whitney', 'u', 'test', '', '2', 'test', '', 'fisher', 'exact', 'test', '', 'appropriate', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'qsofaquick', 'sofa', '', 'altalanine', 'aminotransferase', '', 'il-6interleukin-6', '', 'data', 'median', '', 'iqr', '', 'n', '', '', '', '', 'p', 'value', 'calculate', 'mann-whitney', 'u', 'test', '', '2', 'test', '', 'fisher', 'exact', 'test', '', 'appropriate', '', 'ecmoextracorporeal', 'membrane', 'oxygenation', '', 'ardsacute', 'respiratory', 'distress', 'syndrome', '', 'icuintensive', 'care', 'unit', '', 'covid-19coronavirus', 'disease', '2019', '', 'median', 'time', 'illness', 'onset', '', 'ie', '', 'admission', '', 'discharge', '220', 'day', '', 'iqr', '180250', '', '', 'whereas', 'median', 'time', 'death', '185', 'day', '', '150220', '', 'table', '2', '', '', '32', 'patient', 'require', 'invasive', 'mechanical', 'ventilation', '', '31', '', '97', '', '', 'die', '', 'median', 'time', 'illness', 'onset', 'invasive', 'mechanical', 'ventilation', '145', 'day', '', '120190', '', '', 'extracorporeal', 'membrane', 'oxygenation', 'three', 'patient', '', 'none', 'survive', '', 'sepsis', 'frequently', 'observe', 'complication', '', 'follow', 'respiratory', 'failure', '', 'ards', '', 'heart', 'failure', '', 'septic', 'shock', '', 'table', '2', '', '', 'half', 'non-survivors', 'experience', 'secondary', 'infection', '', 'ventilator-associated', 'pneumonia', 'occur', 'ten', '', '31', '', '', '32', 'patient', 'require', 'invasive', 'mechanical', 'ventilation', '', 'frequency', 'complication', 'higher', 'non-survivors', 'survivor', '', 'table', '2', '', '', 'univariable', 'analysis', '', 'odds', 'in-hospital', 'death', 'higher', 'patient', 'diabetes', 'coronary', 'heart', 'disease', '', 'table', '3', '', '', 'age', '', 'lymphopenia', '', 'leucocytosis', '', 'elevate', 'alt', '', 'lactate', 'dehydrogenase', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'creatine', 'kinase', '', 'd-dimer', '', 'serum', 'ferritin', '', 'il-inhibitor', '', 'prothrombin', 'time', '', 'creatinine', '', 'procalcitonin', 'associate', 'death', '', 'table', '3', '', 'table', '3risk', 'factor', 'associate', 'in-hospital', 'deathunivariable', '', '95', '', 'ci', '', 'p', 'valuemultivariable', '', '95', '', 'ci', '', 'p', 'valuedemographics', 'clinical', 'characteristicsage', '', 'year', '', '', 'per', '1', 'unit', 'increase114', '', '109118', '', '', '00001110', '', '103117', '', '00043female', 'sex', '', 'v', 'male', '', '061', '', '031120', '', '015', '', 'current', 'smoker', '', 'v', 'non-smoker', '', '223', '', '065763', '', '020', '', 'comorbidity', 'present', '', 'v', 'present', '', 'chronic', 'obstructive', 'lung', 'disease540', '', '0963040', '', '0056', '', 'coronary', 'heart', 'disease2140', '', '4649876', '', '', '00001214', '', '0261779', '', '048diabetes285', '', '135605', '', '00062', '', 'hypertension305', '', '157592', '', '00010', '', 'respiratory', 'rate', '', 'breath', 'per', 'min241', '', 'ref', '', '', '', '24889', '', '4341819', '', '', '00001', '', 'sofa', 'score614', '', '3481085', '', '', '00001565', '', '2611223', '', '', '00001qsofa', 'score1200', '', '5062843', '', '', '00001', '', 'laboratory', 'findingswhite', 'blood', 'cell', 'count', '', '', '109', 'per', 'l', '', '4073', '', '026210', '', '056', '', '4101', '', 'ref', '', '', '', '10660', '', '3021441', '', '', '00001', '', 'lymphocyte', 'count', '', '', '109', 'per', 'l', '', '', 'per', '1', 'unit', 'increase002', '', '001008', '', '', '00001019', '', '002162', '', '013alt', '', 'ul401', '', 'ref', '', '', '', '40287', '', '148557', '', '00018', '', 'creatinine', '', 'moll1331', '', 'ref', '', '', '', '133439', '', '1011906', '', '0048', '', 'lactate', 'dehydrogenase', '', 'ul2451', '', 'ref', '', '', '', '2454543', '', '61033844', '', '00002', '', 'creatine', 'kinase', '', 'ul1851', '', 'ref', '', '', '', '185256', '', '103636', '', '0043', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'pgml281', '', 'ref', '', '', '', '288007', '', '103462036', '', '', '00001', '', 'd-dimer', '', 'gml051', '', 'ref', '', '', '1', '', 'ref', '', '', '', '05196', '', '052743', '', '032214', '', '0212139', '', '052', '', '12004', '', '6526156', '', '', '000011842', '', '26412855', '', '00033prothrombin', 'time', '', '', '161', '', 'ref', '', '', '16462', '', '1291650', '', '0019', '', 'serum', 'ferritin', '', 'gl3001', '', 'ref', '', '', '', '300910', '', '2044058', '', '00038', '', 'il-inhibitor', '', 'pgml', '', '', 'per', '1', 'unit', 'increase112', '', '103123', '', '00080', '', 'procalcitonin', '', 'ngml', '', '', 'per', '1', 'unit', 'increase1375', '', '18110440', '', '0011', '', 'orodds', 'ratio', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'qsofaquick', 'sofa', '', 'altalanine', 'aminotransferase', '', 'il-6interleukin-6', '', '', 'per', '1', 'unit', 'increase', '', 'open', 'table', 'new', 'tab', 'orodds', 'ratio', '', 'sofasequential', 'organ', 'failure', 'assessment', '', 'qsofaquick', 'sofa', '', 'altalanine', 'aminotransferase', '', 'il-6interleukin-6', '', 'include', '171', 'patient', 'complete', 'data', 'variable', '', '53', 'non-survivors', '118', 'survivor', '', 'multivariable', 'logistic', 'regression', 'model', '', 'find', 'older', 'age', '', 'higher', 'sofa', 'score', '', 'd-dimer', 'greater', '1', 'gml', 'admission', 'associate', 'increase', 'odds', 'death', '', 'table', '3', '', '', 'adjust', 'study', 'centre', '', 'generalise', 'linear', 'model', 'show', 'similar', 'result', '', 'appendix', 'p', '5', '', '', 'survivor', '', 'median', 'duration', 'viral', 'shed', '200', 'day', '', 'iqr', '170240', '', 'illness', 'onset', '', 'virus', 'continuously', 'detectable', 'death', 'non-survivors', '', 'table', '2', '', 'figure', '1', '', '', 'shortest', 'observe', 'duration', 'viral', 'shed', 'among', 'survivor', '8', 'day', '', 'whereas', 'longest', '37', 'day', '', 'among', '29', 'patient', 'receive', 'lopinavirritonavir', 'discharge', '', 'median', 'time', 'illness', 'onset', 'initiation', 'antiviral', 'treatment', '140', 'day', '', 'iqr', '100170', '', 'median', 'duration', 'viral', 'shed', '220', 'day', '', '180240', '', '', 'median', 'duration', 'viral', 'shed', '190', 'day', '', '170220', '', 'patient', 'severe', 'disease', 'status', '240', 'day', '', '220300', '', 'patient', 'critical', 'disease', 'statusfigure', '1clinical', 'course', 'major', 'symptom', 'outcome', 'duration', 'viral', 'shed', 'illness', 'onset', 'patient', 'hospitalise', 'covid-19show', 'full', 'captionfigure', 'show', 'median', 'duration', 'symptom', 'onset', 'complication', 'outcome', '', 'icuintensive', 'care', 'unit', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'ardsacute', 'respiratory', 'distress', 'syndrome', '', 'covid-19coronavirus', 'disease', '2019view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'figure', 'show', 'median', 'duration', 'symptom', 'onset', 'complication', 'outcome', '', 'icuintensive', 'care', 'unit', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'ardsacute', 'respiratory', 'distress', 'syndrome', '', 'covid-19coronavirus', 'disease', '2019', '', 'major', 'laboratory', 'marker', 'track', 'illness', 'onset', '', 'figure', '2', '', '', 'baseline', 'lymphocyte', 'count', 'significantly', 'higher', 'survivor', 'non-survivors', '', 'survivor', '', 'lymphocyte', 'count', 'lowest', 'day', '7', 'illness', 'onset', 'improve', 'hospitalisation', '', 'whereas', 'severe', 'lymphopenia', 'observe', 'death', 'non-survivors', '', 'levels', 'd-dimer', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'serum', 'ferritin', '', 'lactate', 'dehydrogenase', '', 'il-inhibitor', 'clearly', 'elevate', 'non-survivors', 'compare', 'survivor', 'throughout', 'clinical', 'course', '', 'increase', 'illness', 'deterioration', '', 'figure', '2', '', '', 'non-survivors', '', 'high-sensitivity', 'cardiac', 'troponin', 'increase', 'rapidly', 'day', '16', 'disease', 'onset', '', 'whereas', 'lactate', 'dehydrogenase', 'increase', 'survivor', 'non-survivors', 'early', 'stage', 'illness', '', 'decrease', 'day', '13', 'survivorsfigure', '2temporal', 'change', 'laboratory', 'marker', 'illness', 'onset', 'patient', 'hospitalise', 'covid-19show', 'full', 'captionfigure', 'show', 'temporal', 'change', 'd-dimer', '', '', '', 'lymphocyte', '', 'b', '', '', 'il-inhibitor', '', 'c', '', '', 'serum', 'ferritin', '', '', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'e', '', '', 'lactate', 'dehydrogenase', '', 'f', '', '', 'differences', 'survivor', 'non-survivors', 'significant', 'timepoints', 'show', '', 'except', 'day', '4', 'illness', 'onset', 'd-dimer', '', 'il-inhibitor', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'serum', 'ferritin', '', '', '', 'median', 'value', 'day', '16', 'exceed', 'upper', 'limit', 'detection', '', 'indicate', 'dash', '', 'covid-19coronavirus', 'disease', '2019', '', 'il-6interleukin-6view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'figure', 'show', 'temporal', 'change', 'd-dimer', '', '', '', 'lymphocyte', '', 'b', '', '', 'il-inhibitor', '', 'c', '', '', 'serum', 'ferritin', '', '', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'e', '', '', 'lactate', 'dehydrogenase', '', 'f', '', '', 'differences', 'survivor', 'non-survivors', 'significant', 'timepoints', 'show', '', 'except', 'day', '4', 'illness', 'onset', 'd-dimer', '', 'il-inhibitor', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'serum', 'ferritin', '', '', '', 'median', 'value', 'day', '16', 'exceed', 'upper', 'limit', 'detection', '', 'indicate', 'dash', '', 'covid-19coronavirus', 'disease', '2019', '', 'il-6interleukin-6', '', 'median', 'time', 'illness', 'onset', 'dyspnoea', 'similar', 'survivor', 'non-survivors', '', 'median', 'duration', 'dyspnoea', '130', 'day', '', '90165', '', 'survivor', '', 'table', '2', '', 'figure', '1', '', '', 'survivor', '', 'median', 'duration', 'fever', '120', 'day', '', '80130', '', 'cough', 'persist', '190', 'day', '', 'iqr', '120230', '', 'figure', '1', '', '', '62', '', '45', '', '', 'survivor', 'still', 'cough', 'discharge', '39', '', '72', '', '', 'non-survivors', 'still', 'cough', 'time', 'death', '', 'dynamic', 'profile', 'fever', '', 'cough', '', 'dyspnoea', 'show', 'appendix', '', 'p', '6', '', '', 'sepsis', 'develop', 'median', '90', 'day', '', '70130', '', 'illness', 'onset', 'among', 'patient', '', 'follow', 'ards', '', '120', 'day', '', '80150', '', '', '', 'acute', 'cardiac', 'injury', '', '150', 'day', '', '100170', '', '', '', 'acute', 'kidney', 'injury', '', '150', 'day', '', '130195', '', '', '', 'secondary', 'infection', '', '170', 'day', '', '130190', '', '', '', 'initiation', 'time', 'duration', 'systematic', 'corticosteroid', 'similar', 'two', 'group', '', 'among', 'non-survivors', '', 'median', 'time', 'illness', 'onset', '100', 'day', '', '70140', '', 'sepsis', '', '120', 'day', '', '80150', '', 'ards', '', '145', 'day', '', '95170', '', 'acute', 'cardiac', 'injury', '', '170', 'day', '', '130190', '', 'secondary', 'infection', '', 'figure', '1', '', 'table', '2', '', '', 'among', 'survivor', '', 'secondary', 'infection', '', 'acute', 'kidney', 'injury', '', 'acute', 'cardiac', 'injury', 'observe', 'one', 'patient', '', 'occur', '9', 'day', '', 'acute', 'kidney', 'injury', '', '', '14', 'day', '', 'secondary', 'infection', '', '', '21', 'day', '', 'acute', 'cardiac', 'injury', '', 'illness', 'onset', '', 'median', 'time', 'dyspnoea', 'intubation', '100', 'day', '', 'iqr', '50125', '', 'patient', 'receive', 'invasive', 'mechanical', 'ventilation', 'time', 'invasive', 'mechanical', 'ventilation', 'occurrence', 'ventilator-associated', 'pneumonia', '80', 'day', '', '2090', '', 'figure', '1', '', '', 'retrospective', 'cohort', 'study', 'identify', 'several', 'risk', 'factor', 'death', 'adult', 'wuhan', 'hospitalise', 'covid-19', '', 'particular', '', 'older', 'age', '', 'd-dimer', 'level', 'greater', '1', 'gml', '', 'higher', 'sofa', 'score', 'admission', 'associate', 'higher', 'odds', 'in-hospital', 'death', '', 'additionally', '', 'elevate', 'level', 'blood', 'il-inhibitor', '', 'high-sensitivity', 'cardiac', 'troponin', '', 'lactate', 'dehydrogenase', 'lymphopenia', 'commonly', 'severe', 'covid-19', 'illness', '', 'sustained', 'viral', 'detection', 'throat', 'sample', 'observe', 'survivor', 'non-survivors', '', 'previously', '', 'older', 'age', 'report', 'important', 'independent', 'predictor', 'mortality', 'sars', 'mers14choi', 'kw', 'chau', 'tn', 'tsang', 'aloutcomes', 'prognostic', 'factor', '267', 'patient', 'severe', 'acute', 'respiratory', 'syndrome', 'hong', 'kongann', 'intern', 'med', '', '2003', '', '139', '', '715-723google', '', '15hong', 'k-h', 'choi', 'j-p', 'hong', 's-h', 'alpredictors', 'mortality', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'thorax', '', '2018', '', '73', '', '286-289google', 'current', 'study', 'confirm', 'increase', 'age', 'associate', 'death', 'patient', 'covid-19', '', 'previous', 'study', 'macaque', 'inoculate', 'sars-cov', 'find', 'older', 'macaque', 'stronger', 'host', 'innate', 'response', 'virus', 'infection', 'younger', 'adult', '', 'increase', 'differential', 'expression', 'gene', 'associate', 'inflammation', '', 'whereas', 'expression', 'type', 'interferon', 'beta', 'reduced16smits', 'sl', 'de', 'lang', 'van', 'den', 'brand', 'jma', 'alexacerbated', 'innate', 'host', 'response', 'sars-cov', 'age', 'non-human', 'primatesplos', 'pathog', '', '2010', '', '6', '', 'e1000756-egoogle', 'age-dependent', 'defect', 't-cell', 'b-cell', 'function', 'excess', 'production', 'type', '2', 'cytokine', 'lead', 'deficiency', 'control', 'viral', 'replication', 'prolong', 'proinflammatory', 'response', '', 'potentially', 'lead', 'poor', 'outcome17opal', 'sm', 'girard', 'td', 'ely', 'ew', 'immunopathogenesis', 'sepsis', 'elderly', 'patientsclin', 'infect', 'dis', '', '2005', '', '41', '', 's504-s512google', 'sofa', 'score', 'diagnostic', 'marker', 'sepsis', 'septic', 'shock', '', 'reflect', 'state', 'degree', 'multi-organ', 'dysfunction18singer', 'deutschman', 'cs', 'seymour', 'cw', 'althe', 'third', 'international', 'consensus', 'definitions', 'sepsis', 'septic', 'shock', '', 'sepsis-3', '', 'jama', '', '2016', '', '315', '', '801-810google', '', '19ferreira', 'fl', 'bota', 'dp', 'bross', 'mlot', 'c', 'vincent', 'jl', 'serial', 'evaluation', 'sofa', 'score', 'predict', 'outcome', 'critically', 'ill', 'patientsjama', '', '2001', '', '286', '', '1754-1758google', 'although', 'bacterial', 'infection', 'usually', 'regard', 'lead', 'cause', 'sepsis', '', 'viral', 'infection', 'cause', 'sepsis', 'syndrome', '', 'previously', '', 'determine', 'sepsis', 'occur', 'nearly', '40', '', 'adult', 'community-acquired', 'pneumonia', 'due', 'viral', 'infection20zhou', 'f', 'wang', 'liu', 'aldisease', 'severity', 'clinical', 'outcome', 'community-acquired', 'pneumonia', 'cause', 'non-influenza', 'respiratory', 'virus', 'adult', '', 'multicentre', 'prospective', 'registry', 'study', 'cap-china', 'networkeur', 'respir', 'j', '', '2019', '', '54', '', '1802406google', 'current', 'study', '', 'find', 'half', 'patient', 'develop', 'sepsis', '', 'additionally', '', 'find', '70', '', 'patient', 'white', 'blood', 'cell', 'count', '100', '', '109', 'per', 'l', 'procalcitonin', '025', 'ngml', '', 'bacterial', 'pathogen', 'detect', 'patient', 'admission', '', 'sepsis', 'common', 'complication', '', 'directly', 'cause', 'sars-cov-2', 'infection', '', 'research', 'investigate', 'pathogenesis', 'sepsis', 'covid-19', 'illness', '', 'cardiac', 'complication', '', 'include', 'new', 'worsen', 'heart', 'failure', '', 'new', 'worsen', 'arrhythmia', '', 'myocardial', 'infarction', 'common', 'patient', 'pneumonia', '', 'cardiac', 'arrest', 'occur', '3', '', 'inpatient', 'pneumonia21marrie', 'tj', 'shariatzadeh', 'mr', 'community-acquired', 'pneumonia', 'require', 'admission', 'intensive', 'care', 'unit', '', 'descriptive', 'studymedicine', '', 'baltimore', '', '', '2007', '', '86', '', '103-111google', 'risk', 'factor', 'cardiac', 'event', 'pneumonia', 'include', 'older', 'age', '', 'pre-existing', 'cardiovascular', 'disease', '', 'greater', 'severity', 'pneumonia', 'presentation22corrales-medina', 'vf', 'musher', 'dm', 'shachkina', 'chirinos', 'ja', 'acute', 'pneumonia', 'cardiovascular', 'systemlancet', '', '2013', '', '381', '', '496-505google', 'coronary', 'heart', 'disease', 'find', 'associate', 'acute', 'cardiac', 'event', 'poor', 'outcome', 'influenza', 'respiratory', 'viral', 'infections22corrales-medina', 'vf', 'musher', 'dm', 'shachkina', 'chirinos', 'ja', 'acute', 'pneumonia', 'cardiovascular', 'systemlancet', '', '2013', '', '381', '', '496-505google', '', '23udell', 'ja', 'zawi', 'r', 'bhatt', 'dl', 'alassociation', 'influenza', 'vaccination', 'cardiovascular', 'outcome', 'high-risk', 'patient', '', 'meta-analysisjama', '', '2013', '', '310', '', '1711-1720google', '', '24blackburn', 'r', 'zhao', 'h', 'pebody', 'r', 'hayward', 'warren-gash', 'c', 'laboratory-confirmed', 'respiratory', 'infection', 'predictor', 'hospital', 'admission', 'myocardial', 'infarction', 'stroke', '', 'time-series', 'analysis', 'english', 'data', '20042015clin', 'infect', 'dis', '', '2018', '', '67', '', '8-17google', 'study', '', 'increase', 'high-sensitivity', 'cardiac', 'troponin', 'hospitalisation', 'find', 'half', 'die', '', 'first', 'autopsy', '53-year-old', 'woman', 'chronic', 'renal', 'failure', 'jinyintan', 'hospital', 'show', 'acute', 'myocardial', 'infarction', '', 'data', 'publish', '', 'personal', 'communication', 'pathologist', 'chinese', 'academy', 'science', '', '', '90', '', 'inpatient', 'pneumonia', 'increase', 'coagulation', 'activity', '', 'mark', 'increase', 'd-dimer', 'concentrations25milbrandt', 'eb', 'reade', 'mc', 'lee', 'alprevalence', 'significance', 'coagulation', 'abnormality', 'community-acquired', 'pneumoniamol', 'med', '', '2009', '', '15', '', '438-445google', 'study', '', 'find', 'd-dimer', 'greater', '1', 'gml', 'associate', 'fatal', 'outcome', 'covid-19', '', 'high', 'level', 'd-dimer', 'report', 'association', '28-day', 'mortality', 'patient', 'infection', 'sepsis', 'identify', 'emergency', 'department26rodelo', 'jr', 'de', 'la', 'rosa', 'g', 'valencia', 'ml', 'ald-dimer', 'significant', 'prognostic', 'factor', 'patient', 'suspect', 'infection', 'sepsisam', 'j', 'emerg', 'med', '', '2012', '', '30', '', '1991-1999google', 'contributory', 'mechanism', 'include', 'systemic', 'pro-inflammatory', 'cytokine', 'response', 'mediator', 'atherosclerosis', 'directly', 'contribute', 'plaque', 'rupture', 'local', 'inflammation', '', 'induction', 'procoagulant', 'factor', '', 'haemodynamic', 'change', '', 'predispose', 'ischaemia', 'thrombosis27smeeth', 'l', 'thomas', 'sl', 'hall', 'aj', 'hubbard', 'r', 'farrington', 'p', 'vallance', 'p', 'risk', 'myocardial', 'infarction', 'stroke', 'acute', 'infection', 'vaccinationn', 'engl', 'j', 'med', '', '2004', '', '351', '', '2611-2618google', '', '28corrales-medina', 'vf', 'musher', 'dm', 'wells', 'ga', 'chirinos', 'ja', 'chen', 'l', 'fine', 'mj', 'cardiac', 'complication', 'patient', 'community-acquired', 'pneumonia', '', 'incidence', '', 'time', '', 'risk', 'factor', '', 'association', 'short-term', 'mortalitycirculation', '', '2012', '', '125', '', '773-781google', '', '29davidson', 'ja', 'warren-gash', 'c', 'cardiovascular', 'complication', 'acute', 'respiratory', 'infection', '', 'current', 'research', 'future', 'directionsexpert', 'rev', 'anti', 'infect', 'ther', '', '2019', '', '17', '', '939-942google', 'addition', '', 'angiotensin', 'convert', 'enzyme', '2', '', 'receptor', 'sars-cov-2', '', 'express', 'myocytes', 'vascular', 'endothelial', 'cells30gallagher', 'pe', 'ferrario', 'cm', 'tallant', 'ea', 'regulation', 'ace2', 'cardiac', 'myocytes', 'fibroblastsam', 'j', 'physiol', 'heart', 'circ', 'physiol', '', '2008', '', '295', '', 'h2373-h2479google', '', '31mendoza-torres', 'e', 'oyarzn', 'mondaca-ruff', 'alace2', 'vasoactive', 'peptide', '', 'novel', 'player', 'cardiovascularrenal', 'remodel', 'hypertensionther', 'adv', 'cardiovasc', 'dis', '', '2015', '', '9', '', '217-237google', 'least', 'theoretical', 'potential', 'possibility', 'direct', 'cardiac', 'involvement', 'virus', '', 'note', '', 'interstitial', 'mononuclear', 'inflammatory', 'infiltrate', 'heart', 'tissue', 'document', 'fatal', 'case', 'covid-19', '', 'although', 'viral', 'detection', 'study', 'reported32xu', 'z', 'shi', 'l', 'wang', 'alpathological', 'find', 'covid-19', 'associate', 'acute', 'respiratory', 'distress', 'syndromelancet', 'respir', 'med', '', '2020', '', '', 'publish', 'online', 'feb', '18', '', 'urlplaceholder', 'level', 'duration', 'infectious', 'virus', 'replication', 'important', 'factor', 'assess', 'risk', 'transmission', 'guide', 'decision', 'regard', 'isolation', 'patient', '', 'coronavirus', 'rna', 'detection', 'sensitive', 'virus', 'isolation', '', 'study', 'qualitative', 'quantitative', 'viral', 'rna', 'test', 'potential', 'marker', 'infectious', 'coronavirus', '', 'sars-cov', '', 'viral', 'rna', 'detect', 'respiratory', 'specimen', 'third', 'patient', 'long', '4', 'week', 'disease', 'onset33xu', 'zhang', 'z', 'jin', 'l', 'alpersistent', 'shed', 'viable', 'sars-cov', 'urine', 'stool', 'sars', 'patient', 'convalescent', 'phaseeur', 'j', 'clin', 'microbiol', 'infect', 'dis', '', '2005', '', '24', '', '165-171google', 'similarly', '', 'duration', 'mers-cov', 'rna', 'detection', 'lower', 'respiratory', 'specimans', 'persist', 'least', '3', 'weeks34corman', 'vm', 'albarrak', 'omrani', 'alviral', 'shed', 'antibody', 'response', '37', 'patient', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'infectionclin', 'infect', 'dis', '', '2016', '', '62', '', '477-483google', '', '35oh', 'md', 'park', 'wb', 'choe', 'pg', 'alviral', 'load', 'kinetics', 'mers', 'coronavirus', 'infectionn', 'engl', 'j', 'med', '', '2016', '', '375', '', '1303-1405google', 'whereas', 'duration', 'sars-cov-2', 'rna', 'detection', 'well', 'characterise', '', 'current', 'study', '', 'find', 'detectable', 'sars-cov-2', 'rna', 'persist', 'median', '20', 'day', 'survivor', 'sustain', 'death', 'non-survivors', '', 'important', 'implication', 'patient', 'isolation', 'decision', 'guidance', 'around', 'length', 'antiviral', 'treatment', '', 'severe', 'influenza', 'virus', 'infection', '', 'prolong', 'viral', 'shed', 'associate', 'fatal', 'outcome', 'delay', 'antiviral', 'treatment', 'independent', 'risk', 'factor', 'prolong', 'virus', 'detection36wang', 'guo', 'q', 'yan', 'z', 'alfactors', 'associate', 'prolong', 'viral', 'shed', 'patient', 'avian', 'influenza', '', 'h7n9', '', 'virus', 'infectionj', 'infect', 'dis', '', '2018', '', '217', '', '1708-1717google', 'similarly', '', 'effective', 'antiviral', 'treatment', 'improve', 'outcome', 'covid-19', '', 'although', 'observe', 'shorten', 'viral', 'shed', 'duration', 'lopinavirritonavir', 'treatment', 'current', 'study', '', 'randomised', 'clinical', 'trial', 'lopinavirritonavir', '', 'chictr2000029308', '', 'intravenous', 'remdesivir', '', 'nct04257656', '', 'nct04252664', '', 'treatment', 'covid-19', 'currently', 'progress', '', 'study', 'limitation', '', 'first', '', 'due', 'retrospective', 'study', 'design', '', 'laboratory', 'test', 'patient', '', 'include', 'lactate', 'dehydrogenase', '', 'il-inhibitor', '', 'serum', 'ferritin', '', 'therefore', '', 'role', 'underestimate', 'predict', 'in-hospital', 'death', '', 'second', '', 'patient', 'sometimes', 'transfer', 'late', 'illness', 'two', 'include', 'hospital', '', 'effective', 'antiviral', '', 'inadequate', 'adherence', 'standard', 'supportive', 'therapy', '', 'high-dose', 'corticosteroid', 'contribute', 'poor', 'clinical', 'outcome', 'patient', '', 'third', '', 'estimate', 'duration', 'viral', 'shed', 'limit', 'frequency', 'respiratory', 'specimen', 'collection', '', 'quantitative', 'viral', 'rna', 'detection', '', 'relatively', 'low', 'positive', 'rate', 'sars-cov-2', 'rna', 'detection', 'throat-swabs37zou', 'l', 'ruan', 'f', 'huang', 'alsars-cov-2', 'viral', 'load', 'upper', 'respiratory', 'specimen', 'infect', 'patientsn', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'feb', '19', '', '', 'doi101056nejmc2001737google', 'fourth', '', 'exclude', 'patient', 'still', 'hospital', 'jan', '31', '', '2020', '', 'thus', 'relatively', 'severe', 'disease', 'earlier', 'stage', '', 'case', 'fatality', 'ratio', 'study', 'reflect', 'true', 'mortality', 'covid-19', '', 'last', 'least', '', 'interpretation', 'find', 'limit', 'sample', 'size', '', 'however', '', 'include', 'adult', 'patient', 'two', 'designate', 'hospital', 'covid-19', '', 'believe', 'study', 'population', 'representative', 'case', 'diagnose', 'treat', 'wuhan', '', 'best', 'knowledge', '', 'largest', 'retrospective', 'cohort', 'study', 'among', 'patient', 'covid-19', 'experience', 'definite', 'outcome', '', 'find', 'older', 'age', '', 'higher', 'sofa', 'score', '', 'elevate', 'd-dimer', 'admission', 'risk', 'factor', 'death', 'adult', 'patient', 'covid-19', '', 'prolong', 'viral', 'shed', 'provide', 'rationale', 'test', 'novel', 'coronavirus', 'antiviral', 'intervention', 'effort', 'improve', 'outcome', '', 'online', 'publication', 'correct', '', 'correct', 'version', 'first', 'appear', 'thelancetcom', 'march', '12', '', '2020', 'online', 'publication', 'correct', '', 'correct', 'version', 'first', 'appear', 'thelancetcom', 'march', '12', '', '2020', 'contributors', 'bc', 'hc', 'idea', 'design', 'study', 'full', 'access', 'data', 'study', 'responsibility', 'integrity', 'data', 'accuracy', 'data', 'analysis', '', 'bc', '', 'fz', '', 'gf', '', 'zl', '', 'jxi', '', 'yl', 'draft', 'paper', '', 'bc', '', 'fz', '', 'rd', '', 'gf', '', 'zl', '', 'xg', '', 'hl', '', 'ywa', 'analysis', '', 'author', 'critically', 'revise', 'manuscript', 'important', 'intellectual', 'content', 'give', 'final', 'approval', 'version', 'publish', '', 'fz', '', 'rd', '', 'gf', '', 'zl', '', 'yl', '', 'bs', '', 'lg', '', 'ywe', '', 'xw', '', 'jxu', '', 'st', '', 'yz', 'collect', 'data', '', 'author', 'agree', 'accountable', 'aspect', 'work', 'ensure', 'question', 'relate', 'accuracy', 'integrity', 'part', 'work', 'appropriately', 'investigate', 'resolve', '', 'declaration', 'interest', 'declare', 'compete', 'interest', '', 'acknowledgments', 'study', 'receive', 'follow', 'fund', '', 'chinese', 'academy', 'medical', 'sciences', 'innovation', 'fund', 'medical', 'sciences', '', 'cifms', '2018-i2m-1003', '', '', 'national', 'science', 'grant', 'distinguished', 'young', 'scholars', '', '81425001h0104', '', '', 'national', 'key', 'research', 'development', 'program', 'china', '', '2018yfc1200100', '', '2018yfc1200102', '', '', 'beijing', 'science', 'technology', 'project', '', 'z19110700660000', '', '', 'major', 'projects', 'national', 'science', 'technology', 'new', 'drug', 'creation', 'development', '', '2020zx09201001', '', '', 'acknowledge', 'health-care', 'worker', 'involve', 'diagnosis', 'treatment', 'patient', 'wuhan', '', 'chen', 'wang', '', 'peking', 'union', 'medical', 'college', '', 'beijing', '', 'china', '', '', 'peter', 'w', 'horby', '', 'university', 'oxford', '', 'oxford', '', 'uk', '', '', 'frederick', 'g', 'hayden', '', 'university', 'virginia', 'school', 'medicine', '', 'charlottesville', '', 'va', '', 'usa', '', 'guidance', 'study', 'design', 'interpretation', 'result', '', 'review', 'manuscript', '', 'download', 'pdf', '', '53', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'department', 'errorfull-textpdfdepartment', 'errorfull-textpdfcovid-19', 'cytokine', 'storm', '', 'interplay', 'inflammation', 'coagulationfull-textpdfendothelial', 'cell', 'infection', 'endotheliitis', 'covid-19full-textpdf']",7807,"{'': 2393, 'patient': 98, 'study': 45, '1': 45, 'day': 44, 'viral': 43, 'respiratory': 41, '2': 40, 'covid-19': 38, 'wuhan': 37, 'hospital': 34, 'illness': 33, '2020': 33, 'coronavirus': 32, 'shed': 32, 'death': 32, 'acute': 31, 'disease': 30, 'clinical': 29, 'survivor': 29}","{'infection': 25, 'sars-cov-2': 27, 'il-inhibitor': 11}",63,-0.7717
DOI:10.1016/S1473-3099(20)30287-5,10.1016/S1473-3099(20)30287-5,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['epidemiology', 'transmission', 'covid-19', '391', 'case', '1286', 'close', 'contact', 'shenzhen', '', 'china', '', 'retrospective', 'cohort', 'study']","['BackgroundRapid spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) Wuhan , China , prompt heighten surveillance Shenzhen , China .', 'The result data provide rare opportunity measure key metric disease course , transmission , impact control measures.MethodsFrom Jan 14 Feb 12 , 2020 , Shenzhen Center Disease Control Prevention identify 391 SARS-CoV-2 case 1286 close contact .', 'We compare case identify symptomatic surveillance contact trace , estimate time symptom onset confirmation , isolation , admission hospital .', 'We estimate metric disease transmission analyse factor influence transmission risk.FindingsCases older general population ( mean age 45 year ) balance male ( n=187 ) female ( n=204 ) .', '356 ( 91 % ) 391 case mild moderate clinical severity initial assessment .', 'As Feb 22 , 2020 , three case die 225 recover ( median time recovery 21 day ; 95 % CI 20–22 ) .', 'Cases isolate average 4·6 day ( 95 % CI 4·1–5·0 ) develop symptom ; contact trace reduce 1·9 day ( 95 % CI 1·1–2·7 ) .', 'Household contact travel case higher risk infection ( odds ratio 6·27 [ 95 % CI 1·49–26·33 ] household contact 7·06 [ 1·43–34·91 ] travel case ) close contact .', 'The household secondary attack rate 11·2 % ( 95 % CI 9·1–13·8 ) , child likely infect adult ( infection rate 7·4 % child < 10 year v population average 6·6 % ) .', 'The observe reproductive number ( R ) 0·4 ( 95 % CI 0·3–0·5 ) , mean serial interval 6·3 day ( 95 % CI 5·2–7·6 ) .InterpretationOur data case well infect uninfected close contact provide key insight epidemiology SARS-CoV-2 .', 'This analysis show isolation contact trace reduce time case infectious community , thereby reduce R. The overall impact isolation contact trace , however , uncertain highly dependent number asymptomatic case .', 'Moreover , child similar risk infection general population , although le likely severe symptom ; hence consider analysis transmission control.FundingEmergency Response Program Harbin Institute Technology , Emergency Response Program Peng Cheng Laboratory , US Centers Disease Control Prevention .', 'Rapid spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) Wuhan , China , prompt heighten surveillance Shenzhen , China .', 'The result data provide rare opportunity measure key metric disease course , transmission , impact control measure .', 'From Jan 14 Feb 12 , 2020 , Shenzhen Center Disease Control Prevention identify 391 SARS-CoV-2 case 1286 close contact .', 'We compare case identify symptomatic surveillance contact trace , estimate time symptom onset confirmation , isolation , admission hospital .', 'We estimate metric disease transmission analyse factor influence transmission risk .', 'Cases older general population ( mean age 45 year ) balance male ( n=187 ) female ( n=204 ) .', '356 ( 91 % ) 391 case mild moderate clinical severity initial assessment .', 'As Feb 22 , 2020 , three case die 225 recover ( median time recovery 21 day ; 95 % CI 20–22 ) .', 'Cases isolate average 4·6 day ( 95 % CI 4·1–5·0 ) develop symptom ; contact trace reduce 1·9 day ( 95 % CI 1·1–2·7 ) .', 'Household contact travel case higher risk infection ( odds ratio 6·27 [ 95 % CI 1·49–26·33 ] household contact 7·06 [ 1·43–34·91 ] travel case ) close contact .', 'The household secondary attack rate 11·2 % ( 95 % CI 9·1–13·8 ) , child likely infect adult ( infection rate 7·4 % child < 10 year v population average 6·6 % ) .', 'The observe reproductive number ( R ) 0·4 ( 95 % CI 0·3–0·5 ) , mean serial interval 6·3 day ( 95 % CI 5·2–7·6 ) .', 'Our data case well infect uninfected close contact provide key insight epidemiology SARS-CoV-2 .', 'This analysis show isolation contact trace reduce time case infectious community , thereby reduce R. The overall impact isolation contact trace , however , uncertain highly dependent number asymptomatic case .', 'Moreover , child similar risk infection general population , although le likely severe symptom ; hence consider analysis transmission control .', 'Emergency Response Program Harbin Institute Technology , Emergency Response Program Peng Cheng Laboratory , US Centers Disease Control Prevention .', 'Since emerge Wuhan , China , December , 2019,1Li Q Guan X Wu P et al.Early transmission dynamic Wuhan , China , novel coronavirus-infected pneumonia.N Engl J Med .', '2020 ; 382 : 1199-1207CrossrefPubMedScopus ( 526 ) Google Scholar coronavirus disease 2019 ( COVID-19 ) epidemic cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) progress rapidly pandemic .', 'COVID-19 characterise fever , cough , fatigue , shortness breath , pneumonia , respiratory tract symptoms,2Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513SummaryFull TextFull Text PDFPubMedScopus ( 559 ) Google Scholar , 3Wang D Hu B Hu C et al.Clinical characteristic 138 hospitalize patient 2019 novel coronavirus-infected pneumonia Wuhan , China.JAMA .', '2020 ; 323 : 1061-1069CrossrefScopus ( 590 ) Google Scholar , 4Yang Y Lu Q-B Ming-Jin L et al.Epidemiological clinical feature 2019 novel coronavirus outbreak China.MedRxiv .', '2020 ; ( publish online Feb 21 . )', '( preprint ) .DOI : 10.1101/2020.02.10.20021675Google Scholar many case progress death .', 'As April 15 , 2020 , 1 914 916 confirm case 123 010 death report worldwide.5WHOCoronavirus disease ( COVID-19 ) situation report .', 'urlplaceholder 2020Date access : February 21 , 2020Google Scholar Most case initially confine Hubei province China , since substantial spread elsewhere China worldwide .', 'A rapid robust response global scientific community describe many important aspect SARS-CoV-2 transmission natural history,1Li Q Guan X Wu P et al.Early transmission dynamic Wuhan , China , novel coronavirus-infected pneumonia.N Engl J Med .', '2020 ; 382 : 1199-1207CrossrefPubMedScopus ( 526 ) Google Scholar , 2Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513SummaryFull TextFull Text PDFPubMedScopus ( 559 ) Google Scholar , 6Lauer SA Grantz KH Bi Q et al.The incubation period coronavirus disease 2019 ( COVID-19 ) publicly report confirm case : estimation application.Ann Int Med .', '2020 ; ( publish online March 10 ) DOI : 10.7326/M20-0504CrossrefPubMedScopus ( 56 ) Google Scholar , 7Backer JA Klinkenberg D Wallinga J Incubation period 2019 novel coronavirus ( 2019-nCoV ) infection among traveller Wuhan , China , 20–28 January 2020.Euro Surveill .', '2020 ; 252000062CrossrefScopus ( 49 ) Google Scholar , 8Chan JF-W Yuan S Kok K-H et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; 395 : 514-523SummaryFull TextFull Text PDFPubMedScopus ( 398 ) Google Scholar key question remain .', 'If well track , early introduction emerge pathogen provide unique opportunity characterise transmission , natural history , effectiveness screen .', 'Careful monitor case low probability infection general community enable inference , important model course outbreak , difficult make widely disseminate epidemic .', 'In particular , make assumption case likely infect impossible pathogen widespread .', 'Furthermore , early phase , uninfected asymptomatic contact often closely track , provide important information transmission natural history .', 'Combined , data early introduction use give insight natural history disease,9Lessler J Reich NG Cummings DAT Nair HP Jordan HT Thompson N Outbreak 2009 pandemic influenza A ( H1N1 ) New York City school.N Engl J Med .', '2009 ; 361 : 2628-2636CrossrefPubMedScopus ( 227 ) Google Scholar transmission characteristics,10Lipsitch M Cohen T Cooper B et al.Transmission dynamic control severe acute respiratory syndrome.Science .', '2003 ; 300 : 1966-1970CrossrefPubMedScopus ( 652 ) Google Scholar unseen burden infection.11Lessler J Salje H Van Kerkhove MD et al.Estimating severity subclinical burden Middle East respiratory syndrome coronavirus infection Kingdom Saudi Arabia.Am J Epidemiol .', '2016 ; 183 : 657-663CrossrefPubMedScopus ( 19 ) Google Scholar Research contextEvidence studyThe emergence severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) accompany substantial increase research publication range transmissibility SARS-CoV-2 clinical characteristic infection .', 'As March 23 , 2020 , search PubMed use keywords ( “ COVID-19 ” OR “ SARS-nCoV-2 ” OR “ novel coronavirus ” ) AND ( “ serial interval ” OR “ incubation period ” OR “ attack rate ” ) yield 14 article estimate either serial interval incubation period coronavirus disease 2019 ( COVID-19 ) one investigate secondary attack rate .', 'However , estimate come either Wuhan publicly available case data ; instance , incomplete capture infection case might produce bias estimates.Added value studyThis study , knowledge , first analysis SARS-CoV-2 transmission COVID-19 natural history base large primary dataset case close contact , mode surveillance ( ie , symptom-based versus contact-based ) sufficiently document RT-PCR test nearly universal .', 'We present one first estimate serial interval , secondary household attack rate , dispersion ( ie , tendency towards super spread ) SARS-CoV-2 base active surveillance data .', 'We find attack rate differ significantly age , average 7 % close contact become infect , around 80 % contact show symptom , 3 % infection manifest severe disease initial assessment .', 'We also find contact-based surveillance Shenzhen reduce duration infect individual transmit community 2 day .', 'These find important understand burden COVID-19 strategic plan across world.Implications available evidenceThese result shed light SARS-CoV-2 transmit , severe , effective control measure specific context .', 'We provide key piece evidence support intensive contact trace highlight child might important target intervention aim reduce transmission , even get sick .', 'Evidence study The emergence severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) accompany substantial increase research publication range transmissibility SARS-CoV-2 clinical characteristic infection .', 'As March 23 , 2020 , search PubMed use keywords ( “ COVID-19 ” OR “ SARS-nCoV-2 ” OR “ novel coronavirus ” ) AND ( “ serial interval ” OR “ incubation period ” OR “ attack rate ” ) yield 14 article estimate either serial interval incubation period coronavirus disease 2019 ( COVID-19 ) one investigate secondary attack rate .', 'However , estimate come either Wuhan publicly available case data ; instance , incomplete capture infection case might produce bias estimate .', 'Added value study This study , knowledge , first analysis SARS-CoV-2 transmission COVID-19 natural history base large primary dataset case close contact , mode surveillance ( ie , symptom-based versus contact-based ) sufficiently document RT-PCR test nearly universal .', 'We present one first estimate serial interval , secondary household attack rate , dispersion ( ie , tendency towards super spread ) SARS-CoV-2 base active surveillance data .', 'We find attack rate differ significantly age , average 7 % close contact become infect , around 80 % contact show symptom , 3 % infection manifest severe disease initial assessment .', 'We also find contact-based surveillance Shenzhen reduce duration infect individual transmit community 2 day .', 'These find important understand burden COVID-19 strategic plan across world .', 'Implications available evidence These result shed light SARS-CoV-2 transmit , severe , effective control measure specific context .', 'We provide key piece evidence support intensive contact trace highlight child might important target intervention aim reduce transmission , even get sick .', 'Here , use data collect Shenzhen Center Disease Control Prevention ( Shenzhen CDC ) 391 case COVID-19 1286 close contact characterise key aspect epidemiology outside Hubei province .', 'We characterise difference demographic severity case identify symptom-based surveillance monitor close case contact , estimate time key event , confirmation , isolation , recovery .', 'Using data contact trace , characterise SARS-CoV-2 transmission estimate key value , household secondary attack rate , serial interval , observe reproductive number ( R ) .', 'On Jan 8 , 2020 , Shenzhen CDC identify first case pneumonia unknown cause begin monitor traveller Hubei province symptom COVID-19 .', 'Over next 2 week surveillance programme expand include traveller Hubei regardless symptom , patient local hospital , individual detect fever screen neighbourhood local clinic .', 'Suspected case close contact test SARS-CoV-2 RT-PCR nasal swab 28 qualify local hospital , ten district-level CDCs , two third-party test organisation , final confirmation do Guangdong Provincial Center Disease Control Prevention ( Guangdong CDC ) Shenzhen CDC ( appendix 2 p 11 ) .', 'Close contact identify contact trace confirm case define live apartment , share meal , travel , socially interact index case 2 day symptom onset .', 'Casual contact ( eg , clinic patient ) close contact ( eg , nurse ) wear mask exposure include group .', 'Symptomatic case isolate treat designate hospital regardless RT-PCR test result .', 'Asymptomatic individual test positive quarantine centralise facility .', 'Close contact traveller Hubei test negative quarantine home central facility , monitor 14 day .', 'RT-PCR test require close contact begin isolation , release conditional negative RT-PCR result .', 'Basic demographic , sign symptom , clinical severity , exposure history record confirm case .', 'Here , analyse confirm case identify Shenzhen CDC Jan 14 Feb 12 , 2020 , close contact case confirm Feb 9 , 2020 .', 'This work do support ongoing public health response , hence determine human subject research consultation Johns Hopkins Bloomberg School Public Health institutional review board .', 'Data collection part continue public health investigation emerge outbreak therefore individual inform consent waive .', 'The study approve ethic committee Shenzhen CDC .', 'Analytical datasets construct anonymised manner , analysis personally identifiable data take place onsite Shenzhen CDC .', 'We define symptom-based surveillance include symptomatic screen airport train station , community fever monitor , home observation recent traveller Hubei , test patient admit hospital .', 'Contact-based surveillance identification case monitor test close contact confirm case , independently symptom presentation .', 'By protocol , contact-based group test SARS-CoV-2 infection regardless symptom , whereas category test show sign symptom disease .', 'At first clinical assessment , data record 21 sign symptom ( appendix 2 p 1 ) , disease severity assess .', 'Cases fever , respiratory symptom , radiographic evidence pneumonia classify moderate symptom .', 'Cases classify severe symptom follow : breathe rate 30 breath per min higher ; oxygen saturation level 93 % lower rest ; oxygen concentration level PaO2/FiO2 ( ratio arterial oxygen partial pressure fractional inspire oxygen ) 300 mm Hg ( 1 mm Hg=0·133 kPa ) lower ; lung infiltrate higher 50 % within 24–48 h ; respiratory failure require mechanical ventilation ; septic shock ; multiple organ dysfunction failure .', 'All symptomatic case classify mild .', 'Relationships demographic , mode detection , symptom severity assess characterise χ2 test , simple multiple logistic regression .', ""Distributions fit time key event confirm case 's course infection treatment ."", 'The time infection symptom onset ( incubation period ) assume log-normally distribute estimate previously described.12Reich NG Lessler J Azman A Kamvar ZN Analysis coarsely observe data [ R package coarseDataTools version 0·6–5 ] .', 'Version 0.6–5 .', 'urlplaceholder Dec 6 , 2019Date access : February 16 , 2020Google Scholar , 13Reich NG Lessler J Cummings DAT Brookmeyer R Estimating incubation period distribution coarse data.Stat Med .', '2009 ; 28 : 2769-2784CrossrefPubMedScopus ( 34 ) Google Scholar , 14Reich NG Lessler J Cummings DAT Brookmeyer R Estimating absolute relative case fatality ratio infectious disease surveillance data.Biometrics .', '2012 ; 68 : 598-606CrossrefPubMedScopus ( 9 ) Google Scholar We determine leave right boundary possible exposure symptom onset time .', 'Cases recently travel Hubei assume expose .', 'Cases without recent travel history exposure confirm case assume expose time earliest latest possible contact case .', 'Only case could identify earliest latest possible time exposure date symptom onset include analysis .', 'Time symptom onset recovery estimate use parametric survival method .', 'Patients recover consider censor Feb 22 , 2020 , time death .', 'All delay distribution estimate directly fit parametric distribution time symptom onset arrival Shenzhen , confirmation , isolation , admission hospital .', 'Confidence interval calculate bootstrapping standard parametric estimators.15Efron B Gong G A leisurely look bootstrap , jackknife , cross-validation.Am Stat .', '1983 ; 37 : 36-48Google Scholar Transmission characterise examine relationship confirm case infect uninfected close contact .', 'The household secondary attack rate calculate percentage household contact ( share room , apartment , sleep arrangement ) later confirm SARS-CoV-2 infection .', 'The distribution serial interval ( time symptom onset confirm case infect contact ) calculate fit parametric distribution time symptom onset clear case–contact pair .', 'The mean R distribution individual reproductive number ( ie , number secondary infection cause case ) calculate number secondary infection observe among close contact index case , ambiguity resolve multiple imputation ( appendix 2 p 11 ) .', 'The relative odds transmission among contact various type estimate use conditional logistic regression random-effects model , account differ number possible infect individual risk group .', 'When assess impact characteristic infect individual , include risk set single potential infect individual clearly identifiable .', 'Confidence interval estimate use bootstrapping standard parametric approach .', 'The sponsor study role study design , data collection , data analysis , data interpretation , write report .', 'Shenzhen CDC full access data study , correspond author share final responsibility decision submit publication .', 'Between Jan 14 Feb 12 , 2020 , Shenzhen CDC confirm 391 case SARS-CoV-2 infection ( table 1 ) .', 'Of 379 know mode detection , 292 ( 77 % ) detect symptom-based surveillance .', 'Overall , approximately equal number male female case ( 187 v 204 ) .', 'The mean age population 45 year , 307 ( 79 % ) 391 case adult age 30–69 year .', 'At time first clinical assessment , case mild ( 102 [ 26 % ] 391 ) moderate ( 254 [ 65 % ] 391 ) , 35 ( 9 % ) severe .', '330 ( 84 % ) 391 case fever time initial assessment , 25 ( 6 % ) 391 sign symptom .', 'As Feb 22 , 2020 , final clinical outcome know 228 391 case data , three die ( capture symptom-based surveillance ) 225 recovered.Table 1Demographic clinical characteristic case contact-based versus symptom-based surveillanceContact-based surveillance ( n=87 ) Symptom-based surveillance ( n=292 ) Unknown ( n=12 ) Total ( n=391 ) p valueSexFemale63 ( 72 % ) 131 ( 45 % ) 10 ( 83 % ) 204 ( 52 % ) < 0·0001Male24 ( 28 % ) 161 ( 55 % ) 2 ( 17 % ) 187 ( 48 % ) .. Age0–9 years13 ( 15 % ) 6 ( 2 % ) 1 ( 8 % ) 20 ( 5 % ) < 0·000110–19 years5 ( 6 % ) 6 ( 2 % ) 1 ( 8 % ) 12 ( 3 % ) .. 20–29 years11 ( 13 % ) 23 ( 8 % ) 0 ( 0 % ) 34 ( 9 % ) .. 30–39 years15 ( 17 % ) 71 ( 24 % ) 1 ( 8 % ) 87 ( 22 % ) .. 40–49 years9 ( 10 % ) 49 ( 17 % ) 2 ( 17 % ) 60 ( 15 % ) .. 50–59 years10 ( 12 % ) 63 ( 22 % ) 1 ( 8 % ) 74 ( 19 % ) .. 60–69 years20 ( 23 % ) 60 ( 21 % ) 6 ( 50 % ) 86 ( 22 % ) .. ≥70 years4 ( 5 % ) 14 ( 5 % ) 0 ( 0 % ) 18 ( 5 % ) .. SeverityMild18 ( 21 % ) 82 ( 28 % ) 2 ( 17 % ) 102 ( 26 % ) 0·03Moderate66 ( 76 % ) 180 ( 62 % ) 8 ( 67 % ) 254 ( 65 % ) .. Severe3 ( 3 % ) 30 ( 10 % ) 2 ( 17 % ) 35 ( 9 % ) .. SymptomaticNo17 ( 20 % ) 8 ( 3 % ) 0 ( 0 % ) 25 ( 6 % ) < 0·0001Yes70 ( 80 % ) 284 ( 97 % ) 12 ( 100 % ) 366 ( 94 % ) .. FeverNo25 ( 29 % ) 34 ( 12 % ) 2 ( 17 % ) 61 ( 16 % ) 0·0002Yes62 ( 71 % ) 258 ( 88 % ) 10 ( 83 % ) 330 ( 84 % ) .. Open table new tab A larger proportion case detect symptom-based surveillance male ( 161 [ 55 % ] 292 v 24 [ 28 % ] 87 ) age 20–69 year ( 266 [ 91 % ] 292 v 65 [ 75 % ] 87 ) detect contact-based surveillance ( Table 1 , Table 2 ) .', 'At time first clinical assessment , 25 ( 29 % ) 87 case contact-based surveillance group fever , 17 ( 20 % ) 87 symptom .', 'By contrast , 258 ( 88 % ) 292 symptom-based surveillance group fever , eight report symptoms.Table 2Association clinical demographic factor mode detection severity initial assessmentOutcome : symptom-based surveillanceOutcome : moderate severe assessmentUnivariate regressionMultivariate regressionUnivariate regressionMultivariate regressionOR2·5 % 97·5 % OR2·5 % 97·5 % OR2·5 % 97·5 % OR2·5 % 97·5 % SexFemaleRef .... Ref .... Ref .... Ref .... Male3·231·935·533·061·775·441·300·822·071·370·852·22Age0–9 years0·070·020·230·080·020·250·880·302·770·670·222·2310–19 years0·190·050·770·170·040·761·080·285·270·880·224·4020–29 years0·330·120·890·370·131·020·650·281·560·610·261·4930–39 years0·750·311·770·80·321·931·170·582·371·150·572·3340–49 years0·860·322·330·790·292·191·270·582·831·210·552·7250–59 yearsRef .... Ref .... Ref .... Ref .... 60–69 years0·480·21·080·440·181·041·500·723·161·430·683·03≥70 years0·560·162·250·450·121·891·410·455·431·280·404·96SeverityMildRef .... Ref ................ Moderate0·60·331·050·510·260·94 ............ Severe2·20·689·841·510·427·23 ............ FeverNoRef .......... Ref .......... Yes3·061·695·49 ...... 0·940·491·75 ...... SymptomaticNoRef .......... Ref .......... Yes8·623·6821·89 ...... 0·510·151·390·550·291·01Surveillance methodContact-based ............ Ref .......... Symptom-based ............ 0·670·371·17 ...... OR=odds ratio .', 'Open table new tab OR=odds ratio .', 'In multiple logistic regression , male sex associate severe symptom ( odds ratio [ OR ] 2·5 [ 95 % CI 1·1–6·1 ] ) .', 'The probability severe symptom increase slightly age , although individual age 60–69 year significantly increase risk compare reference category , individual age 50–59 year ( OR 3·4 [ 95 % 1·4–9·5 ] ) .', 'Based 183 case well define period exposure symptom onset ( appendix 2 p 8 ) , estimate median incubation period COVID-19 4·8 day ( 95 % CI 4·2–5·4 ; figure 1 , appendix 2 p 2 ) , estimate 95 % develop symptom within 14·0 day ( 95 % CI 12·2–15·9 ) infection .', 'We estimate 5·0 % case develop symptom would show symptom 14 day infection.Figure 1Incubation period serial interval COVID-19Show full caption ( A ) Proportion case develop symptom coronavirus disease 2019 ( COVID-19 ) day infection ( ie , cumulative distribution function incubation period ) .', '( B ) Proportion case infect index case develop symptom give number day day symptom onset index case ( ie , cumulative distribution function serial interval ) .', 'The maximum-likelihood estimate parametric distribution cumulative distribution function show , along 1000 parametric bootstrap estimate cumulative distribution function .', 'The median incubation period COVID-19 estimate 4·8 day ( 95 % CI 4·2–5·4 ) .', '5 % case develop symptom 1·6 day ( 95 % CI 1·3–2·0 ) infection , 95 % 14·0 day ( 12·2–15·9 ) .', 'We estimate median serial interval COVID-19 5·4 day ( 95 % CI 4·4–6·5 ) .', '5 % infect case develop symptom 1·3 day ( 95 % CI 0·9–1·9 ) symptom onset index case , 95 % 14·3 day ( 11·1–17·6 ) .View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Proportion case develop symptom coronavirus disease 2019 ( COVID-19 ) day infection ( ie , cumulative distribution function incubation period ) .', '( B ) Proportion case infect index case develop symptom give number day day symptom onset index case ( ie , cumulative distribution function serial interval ) .', 'The maximum-likelihood estimate parametric distribution cumulative distribution function show , along 1000 parametric bootstrap estimate cumulative distribution function .', 'The median incubation period COVID-19 estimate 4·8 day ( 95 % CI 4·2–5·4 ) .', '5 % case develop symptom 1·6 day ( 95 % CI 1·3–2·0 ) infection , 95 % 14·0 day ( 12·2–15·9 ) .', 'We estimate median serial interval COVID-19 5·4 day ( 95 % CI 4·4–6·5 ) .', '5 % infect case develop symptom 1·3 day ( 95 % CI 0·9–1·9 ) symptom onset index case , 95 % 14·3 day ( 11·1–17·6 ) .', 'Based 228 case know outcome , estimate median time recovery 20·8 day ( 95 % CI 20·1–21·5 ) .', 'We estimate median time recovery 22·4 day ( 95 % CI 20·8–24·1 ) individual age 50–59 year , estimate significantly shorter younger adult ( eg , 19·2 day individual age 20–29 year ; appendix 2 pp 3 , 10 ) .', 'In multiple regression model include sex , age , baseline severity , method detection , addition age , baseline severity associate time recovery ( appendix 2 p 3 ) .', 'Compared case mild symptom , severe symptom 41 % ( 95 % CI 24–60 ) longer time recovery ( appendix 2 p 3 ) .', 'As Feb 22 , 2020 , three case die .', 'These death occur 35–44 day symptom onset 27–33 day confirmation .', 'Cases detect symptom-based surveillance confirm average 5·5 day ( 95 % CI 5·0–5·9 ) symptom onset ( figure 2 , appendix 2 p 2 ) , whereas detect contact-based surveillance confirm average 3·2 day ( 95 % CI 2·7–3·8 ) symptom onset .', '17 ( 5 % ) 342 case know onset date start date quarantine isolate develop symptom .', 'Among isolate develop symptom , symptom-based surveillance group , average , isolate 4·6 day ( 95 % CI 4·1–5·0 ) symptom onset , whereas contact-based surveillance group isolate 2·7 day ( 2·1–3·3 ) symptom onset .', 'Hence , contact-based surveillance associate 2·3-day ( 95 % CI 1·5–3·0 ) decrease time confirmation 1·9-day ( 1·1–2·7 ) decrease time isolation .', 'The mean time symptom onset admission hospital similar time symptom onset isolation symptom-based contact-based surveillance group ( figure 2 , appendix 2 p 2 ) .Figure 2Time symptom onset SARS-CoV-2 confirmation ( A ) , admission hospital ( B ) , isolation among case ( C ) detect contact-based symptom-based surveillanceShow full captionThe maximum-likelihood estimate parametric distribution cumulative distribution function show , along 1000 parametric bootstrap estimate cumulative distribution function .', 'Panel A show estimate proportion case confirm RT-PCR , accord number day symptom onset .', 'We estimate 50 % case detect symptom-based surveillance confirm RT-PCR within 4·6 day ( 95 % CI 4·2–5·0 ) symptom onset , 95 % confirm RT-PCR within 12·7 day ( 11·5–13·8 ) symptom onset .', 'Contact-based surveillance reduce day symptom onset RT-PCR confirmation 2·9 day ( 95 % CI 2·4–3·4 ) 50 % case 6·6 day ( 5·3–8·0 ) 95 % case .', 'Panel B show estimate proportion case admit hospital , accord number day symptom onset .', 'We estimate 50 % case detect symptom-based surveillance admit hospital 3·4 day ( 95 % CI 3·1–3·8 ) symptom onset , 95 % 12·4 day ( 10·9–13·8 ) .', 'Contact-based surveillance reduce day symptom onset hospital admission 2·1 day ( 95 % CI 1·7–2·6 ) 50 % case , 6·0 day ( 95 % CI 4·5–7·5 ) 95 % case .', 'Panel C show estimate proportion case isolate , accord number day symptom onset .', 'We estimate 50 % case detect symptom-based surveillance isolate 3·4 day ( 95 % CI 3·1–3·7 ) symptom onset , 95 % 12·2 day ( 95 % CI 10·8–13·6 ) .', 'Contact-based surveillance reduce day symptom onset isolation 2·2 day ( 95 % CI 1·7–2·6 ) 50 % case , 6·5 day ( 4·7–8·2 ) 95 % cases.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) The maximum-likelihood estimate parametric distribution cumulative distribution function show , along 1000 parametric bootstrap estimate cumulative distribution function .', 'Panel A show estimate proportion case confirm RT-PCR , accord number day symptom onset .', 'We estimate 50 % case detect symptom-based surveillance confirm RT-PCR within 4·6 day ( 95 % CI 4·2–5·0 ) symptom onset , 95 % confirm RT-PCR within 12·7 day ( 11·5–13·8 ) symptom onset .', 'Contact-based surveillance reduce day symptom onset RT-PCR confirmation 2·9 day ( 95 % CI 2·4–3·4 ) 50 % case 6·6 day ( 5·3–8·0 ) 95 % case .', 'Panel B show estimate proportion case admit hospital , accord number day symptom onset .', 'We estimate 50 % case detect symptom-based surveillance admit hospital 3·4 day ( 95 % CI 3·1–3·8 ) symptom onset , 95 % 12·4 day ( 10·9–13·8 ) .', 'Contact-based surveillance reduce day symptom onset hospital admission 2·1 day ( 95 % CI 1·7–2·6 ) 50 % case , 6·0 day ( 95 % CI 4·5–7·5 ) 95 % case .', 'Panel C show estimate proportion case isolate , accord number day symptom onset .', 'We estimate 50 % case detect symptom-based surveillance isolate 3·4 day ( 95 % CI 3·1–3·7 ) symptom onset , 95 % 12·2 day ( 95 % CI 10·8–13·6 ) .', 'Contact-based surveillance reduce day symptom onset isolation 2·2 day ( 95 % CI 1·7–2·6 ) 50 % case , 6·5 day ( 4·7–8·2 ) 95 % case .', '191 ( 64 % ) 298 traveller develop symptom arrive Shenzhen , mean time arrival symptom onset 4·9 day ( 95 % CI 4·2–5·5 ; appendix 2 p 2 ) .', 'Those develop symptom arrival day arrival confirm case average 4·5 day ( 95 % CI 3·8–5·1 ) arrival , isolate average 3·1 day ( 2·5–3·7 ) arrival .', 'Overall , 1286 close contact identify index case test positive SARS-CoV-2 Jan 14 Feb 9 , 2020 , 244 ( 84 % ) 292 case least one close contact .', '622 ( 95 % ) 653 close contact know date period quarantine follow 12 day longer .', '98 close contact test positive SARS-CoV-2 infection RT-PCR , one presumptive infection .', 'Assuming miss test result uninfected , find secondary attack rate 11·2 % ( 95 % CI 9·1–13·8 ) among household contact 6·6 % ( 5·4–8·1 ) overall ( secondary attack rate increase 14·9 % [ 12·1–18·2 ] among household contact 9·7 % [ 7·9–11·8 ] overall miss result remove denominator ) .', 'In multiple conditional logistic regression analysis contact type , household contact ( OR 6·3 ; 95 % CI 1·5–26·3 ) travel together ( OR 7·1 ; 1·4–34·9 ) significantly associate infection ( table 3 ) .', 'Reporting contact occur often also associate increase risk infection compare moderate-frequency contact ( OR 8·8 ; 95 % CI 2·6–30·1 ; table 3 ) .Table 3Group-specific attack rate risk factor SAR-CoV-2 infection among close contactsNumber case * * 15 confirm close contact exclude analysis contact trace report negative close contact cluster miss .', 'Close contact miss data sex , age , contact type , contact frequency shown.Number infectedAttack rate ( 95 % CI ) Univariate regressionMultivariate regressionOdds ratio2·5 % 97·5 % Odds ratio2·5 % 97·5 % SexFemale5585810·4 % ( 8·1–13·2 ) Ref .......... Male486265·3 % ( 3·7–7·7 ) 0·430·210·86 ...... Age0–9 years148117·4 % ( 4·2–12·8 ) 2·330·3814·05 ...... 10–19 years8567·1 % ( 3·3–14·6 ) 3·500·5323·24 ...... 20–29 years11476·1 % ( 3·0–12·1 ) 4·910·7432·64 ...... 30–39 years268166·0 % ( 3·7–9·5 ) 1·840·349·80 ...... 40–49 years14374·9 % ( 2·4–9·8 ) 3·460·5521·92 ...... 50–59 years110109·1 % ( 5·0–15·9 ) Ref .......... 60–69 years1302015·4 % ( 10·2–22·6 ) 5·681·0132·09 ...... ≥70 years7279·7 % ( 4·8–18·7 ) 4·260·6428·44 ...... Contact type : householdNo45640·9 % ( 0·3–2·2 ) Ref .... Ref .... Yes6867711·2 % ( 9·1–13·8 ) 15·103·6961·696·271·4926·33Contact type : travelNo824637·6 % ( 6·0–9·7 ) Ref .... Ref .... Yes318185·7 % ( 3·6–8·8 ) 9·131·8545·087·061·4334·91Contact type : mealNo435204·6 % ( 3·0–7·0 ) Ref .... Ref .... Yes707618·6 % ( 6·8–10·9 ) 23·012·51211·27·130·7369·32Contact frequencyRare23010·4 % ( 0·02–2·4 ) < 0·00010Inf ...... Moderate30593·0 % ( 1·6–5·5 ) Ref .......... Often5557112·8 % ( 10·3–15·8 ) 8·82·5830·06 ...... SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'Inf=infinity .', '* 15 confirm close contact exclude analysis contact trace report negative close contact cluster miss .', 'Close contact miss data sex , age , contact type , contact frequency show .', 'Open table new tab SARS-CoV-2=severe acute respiratory syndrome coronavirus 2 .', 'Inf=infinity .', 'Attack rate similar across age category infect contact ( table 3 ) , although observe indication elevate attack rate older age group ( figure 3 ) .', 'Notably , rate infection child younger 10 year ( 7·4 % ) similar population average ( 6·6 % ) .', 'There significant association probability infection age index case .', 'Surprisingly , univariate analysis longer time community isolation associate reduce risk cause infection ( data show ) .', 'However , association longer significant adjust contact frequency type.Figure 3Attack rate among close contact , baseline severity , proportion case without fever initial assessment age groupShow full caption * Proportion close contact attack rate ; proportion case severe symptom fever initial assessment.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) * Proportion close contact attack rate ; proportion case severe symptom fever initial assessment .', 'Based 48 pair case clear relationship index case secondary case time symptom onset , estimate serial interval gamma distribute mean 6·3 day ( 95 % CI 5·2–7·6 ) SD 4·2 day ( 95 % CI 3·1–5·3 ; figure 1B , appendix 2 p 2 ) .', 'Hence , 95 % secondary case expect develop symptom within 14·3 day ( 95 % CI 11·1–17·6 ) infector .', 'This estimate include effect isolation truncate serial interval .', 'Stratified result show infect individual isolate le 3 day infection average serial interval 3·6 day , increase 8·1 day infect individual isolate third day symptom onset later ( appendix 2 p 3 ) .', 'The mean number secondary case cause index case ( ie , observe reproductive number , R ) , 0·4 ( 95 % CI 0·3–0·5 ) .', 'The distribution individual R value highly over-dispersed , 80 % infection cause 8·9 % ( 95 % CI 3·5–10·8 ) case ( negative binomial dispersion parameter 0·58 ; 95 % CI 0·35–1·18 ) .', 'We examine potential impact surveillance isolation truncate infectious period .', 'Because scarce understand infectious period follow SARS-CoV-2 infection , consider range possible infectious period infectiousness vary time follow gamma distribution ( appendix 2 p 11 ) .', 'We define mean infectious day ( ie , average number day symptom onset infect individual expect infect secondary case ) weight mean infectious period , day weight relative infectiousness .', 'We consider period mean infectious day le 15 day symptom onset ( roughly period SARS early SARS-CoV-2 report ) ,16Peiris JSM Chu CM Cheng VCC et al.Clinical progression viral load community outbreak coronavirus-associated SARS pneumonia : prospective study.Lancet .', '2003 ; 361 : 1767-1772SummaryFull TextFull Text PDFPubMedScopus ( 1025 ) Google Scholar , 17Zou L Ruan F Huang M et al.SARS-CoV-2 viral load upper respiratory specimen infect patients.N Engl J Med .', '2020 ; 382 : 1177-1179CrossrefPubMedScopus ( 129 ) Google Scholar assume R0=2·6 isolation effectively end infectious period .', 'Under assumption find mean infectious day greater 5 day , might possible bring R one case detect symptom-based surveillance , accomplish contact-based surveillance mean infectious day greater 3 day ( appendix 2 p 9 ) .', 'For impact passive surveillance alone achieve observe R 0·4 , project mean infectious day must least 5·5 day ( likely greater ) symptom onset .', 'Even transmission completely eliminate group capture surveillance ( eg , could get perfect surveillance day symptom onset ) , assume R0=2·6 , case capture surveillance must , isolate , expect cause 61 % onward transmission achieve local elimination surveillance isolation alone ( appendix 2 p 9 ) .', 'This analysis early SARS-CoV-2 case close contact Shenzhen , China , provide insight natural history , transmission , control disease .', 'The value estimate provide evidentiary foundation predict impact virus , evaluate control measure , guide global response .', 'Analyses case detect , use data individual expose infect , indicate infection rate young child lower population average ( even rate clinical disease ) .', 'We able directly estimate important transmission parameter , show , least among observe contact , transmission rate low .', 'Estimates distribution time symptom onset case isolation surveillance type reveal heighten surveillance combine case isolation could plausibly account low rate transmission .', 'These result paint positive picture impact heighten surveillance isolation Shenzhen .', 'However , uncertainty number asymptomatic case miss surveillance ability transmit SARS-CoV-2 must temper hope stop COVID-19 pandemic measure .', 'This work support understand COVID-19 disease fairly short incubation period ( mean 4–6 day ) long clinical course,2Chen N Zhou M Dong X et al.Epidemiological clinical characteristic 99 case 2019 novel coronavirus pneumonia Wuhan , China : descriptive study.Lancet .', '2020 ; 395 : 507-513SummaryFull TextFull Text PDFPubMedScopus ( 559 ) Google Scholar , 7Backer JA Klinkenberg D Wallinga J Incubation period 2019 novel coronavirus ( 2019-nCoV ) infection among traveller Wuhan , China , 20–28 January 2020.Euro Surveill .', '2020 ; 252000062CrossrefScopus ( 49 ) Google Scholar , 18Pan F Ye T Sun P et al.Time course lung change chest CT recovery 2019 novel coronavirus ( COVID-19 ) pneumonia.Radiology .', '2020 ; ( publish online Feb 13 .', ') DOI:10.1148/radiol.2020200370CrossrefPubMedGoogle Scholar patient take many week die recover .', 'Notably , however , estimate higher proportion case take 14 day develop symptom ( 5 % ) estimate study Lauer colleague ( 1 % ) .6Lauer SA Grantz KH Bi Q et al.The incubation period coronavirus disease 2019 ( COVID-19 ) publicly report confirm case : estimation application.Ann Int Med .', '2020 ; ( publish online March 10 ) DOI : 10.7326/M20-0504CrossrefPubMedScopus ( 56 ) Google Scholar Focusing case detect contact-based surveillance add nuance previous characterisation COVID-19 .', 'Since RT-PCR test contact near universal , assume case reflective average SARS-CoV-2 infection case detect symptomatic surveillance .', 'In contact-based surveillance group , tendency case male older ( beyond underlie population distribution ) disappear .', 'Furthermore , group , 20 % case asymptomatic time first clinical assessment nearly 30 % fever .', 'This observation consistent reasonably high rate asymptomatic carriage , lower suggest model studies,19Imai N Cori A Dorigatti I Baguelin M Donnelly CA Riley S Ferguson NM Report 3 : transmissibility 2019-nCoV .', 'urlplaceholder Jan 25 , 2020Date access : February 24 , 2020Google Scholar although RT-PCR imperfect sensitivity.20Fang Y Zhang H Xie J et al.Sensitivity chest CT COVID-19 : comparison RT-PCR.Radiology .', '2020 ; ( publish online Feb 19 .', ') DOI:10.1148/radiol.2020200432CrossrefGoogle Scholar In Shenzhen , SARS-CoV-2 transmission probably occur close contact , individual share household .', 'However , even group fewer one six contact ( ie , secondary attack rate 11–15 % ) infect , overall observe far fewer one ( 0·4 ) onward transmission per primary case .', 'As note , low transmission level might part due impact isolation surveillance , equally likely unobserved transmission role .', 'We also estimate reasonably high rate overdispersion number case cause infect individual , leave open possibility large COVID-19 cluster occur even surveillance isolation force R one—events could potentially overwhelm surveillance system .', 'This work numerous limitation .', 'As active outbreak response , data collect multiple team protocol , necessity , change situation develop .', 'Hence , might noise inconsistency definition .', 'Notably , definition confirm case change require symptom near end analysis period ( Feb 7 ) , sensitivity analysis show truncate data point qualitatively influence result ( appendix 2 pp 5–6 ) .', 'It , likewise , impossible identify every potential contact individual , contact trace focus close contact likely infect ; hence R assuredly lower true reproductive number population .', 'Asymptomatic traveller miss symptom-based surveillance , even test , asymptomatic contact might miss imperfect sensitivity RT-PCR test.20Fang Y Zhang H Xie J et al.Sensitivity chest CT COVID-19 : comparison RT-PCR.Radiology .', '2020 ; ( publish online Feb 19 .', ') DOI:10.1148/radiol.2020200432CrossrefGoogle Scholar Recovery time Shenzhen likely inflate case require isolate 2 week release conditional negative RT-PCR test .', 'Although guideline contact trace case detection suppose implement across country , whether impact contact trace generalise part China depend range factor , include local test capacity surveillance resource .', 'As SARS-CoV-2 continue spread , important continue expand knowledge transmission natural history .', 'Data early phase local outbreak , detail contact trace possible source infection still reliably infer , particularly powerful estimate critical value pertinent describe transmission natural history disease .', 'This especially true information uninfected contact mode detection use , do .', 'The result estimate provide important input interpret surveillance data , evaluate intervention , set public health policy .', 'This online publication correct .', 'The correct version first appear thelancet.com/infection May 5 , 2020 This online publication correct .', 'The correct version first appear thelancet.com/infection May 5 , 2020 Contributors YoW , SM , XZ , ZZ , XL , LW , WG , CC , XT , XW , YuW , SH , TF collect data .', 'JL , QB , SAT , CY statistical analysis , draft manuscript figure .', 'TZ , BS , YS , JZ , TM , CY collect clean data .', 'QB , TM , JL , TF conceive study supervise data collection .', 'Declaration interest We declare compete interest .', 'Acknowledgments TM , CY , TZ , BS , YS , JZ fund Emergency Response Program Harbin Institute Technology ( HITERP010 ) Emergency Response Program Peng Cheng Laboratory ( PCLERP001 ) .', 'JL , SAT , QB fund grant US Centers Disease Control Prevention ( NU2GGH002000 ) .', 'We thank A Azman , D Cummings , S Lauer , J Wallinga , M Mina advice input manuscript analysis .', 'We thank patient , close contact , family involve study , well front-line medical staff public health worker collect important data .', 'Download .pdf ( .34 MB ) Help pdf file Chinese translation abstract Download .pdf ( .42 MB ) Help pdf file Supplementary appendix 2 Impact contact trace SARS-CoV-2 transmissionFull-TextPDFCorrection Lancet Infectious Diseases 2020 ; publish online April 27. urlplaceholder']","['backgroundrapid', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'wuhan', '', 'china', '', 'prompt', 'heighten', 'surveillance', 'shenzhen', '', 'china', '', 'result', 'data', 'provide', 'rare', 'opportunity', 'measure', 'key', 'metric', 'disease', 'course', '', 'transmission', '', 'impact', 'control', 'measuresmethodsfrom', 'jan', '14', 'feb', '12', '', '2020', '', 'shenzhen', 'center', 'disease', 'control', 'prevention', 'identify', '391', 'sars-cov-2', 'case', '1286', 'close', 'contact', '', 'compare', 'case', 'identify', 'symptomatic', 'surveillance', 'contact', 'trace', '', 'estimate', 'time', 'symptom', 'onset', 'confirmation', '', 'isolation', '', 'admission', 'hospital', '', 'estimate', 'metric', 'disease', 'transmission', 'analyse', 'factor', 'influence', 'transmission', 'riskfindingscases', 'older', 'general', 'population', '', 'mean', 'age', '45', 'year', '', 'balance', 'male', '', 'n187', '', 'female', '', 'n204', '', '', '356', '', '91', '', '', '391', 'case', 'mild', 'moderate', 'clinical', 'severity', 'initial', 'assessment', '', 'feb', '22', '', '2020', '', 'three', 'case', 'die', '225', 'recover', '', 'median', 'time', 'recovery', '21', 'day', '', '95', '', 'ci', '2022', '', '', 'cases', 'isolate', 'average', '46', 'day', '', '95', '', 'ci', '4150', '', 'develop', 'symptom', '', 'contact', 'trace', 'reduce', '19', 'day', '', '95', '', 'ci', '1127', '', '', 'household', 'contact', 'travel', 'case', 'higher', 'risk', 'infection', '', 'odds', 'ratio', '627', '', '95', '', 'ci', '1492633', '', 'household', 'contact', '706', '', '1433491', '', 'travel', 'case', '', 'close', 'contact', '', 'household', 'secondary', 'attack', 'rate', '112', '', '', '95', '', 'ci', '91138', '', '', 'child', 'likely', 'infect', 'adult', '', 'infection', 'rate', '74', '', 'child', '', '10', 'year', 'v', 'population', 'average', '66', '', '', '', 'observe', 'reproductive', 'number', '', 'r', '', '04', '', '95', '', 'ci', '0305', '', '', 'mean', 'serial', 'interval', '63', 'day', '', '95', '', 'ci', '5276', '', 'interpretationour', 'data', 'case', 'well', 'infect', 'uninfected', 'close', 'contact', 'provide', 'key', 'insight', 'epidemiology', 'sars-cov-2', '', 'analysis', 'show', 'isolation', 'contact', 'trace', 'reduce', 'time', 'case', 'infectious', 'community', '', 'thereby', 'reduce', 'r', 'overall', 'impact', 'isolation', 'contact', 'trace', '', 'however', '', 'uncertain', 'highly', 'dependent', 'number', 'asymptomatic', 'case', '', 'moreover', '', 'child', 'similar', 'risk', 'infection', 'general', 'population', '', 'although', 'le', 'likely', 'severe', 'symptom', '', 'hence', 'consider', 'analysis', 'transmission', 'controlfundingemergency', 'response', 'program', 'harbin', 'institute', 'technology', '', 'emergency', 'response', 'program', 'peng', 'cheng', 'laboratory', '', 'us', 'centers', 'disease', 'control', 'prevention', '', 'rapid', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'wuhan', '', 'china', '', 'prompt', 'heighten', 'surveillance', 'shenzhen', '', 'china', '', 'result', 'data', 'provide', 'rare', 'opportunity', 'measure', 'key', 'metric', 'disease', 'course', '', 'transmission', '', 'impact', 'control', 'measure', '', 'jan', '14', 'feb', '12', '', '2020', '', 'shenzhen', 'center', 'disease', 'control', 'prevention', 'identify', '391', 'sars-cov-2', 'case', '1286', 'close', 'contact', '', 'compare', 'case', 'identify', 'symptomatic', 'surveillance', 'contact', 'trace', '', 'estimate', 'time', 'symptom', 'onset', 'confirmation', '', 'isolation', '', 'admission', 'hospital', '', 'estimate', 'metric', 'disease', 'transmission', 'analyse', 'factor', 'influence', 'transmission', 'risk', '', 'cases', 'older', 'general', 'population', '', 'mean', 'age', '45', 'year', '', 'balance', 'male', '', 'n187', '', 'female', '', 'n204', '', '', '356', '', '91', '', '', '391', 'case', 'mild', 'moderate', 'clinical', 'severity', 'initial', 'assessment', '', 'feb', '22', '', '2020', '', 'three', 'case', 'die', '225', 'recover', '', 'median', 'time', 'recovery', '21', 'day', '', '95', '', 'ci', '2022', '', '', 'cases', 'isolate', 'average', '46', 'day', '', '95', '', 'ci', '4150', '', 'develop', 'symptom', '', 'contact', 'trace', 'reduce', '19', 'day', '', '95', '', 'ci', '1127', '', '', 'household', 'contact', 'travel', 'case', 'higher', 'risk', 'infection', '', 'odds', 'ratio', '627', '', '95', '', 'ci', '1492633', '', 'household', 'contact', '706', '', '1433491', '', 'travel', 'case', '', 'close', 'contact', '', 'household', 'secondary', 'attack', 'rate', '112', '', '', '95', '', 'ci', '91138', '', '', 'child', 'likely', 'infect', 'adult', '', 'infection', 'rate', '74', '', 'child', '', '10', 'year', 'v', 'population', 'average', '66', '', '', '', 'observe', 'reproductive', 'number', '', 'r', '', '04', '', '95', '', 'ci', '0305', '', '', 'mean', 'serial', 'interval', '63', 'day', '', '95', '', 'ci', '5276', '', '', 'data', 'case', 'well', 'infect', 'uninfected', 'close', 'contact', 'provide', 'key', 'insight', 'epidemiology', 'sars-cov-2', '', 'analysis', 'show', 'isolation', 'contact', 'trace', 'reduce', 'time', 'case', 'infectious', 'community', '', 'thereby', 'reduce', 'r', 'overall', 'impact', 'isolation', 'contact', 'trace', '', 'however', '', 'uncertain', 'highly', 'dependent', 'number', 'asymptomatic', 'case', '', 'moreover', '', 'child', 'similar', 'risk', 'infection', 'general', 'population', '', 'although', 'le', 'likely', 'severe', 'symptom', '', 'hence', 'consider', 'analysis', 'transmission', 'control', '', 'emergency', 'response', 'program', 'harbin', 'institute', 'technology', '', 'emergency', 'response', 'program', 'peng', 'cheng', 'laboratory', '', 'us', 'centers', 'disease', 'control', 'prevention', '', 'since', 'emerge', 'wuhan', '', 'china', '', 'december', '', '20191li', 'q', 'guan', 'x', 'wu', 'p', 'alearly', 'transmission', 'dynamic', 'wuhan', '', 'china', '', 'novel', 'coronavirus-infected', 'pneumonian', 'engl', 'j', 'med', '', '2020', '', '382', '', '1199-1207crossrefpubmedscopus', '', '526', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'epidemic', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'progress', 'rapidly', 'pandemic', '', 'covid-19', 'characterise', 'fever', '', 'cough', '', 'fatigue', '', 'shortness', 'breath', '', 'pneumonia', '', 'respiratory', 'tract', 'symptoms2chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '559', '', '', '3wang', 'hu', 'b', 'hu', 'c', 'alclinical', 'characteristic', '138', 'hospitalize', 'patient', '2019', 'novel', 'coronavirus-infected', 'pneumonia', 'wuhan', '', 'chinajama', '', '2020', '', '323', '', '1061-1069crossrefscopus', '', '590', '', '', '4yang', 'lu', 'q-b', 'ming-jin', 'l', 'alepidemiological', 'clinical', 'feature', '2019', 'novel', 'coronavirus', 'outbreak', 'chinamedrxiv', '', '2020', '', '', 'publish', 'online', 'feb', '21', '', '', '', 'preprint', '', 'doi', '', '1011012020021020021675google', 'case', 'progress', 'death', '', 'april', '15', '', '2020', '', '1', '914', '916', 'confirm', 'case', '123', '010', 'death', 'report', 'worldwide5whocoronavirus', 'disease', '', 'covid-19', '', 'situation', 'report', '', 'urlplaceholder', '2020date', 'access', '', 'february', '21', '', '2020google', 'case', 'initially', 'confine', 'hubei', 'province', 'china', '', 'since', 'substantial', 'spread', 'elsewhere', 'china', 'worldwide', '', 'rapid', 'robust', 'response', 'global', 'scientific', 'community', 'describe', 'important', 'aspect', 'sars-cov-2', 'transmission', 'natural', 'history1li', 'q', 'guan', 'x', 'wu', 'p', 'alearly', 'transmission', 'dynamic', 'wuhan', '', 'china', '', 'novel', 'coronavirus-infected', 'pneumonian', 'engl', 'j', 'med', '', '2020', '', '382', '', '1199-1207crossrefpubmedscopus', '', '526', '', '', '2chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '559', '', '', '6lauer', 'sa', 'grantz', 'kh', 'bi', 'q', 'althe', 'incubation', 'period', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'publicly', 'report', 'confirm', 'case', '', 'estimation', 'applicationann', 'int', 'med', '', '2020', '', '', 'publish', 'online', 'march', '10', '', 'doi', '', '107326m20-0504crossrefpubmedscopus', '', '56', '', '', '7backer', 'ja', 'klinkenberg', 'wallinga', 'j', 'incubation', 'period', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', 'infection', 'among', 'traveller', 'wuhan', '', 'china', '', '2028', 'january', '2020euro', 'surveill', '', '2020', '', '252000062crossrefscopus', '', '49', '', '', '8chan', 'jf-w', 'yuan', 'kok', 'k-h', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '395', '', '514-523summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '398', '', 'key', 'question', 'remain', '', 'well', 'track', '', 'early', 'emerge', 'pathogen', 'provide', 'unique', 'opportunity', 'characterise', 'transmission', '', 'natural', 'history', '', 'effectiveness', 'screen', '', 'careful', 'monitor', 'case', 'low', 'probability', 'infection', 'general', 'community', 'enable', 'inference', '', 'important', 'model', 'course', 'outbreak', '', 'difficult', 'widely', 'disseminate', 'epidemic', '', 'particular', '', 'assumption', 'case', 'likely', 'infect', 'impossible', 'pathogen', 'widespread', '', 'furthermore', '', 'early', 'phase', '', 'uninfected', 'asymptomatic', 'contact', 'often', 'closely', 'track', '', 'provide', 'important', 'information', 'transmission', 'natural', 'history', '', 'combined', '', 'data', 'early', 'give', 'insight', 'natural', 'history', 'disease9lessler', 'j', 'reich', 'ng', 'cummings', 'dat', 'nair', 'hp', 'jordan', 'ht', 'thompson', 'n', 'outbreak', '2009', 'pandemic', 'influenza', '', 'h1n1', '', 'new', 'york', 'city', 'schooln', 'engl', 'j', 'med', '', '2009', '', '361', '', '2628-2636crossrefpubmedscopus', '', '227', '', 'transmission', 'characteristics10lipsitch', 'cohen', 'cooper', 'b', 'altransmission', 'dynamic', 'control', 'severe', 'acute', 'respiratory', 'syndromescience', '', '2003', '', '300', '', '1966-1970crossrefpubmedscopus', '', '652', '', 'unseen', 'burden', 'infection11lessler', 'j', 'salje', 'h', 'van', 'kerkhove', 'md', 'alestimating', 'severity', 'subclinical', 'burden', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'kingdom', 'saudi', 'arabiaam', 'j', 'epidemiol', '', '2016', '', '183', '', '657-663crossrefpubmedscopus', '', '19', '', 'research', 'contextevidence', 'studythe', 'emergence', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'accompany', 'substantial', 'increase', 'research', 'publication', 'range', 'transmissibility', 'sars-cov-2', 'clinical', 'characteristic', 'infection', '', 'march', '23', '', '2020', '', 'search', 'keywords', '', '', 'covid-19', '', '', 'sars-ncov-2', '', '', 'novel', 'coronavirus', '', '', '', '', 'serial', 'interval', '', '', 'incubation', 'period', '', '', 'attack', 'rate', '', '', 'yield', '14', 'article', 'estimate', 'either', 'serial', 'interval', 'incubation', 'period', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'one', 'investigate', 'secondary', 'attack', 'rate', '', 'however', '', 'estimate', 'either', 'wuhan', 'publicly', 'available', 'case', 'data', '', 'instance', '', 'incomplete', 'capture', 'infection', 'case', 'produce', 'bias', 'estimatesadded', 'value', 'studythis', 'study', '', 'knowledge', '', 'first', 'analysis', 'sars-cov-2', 'transmission', 'covid-19', 'natural', 'history', 'base', 'large', 'primary', 'dataset', 'case', 'close', 'contact', '', 'mode', 'surveillance', '', 'ie', '', 'symptom-based', 'versus', 'contact-based', '', 'sufficiently', 'document', 'rt-pcr', 'test', 'nearly', 'universal', '', 'present', 'one', 'first', 'estimate', 'serial', 'interval', '', 'secondary', 'household', 'attack', 'rate', '', 'dispersion', '', 'ie', '', 'tendency', 'towards', 'super', 'spread', '', 'sars-cov-2', 'base', 'active', 'surveillance', 'data', '', 'find', 'attack', 'rate', 'differ', 'significantly', 'age', '', 'average', '7', '', 'close', 'contact', 'become', 'infect', '', 'around', '80', '', 'contact', 'show', 'symptom', '', '3', '', 'infection', 'manifest', 'severe', 'disease', 'initial', 'assessment', '', 'find', 'contact-based', 'surveillance', 'shenzhen', 'reduce', 'duration', 'infect', 'individual', 'transmit', 'community', '2', 'day', '', 'find', 'important', 'understand', 'burden', 'covid-19', 'strategic', 'plan', 'across', 'worldimplications', 'available', 'evidencethese', 'result', 'shed', 'light', 'sars-cov-2', 'transmit', '', 'severe', '', 'effective', 'control', 'measure', 'specific', 'context', '', 'provide', 'key', 'piece', 'evidence', 'support', 'intensive', 'contact', 'trace', 'highlight', 'child', 'important', 'target', 'intervention', 'aim', 'reduce', 'transmission', '', 'sick', '', 'evidence', 'study', 'emergence', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'accompany', 'substantial', 'increase', 'research', 'publication', 'range', 'transmissibility', 'sars-cov-2', 'clinical', 'characteristic', 'infection', '', 'march', '23', '', '2020', '', 'search', 'keywords', '', '', 'covid-19', '', '', 'sars-ncov-2', '', '', 'novel', 'coronavirus', '', '', '', '', 'serial', 'interval', '', '', 'incubation', 'period', '', '', 'attack', 'rate', '', '', 'yield', '14', 'article', 'estimate', 'either', 'serial', 'interval', 'incubation', 'period', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'one', 'investigate', 'secondary', 'attack', 'rate', '', 'however', '', 'estimate', 'either', 'wuhan', 'publicly', 'available', 'case', 'data', '', 'instance', '', 'incomplete', 'capture', 'infection', 'case', 'produce', 'bias', 'estimate', '', 'added', 'value', 'study', 'study', '', 'knowledge', '', 'first', 'analysis', 'sars-cov-2', 'transmission', 'covid-19', 'natural', 'history', 'base', 'large', 'primary', 'dataset', 'case', 'close', 'contact', '', 'mode', 'surveillance', '', 'ie', '', 'symptom-based', 'versus', 'contact-based', '', 'sufficiently', 'document', 'rt-pcr', 'test', 'nearly', 'universal', '', 'present', 'one', 'first', 'estimate', 'serial', 'interval', '', 'secondary', 'household', 'attack', 'rate', '', 'dispersion', '', 'ie', '', 'tendency', 'towards', 'super', 'spread', '', 'sars-cov-2', 'base', 'active', 'surveillance', 'data', '', 'find', 'attack', 'rate', 'differ', 'significantly', 'age', '', 'average', '7', '', 'close', 'contact', 'become', 'infect', '', 'around', '80', '', 'contact', 'show', 'symptom', '', '3', '', 'infection', 'manifest', 'severe', 'disease', 'initial', 'assessment', '', 'find', 'contact-based', 'surveillance', 'shenzhen', 'reduce', 'duration', 'infect', 'individual', 'transmit', 'community', '2', 'day', '', 'find', 'important', 'understand', 'burden', 'covid-19', 'strategic', 'plan', 'across', 'world', '', 'implications', 'available', 'evidence', 'result', 'shed', 'light', 'sars-cov-2', 'transmit', '', 'severe', '', 'effective', 'control', 'measure', 'specific', 'context', '', 'provide', 'key', 'piece', 'evidence', 'support', 'intensive', 'contact', 'trace', 'highlight', 'child', 'important', 'target', 'intervention', 'aim', 'reduce', 'transmission', '', 'sick', '', '', 'data', 'collect', 'shenzhen', 'center', 'disease', 'control', 'prevention', '', 'shenzhen', 'cdc', '', '391', 'case', 'covid-19', '1286', 'close', 'contact', 'characterise', 'key', 'aspect', 'epidemiology', 'outside', 'hubei', 'province', '', 'characterise', 'difference', 'demographic', 'severity', 'case', 'identify', 'symptom-based', 'surveillance', 'monitor', 'close', 'case', 'contact', '', 'estimate', 'time', 'key', 'event', '', 'confirmation', '', 'isolation', '', 'recovery', '', 'using', 'data', 'contact', 'trace', '', 'characterise', 'sars-cov-2', 'transmission', 'estimate', 'key', 'value', '', 'household', 'secondary', 'attack', 'rate', '', 'serial', 'interval', '', 'observe', 'reproductive', 'number', '', 'r', '', '', 'jan', '8', '', '2020', '', 'shenzhen', 'cdc', 'identify', 'first', 'case', 'pneumonia', 'unknown', 'cause', 'begin', 'monitor', 'traveller', 'hubei', 'province', 'symptom', 'covid-19', '', 'next', '2', 'week', 'surveillance', 'programme', 'expand', 'include', 'traveller', 'hubei', 'regardless', 'symptom', '', 'patient', 'local', 'hospital', '', 'individual', 'detect', 'fever', 'screen', 'neighbourhood', 'local', 'clinic', '', 'suspected', 'case', 'close', 'contact', 'test', 'sars-cov-2', 'rt-pcr', 'nasal', 'swab', '28', 'qualify', 'local', 'hospital', '', 'ten', 'district-level', 'cdcs', '', 'two', 'third-party', 'test', 'organisation', '', 'final', 'confirmation', 'guangdong', 'provincial', 'center', 'disease', 'control', 'prevention', '', 'guangdong', 'cdc', '', 'shenzhen', 'cdc', '', 'appendix', '2', 'p', '11', '', '', 'close', 'contact', 'identify', 'contact', 'trace', 'confirm', 'case', 'define', 'live', 'apartment', '', 'share', 'meal', '', 'travel', '', 'socially', 'interact', 'index', 'case', '2', 'day', 'symptom', 'onset', '', 'casual', 'contact', '', 'eg', '', 'clinic', 'patient', '', 'close', 'contact', '', 'eg', '', 'nurse', '', 'wear', 'mask', 'exposure', 'include', 'group', '', 'symptomatic', 'case', 'isolate', 'treat', 'designate', 'hospital', 'regardless', 'rt-pcr', 'test', 'result', '', 'asymptomatic', 'individual', 'test', 'positive', 'quarantine', 'centralise', 'facility', '', 'close', 'contact', 'traveller', 'hubei', 'test', 'negative', 'quarantine', 'home', 'central', 'facility', '', 'monitor', '14', 'day', '', 'rt-pcr', 'test', 'require', 'close', 'contact', 'begin', 'isolation', '', 'release', 'conditional', 'negative', 'rt-pcr', 'result', '', 'basic', 'demographic', '', 'sign', 'symptom', '', 'clinical', 'severity', '', 'exposure', 'history', 'record', 'confirm', 'case', '', '', 'analyse', 'confirm', 'case', 'identify', 'shenzhen', 'cdc', 'jan', '14', 'feb', '12', '', '2020', '', 'close', 'contact', 'case', 'confirm', 'feb', '9', '', '2020', '', 'work', 'support', 'ongoing', 'public', 'health', 'response', '', 'hence', 'determine', 'human', 'research', 'consultation', 'johns', 'hopkins', 'bloomberg', 'school', 'public', 'health', 'institutional', 'review', 'board', '', 'data', 'collection', 'part', 'continue', 'public', 'health', 'investigation', 'emerge', 'outbreak', 'therefore', 'individual', 'inform', 'consent', 'waive', '', 'study', 'approve', 'ethic', 'committee', 'shenzhen', 'cdc', '', 'analytical', 'datasets', 'construct', 'anonymised', 'manner', '', 'analysis', 'personally', 'identifiable', 'data', 'place', 'onsite', 'shenzhen', 'cdc', '', 'define', 'symptom-based', 'surveillance', 'include', 'symptomatic', 'screen', 'airport', 'train', 'station', '', 'community', 'fever', 'monitor', '', 'home', 'observation', 'recent', 'traveller', 'hubei', '', 'test', 'patient', 'admit', 'hospital', '', 'contact-based', 'surveillance', 'identification', 'case', 'monitor', 'test', 'close', 'contact', 'confirm', 'case', '', 'independently', 'symptom', 'presentation', '', 'protocol', '', 'contact-based', 'group', 'test', 'sars-cov-2', 'infection', 'regardless', 'symptom', '', 'whereas', 'category', 'test', 'show', 'sign', 'symptom', 'disease', '', 'first', 'clinical', 'assessment', '', 'data', 'record', '21', 'sign', 'symptom', '', 'appendix', '2', 'p', '1', '', '', 'disease', 'severity', 'assess', '', 'cases', 'fever', '', 'respiratory', 'symptom', '', 'radiographic', 'evidence', 'pneumonia', 'classify', 'moderate', 'symptom', '', 'cases', 'classify', 'severe', 'symptom', 'follow', '', 'breathe', 'rate', '30', 'breath', 'per', 'min', 'higher', '', 'oxygen', 'saturation', 'level', '93', '', 'lower', 'rest', '', 'oxygen', 'concentration', 'level', 'pao2fio2', '', 'ratio', 'arterial', 'oxygen', 'partial', 'pressure', 'fractional', 'inspire', 'oxygen', '', '300', 'mm', 'hg', '', '1', 'mm', 'hg0133', 'kpa', '', 'lower', '', 'lung', 'infiltrate', 'higher', '50', '', 'within', '2448', 'h', '', 'respiratory', 'failure', 'require', 'mechanical', 'ventilation', '', 'septic', 'shock', '', 'multiple', 'organ', 'dysfunction', 'failure', '', 'symptomatic', 'case', 'classify', 'mild', '', 'relationships', 'demographic', '', 'mode', 'detection', '', 'symptom', 'severity', 'assess', 'characterise', '2', 'test', '', 'simple', 'multiple', 'logistic', 'regression', '', 'distributions', 'fit', 'time', 'key', 'event', 'confirm', 'case', 'course', 'infection', 'treatment', '', 'time', 'infection', 'symptom', 'onset', '', 'incubation', 'period', '', 'assume', 'log-normally', 'distribute', 'estimate', 'previously', 'described12reich', 'ng', 'lessler', 'j', 'azman', 'kamvar', 'zn', 'analysis', 'coarsely', 'observe', 'data', '', 'r', 'package', 'coarsedatatools', 'version', '065', '', '', 'version', '065', '', 'urlplaceholder', 'dec', '6', '', '2019date', 'access', '', 'february', '16', '', '2020google', '', '13reich', 'ng', 'lessler', 'j', 'cummings', 'dat', 'brookmeyer', 'r', 'estimating', 'incubation', 'period', 'distribution', 'coarse', 'datastat', 'med', '', '2009', '', '28', '', '2769-2784crossrefpubmedscopus', '', '34', '', '', '14reich', 'ng', 'lessler', 'j', 'cummings', 'dat', 'brookmeyer', 'r', 'estimating', 'absolute', 'relative', 'case', 'fatality', 'ratio', 'infectious', 'disease', 'surveillance', 'databiometrics', '', '2012', '', '68', '', '598-606crossrefpubmedscopus', '', '9', '', 'determine', 'leave', 'boundary', 'possible', 'exposure', 'symptom', 'onset', 'time', '', 'cases', 'recently', 'travel', 'hubei', 'assume', 'expose', '', 'cases', 'without', 'recent', 'travel', 'history', 'exposure', 'confirm', 'case', 'assume', 'expose', 'time', 'earliest', 'latest', 'possible', 'contact', 'case', '', 'case', 'identify', 'earliest', 'latest', 'possible', 'time', 'exposure', 'date', 'symptom', 'onset', 'include', 'analysis', '', 'time', 'symptom', 'onset', 'recovery', 'estimate', 'parametric', 'survival', 'method', '', 'patients', 'recover', 'consider', 'censor', 'feb', '22', '', '2020', '', 'time', 'death', '', 'delay', 'distribution', 'estimate', 'directly', 'fit', 'parametric', 'distribution', 'time', 'symptom', 'onset', 'arrival', 'shenzhen', '', 'confirmation', '', 'isolation', '', 'admission', 'hospital', '', 'confidence', 'interval', 'calculate', 'bootstrapping', 'standard', 'parametric', 'estimators15efron', 'b', 'gong', 'g', 'leisurely', 'look', 'bootstrap', '', 'jackknife', '', 'cross-validationam', 'stat', '', '1983', '', '37', '', '36-48google', 'transmission', 'characterise', 'examine', 'relationship', 'confirm', 'case', 'infect', 'uninfected', 'close', 'contact', '', 'household', 'secondary', 'attack', 'rate', 'calculate', 'percentage', 'household', 'contact', '', 'share', 'room', '', 'apartment', '', 'sleep', 'arrangement', '', 'later', 'confirm', 'sars-cov-2', 'infection', '', 'distribution', 'serial', 'interval', '', 'time', 'symptom', 'onset', 'confirm', 'case', 'infect', 'contact', '', 'calculate', 'fit', 'parametric', 'distribution', 'time', 'symptom', 'onset', 'clear', 'casecontact', 'pair', '', 'mean', 'r', 'distribution', 'individual', 'reproductive', 'number', '', 'ie', '', 'number', 'secondary', 'infection', 'cause', 'case', '', 'calculate', 'number', 'secondary', 'infection', 'observe', 'among', 'close', 'contact', 'index', 'case', '', 'ambiguity', 'resolve', 'multiple', 'imputation', '', 'appendix', '2', 'p', '11', '', '', 'relative', 'odds', 'transmission', 'among', 'contact', 'various', 'type', 'estimate', 'conditional', 'logistic', 'regression', 'random-effects', 'model', '', 'account', 'differ', 'number', 'possible', 'infect', 'individual', 'risk', 'group', '', 'assess', 'impact', 'characteristic', 'infect', 'individual', '', 'include', 'risk', 'set', 'single', 'potential', 'infect', 'individual', 'clearly', 'identifiable', '', 'confidence', 'interval', 'estimate', 'bootstrapping', 'standard', 'parametric', 'approach', '', 'sponsor', 'study', 'role', 'study', 'design', '', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'shenzhen', 'cdc', 'full', 'access', 'data', 'study', '', 'correspond', 'author', 'share', 'final', 'responsibility', 'decision', 'submit', 'publication', '', 'jan', '14', 'feb', '12', '', '2020', '', 'shenzhen', 'cdc', 'confirm', '391', 'case', 'sars-cov-2', 'infection', '', 'table', '1', '', '', '379', 'mode', 'detection', '', '292', '', '77', '', '', 'detect', 'symptom-based', 'surveillance', '', 'overall', '', 'approximately', 'equal', 'number', 'male', 'female', 'case', '', '187', 'v', '204', '', '', 'mean', 'age', 'population', '45', 'year', '', '307', '', '79', '', '', '391', 'case', 'adult', 'age', '3069', 'year', '', 'time', 'first', 'clinical', 'assessment', '', 'case', 'mild', '', '102', '', '26', '', '', '391', '', 'moderate', '', '254', '', '65', '', '', '391', '', '', '35', '', '9', '', '', 'severe', '', '330', '', '84', '', '', '391', 'case', 'fever', 'time', 'initial', 'assessment', '', '25', '', '6', '', '', '391', 'sign', 'symptom', '', 'feb', '22', '', '2020', '', 'final', 'clinical', 'outcome', '228', '391', 'case', 'data', '', 'three', 'die', '', 'capture', 'symptom-based', 'surveillance', '', '225', 'recoveredtable', '1demographic', 'clinical', 'characteristic', 'case', 'contact-based', 'versus', 'symptom-based', 'surveillancecontact-based', 'surveillance', '', 'n87', '', 'symptom-based', 'surveillance', '', 'n292', '', 'unknown', '', 'n12', '', 'total', '', 'n391', '', 'p', 'valuesexfemale63', '', '72', '', '', '131', '', '45', '', '', '10', '', '83', '', '', '204', '', '52', '', '', '', '00001male24', '', '28', '', '', '161', '', '55', '', '', '2', '', '17', '', '', '187', '', '48', '', '', '', 'age09', 'years13', '', '15', '', '', '6', '', '2', '', '', '1', '', '8', '', '', '20', '', '5', '', '', '', '000011019', 'years5', '', '6', '', '', '6', '', '2', '', '', '1', '', '8', '', '', '12', '', '3', '', '', '', '2029', 'years11', '', '13', '', '', '23', '', '8', '', '', '0', '', '0', '', '', '34', '', '9', '', '', '', '3039', 'years15', '', '17', '', '', '71', '', '24', '', '', '1', '', '8', '', '', '87', '', '22', '', '', '', '4049', 'years9', '', '10', '', '', '49', '', '17', '', '', '2', '', '17', '', '', '60', '', '15', '', '', '', '5059', 'years10', '', '12', '', '', '63', '', '22', '', '', '1', '', '8', '', '', '74', '', '19', '', '', '', '6069', 'years20', '', '23', '', '', '60', '', '21', '', '', '6', '', '50', '', '', '86', '', '22', '', '', '', '70', 'years4', '', '5', '', '', '14', '', '5', '', '', '0', '', '0', '', '', '18', '', '5', '', '', '', 'severitymild18', '', '21', '', '', '82', '', '28', '', '', '2', '', '17', '', '', '102', '', '26', '', '', '003moderate66', '', '76', '', '', '180', '', '62', '', '', '8', '', '67', '', '', '254', '', '65', '', '', '', 'severe3', '', '3', '', '', '30', '', '10', '', '', '2', '', '17', '', '', '35', '', '9', '', '', '', 'symptomaticno17', '', '20', '', '', '8', '', '3', '', '', '0', '', '0', '', '', '25', '', '6', '', '', '', '00001yes70', '', '80', '', '', '284', '', '97', '', '', '12', '', '100', '', '', '366', '', '94', '', '', '', 'feverno25', '', '29', '', '', '34', '', '12', '', '', '2', '', '17', '', '', '61', '', '16', '', '', '00002yes62', '', '71', '', '', '258', '', '88', '', '', '10', '', '83', '', '', '330', '', '84', '', '', '', 'open', 'table', 'new', 'tab', 'larger', 'proportion', 'case', 'detect', 'symptom-based', 'surveillance', 'male', '', '161', '', '55', '', '', '292', 'v', '24', '', '28', '', '', '87', '', 'age', '2069', 'year', '', '266', '', '91', '', '', '292', 'v', '65', '', '75', '', '', '87', '', 'detect', 'contact-based', 'surveillance', '', 'table', '1', '', 'table', '2', '', '', 'time', 'first', 'clinical', 'assessment', '', '25', '', '29', '', '', '87', 'case', 'contact-based', 'surveillance', 'group', 'fever', '', '17', '', '20', '', '', '87', 'symptom', '', 'contrast', '', '258', '', '88', '', '', '292', 'symptom-based', 'surveillance', 'group', 'fever', '', 'eight', 'report', 'symptomstable', '2association', 'clinical', 'demographic', 'factor', 'mode', 'detection', 'severity', 'initial', 'assessmentoutcome', '', 'symptom-based', 'surveillanceoutcome', '', 'moderate', 'severe', 'assessmentunivariate', 'regressionmultivariate', 'regressionunivariate', 'regressionmultivariate', 'regressionor25', '', '975', '', 'or25', '', '975', '', 'or25', '', '975', '', 'or25', '', '975', '', 'sexfemaleref', '', 'ref', '', 'ref', '', 'ref', '', 'male323193553306177544130082207137085222age09', 'years0070020230080020250880302770670222231019', 'years0190050770170040761080285270880224402029', 'years0330120890370131020650281560610261493039', 'years075031177080321931170582371150572334049', 'years0860322330790292191270582831210552725059', 'yearsref', '', 'ref', '', 'ref', '', 'ref', '', '6069', 'years0480210804401810415007231614306830370', 'years056016225045012189141045543128040496severitymildref', '', 'ref', '', 'moderate06033105051026094', '', 'severe22068984151042723', '', 'fevernoref', '', 'ref', '', 'yes306169549', '', '094049175', '', 'symptomaticnoref', '', 'ref', '', 'yes8623682189', '', '051015139055029101surveillance', 'methodcontact-based', '', 'ref', '', 'symptom-based', '', '067037117', '', 'orodds', 'ratio', '', 'open', 'table', 'new', 'tab', 'orodds', 'ratio', '', 'multiple', 'logistic', 'regression', '', 'male', 'sex', 'associate', 'severe', 'symptom', '', 'odds', 'ratio', '', '', '25', '', '95', '', 'ci', '1161', '', '', '', 'probability', 'severe', 'symptom', 'increase', 'slightly', 'age', '', 'although', 'individual', 'age', '6069', 'year', 'significantly', 'increase', 'risk', 'compare', 'reference', 'category', '', 'individual', 'age', '5059', 'year', '', '34', '', '95', '', '1495', '', '', '', 'based', '183', 'case', 'well', 'define', 'period', 'exposure', 'symptom', 'onset', '', 'appendix', '2', 'p', '8', '', '', 'estimate', 'median', 'incubation', 'period', 'covid-19', '48', 'day', '', '95', '', 'ci', '4254', '', 'figure', '1', '', 'appendix', '2', 'p', '2', '', '', 'estimate', '95', '', 'develop', 'symptom', 'within', '140', 'day', '', '95', '', 'ci', '122159', '', 'infection', '', 'estimate', '50', '', 'case', 'develop', 'symptom', 'show', 'symptom', '14', 'day', 'infectionfigure', '1incubation', 'period', 'serial', 'interval', 'covid-19show', 'full', 'caption', '', '', 'proportion', 'case', 'develop', 'symptom', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'day', 'infection', '', 'ie', '', 'cumulative', 'distribution', 'function', 'incubation', 'period', '', '', '', 'b', '', 'proportion', 'case', 'infect', 'index', 'case', 'develop', 'symptom', 'give', 'number', 'day', 'day', 'symptom', 'onset', 'index', 'case', '', 'ie', '', 'cumulative', 'distribution', 'function', 'serial', 'interval', '', '', 'maximum-likelihood', 'estimate', 'parametric', 'distribution', 'cumulative', 'distribution', 'function', 'show', '', 'along', '1000', 'parametric', 'bootstrap', 'estimate', 'cumulative', 'distribution', 'function', '', 'median', 'incubation', 'period', 'covid-19', 'estimate', '48', 'day', '', '95', '', 'ci', '4254', '', '', '5', '', 'case', 'develop', 'symptom', '16', 'day', '', '95', '', 'ci', '1320', '', 'infection', '', '95', '', '140', 'day', '', '122159', '', '', 'estimate', 'median', 'serial', 'interval', 'covid-19', '54', 'day', '', '95', '', 'ci', '4465', '', '', '5', '', 'infect', 'case', 'develop', 'symptom', '13', 'day', '', '95', '', 'ci', '0919', '', 'symptom', 'onset', 'index', 'case', '', '95', '', '143', 'day', '', '111176', '', 'view', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'proportion', 'case', 'develop', 'symptom', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'day', 'infection', '', 'ie', '', 'cumulative', 'distribution', 'function', 'incubation', 'period', '', '', '', 'b', '', 'proportion', 'case', 'infect', 'index', 'case', 'develop', 'symptom', 'give', 'number', 'day', 'day', 'symptom', 'onset', 'index', 'case', '', 'ie', '', 'cumulative', 'distribution', 'function', 'serial', 'interval', '', '', 'maximum-likelihood', 'estimate', 'parametric', 'distribution', 'cumulative', 'distribution', 'function', 'show', '', 'along', '1000', 'parametric', 'bootstrap', 'estimate', 'cumulative', 'distribution', 'function', '', 'median', 'incubation', 'period', 'covid-19', 'estimate', '48', 'day', '', '95', '', 'ci', '4254', '', '', '5', '', 'case', 'develop', 'symptom', '16', 'day', '', '95', '', 'ci', '1320', '', 'infection', '', '95', '', '140', 'day', '', '122159', '', '', 'estimate', 'median', 'serial', 'interval', 'covid-19', '54', 'day', '', '95', '', 'ci', '4465', '', '', '5', '', 'infect', 'case', 'develop', 'symptom', '13', 'day', '', '95', '', 'ci', '0919', '', 'symptom', 'onset', 'index', 'case', '', '95', '', '143', 'day', '', '111176', '', '', 'based', '228', 'case', 'outcome', '', 'estimate', 'median', 'time', 'recovery', '208', 'day', '', '95', '', 'ci', '201215', '', '', 'estimate', 'median', 'time', 'recovery', '224', 'day', '', '95', '', 'ci', '208241', '', 'individual', 'age', '5059', 'year', '', 'estimate', 'significantly', 'shorter', 'younger', 'adult', '', 'eg', '', '192', 'day', 'individual', 'age', '2029', 'year', '', 'appendix', '2', 'pp', '3', '', '10', '', '', 'multiple', 'regression', 'model', 'include', 'sex', '', 'age', '', 'baseline', 'severity', '', 'method', 'detection', '', 'addition', 'age', '', 'baseline', 'severity', 'associate', 'time', 'recovery', '', 'appendix', '2', 'p', '3', '', '', 'compared', 'case', 'mild', 'symptom', '', 'severe', 'symptom', '41', '', '', '95', '', 'ci', '2460', '', 'longer', 'time', 'recovery', '', 'appendix', '2', 'p', '3', '', '', 'feb', '22', '', '2020', '', 'three', 'case', 'die', '', 'death', 'occur', '3544', 'day', 'symptom', 'onset', '2733', 'day', 'confirmation', '', 'cases', 'detect', 'symptom-based', 'surveillance', 'confirm', 'average', '55', 'day', '', '95', '', 'ci', '5059', '', 'symptom', 'onset', '', 'figure', '2', '', 'appendix', '2', 'p', '2', '', '', 'whereas', 'detect', 'contact-based', 'surveillance', 'confirm', 'average', '32', 'day', '', '95', '', 'ci', '2738', '', 'symptom', 'onset', '', '17', '', '5', '', '', '342', 'case', 'onset', 'date', 'start', 'date', 'quarantine', 'isolate', 'develop', 'symptom', '', 'among', 'isolate', 'develop', 'symptom', '', 'symptom-based', 'surveillance', 'group', '', 'average', '', 'isolate', '46', 'day', '', '95', '', 'ci', '4150', '', 'symptom', 'onset', '', 'whereas', 'contact-based', 'surveillance', 'group', 'isolate', '27', 'day', '', '2133', '', 'symptom', 'onset', '', 'hence', '', 'contact-based', 'surveillance', 'associate', '23-day', '', '95', '', 'ci', '1530', '', 'decrease', 'time', 'confirmation', '19-day', '', '1127', '', 'decrease', 'time', 'isolation', '', 'mean', 'time', 'symptom', 'onset', 'admission', 'hospital', 'similar', 'time', 'symptom', 'onset', 'isolation', 'symptom-based', 'contact-based', 'surveillance', 'group', '', 'figure', '2', '', 'appendix', '2', 'p', '2', '', 'figure', '2time', 'symptom', 'onset', 'sars-cov-2', 'confirmation', '', '', '', 'admission', 'hospital', '', 'b', '', '', 'isolation', 'among', 'case', '', 'c', '', 'detect', 'contact-based', 'symptom-based', 'surveillanceshow', 'full', 'captionthe', 'maximum-likelihood', 'estimate', 'parametric', 'distribution', 'cumulative', 'distribution', 'function', 'show', '', 'along', '1000', 'parametric', 'bootstrap', 'estimate', 'cumulative', 'distribution', 'function', '', 'panel', 'show', 'estimate', 'proportion', 'case', 'confirm', 'rt-pcr', '', 'accord', 'number', 'day', 'symptom', 'onset', '', 'estimate', '50', '', 'case', 'detect', 'symptom-based', 'surveillance', 'confirm', 'rt-pcr', 'within', '46', 'day', '', '95', '', 'ci', '4250', '', 'symptom', 'onset', '', '95', '', 'confirm', 'rt-pcr', 'within', '127', 'day', '', '115138', '', 'symptom', 'onset', '', 'contact-based', 'surveillance', 'reduce', 'day', 'symptom', 'onset', 'rt-pcr', 'confirmation', '29', 'day', '', '95', '', 'ci', '2434', '', '50', '', 'case', '66', 'day', '', '5380', '', '95', '', 'case', '', 'panel', 'b', 'show', 'estimate', 'proportion', 'case', 'admit', 'hospital', '', 'accord', 'number', 'day', 'symptom', 'onset', '', 'estimate', '50', '', 'case', 'detect', 'symptom-based', 'surveillance', 'admit', 'hospital', '34', 'day', '', '95', '', 'ci', '3138', '', 'symptom', 'onset', '', '95', '', '124', 'day', '', '109138', '', '', 'contact-based', 'surveillance', 'reduce', 'day', 'symptom', 'onset', 'hospital', 'admission', '21', 'day', '', '95', '', 'ci', '1726', '', '50', '', 'case', '', '60', 'day', '', '95', '', 'ci', '4575', '', '95', '', 'case', '', 'panel', 'c', 'show', 'estimate', 'proportion', 'case', 'isolate', '', 'accord', 'number', 'day', 'symptom', 'onset', '', 'estimate', '50', '', 'case', 'detect', 'symptom-based', 'surveillance', 'isolate', '34', 'day', '', '95', '', 'ci', '3137', '', 'symptom', 'onset', '', '95', '', '122', 'day', '', '95', '', 'ci', '108136', '', '', 'contact-based', 'surveillance', 'reduce', 'day', 'symptom', 'onset', 'isolation', '22', 'day', '', '95', '', 'ci', '1726', '', '50', '', 'case', '', '65', 'day', '', '4782', '', '95', '', 'casesview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'maximum-likelihood', 'estimate', 'parametric', 'distribution', 'cumulative', 'distribution', 'function', 'show', '', 'along', '1000', 'parametric', 'bootstrap', 'estimate', 'cumulative', 'distribution', 'function', '', 'panel', 'show', 'estimate', 'proportion', 'case', 'confirm', 'rt-pcr', '', 'accord', 'number', 'day', 'symptom', 'onset', '', 'estimate', '50', '', 'case', 'detect', 'symptom-based', 'surveillance', 'confirm', 'rt-pcr', 'within', '46', 'day', '', '95', '', 'ci', '4250', '', 'symptom', 'onset', '', '95', '', 'confirm', 'rt-pcr', 'within', '127', 'day', '', '115138', '', 'symptom', 'onset', '', 'contact-based', 'surveillance', 'reduce', 'day', 'symptom', 'onset', 'rt-pcr', 'confirmation', '29', 'day', '', '95', '', 'ci', '2434', '', '50', '', 'case', '66', 'day', '', '5380', '', '95', '', 'case', '', 'panel', 'b', 'show', 'estimate', 'proportion', 'case', 'admit', 'hospital', '', 'accord', 'number', 'day', 'symptom', 'onset', '', 'estimate', '50', '', 'case', 'detect', 'symptom-based', 'surveillance', 'admit', 'hospital', '34', 'day', '', '95', '', 'ci', '3138', '', 'symptom', 'onset', '', '95', '', '124', 'day', '', '109138', '', '', 'contact-based', 'surveillance', 'reduce', 'day', 'symptom', 'onset', 'hospital', 'admission', '21', 'day', '', '95', '', 'ci', '1726', '', '50', '', 'case', '', '60', 'day', '', '95', '', 'ci', '4575', '', '95', '', 'case', '', 'panel', 'c', 'show', 'estimate', 'proportion', 'case', 'isolate', '', 'accord', 'number', 'day', 'symptom', 'onset', '', 'estimate', '50', '', 'case', 'detect', 'symptom-based', 'surveillance', 'isolate', '34', 'day', '', '95', '', 'ci', '3137', '', 'symptom', 'onset', '', '95', '', '122', 'day', '', '95', '', 'ci', '108136', '', '', 'contact-based', 'surveillance', 'reduce', 'day', 'symptom', 'onset', 'isolation', '22', 'day', '', '95', '', 'ci', '1726', '', '50', '', 'case', '', '65', 'day', '', '4782', '', '95', '', 'case', '', '191', '', '64', '', '', '298', 'traveller', 'develop', 'symptom', 'arrive', 'shenzhen', '', 'mean', 'time', 'arrival', 'symptom', 'onset', '49', 'day', '', '95', '', 'ci', '4255', '', 'appendix', '2', 'p', '2', '', '', 'develop', 'symptom', 'arrival', 'day', 'arrival', 'confirm', 'case', 'average', '45', 'day', '', '95', '', 'ci', '3851', '', 'arrival', '', 'isolate', 'average', '31', 'day', '', '2537', '', 'arrival', '', 'overall', '', '1286', 'close', 'contact', 'identify', 'index', 'case', 'test', 'positive', 'sars-cov-2', 'jan', '14', 'feb', '9', '', '2020', '', '244', '', '84', '', '', '292', 'case', 'least', 'one', 'close', 'contact', '', '622', '', '95', '', '', '653', 'close', 'contact', 'date', 'period', 'quarantine', 'follow', '12', 'day', 'longer', '', '98', 'close', 'contact', 'test', 'positive', 'sars-cov-2', 'infection', 'rt-pcr', '', 'one', 'presumptive', 'infection', '', 'assuming', 'miss', 'test', 'result', 'uninfected', '', 'find', 'secondary', 'attack', 'rate', '112', '', '', '95', '', 'ci', '91138', '', 'among', 'household', 'contact', '66', '', '', '5481', '', 'overall', '', 'secondary', 'attack', 'rate', 'increase', '149', '', '', '121182', '', 'among', 'household', 'contact', '97', '', '', '79118', '', 'overall', 'miss', 'result', 'remove', 'denominator', '', '', 'multiple', 'conditional', 'logistic', 'regression', 'analysis', 'contact', 'type', '', 'household', 'contact', '', '63', '', '95', '', 'ci', '15263', '', 'travel', 'together', '', '71', '', '14349', '', 'significantly', 'associate', 'infection', '', 'table', '3', '', '', 'reporting', 'contact', 'occur', 'often', 'associate', 'increase', 'risk', 'infection', 'compare', 'moderate-frequency', 'contact', '', '88', '', '95', '', 'ci', '26301', '', 'table', '3', '', 'table', '3group-specific', 'attack', 'rate', 'risk', 'factor', 'sar-cov-2', 'infection', 'among', 'close', 'contactsnumber', 'case', '', '', '15', 'confirm', 'close', 'contact', 'exclude', 'analysis', 'contact', 'trace', 'report', 'negative', 'close', 'contact', 'cluster', 'miss', '', 'close', 'contact', 'miss', 'data', 'sex', '', 'age', '', 'contact', 'type', '', 'contact', 'frequency', 'shownnumber', 'infectedattack', 'rate', '', '95', '', 'ci', '', 'univariate', 'regressionmultivariate', 'regressionodds', 'ratio25', '', '975', '', 'odds', 'ratio25', '', '975', '', 'sexfemale55858104', '', '', '81132', '', 'ref', '', 'male4862653', '', '', '3777', '', '043021086', '', 'age09', 'years1481174', '', '', '42128', '', '2330381405', '', '1019', 'years85671', '', '', '33146', '', '3500532324', '', '2029', 'years114761', '', '', '30121', '', '4910743264', '', '3039', 'years2681660', '', '', '3795', '', '184034980', '', '4049', 'years143749', '', '', '2498', '', '3460552192', '', '5059', 'years1101091', '', '', '50159', '', 'ref', '', '6069', 'years13020154', '', '', '102226', '', '5681013209', '', '70', 'years72797', '', '', '48187', '', '4260642844', '', 'contact', 'type', '', 'householdno456409', '', '', '0322', '', 'ref', '', 'ref', '', 'yes68677112', '', '', '91138', '', '151036961696271492633contact', 'type', '', 'travelno8246376', '', '', '6097', '', 'ref', '', 'ref', '', 'yes3181857', '', '', '3688', '', '91318545087061433491contact', 'type', '', 'mealno4352046', '', '', '3070', '', 'ref', '', 'ref', '', 'yes7076186', '', '', '68109', '', '230125121127130736932contact', 'frequencyrare230104', '', '', '00224', '', '', '000010inf', '', 'moderate305930', '', '', '1655', '', 'ref', '', 'often55571128', '', '', '103158', '', '882583006', '', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'infinfinity', '', '', '15', 'confirm', 'close', 'contact', 'exclude', 'analysis', 'contact', 'trace', 'report', 'negative', 'close', 'contact', 'cluster', 'miss', '', 'close', 'contact', 'miss', 'data', 'sex', '', 'age', '', 'contact', 'type', '', 'contact', 'frequency', 'show', '', 'open', 'table', 'new', 'tab', 'sars-cov-2severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'infinfinity', '', 'attack', 'rate', 'similar', 'across', 'age', 'category', 'infect', 'contact', '', 'table', '3', '', '', 'although', 'observe', 'indication', 'elevate', 'attack', 'rate', 'older', 'age', 'group', '', 'figure', '3', '', '', 'notably', '', 'rate', 'infection', 'child', 'younger', '10', 'year', '', '74', '', '', 'similar', 'population', 'average', '', '66', '', '', '', 'significant', 'association', 'probability', 'infection', 'age', 'index', 'case', '', 'surprisingly', '', 'univariate', 'analysis', 'longer', 'time', 'community', 'isolation', 'associate', 'reduce', 'risk', 'cause', 'infection', '', 'data', 'show', '', '', 'however', '', 'association', 'longer', 'significant', 'adjust', 'contact', 'frequency', 'typefigure', '3attack', 'rate', 'among', 'close', 'contact', '', 'baseline', 'severity', '', 'proportion', 'case', 'without', 'fever', 'initial', 'assessment', 'age', 'groupshow', 'full', 'caption', '', 'proportion', 'close', 'contact', 'attack', 'rate', '', 'proportion', 'case', 'severe', 'symptom', 'fever', 'initial', 'assessmentview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', 'proportion', 'close', 'contact', 'attack', 'rate', '', 'proportion', 'case', 'severe', 'symptom', 'fever', 'initial', 'assessment', '', 'based', '48', 'pair', 'case', 'clear', 'relationship', 'index', 'case', 'secondary', 'case', 'time', 'symptom', 'onset', '', 'estimate', 'serial', 'interval', 'gamma', 'distribute', 'mean', '63', 'day', '', '95', '', 'ci', '5276', '', 'sd', '42', 'day', '', '95', '', 'ci', '3153', '', 'figure', '1b', '', 'appendix', '2', 'p', '2', '', '', 'hence', '', '95', '', 'secondary', 'case', 'expect', 'develop', 'symptom', 'within', '143', 'day', '', '95', '', 'ci', '111176', '', 'infector', '', 'estimate', 'include', 'effect', 'isolation', 'truncate', 'serial', 'interval', '', 'stratified', 'result', 'show', 'infect', 'individual', 'isolate', 'le', '3', 'day', 'infection', 'average', 'serial', 'interval', '36', 'day', '', 'increase', '81', 'day', 'infect', 'individual', 'isolate', 'third', 'day', 'symptom', 'onset', 'later', '', 'appendix', '2', 'p', '3', '', '', 'mean', 'number', 'secondary', 'case', 'cause', 'index', 'case', '', 'ie', '', 'observe', 'reproductive', 'number', '', 'r', '', '', '04', '', '95', '', 'ci', '0305', '', '', 'distribution', 'individual', 'r', 'value', 'highly', 'over-dispersed', '', '80', '', 'infection', 'cause', '89', '', '', '95', '', 'ci', '35108', '', 'case', '', 'negative', 'binomial', 'dispersion', 'parameter', '058', '', '95', '', 'ci', '035118', '', '', 'examine', 'potential', 'impact', 'surveillance', 'isolation', 'truncate', 'infectious', 'period', '', 'scarce', 'understand', 'infectious', 'period', 'follow', 'sars-cov-2', 'infection', '', 'consider', 'range', 'possible', 'infectious', 'period', 'infectiousness', 'vary', 'time', 'follow', 'gamma', 'distribution', '', 'appendix', '2', 'p', '11', '', '', 'define', 'mean', 'infectious', 'day', '', 'ie', '', 'average', 'number', 'day', 'symptom', 'onset', 'infect', 'individual', 'expect', 'infect', 'secondary', 'case', '', 'weight', 'mean', 'infectious', 'period', '', 'day', 'weight', 'relative', 'infectiousness', '', 'consider', 'period', 'mean', 'infectious', 'day', 'le', '15', 'day', 'symptom', 'onset', '', 'roughly', 'period', 'sars', 'early', 'sars-cov-2', 'report', '', '16peiris', 'jsm', 'chu', 'cm', 'cheng', 'vcc', 'alclinical', 'progression', 'viral', 'load', 'community', 'outbreak', 'coronavirus-associated', 'sars', 'pneumonia', '', 'prospective', 'studylancet', '', '2003', '', '361', '', '1767-1772summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '1025', '', '', '17zou', 'l', 'ruan', 'f', 'huang', 'alsars-cov-2', 'viral', 'load', 'upper', 'respiratory', 'specimen', 'infect', 'patientsn', 'engl', 'j', 'med', '', '2020', '', '382', '', '1177-1179crossrefpubmedscopus', '', '129', '', 'assume', 'r026', 'isolation', 'effectively', 'end', 'infectious', 'period', '', 'assumption', 'find', 'mean', 'infectious', 'day', 'greater', '5', 'day', '', 'possible', 'bring', 'r', 'one', 'case', 'detect', 'symptom-based', 'surveillance', '', 'accomplish', 'contact-based', 'surveillance', 'mean', 'infectious', 'day', 'greater', '3', 'day', '', 'appendix', '2', 'p', '9', '', '', 'impact', 'passive', 'surveillance', 'alone', 'achieve', 'observe', 'r', '04', '', 'project', 'mean', 'infectious', 'day', 'must', 'least', '55', 'day', '', 'likely', 'greater', '', 'symptom', 'onset', '', 'transmission', 'completely', 'eliminate', 'group', 'capture', 'surveillance', '', 'eg', '', 'perfect', 'surveillance', 'day', 'symptom', 'onset', '', '', 'assume', 'r026', '', 'case', 'capture', 'surveillance', 'must', '', 'isolate', '', 'expect', 'cause', '61', '', 'onward', 'transmission', 'achieve', 'local', 'elimination', 'surveillance', 'isolation', 'alone', '', 'appendix', '2', 'p', '9', '', '', 'analysis', 'early', 'sars-cov-2', 'case', 'close', 'contact', 'shenzhen', '', 'china', '', 'provide', 'insight', 'natural', 'history', '', 'transmission', '', 'control', 'disease', '', 'value', 'estimate', 'provide', 'evidentiary', 'foundation', 'predict', 'impact', 'virus', '', 'evaluate', 'control', 'measure', '', 'guide', 'global', 'response', '', 'analyses', 'case', 'detect', '', 'data', 'individual', 'expose', 'infect', '', 'indicate', 'infection', 'rate', 'young', 'child', 'lower', 'population', 'average', '', 'rate', 'clinical', 'disease', '', '', 'able', 'directly', 'estimate', 'important', 'transmission', 'parameter', '', 'show', '', 'least', 'among', 'observe', 'contact', '', 'transmission', 'rate', 'low', '', 'estimates', 'distribution', 'time', 'symptom', 'onset', 'case', 'isolation', 'surveillance', 'type', 'reveal', 'heighten', 'surveillance', 'combine', 'case', 'isolation', 'plausibly', 'account', 'low', 'rate', 'transmission', '', 'result', 'paint', 'positive', 'picture', 'impact', 'heighten', 'surveillance', 'isolation', 'shenzhen', '', 'however', '', 'uncertainty', 'number', 'asymptomatic', 'case', 'miss', 'surveillance', 'ability', 'transmit', 'sars-cov-2', 'must', 'temper', 'hope', 'stop', 'covid-19', 'pandemic', 'measure', '', 'work', 'support', 'understand', 'covid-19', 'disease', 'fairly', 'short', 'incubation', 'period', '', 'mean', '46', 'day', '', 'long', 'clinical', 'course2chen', 'n', 'zhou', 'dong', 'x', 'alepidemiological', 'clinical', 'characteristic', '99', 'case', '2019', 'novel', 'coronavirus', 'pneumonia', 'wuhan', '', 'china', '', 'descriptive', 'studylancet', '', '2020', '', '395', '', '507-513summaryfull', 'textfull', 'text', 'pdfpubmedscopus', '', '559', '', '', '7backer', 'ja', 'klinkenberg', 'wallinga', 'j', 'incubation', 'period', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', 'infection', 'among', 'traveller', 'wuhan', '', 'china', '', '2028', 'january', '2020euro', 'surveill', '', '2020', '', '252000062crossrefscopus', '', '49', '', '', '18pan', 'f', 'ye', 'sun', 'p', 'altime', 'course', 'lung', 'change', 'chest', 'ct', 'recovery', '2019', 'novel', 'coronavirus', '', 'covid-19', '', 'pneumoniaradiology', '', '2020', '', '', 'publish', 'online', 'feb', '13', '', '', 'doi101148radiol2020200370crossrefpubmedgoogle', 'patient', 'week', 'die', 'recover', '', 'notably', '', 'however', '', 'estimate', 'higher', 'proportion', 'case', '14', 'day', 'develop', 'symptom', '', '5', '', '', 'estimate', 'study', 'lauer', 'colleague', '', '1', '', '', '6lauer', 'sa', 'grantz', 'kh', 'bi', 'q', 'althe', 'incubation', 'period', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'publicly', 'report', 'confirm', 'case', '', 'estimation', 'applicationann', 'int', 'med', '', '2020', '', '', 'publish', 'online', 'march', '10', '', 'doi', '', '107326m20-0504crossrefpubmedscopus', '', '56', '', 'focusing', 'case', 'detect', 'contact-based', 'surveillance', 'add', 'nuance', 'previous', 'characterisation', 'covid-19', '', 'since', 'rt-pcr', 'test', 'contact', 'near', 'universal', '', 'assume', 'case', 'reflective', 'average', 'sars-cov-2', 'infection', 'case', 'detect', 'symptomatic', 'surveillance', '', 'contact-based', 'surveillance', 'group', '', 'tendency', 'case', 'male', 'older', '', 'beyond', 'underlie', 'population', 'distribution', '', 'disappear', '', 'furthermore', '', 'group', '', '20', '', 'case', 'asymptomatic', 'time', 'first', 'clinical', 'assessment', 'nearly', '30', '', 'fever', '', 'observation', 'consistent', 'reasonably', 'high', 'rate', 'asymptomatic', 'carriage', '', 'lower', 'suggest', 'model', 'studies19imai', 'n', 'cori', 'dorigatti', 'baguelin', 'donnelly', 'ca', 'riley', 'ferguson', 'nm', 'report', '3', '', 'transmissibility', '2019-ncov', '', 'urlplaceholder', 'jan', '25', '', '2020date', 'access', '', 'february', '24', '', '2020google', 'although', 'rt-pcr', 'imperfect', 'sensitivity20fang', 'zhang', 'h', 'xie', 'j', 'alsensitivity', 'chest', 'ct', 'covid-19', '', 'comparison', 'rt-pcrradiology', '', '2020', '', '', 'publish', 'online', 'feb', '19', '', '', 'doi101148radiol2020200432crossrefgoogle', 'shenzhen', '', 'sars-cov-2', 'transmission', 'probably', 'occur', 'close', 'contact', '', 'individual', 'share', 'household', '', 'however', '', 'group', 'fewer', 'one', 'six', 'contact', '', 'ie', '', 'secondary', 'attack', 'rate', '1115', '', '', 'infect', '', 'overall', 'observe', 'far', 'fewer', 'one', '', '04', '', 'onward', 'transmission', 'per', 'primary', 'case', '', 'note', '', 'low', 'transmission', 'level', 'part', 'due', 'impact', 'isolation', 'surveillance', '', 'equally', 'likely', 'unobserved', 'transmission', 'role', '', 'estimate', 'reasonably', 'high', 'rate', 'overdispersion', 'number', 'case', 'cause', 'infect', 'individual', '', 'leave', 'open', 'possibility', 'large', 'covid-19', 'cluster', 'occur', 'surveillance', 'isolation', 'force', 'r', 'oneevents', 'potentially', 'overwhelm', 'surveillance', 'system', '', 'work', 'numerous', 'limitation', '', 'active', 'outbreak', 'response', '', 'data', 'collect', 'multiple', 'team', 'protocol', '', 'necessity', '', 'change', 'situation', 'develop', '', 'hence', '', 'noise', 'inconsistency', 'definition', '', 'notably', '', 'definition', 'confirm', 'case', 'change', 'require', 'symptom', 'near', 'end', 'analysis', 'period', '', 'feb', '7', '', '', 'sensitivity', 'analysis', 'show', 'truncate', 'data', 'point', 'qualitatively', 'influence', 'result', '', 'appendix', '2', 'pp', '56', '', '', '', 'likewise', '', 'impossible', 'identify', 'every', 'potential', 'contact', 'individual', '', 'contact', 'trace', 'focus', 'close', 'contact', 'likely', 'infect', '', 'hence', 'r', 'assuredly', 'lower', 'true', 'reproductive', 'number', 'population', '', 'asymptomatic', 'traveller', 'miss', 'symptom-based', 'surveillance', '', 'test', '', 'asymptomatic', 'contact', 'miss', 'imperfect', 'sensitivity', 'rt-pcr', 'test20fang', 'zhang', 'h', 'xie', 'j', 'alsensitivity', 'chest', 'ct', 'covid-19', '', 'comparison', 'rt-pcrradiology', '', '2020', '', '', 'publish', 'online', 'feb', '19', '', '', 'doi101148radiol2020200432crossrefgoogle', 'recovery', 'time', 'shenzhen', 'likely', 'inflate', 'case', 'require', 'isolate', '2', 'week', 'release', 'conditional', 'negative', 'rt-pcr', 'test', '', 'although', 'guideline', 'contact', 'trace', 'case', 'detection', 'suppose', 'implement', 'across', 'country', '', 'whether', 'impact', 'contact', 'trace', 'generalise', 'part', 'china', 'depend', 'range', 'factor', '', 'include', 'local', 'test', 'capacity', 'surveillance', 'resource', '', 'sars-cov-2', 'continue', 'spread', '', 'important', 'continue', 'expand', 'knowledge', 'transmission', 'natural', 'history', '', 'data', 'early', 'phase', 'local', 'outbreak', '', 'detail', 'contact', 'trace', 'possible', 'source', 'infection', 'still', 'reliably', 'infer', '', 'particularly', 'powerful', 'estimate', 'critical', 'value', 'pertinent', 'describe', 'transmission', 'natural', 'history', 'disease', '', 'especially', 'true', 'information', 'uninfected', 'contact', 'mode', 'detection', '', '', 'result', 'estimate', 'provide', 'important', 'input', 'interpret', 'surveillance', 'data', '', 'evaluate', 'intervention', '', 'set', 'public', 'health', 'policy', '', 'online', 'publication', 'correct', '', 'correct', 'version', 'first', 'appear', 'thelancetcominfection', '5', '', '2020', 'online', 'publication', 'correct', '', 'correct', 'version', 'first', 'appear', 'thelancetcominfection', '5', '', '2020', 'contributors', 'yow', '', 'sm', '', 'xz', '', 'zz', '', 'xl', '', 'lw', '', 'wg', '', 'cc', '', 'xt', '', 'xw', '', 'yuw', '', 'sh', '', 'tf', 'collect', 'data', '', 'jl', '', 'qb', '', 'sat', '', 'cy', 'statistical', 'analysis', '', 'draft', 'manuscript', 'figure', '', 'tz', '', 'bs', '', 'ys', '', 'jz', '', 'tm', '', 'cy', 'collect', 'clean', 'data', '', 'qb', '', 'tm', '', 'jl', '', 'tf', 'conceive', 'study', 'supervise', 'data', 'collection', '', 'declaration', 'interest', 'declare', 'compete', 'interest', '', 'acknowledgments', 'tm', '', 'cy', '', 'tz', '', 'bs', '', 'ys', '', 'jz', 'fund', 'emergency', 'response', 'program', 'harbin', 'institute', 'technology', '', 'hiterp010', '', 'emergency', 'response', 'program', 'peng', 'cheng', 'laboratory', '', 'pclerp001', '', '', 'jl', '', 'sat', '', 'qb', 'fund', 'grant', 'us', 'centers', 'disease', 'control', 'prevention', '', 'nu2ggh002000', '', '', 'azman', '', 'cummings', '', 'lauer', '', 'j', 'wallinga', '', 'mina', 'advice', 'input', 'manuscript', 'analysis', '', 'patient', '', 'close', 'contact', '', 'family', 'involve', 'study', '', 'well', 'front-line', 'medical', 'staff', 'public', 'health', 'worker', 'collect', 'important', 'data', '', 'download', 'pdf', '', '34', 'mb', '', 'help', 'pdf', 'file', 'chinese', 'translation', 'download', 'pdf', '', '42', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', '2', 'impact', 'contact', 'trace', 'sars-cov-2', 'transmissionfull-textpdfcorrection', 'lancet', 'infectious', 'diseases', '2020', '', 'publish', 'online', 'april', '27', 'urlplaceholder']",6647,"{'': 1720, 'case': 144, 'day': 104, 'symptom': 94, 'contact': 88, '95': 80, 'surveillance': 62, 'ci': 60, 'estimate': 57, 'onset': 52, '2': 46, 'infection': 42, 'close': 39, 'time': 35, 'sars-cov-2': 34, 'transmission': 34, '2020': 34, 'data': 32, 'rate': 32, 'covid-19': 29}","{'infection': 42, 'sars-cov-2': 34}",76,-0.3612
DOI:10.1016/S0140-6736(20)30938-7,10.1016/S0140-6736(20)30938-7,Editorial,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['india', 'covid-19', 'lockdown']","['The largest COVID-19 national lockdown world extend May 3 .', 'As April 22 , India report 18 985 confirm case 603 death COVID-19 31 state union territory since first case Jan 30 .', 'India quick close international border enforce immediate lockdown , WHO praise “ tough timely ” .', 'The lockdown also give government time prepare possible surge case pandemic forecast peak come week .', ""Still , India 's population 1·3 billion across diverse state , health inequality , widen economic social disparity , distinct cultural value present unique challenge ."", 'Preparedness response COVID-19 differ state level .', 'Kerala draw experience Nipah virus 2018 use extensive test , contact trace , community mobilisation contain virus maintain low mortality rate .', 'It also set thousand temporary shelter migrant worker .', ""Odisha 's exposure previous natural disaster mean crisis precaution already place repurposed ."", 'Maharashtra use drone monitor physical distance lockdown apply cluster containment strategy : three patient diagnose , house within 3 km survey detect case , trace contact , raise awareness .', 'Whether strategy successful still unclear .', 'The premise rely community transmission , danger stigmatisation coercion .', ""But state deserve much credit India 's COVID-19 response ."", ""The government 's sudden enforcement lockdown seem hastily prepare immediately disadvantage already vulnerable population ."", 'There mass exodus migrant worker concern rise starvation among people work informal economy .', 'Implementing public health measure difficult place overcrowd live condition inadequate hygiene sanitation .', 'Non-COVID-19 health service disrupt .', ""Reports suggest government 's effort provide financial support measure food security ease pressure insufficient meet demand ."", 'But better plan communication could help avert crisis .', 'Rates test low ( 0·28 per 1000 people April 20 ) .', 'Capacity issue , absence political , operational feasibility blame .', 'However , effort reverse situation underway hundred thousand test kit become available , test company laboratory approve .', 'Testing need expand exponentially well strategically tool provide epidemiological evidence .', ""India 's response also constrain shortage health worker , remedied new reform would mobilise additional health-care worker different source ."", 'One threat COVID-19 response India spread misinformation drive fear , stigma , blame .', 'There rise level violence health-care worker stigmatisation people suspect COVID-19 , could impede report illness .', 'The pandemic also use fan anti-Muslim sentiment violence , gather connect group Tablighi Jamaat identify responsible many case .', ""A welcome initiative combat fake news lead group 400 multidisciplinary Indian scientist , voluntarily form Indian Scientists ' Response COVID-19 fight myth misinformation disease ."", ""In India 's favour young population ( 65 % age < 35 year ) , date , le severe pandemic fear ."", 'The lockdown already desire effect flatten epidemic curve .', 'From April 20 , state begin ease restriction basis district profile infection hotspot ( form cluster containment ) .', 'The immediate challenge keep infection manageable level ensure ability test , trace contact , isolate patient , implement COVID care plan , disseminate timely information .', 'The central government loosen control give state autonomy fund decision make .', 'India must also pay much greater attention health sector recognise importance strong public sector capacity , especially primary care district level .', ""India 's public health-care system chronically underfunded ( 1·28 % GDP ) , leave primary care weak ."", ""This pandemic could much need wake-up call necessity long-term change India 's health system ."", 'View Large Image Copyright © 2020 Prakash Singh/AFP/Getty Images View Large Image Copyright © 2020 Prakash Singh/AFP/Getty Images']","['largest', 'covid-19', 'national', 'lockdown', 'world', 'extend', '3', '', 'april', '22', '', 'india', 'report', '18', '985', 'confirm', 'case', '603', 'death', 'covid-19', '31', 'state', 'union', 'territory', 'since', 'first', 'case', 'jan', '30', '', 'india', 'quick', 'close', 'international', 'border', 'enforce', 'immediate', 'lockdown', '', 'praise', '', 'tough', 'timely', '', '', 'lockdown', 'give', 'government', 'time', 'prepare', 'possible', 'surge', 'case', 'pandemic', 'forecast', 'peak', 'week', '', 'still', '', 'india', 'population', '13', 'billion', 'across', 'diverse', 'state', '', 'health', 'inequality', '', 'widen', 'economic', 'social', 'disparity', '', 'distinct', 'cultural', 'value', 'present', 'unique', 'challenge', '', 'preparedness', 'response', 'covid-19', 'differ', 'state', 'level', '', 'kerala', 'draw', 'experience', 'nipah', 'virus', '2018', 'extensive', 'test', '', 'contact', 'trace', '', 'community', 'mobilisation', 'contain', 'virus', 'maintain', 'low', 'mortality', 'rate', '', 'set', 'thousand', 'temporary', 'shelter', 'migrant', 'worker', '', 'odisha', 'exposure', 'previous', 'natural', 'disaster', 'mean', 'crisis', 'precaution', 'already', 'place', 'repurposed', '', 'maharashtra', 'drone', 'monitor', 'physical', 'distance', 'lockdown', 'apply', 'cluster', 'containment', 'strategy', '', 'three', 'patient', 'diagnose', '', 'house', 'within', '3', 'km', 'survey', 'detect', 'case', '', 'trace', 'contact', '', 'raise', 'awareness', '', 'whether', 'strategy', 'successful', 'still', 'unclear', '', 'premise', 'rely', 'community', 'transmission', '', 'danger', 'stigmatisation', 'coercion', '', 'state', 'deserve', 'much', 'credit', 'india', 'covid-19', 'response', '', 'government', 'sudden', 'enforcement', 'lockdown', 'hastily', 'prepare', 'immediately', 'disadvantage', 'already', 'vulnerable', 'population', '', 'mass', 'exodus', 'migrant', 'worker', 'concern', 'rise', 'starvation', 'among', 'people', 'work', 'informal', 'economy', '', 'implementing', 'public', 'health', 'measure', 'difficult', 'place', 'overcrowd', 'live', 'condition', 'inadequate', 'hygiene', 'sanitation', '', 'non-covid-19', 'health', 'service', 'disrupt', '', 'reports', 'suggest', 'government', 'effort', 'provide', 'financial', 'support', 'measure', 'food', 'security', 'ease', 'pressure', 'insufficient', 'meet', 'demand', '', 'better', 'plan', 'communication', 'help', 'avert', 'crisis', '', 'rates', 'test', 'low', '', '028', 'per', '1000', 'people', 'april', '20', '', '', 'capacity', 'issue', '', 'absence', 'political', '', 'operational', 'feasibility', 'blame', '', 'however', '', 'effort', 'reverse', 'situation', 'underway', 'hundred', 'thousand', 'test', 'kit', 'become', 'available', '', 'test', 'company', 'laboratory', 'approve', '', 'testing', 'expand', 'exponentially', 'well', 'strategically', 'tool', 'provide', 'epidemiological', 'evidence', '', 'india', 'response', 'constrain', 'shortage', 'health', 'worker', '', 'remedied', 'new', 'reform', 'mobilise', 'additional', 'health-care', 'worker', 'different', 'source', '', 'one', 'threat', 'covid-19', 'response', 'india', 'spread', 'misinformation', 'drive', 'fear', '', 'stigma', '', 'blame', '', 'rise', 'level', 'violence', 'health-care', 'worker', 'stigmatisation', 'people', 'suspect', 'covid-19', '', 'impede', 'report', 'illness', '', 'pandemic', 'fan', 'anti-muslim', 'sentiment', 'violence', '', 'gather', 'connect', 'group', 'tablighi', 'jamaat', 'identify', 'responsible', 'case', '', 'welcome', 'initiative', 'combat', 'fake', 'news', 'lead', 'group', '400', 'multidisciplinary', 'indian', 'scientist', '', 'voluntarily', 'form', 'indian', 'scientists', '', 'response', 'covid-19', 'fight', 'myth', 'misinformation', 'disease', '', 'india', 'favour', 'young', 'population', '', '65', '', 'age', '', '35', 'year', '', '', 'date', '', 'le', 'severe', 'pandemic', 'fear', '', 'lockdown', 'already', 'desire', 'effect', 'flatten', 'epidemic', 'curve', '', 'april', '20', '', 'state', 'begin', 'ease', 'restriction', 'basis', 'district', 'profile', 'infection', 'hotspot', '', 'form', 'cluster', 'containment', '', '', 'immediate', 'challenge', 'keep', 'infection', 'manageable', 'level', 'ensure', 'ability', 'test', '', 'trace', 'contact', '', 'isolate', 'patient', '', 'implement', 'covid', 'care', 'plan', '', 'disseminate', 'timely', 'information', '', 'central', 'government', 'loosen', 'control', 'give', 'state', 'autonomy', 'fund', 'decision', '', 'india', 'must', 'pay', 'much', 'greater', 'attention', 'health', 'sector', 'recognise', 'importance', 'strong', 'public', 'sector', 'capacity', '', 'especially', 'primary', 'care', 'district', 'level', '', 'india', 'public', 'health-care', 'system', 'chronically', 'underfunded', '', '128', '', 'gdp', '', '', 'leave', 'primary', 'care', 'weak', '', 'pandemic', 'much', 'wake-up', 'call', 'necessity', 'long-term', 'change', 'india', 'health', 'system', '', 'view', 'large', 'image', 'copyright', '', '2020', 'prakash', 'singhafpgetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'prakash', 'singhafpgetty', 'images']",530,"{'': 84, 'india': 10, 'covid-19': 7, 'lockdown': 6, 'state': 6, 'health': 6, 'case': 5, 'response': 5, 'test': 5, 'worker': 5, 'government': 4, 'pandemic': 4, 'level': 4, 'april': 3, 'population': 3, 'contact': 3, 'trace': 3, 'already': 3, 'much': 3, 'people': 3}",{'infection': 2},2,-0.0258
DOI:10.1016/S0140-6736(20)30985-5,10.1016/S0140-6736(20)30985-5,Comment,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['policy', 'maker', 'covid-19', 'protective', 'immunity']","['About third world lockdown public health measure curb spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , virus cause coronavirus disease 2019 ( COVID-19 ) .', 'Policy maker increasingly press articulate rationale strategy move lockdown ; process re-emergence already cautiously start Austria , Switzerland , Denmark , Wuhan , US state .', 'As counterpoise disease spread socioeconomic cost debate , essential policy maker affect country best possible data understand inform course action .', 'Strategies various country aim stagger return work basis disease severity risk age take account expose even lower-risk individual , young people comorbidities , virus increase herd immunity still result pandemic spread .', 'The selective pressure SARS-CoV-2 transmission—stop transmission stop virus .', 'The linchpin strategy move lockdown seemingly rest increase test contact trace , possible return-to-work permit base immune status,1Studdert DM Hall MA Disease control , civil liberty , mass testing—calibrating restriction COVID-19 pandemic.N Engl J Med .', '2020 ; ( publish online April 9 .', ') DOI:10.1056/NEJMp2007637Google Scholar repurposed new therapeutics,2Martinez MA Compounds therapeutic potential novel respiratory 2019 coronavirus.Antimicrob Agents Chemother .', '2020 ; 64 : e00399-e00420Google Scholar , finally , vaccination.3Amanat F Krammer F SARS-CoV-2 vaccine : status report.Immunity .', '2020 ; 52 : 583-589Google Scholar , 4Thanh Le T Andreadakis Z Kumar A et al.The COVID-19 vaccine development landscape.Nat Rev Drug Discov .', '2020 ; ( publish online April 9 .', ') DOI:10.1038/d41573-020-00073-5Google Scholar This approach broadly sensible , yet immunology complex branch molecular medicine policy maker need alert important aspect immunology relation COVID-19 .', 'There certainty immunological correlate antiviral protection proportion population must attain , make impossible identify point level immunity reach .', 'Current discussion , example , address notion scale antibody test determine immune , thus give indication extent herd immunity confirm could re-enter workforce .', 'There question address accuracy test practicality implementation laboratory-based versus home-use assays.5Adams ER Anand R Andersson M et al.Evaluation antibody test SARS-Cov-2 use ELISA lateral flow immunoassays.bioRxiv .', '2020 ; ( publish online April 20 . )', '( preprint ) urlplaceholder Scholar For country contemplate issue , another crucial question solid assumption antibody SARS-CoV-2 spike protein equate functional protection ?', 'Furthermore , presence antibody protective , decide proportion population require antibody mitigate subsequent wave case COVID-19 ?', 'Any discussion inform consideration correlate protection .', 'Initially propose Stanley Plotkin,6Plotkin SA Vaccination major infectious diseases.CR Acad Sci III .', '1999 ; 322 : 943-951Google Scholar , 7Plotkin SA Immunologic correlate protection induce vaccination.Pediatr Infect Dis J .', '2001 ; 20 : 63-75Google Scholar concept rest notion empirically define , quantifiable immune parameter determine attainment protection give pathogen .', 'Caution need total measurable antibody precisely protective , virus-neutralising antibody .', 'Furthermore , study COVID-19 show 10–20 % symptomatically infect people little detectable antibody.8Tan W Lu Y Zhang J et al.Viral kinetics antibody response patient COVID-19.medRxiv .', '2020 ; ( publish online March 26 . )', '( preprint ) urlplaceholder Scholar In case COVID-19 , low virus-binding antibody titre might correlate lethal near-lethal infection , mild infection little antigenic stimulation .', 'Importantly , scientist must identify correlate protection also robust understand correlate progression severe COVID-19 , since knowledge latter inform former .', 'The route certainty degree nature immunity require protection require evidence formal proof use approach titrate transfer antibody T lymphocyte define protection non-human primate model , use , example , study Ebola virus.9Stanley DA Honko AN Asiedu C et al.Chimpanzee adenovirus vaccine generate acute durable protective immunity ebolavirus challenge.Nat Med .', '2014 ; 20 : 1126-1129Google Scholar A study survivor SARS show 90 % functional , virus-neutralising antibody around 50 % strong T-lymphocyte responses.10Li CK Wu H Yan H et al.T cell response whole SARS coronavirus humans.J Immunol .', '2008 ; 181 : 5490-5500Google Scholar These observation bolster confidence simple view survivor severe COVID-19 would expect protective antibody .', 'A caveat study , either SARS survivor COVID-19 patient , focus people hospitalise severe , symptomatic disease .', 'Similar data urgently need individual SARS-CoV-2 infection hospitalise .', 'How long immunity COVID-19 likely last ?', 'The best estimate come closely relate coronaviruses suggest , people antibody response , immunity might wane , detectable beyond 1 year hospitalisation.10Li CK Wu H Yan H et al.T cell response whole SARS coronavirus humans.J Immunol .', '2008 ; 181 : 5490-5500Google Scholar , 11Temperton NJ Chan PK Simmons G et al.Longitudinally profile neutralize antibody response SARS coronavirus pseudotypes.Emerg Infect Dis .', '2005 ; 11 : 411-416Google Scholar , 12Choe PG Perera RAPM Park WB et al.MERS-CoV antibody response 1 year symptom onset , South Korea , 2015.Emerg Infect Dis .', '2017 ; 23 : 1079-1084Google Scholar Obviously , longitudinal study duration 1 year little reassurance give possibility could another wave COVID-19 case 3 4 year .', 'Specific T-lymphocyte immunity Middle East respiratory syndrome coronavirus , however , detectable 4 year , considerably longer antibody responses.13Channappanavar R Zhao J Perlman S T cell-mediated immune response respiratory coronaviruses.Immunol Res .', '2014 ; 59 : 118-128Google Scholar Some uncertainty COVID-19 protective immunity could address monitor frequency reinfection SARS-CoV-2 .', 'Anecdotal report reinfection China South Korea regard caution individual seem clear SARS-CoV-2 infection test negative PCR might nevertheless harbour persistent virus .', 'Virus sequence study help resolve issue case confirm reinfection important understand reinfection correlate lower immunity .', 'Policy brief UK country rightly emphasise imperative collect seroprevalence data.14Department Health Social Care , UK GovernmentGovernment begin large-scale virus infection antibody test study .', 'urlplaceholder April 23 , 2020Date access : April 24 , 2020Google Scholar This approach sometimes construe narrow sense test would allow people back work .', 'However , seroprevalence data show proportion population expose potentially immune virus , thus wholly distinct snapshot people access PCR test .', 'How one determine much herd immunity sufficient mitigate subsequent substantial outbreak COVID-19 ?', 'This calculation depend several variables,15Anderson RM May RM Vaccination herd immunity infectious diseases.Nature .', '1985 ; 318 : 323-329Google Scholar include calculate basic reproduction number ( R0 ) , currently believe 2·2 SARS-CoV-2.16Li Q Guan X Wu P et al.Early transmission dynamic Wuhan , China , novel coronavirus-infected pneumonia.N Engl J Med .', '2020 ; 382 : 1199-1207Google Scholar On basis estimate R0 , herd immunity calculation suggest least 60 % population would need protective immunity , either natural infection vaccination.17Guerra FM Bolotin S Lim G et al.The basic reproduction number ( RO ) measles : systematic review.Lancet Infect Dis .', '2017 ; 17 : e420-e428Google Scholar This percentage increase R0 underestimate .', 'Most available COVID-19 serology data derive people hospitalise severe infection.8Tan W Lu Y Zhang J et al.Viral kinetics antibody response patient COVID-19.medRxiv .', '2020 ; ( publish online March 26 . )', '( preprint ) urlplaceholder Scholar , 18Wu F Wang A Liu M et al.Neutralizing antibody response SARS-CoV-2 COVID-19 recover patient cohort implications.bioRxiv .', '2020 ; ( publish online April 20 . )', 'urlplaceholder Scholar In group , around 90 % develop IgG antibody within first 2 week symptomatic infection appearance coincide disappearance virus,18Wu F Wang A Liu M et al.Neutralizing antibody response SARS-CoV-2 COVID-19 recover patient cohort implications.bioRxiv .', '2020 ; ( publish online April 20 . )', 'urlplaceholder Scholar support causal relationship event .', 'However , key question concern antibody non-hospitalised individual either milder disease symptom .', 'Anecdotal result community sample yield estimate 10 % test “ control ” develop specific IgG antibody .', 'We await larger seroprevalence datasets , seem likely natural exposure pandemic might , short medium term , deliver require level herd immunity substantial need mass vaccination programme .', 'There 100 candidate COVID-19 vaccine development , handful , soon , phase 1 trial ass safety immunogenicity.4Thanh Le T Andreadakis Z Kumar A et al.The COVID-19 vaccine development landscape.Nat Rev Drug Discov .', '2020 ; ( publish online April 9 .', ') DOI:10.1038/d41573-020-00073-5Google Scholar Candidate vaccine encompass diverse platform differ potency immunity stimulate , specific arsenal immune mediator mobilise , number require boost , durability protection , tractability production supply chains.3Amanat F Krammer F SARS-CoV-2 vaccine : status report.Immunity .', '2020 ; 52 : 583-589Google Scholar , 4Thanh Le T Andreadakis Z Kumar A et al.The COVID-19 vaccine development landscape.Nat Rev Drug Discov .', '2020 ; ( publish online April 9 .', ') DOI:10.1038/d41573-020-00073-5Google Scholar Safety evaluation candidate COVID-19 vaccine need highest rigour .', 'Some feature immune response induce infection , high concentration tumour necrosis factor interleukin 6 , could elicit candidate vaccine , identify biomarkers severe outcome.19Feldmann M Maini RN Woody JN et al.Trials anti-tumour necrosis factor therapy COVID-19 urgently needed.Lancet .', '2020 ; ( publish online April 9 . )', 'urlplaceholder Scholar Researchers commend decade iterative effort , bring u point many candidate vaccine development novel virus first sequence January , 2020 .', 'Delivery efficacious vaccine competitive race finish , consider evaluation safe , potent , global response.4Thanh Le T Andreadakis Z Kumar A et al.The COVID-19 vaccine development landscape.Nat Rev Drug Discov .', '2020 ; ( publish online April 9 .', ') DOI:10.1038/d41573-020-00073-5Google Scholar Few would disagree science guide clinical therapeutic approach infect person .', 'Science must also guide policy decision .', 'Reliance comprehensive seroprevalence data solid , research-based grasp correlate protection allow policy guide secure , evidence-based assumption herd immunity , rather optimistic guess .', 'View Large Image Copyright © 2020 Ramon Andrade 3Dciencia/Science Photo Library View Large Image Copyright © 2020 Ramon Andrade 3Dciencia/Science Photo Library We declare compete interest .']","['third', 'world', 'lockdown', 'public', 'health', 'measure', 'curb', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'virus', 'cause', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'policy', 'maker', 'increasingly', 'press', 'articulate', 'rationale', 'strategy', 'move', 'lockdown', '', 'process', 're-emergence', 'already', 'cautiously', 'start', 'austria', '', 'switzerland', '', 'denmark', '', 'wuhan', '', 'us', 'state', '', 'counterpoise', 'disease', 'spread', 'socioeconomic', 'cost', 'debate', '', 'essential', 'policy', 'maker', 'affect', 'country', 'best', 'possible', 'data', 'understand', 'inform', 'course', 'action', '', 'strategies', 'various', 'country', 'aim', 'stagger', 'return', 'work', 'basis', 'disease', 'severity', 'risk', 'age', 'account', 'expose', 'lower-risk', 'individual', '', 'young', 'people', 'comorbidities', '', 'virus', 'increase', 'herd', 'immunity', 'still', 'result', 'pandemic', 'spread', '', 'selective', 'pressure', 'sars-cov-2', 'transmissionstop', 'transmission', 'stop', 'virus', '', 'linchpin', 'strategy', 'move', 'lockdown', 'seemingly', 'rest', 'increase', 'test', 'contact', 'trace', '', 'possible', 'return-to-work', 'permit', 'base', 'immune', 'status1studdert', 'dm', 'hall', 'disease', 'control', '', 'civil', 'liberty', '', 'mass', 'testingcalibrating', 'restriction', 'covid-19', 'pandemicn', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'doi101056nejmp2007637google', 'repurposed', 'new', 'therapeutics2martinez', 'compounds', 'therapeutic', 'potential', 'novel', 'respiratory', '2019', 'coronavirusantimicrob', 'agents', 'chemother', '', '2020', '', '64', '', 'e00399-e00420google', '', 'finally', '', 'vaccination3amanat', 'f', 'krammer', 'f', 'sars-cov-2', 'vaccine', '', 'status', 'reportimmunity', '', '2020', '', '52', '', '583-589google', '', '4thanh', 'le', 'andreadakis', 'z', 'kumar', 'althe', 'covid-19', 'vaccine', 'development', 'landscapenat', 'rev', 'drug', 'discov', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'doi101038d41573-020-00073-5google', 'approach', 'broadly', 'sensible', '', 'yet', 'immunology', 'complex', 'branch', 'molecular', 'medicine', 'policy', 'maker', 'alert', 'important', 'aspect', 'immunology', 'relation', 'covid-19', '', 'certainty', 'immunological', 'correlate', 'antiviral', 'protection', 'proportion', 'population', 'must', 'attain', '', 'impossible', 'identify', 'point', 'level', 'immunity', 'reach', '', 'current', 'discussion', '', 'example', '', 'address', 'notion', 'scale', 'antibody', 'test', 'determine', 'immune', '', 'thus', 'give', 'indication', 'extent', 'herd', 'immunity', 'confirm', 're-enter', 'workforce', '', 'question', 'address', 'accuracy', 'test', 'practicality', 'implementation', 'laboratory-based', 'versus', 'home-use', 'assays5adams', 'er', 'anand', 'r', 'andersson', 'alevaluation', 'antibody', 'test', 'sars-cov-2', 'elisa', 'lateral', 'flow', 'immunoassaysbiorxiv', '', '2020', '', '', 'publish', 'online', 'april', '20', '', '', '', 'preprint', '', 'urlplaceholder', 'country', 'contemplate', 'issue', '', 'another', 'crucial', 'question', 'solid', 'assumption', 'antibody', 'sars-cov-2', 'spike', 'protein', 'equate', 'functional', 'protection', '', 'furthermore', '', 'presence', 'antibody', 'protective', '', 'decide', 'proportion', 'population', 'require', 'antibody', 'mitigate', 'subsequent', 'wave', 'case', 'covid-19', '', 'discussion', 'inform', 'consideration', 'correlate', 'protection', '', 'initially', 'propose', 'stanley', 'plotkin6plotkin', 'sa', 'vaccination', 'major', 'infectious', 'diseasescr', 'acad', 'sci', 'iii', '', '1999', '', '322', '', '943-951google', '', '7plotkin', 'sa', 'immunologic', 'correlate', 'protection', 'induce', 'vaccinationpediatr', 'infect', 'dis', 'j', '', '2001', '', '20', '', '63-75google', 'concept', 'rest', 'notion', 'empirically', 'define', '', 'quantifiable', 'immune', 'parameter', 'determine', 'attainment', 'protection', 'give', 'pathogen', '', 'caution', 'total', 'measurable', 'antibody', 'precisely', 'protective', '', 'virus-neutralising', 'antibody', '', 'furthermore', '', 'study', 'covid-19', 'show', '1020', '', 'symptomatically', 'infect', 'people', 'little', 'detectable', 'antibody8tan', 'w', 'lu', 'zhang', 'j', 'alviral', 'kinetics', 'antibody', 'response', 'patient', 'covid-19medrxiv', '', '2020', '', '', 'publish', 'online', 'march', '26', '', '', '', 'preprint', '', 'urlplaceholder', 'case', 'covid-19', '', 'low', 'virus-binding', 'antibody', 'titre', 'correlate', 'lethal', 'near-lethal', 'infection', '', 'mild', 'infection', 'little', 'antigenic', 'stimulation', '', 'importantly', '', 'scientist', 'must', 'identify', 'correlate', 'protection', 'robust', 'understand', 'correlate', 'progression', 'severe', 'covid-19', '', 'since', 'knowledge', 'latter', 'inform', 'former', '', 'route', 'certainty', 'degree', 'nature', 'immunity', 'require', 'protection', 'require', 'evidence', 'formal', 'proof', 'approach', 'titrate', 'transfer', 'antibody', 'lymphocyte', 'define', 'protection', 'non-human', 'primate', 'model', '', '', 'example', '', 'study', 'ebola', 'virus9stanley', 'da', 'honko', 'asiedu', 'c', 'alchimpanzee', 'adenovirus', 'vaccine', 'generate', 'acute', 'durable', 'protective', 'immunity', 'ebolavirus', 'challengenat', 'med', '', '2014', '', '20', '', '1126-1129google', 'study', 'survivor', 'sars', 'show', '90', '', 'functional', '', 'virus-neutralising', 'antibody', 'around', '50', '', 'strong', 't-lymphocyte', 'responses10li', 'ck', 'wu', 'h', 'yan', 'h', 'alt', 'cell', 'response', 'whole', 'sars', 'coronavirus', 'humansj', 'immunol', '', '2008', '', '181', '', '5490-5500google', 'observation', 'bolster', 'confidence', 'simple', 'view', 'survivor', 'severe', 'covid-19', 'expect', 'protective', 'antibody', '', 'caveat', 'study', '', 'either', 'sars', 'survivor', 'covid-19', 'patient', '', 'focus', 'people', 'hospitalise', 'severe', '', 'symptomatic', 'disease', '', 'similar', 'data', 'urgently', 'individual', 'sars-cov-2', 'infection', 'hospitalise', '', 'long', 'immunity', 'covid-19', 'likely', 'last', '', 'best', 'estimate', 'closely', 'relate', 'coronaviruses', 'suggest', '', 'people', 'antibody', 'response', '', 'immunity', 'wane', '', 'detectable', 'beyond', '1', 'year', 'hospitalisation10li', 'ck', 'wu', 'h', 'yan', 'h', 'alt', 'cell', 'response', 'whole', 'sars', 'coronavirus', 'humansj', 'immunol', '', '2008', '', '181', '', '5490-5500google', '', '11temperton', 'nj', 'chan', 'pk', 'simmons', 'g', 'allongitudinally', 'profile', 'neutralize', 'antibody', 'response', 'sars', 'coronavirus', 'pseudotypesemerg', 'infect', 'dis', '', '2005', '', '11', '', '411-416google', '', '12choe', 'pg', 'perera', 'rapm', 'park', 'wb', 'almers-cov', 'antibody', 'response', '1', 'year', 'symptom', 'onset', '', 'south', 'korea', '', '2015emerg', 'infect', 'dis', '', '2017', '', '23', '', '1079-1084google', 'obviously', '', 'longitudinal', 'study', 'duration', '1', 'year', 'little', 'reassurance', 'give', 'possibility', 'another', 'wave', 'covid-19', 'case', '3', '4', 'year', '', 'specific', 't-lymphocyte', 'immunity', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'however', '', 'detectable', '4', 'year', '', 'considerably', 'longer', 'antibody', 'responses13channappanavar', 'r', 'zhao', 'j', 'perlman', 'cell-mediated', 'immune', 'response', 'respiratory', 'coronavirusesimmunol', 'res', '', '2014', '', '59', '', '118-128google', 'uncertainty', 'covid-19', 'protective', 'immunity', 'address', 'monitor', 'frequency', 'reinfection', 'sars-cov-2', '', 'anecdotal', 'report', 'reinfection', 'china', 'south', 'korea', 'regard', 'caution', 'individual', 'clear', 'sars-cov-2', 'infection', 'test', 'negative', 'pcr', 'nevertheless', 'harbour', 'persistent', 'virus', '', 'virus', 'sequence', 'study', 'help', 'resolve', 'issue', 'case', 'confirm', 'reinfection', 'important', 'understand', 'reinfection', 'correlate', 'lower', 'immunity', '', 'policy', 'brief', 'uk', 'country', 'rightly', 'emphasise', 'imperative', 'collect', 'seroprevalence', 'data14department', 'health', 'social', 'care', '', 'uk', 'governmentgovernment', 'begin', 'large-scale', 'virus', 'infection', 'antibody', 'test', 'study', '', 'urlplaceholder', 'april', '23', '', '2020date', 'access', '', 'april', '24', '', '2020google', 'approach', 'sometimes', 'construe', 'narrow', 'sense', 'test', 'allow', 'people', 'back', 'work', '', 'however', '', 'seroprevalence', 'data', 'show', 'proportion', 'population', 'expose', 'potentially', 'immune', 'virus', '', 'thus', 'wholly', 'distinct', 'snapshot', 'people', 'access', 'pcr', 'test', '', 'one', 'determine', 'much', 'herd', 'immunity', 'sufficient', 'mitigate', 'subsequent', 'substantial', 'outbreak', 'covid-19', '', 'calculation', 'depend', 'several', 'variables15anderson', 'rm', 'rm', 'vaccination', 'herd', 'immunity', 'infectious', 'diseasesnature', '', '1985', '', '318', '', '323-329google', 'include', 'calculate', 'basic', 'reproduction', 'number', '', 'r0', '', '', 'currently', 'believe', '22', 'sars-cov-216li', 'q', 'guan', 'x', 'wu', 'p', 'alearly', 'transmission', 'dynamic', 'wuhan', '', 'china', '', 'novel', 'coronavirus-infected', 'pneumonian', 'engl', 'j', 'med', '', '2020', '', '382', '', '1199-1207google', 'basis', 'estimate', 'r0', '', 'herd', 'immunity', 'calculation', 'suggest', 'least', '60', '', 'population', 'protective', 'immunity', '', 'either', 'natural', 'infection', 'vaccination17guerra', 'fm', 'bolotin', 'lim', 'g', 'althe', 'basic', 'reproduction', 'number', '', 'ro', '', 'measles', '', 'systematic', 'reviewlancet', 'infect', 'dis', '', '2017', '', '17', '', 'e420-e428google', 'percentage', 'increase', 'r0', 'underestimate', '', 'available', 'covid-19', 'serology', 'data', 'derive', 'people', 'hospitalise', 'severe', 'infection8tan', 'w', 'lu', 'zhang', 'j', 'alviral', 'kinetics', 'antibody', 'response', 'patient', 'covid-19medrxiv', '', '2020', '', '', 'publish', 'online', 'march', '26', '', '', '', 'preprint', '', 'urlplaceholder', '', '18wu', 'f', 'wang', 'liu', 'alneutralizing', 'antibody', 'response', 'sars-cov-2', 'covid-19', 'recover', 'patient', 'cohort', 'implicationsbiorxiv', '', '2020', '', '', 'publish', 'online', 'april', '20', '', '', 'urlplaceholder', 'group', '', 'around', '90', '', 'develop', 'igg', 'antibody', 'within', 'first', '2', 'week', 'symptomatic', 'infection', 'appearance', 'coincide', 'disappearance', 'virus18wu', 'f', 'wang', 'liu', 'alneutralizing', 'antibody', 'response', 'sars-cov-2', 'covid-19', 'recover', 'patient', 'cohort', 'implicationsbiorxiv', '', '2020', '', '', 'publish', 'online', 'april', '20', '', '', 'urlplaceholder', 'support', 'causal', 'relationship', 'event', '', 'however', '', 'key', 'question', 'concern', 'antibody', 'non-hospitalised', 'individual', 'either', 'milder', 'disease', 'symptom', '', 'anecdotal', 'result', 'community', 'sample', 'yield', 'estimate', '10', '', 'test', '', 'control', '', 'develop', 'specific', 'igg', 'antibody', '', 'await', 'larger', 'seroprevalence', 'datasets', '', 'likely', 'natural', 'exposure', 'pandemic', '', 'short', 'medium', 'term', '', 'deliver', 'require', 'level', 'herd', 'immunity', 'substantial', 'mass', 'vaccination', 'programme', '', '100', 'candidate', 'covid-19', 'vaccine', 'development', '', 'handful', '', 'soon', '', 'phase', '1', 'trial', 'ass', 'safety', 'immunogenicity4thanh', 'le', 'andreadakis', 'z', 'kumar', 'althe', 'covid-19', 'vaccine', 'development', 'landscapenat', 'rev', 'drug', 'discov', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'doi101038d41573-020-00073-5google', 'candidate', 'vaccine', 'encompass', 'diverse', 'platform', 'differ', 'potency', 'immunity', 'stimulate', '', 'specific', 'arsenal', 'immune', 'mediator', 'mobilise', '', 'number', 'require', 'boost', '', 'durability', 'protection', '', 'tractability', 'production', 'supply', 'chains3amanat', 'f', 'krammer', 'f', 'sars-cov-2', 'vaccine', '', 'status', 'reportimmunity', '', '2020', '', '52', '', '583-589google', '', '4thanh', 'le', 'andreadakis', 'z', 'kumar', 'althe', 'covid-19', 'vaccine', 'development', 'landscapenat', 'rev', 'drug', 'discov', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'doi101038d41573-020-00073-5google', 'safety', 'evaluation', 'candidate', 'covid-19', 'vaccine', 'highest', 'rigour', '', 'feature', 'immune', 'response', 'induce', 'infection', '', 'high', 'concentration', 'tumour', 'necrosis', 'factor', 'interleukin', '6', '', 'elicit', 'candidate', 'vaccine', '', 'identify', 'biomarkers', 'severe', 'outcome19feldmann', 'maini', 'rn', 'woody', 'jn', 'altrials', 'anti-tumour', 'necrosis', 'factor', 'therapy', 'covid-19', 'urgently', 'neededlancet', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'urlplaceholder', 'researchers', 'commend', 'decade', 'iterative', 'effort', '', 'bring', 'u', 'point', 'candidate', 'vaccine', 'development', 'novel', 'virus', 'first', 'sequence', 'january', '', '2020', '', 'delivery', 'efficacious', 'vaccine', 'competitive', 'race', 'finish', '', 'consider', 'evaluation', 'safe', '', 'potent', '', 'global', 'response4thanh', 'le', 'andreadakis', 'z', 'kumar', 'althe', 'covid-19', 'vaccine', 'development', 'landscapenat', 'rev', 'drug', 'discov', '', '2020', '', '', 'publish', 'online', 'april', '9', '', '', 'doi101038d41573-020-00073-5google', 'disagree', 'science', 'guide', 'clinical', 'therapeutic', 'approach', 'infect', 'person', '', 'science', 'must', 'guide', 'policy', 'decision', '', 'reliance', 'comprehensive', 'seroprevalence', 'data', 'solid', '', 'research-based', 'grasp', 'correlate', 'protection', 'allow', 'policy', 'guide', 'secure', '', 'evidence-based', 'assumption', 'herd', 'immunity', '', 'optimistic', 'guess', '', 'view', 'large', 'image', 'copyright', '', '2020', 'ramon', 'andrade', '3dcienciascience', 'photo', 'library', 'view', 'large', 'image', 'copyright', '', '2020', 'ramon', 'andrade', '3dcienciascience', 'photo', 'library', 'declare', 'compete', 'interest', '']",1419,"{'': 247, 'covid-19': 23, 'antibody': 23, '2020': 18, 'immunity': 17, 'vaccine': 13, 'sars-cov-2': 11, 'publish': 11, 'online': 11, 'april': 11, 'response': 11, 'protection': 10, 'test': 9, 'virus': 8, 'correlate': 8, 'infection': 8, 'people': 7, 'herd': 7, 'immune': 7, 'urlplaceholder': 7}","{'infection': 8, 'sars-cov-2': 11, 'safety': 2}",21,0.3818
DOI:10.1016/S0140-6736(20)30251-8,10.1016/S0140-6736(20)30251-8,Articles,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['genomic', 'characterisation', 'epidemiology', '2019', 'novel', 'coronavirus', '', 'implication', 'virus', 'origin', 'receptor', 'bind']","['BackgroundIn late December , 2019 , patient present viral pneumonia due unidentified microbial agent report Wuhan , China .', 'A novel coronavirus subsequently identify causative pathogen , provisionally name 2019 novel coronavirus ( 2019-nCoV ) .', 'As Jan 26 , 2020 , 2000 case 2019-nCoV infection confirm , involve people live visit Wuhan , human-to-human transmission confirmed.MethodsWe next-generation sequence sample bronchoalveolar lavage fluid culture isolate nine inpatient , eight visit Huanan seafood market Wuhan .', 'Complete partial 2019-nCoV genome sequence obtain individual .', 'Viral contigs connect use Sanger sequence obtain full-length genome , terminal region determine rapid amplification cDNA end .', 'Phylogenetic analysis 2019-nCoV genome coronaviruses use determine evolutionary history virus help infer likely origin .', 'Homology model do explore likely receptor-binding property virus.FindingsThe ten genome sequence 2019-nCoV obtain nine patient extremely similar , exhibit 99·98 % sequence identity .', 'Notably , 2019-nCoV closely relate ( 88 % identity ) two bat-derived severe acute respiratory syndrome ( SARS ) -like coronaviruses , bat-SL-CoVZC45 bat-SL-CoVZXC21 , collect 2018 Zhoushan , eastern China , distant SARS-CoV ( 79 % ) MERS-CoV ( 50 % ) .', 'Phylogenetic analysis reveal 2019-nCoV fell within subgenus Sarbecovirus genus Betacoronavirus , relatively long branch length closest relative bat-SL-CoVZC45 bat-SL-CoVZXC21 , genetically distinct SARS-CoV .', 'Notably , homology model reveal 2019-nCoV similar receptor-binding domain structure SARS-CoV , despite amino acid variation key residues.Interpretation2019-nCoV sufficiently divergent SARS-CoV consider new human-infecting betacoronavirus .', 'Although phylogenetic analysis suggest bat might original host virus , animal sell seafood market Wuhan might represent intermediate host facilitate emergence virus human .', 'Importantly , structural analysis suggest 2019-nCoV might able bind angiotensin-converting enzyme 2 receptor human .', 'The future evolution , adaptation , spread virus warrant urgent investigation.FundingNational Key Research Development Program China , National Major Project Control Prevention Infectious Disease China , Chinese Academy Sciences , Shandong First Medical University .', 'In late December , 2019 , patient present viral pneumonia due unidentified microbial agent report Wuhan , China .', 'A novel coronavirus subsequently identify causative pathogen , provisionally name 2019 novel coronavirus ( 2019-nCoV ) .', 'As Jan 26 , 2020 , 2000 case 2019-nCoV infection confirm , involve people live visit Wuhan , human-to-human transmission confirm .', 'We next-generation sequence sample bronchoalveolar lavage fluid culture isolate nine inpatient , eight visit Huanan seafood market Wuhan .', 'Complete partial 2019-nCoV genome sequence obtain individual .', 'Viral contigs connect use Sanger sequence obtain full-length genome , terminal region determine rapid amplification cDNA end .', 'Phylogenetic analysis 2019-nCoV genome coronaviruses use determine evolutionary history virus help infer likely origin .', 'Homology model do explore likely receptor-binding property virus .', 'The ten genome sequence 2019-nCoV obtain nine patient extremely similar , exhibit 99·98 % sequence identity .', 'Notably , 2019-nCoV closely relate ( 88 % identity ) two bat-derived severe acute respiratory syndrome ( SARS ) -like coronaviruses , bat-SL-CoVZC45 bat-SL-CoVZXC21 , collect 2018 Zhoushan , eastern China , distant SARS-CoV ( 79 % ) MERS-CoV ( 50 % ) .', 'Phylogenetic analysis reveal 2019-nCoV fell within subgenus Sarbecovirus genus Betacoronavirus , relatively long branch length closest relative bat-SL-CoVZC45 bat-SL-CoVZXC21 , genetically distinct SARS-CoV .', 'Notably , homology model reveal 2019-nCoV similar receptor-binding domain structure SARS-CoV , despite amino acid variation key residue .', '2019-nCoV sufficiently divergent SARS-CoV consider new human-infecting betacoronavirus .', 'Although phylogenetic analysis suggest bat might original host virus , animal sell seafood market Wuhan might represent intermediate host facilitate emergence virus human .', 'Importantly , structural analysis suggest 2019-nCoV might able bind angiotensin-converting enzyme 2 receptor human .', 'The future evolution , adaptation , spread virus warrant urgent investigation .', 'National Key Research Development Program China , National Major Project Control Prevention Infectious Disease China , Chinese Academy Sciences , Shandong First Medical University .', 'Viruses family Coronaviridae posse single-strand , positive-sense RNA genome range 26 32 kilobases length.1Su S Wong G Shi W et al.Epidemiology , genetic recombination , pathogenesis coronaviruses.Trends Microbiol .', '2016 ; 24 : 490-502Google Scholar Coronaviruses identify several avian hosts,2Cavanagh D Coronavirus avian infectious bronchitis virus.Vet Res .', '2007 ; 38 : 281-297Google Scholar , 3Ismail MM Tang AY Saif YM Pathogenicity turkey coronavirus turkey chickens.Avian Dis .', '2003 ; 47 : 515-522Google Scholar well various mammal , include camel , bat , mask palm civet , mouse , dog , cat .', 'Novel mammalian coronaviruses regularly identified.1Su S Wong G Shi W et al.Epidemiology , genetic recombination , pathogenesis coronaviruses.Trends Microbiol .', '2016 ; 24 : 490-502Google Scholar For example , HKU2-related coronavirus bat origin responsible fatal acute diarrhoea syndrome pig 2018.4Zhou P Fan H Lan T et al.Fatal swine acute diarrhoea syndrome cause HKU2-related coronavirus bat origin.Nature .', '2018 ; 556 : 255-258Google Scholar Among several coronaviruses pathogenic human , associate mild clinical symptoms,1Su S Wong G Shi W et al.Epidemiology , genetic recombination , pathogenesis coronaviruses.Trends Microbiol .', '2016 ; 24 : 490-502Google Scholar two notable exception : severe acute respiratory syndrome ( SARS ) coronavirus ( SARS-CoV ) , novel betacoronavirus emerge Guangdong , southern China , November , 2002,5Peiris JS Guan Y Yuen KY Severe acute respiratory syndrome.Nat Med .', '2004 ; 10 : S88-S97Google Scholar result 8000 human infection 774 death 37 country 2002–03 ; 6Chan-Yeung M Xu RH SARS : epidemiology.Respirology .', '2003 ; 8 : S9-S14Google Scholar Middle East respiratory syndrome ( MERS ) coronavirus ( MERS-CoV ) , first detect Saudi Arabia 20127Zaki AM van Boheemen S Bestebroer TM Osterhaus AD Fouchier RA Isolation novel coronavirus man pneumonia Saudi Arabia.N Engl J Med .', '2012 ; 367 : 1814-1820Google Scholar responsible 2494 laboratory-confirmed case infection 858 fatality since September , 2012 , include 38 death follow single introduction South Korea.8Lee J Chowell G Jung E A dynamic compartmental model Middle East respiratory syndrome outbreak Republic Korea : retrospective analysis control intervention superspreading events.J Theor Biol .', '2016 ; 408 : 118-126Google Scholar , 9Lee JY Kim YJ Chung EH et al.The clinical virological feature first import case cause MERS-CoV outbreak South Korea , 2015.BMC Infect Dis .', '2017 ; 17 : 498Google Scholar Research contextEvidence studyThe causal agent outbreak severe pneumonia Wuhan , China , novel coronavirus , provisionally name 2019 novel coronavirus ( 2019-nCoV ) .', 'The first case report December , 2019.Added value studyWe describe genomic characteristic 2019-nCoV similarity difference coronaviruses , include virus cause severe acute respiratory syndrome epidemic 2002–03 .', 'Genome sequence 2019-nCoV sample nine patient among early case severe infection almost genetically identical , suggest recent emergence virus human outbreak detect relatively rapidly .', '2019-nCoV closely relate betacoronaviruses bat origin , indicate animal likely reservoir host emerge viral pathogen.Implications available evidenceBy document presence 2019-nCoV sample patient , study extend previous evidence virus lead novel pneumonia cause severe disease Wuhan geographical locality .', 'Currently available data suggest 2019-nCoV infect human population bat reservoir , although remain unclear currently unknown animal specie act intermediate host bat human .', 'Evidence study The causal agent outbreak severe pneumonia Wuhan , China , novel coronavirus , provisionally name 2019 novel coronavirus ( 2019-nCoV ) .', 'The first case report December , 2019 .', 'Added value study We describe genomic characteristic 2019-nCoV similarity difference coronaviruses , include virus cause severe acute respiratory syndrome epidemic 2002–03 .', 'Genome sequence 2019-nCoV sample nine patient among early case severe infection almost genetically identical , suggest recent emergence virus human outbreak detect relatively rapidly .', '2019-nCoV closely relate betacoronaviruses bat origin , indicate animal likely reservoir host emerge viral pathogen .', 'Implications available evidence By document presence 2019-nCoV sample patient , study extend previous evidence virus lead novel pneumonia cause severe disease Wuhan geographical locality .', 'Currently available data suggest 2019-nCoV infect human population bat reservoir , although remain unclear currently unknown animal specie act intermediate host bat human .', 'In late December , 2019 , several patient viral pneumonia find epidemiologically associate Huanan seafood market Wuhan , Hubei province China , number non-aquatic animal bird rabbit also sale outbreak .', 'A novel , human-infecting coronavirus,10Tan W Zhao X Ma X et al.A novel coronavirus genome identify cluster pneumonia cases—Wuhan , China 2019–2020.China CDC Weekly .', '2020 ; 2 : 61-62Google Scholar , 11Zhu N Zhang D Wang W et al.A novel coronavirus patient pneumonia China , 2019.N Engl J Med .', '2020 ; ( publish online Jan 24 .', ') DOI:10.1056/NEJMoa2001017Google Scholar provisionally name 2019 novel coronavirus ( 2019-nCoV ) , identify use next-generation sequence .', 'As Jan 28 , 2020 , China report 5900 confirm 9000 suspect case 2019-nCoV infection across 33 Chinese province municipality , 106 fatality .', 'In addition , 2019-nCoV report Thailand , Japan , South Korea , Malaysia , Singapore , USA .', 'Infections medical worker family cluster also report human-to-human transmission confirmed.12Chan JFW Yuan S Kok KH et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; ( publish online Jan 24 ) urlplaceholder Scholar Most infect patient high fever dyspnoea , chest radiograph reveal invasive lesion lungs.12Chan JFW Yuan S Kok KH et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; ( publish online Jan 24 ) urlplaceholder Scholar , 13Huang C Wang Y Li X et al.Clinical feature patient infect 2019 novel coronavirus Wuhan , China.Lancet .', '2020 ; ( publish online Jan 24 ) urlplaceholder Scholar We report epidemiological data nine inpatient , least three hospital Wuhan , diagnose viral pneumonia unidentified cause .', 'Using next-generation sequence bronchoalveolar lavage fluid sample culture isolate patient , 2019-nCoV find .', 'We describe genomic characterisation ten genome novel virus , provide important information origin cell receptor bind virus .', 'Nine patient viral pneumonia negative common respiratory pathogen , present least three hospital Wuhan , include study .', 'Eight patient visit Huanan seafood market onset illness , one patient ( WH04 ) visit market stay hotel near market Dec 23 Dec 27 , 2019 ( table ) .', 'Five patient ( WH19001 , WH19002 , WH19004 , WH19008 , YS8011 ) sample collect Chinese Center Disease Control Prevention ( CDC ) test 18 virus four bacteria use RespiFinderSmart22 Kit ( PathoFinder , Maastricht , Netherlands ) LightCycler 480 Real-Time PCR system ( Roche , Rotkreuz , Switzerland ) .', 'Presence SARS-CoV MERS-CoV test use previously report method.14Niu P Shen J Zhu N Lu R Tan W Two-tube multiplex real-time reverse transcription PCR detect six human coronaviruses.Virol Sin .', '2016 ; 31 : 85-88Google Scholar All five CDC sample negative common respiratory pathogen screen .', 'Four patient ( WH01 , WH02 , WH03 , WH04 ) sample collect BGI ( Beijing , China ) , test five virus one bacterium use RespiPathogen 6 Kit ( Jiangsu Macro & Micro Test , Nantong , China ) Applied Biosystems ABI 7500 Real-Time PCR system ( ThermoFisher Scientific , Foster City , CA , USA ) .', 'All four sample negative target respiratory pathogens.TableInformation sample take nine patient infect 2019-nCoVPatient informationSample informationGenome sequence obtainedExposure Huanan seafood marketDate symptom onsetAdmission dateSample typeCollection dateCt valueSamples WH19001 WH19005YesDec 23 , 2019Dec 29 , 2019BALF culture virusDec 30 , 201930·23CompleteSample WH19002YesDec 22 , 2019NABALFDec 30 , 201930·50Partial ( 27 130 nucleotide ) Sample WH19004YesNANABALFJan 1 , 202032·14CompleteSample WH19008YesNADec 29 , 2019BALFDec 30 , 201926·35CompleteSample YS8011YesNANAThroat swabJan 7 , 202022·85CompleteSample WH01YesNANABALFDec 26 , 201932·60CompleteSample WH02YesNANABALFDec 31 , 201934·23Partial ( 19 503 nucleotide ) Sample WH03YesDec 26 , 2019NABALFJan 1 , 202025·38CompleteSample WH04No * * Patient stay hotel near Huanan seafood market Dec 23 Dec 27 , 2019 , report fever Dec 27 , 2019.Dec 27 , 2019NABALFJan 5 , 202025·23CompleteCt=threshold cycle .', 'BALF=bronchoalveolar lavage fluid .', 'NA=not available .', '2019-nCoV=2019 novel coronavirus .', '* Patient stay hotel near Huanan seafood market Dec 23 Dec 27 , 2019 , report fever Dec 27 , 2019 .', 'Open table new tab Ct=threshold cycle .', 'BALF=bronchoalveolar lavage fluid .', 'NA=not available .', '2019-nCoV=2019 novel coronavirus .', 'Special-pathogen-free human airway epithelial ( HAE ) cell use virus isolation .', 'Briefly , bronchoalveolar lavage fluid throat swab patient inoculate HAE cell apical surface .', 'HAE cell maintain air–liquid interface incubate 37°C .', 'The cell monitor daily cytopathic effect light microscopy cell supernatant collect use quantitative RT-PCR assay .', 'After three passage , apical sample collect sequence .', 'All collect sample send BGI sequence .', ""140 μL bronchoalveolar lavage fluid sample ( WH01 WH04 ) reserve RNA extraction use QIAamp Viral RNA Mini Kit ( 52904 ; Qiagen , Heiden , Germany ) , accord manufacturer 's recommendation ."", 'A probe-captured technique use remove human nucleic acid .', 'The remain RNA reverse-transcribed cDNA , follow second-strand synthesis .', 'Using synthetic double-stranded DNA , DNA library construct DNA-fragmentation , end-repair , adaptor-ligation , PCR amplification .', 'The construct library qualify Invitrogen Qubit 2.0 Fluorometer ( ThermoFisher , Foster City , CA , USA ) , qualify double-stranded DNA library transform single-stranded circular DNA library DNA-denaturation circularisation .', 'DNA nanoballs generate single-stranded circular DNA roll circle amplification , qualify Qubit 2.0 load onto flow cell sequence PE100 DNBSEQ-T7 platform ( MGI , Shenzhen , China ) .', 'After remove adapter , low-quality , low-complexity read , high-quality genome sequence data generate .', 'Sequence read first filter human reference genome ( hg19 ) use Burrows-Wheeler Alignment.15Li H Durbin R Fast accurate short read alignment Burrows-Wheeler transform.Bioinformatics .', '2009 ; 25 : 1754-1760Google Scholar The remain data align local nucleotide database ( use Burrows-Wheeler Alignment ) non-redundant protein database ( use RapSearch ) ,16Zhao Y Tang H Ye Y RAPSearch2 : fast memory-efficient protein similarity search tool next-generation sequence data.Bioinformatics .', '2012 ; 28 : 125-126Google Scholar download US National Center Biotechnology Information website , contain coronaviruses publish .', 'Finally , map read assemble SPAdes17Nurk S Bankevich A Antipov D et al.Assembling genome mini-metagenomes highly chimeric reads.in : Deng M Jiang R Sun F Zhang X Research computational molecular biology ( RECOMB 2013 ) : lecture note computer science .', 'vol 7821 .', 'Springer , Berlin2013 : 158-170Google Scholar obtain high-quality coronavirus genome sequence .', 'Primers design use OLIGO Primer Analysis Software version 6.44 basis assemble partial genome , verify Primer-Blast ( detail primer sequencs use please contact correspond author ) .', 'PCR set follow : 4·5 μL 10X buffer , 4 μL dNTP mix ( 2·5 μmol/L ) , 1 μL primer ( 10 μmol/L ) , 0·75 unit HS Ex Taq ( Takara Biomedical Technology , Beijing , China ) , total volume 30 μL .', 'The cDNAs reverse transcribe clinical sample use template , random primer use .', 'The follow program run thermocycler : 95°C 5 min ; 40 cycle 95°C 30 , 55°C 30 , 72°C 1 min determine product size ; 72°C 7 min ; 4°C hold .', 'Finally , PCR product separate agarose gel electrophoresis , product expect size sequence end Applied Biosystems 3730 DNA Analyzer platform ( Applied Biosystems , Life Technologies , Foster City , CA , USA ; detail expect size please contact correspond author ) .', 'The whole-genome sequence 2019-nCoV six sample ( WH19001 , WH19005 , WH19002 , WH19004 , WH19008 , YS8011 ) generate combination Sanger , Illumina , Oxford nanopore sequence .', 'First , viral RNAs extract directly clinical sample QIAamp Viral RNA Mini Kit , use synthesise cDNA SuperScript III Reverse Transcriptase ( ThermoFisher , Waltham , MA , USA ) N6 random primer , follow second-strand synthesis DNA Polymerase I , Large ( Klenow ) Fragment ( ThermoFisher ) .', 'Viral cDNA library prepare use Nextera XT Library Prep Kit ( Illumina , San Diego , CA , USA ) , purify Agencourt AMPure XP bead ( Beckman Coulter , Brea , CA , USA ) , follow quantification Invitrogen Qubit 2.0 Fluorometer .', 'The result DNA library sequence either MiSeq iSeq platform ( Illumina ) use 300-cycle reagent kit .', 'About 1·2–5 GB data obtain sample .', 'The raw fastQ file virus sample filter use previously describe criteria,18Pan M Gao R Lv Q et al.Human infection novel , highly pathogenic avian influenza A ( H5N6 ) virus : virological clinical findings.J Infect .', '2016 ; 72 : 52-59Google Scholar subject de novo assembly CLCBio software version 11.0.1 .', 'Mapped assembly also do use bat-derived SARS-like coronavirus isolate bat-SL-CoVZC45 ( accession number MG772933.1 ) reference .', 'Variant call , genome alignment , sequence illustration generate CLCBio software , assemble genome sequence confirm Sanger sequence .', ""Rapid amplification cDNA end ( RACE ) do obtain sequence 5′ 3′ terminus , use Invitrogen 5′ RACE System 3′ RACE System ( Invitrogen , Carlsbad , CA , USA ) , accord manufacturer 's instruction ."", 'Gene-specific primer ( appendix p 1 ) 5′ 3′ RACE PCR amplification design obtain fragment approximately 400–500 bp two region .', ""Purified PCR product clone pMD18-T Simple Vector ( TaKaRa , Takara Biotechnology , Dalian , China ) chemically competent Escherichia coli ( DH5α cell ; TaKaRa ) , accord manufacturer 's instruction ."", 'PCR product sequence use M13 forward reverse primer .', 'Reference virus genome obtain GenBank use Blastn 2019-nCoV query .', 'The open read frame verify genome sequence predict use Geneious ( version 11.1.5 ) annotate use Conserved Domain Database.19Marchler-Bauer A Bo Y Han L et al.CDD/SPARCLE : functional classification protein via subfamily domain architectures.Nucleic Acids Res .', '2017 ; 45 : D200-D203Google Scholar Pairwise sequence identity also calculate use Geneious .', 'Potential genetic recombination investigate use SimPlot software ( version 3.5.1 ) 20Lole KS Bollinger RC Paranjape RS et al.Full-length human immunodeficiency virus type 1 genome subtype C-infected seroconverters India , evidence intersubtype recombination.J Virol .', '1999 ; 73 : 152-160Google Scholar phylogenetic analysis .', 'Sequence alignment 2019-nCoV reference sequence do Mafft software ( version 7.450 ) .21Nakamura T Yamada KD Tomii K Katoh K Parallelization MAFFT large-scale multiple sequence alignments.Bioinformatics .', '2018 ; 34 : 2490-2492Google Scholar Phylogenetic analysis complete genome major cod region do RAxML software ( version 8.2.9 ) 22Stamatakis A RAxML version 8 : tool phylogenetic analysis post-analysis large phylogenies.Bioinformatics .', '2014 ; 30 : 1312-1313Google Scholar 1000 bootstrap replicate , employ general time reversible nucleotide substitution model .', 'On basis genome sequence obtain , real-time PCR detection assay develop .', 'PCR primer probe design use Applied Biosystems Primer Express Software ( ThermoFisher Scientific , Foster City , CA , USA ) basis sequence virus genome .', 'The specific primer probe set ( label reporter 6-carboxyfluorescein [ FAM ] quencher Black Hole Quencher 1 [ BHQ1 ] ) orf1a follow : forward primer 5′-AGAAGATTGGTTAGATGATGATAGT-3′ ; reverse primer 5′-TTCCATCTCTAATTGAGGTTGAACC-3′ ; probe 5′-FAM-TCCTCACTGCCGTCTTGTTGACCA-BHQ1-3′ .', 'The human GAPDH gene use internal control ( forward primer 5′-TCAAGAAGGTGGTGAAGCAGG-3′ ; reverse primer 5′-CAGCGTCAAAGGTGGAGGAGT-3′ ; probe 5′-VIC-CCTCAAGGGCATCCTGGGCTACACT-BHQ1-3′ ) .', 'Primers probe synthesise BGI ( Beijing , China ) .', 'RT-PCR do Applied Biosystems 7300 Real-Time PCR System ( ThermoScientific ) , 30 μL reaction volume consist 14 μL dilute RNA , 15 μL 2X Taqman One-Step RT-PCR Master Mix Reagents ( 4309169 ; Applied Biosystems , ThermoFisher ) , 0·5 μL 40X MultiScribe RNase inhibitor mixture , 0·75 μL forward primer ( 10 μmol/L ) , 0·75 μL reverse primer ( 10 μmol/L ) , 0·375 μL probe ( 10 μmol/L ) .', 'Thermal cycle parameter 30 min 42°C , follow 10 min 95°C , subsequent 40 cycle amplification ( 95°C 15 58°C 45 ) .', 'Fluorescence record 58°C phase .', 'The funder study role data collection , data analysis , data interpretation , write report .', 'GFG WS access data study , GFG , WS , WT , WC , GW responsible decision submit publication .', ""From nine patient ' sample analyse , eight complete two partial genome sequence 2019-nCoV obtain ."", 'These data deposit China National Microbiological Data Center ( accession number NMDC10013002 genome accession number NMDC60013002-01 NMDC60013002-10 ) data BGI deposit China National GeneBank ( accession number CNA0007332–35 ) .', 'Based genome , develop real-time PCR assay test original clinical sample BGI ( WH01 , WH02 , WH03 , WH04 ) determine threshold cycle ( Ct ) value ( table ) .', 'The remain sample test different real-time PCR assay develop Chinese CDC , Ct value range 22·85 32·41 ( table ) .', 'These result confirm presence 2019-nCoV patient .', 'Bronchoalveolar lavage fluid sample culture virus nine patient use next-generation sequence .', 'After remove host ( human ) read , de novo assembly do contigs obtain use query search non-redundant protein database .', 'Some contigs identify sample closely relate bat SARS-like betacoronavirus bat-SL-CoVZC45 betacoronavirus.23Hu D Zhu C Ai L et al.Genomic characterization infectivity novel SARS-like coronavirus Chinese bats.Emerg Microbes Infect .', '2018 ; 7 : 154Google Scholar Bat-SL-CoVZC45 use reference genome read pool map , generate consensus sequence correspond pool .', 'These consensus sequence use new reference genome .', 'Eight complete genome two partial genome ( sample WH19002 WH02 ; table ) obtain .', 'The de novo assembly clean read pool identify long contigs correspond virus high abundance .', 'The eight complete genome nearly identical across whole genome , sequence identity 99·98 % , indicative recent emergence human population ( figure 1A ) .', 'The largest nucleotide difference four mutation .', 'Notably , sequence identity two virus genome patient ( WH19001 , bronchoalveolar lavage fluid , WH19005 , cell culture ) 99·99 % , 100 % identity amino acid level .', 'In addition , partial genome sample WH02 WH19002 also nearly 100 % identity complete genome across align gene regions.Figure 1Sequence comparison genomic organisation 2019-nCoVShow full caption ( A ) Sequence alignment eight full-length genome 2019-nCoV , 29 829 base pair length , nucleotide truncate end genome .', '( B ) Coding region 2019-nCoV , bat-SL-CoVZC45 , bat-SL-CoVZXC21 , SARS-CoV , MERS-CoV .', 'Only open read frame 100 nucleotide show .', '2019-nCoV=2019 novel coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus .', 'MERS-CoV=Middle East respiratory syndrome coronavirus.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Sequence alignment eight full-length genome 2019-nCoV , 29 829 base pair length , nucleotide truncate end genome .', '( B ) Coding region 2019-nCoV , bat-SL-CoVZC45 , bat-SL-CoVZXC21 , SARS-CoV , MERS-CoV .', 'Only open read frame 100 nucleotide show .', '2019-nCoV=2019 novel coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus .', 'MERS-CoV=Middle East respiratory syndrome coronavirus .', 'A Blastn search complete genome 2019-nCoV reveal closely relate virus available GenBank bat-SL-CoVZC45 ( sequence identity 87·99 % ; query coverage 99 % ) another SARS-like betacoronavirus bat origin , bat-SL-CoVZXC21 ( accession number MG772934 ; 23Hu D Zhu C Ai L et al.Genomic characterization infectivity novel SARS-like coronavirus Chinese bats.Emerg Microbes Infect .', '2018 ; 7 : 154Google Scholar 87·23 % ; query coverage 98 % ) .', 'In five gene region ( E , M , 7 , N , 14 ) , sequence identity greater 90 % , highest 98·7 % E gene ( figure 2A ) .', 'The S gene 2019-nCoV exhibit lowest sequence identity bat-SL-CoVZC45 bat-SL-CoVZXC21 , around 75 % .', 'In addition , sequence identity 1b ( 86 % ) lower 1a ( 90 % ; figure 2A ) .', 'Most encode protein exhibit high sequence identity 2019-nCoV relate bat-derived coronaviruses ( figure 2a ) .', 'The notable exception spike protein , around 80 % sequence identity , protein 13 , 73·2 % sequence identity .', 'Notably , 2019-nCoV strain le genetically similar SARS-CoV ( 79 % ) MERS-CoV ( 50 % ) .', 'The similarity 2019-nCoV relate virus visualise use SimPlot software , 2019-nCoV consensus sequence employ query ( figure 2B ) .Figure 2Sequence identity consensus 2019-nCoV representative betacoronavirus genomesShow full caption ( A ) Sequence identity 2019-nCoV compare SARS-CoV GZ02 ( accession number AY390556 ) bat SARS-like coronaviruses bat-SL-CoVZC45 ( MG772933 ) bat-SL-CoVZXC21 ( MG772934 ) .', '( B ) Similarity 2019-nCoV relate virus .', '2019-nCoV=2019 novel coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Sequence identity 2019-nCoV compare SARS-CoV GZ02 ( accession number AY390556 ) bat SARS-like coronaviruses bat-SL-CoVZC45 ( MG772933 ) bat-SL-CoVZXC21 ( MG772934 ) .', '( B ) Similarity 2019-nCoV relate virus .', '2019-nCoV=2019 novel coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus .', 'Comparison predict cod region 2019-nCoV show possess similar genomic organisation bat-SL-CoVZC45 , bat-SL-CoVZXC21 , SARS-CoV ( figure 1B ) .', 'At least 12 cod region predict , include 1ab , S , 3 , E , M , 7 , 8 , 9 , 10b , N , 13 , 14 ( figure 1B ) .', 'The length protein encode 2019-nCoV , bat-SL-CoVZC45 , bat-SL-CoVZXC21 similar , minor insertion deletion .', 'A notable difference longer spike protein encode 2019-nCoV compare bat SARS-like coronaviruses , SARS-CoV , MERS-CoV ( figure 1B ) .', 'Phylogenetic analysis 2019-nCoV closely relate reference genome , well representative betacoronaviruses , reveal five subgenus form five well support branch ( figure 3 ) .', 'The subgenus Sarbecovirus could classify three well support clade : two SARS-CoV-related strain Rhinolophus sp Bulgaria ( accession number GU190215 ) Kenya ( KY352407 ) form clade 1 ; ten 2019-nCoV Wuhan two bat-derived SARS-like strain Zhoushan eastern China ( bat-SL-CoVZC45 bat-SL-CoVZXC21 ) form clade 2 , notable long branch separate human bat virus ; SARS-CoV strain human many genetically similar SARS-like coronaviruses bat collect southwestern China form clade 3 , bat-derived coronaviruses also fall basal position ( figure 3 ) .', 'In addition , 2019-nCoV distinct SARS-CoV phylogeny complete RNA-dependent RNA polymerase ( RdRp ) gene ( appendix p 2 ) .', 'This evidence indicate 2019-nCoV novel betacoronavirus subgenus Sarbecovirus.Figure 3Phylogenetic analysis full-length genome 2019-nCoV representative virus genus BetacoronavirusShow full caption2019-nCoV=2019 novel coronavirus .', 'MERS-CoV=Middle East respiratory syndrome coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) 2019-nCoV=2019 novel coronavirus .', 'MERS-CoV=Middle East respiratory syndrome coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus .', 'As sequence similarity plot reveal change genetic distance among virus across 2019-nCoV genome , additional phylogenetic analysis major encode region representative member subgenus Sarbecovirus .', 'Consistent genome phylogeny , 2019-nCoV , bat-SL-CoVZC45 , bat-SL-CoVZXC21 cluster together tree 1a spike gene ( appendix p 3 ) .', 'By contrast , 2019-nCoV cluster bat-SL-CoVZC45 bat-SL-CoVZXC21 1b tree , instead form distinct clade SARS-CoV , bat-SL-CoVZC45 , bat-SL-CoVZXC21 ( appendix p 3 ) , indicative potential recombination event 1b , although probably occur bat coronaviruses rather 2019-nCoV .', 'Phylogenetic analysis 2019-nCoV genome exclude 1b reveal similar evolutionary relationship full-length viral genome ( appendix p 3 ) .', 'The envelope spike ( S ) protein mediate receptor bind membrane fusion24Li F Structure , function , evolution coronavirus spike proteins.Annu Rev Virol .', '2016 ; 3 : 237-261Google Scholar crucial determine host tropism transmission capacity.25Lu G Wang Q Gao GF Bat-to-human : spike feature determine ‘ host jump ’ coronaviruses SARS-CoV , MERS-CoV , beyond.Trends Microbiol .', '2015 ; 23 : 468-478Google Scholar , 26Wang Q Wong G Lu G Yan J Gao GF MERS-CoV spike protein : target vaccine therapeutics.Antiviral Res .', '2016 ; 133 : 165-177Google Scholar Generally , spike protein coronaviruses functionally divide S1 domain ( especially position 318–510 SARS-CoV ) , responsible receptor bind , S2 domain , responsible cell membrane fusion.27He Y Zhou Y Liu S et al.Receptor-binding domain SARS-CoV spike protein induce highly potent neutralize antibody : implication develop subunit vaccine.Biochem Biophys Res Commun .', '2004 ; 324 : 773-781Google Scholar The 2019-nCoV S2 protein show around 93 % sequence identity bat-SL-CoVZC45 bat-SL-CoVZXC21—much higher S1 domain , around 68 % identity bat-derived virus .', 'Both N-terminal domain C-terminal domain S1 domain bind host receptors.28Li F Evidence common evolutionary origin coronavirus spike protein receptor-binding subunits.J Virol .', '2012 ; 86 : 2856-2858Google Scholar We inspect amino acid variation spike protein among Sarbecovirus coronaviruses ( figure 4 ) .', 'Although 2019-nCoV SARS-CoV fell within different clade ( figure 3 ) , still possess around 50 conserve amino acid S1 , whereas bat-derived virus display mutational difference ( figure 4 ) .', 'Most position C-terminal domain ( figure 4 ) .', 'In addition , number deletion event , include position 455–457 , 463–464 , 485–497 , find bat-derived strain ( figure 4 ) .Figure 4Specific amino acid variation among spike protein subgenus sarbecovirusShow full captionViruses order tree topology ( show figure 3 ) top bottom .', 'One-letter code use amino acid .', 'CoV=coronavirus .', '2019-nCoV=2019 novel coronavirus .', 'SARS=severe acute respiratory syndrome .', '* Bat-derived SARS-like virus grow human cell line mouse .', '†Bat-derived SARS-like virus without experimental data available.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) Viruses order tree topology ( show figure 3 ) top bottom .', 'One-letter code use amino acid .', 'CoV=coronavirus .', '2019-nCoV=2019 novel coronavirus .', 'SARS=severe acute respiratory syndrome .', '* Bat-derived SARS-like virus grow human cell line mouse .', '†Bat-derived SARS-like virus without experimental data available .', 'The receptor-binding domain betacoronaviruses , directly engage receptor , commonly locate C-terminal domain S1 , SARS-CoV29Li F Li W Farzan M Harrison SC Structure SARS coronavirus spike receptor-binding domain complexed receptor.Science .', '2005 ; 309 : 1864-1868Google Scholar lineage B , MERS-CoV30Lu G Hu Y Wang Q et al.Molecular basis bind novel human coronavirus MERS-CoV receptor CD26.Nature .', '2013 ; 500 : 227-231Google Scholar , 31Wang N Shi X Jiang L et al.Structure MERS-CoV spike receptor-binding domain complexed human receptor DPP4.Cell Res .', '2013 ; 23 : 986-993Google Scholar BatCoV HKU4,32Wang Q Qi J Yuan Y et al.Bat origin MERS-CoV support bat coronavirus HKU4 usage human receptor CD26.Cell Host Microbe .', '2014 ; 16 : 328-337Google Scholar lineage C ( figure 5 ) .', 'Through phylogenetic analysis receptor-binding domain four different lineage betacoronaviruses ( appendix p 4 ) , find , although 2019-nCoV closer bat-SL-CoVZC45 bat-SL-CoVZXC21 whole-genome level , receptor-binding domain 2019-nCoV fell within lineage B closer SARS-CoV ( figure 5A ) .', 'The three-dimensional structure 2019-nCoV receptor-binding domain model use Swiss-Model program33Waterhouse A Bertoni M Bienert S et al.SWISS-MODEL : homology model protein structure complexes.Nucleic Acids Res .', '2018 ; 46 : W296-W303Google Scholar SARS-CoV receptor-binding domain structure ( Protein Data Bank ID 2DD8 ) 34Prabakaran P Gan J Feng Y et al.Structure severe acute respiratory syndrome coronavirus receptor-binding domain complexed neutralize antibody.J Biol Chem .', '2006 ; 281 : 15829-15836Google Scholar template .', 'This analysis suggest , like betacoronaviruses , receptor-binding domain compose core external subdomain ( figure 5B–D ) .', 'Notably , external subdomain 2019-nCoV receptor-binding domain similar SARS-CoV .', 'This result suggest 2019-nCoV might also use angiotensin-converting enzyme 2 ( ACE2 ) cell receptor .', 'However , also observe several key residue responsible bind SARS-CoV receptor-binding domain ACE2 receptor variable 2019-nCoV receptor-binding domain ( include Asn439 , Asn501 , Gln493 , Gly485 Phe486 ; 2019-nCoV number ) .Figure 5Phylogenetic analysis homology model receptor-binding domain 2019-nCoV , SARS-CoV , MERS-CoVShow full caption ( A ) Phylogenetic analysis receptor-binding domain various betacoronaviruses .', 'The star highlight 2019-nCoV question mark mean receptor use virus remain unknown .', 'Structural comparison receptor-binding domain SARS-CoV ( B ) , 2019-nCoV ( C ) , MERS-CoV ( D ) bind receptor .', 'Core subdomains magenta , external subdomains SARS-CoV , 2019-nCoV , MERS CoV orange , dark blue , green , respectively .', 'Variable residue SARS-CoV 2019-nCoV receptor-binding site highlight stick .', 'CoV=coronavirus .', '2019-nCoV=2019 novel coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus .', 'MERS=Middle East respiratory syndrome coronavirus.View Large Image Figure ViewerDownload Hi-res image Download ( PPT ) ( A ) Phylogenetic analysis receptor-binding domain various betacoronaviruses .', 'The star highlight 2019-nCoV question mark mean receptor use virus remain unknown .', 'Structural comparison receptor-binding domain SARS-CoV ( B ) , 2019-nCoV ( C ) , MERS-CoV ( D ) bind receptor .', 'Core subdomains magenta , external subdomains SARS-CoV , 2019-nCoV , MERS CoV orange , dark blue , green , respectively .', 'Variable residue SARS-CoV 2019-nCoV receptor-binding site highlight stick .', 'CoV=coronavirus .', '2019-nCoV=2019 novel coronavirus .', 'SARS-CoV=severe acute respiratory syndrome coronavirus .', 'MERS=Middle East respiratory syndrome coronavirus .', 'From genomic surveillance clinical sample patient viral pneumonia Wuhan , China , novel coronavirus ( term 2019-nCoV ) identified.10Tan W Zhao X Ma X et al.A novel coronavirus genome identify cluster pneumonia cases—Wuhan , China 2019–2020.China CDC Weekly .', '2020 ; 2 : 61-62Google Scholar , 11Zhu N Zhang D Wang W et al.A novel coronavirus patient pneumonia China , 2019.N Engl J Med .', '2020 ; ( publish online Jan 24 .', "") DOI:10.1056/NEJMoa2001017Google Scholar Our phylogenetic analysis 2019-nCoV , sequence nine patient ' sample , show virus belong subgenus Sarbecovirus ."", '2019-nCoV similar two bat-derived coronavirus strain , bat-SL-CoVZC45 bat-SL-CoVZXC21 , know human-infecting coronaviruses , include virus cause SARS outbreak 2003 .', 'Epidemiologically , eight nine patient study history exposure Huanan seafood market Wuhan , suggest might close contact infection source market .', 'However , one patient never visit market , although stay hotel near market onset illness .', 'This find suggest either possible droplet transmission patient infect currently unknown source .', 'Evidence cluster infect family member medical worker confirm presence human-to-human transmission.12Chan JFW Yuan S Kok KH et al.A familial cluster pneumonia associate 2019 novel coronavirus indicate person-to-person transmission : study family cluster.Lancet .', '2020 ; ( publish online Jan 24 ) urlplaceholder Scholar Clearly , infection major public health concern , particularly outbreak coincide peak Chinese Spring Festival travel rush , hundred million people travel China .', 'As typical RNA virus , average evolutionary rate coronaviruses roughly 10−4 nucleotide substitution per site per year,1Su S Wong G Shi W et al.Epidemiology , genetic recombination , pathogenesis coronaviruses.Trends Microbiol .', '2016 ; 24 : 490-502Google Scholar mutation arise every replication cycle .', 'It , therefore , strike sequence 2019-nCoV different patient describe almost identical , greater 99·9 % sequence identity .', 'This find suggest 2019-nCoV originate one source within short period detect relatively rapidly .', 'However , virus transmit individual , constant surveillance mutation arise need .', 'Phylogenetic analysis show bat-derived coronaviruses fell within five subgenus genus Betacoronavirus .', 'Moreover , bat-derived coronaviruses fell basal position subgenus Sarbecovirus , 2019-nCoV closely relate bat-SL-CoVZC45 bat-SL-CoVZXC21 , also sample bats.23Hu D Zhu C Ai L et al.Genomic characterization infectivity novel SARS-like coronavirus Chinese bats.Emerg Microbes Infect .', '2018 ; 7 : 154Google Scholar These data consistent bat reservoir coronaviruses general 2019-nCoV particular .', 'However , despite importance bat , several fact suggest another animal act intermediate host bat human .', 'First , outbreak first report late December , 2019 , bat specie Wuhan hibernate .', 'Second , bat sell find Huanan seafood market , whereas various non-aquatic animal ( include mammal ) available purchase .', 'Third , sequence identity 2019-nCoV close relative bat-SL-CoVZC45 bat-SL-CoVZXC21 le 90 % , reflect relatively long branch .', 'Hence , bat-SL-CoVZC45 bat-SL-CoVZXC21 direct ancestor 2019-nCoV .', 'Fourth , SARS-CoV MERS-CoV , bat act natural reservoir , another animal ( mask palm civet SARS-CoV35Guan Y Zheng BJ He YQ et al.Isolation characterization virus relate SARS coronavirus animal southern China.Science .', '2003 ; 302 : 276-278Google Scholar dromedary camel MERS-CoV ) 36Alagaili AN Briese T Mishra N et al.Middle East respiratory syndrome coronavirus infection dromedary camel Saudi Arabia.mBio .', '2014 ; 5 : e00884-e00914Google Scholar act intermediate host , human terminal host .', 'Therefore , basis current data , seem likely 2019-nCoV cause Wuhan outbreak might also initially host bat , might transmit human via currently unknown wild animal ( ) sell Huanan seafood market .', 'Previous study uncover several receptor different coronaviruses bind , ACE2 SARS-CoV29Li F Li W Farzan M Harrison SC Structure SARS coronavirus spike receptor-binding domain complexed receptor.Science .', '2005 ; 309 : 1864-1868Google Scholar CD26 MERS-CoV.30Lu G Hu Y Wang Q et al.Molecular basis bind novel human coronavirus MERS-CoV receptor CD26.Nature .', '2013 ; 500 : 227-231Google Scholar Our molecular model show structural similarity receptor-binding domain SARS-CoV 2019-nCoV .', 'Therefore , suggest 2019-nCoV might use ACE2 receptor , despite presence amino acid mutation 2019-nCoV receptor-binding domain .', 'Although previous study use HeLa cell express ACE2 protein show 2019-nCoV could employ ACE2 receptor,37Zhou P Yang X-L Wang X-G et al.Discovery novel coronavirus associate recent pneumonia outbreak human potential bat origin.bioRxiv .', '2020 ; ( publish online Jan 23 .', ') DOI:10.1101/2020.01.22.914952Google Scholar whether mutation affect ACE2 bind change receptor tropism require study .', 'Recombination see frequently coronaviruses.1Su S Wong G Shi W et al.Epidemiology , genetic recombination , pathogenesis coronaviruses.Trends Microbiol .', '2016 ; 24 : 490-502Google Scholar As expect , detect recombination Sarbecoviruses analyse .', 'Our result suggest recombination event complex likely occur bat coronaviruses 2019-nCoV .', 'Hence , despite occurrence , recombination probably reason emergence virus , although inference might change closely relate animal virus identify .', 'In conclusion , describe genomic structure seventh human coronavirus cause severe pneumonia shed light origin receptor-binding property .', 'More generally , disease outbreak link 2019-nCoV highlight hide virus reservoir wild animal potential occasionally spill human population .', 'Contributors GFG , WT , WS , WC , WX , GW design study .', 'RL , XZ , PN , HW , WW , BH , NZ , XM , WZ , LZ , JC , YM , JW , YL , JY , ZX , JM , WJL , DW experiment .', 'BY , FZ , ZH provide sample .', 'WS , WC , WT , JL , HS , YB , LW , TH , HZ analyse data .', 'WS , WT , JL write report .', 'ECH GFG revise report .', 'Declaration interest We declare compete interest .', 'Data available various website make publicly available ( information find first paragraph Results section ) .', 'Acknowledgments This work support National Key Research Development Programme China ( 2016YFD0500301 , 2020YFC0840800 , 2020YFC0840900 ) , National Major Project Control Prevention Infectious Disease China ( 2017ZX10104001 , 2018ZX10101002 , 2018ZX10101004 , 2018ZX10732-401 ) , State Key Research Development Program China ( 2019YFC1200501 ) , Strategic Priority Research Programme Chinese Academy Sciences ( XDB29010102 ) , Academic Promotion Programme Shandong First Medical University ( 2019QL006 2019PT008 ) .', 'WS support Taishan Scholars Programme Shandong Province ( ts201511056 ) .', 'Download .pdf ( .94 MB ) Help pdf file Supplementary appendix Viral load SARS-CoV-2 clinical samplesFull-TextPDF']","['backgroundin', 'late', 'december', '', '2019', '', 'patient', 'present', 'viral', 'pneumonia', 'due', 'unidentified', 'microbial', 'agent', 'report', 'wuhan', '', 'china', '', 'novel', 'coronavirus', 'subsequently', 'identify', 'causative', 'pathogen', '', 'provisionally', 'name', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'jan', '26', '', '2020', '', '2000', 'case', '2019-ncov', 'infection', 'confirm', '', 'involve', 'people', 'live', 'visit', 'wuhan', '', 'human-to-human', 'transmission', 'confirmedmethodswe', 'next-generation', 'sequence', 'sample', 'bronchoalveolar', 'lavage', 'fluid', 'culture', 'isolate', 'nine', 'inpatient', '', 'eight', 'visit', 'huanan', 'seafood', 'market', 'wuhan', '', 'complete', 'partial', '2019-ncov', 'genome', 'sequence', 'obtain', 'individual', '', 'viral', 'contigs', 'connect', 'sanger', 'sequence', 'obtain', 'full-length', 'genome', '', 'terminal', 'region', 'determine', 'rapid', 'amplification', 'cdna', 'end', '', 'phylogenetic', 'analysis', '2019-ncov', 'genome', 'coronaviruses', 'determine', 'evolutionary', 'history', 'virus', 'help', 'infer', 'likely', 'origin', '', 'homology', 'model', 'explore', 'likely', 'receptor-binding', 'property', 'virusfindingsthe', 'ten', 'genome', 'sequence', '2019-ncov', 'obtain', 'nine', 'patient', 'extremely', 'similar', '', 'exhibit', '9998', '', 'sequence', 'identity', '', 'notably', '', '2019-ncov', 'closely', 'relate', '', '88', '', 'identity', '', 'two', 'bat-derived', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '-like', 'coronaviruses', '', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'collect', '2018', 'zhoushan', '', 'eastern', 'china', '', 'distant', 'sars-cov', '', '79', '', '', 'mers-cov', '', '50', '', '', '', 'phylogenetic', 'analysis', 'reveal', '2019-ncov', 'fell', 'within', 'subgenus', 'sarbecovirus', 'genus', 'betacoronavirus', '', 'relatively', 'long', 'branch', 'length', 'closest', 'relative', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'genetically', 'distinct', 'sars-cov', '', 'notably', '', 'homology', 'model', 'reveal', '2019-ncov', 'similar', 'receptor-binding', 'domain', 'structure', 'sars-cov', '', 'despite', 'amino', 'acid', 'variation', 'key', 'residuesinterpretation2019-ncov', 'sufficiently', 'divergent', 'sars-cov', 'consider', 'new', 'human-infecting', 'betacoronavirus', '', 'although', 'phylogenetic', 'analysis', 'suggest', 'bat', 'original', 'host', 'virus', '', 'animal', 'sell', 'seafood', 'market', 'wuhan', 'represent', 'intermediate', 'host', 'facilitate', 'emergence', 'virus', 'human', '', 'importantly', '', 'structural', 'analysis', 'suggest', '2019-ncov', 'able', 'bind', 'angiotensin-converting', 'enzyme', '2', 'receptor', 'human', '', 'future', 'evolution', '', 'adaptation', '', 'spread', 'virus', 'warrant', 'urgent', 'investigationfundingnational', 'key', 'research', 'development', 'program', 'china', '', 'national', 'major', 'project', 'control', 'prevention', 'infectious', 'disease', 'china', '', 'chinese', 'academy', 'sciences', '', 'shandong', 'first', 'medical', 'university', '', 'late', 'december', '', '2019', '', 'patient', 'present', 'viral', 'pneumonia', 'due', 'unidentified', 'microbial', 'agent', 'report', 'wuhan', '', 'china', '', 'novel', 'coronavirus', 'subsequently', 'identify', 'causative', 'pathogen', '', 'provisionally', 'name', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'jan', '26', '', '2020', '', '2000', 'case', '2019-ncov', 'infection', 'confirm', '', 'involve', 'people', 'live', 'visit', 'wuhan', '', 'human-to-human', 'transmission', 'confirm', '', 'next-generation', 'sequence', 'sample', 'bronchoalveolar', 'lavage', 'fluid', 'culture', 'isolate', 'nine', 'inpatient', '', 'eight', 'visit', 'huanan', 'seafood', 'market', 'wuhan', '', 'complete', 'partial', '2019-ncov', 'genome', 'sequence', 'obtain', 'individual', '', 'viral', 'contigs', 'connect', 'sanger', 'sequence', 'obtain', 'full-length', 'genome', '', 'terminal', 'region', 'determine', 'rapid', 'amplification', 'cdna', 'end', '', 'phylogenetic', 'analysis', '2019-ncov', 'genome', 'coronaviruses', 'determine', 'evolutionary', 'history', 'virus', 'help', 'infer', 'likely', 'origin', '', 'homology', 'model', 'explore', 'likely', 'receptor-binding', 'property', 'virus', '', 'ten', 'genome', 'sequence', '2019-ncov', 'obtain', 'nine', 'patient', 'extremely', 'similar', '', 'exhibit', '9998', '', 'sequence', 'identity', '', 'notably', '', '2019-ncov', 'closely', 'relate', '', '88', '', 'identity', '', 'two', 'bat-derived', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '-like', 'coronaviruses', '', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'collect', '2018', 'zhoushan', '', 'eastern', 'china', '', 'distant', 'sars-cov', '', '79', '', '', 'mers-cov', '', '50', '', '', '', 'phylogenetic', 'analysis', 'reveal', '2019-ncov', 'fell', 'within', 'subgenus', 'sarbecovirus', 'genus', 'betacoronavirus', '', 'relatively', 'long', 'branch', 'length', 'closest', 'relative', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'genetically', 'distinct', 'sars-cov', '', 'notably', '', 'homology', 'model', 'reveal', '2019-ncov', 'similar', 'receptor-binding', 'domain', 'structure', 'sars-cov', '', 'despite', 'amino', 'acid', 'variation', 'key', 'residue', '', '2019-ncov', 'sufficiently', 'divergent', 'sars-cov', 'consider', 'new', 'human-infecting', 'betacoronavirus', '', 'although', 'phylogenetic', 'analysis', 'suggest', 'bat', 'original', 'host', 'virus', '', 'animal', 'sell', 'seafood', 'market', 'wuhan', 'represent', 'intermediate', 'host', 'facilitate', 'emergence', 'virus', 'human', '', 'importantly', '', 'structural', 'analysis', 'suggest', '2019-ncov', 'able', 'bind', 'angiotensin-converting', 'enzyme', '2', 'receptor', 'human', '', 'future', 'evolution', '', 'adaptation', '', 'spread', 'virus', 'warrant', 'urgent', 'investigation', '', 'national', 'key', 'research', 'development', 'program', 'china', '', 'national', 'major', 'project', 'control', 'prevention', 'infectious', 'disease', 'china', '', 'chinese', 'academy', 'sciences', '', 'shandong', 'first', 'medical', 'university', '', 'viruses', 'family', 'coronaviridae', 'posse', 'single-strand', '', 'positive-sense', 'rna', 'genome', 'range', '26', '32', 'kilobases', 'length1su', 'wong', 'g', 'shi', 'w', 'alepidemiology', '', 'genetic', 'recombination', '', 'pathogenesis', 'coronavirusestrends', 'microbiol', '', '2016', '', '24', '', '490-502google', 'coronaviruses', 'identify', 'several', 'avian', 'hosts2cavanagh', 'coronavirus', 'avian', 'infectious', 'bronchitis', 'virusvet', 'res', '', '2007', '', '38', '', '281-297google', '', '3ismail', 'mm', 'tang', 'ay', 'saif', 'ym', 'pathogenicity', 'turkey', 'coronavirus', 'turkey', 'chickensavian', 'dis', '', '2003', '', '47', '', '515-522google', 'well', 'various', 'mammal', '', 'include', 'camel', '', 'bat', '', 'mask', 'palm', 'civet', '', 'mouse', '', 'dog', '', 'cat', '', 'novel', 'mammalian', 'coronaviruses', 'regularly', 'identified1su', 'wong', 'g', 'shi', 'w', 'alepidemiology', '', 'genetic', 'recombination', '', 'pathogenesis', 'coronavirusestrends', 'microbiol', '', '2016', '', '24', '', '490-502google', 'example', '', 'hku2-related', 'coronavirus', 'bat', 'origin', 'responsible', 'fatal', 'acute', 'diarrhoea', 'syndrome', 'pig', '20184zhou', 'p', 'fan', 'h', 'lan', 'alfatal', 'swine', 'acute', 'diarrhoea', 'syndrome', 'cause', 'hku2-related', 'coronavirus', 'bat', 'originnature', '', '2018', '', '556', '', '255-258google', 'among', 'several', 'coronaviruses', 'pathogenic', 'human', '', 'associate', 'mild', 'clinical', 'symptoms1su', 'wong', 'g', 'shi', 'w', 'alepidemiology', '', 'genetic', 'recombination', '', 'pathogenesis', 'coronavirusestrends', 'microbiol', '', '2016', '', '24', '', '490-502google', 'two', 'notable', 'exception', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'coronavirus', '', 'sars-cov', '', '', 'novel', 'betacoronavirus', 'emerge', 'guangdong', '', 'southern', 'china', '', 'november', '', '20025peiris', 'js', 'guan', 'yuen', 'ky', 'severe', 'acute', 'respiratory', 'syndromenat', 'med', '', '2004', '', '10', '', 's88-s97google', 'result', '8000', 'human', 'infection', '774', 'death', '37', 'country', '200203', '', '6chan-yeung', 'xu', 'rh', 'sars', '', 'epidemiologyrespirology', '', '2003', '', '8', '', 's9-s14google', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'coronavirus', '', 'mers-cov', '', '', 'first', 'detect', 'saudi', 'arabia', '20127zaki', 'van', 'boheemen', 'bestebroer', 'tm', 'osterhaus', 'ad', 'fouchier', 'ra', 'isolation', 'novel', 'coronavirus', 'man', 'pneumonia', 'saudi', 'arabian', 'engl', 'j', 'med', '', '2012', '', '367', '', '1814-1820google', 'responsible', '2494', 'laboratory-confirmed', 'case', 'infection', '858', 'fatality', 'since', 'september', '', '2012', '', 'include', '38', 'death', 'follow', 'single', 'south', 'korea8lee', 'j', 'chowell', 'g', 'jung', 'e', 'dynamic', 'compartmental', 'model', 'middle', 'east', 'respiratory', 'syndrome', 'outbreak', 'republic', 'korea', '', 'retrospective', 'analysis', 'control', 'intervention', 'superspreading', 'eventsj', 'theor', 'biol', '', '2016', '', '408', '', '118-126google', '', '9lee', 'jy', 'kim', 'yj', 'chung', 'eh', 'althe', 'clinical', 'virological', 'feature', 'first', 'import', 'case', 'cause', 'mers-cov', 'outbreak', 'south', 'korea', '', '2015bmc', 'infect', 'dis', '', '2017', '', '17', '', '498google', 'research', 'contextevidence', 'studythe', 'causal', 'agent', 'outbreak', 'severe', 'pneumonia', 'wuhan', '', 'china', '', 'novel', 'coronavirus', '', 'provisionally', 'name', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'first', 'case', 'report', 'december', '', '2019added', 'value', 'studywe', 'describe', 'genomic', 'characteristic', '2019-ncov', 'similarity', 'difference', 'coronaviruses', '', 'include', 'virus', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemic', '200203', '', 'genome', 'sequence', '2019-ncov', 'sample', 'nine', 'patient', 'among', 'early', 'case', 'severe', 'infection', 'almost', 'genetically', 'identical', '', 'suggest', 'recent', 'emergence', 'virus', 'human', 'outbreak', 'detect', 'relatively', 'rapidly', '', '2019-ncov', 'closely', 'relate', 'betacoronaviruses', 'bat', 'origin', '', 'indicate', 'animal', 'likely', 'reservoir', 'host', 'emerge', 'viral', 'pathogenimplications', 'available', 'evidenceby', 'document', 'presence', '2019-ncov', 'sample', 'patient', '', 'study', 'extend', 'previous', 'evidence', 'virus', 'lead', 'novel', 'pneumonia', 'cause', 'severe', 'disease', 'wuhan', 'geographical', 'locality', '', 'currently', 'available', 'data', 'suggest', '2019-ncov', 'infect', 'human', 'population', 'bat', 'reservoir', '', 'although', 'remain', 'unclear', 'currently', 'unknown', 'animal', 'specie', 'act', 'intermediate', 'host', 'bat', 'human', '', 'evidence', 'study', 'causal', 'agent', 'outbreak', 'severe', 'pneumonia', 'wuhan', '', 'china', '', 'novel', 'coronavirus', '', 'provisionally', 'name', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'first', 'case', 'report', 'december', '', '2019', '', 'added', 'value', 'study', 'describe', 'genomic', 'characteristic', '2019-ncov', 'similarity', 'difference', 'coronaviruses', '', 'include', 'virus', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemic', '200203', '', 'genome', 'sequence', '2019-ncov', 'sample', 'nine', 'patient', 'among', 'early', 'case', 'severe', 'infection', 'almost', 'genetically', 'identical', '', 'suggest', 'recent', 'emergence', 'virus', 'human', 'outbreak', 'detect', 'relatively', 'rapidly', '', '2019-ncov', 'closely', 'relate', 'betacoronaviruses', 'bat', 'origin', '', 'indicate', 'animal', 'likely', 'reservoir', 'host', 'emerge', 'viral', 'pathogen', '', 'implications', 'available', 'evidence', 'document', 'presence', '2019-ncov', 'sample', 'patient', '', 'study', 'extend', 'previous', 'evidence', 'virus', 'lead', 'novel', 'pneumonia', 'cause', 'severe', 'disease', 'wuhan', 'geographical', 'locality', '', 'currently', 'available', 'data', 'suggest', '2019-ncov', 'infect', 'human', 'population', 'bat', 'reservoir', '', 'although', 'remain', 'unclear', 'currently', 'unknown', 'animal', 'specie', 'act', 'intermediate', 'host', 'bat', 'human', '', 'late', 'december', '', '2019', '', 'several', 'patient', 'viral', 'pneumonia', 'find', 'epidemiologically', 'associate', 'huanan', 'seafood', 'market', 'wuhan', '', 'hubei', 'province', 'china', '', 'number', 'non-aquatic', 'animal', 'bird', 'rabbit', 'sale', 'outbreak', '', 'novel', '', 'human-infecting', 'coronavirus10tan', 'w', 'zhao', 'x', 'x', 'ala', 'novel', 'coronavirus', 'genome', 'identify', 'cluster', 'pneumonia', 'caseswuhan', '', 'china', '20192020china', 'cdc', 'weekly', '', '2020', '', '2', '', '61-62google', '', '11zhu', 'n', 'zhang', 'wang', 'w', 'ala', 'novel', 'coronavirus', 'patient', 'pneumonia', 'china', '', '2019n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'jan', '24', '', '', 'doi101056nejmoa2001017google', 'provisionally', 'name', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', '', 'identify', 'next-generation', 'sequence', '', 'jan', '28', '', '2020', '', 'china', 'report', '5900', 'confirm', '9000', 'suspect', 'case', '2019-ncov', 'infection', 'across', '33', 'chinese', 'province', 'municipality', '', '106', 'fatality', '', 'addition', '', '2019-ncov', 'report', 'thailand', '', 'japan', '', 'south', 'korea', '', 'malaysia', '', 'singapore', '', 'usa', '', 'infections', 'medical', 'worker', 'family', 'cluster', 'report', 'human-to-human', 'transmission', 'confirmed12chan', 'jfw', 'yuan', 'kok', 'kh', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '', 'publish', 'online', 'jan', '24', '', 'urlplaceholder', 'infect', 'patient', 'high', 'fever', 'dyspnoea', '', 'chest', 'radiograph', 'reveal', 'invasive', 'lesion', 'lungs12chan', 'jfw', 'yuan', 'kok', 'kh', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '', 'publish', 'online', 'jan', '24', '', 'urlplaceholder', '', '13huang', 'c', 'wang', 'li', 'x', 'alclinical', 'feature', 'patient', 'infect', '2019', 'novel', 'coronavirus', 'wuhan', '', 'chinalancet', '', '2020', '', '', 'publish', 'online', 'jan', '24', '', 'urlplaceholder', 'report', 'epidemiological', 'data', 'nine', 'inpatient', '', 'least', 'three', 'hospital', 'wuhan', '', 'diagnose', 'viral', 'pneumonia', 'unidentified', 'cause', '', 'using', 'next-generation', 'sequence', 'bronchoalveolar', 'lavage', 'fluid', 'sample', 'culture', 'isolate', 'patient', '', '2019-ncov', 'find', '', 'describe', 'genomic', 'characterisation', 'ten', 'genome', 'novel', 'virus', '', 'provide', 'important', 'information', 'origin', 'cell', 'receptor', 'bind', 'virus', '', 'nine', 'patient', 'viral', 'pneumonia', 'negative', 'common', 'respiratory', 'pathogen', '', 'present', 'least', 'three', 'hospital', 'wuhan', '', 'include', 'study', '', 'eight', 'patient', 'visit', 'huanan', 'seafood', 'market', 'onset', 'illness', '', 'one', 'patient', '', 'wh04', '', 'visit', 'market', 'stay', 'hotel', 'near', 'market', 'dec', '23', 'dec', '27', '', '2019', '', 'table', '', '', 'five', 'patient', '', 'wh19001', '', 'wh19002', '', 'wh19004', '', 'wh19008', '', 'ys8011', '', 'sample', 'collect', 'chinese', 'center', 'disease', 'control', 'prevention', '', 'cdc', '', 'test', '18', 'virus', 'four', 'bacteria', 'respifindersmart22', 'kit', '', 'pathofinder', '', 'maastricht', '', 'netherlands', '', 'lightcycler', '480', 'real-time', 'pcr', 'system', '', 'roche', '', 'rotkreuz', '', 'switzerland', '', '', 'presence', 'sars-cov', 'mers-cov', 'test', 'previously', 'report', 'method14niu', 'p', 'shen', 'j', 'zhu', 'n', 'lu', 'r', 'tan', 'w', 'two-tube', 'multiplex', 'real-time', 'reverse', 'transcription', 'pcr', 'detect', 'six', 'human', 'coronavirusesvirol', 'sin', '', '2016', '', '31', '', '85-88google', 'five', 'cdc', 'sample', 'negative', 'common', 'respiratory', 'pathogen', 'screen', '', 'four', 'patient', '', 'wh01', '', 'wh02', '', 'wh03', '', 'wh04', '', 'sample', 'collect', 'bgi', '', 'beijing', '', 'china', '', '', 'test', 'five', 'virus', 'one', 'bacterium', 'respipathogen', '6', 'kit', '', 'jiangsu', 'macro', '', 'micro', 'test', '', 'nantong', '', 'china', '', 'applied', 'biosystems', 'abi', '7500', 'real-time', 'pcr', 'system', '', 'thermofisher', 'scientific', '', 'foster', 'city', '', 'ca', '', 'usa', '', '', 'four', 'sample', 'negative', 'target', 'respiratory', 'pathogenstableinformation', 'sample', 'nine', 'patient', 'infect', '2019-ncovpatient', 'informationsample', 'informationgenome', 'sequence', 'obtainedexposure', 'huanan', 'seafood', 'marketdate', 'symptom', 'onsetadmission', 'datesample', 'typecollection', 'datect', 'valuesamples', 'wh19001', 'wh19005yesdec', '23', '', '2019dec', '29', '', '2019balf', 'culture', 'virusdec', '30', '', '20193023completesample', 'wh19002yesdec', '22', '', '2019nabalfdec', '30', '', '20193050partial', '', '27', '130', 'nucleotide', '', 'sample', 'wh19004yesnanabalfjan', '1', '', '20203214completesample', 'wh19008yesnadec', '29', '', '2019balfdec', '30', '', '20192635completesample', 'ys8011yesnanathroat', 'swabjan', '7', '', '20202285completesample', 'wh01yesnanabalfdec', '26', '', '20193260completesample', 'wh02yesnanabalfdec', '31', '', '20193423partial', '', '19', '503', 'nucleotide', '', 'sample', 'wh03yesdec', '26', '', '2019nabalfjan', '1', '', '20202538completesample', 'wh04no', '', '', 'patient', 'stay', 'hotel', 'near', 'huanan', 'seafood', 'market', 'dec', '23', 'dec', '27', '', '2019', '', 'report', 'fever', 'dec', '27', '', '2019dec', '27', '', '2019nabalfjan', '5', '', '20202523completectthreshold', 'cycle', '', 'balfbronchoalveolar', 'lavage', 'fluid', '', 'nanot', 'available', '', '2019-ncov2019', 'novel', 'coronavirus', '', '', 'patient', 'stay', 'hotel', 'near', 'huanan', 'seafood', 'market', 'dec', '23', 'dec', '27', '', '2019', '', 'report', 'fever', 'dec', '27', '', '2019', '', 'open', 'table', 'new', 'tab', 'ctthreshold', 'cycle', '', 'balfbronchoalveolar', 'lavage', 'fluid', '', 'nanot', 'available', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'special-pathogen-free', 'human', 'airway', 'epithelial', '', 'hae', '', 'cell', 'virus', 'isolation', '', 'briefly', '', 'bronchoalveolar', 'lavage', 'fluid', 'throat', 'swab', 'patient', 'inoculate', 'hae', 'cell', 'apical', 'surface', '', 'hae', 'cell', 'maintain', 'airliquid', 'interface', 'incubate', '37c', '', 'cell', 'monitor', 'daily', 'cytopathic', 'effect', 'light', 'microscopy', 'cell', 'supernatant', 'collect', 'quantitative', 'rt-pcr', 'assay', '', 'three', 'passage', '', 'apical', 'sample', 'collect', 'sequence', '', 'collect', 'sample', 'send', 'bgi', 'sequence', '', '140', 'l', 'bronchoalveolar', 'lavage', 'fluid', 'sample', '', 'wh01', 'wh04', '', 'reserve', 'rna', 'extraction', 'qiaamp', 'viral', 'rna', 'mini', 'kit', '', '52904', '', 'qiagen', '', 'heiden', '', 'germany', '', '', 'accord', 'manufacturer', 'recommendation', '', 'probe-captured', 'technique', 'remove', 'human', 'nucleic', 'acid', '', 'remain', 'rna', 'reverse-transcribed', 'cdna', '', 'follow', 'second-strand', 'synthesis', '', 'using', 'synthetic', 'double-stranded', 'dna', '', 'dna', 'library', 'construct', 'dna-fragmentation', '', 'end-repair', '', 'adaptor-ligation', '', 'pcr', 'amplification', '', 'construct', 'library', 'qualify', 'invitrogen', 'qubit', '20', 'fluorometer', '', 'thermofisher', '', 'foster', 'city', '', 'ca', '', 'usa', '', '', 'qualify', 'double-stranded', 'dna', 'library', 'transform', 'single-stranded', 'circular', 'dna', 'library', 'dna-denaturation', 'circularisation', '', 'dna', 'nanoballs', 'generate', 'single-stranded', 'circular', 'dna', 'roll', 'circle', 'amplification', '', 'qualify', 'qubit', '20', 'load', 'onto', 'flow', 'cell', 'sequence', 'pe100', 'dnbseq-t7', 'platform', '', 'mgi', '', 'shenzhen', '', 'china', '', '', 'remove', 'adapter', '', 'low-quality', '', 'low-complexity', 'read', '', 'high-quality', 'genome', 'sequence', 'data', 'generate', '', 'sequence', 'read', 'first', 'filter', 'human', 'reference', 'genome', '', 'hg19', '', 'burrows-wheeler', 'alignment15li', 'h', 'durbin', 'r', 'fast', 'accurate', 'short', 'read', 'alignment', 'burrows-wheeler', 'transformbioinformatics', '', '2009', '', '25', '', '1754-1760google', 'remain', 'data', 'align', 'local', 'nucleotide', 'database', '', 'burrows-wheeler', 'alignment', '', 'non-redundant', 'protein', 'database', '', 'rapsearch', '', '16zhao', 'tang', 'h', 'ye', 'rapsearch2', '', 'fast', 'memory-efficient', 'protein', 'similarity', 'search', 'tool', 'next-generation', 'sequence', 'databioinformatics', '', '2012', '', '28', '', '125-126google', 'download', 'us', 'national', 'center', 'biotechnology', 'information', 'website', '', 'contain', 'coronaviruses', 'publish', '', 'finally', '', 'map', 'read', 'assemble', 'spades17nurk', 'bankevich', 'antipov', 'alassembling', 'genome', 'mini-metagenomes', 'highly', 'chimeric', 'readsin', '', 'deng', 'jiang', 'r', 'sun', 'f', 'zhang', 'x', 'research', 'computational', 'molecular', 'biology', '', 'recomb', '2013', '', '', 'lecture', 'note', 'computer', 'science', '', 'vol', '7821', '', 'springer', '', 'berlin2013', '', '158-170google', 'obtain', 'high-quality', 'coronavirus', 'genome', 'sequence', '', 'primers', 'design', 'oligo', 'primer', 'analysis', 'software', 'version', '644', 'basis', 'assemble', 'partial', 'genome', '', 'verify', 'primer-blast', '', 'detail', 'primer', 'sequencs', 'please', 'contact', 'correspond', 'author', '', '', 'pcr', 'set', 'follow', '', '45', 'l', '10x', 'buffer', '', '4', 'l', 'dntp', 'mix', '', '25', 'moll', '', '', '1', 'l', 'primer', '', '10', 'moll', '', '', '075', 'unit', 'hs', 'ex', 'taq', '', 'takara', 'biomedical', 'technology', '', 'beijing', '', 'china', '', '', 'total', 'volume', '30', 'l', '', 'cdnas', 'reverse', 'transcribe', 'clinical', 'sample', 'template', '', 'random', 'primer', '', 'follow', 'program', 'thermocycler', '', '95c', '5', 'min', '', '40', 'cycle', '95c', '30', '', '55c', '30', '', '72c', '1', 'min', 'determine', 'product', 'size', '', '72c', '7', 'min', '', '4c', 'hold', '', 'finally', '', 'pcr', 'product', 'separate', 'agarose', 'gel', 'electrophoresis', '', 'product', 'expect', 'size', 'sequence', 'end', 'applied', 'biosystems', '3730', 'dna', 'analyzer', 'platform', '', 'applied', 'biosystems', '', 'life', 'technologies', '', 'foster', 'city', '', 'ca', '', 'usa', '', 'detail', 'expect', 'size', 'please', 'contact', 'correspond', 'author', '', '', 'whole-genome', 'sequence', '2019-ncov', 'six', 'sample', '', 'wh19001', '', 'wh19005', '', 'wh19002', '', 'wh19004', '', 'wh19008', '', 'ys8011', '', 'generate', 'combination', 'sanger', '', 'illumina', '', 'oxford', 'nanopore', 'sequence', '', 'first', '', 'viral', 'rnas', 'extract', 'directly', 'clinical', 'sample', 'qiaamp', 'viral', 'rna', 'mini', 'kit', '', 'synthesise', 'cdna', 'superscript', 'iii', 'reverse', 'transcriptase', '', 'thermofisher', '', 'waltham', '', '', 'usa', '', 'n6', 'random', 'primer', '', 'follow', 'second-strand', 'synthesis', 'dna', 'polymerase', '', 'large', '', 'klenow', '', 'fragment', '', 'thermofisher', '', '', 'viral', 'cdna', 'library', 'prepare', 'nextera', 'xt', 'library', 'prep', 'kit', '', 'illumina', '', 'san', 'diego', '', 'ca', '', 'usa', '', '', 'purify', 'agencourt', 'ampure', 'xp', 'bead', '', 'beckman', 'coulter', '', 'brea', '', 'ca', '', 'usa', '', '', 'follow', 'quantification', 'invitrogen', 'qubit', '20', 'fluorometer', '', 'result', 'dna', 'library', 'sequence', 'either', 'miseq', 'iseq', 'platform', '', 'illumina', '', '300-cycle', 'reagent', 'kit', '', '125', 'gb', 'data', 'obtain', 'sample', '', 'raw', 'fastq', 'file', 'virus', 'sample', 'filter', 'previously', 'describe', 'criteria18pan', 'gao', 'r', 'lv', 'q', 'alhuman', 'infection', 'novel', '', 'highly', 'pathogenic', 'avian', 'influenza', '', 'h5n6', '', 'virus', '', 'virological', 'clinical', 'findingsj', 'infect', '', '2016', '', '72', '', '52-59google', 'de', 'novo', 'assembly', 'clcbio', 'software', 'version', '1101', '', 'mapped', 'assembly', 'bat-derived', 'sars-like', 'coronavirus', 'isolate', 'bat-sl-covzc45', '', 'accession', 'number', 'mg7729331', '', 'reference', '', 'variant', 'call', '', 'genome', 'alignment', '', 'sequence', 'illustration', 'generate', 'clcbio', 'software', '', 'assemble', 'genome', 'sequence', 'confirm', 'sanger', 'sequence', '', 'rapid', 'amplification', 'cdna', 'end', '', 'race', '', 'obtain', 'sequence', '5', '3', 'terminus', '', 'invitrogen', '5', 'race', 'system', '3', 'race', 'system', '', 'invitrogen', '', 'carlsbad', '', 'ca', '', 'usa', '', '', 'accord', 'manufacturer', 'instruction', '', 'gene-specific', 'primer', '', 'appendix', 'p', '1', '', '5', '3', 'race', 'pcr', 'amplification', 'design', 'obtain', 'fragment', 'approximately', '400500', 'bp', 'two', 'region', '', 'purified', 'pcr', 'product', 'clone', 'pmd18-t', 'simple', 'vector', '', 'takara', '', 'takara', 'biotechnology', '', 'dalian', '', 'china', '', 'chemically', 'competent', 'escherichia', 'coli', '', 'dh5', 'cell', '', 'takara', '', '', 'accord', 'manufacturer', 'instruction', '', 'pcr', 'product', 'sequence', 'm13', 'forward', 'reverse', 'primer', '', 'reference', 'virus', 'genome', 'obtain', 'genbank', 'blastn', '2019-ncov', 'query', '', 'open', 'read', 'frame', 'verify', 'genome', 'sequence', 'predict', 'geneious', '', 'version', '1115', '', 'annotate', 'conserved', 'domain', 'database19marchler-bauer', 'bo', 'han', 'l', 'alcddsparcle', '', 'functional', 'classification', 'protein', 'via', 'subfamily', 'domain', 'architecturesnucleic', 'acids', 'res', '', '2017', '', '45', '', 'd200-d203google', 'pairwise', 'sequence', 'identity', 'calculate', 'geneious', '', 'potential', 'genetic', 'recombination', 'investigate', 'simplot', 'software', '', 'version', '351', '', '20lole', 'ks', 'bollinger', 'rc', 'paranjape', 'rs', 'alfull-length', 'human', 'immunodeficiency', 'virus', 'type', '1', 'genome', 'subtype', 'c-infected', 'seroconverters', 'india', '', 'evidence', 'intersubtype', 'recombinationj', 'virol', '', '1999', '', '73', '', '152-160google', 'phylogenetic', 'analysis', '', 'sequence', 'alignment', '2019-ncov', 'reference', 'sequence', 'mafft', 'software', '', 'version', '7450', '', '21nakamura', 'yamada', 'kd', 'tomii', 'k', 'katoh', 'k', 'parallelization', 'mafft', 'large-scale', 'multiple', 'sequence', 'alignmentsbioinformatics', '', '2018', '', '34', '', '2490-2492google', 'phylogenetic', 'analysis', 'complete', 'genome', 'major', 'cod', 'region', 'raxml', 'software', '', 'version', '829', '', '22stamatakis', 'raxml', 'version', '8', '', 'tool', 'phylogenetic', 'analysis', 'post-analysis', 'large', 'phylogeniesbioinformatics', '', '2014', '', '30', '', '1312-1313google', '1000', 'bootstrap', 'replicate', '', 'employ', 'general', 'time', 'reversible', 'nucleotide', 'substitution', 'model', '', 'basis', 'genome', 'sequence', 'obtain', '', 'real-time', 'pcr', 'detection', 'assay', 'develop', '', 'pcr', 'primer', 'probe', 'design', 'applied', 'biosystems', 'primer', 'express', 'software', '', 'thermofisher', 'scientific', '', 'foster', 'city', '', 'ca', '', 'usa', '', 'basis', 'sequence', 'virus', 'genome', '', 'specific', 'primer', 'probe', 'set', '', 'label', 'reporter', '6-carboxyfluorescein', '', 'fam', '', 'quencher', 'black', 'hole', 'quencher', '1', '', 'bhq1', '', '', 'orf1a', 'follow', '', 'forward', 'primer', '5-agaagattggttagatgatgatagt-3', '', 'reverse', 'primer', '5-ttccatctctaattgaggttgaacc-3', '', 'probe', '5-fam-tcctcactgccgtcttgttgacca-bhq1-3', '', 'human', 'gapdh', 'gene', 'internal', 'control', '', 'forward', 'primer', '5-tcaagaaggtggtgaagcagg-3', '', 'reverse', 'primer', '5-cagcgtcaaaggtggaggagt-3', '', 'probe', '5-vic-cctcaagggcatcctgggctacact-bhq1-3', '', '', 'primers', 'probe', 'synthesise', 'bgi', '', 'beijing', '', 'china', '', '', 'rt-pcr', 'applied', 'biosystems', '7300', 'real-time', 'pcr', 'system', '', 'thermoscientific', '', '', '30', 'l', 'reaction', 'volume', 'consist', '14', 'l', 'dilute', 'rna', '', '15', 'l', '2x', 'taqman', 'one-step', 'rt-pcr', 'master', 'mix', 'reagents', '', '4309169', '', 'applied', 'biosystems', '', 'thermofisher', '', '', '05', 'l', '40x', 'multiscribe', 'rnase', 'inhibitor', 'mixture', '', '075', 'l', 'forward', 'primer', '', '10', 'moll', '', '', '075', 'l', 'reverse', 'primer', '', '10', 'moll', '', '', '0375', 'l', 'probe', '', '10', 'moll', '', '', 'thermal', 'cycle', 'parameter', '30', 'min', '42c', '', 'follow', '10', 'min', '95c', '', 'subsequent', '40', 'cycle', 'amplification', '', '95c', '15', '58c', '45', '', '', 'fluorescence', 'record', '58c', 'phase', '', 'funder', 'study', 'role', 'data', 'collection', '', 'data', 'analysis', '', 'data', 'interpretation', '', 'write', 'report', '', 'gfg', 'ws', 'access', 'data', 'study', '', 'gfg', '', 'ws', '', 'wt', '', 'wc', '', 'gw', 'responsible', 'decision', 'submit', 'publication', '', 'nine', 'patient', '', 'sample', 'analyse', '', 'eight', 'complete', 'two', 'partial', 'genome', 'sequence', '2019-ncov', 'obtain', '', 'data', 'deposit', 'china', 'national', 'microbiological', 'data', 'center', '', 'accession', 'number', 'nmdc10013002', 'genome', 'accession', 'number', 'nmdc60013002-01', 'nmdc60013002-10', '', 'data', 'bgi', 'deposit', 'china', 'national', 'genebank', '', 'accession', 'number', 'cna000733235', '', '', 'based', 'genome', '', 'develop', 'real-time', 'pcr', 'assay', 'test', 'original', 'clinical', 'sample', 'bgi', '', 'wh01', '', 'wh02', '', 'wh03', '', 'wh04', '', 'determine', 'threshold', 'cycle', '', 'ct', '', 'value', '', 'table', '', '', 'remain', 'sample', 'test', 'different', 'real-time', 'pcr', 'assay', 'develop', 'chinese', 'cdc', '', 'ct', 'value', 'range', '2285', '3241', '', 'table', '', '', 'result', 'confirm', 'presence', '2019-ncov', 'patient', '', 'bronchoalveolar', 'lavage', 'fluid', 'sample', 'culture', 'virus', 'nine', 'patient', 'next-generation', 'sequence', '', 'remove', 'host', '', 'human', '', 'read', '', 'de', 'novo', 'assembly', 'contigs', 'obtain', 'query', 'search', 'non-redundant', 'protein', 'database', '', 'contigs', 'identify', 'sample', 'closely', 'relate', 'bat', 'sars-like', 'betacoronavirus', 'bat-sl-covzc45', 'betacoronavirus23hu', 'zhu', 'c', 'ai', 'l', 'algenomic', 'characterization', 'infectivity', 'novel', 'sars-like', 'coronavirus', 'chinese', 'batsemerg', 'microbes', 'infect', '', '2018', '', '7', '', '154google', 'bat-sl-covzc45', 'reference', 'genome', 'read', 'pool', 'map', '', 'generate', 'consensus', 'sequence', 'correspond', 'pool', '', 'consensus', 'sequence', 'new', 'reference', 'genome', '', 'eight', 'complete', 'genome', 'two', 'partial', 'genome', '', 'sample', 'wh19002', 'wh02', '', 'table', '', 'obtain', '', 'de', 'novo', 'assembly', 'clean', 'read', 'pool', 'identify', 'long', 'contigs', 'correspond', 'virus', 'high', 'abundance', '', 'eight', 'complete', 'genome', 'nearly', 'identical', 'across', 'whole', 'genome', '', 'sequence', 'identity', '9998', '', '', 'indicative', 'recent', 'emergence', 'human', 'population', '', 'figure', '1a', '', '', 'largest', 'nucleotide', 'difference', 'four', 'mutation', '', 'notably', '', 'sequence', 'identity', 'two', 'virus', 'genome', 'patient', '', 'wh19001', '', 'bronchoalveolar', 'lavage', 'fluid', '', 'wh19005', '', 'cell', 'culture', '', '9999', '', '', '100', '', 'identity', 'amino', 'acid', 'level', '', 'addition', '', 'partial', 'genome', 'sample', 'wh02', 'wh19002', 'nearly', '100', '', 'identity', 'complete', 'genome', 'across', 'align', 'gene', 'regionsfigure', '1sequence', 'comparison', 'genomic', 'organisation', '2019-ncovshow', 'full', 'caption', '', '', 'sequence', 'alignment', 'eight', 'full-length', 'genome', '2019-ncov', '', '29', '829', 'base', 'pair', 'length', '', 'nucleotide', 'truncate', 'end', 'genome', '', '', 'b', '', 'coding', 'region', '2019-ncov', '', 'bat-sl-covzc45', '', 'bat-sl-covzxc21', '', 'sars-cov', '', 'mers-cov', '', 'open', 'read', 'frame', '100', 'nucleotide', 'show', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-covmiddle', 'east', 'respiratory', 'syndrome', 'coronavirusview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'sequence', 'alignment', 'eight', 'full-length', 'genome', '2019-ncov', '', '29', '829', 'base', 'pair', 'length', '', 'nucleotide', 'truncate', 'end', 'genome', '', '', 'b', '', 'coding', 'region', '2019-ncov', '', 'bat-sl-covzc45', '', 'bat-sl-covzxc21', '', 'sars-cov', '', 'mers-cov', '', 'open', 'read', 'frame', '100', 'nucleotide', 'show', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-covmiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'blastn', 'search', 'complete', 'genome', '2019-ncov', 'reveal', 'closely', 'relate', 'virus', 'available', 'genbank', 'bat-sl-covzc45', '', 'sequence', 'identity', '8799', '', '', 'query', 'coverage', '99', '', '', 'another', 'sars-like', 'betacoronavirus', 'bat', 'origin', '', 'bat-sl-covzxc21', '', 'accession', 'number', 'mg772934', '', '23hu', 'zhu', 'c', 'ai', 'l', 'algenomic', 'characterization', 'infectivity', 'novel', 'sars-like', 'coronavirus', 'chinese', 'batsemerg', 'microbes', 'infect', '', '2018', '', '7', '', '154google', '8723', '', '', 'query', 'coverage', '98', '', '', '', 'five', 'gene', 'region', '', 'e', '', '', '7', '', 'n', '', '14', '', '', 'sequence', 'identity', 'greater', '90', '', '', 'highest', '987', '', 'e', 'gene', '', 'figure', '2a', '', '', 'gene', '2019-ncov', 'exhibit', 'lowest', 'sequence', 'identity', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'around', '75', '', '', 'addition', '', 'sequence', 'identity', '1b', '', '86', '', '', 'lower', '1a', '', '90', '', '', 'figure', '2a', '', '', 'encode', 'protein', 'exhibit', 'high', 'sequence', 'identity', '2019-ncov', 'relate', 'bat-derived', 'coronaviruses', '', 'figure', '2a', '', '', 'notable', 'exception', 'spike', 'protein', '', 'around', '80', '', 'sequence', 'identity', '', 'protein', '13', '', '732', '', 'sequence', 'identity', '', 'notably', '', '2019-ncov', 'strain', 'le', 'genetically', 'similar', 'sars-cov', '', '79', '', '', 'mers-cov', '', '50', '', '', '', 'similarity', '2019-ncov', 'relate', 'virus', 'visualise', 'simplot', 'software', '', '2019-ncov', 'consensus', 'sequence', 'employ', 'query', '', 'figure', '2b', '', 'figure', '2sequence', 'identity', 'consensus', '2019-ncov', 'representative', 'betacoronavirus', 'genomesshow', 'full', 'caption', '', '', 'sequence', 'identity', '2019-ncov', 'compare', 'sars-cov', 'gz02', '', 'accession', 'number', 'ay390556', '', 'bat', 'sars-like', 'coronaviruses', 'bat-sl-covzc45', '', 'mg772933', '', 'bat-sl-covzxc21', '', 'mg772934', '', '', '', 'b', '', 'similarity', '2019-ncov', 'relate', 'virus', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirusview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'sequence', 'identity', '2019-ncov', 'compare', 'sars-cov', 'gz02', '', 'accession', 'number', 'ay390556', '', 'bat', 'sars-like', 'coronaviruses', 'bat-sl-covzc45', '', 'mg772933', '', 'bat-sl-covzxc21', '', 'mg772934', '', '', '', 'b', '', 'similarity', '2019-ncov', 'relate', 'virus', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'comparison', 'predict', 'cod', 'region', '2019-ncov', 'show', 'possess', 'similar', 'genomic', 'organisation', 'bat-sl-covzc45', '', 'bat-sl-covzxc21', '', 'sars-cov', '', 'figure', '1b', '', '', 'least', '12', 'cod', 'region', 'predict', '', 'include', '1ab', '', '', '3', '', 'e', '', '', '7', '', '8', '', '9', '', '10b', '', 'n', '', '13', '', '14', '', 'figure', '1b', '', '', 'length', 'protein', 'encode', '2019-ncov', '', 'bat-sl-covzc45', '', 'bat-sl-covzxc21', 'similar', '', 'minor', 'insertion', 'deletion', '', 'notable', 'difference', 'longer', 'spike', 'protein', 'encode', '2019-ncov', 'compare', 'bat', 'sars-like', 'coronaviruses', '', 'sars-cov', '', 'mers-cov', '', 'figure', '1b', '', '', 'phylogenetic', 'analysis', '2019-ncov', 'closely', 'relate', 'reference', 'genome', '', 'well', 'representative', 'betacoronaviruses', '', 'reveal', 'five', 'subgenus', 'form', 'five', 'well', 'support', 'branch', '', 'figure', '3', '', '', 'subgenus', 'sarbecovirus', 'classify', 'three', 'well', 'support', 'clade', '', 'two', 'sars-cov-related', 'strain', 'rhinolophus', 'sp', 'bulgaria', '', 'accession', 'number', 'gu190215', '', 'kenya', '', 'ky352407', '', 'form', 'clade', '1', '', 'ten', '2019-ncov', 'wuhan', 'two', 'bat-derived', 'sars-like', 'strain', 'zhoushan', 'eastern', 'china', '', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'form', 'clade', '2', '', 'notable', 'long', 'branch', 'separate', 'human', 'bat', 'virus', '', 'sars-cov', 'strain', 'human', 'genetically', 'similar', 'sars-like', 'coronaviruses', 'bat', 'collect', 'southwestern', 'china', 'form', 'clade', '3', '', 'bat-derived', 'coronaviruses', 'fall', 'basal', 'position', '', 'figure', '3', '', '', 'addition', '', '2019-ncov', 'distinct', 'sars-cov', 'phylogeny', 'complete', 'rna-dependent', 'rna', 'polymerase', '', 'rdrp', '', 'gene', '', 'appendix', 'p', '2', '', '', 'evidence', 'indicate', '2019-ncov', 'novel', 'betacoronavirus', 'subgenus', 'sarbecovirusfigure', '3phylogenetic', 'analysis', 'full-length', 'genome', '2019-ncov', 'representative', 'virus', 'genus', 'betacoronavirusshow', 'full', 'caption2019-ncov2019', 'novel', 'coronavirus', '', 'mers-covmiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirusview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'mers-covmiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sequence', 'similarity', 'plot', 'reveal', 'change', 'genetic', 'distance', 'among', 'virus', 'across', '2019-ncov', 'genome', '', 'additional', 'phylogenetic', 'analysis', 'major', 'encode', 'region', 'representative', 'member', 'subgenus', 'sarbecovirus', '', 'consistent', 'genome', 'phylogeny', '', '2019-ncov', '', 'bat-sl-covzc45', '', 'bat-sl-covzxc21', 'cluster', 'together', 'tree', '1a', 'spike', 'gene', '', 'appendix', 'p', '3', '', '', 'contrast', '', '2019-ncov', 'cluster', 'bat-sl-covzc45', 'bat-sl-covzxc21', '1b', 'tree', '', 'instead', 'form', 'distinct', 'clade', 'sars-cov', '', 'bat-sl-covzc45', '', 'bat-sl-covzxc21', '', 'appendix', 'p', '3', '', '', 'indicative', 'potential', 'recombination', 'event', '1b', '', 'although', 'probably', 'occur', 'bat', 'coronaviruses', '2019-ncov', '', 'phylogenetic', 'analysis', '2019-ncov', 'genome', 'exclude', '1b', 'reveal', 'similar', 'evolutionary', 'relationship', 'full-length', 'viral', 'genome', '', 'appendix', 'p', '3', '', '', 'envelope', 'spike', '', '', 'protein', 'mediate', 'receptor', 'bind', 'membrane', 'fusion24li', 'f', 'structure', '', 'function', '', 'evolution', 'coronavirus', 'spike', 'proteinsannu', 'rev', 'virol', '', '2016', '', '3', '', '237-261google', 'crucial', 'determine', 'host', 'tropism', 'transmission', 'capacity25lu', 'g', 'wang', 'q', 'gao', 'gf', 'bat-to-human', '', 'spike', 'feature', 'determine', '', 'host', 'jump', '', 'coronaviruses', 'sars-cov', '', 'mers-cov', '', 'beyondtrends', 'microbiol', '', '2015', '', '23', '', '468-478google', '', '26wang', 'q', 'wong', 'g', 'lu', 'g', 'yan', 'j', 'gao', 'gf', 'mers-cov', 'spike', 'protein', '', 'target', 'vaccine', 'therapeuticsantiviral', 'res', '', '2016', '', '133', '', '165-177google', 'generally', '', 'spike', 'protein', 'coronaviruses', 'functionally', 'divide', 's1', 'domain', '', 'especially', 'position', '318510', 'sars-cov', '', '', 'responsible', 'receptor', 'bind', '', 's2', 'domain', '', 'responsible', 'cell', 'membrane', 'fusion27he', 'zhou', 'liu', 'alreceptor-binding', 'domain', 'sars-cov', 'spike', 'protein', 'induce', 'highly', 'potent', 'neutralize', 'antibody', '', 'implication', 'develop', 'subunit', 'vaccinebiochem', 'biophys', 'res', 'commun', '', '2004', '', '324', '', '773-781google', '2019-ncov', 's2', 'protein', 'show', 'around', '93', '', 'sequence', 'identity', 'bat-sl-covzc45', 'bat-sl-covzxc21much', 'higher', 's1', 'domain', '', 'around', '68', '', 'identity', 'bat-derived', 'virus', '', 'n-terminal', 'domain', 'c-terminal', 'domain', 's1', 'domain', 'bind', 'host', 'receptors28li', 'f', 'evidence', 'common', 'evolutionary', 'origin', 'coronavirus', 'spike', 'protein', 'receptor-binding', 'subunitsj', 'virol', '', '2012', '', '86', '', '2856-2858google', 'inspect', 'amino', 'acid', 'variation', 'spike', 'protein', 'among', 'sarbecovirus', 'coronaviruses', '', 'figure', '4', '', '', 'although', '2019-ncov', 'sars-cov', 'fell', 'within', 'different', 'clade', '', 'figure', '3', '', '', 'still', 'possess', 'around', '50', 'conserve', 'amino', 'acid', 's1', '', 'whereas', 'bat-derived', 'virus', 'display', 'mutational', 'difference', '', 'figure', '4', '', '', 'position', 'c-terminal', 'domain', '', 'figure', '4', '', '', 'addition', '', 'number', 'deletion', 'event', '', 'include', 'position', '455457', '', '463464', '', '485497', '', 'find', 'bat-derived', 'strain', '', 'figure', '4', '', 'figure', '4specific', 'amino', 'acid', 'variation', 'among', 'spike', 'protein', 'subgenus', 'sarbecovirusshow', 'full', 'captionviruses', 'order', 'tree', 'topology', '', 'show', 'figure', '3', '', 'top', 'bottom', '', 'one-letter', 'code', 'amino', 'acid', '', 'covcoronavirus', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sarssevere', 'acute', 'respiratory', 'syndrome', '', '', 'bat-derived', 'sars-like', 'virus', 'grow', 'human', 'cell', 'mouse', '', 'bat-derived', 'sars-like', 'virus', 'without', 'experimental', 'data', 'availableview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', 'viruses', 'order', 'tree', 'topology', '', 'show', 'figure', '3', '', 'top', 'bottom', '', 'one-letter', 'code', 'amino', 'acid', '', 'covcoronavirus', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sarssevere', 'acute', 'respiratory', 'syndrome', '', '', 'bat-derived', 'sars-like', 'virus', 'grow', 'human', 'cell', 'mouse', '', 'bat-derived', 'sars-like', 'virus', 'without', 'experimental', 'data', 'available', '', 'receptor-binding', 'domain', 'betacoronaviruses', '', 'directly', 'engage', 'receptor', '', 'commonly', 'locate', 'c-terminal', 'domain', 's1', '', 'sars-cov29li', 'f', 'li', 'w', 'farzan', 'harrison', 'sc', 'structure', 'sars', 'coronavirus', 'spike', 'receptor-binding', 'domain', 'complexed', 'receptorscience', '', '2005', '', '309', '', '1864-1868google', 'lineage', 'b', '', 'mers-cov30lu', 'g', 'hu', 'wang', 'q', 'almolecular', 'basis', 'bind', 'novel', 'human', 'coronavirus', 'mers-cov', 'receptor', 'cd26nature', '', '2013', '', '500', '', '227-231google', '', '31wang', 'n', 'shi', 'x', 'jiang', 'l', 'alstructure', 'mers-cov', 'spike', 'receptor-binding', 'domain', 'complexed', 'human', 'receptor', 'dpp4cell', 'res', '', '2013', '', '23', '', '986-993google', 'batcov', 'hku432wang', 'q', 'qi', 'j', 'yuan', 'albat', 'origin', 'mers-cov', 'support', 'bat', 'coronavirus', 'hku4', 'usage', 'human', 'receptor', 'cd26cell', 'host', 'microbe', '', '2014', '', '16', '', '328-337google', 'lineage', 'c', '', 'figure', '5', '', '', 'phylogenetic', 'analysis', 'receptor-binding', 'domain', 'four', 'different', 'lineage', 'betacoronaviruses', '', 'appendix', 'p', '4', '', '', 'find', '', 'although', '2019-ncov', 'closer', 'bat-sl-covzc45', 'bat-sl-covzxc21', 'whole-genome', 'level', '', 'receptor-binding', 'domain', '2019-ncov', 'fell', 'within', 'lineage', 'b', 'closer', 'sars-cov', '', 'figure', '5a', '', '', 'three-dimensional', 'structure', '2019-ncov', 'receptor-binding', 'domain', 'model', 'swiss-model', 'program33waterhouse', 'bertoni', 'bienert', 'alswiss-model', '', 'homology', 'model', 'protein', 'structure', 'complexesnucleic', 'acids', 'res', '', '2018', '', '46', '', 'w296-w303google', 'sars-cov', 'receptor-binding', 'domain', 'structure', '', 'protein', 'data', 'bank', 'id', '2dd8', '', '34prabakaran', 'p', 'gan', 'j', 'feng', 'alstructure', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'receptor-binding', 'domain', 'complexed', 'neutralize', 'antibodyj', 'biol', 'chem', '', '2006', '', '281', '', '15829-15836google', 'template', '', 'analysis', 'suggest', '', 'like', 'betacoronaviruses', '', 'receptor-binding', 'domain', 'compose', 'core', 'external', 'subdomain', '', 'figure', '5bd', '', '', 'notably', '', 'external', 'subdomain', '2019-ncov', 'receptor-binding', 'domain', 'similar', 'sars-cov', '', 'result', 'suggest', '2019-ncov', 'angiotensin-converting', 'enzyme', '2', '', 'ace2', '', 'cell', 'receptor', '', 'however', '', 'observe', 'several', 'key', 'residue', 'responsible', 'bind', 'sars-cov', 'receptor-binding', 'domain', 'ace2', 'receptor', 'variable', '2019-ncov', 'receptor-binding', 'domain', '', 'include', 'asn439', '', 'asn501', '', 'gln493', '', 'gly485', 'phe486', '', '2019-ncov', 'number', '', 'figure', '5phylogenetic', 'analysis', 'homology', 'model', 'receptor-binding', 'domain', '2019-ncov', '', 'sars-cov', '', 'mers-covshow', 'full', 'caption', '', '', 'phylogenetic', 'analysis', 'receptor-binding', 'domain', 'various', 'betacoronaviruses', '', 'star', 'highlight', '2019-ncov', 'question', 'mark', 'mean', 'receptor', 'virus', 'remain', 'unknown', '', 'structural', 'comparison', 'receptor-binding', 'domain', 'sars-cov', '', 'b', '', '', '2019-ncov', '', 'c', '', '', 'mers-cov', '', '', 'bind', 'receptor', '', 'core', 'subdomains', 'magenta', '', 'external', 'subdomains', 'sars-cov', '', '2019-ncov', '', 'mers', 'cov', 'orange', '', 'dark', 'blue', '', 'green', '', 'respectively', '', 'variable', 'residue', 'sars-cov', '2019-ncov', 'receptor-binding', 'site', 'highlight', 'stick', '', 'covcoronavirus', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'mersmiddle', 'east', 'respiratory', 'syndrome', 'coronavirusview', 'large', 'image', 'figure', 'viewerdownload', 'hi-res', 'image', 'download', '', 'ppt', '', '', '', 'phylogenetic', 'analysis', 'receptor-binding', 'domain', 'various', 'betacoronaviruses', '', 'star', 'highlight', '2019-ncov', 'question', 'mark', 'mean', 'receptor', 'virus', 'remain', 'unknown', '', 'structural', 'comparison', 'receptor-binding', 'domain', 'sars-cov', '', 'b', '', '', '2019-ncov', '', 'c', '', '', 'mers-cov', '', '', 'bind', 'receptor', '', 'core', 'subdomains', 'magenta', '', 'external', 'subdomains', 'sars-cov', '', '2019-ncov', '', 'mers', 'cov', 'orange', '', 'dark', 'blue', '', 'green', '', 'respectively', '', 'variable', 'residue', 'sars-cov', '2019-ncov', 'receptor-binding', 'site', 'highlight', 'stick', '', 'covcoronavirus', '', '2019-ncov2019', 'novel', 'coronavirus', '', 'sars-covsevere', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'mersmiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'genomic', 'surveillance', 'clinical', 'sample', 'patient', 'viral', 'pneumonia', 'wuhan', '', 'china', '', 'novel', 'coronavirus', '', 'term', '2019-ncov', '', 'identified10tan', 'w', 'zhao', 'x', 'x', 'ala', 'novel', 'coronavirus', 'genome', 'identify', 'cluster', 'pneumonia', 'caseswuhan', '', 'china', '20192020china', 'cdc', 'weekly', '', '2020', '', '2', '', '61-62google', '', '11zhu', 'n', 'zhang', 'wang', 'w', 'ala', 'novel', 'coronavirus', 'patient', 'pneumonia', 'china', '', '2019n', 'engl', 'j', 'med', '', '2020', '', '', 'publish', 'online', 'jan', '24', '', '', 'doi101056nejmoa2001017google', 'phylogenetic', 'analysis', '2019-ncov', '', 'sequence', 'nine', 'patient', '', 'sample', '', 'show', 'virus', 'belong', 'subgenus', 'sarbecovirus', '', '2019-ncov', 'similar', 'two', 'bat-derived', 'coronavirus', 'strain', '', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'human-infecting', 'coronaviruses', '', 'include', 'virus', 'cause', 'sars', 'outbreak', '2003', '', 'epidemiologically', '', 'eight', 'nine', 'patient', 'study', 'history', 'exposure', 'huanan', 'seafood', 'market', 'wuhan', '', 'suggest', 'close', 'contact', 'infection', 'source', 'market', '', 'however', '', 'one', 'patient', 'never', 'visit', 'market', '', 'although', 'stay', 'hotel', 'near', 'market', 'onset', 'illness', '', 'find', 'suggest', 'either', 'possible', 'droplet', 'transmission', 'patient', 'infect', 'currently', 'unknown', 'source', '', 'evidence', 'cluster', 'infect', 'family', 'member', 'medical', 'worker', 'confirm', 'presence', 'human-to-human', 'transmission12chan', 'jfw', 'yuan', 'kok', 'kh', 'ala', 'familial', 'cluster', 'pneumonia', 'associate', '2019', 'novel', 'coronavirus', 'indicate', 'person-to-person', 'transmission', '', 'study', 'family', 'clusterlancet', '', '2020', '', '', 'publish', 'online', 'jan', '24', '', 'urlplaceholder', 'clearly', '', 'infection', 'major', 'public', 'health', 'concern', '', 'particularly', 'outbreak', 'coincide', 'peak', 'chinese', 'spring', 'festival', 'travel', 'rush', '', 'hundred', 'million', 'people', 'travel', 'china', '', 'typical', 'rna', 'virus', '', 'average', 'evolutionary', 'rate', 'coronaviruses', 'roughly', '104', 'nucleotide', 'substitution', 'per', 'site', 'per', 'year1su', 'wong', 'g', 'shi', 'w', 'alepidemiology', '', 'genetic', 'recombination', '', 'pathogenesis', 'coronavirusestrends', 'microbiol', '', '2016', '', '24', '', '490-502google', 'mutation', 'arise', 'every', 'replication', 'cycle', '', '', 'therefore', '', 'strike', 'sequence', '2019-ncov', 'different', 'patient', 'describe', 'almost', 'identical', '', 'greater', '999', '', 'sequence', 'identity', '', 'find', 'suggest', '2019-ncov', 'originate', 'one', 'source', 'within', 'short', 'period', 'detect', 'relatively', 'rapidly', '', 'however', '', 'virus', 'transmit', 'individual', '', 'constant', 'surveillance', 'mutation', 'arise', '', 'phylogenetic', 'analysis', 'show', 'bat-derived', 'coronaviruses', 'fell', 'within', 'five', 'subgenus', 'genus', 'betacoronavirus', '', 'moreover', '', 'bat-derived', 'coronaviruses', 'fell', 'basal', 'position', 'subgenus', 'sarbecovirus', '', '2019-ncov', 'closely', 'relate', 'bat-sl-covzc45', 'bat-sl-covzxc21', '', 'sample', 'bats23hu', 'zhu', 'c', 'ai', 'l', 'algenomic', 'characterization', 'infectivity', 'novel', 'sars-like', 'coronavirus', 'chinese', 'batsemerg', 'microbes', 'infect', '', '2018', '', '7', '', '154google', 'data', 'consistent', 'bat', 'reservoir', 'coronaviruses', 'general', '2019-ncov', 'particular', '', 'however', '', 'despite', 'importance', 'bat', '', 'several', 'fact', 'suggest', 'another', 'animal', 'act', 'intermediate', 'host', 'bat', 'human', '', 'first', '', 'outbreak', 'first', 'report', 'late', 'december', '', '2019', '', 'bat', 'specie', 'wuhan', 'hibernate', '', 'second', '', 'bat', 'sell', 'find', 'huanan', 'seafood', 'market', '', 'whereas', 'various', 'non-aquatic', 'animal', '', 'include', 'mammal', '', 'available', 'purchase', '', 'third', '', 'sequence', 'identity', '2019-ncov', 'close', 'relative', 'bat-sl-covzc45', 'bat-sl-covzxc21', 'le', '90', '', '', 'reflect', 'relatively', 'long', 'branch', '', 'hence', '', 'bat-sl-covzc45', 'bat-sl-covzxc21', 'direct', 'ancestor', '2019-ncov', '', 'fourth', '', 'sars-cov', 'mers-cov', '', 'bat', 'act', 'natural', 'reservoir', '', 'another', 'animal', '', 'mask', 'palm', 'civet', 'sars-cov35guan', 'zheng', 'bj', 'yq', 'alisolation', 'characterization', 'virus', 'relate', 'sars', 'coronavirus', 'animal', 'southern', 'chinascience', '', '2003', '', '302', '', '276-278google', 'dromedary', 'camel', 'mers-cov', '', '36alagaili', 'briese', 'mishra', 'n', 'almiddle', 'east', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'dromedary', 'camel', 'saudi', 'arabiambio', '', '2014', '', '5', '', 'e00884-e00914google', 'act', 'intermediate', 'host', '', 'human', 'terminal', 'host', '', 'therefore', '', 'basis', 'current', 'data', '', 'likely', '2019-ncov', 'cause', 'wuhan', 'outbreak', 'initially', 'host', 'bat', '', 'transmit', 'human', 'via', 'currently', 'unknown', 'wild', 'animal', '', '', 'sell', 'huanan', 'seafood', 'market', '', 'previous', 'study', 'uncover', 'several', 'receptor', 'different', 'coronaviruses', 'bind', '', 'ace2', 'sars-cov29li', 'f', 'li', 'w', 'farzan', 'harrison', 'sc', 'structure', 'sars', 'coronavirus', 'spike', 'receptor-binding', 'domain', 'complexed', 'receptorscience', '', '2005', '', '309', '', '1864-1868google', 'cd26', 'mers-cov30lu', 'g', 'hu', 'wang', 'q', 'almolecular', 'basis', 'bind', 'novel', 'human', 'coronavirus', 'mers-cov', 'receptor', 'cd26nature', '', '2013', '', '500', '', '227-231google', 'molecular', 'model', 'show', 'structural', 'similarity', 'receptor-binding', 'domain', 'sars-cov', '2019-ncov', '', 'therefore', '', 'suggest', '2019-ncov', 'ace2', 'receptor', '', 'despite', 'presence', 'amino', 'acid', 'mutation', '2019-ncov', 'receptor-binding', 'domain', '', 'although', 'previous', 'study', 'hela', 'cell', 'express', 'ace2', 'protein', 'show', '2019-ncov', 'employ', 'ace2', 'receptor37zhou', 'p', 'yang', 'x-l', 'wang', 'x-g', 'aldiscovery', 'novel', 'coronavirus', 'associate', 'recent', 'pneumonia', 'outbreak', 'human', 'potential', 'bat', 'originbiorxiv', '', '2020', '', '', 'publish', 'online', 'jan', '23', '', '', 'doi10110120200122914952google', 'whether', 'mutation', 'affect', 'ace2', 'bind', 'change', 'receptor', 'tropism', 'require', 'study', '', 'recombination', 'frequently', 'coronaviruses1su', 'wong', 'g', 'shi', 'w', 'alepidemiology', '', 'genetic', 'recombination', '', 'pathogenesis', 'coronavirusestrends', 'microbiol', '', '2016', '', '24', '', '490-502google', 'expect', '', 'detect', 'recombination', 'sarbecoviruses', 'analyse', '', 'result', 'suggest', 'recombination', 'event', 'complex', 'likely', 'occur', 'bat', 'coronaviruses', '2019-ncov', '', 'hence', '', 'despite', 'occurrence', '', 'recombination', 'probably', 'reason', 'emergence', 'virus', '', 'although', 'inference', 'change', 'closely', 'relate', 'animal', 'virus', 'identify', '', 'conclusion', '', 'describe', 'genomic', 'structure', 'seventh', 'human', 'coronavirus', 'cause', 'severe', 'pneumonia', 'shed', 'light', 'origin', 'receptor-binding', 'property', '', 'generally', '', 'disease', 'outbreak', 'link', '2019-ncov', 'highlight', 'hide', 'virus', 'reservoir', 'wild', 'animal', 'potential', 'occasionally', 'spill', 'human', 'population', '', 'contributors', 'gfg', '', 'wt', '', 'ws', '', 'wc', '', 'wx', '', 'gw', 'design', 'study', '', 'rl', '', 'xz', '', 'pn', '', 'hw', '', 'ww', '', 'bh', '', 'nz', '', 'xm', '', 'wz', '', 'lz', '', 'jc', '', 'ym', '', 'jw', '', 'yl', '', 'jy', '', 'zx', '', 'jm', '', 'wjl', '', 'dw', 'experiment', '', '', 'fz', '', 'zh', 'provide', 'sample', '', 'ws', '', 'wc', '', 'wt', '', 'jl', '', 'hs', '', 'yb', '', 'lw', '', 'th', '', 'hz', 'analyse', 'data', '', 'ws', '', 'wt', '', 'jl', 'write', 'report', '', 'ech', 'gfg', 'revise', 'report', '', 'declaration', 'interest', 'declare', 'compete', 'interest', '', 'data', 'available', 'various', 'website', 'publicly', 'available', '', 'information', 'find', 'first', 'paragraph', 'results', 'section', '', '', 'acknowledgments', 'work', 'support', 'national', 'key', 'research', 'development', 'programme', 'china', '', '2016yfd0500301', '', '2020yfc0840800', '', '2020yfc0840900', '', '', 'national', 'major', 'project', 'control', 'prevention', 'infectious', 'disease', 'china', '', '2017zx10104001', '', '2018zx10101002', '', '2018zx10101004', '', '2018zx10732-401', '', '', 'state', 'key', 'research', 'development', 'program', 'china', '', '2019yfc1200501', '', '', 'strategic', 'priority', 'research', 'programme', 'chinese', 'academy', 'sciences', '', 'xdb29010102', '', '', 'academic', 'promotion', 'programme', 'shandong', 'first', 'medical', 'university', '', '2019ql006', '2019pt008', '', '', 'ws', 'support', 'taishan', 'scholars', 'programme', 'shandong', 'province', '', 'ts201511056', '', '', 'download', 'pdf', '', '94', 'mb', '', 'help', 'pdf', 'file', 'supplementary', 'appendix', 'viral', 'load', 'sars-cov-2', 'clinical', 'samplesfull-textpdf']",5986,"{'': 1289, '2019-ncov': 102, 'coronavirus': 65, 'sequence': 62, 'virus': 51, 'genome': 50, 'novel': 45, 'sars-cov': 37, 'human': 34, 'patient': 33, 'sample': 33, 'domain': 33, 'china': 32, 'respiratory': 29, 'bat': 29, 'receptor-binding': 28, 'figure': 28, 'coronaviruses': 27, 'syndrome': 27, 'analysis': 25}","{'infection': 11, 'sars-cov-2': 1}",12,0.4215
DOI:10.1016/S0140-6736(20)31129-6,10.1016/S0140-6736(20)31129-6,Comment,2020-05-22 00:00:00,LANCET,2020-05-23 22:13:35.057884,"['kawasaki-like', 'disease', '', 'emerge', 'complication', 'covid-19', 'pandemic']","['Children date bear minimal medical burden global COVID-19 pandemic .', 'Epidemiological data many country show child small minority test positive .', 'Children younger 18 year make 1·7 % national case USA,1Coronavirus Disease 2019 Children—United States , February 12–April 2 , 2020.MMWR Morb Mortal Wkly Rep. 2020 ; 69 : 422-426Google Scholar 1 % case Netherlands,2Children COVID-19 .', 'National Institute Public Health Environment ( RIVM ) , Amsterdam2020 urlplaceholder May 5 , 2020Google Scholar 2·0 % large observational cohort UK.3Docherty AB Harrison EM Green CA et al.Features 16,749 hospitalise UK patient COVID-19 use ISARIC WHO Clinical Characterisation Protocol.medRxiv .', '2020 ; ( publish online April 28 . )', '( preprint ) .DOI : 10.1101/2020.04.23.20076042Google Scholar Whether proportion reflect lower susceptibility among child versus adults,4Zhang J Litvinova M Liang Y et al.Changes contact pattern shape dynamic COVID-19 outbreak China.Science .', '2020 ; ( publish online April 29 .', ') DOI:10.1126/science.abb8001Google Scholar similar infection rate , much higher proportion asymptomatic disease , unclear.5Bi Q Wu Y Mei S et al.Epidemiology transmission COVID-19 391 case 1286 close contact Shenzhen , China : retrospective cohort study.Lancet Infect Dis .', '2020 ; ( publish online April 27 . )', 'urlplaceholder Scholar Studies several country confirm severe illness death due COVID-19 among child rare,1Coronavirus Disease 2019 Children—United States , February 12–April 2 , 2020.MMWR Morb Mortal Wkly Rep. 2020 ; 69 : 422-426Google Scholar , 6Dong Y Mo X Hu Y et al.Epidemiology COVID-19 among child China.Pediatrics .', '2020 ; ( publish online March 16 .', ') DOI:10.1542/peds.2020-0702Google Scholar accurate estimate unavailable absence true population denominator .', 'Attention shift vulnerability child two reason .', 'First , degree child transmit COVID-19 key country reopen community lockdown .', ""Second , new concern novel severe Kawasaki-like disease child relate COVID-19 , include Lucio Verdoni colleagues'7Verdoni L Mazza A Gervasoni A et al.An outbreak severe Kawasaki-like disease Italian epicentre SARS-CoV-2 epidemic : observational cohort study.Lancet ."", '2020 ; ( publish online May 13 . )', 'urlplaceholder Scholar description outbreak Italy The Lancet , change understand disease child .', 'Kawasaki disease rare acute paediatric vasculitis , coronary artery aneurysm main complication .', 'The diagnosis base presence persistent fever , exanthema , lymphadenopathy , conjunctival injection , change mucosa extremities.8Dietz SM van Stijn D Burgner D et al.Dissecting Kawasaki disease : state-of-the-art review.Eur J Pediatr .', '2017 ; 176 : 995-1009Google Scholar , 9McCrindle BW Rowley AH Newburger JW et al.Diagnosis , treatment , long-term management Kawasaki disease : scientific statement health professional American Heart Association.Circulation .', '2017 ; 135 : e927-e999Google Scholar Verdoni colleague describe ten case ( seven boy , three girl ; age 7·5 year [ SD 3·5 ] ) Kawasaki-like disease occur Bergamo , Italy , peak pandemic country ( Feb 18 April 20 , 2020 ) , monthly incidence 30-fold higher observe Kawasaki disease across previous 5 year .', 'Bergamo city highest rate infection death Italy time .', 'Within cluster five child feature similar Kawasaki disease ( ie , non-purulent conjunctivitis , polymorphic rash , mucosal change , swell extremity ) ; however , another five child present fewer three diagnostic clinical sign older patient classic Kawasaki disease .', 'There also high proportion shock , five ten child present hypotension require fluid resuscitation , two ten child need inotropic support .', 'Two ten child positive severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) PCR swab eight ten SARS-CoV-2-positive serology test ; however , test do contemporaneously episode , clinical relevance unclear .', 'The majority patient Kawasaki disease respond well intravenous immunoglobulin ; however , 10–20 % require additional anti-inflammatory treatment.9McCrindle BW Rowley AH Newburger JW et al.Diagnosis , treatment , long-term management Kawasaki disease : scientific statement health professional American Heart Association.Circulation .', '2017 ; 135 : e927-e999Google Scholar In cohort , eight ten child receive high-dose corticosteroid addition intravenous immunoglobulin .', 'These difference raise question whether cluster Kawasaki disease SARS-CoV-2 trigger agent , represent emerge Kawasaki-like disease characterise multisystem inflammation .', 'The diagnosis Kawasaki disease base clinical laboratory criterion hinder lack diagnostic test .', 'Understanding pathophysiology emerge phenomenon might provide welcome insight understand Kawasaki disease .', 'Anecdotally , clinician across Europe identify cluster similar case .', 'In UK , paediatrician identify small group child present shock multisystem inflammation critical care unit , coronary artery aneurysm , group le severely ill child Kawasaki-like disease , respond variety immunomodulatory treatment , include intravenous immunoglobulin , corticosteroid , biologics infliximab anakinra ( Whittaker E , unpublished ) .', 'Long-term echocardiogram data coronary artery aneurysm pending .', 'In response cluster London , UK , notify National Health Service emergence unusual disorder , alert issue April 25 .', 'On basis review clinical laboratory feature , case definition syndrome provisionally call paediatric inflammatory multisystem syndrome temporally associate SARS-CoV-2 ( PIMS-TS ) formulate expert UK publish Royal College Paediatrics Child Health.10Royal College Paediatrics Child HealthGuidance—Paediatric multisystem inflammatory syndrome temporally associate COVID-19 .', 'urlplaceholder 2020Google Scholar Correspondence11Riphagen S Gomez X Gonzalez-Martinez C Wilkinson N Theocharis P Hyperinflammatory shock child COVID-19 pandemic.Lancet .', '2020 ; ( publish online May 7 . )', 'urlplaceholder Scholar The Lancet May 7 , 2020 , describe nine child PIMS-TS require critical care south London highlight severe end spectrum disease .', 'The recognition disease late first pandemic wave might relate rarity difficulty recognise uncommon syndrome fragment health-care system rapidly reorganise deal pandemic .', 'Alternatively , might reflect mechanism PIMS-TS .', 'Alternatively , suggest mechanism Kawasaki-like disease describe PIMS-TS might represent post-infectious inflammatory syndrome , might antibody immune-complex mediate , particularly Italian cohort little evidence viral replication .', 'For prospective study , measure antibody time presentation , well consent patient appropriate research sample , essential elucidate mechanism syndrome .', 'Although Article suggest possible emerge inflammatory syndrome associate COVID-19 , crucial reiterate—for parent health-care worker alike—that child remain minimally affect SARS-CoV-2 infection overall .', 'Understanding inflammatory phenomenon child might provide vital information immune response SARS-CoV-2 possible correlate immune protection might relevance adult child .', 'In particular , antibody-mediated phenomenon , might implication vaccine study , might also explain child become ill COVID-19 , majority unaffected asymptomatic .', 'In UK , British Paediatric Surveillance Unit study rapidly open explore extent PIMS-TS nationally .', 'Two COVID-19 priority study UK ( DIAMONDS [ Central Portfolio Management System 45537 ] ISARIC [ UK Clinical Research Network 14152 ] ) collaborate ensure every child emerge syndrome opportunity consent take part study explore mechanism .', 'International discussion underway facilitate standardise approach investigation management child , include treatment strategy prevent long-term adverse outcome coronary artery aneurysm .', 'View Large Image Copyright © 2020 Jill Lehmann Photography/Getty Images View Large Image Copyright © 2020 Jill Lehmann Photography/Getty Images RMV President Royal College Paediatrics Child Health .', 'EW Secretary British Paediatric Allergy Immunity Infection Group .', 'She member PIMS-TS Study Group .', 'An outbreak severe Kawasaki-like disease Italian epicentre SARS-CoV-2 epidemic : observational cohort studyFull-TextPDF']","['children', 'date', 'bear', 'minimal', 'medical', 'burden', 'global', 'covid-19', 'pandemic', '', 'epidemiological', 'data', 'country', 'show', 'child', 'small', 'minority', 'test', 'positive', '', 'children', 'younger', '18', 'year', '17', '', 'national', 'case', 'usa1coronavirus', 'disease', '2019', 'childrenunited', 'states', '', 'february', '12april', '2', '', '2020mmwr', 'morb', 'mortal', 'wkly', 'rep', '2020', '', '69', '', '422-426google', '1', '', 'case', 'netherlands2children', 'covid-19', '', 'national', 'institute', 'public', 'health', 'environment', '', 'rivm', '', '', 'amsterdam2020', 'urlplaceholder', '5', '', '2020google', '20', '', 'large', 'observational', 'cohort', 'uk3docherty', 'ab', 'harrison', 'em', 'green', 'ca', 'alfeatures', '16749', 'hospitalise', 'uk', 'patient', 'covid-19', 'isaric', 'clinical', 'characterisation', 'protocolmedrxiv', '', '2020', '', '', 'publish', 'online', 'april', '28', '', '', '', 'preprint', '', 'doi', '', '1011012020042320076042google', 'whether', 'proportion', 'reflect', 'lower', 'susceptibility', 'among', 'child', 'versus', 'adults4zhang', 'j', 'litvinova', 'liang', 'alchanges', 'contact', 'pattern', 'shape', 'dynamic', 'covid-19', 'outbreak', 'chinascience', '', '2020', '', '', 'publish', 'online', 'april', '29', '', '', 'doi101126scienceabb8001google', 'similar', 'infection', 'rate', '', 'much', 'higher', 'proportion', 'asymptomatic', 'disease', '', 'unclear5bi', 'q', 'wu', 'mei', 'alepidemiology', 'transmission', 'covid-19', '391', 'case', '1286', 'close', 'contact', 'shenzhen', '', 'china', '', 'retrospective', 'cohort', 'studylancet', 'infect', 'dis', '', '2020', '', '', 'publish', 'online', 'april', '27', '', '', 'urlplaceholder', 'studies', 'several', 'country', 'confirm', 'severe', 'illness', 'death', 'due', 'covid-19', 'among', 'child', 'rare1coronavirus', 'disease', '2019', 'childrenunited', 'states', '', 'february', '12april', '2', '', '2020mmwr', 'morb', 'mortal', 'wkly', 'rep', '2020', '', '69', '', '422-426google', '', '6dong', 'mo', 'x', 'hu', 'alepidemiology', 'covid-19', 'among', 'child', 'chinapediatrics', '', '2020', '', '', 'publish', 'online', 'march', '16', '', '', 'doi101542peds2020-0702google', 'accurate', 'estimate', 'unavailable', 'absence', 'true', 'population', 'denominator', '', 'attention', 'shift', 'vulnerability', 'child', 'two', 'reason', '', 'first', '', 'degree', 'child', 'transmit', 'covid-19', 'key', 'country', 'reopen', 'community', 'lockdown', '', 'second', '', 'new', 'concern', 'novel', 'severe', 'kawasaki-like', 'disease', 'child', 'relate', 'covid-19', '', 'include', 'lucio', 'verdoni', 'colleagues7verdoni', 'l', 'mazza', 'gervasoni', 'alan', 'outbreak', 'severe', 'kawasaki-like', 'disease', 'italian', 'epicentre', 'sars-cov-2', 'epidemic', '', 'observational', 'cohort', 'studylancet', '', '2020', '', '', 'publish', 'online', '13', '', '', 'urlplaceholder', 'description', 'outbreak', 'italy', 'lancet', '', 'change', 'understand', 'disease', 'child', '', 'kawasaki', 'disease', 'rare', 'acute', 'paediatric', 'vasculitis', '', 'coronary', 'artery', 'aneurysm', 'main', 'complication', '', 'diagnosis', 'base', 'presence', 'persistent', 'fever', '', 'exanthema', '', 'lymphadenopathy', '', 'conjunctival', 'injection', '', 'change', 'mucosa', 'extremities8dietz', 'sm', 'van', 'stijn', 'burgner', 'aldissecting', 'kawasaki', 'disease', '', 'state-of-the-art', 'revieweur', 'j', 'pediatr', '', '2017', '', '176', '', '995-1009google', '', '9mccrindle', 'bw', 'rowley', 'ah', 'newburger', 'jw', 'aldiagnosis', '', 'treatment', '', 'long-term', 'management', 'kawasaki', 'disease', '', 'scientific', 'statement', 'health', 'professional', 'american', 'heart', 'associationcirculation', '', '2017', '', '135', '', 'e927-e999google', 'verdoni', 'colleague', 'describe', 'ten', 'case', '', 'seven', 'boy', '', 'three', 'girl', '', 'age', '75', 'year', '', 'sd', '35', '', '', 'kawasaki-like', 'disease', 'occur', 'bergamo', '', 'italy', '', 'peak', 'pandemic', 'country', '', 'feb', '18', 'april', '20', '', '2020', '', '', 'monthly', 'incidence', '30-fold', 'higher', 'observe', 'kawasaki', 'disease', 'across', 'previous', '5', 'year', '', 'bergamo', 'city', 'highest', 'rate', 'infection', 'death', 'italy', 'time', '', 'within', 'cluster', 'five', 'child', 'feature', 'similar', 'kawasaki', 'disease', '', 'ie', '', 'non-purulent', 'conjunctivitis', '', 'polymorphic', 'rash', '', 'mucosal', 'change', '', 'swell', 'extremity', '', '', 'however', '', 'another', 'five', 'child', 'present', 'fewer', 'three', 'diagnostic', 'clinical', 'sign', 'older', 'patient', 'classic', 'kawasaki', 'disease', '', 'high', 'proportion', 'shock', '', 'five', 'ten', 'child', 'present', 'hypotension', 'require', 'fluid', 'resuscitation', '', 'two', 'ten', 'child', 'inotropic', 'support', '', 'two', 'ten', 'child', 'positive', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'pcr', 'swab', 'eight', 'ten', 'sars-cov-2-positive', 'serology', 'test', '', 'however', '', 'test', 'contemporaneously', 'episode', '', 'clinical', 'relevance', 'unclear', '', 'majority', 'patient', 'kawasaki', 'disease', 'respond', 'well', 'intravenous', 'immunoglobulin', '', 'however', '', '1020', '', 'require', 'additional', 'anti-inflammatory', 'treatment9mccrindle', 'bw', 'rowley', 'ah', 'newburger', 'jw', 'aldiagnosis', '', 'treatment', '', 'long-term', 'management', 'kawasaki', 'disease', '', 'scientific', 'statement', 'health', 'professional', 'american', 'heart', 'associationcirculation', '', '2017', '', '135', '', 'e927-e999google', 'cohort', '', 'eight', 'ten', 'child', 'receive', 'high-dose', 'corticosteroid', 'addition', 'intravenous', 'immunoglobulin', '', 'difference', 'raise', 'question', 'whether', 'cluster', 'kawasaki', 'disease', 'sars-cov-2', 'trigger', 'agent', '', 'represent', 'emerge', 'kawasaki-like', 'disease', 'characterise', 'multisystem', 'inflammation', '', 'diagnosis', 'kawasaki', 'disease', 'base', 'clinical', 'laboratory', 'criterion', 'hinder', 'diagnostic', 'test', '', 'understanding', 'pathophysiology', 'emerge', 'phenomenon', 'provide', 'welcome', 'insight', 'understand', 'kawasaki', 'disease', '', 'anecdotally', '', 'clinician', 'across', 'europe', 'identify', 'cluster', 'similar', 'case', '', 'uk', '', 'paediatrician', 'identify', 'small', 'group', 'child', 'present', 'shock', 'multisystem', 'inflammation', 'critical', 'care', 'unit', '', 'coronary', 'artery', 'aneurysm', '', 'group', 'le', 'severely', 'ill', 'child', 'kawasaki-like', 'disease', '', 'respond', 'variety', 'immunomodulatory', 'treatment', '', 'include', 'intravenous', 'immunoglobulin', '', 'corticosteroid', '', 'biologics', 'infliximab', 'anakinra', '', 'whittaker', 'e', '', 'unpublished', '', '', 'long-term', 'echocardiogram', 'data', 'coronary', 'artery', 'aneurysm', 'pending', '', 'response', 'cluster', 'london', '', 'uk', '', 'notify', 'national', 'health', 'service', 'emergence', 'unusual', 'disorder', '', 'alert', 'issue', 'april', '25', '', 'basis', 'review', 'clinical', 'laboratory', 'feature', '', 'case', 'definition', 'syndrome', 'provisionally', 'call', 'paediatric', 'inflammatory', 'multisystem', 'syndrome', 'temporally', 'associate', 'sars-cov-2', '', 'pims-ts', '', 'formulate', 'expert', 'uk', 'publish', 'royal', 'college', 'paediatrics', 'child', 'health10royal', 'college', 'paediatrics', 'child', 'healthguidancepaediatric', 'multisystem', 'inflammatory', 'syndrome', 'temporally', 'associate', 'covid-19', '', 'urlplaceholder', '2020google', 'correspondence11riphagen', 'gomez', 'x', 'gonzalez-martinez', 'c', 'wilkinson', 'n', 'theocharis', 'p', 'hyperinflammatory', 'shock', 'child', 'covid-19', 'pandemiclancet', '', '2020', '', '', 'publish', 'online', '7', '', '', 'urlplaceholder', 'lancet', '7', '', '2020', '', 'describe', 'nine', 'child', 'pims-ts', 'require', 'critical', 'care', 'south', 'london', 'highlight', 'severe', 'end', 'spectrum', 'disease', '', 'recognition', 'disease', 'late', 'first', 'pandemic', 'wave', 'relate', 'rarity', 'difficulty', 'recognise', 'uncommon', 'syndrome', 'fragment', 'health-care', 'system', 'rapidly', 'reorganise', 'deal', 'pandemic', '', 'alternatively', '', 'reflect', 'mechanism', 'pims-ts', '', 'alternatively', '', 'suggest', 'mechanism', 'kawasaki-like', 'disease', 'describe', 'pims-ts', 'represent', 'post-infectious', 'inflammatory', 'syndrome', '', 'antibody', 'immune-complex', 'mediate', '', 'particularly', 'italian', 'cohort', 'little', 'evidence', 'viral', 'replication', '', 'prospective', 'study', '', 'measure', 'antibody', 'time', 'presentation', '', 'well', 'consent', 'patient', 'appropriate', 'research', 'sample', '', 'essential', 'elucidate', 'mechanism', 'syndrome', '', 'although', 'article', 'suggest', 'possible', 'emerge', 'inflammatory', 'syndrome', 'associate', 'covid-19', '', 'crucial', 'reiteratefor', 'parent', 'health-care', 'worker', 'alikethat', 'child', 'remain', 'minimally', 'affect', 'sars-cov-2', 'infection', 'overall', '', 'understanding', 'inflammatory', 'phenomenon', 'child', 'provide', 'vital', 'information', 'immune', 'response', 'sars-cov-2', 'possible', 'correlate', 'immune', 'protection', 'relevance', 'adult', 'child', '', 'particular', '', 'antibody-mediated', 'phenomenon', '', 'implication', 'vaccine', 'study', '', 'explain', 'child', 'become', 'ill', 'covid-19', '', 'majority', 'unaffected', 'asymptomatic', '', 'uk', '', 'british', 'paediatric', 'surveillance', 'unit', 'study', 'rapidly', 'open', 'explore', 'extent', 'pims-ts', 'nationally', '', 'two', 'covid-19', 'priority', 'study', 'uk', '', 'diamonds', '', 'central', 'portfolio', 'management', 'system', '45537', '', 'isaric', '', 'uk', 'clinical', 'research', 'network', '14152', '', '', 'collaborate', 'ensure', 'every', 'child', 'emerge', 'syndrome', 'opportunity', 'consent', 'part', 'study', 'explore', 'mechanism', '', 'international', 'discussion', 'underway', 'facilitate', 'standardise', 'approach', 'investigation', 'management', 'child', '', 'include', 'treatment', 'strategy', 'prevent', 'long-term', 'adverse', 'outcome', 'coronary', 'artery', 'aneurysm', '', 'view', 'large', 'image', 'copyright', '', '2020', 'jill', 'lehmann', 'photographygetty', 'images', 'view', 'large', 'image', 'copyright', '', '2020', 'jill', 'lehmann', 'photographygetty', 'images', 'rmv', 'president', 'royal', 'college', 'paediatrics', 'child', 'health', '', 'ew', 'secretary', 'british', 'paediatric', 'allergy', 'immunity', 'infection', 'group', '', 'member', 'pims-ts', 'study', 'group', '', 'outbreak', 'severe', 'kawasaki-like', 'disease', 'italian', 'epicentre', 'sars-cov-2', 'epidemic', '', 'observational', 'cohort', 'studyfull-textpdf']",1062,"{'': 190, 'child': 27, 'disease': 24, 'covid-19': 14, '2020': 12, 'kawasaki': 11, 'syndrome': 9, 'uk': 7, 'publish': 7, 'kawasaki-like': 7, 'sars-cov-2': 7, 'case': 6, 'cohort': 6, 'clinical': 6, 'online': 6, 'severe': 6, 'ten': 6, 'pims-ts': 6, 'study': 6, 'health': 5}","{'infliximab': 1, 'infection': 4, 'sars-cov-2': 7}",12,0.1779
DOI:10.1056/NEJMoa2007764,10.1056/NEJMoa2007764,Original Article,2020-05-22 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['remdesivir', 'covid-19', '', 'preliminary', 'report']","['In randomize , double-blind trial 1063 adult hospitalize Covid-19 , 10-day course intravenous remdesivir superior placebo shorten time recovery .', 'The estimate mortality 14 day 7.1 % remdesivir group 11.9 % placebo group .']","['randomize', '', 'double-blind', 'trial', '1063', 'adult', 'hospitalize', 'covid-19', '', '10-day', 'course', 'intravenous', 'remdesivir', 'superior', 'placebo', 'shorten', 'time', 'recovery', '', 'estimate', 'mortality', '14', 'day', '71', '', 'remdesivir', 'group', '119', '', 'placebo', 'group', '']",32,"{'': 6, 'remdesivir': 2, 'placebo': 2, 'group': 2, 'randomize': 1, 'double-blind': 1, 'trial': 1, '1063': 1, 'adult': 1, 'hospitalize': 1, 'covid-19': 1, '10-day': 1, 'course': 1, 'intravenous': 1, 'superior': 1, 'shorten': 1, 'time': 1, 'recovery': 1, 'estimate': 1, 'mortality': 1}",{},0,0.5423
DOI:10.1056/NEJMoa2007016,10.1056/NEJMoa2007016,Original Article,2020-04-10 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['compassionate-use', 'remdesivir', 'severe', 'covid-19']","['A cohort patient severe Covid-19 receive treatment remdesivir compassionate-use protocol .', 'Improvement oxygen-support status observe 68 % patient , overall mortality 13 % median follow-up 18 day .']","['cohort', 'patient', 'severe', 'covid-19', 'receive', 'treatment', 'remdesivir', 'compassionate-use', 'protocol', '', 'improvement', 'oxygen-support', 'status', 'observe', '68', '', 'patient', '', 'overall', 'mortality', '13', '', 'median', 'follow-up', '18', 'day', '']",27,"{'': 5, 'patient': 2, 'cohort': 1, 'severe': 1, 'covid-19': 1, 'receive': 1, 'treatment': 1, 'remdesivir': 1, 'compassionate-use': 1, 'protocol': 1, 'improvement': 1, 'oxygen-support': 1, 'status': 1, 'observe': 1, '68': 1, 'overall': 1, 'mortality': 1, '13': 1, 'median': 1, 'follow-up': 1}",{},0,0.1027
DOI:10.1056/NEJMoa2012410,10.1056/NEJMoa2012410,Original Article,2020-05-07 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['observational', 'study', 'hydroxychloroquine', 'covid-19']","['Among 1376 patient Covid-19 admit New York City hospital , 59 % treat hydroxychloroquine .', 'Patients select treatment severely ill. After adjustment patient ’ baseline characteristic , significant association hydroxychloroquine use intubation death ( hazard ratio , 1.04 ; 95 % CI , 0.82 1.32 ) .']","['among', '1376', 'patient', 'covid-19', 'admit', 'new', 'york', 'city', 'hospital', '', '59', '', 'treat', 'hydroxychloroquine', '', 'patients', 'select', 'treatment', 'severely', 'ill', 'adjustment', 'patient', '', 'baseline', 'characteristic', '', 'significant', 'association', 'hydroxychloroquine', 'intubation', 'death', '', 'hazard', 'ratio', '', '104', '', '95', '', 'ci', '', '082', '132', '', '']",45,"{'': 12, 'patient': 2, 'hydroxychloroquine': 2, 'among': 1, '1376': 1, 'covid-19': 1, 'admit': 1, 'new': 1, 'york': 1, 'city': 1, 'hospital': 1, '59': 1, 'treat': 1, 'patients': 1, 'select': 1, 'treatment': 1, 'severely': 1, 'ill': 1, 'adjustment': 1, 'baseline': 1}",{'hydroxychloroquine': 2},2,-0.6597
DOI:10.1056/NEJMoa2001282,10.1056/NEJMoa2001282,Original Article,2020-05-07 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['oral', 'lopinavirritonavir', 'severe', 'covid-19']","['Investigators China report result open-label , randomize clinical trial lopinavir–ritonavir treatment Covid-19 199 infect adult patient .', 'The primary end point time clinical improvement .']","['investigators', 'china', 'report', 'result', 'open-label', '', 'randomize', 'clinical', 'trial', 'lopinavirritonavir', 'treatment', 'covid-19', '199', 'infect', 'adult', 'patient', '', 'primary', 'end', 'point', 'time', 'clinical', 'improvement', '']",24,"{'': 3, 'clinical': 2, 'investigators': 1, 'china': 1, 'report': 1, 'result': 1, 'open-label': 1, 'randomize': 1, 'trial': 1, 'lopinavirritonavir': 1, 'treatment': 1, 'covid-19': 1, '199': 1, 'infect': 1, 'adult': 1, 'patient': 1, 'primary': 1, 'end': 1, 'point': 1, 'time': 1}",{},0,0.4588
DOI:10.1056/NEJMcpc2002418,10.1056/NEJMcpc2002418,Case Records of the Massachusetts General Hospital,2020-05-13 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['man', 'covid-19', 'acute', 'kidney', 'injury']","['A 68-year-old man admit hospital fever , shortness breath , acute kidney injury .', 'Testing nasopharyngeal swab SARS-CoV-2 RNA positive .', 'Respiratory failure hypotension develop .', 'The creatinine level 6.9 mg per deciliter ( normal range , 0.6 1.5 ) , urea nitrogen level 111 mg per deciliter ( normal range , 8 25 ) .', 'Management decision make .']","['68-year-old', 'man', 'admit', 'hospital', 'fever', '', 'shortness', 'breath', '', 'acute', 'kidney', 'injury', '', 'testing', 'nasopharyngeal', 'swab', 'sars-cov-2', 'rna', 'positive', '', 'respiratory', 'failure', 'hypotension', 'develop', '', 'creatinine', 'level', '69', 'mg', 'per', 'deciliter', '', 'normal', 'range', '', '06', '15', '', '', 'urea', 'nitrogen', 'level', '111', 'mg', 'per', 'deciliter', '', 'normal', 'range', '', '8', '25', '', '', 'management', 'decision', '']",57,"{'': 14, 'level': 2, 'mg': 2, 'per': 2, 'deciliter': 2, 'normal': 2, 'range': 2, '68-year-old': 1, 'man': 1, 'admit': 1, 'hospital': 1, 'fever': 1, 'shortness': 1, 'breath': 1, 'acute': 1, 'kidney': 1, 'injury': 1, 'testing': 1, 'nasopharyngeal': 1, 'swab': 1}",{'sars-cov-2': 1},1,-0.1779
DOI:10.1056/NEJMp2005630,10.1056/NEJMp2005630,Perspective,2020-05-21 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['developing', 'covid-19', 'vaccines', 'pandemic', 'speed']","['An ideal vaccine platform would support development viral sequence clinical trial le 16 week , demonstrate elicitation consistent immune response across pathogen , suitable large-scale manufacture use pathogen-agnostic platform .']","['ideal', 'vaccine', 'platform', 'support', 'development', 'viral', 'sequence', 'clinical', 'trial', 'le', '16', 'week', '', 'demonstrate', 'elicitation', 'consistent', 'immune', 'response', 'across', 'pathogen', '', 'suitable', 'large-scale', 'manufacture', 'pathogen-agnostic', 'platform', '']",27,"{'': 3, 'platform': 2, 'ideal': 1, 'vaccine': 1, 'support': 1, 'development': 1, 'viral': 1, 'sequence': 1, 'clinical': 1, 'trial': 1, 'le': 1, '16': 1, 'week': 1, 'demonstrate': 1, 'elicitation': 1, 'consistent': 1, 'immune': 1, 'response': 1, 'across': 1, 'pathogen': 1}",{},0,0.8074
DOI:10.1056/NEJMcibr2007042,10.1056/NEJMcibr2007042,Clinical Implications of Basic Research,2020-05-20 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['dynamic', 'developments', 'screening', 'candidate', 'drugs']","['Molecular-dynamics simulation together virtual high-throughput screen provide mean quick evaluation exist drug antiviral activity .', 'The author explain method serve quest drug treat Covid-19 .']","['molecular-dynamics', 'simulation', 'together', 'virtual', 'high-throughput', 'screen', 'provide', 'mean', 'quick', 'evaluation', 'exist', 'drug', 'antiviral', 'activity', '', 'author', 'explain', 'method', 'serve', 'quest', 'drug', 'treat', 'covid-19', '']",24,"{'drug': 2, '': 2, 'molecular-dynamics': 1, 'simulation': 1, 'together': 1, 'virtual': 1, 'high-throughput': 1, 'screen': 1, 'provide': 1, 'mean': 1, 'quick': 1, 'evaluation': 1, 'exist': 1, 'antiviral': 1, 'activity': 1, 'author': 1, 'explain': 1, 'method': 1, 'serve': 1, 'quest': 1}",{},0,0.4019
DOI:10.1056/NEJMcp2009575,10.1056/NEJMcp2009575,Clinical Practice,2020-05-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['severe', 'covid-19']","['Patients severe Covid-19 closely monitor regard need endotracheal intubation ; intubate patient receive lung-protective ventilation .', 'Data randomize , control trial await inform use antiviral immunomodulatory therapy ; preliminary data support benefit remdesivir population .']","['patients', 'severe', 'covid-19', 'closely', 'monitor', 'regard', 'endotracheal', 'intubation', '', 'intubate', 'patient', 'receive', 'lung-protective', 'ventilation', '', 'data', 'randomize', '', 'control', 'trial', 'await', 'inform', 'antiviral', 'immunomodulatory', 'therapy', '', 'preliminary', 'data', 'support', 'benefit', 'remdesivir', 'population', '']",33,"{'': 5, 'data': 2, 'patients': 1, 'severe': 1, 'covid-19': 1, 'closely': 1, 'monitor': 1, 'regard': 1, 'endotracheal': 1, 'intubation': 1, 'intubate': 1, 'patient': 1, 'receive': 1, 'lung-protective': 1, 'ventilation': 1, 'randomize': 1, 'control': 1, 'trial': 1, 'await': 1, 'inform': 1}",{},0,0.5423
DOI:10.1056/NEJMcp2009249,10.1056/NEJMcp2009249,Clinical Practice,2020-04-24 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['mild', 'moderate', 'covid-19']","['The diagnosis Covid-19 usually base detection SARS-CoV-2 PCR test ( commonly nasopharyngeal swab ) ; false negative may occur .', 'Available data guide treatment substantial limitation ; randomize trial several treatment ( e.g. , hydroxychloroquine , remdesivir , favipiravir ) ongoing .']","['diagnosis', 'covid-19', 'usually', 'base', 'detection', 'sars-cov-2', 'pcr', 'test', '', 'commonly', 'nasopharyngeal', 'swab', '', '', 'false', 'negative', 'occur', '', 'available', 'data', 'guide', 'treatment', 'substantial', 'limitation', '', 'randomize', 'trial', 'several', 'treatment', '', 'eg', '', 'hydroxychloroquine', '', 'remdesivir', '', 'favipiravir', '', 'ongoing', '']",40,"{'': 11, 'treatment': 2, 'diagnosis': 1, 'covid-19': 1, 'usually': 1, 'base': 1, 'detection': 1, 'sars-cov-2': 1, 'pcr': 1, 'test': 1, 'commonly': 1, 'nasopharyngeal': 1, 'swab': 1, 'false': 1, 'negative': 1, 'occur': 1, 'available': 1, 'data': 1, 'guide': 1, 'substantial': 1}","{'hydroxychloroquine': 1, 'sars-cov-2': 1}",2,-0.6249
DOI:10.1056/NEJMc2017424,10.1056/NEJMc2017424,Correspondence,2020-05-22 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['surgery', 'scheduling', 'crisis']","['After New York medical center convert ORs ICUs cut operative time 90 % , clinician develop triage system guide schedule decision .', 'Their approach consider clinical urgency expect intensity resource utilization .']","['new', 'york', 'medical', 'center', 'convert', 'ors', 'icus', 'cut', 'operative', 'time', '90', '', '', 'clinician', 'develop', 'triage', 'system', 'guide', 'schedule', 'decision', '', 'approach', 'consider', 'clinical', 'urgency', 'expect', 'intensity', 'resource', 'utilization', '']",30,"{'': 4, 'new': 1, 'york': 1, 'medical': 1, 'center': 1, 'convert': 1, 'ors': 1, 'icus': 1, 'cut': 1, 'operative': 1, 'time': 1, '90': 1, 'clinician': 1, 'develop': 1, 'triage': 1, 'system': 1, 'guide': 1, 'schedule': 1, 'decision': 1, 'approach': 1}",{},0,-0.2732
DOI:10.1056/NEJMc2014819,10.1056/NEJMc2014819,Correspondence,2020-05-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['repurposing', 'pediatric', 'icu', 'adults']","['A Boston hospital transform pediatric ICU treat adult patient .', 'Preserving original PICU team minimize unnecessary change personnel environment help rapid transition .']","['boston', 'hospital', 'transform', 'pediatric', 'icu', 'treat', 'adult', 'patient', '', 'preserving', 'original', 'picu', 'team', 'minimize', 'unnecessary', 'change', 'personnel', 'environment', 'help', 'rapid', 'transition', '']",22,"{'': 2, 'boston': 1, 'hospital': 1, 'transform': 1, 'pediatric': 1, 'icu': 1, 'treat': 1, 'adult': 1, 'patient': 1, 'preserving': 1, 'original': 1, 'picu': 1, 'team': 1, 'minimize': 1, 'unnecessary': 1, 'change': 1, 'personnel': 1, 'environment': 1, 'help': 1, 'rapid': 1}",{},0,0.7717
DOI:10.1056/NEJMvcm2014809,10.1056/NEJMvcm2014809,Videos in Clinical Medicine,2020-05-19 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['personal', 'protective', 'equipment', 'covid-19']",['This video demonstrate procedure don doff one type PPE recommend CDC use hospital minimize risk exposure infectious material care patient Covid-19 .'],"['video', 'demonstrate', 'procedure', 'doff', 'one', 'type', 'ppe', 'recommend', 'cdc', 'hospital', 'minimize', 'risk', 'exposure', 'infectious', 'material', 'care', 'patient', 'covid-19', '']",19,"{'video': 1, 'demonstrate': 1, 'procedure': 1, 'doff': 1, 'one': 1, 'type': 1, 'ppe': 1, 'recommend': 1, 'cdc': 1, 'hospital': 1, 'minimize': 1, 'risk': 1, 'exposure': 1, 'infectious': 1, 'material': 1, 'care': 1, 'patient': 1, 'covid-19': 1, '': 1}",{},0,0.5574
DOI:10.1056/NEJMc2010853,10.1056/NEJMc2010853,Correspondence,2020-05-07 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['transforming', 'ors', 'icus']","['In epicenter New York City , medical center rapidly transform unused facility increase critical care capacity .', 'In process , repurposes equipment , retrain staff , modify ventilation system , construct new wall .']","['epicenter', 'new', 'york', 'city', '', 'medical', 'center', 'rapidly', 'transform', 'unused', 'facility', 'increase', 'critical', 'care', 'capacity', '', 'process', '', 'repurposes', 'equipment', '', 'retrain', 'staff', '', 'modify', 'ventilation', 'system', '', 'construct', 'new', 'wall', '']",32,"{'': 7, 'new': 2, 'epicenter': 1, 'york': 1, 'city': 1, 'medical': 1, 'center': 1, 'rapidly': 1, 'transform': 1, 'unused': 1, 'facility': 1, 'increase': 1, 'critical': 1, 'care': 1, 'capacity': 1, 'process': 1, 'repurposes': 1, 'equipment': 1, 'retrain': 1, 'staff': 1}",{},0,0.4939
DOI:10.1056/NEJMc2009432,10.1056/NEJMc2009432,Correspondence,2020-05-21 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['opening', 'new', 'supply', 'chains']",['A Massachusetts economic-development agency assemble diverse team help manufacturer open new supply chain start produce material need alleviate critical shortage fight epidemic .'],"['massachusetts', 'economic-development', 'agency', 'assemble', 'diverse', 'team', 'help', 'manufacturer', 'open', 'new', 'supply', 'chain', 'start', 'produce', 'material', 'alleviate', 'critical', 'shortage', 'fight', 'epidemic', '']",21,"{'massachusetts': 1, 'economic-development': 1, 'agency': 1, 'assemble': 1, 'diverse': 1, 'team': 1, 'help': 1, 'manufacturer': 1, 'open': 1, 'new': 1, 'supply': 1, 'chain': 1, 'start': 1, 'produce': 1, 'material': 1, 'alleviate': 1, 'critical': 1, 'shortage': 1, 'fight': 1, 'epidemic': 1}",{},0,-0.4939
DOI:10.1056/NEJMsb2005114,10.1056/NEJMsb2005114,Sounding Board,2020-05-21 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['allocating', 'scarce', 'medical', 'resources', 'covid-19']","['The Covid-19 pandemic already stress health care system throughout world , require ration medical equipment care .', 'The author discus ethical value relevant health care ration provide six recommendation guide fair allocation scarce medical resource pandemic .']","['covid-19', 'pandemic', 'already', 'stress', 'health', 'care', 'system', 'throughout', 'world', '', 'require', 'ration', 'medical', 'equipment', 'care', '', 'author', 'discus', 'ethical', 'value', 'relevant', 'health', 'care', 'ration', 'provide', 'six', 'recommendation', 'guide', 'fair', 'allocation', 'scarce', 'medical', 'resource', 'pandemic', '']",35,"{'care': 3, '': 3, 'pandemic': 2, 'health': 2, 'ration': 2, 'medical': 2, 'covid-19': 1, 'already': 1, 'stress': 1, 'system': 1, 'throughout': 1, 'world': 1, 'require': 1, 'equipment': 1, 'author': 1, 'discus': 1, 'ethical': 1, 'value': 1, 'relevant': 1, 'provide': 1}",{},0,0.93
DOI:10.1056/NEJMc2009409,10.1056/NEJMc2009409,Correspondence,2020-04-30 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['staying', 'ahead', 'wave']","['This report hard-hit hospital Long Island , New York , explain local coronavirus epidemic lead rapid innovation .', 'The ED set forward-triage treatment unit split-flow process expedite care .', 'Ways find produce face shield hand sanitizer sterilize use N95 respirator .']","['report', 'hard-hit', 'hospital', 'long', 'island', '', 'new', 'york', '', 'explain', 'local', 'coronavirus', 'epidemic', 'lead', 'rapid', 'innovation', '', 'ed', 'set', 'forward-triage', 'treatment', 'unit', 'split-flow', 'process', 'expedite', 'care', '', 'ways', 'find', 'produce', 'face', 'shield', 'hand', 'sanitizer', 'sterilize', 'n95', 'respirator', '']",38,"{'': 5, 'report': 1, 'hard-hit': 1, 'hospital': 1, 'long': 1, 'island': 1, 'new': 1, 'york': 1, 'explain': 1, 'local': 1, 'coronavirus': 1, 'epidemic': 1, 'lead': 1, 'rapid': 1, 'innovation': 1, 'ed': 1, 'set': 1, 'forward-triage': 1, 'treatment': 1, 'unit': 1}",{},0,0.8402
DOI:10.1056/NEJMc2007589,10.1056/NEJMc2007589,Correspondence,2020-04-03 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['protective', 'shield', 'intubation']","['A four-sided plexiglas box access hole operator use provide additional protection operator perform intubation .', 'The box reduce amount material expel simulate patient cough end operator .', 'This letter accompany video show simulation .']","['four-sided', 'plexiglas', 'box', 'access', 'hole', 'operator', 'provide', 'additional', 'protection', 'operator', 'perform', 'intubation', '', 'box', 'reduce', 'amount', 'material', 'expel', 'simulate', 'patient', 'cough', 'end', 'operator', '', 'letter', 'accompany', 'video', 'show', 'simulation', '']",30,"{'operator': 3, '': 3, 'box': 2, 'four-sided': 1, 'plexiglas': 1, 'access': 1, 'hole': 1, 'provide': 1, 'additional': 1, 'protection': 1, 'perform': 1, 'intubation': 1, 'reduce': 1, 'amount': 1, 'material': 1, 'expel': 1, 'simulate': 1, 'patient': 1, 'cough': 1, 'end': 1}",{},0,-0.4404
DOI:10.1056/NEJMc2010025,10.1056/NEJMc2010025,Correspondence,2020-04-30 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['pursuit', 'ppe']","['A chief physician executive find involve complexity try secure shipment much-needed personal protective equipment hospital .', 'In end , seem like scene gangster movie .']","['chief', 'physician', 'executive', 'find', 'involve', 'complexity', 'secure', 'shipment', 'much-needed', 'personal', 'protective', 'equipment', 'hospital', '', 'end', '', 'like', 'scene', 'gangster', 'movie', '']",21,"{'': 3, 'chief': 1, 'physician': 1, 'executive': 1, 'find': 1, 'involve': 1, 'complexity': 1, 'secure': 1, 'shipment': 1, 'much-needed': 1, 'personal': 1, 'protective': 1, 'equipment': 1, 'hospital': 1, 'end': 1, 'like': 1, 'scene': 1, 'gangster': 1, 'movie': 1}",{},0,0.5994
DOI:10.1056/NEJMoa2015432,10.1056/NEJMoa2015432,Original Article,2020-05-21 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['angiogenesis', 'covid-19']",['Autopsy examination lung seven patient die Covid-19 show intussusceptive angiogenesis greater profusion find lung patient die influenza uninfected lung reject transplantation .'],"['autopsy', 'examination', 'lung', 'seven', 'patient', 'die', 'covid-19', 'show', 'intussusceptive', 'angiogenesis', 'greater', 'profusion', 'find', 'lung', 'patient', 'die', 'influenza', 'uninfected', 'lung', 'reject', 'transplantation', '']",22,"{'lung': 3, 'patient': 2, 'die': 2, 'autopsy': 1, 'examination': 1, 'seven': 1, 'covid-19': 1, 'show': 1, 'intussusceptive': 1, 'angiogenesis': 1, 'greater': 1, 'profusion': 1, 'find': 1, 'influenza': 1, 'uninfected': 1, 'reject': 1, 'transplantation': 1, '': 1}",{},0,-0.8402
DOI:10.1056/NEJMc2011400,10.1056/NEJMc2011400,Correspondence,2020-05-13 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['multiorgan', 'renal', 'tropism', 'sars-cov-2']","['In autopsy series , author find SARS-CoV-2 organotropism beyond respiratory tract , include kidney , heart , liver , brain .', 'They speculate organotropism influence course Covid-19 disease , possibly , aggravate preexist condition .']","['autopsy', 'series', '', 'author', 'find', 'sars-cov-2', 'organotropism', 'beyond', 'respiratory', 'tract', '', 'include', 'kidney', '', 'heart', '', 'liver', '', 'brain', '', 'speculate', 'organotropism', 'influence', 'course', 'covid-19', 'disease', '', 'possibly', '', 'aggravate', 'preexist', 'condition', '']",33,"{'': 9, 'organotropism': 2, 'autopsy': 1, 'series': 1, 'author': 1, 'find': 1, 'sars-cov-2': 1, 'beyond': 1, 'respiratory': 1, 'tract': 1, 'include': 1, 'kidney': 1, 'heart': 1, 'liver': 1, 'brain': 1, 'speculate': 1, 'influence': 1, 'course': 1, 'covid-19': 1, 'disease': 1}",{'sars-cov-2': 1},1,-0.5423
DOI:10.1056/NEJMc2013656,10.1056/NEJMc2013656,Correspondence,2020-05-05 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['prolonged', 'aptt', 'patients', 'covid-19']","['In study , 20 % patient Covid-19 prolong activate partial-thromboplastin time ( aPTT ) .', 'In 90 % case , cause lupus anticoagulant , associate bleed .', 'Patients Covid-19 susceptible thrombose .', 'The presence prolong aPTT , general , consider contraindication anticoagulation .']","['study', '', '20', '', 'patient', 'covid-19', 'prolong', 'activate', 'partial-thromboplastin', 'time', '', 'aptt', '', '', '90', '', 'case', '', 'cause', 'lupus', 'anticoagulant', '', 'associate', 'bleed', '', 'patients', 'covid-19', 'susceptible', 'thrombose', '', 'presence', 'prolong', 'aptt', '', 'general', '', 'consider', 'contraindication', 'anticoagulation', '']",40,"{'': 13, 'covid-19': 2, 'prolong': 2, 'aptt': 2, 'study': 1, '20': 1, 'patient': 1, 'activate': 1, 'partial-thromboplastin': 1, 'time': 1, '90': 1, 'case': 1, 'cause': 1, 'lupus': 1, 'anticoagulant': 1, 'associate': 1, 'bleed': 1, 'patients': 1, 'susceptible': 1, 'thrombose': 1}",{},0,0.0
DOI:10.1056/NEJMc2009567,10.1056/NEJMc2009567,Correspondence,2020-04-29 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', 'immune-mediated', 'inflammatory', 'diseases']","['The author describe patient New York City know immune-mediated inflammatory disease Covid-19 develop receive biologics , immunomodulatory therapy , .', 'The incidence hospitalization among patient consistent among patient Covid-19 general population New York City .']","['author', 'describe', 'patient', 'new', 'york', 'city', 'immune-mediated', 'inflammatory', 'disease', 'covid-19', 'develop', 'receive', 'biologics', '', 'immunomodulatory', 'therapy', '', '', 'incidence', 'hospitalization', 'among', 'patient', 'consistent', 'among', 'patient', 'covid-19', 'general', 'population', 'new', 'york', 'city', '']",32,"{'': 4, 'patient': 3, 'new': 2, 'york': 2, 'city': 2, 'covid-19': 2, 'among': 2, 'author': 1, 'describe': 1, 'immune-mediated': 1, 'inflammatory': 1, 'disease': 1, 'develop': 1, 'receive': 1, 'biologics': 1, 'immunomodulatory': 1, 'therapy': 1, 'incidence': 1, 'hospitalization': 1, 'consistent': 1}",{},0,0.0
DOI:10.1056/NEJMc2011117,10.1056/NEJMc2011117,Correspondence,2020-04-24 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['kidney-transplant', 'recipients', 'covid-19']","['A cohort 36 consecutive kidney-transplant recipient le fever , lower CD3 , CD4 , CD8 cell count , rapid clinical deterioration , higher mortality general population patient Covid-19 .']","['cohort', '36', 'consecutive', 'kidney-transplant', 'recipient', 'le', 'fever', '', 'lower', 'cd3', '', 'cd4', '', 'cd8', 'cell', 'count', '', 'rapid', 'clinical', 'deterioration', '', 'higher', 'mortality', 'general', 'population', 'patient', 'covid-19', '']",28,"{'': 6, 'cohort': 1, '36': 1, 'consecutive': 1, 'kidney-transplant': 1, 'recipient': 1, 'le': 1, 'fever': 1, 'lower': 1, 'cd3': 1, 'cd4': 1, 'cd8': 1, 'cell': 1, 'count': 1, 'rapid': 1, 'clinical': 1, 'deterioration': 1, 'higher': 1, 'mortality': 1, 'general': 1}",{},0,-0.296
DOI:10.1056/NEJMc2011595,10.1056/NEJMc2011595,Correspondence,2020-04-28 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['cancer', 'management', 'india', 'covid-19']","['India ’ largest cancer center adopt proactive , multipronged approach provide treatment , face reality service must scale back nationwide lockdown .', 'Prioritization criterion guide treatment decision .']","['india', '', 'largest', 'cancer', 'center', 'adopt', 'proactive', '', 'multipronged', 'approach', 'provide', 'treatment', '', 'face', 'reality', 'service', 'must', 'scale', 'back', 'nationwide', 'lockdown', '', 'prioritization', 'criterion', 'guide', 'treatment', 'decision', '']",28,"{'': 5, 'treatment': 2, 'india': 1, 'largest': 1, 'cancer': 1, 'center': 1, 'adopt': 1, 'proactive': 1, 'multipronged': 1, 'approach': 1, 'provide': 1, 'face': 1, 'reality': 1, 'service': 1, 'must': 1, 'scale': 1, 'back': 1, 'nationwide': 1, 'lockdown': 1, 'prioritization': 1}",{},0,-0.2263
DOI:10.1056/NEJMc2009191,10.1056/NEJMc2009191,Correspondence,2020-04-17 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['guillainbarr', 'syndrome', 'covid-19']","['Five patient Guillain–Barré syndrome 5 10 day onset Covid-19 describe .', 'Three severe weakness axonal pattern electrophysiological study , two normal protein level cerebrospinal fluid .', 'The virus find CSF .']","['five', 'patient', 'guillainbarr', 'syndrome', '5', '10', 'day', 'onset', 'covid-19', 'describe', '', 'three', 'severe', 'weakness', 'axonal', 'pattern', 'electrophysiological', 'study', '', 'two', 'normal', 'protein', 'level', 'cerebrospinal', 'fluid', '', 'virus', 'find', 'csf', '']",30,"{'': 4, 'five': 1, 'patient': 1, 'guillainbarr': 1, 'syndrome': 1, '5': 1, '10': 1, 'day': 1, 'onset': 1, 'covid-19': 1, 'describe': 1, 'three': 1, 'severe': 1, 'weakness': 1, 'axonal': 1, 'pattern': 1, 'electrophysiological': 1, 'study': 1, 'two': 1, 'normal': 1}",{},0,-0.6597
DOI:10.1056/NEJMp2014836,10.1056/NEJMp2014836,Perspective,2020-05-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['failing', 'test']","['Tragically , United States , unable match country ’ pandemic response , tally Covid-19 case death world .', 'Why U.S. response ineffectual ?', 'A key answer test , slow start difficult ramp .']","['tragically', '', 'united', 'states', '', 'unable', 'match', 'country', '', 'pandemic', 'response', '', 'tally', 'covid-19', 'case', 'death', 'world', '', 'us', 'response', 'ineffectual', '', 'key', 'answer', 'test', '', 'slow', 'start', 'difficult', 'ramp', '']",31,"{'': 8, 'response': 2, 'tragically': 1, 'united': 1, 'states': 1, 'unable': 1, 'match': 1, 'country': 1, 'pandemic': 1, 'tally': 1, 'covid-19': 1, 'case': 1, 'death': 1, 'world': 1, 'us': 1, 'ineffectual': 1, 'key': 1, 'answer': 1, 'test': 1, 'slow': 1}",{},0,-0.8591
DOI:10.1056/NEJMe2007263,10.1056/NEJMe2007263,Editorial,2020-04-23 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['ten', 'weeks', 'crush', 'curve']","['Harvey Fineberg call forceful , focus campaign eradicate Covid-19 outline six step mobilize organize nation crush curve early June .']","['harvey', 'fineberg', 'call', 'forceful', '', 'focus', 'campaign', 'eradicate', 'covid-19', 'outline', 'six', 'step', 'mobilize', 'organize', 'nation', 'crush', 'curve', 'early', 'june', '']",20,"{'': 2, 'harvey': 1, 'fineberg': 1, 'call': 1, 'forceful': 1, 'focus': 1, 'campaign': 1, 'eradicate': 1, 'covid-19': 1, 'outline': 1, 'six': 1, 'step': 1, 'mobilize': 1, 'organize': 1, 'nation': 1, 'crush': 1, 'curve': 1, 'early': 1, 'june': 1}",{},0,-0.1531
DOI:10.1056/NEJMvcm2010260,10.1056/NEJMvcm2010260,Videos in Clinical Medicine,2020-04-17 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['obtain', 'nasopharyngeal', 'swab', 'specimen']","['Collecting specimen surface respiratory mucosa nasopharyngeal swab procedure use diagnose Covid-19 well respiratory viral infection certain bacterial infection adult child .', 'This video describe collection specimen detection Covid-19 .']","['collecting', 'specimen', 'surface', 'respiratory', 'mucosa', 'nasopharyngeal', 'swab', 'procedure', 'diagnose', 'covid-19', 'well', 'respiratory', 'viral', 'infection', 'certain', 'bacterial', 'infection', 'adult', 'child', '', 'video', 'describe', 'collection', 'specimen', 'detection', 'covid-19', '']",27,"{'specimen': 2, 'respiratory': 2, 'covid-19': 2, 'infection': 2, '': 2, 'collecting': 1, 'surface': 1, 'mucosa': 1, 'nasopharyngeal': 1, 'swab': 1, 'procedure': 1, 'diagnose': 1, 'well': 1, 'viral': 1, 'certain': 1, 'bacterial': 1, 'adult': 1, 'child': 1, 'video': 1, 'describe': 1}",{'infection': 2},2,0.4939
DOI:10.1056/NEJMp2015024,10.1056/NEJMp2015024,Perspective,2020-05-20 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['pandemic', 'teacher']","['As palliative care leader plan Covid surge , see plan worst ’ simple imagine ask patient .', 'In many way , pandemic force clinician gain insight experience seriously ill patient .']","['palliative', 'care', 'leader', 'plan', 'covid', 'surge', '', 'plan', 'worst', '', 'simple', 'imagine', 'ask', 'patient', '', 'way', '', 'pandemic', 'force', 'clinician', 'gain', 'insight', 'experience', 'seriously', 'ill', 'patient', '']",27,"{'': 5, 'plan': 2, 'patient': 2, 'palliative': 1, 'care': 1, 'leader': 1, 'covid': 1, 'surge': 1, 'worst': 1, 'simple': 1, 'imagine': 1, 'ask': 1, 'way': 1, 'pandemic': 1, 'force': 1, 'clinician': 1, 'gain': 1, 'insight': 1, 'experience': 1, 'seriously': 1}",{},0,-0.25
DOI:10.1056/NEJMp2011418,10.1056/NEJMp2011418,Perspective,2020-05-20 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['becoming', 'plague', 'doctor']","['Despite fearsome appearance , plague doctor ’ costume — “ personal protective equipment ” Middle Ages — noble purpose .', 'It intend enable physician safely care patient Black Death .']","['despite', 'fearsome', 'appearance', '', 'plague', 'doctor', '', 'costume', '', '', 'personal', 'protective', 'equipment', '', 'middle', 'ages', '', 'noble', 'purpose', '', 'intend', 'enable', 'physician', 'safely', 'care', 'patient', 'black', 'death', '']",29,"{'': 8, 'despite': 1, 'fearsome': 1, 'appearance': 1, 'plague': 1, 'doctor': 1, 'costume': 1, 'personal': 1, 'protective': 1, 'equipment': 1, 'middle': 1, 'ages': 1, 'noble': 1, 'purpose': 1, 'intend': 1, 'enable': 1, 'physician': 1, 'safely': 1, 'care': 1, 'patient': 1}",{},0,0.7755
DOI:10.1056/NEJMp2008300,10.1056/NEJMp2008300,Perspective,2020-05-19 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', 'crisis', 'triage']","['Crisis triage protocol seek optimize health outcome , require explicit protection core value , equal moral worth people , include disability .', 'Some thoughtful policy capable meet goal .']","['crisis', 'triage', 'protocol', 'seek', 'optimize', 'health', 'outcome', '', 'require', 'explicit', 'protection', 'core', 'value', '', 'equal', 'moral', 'worth', 'people', '', 'include', 'disability', '', 'thoughtful', 'policy', 'capable', 'meet', 'goal', '']",28,"{'': 5, 'crisis': 1, 'triage': 1, 'protocol': 1, 'seek': 1, 'optimize': 1, 'health': 1, 'outcome': 1, 'require': 1, 'explicit': 1, 'protection': 1, 'core': 1, 'value': 1, 'equal': 1, 'moral': 1, 'worth': 1, 'people': 1, 'include': 1, 'disability': 1, 'thoughtful': 1}",{},0,0.765
DOI:10.1056/NEJMc2013400,10.1056/NEJMc2013400,Correspondence,2020-05-13 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['coronavirus', 'cats']","['SARS-CoV-2 detect three cat cohoused cat experimentally inoculate virus .', 'Cats may silent intermediate host SARS-CoV-2 .']","['sars-cov-2', 'detect', 'three', 'cat', 'cohoused', 'cat', 'experimentally', 'inoculate', 'virus', '', 'cats', 'silent', 'intermediate', 'host', 'sars-cov-2', '']",16,"{'sars-cov-2': 2, 'cat': 2, '': 2, 'detect': 1, 'three': 1, 'cohoused': 1, 'experimentally': 1, 'inoculate': 1, 'virus': 1, 'cats': 1, 'silent': 1, 'intermediate': 1, 'host': 1}",{'sars-cov-2': 2},2,0.0
DOI:10.1056/NEJMp2011997,10.1056/NEJMp2011997,Perspective,2020-05-19 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['respecting', 'disability', 'rights']","['Disability right advocate file complaint regard crisis standard care put forth several U.S. state .', 'Policymakers hospital take key step honor commitment antidiscrimination principle appropriately stewarding scarce resource .']","['disability', 'advocate', 'file', 'complaint', 'regard', 'crisis', 'standard', 'care', 'put', 'forth', 'several', 'us', 'state', '', 'policymakers', 'hospital', 'key', 'step', 'honor', 'commitment', 'antidiscrimination', 'principle', 'appropriately', 'stewarding', 'scarce', 'resource', '']",27,"{'': 2, 'disability': 1, 'advocate': 1, 'file': 1, 'complaint': 1, 'regard': 1, 'crisis': 1, 'standard': 1, 'care': 1, 'put': 1, 'forth': 1, 'several': 1, 'us': 1, 'state': 1, 'policymakers': 1, 'hospital': 1, 'key': 1, 'step': 1, 'honor': 1, 'commitment': 1}",{},0,0.4019
DOI:10.1056/NEJMp2016822,10.1056/NEJMp2016822,Perspective,2020-05-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['wrong', 'useful']","['Mechanistic epidemiologic model design help u systematically examine implication various assumption highly nonlinear process hard predict use intuition .', 'Used appropriately , help guide u pandemic .']","['mechanistic', 'epidemiologic', 'model', 'design', 'help', 'u', 'systematically', 'examine', 'implication', 'various', 'assumption', 'highly', 'nonlinear', 'process', 'hard', 'predict', 'intuition', '', 'used', 'appropriately', '', 'help', 'guide', 'u', 'pandemic', '']",26,"{'': 3, 'help': 2, 'u': 2, 'mechanistic': 1, 'epidemiologic': 1, 'model': 1, 'design': 1, 'systematically': 1, 'examine': 1, 'implication': 1, 'various': 1, 'assumption': 1, 'highly': 1, 'nonlinear': 1, 'process': 1, 'hard': 1, 'predict': 1, 'intuition': 1, 'used': 1, 'appropriately': 1}",{},0,0.577
DOI:10.1056/NEJMc2015630,10.1056/NEJMc2015630,Correspondence,2020-05-19 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['acute', 'myocardial', 'infarction', 'covid-19']","['Data Kaiser Permanente Northern California health care system use compare rate hospitalization acute MI March 4 April 14 , 2020 ( Covid-19 period ) rate period 2019 rate earlier period 2020 .', 'Rates hospitalization acute MI decrease 48 % Covid-19 period .']","['data', 'kaiser', 'permanente', 'northern', 'california', 'health', 'care', 'system', 'compare', 'rate', 'hospitalization', 'acute', 'mi', 'march', '4', 'april', '14', '', '2020', '', 'covid-19', 'period', '', 'rate', 'period', '2019', 'rate', 'earlier', 'period', '2020', '', 'rates', 'hospitalization', 'acute', 'mi', 'decrease', '48', '', 'covid-19', 'period', '']",41,"{'': 6, 'period': 4, 'rate': 3, 'hospitalization': 2, 'acute': 2, 'mi': 2, '2020': 2, 'covid-19': 2, 'data': 1, 'kaiser': 1, 'permanente': 1, 'northern': 1, 'california': 1, 'health': 1, 'care': 1, 'system': 1, 'compare': 1, 'march': 1, '4': 1, 'april': 1}",{},0,0.4939
DOI:10.1056/NEJMc2014816,10.1056/NEJMc2014816,Correspondence,2020-05-08 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['stroke', 'imaging', 'covid-19', 'pandemic']","['The author review image database use determine whether patient acute stroke eligible undergo endovascular thrombectomy .', 'They find 39 % decrease use image 29-day prepandemic period February 2020 14-day early-pandemic period late March early April .']","['author', 'review', 'image', 'database', 'determine', 'whether', 'patient', 'acute', 'stroke', 'eligible', 'undergo', 'endovascular', 'thrombectomy', '', 'find', '39', '', 'decrease', 'image', '29-day', 'prepandemic', 'period', 'february', '2020', '14-day', 'early-pandemic', 'period', 'late', 'march', 'early', 'april', '']",32,"{'': 3, 'image': 2, 'period': 2, 'author': 1, 'review': 1, 'database': 1, 'determine': 1, 'whether': 1, 'patient': 1, 'acute': 1, 'stroke': 1, 'eligible': 1, 'undergo': 1, 'endovascular': 1, 'thrombectomy': 1, 'find': 1, '39': 1, 'decrease': 1, '29-day': 1, 'prepandemic': 1}",{},0,0.0
DOI:10.1056/NEJMc2009787,10.1056/NEJMc2009787,Correspondence,2020-04-28 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['stroke', 'young', 'patients', 'covid-19']","['Five patient younger 50 year age large-vessel stroke Covid-19 infection present health system New York City 2-week period .', 'The author report patient ’ clinical characteristic , include presence absence symptom Covid-19 .']","['five', 'patient', 'younger', '50', 'year', 'age', 'large-vessel', 'stroke', 'covid-19', 'infection', 'present', 'health', 'system', 'new', 'york', 'city', '2-week', 'period', '', 'author', 'report', 'patient', '', 'clinical', 'characteristic', '', 'include', 'presence', 'absence', 'symptom', 'covid-19', '']",32,"{'': 4, 'patient': 2, 'covid-19': 2, 'five': 1, 'younger': 1, '50': 1, 'year': 1, 'age': 1, 'large-vessel': 1, 'stroke': 1, 'infection': 1, 'present': 1, 'health': 1, 'system': 1, 'new': 1, 'york': 1, 'city': 1, '2-week': 1, 'period': 1, 'author': 1}",{'infection': 1},1,0.0
DOI:10.1056/NEJMc2008597,10.1056/NEJMc2008597,Correspondence,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['neurologic', 'features', 'sars-cov-2', 'infection']","['In consecutive series 64 patient Covid-19 ARDS , 58 undergo neurologic examination , severe agitation corticospinal sign common .', 'In 2 13 patient , MRI brain show small acute stroke , 1 patient , image show subacute stroke .']","['consecutive', 'series', '64', 'patient', 'covid-19', 'ards', '', '58', 'undergo', 'neurologic', 'examination', '', 'severe', 'agitation', 'corticospinal', 'sign', 'common', '', '2', '13', 'patient', '', 'mri', 'brain', 'show', 'small', 'acute', 'stroke', '', '1', 'patient', '', 'image', 'show', 'subacute', 'stroke', '']",37,"{'': 7, 'patient': 3, 'show': 2, 'stroke': 2, 'consecutive': 1, 'series': 1, '64': 1, 'covid-19': 1, 'ards': 1, '58': 1, 'undergo': 1, 'neurologic': 1, 'examination': 1, 'severe': 1, 'agitation': 1, 'corticospinal': 1, 'sign': 1, 'common': 1, '2': 1, '13': 1}",{},0,-0.5574
DOI:10.1056/NEJMc2009020,10.1056/NEJMc2009020,Correspondence,2020-04-17 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['st-segment', 'elevation', 'covid-19']","['Eighteen patient Covid-19 present ST-segment elevation ECG develop hospitalization .', 'Eight patient receive diagnosis acute myocardial infarction , 10 noncoronary myocardial injury .', 'Thirteen patient die hospital .']","['eighteen', 'patient', 'covid-19', 'present', 'st-segment', 'elevation', 'ecg', 'develop', 'hospitalization', '', 'eight', 'patient', 'receive', 'diagnosis', 'acute', 'myocardial', 'infarction', '', '10', 'noncoronary', 'myocardial', 'injury', '', 'thirteen', 'patient', 'die', 'hospital', '']",28,"{'': 4, 'patient': 3, 'myocardial': 2, 'eighteen': 1, 'covid-19': 1, 'present': 1, 'st-segment': 1, 'elevation': 1, 'ecg': 1, 'develop': 1, 'hospitalization': 1, 'eight': 1, 'receive': 1, 'diagnosis': 1, 'acute': 1, 'infarction': 1, '10': 1, 'noncoronary': 1, 'injury': 1, 'thirteen': 1}",{},0,-0.7717
DOI:10.1056/NEJMc2010418,10.1056/NEJMc2010418,Correspondence,2020-04-29 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['out-of-hospital', 'cardiac', 'arrest', 'covid-19']","['From February 21 April 1 , 2019 , total 229 case out-of-hospital cardiac arrest report four province Lombardy , Italy .', 'During period 2020 ( first 40 day Covid-19 epidemic ) , 362 case report — 58 % increase .', 'Of additional 133 case 2020 , total 103 involve suspect diagnose Covid-19 .']","['february', '21', 'april', '1', '', '2019', '', 'total', '229', 'case', 'out-of-hospital', 'cardiac', 'arrest', 'report', 'four', 'province', 'lombardy', '', 'italy', '', 'period', '2020', '', 'first', '40', 'day', 'covid-19', 'epidemic', '', '', '362', 'case', 'report', '', '58', '', 'increase', '', 'additional', '133', 'case', '2020', '', 'total', '103', 'involve', 'suspect', 'diagnose', 'covid-19', '']",50,"{'': 12, 'case': 3, 'total': 2, 'report': 2, '2020': 2, 'covid-19': 2, 'february': 1, '21': 1, 'april': 1, '1': 1, '2019': 1, '229': 1, 'out-of-hospital': 1, 'cardiac': 1, 'arrest': 1, 'four': 1, 'province': 1, 'lombardy': 1, 'italy': 1, 'period': 1}",{},0,-0.3182
DOI:10.1056/NEJMc2009166,10.1056/NEJMc2009166,Correspondence,2020-04-28 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['acute', 'coronary', 'syndrome', 'covid-19', 'outbreak']","['During Covid-19 outbreak northern Italy , daily rate admission acute coronary syndrome 15 hospital significantly lower rate two control interval ( 13.3 admission vs. 18.0 18.9 admission two control period ) .']","['covid-19', 'outbreak', 'northern', 'italy', '', 'daily', 'rate', 'admission', 'acute', 'coronary', 'syndrome', '15', 'hospital', 'significantly', 'lower', 'rate', 'two', 'control', 'interval', '', '133', 'admission', '180', '189', 'admission', 'two', 'control', 'period', '', '']",30,"{'': 4, 'admission': 3, 'rate': 2, 'two': 2, 'control': 2, 'covid-19': 1, 'outbreak': 1, 'northern': 1, 'italy': 1, 'daily': 1, 'acute': 1, 'coronary': 1, 'syndrome': 1, '15': 1, 'hospital': 1, 'significantly': 1, 'lower': 1, 'interval': 1, '133': 1, '180': 1}",{},0,-0.296
DOI:10.1056/NEJMoa2007621,10.1056/NEJMoa2007621,Original Article,2020-05-01 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', '', 'cardiovascular', 'disease', '', 'drug', 'therapy']","['Data 8910 patient hospitalize diagnosis Covid-19 analyze .', 'Cardiovascular disease associate increase risk in-hospital death .', 'Neither use angiotensin-converting–enzyme inhibitor use angiotensin-receptor blocker associate increase risk in-hospital death .']","['data', '8910', 'patient', 'hospitalize', 'diagnosis', 'covid-19', 'analyze', '', 'cardiovascular', 'disease', 'associate', 'increase', 'risk', 'in-hospital', 'death', '', 'neither', 'angiotensin-convertingenzyme', 'inhibitor', 'angiotensin-receptor', 'blocker', 'associate', 'increase', 'risk', 'in-hospital', 'death', '']",27,"{'': 3, 'associate': 2, 'increase': 2, 'risk': 2, 'in-hospital': 2, 'death': 2, 'data': 1, '8910': 1, 'patient': 1, 'hospitalize': 1, 'diagnosis': 1, 'covid-19': 1, 'analyze': 1, 'cardiovascular': 1, 'disease': 1, 'neither': 1, 'angiotensin-convertingenzyme': 1, 'inhibitor': 1, 'angiotensin-receptor': 1, 'blocker': 1}",{},0,-0.8008
DOI:10.1056/NEJMoa2006923,10.1056/NEJMoa2006923,Original Article,2020-05-01 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['reninangiotensinaldosterone', 'system', 'blockers', 'covid-19']","['This population-based case–control study northern Italy show use ACE inhibitor ARBs frequent among patient Covid-19 higher prevalence cardiovascular disease .', 'However , evidence ACE inhibitor ARBs affect risk Covid-19 .']","['population-based', 'casecontrol', 'study', 'northern', 'italy', 'show', 'ace', 'inhibitor', 'arbs', 'frequent', 'among', 'patient', 'covid-19', 'higher', 'prevalence', 'cardiovascular', 'disease', '', 'however', '', 'evidence', 'ace', 'inhibitor', 'arbs', 'affect', 'risk', 'covid-19', '']",28,"{'': 3, 'ace': 2, 'inhibitor': 2, 'arbs': 2, 'covid-19': 2, 'population-based': 1, 'casecontrol': 1, 'study': 1, 'northern': 1, 'italy': 1, 'show': 1, 'frequent': 1, 'among': 1, 'patient': 1, 'higher': 1, 'prevalence': 1, 'cardiovascular': 1, 'disease': 1, 'however': 1, 'evidence': 1}",{},0,-0.4019
DOI:10.1056/NEJMoa2008975,10.1056/NEJMoa2008975,Original Article,2020-05-01 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['raas', 'inhibitors', 'risk', 'covid-19']","['There concern patient take renin–angiotensin–aldosterone system blocker increase risk Covid-19 , angiotensin-converting enzyme 2 receptor virus .', 'This study show increase likelihood positive Covid-19 test severe Covid-19 patient take five common class antihypertensive drug .']","['concern', 'patient', 'reninangiotensinaldosterone', 'system', 'blocker', 'increase', 'risk', 'covid-19', '', 'angiotensin-converting', 'enzyme', '2', 'receptor', 'virus', '', 'study', 'show', 'increase', 'likelihood', 'positive', 'covid-19', 'test', 'severe', 'covid-19', 'patient', 'five', 'common', 'class', 'antihypertensive', 'drug', '']",31,"{'covid-19': 3, '': 3, 'patient': 2, 'increase': 2, 'concern': 1, 'reninangiotensinaldosterone': 1, 'system': 1, 'blocker': 1, 'risk': 1, 'angiotensin-converting': 1, 'enzyme': 1, '2': 1, 'receptor': 1, 'virus': 1, 'study': 1, 'show': 1, 'likelihood': 1, 'positive': 1, 'test': 1, 'severe': 1}",{},0,0.5423
DOI:10.1056/NEJMc2005396,10.1056/NEJMc2005396,Correspondence,2020-05-08 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['ace', 'inhibitors', 'arbs', 'incident', 'influenza']","['Certain influenza strain SARS-CoV-2 gain access cell mean ACE2 receptor .', 'In database study United Kingdom , investigator observe null-to-protective effect influenza susceptibility among take ACE inhibitor angiotensin-receptor blocker , possibly owe mechanism relevant infection coronaviruses , include SARS-CoV-2 .']","['certain', 'influenza', 'strain', 'sars-cov-2', 'gain', 'access', 'cell', 'mean', 'ace2', 'receptor', '', 'database', 'study', 'united', 'kingdom', '', 'investigator', 'observe', 'null-to-protective', 'effect', 'influenza', 'susceptibility', 'among', 'ace', 'inhibitor', 'angiotensin-receptor', 'blocker', '', 'possibly', 'owe', 'mechanism', 'relevant', 'infection', 'coronaviruses', '', 'include', 'sars-cov-2', '']",38,"{'': 5, 'influenza': 2, 'sars-cov-2': 2, 'certain': 1, 'strain': 1, 'gain': 1, 'access': 1, 'cell': 1, 'mean': 1, 'ace2': 1, 'receptor': 1, 'database': 1, 'study': 1, 'united': 1, 'kingdom': 1, 'investigator': 1, 'observe': 1, 'null-to-protective': 1, 'effect': 1, 'susceptibility': 1}","{'infection': 1, 'sars-cov-2': 2}",3,0.7783
DOI:10.1056/NEJMsr2005760,10.1056/NEJMsr2005760,Special Report,2020-04-23 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['raas', 'inhibitors', 'patients', 'covid-19']","['The effect renin–angiotensin–aldosterone system blocker angiotensin-converting enzyme 2 level activity human uncertain .', 'The author hypothesize ACE2 may beneficial rather harmful lung injury suggest RAAS-inhibitor withdrawal may harmful high-risk patient know suspect Covid-19 .']","['effect', 'reninangiotensinaldosterone', 'system', 'blocker', 'angiotensin-converting', 'enzyme', '2', 'level', 'activity', 'human', 'uncertain', '', 'author', 'hypothesize', 'ace2', 'beneficial', 'harmful', 'lung', 'injury', 'suggest', 'raas-inhibitor', 'withdrawal', 'harmful', 'high-risk', 'patient', 'suspect', 'covid-19', '']",28,"{'': 2, 'harmful': 2, 'effect': 1, 'reninangiotensinaldosterone': 1, 'system': 1, 'blocker': 1, 'angiotensin-converting': 1, 'enzyme': 1, '2': 1, 'level': 1, 'activity': 1, 'human': 1, 'uncertain': 1, 'author': 1, 'hypothesize': 1, 'ace2': 1, 'beneficial': 1, 'lung': 1, 'injury': 1, 'suggest': 1}",{},0,-0.4939
DOI:10.1056/NEJMc2011592,10.1056/NEJMc2011592,Correspondence,2020-05-08 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['suppressing', 'epidemic', 'new', 'south', 'wales']","['Australia appear largely suppress first wave Covid-19 infection .', 'The author describe key response , include travel restriction , effective identification isolation infect people , quarantine expose .']","['australia', 'appear', 'largely', 'suppress', 'first', 'wave', 'covid-19', 'infection', '', 'author', 'describe', 'key', 'response', '', 'include', 'travel', 'restriction', '', 'effective', 'identification', 'isolation', 'infect', 'people', '', 'quarantine', 'expose', '']",27,"{'': 5, 'australia': 1, 'appear': 1, 'largely': 1, 'suppress': 1, 'first': 1, 'wave': 1, 'covid-19': 1, 'infection': 1, 'author': 1, 'describe': 1, 'key': 1, 'response': 1, 'include': 1, 'travel': 1, 'restriction': 1, 'effective': 1, 'identification': 1, 'isolation': 1, 'infect': 1}",{'infection': 1},1,-0.3182
DOI:10.1056/NEJMc2011599,10.1056/NEJMc2011599,Correspondence,2020-05-05 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['adaptations', 'lessons', 'province', 'bergamo']","['A referral hospital hardest-hit region Italy manage continuously increase number daily admission Covid-19 delay response province allow rapid spread virus .', 'Nineteen physician province die .']","['referral', 'hospital', 'hardest-hit', 'region', 'italy', 'manage', 'continuously', 'increase', 'number', 'daily', 'admission', 'covid-19', 'delay', 'response', 'province', 'allow', 'rapid', 'spread', 'virus', '', 'nineteen', 'physician', 'province', 'die', '']",25,"{'province': 2, '': 2, 'referral': 1, 'hospital': 1, 'hardest-hit': 1, 'region': 1, 'italy': 1, 'manage': 1, 'continuously': 1, 'increase': 1, 'number': 1, 'daily': 1, 'admission': 1, 'covid-19': 1, 'delay': 1, 'response': 1, 'allow': 1, 'rapid': 1, 'spread': 1, 'virus': 1}",{},0,-0.4019
DOI:10.1056/NEJMoa2006100,10.1056/NEJMoa2006100,Original Article,2020-04-14 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['sars-cov-2', 'iceland']","['Despite timely implementation test SARS-CoV-2 virus , contact-tracing scheme , social-distancing measure , infection spread Iceland .', 'However , detect increase proportion infect person March 13 April 4 , 2020 .']","['despite', 'timely', 'implementation', 'test', 'sars-cov-2', 'virus', '', 'contact-tracing', 'scheme', '', 'social-distancing', 'measure', '', 'infection', 'spread', 'iceland', '', 'however', '', 'detect', 'increase', 'proportion', 'infect', 'person', 'march', '13', 'april', '4', '', '2020', '']",31,"{'': 7, 'despite': 1, 'timely': 1, 'implementation': 1, 'test': 1, 'sars-cov-2': 1, 'virus': 1, 'contact-tracing': 1, 'scheme': 1, 'social-distancing': 1, 'measure': 1, 'infection': 1, 'spread': 1, 'iceland': 1, 'however': 1, 'detect': 1, 'increase': 1, 'proportion': 1, 'infect': 1, 'person': 1}","{'infection': 1, 'sars-cov-2': 1}",2,0.3182
DOI:10.1056/NEJMc2010122,10.1056/NEJMc2010122,Correspondence,2020-05-07 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['french', 'pandemic', 'resistance']","['Just 4 year ED face flood patient severely wound terrorist attack , Paris hospital make large-scale change care people Covid-19 preserve access others need urgent treatment .']","['4', 'year', 'ed', 'face', 'flood', 'patient', 'severely', 'wound', 'terrorist', 'attack', '', 'paris', 'hospital', 'large-scale', 'change', 'care', 'people', 'covid-19', 'preserve', 'access', 'others', 'urgent', 'treatment', '']",24,"{'': 2, '4': 1, 'year': 1, 'ed': 1, 'face': 1, 'flood': 1, 'patient': 1, 'severely': 1, 'wound': 1, 'terrorist': 1, 'attack': 1, 'paris': 1, 'hospital': 1, 'large-scale': 1, 'change': 1, 'care': 1, 'people': 1, 'covid-19': 1, 'preserve': 1, 'access': 1}",{},0,-0.7783
DOI:10.1056/NEJMc2010419,10.1056/NEJMc2010419,Correspondence,2020-04-17 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', 'new', 'york', 'city']","['In series 393 consecutive patient admit Covid-19 two New York City hospital March 3 March 27 , third patient receive invasive mechanical ventilation , 10 % patient die , 24 % still hospitalize April 10 .']","['series', '393', 'consecutive', 'patient', 'admit', 'covid-19', 'two', 'new', 'york', 'city', 'hospital', 'march', '3', 'march', '27', '', 'third', 'patient', 'receive', 'invasive', 'mechanical', 'ventilation', '', '10', '', 'patient', 'die', '', '24', '', 'still', 'hospitalize', 'april', '10', '']",35,"{'': 6, 'patient': 3, 'march': 2, '10': 2, 'series': 1, '393': 1, 'consecutive': 1, 'admit': 1, 'covid-19': 1, 'two': 1, 'new': 1, 'york': 1, 'city': 1, 'hospital': 1, '3': 1, '27': 1, 'third': 1, 'receive': 1, 'invasive': 1, 'mechanical': 1}",{},0,-0.4767
DOI:10.1056/NEJMoa2008457,10.1056/NEJMoa2008457,Original Article,2020-04-24 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['presymptomatic', 'sars-cov-2', 'nursing', 'facility']","['The author assess transmission SARS-CoV-2 evaluate adequacy symptom-based screen skilled nurse facility .', 'More half resident positive test result asymptomatic time test .', 'Infection-control strategy focus solely symptomatic resident sufficient prevent transmission .']","['author', 'assess', 'transmission', 'sars-cov-2', 'evaluate', 'adequacy', 'symptom-based', 'screen', 'skilled', 'nurse', 'facility', '', 'half', 'resident', 'positive', 'test', 'result', 'asymptomatic', 'time', 'test', '', 'infection-control', 'strategy', 'focus', 'solely', 'symptomatic', 'resident', 'sufficient', 'prevent', 'transmission', '']",31,"{'': 3, 'transmission': 2, 'resident': 2, 'test': 2, 'author': 1, 'assess': 1, 'sars-cov-2': 1, 'evaluate': 1, 'adequacy': 1, 'symptom-based': 1, 'screen': 1, 'skilled': 1, 'nurse': 1, 'facility': 1, 'half': 1, 'positive': 1, 'result': 1, 'asymptomatic': 1, 'time': 1, 'infection-control': 1}",{'sars-cov-2': 1},1,0.6077
DOI:10.1056/NEJMoa2005412,10.1056/NEJMoa2005412,Original Article,2020-03-27 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', 'outbreak', 'long-term', 'care', 'facility']","['On February 28 , 2020 , public health official Seattle area inform Covid-19 infection long-term care facility .', 'An investigation identify 167 infect person associate facility , include resident , health care personnel , visitor ; third 101 resident identify die .']","['february', '28', '', '2020', '', 'public', 'health', 'official', 'seattle', 'area', 'inform', 'covid-19', 'infection', 'long-term', 'care', 'facility', '', 'investigation', 'identify', '167', 'infect', 'person', 'associate', 'facility', '', 'include', 'resident', '', 'health', 'care', 'personnel', '', 'visitor', '', 'third', '101', 'resident', 'identify', 'die', '']",40,"{'': 8, 'health': 2, 'care': 2, 'facility': 2, 'identify': 2, 'resident': 2, 'february': 1, '28': 1, '2020': 1, 'public': 1, 'official': 1, 'seattle': 1, 'area': 1, 'inform': 1, 'covid-19': 1, 'infection': 1, 'long-term': 1, 'investigation': 1, '167': 1, 'infect': 1}",{'infection': 1},1,0.3612
DOI:10.1056/NEJMc2001468,10.1056/NEJMc2001468,Correspondence,2020-03-05 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['2019-ncov', 'transmission', 'asymptomatic', 'patient']","['In report , investigator Germany detect spread novel coronavirus ( 2019-nCoV ) person recently travel China Germany business trip .', 'This transmission occur apparent onset illness index patient associate additional transmission event Germany .']","['report', '', 'investigator', 'germany', 'detect', 'spread', 'novel', 'coronavirus', '', '2019-ncov', '', 'person', 'recently', 'travel', 'china', 'germany', 'business', 'trip', '', 'transmission', 'occur', 'apparent', 'onset', 'illness', 'index', 'patient', 'associate', 'additional', 'transmission', 'event', 'germany', '']",32,"{'': 5, 'germany': 3, 'transmission': 2, 'report': 1, 'investigator': 1, 'detect': 1, 'spread': 1, 'novel': 1, 'coronavirus': 1, '2019-ncov': 1, 'person': 1, 'recently': 1, 'travel': 1, 'china': 1, 'business': 1, 'trip': 1, 'occur': 1, 'apparent': 1, 'onset': 1, 'illness': 1}",{},0,-0.1027
DOI:10.1056/NEJMc2004973,10.1056/NEJMc2004973,Correspondence,2020-04-16 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['aerosol', 'surface', 'stability', 'sars-cov-2']","['In research letter , investigator report stability SARS-CoV-2 SARS-CoV-1 experimental condition .', 'The viability two virus assess aerosol plastic , stainless steel , copper , cardboard .']","['research', 'letter', '', 'investigator', 'report', 'stability', 'sars-cov-2', 'sars-cov-1', 'experimental', 'condition', '', 'viability', 'two', 'virus', 'assess', 'aerosol', 'plastic', '', 'stainless', 'steel', '', 'copper', '', 'cardboard', '']",25,"{'': 6, 'research': 1, 'letter': 1, 'investigator': 1, 'report': 1, 'stability': 1, 'sars-cov-2': 1, 'sars-cov-1': 1, 'experimental': 1, 'condition': 1, 'viability': 1, 'two': 1, 'virus': 1, 'assess': 1, 'aerosol': 1, 'plastic': 1, 'stainless': 1, 'steel': 1, 'copper': 1, 'cardboard': 1}",{'sars-cov-2': 1},1,0.0
DOI:10.1056/NEJMc2007800,10.1056/NEJMc2007800,Correspondence,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['oral', 'fluid', 'droplets', 'generated', 'speech']","['In experiment , investigator use laser darken box visualize droplet generate speech .', 'The droplet decrease number lower-amplitude speech almost eliminate speaker ’ mouth cover damp cloth ( show video ) .']","['experiment', '', 'investigator', 'laser', 'darken', 'box', 'visualize', 'droplet', 'generate', 'speech', '', 'droplet', 'decrease', 'number', 'lower-amplitude', 'speech', 'almost', 'eliminate', 'speaker', '', 'mouth', 'cover', 'damp', 'cloth', '', 'show', 'video', '', '']",29,"{'': 6, 'droplet': 2, 'speech': 2, 'experiment': 1, 'investigator': 1, 'laser': 1, 'darken': 1, 'box': 1, 'visualize': 1, 'generate': 1, 'decrease': 1, 'number': 1, 'lower-amplitude': 1, 'almost': 1, 'eliminate': 1, 'speaker': 1, 'mouth': 1, 'cover': 1, 'damp': 1, 'cloth': 1}",{},0,0.0772
DOI:10.1056/NEJMc2009324,10.1056/NEJMc2009324,Correspondence,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['aerosols', 'transmission', 'sars-cov-2']","['With reference letter use laser light scatter visualize droplet emanate speech , author describe nature aerosol potential transmission SARS-CoV-2 .']","['reference', 'letter', 'laser', 'light', 'scatter', 'visualize', 'droplet', 'emanate', 'speech', '', 'author', 'describe', 'nature', 'aerosol', 'potential', 'transmission', 'sars-cov-2', '']",18,"{'': 2, 'reference': 1, 'letter': 1, 'laser': 1, 'light': 1, 'scatter': 1, 'visualize': 1, 'droplet': 1, 'emanate': 1, 'speech': 1, 'author': 1, 'describe': 1, 'nature': 1, 'aerosol': 1, 'potential': 1, 'transmission': 1, 'sars-cov-2': 1}",{'sars-cov-2': 1},1,0.0
DOI:10.1056/NEJMc2007617,10.1056/NEJMc2007617,Correspondence,2020-05-01 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['children', 'covid-19', 'italy']","['This letter describe cohort 100 child younger 18 year age RT-PCR–confirmed Covid-19 assess 17 pediatric emergency department Italy .', 'The descriptive result compare previously publish result involve child China United States .']","['letter', 'describe', 'cohort', '100', 'child', 'younger', '18', 'year', 'age', 'rt-pcrconfirmed', 'covid-19', 'assess', '17', 'pediatric', 'emergency', 'department', 'italy', '', 'descriptive', 'result', 'compare', 'previously', 'publish', 'result', 'involve', 'child', 'china', 'united', 'states', '']",30,"{'child': 2, '': 2, 'result': 2, 'letter': 1, 'describe': 1, 'cohort': 1, '100': 1, 'younger': 1, '18': 1, 'year': 1, 'age': 1, 'rt-pcrconfirmed': 1, 'covid-19': 1, 'assess': 1, '17': 1, 'pediatric': 1, 'emergency': 1, 'department': 1, 'italy': 1, 'descriptive': 1}",{},0,0.0516
DOI:10.1056/NEJMc2005073,10.1056/NEJMc2005073,Correspondence,2020-04-23 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['sars-cov-2', 'infection', 'children']","['In report , investigator Wuhan , China , describe spectrum Covid-19 illness child age 16 year .', 'Of 1391 child assess test period 4 week , 171 ( 12.3 % ) confirm SARS-CoV-2 infection .']","['report', '', 'investigator', 'wuhan', '', 'china', '', 'describe', 'spectrum', 'covid-19', 'illness', 'child', 'age', '16', 'year', '', '1391', 'child', 'assess', 'test', 'period', '4', 'week', '', '171', '', '123', '', '', 'confirm', 'sars-cov-2', 'infection', '']",33,"{'': 9, 'child': 2, 'report': 1, 'investigator': 1, 'wuhan': 1, 'china': 1, 'describe': 1, 'spectrum': 1, 'covid-19': 1, 'illness': 1, 'age': 1, '16': 1, 'year': 1, '1391': 1, 'assess': 1, 'test': 1, 'period': 1, '4': 1, 'week': 1, '171': 1}","{'infection': 1, 'sars-cov-2': 1}",2,-0.4019
DOI:10.1056/NEJMc2003717,10.1056/NEJMc2003717,Correspondence,2020-04-02 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['children', 'covid-19', 'wuhan', '', 'china']","['A retrospective analysis routine surveillance data involve child hospitalize central Wuhan , China , acute lower respiratory infection early January 2020 reveal six case Covid-19 .', 'The author report clinical characteristic child laboratory data .']","['retrospective', 'analysis', 'routine', 'surveillance', 'data', 'involve', 'child', 'hospitalize', 'central', 'wuhan', '', 'china', '', 'acute', 'lower', 'respiratory', 'infection', 'early', 'january', '2020', 'reveal', 'six', 'case', 'covid-19', '', 'author', 'report', 'clinical', 'characteristic', 'child', 'laboratory', 'data', '']",33,"{'': 4, 'data': 2, 'child': 2, 'retrospective': 1, 'analysis': 1, 'routine': 1, 'surveillance': 1, 'involve': 1, 'hospitalize': 1, 'central': 1, 'wuhan': 1, 'china': 1, 'acute': 1, 'lower': 1, 'respiratory': 1, 'infection': 1, 'early': 1, 'january': 1, '2020': 1, 'reveal': 1}",{'infection': 1},1,-0.296
DOI:10.1056/NEJMp2005638,10.1056/NEJMp2005638,Perspective,2020-04-30 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['feeding', 'low-income', 'children', 'pandemic']","['U.S. government program serve nearly 35 million child daily , deliver vital nutrition financial assistance family need .', 'With program interrupt , essential element Covid-19 response feed child low-income family .']","['us', 'government', 'program', 'serve', 'nearly', '35', 'million', 'child', 'daily', '', 'deliver', 'vital', 'nutrition', 'financial', 'assistance', 'family', '', 'program', 'interrupt', '', 'essential', 'element', 'covid-19', 'response', 'feed', 'child', 'low-income', 'family', '']",29,"{'': 4, 'program': 2, 'child': 2, 'family': 2, 'us': 1, 'government': 1, 'serve': 1, 'nearly': 1, '35': 1, 'million': 1, 'daily': 1, 'deliver': 1, 'vital': 1, 'nutrition': 1, 'financial': 1, 'assistance': 1, 'interrupt': 1, 'essential': 1, 'element': 1, 'covid-19': 1}",{},0,-0.0516
DOI:10.1056/NEJMoa2004500,10.1056/NEJMoa2004500,Original Article,2020-03-30 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', '', 'early', 'icu', 'experience', '', 'seattle']","['Clinicians investigator report first 24 patient admit ICUs nine Seattle area hospital .', 'Key aspect clinical presentation , treatment , outcome describe .']","['clinicians', 'investigator', 'report', 'first', '24', 'patient', 'admit', 'icus', 'nine', 'seattle', 'area', 'hospital', '', 'key', 'aspect', 'clinical', 'presentation', '', 'treatment', '', 'outcome', 'describe', '']",23,"{'': 4, 'clinicians': 1, 'investigator': 1, 'report': 1, 'first': 1, '24': 1, 'patient': 1, 'admit': 1, 'icus': 1, 'nine': 1, 'seattle': 1, 'area': 1, 'hospital': 1, 'key': 1, 'aspect': 1, 'clinical': 1, 'presentation': 1, 'treatment': 1, 'outcome': 1, 'describe': 1}",{},0,0.2023
DOI:10.1056/NEJMoa2001191,10.1056/NEJMoa2001191,Original Article,2020-03-05 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['first', 'us', '', 'confirmed', 'case', '2019-ncov', 'infection']","['A healthy 35-year-old man visit Wuhan , China , present cough fever progress pneumonia .', 'This report describe diagnosis , clinical course , management condition .', 'The case highlight importance close coordination clinician public health authority local , state , federal level .']","['healthy', '35-year-old', 'man', 'visit', 'wuhan', '', 'china', '', 'present', 'cough', 'fever', 'progress', 'pneumonia', '', 'report', 'describe', 'diagnosis', '', 'clinical', 'course', '', 'management', 'condition', '', 'case', 'highlight', 'importance', 'close', 'coordination', 'clinician', 'public', 'health', 'authority', 'local', '', 'state', '', 'federal', 'level', '']",40,"{'': 9, 'healthy': 1, '35-year-old': 1, 'man': 1, 'visit': 1, 'wuhan': 1, 'china': 1, 'present': 1, 'cough': 1, 'fever': 1, 'progress': 1, 'pneumonia': 1, 'report': 1, 'describe': 1, 'diagnosis': 1, 'clinical': 1, 'course': 1, 'management': 1, 'condition': 1, 'case': 1}",{},0,0.8658
DOI:10.1056/NEJMc2008646,10.1056/NEJMc2008646,Correspondence,2020-05-01 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['detection', 'covid-19', 'citywide', 'surveillance', 'platform']","['The Seattle Flu study , initiate 2018 , mail kit home collection midnasal swab people report respiratory symptom .', 'From January 1 March 9 , 2020 , specimen 2,353 people also test SARS-CoV-2 ; 25 ( 1.1 % ) test positive .', 'A specimen collect February 24 , 2020 , first document U.S. case community transmission time .']","['seattle', 'flu', 'study', '', 'initiate', '2018', '', 'mail', 'kit', 'home', 'collection', 'midnasal', 'swab', 'people', 'report', 'respiratory', 'symptom', '', 'january', '1', 'march', '9', '', '2020', '', 'specimen', '2353', 'people', 'test', 'sars-cov-2', '', '25', '', '11', '', '', 'test', 'positive', '', 'specimen', 'collect', 'february', '24', '', '2020', '', 'first', 'document', 'us', 'case', 'community', 'transmission', 'time', '']",54,"{'': 13, 'people': 2, '2020': 2, 'specimen': 2, 'test': 2, 'seattle': 1, 'flu': 1, 'study': 1, 'initiate': 1, '2018': 1, 'mail': 1, 'kit': 1, 'home': 1, 'collection': 1, 'midnasal': 1, 'swab': 1, 'report': 1, 'respiratory': 1, 'symptom': 1, 'january': 1}",{'sars-cov-2': 1},1,0.25
DOI:10.1056/NEJMc2009316,10.1056/NEJMc2009316,Correspondence,2020-04-13 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['sars-cov-2', 'testing', 'obstetrical', 'patients']","['Among 215 pregnant woman admit New York hospital delivery undergo universal test SARS-CoV-2 , one eight asymptomatic woman positive result , woman Covid-19 asymptomatic .']","['among', '215', 'pregnant', 'woman', 'admit', 'new', 'york', 'hospital', 'delivery', 'undergo', 'universal', 'test', 'sars-cov-2', '', 'one', 'eight', 'asymptomatic', 'woman', 'positive', 'result', '', 'woman', 'covid-19', 'asymptomatic', '']",25,"{'woman': 3, '': 3, 'asymptomatic': 2, 'among': 1, '215': 1, 'pregnant': 1, 'admit': 1, 'new': 1, 'york': 1, 'hospital': 1, 'delivery': 1, 'undergo': 1, 'universal': 1, 'test': 1, 'sars-cov-2': 1, 'one': 1, 'eight': 1, 'positive': 1, 'result': 1, 'covid-19': 1}",{'sars-cov-2': 1},1,0.6597
DOI:10.1056/NEJMc2009226,10.1056/NEJMc2009226,Correspondence,2020-04-17 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['pregnant', 'women', 'covid-19', 'wuhan', '', 'china']","['Among 118 pregnant woman Covid-19 Wuhan , China , vast majority mild course disease .']","['among', '118', 'pregnant', 'woman', 'covid-19', 'wuhan', '', 'china', '', 'vast', 'majority', 'mild', 'course', 'disease', '']",15,"{'': 3, 'among': 1, '118': 1, 'pregnant': 1, 'woman': 1, 'covid-19': 1, 'wuhan': 1, 'china': 1, 'vast': 1, 'majority': 1, 'mild': 1, 'course': 1, 'disease': 1}",{},0,0.0
DOI:10.1056/NEJMc2010614,10.1056/NEJMc2010614,Correspondence,2020-04-22 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['late-onset', 'neonatal', 'sepsis', 'covid-19']","['The condition 3-week-old boy nasal congestion , tachypnea , reduce feed deteriorate , undergo intubation receive hemodynamic support pediatric intensive care unit .', 'Chest radiography show bilateral linear opacity , nasal swab positive SARS-CoV-2 .']","['condition', '3-week-old', 'boy', 'nasal', 'congestion', '', 'tachypnea', '', 'reduce', 'feed', 'deteriorate', '', 'undergo', 'intubation', 'receive', 'hemodynamic', 'support', 'pediatric', 'intensive', 'care', 'unit', '', 'chest', 'radiography', 'show', 'bilateral', 'linear', 'opacity', '', 'nasal', 'swab', 'positive', 'sars-cov-2', '']",34,"{'': 6, 'nasal': 2, 'condition': 1, '3-week-old': 1, 'boy': 1, 'congestion': 1, 'tachypnea': 1, 'reduce': 1, 'feed': 1, 'deteriorate': 1, 'undergo': 1, 'intubation': 1, 'receive': 1, 'hemodynamic': 1, 'support': 1, 'pediatric': 1, 'intensive': 1, 'care': 1, 'unit': 1, 'chest': 1}",{'sars-cov-2': 1},1,0.8591
DOI:10.1056/NEJMc2007605,10.1056/NEJMc2007605,Correspondence,2020-04-16 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['uncomplicated', 'delivery', 'patient', 'covid-19']","['The peripartum care woman Covid-19 39 week gestation describe .', 'The woman neonate discharge home hospital day 6 .', 'Care take avoid infect hospital staff , 7 day delivery , caregiver appear infect .']","['peripartum', 'care', 'woman', 'covid-19', '39', 'week', 'gestation', 'describe', '', 'woman', 'neonate', 'discharge', 'home', 'hospital', 'day', '6', '', 'care', 'avoid', 'infect', 'hospital', 'staff', '', '7', 'day', 'delivery', '', 'caregiver', 'appear', 'infect', '']",31,"{'': 5, 'care': 2, 'woman': 2, 'hospital': 2, 'day': 2, 'infect': 2, 'peripartum': 1, 'covid-19': 1, '39': 1, 'week': 1, 'gestation': 1, 'describe': 1, 'neonate': 1, 'discharge': 1, 'home': 1, '6': 1, 'avoid': 1, 'staff': 1, '7': 1, 'delivery': 1}",{},0,0.6369
DOI:10.1056/NEJMoa2002032,10.1056/NEJMoa2002032,Original Article,2020-02-28 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['characteristics', 'covid-19', 'china']","['In study , researcher describe clinical characteristic coronavirus disease 2019 select cohort 1099 patient laboratory-confirmed disease throughout mainland China first 2 month current outbreak .']","['study', '', 'researcher', 'describe', 'clinical', 'characteristic', 'coronavirus', 'disease', '2019', 'select', 'cohort', '1099', 'patient', 'laboratory-confirmed', 'disease', 'throughout', 'mainland', 'china', 'first', '2', 'month', 'current', 'outbreak', '']",24,"{'': 2, 'disease': 2, 'study': 1, 'researcher': 1, 'describe': 1, 'clinical': 1, 'characteristic': 1, 'coronavirus': 1, '2019': 1, 'select': 1, 'cohort': 1, '1099': 1, 'patient': 1, 'laboratory-confirmed': 1, 'throughout': 1, 'mainland': 1, 'china': 1, 'first': 1, '2': 1, 'month': 1}",{},0,0.0
DOI:10.1056/NEJMoa2001316,10.1056/NEJMoa2001316,Original Article,2020-03-26 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['early', 'transmission', 'dynamics', '2019-ncov']","['The author provide epidemiologic analysis first 425 confirm case infection novel coronavirus Wuhan , China .', 'This analysis provide estimate epidemic double time basic reproductive number show clear evidence sustain human-to-human transmission .']","['author', 'provide', 'epidemiologic', 'analysis', 'first', '425', 'confirm', 'case', 'infection', 'novel', 'coronavirus', 'wuhan', '', 'china', '', 'analysis', 'provide', 'estimate', 'epidemic', 'double', 'time', 'basic', 'reproductive', 'number', 'show', 'clear', 'evidence', 'sustain', 'human-to-human', 'transmission', '']",31,"{'': 3, 'provide': 2, 'analysis': 2, 'author': 1, 'epidemiologic': 1, 'first': 1, '425': 1, 'confirm': 1, 'case': 1, 'infection': 1, 'novel': 1, 'coronavirus': 1, 'wuhan': 1, 'china': 1, 'estimate': 1, 'epidemic': 1, 'double': 1, 'time': 1, 'basic': 1, 'reproductive': 1}",{'infection': 1},1,0.6369
DOI:10.1056/NEJMoa2001017,10.1056/NEJMoa2001017,Original Article,2020-02-20 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['novel', 'coronavirus', 'china']","['The author report emergence isolation previously unknown betacoronavirus , seventh member family coronaviruses infect human , Wuhan , China .', 'Findings three patient describe .']","['author', 'report', 'emergence', 'isolation', 'previously', 'unknown', 'betacoronavirus', '', 'seventh', 'member', 'family', 'coronaviruses', 'infect', 'human', '', 'wuhan', '', 'china', '', 'findings', 'three', 'patient', 'describe', '']",24,"{'': 5, 'author': 1, 'report': 1, 'emergence': 1, 'isolation': 1, 'previously': 1, 'unknown': 1, 'betacoronavirus': 1, 'seventh': 1, 'member': 1, 'family': 1, 'coronaviruses': 1, 'infect': 1, 'human': 1, 'wuhan': 1, 'china': 1, 'findings': 1, 'three': 1, 'patient': 1, 'describe': 1}",{},0,-0.4019
DOI:10.1056/NEJMc2003100,10.1056/NEJMc2003100,Correspondence,2020-04-09 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['sars-cov-2', 'infection', 'travelers', 'returning', 'wuhan']","['Data traveler return area many case Covid-19 may useful estimate incidence .', 'The author report follow-up data 94 person board evacuation flight Wuhan , China , Singapore January 30 , 2020 .']","['data', 'traveler', 'return', 'area', 'case', 'covid-19', 'useful', 'estimate', 'incidence', '', 'author', 'report', 'follow-up', 'data', '94', 'person', 'board', 'evacuation', 'flight', 'wuhan', '', 'china', '', 'singapore', 'january', '30', '', '2020', '']",29,"{'': 5, 'data': 2, 'traveler': 1, 'return': 1, 'area': 1, 'case': 1, 'covid-19': 1, 'useful': 1, 'estimate': 1, 'incidence': 1, 'author': 1, 'report': 1, 'follow-up': 1, '94': 1, 'person': 1, 'board': 1, 'evacuation': 1, 'flight': 1, 'wuhan': 1, 'china': 1}",{},0,0.4404
DOI:10.1056/NEJMc2005696,10.1056/NEJMc2005696,Correspondence,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['death', 'covid-19', 'health', 'workers', 'china']","['This report describe death Covid-19 23 health care worker , include physician , surgeon , nurse , electrocardiography technician .', 'Only 2 health care worker physician respiratory medicine specifically assign treat patient Covid-19 .', 'Eleven come retirement serve clinician .']","['report', 'describe', 'death', 'covid-19', '23', 'health', 'care', 'worker', '', 'include', 'physician', '', 'surgeon', '', 'nurse', '', 'electrocardiography', 'technician', '', '2', 'health', 'care', 'worker', 'physician', 'respiratory', 'medicine', 'specifically', 'assign', 'treat', 'patient', 'covid-19', '', 'eleven', 'retirement', 'serve', 'clinician', '']",37,"{'': 7, 'covid-19': 2, 'health': 2, 'care': 2, 'worker': 2, 'physician': 2, 'report': 1, 'describe': 1, 'death': 1, '23': 1, 'include': 1, 'surgeon': 1, 'nurse': 1, 'electrocardiography': 1, 'technician': 1, '2': 1, 'respiratory': 1, 'medicine': 1, 'specifically': 1, 'assign': 1}",{},0,0.6369
DOI:https://interactives.nejm.org/iv/playlist_branded/index.html,https://interactives.nejm.org/iv/playlist_branded/index.html,,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['nejm', 'covid-19', 'update']",['Listen conversation editor Eric Rubin Lindsey Baden current coronavirus outbreak .'],"['listen', 'conversation', 'editor', 'eric', 'rubin', 'lindsey', 'baden', 'current', 'coronavirus', 'outbreak', '']",11,"{'listen': 1, 'conversation': 1, 'editor': 1, 'eric': 1, 'rubin': 1, 'lindsey': 1, 'baden': 1, 'current': 1, 'coronavirus': 1, 'outbreak': 1, '': 1}",{},0,0.0
DOI:http://www.healthmap.org/ncov2019/,http://www.healthmap.org/ncov2019/,,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['healthmap', 'coronavirus', 'outbreak']","['The HealthMap team Boston Children ’ Hospital track publicly report confirm suspect case Covid-19 throughout world .', 'The map automatically update show current data .']","['healthmap', 'team', 'boston', 'children', '', 'hospital', 'track', 'publicly', 'report', 'confirm', 'suspect', 'case', 'covid-19', 'throughout', 'world', '', 'map', 'automatically', 'update', 'show', 'current', 'data', '']",23,"{'': 3, 'healthmap': 1, 'team': 1, 'boston': 1, 'children': 1, 'hospital': 1, 'track': 1, 'publicly': 1, 'report': 1, 'confirm': 1, 'suspect': 1, 'case': 1, 'covid-19': 1, 'throughout': 1, 'world': 1, 'map': 1, 'automatically': 1, 'update': 1, 'show': 1, 'current': 1}",{},0,-0.296
DOI:https://www.nejm.org10.1056/NEJMicm1501197,https://www.nejm.org10.1056/NEJMicm1501197,,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,['sneeze'],"['This video capture emission sneeze cloud .', 'The largest droplet rapidly settle within 1 2 away person .', 'The smaller evaporate droplet travel dimension room land 6 8 away .']","['video', 'capture', 'emission', 'sneeze', 'cloud', '', 'largest', 'droplet', 'rapidly', 'settle', 'within', '1', '2', 'away', 'person', '', 'smaller', 'evaporate', 'droplet', 'travel', 'dimension', 'room', 'land', '6', '8', 'away', '']",27,"{'': 3, 'droplet': 2, 'away': 2, 'video': 1, 'capture': 1, 'emission': 1, 'sneeze': 1, 'cloud': 1, 'largest': 1, 'rapidly': 1, 'settle': 1, 'within': 1, '1': 1, '2': 1, 'person': 1, 'smaller': 1, 'evaporate': 1, 'travel': 1, 'dimension': 1, 'room': 1}",{},0,0.0
DOI:https://www.nejm.org10.1056/NEJMicm072576,https://www.nejm.org10.1056/NEJMicm072576,,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['coughing', 'aerosols']","['Sequential schlieren image cough , show video , record 3000 frame per second .', 'A maximum airspeed 8 per second ( 18 mph ) observe , average half-second cough .']","['sequential', 'schlieren', 'image', 'cough', '', 'show', 'video', '', 'record', '3000', 'frame', 'per', 'second', '', 'maximum', 'airspeed', '8', 'per', 'second', '', '18', 'mph', '', 'observe', '', 'average', 'half-second', 'cough', '']",29,"{'': 7, 'cough': 2, 'per': 2, 'second': 2, 'sequential': 1, 'schlieren': 1, 'image': 1, 'show': 1, 'video': 1, 'record': 1, '3000': 1, 'frame': 1, 'maximum': 1, 'airspeed': 1, '8': 1, '18': 1, 'mph': 1, 'observe': 1, 'average': 1, 'half-second': 1}",{},0,0.0
DOI:https://theforum.sph.harvard.edu/events/covid-19,https://theforum.sph.harvard.edu/events/covid-19,,2020-04-15 00:00:00,NEJM,2020-05-23 22:13:35.057884,"['covid-19', '', '']","['This symposium , hold April 21 , 2020 , Harvard T.H .', 'Chan School Public Health NEJM , present timely conversation public health leader Covid-19 collective next step , secure crucial supply hope treatment vaccine lift restriction .']","['symposium', '', 'hold', 'april', '21', '', '2020', '', 'harvard', 'th', '', 'chan', 'school', 'public', 'health', 'nejm', '', 'present', 'timely', 'conversation', 'public', 'health', 'leader', 'covid-19', 'collective', 'next', 'step', '', 'secure', 'crucial', 'supply', 'hope', 'treatment', 'vaccine', 'lift', 'restriction', '']",37,"{'': 7, 'public': 2, 'health': 2, 'symposium': 1, 'hold': 1, 'april': 1, '21': 1, '2020': 1, 'harvard': 1, 'th': 1, 'chan': 1, 'school': 1, 'nejm': 1, 'present': 1, 'timely': 1, 'conversation': 1, 'leader': 1, 'covid-19': 1, 'collective': 1, 'next': 1}",{},0,0.4939
DOI:10.1016/j.kint.2020.05.003,10.1016/j.kint.2020.05.003,Kidney Int,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['multivesicular', 'bodies', '', 'mvb', '', 'mimicking', 'sars-cov-2', 'patient', 'without', 'covid-19', '']",['Kidney Int'],"['kidney', 'int']",2,"{'kidney': 1, 'int': 1}",{},0,0.0
DOI:10.1016/j.micinf.2020.05.004,10.1016/j.micinf.2020.05.004,Microbes Infect,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['sars-cov', 'sars-cov-2', '', 'safety', 'broad-spectrum', 'important', 'coronavirus', 'vaccine', 'development', '']","['The global pandemic COVID-19 cause SARS-CoV-2 ( also know 2019-nCoV HCoV-19 ) pose serious threat public health economic stability worldwide , thus call development vaccine SARS-CoV-2 emerge reemerging coronaviruses .', 'Since SARS-CoV-2 SARS-CoV high similarity genomic sequence share cellular receptor ( ACE2 ) , essential learn lesson experience development SARS-CoV vaccine development SARS-CoV-2 vaccine .', 'In review , summarize current knowledge advantage disadvantage SARS-CoV vaccine candidate prospect strategy development safe , effective broad-spectrum coronavirus vaccine prevention infection currently circulate SARS-CoV-2 emerge reemerging coronaviruses may cause future epidemic pandemic .']","['global', 'pandemic', 'covid-19', 'cause', 'sars-cov-2', '', '2019-ncov', 'hcov-19', '', 'pose', 'serious', 'threat', 'public', 'health', 'economic', 'stability', 'worldwide', '', 'thus', 'call', 'development', 'vaccine', 'sars-cov-2', 'emerge', 'reemerging', 'coronaviruses', '', 'since', 'sars-cov-2', 'sars-cov', 'high', 'similarity', 'genomic', 'sequence', 'share', 'cellular', 'receptor', '', 'ace2', '', '', 'essential', 'learn', 'lesson', 'experience', 'development', 'sars-cov', 'vaccine', 'development', 'sars-cov-2', 'vaccine', '', 'review', '', 'summarize', 'current', 'knowledge', 'advantage', 'disadvantage', 'sars-cov', 'vaccine', 'candidate', 'prospect', 'strategy', 'development', 'safe', '', 'effective', 'broad-spectrum', 'coronavirus', 'vaccine', 'prevention', 'infection', 'currently', 'circulate', 'sars-cov-2', 'emerge', 'reemerging', 'coronaviruses', 'cause', 'future', 'epidemic', 'pandemic', '']",84,"{'': 11, 'sars-cov-2': 5, 'vaccine': 5, 'development': 4, 'sars-cov': 3, 'pandemic': 2, 'cause': 2, 'emerge': 2, 'reemerging': 2, 'coronaviruses': 2, 'global': 1, 'covid-19': 1, '2019-ncov': 1, 'hcov-19': 1, 'pose': 1, 'serious': 1, 'threat': 1, 'public': 1, 'health': 1, 'economic': 1}","{'infection': 1, 'sars-cov-2': 5}",6,0.5994
DOI:10.1002/eji.202048663,10.1002/eji.202048663,Eur J Immunol,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['covid-19', 'vaccine', '', 'unknown', '']","['Vaccine development SARS-CoV-2 draw attention around globe due explode pandemic .', 'Although COVID-19 cause new coronavirus , SARS-CoV-2 , previous research coronavirus vaccine , FIPV , SARS MERS , provide valuable information rapid development COVID-19 vaccine .', 'However , important knowledge gap remain - specific SARS-CoV-2 , others fundamental immunology vaccinology .', 'Here discus area need address COVID-19 vaccine development , learn example vaccine development past .', 'Since begin outbreak , research progress COVID-19 remarkable .', 'We therefore optimistic rapid development COVID-19 vaccine .', 'This article protect copyright .', 'All right reserve .']","['vaccine', 'development', 'sars-cov-2', 'draw', 'attention', 'around', 'globe', 'due', 'explode', 'pandemic', '', 'although', 'covid-19', 'cause', 'new', 'coronavirus', '', 'sars-cov-2', '', 'previous', 'research', 'coronavirus', 'vaccine', '', 'fipv', '', 'sars', 'mers', '', 'provide', 'valuable', 'information', 'rapid', 'development', 'covid-19', 'vaccine', '', 'however', '', 'important', 'knowledge', 'gap', 'remain', '-', 'specific', 'sars-cov-2', '', 'others', 'fundamental', 'immunology', 'vaccinology', '', 'discus', 'area', 'address', 'covid-19', 'vaccine', 'development', '', 'learn', 'example', 'vaccine', 'development', 'past', '', 'since', 'begin', 'outbreak', '', 'research', 'progress', 'covid-19', 'remarkable', '', 'therefore', 'optimistic', 'rapid', 'development', 'covid-19', 'vaccine', '', 'article', 'protect', 'copyright', '', 'reserve', '']",87,"{'': 17, 'vaccine': 6, 'development': 5, 'covid-19': 5, 'sars-cov-2': 3, 'coronavirus': 2, 'research': 2, 'rapid': 2, 'draw': 1, 'attention': 1, 'around': 1, 'globe': 1, 'due': 1, 'explode': 1, 'pandemic': 1, 'although': 1, 'cause': 1, 'new': 1, 'previous': 1, 'fipv': 1}",{'sars-cov-2': 3},3,0.5994
DOI:10.1111/resp.13852,10.1111/resp.13852,Respirology,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['role', 'sars-cov-2', 'antibody', 'covid-19', '', 'healing', '', 'harm', 'time', '']",['Respirology'],['respirology'],1,{'respirology': 1},{},0,0.0
DOI:10.1111/and.13654,10.1111/and.13654,Andrologia,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['covid-19', 'impact', 'male', 'fertility', '']","['The pandemic cause Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) lead several hypothesis functional alteration different organ .', 'The direct influence virus male urogenital organ still evaluate .', 'However hypothesis already make , especially andrological field , biological similarity SARS-CoV SARS-CoV2 .', ""As well SARS-CoV , SARS CoV-2 us 'Angiotensin Converting Enzyme-2 ' ( ACE2 ) receptor enter human cell ."", 'It find ACE2 , Angiotensin ( 1-7 ) MAS receptor present , lung , also testicle , particular Leydig Sertoli cell .', 'A first hypothesis virus could enter testicle lead alteration testicular functionality .', 'A second hypothesis bind virus ACE2 receptor , could cause excess ACE2 give rise typical inflammatory response .', 'The inflammatory cell could interfere function Leydig Sertoli cell .', 'Both hypothesis evaluate confirm , order possibly monitor fertility patient COVID-19+ .']","['pandemic', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'lead', 'several', 'hypothesis', 'functional', 'alteration', 'different', 'organ', '', 'direct', 'influence', 'virus', 'male', 'urogenital', 'organ', 'still', 'evaluate', '', 'however', 'hypothesis', 'already', '', 'especially', 'andrological', 'field', '', 'biological', 'similarity', 'sars-cov', 'sars-cov2', '', 'well', 'sars-cov', '', 'sars', 'cov-2', 'us', 'angiotensin', 'converting', 'enzyme-2', '', '', 'ace2', '', 'receptor', 'enter', 'human', 'cell', '', 'find', 'ace2', '', 'angiotensin', '', '1-7', '', 'mas', 'receptor', 'present', '', 'lung', '', 'testicle', '', 'particular', 'leydig', 'sertoli', 'cell', '', 'first', 'hypothesis', 'virus', 'enter', 'testicle', 'lead', 'alteration', 'testicular', 'functionality', '', 'second', 'hypothesis', 'bind', 'virus', 'ace2', 'receptor', '', 'cause', 'excess', 'ace2', 'give', 'rise', 'typical', 'inflammatory', 'response', '', 'inflammatory', 'cell', 'interfere', 'function', 'leydig', 'sertoli', 'cell', '', 'hypothesis', 'evaluate', 'confirm', '', 'order', 'possibly', 'monitor', 'fertility', 'patient', 'covid-19', '']",124,"{'': 25, 'hypothesis': 5, 'ace2': 4, 'cell': 4, 'virus': 3, 'receptor': 3, 'cause': 2, 'lead': 2, 'alteration': 2, 'organ': 2, 'evaluate': 2, 'sars-cov': 2, 'angiotensin': 2, 'enter': 2, 'testicle': 2, 'leydig': 2, 'sertoli': 2, 'inflammatory': 2, 'pandemic': 1, 'severe': 1}",{'sars-cov-2': 1},1,-0.3818
DOI:10.1016/j.wneu.2020.05.019,10.1016/j.wneu.2020.05.019,World Neurosurg,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['response', 'sars-cov-2', 'pandemic', 'non-covid-19', 'designated', 'latin-american', 'neurosurgery', 'department', '']",['World Neurosurg'],"['world', 'neurosurg']",2,"{'world': 1, 'neurosurg': 1}",{},0,0.0
DOI:10.1016/j.jhep.2020.05.002,10.1016/j.jhep.2020.05.002,J Hepatol,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['sars-cov-2', 'infection', 'liver', 'directly', 'contribute', 'hepatic', 'impairment', 'patient', 'covid-19', '']","['BACKGROUND : Liver enzyme abnormality common patient coronavirus disease 2019 ( COVID-19 ) .', 'Whether SARS-CoV-2 infection lead liver damage per se remain unknown .', 'Here report clinical characteristic liver pathological manifestation COVID-19 patient liver enzyme abnormality .', 'METHODS : We receive 156 patient diagnose COVID-19 two designate center China , compare clinical feature patient elevate aminotransferase .', 'Postmortem liver biopsy obtain two case elevate aminotransferase .', 'We investigate pattern liver impairment electron microscopy , immunohistochemistry , TUNEL assay , pathological study .', 'RESULTS : 64 156 ( 41.0 % ) COVID-19 patient elevate aminotransferase .', 'The median level ALT 50 U/L vs. 19 U/L , respectively , AST 45.5 U/L vs. 24 U/L , respectively abnormal normal aminotransferase group .', 'The liver enzyme abnormality associate disease severity , well series laboratory test include higher A-aDO2 , higher GGT , lower albumin , decrease CD4+ T cell B lymphocyte .', 'Ultrastructural examination identify typical coronavirus particle characterize spike structure cytoplasm hepatocytes two COVID-19 case .', 'SARS-CoV-2 infect hepatocytes display conspicuous mitochondrial swell , endoplasmic reticulum dilatation , glycogen granule decrease .', 'Histologically , massive hepatic apoptosis certain binuclear hepatocytes observe .', 'Taken together , ultrastructural histological evidence indicate typical lesion viral infection .', 'Immunohistochemical result show scanty CD4+ CD8+ lymphocyte .', 'No obvious eosinophil infiltration , cholestasis , fibrin deposition , granuloma , massive central necrosis , interface hepatitis observe .', 'CONCLUSIONS : SARS-CoV-2 infection liver crucial cause hepatic impairment COVID-19 patient .', 'Hence , surveillance viral clearance liver long outcome COVID-19 require .']","['background', '', 'liver', 'enzyme', 'abnormality', 'common', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'whether', 'sars-cov-2', 'infection', 'lead', 'liver', 'damage', 'per', 'se', 'remain', 'unknown', '', 'report', 'clinical', 'characteristic', 'liver', 'pathological', 'manifestation', 'covid-19', 'patient', 'liver', 'enzyme', 'abnormality', '', 'methods', '', 'receive', '156', 'patient', 'diagnose', 'covid-19', 'two', 'designate', 'center', 'china', '', 'compare', 'clinical', 'feature', 'patient', 'elevate', 'aminotransferase', '', 'postmortem', 'liver', 'biopsy', 'obtain', 'two', 'case', 'elevate', 'aminotransferase', '', 'investigate', 'pattern', 'liver', 'impairment', 'electron', 'microscopy', '', 'immunohistochemistry', '', 'tunel', 'assay', '', 'pathological', 'study', '', 'results', '', '64', '156', '', '410', '', '', 'covid-19', 'patient', 'elevate', 'aminotransferase', '', 'median', 'level', 'alt', '50', 'ul', '19', 'ul', '', 'respectively', '', 'ast', '455', 'ul', '24', 'ul', '', 'respectively', 'abnormal', 'normal', 'aminotransferase', 'group', '', 'liver', 'enzyme', 'abnormality', 'associate', 'disease', 'severity', '', 'well', 'series', 'laboratory', 'test', 'include', 'higher', 'a-ado2', '', 'higher', 'ggt', '', 'lower', 'albumin', '', 'decrease', 'cd4', 'cell', 'b', 'lymphocyte', '', 'ultrastructural', 'examination', 'identify', 'typical', 'coronavirus', 'particle', 'characterize', 'spike', 'structure', 'cytoplasm', 'hepatocytes', 'two', 'covid-19', 'case', '', 'sars-cov-2', 'infect', 'hepatocytes', 'display', 'conspicuous', 'mitochondrial', 'swell', '', 'endoplasmic', 'reticulum', 'dilatation', '', 'glycogen', 'granule', 'decrease', '', 'histologically', '', 'massive', 'hepatic', 'apoptosis', 'certain', 'binuclear', 'hepatocytes', 'observe', '', 'taken', 'together', '', 'ultrastructural', 'histological', 'evidence', 'indicate', 'typical', 'lesion', 'viral', 'infection', '', 'immunohistochemical', 'result', 'show', 'scanty', 'cd4', 'cd8', 'lymphocyte', '', 'obvious', 'eosinophil', 'infiltration', '', 'cholestasis', '', 'fibrin', 'deposition', '', 'granuloma', '', 'massive', 'central', 'necrosis', '', 'interface', 'hepatitis', 'observe', '', 'conclusions', '', 'sars-cov-2', 'infection', 'liver', 'crucial', 'cause', 'hepatic', 'impairment', 'covid-19', 'patient', '', 'hence', '', 'surveillance', 'viral', 'clearance', 'liver', 'long', 'outcome', 'covid-19', 'require', '']",245,"{'': 47, 'liver': 9, 'covid-19': 7, 'patient': 6, 'aminotransferase': 4, 'ul': 4, 'enzyme': 3, 'abnormality': 3, 'sars-cov-2': 3, 'infection': 3, 'two': 3, 'elevate': 3, 'hepatocytes': 3, 'coronavirus': 2, 'disease': 2, 'clinical': 2, 'pathological': 2, '156': 2, 'case': 2, 'impairment': 2}","{'infection': 3, 'sars-cov-2': 3}",6,-0.4939
DOI:10.1111/pan.13924,10.1111/pan.13924,Paediatr Anaesth,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['anesthetic', 'concern', 'pediatric', 'patient', 'era', 'covid-19', '']","['Aftera novel human coronavirus , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , report China December 2019 , disease quicklyreached pandemic level .', 'On January 30 , 2020 , World Health Organization ( WHO ) declare SARS-CoV-2 outbreak constitute Public Health Emergency International Concern .', 'The caseload increase exponentially , WHO report 182,000 global case 17 March 2020 , 2.6 million 23 April .', 'The clinical situation complex , child present different clinical feature compare adult .', 'Several article recommendation anesthetic management adult patient COVID-19 publish , specific recommendation pediatric anesthesiologist make yet .', 'This article address specific concern anesthetic management pediatric population COVID-19 .']","['aftera', 'novel', 'human', 'coronavirus', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'report', 'china', 'december', '2019', '', 'disease', 'quicklyreached', 'pandemic', 'level', '', 'january', '30', '', '2020', '', 'world', 'health', 'organization', '', '', 'declare', 'sars-cov-2', 'outbreak', 'constitute', 'public', 'health', 'emergency', 'international', 'concern', '', 'caseload', 'increase', 'exponentially', '', 'report', '182000', 'global', 'case', '17', 'march', '2020', '', '26', 'million', '23', 'april', '', 'clinical', 'situation', 'complex', '', 'child', 'present', 'different', 'clinical', 'feature', 'compare', 'adult', '', 'several', 'article', 'recommendation', 'anesthetic', 'management', 'adult', 'patient', 'covid-19', 'publish', '', 'specific', 'recommendation', 'pediatric', 'anesthesiologist', 'yet', '', 'article', 'address', 'specific', 'concern', 'anesthetic', 'management', 'pediatric', 'population', 'covid-19', '']",100,"{'': 19, 'coronavirus': 2, 'sars-cov-2': 2, 'report': 2, '2020': 2, 'health': 2, 'concern': 2, 'clinical': 2, 'adult': 2, 'article': 2, 'recommendation': 2, 'anesthetic': 2, 'management': 2, 'covid-19': 2, 'specific': 2, 'pediatric': 2, 'aftera': 1, 'novel': 1, 'human': 1, 'severe': 1}",{'sars-cov-2': 2},2,-0.1531
DOI:10.1111/dth.13636,10.1111/dth.13636,Dermatol Ther,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['case', 'goggle-mask-related', 'impetigo', 'time', 'covid-19', 'pandemic', '']",['Dermatol Ther'],"['dermatol', 'ther']",2,"{'dermatol': 1, 'ther': 1}",{},0,0.0
DOI:10.1136/bmj.m2044,10.1136/bmj.m2044,BMJ,2020-05-22 00:00:00,PUBMED,2020-05-23 22:13:35.057884,"['world', 'leader', 'adopt', 'resolution', 'study', 'response', 'covid-19', '']",['BMJ'],['bmj'],1,{'bmj': 1},{},0,0.0
ID:126981,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention']","['INTRODUCTION — Coronaviruses important human animal pathogen .', 'At end 2019 , novel coronavirus identify cause cluster pneumonia case Wuhan , city Hubei Province China .', 'It rapidly spread , result epidemic throughout China , follow increase number case country throughout world .', 'In February 2020 , World Health Organization designate disease COVID-19 , stand coronavirus disease 2019 [ 1 ] .', 'The virus cause COVID-19 designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) ; previously , refer 2019-nCoV.Understanding COVID-19 evolve .', 'Interim guidance issue World Health Organization United States Centers Disease Control Prevention [ 2,3 ] .', 'Links relate society guideline find elsewhere .', ""( See 'Society guideline link ' ."", ') This topic discus virology , epidemiology , clinical feature , diagnosis , prevention COVID-19 .', 'The management COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' . )"", '( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', "") Issues relate COVID-19 specific population discuss elsewhere : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", ') Community-acquired coronaviruses , severe acute respiratory syndrome ( SARS ) coronavirus , Middle East respiratory syndrome ( MERS ) coronavirus discuss separately .', ""( See `` Coronaviruses '' `` Severe acute respiratory syndrome ( SARS ) '' `` Middle East respiratory syndrome coronavirus : Virology , pathogenesis , epidemiology '' ."", ') VIROLOGY — Full-genome sequence phylogenic analysis indicate coronavirus cause COVID-19 betacoronavirus subgenus severe acute respiratory syndrome ( SARS ) virus ( well several bat coronaviruses ) , different clade .', 'The structure receptor-binding gene region similar SARS coronavirus , virus show use receptor , angiotensin-converting enzyme 2 ( ACE2 ) , cell entry [ 4 ] .', 'The Coronavirus Study Group International Committee Taxonomy Viruses propose virus designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) [ 5 ] .The Middle East respiratory syndrome ( MERS ) virus , another betacoronavirus , appear distantly relate [ 6,7 ] .', 'The closest RNA sequence similarity two bat coronaviruses , appear likely bat primary source ; whether COVID-19 virus transmit directly bat mechanism ( eg , intermediate host ) unknown [ 8 ] .', ""( See `` Coronaviruses '' , section 'Viral serotypes ' ."", ') In phylogenetic analysis 103 strain SARS-CoV-2 China , two different type SARS-CoV-2 identify , designate type L ( account 70 percent strain ) type S ( account 30 percent ) [ 9 ] .', 'The L type predominate early day epidemic China , account lower proportion strain outside Wuhan Wuhan .', 'The clinical implication find uncertain .', 'EPIDEMIOLOGYGeographic distribution — Globally , five million confirm case COVID-19 report .', 'Updated case count English find World Health Organization European Centre Disease Prevention Control website .', 'An interactive map highlight confirm case throughout world find .', 'Since first report case Wuhan , city Hubei Province China , end 2019 , case report continent , except Antarctica.In United States , COVID-19 report 50 state , Washington DC , least four territory [ 10 ] .', 'The cumulative incidence vary state likely depend number factor , include population density demographic , extent test report , time mitigation strategy .', 'In United States , outbreak long-term care facility homeless shelter emphasize risk exposure infection congregate set [ 11-13 ] .', ""( See 'Risk transmission ' ."", ') Transmission — Understanding transmission risk incomplete .', 'Epidemiologic investigation Wuhan begin outbreak identify initial association seafood market sell live animal , patient work visit subsequently close disinfection [ 14 ] .', 'However , outbreak progress , person-to-person spread become main mode transmission .', 'Person-to-personRoute person-to-person transmission — Direct person-to-person transmission primary mean transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'It think occur close-range contact , mainly via respiratory droplet ; virus release respiratory secretion person infection cough , sneeze , talk infect another person make direct contact mucous membrane ; infection also occur person touch infect surface touch eye , nose , mouth .', 'Droplets typically travel six foot ( two meter ) .', 'Whether SARS-CoV-2 transmit airborne route ( particle smaller droplet remain air time distance ) natural condition controversial issue .', 'One letter editor describe study SARS-CoV-2 grow tissue culture remain viable experimentally generate aerosol least three hour [ 15 ] ; study identify viral RNA ventilation system air sample hospital room patient COVID-19 , culture viable virus perform study [ 16-18 ] .', 'Other study use specialize image visualize respiratory exhalation suggest respiratory droplet may get aerosolize carry gas cloud horizontal trajectory beyond six foot ( two meter ) speak , cough , sneeze [ 19-21 ] .', 'However , direct relevance find epidemiology COVID-19 clinical implication unclear .', 'Long-range airborne transmission SARS-CoV-2 clearly document [ 22 ] , report health care worker expose patient undiagnosed infection use contact droplet precaution , secondary infection identify despite absence airborne precaution [ 23,24 ] .', 'Reflecting current uncertainty regard transmission mechanism , recommendation airborne precaution health care set vary location ; airborne precaution universally recommend aerosol-generating procedure perform .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') SARS-CoV-2 detect non-respiratory specimen , include stool , blood , ocular secretion , semen , role site transmission uncertain [ 25-30 ] .', 'In particular , several report describe detection SARS-CoV-2 RNA stool specimen , even viral RNA could longer detect upper respiratory specimen [ 28,29 ] , live virus culture stool rare case [ 26,31 ] .', 'Although would difficult confirm , fecal-oral transmission clinically describe , accord joint WHO-China report , appear significant factor spread infection [ 32 ] .', 'Detection SARS-CoV-2 RNA blood also report study test [ 25,26,29,33 ] .', 'However , likelihood bloodborne transmission ( eg , blood product needlesticks ) appear low ; respiratory virus generally transmit bloodborne route , transfusion-transmitted infection report SARS-CoV-2 relate MERS-CoV SARS-CoV [ 34 ] .', ""( See `` Blood donor screen : Laboratory test '' , section 'Emerging infectious disease agent ' ."", ') Viral shed period infectivity — The precise interval individual COVID-19 infectious uncertain .', 'It appear SARS-CoV-2 transmit prior development symptom throughout course illness , particularly early course .', 'However , data inform issue study evaluate viral RNA detection respiratory specimen ; detection viral RNA necessarily indicate presence infectious virus , thus prolong viral RNA detection follow resolution illness necessarily indicate infectiousness .', 'Largely indirect data suggest infect individual likely infectious earlier stage infection .', 'Viral RNA level upper respiratory specimen appear higher soon symptom onset compare later illness [ 35-39 ] .', 'Additionally , study nine patient mild COVID-19 , infectious virus isolate naso/oropharyngeal sputum specimen first eight day illness , interval , despite continue high viral RNA level site [ 37 ] .', 'One model study , base time infection among 77 transmission pair China ( mean serial interval 5.8 day onset symptom pair ) assumption incubation period , suggest infectiousness start 2.3 day prior symptom onset , peak 0.7 day symptom onset , decline within seven day ; however , patient isolate follow symptom onset , would reduce risk transmission later illness regardless infectiousness [ 38 ] .', 'In another study evaluate 2500 close contact 100 patient COVID-19 Taiwan , 22 secondary case first exposure index case within six day symptom onset ; infection document 850 contact whose exposure interval [ 40 ] .Transmission SARS-CoV-2 asymptomatic individual ( individual within incubation period ) also well document [ 41-46 ] .', 'The biologic basis support study SARS-CoV-2 outbreak long-term care facility , infectious virus culture reverse transcription polymerase chain reaction ( RT-PCR ) -positive upper respiratory tract specimen presymptomatic asymptomatic patient early six day prior development typical symptom [ 47 ] .', 'However , extent asymptomatic presymptomatic transmission occur much contribute pandemic remain unknown .', 'In analysis 157 locally acquire COVID-19 case Singapore , transmission incubation period estimate account 6.4 percent ; case , exposure occur one three day prior symptom development [ 48 ] .', 'Large-scale serologic screen may able provide better sense scope asymptomatic infection inform epidemiologic analysis ; several serologic test SARS-CoV-2 grant emergency use authorization US Food Drug Administration ( FDA ) [ 49,50 ] .', 'How long person remain infectious also uncertain , available data suggest prolong viral RNA shed symptom resolution clearly associate prolong infectiousness .', 'The duration viral RNA shed variable ; appear wide range , may depend severity illness [ 29,37,51-53 ] .', 'In one study 21 patient mild illness ( hypoxia ) , 90 percent repeat negative viral RNA test nasopharyngeal swab 10 day onset symptom ; test positive longer patient severe illness [ 51 ] .', 'In contrast , another study 56 patient mild moderate illness ( none require intensive care ) , median duration viral RNA shed naso- oropharyngeal specimen 24 day , longest 42 day [ 54 ] .', 'However , mention , detectable viral RNA always correlate isolation infectious virus , may threshold viral RNA level infectivity unlikely .', 'In study nine patient mild COVID-19 describe , infectious virus detect respiratory specimen viral RNA level < 106 copies/mL [ 37 ] .', 'According information United States Centers Disease Control Prevention ( CDC ) , patient continue detectable viral RNA upper respiratory sample follow clinical recovery , three day recovery , RNA concentration generally level replication-competent virus reliably isolate ; additionally , isolation infectious virus upper respiratory specimen nine day illness onset yet document [ 55 ] .', 'Infectious virus also isolate respiratory specimen patient repeat positive RNA test follow clinical improvement initial viral clearance [ 56 ] .', ""( See 'Immunity risk reinfection ' ."", ') One study report patient critical COVID-19 replicative virus isolate stool 28 day follow symptom onset ; data need understand frequency clinical significance find [ 31 ] .', 'The relevance viral RNA detection duration infection control precaution discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' ."", ') Risk transmission — The risk transmission individual SARS-CoV-2 infection vary type duration exposure , use preventive measure , likely individual factor ( eg , amount virus respiratory secretion ) .', 'Most secondary infection describe among household contact , congregate health care set personal protective equipment use ( include hospital [ 57 ] long-term care facility [ 11 ] ) , close set ( eg , cruise ship [ 58 ] ) .', 'However , report cluster case social work gather also highlight risk transmission close , non-household contact.Contact trace early stage epidemic various location suggest secondary infection among household contact , secondary attack rate 15 percent [ 32,59-62 ] ; study suggest even higher household infection rate [ 46,63,64 ] .', 'According joint WHO-China report , rate secondary COVID-19 various location range 1 5 percent among ten thousand close contact confirm patient China ; occur within household , in-household secondary attack rate 3 10 percent [ 32 ] .', 'In United States , symptomatic secondary attack rate 0.45 percent among 445 close contact 10 confirm patient ; among household member , rate 10.5 percent [ 59 ] .', 'In similar study Korea , rate comparable , secondary infection 0.55 percent contact 7.6 percent family member [ 60 ] .Clusters case also report follow family , work , social gather close , personal contact occur [ 65,66 ] .', 'As example , epidemiologic analysis cluster case state Illinois show probable transmission two family gather communal food consume , embrace share , extend face-to-face conversation exchange symptomatic individual later confirm COVID-19 [ 65 ] .', 'A report outbreak among choir group , 33 confirm 20 probable case identify among 61 member attend practice session , raise possibility high transmission risk sing close proximity [ 67 ] .The risk transmission indirect contact ( eg , pass someone infection street , handle item previously handle someone infection ) well establish likely low .', 'Environmental contamination — Virus present contaminate surface may another source infection susceptible individual touch surface transfer infectious virus mucous membrane mouth , eye , nose .', 'The frequency relative importance type transmission remain unclear .', ""It may likely potential source infection set heavy viral contamination ( eg , infect individual 's household health care set ) ."", 'Extensive SARS-CoV-2 contamination environmental surface hospital room patient COVID-19 describe [ 16,68 ] .', 'In study Singapore , viral RNA detect nearly surface test ( handle , light switch , bed handrail , interior door window , toilet bowl , sink basin ) airborne infection isolation room patient symptomatic mild COVID-19 prior routine clean [ 16 ] .', 'Viral RNA detect similar surface room two symptomatic patient follow routine clean ( sodium dichloroisocyanurate ) .', 'Of note , viral RNA detection necessarily indicate presence infectious virus [ 37 ] .', 'It unknown long SARS-CoV-2 persist surface [ 15,69,70 ] ; coronaviruses test may survive inanimate surface six nine day without disinfection .', 'In study evaluate survival virus dry plastic surface room temperature , specimen contain SARS-CoV ( virus closely relate SARS-CoV-2 ) detectable infectivity six nine day [ 70 ] .', 'However , systematic review similar study , various disinfectant ( include ethanol concentration 62 71 % ) inactivate number coronaviruses relate SARS-CoV-2 within one minute [ 69 ] .', 'Based data concern coronaviruses , duration viral persistence surface also likely depend ambient temperature , relative humidity , size initial inoculum [ 71 ] .These data highlight importance environmental disinfection home health care set .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Environmental disinfection ' ."", ') Uncertain risk animal contact — SARS-CoV-2 infection think originally transmit human animal host , ongoing risk transmission animal contact uncertain .', 'There evidence suggest animal ( include domesticate animal ) major source infection human .', 'SARS-CoV-2 infection describe animal natural experimental set .', 'There rare report animal SARS-CoV-2 infection ( include asymptomatic infection dog symptomatic infection cat ) follow close contact human COVID-19 [ 72,73 ] .', 'Moreover , asymptomatic , experimentally infect domestic cat may transmit SARS-CoV-2 cat cage [ 74 ] .', 'The risk infection may vary specie .', 'In one study evaluate infection animal intranasal viral inoculation , SARS-CoV-2 replicate efficiently ferret cat ; viral replication also detect dog , appear le susceptible overall experimental infection [ 75 ] .', 'Pigs poultry susceptible infection .', 'Given uncertainty regard transmission risk apparent susceptibility animal SARS-CoV-2 infection , United States CDC recommend pet keep away animal people outside household people confirm suspect COVID-19 try avoid close contact household pet , human household member , duration self-isolation period .', 'There report domesticate animal transmit SARS-CoV-2 infection human .', 'Immunity risk reinfection — Antibodies virus induce become infect .', 'Preliminary evidence suggest antibody protective , remain definitively establish .', 'Moreover , unknown whether infect patient mount protective immune response long protective effect last.Data protective immunity follow COVID-19 emerge [ 36,37,76 ] .', 'A case series evaluate convalescent plasma treatment COVID-19 identify neutralize activity plasma recover patient appear transfer recipient follow plasma infusion [ 76 ] .', 'Similarly , another study 23 patient recover COVID-19 , antibody receptor-binding domain spike protein nucleocapsid protein detect enzyme-linked immunosorbent assay ( ELISA ) patient 14 day follow onset symptom ; ELISA antibody titer correlate neutralize activity [ 36 ] .', 'Animal study suggest immune response infection may offer protection reinfection , least short term .', 'In one study nine rhesus macaque experimentally infect SARS-CoV-2 , animal develop neutralize antibody ; upon rechallenge viral dose 35 day later , anamnestic immune response , nasal swab , lower viral RNA level rapid viral RNA decline compare initial challenge challenge naïve control animal [ 77 ] .', 'Studies evaluate SARS-CoV-2 vaccine candidate macaque also suggest immune response vaccination result lower level viral RNA respiratory tract specimen follow viral challenge compare unvaccinated control [ 78,79 ] .', 'Some study report positive RT-PCR test SARS-CoV-2 patient laboratory-confirmed COVID-19 follow clinical improvement negative result two consecutive test [ 80,81 ] .', 'However , positive test occur shortly negative test , associate worsen symptom , may represent infectious virus , likely reflect reinfection .', 'Specifically , report Korea Centers Disease Control Prevention patient COVID-19 repeat positive RNA test previously clear isolation , infectious virus could isolate cell culture 108 patient test [ 56 ] .', 'Among 790 contact , newly confirm case trace exposure period repeat positive test.As , FDA grant emergency use authorization test identify antibody SARS-CoV-2 serum plasma [ 50 ] .', 'Should evidence confirm presence antibody reflect protective immune response , serologic screen important tool understand population immunity distinguish individual lower risk reinfection.CLINICAL FEATURESIncubation period — The incubation period COVID-19 think within 14 day follow exposure , case occur approximately four five day exposure [ 82-84 ] .In study 1099 patient confirm symptomatic COVID-19 , median incubation period four day ( interquartile range two seven day ) [ 83 ] .', 'Using data 181 publicly report , confirm case China identifiable exposure , one model study estimate symptom would develop 2.5 percent infect individual within 2.2 day 97.5 percent infect individual within 11.5 day [ 85 ] .', 'The median incubation period study 5.1 days.Spectrum illness severity case fatality rate — The spectrum symptomatic infection range mild critical ; infection severe [ 57,84,86-90 ] .', 'Specifically , report Chinese Center Disease Control Prevention include approximately 44,500 confirm infection estimation disease severity [ 91 ] : ●Mild ( mild pneumonia ) report 81 percent.●Severe disease ( eg , dyspnea , hypoxia , > 50 percent lung involvement image within 24 48 hour ) report 14 percent.●Critical disease ( eg , respiratory failure , shock , multiorgan dysfunction ) report 5 percent.●The overall case fatality rate 2.3 percent ; death report among noncritical case .', 'Among hospitalize patient , proportion critical fatal disease higher [ 92-94 ] .', 'In study include 2634 patient hospitalize COVID-19 New York City area , 14 percent treat intensive care unit 12 percent receive invasive mechanical ventilation , mortality among receive mechanical ventilation 88 percent [ 92 ] .', 'However , analysis limit patient either discharge die admission , patient represent fewer half total population admit COVID-19 ; thus , proportion critically ill patient associate mortality rate may accurately reflect entire hospitalize population .', 'The proportion severe fatal infection may also vary location .', 'According joint World Health Organization ( WHO ) -China fact-finding mission , case fatality rate range 5.8 percent Wuhan 0.7 percent rest China [ 32 ] .', 'A model study suggest adjust case fatality rate mainland China 1.4 percent [ 95 ] .', 'Most fatal case occur patient advance age underlie medical comorbidities [ 52,91 ] .', 'In Italy , 12 percent detect COVID-19 case 16 percent hospitalize patient admit intensive care unit ; estimate case fatality rate 7.2 percent mid-March [ 96,97 ] .', 'In contrast , estimate case fatality rate mid-March South Korea 0.9 percent [ 98 ] .', 'This may relate distinct demographic infection ; Italy , median age patient infection 64 year , whereas Korea median age 40 .', ""( See 'Impact age ' ."", ') Risk factor severe illness — Severe illness occur otherwise healthy individual age , predominantly occur adult advance age underlie medical comorbidities .', 'The impact age discuss elsewhere .', ""( See 'Impact age ' ."", ') Comorbidities condition associate severe illness mortality include ( table 1 ) [ 52,91,99-102 ] : ●Cardiovascular disease●Diabetes mellitus●Hypertension●Chronic lung disease●Cancer ( particular hematologic malignancy , lung cancer , metastatic disease ) [ 103 ] ●Chronic kidney disease●Obesity ●SmokingThe United States Centers Disease Control Prevention ( CDC ) also include immunocompromising condition liver disease potential risk factor severe illness [ 104 ] , although specific data regard risk associate condition limit .', 'In subset 355 patient die COVID-19 Italy , mean number pre-existing comorbidities 2.7 , 3 patient underlie condition [ 97 ] .', 'Among patient advance age medical comorbidities , COVID-19 frequently severe .', 'For example , SARS-CoV-2 outbreak across several long-term care facility Washington State , median age 101 facility resident affect 83 year , 94 percent chronic underlie condition ; hospitalization preliminary case fatality rate 55 34 percent , respectively [ 105 ] .Males comprise disproportionately high number death cohort China , Italy , United States [ 92,97,106 ] .In number state United States , black Latino individual also appear comprise disproportionately high number infection death due COVID-19 , possibly relate underlie socioeconomic disparity [ 107-111 ] .', 'Particular laboratory feature also associate worse outcome ( table 2 ) .', 'These include [ 52,112,113 ] : ●Lymphopenia●Elevated liver enzymes●Elevated lactate dehydrogenase ( LDH ) ●Elevated inflammatory marker ( eg , C-reactive protein [ CRP ] , ferritin ) ●Elevated D-dimer ( > 1 mcg/mL ) ●Elevated prothrombin time ( PT ) ●Elevated troponin ●Elevated creatine phosphokinase ( CPK ) ●Acute kidney injuryAs example , one study , progressive decline lymphocyte count rise D-dimer time observe nonsurvivors compare stable level survivor [ 57 ] .Patients severe disease also report higher viral RNA level respiratory specimen milder disease [ 51 ] , although association observe different study measure viral RNA salivary specimen [ 36 ] .', 'Impact age — Individuals age acquire severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection , although adult middle age older commonly affect , older adult likely severe disease .', 'In several cohort hospitalize patient confirm COVID-19 , median age range 49 56 year [ 57,87,88 ] .', 'In report Chinese Center Disease Control Prevention include approximately 44,500 confirm infection , 87 percent patient 30 79 year old [ 91 ] .', 'Similarly , model study base data mainland China , hospitalization rate COVID-19 increase age , 1 percent rate 20 29 year old , 4 percent rate 50 59 year old , 18 percent older 80 year [ 95 ] .', 'Older age also associate increase mortality [ 91,92,97 ] .', 'In report Chinese Center Disease Control Prevention , case fatality rate 8 15 percent among age 70 79 year 80 year older , respectively , contrast 2.3 percent case fatality rate among entire cohort [ 91 ] .', 'Similar find report Italy , case fatality rate 12 20 percent among age 70 79 year 80 year older , respectively [ 97 ] .In United States , 2449 patient diagnose COVID-19 February 12 March 16 , 2020 age , hospitalization , intensive care unit ( ICU ) information available [ 114 ] ; 67 percent case diagnose age ≥45 year , , similar find China , mortality highest among older individual , 80 percent death occur age ≥65 years.Symptomatic infection child appear relatively uncommon ; occur , usually mild , although severe case report [ 115-118 ] .', 'Details COVID-19 child discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' . )"", 'Asymptomatic infection — Asymptomatic infection well document [ 84,119-125 ] .', 'Their precise frequency unknown , several study perform various set suggest common .', 'As example : ●In COVID-19 outbreak cruise ship nearly passenger staff screen SARS-CoV-2 , approximately 17 percent population board test positive February 20 ; half 619 confirm COVID-19 case asymptomatic time diagnosis [ 126 ] .', 'A model study estimate 18 percent true asymptomatic case ( ie , go develop symptom ) , although base number assumption , include incubation period [ 121 ] .', '●In smaller COVID-19 outbreak within skilled nurse facility , 27 48 resident ( 56 percent ) positive screen test asymptomatic time diagnosis , 24 ultimately develop symptom next seven day [ 47 ] .', '●Other study report even higher proportion asymptomatic case [ 13,124 ] .', 'As example , report universal screen program pregnant woman present delivery two New York hospital height pandemic , 29 210 asymptomatic woman without fever ( 14 percent ) positive SARS-CoV-2 reverse transcription polymerase chain reaction ( RT-PCR ) test nasopharyngeal specimen [ 124 ] .', 'Four additional woman fever symptom also test positive .', 'Thus , 33 woman positive SARS-CoV-2 test , 29 ( 88 percent ) asymptomatic presentation.Even patient asymptomatic infection may objective clinical abnormality [ 44,123 ] .', 'As example , study 24 patient asymptomatic infection undergo chest compute tomography ( CT ) , 50 percent typical ground-glass opacity patchy shadow , another 20 percent atypical image abnormality [ 44 ] .', 'Five patient develop low-grade fever , without typical symptom , day diagnosis .', 'In another study 55 patient asymptomatic infection identify contact trace , 67 percent CT evidence pneumonia admission ; two patient develop hypoxia , recover [ 123 ] .', 'Clinical manifestationsInitial presentation — Pneumonia appear frequent serious manifestation infection , characterize primarily fever , cough , dyspnea , bilateral infiltrate chest image [ 57,83,87,88 ] .', 'However , feature , include upper respiratory tract symptom , myalgia , diarrhea , smell taste disorder , also common ( table 3 ) .', 'There specific clinical feature yet reliably distinguish COVID-19 viral respiratory infection , although development dyspnea several day onset initial symptom suggestive .', ""( See 'Course complication ' . )"", 'Most study describe clinical feature COVID-19 perform hospitalize population .', 'In study describe 138 patient hospitalize COVID-19 pneumonia Wuhan , common clinical feature onset illness [ 57 ] : ●Fever 99 percent ( note fever presentation common study ; see ) ●Fatigue 70 percent●Dry cough 59 percent●Anorexia 40 percent●Myalgias 35 percent●Dyspnea 31 percent●Sputum production 27 percentOther cohort study patient confirm COVID-19 report similar range clinical find [ 57,87,127-129 ] .', 'However , fever universal find presentation .', 'In one study , fever report almost patient , approximately 20 percent low grade fever < 100.4°F/38°C [ 87 ] .', 'In another study 1099 patient Wuhan area China , fever ( define axillary temperature 99.5°F/37.5°C ) present 44 percent admission ultimately note 89 percent hospitalization [ 83 ] .', 'In study 5000 patient hospitalize COVID-19 New York , 31 percent temperature > 100.4°F/38°C presentation [ 92 ] .Although highlight initial cohort study China , smell taste disorder ( eg , anosmia dysgeusia ) also report common symptom patient COVID-19 [ 130-132 ] .', 'In survey 59 patient COVID-19 Italy , 34 percent self-reported either smell taste aberration 19 percent report [ 131 ] .', 'In survey 202 outpatient mild COVID-19 Italy , 64 percent report alteration smell taste , 24 percent report severe alteration ; smell taste change report symptom 3 percent overall precede symptom another 12 percent [ 133 ] .', 'Whether find distinguish feature COVID-19 uncertain .', 'In addition respiratory symptom , gastrointestinal symptom ( eg , nausea diarrhea ) also report ; patient , may present complaint [ 57,87,129,134 ] .', 'In systematic review study report gastrointestinal symptom patient confirm COVID-19 , pool prevalence 18 percent overall , diarrhea , nausea/vomiting , abdominal pain report 13 , 10 , 9 percent , respectively [ 28 ] .', 'Other report symptom include headache , sore throat , rhinorrhea [ 83,88 ] .', 'Conjunctivitis also describe [ 27 ] .Dermatologic find patient COVID-19 well characterize .', 'There report maculopapular , urticarial , vesicular eruption transient livedo reticularis [ 135-137 ] .', 'Reddish-purple nodule distal digit similar appearance pernio ( chilblain ) also describe , mainly child young adult document suspect COVID-19 , although association clearly establish [ 137-140 ] .', 'Some call find `` COVID toe .', '`` Course complication — As , symptomatic infection range mild critical .', ""( See 'Spectrum illness severity case fatality rate ' ."", ') Some patient initially nonsevere symptom may progress course week .', 'In one study 138 patient hospitalize Wuhan pneumonia due SARS-CoV-2 , dyspnea develop median five day since onset symptom , hospital admission occur median seven day symptom [ 57 ] .', 'In another study , median time dyspnea eight day [ 87 ] .Several complication COVID-19 describe : ●Acute respiratory distress syndrome ( ARDS ) major complication patient severe disease manifest shortly onset dyspnea .', 'In study 138 patient describe , ARDS develop 20 percent median eight day onset symptom ; mechanical ventilation implement 12.3 percent [ 57 ] .', 'In another study 201 hospitalize patient COVID-19 Wuhan , 41 percent develop ARDS ; age greater 65 year , diabetes mellitus , hypertension associate ARDS [ 112 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Clinical feature critically ill patient ' ."", ') ●Other complication include arrhythmia , acute cardiac injury , shock [ 57,106,141,142 ] .', 'In one study , report 17 , 7 , 9 percent , respectively [ 57 ] .', 'In series 21 severely ill patient admit ICU United States , one-third develop cardiomyopathy [ 141 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' , section 'Clinical feature ' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' , section 'Clinical manifestation ' ."", ') ●Thromboembolic complication , include pulmonary embolism acute stroke ( even patient younger 50 year age without risk factor ) , also report [ 143-148 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Clinical feature ' ."", ') ●Some patient severe COVID-19 laboratory evidence exuberant inflammatory response , similar cytokine release syndrome , persistent fever , elevate inflammatory marker ( eg , D-dimer , ferritin ) , elevate proinflammatory cytokine ; laboratory abnormality associate critical fatal illness [ 87,149,150 ] .', ""( See 'Risk factor severe illness ' . )"", '●Other inflammatory complication describe .', 'Guillain-Barré syndrome may occur , onset 5 10 day initial symptom [ 151 ] .', 'A multisystem inflammatory syndrome clinical feature similar Kawasaki disease toxic shock syndrome also describe child COVID-19 .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' ."", ') ●Secondary infection appear common complication COVID-19 overall , although data limit [ 152,153 ] .', 'In review nine study , mainly China , report rate bacterial fungal coinfections 8 percent ( 62 806 ) ; include mainly respiratory infection bacteremia [ 152 ] .', 'Several report describe presumptive invasive aspergillosis among immunocompetent patient ARDS COVID-19 , although frequency complication uncertain [ 154-156 ] .Autopsy study note detectable SARS-CoV-2 RNA ( , case , antigen ) kidney , liver , heart , brain , blood addition respiratory tract specimen , suggest virus disseminate systemically case ; whether direct viral cytopathic effect site contribute complication observe uncertain [ 157,158 ] .', 'According WHO , recovery time appear around two week mild infection three six week severe disease [ 159 ] .Laboratory find — Common laboratory find among hospitalize patient COVID-19 include lymphopenia , elevate aminotransaminase level , elevate lactate dehydrogenase level , elevate inflammatory marker ( eg , ferritin , C-reactive protein , erythrocyte sedimentation rate ) [ 57,83,129 ] .', 'Lymphopenia especially common , even though total white blood cell count vary [ 57,87,88,160 ] .', 'As example , series 393 adult patient hospitalize COVID-19 New York City , 90 percent lymphocyte count < 1500/microL ; leukocytosis ( > 10,000/microL ) leukopenia ( < 4000/microL ) report approximately 15 percent [ 129 ] .', 'Abnormalities coagulation test also observe ; discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Coagulation abnormality ' ."", ') On admission , many patient pneumonia normal serum procalcitonin level ; however , require ICU care , likely elevate [ 57,87,88 ] .Several laboratory feature , include high D-dimer level severe lymphopenia , associate critical illness mortality [ 88 ] .', 'These discuss elsewhere .', ""( See 'Risk factor severe illness ' ."", ') Imaging find — Chest radiograph may normal early mild disease .', 'In retrospective study 64 patient Hong Kong document COVID-19 , 20 percent abnormality chest radiograph point illness [ 161 ] .', 'Common abnormal radiograph find consolidation grind glass opacity , bilateral , peripheral , lower lung zone distribution ; lung involvement increase course illness , peak severity 10 12 day symptom onset .', 'Although chest CT may sensitive chest radiograph chest CT find may characteristic COVID-19 , find completely rule rule possibility COVID-19 .', 'In United States , American College Radiology ( ACR ) recommend use chest CT screen diagnosis COVID-19 recommend reserve hospitalize patient need management [ 162 ] .', 'If CT perform , Radiological Society North America categorize feature typical , indeterminate , atypical COVID-19 , suggest correspond language interpretation report ( table 4 ) [ 163 ] .', 'Chest CT patient COVID-19 commonly demonstrate ground-glass opacification without consolidative abnormality , consistent viral pneumonia [ 128,164 ] .', 'Case series suggest chest CT abnormality likely bilateral , peripheral distribution , involve lower lobe .', 'Less common find include pleural thicken , pleural effusion , lymphadenopathy .', ""In study 1014 patient Wuhan undergo RT-PCR test chest CT evaluation COVID-19 , `` positive '' chest CT COVID-19 ( determine consensus two radiologist ) sensitivity 97 percent , use PCR test reference ; however , specificity 25 percent [ 165 ] ."", 'The low specificity may relate etiology cause similar CT find .', 'In another study compare chest CTs 219 patient COVID-19 China 205 patient cause viral pneumonia United States , COVID-19 case likely peripheral distribution ( 80 versus 57 percent ) , ground-glass opacity ( 91 versus 68 percent ) , fine reticular opacity ( 56 versus 22 percent ) , vascular thicken ( 59 versus 22 percent ) , reverse halo sign ( 11 versus 1 percent ) , le likely central peripheral distribution ( 14 versus 35 percent ) , air bronchogram ( 14 versus 23 percent ) , pleural thicken ( 15 versus 33 percent ) , pleural effusion ( 4 versus 39 percent ) , lymphadenopathy ( 2.7 versus 10 percent ) [ 166 ] .', 'A group radiologist study able distinguish COVID-19 high specificity moderate sensitivity.As chest radiograph , chest CT may normal soon onset symptom , abnormality likely develop course illness [ 127,167 ] .', 'However , chest CT abnormality also identify patient prior development symptom even prior detection viral RNA upper respiratory specimen [ 128,168 ] .Among patient clinically improve , resolution radiographic abnormality may lag behind improvement fever hypoxia [ 169 ] .DIAGNOSISClinical suspicion criterion test — The possibility COVID-19 consider primarily patient new onset fever and/or respiratory tract symptom ( eg , cough , dyspnea ) .', 'It also consider patient severe lower respiratory tract illness without clear cause .', ""Other consistent symptom include myalgia , diarrhea , smell taste aberrancy ( table 3 ) ( see 'Initial presentation ' ) ."", 'Although syndrome occur viral respiratory illness , likelihood COVID-19 increase patient : ●Resides travel within prior 14 day location community transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ; ie , large number case link specific transmission chain ) ; location , residence congregate set association event cluster case report particularly high risk exposure .', ""( See 'Geographic distribution ' 'Risk transmission ' . )"", 'or●Has close contact confirm suspect case COVID-19 prior 14 day , include work health care set .', 'Close contact include within approximately six foot ( two meter ) individual COVID-19 minute wear personal protective equipment ( PPE ) direct contact infectious secretion wear PPE.Patients suspect COVID-19 need emergency care encourage call prior present health care facility evaluation .', 'Many patient evaluate regard need test phone .', 'For patient health care facility , infection control measure implement soon possibility COVID-19 suspect .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' . )"", '( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') If possible , symptomatic patient suspect infection undergo test ; diagnosis definitively make without microbiologic test .', 'However , limit capacity may preclude test patient suspect COVID-19 .', 'Local health department may specific criterion test .', 'In United States , Centers Disease Control Prevention ( CDC ) Infectious Diseases Society America ( IDSA ) suggest priority test ( table 5 ) ; high-priority individual include hospitalize patient ( especially critically ill patient unexplained respiratory illness ) symptomatic individual health care worker first responder , work reside congregate live set , risk factor severe disease [ 170,171 ] .', 'Testing certain asymptomatic individual may also important public health infection control purpose ( eg , congregate set COVID-19 case identify , prior time-sensitive surgical procedure , prior time-sensitive aerosol-generating procedure PPE supply limit , hospitalize patient location prevalence high [ eg , ≥10 percent ] ) .', 'The IDSA also recommend SARS-CoV-2 test asymptomatic immunocompromised patient require hospitalization asymptomatic individual prior receive immunosuppressive therapy [ 172 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' , section 'Pretransplantation screen ' ."", ') Testing criterion suggest World Health Organization ( WHO ) find technical guidance online .', 'These criterion use European Centre Disease Prevention Control.In many case , limit availability test , diagnosis COVID-19 make presumptively base compatible clinical presentation set exposure risk , particularly cause symptom evident .', 'The management suspect case test available discuss elsewhere .', ""( See 'COVID-19 test readily available ' ."", ') Microbiologic diagnosisNAAT ( RT-PCR ) diagnose current infection — The diagnosis COVID-19 make direct detection SARS-CoV-2 RNA nucleic acid amplification test ( NAATs ) , primarily reverse transcription polymerase chain reaction ( RT-PCR ) [ 173 ] .', 'Various RT-PCR assay use around world ; different assay amplify detect different region SARS-CoV-2 genome .', 'Most target two gene , include nucleocapsid ( N ) , envelope ( E ) , spike ( S ) gene , region first open read frame , include RNA-dependent RNA polymerase ( RdRp ) gene [ 174 ] .', 'In United States , Food Drug Administration ( FDA ) grant emergency use authorization many different RT-PCR assay [ 50 ] ; test perform CDC , local public health department , hospital laboratory , certain commercial reference laboratory .', 'These test different performance characteristic time result ( range 15 minute several hour ) require different specimen type .', 'The turnaround time clinician receive result also depend often laboratory perform test .', 'Point-of-care NAATs also develop , although le sensitive laboratory-based test [ 175 ] .', 'Specimen collection — Upper respiratory sample primary specimen SARS-CoV-2 NAAT .', 'In United States , CDC recommend collection one follow specimen [ 176 ] : ●Nasopharyngeal swab specimen , collect health care professional ●Oropharyngeal swab specimen , collect health care professional ●Nasal swab specimen anterior naris , collect health care professional patient on-site home ( United States , FDA grant emergency use authorization home-collection test kit mail laboratory test [ 177,178 ] ) ●Nasal nasopharyngeal wash/aspirate , collect health care professionalHowever , uncertainty regard optimal upper respiratory tract specimen .', 'The IDSA suggest nasopharyngeal , mid-turbinate , nasal specimen rather oropharyngeal specimen ( saliva ) limit data suggest lower sensitivity oropharyngeal specimen lack data accuracy saliva specimen [ 172 ] .Lower respiratory tract specimen also option test ; IDSA suggest reserve hospitalize patient initial negative test upper respiratory tract specimen suspicion lower respiratory tract SARS-CoV-2 infection remain [ 172 ] .', 'For lower respiratory tract specimen , expectorate sputum collect patient productive cough , tracheal aspirate bronchoalveolar lavage collect patient intubate .', 'Induction sputum recommend .', 'Additional information test handle clinical specimen find CDC website .', 'Infection control practice specimen collection discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') Data compare accuracy test various site limit suggest test sensitivity may vary type specimen .', 'Lower respiratory tract specimen may higher viral load likely yield positive test upper respiratory tract specimen [ 26,33 ] .', 'In study 205 patient COVID-19 sample various site , highest rate positive viral RNA test report bronchoalveolar lavage ( 95 percent , 14 15 specimen ) sputum ( 72 percent , 72 104 specimen ) , compare oropharyngeal swab ( 32 percent , 126 398 specimen ) [ 26 ] .', 'Data study suggest viral RNA level higher frequently detect nasal compare oral specimen , although eight nasal swab test .', 'Similarly , another study 117 pair nasopharyngeal oropharyngeal specimen 12 patient test simultaneously , 32 pair discordant one test positive negative : nasopharyngeal specimen test positive 66 percent pair compare 34 percent oropharyngeal specimen [ 39 ] .', 'However , study identify higher viral RNA level nasopharyngeal compare oropharyngeal specimen [ 37 ] .', 'Interpretation — A positive NAAT SARS-CoV-2 generally confirm diagnosis COVID-19 .', 'However , false-negative test upper respiratory specimen well document .', 'If initial test negative suspicion COVID-19 remain determine presence infection important management infection control , suggest repeat test .', 'Repeat test perform 24 48 hour initial test .', 'In case , WHO IDSA recommend test lower respiratory tract specimen patient evidence lower respiratory tract illness [ 172,179 ] .', 'Infection control precaution COVID-19 continue repeat evaluation perform .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') In many case , limit availability test concern false-negative result , diagnosis COVID-19 make presumptively base compatible clinical presentation set exposure risk ( residence travel area widespread community transmission know contact ) .', 'In case , particularly hospitalize patient negative SARS-CoV-2 NAAT , characteristic laboratory image find support clinical diagnosis COVID-19 reason maintain infection control precaution .', 'Nevertheless , potential cause symptom also consider patient negative SARS-CoV-2 NAATs .', 'The interpretation inconclusive indeterminate result depend specific NAAT perform ; clinician confer perform laboratory additional testing.The accuracy predictive value SARS-CoV-2 NAAT systematically evaluate , sensitivity test likely depend precise assay , type specimen obtain , quality specimen , duration illness time test .', 'In study 51 patient hospitalize China fever acute respiratory symptom ultimately positive SARS-CoV-2 RT-PCR test ( mainly throat swab ) , 15 patient ( 29 percent ) negative initial test diagnose serial test [ 180 ] .', 'In similar study 70 patient Singapore , initial nasopharyngeal test negative 8 patient ( 11 percent ) [ 181 ] .', 'In study , rare patient repeatedly negative test positive four tests.The likelihood detectable SARS-CoV-2 RNA may also vary duration illness [ 182,183 ] .', 'In analysis seven study ( include two unpublished report ) evaluate RT-PCR performance time since symptom onset exposure , estimate rate false-negative result 100 percent day exposure , 38 percent day 5 ( estimate first day symptom ) , 20 percent day 8 , 66 percent day 21 [ 182 ] .', 'Heterogeneity across study assumption make analysis ( eg , incubation period time exposure ) reduce confidence result .', 'One study include analysis use combination RT-PCR immunoglobulin ( Ig ) M serologic test make diagnosis COVID-19 suggest RT-PCR negative rate < 10 percent day 1 3 illness , > 20 percent day 6 , > 50 percent day 14 ; however , result also interpret caution , since serologic test use validate detection acute infection IgM test frequently falsely positive [ 183 ] .', 'Other study suggest viral RNA level higher early course infection individual detectable viral RNA several week follow onset symptom , discuss elsewhere .', ""( See 'Viral shed period infectivity ' ."", ') There also difference limit detection among major commercial laboratory RT-PCR assay , retesting sample different platform may yield conflict result [ 184 ] .', 'Additionally , point-of-care NAAT assay may sensitive laboratory-based test [ 175 ] .Test performance specimen type ( eg , nasopharyngeal , oropharyngeal , lower respiratory tract ) discuss elsewhere .', ""( See 'Specimen collection ' ."", ') Serology identify prior infection — Serologic test detect antibody SARS-CoV-2 blood , adequately validate help identify patient COVID-19 .', 'Serologic test may also able identify patient current infection ( particularly present late course illness ) , le likely reactive first several day week infection , thus may le utility diagnosis acute set [ 183,185-187 ] .', 'Additionally , individual result interpret caution set low seroprevalence , even serologic test high specificity still low positive predictive value ( ie , positive test may likely reflect false positive true positive ) [ 188 ] .', 'In United States , several serologic test grant emergency use authorization FDA use laboratory certify perform moderate- high-complexity test [ 50 ] .', 'The FDA highlight serologic test use sole test diagnose exclude active SARS-CoV-2 infection .', 'The sensitivity specificity many serologic test uncertain ; catalog test find centerforhealthsecurity.org.Detectable antibody generally take several day week develop .', 'In study 173 patient COVID-19 , median time symptom onset antibody detection ( enzyme-linked immunosorbent assay [ ELISA ] detect antibody receptor-binding domain spike protein ) 12 day IgM 14 day IgG [ 185 ] .', 'In first week since symptom onset , fewer 40 percent detectable antibody ; day 15 , IgM IgG detectable 94 80 percent , respectively .', 'The accuracy time antibody detection vary particular test use .', 'Studies evaluate specificity serologic test broad population lack ; particular , rate cross-reactivity coronaviruses potential concern , IgM test prone false-positive results.Large-scale serologic screen validate test may able provide better sense scope burden disease ( identify people diagnose PCR may asymptomatic subclinical infection ) also identify individual may immunity infection ; serologic correlate protective immunity , however , define .', ""( See 'Viral shed period infectivity ' 'Immunity risk reinfection ' ."", ') Other tests●Tests identify SARS-CoV-2 antigen development .', ""Rapid antigen test easy use perform point care , respiratory pathogen , typically le sensitive nucleic acid amplification test ( see `` Diagnosis seasonal influenza adult '' , section 'Rapid antigen test ' ) ."", 'Several manufacturer sell rapid , point-of-care antigen test , United States , FDA start issue emergency use authorization test [ 189 ] .', 'Clinicians aware possibility false negative antigen test .', 'The WHO previously caution use rapid test base antigen test antibody detection undergo adequate validation concern regard false-positive false-negative result [ 190 ] .●For safety reason , specimen patient suspect document COVID-19 submit clinical laboratory viral culture .', 'Viral culture mainly reserve research purpose .', ""( See 'Viral shed period infectivity ' ."", ') Testing pathogen — If influenza circulate community , reasonable also test influenza test SARS-CoV-2 , could management implication .', 'However , detection another viral ( bacterial ) pathogen necessarily rule SARS-CoV-2 location widespread transmission .', 'Coinfection SARS-CoV-2 respiratory virus , include influenza , describe , report frequency variable [ 92,191-193 ] .MANAGEMENT — Home management appropriate patient mild infection ( eg , fever , cough , and/or myalgia without dyspnea ) asymptomatic infection adequately self-isolate outpatient set .', 'Management patient focus prevention transmission others monitor clinical deterioration , prompt hospitalization .', 'Management patient warrant hospitalization consist ensure appropriate infection control supportive care ( include oxygenation potentially ventilatory support acute respiratory distress syndrome ) .', 'Investigational approach also evaluate , use set clinical trial , whenever available .', ""Management COVID-19 discuss detail elsewhere : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') PREVENTIONInfection control health care set — In location community transmission widespread , preventive strategy individual health care set warrant reduce potential exposure .', 'Additional measure warrant patient suspect confirm COVID-19 .', 'Infection control health care set discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control health care set ' ."", ') Personal preventive measure — If community transmission SARS-CoV-2 present , resident encourage practice social distance stay home much possible maintain six foot ( two meter ) distance others leave home .', 'In particular , individual avoid crowd close contact ill individual .', 'The follow general measure additionally recommend reduce transmission infection : ●Diligent hand wash , particularly touch surface public .', 'Use hand sanitizer contain least 60 percent alcohol reasonable alternative hand visibly dirty .', '●Respiratory hygiene ( eg , cover cough sneeze ) .●Avoiding touch face ( particular eye , nose , mouth ) .', 'The American Academy Ophthalmology suggest people wear contact lens , make people touch eye frequently [ 194 ] .●Cleaning disinfect object surface frequently touch .', 'The CDC issue guidance disinfection home set ; list Environmental Protection Agency-registered product find .', 'These measure follow individual , emphasize older adult individual chronic medical condition , particular .', 'For people without respiratory symptom , WHO recommend wear medical mask community , since decrease importance general measure prevent infection may result unnecessary cost supply problem ; WHO also emphasize medical mask prioritize health care worker [ 195 ] .', 'Recommendations use mask healthy member community vary country [ 196 ] .', 'In United States , CDC update recommendation early April advise individual wear cloth face cover ( eg , homemade mask bandana ) public set social distance difficult achieve , especially area substantial community transmission [ 197 ] .', 'Individuals counsel avoid touch eye , nose , mouth remove cover , practice hand hygiene handle , launder routinely .', 'Clinicians emphasize face cover diminish importance preventive measure , social distance hand hygiene .', 'The rationale face cover primarily contain secretion prevent transmission individual asymptomatic presymptomatic infection .', 'The CDC also reiterate face cover recommendation include medical mask , reserve health care workers.Individuals care patient suspect document COVID-19 home also wear face cover room patient ( patient wear face cover ) .', 'Individuals develop acute respiratory illness ( eg , fever and/or respiratory symptom ) encourage self-isolate home ( away individual pet household ) duration illness wear face cover around people .', 'Some may warrant evaluation COVID-19 .', ""( See 'Clinical suspicion criterion test ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Isolation home ' . )"", 'The efficacy mask contain SARS-CoV-2 uncertain .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') The CDC include recommend measure prevent spread community website .', 'Managing asymptomatic individual potential exposure — In area SARS-CoV-2 prevalent , resident encourage stay alert symptom practice social distance stay home much possible maintain six foot ( two meter ) distance others leave home .', 'In United States , CDC suggest approach resident [ 198 ] .', 'For return international travel ( include cruise ship travel ) close contact patient suspect confirm COVID-19 ( include 48 hour prior patient develop symptom ) , CDC also suggest [ 198,199 ] : ●Self-quarantine home 14 day follow last exposure , maintenance least six foot ( two meter ) others time .', '●Avoiding contact individual high risk severe illness ( unless household member exposure ) .', ""( See 'Risk factor severe illness ' ."", ') ●Twice-daily temperature check monitor fever , cough , dyspnea .', 'If develop clinical manifestation , continue stay home away household member contact medical provider .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' , section 'Management counsel outpatient ' . )"", 'For asymptomatic individual critical infrastructure worker , CDC provide guidance return work 14-day post-exposure period symptom temperature monitor , mask use , social distance , workspace disinfection [ 200 ] .Management health care worker document exposure discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Return work health care worker ' . )"", 'Public health measure — On January 30 , 2020 , WHO declare COVID-19 outbreak public health emergency international concern , March 2020 , begin characterize pandemic order emphasize gravity situation urge country take action detect infection prevent spread .', 'Throughout world , country employ various nonpharmaceutical intervention reduce transmission .', 'In addition personal preventive measure ( eg , hand hygiene , respiratory etiquette face cover , environmental disinfection ) , transmission reduction strategy include : ●Social/physical distance order ●Stay-at-home orders●School , venue , nonessential business closure●Bans public gatherings●Travel restriction exit and/or entry screening●Aggressive case identification isolation ( separate individual infection others ) ●Contact trace quarantine ( separate individual expose others ) These measure associate reduction incidence SARS-CoV-2 infection time , although relative contribution difficult ass , country employ combination intervention .', 'As example , epidemiologic study Wuhan , number intervention ( implementation travel restriction around Wuhan home quarantine compulsory mask-wearing public , follow centralize quarantine case contact , follow proactive symptom screen resident ) associate progressive reduction incidence confirm case Wuhan decrease effective reproduction number ( ie , average number secondary case case population make susceptible nonsusceptible individual ) > 3 prior intervention 0.3 [ 201 ] .', 'In another study China , city combine control measure preemptively implement prior identification COVID-19 case record 33 percent fewer laboratory-confirmed case first week outbreak compare city implement control measure later [ 202 ] .', 'In study United States evaluate incident case border county Illinois , issue stay-at-home order , Iowa , , county Iowa experience rapid increase case follow implementation order Illinois , estimate result 217 excess case one month [ 203 ] .', 'For country incidence decline relaxation transmission reduction measure consider , WHO issue interim guidance implementation , include step-wise approach adjust accord local circumstance prioritize protect vulnerable population ; recommend personal preventive measure maintain public health effort detect case isolation identify contact quarantine strengthen [ 204,205 ] .Specific recommendation global travel available WHO website .', 'In United States , CDC currently recommend individual avoid nonessential international travel nonessential travel domestic location [ 206 ] .', 'Because risk travel change rapidly , traveler check United States government website restriction .', 'Investigational approachesVaccines — Numerous vaccine candidate evaluate prevention COVID-19 [ 207 ] .', 'These include various type vaccine , include nucleic acid-based ( mRNA DNA ) vaccine , viral-vector vaccine , inactivate recombinant protein vaccine [ 208 ] .', 'The different vaccine platform vary potential safety immunogenicity , speed cost manufacture , feature important meet global demand.There also interest Bacille-Calmette-Guerin ( BCG ) immunization prevention COVID-19 , clinical trial underway evaluate use among health care worker [ 209 ] .', 'Studies suggest , although primary purpose prevention tuberculosis , BCG immunization induce nonspecific immune response may protective effect non-mycobacterial , include viral , infection [ 210,211 ] .', 'Any impact BCG immunization COVID-19 unknown .', 'The WHO recommend BCG vaccination use prevention lessen severity COVID-19 , pending data [ 212 ] .', 'Post-exposure prophylaxis — Clinical trial also conduct United States elsewhere evaluate safety efficacy post-exposure drug prophylaxis COVID-19 [ 213,214 ] .', 'No agent know effective prevent infection ; suggest post-exposure prophylaxis attempt outside clinical trial .', 'SPECIAL SITUATIONSPregnant breastfeed woman — The general approach prevention , evaluation , diagnosis , treatment pregnant woman suspect COVID-19 largely similar nonpregnant individual .', 'Issues specific pregnant breastfeed woman discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' . )"", 'Children — Symptomatic infection child appear relatively uncommon ; occur , usually mild , although severe case report [ 115-118 ] .', 'Details COVID-19 child discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' . )"", 'COVID-19 test readily available — In case , test COVID-19 may accessible , particularly individual compatible mild illness warrant hospitalization know COVID-19 exposure high-risk travel history .', 'In United States , limit official guidance situation , approach may depend prevalence COVID-19 area .', 'If clinician sufficient concern possible COVID-19 ( eg , community transmission apparent cause symptom ) , reasonable assume patient COVID-19 advise patient self-isolate home ( hospitalization warrant ) alert clinician worsen symptom .', 'Outpatient management COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' , section 'Management counsel outpatient ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control home set ' . )"", 'SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) pregnancy ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●In late 2019 , novel coronavirus , designate SARS-CoV-2 , identify cause outbreak acute respiratory illness Wuhan , city China ."", 'In February 2020 , World Health Organization ( WHO ) designate disease COVID-19 , stand coronavirus disease 2019 .', ""( See 'Introduction ' ."", ') ●Since first report COVID-19 , infection spread include five million confirm case worldwide , prompt WHO declare public health emergency late January 2020 characterize pandemic March 2020 .', ""( See 'Epidemiology ' ."", ') ●The possibility COVID-19 consider primarily patient fever and/or respiratory tract symptom reside travel area community transmission recent close contact confirm suspect case COVID-19 .', 'Clinicians also aware possibility COVID-19 patient severe respiratory illness etiology identify .', 'Other symptom also associate COVID-19 ( table 3 ) .', 'Limitations test capacity may preclude test patient suspect infection ; suggest priority include hospitalize patient symptomatic individual health care worker first responder , work reside congregate live set , risk factor severe disease ( table 5 ) .', ""( See 'Clinical feature ' 'Diagnosis ' ."", ') ●The microbiologic diagnosis make positive nucleic acid amplification test ( eg , reverse transcription polymerase chain reaction [ RT-PCR ] ) SARS-CoV-2 .', 'An upper respiratory tract specimen prefer initial test specimen .', 'If possible , symptomatic patient suspect infection undergo test .', 'However , limit test capacity concern false-negative test , diagnosis often presumptively make base consistent clinical epidemiologic feature .', 'Serologic test help identify individual prior infection le utility first week infection .', ""( See 'Microbiologic diagnosis ' ."", ') ●Upon suspicion COVID-19 , infection control measure implement .', 'Infection control home health care set discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control health care set ' . )"", '●Home management appropriate patient mild illness adequately self-isolate outpatient set .', 'A minority patient need critical care .', 'Home , hospital , intensive care unit management patient COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') ●To reduce risk transmission community , individual advise wash hand diligently , practice respiratory hygiene ( eg , cover cough ) , avoid crowd close contact ill individual , possible .', 'Social distance recommend location community transmission .', 'In location , face cover advise public set .', ""( See 'Personal preventive measure ' ."", ') ●Interim guidance issue WHO CDC .', 'These update ongoing basis .', ""( See 'Society guideline link ' . )""]","['', 'coronaviruses', 'important', 'human', 'animal', 'pathogen', '', 'end', '2019', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'rapidly', 'spread', '', 'result', 'epidemic', 'throughout', 'china', '', 'follow', 'increase', 'number', 'case', 'country', 'throughout', 'world', '', 'february', '2020', '', 'world', 'health', 'organization', 'designate', 'disease', 'covid-19', '', 'stand', 'coronavirus', 'disease', '2019', '', '1', '', '', 'virus', 'cause', 'covid-19', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'previously', '', 'refer', '2019-ncovunderstanding', 'covid-19', 'evolve', '', 'interim', 'guidance', 'issue', 'world', 'health', 'organization', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', '23', '', '', 'links', 'relate', 'society', 'guideline', 'find', 'elsewhere', '', '', 'society', 'guideline', 'link', '', '', '', 'topic', 'discus', 'virology', '', 'epidemiology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', 'covid-19', '', 'management', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'issues', 'relate', 'covid-19', 'specific', 'population', 'discuss', 'elsewhere', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', 'community-acquired', 'coronaviruses', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'coronavirus', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'coronavirus', 'discuss', 'separately', '', '', '', 'coronaviruses', '', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'virology', '', 'pathogenesis', '', 'epidemiology', '', '', '', 'virology', '', 'full-genome', 'sequence', 'phylogenic', 'analysis', 'indicate', 'coronavirus', 'cause', 'covid-19', 'betacoronavirus', 'subgenus', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'virus', '', 'well', 'several', 'bat', 'coronaviruses', '', '', 'different', 'clade', '', 'structure', 'receptor-binding', 'gene', 'region', 'similar', 'sars', 'coronavirus', '', 'virus', 'show', 'receptor', '', 'angiotensin-converting', 'enzyme', '2', '', 'ace2', '', '', 'cell', 'entry', '', '4', '', '', 'coronavirus', 'study', 'group', 'international', 'committee', 'taxonomy', 'viruses', 'propose', 'virus', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', '5', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'virus', '', 'another', 'betacoronavirus', '', 'appear', 'distantly', 'relate', '', '67', '', '', 'closest', 'rna', 'sequence', 'similarity', 'two', 'bat', 'coronaviruses', '', 'appear', 'likely', 'bat', 'primary', 'source', '', 'whether', 'covid-19', 'virus', 'transmit', 'directly', 'bat', 'mechanism', '', 'eg', '', 'intermediate', 'host', '', 'unknown', '', '8', '', '', '', '', 'coronaviruses', '', '', 'section', 'viral', 'serotypes', '', '', '', 'phylogenetic', 'analysis', '103', 'strain', 'sars-cov-2', 'china', '', 'two', 'different', 'type', 'sars-cov-2', 'identify', '', 'designate', 'type', 'l', '', 'account', '70', 'percent', 'strain', '', 'type', '', 'account', '30', 'percent', '', '', '9', '', '', 'l', 'type', 'predominate', 'early', 'day', 'epidemic', 'china', '', 'account', 'lower', 'proportion', 'strain', 'outside', 'wuhan', 'wuhan', '', 'clinical', 'implication', 'find', 'uncertain', '', 'epidemiologygeographic', 'distribution', '', 'globally', '', 'five', 'million', 'confirm', 'case', 'covid-19', 'report', '', 'updated', 'case', 'count', 'english', 'find', 'world', 'health', 'organization', 'european', 'centre', 'disease', 'prevention', 'control', 'website', '', 'interactive', 'map', 'highlight', 'confirm', 'case', 'throughout', 'world', 'find', '', 'since', 'first', 'report', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'end', '2019', '', 'case', 'report', 'continent', '', 'except', 'antarcticain', 'united', 'states', '', 'covid-19', 'report', '50', 'state', '', 'washington', 'dc', '', 'least', 'four', 'territory', '', '10', '', '', 'cumulative', 'incidence', 'vary', 'state', 'likely', 'depend', 'number', 'factor', '', 'include', 'population', 'density', 'demographic', '', 'extent', 'test', 'report', '', 'time', 'mitigation', 'strategy', '', 'united', 'states', '', 'outbreak', 'long-term', 'care', 'facility', 'homeless', 'shelter', 'emphasize', 'risk', 'exposure', 'infection', 'congregate', 'set', '', '11-13', '', '', '', 'risk', 'transmission', '', '', '', 'transmission', '', 'understanding', 'transmission', 'risk', 'incomplete', '', 'epidemiologic', 'investigation', 'wuhan', 'begin', 'outbreak', 'identify', 'initial', 'association', 'seafood', 'market', 'sell', 'live', 'animal', '', 'patient', 'work', 'visit', 'subsequently', 'close', 'disinfection', '', '14', '', '', 'however', '', 'outbreak', 'progress', '', 'person-to-person', 'spread', 'become', 'main', 'mode', 'transmission', '', 'person-to-personroute', 'person-to-person', 'transmission', '', 'direct', 'person-to-person', 'transmission', 'primary', 'mean', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'occur', 'close-range', 'contact', '', 'mainly', 'via', 'respiratory', 'droplet', '', 'virus', 'release', 'respiratory', 'secretion', 'person', 'infection', 'cough', '', 'sneeze', '', 'talk', 'infect', 'another', 'person', 'direct', 'contact', 'mucous', 'membrane', '', 'infection', 'occur', 'person', 'touch', 'infect', 'surface', 'touch', 'eye', '', 'nose', '', 'mouth', '', 'droplets', 'typically', 'travel', 'six', 'foot', '', 'two', 'meter', '', '', 'whether', 'sars-cov-2', 'transmit', 'airborne', 'route', '', 'particle', 'smaller', 'droplet', 'remain', 'air', 'time', 'distance', '', 'natural', 'condition', 'controversial', 'issue', '', 'one', 'letter', 'editor', 'describe', 'study', 'sars-cov-2', 'grow', 'tissue', 'culture', 'remain', 'viable', 'experimentally', 'generate', 'aerosol', 'least', 'three', 'hour', '', '15', '', '', 'study', 'identify', 'viral', 'rna', 'ventilation', 'system', 'air', 'sample', 'hospital', 'room', 'patient', 'covid-19', '', 'culture', 'viable', 'virus', 'perform', 'study', '', '16-18', '', '', 'study', 'specialize', 'image', 'visualize', 'respiratory', 'exhalation', 'suggest', 'respiratory', 'droplet', 'aerosolize', 'carry', 'gas', 'cloud', 'horizontal', 'trajectory', 'beyond', 'six', 'foot', '', 'two', 'meter', '', 'speak', '', 'cough', '', 'sneeze', '', '19-21', '', '', 'however', '', 'direct', 'relevance', 'find', 'epidemiology', 'covid-19', 'clinical', 'implication', 'unclear', '', 'long-range', 'airborne', 'transmission', 'sars-cov-2', 'clearly', 'document', '', '22', '', '', 'report', 'health', 'care', 'worker', 'expose', 'patient', 'undiagnosed', 'infection', 'contact', 'droplet', 'precaution', '', 'secondary', 'infection', 'identify', 'despite', 'absence', 'airborne', 'precaution', '', '2324', '', '', 'reflecting', 'current', 'uncertainty', 'regard', 'transmission', 'mechanism', '', 'recommendation', 'airborne', 'precaution', 'health', 'care', 'set', 'vary', 'location', '', 'airborne', 'precaution', 'universally', 'recommend', 'aerosol-generating', 'procedure', 'perform', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'sars-cov-2', 'detect', 'non-respiratory', 'specimen', '', 'include', 'stool', '', 'blood', '', 'ocular', 'secretion', '', 'semen', '', 'role', 'site', 'transmission', 'uncertain', '', '25-30', '', '', 'particular', '', 'several', 'report', 'describe', 'detection', 'sars-cov-2', 'rna', 'stool', 'specimen', '', 'viral', 'rna', 'longer', 'detect', 'upper', 'respiratory', 'specimen', '', '2829', '', '', 'live', 'virus', 'culture', 'stool', 'rare', 'case', '', '2631', '', '', 'although', 'difficult', 'confirm', '', 'fecal-oral', 'transmission', 'clinically', 'describe', '', 'accord', 'joint', 'who-china', 'report', '', 'appear', 'significant', 'factor', 'spread', 'infection', '', '32', '', '', 'detection', 'sars-cov-2', 'rna', 'blood', 'report', 'study', 'test', '', '25262933', '', '', 'however', '', 'likelihood', 'bloodborne', 'transmission', '', 'eg', '', 'blood', 'product', 'needlesticks', '', 'appear', 'low', '', 'respiratory', 'virus', 'generally', 'transmit', 'bloodborne', 'route', '', 'transfusion-transmitted', 'infection', 'report', 'sars-cov-2', 'relate', 'mers-cov', 'sars-cov', '', '34', '', '', '', '', 'blood', 'donor', 'screen', '', 'laboratory', 'test', '', '', 'section', 'emerging', 'infectious', 'disease', 'agent', '', '', '', 'viral', 'shed', 'period', 'infectivity', '', 'precise', 'interval', 'individual', 'covid-19', 'infectious', 'uncertain', '', 'appear', 'sars-cov-2', 'transmit', 'prior', 'development', 'symptom', 'throughout', 'course', 'illness', '', 'particularly', 'early', 'course', '', 'however', '', 'data', 'inform', 'issue', 'study', 'evaluate', 'viral', 'rna', 'detection', 'respiratory', 'specimen', '', 'detection', 'viral', 'rna', 'necessarily', 'indicate', 'presence', 'infectious', 'virus', '', 'thus', 'prolong', 'viral', 'rna', 'detection', 'follow', 'resolution', 'illness', 'necessarily', 'indicate', 'infectiousness', '', 'largely', 'indirect', 'data', 'suggest', 'infect', 'individual', 'likely', 'infectious', 'earlier', 'stage', 'infection', '', 'viral', 'rna', 'level', 'upper', 'respiratory', 'specimen', 'appear', 'higher', 'soon', 'symptom', 'onset', 'compare', 'later', 'illness', '', '35-39', '', '', 'additionally', '', 'study', 'nine', 'patient', 'mild', 'covid-19', '', 'infectious', 'virus', 'isolate', 'nasooropharyngeal', 'sputum', 'specimen', 'first', 'eight', 'day', 'illness', '', 'interval', '', 'despite', 'continue', 'high', 'viral', 'rna', 'level', 'site', '', '37', '', '', 'one', 'model', 'study', '', 'base', 'time', 'infection', 'among', '77', 'transmission', 'pair', 'china', '', 'mean', 'serial', 'interval', '58', 'day', 'onset', 'symptom', 'pair', '', 'assumption', 'incubation', 'period', '', 'suggest', 'infectiousness', 'start', '23', 'day', 'prior', 'symptom', 'onset', '', 'peak', '07', 'day', 'symptom', 'onset', '', 'decline', 'within', 'seven', 'day', '', 'however', '', 'patient', 'isolate', 'follow', 'symptom', 'onset', '', 'reduce', 'risk', 'transmission', 'later', 'illness', 'regardless', 'infectiousness', '', '38', '', '', 'another', 'study', 'evaluate', '2500', 'close', 'contact', '100', 'patient', 'covid-19', 'taiwan', '', '22', 'secondary', 'case', 'first', 'exposure', 'index', 'case', 'within', 'six', 'day', 'symptom', 'onset', '', 'infection', 'document', '850', 'contact', 'whose', 'exposure', 'interval', '', '40', '', 'transmission', 'sars-cov-2', 'asymptomatic', 'individual', '', 'individual', 'within', 'incubation', 'period', '', 'well', 'document', '', '41-46', '', '', 'biologic', 'basis', 'support', 'study', 'sars-cov-2', 'outbreak', 'long-term', 'care', 'facility', '', 'infectious', 'virus', 'culture', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', '-positive', 'upper', 'respiratory', 'tract', 'specimen', 'presymptomatic', 'asymptomatic', 'patient', 'early', 'six', 'day', 'prior', 'development', 'typical', 'symptom', '', '47', '', '', 'however', '', 'extent', 'asymptomatic', 'presymptomatic', 'transmission', 'occur', 'much', 'contribute', 'pandemic', 'remain', 'unknown', '', 'analysis', '157', 'locally', 'acquire', 'covid-19', 'case', 'singapore', '', 'transmission', 'incubation', 'period', 'estimate', 'account', '64', 'percent', '', 'case', '', 'exposure', 'occur', 'one', 'three', 'day', 'prior', 'symptom', 'development', '', '48', '', '', 'large-scale', 'serologic', 'screen', 'able', 'provide', 'better', 'sense', 'scope', 'asymptomatic', 'infection', 'inform', 'epidemiologic', 'analysis', '', 'several', 'serologic', 'test', 'sars-cov-2', 'grant', 'emergency', 'authorization', 'us', 'food', 'drug', 'administration', '', 'fda', '', '', '4950', '', '', 'long', 'person', 'remain', 'infectious', 'uncertain', '', 'available', 'data', 'suggest', 'prolong', 'viral', 'rna', 'shed', 'symptom', 'resolution', 'clearly', 'associate', 'prolong', 'infectiousness', '', 'duration', 'viral', 'rna', 'shed', 'variable', '', 'appear', 'wide', 'range', '', 'depend', 'severity', 'illness', '', '293751-53', '', '', 'one', 'study', '21', 'patient', 'mild', 'illness', '', 'hypoxia', '', '', '90', 'percent', 'repeat', 'negative', 'viral', 'rna', 'test', 'nasopharyngeal', 'swab', '10', 'day', 'onset', 'symptom', '', 'test', 'positive', 'longer', 'patient', 'severe', 'illness', '', '51', '', '', 'contrast', '', 'another', 'study', '56', 'patient', 'mild', 'moderate', 'illness', '', 'none', 'require', 'intensive', 'care', '', '', 'median', 'duration', 'viral', 'rna', 'shed', 'naso-', 'oropharyngeal', 'specimen', '24', 'day', '', 'longest', '42', 'day', '', '54', '', '', 'however', '', 'mention', '', 'detectable', 'viral', 'rna', 'always', 'correlate', 'isolation', 'infectious', 'virus', '', 'threshold', 'viral', 'rna', 'level', 'infectivity', 'unlikely', '', 'study', 'nine', 'patient', 'mild', 'covid-19', 'describe', '', 'infectious', 'virus', 'detect', 'respiratory', 'specimen', 'viral', 'rna', 'level', '', '106', 'copiesml', '', '37', '', '', 'according', 'information', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', '', 'patient', 'continue', 'detectable', 'viral', 'rna', 'upper', 'respiratory', 'sample', 'follow', 'clinical', 'recovery', '', 'three', 'day', 'recovery', '', 'rna', 'concentration', 'generally', 'level', 'replication-competent', 'virus', 'reliably', 'isolate', '', 'additionally', '', 'isolation', 'infectious', 'virus', 'upper', 'respiratory', 'specimen', 'nine', 'day', 'illness', 'onset', 'yet', 'document', '', '55', '', '', 'infectious', 'virus', 'isolate', 'respiratory', 'specimen', 'patient', 'repeat', 'positive', 'rna', 'test', 'follow', 'clinical', 'improvement', 'initial', 'viral', 'clearance', '', '56', '', '', '', 'immunity', 'risk', 'reinfection', '', '', '', 'one', 'study', 'report', 'patient', 'critical', 'covid-19', 'replicative', 'virus', 'isolate', 'stool', '28', 'day', 'follow', 'symptom', 'onset', '', 'data', 'understand', 'frequency', 'clinical', 'significance', 'find', '', '31', '', '', 'relevance', 'viral', 'rna', 'detection', 'duration', 'infection', 'control', 'precaution', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', '', 'risk', 'transmission', '', 'risk', 'transmission', 'individual', 'sars-cov-2', 'infection', 'vary', 'type', 'duration', 'exposure', '', 'preventive', 'measure', '', 'likely', 'individual', 'factor', '', 'eg', '', 'amount', 'virus', 'respiratory', 'secretion', '', '', 'secondary', 'infection', 'describe', 'among', 'household', 'contact', '', 'congregate', 'health', 'care', 'set', 'personal', 'protective', 'equipment', '', 'include', 'hospital', '', '57', '', 'long-term', 'care', 'facility', '', '11', '', '', '', 'close', 'set', '', 'eg', '', 'cruise', 'ship', '', '58', '', '', '', 'however', '', 'report', 'cluster', 'case', 'social', 'work', 'gather', 'highlight', 'risk', 'transmission', 'close', '', 'non-household', 'contactcontact', 'trace', 'early', 'stage', 'epidemic', 'various', 'location', 'suggest', 'secondary', 'infection', 'among', 'household', 'contact', '', 'secondary', 'attack', 'rate', '15', 'percent', '', '3259-62', '', '', 'study', 'suggest', 'higher', 'household', 'infection', 'rate', '', '466364', '', '', 'according', 'joint', 'who-china', 'report', '', 'rate', 'secondary', 'covid-19', 'various', 'location', 'range', '1', '5', 'percent', 'among', 'ten', 'thousand', 'close', 'contact', 'confirm', 'patient', 'china', '', 'occur', 'within', 'household', '', 'in-household', 'secondary', 'attack', 'rate', '3', '10', 'percent', '', '32', '', '', 'united', 'states', '', 'symptomatic', 'secondary', 'attack', 'rate', '045', 'percent', 'among', '445', 'close', 'contact', '10', 'confirm', 'patient', '', 'among', 'household', 'member', '', 'rate', '105', 'percent', '', '59', '', '', 'similar', 'study', 'korea', '', 'rate', 'comparable', '', 'secondary', 'infection', '055', 'percent', 'contact', '76', 'percent', 'family', 'member', '', '60', '', 'clusters', 'case', 'report', 'follow', 'family', '', 'work', '', 'social', 'gather', 'close', '', 'personal', 'contact', 'occur', '', '6566', '', '', 'example', '', 'epidemiologic', 'analysis', 'cluster', 'case', 'state', 'illinois', 'show', 'probable', 'transmission', 'two', 'family', 'gather', 'communal', 'food', 'consume', '', 'embrace', 'share', '', 'extend', 'face-to-face', 'conversation', 'exchange', 'symptomatic', 'individual', 'later', 'confirm', 'covid-19', '', '65', '', '', 'report', 'outbreak', 'among', 'choir', 'group', '', '33', 'confirm', '20', 'probable', 'case', 'identify', 'among', '61', 'member', 'attend', 'practice', 'session', '', 'raise', 'possibility', 'high', 'transmission', 'risk', 'sing', 'close', 'proximity', '', '67', '', 'risk', 'transmission', 'indirect', 'contact', '', 'eg', '', 'pass', 'someone', 'infection', 'street', '', 'handle', 'item', 'previously', 'handle', 'someone', 'infection', '', 'well', 'establish', 'likely', 'low', '', 'environmental', 'contamination', '', 'virus', 'present', 'contaminate', 'surface', 'another', 'source', 'infection', 'susceptible', 'individual', 'touch', 'surface', 'transfer', 'infectious', 'virus', 'mucous', 'membrane', 'mouth', '', 'eye', '', 'nose', '', 'frequency', 'relative', 'importance', 'type', 'transmission', 'remain', 'unclear', '', 'likely', 'potential', 'source', 'infection', 'set', 'heavy', 'viral', 'contamination', '', 'eg', '', 'infect', 'individual', 'household', 'health', 'care', 'set', '', '', 'extensive', 'sars-cov-2', 'contamination', 'environmental', 'surface', 'hospital', 'room', 'patient', 'covid-19', 'describe', '', '1668', '', '', 'study', 'singapore', '', 'viral', 'rna', 'detect', 'nearly', 'surface', 'test', '', 'handle', '', 'light', 'switch', '', 'bed', 'handrail', '', 'interior', 'door', 'window', '', 'toilet', 'bowl', '', 'sink', 'basin', '', 'airborne', 'infection', 'isolation', 'room', 'patient', 'symptomatic', 'mild', 'covid-19', 'prior', 'routine', 'clean', '', '16', '', '', 'viral', 'rna', 'detect', 'similar', 'surface', 'room', 'two', 'symptomatic', 'patient', 'follow', 'routine', 'clean', '', 'sodium', 'dichloroisocyanurate', '', '', 'note', '', 'viral', 'rna', 'detection', 'necessarily', 'indicate', 'presence', 'infectious', 'virus', '', '37', '', '', 'unknown', 'long', 'sars-cov-2', 'persist', 'surface', '', '156970', '', '', 'coronaviruses', 'test', 'survive', 'inanimate', 'surface', 'six', 'nine', 'day', 'without', 'disinfection', '', 'study', 'evaluate', 'survival', 'virus', 'dry', 'plastic', 'surface', 'room', 'temperature', '', 'specimen', 'contain', 'sars-cov', '', 'virus', 'closely', 'relate', 'sars-cov-2', '', 'detectable', 'infectivity', 'six', 'nine', 'day', '', '70', '', '', 'however', '', 'systematic', 'review', 'similar', 'study', '', 'various', 'disinfectant', '', 'include', 'ethanol', 'concentration', '62', '71', '', '', 'inactivate', 'number', 'coronaviruses', 'relate', 'sars-cov-2', 'within', 'one', 'minute', '', '69', '', '', 'based', 'data', 'concern', 'coronaviruses', '', 'duration', 'viral', 'persistence', 'surface', 'likely', 'depend', 'ambient', 'temperature', '', 'relative', 'humidity', '', 'size', 'initial', 'inoculum', '', '71', '', 'data', 'highlight', 'importance', 'environmental', 'disinfection', 'home', 'health', 'care', 'set', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'environmental', 'disinfection', '', '', '', 'uncertain', 'risk', 'animal', 'contact', '', 'sars-cov-2', 'infection', 'originally', 'transmit', 'human', 'animal', 'host', '', 'ongoing', 'risk', 'transmission', 'animal', 'contact', 'uncertain', '', 'evidence', 'suggest', 'animal', '', 'include', 'domesticate', 'animal', '', 'major', 'source', 'infection', 'human', '', 'sars-cov-2', 'infection', 'describe', 'animal', 'natural', 'experimental', 'set', '', 'rare', 'report', 'animal', 'sars-cov-2', 'infection', '', 'include', 'asymptomatic', 'infection', 'dog', 'symptomatic', 'infection', 'cat', '', 'follow', 'close', 'contact', 'human', 'covid-19', '', '7273', '', '', 'moreover', '', 'asymptomatic', '', 'experimentally', 'infect', 'domestic', 'cat', 'transmit', 'sars-cov-2', 'cat', 'cage', '', '74', '', '', 'risk', 'infection', 'vary', 'specie', '', 'one', 'study', 'evaluate', 'infection', 'animal', 'intranasal', 'viral', 'inoculation', '', 'sars-cov-2', 'replicate', 'efficiently', 'ferret', 'cat', '', 'viral', 'replication', 'detect', 'dog', '', 'appear', 'le', 'susceptible', 'overall', 'experimental', 'infection', '', '75', '', '', 'pigs', 'poultry', 'susceptible', 'infection', '', 'given', 'uncertainty', 'regard', 'transmission', 'risk', 'apparent', 'susceptibility', 'animal', 'sars-cov-2', 'infection', '', 'united', 'states', 'cdc', 'recommend', 'pet', 'keep', 'away', 'animal', 'people', 'outside', 'household', 'people', 'confirm', 'suspect', 'covid-19', 'avoid', 'close', 'contact', 'household', 'pet', '', 'human', 'household', 'member', '', 'duration', 'self-isolation', 'period', '', 'report', 'domesticate', 'animal', 'transmit', 'sars-cov-2', 'infection', 'human', '', 'immunity', 'risk', 'reinfection', '', 'antibodies', 'virus', 'induce', 'become', 'infect', '', 'preliminary', 'evidence', 'suggest', 'antibody', 'protective', '', 'remain', 'definitively', 'establish', '', 'moreover', '', 'unknown', 'whether', 'infect', 'patient', 'mount', 'protective', 'immune', 'response', 'long', 'protective', 'effect', 'lastdata', 'protective', 'immunity', 'follow', 'covid-19', 'emerge', '', '363776', '', '', 'case', 'series', 'evaluate', 'convalescent', 'plasma', 'treatment', 'covid-19', 'identify', 'neutralize', 'activity', 'plasma', 'recover', 'patient', 'appear', 'transfer', 'recipient', 'follow', 'plasma', 'infusion', '', '76', '', '', 'similarly', '', 'another', 'study', '23', 'patient', 'recover', 'covid-19', '', 'antibody', 'receptor-binding', 'domain', 'spike', 'protein', 'nucleocapsid', 'protein', 'detect', 'enzyme-linked', 'immunosorbent', 'assay', '', 'elisa', '', 'patient', '14', 'day', 'follow', 'onset', 'symptom', '', 'elisa', 'antibody', 'titer', 'correlate', 'neutralize', 'activity', '', '36', '', '', 'animal', 'study', 'suggest', 'immune', 'response', 'infection', 'offer', 'protection', 'reinfection', '', 'least', 'short', 'term', '', 'one', 'study', 'nine', 'rhesus', 'macaque', 'experimentally', 'infect', 'sars-cov-2', '', 'animal', 'develop', 'neutralize', 'antibody', '', 'upon', 'rechallenge', 'viral', 'dose', '35', 'day', 'later', '', 'anamnestic', 'immune', 'response', '', 'nasal', 'swab', '', 'lower', 'viral', 'rna', 'level', 'rapid', 'viral', 'rna', 'decline', 'compare', 'initial', 'challenge', 'challenge', 'nave', 'control', 'animal', '', '77', '', '', 'studies', 'evaluate', 'sars-cov-2', 'vaccine', 'candidate', 'macaque', 'suggest', 'immune', 'response', 'vaccination', 'result', 'lower', 'level', 'viral', 'rna', 'respiratory', 'tract', 'specimen', 'follow', 'viral', 'challenge', 'compare', 'unvaccinated', 'control', '', '7879', '', '', 'study', 'report', 'positive', 'rt-pcr', 'test', 'sars-cov-2', 'patient', 'laboratory-confirmed', 'covid-19', 'follow', 'clinical', 'improvement', 'negative', 'result', 'two', 'consecutive', 'test', '', '8081', '', '', 'however', '', 'positive', 'test', 'occur', 'shortly', 'negative', 'test', '', 'associate', 'worsen', 'symptom', '', 'represent', 'infectious', 'virus', '', 'likely', 'reflect', 'reinfection', '', 'specifically', '', 'report', 'korea', 'centers', 'disease', 'control', 'prevention', 'patient', 'covid-19', 'repeat', 'positive', 'rna', 'test', 'previously', 'clear', 'isolation', '', 'infectious', 'virus', 'isolate', 'cell', 'culture', '108', 'patient', 'test', '', '56', '', '', 'among', '790', 'contact', '', 'newly', 'confirm', 'case', 'trace', 'exposure', 'period', 'repeat', 'positive', 'testas', '', 'fda', 'grant', 'emergency', 'authorization', 'test', 'identify', 'antibody', 'sars-cov-2', 'serum', 'plasma', '', '50', '', '', 'evidence', 'confirm', 'presence', 'antibody', 'reflect', 'protective', 'immune', 'response', '', 'serologic', 'screen', 'important', 'tool', 'understand', 'population', 'immunity', 'distinguish', 'individual', 'lower', 'risk', 'reinfectionclinical', 'featuresincubation', 'period', '', 'incubation', 'period', 'covid-19', 'within', '14', 'day', 'follow', 'exposure', '', 'case', 'occur', 'approximately', 'four', 'five', 'day', 'exposure', '', '82-84', '', 'study', '1099', 'patient', 'confirm', 'symptomatic', 'covid-19', '', 'median', 'incubation', 'period', 'four', 'day', '', 'interquartile', 'range', 'two', 'seven', 'day', '', '', '83', '', '', 'using', 'data', '181', 'publicly', 'report', '', 'confirm', 'case', 'china', 'identifiable', 'exposure', '', 'one', 'model', 'study', 'estimate', 'symptom', 'develop', '25', 'percent', 'infect', 'individual', 'within', '22', 'day', '975', 'percent', 'infect', 'individual', 'within', '115', 'day', '', '85', '', '', 'median', 'incubation', 'period', 'study', '51', 'daysspectrum', 'illness', 'severity', 'case', 'fatality', 'rate', '', 'spectrum', 'symptomatic', 'infection', 'range', 'mild', 'critical', '', 'infection', 'severe', '', '578486-90', '', '', 'specifically', '', 'report', 'chinese', 'center', 'disease', 'control', 'prevention', 'include', 'approximately', '44500', 'confirm', 'infection', 'estimation', 'disease', 'severity', '', '91', '', '', 'mild', '', 'mild', 'pneumonia', '', 'report', '81', 'percentsevere', 'disease', '', 'eg', '', 'dyspnea', '', 'hypoxia', '', '', '50', 'percent', 'lung', 'involvement', 'image', 'within', '24', '48', 'hour', '', 'report', '14', 'percentcritical', 'disease', '', 'eg', '', 'respiratory', 'failure', '', 'shock', '', 'multiorgan', 'dysfunction', '', 'report', '5', 'percentthe', 'overall', 'case', 'fatality', 'rate', '23', 'percent', '', 'death', 'report', 'among', 'noncritical', 'case', '', 'among', 'hospitalize', 'patient', '', 'proportion', 'critical', 'fatal', 'disease', 'higher', '', '92-94', '', '', 'study', 'include', '2634', 'patient', 'hospitalize', 'covid-19', 'new', 'york', 'city', 'area', '', '14', 'percent', 'treat', 'intensive', 'care', 'unit', '12', 'percent', 'receive', 'invasive', 'mechanical', 'ventilation', '', 'mortality', 'among', 'receive', 'mechanical', 'ventilation', '88', 'percent', '', '92', '', '', 'however', '', 'analysis', 'limit', 'patient', 'either', 'discharge', 'die', 'admission', '', 'patient', 'represent', 'fewer', 'half', 'total', 'population', 'admit', 'covid-19', '', 'thus', '', 'proportion', 'critically', 'ill', 'patient', 'associate', 'mortality', 'rate', 'accurately', 'reflect', 'entire', 'hospitalize', 'population', '', 'proportion', 'severe', 'fatal', 'infection', 'vary', 'location', '', 'according', 'joint', 'world', 'health', 'organization', '', '', '-china', 'fact-finding', 'mission', '', 'case', 'fatality', 'rate', 'range', '58', 'percent', 'wuhan', '07', 'percent', 'rest', 'china', '', '32', '', '', 'model', 'study', 'suggest', 'adjust', 'case', 'fatality', 'rate', 'mainland', 'china', '14', 'percent', '', '95', '', '', 'fatal', 'case', 'occur', 'patient', 'advance', 'age', 'underlie', 'medical', 'comorbidities', '', '5291', '', '', 'italy', '', '12', 'percent', 'detect', 'covid-19', 'case', '16', 'percent', 'hospitalize', 'patient', 'admit', 'intensive', 'care', 'unit', '', 'estimate', 'case', 'fatality', 'rate', '72', 'percent', 'mid-march', '', '9697', '', '', 'contrast', '', 'estimate', 'case', 'fatality', 'rate', 'mid-march', 'south', 'korea', '09', 'percent', '', '98', '', '', 'relate', 'distinct', 'demographic', 'infection', '', 'italy', '', 'median', 'age', 'patient', 'infection', '64', 'year', '', 'whereas', 'korea', 'median', 'age', '40', '', '', 'impact', 'age', '', '', '', 'risk', 'factor', 'severe', 'illness', '', 'severe', 'illness', 'occur', 'otherwise', 'healthy', 'individual', 'age', '', 'predominantly', 'occur', 'adult', 'advance', 'age', 'underlie', 'medical', 'comorbidities', '', 'impact', 'age', 'discuss', 'elsewhere', '', '', 'impact', 'age', '', '', '', 'comorbidities', 'condition', 'associate', 'severe', 'illness', 'mortality', 'include', '', 'table', '1', '', '', '529199-102', '', '', 'cardiovascular', 'diseasediabetes', 'mellitushypertensionchronic', 'lung', 'diseasecancer', '', 'particular', 'hematologic', 'malignancy', '', 'lung', 'cancer', '', 'metastatic', 'disease', '', '', '103', '', 'chronic', 'kidney', 'diseaseobesity', 'smokingthe', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'include', 'immunocompromising', 'condition', 'liver', 'disease', 'potential', 'risk', 'factor', 'severe', 'illness', '', '104', '', '', 'although', 'specific', 'data', 'regard', 'risk', 'associate', 'condition', 'limit', '', 'subset', '355', 'patient', 'die', 'covid-19', 'italy', '', 'mean', 'number', 'pre-existing', 'comorbidities', '27', '', '3', 'patient', 'underlie', 'condition', '', '97', '', '', 'among', 'patient', 'advance', 'age', 'medical', 'comorbidities', '', 'covid-19', 'frequently', 'severe', '', 'example', '', 'sars-cov-2', 'outbreak', 'across', 'several', 'long-term', 'care', 'facility', 'washington', 'state', '', 'median', 'age', '101', 'facility', 'resident', 'affect', '83', 'year', '', '94', 'percent', 'chronic', 'underlie', 'condition', '', 'hospitalization', 'preliminary', 'case', 'fatality', 'rate', '55', '34', 'percent', '', 'respectively', '', '105', '', 'males', 'comprise', 'disproportionately', 'high', 'number', 'death', 'cohort', 'china', '', 'italy', '', 'united', 'states', '', '9297106', '', 'number', 'state', 'united', 'states', '', 'black', 'latino', 'individual', 'appear', 'comprise', 'disproportionately', 'high', 'number', 'infection', 'death', 'due', 'covid-19', '', 'possibly', 'relate', 'underlie', 'socioeconomic', 'disparity', '', '107-111', '', '', 'particular', 'laboratory', 'feature', 'associate', 'worse', 'outcome', '', 'table', '2', '', '', 'include', '', '52112113', '', '', 'lymphopeniaelevated', 'liver', 'enzymeselevated', 'lactate', 'dehydrogenase', '', 'ldh', '', 'elevated', 'inflammatory', 'marker', '', 'eg', '', 'c-reactive', 'protein', '', 'crp', '', '', 'ferritin', '', 'elevated', 'd-dimer', '', '', '1', 'mcgml', '', 'elevated', 'prothrombin', 'time', '', 'pt', '', 'elevated', 'troponin', 'elevated', 'creatine', 'phosphokinase', '', 'cpk', '', 'acute', 'kidney', 'injuryas', 'example', '', 'one', 'study', '', 'progressive', 'decline', 'lymphocyte', 'count', 'rise', 'd-dimer', 'time', 'observe', 'nonsurvivors', 'compare', 'stable', 'level', 'survivor', '', '57', '', 'patients', 'severe', 'disease', 'report', 'higher', 'viral', 'rna', 'level', 'respiratory', 'specimen', 'milder', 'disease', '', '51', '', '', 'although', 'association', 'observe', 'different', 'study', 'measure', 'viral', 'rna', 'salivary', 'specimen', '', '36', '', '', 'impact', 'age', '', 'individuals', 'age', 'acquire', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', '', 'although', 'adult', 'middle', 'age', 'older', 'commonly', 'affect', '', 'older', 'adult', 'likely', 'severe', 'disease', '', 'several', 'cohort', 'hospitalize', 'patient', 'confirm', 'covid-19', '', 'median', 'age', 'range', '49', '56', 'year', '', '578788', '', '', 'report', 'chinese', 'center', 'disease', 'control', 'prevention', 'include', 'approximately', '44500', 'confirm', 'infection', '', '87', 'percent', 'patient', '30', '79', 'year', 'old', '', '91', '', '', 'similarly', '', 'model', 'study', 'base', 'data', 'mainland', 'china', '', 'hospitalization', 'rate', 'covid-19', 'increase', 'age', '', '1', 'percent', 'rate', '20', '29', 'year', 'old', '', '4', 'percent', 'rate', '50', '59', 'year', 'old', '', '18', 'percent', 'older', '80', 'year', '', '95', '', '', 'older', 'age', 'associate', 'increase', 'mortality', '', '919297', '', '', 'report', 'chinese', 'center', 'disease', 'control', 'prevention', '', 'case', 'fatality', 'rate', '8', '15', 'percent', 'among', 'age', '70', '79', 'year', '80', 'year', 'older', '', 'respectively', '', 'contrast', '23', 'percent', 'case', 'fatality', 'rate', 'among', 'entire', 'cohort', '', '91', '', '', 'similar', 'find', 'report', 'italy', '', 'case', 'fatality', 'rate', '12', '20', 'percent', 'among', 'age', '70', '79', 'year', '80', 'year', 'older', '', 'respectively', '', '97', '', 'united', 'states', '', '2449', 'patient', 'diagnose', 'covid-19', 'february', '12', 'march', '16', '', '2020', 'age', '', 'hospitalization', '', 'intensive', 'care', 'unit', '', 'icu', '', 'information', 'available', '', '114', '', '', '67', 'percent', 'case', 'diagnose', 'age', '45', 'year', '', '', 'similar', 'find', 'china', '', 'mortality', 'highest', 'among', 'older', 'individual', '', '80', 'percent', 'death', 'occur', 'age', '65', 'yearssymptomatic', 'infection', 'child', 'appear', 'relatively', 'uncommon', '', 'occur', '', 'usually', 'mild', '', 'although', 'severe', 'case', 'report', '', '115-118', '', '', 'details', 'covid-19', 'child', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', 'asymptomatic', 'infection', '', 'asymptomatic', 'infection', 'well', 'document', '', '84119-125', '', '', 'precise', 'frequency', 'unknown', '', 'several', 'study', 'perform', 'various', 'set', 'suggest', 'common', '', 'example', '', 'covid-19', 'outbreak', 'cruise', 'ship', 'nearly', 'passenger', 'staff', 'screen', 'sars-cov-2', '', 'approximately', '17', 'percent', 'population', 'board', 'test', 'positive', 'february', '20', '', 'half', '619', 'confirm', 'covid-19', 'case', 'asymptomatic', 'time', 'diagnosis', '', '126', '', '', 'model', 'study', 'estimate', '18', 'percent', 'true', 'asymptomatic', 'case', '', 'ie', '', 'develop', 'symptom', '', '', 'although', 'base', 'number', 'assumption', '', 'include', 'incubation', 'period', '', '121', '', '', 'smaller', 'covid-19', 'outbreak', 'within', 'skilled', 'nurse', 'facility', '', '27', '48', 'resident', '', '56', 'percent', '', 'positive', 'screen', 'test', 'asymptomatic', 'time', 'diagnosis', '', '24', 'ultimately', 'develop', 'symptom', 'next', 'seven', 'day', '', '47', '', '', 'study', 'report', 'higher', 'proportion', 'asymptomatic', 'case', '', '13124', '', '', 'example', '', 'report', 'universal', 'screen', 'program', 'pregnant', 'woman', 'present', 'delivery', 'two', 'new', 'york', 'hospital', 'height', 'pandemic', '', '29', '210', 'asymptomatic', 'woman', 'without', 'fever', '', '14', 'percent', '', 'positive', 'sars-cov-2', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'test', 'nasopharyngeal', 'specimen', '', '124', '', '', 'four', 'additional', 'woman', 'fever', 'symptom', 'test', 'positive', '', 'thus', '', '33', 'woman', 'positive', 'sars-cov-2', 'test', '', '29', '', '88', 'percent', '', 'asymptomatic', 'presentationeven', 'patient', 'asymptomatic', 'infection', 'objective', 'clinical', 'abnormality', '', '44123', '', '', 'example', '', 'study', '24', 'patient', 'asymptomatic', 'infection', 'undergo', 'chest', 'compute', 'tomography', '', 'ct', '', '', '50', 'percent', 'typical', 'ground-glass', 'opacity', 'patchy', 'shadow', '', 'another', '20', 'percent', 'atypical', 'image', 'abnormality', '', '44', '', '', 'five', 'patient', 'develop', 'low-grade', 'fever', '', 'without', 'typical', 'symptom', '', 'day', 'diagnosis', '', 'another', 'study', '55', 'patient', 'asymptomatic', 'infection', 'identify', 'contact', 'trace', '', '67', 'percent', 'ct', 'evidence', 'pneumonia', 'admission', '', 'two', 'patient', 'develop', 'hypoxia', '', 'recover', '', '123', '', '', 'clinical', 'manifestationsinitial', 'presentation', '', 'pneumonia', 'appear', 'frequent', 'serious', 'manifestation', 'infection', '', 'characterize', 'primarily', 'fever', '', 'cough', '', 'dyspnea', '', 'bilateral', 'infiltrate', 'chest', 'image', '', '57838788', '', '', 'however', '', 'feature', '', 'include', 'upper', 'respiratory', 'tract', 'symptom', '', 'myalgia', '', 'diarrhea', '', 'smell', 'taste', 'disorder', '', 'common', '', 'table', '3', '', '', 'specific', 'clinical', 'feature', 'yet', 'reliably', 'distinguish', 'covid-19', 'viral', 'respiratory', 'infection', '', 'although', 'development', 'dyspnea', 'several', 'day', 'onset', 'initial', 'symptom', 'suggestive', '', '', 'course', 'complication', '', '', '', 'study', 'describe', 'clinical', 'feature', 'covid-19', 'perform', 'hospitalize', 'population', '', 'study', 'describe', '138', 'patient', 'hospitalize', 'covid-19', 'pneumonia', 'wuhan', '', 'common', 'clinical', 'feature', 'onset', 'illness', '', '57', '', '', 'fever', '99', 'percent', '', 'note', 'fever', 'presentation', 'common', 'study', '', '', 'fatigue', '70', 'percentdry', 'cough', '59', 'percentanorexia', '40', 'percentmyalgias', '35', 'percentdyspnea', '31', 'percentsputum', 'production', '27', 'percentother', 'cohort', 'study', 'patient', 'confirm', 'covid-19', 'report', 'similar', 'range', 'clinical', 'find', '', '5787127-129', '', '', 'however', '', 'fever', 'universal', 'find', 'presentation', '', 'one', 'study', '', 'fever', 'report', 'almost', 'patient', '', 'approximately', '20', 'percent', 'low', 'grade', 'fever', '', '1004f38c', '', '87', '', '', 'another', 'study', '1099', 'patient', 'wuhan', 'area', 'china', '', 'fever', '', 'define', 'axillary', 'temperature', '995f375c', '', 'present', '44', 'percent', 'admission', 'ultimately', 'note', '89', 'percent', 'hospitalization', '', '83', '', '', 'study', '5000', 'patient', 'hospitalize', 'covid-19', 'new', 'york', '', '31', 'percent', 'temperature', '', '1004f38c', 'presentation', '', '92', '', 'although', 'highlight', 'initial', 'cohort', 'study', 'china', '', 'smell', 'taste', 'disorder', '', 'eg', '', 'anosmia', 'dysgeusia', '', 'report', 'common', 'symptom', 'patient', 'covid-19', '', '130-132', '', '', 'survey', '59', 'patient', 'covid-19', 'italy', '', '34', 'percent', 'self-reported', 'either', 'smell', 'taste', 'aberration', '19', 'percent', 'report', '', '131', '', '', 'survey', '202', 'outpatient', 'mild', 'covid-19', 'italy', '', '64', 'percent', 'report', 'alteration', 'smell', 'taste', '', '24', 'percent', 'report', 'severe', 'alteration', '', 'smell', 'taste', 'change', 'report', 'symptom', '3', 'percent', 'overall', 'precede', 'symptom', 'another', '12', 'percent', '', '133', '', '', 'whether', 'find', 'distinguish', 'feature', 'covid-19', 'uncertain', '', 'addition', 'respiratory', 'symptom', '', 'gastrointestinal', 'symptom', '', 'eg', '', 'nausea', 'diarrhea', '', 'report', '', 'patient', '', 'present', 'complaint', '', '5787129134', '', '', 'systematic', 'review', 'study', 'report', 'gastrointestinal', 'symptom', 'patient', 'confirm', 'covid-19', '', 'pool', 'prevalence', '18', 'percent', 'overall', '', 'diarrhea', '', 'nauseavomiting', '', 'abdominal', 'pain', 'report', '13', '', '10', '', '9', 'percent', '', 'respectively', '', '28', '', '', 'report', 'symptom', 'include', 'headache', '', 'sore', 'throat', '', 'rhinorrhea', '', '8388', '', '', 'conjunctivitis', 'describe', '', '27', '', 'dermatologic', 'find', 'patient', 'covid-19', 'well', 'characterize', '', 'report', 'maculopapular', '', 'urticarial', '', 'vesicular', 'eruption', 'transient', 'livedo', 'reticularis', '', '135-137', '', '', 'reddish-purple', 'nodule', 'distal', 'digit', 'similar', 'appearance', 'pernio', '', 'chilblain', '', 'describe', '', 'mainly', 'child', 'young', 'adult', 'document', 'suspect', 'covid-19', '', 'although', 'association', 'clearly', 'establish', '', '137-140', '', '', 'call', 'find', '', 'covid', 'toe', '', '', 'course', 'complication', '', '', 'symptomatic', 'infection', 'range', 'mild', 'critical', '', '', 'spectrum', 'illness', 'severity', 'case', 'fatality', 'rate', '', '', '', 'patient', 'initially', 'nonsevere', 'symptom', 'progress', 'course', 'week', '', 'one', 'study', '138', 'patient', 'hospitalize', 'wuhan', 'pneumonia', 'due', 'sars-cov-2', '', 'dyspnea', 'develop', 'median', 'five', 'day', 'since', 'onset', 'symptom', '', 'hospital', 'admission', 'occur', 'median', 'seven', 'day', 'symptom', '', '57', '', '', 'another', 'study', '', 'median', 'time', 'dyspnea', 'eight', 'day', '', '87', '', 'several', 'complication', 'covid-19', 'describe', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'major', 'complication', 'patient', 'severe', 'disease', 'manifest', 'shortly', 'onset', 'dyspnea', '', 'study', '138', 'patient', 'describe', '', 'ards', 'develop', '20', 'percent', 'median', 'eight', 'day', 'onset', 'symptom', '', 'mechanical', 'ventilation', 'implement', '123', 'percent', '', '57', '', '', 'another', 'study', '201', 'hospitalize', 'patient', 'covid-19', 'wuhan', '', '41', 'percent', 'develop', 'ards', '', 'age', 'greater', '65', 'year', '', 'diabetes', 'mellitus', '', 'hypertension', 'associate', 'ards', '', '112', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'clinical', 'feature', 'critically', 'ill', 'patient', '', '', '', 'complication', 'include', 'arrhythmia', '', 'acute', 'cardiac', 'injury', '', 'shock', '', '57106141142', '', '', 'one', 'study', '', 'report', '17', '', '7', '', '9', 'percent', '', 'respectively', '', '57', '', '', 'series', '21', 'severely', 'ill', 'patient', 'admit', 'icu', 'united', 'states', '', 'one-third', 'develop', 'cardiomyopathy', '', '141', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'section', 'clinical', 'feature', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'section', 'clinical', 'manifestation', '', '', '', 'thromboembolic', 'complication', '', 'include', 'pulmonary', 'embolism', 'acute', 'stroke', '', 'patient', 'younger', '50', 'year', 'age', 'without', 'risk', 'factor', '', '', 'report', '', '143-148', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'clinical', 'feature', '', '', '', 'patient', 'severe', 'covid-19', 'laboratory', 'evidence', 'exuberant', 'inflammatory', 'response', '', 'similar', 'cytokine', 'release', 'syndrome', '', 'persistent', 'fever', '', 'elevate', 'inflammatory', 'marker', '', 'eg', '', 'd-dimer', '', 'ferritin', '', '', 'elevate', 'proinflammatory', 'cytokine', '', 'laboratory', 'abnormality', 'associate', 'critical', 'fatal', 'illness', '', '87149150', '', '', '', 'risk', 'factor', 'severe', 'illness', '', '', '', 'inflammatory', 'complication', 'describe', '', 'guillain-barr', 'syndrome', 'occur', '', 'onset', '5', '10', 'day', 'initial', 'symptom', '', '151', '', '', 'multisystem', 'inflammatory', 'syndrome', 'clinical', 'feature', 'similar', 'kawasaki', 'disease', 'toxic', 'shock', 'syndrome', 'describe', 'child', 'covid-19', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', 'secondary', 'infection', 'appear', 'common', 'complication', 'covid-19', 'overall', '', 'although', 'data', 'limit', '', '152153', '', '', 'review', 'nine', 'study', '', 'mainly', 'china', '', 'report', 'rate', 'bacterial', 'fungal', 'coinfections', '8', 'percent', '', '62', '806', '', '', 'include', 'mainly', 'respiratory', 'infection', 'bacteremia', '', '152', '', '', 'several', 'report', 'describe', 'presumptive', 'invasive', 'aspergillosis', 'among', 'immunocompetent', 'patient', 'ards', 'covid-19', '', 'although', 'frequency', 'complication', 'uncertain', '', '154-156', '', 'autopsy', 'study', 'note', 'detectable', 'sars-cov-2', 'rna', '', '', 'case', '', 'antigen', '', 'kidney', '', 'liver', '', 'heart', '', 'brain', '', 'blood', 'addition', 'respiratory', 'tract', 'specimen', '', 'suggest', 'virus', 'disseminate', 'systemically', 'case', '', 'whether', 'direct', 'viral', 'cytopathic', 'effect', 'site', 'contribute', 'complication', 'observe', 'uncertain', '', '157158', '', '', 'according', '', 'recovery', 'time', 'appear', 'around', 'two', 'week', 'mild', 'infection', 'three', 'six', 'week', 'severe', 'disease', '', '159', '', 'laboratory', 'find', '', 'common', 'laboratory', 'find', 'among', 'hospitalize', 'patient', 'covid-19', 'include', 'lymphopenia', '', 'elevate', 'aminotransaminase', 'level', '', 'elevate', 'lactate', 'dehydrogenase', 'level', '', 'elevate', 'inflammatory', 'marker', '', 'eg', '', 'ferritin', '', 'c-reactive', 'protein', '', 'erythrocyte', 'sedimentation', 'rate', '', '', '5783129', '', '', 'lymphopenia', 'especially', 'common', '', 'though', 'total', 'white', 'blood', 'cell', 'count', 'vary', '', '578788160', '', '', 'example', '', 'series', '393', 'adult', 'patient', 'hospitalize', 'covid-19', 'new', 'york', 'city', '', '90', 'percent', 'lymphocyte', 'count', '', '1500microl', '', 'leukocytosis', '', '', '10000microl', '', 'leukopenia', '', '', '4000microl', '', 'report', 'approximately', '15', 'percent', '', '129', '', '', 'abnormalities', 'coagulation', 'test', 'observe', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'coagulation', 'abnormality', '', '', '', 'admission', '', 'patient', 'pneumonia', 'normal', 'serum', 'procalcitonin', 'level', '', 'however', '', 'require', 'icu', 'care', '', 'likely', 'elevate', '', '578788', '', 'several', 'laboratory', 'feature', '', 'include', 'high', 'd-dimer', 'level', 'severe', 'lymphopenia', '', 'associate', 'critical', 'illness', 'mortality', '', '88', '', '', 'discuss', 'elsewhere', '', '', 'risk', 'factor', 'severe', 'illness', '', '', '', 'imaging', 'find', '', 'chest', 'radiograph', 'normal', 'early', 'mild', 'disease', '', 'retrospective', 'study', '64', 'patient', 'hong', 'kong', 'document', 'covid-19', '', '20', 'percent', 'abnormality', 'chest', 'radiograph', 'point', 'illness', '', '161', '', '', 'common', 'abnormal', 'radiograph', 'find', 'consolidation', 'grind', 'glass', 'opacity', '', 'bilateral', '', 'peripheral', '', 'lower', 'lung', 'zone', 'distribution', '', 'lung', 'involvement', 'increase', 'course', 'illness', '', 'peak', 'severity', '10', '12', 'day', 'symptom', 'onset', '', 'although', 'chest', 'ct', 'sensitive', 'chest', 'radiograph', 'chest', 'ct', 'find', 'characteristic', 'covid-19', '', 'find', 'completely', 'rule', 'rule', 'possibility', 'covid-19', '', 'united', 'states', '', 'american', 'college', 'radiology', '', 'acr', '', 'recommend', 'chest', 'ct', 'screen', 'diagnosis', 'covid-19', 'recommend', 'reserve', 'hospitalize', 'patient', 'management', '', '162', '', '', 'ct', 'perform', '', 'radiological', 'society', 'north', 'america', 'categorize', 'feature', 'typical', '', 'indeterminate', '', 'atypical', 'covid-19', '', 'suggest', 'correspond', 'language', 'interpretation', 'report', '', 'table', '4', '', '', '163', '', '', 'chest', 'ct', 'patient', 'covid-19', 'commonly', 'demonstrate', 'ground-glass', 'opacification', 'without', 'consolidative', 'abnormality', '', 'consistent', 'viral', 'pneumonia', '', '128164', '', '', 'case', 'series', 'suggest', 'chest', 'ct', 'abnormality', 'likely', 'bilateral', '', 'peripheral', 'distribution', '', 'involve', 'lower', 'lobe', '', 'less', 'common', 'find', 'include', 'pleural', 'thicken', '', 'pleural', 'effusion', '', 'lymphadenopathy', '', 'study', '1014', 'patient', 'wuhan', 'undergo', 'rt-pcr', 'test', 'chest', 'ct', 'evaluation', 'covid-19', '', '', 'positive', '', 'chest', 'ct', 'covid-19', '', 'determine', 'consensus', 'two', 'radiologist', '', 'sensitivity', '97', 'percent', '', 'pcr', 'test', 'reference', '', 'however', '', 'specificity', '25', 'percent', '', '165', '', '', 'low', 'specificity', 'relate', 'etiology', 'cause', 'similar', 'ct', 'find', '', 'another', 'study', 'compare', 'chest', 'cts', '219', 'patient', 'covid-19', 'china', '205', 'patient', 'cause', 'viral', 'pneumonia', 'united', 'states', '', 'covid-19', 'case', 'likely', 'peripheral', 'distribution', '', '80', 'versus', '57', 'percent', '', '', 'ground-glass', 'opacity', '', '91', 'versus', '68', 'percent', '', '', 'fine', 'reticular', 'opacity', '', '56', 'versus', '22', 'percent', '', '', 'vascular', 'thicken', '', '59', 'versus', '22', 'percent', '', '', 'reverse', 'halo', 'sign', '', '11', 'versus', '1', 'percent', '', '', 'le', 'likely', 'central', 'peripheral', 'distribution', '', '14', 'versus', '35', 'percent', '', '', 'air', 'bronchogram', '', '14', 'versus', '23', 'percent', '', '', 'pleural', 'thicken', '', '15', 'versus', '33', 'percent', '', '', 'pleural', 'effusion', '', '4', 'versus', '39', 'percent', '', '', 'lymphadenopathy', '', '27', 'versus', '10', 'percent', '', '', '166', '', '', 'group', 'radiologist', 'study', 'able', 'distinguish', 'covid-19', 'high', 'specificity', 'moderate', 'sensitivityas', 'chest', 'radiograph', '', 'chest', 'ct', 'normal', 'soon', 'onset', 'symptom', '', 'abnormality', 'likely', 'develop', 'course', 'illness', '', '127167', '', '', 'however', '', 'chest', 'ct', 'abnormality', 'identify', 'patient', 'prior', 'development', 'symptom', 'prior', 'detection', 'viral', 'rna', 'upper', 'respiratory', 'specimen', '', '128168', '', 'among', 'patient', 'clinically', 'improve', '', 'resolution', 'radiographic', 'abnormality', 'lag', 'behind', 'improvement', 'fever', 'hypoxia', '', '169', '', 'diagnosisclinical', 'suspicion', 'criterion', 'test', '', 'possibility', 'covid-19', 'consider', 'primarily', 'patient', 'new', 'onset', 'fever', 'andor', 'respiratory', 'tract', 'symptom', '', 'eg', '', 'cough', '', 'dyspnea', '', '', 'consider', 'patient', 'severe', 'lower', 'respiratory', 'tract', 'illness', 'without', 'clear', 'cause', '', 'consistent', 'symptom', 'include', 'myalgia', '', 'diarrhea', '', 'smell', 'taste', 'aberrancy', '', 'table', '3', '', '', 'initial', 'presentation', '', '', '', 'although', 'syndrome', 'occur', 'viral', 'respiratory', 'illness', '', 'likelihood', 'covid-19', 'increase', 'patient', '', 'resides', 'travel', 'within', 'prior', '14', 'day', 'location', 'community', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'ie', '', 'large', 'number', 'case', 'link', 'specific', 'transmission', 'chain', '', '', 'location', '', 'residence', 'congregate', 'set', 'association', 'event', 'cluster', 'case', 'report', 'particularly', 'high', 'risk', 'exposure', '', '', 'geographic', 'distribution', '', 'risk', 'transmission', '', '', '', 'orhas', 'close', 'contact', 'confirm', 'suspect', 'case', 'covid-19', 'prior', '14', 'day', '', 'include', 'work', 'health', 'care', 'set', '', 'close', 'contact', 'include', 'within', 'approximately', 'six', 'foot', '', 'two', 'meter', '', 'individual', 'covid-19', 'minute', 'wear', 'personal', 'protective', 'equipment', '', 'ppe', '', 'direct', 'contact', 'infectious', 'secretion', 'wear', 'ppepatients', 'suspect', 'covid-19', 'emergency', 'care', 'encourage', 'call', 'prior', 'present', 'health', 'care', 'facility', 'evaluation', '', 'patient', 'evaluate', 'regard', 'test', 'phone', '', 'patient', 'health', 'care', 'facility', '', 'infection', 'control', 'measure', 'implement', 'soon', 'possibility', 'covid-19', 'suspect', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'possible', '', 'symptomatic', 'patient', 'suspect', 'infection', 'undergo', 'test', '', 'diagnosis', 'definitively', 'without', 'microbiologic', 'test', '', 'however', '', 'limit', 'capacity', 'preclude', 'test', 'patient', 'suspect', 'covid-19', '', 'local', 'health', 'department', 'specific', 'criterion', 'test', '', 'united', 'states', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'infectious', 'diseases', 'society', 'america', '', 'idsa', '', 'suggest', 'priority', 'test', '', 'table', '5', '', '', 'high-priority', 'individual', 'include', 'hospitalize', 'patient', '', 'especially', 'critically', 'ill', 'patient', 'unexplained', 'respiratory', 'illness', '', 'symptomatic', 'individual', 'health', 'care', 'worker', 'first', 'responder', '', 'work', 'reside', 'congregate', 'live', 'set', '', 'risk', 'factor', 'severe', 'disease', '', '170171', '', '', 'testing', 'certain', 'asymptomatic', 'individual', 'important', 'public', 'health', 'infection', 'control', 'purpose', '', 'eg', '', 'congregate', 'set', 'covid-19', 'case', 'identify', '', 'prior', 'time-sensitive', 'surgical', 'procedure', '', 'prior', 'time-sensitive', 'aerosol-generating', 'procedure', 'ppe', 'supply', 'limit', '', 'hospitalize', 'patient', 'location', 'prevalence', 'high', '', 'eg', '', '10', 'percent', '', '', '', 'idsa', 'recommend', 'sars-cov-2', 'test', 'asymptomatic', 'immunocompromised', 'patient', 'require', 'hospitalization', 'asymptomatic', 'individual', 'prior', 'receive', 'immunosuppressive', 'therapy', '', '172', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', 'section', 'pretransplantation', 'screen', '', '', '', 'testing', 'criterion', 'suggest', 'world', 'health', 'organization', '', '', 'find', 'technical', 'guidance', 'online', '', 'criterion', 'european', 'centre', 'disease', 'prevention', 'controlin', 'case', '', 'limit', 'availability', 'test', '', 'diagnosis', 'covid-19', 'presumptively', 'base', 'compatible', 'clinical', 'presentation', 'set', 'exposure', 'risk', '', 'particularly', 'cause', 'symptom', 'evident', '', 'management', 'suspect', 'case', 'test', 'available', 'discuss', 'elsewhere', '', '', 'covid-19', 'test', 'readily', 'available', '', '', '', 'microbiologic', 'diagnosisnaat', '', 'rt-pcr', '', 'diagnose', 'current', 'infection', '', 'diagnosis', 'covid-19', 'direct', 'detection', 'sars-cov-2', 'rna', 'nucleic', 'acid', 'amplification', 'test', '', 'naats', '', '', 'primarily', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', '', '173', '', '', 'various', 'rt-pcr', 'assay', 'around', 'world', '', 'different', 'assay', 'amplify', 'detect', 'different', 'region', 'sars-cov-2', 'genome', '', 'target', 'two', 'gene', '', 'include', 'nucleocapsid', '', 'n', '', '', 'envelope', '', 'e', '', '', 'spike', '', '', 'gene', '', 'region', 'first', 'open', 'read', 'frame', '', 'include', 'rna-dependent', 'rna', 'polymerase', '', 'rdrp', '', 'gene', '', '174', '', '', 'united', 'states', '', 'food', 'drug', 'administration', '', 'fda', '', 'grant', 'emergency', 'authorization', 'different', 'rt-pcr', 'assay', '', '50', '', '', 'test', 'perform', 'cdc', '', 'local', 'public', 'health', 'department', '', 'hospital', 'laboratory', '', 'certain', 'commercial', 'reference', 'laboratory', '', 'test', 'different', 'performance', 'characteristic', 'time', 'result', '', 'range', '15', 'minute', 'several', 'hour', '', 'require', 'different', 'specimen', 'type', '', 'turnaround', 'time', 'clinician', 'receive', 'result', 'depend', 'often', 'laboratory', 'perform', 'test', '', 'point-of-care', 'naats', 'develop', '', 'although', 'le', 'sensitive', 'laboratory-based', 'test', '', '175', '', '', 'specimen', 'collection', '', 'upper', 'respiratory', 'sample', 'primary', 'specimen', 'sars-cov-2', 'naat', '', 'united', 'states', '', 'cdc', 'recommend', 'collection', 'one', 'follow', 'specimen', '', '176', '', '', 'nasopharyngeal', 'swab', 'specimen', '', 'collect', 'health', 'care', 'professional', 'oropharyngeal', 'swab', 'specimen', '', 'collect', 'health', 'care', 'professional', 'nasal', 'swab', 'specimen', 'anterior', 'naris', '', 'collect', 'health', 'care', 'professional', 'patient', 'on-site', 'home', '', 'united', 'states', '', 'fda', 'grant', 'emergency', 'authorization', 'home-collection', 'test', 'kit', 'mail', 'laboratory', 'test', '', '177178', '', '', 'nasal', 'nasopharyngeal', 'washaspirate', '', 'collect', 'health', 'care', 'professionalhowever', '', 'uncertainty', 'regard', 'optimal', 'upper', 'respiratory', 'tract', 'specimen', '', 'idsa', 'suggest', 'nasopharyngeal', '', 'mid-turbinate', '', 'nasal', 'specimen', 'oropharyngeal', 'specimen', '', 'saliva', '', 'limit', 'data', 'suggest', 'lower', 'sensitivity', 'oropharyngeal', 'specimen', 'data', 'accuracy', 'saliva', 'specimen', '', '172', '', 'lower', 'respiratory', 'tract', 'specimen', 'option', 'test', '', 'idsa', 'suggest', 'reserve', 'hospitalize', 'patient', 'initial', 'negative', 'test', 'upper', 'respiratory', 'tract', 'specimen', 'suspicion', 'lower', 'respiratory', 'tract', 'sars-cov-2', 'infection', 'remain', '', '172', '', '', 'lower', 'respiratory', 'tract', 'specimen', '', 'expectorate', 'sputum', 'collect', 'patient', 'productive', 'cough', '', 'tracheal', 'aspirate', 'bronchoalveolar', 'lavage', 'collect', 'patient', 'intubate', '', 'induction', 'sputum', 'recommend', '', 'additional', 'information', 'test', 'handle', 'clinical', 'specimen', 'find', 'cdc', 'website', '', 'infection', 'control', 'practice', 'specimen', 'collection', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'data', 'compare', 'accuracy', 'test', 'various', 'site', 'limit', 'suggest', 'test', 'sensitivity', 'vary', 'type', 'specimen', '', 'lower', 'respiratory', 'tract', 'specimen', 'higher', 'viral', 'load', 'likely', 'yield', 'positive', 'test', 'upper', 'respiratory', 'tract', 'specimen', '', '2633', '', '', 'study', '205', 'patient', 'covid-19', 'sample', 'various', 'site', '', 'highest', 'rate', 'positive', 'viral', 'rna', 'test', 'report', 'bronchoalveolar', 'lavage', '', '95', 'percent', '', '14', '15', 'specimen', '', 'sputum', '', '72', 'percent', '', '72', '104', 'specimen', '', '', 'compare', 'oropharyngeal', 'swab', '', '32', 'percent', '', '126', '398', 'specimen', '', '', '26', '', '', 'data', 'study', 'suggest', 'viral', 'rna', 'level', 'higher', 'frequently', 'detect', 'nasal', 'compare', 'oral', 'specimen', '', 'although', 'eight', 'nasal', 'swab', 'test', '', 'similarly', '', 'another', 'study', '117', 'pair', 'nasopharyngeal', 'oropharyngeal', 'specimen', '12', 'patient', 'test', 'simultaneously', '', '32', 'pair', 'discordant', 'one', 'test', 'positive', 'negative', '', 'nasopharyngeal', 'specimen', 'test', 'positive', '66', 'percent', 'pair', 'compare', '34', 'percent', 'oropharyngeal', 'specimen', '', '39', '', '', 'however', '', 'study', 'identify', 'higher', 'viral', 'rna', 'level', 'nasopharyngeal', 'compare', 'oropharyngeal', 'specimen', '', '37', '', '', 'interpretation', '', 'positive', 'naat', 'sars-cov-2', 'generally', 'confirm', 'diagnosis', 'covid-19', '', 'however', '', 'false-negative', 'test', 'upper', 'respiratory', 'specimen', 'well', 'document', '', 'initial', 'test', 'negative', 'suspicion', 'covid-19', 'remain', 'determine', 'presence', 'infection', 'important', 'management', 'infection', 'control', '', 'suggest', 'repeat', 'test', '', 'repeat', 'test', 'perform', '24', '48', 'hour', 'initial', 'test', '', 'case', '', 'idsa', 'recommend', 'test', 'lower', 'respiratory', 'tract', 'specimen', 'patient', 'evidence', 'lower', 'respiratory', 'tract', 'illness', '', '172179', '', '', 'infection', 'control', 'precaution', 'covid-19', 'continue', 'repeat', 'evaluation', 'perform', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'case', '', 'limit', 'availability', 'test', 'concern', 'false-negative', 'result', '', 'diagnosis', 'covid-19', 'presumptively', 'base', 'compatible', 'clinical', 'presentation', 'set', 'exposure', 'risk', '', 'residence', 'travel', 'area', 'widespread', 'community', 'transmission', 'contact', '', '', 'case', '', 'particularly', 'hospitalize', 'patient', 'negative', 'sars-cov-2', 'naat', '', 'characteristic', 'laboratory', 'image', 'find', 'support', 'clinical', 'diagnosis', 'covid-19', 'reason', 'maintain', 'infection', 'control', 'precaution', '', 'nevertheless', '', 'potential', 'cause', 'symptom', 'consider', 'patient', 'negative', 'sars-cov-2', 'naats', '', 'interpretation', 'inconclusive', 'indeterminate', 'result', 'depend', 'specific', 'naat', 'perform', '', 'clinician', 'confer', 'perform', 'laboratory', 'additional', 'testingthe', 'accuracy', 'predictive', 'value', 'sars-cov-2', 'naat', 'systematically', 'evaluate', '', 'sensitivity', 'test', 'likely', 'depend', 'precise', 'assay', '', 'type', 'specimen', 'obtain', '', 'quality', 'specimen', '', 'duration', 'illness', 'time', 'test', '', 'study', '51', 'patient', 'hospitalize', 'china', 'fever', 'acute', 'respiratory', 'symptom', 'ultimately', 'positive', 'sars-cov-2', 'rt-pcr', 'test', '', 'mainly', 'throat', 'swab', '', '', '15', 'patient', '', '29', 'percent', '', 'negative', 'initial', 'test', 'diagnose', 'serial', 'test', '', '180', '', '', 'similar', 'study', '70', 'patient', 'singapore', '', 'initial', 'nasopharyngeal', 'test', 'negative', '8', 'patient', '', '11', 'percent', '', '', '181', '', '', 'study', '', 'rare', 'patient', 'repeatedly', 'negative', 'test', 'positive', 'four', 'teststhe', 'likelihood', 'detectable', 'sars-cov-2', 'rna', 'vary', 'duration', 'illness', '', '182183', '', '', 'analysis', 'seven', 'study', '', 'include', 'two', 'unpublished', 'report', '', 'evaluate', 'rt-pcr', 'performance', 'time', 'since', 'symptom', 'onset', 'exposure', '', 'estimate', 'rate', 'false-negative', 'result', '100', 'percent', 'day', 'exposure', '', '38', 'percent', 'day', '5', '', 'estimate', 'first', 'day', 'symptom', '', '', '20', 'percent', 'day', '8', '', '66', 'percent', 'day', '21', '', '182', '', '', 'heterogeneity', 'across', 'study', 'assumption', 'analysis', '', 'eg', '', 'incubation', 'period', 'time', 'exposure', '', 'reduce', 'confidence', 'result', '', 'one', 'study', 'include', 'analysis', 'combination', 'rt-pcr', 'immunoglobulin', '', 'ig', '', 'serologic', 'test', 'diagnosis', 'covid-19', 'suggest', 'rt-pcr', 'negative', 'rate', '', '10', 'percent', 'day', '1', '3', 'illness', '', '', '20', 'percent', 'day', '6', '', '', '50', 'percent', 'day', '14', '', 'however', '', 'result', 'interpret', 'caution', '', 'since', 'serologic', 'test', 'validate', 'detection', 'acute', 'infection', 'igm', 'test', 'frequently', 'falsely', 'positive', '', '183', '', '', 'study', 'suggest', 'viral', 'rna', 'level', 'higher', 'early', 'course', 'infection', 'individual', 'detectable', 'viral', 'rna', 'several', 'week', 'follow', 'onset', 'symptom', '', 'discuss', 'elsewhere', '', '', 'viral', 'shed', 'period', 'infectivity', '', '', '', 'difference', 'limit', 'detection', 'among', 'major', 'commercial', 'laboratory', 'rt-pcr', 'assay', '', 'retesting', 'sample', 'different', 'platform', 'yield', 'conflict', 'result', '', '184', '', '', 'additionally', '', 'point-of-care', 'naat', 'assay', 'sensitive', 'laboratory-based', 'test', '', '175', '', 'test', 'performance', 'specimen', 'type', '', 'eg', '', 'nasopharyngeal', '', 'oropharyngeal', '', 'lower', 'respiratory', 'tract', '', 'discuss', 'elsewhere', '', '', 'specimen', 'collection', '', '', '', 'serology', 'identify', 'prior', 'infection', '', 'serologic', 'test', 'detect', 'antibody', 'sars-cov-2', 'blood', '', 'adequately', 'validate', 'help', 'identify', 'patient', 'covid-19', '', 'serologic', 'test', 'able', 'identify', 'patient', 'current', 'infection', '', 'particularly', 'present', 'late', 'course', 'illness', '', '', 'le', 'likely', 'reactive', 'first', 'several', 'day', 'week', 'infection', '', 'thus', 'le', 'utility', 'diagnosis', 'acute', 'set', '', '183185-187', '', '', 'additionally', '', 'individual', 'result', 'interpret', 'caution', 'set', 'low', 'seroprevalence', '', 'serologic', 'test', 'high', 'specificity', 'still', 'low', 'positive', 'predictive', 'value', '', 'ie', '', 'positive', 'test', 'likely', 'reflect', 'false', 'positive', 'true', 'positive', '', '', '188', '', '', 'united', 'states', '', 'several', 'serologic', 'test', 'grant', 'emergency', 'authorization', 'fda', 'laboratory', 'certify', 'perform', 'moderate-', 'high-complexity', 'test', '', '50', '', '', 'fda', 'highlight', 'serologic', 'test', 'sole', 'test', 'diagnose', 'exclude', 'active', 'sars-cov-2', 'infection', '', 'sensitivity', 'specificity', 'serologic', 'test', 'uncertain', '', 'catalog', 'test', 'find', 'centerforhealthsecurityorgdetectable', 'antibody', 'generally', 'several', 'day', 'week', 'develop', '', 'study', '173', 'patient', 'covid-19', '', 'median', 'time', 'symptom', 'onset', 'antibody', 'detection', '', 'enzyme-linked', 'immunosorbent', 'assay', '', 'elisa', '', 'detect', 'antibody', 'receptor-binding', 'domain', 'spike', 'protein', '', '12', 'day', 'igm', '14', 'day', 'igg', '', '185', '', '', 'first', 'week', 'since', 'symptom', 'onset', '', 'fewer', '40', 'percent', 'detectable', 'antibody', '', 'day', '15', '', 'igm', 'igg', 'detectable', '94', '80', 'percent', '', 'respectively', '', 'accuracy', 'time', 'antibody', 'detection', 'vary', 'particular', 'test', '', 'studies', 'evaluate', 'specificity', 'serologic', 'test', 'broad', 'population', '', 'particular', '', 'rate', 'cross-reactivity', 'coronaviruses', 'potential', 'concern', '', 'igm', 'test', 'prone', 'false-positive', 'resultslarge-scale', 'serologic', 'screen', 'validate', 'test', 'able', 'provide', 'better', 'sense', 'scope', 'burden', 'disease', '', 'identify', 'people', 'diagnose', 'pcr', 'asymptomatic', 'subclinical', 'infection', '', 'identify', 'individual', 'immunity', 'infection', '', 'serologic', 'correlate', 'protective', 'immunity', '', 'however', '', 'define', '', '', 'viral', 'shed', 'period', 'infectivity', '', 'immunity', 'risk', 'reinfection', '', '', '', 'teststests', 'identify', 'sars-cov-2', 'antigen', 'development', '', 'rapid', 'antigen', 'test', 'perform', 'point', 'care', '', 'respiratory', 'pathogen', '', 'typically', 'le', 'sensitive', 'nucleic', 'acid', 'amplification', 'test', '', '', 'diagnosis', 'seasonal', 'influenza', 'adult', '', '', 'section', 'rapid', 'antigen', 'test', '', '', '', 'several', 'manufacturer', 'sell', 'rapid', '', 'point-of-care', 'antigen', 'test', '', 'united', 'states', '', 'fda', 'start', 'issue', 'emergency', 'authorization', 'test', '', '189', '', '', 'clinicians', 'aware', 'possibility', 'false', 'negative', 'antigen', 'test', '', 'previously', 'caution', 'rapid', 'test', 'base', 'antigen', 'test', 'antibody', 'detection', 'undergo', 'adequate', 'validation', 'concern', 'regard', 'false-positive', 'false-negative', 'result', '', '190', '', 'safety', 'reason', '', 'specimen', 'patient', 'suspect', 'document', 'covid-19', 'submit', 'clinical', 'laboratory', 'viral', 'culture', '', 'viral', 'culture', 'mainly', 'reserve', 'research', 'purpose', '', '', 'viral', 'shed', 'period', 'infectivity', '', '', '', 'testing', 'pathogen', '', 'influenza', 'circulate', 'community', '', 'reasonable', 'test', 'influenza', 'test', 'sars-cov-2', '', 'management', 'implication', '', 'however', '', 'detection', 'another', 'viral', '', 'bacterial', '', 'pathogen', 'necessarily', 'rule', 'sars-cov-2', 'location', 'widespread', 'transmission', '', 'coinfection', 'sars-cov-2', 'respiratory', 'virus', '', 'include', 'influenza', '', 'describe', '', 'report', 'frequency', 'variable', '', '92191-193', '', 'management', '', 'home', 'management', 'appropriate', 'patient', 'mild', 'infection', '', 'eg', '', 'fever', '', 'cough', '', 'andor', 'myalgia', 'without', 'dyspnea', '', 'asymptomatic', 'infection', 'adequately', 'self-isolate', 'outpatient', 'set', '', 'management', 'patient', 'focus', 'prevention', 'transmission', 'others', 'monitor', 'clinical', 'deterioration', '', 'prompt', 'hospitalization', '', 'management', 'patient', 'warrant', 'hospitalization', 'consist', 'ensure', 'appropriate', 'infection', 'control', 'supportive', 'care', '', 'include', 'oxygenation', 'potentially', 'ventilatory', 'support', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'investigational', 'approach', 'evaluate', '', 'set', 'clinical', 'trial', '', 'whenever', 'available', '', 'management', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'preventioninfection', 'control', 'health', 'care', 'set', '', 'location', 'community', 'transmission', 'widespread', '', 'preventive', 'strategy', 'individual', 'health', 'care', 'set', 'warrant', 'reduce', 'potential', 'exposure', '', 'additional', 'measure', 'warrant', 'patient', 'suspect', 'confirm', 'covid-19', '', 'infection', 'control', 'health', 'care', 'set', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'personal', 'preventive', 'measure', '', 'community', 'transmission', 'sars-cov-2', 'present', '', 'resident', 'encourage', 'practice', 'social', 'distance', 'stay', 'home', 'much', 'possible', 'maintain', 'six', 'foot', '', 'two', 'meter', '', 'distance', 'others', 'leave', 'home', '', 'particular', '', 'individual', 'avoid', 'crowd', 'close', 'contact', 'ill', 'individual', '', 'follow', 'general', 'measure', 'additionally', 'recommend', 'reduce', 'transmission', 'infection', '', 'diligent', 'hand', 'wash', '', 'particularly', 'touch', 'surface', 'public', '', 'hand', 'sanitizer', 'contain', 'least', '60', 'percent', 'alcohol', 'reasonable', 'alternative', 'hand', 'visibly', 'dirty', '', 'respiratory', 'hygiene', '', 'eg', '', 'cover', 'cough', 'sneeze', '', 'avoiding', 'touch', 'face', '', 'particular', 'eye', '', 'nose', '', 'mouth', '', '', 'american', 'academy', 'ophthalmology', 'suggest', 'people', 'wear', 'contact', 'lens', '', 'people', 'touch', 'eye', 'frequently', '', '194', '', 'cleaning', 'disinfect', 'object', 'surface', 'frequently', 'touch', '', 'cdc', 'issue', 'guidance', 'disinfection', 'home', 'set', '', 'list', 'environmental', 'protection', 'agency-registered', 'product', 'find', '', 'measure', 'follow', 'individual', '', 'emphasize', 'older', 'adult', 'individual', 'chronic', 'medical', 'condition', '', 'particular', '', 'people', 'without', 'respiratory', 'symptom', '', 'recommend', 'wear', 'medical', 'mask', 'community', '', 'since', 'decrease', 'importance', 'general', 'measure', 'prevent', 'infection', 'result', 'unnecessary', 'cost', 'supply', 'problem', '', 'emphasize', 'medical', 'mask', 'prioritize', 'health', 'care', 'worker', '', '195', '', '', 'recommendations', 'mask', 'healthy', 'member', 'community', 'vary', 'country', '', '196', '', '', 'united', 'states', '', 'cdc', 'update', 'recommendation', 'early', 'april', 'advise', 'individual', 'wear', 'cloth', 'face', 'cover', '', 'eg', '', 'homemade', 'mask', 'bandana', '', 'public', 'set', 'social', 'distance', 'difficult', 'achieve', '', 'especially', 'area', 'substantial', 'community', 'transmission', '', '197', '', '', 'individuals', 'counsel', 'avoid', 'touch', 'eye', '', 'nose', '', 'mouth', 'remove', 'cover', '', 'practice', 'hand', 'hygiene', 'handle', '', 'launder', 'routinely', '', 'clinicians', 'emphasize', 'face', 'cover', 'diminish', 'importance', 'preventive', 'measure', '', 'social', 'distance', 'hand', 'hygiene', '', 'rationale', 'face', 'cover', 'primarily', 'contain', 'secretion', 'prevent', 'transmission', 'individual', 'asymptomatic', 'presymptomatic', 'infection', '', 'cdc', 'reiterate', 'face', 'cover', 'recommendation', 'include', 'medical', 'mask', '', 'reserve', 'health', 'care', 'workersindividuals', 'care', 'patient', 'suspect', 'document', 'covid-19', 'home', 'wear', 'face', 'cover', 'room', 'patient', '', 'patient', 'wear', 'face', 'cover', '', '', 'individuals', 'develop', 'acute', 'respiratory', 'illness', '', 'eg', '', 'fever', 'andor', 'respiratory', 'symptom', '', 'encourage', 'self-isolate', 'home', '', 'away', 'individual', 'pet', 'household', '', 'duration', 'illness', 'wear', 'face', 'cover', 'around', 'people', '', 'warrant', 'evaluation', 'covid-19', '', '', 'clinical', 'suspicion', 'criterion', 'test', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'isolation', 'home', '', '', '', 'efficacy', 'mask', 'contain', 'sars-cov-2', 'uncertain', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'cdc', 'include', 'recommend', 'measure', 'prevent', 'spread', 'community', 'website', '', 'managing', 'asymptomatic', 'individual', 'potential', 'exposure', '', 'area', 'sars-cov-2', 'prevalent', '', 'resident', 'encourage', 'stay', 'alert', 'symptom', 'practice', 'social', 'distance', 'stay', 'home', 'much', 'possible', 'maintain', 'six', 'foot', '', 'two', 'meter', '', 'distance', 'others', 'leave', 'home', '', 'united', 'states', '', 'cdc', 'suggest', 'approach', 'resident', '', '198', '', '', 'return', 'international', 'travel', '', 'include', 'cruise', 'ship', 'travel', '', 'close', 'contact', 'patient', 'suspect', 'confirm', 'covid-19', '', 'include', '48', 'hour', 'prior', 'patient', 'develop', 'symptom', '', '', 'cdc', 'suggest', '', '198199', '', '', 'self-quarantine', 'home', '14', 'day', 'follow', 'last', 'exposure', '', 'maintenance', 'least', 'six', 'foot', '', 'two', 'meter', '', 'others', 'time', '', 'avoiding', 'contact', 'individual', 'high', 'risk', 'severe', 'illness', '', 'unless', 'household', 'member', 'exposure', '', '', '', 'risk', 'factor', 'severe', 'illness', '', '', '', 'twice-daily', 'temperature', 'check', 'monitor', 'fever', '', 'cough', '', 'dyspnea', '', 'develop', 'clinical', 'manifestation', '', 'continue', 'stay', 'home', 'away', 'household', 'member', 'contact', 'medical', 'provider', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'section', 'management', 'counsel', 'outpatient', '', '', '', 'asymptomatic', 'individual', 'critical', 'infrastructure', 'worker', '', 'cdc', 'provide', 'guidance', 'return', 'work', '14-day', 'post-exposure', 'period', 'symptom', 'temperature', 'monitor', '', 'mask', '', 'social', 'distance', '', 'workspace', 'disinfection', '', '200', '', 'management', 'health', 'care', 'worker', 'document', 'exposure', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'return', 'work', 'health', 'care', 'worker', '', '', '', 'public', 'health', 'measure', '', 'january', '30', '', '2020', '', 'declare', 'covid-19', 'outbreak', 'public', 'health', 'emergency', 'international', 'concern', '', 'march', '2020', '', 'begin', 'characterize', 'pandemic', 'order', 'emphasize', 'gravity', 'situation', 'urge', 'country', 'action', 'detect', 'infection', 'prevent', 'spread', '', 'throughout', 'world', '', 'country', 'employ', 'various', 'nonpharmaceutical', 'intervention', 'reduce', 'transmission', '', 'addition', 'personal', 'preventive', 'measure', '', 'eg', '', 'hand', 'hygiene', '', 'respiratory', 'etiquette', 'face', 'cover', '', 'environmental', 'disinfection', '', '', 'transmission', 'reduction', 'strategy', 'include', '', 'socialphysical', 'distance', 'order', 'stay-at-home', 'ordersschool', '', 'venue', '', 'nonessential', 'business', 'closurebans', 'public', 'gatheringstravel', 'restriction', 'exit', 'andor', 'entry', 'screeningaggressive', 'case', 'identification', 'isolation', '', 'separate', 'individual', 'infection', 'others', '', 'contact', 'trace', 'quarantine', '', 'separate', 'individual', 'expose', 'others', '', 'measure', 'associate', 'reduction', 'incidence', 'sars-cov-2', 'infection', 'time', '', 'although', 'relative', 'contribution', 'difficult', 'ass', '', 'country', 'employ', 'combination', 'intervention', '', 'example', '', 'epidemiologic', 'study', 'wuhan', '', 'number', 'intervention', '', 'implementation', 'travel', 'restriction', 'around', 'wuhan', 'home', 'quarantine', 'compulsory', 'mask-wearing', 'public', '', 'follow', 'centralize', 'quarantine', 'case', 'contact', '', 'follow', 'proactive', 'symptom', 'screen', 'resident', '', 'associate', 'progressive', 'reduction', 'incidence', 'confirm', 'case', 'wuhan', 'decrease', 'effective', 'reproduction', 'number', '', 'ie', '', 'average', 'number', 'secondary', 'case', 'case', 'population', 'susceptible', 'nonsusceptible', 'individual', '', '', '3', 'prior', 'intervention', '03', '', '201', '', '', 'another', 'study', 'china', '', 'city', 'combine', 'control', 'measure', 'preemptively', 'implement', 'prior', 'identification', 'covid-19', 'case', 'record', '33', 'percent', 'fewer', 'laboratory-confirmed', 'case', 'first', 'week', 'outbreak', 'compare', 'city', 'implement', 'control', 'measure', 'later', '', '202', '', '', 'study', 'united', 'states', 'evaluate', 'incident', 'case', 'border', 'county', 'illinois', '', 'issue', 'stay-at-home', 'order', '', 'iowa', '', '', 'county', 'iowa', 'experience', 'rapid', 'increase', 'case', 'follow', 'implementation', 'order', 'illinois', '', 'estimate', 'result', '217', 'excess', 'case', 'one', 'month', '', '203', '', '', 'country', 'incidence', 'decline', 'relaxation', 'transmission', 'reduction', 'measure', 'consider', '', 'issue', 'interim', 'guidance', 'implementation', '', 'include', 'step-wise', 'approach', 'adjust', 'accord', 'local', 'circumstance', 'prioritize', 'protect', 'vulnerable', 'population', '', 'recommend', 'personal', 'preventive', 'measure', 'maintain', 'public', 'health', 'effort', 'detect', 'case', 'isolation', 'identify', 'contact', 'quarantine', 'strengthen', '', '204205', '', 'specific', 'recommendation', 'global', 'travel', 'available', 'website', '', 'united', 'states', '', 'cdc', 'currently', 'recommend', 'individual', 'avoid', 'nonessential', 'international', 'travel', 'nonessential', 'travel', 'domestic', 'location', '', '206', '', '', 'risk', 'travel', 'change', 'rapidly', '', 'traveler', 'check', 'united', 'states', 'government', 'website', 'restriction', '', 'investigational', 'approachesvaccines', '', 'numerous', 'vaccine', 'candidate', 'evaluate', 'prevention', 'covid-19', '', '207', '', '', 'include', 'various', 'type', 'vaccine', '', 'include', 'nucleic', 'acid-based', '', 'mrna', 'dna', '', 'vaccine', '', 'viral-vector', 'vaccine', '', 'inactivate', 'recombinant', 'protein', 'vaccine', '', '208', '', '', 'different', 'vaccine', 'platform', 'vary', 'potential', 'safety', 'immunogenicity', '', 'speed', 'cost', 'manufacture', '', 'feature', 'important', 'meet', 'global', 'demandthere', 'interest', 'bacille-calmette-guerin', '', 'bcg', '', 'immunization', 'prevention', 'covid-19', '', 'clinical', 'trial', 'underway', 'evaluate', 'among', 'health', 'care', 'worker', '', '209', '', '', 'studies', 'suggest', '', 'although', 'primary', 'purpose', 'prevention', 'tuberculosis', '', 'bcg', 'immunization', 'induce', 'nonspecific', 'immune', 'response', 'protective', 'effect', 'non-mycobacterial', '', 'include', 'viral', '', 'infection', '', '210211', '', '', 'impact', 'bcg', 'immunization', 'covid-19', 'unknown', '', 'recommend', 'bcg', 'vaccination', 'prevention', 'lessen', 'severity', 'covid-19', '', 'pending', 'data', '', '212', '', '', 'post-exposure', 'prophylaxis', '', 'clinical', 'trial', 'conduct', 'united', 'states', 'elsewhere', 'evaluate', 'safety', 'efficacy', 'post-exposure', 'drug', 'prophylaxis', 'covid-19', '', '213214', '', '', 'agent', 'effective', 'prevent', 'infection', '', 'suggest', 'post-exposure', 'prophylaxis', 'attempt', 'outside', 'clinical', 'trial', '', 'special', 'situationspregnant', 'breastfeed', 'woman', '', 'general', 'approach', 'prevention', '', 'evaluation', '', 'diagnosis', '', 'treatment', 'pregnant', 'woman', 'suspect', 'covid-19', 'largely', 'similar', 'nonpregnant', 'individual', '', 'issues', 'specific', 'pregnant', 'breastfeed', 'woman', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', 'children', '', 'symptomatic', 'infection', 'child', 'appear', 'relatively', 'uncommon', '', 'occur', '', 'usually', 'mild', '', 'although', 'severe', 'case', 'report', '', '115-118', '', '', 'details', 'covid-19', 'child', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', 'covid-19', 'test', 'readily', 'available', '', 'case', '', 'test', 'covid-19', 'accessible', '', 'particularly', 'individual', 'compatible', 'mild', 'illness', 'warrant', 'hospitalization', 'covid-19', 'exposure', 'high-risk', 'travel', 'history', '', 'united', 'states', '', 'limit', 'official', 'guidance', 'situation', '', 'approach', 'depend', 'prevalence', 'covid-19', 'area', '', 'clinician', 'sufficient', 'concern', 'possible', 'covid-19', '', 'eg', '', 'community', 'transmission', 'apparent', 'cause', 'symptom', '', '', 'reasonable', 'assume', 'patient', 'covid-19', 'advise', 'patient', 'self-isolate', 'home', '', 'hospitalization', 'warrant', '', 'alert', 'clinician', 'worsen', 'symptom', '', 'outpatient', 'management', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'section', 'management', 'counsel', 'outpatient', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'home', 'set', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', 'summary', 'recommendationsin', 'late', '2019', '', 'novel', 'coronavirus', '', 'designate', 'sars-cov-2', '', 'identify', 'cause', 'outbreak', 'acute', 'respiratory', 'illness', 'wuhan', '', 'city', 'china', '', 'february', '2020', '', 'world', 'health', 'organization', '', '', 'designate', 'disease', 'covid-19', '', 'stand', 'coronavirus', 'disease', '2019', '', '', '', '', '', 'since', 'first', 'report', 'covid-19', '', 'infection', 'spread', 'include', 'five', 'million', 'confirm', 'case', 'worldwide', '', 'prompt', 'declare', 'public', 'health', 'emergency', 'late', 'january', '2020', 'characterize', 'pandemic', 'march', '2020', '', '', 'epidemiology', '', '', '', 'possibility', 'covid-19', 'consider', 'primarily', 'patient', 'fever', 'andor', 'respiratory', 'tract', 'symptom', 'reside', 'travel', 'area', 'community', 'transmission', 'recent', 'close', 'contact', 'confirm', 'suspect', 'case', 'covid-19', '', 'clinicians', 'aware', 'possibility', 'covid-19', 'patient', 'severe', 'respiratory', 'illness', 'etiology', 'identify', '', 'symptom', 'associate', 'covid-19', '', 'table', '3', '', '', 'limitations', 'test', 'capacity', 'preclude', 'test', 'patient', 'suspect', 'infection', '', 'suggest', 'priority', 'include', 'hospitalize', 'patient', 'symptomatic', 'individual', 'health', 'care', 'worker', 'first', 'responder', '', 'work', 'reside', 'congregate', 'live', 'set', '', 'risk', 'factor', 'severe', 'disease', '', 'table', '5', '', '', '', 'clinical', 'feature', '', 'diagnosis', '', '', '', 'microbiologic', 'diagnosis', 'positive', 'nucleic', 'acid', 'amplification', 'test', '', 'eg', '', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', '', 'sars-cov-2', '', 'upper', 'respiratory', 'tract', 'specimen', 'prefer', 'initial', 'test', 'specimen', '', 'possible', '', 'symptomatic', 'patient', 'suspect', 'infection', 'undergo', 'test', '', 'however', '', 'limit', 'test', 'capacity', 'concern', 'false-negative', 'test', '', 'diagnosis', 'often', 'presumptively', 'base', 'consistent', 'clinical', 'epidemiologic', 'feature', '', 'serologic', 'test', 'help', 'identify', 'individual', 'prior', 'infection', 'le', 'utility', 'first', 'week', 'infection', '', '', 'microbiologic', 'diagnosis', '', '', '', 'upon', 'suspicion', 'covid-19', '', 'infection', 'control', 'measure', 'implement', '', 'infection', 'control', 'home', 'health', 'care', 'set', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'home', 'management', 'appropriate', 'patient', 'mild', 'illness', 'adequately', 'self-isolate', 'outpatient', 'set', '', 'minority', 'patient', 'critical', 'care', '', 'home', '', 'hospital', '', 'intensive', 'care', 'unit', 'management', 'patient', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'reduce', 'risk', 'transmission', 'community', '', 'individual', 'advise', 'wash', 'hand', 'diligently', '', 'practice', 'respiratory', 'hygiene', '', 'eg', '', 'cover', 'cough', '', '', 'avoid', 'crowd', 'close', 'contact', 'ill', 'individual', '', 'possible', '', 'social', 'distance', 'recommend', 'location', 'community', 'transmission', '', 'location', '', 'face', 'cover', 'advise', 'public', 'set', '', '', 'personal', 'preventive', 'measure', '', '', '', 'interim', 'guidance', 'issue', 'cdc', '', 'update', 'ongoing', 'basis', '', '', 'society', 'guideline', 'link', '', '', '']",9697,"{'': 2311, 'covid-19': 173, 'patient': 139, 'infection': 109, 'test': 107, 'percent': 96, 'disease': 76, 'study': 73, 'case': 67, 'respiratory': 65, 'sars-cov-2': 63, 'care': 59, 'coronavirus': 58, 'report': 56, 'symptom': 56, 'specimen': 55, 'viral': 52, 'health': 50, 'day': 50, '2019': 48}","{'infection': 109, 'sars-cov-2': 63, 'safety': 3}",175,0.6908
ID:128190,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child']","['INTRODUCTION — At end 2019 , novel coronavirus identify cause cluster pneumonia case Wuhan , city Hubei province China .', 'It rapidly spread , result epidemic throughout China , follow increase number case country globally .', 'In February 2020 , World Health Organization ( WHO ) designate disease COVID-19 , stand coronavirus disease 2019 [ 1 ] .', 'The virus cause COVID-19 designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) ; previously , refer 2019-nCoV .', 'The WHO declare COVID-19 pandemic March 11 , 2020 [ 2 ] .In child , COVID-19 usually mild .', 'However , rare case , child severely affect , clinical manifestation may differ adult .', 'In April 2020 , report emerge United Kingdom presentation child similar incomplete Kawasaki disease ( KD ) toxic shock syndrome [ 3,4 ] .', 'Since , increase report similarly affect child part world [ 5-8 ] .', ""The syndrome term multisystem inflammatory syndrome child ( MIS-C ; also refer pediatric multisystem inflammatory syndrome [ PMIS ] , pediatric inflammatory multisystem syndrome [ PIMS ] , pediatric hyperinflammatory syndrome , pediatric hyperinflammatory shock ) .This topic outline know epidemiology , clinical presentation , diagnosis , management MIS-C. Other aspect COVID-19 child adult discuss separately : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", ') Understanding COVID-19 MIS-C evolve .', 'Interim guidance issue WHO United States Centers Disease Control Prevention ( CDC ) [ 5,9,10 ] .', 'Links relate society guideline find elsewhere .', ""( See 'Society guideline link ' ."", ') EPIDEMIOLOGY — While incidence MIS-C unknown , appear rare complication COVID-19 children.The initial report MIS-C emerge United Kingdom April , 2020 [ 3,4 ] .', ""Since , report similarly affect child part world , include Europe , Canada , United States ( majority case United States New York ) [ 5-8,11-13 ] .Many child MIS-C meet criterion complete incomplete Kawasaki disease ( KD ) ( see 'Clinical manifestation ' ) ."", 'However , epidemiology differ classic KD , The pattern emerge available case series MIS-C case occur older child adolescent previously healthy [ 3,6,11 ] .', 'Black child may disproportionally affect .', 'By contrast , classic KD typically affect infant young child higher incidence East Asia child Asian descent .', ""( See `` Kawasaki disease : Epidemiology etiology '' , section 'Epidemiology ' ."", ') The epidemiology MIS-C also differ acute COVID-19 illness child , tend severe infant < 1 year age child underlie health problem .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' , section 'Potential risk factor severe disease ' ."", ') The first report MIS-C series eight child see tertiary center South East England [ 3 ] .', 'In three subsequent case series United Kingdom ( n = 37 ) , France ( n = 35 ) , New York ( n = 33 ) , majority child previously healthy ( 95 percent United Kingdom series , 89 percent French series , 79 percent New York series ) [ 11,14 ] .', 'The common comorbidities obesity asthma .', 'Boys account approximately 60 percent case .', 'The average age 9 11 year ( range 1 17 year ) .It unclear risk develop MIS-C vary race , though black child account disproportionally high number case Asian child account small number case initial report .', 'In United Kingdom series , 46 percent patient black , 19 percent white , 11 percent Asian , 5 percent biracial [ 11 ] .', 'In New York series , 24 percent black , 27 percent Hispanic , 9 percent white , 9 percent Asian [ 11 ] .Based pattern see United Kingdom , New York , Italy , seem lag several week peak COVID-19 case within community peak MIS-C case [ 6,11,15 ] .', 'For example , London , peak COVID-19 case occur first second week April , peak MIS-C case occur first second week May [ 11,15 ] .', 'This three- four-week lag coincide time acquire immunity suggest MIS-C may represent postinfectious complication virus rather acute infection , least children.PATHOPHYSIOLOGY — The pathophysiology MIS-C well understand .', 'It suggest syndrome result abnormal immune response virus , similarity Kawasaki disease ( KD ) , macrophage activation syndrome ( MAS ) , cytokine release syndrome .', 'The mechanism SARS-CoV-2 trigger abnormal immune response unknown .', ""A postinfectious process suggest , base time rise case relative peak COVID-19 case community , discuss ( see 'Epidemiology ' ) ."", 'This also support find many affect child negative polymerase chain reaction ( PCR ) test SARS-CoV-2 positive serology .', 'However , child positive PCR test .', 'In early case series United Kingdom , New York , Italy , 59 child PCR serology perform [ 6,11 ] .', 'Of , 70 percent positive serology negative PCR , 22 percent positive test , 8 percent negative tests.Understanding mechanism exaggerate immune response MIS-C area active investigation .', 'The pathophysiology KD , MAS , cytokine release syndrome discuss separately .', ""( See `` Kawasaki disease : Epidemiology etiology '' , section 'Immunologic response ' `` Clinical feature diagnosis hemophagocytic lymphohistiocytosis '' , section 'Pathophysiology ' `` Cytokine release syndrome ( CRS ) '' , section 'Pathophysiology ' ."", ') CLINICAL MANIFESTATIONSPresenting symptom — In available case report , clinical presentation similar , include [ 3,6,7,11,14 ] : ●Persistent fever ( median duration four day ) – 100 percent●Gastrointestinal symptom ( abdominal pain , vomit , diarrhea ) – 60 97 percent●Rash – 50 60 percent●Neurocognitive symptom ( headache , lethargy , confusion ) – 30 58 percent●Respiratory symptom – 32 65 percent●Conjunctivitis – 32 percent●Mucous membrane involvement – 19 percent●Sore throat – 14 percent●Swollen hands/feet – 8 percentGastrointestinal symptom ( abdominal pain , vomit , diarrhea ) particularly common prominent , child mimic appendicitis [ 14,16 ] .', 'Some child note terminal ileitis abdominal image and/or colitis colonoscopy .', ""( See 'Imaging find ' ."", ') Many patient present three five day fever , go develop warm shock .', 'Patients present fewer day fever report .', 'Shock often refractory volume resuscitation , require vasopressor , case , mechanical hemodynamic support.Pulmonary involvement prominent feature case , though many child require mechanical ventilation cardiovascular stabilization .', 'Respiratory symptom ( tachypnea , labor breathe ) , present , often due severe shock .', 'Cough uncommon.Clinical find — In available case report , common clinical find include [ 3,6,7,11,14 ] : ●Shock – 60 80 percent●Criteria meet complete Kawasaki disease ( KD ) ( table 1 ) – 50 64 percent●Myocardial dysfunction ( echocardiogram elevate troponin/brain natriuretic peptide [ BNP ] ) – 50 100 percent●Acute respiratory failure require noninvasive invasive ventilation – 52 68 percent●Acute kidney injury ( case mild ) – 38 70 percent●Serositis ( small pleural , pericardial , ascitic effusion ) – 24 50 percent●Acute hepatic failure – 21 percentLaboratory find — Laboratory abnormality note available case series include [ 3,6,7,11,14,17 ] : ●Abnormal blood cell count , include : •Lymphocytopenia – 80 95 percent•Neutrophilia – 80 90 percent•Mild anemia – 70 percent•Thrombocytopenia – 30 80 percent●Elevated inflammatory marker , include : •C-reactive protein – 90 95 percent•Erythrocyte sedimentation rate – 80 percent•Procalcitonin•D-dimer – 80 95 percent•Fibrinogen – 90 percent•Ferritin – 75 percent•Interleukin-6 ( IL-6 ) ●Elevated cardiac marker : •Troponin – 60 90 percent•BNP NT-pro-BNP – 90 100 percent●Hypoalbuminemia – 73 percent●Mildly elevate liver enzyme – 70 percent●Elevated lactate dehydrogenase – 50 60 percent●Hypertriglyceridemia – 70 percentImaging find — Findings diagnostic image may include [ 3,6,11,14 ] : ●Echocardiography – Echocardiographic find may include depress leave ventricular ( LV ) function coronary artery ( CA ) abnormality , include dilation aneurysm , mitral valve regurgitation , pericardial effusion [ 14 ] .', 'Approximately 50 60 percent patient depress LV function .', 'CA abnormality see approximately 20 50 percent patient .', 'This considerably higher classic KD , rate CA involvement approximately 10 15 percent .', ""( See `` Cardiovascular sequela Kawasaki disease : Clinical feature evaluation '' , section 'Coronary artery abnormality ' ."", ') ●Chest radiograph – Many patient normal chest radiograph .', 'Abnormal find include small pleural effusion , patchy consolidation , focal consolidation , atelectasis.●Computed tomography ( CT ) chest – Chest CT ( obtain ) generally find similar chest radiograph .', 'A patient nodular ground-glass opacification.●Abdominal image – Findings abdominal ultrasound CT include free fluid , ascites , bowel mesenteric inflammation include terminal ileitis , mesenteric adenopathy/adenitis , pericholecystic edema [ 16 ] .CASE DEFINITION — The criterion use case definition vary slightly different health agency ( table 2 ) [ 5,8,17 ] .', 'For example , Centers Disease Control Prevention ( CDC ) case definition require child severe symptom require hospitalization , whereas World Health Organization ( WHO ) case .', 'An advantage WHO definition provide detail regard clinical sign multisystem involvement .', 'These definition likely change information become available.CDC case definition — According case definition put forth United States CDC , MIS-C define meet follow criterion ( table 2 ) [ 5 ] : ●Age < 21 years•A presentation consistent MIS-C , include follow : •Fever > 38.0°C ≥24 hour , report subjective fever last ≥24 hours•Laboratory evidence inflammation ( eg , elevate C-reactive protein , erythrocyte sedimentation rate , fibrinogen , procalcitonin , D-dimer , ferritin , lactic acid dehydrogenase , interleukin-6 [ IL-6 ] level ; neutrophilia ; lymphocytopenia ; and/or hypoalbuminemia ) •Severe illness require hospitalization•≥2 organ system involve ( cardiac , renal , respiratory , hematologic , gastrointestinal , dermatologic , and/or neurologic ) ●No alternative plausible diagnoses●Recent current SARS-CoV-2 infection exposure , define follow : •Positive SARS-CoV-2 polymerase chain reaction ( PCR ) •Positive serology SARS-CoV-2•Positive antigen test•COVID-19 exposure within four week prior onset symptomsPatients meet criterion also fulfill full partial criterion Kawasaki disease ( KD ) consider MIS-C report .', 'In addition , MIS-C consider pediatric death evidence SARS-CoV-2 infection.WHO case definition — The case definition put forth WHO follow ( table 2 ) [ 8 ] : ●Age 0 19 year old , and●Fever ≥3 day , and●Elevated marker inflammation ( eg , erythrocyte sedimentation rate , C-reactive protein , procalcitonin ) , and●No obvious microbial cause inflammation , include bacterial sepsis staphylococcal/streptococcal shock syndrome , and●Evidence SARS-CoV-2 infection ( positive reverse transcription PCR [ RT-PCR ] , antigen test , serology ) contact individual COVID-19 , and●Clinical sign multisystem involvement ( least two follow ) : •Rash , bilateral nonpurulent conjunctivitis , mucocutaneous inflammation sign ( oral , hand , foot ) •Hypotension shock•Cardiac dysfunction , pericarditis , valvulitis , coronary abnormality ( include echocardiographic find elevate troponin/brain natriuretic peptide [ BNP ] ) •Evidence coagulopathy ( prolong prothrombin time partial thromboplastin time ; elevate D-dimer ) •Acute gastrointestinal symptom ( diarrhea , vomit , abdominal pain ) Spectrum disease — As learn COVID-19 MIS-C child , become apparent spectrum disease range mild severe [ 11 ] .', 'Our understand full spectrum , include subphenotypes , evolving.●COVID-19 without exaggerate immune response – In child , COVID-19 cause mild symptom .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' , section 'Clinical manifestation ' ."", ') ●COVID-19-associated febrile inflammatory state – Some child may present persistent fever mild symptom ( eg , headache , fatigue ) .', 'Inflammatory marker ( especially ferritin ) may elevate , sign multisystem involvement lacking.●COVID-19-associated KD – Some child meet criterion complete incomplete KD ( table 1 ) develop shock multisystem involvement .', 'It unclear incidence coronary artery ( CA ) aneurysm higher COVID-19-associated KD compare classic KD .', 'Further study need .', ""( See `` Kawasaki disease : Clinical feature diagnosis '' ."", ') ●COVID-19-associated MIS-C – Children MIS-C severe presentation , markedly elevate inflammatory marker multisystem involvement .', 'Cardiac involvement shock common , discuss .', ""( See 'Clinical manifestation ' ."", ') It remain unclear common presentation , frequently child progress mild severe manifestation , risk factor progression .', ""We hope learn full spectrum disease additional case report , likely case definition ( see 'Case definition ' ) change information become available.EVALUATIONLaboratory test — The initial laboratory evaluation child suspect MIS-C depend presentation.●Moderate severe – For child moderate severe symptom , suggest follow : •Complete blood cell count differential•C-reactive protein erythrocyte sedimentation rate ( optional : procalcitonin ) •Ferritin level•Liver function test lactate dehydrogenase•Serum electrolyte renal function tests•Urinalysis•Coagulation study ( prothrombin time/international normalize ratio , activate partial thromboplastin time , D-dimer , fibrinogen , antithrombin-3 ) •Troponin creatine kinase-MB•Brain natriuretic peptide ( BNP ) , NT-pro-BNP•Cytokine panel ( available ) Inflammatory marker ( C-reactive protein , erythrocyte sedimentation rate , procalcitonin , ferritin ) measure time admission serially monitor progression.●Well-appearing – For patient present fever ≥3 day well-appearing mild symptom suggestive MIS-C , reasonable perform limit evaluation initially ."", 'For example , may reasonable start complete blood count C-reactive protein obtain additional test abnormal.Testing SARS-CoV-2 — All patient suspect MIS-C test SARS-CoV-2 , include serology reverse transcription polymerase chain reaction ( RT-PCR ) nasopharyngeal swab .', ""As previously discuss , affect child positive serology negative PCR , though positive PCRs ( see 'Pathophysiology ' ) ."", 'Testing SARS-CoV-2 discuss greater detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Microbiologic diagnosis ' ."", ') Testing pathogen — Testing viral bacterial pathogen include [ 17 ] : ●Blood culture●Urine culture●Throat culture●Stool culture●Nasopharyngeal aspirate throat swab respiratory viral panel●Epstein-Barr virus serology PCR●Cytomegalovirus serology PCR●Enterovirus PCR●Adenovirus PCRThis test appropriate child moderate severe MIS-C ( ie , child require hospitalization ) .', 'However , extensive infectious work-up generally necessary well-appearing child present mild symptom .', 'In patient , microbiologic test do clinically indicate accord age child his/her specific symptom ( eg , throat culture child sore throat , respiratory viral panel respiratory symptom ) .', 'Testing follow general approach use fever evaluation broadly .', ""( See `` Fever without source child 3 36 month age : Evaluation management '' ."", ') Detection respiratory pathogen ( eg , rhinovirus , influenza , respiratory syncytial virus ) nasopharyngeal specimen exclude COVID-19.Additional test pathogen may warrant , depend geographic location exposure history .', 'This may include : ●Murine typhus●Leptospirosis serologyCardiac test — In addition troponin BNP/NT-pro-BNP level , cardiac evaluation patient suspect MIS-C include 12-lead electrocardiogram ( ECG ) echocardiography .', 'Echocardiography also recommend child document SARS-CoV-2 meet criterion MIS-C either shock feature consistent incomplete complete Kawasaki disease ( KD ) .Children adolescent mild COVID-19 without sign systemic inflammation unlikely coronary artery ( CA ) change myocarditis .', 'In child , echocardiography generally necessary may consider specific clinical concerns.In child MIS-C , baseline ECGs may nonspecific , though arrhythmia heart block describe [ 3,18 ] .', 'Findings initial echocardiography may include CA dilation , leave ventricular ( LV ) systolic dysfunction , pericardial effusion .', 'The CA abnormality progress aneurysm , include giant coronary aneurysm [ 3 ] .●Echocardiographic evaluation – The echocardiographic evaluation include follow : •Quantitative assessment LV size systolic function ( LV end-diastolic volume , ejection fraction ) •Qualitative assessment right ventricular systolic function•CA abnormality ( dilation aneurysm ) •Assessment valvar function•Evaluation presence size pericardial effusion•Evaluation intracardiac thrombosis and/or pulmonary artery thrombosis , particularly apical thrombus severe LV dysfunction•Strain image LV diastolic function ( optional ) CA assessment base Z-scores , classification schema use KD ( table 3 ) , discuss separately .', ""( See `` Cardiovascular sequela Kawasaki disease : Clinical feature evaluation '' , section 'Echocardiography ' ."", ') ●Timing follow-up echocardiography – At center , echocardiography perform time diagnosis , follow-up examination follow interval : •In patient initially normal function normal CA dimension , follow-up echocardiogram perform one two week post-diagnosis recheck CA size.•In patient CA dilation/aneurysm initial echocardiogram , echocardiography repeat every two three day CA size stable approximately week.•For patient systolic dysfunction/myocarditis normal CAs initial echocardiogram , echocardiogram repeat clinically indicate , include repeat image CAs study.•For patient evidence CA involvement systolic dysfunction/myocarditis acute phase , cardiac magnetic resonance image consider approximately one three month acute illness ass ventricular function evaluate edema , diffuse fibrosis , scar myocardial delay enhancement.DIFFERENTIAL DIAGNOSIS — In child present sign symptom consistent MIS-C , differential diagnosis broad include infectious inflammatory condition : ●Bacterial sepsis – Bacterial sepsis important consideration child present fever , shock , elevate inflammatory marker .', ""All child suspect moderate severe MIS-C blood culture send , empiric antibiotic administer pending culture result ( see 'Antibiotic therapy ' ) ."", 'Certain clinical feature help distinguish MIS-C bacterial sepsis .', 'For example , cardiac involvement , particularly coronary artery ( CA ) involvement , uncommon bacterial sepsis .', 'Ultimately , microbiologic test ( ie , SARS-CoV-2 test , bacterial culture ) necessary make distinction .', ""( See `` Systemic inflammatory response syndrome ( SIRS ) sepsis child : Definitions , epidemiology , clinical manifestation , diagnosis '' ."", "") ●Kawasaki disease ( KD ) – Some child along MIS-C spectrum meet criterion complete incomplete KD ( table 1 ) ( see 'Spectrum disease ' ) ."", 'However , appear key difference .', 'For example , MIS-C appear affect older child adolescent , whereas classic KD typically affect infant young child .', 'In addition , risk CA involvement myocardial dysfunction may higher MIS-C compare classic KD .', 'KD shock syndrome well describe common classic KD population , whereas shock seem prominent presentation MIS-C .', 'Ultimately , designation MIS-C versus KD base SARS-CoV-2 test .', 'Patients positive SARS-CoV-2 test ( exposure individual COVID-19 ) also fulfill full partial criterion KD consider MIS-C receive standard treatment KD .', ""( See `` Kawasaki disease : Clinical feature diagnosis '' ."", ') ●Toxic shock syndrome – Staphylococcal streptococcal toxic shock syndrome share many similarity MIS-C ( table 4 ) .', 'Microbiologic test ( ie , SARS-CoV-2 test , bacterial culture ) necessary make distinction .', ""( See `` Staphylococcal toxic shock syndrome '' `` Invasive group A streptococcal infection toxic shock syndrome : Epidemiology , clinical manifestation , diagnosis '' ."", "") ●Appendicitis – As discuss , many child MIS-C present fever associate abdominal pain vomit ( see 'Presenting symptom ' ) ."", 'This mimic presentation acute appendicitis .', 'Abdominal image may necessary make distinction .', ""( See 'Imaging find ' `` Acute appendicitis child : Clinical manifestation diagnosis '' ."", ') ●Other viral infection – Other viral pathogen may manifest multisystem involvement and/or myocarditis include Epstein-Barr virus , cytomegalovirus , adenovirus , enterovirus .', 'These virus rarely cause severe multisystem disease immunocompetent child .', ""Serology polymerase chain reaction ( PCR ) test distinguish COVID-19-related MIS-C. ( See `` Clinical manifestation treatment Epstein-Barr virus infection '' `` Overview cytomegalovirus infection child '' `` Pathogenesis , epidemiology , clinical manifestation adenovirus infection '' ."", ') ●Hemophagocytic lymphohistiocytosis ( HLH ) /macrophage activation syndrome ( MAS ) – HLH MAS aggressive life-threatening condition feature common MIS-C. HLH/MAS syndrome excessive immune activation occur previously healthy child ( often trigger infection ) child underlie rheumatologic condition .', 'Most child HLH/MAS acutely ill multiorgan involvement , cytopenia , liver function abnormality , neurologic symptom .', 'Cardiac gastrointestinal involvement le common , neurologic symptom prominent .', 'The diagnosis MAS/HLH require specialize immunologic test , discuss separately .', ""( See `` Clinical feature diagnosis hemophagocytic lymphohistiocytosis '' , section 'Specialized test ' ."", ') ●Systemic lupus erythematosus ( SLE ) – SLE present fulminant multisystem illness .', 'Such patient generally considerable kidney central nervous system involvement , common feature MIS-C .', 'In addition , though patient SLE may present acutely fulminant illness , report feel fatigue unwell extend period time prior onset severe symptom .', 'This case MIS-C , child completely well prior acute onset febrile illness .', ""( See `` Childhood-onset systemic lupus erythematosus ( SLE ) : Clinical manifestation diagnosis '' ."", ') ●Vasculitis – Other vasculitides present fever , rash , elevate inflammatory marker .', ""Rashes see COVID-19-associated illness appearance mimic vasculitis ( eg , pernio [ chilblain ] -like lesion acral surface , sometimes refer `` COVID toe '' ) , vasculitic ."", ""( See `` Vasculitis child : Evaluation overview '' `` Coronavirus disease 2019 ( COVID-19 ) : Cutaneous manifestation issue relate dermatologic care '' , section 'Cutaneous manifestation COVID-19 ' ."", ') MANAGEMENTSetting care — Children moderate severe sign symptom admit hospital .', 'The level care determine severity illness .', 'Admission pediatric intensive care unit appropriate child hemodynamic instability ( shock , arrhythmia ) , significant respiratory compromise , potentially life-threatening complication .', 'In available case series , patient require pediatric intensive care unit care [ 3,4,6,11 ] .It may reasonable manage select patient mild symptom outpatient set .', ""However , give uncertainty regard risk progression mild severe ( see 'Spectrum disease ' ) , hospital admission advise patient markedly elevate inflammatory marker level monitor trend down.For child manage outpatient set , critical provide instruction seek care ensure appropriate follow-up ."", 'Most child follow-up within 48 hour persistently febrile .', 'Follow-up include clinical assessment repeat laboratory testing.Multidisciplinary care — By definition , MIS-C multisystem disease , care affect child require coordination many different specialty .', 'This may include : ●Pediatric infectious disease specialists●Pediatric rheumatologists●Pediatric cardiologists●Pediatric intensivists●Pediatric hematologistsAntimicrobial therapyAntibiotic therapy — MIS-C present sign symptom mimic septic shock toxic shock syndrome .', 'Thus , patient present severe multisystem involvement , particularly shock , receive prompt empiric broad-spectrum antibiotic therapy pending culture result .', 'An appropriate empiric regimen consist ceftriaxone plus vancomycin .', 'Ceftaroline plus piperacillin-tazobactam alternative regimen , particularly child acute kidney injury .', 'Clindamycin add feature consistent toxin-mediated illness ( eg , erythroderma ) .', ""Antibiotics discontinue bacterial infection exclude child 's clinical status stabilize ."", ""( See `` Septic shock child : Rapid recognition initial resuscitation ( first hour ) '' , section 'Empiric regimen ' `` Staphylococcal toxic shock syndrome '' , section 'Empiric therapy ' ."", ') Antiviral therapy — The role SARS-CoV-2 antiviral therapy ( eg , remdesivir ) management MIS-C uncertain .', ""Many patient polymerase chain reaction ( PCR ) -negative SARS-CoV-2 , MIS-C may represent postinfectious complication rather active infection ( see 'Pathophysiology ' ) ."", 'However , child positive PCR test may current infection .', 'Thus , antiviral therapy may potential impact disease process , , patient .', 'Use antiviral agent generally limit child severe MIS-C manifestation .', 'We advise consultation infectious disease specialist guide decision-making .', 'Choice SARS-CoV-2 antiviral agent , dose , side effect , monitor discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' , section 'Antiviral therapy select patient ' ."", ') Additional therapy base presentation — Additional therapy depend clinical presentation .', 'These presentation overlap , may appropriate provide intervention one category .', 'For example , patient present Kawasaki disease ( KD ) associate warm shock receive treatment KD ( ie intravenous immune globulin [ IVIG ] aspirin ) appropriate hemodynamic support ( ie , volume expansion epinephrine ) .Shock — Children present shock resuscitate accord standard protocol ( algorithm 1 ) .', 'In available case series , child MIS-C present warm shock refractory volume expansion .', 'Epinephrine prefer vasoactive agent management warm shock child .', 'In child present significant ventricular dysfunction , milrinone may helpful .', 'Management shock pediatric patient discuss greater detail separately .', ""( See `` Initial management shock child '' ."", ') Features Kawasaki disease — Patients meet criterion incomplete complete KD ( table 1 ) receive standard therapy KD , include IVIG , aspirin , , persistent sign inflammation coronary artery ( CA ) dilation/aneurysm , glucocorticoid .', 'Treatment KD summarize figure ( algorithm 2 ) discuss greater detail separately .', ""( See `` Kawasaki disease : Initial treatment prognosis '' `` Incomplete ( atypical ) Kawasaki disease '' ."", ') Myocardial dysfunction — During acute inflammatory phase illness , child myocardial dysfunction may present arrhythmia hemodynamic compromise .', 'Serial echocardiographic assessment cardiac function monitor brain natriuretic peptide ( BNP ) troponin level help guide therapy .', 'Management focus supportive care maintain hemodynamic stability ensure adequate systemic perfusion .', 'IVIG often use severe case clinical picture consistent myocarditis , though conclusive evidence benefit lack .', 'Continuous cardiac monitor essential arrhythmia promptly detect treat .', 'Patients significant ventricular dysfunction treat intravenous diuretic inotropic agent , milrinone , dopamine , dobutamine .', 'In case fulminant disease , mechanical hemodynamic support may necessary form extracorporeal membrane oxygenation ( ECMO ) ventricular assist device .', 'Management myocarditis discuss separately .', ""( See `` Treatment prognosis myocarditis child '' ."", ') Thrombotic complication — Patients MIS-C risk experience thrombotic complication .', 'For example , patient KD large giant CA aneurysm risk myocardial infarction .', 'In addition , patient may risk venous thromboembolism ( VTE ) , include pulmonary embolus , due hypercoagulability associate COVID-19 .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", ') ●Patients feature KD – All patient meet criterion complete incomplete KD receive antithrombotic therapy , , minimum , include low-dose aspirin .', 'Additional antiplatelet and/or anticoagulant therapy may warrant select patient , depend degree CA dilation , summarize figure ( algorithm 3 ) discuss separately .', ""( See `` Cardiovascular sequela Kawasaki disease : Management prognosis '' , section 'Prevention coronary thrombosis ' ."", ') ●Patients leave ventricular ( LV ) dysfunction – Systemic anticoagulation may appropriate patient moderate severe LV dysfunction , discuss separately .', ""( See `` Treatment prognosis myocarditis child '' , section 'Anticoagulation ' ."", ') ●Other patient – In patient without KD significant LV dysfunction , decision initiate therapy prevention VTE individualize .', 'The diagnosis COVID-19-related MIS-C consider major risk factor VTE .', 'VTE prophylaxis generally appropriate older child adolescent hospitalize moderate severe MIS-C , provide bleed risk low .', ""In infant young child , decision make case-by-case basis , weigh VTE risk factor patient 's bleed risk ."", 'When VTE prophylaxis use , low molecular weight heparin generally prefer agent .', 'Nonpharmacologic strategy VTE prophylaxis ( eg , intermittent pneumatic compression device [ size permit ] early mobilization ) encourage , MIS-C-related coagulopathy may merit higher level intervention .', 'The approach VTE prophylaxis hospitalize child discuss greater detail separately .', ""( See `` Venous thrombosis thromboembolism child : Treatment , prevention , outcome '' , section 'Venous thromboembolism prophylaxis ' ."", ') Adjunctive immune-modifying therapy — The benefit risk adjunctive therapy ( glucocorticoid , interleukin-1 [ IL-1 ] inhibitor [ eg , anakinra , canakinumab ] , IL-6 inhibitor [ eg , tocilizumab ] , convalescent plasma recover COVID-19 patient ) uncertain .', 'Consultation pediatric infectious disease rheumatology specialist advise .', ""We make decision use adjunctive therapy case-by-case basis , accord disease severity marker inflammation active SARS-CoV-2 infection.As discuss , glucocorticoid appropriate patient feature KD persistent fever IVIG CA dilation/aneurysm ( see 'Features Kawasaki disease ' ) ."", 'In addition , glucocorticoid consider patient cytokine release syndrome ( CRS ; also call cytokine storm , characterize persistent fever , markedly elevate inflammatory marker [ eg , C-reactive protein , D-dimer , ferritin ] elevate proinflammatory cytokine [ eg , IL-6 ] ) .', 'Anakinra , canakinumab , tocilizumab alternative option treatment CRS patient receive glucocorticoid refractory glucocorticoid .', 'Such decision make direction pediatric rheumatologist occur context clinical trial whenever possible .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Others ' ."", ') OUTCOME — The prognosis MIS-C uncertain , give new clinical entity understand disease still evolve .', 'Though MIS-C many similarity Kawasaki disease ( KD ) toxic shock syndrome , clear disease course MIS-C severe , child require intensive care intervention .', 'Most child survive , several death report [ 3,5,7 ] .', 'Of approximately 230 case suspect MIS-C report mid-May 2020 , least five death [ 7 ] .CASE REPORTING — Health care provider care care patient younger 21 year age meet MIS-C criterion ( table 2 ) report suspect case local , state , territorial health department .', ""Additional information find Centers Disease Control Prevention ( CDC ) website World Health Organization ( WHO ) website.SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately : ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") ● ( See `` Society guideline link : Kawasaki disease '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print email topic patient .', ""( You also locate patient education article variety subject search `` patient education '' keyword [ ] interest ."", "") ●Basics topic : • ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' ."", "") • ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ."", "") • ( See `` Patient education : Kawasaki disease ( The Basics ) '' ."", ') SUMMARY AND RECOMMENDATIONS●Coronavirus disease 2019 ( COVID-19 ) child usually mild .', 'However , rare case , child severely affect , clinical manifestation may differ adult .', 'In April 2020 , report emerge presentation child similar Kawasaki disease ( KD ) toxic shock syndrome .', 'Since , increase report similarly affect child around world .', 'The syndrome term multisystem inflammatory syndrome child ( MIS-C ) .', ""( See 'Introduction ' ."", ') ●The clinical presentation MIS-C may include persistent fever , gastrointestinal symptom ( abdominal pain , vomit , diarrhea ) , rash , conjunctivitis .', 'Patients typically present three five day fever , follow development shock .', 'Laboratory find include lymphocytopenia , elevate inflammatory marker ( C-reactive protein , erythrocyte sedimentation rate , D-dimer ) , elevate cardiac marker ( troponin , brain natriuretic peptide [ BNP ] ) .', ""( See 'Clinical manifestation ' ."", ') ●Case definition MIS-C summarize table ( table 2 ) .', 'There appear spectrum disease .', ""( See 'Case definition ' 'Spectrum disease ' ."", "") ●The initial evaluation child suspect MIS-C generally include follow , though limit evaluation may appropriate child mild presentation ( see 'Evaluation ' ) : •Laboratory test : -Complete blood cell count differential-C-reactive protein erythrocyte sedimentation rate ( optional : procalcitonin ) -Ferritin level-Liver function test lactate dehydrogenase-Serum electrolyte renal function tests-Coagulation study ( activate partial thromboplastin time , international normalize ratio/prothrombin time , D-dimer , fibrinogen , antithrombin-3 ) -Troponin-BNP-Blood culture-Cytokine panel ( available ) •Testing severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , include serology reverse transcription polymerase chain reaction ( RT-PCR ) ( see `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Microbiologic diagnosis ' ) •Testing viral bacterial pathogen ( see 'Testing pathogen ' ) •Cardiac evaluation include 12-lead electrocardiogram ( ECG ) echocardiography ( see 'Cardiac test ' ) ●Management MIS-C include follow ( see 'Management ' ) : •Multidisciplinary care – By definition , MIS-C multisystem disease , care affect child require coordination many different specialty ."", 'Infectious disease rheumatology specialist consult early .', 'Pediatric cardiologist consult patient myocardial dysfunction sign KD .', ""( See 'Multidisciplinary care ' ."", ') •Children present shock resuscitate accord standard protocol ( algorithm 1 ) .', ""( See `` Initial management shock child '' ."", ') •Empiric antibiotic therapy appropriate patient present severe multisystem involvement particularly shock .', ""( See 'Antibiotic therapy ' ."", ') •Use antiviral therapy ( eg , remdesivir ) generally limit child severe MIS-C manifestation guide infectious disease specialist , preferably context clinical trial .', ""( See 'Antiviral therapy ' ."", ') •Patients meet criterion incomplete complete KD ( table 1 ) receive standard therapy KD , include intravenous immune globulin ( IVIG ) , aspirin , , persistent sign inflammation coronary artery ( CA ) involvement , glucocorticoid ( algorithm 2 ) .', ""( See `` Kawasaki disease : Initial treatment prognosis '' `` Incomplete ( atypical ) Kawasaki disease '' ."", ') •Management myocardial dysfunction focus supportive care maintain hemodynamic stability ensure adequate systemic perfusion .', 'IVIG often use , though conclusive evidence benefit lack .', 'Continuous cardiac monitor essential arrhythmia promptly detect treat .', ""( See 'Myocardial dysfunction ' `` Treatment prognosis myocarditis child '' ."", ') •Patients MIS-C risk experience thrombotic complication , antithrombotic therapy warrant many case ( eg , low-dose aspirin patient KD , systemic anticoagulation patient moderate severe ventricular dysfunction ) .', ""( See 'Thrombotic complication ' ."", ') •The benefit risk adjunctive therapy ( glucocorticoid , IL-1 inhibitor [ eg , anakinra , canakinumab ] , IL-6 inhibitor [ eg , tocilizumab ] , convalescent plasma recover COVID-19 patient ) uncertain .', 'Consultation pediatric infectious disease rheumatology specialist advise .', ""( See 'Adjunctive immune-modifying therapy ' ."", ') •Children cardiac dysfunction CA abnormality follow-up cardiology discharge , serial echocardiography ass CA aneurysm .', ""( See 'Cardiac test ' ."", ') ●Health care provider care care patient younger 21 year age meet MIS-C criterion ( table 2 ) report suspect case local , state , territorial health department .', 'Additional information find Centers Disease Control Prevention ( CDC ) website World Health Organization ( WHO ) website .', ""( See 'Case report ' ."", ') ●The prognosis MIS-C uncertain , give new clinical entity understand disease still evolve .', 'Most child survive , though death report .', ""( See 'Outcome ' . )""]","['', 'end', '2019', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'rapidly', 'spread', '', 'result', 'epidemic', 'throughout', 'china', '', 'follow', 'increase', 'number', 'case', 'country', 'globally', '', 'february', '2020', '', 'world', 'health', 'organization', '', '', 'designate', 'disease', 'covid-19', '', 'stand', 'coronavirus', 'disease', '2019', '', '1', '', '', 'virus', 'cause', 'covid-19', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'previously', '', 'refer', '2019-ncov', '', 'declare', 'covid-19', 'pandemic', 'march', '11', '', '2020', '', '2', '', 'child', '', 'covid-19', 'usually', 'mild', '', 'however', '', 'rare', 'case', '', 'child', 'severely', 'affect', '', 'clinical', 'manifestation', 'differ', 'adult', '', 'april', '2020', '', 'report', 'emerge', 'united', 'kingdom', 'presentation', 'child', 'similar', 'incomplete', 'kawasaki', 'disease', '', 'kd', '', 'toxic', 'shock', 'syndrome', '', '34', '', '', 'since', '', 'increase', 'report', 'similarly', 'affect', 'child', 'part', 'world', '', '5-8', '', '', 'syndrome', 'term', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'mis-c', '', 'refer', 'pediatric', 'multisystem', 'inflammatory', 'syndrome', '', 'pmis', '', '', 'pediatric', 'inflammatory', 'multisystem', 'syndrome', '', 'pims', '', '', 'pediatric', 'hyperinflammatory', 'syndrome', '', 'pediatric', 'hyperinflammatory', 'shock', '', 'topic', 'outline', 'epidemiology', '', 'clinical', 'presentation', '', 'diagnosis', '', 'management', 'mis-c', 'aspect', 'covid-19', 'child', 'adult', 'discuss', 'separately', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', 'understanding', 'covid-19', 'mis-c', 'evolve', '', 'interim', 'guidance', 'issue', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', '', '5910', '', '', 'links', 'relate', 'society', 'guideline', 'find', 'elsewhere', '', '', 'society', 'guideline', 'link', '', '', '', 'epidemiology', '', 'incidence', 'mis-c', 'unknown', '', 'appear', 'rare', 'complication', 'covid-19', 'childrenthe', 'initial', 'report', 'mis-c', 'emerge', 'united', 'kingdom', 'april', '', '2020', '', '34', '', '', 'since', '', 'report', 'similarly', 'affect', 'child', 'part', 'world', '', 'include', 'europe', '', 'canada', '', 'united', 'states', '', 'majority', 'case', 'united', 'states', 'new', 'york', '', '', '5-811-13', '', 'child', 'mis-c', 'meet', 'criterion', 'complete', 'incomplete', 'kawasaki', 'disease', '', 'kd', '', '', 'clinical', 'manifestation', '', '', '', 'however', '', 'epidemiology', 'differ', 'classic', 'kd', '', 'pattern', 'emerge', 'available', 'case', 'series', 'mis-c', 'case', 'occur', 'older', 'child', 'adolescent', 'previously', 'healthy', '', '3611', '', '', 'black', 'child', 'disproportionally', 'affect', '', 'contrast', '', 'classic', 'kd', 'typically', 'affect', 'infant', 'young', 'child', 'higher', 'incidence', 'east', 'asia', 'child', 'asian', 'descent', '', '', '', 'kawasaki', 'disease', '', 'epidemiology', 'etiology', '', '', 'section', 'epidemiology', '', '', '', 'epidemiology', 'mis-c', 'differ', 'acute', 'covid-19', 'illness', 'child', '', 'tend', 'severe', 'infant', '', '1', 'year', 'age', 'child', 'underlie', 'health', 'problem', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', 'section', 'potential', 'risk', 'factor', 'severe', 'disease', '', '', '', 'first', 'report', 'mis-c', 'series', 'eight', 'child', 'tertiary', 'center', 'south', 'east', 'england', '', '3', '', '', 'three', 'subsequent', 'case', 'series', 'united', 'kingdom', '', 'n', '', '37', '', '', 'france', '', 'n', '', '35', '', '', 'new', 'york', '', 'n', '', '33', '', '', 'majority', 'child', 'previously', 'healthy', '', '95', 'percent', 'united', 'kingdom', 'series', '', '89', 'percent', 'french', 'series', '', '79', 'percent', 'new', 'york', 'series', '', '', '1114', '', '', 'common', 'comorbidities', 'obesity', 'asthma', '', 'boys', 'account', 'approximately', '60', 'percent', 'case', '', 'average', 'age', '9', '11', 'year', '', 'range', '1', '17', 'year', '', 'unclear', 'risk', 'develop', 'mis-c', 'vary', 'race', '', 'though', 'black', 'child', 'account', 'disproportionally', 'high', 'number', 'case', 'asian', 'child', 'account', 'small', 'number', 'case', 'initial', 'report', '', 'united', 'kingdom', 'series', '', '46', 'percent', 'patient', 'black', '', '19', 'percent', 'white', '', '11', 'percent', 'asian', '', '5', 'percent', 'biracial', '', '11', '', '', 'new', 'york', 'series', '', '24', 'percent', 'black', '', '27', 'percent', 'hispanic', '', '9', 'percent', 'white', '', '9', 'percent', 'asian', '', '11', '', 'based', 'pattern', 'united', 'kingdom', '', 'new', 'york', '', 'italy', '', 'lag', 'several', 'week', 'peak', 'covid-19', 'case', 'within', 'community', 'peak', 'mis-c', 'case', '', '61115', '', '', 'example', '', 'london', '', 'peak', 'covid-19', 'case', 'occur', 'first', 'second', 'week', 'april', '', 'peak', 'mis-c', 'case', 'occur', 'first', 'second', 'week', '', '1115', '', '', 'three-', 'four-week', 'lag', 'coincide', 'time', 'acquire', 'immunity', 'suggest', 'mis-c', 'represent', 'postinfectious', 'complication', 'virus', 'acute', 'infection', '', 'least', 'childrenpathophysiology', '', 'pathophysiology', 'mis-c', 'well', 'understand', '', 'suggest', 'syndrome', 'result', 'abnormal', 'immune', 'response', 'virus', '', 'similarity', 'kawasaki', 'disease', '', 'kd', '', '', 'macrophage', 'activation', 'syndrome', '', 'mas', '', '', 'cytokine', 'release', 'syndrome', '', 'mechanism', 'sars-cov-2', 'trigger', 'abnormal', 'immune', 'response', 'unknown', '', 'postinfectious', 'process', 'suggest', '', 'base', 'time', 'rise', 'case', 'relative', 'peak', 'covid-19', 'case', 'community', '', 'discuss', '', 'epidemiology', '', '', '', 'support', 'find', 'affect', 'child', 'negative', 'polymerase', 'chain', 'reaction', '', 'pcr', '', 'test', 'sars-cov-2', 'positive', 'serology', '', 'however', '', 'child', 'positive', 'pcr', 'test', '', 'early', 'case', 'series', 'united', 'kingdom', '', 'new', 'york', '', 'italy', '', '59', 'child', 'pcr', 'serology', 'perform', '', '611', '', '', '', '70', 'percent', 'positive', 'serology', 'negative', 'pcr', '', '22', 'percent', 'positive', 'test', '', '8', 'percent', 'negative', 'testsunderstanding', 'mechanism', 'exaggerate', 'immune', 'response', 'mis-c', 'area', 'active', 'investigation', '', 'pathophysiology', 'kd', '', 'mas', '', 'cytokine', 'release', 'syndrome', 'discuss', 'separately', '', '', '', 'kawasaki', 'disease', '', 'epidemiology', 'etiology', '', '', 'section', 'immunologic', 'response', '', '', 'clinical', 'feature', 'diagnosis', 'hemophagocytic', 'lymphohistiocytosis', '', '', 'section', 'pathophysiology', '', '', 'cytokine', 'release', 'syndrome', '', 'crs', '', '', '', 'section', 'pathophysiology', '', '', '', 'clinical', 'manifestationspresenting', 'symptom', '', 'available', 'case', 'report', '', 'clinical', 'presentation', 'similar', '', 'include', '', '3671114', '', '', 'persistent', 'fever', '', 'median', 'duration', 'four', 'day', '', '', '100', 'percentgastrointestinal', 'symptom', '', 'abdominal', 'pain', '', 'vomit', '', 'diarrhea', '', '', '60', '97', 'percentrash', '', '50', '60', 'percentneurocognitive', 'symptom', '', 'headache', '', 'lethargy', '', 'confusion', '', '', '30', '58', 'percentrespiratory', 'symptom', '', '32', '65', 'percentconjunctivitis', '', '32', 'percentmucous', 'membrane', 'involvement', '', '19', 'percentsore', 'throat', '', '14', 'percentswollen', 'handsfeet', '', '8', 'percentgastrointestinal', 'symptom', '', 'abdominal', 'pain', '', 'vomit', '', 'diarrhea', '', 'particularly', 'common', 'prominent', '', 'child', 'mimic', 'appendicitis', '', '1416', '', '', 'child', 'note', 'terminal', 'ileitis', 'abdominal', 'image', 'andor', 'colitis', 'colonoscopy', '', '', 'imaging', 'find', '', '', '', 'patient', 'present', 'three', 'five', 'day', 'fever', '', 'develop', 'warm', 'shock', '', 'patients', 'present', 'fewer', 'day', 'fever', 'report', '', 'shock', 'often', 'refractory', 'volume', 'resuscitation', '', 'require', 'vasopressor', '', 'case', '', 'mechanical', 'hemodynamic', 'supportpulmonary', 'involvement', 'prominent', 'feature', 'case', '', 'though', 'child', 'require', 'mechanical', 'ventilation', 'cardiovascular', 'stabilization', '', 'respiratory', 'symptom', '', 'tachypnea', '', 'labor', 'breathe', '', '', 'present', '', 'often', 'due', 'severe', 'shock', '', 'cough', 'uncommonclinical', 'find', '', 'available', 'case', 'report', '', 'common', 'clinical', 'find', 'include', '', '3671114', '', '', 'shock', '', '60', '80', 'percentcriteria', 'meet', 'complete', 'kawasaki', 'disease', '', 'kd', '', '', 'table', '1', '', '', '50', '64', 'percentmyocardial', 'dysfunction', '', 'echocardiogram', 'elevate', 'troponinbrain', 'natriuretic', 'peptide', '', 'bnp', '', '', '', '50', '100', 'percentacute', 'respiratory', 'failure', 'require', 'noninvasive', 'invasive', 'ventilation', '', '52', '68', 'percentacute', 'kidney', 'injury', '', 'case', 'mild', '', '', '38', '70', 'percentserositis', '', 'small', 'pleural', '', 'pericardial', '', 'ascitic', 'effusion', '', '', '24', '50', 'percentacute', 'hepatic', 'failure', '', '21', 'percentlaboratory', 'find', '', 'laboratory', 'abnormality', 'note', 'available', 'case', 'series', 'include', '', '367111417', '', '', 'abnormal', 'blood', 'cell', 'count', '', 'include', '', 'lymphocytopenia', '', '80', '95', 'percentneutrophilia', '', '80', '90', 'percentmild', 'anemia', '', '70', 'percentthrombocytopenia', '', '30', '80', 'percentelevated', 'inflammatory', 'marker', '', 'include', '', 'c-reactive', 'protein', '', '90', '95', 'percenterythrocyte', 'sedimentation', 'rate', '', '80', 'percentprocalcitonind-dimer', '', '80', '95', 'percentfibrinogen', '', '90', 'percentferritin', '', '75', 'percentinterleukin-6', '', 'il-inhibitor', '', 'elevated', 'cardiac', 'marker', '', 'troponin', '', '60', '90', 'percentbnp', 'nt-pro-bnp', '', '90', '100', 'percenthypoalbuminemia', '', '73', 'percentmildly', 'elevate', 'liver', 'enzyme', '', '70', 'percentelevated', 'lactate', 'dehydrogenase', '', '50', '60', 'percenthypertriglyceridemia', '', '70', 'percentimaging', 'find', '', 'findings', 'diagnostic', 'image', 'include', '', '361114', '', '', 'echocardiography', '', 'echocardiographic', 'find', 'include', 'depress', 'leave', 'ventricular', '', 'lv', '', 'function', 'coronary', 'artery', '', 'ca', '', 'abnormality', '', 'include', 'dilation', 'aneurysm', '', 'mitral', 'valve', 'regurgitation', '', 'pericardial', 'effusion', '', '14', '', '', 'approximately', '50', '60', 'percent', 'patient', 'depress', 'lv', 'function', '', 'ca', 'abnormality', 'approximately', '20', '50', 'percent', 'patient', '', 'considerably', 'higher', 'classic', 'kd', '', 'rate', 'ca', 'involvement', 'approximately', '10', '15', 'percent', '', '', '', 'cardiovascular', 'sequela', 'kawasaki', 'disease', '', 'clinical', 'feature', 'evaluation', '', '', 'section', 'coronary', 'artery', 'abnormality', '', '', '', 'chest', 'radiograph', '', 'patient', 'normal', 'chest', 'radiograph', '', 'abnormal', 'find', 'include', 'small', 'pleural', 'effusion', '', 'patchy', 'consolidation', '', 'focal', 'consolidation', '', 'atelectasiscomputed', 'tomography', '', 'ct', '', 'chest', '', 'chest', 'ct', '', 'obtain', '', 'generally', 'find', 'similar', 'chest', 'radiograph', '', 'patient', 'nodular', 'ground-glass', 'opacificationabdominal', 'image', '', 'findings', 'abdominal', 'ultrasound', 'ct', 'include', 'free', 'fluid', '', 'ascites', '', 'bowel', 'mesenteric', 'inflammation', 'include', 'terminal', 'ileitis', '', 'mesenteric', 'adenopathyadenitis', '', 'pericholecystic', 'edema', '', '16', '', 'case', 'definition', '', 'criterion', 'case', 'definition', 'vary', 'slightly', 'different', 'health', 'agency', '', 'table', '2', '', '', '5817', '', '', 'example', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'case', 'definition', 'require', 'child', 'severe', 'symptom', 'require', 'hospitalization', '', 'whereas', 'world', 'health', 'organization', '', '', 'case', '', 'advantage', 'definition', 'provide', 'detail', 'regard', 'clinical', 'sign', 'multisystem', 'involvement', '', 'definition', 'likely', 'change', 'information', 'become', 'availablecdc', 'case', 'definition', '', 'according', 'case', 'definition', 'put', 'forth', 'united', 'states', 'cdc', '', 'mis-c', 'define', 'meet', 'follow', 'criterion', '', 'table', '2', '', '', '5', '', '', 'age', '', '21', 'yearsa', 'presentation', 'consistent', 'mis-c', '', 'include', 'follow', '', 'fever', '', '380c', '24', 'hour', '', 'report', 'subjective', 'fever', 'last', '24', 'hourslaboratory', 'evidence', 'inflammation', '', 'eg', '', 'elevate', 'c-reactive', 'protein', '', 'erythrocyte', 'sedimentation', 'rate', '', 'fibrinogen', '', 'procalcitonin', '', 'd-dimer', '', 'ferritin', '', 'lactic', 'acid', 'dehydrogenase', '', 'interleukin-6', '', 'il-inhibitor', '', 'level', '', 'neutrophilia', '', 'lymphocytopenia', '', 'andor', 'hypoalbuminemia', '', 'severe', 'illness', 'require', 'hospitalization2', 'organ', 'system', 'involve', '', 'cardiac', '', 'renal', '', 'respiratory', '', 'hematologic', '', 'gastrointestinal', '', 'dermatologic', '', 'andor', 'neurologic', '', 'alternative', 'plausible', 'diagnosesrecent', 'current', 'sars-cov-2', 'infection', 'exposure', '', 'define', 'follow', '', 'positive', 'sars-cov-2', 'polymerase', 'chain', 'reaction', '', 'pcr', '', 'positive', 'serology', 'sars-cov-2positive', 'antigen', 'testcovid-19', 'exposure', 'within', 'four', 'week', 'prior', 'onset', 'symptomspatients', 'meet', 'criterion', 'fulfill', 'full', 'partial', 'criterion', 'kawasaki', 'disease', '', 'kd', '', 'consider', 'mis-c', 'report', '', 'addition', '', 'mis-c', 'consider', 'pediatric', 'death', 'evidence', 'sars-cov-2', 'infectionwho', 'case', 'definition', '', 'case', 'definition', 'put', 'forth', 'follow', '', 'table', '2', '', '', '8', '', '', 'age', '0', '19', 'year', 'old', '', 'andfever', '3', 'day', '', 'andelevated', 'marker', 'inflammation', '', 'eg', '', 'erythrocyte', 'sedimentation', 'rate', '', 'c-reactive', 'protein', '', 'procalcitonin', '', '', 'andno', 'obvious', 'microbial', 'cause', 'inflammation', '', 'include', 'bacterial', 'sepsis', 'staphylococcalstreptococcal', 'shock', 'syndrome', '', 'andevidence', 'sars-cov-2', 'infection', '', 'positive', 'reverse', 'transcription', 'pcr', '', 'rt-pcr', '', '', 'antigen', 'test', '', 'serology', '', 'contact', 'individual', 'covid-19', '', 'andclinical', 'sign', 'multisystem', 'involvement', '', 'least', 'two', 'follow', '', '', 'rash', '', 'bilateral', 'nonpurulent', 'conjunctivitis', '', 'mucocutaneous', 'inflammation', 'sign', '', 'oral', '', 'hand', '', 'foot', '', 'hypotension', 'shockcardiac', 'dysfunction', '', 'pericarditis', '', 'valvulitis', '', 'coronary', 'abnormality', '', 'include', 'echocardiographic', 'find', 'elevate', 'troponinbrain', 'natriuretic', 'peptide', '', 'bnp', '', '', 'evidence', 'coagulopathy', '', 'prolong', 'prothrombin', 'time', 'partial', 'thromboplastin', 'time', '', 'elevate', 'd-dimer', '', 'acute', 'gastrointestinal', 'symptom', '', 'diarrhea', '', 'vomit', '', 'abdominal', 'pain', '', 'spectrum', 'disease', '', 'learn', 'covid-19', 'mis-c', 'child', '', 'become', 'apparent', 'spectrum', 'disease', 'range', 'mild', 'severe', '', '11', '', '', 'understand', 'full', 'spectrum', '', 'include', 'subphenotypes', '', 'evolvingcovid-19', 'without', 'exaggerate', 'immune', 'response', '', 'child', '', 'covid-19', 'cause', 'mild', 'symptom', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', 'section', 'clinical', 'manifestation', '', '', '', 'covid-19-associated', 'febrile', 'inflammatory', 'state', '', 'child', 'present', 'persistent', 'fever', 'mild', 'symptom', '', 'eg', '', 'headache', '', 'fatigue', '', '', 'inflammatory', 'marker', '', 'especially', 'ferritin', '', 'elevate', '', 'sign', 'multisystem', 'involvement', 'lackingcovid-19-associated', 'kd', '', 'child', 'meet', 'criterion', 'complete', 'incomplete', 'kd', '', 'table', '1', '', 'develop', 'shock', 'multisystem', 'involvement', '', 'unclear', 'incidence', 'coronary', 'artery', '', 'ca', '', 'aneurysm', 'higher', 'covid-19-associated', 'kd', 'compare', 'classic', 'kd', '', 'study', '', '', '', 'kawasaki', 'disease', '', 'clinical', 'feature', 'diagnosis', '', '', '', 'covid-19-associated', 'mis-c', '', 'children', 'mis-c', 'severe', 'presentation', '', 'markedly', 'elevate', 'inflammatory', 'marker', 'multisystem', 'involvement', '', 'cardiac', 'involvement', 'shock', 'common', '', 'discuss', '', '', 'clinical', 'manifestation', '', '', '', 'remain', 'unclear', 'common', 'presentation', '', 'frequently', 'child', 'progress', 'mild', 'severe', 'manifestation', '', 'risk', 'factor', 'progression', '', 'hope', 'learn', 'full', 'spectrum', 'disease', 'additional', 'case', 'report', '', 'likely', 'case', 'definition', '', 'case', 'definition', '', '', 'change', 'information', 'become', 'availableevaluationlaboratory', 'test', '', 'initial', 'laboratory', 'evaluation', 'child', 'suspect', 'mis-c', 'depend', 'presentationmoderate', 'severe', '', 'child', 'moderate', 'severe', 'symptom', '', 'suggest', 'follow', '', 'complete', 'blood', 'cell', 'count', 'differentialc-reactive', 'protein', 'erythrocyte', 'sedimentation', 'rate', '', 'optional', '', 'procalcitonin', '', 'ferritin', 'levelliver', 'function', 'test', 'lactate', 'dehydrogenaseserum', 'electrolyte', 'renal', 'function', 'testsurinalysiscoagulation', 'study', '', 'prothrombin', 'timeinternational', 'normalize', 'ratio', '', 'activate', 'partial', 'thromboplastin', 'time', '', 'd-dimer', '', 'fibrinogen', '', 'antithrombin-3', '', 'troponin', 'creatine', 'kinase-mbbrain', 'natriuretic', 'peptide', '', 'bnp', '', '', 'nt-pro-bnpcytokine', 'panel', '', 'available', '', 'inflammatory', 'marker', '', 'c-reactive', 'protein', '', 'erythrocyte', 'sedimentation', 'rate', '', 'procalcitonin', '', 'ferritin', '', 'measure', 'time', 'admission', 'serially', 'monitor', 'progressionwell-appearing', '', 'patient', 'present', 'fever', '3', 'day', 'well-appearing', 'mild', 'symptom', 'suggestive', 'mis-c', '', 'reasonable', 'perform', 'limit', 'evaluation', 'initially', '', 'example', '', 'reasonable', 'start', 'complete', 'blood', 'count', 'c-reactive', 'protein', 'obtain', 'additional', 'test', 'abnormaltesting', 'sars-cov-2', '', 'patient', 'suspect', 'mis-c', 'test', 'sars-cov-2', '', 'include', 'serology', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'nasopharyngeal', 'swab', '', 'previously', 'discuss', '', 'affect', 'child', 'positive', 'serology', 'negative', 'pcr', '', 'though', 'positive', 'pcrs', '', 'pathophysiology', '', '', '', 'testing', 'sars-cov-2', 'discuss', 'greater', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'microbiologic', 'diagnosis', '', '', '', 'testing', 'pathogen', '', 'testing', 'viral', 'bacterial', 'pathogen', 'include', '', '17', '', '', 'blood', 'cultureurine', 'culturethroat', 'culturestool', 'culturenasopharyngeal', 'aspirate', 'throat', 'swab', 'respiratory', 'viral', 'panelepstein-barr', 'virus', 'serology', 'pcrcytomegalovirus', 'serology', 'pcrenterovirus', 'pcradenovirus', 'pcrthis', 'test', 'appropriate', 'child', 'moderate', 'severe', 'mis-c', '', 'ie', '', 'child', 'require', 'hospitalization', '', '', 'however', '', 'extensive', 'infectious', 'work-up', 'generally', 'necessary', 'well-appearing', 'child', 'present', 'mild', 'symptom', '', 'patient', '', 'microbiologic', 'test', 'clinically', 'indicate', 'accord', 'age', 'child', 'hisher', 'specific', 'symptom', '', 'eg', '', 'throat', 'culture', 'child', 'sore', 'throat', '', 'respiratory', 'viral', 'panel', 'respiratory', 'symptom', '', '', 'testing', 'follow', 'general', 'approach', 'fever', 'evaluation', 'broadly', '', '', '', 'fever', 'without', 'source', 'child', '3', '36', 'month', 'age', '', 'evaluation', 'management', '', '', '', 'detection', 'respiratory', 'pathogen', '', 'eg', '', 'rhinovirus', '', 'influenza', '', 'respiratory', 'syncytial', 'virus', '', 'nasopharyngeal', 'specimen', 'exclude', 'covid-19additional', 'test', 'pathogen', 'warrant', '', 'depend', 'geographic', 'location', 'exposure', 'history', '', 'include', '', 'murine', 'typhusleptospirosis', 'serologycardiac', 'test', '', 'addition', 'troponin', 'bnpnt-pro-bnp', 'level', '', 'cardiac', 'evaluation', 'patient', 'suspect', 'mis-c', 'include', '12-lead', 'electrocardiogram', '', 'ecg', '', 'echocardiography', '', 'echocardiography', 'recommend', 'child', 'document', 'sars-cov-2', 'meet', 'criterion', 'mis-c', 'either', 'shock', 'feature', 'consistent', 'incomplete', 'complete', 'kawasaki', 'disease', '', 'kd', '', 'children', 'adolescent', 'mild', 'covid-19', 'without', 'sign', 'systemic', 'inflammation', 'unlikely', 'coronary', 'artery', '', 'ca', '', 'change', 'myocarditis', '', 'child', '', 'echocardiography', 'generally', 'necessary', 'consider', 'specific', 'clinical', 'concernsin', 'child', 'mis-c', '', 'baseline', 'ecgs', 'nonspecific', '', 'though', 'arrhythmia', 'heart', 'block', 'describe', '', '318', '', '', 'findings', 'initial', 'echocardiography', 'include', 'ca', 'dilation', '', 'leave', 'ventricular', '', 'lv', '', 'systolic', 'dysfunction', '', 'pericardial', 'effusion', '', 'ca', 'abnormality', 'progress', 'aneurysm', '', 'include', 'giant', 'coronary', 'aneurysm', '', '3', '', 'echocardiographic', 'evaluation', '', 'echocardiographic', 'evaluation', 'include', 'follow', '', 'quantitative', 'assessment', 'lv', 'size', 'systolic', 'function', '', 'lv', 'end-diastolic', 'volume', '', 'ejection', 'fraction', '', 'qualitative', 'assessment', 'ventricular', 'systolic', 'functionca', 'abnormality', '', 'dilation', 'aneurysm', '', 'assessment', 'valvar', 'functionevaluation', 'presence', 'size', 'pericardial', 'effusionevaluation', 'intracardiac', 'thrombosis', 'andor', 'pulmonary', 'artery', 'thrombosis', '', 'particularly', 'apical', 'thrombus', 'severe', 'lv', 'dysfunctionstrain', 'image', 'lv', 'diastolic', 'function', '', 'optional', '', 'ca', 'assessment', 'base', 'z-scores', '', 'classification', 'schema', 'kd', '', 'table', '3', '', '', 'discuss', 'separately', '', '', '', 'cardiovascular', 'sequela', 'kawasaki', 'disease', '', 'clinical', 'feature', 'evaluation', '', '', 'section', 'echocardiography', '', '', '', 'timing', 'follow-up', 'echocardiography', '', 'center', '', 'echocardiography', 'perform', 'time', 'diagnosis', '', 'follow-up', 'examination', 'follow', 'interval', '', 'patient', 'initially', 'normal', 'function', 'normal', 'ca', 'dimension', '', 'follow-up', 'echocardiogram', 'perform', 'one', 'two', 'week', 'post-diagnosis', 'recheck', 'ca', 'sizein', 'patient', 'ca', 'dilationaneurysm', 'initial', 'echocardiogram', '', 'echocardiography', 'repeat', 'every', 'two', 'three', 'day', 'ca', 'size', 'stable', 'approximately', 'weekfor', 'patient', 'systolic', 'dysfunctionmyocarditis', 'normal', 'cas', 'initial', 'echocardiogram', '', 'echocardiogram', 'repeat', 'clinically', 'indicate', '', 'include', 'repeat', 'image', 'cas', 'studyfor', 'patient', 'evidence', 'ca', 'involvement', 'systolic', 'dysfunctionmyocarditis', 'acute', 'phase', '', 'cardiac', 'magnetic', 'resonance', 'image', 'consider', 'approximately', 'one', 'three', 'month', 'acute', 'illness', 'ass', 'ventricular', 'function', 'evaluate', 'edema', '', 'diffuse', 'fibrosis', '', 'scar', 'myocardial', 'delay', 'enhancementdifferential', 'diagnosis', '', 'child', 'present', 'sign', 'symptom', 'consistent', 'mis-c', '', 'differential', 'diagnosis', 'broad', 'include', 'infectious', 'inflammatory', 'condition', '', 'bacterial', 'sepsis', '', 'bacterial', 'sepsis', 'important', 'consideration', 'child', 'present', 'fever', '', 'shock', '', 'elevate', 'inflammatory', 'marker', '', 'child', 'suspect', 'moderate', 'severe', 'mis-c', 'blood', 'culture', 'send', '', 'empiric', 'antibiotic', 'administer', 'pending', 'culture', 'result', '', 'antibiotic', 'therapy', '', '', '', 'certain', 'clinical', 'feature', 'help', 'distinguish', 'mis-c', 'bacterial', 'sepsis', '', 'example', '', 'cardiac', 'involvement', '', 'particularly', 'coronary', 'artery', '', 'ca', '', 'involvement', '', 'uncommon', 'bacterial', 'sepsis', '', 'ultimately', '', 'microbiologic', 'test', '', 'ie', '', 'sars-cov-2', 'test', '', 'bacterial', 'culture', '', 'necessary', 'distinction', '', '', '', 'systemic', 'inflammatory', 'response', 'syndrome', '', 'sirs', '', 'sepsis', 'child', '', 'definitions', '', 'epidemiology', '', 'clinical', 'manifestation', '', 'diagnosis', '', '', '', 'kawasaki', 'disease', '', 'kd', '', '', 'child', 'along', 'mis-c', 'spectrum', 'meet', 'criterion', 'complete', 'incomplete', 'kd', '', 'table', '1', '', '', 'spectrum', 'disease', '', '', '', 'however', '', 'appear', 'key', 'difference', '', 'example', '', 'mis-c', 'appear', 'affect', 'older', 'child', 'adolescent', '', 'whereas', 'classic', 'kd', 'typically', 'affect', 'infant', 'young', 'child', '', 'addition', '', 'risk', 'ca', 'involvement', 'myocardial', 'dysfunction', 'higher', 'mis-c', 'compare', 'classic', 'kd', '', 'kd', 'shock', 'syndrome', 'well', 'describe', 'common', 'classic', 'kd', 'population', '', 'whereas', 'shock', 'prominent', 'presentation', 'mis-c', '', 'ultimately', '', 'designation', 'mis-c', 'versus', 'kd', 'base', 'sars-cov-2', 'test', '', 'patients', 'positive', 'sars-cov-2', 'test', '', 'exposure', 'individual', 'covid-19', '', 'fulfill', 'full', 'partial', 'criterion', 'kd', 'consider', 'mis-c', 'receive', 'standard', 'treatment', 'kd', '', '', '', 'kawasaki', 'disease', '', 'clinical', 'feature', 'diagnosis', '', '', '', 'toxic', 'shock', 'syndrome', '', 'staphylococcal', 'streptococcal', 'toxic', 'shock', 'syndrome', 'share', 'similarity', 'mis-c', '', 'table', '4', '', '', 'microbiologic', 'test', '', 'ie', '', 'sars-cov-2', 'test', '', 'bacterial', 'culture', '', 'necessary', 'distinction', '', '', '', 'staphylococcal', 'toxic', 'shock', 'syndrome', '', '', 'invasive', 'group', 'streptococcal', 'infection', 'toxic', 'shock', 'syndrome', '', 'epidemiology', '', 'clinical', 'manifestation', '', 'diagnosis', '', '', '', 'appendicitis', '', 'discuss', '', 'child', 'mis-c', 'present', 'fever', 'associate', 'abdominal', 'pain', 'vomit', '', 'presenting', 'symptom', '', '', '', 'mimic', 'presentation', 'acute', 'appendicitis', '', 'abdominal', 'image', 'necessary', 'distinction', '', '', 'imaging', 'find', '', '', 'acute', 'appendicitis', 'child', '', 'clinical', 'manifestation', 'diagnosis', '', '', '', 'viral', 'infection', '', 'viral', 'pathogen', 'manifest', 'multisystem', 'involvement', 'andor', 'myocarditis', 'include', 'epstein-barr', 'virus', '', 'cytomegalovirus', '', 'adenovirus', '', 'enterovirus', '', 'virus', 'rarely', 'cause', 'severe', 'multisystem', 'disease', 'immunocompetent', 'child', '', 'serology', 'polymerase', 'chain', 'reaction', '', 'pcr', '', 'test', 'distinguish', 'covid-19-related', 'mis-c', '', '', 'clinical', 'manifestation', 'treatment', 'epstein-barr', 'virus', 'infection', '', '', 'overview', 'cytomegalovirus', 'infection', 'child', '', '', 'pathogenesis', '', 'epidemiology', '', 'clinical', 'manifestation', 'adenovirus', 'infection', '', '', '', 'hemophagocytic', 'lymphohistiocytosis', '', 'hlh', '', 'macrophage', 'activation', 'syndrome', '', 'mas', '', '', 'hlh', 'mas', 'aggressive', 'life-threatening', 'condition', 'feature', 'common', 'mis-c', 'hlhmas', 'syndrome', 'excessive', 'immune', 'activation', 'occur', 'previously', 'healthy', 'child', '', 'often', 'trigger', 'infection', '', 'child', 'underlie', 'rheumatologic', 'condition', '', 'child', 'hlhmas', 'acutely', 'ill', 'multiorgan', 'involvement', '', 'cytopenia', '', 'liver', 'function', 'abnormality', '', 'neurologic', 'symptom', '', 'cardiac', 'gastrointestinal', 'involvement', 'le', 'common', '', 'neurologic', 'symptom', 'prominent', '', 'diagnosis', 'mashlh', 'require', 'specialize', 'immunologic', 'test', '', 'discuss', 'separately', '', '', '', 'clinical', 'feature', 'diagnosis', 'hemophagocytic', 'lymphohistiocytosis', '', '', 'section', 'specialized', 'test', '', '', '', 'systemic', 'lupus', 'erythematosus', '', 'sle', '', '', 'sle', 'present', 'fulminant', 'multisystem', 'illness', '', 'patient', 'generally', 'considerable', 'kidney', 'central', 'nervous', 'system', 'involvement', '', 'common', 'feature', 'mis-c', '', 'addition', '', 'though', 'patient', 'sle', 'present', 'acutely', 'fulminant', 'illness', '', 'report', 'feel', 'fatigue', 'unwell', 'extend', 'period', 'time', 'prior', 'onset', 'severe', 'symptom', '', 'case', 'mis-c', '', 'child', 'completely', 'well', 'prior', 'acute', 'onset', 'febrile', 'illness', '', '', '', 'childhood-onset', 'systemic', 'lupus', 'erythematosus', '', 'sle', '', '', 'clinical', 'manifestation', 'diagnosis', '', '', '', 'vasculitis', '', 'vasculitides', 'present', 'fever', '', 'rash', '', 'elevate', 'inflammatory', 'marker', '', 'rashes', 'covid-19-associated', 'illness', 'appearance', 'mimic', 'vasculitis', '', 'eg', '', 'pernio', '', 'chilblain', '', '-like', 'lesion', 'acral', 'surface', '', 'sometimes', 'refer', '', 'covid', 'toe', '', '', '', 'vasculitic', '', '', '', 'vasculitis', 'child', '', 'evaluation', 'overview', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cutaneous', 'manifestation', 'issue', 'relate', 'dermatologic', 'care', '', '', 'section', 'cutaneous', 'manifestation', 'covid-19', '', '', '', 'managementsetting', 'care', '', 'children', 'moderate', 'severe', 'sign', 'symptom', 'admit', 'hospital', '', 'level', 'care', 'determine', 'severity', 'illness', '', 'admission', 'pediatric', 'intensive', 'care', 'unit', 'appropriate', 'child', 'hemodynamic', 'instability', '', 'shock', '', 'arrhythmia', '', '', 'significant', 'respiratory', 'compromise', '', 'potentially', 'life-threatening', 'complication', '', 'available', 'case', 'series', '', 'patient', 'require', 'pediatric', 'intensive', 'care', 'unit', 'care', '', '34611', '', 'reasonable', 'manage', 'select', 'patient', 'mild', 'symptom', 'outpatient', 'set', '', 'however', '', 'give', 'uncertainty', 'regard', 'risk', 'progression', 'mild', 'severe', '', 'spectrum', 'disease', '', '', '', 'hospital', 'admission', 'advise', 'patient', 'markedly', 'elevate', 'inflammatory', 'marker', 'level', 'monitor', 'trend', 'downfor', 'child', 'manage', 'outpatient', 'set', '', 'critical', 'provide', 'instruction', 'seek', 'care', 'ensure', 'appropriate', 'follow-up', '', 'child', 'follow-up', 'within', '48', 'hour', 'persistently', 'febrile', '', 'follow-up', 'include', 'clinical', 'assessment', 'repeat', 'laboratory', 'testingmultidisciplinary', 'care', '', 'definition', '', 'mis-c', 'multisystem', 'disease', '', 'care', 'affect', 'child', 'require', 'coordination', 'different', 'specialty', '', 'include', '', 'pediatric', 'infectious', 'disease', 'specialistspediatric', 'rheumatologistspediatric', 'cardiologistspediatric', 'intensivistspediatric', 'hematologistsantimicrobial', 'therapyantibiotic', 'therapy', '', 'mis-c', 'present', 'sign', 'symptom', 'mimic', 'septic', 'shock', 'toxic', 'shock', 'syndrome', '', 'thus', '', 'patient', 'present', 'severe', 'multisystem', 'involvement', '', 'particularly', 'shock', '', 'receive', 'prompt', 'empiric', 'broad-spectrum', 'antibiotic', 'therapy', 'pending', 'culture', 'result', '', 'appropriate', 'empiric', 'regimen', 'consist', 'ceftriaxone', 'plus', 'vancomycin', '', 'ceftaroline', 'plus', 'piperacillin-tazobactam', 'alternative', 'regimen', '', 'particularly', 'child', 'acute', 'kidney', 'injury', '', 'clindamycin', 'add', 'feature', 'consistent', 'toxin-mediated', 'illness', '', 'eg', '', 'erythroderma', '', '', 'antibiotics', 'discontinue', 'bacterial', 'infection', 'exclude', 'child', 'clinical', 'status', 'stabilize', '', '', '', 'septic', 'shock', 'child', '', 'rapid', 'recognition', 'initial', 'resuscitation', '', 'first', 'hour', '', '', '', 'section', 'empiric', 'regimen', '', '', 'staphylococcal', 'toxic', 'shock', 'syndrome', '', '', 'section', 'empiric', 'therapy', '', '', '', 'antiviral', 'therapy', '', 'role', 'sars-cov-2', 'antiviral', 'therapy', '', 'eg', '', 'remdesivir', '', 'management', 'mis-c', 'uncertain', '', 'patient', 'polymerase', 'chain', 'reaction', '', 'pcr', '', '-negative', 'sars-cov-2', '', 'mis-c', 'represent', 'postinfectious', 'complication', 'active', 'infection', '', 'pathophysiology', '', '', '', 'however', '', 'child', 'positive', 'pcr', 'test', 'current', 'infection', '', 'thus', '', 'antiviral', 'therapy', 'potential', 'impact', 'disease', 'process', '', '', 'patient', '', 'antiviral', 'agent', 'generally', 'limit', 'child', 'severe', 'mis-c', 'manifestation', '', 'advise', 'consultation', 'infectious', 'disease', 'specialist', 'guide', 'decision-making', '', 'choice', 'sars-cov-2', 'antiviral', 'agent', '', 'dose', '', 'side', 'effect', '', 'monitor', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', 'section', 'antiviral', 'therapy', 'select', 'patient', '', '', '', 'additional', 'therapy', 'base', 'presentation', '', 'additional', 'therapy', 'depend', 'clinical', 'presentation', '', 'presentation', 'overlap', '', 'appropriate', 'provide', 'intervention', 'one', 'category', '', 'example', '', 'patient', 'present', 'kawasaki', 'disease', '', 'kd', '', 'associate', 'warm', 'shock', 'receive', 'treatment', 'kd', '', 'ie', 'intravenous', 'immune', 'globulin', '', 'ivig', '', 'aspirin', '', 'appropriate', 'hemodynamic', 'support', '', 'ie', '', 'volume', 'expansion', 'epinephrine', '', 'shock', '', 'children', 'present', 'shock', 'resuscitate', 'accord', 'standard', 'protocol', '', 'algorithm', '1', '', '', 'available', 'case', 'series', '', 'child', 'mis-c', 'present', 'warm', 'shock', 'refractory', 'volume', 'expansion', '', 'epinephrine', 'prefer', 'vasoactive', 'agent', 'management', 'warm', 'shock', 'child', '', 'child', 'present', 'significant', 'ventricular', 'dysfunction', '', 'milrinone', 'helpful', '', 'management', 'shock', 'pediatric', 'patient', 'discuss', 'greater', 'detail', 'separately', '', '', '', 'initial', 'management', 'shock', 'child', '', '', '', 'features', 'kawasaki', 'disease', '', 'patients', 'meet', 'criterion', 'incomplete', 'complete', 'kd', '', 'table', '1', '', 'receive', 'standard', 'therapy', 'kd', '', 'include', 'ivig', '', 'aspirin', '', '', 'persistent', 'sign', 'inflammation', 'coronary', 'artery', '', 'ca', '', 'dilationaneurysm', '', 'glucocorticoid', '', 'treatment', 'kd', 'summarize', 'figure', '', 'algorithm', '2', '', 'discuss', 'greater', 'detail', 'separately', '', '', '', 'kawasaki', 'disease', '', 'initial', 'treatment', 'prognosis', '', '', 'incomplete', '', 'atypical', '', 'kawasaki', 'disease', '', '', '', 'myocardial', 'dysfunction', '', 'acute', 'inflammatory', 'phase', 'illness', '', 'child', 'myocardial', 'dysfunction', 'present', 'arrhythmia', 'hemodynamic', 'compromise', '', 'serial', 'echocardiographic', 'assessment', 'cardiac', 'function', 'monitor', 'brain', 'natriuretic', 'peptide', '', 'bnp', '', 'troponin', 'level', 'help', 'guide', 'therapy', '', 'management', 'focus', 'supportive', 'care', 'maintain', 'hemodynamic', 'stability', 'ensure', 'adequate', 'systemic', 'perfusion', '', 'ivig', 'often', 'severe', 'case', 'clinical', 'picture', 'consistent', 'myocarditis', '', 'though', 'conclusive', 'evidence', 'benefit', '', 'continuous', 'cardiac', 'monitor', 'essential', 'arrhythmia', 'promptly', 'detect', 'treat', '', 'patients', 'significant', 'ventricular', 'dysfunction', 'treat', 'intravenous', 'diuretic', 'inotropic', 'agent', '', 'milrinone', '', 'dopamine', '', 'dobutamine', '', 'case', 'fulminant', 'disease', '', 'mechanical', 'hemodynamic', 'support', 'necessary', 'form', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'ventricular', 'assist', 'device', '', 'management', 'myocarditis', 'discuss', 'separately', '', '', '', 'treatment', 'prognosis', 'myocarditis', 'child', '', '', '', 'thrombotic', 'complication', '', 'patients', 'mis-c', 'risk', 'experience', 'thrombotic', 'complication', '', 'example', '', 'patient', 'kd', 'large', 'giant', 'ca', 'aneurysm', 'risk', 'myocardial', 'infarction', '', 'addition', '', 'patient', 'risk', 'venous', 'thromboembolism', '', 'vte', '', '', 'include', 'pulmonary', 'embolus', '', 'due', 'hypercoagulability', 'associate', 'covid-19', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'patients', 'feature', 'kd', '', 'patient', 'meet', 'criterion', 'complete', 'incomplete', 'kd', 'receive', 'antithrombotic', 'therapy', '', '', 'minimum', '', 'include', 'low-dose', 'aspirin', '', 'additional', 'antiplatelet', 'andor', 'anticoagulant', 'therapy', 'warrant', 'select', 'patient', '', 'depend', 'degree', 'ca', 'dilation', '', 'summarize', 'figure', '', 'algorithm', '3', '', 'discuss', 'separately', '', '', '', 'cardiovascular', 'sequela', 'kawasaki', 'disease', '', 'management', 'prognosis', '', '', 'section', 'prevention', 'coronary', 'thrombosis', '', '', '', 'patients', 'leave', 'ventricular', '', 'lv', '', 'dysfunction', '', 'systemic', 'anticoagulation', 'appropriate', 'patient', 'moderate', 'severe', 'lv', 'dysfunction', '', 'discuss', 'separately', '', '', '', 'treatment', 'prognosis', 'myocarditis', 'child', '', '', 'section', 'anticoagulation', '', '', '', 'patient', '', 'patient', 'without', 'kd', 'significant', 'lv', 'dysfunction', '', 'decision', 'initiate', 'therapy', 'prevention', 'vte', 'individualize', '', 'diagnosis', 'covid-19-related', 'mis-c', 'consider', 'major', 'risk', 'factor', 'vte', '', 'vte', 'prophylaxis', 'generally', 'appropriate', 'older', 'child', 'adolescent', 'hospitalize', 'moderate', 'severe', 'mis-c', '', 'provide', 'bleed', 'risk', 'low', '', 'infant', 'young', 'child', '', 'decision', 'case-by-case', 'basis', '', 'weigh', 'vte', 'risk', 'factor', 'patient', 'bleed', 'risk', '', 'vte', 'prophylaxis', '', 'low', 'molecular', 'weight', 'heparin', 'generally', 'prefer', 'agent', '', 'nonpharmacologic', 'strategy', 'vte', 'prophylaxis', '', 'eg', '', 'intermittent', 'pneumatic', 'compression', 'device', '', 'size', 'permit', '', 'early', 'mobilization', '', 'encourage', '', 'mis-c-related', 'coagulopathy', 'merit', 'higher', 'level', 'intervention', '', 'approach', 'vte', 'prophylaxis', 'hospitalize', 'child', 'discuss', 'greater', 'detail', 'separately', '', '', '', 'venous', 'thrombosis', 'thromboembolism', 'child', '', 'treatment', '', 'prevention', '', 'outcome', '', '', 'section', 'venous', 'thromboembolism', 'prophylaxis', '', '', '', 'adjunctive', 'immune-modifying', 'therapy', '', 'benefit', 'risk', 'adjunctive', 'therapy', '', 'glucocorticoid', '', 'interleukin-1', '', 'il-inhibitor', '', 'inhibitor', '', 'eg', '', 'anakinra', '', 'canakinumab', '', '', 'il-inhibitor', 'inhibitor', '', 'eg', '', 'tocilizumab', '', '', 'convalescent', 'plasma', 'recover', 'covid-19', 'patient', '', 'uncertain', '', 'consultation', 'pediatric', 'infectious', 'disease', 'rheumatology', 'specialist', 'advise', '', 'decision', 'adjunctive', 'therapy', 'case-by-case', 'basis', '', 'accord', 'disease', 'severity', 'marker', 'inflammation', 'active', 'sars-cov-2', 'infectionas', 'discuss', '', 'glucocorticoid', 'appropriate', 'patient', 'feature', 'kd', 'persistent', 'fever', 'ivig', 'ca', 'dilationaneurysm', '', 'features', 'kawasaki', 'disease', '', '', '', 'addition', '', 'glucocorticoid', 'consider', 'patient', 'cytokine', 'release', 'syndrome', '', 'crs', '', 'call', 'cytokine', 'storm', '', 'characterize', 'persistent', 'fever', '', 'markedly', 'elevate', 'inflammatory', 'marker', '', 'eg', '', 'c-reactive', 'protein', '', 'd-dimer', '', 'ferritin', '', 'elevate', 'proinflammatory', 'cytokine', '', 'eg', '', 'il-inhibitor', '', '', '', 'anakinra', '', 'canakinumab', '', 'tocilizumab', 'alternative', 'option', 'treatment', 'crs', 'patient', 'receive', 'glucocorticoid', 'refractory', 'glucocorticoid', '', 'decision', 'direction', 'pediatric', 'rheumatologist', 'occur', 'context', 'clinical', 'trial', 'whenever', 'possible', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'others', '', '', '', 'outcome', '', 'prognosis', 'mis-c', 'uncertain', '', 'give', 'new', 'clinical', 'entity', 'understand', 'disease', 'still', 'evolve', '', 'though', 'mis-c', 'similarity', 'kawasaki', 'disease', '', 'kd', '', 'toxic', 'shock', 'syndrome', '', 'clear', 'disease', 'course', 'mis-c', 'severe', '', 'child', 'require', 'intensive', 'care', 'intervention', '', 'child', 'survive', '', 'several', 'death', 'report', '', '357', '', '', 'approximately', '230', 'case', 'suspect', 'mis-c', 'report', 'mid-may', '2020', '', 'least', 'five', 'death', '', '7', '', 'case', 'reporting', '', 'health', 'care', 'provider', 'care', 'care', 'patient', 'younger', '21', 'year', 'age', 'meet', 'mis-c', 'criterion', '', 'table', '2', '', 'report', 'suspect', 'case', 'local', '', 'state', '', 'territorial', 'health', 'department', '', 'additional', 'information', 'find', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'website', 'world', 'health', 'organization', '', '', 'websitesociety', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'kawasaki', 'disease', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'email', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'education', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', '', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', '', '', '', '', 'patient', 'education', '', 'kawasaki', 'disease', '', 'basics', '', '', '', '', 'summary', 'recommendationscoronavirus', 'disease', '2019', '', 'covid-19', '', 'child', 'usually', 'mild', '', 'however', '', 'rare', 'case', '', 'child', 'severely', 'affect', '', 'clinical', 'manifestation', 'differ', 'adult', '', 'april', '2020', '', 'report', 'emerge', 'presentation', 'child', 'similar', 'kawasaki', 'disease', '', 'kd', '', 'toxic', 'shock', 'syndrome', '', 'since', '', 'increase', 'report', 'similarly', 'affect', 'child', 'around', 'world', '', 'syndrome', 'term', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'mis-c', '', '', '', '', '', '', 'clinical', 'presentation', 'mis-c', 'include', 'persistent', 'fever', '', 'gastrointestinal', 'symptom', '', 'abdominal', 'pain', '', 'vomit', '', 'diarrhea', '', '', 'rash', '', 'conjunctivitis', '', 'patients', 'typically', 'present', 'three', 'five', 'day', 'fever', '', 'follow', 'development', 'shock', '', 'laboratory', 'find', 'include', 'lymphocytopenia', '', 'elevate', 'inflammatory', 'marker', '', 'c-reactive', 'protein', '', 'erythrocyte', 'sedimentation', 'rate', '', 'd-dimer', '', '', 'elevate', 'cardiac', 'marker', '', 'troponin', '', 'brain', 'natriuretic', 'peptide', '', 'bnp', '', '', '', '', 'clinical', 'manifestation', '', '', '', 'case', 'definition', 'mis-c', 'summarize', 'table', '', 'table', '2', '', '', 'appear', 'spectrum', 'disease', '', '', 'case', 'definition', '', 'spectrum', 'disease', '', '', '', 'initial', 'evaluation', 'child', 'suspect', 'mis-c', 'generally', 'include', 'follow', '', 'though', 'limit', 'evaluation', 'appropriate', 'child', 'mild', 'presentation', '', 'evaluation', '', '', '', 'laboratory', 'test', '', '-complete', 'blood', 'cell', 'count', 'differential-c-reactive', 'protein', 'erythrocyte', 'sedimentation', 'rate', '', 'optional', '', 'procalcitonin', '', '-ferritin', 'level-liver', 'function', 'test', 'lactate', 'dehydrogenase-serum', 'electrolyte', 'renal', 'function', 'tests-coagulation', 'study', '', 'activate', 'partial', 'thromboplastin', 'time', '', 'international', 'normalize', 'ratioprothrombin', 'time', '', 'd-dimer', '', 'fibrinogen', '', 'antithrombin-3', '', '-troponin-bnp-blood', 'culture-cytokine', 'panel', '', 'available', '', 'testing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'include', 'serology', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'microbiologic', 'diagnosis', '', '', 'testing', 'viral', 'bacterial', 'pathogen', '', 'testing', 'pathogen', '', '', 'cardiac', 'evaluation', 'include', '12-lead', 'electrocardiogram', '', 'ecg', '', 'echocardiography', '', 'cardiac', 'test', '', '', 'management', 'mis-c', 'include', 'follow', '', 'management', '', '', '', 'multidisciplinary', 'care', '', 'definition', '', 'mis-c', 'multisystem', 'disease', '', 'care', 'affect', 'child', 'require', 'coordination', 'different', 'specialty', '', 'infectious', 'disease', 'rheumatology', 'specialist', 'consult', 'early', '', 'pediatric', 'cardiologist', 'consult', 'patient', 'myocardial', 'dysfunction', 'sign', 'kd', '', '', 'multidisciplinary', 'care', '', '', '', 'children', 'present', 'shock', 'resuscitate', 'accord', 'standard', 'protocol', '', 'algorithm', '1', '', '', '', '', 'initial', 'management', 'shock', 'child', '', '', '', 'empiric', 'antibiotic', 'therapy', 'appropriate', 'patient', 'present', 'severe', 'multisystem', 'involvement', 'particularly', 'shock', '', '', 'antibiotic', 'therapy', '', '', '', 'antiviral', 'therapy', '', 'eg', '', 'remdesivir', '', 'generally', 'limit', 'child', 'severe', 'mis-c', 'manifestation', 'guide', 'infectious', 'disease', 'specialist', '', 'preferably', 'context', 'clinical', 'trial', '', '', 'antiviral', 'therapy', '', '', '', 'patients', 'meet', 'criterion', 'incomplete', 'complete', 'kd', '', 'table', '1', '', 'receive', 'standard', 'therapy', 'kd', '', 'include', 'intravenous', 'immune', 'globulin', '', 'ivig', '', '', 'aspirin', '', '', 'persistent', 'sign', 'inflammation', 'coronary', 'artery', '', 'ca', '', 'involvement', '', 'glucocorticoid', '', 'algorithm', '2', '', '', '', '', 'kawasaki', 'disease', '', 'initial', 'treatment', 'prognosis', '', '', 'incomplete', '', 'atypical', '', 'kawasaki', 'disease', '', '', '', 'management', 'myocardial', 'dysfunction', 'focus', 'supportive', 'care', 'maintain', 'hemodynamic', 'stability', 'ensure', 'adequate', 'systemic', 'perfusion', '', 'ivig', 'often', '', 'though', 'conclusive', 'evidence', 'benefit', '', 'continuous', 'cardiac', 'monitor', 'essential', 'arrhythmia', 'promptly', 'detect', 'treat', '', '', 'myocardial', 'dysfunction', '', '', 'treatment', 'prognosis', 'myocarditis', 'child', '', '', '', 'patients', 'mis-c', 'risk', 'experience', 'thrombotic', 'complication', '', 'antithrombotic', 'therapy', 'warrant', 'case', '', 'eg', '', 'low-dose', 'aspirin', 'patient', 'kd', '', 'systemic', 'anticoagulation', 'patient', 'moderate', 'severe', 'ventricular', 'dysfunction', '', '', '', 'thrombotic', 'complication', '', '', '', 'benefit', 'risk', 'adjunctive', 'therapy', '', 'glucocorticoid', '', 'il-inhibitor', 'inhibitor', '', 'eg', '', 'anakinra', '', 'canakinumab', '', '', 'il-inhibitor', 'inhibitor', '', 'eg', '', 'tocilizumab', '', '', 'convalescent', 'plasma', 'recover', 'covid-19', 'patient', '', 'uncertain', '', 'consultation', 'pediatric', 'infectious', 'disease', 'rheumatology', 'specialist', 'advise', '', '', 'adjunctive', 'immune-modifying', 'therapy', '', '', '', 'children', 'cardiac', 'dysfunction', 'ca', 'abnormality', 'follow-up', 'cardiology', 'discharge', '', 'serial', 'echocardiography', 'ass', 'ca', 'aneurysm', '', '', 'cardiac', 'test', '', '', '', 'health', 'care', 'provider', 'care', 'care', 'patient', 'younger', '21', 'year', 'age', 'meet', 'mis-c', 'criterion', '', 'table', '2', '', 'report', 'suspect', 'case', 'local', '', 'state', '', 'territorial', 'health', 'department', '', 'additional', 'information', 'find', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'website', 'world', 'health', 'organization', '', '', 'website', '', '', 'case', 'report', '', '', '', 'prognosis', 'mis-c', 'uncertain', '', 'give', 'new', 'clinical', 'entity', 'understand', 'disease', 'still', 'evolve', '', 'child', 'survive', '', 'though', 'death', 'report', '', '', 'outcome', '', '', '']",5489,"{'': 1562, 'child': 97, 'disease': 75, 'mis-c': 68, 'patient': 58, 'case': 48, 'covid-19': 41, 'kd': 40, 'include': 38, 'clinical': 37, 'shock': 36, 'syndrome': 29, 'severe': 28, 'test': 26, 'therapy': 26, 'kawasaki': 25, 'coronavirus': 24, 'care': 24, 'symptom': 24, '2019': 23}","{'tocilizumab': 3, 'infection': 13, 'sars-cov-2': 20, 'il-inhibitor': 8}",44,0.5994
ID:127965,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'gastrointestinal', 'disease', 'adult']","['INTRODUCTION — At end 2019 , SARS-CoV-2 , novel coronavirus identify cause cluster pneumonia case Wuhan , city Hubei Province China .', 'Coronavirus disease 2019 ( COVID-19 ) primarily manifest lung infection symptom range mild upper respiratory infection severe pneumonia , acute respiratory distress syndrome , death .', 'COVID-19 disproportionately affect patient pre-existing comorbidities and/or older adult .', 'All medical professional , include gastroenterology hepatology clinician , task rapidly adjust practice curtail spread COVID-19 , provide care patients.This topic discus COVID-19-related issue patient gastrointestinal liver disease .', 'As understand COVID-19 illness continue evolve , approach diagnosis management may require modification well .', ""Other important aspect COVID-19 infection discuss detail separately : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' . )"", ""● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", ') POSSIBLE RISK FACTORS FOR COVID-19 — Some patient chronic gastrointestinal ( GI ) liver disease may increase risk COVID-19 severe illness .', 'Potential risk factor patient include chronic inflammatory disease , comorbidities ( eg , diabetes mellitus ) , immune-modifying therapy , need regular office , endoscopy center , laboratory visit .', ""These patient group include [ 1 ] : ●Patients cirrhosis●Patients chronic cholestatic liver disease ( eg , primary sclerosing cholangitis , primary biliary cholangitis ) ●Liver transplantation recipient [ 2 ] ( see `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' ) For patient inflammatory bowel disease ( IBD ) , preliminary data suggest prevalence COVID-19 higher general population [ 3-6 ] ."", 'The risk COVID-19 patient biologic therapy chronic inflammatory disease ( eg , IBD , rheumatoid arthritis , psoriasis ) uncertain [ 5 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') The gastrointestinal tract may susceptible SARS-CoV-2 infection widely express angiotensin-converting enzyme 2 ( ACE2 ) receptor intestine [ 7 ] .', 'ACE2 receptor SARS-CoV-2 virus , digestive symptom associate SARS-CoV-2 infection may cause direct viral attack well tissue organ damage due immune response [ 8,9 ] .', 'Staining tissue specimen patient COVID-19 demonstrate positive area mainly distribute cytoplasm gastric intestinal epithelial cell cilium glandular epithelial cell [ 8 ] .', 'In addition , viral nucleocapsid protein detect cytoplasm gastric , duodenal , rectal glandular epithelial cell .', 'However , understand pathogenesis digestive disease associate SARS-CoV-2 virus evolve , effect exist chronic GI disorder remain uncertain [ 10 ] .CLINICAL MANIFESTATIONS AND DIAGNOSTIC TESTINGSymptoms disease flare mimic COVID-19 — The clinical presentation several gastrointestinal ( GI ) liver disease ( eg , Crohn disease , ulcerative colitis , autoimmune hepatitis ) mimic COVID-19 infection [ 11 ] .', 'Examples include disease manifest diarrhea , anorexia , acute hepatitis and/or abnormal liver biochemical function test [ 12 ] .', 'Thus , patient exist diagnosis chronic GI liver disease , clinician need ass whether symptom relate disease flare COVID-19 .', 'The approach test COVID-19 discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') Digestive symptom — Patients COVID-19 typically present fever respiratory symptom ; however , gastrointestinal symptom commonly report patient diagnose COVID-19 [ 7,12-15 ] .', 'For example , study include 318 adult patient hospitalize COVID-19 , 195 patient ( 61 percent ) report least one digestive symptom , frequently report symptom anorexia 110 patient ( 35 percent ) , diarrhea 107 patient ( 34 percent ) , nausea 84 patient ( 26 percent ) [ 13 ] .', 'Similarly , another study 204 patient COVID-19 , 103 patient ( 51 percent ) report least one digestive symptom , commonly report symptom anorexia diarrhea [ 12 ] .', 'Some patient COVID-19 present isolate GI symptom may precede development respiratory symptom [ 16,17 ] .', 'As example , study 1141 patient COVID-19 , 183 patient ( 16 percent ) present GI symptom ( eg , diarrhea , nausea , vomit ) absence respiratory complaint [ 16 ] .', 'Limited data suggest diarrheal symptom patient COVID-19 associate virus RNA stool [ 14,18,19 ] .', 'In study 84 patient SARS-CoV-2 pneumonia , stool sample patient diarrhea higher rate detect SARS-CoV-2 virus RNA real time polymerase chain reaction compare patient without diarrhea ( 69 versus 17 percent ) [ 18 ] .', 'Hepatic manifestation — The clinical presentation COVID-19 may include hepatic manifestation acute hepatitis abnormal liver biochemical function test [ 20 ] .', 'When test COVID-19 patient GI symptom — The diagnosis COVID-19 suspect primarily patient new onset fever and/or respiratory tract symptom ( eg , cough , dyspnea ) , consistent symptom include myalgia , diarrhea , aberrancy sense smell taste .', 'For patient GI symptom , favor test COVID-19 follow case [ 21 ] : ●Hospitalized patient new onset GI symptoms●Outpatients new onset GI symptom 48 hours●Patients establish GI disease ( eg , Crohn disease ) symptom suggestive disease flare ( eg , diarrhea , vomit ) In minority patient , GI symptom diarrhea may present symptom may precede development respiratory symptom [ 16,17,21 ] .', ""While diagnosis COVID-19 may suspect base present symptom , additional factor inform decision perform test include patient 's geographic location , risk exposure , rate community transmission , availability test ."", 'The epidemiology diagnosis COVID-19 discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') Additionally , stool test exclude Clostridioides ( C. , formerly Clostridium ) difficile infection obtain patient diarrhea risk C. difficile infection ( eg , recent antibiotic use ) may require therapy ( eg , antidiarrheal agent ) control symptom .', ""( See 'Managing symptom relate viral infection ' ."", ') Managing symptom relate viral infection — For symptomatic therapy infectious diarrhea , antidiarrheal agent loperamide use initial dose 4 mg maximum daily dose 16 mg patient without fever , bloody stool , risk factor C. difficile infection .', 'Use loperamide patient acute diarrhea discuss separately .', ""( See `` Approach adult acute diarrhea resource-rich set '' , section 'Management ' ."", ') For patient symptom gastroenteritis ( eg , nausea , vomit ) , antiemetic drug often help relieve symptom , addition supportive measure include oral intravenous hydration .', 'Management patient gastroenteritis use antiemetic discuss separately .', ""( See `` Acute viral gastroenteritis adult '' , section 'Treatment ' `` Characteristics antiemetic drug '' . )"", 'Symptomatic therapy digestive symptom may reduce risk complication electrolyte disturbance ( eg , hypokalemia ) colonic ischemia relate volume depletion .', ""( See `` Colonic ischemia '' ."", ') Specific management COVID-19 discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' . ) ."", ""MANAGEMENT PRINCIPLESGeneral strategy reduce risk infection — If community transmission SARS-CoV-2 virus present , preventive measure reduce exposure virus include ( see `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Prevention ' ) : ●General preventive measure hand hygiene social distancing.●Use telemedicine visit ongoing disease management.●Decreased frequency routine laboratory image surveillance associate risk deem low ."", ""●Delay nonurgent endoscopic procedure ( eg , colorectal cancer screen ) ( see 'Implications endoscopy ' ) ."", '●Use lower-volume laboratory off-site larger healthcare facilities.●For patient stable disease without know suspect COVID-19 , continue establish medication regimen avoid disease flare may result need diagnostic test and/or inpatient hospitalization.●For patient glucocorticoid , therapy abruptly discontinue , use lowest dose possible control underlie disease , regardless COVID-19 exposure infection status.Inflammatory bowel diseaseDiagnostic consideration pandemic — For patient symptom active inflammatory bowel disease ( IBD ) ( eg , diarrhea ) also risk COVID-19 ( eg , recent exposure , high rate community transmission ) , evaluation include COVID-19 test , stool study exclude enteric infection ( eg , C. difficile infection ) , noninvasive inflammatory marker ( eg , C-reactive protein , fecal calprotectin ) , serum drug trough level ( patient biologic therapy ) .', ""( See `` Treatment Crohn disease adult : Dosing monitor tumor necrosis factor-alpha inhibitor '' , section 'Monitoring ' `` Overview dose monitor biologic agent small molecule treat ulcerative colitis adult '' ."", ') However , patient SARS-CoV-2 virus , nonspecific marker inflammation ( eg , C-reactive protein ) may elevate due COVID-19 rather IBD .', ""( See `` Clinical manifestation , diagnosis , prognosis Crohn ’ disease adult '' `` Clinical manifestation , diagnosis , prognosis ulcerative colitis adult '' . )"", 'If fecal marker ( eg , fecal calprotectin , lactoferrin ) elevate , endoscopic evaluation necessary , negative test result indicate absence active bowel inflammation .', 'For patient establish diagnosis IBD , elevate fecal inflammatory marker level along typical symptom active disease ( eg , diarrhea ) absence infection sufficient initiate IBD treatment .', ""( See `` Medical management low-risk adult patient mild moderate ulcerative colitis '' , section 'Pretreatment evaluation ' ."", ') Urgent endoscopic evaluation reserve patient result change management [ 6 ] .', 'For example , patient suspect severe acute ulcerative colitis typically start glucocorticoid intravenously still require least limit lower endoscopy biopsy confirm diagnosis exclude condition ( eg , viral infection ) .', ""( See `` Management hospitalize adult patient severe ulcerative colitis '' , section 'Pretreatment evaluation ' . )"", 'Patients without COVID-19Patients IBD remission — Available data suggest patient IBD remission higher risk SARS-CoV-2 virus infection patient continue maintenance therapy sustain remission [ 3,4,6 ] .', 'Discontinuing maintenance therapy associate disease relapse may require hospitalization and/or glucocorticoid therapy , thus , increase risk COVID-19 [ 3,22 ] .Therapies maintain remission patient Crohn disease discuss separately .', ""( See `` Overview medical management mild ( low risk ) Crohn disease adult '' , section 'Maintenance remission ' `` Overview medical management high-risk , adult patient moderate severe Crohn disease '' , section 'Maintenance therapy ' ."", ') Therapies maintain remission patient ulcerative colitis discuss separately .', ""( See `` Medical management low-risk adult patient mild moderate ulcerative colitis '' , section 'Maintenance remission ' `` Management moderate severe ulcerative colitis adult '' , section 'Maintenance remission ' ."", ') Patients active IBD — For patient flare Crohn disease ulcerative colitis absence COVID-19 , add escalate anti-inflammatory biologic therapy may require symptomatic improvement induce remission .', ""( See 'Diagnostic consideration pandemic ' . )"", 'For example , therapeutic option mild IBD include oral budesonide , aminosalicylates , topical ( rectal ) therapy , option moderately severely active IBD include biologic therapy ( eg , anti-tumor necrosis factor [ TNF ] agent , anti-integrin agent , anti-interleukin agent ) [ 6 ] .', 'The approach use therapy change pandemic .', 'However , systemic glucocorticoid deem necessary patient active IBD pandemic , lowest dose glucocorticoid result clinical response use short duration transition another therapy glucocorticoid-sparing [ 6 ] .', 'For example , management patient hospitalize severe ulcerative colitis absence COVID-19 may include treatment glucocorticoid ( eg , methylprednisolone 16 20 mg intravenously every eight hour ) three day , clinical response , medical therapy escalate infliximab [ 6,23 ] .', 'Surgery alternative option patient improve medical therapy .', 'Additionally , COVID-19 era , initial use infliximab dose 5 mg/kg rather glucocorticoid therapy reasonable approach .', 'Management hospitalize patient ulcerative colitis include escalate medical therapy discuss detail separately .', ""( See `` Management hospitalize adult patient severe ulcerative colitis '' ."", "") Diagnosis , pretreatment assessment , medical management Crohn disease discuss separately : ● ( See `` Clinical manifestation , diagnosis , prognosis Crohn ’ disease adult '' ."", "") ● ( See `` Overview medical management mild ( low risk ) Crohn disease adult '' ."", "") ● ( See `` Overview medical management high-risk , adult patient moderate severe Crohn disease '' ."", "") Diagnosis , pretreatment assessment , medical management ulcerative colitis discuss separately : ● ( See `` Clinical manifestation , diagnosis , prognosis ulcerative colitis adult '' ."", "") ● ( See `` Medical management low-risk adult patient mild moderate ulcerative colitis '' ."", "") ● ( See `` Management moderate severe ulcerative colitis adult '' ."", "") ● ( See `` Management hospitalize adult patient severe ulcerative colitis '' ."", ') Patients COVID-19Adjusting IBD medication — Adjustments medication regimen patient IBD suspect know COVID-19 individualize base severity infection , patient comorbidities , exist medication regimen .', 'Expanding indication SARS-CoV-2 test ( eg , screen prior endoscopy ) may result increase identification asymptomatic patient infect [ 6 ] .', 'The goal medication adjustment reduce immunosuppression active viral infection lower risk COVID-19-related complication ( eg , pneumonia ) [ 24 ] .', ""Our overall approach patient IBD remission include [ 25-27 ] ( see `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ) : ●Therapies continue without interruption : •Budesonide.•Aminosalicylates.•Topical rectal therapy ( eg , topical glucocorticoid ) .•Antibiotics.●Therapies require adjustment : •Systemic glucocorticoid – Reduce dose systemic glucocorticoid ( eg , prednisone dose < 20 mg daily ) transition oral budesonide ."", ""( See `` Overview budesonide therapy adult inflammatory bowel disease '' ."", ') Although systemic glucocorticoid convey increase risk infection , abrupt discontinuation possible , patient receive lowest require dose shortest period time necessary minimize adverse reaction .', ""( See `` Major side effect systemic glucocorticoid '' ."", ') •Immunomodulators – Discontinue thiopurines ( ie , azathioprine , 6-mercaptopurine ) methotrexate .', '•Tofacitinib – Discontinue tofacitinib , small molecule Janus kinase inhibitor associate increase risk viral infection ( ie , herpes zoster infection ) mechanism action suppress T-cell function .', ""( See `` Management moderate severe ulcerative colitis adult '' , section 'Tofacitinib ' . )"", '•Biologic agent – Discontinue biologic therapy ( anti-TNF agent , ustekinumab , vedolizumab ) .Resumption therapy — The optimal time resume immunosuppressive medication SARS-CoV-2 infection uncertain , expert consensus state medication resume negative test COVID-19 and/or symptom-free observation period 14 day .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') Preliminary data suggest induction therapy active ulcerative colitis set recent mild COVID-19 associate increase risk progress severe infection .', 'In case report 54-year-old female patient mild COVID-19 active ulcerative colitis , treatment infliximab week 6 7 follow diagnosis associate achieve clinical remission recovery COVID-19 [ 28 ] .', 'Prognosis — Case series include patient SARS-CoV-2 infection chronic inflammatory disease ( rheumatoid arthritis , IBD ) provide preliminary outcome data [ 5,28 ] .', 'As example , study 86 patient COVID-19 set immune-mediated inflammatory disease ( include 37 patient IBD ) , 14 patient ( 16 percent ) require hospitalization , mortality rate 7 percent [ 5 ] .', 'In another study 40 patient IBD SARS-CoV-2 infection , include 11 patient ( 28 percent ) immunomodulators seven patient ( 18 percent ) biologic monotherapy , 21 patient ( 53 percent ) hospitalize , none require intensive care unit admission [ 28 ] .', 'However , two patient ulcerative colitis ( 5 percent ) die complication acute respiratory distress syndrome ; patient older ( ie , > 75 year age ) , one patient methotrexate.DISEASE REGISTRIES — Data patient chronic gastrointestinal liver disease infect SARS-CoV-2 virus accumulate , disease-specific patient registry include : ●SECURE-IBD registry – The SECURE-IBD registry international database collect data disease severity outcome patient inflammatory bowel disease ( IBD ) infect SARS-CoV-2 virus [ 29 ] .', 'The available data suggest hospitalization rate highest among patient moderately severely active IBD , emphasize importance treat active inflammation .', ""( See 'Patients COVID-19 ' ."", ') ●SECURE-Cirrhosis registry – The SECURE-Cirrhosis registry international database collect data disease severity outcome patient chronic liver disease ( ie , cirrhosis , liver transplantation recipient ) [ 30 ] .IMPLICATIONS FOR ENDOSCOPY — During COVID-19 pandemic , nonurgent endoscopic procedure defer goal reduce transmission SARS-CoV-2 virus infection , conserve personal protective equipment , reserve clinical resource manage patient COVID-19 .', 'The decision perform endoscopic procedure necessary protocol inform state , local , institutional rule addition guidance professional society [ 31,32 ] .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' , section 'Gastroenterology hepatology ' ."", ') Indications elective procedure delay , addition indication urgent emergent procedure delay , find American Society Gastrointestinal Endoscopy website.Strategies reduce risk transmit infection gastrointestinal endoscopy endorse professional society , include use personal protective equipment , access here.Infection control strategy use aerosol-generating procedure ( eg , upper gastrointestinal endoscopy , endoscopic retrograde cholangiopancreatography [ ERCP ] , endoscopic ultrasound ) discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control health care set ' ."", ') The approach manage patient acute gastrointestinal ( GI ) liver disease modify COVID-19 pandemic [ 33 ] : ●Patients GI bleed – Early report suggest GI bleed common indication gastroenterology consultation COVID-19 pandemic , strategy use medical therapy delay endoscopic evaluation develop [ 34,35 ] .', 'Some center suggest medical therapy patient suspect nonvariceal upper GI bleed include continuous intravenous proton pump inhibitor , antiemetic , optimize coagulation status [ 34 ] .', 'For example , series six patient acute upper GI bleed COVID-19 pneumonia , management include intravenous proton pump inhibitor clinical observation , patient require urgent endoscopy hospitalization [ 35 ] .', 'Rationale conservative approach also include data suggest delay endoscopy 24 hour associate increase mortality patient acute upper GI bleed [ 36 ] .', 'For patient lower GI bleed set COVID-19 , endoscopic evaluation initially delay perform outpatient basis resolution acute illness [ 34 ] .', 'Timing endoscopy patient GI bleed discuss separately .', ""( See `` Approach acute upper gastrointestinal bleed adult '' `` Approach acute lower gastrointestinal bleed adult '' ."", "") ●Patients acute cholangitis biliary obstruction – Strategies manage patient acute cholangitis and/or obstructive jaundice inform available resource ( eg , endoscopy space , nurse , anesthesia service ) , patient 's hemodynamic status location ( eg , intensive care unit ) availability alternative ERCP ( eg , percutaneous transhepatic cholangiography , initial medical management ) [ 34,37 ] ."", 'Management acute cholangitis discuss detail separately .', ""( See `` Acute cholangitis : Clinical manifestation , diagnosis , management '' ."", ') SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' ."", ') SUMMARY AND RECOMMENDATIONS●Patients COVID-19 typically present fever respiratory symptom ; however , gastrointestinal symptom ( GI ) ( eg , anorexia , diarrhea , nausea ) report patient diagnose COVID-19 .', ""( See 'Digestive symptom ' ."", "") ●We favor test COVID-19 follow patient , even absence respiratory symptom ( see 'When test COVID-19 patient GI symptom ' ) : •Hospitalized patient new onset GI symptoms•Outpatients new onset GI symptom 48 hours•Patients establish GI disease ( eg , Crohn disease ) symptom suggestive disease flare ( eg , diarrhea , vomit ) While diagnosis COVID-19 may suspect base present symptom , additional factor inform decision perform test include patient 's geographic location , risk exposure , rate community transmission , availability test ."", '●For patient symptom active inflammatory bowel disease ( IBD ) ( eg , diarrhea ) also risk COVID-19 , evaluation include COVID-19 test , stool study exclude enteric infection , noninvasive inflammatory marker ( eg , fecal calprotectin ) , serum drug trough level ( patient biologic therapy ) .', ""( See 'Diagnostic consideration pandemic ' ."", ') ●Patients IBD remission continue maintenance therapy sustain remission .', 'Discontinuing maintenance therapy associate disease relapse may require hospitalization and/or glucocorticoid therapy , thus , may increase risk COVID-19 .', ""( See 'Patients IBD remission ' ."", ') ●Strategies reduce risk transmit SARS-CoV-2 virus gastrointestinal endoscopy endorse professional society access .', ""( See 'Implications endoscopy ' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' . )""]","['', 'end', '2019', '', 'sars-cov-2', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'primarily', 'manifest', 'lung', 'infection', 'symptom', 'range', 'mild', 'upper', 'respiratory', 'infection', 'severe', 'pneumonia', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'death', '', 'covid-19', 'disproportionately', 'affect', 'patient', 'pre-existing', 'comorbidities', 'andor', 'older', 'adult', '', 'medical', 'professional', '', 'include', 'gastroenterology', 'hepatology', 'clinician', '', 'task', 'rapidly', 'adjust', 'practice', 'curtail', 'spread', 'covid-19', '', 'provide', 'care', 'patientsthis', 'topic', 'discus', 'covid-19-related', 'issue', 'patient', 'gastrointestinal', 'liver', 'disease', '', 'understand', 'covid-19', 'illness', 'continue', 'evolve', '', 'approach', 'diagnosis', 'management', 'require', 'modification', 'well', '', 'important', 'aspect', 'covid-19', 'infection', 'discuss', 'detail', 'separately', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', 'possible', 'risk', 'factors', 'covid-19', '', 'patient', 'chronic', 'gastrointestinal', '', 'gi', '', 'liver', 'disease', 'increase', 'risk', 'covid-19', 'severe', 'illness', '', 'potential', 'risk', 'factor', 'patient', 'include', 'chronic', 'inflammatory', 'disease', '', 'comorbidities', '', 'eg', '', 'diabetes', 'mellitus', '', '', 'immune-modifying', 'therapy', '', 'regular', 'office', '', 'endoscopy', 'center', '', 'laboratory', 'visit', '', 'patient', 'group', 'include', '', '1', '', '', 'patients', 'cirrhosispatients', 'chronic', 'cholestatic', 'liver', 'disease', '', 'eg', '', 'primary', 'sclerosing', 'cholangitis', '', 'primary', 'biliary', 'cholangitis', '', 'liver', 'transplantation', 'recipient', '', '2', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', 'patient', 'inflammatory', 'bowel', 'disease', '', 'ibd', '', '', 'preliminary', 'data', 'suggest', 'prevalence', 'covid-19', 'higher', 'general', 'population', '', '3-6', '', '', 'risk', 'covid-19', 'patient', 'biologic', 'therapy', 'chronic', 'inflammatory', 'disease', '', 'eg', '', 'ibd', '', 'arthritis', 'arthritis', '', 'psoriasis', '', 'uncertain', '', '5', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'gastrointestinal', 'tract', 'susceptible', 'sars-cov-2', 'infection', 'widely', 'express', 'angiotensin-converting', 'enzyme', '2', '', 'ace2', '', 'receptor', 'intestine', '', '7', '', '', 'ace2', 'receptor', 'sars-cov-2', 'virus', '', 'digestive', 'symptom', 'associate', 'sars-cov-2', 'infection', 'cause', 'direct', 'viral', 'attack', 'well', 'tissue', 'organ', 'damage', 'due', 'immune', 'response', '', '89', '', '', 'staining', 'tissue', 'specimen', 'patient', 'covid-19', 'demonstrate', 'positive', 'area', 'mainly', 'distribute', 'cytoplasm', 'gastric', 'intestinal', 'epithelial', 'cell', 'cilium', 'glandular', 'epithelial', 'cell', '', '8', '', '', 'addition', '', 'viral', 'nucleocapsid', 'protein', 'detect', 'cytoplasm', 'gastric', '', 'duodenal', '', 'rectal', 'glandular', 'epithelial', 'cell', '', 'however', '', 'understand', 'pathogenesis', 'digestive', 'disease', 'associate', 'sars-cov-2', 'virus', 'evolve', '', 'effect', 'exist', 'chronic', 'gi', 'disorder', 'remain', 'uncertain', '', '10', '', 'clinical', 'manifestations', 'diagnostic', 'testingsymptoms', 'disease', 'flare', 'mimic', 'covid-19', '', 'clinical', 'presentation', 'several', 'gastrointestinal', '', 'gi', '', 'liver', 'disease', '', 'eg', '', 'crohn', 'disease', '', 'ulcerative', 'colitis', '', 'autoimmune', 'hepatitis', '', 'mimic', 'covid-19', 'infection', '', '11', '', '', 'examples', 'include', 'disease', 'manifest', 'diarrhea', '', 'anorexia', '', 'acute', 'hepatitis', 'andor', 'abnormal', 'liver', 'biochemical', 'function', 'test', '', '12', '', '', 'thus', '', 'patient', 'exist', 'diagnosis', 'chronic', 'gi', 'liver', 'disease', '', 'clinician', 'ass', 'whether', 'symptom', 'relate', 'disease', 'flare', 'covid-19', '', 'approach', 'test', 'covid-19', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'digestive', 'symptom', '', 'patients', 'covid-19', 'typically', 'present', 'fever', 'respiratory', 'symptom', '', 'however', '', 'gastrointestinal', 'symptom', 'commonly', 'report', 'patient', 'diagnose', 'covid-19', '', '712-15', '', '', 'example', '', 'study', 'include', '318', 'adult', 'patient', 'hospitalize', 'covid-19', '', '195', 'patient', '', '61', 'percent', '', 'report', 'least', 'one', 'digestive', 'symptom', '', 'frequently', 'report', 'symptom', 'anorexia', '110', 'patient', '', '35', 'percent', '', '', 'diarrhea', '107', 'patient', '', '34', 'percent', '', '', 'nausea', '84', 'patient', '', '26', 'percent', '', '', '13', '', '', 'similarly', '', 'another', 'study', '204', 'patient', 'covid-19', '', '103', 'patient', '', '51', 'percent', '', 'report', 'least', 'one', 'digestive', 'symptom', '', 'commonly', 'report', 'symptom', 'anorexia', 'diarrhea', '', '12', '', '', 'patient', 'covid-19', 'present', 'isolate', 'gi', 'symptom', 'precede', 'development', 'respiratory', 'symptom', '', '1617', '', '', 'example', '', 'study', '1141', 'patient', 'covid-19', '', '183', 'patient', '', '16', 'percent', '', 'present', 'gi', 'symptom', '', 'eg', '', 'diarrhea', '', 'nausea', '', 'vomit', '', 'absence', 'respiratory', 'complaint', '', '16', '', '', 'limited', 'data', 'suggest', 'diarrheal', 'symptom', 'patient', 'covid-19', 'associate', 'virus', 'rna', 'stool', '', '141819', '', '', 'study', '84', 'patient', 'sars-cov-2', 'pneumonia', '', 'stool', 'sample', 'patient', 'diarrhea', 'higher', 'rate', 'detect', 'sars-cov-2', 'virus', 'rna', 'real', 'time', 'polymerase', 'chain', 'reaction', 'compare', 'patient', 'without', 'diarrhea', '', '69', 'versus', '17', 'percent', '', '', '18', '', '', 'hepatic', 'manifestation', '', 'clinical', 'presentation', 'covid-19', 'include', 'hepatic', 'manifestation', 'acute', 'hepatitis', 'abnormal', 'liver', 'biochemical', 'function', 'test', '', '20', '', '', 'test', 'covid-19', 'patient', 'gi', 'symptom', '', 'diagnosis', 'covid-19', 'suspect', 'primarily', 'patient', 'new', 'onset', 'fever', 'andor', 'respiratory', 'tract', 'symptom', '', 'eg', '', 'cough', '', 'dyspnea', '', '', 'consistent', 'symptom', 'include', 'myalgia', '', 'diarrhea', '', 'aberrancy', 'sense', 'smell', 'taste', '', 'patient', 'gi', 'symptom', '', 'favor', 'test', 'covid-19', 'follow', 'case', '', '21', '', '', 'hospitalized', 'patient', 'new', 'onset', 'gi', 'symptomsoutpatients', 'new', 'onset', 'gi', 'symptom', '48', 'hourspatients', 'establish', 'gi', 'disease', '', 'eg', '', 'crohn', 'disease', '', 'symptom', 'suggestive', 'disease', 'flare', '', 'eg', '', 'diarrhea', '', 'vomit', '', 'minority', 'patient', '', 'gi', 'symptom', 'diarrhea', 'present', 'symptom', 'precede', 'development', 'respiratory', 'symptom', '', '161721', '', '', 'diagnosis', 'covid-19', 'suspect', 'base', 'present', 'symptom', '', 'additional', 'factor', 'inform', 'decision', 'perform', 'test', 'include', 'patient', 'geographic', 'location', '', 'risk', 'exposure', '', 'rate', 'community', 'transmission', '', 'availability', 'test', '', 'epidemiology', 'diagnosis', 'covid-19', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'additionally', '', 'stool', 'test', 'exclude', 'clostridioides', '', 'c', '', 'formerly', 'clostridium', '', 'difficile', 'infection', 'obtain', 'patient', 'diarrhea', 'risk', 'c', 'difficile', 'infection', '', 'eg', '', 'recent', 'antibiotic', '', 'require', 'therapy', '', 'eg', '', 'antidiarrheal', 'agent', '', 'control', 'symptom', '', '', 'managing', 'symptom', 'relate', 'viral', 'infection', '', '', '', 'managing', 'symptom', 'relate', 'viral', 'infection', '', 'symptomatic', 'therapy', 'infectious', 'diarrhea', '', 'antidiarrheal', 'agent', 'loperamide', 'initial', 'dose', '4', 'mg', 'maximum', 'daily', 'dose', '16', 'mg', 'patient', 'without', 'fever', '', 'bloody', 'stool', '', 'risk', 'factor', 'c', 'difficile', 'infection', '', 'loperamide', 'patient', 'acute', 'diarrhea', 'discuss', 'separately', '', '', '', 'approach', 'adult', 'acute', 'diarrhea', 'resource-rich', 'set', '', '', 'section', 'management', '', '', '', 'patient', 'symptom', 'gastroenteritis', '', 'eg', '', 'nausea', '', 'vomit', '', '', 'antiemetic', 'drug', 'often', 'help', 'relieve', 'symptom', '', 'addition', 'supportive', 'measure', 'include', 'oral', 'intravenous', 'hydration', '', 'management', 'patient', 'gastroenteritis', 'antiemetic', 'discuss', 'separately', '', '', '', 'acute', 'viral', 'gastroenteritis', 'adult', '', '', 'section', 'treatment', '', '', 'characteristics', 'antiemetic', 'drug', '', '', '', 'symptomatic', 'therapy', 'digestive', 'symptom', 'reduce', 'risk', 'complication', 'electrolyte', 'disturbance', '', 'eg', '', 'hypokalemia', '', 'colonic', 'ischemia', 'relate', 'volume', 'depletion', '', '', '', 'colonic', 'ischemia', '', '', '', 'specific', 'management', 'covid-19', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', '', 'management', 'principlesgeneral', 'strategy', 'reduce', 'risk', 'infection', '', 'community', 'transmission', 'sars-cov-2', 'virus', 'present', '', 'preventive', 'measure', 'reduce', 'exposure', 'virus', 'include', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'prevention', '', '', '', 'general', 'preventive', 'measure', 'hand', 'hygiene', 'social', 'distancinguse', 'telemedicine', 'visit', 'ongoing', 'disease', 'managementdecreased', 'frequency', 'routine', 'laboratory', 'image', 'surveillance', 'associate', 'risk', 'deem', 'low', '', 'delay', 'nonurgent', 'endoscopic', 'procedure', '', 'eg', '', 'colorectal', 'cancer', 'screen', '', '', 'implications', 'endoscopy', '', '', '', 'lower-volume', 'laboratory', 'off-site', 'larger', 'healthcare', 'facilitiesfor', 'patient', 'stable', 'disease', 'without', 'suspect', 'covid-19', '', 'continue', 'establish', 'medication', 'regimen', 'avoid', 'disease', 'flare', 'result', 'diagnostic', 'test', 'andor', 'inpatient', 'hospitalizationfor', 'patient', 'glucocorticoid', '', 'therapy', 'abruptly', 'discontinue', '', 'lowest', 'dose', 'possible', 'control', 'underlie', 'disease', '', 'regardless', 'covid-19', 'exposure', 'infection', 'statusinflammatory', 'bowel', 'diseasediagnostic', 'consideration', 'pandemic', '', 'patient', 'symptom', 'active', 'inflammatory', 'bowel', 'disease', '', 'ibd', '', '', 'eg', '', 'diarrhea', '', 'risk', 'covid-19', '', 'eg', '', 'recent', 'exposure', '', 'high', 'rate', 'community', 'transmission', '', '', 'evaluation', 'include', 'covid-19', 'test', '', 'stool', 'study', 'exclude', 'enteric', 'infection', '', 'eg', '', 'c', 'difficile', 'infection', '', '', 'noninvasive', 'inflammatory', 'marker', '', 'eg', '', 'c-reactive', 'protein', '', 'fecal', 'calprotectin', '', '', 'serum', 'drug', 'trough', 'level', '', 'patient', 'biologic', 'therapy', '', '', '', '', 'treatment', 'crohn', 'disease', 'adult', '', 'dosing', 'monitor', 'tumor', 'necrosis', 'factor-alpha', 'inhibitor', '', '', 'section', 'monitoring', '', '', 'overview', 'dose', 'monitor', 'biologic', 'agent', 'small', 'molecule', 'treat', 'ulcerative', 'colitis', 'adult', '', '', '', 'however', '', 'patient', 'sars-cov-2', 'virus', '', 'nonspecific', 'marker', 'inflammation', '', 'eg', '', 'c-reactive', 'protein', '', 'elevate', 'due', 'covid-19', 'ibd', '', '', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'prognosis', 'crohn', '', 'disease', 'adult', '', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'prognosis', 'ulcerative', 'colitis', 'adult', '', '', '', 'fecal', 'marker', '', 'eg', '', 'fecal', 'calprotectin', '', 'lactoferrin', '', 'elevate', '', 'endoscopic', 'evaluation', 'necessary', '', 'negative', 'test', 'result', 'indicate', 'absence', 'active', 'bowel', 'inflammation', '', 'patient', 'establish', 'diagnosis', 'ibd', '', 'elevate', 'fecal', 'inflammatory', 'marker', 'level', 'along', 'typical', 'symptom', 'active', 'disease', '', 'eg', '', 'diarrhea', '', 'absence', 'infection', 'sufficient', 'initiate', 'ibd', 'treatment', '', '', '', 'medical', 'management', 'low-risk', 'adult', 'patient', 'mild', 'moderate', 'ulcerative', 'colitis', '', '', 'section', 'pretreatment', 'evaluation', '', '', '', 'urgent', 'endoscopic', 'evaluation', 'reserve', 'patient', 'result', 'change', 'management', '', '6', '', '', 'example', '', 'patient', 'suspect', 'severe', 'acute', 'ulcerative', 'colitis', 'typically', 'start', 'glucocorticoid', 'intravenously', 'still', 'require', 'least', 'limit', 'lower', 'endoscopy', 'biopsy', 'confirm', 'diagnosis', 'exclude', 'condition', '', 'eg', '', 'viral', 'infection', '', '', '', '', 'management', 'hospitalize', 'adult', 'patient', 'severe', 'ulcerative', 'colitis', '', '', 'section', 'pretreatment', 'evaluation', '', '', '', 'patients', 'without', 'covid-19patients', 'ibd', 'remission', '', 'available', 'data', 'suggest', 'patient', 'ibd', 'remission', 'higher', 'risk', 'sars-cov-2', 'virus', 'infection', 'patient', 'continue', 'maintenance', 'therapy', 'sustain', 'remission', '', '346', '', '', 'discontinuing', 'maintenance', 'therapy', 'associate', 'disease', 'relapse', 'require', 'hospitalization', 'andor', 'glucocorticoid', 'therapy', '', 'thus', '', 'increase', 'risk', 'covid-19', '', '322', '', 'therapies', 'maintain', 'remission', 'patient', 'crohn', 'disease', 'discuss', 'separately', '', '', '', 'overview', 'medical', 'management', 'mild', '', 'low', 'risk', '', 'crohn', 'disease', 'adult', '', '', 'section', 'maintenance', 'remission', '', '', 'overview', 'medical', 'management', 'high-risk', '', 'adult', 'patient', 'moderate', 'severe', 'crohn', 'disease', '', '', 'section', 'maintenance', 'therapy', '', '', '', 'therapies', 'maintain', 'remission', 'patient', 'ulcerative', 'colitis', 'discuss', 'separately', '', '', '', 'medical', 'management', 'low-risk', 'adult', 'patient', 'mild', 'moderate', 'ulcerative', 'colitis', '', '', 'section', 'maintenance', 'remission', '', '', 'management', 'moderate', 'severe', 'ulcerative', 'colitis', 'adult', '', '', 'section', 'maintenance', 'remission', '', '', '', 'patients', 'active', 'ibd', '', 'patient', 'flare', 'crohn', 'disease', 'ulcerative', 'colitis', 'absence', 'covid-19', '', 'add', 'escalate', 'anti-inflammatory', 'biologic', 'therapy', 'require', 'symptomatic', 'improvement', 'induce', 'remission', '', '', 'diagnostic', 'consideration', 'pandemic', '', '', '', 'example', '', 'therapeutic', 'option', 'mild', 'ibd', 'include', 'oral', 'budesonide', '', 'aminosalicylates', '', 'topical', '', 'rectal', '', 'therapy', '', 'option', 'moderately', 'severely', 'active', 'ibd', 'include', 'biologic', 'therapy', '', 'eg', '', 'anti-tumor', 'necrosis', 'factor', '', 'certolizumab', '', 'agent', '', 'anti-integrin', 'agent', '', 'anti-interleukin', 'agent', '', '', '6', '', '', 'approach', 'therapy', 'change', 'pandemic', '', 'however', '', 'systemic', 'glucocorticoid', 'deem', 'necessary', 'patient', 'active', 'ibd', 'pandemic', '', 'lowest', 'dose', 'glucocorticoid', 'result', 'clinical', 'response', 'short', 'duration', 'transition', 'another', 'therapy', 'glucocorticoid-sparing', '', '6', '', '', 'example', '', 'management', 'patient', 'hospitalize', 'severe', 'ulcerative', 'colitis', 'absence', 'covid-19', 'include', 'treatment', 'glucocorticoid', '', 'eg', '', 'methylprednisolone', '16', '20', 'mg', 'intravenously', 'every', 'eight', 'hour', '', 'three', 'day', '', 'clinical', 'response', '', 'medical', 'therapy', 'escalate', 'infliximab', '', '623', '', '', 'surgery', 'alternative', 'option', 'patient', 'improve', 'medical', 'therapy', '', 'additionally', '', 'covid-19', 'era', '', 'initial', 'infliximab', 'dose', '5', 'mgkg', 'glucocorticoid', 'therapy', 'reasonable', 'approach', '', 'management', 'hospitalize', 'patient', 'ulcerative', 'colitis', 'include', 'escalate', 'medical', 'therapy', 'discuss', 'detail', 'separately', '', '', '', 'management', 'hospitalize', 'adult', 'patient', 'severe', 'ulcerative', 'colitis', '', '', '', 'diagnosis', '', 'pretreatment', 'assessment', '', 'medical', 'management', 'crohn', 'disease', 'discuss', 'separately', '', '', '', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'prognosis', 'crohn', '', 'disease', 'adult', '', '', '', '', '', '', 'overview', 'medical', 'management', 'mild', '', 'low', 'risk', '', 'crohn', 'disease', 'adult', '', '', '', '', '', '', 'overview', 'medical', 'management', 'high-risk', '', 'adult', 'patient', 'moderate', 'severe', 'crohn', 'disease', '', '', '', 'diagnosis', '', 'pretreatment', 'assessment', '', 'medical', 'management', 'ulcerative', 'colitis', 'discuss', 'separately', '', '', '', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'prognosis', 'ulcerative', 'colitis', 'adult', '', '', '', '', '', '', 'medical', 'management', 'low-risk', 'adult', 'patient', 'mild', 'moderate', 'ulcerative', 'colitis', '', '', '', '', '', '', 'management', 'moderate', 'severe', 'ulcerative', 'colitis', 'adult', '', '', '', '', '', '', 'management', 'hospitalize', 'adult', 'patient', 'severe', 'ulcerative', 'colitis', '', '', '', 'patients', 'covid-19adjusting', 'ibd', 'medication', '', 'adjustments', 'medication', 'regimen', 'patient', 'ibd', 'suspect', 'covid-19', 'individualize', 'base', 'severity', 'infection', '', 'patient', 'comorbidities', '', 'exist', 'medication', 'regimen', '', 'expanding', 'indication', 'sars-cov-2', 'test', '', 'eg', '', 'screen', 'prior', 'endoscopy', '', 'result', 'increase', 'identification', 'asymptomatic', 'patient', 'infect', '', '6', '', '', 'goal', 'medication', 'adjustment', 'reduce', 'immunosuppression', 'active', 'viral', 'infection', 'lower', 'risk', 'covid-19-related', 'complication', '', 'eg', '', 'pneumonia', '', '', '24', '', '', 'overall', 'approach', 'patient', 'ibd', 'remission', 'include', '', '25-27', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', 'therapies', 'continue', 'without', 'interruption', '', 'budesonideaminosalicylatestopical', 'rectal', 'therapy', '', 'eg', '', 'topical', 'glucocorticoid', '', 'antibioticstherapies', 'require', 'adjustment', '', 'systemic', 'glucocorticoid', '', 'reduce', 'dose', 'systemic', 'glucocorticoid', '', 'eg', '', 'prednisone', 'dose', '', '20', 'mg', 'daily', '', 'transition', 'oral', 'budesonide', '', '', '', 'overview', 'budesonide', 'therapy', 'adult', 'inflammatory', 'bowel', 'disease', '', '', '', 'although', 'systemic', 'glucocorticoid', 'convey', 'increase', 'risk', 'infection', '', 'abrupt', 'discontinuation', 'possible', '', 'patient', 'receive', 'lowest', 'require', 'dose', 'shortest', 'period', 'time', 'necessary', 'minimize', 'adverse', 'reaction', '', '', '', 'major', 'side', 'effect', 'systemic', 'glucocorticoid', '', '', '', 'immunomodulators', '', 'discontinue', 'thiopurines', '', 'ie', '', 'azathioprine', '', '6-mercaptopurine', '', 'methotrexate', '', 'tofacitinib', '', 'discontinue', 'tofacitinib', '', 'small', 'molecule', 'janus', 'kinase', 'inhibitor', 'associate', 'increase', 'risk', 'viral', 'infection', '', 'ie', '', 'herpes', 'zoster', 'infection', '', 'mechanism', 'action', 'suppress', 't-cell', 'function', '', '', '', 'management', 'moderate', 'severe', 'ulcerative', 'colitis', 'adult', '', '', 'section', 'tofacitinib', '', '', '', 'biologic', 'agent', '', 'discontinue', 'biologic', 'therapy', '', 'anti-tnf', 'agent', '', 'ustekinumab', '', 'vedolizumab', '', 'resumption', 'therapy', '', 'optimal', 'time', 'resume', 'immunosuppressive', 'medication', 'sars-cov-2', 'infection', 'uncertain', '', 'expert', 'consensus', 'state', 'medication', 'resume', 'negative', 'test', 'covid-19', 'andor', 'symptom-free', 'observation', 'period', '14', 'day', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'preliminary', 'data', 'suggest', 'induction', 'therapy', 'active', 'ulcerative', 'colitis', 'set', 'recent', 'mild', 'covid-19', 'associate', 'increase', 'risk', 'progress', 'severe', 'infection', '', 'case', 'report', '54-year-old', 'female', 'patient', 'mild', 'covid-19', 'active', 'ulcerative', 'colitis', '', 'treatment', 'infliximab', 'week', '6', '7', 'follow', 'diagnosis', 'associate', 'achieve', 'clinical', 'remission', 'recovery', 'covid-19', '', '28', '', '', 'prognosis', '', 'case', 'series', 'include', 'patient', 'sars-cov-2', 'infection', 'chronic', 'inflammatory', 'disease', '', 'arthritis', 'arthritis', '', 'ibd', '', 'provide', 'preliminary', 'outcome', 'data', '', '528', '', '', 'example', '', 'study', '86', 'patient', 'covid-19', 'set', 'immune-mediated', 'inflammatory', 'disease', '', 'include', '37', 'patient', 'ibd', '', '', '14', 'patient', '', '16', 'percent', '', 'require', 'hospitalization', '', 'mortality', 'rate', '7', 'percent', '', '5', '', '', 'another', 'study', '40', 'patient', 'ibd', 'sars-cov-2', 'infection', '', 'include', '11', 'patient', '', '28', 'percent', '', 'immunomodulators', 'seven', 'patient', '', '18', 'percent', '', 'biologic', 'monotherapy', '', '21', 'patient', '', '53', 'percent', '', 'hospitalize', '', 'none', 'require', 'intensive', 'care', 'unit', 'admission', '', '28', '', '', 'however', '', 'two', 'patient', 'ulcerative', 'colitis', '', '5', 'percent', '', 'die', 'complication', 'acute', 'respiratory', 'distress', 'syndrome', '', 'patient', 'older', '', 'ie', '', '', '75', 'year', 'age', '', '', 'one', 'patient', 'methotrexatedisease', 'registries', '', 'data', 'patient', 'chronic', 'gastrointestinal', 'liver', 'disease', 'infect', 'sars-cov-2', 'virus', 'accumulate', '', 'disease-specific', 'patient', 'registry', 'include', '', 'secure-ibd', 'registry', '', 'secure-ibd', 'registry', 'international', 'database', 'collect', 'data', 'disease', 'severity', 'outcome', 'patient', 'inflammatory', 'bowel', 'disease', '', 'ibd', '', 'infect', 'sars-cov-2', 'virus', '', '29', '', '', 'available', 'data', 'suggest', 'hospitalization', 'rate', 'highest', 'among', 'patient', 'moderately', 'severely', 'active', 'ibd', '', 'emphasize', 'importance', 'treat', 'active', 'inflammation', '', '', 'patients', 'covid-19', '', '', '', 'secure-cirrhosis', 'registry', '', 'secure-cirrhosis', 'registry', 'international', 'database', 'collect', 'data', 'disease', 'severity', 'outcome', 'patient', 'chronic', 'liver', 'disease', '', 'ie', '', 'cirrhosis', '', 'liver', 'transplantation', 'recipient', '', '', '30', '', 'implications', 'endoscopy', '', 'covid-19', 'pandemic', '', 'nonurgent', 'endoscopic', 'procedure', 'defer', 'goal', 'reduce', 'transmission', 'sars-cov-2', 'virus', 'infection', '', 'conserve', 'personal', 'protective', 'equipment', '', 'reserve', 'clinical', 'resource', 'manage', 'patient', 'covid-19', '', 'decision', 'perform', 'endoscopic', 'procedure', 'necessary', 'protocol', 'inform', 'state', '', 'local', '', 'institutional', 'rule', 'addition', 'guidance', 'professional', 'society', '', '3132', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'section', 'gastroenterology', 'hepatology', '', '', '', 'indications', 'elective', 'procedure', 'delay', '', 'addition', 'indication', 'urgent', 'emergent', 'procedure', 'delay', '', 'find', 'american', 'society', 'gastrointestinal', 'endoscopy', 'websitestrategies', 'reduce', 'risk', 'transmit', 'infection', 'gastrointestinal', 'endoscopy', 'endorse', 'professional', 'society', '', 'include', 'personal', 'protective', 'equipment', '', 'access', 'hereinfection', 'control', 'strategy', 'aerosol-generating', 'procedure', '', 'eg', '', 'upper', 'gastrointestinal', 'endoscopy', '', 'endoscopic', 'retrograde', 'cholangiopancreatography', '', 'ercp', '', '', 'endoscopic', 'ultrasound', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'approach', 'manage', 'patient', 'acute', 'gastrointestinal', '', 'gi', '', 'liver', 'disease', 'modify', 'covid-19', 'pandemic', '', '33', '', '', 'patients', 'gi', 'bleed', '', 'early', 'report', 'suggest', 'gi', 'bleed', 'common', 'indication', 'gastroenterology', 'consultation', 'covid-19', 'pandemic', '', 'strategy', 'medical', 'therapy', 'delay', 'endoscopic', 'evaluation', 'develop', '', '3435', '', '', 'center', 'suggest', 'medical', 'therapy', 'patient', 'suspect', 'nonvariceal', 'upper', 'gi', 'bleed', 'include', 'continuous', 'intravenous', 'proton', 'pump', 'inhibitor', '', 'antiemetic', '', 'optimize', 'coagulation', 'status', '', '34', '', '', 'example', '', 'series', 'six', 'patient', 'acute', 'upper', 'gi', 'bleed', 'covid-19', 'pneumonia', '', 'management', 'include', 'intravenous', 'proton', 'pump', 'inhibitor', 'clinical', 'observation', '', 'patient', 'require', 'urgent', 'endoscopy', 'hospitalization', '', '35', '', '', 'rationale', 'conservative', 'approach', 'include', 'data', 'suggest', 'delay', 'endoscopy', '24', 'hour', 'associate', 'increase', 'mortality', 'patient', 'acute', 'upper', 'gi', 'bleed', '', '36', '', '', 'patient', 'lower', 'gi', 'bleed', 'set', 'covid-19', '', 'endoscopic', 'evaluation', 'initially', 'delay', 'perform', 'outpatient', 'basis', 'resolution', 'acute', 'illness', '', '34', '', '', 'timing', 'endoscopy', 'patient', 'gi', 'bleed', 'discuss', 'separately', '', '', '', 'approach', 'acute', 'upper', 'gastrointestinal', 'bleed', 'adult', '', '', 'approach', 'acute', 'lower', 'gastrointestinal', 'bleed', 'adult', '', '', '', 'patients', 'acute', 'cholangitis', 'biliary', 'obstruction', '', 'strategies', 'manage', 'patient', 'acute', 'cholangitis', 'andor', 'obstructive', 'jaundice', 'inform', 'available', 'resource', '', 'eg', '', 'endoscopy', 'space', '', 'nurse', '', 'anesthesia', 'service', '', '', 'patient', 'hemodynamic', 'status', 'location', '', 'eg', '', 'intensive', 'care', 'unit', '', 'availability', 'alternative', 'ercp', '', 'eg', '', 'percutaneous', 'transhepatic', 'cholangiography', '', 'initial', 'medical', 'management', '', '', '3437', '', '', 'management', 'acute', 'cholangitis', 'discuss', 'detail', 'separately', '', '', '', 'acute', 'cholangitis', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'management', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', '', 'summary', 'recommendationspatients', 'covid-19', 'typically', 'present', 'fever', 'respiratory', 'symptom', '', 'however', '', 'gastrointestinal', 'symptom', '', 'gi', '', '', 'eg', '', 'anorexia', '', 'diarrhea', '', 'nausea', '', 'report', 'patient', 'diagnose', 'covid-19', '', '', 'digestive', 'symptom', '', '', '', 'favor', 'test', 'covid-19', 'follow', 'patient', '', 'absence', 'respiratory', 'symptom', '', 'test', 'covid-19', 'patient', 'gi', 'symptom', '', '', '', 'hospitalized', 'patient', 'new', 'onset', 'gi', 'symptomsoutpatients', 'new', 'onset', 'gi', 'symptom', '48', 'hourspatients', 'establish', 'gi', 'disease', '', 'eg', '', 'crohn', 'disease', '', 'symptom', 'suggestive', 'disease', 'flare', '', 'eg', '', 'diarrhea', '', 'vomit', '', 'diagnosis', 'covid-19', 'suspect', 'base', 'present', 'symptom', '', 'additional', 'factor', 'inform', 'decision', 'perform', 'test', 'include', 'patient', 'geographic', 'location', '', 'risk', 'exposure', '', 'rate', 'community', 'transmission', '', 'availability', 'test', '', 'patient', 'symptom', 'active', 'inflammatory', 'bowel', 'disease', '', 'ibd', '', '', 'eg', '', 'diarrhea', '', 'risk', 'covid-19', '', 'evaluation', 'include', 'covid-19', 'test', '', 'stool', 'study', 'exclude', 'enteric', 'infection', '', 'noninvasive', 'inflammatory', 'marker', '', 'eg', '', 'fecal', 'calprotectin', '', '', 'serum', 'drug', 'trough', 'level', '', 'patient', 'biologic', 'therapy', '', '', '', 'diagnostic', 'consideration', 'pandemic', '', '', '', 'patients', 'ibd', 'remission', 'continue', 'maintenance', 'therapy', 'sustain', 'remission', '', 'discontinuing', 'maintenance', 'therapy', 'associate', 'disease', 'relapse', 'require', 'hospitalization', 'andor', 'glucocorticoid', 'therapy', '', 'thus', '', 'increase', 'risk', 'covid-19', '', '', 'patients', 'ibd', 'remission', '', '', '', 'strategies', 'reduce', 'risk', 'transmit', 'sars-cov-2', 'virus', 'gastrointestinal', 'endoscopy', 'endorse', 'professional', 'society', 'access', '', '', 'implications', 'endoscopy', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', '']",3296,"{'': 936, 'patient': 99, 'covid-19': 76, 'disease': 66, 'symptom': 41, 'eg': 36, 'infection': 33, 'management': 33, 'adult': 32, 'therapy': 32, 'include': 26, 'gi': 25, 'diagnosis': 24, 'risk': 24, 'ibd': 23, 'ulcerative': 22, 'colitis': 22, '2019': 20, 'coronavirus': 20, 'sars-cov-2': 18}","{'ustekinumab': 1, 'tofacitinib': 3, 'infliximab': 3, 'certolizumab': 1, 'methotrexate': 1, 'azathioprine': 1, 'infection': 33, 'sars-cov-2': 18, 'psoriasis': 1, 'arthritis': 4, 'crohn': 13, 'anti-tnf': 1}",80,-0.8225
ID:127582,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation']","['INTRODUCTION — Solid organ transplant recipient may increase risk COVID-19 immunosuppressed frequent contact health care system .', 'There also theoretical risk transmission SARS-CoV-2 ( virus cause COVID-19 ) organ transplantation , although case organ transplant-transmitted infection describe date.This topic review aspect COVID-19 specific solid organ transplantation , include screen prior transplantation , distinct clinical feature , manage immunosuppression , important drug interaction .', ""Other aspect COVID-19 care discuss separately : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", ') ● ( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') RISK OF TRANSMISSIONPotential donor-derived infection — The risk transmit SARS-CoV-2 organ donor recipient theoretical base upon detection viral RNA organ transplant ( eg , lung , heart , kidney , intestine ) site ( ie , blood , urine ) [ 1-4 ] .', 'While clear viable infectious virus culture lung part respiratory gastrointestinal ( GI ) tract , additional study need determine whether SARS-CoV-2 detect extra-respiratory site intact , replication competent , therefore transmissible non-lung organ transplantation.To date , organ donor-derived infection report .', 'Similarly , bloodborne transmission report expect ; frequency SARS-CoV-2 viremia magnitude low [ 1,4-6 ] .', ""( See `` Blood donor screen : Medical history '' , section 'SARS-CoV-2 ( evidence transfusion-transmitted infection ) ' ."", ') Posttransplantation risk — It know whether solid organ transplant recipient higher risk acquire SARS-CoV-2 infection general population .', 'However , chronic immunosuppression may lower infectious dose need cause COVID-19 impair adequate immune control infection establish .', 'Organ transplant recipient also frequent contact health care system therefore potentially likely expose virus.Like immunosuppressed person , solid organ transplant recipient may shed greater amount virus longer duration otherwise healthy host .', 'Thus , may likely spread infection others .', 'Further data need confirm theory quantify viral dynamic transmission risk solid organ transplant population.DEFERRAL OF NONURGENT TRANSPLANTATION — To minimize risk infection conserve hospital resource , elective transplantation ( eg , living-donor kidney transplantation ) nonurgent , deceased-donor transplantation defer transplant center community prevalence COVID-19 high and/or resource ( personnel , hospital intensive care unit [ ICU ] bed , operate room , equipment ) limit [ 7 ] .Life-saving transplantation continue perform , Centers Medicare & Medicaid Services classify organ transplantation tier 3b activity : Do delay , basis assessment potential risk compare know benefit [ 8 ] .PRETRANSPLANTATION SCREENING — All organ donor potential recipient screen COVID-19 prior organ procurement .', 'This necessary prevent initiation potent induction immunosuppression context active infection safety organ transplant recipient ( typically potently immunosuppressed immediate posttransplant period ) organ procurement team.Reverse-transcriptase polymerase chain reaction ( RT-PCR ; primarily use detect active infection ) main assay use screen .', 'The utility serology ( primarily use detect past infection ) pretransplant screen establish .', 'However , performance characteristic serology well establish among solid organ transplant recipient , serology may become helpful adjunct assay .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Microbiologic diagnosis ' ."", ') Donor screen — All donor screen COVID-19 [ 9 ] .', 'We generally perform careful history , obtain chest image , perform microbiologic test .', 'In case decision proceed transplantation take account urgency transplant risk benefit individual .', 'As general principle : ●Donors know suspect active COVID-19 base exposure , symptom , chest image generally decline deferred.●Donors know suspect COVID-19 within past 28 day generally decline deferred.●Donors expose individual know suspect COVID-19 recent past ( eg , within past 21 day ) generally decline defer .', 'However , donor test negative COVID-19 , transplantation consider select case ( eg , transplantation urgently life-saving ) .●Donors also test SARS-CoV-2 infection RT-PCR perform respiratory tract sample .', 'The approach screen vary among institution organ transplant : •For decease organ donor ( especially lung donor ) , recommend sample upper respiratory tract ( eg , nasopharyngeal swab ) lower respiratory tract ( eg , bronchoalveolar lavage ) screen , base upon data suggest increase sensitivity lower tract ( ie , sputum , bronchoalveolar lavage ) specimen compare upper tract specimens.•For donor , screen COVID-19 perform single upper respiratory tract sample , minimum .', 'The need obtain serial sample and/or lower respiratory tract sample vary among center often individualized.For live donor test positive COVID-19 decease donor recover COVID-19 , optimal deferral period know .', 'Based upon mean duration viral shed ( 20 day ) [ 10 ] , American Society Transplantation ( AST ) suggest wait least 28 day time diagnosis complete resolution symptom ( live donor ) organ donation/procurement consider [ 9 ] .', 'As knowledge COVID-19 accumulate , screen recommendation expect evolve.Candidate screen — All potential organ transplant recipient screen COVID-19 history , chest image , microbiologic test prior transplantation .', 'Although data lack , COVID-19 asymptomatic , concern intense immunosuppression give time transplantation could result rapidly progressive potentially fatal COVID-19 : ●All potential organ recipient screen COVID-19 prior transplantation .', 'At transplant center include RT-PCR upper respiratory tract specimen ( eg , nasopharyngeal swab ) , thorough symptom exposure history , chest image .', 'A chest radiograph usually sufficient patient lack respiratory symptom , however , respiratory symptom ( even minor ) , compute tomography ( CT ) chest appropriate.●Candidates active COVID-19 and/or sign symptom respiratory illness generally defer transplantation.For patient active COVID-19 patient screen positive , optimal deferral period know .', 'The AST suggest wait symptom resolve least two RT-PCRs SARS-CoV-2 negative [ 9 ] .', 'As transplantation , risk transplantation must balance risk transplant patient acute recent COVID-19.PREVENTION — Preventive measure organ transplant recipient similar define general population ( eg , social distance , careful hand respiratory hygiene ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Prevention ' ."", ') One additional consideration solid organ transplant recipient COVID-19 may shed greater amount virus longer duration nonimmunosuppressed patient .', 'Thus , longer duration isolation and/or test document viral clearance help reduce likelihood spread infection others may need .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control home set ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' ."", ') ACTIVE COVID-19 IN SOLID ORGAN TRANSPLANT RECIPIENTSClinical presentationClinical feature — Clinical feature COVID-19 among solid organ transplant recipient variable similar nonimmunocompromised patient .', 'However , fever appear le common , possibly consequence effect immunosuppressive therapy systemic inflammatory response [ 11-13 ] .', 'As example , two case series solid organ transplant recipient New York City , fever present symptom 58 70 percent [ 12,13 ] .', 'Lymphopenia also common may profound nontransplant patient COVID-19 [ 13 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical feature ' ."", ') Severity illness — It unclear solid organ transplant recipient higher risk severe disease compare nontransplant patient infect SARS-CoV-2 .', 'Many solid organ transplant recipient medical comorbidities ( eg , hypertension , diabetes mellitus , chronic kidney disease , cardiovascular disease ) associate severe COVID-19 disease mortality , make attributable impact solid organ transplantation disease severity difficult assess.Limited data suggest solid organ transplant recipient COVID-19 infection may severe disease , similar describe non-solid organ transplant patient serious underlie comorbidities [ 12,13 ] .', 'As example , study 90 solid organ transplant recipient cite , 24 percent mild disease ( outpatient care ) , 46 percent moderate disease ( admit general inpatient floor ) , 30 percent severe disease ( mechanical ventilation , admission intensive care unit [ ICU ] , death ) [ 12 ] .', 'At median 20 day , mortality rate 18 percent .', 'Compared patient mild moderate disease , severe disease older likely hypertension active cancer , comorbidities associate severe disease general population significantly different group .', 'In addition , significant difference group type organ transplant median time transplant COVID-19 diagnosis.Risk factor severe COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ."", ') Effect immunosuppression — The impact immunosuppression solid organ transplant population COVID-19 disease severity remain unclear .', 'The pathogenesis COVID-19 appear represent interplay direct virally mediate injury associate host response , experimental data suggest dysregulated hyperintense immune response may mediate severe disease [ 14 ] .', 'Since immunosuppressive agent modulate several aspect host immune response , severity COVID-19 infection could potentially affect type , combination , intensity immunosuppression .', 'As example , certain immunosuppressive medication either directly ( eg , lymphocyte-depleting antibody ) indirectly ( eg , antimetabolite ) cause lymphopenia , report risk factor severe COVID-19 illness .', 'Specific agent independently associate decrease immune response vaccine ( eg , mammalian [ mechanistic ] target rapamycin [ mTOR ] inhibitor , mycophenolate ) could theoretically impair ability develop adequate immune response natural infection .', 'Conversely , experimental data suggest mTOR inhibitor may biological activity SARS-CoV-2 [ 15 ] .', 'Additional study require determine impact specific immunosuppressive agent course COVID-19 infection.Diagnosis — Criteria test COVID-19 solid organ transplant recipient similar general population .', 'However , clinician higher index suspicion infection , generally recommend immunosuppressed individual : ●For solid organ transplant recipient suspect COVID-19 hospitalize , test recommended.●For solid organ transplant recipient mild symptom , optimal practice define .', 'While favor test patient base upon potential rapid disease progression , others favor make clinical diagnosis monitor patient home .', 'Thus , decision often individualize base upon local COVID-19 prevalence , available resource , patient-provider preference.●Routine screen asymptomatic solid organ transplant recipient recommended.Specific test method discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical suspicion criterion test ' ."", ') ManagementGeneral consideration — The approach management acute COVID-19 infection solid organ transplant recipient similar nontransplant patient .', 'All specific antiviral agent use treatment COVID-19 investigational .', 'Use agent generally limit hospitalize patient risk severe disease .', ""When possible , treatment give part clinical trial.These issue discuss detail separately : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') Adjusting immunosuppression — Adjustments immunosuppressive regimen necessarily individualize , base upon disease severity , specific regimen use , type organ transplant , time posttransplant , risk acute allograft rejection [ 12 ] .Although optimal approach define , usually reduce immunosuppression patient moderate severe COVID-19 infection ( eg , require hospitalization ) : ●As first step , often reduce hold antimetabolite ( eg , mycophenolate mofetil/sodium ) , particularly patient lymphopenia ( eg , absolute lymphocyte count < 700 cells/mL ) .●We generally continue calcineurin inhibitor ( CNI ) CNIs inhibit interleukin ( IL ) -6 IL-1 pathway , may contribute development severe , dysregulated immune response see patient severe COVID-19.●We typically avoid use high-dose glucocorticoid agent associate prolong viral shed may predispose poor outcome , base experience epidemic coronaviruses .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Limited role glucocorticoid ' ."", ') However , case decision reduce immunosuppression must carefully weigh risk acute rejection , particularly transplant recipient generally require high level maintenance immunosuppression ( eg , lung heart recipient ) .', 'The optimal management immunosuppressive therapy solid organ transplant recipient COVID-19 infection know , data limit case report series [ 12,13,16,17 ] .There also concern COVID-19 infection may increase risk acute rejection overly intense inflammatory host immune response might contribute overall disease severity .', 'Thus , attenuate immune response maintain low-dose immunosuppression could theoretically beneficial .', 'In addition , experimental data suggest certain immunosuppressive agent mTOR inhibitor may biological activity SARS-CoV-2 [ 15 ] .', ""Additional study require confirm findings.Additional guidance adjust immunosuppression transplant recipient active infection find follow topic review : ● ( See `` Kidney transplantation adult : Maintenance immunosuppressive therapy '' , section 'Patients develop infection ' ."", "") ● ( See `` Maintenance immunosuppression follow lung transplantation '' , section 'Monitoring adjust maintenance therapy ' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' , section 'Issues ventricular assist device cardiac transplantation ' ."", ') Recommendations specific medical society list separately .', ""( See 'Society guideline link ' ."", ') Drug-drug interaction — A number experimental COVID-19 therapy potential drug-drug interaction medication commonly use among solid organ transplant recipient .', 'In particular , medication prolong QT interval ( eg , hydroxychloroquine , azithromycin ) use caution since many solid organ transplant recipient take CNI , may also prolong QT interval .', 'In addition , care take protease inhibitor ( lopinavir ritonavir ) , reduce metabolism significantly increase blood level CNIs ( table 1 ) .', 'SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●COVID-19 pose new challenge individual solid organ transplant candidate recipient , well process organ transplantation ."", ""( See 'Introduction ' ."", ') ●There theoretical risk transmit SARS-CoV-2 ( virus cause COVID-19 ) organ donor recipient base upon detection viral RNA organ transplant ( eg , lung , heart , kidney , intestine ) , although donor-derived infection report date .', ""( See 'Potential donor-derived infection ' ."", ') ●Because risk potential transmit SARS-CoV-2 health care provider , solid organ donor transplant candidate screen COVID-19 history , chest image , microbiologic test .', ""( See 'Pretransplantation screen ' ."", ') ●Posttransplantation , solid organ transplant recipient may increase risk acquisition COVID-19 immunocompromised frequent contact health care system , although association study .', ""( See 'Posttransplantation risk ' ."", ') ●The clinical manifestation COVID-19 solid organ transplant recipient variable similar observe nonimmunocompromised patient .', 'However , fever appear le common .', 'Whether disease course severe know .', ""( See 'Clinical presentation ' 'Severity illness ' ."", ') ●The approach diagnosis similar general population .', 'Because sign symptom COVID-19 may subtle transplant recipient disease progression rapid , clinician lower threshold evaluate test transplant recipient .', ""( See 'Diagnosis ' ."", ') ●The approach management ( eg , use antiviral , supportive care ) also similar general population , although careful attention pay potential drug-drug interaction effect immunosuppressive regimen .', ""( See 'General consideration ' 'Drug-drug interaction ' ."", ') ●Adjustments immunosuppressive regimen necessarily individualize , base upon disease severity , specific regimen use , type organ transplant , time posttransplant , risk acute allograft rejection .', 'Some organ transplant recipient recover without reduction immunosuppression , carry risk rejection immune reconstitution .', 'Conversely , continue immunosuppression may enhance risk uncontrolled infection .', ""( See 'Adjusting immunosuppression ' . )""]","['', 'solid', 'organ', 'transplant', 'recipient', 'increase', 'risk', 'covid-19', 'immunosuppressed', 'frequent', 'contact', 'health', 'care', 'system', '', 'theoretical', 'risk', 'transmission', 'sars-cov-2', '', 'virus', 'cause', 'covid-19', '', 'organ', 'transplantation', '', 'although', 'case', 'organ', 'transplant-transmitted', 'infection', 'describe', 'datethis', 'topic', 'review', 'aspect', 'covid-19', 'specific', 'solid', 'organ', 'transplantation', '', 'include', 'screen', 'prior', 'transplantation', '', 'distinct', 'clinical', 'feature', '', 'manage', 'immunosuppression', '', 'important', 'drug', 'interaction', '', 'aspect', 'covid-19', 'care', 'discuss', 'separately', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'risk', 'transmissionpotential', 'donor-derived', 'infection', '', 'risk', 'transmit', 'sars-cov-2', 'organ', 'donor', 'recipient', 'theoretical', 'base', 'upon', 'detection', 'viral', 'rna', 'organ', 'transplant', '', 'eg', '', 'lung', '', 'heart', '', 'kidney', '', 'intestine', '', 'site', '', 'ie', '', 'blood', '', 'urine', '', '', '1-4', '', '', 'clear', 'viable', 'infectious', 'virus', 'culture', 'lung', 'part', 'respiratory', 'gastrointestinal', '', 'gi', '', 'tract', '', 'additional', 'study', 'determine', 'whether', 'sars-cov-2', 'detect', 'extra-respiratory', 'site', 'intact', '', 'replication', 'competent', '', 'therefore', 'transmissible', 'non-lung', 'organ', 'transplantationto', 'date', '', 'organ', 'donor-derived', 'infection', 'report', '', 'similarly', '', 'bloodborne', 'transmission', 'report', 'expect', '', 'frequency', 'sars-cov-2', 'viremia', 'magnitude', 'low', '', '14-6', '', '', '', '', 'blood', 'donor', 'screen', '', 'medical', 'history', '', '', 'section', 'sars-cov-2', '', 'evidence', 'transfusion-transmitted', 'infection', '', '', '', '', 'posttransplantation', 'risk', '', 'whether', 'solid', 'organ', 'transplant', 'recipient', 'higher', 'risk', 'acquire', 'sars-cov-2', 'infection', 'general', 'population', '', 'however', '', 'chronic', 'immunosuppression', 'lower', 'infectious', 'dose', 'cause', 'covid-19', 'impair', 'adequate', 'immune', 'control', 'infection', 'establish', '', 'organ', 'transplant', 'recipient', 'frequent', 'contact', 'health', 'care', 'system', 'therefore', 'potentially', 'likely', 'expose', 'viruslike', 'immunosuppressed', 'person', '', 'solid', 'organ', 'transplant', 'recipient', 'shed', 'greater', 'amount', 'virus', 'longer', 'duration', 'otherwise', 'healthy', 'host', '', 'thus', '', 'likely', 'spread', 'infection', 'others', '', 'data', 'confirm', 'theory', 'quantify', 'viral', 'dynamic', 'transmission', 'risk', 'solid', 'organ', 'transplant', 'populationdeferral', 'nonurgent', 'transplantation', '', 'minimize', 'risk', 'infection', 'conserve', 'hospital', 'resource', '', 'elective', 'transplantation', '', 'eg', '', 'living-donor', 'kidney', 'transplantation', '', 'nonurgent', '', 'deceased-donor', 'transplantation', 'defer', 'transplant', 'center', 'community', 'prevalence', 'covid-19', 'high', 'andor', 'resource', '', 'personnel', '', 'hospital', 'intensive', 'care', 'unit', '', 'icu', '', 'bed', '', 'operate', 'room', '', 'equipment', '', 'limit', '', '7', '', 'life-saving', 'transplantation', 'continue', 'perform', '', 'centers', 'medicare', '', 'medicaid', 'services', 'classify', 'organ', 'transplantation', 'tier', '3b', 'activity', '', 'delay', '', 'basis', 'assessment', 'potential', 'risk', 'compare', 'benefit', '', '8', '', 'pretransplantation', 'screening', '', 'organ', 'donor', 'potential', 'recipient', 'screen', 'covid-19', 'prior', 'organ', 'procurement', '', 'necessary', 'prevent', 'initiation', 'potent', 'induction', 'immunosuppression', 'context', 'active', 'infection', 'safety', 'organ', 'transplant', 'recipient', '', 'typically', 'potently', 'immunosuppressed', 'immediate', 'posttransplant', 'period', '', 'organ', 'procurement', 'teamreverse-transcriptase', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'primarily', 'detect', 'active', 'infection', '', 'main', 'assay', 'screen', '', 'utility', 'serology', '', 'primarily', 'detect', 'past', 'infection', '', 'pretransplant', 'screen', 'establish', '', 'however', '', 'performance', 'characteristic', 'serology', 'well', 'establish', 'among', 'solid', 'organ', 'transplant', 'recipient', '', 'serology', 'become', 'helpful', 'adjunct', 'assay', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'microbiologic', 'diagnosis', '', '', '', 'donor', 'screen', '', 'donor', 'screen', 'covid-19', '', '9', '', '', 'generally', 'perform', 'careful', 'history', '', 'obtain', 'chest', 'image', '', 'perform', 'microbiologic', 'test', '', 'case', 'decision', 'proceed', 'transplantation', 'account', 'urgency', 'transplant', 'risk', 'benefit', 'individual', '', 'general', 'principle', '', 'donors', 'suspect', 'active', 'covid-19', 'base', 'exposure', '', 'symptom', '', 'chest', 'image', 'generally', 'decline', 'deferreddonors', 'suspect', 'covid-19', 'within', 'past', '28', 'day', 'generally', 'decline', 'deferreddonors', 'expose', 'individual', 'suspect', 'covid-19', 'recent', 'past', '', 'eg', '', 'within', 'past', '21', 'day', '', 'generally', 'decline', 'defer', '', 'however', '', 'donor', 'test', 'negative', 'covid-19', '', 'transplantation', 'consider', 'select', 'case', '', 'eg', '', 'transplantation', 'urgently', 'life-saving', '', 'donors', 'test', 'sars-cov-2', 'infection', 'rt-pcr', 'perform', 'respiratory', 'tract', 'sample', '', 'approach', 'screen', 'vary', 'among', 'institution', 'organ', 'transplant', '', 'decease', 'organ', 'donor', '', 'especially', 'lung', 'donor', '', '', 'recommend', 'sample', 'upper', 'respiratory', 'tract', '', 'eg', '', 'nasopharyngeal', 'swab', '', 'lower', 'respiratory', 'tract', '', 'eg', '', 'bronchoalveolar', 'lavage', '', 'screen', '', 'base', 'upon', 'data', 'suggest', 'increase', 'sensitivity', 'lower', 'tract', '', 'ie', '', 'sputum', '', 'bronchoalveolar', 'lavage', '', 'specimen', 'compare', 'upper', 'tract', 'specimensfor', 'donor', '', 'screen', 'covid-19', 'perform', 'single', 'upper', 'respiratory', 'tract', 'sample', '', 'minimum', '', 'obtain', 'serial', 'sample', 'andor', 'lower', 'respiratory', 'tract', 'sample', 'vary', 'among', 'center', 'often', 'individualizedfor', 'live', 'donor', 'test', 'positive', 'covid-19', 'decease', 'donor', 'recover', 'covid-19', '', 'optimal', 'deferral', 'period', '', 'based', 'upon', 'mean', 'duration', 'viral', 'shed', '', '20', 'day', '', '', '10', '', '', 'american', 'society', 'transplantation', '', 'ast', '', 'suggest', 'wait', 'least', '28', 'day', 'time', 'diagnosis', 'complete', 'resolution', 'symptom', '', 'live', 'donor', '', 'organ', 'donationprocurement', 'consider', '', '9', '', '', 'knowledge', 'covid-19', 'accumulate', '', 'screen', 'recommendation', 'expect', 'evolvecandidate', 'screen', '', 'potential', 'organ', 'transplant', 'recipient', 'screen', 'covid-19', 'history', '', 'chest', 'image', '', 'microbiologic', 'test', 'prior', 'transplantation', '', 'although', 'data', '', 'covid-19', 'asymptomatic', '', 'concern', 'intense', 'immunosuppression', 'give', 'time', 'transplantation', 'result', 'rapidly', 'progressive', 'potentially', 'fatal', 'covid-19', '', 'potential', 'organ', 'recipient', 'screen', 'covid-19', 'prior', 'transplantation', '', 'transplant', 'center', 'include', 'rt-pcr', 'upper', 'respiratory', 'tract', 'specimen', '', 'eg', '', 'nasopharyngeal', 'swab', '', '', 'thorough', 'symptom', 'exposure', 'history', '', 'chest', 'image', '', 'chest', 'radiograph', 'usually', 'sufficient', 'patient', 'respiratory', 'symptom', '', 'however', '', 'respiratory', 'symptom', '', 'minor', '', '', 'compute', 'tomography', '', 'ct', '', 'chest', 'appropriatecandidates', 'active', 'covid-19', 'andor', 'sign', 'symptom', 'respiratory', 'illness', 'generally', 'defer', 'transplantationfor', 'patient', 'active', 'covid-19', 'patient', 'screen', 'positive', '', 'optimal', 'deferral', 'period', '', 'ast', 'suggest', 'wait', 'symptom', 'resolve', 'least', 'two', 'rt-pcrs', 'sars-cov-2', 'negative', '', '9', '', '', 'transplantation', '', 'risk', 'transplantation', 'must', 'balance', 'risk', 'transplant', 'patient', 'acute', 'recent', 'covid-19prevention', '', 'preventive', 'measure', 'organ', 'transplant', 'recipient', 'similar', 'define', 'general', 'population', '', 'eg', '', 'social', 'distance', '', 'careful', 'hand', 'respiratory', 'hygiene', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'prevention', '', '', '', 'one', 'additional', 'consideration', 'solid', 'organ', 'transplant', 'recipient', 'covid-19', 'shed', 'greater', 'amount', 'virus', 'longer', 'duration', 'nonimmunosuppressed', 'patient', '', 'thus', '', 'longer', 'duration', 'isolation', 'andor', 'test', 'document', 'viral', 'clearance', 'help', 'reduce', 'likelihood', 'spread', 'infection', 'others', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'home', 'set', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', '', 'active', 'covid-19', 'solid', 'organ', 'transplant', 'recipientsclinical', 'presentationclinical', 'feature', '', 'clinical', 'feature', 'covid-19', 'among', 'solid', 'organ', 'transplant', 'recipient', 'variable', 'similar', 'nonimmunocompromised', 'patient', '', 'however', '', 'fever', 'appear', 'le', 'common', '', 'possibly', 'consequence', 'effect', 'immunosuppressive', 'therapy', 'systemic', 'inflammatory', 'response', '', '11-13', '', '', 'example', '', 'two', 'case', 'series', 'solid', 'organ', 'transplant', 'recipient', 'new', 'york', 'city', '', 'fever', 'present', 'symptom', '58', '70', 'percent', '', '1213', '', '', 'lymphopenia', 'common', 'profound', 'nontransplant', 'patient', 'covid-19', '', '13', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'feature', '', '', '', 'severity', 'illness', '', 'unclear', 'solid', 'organ', 'transplant', 'recipient', 'higher', 'risk', 'severe', 'disease', 'compare', 'nontransplant', 'patient', 'infect', 'sars-cov-2', '', 'solid', 'organ', 'transplant', 'recipient', 'medical', 'comorbidities', '', 'eg', '', 'hypertension', '', 'diabetes', 'mellitus', '', 'chronic', 'kidney', 'disease', '', 'cardiovascular', 'disease', '', 'associate', 'severe', 'covid-19', 'disease', 'mortality', '', 'attributable', 'impact', 'solid', 'organ', 'transplantation', 'disease', 'severity', 'difficult', 'assesslimited', 'data', 'suggest', 'solid', 'organ', 'transplant', 'recipient', 'covid-19', 'infection', 'severe', 'disease', '', 'similar', 'describe', 'non-solid', 'organ', 'transplant', 'patient', 'serious', 'underlie', 'comorbidities', '', '1213', '', '', 'example', '', 'study', '90', 'solid', 'organ', 'transplant', 'recipient', 'cite', '', '24', 'percent', 'mild', 'disease', '', 'outpatient', 'care', '', '', '46', 'percent', 'moderate', 'disease', '', 'admit', 'general', 'inpatient', 'floor', '', '', '30', 'percent', 'severe', 'disease', '', 'mechanical', 'ventilation', '', 'admission', 'intensive', 'care', 'unit', '', 'icu', '', '', 'death', '', '', '12', '', '', 'median', '20', 'day', '', 'mortality', 'rate', '18', 'percent', '', 'compared', 'patient', 'mild', 'moderate', 'disease', '', 'severe', 'disease', 'older', 'likely', 'hypertension', 'active', 'cancer', '', 'comorbidities', 'associate', 'severe', 'disease', 'general', 'population', 'significantly', 'different', 'group', '', 'addition', '', 'significant', 'difference', 'group', 'type', 'organ', 'transplant', 'median', 'time', 'transplant', 'covid-19', 'diagnosisrisk', 'factor', 'severe', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'effect', 'immunosuppression', '', 'impact', 'immunosuppression', 'solid', 'organ', 'transplant', 'population', 'covid-19', 'disease', 'severity', 'remain', 'unclear', '', 'pathogenesis', 'covid-19', 'appear', 'represent', 'interplay', 'direct', 'virally', 'mediate', 'injury', 'associate', 'host', 'response', '', 'experimental', 'data', 'suggest', 'dysregulated', 'hyperintense', 'immune', 'response', 'mediate', 'severe', 'disease', '', '14', '', '', 'since', 'immunosuppressive', 'agent', 'modulate', 'several', 'aspect', 'host', 'immune', 'response', '', 'severity', 'covid-19', 'infection', 'potentially', 'affect', 'type', '', 'combination', '', 'intensity', 'immunosuppression', '', 'example', '', 'certain', 'immunosuppressive', 'medication', 'either', 'directly', '', 'eg', '', 'lymphocyte-depleting', 'antibody', '', 'indirectly', '', 'eg', '', 'antimetabolite', '', 'cause', 'lymphopenia', '', 'report', 'risk', 'factor', 'severe', 'covid-19', 'illness', '', 'specific', 'agent', 'independently', 'associate', 'decrease', 'immune', 'response', 'vaccine', '', 'eg', '', 'mammalian', '', 'mechanistic', '', 'target', 'rapamycin', '', 'mtor', '', 'inhibitor', '', 'mofetil', '', 'theoretically', 'impair', 'ability', 'develop', 'adequate', 'immune', 'response', 'natural', 'infection', '', 'conversely', '', 'experimental', 'data', 'suggest', 'mtor', 'inhibitor', 'biological', 'activity', 'sars-cov-2', '', '15', '', '', 'additional', 'study', 'require', 'determine', 'impact', 'specific', 'immunosuppressive', 'agent', 'course', 'covid-19', 'infectiondiagnosis', '', 'criteria', 'test', 'covid-19', 'solid', 'organ', 'transplant', 'recipient', 'similar', 'general', 'population', '', 'however', '', 'clinician', 'higher', 'index', 'suspicion', 'infection', '', 'generally', 'recommend', 'immunosuppressed', 'individual', '', 'solid', 'organ', 'transplant', 'recipient', 'suspect', 'covid-19', 'hospitalize', '', 'test', 'recommendedfor', 'solid', 'organ', 'transplant', 'recipient', 'mild', 'symptom', '', 'optimal', 'practice', 'define', '', 'favor', 'test', 'patient', 'base', 'upon', 'potential', 'rapid', 'disease', 'progression', '', 'others', 'favor', 'clinical', 'diagnosis', 'monitor', 'patient', 'home', '', 'thus', '', 'decision', 'often', 'individualize', 'base', 'upon', 'local', 'covid-19', 'prevalence', '', 'available', 'resource', '', 'patient-provider', 'preferenceroutine', 'screen', 'asymptomatic', 'solid', 'organ', 'transplant', 'recipient', 'recommendedspecific', 'test', 'method', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'suspicion', 'criterion', 'test', '', '', '', 'managementgeneral', 'consideration', '', 'approach', 'management', 'acute', 'covid-19', 'infection', 'solid', 'organ', 'transplant', 'recipient', 'similar', 'nontransplant', 'patient', '', 'specific', 'antiviral', 'agent', 'treatment', 'covid-19', 'investigational', '', 'agent', 'generally', 'limit', 'hospitalize', 'patient', 'risk', 'severe', 'disease', '', 'possible', '', 'treatment', 'give', 'part', 'clinical', 'trialthese', 'issue', 'discuss', 'detail', 'separately', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'adjusting', 'immunosuppression', '', 'adjustments', 'immunosuppressive', 'regimen', 'necessarily', 'individualize', '', 'base', 'upon', 'disease', 'severity', '', 'specific', 'regimen', '', 'type', 'organ', 'transplant', '', 'time', 'posttransplant', '', 'risk', 'acute', 'allograft', 'rejection', '', '12', '', 'although', 'optimal', 'approach', 'define', '', 'usually', 'reduce', 'immunosuppression', 'patient', 'moderate', 'severe', 'covid-19', 'infection', '', 'eg', '', 'require', 'hospitalization', '', '', 'first', 'step', '', 'often', 'reduce', 'hold', 'antimetabolite', '', 'eg', '', 'mofetil', 'mofetilsodium', '', '', 'particularly', 'patient', 'lymphopenia', '', 'eg', '', 'absolute', 'lymphocyte', 'count', '', '700', 'cellsml', '', 'generally', 'continue', 'calcineurin', 'inhibitor', '', 'cni', '', 'cnis', 'inhibit', 'interleukin', '', 'il', '', '-6', 'il-inhibitor', 'pathway', '', 'contribute', 'development', 'severe', '', 'dysregulated', 'immune', 'response', 'patient', 'severe', 'covid-19we', 'typically', 'avoid', 'high-dose', 'glucocorticoid', 'agent', 'associate', 'prolong', 'viral', 'shed', 'predispose', 'poor', 'outcome', '', 'base', 'experience', 'epidemic', 'coronaviruses', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'limited', 'role', 'glucocorticoid', '', '', '', 'however', '', 'case', 'decision', 'reduce', 'immunosuppression', 'must', 'carefully', 'weigh', 'risk', 'acute', 'rejection', '', 'particularly', 'transplant', 'recipient', 'generally', 'require', 'high', 'level', 'maintenance', 'immunosuppression', '', 'eg', '', 'lung', 'heart', 'recipient', '', '', 'optimal', 'management', 'immunosuppressive', 'therapy', 'solid', 'organ', 'transplant', 'recipient', 'covid-19', 'infection', '', 'data', 'limit', 'case', 'report', 'series', '', '12131617', '', 'concern', 'covid-19', 'infection', 'increase', 'risk', 'acute', 'rejection', 'overly', 'intense', 'inflammatory', 'host', 'immune', 'response', 'contribute', 'overall', 'disease', 'severity', '', 'thus', '', 'attenuate', 'immune', 'response', 'maintain', 'low-dose', 'immunosuppression', 'theoretically', 'beneficial', '', 'addition', '', 'experimental', 'data', 'suggest', 'certain', 'immunosuppressive', 'agent', 'mtor', 'inhibitor', 'biological', 'activity', 'sars-cov-2', '', '15', '', '', 'additional', 'study', 'require', 'confirm', 'findingsadditional', 'guidance', 'adjust', 'immunosuppression', 'transplant', 'recipient', 'active', 'infection', 'find', 'follow', 'topic', 'review', '', '', '', '', 'kidney', 'transplantation', 'adult', '', 'maintenance', 'immunosuppressive', 'therapy', '', '', 'section', 'patients', 'develop', 'infection', '', '', '', '', '', '', 'maintenance', 'immunosuppression', 'follow', 'lung', 'transplantation', '', '', 'section', 'monitoring', 'adjust', 'maintenance', 'therapy', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'section', 'issues', 'ventricular', 'assist', 'device', 'cardiac', 'transplantation', '', '', '', 'recommendations', 'specific', 'medical', 'society', 'list', 'separately', '', '', 'society', 'guideline', 'link', '', '', '', 'drug-drug', 'interaction', '', 'number', 'experimental', 'covid-19', 'therapy', 'potential', 'drug-drug', 'interaction', 'medication', 'commonly', 'among', 'solid', 'organ', 'transplant', 'recipient', '', 'particular', '', 'medication', 'prolong', 'qt', 'interval', '', 'eg', '', 'hydroxychloroquine', '', 'azithromycin', '', 'caution', 'since', 'solid', 'organ', 'transplant', 'recipient', 'cni', '', 'prolong', 'qt', 'interval', '', 'addition', '', 'care', 'protease', 'inhibitor', '', 'lopinavir', 'ritonavir', '', '', 'reduce', 'metabolism', 'significantly', 'increase', 'blood', 'level', 'cnis', '', 'table', '1', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'summary', 'recommendationscovid-19', 'pose', 'new', 'challenge', 'individual', 'solid', 'organ', 'transplant', 'candidate', 'recipient', '', 'well', 'process', 'organ', 'transplantation', '', '', '', '', '', 'theoretical', 'risk', 'transmit', 'sars-cov-2', '', 'virus', 'cause', 'covid-19', '', 'organ', 'donor', 'recipient', 'base', 'upon', 'detection', 'viral', 'rna', 'organ', 'transplant', '', 'eg', '', 'lung', '', 'heart', '', 'kidney', '', 'intestine', '', '', 'although', 'donor-derived', 'infection', 'report', 'date', '', '', 'potential', 'donor-derived', 'infection', '', '', '', 'risk', 'potential', 'transmit', 'sars-cov-2', 'health', 'care', 'provider', '', 'solid', 'organ', 'donor', 'transplant', 'candidate', 'screen', 'covid-19', 'history', '', 'chest', 'image', '', 'microbiologic', 'test', '', '', 'pretransplantation', 'screen', '', '', '', 'posttransplantation', '', 'solid', 'organ', 'transplant', 'recipient', 'increase', 'risk', 'acquisition', 'covid-19', 'immunocompromised', 'frequent', 'contact', 'health', 'care', 'system', '', 'although', 'association', 'study', '', '', 'posttransplantation', 'risk', '', '', '', 'clinical', 'manifestation', 'covid-19', 'solid', 'organ', 'transplant', 'recipient', 'variable', 'similar', 'observe', 'nonimmunocompromised', 'patient', '', 'however', '', 'fever', 'appear', 'le', 'common', '', 'whether', 'disease', 'course', 'severe', '', '', 'clinical', 'presentation', '', 'severity', 'illness', '', '', '', 'approach', 'diagnosis', 'similar', 'general', 'population', '', 'sign', 'symptom', 'covid-19', 'subtle', 'transplant', 'recipient', 'disease', 'progression', 'rapid', '', 'clinician', 'lower', 'threshold', 'evaluate', 'test', 'transplant', 'recipient', '', '', 'diagnosis', '', '', '', 'approach', 'management', '', 'eg', '', 'antiviral', '', 'supportive', 'care', '', 'similar', 'general', 'population', '', 'although', 'careful', 'attention', 'pay', 'potential', 'drug-drug', 'interaction', 'effect', 'immunosuppressive', 'regimen', '', '', 'general', 'consideration', '', 'drug-drug', 'interaction', '', '', '', 'adjustments', 'immunosuppressive', 'regimen', 'necessarily', 'individualize', '', 'base', 'upon', 'disease', 'severity', '', 'specific', 'regimen', '', 'type', 'organ', 'transplant', '', 'time', 'posttransplant', '', 'risk', 'acute', 'allograft', 'rejection', '', 'organ', 'transplant', 'recipient', 'recover', 'without', 'reduction', 'immunosuppression', '', 'carry', 'risk', 'rejection', 'immune', 'reconstitution', '', 'conversely', '', 'continue', 'immunosuppression', 'enhance', 'risk', 'uncontrolled', 'infection', '', '', 'adjusting', 'immunosuppression', '', '', '']",2665,"{'': 714, 'covid-19': 73, 'organ': 54, 'transplant': 47, 'disease': 47, 'recipient': 36, 'infection': 30, 'patient': 30, 'solid': 28, 'risk': 26, 'coronavirus': 24, '2019': 24, 'transplantation': 23, 'eg': 19, 'screen': 18, 'immunosuppression': 17, 'care': 16, 'severe': 15, 'clinical': 14, 'donor': 14}","{'mofetil': 2, 'hydroxychloroquine': 1, 'infection': 30, 'sars-cov-2': 13, 'safety': 1, 'il-inhibitor': 1}",48,0.8176
ID:127933,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'care', 'patient', 'systemic', 'rheumatic', 'disease', 'pandemic']","['INTRODUCTION — At end 2019 , novel coronavirus name severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) identify cause cluster pneumonia case Wuhan , city Hubei Province China .', 'By 2020 , infection virus lead pandemic spread throughout country world .', 'The illness cause virus , term coronavirus disease 2019 ( COVID-19 ) , primarily manifest lung infection symptom range mild upper respiratory infection severe pneumonia , acute respiratory distress syndrome , death .', 'Severe illness occur healthy individual , also patient underlie medical condition , include patient systemic rheumatic disease .', 'All medical professional , include rheumatology clinician , task rapidly adjust practice curtail spread COVID-19 , provide life-sustaining care patients.This topic discus care patient systemic rheumatic disease COVID-19 pandemic .', ""Other important aspect COVID-19 infection discuss detail separately : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Questions answer '' ."", ') RISK OF COVID-19 INFECTIONDisease- comorbidity-related risk — The presence rheumatic disease alone know associate increase risk develop COVID-19 adverse outcome infection .', 'However , patient various rheumatic disease higher prevalence several comorbidities advance age , chronic pulmonary kidney disease , heart disease , hypertension , obesity , diabetes [ 1-7 ] , turn risk factor severe illness COVID-19 .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Impact age ' ."", ') There limit evidence regard degree risk associate establish rheumatic disease .', 'In one series 86 patient New York immune-mediated inflammatory disease diagnose definite presume COVID-19 , proportion patient require hospitalization similar infect patient general population New York City [ 8 ] .', ""However , limit observational data suggest patient active rheumatic disease may higher risk develop infection [ 9-11 ] , although study perform prior COVID-19 pandemic.Certain laboratory abnormality see patient systemic rheumatic disease associate poor outcome patient COVID-19 , lymphopenia ( particularly low CD4+ T cell ) elevate level C-reactive protein , interleukin 6 ( IL-6 ) , creatine kinase ( see `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ) ; abnormality result infection immune response infection ."", 'It unknown whether abnormality , pre-existing due another disorder ( eg , systemic rheumatic disease ) , impact disease outcome.Risks associate rheumatic disease therapy — It know whether association specific rheumatologic treatment increase risk COVID-19 complication , although rheumatic disease therapy associate higher risk infection [ 12,13 ] .', 'Limited data observational study mix , report suggest may increase risk COVID-19 patient receive systemic rheumatic disease therapy , others suggest decrease risk .', 'As example : ●In series 86 patient New York diagnose definite presume COVID-19 , also immune-mediated inflammatory disease ( include rheumatoid arthritis , psoriasis psoriatic arthritis , ankylose spondylitis , inflammatory bowel disease ) , receive biologic agent Janus kinase ( JAK ) inhibitor baseline likely require hospitalization infection patient receive nonbiologic conventional immunosuppressive agent [ 8 ] .●In report Lombardy region Italy , COVID-19 highly prevalent , 320 patient rheumatic disease receive biologic target synthetic disease-modifying antirheumatic drug ( DMARD ) , eight diagnose strongly suspect COVID-19 , five additional patient experience know exposure infect individual remain asymptomatic [ 14 ] .', 'Only one rheumatic disease patient require hospital admission treat several day low-flow oxygen .', 'During period , 33,000 case COVID-19 diagnose region 1250 require admission intensive care.●Another report Lombardy region Italy , involve 1193 patient psoriasis receive either biologic agent conventional small molecule drug , find compare general population region , patient treat biologics higher risk symptomatic COVID-19 ( odds ratio [ OR ] 3.43 [ 95 % CI 2.25-5.73 ] ) , self-quarantined home ( OR 9.05 [ 95 % CI 5.61-14.61 ] ) , hospitalize ( OR 3.59 [ 95 % CI 1.49-8.63 ] ) ; however , find increase risk admission intensive care unit death [ 15 ] .●Although speculation regard potential protective role hydroxychloroquine ( HCQ ) COVID-19 therapy , substantial number patient among clinician- patient self-reported cohort rheumatic disease patient COVID-19 take HCQ time diagnose infection ( 22 28 percent patient , respectively , April 27 , 2020 ) [ 16 ] .', 'A majority patient take HCQ also take immune-modulating therapies.CLINICAL MANIFESTATIONS AND DIAGNOSTIC CONSIDERATIONSClinical presentation infection rheumatic disease patient — The clinical feature COVID-19 among patient systemic rheumatic disease variable know different patient without underlie disease .', ""There insufficient data report case determine whether type rheumatic disease intensity immunosuppressive agent use influence clinical presentation COVID-19 population ( see 'Disease registry ' ) ."", 'However , possible rheumatic disease feature may difficult distinguish COVID-19 .', ""( See 'Rheumatic disease feature mimic mimic COVID-19 ' ."", ') Rheumatic disease feature mimic mimic COVID-19 — A variety rheumatic disease may clinical feature mimic mimic COVID-19 , malaise , myalgia , fatigue .', 'For patient carry exist diagnosis rheumatic disease , clinician may need distinguish disease flare possible COVID-19 infection , high level suspicion maintain COVID-19 may prevalent .', 'The approach test COVID-19 discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", "") Specific example condition include disease manifest fever ( eg , systemic lupus erythematosus [ SLE ] ) , headache ( eg , giant cell arteritis [ GCA ] ) , gastrointestinal symptom ( eg , spondyloarthritis , systemic sclerosis [ SSc ] , SLE , Behçet syndrome ) , dyspnea ( eg , interstitial pulmonary disease due rheumatoid arthritis , SSc , SLE ) , stroke ( eg , antiphospholipid syndrome [ APS ] ) , pernio- chilblain-like lesion , sometimes call `` COVID toe '' ( eg , chilblain lupus erythematosus ) , Kawasaki-like multisystem inflammatory syndrome child ( MIC-S ) , sometimes term pediatric multisystem inflammatory syndrome ( eg , Kawasaki disease ) ."", ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical manifestation ' `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' , section 'Clinical manifestation ' `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Clinical feature ' ."", ') In addition , laboratory abnormality elevate erythrocyte sedimentation rate , C-reactive protein level , ferritin , interleukin 6 ( IL-6 ) , creatine kinase level see infection various rheumatic diseases.Medications use treat rheumatic disease may also cause adverse effect mimic clinical manifestation COVID-19 ( eg , sulfasalazine [ SSZ ] , may cause gastrointestinal symptom , methotrexate [ MTX ] , may cause pulmonary abnormality ) .Referral rheumatologic evaluation may appropriate patient know suspect COVID-19 establish rheumatic disease diagnosis yet additional clinical feature concern rheumatic disease ( eg , find suggestive synovitis serology characteristic autoimmune rheumatic disease ) .MANAGEMENT OF PATIENTS WITH KNOWN OR SUSPECTED SARS-CoV-2 EXPOSURE OR INFECTIONMedication management stable asymptomatic patient follow exposure — Adjustments medication regimen patient stable rheumatic disease asymptomatic think recently expose severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) virus individualize .', 'Our general approach follow [ 17 ] : ●Hydroxychloroquine ( HCQ ) /chloroquine ( CQ ) , sulfasalazine ( SSZ ) , nonsteroidal antiinflammatory drug ( NSAIDs ) may continued.●Whether methotrexate ( MTX ) leflunomide ( LEF ) discontinue must assess case-by-case basis weigh potential risk infection sequela possible risk rheumatic disease flare period drug hold .', 'If medication temporarily hold , generally resume pending negative test result COVID-19 two week symptom-free observation.●Cyclophosphamide ( CYC ) , mycophenolate mofetil ( MMF ) , azathioprine ( AZA ) , tacrolimus , anti-tumor necrosis factor ( TNF ) agent , abatacept , Janus kinase ( JAK ) inhibitor ( eg , tofacitinib ) stop temporarily , pending negative test result COVID-19 two week symptom-free observation.●Interleukin 6 ( IL-6 ) receptor inhibitor may continue select patient , particularly high risk develop cytokine release-like syndrome , preferably study protocol .', ""The decision use agent make close consultation expert infectious disease critical care involve management patient 's acute illness ."", 'The role IL-6 blockade management COVID-19 discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' ."", ') The approach describe largely base upon expert opinion extrapolation management patient medication develop infection consistent management practice recommend American College Rheumatology ( ACR ) [ 17 ] , well generally similar guideline [ 18,19 ] .', ""( See 'Society guideline link ' ."", ') Use NSAIDs , include indication contraindication use , would differ patient without exposure SARS-CoV-2 , consistent international specialty guideline , give lack scientific evidence novel increase risk associate NSAID use patient COVID-19 [ 17,20-22 ] .', 'HCQ SSZ continue give relatively low risk serious infection associate either [ 23,24 ] .', 'In addition , disease systemic lupus erythematosus ( SLE ) , discontinuation HCQ associate disease flare .', 'The limit evidence role HCQ/CQ management COVID-19 discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Hydroxychloroquine/chloroquine ' ."", ') While treatment MTX LEF also associate relatively low risk serious infection [ 25,26 ] , particularly give monotherapy , decide whether continue medication case-by-case basis.The rationale temporarily discontinue immunosuppressive drug , biologic agent , JAK inhibitor base upon associate increase risk serious infection compare conventional disease-modifying antirheumatic drug ( DMARDs ) [ 12,13 ] , theoretically low likelihood disease flare withhold medication limit time period .', 'One exception discontinuation biologic agent may use IL-6 inhibitor , give report potential benefit patient develop intense inflammatory state similar cytokine release syndrome due severe COVID-19 ; however , randomize trial examine efficacy infection ongoing .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' ."", ') Medication management document presumptive COVID-19 — Adjustments medication regimen patient document presumptive COVID-19 individualize specific attention severity infection .', 'Our overall approach follow : ●Antimalarial therapy ( ie , HCQ/CQ ) may continue , caveat hospitalize patient may require additional surveillance give cardiotoxicity may heighten patient COVID-19 .', 'Concomitant use medication prolong QT interval avoid .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' , section 'Patients receive QT-prolonging treatment ( eg , hydroxychloroquine , chloroquine , azithromycin , etc ) ' ."", ') ●SSZ , MTX , LEF , immunosuppressant ( eg , MMF , AZA ) , biologic agent IL-6 receptor inhibitor , JAK inhibitor stop held.●For patient severe respiratory , cardiac , kidney involvement , NSAIDs discontinue would patient without COVID-19.●IL-6 receptor inhibitor may continue select patient , particularly high risk develop cytokine release-like syndrome , preferably study protocol .', ""The decision use agent make close consultation expert infectious disease critical care involve management patient 's acute illness ."", 'The role IL-6 blockade management COVID-19 discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' ."", ') ●Glucocorticoids abruptly discontinued.The approach describe largely base upon expert opinion extrapolation management patient take medication develop serious infection consistent management practice recommend ACR [ 17 ] , well generally similar guideline [ 18,19 ] .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' , section 'Rheumatology ' ."", "") Given low risk serious infection associate HCQ CQ well potential benefit prevent rheumatic disease flare , generally continue therapy patient already take ( see 'Medication management stable asymptomatic patient follow exposure ' ) ."", 'The rationale hold SSZ mainly relate concern potential adverse effect agent ( eg , gastrointestinal upset , diarrhea , hepatitis , cytopenia , , rarely , pneumonitis ) could confuse clinical laboratory manifestation COVID-19 .', 'Additionally , temporarily hold SSZ two three week would unlikely result significant rheumatic disease flares.We discontinue MTX , LEF , immunosuppressant , biologic agent IL-6 blocker , JAK inhibitor give concern impair host defense COVID-19 risk cause additional infection , although data confirm convincingly refute risk .', 'In addition , risk rheumatic disease flare likely relatively low limit period antirheumatic drug likely hold .', 'Most infection associate medication bacterial opportunistic origin ; risk remain relevant , substantial proportion patient COVID-19 develop complication bacterial pneumonia [ 27 ] .', 'Additional risk treatment certain biologics JAK inhibitor include reactivation viral infection , include herpes zoster [ 28 ] .Although glucocorticoid convey increase risk infection , abrupt discontinuation feasible safe seriously ill patient .', 'To minimize adverse reaction , treat patient require glucocorticoid systemic rheumatic disease lowest necessary dose shortest period time .', ""( See `` Major side effect systemic glucocorticoid '' ."", ') Postinfection management — The optimal time resume immunosuppressive medication infection COVID-19 unknown ; generally restart immunosuppressive medication patient longer symptomatic least two week pass since document infection .', 'There limit data address issue .', 'In small observational study nine patient , seroconversion detect patient two week , viral load progressively decrease , despite detection , live virus unable isolate eight day [ 29 ] .', 'Further information regard long patient may remain infectious needed.MANAGEMENT CONSIDERATIONS FOR PATIENTS IN THE ABSENCE OF INFECTION OR KNOWN EXPOSUREGeneral principles●Patients rheumatic disease practice widely recommend prevention strategy focus mitigate infection risk .', 'This include adopt practice optimal hand hygiene , physical distance , wear mask public adequate physical distance possible .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Prevention ' ."", ') ●For patient newly diagnose , stable , active disease , management generally differ usual treatment approach absence COVID-19 .', ""We initiate continue medication indicate management patient 's systemic rheumatic disease ."", 'These may include conventional disease-modifying antirheumatic drug ( DMARDs ) immunosuppressive agent , include hydroxychloroquine ( HCQ ) /chloroquine ( CQ ) , sulfasalazine ( SSZ ) , methotrexate ( MTX ) , leflunomide ( LEF ) , tacrolimus , cyclosporine ( CSA ) , mycophenolate mofetil ( MMF ) , azathioprine ( AZA ) ; biologic agent ( eg , abatacept , tocilizumab ) ; Janus kinase ( JAK ) inhibitor ; nonsteroidal antiinflammatory drug ( NSAIDs ) .Continuation HCQ/CQ particularly important patient systemic lupus erythematosus ( SLE ) , available , especially active severe disease pregnant.●Glucocorticoids abruptly discontinue , use lowest dose possible control underlie rheumatic disease , regardless exposure infection status.Modifications routine rheumatologic care — Modifications routine rheumatologic care minimize risk exposure COVID-19 possible include : ●Optimal use telehealth visits.●Decreased frequency routine laboratory surveillance associate risk deem low .', ""Decisions regard safest interval test need individualize , base , example , upon patient 's overall clinical status , comorbidities , prior stability test , medication use.●Use lower-volume laboratory offsite larger health care facilities.●For patient area affect epidemic receive treatment infusion center , additional treatment option may appropriate switch form medication medication class self-administered subcutaneous injection ."", 'However , neither theoretical add safety benefit risk disease flare approach formally evaluate set , decision individualized.Prognosis — There available evidence identify risk factor poor outcome COVID-19 infection specific patient rheumatic disease , evidence adverse rheumatic disease outcome follow infection short-term risk increase disease activity due temporary drug discontinuation.DISEASE REGISTRIES — To improve understand impact severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) virus infection patient systemic rheumatic disease , strongly urge patient enrol patient registry whenever possible , include follow national regional registry : ●COVID-19 Global Rheumatology Alliance registry●The EULAR – COVID-19 Reporting registry rheumatologist cliniciansLINKS FOR PATIENT EDUCATION — Links resource information coronavirus disease 2019 ( COVID-19 ) patient rheumatic disease select rheumatology society government-sponsored guideline present separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' , section 'Rheumatology ' ."", ') SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' , section 'Rheumatology ' ."", ') SUMMARY AND RECOMMENDATIONS●The presence rheumatic disease alone know associate increase risk develop coronavirus disease 2019 ( COVID-19 ) adverse outcome infection .', 'Patients various rheumatic disease , however , higher prevalence several comorbidities advance age , chronic pulmonary kidney disease , heart disease , hypertension , obesity , diabetes , turn risk factor severe illness COVID-19 .', ""( See 'Disease- comorbidity-related risk ' ."", ') ●It know whether specific rheumatologic treatment associate increase risk COVID-19 complication , although rheumatic disease therapy associate higher risk infection .', ""( See 'Risks associate rheumatic disease therapy ' ."", ') ●The clinical feature COVID-19 among patient systemic rheumatic disease variable know different patient without underlie disease .', 'However , variety rheumatic disease may clinical feature mimic mimic COVID-19 , malaise , myalgia , fatigue .', 'For patient carry exist diagnosis rheumatic disease , clinician may need distinguish disease flare possible COVID-19 infection , high level suspicion maintain COVID-19 may prevalent .', ""( See 'Clinical presentation infection rheumatic disease patient ' 'Rheumatic disease feature mimic mimic COVID-19 ' ."", ') ●Adjustments medication regimen patient stable rheumatic disease asymptomatic think recently expose severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) virus individualize .', ""Our general approach follow ( see 'Medication management stable asymptomatic patient follow exposure ' ) : •Hydroxychloroquine ( HCQ ) /chloroquine ( CQ ) , sulfasalazine ( SSZ ) , nonsteroidal antiinflammatory drug ( NSAIDs ) may continued.•Methotrexate ( MTX ) leflunomide ( LEF ) discontinuation determine case-by-case basis.•Cyclophosphamide ( CYC ) , mycophenolate mofetil ( MMF ) , azathioprine ( AZA ) , tacrolimus , anti-tumor necrosis factor ( TNF ) agent , abatacept , Janus kinase ( JAK ) inhibitor ( eg , tofacitinib ) stop temporarily , pending negative test result COVID-19 two week symptom-free observation.•Interleukin 6 ( IL-6 ) receptor inhibitor may continue select patient , particularly high risk develop cytokine release-like syndrome , preferably study protocol.●Adjustments medication regimen patient document presumptive COVID-19 individualize specific attention severity infection ."", ""Our general approach follow ( see 'Medication management document presumptive COVID-19 ' ) : •HCQ/CQ may continue , caveat hospitalize patient may require additional surveillance give cardiotoxicity may heighten patient COVID-19.•SSZ , MTX , LEF , immunosuppressant ( eg , MMF , AZA ) , biologic agent IL-6 receptor inhibitor , JAK inhibitor stop held.•For patient severe respiratory , cardiac , kidney involvement , NSAIDs discontinue , would patient without COVID-19.•IL-6 receptor inhibitor may continue select patient , particularly high risk develop cytokine release-like syndrome , preferably study protocol ."", '•Glucocorticoids abruptly discontinued.●The optimal time resume immunosuppressive medication infection COVID-19 unknown ; generally restart immunosuppressive medication patient longer symptomatic least two week pass since document infection .', ""( See 'Postinfection management ' ."", ') ●The management patient newly diagnose , stable , active rheumatic disease know infection exposure SARS-CoV-2 generally differ usual treatment approach absence COVID-19 .', ""We initiate continue medication indicate management patient 's systemic rheumatic disease ."", ""( See 'General principle ' ."", ') ●Modifications routine rheumatologic care minimize risk exposure COVID-19 possible include optimal use telehealth visit , decrease frequency routine laboratory surveillance associate risk deem low , use lower-volume laboratory offsite larger health care facility .', ""( See 'Modifications routine rheumatologic care ' ."", ') ●There available evidence identify risk factor poor outcome COVID-19 infection specific patient rheumatic disease , evidence adverse rheumatic disease outcome follow infection short-term risk increase disease activity due temporary drug discontinuation .', ""( See 'Prognosis ' . )""]","['', 'end', '2019', '', 'novel', 'coronavirus', 'name', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', '2020', '', 'infection', 'virus', 'lead', 'pandemic', 'spread', 'throughout', 'country', 'world', '', 'illness', 'cause', 'virus', '', 'term', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'primarily', 'manifest', 'lung', 'infection', 'symptom', 'range', 'mild', 'upper', 'respiratory', 'infection', 'severe', 'pneumonia', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'death', '', 'severe', 'illness', 'occur', 'healthy', 'individual', '', 'patient', 'underlie', 'medical', 'condition', '', 'include', 'patient', 'systemic', 'rheumatic', 'disease', '', 'medical', 'professional', '', 'include', 'rheumatology', 'clinician', '', 'task', 'rapidly', 'adjust', 'practice', 'curtail', 'spread', 'covid-19', '', 'provide', 'life-sustaining', 'care', 'patientsthis', 'topic', 'discus', 'care', 'patient', 'systemic', 'rheumatic', 'disease', 'covid-19', 'pandemic', '', 'important', 'aspect', 'covid-19', 'infection', 'discuss', 'detail', 'separately', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'questions', 'answer', '', '', '', 'risk', 'covid-19', 'infectiondisease-', 'comorbidity-related', 'risk', '', 'presence', 'rheumatic', 'disease', 'alone', 'associate', 'increase', 'risk', 'develop', 'covid-19', 'adverse', 'outcome', 'infection', '', 'however', '', 'patient', 'various', 'rheumatic', 'disease', 'higher', 'prevalence', 'several', 'comorbidities', 'advance', 'age', '', 'chronic', 'pulmonary', 'kidney', 'disease', '', 'heart', 'disease', '', 'hypertension', '', 'obesity', '', 'diabetes', '', '1-7', '', '', 'turn', 'risk', 'factor', 'severe', 'illness', 'covid-19', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'impact', 'age', '', '', '', 'limit', 'evidence', 'regard', 'degree', 'risk', 'associate', 'establish', 'rheumatic', 'disease', '', 'one', 'series', '86', 'patient', 'new', 'york', 'immune-mediated', 'inflammatory', 'disease', 'diagnose', 'definite', 'presume', 'covid-19', '', 'proportion', 'patient', 'require', 'hospitalization', 'similar', 'infect', 'patient', 'general', 'population', 'new', 'york', 'city', '', '8', '', '', 'however', '', 'limit', 'observational', 'data', 'suggest', 'patient', 'active', 'rheumatic', 'disease', 'higher', 'risk', 'develop', 'infection', '', '9-11', '', '', 'although', 'study', 'perform', 'prior', 'covid-19', 'pandemiccertain', 'laboratory', 'abnormality', 'patient', 'systemic', 'rheumatic', 'disease', 'associate', 'poor', 'outcome', 'patient', 'covid-19', '', 'lymphopenia', '', 'particularly', 'low', 'cd4', 'cell', '', 'elevate', 'level', 'c-reactive', 'protein', '', 'interleukin', '6', '', 'il-inhibitor', '', '', 'creatine', 'kinase', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'abnormality', 'result', 'infection', 'immune', 'response', 'infection', '', 'unknown', 'whether', 'abnormality', '', 'pre-existing', 'due', 'another', 'disorder', '', 'eg', '', 'systemic', 'rheumatic', 'disease', '', '', 'impact', 'disease', 'outcomerisks', 'associate', 'rheumatic', 'disease', 'therapy', '', 'whether', 'association', 'specific', 'rheumatologic', 'treatment', 'increase', 'risk', 'covid-19', 'complication', '', 'although', 'rheumatic', 'disease', 'therapy', 'associate', 'higher', 'risk', 'infection', '', '1213', '', '', 'limited', 'data', 'observational', 'study', 'mix', '', 'report', 'suggest', 'increase', 'risk', 'covid-19', 'patient', 'receive', 'systemic', 'rheumatic', 'disease', 'therapy', '', 'others', 'suggest', 'decrease', 'risk', '', 'example', '', 'series', '86', 'patient', 'new', 'york', 'diagnose', 'definite', 'presume', 'covid-19', '', 'immune-mediated', 'inflammatory', 'disease', '', 'include', 'arthritis', 'arthritis', '', 'psoriasis', 'psoriatic', 'arthritis', '', 'ankylose', 'spondylitis', '', 'inflammatory', 'bowel', 'disease', '', '', 'receive', 'biologic', 'agent', 'janus', 'kinase', '', 'jak', '', 'inhibitor', 'baseline', 'likely', 'require', 'hospitalization', 'infection', 'patient', 'receive', 'nonbiologic', 'conventional', 'immunosuppressive', 'agent', '', '8', '', 'report', 'lombardy', 'region', 'italy', '', 'covid-19', 'highly', 'prevalent', '', '320', 'patient', 'rheumatic', 'disease', 'receive', 'biologic', 'target', 'synthetic', 'disease-modifying', 'antirheumatic', 'drug', '', 'dmard', '', '', 'eight', 'diagnose', 'strongly', 'suspect', 'covid-19', '', 'five', 'additional', 'patient', 'experience', 'exposure', 'infect', 'individual', 'remain', 'asymptomatic', '', '14', '', '', 'one', 'rheumatic', 'disease', 'patient', 'require', 'hospital', 'admission', 'treat', 'several', 'day', 'low-flow', 'oxygen', '', 'period', '', '33000', 'case', 'covid-19', 'diagnose', 'region', '1250', 'require', 'admission', 'intensive', 'careanother', 'report', 'lombardy', 'region', 'italy', '', 'involve', '1193', 'patient', 'psoriasis', 'receive', 'either', 'biologic', 'agent', 'conventional', 'small', 'molecule', 'drug', '', 'find', 'compare', 'general', 'population', 'region', '', 'patient', 'treat', 'biologics', 'higher', 'risk', 'symptomatic', 'covid-19', '', 'odds', 'ratio', '', '', '343', '', '95', '', 'ci', '225-573', '', '', '', 'self-quarantined', 'home', '', '905', '', '95', '', 'ci', '561-1461', '', '', '', 'hospitalize', '', '359', '', '95', '', 'ci', '149-863', '', '', '', 'however', '', 'find', 'increase', 'risk', 'admission', 'intensive', 'care', 'unit', 'death', '', '15', '', 'although', 'speculation', 'regard', 'potential', 'protective', 'role', 'hydroxychloroquine', '', 'hcq', '', 'covid-19', 'therapy', '', 'substantial', 'number', 'patient', 'among', 'clinician-', 'patient', 'self-reported', 'cohort', 'rheumatic', 'disease', 'patient', 'covid-19', 'hcq', 'time', 'diagnose', 'infection', '', '22', '28', 'percent', 'patient', '', 'respectively', '', 'april', '27', '', '2020', '', '', '16', '', '', 'majority', 'patient', 'hcq', 'immune-modulating', 'therapiesclinical', 'manifestations', 'diagnostic', 'considerationsclinical', 'presentation', 'infection', 'rheumatic', 'disease', 'patient', '', 'clinical', 'feature', 'covid-19', 'among', 'patient', 'systemic', 'rheumatic', 'disease', 'variable', 'different', 'patient', 'without', 'underlie', 'disease', '', 'insufficient', 'data', 'report', 'case', 'determine', 'whether', 'type', 'rheumatic', 'disease', 'intensity', 'immunosuppressive', 'agent', 'influence', 'clinical', 'presentation', 'covid-19', 'population', '', 'disease', 'registry', '', '', '', 'however', '', 'possible', 'rheumatic', 'disease', 'feature', 'difficult', 'distinguish', 'covid-19', '', '', 'rheumatic', 'disease', 'feature', 'mimic', 'mimic', 'covid-19', '', '', '', 'rheumatic', 'disease', 'feature', 'mimic', 'mimic', 'covid-19', '', 'variety', 'rheumatic', 'disease', 'clinical', 'feature', 'mimic', 'mimic', 'covid-19', '', 'malaise', '', 'myalgia', '', 'fatigue', '', 'patient', 'carry', 'exist', 'diagnosis', 'rheumatic', 'disease', '', 'clinician', 'distinguish', 'disease', 'flare', 'possible', 'covid-19', 'infection', '', 'high', 'level', 'suspicion', 'maintain', 'covid-19', 'prevalent', '', 'approach', 'test', 'covid-19', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'specific', 'example', 'condition', 'include', 'disease', 'manifest', 'fever', '', 'eg', '', 'systemic', 'lupus', 'erythematosus', '', 'sle', '', '', '', 'headache', '', 'eg', '', 'giant', 'cell', 'arteritis', '', 'gca', '', '', '', 'gastrointestinal', 'symptom', '', 'eg', '', 'arthritis', '', 'systemic', 'sclerosis', '', 'ssc', '', '', 'sle', '', 'behet', 'syndrome', '', '', 'dyspnea', '', 'eg', '', 'interstitial', 'pulmonary', 'disease', 'due', 'arthritis', 'arthritis', '', 'ssc', '', 'sle', '', '', 'stroke', '', 'eg', '', 'antiphospholipid', 'syndrome', '', 'aps', '', '', '', 'pernio-', 'chilblain-like', 'lesion', '', 'sometimes', 'call', '', 'covid', 'toe', '', '', 'eg', '', 'chilblain', 'lupus', 'erythematosus', '', '', 'kawasaki-like', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'mic-s', '', '', 'sometimes', 'term', 'pediatric', 'multisystem', 'inflammatory', 'syndrome', '', 'eg', '', 'kawasaki', 'disease', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'manifestation', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', 'section', 'clinical', 'manifestation', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'clinical', 'feature', '', '', '', 'addition', '', 'laboratory', 'abnormality', 'elevate', 'erythrocyte', 'sedimentation', 'rate', '', 'c-reactive', 'protein', 'level', '', 'ferritin', '', 'interleukin', '6', '', 'il-inhibitor', '', '', 'creatine', 'kinase', 'level', 'infection', 'various', 'rheumatic', 'diseasesmedications', 'treat', 'rheumatic', 'disease', 'cause', 'adverse', 'effect', 'mimic', 'clinical', 'manifestation', 'covid-19', '', 'eg', '', 'sulfasalazine', '', 'ssz', '', '', 'cause', 'gastrointestinal', 'symptom', '', 'methotrexate', '', 'mtx', '', '', 'cause', 'pulmonary', 'abnormality', '', 'referral', 'rheumatologic', 'evaluation', 'appropriate', 'patient', 'suspect', 'covid-19', 'establish', 'rheumatic', 'disease', 'diagnosis', 'yet', 'additional', 'clinical', 'feature', 'concern', 'rheumatic', 'disease', '', 'eg', '', 'find', 'suggestive', 'synovitis', 'serology', 'characteristic', 'autoimmune', 'rheumatic', 'disease', '', 'management', 'patients', 'known', 'suspected', 'sars-cov-2', 'exposure', 'infectionmedication', 'management', 'stable', 'asymptomatic', 'patient', 'follow', 'exposure', '', 'adjustments', 'medication', 'regimen', 'patient', 'stable', 'rheumatic', 'disease', 'asymptomatic', 'recently', 'expose', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'virus', 'individualize', '', 'general', 'approach', 'follow', '', '17', '', '', 'hydroxychloroquine', '', 'hcq', '', 'hydroxychloroquine', '', 'cq', '', '', 'sulfasalazine', '', 'ssz', '', '', 'nonsteroidal', 'antiinflammatory', 'drug', '', 'nsaids', '', 'continuedwhether', 'methotrexate', '', 'mtx', '', 'leflunomide', '', 'lef', '', 'discontinue', 'must', 'assess', 'case-by-case', 'basis', 'weigh', 'potential', 'risk', 'infection', 'sequela', 'possible', 'risk', 'rheumatic', 'disease', 'flare', 'period', 'drug', 'hold', '', 'medication', 'temporarily', 'hold', '', 'generally', 'resume', 'pending', 'negative', 'test', 'result', 'covid-19', 'two', 'week', 'symptom-free', 'observationcyclophosphamide', '', 'cyc', '', '', 'mofetil', 'mofetil', '', 'mmf', '', '', 'azathioprine', '', 'aza', '', '', 'tacrolimus', '', 'anti-tumor', 'necrosis', 'factor', '', 'certolizumab', '', 'agent', '', 'abatacept', '', 'janus', 'kinase', '', 'jak', '', 'inhibitor', '', 'eg', '', 'tofacitinib', '', 'stop', 'temporarily', '', 'pending', 'negative', 'test', 'result', 'covid-19', 'two', 'week', 'symptom-free', 'observationinterleukin', '6', '', 'il-inhibitor', '', 'receptor', 'inhibitor', 'continue', 'select', 'patient', '', 'particularly', 'high', 'risk', 'develop', 'cytokine', 'release-like', 'syndrome', '', 'preferably', 'study', 'protocol', '', 'decision', 'agent', 'close', 'consultation', 'expert', 'infectious', 'disease', 'critical', 'care', 'involve', 'management', 'patient', 'acute', 'illness', '', 'role', 'il-inhibitor', 'blockade', 'management', 'covid-19', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'approach', 'describe', 'largely', 'base', 'upon', 'expert', 'opinion', 'extrapolation', 'management', 'patient', 'medication', 'develop', 'infection', 'consistent', 'management', 'practice', 'recommend', 'american', 'college', 'rheumatology', '', 'acr', '', '', '17', '', '', 'well', 'generally', 'similar', 'guideline', '', '1819', '', '', '', 'society', 'guideline', 'link', '', '', '', 'nsaids', '', 'include', 'indication', 'contraindication', '', 'differ', 'patient', 'without', 'exposure', 'sars-cov-2', '', 'consistent', 'international', 'specialty', 'guideline', '', 'give', 'scientific', 'evidence', 'novel', 'increase', 'risk', 'associate', 'nsaid', 'patient', 'covid-19', '', '1720-22', '', '', 'hcq', 'ssz', 'continue', 'give', 'relatively', 'low', 'risk', 'serious', 'infection', 'associate', 'either', '', '2324', '', '', 'addition', '', 'disease', 'systemic', 'lupus', 'erythematosus', '', 'sle', '', '', 'discontinuation', 'hcq', 'associate', 'disease', 'flare', '', 'limit', 'evidence', 'role', 'hcqcq', 'management', 'covid-19', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'hydroxychloroquinechloroquine', '', '', '', 'treatment', 'mtx', 'lef', 'associate', 'relatively', 'low', 'risk', 'serious', 'infection', '', '2526', '', '', 'particularly', 'give', 'monotherapy', '', 'decide', 'whether', 'continue', 'medication', 'case-by-case', 'basisthe', 'rationale', 'temporarily', 'discontinue', 'immunosuppressive', 'drug', '', 'biologic', 'agent', '', 'jak', 'inhibitor', 'base', 'upon', 'associate', 'increase', 'risk', 'serious', 'infection', 'compare', 'conventional', 'disease-modifying', 'antirheumatic', 'drug', '', 'dmards', '', '', '1213', '', '', 'theoretically', 'low', 'likelihood', 'disease', 'flare', 'withhold', 'medication', 'limit', 'time', 'period', '', 'one', 'exception', 'discontinuation', 'biologic', 'agent', 'il-inhibitor', 'inhibitor', '', 'give', 'report', 'potential', 'benefit', 'patient', 'develop', 'intense', 'inflammatory', 'state', 'similar', 'cytokine', 'release', 'syndrome', 'due', 'severe', 'covid-19', '', 'however', '', 'randomize', 'trial', 'examine', 'efficacy', 'infection', 'ongoing', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'medication', 'management', 'document', 'presumptive', 'covid-19', '', 'adjustments', 'medication', 'regimen', 'patient', 'document', 'presumptive', 'covid-19', 'individualize', 'specific', 'attention', 'severity', 'infection', '', 'overall', 'approach', 'follow', '', 'antimalarial', 'therapy', '', 'ie', '', 'hcqcq', '', 'continue', '', 'caveat', 'hospitalize', 'patient', 'require', 'additional', 'surveillance', 'give', 'cardiotoxicity', 'heighten', 'patient', 'covid-19', '', 'concomitant', 'medication', 'prolong', 'qt', 'interval', 'avoid', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'section', 'patients', 'receive', 'qt-prolonging', 'treatment', '', 'eg', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'azithromycin', '', 'etc', '', '', '', '', 'ssz', '', 'mtx', '', 'lef', '', 'immunosuppressant', '', 'eg', '', 'mmf', '', 'aza', '', '', 'biologic', 'agent', 'il-inhibitor', 'receptor', 'inhibitor', '', 'jak', 'inhibitor', 'stop', 'heldfor', 'patient', 'severe', 'respiratory', '', 'cardiac', '', 'kidney', 'involvement', '', 'nsaids', 'discontinue', 'patient', 'without', 'covid-19il-6', 'receptor', 'inhibitor', 'continue', 'select', 'patient', '', 'particularly', 'high', 'risk', 'develop', 'cytokine', 'release-like', 'syndrome', '', 'preferably', 'study', 'protocol', '', 'decision', 'agent', 'close', 'consultation', 'expert', 'infectious', 'disease', 'critical', 'care', 'involve', 'management', 'patient', 'acute', 'illness', '', 'role', 'il-inhibitor', 'blockade', 'management', 'covid-19', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'glucocorticoids', 'abruptly', 'discontinuedthe', 'approach', 'describe', 'largely', 'base', 'upon', 'expert', 'opinion', 'extrapolation', 'management', 'patient', 'medication', 'develop', 'serious', 'infection', 'consistent', 'management', 'practice', 'recommend', 'acr', '', '17', '', '', 'well', 'generally', 'similar', 'guideline', '', '1819', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'section', 'rheumatology', '', '', '', 'given', 'low', 'risk', 'serious', 'infection', 'associate', 'hcq', 'cq', 'well', 'potential', 'benefit', 'prevent', 'rheumatic', 'disease', 'flare', '', 'generally', 'continue', 'therapy', 'patient', 'already', '', 'medication', 'management', 'stable', 'asymptomatic', 'patient', 'follow', 'exposure', '', '', '', 'rationale', 'hold', 'ssz', 'mainly', 'relate', 'concern', 'potential', 'adverse', 'effect', 'agent', '', 'eg', '', 'gastrointestinal', 'upset', '', 'diarrhea', '', 'hepatitis', '', 'cytopenia', '', '', 'rarely', '', 'pneumonitis', '', 'confuse', 'clinical', 'laboratory', 'manifestation', 'covid-19', '', 'additionally', '', 'temporarily', 'hold', 'ssz', 'two', 'three', 'week', 'unlikely', 'result', 'significant', 'rheumatic', 'disease', 'flareswe', 'discontinue', 'mtx', '', 'lef', '', 'immunosuppressant', '', 'biologic', 'agent', 'il-inhibitor', 'blocker', '', 'jak', 'inhibitor', 'give', 'concern', 'impair', 'host', 'defense', 'covid-19', 'risk', 'cause', 'additional', 'infection', '', 'although', 'data', 'confirm', 'convincingly', 'refute', 'risk', '', 'addition', '', 'risk', 'rheumatic', 'disease', 'flare', 'likely', 'relatively', 'low', 'limit', 'period', 'antirheumatic', 'drug', 'likely', 'hold', '', 'infection', 'associate', 'medication', 'bacterial', 'opportunistic', 'origin', '', 'risk', 'remain', 'relevant', '', 'substantial', 'proportion', 'patient', 'covid-19', 'develop', 'complication', 'bacterial', 'pneumonia', '', '27', '', '', 'additional', 'risk', 'treatment', 'certain', 'biologics', 'jak', 'inhibitor', 'include', 'reactivation', 'viral', 'infection', '', 'include', 'herpes', 'zoster', '', '28', '', 'although', 'glucocorticoid', 'convey', 'increase', 'risk', 'infection', '', 'abrupt', 'discontinuation', 'feasible', 'safe', 'seriously', 'ill', 'patient', '', 'minimize', 'adverse', 'reaction', '', 'treat', 'patient', 'require', 'glucocorticoid', 'systemic', 'rheumatic', 'disease', 'lowest', 'necessary', 'dose', 'shortest', 'period', 'time', '', '', '', 'major', 'side', 'effect', 'systemic', 'glucocorticoid', '', '', '', 'postinfection', 'management', '', 'optimal', 'time', 'resume', 'immunosuppressive', 'medication', 'infection', 'covid-19', 'unknown', '', 'generally', 'restart', 'immunosuppressive', 'medication', 'patient', 'longer', 'symptomatic', 'least', 'two', 'week', 'pass', 'since', 'document', 'infection', '', 'limit', 'data', 'address', 'issue', '', 'small', 'observational', 'study', 'nine', 'patient', '', 'seroconversion', 'detect', 'patient', 'two', 'week', '', 'viral', 'load', 'progressively', 'decrease', '', 'despite', 'detection', '', 'live', 'virus', 'unable', 'isolate', 'eight', 'day', '', '29', '', '', 'information', 'regard', 'long', 'patient', 'remain', 'infectious', 'neededmanagement', 'considerations', 'patients', 'absence', 'infection', 'known', 'exposuregeneral', 'principlespatients', 'rheumatic', 'disease', 'practice', 'widely', 'recommend', 'prevention', 'strategy', 'focus', 'mitigate', 'infection', 'risk', '', 'include', 'adopt', 'practice', 'optimal', 'hand', 'hygiene', '', 'physical', 'distance', '', 'wear', 'mask', 'public', 'adequate', 'physical', 'distance', 'possible', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'prevention', '', '', '', 'patient', 'newly', 'diagnose', '', 'stable', '', 'active', 'disease', '', 'management', 'generally', 'differ', 'usual', 'treatment', 'approach', 'absence', 'covid-19', '', 'initiate', 'continue', 'medication', 'indicate', 'management', 'patient', 'systemic', 'rheumatic', 'disease', '', 'include', 'conventional', 'disease-modifying', 'antirheumatic', 'drug', '', 'dmards', '', 'immunosuppressive', 'agent', '', 'include', 'hydroxychloroquine', '', 'hcq', '', 'hydroxychloroquine', '', 'cq', '', '', 'sulfasalazine', '', 'ssz', '', '', 'methotrexate', '', 'mtx', '', '', 'leflunomide', '', 'lef', '', '', 'tacrolimus', '', 'cyclosporine', '', 'csa', '', '', 'mofetil', 'mofetil', '', 'mmf', '', '', 'azathioprine', '', 'aza', '', '', 'biologic', 'agent', '', 'eg', '', 'abatacept', '', 'tocilizumab', '', '', 'janus', 'kinase', '', 'jak', '', 'inhibitor', '', 'nonsteroidal', 'antiinflammatory', 'drug', '', 'nsaids', '', 'continuation', 'hcqcq', 'particularly', 'important', 'patient', 'systemic', 'lupus', 'erythematosus', '', 'sle', '', '', 'available', '', 'especially', 'active', 'severe', 'disease', 'pregnantglucocorticoids', 'abruptly', 'discontinue', '', 'lowest', 'dose', 'possible', 'control', 'underlie', 'rheumatic', 'disease', '', 'regardless', 'exposure', 'infection', 'statusmodifications', 'routine', 'rheumatologic', 'care', '', 'modifications', 'routine', 'rheumatologic', 'care', 'minimize', 'risk', 'exposure', 'covid-19', 'possible', 'include', '', 'optimal', 'telehealth', 'visitsdecreased', 'frequency', 'routine', 'laboratory', 'surveillance', 'associate', 'risk', 'deem', 'low', '', 'decisions', 'regard', 'safest', 'interval', 'test', 'individualize', '', 'base', '', 'example', '', 'upon', 'patient', 'overall', 'clinical', 'status', '', 'comorbidities', '', 'prior', 'stability', 'test', '', 'medication', 'useuse', 'lower-volume', 'laboratory', 'offsite', 'larger', 'health', 'care', 'facilitiesfor', 'patient', 'area', 'affect', 'epidemic', 'receive', 'treatment', 'infusion', 'center', '', 'additional', 'treatment', 'option', 'appropriate', 'switch', 'form', 'medication', 'medication', 'class', 'self-administered', 'subcutaneous', 'injection', '', 'however', '', 'neither', 'theoretical', 'add', 'safety', 'benefit', 'risk', 'disease', 'flare', 'approach', 'formally', 'evaluate', 'set', '', 'decision', 'individualizedprognosis', '', 'available', 'evidence', 'identify', 'risk', 'factor', 'poor', 'outcome', 'covid-19', 'infection', 'specific', 'patient', 'rheumatic', 'disease', '', 'evidence', 'adverse', 'rheumatic', 'disease', 'outcome', 'follow', 'infection', 'short-term', 'risk', 'increase', 'disease', 'activity', 'due', 'temporary', 'drug', 'discontinuationdisease', 'registries', '', 'improve', 'understand', 'impact', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'virus', 'infection', 'patient', 'systemic', 'rheumatic', 'disease', '', 'strongly', 'urge', 'patient', 'enrol', 'patient', 'registry', 'whenever', 'possible', '', 'include', 'follow', 'national', 'regional', 'registry', '', 'covid-19', 'global', 'rheumatology', 'alliance', 'registrythe', 'eular', '', 'covid-19', 'reporting', 'registry', 'rheumatologist', 'clinicianslinks', 'patient', 'education', '', 'links', 'resource', 'information', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'patient', 'rheumatic', 'disease', 'select', 'rheumatology', 'society', 'government-sponsored', 'guideline', 'present', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', 'section', 'rheumatology', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'section', 'rheumatology', '', '', '', 'summary', 'recommendationsthe', 'presence', 'rheumatic', 'disease', 'alone', 'associate', 'increase', 'risk', 'develop', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'adverse', 'outcome', 'infection', '', 'patients', 'various', 'rheumatic', 'disease', '', 'however', '', 'higher', 'prevalence', 'several', 'comorbidities', 'advance', 'age', '', 'chronic', 'pulmonary', 'kidney', 'disease', '', 'heart', 'disease', '', 'hypertension', '', 'obesity', '', 'diabetes', '', 'turn', 'risk', 'factor', 'severe', 'illness', 'covid-19', '', '', 'disease-', 'comorbidity-related', 'risk', '', '', '', 'whether', 'specific', 'rheumatologic', 'treatment', 'associate', 'increase', 'risk', 'covid-19', 'complication', '', 'although', 'rheumatic', 'disease', 'therapy', 'associate', 'higher', 'risk', 'infection', '', '', 'risks', 'associate', 'rheumatic', 'disease', 'therapy', '', '', '', 'clinical', 'feature', 'covid-19', 'among', 'patient', 'systemic', 'rheumatic', 'disease', 'variable', 'different', 'patient', 'without', 'underlie', 'disease', '', 'however', '', 'variety', 'rheumatic', 'disease', 'clinical', 'feature', 'mimic', 'mimic', 'covid-19', '', 'malaise', '', 'myalgia', '', 'fatigue', '', 'patient', 'carry', 'exist', 'diagnosis', 'rheumatic', 'disease', '', 'clinician', 'distinguish', 'disease', 'flare', 'possible', 'covid-19', 'infection', '', 'high', 'level', 'suspicion', 'maintain', 'covid-19', 'prevalent', '', '', 'clinical', 'presentation', 'infection', 'rheumatic', 'disease', 'patient', '', 'rheumatic', 'disease', 'feature', 'mimic', 'mimic', 'covid-19', '', '', '', 'adjustments', 'medication', 'regimen', 'patient', 'stable', 'rheumatic', 'disease', 'asymptomatic', 'recently', 'expose', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'virus', 'individualize', '', 'general', 'approach', 'follow', '', 'medication', 'management', 'stable', 'asymptomatic', 'patient', 'follow', 'exposure', '', '', '', 'hydroxychloroquine', '', 'hcq', '', 'hydroxychloroquine', '', 'cq', '', '', 'sulfasalazine', '', 'ssz', '', '', 'nonsteroidal', 'antiinflammatory', 'drug', '', 'nsaids', '', 'continuedmethotrexate', '', 'mtx', '', 'leflunomide', '', 'lef', '', 'discontinuation', 'determine', 'case-by-case', 'basiscyclophosphamide', '', 'cyc', '', '', 'mofetil', 'mofetil', '', 'mmf', '', '', 'azathioprine', '', 'aza', '', '', 'tacrolimus', '', 'anti-tumor', 'necrosis', 'factor', '', 'certolizumab', '', 'agent', '', 'abatacept', '', 'janus', 'kinase', '', 'jak', '', 'inhibitor', '', 'eg', '', 'tofacitinib', '', 'stop', 'temporarily', '', 'pending', 'negative', 'test', 'result', 'covid-19', 'two', 'week', 'symptom-free', 'observationinterleukin', '6', '', 'il-inhibitor', '', 'receptor', 'inhibitor', 'continue', 'select', 'patient', '', 'particularly', 'high', 'risk', 'develop', 'cytokine', 'release-like', 'syndrome', '', 'preferably', 'study', 'protocoladjustments', 'medication', 'regimen', 'patient', 'document', 'presumptive', 'covid-19', 'individualize', 'specific', 'attention', 'severity', 'infection', '', 'general', 'approach', 'follow', '', 'medication', 'management', 'document', 'presumptive', 'covid-19', '', '', '', 'hcqcq', 'continue', '', 'caveat', 'hospitalize', 'patient', 'require', 'additional', 'surveillance', 'give', 'cardiotoxicity', 'heighten', 'patient', 'covid-19ssz', '', 'mtx', '', 'lef', '', 'immunosuppressant', '', 'eg', '', 'mmf', '', 'aza', '', '', 'biologic', 'agent', 'il-inhibitor', 'receptor', 'inhibitor', '', 'jak', 'inhibitor', 'stop', 'heldfor', 'patient', 'severe', 'respiratory', '', 'cardiac', '', 'kidney', 'involvement', '', 'nsaids', 'discontinue', '', 'patient', 'without', 'covid-19il-6', 'receptor', 'inhibitor', 'continue', 'select', 'patient', '', 'particularly', 'high', 'risk', 'develop', 'cytokine', 'release-like', 'syndrome', '', 'preferably', 'study', 'protocol', '', 'glucocorticoids', 'abruptly', 'discontinuedthe', 'optimal', 'time', 'resume', 'immunosuppressive', 'medication', 'infection', 'covid-19', 'unknown', '', 'generally', 'restart', 'immunosuppressive', 'medication', 'patient', 'longer', 'symptomatic', 'least', 'two', 'week', 'pass', 'since', 'document', 'infection', '', '', 'postinfection', 'management', '', '', '', 'management', 'patient', 'newly', 'diagnose', '', 'stable', '', 'active', 'rheumatic', 'disease', 'infection', 'exposure', 'sars-cov-2', 'generally', 'differ', 'usual', 'treatment', 'approach', 'absence', 'covid-19', '', 'initiate', 'continue', 'medication', 'indicate', 'management', 'patient', 'systemic', 'rheumatic', 'disease', '', '', 'general', 'principle', '', '', '', 'modifications', 'routine', 'rheumatologic', 'care', 'minimize', 'risk', 'exposure', 'covid-19', 'possible', 'include', 'optimal', 'telehealth', 'visit', '', 'decrease', 'frequency', 'routine', 'laboratory', 'surveillance', 'associate', 'risk', 'deem', 'low', '', 'lower-volume', 'laboratory', 'offsite', 'larger', 'health', 'care', 'facility', '', '', 'modifications', 'routine', 'rheumatologic', 'care', '', '', '', 'available', 'evidence', 'identify', 'risk', 'factor', 'poor', 'outcome', 'covid-19', 'infection', 'specific', 'patient', 'rheumatic', 'disease', '', 'evidence', 'adverse', 'rheumatic', 'disease', 'outcome', 'follow', 'infection', 'short-term', 'risk', 'increase', 'disease', 'activity', 'due', 'temporary', 'drug', 'discontinuation', '', '', 'prognosis', '', '', '']",3198,"{'': 839, 'disease': 105, 'covid-19': 87, 'patient': 82, 'rheumatic': 54, 'infection': 46, 'risk': 46, 'coronavirus': 30, 'management': 27, '2019': 26, 'medication': 24, 'clinical': 20, 'inhibitor': 19, 'associate': 18, 'feature': 17, 'eg': 17, 'systemic': 16, 'section': 16, 'agent': 16, 'severe': 14}","{'tocilizumab': 1, 'tofacitinib': 2, 'abatacept': 3, 'certolizumab': 2, 'methotrexate': 3, 'mofetil': 6, 'azathioprine': 3, 'tacrolimus': 3, 'hydroxychloroquine': 9, 'leflunomide': 3, 'infection': 46, 'sulfasalazine': 4, 'sars-cov-2': 7, 'safety': 1, 'psoriasis': 2, 'arthritis': 6, 'spondylitis': 1, 'il-inhibitor': 13, 'jak': 9}",124,-0.9169
ID:127762,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'intensive', 'care', 'ventilation', 'anesthesia', 'machine']","['INTRODUCTION — The pneumonia associate novel coronavirus disease 2019 ( COVID-19 nCoV ) may lead respiratory failure profound hypoxemia require endotracheal intubation mechanical ventilation .', 'The rapidly spread pandemic may result utilization available intensive care unit ( ICU ) ventilator individual institution region .', 'Repurposing anesthesia machine longer-term use day week ventilate COVID-19 patient patient require mechanical ventilation propose , somewhat unprecedented .', 'Furthermore , anesthesia machine rarely use administer inhalation anesthetic prolong ventilation .', 'This topic address management short-term long-term intensive care ventilation anesthesia machine , emphasize use patient COVID-19 pneumonia [ 1 ] .', 'Airway management anesthetic care patient suspect confirm diagnosis COVID-19 infection surgical procedure , include prevent infection anesthesia personnel contamination anesthesia machine equipment address separate topic .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", ') Use standard ICU ventilator ventilation critically ill patient COVID-19 patient discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Ventilator management acute respiratory distress syndrome ' ."", "") Other detail regard obstetric critical care patient COVID-19 infection , general medical management available additional topic : ● ( See `` Neuraxial analgesia labor delivery ( include instrument delivery ) '' , section 'Patients suspect confirm COVID-19 ' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", ') ● ( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') PREVENTION OF ANESTHESIA MACHINE CONTAMINATION — Preventing contamination external part anesthesia machine , breathe system ventilator , connection gas analyzer attach monitor equipment use patient COVID-19 describe another topic .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' , section 'Protection anesthesia equipment ' ."", ') Contamination anesthesia machine use intensive care ventilator patient know COVID-19 infection likely use surgical procedure duration extent machine exposure .', 'Based study coronaviruses , estimate infect patient exhale 0 100,000 virus particle per 30 minute , many 4,800,000 particle per day [ 2 ] .', 'However , single filter viral filtration efficiency ( VFE ) 99.9999 percent ( ie , good mechanical pleat filter expiratory limb ) would allow 4.8 particle , average , pas .', 'If two filter use heat moisture exchange filter ( HMEF ) contain electrostatic filter place airway plus mechanical pleat filter place expiratory limb breathe circuit ( figure 1 ) , combine VFE high ( perhaps high 99.99999999 percent ) , render contamination anesthesia machine unlikely , even use multiple day ( fresh filter day ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' , section 'Contamination internal component anesthesia machine ' ."", ') LOCATIONS FOR ANESTHESIA MACHINES — Location ( ) select use anesthesia machine ventilate COVID-19-positive patient institution-dependent due consideration layout select hospital area ( ) , location room negative pressure capability , availability source electrical power , high-pressure oxygen , medical air [ 1,3 ] .', 'Personnel consideration include availability anesthesia personnel manage ventilation anesthesia machine , convenience critical care consultant .', 'When multiple anesthesia machine use single location , compress gas pipeline assess ensure supply adequate meet consumption supply area multiple anesthesia ventilator use high fresh gas flow ( FGFs ) .', 'The electrical supply also assess ensure circuit overload , particularly area outside operate room ( OR ) .Availability compatible connection scavenger system waste anesthesia gas disposal outlet medical vacuum outlet another necessary consideration inhalation anesthetic agent administer use anesthesia machine .', 'However , gas scavenge necessary inhalation agent avoid .', ""( See 'Differences anesthesia machine ventilator ICU ventilator ' 'Use inhalation anesthetic sedation ' ."", ') Institutional option location anesthesia machine ventilator may include intensive care unit ( ICU ) room , presurgical hold area , post-anesthesia care unit ( PACUs ) , individual ORs [ 1 ] .', 'In institution , may possible treat two COVID-19 patient OR multiple source oxygen medical air , anesthesia personnel ( ie , anesthesiologist , Certified Registered Nurse Anesthetists [ CRNAs ] , Certified Anesthesiologist Assistants [ CAAs ] ) deploy easily OR set .', 'Notably , American Society Anesthesiologists ( ASA ) Anesthesia Patient Safety Foundation ( APSF ) guideline repurposing anesthesia machine longer-term ventilation recommend anesthesia professional immediately available time manage monitor anesthesia ventilator ( administration inhalation anesthetic agent , use ) , well assist respiratory care ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators Quick Reference : Setup Monitoring Instructions – Anesthesia Machine ICU Ventilator ) , regardless location ( ) anesthesia machine [ 4,5 ] .', ""( See 'Monitoring long-term ventilation ' 'Monitoring sedation inhalation anesthetic ' . )"", 'LONG-TERM VENTILATION WITH ANESTHESIA MACHINES — The American Society Anesthesiologists ( ASA ) Anesthesia Patient Safety Foundation ( APSF ) develop guidance anesthesia care team member regard repurposing anesthesia machine longer-term ventilation ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators Quick Reference : Setup Monitoring Instructions – Anesthesia Machine ICU Ventilator ) [ 4,5 ] .', 'These professional society recommend anesthesia professional immediately available time manage monitor anesthesia ventilator .', 'Professional staff anesthesiologist ( eg , intensivists , well respiratory therapist , intensive care unit [ ICU ] nurse ) expert respiratory care , familiar anesthesia machine .', 'Because increase amount interaction require , use anesthesia machine ventilator patient require mechanical ventilation period time , COVID-19-positive , may good option optimal use institutional resources.Limited data regard duration mechanical ventilation COVID-19 patient suggest two week often necessary .', 'Collaboration critical care team throughout period clearly essential achieve optimal respiratory care , manage systemic problem patient severe COVID-19 disease .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Ventilator management acute respiratory distress syndrome ' ."", ') Differences anesthesia machine ventilator ICU ventilator — Data limit regard capability anesthesia machine ventilator develop various manufacturer mimic ICU ventilator parameter reliably provide continuous mechanical ventilation prolong period time .', 'Although newer anesthesia ventilator incorporate multiple control assist mode ventilation nearly identical intensive care ventilator , several important technical issue unique anesthesia machine , must consider use long-term ventilation.Adjusting humidification inspire gases●The need adjust fresh gas flow ( FGF ) prevent condense water accumulation breathe circuit [ 3 ] .', 'Intensive care ventilator deliver fresh gas inspiration , discharge exhale gas room .', 'Because compress gas zero humidity , active humidification necessary .', 'The ability alter FGF fraction exhale gas rebreathed key feature distinguish anesthesia ventilator ICU ventilator .', 'FGF typically reduce general anesthesia conserve inhalation anesthetic agent .', 'A FGF lower minute ventilation increase rebreathing exhale gas , humidify body .', 'The reaction rebreathed carbon dioxide ( CO2 ) CO2 absorbent produce additional humidity within circuit .', ""Experience date indicate anesthesia machine long-term use ICU ventilator , reduce FGF lead excessive humidity breathe circuit , need change CO2 absorbent frequently ( see `` Anesthesia machine : Prevention , diagnosis , management malfunction '' , section 'Carbon dioxide absorbent exhaustion toxicity ' ) ."", 'This additional humidity clinically significant lead water condensation within breathe circuit increase resistance gas flow system , interfere sensor respiratory gas analyzer flow sensor , increase risk coinfections [ 3 ] .', 'For reason , significant accumulation water breathe circuit ( typically expiratory limb ) must empty .', 'Accumulated water empty carefully wear full personal protective equipment ( PPE ) , may contaminate virus .', 'Condensers water trap may add breathe system aid manage excessive humidity [ 2 ] .', 'Issues supply chain limit purchase water trap COVID-19 pandemic ; however , new option design test institution [ 3 ] .To prevent buildup humidity decrease use CO2 absorbent , recommend FGF set equal minute ventilation initially ( approximately 6 8 L/minute adult patient ) .', 'Generally , apparent one two hour excess moisture accumulate breathe circuit .', 'If , FGF increase incrementally ( eg , 0.5 1 L/min ) humidity control .', 'Alternately , FGF set higher ( eg , 1.5 time minute ventilation ) initially , reduce increment 500 mL/minute vigilant monitor appearance humidity inspiratory limb .', 'Once FGF exceed 1.5 time minute ventilation , little rebreathing , increase FGF provide advantage waste compress gas ( oxygen medical air ) .●The need long-term humidification warm inspire gas .', 'Critical care patient inspire warm humidify gas prevent dry secretion respiratory epithelium .', 'At low FGFs typically use operate room ( OR ) , inspire gas humidify due rebreathing [ 6,7 ] , also release heat humidity reaction CO2 absorbent [ 8 ] .', 'The presence condensate inspiratory hose indicate inspire gas relative humidity > 100 percent room temperature.However , heat moisture exchange filter ( HMEF ) may necessary high FGFs use prevent condense water accumulation prolong ventilation anesthesia machine .', 'The HMEF place endotracheal tube connection breathe circuit ( Y-piece gas sample port ( figure 1 ) ) .', 'This HMEF ensure adequate humidity maintain lung also filter viral particle .', 'Filters HMEFs airway prone obstruction moisture secretion .', 'Compared OR set , obstruction airway filter HMEF place anesthesia machine breathe circuit ICU may le likely detect early since may constant attendance anesthesia professional .', 'Airway filter HMEFs inspect le frequently every hour , change obstruction concern , every 24 hour .', 'Devices actively humidify inspire gas recommend .', 'They cause problem ventilation monitor since anesthesia machine design handle large amount condense water within breathe circuit .', ""Unique safety issues●The need place second high-quality viral filter ( typically pleat mechanical filter need heat humidity exchange property ) expiratory limb anesthesia machine breathe circuit use ventilation COVID-19 patient , even filter HMEF place airway ( figure 1 ) ( see `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' , section 'Contamination internal component anesthesia machine ' ) ."", 'The filter expiratory limb likely leave place longer period time filter place airway ; however , data predict filter performance time .', 'Since many institution filter shortage , expiratory limb filter change necessary.●Potential need prevent accidental administration inhalation anesthetic agent .', 'If plan administer inhalation anesthetic achieve patient sedation , vaporizer volatile agent remove drain .', 'Also , nitrous oxide ( N2O ) cylinder pipeline hose remove .', 'These measure ensure inhalation anesthetic agent accidentally administer .', 'However , institution inadequate supply intravenous sedative analgesic agent commonly use ICU may consider emergency use low do volatile inhalation anesthetic agent ( isoflurane sevoflurane ) , explain .', ""( See 'Use inhalation anesthetic sedation ' ."", ') ●The potential CO2 absorbent expire .', 'The inspire CO2 color indicator CO2 absorbent monitor frequently .', 'The absorbent replace inspire CO2 increase ( eg , 5 mmHg ) CO2 absorbent color indicate become exhaust .', 'If ventilation must interrupt change absorbent , patient temporarily ventilate alternative mean .', 'Furthermore , potential reaction CO2 absorbent may occur volatile anesthetic agent employ absorbent become dry FGF .', ""( See `` Anesthesia machine : Prevention , diagnosis , management malfunction '' , section 'Carbon dioxide absorbent exhaustion toxicity ' ."", ') There three reason simply remove CO2 absorber canister , use empty absorber canister : •CO2 absorption important prevent hypercarbia FGF decrease 1 1.5 time minute ventilation ( purposely inadvertently ) .•The breathe system may leak canister remove .', 'The valve instal machine prevent leak intend use short period canister change , dependable longer-term use•The canister leave empty would significantly increase compliance breathe system.●Potential need adjust scavenger system anesthesia machine .', 'If anesthesia machine use outside OR , may possible connect scavenger system compatible waste anesthesia gas disposal vacuum outlet .', 'Waste anesthetic gas disposal outlet typically find operate procedure room , waste gas hose anesthesia machine may compatible medical vacuum outlet find elsewhere .', ""Waste anesthetic gas scavenge necessary use inhalation anesthetic agent plan ( see 'Use inhalation anesthetic sedation ' ) ."", 'Importantly , scavenger system reservoir bag ( close scavenger system ) connect vacuum , cause high PEEP peak pressure due backup waste gas breathe system .', 'Options include : •If inhalation anesthetic agent use ( picture 1 ) : -Disconnection scavenger system hose come breathe system ventilator -Removal scavenger reservoir bag ( close scavenger system ) •If inhalation anesthetic agent use , scavenge require .', 'Connection scavenger system suction location outside OR ( eg , ICU ) may difficult connection incompatible .', 'In case , alternate tube connector , connection adapter may use .', 'When higher usual FGFs use , scavenger suction must adjust upward ensure proper function .', '●Potential need modify oxygen utilization anesthesia machine ventilator institutional oxygen supply limit factor [ 3,9 ] : •Delay delivery liquid oxygen hospital•Excessive use oxygen hospital , oxygen vaporizer ( liquid oxygen convert gas oxygen ) become cover ice , result inefficiency •Inability flow oxygen pipeline branch keep demand due caliber pipeline , number ventilator , anesthesia machine , oxygen flowmeters branch .', 'This typically problem older hospitals.When oxygen consumption outstrip maximum oxygen supply , ventilator , anesthesia machine , oxygen flowmeters pipeline branch affect .', 'Thus , inspire oxygen concentration deliver individual anesthesia machine decrease air use , machine alarm may activate inspiratory cycle .', 'Anesthesia machine bellow ventilator typically use oxygen drive gas compress bellow ; ventilator consume oxygen rate approximate minute ventilation plus additional oxygen use FGF rate FGF time percent oxygen , sporadic consumption increase dramatically inspiration .', 'However , machine bellow ventilator may modify qualify clinical engineer power compress air instead oxygen [ 3,9 ] , modification make must make machine use ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators ) .Conversely , anesthesia machine electrically power ( ie , piston turbine ) ventilator similar ICU ventilator , typically consume oxygen rate minute ventilation time percent oxygen , consume oxygen deliver fresh gas .', '●The need periodic performance anesthesia machine self-test ( ie , power-up test ) approximately every 24 72 hour .', 'The ASA anesthesia machine manufacturer recommend pre-use check every day prior use machine OR set .', 'For prolong use , manufacture state do approximately every three day .', 'Experience show problem inaccurate ventilation delivery monitor may occur anesthesia machine restart check three-day intervals.Notably , alternative mean ventilation necessary ( eg , manual resuscitator second ventilator ) machine power , restart , check .', ""A step-by-step procedure follow ensure equipment available prevent patient lung de-recruitment , well limit spillage breathe circuit gas contaminant protect anesthesia personnel process ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators ASA 's Quick Reference : Setup Monitoring Instructions – Anesthesia Machines ICU Ventilator ) [ 4,5 ] ."", 'A suggest procedure develop APSF ASA ( refer APSF/ASA Procedure Supporting Patients Anesthesia Machine Self-Test ) [ 10 ] .●The need periodically check breathe circuit possible kink compression since , unlike ICU ventilator , articulate arm anesthesia machine hold breathe circuit bed.●The need minimize potential error setup anesthesia machine , initiation control ventilation , respiratory monitor location outside OR suite , ideally deploy multiple machine model within one hospital unit ( eg , ICU , post-anesthesia care unit [ PACU ] ) .', 'Adjusting ventilatory settings●The need understand specific capability differ among individual anesthesia machine : •Newer anesthesia machine ventilator capability similar modern ICU ventilator , flexible set deliver mode ventilation ( include assist mode ) compare older model .', 'Newer model compliance compensation tidal volume delivery unaffected change FGF generally prefer ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators ) .', '•Newer machine also equip breathe system ventilator sterilize patient , better choice COVID-19 infection.•Older model reserve surgical patient ventilation patient without COVID-19 respiratory disease , feasible.●The need understand set performance anesthesia machine ventilator differ ICU ventilator make adjustment ventilator set : •Anesthesia machine default pressure support extra breath control mode .', 'Care must take add change ventilator modes.•Anesthesia machine may lower peak inspiratory flow rate .', 'Negative airway pressure occur patient inhale faster maximum inspiratory flow rate provide ventilator.•Anesthesia machine millisecond slower respond patient effort circle breathe system interpose patient anesthesia ventilator [ 11 ] , cause hyperventilation air-hungry patient.•Inspiratory time directly set anesthesia machine .', 'Most anesthesia machine provide direct control inspiratory time ; instead control indirectly set I : E ratio respiratory rate.Options set anesthesia machine ventilator include : -In volume control mode ( include synchronize intermittent mandatory ventilation [ SIMV ] ) , inspiratory flow rate increase increase tidal volume decrease inspiratory time ( accomplish reduce I : E ratio increase respiratory rate ) .', 'Introducing inspiratory pause ( Tpause TIP ) also increase inspiratory flow rate active portion inspiration , pause.-In pressure control support mode , inspiratory flow rate increase lower flow trigger level ventilation ( also increase speed pressure-support provide ) , decrease rise time pressure support ( increase inspiratory flow rate ) .', ""On Draeger anesthesia machine ventilator , flow trigger level call `` Trigger L/min '' rise time call `` Tslope . ''"", ""On GE Healthcare Systems anesthesia machine ventilator , flow trigger level call `` Flow Trigger '' rise time call `` Rise Rate . ''"", 'However , lower flow trigger level may cause extra mis-triggered breath patient ; occur , flow trigger level must increase .', 'On Draeger machine ventilator , maximum inspiratory flow govern facility-level set , although on-site clinical engineer adjust parameter allow maximum inspiratory flow 75 L/min.●Potential need modify default ventilator parameter alarm set .', 'Default set anesthesia machine , minute ventilation , airway pressure , positive end-expiratory pressure ( PEEP ) level , alarm , may modify better match ICU ventilator .', 'The default alarm volume set maximum.●The potential fraction inspire oxygen ( FiO2 ) concentration breathe circuit lower set oxygen gas concentration anesthesia machine ( FgO2 ) , especially lower FGFs .', 'Because rebreathing occur anesthesia machine circle breathe circuit , inspire oxygen concentration depend ratio oxygen air deliver fresh gas ( determine FGF set ) total FGF ( influence amount rebreathing ) .', ""Thus , inspire oxygen concentration must continuously monitor ( see 'Monitoring sedation inhalation anesthetic ' ) ."", '●Notably , total FGF high ( eg , > 12 L/minute ) , FiO2 100 percent deliver total FGF higher maximum possible flow oxygen .', 'For instance , total FGF 15 L/minute necessary , maximum oxygen flow 12 L/min , 3 L/min air must add .', 'This may confuse anesthesia machine control total FGF oxygen percent.Monitoring long-term ventilation — An anesthesia professional available start ventilation subsequently monitor degree moisture accumulation , inspire expire CO2 , filter integrity , overall anesthesia machine function , effectiveness ventilation [ 1 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Ventilator management acute respiratory distress syndrome ' . )"", 'The APSF/ASA guideline address additional maintenance monitor requirement use anesthesia machine long-term ventilation COVID-19 patient ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators Quick Reference : Setup Monitoring Instructions - Anesthesia Machine ICU Ventilator ) [ 4,5 ] .', 'These additional consideration necessary due use extra filter may become clog , tendency accumulate condense water breathe circuit , risk aerosolize droplet contain COVID-19 virus.Documentation enhance monitor continuous intermittent parameter necessary .', 'This may achieve automatically anesthesia machine connect hospital network record electronic medical record [ 1 ] , manually use template develop purpose anesthesia team.Patient monitor — Baseline monitor parameter ( eg , tidal volume , plateau pressure [ Pplat ] , minute ventilation ) record ventilation initiate .', 'If spirometry available , save photograph baseline trace reference loop may aid later diagnosis filter obstructions.Continuously monitor parameter ( preset alarm ) check record hour include : ●Inspired oxygen concentration .', '●Inspired expire CO2.●Inspiratory pressure.●Tidal volume respiratory rate .', '●Low oxygen pressure alarm .', 'If anesthesia machine oxygen-driven bellow use , low oxygen pressure alarm trigger inspiration may indicate high demand institutional central oxygen pipeline system , particularly multiple ventilator simultaneously use .', ""( See 'Differences anesthesia machine ventilator ICU ventilator ' ."", ') Intermittently monitor ventilatory physiologic parameter include : ●Check Pplat least every four hour , change PEEP tidal volume , ensure ≤30 cm H2O .', 'Measurement Pplat accomplish 0.5 second inspiratory pause .', 'Unlike many ICU ventilator , anesthesia machine control manually initiate inspiratory pause .', 'On anesthesia machine ventilator , 0.5 second inspiratory pause generate temporarily set mode volume ventilation tidal volume patient receive , 10 breath per minute , I : E ratio 1:2 50 percent inspiratory pause ( Tpause TIP ) .', ""( See 'Adjusting ventilatory set ' ."", ') ●Check flow read approximately every four hour , since may become le accurate time .', 'If machine equip inspiratory expiratory flow sensor , gradual increase difference inspire exhale tidal volume measurement usually indicate startup test need recalibrate breathe system flow sensors.●Confirm leak around endotracheal tube cuff every hour leak produce respiratory droplet aerosolize viral particle .', 'A leak around endotracheal tube cuff typically manifest measure exhale tidal volume lower measure inhale tidal volume , flow-volume loop close [ 12 ] .', 'At low FGFs bellow ventilator may progressively empty , reservoir bag progressively deflate machine piston turbine ventilator .', 'High FGF compensate small leak , obscure indicator breathe circuit volume.Machine maintenance monitor — Intermittent inspection maintenance proper anesthesia machine breathe circuit function include : ●Inspect breathe circuit hose water trap excessive condense water every hour .', 'An oscillate obstructive gas flow trace exhalation indicate condense water accumulation expiratory , scavenger , ventilator hose .', 'An oscillate obstructive gas flow trace inhalation indicate condense water accumulation inspiratory ventilator hose.If fluid accumulate breathe circuit threaten impede ventilation , must remove [ 3 ] .', 'Plans place ventilate patient circuit empty .', 'One novel method describe placement airway filter case Luer connector expiratory limb serve water trap , enable aspiration condense water syringe without interrupt ventilation [ 3 ] .', 'Further , proper collection disposal procedure contaminate water PPE personnel perform procedure necessary since fluid remove may contaminate virus.●Inspect breathe circuit hose possible kink compression every hour well.●Inspect airway expiratory limb breathe circuit filter every hour check excessive humidity secretion may cause obstruction gas flow .', 'The airway filter highest risk ( figure 1 ) .', 'Obstructed filter must change .', 'Otherwise , filter typically replace every 24 hour .', 'High peak airway pressure volume ventilation low tidal volume pressure ventilation sign profound obstruction filter place airway expiratory limb ( figure 1 ) [ 3 ] .', 'Decreased peak expiratory flow prolongation expiratory flow earlier indication partial obstruction one filter [ 12 ] .', 'Significant obstruction either filter also create additional PEEP , difference set actual PEEP see airway pressure expiratory limb filter obstruct .', 'Notably , additional PEEP invisible airway filter obstruct since airway pressure measure downstream filter .', '●Check CO2 absorbent color inspire CO2 value every hour ensure absorbent still function properly need exchange .', 'This especially important lower FGFs used.●Confirm anesthesia machine startup test perform every 24 72 hour ( refer APSF/ASA Procedure Supporting Patients Anesthesia Machine Self-Test ) [ 10 ] .', ""( See 'Differences anesthesia machine ventilator ICU ventilator ' ."", ') USE OF INHALATION ANESTHETICS FOR SEDATION — During COVID-19 pandemic , shortage intravenous sedative analgesic agent usually employ sedate critically ill patient mechanical ventilation may lead institution consider use low do potent volatile inhalation anesthetic agent ( isoflurane sevoflurane ) [ 13 ] .', 'Compared critically ill patient require mechanical ventilation , patient acute respiratory distress syndrome ( ARDS ) due COVID-19 higher sedation requirement may due younger age , higher respiratory drive , particularly intense inflammatory response [ 14,15 ] .', ""Although recommend routine administration inhalation anesthetic agent critically ill patient prolong period due scant safety data set , well disadvantage ( see 'Advantages disadvantage ' ) , ready availability agent advantage anesthesia machine use provide mechanical ventilation ."", ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Sedation analgesia ' ."", "") The American Society Anesthesiologists ( ASA ) Anesthesia Patient Safety Foundation ( APSF ) develop guideline emergency use ( refer APSF/ASA Guidance Use Volatile Anesthetic Sedation ICU Patients ) [ 16 ] .Intravenous sedative-analgesic regimen usually employ sedate critically ill patient mechanical ventilation discuss separate topic : ● ( See `` Sedative-analgesic medication critically ill adult : Selection , initiation , maintenance , withdrawal '' ."", "") ● ( See `` Sedative-analgesic medication critically ill adult : Properties , dosage regimen , adverse effect '' ."", "") ● ( See `` Pain control critically ill adult patient '' ."", ') Dosing achieve sedation — Administration low do either sevoflurane ( eg , 0.5 1.4 percent ) isoflurane ( eg , 0.2 0.7 percent ) long-term sedation reasonable use volatile inhalation anesthetic agent become necessary.Factors influence dose include whether target level sedation achieve satisfactory patient comfort .', 'The presence ventilator dyssynchrony may necessitate deepen anesthetic/sedation level .', 'Conversely , hypotension present , lighten anesthetic/sedation level necessary .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Clinical effect ' ."", ') When decision make allow patient awaken , anesthetic vaporizer turn , fresh gas flow ( FGF ) increase .', 'Washout anesthetic agent rapid predictable , patient typically able respond command assess extubation within 10 15 minute .', ""( See `` Emergence general anesthesia '' , section 'Inhalation agent ' ."", "") Monitoring sedation inhalation anesthetic — In addition suggest monitor note use anesthesia machine long-term ventilation ( see 'Monitoring long-term ventilation ' ) , specialize monitor require constant presence anesthesia provider necessary administration inhalation anesthetic agents.Patient monitor sedation●Continuously monitor parameter include : •End-tidal anesthetic concentration , titration anesthetic dose minimal effective end-tidal concentration ."", 'The low-level high-level alarm anesthetic gas monitor enabled.•Exhaled end-tidal carbon dioxide ( ETCO2 ) monitor possibility malignant hyperthermia ( severely acutely increase ETCO2 ) , help manage ventilation .', ""( See 'Monitoring long-term ventilation ' ."", "") •Temperature , since potent inhalation anesthetic lower core temperature ( see `` Perioperative temperature management '' , section 'Anesthetic effect thermoregulation ' ) , monitor possibility malignant hyperthermia ( acutely increase temperature > 102°F [ 38.9°C ) .●Other monitor parameter include : •Hemodynamic monitor per usual standard care individual critically ill patient , may useful evaluate cardiovascular response inhalation anesthetic agent ."", ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Hemodynamic monitor ' `` Inhalation anesthetic agent : Clinical effect us '' , section 'Cardiovascular effect ' ."", ') •Serum creatinine liver function test obtain interval may daily ( consultation critical care team ) , check renal hepatic dysfunction long-term administration volatile anesthetic agent.Equipment monitor sedation — Intermittent inspection maintenance anesthetic administration include : ●The fill level anesthetic vaporizer check every hour since rapid utilization volatile inhalation anesthetic agent occur due high FGF ; refill anesthetic level < 20 percent full.Liquid anesthetic use estimate .', 'One mL liquid volatile anesthetic agent yield approximately 200 mL gas anesthetic ( specific value 195 mL isoflurane 184 mL sevoflurane ) .', 'Thus , 10 L/min FGF , liquid volatile anesthetic consumption approximately 30 mL/hour 1 percent inhale concentration deliver .', 'Most vaporizer hold approximately 200 ml liquid , refill would need multiple time day even lower do note use isoflurane sevoflurane patient sedation mechanical ventilation .', ""( See 'Dosing achieve sedation ' ."", ') One way reduce consumption volatile anesthetic agent reduce FGF .', 'Another way agent consumption use anesthetic reflector device AnaConDa Mirus [ 17-22 ] .', 'These device design administration inhalation anesthetic agent use traditional intensive care unit ( ICU ) ventilator , approve use United States .', 'The device place Y-piece patient , vaporize small amount anesthetic liquid , absorb exhale anesthetic , re-inhaled next breath ( much like heat moisture exchanger [ HME ] absorb conserve humidity ) .', 'Notably , room contamination still occur use device unless scavenge system employ [ 20-22 ] .', '●Proper function scavenge system confirm administration inhalation anesthetic initiate , every 24 hour major change rate FGF .', 'Anesthetic vapor consume rapidly scavenger system require high vacuum flow high FGF use .', 'Advantages disadvantage — Advantages disadvantage specific agent ( sevoflurane versus isoflurane ) discuss separately .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Sevoflurane ' `` Inhalation anesthetic agent : Clinical effect us '' , section 'Isoflurane ' ."", ') Potential advantage disadvantage long-term use sevoflurane isoflurane sedation mechanically ventilate patient COVID-19 induce respiratory failure include : ●Advantages•Effective sedative effect , rapid onset offset allow easy titratability .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Sedation anesthesia ' ."", ') •Minimal metabolism likely minimal organ toxicity .', ""( See `` Inhalation anesthetic agent : Properties delivery '' , section 'Metabolism ' ."", ') •Ready availability shortage intravenous sedative analgesic agent usually employ sedation mechanical ventilation [ 13 ] .', 'Reports unusually high sedation requirement many COVID-19 patient may contribute shortage multiple commonly use intravenous agent [ 13,14 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Sedation analgesia ' ."", ') .•Potentially advantageous respiratory effects-Bronchodilation , attenuation bronchospasm decrease airway responsiveness .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Respiratory effect ' ."", ') -Pulmonary anti-inflammatory effect ( eg , reduction pro-inflammatory cytokine release ) may minimize extent lung injury [ 23-27 ] .', ""( See `` One lung ventilation : General principle '' , section 'Intravenous versus inhalation anesthetic ' ."", ') •Dose-dependent muscle relaxation mechanical ventilation .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Skeletal smooth muscle relaxation ' ."", ') ●Disadvantages•Scant safety data regard use inhalation anesthetic agent prolong period critically ill patient .', 'However , long-term sedation sevoflurane isoflurane employ nation sedation patient adult respiratory distress syndrome ( ARDS ) critical illness , without evidence renal hepatic injury [ 26-30 ] .•Rapid utilization volatile inhalation anesthetic agent occur due high FGF .', 'Thus , hourly inspection anesthetic vaporizer fill level analysis end-tidal anesthetic concentration particularly important .', ""( See 'Monitoring sedation inhalation anesthetic ' ."", ') •Potential inadequate sedation due vaporizer run dry , particularly patient receive neuromuscular block agent .', 'Thus , patient anesthesia machine anesthetic vaporizer must carefully monitor .', '•Potential difficulty connection anesthesia machine scavenger system compatible waste anesthesia gas disposal outlet set outside operate room ( OR ) .', ""( See 'Differences anesthesia machine ventilator ICU ventilator ' ."", ') •Lack familiarity among non-anesthesia personnel care critically ill patient ARDS ( eg , intensivists , nurse , respiratory therapist ) regard use anesthesia machine administer volatile inhalation anesthetic agent , dose agent , potential pitfall may occur administration ( refer APSF/ASA Guidance Use Volatile Anesthetic Sedation ICU Patients ) [ 16 ] .', '•Need constant presence anesthesia personnel recommend ASA APSF ( refer APSF/ASA Guidance Use Volatile Anesthetic Sedation ICU Patients ) [ 16 ] .', '•Potentially undesirable systemic effect potent volatile anesthetic agent critically ill patient , include : -Cardiovascular effect ( eg , myocardial depression vasodilatory property result dose-dependent reduction blood pressure cardiac output ) .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Cardiovascular effect ' ."", ') -Adverse respiratory effect include airway irritation , particularly pungent agent isoflurane , well respiratory depression .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Respiratory effect ' ."", ') -Cerebral effect ( eg , dose-dependent cerebral vasodilation , blunt cerebral autoregulation uncouple cerebral blood flow ( CBF ) metabolism , thereby increase CBF intracranial pressure ( ICP ) .', 'Thus , patient know suspect elevation ICP candidate sedation inhalation anesthetic agent .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Effects cerebral physiology ' ."", ') •Although rare , potential potent inhalation anesthetic agent cause malignant hyperthermia .', ""( See `` Inhalation anesthetic agent : Clinical effect us '' , section 'Malignant hyperthermia ( volatile inhalation agent ) ' ."", ') COLLABORATION WITH CRITICAL CARE CONSULTANTS — Collaboration coordination critical care clinician essential care COVID-19 patient regard initial decision use anesthesia machine , management long-term ventilation comorbidities critically ill COVID-19 patient ( eg , cardiovascular renal complication , coinfection sepsis ) [ 31-35 ] .', ""These issue discuss detail separate topic : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", ') SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●Contamination anesthesia machine , breathe system ventilator , connect gas analyzer likely use intensive care ventilator compare use surgical procedure patient novel coronavirus disease 2019 ( COVID-19 nCoV ) infection duration extent machine exposure ."", 'However , two filter use ( eg , heat moisture exchange filter [ HMEF ] contain electrostatic filter place airway plus mechanical pleat filter place expiratory limb breathe circuit ) , combine viral filtration efficiency ( VFE ) high , render contamination anesthesia machine unlikely , even use multiple day ( fresh filter day ) .', ""( See 'Prevention anesthesia machine contamination ' ."", ') ●Locations select use anesthesia machine ventilate COVID-19 patient institution-dependent depend layout select hospital area ( ) , location room negative pressure capability , availability source high-pressure oxygen medical air , availability compatible connection scavenger system waste anesthesia gas disposal outlet inhalation anesthetic agent use , availability anesthesia personnel manage anesthesia machine .', ""( See 'Locations anesthesia machine ' ."", ') ●The American Society Anesthesiologists ( ASA ) Anesthesia Patient Safety Foundation ( APSF ) develop guidance repurposing anesthesia machine longer-term ventilation ( refer APSF/ASA Guidance Purposing Anesthesia Machines ICU Ventilators Quick Reference : Setup Monitoring Instructions – Anesthesia Machine ICU Ventilator ) .', ""Although newer anesthesia ventilator incorporate multiple control assist mode ventilation nearly identical ventilator intensive care unit ( ICU ) , several important technical issue unique anesthesia machine use ( see 'Differences anesthesia machine ventilator ICU ventilator ' ) : •The age specific capability individual anesthesia machine ( newer anesthesia machine flexible capability deliver mode ventilation ) .•The need adjust fresh gas flow ( FGF ) prevent condense water accumulation breathe circuit.•The need long-term humification warm inspire gases.•The need two high-quality viral filter ( one airway expiratory limb breathe circuit ( figure 1 ) ) .•The need understand set performance anesthesia machine ventilator different ICU ventilators.•Potential need modify default ventilator parameter alarm settings.•The potential carbon dioxide ( CO2 ) absorbent expire.•The potential fraction inspire oxygen ( FiO2 ) concentration breathe circuit lower set oxygen gas concentration anesthesia machine ( FgO2 ) .•The need prevent accidental administration inhalation anesthetic agent , inhalation anesthetic administer achieve patient sedation.•Potential need adjust scavenger system prevent backpressure breathe system anesthesia machine use outside operate room ( OR ) .•The need periodic performance anesthesia machine self-test ( ie , power-up test ) approximately every 24 72 hours.•The need periodically check breathe circuit possible kink compression.•The need minimize potential error setup anesthesia machine , initiation control ventilation , respiratory monitor location outside OR , ideally deploy multiple machine model within one hospital unit.●An anesthesia professional available start monitor ventilation overall anesthesia machine function ( see 'Monitoring long-term ventilation ' ) : •Continuously intermittently monitor patient parameter ( preset alarm ) check record hour include ( see 'Patient monitor ' ) : -Inspired oxygen concentration -Inspired expire CO2-Inspiratory pressure-Tidal volume respiratory rate-Low oxygen pressure alarm-Check Pplat least every four hour , change positive end-expiratory pressure ( PEEP ) tidal volume-Check flow read approximately every four hour -Confirm leak around endotracheal tube cuff every hour •Intermittently machine monitor include inspection ( see 'Machine maintenance monitor ' ) : -Breathing circuit hose water trap excessive condense water every hour.-Breathing circuit hose possible kink compression every hour-Airway expiratory limb breathe circuit filter every hour excessive humidity secretions-CO2 absorbent color inspire CO2 value every hour -Documentation anesthesia machine startup test performance every 24 72 hour ●Although intravenous sedative-analgesic regimen usually employ sedate critically ill patient mechanical ventilation , institution shortage intravenous agent may consider use low do potent volatile inhalation anesthetic agent long-term sedation ( ie , sevoflurane [ 0.5 1.4 % ] isoflurane [ 0.2 0.7 % ] ; refer APSF/ASA Guidance Use Volatile Anesthetic Sedation ICU Patients ) ."", ""( See 'Use inhalation anesthetic sedation ' 'Dosing achieve sedation ' ."", "") ●Advantages disadvantage use inhalation anesthetic agent set include ( see 'Advantages disadvantage ' ) : •Advantages -Effective sedative effect , rapid onset offset allow easy titratability-Minimal metabolism likely minimal organ toxicity-Readily available-Advantageous respiratory effect include bronchodilation possible pulmonary anti-inflammatory effect -Dose-dependent muscle relaxation•Disadvantages -Scant safety data regard use inhalation anesthetic agent prolong periods-Lack familiarity among non-anesthesia personnel care critically ill patient -Need constant presence anesthesia personnel -Rapid utilization volatile inhalation anesthetic agent due high FGF , potential inadequate sedation-Potential difficulty connection anesthesia machine scavenger system compatible waste anesthesia gas disposal outlets-Potentially undesirable cardiovascular , respiratory , cerebral effect potent volatile anesthetic agent critically ill patients-Although rare , potential malignant hyperthermia ●Specialized additional monitor necessary inhalation anesthetic administer long-term sedation , require constant presence anesthesia provider specialize monitor include ( see 'Monitoring sedation inhalation anesthetic ' ) : •Patient parameter ( see 'Patient monitor sedation ' ) : -End-tidal anesthetic concentration , low high alarms-Exhaled end-tidal carbon dioxide ( ETCO2 ) -Temperature-Hemodynamic monitor per usual standard individual critically ill patient-Serum creatinine liver function test appropriate intervals•Equipment monitor ( see 'Equipment monitor sedation ' ) : -The fill level anesthetic vaporizer check every hour -Proper function scavenge system confirm initially , every 24 hour major change FGF rate●Collaboration coordination critical care clinician essential regard initial decision long-term ventilation anesthesia ventilator , management ventilation comorbidities critically ill patient ( eg , cardiovascular renal complication , coinfection sepsis ) ."", ""( See 'Collaboration critical care consultant ' . )""]","['', 'pneumonia', 'associate', 'novel', 'coronavirus', 'disease', '2019', '', 'covid-19', 'ncov', '', 'lead', 'respiratory', 'failure', 'profound', 'hypoxemia', 'require', 'endotracheal', 'intubation', 'mechanical', 'ventilation', '', 'rapidly', 'spread', 'pandemic', 'result', 'utilization', 'available', 'intensive', 'care', 'unit', '', 'icu', '', 'ventilator', 'individual', 'institution', 'region', '', 'repurposing', 'anesthesia', 'machine', 'longer-term', 'day', 'week', 'ventilate', 'covid-19', 'patient', 'patient', 'require', 'mechanical', 'ventilation', 'propose', '', 'somewhat', 'unprecedented', '', 'furthermore', '', 'anesthesia', 'machine', 'rarely', 'administer', 'inhalation', 'anesthetic', 'prolong', 'ventilation', '', 'topic', 'address', 'management', 'short-term', 'long-term', 'intensive', 'care', 'ventilation', 'anesthesia', 'machine', '', 'emphasize', 'patient', 'covid-19', 'pneumonia', '', '1', '', '', 'airway', 'management', 'anesthetic', 'care', 'patient', 'suspect', 'confirm', 'diagnosis', 'covid-19', 'infection', 'surgical', 'procedure', '', 'include', 'prevent', 'infection', 'anesthesia', 'personnel', 'contamination', 'anesthesia', 'machine', 'equipment', 'address', 'separate', 'topic', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', 'standard', 'icu', 'ventilator', 'ventilation', 'critically', 'ill', 'patient', 'covid-19', 'patient', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'ventilator', 'management', 'acute', 'respiratory', 'distress', 'syndrome', '', '', '', 'detail', 'regard', 'obstetric', 'critical', 'care', 'patient', 'covid-19', 'infection', '', 'general', 'medical', 'management', 'available', 'additional', 'topic', '', '', '', '', 'neuraxial', 'analgesia', 'labor', 'delivery', '', 'include', 'instrument', 'delivery', '', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'prevention', 'anesthesia', 'machine', 'contamination', '', 'preventing', 'contamination', 'external', 'part', 'anesthesia', 'machine', '', 'breathe', 'system', 'ventilator', '', 'connection', 'gas', 'analyzer', 'attach', 'monitor', 'equipment', 'patient', 'covid-19', 'describe', 'another', 'topic', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', 'section', 'protection', 'anesthesia', 'equipment', '', '', '', 'contamination', 'anesthesia', 'machine', 'intensive', 'care', 'ventilator', 'patient', 'covid-19', 'infection', 'likely', 'surgical', 'procedure', 'duration', 'extent', 'machine', 'exposure', '', 'based', 'study', 'coronaviruses', '', 'estimate', 'infect', 'patient', 'exhale', '0', '100000', 'virus', 'particle', 'per', '30', 'minute', '', '4800000', 'particle', 'per', 'day', '', '2', '', '', 'however', '', 'single', 'filter', 'viral', 'filtration', 'efficiency', '', 'vfe', '', '999999', 'percent', '', 'ie', '', 'mechanical', 'pleat', 'filter', 'expiratory', 'limb', '', 'allow', '48', 'particle', '', 'average', '', 'pas', '', 'two', 'filter', 'heat', 'moisture', 'exchange', 'filter', '', 'hmef', '', 'contain', 'electrostatic', 'filter', 'place', 'airway', 'plus', 'mechanical', 'pleat', 'filter', 'place', 'expiratory', 'limb', 'breathe', 'circuit', '', 'figure', '1', '', '', 'combine', 'vfe', 'high', '', 'perhaps', 'high', '9999999999', 'percent', '', '', 'render', 'contamination', 'anesthesia', 'machine', 'unlikely', '', 'multiple', 'day', '', 'fresh', 'filter', 'day', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', 'section', 'contamination', 'internal', 'component', 'anesthesia', 'machine', '', '', '', 'locations', 'anesthesia', 'machines', '', 'location', '', '', 'select', 'anesthesia', 'machine', 'ventilate', 'covid-19-positive', 'patient', 'institution-dependent', 'due', 'consideration', 'layout', 'select', 'hospital', 'area', '', '', '', 'location', 'room', 'negative', 'pressure', 'capability', '', 'availability', 'source', 'electrical', 'power', '', 'high-pressure', 'oxygen', '', 'medical', 'air', '', '13', '', '', 'personnel', 'consideration', 'include', 'availability', 'anesthesia', 'personnel', 'manage', 'ventilation', 'anesthesia', 'machine', '', 'convenience', 'critical', 'care', 'consultant', '', 'multiple', 'anesthesia', 'machine', 'single', 'location', '', 'compress', 'gas', 'pipeline', 'assess', 'ensure', 'supply', 'adequate', 'meet', 'consumption', 'supply', 'area', 'multiple', 'anesthesia', 'ventilator', 'high', 'fresh', 'gas', 'flow', '', 'fgfs', '', '', 'electrical', 'supply', 'assess', 'ensure', 'circuit', 'overload', '', 'particularly', 'area', 'outside', 'operate', 'room', '', '', 'availability', 'compatible', 'connection', 'scavenger', 'system', 'waste', 'anesthesia', 'gas', 'disposal', 'outlet', 'medical', 'vacuum', 'outlet', 'another', 'necessary', 'consideration', 'inhalation', 'anesthetic', 'agent', 'administer', 'anesthesia', 'machine', '', 'however', '', 'gas', 'scavenge', 'necessary', 'inhalation', 'agent', 'avoid', '', '', 'differences', 'anesthesia', 'machine', 'ventilator', 'icu', 'ventilator', '', 'inhalation', 'anesthetic', 'sedation', '', '', '', 'institutional', 'option', 'location', 'anesthesia', 'machine', 'ventilator', 'include', 'intensive', 'care', 'unit', '', 'icu', '', 'room', '', 'presurgical', 'hold', 'area', '', 'post-anesthesia', 'care', 'unit', '', 'pacus', '', '', 'individual', 'ors', '', '1', '', '', 'institution', '', 'possible', 'treat', 'two', 'covid-19', 'patient', 'multiple', 'source', 'oxygen', 'medical', 'air', '', 'anesthesia', 'personnel', '', 'ie', '', 'anesthesiologist', '', 'certified', 'registered', 'nurse', 'anesthetists', '', 'crnas', '', '', 'certified', 'anesthesiologist', 'assistants', '', 'caas', '', '', 'deploy', 'set', '', 'notably', '', 'american', 'society', 'anesthesiologists', '', 'asa', '', 'anesthesia', 'patient', 'safety', 'foundation', '', 'apsf', '', 'guideline', 'repurposing', 'anesthesia', 'machine', 'longer-term', 'ventilation', 'recommend', 'anesthesia', 'professional', 'immediately', 'available', 'time', 'manage', 'monitor', 'anesthesia', 'ventilator', '', 'administration', 'inhalation', 'anesthetic', 'agent', '', '', '', 'well', 'assist', 'respiratory', 'care', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', 'quick', 'reference', '', 'setup', 'monitoring', 'instructions', '', 'anesthesia', 'machine', 'icu', 'ventilator', '', '', 'regardless', 'location', '', '', 'anesthesia', 'machine', '', '45', '', '', '', 'monitoring', 'long-term', 'ventilation', '', 'monitoring', 'sedation', 'inhalation', 'anesthetic', '', '', '', 'long-term', 'ventilation', 'anesthesia', 'machines', '', 'american', 'society', 'anesthesiologists', '', 'asa', '', 'anesthesia', 'patient', 'safety', 'foundation', '', 'apsf', '', 'develop', 'guidance', 'anesthesia', 'care', 'team', 'member', 'regard', 'repurposing', 'anesthesia', 'machine', 'longer-term', 'ventilation', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', 'quick', 'reference', '', 'setup', 'monitoring', 'instructions', '', 'anesthesia', 'machine', 'icu', 'ventilator', '', '', '45', '', '', 'professional', 'society', 'recommend', 'anesthesia', 'professional', 'immediately', 'available', 'time', 'manage', 'monitor', 'anesthesia', 'ventilator', '', 'professional', 'staff', 'anesthesiologist', '', 'eg', '', 'intensivists', '', 'well', 'respiratory', 'therapist', '', 'intensive', 'care', 'unit', '', 'icu', '', 'nurse', '', 'expert', 'respiratory', 'care', '', 'familiar', 'anesthesia', 'machine', '', 'increase', 'amount', 'interaction', 'require', '', 'anesthesia', 'machine', 'ventilator', 'patient', 'require', 'mechanical', 'ventilation', 'period', 'time', '', 'covid-19-positive', '', 'option', 'optimal', 'institutional', 'resourceslimited', 'data', 'regard', 'duration', 'mechanical', 'ventilation', 'covid-19', 'patient', 'suggest', 'two', 'week', 'often', 'necessary', '', 'collaboration', 'critical', 'care', 'team', 'throughout', 'period', 'clearly', 'essential', 'achieve', 'optimal', 'respiratory', 'care', '', 'manage', 'systemic', 'problem', 'patient', 'severe', 'covid-19', 'disease', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'ventilator', 'management', 'acute', 'respiratory', 'distress', 'syndrome', '', '', '', 'differences', 'anesthesia', 'machine', 'ventilator', 'icu', 'ventilator', '', 'data', 'limit', 'regard', 'capability', 'anesthesia', 'machine', 'ventilator', 'develop', 'various', 'manufacturer', 'mimic', 'icu', 'ventilator', 'parameter', 'reliably', 'provide', 'continuous', 'mechanical', 'ventilation', 'prolong', 'period', 'time', '', 'although', 'newer', 'anesthesia', 'ventilator', 'incorporate', 'multiple', 'control', 'assist', 'mode', 'ventilation', 'nearly', 'identical', 'intensive', 'care', 'ventilator', '', 'several', 'important', 'technical', 'issue', 'unique', 'anesthesia', 'machine', '', 'must', 'consider', 'long-term', 'ventilationadjusting', 'humidification', 'inspire', 'gasesthe', 'adjust', 'fresh', 'gas', 'flow', '', 'fgf', '', 'prevent', 'condense', 'water', 'accumulation', 'breathe', 'circuit', '', '3', '', '', 'intensive', 'care', 'ventilator', 'deliver', 'fresh', 'gas', 'inspiration', '', 'discharge', 'exhale', 'gas', 'room', '', 'compress', 'gas', 'zero', 'humidity', '', 'active', 'humidification', 'necessary', '', 'ability', 'alter', 'fgf', 'fraction', 'exhale', 'gas', 'rebreathed', 'key', 'feature', 'distinguish', 'anesthesia', 'ventilator', 'icu', 'ventilator', '', 'fgf', 'typically', 'reduce', 'general', 'anesthesia', 'conserve', 'inhalation', 'anesthetic', 'agent', '', 'fgf', 'lower', 'minute', 'ventilation', 'increase', 'rebreathing', 'exhale', 'gas', '', 'humidify', 'body', '', 'reaction', 'rebreathed', 'carbon', 'dioxide', '', 'co2', '', 'co2', 'absorbent', 'produce', 'additional', 'humidity', 'within', 'circuit', '', 'experience', 'date', 'indicate', 'anesthesia', 'machine', 'long-term', 'icu', 'ventilator', '', 'reduce', 'fgf', 'lead', 'excessive', 'humidity', 'breathe', 'circuit', '', 'change', 'co2', 'absorbent', 'frequently', '', '', 'anesthesia', 'machine', '', 'prevention', '', 'diagnosis', '', 'management', 'malfunction', '', '', 'section', 'carbon', 'dioxide', 'absorbent', 'exhaustion', 'toxicity', '', '', '', 'additional', 'humidity', 'clinically', 'significant', 'lead', 'water', 'condensation', 'within', 'breathe', 'circuit', 'increase', 'resistance', 'gas', 'flow', 'system', '', 'interfere', 'sensor', 'respiratory', 'gas', 'analyzer', 'flow', 'sensor', '', 'increase', 'risk', 'coinfections', '', '3', '', '', 'reason', '', 'significant', 'accumulation', 'water', 'breathe', 'circuit', '', 'typically', 'expiratory', 'limb', '', 'must', 'empty', '', 'accumulated', 'water', 'empty', 'carefully', 'wear', 'full', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'contaminate', 'virus', '', 'condensers', 'water', 'trap', 'add', 'breathe', 'system', 'aid', 'manage', 'excessive', 'humidity', '', '2', '', '', 'issues', 'supply', 'chain', 'limit', 'purchase', 'water', 'trap', 'covid-19', 'pandemic', '', 'however', '', 'new', 'option', 'design', 'test', 'institution', '', '3', '', 'prevent', 'buildup', 'humidity', 'decrease', 'co2', 'absorbent', '', 'recommend', 'fgf', 'set', 'equal', 'minute', 'ventilation', 'initially', '', 'approximately', '6', '8', 'lminute', 'adult', 'patient', '', '', 'generally', '', 'apparent', 'one', 'two', 'hour', 'excess', 'moisture', 'accumulate', 'breathe', 'circuit', '', '', 'fgf', 'increase', 'incrementally', '', 'eg', '', '05', '1', 'lmin', '', 'humidity', 'control', '', 'alternately', '', 'fgf', 'set', 'higher', '', 'eg', '', '15', 'time', 'minute', 'ventilation', '', 'initially', '', 'reduce', 'increment', '500', 'mlminute', 'vigilant', 'monitor', 'appearance', 'humidity', 'inspiratory', 'limb', '', 'fgf', 'exceed', '15', 'time', 'minute', 'ventilation', '', 'little', 'rebreathing', '', 'increase', 'fgf', 'provide', 'advantage', 'waste', 'compress', 'gas', '', 'oxygen', 'medical', 'air', '', 'long-term', 'humidification', 'warm', 'inspire', 'gas', '', 'critical', 'care', 'patient', 'inspire', 'warm', 'humidify', 'gas', 'prevent', 'dry', 'secretion', 'respiratory', 'epithelium', '', 'low', 'fgfs', 'typically', 'operate', 'room', '', '', '', 'inspire', 'gas', 'humidify', 'due', 'rebreathing', '', '67', '', '', 'release', 'heat', 'humidity', 'reaction', 'co2', 'absorbent', '', '8', '', '', 'presence', 'condensate', 'inspiratory', 'hose', 'indicate', 'inspire', 'gas', 'relative', 'humidity', '', '100', 'percent', 'room', 'temperaturehowever', '', 'heat', 'moisture', 'exchange', 'filter', '', 'hmef', '', 'necessary', 'high', 'fgfs', 'prevent', 'condense', 'water', 'accumulation', 'prolong', 'ventilation', 'anesthesia', 'machine', '', 'hmef', 'place', 'endotracheal', 'tube', 'connection', 'breathe', 'circuit', '', 'y-piece', 'gas', 'sample', 'port', '', 'figure', '1', '', '', '', 'hmef', 'ensure', 'adequate', 'humidity', 'maintain', 'lung', 'filter', 'viral', 'particle', '', 'filters', 'hmefs', 'airway', 'prone', 'obstruction', 'moisture', 'secretion', '', 'compared', 'set', '', 'obstruction', 'airway', 'filter', 'hmef', 'place', 'anesthesia', 'machine', 'breathe', 'circuit', 'icu', 'le', 'likely', 'detect', 'early', 'since', 'constant', 'attendance', 'anesthesia', 'professional', '', 'airway', 'filter', 'hmefs', 'inspect', 'le', 'frequently', 'every', 'hour', '', 'change', 'obstruction', 'concern', '', 'every', '24', 'hour', '', 'devices', 'actively', 'humidify', 'inspire', 'gas', 'recommend', '', 'cause', 'problem', 'ventilation', 'monitor', 'since', 'anesthesia', 'machine', 'design', 'handle', 'large', 'amount', 'condense', 'water', 'within', 'breathe', 'circuit', '', 'unique', 'safety', 'issuesthe', 'place', 'second', 'high-quality', 'viral', 'filter', '', 'typically', 'pleat', 'mechanical', 'filter', 'heat', 'humidity', 'exchange', 'property', '', 'expiratory', 'limb', 'anesthesia', 'machine', 'breathe', 'circuit', 'ventilation', 'covid-19', 'patient', '', 'filter', 'hmef', 'place', 'airway', '', 'figure', '1', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', 'section', 'contamination', 'internal', 'component', 'anesthesia', 'machine', '', '', '', 'filter', 'expiratory', 'limb', 'likely', 'leave', 'place', 'longer', 'period', 'time', 'filter', 'place', 'airway', '', 'however', '', 'data', 'predict', 'filter', 'performance', 'time', '', 'since', 'institution', 'filter', 'shortage', '', 'expiratory', 'limb', 'filter', 'change', 'necessarypotential', 'prevent', 'accidental', 'administration', 'inhalation', 'anesthetic', 'agent', '', 'plan', 'administer', 'inhalation', 'anesthetic', 'achieve', 'patient', 'sedation', '', 'vaporizer', 'volatile', 'agent', 'remove', 'drain', '', '', 'nitrous', 'oxide', '', 'n2o', '', 'cylinder', 'pipeline', 'hose', 'remove', '', 'measure', 'ensure', 'inhalation', 'anesthetic', 'agent', 'accidentally', 'administer', '', 'however', '', 'institution', 'inadequate', 'supply', 'intravenous', 'sedative', 'analgesic', 'agent', 'commonly', 'icu', 'consider', 'emergency', 'low', 'volatile', 'inhalation', 'anesthetic', 'agent', '', 'isoflurane', 'sevoflurane', '', '', 'explain', '', '', 'inhalation', 'anesthetic', 'sedation', '', '', '', 'potential', 'co2', 'absorbent', 'expire', '', 'inspire', 'co2', 'color', 'indicator', 'co2', 'absorbent', 'monitor', 'frequently', '', 'absorbent', 'replace', 'inspire', 'co2', 'increase', '', 'eg', '', '5', 'mmhg', '', 'co2', 'absorbent', 'color', 'indicate', 'become', 'exhaust', '', 'ventilation', 'must', 'interrupt', 'change', 'absorbent', '', 'patient', 'temporarily', 'ventilate', 'alternative', 'mean', '', 'furthermore', '', 'potential', 'reaction', 'co2', 'absorbent', 'occur', 'volatile', 'anesthetic', 'agent', 'employ', 'absorbent', 'become', 'dry', 'fgf', '', '', '', 'anesthesia', 'machine', '', 'prevention', '', 'diagnosis', '', 'management', 'malfunction', '', '', 'section', 'carbon', 'dioxide', 'absorbent', 'exhaustion', 'toxicity', '', '', '', 'three', 'reason', 'simply', 'remove', 'co2', 'absorber', 'canister', '', 'empty', 'absorber', 'canister', '', 'co2', 'absorption', 'important', 'prevent', 'hypercarbia', 'fgf', 'decrease', '1', '15', 'time', 'minute', 'ventilation', '', 'purposely', 'inadvertently', '', 'breathe', 'system', 'leak', 'canister', 'remove', '', 'valve', 'instal', 'machine', 'prevent', 'leak', 'intend', 'short', 'period', 'canister', 'change', '', 'dependable', 'longer-term', 'usethe', 'canister', 'leave', 'empty', 'significantly', 'increase', 'compliance', 'breathe', 'systempotential', 'adjust', 'scavenger', 'system', 'anesthesia', 'machine', '', 'anesthesia', 'machine', 'outside', '', 'possible', 'connect', 'scavenger', 'system', 'compatible', 'waste', 'anesthesia', 'gas', 'disposal', 'vacuum', 'outlet', '', 'waste', 'anesthetic', 'gas', 'disposal', 'outlet', 'typically', 'find', 'operate', 'procedure', 'room', '', 'waste', 'gas', 'hose', 'anesthesia', 'machine', 'compatible', 'medical', 'vacuum', 'outlet', 'find', 'elsewhere', '', 'waste', 'anesthetic', 'gas', 'scavenge', 'necessary', 'inhalation', 'anesthetic', 'agent', 'plan', '', 'inhalation', 'anesthetic', 'sedation', '', '', '', 'importantly', '', 'scavenger', 'system', 'reservoir', 'bag', '', 'close', 'scavenger', 'system', '', 'connect', 'vacuum', '', 'cause', 'high', 'peep', 'peak', 'pressure', 'due', 'backup', 'waste', 'gas', 'breathe', 'system', '', 'options', 'include', '', 'inhalation', 'anesthetic', 'agent', '', 'picture', '1', '', '', '-disconnection', 'scavenger', 'system', 'hose', 'breathe', 'system', 'ventilator', '-removal', 'scavenger', 'reservoir', 'bag', '', 'close', 'scavenger', 'system', '', 'inhalation', 'anesthetic', 'agent', '', 'scavenge', 'require', '', 'connection', 'scavenger', 'system', 'suction', 'location', 'outside', '', 'eg', '', 'icu', '', 'difficult', 'connection', 'incompatible', '', 'case', '', 'alternate', 'tube', 'connector', '', 'connection', 'adapter', '', 'higher', 'usual', 'fgfs', '', 'scavenger', 'suction', 'must', 'adjust', 'upward', 'ensure', 'proper', 'function', '', 'potential', 'modify', 'oxygen', 'utilization', 'anesthesia', 'machine', 'ventilator', 'institutional', 'oxygen', 'supply', 'limit', 'factor', '', '39', '', '', 'delay', 'delivery', 'liquid', 'oxygen', 'hospitalexcessive', 'oxygen', 'hospital', '', 'oxygen', 'vaporizer', '', 'liquid', 'oxygen', 'convert', 'gas', 'oxygen', '', 'become', 'cover', 'ice', '', 'result', 'inefficiency', 'inability', 'flow', 'oxygen', 'pipeline', 'branch', 'keep', 'demand', 'due', 'caliber', 'pipeline', '', 'number', 'ventilator', '', 'anesthesia', 'machine', '', 'oxygen', 'flowmeters', 'branch', '', 'typically', 'problem', 'older', 'hospitalswhen', 'oxygen', 'consumption', 'outstrip', 'maximum', 'oxygen', 'supply', '', 'ventilator', '', 'anesthesia', 'machine', '', 'oxygen', 'flowmeters', 'pipeline', 'branch', 'affect', '', 'thus', '', 'inspire', 'oxygen', 'concentration', 'deliver', 'individual', 'anesthesia', 'machine', 'decrease', 'air', '', 'machine', 'alarm', 'activate', 'inspiratory', 'cycle', '', 'anesthesia', 'machine', 'bellow', 'ventilator', 'typically', 'oxygen', 'drive', 'gas', 'compress', 'bellow', '', 'ventilator', 'consume', 'oxygen', 'rate', 'approximate', 'minute', 'ventilation', 'plus', 'additional', 'oxygen', 'fgf', 'rate', 'fgf', 'time', 'percent', 'oxygen', '', 'sporadic', 'consumption', 'increase', 'dramatically', 'inspiration', '', 'however', '', 'machine', 'bellow', 'ventilator', 'modify', 'qualify', 'clinical', 'engineer', 'power', 'compress', 'air', 'instead', 'oxygen', '', '39', '', '', 'modification', 'must', 'machine', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', '', 'conversely', '', 'anesthesia', 'machine', 'electrically', 'power', '', 'ie', '', 'piston', 'turbine', '', 'ventilator', 'similar', 'icu', 'ventilator', '', 'typically', 'consume', 'oxygen', 'rate', 'minute', 'ventilation', 'time', 'percent', 'oxygen', '', 'consume', 'oxygen', 'deliver', 'fresh', 'gas', '', 'periodic', 'performance', 'anesthesia', 'machine', 'self-test', '', 'ie', '', 'power-up', 'test', '', 'approximately', 'every', '24', '72', 'hour', '', 'asa', 'anesthesia', 'machine', 'manufacturer', 'recommend', 'pre-use', 'check', 'every', 'day', 'prior', 'machine', 'set', '', 'prolong', '', 'manufacture', 'state', 'approximately', 'every', 'three', 'day', '', 'experience', 'show', 'problem', 'inaccurate', 'ventilation', 'delivery', 'monitor', 'occur', 'anesthesia', 'machine', 'restart', 'check', 'three-day', 'intervalsnotably', '', 'alternative', 'mean', 'ventilation', 'necessary', '', 'eg', '', 'manual', 'resuscitator', 'second', 'ventilator', '', 'machine', 'power', '', 'restart', '', 'check', '', 'step-by-step', 'procedure', 'follow', 'ensure', 'equipment', 'available', 'prevent', 'patient', 'lung', 'de-recruitment', '', 'well', 'limit', 'spillage', 'breathe', 'circuit', 'gas', 'contaminant', 'protect', 'anesthesia', 'personnel', 'process', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', 'asa', 'quick', 'reference', '', 'setup', 'monitoring', 'instructions', '', 'anesthesia', 'machines', 'icu', 'ventilator', '', '', '45', '', '', 'suggest', 'procedure', 'develop', 'apsf', 'asa', '', 'refer', 'apsfasa', 'procedure', 'supporting', 'patients', 'anesthesia', 'machine', 'self-test', '', '', '10', '', 'periodically', 'check', 'breathe', 'circuit', 'possible', 'kink', 'compression', 'since', '', 'unlike', 'icu', 'ventilator', '', 'articulate', 'arm', 'anesthesia', 'machine', 'hold', 'breathe', 'circuit', 'bedthe', 'minimize', 'potential', 'error', 'setup', 'anesthesia', 'machine', '', 'initiation', 'control', 'ventilation', '', 'respiratory', 'monitor', 'location', 'outside', 'suite', '', 'ideally', 'deploy', 'multiple', 'machine', 'model', 'within', 'one', 'hospital', 'unit', '', 'eg', '', 'icu', '', 'post-anesthesia', 'care', 'unit', '', 'pacu', '', '', '', 'adjusting', 'ventilatory', 'settingsthe', 'understand', 'specific', 'capability', 'differ', 'among', 'individual', 'anesthesia', 'machine', '', 'newer', 'anesthesia', 'machine', 'ventilator', 'capability', 'similar', 'modern', 'icu', 'ventilator', '', 'flexible', 'set', 'deliver', 'mode', 'ventilation', '', 'include', 'assist', 'mode', '', 'compare', 'older', 'model', '', 'newer', 'model', 'compliance', 'compensation', 'tidal', 'volume', 'delivery', 'unaffected', 'change', 'fgf', 'generally', 'prefer', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', '', '', 'newer', 'machine', 'equip', 'breathe', 'system', 'ventilator', 'sterilize', 'patient', '', 'better', 'choice', 'covid-19', 'infectionolder', 'model', 'reserve', 'surgical', 'patient', 'ventilation', 'patient', 'without', 'covid-19', 'respiratory', 'disease', '', 'feasiblethe', 'understand', 'set', 'performance', 'anesthesia', 'machine', 'ventilator', 'differ', 'icu', 'ventilator', 'adjustment', 'ventilator', 'set', '', 'anesthesia', 'machine', 'default', 'pressure', 'support', 'extra', 'breath', 'control', 'mode', '', 'care', 'must', 'add', 'change', 'ventilator', 'modesanesthesia', 'machine', 'lower', 'peak', 'inspiratory', 'flow', 'rate', '', 'negative', 'airway', 'pressure', 'occur', 'patient', 'inhale', 'faster', 'maximum', 'inspiratory', 'flow', 'rate', 'provide', 'ventilatoranesthesia', 'machine', 'millisecond', 'slower', 'respond', 'patient', 'effort', 'circle', 'breathe', 'system', 'interpose', 'patient', 'anesthesia', 'ventilator', '', '11', '', '', 'cause', 'hyperventilation', 'air-hungry', 'patientinspiratory', 'time', 'directly', 'set', 'anesthesia', 'machine', '', 'anesthesia', 'machine', 'provide', 'direct', 'control', 'inspiratory', 'time', '', 'instead', 'control', 'indirectly', 'set', '', 'e', 'ratio', 'respiratory', 'rateoptions', 'set', 'anesthesia', 'machine', 'ventilator', 'include', '', '-in', 'volume', 'control', 'mode', '', 'include', 'synchronize', 'intermittent', 'mandatory', 'ventilation', '', 'simv', '', '', '', 'inspiratory', 'flow', 'rate', 'increase', 'increase', 'tidal', 'volume', 'decrease', 'inspiratory', 'time', '', 'accomplish', 'reduce', '', 'e', 'ratio', 'increase', 'respiratory', 'rate', '', '', 'introducing', 'inspiratory', 'pause', '', 'tpause', 'tip', '', 'increase', 'inspiratory', 'flow', 'rate', 'active', 'portion', 'inspiration', '', 'pause-in', 'pressure', 'control', 'support', 'mode', '', 'inspiratory', 'flow', 'rate', 'increase', 'lower', 'flow', 'trigger', 'level', 'ventilation', '', 'increase', 'speed', 'pressure-support', 'provide', '', '', 'decrease', 'rise', 'time', 'pressure', 'support', '', 'increase', 'inspiratory', 'flow', 'rate', '', '', 'draeger', 'anesthesia', 'machine', 'ventilator', '', 'flow', 'trigger', 'level', 'call', '', 'trigger', 'lmin', '', 'rise', 'time', 'call', '', 'tslope', '', '', 'ge', 'healthcare', 'systems', 'anesthesia', 'machine', 'ventilator', '', 'flow', 'trigger', 'level', 'call', '', 'flow', 'trigger', '', 'rise', 'time', 'call', '', 'rise', 'rate', '', '', 'however', '', 'lower', 'flow', 'trigger', 'level', 'cause', 'extra', 'mis-triggered', 'breath', 'patient', '', 'occur', '', 'flow', 'trigger', 'level', 'must', 'increase', '', 'draeger', 'machine', 'ventilator', '', 'maximum', 'inspiratory', 'flow', 'govern', 'facility-level', 'set', '', 'although', 'on-site', 'clinical', 'engineer', 'adjust', 'parameter', 'allow', 'maximum', 'inspiratory', 'flow', '75', 'lminpotential', 'modify', 'default', 'ventilator', 'parameter', 'alarm', 'set', '', 'default', 'set', 'anesthesia', 'machine', '', 'minute', 'ventilation', '', 'airway', 'pressure', '', 'positive', 'end-expiratory', 'pressure', '', 'peep', '', 'level', '', 'alarm', '', 'modify', 'better', 'match', 'icu', 'ventilator', '', 'default', 'alarm', 'volume', 'set', 'maximumthe', 'potential', 'fraction', 'inspire', 'oxygen', '', 'fio2', '', 'concentration', 'breathe', 'circuit', 'lower', 'set', 'oxygen', 'gas', 'concentration', 'anesthesia', 'machine', '', 'fgo2', '', '', 'especially', 'lower', 'fgfs', '', 'rebreathing', 'occur', 'anesthesia', 'machine', 'circle', 'breathe', 'circuit', '', 'inspire', 'oxygen', 'concentration', 'depend', 'ratio', 'oxygen', 'air', 'deliver', 'fresh', 'gas', '', 'determine', 'fgf', 'set', '', 'total', 'fgf', '', 'influence', 'amount', 'rebreathing', '', '', 'thus', '', 'inspire', 'oxygen', 'concentration', 'must', 'continuously', 'monitor', '', 'monitoring', 'sedation', 'inhalation', 'anesthetic', '', '', '', 'notably', '', 'total', 'fgf', 'high', '', 'eg', '', '', '12', 'lminute', '', '', 'fio2', '100', 'percent', 'deliver', 'total', 'fgf', 'higher', 'maximum', 'possible', 'flow', 'oxygen', '', 'instance', '', 'total', 'fgf', '15', 'lminute', 'necessary', '', 'maximum', 'oxygen', 'flow', '12', 'lmin', '', '3', 'lmin', 'air', 'must', 'add', '', 'confuse', 'anesthesia', 'machine', 'control', 'total', 'fgf', 'oxygen', 'percentmonitoring', 'long-term', 'ventilation', '', 'anesthesia', 'professional', 'available', 'start', 'ventilation', 'subsequently', 'monitor', 'degree', 'moisture', 'accumulation', '', 'inspire', 'expire', 'co2', '', 'filter', 'integrity', '', 'overall', 'anesthesia', 'machine', 'function', '', 'effectiveness', 'ventilation', '', '1', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'ventilator', 'management', 'acute', 'respiratory', 'distress', 'syndrome', '', '', '', 'apsfasa', 'guideline', 'address', 'additional', 'maintenance', 'monitor', 'requirement', 'anesthesia', 'machine', 'long-term', 'ventilation', 'covid-19', 'patient', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', 'quick', 'reference', '', 'setup', 'monitoring', 'instructions', '-', 'anesthesia', 'machine', 'icu', 'ventilator', '', '', '45', '', '', 'additional', 'consideration', 'necessary', 'due', 'extra', 'filter', 'become', 'clog', '', 'tendency', 'accumulate', 'condense', 'water', 'breathe', 'circuit', '', 'risk', 'aerosolize', 'droplet', 'contain', 'covid-19', 'virusdocumentation', 'enhance', 'monitor', 'continuous', 'intermittent', 'parameter', 'necessary', '', 'achieve', 'automatically', 'anesthesia', 'machine', 'connect', 'hospital', 'network', 'record', 'electronic', 'medical', 'record', '', '1', '', '', 'manually', 'template', 'develop', 'purpose', 'anesthesia', 'teampatient', 'monitor', '', 'baseline', 'monitor', 'parameter', '', 'eg', '', 'tidal', 'volume', '', 'plateau', 'pressure', '', 'pplat', '', '', 'minute', 'ventilation', '', 'record', 'ventilation', 'initiate', '', 'spirometry', 'available', '', 'save', 'photograph', 'baseline', 'trace', 'reference', 'loop', 'aid', 'later', 'diagnosis', 'filter', 'obstructionscontinuously', 'monitor', 'parameter', '', 'preset', 'alarm', '', 'check', 'record', 'hour', 'include', '', 'inspired', 'oxygen', 'concentration', '', 'inspired', 'expire', 'co2inspiratory', 'pressuretidal', 'volume', 'respiratory', 'rate', '', 'low', 'oxygen', 'pressure', 'alarm', '', 'anesthesia', 'machine', 'oxygen-driven', 'bellow', '', 'low', 'oxygen', 'pressure', 'alarm', 'trigger', 'inspiration', 'indicate', 'high', 'demand', 'institutional', 'central', 'oxygen', 'pipeline', 'system', '', 'particularly', 'multiple', 'ventilator', 'simultaneously', '', '', 'differences', 'anesthesia', 'machine', 'ventilator', 'icu', 'ventilator', '', '', '', 'intermittently', 'monitor', 'ventilatory', 'physiologic', 'parameter', 'include', '', 'check', 'pplat', 'least', 'every', 'four', 'hour', '', 'change', 'peep', 'tidal', 'volume', '', 'ensure', '30', 'cm', 'h2o', '', 'measurement', 'pplat', 'accomplish', '05', 'second', 'inspiratory', 'pause', '', 'unlike', 'icu', 'ventilator', '', 'anesthesia', 'machine', 'control', 'manually', 'initiate', 'inspiratory', 'pause', '', 'anesthesia', 'machine', 'ventilator', '', '05', 'second', 'inspiratory', 'pause', 'generate', 'temporarily', 'set', 'mode', 'volume', 'ventilation', 'tidal', 'volume', 'patient', 'receive', '', '10', 'breath', 'per', 'minute', '', '', 'e', 'ratio', '12', '50', 'percent', 'inspiratory', 'pause', '', 'tpause', 'tip', '', '', '', 'adjusting', 'ventilatory', 'set', '', '', '', 'check', 'flow', 'read', 'approximately', 'every', 'four', 'hour', '', 'since', 'become', 'le', 'accurate', 'time', '', 'machine', 'equip', 'inspiratory', 'expiratory', 'flow', 'sensor', '', 'gradual', 'increase', 'difference', 'inspire', 'exhale', 'tidal', 'volume', 'measurement', 'usually', 'indicate', 'startup', 'test', 'recalibrate', 'breathe', 'system', 'flow', 'sensorsconfirm', 'leak', 'around', 'endotracheal', 'tube', 'cuff', 'every', 'hour', 'leak', 'produce', 'respiratory', 'droplet', 'aerosolize', 'viral', 'particle', '', 'leak', 'around', 'endotracheal', 'tube', 'cuff', 'typically', 'manifest', 'measure', 'exhale', 'tidal', 'volume', 'lower', 'measure', 'inhale', 'tidal', 'volume', '', 'flow-volume', 'loop', 'close', '', '12', '', '', 'low', 'fgfs', 'bellow', 'ventilator', 'progressively', 'empty', '', 'reservoir', 'bag', 'progressively', 'deflate', 'machine', 'piston', 'turbine', 'ventilator', '', 'high', 'fgf', 'compensate', 'small', 'leak', '', 'obscure', 'indicator', 'breathe', 'circuit', 'volumemachine', 'maintenance', 'monitor', '', 'intermittent', 'inspection', 'maintenance', 'proper', 'anesthesia', 'machine', 'breathe', 'circuit', 'function', 'include', '', 'inspect', 'breathe', 'circuit', 'hose', 'water', 'trap', 'excessive', 'condense', 'water', 'every', 'hour', '', 'oscillate', 'obstructive', 'gas', 'flow', 'trace', 'exhalation', 'indicate', 'condense', 'water', 'accumulation', 'expiratory', '', 'scavenger', '', 'ventilator', 'hose', '', 'oscillate', 'obstructive', 'gas', 'flow', 'trace', 'inhalation', 'indicate', 'condense', 'water', 'accumulation', 'inspiratory', 'ventilator', 'hoseif', 'fluid', 'accumulate', 'breathe', 'circuit', 'threaten', 'impede', 'ventilation', '', 'must', 'remove', '', '3', '', '', 'plans', 'place', 'ventilate', 'patient', 'circuit', 'empty', '', 'one', 'novel', 'method', 'describe', 'placement', 'airway', 'filter', 'case', 'luer', 'connector', 'expiratory', 'limb', 'serve', 'water', 'trap', '', 'enable', 'aspiration', 'condense', 'water', 'syringe', 'without', 'interrupt', 'ventilation', '', '3', '', '', '', 'proper', 'collection', 'disposal', 'procedure', 'contaminate', 'water', 'ppe', 'personnel', 'perform', 'procedure', 'necessary', 'since', 'fluid', 'remove', 'contaminate', 'virusinspect', 'breathe', 'circuit', 'hose', 'possible', 'kink', 'compression', 'every', 'hour', 'wellinspect', 'airway', 'expiratory', 'limb', 'breathe', 'circuit', 'filter', 'every', 'hour', 'check', 'excessive', 'humidity', 'secretion', 'cause', 'obstruction', 'gas', 'flow', '', 'airway', 'filter', 'highest', 'risk', '', 'figure', '1', '', '', 'obstructed', 'filter', 'must', 'change', '', 'otherwise', '', 'filter', 'typically', 'replace', 'every', '24', 'hour', '', 'high', 'peak', 'airway', 'pressure', 'volume', 'ventilation', 'low', 'tidal', 'volume', 'pressure', 'ventilation', 'sign', 'profound', 'obstruction', 'filter', 'place', 'airway', 'expiratory', 'limb', '', 'figure', '1', '', '', '3', '', '', 'decreased', 'peak', 'expiratory', 'flow', 'prolongation', 'expiratory', 'flow', 'earlier', 'indication', 'partial', 'obstruction', 'one', 'filter', '', '12', '', '', 'significant', 'obstruction', 'either', 'filter', 'create', 'additional', 'peep', '', 'difference', 'set', 'actual', 'peep', 'airway', 'pressure', 'expiratory', 'limb', 'filter', 'obstruct', '', 'notably', '', 'additional', 'peep', 'invisible', 'airway', 'filter', 'obstruct', 'since', 'airway', 'pressure', 'measure', 'downstream', 'filter', '', 'check', 'co2', 'absorbent', 'color', 'inspire', 'co2', 'value', 'every', 'hour', 'ensure', 'absorbent', 'still', 'function', 'properly', 'exchange', '', 'especially', 'important', 'lower', 'fgfs', 'usedconfirm', 'anesthesia', 'machine', 'startup', 'test', 'perform', 'every', '24', '72', 'hour', '', 'refer', 'apsfasa', 'procedure', 'supporting', 'patients', 'anesthesia', 'machine', 'self-test', '', '', '10', '', '', '', 'differences', 'anesthesia', 'machine', 'ventilator', 'icu', 'ventilator', '', '', '', 'inhalation', 'anesthetics', 'sedation', '', 'covid-19', 'pandemic', '', 'shortage', 'intravenous', 'sedative', 'analgesic', 'agent', 'usually', 'employ', 'sedate', 'critically', 'ill', 'patient', 'mechanical', 'ventilation', 'lead', 'institution', 'consider', 'low', 'potent', 'volatile', 'inhalation', 'anesthetic', 'agent', '', 'isoflurane', 'sevoflurane', '', '', '13', '', '', 'compared', 'critically', 'ill', 'patient', 'require', 'mechanical', 'ventilation', '', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'due', 'covid-19', 'higher', 'sedation', 'requirement', 'due', 'younger', 'age', '', 'higher', 'respiratory', 'drive', '', 'particularly', 'intense', 'inflammatory', 'response', '', '1415', '', '', 'although', 'recommend', 'routine', 'administration', 'inhalation', 'anesthetic', 'agent', 'critically', 'ill', 'patient', 'prolong', 'period', 'due', 'scant', 'safety', 'data', 'set', '', 'well', 'disadvantage', '', 'advantages', 'disadvantage', '', '', '', 'ready', 'availability', 'agent', 'advantage', 'anesthesia', 'machine', 'provide', 'mechanical', 'ventilation', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'sedation', 'analgesia', '', '', '', 'american', 'society', 'anesthesiologists', '', 'asa', '', 'anesthesia', 'patient', 'safety', 'foundation', '', 'apsf', '', 'develop', 'guideline', 'emergency', '', 'refer', 'apsfasa', 'guidance', 'volatile', 'anesthetic', 'sedation', 'icu', 'patients', '', '', '16', '', 'intravenous', 'sedative-analgesic', 'regimen', 'usually', 'employ', 'sedate', 'critically', 'ill', 'patient', 'mechanical', 'ventilation', 'discuss', 'separate', 'topic', '', '', '', '', 'sedative-analgesic', 'medication', 'critically', 'ill', 'adult', '', 'selection', '', 'initiation', '', 'maintenance', '', 'withdrawal', '', '', '', '', '', '', 'sedative-analgesic', 'medication', 'critically', 'ill', 'adult', '', 'properties', '', 'dosage', 'regimen', '', 'adverse', 'effect', '', '', '', '', '', '', 'pain', 'control', 'critically', 'ill', 'adult', 'patient', '', '', '', 'dosing', 'achieve', 'sedation', '', 'administration', 'low', 'either', 'sevoflurane', '', 'eg', '', '05', '14', 'percent', '', 'isoflurane', '', 'eg', '', '02', '07', 'percent', '', 'long-term', 'sedation', 'reasonable', 'volatile', 'inhalation', 'anesthetic', 'agent', 'become', 'necessaryfactors', 'influence', 'dose', 'include', 'whether', 'target', 'level', 'sedation', 'achieve', 'satisfactory', 'patient', 'comfort', '', 'presence', 'ventilator', 'dyssynchrony', 'necessitate', 'deepen', 'anestheticsedation', 'level', '', 'conversely', '', 'hypotension', 'present', '', 'lighten', 'anestheticsedation', 'level', 'necessary', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'clinical', 'effect', '', '', '', 'decision', 'allow', 'patient', 'awaken', '', 'anesthetic', 'vaporizer', 'turn', '', 'fresh', 'gas', 'flow', '', 'fgf', '', 'increase', '', 'washout', 'anesthetic', 'agent', 'rapid', 'predictable', '', 'patient', 'typically', 'able', 'respond', 'command', 'assess', 'extubation', 'within', '10', '15', 'minute', '', '', '', 'emergence', 'general', 'anesthesia', '', '', 'section', 'inhalation', 'agent', '', '', '', 'monitoring', 'sedation', 'inhalation', 'anesthetic', '', 'addition', 'suggest', 'monitor', 'note', 'anesthesia', 'machine', 'long-term', 'ventilation', '', 'monitoring', 'long-term', 'ventilation', '', '', '', 'specialize', 'monitor', 'require', 'constant', 'presence', 'anesthesia', 'provider', 'necessary', 'administration', 'inhalation', 'anesthetic', 'agentspatient', 'monitor', 'sedationcontinuously', 'monitor', 'parameter', 'include', '', 'end-tidal', 'anesthetic', 'concentration', '', 'titration', 'anesthetic', 'dose', 'minimal', 'effective', 'end-tidal', 'concentration', '', 'low-level', 'high-level', 'alarm', 'anesthetic', 'gas', 'monitor', 'enabledexhaled', 'end-tidal', 'carbon', 'dioxide', '', 'etco2', '', 'monitor', 'possibility', 'malignant', 'hyperthermia', '', 'severely', 'acutely', 'increase', 'etco2', '', '', 'help', 'manage', 'ventilation', '', '', 'monitoring', 'long-term', 'ventilation', '', '', '', 'temperature', '', 'since', 'potent', 'inhalation', 'anesthetic', 'lower', 'core', 'temperature', '', '', 'perioperative', 'temperature', 'management', '', '', 'section', 'anesthetic', 'effect', 'thermoregulation', '', '', '', 'monitor', 'possibility', 'malignant', 'hyperthermia', '', 'acutely', 'increase', 'temperature', '', '102f', '', '389c', '', 'monitor', 'parameter', 'include', '', 'hemodynamic', 'monitor', 'per', 'usual', 'standard', 'care', 'individual', 'critically', 'ill', 'patient', '', 'useful', 'evaluate', 'cardiovascular', 'response', 'inhalation', 'anesthetic', 'agent', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'hemodynamic', 'monitor', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'cardiovascular', 'effect', '', '', '', 'serum', 'creatinine', 'liver', 'function', 'test', 'obtain', 'interval', 'daily', '', 'consultation', 'critical', 'care', 'team', '', '', 'check', 'renal', 'hepatic', 'dysfunction', 'long-term', 'administration', 'volatile', 'anesthetic', 'agentequipment', 'monitor', 'sedation', '', 'intermittent', 'inspection', 'maintenance', 'anesthetic', 'administration', 'include', '', 'fill', 'level', 'anesthetic', 'vaporizer', 'check', 'every', 'hour', 'since', 'rapid', 'utilization', 'volatile', 'inhalation', 'anesthetic', 'agent', 'occur', 'due', 'high', 'fgf', '', 'refill', 'anesthetic', 'level', '', '20', 'percent', 'fullliquid', 'anesthetic', 'estimate', '', 'one', 'ml', 'liquid', 'volatile', 'anesthetic', 'agent', 'yield', 'approximately', '200', 'ml', 'gas', 'anesthetic', '', 'specific', 'value', '195', 'ml', 'isoflurane', '184', 'ml', 'sevoflurane', '', '', 'thus', '', '10', 'lmin', 'fgf', '', 'liquid', 'volatile', 'anesthetic', 'consumption', 'approximately', '30', 'mlhour', '1', 'percent', 'inhale', 'concentration', 'deliver', '', 'vaporizer', 'hold', 'approximately', '200', 'ml', 'liquid', '', 'refill', 'multiple', 'time', 'day', 'lower', 'note', 'isoflurane', 'sevoflurane', 'patient', 'sedation', 'mechanical', 'ventilation', '', '', 'dosing', 'achieve', 'sedation', '', '', '', 'one', 'way', 'reduce', 'consumption', 'volatile', 'anesthetic', 'agent', 'reduce', 'fgf', '', 'another', 'way', 'agent', 'consumption', 'anesthetic', 'reflector', 'device', 'anaconda', 'mirus', '', '17-22', '', '', 'device', 'design', 'administration', 'inhalation', 'anesthetic', 'agent', 'traditional', 'intensive', 'care', 'unit', '', 'icu', '', 'ventilator', '', 'approve', 'united', 'states', '', 'device', 'place', 'y-piece', 'patient', '', 'vaporize', 'small', 'amount', 'anesthetic', 'liquid', '', 'absorb', 'exhale', 'anesthetic', '', 're-inhaled', 'next', 'breath', '', 'much', 'like', 'heat', 'moisture', 'exchanger', '', 'hme', '', 'absorb', 'conserve', 'humidity', '', '', 'notably', '', 'room', 'contamination', 'still', 'occur', 'device', 'unless', 'scavenge', 'system', 'employ', '', '20-22', '', '', 'proper', 'function', 'scavenge', 'system', 'confirm', 'administration', 'inhalation', 'anesthetic', 'initiate', '', 'every', '24', 'hour', 'major', 'change', 'rate', 'fgf', '', 'anesthetic', 'vapor', 'consume', 'rapidly', 'scavenger', 'system', 'require', 'high', 'vacuum', 'flow', 'high', 'fgf', '', 'advantages', 'disadvantage', '', 'advantages', 'disadvantage', 'specific', 'agent', '', 'sevoflurane', 'versus', 'isoflurane', '', 'discuss', 'separately', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'sevoflurane', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'isoflurane', '', '', '', 'potential', 'advantage', 'disadvantage', 'long-term', 'sevoflurane', 'isoflurane', 'sedation', 'mechanically', 'ventilate', 'patient', 'covid-19', 'induce', 'respiratory', 'failure', 'include', '', 'advantageseffective', 'sedative', 'effect', '', 'rapid', 'onset', 'offset', 'allow', 'titratability', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'sedation', 'anesthesia', '', '', '', 'minimal', 'metabolism', 'likely', 'minimal', 'organ', 'toxicity', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'properties', 'delivery', '', '', 'section', 'metabolism', '', '', '', 'ready', 'availability', 'shortage', 'intravenous', 'sedative', 'analgesic', 'agent', 'usually', 'employ', 'sedation', 'mechanical', 'ventilation', '', '13', '', '', 'reports', 'unusually', 'high', 'sedation', 'requirement', 'covid-19', 'patient', 'contribute', 'shortage', 'multiple', 'commonly', 'intravenous', 'agent', '', '1314', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'sedation', 'analgesia', '', '', '', 'potentially', 'advantageous', 'respiratory', 'effects-bronchodilation', '', 'attenuation', 'bronchospasm', 'decrease', 'airway', 'responsiveness', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'respiratory', 'effect', '', '', '', '-pulmonary', 'anti-inflammatory', 'effect', '', 'eg', '', 'reduction', 'pro-inflammatory', 'cytokine', 'release', '', 'minimize', 'extent', 'lung', 'injury', '', '23-27', '', '', '', '', 'one', 'lung', 'ventilation', '', 'general', 'principle', '', '', 'section', 'intravenous', 'versus', 'inhalation', 'anesthetic', '', '', '', 'dose-dependent', 'muscle', 'relaxation', 'mechanical', 'ventilation', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'skeletal', 'smooth', 'muscle', 'relaxation', '', '', '', 'disadvantagesscant', 'safety', 'data', 'regard', 'inhalation', 'anesthetic', 'agent', 'prolong', 'period', 'critically', 'ill', 'patient', '', 'however', '', 'long-term', 'sedation', 'sevoflurane', 'isoflurane', 'employ', 'nation', 'sedation', 'patient', 'adult', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'critical', 'illness', '', 'without', 'evidence', 'renal', 'hepatic', 'injury', '', '26-30', '', 'rapid', 'utilization', 'volatile', 'inhalation', 'anesthetic', 'agent', 'occur', 'due', 'high', 'fgf', '', 'thus', '', 'hourly', 'inspection', 'anesthetic', 'vaporizer', 'fill', 'level', 'analysis', 'end-tidal', 'anesthetic', 'concentration', 'particularly', 'important', '', '', 'monitoring', 'sedation', 'inhalation', 'anesthetic', '', '', '', 'potential', 'inadequate', 'sedation', 'due', 'vaporizer', 'dry', '', 'particularly', 'patient', 'receive', 'neuromuscular', 'block', 'agent', '', 'thus', '', 'patient', 'anesthesia', 'machine', 'anesthetic', 'vaporizer', 'must', 'carefully', 'monitor', '', 'potential', 'difficulty', 'connection', 'anesthesia', 'machine', 'scavenger', 'system', 'compatible', 'waste', 'anesthesia', 'gas', 'disposal', 'outlet', 'set', 'outside', 'operate', 'room', '', '', '', '', 'differences', 'anesthesia', 'machine', 'ventilator', 'icu', 'ventilator', '', '', '', 'familiarity', 'among', 'non-anesthesia', 'personnel', 'care', 'critically', 'ill', 'patient', 'ards', '', 'eg', '', 'intensivists', '', 'nurse', '', 'respiratory', 'therapist', '', 'regard', 'anesthesia', 'machine', 'administer', 'volatile', 'inhalation', 'anesthetic', 'agent', '', 'dose', 'agent', '', 'potential', 'pitfall', 'occur', 'administration', '', 'refer', 'apsfasa', 'guidance', 'volatile', 'anesthetic', 'sedation', 'icu', 'patients', '', '', '16', '', '', 'constant', 'presence', 'anesthesia', 'personnel', 'recommend', 'asa', 'apsf', '', 'refer', 'apsfasa', 'guidance', 'volatile', 'anesthetic', 'sedation', 'icu', 'patients', '', '', '16', '', '', 'potentially', 'undesirable', 'systemic', 'effect', 'potent', 'volatile', 'anesthetic', 'agent', 'critically', 'ill', 'patient', '', 'include', '', '-cardiovascular', 'effect', '', 'eg', '', 'myocardial', 'depression', 'vasodilatory', 'property', 'result', 'dose-dependent', 'reduction', 'blood', 'pressure', 'cardiac', 'output', '', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'cardiovascular', 'effect', '', '', '', '-adverse', 'respiratory', 'effect', 'include', 'airway', 'irritation', '', 'particularly', 'pungent', 'agent', 'isoflurane', '', 'well', 'respiratory', 'depression', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'respiratory', 'effect', '', '', '', '-cerebral', 'effect', '', 'eg', '', 'dose-dependent', 'cerebral', 'vasodilation', '', 'blunt', 'cerebral', 'autoregulation', 'uncouple', 'cerebral', 'blood', 'flow', '', 'cbf', '', 'metabolism', '', 'thereby', 'increase', 'cbf', 'intracranial', 'pressure', '', 'icp', '', '', 'thus', '', 'patient', 'suspect', 'elevation', 'icp', 'candidate', 'sedation', 'inhalation', 'anesthetic', 'agent', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'effects', 'cerebral', 'physiology', '', '', '', 'although', 'rare', '', 'potential', 'potent', 'inhalation', 'anesthetic', 'agent', 'cause', 'malignant', 'hyperthermia', '', '', '', 'inhalation', 'anesthetic', 'agent', '', 'clinical', 'effect', 'us', '', '', 'section', 'malignant', 'hyperthermia', '', 'volatile', 'inhalation', 'agent', '', '', '', '', 'collaboration', 'critical', 'care', 'consultants', '', 'collaboration', 'coordination', 'critical', 'care', 'clinician', 'essential', 'care', 'covid-19', 'patient', 'regard', 'initial', 'decision', 'anesthesia', 'machine', '', 'management', 'long-term', 'ventilation', 'comorbidities', 'critically', 'ill', 'covid-19', 'patient', '', 'eg', '', 'cardiovascular', 'renal', 'complication', '', 'coinfection', 'sepsis', '', '', '31-35', '', '', 'issue', 'discuss', 'detail', 'separate', 'topic', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'summary', 'recommendationscontamination', 'anesthesia', 'machine', '', 'breathe', 'system', 'ventilator', '', 'connect', 'gas', 'analyzer', 'likely', 'intensive', 'care', 'ventilator', 'compare', 'surgical', 'procedure', 'patient', 'novel', 'coronavirus', 'disease', '2019', '', 'covid-19', 'ncov', '', 'infection', 'duration', 'extent', 'machine', 'exposure', '', 'however', '', 'two', 'filter', '', 'eg', '', 'heat', 'moisture', 'exchange', 'filter', '', 'hmef', '', 'contain', 'electrostatic', 'filter', 'place', 'airway', 'plus', 'mechanical', 'pleat', 'filter', 'place', 'expiratory', 'limb', 'breathe', 'circuit', '', '', 'combine', 'viral', 'filtration', 'efficiency', '', 'vfe', '', 'high', '', 'render', 'contamination', 'anesthesia', 'machine', 'unlikely', '', 'multiple', 'day', '', 'fresh', 'filter', 'day', '', '', '', 'prevention', 'anesthesia', 'machine', 'contamination', '', '', '', 'locations', 'select', 'anesthesia', 'machine', 'ventilate', 'covid-19', 'patient', 'institution-dependent', 'depend', 'layout', 'select', 'hospital', 'area', '', '', '', 'location', 'room', 'negative', 'pressure', 'capability', '', 'availability', 'source', 'high-pressure', 'oxygen', 'medical', 'air', '', 'availability', 'compatible', 'connection', 'scavenger', 'system', 'waste', 'anesthesia', 'gas', 'disposal', 'outlet', 'inhalation', 'anesthetic', 'agent', '', 'availability', 'anesthesia', 'personnel', 'manage', 'anesthesia', 'machine', '', '', 'locations', 'anesthesia', 'machine', '', '', '', 'american', 'society', 'anesthesiologists', '', 'asa', '', 'anesthesia', 'patient', 'safety', 'foundation', '', 'apsf', '', 'develop', 'guidance', 'repurposing', 'anesthesia', 'machine', 'longer-term', 'ventilation', '', 'refer', 'apsfasa', 'guidance', 'purposing', 'anesthesia', 'machines', 'icu', 'ventilators', 'quick', 'reference', '', 'setup', 'monitoring', 'instructions', '', 'anesthesia', 'machine', 'icu', 'ventilator', '', '', 'although', 'newer', 'anesthesia', 'ventilator', 'incorporate', 'multiple', 'control', 'assist', 'mode', 'ventilation', 'nearly', 'identical', 'ventilator', 'intensive', 'care', 'unit', '', 'icu', '', '', 'several', 'important', 'technical', 'issue', 'unique', 'anesthesia', 'machine', '', 'differences', 'anesthesia', 'machine', 'ventilator', 'icu', 'ventilator', '', '', '', 'age', 'specific', 'capability', 'individual', 'anesthesia', 'machine', '', 'newer', 'anesthesia', 'machine', 'flexible', 'capability', 'deliver', 'mode', 'ventilation', '', 'adjust', 'fresh', 'gas', 'flow', '', 'fgf', '', 'prevent', 'condense', 'water', 'accumulation', 'breathe', 'circuitthe', 'long-term', 'humification', 'warm', 'inspire', 'gasesthe', 'two', 'high-quality', 'viral', 'filter', '', 'one', 'airway', 'expiratory', 'limb', 'breathe', 'circuit', '', 'figure', '1', '', '', 'understand', 'set', 'performance', 'anesthesia', 'machine', 'ventilator', 'different', 'icu', 'ventilatorspotential', 'modify', 'default', 'ventilator', 'parameter', 'alarm', 'settingsthe', 'potential', 'carbon', 'dioxide', '', 'co2', '', 'absorbent', 'expirethe', 'potential', 'fraction', 'inspire', 'oxygen', '', 'fio2', '', 'concentration', 'breathe', 'circuit', 'lower', 'set', 'oxygen', 'gas', 'concentration', 'anesthesia', 'machine', '', 'fgo2', '', 'prevent', 'accidental', 'administration', 'inhalation', 'anesthetic', 'agent', '', 'inhalation', 'anesthetic', 'administer', 'achieve', 'patient', 'sedationpotential', 'adjust', 'scavenger', 'system', 'prevent', 'backpressure', 'breathe', 'system', 'anesthesia', 'machine', 'outside', 'operate', 'room', '', '', 'periodic', 'performance', 'anesthesia', 'machine', 'self-test', '', 'ie', '', 'power-up', 'test', '', 'approximately', 'every', '24', '72', 'hoursthe', 'periodically', 'check', 'breathe', 'circuit', 'possible', 'kink', 'compressionthe', 'minimize', 'potential', 'error', 'setup', 'anesthesia', 'machine', '', 'initiation', 'control', 'ventilation', '', 'respiratory', 'monitor', 'location', 'outside', '', 'ideally', 'deploy', 'multiple', 'machine', 'model', 'within', 'one', 'hospital', 'unitan', 'anesthesia', 'professional', 'available', 'start', 'monitor', 'ventilation', 'overall', 'anesthesia', 'machine', 'function', '', 'monitoring', 'long-term', 'ventilation', '', '', '', 'continuously', 'intermittently', 'monitor', 'patient', 'parameter', '', 'preset', 'alarm', '', 'check', 'record', 'hour', 'include', '', 'patient', 'monitor', '', '', '', '-inspired', 'oxygen', 'concentration', '-inspired', 'expire', 'co2-inspiratory', 'pressure-tidal', 'volume', 'respiratory', 'rate-low', 'oxygen', 'pressure', 'alarm-check', 'pplat', 'least', 'every', 'four', 'hour', '', 'change', 'positive', 'end-expiratory', 'pressure', '', 'peep', '', 'tidal', 'volume-check', 'flow', 'read', 'approximately', 'every', 'four', 'hour', '-confirm', 'leak', 'around', 'endotracheal', 'tube', 'cuff', 'every', 'hour', 'intermittently', 'machine', 'monitor', 'include', 'inspection', '', 'machine', 'maintenance', 'monitor', '', '', '', '-breathing', 'circuit', 'hose', 'water', 'trap', 'excessive', 'condense', 'water', 'every', 'hour-breathing', 'circuit', 'hose', 'possible', 'kink', 'compression', 'every', 'hour-airway', 'expiratory', 'limb', 'breathe', 'circuit', 'filter', 'every', 'hour', 'excessive', 'humidity', 'secretions-co2', 'absorbent', 'color', 'inspire', 'co2', 'value', 'every', 'hour', '-documentation', 'anesthesia', 'machine', 'startup', 'test', 'performance', 'every', '24', '72', 'hour', 'although', 'intravenous', 'sedative-analgesic', 'regimen', 'usually', 'employ', 'sedate', 'critically', 'ill', 'patient', 'mechanical', 'ventilation', '', 'institution', 'shortage', 'intravenous', 'agent', 'consider', 'low', 'potent', 'volatile', 'inhalation', 'anesthetic', 'agent', 'long-term', 'sedation', '', 'ie', '', 'sevoflurane', '', '05', '14', '', '', 'isoflurane', '', '02', '07', '', '', '', 'refer', 'apsfasa', 'guidance', 'volatile', 'anesthetic', 'sedation', 'icu', 'patients', '', '', '', 'inhalation', 'anesthetic', 'sedation', '', 'dosing', 'achieve', 'sedation', '', '', '', 'advantages', 'disadvantage', 'inhalation', 'anesthetic', 'agent', 'set', 'include', '', 'advantages', 'disadvantage', '', '', '', 'advantages', '-effective', 'sedative', 'effect', '', 'rapid', 'onset', 'offset', 'allow', 'titratability-minimal', 'metabolism', 'likely', 'minimal', 'organ', 'toxicity-readily', 'available-advantageous', 'respiratory', 'effect', 'include', 'bronchodilation', 'possible', 'pulmonary', 'anti-inflammatory', 'effect', '-dose-dependent', 'muscle', 'relaxationdisadvantages', '-scant', 'safety', 'data', 'regard', 'inhalation', 'anesthetic', 'agent', 'prolong', 'periods-lack', 'familiarity', 'among', 'non-anesthesia', 'personnel', 'care', 'critically', 'ill', 'patient', '-need', 'constant', 'presence', 'anesthesia', 'personnel', '-rapid', 'utilization', 'volatile', 'inhalation', 'anesthetic', 'agent', 'due', 'high', 'fgf', '', 'potential', 'inadequate', 'sedation-potential', 'difficulty', 'connection', 'anesthesia', 'machine', 'scavenger', 'system', 'compatible', 'waste', 'anesthesia', 'gas', 'disposal', 'outlets-potentially', 'undesirable', 'cardiovascular', '', 'respiratory', '', 'cerebral', 'effect', 'potent', 'volatile', 'anesthetic', 'agent', 'critically', 'ill', 'patients-although', 'rare', '', 'potential', 'malignant', 'hyperthermia', 'specialized', 'additional', 'monitor', 'necessary', 'inhalation', 'anesthetic', 'administer', 'long-term', 'sedation', '', 'require', 'constant', 'presence', 'anesthesia', 'provider', 'specialize', 'monitor', 'include', '', 'monitoring', 'sedation', 'inhalation', 'anesthetic', '', '', '', 'patient', 'parameter', '', 'patient', 'monitor', 'sedation', '', '', '', '-end-tidal', 'anesthetic', 'concentration', '', 'low', 'high', 'alarms-exhaled', 'end-tidal', 'carbon', 'dioxide', '', 'etco2', '', '-temperature-hemodynamic', 'monitor', 'per', 'usual', 'standard', 'individual', 'critically', 'ill', 'patient-serum', 'creatinine', 'liver', 'function', 'test', 'appropriate', 'intervalsequipment', 'monitor', '', 'equipment', 'monitor', 'sedation', '', '', '', '-the', 'fill', 'level', 'anesthetic', 'vaporizer', 'check', 'every', 'hour', '-proper', 'function', 'scavenge', 'system', 'confirm', 'initially', '', 'every', '24', 'hour', 'major', 'change', 'fgf', 'ratecollaboration', 'coordination', 'critical', 'care', 'clinician', 'essential', 'regard', 'initial', 'decision', 'long-term', 'ventilation', 'anesthesia', 'ventilator', '', 'management', 'ventilation', 'comorbidities', 'critically', 'ill', 'patient', '', 'eg', '', 'cardiovascular', 'renal', 'complication', '', 'coinfection', 'sepsis', '', '', '', 'collaboration', 'critical', 'care', 'consultant', '', '', '']",6198,"{'': 1354, 'anesthesia': 147, 'machine': 118, 'anesthetic': 93, 'patient': 80, 'ventilator': 78, 'ventilation': 66, 'inhalation': 60, 'agent': 59, 'covid-19': 46, 'gas': 43, 'icu': 42, 'care': 41, 'monitor': 41, 'oxygen': 41, 'filter': 40, 'breathe': 39, 'sedation': 37, 'flow': 34, 'airway': 32}","{'infection': 9, 'safety': 8}",17,0.296
ID:127926,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability']","['INTRODUCTION — A novel coronavirus identify late 2019 rapidly reach pandemic proportion .', 'The World Health Organization designate disease cause virus ( severe acute respiratory syndrome coronavirus 2 [ SARS-CoV-2 ] ) coronavirus disease 2019 ( COVID-19 ) .Individuals COVID-19 may number coagulation abnormality ( direction underlie hypercoagulable state ) , raise question appropriate evaluation intervention prevent treat thrombosis .', ""Interim guidance publish International Society Thrombosis Haemostasis ( ISTH ) , frequently ask question post website American Society Hematology ( ASH ) American College Cardiology ( ACC ) .This topic review evaluation management coagulation abnormality individual COVID-19.Separate topic discus follow : ●General management – ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ●Critical care – ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ●Extracorporeal membrane oxygenation ( ECMO ) – ( See `` Extracorporeal membrane oxygenation ( ECMO ) adult '' ."", "") ●Pregnancy – ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ●Anesthesia – ( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", "") PATHOGENESIS — The pathogenesis hypercoagulability COVID-19 incompletely understood.Virchow 's triad — Hypercoagulability think term Virchow 's triad ( see `` Overview cause venous thrombosis '' , section 'Virchow 's triad ' ) ."", 'All three major contribution clot formation apply severe COVID-19 infection : ●Endothelial injury – There evidence direct invasion endothelial cell severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) virus , potentially lead cell injury .', 'Other source endothelial injury include intravascular catheter mediator acute systemic inflammatory response cytokine ( eg , interleukin [ IL ] -6 ) acute phase reactant [ 1 ] .', 'The contribution complement-mediated endothelial injury suggest [ 2 ] .', ""( See `` The endothelium : A primer '' `` Complications central venous catheter prevention '' `` Acute phase reactant '' ."", ') ●Stasis – Immobilization cause stasis blood flow hospitalize critically ill patient , regardless whether COVID-19.●Hypercoagulable state – A number change circulate prothrombotic factor report propose patient severe COVID-19 [ 3,4 ] : •Elevated factor VIII •Elevated fibrinogen•Circulating prothrombotic microparticles•Neutrophil extracellular trap ( NETs ) Very elevate level D-dimer observe correlate illness severity ; D-dimer degradation product cross-link fibrin indicate augment thrombin generation fibrin dissolution plasmin .', 'However , high D-dimer level common acutely ill individual number infectious inflammatory disease .', 'Likewise , antiphospholipid antibody , prolong activate partial thromboplastin time ( aPTT ) , common viral infection , often transient always imply increase risk thrombosis .', ""( See 'Coagulation abnormality ' 'Clinical feature ' . )"", ""Coagulation abnormality — The predominant coagulation abnormality patient COVID-19 suggest hypercoagulable state consistent uncontrolled clinical observation increase risk venous thromboembolism ( see 'VTE ' ) ."", 'This state term thromboinflammation COVID-19-associated coagulopathy ( CAC ) expert [ 5,6 ] .', 'It appear distinct disseminate intravascular coagulation ( DIC ) , though DIC report severely affect patients.Laboratory find characterize series 24 select patient severe COVID-19 pneumonia ( intubate ) evaluate along standard coagulation test assay include von Willebrand factor ( VWF ) thromboelastography ( TEG ) [ 3 ] : ●Coagulation testing•Prothrombin time ( PT ) aPTT normal slightly prolonged•Platelet count normal increase ( mean , 348,000/microL ) •Fibrinogen increase ( mean , 680 mg/dL ; range 234 1344 ) •D-dimer increase ( mean , 4877 ng/mL ; range , 1197 16,954 ) ●Other assays•Factor VIII activity increase ( mean , 297 units/dL ) •VWF antigen greatly increase ( mean , 529 ; range 210 863 ) , consistent endothelial injury perturbation•Minor change natural anticoagulants-Small decrease antithrombin free protein S-Small increase protein C ●TEG findings•Reaction time ( R ) shorten , consistent increase early thrombin burst , 50 percent patients•Clot formation time ( K ) shorten , consistent increase fibrin generation , 83 percent•Maximum amplitude ( MA ) increase , consistent greater clot strength , 83 percent•Clot lysis 30 minute ( LY30 ) reduce , consistent reduce fibrinolysis , 100 percentTesting study perform arterial blood patient arterial catheter place , venous blood use .', 'Heparinase include since patient receive low molecular weight ( LMW ) heparin .', 'Other study report similar find consistent hypercoagulable state , include high D-dimer , VWF antigen activity , factor VIII activity [ 4,7 ] .', 'One study suggest patient COVID-19 higher platelet count patient coronavirus infection [ 8 ] .', 'Early case series , include series 183 consecutive patient Wuhan , China , suggest thrombocytopenia prolongation PT aPTT mark [ 9-12 ] .', 'It clear result differ somewhat later find le severe PT aPTT prolongation .', ""One possible explanation patient sicker , perhaps earlier pandemic disease recognize quickly , result delay patient presentation and/or treatment.Another explanation isolate prolong aPTT presence lupus anticoagulant ( LA ) ( see `` Clinical use coagulation test '' , section 'Causes prolong aPTT ' ) ."", 'Two study find high rate LA patient prolong aPTT ( 50 57 test individual [ 88 percent ] 31 34 test individual [ 91 percent ] ) [ 13,14 ] .', 'The presence LA may lead artifactual prolongation aPTT reflect increase bleed risk ; patient LA receive anticoagulation indicate .', ""( See 'Management ' . )"", 'Some marker derange coagulation ( eg , D-dimer ) appear correlate illness severity .', 'D-dimer often increase , sometimes markedly , individual overt DIC intensive care unit ( ICU ) .', 'Principles TEG interpretation TEG trace illustrate figure ( figure 1 ) discuss detail separately .', ""( See `` Platelet function test '' , section 'Thromboelastography ( TEG ) ROTEM ' `` Acute coagulopathy associate trauma '' , section 'Thromboelastography ' ."", ') Distinction DIC — The hypercoagulable state associate COVID-19 refer disseminate intravascular coagulation ( DIC ) -like state , especially many affect individual acutely ill meet criterion probable DIC score system publish International Society Thrombosis Haemostasis ( ISTH ) 2009 [ 15 ] .', 'However , major clinical find COVID-19 thrombosis , whereas major find acute decompensated DIC bleeding.Likewise , COVID-19 similar laboratory find DIC , include mark increase D-dimer case , mild thrombocytopenia .', 'However , coagulation parameter COVID-19 distinct DIC .', 'In COVID-19 , typical find include high fibrinogen high factor VIII activity , suggest major consumption coagulation factor occur [ 3 ] .', ""( See 'Coagulation abnormality ' ."", ') In contrast , acute decompensated DIC associate low fibrinogen due consumption clot factor .', 'In one largest series report thromboembolic event , none patient develop overt DIC [ 16 ] .Typically , bleed predominate acute decompensated DIC thrombosis predominate chronic compensate DIC , although significant overlap .', 'Thus , hypercoagulable state patient COVID-19 similar compensate DIC acute DIC .', 'However , COVID-19 , platelet count aPTT typically normal .', ""( See `` Disseminated intravascular coagulation ( DIC ) adult : Evaluation management '' , section 'Pathogenesis ' ."", ') This ISTH score system base laboratory find intend use patient underlie condition know associate DIC [ 15 ] .', 'COVID-19 would qualify base severe infection .', ""Points give thrombocytopenia ( 1 point platelet count 50,000 100,000/microL ; 2 point < 50,000/microL ) , prolong PT ( 1 point 3 6 second prolongation ; 2 point 6 second ) , low fibrinogen ( 1 point < 100 mg/dL ) , increase D-dimer ( 2 point moderate increase ; 3 point `` strong '' increase ) ."", 'A score 5 point suggest DIC probable .', 'Despite , diagnosis DIC make clinically ; gold standard single test combination test pathognomonic .', 'Compared expert opinion , ISTH score system report sensitivity 91 percent specificity 97 percent [ 15 ] .', ""( See 'Coagulation abnormality ' ."", ') Regardless whether difference DIC similarity emphasize , many basic principle DIC management apply , include importance treat underlie condition , importance base intervention clinical picture rather laboratory test alone , need provide anticoagulation thrombosis appropriate hemostatic therapy bleed .', ""( See `` Disseminated intravascular coagulation ( DIC ) adult : Evaluation management '' , section 'Treatment ' ."", ') CLINICAL FEATURESVTE — Venous thromboembolism ( VTE ) , include extensive deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) , common acutely ill patient COVID-19 , see one-third patient intensive care unit ( ICU ) , even prophylactic anticoagulation use .', 'Two autopsy study emphasize contribution hypercoagulability associate inflammation patient die COVID-19 : ●Post-mortem examination 21 individual COVID-19 find prominent PE four , microthrombi alveolar capillary 5 11 ( 45 percent ) available histology [ 17 ] .', 'Three evidence thrombotic microangiopathy fibrin thrombus glomerular capillary .', 'The average age 76 year , high body mass index ( BMI ; mean , 31 kg/m2 ; normal 18.5 < 25 ) .', 'Information use anticoagulation prior death available 11 , 11 receive form anticoagulation .', 'Underlying cardiovascular disease , hypertension , diabetes mellitus common.●Post-mortem examination 12 consecutive individual COVID-19 ( 8 male ; 10 hospitalize ) reveal DVT 7 12 ( 58 percent ) [ 18 ] .', 'All case DVT bilateral leg involvement , none suspect death .', 'Of 12 lung histology available , 5 ( 42 percent ) evidence thrombosis .', 'PE cause death four .', 'In D-dimer test , extremely high value ( two > 20,000 ng/mL one > 100,000 ng/mL ; normal value < 500 ng/mL [ < 500 mcg/L ] ) .', 'Use anticoagulation prior death report 4 12 .', 'The mean BMI 28.7 kg/m2 ; three patient normal BMI , cancer , ulcerative colitis , and/or chronic kidney disease .', 'Both study note preponderance male high prevalence obesity chronic medical comorbidities , especially cardiovascular disease , hypertension , diabetes mellitus .', 'ICU — Case series intensive care unit ( ICU ) patient report high rate VTE ( range , 20 43 percent ) , mostly pulmonary embolism ( PE ) , often despite prophylactic-dose anticoagulation : ●A series 184 sequential patient severe COVID-19 ICU report PE 25 ( 14 percent ) , deep vein thrombosis ( DVT ) 1 , catheter-associated thrombosis 2 [ 16 ] .', 'The cumulative incidence VTE ( base different duration follow-up ) calculate 27 percent .', 'All receive least standard dose thromboprophylaxis .', 'The group whole ill , 13 percent require renal replacement therapy 13 percent mortality .', 'Three-fourths patient male , several active cancer ( independent VTE risk factor ) .', '●A series 150 ICU patient report VTE 64 ( 43 percent , mostly PE ) clot extracorporeal circuit 28 29 receive continuous renal replacement therapy 2 12 undergo extracorporeal membrane oxygenation ( ECMO ) [ 7 ] .', 'All patient receive thromboprophylaxis ( mostly low molecular weight [ LMW ] heparin ) , 70 percent prophylactic dose 30 percent therapeutic dose .', 'This study also compare subgroup 77 patient COVID-19-associated acute respiratory distress syndrome ( ARDS ) match cohort 145 patient non-COVID-19-ARDS find rate thrombotic complication ( mostly PE ) higher COVID-19 patient ( 12 versus 2 percent ) .●A series 107 ICU patient report PE 22 ( 21 percent ; cumulative incidence 15 day , 20 percent ) [ 19 ] .', 'Of 22 patient PE , 20 receive prophylactic anticoagulation 2 receive therapeutic-dose anticoagulation ( prior VTE atrial fibrillation ) .', 'By comparison , incidence PE two match cohort ( one time interval previous year one concurrent patient influenza rather COVID-19 ) 6 8 percent , respectively.●A series include 74 ICU patient report VTE 29 ( 39 percent ) , cumulative incidence 25 percent 7 day 48 percent 14 day [ 20 ] .', 'All individual receive anticoagulation , prophylactic level .', 'None patient receive therapeutic level anticoagulation admission develop VTE.●An earlier series 81 patient severe COVID-19 pneumonia report VTE 20 ( 25 percent ) [ 21 ] .●A study perform screen leg ultrasound 26 individual COVID-19 ICU receive either prophylactic-dose therapeutic-dose anticoagulation find VTE 18 ( 69 percent ) , include bilateral clot 10 ( 38 percent ) [ 22 ] .', 'Some individual additional VTE risk factor include cancer , recent surgery , high BMI , prior VTE ; 7 ( 27 percent ) receive anticoagulation prior admission.VTE risk range expert would suggest aggressive thromboprophylaxis dose anticoagulant even empiric therapeutic-dose anticoagulation VTE prevention .', 'Some study note higher average body mass index affect individual , suggest obesity , along risk factor , may warrant consideration decision-making regard intensity anticoagulation .', ""( See 'Possible/uncertain role therapeutic-level anticoagulation critically ill patient ' ."", ') Inpatients ( non-ICU ) — Data limit regard rate VTE inpatient intensive care unit ( ICU ) .', 'The series 39 percent rate VTE ICU patient also include 124 non-ICU patient , , 4 ( 3 percent ) diagnose VTE [ 20 ] .A series Ireland include 50 patient regular medical ward report similar find ICU patient , include high D-dimer fibrinogen normal platelet count clot time [ 23 ] .', 'Outpatients — We aware thrombotic event observe COVID-19 patient admit hospital , data incidence available .', 'Arterial event — There also report arterial thrombosis , include central nervous system ( CNS ) .', 'As example : ●CNS – A single health system identify five case acute ischemic stroke associate COVID-19 two-week period , symptom suggest large-vessel occlusion ; patient 50 year age [ 24 ] .', 'In time period pandemic , approximately 0.7 large vessel stroke per two-week interval individual age 50 .', 'In one series ICU patient discuss , ischemic stroke observe 3 184 ( cumulative incidence , 3.7 percent ) [ 16 ] .', 'In another one series discuss , cerebral ischemia see 3 150 [ 7 ] .●Limbs – A report describe 20 patient COVID-19 develop acute limb ischemia single institution three-month period [ 25 ] .', 'This represent significant increase limb ischemia previous year ( 16 percent , versus 2 percent early 2019 ) .', 'Most male ( 18 20 ) , average age 75 year .', 'Surgical revascularization procedure perform 17 , 12 ( 71 percent ) successful , lower-than-expected success rate .', 'Individuals receive postoperative heparin require reintervention , although benefit postoperative heparin reach statistical significance .', 'Another report describe four patient acute limb ischemia due thrombosis , two young comorbidities ( 53-year-old man develop aorto-iliac thrombosis 37-year-old man develop humeral artery thrombosis ) [ 26 ] .', 'Both receive prophylactic-dose LMW heparin time thrombosis develop high D-dimer ( > 9000 ng/mL ) .', 'Myocardial infarction also report emphasize available series.Microvascular thrombosis — Autopsy study individual die COVID-19 demonstrate microvascular thrombosis lung [ 2,6 ] .', 'The mechanism unclear may involve hypercoagulability , direct endothelial injury , complement activation , process .', 'In absence definitive data regard mechanism therapy , would pursue specialize test thrombotic microangiopathies ( eg , ADAMTS13 activity , complement study ) specialize therapy ( eg , plasma exchange , anti-complement therapy ) outside research study.Bleeding — Bleeding le common clot patient COVID-19 , may occur , especially set anticoagulation .', 'As example , subset 25 ICU patient evaluate abnormal neurologic find , one evidence intracranial hemorrhage well ischemic lesion [ 7 ] .', 'Three patient series also hemorrhagic complication , include two intracerebral bleed associate head trauma one hemorrhagic complication extracorporeal membrane oxygenation ( ECMO ) .', 'Three others series evidence intracerebral ischemia .', ""( See 'Arterial event ' ."", ') EVALUATION — The evaluation patient COVID-19 coagulation abnormality ( suspect document ) challenge due limit data clinical parameter coagulation abnormality act upon concern relate perform diagnostic image procedure acutely ill potentially contagious patient .', 'A general approach follow , although decision may make treat clinician base evaluation patient .', 'This approach consistent guidance International Society Thrombosis Haemostasis ( ISTH ) , American Society Hematology ( ASH ) , American College Cardiology ( ACC ) [ 5,27,28 ] .', ""Routine test ( patient ) ●Inpatients – We ass follow inpatient COVID-19 : •Complete blood count ( CBC ) include platelet count•Coagulation study ( prothrombin time [ PT ] activate partial thromboplastin time [ aPTT ] ) •Fibrinogen•D-dimerRepeat test reasonable daily basis le frequently , depend acuity patient 's illness , initial result , trend value ."", ""Measurement D-dimer per day generally indicated.As note , common laboratory find include ( see 'Coagulation abnormality ' ) : •High D-dimer •High fibrinogen•Normal mildly prolong PT aPTT•Mild thrombocytopenia thrombocytosis , normal platelet countWe intervene abnormal coagulation study absence clinical indication ."", 'However , find may prognostic value may impact decision-making level care and/or investigational therapy direct treat infection .', 'As example , increase D-dimer associate poor prognosis .', ""( See 'Investigational therapy ' ."", ') Atypical find markedly prolong aPTT ( proportion PT ) , low fibrinogen , severe thrombocytopenia suggest another condition may present additional evaluation may indicate .', ""( See 'Role additional test ' ."", ') We routinely test thrombotic thrombocytopenic purpura ( TTP ) , thrombotic microangiopathies , antiphospholipid antibody ( aPL ) .', 'There therapeutic implication transiently positive aPL absence clinical find .', 'Transient aPL positivity often see acute infection .', ""( See `` Diagnosis antiphospholipid syndrome '' , section 'Other condition associate aPL ' ."", ') We routinely perform image screen purpose , evidence indicate practice improve outcome , may unnecessarily expose health care worker additional infectious risk .', 'However , image appropriate individual symptom , discuss .', ""( See 'Role additional test ' ."", ') ●Outpatients – For outpatient , routine coagulation test require .', 'Evaluation abnormal symptom find examination similar inpatient .', ""( See 'Role additional test ' ."", ') Role additional testingDiagnosis DVT PE — Evaluation deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) may challenge symptom PE overlap COVID-19 , image study may feasible case .', 'The threshold evaluation diagnosis DVT PE low give high frequency event presence additional venous thromboembolism ( VTE ) risk factor many individual .', ""( See 'VTE ' . )"", '●DVT – Individuals suspect DVT compression ultrasonography feasible accord standard indication .', ""( See `` Clinical presentation diagnosis nonpregnant adult suspect deep vein thrombosis lower extremity '' ."", ') ●PE – We agree guidance American Society Hematology ( ASH ) regard diagnosis PE , include follow [ 29 ] : •A normal D-dimer sufficient exclude diagnosis PE .', 'An increase D-dimer specific VTE sufficient make diagnosis.•In patient suspect PE due unexplained hypotension , tachycardia , worsen respiratory status , risk factor thrombosis , compute tomography pulmonary angiography ( CTPA ) prefer test confirm exclude diagnosis .', 'Ventilation/perfusion ( V/Q ) scan alternative CTPA perform inconclusive , although V/Q scan may unhelpful individual significant pulmonary involvement COVID-19 .', 'Consultation pulmonary embolism response team ( PERT ) decision-making advise possible .', ""( See `` Clinical presentation , evaluation , diagnosis nonpregnant adult suspect acute pulmonary embolism '' ."", ') The role full-dose anticoagulation CTPA V/Q scan feasible discuss .', ""( See 'Documented presume VTE ' ."", ') Infection control procedure follow patient undergo image study .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Infection control health care set ' ."", ') Evaluation atypical laboratory find — As note , typical laboratory find COVID-19 monitor prognostic value .', ""( See 'Routine test ( patient ) ' ."", "") Laboratory find atypical COVID-19 , severe thrombocytopenia ( eg , platelet count < 50,000/microL ) , prolong aPTT proportion PT , markedly reduce fibrinogen , evaluate do individual without COVID-19 , discuss separate topic review : ●Thrombocytopenia – ( See `` Approach adult unexplained thrombocytopenia '' ."", "") ●Abnormal coagulation test – ( See `` Clinical use coagulation test '' , section 'Evaluation abnormal result ' ."", ') Evaluation bleed — The evaluation discuss separately .', ""( See `` Approach adult suspect bleed disorder '' `` Clinical use coagulation test '' , section 'Patient anticoagulant ' ."", ') Management bleed depend underlie cause .', ""( See 'Treatment bleed ' ."", ') MANAGEMENTOverview management consideration — Management challenge .', 'Hypercoagulability appear adversely impact prognosis , high-quality study support intervention go beyond standard indication , antithrombotic therapy carry risk increase bleed [ 30 ] .', 'In absence high-quality data guide management , institution may vary aggressively approach prevention treatment thromboembolic complication .', 'Enrollment clinical trial encourage help determine best approach [ 31 ] .', 'Regardless clinical trial enrollment , adherence institutional protocol input individual expertise hemostasis thrombosis advise balance risk thrombosis bleed guide decision antithrombotic therapy ; bleed cause administration excessive antithrombotic therapy may require prothrombotic treatment increase thrombotic risk.Acknowledging lack evidence , agree interim guidance International Society Thrombosis Haemostasis ( ISTH ) [ 27,32 ] .', 'Our approach summarize table ( table 1 ) discuss follow sections.Management coagulation abnormality patient COVID-19 receive extracorporeal membrane oxygenation ( ECMO ) discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Additional option ' `` Extracorporeal membrane oxygenation ( ECMO ) adult '' ."", ') Inpatient VTE prophylaxis●Indications – Venous thromboembolism ( VTE ) prophylaxis appropriate hospitalize medical , surgical , obstetric patient COVID-19 ( algorithm 1 ) , unless contraindication anticoagulation ( eg , active bleed serious bleed prior 24 48 hour ) use heparin ( eg , history heparin-induced thrombocytopenia [ HIT ] , case alternative agent fondaparinux may use ) .•ICU – All patient COVID-19 intensive care unit ( ICU ) require thromboprophylaxis .', 'As discuss , would empirically use intermediate-dose therapeutic-dose anticoagulation severely ill individual absence document VTE .', ""( See 'Possible/uncertain role therapeutic-level anticoagulation critically ill patient ' ."", ') •Medical ( non-ICU ) – All hospitalize medical patient treat prophylactic-dose low molecular weight ( LMW ) heparin ( unfractionated heparin LMW heparin unavailable ) thromboprophylaxis .', '•Surgical – Perioperative VTE prophylaxis especially important patient COVID-19 hospitalize surgical procedure .', 'Details time choice agent discuss separately .', ""( See `` Prevention venous thromboembolism adult orthopedic surgical patient '' `` Prevention venous thromboembolic disease adult nonorthopedic surgical patient '' ."", ') •Obstetric – We would also use VTE prophylaxis obstetric patient COVID-19 hospital prior follow delivery .', 'LMW heparin appropriate delivery expect within 24 hour delivery ; unfractionated heparin use faster discontinuation need ( eg , delivery , neuraxial anesthesia , invasive procedure anticipate within approximately 12 24 hour 36 37 week gestation ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Medical obstetric care hospitalize patient ' `` Use anticoagulant pregnancy postpartum '' ."", "") ●Dosing – Dosing ( subcutaneous ) generally follow ; however , many expert recommend higher do critically ill individual , especially ICU ( see 'Possible/uncertain role therapeutic-level anticoagulation critically ill patient ' ) : •Enoxaparin – For patient creatinine clearance ( CrCl ) > 30 mL/min , 40 mg daily ; CrCl 15 30 mL/min , 30 mg daily.•Dalteparin – 5000 unit daily.•Nadroparin – For patient ≤70 kg , 3800 4000 anti-factor Xa unit daily ; patient > 70 kg , 5700 unit daily ."", 'In case , do 50 anti-factor Xa units/kg every 12 hour use .', '•Tinzaparin – 4500 anti-factor Xa unit daily.For patient CrCl < 15 mL/min renal replacement therapy , use unfractionated heparin , much le dependent elimination kidney .', 'The table information adjustment kidney impairment ( table 2 ) , obesity ( table 3 ) , pregnancy ( table 4 ) .●Supporting evidence – LMW heparin know reduce risk VTE may antiinflammatory property .', 'In retrospective series 2773 individual hospitalize COVID-19 , 786 ( 28 percent ) receive systemic anticoagulation , anticoagulation associate improve in-hospital survival intubate patient ( 71 percent , versus 37 percent anticoagulated ) [ 33 ] .', 'Intubated patient represent approximately 14 percent cohort ; cohort whole , anticoagulation associate better in-hospital survival ( 78 versus 77 percent ) .', 'Bleeding event occur 3 percent anticoagulated patient 2 percent anticoagulated ( statistically significant difference ) .In retrospective study 449 individual severe COVID-19 , enoxaparin ( 40 60 mg daily ) appear associate improve survival compare pharmacologic prophylaxis , especially high D-dimer [ 12 ] .', '•The survival difference see subset individual high sepsis-induced coagulopathy score ( 28-day mortality , 40 percent heparin versus 64 percent without ) high D-dimer , cohort whole .', '•The magnitude benefit greater higher D-dimer value .', 'The reduce mortality become statistically significant six time upper limit normal ( 33 versus 52 percent ) .', 'One small series ( 16 patient ) use higher prophylactic do nadroparin along clopidogrel report VTE event ; small size study lack control group limit interpretation [ 4 ] .', 'As discuss , high percentage ( 25 43 percent ) individual COVID-19 ICU VTE despite prophylactic-dose anticoagulation , prompt many expert suggest higher do .', ""( See 'VTE ' 'Indications full-dose anticoagulation ' ."", ') One study monitor antithrombin ( AT ) level provide AT concentrate decrease level [ 4 ] .', 'However , generally would measure AT level consider AT concentrate unless individual know inherit AT deficiency exhibit heparin resistance association low AT level .', ""( See `` Antithrombin deficiency '' , section 'Heparin resistance ' ."", ') Indications full-dose anticoagulation — Therapeutic-dose ( full-dose ) anticoagulation ( eg , enoxaparin 1 mg/kg every 12 hour ) appropriate follow set , unless contraindication anticoagulation ( eg , active bleed serious bleed prior 24 48 hour ) use heparin ( eg , history heparin-induced thrombocytopenia [ HIT ] , case alternative agent fondaparinux may use ) ( algorithm 1 ) : Documented presume VTE — Therapeutic-dose ( full-dose ) anticoagulation appropriate document venous thromboembolism ( VTE ) , similar individual without COVID-19 .', ""( See 'Diagnosis DVT PE ' ."", ') Full-dose anticoagulation also reasonable case suspect VTE standard confirmatory test available feasible , include follow : ●In patient compute tomography pulmonary angiography ( CTPA ) ventilation/perfusion ( V/Q ) scan feasible , follow may sufficient initiate treatment : •Confirmation deep vein thrombosis ( DVT ) use bilateral compression ultrasonography legs.•Transthoracic echocardiography point-of-care ultrasound demonstrate clot transit main pulmonary artery.●In patient confirmatory test possible , may reasonable treat empirically full-dose anticoagulation base one follow : •Sudden deterioration respiratory status intubate patient consistent pulmonary embolism ( PE ) , especially chest radiography and/or inflammatory marker stable improve change attribute cardiac cause .', '•Otherwise unexplained respiratory failure ( eg , due fluid overload acute respiratory distress syndrome [ ARDS ] ) , especially fibrinogen and/or D-dimer high .', '•Physical find consistent thrombosis ( superficial thrombophlebitis retiform purpura explain condition ) .For patient acute VTE discharge hospital , extend thromboprophylaxis may reasonable .', ""( See 'Patients discharge hospital ' . )"", 'Clotting intravascular access device — Full-dose anticoagulation appropriate individual recurrent clot intravascular access device ( arterial line , central venous catheter ) despite prophylactic-intensity anticoagulation.Full-dose anticoagulation also appropriate clot extracorporeal circuit ( continuous renal replacement therapy , extracorporeal membrane oxygenation [ ECMO ] ) .', 'Details discuss separately .', ""( See `` Extracorporeal membrane oxygenation ( ECMO ) adult '' ."", ') Possible/uncertain role therapeutic-level anticoagulation critically ill patient — The question treatment-dose anticoagulation thromboprophylaxis also raise critically ill individual ICU confirm suspect acute VTE high risk , describe .', ""( See 'VTE ' ."", "") Many center recommend intermediate-dose even therapeutic-intensity anticoagulation individual ( see `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Venous thromboembolism prevention ' ) ."", 'There data compare different level anticoagulation patient ( prophylactic , intermediate , therapeutic dose ) , clinical trial progress .', 'Enrollment trial encourage .', 'As state American Society Hematology ( ASH ) , empiric full-dose anticoagulation individual VTE remain controversial , since data demonstrate improve outcome lack , risk factor VTE also risk factor increase risk bleed [ 29 ] .', 'Thus , VTE suspect , confirmatory test obtain indication full-dose anticoagulation seek possible , especially individual ICU .', 'This test find support therapeutic-dose anticoagulation discuss .', ""( See 'Diagnosis DVT PE ' ."", "") Indications tPA — Tissue plasminogen activator ( tPA ) appropriate usual indication , unless contraindication : ●Limb-threatening DVT – ( See `` Catheter-directed thrombolytic therapy deep venous thrombosis lower extremity : Patient selection administration '' ."", "") ●Massive PE – ( See `` Approach thrombolytic ( fibrinolytic ) therapy acute pulmonary embolism : Patient selection administration '' ."", "") ●Acute stroke – ( See `` Approach reperfusion therapy acute ischemic stroke '' . )"", ""●Acute myocardial infarction – ( See `` Acute ST-elevation myocardial infarction : The use fibrinolytic therapy '' . )"", 'Consultation pulmonary embolism response team ( PERT ) stroke team decision-making advise possible .', 'In contrast , use tPA individual nonspecific find hypoxia laboratory evidence hypercoagulability .', 'A case series describe administration tPA three individual ARDS associate COVID-19 access eligible intervention ECMO [ 34 ] .', 'One individual transient improvement laboratory parameter ultimately die .', 'The two improvement laboratory parameter ; clinical outcome described.Outpatient thromboprophylaxisPatients discharge hospital — Individuals document VTE require minimum three month anticoagulation , discuss separately .', ""( See `` Overview treatment lower extremity deep vein thrombosis ( DVT ) '' , section 'Duration therapy ' `` Treatment , prognosis , follow-up acute pulmonary embolism adult '' ."", ') Some individual VTE may also warrant extend thromboprophylaxis follow discharge hospital : ●We would likely use post-discharge prophylactic anticoagulation individual risk factor VTE immobilization , recent surgery , trauma .', '●We would use criterion similar use APEX MARINER trial , include immobility older age .', 'Most hospitalize patient COVID-19 would meet criterion .', '●However , bleed risk also need incorporate decision-making .', '●Options post-discharge prophylaxis include use clinical trial , rivaroxaban 10 mg daily 31 39 day [ 35 ] .', 'This subject discuss detail separately .', ""( See `` Prevention venous thromboembolic disease acutely ill hospitalize medical adult '' , section 'Duration prophylaxis ' . )"", 'Patients admit hospital — Outpatient thromboprophylaxis may also appropriate select individual COVID-19 admit hospital , especially thrombotic risk factor prior VTE recent surgery , trauma , immobilization , note practice base clinical judgment .', 'There trial address thromboprophylaxis outpatient COVID-19.If thromboprophylaxis use outpatient , would use regimen rivaroxaban 10 mg daily 31 39 day [ 35 ] .', 'Treatment bleed — Bleeding appear major manifestation COVID-19 .', 'However , patient may bleed reason , include trauma and/or treatment anticoagulation .', ""( See 'Bleeding ' ."", "") The approach bleed similar individual without COVID-19 may involve anticoagulant reversal and/or discontinuation , transfusion thrombocytopenia hypofibrinogenemia , specific therapy factor replacement.●Anticoagulant-associated bleed – ( See `` Management warfarin-associated bleed supratherapeutic INR '' `` Management bleed patient receive direct oral anticoagulant '' `` Reversal anticoagulation intracranial hemorrhage '' ."", "") ●Trauma coagulopathy – ( See `` Acute coagulopathy associate trauma '' ."", "") ●An underlie bleed disorder immune thrombocytopenia ( ITP ) , hemophilia , von Willebrand disease ( VWD ) – ( See `` Immune thrombocytopenia ( ITP ) adult : Initial treatment prognosis '' `` Treatment bleed perioperative management hemophilia A B '' `` von Willebrand disease ( VWD ) : Treatment major bleed major surgery '' ."", ') Antifibrinolytic agent ( tranexamic acid , epsilon aminocaproic acid ) generally use patient disseminate intravascular coagulation ( DIC ) , due concern may tip balance towards thrombosis .', 'Thus , avoid patient COVID-19-associated hypercoagulable state predominant find .', ""( See 'Distinction DIC ' `` Disseminated intravascular coagulation ( DIC ) adult : Evaluation management '' , section 'Prevention/treatment bleed ' ."", ') Fibrinogen often increase COVID-19 , supplementation fibrinogen require unless bleed attributable hypofibrinogenemia dysfibrinogenemia ( fibrinogen activity level < 150 200 mg/dL ) .', ""( See 'Coagulation abnormality ' `` Disorders fibrinogen '' , section 'Treatment/prevention bleed ' ."", ') Investigational therapy — A number therapy COVID-19 investigation , may impact thrombotic risk .', 'However , effect treatment hemostasis patient population well study .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') Participation clinical trial encourage order improve understand effective safest mean prevent treat thrombotic complication COVID-19 .', 'Investigational therapy may appropriate life-threatening situation part clinical trial , markedly increase D-dimer may use one criterion identify individual worse prognosis .', 'Close monitor clinical sign thrombosis bleed advise individual COVID-19 , input individual expertise hemostasis thrombosis severe unusual presentations.SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) ●Society guideline patient ( see `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ) SUMMARY AND RECOMMENDATIONS●Coronavirus disease 2019 ( COVID-19 ) associate hypercoagulable state associate acute inflammatory change laboratory find distinct acute disseminate intravascular coagulation ( DIC ) , save severe disease ."", 'Fibrinogen D-dimer increase , typically modest prolongation prothrombin time ( PT ) activate partial thromboplastin time ( aPTT ) mild thrombocytosis thrombocytopenia .', 'The presence lupus anticoagulant ( LA ) common individual prolong aPTT .', 'The pathogenesis abnormality incompletely understand , may many contribute factor relate acute inflammatory response disease .', ""( See 'Pathogenesis ' ."", ') ●The risk venous thromboembolism ( VTE ) markedly increase , especially patient intensive care unit ( ICU ) , case series report prevalence 25 43 percent ICU patient , often despite prophylactic-dose anticoagulation .', 'The risk thrombotic event ( stroke , microvascular thrombosis ) le clear .', ""( See 'Clinical feature ' ."", ') ●All patient admit hospital COVID-19 baseline complete blood count ( CBC ) platelet count , PT , aPTT , fibrinogen , D-dimer .', ""Repeat test do accord patient 's clinical status ."", 'Outpatients require coagulation test .', 'The main purpose test obtain prognostic information may use inform level care .', ""( See 'Routine test ( patient ) ' ."", ') ●Imaging study appropriate suspect VTE feasible .', 'If standard diagnostic study feasible , option determine need therapeutic-dose anticoagulation available , discuss .', 'Laboratory abnormality typical COVID-19 evaluate , describe .', ""( See 'Role additional test ' ."", ') ●Management challenge due acuity illness paucity high-quality evidence regard efficacy safety different approach prevent treat thromboembolic complication disease .', 'Our general approach , summarize table ( table 1 ) depict algorithm ( algorithm 1 ) , include : •All inpatient receive thromboprophylaxis unless contraindicate .', 'Low molecular weight ( LMW ) heparin prefer , unfractionated heparin use LMW heparin unavailable kidney function severely impair .', 'Some institutional protocol include aggressive anticoagulation intermediate-dose even therapeutic-dose anticoagulation thromboprophylaxis .', ""( See 'Inpatient VTE prophylaxis ' 'Possible/uncertain role therapeutic-level anticoagulation critically ill patient ' ."", ') •Therapeutic-dose ( full-dose ) anticoagulation appropriate treat deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) , unless contraindicate .', ""( See 'Indications full-dose anticoagulation ' ."", ') •Bleeding unusual occur .', 'If occur , treatment similar non-COVID-19 patient may include transfusion , anticoagulant reversal discontinuation , specific product underlie bleed disorder .', ""( See 'Treatment bleed ' ."", ') •Participation clinical trial encourage order improve understand effective safest mean prevent treat thrombotic complication COVID-19 .', 'Disease-specific therapy investigation may impact thrombotic risk , effect treatment hemostasis patient population well document .', ""( See 'Investigational therapy ' . )""]","['', 'novel', 'coronavirus', 'identify', 'late', '2019', 'rapidly', 'reach', 'pandemic', 'proportion', '', 'world', 'health', 'organization', 'designate', 'disease', 'cause', 'virus', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'individuals', 'covid-19', 'number', 'coagulation', 'abnormality', '', 'direction', 'underlie', 'hypercoagulable', 'state', '', '', 'raise', 'question', 'appropriate', 'evaluation', 'intervention', 'prevent', 'treat', 'thrombosis', '', 'interim', 'guidance', 'publish', 'international', 'society', 'thrombosis', 'haemostasis', '', 'isth', '', '', 'frequently', 'ask', 'question', 'post', 'website', 'american', 'society', 'hematology', '', 'ash', '', 'american', 'college', 'cardiology', '', 'acc', '', 'topic', 'review', 'evaluation', 'management', 'coagulation', 'abnormality', 'individual', 'covid-19separate', 'topic', 'discus', 'follow', '', 'general', 'management', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', 'critical', 'care', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'adult', '', '', '', 'pregnancy', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', 'anesthesia', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', 'pathogenesis', '', 'pathogenesis', 'hypercoagulability', 'covid-19', 'incompletely', 'understoodvirchow', 'triad', '', 'hypercoagulability', 'term', 'virchow', 'triad', '', '', 'overview', 'cause', 'venous', 'thrombosis', '', '', 'section', 'virchow', 'triad', '', '', '', 'three', 'major', 'contribution', 'clot', 'formation', 'apply', 'severe', 'covid-19', 'infection', '', 'endothelial', 'injury', '', 'evidence', 'direct', 'invasion', 'endothelial', 'cell', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'virus', '', 'potentially', 'lead', 'cell', 'injury', '', 'source', 'endothelial', 'injury', 'include', 'intravascular', 'catheter', 'mediator', 'acute', 'systemic', 'inflammatory', 'response', 'cytokine', '', 'eg', '', 'interleukin', '', 'il', '', '-6', '', 'acute', 'phase', 'reactant', '', '1', '', '', 'contribution', 'complement-mediated', 'endothelial', 'injury', 'suggest', '', '2', '', '', '', '', 'endothelium', '', 'primer', '', '', 'complications', 'central', 'venous', 'catheter', 'prevention', '', '', 'acute', 'phase', 'reactant', '', '', '', 'stasis', '', 'immobilization', 'cause', 'stasis', 'blood', 'flow', 'hospitalize', 'critically', 'ill', 'patient', '', 'regardless', 'whether', 'covid-19hypercoagulable', 'state', '', 'number', 'change', 'circulate', 'prothrombotic', 'factor', 'report', 'propose', 'patient', 'severe', 'covid-19', '', '34', '', '', 'elevated', 'factor', 'viii', 'elevated', 'fibrinogencirculating', 'prothrombotic', 'microparticlesneutrophil', 'extracellular', 'trap', '', 'nets', '', 'elevate', 'level', 'd-dimer', 'observe', 'correlate', 'illness', 'severity', '', 'd-dimer', 'degradation', 'product', 'cross-link', 'fibrin', 'indicate', 'augment', 'thrombin', 'generation', 'fibrin', 'dissolution', 'plasmin', '', 'however', '', 'high', 'd-dimer', 'level', 'common', 'acutely', 'ill', 'individual', 'number', 'infectious', 'inflammatory', 'disease', '', 'likewise', '', 'antiphospholipid', 'antibody', '', 'prolong', 'activate', 'partial', 'thromboplastin', 'time', '', 'aptt', '', '', 'common', 'viral', 'infection', '', 'often', 'transient', 'always', 'imply', 'increase', 'risk', 'thrombosis', '', '', 'coagulation', 'abnormality', '', 'clinical', 'feature', '', '', '', 'coagulation', 'abnormality', '', 'predominant', 'coagulation', 'abnormality', 'patient', 'covid-19', 'suggest', 'hypercoagulable', 'state', 'consistent', 'uncontrolled', 'clinical', 'observation', 'increase', 'risk', 'venous', 'thromboembolism', '', 'vte', '', '', '', 'state', 'term', 'thromboinflammation', 'covid-19-associated', 'coagulopathy', '', 'cac', '', 'expert', '', '56', '', '', 'appear', 'distinct', 'disseminate', 'intravascular', 'coagulation', '', 'dic', '', '', 'though', 'dic', 'report', 'severely', 'affect', 'patientslaboratory', 'find', 'characterize', 'series', '24', 'select', 'patient', 'severe', 'covid-19', 'pneumonia', '', 'intubate', '', 'evaluate', 'along', 'standard', 'coagulation', 'test', 'assay', 'include', 'von', 'willebrand', 'factor', '', 'vwf', '', 'thromboelastography', '', 'teg', '', '', '3', '', '', 'coagulation', 'testingprothrombin', 'time', '', 'pt', '', 'aptt', 'normal', 'slightly', 'prolongedplatelet', 'count', 'normal', 'increase', '', 'mean', '', '348000microl', '', 'fibrinogen', 'increase', '', 'mean', '', '680', 'mgdl', '', 'range', '234', '1344', '', 'd-dimer', 'increase', '', 'mean', '', '4877', 'ngml', '', 'range', '', '1197', '16954', '', 'assaysfactor', 'viii', 'activity', 'increase', '', 'mean', '', '297', 'unitsdl', '', 'vwf', 'antigen', 'greatly', 'increase', '', 'mean', '', '529', '', 'range', '210', '863', '', '', 'consistent', 'endothelial', 'injury', 'perturbationminor', 'change', 'natural', 'anticoagulants-small', 'decrease', 'antithrombin', 'free', 'protein', 's-small', 'increase', 'protein', 'c', 'teg', 'findingsreaction', 'time', '', 'r', '', 'shorten', '', 'consistent', 'increase', 'early', 'thrombin', 'burst', '', '50', 'percent', 'patientsclot', 'formation', 'time', '', 'k', '', 'shorten', '', 'consistent', 'increase', 'fibrin', 'generation', '', '83', 'percentmaximum', 'amplitude', '', '', 'increase', '', 'consistent', 'greater', 'clot', 'strength', '', '83', 'percentclot', 'lysis', '30', 'minute', '', 'ly30', '', 'reduce', '', 'consistent', 'reduce', 'fibrinolysis', '', '100', 'percenttesting', 'study', 'perform', 'arterial', 'blood', 'patient', 'arterial', 'catheter', 'place', '', 'venous', 'blood', '', 'heparinase', 'include', 'since', 'patient', 'receive', 'low', 'molecular', 'weight', '', 'lmw', '', 'heparin', '', 'study', 'report', 'similar', 'find', 'consistent', 'hypercoagulable', 'state', '', 'include', 'high', 'd-dimer', '', 'vwf', 'antigen', 'activity', '', 'factor', 'viii', 'activity', '', '47', '', '', 'one', 'study', 'suggest', 'patient', 'covid-19', 'higher', 'platelet', 'count', 'patient', 'coronavirus', 'infection', '', '8', '', '', 'early', 'case', 'series', '', 'include', 'series', '183', 'consecutive', 'patient', 'wuhan', '', 'china', '', 'suggest', 'thrombocytopenia', 'prolongation', 'pt', 'aptt', 'mark', '', '9-12', '', '', 'clear', 'result', 'differ', 'somewhat', 'later', 'find', 'le', 'severe', 'pt', 'aptt', 'prolongation', '', 'one', 'possible', 'explanation', 'patient', 'sicker', '', 'perhaps', 'earlier', 'pandemic', 'disease', 'recognize', 'quickly', '', 'result', 'delay', 'patient', 'presentation', 'andor', 'treatmentanother', 'explanation', 'isolate', 'prolong', 'aptt', 'presence', 'lupus', 'anticoagulant', '', 'la', '', '', '', 'clinical', 'coagulation', 'test', '', '', 'section', 'causes', 'prolong', 'aptt', '', '', '', 'two', 'study', 'find', 'high', 'rate', 'la', 'patient', 'prolong', 'aptt', '', '50', '57', 'test', 'individual', '', '88', 'percent', '', '31', '34', 'test', 'individual', '', '91', 'percent', '', '', '', '1314', '', '', 'presence', 'la', 'lead', 'artifactual', 'prolongation', 'aptt', 'reflect', 'increase', 'bleed', 'risk', '', 'patient', 'la', 'receive', 'anticoagulation', 'indicate', '', '', 'management', '', '', '', 'marker', 'derange', 'coagulation', '', 'eg', '', 'd-dimer', '', 'appear', 'correlate', 'illness', 'severity', '', 'd-dimer', 'often', 'increase', '', 'sometimes', 'markedly', '', 'individual', 'overt', 'dic', 'intensive', 'care', 'unit', '', 'icu', '', '', 'principles', 'teg', 'interpretation', 'teg', 'trace', 'illustrate', 'figure', '', 'figure', '1', '', 'discuss', 'detail', 'separately', '', '', '', 'platelet', 'function', 'test', '', '', 'section', 'thromboelastography', '', 'teg', '', 'rotem', '', '', 'acute', 'coagulopathy', 'associate', 'trauma', '', '', 'section', 'thromboelastography', '', '', '', 'distinction', 'dic', '', 'hypercoagulable', 'state', 'associate', 'covid-19', 'refer', 'disseminate', 'intravascular', 'coagulation', '', 'dic', '', '-like', 'state', '', 'especially', 'affect', 'individual', 'acutely', 'ill', 'meet', 'criterion', 'probable', 'dic', 'score', 'system', 'publish', 'international', 'society', 'thrombosis', 'haemostasis', '', 'isth', '', '2009', '', '15', '', '', 'however', '', 'major', 'clinical', 'find', 'covid-19', 'thrombosis', '', 'whereas', 'major', 'find', 'acute', 'decompensated', 'dic', 'bleedinglikewise', '', 'covid-19', 'similar', 'laboratory', 'find', 'dic', '', 'include', 'mark', 'increase', 'd-dimer', 'case', '', 'mild', 'thrombocytopenia', '', 'however', '', 'coagulation', 'parameter', 'covid-19', 'distinct', 'dic', '', 'covid-19', '', 'typical', 'find', 'include', 'high', 'fibrinogen', 'high', 'factor', 'viii', 'activity', '', 'suggest', 'major', 'consumption', 'coagulation', 'factor', 'occur', '', '3', '', '', '', 'coagulation', 'abnormality', '', '', '', 'contrast', '', 'acute', 'decompensated', 'dic', 'associate', 'low', 'fibrinogen', 'due', 'consumption', 'clot', 'factor', '', 'one', 'largest', 'series', 'report', 'thromboembolic', 'event', '', 'none', 'patient', 'develop', 'overt', 'dic', '', '16', '', 'typically', '', 'bleed', 'predominate', 'acute', 'decompensated', 'dic', 'thrombosis', 'predominate', 'chronic', 'compensate', 'dic', '', 'although', 'significant', 'overlap', '', 'thus', '', 'hypercoagulable', 'state', 'patient', 'covid-19', 'similar', 'compensate', 'dic', 'acute', 'dic', '', 'however', '', 'covid-19', '', 'platelet', 'count', 'aptt', 'typically', 'normal', '', '', '', 'disseminated', 'intravascular', 'coagulation', '', 'dic', '', 'adult', '', 'evaluation', 'management', '', '', 'section', 'pathogenesis', '', '', '', 'isth', 'score', 'system', 'base', 'laboratory', 'find', 'intend', 'patient', 'underlie', 'condition', 'associate', 'dic', '', '15', '', '', 'covid-19', 'qualify', 'base', 'severe', 'infection', '', 'points', 'give', 'thrombocytopenia', '', '1', 'point', 'platelet', 'count', '50000', '100000microl', '', '2', 'point', '', '50000microl', '', '', 'prolong', 'pt', '', '1', 'point', '3', '6', 'second', 'prolongation', '', '2', 'point', '6', 'second', '', '', 'low', 'fibrinogen', '', '1', 'point', '', '100', 'mgdl', '', '', 'increase', 'd-dimer', '', '2', 'point', 'moderate', 'increase', '', '3', 'point', '', 'strong', '', 'increase', '', '', 'score', '5', 'point', 'suggest', 'dic', 'probable', '', 'despite', '', 'diagnosis', 'dic', 'clinically', '', 'gold', 'standard', 'single', 'test', 'combination', 'test', 'pathognomonic', '', 'compared', 'expert', 'opinion', '', 'isth', 'score', 'system', 'report', 'sensitivity', '91', 'percent', 'specificity', '97', 'percent', '', '15', '', '', '', 'coagulation', 'abnormality', '', '', '', 'regardless', 'whether', 'difference', 'dic', 'similarity', 'emphasize', '', 'basic', 'principle', 'dic', 'management', 'apply', '', 'include', 'importance', 'treat', 'underlie', 'condition', '', 'importance', 'base', 'intervention', 'clinical', 'picture', 'laboratory', 'test', 'alone', '', 'provide', 'anticoagulation', 'thrombosis', 'appropriate', 'hemostatic', 'therapy', 'bleed', '', '', '', 'disseminated', 'intravascular', 'coagulation', '', 'dic', '', 'adult', '', 'evaluation', 'management', '', '', 'section', 'treatment', '', '', '', 'clinical', 'featuresvte', '', 'venous', 'thromboembolism', '', 'vte', '', '', 'include', 'extensive', 'deep', 'vein', 'thrombosis', '', 'dvt', '', 'pulmonary', 'embolism', '', 'pe', '', '', 'common', 'acutely', 'ill', 'patient', 'covid-19', '', 'one-third', 'patient', 'intensive', 'care', 'unit', '', 'icu', '', '', 'prophylactic', 'anticoagulation', '', 'two', 'autopsy', 'study', 'emphasize', 'contribution', 'hypercoagulability', 'associate', 'inflammation', 'patient', 'die', 'covid-19', '', 'post-mortem', 'examination', '21', 'individual', 'covid-19', 'find', 'prominent', 'pe', 'four', '', 'microthrombi', 'alveolar', 'capillary', '5', '11', '', '45', 'percent', '', 'available', 'histology', '', '17', '', '', 'three', 'evidence', 'thrombotic', 'microangiopathy', 'fibrin', 'thrombus', 'glomerular', 'capillary', '', 'average', 'age', '76', 'year', '', 'high', 'body', 'mass', 'index', '', 'bmi', '', 'mean', '', '31', 'kgm2', '', 'normal', '185', '', '25', '', '', 'information', 'anticoagulation', 'prior', 'death', 'available', '11', '', '11', 'receive', 'form', 'anticoagulation', '', 'underlying', 'cardiovascular', 'disease', '', 'hypertension', '', 'diabetes', 'mellitus', 'commonpost-mortem', 'examination', '12', 'consecutive', 'individual', 'covid-19', '', '8', 'male', '', '10', 'hospitalize', '', 'reveal', 'dvt', '7', '12', '', '58', 'percent', '', '', '18', '', '', 'case', 'dvt', 'bilateral', 'leg', 'involvement', '', 'none', 'suspect', 'death', '', '12', 'lung', 'histology', 'available', '', '5', '', '42', 'percent', '', 'evidence', 'thrombosis', '', 'pe', 'cause', 'death', 'four', '', 'd-dimer', 'test', '', 'extremely', 'high', 'value', '', 'two', '', '20000', 'ngml', 'one', '', '100000', 'ngml', '', 'normal', 'value', '', '500', 'ngml', '', '', '500', 'mcgl', '', '', '', 'anticoagulation', 'prior', 'death', 'report', '4', '12', '', 'mean', 'bmi', '287', 'kgm2', '', 'three', 'patient', 'normal', 'bmi', '', 'cancer', '', 'ulcerative', 'colitis', '', 'andor', 'chronic', 'kidney', 'disease', '', 'study', 'note', 'preponderance', 'male', 'high', 'prevalence', 'obesity', 'chronic', 'medical', 'comorbidities', '', 'especially', 'cardiovascular', 'disease', '', 'hypertension', '', 'diabetes', 'mellitus', '', 'icu', '', 'case', 'series', 'intensive', 'care', 'unit', '', 'icu', '', 'patient', 'report', 'high', 'rate', 'vte', '', 'range', '', '20', '43', 'percent', '', '', 'mostly', 'pulmonary', 'embolism', '', 'pe', '', '', 'often', 'despite', 'prophylactic-dose', 'anticoagulation', '', 'series', '184', 'sequential', 'patient', 'severe', 'covid-19', 'icu', 'report', 'pe', '25', '', '14', 'percent', '', '', 'deep', 'vein', 'thrombosis', '', 'dvt', '', '1', '', 'catheter-associated', 'thrombosis', '2', '', '16', '', '', 'cumulative', 'incidence', 'vte', '', 'base', 'different', 'duration', 'follow-up', '', 'calculate', '27', 'percent', '', 'receive', 'least', 'standard', 'dose', 'thromboprophylaxis', '', 'group', 'whole', 'ill', '', '13', 'percent', 'require', 'renal', 'replacement', 'therapy', '13', 'percent', 'mortality', '', 'three-fourths', 'patient', 'male', '', 'several', 'active', 'cancer', '', 'independent', 'vte', 'risk', 'factor', '', '', 'series', '150', 'icu', 'patient', 'report', 'vte', '64', '', '43', 'percent', '', 'mostly', 'pe', '', 'clot', 'extracorporeal', 'circuit', '28', '29', 'receive', 'continuous', 'renal', 'replacement', 'therapy', '2', '12', 'undergo', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', '7', '', '', 'patient', 'receive', 'thromboprophylaxis', '', 'mostly', 'low', 'molecular', 'weight', '', 'lmw', '', 'heparin', '', '', '70', 'percent', 'prophylactic', 'dose', '30', 'percent', 'therapeutic', 'dose', '', 'study', 'compare', 'subgroup', '77', 'patient', 'covid-19-associated', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'match', 'cohort', '145', 'patient', 'non-covid-19-ards', 'find', 'rate', 'thrombotic', 'complication', '', 'mostly', 'pe', '', 'higher', 'covid-19', 'patient', '', '12', 'versus', '2', 'percent', '', 'series', '107', 'icu', 'patient', 'report', 'pe', '22', '', '21', 'percent', '', 'cumulative', 'incidence', '15', 'day', '', '20', 'percent', '', '', '19', '', '', '22', 'patient', 'pe', '', '20', 'receive', 'prophylactic', 'anticoagulation', '2', 'receive', 'therapeutic-dose', 'anticoagulation', '', 'prior', 'vte', 'atrial', 'fibrillation', '', '', 'comparison', '', 'incidence', 'pe', 'two', 'match', 'cohort', '', 'one', 'time', 'interval', 'previous', 'year', 'one', 'concurrent', 'patient', 'influenza', 'covid-19', '', '6', '8', 'percent', '', 'respectivelya', 'series', 'include', '74', 'icu', 'patient', 'report', 'vte', '29', '', '39', 'percent', '', '', 'cumulative', 'incidence', '25', 'percent', '7', 'day', '48', 'percent', '14', 'day', '', '20', '', '', 'individual', 'receive', 'anticoagulation', '', 'prophylactic', 'level', '', 'none', 'patient', 'receive', 'therapeutic', 'level', 'anticoagulation', 'admission', 'develop', 'vtean', 'earlier', 'series', '81', 'patient', 'severe', 'covid-19', 'pneumonia', 'report', 'vte', '20', '', '25', 'percent', '', '', '21', '', 'study', 'perform', 'screen', 'leg', 'ultrasound', '26', 'individual', 'covid-19', 'icu', 'receive', 'either', 'prophylactic-dose', 'therapeutic-dose', 'anticoagulation', 'find', 'vte', '18', '', '69', 'percent', '', '', 'include', 'bilateral', 'clot', '10', '', '38', 'percent', '', '', '22', '', '', 'individual', 'additional', 'vte', 'risk', 'factor', 'include', 'cancer', '', 'recent', 'surgery', '', 'high', 'bmi', '', 'prior', 'vte', '', '7', '', '27', 'percent', '', 'receive', 'anticoagulation', 'prior', 'admissionvte', 'risk', 'range', 'expert', 'suggest', 'aggressive', 'thromboprophylaxis', 'dose', 'anticoagulant', 'empiric', 'therapeutic-dose', 'anticoagulation', 'vte', 'prevention', '', 'study', 'note', 'higher', 'average', 'body', 'mass', 'index', 'affect', 'individual', '', 'suggest', 'obesity', '', 'along', 'risk', 'factor', '', 'warrant', 'consideration', 'decision-making', 'regard', 'intensity', 'anticoagulation', '', '', 'possibleuncertain', 'role', 'therapeutic-level', 'anticoagulation', 'critically', 'ill', 'patient', '', '', '', 'inpatients', '', 'non-icu', '', '', 'data', 'limit', 'regard', 'rate', 'vte', 'inpatient', 'intensive', 'care', 'unit', '', 'icu', '', '', 'series', '39', 'percent', 'rate', 'vte', 'icu', 'patient', 'include', '124', 'non-icu', 'patient', '', '', '4', '', '3', 'percent', '', 'diagnose', 'vte', '', '20', '', 'series', 'ireland', 'include', '50', 'patient', 'regular', 'medical', 'ward', 'report', 'similar', 'find', 'icu', 'patient', '', 'include', 'high', 'd-dimer', 'fibrinogen', 'normal', 'platelet', 'count', 'clot', 'time', '', '23', '', '', 'outpatients', '', 'aware', 'thrombotic', 'event', 'observe', 'covid-19', 'patient', 'admit', 'hospital', '', 'data', 'incidence', 'available', '', 'arterial', 'event', '', 'report', 'arterial', 'thrombosis', '', 'include', 'central', 'nervous', 'system', '', 'cns', '', '', 'example', '', 'cns', '', 'single', 'health', 'system', 'identify', 'five', 'case', 'acute', 'ischemic', 'stroke', 'associate', 'covid-19', 'two-week', 'period', '', 'symptom', 'suggest', 'large-vessel', 'occlusion', '', 'patient', '50', 'year', 'age', '', '24', '', '', 'time', 'period', 'pandemic', '', 'approximately', '07', 'large', 'vessel', 'stroke', 'per', 'two-week', 'interval', 'individual', 'age', '50', '', 'one', 'series', 'icu', 'patient', 'discuss', '', 'ischemic', 'stroke', 'observe', '3', '184', '', 'cumulative', 'incidence', '', '37', 'percent', '', '', '16', '', '', 'another', 'one', 'series', 'discuss', '', 'cerebral', 'ischemia', '3', '150', '', '7', '', 'limbs', '', 'report', 'describe', '20', 'patient', 'covid-19', 'develop', 'acute', 'limb', 'ischemia', 'single', 'institution', 'three-month', 'period', '', '25', '', '', 'represent', 'significant', 'increase', 'limb', 'ischemia', 'previous', 'year', '', '16', 'percent', '', 'versus', '2', 'percent', 'early', '2019', '', '', 'male', '', '18', '20', '', '', 'average', 'age', '75', 'year', '', 'surgical', 'revascularization', 'procedure', 'perform', '17', '', '12', '', '71', 'percent', '', 'successful', '', 'lower-than-expected', 'success', 'rate', '', 'individuals', 'receive', 'postoperative', 'heparin', 'require', 'reintervention', '', 'although', 'benefit', 'postoperative', 'heparin', 'reach', 'statistical', 'significance', '', 'another', 'report', 'describe', 'four', 'patient', 'acute', 'limb', 'ischemia', 'due', 'thrombosis', '', 'two', 'young', 'comorbidities', '', '53-year-old', 'man', 'develop', 'aorto-iliac', 'thrombosis', '37-year-old', 'man', 'develop', 'humeral', 'artery', 'thrombosis', '', '', '26', '', '', 'receive', 'prophylactic-dose', 'lmw', 'heparin', 'time', 'thrombosis', 'develop', 'high', 'd-dimer', '', '', '9000', 'ngml', '', '', 'myocardial', 'infarction', 'report', 'emphasize', 'available', 'seriesmicrovascular', 'thrombosis', '', 'autopsy', 'study', 'individual', 'die', 'covid-19', 'demonstrate', 'microvascular', 'thrombosis', 'lung', '', '26', '', '', 'mechanism', 'unclear', 'involve', 'hypercoagulability', '', 'direct', 'endothelial', 'injury', '', 'complement', 'activation', '', 'process', '', 'absence', 'definitive', 'data', 'regard', 'mechanism', 'therapy', '', 'pursue', 'specialize', 'test', 'thrombotic', 'microangiopathies', '', 'eg', '', 'adamts13', 'activity', '', 'complement', 'study', '', 'specialize', 'therapy', '', 'eg', '', 'plasma', 'exchange', '', 'anti-complement', 'therapy', '', 'outside', 'research', 'studybleeding', '', 'bleeding', 'le', 'common', 'clot', 'patient', 'covid-19', '', 'occur', '', 'especially', 'set', 'anticoagulation', '', 'example', '', 'subset', '25', 'icu', 'patient', 'evaluate', 'abnormal', 'neurologic', 'find', '', 'one', 'evidence', 'intracranial', 'hemorrhage', 'well', 'ischemic', 'lesion', '', '7', '', '', 'three', 'patient', 'series', 'hemorrhagic', 'complication', '', 'include', 'two', 'intracerebral', 'bleed', 'associate', 'head', 'trauma', 'one', 'hemorrhagic', 'complication', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', 'three', 'others', 'series', 'evidence', 'intracerebral', 'ischemia', '', '', 'arterial', 'event', '', '', '', 'evaluation', '', 'evaluation', 'patient', 'covid-19', 'coagulation', 'abnormality', '', 'suspect', 'document', '', 'challenge', 'due', 'limit', 'data', 'clinical', 'parameter', 'coagulation', 'abnormality', 'act', 'upon', 'concern', 'relate', 'perform', 'diagnostic', 'image', 'procedure', 'acutely', 'ill', 'potentially', 'contagious', 'patient', '', 'general', 'approach', 'follow', '', 'although', 'decision', 'treat', 'clinician', 'base', 'evaluation', 'patient', '', 'approach', 'consistent', 'guidance', 'international', 'society', 'thrombosis', 'haemostasis', '', 'isth', '', '', 'american', 'society', 'hematology', '', 'ash', '', '', 'american', 'college', 'cardiology', '', 'acc', '', '', '52728', '', '', 'routine', 'test', '', 'patient', '', 'inpatients', '', 'ass', 'follow', 'inpatient', 'covid-19', '', 'complete', 'blood', 'count', '', 'cbc', '', 'include', 'platelet', 'countcoagulation', 'study', '', 'prothrombin', 'time', '', 'pt', '', 'activate', 'partial', 'thromboplastin', 'time', '', 'aptt', '', '', 'fibrinogend-dimerrepeat', 'test', 'reasonable', 'daily', 'basis', 'le', 'frequently', '', 'depend', 'acuity', 'patient', 'illness', '', 'initial', 'result', '', 'trend', 'value', '', 'measurement', 'd-dimer', 'per', 'day', 'generally', 'indicatedas', 'note', '', 'common', 'laboratory', 'find', 'include', '', 'coagulation', 'abnormality', '', '', '', 'high', 'd-dimer', 'high', 'fibrinogennormal', 'mildly', 'prolong', 'pt', 'apttmild', 'thrombocytopenia', 'thrombocytosis', '', 'normal', 'platelet', 'countwe', 'intervene', 'abnormal', 'coagulation', 'study', 'absence', 'clinical', 'indication', '', 'however', '', 'find', 'prognostic', 'value', 'impact', 'decision-making', 'level', 'care', 'andor', 'investigational', 'therapy', 'direct', 'treat', 'infection', '', 'example', '', 'increase', 'd-dimer', 'associate', 'poor', 'prognosis', '', '', 'investigational', 'therapy', '', '', '', 'atypical', 'find', 'markedly', 'prolong', 'aptt', '', 'proportion', 'pt', '', '', 'low', 'fibrinogen', '', 'severe', 'thrombocytopenia', 'suggest', 'another', 'condition', 'present', 'additional', 'evaluation', 'indicate', '', '', 'role', 'additional', 'test', '', '', '', 'routinely', 'test', 'thrombotic', 'thrombocytopenic', 'purpura', '', 'ttp', '', '', 'thrombotic', 'microangiopathies', '', 'antiphospholipid', 'antibody', '', 'apl', '', '', 'therapeutic', 'implication', 'transiently', 'positive', 'apl', 'absence', 'clinical', 'find', '', 'transient', 'apl', 'positivity', 'often', 'acute', 'infection', '', '', '', 'diagnosis', 'antiphospholipid', 'syndrome', '', '', 'section', 'condition', 'associate', 'apl', '', '', '', 'routinely', 'perform', 'image', 'screen', 'purpose', '', 'evidence', 'indicate', 'practice', 'improve', 'outcome', '', 'unnecessarily', 'expose', 'health', 'care', 'worker', 'additional', 'infectious', 'risk', '', 'however', '', 'image', 'appropriate', 'individual', 'symptom', '', 'discuss', '', '', 'role', 'additional', 'test', '', '', '', 'outpatients', '', 'outpatient', '', 'routine', 'coagulation', 'test', 'require', '', 'evaluation', 'abnormal', 'symptom', 'find', 'examination', 'similar', 'inpatient', '', '', 'role', 'additional', 'test', '', '', '', 'role', 'additional', 'testingdiagnosis', 'dvt', 'pe', '', 'evaluation', 'deep', 'vein', 'thrombosis', '', 'dvt', '', 'pulmonary', 'embolism', '', 'pe', '', 'challenge', 'symptom', 'pe', 'overlap', 'covid-19', '', 'image', 'study', 'feasible', 'case', '', 'threshold', 'evaluation', 'diagnosis', 'dvt', 'pe', 'low', 'give', 'high', 'frequency', 'event', 'presence', 'additional', 'venous', 'thromboembolism', '', 'vte', '', 'risk', 'factor', 'individual', '', '', 'vte', '', '', '', 'dvt', '', 'individuals', 'suspect', 'dvt', 'compression', 'ultrasonography', 'feasible', 'accord', 'standard', 'indication', '', '', '', 'clinical', 'presentation', 'diagnosis', 'nonpregnant', 'adult', 'suspect', 'deep', 'vein', 'thrombosis', 'lower', 'extremity', '', '', '', 'pe', '', 'agree', 'guidance', 'american', 'society', 'hematology', '', 'ash', '', 'regard', 'diagnosis', 'pe', '', 'include', 'follow', '', '29', '', '', 'normal', 'd-dimer', 'sufficient', 'exclude', 'diagnosis', 'pe', '', 'increase', 'd-dimer', 'specific', 'vte', 'sufficient', 'diagnosisin', 'patient', 'suspect', 'pe', 'due', 'unexplained', 'hypotension', '', 'tachycardia', '', 'worsen', 'respiratory', 'status', '', 'risk', 'factor', 'thrombosis', '', 'compute', 'tomography', 'pulmonary', 'angiography', '', 'ctpa', '', 'prefer', 'test', 'confirm', 'exclude', 'diagnosis', '', 'ventilationperfusion', '', 'vq', '', 'scan', 'alternative', 'ctpa', 'perform', 'inconclusive', '', 'although', 'vq', 'scan', 'unhelpful', 'individual', 'significant', 'pulmonary', 'involvement', 'covid-19', '', 'consultation', 'pulmonary', 'embolism', 'response', 'team', '', 'pert', '', 'decision-making', 'advise', 'possible', '', '', '', 'clinical', 'presentation', '', 'evaluation', '', 'diagnosis', 'nonpregnant', 'adult', 'suspect', 'acute', 'pulmonary', 'embolism', '', '', '', 'role', 'full-dose', 'anticoagulation', 'ctpa', 'vq', 'scan', 'feasible', 'discuss', '', '', 'documented', 'presume', 'vte', '', '', '', 'infection', 'control', 'procedure', 'follow', 'patient', 'undergo', 'image', 'study', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'evaluation', 'atypical', 'laboratory', 'find', '', 'note', '', 'typical', 'laboratory', 'find', 'covid-19', 'monitor', 'prognostic', 'value', '', '', 'routine', 'test', '', 'patient', '', '', '', '', 'laboratory', 'find', 'atypical', 'covid-19', '', 'severe', 'thrombocytopenia', '', 'eg', '', 'platelet', 'count', '', '50000microl', '', '', 'prolong', 'aptt', 'proportion', 'pt', '', 'markedly', 'reduce', 'fibrinogen', '', 'evaluate', 'individual', 'without', 'covid-19', '', 'discuss', 'separate', 'topic', 'review', '', 'thrombocytopenia', '', '', '', 'approach', 'adult', 'unexplained', 'thrombocytopenia', '', '', '', 'abnormal', 'coagulation', 'test', '', '', '', 'clinical', 'coagulation', 'test', '', '', 'section', 'evaluation', 'abnormal', 'result', '', '', '', 'evaluation', 'bleed', '', 'evaluation', 'discuss', 'separately', '', '', '', 'approach', 'adult', 'suspect', 'bleed', 'disorder', '', '', 'clinical', 'coagulation', 'test', '', '', 'section', 'patient', 'anticoagulant', '', '', '', 'management', 'bleed', 'depend', 'underlie', 'cause', '', '', 'treatment', 'bleed', '', '', '', 'managementoverview', 'management', 'consideration', '', 'management', 'challenge', '', 'hypercoagulability', 'appear', 'adversely', 'impact', 'prognosis', '', 'high-quality', 'study', 'support', 'intervention', 'beyond', 'standard', 'indication', '', 'antithrombotic', 'therapy', 'carry', 'risk', 'increase', 'bleed', '', '30', '', '', 'absence', 'high-quality', 'data', 'guide', 'management', '', 'institution', 'vary', 'aggressively', 'approach', 'prevention', 'treatment', 'thromboembolic', 'complication', '', 'enrollment', 'clinical', 'trial', 'encourage', 'help', 'determine', 'best', 'approach', '', '31', '', '', 'regardless', 'clinical', 'trial', 'enrollment', '', 'adherence', 'institutional', 'protocol', 'input', 'individual', 'expertise', 'hemostasis', 'thrombosis', 'advise', 'balance', 'risk', 'thrombosis', 'bleed', 'guide', 'decision', 'antithrombotic', 'therapy', '', 'bleed', 'cause', 'administration', 'excessive', 'antithrombotic', 'therapy', 'require', 'prothrombotic', 'treatment', 'increase', 'thrombotic', 'riskacknowledging', 'evidence', '', 'agree', 'interim', 'guidance', 'international', 'society', 'thrombosis', 'haemostasis', '', 'isth', '', '', '2732', '', '', 'approach', 'summarize', 'table', '', 'table', '1', '', 'discuss', 'follow', 'sectionsmanagement', 'coagulation', 'abnormality', 'patient', 'covid-19', 'receive', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'additional', 'option', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'adult', '', '', '', 'inpatient', 'vte', 'prophylaxisindications', '', 'venous', 'thromboembolism', '', 'vte', '', 'prophylaxis', 'appropriate', 'hospitalize', 'medical', '', 'surgical', '', 'obstetric', 'patient', 'covid-19', '', 'algorithm', '1', '', '', 'unless', 'contraindication', 'anticoagulation', '', 'eg', '', 'active', 'bleed', 'serious', 'bleed', 'prior', '24', '48', 'hour', '', 'heparin', '', 'eg', '', 'history', 'heparin-induced', 'thrombocytopenia', '', 'hit', '', '', 'case', 'alternative', 'agent', 'fondaparinux', '', 'icu', '', 'patient', 'covid-19', 'intensive', 'care', 'unit', '', 'icu', '', 'require', 'thromboprophylaxis', '', 'discuss', '', 'empirically', 'intermediate-dose', 'therapeutic-dose', 'anticoagulation', 'severely', 'ill', 'individual', 'absence', 'document', 'vte', '', '', 'possibleuncertain', 'role', 'therapeutic-level', 'anticoagulation', 'critically', 'ill', 'patient', '', '', '', 'medical', '', 'non-icu', '', '', 'hospitalize', 'medical', 'patient', 'treat', 'prophylactic-dose', 'low', 'molecular', 'weight', '', 'lmw', '', 'heparin', '', 'unfractionated', 'heparin', 'lmw', 'heparin', 'unavailable', '', 'thromboprophylaxis', '', 'surgical', '', 'perioperative', 'vte', 'prophylaxis', 'especially', 'important', 'patient', 'covid-19', 'hospitalize', 'surgical', 'procedure', '', 'details', 'time', 'choice', 'agent', 'discuss', 'separately', '', '', '', 'prevention', 'venous', 'thromboembolism', 'adult', 'orthopedic', 'surgical', 'patient', '', '', 'prevention', 'venous', 'thromboembolic', 'disease', 'adult', 'nonorthopedic', 'surgical', 'patient', '', '', '', 'obstetric', '', 'vte', 'prophylaxis', 'obstetric', 'patient', 'covid-19', 'hospital', 'prior', 'follow', 'delivery', '', 'lmw', 'heparin', 'appropriate', 'delivery', 'expect', 'within', '24', 'hour', 'delivery', '', 'unfractionated', 'heparin', 'faster', 'discontinuation', '', 'eg', '', 'delivery', '', 'neuraxial', 'anesthesia', '', 'invasive', 'procedure', 'anticipate', 'within', 'approximately', '12', '24', 'hour', '36', '37', 'week', 'gestation', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'medical', 'obstetric', 'care', 'hospitalize', 'patient', '', '', 'anticoagulant', 'pregnancy', 'postpartum', '', '', '', 'dosing', '', 'dosing', '', 'subcutaneous', '', 'generally', 'follow', '', 'however', '', 'expert', 'recommend', 'higher', 'critically', 'ill', 'individual', '', 'especially', 'icu', '', 'possibleuncertain', 'role', 'therapeutic-level', 'anticoagulation', 'critically', 'ill', 'patient', '', '', '', 'enoxaparin', '', 'patient', 'creatinine', 'clearance', '', 'crcl', '', '', '30', 'mlmin', '', '40', 'mg', 'daily', '', 'crcl', '15', '30', 'mlmin', '', '30', 'mg', 'dailydalteparin', '', '5000', 'unit', 'dailynadroparin', '', 'patient', '70', 'kg', '', '3800', '4000', 'anti-factor', 'xa', 'unit', 'daily', '', 'patient', '', '70', 'kg', '', '5700', 'unit', 'daily', '', 'case', '', '50', 'anti-factor', 'xa', 'unitskg', 'every', '12', 'hour', '', 'tinzaparin', '', '4500', 'anti-factor', 'xa', 'unit', 'dailyfor', 'patient', 'crcl', '', '15', 'mlmin', 'renal', 'replacement', 'therapy', '', 'unfractionated', 'heparin', '', 'much', 'le', 'dependent', 'elimination', 'kidney', '', 'table', 'information', 'adjustment', 'kidney', 'impairment', '', 'table', '2', '', '', 'obesity', '', 'table', '3', '', '', 'pregnancy', '', 'table', '4', '', 'supporting', 'evidence', '', 'lmw', 'heparin', 'reduce', 'risk', 'vte', 'antiinflammatory', 'property', '', 'retrospective', 'series', '2773', 'individual', 'hospitalize', 'covid-19', '', '786', '', '28', 'percent', '', 'receive', 'systemic', 'anticoagulation', '', 'anticoagulation', 'associate', 'improve', 'in-hospital', 'survival', 'intubate', 'patient', '', '71', 'percent', '', 'versus', '37', 'percent', 'anticoagulated', '', '', '33', '', '', 'intubated', 'patient', 'represent', 'approximately', '14', 'percent', 'cohort', '', 'cohort', 'whole', '', 'anticoagulation', 'associate', 'better', 'in-hospital', 'survival', '', '78', 'versus', '77', 'percent', '', '', 'bleeding', 'event', 'occur', '3', 'percent', 'anticoagulated', 'patient', '2', 'percent', 'anticoagulated', '', 'statistically', 'significant', 'difference', '', 'retrospective', 'study', '449', 'individual', 'severe', 'covid-19', '', 'enoxaparin', '', '40', '60', 'mg', 'daily', '', 'appear', 'associate', 'improve', 'survival', 'compare', 'pharmacologic', 'prophylaxis', '', 'especially', 'high', 'd-dimer', '', '12', '', '', 'survival', 'difference', 'subset', 'individual', 'high', 'sepsis-induced', 'coagulopathy', 'score', '', '28-day', 'mortality', '', '40', 'percent', 'heparin', 'versus', '64', 'percent', 'without', '', 'high', 'd-dimer', '', 'cohort', 'whole', '', 'magnitude', 'benefit', 'greater', 'higher', 'd-dimer', 'value', '', 'reduce', 'mortality', 'become', 'statistically', 'significant', 'six', 'time', 'upper', 'limit', 'normal', '', '33', 'versus', '52', 'percent', '', '', 'one', 'small', 'series', '', '16', 'patient', '', 'higher', 'prophylactic', 'nadroparin', 'along', 'clopidogrel', 'report', 'vte', 'event', '', 'small', 'size', 'study', 'control', 'group', 'limit', 'interpretation', '', '4', '', '', 'discuss', '', 'high', 'percentage', '', '25', '43', 'percent', '', 'individual', 'covid-19', 'icu', 'vte', 'despite', 'prophylactic-dose', 'anticoagulation', '', 'prompt', 'expert', 'suggest', 'higher', '', '', 'vte', '', 'indications', 'full-dose', 'anticoagulation', '', '', '', 'one', 'study', 'monitor', 'antithrombin', '', '', 'level', 'provide', 'concentrate', 'decrease', 'level', '', '4', '', '', 'however', '', 'generally', 'measure', 'level', 'consider', 'concentrate', 'unless', 'individual', 'inherit', 'deficiency', 'exhibit', 'heparin', 'resistance', 'association', 'low', 'level', '', '', '', 'antithrombin', 'deficiency', '', '', 'section', 'heparin', 'resistance', '', '', '', 'indications', 'full-dose', 'anticoagulation', '', 'therapeutic-dose', '', 'full-dose', '', 'anticoagulation', '', 'eg', '', 'enoxaparin', '1', 'mgkg', 'every', '12', 'hour', '', 'appropriate', 'follow', 'set', '', 'unless', 'contraindication', 'anticoagulation', '', 'eg', '', 'active', 'bleed', 'serious', 'bleed', 'prior', '24', '48', 'hour', '', 'heparin', '', 'eg', '', 'history', 'heparin-induced', 'thrombocytopenia', '', 'hit', '', '', 'case', 'alternative', 'agent', 'fondaparinux', '', '', 'algorithm', '1', '', '', 'documented', 'presume', 'vte', '', 'therapeutic-dose', '', 'full-dose', '', 'anticoagulation', 'appropriate', 'document', 'venous', 'thromboembolism', '', 'vte', '', '', 'similar', 'individual', 'without', 'covid-19', '', '', 'diagnosis', 'dvt', 'pe', '', '', '', 'full-dose', 'anticoagulation', 'reasonable', 'case', 'suspect', 'vte', 'standard', 'confirmatory', 'test', 'available', 'feasible', '', 'include', 'follow', '', 'patient', 'compute', 'tomography', 'pulmonary', 'angiography', '', 'ctpa', '', 'ventilationperfusion', '', 'vq', '', 'scan', 'feasible', '', 'follow', 'sufficient', 'initiate', 'treatment', '', 'confirmation', 'deep', 'vein', 'thrombosis', '', 'dvt', '', 'bilateral', 'compression', 'ultrasonography', 'legstransthoracic', 'echocardiography', 'point-of-care', 'ultrasound', 'demonstrate', 'clot', 'transit', 'main', 'pulmonary', 'arteryin', 'patient', 'confirmatory', 'test', 'possible', '', 'reasonable', 'treat', 'empirically', 'full-dose', 'anticoagulation', 'base', 'one', 'follow', '', 'sudden', 'deterioration', 'respiratory', 'status', 'intubate', 'patient', 'consistent', 'pulmonary', 'embolism', '', 'pe', '', '', 'especially', 'chest', 'radiography', 'andor', 'inflammatory', 'marker', 'stable', 'improve', 'change', 'attribute', 'cardiac', 'cause', '', 'otherwise', 'unexplained', 'respiratory', 'failure', '', 'eg', '', 'due', 'fluid', 'overload', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', '', 'especially', 'fibrinogen', 'andor', 'd-dimer', 'high', '', 'physical', 'find', 'consistent', 'thrombosis', '', 'superficial', 'thrombophlebitis', 'retiform', 'purpura', 'explain', 'condition', '', 'patient', 'acute', 'vte', 'discharge', 'hospital', '', 'extend', 'thromboprophylaxis', 'reasonable', '', '', 'patients', 'discharge', 'hospital', '', '', '', 'clotting', 'intravascular', 'access', 'device', '', 'full-dose', 'anticoagulation', 'appropriate', 'individual', 'recurrent', 'clot', 'intravascular', 'access', 'device', '', 'arterial', '', 'central', 'venous', 'catheter', '', 'despite', 'prophylactic-intensity', 'anticoagulationfull-dose', 'anticoagulation', 'appropriate', 'clot', 'extracorporeal', 'circuit', '', 'continuous', 'renal', 'replacement', 'therapy', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', '', 'details', 'discuss', 'separately', '', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'adult', '', '', '', 'possibleuncertain', 'role', 'therapeutic-level', 'anticoagulation', 'critically', 'ill', 'patient', '', 'question', 'treatment-dose', 'anticoagulation', 'thromboprophylaxis', 'raise', 'critically', 'ill', 'individual', 'icu', 'confirm', 'suspect', 'acute', 'vte', 'high', 'risk', '', 'describe', '', '', 'vte', '', '', '', 'center', 'recommend', 'intermediate-dose', 'therapeutic-intensity', 'anticoagulation', 'individual', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'venous', 'thromboembolism', 'prevention', '', '', '', 'data', 'compare', 'different', 'level', 'anticoagulation', 'patient', '', 'prophylactic', '', 'intermediate', '', 'therapeutic', 'dose', '', '', 'clinical', 'trial', 'progress', '', 'enrollment', 'trial', 'encourage', '', 'state', 'american', 'society', 'hematology', '', 'ash', '', '', 'empiric', 'full-dose', 'anticoagulation', 'individual', 'vte', 'remain', 'controversial', '', 'since', 'data', 'demonstrate', 'improve', 'outcome', '', 'risk', 'factor', 'vte', 'risk', 'factor', 'increase', 'risk', 'bleed', '', '29', '', '', 'thus', '', 'vte', 'suspect', '', 'confirmatory', 'test', 'obtain', 'indication', 'full-dose', 'anticoagulation', 'seek', 'possible', '', 'especially', 'individual', 'icu', '', 'test', 'find', 'support', 'therapeutic-dose', 'anticoagulation', 'discuss', '', '', 'diagnosis', 'dvt', 'pe', '', '', '', 'indications', 'tpa', '', 'tissue', 'plasminogen', 'activator', '', 'tpa', '', 'appropriate', 'usual', 'indication', '', 'unless', 'contraindication', '', 'limb-threatening', 'dvt', '', '', '', 'catheter-directed', 'thrombolytic', 'therapy', 'deep', 'venous', 'thrombosis', 'lower', 'extremity', '', 'patient', 'selection', 'administration', '', '', '', 'massive', 'pe', '', '', '', 'approach', 'thrombolytic', '', 'fibrinolytic', '', 'therapy', 'acute', 'pulmonary', 'embolism', '', 'patient', 'selection', 'administration', '', '', '', 'acute', 'stroke', '', '', '', 'approach', 'reperfusion', 'therapy', 'acute', 'ischemic', 'stroke', '', '', '', 'acute', 'myocardial', 'infarction', '', '', '', 'acute', 'st-elevation', 'myocardial', 'infarction', '', 'fibrinolytic', 'therapy', '', '', '', 'consultation', 'pulmonary', 'embolism', 'response', 'team', '', 'pert', '', 'stroke', 'team', 'decision-making', 'advise', 'possible', '', 'contrast', '', 'tpa', 'individual', 'nonspecific', 'find', 'hypoxia', 'laboratory', 'evidence', 'hypercoagulability', '', 'case', 'series', 'describe', 'administration', 'tpa', 'three', 'individual', 'ards', 'associate', 'covid-19', 'access', 'eligible', 'intervention', 'ecmo', '', '34', '', '', 'one', 'individual', 'transient', 'improvement', 'laboratory', 'parameter', 'ultimately', 'die', '', 'two', 'improvement', 'laboratory', 'parameter', '', 'clinical', 'outcome', 'describedoutpatient', 'thromboprophylaxispatients', 'discharge', 'hospital', '', 'individuals', 'document', 'vte', 'require', 'minimum', 'three', 'month', 'anticoagulation', '', 'discuss', 'separately', '', '', '', 'overview', 'treatment', 'lower', 'extremity', 'deep', 'vein', 'thrombosis', '', 'dvt', '', '', '', 'section', 'duration', 'therapy', '', '', 'treatment', '', 'prognosis', '', 'follow-up', 'acute', 'pulmonary', 'embolism', 'adult', '', '', '', 'individual', 'vte', 'warrant', 'extend', 'thromboprophylaxis', 'follow', 'discharge', 'hospital', '', 'likely', 'post-discharge', 'prophylactic', 'anticoagulation', 'individual', 'risk', 'factor', 'vte', 'immobilization', '', 'recent', 'surgery', '', 'trauma', '', 'criterion', 'similar', 'apex', 'mariner', 'trial', '', 'include', 'immobility', 'older', 'age', '', 'hospitalize', 'patient', 'covid-19', 'meet', 'criterion', '', 'however', '', 'bleed', 'risk', 'incorporate', 'decision-making', '', 'options', 'post-discharge', 'prophylaxis', 'include', 'clinical', 'trial', '', 'rivaroxaban', '10', 'mg', 'daily', '31', '39', 'day', '', '35', '', '', 'discuss', 'detail', 'separately', '', '', '', 'prevention', 'venous', 'thromboembolic', 'disease', 'acutely', 'ill', 'hospitalize', 'medical', 'adult', '', '', 'section', 'duration', 'prophylaxis', '', '', '', 'patients', 'admit', 'hospital', '', 'outpatient', 'thromboprophylaxis', 'appropriate', 'select', 'individual', 'covid-19', 'admit', 'hospital', '', 'especially', 'thrombotic', 'risk', 'factor', 'prior', 'vte', 'recent', 'surgery', '', 'trauma', '', 'immobilization', '', 'note', 'practice', 'base', 'clinical', 'judgment', '', 'trial', 'address', 'thromboprophylaxis', 'outpatient', 'covid-19if', 'thromboprophylaxis', 'outpatient', '', 'regimen', 'rivaroxaban', '10', 'mg', 'daily', '31', '39', 'day', '', '35', '', '', 'treatment', 'bleed', '', 'bleeding', 'appear', 'major', 'manifestation', 'covid-19', '', 'however', '', 'patient', 'bleed', 'reason', '', 'include', 'trauma', 'andor', 'treatment', 'anticoagulation', '', '', 'bleeding', '', '', '', 'approach', 'bleed', 'similar', 'individual', 'without', 'covid-19', 'involve', 'anticoagulant', 'reversal', 'andor', 'discontinuation', '', 'transfusion', 'thrombocytopenia', 'hypofibrinogenemia', '', 'specific', 'therapy', 'factor', 'replacementanticoagulant-associated', 'bleed', '', '', '', 'management', 'warfarin-associated', 'bleed', 'supratherapeutic', 'inr', '', '', 'management', 'bleed', 'patient', 'receive', 'direct', 'oral', 'anticoagulant', '', '', 'reversal', 'anticoagulation', 'intracranial', 'hemorrhage', '', '', '', 'trauma', 'coagulopathy', '', '', '', 'acute', 'coagulopathy', 'associate', 'trauma', '', '', '', 'underlie', 'bleed', 'disorder', 'immune', 'thrombocytopenia', '', 'itp', '', '', 'hemophilia', '', 'von', 'willebrand', 'disease', '', 'vwd', '', '', '', '', 'immune', 'thrombocytopenia', '', 'itp', '', 'adult', '', 'initial', 'treatment', 'prognosis', '', '', 'treatment', 'bleed', 'perioperative', 'management', 'hemophilia', 'b', '', '', 'von', 'willebrand', 'disease', '', 'vwd', '', '', 'treatment', 'major', 'bleed', 'major', 'surgery', '', '', '', 'antifibrinolytic', 'agent', '', 'tranexamic', 'acid', '', 'epsilon', 'aminocaproic', 'acid', '', 'generally', 'patient', 'disseminate', 'intravascular', 'coagulation', '', 'dic', '', '', 'due', 'concern', 'tip', 'balance', 'towards', 'thrombosis', '', 'thus', '', 'avoid', 'patient', 'covid-19-associated', 'hypercoagulable', 'state', 'predominant', 'find', '', '', 'distinction', 'dic', '', '', 'disseminated', 'intravascular', 'coagulation', '', 'dic', '', 'adult', '', 'evaluation', 'management', '', '', 'section', 'preventiontreatment', 'bleed', '', '', '', 'fibrinogen', 'often', 'increase', 'covid-19', '', 'supplementation', 'fibrinogen', 'require', 'unless', 'bleed', 'attributable', 'hypofibrinogenemia', 'dysfibrinogenemia', '', 'fibrinogen', 'activity', 'level', '', '150', '200', 'mgdl', '', '', '', 'coagulation', 'abnormality', '', '', 'disorders', 'fibrinogen', '', '', 'section', 'treatmentprevention', 'bleed', '', '', '', 'investigational', 'therapy', '', 'number', 'therapy', 'covid-19', 'investigation', '', 'impact', 'thrombotic', 'risk', '', 'however', '', 'effect', 'treatment', 'hemostasis', 'patient', 'population', 'well', 'study', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'participation', 'clinical', 'trial', 'encourage', 'order', 'improve', 'understand', 'effective', 'safest', 'mean', 'prevent', 'treat', 'thrombotic', 'complication', 'covid-19', '', 'investigational', 'therapy', 'appropriate', 'life-threatening', 'situation', 'part', 'clinical', 'trial', '', 'markedly', 'increase', 'd-dimer', 'one', 'criterion', 'identify', 'individual', 'worse', 'prognosis', '', 'close', 'monitor', 'clinical', 'sign', 'thrombosis', 'bleed', 'advise', 'individual', 'covid-19', '', 'input', 'individual', 'expertise', 'hemostasis', 'thrombosis', 'severe', 'unusual', 'presentationssociety', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'society', 'guideline', 'patient', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', 'summary', 'recommendationscoronavirus', 'disease', '2019', '', 'covid-19', '', 'associate', 'hypercoagulable', 'state', 'associate', 'acute', 'inflammatory', 'change', 'laboratory', 'find', 'distinct', 'acute', 'disseminate', 'intravascular', 'coagulation', '', 'dic', '', '', 'save', 'severe', 'disease', '', 'fibrinogen', 'd-dimer', 'increase', '', 'typically', 'modest', 'prolongation', 'prothrombin', 'time', '', 'pt', '', 'activate', 'partial', 'thromboplastin', 'time', '', 'aptt', '', 'mild', 'thrombocytosis', 'thrombocytopenia', '', 'presence', 'lupus', 'anticoagulant', '', 'la', '', 'common', 'individual', 'prolong', 'aptt', '', 'pathogenesis', 'abnormality', 'incompletely', 'understand', '', 'contribute', 'factor', 'relate', 'acute', 'inflammatory', 'response', 'disease', '', '', 'pathogenesis', '', '', '', 'risk', 'venous', 'thromboembolism', '', 'vte', '', 'markedly', 'increase', '', 'especially', 'patient', 'intensive', 'care', 'unit', '', 'icu', '', '', 'case', 'series', 'report', 'prevalence', '25', '43', 'percent', 'icu', 'patient', '', 'often', 'despite', 'prophylactic-dose', 'anticoagulation', '', 'risk', 'thrombotic', 'event', '', 'stroke', '', 'microvascular', 'thrombosis', '', 'le', 'clear', '', '', 'clinical', 'feature', '', '', '', 'patient', 'admit', 'hospital', 'covid-19', 'baseline', 'complete', 'blood', 'count', '', 'cbc', '', 'platelet', 'count', '', 'pt', '', 'aptt', '', 'fibrinogen', '', 'd-dimer', '', 'repeat', 'test', 'accord', 'patient', 'clinical', 'status', '', 'outpatients', 'require', 'coagulation', 'test', '', 'main', 'purpose', 'test', 'obtain', 'prognostic', 'information', 'inform', 'level', 'care', '', '', 'routine', 'test', '', 'patient', '', '', '', '', 'imaging', 'study', 'appropriate', 'suspect', 'vte', 'feasible', '', 'standard', 'diagnostic', 'study', 'feasible', '', 'option', 'determine', 'therapeutic-dose', 'anticoagulation', 'available', '', 'discuss', '', 'laboratory', 'abnormality', 'typical', 'covid-19', 'evaluate', '', 'describe', '', '', 'role', 'additional', 'test', '', '', '', 'management', 'challenge', 'due', 'acuity', 'illness', 'paucity', 'high-quality', 'evidence', 'regard', 'efficacy', 'safety', 'different', 'approach', 'prevent', 'treat', 'thromboembolic', 'complication', 'disease', '', 'general', 'approach', '', 'summarize', 'table', '', 'table', '1', '', 'depict', 'algorithm', '', 'algorithm', '1', '', '', 'include', '', 'inpatient', 'receive', 'thromboprophylaxis', 'unless', 'contraindicate', '', 'low', 'molecular', 'weight', '', 'lmw', '', 'heparin', 'prefer', '', 'unfractionated', 'heparin', 'lmw', 'heparin', 'unavailable', 'kidney', 'function', 'severely', 'impair', '', 'institutional', 'protocol', 'include', 'aggressive', 'anticoagulation', 'intermediate-dose', 'therapeutic-dose', 'anticoagulation', 'thromboprophylaxis', '', '', 'inpatient', 'vte', 'prophylaxis', '', 'possibleuncertain', 'role', 'therapeutic-level', 'anticoagulation', 'critically', 'ill', 'patient', '', '', '', 'therapeutic-dose', '', 'full-dose', '', 'anticoagulation', 'appropriate', 'treat', 'deep', 'vein', 'thrombosis', '', 'dvt', '', 'pulmonary', 'embolism', '', 'pe', '', '', 'unless', 'contraindicate', '', '', 'indications', 'full-dose', 'anticoagulation', '', '', '', 'bleeding', 'unusual', 'occur', '', 'occur', '', 'treatment', 'similar', 'non-covid-19', 'patient', 'include', 'transfusion', '', 'anticoagulant', 'reversal', 'discontinuation', '', 'specific', 'product', 'underlie', 'bleed', 'disorder', '', '', 'treatment', 'bleed', '', '', '', 'participation', 'clinical', 'trial', 'encourage', 'order', 'improve', 'understand', 'effective', 'safest', 'mean', 'prevent', 'treat', 'thrombotic', 'complication', 'covid-19', '', 'disease-specific', 'therapy', 'investigation', 'impact', 'thrombotic', 'risk', '', 'effect', 'treatment', 'hemostasis', 'patient', 'population', 'well', 'document', '', '', 'investigational', 'therapy', '', '', '']",5661,"{'': 1534, 'patient': 110, 'covid-19': 72, 'anticoagulation': 53, 'vte': 45, 'percent': 45, 'individual': 43, 'thrombosis': 35, 'bleed': 32, 'coagulation': 31, 'test': 31, 'acute': 29, 'disease': 28, 'include': 28, 'increase': 27, 'find': 27, 'clinical': 26, 'dic': 26, 'therapy': 25, 'd-dimer': 24}","{'infection': 9, 'sars-cov-2': 2, 'safety': 1}",12,0.4404
ID:127978,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cutaneous', 'manifestation', 'issue', 'relate', 'dermatologic', 'care']","['INTRODUCTION — Coronavirus disease 2019 ( COVID-19 ) , cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , raise many critical issue dermatology dermatologic care .', 'Addressing issue necessary , yet also challenge , direct data base recommendation [ 1 ] .This topic discus issue relate dermatologic care COVID-19 pandemic .', ""Other relevant aspect SARS-CoV-2 infection patient management discuss detail separately.● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Questions answer '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Care patient systemic rheumatic disease pandemic '' ."", ') CUTANEOUS MANIFESTATIONS OF COVID-19 — Case series around world identify range potential dermatologic manifestation COVID-19 [ 2,3 ] .', 'The frequency ( range 0.2 20.4 percent case ) time cutaneous manifestation COVID-19 difficult ascertain [ 4-6 ] .', 'Also unclear association certain skin manifestation illness severity [ 7 ] .', ""Moreover , exclude patient observe skin find may represent cutaneous reaction numerous treatment use COVID-19 [ 7,8 ] .The American Academy Dermatology 's COVID-19 Registry , collaboration American Academy Dermatology International League Dermatologic Societies , attempt collate case better define cutaneous manifestation COVID-19 [ 9 ] ."", ""( See 'Registries ' ."", ') Reported dermatologic manifestation COVID-19 include : ●Exanthematous ( morbilliform ) rash – In several case series , morbilliform rash predominantly involve trunk report common cutaneous manifestation COVID-19 [ 2,3,5,10,11 ] .', ""The rash note either disease onset , frequently , hospital discharge recovery [ 5 ] .●Pernio ( chilblain ) -like acral lesion – Pernio ( chilblain ) -like lesion acral surface ( `` COVID toe '' ) describe across age spectrum patient confirm suspect COVID-19 , absence cold exposure underlie condition associate pernio [ 2,3,12-17 ] ."", 'Our understand pathogenesis lesion still evolution , though appear primarily inflammatory process [ 3,15,17,18 ] .', 'They present erythematous-violaceous purpuric macule finger , elbow , toe , lateral aspect foot , without accompany edema pruritus .', 'Resolution may occur two eight weeks.Patients present new-onset , pernio-like lesion clear cause test severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) polymerase chain reaction ( PCR ) .', 'For patient lesion > 4 week , immunoglobulin M ( IgM ) immunoglobulin G ( IgG ) antibody test may appropriate , follow local guideline depend quality available test .', 'Work-up cause pernio discuss greater detail separately .', ""( See `` Pernio ( chilblain ) '' ."", ') There treatment guideline COVID-19-associated , pernio-like lesion foot hand .', 'However , high-potency topical corticosteroid may helpful lesion cause discomfort.●Livedo-like/retiform purpura/necrotic vascular lesion – Livedo reticularis , retiform purpura , livedoid lesion report patient COVID-19 [ 13,19-22 ] .', 'Retiform purpura necrotic vascular lesion describe three patient severe pulmonary disease [ 21 ] .', 'Histologic immunohistochemistry study skin biopsy reveal pattern complement-mediated microvascular injury involve normally appear skin .', 'Histopathologic find thrombotic vasculopathy and/or laboratory coagulation alteration demonstrate patient severe COVID-19 acral , ischemic lesion [ 18,22 ] .', ""( See `` Approach patient retiform ( angulate ) purpura '' `` Livedoid vasculopathy '' `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", ') ●Urticaria – Acute urticaria without concomitant fever report present sign COVID-19 infection [ 2,3,5,13,23 ] .●Vesicular ( varicella-like ) eruption – There several report describe vesicular-pustular , varicella-like eruption associate COVID-19 [ 2,13,24,25 ] .', 'In series 24 patient , eruption small papule , vesicle , pustule appear 4 30 day onset COVID symptom resolve median 10 day [ 26 ] .', 'A real-time PCR SARS-CoV-2 vesicle content perform four patient yield negative result .', 'Seventeen 24 patient take medication , rule drug reaction.●Multisystem inflammatory syndrome child ( MIS-C ) – An erythematous , polymorphic rash , erythema and/or firm induration hand foot , oral mucositis , conjunctivitis , along systemic , laboratory , image find atypical , severe Kawasaki disease , describe cohort 10 Italian child COVID-19 pandemic [ 27 ] .', 'Similar case report United Kingdom [ 28 ] , United States , country .', 'Case definition MIS-C propose World Health Organization United States Centers Disease Control Prevention .', ""( See `` Kawasaki disease : Epidemiology etiology '' , section 'Multisystem inflammatory syndrome child ' ."", ') Less frequently report dermatologic manifestation include papulosquamous eruption [ 29 ] , erythema multiforme-like lesion [ 30,31 ] , dengue-like rash [ 32,33 ] , petechia [ 34 ] , gangrene [ 35 ] .Some infant bear mother COVID-19 birth transient rash .', 'In review nine small case series China include total 65 pregnant woman infect SARS-CoV-2 pregnancy 67 newborn , two newborn present rash [ 36 ] .', 'The rash describe one infant diffuse , maculopapular eruption resolve one day desquamation another diffuse , red , miliaria-like eruption disappear 10 day without treatment [ 37 ] .DERMATOLOGIC CONDITIONS RELATED TO COVID-19 PANDEMIC — Skin injury , mechanical/friction dermatitis , irritant contact dermatitis due personal protective equipment ( PPE ) hand hygiene measure report majority health care worker involve direct care patient COVID-19 [ 38 ] .Personal protective equipment-induced skin injury — Health care worker care COVID-19 patient patient potentially infect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) may spend long hour wear PPE .', 'The American Academy Dermatology release recommendation prevent treat occupationally induce dermatologic condition COVID-19 pandemic.PPE-induced skin injury common , occur 43 97 percent Chinese health care worker [ 38-40 ] .', 'Long duration PPE use ( > 6 hour per day ) increase rate skin damage [ 38,39 ] .', 'Masks , goggle , face shield , glove apply pressure , create abrasion , retain moisture injure nasal bridge , cheek , forehead , hand [ 38-40 ] .PPE-induced injury include desquamation , erythema , maceration , fissure , papule , erosion , lead itch pain [ 39 ] .', 'PPE use also aggravate underlie skin condition [ 41 ] .Prevention PPE-related injury potential reduce PPE protocol breach due inadvertent adjustment touch [ 42 ] .', 'The use barrier film dress pressure point don PPE may reduce type injury [ 41,43-46 ] .', 'However , effect preventive measure PPE ability prevent viral spread well characterize , caution warrant [ 42,44 ] .', 'Hand hygiene-related dermatitis — Hand hygiene consider key tool COVID-19 .', 'Hand eczema already issue among health care worker likely even greater problem higher rate hand wash glove use pandemic [ 47 ] .The frequency irritant contact dermatitis hand may reduce frequent usage emollient , wash lukewarm water instead hot water , usage alcohol-based cleanser hand visibly dirty [ 41,45,48,49 ] .', 'Overzealous hand hygiene may cause hand eczema general population well [ 50 ] .The American Academy Dermatology release recommendation prevent treat occupationally induce dermatologic condition COVID-19 pandemic .', ""( See `` Irritant contact dermatitis adult '' `` Chronic hand eczema '' ."", ') THERAPEUTIC CONSIDERATIONS DURING THE PANDEMIC — The COVID-19 pandemic lead necessary adjustment therapeutic approach dermatologic disease .', 'Considerations immunosuppressive therapy , phototherapy , skin cancer treatment review .', 'Various professional organization also release guideline clinical care pandemic .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' , section 'Dermatology ' ."", ') Use biologic immunosuppressive therapy — Biologic immunosuppressive therapy play important role management wide variety dermatologic disease , psoriasis , atopic dermatitis , inflammatory autoimmune condition .', 'The risk immunomodulatory therapy relation COVID-19 remain unclear .', 'Although generally accept patient without COVID-19 already take immunosuppressive drug dermatologic disease continue therapy , cautious approach typically take patient suspect confirm COVID-19 patient consider start new immunosuppressive therapy .', ""( See 'Patients without COVID-19 ' 'Patients presume confirm COVID-19 ' ."", ') Assessment risk — The uncertainty regard impact biologic immunosuppressive therapy severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection risk COVID-19 severity make risk assessment challenge [ 51-53 ] .', 'Specific challenge risk assessment include paucity data , various mechanism action immunosuppressive drug , need consider patient-specific disease-specific morbidity comorbidities .', 'Some author propose broad immunosuppression induce small molecule immunosuppressant ( eg , cyclosporine , mycophenolate , azathioprine ) may greater concern target immunosuppression induce biologic drug ; however , relative safety individual immunosuppressant remain unclear [ 54 ] .Consideration potential risk immunosuppressive therapy must also balance consideration detrimental effect skin disease associate condition may result cessation effective therapy [ 55 ] .', 'Cutaneous disease may flare , occasional patient may achieve level response upon reintroduction previously effective biologic therapy [ 52,53 ] .', 'Of note , long half-lives biologic agent mean immunosuppressive effect concern may still persist time follow decision stop therapy.Studies evaluate use immunomodulatory therapy relation COVID-19 patient dermatologic disease limit insufficient draw conclusion risk population [ 56-58 ] .', 'It unclear whether data clinical trial assess risk upper respiratory infection biologic therapy dermatologic disease applicable SARS-CoV-2 infection [ 53,59-61 ] .In support theory risk continue biologic therapy skin disease may low , one retrospective study 5206 patient northern Italy treat biologic agent plaque psoriasis February 20 April 1 , 2020 , find COVID-19-related death four COVID-19-related hospitalization [ 56 ] .', 'In addition , case control study perform Lombardy region Italy involve assessment 1193 patient psoriasis treat biologic small molecule therapy approximately 10 million control February 21 April 9 , 2020 , find higher risk test positive COVID-19 , self-quarantined home due COVID-19 , hospitalize due COVID-19 among psoriasis patient receive biologic therapy compare control find statistically significant increase risk intensive care unit admission die population [ 57 ] .Although potential beneficial effect biologic inhibitor tumor necrosis factor ( TNF ) -alpha interleukin ( IL ) 17 COVID-19 propose base upon theory immunosuppressive drug might inhibitory effect damage immune response think contribute organ damage COVID-19 , prove [ 62-65 ] .', 'Data IL-6 pathway inhibitor review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Course complication ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' ."", ') Patients without COVID-19 — Decisions use immunosuppressive therapy patient without sign symptom COVID-19 global pandemic make case-by-case basis conjunction patient .', ""This may involve review patient 's comorbidities , severity disease originally treat , limit available data , expert opinion , local recommendation , patient preference.Continuation immunosuppressive therapy — Based upon absence evidence suggest benefit discontinue immunosuppressive therapy patient without COVID-19 potential detrimental effect discontinue effective therapy , continuation biologic small molecule immunosuppressant dermatologic disease generally consider safe appropriate option patient suspect document COVID-19 ."", 'Examples society support approach include American Academy Dermatology [ 66 ] , National Psoriasis Foundation [ 67 ] , International Psoriasis Council [ 68 ] , British Academy Dermatology [ 69 ] , International League Dermatological Societies [ 70 ] .Initiation immunosuppressive therapy — Routine avoidance initiate new immunosuppressive therapy dermatologic disease patient without COVID-19 consider necessary .', 'However , give uncertainty remain regard effect immunosuppressive therapy COVID-19 , decision start new immunosuppressive drug dermatologic disease take carefully , involve case-specific review potential risk benefit therapy .', 'In particular , patient perceive increase risk severe COVID-19 , may prudent consider defer immunosuppressive treatment favor therapy [ 66 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ."", ') Some author propose test SARS-CoV-2 infection immunity prior initiation immunosuppressive therapy [ 71 ] .', 'However , value approach unclear.Patients presume confirm COVID-19 — Active infection accept indication discontinuation avoidance initiation immunosuppressive therapy .', 'Some professional society , include American Academy Dermatology , issue statement recommend discontinuation immunosuppressive drug patient develop COVID-19 , although remain area debate [ 72 ] .', 'This approach may appropriate default patient confirm COVID-19 .', 'Immunosuppressive therapy may resume , need , follow complete recovery COVID-19.However , give uncertainty effect various immunosuppressant course COVID-19 , decision discontinue treatment patient COVID-19 make case-by-case basis .', 'Other factor may influence decision cease treatment may include severity COVID-19 , potential biologic treatment may reduce risk cytokine storm , potential negative ramification treatment cessation flare immunologic activity , include dermatologic disease comorbidities.Phototherapy — In-office phototherapy typically involve frequent clinic visit , potentially increase exposure patient clinical staff SARS-CoV-2 .', 'Thus , risk benefit office-based phototherapy weigh carefully individual patient .', 'Home phototherapy alternative may prefer method phototherapy pandemic may feasible patient .', 'If in-office phototherapy necessary , careful precaution , include screen symptom , limit visitor , personal protective equipment ( PPE ) use , equipment disinfection , take reduce risk transmission infection [ 73,74 ] .', 'Alternatives phototherapy also consider .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control health care set ' ."", ') Skin cancer — Many full body skin examination , biopsy , skin cancer excision postpone due COVID-19 pandemic , may lead delay diagnosis treatment .', 'Triage management strategy COVID-19 pandemic melanoma , advance squamous cell carcinoma , advance basal cell carcinoma develop several group , include National Comprehensive Cancer Network , European Society Medical Oncology , American College Mohs Surgery , deferment surgery prompt surgery dependent upon type lesion reason visit [ 75-77 ] .', 'The United States Cutaneous Lymphoma Consortium publish recommendation treatment cutaneous lymphoma COVID-19 pandemic [ 78 ] .For patient advance melanoma nonmelanoma skin cancer treatment , recommendation cease skin cancer-related systemic therapy [ 79,80 ] .', 'However , decision regard continuation initiation systemic target therapy immunotherapy must make case-by-case basis , careful evaluation benefit versus risks.General specific issue relate care cancer patient pandemic discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", ') DELIVERY OF CARE DURING THE PANDEMIC — Local guideline performance routine , nonurgent medical care pandemic differ continue evolve .', 'In many set , pandemic lead increase use telemedicine dermatologic care ( ie , teledermatology ) .', 'In scenario in-person care remain necessary appropriate , precaution limit risk transmission infection indicate .', ""( See 'Telemedicine ' 'In-person care ' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' , section 'Dermatology ' ."", ') Telemedicine — Telemedicine provide opportunity provide care reduce risk exposure clinician , staff , patient individual COVID-19 [ 81,82 ] .', 'Both synchronous ( eg , simultaneous , two-way communication patient clinician via telephone videoconferencing ) asynchronous ( eg , store-and-forward transmission image later assessment clinician ) modality utilize teledermatology care [ 83 ] .', 'A structure triage process may helpful identify patient require in-person , rather telemedicine , visit [ 84,85 ] .', 'Telemedicine may also appropriate option inpatient dermatologic care scenario .', 'The Society Dermatology Hospitalists produce algorithm guide triaging consultation performance safe inpatient dermatologic care [ 86 ] .', 'Concerns raise privacy security telemedicine [ 87,88 ] .', 'The platform select compliant local privacy regulation .', 'Due COVID-19 pandemic , regulatory body relax waive rule allow flexibility telemedicine [ 89 ] .In-person care — In-person visit perform appropriate infection control precaution .', 'This typically include least patient screen use appropriate personal protective equipment ( PPE ) [ 90-92 ] .', 'Best practice infection control clinical set review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control health care set ' ."", ') Although risk transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) procedure dermoscopy remain unclear , clinician cognizant potential transmission equipment may come contact multiple patient .', 'In regard dermoscopy , noncontact dermoscopy prefer form dermoscopy pandemic .', 'Examples additional suggestion reduce risk disease transmission dermoscopy include disinfection dermatoscope alcohol least one minute prior follow examination , use polyvinyl chloride food wrap glass slide lens lesion , use alcohol gel interface medium , use disposable dermoscopic lens cover [ 93-95 ] .REGISTRIES — Multiple registry develop , goal increase knowledge dermatologic manifestation impact COVID-19 patient dermatologic disease .', 'Examples include : ●General dermatologic manifestation COVID-19 patient pre-existing dermatologic condition : •American Academy Dermatology/International League Dermatological Societies COVID-19 Registry●Psoriasis : •Psoriasis Registry Outcomes , Therapy , Epidemiology COVID-19 Infection ( PsoPROTECT ) •Surveillance Epidemiology Coronavirus ( COVID-19 ) Under Research Exclusion Registry ( SECURE-Psoriasis Registry ) ●Atopic dermatitis : •Surveillance Epidemiology Coronavirus ( COVID-19 ) Under Research Exclusion Registry ( SECURE-AD Registry ) ●Alopecia : •Surveillance Epidemiology Coronavirus ( COVID-19 ) Under Research Exclusion Registry ( SECURE-Alopecia Registry ) ●Hidradenitis suppurativa : •Global Hidradenitis Suppurativa COIVD-19 Registry●Acral change pediatric population : •COVID Acral Ischemia/Perniosis Children RegistryDisease registry rheumatologic disease review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Care patient systemic rheumatic disease pandemic '' , section 'Disease registry ' ."", ') SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) pregnancy ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●Multiple skin manifestation describe patient confirm suspect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection ."", 'These include morbilliform rash ; urticaria ; pernio-like , acral lesion ; livedo-like , vascular lesion ; vesicular , varicella-like eruption .', 'A severe multisystem inflammatory syndrome mucocutaneous , systemic , laboratory , image find atypical , severe Kawasaki disease also report child adolescent coronavirus disease 2019 ( COVID-19 ) .', ""( See 'Cutaneous manifestation COVID-19 ' ."", ') ●Skin injury , mechanical/friction dermatitis , hand irritant contact dermatitis due personal protective equipment ( PPE ) hand hygiene measure report majority health care worker involve care patient COVID-19 .', 'Use barrier film dress pressure point PPE frequent use emollient hand wash may help reduce skin damage irritation .', ""( See 'Dermatologic condition relate COVID-19 pandemic ' ."", ') ●The COVID-19 pandemic contribute need adjust aspect dermatologic care .', 'Examples include adjustment approach immunosuppressive treatment , phototherapy , skin cancer treatment , routine clinical care .', ""( See 'Therapeutic consideration pandemic ' 'Delivery care pandemic ' ."", ') ●The impact immunosuppressive therapy dermatologic disease risk SARS-CoV-2 infection risk complication COVID-19 unclear .', 'The decision continue start immunosuppressive therapy dermatologic disease pandemic make case-by-case basis .', ""Examples important factor consider include patient 's infection status , immunosuppressant consideration , impact treatment cessation dermatologic disease comorbidities ."", ""( See 'Therapeutic consideration pandemic ' ."", ') ●Given absence evidence indicate benefit discontinue immunosuppressive therapy patient without COVID-19 , continuation immunosuppressive therapy dermatologic disease consider safe appropriate option population .', 'The decision start new immunosuppressive drug include careful consideration potential risk benefit therapy .', 'For patient risk severe COVID-19 , may appropriate defer immunosuppressive treatment favor therapy .', ""( See 'Patients without COVID-19 ' ."", ') ●Active infection accept indication discontinuation avoidance initiation immunosuppressive therapy , professional organization , include American Academy Dermatology , issue statement recommend discontinuation immunosuppressive drug cutaneous disease patient develop COVID-19 .', 'Given paucity evidence risk benefit discontinuation , decision continue discontinue immunosuppressive treatment patient presume confirm COVID-19 may make case-by-case basis .', 'If discontinue , immunosuppressive therapy may resume upon complete recovery form COVID-19 .', ""( See 'Patients presume confirm COVID-19 ' ."", ') ●The COVID-19 pandemic contribute increase use telemedicine routine clinical care .', 'When in-person visit perform , appropriate infection control precaution implement .', ""( See 'Delivery care pandemic ' . )""]","['', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'raise', 'critical', 'issue', 'dermatology', 'dermatologic', 'care', '', 'addressing', 'issue', 'necessary', '', 'yet', 'challenge', '', 'direct', 'data', 'base', 'recommendation', '', '1', '', 'topic', 'discus', 'issue', 'relate', 'dermatologic', 'care', 'covid-19', 'pandemic', '', 'relevant', 'aspect', 'sars-cov-2', 'infection', 'patient', 'management', 'discuss', 'detail', 'separately', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'questions', 'answer', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'care', 'patient', 'systemic', 'rheumatic', 'disease', 'pandemic', '', '', '', 'cutaneous', 'manifestations', 'covid-19', '', 'case', 'series', 'around', 'world', 'identify', 'range', 'potential', 'dermatologic', 'manifestation', 'covid-19', '', '23', '', '', 'frequency', '', 'range', '02', '204', 'percent', 'case', '', 'time', 'cutaneous', 'manifestation', 'covid-19', 'difficult', 'ascertain', '', '4-6', '', '', 'unclear', 'association', 'certain', 'skin', 'manifestation', 'illness', 'severity', '', '7', '', '', 'moreover', '', 'exclude', 'patient', 'observe', 'skin', 'find', 'represent', 'cutaneous', 'reaction', 'numerous', 'treatment', 'covid-19', '', '78', '', 'american', 'academy', 'dermatology', 'covid-19', 'registry', '', 'collaboration', 'american', 'academy', 'dermatology', 'international', 'league', 'dermatologic', 'societies', '', 'attempt', 'collate', 'case', 'better', 'define', 'cutaneous', 'manifestation', 'covid-19', '', '9', '', '', '', 'registries', '', '', '', 'reported', 'dermatologic', 'manifestation', 'covid-19', 'include', '', 'exanthematous', '', 'morbilliform', '', 'rash', '', 'several', 'case', 'series', '', 'morbilliform', 'rash', 'predominantly', 'involve', 'trunk', 'report', 'common', 'cutaneous', 'manifestation', 'covid-19', '', '2351011', '', '', 'rash', 'note', 'either', 'disease', 'onset', '', 'frequently', '', 'hospital', 'discharge', 'recovery', '', '5', '', 'pernio', '', 'chilblain', '', '-like', 'acral', 'lesion', '', 'pernio', '', 'chilblain', '', '-like', 'lesion', 'acral', 'surface', '', '', 'covid', 'toe', '', '', 'describe', 'across', 'age', 'spectrum', 'patient', 'confirm', 'suspect', 'covid-19', '', 'absence', 'cold', 'exposure', 'underlie', 'condition', 'associate', 'pernio', '', '2312-17', '', '', 'understand', 'pathogenesis', 'lesion', 'still', 'evolution', '', 'though', 'appear', 'primarily', 'inflammatory', 'process', '', '3151718', '', '', 'present', 'erythematous-violaceous', 'purpuric', 'macule', 'finger', '', 'elbow', '', 'toe', '', 'lateral', 'aspect', 'foot', '', 'without', 'accompany', 'edema', 'pruritus', '', 'resolution', 'occur', 'two', 'eight', 'weekspatients', 'present', 'new-onset', '', 'pernio-like', 'lesion', 'clear', 'cause', 'test', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'polymerase', 'chain', 'reaction', '', 'pcr', '', '', 'patient', 'lesion', '', '4', 'week', '', 'immunoglobulin', '', 'igm', '', 'immunoglobulin', 'g', '', 'igg', '', 'antibody', 'test', 'appropriate', '', 'follow', 'local', 'guideline', 'depend', 'quality', 'available', 'test', '', 'work-up', 'cause', 'pernio', 'discuss', 'greater', 'detail', 'separately', '', '', '', 'pernio', '', 'chilblain', '', '', '', '', 'treatment', 'guideline', 'covid-19-associated', '', 'pernio-like', 'lesion', 'foot', 'hand', '', 'however', '', 'high-potency', 'topical', 'corticosteroid', 'helpful', 'lesion', 'cause', 'discomfortlivedo-likeretiform', 'purpuranecrotic', 'vascular', 'lesion', '', 'livedo', 'reticularis', '', 'retiform', 'purpura', '', 'livedoid', 'lesion', 'report', 'patient', 'covid-19', '', '1319-22', '', '', 'retiform', 'purpura', 'necrotic', 'vascular', 'lesion', 'describe', 'three', 'patient', 'severe', 'pulmonary', 'disease', '', '21', '', '', 'histologic', 'immunohistochemistry', 'study', 'skin', 'biopsy', 'reveal', 'pattern', 'complement-mediated', 'microvascular', 'injury', 'involve', 'normally', 'appear', 'skin', '', 'histopathologic', 'find', 'thrombotic', 'vasculopathy', 'andor', 'laboratory', 'coagulation', 'alteration', 'demonstrate', 'patient', 'severe', 'covid-19', 'acral', '', 'ischemic', 'lesion', '', '1822', '', '', '', '', 'approach', 'patient', 'retiform', '', 'angulate', '', 'purpura', '', '', 'livedoid', 'vasculopathy', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'urticaria', '', 'acute', 'urticaria', 'without', 'concomitant', 'fever', 'report', 'present', 'sign', 'covid-19', 'infection', '', '2351323', '', 'vesicular', '', 'varicella-like', '', 'eruption', '', 'several', 'report', 'describe', 'vesicular-pustular', '', 'varicella-like', 'eruption', 'associate', 'covid-19', '', '2132425', '', '', 'series', '24', 'patient', '', 'eruption', 'small', 'papule', '', 'vesicle', '', 'pustule', 'appear', '4', '30', 'day', 'onset', 'covid', 'symptom', 'resolve', 'median', '10', 'day', '', '26', '', '', 'real-time', 'pcr', 'sars-cov-2', 'vesicle', 'content', 'perform', 'four', 'patient', 'yield', 'negative', 'result', '', 'seventeen', '24', 'patient', 'medication', '', 'rule', 'drug', 'reactionmultisystem', 'inflammatory', 'syndrome', 'child', '', 'mis-c', '', '', 'erythematous', '', 'polymorphic', 'rash', '', 'erythema', 'andor', 'firm', 'induration', 'hand', 'foot', '', 'oral', 'mucositis', '', 'conjunctivitis', '', 'along', 'systemic', '', 'laboratory', '', 'image', 'find', 'atypical', '', 'severe', 'kawasaki', 'disease', '', 'describe', 'cohort', '10', 'italian', 'child', 'covid-19', 'pandemic', '', '27', '', '', 'similar', 'case', 'report', 'united', 'kingdom', '', '28', '', '', 'united', 'states', '', 'country', '', 'case', 'definition', 'mis-c', 'propose', 'world', 'health', 'organization', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', '', '', 'kawasaki', 'disease', '', 'epidemiology', 'etiology', '', '', 'section', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', 'less', 'frequently', 'report', 'dermatologic', 'manifestation', 'include', 'papulosquamous', 'eruption', '', '29', '', '', 'erythema', 'multiforme-like', 'lesion', '', '3031', '', '', 'dengue-like', 'rash', '', '3233', '', '', 'petechia', '', '34', '', '', 'gangrene', '', '35', '', 'infant', 'bear', 'mother', 'covid-19', 'birth', 'transient', 'rash', '', 'review', 'nine', 'small', 'case', 'series', 'china', 'include', 'total', '65', 'pregnant', 'woman', 'infect', 'sars-cov-2', 'pregnancy', '67', 'newborn', '', 'two', 'newborn', 'present', 'rash', '', '36', '', '', 'rash', 'describe', 'one', 'infant', 'diffuse', '', 'maculopapular', 'eruption', 'resolve', 'one', 'day', 'desquamation', 'another', 'diffuse', '', 'red', '', 'miliaria-like', 'eruption', 'disappear', '10', 'day', 'without', 'treatment', '', '37', '', 'dermatologic', 'conditions', 'related', 'covid-19', 'pandemic', '', 'skin', 'injury', '', 'mechanicalfriction', 'dermatitis', '', 'irritant', 'contact', 'dermatitis', 'due', 'personal', 'protective', 'equipment', '', 'ppe', '', 'hand', 'hygiene', 'measure', 'report', 'majority', 'health', 'care', 'worker', 'involve', 'direct', 'care', 'patient', 'covid-19', '', '38', '', 'personal', 'protective', 'equipment-induced', 'skin', 'injury', '', 'health', 'care', 'worker', 'care', 'covid-19', 'patient', 'patient', 'potentially', 'infect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'spend', 'long', 'hour', 'wear', 'ppe', '', 'american', 'academy', 'dermatology', 'release', 'recommendation', 'prevent', 'treat', 'occupationally', 'induce', 'dermatologic', 'condition', 'covid-19', 'pandemicppe-induced', 'skin', 'injury', 'common', '', 'occur', '43', '97', 'percent', 'chinese', 'health', 'care', 'worker', '', '38-40', '', '', 'long', 'duration', 'ppe', '', '', '6', 'hour', 'per', 'day', '', 'increase', 'rate', 'skin', 'damage', '', '3839', '', '', 'masks', '', 'goggle', '', 'face', 'shield', '', 'glove', 'apply', 'pressure', '', 'create', 'abrasion', '', 'retain', 'moisture', 'injure', 'nasal', 'bridge', '', 'cheek', '', 'forehead', '', 'hand', '', '38-40', '', 'ppe-induced', 'injury', 'include', 'desquamation', '', 'erythema', '', 'maceration', '', 'fissure', '', 'papule', '', 'erosion', '', 'lead', 'itch', 'pain', '', '39', '', '', 'ppe', 'aggravate', 'underlie', 'skin', 'condition', '', '41', '', 'prevention', 'ppe-related', 'injury', 'potential', 'reduce', 'ppe', 'protocol', 'breach', 'due', 'inadvertent', 'adjustment', 'touch', '', '42', '', '', 'barrier', 'film', 'dress', 'pressure', 'point', 'ppe', 'reduce', 'type', 'injury', '', '4143-46', '', '', 'however', '', 'effect', 'preventive', 'measure', 'ppe', 'ability', 'prevent', 'viral', 'spread', 'well', 'characterize', '', 'caution', 'warrant', '', '4244', '', '', 'hand', 'hygiene-related', 'dermatitis', '', 'hand', 'hygiene', 'consider', 'key', 'tool', 'covid-19', '', 'hand', 'eczema', 'already', 'issue', 'among', 'health', 'care', 'worker', 'likely', 'greater', 'problem', 'higher', 'rate', 'hand', 'wash', 'glove', 'pandemic', '', '47', '', 'frequency', 'irritant', 'contact', 'dermatitis', 'hand', 'reduce', 'frequent', 'usage', 'emollient', '', 'wash', 'lukewarm', 'water', 'instead', 'hot', 'water', '', 'usage', 'alcohol-based', 'cleanser', 'hand', 'visibly', 'dirty', '', '41454849', '', '', 'overzealous', 'hand', 'hygiene', 'cause', 'hand', 'eczema', 'general', 'population', 'well', '', '50', '', 'american', 'academy', 'dermatology', 'release', 'recommendation', 'prevent', 'treat', 'occupationally', 'induce', 'dermatologic', 'condition', 'covid-19', 'pandemic', '', '', '', 'irritant', 'contact', 'dermatitis', 'adult', '', '', 'chronic', 'hand', 'eczema', '', '', '', 'therapeutic', 'considerations', 'pandemic', '', 'covid-19', 'pandemic', 'lead', 'necessary', 'adjustment', 'therapeutic', 'approach', 'dermatologic', 'disease', '', 'considerations', 'immunosuppressive', 'therapy', '', 'phototherapy', '', 'skin', 'cancer', 'treatment', 'review', '', 'various', 'professional', 'organization', 'release', 'guideline', 'clinical', 'care', 'pandemic', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'section', 'dermatology', '', '', '', 'biologic', 'immunosuppressive', 'therapy', '', 'biologic', 'immunosuppressive', 'therapy', 'play', 'important', 'role', 'management', 'wide', 'variety', 'dermatologic', 'disease', '', 'psoriasis', '', 'atopic', 'dermatitis', '', 'inflammatory', 'autoimmune', 'condition', '', 'risk', 'immunomodulatory', 'therapy', 'relation', 'covid-19', 'remain', 'unclear', '', 'although', 'generally', 'accept', 'patient', 'without', 'covid-19', 'already', 'immunosuppressive', 'drug', 'dermatologic', 'disease', 'continue', 'therapy', '', 'cautious', 'approach', 'typically', 'patient', 'suspect', 'confirm', 'covid-19', 'patient', 'consider', 'start', 'new', 'immunosuppressive', 'therapy', '', '', 'patients', 'without', 'covid-19', '', 'patients', 'presume', 'confirm', 'covid-19', '', '', '', 'assessment', 'risk', '', 'uncertainty', 'regard', 'impact', 'biologic', 'immunosuppressive', 'therapy', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', 'risk', 'covid-19', 'severity', 'risk', 'assessment', 'challenge', '', '51-53', '', '', 'specific', 'challenge', 'risk', 'assessment', 'include', 'paucity', 'data', '', 'various', 'mechanism', 'action', 'immunosuppressive', 'drug', '', 'consider', 'patient-specific', 'disease-specific', 'morbidity', 'comorbidities', '', 'author', 'propose', 'broad', 'immunosuppression', 'induce', 'small', 'molecule', 'immunosuppressant', '', 'eg', '', 'cyclosporine', '', 'mofetil', '', 'azathioprine', '', 'greater', 'concern', 'target', 'immunosuppression', 'induce', 'biologic', 'drug', '', 'however', '', 'relative', 'safety', 'individual', 'immunosuppressant', 'remain', 'unclear', '', '54', '', 'consideration', 'potential', 'risk', 'immunosuppressive', 'therapy', 'must', 'balance', 'consideration', 'detrimental', 'effect', 'skin', 'disease', 'associate', 'condition', 'result', 'cessation', 'effective', 'therapy', '', '55', '', '', 'cutaneous', 'disease', 'flare', '', 'occasional', 'patient', 'achieve', 'level', 'response', 'upon', 'reintroduction', 'previously', 'effective', 'biologic', 'therapy', '', '5253', '', '', 'note', '', 'long', 'half-lives', 'biologic', 'agent', 'mean', 'immunosuppressive', 'effect', 'concern', 'still', 'persist', 'time', 'follow', 'decision', 'stop', 'therapystudies', 'evaluate', 'immunomodulatory', 'therapy', 'relation', 'covid-19', 'patient', 'dermatologic', 'disease', 'limit', 'insufficient', 'draw', 'conclusion', 'risk', 'population', '', '56-58', '', '', 'unclear', 'whether', 'data', 'clinical', 'trial', 'assess', 'risk', 'upper', 'respiratory', 'infection', 'biologic', 'therapy', 'dermatologic', 'disease', 'applicable', 'sars-cov-2', 'infection', '', '5359-61', '', 'support', 'theory', 'risk', 'continue', 'biologic', 'therapy', 'skin', 'disease', 'low', '', 'one', 'retrospective', 'study', '5206', 'patient', 'northern', 'italy', 'treat', 'biologic', 'agent', 'plaque', 'psoriasis', 'february', '20', 'april', '1', '', '2020', '', 'find', 'covid-19-related', 'death', 'four', 'covid-19-related', 'hospitalization', '', '56', '', '', 'addition', '', 'case', 'control', 'study', 'perform', 'lombardy', 'region', 'italy', 'involve', 'assessment', '1193', 'patient', 'psoriasis', 'treat', 'biologic', 'small', 'molecule', 'therapy', 'approximately', '10', 'million', 'control', 'february', '21', 'april', '9', '', '2020', '', 'find', 'higher', 'risk', 'test', 'positive', 'covid-19', '', 'self-quarantined', 'home', 'due', 'covid-19', '', 'hospitalize', 'due', 'covid-19', 'among', 'psoriasis', 'patient', 'receive', 'biologic', 'therapy', 'compare', 'control', 'find', 'statistically', 'significant', 'increase', 'risk', 'intensive', 'care', 'unit', 'admission', 'die', 'population', '', '57', '', 'although', 'potential', 'beneficial', 'effect', 'biologic', 'inhibitor', 'tumor', 'necrosis', 'factor', '', 'certolizumab', '', '-alpha', 'interleukin', '', 'il', '', '17', 'covid-19', 'propose', 'base', 'upon', 'theory', 'immunosuppressive', 'drug', 'inhibitory', 'effect', 'damage', 'immune', 'response', 'contribute', 'organ', 'damage', 'covid-19', '', 'prove', '', '62-65', '', '', 'data', 'il-inhibitor', 'pathway', 'inhibitor', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'course', 'complication', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'patients', 'without', 'covid-19', '', 'decisions', 'immunosuppressive', 'therapy', 'patient', 'without', 'sign', 'symptom', 'covid-19', 'global', 'pandemic', 'case-by-case', 'basis', 'conjunction', 'patient', '', 'involve', 'review', 'patient', 'comorbidities', '', 'severity', 'disease', 'originally', 'treat', '', 'limit', 'available', 'data', '', 'expert', 'opinion', '', 'local', 'recommendation', '', 'patient', 'preferencecontinuation', 'immunosuppressive', 'therapy', '', 'based', 'upon', 'absence', 'evidence', 'suggest', 'benefit', 'discontinue', 'immunosuppressive', 'therapy', 'patient', 'without', 'covid-19', 'potential', 'detrimental', 'effect', 'discontinue', 'effective', 'therapy', '', 'continuation', 'biologic', 'small', 'molecule', 'immunosuppressant', 'dermatologic', 'disease', 'generally', 'consider', 'safe', 'appropriate', 'option', 'patient', 'suspect', 'document', 'covid-19', '', 'examples', 'society', 'support', 'approach', 'include', 'american', 'academy', 'dermatology', '', '66', '', '', 'national', 'psoriasis', 'foundation', '', '67', '', '', 'international', 'psoriasis', 'council', '', '68', '', '', 'british', 'academy', 'dermatology', '', '69', '', '', 'international', 'league', 'dermatological', 'societies', '', '70', '', 'initiation', 'immunosuppressive', 'therapy', '', 'routine', 'avoidance', 'initiate', 'new', 'immunosuppressive', 'therapy', 'dermatologic', 'disease', 'patient', 'without', 'covid-19', 'consider', 'necessary', '', 'however', '', 'give', 'uncertainty', 'remain', 'regard', 'effect', 'immunosuppressive', 'therapy', 'covid-19', '', 'decision', 'start', 'new', 'immunosuppressive', 'drug', 'dermatologic', 'disease', 'carefully', '', 'involve', 'case-specific', 'review', 'potential', 'risk', 'benefit', 'therapy', '', 'particular', '', 'patient', 'perceive', 'increase', 'risk', 'severe', 'covid-19', '', 'prudent', 'consider', 'defer', 'immunosuppressive', 'treatment', 'favor', 'therapy', '', '66', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'author', 'propose', 'test', 'sars-cov-2', 'infection', 'immunity', 'prior', 'initiation', 'immunosuppressive', 'therapy', '', '71', '', '', 'however', '', 'value', 'approach', 'unclearpatients', 'presume', 'confirm', 'covid-19', '', 'active', 'infection', 'accept', 'indication', 'discontinuation', 'avoidance', 'initiation', 'immunosuppressive', 'therapy', '', 'professional', 'society', '', 'include', 'american', 'academy', 'dermatology', '', 'issue', 'statement', 'recommend', 'discontinuation', 'immunosuppressive', 'drug', 'patient', 'develop', 'covid-19', '', 'although', 'remain', 'area', 'debate', '', '72', '', '', 'approach', 'appropriate', 'default', 'patient', 'confirm', 'covid-19', '', 'immunosuppressive', 'therapy', 'resume', '', '', 'follow', 'complete', 'recovery', 'covid-19however', '', 'give', 'uncertainty', 'effect', 'various', 'immunosuppressant', 'course', 'covid-19', '', 'decision', 'discontinue', 'treatment', 'patient', 'covid-19', 'case-by-case', 'basis', '', 'factor', 'influence', 'decision', 'cease', 'treatment', 'include', 'severity', 'covid-19', '', 'potential', 'biologic', 'treatment', 'reduce', 'risk', 'cytokine', 'storm', '', 'potential', 'negative', 'ramification', 'treatment', 'cessation', 'flare', 'immunologic', 'activity', '', 'include', 'dermatologic', 'disease', 'comorbiditiesphototherapy', '', 'in-office', 'phototherapy', 'typically', 'involve', 'frequent', 'clinic', 'visit', '', 'potentially', 'increase', 'exposure', 'patient', 'clinical', 'staff', 'sars-cov-2', '', 'thus', '', 'risk', 'benefit', 'office-based', 'phototherapy', 'weigh', 'carefully', 'individual', 'patient', '', 'home', 'phototherapy', 'alternative', 'prefer', 'method', 'phototherapy', 'pandemic', 'feasible', 'patient', '', 'in-office', 'phototherapy', 'necessary', '', 'careful', 'precaution', '', 'include', 'screen', 'symptom', '', 'limit', 'visitor', '', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'equipment', 'disinfection', '', 'reduce', 'risk', 'transmission', 'infection', '', '7374', '', '', 'alternatives', 'phototherapy', 'consider', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'skin', 'cancer', '', 'full', 'body', 'skin', 'examination', '', 'biopsy', '', 'skin', 'cancer', 'excision', 'postpone', 'due', 'covid-19', 'pandemic', '', 'lead', 'delay', 'diagnosis', 'treatment', '', 'triage', 'management', 'strategy', 'covid-19', 'pandemic', 'melanoma', '', 'advance', 'squamous', 'cell', 'carcinoma', '', 'advance', 'basal', 'cell', 'carcinoma', 'develop', 'several', 'group', '', 'include', 'national', 'comprehensive', 'cancer', 'network', '', 'european', 'society', 'medical', 'oncology', '', 'american', 'college', 'mohs', 'surgery', '', 'deferment', 'surgery', 'prompt', 'surgery', 'dependent', 'upon', 'type', 'lesion', 'reason', 'visit', '', '75-77', '', '', 'united', 'states', 'cutaneous', 'lymphoma', 'consortium', 'publish', 'recommendation', 'treatment', 'cutaneous', 'lymphoma', 'covid-19', 'pandemic', '', '78', '', 'patient', 'advance', 'melanoma', 'nonmelanoma', 'skin', 'cancer', 'treatment', '', 'recommendation', 'cease', 'skin', 'cancer-related', 'systemic', 'therapy', '', '7980', '', '', 'however', '', 'decision', 'regard', 'continuation', 'initiation', 'systemic', 'target', 'therapy', 'immunotherapy', 'must', 'case-by-case', 'basis', '', 'careful', 'evaluation', 'benefit', 'versus', 'risksgeneral', 'specific', 'issue', 'relate', 'care', 'cancer', 'patient', 'pandemic', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', 'delivery', 'care', 'pandemic', '', 'local', 'guideline', 'performance', 'routine', '', 'nonurgent', 'medical', 'care', 'pandemic', 'differ', 'continue', 'evolve', '', 'set', '', 'pandemic', 'lead', 'increase', 'telemedicine', 'dermatologic', 'care', '', 'ie', '', 'teledermatology', '', '', 'scenario', 'in-person', 'care', 'remain', 'necessary', 'appropriate', '', 'precaution', 'limit', 'risk', 'transmission', 'infection', 'indicate', '', '', 'telemedicine', '', 'in-person', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'section', 'dermatology', '', '', '', 'telemedicine', '', 'telemedicine', 'provide', 'opportunity', 'provide', 'care', 'reduce', 'risk', 'exposure', 'clinician', '', 'staff', '', 'patient', 'individual', 'covid-19', '', '8182', '', '', 'synchronous', '', 'eg', '', 'simultaneous', '', 'two-way', 'communication', 'patient', 'clinician', 'via', 'telephone', 'videoconferencing', '', 'asynchronous', '', 'eg', '', 'store-and-forward', 'transmission', 'image', 'later', 'assessment', 'clinician', '', 'modality', 'utilize', 'teledermatology', 'care', '', '83', '', '', 'structure', 'triage', 'process', 'helpful', 'identify', 'patient', 'require', 'in-person', '', 'telemedicine', '', 'visit', '', '8485', '', '', 'telemedicine', 'appropriate', 'option', 'inpatient', 'dermatologic', 'care', 'scenario', '', 'society', 'dermatology', 'hospitalists', 'produce', 'algorithm', 'guide', 'triaging', 'consultation', 'performance', 'safe', 'inpatient', 'dermatologic', 'care', '', '86', '', '', 'concerns', 'raise', 'privacy', 'security', 'telemedicine', '', '8788', '', '', 'platform', 'select', 'compliant', 'local', 'privacy', 'regulation', '', 'due', 'covid-19', 'pandemic', '', 'regulatory', 'body', 'relax', 'waive', 'rule', 'allow', 'flexibility', 'telemedicine', '', '89', '', 'in-person', 'care', '', 'in-person', 'visit', 'perform', 'appropriate', 'infection', 'control', 'precaution', '', 'typically', 'include', 'least', 'patient', 'screen', 'appropriate', 'personal', 'protective', 'equipment', '', 'ppe', '', '', '90-92', '', '', 'best', 'practice', 'infection', 'control', 'clinical', 'set', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'although', 'risk', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'procedure', 'dermoscopy', 'remain', 'unclear', '', 'clinician', 'cognizant', 'potential', 'transmission', 'equipment', 'contact', 'multiple', 'patient', '', 'regard', 'dermoscopy', '', 'noncontact', 'dermoscopy', 'prefer', 'form', 'dermoscopy', 'pandemic', '', 'examples', 'additional', 'suggestion', 'reduce', 'risk', 'disease', 'transmission', 'dermoscopy', 'include', 'disinfection', 'dermatoscope', 'alcohol', 'least', 'one', 'minute', 'prior', 'follow', 'examination', '', 'polyvinyl', 'chloride', 'food', 'wrap', 'glass', 'slide', 'lens', 'lesion', '', 'alcohol', 'gel', 'interface', 'medium', '', 'disposable', 'dermoscopic', 'lens', 'cover', '', '93-95', '', 'registries', '', 'multiple', 'registry', 'develop', '', 'goal', 'increase', 'knowledge', 'dermatologic', 'manifestation', 'impact', 'covid-19', 'patient', 'dermatologic', 'disease', '', 'examples', 'include', '', 'general', 'dermatologic', 'manifestation', 'covid-19', 'patient', 'pre-existing', 'dermatologic', 'condition', '', 'american', 'academy', 'dermatologyinternational', 'league', 'dermatological', 'societies', 'covid-19', 'registrypsoriasis', '', 'psoriasis', 'registry', 'outcomes', '', 'therapy', '', 'epidemiology', 'covid-19', 'infection', '', 'psoprotect', '', 'surveillance', 'epidemiology', 'coronavirus', '', 'covid-19', '', 'research', 'exclusion', 'registry', '', 'secure-psoriasis', 'registry', '', 'atopic', 'dermatitis', '', 'surveillance', 'epidemiology', 'coronavirus', '', 'covid-19', '', 'research', 'exclusion', 'registry', '', 'secure-ad', 'registry', '', 'alopecia', '', 'surveillance', 'epidemiology', 'coronavirus', '', 'covid-19', '', 'research', 'exclusion', 'registry', '', 'secure-alopecia', 'registry', '', 'hidradenitis', 'suppurativa', '', 'global', 'hidradenitis', 'suppurativa', 'coivd-19', 'registryacral', 'change', 'pediatric', 'population', '', 'covid', 'acral', 'ischemiaperniosis', 'children', 'registrydisease', 'registry', 'rheumatologic', 'disease', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'care', 'patient', 'systemic', 'rheumatic', 'disease', 'pandemic', '', '', 'section', 'disease', 'registry', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'basics', '', '', '', 'summary', 'recommendationsmultiple', 'skin', 'manifestation', 'describe', 'patient', 'confirm', 'suspect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', '', 'include', 'morbilliform', 'rash', '', 'urticaria', '', 'pernio-like', '', 'acral', 'lesion', '', 'livedo-like', '', 'vascular', 'lesion', '', 'vesicular', '', 'varicella-like', 'eruption', '', 'severe', 'multisystem', 'inflammatory', 'syndrome', 'mucocutaneous', '', 'systemic', '', 'laboratory', '', 'image', 'find', 'atypical', '', 'severe', 'kawasaki', 'disease', 'report', 'child', 'adolescent', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', '', 'cutaneous', 'manifestation', 'covid-19', '', '', '', 'skin', 'injury', '', 'mechanicalfriction', 'dermatitis', '', 'hand', 'irritant', 'contact', 'dermatitis', 'due', 'personal', 'protective', 'equipment', '', 'ppe', '', 'hand', 'hygiene', 'measure', 'report', 'majority', 'health', 'care', 'worker', 'involve', 'care', 'patient', 'covid-19', '', 'barrier', 'film', 'dress', 'pressure', 'point', 'ppe', 'frequent', 'emollient', 'hand', 'wash', 'help', 'reduce', 'skin', 'damage', 'irritation', '', '', 'dermatologic', 'condition', 'relate', 'covid-19', 'pandemic', '', '', '', 'covid-19', 'pandemic', 'contribute', 'adjust', 'aspect', 'dermatologic', 'care', '', 'examples', 'include', 'adjustment', 'approach', 'immunosuppressive', 'treatment', '', 'phototherapy', '', 'skin', 'cancer', 'treatment', '', 'routine', 'clinical', 'care', '', '', 'therapeutic', 'consideration', 'pandemic', '', 'delivery', 'care', 'pandemic', '', '', '', 'impact', 'immunosuppressive', 'therapy', 'dermatologic', 'disease', 'risk', 'sars-cov-2', 'infection', 'risk', 'complication', 'covid-19', 'unclear', '', 'decision', 'continue', 'start', 'immunosuppressive', 'therapy', 'dermatologic', 'disease', 'pandemic', 'case-by-case', 'basis', '', 'examples', 'important', 'factor', 'consider', 'include', 'patient', 'infection', 'status', '', 'immunosuppressant', 'consideration', '', 'impact', 'treatment', 'cessation', 'dermatologic', 'disease', 'comorbidities', '', '', 'therapeutic', 'consideration', 'pandemic', '', '', '', 'given', 'absence', 'evidence', 'indicate', 'benefit', 'discontinue', 'immunosuppressive', 'therapy', 'patient', 'without', 'covid-19', '', 'continuation', 'immunosuppressive', 'therapy', 'dermatologic', 'disease', 'consider', 'safe', 'appropriate', 'option', 'population', '', 'decision', 'start', 'new', 'immunosuppressive', 'drug', 'include', 'careful', 'consideration', 'potential', 'risk', 'benefit', 'therapy', '', 'patient', 'risk', 'severe', 'covid-19', '', 'appropriate', 'defer', 'immunosuppressive', 'treatment', 'favor', 'therapy', '', '', 'patients', 'without', 'covid-19', '', '', '', 'active', 'infection', 'accept', 'indication', 'discontinuation', 'avoidance', 'initiation', 'immunosuppressive', 'therapy', '', 'professional', 'organization', '', 'include', 'american', 'academy', 'dermatology', '', 'issue', 'statement', 'recommend', 'discontinuation', 'immunosuppressive', 'drug', 'cutaneous', 'disease', 'patient', 'develop', 'covid-19', '', 'given', 'paucity', 'evidence', 'risk', 'benefit', 'discontinuation', '', 'decision', 'continue', 'discontinue', 'immunosuppressive', 'treatment', 'patient', 'presume', 'confirm', 'covid-19', 'case-by-case', 'basis', '', 'discontinue', '', 'immunosuppressive', 'therapy', 'resume', 'upon', 'complete', 'recovery', 'form', 'covid-19', '', '', 'patients', 'presume', 'confirm', 'covid-19', '', '', '', 'covid-19', 'pandemic', 'contribute', 'increase', 'telemedicine', 'routine', 'clinical', 'care', '', 'in-person', 'visit', 'perform', '', 'appropriate', 'infection', 'control', 'precaution', 'implement', '', '', 'delivery', 'care', 'pandemic', '', '', '']",3360,"{'': 854, 'covid-19': 100, 'patient': 68, 'disease': 57, 'care': 41, 'therapy': 38, 'coronavirus': 36, 'immunosuppressive': 33, 'dermatologic': 31, 'pandemic': 31, '2019': 27, 'risk': 26, 'infection': 22, 'skin': 21, 'include': 19, 'treatment': 17, 'lesion': 16, 'hand': 16, 'severe': 14, 'biologic': 14}","{'certolizumab': 1, 'mofetil': 1, 'azathioprine': 1, 'infection': 22, 'sars-cov-2': 13, 'safety': 1, 'psoriasis': 7, 'il-inhibitor': 2}",48,0.4215
ID:127766,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'questions', 'answer']","['Written doctor editor UpToDateAll topic update new evidence become available peer review process complete.Literature review current : May 2020 .', '| This topic last update : May 12 , 2020.This topic provide answer commonly ask question UpToDate user .', ""Additional content coronavirus disease 2019 ( COVID-19 ) provide separately.● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") ● ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ."", "") ● ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Questions answer '' ."", ') PRENATAL CAREAre pregnant woman susceptible COVID-19 higher risk complication COVID-19 ? No , limit available data suggest pregnant woman increase risk severe clinical course COVID-19 compare nonpregnant person similar age , infect pregnant patient recover without undergo delivery .', 'In pregnant woman develop COVID-19 pneumonia , early data show approximately rate intensive care unit admission nonpregnant counterpart .', 'However , maternal death report medical literature .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Maternal course ' ."", ') Does COVID-19 increase risk pregnancy complication ? Yes , infect woman , especially develop pneumonia , appear increase frequency preterm birth ( birth 37 week gestation ) cesarean delivery , likely relate severe maternal illness .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Pregnancy complication ' ."", ') Does SARS-CoV-2 cross placenta ? There definite evidence severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) cross placenta infect fetus ; however , case placental tissue membrane positive SARS-CoV-2 case possible utero infection report .', 'The neonatal case may false-positive test result due acquisition infection soon birth .', 'Reports COVID-19 infection neonate generally describe mild disease .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Vertical transmission ' ."", ') How prenatal care modify decrease risk contract COVID-19 ? The American College Obstetricians Gynecologists ( ACOG ) Society Maternal-Fetal Medicine support modify traditional protocol prenatal visit limit person-to-person contact thus help prevent spread COVID-19 .', 'Modifications tailor low- versus high-risk pregnancy ( eg , multiple gestation , hypertension , diabetes ) may include telehealth , reduce number in-person visit , time visit , group test ( eg , aneuploidy , diabetes , infection screen ) minimize maternal contact others , restrict visitor visit test , time indicate obstetric ultrasound examination , time frequency use nonstress test biophysical profile .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Routine prenatal care uninfected woman ' ."", ') Should low-dose aspirin avoid pregnant woman COVID-19 ? Concern possible negative effect nonsteroidal anti-inflammatory drug ( NSAIDs ) raise anecdotal report young , nonpregnant patient receive NSAIDs ( ibuprofen ) early course infection experience severe disease .', 'However , clinical population-based data directly address risk NSAIDs .', 'For patient suspect confirm COVID-19 low-dose aspirin indicate ( eg , prevention preeclampsia ) , ACOG suggest individualize approach continuation versus discontinuation .', 'For example , continue preeclampsia prophylaxis likely worthwhile severely critically ill patient near term .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Use standard medication manage pregnancy complication ' ."", ') Should antenatal glucocorticoid avoid pregnant woman COVID-19 ? For general population , Centers Disease Control Prevention ( CDC ) recommend avoid glucocorticoid COVID-19-positive person associate increase risk mortality patient influenza delay viral clearance patient Middle East respiratory syndrome coronavirus ( MERS-CoV ) infection .', 'However , CDC address use antenatal glucocorticoid reduce neonatal morbidity mortality preterm birth.Because clear benefit antenatal betamethasone administration 24+0 33+6 week gestation patient risk preterm birth within seven day , ACOG continue recommend use standard indication pregnant patient suspect confirm COVID-19 .', 'However , pregnant patient suspect confirm COVID-19 34+0 36+6 week gestation risk preterm birth within seven day , benefit neonate le clear , ACOG advise administer course betamethasone patient .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Use standard medication manage pregnancy complication ' ."", ') LABOR AND DELIVERYIs maternal COVID-19 indication cesarean delivery ? No , COVID-19 indication alter route delivery .', 'Even vertical transmission confirm additional data report , would indication cesarean delivery since would increase maternal risk would unlikely improve newborn outcome .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Route delivery ' ."", ') Should plan induction labor cesarean delivery asymptomatic woman postpone pandemic ? No , asymptomatic woman , induction labor cesarean delivery appropriate medical indication postpone reschedule .', 'This include 39-week induction cesarean delivery patient counsel .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Timing delivery infect woman ' ."", ') How labor pain manage woman COVID-19 ? A neuraxial anesthetic generally prefer option management labor pain provide good analgesia thus reduce cardiopulmonary stress pain anxiety .', 'In addition , available case emergency cesarean require , thus obviate need general anesthesia .', 'The Society Obstetric Anesthesia Perinatology ( SOAP ) suggest consider suspend use nitrous oxide labor analgesia patient confirm suspect COVID-19 insufficient data clean , filter , potential aerosolization nitrous oxide system .', 'They also urge consideration limit use intravenous patient control analgesia risk respiratory depression .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Analgesia anesthesia ' ."", ') Can asymptomatic partner/support person attend labor delivery ? Practices vary institution .', 'At minimum , support person screen accordance hospital policy , symptom consistent COVID-19 , exposure confirm case within 14 day , positive test COVID-19 within 14 day allow attend labor birth .', 'Most facility recognize support person important many labor woman permit one support person must remain labor woman ( may leave room return ) .', ""Additional support person part patient 's labor delivery via video ."", ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Infection control precaution ' ."", ') POSTPARTUMHow baby evaluate ? If mother know COVID-19 , infant COVID-19 suspect test , isolate healthy infant , care accord infection control precaution patient confirm suspect COVID-19 .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Infant evaluation ' ."", "") Should mother COVID-19 separate baby ? The CDC advise health care facility determine whether separate mother know suspect COVID-19 infant case-by-case basis , consider factor mother 's clinical condition ."", ""Separation unnecessary infant 's SARS-CoV-2 test result positive ."", 'If separation indicate ( mother transmission-based precaution ) implement , measure reduce potential mother-to-infant transmission utilize ( eg , physical barrier , mother-baby ≥6 foot separation , maternal use personal protective equipment hand hygiene , use healthy adult infant care ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Mother-baby contact ' ."", ') How long mother-baby precaution home continue recent infection ? After discharge birth facility , mother symptomatic COVID-19 infection maintain distance least six foot newborn use face mask hand hygiene newborn care ( 1 ) least 3 day ( 72 hour ) pass since recovery ( resolution fever without use fever-reducing medication plus improvement respiratory symptom [ cough , shortness breath ] ) ( 2 ) least 10 day pass since symptom first appear .', 'For mother laboratory-confirmed COVID-19 never symptomatic , transmission precaution discontinue least 10 day pass since date first positive COVID-19 diagnostic test .', 'Test-based strategy discontinuation precaution also available .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'After hospital discharge ' ."", ') Can breast milk transmit SARS-CoV-2 ? It unknown whether SARS-CoV-2 transmit breast milk breast milk sample test .', 'One report test find virus breast milk six patient another find virus one three sample breast milk test .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Breastfeeding formula feed ' ."", ') What precaution mother confirm suspect COVID-19 take breastfeed ? Droplet transmission infect mother baby could occur close contact breastfeed .', 'To minimize direct contact , ideally , infant feed express breastmilk healthy caregiver follow hygiene precaution mother recover prove uninfected .', 'In case , mother use strict handwash pump wear face mask pump .', 'If approach possible , mother take precaution prevent transmission infant breastfeed ( include hand breast hygiene use face mask ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Breastfeeding formula feed ' ."", ') Can postpartum woman COVID-19 take NSAIDs postpartum analgesia ? Concern possible negative effect nonsteroidal anti-inflammatory drug ( NSAIDs ) raise anecdotal report young , nonpregnant patient receive NSAIDs ( ibuprofen ) early course infection experience severe disease .', 'However , clinical population-based data directly address risk NSAIDs .', 'Given absence data , European Medicines Agency World Health Organization recommend avoid NSAIDs clinically indicate .', 'Given uncertainty , suggest use acetaminophen prefer analgesic agent , possible , NSAIDs need , lowest effective dose use .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Analgesia ' ."", ') REFERENCES — Supporting reference find link UpToDate topic .']","['written', 'doctor', 'editor', 'uptodateall', 'topic', 'update', 'new', 'evidence', 'become', 'available', 'peer', 'review', 'process', 'completeliterature', 'review', 'current', '', '2020', '', '', 'topic', 'last', 'update', '', '12', '', '2020this', 'topic', 'provide', 'answer', 'commonly', 'ask', 'question', 'uptodate', 'user', '', 'additional', 'content', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'provide', 'separately', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', '', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'questions', 'answer', '', '', '', 'prenatal', 'careare', 'pregnant', 'woman', 'susceptible', 'covid-19', 'higher', 'risk', 'complication', 'covid-19', '', '', 'limit', 'available', 'data', 'suggest', 'pregnant', 'woman', 'increase', 'risk', 'severe', 'clinical', 'course', 'covid-19', 'compare', 'nonpregnant', 'person', 'similar', 'age', '', 'infect', 'pregnant', 'patient', 'recover', 'without', 'undergo', 'delivery', '', 'pregnant', 'woman', 'develop', 'covid-19', 'pneumonia', '', 'early', 'data', 'show', 'approximately', 'rate', 'intensive', 'care', 'unit', 'admission', 'nonpregnant', 'counterpart', '', 'however', '', 'maternal', 'death', 'report', 'medical', 'literature', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'maternal', 'course', '', '', '', 'covid-19', 'increase', 'risk', 'pregnancy', 'complication', '', 'yes', '', 'infect', 'woman', '', 'especially', 'develop', 'pneumonia', '', 'appear', 'increase', 'frequency', 'preterm', 'birth', '', 'birth', '37', 'week', 'gestation', '', 'cesarean', 'delivery', '', 'likely', 'relate', 'severe', 'maternal', 'illness', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'pregnancy', 'complication', '', '', '', 'sars-cov-2', 'cross', 'placenta', '', 'definite', 'evidence', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'cross', 'placenta', 'infect', 'fetus', '', 'however', '', 'case', 'placental', 'tissue', 'membrane', 'positive', 'sars-cov-2', 'case', 'possible', 'utero', 'infection', 'report', '', 'neonatal', 'case', 'false-positive', 'test', 'result', 'due', 'acquisition', 'infection', 'soon', 'birth', '', 'reports', 'covid-19', 'infection', 'neonate', 'generally', 'describe', 'mild', 'disease', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'vertical', 'transmission', '', '', '', 'prenatal', 'care', 'modify', 'decrease', 'risk', 'contract', 'covid-19', '', 'american', 'college', 'obstetricians', 'gynecologists', '', 'acog', '', 'society', 'maternal-fetal', 'medicine', 'support', 'modify', 'traditional', 'protocol', 'prenatal', 'visit', 'limit', 'person-to-person', 'contact', 'thus', 'help', 'prevent', 'spread', 'covid-19', '', 'modifications', 'tailor', 'low-', 'versus', 'high-risk', 'pregnancy', '', 'eg', '', 'multiple', 'gestation', '', 'hypertension', '', 'diabetes', '', 'include', 'telehealth', '', 'reduce', 'number', 'in-person', 'visit', '', 'time', 'visit', '', 'group', 'test', '', 'eg', '', 'aneuploidy', '', 'diabetes', '', 'infection', 'screen', '', 'minimize', 'maternal', 'contact', 'others', '', 'restrict', 'visitor', 'visit', 'test', '', 'time', 'indicate', 'obstetric', 'ultrasound', 'examination', '', 'time', 'frequency', 'nonstress', 'test', 'biophysical', 'profile', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'routine', 'prenatal', 'care', 'uninfected', 'woman', '', '', '', 'low-dose', 'aspirin', 'avoid', 'pregnant', 'woman', 'covid-19', '', 'concern', 'possible', 'negative', 'effect', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'raise', 'anecdotal', 'report', 'young', '', 'nonpregnant', 'patient', 'receive', 'nsaids', '', 'ibuprofen', '', 'early', 'course', 'infection', 'experience', 'severe', 'disease', '', 'however', '', 'clinical', 'population-based', 'data', 'directly', 'address', 'risk', 'nsaids', '', 'patient', 'suspect', 'confirm', 'covid-19', 'low-dose', 'aspirin', 'indicate', '', 'eg', '', 'prevention', 'preeclampsia', '', '', 'acog', 'suggest', 'individualize', 'approach', 'continuation', 'versus', 'discontinuation', '', 'example', '', 'continue', 'preeclampsia', 'prophylaxis', 'likely', 'worthwhile', 'severely', 'critically', 'ill', 'patient', 'near', 'term', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'standard', 'medication', 'manage', 'pregnancy', 'complication', '', '', '', 'antenatal', 'glucocorticoid', 'avoid', 'pregnant', 'woman', 'covid-19', '', 'general', 'population', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'recommend', 'avoid', 'glucocorticoid', 'covid-19-positive', 'person', 'associate', 'increase', 'risk', 'mortality', 'patient', 'influenza', 'delay', 'viral', 'clearance', 'patient', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', 'infection', '', 'however', '', 'cdc', 'address', 'antenatal', 'glucocorticoid', 'reduce', 'neonatal', 'morbidity', 'mortality', 'preterm', 'birthbecause', 'clear', 'benefit', 'antenatal', 'betamethasone', 'administration', '240', '336', 'week', 'gestation', 'patient', 'risk', 'preterm', 'birth', 'within', 'seven', 'day', '', 'acog', 'continue', 'recommend', 'standard', 'indication', 'pregnant', 'patient', 'suspect', 'confirm', 'covid-19', '', 'however', '', 'pregnant', 'patient', 'suspect', 'confirm', 'covid-19', '340', '366', 'week', 'gestation', 'risk', 'preterm', 'birth', 'within', 'seven', 'day', '', 'benefit', 'neonate', 'le', 'clear', '', 'acog', 'advise', 'administer', 'course', 'betamethasone', 'patient', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'standard', 'medication', 'manage', 'pregnancy', 'complication', '', '', '', 'labor', 'deliveryis', 'maternal', 'covid-19', 'indication', 'cesarean', 'delivery', '', '', 'covid-19', 'indication', 'alter', 'route', 'delivery', '', 'vertical', 'transmission', 'confirm', 'additional', 'data', 'report', '', 'indication', 'cesarean', 'delivery', 'since', 'increase', 'maternal', 'risk', 'unlikely', 'improve', 'newborn', 'outcome', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'route', 'delivery', '', '', '', 'plan', 'induction', 'labor', 'cesarean', 'delivery', 'asymptomatic', 'woman', 'postpone', 'pandemic', '', '', 'asymptomatic', 'woman', '', 'induction', 'labor', 'cesarean', 'delivery', 'appropriate', 'medical', 'indication', 'postpone', 'reschedule', '', 'include', '39-week', 'induction', 'cesarean', 'delivery', 'patient', 'counsel', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'timing', 'delivery', 'infect', 'woman', '', '', '', 'labor', 'pain', 'manage', 'woman', 'covid-19', '', 'neuraxial', 'anesthetic', 'generally', 'prefer', 'option', 'management', 'labor', 'pain', 'provide', 'analgesia', 'thus', 'reduce', 'cardiopulmonary', 'stress', 'pain', 'anxiety', '', 'addition', '', 'available', 'case', 'emergency', 'cesarean', 'require', '', 'thus', 'obviate', 'general', 'anesthesia', '', 'society', 'obstetric', 'anesthesia', 'perinatology', '', 'soap', '', 'suggest', 'consider', 'suspend', 'nitrous', 'oxide', 'labor', 'analgesia', 'patient', 'confirm', 'suspect', 'covid-19', 'insufficient', 'data', 'clean', '', 'filter', '', 'potential', 'aerosolization', 'nitrous', 'oxide', 'system', '', 'urge', 'consideration', 'limit', 'intravenous', 'patient', 'control', 'analgesia', 'risk', 'respiratory', 'depression', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'analgesia', 'anesthesia', '', '', '', 'asymptomatic', 'partnersupport', 'person', 'attend', 'labor', 'delivery', '', 'practices', 'vary', 'institution', '', 'minimum', '', 'support', 'person', 'screen', 'accordance', 'hospital', 'policy', '', 'symptom', 'consistent', 'covid-19', '', 'exposure', 'confirm', 'case', 'within', '14', 'day', '', 'positive', 'test', 'covid-19', 'within', '14', 'day', 'allow', 'attend', 'labor', 'birth', '', 'facility', 'recognize', 'support', 'person', 'important', 'labor', 'woman', 'permit', 'one', 'support', 'person', 'must', 'remain', 'labor', 'woman', '', 'leave', 'room', 'return', '', '', 'additional', 'support', 'person', 'part', 'patient', 'labor', 'delivery', 'via', 'video', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'infection', 'control', 'precaution', '', '', '', 'postpartumhow', 'baby', 'evaluate', '', 'mother', 'covid-19', '', 'infant', 'covid-19', 'suspect', 'test', '', 'isolate', 'healthy', 'infant', '', 'care', 'accord', 'infection', 'control', 'precaution', 'patient', 'confirm', 'suspect', 'covid-19', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'infant', 'evaluation', '', '', '', 'mother', 'covid-19', 'separate', 'baby', '', 'cdc', 'advise', 'health', 'care', 'facility', 'determine', 'whether', 'separate', 'mother', 'suspect', 'covid-19', 'infant', 'case-by-case', 'basis', '', 'consider', 'factor', 'mother', 'clinical', 'condition', '', 'separation', 'unnecessary', 'infant', 'sars-cov-2', 'test', 'result', 'positive', '', 'separation', 'indicate', '', 'mother', 'transmission-based', 'precaution', '', 'implement', '', 'measure', 'reduce', 'potential', 'mother-to-infant', 'transmission', 'utilize', '', 'eg', '', 'physical', 'barrier', '', 'mother-baby', '6', 'foot', 'separation', '', 'maternal', 'personal', 'protective', 'equipment', 'hand', 'hygiene', '', 'healthy', 'adult', 'infant', 'care', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'mother-baby', 'contact', '', '', '', 'long', 'mother-baby', 'precaution', 'home', 'continue', 'recent', 'infection', '', 'discharge', 'birth', 'facility', '', 'mother', 'symptomatic', 'covid-19', 'infection', 'maintain', 'distance', 'least', 'six', 'foot', 'newborn', 'face', 'mask', 'hand', 'hygiene', 'newborn', 'care', '', '1', '', 'least', '3', 'day', '', '72', 'hour', '', 'pass', 'since', 'recovery', '', 'resolution', 'fever', 'without', 'fever-reducing', 'medication', 'plus', 'improvement', 'respiratory', 'symptom', '', 'cough', '', 'shortness', 'breath', '', '', '', '2', '', 'least', '10', 'day', 'pass', 'since', 'symptom', 'first', 'appear', '', 'mother', 'laboratory-confirmed', 'covid-19', 'never', 'symptomatic', '', 'transmission', 'precaution', 'discontinue', 'least', '10', 'day', 'pass', 'since', 'date', 'first', 'positive', 'covid-19', 'diagnostic', 'test', '', 'test-based', 'strategy', 'discontinuation', 'precaution', 'available', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'hospital', 'discharge', '', '', '', 'breast', 'milk', 'transmit', 'sars-cov-2', '', 'unknown', 'whether', 'sars-cov-2', 'transmit', 'breast', 'milk', 'breast', 'milk', 'sample', 'test', '', 'one', 'report', 'test', 'find', 'virus', 'breast', 'milk', 'six', 'patient', 'another', 'find', 'virus', 'one', 'three', 'sample', 'breast', 'milk', 'test', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'breastfeeding', 'formula', 'feed', '', '', '', 'precaution', 'mother', 'confirm', 'suspect', 'covid-19', 'breastfeed', '', 'droplet', 'transmission', 'infect', 'mother', 'baby', 'occur', 'close', 'contact', 'breastfeed', '', 'minimize', 'direct', 'contact', '', 'ideally', '', 'infant', 'feed', 'express', 'breastmilk', 'healthy', 'caregiver', 'follow', 'hygiene', 'precaution', 'mother', 'recover', 'prove', 'uninfected', '', 'case', '', 'mother', 'strict', 'handwash', 'pump', 'wear', 'face', 'mask', 'pump', '', 'approach', 'possible', '', 'mother', 'precaution', 'prevent', 'transmission', 'infant', 'breastfeed', '', 'include', 'hand', 'breast', 'hygiene', 'face', 'mask', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'breastfeeding', 'formula', 'feed', '', '', '', 'postpartum', 'woman', 'covid-19', 'nsaids', 'postpartum', 'analgesia', '', 'concern', 'possible', 'negative', 'effect', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'raise', 'anecdotal', 'report', 'young', '', 'nonpregnant', 'patient', 'receive', 'nsaids', '', 'ibuprofen', '', 'early', 'course', 'infection', 'experience', 'severe', 'disease', '', 'however', '', 'clinical', 'population-based', 'data', 'directly', 'address', 'risk', 'nsaids', '', 'given', 'absence', 'data', '', 'european', 'medicines', 'agency', 'world', 'health', 'organization', 'recommend', 'avoid', 'nsaids', 'clinically', 'indicate', '', 'given', 'uncertainty', '', 'suggest', 'acetaminophen', 'prefer', 'analgesic', 'agent', '', 'possible', '', 'nsaids', '', 'lowest', 'effective', 'dose', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'analgesia', '', '', '', 'references', '', 'supporting', 'reference', 'find', 'link', 'uptodate', 'topic', '']",1645,"{'': 471, 'covid-19': 59, 'disease': 35, 'coronavirus': 32, '2019': 30, 'pregnancy': 22, 'patient': 20, 'issue': 18, 'section': 16, 'woman': 14, 'infection': 12, 'delivery': 12, 'mother': 12, 'care': 11, 'risk': 11, 'test': 11, 'labor': 11, 'nsaids': 9, 'precaution': 9, 'pregnant': 8}","{'infection': 12, 'sars-cov-2': 6}",18,0.0
ID:127454,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'questions', 'answer']","['Written doctor editor UpToDateAll topic update new evidence become available peer review process complete.Literature review current : Apr 2020 .', '| This topic last update : May 14 , 2020.This topic provide answer commonly ask question UpToDate user .', 'Additional content coronavirus disease 2019 ( COVID-19 ) provide separately .', ""● ( See `` Coronavirus disease 2019 ( COVID-19 ) pregnancy : Questions answer '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Intensive care ventilation anesthesia machine '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial infarction coronary artery disease issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Psychiatric symptom disorder '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", ') Links society government-sponsored guideline select country region around world provide separately .', ""● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' ."", "") ● ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") Additional COVID-19 content patient education also provide separately.● ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ."", "") ● ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' ."", "") ● ( See `` Patient education : Coronavirus disease 2019 ( COVID-19 ) pregnancy ( The Basics ) '' ."", ') TRANSMISSIONHow SARS-CoV-2 ( virus cause COVID-19 ) transmit ? Person-to-person spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) think occur mainly via respiratory droplet , resemble spread influenza .', 'With droplet transmission , virus release respiratory secretion person infection cough , sneeze , talk infect another person make direct contact mucous membrane .', 'Infection also occur person touch contaminate surface touch eye , nose , mouth .', 'Droplets typically travel six foot ( two meter ) linger air .', 'In one report , SARS-CoV-2 remain viable aerosol experimental condition least three hour ; however , whether clinically meaningful uncertain.While SARS-CoV-2 RNA detect non-respiratory specimen ( eg , stool , blood ) , neither fecal-oral bloodborne transmission appear significant source infection .', 'SARS-CoV-2 infection describe animal , evidence suggest animal major source transmission .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Transmission ' ."", ') What incubation period COVID-19 ? The incubation period COVID-19 think within 14 day follow exposure , case occur approximately four five day exposure .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Incubation period ' ."", ') CLINICAL PRESENTATIONWhat clinical presentation natural history COVID-19 ? The spectrum illness associate COVID-19 wide , range asymptomatic infection life-threatening respiratory failure .', 'When symptom present , typically arise approximately four five day exposure .', 'Symptoms mild approximately 80 percent case often include fever , fatigue , dry cough .', 'Smell taste disorder also report patient COVID-19 ; whether symptom distinguish feature unknown .', 'Gastrointestinal symptom frequently report may present feature patient .', 'Headache , rhinorrhea , sore throat le common .', 'Dyspnea affect approximately 20 30 percent patient , typically arise five eight day symptom onset .', 'Progression dyspnea acute respiratory distress syndrome ( ARDS ) rapid ; thus , onset dyspnea generally indication hospital evaluation management.Pneumonia common manifestation severe disease .', 'ARDS develop sizable minority symptomatic patient associate cytokine release syndrome , characterize fever , progressive hypoxia and/or hypotension , markedly elevate inflammatory marker .', 'ARDS lead cause death , follow sepsis , cardiac complication , secondary infection .', 'The overall case fatality rate estimate two three percent .', 'While severe fatal illness occur anyone , risk rise dramatically age presence chronic illness , include cardiovascular disease , pulmonary disease , diabetes mellitus , kidney disease , cancer .', 'For recover , illness often prolong , last approximately two week mild disease three six week severe disease .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical feature ' ."", ') Is way distinguish COVID-19 clinically respiratory illness , particularly influenza ? No , clinical feature COVID-19 overlap substantially influenza respiratory viral illness .', 'There way distinguish among without test .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical feature ' ."", ') What factor associate severe COVID-19 ? Severe illness occur otherwise healthy individual age , predominantly occur adult advance age underlie medical comorbidities .', 'Comorbidities associate severe illness mortality include : ●Cardiovascular disease●Diabetes mellitus●Hypertension●Chronic lung disease●Cancer●Chronic kidney disease●Obesity ( body mass index ≥30 ) Immunosuppression also presume risk factor severe illness mortality , yet definitively demonstrate study .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ."", ') What major thrombotic complication patient COVID-19 ? COVID-19 hypercoagulable state associate increase risk venous thromboembolism ( VTE ) , often pulmonary embolism ( PE ) .', 'The risk highest individual intensive care unit ( ICU ) , often despite prophylactic anticoagulation .', 'The rate arterial event unclear , rate VTE lower hospitalize medical patient .', 'Bleeding common see , especially set trauma and/or anticoagulation .', 'Thrombotic complication treat therapeutic dose anticoagulation .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'VTE ' ."", ') What major coagulation abnormality patient COVID-19 ? A number laboratory abnormality report , include high fibrinogen D-dimer mild prolongation prothrombin time ( PT ) activate partial thromboplastin time ( aPTT ) .', 'Abnormal coagulation study mainly use monitor clinical status help determine level care .', 'Very high D-dimer associate high mortality rate .', 'Atypical find ( eg , severe thrombocytopenia ) evaluate .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Coagulation abnormality ' ."", ') EVALUATIONWhen patient confirm suspect COVID-19 advise stay home ?', 'Go hospital ? Home management appropriate patient mild symptom ( eg , fever , cough , and/or myalgia without dyspnea ) , provide adequately isolate , monitor , support outpatient set .', 'However , low threshold clinically evaluate patient risk factor severe illness , even mild symptom .', 'Patients manage home educate potential worsen disease advise closely monitor symptom serious disease , include dyspnea persistent chest pain .', 'The development symptom prompt clinical evaluation possible hospitalization .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' , section 'Determine in-person evaluation warrant ' ."", ') What different type test COVID-19 ? There two major type test COVID-19 : ●Nucleic acid amplification test ( NAATs ; eg , reverse transcription polymerase chain reaction [ RT-PCR ] ) – RT-PCR SARS-CoV-2 primary test use diagnose active COVID-19 .', 'The test typically perform nasopharyngeal swab , also perform respiratory tract specimen ( eg , oropharyngeal swab , lower respiratory tract sample ) .', 'There several different RT-PCR assay available , sensitivity specificity assay differ .', '●Serology – Serologic test measure antibody SARS-CoV-2 primarily use identify patient COVID-19 past .', 'While serologic assay help identify patient acute infection , reliable RT-PCR recommend purpose .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') How accurate RT-PCR SARS-CoV-2 ?', 'Should two test perform one ? Tests COVID-19 new , determine accuracy challenge .', 'A positive RT-PCR SARS-CoV-2 generally confirm diagnosis COVID-19 .', 'However , false-negative test upper respiratory specimen well document .', 'If initial test negative suspicion COVID-19 remain determine presence infection important management infection control , suggest repeat test .', 'For hospitalize patient evidence lower respiratory tract involvement , repeat test perform expectorate sputum tracheal aspirate , available .', 'In many case , limit availability test concern false-negative result , diagnosis COVID-19 make presumptively base compatible clinical presentation set exposure risk ( residence travel area widespread community transmission know contact ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", "") HOME CAREWhat advice give patient know presume COVID-19 manage home ? For patient COVID-19 manage home , advise follow : ●Supportive care antipyretics/analgesics ( eg , acetaminophen ) hydration ●Close contact health care provider ●Monitoring clinical worsen , particularly development dyspnea , prompt clinical evaluation possible hospitalization●Separation household member , include pet ( eg , stay separate room possible wear mask room ) ●Frequent hand wash family members●Frequent disinfection commonly touch surface ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' , section 'Management counsel outpatient ' ."", ') How long patient care home stay isolate ? The optimal duration home isolation uncertain .', 'The United States Centers Disease Control Prevention ( CDC ) issue recommendation discontinuation home isolation , include test-based non-test-based strategy .', 'The choice strategy must determine case-by-case basis , since strategy potential limitation .', 'When test-based strategy use , patient may discontinue home isolation : ●Resolution fever without use fever-reducing medication AND●Improvement respiratory symptom ( eg , cough , shortness breath ) AND●Negative result US Food Drug Administration ( FDA ) emergency use authorize molecular assay COVID-19 least two consecutive respiratory specimen collect ≥24 hour apart ( total two negative specimen ) When symptom-based strategy use , patient may discontinue home isolation follow criterion meet : ●At least 10 day pass since symptom first appear AND●At least three day ( 72 hour ) pass since recovery symptom ( define resolution fever without use fever-reducing medication improvement respiratory symptom [ eg , cough , shortness breath ] ) In case , patient may laboratory-confirmed COVID-19 , symptom test .', 'In patient , home isolation may discontinue use test-based strategy time-based strategy ( least 10 day pass since date first positive COVID-19 test ) long evidence subsequent illness .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' ."", ') MEDICATIONSWhat treatment option patient COVID-19 ?', 'Do prove efficacy ? All agent use treatment COVID-19 investigational .', 'Use agent generally limit hospitalize patient risk severe disease .', 'When possible , treatment give part clinical trial .', 'Agents appear promise list : ●Remdesivir novel nucleotide analogue .', 'Emerging data suggest clinical benefit use , recommend remdesivir hospitalize patient severe disease .', 'Although widely available , US Food Drug Administration ( FDA ) authorize emergency use , several center United States elsewhere perform randomize trial evaluate efficacy .', '●Convalescent plasma individual recover COVID-19 contain antibody could potentially hasten recovery patient active COVID-19 .', 'In United States , FDA accept emergency investigational new drug application use convalescent plasma patient severe life-threatening COVID-19.●Interleukin ( IL ) -6 pathway inhibitor , tocilizumab , evaluate patient severe disease and/or feature consistent cytokine release syndrome .', 'Evidence efficacy anecdotal.●Hydroxychloroquine older , oral agent direct antiviral activity SARS-CoV-2 vitro .', 'We suggest use hydroxychloroquine outside clinical trial lack clear benefit use potential toxicities.Other investigational agent include favipiravir , interferon beta , lopinavir-ritonavir , combination therapy hydroxychloroquine plus azithromycin .', 'Because treatment option investigational , monitor adverse effect important part care .', 'Registries clinical trial find WHO website clinicaltrials.gov .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') Should I use acetaminophen NSAIDs provide supportive care ? Nonsteroidal anti-inflammatory drug ( NSAIDs ) theorize cause harm patient COVID-19 , clinical population-based data directly address risk .', 'Given uncertainty , use acetaminophen prefer antipyretic agent patient rather NSAIDs .', 'If NSAIDs need , use lowest effective dose .', 'We routinely discontinue NSAIDs patient use management chronic illness .', 'The FDA , European Medicines Agency ( EMA ) , World Health Organization ( WHO ) recommend NSAIDs avoid clinically indicate .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Uncertainty NSAID use ' ."", ') Should glucocorticoid use treatment COVID-19 ? No , agree recommendation WHO United States Centers Disease Control Prevention ( CDC ) systemic glucocorticoid use patient COVID-19 , unless indication ( eg , exacerbation chronic obstructive pulmonary disease ) .', 'Glucocorticoids associate increase risk mortality patient influenza delay viral clearance patient Middle East respiratory syndrome coronavirus ( MERS-CoV ) infection .', 'Although widely use management severe acute respiratory syndrome ( SARS ) , good evidence benefit , persuasive evidence adverse short- long-term harm .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Limited role glucocorticoid ' ."", ') Do ACE inhibitor ARBs increase likelihood severe COVID-19 ? Patients receive angiotensin-converting-enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARBs ) continue treatment agent .', 'The membrane-bound ACE2 function receptor SARS-CoV-2 , ACE inhibitor ARBs may increase expression ACE2 , speculation patient COVID-19 receive agent may increase risk severe disease .', 'However , evidence support association ACE inhibitor ARBs severe disease , also possible drug may attenuate severity disease .', 'In addition , stop agent patient exacerbate comorbid cardiovascular kidney disease increase mortality .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'ACE inhibitors/ARBs ' `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' , section 'Renin angiotensin system inhibitor ' ."", ') When anticoagulation use , much ? All inpatient COVID-19 ( intensive care unit [ ICU ] , medical , surgical , obstetric ) receive thromboprophylaxis unless contraindicate ( algorithm 1 ) .', 'Prophylactic dose low-molecular-weight ( LMW ) heparin prefer , prophylactic dose unfractionated heparin use LMW heparin unavailable kidney function severely impair .', 'Some institutional protocol include aggressive anticoagulation intermediate dose even therapeutic dose anticoagulation thromboprophylaxis , especially ICU , continue anticoagulation select patient follow discharge .', 'Data lack efficacy safety approach , enrollment clinical trial encourage .', 'Full ( therapeutic ) -dose anticoagulation use venous thromboembolism ( VTE ) treatment .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Management ' ."", ') PREVENTION AND INFECTION CONTROLHave medication show prevent COVID-19 ? No agent know effective prevent COVID-19 .', 'While hydroxychloroquine study prophylactic agent , safety efficacy prove .', 'We suggest neither medication use prophylaxis outside clinical trial .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') What PPE recommend health care worker take care patient suspect confirm COVID-19 ? Any personnel enter room patient suspect confirm COVID-19 wear appropriate personal protective equipment ( PPE ) : gown , glove , eye protection ( eyeglass alone insufficient ) , respirator ( eg , N95 respirator ) .', 'If supply respirator limit , facemasks acceptable alternative , except aerosol-generating procedure ( eg , tracheal intubation , tracheotomy , bronchoscopy , noninvasive ventilation , cardiopulmonary resuscitation ) .', 'Health care worker aware appropriate sequence put ( figure 1 ) take ( figure 2 ) PPE avoid contamination.In addition , patient undergo aerosol-generating procedure place negative-pressure room .', 'Most patient place single-occupancy , neutral-pressure room door close .', 'Patients suspect know COVID-19 place positive-pressure room .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') IMMUNITYDoes protective immunity develop SARS-CoV-2 infection ?', 'Can reinfection occur ? Antibodies virus induce become infect .', 'Preliminary evidence suggest antibody protective , remain definitively establish .', 'Moreover , unknown whether infect patient mount protective immune response long protective effect last .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Immunity risk reinfection ' ."", ') SPECIAL POPULATIONSAsthma/COPDShould patient use inhale glucocorticoid asthma COPD advise stop medication prevent COVID-19 ? No , patient asthma chronic obstructive pulmonary disease ( COPD ) need inhale glucocorticoid maintain control asthma COPD continue usual dose .', 'When indicate , inhale steroid help minimize risk asthma COPD exacerbation associate need interaction health care system .', 'There good evidence inhale glucocorticoid increase susceptibility COVID-19 adverse effect course infection .', 'Stopping may worsen asthma COPD control thereby increase risk complication COVID-19 , acquire .', ""( See `` An overview asthma management '' , section 'Advice relate COVID-19 pandemic ' `` Stable COPD : Overview management '' , section 'Advice relate COVID-19 ' ."", ') Should patient COVID-19 acute exacerbation asthma COPD treat systemic glucocorticoid ? Yes , patient COVID-19 infection concomitant acute exacerbation asthma COPD receive prompt treatment systemic glucocorticoid indicate usual guideline .', 'Delaying therapy increase risk life-threatening exacerbation .', 'While World Health Organization ( WHO ) United States Centers Disease Control Prevention ( CDC ) recommend glucocorticoid routinely use treatment COVID-19 infection , exacerbation asthma COPD consider appropriate indication use .', 'Overall , know benefit systemic glucocorticoid exacerbation asthma COPD outweigh potential harm COVID-19 infection .', ""( See `` An overview asthma management '' , section 'Advice relate COVID-19 pandemic ' `` Stable COPD : Overview management '' , section 'Advice relate COVID-19 ' ."", ') Pregnancy , delivery , breastfeedingWhat special consideration pregnant breastfeed woman ? Issues relate COVID-19 pregnancy , delivery , postpartum period discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' `` Coronavirus disease 2019 ( COVID-19 ) pregnancy : Questions answer '' ."", ') PediatricsWhat multisystem inflammatory syndrome child ? Multisystem inflammatory syndrome child ( MIS-C ) rare serious condition report child Europe , United States , Canada association current recent COVID-19 infection exposure .', 'It share clinical feature Kawasaki disease ( KD ) , KD shock , toxic shock syndrome .', 'Clinical feature include persistent fever , severe illness involvement multiple organ system , elevate inflammatory marker ( table 1 ) .', 'Most child MIS-C survive , although many require intensive care .', 'Pending additional information , child clinical feature MIS-C promptly refer specialist pediatric infectious disease , rheumatology , cardiology , and/or critical care , necessary .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' ."", ') BLOOD DONATIONWhat I tell patient donate blood plasma pandemic ? Blood donation particularly important pandemic due concern supply could become critically low .', 'Having history COVID-19 exclusion donation long illness resolve least 14 day prior donation .', 'Persons recover COVID-19 encourage donate plasma , convalescent plasma investigational treatment COVID-19 .', 'Information donate blood plasma find American Red Cross AABB website contact community blood center .', ""( See `` Blood donor screen : Medical history '' , section 'COVID-19 pandemic revise deferral criterion ' `` Clinical use plasma component '' , section 'Convalescent plasma ' ."", ') REFERENCESSupporting reference find link UpToDate topic .']","['written', 'doctor', 'editor', 'uptodateall', 'topic', 'update', 'new', 'evidence', 'become', 'available', 'peer', 'review', 'process', 'completeliterature', 'review', 'current', '', 'apr', '2020', '', '', 'topic', 'last', 'update', '', '14', '', '2020this', 'topic', 'provide', 'answer', 'commonly', 'ask', 'question', 'uptodate', 'user', '', 'additional', 'content', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'provide', 'separately', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'questions', 'answer', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'intensive', 'care', 'ventilation', 'anesthesia', 'machine', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'infarction', 'coronary', 'artery', 'disease', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'psychiatric', 'symptom', 'disorder', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'additional', 'covid-19', 'content', 'patient', 'education', 'provide', 'separately', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', '', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', '', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'basics', '', '', '', '', 'transmissionhow', 'sars-cov-2', '', 'virus', 'cause', 'covid-19', '', 'transmit', '', 'person-to-person', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'occur', 'mainly', 'via', 'respiratory', 'droplet', '', 'resemble', 'spread', 'influenza', '', 'droplet', 'transmission', '', 'virus', 'release', 'respiratory', 'secretion', 'person', 'infection', 'cough', '', 'sneeze', '', 'talk', 'infect', 'another', 'person', 'direct', 'contact', 'mucous', 'membrane', '', 'infection', 'occur', 'person', 'touch', 'contaminate', 'surface', 'touch', 'eye', '', 'nose', '', 'mouth', '', 'droplets', 'typically', 'travel', 'six', 'foot', '', 'two', 'meter', '', 'linger', 'air', '', 'one', 'report', '', 'sars-cov-2', 'remain', 'viable', 'aerosol', 'experimental', 'condition', 'least', 'three', 'hour', '', 'however', '', 'whether', 'clinically', 'meaningful', 'uncertainwhile', 'sars-cov-2', 'rna', 'detect', 'non-respiratory', 'specimen', '', 'eg', '', 'stool', '', 'blood', '', '', 'neither', 'fecal-oral', 'bloodborne', 'transmission', 'appear', 'significant', 'source', 'infection', '', 'sars-cov-2', 'infection', 'describe', 'animal', '', 'evidence', 'suggest', 'animal', 'major', 'source', 'transmission', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'transmission', '', '', '', 'incubation', 'period', 'covid-19', '', 'incubation', 'period', 'covid-19', 'within', '14', 'day', 'follow', 'exposure', '', 'case', 'occur', 'approximately', 'four', 'five', 'day', 'exposure', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'incubation', 'period', '', '', '', 'clinical', 'presentationwhat', 'clinical', 'presentation', 'natural', 'history', 'covid-19', '', 'spectrum', 'illness', 'associate', 'covid-19', 'wide', '', 'range', 'asymptomatic', 'infection', 'life-threatening', 'respiratory', 'failure', '', 'symptom', 'present', '', 'typically', 'arise', 'approximately', 'four', 'five', 'day', 'exposure', '', 'symptoms', 'mild', 'approximately', '80', 'percent', 'case', 'often', 'include', 'fever', '', 'fatigue', '', 'dry', 'cough', '', 'smell', 'taste', 'disorder', 'report', 'patient', 'covid-19', '', 'whether', 'symptom', 'distinguish', 'feature', 'unknown', '', 'gastrointestinal', 'symptom', 'frequently', 'report', 'present', 'feature', 'patient', '', 'headache', '', 'rhinorrhea', '', 'sore', 'throat', 'le', 'common', '', 'dyspnea', 'affect', 'approximately', '20', '30', 'percent', 'patient', '', 'typically', 'arise', 'five', 'eight', 'day', 'symptom', 'onset', '', 'progression', 'dyspnea', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'rapid', '', 'thus', '', 'onset', 'dyspnea', 'generally', 'indication', 'hospital', 'evaluation', 'managementpneumonia', 'common', 'manifestation', 'severe', 'disease', '', 'ards', 'develop', 'sizable', 'minority', 'symptomatic', 'patient', 'associate', 'cytokine', 'release', 'syndrome', '', 'characterize', 'fever', '', 'progressive', 'hypoxia', 'andor', 'hypotension', '', 'markedly', 'elevate', 'inflammatory', 'marker', '', 'ards', 'lead', 'cause', 'death', '', 'follow', 'sepsis', '', 'cardiac', 'complication', '', 'secondary', 'infection', '', 'overall', 'case', 'fatality', 'rate', 'estimate', 'two', 'three', 'percent', '', 'severe', 'fatal', 'illness', 'occur', 'anyone', '', 'risk', 'rise', 'dramatically', 'age', 'presence', 'chronic', 'illness', '', 'include', 'cardiovascular', 'disease', '', 'pulmonary', 'disease', '', 'diabetes', 'mellitus', '', 'kidney', 'disease', '', 'cancer', '', 'recover', '', 'illness', 'often', 'prolong', '', 'last', 'approximately', 'two', 'week', 'mild', 'disease', 'three', 'six', 'week', 'severe', 'disease', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'feature', '', '', '', 'way', 'distinguish', 'covid-19', 'clinically', 'respiratory', 'illness', '', 'particularly', 'influenza', '', '', 'clinical', 'feature', 'covid-19', 'overlap', 'substantially', 'influenza', 'respiratory', 'viral', 'illness', '', 'way', 'distinguish', 'among', 'without', 'test', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'feature', '', '', '', 'factor', 'associate', 'severe', 'covid-19', '', 'severe', 'illness', 'occur', 'otherwise', 'healthy', 'individual', 'age', '', 'predominantly', 'occur', 'adult', 'advance', 'age', 'underlie', 'medical', 'comorbidities', '', 'comorbidities', 'associate', 'severe', 'illness', 'mortality', 'include', '', 'cardiovascular', 'diseasediabetes', 'mellitushypertensionchronic', 'lung', 'diseasecancerchronic', 'kidney', 'diseaseobesity', '', 'body', 'mass', 'index', '30', '', 'immunosuppression', 'presume', 'risk', 'factor', 'severe', 'illness', 'mortality', '', 'yet', 'definitively', 'demonstrate', 'study', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'major', 'thrombotic', 'complication', 'patient', 'covid-19', '', 'covid-19', 'hypercoagulable', 'state', 'associate', 'increase', 'risk', 'venous', 'thromboembolism', '', 'vte', '', '', 'often', 'pulmonary', 'embolism', '', 'pe', '', '', 'risk', 'highest', 'individual', 'intensive', 'care', 'unit', '', 'icu', '', '', 'often', 'despite', 'prophylactic', 'anticoagulation', '', 'rate', 'arterial', 'event', 'unclear', '', 'rate', 'vte', 'lower', 'hospitalize', 'medical', 'patient', '', 'bleeding', 'common', '', 'especially', 'set', 'trauma', 'andor', 'anticoagulation', '', 'thrombotic', 'complication', 'treat', 'therapeutic', 'dose', 'anticoagulation', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'vte', '', '', '', 'major', 'coagulation', 'abnormality', 'patient', 'covid-19', '', 'number', 'laboratory', 'abnormality', 'report', '', 'include', 'high', 'fibrinogen', 'd-dimer', 'mild', 'prolongation', 'prothrombin', 'time', '', 'pt', '', 'activate', 'partial', 'thromboplastin', 'time', '', 'aptt', '', '', 'abnormal', 'coagulation', 'study', 'mainly', 'monitor', 'clinical', 'status', 'help', 'determine', 'level', 'care', '', 'high', 'd-dimer', 'associate', 'high', 'mortality', 'rate', '', 'atypical', 'find', '', 'eg', '', 'severe', 'thrombocytopenia', '', 'evaluate', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'coagulation', 'abnormality', '', '', '', 'evaluationwhen', 'patient', 'confirm', 'suspect', 'covid-19', 'advise', 'stay', 'home', '', 'hospital', '', 'home', 'management', 'appropriate', 'patient', 'mild', 'symptom', '', 'eg', '', 'fever', '', 'cough', '', 'andor', 'myalgia', 'without', 'dyspnea', '', '', 'provide', 'adequately', 'isolate', '', 'monitor', '', 'support', 'outpatient', 'set', '', 'however', '', 'low', 'threshold', 'clinically', 'evaluate', 'patient', 'risk', 'factor', 'severe', 'illness', '', 'mild', 'symptom', '', 'patients', 'manage', 'home', 'educate', 'potential', 'worsen', 'disease', 'advise', 'closely', 'monitor', 'symptom', 'serious', 'disease', '', 'include', 'dyspnea', 'persistent', 'chest', 'pain', '', 'development', 'symptom', 'prompt', 'clinical', 'evaluation', 'possible', 'hospitalization', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'section', 'determine', 'in-person', 'evaluation', 'warrant', '', '', '', 'different', 'type', 'test', 'covid-19', '', 'two', 'major', 'type', 'test', 'covid-19', '', 'nucleic', 'acid', 'amplification', 'test', '', 'naats', '', 'eg', '', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', '', '', 'rt-pcr', 'sars-cov-2', 'primary', 'test', 'diagnose', 'active', 'covid-19', '', 'test', 'typically', 'perform', 'nasopharyngeal', 'swab', '', 'perform', 'respiratory', 'tract', 'specimen', '', 'eg', '', 'oropharyngeal', 'swab', '', 'lower', 'respiratory', 'tract', 'sample', '', '', 'several', 'different', 'rt-pcr', 'assay', 'available', '', 'sensitivity', 'specificity', 'assay', 'differ', '', 'serology', '', 'serologic', 'test', 'measure', 'antibody', 'sars-cov-2', 'primarily', 'identify', 'patient', 'covid-19', 'past', '', 'serologic', 'assay', 'help', 'identify', 'patient', 'acute', 'infection', '', 'reliable', 'rt-pcr', 'recommend', 'purpose', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'accurate', 'rt-pcr', 'sars-cov-2', '', 'two', 'test', 'perform', 'one', '', 'tests', 'covid-19', 'new', '', 'determine', 'accuracy', 'challenge', '', 'positive', 'rt-pcr', 'sars-cov-2', 'generally', 'confirm', 'diagnosis', 'covid-19', '', 'however', '', 'false-negative', 'test', 'upper', 'respiratory', 'specimen', 'well', 'document', '', 'initial', 'test', 'negative', 'suspicion', 'covid-19', 'remain', 'determine', 'presence', 'infection', 'important', 'management', 'infection', 'control', '', 'suggest', 'repeat', 'test', '', 'hospitalize', 'patient', 'evidence', 'lower', 'respiratory', 'tract', 'involvement', '', 'repeat', 'test', 'perform', 'expectorate', 'sputum', 'tracheal', 'aspirate', '', 'available', '', 'case', '', 'limit', 'availability', 'test', 'concern', 'false-negative', 'result', '', 'diagnosis', 'covid-19', 'presumptively', 'base', 'compatible', 'clinical', 'presentation', 'set', 'exposure', 'risk', '', 'residence', 'travel', 'area', 'widespread', 'community', 'transmission', 'contact', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'home', 'carewhat', 'advice', 'give', 'patient', 'presume', 'covid-19', 'manage', 'home', '', 'patient', 'covid-19', 'manage', 'home', '', 'advise', 'follow', '', 'supportive', 'care', 'antipyreticsanalgesics', '', 'eg', '', 'acetaminophen', '', 'hydration', 'close', 'contact', 'health', 'care', 'provider', 'monitoring', 'clinical', 'worsen', '', 'particularly', 'development', 'dyspnea', '', 'prompt', 'clinical', 'evaluation', 'possible', 'hospitalizationseparation', 'household', 'member', '', 'include', 'pet', '', 'eg', '', 'stay', 'separate', 'room', 'possible', 'wear', 'mask', 'room', '', 'frequent', 'hand', 'wash', 'family', 'membersfrequent', 'disinfection', 'commonly', 'touch', 'surface', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'section', 'management', 'counsel', 'outpatient', '', '', '', 'long', 'patient', 'care', 'home', 'stay', 'isolate', '', 'optimal', 'duration', 'home', 'isolation', 'uncertain', '', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'issue', 'recommendation', 'discontinuation', 'home', 'isolation', '', 'include', 'test-based', 'non-test-based', 'strategy', '', 'choice', 'strategy', 'must', 'determine', 'case-by-case', 'basis', '', 'since', 'strategy', 'potential', 'limitation', '', 'test-based', 'strategy', '', 'patient', 'discontinue', 'home', 'isolation', '', 'resolution', 'fever', 'without', 'fever-reducing', 'medication', 'andimprovement', 'respiratory', 'symptom', '', 'eg', '', 'cough', '', 'shortness', 'breath', '', 'andnegative', 'result', 'us', 'food', 'drug', 'administration', '', 'fda', '', 'emergency', 'authorize', 'molecular', 'assay', 'covid-19', 'least', 'two', 'consecutive', 'respiratory', 'specimen', 'collect', '24', 'hour', 'apart', '', 'total', 'two', 'negative', 'specimen', '', 'symptom-based', 'strategy', '', 'patient', 'discontinue', 'home', 'isolation', 'follow', 'criterion', 'meet', '', 'least', '10', 'day', 'pass', 'since', 'symptom', 'first', 'appear', 'andat', 'least', 'three', 'day', '', '72', 'hour', '', 'pass', 'since', 'recovery', 'symptom', '', 'define', 'resolution', 'fever', 'without', 'fever-reducing', 'medication', 'improvement', 'respiratory', 'symptom', '', 'eg', '', 'cough', '', 'shortness', 'breath', '', '', 'case', '', 'patient', 'laboratory-confirmed', 'covid-19', '', 'symptom', 'test', '', 'patient', '', 'home', 'isolation', 'discontinue', 'test-based', 'strategy', 'time-based', 'strategy', '', 'least', '10', 'day', 'pass', 'since', 'date', 'first', 'positive', 'covid-19', 'test', '', 'long', 'evidence', 'subsequent', 'illness', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', '', 'medicationswhat', 'treatment', 'option', 'patient', 'covid-19', '', 'prove', 'efficacy', '', 'agent', 'treatment', 'covid-19', 'investigational', '', 'agent', 'generally', 'limit', 'hospitalize', 'patient', 'risk', 'severe', 'disease', '', 'possible', '', 'treatment', 'give', 'part', 'clinical', 'trial', '', 'agents', 'appear', 'promise', 'list', '', 'remdesivir', 'novel', 'nucleotide', 'analogue', '', 'emerging', 'data', 'suggest', 'clinical', 'benefit', '', 'recommend', 'remdesivir', 'hospitalize', 'patient', 'severe', 'disease', '', 'although', 'widely', 'available', '', 'us', 'food', 'drug', 'administration', '', 'fda', '', 'authorize', 'emergency', '', 'several', 'center', 'united', 'states', 'elsewhere', 'perform', 'randomize', 'trial', 'evaluate', 'efficacy', '', 'convalescent', 'plasma', 'individual', 'recover', 'covid-19', 'contain', 'antibody', 'potentially', 'hasten', 'recovery', 'patient', 'active', 'covid-19', '', 'united', 'states', '', 'fda', 'accept', 'emergency', 'investigational', 'new', 'drug', 'application', 'convalescent', 'plasma', 'patient', 'severe', 'life-threatening', 'covid-19interleukin', '', 'il', '', '-6', 'pathway', 'inhibitor', '', 'tocilizumab', '', 'evaluate', 'patient', 'severe', 'disease', 'andor', 'feature', 'consistent', 'cytokine', 'release', 'syndrome', '', 'evidence', 'efficacy', 'anecdotalhydroxychloroquine', 'older', '', 'oral', 'agent', 'direct', 'antiviral', 'activity', 'sars-cov-2', 'vitro', '', 'suggest', 'hydroxychloroquine', 'outside', 'clinical', 'trial', 'clear', 'benefit', 'potential', 'toxicitiesother', 'investigational', 'agent', 'include', 'favipiravir', '', 'interferon', 'beta', '', 'lopinavir-ritonavir', '', 'combination', 'therapy', 'hydroxychloroquine', 'plus', 'azithromycin', '', 'treatment', 'option', 'investigational', '', 'monitor', 'adverse', 'effect', 'important', 'part', 'care', '', 'registries', 'clinical', 'trial', 'find', 'website', 'clinicaltrialsgov', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'acetaminophen', 'nsaids', 'provide', 'supportive', 'care', '', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'theorize', 'cause', 'harm', 'patient', 'covid-19', '', 'clinical', 'population-based', 'data', 'directly', 'address', 'risk', '', 'given', 'uncertainty', '', 'acetaminophen', 'prefer', 'antipyretic', 'agent', 'patient', 'nsaids', '', 'nsaids', '', 'lowest', 'effective', 'dose', '', 'routinely', 'discontinue', 'nsaids', 'patient', 'management', 'chronic', 'illness', '', 'fda', '', 'european', 'medicines', 'agency', '', 'ema', '', '', 'world', 'health', 'organization', '', '', 'recommend', 'nsaids', 'avoid', 'clinically', 'indicate', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'uncertainty', 'nsaid', '', '', '', 'glucocorticoid', 'treatment', 'covid-19', '', '', 'agree', 'recommendation', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'systemic', 'glucocorticoid', 'patient', 'covid-19', '', 'unless', 'indication', '', 'eg', '', 'exacerbation', 'chronic', 'obstructive', 'pulmonary', 'disease', '', '', 'glucocorticoids', 'associate', 'increase', 'risk', 'mortality', 'patient', 'influenza', 'delay', 'viral', 'clearance', 'patient', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', 'infection', '', 'although', 'widely', 'management', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', 'evidence', 'benefit', '', 'persuasive', 'evidence', 'adverse', 'short-', 'long-term', 'harm', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'limited', 'role', 'glucocorticoid', '', '', '', 'ace', 'inhibitor', 'arbs', 'increase', 'likelihood', 'severe', 'covid-19', '', 'patients', 'receive', 'angiotensin-converting-enzyme', '', 'ace', '', 'inhibitor', 'angiotensin', 'receptor', 'blocker', '', 'arbs', '', 'continue', 'treatment', 'agent', '', 'membrane-bound', 'ace2', 'function', 'receptor', 'sars-cov-2', '', 'ace', 'inhibitor', 'arbs', 'increase', 'expression', 'ace2', '', 'speculation', 'patient', 'covid-19', 'receive', 'agent', 'increase', 'risk', 'severe', 'disease', '', 'however', '', 'evidence', 'support', 'association', 'ace', 'inhibitor', 'arbs', 'severe', 'disease', '', 'possible', 'drug', 'attenuate', 'severity', 'disease', '', 'addition', '', 'stop', 'agent', 'patient', 'exacerbate', 'comorbid', 'cardiovascular', 'kidney', 'disease', 'increase', 'mortality', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'ace', 'inhibitorsarbs', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'section', 'renin', 'angiotensin', 'system', 'inhibitor', '', '', '', 'anticoagulation', '', 'much', '', 'inpatient', 'covid-19', '', 'intensive', 'care', 'unit', '', 'icu', '', '', 'medical', '', 'surgical', '', 'obstetric', '', 'receive', 'thromboprophylaxis', 'unless', 'contraindicate', '', 'algorithm', '1', '', '', 'prophylactic', 'dose', 'low-molecular-weight', '', 'lmw', '', 'heparin', 'prefer', '', 'prophylactic', 'dose', 'unfractionated', 'heparin', 'lmw', 'heparin', 'unavailable', 'kidney', 'function', 'severely', 'impair', '', 'institutional', 'protocol', 'include', 'aggressive', 'anticoagulation', 'intermediate', 'dose', 'therapeutic', 'dose', 'anticoagulation', 'thromboprophylaxis', '', 'especially', 'icu', '', 'continue', 'anticoagulation', 'select', 'patient', 'follow', 'discharge', '', 'data', 'efficacy', 'safety', 'approach', '', 'enrollment', 'clinical', 'trial', 'encourage', '', 'full', '', 'therapeutic', '', '-dose', 'anticoagulation', 'venous', 'thromboembolism', '', 'vte', '', 'treatment', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'management', '', '', '', 'prevention', 'infection', 'controlhave', 'medication', 'show', 'prevent', 'covid-19', '', 'agent', 'effective', 'prevent', 'covid-19', '', 'hydroxychloroquine', 'study', 'prophylactic', 'agent', '', 'safety', 'efficacy', 'prove', '', 'suggest', 'neither', 'medication', 'prophylaxis', 'outside', 'clinical', 'trial', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'ppe', 'recommend', 'health', 'care', 'worker', 'care', 'patient', 'suspect', 'confirm', 'covid-19', '', 'personnel', 'enter', 'room', 'patient', 'suspect', 'confirm', 'covid-19', 'wear', 'appropriate', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'gown', '', 'glove', '', 'eye', 'protection', '', 'eyeglass', 'alone', 'insufficient', '', '', 'respirator', '', 'eg', '', 'n95', 'respirator', '', '', 'supply', 'respirator', 'limit', '', 'facemasks', 'acceptable', 'alternative', '', 'except', 'aerosol-generating', 'procedure', '', 'eg', '', 'tracheal', 'intubation', '', 'tracheotomy', '', 'bronchoscopy', '', 'noninvasive', 'ventilation', '', 'cardiopulmonary', 'resuscitation', '', '', 'health', 'care', 'worker', 'aware', 'appropriate', 'sequence', 'put', '', 'figure', '1', '', '', 'figure', '2', '', 'ppe', 'avoid', 'contaminationin', 'addition', '', 'patient', 'undergo', 'aerosol-generating', 'procedure', 'place', 'negative-pressure', 'room', '', 'patient', 'place', 'single-occupancy', '', 'neutral-pressure', 'room', 'door', 'close', '', 'patients', 'suspect', 'covid-19', 'place', 'positive-pressure', 'room', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'immunitydoes', 'protective', 'immunity', 'develop', 'sars-cov-2', 'infection', '', 'reinfection', 'occur', '', 'antibodies', 'virus', 'induce', 'become', 'infect', '', 'preliminary', 'evidence', 'suggest', 'antibody', 'protective', '', 'remain', 'definitively', 'establish', '', 'moreover', '', 'unknown', 'whether', 'infect', 'patient', 'mount', 'protective', 'immune', 'response', 'long', 'protective', 'effect', 'last', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'immunity', 'risk', 'reinfection', '', '', '', 'special', 'populationsasthmacopdshould', 'patient', 'inhale', 'glucocorticoid', 'asthma', 'copd', 'advise', 'stop', 'medication', 'prevent', 'covid-19', '', '', 'patient', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', 'inhale', 'glucocorticoid', 'maintain', 'control', 'asthma', 'copd', 'continue', 'usual', 'dose', '', 'indicate', '', 'inhale', 'steroid', 'help', 'minimize', 'risk', 'asthma', 'copd', 'exacerbation', 'associate', 'interaction', 'health', 'care', 'system', '', 'evidence', 'inhale', 'glucocorticoid', 'increase', 'susceptibility', 'covid-19', 'adverse', 'effect', 'course', 'infection', '', 'stopping', 'worsen', 'asthma', 'copd', 'control', 'thereby', 'increase', 'risk', 'complication', 'covid-19', '', 'acquire', '', '', '', 'overview', 'asthma', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', 'pandemic', '', '', 'stable', 'copd', '', 'overview', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', '', '', '', 'patient', 'covid-19', 'acute', 'exacerbation', 'asthma', 'copd', 'treat', 'systemic', 'glucocorticoid', '', 'yes', '', 'patient', 'covid-19', 'infection', 'concomitant', 'acute', 'exacerbation', 'asthma', 'copd', 'receive', 'prompt', 'treatment', 'systemic', 'glucocorticoid', 'indicate', 'usual', 'guideline', '', 'delaying', 'therapy', 'increase', 'risk', 'life-threatening', 'exacerbation', '', 'world', 'health', 'organization', '', '', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'recommend', 'glucocorticoid', 'routinely', 'treatment', 'covid-19', 'infection', '', 'exacerbation', 'asthma', 'copd', 'consider', 'appropriate', 'indication', '', 'overall', '', 'benefit', 'systemic', 'glucocorticoid', 'exacerbation', 'asthma', 'copd', 'outweigh', 'potential', 'harm', 'covid-19', 'infection', '', '', '', 'overview', 'asthma', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', 'pandemic', '', '', 'stable', 'copd', '', 'overview', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', '', '', '', 'pregnancy', '', 'delivery', '', 'breastfeedingwhat', 'special', 'consideration', 'pregnant', 'breastfeed', 'woman', '', 'issues', 'relate', 'covid-19', 'pregnancy', '', 'delivery', '', 'postpartum', 'period', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'questions', 'answer', '', '', '', 'pediatricswhat', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'mis-c', '', 'rare', 'serious', 'condition', 'report', 'child', 'europe', '', 'united', 'states', '', 'canada', 'association', 'current', 'recent', 'covid-19', 'infection', 'exposure', '', 'share', 'clinical', 'feature', 'kawasaki', 'disease', '', 'kd', '', '', 'kd', 'shock', '', 'toxic', 'shock', 'syndrome', '', 'clinical', 'feature', 'include', 'persistent', 'fever', '', 'severe', 'illness', 'involvement', 'multiple', 'organ', 'system', '', 'elevate', 'inflammatory', 'marker', '', 'table', '1', '', '', 'child', 'mis-c', 'survive', '', 'although', 'require', 'intensive', 'care', '', 'pending', 'additional', 'information', '', 'child', 'clinical', 'feature', 'mis-c', 'promptly', 'refer', 'specialist', 'pediatric', 'infectious', 'disease', '', 'rheumatology', '', 'cardiology', '', 'andor', 'critical', 'care', '', 'necessary', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', 'blood', 'donationwhat', 'tell', 'patient', 'donate', 'blood', 'plasma', 'pandemic', '', 'blood', 'donation', 'particularly', 'important', 'pandemic', 'due', 'concern', 'supply', 'become', 'critically', 'low', '', 'history', 'covid-19', 'exclusion', 'donation', 'long', 'illness', 'resolve', 'least', '14', 'day', 'prior', 'donation', '', 'persons', 'recover', 'covid-19', 'encourage', 'donate', 'plasma', '', 'convalescent', 'plasma', 'investigational', 'treatment', 'covid-19', '', 'information', 'donate', 'blood', 'plasma', 'find', 'american', 'red', 'cross', 'aabb', 'website', 'contact', 'community', 'blood', 'center', '', '', '', 'blood', 'donor', 'screen', '', 'medical', 'history', '', '', 'section', 'covid-19', 'pandemic', 'revise', 'deferral', 'criterion', '', '', 'clinical', 'plasma', 'component', '', '', 'section', 'convalescent', 'plasma', '', '', '', 'referencessupporting', 'reference', 'find', 'link', 'uptodate', 'topic', '']",3237,"{'': 957, 'covid-19': 108, 'disease': 75, 'coronavirus': 51, 'patient': 50, '2019': 49, 'clinical': 30, 'section': 26, 'care': 22, 'management': 21, 'infection': 21, 'severe': 20, 'feature': 18, 'respiratory': 16, 'home': 15, 'illness': 15, 'risk': 15, 'test': 15, 'symptom': 14, 'diagnosis': 13}","{'tocilizumab': 1, 'hydroxychloroquine': 3, 'infection': 21, 'sars-cov-2': 12, 'vitro': 1, 'safety': 2}",40,0.0
ID:127429,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult']","['INTRODUCTION — Coronaviruses important human animal pathogen .', 'At end 2019 , novel coronavirus identify cause cluster pneumonia case Wuhan , city Hubei Province China .', 'It rapidly spread , result global pandemic .', 'The disease designate COVID-19 , stand coronavirus disease 2019 [ 1 ] .', 'The virus cause COVID-19 designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) ; previously , refer 2019-nCoV.This topic discus management COVID-19 hospitalize adult .', 'Our approach hospital management base limit data evolve rapidly clinical data emerge .', 'Clinicians consult local protocol management , may differ approach .', 'Interim guidance issue World Health Organization , United States , Centers Disease Control Prevention [ 2,3 ] National Institutes Health COVID-19 Treatment Guidelines Panel [ 4 ] .', 'Links relate society guideline find elsewhere .', ""( See 'Society guideline link ' ."", ') The management patient COVID-19 home outpatient set discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' . )"", '( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') The epidemiology , clinical feature , diagnosis , prevention COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") Issues relate COVID-19 specific population discuss elsewhere : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", ') Community-acquired coronaviruses , severe acute respiratory syndrome ( SARS ) coronavirus , Middle East respiratory syndrome ( MERS ) coronavirus discuss separately .', ""( See `` Coronaviruses '' `` Severe acute respiratory syndrome ( SARS ) '' `` Middle East respiratory syndrome coronavirus : Virology , pathogenesis , epidemiology '' ."", ') EVALUATION — Our objective evaluation hospitalize patient document suspect COVID-19 evaluate feature associate severe illness ( table 1 ) identify organ dysfunction comorbidities could complicate potential therapy .', 'The diagnosis COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') Although check several laboratory test evaluate patient document suspect COVID-19 , prognostic value many remain uncertain , institution may include test .', ""At least initially , check follow laboratory study daily : ●Complete blood count ( CBC ) differential , focus total lymphocyte count trend●Complete metabolic panel●Creatine kinase ( CK ) ●C-reactive protein ( CRP ) ●FerritinInitially , check follow study every day ( daily elevate intensive care unit ) : ●Prothrombin time ( PT ) /partial prothrombin time ( PTT ) /fibrinogen●D-dimerWe check follow study baseline repeat abnormal clinical worsen : ●Lactate dehydrogenase , repeat daily elevated●Troponin , repeat every two three day elevated●Electrocardiogram ( ECG ) , least one repeat test start QTc-prolonging agent ( see `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' , section 'Monitoring QT prolongation ' ) We also check hepatitis B virus serology , hepatitis C virus antibody , HIV antigen/antibody test previously perform ."", ""Chronic viral hepatitis could affect interpretation transaminase elevation exacerbate hepatotoxicity certain therapy ; underlie HIV infection may change assessment patient 's risk deterioration would warrant initiation antiretroviral therapy ."", 'We check portable chest radiograph hospitalize patient COVID-19 ; patient , sufficient initial evaluation pulmonary complication extent lung involvement .', 'Although chest compute tomography ( CT ) frequently use China evaluation patient COVID-19 , reserve chest CT circumstance might change clinical management , part minimize infection control issue relate transport .', 'This consistent recommendation American College Radiology [ 5 ] .', 'Although certain characteristic chest CT find may see COVID-19 , reliably distinguish COVID-19 cause viral pneumonia .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Imaging find ' ."", ') We routinely obtain echocardiogram patient COVID-19 ; development might warrant echocardiogram include increase troponin level hemodynamic compromise cardiovascular find suggestive cardiomyopathy .', 'Acute myocardial injury describe complication COVID-19 .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' , section 'When suspect myocardial injury key consideration ' . )"", 'Secondary bacterial infection frequently report feature COVID-19 ; suspect ( eg , base chest image sudden deterioration ) , check two set blood culture sputum Gram stain culture .', 'Procalcitonin check ass risk secondary bacterial infection ; however , since elevate procalcitonin level report COVID-19 progress , may le specific bacterial infection later disease course [ 6-9 ] .', 'As , prognostic value result test use evaluate patient COVID-19 uncertain , optimal use marker remain unknown .', 'As example , although clinician also note potential utility troponin level inform risk severe COVID-19 provide baseline comparison patient develop manifestation myocardial injury [ 10 ] , others reserve troponin level test patient specific clinical suspicion acute coronary syndrome [ 11 ] .', 'One concern result could lead unnecessary use medical resource ( eg , serial troponins , electrocardiogram cardiology consult elevate troponin ) .', 'If troponin check patient COVID-19 , clinician aware elevate level necessarily indicate acute coronary syndrome .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' , section 'Troponin ' . )"", 'GENERAL MANAGEMENT ISSUESEmpiric treatment bacterial pneumonia select patient — For patient document COVID-19 , routinely administer empiric therapy bacterial pneumonia .', 'Data limit , bacterial superinfection appear prominent feature COVID-19 .', 'However , since clinical feature COVID-19 may difficult distinguish bacterial pneumonia , empiric treatment community-acquired pneumonia reasonable diagnosis uncertain .', 'Empiric treatment bacterial pneumonia may also reasonable patient document COVID-19 clinical suspicion ( eg , new fever defervescence new consolidation chest image ) .', 'If empiric antibiotic therapy initiate , attempt make microbial diagnosis ( eg , sputum Gram stain culture , urinary antigen test ) reevaluate need continue antibiotic therapy daily .', 'In set , low procalcitonin may helpful suggest bacterial pneumonia ; however , elevate procalcitonin describe COVID-19 , particularly late course illness , necessarily indicate bacterial infection [ 6-9 ] .', ""( See `` Procalcitonin use lower respiratory tract infection '' , section 'Guiding antibiotic therapy ' ."", ') The diagnosis empiric antibiotic regimen community-acquired health care-associated pneumonia discuss elsewhere .', ""( See `` Overview community-acquired pneumonia adult '' `` Epidemiology , pathogenesis , microbiology , diagnosis hospital-acquired ventilator-associated pneumonia adult '' `` Treatment hospital-acquired ventilator-associated pneumonia adult '' ."", ') Prevention evaluation venous thromboembolism — We favor pharmacologic prophylaxis venous thromboembolism hospitalize patient COVID-19 , consistent recommendation several expert society [ 12-14 ] .', 'Dosing selection pharmacologic agent prevent venous thromboembolism hospitalize patient COVID-19 discuss detail elsewhere ( algorithm 1 ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Inpatient VTE prophylaxis ' ."", ') Several study suggest high rate thromboembolic complication among hospitalize patient COVID-19 , particularly critically ill .', 'The thromboembolic risk COVID-19 well evaluation management complication discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'VTE ' `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Indications full-dose anticoagulation ' ."", ') Uncertainty NSAID use — There minimal data inform risk non-steroidal anti-inflammatory drug ( NSAIDs ) set COVID-19 .', ""We use acetaminophen prefer antipyretic agent , possible , NSAIDs need , use lowest effective dose ; consistent general approach fever reduction adult ( see `` Pathophysiology treatment fever adult '' , section 'Treating fever ' ) ."", 'We discontinue NSAIDs patient chronically condition , unless reason stop ( eg , renal injury , gastrointestinal bleed ) .', 'Concern possible negative effect NSAIDs raise anecdotal report young patient receive NSAIDs early course infection experience severe disease [ 15,16 ] .', 'However , clinical population-based data directly address risk NSAIDs .', 'Given absence data , European Medicines Agency ( EMA ) , WHO , United States National Institutes Health ( NIH ) COVID-19 Treatment Guidelines Panel recommend NSAIDs avoid clinically indicate [ 4,17,18 ] .', 'Avoiding nebulized medication — Inhaled medication administer meter dose inhaler , whenever possible , rather nebulizer , avoid risk aerosolization SARS-CoV-2 nebulization .', 'If nebulizer must use , appropriate infection control precaution take .', 'These discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Nebulized medication ( spontaneously breathe patient ) ' ."", ') Limited role glucocorticoid — We agree recommendation WHO CDC systemic glucocorticoid use patient COVID-19 , unless indication ( eg , exacerbation chronic obstructive pulmonary disease ) [ 19,20 ] .For without pre-existing pulmonary disease , also avoid inhale glucocorticoid .', 'The use inhale glucocorticoid patient asthma chronic obstructive pulmonary disease set COVID-19 discuss detail elsewhere .', ""( See `` Acute exacerbation asthma adult : Emergency department inpatient management '' , section 'Advice relate covid-19 pandemic ' `` Stable COPD : Overview management '' , section 'Advice relate COVID-19 ' ."", ') Glucocorticoids associate increase risk mortality patient influenza delay viral clearance patient Middle East respiratory syndrome coronavirus ( MERS-CoV ) infection .', 'Although widely use management SARS , good evidence benefit , persuasive evidence adverse short- long-term harm [ 21 ] .', ""( See `` Treatment seasonal influenza adult '' , section 'Adjunctive therapy ' `` Middle East respiratory syndrome coronavirus : Treatment prevention '' , section 'Treatment ' ."", ') The approach glucocorticoid among critically ill patient COVID-19 discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Glucocorticoids ' ."", ') Managing chronic medicationsACE inhibitors/ARBs — Patients receive angiotensin-converting enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARBs ) continue treatment agent reason discontinuation ( eg , hypotension , acute kidney injury ) .', 'This approach support multiple guideline panel [ 22-26 ] .', 'There speculation patient COVID-19 receive agent may increase risk adverse outcome , support find observational study .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' , section 'Renin angiotensin system inhibitor ' ."", ') Conversely , ARBs also propose potential protective effect base mechanism action [ 27 ] , trial evidence support hypothesis .', 'We use ACE inhibitor ARBs potential COVID-19 treatment.Statins — We make point continue statin hospitalize patient COVID-19 already take .', 'A high proportion patient severe COVID-19 underlie cardiovascular disease , diabetes mellitus , indication use statin .', 'Moreover , acute cardiac injury report complication COVID-19 .', 'Although clinician may concern hepatotoxicity statin , particularly since transaminase elevation common COVID-19 , evidence indicate liver injury statin uncommon .', ""( See `` Statins : Actions , side effect , administration '' , section 'Hepatic dysfunction ' . )"", 'Whether statin could impact natural history SARS-CoV-2 infection clear .', 'Statins know inhibitor MYD88 pathway , result mark inflammation , report stabilize MYD88 level set external stress vitro animal study [ 28 ] .', 'Dysregulation MYD88 note associate poor outcome SARS-CoV MERS-CoV infection , describe SARS-CoV-2 .', 'Although statin might benefit patient COVID-19 , data needed.Immunomodulatory agent — Use immunosuppressing agent associate increase risk severe disease respiratory virus , decision discontinue prednisone , biologics , immunosuppressive drug set COVID-19 must determine case-by-case basis .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' , section 'Patients COVID-19 symptom know COVID-19 exposure ' `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' , section 'Adjusting immunosuppression ' . )"", 'For individual underlie condition require treatment agent suspect document COVID-19 , evidence routinely discontinue treatment benefit .', 'In addition , discontinue medication may result loss response agent reintroduce .', 'The approach continue immunomodulatory therapy patient without infection support statement dermatology , rheumatology , gastroenterology society [ 29-32 ] .Infection control — Infection control essential component management patient suspect document COVID-19 .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' . )"", 'COVID-19-SPECIFIC THERAPYSpecific treatment — Several treatment evaluate COVID-19 .', 'Although treatment clinically available indication , use COVID-19 remain investigational.Remdesivir — Remdesivir novel nucleotide analogue activity severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) vitro [ 33 ] .', 'In United States , Food Drug Administration ( FDA ) issue emergency use authorization remdesivir hospitalize child adult severe COVID-19 ( SpO2 ≤94 percent room air , require supplemental oxygen , mechanical ventilation , extracorporeal membrane oxygenation [ ECMO ] ) [ 34 ] .', 'The suggest adult dose 200 mg intravenously day 1 follow 100 mg daily 10 day total patient mechanical ventilation ECMO 5 day total patient ( extension 10 day clinical improvement ) .', 'Remdesivir recommend patient alanine aminotransferase ≥5 time upper limit normal ( discontinue rise level treatment sign liver injury ) .', 'The pharmacokinetics remdesivir set renal impairment uncertain , prepare cyclodextrin vehicle accumulate renal impairment may toxic ; thus , remdesivir recommend patient estimate glomerular filtration rate ( eGFR ) < 30 mL/min per 1.73 m2 unless potential benefit outweigh potential risk .', 'Data comparative , randomize trial need define effect remdesivir COVID-19 ; data emerge remain limit mix .', 'Overall , preliminary result confirm , likely clinical benefit remdesivir , although patient population likely benefit remain uncertain.The United States National Institute Allergy Infectious Diseases announce preliminary result multinational , randomize , placebo-controlled trial remdesivir among 1063 patient confirm COVID-19 evidence lung involvement [ 35 ] .', 'On interim analysis , remdesivir result faster time recovery , define discharge hospital longer require supplemental oxygen ( median 11 versus 15 day placebo , p < 0.001 ) .', 'There also trend towards lower mortality statistically significant ( 8 versus 11.6 percent placebo , p = 0.059 ) .', 'Final analysis peer review data pending .', 'In contrast , double-blind randomize trial China 237 patient severe COVID-19 ( hypoxia radiographically confirm pneumonia ) , time clinical improvement statistically different remdesivir compare placebo 10 day ( median 21 versus 23 day ; hazard ratio improvement 1.23 [ 95 % CI 0.87-1.75 ] ) [ 36 ] .', 'Clinical improvement define discharge hospital two-point improvement six-point clinical score range death mechanical ventilation lower level oxygen support discharge .', 'This study include one patient mechanical ventilation baseline .', 'Mortality 28 day also similar remdesivir placebo ( 14 versus 13 percent ) ; also difference time viral clearance .', 'Among patient receive treatment within 10 day symptom onset , trend towards lower mortality rapid clinical improvement remdesivir , difference statistically significant .', 'Remdesivir stop early adverse event ( include gastrointestinal symptom , aminotransferase bilirubin elevation , worsen cardiopulmonary status ) 12 percent , compare 5 percent placebo group .', 'Several limitation reduce confidence find effect ; concomitant therapy ( lopinavir-ritonavir , interferon alpha-2b , and/or corticosteroid ) use study participant , patient remdesivir group higher proportion comorbidities ( hypertension , diabetes mellitus , coronary heart disease ) , study stop early poor enrollment ( target enrollment pre-determined demonstrate effect 435 patient ) .', 'Early data suggest 5 day remdesivir result similar outcome 10 .', 'In preliminary report manufacturer randomize , open-label trial among nearly 400 patient severe COVID-19 mechanical ventilation , rate clinical recovery discharge day 14 statistically different remdesivir give 5 day ( 65 60 percent , respectively ) versus 10 day ( 54 52 percent , respectively ) [ 37 ] .', 'Mortality rate day 14 8 11 percent 5 10 day treatment , respectively , vary geographic location.Use remdesivir also describe several case series [ 38-40 ] .', 'In one multicenter , multinational series , 53 patient severe COVID-19 hypoxia receive compassionate-use remdesivir 10 day median 18 day follow-up ; 68 percent clinical improvement ( decrease requirement oxygen support hospital discharge ) , 13 percent die [ 40 ] .', 'Of 30 patient mechanically ventilate baseline , 17 ( 57 percent ) extubated , three four patient extracorporeal membrane oxygenation ( ECMO ) take .', 'Reported side effect include nausea , vomit , transaminase elevation .', 'In preliminary report trial remdesivir among patient severe COVID-19 , grade 3 aminotransferase elevation occur 7 percent lead drug discontinuation 3 percent [ 37 ] .', 'Other adverse event describe patient receive remdesivir include worsen kidney injury , multiple organ failure , worsen cardiopulmonary status [ 36,40 ] .', 'Convalescent plasma — In United States , FDA accept investigational new drug application use convalescent plasma patient severe life-threatening COVID-19 [ 41 ] ; pathway use application include clinical trial , expand access program , emergency individual use .', 'Use convalescent plasma describe case series [ 42-44 ] .', 'One case series describe administration plasma donor completely recover COVID-19 five patient severe COVID-19 mechanical ventilation persistently high viral titer despite investigational antiviral treatment [ 42 ] .', 'The patient decrease nasopharyngeal viral load , decrease disease severity score , improve oxygenation 12 day transfusion .', 'However , find establish causal effect , efficacy convalescent plasma remain unknown .', 'In another case series six patient receive convalescent plasma late course illness , five die despite SARS-CoV-2 viral clearance within three day treatment [ 44 ] .', 'Finding appropriate donor establish test confirm neutralize activity plasma may logistical challenge .', 'In United States , American Red Cross help collect distribute convalescent plasma throughout country [ 45 ] .', ""( See `` Clinical use plasma component '' , section 'Convalescent plasma ' ."", ') The FDA also facilitate evaluation hyperimmune globulin patient COVID-19 [ 45 ] .', 'IL-6 pathway inhibitor — Markedly elevate inflammatory marker ( eg , D-dimer , ferritin ) elevate pro-inflammatory cytokine ( include interleukin [ IL ] -6 ) associate critical fatal COVID-19 , block inflammatory pathway hypothesize prevent disease progression .', 'Tocilizumab IL-6 receptor inhibitor use rheumatic disease cytokine release syndrome evaluate randomize trial treatment COVID-19 .', 'Case report observational study describe use tocilizumab patient COVID-19 [ 46-53 ] .', 'As example , study 63 patient severe COVID-19 laboratory result suggest pro-inflammatory pro-thrombotic state , major adverse event think directly relate tocilizumab ( give intravenously subcutaneously ) , associate decrease C-reactive protein , D-dimer , ferritin level ; overall , 14-day mortality rate 11 percent [ 51 ] .Sarilumab siltuximab agent target IL-6 pathway also evaluate clinical trial .', 'Hydroxychloroquine/chloroquine — There insufficient data thus far know whether hydroxychloroquine chloroquine role treatment COVID-19 .', 'For reason , strongly recommend patient refer clinical trial whenever possible .', 'In United States , FDA issue emergency use authorization allow use agent adolescent adult hospitalize COVID-19 participation clinical trial feasible [ 54 ] .', 'When clinical trial available , suggest routinely use hydroxychloroquine chloroquine give lack clear benefit limit data potential toxicity .', 'If drug use COVID-19 outside clinical trial , Infectious Diseases Society America ( IDSA ) encourage creation registry , possible , systematically evaluate safety efficacy [ 55 ] .', 'Additionally , hydroxychloroquine chloroquine use outside clinical trial , potential adverse effect carefully assess .', 'In particular , agent prolong QT interval avoid patient prolong baseline QTc interval agent affect cardiac conduction , otherwise use close monitor .', 'The American College Cardiology suggest QTc monitor parameter set [ 56 ] .', 'QTc monitor set discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' , section 'Monitoring QT prolongation ' ."", ') Other risk ( eg , retinopathy cardiomyopathy ) primarily longer-term use higher cumulative do , consideration decide use agent .', 'Catastrophic outcome report hydroxychloroquine chloroquine overdose ; individual use medication without medical supervision [ 57,58 ] .', ""( See `` Antimalarial drug treatment rheumatic disease '' , section 'Adverse effect ' ."", ') Both chloroquine hydroxychloroquine report inhibit SARS-CoV-2 vitro , although hydroxychloroquine appear potent antiviral activity [ 59 ] .', 'Randomized trial evaluate clinical use underway .', 'However , publish clinical data either agent limit , methodologic problem , suggest clear benefit [ 60-65 ] .', 'In open-label randomize trial 150 hospitalize patient mild moderate COVID-19 ( either pneumonia pneumonia without hypoxia ) , add hydroxychloroquine standard care improve rate SARS-CoV-2 clearance ( 84 versus 81 percent standard care alone ) result symptomatic improvement ( 60 versus 66 percent ) 28 day [ 64 ] .', 'Methodologic concern trial include concomitant co-therapies , baseline difference group , lack blind placebo control .', 'Available evidence suggest benefit patient severe COVID-19 , although data population limit observational study .', 'In observational study nearly 1400 patient COVID-19 admit hospital New York , hydroxychloroquine use report 811 patient associate higher risk intubation death ( hazard ratio [ HR ] 2.37 ) [ 62 ] .', 'Patients receive hydroxychloroquine older , likely comorbidities , severe illness , likely confound variable ; multivariate analysis compare patient propensity score-matched subset 274 patient receive hydroxychloroquine , association hydroxychloroquine use intubation death ( adjust HR 1.04 ) .', 'In another observational study France 180 patient severe COVID-19 require oxygen supplementation critical care , rate transfer intensive care unit death similar among receive hydroxychloroquine [ 65 ] .Studies , however , highlight potential toxicity hydroxychloroquine chloroquine .', 'One trial compare two do chloroquine COVID-19 stop early higher mortality rate high-dose group [ 66 ] .', 'In observational study 84 patient receive hydroxychloroquine , 10 percent electrocardiographic change prompt discontinuation [ 65 ] .', 'QTc prolongation hydroxychloroquine chloroquine discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' , section 'Patients receive QT-prolonging treatment ( eg , hydroxychloroquine , chloroquine , azithromycin , etc ) ' ."", ') The evidence combination hydroxychloroquine azithromycin discuss elsewhere .', ""( See 'Others ' ."", ') Others — Many agent know putative antiviral immunomodulating effect propose use patient COVID-19 [ 67-71 ] , preclinical clinical evaluation .', 'Use agent COVID-19 limit clinical trial ; efficacy prove , extensive off-label use may result excess toxicity critical shortage drug prove indication .', 'A registry international clinical trial find covid-trials.org , well WHO website clinicaltrials.gov .', '●Favipiravir – Favipiravir RNA polymerase inhibitor available Asian country treatment influenza , evaluate clinical trial treatment COVID-19 United States .', 'In study patient non-severe disease ( include oxygen saturation > 93 percent ) , use favipiravir associate faster rate viral clearance ( median time clearance 4 versus 11 day ) frequent radiographic improvement ( 91 versus 62 percent day 14 ) compare lopinavir-ritonavir [ 72 ] .', 'However , therapy administer non-randomized , open-label study , result interpret caution give potential confounders.●Interferon beta – Interest interferon beta SARS-CoV-2 spur evidence suggest vitro activity Middle East respiratory syndrome coronavirus ( MERS-CoV ) good outcome animal model MERS-CoV infection [ 73-75 ] .', 'In one open-label randomize trial Hong Kong , 127 adult hospitalize primarily nonsevere COVID-19 randomly assign 2:1 combination intervention ( interferon beta , ribavirin , plus lopinavir-ritonavir symptom onset within 7 day ribavirin plus lopinavir-ritonavir symptom onset 7 14 day ) versus control ( lopinavir-ritonavir alone ) [ 76 ] .', 'Patients intervention group rapid time negative SARS-CoV-2 reverse transcription polymerase chain reaction ( RT-PCR ) test nasopharyngeal swab ( median 7 versus 12 day ) , clinical improvement ( median 4 versus 8 day ) , hospital discharge ( median 9 versus 15 day ) ; subgroup analysis , difference observe among patient symptom onset within 7 day thus receive interferon beta part intervention .', 'Adverse effect similar intervention control group .', 'No hemolysis detect ribavirin ( 400 mg orally twice daily ) .', 'Further study need clarify role interferon beta COVID-19 therapy.●Other immunomodulatory agent – Because observation patient clinical presentation resemble cytokine release syndrome association severe disease number pro-inflammatory marker , interrupt inflammatory cascade propose potential therapeutic target severe COVID-19 .', ""In addition IL-6 pathway inhibitor ( see 'IL-6 pathway inhibitor ' ) , immunomodulatory agent various class , include IL-1 inhibitor , kinase inhibitor , complement inhibitor , evaluate ."", 'Their use describe case series observational study [ 68,77-80 ] .', 'As example , retrospective study patient COVID-19 , acute respiratory distress syndrome ( ARDS ) require non-invasive ventilation , markedly elevate C-reactive protein ( CRP ) ferritin , receipt high-dose anakinra 29 patient ( addition hydroxychloroquine lopinavir-ritonavir ) associate lower 21-day mortality rate compare historical cohort 16 patient receive hydroxychloroquine lopinavir-ritonavir ( 10 versus 44 percent ) ; however , historical group older , likelihood , unmeasured confounders make find difficult interpret [ 77 ] .', 'Results randomize trial necessary determine effect agent .', '●Azithromycin hydroxychloroquine – We use azithromycin combination hydroxychloroquine treat COVID-19 .', 'Use combination describe observational study [ 60,63,81,82 ] .', 'Although one study suggest use azithromycin combination hydroxychloroquine associate rapid resolution virus detection hydroxychloroquine alone [ 60 ] , result interpret caution small sample size , substantial methodologic concern [ 83 ] , unclear biologic plausibility .', 'Another small observational study patient severe illness suggest rapid viral RNA clearance combination [ 81 ] .', 'Furthermore , azithromycin hydroxychloroquine associate QTc prolongation , combine use may potentiate adverse effect .', 'In large observational study patient hospitalize COVID-19 New York , adjust mortality rate among receive azithromycin plus hydroxychloroquine similar compare receive neither agent , rate cardiac arrest higher [ 63 ] .●Lopinavir-ritonavir – This combine protease inhibitor , primarily use HIV infection , vitro activity SARS-CoV [ 84 ] appear activity MERS-CoV animal study [ 73 ] .', 'However , lopinavir-ritonavir appear minimal role treatment SARS-CoV-2 infection outside clinical trial .', 'The WHO launch multinational trial evaluate remdesivir , hydroxychloroquine/chloroquine , lopinavir-ritonavir without interferon beta [ 85 ] .', 'Results randomize trial demonstrate clear benefit lopinavir-ritonavir .', 'In randomize trial 199 patient severe COVID-19 , addition lopinavir-ritonavir ( 400/100 mg ) twice daily 14 day standard care decrease time clinical improvement compare standard care alone [ 86 ] .', 'There trend towards decrease mortality lopinavir-ritonavir ( 19 versus 25 percent ) , numerical difference mortality greater among randomize within 12 day symptom onset , neither difference statistically significant .', 'The rate SARS-CoV-2 decline similar group receive lopinavir-ritonavir group .', 'Lopinavir-ritonavir stop early 14 percent adverse effect .', ""If lopinavir-ritonavir use , patient 's HIV status know ."", 'If patient HIV , lopinavir-ritonavir use standard combination antiretroviral regimen .', 'Approach — The optimal approach treatment COVID-19 uncertain .', 'Although trial data suggest benefit remdesivir , data preliminary formally peer review report , otherwise therapy clearly prove effective ; potential therapy , evidence use come primarily observational case series anecdotal use base vitro extrapolate indirect evidence.Thus , available , strongly recommend enrollment well-controlled clinical trial .', 'Our approach consistent recommendation expert group United States .', 'The IDSA recommend COVID-19-specific therapy give context clinical trial additionally recommend certain therapy ( include hydroxychloroquine plus azithromycin , lopinavir-ritonavir , tocilizumab ) administer context clinical trial greater level uncertainty potential toxicity [ 55 ] .', 'Similarly , NIH COVID-19 Treatment Guidelines Panel note insufficient evidence recommend antiviral immune-based therapy specifically recommend use certain therapy ( include hydroxychloroquine plus azithromycin , HIV protease inhibitor , interferon , Janus kinase inhibitor ) outside context clinical trial [ 4 ] .A registry international clinical trial find covid-trials.org , well WHO website clinicaltrials.gov .', 'We use risk-based approach try enroll patient may likely benefit .', 'The approach dependent local availability clinical trial may universally applicable .', 'Clinicians consult local protocol management.Defining disease severity — Mild disease characterize fever , malaise , cough , upper respiratory symptom , and/or le common feature COVID-19 , absence dyspnea .', 'Most patient need hospitalization .', 'If patient develop dyspnea , raise concern least moderate severity disease , patient often warrant hospitalization .', 'Patients infiltrate chest image still consider moderate disease , presence follow feature indicate severe disease : ●Hypoxia ( oxygen saturation ≤93 percent room air PaO2/FiO2 < 300 mmHg ) ●Tachypnea ( respiratory rate > 30 breath per minute ) respiratory distress●More 50 percent involvement lung parenchyma chest imagingThese feature use China characterize severe disease large cohort patient [ 87 ] consistent United States NIH COVID-19 Treatment Guidelines Panel definition severe infection [ 4 ] .', 'We also treat patient certain laboratory abnormality ( table 1 ) similar patient severe disease , abnormality associate disease progression several studies.Nonsevere disease — For patient nonsevere disease , suggest supportive care , close monitor clinical worsen .', ""If develop feature severe disease ( eg , hypoxia , tachypnea , respiratory distress ( see 'Defining disease severity ' ) ) , laboratory feature associate disease progression ( table 1 ) , treat describe ."", ""( See 'Severe ( include critical ) disease ' ."", ') Some clinical trial may available patient nonsevere disease .', 'If , prioritize patient epidemiologic risk factor associate development severe illness ( table 2 ) .', 'We generally treat patient nonsevere disease experimental agent outside context clinical trial.Severe ( include critical ) disease — We prioritize COVID-19-specific therapy hospitalize patient severe disease laboratory risk factor disease progression ( table 1 ) .', 'For hospitalize patient severe COVID-19 , recommend remdesivir , available .', ""In United States , remdesivir obtain FDA 's emergency use authorization , although availability limit hospital designate distribution federal government [ 88 ] ."", 'For pregnant individual , remdesivir may also obtain compassionate use program .', ""( See 'Remdesivir ' ."", ') For patient severe disease laboratory risk factor disease progression ( table 1 ) get remdesivir route , recommend referral clinical trial treatment .', 'We also refer patient able get remdesivir emergency use authorization clinical trial agent , allow concurrent use remdesivir .', 'In addition remdesivir , therapy evaluate trial include convalescent plasma hydroxychloroquine .', 'Patients feature similar cytokine release syndrome ( eg , persistent fever elevate cytokine level , ferritin , D-dimer , and/or inflammatory marker ) may also eligible clinical trial IL-6 pathway inhibitor immunomodulators .', 'A registry international clinical trial find covid-trials.org .', 'Detailed discussion agent find elsewhere .', ""( See 'Specific treatment ' . )"", ""If neither clinical trial emergency-use remdesivir option , clinician may able obtain convalescent plasma investigational treatment COVID-19 ; United States , may access FDA 's investigational new drug application expand access program [ 41 ] ."", ""( See 'Convalescent plasma ' ."", ') Although treatment hypothesize greater impact give early course disease , optimal time implementation therapy remain unknown .', 'Until data available , uncertain patient would benefit best allocate potentially limit clinical trial slot emergency use agents.Several agent investigate treatment COVID-19 available medical indication , repurposed use COVID-19 describe .', 'There insufficient data know whether agent role treatment COVID-19 ; thus , strongly recommend patient refer clinical trial whenever possible.When clinical trial option remdesivir convalescent plasma obtain , favor supportive care rather off-label use available agent unknown efficacy COVID-19 .', 'In particular , suggest routinely use hydroxychloroquine chloroquine outside clinical trial ; limit available data suggest clear benefit suggest potential toxicity .', 'However , acknowledge , absence option , clinician may choose use certain agent ( eg , hydroxychloroquine , IL-6 pathway inhibitor patient evidence severe pro-inflammatory state ) severely ill patient .', 'If drug use COVID-19 outside clinical trial , IDSA encourage creation registry systematically evaluate safety efficacy [ 55 ] .', 'MANAGEMENT OF HYPOXIA , ARDS , AND OTHER COMPLICATIONS — Patients severe disease often need oxygenation support .', 'High-flow oxygen noninvasive positive-pressure ventilation use , safety measure uncertain , consider aerosol-generating procedure warrant specific isolation precaution .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Respiratory care nonintubated patient ' . )"", 'Some patient may develop acute respiratory distress syndrome ( ARDS ) warrant intubation mechanical ventilation .', 'Management ARDS patient COVID-19 critical care issue discuss detail elsewhere ( table 3 ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' . )"", 'In addition ARDS , complication infection include arrhythmia , acute cardiac injury , acute kidney injury , thromboembolic event , shock .', 'Management complication discuss elsewhere .', ""● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' , section 'Acute kidney injury ' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", ') DISCHARGE — The decision discharge patient COVID-19 generally condition depend need hospital-level care monitor .', 'Continued need infection control precaution prevent discharge home patient appropriately self-isolate ; long-term care facility may specific requirement prior accept patient COVID-19 .', 'Criteria discontinue precaution infection control issue long-term care facility discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Long-term care facility ' ."", ') Patients COVID-19 generally warrant outpatient follow-up telehealth in-person visit follow discharge hospital .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' , section 'Outpatient management follow inpatient ED discharge ' ."", ') We encourage patient recover COVID-19 consider donate convalescent plasma .', 'Interested patient refer community blood center , United States , American Red Cross determine whether meet eligibility criterion donation .', ""( See `` Clinical use plasma component '' , section 'COVID-19 pandemic ' . )"", 'INSTITUTIONAL PROTOCOLS — Several academic medical institution United States develop COVID-19 management protocol publicly available .', ""Given paucity high-quality clinical evidence management COVID-19 , safety efficacy strategy uncertain : ●Brigham Women 's Hospital●Massachusetts General Hospital●Michigan Medicine●Nebraska Medicine●Penn Medicine●University Washington MedicinePartners Health also release resource clinician organization resource-limited set ."", 'SPECIAL SITUATIONSPregnant breastfeed woman — The management pregnant breastfeed woman COVID-19 discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Pregnant breastfeed woman ' ."", ') People HIV — Data impact HIV infection natural history COVID-19 limit [ 89,90 ] .', 'However , many comorbid condition associate severe COVID-19 ( eg , cardiovascular disease ) occur frequently among patient HIV , , addition CD4 cell count , consider risk stratification .', 'Additionally , drug interaction antiretroviral agent important ass start new therapy .', 'Otherwise , management COVID-19 patient HIV patient without HIV ; HIV reason exclude patient clinical trial intervention [ 91 ] .', 'Lopinavir-ritonavir use trial patient COVID-19 , although data one randomize trial suggest benefit [ 86 ] .', 'If patient HIV protease inhibitor-containing regimen , change include protease inhibitor outside context clinical trial without consultation expert management HIV [ 92 ] .SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) pregnancy ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●A novel coronavirus identify cause cluster pneumonia case Wuhan , China end 2019 ; subsequently spread rapidly , result global pandemic ."", 'The disease designate COVID-19 , stand coronavirus disease 2019 .', 'The virus cause COVID-19 designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'The optimal approach treatment COVID-19 uncertain .', 'Our approach base limit data evolve rapidly clinical data emerge .', ""( See 'Introduction ' ."", ') ●Many patient know suspect COVID-19 mild disease warrant hospital-level care .', 'Having patient recover home prefer , prevent additional potential exposure health care set reduce burden health care system .', 'Identification patient manage outpatient set discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", ') ●The evaluation hospitalize patient document suspect COVID-19 ass feature associate severe illness identify organ dysfunction comorbidities could complicate potential therapy ( table 2 ) .', ""( See 'Evaluation ' ."", ') ●Patients hospitalize COVID-19 receive pharmacologic prophylaxis venous thromboembolism ( algorithm 1 ) .', 'COVID-19 associate thromboembolic complication .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", ') ●There minimal data inform risk non-steroidal anti-inflammatory drug ( NSAIDs ) set COVID-19 .', 'We suggest acetaminophen prefer antipyretic agent , possible ( Grade 2C ) .', 'If NSAIDs need , use lowest effective dose .', 'We discontinue NSAIDs patient chronically condition reason stop .', ""( See 'Uncertainty NSAID use ' ."", ') ●Specific concern COVID-19 impact decision start stop angiotensin-converting enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARBs ) .', 'People ACE inhibitor ARB another indication stop medication .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' , section 'Renin angiotensin system inhibitor ' ."", ') ●We make point continue statin hospitalize patient COVID-19 already take .', ""( See 'Statins ' ."", ') ●The optimal use COVID-19-specific therapy uncertain ; preliminary , unpublished trial data suggest benefit remdesivir , agent clearly prove effective .', 'For potential therapy , evidence use low quality .', 'For reason , patient refer clinical trial whenever possible .', 'Clinicians consult local protocol management .', ""( See 'Approach ' ."", ') •For patient nonsevere disease laboratory feature associate severe disease ( table 1 ) , care primarily supportive , close monitor disease progression .', 'If clinical trial available patient , prioritize advance age ( eg , > 65 year ) comorbidities associate risk progressive disease ( table 2 ) .', ""( See 'Defining disease severity ' 'Nonsevere disease ' ."", ') •For hospitalize patient severe disease , recommend remdesivir , available ( Grade 1C ) .', 'In United States , remdesivir may available US Food Drug Administration ( FDA ) emergency use authorization .', ""( See 'Remdesivir ' ."", ') •For hospitalize patient severe disease laboratory feature associate severe disease ( table 1 ) get remdesivir emergency use authorization , recommend referral clinical trial ( Grade 1C ) .', 'Clinical trial remdesivir ongoing ; investigational therapy include convalescent plasma , hydroxychloroquine , interleukin ( IL ) -6 pathway inhibitor , immunomodulatory agent .', 'We also refer patient able get remdesivir emergency use authorization clinical trial agent , allow concurrent use remdesivir .', ""( See 'Severe ( include critical ) disease ' ."", "") If neither clinical trial remdesivir emergency use authorization available , clinician may able obtain convalescent plasma investigational use patient severe disease ; United States , request FDA 's expand access program ."", ""( See 'Convalescent plasma ' ."", ') When none option available , favor supportive care .', 'In particular , suggest routinely use hydroxychloroquine chloroquine outside context clinical trial give lack clear benefit limit data potential toxicity ( Grade 2C ) .', 'We also suggest use lopinavir-ritonavir COVID-19 therapy outside clinical trial ( Grade 2B ) .', ""( See 'Hydroxychloroquine/chloroquine ' 'Others ' ."", ') ●Patients severe disease often need oxygenation support .', 'Some patient may develop acute respiratory distress syndrome ( ARDS ) warrant intubation mechanical ventilation .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') ●Infection control essential component management patient suspect document COVID-19 .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') ACKNOWLEDGMENTS — The author would like acknowledge Eric Meyerowitz , MD , Camille Kotton , MD , Michael Mansour , MD , Pritha Sen , MD , Ramy Elshaboury , PharmD , Ronak Gandhi , PharmD , Boris Juelg , MD , contribution topic review .']","['', 'coronaviruses', 'important', 'human', 'animal', 'pathogen', '', 'end', '2019', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'rapidly', 'spread', '', 'result', 'global', 'pandemic', '', 'disease', 'designate', 'covid-19', '', 'stand', 'coronavirus', 'disease', '2019', '', '1', '', '', 'virus', 'cause', 'covid-19', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'previously', '', 'refer', '2019-ncovthis', 'topic', 'discus', 'management', 'covid-19', 'hospitalize', 'adult', '', 'approach', 'hospital', 'management', 'base', 'limit', 'data', 'evolve', 'rapidly', 'clinical', 'data', 'emerge', '', 'clinicians', 'consult', 'local', 'protocol', 'management', '', 'differ', 'approach', '', 'interim', 'guidance', 'issue', 'world', 'health', 'organization', '', 'united', 'states', '', 'centers', 'disease', 'control', 'prevention', '', '23', '', 'national', 'institutes', 'health', 'covid-19', 'treatment', 'guidelines', 'panel', '', '4', '', '', 'links', 'relate', 'society', 'guideline', 'find', 'elsewhere', '', '', 'society', 'guideline', 'link', '', '', '', 'management', 'patient', 'covid-19', 'home', 'outpatient', 'set', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'epidemiology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'issues', 'relate', 'covid-19', 'specific', 'population', 'discuss', 'elsewhere', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', 'community-acquired', 'coronaviruses', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'coronavirus', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'coronavirus', 'discuss', 'separately', '', '', '', 'coronaviruses', '', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'virology', '', 'pathogenesis', '', 'epidemiology', '', '', '', 'evaluation', '', 'objective', 'evaluation', 'hospitalize', 'patient', 'document', 'suspect', 'covid-19', 'evaluate', 'feature', 'associate', 'severe', 'illness', '', 'table', '1', '', 'identify', 'organ', 'dysfunction', 'comorbidities', 'complicate', 'potential', 'therapy', '', 'diagnosis', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'although', 'check', 'several', 'laboratory', 'test', 'evaluate', 'patient', 'document', 'suspect', 'covid-19', '', 'prognostic', 'value', 'remain', 'uncertain', '', 'institution', 'include', 'test', '', 'least', 'initially', '', 'check', 'follow', 'laboratory', 'study', 'daily', '', 'complete', 'blood', 'count', '', 'cbc', '', 'differential', '', 'focus', 'total', 'lymphocyte', 'count', 'trendcomplete', 'metabolic', 'panelcreatine', 'kinase', '', 'ck', '', 'c-reactive', 'protein', '', 'crp', '', 'ferritininitially', '', 'check', 'follow', 'study', 'every', 'day', '', 'daily', 'elevate', 'intensive', 'care', 'unit', '', '', 'prothrombin', 'time', '', 'pt', '', 'partial', 'prothrombin', 'time', '', 'ptt', '', 'fibrinogend-dimerwe', 'check', 'follow', 'study', 'baseline', 'repeat', 'abnormal', 'clinical', 'worsen', '', 'lactate', 'dehydrogenase', '', 'repeat', 'daily', 'elevatedtroponin', '', 'repeat', 'every', 'two', 'three', 'day', 'elevatedelectrocardiogram', '', 'ecg', '', '', 'least', 'one', 'repeat', 'test', 'start', 'qtc-prolonging', 'agent', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'section', 'monitoring', 'qt', 'prolongation', '', '', 'check', 'hepatitis', 'b', 'virus', 'serology', '', 'hepatitis', 'c', 'virus', 'antibody', '', 'hiv', 'antigenantibody', 'test', 'previously', 'perform', '', 'chronic', 'viral', 'hepatitis', 'affect', 'interpretation', 'transaminase', 'elevation', 'exacerbate', 'hepatotoxicity', 'certain', 'therapy', '', 'underlie', 'hiv', 'infection', 'change', 'assessment', 'patient', 'risk', 'deterioration', 'warrant', 'initiation', 'antiretroviral', 'therapy', '', 'check', 'portable', 'chest', 'radiograph', 'hospitalize', 'patient', 'covid-19', '', 'patient', '', 'sufficient', 'initial', 'evaluation', 'pulmonary', 'complication', 'extent', 'lung', 'involvement', '', 'although', 'chest', 'compute', 'tomography', '', 'ct', '', 'frequently', 'china', 'evaluation', 'patient', 'covid-19', '', 'reserve', 'chest', 'ct', 'circumstance', 'change', 'clinical', 'management', '', 'part', 'minimize', 'infection', 'control', 'issue', 'relate', 'transport', '', 'consistent', 'recommendation', 'american', 'college', 'radiology', '', '5', '', '', 'although', 'certain', 'characteristic', 'chest', 'ct', 'find', 'covid-19', '', 'reliably', 'distinguish', 'covid-19', 'cause', 'viral', 'pneumonia', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'imaging', 'find', '', '', '', 'routinely', 'obtain', 'echocardiogram', 'patient', 'covid-19', '', 'development', 'warrant', 'echocardiogram', 'include', 'increase', 'troponin', 'level', 'hemodynamic', 'compromise', 'cardiovascular', 'find', 'suggestive', 'cardiomyopathy', '', 'acute', 'myocardial', 'injury', 'describe', 'complication', 'covid-19', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'section', 'suspect', 'myocardial', 'injury', 'key', 'consideration', '', '', '', 'secondary', 'bacterial', 'infection', 'frequently', 'report', 'feature', 'covid-19', '', 'suspect', '', 'eg', '', 'base', 'chest', 'image', 'sudden', 'deterioration', '', '', 'check', 'two', 'set', 'blood', 'culture', 'sputum', 'gram', 'stain', 'culture', '', 'procalcitonin', 'check', 'ass', 'risk', 'secondary', 'bacterial', 'infection', '', 'however', '', 'since', 'elevate', 'procalcitonin', 'level', 'report', 'covid-19', 'progress', '', 'le', 'specific', 'bacterial', 'infection', 'later', 'disease', 'course', '', '6-9', '', '', '', 'prognostic', 'value', 'result', 'test', 'evaluate', 'patient', 'covid-19', 'uncertain', '', 'optimal', 'marker', 'remain', 'unknown', '', 'example', '', 'although', 'clinician', 'note', 'potential', 'utility', 'troponin', 'level', 'inform', 'risk', 'severe', 'covid-19', 'provide', 'baseline', 'comparison', 'patient', 'develop', 'manifestation', 'myocardial', 'injury', '', '10', '', '', 'others', 'reserve', 'troponin', 'level', 'test', 'patient', 'specific', 'clinical', 'suspicion', 'acute', 'coronary', 'syndrome', '', '11', '', '', 'one', 'concern', 'result', 'lead', 'unnecessary', 'medical', 'resource', '', 'eg', '', 'serial', 'troponins', '', 'electrocardiogram', 'cardiology', 'consult', 'elevate', 'troponin', '', '', 'troponin', 'check', 'patient', 'covid-19', '', 'clinician', 'aware', 'elevate', 'level', 'necessarily', 'indicate', 'acute', 'coronary', 'syndrome', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'section', 'troponin', '', '', '', 'general', 'management', 'issuesempiric', 'treatment', 'bacterial', 'pneumonia', 'select', 'patient', '', 'patient', 'document', 'covid-19', '', 'routinely', 'administer', 'empiric', 'therapy', 'bacterial', 'pneumonia', '', 'data', 'limit', '', 'bacterial', 'superinfection', 'appear', 'prominent', 'feature', 'covid-19', '', 'however', '', 'since', 'clinical', 'feature', 'covid-19', 'difficult', 'distinguish', 'bacterial', 'pneumonia', '', 'empiric', 'treatment', 'community-acquired', 'pneumonia', 'reasonable', 'diagnosis', 'uncertain', '', 'empiric', 'treatment', 'bacterial', 'pneumonia', 'reasonable', 'patient', 'document', 'covid-19', 'clinical', 'suspicion', '', 'eg', '', 'new', 'fever', 'defervescence', 'new', 'consolidation', 'chest', 'image', '', '', 'empiric', 'antibiotic', 'therapy', 'initiate', '', 'attempt', 'microbial', 'diagnosis', '', 'eg', '', 'sputum', 'gram', 'stain', 'culture', '', 'urinary', 'antigen', 'test', '', 'reevaluate', 'continue', 'antibiotic', 'therapy', 'daily', '', 'set', '', 'low', 'procalcitonin', 'helpful', 'suggest', 'bacterial', 'pneumonia', '', 'however', '', 'elevate', 'procalcitonin', 'describe', 'covid-19', '', 'particularly', 'late', 'course', 'illness', '', 'necessarily', 'indicate', 'bacterial', 'infection', '', '6-9', '', '', '', '', 'procalcitonin', 'lower', 'respiratory', 'tract', 'infection', '', '', 'section', 'guiding', 'antibiotic', 'therapy', '', '', '', 'diagnosis', 'empiric', 'antibiotic', 'regimen', 'community-acquired', 'health', 'care-associated', 'pneumonia', 'discuss', 'elsewhere', '', '', '', 'overview', 'community-acquired', 'pneumonia', 'adult', '', '', 'epidemiology', '', 'pathogenesis', '', 'microbiology', '', 'diagnosis', 'hospital-acquired', 'ventilator-associated', 'pneumonia', 'adult', '', '', 'treatment', 'hospital-acquired', 'ventilator-associated', 'pneumonia', 'adult', '', '', '', 'prevention', 'evaluation', 'venous', 'thromboembolism', '', 'favor', 'pharmacologic', 'prophylaxis', 'venous', 'thromboembolism', 'hospitalize', 'patient', 'covid-19', '', 'consistent', 'recommendation', 'several', 'expert', 'society', '', '12-14', '', '', 'dosing', 'selection', 'pharmacologic', 'agent', 'prevent', 'venous', 'thromboembolism', 'hospitalize', 'patient', 'covid-19', 'discuss', 'detail', 'elsewhere', '', 'algorithm', '1', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'inpatient', 'vte', 'prophylaxis', '', '', '', 'several', 'study', 'suggest', 'high', 'rate', 'thromboembolic', 'complication', 'among', 'hospitalize', 'patient', 'covid-19', '', 'particularly', 'critically', 'ill', '', 'thromboembolic', 'risk', 'covid-19', 'well', 'evaluation', 'management', 'complication', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'vte', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'indications', 'full-dose', 'anticoagulation', '', '', '', 'uncertainty', 'nsaid', '', 'minimal', 'data', 'inform', 'risk', 'non-steroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'set', 'covid-19', '', 'acetaminophen', 'prefer', 'antipyretic', 'agent', '', 'possible', '', 'nsaids', '', 'lowest', 'effective', 'dose', '', 'consistent', 'general', 'approach', 'fever', 'reduction', 'adult', '', '', 'pathophysiology', 'treatment', 'fever', 'adult', '', '', 'section', 'treating', 'fever', '', '', '', 'discontinue', 'nsaids', 'patient', 'chronically', 'condition', '', 'unless', 'reason', 'stop', '', 'eg', '', 'renal', 'injury', '', 'gastrointestinal', 'bleed', '', '', 'concern', 'possible', 'negative', 'effect', 'nsaids', 'raise', 'anecdotal', 'report', 'young', 'patient', 'receive', 'nsaids', 'early', 'course', 'infection', 'experience', 'severe', 'disease', '', '1516', '', '', 'however', '', 'clinical', 'population-based', 'data', 'directly', 'address', 'risk', 'nsaids', '', 'given', 'absence', 'data', '', 'european', 'medicines', 'agency', '', 'ema', '', '', '', 'united', 'states', 'national', 'institutes', 'health', '', 'nih', '', 'covid-19', 'treatment', 'guidelines', 'panel', 'recommend', 'nsaids', 'avoid', 'clinically', 'indicate', '', '41718', '', '', 'avoiding', 'nebulized', 'medication', '', 'inhaled', 'medication', 'administer', 'meter', 'dose', 'inhaler', '', 'whenever', 'possible', '', 'nebulizer', '', 'avoid', 'risk', 'aerosolization', 'sars-cov-2', 'nebulization', '', 'nebulizer', 'must', '', 'appropriate', 'infection', 'control', 'precaution', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'nebulized', 'medication', '', 'spontaneously', 'breathe', 'patient', '', '', '', '', 'limited', 'role', 'glucocorticoid', '', 'agree', 'recommendation', 'cdc', 'systemic', 'glucocorticoid', 'patient', 'covid-19', '', 'unless', 'indication', '', 'eg', '', 'exacerbation', 'chronic', 'obstructive', 'pulmonary', 'disease', '', '', '1920', '', 'without', 'pre-existing', 'pulmonary', 'disease', '', 'avoid', 'inhale', 'glucocorticoid', '', 'inhale', 'glucocorticoid', 'patient', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', 'set', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'acute', 'exacerbation', 'asthma', 'adult', '', 'emergency', 'department', 'inpatient', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', 'pandemic', '', '', 'stable', 'copd', '', 'overview', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', '', '', '', 'glucocorticoids', 'associate', 'increase', 'risk', 'mortality', 'patient', 'influenza', 'delay', 'viral', 'clearance', 'patient', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', 'infection', '', 'although', 'widely', 'management', 'sars', '', 'evidence', 'benefit', '', 'persuasive', 'evidence', 'adverse', 'short-', 'long-term', 'harm', '', '21', '', '', '', '', 'treatment', 'seasonal', 'influenza', 'adult', '', '', 'section', 'adjunctive', 'therapy', '', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'treatment', 'prevention', '', '', 'section', 'treatment', '', '', '', 'approach', 'glucocorticoid', 'among', 'critically', 'ill', 'patient', 'covid-19', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'glucocorticoids', '', '', '', 'managing', 'chronic', 'medicationsace', 'inhibitorsarbs', '', 'patients', 'receive', 'angiotensin-converting', 'enzyme', '', 'ace', '', 'inhibitor', 'angiotensin', 'receptor', 'blocker', '', 'arbs', '', 'continue', 'treatment', 'agent', 'reason', 'discontinuation', '', 'eg', '', 'hypotension', '', 'acute', 'kidney', 'injury', '', '', 'approach', 'support', 'multiple', 'guideline', 'panel', '', '22-26', '', '', 'speculation', 'patient', 'covid-19', 'receive', 'agent', 'increase', 'risk', 'adverse', 'outcome', '', 'support', 'find', 'observational', 'study', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'section', 'renin', 'angiotensin', 'system', 'inhibitor', '', '', '', 'conversely', '', 'arbs', 'propose', 'potential', 'protective', 'effect', 'base', 'mechanism', 'action', '', '27', '', '', 'trial', 'evidence', 'support', 'hypothesis', '', 'ace', 'inhibitor', 'arbs', 'potential', 'covid-19', 'treatmentstatins', '', 'point', 'continue', 'statin', 'hospitalize', 'patient', 'covid-19', 'already', '', 'high', 'proportion', 'patient', 'severe', 'covid-19', 'underlie', 'cardiovascular', 'disease', '', 'diabetes', 'mellitus', '', 'indication', 'statin', '', 'moreover', '', 'acute', 'cardiac', 'injury', 'report', 'complication', 'covid-19', '', 'although', 'clinician', 'concern', 'hepatotoxicity', 'statin', '', 'particularly', 'since', 'transaminase', 'elevation', 'common', 'covid-19', '', 'evidence', 'indicate', 'liver', 'injury', 'statin', 'uncommon', '', '', '', 'statins', '', 'actions', '', 'side', 'effect', '', 'administration', '', '', 'section', 'hepatic', 'dysfunction', '', '', '', 'whether', 'statin', 'impact', 'natural', 'history', 'sars-cov-2', 'infection', 'clear', '', 'statins', 'inhibitor', 'myd88', 'pathway', '', 'result', 'mark', 'inflammation', '', 'report', 'stabilize', 'myd88', 'level', 'set', 'external', 'stress', 'vitro', 'animal', 'study', '', '28', '', '', 'dysregulation', 'myd88', 'note', 'associate', 'poor', 'outcome', 'sars-cov', 'mers-cov', 'infection', '', 'describe', 'sars-cov-2', '', 'although', 'statin', 'benefit', 'patient', 'covid-19', '', 'data', 'neededimmunomodulatory', 'agent', '', 'immunosuppressing', 'agent', 'associate', 'increase', 'risk', 'severe', 'disease', 'respiratory', 'virus', '', 'decision', 'discontinue', 'prednisone', '', 'biologics', '', 'immunosuppressive', 'drug', 'set', 'covid-19', 'must', 'determine', 'case-by-case', 'basis', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', 'section', 'patients', 'covid-19', 'symptom', 'covid-19', 'exposure', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', 'section', 'adjusting', 'immunosuppression', '', '', '', 'individual', 'underlie', 'condition', 'require', 'treatment', 'agent', 'suspect', 'document', 'covid-19', '', 'evidence', 'routinely', 'discontinue', 'treatment', 'benefit', '', 'addition', '', 'discontinue', 'medication', 'result', 'loss', 'response', 'agent', 'reintroduce', '', 'approach', 'continue', 'immunomodulatory', 'therapy', 'patient', 'without', 'infection', 'support', 'statement', 'dermatology', '', 'rheumatology', '', 'gastroenterology', 'society', '', '29-32', '', 'infection', 'control', '', 'infection', 'control', 'essential', 'component', 'management', 'patient', 'suspect', 'document', 'covid-19', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'covid-19-specific', 'therapyspecific', 'treatment', '', 'several', 'treatment', 'evaluate', 'covid-19', '', 'although', 'treatment', 'clinically', 'available', 'indication', '', 'covid-19', 'remain', 'investigationalremdesivir', '', 'remdesivir', 'novel', 'nucleotide', 'analogue', 'activity', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'vitro', '', '33', '', '', 'united', 'states', '', 'food', 'drug', 'administration', '', 'fda', '', 'issue', 'emergency', 'authorization', 'remdesivir', 'hospitalize', 'child', 'adult', 'severe', 'covid-19', '', 'spo2', '94', 'percent', 'room', 'air', '', 'require', 'supplemental', 'oxygen', '', 'mechanical', 'ventilation', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', '', '34', '', '', 'suggest', 'adult', 'dose', '200', 'mg', 'intravenously', 'day', '1', 'follow', '100', 'mg', 'daily', '10', 'day', 'total', 'patient', 'mechanical', 'ventilation', 'ecmo', '5', 'day', 'total', 'patient', '', 'extension', '10', 'day', 'clinical', 'improvement', '', '', 'remdesivir', 'recommend', 'patient', 'alanine', 'aminotransferase', '5', 'time', 'upper', 'limit', 'normal', '', 'discontinue', 'rise', 'level', 'treatment', 'sign', 'liver', 'injury', '', '', 'pharmacokinetics', 'remdesivir', 'set', 'renal', 'impairment', 'uncertain', '', 'prepare', 'cyclodextrin', 'vehicle', 'accumulate', 'renal', 'impairment', 'toxic', '', 'thus', '', 'remdesivir', 'recommend', 'patient', 'estimate', 'glomerular', 'filtration', 'rate', '', 'egfr', '', '', '30', 'mlmin', 'per', '173', 'm2', 'unless', 'potential', 'benefit', 'outweigh', 'potential', 'risk', '', 'data', 'comparative', '', 'randomize', 'trial', 'define', 'effect', 'remdesivir', 'covid-19', '', 'data', 'emerge', 'remain', 'limit', 'mix', '', 'overall', '', 'preliminary', 'result', 'confirm', '', 'likely', 'clinical', 'benefit', 'remdesivir', '', 'although', 'patient', 'population', 'likely', 'benefit', 'remain', 'uncertainthe', 'united', 'states', 'national', 'institute', 'allergy', 'infectious', 'diseases', 'announce', 'preliminary', 'result', 'multinational', '', 'randomize', '', 'placebo-controlled', 'trial', 'remdesivir', 'among', '1063', 'patient', 'confirm', 'covid-19', 'evidence', 'lung', 'involvement', '', '35', '', '', 'interim', 'analysis', '', 'remdesivir', 'result', 'faster', 'time', 'recovery', '', 'define', 'discharge', 'hospital', 'longer', 'require', 'supplemental', 'oxygen', '', 'median', '11', 'versus', '15', 'day', 'placebo', '', 'p', '', '0001', '', '', 'trend', 'towards', 'lower', 'mortality', 'statistically', 'significant', '', '8', 'versus', '116', 'percent', 'placebo', '', 'p', '', '0059', '', '', 'final', 'analysis', 'peer', 'review', 'data', 'pending', '', 'contrast', '', 'double-blind', 'randomize', 'trial', 'china', '237', 'patient', 'severe', 'covid-19', '', 'hypoxia', 'radiographically', 'confirm', 'pneumonia', '', '', 'time', 'clinical', 'improvement', 'statistically', 'different', 'remdesivir', 'compare', 'placebo', '10', 'day', '', 'median', '21', 'versus', '23', 'day', '', 'hazard', 'ratio', 'improvement', '123', '', '95', '', 'ci', '087-175', '', '', '', '36', '', '', 'clinical', 'improvement', 'define', 'discharge', 'hospital', 'two-point', 'improvement', 'six-point', 'clinical', 'score', 'range', 'death', 'mechanical', 'ventilation', 'lower', 'level', 'oxygen', 'support', 'discharge', '', 'study', 'include', 'one', 'patient', 'mechanical', 'ventilation', 'baseline', '', 'mortality', '28', 'day', 'similar', 'remdesivir', 'placebo', '', '14', 'versus', '13', 'percent', '', '', 'difference', 'time', 'viral', 'clearance', '', 'among', 'patient', 'receive', 'treatment', 'within', '10', 'day', 'symptom', 'onset', '', 'trend', 'towards', 'lower', 'mortality', 'rapid', 'clinical', 'improvement', 'remdesivir', '', 'difference', 'statistically', 'significant', '', 'remdesivir', 'stop', 'early', 'adverse', 'event', '', 'include', 'gastrointestinal', 'symptom', '', 'aminotransferase', 'bilirubin', 'elevation', '', 'worsen', 'cardiopulmonary', 'status', '', '12', 'percent', '', 'compare', '5', 'percent', 'placebo', 'group', '', 'several', 'limitation', 'reduce', 'confidence', 'find', 'effect', '', 'concomitant', 'therapy', '', 'lopinavir-ritonavir', '', 'interferon', 'alpha-2b', '', 'andor', 'corticosteroid', '', 'study', 'participant', '', 'patient', 'remdesivir', 'group', 'higher', 'proportion', 'comorbidities', '', 'hypertension', '', 'diabetes', 'mellitus', '', 'coronary', 'heart', 'disease', '', '', 'study', 'stop', 'early', 'poor', 'enrollment', '', 'target', 'enrollment', 'pre-determined', 'demonstrate', 'effect', '435', 'patient', '', '', 'early', 'data', 'suggest', '5', 'day', 'remdesivir', 'result', 'similar', 'outcome', '10', '', 'preliminary', 'report', 'manufacturer', 'randomize', '', 'open-label', 'trial', 'among', 'nearly', '400', 'patient', 'severe', 'covid-19', 'mechanical', 'ventilation', '', 'rate', 'clinical', 'recovery', 'discharge', 'day', '14', 'statistically', 'different', 'remdesivir', 'give', '5', 'day', '', '65', '60', 'percent', '', 'respectively', '', 'versus', '10', 'day', '', '54', '52', 'percent', '', 'respectively', '', '', '37', '', '', 'mortality', 'rate', 'day', '14', '8', '11', 'percent', '5', '10', 'day', 'treatment', '', 'respectively', '', 'vary', 'geographic', 'locationuse', 'remdesivir', 'describe', 'several', 'case', 'series', '', '38-40', '', '', 'one', 'multicenter', '', 'multinational', 'series', '', '53', 'patient', 'severe', 'covid-19', 'hypoxia', 'receive', 'compassionate-use', 'remdesivir', '10', 'day', 'median', '18', 'day', 'follow-up', '', '68', 'percent', 'clinical', 'improvement', '', 'decrease', 'requirement', 'oxygen', 'support', 'hospital', 'discharge', '', '', '13', 'percent', 'die', '', '40', '', '', '30', 'patient', 'mechanically', 'ventilate', 'baseline', '', '17', '', '57', 'percent', '', 'extubated', '', 'three', 'four', 'patient', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', 'reported', 'side', 'effect', 'include', 'nausea', '', 'vomit', '', 'transaminase', 'elevation', '', 'preliminary', 'report', 'trial', 'remdesivir', 'among', 'patient', 'severe', 'covid-19', '', 'grade', '3', 'aminotransferase', 'elevation', 'occur', '7', 'percent', 'lead', 'drug', 'discontinuation', '3', 'percent', '', '37', '', '', 'adverse', 'event', 'describe', 'patient', 'receive', 'remdesivir', 'include', 'worsen', 'kidney', 'injury', '', 'multiple', 'organ', 'failure', '', 'worsen', 'cardiopulmonary', 'status', '', '3640', '', '', 'convalescent', 'plasma', '', 'united', 'states', '', 'fda', 'accept', 'investigational', 'new', 'drug', 'application', 'convalescent', 'plasma', 'patient', 'severe', 'life-threatening', 'covid-19', '', '41', '', '', 'pathway', 'application', 'include', 'clinical', 'trial', '', 'expand', 'access', 'program', '', 'emergency', 'individual', '', 'convalescent', 'plasma', 'describe', 'case', 'series', '', '42-44', '', '', 'one', 'case', 'series', 'describe', 'administration', 'plasma', 'donor', 'completely', 'recover', 'covid-19', 'five', 'patient', 'severe', 'covid-19', 'mechanical', 'ventilation', 'persistently', 'high', 'viral', 'titer', 'despite', 'investigational', 'antiviral', 'treatment', '', '42', '', '', 'patient', 'decrease', 'nasopharyngeal', 'viral', 'load', '', 'decrease', 'disease', 'severity', 'score', '', 'improve', 'oxygenation', '12', 'day', 'transfusion', '', 'however', '', 'find', 'establish', 'causal', 'effect', '', 'efficacy', 'convalescent', 'plasma', 'remain', 'unknown', '', 'another', 'case', 'series', 'six', 'patient', 'receive', 'convalescent', 'plasma', 'late', 'course', 'illness', '', 'five', 'die', 'despite', 'sars-cov-2', 'viral', 'clearance', 'within', 'three', 'day', 'treatment', '', '44', '', '', 'finding', 'appropriate', 'donor', 'establish', 'test', 'confirm', 'neutralize', 'activity', 'plasma', 'logistical', 'challenge', '', 'united', 'states', '', 'american', 'red', 'cross', 'help', 'collect', 'distribute', 'convalescent', 'plasma', 'throughout', 'country', '', '45', '', '', '', '', 'clinical', 'plasma', 'component', '', '', 'section', 'convalescent', 'plasma', '', '', '', 'fda', 'facilitate', 'evaluation', 'hyperimmune', 'globulin', 'patient', 'covid-19', '', '45', '', '', 'il-inhibitor', 'pathway', 'inhibitor', '', 'markedly', 'elevate', 'inflammatory', 'marker', '', 'eg', '', 'd-dimer', '', 'ferritin', '', 'elevate', 'pro-inflammatory', 'cytokine', '', 'include', 'interleukin', '', 'il', '', '-6', '', 'associate', 'critical', 'fatal', 'covid-19', '', 'block', 'inflammatory', 'pathway', 'hypothesize', 'prevent', 'disease', 'progression', '', 'tocilizumab', 'il-inhibitor', 'receptor', 'inhibitor', 'rheumatic', 'disease', 'cytokine', 'release', 'syndrome', 'evaluate', 'randomize', 'trial', 'treatment', 'covid-19', '', 'case', 'report', 'observational', 'study', 'describe', 'tocilizumab', 'patient', 'covid-19', '', '46-53', '', '', 'example', '', 'study', '63', 'patient', 'severe', 'covid-19', 'laboratory', 'result', 'suggest', 'pro-inflammatory', 'pro-thrombotic', 'state', '', 'major', 'adverse', 'event', 'directly', 'relate', 'tocilizumab', '', 'give', 'intravenously', 'subcutaneously', '', '', 'associate', 'decrease', 'c-reactive', 'protein', '', 'd-dimer', '', 'ferritin', 'level', '', 'overall', '', '14-day', 'mortality', 'rate', '11', 'percent', '', '51', '', 'sarilumab', 'siltuximab', 'agent', 'target', 'il-inhibitor', 'pathway', 'evaluate', 'clinical', 'trial', '', 'hydroxychloroquinechloroquine', '', 'insufficient', 'data', 'thus', 'far', 'whether', 'hydroxychloroquine', 'hydroxychloroquine', 'role', 'treatment', 'covid-19', '', 'reason', '', 'strongly', 'recommend', 'patient', 'refer', 'clinical', 'trial', 'whenever', 'possible', '', 'united', 'states', '', 'fda', 'issue', 'emergency', 'authorization', 'allow', 'agent', 'adolescent', 'adult', 'hospitalize', 'covid-19', 'participation', 'clinical', 'trial', 'feasible', '', '54', '', '', 'clinical', 'trial', 'available', '', 'suggest', 'routinely', 'hydroxychloroquine', 'hydroxychloroquine', 'give', 'clear', 'benefit', 'limit', 'data', 'potential', 'toxicity', '', 'drug', 'covid-19', 'outside', 'clinical', 'trial', '', 'infectious', 'diseases', 'society', 'america', '', 'idsa', '', 'encourage', 'creation', 'registry', '', 'possible', '', 'systematically', 'evaluate', 'safety', 'efficacy', '', '55', '', '', 'additionally', '', 'hydroxychloroquine', 'hydroxychloroquine', 'outside', 'clinical', 'trial', '', 'potential', 'adverse', 'effect', 'carefully', 'assess', '', 'particular', '', 'agent', 'prolong', 'qt', 'interval', 'avoid', 'patient', 'prolong', 'baseline', 'qtc', 'interval', 'agent', 'affect', 'cardiac', 'conduction', '', 'otherwise', 'close', 'monitor', '', 'american', 'college', 'cardiology', 'suggest', 'qtc', 'monitor', 'parameter', 'set', '', '56', '', '', 'qtc', 'monitor', 'set', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'section', 'monitoring', 'qt', 'prolongation', '', '', '', 'risk', '', 'eg', '', 'retinopathy', 'cardiomyopathy', '', 'primarily', 'longer-term', 'higher', 'cumulative', '', 'consideration', 'decide', 'agent', '', 'catastrophic', 'outcome', 'report', 'hydroxychloroquine', 'hydroxychloroquine', 'overdose', '', 'individual', 'medication', 'without', 'medical', 'supervision', '', '5758', '', '', '', '', 'antimalarial', 'drug', 'treatment', 'rheumatic', 'disease', '', '', 'section', 'adverse', 'effect', '', '', '', 'hydroxychloroquine', 'hydroxychloroquine', 'report', 'inhibit', 'sars-cov-2', 'vitro', '', 'although', 'hydroxychloroquine', 'appear', 'potent', 'antiviral', 'activity', '', '59', '', '', 'randomized', 'trial', 'evaluate', 'clinical', 'underway', '', 'however', '', 'publish', 'clinical', 'data', 'either', 'agent', 'limit', '', 'methodologic', 'problem', '', 'suggest', 'clear', 'benefit', '', '60-65', '', '', 'open-label', 'randomize', 'trial', '150', 'hospitalize', 'patient', 'mild', 'moderate', 'covid-19', '', 'either', 'pneumonia', 'pneumonia', 'without', 'hypoxia', '', '', 'add', 'hydroxychloroquine', 'standard', 'care', 'improve', 'rate', 'sars-cov-2', 'clearance', '', '84', 'versus', '81', 'percent', 'standard', 'care', 'alone', '', 'result', 'symptomatic', 'improvement', '', '60', 'versus', '66', 'percent', '', '28', 'day', '', '64', '', '', 'methodologic', 'concern', 'trial', 'include', 'concomitant', 'co-therapies', '', 'baseline', 'difference', 'group', '', 'blind', 'placebo', 'control', '', 'available', 'evidence', 'suggest', 'benefit', 'patient', 'severe', 'covid-19', '', 'although', 'data', 'population', 'limit', 'observational', 'study', '', 'observational', 'study', 'nearly', '1400', 'patient', 'covid-19', 'admit', 'hospital', 'new', 'york', '', 'hydroxychloroquine', 'report', '811', 'patient', 'associate', 'higher', 'risk', 'intubation', 'death', '', 'hazard', 'ratio', '', 'hr', '', '237', '', '', '62', '', '', 'patients', 'receive', 'hydroxychloroquine', 'older', '', 'likely', 'comorbidities', '', 'severe', 'illness', '', 'likely', 'confound', 'variable', '', 'multivariate', 'analysis', 'compare', 'patient', 'propensity', 'score-matched', 'subset', '274', 'patient', 'receive', 'hydroxychloroquine', '', 'association', 'hydroxychloroquine', 'intubation', 'death', '', 'adjust', 'hr', '104', '', '', 'another', 'observational', 'study', 'france', '180', 'patient', 'severe', 'covid-19', 'require', 'oxygen', 'supplementation', 'critical', 'care', '', 'rate', 'transfer', 'intensive', 'care', 'unit', 'death', 'similar', 'among', 'receive', 'hydroxychloroquine', '', '65', '', 'studies', '', 'however', '', 'highlight', 'potential', 'toxicity', 'hydroxychloroquine', 'hydroxychloroquine', '', 'one', 'trial', 'compare', 'two', 'hydroxychloroquine', 'covid-19', 'stop', 'early', 'higher', 'mortality', 'rate', 'high-dose', 'group', '', '66', '', '', 'observational', 'study', '84', 'patient', 'receive', 'hydroxychloroquine', '', '10', 'percent', 'electrocardiographic', 'change', 'prompt', 'discontinuation', '', '65', '', '', 'qtc', 'prolongation', 'hydroxychloroquine', 'hydroxychloroquine', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'section', 'patients', 'receive', 'qt-prolonging', 'treatment', '', 'eg', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'azithromycin', '', 'etc', '', '', '', '', 'evidence', 'combination', 'hydroxychloroquine', 'azithromycin', 'discuss', 'elsewhere', '', '', 'others', '', '', '', 'others', '', 'agent', 'putative', 'antiviral', 'immunomodulating', 'effect', 'propose', 'patient', 'covid-19', '', '67-71', '', '', 'preclinical', 'clinical', 'evaluation', '', 'agent', 'covid-19', 'limit', 'clinical', 'trial', '', 'efficacy', 'prove', '', 'extensive', 'off-label', 'result', 'excess', 'toxicity', 'critical', 'shortage', 'drug', 'prove', 'indication', '', 'registry', 'international', 'clinical', 'trial', 'find', 'covid-trialsorg', '', 'well', 'website', 'clinicaltrialsgov', '', 'favipiravir', '', 'favipiravir', 'rna', 'polymerase', 'inhibitor', 'available', 'asian', 'country', 'treatment', 'influenza', '', 'evaluate', 'clinical', 'trial', 'treatment', 'covid-19', 'united', 'states', '', 'study', 'patient', 'non-severe', 'disease', '', 'include', 'oxygen', 'saturation', '', '93', 'percent', '', '', 'favipiravir', 'associate', 'faster', 'rate', 'viral', 'clearance', '', 'median', 'time', 'clearance', '4', 'versus', '11', 'day', '', 'frequent', 'radiographic', 'improvement', '', '91', 'versus', '62', 'percent', 'day', '14', '', 'compare', 'lopinavir-ritonavir', '', '72', '', '', 'however', '', 'therapy', 'administer', 'non-randomized', '', 'open-label', 'study', '', 'result', 'interpret', 'caution', 'give', 'potential', 'confoundersinterferon', 'beta', '', 'interest', 'interferon', 'beta', 'sars-cov-2', 'spur', 'evidence', 'suggest', 'vitro', 'activity', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', 'outcome', 'animal', 'model', 'mers-cov', 'infection', '', '73-75', '', '', 'one', 'open-label', 'randomize', 'trial', 'hong', 'kong', '', '127', 'adult', 'hospitalize', 'primarily', 'nonsevere', 'covid-19', 'randomly', 'assign', '21', 'combination', 'intervention', '', 'interferon', 'beta', '', 'ribavirin', '', 'plus', 'lopinavir-ritonavir', 'symptom', 'onset', 'within', '7', 'day', 'ribavirin', 'plus', 'lopinavir-ritonavir', 'symptom', 'onset', '7', '14', 'day', '', 'versus', 'control', '', 'lopinavir-ritonavir', 'alone', '', '', '76', '', '', 'patients', 'intervention', 'group', 'rapid', 'time', 'negative', 'sars-cov-2', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'test', 'nasopharyngeal', 'swab', '', 'median', '7', 'versus', '12', 'day', '', '', 'clinical', 'improvement', '', 'median', '4', 'versus', '8', 'day', '', '', 'hospital', 'discharge', '', 'median', '9', 'versus', '15', 'day', '', '', 'subgroup', 'analysis', '', 'difference', 'observe', 'among', 'patient', 'symptom', 'onset', 'within', '7', 'day', 'thus', 'receive', 'interferon', 'beta', 'part', 'intervention', '', 'adverse', 'effect', 'similar', 'intervention', 'control', 'group', '', 'hemolysis', 'detect', 'ribavirin', '', '400', 'mg', 'orally', 'twice', 'daily', '', '', 'study', 'clarify', 'role', 'interferon', 'beta', 'covid-19', 'therapyother', 'immunomodulatory', 'agent', '', 'observation', 'patient', 'clinical', 'presentation', 'resemble', 'cytokine', 'release', 'syndrome', 'association', 'severe', 'disease', 'number', 'pro-inflammatory', 'marker', '', 'interrupt', 'inflammatory', 'cascade', 'propose', 'potential', 'therapeutic', 'target', 'severe', 'covid-19', '', 'addition', 'il-inhibitor', 'pathway', 'inhibitor', '', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'immunomodulatory', 'agent', 'various', 'class', '', 'include', 'il-inhibitor', 'inhibitor', '', 'kinase', 'inhibitor', '', 'complement', 'inhibitor', '', 'evaluate', '', 'describe', 'case', 'series', 'observational', 'study', '', '6877-80', '', '', 'example', '', 'retrospective', 'study', 'patient', 'covid-19', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'require', 'non-invasive', 'ventilation', '', 'markedly', 'elevate', 'c-reactive', 'protein', '', 'crp', '', 'ferritin', '', 'receipt', 'high-dose', 'anakinra', '29', 'patient', '', 'addition', 'hydroxychloroquine', 'lopinavir-ritonavir', '', 'associate', 'lower', '21-day', 'mortality', 'rate', 'compare', 'historical', 'cohort', '16', 'patient', 'receive', 'hydroxychloroquine', 'lopinavir-ritonavir', '', '10', 'versus', '44', 'percent', '', '', 'however', '', 'historical', 'group', 'older', '', 'likelihood', '', 'unmeasured', 'confounders', 'find', 'difficult', 'interpret', '', '77', '', '', 'results', 'randomize', 'trial', 'necessary', 'determine', 'effect', 'agent', '', 'azithromycin', 'hydroxychloroquine', '', 'azithromycin', 'combination', 'hydroxychloroquine', 'treat', 'covid-19', '', 'combination', 'describe', 'observational', 'study', '', '60638182', '', '', 'although', 'one', 'study', 'suggest', 'azithromycin', 'combination', 'hydroxychloroquine', 'associate', 'rapid', 'resolution', 'virus', 'detection', 'hydroxychloroquine', 'alone', '', '60', '', '', 'result', 'interpret', 'caution', 'small', 'sample', 'size', '', 'substantial', 'methodologic', 'concern', '', '83', '', '', 'unclear', 'biologic', 'plausibility', '', 'another', 'small', 'observational', 'study', 'patient', 'severe', 'illness', 'suggest', 'rapid', 'viral', 'rna', 'clearance', 'combination', '', '81', '', '', 'furthermore', '', 'azithromycin', 'hydroxychloroquine', 'associate', 'qtc', 'prolongation', '', 'combine', 'potentiate', 'adverse', 'effect', '', 'large', 'observational', 'study', 'patient', 'hospitalize', 'covid-19', 'new', 'york', '', 'adjust', 'mortality', 'rate', 'among', 'receive', 'azithromycin', 'plus', 'hydroxychloroquine', 'similar', 'compare', 'receive', 'neither', 'agent', '', 'rate', 'cardiac', 'arrest', 'higher', '', '63', '', 'lopinavir-ritonavir', '', 'combine', 'protease', 'inhibitor', '', 'primarily', 'hiv', 'infection', '', 'vitro', 'activity', 'sars-cov', '', '84', '', 'appear', 'activity', 'mers-cov', 'animal', 'study', '', '73', '', '', 'however', '', 'lopinavir-ritonavir', 'appear', 'minimal', 'role', 'treatment', 'sars-cov-2', 'infection', 'outside', 'clinical', 'trial', '', 'launch', 'multinational', 'trial', 'evaluate', 'remdesivir', '', 'hydroxychloroquinechloroquine', '', 'lopinavir-ritonavir', 'without', 'interferon', 'beta', '', '85', '', '', 'results', 'randomize', 'trial', 'demonstrate', 'clear', 'benefit', 'lopinavir-ritonavir', '', 'randomize', 'trial', '199', 'patient', 'severe', 'covid-19', '', 'addition', 'lopinavir-ritonavir', '', '400100', 'mg', '', 'twice', 'daily', '14', 'day', 'standard', 'care', 'decrease', 'time', 'clinical', 'improvement', 'compare', 'standard', 'care', 'alone', '', '86', '', '', 'trend', 'towards', 'decrease', 'mortality', 'lopinavir-ritonavir', '', '19', 'versus', '25', 'percent', '', '', 'numerical', 'difference', 'mortality', 'greater', 'among', 'randomize', 'within', '12', 'day', 'symptom', 'onset', '', 'neither', 'difference', 'statistically', 'significant', '', 'rate', 'sars-cov-2', 'decline', 'similar', 'group', 'receive', 'lopinavir-ritonavir', 'group', '', 'lopinavir-ritonavir', 'stop', 'early', '14', 'percent', 'adverse', 'effect', '', 'lopinavir-ritonavir', '', 'patient', 'hiv', 'status', '', 'patient', 'hiv', '', 'lopinavir-ritonavir', 'standard', 'combination', 'antiretroviral', 'regimen', '', 'approach', '', 'optimal', 'approach', 'treatment', 'covid-19', 'uncertain', '', 'although', 'trial', 'data', 'suggest', 'benefit', 'remdesivir', '', 'data', 'preliminary', 'formally', 'peer', 'review', 'report', '', 'otherwise', 'therapy', 'clearly', 'prove', 'effective', '', 'potential', 'therapy', '', 'evidence', 'primarily', 'observational', 'case', 'series', 'anecdotal', 'base', 'vitro', 'extrapolate', 'indirect', 'evidencethus', '', 'available', '', 'strongly', 'recommend', 'enrollment', 'well-controlled', 'clinical', 'trial', '', 'approach', 'consistent', 'recommendation', 'expert', 'group', 'united', 'states', '', 'idsa', 'recommend', 'covid-19-specific', 'therapy', 'give', 'context', 'clinical', 'trial', 'additionally', 'recommend', 'certain', 'therapy', '', 'include', 'hydroxychloroquine', 'plus', 'azithromycin', '', 'lopinavir-ritonavir', '', 'tocilizumab', '', 'administer', 'context', 'clinical', 'trial', 'greater', 'level', 'uncertainty', 'potential', 'toxicity', '', '55', '', '', 'similarly', '', 'nih', 'covid-19', 'treatment', 'guidelines', 'panel', 'note', 'insufficient', 'evidence', 'recommend', 'antiviral', 'immune-based', 'therapy', 'specifically', 'recommend', 'certain', 'therapy', '', 'include', 'hydroxychloroquine', 'plus', 'azithromycin', '', 'hiv', 'protease', 'inhibitor', '', 'interferon', '', 'janus', 'kinase', 'inhibitor', '', 'outside', 'context', 'clinical', 'trial', '', '4', '', 'registry', 'international', 'clinical', 'trial', 'find', 'covid-trialsorg', '', 'well', 'website', 'clinicaltrialsgov', '', 'risk-based', 'approach', 'enroll', 'patient', 'likely', 'benefit', '', 'approach', 'dependent', 'local', 'availability', 'clinical', 'trial', 'universally', 'applicable', '', 'clinicians', 'consult', 'local', 'protocol', 'managementdefining', 'disease', 'severity', '', 'mild', 'disease', 'characterize', 'fever', '', 'malaise', '', 'cough', '', 'upper', 'respiratory', 'symptom', '', 'andor', 'le', 'common', 'feature', 'covid-19', '', 'absence', 'dyspnea', '', 'patient', 'hospitalization', '', 'patient', 'develop', 'dyspnea', '', 'raise', 'concern', 'least', 'moderate', 'severity', 'disease', '', 'patient', 'often', 'warrant', 'hospitalization', '', 'patients', 'infiltrate', 'chest', 'image', 'still', 'consider', 'moderate', 'disease', '', 'presence', 'follow', 'feature', 'indicate', 'severe', 'disease', '', 'hypoxia', '', 'oxygen', 'saturation', '93', 'percent', 'room', 'air', 'pao2fio2', '', '300', 'mmhg', '', 'tachypnea', '', 'respiratory', 'rate', '', '30', 'breath', 'per', 'minute', '', 'respiratory', 'distressmore', '50', 'percent', 'involvement', 'lung', 'parenchyma', 'chest', 'imagingthese', 'feature', 'china', 'characterize', 'severe', 'disease', 'large', 'cohort', 'patient', '', '87', '', 'consistent', 'united', 'states', 'nih', 'covid-19', 'treatment', 'guidelines', 'panel', 'definition', 'severe', 'infection', '', '4', '', '', 'treat', 'patient', 'certain', 'laboratory', 'abnormality', '', 'table', '1', '', 'similar', 'patient', 'severe', 'disease', '', 'abnormality', 'associate', 'disease', 'progression', 'several', 'studiesnonsevere', 'disease', '', 'patient', 'nonsevere', 'disease', '', 'suggest', 'supportive', 'care', '', 'close', 'monitor', 'clinical', 'worsen', '', 'develop', 'feature', 'severe', 'disease', '', 'eg', '', 'hypoxia', '', 'tachypnea', '', 'respiratory', 'distress', '', 'defining', 'disease', 'severity', '', '', '', '', 'laboratory', 'feature', 'associate', 'disease', 'progression', '', 'table', '1', '', '', 'treat', 'describe', '', '', 'severe', '', 'include', 'critical', '', 'disease', '', '', '', 'clinical', 'trial', 'available', 'patient', 'nonsevere', 'disease', '', '', 'prioritize', 'patient', 'epidemiologic', 'risk', 'factor', 'associate', 'development', 'severe', 'illness', '', 'table', '2', '', '', 'generally', 'treat', 'patient', 'nonsevere', 'disease', 'experimental', 'agent', 'outside', 'context', 'clinical', 'trialsevere', '', 'include', 'critical', '', 'disease', '', 'prioritize', 'covid-19-specific', 'therapy', 'hospitalize', 'patient', 'severe', 'disease', 'laboratory', 'risk', 'factor', 'disease', 'progression', '', 'table', '1', '', '', 'hospitalize', 'patient', 'severe', 'covid-19', '', 'recommend', 'remdesivir', '', 'available', '', 'united', 'states', '', 'remdesivir', 'obtain', 'fda', 'emergency', 'authorization', '', 'although', 'availability', 'limit', 'hospital', 'designate', 'distribution', 'federal', 'government', '', '88', '', '', 'pregnant', 'individual', '', 'remdesivir', 'obtain', 'compassionate', 'program', '', '', 'remdesivir', '', '', '', 'patient', 'severe', 'disease', 'laboratory', 'risk', 'factor', 'disease', 'progression', '', 'table', '1', '', 'remdesivir', 'route', '', 'recommend', 'referral', 'clinical', 'trial', 'treatment', '', 'refer', 'patient', 'able', 'remdesivir', 'emergency', 'authorization', 'clinical', 'trial', 'agent', '', 'allow', 'concurrent', 'remdesivir', '', 'addition', 'remdesivir', '', 'therapy', 'evaluate', 'trial', 'include', 'convalescent', 'plasma', 'hydroxychloroquine', '', 'patients', 'feature', 'similar', 'cytokine', 'release', 'syndrome', '', 'eg', '', 'persistent', 'fever', 'elevate', 'cytokine', 'level', '', 'ferritin', '', 'd-dimer', '', 'andor', 'inflammatory', 'marker', '', 'eligible', 'clinical', 'trial', 'il-inhibitor', 'pathway', 'inhibitor', 'immunomodulators', '', 'registry', 'international', 'clinical', 'trial', 'find', 'covid-trialsorg', '', 'detailed', 'discussion', 'agent', 'find', 'elsewhere', '', '', 'specific', 'treatment', '', '', '', 'neither', 'clinical', 'trial', 'emergency-use', 'remdesivir', 'option', '', 'clinician', 'able', 'obtain', 'convalescent', 'plasma', 'investigational', 'treatment', 'covid-19', '', 'united', 'states', '', 'access', 'fda', 'investigational', 'new', 'drug', 'application', 'expand', 'access', 'program', '', '41', '', '', '', 'convalescent', 'plasma', '', '', '', 'although', 'treatment', 'hypothesize', 'greater', 'impact', 'give', 'early', 'course', 'disease', '', 'optimal', 'time', 'implementation', 'therapy', 'remain', 'unknown', '', 'data', 'available', '', 'uncertain', 'patient', 'benefit', 'best', 'allocate', 'potentially', 'limit', 'clinical', 'trial', 'slot', 'emergency', 'agentsseveral', 'agent', 'investigate', 'treatment', 'covid-19', 'available', 'medical', 'indication', '', 'repurposed', 'covid-19', 'describe', '', 'insufficient', 'data', 'whether', 'agent', 'role', 'treatment', 'covid-19', '', 'thus', '', 'strongly', 'recommend', 'patient', 'refer', 'clinical', 'trial', 'whenever', 'possiblewhen', 'clinical', 'trial', 'option', 'remdesivir', 'convalescent', 'plasma', 'obtain', '', 'favor', 'supportive', 'care', 'off-label', 'available', 'agent', 'unknown', 'efficacy', 'covid-19', '', 'particular', '', 'suggest', 'routinely', 'hydroxychloroquine', 'hydroxychloroquine', 'outside', 'clinical', 'trial', '', 'limit', 'available', 'data', 'suggest', 'clear', 'benefit', 'suggest', 'potential', 'toxicity', '', 'however', '', 'acknowledge', '', 'absence', 'option', '', 'clinician', 'choose', 'certain', 'agent', '', 'eg', '', 'hydroxychloroquine', '', 'il-inhibitor', 'pathway', 'inhibitor', 'patient', 'evidence', 'severe', 'pro-inflammatory', 'state', '', 'severely', 'ill', 'patient', '', 'drug', 'covid-19', 'outside', 'clinical', 'trial', '', 'idsa', 'encourage', 'creation', 'registry', 'systematically', 'evaluate', 'safety', 'efficacy', '', '55', '', '', 'management', 'hypoxia', '', 'ards', '', 'complications', '', 'patients', 'severe', 'disease', 'often', 'oxygenation', 'support', '', 'high-flow', 'oxygen', 'noninvasive', 'positive-pressure', 'ventilation', '', 'safety', 'measure', 'uncertain', '', 'consider', 'aerosol-generating', 'procedure', 'warrant', 'specific', 'isolation', 'precaution', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'respiratory', 'care', 'nonintubated', 'patient', '', '', '', 'patient', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'warrant', 'intubation', 'mechanical', 'ventilation', '', 'management', 'ards', 'patient', 'covid-19', 'critical', 'care', 'issue', 'discuss', 'detail', 'elsewhere', '', 'table', '3', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'addition', 'ards', '', 'complication', 'infection', 'include', 'arrhythmia', '', 'acute', 'cardiac', 'injury', '', 'acute', 'kidney', 'injury', '', 'thromboembolic', 'event', '', 'shock', '', 'management', 'complication', 'discuss', 'elsewhere', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'section', 'acute', 'kidney', 'injury', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'discharge', '', 'decision', 'discharge', 'patient', 'covid-19', 'generally', 'condition', 'depend', 'hospital-level', 'care', 'monitor', '', 'continued', 'infection', 'control', 'precaution', 'prevent', 'discharge', 'home', 'patient', 'appropriately', 'self-isolate', '', 'long-term', 'care', 'facility', 'specific', 'requirement', 'prior', 'accept', 'patient', 'covid-19', '', 'criteria', 'discontinue', 'precaution', 'infection', 'control', 'issue', 'long-term', 'care', 'facility', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'long-term', 'care', 'facility', '', '', '', 'patients', 'covid-19', 'generally', 'warrant', 'outpatient', 'follow-up', 'telehealth', 'in-person', 'visit', 'follow', 'discharge', 'hospital', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'section', 'outpatient', 'management', 'follow', 'inpatient', 'ed', 'discharge', '', '', '', 'encourage', 'patient', 'recover', 'covid-19', 'consider', 'donate', 'convalescent', 'plasma', '', 'interested', 'patient', 'refer', 'community', 'blood', 'center', '', 'united', 'states', '', 'american', 'red', 'cross', 'determine', 'whether', 'meet', 'eligibility', 'criterion', 'donation', '', '', '', 'clinical', 'plasma', 'component', '', '', 'section', 'covid-19', 'pandemic', '', '', '', 'institutional', 'protocols', '', 'several', 'academic', 'medical', 'institution', 'united', 'states', 'develop', 'covid-19', 'management', 'protocol', 'publicly', 'available', '', 'given', 'paucity', 'high-quality', 'clinical', 'evidence', 'management', 'covid-19', '', 'safety', 'efficacy', 'strategy', 'uncertain', '', 'brigham', 'women', 'hospitalmassachusetts', 'general', 'hospitalmichigan', 'medicinenebraska', 'medicinepenn', 'medicineuniversity', 'washington', 'medicinepartners', 'health', 'release', 'resource', 'clinician', 'organization', 'resource-limited', 'set', '', 'special', 'situationspregnant', 'breastfeed', 'woman', '', 'management', 'pregnant', 'breastfeed', 'woman', 'covid-19', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'pregnant', 'breastfeed', 'woman', '', '', '', 'people', 'hiv', '', 'data', 'impact', 'hiv', 'infection', 'natural', 'history', 'covid-19', 'limit', '', '8990', '', '', 'however', '', 'comorbid', 'condition', 'associate', 'severe', 'covid-19', '', 'eg', '', 'cardiovascular', 'disease', '', 'occur', 'frequently', 'among', 'patient', 'hiv', '', '', 'addition', 'cd4', 'cell', 'count', '', 'consider', 'risk', 'stratification', '', 'additionally', '', 'drug', 'interaction', 'antiretroviral', 'agent', 'important', 'ass', 'start', 'new', 'therapy', '', 'otherwise', '', 'management', 'covid-19', 'patient', 'hiv', 'patient', 'without', 'hiv', '', 'hiv', 'reason', 'exclude', 'patient', 'clinical', 'trial', 'intervention', '', '91', '', '', 'lopinavir-ritonavir', 'trial', 'patient', 'covid-19', '', 'although', 'data', 'one', 'randomize', 'trial', 'suggest', 'benefit', '', '86', '', '', 'patient', 'hiv', 'protease', 'inhibitor-containing', 'regimen', '', 'change', 'include', 'protease', 'inhibitor', 'outside', 'context', 'clinical', 'trial', 'without', 'consultation', 'expert', 'management', 'hiv', '', '92', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', 'summary', 'recommendationsa', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'china', 'end', '2019', '', 'subsequently', 'spread', 'rapidly', '', 'result', 'global', 'pandemic', '', 'disease', 'designate', 'covid-19', '', 'stand', 'coronavirus', 'disease', '2019', '', 'virus', 'cause', 'covid-19', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'optimal', 'approach', 'treatment', 'covid-19', 'uncertain', '', 'approach', 'base', 'limit', 'data', 'evolve', 'rapidly', 'clinical', 'data', 'emerge', '', '', '', '', '', 'patient', 'suspect', 'covid-19', 'mild', 'disease', 'warrant', 'hospital-level', 'care', '', 'patient', 'recover', 'home', 'prefer', '', 'prevent', 'additional', 'potential', 'exposure', 'health', 'care', 'set', 'reduce', 'burden', 'health', 'care', 'system', '', 'identification', 'patient', 'manage', 'outpatient', 'set', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', 'evaluation', 'hospitalize', 'patient', 'document', 'suspect', 'covid-19', 'ass', 'feature', 'associate', 'severe', 'illness', 'identify', 'organ', 'dysfunction', 'comorbidities', 'complicate', 'potential', 'therapy', '', 'table', '2', '', '', '', 'evaluation', '', '', '', 'patients', 'hospitalize', 'covid-19', 'receive', 'pharmacologic', 'prophylaxis', 'venous', 'thromboembolism', '', 'algorithm', '1', '', '', 'covid-19', 'associate', 'thromboembolic', 'complication', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'minimal', 'data', 'inform', 'risk', 'non-steroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'set', 'covid-19', '', 'suggest', 'acetaminophen', 'prefer', 'antipyretic', 'agent', '', 'possible', '', 'grade', '2c', '', '', 'nsaids', '', 'lowest', 'effective', 'dose', '', 'discontinue', 'nsaids', 'patient', 'chronically', 'condition', 'reason', 'stop', '', '', 'uncertainty', 'nsaid', '', '', '', 'specific', 'concern', 'covid-19', 'impact', 'decision', 'start', 'stop', 'angiotensin-converting', 'enzyme', '', 'ace', '', 'inhibitor', 'angiotensin', 'receptor', 'blocker', '', 'arbs', '', '', 'people', 'ace', 'inhibitor', 'arb', 'another', 'indication', 'stop', 'medication', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'section', 'renin', 'angiotensin', 'system', 'inhibitor', '', '', '', 'point', 'continue', 'statin', 'hospitalize', 'patient', 'covid-19', 'already', '', '', 'statins', '', '', '', 'optimal', 'covid-19-specific', 'therapy', 'uncertain', '', 'preliminary', '', 'unpublished', 'trial', 'data', 'suggest', 'benefit', 'remdesivir', '', 'agent', 'clearly', 'prove', 'effective', '', 'potential', 'therapy', '', 'evidence', 'low', 'quality', '', 'reason', '', 'patient', 'refer', 'clinical', 'trial', 'whenever', 'possible', '', 'clinicians', 'consult', 'local', 'protocol', 'management', '', '', 'approach', '', '', '', 'patient', 'nonsevere', 'disease', 'laboratory', 'feature', 'associate', 'severe', 'disease', '', 'table', '1', '', '', 'care', 'primarily', 'supportive', '', 'close', 'monitor', 'disease', 'progression', '', 'clinical', 'trial', 'available', 'patient', '', 'prioritize', 'advance', 'age', '', 'eg', '', '', '65', 'year', '', 'comorbidities', 'associate', 'risk', 'progressive', 'disease', '', 'table', '2', '', '', '', 'defining', 'disease', 'severity', '', 'nonsevere', 'disease', '', '', '', 'hospitalize', 'patient', 'severe', 'disease', '', 'recommend', 'remdesivir', '', 'available', '', 'grade', '1c', '', '', 'united', 'states', '', 'remdesivir', 'available', 'us', 'food', 'drug', 'administration', '', 'fda', '', 'emergency', 'authorization', '', '', 'remdesivir', '', '', '', 'hospitalize', 'patient', 'severe', 'disease', 'laboratory', 'feature', 'associate', 'severe', 'disease', '', 'table', '1', '', 'remdesivir', 'emergency', 'authorization', '', 'recommend', 'referral', 'clinical', 'trial', '', 'grade', '1c', '', '', 'clinical', 'trial', 'remdesivir', 'ongoing', '', 'investigational', 'therapy', 'include', 'convalescent', 'plasma', '', 'hydroxychloroquine', '', 'interleukin', '', 'il', '', '-6', 'pathway', 'inhibitor', '', 'immunomodulatory', 'agent', '', 'refer', 'patient', 'able', 'remdesivir', 'emergency', 'authorization', 'clinical', 'trial', 'agent', '', 'allow', 'concurrent', 'remdesivir', '', '', 'severe', '', 'include', 'critical', '', 'disease', '', '', '', 'neither', 'clinical', 'trial', 'remdesivir', 'emergency', 'authorization', 'available', '', 'clinician', 'able', 'obtain', 'convalescent', 'plasma', 'investigational', 'patient', 'severe', 'disease', '', 'united', 'states', '', 'request', 'fda', 'expand', 'access', 'program', '', '', 'convalescent', 'plasma', '', '', '', 'none', 'option', 'available', '', 'favor', 'supportive', 'care', '', 'particular', '', 'suggest', 'routinely', 'hydroxychloroquine', 'hydroxychloroquine', 'outside', 'context', 'clinical', 'trial', 'give', 'clear', 'benefit', 'limit', 'data', 'potential', 'toxicity', '', 'grade', '2c', '', '', 'suggest', 'lopinavir-ritonavir', 'covid-19', 'therapy', 'outside', 'clinical', 'trial', '', 'grade', '2b', '', '', '', 'hydroxychloroquinechloroquine', '', 'others', '', '', '', 'patients', 'severe', 'disease', 'often', 'oxygenation', 'support', '', 'patient', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'warrant', 'intubation', 'mechanical', 'ventilation', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'infection', 'control', 'essential', 'component', 'management', 'patient', 'suspect', 'document', 'covid-19', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'acknowledgments', '', 'author', 'like', 'acknowledge', 'eric', 'meyerowitz', '', 'md', '', 'camille', 'kotton', '', 'md', '', 'michael', 'mansour', '', 'md', '', 'pritha', 'sen', '', 'md', '', 'ramy', 'elshaboury', '', 'pharmd', '', 'ronak', 'gandhi', '', 'pharmd', '', 'boris', 'juelg', '', 'md', '', 'contribution', 'topic', 'review', '']",6476,"{'': 1674, 'covid-19': 168, 'patient': 140, 'disease': 110, 'clinical': 70, 'coronavirus': 59, 'trial': 59, '2019': 50, 'severe': 46, 'hydroxychloroquine': 43, 'remdesivir': 41, 'treatment': 38, 'care': 35, 'section': 34, 'agent': 33, 'day': 32, 'management': 31, 'infection': 29, 'data': 27, 'elsewhere': 27}","{'tocilizumab': 4, 'hydroxychloroquine': 43, 'infection': 29, 'sars-cov-2': 13, 'vitro': 6, 'safety': 4, 'il-inhibitor': 8}",107,0.4767
ID:127419,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue']","['INTRODUCTION — A novel coronavirus identify late 2019 cause cluster pneumonia case Wuhan , China .', 'It since rapidly spread result pandemic .', 'The World Health Organization designate disease term COVID-19 ( ie , Coronavirus Disease 2019 ) [ 1 ] .', 'The virus cause COVID-19 designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'The major morbidity mortality COVID-19 largely due acute viral pneumonitis evolve acute respiratory distress syndrome ( ARDS ) .This topic discus epidemiology , clinical feature , management patient become critically ill due COVID-19 .', 'Other aspect COVID-19 , coronavirus-related disease ( severe acute respiratory syndrome [ SARS ] Middle East respiratory syndrome [ MERS ] ) , discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' `` Coronaviruses '' `` Severe acute respiratory syndrome ( SARS ) '' `` Middle East respiratory syndrome coronavirus : Virology , pathogenesis , epidemiology '' ."", ') GUIDELINES AND HOSPITAL POLICIES — The advice topic base upon data derive management patient acute respiratory distress syndrome , emerge retrospective data patient COVID-19 , expert opinion , anecdotal observation clinician treat patient COVID-19 China , Italy , Washington state ( USA ) , large outbreak occur .', 'Guidelines issue several society organization include Society Critical Care Medicine , Chinese Thoracic Society , Australian New Zealand Intensive Care Society ( ANZICS ) , World Health Organization United States Centers Disease Control Prevention National Institutes Health [ 2-7 ] .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' ."", ') Learning region deal overwhelm burden COVID-19 date , essential hospital health system develop task force manage patient admit disorder .', 'This involve , limit , designate COVID-19-specific intensive care unit ( ICUs ) ICU team , create back expand staff schedule , utilize detail protocol infection prevention medical management , access research trial patient COVID-19 , ensure adequate personal protection equipment ( PPE ) supply train , forecast demand , prioritize diagnostic lab testing.EPIDEMIOLOGY — Reports suggest among infect severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , 20 percent develop severe disease require hospitalization [ 8-15 ] .', 'Although rate vary , among hospitalize , one-quarter need intensive care unit ( ICU ) admission , represent approximately 5 8 percent total infect population .', 'Differences rate ICU admission may relate cultural difference practice admission criterion ICU well difference predispose factor age comorbidities test availability population serve .', '●China – In Chinese cohort , rate ICU admission severe illness range 7 26 percent [ 9,10,15,16 ] .', '●Italy - Consistent range report China , preliminary report Italy suggest proportion ICU admission 5 12 percent total positive SARS-CoV-2 case , 16 percent hospitalize patient [ 17,18 ] .', '●United States America – In early study 21 critically ill patient Washington State , USA , 81 percent patient COVID-19 pneumonia admit ICU 71 percent mechanically ventilate [ 19 ] .', 'However , high rate likely reflect older age population largely come nurse home region .', 'A larger analysis 2449 patient report hospitalization rate 20 31 percent ICU admission rate 4.9 11.5 percent [ 20 ] .While three-quarters critically ill patient male Chinese cohort , data mix report suggest equal proportion men woman [ 18,19 ] suggest male predominance [ 21,22 ] .', ""CLINICAL FEATURES IN CRITICALLY ILL PATIENTSClinical feature complication — General clinical feature COVID-19 patient risk factor progression discuss separately ( see `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical feature ' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ) ."", 'Discussion limit clinical feature critically ill.●Rate progression – Retrospective study critically ill patient suggest among patient develop critical illness , include acute respiratory distress syndrome ( ARDS ) , onset dyspnea relatively late ( median 6.5 day symptom onset ) , progression ARDS swift thereafter ( median 2.5 day onset dyspnea ) [ 9,10,19,23,24 ] .', '●Clinical feature – Among critically ill , profound acute hypoxemic respiratory failure ARDS dominant find [ 8-10,19,21,22,24-28 ] .', 'Hypercapnia rare .', 'Fevers tend wax wane ICU admission .', 'The need mechanical ventilation critically ill high range 30 100 percent [ 9,19,21,22,25,28 ] .', '●Length stay – Early clinical report suggest length intensive care unit ( ICU ) stay appear long many patient remain intubate one two week longer [ 22 ] .', 'Reports expert field suggest many patient fail early attempt wean ( eg , within first week ) , although appear predict eventual ability wean extubate .', 'Only small proportion patient require tracheostomy .', ""( See 'Extubation wean ' 'Tracheostomy ' ."", ') ●Complications – Common complication COVID-19-related ARDS include acute kidney injury ( AKI ) , elevate liver enzyme , cardiac injury include cardiomyopathy , pericarditis , pericardial effusion , arrhythmia , sudden cardiac death .', 'As example , single-center retrospective cohort China 52 critically ill patient COVID-19 , complication include AKI ( 29 percent ; half need renal replacement therapy ) , liver dysfunction ( 29 percent ) , cardiac injury ( 23 percent ) [ 9 ] .', '•Cardiac injury appear late complication , develop respiratory illness improve .', 'A high rate cardiomyopathy note United States cohort ( 33 percent ) , may relate older age population [ 19 ] .', 'In another United States cohort New York City , cardiac complication among mechanically ventilate patient include atrial arrhythmia ( 18 percent ) , myocardial infarction ( 8 percent ) , heart failure ( 2 percent ) [ 27 ] .', 'One case series report five patient develop acute cor pulmonale , occur association hemodynamic instability cardiac arrest [ 29 ] .', 'All case think likely due pulmonary embolism ( PE ) , although definitive diagnosis PE confirm one case .', 'Cardiac complication COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial infarction coronary artery disease issue '' ."", ') •Sepsis , shock , multi-organ failure occur appear le common compare non-COVID-19-related ARDS .', 'The need vasoactive agent variable , although significant proportion need vasopressor support hypotension ( often due sedation medication cardiac dysfunction ) .', 'In cohort study Wuhan , China , 35 percent 52 patient receive vasoactive agent [ 9 ] .', 'In contrast , case series New York City , 95 percent 130 patient receive mechanical ventilation require vasopressor support ; reason specify [ 27 ] .', '•As , acute kidney injury common among critically ill patient COVID-19 , many require renal replacement therapy .', 'This discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' , section 'Acute kidney injury ' ."", ') •Data risk secondary bacterial pneumonia limit , appear major feature COVID-19 .', 'In cohort intubate patient China , hospital-acquired pneumonia , many case resistant pathogen , report 12 percent [ 9 ] .', 'This find may relate high use glucocorticoid ARDS management China .', 'Further data need elucidate rate superinfection country .', '•Lung compliance high compare etiology ARDS rate barotrauma appear low 2 percent develop pneumothorax , compare 25 percent severe acute respiratory syndrome coronavirus ( SARS-CoV ) [ 9,30 ] .', 'There limit data describe lung pathology patient COVID-19 .', 'Case report post mortem case patient undergo biopsy another reason suggest wide variation mononuclear inflammation diffuse alveolar damage , classic ARDS [ 31,32 ] .', ""( See `` Acute respiratory distress syndrome : Epidemiology , pathophysiology , pathology , etiology adult '' , section 'Pathologic stage ' ."", ') •Neurologic complication critically ill patient common , especially delirium encephalopathy manifest prominent agitation confusion along corticospinal tract sign ( hyperreflexia ) .', 'Consistent , intensivists observe sedation requirement high population , particularly immediately intubation .', 'In one series 58 patient COVID-19-related ARDS , delirium/encephalopathy present approximately two-thirds patient [ 33 ] .', 'In addition , three 13 patient brain MRI acute ischemic stroke ; eight MRI study demonstrate leptomeningeal enhancement .', 'Cerebrospinal fluid ( CSF ) seven patient acellular one elevate CSF protein ; PCR assay CSF negative virus .', 'It unclear whether neurologic complication note report due critical illness , medication effect , represent direct effect cytokine SARS-CoV-2 virus [ 33-35 ] .', 'Encephalitis , report , rare [ 36 ] .', 'Similarly , Guillain-Barré-barre syndrome follow SARS-CoV-2 virus infection also describe small case series [ 37 ] .', '•COVID-coagulopathy common population patient develop abnormal coagulation profile others develop thrombosis .', 'These feature discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", ') ●Laboratory – Laboratory find critically ill patient ( eg leukopenia , lymphopenia , leukocytosis , elevate D-dimer , lactate dehydrogenase , ferritin , normal low procalcitonin ) initially modest similar milder illness , although procalcitonin level may elevate lymphopenia profound critically ill patient [ 8,10,26 ] .', ""( See `` Cytokine release syndrome ( CRS ) '' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Laboratory find ' `` Procalcitonin use lower respiratory tract infection '' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' ."", ') Some patient severe COVID-19 laboratory evidence exuberant inflammatory response , similar cytokine release syndrome ( CRS ) , persistent fever , elevate inflammatory marker ( eg , D-dimer , ferritin , interleukin-6 ) , elevate proinflammatory cytokine ; laboratory abnormality associate poor prognosis [ 38 ] .', 'Clinical trial anti-IL-6 agent treatment COVID-19 progress .', 'Further detail regard CRS provide separately .', ""( See `` Cytokine release syndrome ( CRS ) '' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Laboratory find ' `` Procalcitonin use lower respiratory tract infection '' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'IL-6 pathway inhibitor ' . )"", 'The presence antiphospholipid antibody also describe ; however , mostly IgA subclass , clinical significance unclear [ 39 ] .', 'Abnormal coagulation parameter commonly see COVID-19 patient ( eg , elevate D-dimer , prolong prothrombin time ) also discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' `` Diagnosis antiphospholipid syndrome '' ."", ') ●Imaging – Typical image find appear different mild severe case COVID-19 ( eg , ground-glass opacification without consolidative abnormality , consistent viral pneumonia , minimal pleural effusion ) [ 9,40,41 ] .', 'While image chest compute tomography ( CT ) commonly perform Chinese cohort , prefer avoid use , unless necessary ; chest CT use diagnostic tool , use must balance risk patient healthcare worker process patient transport time spend CT room .', 'Characteristic find bedside lung ultrasound include thicken pleural line B line support alveolar consolidation .', 'Pleural effusion unusual [ 42 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Imaging find ' . )"", 'Pathology — There paucity data describe lung pathology COVID-19 pneumonia critically ill patient .', 'Most autopsy report describe hyaline membrane change microvessel thrombosis suggestive early ARDS ( ie , exudative proliferative phase diffuse alveolar damage [ DAD ] ) [ 32,43-48 ] .', 'Other find include bacterial pneumonia ( isolate superimpose DAD ) viral pneumonitis [ 44,48 ] .', 'Less common find include acute fibrinous organize pneumonia ( AFOP ; late stage ) [ 49 ] , amyloid deposition ( heart lung ) , rarely alveolar hemorrhage vasculitis [ 48 ] .', ""( See `` Interpretation lung biopsy result interstitial lung disease '' , section 'Diffuse alveolar damage ' ."", ') Evidence pulmonary thrombosis thromboembolism report autopsy series [ 44,48,50 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Clinical feature ' ."", ') Distant organ involvement also see demonstration virus organ lung , case , acute tubular necrosis generalize thrombotic microangiopathy kidney [ 44,48 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", ') Risk factor progression — Age appear major risk factor predict progression ARDS [ 12,19,20,25 ] .', 'Comorbidities , high fever ( ≥39°C ) , history smoke , select laboratory feature also predict progression death COVID-19 .', 'Importantly , adult age may develop severe disease experience adverse outcome , especially comorbidities .', 'Further detail regard risk disease progression provide separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ."", ') RESPIRATORY CARE OF THE NONINTUBATED PATIENT — Specific aspect respiratory care relevant deteriorate patient COVID-19 admission intensive care unit ( ICU ) discuss ( table 1 ) .', 'These include oxygenation low flow high-flow system , noninvasive ventilation administration nebulized medication .', 'For hospitalize patient develop progressive symptom , early admission ICU prudent feasible .', 'Self-proning — Some expert encourage hospitalize patient spend much time feasible safe prone position receive oxygen ; rationale approach base upon limit direct evidence [ 51,52 ] anecdotal observation field well indirect evidence efficacy ventilate patient .', ""( See 'Prone ventilation ' 'Monitoring noninvasive modality ' ."", ') Oxygenation target — The World Health Organization ( WHO ) suggest titrate oxygen target peripheral oxygen saturation ( SpO2 ) ≥90 percent .', 'For critically ill patient , prefer lowest possible fraction inspire oxygen ( FiO2 ) necessary meet oxygenation goal , ideally target SpO2 90 96 percent , feasible .', 'However , patient may warrant lower target ( eg , patient concomitant acute hypercapnic respiratory failure chronic obstructive pulmonary disease [ COPD ] ) others may warrant higher target ( eg , pregnancy ) .', ""( See `` Overview initiate invasive mechanical ventilation adult intensive care unit '' , section 'Fraction inspire oxygen ' . )"", 'Low flow oxygen — For patient COVID-19 , supplemental oxygenation low flow system via nasal cannula appropriate ( ie , 6 L/min ) .', 'Although degree micro-organism aerosolization low flow rate unknown , reasonable surmise minimal .', 'Higher flow oxygen may administer use simple face mask , venturi face mask , nonrebreather mask ( eg , 10 20 L/minute ) , flow increase , risk dispersion also increase , augment contamination surround environment staff .', 'Many expert patient wear nasal cannula also wear droplet mask , especially transport staff room .', 'Data support practice largely non-peer-reviewed derive simulation experiment make practical sense maneuver reduce infectious risk associate potential aerosolization [ 53-55 ] .', 'Additional information provision low flow oxygen provide separately .', ""( See `` Continuous oxygen delivery system acute care infant , child , adult '' ."", ') Patients higher oxygen requirement — As patient progress , higher amount oxygen need .', 'Options point non-COVID-19 patient high-flow oxygen via nasal cannulae ( HFNC ) initiation noninvasive ventilation ( NIV ) .', 'However , patient COVID-19 , decision controversial subject ongoing debate [ 56,57 ] .', 'Despite controversy , modality use variably .', 'In retrospective cohort , rate HFNC use range 14 63 percent 11 56 percent treat NIV [ 9,22,25,28 ] .', 'While , prospective data describe whether modality successful avoid intubation , one retrospective study describe highest level respiratory support hospitalize COVID-19 patient noninvasive modality ( HFNC NIV ) 5.4 percent patient invasive ventilation 30 percent [ 28 ] .', 'Deciding modality ( noninvasive invasive ventilation ) — We believe decision initiate noninvasive modality , HFNC NIV , make balance risk benefit patient , risk exposure healthcare worker , best use resource ; approach reassess new data become available .', 'We encourage development hospital protocol multidisciplinary approach , include respiratory therapy staff , facilitate decision .', 'In patient COVID-19 acute hypoxemic respiratory failure higher oxygen need low flow oxygen provide , suggest noninvasive modality , may use selectively rather proceed directly intubation ( eg , younger patient without comorbidities tolerate nasal cannulae ) .', 'On hand , patient may warrant avoidance HFNC may benefit proceed directly early intubation ( eg , elderly confuse patient comorbidities several risk factor progression ) .', 'Some expert advocate avoidance modality ( ie , proceed early intubation escalate beyond 6 L/min continue hypoxemia increase work breathe ) .', 'This predicate increase risk aerosolization high likelihood patient need modality ultimately , rapidly deteriorate require mechanical ventilation ( eg , within one three day ) .', 'This approach may reasonable resource available .', 'However , use absolute rule may result excess unnecessary intubation place undue load ventilator demand disease surge .', 'In addition , particularly problematic patient investigation ( eg , COVID-19 test pending ) , patient chronic nocturnal NIV requirement , patient chronic respiratory failure high baseline oxygen requirement , patient do-not-intubate status might benefit otherwise NIV HFNC .', 'Ultimately , recommendation may change time depend case load COVID-19 patient give location .', 'Oxygen via high flow nasal cannula versus noninvasive ventilation — Among noninvasive modality , prefer HFNC .', ""Our preference HFNC base upon limit inconsistent data , , balance , favor HFNC compare NIV patient non-COVID-19-related acute hypoxemic respiratory failure , detail provide separately ( see `` Heated humidify high-flow nasal oxygen adult : Practical consideration potential application '' , section 'Medical patient severe hypoxemic respiratory failure ' ) ."", ""In addition , limit data suggest high failure rate NIV patient Middle East Respiratory Syndrome ( MERS ) [ 58 ] cause acute respiratory distress syndrome ( ARDS ) ( see `` Noninvasive ventilation adult acute respiratory failure : Benefits contraindication '' , section 'Hypoxemic nonhypercapnic respiratory failure NOT due ACPE ' ) ."", 'However , NIV may appropriate patient indication prove efficacy ; include patient acute hypercapnic respiratory failure acute exacerbation chronic obstructive pulmonary disease ( AECOPD ) , patient acute cardiogenic pulmonary edema , patient sleep disorder breathe ( eg , obstructive sleep apnea obesity hypoventilation ) .', 'These data provide separately .', ""( See `` Noninvasive ventilation adult acute respiratory failure : Benefits contraindication '' , section 'Patients likely benefit ' . )"", 'Monitoring noninvasive modality — If HFNC NIV administer , vigilant monitor patient warrant progression frequent clinical arterial blood gas evaluation every one two hour ensure efficacy safe ventilation ( eg , frequent cough may “ safe ” ) .', 'We advocate low threshold intubate patient , particularly show sign rapid progression .', ""( See 'Timing ' ."", ') Although unproven , expert , include u , provide HFNC ( NIV ) patient prone position .', 'Limited evidence case report non-COVID patient acute respiratory distress syndrome anecdotal evidence suggest feasibility improvement oxygenation patient [ 51,59,60 ] .', 'Similarly , preliminary evidence support improvement oxygenation parameter patient COVID-19 receive NIV HFNC [ 61,62 ] .', 'For example , retrospective study , 12 15 COVID-19 patient treat NIV pronation ( median total two cycle , three hour ) experience improvement peripheral oxygen saturation remainder either stabilize deteriorate [ 61 ] .', 'In another prospective study 24 COVID-19 patient hypoxemic respiratory failure , third oxygen flow four liter ( include HFNC ) , 15 patient ( 63 percent ) could tolerate prone position three hour [ 62 ] .', 'Among tolerate prone position , six ( 40 percent ) experience improvement oxygenation prone position three improvement sustain upon resupination .', 'It remain unclear whether pronation avert intubation , accelerate recovery , reduce mortality .', 'Future data warrant identify optimal indication duration pronation , assessment response.Technical detail regard application HFNC NIV provide separately .', ""( See `` Heated humidify high-flow nasal oxygen adult : Practical consideration potential application '' `` Noninvasive ventilation adult acute respiratory failure : Practical aspect initiation '' `` Noninvasive ventilation adult acute respiratory failure : Benefits contraindication '' ."", ') Precautions noninvasive modality — HFNC NIV consider aerosol generate procedure .', 'Thus , HFNC NIV use , airborne addition standard precaution undertake ( ie , airborne infection isolation room [ also know negative pressure room ] , full personal protective equipment ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') ●HFNC – We advocate additionally place surgical N95 mask patient HFNC healthcare worker room , value practice unknown [ 3 ] .', 'Additional precaution HFNC potential reduce risk include start use lowest effective flow rate ( eg , 20 L/minute 0.4 FiO2 ) .', 'Inhaled medication gas ( eg , epoprostenol , nitric oxide bronchodilator ) avoid HFNC .', '●NIV – If NIV initiate , full-face mask rather nasal oronasal mask prefer minimize particle dispersion .', 'The mask preferably good seal anti-asphyxiation valve port .', 'Use helmet propose deliver NIV patient COVID-19 [ 63 ] .', 'However , experience limit delivery method , especially United States .', 'If NIV use , dual limb circuitry filter expiratory limb critical care ventilator may decrease dispersion compare single limb circuitry portable device , although data support lack .', 'We also suggest start continuous positive airway pressure ( CPAP ) use lowest effective pressure ( eg , 5 10 cm H2O ) .There data regard aerosolization HFNC NIV .', 'In normal lung simulation study , dispersion air exhalation increase increase HFNC flow 65 mm ( 10 L/minute ) 172 mm ( 60 L/minute ) mostly along sagittal plane ( ie , nostril ) [ 64 ] .', 'Similar distance find CPAP deliver via nasal pillow ( 332 mm CPAP 20 cm H2O ) .', 'However , significant leakage note CPAP administer via oronasal mask good seal ( picture 1 picture 2 ) .', 'Air leak increase connection device loose .', 'Dispersion seem reduce simulator simulate injure lung .', 'Nebulized medication ( spontaneously breathe patient ) — Nebulizers associate aerosolization potentially increase risk SARS-CoV-2 transmission .', 'In patient suspect document COVID-19 , nebulized bronchodilator therapy reserve acute bronchospasm ( eg , set asthma chronic obstructive pulmonary disease [ COPD ] exacerbation ) .', 'Otherwise , nebulized therapy generally avoid , particular indication without clear evidence-base ; however us ( eg , hypertonic saline cystic fibrosis ) may need individualize .', 'Metered dose inhaler ( MDIs ) spacer device use instead nebulizer management chronic condition ( eg , asthma COPD controller therapy ) .', 'Patients use MDIs hospital formulary.If nebulized therapy use , patient airborne infection isolation room , healthcare worker use contact airborne precaution appropriate personal protection equipment ( PPE ) ; include N95 mask goggle face shield equivalent ( eg , power air-purifying respirator [ PAPR ] mask ] ) well glove gown .', 'All non-essential personnel leave room nebulization .', 'Some expert also suggest re-enter room two three hour follow nebulizer administration .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') Other — Potential transmission SARS-CoV-2 inform use intervention patient document suspect COVID-19 : ●It prudent minimize follow : •Positive airway device chronic nocturnal ventilation support•Chest physical therapy oscillatory devices•Oral airway suctioning●Sputum induction avoided●Bronchoscopy avoid spontaneously breathe patient limit therapeutic indication ( eg , life-threatening hemoptysis , central airway stenosis ) If therapy perform , similar PPE describe nebulizer therapy use .', ""( See 'Nebulized medication ( spontaneously breathe patient ) ' `` Flexible bronchoscopy adult : Overview '' . )"", 'THE DECISION TO INTUBATETiming — Timing intubation population challenge .', 'Most patient acute respiratory distress syndrome ( ARDS ) due COVID-19 warrant intubation mechanical ventilation .', 'Delaying intubation patient acutely decompensates potentially harmful patient healthcare worker advise .', 'For patient escalate oxygen requirement , monitor clinical gas exchange parameter every one two hour low threshold intubate patient follow : ●Rapid progression hour ●Lack improvement > 40 L/minute high flow oxygen fraction inspire oxygen ( FiO2 ) > 0.6●Evolving hypercapnia , increase work breathe , increase tidal volume , worsen mental status ●Hemodynamic instability multiorgan failureMost expert experience manage COVID-19 patient suggest “ early ” intubation .', 'However , definition constitute “ early ” unclear .', 'Use noninvasive mean traditionally use avoid intubation .', ""However , use subject controversy patient COVID-19 ( see 'Patients higher oxygen requirement ' ) ."", 'Clinicians communicate closely regularly potential intubation patient follow treat noninvasively transition intubation smooth rapid identify patient need intubation .', 'Precautions — Intubation highest risk procedure droplet dispersion patient COVID-19 [ 56,65 ] .', 'The follow discussion suitable patient outside operate room ( eg , intensive care unit [ ICU ] emergency department ) ( table 2 ) .', '●We proponent development intubation kit intubation checklist perform rapid sequence intubation ( RSI ) population ( figure 1 ) .', '●Attention pay don full contact airborne personal protective equipment ( PPE ) ( figure 2 figure 3 ) [ 56 ] .', 'Appropriate PPE include fit-tested disposable N95 respirator mask ( picture 3 ) , eye protection power air-purifying respirator ( PAPR ) , also know isolation suit ( picture 4 picture 5 ) .', 'Also include gown , cap beard cover , protective footwear , neck cover , glove ( use double glove technique ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') ●Intubation perform airborne infection isolation room , possible.●Intubation perform qualify individual ( eg , anesthesiologist ) since delay intubation multiple attempt may prolong dispersion place patient risk respiratory arrest .', '●Anecdotally , expert suggest optimize preoxygenation nonaerosol-generating mean ( eg , avoidance high flow oxygen deliver via nasal cannula ) intubation use video laryngoscopy .', 'In patient previously high flow oxygen , expert switch 100 percent nonrebreather mask preoxygenation .', '●When manual bag mask ventilation ( BMV ) need , switch mask supraglottic device manual bag appropriate .', 'When feasible , BMV minimize intubation , bacterial/viral high efficiency hydrophobic filter place facemask breathe circuit resuscitation bag .', 'Having pre-prepared bag-mask filter attach every room COVID-19 patient prudent .', 'Using two-person technique adequate face mask seal also suggested.●Clamping endotracheal tube ( ETT ) connection disconnection appropriate ( eg , capnography test follow intubation ) , patient NOT spontaneously breathe .', '●The ventilator ventilator circuitry ready advance preplanned set already enter soon ETT place confirm capnography , connect directly ETT without additional manual bag .', 'In addition , feasible , in-line suction device in-line adapter bronchoscopy prepare attach ventilator tube advance order avoid unnecessary disconnection placement later point time .', 'The expiratory limb ventilator HEPA filter decrease contamination ventilator environment protect staff change limb circuitry .', '●To minimize exposure , bundle intubation procedure appropriate bundle chest radiograph ETT central venous catheter placement.●Doffing follow strict procedure expert also advocate use viricidal wipe area expose skin intubation ( eg , neck ) ( figure 3 ) .New proposal emerge novel barrier protection intubation .', 'In one pilot study , manually perform intubation inside transparent box describe ( “ aerosol box ” ) [ 66 ] .', 'The box design could place patient ’ head allow intubation perform two circular port cephalad side box .', 'In simulation experiment , cough approximate use latex balloon fluorescent dye .', 'Use box associate significant reduction aerosol deposition individual perform intubation , PPE clothe , surround environment , compare simulation without box .', 'While propose adjunct protection , restriction hand movement may encounter airway manipulation would necessitate abandon procedure simulation may accurately mimic aerosolization behavior virus particle .', 'Such device yet commercially available .', 'Detailed guidance regard intubation operate room , optimal personal protective equipment , procedural detail regard intubation discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' `` Safety operate room '' , section 'COVID-19 ' `` Direct laryngoscopy endotracheal intubation adult '' `` Rapid sequence intubation adult outside operate room '' `` The decision intubate '' `` Induction agent rapid sequence intubation adult outside operate room '' `` Neuromuscular block agent ( NMBAs ) rapid sequence intubation adult outside operate room '' ."", ') VENTILATOR MANAGEMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME — Most patient COVID-19 mechanically ventilate appear acute respiratory distress syndrome ( ARDS ) .', 'Accurate data duration ventilation limit suggest prolong mechanical ventilation two week ( table 1 ) .', 'All step discuss proceed resource allow .', 'Whether different phase COVID-19 pneumonitis require different ventilatory strategy unclear .', 'One school think early phase COVID-19 , severe hypoxemia associate high compliance low alveolar recruitability ( atypical ARDS ) , later phase , severe hypoxemia associate low lung compliance high recruitability ( classic ARDS ) [ 67,68 ] .', 'However , hypothesis , remain unproven optimal ventilatory strategy base upon unclear .', 'Until data available , prefer strategy promote lung protection outline section below.Low tidal volume ventilation ( LTVV ) — As patient ARDS , patient COVID-19 pneumonia develop ARDS require mechanical ventilation receive LTVV target ≤6 mL/kg predict body weight ( PBW ; range 4 8 mL/kg PBW ( table 3 table 4 ) ) .', 'We typically use volume-limited assist control mode , begin tidal volume 6 mL/kg PBW , target plateau pressure ( Pplat ) ≤30 cm H2O , apply positive end-expiratory pressure ( PEEP ) accord strategy outline table ( table 5 ) .', 'This approach base upon several randomize trial meta-analyses report improve mortality LTVV patient ARDS .', 'The experience among Chinese , Italian , United States cohort approach also beneficial population .', 'Modifications deviation mechanical ventilation strategy may require set severe hypercapnia ventilator dyssynchrony ( figure 4 ) .', ""( See `` Ventilator management strategy adult acute respiratory distress syndrome '' , section 'Patients improve deteriorate ' ."", ') Anecdotal report suggest COVID-19 ARDS phenotype one severe hypoxemia responsive high PEEP relatively high lung compliance Pplat ≤30 cm H2O difficult achieve .', 'As consequence , clinician low threshold start higher usual level PEEP ( eg , 10 15 cm H2O ) .Expanded detail LTVV ventilator strategy ARDS provide separately .', ""( See `` Ventilator management strategy adult acute respiratory distress syndrome '' . )"", ""We believe oxygenation goal critically ill patient COVID-19 similar nonventilated patient ( ie , peripheral oxygen saturation 90 96 percent ( see 'Oxygenation target ' ) ) ."", 'However , patent COVID-19 , expert use higher peripheral oxygen saturation ( SpO2 ) goal [ 7 ] .', 'The rationale approach may reduce frequency ventilator adjustment require staff entry room , thereby reduce risk healthcare staff , although data lack support it.Reflecting practice LTVV , one retrospective Italian cohort report median level PEEP 14 cm H2O ( interquartile range [ IQR ] 12 16 cm H2O ) [ 22 ] .', 'Ninety percent patient require FiO2 > 0.5 , median PaO2/FiO2 ratio 160 ( IQR , 114 220 ) .Failure low tidal volume ventilation — For patient COVID-19 fail achieve adequate oxygenation LTVV , agree expert field choose prone ventilation prefer next step .', 'For application , use similar criterion non-COVD-19 patient ( ie , partial arterial pressure oxygen/fraction inspire oxygen [ PaO2 : FiO2 ] ratio < 150 mmHg , FiO2 ≥0.6 , PEEP ≥5 cm H2O ; excessively high airway pressure ; recalcitrant hypoxemia ) , although expert use higher PaO2 : FiO2 ratio , give good response see population .', 'Prone ventilation — Our preference use prone ventilation base know efficacy patient ARDS well limit anecdotal observation intensivists field note unlike patient severe acute respiratory syndrome coronavirus ( SARS-CoV ) , patient COVID-19-related ARDS respond well maneuver [ 69 ] .', 'Those experience ventilate patient COVID-19-related ARDS also promote ventilate patient prone long feasible without prematurely return patient supine position ( ie , 12 16 hour prone per day ) perform maneuver change shift sufficient staff available .', 'The utmost care take avoid ventilator disconnection proning number personnel limit require turn .', 'This video describe prone procedure freely available .', 'Additional detail regard efficacy , contraindication ( table 6 ) application ( table 7 ) prone ventilation provide separately .', ""( See `` Prone ventilation adult patient acute respiratory distress syndrome '' `` Ventilator management strategy adult acute respiratory distress syndrome '' , section 'Ventilator strategy maximize alveolar recruitment ' . )"", 'The good response prone position may due preserve lung compliance population compare patient develop ARDS etiology .', 'Lung compliance change lung volume give pressure .', 'It measure use follow equation : lung compliance ( C ) = change lung volume ( V ) / change transpulmonary pressure ( alveolar pressure [ Palv ] – pleural pressure [ Ppl ] ) ; static lung compliance = tidal volume / Pplat – PEEP .', 'The normal lung compliance approximately 200 mL/cm H2O general compliance > 50 mL/cm H2O note clinician experience ventilate patient COVID-19 .', 'Optimal time criterion discontinue prone ventilation unclear perform individualize basis .', 'It unreasonable use criterion similar study show benefit non-COVID-related ARDS ( eg PaO2 : FiO2 ≥150 mmHg , FiO2 ≤0.6 , PEEP ≤10 cm H2O ) maintain least four hour end last prone session ) [ 70 ] .Additional option — Additional option patient prone ventilation fail include follow : ●Recruitment high PEEP – Recruitment maneuver high PEEP strategy ( table 8 ) may perform address severe hypoxemia ; data support use non COVID-19-related ARDS describe separately .', ""( See `` Ventilator management strategy adult acute respiratory distress syndrome '' , section 'Ventilator strategy maximize alveolar recruitment ' ."", ') ●Pulmonary vasodilator – Pulmonary vasodilator may improve ventilation-perfusion mismatch severe hypoxemia may particularly helpful hypoxemia acute pulmonary arterial hypertension crisis .', 'The two commonly use agent inhale nitric oxide ( NO ) inhale prostacyclin , administer continuous inhalation .', 'Inhaled vasodilator administer close system require skilled personnel use .', 'Potential risk challenge COVID-19 patient include aerosolization clog bacterial/viral filter use ventilator circuit medication administer .', 'Inhaled NO may prefer since associate lower need change filter resultant reduction risk respiratory healthcare provider .', 'Further detail regard use describe separately .', ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Nitric oxide ' `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Prostacyclin ' `` Inhaled nitric oxide adult : Biology indication use '' , section 'Acute hypoxemic respiratory failure ' . )"", '●Neuromuscular block agent ( NMBAs ) – NMBAs may reserve patient refractory hypoxemia ventilator dyssynchrony .', 'We favor routine use patient ARDS since data outcome conflict .', ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Paralysis ( neuromuscular blockade ) ' `` Neuromuscular block agent critically ill patient : Use , agent selection , administration , adverse effect '' . )"", '●Extracorporeal membrane oxygenation ( ECMO ) – While World Health Organization suggest ECMO rescue strategy , use fail prone ventilation evidence-based medical strategy list .', 'In addition , ECMO universally available .', 'As many hospital choose cohort patient COVID-19-only intensive care unit ( ICUs ) , may also challenge deliver ECMO ICUs routinely care ECMO patient ; would require recruitment additional specialize nurse perfusionist staff .', 'ECMO also reduce lymphocyte count raise interleukin-6 level , thereby interfere interpretation laboratory result [ 71 ] .', ""( See `` Extracorporeal membrane oxygenation ( ECMO ) adult '' ."", ') Use rescue strategy vary among center .', 'In single-center retrospective cohort 52 critically ill patient COVID-19 Wuhan , China , approximately 12 percent receive prone ventilation 12 percent receive ECMO [ 9 ] .', 'In contrast , original cohort 138 hospitalize patient COVID-19 , 17 patient require invasive mechanical ventilation , 24 percent treat ECMO .', 'Similarly , Italian cohort , 1 percent critically ill patient receive ECMO [ 22 ] .', 'Additional ventilator precaution — We recommend tight seal ventilator circuitry equipment .', 'For patient tracheostomy , similar recommendation apply .', 'Although efficacy unproven , expert suggest place ventilator intravenous ( IV ) line monitor outside room , feasible ( eg , wall port ) .', 'This allow frequent ventilator adjustment simultaneously decrease risk exposure staff ; although efficacy maneuver unproven .', 'It prudent avoid unnecessary disconnection endotracheal tube ( ETT ) ventilate patient COVID-19 order avoid derecruitment unnecessary exposure virus environment .', 'For example , in-line suction device in-line adapter bronchoscopy prefer , resource allow .', 'If disconnection necessary ( eg , transfer portable ventilator use manual bag ) , ETT temporarily clamp disconnection unclamped reconnection .', 'This consider aerosolize procedure case airborne infection isolation room preferable always feasible.Other infection precaution include use dual limb ventilator circuitry filter place exhalation outlet well heat moisture exchange ( HME ) system rather heat humification single limb circuit .', 'HME place exhalation port ETT ( figure 5 figure 6 ) .', ""( See `` The ventilator circuit '' ."", ') It particularly important adhere standard practice maintain ETT cuff pressure 25 30 cm H2O tight seal exist cuff tracheal wall .', ""( See `` Complications endotracheal tube follow initial placement : Prevention management adult intensive care unit patient '' , section 'Maintain optimal cuff pressure ' ."", ') All ventilator appropriate filter place agree upon filter change schedule ( eg , every six hour ) .', 'The ventilator wipe every filter change .', 'Although airborne isolation room ideal , feasible , patient ventilate non-isolation room need transport airborne isolation room aerosol generate procedure take place ( eg , extubation , bronchoscopy ) .', 'Having protocol place transport prudent .', 'INTERVENTIONS — Ventilated patient require frequent evaluation develop complication require intervention .', 'Details relevant severe acute respiratory syndrome coronavirus-2 ( SARS-CoV-2 ) infection include section mostly relate infectious precaution .', 'In biodistribution study 1070 specimen obtain 205 patient COVID-19 pneumonia , bronchoalveolar lavage fluid specimen show highest positive rate ( 93 percent ) , follow sputum ( 72 percent ) , nasal swab ( 63 percent ) , fibrobronchoscope brush biopsy ( 46 percent ) , pharyngeal swab ( 32 percent ) , feces ( 29 percent ) , blood ( 1 percent ) .', 'No urine specimen test positive [ 72 ] .', 'These data demonstrate SARS-CoV-2 may detect several specimen , although report rate study may determine severity illness individual test .', 'In systematic review 10 retrospective cohort study evaluate transmission severe acute respiratory syndrome coronavirus ( SARS-CoV ) healthcare worker , endotracheal intubation highest risk ( odds ratio [ OR ] 6.6 , 95 % CI 2.3-18.9 ) , follow noninvasive ventilation ( OR 3.1 , 95 % CI 1.4-6.8 ) , tracheostomy ( OR 4.2 , 95 % CI 1.5-11.5 ) , bag-mask ventilation [ 73 ] .', 'Other procedure associate lower insignificant risk transmission know whether apply SARS-CoV-2 .', 'For example , duration close contact aerosolize procedure precaution use describe .', 'Collection respiratory specimen intubate patient — Some intubate patient require upper lower respiratory tract sample diagnostic purpose ( eg , diagnosis COVID-19 ventilator-associated pneumonia [ VAP ] ) .', 'Technically , nasopharyngeal oropharyngeal swab take airborne precaution .', 'However , prefer obtain naso-and oropharyngeal swab tracheal aspirate airborne precaution intensive care unit ( ICU ) .', 'Nonbronchoscopic alveolar lavage ( “ mini-BAL ” ) may also perform alternative bronchoscopy , although experience procedure universal among ICUs .', 'If mini-BAL perform diagnosis COVID-19 , use smaller aliquot lavage fluid prudent ( eg , three 10 mL aliquot obtain 2 3 mL fluid ) .', ""( See `` Clinical presentation diagnostic evaluation ventilator-associated pneumonia '' , section 'Invasive respiratory sample ' ."", ') Bronchoscopy — We agree American Association Bronchology Interventional Pulmonology ( AABIP ) bronchoscopy limit role diagnosis COVID-19 perform indication upper respiratory sample negative ( ie , nasopharyngeal oropharyngeal swab , tracheal aspirate , non-bronchoscopic bronchoalveolar lavage ) suspicion remain high .', 'Bronchoscopy may also perform another diagnosis consider bronchoscopic sample would change management ( eg , suspect Pneumocystis jirovecii immunosuppressed patient ) therapeutic bronchoscopy indicate ( eg , life-threatening hemoptysis airway stenosis ) .', 'Bronchoscopy aerosol-generating procedure perform necessary likely change management .', 'Bronchoscopy establish airway ( eg , endotracheal tube [ ETT ] ) likely carry le risk bronchoscopy spontaneously breathe patient .', 'In patient COVID-19 , bronchoscopy perform airborne infection isolation room .', 'Airborne precaution personal protective equipment ( PPE ) don enter room .', 'Using PPE similar describe intubation appropriate .', ""( See 'The decision intubate ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') Using ETTs inline adapter bronchoscopy ideal prevent disconnection ventilator aerosolization .', 'If bronchoscopy need diagnosis COVID-19 pneumonia , suggest small aliquot 10 mL obtain 2 3 mL lavage fluid place sterile leak-proof container .', 'Clamping suction tube turn suction sample obtain disconnect sample device also prudent .', 'Specimens double zip-locked seal plastic bag , handle usual precaution , label clearly “ COVID-19. ” We prefer use disposable bronchoscope , although universally available .', 'For nondisposable equipment , recommend clean suction channel standard clean solution typically use highly infectious material .', 'We also suggest cover seal vessel contain bronchoscope transport use wipe transport cart bronchoscope display tower leave room .', 'Wipe solution hydrogen peroxide equivalent leave wet surface least one minute .', 'Extubation wean — Patients often ready extubation remain infectious , extubation frequently associate cough , consider aerosol-generating procedure .', 'Similar intubation , encourage use extubation protocol check list specific institution.●Weaning – Readiness extubation follow standard practice perform spontaneous breathe trial ( SBT ) .', 'However , COVID-specific approach include follow : •Equipment – We suggest use close system use T-piece trial SBTs.•SBTs – To reduce risk reintubation follow extubation , prefer higher degree readiness patient COVID-19 .', 'This practice vary may include higher criterion pass SBT .', 'For example , expert use lower pressure support ventilation [ PSV ] parameter ( eg , 0 5 cm H2O ) rather typical 7 cm H2O trial others promote SBT longer period ( eg , two four hour rather typical two hour ) .', 'The rationale alter criterion base upon observation patient COVID-19 intubate longer period non-COVID-patients [ 22 ] anecdotal evidence suggest high volume secretion airway edema ; factor place patient high risk post extubation respiratory failure require reintubation .', 'In addition , prefer extubating patient directly low-flow oxygen rather high flow oxygen deliver via nasal cannulae ( HFNC ) noninvasive ventilation ( NIV ) , may risk virus aerosolization .', ""( See `` Weaning mechanical ventilation : Readiness test '' `` Methods wean mechanical ventilation '' , section 'Spontaneous breathe trial ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') Cuff leak test – Whether cuff leak test ( CLT ) perform routinely prior extubation unclear .', 'However , performance may guide clinical suspicion upper airway edema ( eg , fluid overload ) presence risk factor post extubation stridor ( eg , prolong intubation ≥6 day , age > 80 year , large endotracheal tube , traumatic intubation ) .', 'Performing cuff leak test weigh potential risk aerosolization , similar extubation , preferentially do airborne isolation room .', 'In institution , routinely administer glucocorticoid ( eg , methylprednisolone 20 mg intravenously every four hour total four do ) patient COVID-19 extubation extubate CLT positive glucocorticoid .', 'We base practice upon high rate airway edema note population understand practice may vary depend upon population serve .', ""( See `` Extubation management adult intensive care unit '' , section 'Cuff leak ' ."", ') ●Extubation – We prefer perform extubation airborne isolation room .', 'Respiratory therapist others room extubation adhere airborne precaution include N95 mask eye protection equivalent .', 'In general , two people need extra staff outside room available help additional equipment .', 'Some expert use medication decrease cough ( eg , lidocaine via ETT , low-dose opioid bolus , dexmedetomidine , remifentanil available ) , although data support routine use anti-tussives limit .', 'In ICU , close communication clinician experience intubation regard occurrence extubation COVID-19 patient prudent , case rapid reintubation need , particularly patient pre-designated difficult airway.Both low-flow high-flow oxygen system set readily available .', 'We drape patient ’ chest face plastic cover provide barrier protection patient operator ( eg , plastic poncho ) .', 'We typically put ventilator standby mode ( switch ) immediately prior extubation .', 'After balloon deflation , extra care take extubation keep inline suction catheter engage cuff deflation another handheld suction catheter available removal pharyngeal oral section .', 'The endotracheal tube remove smoothly feasible inspiration , dispose biohazard plastic bag bundle together ventilator tube , plastic drape , tape/ETT holder , inline suction catheter .', 'The bag seal dispose immediately .', 'Further detail regard extubation provide separately .', ""( See `` Extubation management adult intensive care unit '' , section 'Extubation equipment technique ' ."", ') ●Post-extubation care – The patient monitor follow procedure .', 'The threshold reintubate patient postextubation respiratory failure low .', 'Postextubation care support application supplemental oxygen lowest fraction inspire oxygen ( FiO2 ) possible , preferably via low flow nasal canula .', 'Because patient often extubated remain infectious , would advise adhere similar approach oxygen delivery intubation .', ""( See `` Extubation management adult intensive care unit '' , section 'Postextubation management ' 'Oxygenation target ' ."", ') The procedure palliative extubation similar except care follow extubation also include palliative medication cessation neuromuscular blockade .', 'Precautions extubation OR provide separately .', ""( See `` Safety operate room '' , section 'COVID-19 ' . )"", 'Tracheostomy — Reports expert field suggest many patient fail early attempt wean ( eg , within first week ) , although appear predict eventual ability wean extubate .', 'However , patient require tracheostomy ( experience < 10 percent ICU admission ) .', '●Indications – Indications appear similar non-COVID patient ( eg , fail extubation , secretion management , airway edema , neurological impairment impair airway protection ) .●Timing – The optimal time tracheostomy unknown COVID-19 patient .', 'In non-COVID patient , change practice lead intensivists perform tracheostomy around day 7 10 follow initial intubation .', 'Although intensivists perform tracheostomy approximately 7 10 day follow initial intubation patient without COVID-19 , seem reasonable defer tracheostomy patient COVID-19 beyond time frame .', 'COVID-19 patient appear require mechanical ventilation longer patient ( eg , two three week ) , still successfully extubated point .', '●Procedure – Tracheostomy consider high risk procedure aerosolization .', '•Both open percutaneous tracheostomy procedure acceptable COVID patient .', '•The exact procedure determine advance discretion operator minimum number personnel .', '•To minimize cough , neuromuscular blockade prudent .', '•It preferable procedure do bedside airborne isolation room .', 'The operator wear appropriate PPE similar aerosol generate procedure .', 'The tracheostomy tube syringe attach immediate balloon inflation insert .', 'In addition , adapter inline suction catheter attach also appropriate .', ""( See 'Precautions ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') •Procedures open suction , dress change , inner cannula care , tracheostomy change also consider aerosol-generating .', 'Thus , post tracheostomy care also occur airborne isolation room , feasible ( , consider portable HEPA-filtration unit ) .', 'Novel barrier protection perform tracheostomy propose .', 'In one report , tracheostomy perform aerosol-reduction cover high-efficiency particulate air filtration unit place close surgical field [ 74 ] .', 'However , description aerosol deposition provide .', '●Prolonged wean – Tracheostomy collar trial safely do airborne isolation room resumption ventilation close loop system follow trial .', 'However , institution use portable HEPA filter generate negative pressure room use close system dual limb circuitry HEPA filter attach exhalation limb minimize environmental contamination .', 'A surgical mask tracheostomy may also theoretically limit droplet spread .', 'Once patient breathe 24 hour tracheostomy collar ( similar ) , undergo trial speak valve “ cap ” balloon deflate .', 'Placing speak valve cap would consider aerosol generate airborne precaution warrant .', 'However , speak valve place tracheostomy cap , aerosolization le consideration equivalent patient cough low flow oxygen patient may wear mask nose mouth .', 'Decannulation consider aerosol-generating procedure , provide patient remain infectious , usual airborne precaution take .', '●Repeat test – Some institution perform repeat SARS-CoV-2 test determine discontinue infection control precaution inform resource allocation .', 'Whether tracheal nasopharyngeal swab use purpose uncertain .', 'If patient test positive test , continue precaution two test collect 24 hour apart negative ; however , remain uncertain whether viral RNA detection recovery reflect transmissible infection .', ""( See 'Precautions ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Viral shed period infectivity ' . )"", '.', 'Further detail regard tracheostomy provide separately .', ""( See `` Overview tracheostomy '' ."", ') Cardiopulmonary resuscitation — In event cardiac arrest , cardiopulmonary resuscitation ( CPR ) proceed member team wear appropriate PPE .', 'Practicing test run COVID-19 patient cardiac arrest prudent .', 'Bag-mask ventilation avoid ( feasible ) ; ventilator use instead deliver respiratory rate 10 breath per minute ( bpm ) .', 'Guidance advance cardiac life support CPR patient prone return supine position provide separately .', ""( See `` Advanced cardiac life support ( ACLS ) adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' , section 'Patients require cardiopulmonary resuscitation ( CPR ) ' `` Basic life support ( BLS ) adult '' ."", ') Other intervention — Guidance lack regard procedure commonly perform ICU .', 'Many intubate patient routine indication central venous arterial access monitor vasoactive drug infusion .', 'Grouping standard procedure central venous catheter arterial line immediately follow intubation appropriate minimize frequency exposure .', 'The transmission risk blood unknown likely low [ 72 ] .', 'Significant pleural effusion barotrauma appear unusual manifestation COVID-19 .', 'In general , emergently indicate procedure intervention perform indicate , appropriate infectious precaution .', ""( See 'Clinical feature critically ill patient ' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical manifestation ' `` Safety operate room '' , section 'COVID-19 ' . )"", 'Transfer COVID-19 patient limit necessary trip ( eg , image diagnosis would change management , travel airborne isolation room high risk aerosol-generating procedure intubation extubation ) .', 'SUPPORTIVE CARE — General supportive care critically ill patient COVID-19 pneumonia similar patient acute respiratory distress syndrome ( ARDS ) due cause discuss detail separately .', 'Select issue pertinent COVID-19 discuss section .', ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Supportive care ' . )"", 'Routine measure — The supportive care mechanically ventilate patient also apply patient COVID-19 provide several link topic .', 'However , potential difference may pertain COVID-19 patient discuss section : Venous thromboembolism prevention — We agree American Society Hematology Society Critical Care Medicine routine pharmacologic venous thromboembolism ( VTE ) prophylaxis warrant , preferably low molecular weight heparin ( LMWH ; eg , enoxaparin 40 mg SC daily ) , unless contraindication ( eg , bleed , severe thrombocytopenia ) .', ""( See `` Prevention venous thromboembolic disease acutely ill hospitalize medical adult '' ."", ') Because risk VTE appear higher usual population , use aggressive VTE prophylaxis form increase intensity pharmacologic agent ( eg , enoxaparin 0.5 mg/kg every 12 hour , unfractionated heparin 7500 unit every eight hour ) and/or addition mechanical device prudent .', 'Markedly elevate D-dimer level , correlate poor prognosis , use expert guide intensification anticoagulation ( eg , > 6 time upper limit normal ) .', 'For patient creatinine clearance < 30 mL/minute , enoxaparin reduce 30 mg daily change unfractionated heparin depend severity kidney impairment patient weight .', 'Fondaparinux appropriate heparin-induced thrombocytopenia .', 'We believe administer therapeutic anticoagulation ( form prophylaxis ) may assess individual basis .', 'However indication therapeutic anticoagulation , outside document VTE , unclear may include presume VTE ( eg , sudden unexplained deterioration oxygenation hemodynamic instability , acute cor pulmonale ) clot vascular device ( eg , venous , arterial device , hemodialysis device ) .', 'Detailed description VTE risk management COVID-19 patient hypercoagulability provide separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", ') Sedation analgesia — Anecdotal evidence suggest requirement sedation analgesia appear high mechanically ventilate patient COVID-19 heavy use sedative analgesic medication require ventilator synchrony .', 'In practice , target Richmond Agitation-Sedation Scale ( RASS ( table 9 ) ) -1 -2 ( similar different score system ) , patient ventilator dyssynchrony , RASS -2 -3 .', 'RASS -4 -5 target severe dyssynchrony require neuromuscular blockade .', 'For require intravenous ( IV ) infusion , propofol fentanyl generally prefer agent .', 'However , shortage sedative may influence choice agent .', 'We also quickly transition oral medication , provide fluid resuscitation adequate ( eg , oxycodone , hydromorphone , lorazepam , diazepam ) .', 'Further detail regard indication , daily awaken , protocol , dose provide separately .', ""( See `` Sedative-analgesic medication critically ill adult : Selection , initiation , maintenance , withdrawal '' `` Sedative-analgesic medication critically ill adult : Properties , dosage regimen , adverse effect '' `` Pain control critically ill adult patient '' ."", ') Others — Other supportive measure include here.●Nutritional support – The principle nutrition non COVID-19 critically ill patient apply critically-ill COVID-19 patient .', 'We proponent extra protein supplementation , vitamin C D supplementation , trace element supplementation usual recommend daily do .', ""( See `` Nutrition support critically ill patient : An overview '' `` Nutrition support critically ill patient : Enteral nutrition '' `` Nutrition support critically ill patient : Parenteral nutrition '' ."", ') ●Glucose control .', ""( See `` Glycemic control intensive insulin therapy critical illness '' ."", ') ●Stress ulcer prophylaxis .', ""( See `` Stress ulcer intensive care unit : Diagnosis , management , prevention '' `` Management stress ulcer '' ."", ') ●Hemodynamic monitor .', ""( See `` Pulmonary artery catheterization : Indications , contraindication , complication adult '' `` Pulmonary artery catheterization : Interpretation hemodynamic value waveform adult '' `` Novel tool hemodynamic monitor critically ill patient shock '' ."", ') ●Fever management .', ""( See `` Fever intensive care unit '' , section 'Outcomes ' ."", ') ●Early physical therapy .', ""( See `` Post-intensive care syndrome ( PICS ) '' , section 'Prevention treatment ' ."", ') ●Ventilator-associated pneumonia precaution .', ""( See `` Risk factor prevention hospital-acquired ventilator-associated pneumonia adult '' ."", ') Monitoring complication — Critically ill patient COVID-19 follow routinely development complication associate critical illness COVID-19 extrapulmonary manifestation SARS-CoV-2 infection .', 'Only essential personnel enter room infect patient perform daily examination , care , procedure .', ""Common complication include acute kidney injury , mild transaminitis , cardiomyopathy , pericarditis , pericardial effusion , arrhythmia , sudden cardiac death , superinfection ( eg , ventilator-associated pneumonia [ VAP ] ) ( see 'Clinical feature complication ' ) ."", 'We suggest daily laboratory study include complete blood count differential , chemistry , liver function coagulation study , arterial blood gas , ferritin level , D-dimer level , lactate dehydrogenase .', 'Serial measurement cardiac troponins low threshold transthoracic echocardiogram may helpful evaluate suspect cardiac injury.Daily chest radiograph recommend routinely mechanically ventilate patient without COVID-19 .', 'In patient COVID-19 mechanically ventilate , chest radiograph perform indication ( eg , catheter- endotracheal tube [ ETT ] -placement relevant clinical change ) .', 'Chest compute tomography image limit test would change management .', 'This rationale base upon increase risk viral shed procedure require transfer intensive care unit ( ICU ) .', ""( See `` Complications endotracheal tube follow initial placement : Prevention management adult intensive care unit patient '' , section 'Reassessment position ' . )"", 'Fluid electrolyte management — Unless patient sepsis volume depletion high fever gastrointestinal loss , prefer conservative fluid management typical advise patient ARDS .', ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Fluid management ' `` Evaluation management suspect sepsis septic shock adult '' , section 'Intravenous fluid ( first three hour ) ' `` Treatment severe hypovolemia hypovolemic shock adult '' ."", ') The management patient present septic shock due COVID-19 similar patient septic shock cause .', ""( See `` Evaluation management suspect sepsis septic shock adult '' ."", ') Glucocorticoids — We agree Centers Disease Control Prevention ( CDC ) World Health Organization ( WHO ) glucocorticoid routinely administer patient COVID-19 , unless separate evidence-based indication ( eg , asthma chronic obstructive lung disease exacerbation , refractory septic shock , adrenal insufficiency ) .', 'However , administration critically ill patient COVID-19-related ARDS controversial .', 'Based data suggest potential benefit glucocorticoid patient all-cause ARDS , Society Critical Care Medicine ( SCCM ) provide conditional , weak recommendation favor glucocorticoid patient COVID-19 severe ARDS ( eg , patient partial arterial pressure oxygen/fraction inspire oxygen [ PaO2 : FiO2 ] < 100 mmHg ) .', ""Although also weakly recommend glucocorticoid moderate severe “ cause ” ARDS ( ie , non COVID-19-related ARDS ) fail low tidal volume ventilation , suggest administer routinely set COVID-19 ARDS ( see `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Glucocorticoids ' ) ."", 'The rationale administer glucocorticoid population data support benefit include sufficient proportion patient viral pneumonia inform safety ( eg , patient severe acute respiratory syndrome [ SARS ] , Middle East Respiratory syndrome [ MERS ] , influenza ) ; especially important since data patient ARDS due viral pneumonia conflict suggest harm [ 75-78 ] .', 'If clinician choose administer glucocorticoid , SCCM suggest begin within first 14 day , do low , course short ( eg , intravenous dexamethasone 20 mg IV daily five day , 10 mg daily five day ) .', 'Data COVID-19 patient limit single retrospective Chinese cohort , methylprednisolone administration reduce risk death patient COVID-19 compare patient receive methylprednisolone ( hazard ratio [ HR ] 0.38 ; 95 % CI 0.2-0.71 ) [ 25 ] .', 'However , data fundamentally flaw new data gather prospectively shed light controversial issue .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Limited role glucocorticoid ' ."", "") As note , management patient present shock due COVID-19 similar patient septic shock cause ( see 'Fluid electrolyte management ' ) ."", 'Low dose glucocorticoid routinely advise septic shock .', 'In set COVID-19 shock , reserve low dose glucocorticoid ( eg , hydrocortisone 200 400 mg/day divide do ) select patient refractory shock , accordance guideline [ 7 ] .', 'Low dose glucocorticoid routinely advise non-refractory septic shock .', 'The use glucocorticoid septic shock discuss separately .', ""( See `` Glucocorticoid therapy septic shock adult '' , section 'Administration ' ."", ') Nebulized medication — Nebulization consider aerosol-generating procedure .', 'For patient COVID-19 intubate require bronchodilator evidence-based indication ( eg , acute bronchospasm asthma chronic obstructive lung disease exacerbation ) , prefer use in-line meter dose inhaler ( MDIs ; ie , pressurize inhaler ) rather administration via standard jet vibrate mesh nebulizer due lower risk aerosolization associate MDIs [ 79,80 ] .', 'For medication administer via nebulizer , consideration give stop medication essential acute care ( eg , inhale colistin patient bronchiectasis ) use MDI alternative , available formulary ( eg , tobramycin capsule inhaler ) .', 'Consideration give patient use supply MDIs formulary .', 'Placement filter expiratory port ventilation circuit nebulization prudent minimize aerosolization room .', 'Ideally , patient require nebulizer , airborne infection isolation room .', 'Only healthcare staff necessary nebulizer administration ( eg , respiratory therapist nurse ) room initiation procedure airborne precaution similar intubation take .', ""( See 'The decision intubate ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", ') Investigational COVID-19 agent — Several investigational agent propose individual institution work pharmacist clinical researcher enroll patient clinical trial .', 'We suggest development protocol individual ICUs off-label use investigational agent .', 'This area rapidly evolve discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') Management co-infections comorbidities — Critically ill patient COVID-19 intubate risk develop VAP infection typical critically ill and/or intubate patient ( eg , central line urinary tract infection ) .', 'When treat co-infections , potential drug interaction investigational COVID-19 agent assess .', 'Infectious disease expert involve early management COVID-19 patient critically ill. Further detail regard management chronic medication include nonsteroidal anti-inflammatory angiotensin receptor inhibitor provide separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Uncertainty NSAID use ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Managing chronic medication ' ."", ') SPECIAL POPULATIONS — There specific recommendation pregnant woman critically-ill COVID-19 pneumonia .', 'Management similar uninfected patient .', 'Issues regard transmission risk acquire SARS-CoV-2 pregnant woman describe separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Pregnant breastfeed woman ' `` Critical illness pregnancy peripartum period '' `` Acute respiratory failure pregnancy peripartum period '' `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' . )"", 'In patient sickle cell disease critically-ill COVID-19 acute chest syndrome contribute illness , consideration early exchange transfusion surveillance development acute pulmonary hypertension prudent [ 81 ] .', ""( See `` Acute chest syndrome adult sickle cell disease '' , section 'COVID-19 ' ."", "") Issues arise population provide follow link : ●Renal issue ( see `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ) ●Cardiac issue ( see `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial infarction coronary artery disease issue '' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ) ●Airway management operate room issue ( see `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ) ●Cancer care ( see `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ) PROGNOSISMortality — Early data emerge describe outcome COVID-19 critically ill patient develop acute respiratory distress syndrome ( ARDS ) [ 2,8-10,21,22,24-26 ] ."", 'Mortality appear lower patient severe acute respiratory syndrome ( SARS-CoV ) Middle East respiratory syndrome ( MERS ) .', 'The mortality COVID-19 appear drive presence severe ARDS , approximately 50 percent ( range 16 78 percent ) .●In single-center retrospective cohort 52 critically ill Chinese patient COVID-19 , 62 percent die 28 day median duration seven day intensive care unit ( ICU ) admission death [ 9 ] .', 'Among 20 patient survive , three remain mechanical ventilation , three receive noninvasive mechanical ventilation high flow oxygen via nasal cannulae ( HFNC ) , six receive low flow oxygen .', '●In retrospective cohort 201 Chinese patient COVID-19 , mortality 52 percent among develop ARDS [ 25 ] .', 'Among receive mechanical ventilation , 66 percent die , 21 percent discharge 13 percent remain hospitalize .', '●In preliminary study 21 critically ill patient United States , day 5 , 67 percent critically ill patient die , 24 percent remain critically ill , 9.5 percent discharge ICU [ 19 ] .', '●In Italian cohort 1591 patient , ICU morality 26 percent , significant proportion remain ICU time publication , may underestimate true mortality [ 22 ] .', 'Higher mortality initially report male compare female may due predominance male affect COVID-19 Chinese cohort [ 8-10,25,26 ] ; similar difference note preliminary report Italy Washington state , USA [ 18,19 ] .', 'Risk factor death — Across country , consistent major risk factor associate death critically ill patient COVID-19 older age [ 9,10,17,20,22,24,25,82,83 ] .', 'In two Chinese retrospective cohort , death ARDS likely occur older age ≥64 year ( hazard ratio [ HR ] 6.17 ; 95 % 3.26-11.67 ) [ 9,25 ] .', 'Preliminary report Italy United States report similar outcome [ 17,18,20 ] .', 'Other risk factor associate death among critically ill patient include follow [ 9,10,17,20,22,24,25,84 ] : ●The development ARDS , particularly severe ARDS , need mechanical ventilation●Comorbidities ( eg , chronic cardiac pulmonary condition , hypertension , diabetes , chronic kidney disease ) ●Markers inflammation coagulation ( eg , D-dimer level > 1 microg/mL admission , elevate fibrin degradation product , prolong activate partial thromboplastin prothrombin time ) ●Select laboratory study ( eg , worsen lymphopenia , neutrophilia ) The rapidity symptom progression appear predict worse outcome [ 9 ] While high fever associate higher likelihood develop ARDS ( HR 1.77 ; 95 % CI 1.11-2.84 ) , appear associate lower likelihood death ( HR 0.41 ; 95 % CI 0.21-0.82 ) [ 9,25 ] , phenomenon note previously critically ill patient .', ""( See `` Fever intensive care unit '' , section 'Outcomes ' . )"", 'Further detail risk factor associate severe disease provide separately .', ""( See 'Risk factor progression ' ."", ') Long term sequela — The percentage patient require long term care unreported .', 'Similarly , incidence critical care neuromyopathy yet document .', 'In experience rate may higher usual due prolong nature intubation COVID-19 patient higher use neuromuscular blockade sedative , without concurrent glucocorticoid administration .', ""( See `` Neuromuscular weakness relate critical illness '' ."", ') The incidence post-intensive care unit syndrome ( PICS ) also unknown COVID-19 patient .', 'Nonetheless , patient follow treat PICS involve nutritional , physical , psychological , occupational therapy .', ""( See `` Post-intensive care syndrome ( PICS ) '' ."", ') END OF LIFE ISSUES — In public health emergency , value autonomy predominate .', 'Like critical illness , severe illness due COVID-19 carry potential significant psychosocial distress patient , family , surrogate .', 'In addition , unique aspect COVID-19 management portend greater trauma include anxiety stigma surround novel pathogen high-level isolation precaution include visitation limitation prohibition include end life .', 'High level patient , family , surrogate psychosocial distress anticipate combat clear communication strategy early palliative care involvement .', 'Even in-person visitation allow due public health care concern , hospital promote internet base visual communication video communication clinician , family , isolate patient .', 'Discussing end-of-life wish patient family occur early course management , include potentially even diagnosis , especially light poor outcome elderly patient comorbidities develop acute respiratory distress syndrome ( ARDS ) require mechanical ventilation .', 'Consultation palliative care team ethic expert also do assist family decision-making assist clinician contentious issue disagreement may arise .', 'Due unique aspect address need patient family pandemic , several online resource available clinician use COVID-19 specific discussion patient family .', 'They provide helpful language strategy conversation range issue include , limit , triaging , discuss goal care , resource allocation , grieve include : ●VIITALtalk ●Center Advance Palliative Care ●National Coalition Hospice Palliative Care Further principle regard ethical issue intensive care unit ( ICU ) advance care plan discuss separately .', ""( See `` Ethics intensive care unit : Responding request potentially inappropriate therapy adult '' `` Ethics intensive care unit : Informed consent '' `` Withholding withdraw ventilatory support adult intensive care unit '' `` Communication ICU : Holding family meet '' `` Palliative care : Issues intensive care unit adult '' `` Advance care plan advance directive '' , section 'COVID-19 resource ' ."", ') DISCHARGE AND LONG TERM CARE — For patient extubate successfully safely discharge home , routine community precaution apply .', 'For patient require tracheostomy deconditioned critical illness , transfer long term acute care ( LTAC ) facility typical .', 'However , guidance whether patient re-tested .', 'Many , , LTACs require two negative SARS-CoV-2 RT-PCR test perform 24 hour apart accept patient COVID-19 .', 'If positive test delay transfer LTAC , continue infection control precaution advise , rehab wean begin acute care facility .', 'Discontinuation infection control precaution discuss elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' . )"", 'Outcomes patient require long term care unknown .', 'Treatment patient require admission LTAC similar non-COVID patient .', 'Particular attention pay continue venous thromboembolism prophylaxis acute illness fully resolve patient become mobile , although efficacy approach unknown .', 'Duration therapeutic anticoagulation guide indication ; example , minimum three month document presume VTE appropriate shorter duration reasonable device thrombosis .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' . )"", 'The management patient require long term mechanical ventilation discuss separately .', ""( See `` Management prognosis patient require prolong mechanical ventilation '' ."", ') SURGE CAPACITY AND SCARCE RESOURCE ALLOCATION — COVID-19 global pandemic place significant increase demand acute critical care service hospital many region .', 'This necessitate operation maneuver increase capacity able provide care patient , higher acuity patient require intensive care unit ( ICU ) admission mechanical ventilation , patient special isolation requirement .', 'Surge capacity may achieve maximize resource across three domain : ●Care space ( ie , bed ) ●Staff●Physical equipmentIn COVID-19 pandemic , include expand ICU care non-ICU space , utilize non-critical care train staff participate deliver critical care , innovative approach obtain , conserve , increase efficiency physical equipment include personal protective equipment ( PPE ; eg , repeat use N95 mask ) mechanical ventilator ( eg , double ventilation , repurposing operate room ventilator ) .', 'As example , expert publish preliminary data highlight use one ventilator use multiple patient [ 85 ] .', 'However , maneuver design disaster set one might reasonably expect several patient might need life support similar level .', 'Use measure life-saving measure patient COVID-19 could complicate patient match well term ventilator set .', 'Potential use anesthesia ventilator longer-term mechanical ventilation provide separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Intensive care ventilation anesthesia machine '' ."", ') In instance , Italy , despite mobilize surge capacity , demand care still outpace supply overt ration occur [ 86 ] .', 'All hospital face potential acute surge event due COVID-19 another insult process approach allocation scarce resource ICU bed mechanical ventilator .', 'Most individual state United States guidance document adapt local institution [ 87 ] .', 'General principle guide underpin scarce resource allocation policy include : ●Maximization life save and/or life-years saved●Transparency ●Stakeholder public input●Separation clinical team triage process ( eg , ethic committee difficult triage decision ) ●Robust palliative care supportive measure patient provide critical care resourcesSOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●Among patient hospitalize coronavirus disease 2019 ( COVID-19 ) , one-quarter require intensive care unit ( ICU ) admission ."", ""( See 'Introduction ' 'Epidemiology ' ."", ') ●Profound hypoxemic respiratory failure acute respiratory distress syndrome ( ARDS ) dominant find critically ill patient .', 'Common complication include acute kidney injury ( AKI ) , elevate liver enzyme , late development cardiac injury , include sudden cardiac death .', 'Sepsis , shock , multi-organ failure le common .', ""( See 'Clinical feature critically ill patient ' . )"", '●For critically ill patient COVID-19 , prefer lowest possible fraction inspire oxygen ( FiO2 ) necessary meet oxygenation goal , ideally target peripheral oxygen saturation 90 96 percent .', ""( See 'Respiratory care nonintubated patient ' 'Oxygenation target ' 'Low flow oxygen ' ."", ') •The use high-flow oxygen via nasal cannulae ( HFNC ) noninvasive ventilation ( NIV ) controversial base infection control concern frequent need mechanical ventilation despite measure .', 'The decision initiate noninvasive modality require balance risk benefit patient , risk exposure healthcare worker , best use resource ; approach reassess new data become available .', ""( See 'Patients higher oxygen requirement ' . )"", '•In patient COVID-19 acute hypoxemic respiratory failure higher oxygen need low flow oxygen provide , suggest selective use noninvasive measure rather routinely proceed directly intubation ( Grade 2C ) .', 'As example might trial HFNC younger patient without comorbidities tolerate nasal cannulae .', 'In contrast , may proceed directly early intubation patient higher risk ( eg , elderly patient patient comorbidities risk factor progression ) .', '•Among noninvasive modality suggest HFNC rather NIV ( Grade 2C ) .', 'Our preference HFNC base upon limit inconsistent data , , balance , favor HFNC compare NIV HFNC patient non-COVID-19-related acute hypoxemic respiratory failure .', 'NIV via full face mask ( good seal ) may appropriate patient indication prove efficacy include acute hypercapnic respiratory failure acute exacerbation chronic obstructive pulmonary disease , acute cardiogenic pulmonary edema , sleep disorder breathe .', ""( See `` Heated humidify high-flow nasal oxygen adult : Practical consideration potential application '' , section 'Medical patient severe hypoxemic respiratory failure ' `` Noninvasive ventilation adult acute respiratory failure : Benefits contraindication '' , section 'Patients likely benefit ' ."", ') .•For patient COVID-19 receive HFNC NIV , vigilant monitor warrant progression frequent clinical arterial blood gas evaluation every one two hour ensure efficacy safe ventilation .', 'The threshold intubate patient low .', 'Attempting prone position also appropriate .', '●For critically ill patient COVID-19 , intubation delay patient acutely decompensates since potentially harmful patient healthcare worker .', ""We low threshold intubate ( see 'Timing ' ) : •Rapid progression hours•Failure improve despite HFNC > 40 L/min FiO2 > 0.6•Development hypercapnia•Hemodynamic instability multiorgan failure ●Intubation high risk procedure aerosol dispersion patient COVID-19 attention pay don full personal protective equipment ( PPE ) airborne precaution ( figure 2 figure 3 ) well use equipment minimize dispersion ( eg , video laryngoscopy ) development protocol procedure ( eg , check list ) ( table 2 figure 1 ) ."", ""( See 'Precautions ' `` Safety operate room '' , section 'COVID-19 ' ."", ') ●We use low tidal volume ventilation ( LTVV ) target ≤6 mL/kg predict body weight ( PBW ) ( range 4 8 mL/kg PBW ( table 3 table 4 ) ) target plateau pressure ≤30 cm H2O apply positive end-expiratory pressure ( PEEP ) accord strategy outline table ( table 5 ) .', 'For patient COVID-19 fail LTVV , prone ventilation prefer next step ( table 7 table 6 ) .', ""( See 'Ventilator management acute respiratory distress syndrome ' `` Ventilator management strategy adult acute respiratory distress syndrome '' `` Prone ventilation adult patient acute respiratory distress syndrome '' `` Extracorporeal membrane oxygenation ( ECMO ) adult '' . )"", '●Several procedure , include collection respiratory specimen , bronchoscopy , extubation , tracheostomy , cardiopulmonary resuscitation aerosol-generating avoid minimize , possible .', 'All procedure group possible .', ""( See 'Interventions ' ."", ') ●Patients COVID-19 pneumonia mechanically ventilate ARDS receive usual daily surveillance , supportive care include conservative fluid management ( unless patient sepsis volume depletion ) ( table 1 ) .', 'Measurement surveillance cardiac troponins low threshold perform transthoracic echocardiography appropriate early detection cardiac injury .', ""( See 'Supportive care ' 'Monitoring complication ' . )"", '•In critically ill patient COVID-19-induced ARDS specific indication ( eg , acute bronchospasm refractory septic shock ) , suggest administer glucocorticoid ( Grade 2C ) .', 'The rationale administer glucocorticoid population data support benefit non-COVD-19 population include sufficient proportion patient viral pneumonia inform safety data patient ARDS due viral pneumonia ( eg , severe acute respiratory syndrome [ SARS ] , Middle East respiratory syndrome [ MERS ] , influenza ) suggest harm .', ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Glucocorticoids ' . )"", '•For acute bronchodilation , prefer use in-line meter dose inhaler ( MDIs ) rather administration via standard jet vibrate mesh nebulizer due lower risk aerosolization associate MDIs .', 'Individual institution work pharmacy regard compassionate use investigational medication trial enrollment .', 'We suggest development protocol individual ICUs off-label use investigational agent .', ""( See 'Nebulized medication ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') ●For patient COVID-19 develop ARDS , prognosis poor mortality range 52 67 percent .', 'The highest rate death occur ≥64 year .', ""( See 'Prognosis ' ."", ') ●A greater level anxiety trauma among patient family anticipate combat clear communication strategy early palliative care involvement .', 'Precautions continue patient continue test positive COVID-19 discharge long term acute care facility .', ""( See 'End life issue ' 'Discharge long term care ' ."", ') ●Several measure adopt accommodate surge COVID-19 case include include expand ICU care non-ICU space , utilize non-critical care train staff participate deliver critical care , innovative approach obtain , conserve , increase efficiency physical equipment ( eg , personal protective equipment mechanical ventilator ) .', ""( See 'Surge capacity scarce resource allocation ' . )""]","['', 'novel', 'coronavirus', 'identify', 'late', '2019', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'china', '', 'since', 'rapidly', 'spread', 'result', 'pandemic', '', 'world', 'health', 'organization', 'designate', 'disease', 'term', 'covid-19', '', 'ie', '', 'coronavirus', 'disease', '2019', '', '', '1', '', '', 'virus', 'cause', 'covid-19', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'major', 'morbidity', 'mortality', 'covid-19', 'largely', 'due', 'acute', 'viral', 'pneumonitis', 'evolve', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'topic', 'discus', 'epidemiology', '', 'clinical', 'feature', '', 'management', 'patient', 'become', 'critically', 'ill', 'due', 'covid-19', '', 'aspect', 'covid-19', '', 'coronavirus-related', 'disease', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'coronaviruses', '', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'virology', '', 'pathogenesis', '', 'epidemiology', '', '', '', 'guidelines', 'hospital', 'policies', '', 'advice', 'topic', 'base', 'upon', 'data', 'derive', 'management', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', '', 'emerge', 'retrospective', 'data', 'patient', 'covid-19', '', 'expert', 'opinion', '', 'anecdotal', 'observation', 'clinician', 'treat', 'patient', 'covid-19', 'china', '', 'italy', '', 'washington', 'state', '', 'usa', '', '', 'large', 'outbreak', 'occur', '', 'guidelines', 'issue', 'several', 'society', 'organization', 'include', 'society', 'critical', 'care', 'medicine', '', 'chinese', 'thoracic', 'society', '', 'australian', 'new', 'zealand', 'intensive', 'care', 'society', '', 'anzics', '', '', 'world', 'health', 'organization', 'united', 'states', 'centers', 'disease', 'control', 'prevention', 'national', 'institutes', 'health', '', '2-7', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', '', 'learning', 'region', 'deal', 'overwhelm', 'burden', 'covid-19', 'date', '', 'essential', 'hospital', 'health', 'system', 'develop', 'task', 'force', 'manage', 'patient', 'admit', 'disorder', '', 'involve', '', 'limit', '', 'designate', 'covid-19-specific', 'intensive', 'care', 'unit', '', 'icus', '', 'icu', 'team', '', 'create', 'back', 'expand', 'staff', 'schedule', '', 'utilize', 'detail', 'protocol', 'infection', 'prevention', 'medical', 'management', '', 'access', 'research', 'trial', 'patient', 'covid-19', '', 'ensure', 'adequate', 'personal', 'protection', 'equipment', '', 'ppe', '', 'supply', 'train', '', 'forecast', 'demand', '', 'prioritize', 'diagnostic', 'lab', 'testingepidemiology', '', 'reports', 'suggest', 'among', 'infect', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', '20', 'percent', 'develop', 'severe', 'disease', 'require', 'hospitalization', '', '8-15', '', '', 'although', 'rate', 'vary', '', 'among', 'hospitalize', '', 'one-quarter', 'intensive', 'care', 'unit', '', 'icu', '', 'admission', '', 'represent', 'approximately', '5', '8', 'percent', 'total', 'infect', 'population', '', 'differences', 'rate', 'icu', 'admission', 'relate', 'cultural', 'difference', 'practice', 'admission', 'criterion', 'icu', 'well', 'difference', 'predispose', 'factor', 'age', 'comorbidities', 'test', 'availability', 'population', 'serve', '', 'china', '', 'chinese', 'cohort', '', 'rate', 'icu', 'admission', 'severe', 'illness', 'range', '7', '26', 'percent', '', '9101516', '', '', 'italy', '-', 'consistent', 'range', 'report', 'china', '', 'preliminary', 'report', 'italy', 'suggest', 'proportion', 'icu', 'admission', '5', '12', 'percent', 'total', 'positive', 'sars-cov-2', 'case', '', '16', 'percent', 'hospitalize', 'patient', '', '1718', '', '', 'united', 'states', 'america', '', 'early', 'study', '21', 'critically', 'ill', 'patient', 'washington', 'state', '', 'usa', '', '81', 'percent', 'patient', 'covid-19', 'pneumonia', 'admit', 'icu', '71', 'percent', 'mechanically', 'ventilate', '', '19', '', '', 'however', '', 'high', 'rate', 'likely', 'reflect', 'older', 'age', 'population', 'largely', 'nurse', 'home', 'region', '', 'larger', 'analysis', '2449', 'patient', 'report', 'hospitalization', 'rate', '20', '31', 'percent', 'icu', 'admission', 'rate', '49', '115', 'percent', '', '20', '', 'three-quarters', 'critically', 'ill', 'patient', 'male', 'chinese', 'cohort', '', 'data', 'mix', 'report', 'suggest', 'equal', 'proportion', 'men', 'woman', '', '1819', '', 'suggest', 'male', 'predominance', '', '2122', '', '', 'clinical', 'features', 'critically', 'ill', 'patientsclinical', 'feature', 'complication', '', 'general', 'clinical', 'feature', 'covid-19', 'patient', 'risk', 'factor', 'progression', 'discuss', 'separately', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'feature', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'discussion', 'limit', 'clinical', 'feature', 'critically', 'illrate', 'progression', '', 'retrospective', 'study', 'critically', 'ill', 'patient', 'suggest', 'among', 'patient', 'develop', 'critical', 'illness', '', 'include', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', 'onset', 'dyspnea', 'relatively', 'late', '', 'median', '65', 'day', 'symptom', 'onset', '', '', 'progression', 'ards', 'swift', 'thereafter', '', 'median', '25', 'day', 'onset', 'dyspnea', '', '', '910192324', '', '', 'clinical', 'feature', '', 'among', 'critically', 'ill', '', 'profound', 'acute', 'hypoxemic', 'respiratory', 'failure', 'ards', 'dominant', 'find', '', '8-1019212224-28', '', '', 'hypercapnia', 'rare', '', 'fevers', 'tend', 'wax', 'wane', 'icu', 'admission', '', 'mechanical', 'ventilation', 'critically', 'ill', 'high', 'range', '30', '100', 'percent', '', '91921222528', '', '', 'length', 'stay', '', 'early', 'clinical', 'report', 'suggest', 'length', 'intensive', 'care', 'unit', '', 'icu', '', 'stay', 'appear', 'long', 'patient', 'remain', 'intubate', 'one', 'two', 'week', 'longer', '', '22', '', '', 'reports', 'expert', 'field', 'suggest', 'patient', 'fail', 'early', 'attempt', 'wean', '', 'eg', '', 'within', 'first', 'week', '', '', 'although', 'appear', 'predict', 'eventual', 'ability', 'wean', 'extubate', '', 'small', 'proportion', 'patient', 'require', 'tracheostomy', '', '', 'extubation', 'wean', '', 'tracheostomy', '', '', '', 'complications', '', 'common', 'complication', 'covid-19-related', 'ards', 'include', 'acute', 'kidney', 'injury', '', 'aki', '', '', 'elevate', 'liver', 'enzyme', '', 'cardiac', 'injury', 'include', 'cardiomyopathy', '', 'pericarditis', '', 'pericardial', 'effusion', '', 'arrhythmia', '', 'sudden', 'cardiac', 'death', '', 'example', '', 'single-center', 'retrospective', 'cohort', 'china', '52', 'critically', 'ill', 'patient', 'covid-19', '', 'complication', 'include', 'aki', '', '29', 'percent', '', 'half', 'renal', 'replacement', 'therapy', '', '', 'liver', 'dysfunction', '', '29', 'percent', '', '', 'cardiac', 'injury', '', '23', 'percent', '', '', '9', '', '', 'cardiac', 'injury', 'appear', 'late', 'complication', '', 'develop', 'respiratory', 'illness', 'improve', '', 'high', 'rate', 'cardiomyopathy', 'note', 'united', 'states', 'cohort', '', '33', 'percent', '', '', 'relate', 'older', 'age', 'population', '', '19', '', '', 'another', 'united', 'states', 'cohort', 'new', 'york', 'city', '', 'cardiac', 'complication', 'among', 'mechanically', 'ventilate', 'patient', 'include', 'atrial', 'arrhythmia', '', '18', 'percent', '', '', 'myocardial', 'infarction', '', '8', 'percent', '', '', 'heart', 'failure', '', '2', 'percent', '', '', '27', '', '', 'one', 'case', 'series', 'report', 'five', 'patient', 'develop', 'acute', 'cor', 'pulmonale', '', 'occur', 'association', 'hemodynamic', 'instability', 'cardiac', 'arrest', '', '29', '', '', 'case', 'likely', 'due', 'pulmonary', 'embolism', '', 'pe', '', '', 'although', 'definitive', 'diagnosis', 'pe', 'confirm', 'one', 'case', '', 'cardiac', 'complication', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'infarction', 'coronary', 'artery', 'disease', 'issue', '', '', '', 'sepsis', '', 'shock', '', 'multi-organ', 'failure', 'occur', 'appear', 'le', 'common', 'compare', 'non-covid-19-related', 'ards', '', 'vasoactive', 'agent', 'variable', '', 'although', 'significant', 'proportion', 'vasopressor', 'support', 'hypotension', '', 'often', 'due', 'sedation', 'medication', 'cardiac', 'dysfunction', '', '', 'cohort', 'study', 'wuhan', '', 'china', '', '35', 'percent', '52', 'patient', 'receive', 'vasoactive', 'agent', '', '9', '', '', 'contrast', '', 'case', 'series', 'new', 'york', 'city', '', '95', 'percent', '130', 'patient', 'receive', 'mechanical', 'ventilation', 'require', 'vasopressor', 'support', '', 'reason', 'specify', '', '27', '', '', '', 'acute', 'kidney', 'injury', 'common', 'among', 'critically', 'ill', 'patient', 'covid-19', '', 'require', 'renal', 'replacement', 'therapy', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'section', 'acute', 'kidney', 'injury', '', '', '', 'data', 'risk', 'secondary', 'bacterial', 'pneumonia', 'limit', '', 'appear', 'major', 'feature', 'covid-19', '', 'cohort', 'intubate', 'patient', 'china', '', 'hospital-acquired', 'pneumonia', '', 'case', 'resistant', 'pathogen', '', 'report', '12', 'percent', '', '9', '', '', 'find', 'relate', 'high', 'glucocorticoid', 'ards', 'management', 'china', '', 'data', 'elucidate', 'rate', 'superinfection', 'country', '', 'lung', 'compliance', 'high', 'compare', 'etiology', 'ards', 'rate', 'barotrauma', 'appear', 'low', '2', 'percent', 'develop', 'pneumothorax', '', 'compare', '25', 'percent', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', '', '930', '', '', 'limit', 'data', 'describe', 'lung', 'pathology', 'patient', 'covid-19', '', 'case', 'report', 'post', 'mortem', 'case', 'patient', 'undergo', 'biopsy', 'another', 'reason', 'suggest', 'wide', 'variation', 'mononuclear', 'inflammation', 'diffuse', 'alveolar', 'damage', '', 'classic', 'ards', '', '3132', '', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'epidemiology', '', 'pathophysiology', '', 'pathology', '', 'etiology', 'adult', '', '', 'section', 'pathologic', 'stage', '', '', '', 'neurologic', 'complication', 'critically', 'ill', 'patient', 'common', '', 'especially', 'delirium', 'encephalopathy', 'manifest', 'prominent', 'agitation', 'confusion', 'along', 'corticospinal', 'tract', 'sign', '', 'hyperreflexia', '', '', 'consistent', '', 'intensivists', 'observe', 'sedation', 'requirement', 'high', 'population', '', 'particularly', 'immediately', 'intubation', '', 'one', 'series', '58', 'patient', 'covid-19-related', 'ards', '', 'deliriumencephalopathy', 'present', 'approximately', 'two-thirds', 'patient', '', '33', '', '', 'addition', '', 'three', '13', 'patient', 'brain', 'mri', 'acute', 'ischemic', 'stroke', '', 'eight', 'mri', 'study', 'demonstrate', 'leptomeningeal', 'enhancement', '', 'cerebrospinal', 'fluid', '', 'csf', '', 'seven', 'patient', 'acellular', 'one', 'elevate', 'csf', 'protein', '', 'pcr', 'assay', 'csf', 'negative', 'virus', '', 'unclear', 'whether', 'neurologic', 'complication', 'note', 'report', 'due', 'critical', 'illness', '', 'medication', 'effect', '', 'represent', 'direct', 'effect', 'cytokine', 'sars-cov-2', 'virus', '', '33-35', '', '', 'encephalitis', '', 'report', '', 'rare', '', '36', '', '', 'similarly', '', 'guillain-barr-barre', 'syndrome', 'follow', 'sars-cov-2', 'virus', 'infection', 'describe', 'small', 'case', 'series', '', '37', '', '', 'covid-coagulopathy', 'common', 'population', 'patient', 'develop', 'abnormal', 'coagulation', 'profile', 'others', 'develop', 'thrombosis', '', 'feature', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'laboratory', '', 'laboratory', 'find', 'critically', 'ill', 'patient', '', 'eg', 'leukopenia', '', 'lymphopenia', '', 'leukocytosis', '', 'elevate', 'd-dimer', '', 'lactate', 'dehydrogenase', '', 'ferritin', '', 'normal', 'low', 'procalcitonin', '', 'initially', 'modest', 'similar', 'milder', 'illness', '', 'although', 'procalcitonin', 'level', 'elevate', 'lymphopenia', 'profound', 'critically', 'ill', 'patient', '', '81026', '', '', '', '', 'cytokine', 'release', 'syndrome', '', 'crs', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'laboratory', 'find', '', '', 'procalcitonin', 'lower', 'respiratory', 'tract', 'infection', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'patient', 'severe', 'covid-19', 'laboratory', 'evidence', 'exuberant', 'inflammatory', 'response', '', 'similar', 'cytokine', 'release', 'syndrome', '', 'crs', '', '', 'persistent', 'fever', '', 'elevate', 'inflammatory', 'marker', '', 'eg', '', 'd-dimer', '', 'ferritin', '', 'interleukin-6', '', '', 'elevate', 'proinflammatory', 'cytokine', '', 'laboratory', 'abnormality', 'associate', 'poor', 'prognosis', '', '38', '', '', 'clinical', 'trial', 'anti-il-6', 'agent', 'treatment', 'covid-19', 'progress', '', 'detail', 'regard', 'crs', 'provide', 'separately', '', '', '', 'cytokine', 'release', 'syndrome', '', 'crs', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'laboratory', 'find', '', '', 'procalcitonin', 'lower', 'respiratory', 'tract', 'infection', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'il-inhibitor', 'pathway', 'inhibitor', '', '', '', 'presence', 'antiphospholipid', 'antibody', 'describe', '', 'however', '', 'mostly', 'iga', 'subclass', '', 'clinical', 'significance', 'unclear', '', '39', '', '', 'abnormal', 'coagulation', 'parameter', 'commonly', 'covid-19', 'patient', '', 'eg', '', 'elevate', 'd-dimer', '', 'prolong', 'prothrombin', 'time', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'diagnosis', 'antiphospholipid', 'syndrome', '', '', '', 'imaging', '', 'typical', 'image', 'find', 'appear', 'different', 'mild', 'severe', 'case', 'covid-19', '', 'eg', '', 'ground-glass', 'opacification', 'without', 'consolidative', 'abnormality', '', 'consistent', 'viral', 'pneumonia', '', 'minimal', 'pleural', 'effusion', '', '', '94041', '', '', 'image', 'chest', 'compute', 'tomography', '', 'ct', '', 'commonly', 'perform', 'chinese', 'cohort', '', 'prefer', 'avoid', '', 'unless', 'necessary', '', 'chest', 'ct', 'diagnostic', 'tool', '', 'must', 'balance', 'risk', 'patient', 'healthcare', 'worker', 'process', 'patient', 'transport', 'time', 'spend', 'ct', 'room', '', 'characteristic', 'find', 'bedside', 'lung', 'ultrasound', 'include', 'thicken', 'pleural', 'b', 'support', 'alveolar', 'consolidation', '', 'pleural', 'effusion', 'unusual', '', '42', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'imaging', 'find', '', '', '', 'pathology', '', 'paucity', 'data', 'describe', 'lung', 'pathology', 'covid-19', 'pneumonia', 'critically', 'ill', 'patient', '', 'autopsy', 'report', 'describe', 'hyaline', 'membrane', 'change', 'microvessel', 'thrombosis', 'suggestive', 'early', 'ards', '', 'ie', '', 'exudative', 'proliferative', 'phase', 'diffuse', 'alveolar', 'damage', '', 'dad', '', '', '', '3243-48', '', '', 'find', 'include', 'bacterial', 'pneumonia', '', 'isolate', 'superimpose', 'dad', '', 'viral', 'pneumonitis', '', '4448', '', '', 'less', 'common', 'find', 'include', 'acute', 'fibrinous', 'organize', 'pneumonia', '', 'afop', '', 'late', 'stage', '', '', '49', '', '', 'amyloid', 'deposition', '', 'heart', 'lung', '', '', 'rarely', 'alveolar', 'hemorrhage', 'vasculitis', '', '48', '', '', '', '', 'interpretation', 'lung', 'biopsy', 'result', 'interstitial', 'lung', 'disease', '', '', 'section', 'diffuse', 'alveolar', 'damage', '', '', '', 'evidence', 'pulmonary', 'thrombosis', 'thromboembolism', 'report', 'autopsy', 'series', '', '444850', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'clinical', 'feature', '', '', '', 'distant', 'organ', 'involvement', 'demonstration', 'virus', 'organ', 'lung', '', 'case', '', 'acute', 'tubular', 'necrosis', 'generalize', 'thrombotic', 'microangiopathy', 'kidney', '', '4448', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', 'risk', 'factor', 'progression', '', 'age', 'appear', 'major', 'risk', 'factor', 'predict', 'progression', 'ards', '', '12192025', '', '', 'comorbidities', '', 'high', 'fever', '', '39c', '', '', 'history', 'smoke', '', 'select', 'laboratory', 'feature', 'predict', 'progression', 'death', 'covid-19', '', 'importantly', '', 'adult', 'age', 'develop', 'severe', 'disease', 'experience', 'adverse', 'outcome', '', 'especially', 'comorbidities', '', 'detail', 'regard', 'risk', 'disease', 'progression', 'provide', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'respiratory', 'care', 'nonintubated', 'patient', '', 'specific', 'aspect', 'respiratory', 'care', 'relevant', 'deteriorate', 'patient', 'covid-19', 'admission', 'intensive', 'care', 'unit', '', 'icu', '', 'discuss', '', 'table', '1', '', '', 'include', 'oxygenation', 'low', 'flow', 'high-flow', 'system', '', 'noninvasive', 'ventilation', 'administration', 'nebulized', 'medication', '', 'hospitalize', 'patient', 'develop', 'progressive', 'symptom', '', 'early', 'admission', 'icu', 'prudent', 'feasible', '', 'self-proning', '', 'expert', 'encourage', 'hospitalize', 'patient', 'spend', 'much', 'time', 'feasible', 'safe', 'prone', 'position', 'receive', 'oxygen', '', 'rationale', 'approach', 'base', 'upon', 'limit', 'direct', 'evidence', '', '5152', '', 'anecdotal', 'observation', 'field', 'well', 'indirect', 'evidence', 'efficacy', 'ventilate', 'patient', '', '', 'prone', 'ventilation', '', 'monitoring', 'noninvasive', 'modality', '', '', '', 'oxygenation', 'target', '', 'world', 'health', 'organization', '', '', 'suggest', 'titrate', 'oxygen', 'target', 'peripheral', 'oxygen', 'saturation', '', 'spo2', '', '90', 'percent', '', 'critically', 'ill', 'patient', '', 'prefer', 'lowest', 'possible', 'fraction', 'inspire', 'oxygen', '', 'fio2', '', 'necessary', 'meet', 'oxygenation', 'goal', '', 'ideally', 'target', 'spo2', '90', '96', 'percent', '', 'feasible', '', 'however', '', 'patient', 'warrant', 'lower', 'target', '', 'eg', '', 'patient', 'concomitant', 'acute', 'hypercapnic', 'respiratory', 'failure', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', '', 'others', 'warrant', 'higher', 'target', '', 'eg', '', 'pregnancy', '', '', '', '', 'overview', 'initiate', 'invasive', 'mechanical', 'ventilation', 'adult', 'intensive', 'care', 'unit', '', '', 'section', 'fraction', 'inspire', 'oxygen', '', '', '', 'low', 'flow', 'oxygen', '', 'patient', 'covid-19', '', 'supplemental', 'oxygenation', 'low', 'flow', 'system', 'via', 'nasal', 'cannula', 'appropriate', '', 'ie', '', '6', 'lmin', '', '', 'although', 'degree', 'micro-organism', 'aerosolization', 'low', 'flow', 'rate', 'unknown', '', 'reasonable', 'surmise', 'minimal', '', 'higher', 'flow', 'oxygen', 'administer', 'simple', 'face', 'mask', '', 'venturi', 'face', 'mask', '', 'nonrebreather', 'mask', '', 'eg', '', '10', '20', 'lminute', '', '', 'flow', 'increase', '', 'risk', 'dispersion', 'increase', '', 'augment', 'contamination', 'surround', 'environment', 'staff', '', 'expert', 'patient', 'wear', 'nasal', 'cannula', 'wear', 'droplet', 'mask', '', 'especially', 'transport', 'staff', 'room', '', 'data', 'support', 'practice', 'largely', 'non-peer-reviewed', 'derive', 'simulation', 'experiment', 'practical', 'sense', 'maneuver', 'reduce', 'infectious', 'risk', 'associate', 'potential', 'aerosolization', '', '53-55', '', '', 'additional', 'information', 'provision', 'low', 'flow', 'oxygen', 'provide', 'separately', '', '', '', 'continuous', 'oxygen', 'delivery', 'system', 'acute', 'care', 'infant', '', 'child', '', 'adult', '', '', '', 'patients', 'higher', 'oxygen', 'requirement', '', 'patient', 'progress', '', 'higher', 'amount', 'oxygen', '', 'options', 'point', 'non-covid-19', 'patient', 'high-flow', 'oxygen', 'via', 'nasal', 'cannulae', '', 'hfnc', '', 'initiation', 'noninvasive', 'ventilation', '', 'niv', '', '', 'however', '', 'patient', 'covid-19', '', 'decision', 'controversial', 'ongoing', 'debate', '', '5657', '', '', 'despite', 'controversy', '', 'modality', 'variably', '', 'retrospective', 'cohort', '', 'rate', 'hfnc', 'range', '14', '63', 'percent', '11', '56', 'percent', 'treat', 'niv', '', '9222528', '', '', '', 'prospective', 'data', 'describe', 'whether', 'modality', 'successful', 'avoid', 'intubation', '', 'one', 'retrospective', 'study', 'describe', 'highest', 'level', 'respiratory', 'support', 'hospitalize', 'covid-19', 'patient', 'noninvasive', 'modality', '', 'hfnc', 'niv', '', '54', 'percent', 'patient', 'invasive', 'ventilation', '30', 'percent', '', '28', '', '', 'deciding', 'modality', '', 'noninvasive', 'invasive', 'ventilation', '', '', 'believe', 'decision', 'initiate', 'noninvasive', 'modality', '', 'hfnc', 'niv', '', 'balance', 'risk', 'benefit', 'patient', '', 'risk', 'exposure', 'healthcare', 'worker', '', 'best', 'resource', '', 'approach', 'reassess', 'new', 'data', 'become', 'available', '', 'encourage', 'development', 'hospital', 'protocol', 'multidisciplinary', 'approach', '', 'include', 'respiratory', 'therapy', 'staff', '', 'facilitate', 'decision', '', 'patient', 'covid-19', 'acute', 'hypoxemic', 'respiratory', 'failure', 'higher', 'oxygen', 'low', 'flow', 'oxygen', 'provide', '', 'suggest', 'noninvasive', 'modality', '', 'selectively', 'proceed', 'directly', 'intubation', '', 'eg', '', 'younger', 'patient', 'without', 'comorbidities', 'tolerate', 'nasal', 'cannulae', '', '', 'hand', '', 'patient', 'warrant', 'avoidance', 'hfnc', 'benefit', 'proceed', 'directly', 'early', 'intubation', '', 'eg', '', 'elderly', 'confuse', 'patient', 'comorbidities', 'several', 'risk', 'factor', 'progression', '', '', 'expert', 'advocate', 'avoidance', 'modality', '', 'ie', '', 'proceed', 'early', 'intubation', 'escalate', 'beyond', '6', 'lmin', 'continue', 'hypoxemia', 'increase', 'work', 'breathe', '', '', 'predicate', 'increase', 'risk', 'aerosolization', 'high', 'likelihood', 'patient', 'modality', 'ultimately', '', 'rapidly', 'deteriorate', 'require', 'mechanical', 'ventilation', '', 'eg', '', 'within', 'one', 'three', 'day', '', '', 'approach', 'reasonable', 'resource', 'available', '', 'however', '', 'absolute', 'rule', 'result', 'excess', 'unnecessary', 'intubation', 'place', 'undue', 'load', 'ventilator', 'demand', 'disease', 'surge', '', 'addition', '', 'particularly', 'problematic', 'patient', 'investigation', '', 'eg', '', 'covid-19', 'test', 'pending', '', '', 'patient', 'chronic', 'nocturnal', 'niv', 'requirement', '', 'patient', 'chronic', 'respiratory', 'failure', 'high', 'baseline', 'oxygen', 'requirement', '', 'patient', 'do-not-intubate', 'status', 'benefit', 'otherwise', 'niv', 'hfnc', '', 'ultimately', '', 'recommendation', 'change', 'time', 'depend', 'case', 'load', 'covid-19', 'patient', 'give', 'location', '', 'oxygen', 'via', 'high', 'flow', 'nasal', 'cannula', 'versus', 'noninvasive', 'ventilation', '', 'among', 'noninvasive', 'modality', '', 'prefer', 'hfnc', '', 'preference', 'hfnc', 'base', 'upon', 'limit', 'inconsistent', 'data', '', '', 'balance', '', 'favor', 'hfnc', 'compare', 'niv', 'patient', 'non-covid-19-related', 'acute', 'hypoxemic', 'respiratory', 'failure', '', 'detail', 'provide', 'separately', '', '', 'heated', 'humidify', 'high-flow', 'nasal', 'oxygen', 'adult', '', 'practical', 'consideration', 'potential', 'application', '', '', 'section', 'medical', 'patient', 'severe', 'hypoxemic', 'respiratory', 'failure', '', '', '', 'addition', '', 'limit', 'data', 'suggest', 'high', 'failure', 'rate', 'niv', 'patient', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '', '58', '', 'cause', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', '', 'noninvasive', 'ventilation', 'adult', 'acute', 'respiratory', 'failure', '', 'benefits', 'contraindication', '', '', 'section', 'hypoxemic', 'nonhypercapnic', 'respiratory', 'failure', 'due', 'acpe', '', '', '', 'however', '', 'niv', 'appropriate', 'patient', 'indication', 'prove', 'efficacy', '', 'include', 'patient', 'acute', 'hypercapnic', 'respiratory', 'failure', 'acute', 'exacerbation', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'aecopd', '', '', 'patient', 'acute', 'cardiogenic', 'pulmonary', 'edema', '', 'patient', 'sleep', 'disorder', 'breathe', '', 'eg', '', 'obstructive', 'sleep', 'apnea', 'obesity', 'hypoventilation', '', '', 'data', 'provide', 'separately', '', '', '', 'noninvasive', 'ventilation', 'adult', 'acute', 'respiratory', 'failure', '', 'benefits', 'contraindication', '', '', 'section', 'patients', 'likely', 'benefit', '', '', '', 'monitoring', 'noninvasive', 'modality', '', 'hfnc', 'niv', 'administer', '', 'vigilant', 'monitor', 'patient', 'warrant', 'progression', 'frequent', 'clinical', 'arterial', 'blood', 'gas', 'evaluation', 'every', 'one', 'two', 'hour', 'ensure', 'efficacy', 'safe', 'ventilation', '', 'eg', '', 'frequent', 'cough', '', 'safe', '', '', '', 'advocate', 'low', 'threshold', 'intubate', 'patient', '', 'particularly', 'show', 'sign', 'rapid', 'progression', '', '', 'timing', '', '', '', 'although', 'unproven', '', 'expert', '', 'include', 'u', '', 'provide', 'hfnc', '', 'niv', '', 'patient', 'prone', 'position', '', 'limited', 'evidence', 'case', 'report', 'non-covid', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', 'anecdotal', 'evidence', 'suggest', 'feasibility', 'improvement', 'oxygenation', 'patient', '', '515960', '', '', 'similarly', '', 'preliminary', 'evidence', 'support', 'improvement', 'oxygenation', 'parameter', 'patient', 'covid-19', 'receive', 'niv', 'hfnc', '', '6162', '', '', 'example', '', 'retrospective', 'study', '', '12', '15', 'covid-19', 'patient', 'treat', 'niv', 'pronation', '', 'median', 'total', 'two', 'cycle', '', 'three', 'hour', '', 'experience', 'improvement', 'peripheral', 'oxygen', 'saturation', 'remainder', 'either', 'stabilize', 'deteriorate', '', '61', '', '', 'another', 'prospective', 'study', '24', 'covid-19', 'patient', 'hypoxemic', 'respiratory', 'failure', '', 'third', 'oxygen', 'flow', 'four', 'liter', '', 'include', 'hfnc', '', '', '15', 'patient', '', '63', 'percent', '', 'tolerate', 'prone', 'position', 'three', 'hour', '', '62', '', '', 'among', 'tolerate', 'prone', 'position', '', 'six', '', '40', 'percent', '', 'experience', 'improvement', 'oxygenation', 'prone', 'position', 'three', 'improvement', 'sustain', 'upon', 'resupination', '', 'remain', 'unclear', 'whether', 'pronation', 'avert', 'intubation', '', 'accelerate', 'recovery', '', 'reduce', 'mortality', '', 'future', 'data', 'warrant', 'identify', 'optimal', 'indication', 'duration', 'pronation', '', 'assessment', 'responsetechnical', 'detail', 'regard', 'application', 'hfnc', 'niv', 'provide', 'separately', '', '', '', 'heated', 'humidify', 'high-flow', 'nasal', 'oxygen', 'adult', '', 'practical', 'consideration', 'potential', 'application', '', '', 'noninvasive', 'ventilation', 'adult', 'acute', 'respiratory', 'failure', '', 'practical', 'aspect', 'initiation', '', '', 'noninvasive', 'ventilation', 'adult', 'acute', 'respiratory', 'failure', '', 'benefits', 'contraindication', '', '', '', 'precautions', 'noninvasive', 'modality', '', 'hfnc', 'niv', 'consider', 'aerosol', 'generate', 'procedure', '', 'thus', '', 'hfnc', 'niv', '', 'airborne', 'addition', 'standard', 'precaution', 'undertake', '', 'ie', '', 'airborne', 'infection', 'isolation', 'room', '', 'negative', 'pressure', 'room', '', '', 'full', 'personal', 'protective', 'equipment', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'hfnc', '', 'advocate', 'additionally', 'place', 'surgical', 'n95', 'mask', 'patient', 'hfnc', 'healthcare', 'worker', 'room', '', 'value', 'practice', 'unknown', '', '3', '', '', 'additional', 'precaution', 'hfnc', 'potential', 'reduce', 'risk', 'include', 'start', 'lowest', 'effective', 'flow', 'rate', '', 'eg', '', '20', 'lminute', '04', 'fio2', '', '', 'inhaled', 'medication', 'gas', '', 'eg', '', 'epoprostenol', '', 'nitric', 'oxide', 'bronchodilator', '', 'avoid', 'hfnc', '', 'niv', '', 'niv', 'initiate', '', 'full-face', 'mask', 'nasal', 'oronasal', 'mask', 'prefer', 'minimize', 'particle', 'dispersion', '', 'mask', 'preferably', 'seal', 'anti-asphyxiation', 'valve', 'port', '', 'helmet', 'propose', 'deliver', 'niv', 'patient', 'covid-19', '', '63', '', '', 'however', '', 'experience', 'limit', 'delivery', 'method', '', 'especially', 'united', 'states', '', 'niv', '', 'dual', 'limb', 'circuitry', 'filter', 'expiratory', 'limb', 'critical', 'care', 'ventilator', 'decrease', 'dispersion', 'compare', 'single', 'limb', 'circuitry', 'portable', 'device', '', 'although', 'data', 'support', '', 'suggest', 'start', 'continuous', 'positive', 'airway', 'pressure', '', 'cpap', '', 'lowest', 'effective', 'pressure', '', 'eg', '', '5', '10', 'cm', 'h2o', '', 'data', 'regard', 'aerosolization', 'hfnc', 'niv', '', 'normal', 'lung', 'simulation', 'study', '', 'dispersion', 'air', 'exhalation', 'increase', 'increase', 'hfnc', 'flow', '65', 'mm', '', '10', 'lminute', '', '172', 'mm', '', '60', 'lminute', '', 'mostly', 'along', 'sagittal', 'plane', '', 'ie', '', 'nostril', '', '', '64', '', '', 'similar', 'distance', 'find', 'cpap', 'deliver', 'via', 'nasal', 'pillow', '', '332', 'mm', 'cpap', '20', 'cm', 'h2o', '', '', 'however', '', 'significant', 'leakage', 'note', 'cpap', 'administer', 'via', 'oronasal', 'mask', 'seal', '', 'picture', '1', 'picture', '2', '', '', 'air', 'leak', 'increase', 'connection', 'device', 'loose', '', 'dispersion', 'reduce', 'simulator', 'simulate', 'injure', 'lung', '', 'nebulized', 'medication', '', 'spontaneously', 'breathe', 'patient', '', '', 'nebulizers', 'associate', 'aerosolization', 'potentially', 'increase', 'risk', 'sars-cov-2', 'transmission', '', 'patient', 'suspect', 'document', 'covid-19', '', 'nebulized', 'bronchodilator', 'therapy', 'reserve', 'acute', 'bronchospasm', '', 'eg', '', 'set', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', 'exacerbation', '', '', 'otherwise', '', 'nebulized', 'therapy', 'generally', 'avoid', '', 'particular', 'indication', 'without', 'clear', 'evidence-base', '', 'however', 'us', '', 'eg', '', 'hypertonic', 'saline', 'cystic', 'fibrosis', '', 'individualize', '', 'metered', 'dose', 'inhaler', '', 'mdis', '', 'spacer', 'device', 'instead', 'nebulizer', 'management', 'chronic', 'condition', '', 'eg', '', 'asthma', 'copd', 'controller', 'therapy', '', '', 'patients', 'mdis', 'hospital', 'formularyif', 'nebulized', 'therapy', '', 'patient', 'airborne', 'infection', 'isolation', 'room', '', 'healthcare', 'worker', 'contact', 'airborne', 'precaution', 'appropriate', 'personal', 'protection', 'equipment', '', 'ppe', '', '', 'include', 'n95', 'mask', 'goggle', 'face', 'shield', 'equivalent', '', 'eg', '', 'power', 'air-purifying', 'respirator', '', 'papr', '', 'mask', '', '', 'well', 'glove', 'gown', '', 'non-essential', 'personnel', 'leave', 'room', 'nebulization', '', 'expert', 'suggest', 're-enter', 'room', 'two', 'three', 'hour', 'follow', 'nebulizer', 'administration', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', 'potential', 'transmission', 'sars-cov-2', 'inform', 'intervention', 'patient', 'document', 'suspect', 'covid-19', '', 'prudent', 'minimize', 'follow', '', 'positive', 'airway', 'device', 'chronic', 'nocturnal', 'ventilation', 'supportchest', 'physical', 'therapy', 'oscillatory', 'devicesoral', 'airway', 'suctioningsputum', 'induction', 'avoidedbronchoscopy', 'avoid', 'spontaneously', 'breathe', 'patient', 'limit', 'therapeutic', 'indication', '', 'eg', '', 'life-threatening', 'hemoptysis', '', 'central', 'airway', 'stenosis', '', 'therapy', 'perform', '', 'similar', 'ppe', 'describe', 'nebulizer', 'therapy', '', '', 'nebulized', 'medication', '', 'spontaneously', 'breathe', 'patient', '', '', '', 'flexible', 'bronchoscopy', 'adult', '', 'overview', '', '', '', 'decision', 'intubatetiming', '', 'timing', 'intubation', 'population', 'challenge', '', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'due', 'covid-19', 'warrant', 'intubation', 'mechanical', 'ventilation', '', 'delaying', 'intubation', 'patient', 'acutely', 'decompensates', 'potentially', 'harmful', 'patient', 'healthcare', 'worker', 'advise', '', 'patient', 'escalate', 'oxygen', 'requirement', '', 'monitor', 'clinical', 'gas', 'exchange', 'parameter', 'every', 'one', 'two', 'hour', 'low', 'threshold', 'intubate', 'patient', 'follow', '', 'rapid', 'progression', 'hour', 'improvement', '', '40', 'lminute', 'high', 'flow', 'oxygen', 'fraction', 'inspire', 'oxygen', '', 'fio2', '', '', '06evolving', 'hypercapnia', '', 'increase', 'work', 'breathe', '', 'increase', 'tidal', 'volume', '', 'worsen', 'mental', 'status', 'hemodynamic', 'instability', 'multiorgan', 'failuremost', 'expert', 'experience', 'manage', 'covid-19', 'patient', 'suggest', '', 'early', '', 'intubation', '', 'however', '', 'definition', 'constitute', '', 'early', '', 'unclear', '', 'noninvasive', 'mean', 'traditionally', 'avoid', 'intubation', '', 'however', '', 'controversy', 'patient', 'covid-19', '', 'patients', 'higher', 'oxygen', 'requirement', '', '', '', 'clinicians', 'communicate', 'closely', 'regularly', 'potential', 'intubation', 'patient', 'follow', 'treat', 'noninvasively', 'transition', 'intubation', 'smooth', 'rapid', 'identify', 'patient', 'intubation', '', 'precautions', '', 'intubation', 'highest', 'risk', 'procedure', 'droplet', 'dispersion', 'patient', 'covid-19', '', '5665', '', '', 'follow', 'discussion', 'suitable', 'patient', 'outside', 'operate', 'room', '', 'eg', '', 'intensive', 'care', 'unit', '', 'icu', '', 'emergency', 'department', '', '', 'table', '2', '', '', 'proponent', 'development', 'intubation', 'kit', 'intubation', 'checklist', 'perform', 'rapid', 'sequence', 'intubation', '', 'rsi', '', 'population', '', 'figure', '1', '', '', 'attention', 'pay', 'full', 'contact', 'airborne', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'figure', '2', 'figure', '3', '', '', '56', '', '', 'appropriate', 'ppe', 'include', 'fit-tested', 'disposable', 'n95', 'respirator', 'mask', '', 'picture', '3', '', '', 'eye', 'protection', 'power', 'air-purifying', 'respirator', '', 'papr', '', '', 'isolation', 'suit', '', 'picture', '4', 'picture', '5', '', '', 'include', 'gown', '', 'cap', 'beard', 'cover', '', 'protective', 'footwear', '', 'neck', 'cover', '', 'glove', '', 'double', 'glove', 'technique', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'intubation', 'perform', 'airborne', 'infection', 'isolation', 'room', '', 'possibleintubation', 'perform', 'qualify', 'individual', '', 'eg', '', 'anesthesiologist', '', 'since', 'delay', 'intubation', 'multiple', 'attempt', 'prolong', 'dispersion', 'place', 'patient', 'risk', 'respiratory', 'arrest', '', 'anecdotally', '', 'expert', 'suggest', 'optimize', 'preoxygenation', 'nonaerosol-generating', 'mean', '', 'eg', '', 'avoidance', 'high', 'flow', 'oxygen', 'deliver', 'via', 'nasal', 'cannula', '', 'intubation', 'video', 'laryngoscopy', '', 'patient', 'previously', 'high', 'flow', 'oxygen', '', 'expert', 'switch', '100', 'percent', 'nonrebreather', 'mask', 'preoxygenation', '', 'manual', 'bag', 'mask', 'ventilation', '', 'bmv', '', '', 'switch', 'mask', 'supraglottic', 'device', 'manual', 'bag', 'appropriate', '', 'feasible', '', 'bmv', 'minimize', 'intubation', '', 'bacterialviral', 'high', 'efficiency', 'hydrophobic', 'filter', 'place', 'facemask', 'breathe', 'circuit', 'resuscitation', 'bag', '', 'pre-prepared', 'bag-mask', 'filter', 'attach', 'every', 'room', 'covid-19', 'patient', 'prudent', '', 'using', 'two-person', 'technique', 'adequate', 'face', 'mask', 'seal', 'suggestedclamping', 'endotracheal', 'tube', '', 'ett', '', 'connection', 'disconnection', 'appropriate', '', 'eg', '', 'capnography', 'test', 'follow', 'intubation', '', '', 'patient', 'spontaneously', 'breathe', '', 'ventilator', 'ventilator', 'circuitry', 'ready', 'advance', 'preplanned', 'set', 'already', 'enter', 'soon', 'ett', 'place', 'confirm', 'capnography', '', 'connect', 'directly', 'ett', 'without', 'additional', 'manual', 'bag', '', 'addition', '', 'feasible', '', 'in-line', 'suction', 'device', 'in-line', 'adapter', 'bronchoscopy', 'prepare', 'attach', 'ventilator', 'tube', 'advance', 'order', 'avoid', 'unnecessary', 'disconnection', 'placement', 'later', 'point', 'time', '', 'expiratory', 'limb', 'ventilator', 'hepa', 'filter', 'decrease', 'contamination', 'ventilator', 'environment', 'protect', 'staff', 'change', 'limb', 'circuitry', '', 'minimize', 'exposure', '', 'bundle', 'intubation', 'procedure', 'appropriate', 'bundle', 'chest', 'radiograph', 'ett', 'central', 'venous', 'catheter', 'placementdoffing', 'follow', 'strict', 'procedure', 'expert', 'advocate', 'viricidal', 'wipe', 'area', 'expose', 'skin', 'intubation', '', 'eg', '', 'neck', '', '', 'figure', '3', '', 'new', 'proposal', 'emerge', 'novel', 'barrier', 'protection', 'intubation', '', 'one', 'pilot', 'study', '', 'manually', 'perform', 'intubation', 'inside', 'transparent', 'box', 'describe', '', '', 'aerosol', 'box', '', '', '', '66', '', '', 'box', 'design', 'place', 'patient', '', 'head', 'allow', 'intubation', 'perform', 'two', 'circular', 'port', 'cephalad', 'side', 'box', '', 'simulation', 'experiment', '', 'cough', 'approximate', 'latex', 'balloon', 'fluorescent', 'dye', '', 'box', 'associate', 'significant', 'reduction', 'aerosol', 'deposition', 'individual', 'perform', 'intubation', '', 'ppe', 'clothe', '', 'surround', 'environment', '', 'compare', 'simulation', 'without', 'box', '', 'propose', 'adjunct', 'protection', '', 'restriction', 'hand', 'movement', 'encounter', 'airway', 'manipulation', 'necessitate', 'abandon', 'procedure', 'simulation', 'accurately', 'mimic', 'aerosolization', 'behavior', 'virus', 'particle', '', 'device', 'yet', 'commercially', 'available', '', 'detailed', 'guidance', 'regard', 'intubation', 'operate', 'room', '', 'optimal', 'personal', 'protective', 'equipment', '', 'procedural', 'detail', 'regard', 'intubation', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', 'safety', 'operate', 'room', '', '', 'section', 'covid-19', '', '', 'direct', 'laryngoscopy', 'endotracheal', 'intubation', 'adult', '', '', 'rapid', 'sequence', 'intubation', 'adult', 'outside', 'operate', 'room', '', '', 'decision', 'intubate', '', '', 'induction', 'agent', 'rapid', 'sequence', 'intubation', 'adult', 'outside', 'operate', 'room', '', '', 'neuromuscular', 'block', 'agent', '', 'nmbas', '', 'rapid', 'sequence', 'intubation', 'adult', 'outside', 'operate', 'room', '', '', '', 'ventilator', 'management', 'acute', 'respiratory', 'distress', 'syndrome', '', 'patient', 'covid-19', 'mechanically', 'ventilate', 'appear', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', 'accurate', 'data', 'duration', 'ventilation', 'limit', 'suggest', 'prolong', 'mechanical', 'ventilation', 'two', 'week', '', 'table', '1', '', '', 'step', 'discuss', 'proceed', 'resource', 'allow', '', 'whether', 'different', 'phase', 'covid-19', 'pneumonitis', 'require', 'different', 'ventilatory', 'strategy', 'unclear', '', 'one', 'school', 'early', 'phase', 'covid-19', '', 'severe', 'hypoxemia', 'associate', 'high', 'compliance', 'low', 'alveolar', 'recruitability', '', 'atypical', 'ards', '', '', 'later', 'phase', '', 'severe', 'hypoxemia', 'associate', 'low', 'lung', 'compliance', 'high', 'recruitability', '', 'classic', 'ards', '', '', '6768', '', '', 'however', '', 'hypothesis', '', 'remain', 'unproven', 'optimal', 'ventilatory', 'strategy', 'base', 'upon', 'unclear', '', 'data', 'available', '', 'prefer', 'strategy', 'promote', 'lung', 'protection', 'outline', 'section', 'belowlow', 'tidal', 'volume', 'ventilation', '', 'ltvv', '', '', 'patient', 'ards', '', 'patient', 'covid-19', 'pneumonia', 'develop', 'ards', 'require', 'mechanical', 'ventilation', 'receive', 'ltvv', 'target', '6', 'mlkg', 'predict', 'body', 'weight', '', 'pbw', '', 'range', '4', '8', 'mlkg', 'pbw', '', 'table', '3', 'table', '4', '', '', '', 'typically', 'volume-limited', 'assist', 'control', 'mode', '', 'begin', 'tidal', 'volume', '6', 'mlkg', 'pbw', '', 'target', 'plateau', 'pressure', '', 'pplat', '', '30', 'cm', 'h2o', '', 'apply', 'positive', 'end-expiratory', 'pressure', '', 'peep', '', 'accord', 'strategy', 'outline', 'table', '', 'table', '5', '', '', 'approach', 'base', 'upon', 'several', 'randomize', 'trial', 'meta-analyses', 'report', 'improve', 'mortality', 'ltvv', 'patient', 'ards', '', 'experience', 'among', 'chinese', '', 'italian', '', 'united', 'states', 'cohort', 'approach', 'beneficial', 'population', '', 'modifications', 'deviation', 'mechanical', 'ventilation', 'strategy', 'require', 'set', 'severe', 'hypercapnia', 'ventilator', 'dyssynchrony', '', 'figure', '4', '', '', '', '', 'ventilator', 'management', 'strategy', 'adult', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'section', 'patients', 'improve', 'deteriorate', '', '', '', 'anecdotal', 'report', 'suggest', 'covid-19', 'ards', 'phenotype', 'one', 'severe', 'hypoxemia', 'responsive', 'high', 'peep', 'relatively', 'high', 'lung', 'compliance', 'pplat', '30', 'cm', 'h2o', 'difficult', 'achieve', '', 'consequence', '', 'clinician', 'low', 'threshold', 'start', 'higher', 'usual', 'level', 'peep', '', 'eg', '', '10', '15', 'cm', 'h2o', '', 'expanded', 'detail', 'ltvv', 'ventilator', 'strategy', 'ards', 'provide', 'separately', '', '', '', 'ventilator', 'management', 'strategy', 'adult', 'acute', 'respiratory', 'distress', 'syndrome', '', '', '', 'believe', 'oxygenation', 'goal', 'critically', 'ill', 'patient', 'covid-19', 'similar', 'nonventilated', 'patient', '', 'ie', '', 'peripheral', 'oxygen', 'saturation', '90', '96', 'percent', '', 'oxygenation', 'target', '', '', '', '', 'however', '', 'patent', 'covid-19', '', 'expert', 'higher', 'peripheral', 'oxygen', 'saturation', '', 'spo2', '', 'goal', '', '7', '', '', 'rationale', 'approach', 'reduce', 'frequency', 'ventilator', 'adjustment', 'require', 'staff', 'entry', 'room', '', 'thereby', 'reduce', 'risk', 'healthcare', 'staff', '', 'although', 'data', 'support', 'itreflecting', 'practice', 'ltvv', '', 'one', 'retrospective', 'italian', 'cohort', 'report', 'median', 'level', 'peep', '14', 'cm', 'h2o', '', 'interquartile', 'range', '', 'iqr', '', '12', '16', 'cm', 'h2o', '', '', '22', '', '', 'ninety', 'percent', 'patient', 'require', 'fio2', '', '05', '', 'median', 'pao2fio2', 'ratio', '160', '', 'iqr', '', '114', '220', '', 'failure', 'low', 'tidal', 'volume', 'ventilation', '', 'patient', 'covid-19', 'fail', 'achieve', 'adequate', 'oxygenation', 'ltvv', '', 'agree', 'expert', 'field', 'choose', 'prone', 'ventilation', 'prefer', 'next', 'step', '', 'application', '', 'similar', 'criterion', 'non-covd-19', 'patient', '', 'ie', '', 'partial', 'arterial', 'pressure', 'oxygenfraction', 'inspire', 'oxygen', '', 'pao2', '', 'fio2', '', 'ratio', '', '150', 'mmhg', '', 'fio2', '06', '', 'peep', '5', 'cm', 'h2o', '', 'excessively', 'high', 'airway', 'pressure', '', 'recalcitrant', 'hypoxemia', '', '', 'although', 'expert', 'higher', 'pao2', '', 'fio2', 'ratio', '', 'give', 'response', 'population', '', 'prone', 'ventilation', '', 'preference', 'prone', 'ventilation', 'base', 'efficacy', 'patient', 'ards', 'well', 'limit', 'anecdotal', 'observation', 'intensivists', 'field', 'note', 'unlike', 'patient', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', '', 'patient', 'covid-19-related', 'ards', 'respond', 'well', 'maneuver', '', '69', '', '', 'experience', 'ventilate', 'patient', 'covid-19-related', 'ards', 'promote', 'ventilate', 'patient', 'prone', 'long', 'feasible', 'without', 'prematurely', 'return', 'patient', 'supine', 'position', '', 'ie', '', '12', '16', 'hour', 'prone', 'per', 'day', '', 'perform', 'maneuver', 'change', 'shift', 'sufficient', 'staff', 'available', '', 'utmost', 'care', 'avoid', 'ventilator', 'disconnection', 'proning', 'number', 'personnel', 'limit', 'require', 'turn', '', 'video', 'describe', 'prone', 'procedure', 'freely', 'available', '', 'additional', 'detail', 'regard', 'efficacy', '', 'contraindication', '', 'table', '6', '', 'application', '', 'table', '7', '', 'prone', 'ventilation', 'provide', 'separately', '', '', '', 'prone', 'ventilation', 'adult', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'ventilator', 'management', 'strategy', 'adult', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'section', 'ventilator', 'strategy', 'maximize', 'alveolar', 'recruitment', '', '', '', 'response', 'prone', 'position', 'due', 'preserve', 'lung', 'compliance', 'population', 'compare', 'patient', 'develop', 'ards', 'etiology', '', 'lung', 'compliance', 'change', 'lung', 'volume', 'give', 'pressure', '', 'measure', 'follow', 'equation', '', 'lung', 'compliance', '', 'c', '', '', 'change', 'lung', 'volume', '', 'v', '', '', 'change', 'transpulmonary', 'pressure', '', 'alveolar', 'pressure', '', 'palv', '', '', 'pleural', 'pressure', '', 'ppl', '', '', '', 'static', 'lung', 'compliance', '', 'tidal', 'volume', '', 'pplat', '', 'peep', '', 'normal', 'lung', 'compliance', 'approximately', '200', 'mlcm', 'h2o', 'general', 'compliance', '', '50', 'mlcm', 'h2o', 'note', 'clinician', 'experience', 'ventilate', 'patient', 'covid-19', '', 'optimal', 'time', 'criterion', 'discontinue', 'prone', 'ventilation', 'unclear', 'perform', 'individualize', 'basis', '', 'unreasonable', 'criterion', 'similar', 'study', 'show', 'benefit', 'non-covid-related', 'ards', '', 'eg', 'pao2', '', 'fio2', '150', 'mmhg', '', 'fio2', '06', '', 'peep', '10', 'cm', 'h2o', '', 'maintain', 'least', 'four', 'hour', 'end', 'last', 'prone', 'session', '', '', '70', '', 'additional', 'option', '', 'additional', 'option', 'patient', 'prone', 'ventilation', 'fail', 'include', 'follow', '', 'recruitment', 'high', 'peep', '', 'recruitment', 'maneuver', 'high', 'peep', 'strategy', '', 'table', '8', '', 'perform', 'address', 'severe', 'hypoxemia', '', 'data', 'support', 'non', 'covid-19-related', 'ards', 'describe', 'separately', '', '', '', 'ventilator', 'management', 'strategy', 'adult', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'section', 'ventilator', 'strategy', 'maximize', 'alveolar', 'recruitment', '', '', '', 'pulmonary', 'vasodilator', '', 'pulmonary', 'vasodilator', 'improve', 'ventilation-perfusion', 'mismatch', 'severe', 'hypoxemia', 'particularly', 'helpful', 'hypoxemia', 'acute', 'pulmonary', 'arterial', 'hypertension', 'crisis', '', 'two', 'commonly', 'agent', 'inhale', 'nitric', 'oxide', '', '', 'inhale', 'prostacyclin', '', 'administer', 'continuous', 'inhalation', '', 'inhaled', 'vasodilator', 'administer', 'close', 'system', 'require', 'skilled', 'personnel', '', 'potential', 'risk', 'challenge', 'covid-19', 'patient', 'include', 'aerosolization', 'clog', 'bacterialviral', 'filter', 'ventilator', 'circuit', 'medication', 'administer', '', 'inhaled', 'prefer', 'since', 'associate', 'lower', 'change', 'filter', 'resultant', 'reduction', 'risk', 'respiratory', 'healthcare', 'provider', '', 'detail', 'regard', 'describe', 'separately', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'nitric', 'oxide', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'prostacyclin', '', '', 'inhaled', 'nitric', 'oxide', 'adult', '', 'biology', 'indication', '', '', 'section', 'acute', 'hypoxemic', 'respiratory', 'failure', '', '', '', 'neuromuscular', 'block', 'agent', '', 'nmbas', '', '', 'nmbas', 'reserve', 'patient', 'refractory', 'hypoxemia', 'ventilator', 'dyssynchrony', '', 'favor', 'routine', 'patient', 'ards', 'since', 'data', 'outcome', 'conflict', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'paralysis', '', 'neuromuscular', 'blockade', '', '', '', 'neuromuscular', 'block', 'agent', 'critically', 'ill', 'patient', '', '', 'agent', 'selection', '', 'administration', '', 'adverse', 'effect', '', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', 'world', 'health', 'organization', 'suggest', 'ecmo', 'rescue', 'strategy', '', 'fail', 'prone', 'ventilation', 'evidence-based', 'medical', 'strategy', 'list', '', 'addition', '', 'ecmo', 'universally', 'available', '', 'hospital', 'choose', 'cohort', 'patient', 'covid-19-only', 'intensive', 'care', 'unit', '', 'icus', '', '', 'challenge', 'deliver', 'ecmo', 'icus', 'routinely', 'care', 'ecmo', 'patient', '', 'require', 'recruitment', 'additional', 'specialize', 'nurse', 'perfusionist', 'staff', '', 'ecmo', 'reduce', 'lymphocyte', 'count', 'raise', 'interleukin-6', 'level', '', 'thereby', 'interfere', 'interpretation', 'laboratory', 'result', '', '71', '', '', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'adult', '', '', '', 'rescue', 'strategy', 'vary', 'among', 'center', '', 'single-center', 'retrospective', 'cohort', '52', 'critically', 'ill', 'patient', 'covid-19', 'wuhan', '', 'china', '', 'approximately', '12', 'percent', 'receive', 'prone', 'ventilation', '12', 'percent', 'receive', 'ecmo', '', '9', '', '', 'contrast', '', 'original', 'cohort', '138', 'hospitalize', 'patient', 'covid-19', '', '17', 'patient', 'require', 'invasive', 'mechanical', 'ventilation', '', '24', 'percent', 'treat', 'ecmo', '', 'similarly', '', 'italian', 'cohort', '', '1', 'percent', 'critically', 'ill', 'patient', 'receive', 'ecmo', '', '22', '', '', 'additional', 'ventilator', 'precaution', '', 'recommend', 'tight', 'seal', 'ventilator', 'circuitry', 'equipment', '', 'patient', 'tracheostomy', '', 'similar', 'recommendation', 'apply', '', 'although', 'efficacy', 'unproven', '', 'expert', 'suggest', 'place', 'ventilator', 'intravenous', '', 'iv', '', 'monitor', 'outside', 'room', '', 'feasible', '', 'eg', '', 'wall', 'port', '', '', 'allow', 'frequent', 'ventilator', 'adjustment', 'simultaneously', 'decrease', 'risk', 'exposure', 'staff', '', 'although', 'efficacy', 'maneuver', 'unproven', '', 'prudent', 'avoid', 'unnecessary', 'disconnection', 'endotracheal', 'tube', '', 'ett', '', 'ventilate', 'patient', 'covid-19', 'order', 'avoid', 'derecruitment', 'unnecessary', 'exposure', 'virus', 'environment', '', 'example', '', 'in-line', 'suction', 'device', 'in-line', 'adapter', 'bronchoscopy', 'prefer', '', 'resource', 'allow', '', 'disconnection', 'necessary', '', 'eg', '', 'transfer', 'portable', 'ventilator', 'manual', 'bag', '', '', 'ett', 'temporarily', 'clamp', 'disconnection', 'unclamped', 'reconnection', '', 'consider', 'aerosolize', 'procedure', 'case', 'airborne', 'infection', 'isolation', 'room', 'preferable', 'always', 'feasibleother', 'infection', 'precaution', 'include', 'dual', 'limb', 'ventilator', 'circuitry', 'filter', 'place', 'exhalation', 'outlet', 'well', 'heat', 'moisture', 'exchange', '', 'hme', '', 'system', 'heat', 'humification', 'single', 'limb', 'circuit', '', 'hme', 'place', 'exhalation', 'port', 'ett', '', 'figure', '5', 'figure', '6', '', '', '', '', 'ventilator', 'circuit', '', '', '', 'particularly', 'important', 'adhere', 'standard', 'practice', 'maintain', 'ett', 'cuff', 'pressure', '25', '30', 'cm', 'h2o', 'tight', 'seal', 'exist', 'cuff', 'tracheal', 'wall', '', '', '', 'complications', 'endotracheal', 'tube', 'follow', 'initial', 'placement', '', 'prevention', 'management', 'adult', 'intensive', 'care', 'unit', 'patient', '', '', 'section', 'maintain', 'optimal', 'cuff', 'pressure', '', '', '', 'ventilator', 'appropriate', 'filter', 'place', 'agree', 'upon', 'filter', 'change', 'schedule', '', 'eg', '', 'every', 'six', 'hour', '', '', 'ventilator', 'wipe', 'every', 'filter', 'change', '', 'although', 'airborne', 'isolation', 'room', 'ideal', '', 'feasible', '', 'patient', 'ventilate', 'non-isolation', 'room', 'transport', 'airborne', 'isolation', 'room', 'aerosol', 'generate', 'procedure', 'place', '', 'eg', '', 'extubation', '', 'bronchoscopy', '', '', 'protocol', 'place', 'transport', 'prudent', '', 'interventions', '', 'ventilated', 'patient', 'require', 'frequent', 'evaluation', 'develop', 'complication', 'require', 'intervention', '', 'details', 'relevant', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus-2', '', 'sars-cov-2', '', 'infection', 'include', 'section', 'mostly', 'relate', 'infectious', 'precaution', '', 'biodistribution', 'study', '1070', 'specimen', 'obtain', '205', 'patient', 'covid-19', 'pneumonia', '', 'bronchoalveolar', 'lavage', 'fluid', 'specimen', 'show', 'highest', 'positive', 'rate', '', '93', 'percent', '', '', 'follow', 'sputum', '', '72', 'percent', '', '', 'nasal', 'swab', '', '63', 'percent', '', '', 'fibrobronchoscope', 'brush', 'biopsy', '', '46', 'percent', '', '', 'pharyngeal', 'swab', '', '32', 'percent', '', '', 'feces', '', '29', 'percent', '', '', 'blood', '', '1', 'percent', '', '', 'urine', 'specimen', 'test', 'positive', '', '72', '', '', 'data', 'demonstrate', 'sars-cov-2', 'detect', 'several', 'specimen', '', 'although', 'report', 'rate', 'study', 'determine', 'severity', 'illness', 'individual', 'test', '', 'systematic', 'review', '10', 'retrospective', 'cohort', 'study', 'evaluate', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', 'healthcare', 'worker', '', 'endotracheal', 'intubation', 'highest', 'risk', '', 'odds', 'ratio', '', '', '66', '', '95', '', 'ci', '23-189', '', '', 'follow', 'noninvasive', 'ventilation', '', '31', '', '95', '', 'ci', '14-68', '', '', 'tracheostomy', '', '42', '', '95', '', 'ci', '15-115', '', '', 'bag-mask', 'ventilation', '', '73', '', '', 'procedure', 'associate', 'lower', 'insignificant', 'risk', 'transmission', 'whether', 'apply', 'sars-cov-2', '', 'example', '', 'duration', 'close', 'contact', 'aerosolize', 'procedure', 'precaution', 'describe', '', 'collection', 'respiratory', 'specimen', 'intubate', 'patient', '', 'intubate', 'patient', 'require', 'upper', 'lower', 'respiratory', 'tract', 'sample', 'diagnostic', 'purpose', '', 'eg', '', 'diagnosis', 'covid-19', 'ventilator-associated', 'pneumonia', '', 'vap', '', '', '', 'technically', '', 'nasopharyngeal', 'oropharyngeal', 'swab', 'airborne', 'precaution', '', 'however', '', 'prefer', 'obtain', 'naso-and', 'oropharyngeal', 'swab', 'tracheal', 'aspirate', 'airborne', 'precaution', 'intensive', 'care', 'unit', '', 'icu', '', '', 'nonbronchoscopic', 'alveolar', 'lavage', '', '', 'mini-bal', '', '', 'perform', 'alternative', 'bronchoscopy', '', 'although', 'experience', 'procedure', 'universal', 'among', 'icus', '', 'mini-bal', 'perform', 'diagnosis', 'covid-19', '', 'smaller', 'aliquot', 'lavage', 'fluid', 'prudent', '', 'eg', '', 'three', '10', 'ml', 'aliquot', 'obtain', '2', '3', 'ml', 'fluid', '', '', '', '', 'clinical', 'presentation', 'diagnostic', 'evaluation', 'ventilator-associated', 'pneumonia', '', '', 'section', 'invasive', 'respiratory', 'sample', '', '', '', 'bronchoscopy', '', 'agree', 'american', 'association', 'bronchology', 'interventional', 'pulmonology', '', 'aabip', '', 'bronchoscopy', 'limit', 'role', 'diagnosis', 'covid-19', 'perform', 'indication', 'upper', 'respiratory', 'sample', 'negative', '', 'ie', '', 'nasopharyngeal', 'oropharyngeal', 'swab', '', 'tracheal', 'aspirate', '', 'non-bronchoscopic', 'bronchoalveolar', 'lavage', '', 'suspicion', 'remain', 'high', '', 'bronchoscopy', 'perform', 'another', 'diagnosis', 'consider', 'bronchoscopic', 'sample', 'change', 'management', '', 'eg', '', 'suspect', 'pneumocystis', 'jirovecii', 'immunosuppressed', 'patient', '', 'therapeutic', 'bronchoscopy', 'indicate', '', 'eg', '', 'life-threatening', 'hemoptysis', 'airway', 'stenosis', '', '', 'bronchoscopy', 'aerosol-generating', 'procedure', 'perform', 'necessary', 'likely', 'change', 'management', '', 'bronchoscopy', 'establish', 'airway', '', 'eg', '', 'endotracheal', 'tube', '', 'ett', '', '', 'likely', 'carry', 'le', 'risk', 'bronchoscopy', 'spontaneously', 'breathe', 'patient', '', 'patient', 'covid-19', '', 'bronchoscopy', 'perform', 'airborne', 'infection', 'isolation', 'room', '', 'airborne', 'precaution', 'personal', 'protective', 'equipment', '', 'ppe', '', 'enter', 'room', '', 'using', 'ppe', 'similar', 'describe', 'intubation', 'appropriate', '', '', 'decision', 'intubate', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'using', 'etts', 'inline', 'adapter', 'bronchoscopy', 'ideal', 'prevent', 'disconnection', 'ventilator', 'aerosolization', '', 'bronchoscopy', 'diagnosis', 'covid-19', 'pneumonia', '', 'suggest', 'small', 'aliquot', '10', 'ml', 'obtain', '2', '3', 'ml', 'lavage', 'fluid', 'place', 'sterile', 'leak-proof', 'container', '', 'clamping', 'suction', 'tube', 'turn', 'suction', 'sample', 'obtain', 'disconnect', 'sample', 'device', 'prudent', '', 'specimens', 'double', 'zip-locked', 'seal', 'plastic', 'bag', '', 'handle', 'usual', 'precaution', '', 'label', 'clearly', '', 'covid-19', '', 'prefer', 'disposable', 'bronchoscope', '', 'although', 'universally', 'available', '', 'nondisposable', 'equipment', '', 'recommend', 'clean', 'suction', 'channel', 'standard', 'clean', 'solution', 'typically', 'highly', 'infectious', 'material', '', 'suggest', 'cover', 'seal', 'vessel', 'contain', 'bronchoscope', 'transport', 'wipe', 'transport', 'cart', 'bronchoscope', 'display', 'tower', 'leave', 'room', '', 'wipe', 'solution', 'hydrogen', 'peroxide', 'equivalent', 'leave', 'wet', 'surface', 'least', 'one', 'minute', '', 'extubation', 'wean', '', 'patients', 'often', 'ready', 'extubation', 'remain', 'infectious', '', 'extubation', 'frequently', 'associate', 'cough', '', 'consider', 'aerosol-generating', 'procedure', '', 'similar', 'intubation', '', 'encourage', 'extubation', 'protocol', 'check', 'list', 'specific', 'institutionweaning', '', 'readiness', 'extubation', 'follow', 'standard', 'practice', 'perform', 'spontaneous', 'breathe', 'trial', '', 'sbt', '', '', 'however', '', 'covid-specific', 'approach', 'include', 'follow', '', 'equipment', '', 'suggest', 'close', 'system', 't-piece', 'trial', 'sbtssbts', '', 'reduce', 'risk', 'reintubation', 'follow', 'extubation', '', 'prefer', 'higher', 'degree', 'readiness', 'patient', 'covid-19', '', 'practice', 'vary', 'include', 'higher', 'criterion', 'pass', 'sbt', '', 'example', '', 'expert', 'lower', 'pressure', 'support', 'ventilation', '', 'psv', '', 'parameter', '', 'eg', '', '0', '5', 'cm', 'h2o', '', 'typical', '7', 'cm', 'h2o', 'trial', 'others', 'promote', 'sbt', 'longer', 'period', '', 'eg', '', 'two', 'four', 'hour', 'typical', 'two', 'hour', '', '', 'rationale', 'alter', 'criterion', 'base', 'upon', 'observation', 'patient', 'covid-19', 'intubate', 'longer', 'period', 'non-covid-patients', '', '22', '', 'anecdotal', 'evidence', 'suggest', 'high', 'volume', 'secretion', 'airway', 'edema', '', 'factor', 'place', 'patient', 'high', 'risk', 'post', 'extubation', 'respiratory', 'failure', 'require', 'reintubation', '', 'addition', '', 'prefer', 'extubating', 'patient', 'directly', 'low-flow', 'oxygen', 'high', 'flow', 'oxygen', 'deliver', 'via', 'nasal', 'cannulae', '', 'hfnc', '', 'noninvasive', 'ventilation', '', 'niv', '', '', 'risk', 'virus', 'aerosolization', '', '', '', 'weaning', 'mechanical', 'ventilation', '', 'readiness', 'test', '', '', 'methods', 'wean', 'mechanical', 'ventilation', '', '', 'section', 'spontaneous', 'breathe', 'trial', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'cuff', 'leak', 'test', '', 'whether', 'cuff', 'leak', 'test', '', 'clt', '', 'perform', 'routinely', 'prior', 'extubation', 'unclear', '', 'however', '', 'performance', 'guide', 'clinical', 'suspicion', 'upper', 'airway', 'edema', '', 'eg', '', 'fluid', 'overload', '', 'presence', 'risk', 'factor', 'post', 'extubation', 'stridor', '', 'eg', '', 'prolong', 'intubation', '6', 'day', '', 'age', '', '80', 'year', '', 'large', 'endotracheal', 'tube', '', 'traumatic', 'intubation', '', '', 'performing', 'cuff', 'leak', 'test', 'weigh', 'potential', 'risk', 'aerosolization', '', 'similar', 'extubation', '', 'preferentially', 'airborne', 'isolation', 'room', '', 'institution', '', 'routinely', 'administer', 'glucocorticoid', '', 'eg', '', 'methylprednisolone', '20', 'mg', 'intravenously', 'every', 'four', 'hour', 'total', 'four', '', 'patient', 'covid-19', 'extubation', 'extubate', 'clt', 'positive', 'glucocorticoid', '', 'base', 'practice', 'upon', 'high', 'rate', 'airway', 'edema', 'note', 'population', 'understand', 'practice', 'vary', 'depend', 'upon', 'population', 'serve', '', '', '', 'extubation', 'management', 'adult', 'intensive', 'care', 'unit', '', '', 'section', 'cuff', 'leak', '', '', '', 'extubation', '', 'prefer', 'perform', 'extubation', 'airborne', 'isolation', 'room', '', 'respiratory', 'therapist', 'others', 'room', 'extubation', 'adhere', 'airborne', 'precaution', 'include', 'n95', 'mask', 'eye', 'protection', 'equivalent', '', 'general', '', 'two', 'people', 'extra', 'staff', 'outside', 'room', 'available', 'help', 'additional', 'equipment', '', 'expert', 'medication', 'decrease', 'cough', '', 'eg', '', 'lidocaine', 'via', 'ett', '', 'low-dose', 'opioid', 'bolus', '', 'dexmedetomidine', '', 'remifentanil', 'available', '', '', 'although', 'data', 'support', 'routine', 'anti-tussives', 'limit', '', 'icu', '', 'close', 'communication', 'clinician', 'experience', 'intubation', 'regard', 'occurrence', 'extubation', 'covid-19', 'patient', 'prudent', '', 'case', 'rapid', 'reintubation', '', 'particularly', 'patient', 'pre-designated', 'difficult', 'airwayboth', 'low-flow', 'high-flow', 'oxygen', 'system', 'set', 'readily', 'available', '', 'drape', 'patient', '', 'chest', 'face', 'plastic', 'cover', 'provide', 'barrier', 'protection', 'patient', 'operator', '', 'eg', '', 'plastic', 'poncho', '', '', 'typically', 'put', 'ventilator', 'standby', 'mode', '', 'switch', '', 'immediately', 'prior', 'extubation', '', 'balloon', 'deflation', '', 'extra', 'care', 'extubation', 'keep', 'inline', 'suction', 'catheter', 'engage', 'cuff', 'deflation', 'another', 'handheld', 'suction', 'catheter', 'available', 'removal', 'pharyngeal', 'oral', 'section', '', 'endotracheal', 'tube', 'remove', 'smoothly', 'feasible', 'inspiration', '', 'dispose', 'biohazard', 'plastic', 'bag', 'bundle', 'together', 'ventilator', 'tube', '', 'plastic', 'drape', '', 'tapeett', 'holder', '', 'inline', 'suction', 'catheter', '', 'bag', 'seal', 'dispose', 'immediately', '', 'detail', 'regard', 'extubation', 'provide', 'separately', '', '', '', 'extubation', 'management', 'adult', 'intensive', 'care', 'unit', '', '', 'section', 'extubation', 'equipment', 'technique', '', '', '', 'post-extubation', 'care', '', 'patient', 'monitor', 'follow', 'procedure', '', 'threshold', 'reintubate', 'patient', 'postextubation', 'respiratory', 'failure', 'low', '', 'postextubation', 'care', 'support', 'application', 'supplemental', 'oxygen', 'lowest', 'fraction', 'inspire', 'oxygen', '', 'fio2', '', 'possible', '', 'preferably', 'via', 'low', 'flow', 'nasal', 'canula', '', 'patient', 'often', 'extubated', 'remain', 'infectious', '', 'advise', 'adhere', 'similar', 'approach', 'oxygen', 'delivery', 'intubation', '', '', '', 'extubation', 'management', 'adult', 'intensive', 'care', 'unit', '', '', 'section', 'postextubation', 'management', '', 'oxygenation', 'target', '', '', '', 'procedure', 'palliative', 'extubation', 'similar', 'except', 'care', 'follow', 'extubation', 'include', 'palliative', 'medication', 'cessation', 'neuromuscular', 'blockade', '', 'precautions', 'extubation', 'provide', 'separately', '', '', '', 'safety', 'operate', 'room', '', '', 'section', 'covid-19', '', '', '', 'tracheostomy', '', 'reports', 'expert', 'field', 'suggest', 'patient', 'fail', 'early', 'attempt', 'wean', '', 'eg', '', 'within', 'first', 'week', '', '', 'although', 'appear', 'predict', 'eventual', 'ability', 'wean', 'extubate', '', 'however', '', 'patient', 'require', 'tracheostomy', '', 'experience', '', '10', 'percent', 'icu', 'admission', '', '', 'indications', '', 'indications', 'appear', 'similar', 'non-covid', 'patient', '', 'eg', '', 'fail', 'extubation', '', 'secretion', 'management', '', 'airway', 'edema', '', 'neurological', 'impairment', 'impair', 'airway', 'protection', '', 'timing', '', 'optimal', 'time', 'tracheostomy', 'unknown', 'covid-19', 'patient', '', 'non-covid', 'patient', '', 'change', 'practice', 'lead', 'intensivists', 'perform', 'tracheostomy', 'around', 'day', '7', '10', 'follow', 'initial', 'intubation', '', 'although', 'intensivists', 'perform', 'tracheostomy', 'approximately', '7', '10', 'day', 'follow', 'initial', 'intubation', 'patient', 'without', 'covid-19', '', 'reasonable', 'defer', 'tracheostomy', 'patient', 'covid-19', 'beyond', 'time', 'frame', '', 'covid-19', 'patient', 'appear', 'require', 'mechanical', 'ventilation', 'longer', 'patient', '', 'eg', '', 'two', 'three', 'week', '', '', 'still', 'successfully', 'extubated', 'point', '', 'procedure', '', 'tracheostomy', 'consider', 'high', 'risk', 'procedure', 'aerosolization', '', 'open', 'percutaneous', 'tracheostomy', 'procedure', 'acceptable', 'covid', 'patient', '', 'exact', 'procedure', 'determine', 'advance', 'discretion', 'operator', 'minimum', 'number', 'personnel', '', 'minimize', 'cough', '', 'neuromuscular', 'blockade', 'prudent', '', 'preferable', 'procedure', 'bedside', 'airborne', 'isolation', 'room', '', 'operator', 'wear', 'appropriate', 'ppe', 'similar', 'aerosol', 'generate', 'procedure', '', 'tracheostomy', 'tube', 'syringe', 'attach', 'immediate', 'balloon', 'inflation', 'insert', '', 'addition', '', 'adapter', 'inline', 'suction', 'catheter', 'attach', 'appropriate', '', '', 'precautions', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'procedures', 'open', 'suction', '', 'dress', 'change', '', 'inner', 'cannula', 'care', '', 'tracheostomy', 'change', 'consider', 'aerosol-generating', '', 'thus', '', 'post', 'tracheostomy', 'care', 'occur', 'airborne', 'isolation', 'room', '', 'feasible', '', '', 'consider', 'portable', 'hepa-filtration', 'unit', '', '', 'novel', 'barrier', 'protection', 'perform', 'tracheostomy', 'propose', '', 'one', 'report', '', 'tracheostomy', 'perform', 'aerosol-reduction', 'cover', 'high-efficiency', 'particulate', 'air', 'filtration', 'unit', 'place', 'close', 'surgical', 'field', '', '74', '', '', 'however', '', 'description', 'aerosol', 'deposition', 'provide', '', 'prolonged', 'wean', '', 'tracheostomy', 'collar', 'trial', 'safely', 'airborne', 'isolation', 'room', 'resumption', 'ventilation', 'close', 'loop', 'system', 'follow', 'trial', '', 'however', '', 'institution', 'portable', 'hepa', 'filter', 'generate', 'negative', 'pressure', 'room', 'close', 'system', 'dual', 'limb', 'circuitry', 'hepa', 'filter', 'attach', 'exhalation', 'limb', 'minimize', 'environmental', 'contamination', '', 'surgical', 'mask', 'tracheostomy', 'theoretically', 'limit', 'droplet', 'spread', '', 'patient', 'breathe', '24', 'hour', 'tracheostomy', 'collar', '', 'similar', '', '', 'undergo', 'trial', 'speak', 'valve', '', 'cap', '', 'balloon', 'deflate', '', 'placing', 'speak', 'valve', 'cap', 'consider', 'aerosol', 'generate', 'airborne', 'precaution', 'warrant', '', 'however', '', 'speak', 'valve', 'place', 'tracheostomy', 'cap', '', 'aerosolization', 'le', 'consideration', 'equivalent', 'patient', 'cough', 'low', 'flow', 'oxygen', 'patient', 'wear', 'mask', 'nose', 'mouth', '', 'decannulation', 'consider', 'aerosol-generating', 'procedure', '', 'provide', 'patient', 'remain', 'infectious', '', 'usual', 'airborne', 'precaution', '', 'repeat', 'test', '', 'institution', 'perform', 'repeat', 'sars-cov-2', 'test', 'determine', 'discontinue', 'infection', 'control', 'precaution', 'inform', 'resource', 'allocation', '', 'whether', 'tracheal', 'nasopharyngeal', 'swab', 'purpose', 'uncertain', '', 'patient', 'test', 'positive', 'test', '', 'continue', 'precaution', 'two', 'test', 'collect', '24', 'hour', 'apart', 'negative', '', 'however', '', 'remain', 'uncertain', 'whether', 'viral', 'rna', 'detection', 'recovery', 'reflect', 'transmissible', 'infection', '', '', 'precautions', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'viral', 'shed', 'period', 'infectivity', '', '', '', '', 'detail', 'regard', 'tracheostomy', 'provide', 'separately', '', '', '', 'overview', 'tracheostomy', '', '', '', 'cardiopulmonary', 'resuscitation', '', 'event', 'cardiac', 'arrest', '', 'cardiopulmonary', 'resuscitation', '', 'cpr', '', 'proceed', 'member', 'team', 'wear', 'appropriate', 'ppe', '', 'practicing', 'test', 'covid-19', 'patient', 'cardiac', 'arrest', 'prudent', '', 'bag-mask', 'ventilation', 'avoid', '', 'feasible', '', '', 'ventilator', 'instead', 'deliver', 'respiratory', 'rate', '10', 'breath', 'per', 'minute', '', 'bpm', '', '', 'guidance', 'advance', 'cardiac', 'life', 'support', 'cpr', 'patient', 'prone', 'return', 'supine', 'position', 'provide', 'separately', '', '', '', 'advanced', 'cardiac', 'life', 'support', '', 'acls', '', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'section', 'patients', 'require', 'cardiopulmonary', 'resuscitation', '', 'cpr', '', '', '', 'basic', 'life', 'support', '', 'bls', '', 'adult', '', '', '', 'intervention', '', 'guidance', 'regard', 'procedure', 'commonly', 'perform', 'icu', '', 'intubate', 'patient', 'routine', 'indication', 'central', 'venous', 'arterial', 'access', 'monitor', 'vasoactive', 'drug', 'infusion', '', 'grouping', 'standard', 'procedure', 'central', 'venous', 'catheter', 'arterial', 'immediately', 'follow', 'intubation', 'appropriate', 'minimize', 'frequency', 'exposure', '', 'transmission', 'risk', 'blood', 'unknown', 'likely', 'low', '', '72', '', '', 'significant', 'pleural', 'effusion', 'barotrauma', 'appear', 'unusual', 'manifestation', 'covid-19', '', 'general', '', 'emergently', 'indicate', 'procedure', 'intervention', 'perform', 'indicate', '', 'appropriate', 'infectious', 'precaution', '', '', 'clinical', 'feature', 'critically', 'ill', 'patient', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'manifestation', '', '', 'safety', 'operate', 'room', '', '', 'section', 'covid-19', '', '', '', 'transfer', 'covid-19', 'patient', 'limit', 'necessary', 'trip', '', 'eg', '', 'image', 'diagnosis', 'change', 'management', '', 'travel', 'airborne', 'isolation', 'room', 'high', 'risk', 'aerosol-generating', 'procedure', 'intubation', 'extubation', '', '', 'supportive', 'care', '', 'general', 'supportive', 'care', 'critically', 'ill', 'patient', 'covid-19', 'pneumonia', 'similar', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'due', 'cause', 'discuss', 'detail', 'separately', '', 'select', 'issue', 'pertinent', 'covid-19', 'discuss', 'section', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'supportive', 'care', '', '', '', 'routine', 'measure', '', 'supportive', 'care', 'mechanically', 'ventilate', 'patient', 'apply', 'patient', 'covid-19', 'provide', 'several', 'link', 'topic', '', 'however', '', 'potential', 'difference', 'pertain', 'covid-19', 'patient', 'discuss', 'section', '', 'venous', 'thromboembolism', 'prevention', '', 'agree', 'american', 'society', 'hematology', 'society', 'critical', 'care', 'medicine', 'routine', 'pharmacologic', 'venous', 'thromboembolism', '', 'vte', '', 'prophylaxis', 'warrant', '', 'preferably', 'low', 'molecular', 'weight', 'heparin', '', 'lmwh', '', 'eg', '', 'enoxaparin', '40', 'mg', 'sc', 'daily', '', '', 'unless', 'contraindication', '', 'eg', '', 'bleed', '', 'severe', 'thrombocytopenia', '', '', '', '', 'prevention', 'venous', 'thromboembolic', 'disease', 'acutely', 'ill', 'hospitalize', 'medical', 'adult', '', '', '', 'risk', 'vte', 'appear', 'higher', 'usual', 'population', '', 'aggressive', 'vte', 'prophylaxis', 'form', 'increase', 'intensity', 'pharmacologic', 'agent', '', 'eg', '', 'enoxaparin', '05', 'mgkg', 'every', '12', 'hour', '', 'unfractionated', 'heparin', '7500', 'unit', 'every', 'eight', 'hour', '', 'andor', 'addition', 'mechanical', 'device', 'prudent', '', 'markedly', 'elevate', 'd-dimer', 'level', '', 'correlate', 'poor', 'prognosis', '', 'expert', 'guide', 'intensification', 'anticoagulation', '', 'eg', '', '', '6', 'time', 'upper', 'limit', 'normal', '', '', 'patient', 'creatinine', 'clearance', '', '30', 'mlminute', '', 'enoxaparin', 'reduce', '30', 'mg', 'daily', 'change', 'unfractionated', 'heparin', 'depend', 'severity', 'kidney', 'impairment', 'patient', 'weight', '', 'fondaparinux', 'appropriate', 'heparin-induced', 'thrombocytopenia', '', 'believe', 'administer', 'therapeutic', 'anticoagulation', '', 'form', 'prophylaxis', '', 'assess', 'individual', 'basis', '', 'however', 'indication', 'therapeutic', 'anticoagulation', '', 'outside', 'document', 'vte', '', 'unclear', 'include', 'presume', 'vte', '', 'eg', '', 'sudden', 'unexplained', 'deterioration', 'oxygenation', 'hemodynamic', 'instability', '', 'acute', 'cor', 'pulmonale', '', 'clot', 'vascular', 'device', '', 'eg', '', 'venous', '', 'arterial', 'device', '', 'hemodialysis', 'device', '', '', 'detailed', 'description', 'vte', 'risk', 'management', 'covid-19', 'patient', 'hypercoagulability', 'provide', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'sedation', 'analgesia', '', 'anecdotal', 'evidence', 'suggest', 'requirement', 'sedation', 'analgesia', 'appear', 'high', 'mechanically', 'ventilate', 'patient', 'covid-19', 'heavy', 'sedative', 'analgesic', 'medication', 'require', 'ventilator', 'synchrony', '', 'practice', '', 'target', 'richmond', 'agitation-sedation', 'scale', '', 'rass', '', 'table', '9', '', '', '-1', '-2', '', 'similar', 'different', 'score', 'system', '', '', 'patient', 'ventilator', 'dyssynchrony', '', 'rass', '-2', '-3', '', 'rass', '-4', '-5', 'target', 'severe', 'dyssynchrony', 'require', 'neuromuscular', 'blockade', '', 'require', 'intravenous', '', 'iv', '', 'infusion', '', 'propofol', 'fentanyl', 'generally', 'prefer', 'agent', '', 'however', '', 'shortage', 'sedative', 'influence', 'choice', 'agent', '', 'quickly', 'transition', 'oral', 'medication', '', 'provide', 'fluid', 'resuscitation', 'adequate', '', 'eg', '', 'oxycodone', '', 'hydromorphone', '', 'lorazepam', '', 'diazepam', '', '', 'detail', 'regard', 'indication', '', 'daily', 'awaken', '', 'protocol', '', 'dose', 'provide', 'separately', '', '', '', 'sedative-analgesic', 'medication', 'critically', 'ill', 'adult', '', 'selection', '', 'initiation', '', 'maintenance', '', 'withdrawal', '', '', 'sedative-analgesic', 'medication', 'critically', 'ill', 'adult', '', 'properties', '', 'dosage', 'regimen', '', 'adverse', 'effect', '', '', 'pain', 'control', 'critically', 'ill', 'adult', 'patient', '', '', '', 'others', '', 'supportive', 'measure', 'include', 'herenutritional', 'support', '', 'principle', 'nutrition', 'non', 'covid-19', 'critically', 'ill', 'patient', 'apply', 'critically-ill', 'covid-19', 'patient', '', 'proponent', 'extra', 'protein', 'supplementation', '', 'vitamin', 'c', 'supplementation', '', 'trace', 'element', 'supplementation', 'usual', 'recommend', 'daily', '', '', '', 'nutrition', 'support', 'critically', 'ill', 'patient', '', 'overview', '', '', 'nutrition', 'support', 'critically', 'ill', 'patient', '', 'enteral', 'nutrition', '', '', 'nutrition', 'support', 'critically', 'ill', 'patient', '', 'parenteral', 'nutrition', '', '', '', 'glucose', 'control', '', '', '', 'glycemic', 'control', 'intensive', 'insulin', 'therapy', 'critical', 'illness', '', '', '', 'stress', 'ulcer', 'prophylaxis', '', '', '', 'stress', 'ulcer', 'intensive', 'care', 'unit', '', 'diagnosis', '', 'management', '', 'prevention', '', '', 'management', 'stress', 'ulcer', '', '', '', 'hemodynamic', 'monitor', '', '', '', 'pulmonary', 'artery', 'catheterization', '', 'indications', '', 'contraindication', '', 'complication', 'adult', '', '', 'pulmonary', 'artery', 'catheterization', '', 'interpretation', 'hemodynamic', 'value', 'waveform', 'adult', '', '', 'novel', 'tool', 'hemodynamic', 'monitor', 'critically', 'ill', 'patient', 'shock', '', '', '', 'fever', 'management', '', '', '', 'fever', 'intensive', 'care', 'unit', '', '', 'section', 'outcomes', '', '', '', 'early', 'physical', 'therapy', '', '', '', 'post-intensive', 'care', 'syndrome', '', 'pics', '', '', '', 'section', 'prevention', 'treatment', '', '', '', 'ventilator-associated', 'pneumonia', 'precaution', '', '', '', 'risk', 'factor', 'prevention', 'hospital-acquired', 'ventilator-associated', 'pneumonia', 'adult', '', '', '', 'monitoring', 'complication', '', 'critically', 'ill', 'patient', 'covid-19', 'follow', 'routinely', 'development', 'complication', 'associate', 'critical', 'illness', 'covid-19', 'extrapulmonary', 'manifestation', 'sars-cov-2', 'infection', '', 'essential', 'personnel', 'enter', 'room', 'infect', 'patient', 'perform', 'daily', 'examination', '', 'care', '', 'procedure', '', 'common', 'complication', 'include', 'acute', 'kidney', 'injury', '', 'mild', 'transaminitis', '', 'cardiomyopathy', '', 'pericarditis', '', 'pericardial', 'effusion', '', 'arrhythmia', '', 'sudden', 'cardiac', 'death', '', 'superinfection', '', 'eg', '', 'ventilator-associated', 'pneumonia', '', 'vap', '', '', '', 'clinical', 'feature', 'complication', '', '', '', 'suggest', 'daily', 'laboratory', 'study', 'include', 'complete', 'blood', 'count', 'differential', '', 'chemistry', '', 'liver', 'function', 'coagulation', 'study', '', 'arterial', 'blood', 'gas', '', 'ferritin', 'level', '', 'd-dimer', 'level', '', 'lactate', 'dehydrogenase', '', 'serial', 'measurement', 'cardiac', 'troponins', 'low', 'threshold', 'transthoracic', 'echocardiogram', 'helpful', 'evaluate', 'suspect', 'cardiac', 'injurydaily', 'chest', 'radiograph', 'recommend', 'routinely', 'mechanically', 'ventilate', 'patient', 'without', 'covid-19', '', 'patient', 'covid-19', 'mechanically', 'ventilate', '', 'chest', 'radiograph', 'perform', 'indication', '', 'eg', '', 'catheter-', 'endotracheal', 'tube', '', 'ett', '', '-placement', 'relevant', 'clinical', 'change', '', '', 'chest', 'compute', 'tomography', 'image', 'limit', 'test', 'change', 'management', '', 'rationale', 'base', 'upon', 'increase', 'risk', 'viral', 'shed', 'procedure', 'require', 'transfer', 'intensive', 'care', 'unit', '', 'icu', '', '', '', '', 'complications', 'endotracheal', 'tube', 'follow', 'initial', 'placement', '', 'prevention', 'management', 'adult', 'intensive', 'care', 'unit', 'patient', '', '', 'section', 'reassessment', 'position', '', '', '', 'fluid', 'electrolyte', 'management', '', 'unless', 'patient', 'sepsis', 'volume', 'depletion', 'high', 'fever', 'gastrointestinal', 'loss', '', 'prefer', 'conservative', 'fluid', 'management', 'typical', 'advise', 'patient', 'ards', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'fluid', 'management', '', '', 'evaluation', 'management', 'suspect', 'sepsis', 'septic', 'shock', 'adult', '', '', 'section', 'intravenous', 'fluid', '', 'first', 'three', 'hour', '', '', '', 'treatment', 'severe', 'hypovolemia', 'hypovolemic', 'shock', 'adult', '', '', '', 'management', 'patient', 'present', 'septic', 'shock', 'due', 'covid-19', 'similar', 'patient', 'septic', 'shock', 'cause', '', '', '', 'evaluation', 'management', 'suspect', 'sepsis', 'septic', 'shock', 'adult', '', '', '', 'glucocorticoids', '', 'agree', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'world', 'health', 'organization', '', '', 'glucocorticoid', 'routinely', 'administer', 'patient', 'covid-19', '', 'unless', 'separate', 'evidence-based', 'indication', '', 'eg', '', 'asthma', 'chronic', 'obstructive', 'lung', 'disease', 'exacerbation', '', 'refractory', 'septic', 'shock', '', 'adrenal', 'insufficiency', '', '', 'however', '', 'administration', 'critically', 'ill', 'patient', 'covid-19-related', 'ards', 'controversial', '', 'based', 'data', 'suggest', 'potential', 'benefit', 'glucocorticoid', 'patient', 'all-cause', 'ards', '', 'society', 'critical', 'care', 'medicine', '', 'sccm', '', 'provide', 'conditional', '', 'weak', 'recommendation', 'favor', 'glucocorticoid', 'patient', 'covid-19', 'severe', 'ards', '', 'eg', '', 'patient', 'partial', 'arterial', 'pressure', 'oxygenfraction', 'inspire', 'oxygen', '', 'pao2', '', 'fio2', '', '', '100', 'mmhg', '', '', 'although', 'weakly', 'recommend', 'glucocorticoid', 'moderate', 'severe', '', 'cause', '', 'ards', '', 'ie', '', 'non', 'covid-19-related', 'ards', '', 'fail', 'low', 'tidal', 'volume', 'ventilation', '', 'suggest', 'administer', 'routinely', 'set', 'covid-19', 'ards', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'glucocorticoids', '', '', '', 'rationale', 'administer', 'glucocorticoid', 'population', 'data', 'support', 'benefit', 'include', 'sufficient', 'proportion', 'patient', 'viral', 'pneumonia', 'inform', 'safety', '', 'eg', '', 'patient', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '', 'influenza', '', '', 'especially', 'important', 'since', 'data', 'patient', 'ards', 'due', 'viral', 'pneumonia', 'conflict', 'suggest', 'harm', '', '75-78', '', '', 'clinician', 'choose', 'administer', 'glucocorticoid', '', 'sccm', 'suggest', 'begin', 'within', 'first', '14', 'day', '', 'low', '', 'course', 'short', '', 'eg', '', 'intravenous', 'dexamethasone', '20', 'mg', 'iv', 'daily', 'five', 'day', '', '10', 'mg', 'daily', 'five', 'day', '', '', 'data', 'covid-19', 'patient', 'limit', 'single', 'retrospective', 'chinese', 'cohort', '', 'methylprednisolone', 'administration', 'reduce', 'risk', 'death', 'patient', 'covid-19', 'compare', 'patient', 'receive', 'methylprednisolone', '', 'hazard', 'ratio', '', 'hr', '', '038', '', '95', '', 'ci', '02-071', '', '', '25', '', '', 'however', '', 'data', 'fundamentally', 'flaw', 'new', 'data', 'gather', 'prospectively', 'shed', 'light', 'controversial', 'issue', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'limited', 'role', 'glucocorticoid', '', '', '', 'note', '', 'management', 'patient', 'present', 'shock', 'due', 'covid-19', 'similar', 'patient', 'septic', 'shock', 'cause', '', 'fluid', 'electrolyte', 'management', '', '', '', 'low', 'dose', 'glucocorticoid', 'routinely', 'advise', 'septic', 'shock', '', 'set', 'covid-19', 'shock', '', 'reserve', 'low', 'dose', 'glucocorticoid', '', 'eg', '', 'hydrocortisone', '200', '400', 'mgday', 'divide', '', 'select', 'patient', 'refractory', 'shock', '', 'accordance', 'guideline', '', '7', '', '', 'low', 'dose', 'glucocorticoid', 'routinely', 'advise', 'non-refractory', 'septic', 'shock', '', 'glucocorticoid', 'septic', 'shock', 'discuss', 'separately', '', '', '', 'glucocorticoid', 'therapy', 'septic', 'shock', 'adult', '', '', 'section', 'administration', '', '', '', 'nebulized', 'medication', '', 'nebulization', 'consider', 'aerosol-generating', 'procedure', '', 'patient', 'covid-19', 'intubate', 'require', 'bronchodilator', 'evidence-based', 'indication', '', 'eg', '', 'acute', 'bronchospasm', 'asthma', 'chronic', 'obstructive', 'lung', 'disease', 'exacerbation', '', '', 'prefer', 'in-line', 'meter', 'dose', 'inhaler', '', 'mdis', '', 'ie', '', 'pressurize', 'inhaler', '', 'administration', 'via', 'standard', 'jet', 'vibrate', 'mesh', 'nebulizer', 'due', 'lower', 'risk', 'aerosolization', 'associate', 'mdis', '', '7980', '', '', 'medication', 'administer', 'via', 'nebulizer', '', 'consideration', 'give', 'stop', 'medication', 'essential', 'acute', 'care', '', 'eg', '', 'inhale', 'colistin', 'patient', 'bronchiectasis', '', 'mdi', 'alternative', '', 'available', 'formulary', '', 'eg', '', 'tobramycin', 'capsule', 'inhaler', '', '', 'consideration', 'give', 'patient', 'supply', 'mdis', 'formulary', '', 'placement', 'filter', 'expiratory', 'port', 'ventilation', 'circuit', 'nebulization', 'prudent', 'minimize', 'aerosolization', 'room', '', 'ideally', '', 'patient', 'require', 'nebulizer', '', 'airborne', 'infection', 'isolation', 'room', '', 'healthcare', 'staff', 'necessary', 'nebulizer', 'administration', '', 'eg', '', 'respiratory', 'therapist', 'nurse', '', 'room', 'initiation', 'procedure', 'airborne', 'precaution', 'similar', 'intubation', '', '', 'decision', 'intubate', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', 'investigational', 'covid-19', 'agent', '', 'several', 'investigational', 'agent', 'propose', 'individual', 'institution', 'work', 'pharmacist', 'clinical', 'researcher', 'enroll', 'patient', 'clinical', 'trial', '', 'suggest', 'development', 'protocol', 'individual', 'icus', 'off-label', 'investigational', 'agent', '', 'area', 'rapidly', 'evolve', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'management', 'co-infections', 'comorbidities', '', 'critically', 'ill', 'patient', 'covid-19', 'intubate', 'risk', 'develop', 'vap', 'infection', 'typical', 'critically', 'ill', 'andor', 'intubate', 'patient', '', 'eg', '', 'central', 'urinary', 'tract', 'infection', '', '', 'treat', 'co-infections', '', 'potential', 'drug', 'interaction', 'investigational', 'covid-19', 'agent', 'assess', '', 'infectious', 'disease', 'expert', 'involve', 'early', 'management', 'covid-19', 'patient', 'critically', 'ill', 'detail', 'regard', 'management', 'chronic', 'medication', 'include', 'nonsteroidal', 'anti-inflammatory', 'angiotensin', 'receptor', 'inhibitor', 'provide', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'uncertainty', 'nsaid', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'managing', 'chronic', 'medication', '', '', '', 'special', 'populations', '', 'specific', 'recommendation', 'pregnant', 'woman', 'critically-ill', 'covid-19', 'pneumonia', '', 'management', 'similar', 'uninfected', 'patient', '', 'issues', 'regard', 'transmission', 'risk', 'acquire', 'sars-cov-2', 'pregnant', 'woman', 'describe', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'pregnant', 'breastfeed', 'woman', '', '', 'critical', 'illness', 'pregnancy', 'peripartum', 'period', '', '', 'acute', 'respiratory', 'failure', 'pregnancy', 'peripartum', 'period', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', 'patient', 'sickle', 'cell', 'disease', 'critically-ill', 'covid-19', 'acute', 'chest', 'syndrome', 'contribute', 'illness', '', 'consideration', 'early', 'exchange', 'transfusion', 'surveillance', 'development', 'acute', 'pulmonary', 'hypertension', 'prudent', '', '81', '', '', '', '', 'acute', 'chest', 'syndrome', 'adult', 'sickle', 'cell', 'disease', '', '', 'section', 'covid-19', '', '', '', 'issues', 'arise', 'population', 'provide', 'follow', 'link', '', 'renal', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'cardiac', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'infarction', 'coronary', 'artery', 'disease', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', 'airway', 'management', 'operate', 'room', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', 'cancer', 'care', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', 'prognosismortality', '', 'early', 'data', 'emerge', 'describe', 'outcome', 'covid-19', 'critically', 'ill', 'patient', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', '28-10212224-26', '', '', 'mortality', 'appear', 'lower', 'patient', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars-cov', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '', 'mortality', 'covid-19', 'appear', 'drive', 'presence', 'severe', 'ards', '', 'approximately', '50', 'percent', '', 'range', '16', '78', 'percent', '', 'single-center', 'retrospective', 'cohort', '52', 'critically', 'ill', 'chinese', 'patient', 'covid-19', '', '62', 'percent', 'die', '28', 'day', 'median', 'duration', 'seven', 'day', 'intensive', 'care', 'unit', '', 'icu', '', 'admission', 'death', '', '9', '', '', 'among', '20', 'patient', 'survive', '', 'three', 'remain', 'mechanical', 'ventilation', '', 'three', 'receive', 'noninvasive', 'mechanical', 'ventilation', 'high', 'flow', 'oxygen', 'via', 'nasal', 'cannulae', '', 'hfnc', '', '', 'six', 'receive', 'low', 'flow', 'oxygen', '', 'retrospective', 'cohort', '201', 'chinese', 'patient', 'covid-19', '', 'mortality', '52', 'percent', 'among', 'develop', 'ards', '', '25', '', '', 'among', 'receive', 'mechanical', 'ventilation', '', '66', 'percent', 'die', '', '21', 'percent', 'discharge', '13', 'percent', 'remain', 'hospitalize', '', 'preliminary', 'study', '21', 'critically', 'ill', 'patient', 'united', 'states', '', 'day', '5', '', '67', 'percent', 'critically', 'ill', 'patient', 'die', '', '24', 'percent', 'remain', 'critically', 'ill', '', '95', 'percent', 'discharge', 'icu', '', '19', '', '', 'italian', 'cohort', '1591', 'patient', '', 'icu', 'morality', '26', 'percent', '', 'significant', 'proportion', 'remain', 'icu', 'time', 'publication', '', 'underestimate', 'true', 'mortality', '', '22', '', '', 'higher', 'mortality', 'initially', 'report', 'male', 'compare', 'female', 'due', 'predominance', 'male', 'affect', 'covid-19', 'chinese', 'cohort', '', '8-102526', '', '', 'similar', 'difference', 'note', 'preliminary', 'report', 'italy', 'washington', 'state', '', 'usa', '', '1819', '', '', 'risk', 'factor', 'death', '', 'across', 'country', '', 'consistent', 'major', 'risk', 'factor', 'associate', 'death', 'critically', 'ill', 'patient', 'covid-19', 'older', 'age', '', '91017202224258283', '', '', 'two', 'chinese', 'retrospective', 'cohort', '', 'death', 'ards', 'likely', 'occur', 'older', 'age', '64', 'year', '', 'hazard', 'ratio', '', 'hr', '', '617', '', '95', '', '326-1167', '', '', '925', '', '', 'preliminary', 'report', 'italy', 'united', 'states', 'report', 'similar', 'outcome', '', '171820', '', '', 'risk', 'factor', 'associate', 'death', 'among', 'critically', 'ill', 'patient', 'include', 'follow', '', '910172022242584', '', '', 'development', 'ards', '', 'particularly', 'severe', 'ards', '', 'mechanical', 'ventilationcomorbidities', '', 'eg', '', 'chronic', 'cardiac', 'pulmonary', 'condition', '', 'hypertension', '', 'diabetes', '', 'chronic', 'kidney', 'disease', '', 'markers', 'inflammation', 'coagulation', '', 'eg', '', 'd-dimer', 'level', '', '1', 'microgml', 'admission', '', 'elevate', 'fibrin', 'degradation', 'product', '', 'prolong', 'activate', 'partial', 'thromboplastin', 'prothrombin', 'time', '', 'select', 'laboratory', 'study', '', 'eg', '', 'worsen', 'lymphopenia', '', 'neutrophilia', '', 'rapidity', 'symptom', 'progression', 'appear', 'predict', 'worse', 'outcome', '', '9', '', 'high', 'fever', 'associate', 'higher', 'likelihood', 'develop', 'ards', '', 'hr', '177', '', '95', '', 'ci', '111-284', '', '', 'appear', 'associate', 'lower', 'likelihood', 'death', '', 'hr', '041', '', '95', '', 'ci', '021-082', '', '', '925', '', '', 'phenomenon', 'note', 'previously', 'critically', 'ill', 'patient', '', '', '', 'fever', 'intensive', 'care', 'unit', '', '', 'section', 'outcomes', '', '', '', 'detail', 'risk', 'factor', 'associate', 'severe', 'disease', 'provide', 'separately', '', '', 'risk', 'factor', 'progression', '', '', '', 'long', 'term', 'sequela', '', 'percentage', 'patient', 'require', 'long', 'term', 'care', 'unreported', '', 'similarly', '', 'incidence', 'critical', 'care', 'neuromyopathy', 'yet', 'document', '', 'experience', 'rate', 'higher', 'usual', 'due', 'prolong', 'nature', 'intubation', 'covid-19', 'patient', 'higher', 'neuromuscular', 'blockade', 'sedative', '', 'without', 'concurrent', 'glucocorticoid', 'administration', '', '', '', 'neuromuscular', 'weakness', 'relate', 'critical', 'illness', '', '', '', 'incidence', 'post-intensive', 'care', 'unit', 'syndrome', '', 'pics', '', 'unknown', 'covid-19', 'patient', '', 'nonetheless', '', 'patient', 'follow', 'treat', 'pics', 'involve', 'nutritional', '', 'physical', '', 'psychological', '', 'occupational', 'therapy', '', '', '', 'post-intensive', 'care', 'syndrome', '', 'pics', '', '', '', '', 'end', 'life', 'issues', '', 'public', 'health', 'emergency', '', 'value', 'autonomy', 'predominate', '', 'like', 'critical', 'illness', '', 'severe', 'illness', 'due', 'covid-19', 'carry', 'potential', 'significant', 'psychosocial', 'distress', 'patient', '', 'family', '', 'surrogate', '', 'addition', '', 'unique', 'aspect', 'covid-19', 'management', 'portend', 'greater', 'trauma', 'include', 'anxiety', 'stigma', 'surround', 'novel', 'pathogen', 'high-level', 'isolation', 'precaution', 'include', 'visitation', 'limitation', 'prohibition', 'include', 'end', 'life', '', 'high', 'level', 'patient', '', 'family', '', 'surrogate', 'psychosocial', 'distress', 'anticipate', 'combat', 'clear', 'communication', 'strategy', 'early', 'palliative', 'care', 'involvement', '', 'in-person', 'visitation', 'allow', 'due', 'public', 'health', 'care', 'concern', '', 'hospital', 'promote', 'internet', 'base', 'visual', 'communication', 'video', 'communication', 'clinician', '', 'family', '', 'isolate', 'patient', '', 'discussing', 'end-of-life', 'wish', 'patient', 'family', 'occur', 'early', 'course', 'management', '', 'include', 'potentially', 'diagnosis', '', 'especially', 'light', 'poor', 'outcome', 'elderly', 'patient', 'comorbidities', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'require', 'mechanical', 'ventilation', '', 'consultation', 'palliative', 'care', 'team', 'ethic', 'expert', 'assist', 'family', 'decision-making', 'assist', 'clinician', 'contentious', 'issue', 'disagreement', 'arise', '', 'due', 'unique', 'aspect', 'address', 'patient', 'family', 'pandemic', '', 'several', 'online', 'resource', 'available', 'clinician', 'covid-19', 'specific', 'discussion', 'patient', 'family', '', 'provide', 'helpful', 'language', 'strategy', 'conversation', 'range', 'issue', 'include', '', 'limit', '', 'triaging', '', 'discuss', 'goal', 'care', '', 'resource', 'allocation', '', 'grieve', 'include', '', 'viitaltalk', 'center', 'advance', 'palliative', 'care', 'national', 'coalition', 'hospice', 'palliative', 'care', 'principle', 'regard', 'ethical', 'issue', 'intensive', 'care', 'unit', '', 'icu', '', 'advance', 'care', 'plan', 'discuss', 'separately', '', '', '', 'ethics', 'intensive', 'care', 'unit', '', 'responding', 'request', 'potentially', 'inappropriate', 'therapy', 'adult', '', '', 'ethics', 'intensive', 'care', 'unit', '', 'informed', 'consent', '', '', 'withholding', 'withdraw', 'ventilatory', 'support', 'adult', 'intensive', 'care', 'unit', '', '', 'communication', 'icu', '', 'holding', 'family', 'meet', '', '', 'palliative', 'care', '', 'issues', 'intensive', 'care', 'unit', 'adult', '', '', 'advance', 'care', 'plan', 'advance', 'directive', '', '', 'section', 'covid-19', 'resource', '', '', '', 'discharge', 'long', 'term', 'care', '', 'patient', 'extubate', 'successfully', 'safely', 'discharge', 'home', '', 'routine', 'community', 'precaution', 'apply', '', 'patient', 'require', 'tracheostomy', 'deconditioned', 'critical', 'illness', '', 'transfer', 'long', 'term', 'acute', 'care', '', 'ltac', '', 'facility', 'typical', '', 'however', '', 'guidance', 'whether', 'patient', 're-tested', '', '', '', 'ltacs', 'require', 'two', 'negative', 'sars-cov-2', 'rt-pcr', 'test', 'perform', '24', 'hour', 'apart', 'accept', 'patient', 'covid-19', '', 'positive', 'test', 'delay', 'transfer', 'ltac', '', 'continue', 'infection', 'control', 'precaution', 'advise', '', 'rehab', 'wean', 'begin', 'acute', 'care', 'facility', '', 'discontinuation', 'infection', 'control', 'precaution', 'discuss', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', '', 'outcomes', 'patient', 'require', 'long', 'term', 'care', 'unknown', '', 'treatment', 'patient', 'require', 'admission', 'ltac', 'similar', 'non-covid', 'patient', '', 'particular', 'attention', 'pay', 'continue', 'venous', 'thromboembolism', 'prophylaxis', 'acute', 'illness', 'fully', 'resolve', 'patient', 'become', 'mobile', '', 'although', 'efficacy', 'approach', 'unknown', '', 'duration', 'therapeutic', 'anticoagulation', 'guide', 'indication', '', 'example', '', 'minimum', 'three', 'month', 'document', 'presume', 'vte', 'appropriate', 'shorter', 'duration', 'reasonable', 'device', 'thrombosis', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', 'management', 'patient', 'require', 'long', 'term', 'mechanical', 'ventilation', 'discuss', 'separately', '', '', '', 'management', 'prognosis', 'patient', 'require', 'prolong', 'mechanical', 'ventilation', '', '', '', 'surge', 'capacity', 'scarce', 'resource', 'allocation', '', 'covid-19', 'global', 'pandemic', 'place', 'significant', 'increase', 'demand', 'acute', 'critical', 'care', 'service', 'hospital', 'region', '', 'necessitate', 'operation', 'maneuver', 'increase', 'capacity', 'able', 'provide', 'care', 'patient', '', 'higher', 'acuity', 'patient', 'require', 'intensive', 'care', 'unit', '', 'icu', '', 'admission', 'mechanical', 'ventilation', '', 'patient', 'special', 'isolation', 'requirement', '', 'surge', 'capacity', 'achieve', 'maximize', 'resource', 'across', 'three', 'domain', '', 'care', 'space', '', 'ie', '', 'bed', '', 'staffphysical', 'equipmentin', 'covid-19', 'pandemic', '', 'include', 'expand', 'icu', 'care', 'non-icu', 'space', '', 'utilize', 'non-critical', 'care', 'train', 'staff', 'participate', 'deliver', 'critical', 'care', '', 'innovative', 'approach', 'obtain', '', 'conserve', '', 'increase', 'efficiency', 'physical', 'equipment', 'include', 'personal', 'protective', 'equipment', '', 'ppe', '', 'eg', '', 'repeat', 'n95', 'mask', '', 'mechanical', 'ventilator', '', 'eg', '', 'double', 'ventilation', '', 'repurposing', 'operate', 'room', 'ventilator', '', '', 'example', '', 'expert', 'publish', 'preliminary', 'data', 'highlight', 'one', 'ventilator', 'multiple', 'patient', '', '85', '', '', 'however', '', 'maneuver', 'design', 'disaster', 'set', 'one', 'reasonably', 'expect', 'several', 'patient', 'life', 'support', 'similar', 'level', '', 'measure', 'life-saving', 'measure', 'patient', 'covid-19', 'complicate', 'patient', 'match', 'well', 'term', 'ventilator', 'set', '', 'potential', 'anesthesia', 'ventilator', 'longer-term', 'mechanical', 'ventilation', 'provide', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'intensive', 'care', 'ventilation', 'anesthesia', 'machine', '', '', '', 'instance', '', 'italy', '', 'despite', 'mobilize', 'surge', 'capacity', '', 'demand', 'care', 'still', 'outpace', 'supply', 'overt', 'ration', 'occur', '', '86', '', '', 'hospital', 'face', 'potential', 'acute', 'surge', 'event', 'due', 'covid-19', 'another', 'insult', 'process', 'approach', 'allocation', 'scarce', 'resource', 'icu', 'bed', 'mechanical', 'ventilator', '', 'individual', 'state', 'united', 'states', 'guidance', 'document', 'adapt', 'local', 'institution', '', '87', '', '', 'general', 'principle', 'guide', 'underpin', 'scarce', 'resource', 'allocation', 'policy', 'include', '', 'maximization', 'life', 'save', 'andor', 'life-years', 'savedtransparency', 'stakeholder', 'public', 'inputseparation', 'clinical', 'team', 'triage', 'process', '', 'eg', '', 'ethic', 'committee', 'difficult', 'triage', 'decision', '', 'robust', 'palliative', 'care', 'supportive', 'measure', 'patient', 'provide', 'critical', 'care', 'resourcessociety', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'summary', 'recommendationsamong', 'patient', 'hospitalize', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'one-quarter', 'require', 'intensive', 'care', 'unit', '', 'icu', '', 'admission', '', '', '', 'epidemiology', '', '', '', 'profound', 'hypoxemic', 'respiratory', 'failure', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'dominant', 'find', 'critically', 'ill', 'patient', '', 'common', 'complication', 'include', 'acute', 'kidney', 'injury', '', 'aki', '', '', 'elevate', 'liver', 'enzyme', '', 'late', 'development', 'cardiac', 'injury', '', 'include', 'sudden', 'cardiac', 'death', '', 'sepsis', '', 'shock', '', 'multi-organ', 'failure', 'le', 'common', '', '', 'clinical', 'feature', 'critically', 'ill', 'patient', '', '', '', 'critically', 'ill', 'patient', 'covid-19', '', 'prefer', 'lowest', 'possible', 'fraction', 'inspire', 'oxygen', '', 'fio2', '', 'necessary', 'meet', 'oxygenation', 'goal', '', 'ideally', 'target', 'peripheral', 'oxygen', 'saturation', '90', '96', 'percent', '', '', 'respiratory', 'care', 'nonintubated', 'patient', '', 'oxygenation', 'target', '', 'low', 'flow', 'oxygen', '', '', '', 'high-flow', 'oxygen', 'via', 'nasal', 'cannulae', '', 'hfnc', '', 'noninvasive', 'ventilation', '', 'niv', '', 'controversial', 'base', 'infection', 'control', 'concern', 'frequent', 'mechanical', 'ventilation', 'despite', 'measure', '', 'decision', 'initiate', 'noninvasive', 'modality', 'require', 'balance', 'risk', 'benefit', 'patient', '', 'risk', 'exposure', 'healthcare', 'worker', '', 'best', 'resource', '', 'approach', 'reassess', 'new', 'data', 'become', 'available', '', '', 'patients', 'higher', 'oxygen', 'requirement', '', '', '', 'patient', 'covid-19', 'acute', 'hypoxemic', 'respiratory', 'failure', 'higher', 'oxygen', 'low', 'flow', 'oxygen', 'provide', '', 'suggest', 'selective', 'noninvasive', 'measure', 'routinely', 'proceed', 'directly', 'intubation', '', 'grade', '2c', '', '', 'example', 'trial', 'hfnc', 'younger', 'patient', 'without', 'comorbidities', 'tolerate', 'nasal', 'cannulae', '', 'contrast', '', 'proceed', 'directly', 'early', 'intubation', 'patient', 'higher', 'risk', '', 'eg', '', 'elderly', 'patient', 'patient', 'comorbidities', 'risk', 'factor', 'progression', '', '', 'among', 'noninvasive', 'modality', 'suggest', 'hfnc', 'niv', '', 'grade', '2c', '', '', 'preference', 'hfnc', 'base', 'upon', 'limit', 'inconsistent', 'data', '', '', 'balance', '', 'favor', 'hfnc', 'compare', 'niv', 'hfnc', 'patient', 'non-covid-19-related', 'acute', 'hypoxemic', 'respiratory', 'failure', '', 'niv', 'via', 'full', 'face', 'mask', '', 'seal', '', 'appropriate', 'patient', 'indication', 'prove', 'efficacy', 'include', 'acute', 'hypercapnic', 'respiratory', 'failure', 'acute', 'exacerbation', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'acute', 'cardiogenic', 'pulmonary', 'edema', '', 'sleep', 'disorder', 'breathe', '', '', '', 'heated', 'humidify', 'high-flow', 'nasal', 'oxygen', 'adult', '', 'practical', 'consideration', 'potential', 'application', '', '', 'section', 'medical', 'patient', 'severe', 'hypoxemic', 'respiratory', 'failure', '', '', 'noninvasive', 'ventilation', 'adult', 'acute', 'respiratory', 'failure', '', 'benefits', 'contraindication', '', '', 'section', 'patients', 'likely', 'benefit', '', '', '', 'patient', 'covid-19', 'receive', 'hfnc', 'niv', '', 'vigilant', 'monitor', 'warrant', 'progression', 'frequent', 'clinical', 'arterial', 'blood', 'gas', 'evaluation', 'every', 'one', 'two', 'hour', 'ensure', 'efficacy', 'safe', 'ventilation', '', 'threshold', 'intubate', 'patient', 'low', '', 'attempting', 'prone', 'position', 'appropriate', '', 'critically', 'ill', 'patient', 'covid-19', '', 'intubation', 'delay', 'patient', 'acutely', 'decompensates', 'since', 'potentially', 'harmful', 'patient', 'healthcare', 'worker', '', 'low', 'threshold', 'intubate', '', 'timing', '', '', '', 'rapid', 'progression', 'hoursfailure', 'improve', 'despite', 'hfnc', '', '40', 'lmin', 'fio2', '', '06development', 'hypercapniahemodynamic', 'instability', 'multiorgan', 'failure', 'intubation', 'high', 'risk', 'procedure', 'aerosol', 'dispersion', 'patient', 'covid-19', 'attention', 'pay', 'full', 'personal', 'protective', 'equipment', '', 'ppe', '', 'airborne', 'precaution', '', 'figure', '2', 'figure', '3', '', 'well', 'equipment', 'minimize', 'dispersion', '', 'eg', '', 'video', 'laryngoscopy', '', 'development', 'protocol', 'procedure', '', 'eg', '', 'check', 'list', '', '', 'table', '2', 'figure', '1', '', '', '', 'precautions', '', '', 'safety', 'operate', 'room', '', '', 'section', 'covid-19', '', '', '', 'low', 'tidal', 'volume', 'ventilation', '', 'ltvv', '', 'target', '6', 'mlkg', 'predict', 'body', 'weight', '', 'pbw', '', '', 'range', '4', '8', 'mlkg', 'pbw', '', 'table', '3', 'table', '4', '', '', 'target', 'plateau', 'pressure', '30', 'cm', 'h2o', 'apply', 'positive', 'end-expiratory', 'pressure', '', 'peep', '', 'accord', 'strategy', 'outline', 'table', '', 'table', '5', '', '', 'patient', 'covid-19', 'fail', 'ltvv', '', 'prone', 'ventilation', 'prefer', 'next', 'step', '', 'table', '7', 'table', '6', '', '', '', 'ventilator', 'management', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'ventilator', 'management', 'strategy', 'adult', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'prone', 'ventilation', 'adult', 'patient', 'acute', 'respiratory', 'distress', 'syndrome', '', '', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', 'adult', '', '', '', 'several', 'procedure', '', 'include', 'collection', 'respiratory', 'specimen', '', 'bronchoscopy', '', 'extubation', '', 'tracheostomy', '', 'cardiopulmonary', 'resuscitation', 'aerosol-generating', 'avoid', 'minimize', '', 'possible', '', 'procedure', 'group', 'possible', '', '', 'interventions', '', '', '', 'patients', 'covid-19', 'pneumonia', 'mechanically', 'ventilate', 'ards', 'receive', 'usual', 'daily', 'surveillance', '', 'supportive', 'care', 'include', 'conservative', 'fluid', 'management', '', 'unless', 'patient', 'sepsis', 'volume', 'depletion', '', '', 'table', '1', '', '', 'measurement', 'surveillance', 'cardiac', 'troponins', 'low', 'threshold', 'perform', 'transthoracic', 'echocardiography', 'appropriate', 'early', 'detection', 'cardiac', 'injury', '', '', 'supportive', 'care', '', 'monitoring', 'complication', '', '', '', 'critically', 'ill', 'patient', 'covid-19-induced', 'ards', 'specific', 'indication', '', 'eg', '', 'acute', 'bronchospasm', 'refractory', 'septic', 'shock', '', '', 'suggest', 'administer', 'glucocorticoid', '', 'grade', '2c', '', '', 'rationale', 'administer', 'glucocorticoid', 'population', 'data', 'support', 'benefit', 'non-covd-19', 'population', 'include', 'sufficient', 'proportion', 'patient', 'viral', 'pneumonia', 'inform', 'safety', 'data', 'patient', 'ards', 'due', 'viral', 'pneumonia', '', 'eg', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '', 'influenza', '', 'suggest', 'harm', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'glucocorticoids', '', '', '', 'acute', 'bronchodilation', '', 'prefer', 'in-line', 'meter', 'dose', 'inhaler', '', 'mdis', '', 'administration', 'via', 'standard', 'jet', 'vibrate', 'mesh', 'nebulizer', 'due', 'lower', 'risk', 'aerosolization', 'associate', 'mdis', '', 'individual', 'institution', 'work', 'pharmacy', 'regard', 'compassionate', 'investigational', 'medication', 'trial', 'enrollment', '', 'suggest', 'development', 'protocol', 'individual', 'icus', 'off-label', 'investigational', 'agent', '', '', 'nebulized', 'medication', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'patient', 'covid-19', 'develop', 'ards', '', 'prognosis', 'poor', 'mortality', 'range', '52', '67', 'percent', '', 'highest', 'rate', 'death', 'occur', '64', 'year', '', '', 'prognosis', '', '', '', 'greater', 'level', 'anxiety', 'trauma', 'among', 'patient', 'family', 'anticipate', 'combat', 'clear', 'communication', 'strategy', 'early', 'palliative', 'care', 'involvement', '', 'precautions', 'continue', 'patient', 'continue', 'test', 'positive', 'covid-19', 'discharge', 'long', 'term', 'acute', 'care', 'facility', '', '', 'end', 'life', 'issue', '', 'discharge', 'long', 'term', 'care', '', '', '', 'several', 'measure', 'adopt', 'accommodate', 'surge', 'covid-19', 'case', 'include', 'include', 'expand', 'icu', 'care', 'non-icu', 'space', '', 'utilize', 'non-critical', 'care', 'train', 'staff', 'participate', 'deliver', 'critical', 'care', '', 'innovative', 'approach', 'obtain', '', 'conserve', '', 'increase', 'efficiency', 'physical', 'equipment', '', 'eg', '', 'personal', 'protective', 'equipment', 'mechanical', 'ventilator', '', '', '', 'surge', 'capacity', 'scarce', 'resource', 'allocation', '', '', '']",12353,"{'': 3115, 'patient': 308, 'covid-19': 184, 'care': 105, 'respiratory': 86, 'acute': 85, 'disease': 84, 'eg': 80, 'section': 63, 'adult': 63, 'ventilation': 62, 'coronavirus': 61, 'percent': 58, '2019': 55, 'syndrome': 55, 'management': 54, 'intubation': 53, 'include': 52, 'risk': 52, 'ards': 51}","{'infection': 31, 'sars-cov-2': 14, 'safety': 6, 'il-inhibitor': 2}",53,0.3182
ID:127535,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue']","['INTRODUCTION — Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) virus cause coronavirus disease 2019 ( COVID-19 ) .', 'Information COVID-19 evolve rapidly , interim guidance multiple organization constantly update expand .', 'This topic discus issue relate COVID-19 pregnancy delivery.VIROLOGY AND EPIDEMIOLOGY — General issue regard virology , geographic distribution , route transmission , period infectivity , immunity SARS-CoV-2 review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", ') Vertical transmission address .', ""( See 'Vertical transmission ' ."", ') PREVENTION — Pregnant woman follow recommendation nonpregnant person avoid exposure virus ( eg , social distance , hand hygiene , disinfect surface , wear mask public ) .', 'Women epidemiologic history contact monitor .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Personal preventive measure ' ."", ') Pregnant woman child exercise caution .', 'COVID-19 child often mild may asymptomatic , although severe case report .', 'Given possibility transmission SARS-CoV-2 asymptomatic individual ( presymptomatic individual within incubation period ) [ 1-7 ] , Centers Disease Control Prevention recommend child playdates child household ; remain ≥6 foot people household play outside ; wear cloth face cover public set social distance measure difficult maintain [ 8 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' , section 'Should play date playground avoid ? ' . )"", ""Pregnant health care worker additional concern , standard occupational guidance regard work restriction [ 9,10 ] .Pregnant worker occupation health care may continue work deliver , risk mitigation ( reassignment term role reduce risk exposure self-quarantine ) consider reduce individual 's risk infect peripartum , maternal infection broader implication ( eg , exposure health care worker , infant exposure ) [ 9 ] ."", ""The patient 's comorbidities individual work situation guide clinician 's response request medical leave.CLINICAL MANIFESTATIONS — All pregnant woman monitor development symptom sign COVID-19 , particularly close contact confirm case person investigation ."", 'In systematic review include 356 case pregnant woman ( 33 study ) , frequent symptom fever ( 67 percent ) , cough ( 66 percent ) , dyspnea ( 7 percent ) , sore throat ( 7 percent ) , fatigue ( 7 percent ) , myalgia ( 6 percent ) [ 11 ] .', 'Rhinorrhea/nasal congestion , anorexia , nausea/vomiting , headache , possibly abnormality smell and/or taste also report .', 'Laboratory find include lymphopenia ( 14 percent ) , modest increase liver enzyme ( 5 percent ) , thrombocytopenia ( 1 percent ) [ 11 ] .', 'These clinical manifestation similar nonpregnant individual .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", ') Complications infection include acute respiratory distress syndrome , arrhythmia , acute cardiac injury , shock .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", ') Classification disease severity — In United States , National Institutes Health categorize disease severity [ 12 ] : ●Asymptomatic presymptomatic infection – Positive test SARS-CoV-2 symptoms.●Mild illness – Any sign symptom ( eg , fever , cough , sore throat , malaise , headache , muscle pain ) without shortness breath , dyspnea , abnormal chest imaging.●Moderate illness – Evidence lower respiratory disease clinical assessment image saturation oxygen ( SaO2 ) > 93 percent room air sea level.●Severe illness – Respiratory frequency > 30 breath per minute , SaO2 ≤93 percent room air sea level , ratio arterial partial pressure oxygen fraction inspire oxygen ( PaO2/FiO2 ) < 300 , lung infiltrate > 50 percent.●Critical illness – Respiratory failure , septic shock , and/or multiple organ dysfunction.Disease severity also categorize ( Wu classification ) [ 13 ] : ●Mild – No mild symptom ( fever , fatigue , cough , and/or le common feature COVID-19 ) .●Severe – Tachypnea ( respiratory rate > 30 breath per minute ) , hypoxia ( oxygen saturation ≤93 percent room air PaO2/FiO2 < 300 mmHg ) , > 50 percent lung involvement image ) .●Critical ( eg , respiratory failure , shock , multiorgan dysfunction ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Defining disease severity ' ."", ') COURSE IN PREGNANCYMaternal course — Available data multiple small series case report generally suggest pregnancy childbirth increase risk acquire SARS-CoV-2 infection , worsen clinical course COVID-19 compare nonpregnant individual age , infect mother recover without undergo delivery [ 13-28 ] .', 'The population commonly affect severe disease older adult , particularly comorbidities , pregnant woman younger middle age ; however , may comorbid condition increase risk ( eg , obesity ) .', 'It know patient severe COVID-19 laboratory evidence exuberant inflammatory response ( similar cytokine release syndrome ) , associate critical fatal illness .', 'Whether normal immunologic change pregnancy affect occurrence course response unknown .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Course complication ' ."", ') In pregnant woman develop COVID-19 pneumonia , early data show approximately rate intensive care unit ( ICU ) admission nonpregnant population increase risk preterm cesarean delivery .', ""( See 'Pregnancy complication ' ."", ') ●In systematic review include 295 pregnant patient , 4.7 percent admit ICU [ 27 ] .', '●In initial United States experience New York City include 43 pregnant patient confirm COVID-19 , disease course mild 37 ( 86 percent ) , severe 4 ( 9.3 percent ) , critical 2 ( 4.7 percent ) [ 14 ] .', '●In larger cohort 147 pregnant patient WHO-China Joint Mission Report separate report 118 pregnant patient Wuhan , illness severe 8 percent critical 1 percent [ 17 ] .', 'These percentage similar nonpregnant , reproductive-age adult [ 13,29 ] .Severe sequela maternal infection include prolong ventilatory support need extracorporeal membrane oxygenation ( ECMO ) [ 30,31 ] .Several maternal death cardiopulmonary complication , sometimes multiorgan failure , report medical literature [ 32-34 ] .', 'Most woman generally healthy prior SARS-CoV-2 infection.It important note one report New York City , 10 14 patient ( 71 percent ) asymptomatic admission obstetric indication find SARS-CoV-2-positive universal screen go develop symptom delivery admission postpartum [ 14 ] .', 'Of 14 initially asymptomatic patient , 4 remain asymptomatic , 8 develop mild symptom , 2 develop severe/critical disease.While course infection pregnant person similar nonpregnant person , add issue pregnancy , time prenatal care visit screen test uninfected woman , infect woman , potential pregnancy complication , time management labor delivery , postpartum care ( mother-newborn separation , breastfeed , infant care , postpartum depression risk ) .', 'These issue review below.Pregnancy complication — Preterm birth cesarean delivery rate increase .', 'A systematic review include 252 pregnant COVID-19 patient report 15 percent deliver 37 week 70 percent deliver cesarean [ 11 ] .', 'It important emphasize available data generally low quality , reflect small number case disproportionate number patient intubate COVID-19 pneumonia .', 'Fever hypoxemia severe pneumonia may increase risk preterm labor , prelabor rupture membrane , abnormal fetal heart rate pattern , preterm delivery also occur patient without severe respiratory disease .', 'It appear many initial third-trimester case electively deliver cesarean bias intervene catalyze belief management severe maternal respiratory disease would improve delivery ; however , hypothesis unproven.The frequency spontaneous abortion appear increase , data first-trimester infection limit [ 11,27,35 ] .', 'At least five critically ill woman fetal death : four woman die , ECMO [ 30,32,33 ] .', 'Over 95 percent newborn good condition birth ; neonatal complication largely relate preterm birth adverse uterine environment result critical maternal disease [ 11,33,36 ] .Hyperthermia , common COVID-19 , theoretical concern elevation maternal core temperature febrile illness organogenesis first trimester may associate increase risk congenital anomaly , especially neural tube defect , miscarriage ; however , increase incidence outcome observe .', 'Use acetaminophen pregnancy , include first trimester , show overall safe may attenuate pregnancy risk associate fever exposure .', ""( See `` Open neural tube defect : Risk factor , prenatal screen diagnosis , pregnancy management '' , section 'Fever/hyperthermia ' ."", ') Vertical transmission — Vertical transmission prove , possibility transmission exclude .', 'Standards neonatal evaluation delivery infect mother criterion vertical transmission develop .', 'Assessing immunoglobulin M ( IgM ) level virus cord blood sample neonatal nasopharynx , amnion-chorion interface , placental tissue use aseptic technique immediately delivery suggest .', 'Amniotic fluid obtain cesarean delivery could also tested.In woman test positive SARS-CoV-2 nasopharynx , vaginal amniotic fluid specimen negative date [ 35,37,38 ] .', 'Viremia rate patient COVID-19 appear low ( 1 percent one study [ 39 ] ) transient , suggest placental seed vertical transmission unlikely .', 'Few placenta study , almost evidence infection .', 'One exception case report patient confirm COVID-19 second-trimester miscarriage sample take placental cotyledon submembrane positive SARS-CoV-2 ; fetal , amniotic fluid , cord blood , maternal blood vaginal sample negative [ 40 ] .', 'Another report describe one positive placental swab amniotic surface two positive membrane swab amnion chorion manual separation membrane woman severe critical COVID-19 illness deliver cesarean ; none infant positive SARS-CoV-2 [ 41 ] .The extent clinical significance vertical transmission remain unclear .', 'A possible case vertical transmission base newborn laboratory and/or clinical find report [ 20,42-45 ] , SARS-CoV-2 test fetal blood , amniotic fluid , placenta either negative perform .', 'Many infant deliver cesarean positive nasopharyngeal culture SARS-CoV-2 day 1 2 life , elevate IgM level , and/or pneumonia .', 'Positive IgM result definitive evidence utero infection ( false positive cross reactivity occur ) , , many case , early infant infection may due postnatal contact infect parent caregiver [ 46 ] .APPROACH TO DIAGNOSIS — The possibility COVID-19 consider patient new-onset fever/chills and/or respiratory tract symptom ( eg , cough , dyspnea ) .', 'It also consider patient severe lower respiratory tract illness without clear cause .', 'Residing travel location community transmission SARS-CoV-2 close contact confirm suspect case COVID-19 past 14 day heighten suspicion .', 'Patients meet test criterion undergo test SARS-CoV-2 RNA reverse-transcription polymerase chain reaction ( RT-PCR ) nasopharyngeal swab specimen , ideally addition test respiratory pathogen ( eg , influenza , respiratory syncytial virus ) .', ""Criteria test diagnostic issue discuss detail separately ( see `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ) ."", 'In area infection active , believe test patient upon presentation labor delivery ( day schedule admission ) rapid test SARS-CoV-2 reasonable , test available .', ""( See 'Infection control precaution ' . )"", ""This test occur location design reduce risk pass infection uninfected person , dedicate `` walk-in '' `` drive-in '' test location result make readily available obstetric provider ."", 'A positive RT-PCR generally confirm diagnosis COVID-19 , although occasional false-positive test occur [ 47 ] .', 'False-negative test initial test appear common , especially four day precede symptom first day symptom [ 48 ] , report pregnant woman [ 49 ] .', 'Sensitivity depend several factor : specific RT-PCR assay , type specimen obtain ( nasopharyngeal specimen higher sensitivity oropharyngeal nasal specimen ) , quality specimen , duration illness time test [ 47 ] .', 'If initial nasopharyngeal test negative suspicion COVID-19 remain determine presence infection important management infection control , test repeat 24 hour day .', 'Infection control precaution COVID-19 continue repeat evaluation perform .', 'Two subsequent negative sample generally rule infection [ 50 ] .', 'If high suspicion COVID-19 infection diagnosis require management , lower respiratory tract specimen ( eg , sputum , bronchoalveolar lavage ) test higher sensitivity [ 51 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Laboratory find ' ."", ') A chest radiograph sufficient initial evaluation pulmonary complication hospitalize patient COVID-19 .', 'A single chest radiograph carry low fetal radiation dose 0.0005 0.01 mGy .', 'Computed tomography ( CT ) perform , indicate , fetal radiation dose routine chest CT ( table 1 ) also low associate increase risk fetal anomaly pregnancy loss .', 'Some authority advocate pulmonary ultrasound , possibly time obstetric scan , quick diagnosis pneumonia pregnant woman , certain location would quickest way ascertain high suspicion maternal COVID-19 infection [ 52,53 ] .', 'A detail description performance lung ultrasound find elsewhere [ 52 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Evaluation ' `` Diagnostic image pregnant nurse woman '' ."", ') PRENATAL CAREPreventing exposure community — Social distance hygienic measure recommend may difficult pregnant woman homeless , live shelter , live multigenerational dense house , live multiple place short time .', 'Social distance hygienic measure review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Personal preventive measure ' ."", ') Patients potential exposure — Pregnant patient epidemiologic history contact person confirm , probable , suspect COVID-19 self-isolate monitor symptom .', 'The incubation period 14 day .', 'Diagnostic test SARS-CoV-2 infection depend test availability .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Managing asymptomatic individual potential exposure ' ."", ') Further evaluation management patient become symptomatic depend illness severity , underlie comorbidities , clinical status .', 'Those least moderate illness typically hospitalize .', 'These issue time discontinuation precaution review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' ."", ') Routine prenatal care uninfected woman — The American College Obstetricians Gynecologists ( ACOG ) Society Maternal-Fetal Medicine issue guidance regard prenatal care COVID-19 pandemic ( available acog.org SMFM.org ) [ 54,55 ] .', 'It include general guidance test prevent spread COVID-19 , algorithm , suggestion modify traditional protocol prenatal visit .', 'These modification , tailor low- versus high-risk patient ( eg , multiple gestation , hypertension , diabetes ) , include telehealth , reduce number in-person visit , time visit , group test ( eg , aneuploidy , diabetes , infection screen ) minimize maternal contact others , restrict visitor visit test , time indicate obstetric ultrasound examination ( eg , gestational age , fetal anomaly , fetal growth , placental attachment ) , time frequency use nonstress test biophysical profile .', 'There many way reduce time patient , include patient high-risk pregnancy , office [ 56 ] .', 'For example , clinician order 75 gram two-hour oral glucose tolerance test ( GTT ) instead glucose challenge test 100 gram three-hour GTT ( woman positive result ) ; cell-free DNA screen use ( > 10 week ) Down syndrome screen rather combine test ( ie , nuchal translucency ultrasound serum analytes ) .', 'Ideally , every woman telehealth capability mean measure blood pressure home .', ""In author 's practice , pandemic , low-risk pregnant woman come office in-person prenatal visit approximately 12 , 20 , 28 , 36 week gestation ( ie , gestational age ultrasound and/or laboratory test also perform ) minimize person-to-person contact ."", 'Some practice encourage even visit occur telehealth , others include visit approximately 32 week [ 50 ] .', 'When outpatient office visit occur , patient health care worker wear least surgical mask ; partner allow , video communication encouraged.The psychological impact COVID-19 also recognize support offer .', 'In one study , approximately one-third respondent report moderate severe anxiety [ 57 ] .Medical management pregnant woman COVID-19Home care — Most pregnant patient know suspect COVID-19 mild disease ( shortness breath ) warrant hospital-level care absence obstetric problem ( eg , preterm labor ) .', 'Patient instruction aspect home care similar nonpregnant person , except pregnant woman third trimester perform fetal kick count report decrease fetal movement [ 50 ] .', 'Patients experience homelessness provide resource dedicate house unit , available .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control home set ' `` Decreased fetal movement : Diagnosis , evaluation , management '' . )"", 'The US Food Drug Administration expand approval use noninvasive fetal maternal monitor device home patient require fetal and/or maternal monitor condition unrelated COVID-19 [ 58 ] .', 'This help reduce patient health care provider contact potential exposure COVID-19 pandemic.Medical obstetric care hospitalize patient — Pregnant woman mild disease plus comorbidities moderate critical disease hospitalize .', 'Pregnant hospitalize patient severe disease , oxygen requirement plus comorbidities , critical disease care multispecialty team level III IV hospital obstetric service adult intensive care unit ( ICU ) [ 9,50 ] .', 'COVID-19 status alone necessarily reason transfer noncritically ill pregnant woman suspect confirm COVID-19 .', ""( See 'Classification disease severity ' ."", ') Guidelines management hospitalize patient COVID-19 , include evaluation care critically ill patient , review elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') Fetal monitor — A specific management issue pregnant patient fetal monitor viable gestational age .', 'The need frequency fetal test depend upon gestational age , stability maternal vital sign , maternal comorbidities , discussion patient family consider possibly increase risk stillbirth perinatal morbidity absence test .', 'For hospitalize patient , Bluetooth-enabled external fetal monitor transmit fetal heart rate trace obstetric provider .', 'The monitor use continuously unstable hospitalize patient emergency cesarean delivery would perform persistent nonreassuring fetal heart rate pattern .', 'An abnormal trace might also help guide maternal oxygen therapy .', 'In patient stable oxygen saturation ( SaO2 ) , nonstress test perform twice daily , one option .', 'Monitoring preterm labor — Monitoring pregnant patient sign symptom preterm labor routine component obstetric care component maternal monitor pregnant patient hospitalize nonobstetric set .', ""( See `` Preterm labor : Clinical find , diagnostic evaluation , initial treatment '' ."", ') Maternal oxygenation level — Among critically ill COVID-19 patient , profound acute hypoxemic respiratory failure acute respiratory distress syndrome ( ARDS ) dominant find .', 'General supportive care critically ill patient COVID-19 pneumonia similar patient ARDS due cause .', 'Common complication COVID-19-related ARDS include acute kidney injury , elevate liver enzyme , cardiac injury ( eg , cardiomyopathy , pericarditis , pericardial effusion , arrhythmia , sudden cardiac death ) .', 'During pregnancy , maternal peripheral oxygen saturation ( SpO2 ) maintain ≥95 percent , excess oxygen delivery need mother .', 'If SpO2 fall 95 percent , arterial blood gas obtain measure partial pressure oxygen ( PaO2 ) : Maternal PaO2 greater 70 mmHg desirable maintain favorable oxygen diffusion gradient maternal fetal side placenta.In ICU , severely ill patient COVID-19 often manage prone position .', 'Some ICUs extend approach pregnant woman , although even semi-prone position difficult position place pregnant woman last half pregnancy .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' `` Critical illness pregnancy peripartum period '' , section 'Supportive care ' `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", ') Use type venous thromboembolism prophylaxis — Direct data thromboembolic risk COVID-19 limit suggest increase risk .', 'The American Society Hematology , Society Critical Care Medicine , International Society Thrombosis Haemostasis [ 59-61 ] recommend routine pharmacologic venous thromboembolism prophylaxis patient hospitalize COVID-19 unless contraindication ( eg , bleed , severe thrombocytopenia ) .', 'We initiate prophylaxis pregnant/postpartum woman COVID-19 admit hospital management antepartum postpartum obstetric medical disorder severity COVID-19 alone .', 'For antepartum prophylaxis woman severely critically ill may deliver within day , unfractionated heparin 5000 unit subcutaneously every 12 hour reasonable dose .', 'Dosing inpatient clinical scenario discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Inpatient VTE prophylaxis ' 'Postpartum care ' ."", ') Unfractionated heparin generally prefer pregnant woman might proximate delivery readily reverse low molecular weight heparin .', 'Low molecular weight heparin reasonable woman unlikely deliver within several day postpartum .', 'Dosing discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Inpatient VTE prophylaxis ' `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Outpatient thromboprophylaxis ' `` Use anticoagulant pregnancy postpartum '' ."", ') Safety antiviral drug therapy — Several agent evaluate treatment COVID-19 .', 'Although agent clinically available indication , use COVID-19 remain investigational .', '●Remdesivir – At hospital , pregnant woman severe COVID-19 offer remdesivir compassionate-use protocol .', 'Remdesivir novel nucleotide analogue activity SARS-CoV-2 vitro [ 62 ] relate coronaviruses ( include severe acute respiratory syndrome [ SARS ] Middle East respiratory syndrome-related coronavirus [ MERS-CoV ] ) vitro animal study [ 63 ] .', 'It use without report fetal toxicity pregnant woman Ebola Marburg virus disease [ 64 ] use treat , compassionate-use basis , pregnant patient severe COVID-19 .', 'Randomized trial drug COVID-19 pandemic exclude pregnant breastfeed woman .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') ●Other drug – Data early randomize trial generally suggest benefit administration hydroxychloroquine chloroquine .', 'Furthermore , adverse maternal effect include abnormal heart rhythm ( QT interval prolongation ventricular tachycardia ) , especially patient take drug associate QTc prolongation .', 'Therefore , drug use treatment COVID-19 outside ongoing randomize trial .', 'Hydroxychloroquine cross placenta .', 'Accumulation fetal ocular tissue observe animal study , increase risk fetal ocular abnormality observe human , reassure give drug use pregnant woman treatment systemic lupus erythematosus prevention malaria .', 'Available data limit , however , risk fetus rule use different do indication [ 65 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Hydroxychloroquine/chloroquine ' `` Malaria pregnancy : Prevention treatment '' , section 'Safety antimalarial pregnancy ' `` Pregnancy woman systemic lupus erythematosus '' , section 'Medications ' ."", ') Several drug use research study .', 'One drug lopinavir-ritonavir , primarily use treatment HIV infection , include pregnancy .', 'It cross placenta may increase risk preterm delivery , increase risk teratogenic effect observe human .', 'Investigational drug COVID-19 know teratogenic include ribavirin baricitinib .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') Use standard medication manage pregnancy complications●Antenatal betamethasone – For general population , Centers Disease Control Prevention ( CDC ) recommend avoid glucocorticoid COVID-19-positive person associate increase risk mortality patient influenza delay viral clearance patient MERS-CoV infection .', 'However , CDC address use antenatal glucocorticoid reduce neonatal morbidity mortality preterm birth pregnant COVID-19-positive patients.Because clear benefit antenatal betamethasone administration 24+0 33+6 week gestation patient high risk preterm birth within seven day , ACOG continue recommend use standard indication pregnant patient suspect confirm COVID-19 [ 66 ] .', 'However , pregnant patient suspect confirm COVID-19 34+0 36+6 week gestation risk preterm birth within seven day , benefit neonate le clear , ACOG advise administer course betamethasone patient .', 'However , decision may need individualize , weigh neonatal benefit risk potential harm pregnant patient .', ""( See `` Antenatal corticosteroid therapy reduction neonatal respiratory morbidity mortality preterm delivery '' , section 'Gestational age administration ' ."", ') ●Low-dose aspirin – For pregnant woman without COVID-19 , ACOG state low-dose aspirin continue offer medically indicate ( eg , prevention preeclampsia ) [ 67 ] .', 'For suspect confirm COVID-19 low-dose aspirin would indicate , decision continue drug individualize .', 'For example , continue preeclampsia prophylaxis likely worthwhile severely critically ill patient near term .', 'A panel National Institutes Health state person COVID-19 take nonsteroidal anti-inflammatory drug ( NSAIDs ) comorbid condition continue therapy previously direct health care provider [ 12 ] .Concern possible negative effect NSAIDs raise anecdotal report young , nonpregnant patient receive NSAIDs ( ibuprofen ) early course infection experience severe disease [ 68,69 ] .', 'However , clinical population-based data directly address risk NSAIDs .', 'Given absence data , European Medicines Agency World Health Organization recommend avoid NSAIDs COVID-19 patient clinically indicate [ 70,71 ] .', '●Tocolysis – In woman know suspect COVID-19 , prefer tocolytic nifedipine .', 'It suitable alterative indomethacin , subject concern discuss , beta sympathomimetics , increase maternal heart rate .', 'Follow-up woman recover COVID-19 — Development fetal growth restriction theoretic concern describe SARS infection [ 72,73 ] .', 'In absence robust data , authority suggest pregnant woman confirm infection monitor serial ultrasound assessment fetal growth amniotic fluid volume [ 74 ] begin 14 day symptom resolution [ 75 ] .', 'For first- early second-trimester infection , detail fetal morphology scan 18 23 week gestation also indicate .', 'Very limit COVID-19-specific data fetal growth available [ 18 ] .', 'Suboptimal fetal growth due placental insufficiency plausible maternal COVID-19 associate focal avascular villus thrombus larger fetal vessel chorionic plate stem villus [ 76 ] .', 'These lesion could cause COVID-19-related coagulopathy placental hypoxia acute maternal illness , .', 'Timing delivery infect woman — For woman preterm COVID-19 nonsevere illness medical/obstetric indication prompt delivery , delivery indicate ideally occur sometime negative test result obtain isolation status lift , thereby minimize risk postnatal transmission neonate [ 77 ] .In woman severe illness , multiple issue consider , time delivery need individualize [ 50,78 ] .', ""Whether mother 's respiratory disease improve delivery risk postnatal transmission delivery room maternal symptom acute unclear ."", 'It also note maternal antibody production , turn , passive newborn immunity may time develop .', 'On hand , increase oxygen consumption reduce functional residual capacity , normal pregnancy , may facilitate maternal deterioration patient pneumonia [ 79 ] .', 'Excessive uterine distension multiple gestation severe polyhydramnios third trimester may compromise pulmonary function.For hospitalize patient COVID-19 pneumonia intubate , authority advocate consideration delivery pregnancy > 32 34 week .', 'The rationale delivery perform pulmonary situation worsen ongoing maternal hypoxemia place fetus risk compromise .', 'Most authority advocate delivery prior 32 week , even though maternal situation may worsen second week , give know morbidity mortality preterm infants.Timing delivery hospitalize pregnant woman intubate critically ill COVID-19 challenge .', 'After 32 34 week , advocate delivery patient stable , could exacerbate maternal condition .', 'Between viability < 32 week , continue maternal support fetal monitor usually suggest perinatal benefit long maternal situation remain stable improve .', 'In situation , maternal extracorporeal membrane oxygenation may necessary [ 80 ] .', 'MANAGEMENT OF LABOR AND DELIVERY — Although many asymptomatic patient concern leave home COVID-19 pandemic , American College Obstetricians Gynecologists ( ACOG ) continue recommend follow exist evidence-based guidance regard home birth [ 67 ] .', ""( See `` Planned home birth '' ."", ') Infection control precautions●Prehospital notification possible infection – The Centers Disease Control Prevention ( CDC ) recommend pregnant patient confirm suspect COVID-19 notify obstetric unit arrival facility make appropriate infection control preparation [ 81 ] .', 'The obstetric unit ensure infection control practice patient consistent CDC guideline .', '●Evaluation patient present hospital – All patient screen sign symptom COVID-19 , well whether close contact confirm case person investigation , enter hospital admission labor delivery unit [ 82 ] .', 'Screening include check temperature ask fever and/or new cough , shortness breath , sore throat , muscle ache , rhinorrhea/nasal congestion , smell taste abnormality .', 'The CDC advise prioritize test pregnant woman suspect COVID-19 admission develop symptom COVID-19 admission [ 81 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Measures patient , visitor , personnel ' ."", ') Asymptomatic patient presymptomatic patient may present labor delivery unit , implication health care staff management newborn .', 'For reason , area infection community widespread , believe test patient upon presentation labor delivery ( day schedule admission ) rapid SARS-CoV-2 test reasonable , test available .', 'We believe information useful inform infection control precaution intrapartum postpartum , include newborn care [ 14,83,84 ] .', 'During New York City pandemic , 215 pregnant woman admit two New York City hospital delivery screen COVID-19 , 33 ( 15 percent ) SARS-CoV-2-positive [ 21 ] .', 'Of 33 woman , 4 symptomatic 29 asymptomatic ; thus , 13.5 percent asymptomatic patient admit delivery test positive SARS-CoV-2 .', 'Among asymptomatic woman test positive , 3/29 develop postpartum fever , least one patient presume COVID-19 .', 'One additional patient test negative admission become symptomatic postpartum , repeat SARS-CoV-2 test positive .', 'However , find likely generalizable area prevalence COVID-19 low.The evaluation diagnosis woman admit labor delivery suspect COVID-19 similar patient admit hospital suspect disease .', 'The CDC advise prioritize test pregnant woman suspect COVID-19 admission develop symptom COVID-19 admission [ 81 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') ●Use personal protective equipment ( PPE ) labor delivery – Health care worker use appropriate PPE care patient COVID-19 .', 'In addition , patient visitor give face cover upon entry health care set ( medical cloth mask ) universal source control .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Measures patient , visitor , personnel ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') During active labor , particular , concern viral dissemination patient forcefully exhale [ 85 ] .', 'Forceful exhalation may reduce effectiveness mask contain respiratory droplet prevent spread virus .', '●Care COVID-19-positive inpatient – Ideally , pregnant COVID-19 inpatient care specially equip ( eg , negative-pressure ) room antepartum , intrapartum , postpartum COVID-19-only unit , similar adult COVID-19 inpatient usually place dedicate COVID-19-only unit , hall , hospital .', 'Patients suspect confirm COVID-19 normally instruct wear face mask , include labor delivery , may difficult active push [ 85 ] .', 'Infection control precaution regard pregnant patient confirm suspect infection similar hospitalize patient review separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') ●Support person labor delivery – Perhaps controversial issue regard infection control woman labor delivery unit whether allow support person .', 'Most facility recognize support person important many labor woman permit one support person must remain labor woman ( may leave room return ) .', 'A doula consider type health care personnel facility visitor others .', ""( See `` Continuous labor support doula '' ."", ') The support person screen fever symptom enter build accordance hospital policy .', 'Those symptom consistent COVID-19 , exposure confirm case within 14 day , positive test COVID-19 within 14 day allow attend labor birth .', 'If screen negative , require support person wear cloth face cover , minimum , consistent CDC guidance [ 82 ] .', 'If support person arrive health care facility without cloth face cover , face mask issue supply available.A support person screen positive permit hospital .', ""In case additional support person desire , part patient 's labor delivery via video ."", ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Measures patient , visitor , personnel ' ."", ') Route delivery — COVID-19 indication alter route delivery [ 16,54 ] .', 'Cesarean delivery perform standard obstetric indication .', 'Even vertical transmission confirm additional data report , would indication cesarean delivery since would increase maternal risk would unlikely improve newborn outcome .', 'Reports COVID-19 infection neonate generally describe mild disease .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", ') Screening patient schedule induction cesarean delivery — Patients screen COVID-19 undergo pre-induction/pre-cesarean laboratory test day plan induction cesarean delivery .', 'We evaluate symptomatic patient determine whether feasible reschedule result COVID-19 test available .', 'This require balance risk continue pregnancy set positive negative test result .', 'In particular , result positive , patient may become severely ill time since symptom often severe second week illness.In asymptomatic woman , induction labor cesarean delivery appropriate medical indication postpone reschedule ; include 39-week induction cesarean delivery patient counsel .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Course complication ' ."", ') Analgesia anesthesia — In patient know suspect COVID-19 , neuraxial anesthetic contraindicate several advantage labor patient : provide good analgesia thus reduce cardiopulmonary stress pain anxiety , turn , chance viral dissemination , available case emergency cesarean require , thus obviate need general anesthesia .', 'The Society Obstetric Anesthesia Perinatology suggest consider suspend use nitrous oxide labor analgesia patient insufficient data clean , filter , potential aerosolization nitrous oxide system [ 86 ] .', 'They also urge consideration limit use intravenous , patient-controlled analgesia risk respiratory depression .', 'General anesthesia ( intubation extubation ) consider aerosolize procedure , special PPE ( ie , N-95 mask , etc ) wear involve health care provider cesarean delivery .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", ') Magnesium sulfate — In woman respiratory compromise , use magnesium sulfate maternal seizure prophylaxis and/or neonatal neuroprotection decide case-by-case basis since drug may depress respiration .', 'Consultation maternal-fetal medicine pulmonary/critical care specialist advised.Labor management — Generally , management labor alter woman give birth COVID-19 pandemic woman confirm suspect COVID-19 asymptomatic mild [ 85 ] .', 'Person-to-person contact time labor unit hospital limit , safely feasible .', 'For patient require cervical ripen , outpatient mechanical ripen balloon catheter option .', 'For inpatient cervical ripen , use two method ( eg , mechanical misoprostol mechanical oxytocin ) decrease time induction delivery , compare use one agent .', ""( See `` Techniques ripen unfavorable cervix prior induction '' , section 'Outpatient cervical ripen ' `` Techniques ripen unfavorable cervix prior induction '' , section 'Balloon catheter combine prostaglandin ' ."", ') Continuous electronic fetal monitor recommend woman suspect confirm COVID-19 ; increase frequency nonreassuring trace report , case series typically high proportion woman pneumonia .', 'Intake output fluid carefully monitor woman , aggressive hydration avoid since lead pulmonary edema worsen maternal oxygenation may already compromise [ 79 ] .', 'In nonpregnant patient severe COVID-19 , conservative fluid management recommend , long hypotension organ hypoperfusion avoid .', ""( See `` Acute respiratory distress syndrome : Supportive care oxygenation adult '' , section 'Fluid management ' ."", ') SARS-CoV-2 detect vaginal secretion amniotic fluid , rupture fetal membrane internal fetal heart rate monitor may perform usual indication , data limit [ 19 ] .', 'It note labor , particularly push , often cause loss feces , contain virus spread infection [ 39,87 ] .We believe use intervention increase risk infection prove beneficial , example use birth ball peanut ball , limit .', 'As intrapartum oxygen prove fetal benefit , practice oxygen therapy fetal resuscitation abandon ; nasal cannula face mask use contact maternal respiratory tract secretion , handle equipment increase contamination/exposure patient provider .', ""Lastly , advocate delay push second stage , although others suggest minimize duration active push deep breathe maternal expulsive effort may increase exposure patient 's respiratory secretion [ 79 ] ."", ""( See `` Intrapartum category I , II , III fetal heart rate trace : Management '' , section 'In utero resuscitation ' `` Nonpharmacologic approach management labor pain '' , section 'Birth ball ' `` Management normal labor delivery '' , section 'Pushing position technique ' ."", ') Delivery procedure — For woman know suspect infection , ACOG state delay umbilical cord clamp highly unlikely increase risk transmit pathogen infect mother fetus [ 54 ] ; however , institution choose prohibit practice term infant , benefit modest , minimize newborn exposure virus immediate environment reduce chance newborn require phototherapy jaundice .', 'Some institution also prohibit skin-to-skin contact case [ 88 ] , although World Health Organization American Academy Pediatrics advise [ 16,89 ] .', 'One expert group suggest leave vernix caseosa place 24 hour birth since contain antimicrobial peptide [ 90 ] , whereas American Academy Pediatrics advise bath newborn soon reasonably possible birth remove virus potentially present skin surface [ 91 ] .Umbilical cord blood bank perform plan ; risk COVID-19 transmission blood product document unclear present [ 54 ] .Procedures test vertical transmission describe .', ""( See 'Vertical transmission ' ."", ') Intrapartum postpartum fever — COVID-19 infection part differential diagnosis intrapartum postpartum fever , particularly accompany respiratory symptom reduce oxygenation .', 'Such patient test virus , along evaluation common cause intrapartum postpartum infection ( eg , chorioamnionitis , endometritis ) [ 14 ] .', ""( See `` Intrapartum fever '' `` Postpartum endometritis '' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') POSTPARTUM CAREVenous thromboembolism prophylaxis — Venous thromboembolism ( VTE ) prophylaxis consider postpartum woman COVID-19 , decision base individual risk assessment .', 'There wide variation practice .', 'For patient receive antepartum pharmacologic prophylaxis COVID-19 , would administer postpartum prophylaxis remain asymptomatic mildly symptomatic uncomplicated delivery , standard indication postpartum VTE prophylaxis .', 'For patient receive antepartum prophylaxis COVID-19 , authority recommend discontinue prophylaxis upon discharge absence ongoing risk factor VTE ( eg , immobilization , recent surgery ) , whereas others continue prophylaxis 7 14 day ( six week ) patient moderate/severe/critical disease mild disease VTE risk factor [ 50,79,92 ] .', 'These issue discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Inpatient VTE prophylaxis ' `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Outpatient thromboprophylaxis ' `` Use anticoagulant pregnancy postpartum '' ."", ') Maternal monitoring●For patient know suspect COVID-19 asymptomatic , postpartum maternal monitor routine .', ""●For patient mild illness ( see 'Classification disease severity ' ) , check vital sign monitor intake output every 4 hour 24 hour vaginal delivery 48 hour cesarean delivery ."", '●For patient moderate illness , perform continuous pulse oximetry monitor first 24 hour improvement sign symptom , whichever take longer .', ""The type frequency follow-up laboratory study chest image ( initial repeat ) guide patient 's course ."", 'Several institutional protocol available .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Institutional protocol ' ."", ') ●For patient severe critical illness , close maternal monitor care labor delivery unit intensive care unit indicate .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') Infant evaluation — The infant mother COVID-19 consider COVID-19 suspect , test , isolate healthy infant , care accord infection control precaution patient confirm suspect COVID-19 [ 81 ] .', 'Where test capacity available , neonate test SARS-CoV-2 infection soon possible within first 24 hour age use available molecular assay [ 91 ] .', 'Repeat test perform approximately 48 hour age infant still birth facility .', 'Both throat nasopharynx sample , one swab may use conserve swab polymerase chain reaction test reagent .', 'A separate rectal swab obtain test available center .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') Mother-baby contact — Temporary separation mother know suspect COVID-19 newborn propose reduce risk mother-baby transmission , may also adverse consequence [ 93 ] .', 'For example , rooming-in avoid skin-to-skin contact stressful mother ; disrupt breastfeed ; negative effect newborn stress , feed , bonding.The World Health Organization ( WHO ) opine mother suspect , probable , confirm COVID-19 virus infection enable remain together practice skin-to-skin contact [ 16 ] .', 'The Centers Disease Control Prevention ( CDC ) advise determine whether separate mother know suspect COVID-19 infant case-by-case basis , use share decision make mother clinical team [ 81 ] .', ""Factors consider include : ●The mother 's infant 's clinical conditions.●Whether mother 's infection suspect ( SARS-CoV-2 test result ) confirm , infant 's SARS-CoV-2 test result ( separation necessary infant positive test ) .●The mother 's desire breastfeed.●The facility 's ability accommodate mother-baby separation colocation.●The mother 's ability maintain separation go home , meet criterion discontinue temporary separation.●Other risk benefit temporary separation mother know suspect COVID-19 infant.If mother-baby separation implement , follow consider : ●Infant COVID-19 suspect isolate healthy infant care accord Interim Infection Prevention Control Recommendations Patients Suspected Confirmed Coronavirus Disease 2019 ( COVID-19 ) Healthcare Settings.●If another healthy family member provide infant care ( eg , diapering , bath , feed ) , use appropriate personal protective equipment ( healthy family member wear gown , glove , face mask , eye protection ) .If separation indicate ( mother transmission-based precaution ) implement , measure may utilize reduce potential mother-to-infant transmission include : ●Physical barrier ( eg , curtain mother newborn ) construct , newborn keep temperature control isolette ≥6 foot away mother.●The mother wear face mask practice hand hygiene close contact infant , particularly feeding.●If another healthy adult room , care newborn.After hospital discharge — After hospital discharge [ 91,94 ] : ●A mother symptomatic COVID-19 infection maintain distance least six foot newborn use face mask hand hygiene newborn care ( 1 ) least 3 day ( 72 hour ) pass since recovery ( resolution fever without use fever-reducing medication plus improvement respiratory symptom [ cough , shortness breath ] ) ( 2 ) least 10 day pass since symptom first appeared.●For mother laboratory-confirmed COVID-19 never symptomatic , transmission precaution discontinue least 10 day pass since date first positive COVID-19 diagnostic test.These symptom- time-based strategy discontinue transmission precaution ."", 'Test-based strategy also exist discuss detail separately .', 'A disadvantage test-based strategy positive SARS-CoV-2 reverse-transcription polymerase chain reaction ( RT-PCR ) result reflect presence viral RNA necessarily mean viable virus present transmit [ 47 ] .', 'Data regard postinfection risk transmission personal immunity limit [ 95 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Viral shed period infectivity ' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk transmission ' `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Discontinuation precaution ' ."", ') Breastfeeding formula feed — The risk SARS-CoV-2 transmission ingestion breast milk unclear .', 'Although several small series report sample breast milk mother COVID-19 test negative [ 11,96 ] , investigator subsequently report identify sample breast milk positive virus [ 97,98 ] .', 'More data need ass potential risk viral transmission ingest breast milk.There general consensus breastfeed encourage many maternal infant benefit .', 'In set maternal COVID-19 infection , infant may receive passive antibody protection virus since breast milk source antibody anti-infective factor .', ""( See `` Infant benefit breastfeed '' `` Maternal economic benefit breastfeed '' ."", ') If mother baby separation implement , ideally , infant feed express breast milk another healthy caregiver mother recover prove uninfected , provide caregiver healthy follow hygiene precaution [ 81 ] .', 'Expressing breast milk important support establishment maternal milk supply.Before pump , ideally dedicate breast pump , mother wear mask thoroughly clean hand breast soap water clean pump part , bottle , artificial nipple [ 99 ] .', 'The CDC issue guidance clean breast pump breastfeed .', 'If possible , pump equipment thoroughly clean healthy person .', 'If feed healthy caregiver possible , mother confirm COVID-19 symptomatic mother suspect COVID-19 take precaution prevent transmission infant breastfeed ( wear mask , hand breast hygiene , disinfect share surface symptomatic mother contact ) .', 'However , note value precaution , cleanse breast prior breastfeeding/milk expression disinfect external surface milk collection device ( eg , bottle , milk bag ) reduce potential transmission SARS-CoV-2 , formally study [ 100 ] .Ideally , woman choose formula fee another healthy caregiver fee infant .', 'If possible desire , woman must also take appropriate infection control precaution , describe , prevent transmission close contact feeding.Analgesia — Nonsteroidal anti-inflammatory drug ( NSAIDs ) commonly use treatment postpartum pain .', 'As discuss , concern possible negative effect NSAIDs patient COVID-19 raise anecdotal report young , nonpregnant patient receive NSAIDs ( ibuprofen ) early course infection experience severe disease [ 68,69 ] .', 'However , clinical population-based data directly address risk NSAIDs .', 'Given absence data , European Medicines Agency WHO recommend avoid NSAIDs clinically indicate [ 70,71 ] .', 'Given uncertainty , suggest use acetaminophen prefer analgesic agent , possible , NSAIDs need , lowest effective dose use .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Uncertainty NSAID use ' ."", ') Permanent reversible contraception — Permanent contraception ( tubal sterilization ) add significant additional time risk perform uncomplicated cesarean birth thus perform plan .', 'Permanent contraception vaginal birth elective procedure , decision make local level , base upon available resource .', 'If perform reversible contraceptive method desire , alternative form contraception provide ( eg , immediate postpartum long-acting reversible contraception depot medroxyprogesterone acetate ) long patient desire one method .', 'This avoid additional outpatient postpartum visit .', ""( See `` Overview female permanent contraception '' `` Postpartum permanent contraception : Procedures '' `` Postpartum contraception : Counseling method '' ."", "") Discharge hospital — We suggest early discharge postpartum , one day vaginal delivery maximum two day cesarean delivery , limit patient 's personal risk hospital environment [ 85 ] .Candidates mother-infant separation discharge criterion discontinuation separation discuss ."", ""( See 'After hospital discharge ' ."", ') Postpartum office visit — Modifying reduce postpartum outpatient care appropriate reduce risk inadvertent exposure .', 'For example , may possible perform early postpartum assessment , include wind blood pressure check , telehealth .', 'A comprehensive postpartum visit may still important 12 week , especially patient comorbidities patient lose insurance coverage time.All postpartum patient still screen postpartum depression four eight week delivery .', 'The widely use instrument self-report , 10-item Edinburgh Postnatal Depression Scale ( figure 1A-B ) , complete le five minute [ 101 ] , alternative available .', 'As discuss , psychological impact COVID-19 , may include moderate severe anxiety , also recognize support offer .', ""( See `` Postpartum unipolar major depression : Epidemiology , clinical feature , assessment , diagnosis '' , section 'Assessment ' ."", ') PREGNANCY REGISTRIES — Registries develop collect data COVID-19 affect pregnancy newborn .', 'For example : ●Pregnancy CoRonavIrus Outcomes RegIsTrY ( PRIORITY ) official United States registry lead University California , San Francisco.●International Registry Coronavirus Exposure Pregnancy ( IRCEP ) another registry lead international group investigators.SELECTED RESOURCES — In United States , American College Obstetricians Gynecologists , Society Maternal-Fetal Medicine , Centers Disease Control Prevention issue guidance regard prenatal , intrapartum , postpartum care COVID-19 pandemic [ 54,56 ] .', 'This include general guidance test prevent spread COVID-19 suggestion modify traditional protocol prenatal visit , obstetric ultrasound examination , use nonstress test biophysical profile , plan induction cesarean delivery , contact infant.●American College Obstetricians Gynecologists COVID-19 information●Society Maternal-Fetal Medicine●World Health Organization●Centers Disease Control Prevention : •Pregnancy Breastfeeding•Interim Considerations Infection Prevention Control Coronavirus Disease 2019 ( COVID-19 ) Inpatient Obstetric Healthcare Settings●International Society Infectious Disease Obstetrics Gynecology Recommendations Concerning COVID-19 Pregnancy [ 50 ] .●A dedicate website ( www.pregnancycovid19.com ) several helpful pregnancy-specific link information , include information patients.PREGNANCY REGISTRY — Pregnancy CoRonavIrus Outcomes RegIsTrY ( PRIORITY ) nationwide United States study pregnant recently pregnant woman either investigation confirm COVID-19 infection .', 'Providers patient send information via priority.ucsf.edu.SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) pregnancy ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●Pregnant woman follow recommendation nonpregnant person avoid exposure severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , virus cause coronavirus disease 2019 ( COVID-19 ) ."", ""( See 'Prevention ' ."", ') ●Clinical manifestation COVID-19 pregnant woman similar nonpregnant individual .', 'A positive test SARS-CoV-2 generally confirm diagnosis COVID-19 , although false-positive false-negative test possible .', ""( See 'Clinical manifestation ' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical feature ' `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Diagnosis ' ."", ') ●Pregnancy appear increase susceptibility infection worsen clinical course , infect mother recover without undergo delivery .', 'However , severe disease necessitate maternal intensive care unit admission need extracorporeal membrane oxygenation occur , maternal death report .', ""( See 'Maternal course ' . )"", '●Infected woman , especially develop pneumonia , appear increase frequency preterm birth cesarean delivery .', 'These complication likely relate severe maternal illness intrauterine infection appear occur , still investigation .', 'A possible early newborn infection one possible placental infection report .', ""( See 'Pregnancy complication ' 'Vertical transmission ' ."", ') ●The American College Obstetricians Gynecologists ( ACOG ) Society Maternal-Fetal Medicine ( SMFM ) issue guidance regard prenatal care COVID-19 pandemic ( available acog.org SMFM.org ) , include general guidance test prevent spread COVID-19 , suggestion modify traditional protocol prenatal postnatal visit hospital discharge , algorithm assessment management .', 'These modification tailor low- versus high-risk pregnancy .', ""( See 'Prenatal care ' 'Discharge hospital ' 'Postpartum office visit ' ."", ') ●For general population , Centers Disease Control Prevention recommend avoid glucocorticoid COVID-19-positive person potential adverse effect course disease .', 'Because clear benefit antenatal betamethasone administration 24+0 33+6 week gestation patient risk preterm birth within seven day , ACOG continue recommend use standard indication pregnant patient suspect confirm COVID-19 .', ""( See 'Use standard medication manage pregnancy complication ' ."", ') ●For woman preterm COVID-19 nonsevere illness medical/obstetric indication prompt delivery , delivery indicate ideally occur sometime negative test result obtain isolation status lift , thereby minimize risk postnatal transmission neonate .', 'Severely ill patient least 32 34 week gestation COVID-19 pneumonia may benefit early delivery .', ""( See 'Timing delivery infect woman ' ."", ') ●In area infection active , believe test patient upon presentation labor delivery ( day schedule admission ) reasonable , test available .', 'In city high infection prevalence , high proportion asymptomatic patient ( 13.5 percent one study ) admit delivery test positive , clinical implication triage , staff , newborn care .', ""( See 'Infection control precaution ' ."", ') ●Generally , management labor alter woman give birth COVID-19 pandemic woman confirm suspect COVID-19 .', 'SARS-CoV-2 detect vaginal secretion amniotic fluid , rupture fetal membrane internal fetal heart rate monitor may perform usual indication , data limit .', 'COVID-19 indication alter route delivery .', 'The partner/support person screen accordance hospital policy symptom consistent COVID-19 , exposure confirm case within 14 day , positive test COVID-19 within 14 day allow attend labor birth .', ""( See 'Management labor delivery ' ."", ') ●In patient know suspect COVID-19 , neuraxial anesthetic contraindicate several advantage labor patient .', 'The Society Obstetric Anesthesia Perinatology suggest suspend use nitrous oxide labor analgesia patient insufficient data potential aerosolization nitrous oxide system .', ""( See 'Analgesia anesthesia ' ."", ') ●At delivery patient know suspect COVID-19 , institution choose avoid delay cord clamp term infant , benefit modest , minimize newborn exposure virus immediate environment reduce chance newborn require phototherapy jaundice .', ""( See 'Delivery procedure ' ."", ') ●Nonsteroidal anti-inflammatory drug ( NSAIDs ) commonly use treatment postpartum pain ; however , anecdotal report possible negative effect NSAIDs patient COVID-19 .', 'Given uncertainty , use acetaminophen prefer analgesic agent , possible , NSAIDs need , lowest effective dose use .', ""( See 'Analgesia anesthesia ' ."", ') ●Infants bear mother know COVID-19 COVID-19 suspect test , isolate healthy infant , care accord infection control precaution patient confirm suspect COVID-19 .', ""( See 'Infant evaluation ' . )"", '●Whether separate mother know suspect COVID-19 infant determine case-by-case basis .', 'If infant test positive , separation unnecessary .', 'If separation indicate ( mother transmission-based precaution ) implement , measure may utilize reduce potential mother-to-infant transmission , include physical barrier ≥6 foot separation , personal protective equipment hand hygiene , utilization healthy adult infant care ( feed , diapering , bath ) .', ""( See 'Mother-baby contact ' ."", ') ●The virus find sample breast milk , data limit risk transmission infant ingestion breast milk unclear .', 'Droplet transmission newborn could occur close contact feed .', 'In mother confirm COVID-19 symptomatic mother suspect COVID-19 , minimize direct contact , ideally , infant feed express breast milk another caregiver mother recover prove uninfected , provide caregiver healthy follow hygiene precaution .', 'In case , mother wear mask thoroughly clean hand breast pump ; pump part , bottle , artificial nipple clean well .', 'If breastfeed infant directly , similar personal hygienic precaution take .', ""( See 'Breastfeeding formula feed ' ."", ') ●Several agent evaluate treatment COVID-19 .', 'Remdesivir promise use without report fetal toxicity severely ill pregnant woman .', ""( See 'Safety antiviral drug therapy ' . )""]","['', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'virus', 'cause', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'information', 'covid-19', 'evolve', 'rapidly', '', 'interim', 'guidance', 'multiple', 'organization', 'constantly', 'update', 'expand', '', 'topic', 'discus', 'issue', 'relate', 'covid-19', 'pregnancy', 'deliveryvirology', 'epidemiology', '', 'general', 'issue', 'regard', 'virology', '', 'geographic', 'distribution', '', 'route', 'transmission', '', 'period', 'infectivity', '', 'immunity', 'sars-cov-2', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', 'vertical', 'transmission', 'address', '', '', 'vertical', 'transmission', '', '', '', 'prevention', '', 'pregnant', 'woman', 'follow', 'recommendation', 'nonpregnant', 'person', 'avoid', 'exposure', 'virus', '', 'eg', '', 'social', 'distance', '', 'hand', 'hygiene', '', 'disinfect', 'surface', '', 'wear', 'mask', 'public', '', '', 'women', 'epidemiologic', 'history', 'contact', 'monitor', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'personal', 'preventive', 'measure', '', '', '', 'pregnant', 'woman', 'child', 'exercise', 'caution', '', 'covid-19', 'child', 'often', 'mild', 'asymptomatic', '', 'although', 'severe', 'case', 'report', '', 'given', 'possibility', 'transmission', 'sars-cov-2', 'asymptomatic', 'individual', '', 'presymptomatic', 'individual', 'within', 'incubation', 'period', '', '', '1-7', '', '', 'centers', 'disease', 'control', 'prevention', 'recommend', 'child', 'playdates', 'child', 'household', '', 'remain', '6', 'foot', 'people', 'household', 'play', 'outside', '', 'wear', 'cloth', 'face', 'cover', 'public', 'set', 'social', 'distance', 'measure', 'difficult', 'maintain', '', '8', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', 'section', 'play', 'date', 'playground', 'avoid', '', '', '', '', 'pregnant', 'health', 'care', 'worker', 'additional', 'concern', '', 'standard', 'occupational', 'guidance', 'regard', 'work', 'restriction', '', '910', '', 'pregnant', 'worker', 'occupation', 'health', 'care', 'continue', 'work', 'deliver', '', 'risk', 'mitigation', '', 'reassignment', 'term', 'role', 'reduce', 'risk', 'exposure', 'self-quarantine', '', 'consider', 'reduce', 'individual', 'risk', 'infect', 'peripartum', '', 'maternal', 'infection', 'broader', 'implication', '', 'eg', '', 'exposure', 'health', 'care', 'worker', '', 'infant', 'exposure', '', '', '9', '', '', 'patient', 'comorbidities', 'individual', 'work', 'situation', 'guide', 'clinician', 'response', 'request', 'medical', 'leaveclinical', 'manifestations', '', 'pregnant', 'woman', 'monitor', 'development', 'symptom', 'sign', 'covid-19', '', 'particularly', 'close', 'contact', 'confirm', 'case', 'person', 'investigation', '', 'systematic', 'review', 'include', '356', 'case', 'pregnant', 'woman', '', '33', 'study', '', '', 'frequent', 'symptom', 'fever', '', '67', 'percent', '', '', 'cough', '', '66', 'percent', '', '', 'dyspnea', '', '7', 'percent', '', '', 'sore', 'throat', '', '7', 'percent', '', '', 'fatigue', '', '7', 'percent', '', '', 'myalgia', '', '6', 'percent', '', '', '11', '', '', 'rhinorrheanasal', 'congestion', '', 'anorexia', '', 'nauseavomiting', '', 'headache', '', 'possibly', 'abnormality', 'smell', 'andor', 'taste', 'report', '', 'laboratory', 'find', 'include', 'lymphopenia', '', '14', 'percent', '', '', 'modest', 'increase', 'liver', 'enzyme', '', '5', 'percent', '', '', 'thrombocytopenia', '', '1', 'percent', '', '', '11', '', '', 'clinical', 'manifestation', 'similar', 'nonpregnant', 'individual', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', 'complications', 'infection', 'include', 'acute', 'respiratory', 'distress', 'syndrome', '', 'arrhythmia', '', 'acute', 'cardiac', 'injury', '', 'shock', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', 'classification', 'disease', 'severity', '', 'united', 'states', '', 'national', 'institutes', 'health', 'categorize', 'disease', 'severity', '', '12', '', '', 'asymptomatic', 'presymptomatic', 'infection', '', 'positive', 'test', 'sars-cov-2', 'symptomsmild', 'illness', '', 'sign', 'symptom', '', 'eg', '', 'fever', '', 'cough', '', 'sore', 'throat', '', 'malaise', '', 'headache', '', 'muscle', 'pain', '', 'without', 'shortness', 'breath', '', 'dyspnea', '', 'abnormal', 'chest', 'imagingmoderate', 'illness', '', 'evidence', 'lower', 'respiratory', 'disease', 'clinical', 'assessment', 'image', 'saturation', 'oxygen', '', 'sao2', '', '', '93', 'percent', 'room', 'air', 'sea', 'levelsevere', 'illness', '', 'respiratory', 'frequency', '', '30', 'breath', 'per', 'minute', '', 'sao2', '93', 'percent', 'room', 'air', 'sea', 'level', '', 'ratio', 'arterial', 'partial', 'pressure', 'oxygen', 'fraction', 'inspire', 'oxygen', '', 'pao2fio2', '', '', '300', '', 'lung', 'infiltrate', '', '50', 'percentcritical', 'illness', '', 'respiratory', 'failure', '', 'septic', 'shock', '', 'andor', 'multiple', 'organ', 'dysfunctiondisease', 'severity', 'categorize', '', 'wu', 'classification', '', '', '13', '', '', 'mild', '', 'mild', 'symptom', '', 'fever', '', 'fatigue', '', 'cough', '', 'andor', 'le', 'common', 'feature', 'covid-19', '', 'severe', '', 'tachypnea', '', 'respiratory', 'rate', '', '30', 'breath', 'per', 'minute', '', '', 'hypoxia', '', 'oxygen', 'saturation', '93', 'percent', 'room', 'air', 'pao2fio2', '', '300', 'mmhg', '', '', '', '50', 'percent', 'lung', 'involvement', 'image', '', 'critical', '', 'eg', '', 'respiratory', 'failure', '', 'shock', '', 'multiorgan', 'dysfunction', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'defining', 'disease', 'severity', '', '', '', 'course', 'pregnancymaternal', 'course', '', 'available', 'data', 'multiple', 'small', 'series', 'case', 'report', 'generally', 'suggest', 'pregnancy', 'childbirth', 'increase', 'risk', 'acquire', 'sars-cov-2', 'infection', '', 'worsen', 'clinical', 'course', 'covid-19', 'compare', 'nonpregnant', 'individual', 'age', '', 'infect', 'mother', 'recover', 'without', 'undergo', 'delivery', '', '13-28', '', '', 'population', 'commonly', 'affect', 'severe', 'disease', 'older', 'adult', '', 'particularly', 'comorbidities', '', 'pregnant', 'woman', 'younger', 'middle', 'age', '', 'however', '', 'comorbid', 'condition', 'increase', 'risk', '', 'eg', '', 'obesity', '', '', 'patient', 'severe', 'covid-19', 'laboratory', 'evidence', 'exuberant', 'inflammatory', 'response', '', 'similar', 'cytokine', 'release', 'syndrome', '', '', 'associate', 'critical', 'fatal', 'illness', '', 'whether', 'normal', 'immunologic', 'change', 'pregnancy', 'affect', 'occurrence', 'course', 'response', 'unknown', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'course', 'complication', '', '', '', 'pregnant', 'woman', 'develop', 'covid-19', 'pneumonia', '', 'early', 'data', 'show', 'approximately', 'rate', 'intensive', 'care', 'unit', '', 'icu', '', 'admission', 'nonpregnant', 'population', 'increase', 'risk', 'preterm', 'cesarean', 'delivery', '', '', 'pregnancy', 'complication', '', '', '', 'systematic', 'review', 'include', '295', 'pregnant', 'patient', '', '47', 'percent', 'admit', 'icu', '', '27', '', '', 'initial', 'united', 'states', 'experience', 'new', 'york', 'city', 'include', '43', 'pregnant', 'patient', 'confirm', 'covid-19', '', 'disease', 'course', 'mild', '37', '', '86', 'percent', '', '', 'severe', '4', '', '93', 'percent', '', '', 'critical', '2', '', '47', 'percent', '', '', '14', '', '', 'larger', 'cohort', '147', 'pregnant', 'patient', 'who-china', 'joint', 'mission', 'report', 'separate', 'report', '118', 'pregnant', 'patient', 'wuhan', '', 'illness', 'severe', '8', 'percent', 'critical', '1', 'percent', '', '17', '', '', 'percentage', 'similar', 'nonpregnant', '', 'reproductive-age', 'adult', '', '1329', '', 'severe', 'sequela', 'maternal', 'infection', 'include', 'prolong', 'ventilatory', 'support', 'extracorporeal', 'membrane', 'oxygenation', '', 'ecmo', '', '', '3031', '', 'several', 'maternal', 'death', 'cardiopulmonary', 'complication', '', 'sometimes', 'multiorgan', 'failure', '', 'report', 'medical', 'literature', '', '32-34', '', '', 'woman', 'generally', 'healthy', 'prior', 'sars-cov-2', 'infectionit', 'important', 'note', 'one', 'report', 'new', 'york', 'city', '', '10', '14', 'patient', '', '71', 'percent', '', 'asymptomatic', 'admission', 'obstetric', 'indication', 'find', 'sars-cov-2-positive', 'universal', 'screen', 'develop', 'symptom', 'delivery', 'admission', 'postpartum', '', '14', '', '', '14', 'initially', 'asymptomatic', 'patient', '', '4', 'remain', 'asymptomatic', '', '8', 'develop', 'mild', 'symptom', '', '2', 'develop', 'severecritical', 'diseasewhile', 'course', 'infection', 'pregnant', 'person', 'similar', 'nonpregnant', 'person', '', 'add', 'issue', 'pregnancy', '', 'time', 'prenatal', 'care', 'visit', 'screen', 'test', 'uninfected', 'woman', '', 'infect', 'woman', '', 'potential', 'pregnancy', 'complication', '', 'time', 'management', 'labor', 'delivery', '', 'postpartum', 'care', '', 'mother-newborn', 'separation', '', 'breastfeed', '', 'infant', 'care', '', 'postpartum', 'depression', 'risk', '', '', 'issue', 'review', 'belowpregnancy', 'complication', '', 'preterm', 'birth', 'cesarean', 'delivery', 'rate', 'increase', '', 'systematic', 'review', 'include', '252', 'pregnant', 'covid-19', 'patient', 'report', '15', 'percent', 'deliver', '37', 'week', '70', 'percent', 'deliver', 'cesarean', '', '11', '', '', 'important', 'emphasize', 'available', 'data', 'generally', 'low', 'quality', '', 'reflect', 'small', 'number', 'case', 'disproportionate', 'number', 'patient', 'intubate', 'covid-19', 'pneumonia', '', 'fever', 'hypoxemia', 'severe', 'pneumonia', 'increase', 'risk', 'preterm', 'labor', '', 'prelabor', 'rupture', 'membrane', '', 'abnormal', 'fetal', 'heart', 'rate', 'pattern', '', 'preterm', 'delivery', 'occur', 'patient', 'without', 'severe', 'respiratory', 'disease', '', 'appear', 'initial', 'third-trimester', 'case', 'electively', 'deliver', 'cesarean', 'bias', 'intervene', 'catalyze', 'belief', 'management', 'severe', 'maternal', 'respiratory', 'disease', 'improve', 'delivery', '', 'however', '', 'hypothesis', 'unproventhe', 'frequency', 'spontaneous', 'abortion', 'appear', 'increase', '', 'data', 'first-trimester', 'infection', 'limit', '', '112735', '', '', 'least', 'five', 'critically', 'ill', 'woman', 'fetal', 'death', '', 'four', 'woman', 'die', '', 'ecmo', '', '303233', '', '', '95', 'percent', 'newborn', 'condition', 'birth', '', 'neonatal', 'complication', 'largely', 'relate', 'preterm', 'birth', 'adverse', 'uterine', 'environment', 'result', 'critical', 'maternal', 'disease', '', '113336', '', 'hyperthermia', '', 'common', 'covid-19', '', 'theoretical', 'concern', 'elevation', 'maternal', 'core', 'temperature', 'febrile', 'illness', 'organogenesis', 'first', 'trimester', 'associate', 'increase', 'risk', 'congenital', 'anomaly', '', 'especially', 'neural', 'tube', 'defect', '', 'miscarriage', '', 'however', '', 'increase', 'incidence', 'outcome', 'observe', '', 'acetaminophen', 'pregnancy', '', 'include', 'first', 'trimester', '', 'show', 'overall', 'safe', 'attenuate', 'pregnancy', 'risk', 'associate', 'fever', 'exposure', '', '', '', 'open', 'neural', 'tube', 'defect', '', 'risk', 'factor', '', 'prenatal', 'screen', 'diagnosis', '', 'pregnancy', 'management', '', '', 'section', 'feverhyperthermia', '', '', '', 'vertical', 'transmission', '', 'vertical', 'transmission', 'prove', '', 'possibility', 'transmission', 'exclude', '', 'standards', 'neonatal', 'evaluation', 'delivery', 'infect', 'mother', 'criterion', 'vertical', 'transmission', 'develop', '', 'assessing', 'immunoglobulin', '', 'igm', '', 'level', 'virus', 'cord', 'blood', 'sample', 'neonatal', 'nasopharynx', '', 'amnion-chorion', 'interface', '', 'placental', 'tissue', 'aseptic', 'technique', 'immediately', 'delivery', 'suggest', '', 'amniotic', 'fluid', 'obtain', 'cesarean', 'delivery', 'testedin', 'woman', 'test', 'positive', 'sars-cov-2', 'nasopharynx', '', 'vaginal', 'amniotic', 'fluid', 'specimen', 'negative', 'date', '', '353738', '', '', 'viremia', 'rate', 'patient', 'covid-19', 'appear', 'low', '', '1', 'percent', 'one', 'study', '', '39', '', '', 'transient', '', 'suggest', 'placental', 'seed', 'vertical', 'transmission', 'unlikely', '', 'placenta', 'study', '', 'almost', 'evidence', 'infection', '', 'one', 'exception', 'case', 'report', 'patient', 'confirm', 'covid-19', 'second-trimester', 'miscarriage', 'sample', 'placental', 'cotyledon', 'submembrane', 'positive', 'sars-cov-2', '', 'fetal', '', 'amniotic', 'fluid', '', 'cord', 'blood', '', 'maternal', 'blood', 'vaginal', 'sample', 'negative', '', '40', '', '', 'another', 'report', 'describe', 'one', 'positive', 'placental', 'swab', 'amniotic', 'surface', 'two', 'positive', 'membrane', 'swab', 'amnion', 'chorion', 'manual', 'separation', 'membrane', 'woman', 'severe', 'critical', 'covid-19', 'illness', 'deliver', 'cesarean', '', 'none', 'infant', 'positive', 'sars-cov-2', '', '41', '', 'extent', 'clinical', 'significance', 'vertical', 'transmission', 'remain', 'unclear', '', 'possible', 'case', 'vertical', 'transmission', 'base', 'newborn', 'laboratory', 'andor', 'clinical', 'find', 'report', '', '2042-45', '', '', 'sars-cov-2', 'test', 'fetal', 'blood', '', 'amniotic', 'fluid', '', 'placenta', 'either', 'negative', 'perform', '', 'infant', 'deliver', 'cesarean', 'positive', 'nasopharyngeal', 'culture', 'sars-cov-2', 'day', '1', '2', 'life', '', 'elevate', 'igm', 'level', '', 'andor', 'pneumonia', '', 'positive', 'igm', 'result', 'definitive', 'evidence', 'utero', 'infection', '', 'false', 'positive', 'cross', 'reactivity', 'occur', '', '', '', 'case', '', 'early', 'infant', 'infection', 'due', 'postnatal', 'contact', 'infect', 'parent', 'caregiver', '', '46', '', 'approach', 'diagnosis', '', 'possibility', 'covid-19', 'consider', 'patient', 'new-onset', 'feverchills', 'andor', 'respiratory', 'tract', 'symptom', '', 'eg', '', 'cough', '', 'dyspnea', '', '', 'consider', 'patient', 'severe', 'lower', 'respiratory', 'tract', 'illness', 'without', 'clear', 'cause', '', 'residing', 'travel', 'location', 'community', 'transmission', 'sars-cov-2', 'close', 'contact', 'confirm', 'suspect', 'case', 'covid-19', 'past', '14', 'day', 'heighten', 'suspicion', '', 'patients', 'meet', 'test', 'criterion', 'undergo', 'test', 'sars-cov-2', 'rna', 'reverse-transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'nasopharyngeal', 'swab', 'specimen', '', 'ideally', 'addition', 'test', 'respiratory', 'pathogen', '', 'eg', '', 'influenza', '', 'respiratory', 'syncytial', 'virus', '', '', 'criteria', 'test', 'diagnostic', 'issue', 'discuss', 'detail', 'separately', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'area', 'infection', 'active', '', 'believe', 'test', 'patient', 'upon', 'presentation', 'labor', 'delivery', '', 'day', 'schedule', 'admission', '', 'rapid', 'test', 'sars-cov-2', 'reasonable', '', 'test', 'available', '', '', 'infection', 'control', 'precaution', '', '', '', 'test', 'occur', 'location', 'design', 'reduce', 'risk', 'pass', 'infection', 'uninfected', 'person', '', 'dedicate', '', 'walk-in', '', '', 'drive-in', '', 'test', 'location', 'result', 'readily', 'available', 'obstetric', 'provider', '', 'positive', 'rt-pcr', 'generally', 'confirm', 'diagnosis', 'covid-19', '', 'although', 'occasional', 'false-positive', 'test', 'occur', '', '47', '', '', 'false-negative', 'test', 'initial', 'test', 'appear', 'common', '', 'especially', 'four', 'day', 'precede', 'symptom', 'first', 'day', 'symptom', '', '48', '', '', 'report', 'pregnant', 'woman', '', '49', '', '', 'sensitivity', 'depend', 'several', 'factor', '', 'specific', 'rt-pcr', 'assay', '', 'type', 'specimen', 'obtain', '', 'nasopharyngeal', 'specimen', 'higher', 'sensitivity', 'oropharyngeal', 'nasal', 'specimen', '', '', 'quality', 'specimen', '', 'duration', 'illness', 'time', 'test', '', '47', '', '', 'initial', 'nasopharyngeal', 'test', 'negative', 'suspicion', 'covid-19', 'remain', 'determine', 'presence', 'infection', 'important', 'management', 'infection', 'control', '', 'test', 'repeat', '24', 'hour', 'day', '', 'infection', 'control', 'precaution', 'covid-19', 'continue', 'repeat', 'evaluation', 'perform', '', 'two', 'subsequent', 'negative', 'sample', 'generally', 'rule', 'infection', '', '50', '', '', 'high', 'suspicion', 'covid-19', 'infection', 'diagnosis', 'require', 'management', '', 'lower', 'respiratory', 'tract', 'specimen', '', 'eg', '', 'sputum', '', 'bronchoalveolar', 'lavage', '', 'test', 'higher', 'sensitivity', '', '51', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'laboratory', 'find', '', '', '', 'chest', 'radiograph', 'sufficient', 'initial', 'evaluation', 'pulmonary', 'complication', 'hospitalize', 'patient', 'covid-19', '', 'single', 'chest', 'radiograph', 'carry', 'low', 'fetal', 'radiation', 'dose', '00005', '001', 'mgy', '', 'computed', 'tomography', '', 'ct', '', 'perform', '', 'indicate', '', 'fetal', 'radiation', 'dose', 'routine', 'chest', 'ct', '', 'table', '1', '', 'low', 'associate', 'increase', 'risk', 'fetal', 'anomaly', 'pregnancy', 'loss', '', 'authority', 'advocate', 'pulmonary', 'ultrasound', '', 'possibly', 'time', 'obstetric', 'scan', '', 'quick', 'diagnosis', 'pneumonia', 'pregnant', 'woman', '', 'certain', 'location', 'quickest', 'way', 'ascertain', 'high', 'suspicion', 'maternal', 'covid-19', 'infection', '', '5253', '', '', 'detail', 'description', 'performance', 'lung', 'ultrasound', 'find', 'elsewhere', '', '52', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'evaluation', '', '', 'diagnostic', 'image', 'pregnant', 'nurse', 'woman', '', '', '', 'prenatal', 'carepreventing', 'exposure', 'community', '', 'social', 'distance', 'hygienic', 'measure', 'recommend', 'difficult', 'pregnant', 'woman', 'homeless', '', 'live', 'shelter', '', 'live', 'multigenerational', 'dense', 'house', '', 'live', 'multiple', 'place', 'short', 'time', '', 'social', 'distance', 'hygienic', 'measure', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'personal', 'preventive', 'measure', '', '', '', 'patients', 'potential', 'exposure', '', 'pregnant', 'patient', 'epidemiologic', 'history', 'contact', 'person', 'confirm', '', 'probable', '', 'suspect', 'covid-19', 'self-isolate', 'monitor', 'symptom', '', 'incubation', 'period', '14', 'day', '', 'diagnostic', 'test', 'sars-cov-2', 'infection', 'depend', 'test', 'availability', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'managing', 'asymptomatic', 'individual', 'potential', 'exposure', '', '', '', 'evaluation', 'management', 'patient', 'become', 'symptomatic', 'depend', 'illness', 'severity', '', 'underlie', 'comorbidities', '', 'clinical', 'status', '', 'least', 'moderate', 'illness', 'typically', 'hospitalize', '', 'issue', 'time', 'discontinuation', 'precaution', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', '', 'routine', 'prenatal', 'care', 'uninfected', 'woman', '', 'american', 'college', 'obstetricians', 'gynecologists', '', 'acog', '', 'society', 'maternal-fetal', 'medicine', 'issue', 'guidance', 'regard', 'prenatal', 'care', 'covid-19', 'pandemic', '', 'available', 'acogorg', 'smfmorg', '', '', '5455', '', '', 'include', 'general', 'guidance', 'test', 'prevent', 'spread', 'covid-19', '', 'algorithm', '', 'suggestion', 'modify', 'traditional', 'protocol', 'prenatal', 'visit', '', 'modification', '', 'tailor', 'low-', 'versus', 'high-risk', 'patient', '', 'eg', '', 'multiple', 'gestation', '', 'hypertension', '', 'diabetes', '', '', 'include', 'telehealth', '', 'reduce', 'number', 'in-person', 'visit', '', 'time', 'visit', '', 'group', 'test', '', 'eg', '', 'aneuploidy', '', 'diabetes', '', 'infection', 'screen', '', 'minimize', 'maternal', 'contact', 'others', '', 'restrict', 'visitor', 'visit', 'test', '', 'time', 'indicate', 'obstetric', 'ultrasound', 'examination', '', 'eg', '', 'gestational', 'age', '', 'fetal', 'anomaly', '', 'fetal', 'growth', '', 'placental', 'attachment', '', '', 'time', 'frequency', 'nonstress', 'test', 'biophysical', 'profile', '', 'way', 'reduce', 'time', 'patient', '', 'include', 'patient', 'high-risk', 'pregnancy', '', 'office', '', '56', '', '', 'example', '', 'clinician', 'order', '75', 'gram', 'two-hour', 'oral', 'glucose', 'tolerance', 'test', '', 'gtt', '', 'instead', 'glucose', 'challenge', 'test', '100', 'gram', 'three-hour', 'gtt', '', 'woman', 'positive', 'result', '', '', 'cell-free', 'dna', 'screen', '', '', '10', 'week', '', 'syndrome', 'screen', 'combine', 'test', '', 'ie', '', 'nuchal', 'translucency', 'ultrasound', 'serum', 'analytes', '', '', 'ideally', '', 'every', 'woman', 'telehealth', 'capability', 'mean', 'measure', 'blood', 'pressure', 'home', '', 'author', 'practice', '', 'pandemic', '', 'low-risk', 'pregnant', 'woman', 'office', 'in-person', 'prenatal', 'visit', 'approximately', '12', '', '20', '', '28', '', '36', 'week', 'gestation', '', 'ie', '', 'gestational', 'age', 'ultrasound', 'andor', 'laboratory', 'test', 'perform', '', 'minimize', 'person-to-person', 'contact', '', 'practice', 'encourage', 'visit', 'occur', 'telehealth', '', 'others', 'include', 'visit', 'approximately', '32', 'week', '', '50', '', '', 'outpatient', 'office', 'visit', 'occur', '', 'patient', 'health', 'care', 'worker', 'wear', 'least', 'surgical', 'mask', '', 'partner', 'allow', '', 'video', 'communication', 'encouragedthe', 'psychological', 'impact', 'covid-19', 'recognize', 'support', 'offer', '', 'one', 'study', '', 'approximately', 'one-third', 'respondent', 'report', 'moderate', 'severe', 'anxiety', '', '57', '', 'medical', 'management', 'pregnant', 'woman', 'covid-19home', 'care', '', 'pregnant', 'patient', 'suspect', 'covid-19', 'mild', 'disease', '', 'shortness', 'breath', '', 'warrant', 'hospital-level', 'care', 'absence', 'obstetric', 'problem', '', 'eg', '', 'preterm', 'labor', '', '', 'patient', 'instruction', 'aspect', 'home', 'care', 'similar', 'nonpregnant', 'person', '', 'except', 'pregnant', 'woman', 'third', 'trimester', 'perform', 'fetal', 'kick', 'count', 'report', 'decrease', 'fetal', 'movement', '', '50', '', '', 'patients', 'experience', 'homelessness', 'provide', 'resource', 'dedicate', 'house', 'unit', '', 'available', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'home', 'set', '', '', 'decreased', 'fetal', 'movement', '', 'diagnosis', '', 'evaluation', '', 'management', '', '', '', 'us', 'food', 'drug', 'administration', 'expand', 'approval', 'noninvasive', 'fetal', 'maternal', 'monitor', 'device', 'home', 'patient', 'require', 'fetal', 'andor', 'maternal', 'monitor', 'condition', 'unrelated', 'covid-19', '', '58', '', '', 'help', 'reduce', 'patient', 'health', 'care', 'provider', 'contact', 'potential', 'exposure', 'covid-19', 'pandemicmedical', 'obstetric', 'care', 'hospitalize', 'patient', '', 'pregnant', 'woman', 'mild', 'disease', 'plus', 'comorbidities', 'moderate', 'critical', 'disease', 'hospitalize', '', 'pregnant', 'hospitalize', 'patient', 'severe', 'disease', '', 'oxygen', 'requirement', 'plus', 'comorbidities', '', 'critical', 'disease', 'care', 'multispecialty', 'team', 'level', 'iii', 'iv', 'hospital', 'obstetric', 'service', 'adult', 'intensive', 'care', 'unit', '', 'icu', '', '', '950', '', '', 'covid-19', 'status', 'alone', 'necessarily', 'reason', 'transfer', 'noncritically', 'ill', 'pregnant', 'woman', 'suspect', 'confirm', 'covid-19', '', '', 'classification', 'disease', 'severity', '', '', '', 'guidelines', 'management', 'hospitalize', 'patient', 'covid-19', '', 'include', 'evaluation', 'care', 'critically', 'ill', 'patient', '', 'review', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'fetal', 'monitor', '', 'specific', 'management', 'issue', 'pregnant', 'patient', 'fetal', 'monitor', 'viable', 'gestational', 'age', '', 'frequency', 'fetal', 'test', 'depend', 'upon', 'gestational', 'age', '', 'stability', 'maternal', 'vital', 'sign', '', 'maternal', 'comorbidities', '', 'discussion', 'patient', 'family', 'consider', 'possibly', 'increase', 'risk', 'stillbirth', 'perinatal', 'morbidity', 'absence', 'test', '', 'hospitalize', 'patient', '', 'bluetooth-enabled', 'external', 'fetal', 'monitor', 'transmit', 'fetal', 'heart', 'rate', 'trace', 'obstetric', 'provider', '', 'monitor', 'continuously', 'unstable', 'hospitalize', 'patient', 'emergency', 'cesarean', 'delivery', 'perform', 'persistent', 'nonreassuring', 'fetal', 'heart', 'rate', 'pattern', '', 'abnormal', 'trace', 'help', 'guide', 'maternal', 'oxygen', 'therapy', '', 'patient', 'stable', 'oxygen', 'saturation', '', 'sao2', '', '', 'nonstress', 'test', 'perform', 'twice', 'daily', '', 'one', 'option', '', 'monitoring', 'preterm', 'labor', '', 'monitoring', 'pregnant', 'patient', 'sign', 'symptom', 'preterm', 'labor', 'routine', 'component', 'obstetric', 'care', 'component', 'maternal', 'monitor', 'pregnant', 'patient', 'hospitalize', 'nonobstetric', 'set', '', '', '', 'preterm', 'labor', '', 'clinical', 'find', '', 'diagnostic', 'evaluation', '', 'initial', 'treatment', '', '', '', 'maternal', 'oxygenation', 'level', '', 'among', 'critically', 'ill', 'covid-19', 'patient', '', 'profound', 'acute', 'hypoxemic', 'respiratory', 'failure', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'dominant', 'find', '', 'general', 'supportive', 'care', 'critically', 'ill', 'patient', 'covid-19', 'pneumonia', 'similar', 'patient', 'ards', 'due', 'cause', '', 'common', 'complication', 'covid-19-related', 'ards', 'include', 'acute', 'kidney', 'injury', '', 'elevate', 'liver', 'enzyme', '', 'cardiac', 'injury', '', 'eg', '', 'cardiomyopathy', '', 'pericarditis', '', 'pericardial', 'effusion', '', 'arrhythmia', '', 'sudden', 'cardiac', 'death', '', '', 'pregnancy', '', 'maternal', 'peripheral', 'oxygen', 'saturation', '', 'spo2', '', 'maintain', '95', 'percent', '', 'excess', 'oxygen', 'delivery', 'mother', '', 'spo2', 'fall', '95', 'percent', '', 'arterial', 'blood', 'gas', 'obtain', 'measure', 'partial', 'pressure', 'oxygen', '', 'pao2', '', '', 'maternal', 'pao2', 'greater', '70', 'mmhg', 'desirable', 'maintain', 'favorable', 'oxygen', 'diffusion', 'gradient', 'maternal', 'fetal', 'side', 'placentain', 'icu', '', 'severely', 'ill', 'patient', 'covid-19', 'often', 'manage', 'prone', 'position', '', 'icus', 'extend', 'approach', 'pregnant', 'woman', '', 'although', 'semi-prone', 'position', 'difficult', 'position', 'place', 'pregnant', 'woman', 'last', 'half', 'pregnancy', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'critical', 'illness', 'pregnancy', 'peripartum', 'period', '', '', 'section', 'supportive', 'care', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', 'type', 'venous', 'thromboembolism', 'prophylaxis', '', 'direct', 'data', 'thromboembolic', 'risk', 'covid-19', 'limit', 'suggest', 'increase', 'risk', '', 'american', 'society', 'hematology', '', 'society', 'critical', 'care', 'medicine', '', 'international', 'society', 'thrombosis', 'haemostasis', '', '59-61', '', 'recommend', 'routine', 'pharmacologic', 'venous', 'thromboembolism', 'prophylaxis', 'patient', 'hospitalize', 'covid-19', 'unless', 'contraindication', '', 'eg', '', 'bleed', '', 'severe', 'thrombocytopenia', '', '', 'initiate', 'prophylaxis', 'pregnantpostpartum', 'woman', 'covid-19', 'admit', 'hospital', 'management', 'antepartum', 'postpartum', 'obstetric', 'medical', 'disorder', 'severity', 'covid-19', 'alone', '', 'antepartum', 'prophylaxis', 'woman', 'severely', 'critically', 'ill', 'deliver', 'within', 'day', '', 'unfractionated', 'heparin', '5000', 'unit', 'subcutaneously', 'every', '12', 'hour', 'reasonable', 'dose', '', 'dosing', 'inpatient', 'clinical', 'scenario', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'inpatient', 'vte', 'prophylaxis', '', 'postpartum', 'care', '', '', '', 'unfractionated', 'heparin', 'generally', 'prefer', 'pregnant', 'woman', 'proximate', 'delivery', 'readily', 'reverse', 'low', 'molecular', 'weight', 'heparin', '', 'low', 'molecular', 'weight', 'heparin', 'reasonable', 'woman', 'unlikely', 'deliver', 'within', 'several', 'day', 'postpartum', '', 'dosing', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'inpatient', 'vte', 'prophylaxis', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'outpatient', 'thromboprophylaxis', '', '', 'anticoagulant', 'pregnancy', 'postpartum', '', '', '', 'safety', 'antiviral', 'drug', 'therapy', '', 'several', 'agent', 'evaluate', 'treatment', 'covid-19', '', 'although', 'agent', 'clinically', 'available', 'indication', '', 'covid-19', 'remain', 'investigational', '', 'remdesivir', '', 'hospital', '', 'pregnant', 'woman', 'severe', 'covid-19', 'offer', 'remdesivir', 'compassionate-use', 'protocol', '', 'remdesivir', 'novel', 'nucleotide', 'analogue', 'activity', 'sars-cov-2', 'vitro', '', '62', '', 'relate', 'coronaviruses', '', 'include', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'middle', 'east', 'respiratory', 'syndrome-related', 'coronavirus', '', 'mers-cov', '', '', 'vitro', 'animal', 'study', '', '63', '', '', 'without', 'report', 'fetal', 'toxicity', 'pregnant', 'woman', 'ebola', 'marburg', 'virus', 'disease', '', '64', '', 'treat', '', 'compassionate-use', 'basis', '', 'pregnant', 'patient', 'severe', 'covid-19', '', 'randomized', 'trial', 'drug', 'covid-19', 'pandemic', 'exclude', 'pregnant', 'breastfeed', 'woman', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'drug', '', 'data', 'early', 'randomize', 'trial', 'generally', 'suggest', 'benefit', 'administration', 'hydroxychloroquine', 'hydroxychloroquine', '', 'furthermore', '', 'adverse', 'maternal', 'effect', 'include', 'abnormal', 'heart', 'rhythm', '', 'qt', 'interval', 'prolongation', 'ventricular', 'tachycardia', '', '', 'especially', 'patient', 'drug', 'associate', 'qtc', 'prolongation', '', 'therefore', '', 'drug', 'treatment', 'covid-19', 'outside', 'ongoing', 'randomize', 'trial', '', 'hydroxychloroquine', 'cross', 'placenta', '', 'accumulation', 'fetal', 'ocular', 'tissue', 'observe', 'animal', 'study', '', 'increase', 'risk', 'fetal', 'ocular', 'abnormality', 'observe', 'human', '', 'reassure', 'give', 'drug', 'pregnant', 'woman', 'treatment', 'systemic', 'lupus', 'erythematosus', 'prevention', 'malaria', '', 'available', 'data', 'limit', '', 'however', '', 'risk', 'fetus', 'rule', 'different', 'indication', '', '65', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'hydroxychloroquinechloroquine', '', '', 'malaria', 'pregnancy', '', 'prevention', 'treatment', '', '', 'section', 'safety', 'antimalarial', 'pregnancy', '', '', 'pregnancy', 'woman', 'systemic', 'lupus', 'erythematosus', '', '', 'section', 'medications', '', '', '', 'several', 'drug', 'research', 'study', '', 'one', 'drug', 'lopinavir-ritonavir', '', 'primarily', 'treatment', 'hiv', 'infection', '', 'include', 'pregnancy', '', 'cross', 'placenta', 'increase', 'risk', 'preterm', 'delivery', '', 'increase', 'risk', 'teratogenic', 'effect', 'observe', 'human', '', 'investigational', 'drug', 'covid-19', 'teratogenic', 'include', 'ribavirin', 'baracitinib', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'standard', 'medication', 'manage', 'pregnancy', 'complicationsantenatal', 'betamethasone', '', 'general', 'population', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'recommend', 'avoid', 'glucocorticoid', 'covid-19-positive', 'person', 'associate', 'increase', 'risk', 'mortality', 'patient', 'influenza', 'delay', 'viral', 'clearance', 'patient', 'mers-cov', 'infection', '', 'however', '', 'cdc', 'address', 'antenatal', 'glucocorticoid', 'reduce', 'neonatal', 'morbidity', 'mortality', 'preterm', 'birth', 'pregnant', 'covid-19-positive', 'patientsbecause', 'clear', 'benefit', 'antenatal', 'betamethasone', 'administration', '240', '336', 'week', 'gestation', 'patient', 'high', 'risk', 'preterm', 'birth', 'within', 'seven', 'day', '', 'acog', 'continue', 'recommend', 'standard', 'indication', 'pregnant', 'patient', 'suspect', 'confirm', 'covid-19', '', '66', '', '', 'however', '', 'pregnant', 'patient', 'suspect', 'confirm', 'covid-19', '340', '366', 'week', 'gestation', 'risk', 'preterm', 'birth', 'within', 'seven', 'day', '', 'benefit', 'neonate', 'le', 'clear', '', 'acog', 'advise', 'administer', 'course', 'betamethasone', 'patient', '', 'however', '', 'decision', 'individualize', '', 'weigh', 'neonatal', 'benefit', 'risk', 'potential', 'harm', 'pregnant', 'patient', '', '', '', 'antenatal', 'corticosteroid', 'therapy', 'reduction', 'neonatal', 'respiratory', 'morbidity', 'mortality', 'preterm', 'delivery', '', '', 'section', 'gestational', 'age', 'administration', '', '', '', 'low-dose', 'aspirin', '', 'pregnant', 'woman', 'without', 'covid-19', '', 'acog', 'state', 'low-dose', 'aspirin', 'continue', 'offer', 'medically', 'indicate', '', 'eg', '', 'prevention', 'preeclampsia', '', '', '67', '', '', 'suspect', 'confirm', 'covid-19', 'low-dose', 'aspirin', 'indicate', '', 'decision', 'continue', 'drug', 'individualize', '', 'example', '', 'continue', 'preeclampsia', 'prophylaxis', 'likely', 'worthwhile', 'severely', 'critically', 'ill', 'patient', 'near', 'term', '', 'panel', 'national', 'institutes', 'health', 'state', 'person', 'covid-19', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'comorbid', 'condition', 'continue', 'therapy', 'previously', 'direct', 'health', 'care', 'provider', '', '12', '', 'concern', 'possible', 'negative', 'effect', 'nsaids', 'raise', 'anecdotal', 'report', 'young', '', 'nonpregnant', 'patient', 'receive', 'nsaids', '', 'ibuprofen', '', 'early', 'course', 'infection', 'experience', 'severe', 'disease', '', '6869', '', '', 'however', '', 'clinical', 'population-based', 'data', 'directly', 'address', 'risk', 'nsaids', '', 'given', 'absence', 'data', '', 'european', 'medicines', 'agency', 'world', 'health', 'organization', 'recommend', 'avoid', 'nsaids', 'covid-19', 'patient', 'clinically', 'indicate', '', '7071', '', '', 'tocolysis', '', 'woman', 'suspect', 'covid-19', '', 'prefer', 'tocolytic', 'nifedipine', '', 'suitable', 'alterative', 'indomethacin', '', 'concern', 'discuss', '', 'beta', 'sympathomimetics', '', 'increase', 'maternal', 'heart', 'rate', '', 'follow-up', 'woman', 'recover', 'covid-19', '', 'development', 'fetal', 'growth', 'restriction', 'theoretic', 'concern', 'describe', 'sars', 'infection', '', '7273', '', '', 'absence', 'robust', 'data', '', 'authority', 'suggest', 'pregnant', 'woman', 'confirm', 'infection', 'monitor', 'serial', 'ultrasound', 'assessment', 'fetal', 'growth', 'amniotic', 'fluid', 'volume', '', '74', '', 'begin', '14', 'day', 'symptom', 'resolution', '', '75', '', '', 'first-', 'early', 'second-trimester', 'infection', '', 'detail', 'fetal', 'morphology', 'scan', '18', '23', 'week', 'gestation', 'indicate', '', 'limit', 'covid-19-specific', 'data', 'fetal', 'growth', 'available', '', '18', '', '', 'suboptimal', 'fetal', 'growth', 'due', 'placental', 'insufficiency', 'plausible', 'maternal', 'covid-19', 'associate', 'focal', 'avascular', 'villus', 'thrombus', 'larger', 'fetal', 'vessel', 'chorionic', 'plate', 'stem', 'villus', '', '76', '', '', 'lesion', 'cause', 'covid-19-related', 'coagulopathy', 'placental', 'hypoxia', 'acute', 'maternal', 'illness', '', '', 'timing', 'delivery', 'infect', 'woman', '', 'woman', 'preterm', 'covid-19', 'nonsevere', 'illness', 'medicalobstetric', 'indication', 'prompt', 'delivery', '', 'delivery', 'indicate', 'ideally', 'occur', 'sometime', 'negative', 'test', 'result', 'obtain', 'isolation', 'status', 'lift', '', 'thereby', 'minimize', 'risk', 'postnatal', 'transmission', 'neonate', '', '77', '', 'woman', 'severe', 'illness', '', 'multiple', 'issue', 'consider', '', 'time', 'delivery', 'individualize', '', '5078', '', '', 'whether', 'mother', 'respiratory', 'disease', 'improve', 'delivery', 'risk', 'postnatal', 'transmission', 'delivery', 'room', 'maternal', 'symptom', 'acute', 'unclear', '', 'note', 'maternal', 'antibody', 'production', '', 'turn', '', 'passive', 'newborn', 'immunity', 'time', 'develop', '', 'hand', '', 'increase', 'oxygen', 'consumption', 'reduce', 'functional', 'residual', 'capacity', '', 'normal', 'pregnancy', '', 'facilitate', 'maternal', 'deterioration', 'patient', 'pneumonia', '', '79', '', '', 'excessive', 'uterine', 'distension', 'multiple', 'gestation', 'severe', 'polyhydramnios', 'third', 'trimester', 'compromise', 'pulmonary', 'functionfor', 'hospitalize', 'patient', 'covid-19', 'pneumonia', 'intubate', '', 'authority', 'advocate', 'consideration', 'delivery', 'pregnancy', '', '32', '34', 'week', '', 'rationale', 'delivery', 'perform', 'pulmonary', 'situation', 'worsen', 'ongoing', 'maternal', 'hypoxemia', 'place', 'fetus', 'risk', 'compromise', '', 'authority', 'advocate', 'delivery', 'prior', '32', 'week', '', 'though', 'maternal', 'situation', 'worsen', 'second', 'week', '', 'give', 'morbidity', 'mortality', 'preterm', 'infantstiming', 'delivery', 'hospitalize', 'pregnant', 'woman', 'intubate', 'critically', 'ill', 'covid-19', 'challenge', '', '32', '34', 'week', '', 'advocate', 'delivery', 'patient', 'stable', '', 'exacerbate', 'maternal', 'condition', '', 'viability', '', '32', 'week', '', 'continue', 'maternal', 'support', 'fetal', 'monitor', 'usually', 'suggest', 'perinatal', 'benefit', 'long', 'maternal', 'situation', 'remain', 'stable', 'improve', '', 'situation', '', 'maternal', 'extracorporeal', 'membrane', 'oxygenation', 'necessary', '', '80', '', '', 'management', 'labor', 'delivery', '', 'although', 'asymptomatic', 'patient', 'concern', 'leave', 'home', 'covid-19', 'pandemic', '', 'american', 'college', 'obstetricians', 'gynecologists', '', 'acog', '', 'continue', 'recommend', 'follow', 'exist', 'evidence-based', 'guidance', 'regard', 'home', 'birth', '', '67', '', '', '', '', 'planned', 'home', 'birth', '', '', '', 'infection', 'control', 'precautionsprehospital', 'notification', 'possible', 'infection', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'recommend', 'pregnant', 'patient', 'confirm', 'suspect', 'covid-19', 'notify', 'obstetric', 'unit', 'arrival', 'facility', 'appropriate', 'infection', 'control', 'preparation', '', '81', '', '', 'obstetric', 'unit', 'ensure', 'infection', 'control', 'practice', 'patient', 'consistent', 'cdc', 'guideline', '', 'evaluation', 'patient', 'present', 'hospital', '', 'patient', 'screen', 'sign', 'symptom', 'covid-19', '', 'well', 'whether', 'close', 'contact', 'confirm', 'case', 'person', 'investigation', '', 'enter', 'hospital', 'admission', 'labor', 'delivery', 'unit', '', '82', '', '', 'screening', 'include', 'check', 'temperature', 'ask', 'fever', 'andor', 'new', 'cough', '', 'shortness', 'breath', '', 'sore', 'throat', '', 'muscle', 'ache', '', 'rhinorrheanasal', 'congestion', '', 'smell', 'taste', 'abnormality', '', 'cdc', 'advise', 'prioritize', 'test', 'pregnant', 'woman', 'suspect', 'covid-19', 'admission', 'develop', 'symptom', 'covid-19', 'admission', '', '81', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'measures', 'patient', '', 'visitor', '', 'personnel', '', '', '', 'asymptomatic', 'patient', 'presymptomatic', 'patient', 'present', 'labor', 'delivery', 'unit', '', 'implication', 'health', 'care', 'staff', 'management', 'newborn', '', 'reason', '', 'area', 'infection', 'community', 'widespread', '', 'believe', 'test', 'patient', 'upon', 'presentation', 'labor', 'delivery', '', 'day', 'schedule', 'admission', '', 'rapid', 'sars-cov-2', 'test', 'reasonable', '', 'test', 'available', '', 'believe', 'information', 'useful', 'inform', 'infection', 'control', 'precaution', 'intrapartum', 'postpartum', '', 'include', 'newborn', 'care', '', '148384', '', '', 'new', 'york', 'city', 'pandemic', '', '215', 'pregnant', 'woman', 'admit', 'two', 'new', 'york', 'city', 'hospital', 'delivery', 'screen', 'covid-19', '', '33', '', '15', 'percent', '', 'sars-cov-2-positive', '', '21', '', '', '33', 'woman', '', '4', 'symptomatic', '29', 'asymptomatic', '', 'thus', '', '135', 'percent', 'asymptomatic', 'patient', 'admit', 'delivery', 'test', 'positive', 'sars-cov-2', '', 'among', 'asymptomatic', 'woman', 'test', 'positive', '', '329', 'develop', 'postpartum', 'fever', '', 'least', 'one', 'patient', 'presume', 'covid-19', '', 'one', 'additional', 'patient', 'test', 'negative', 'admission', 'become', 'symptomatic', 'postpartum', '', 'repeat', 'sars-cov-2', 'test', 'positive', '', 'however', '', 'find', 'likely', 'generalizable', 'area', 'prevalence', 'covid-19', 'lowthe', 'evaluation', 'diagnosis', 'woman', 'admit', 'labor', 'delivery', 'suspect', 'covid-19', 'similar', 'patient', 'admit', 'hospital', 'suspect', 'disease', '', 'cdc', 'advise', 'prioritize', 'test', 'pregnant', 'woman', 'suspect', 'covid-19', 'admission', 'develop', 'symptom', 'covid-19', 'admission', '', '81', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'personal', 'protective', 'equipment', '', 'ppe', '', 'labor', 'delivery', '', 'health', 'care', 'worker', 'appropriate', 'ppe', 'care', 'patient', 'covid-19', '', 'addition', '', 'patient', 'visitor', 'give', 'face', 'cover', 'upon', 'entry', 'health', 'care', 'set', '', 'medical', 'cloth', 'mask', '', 'universal', 'source', 'control', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'measures', 'patient', '', 'visitor', '', 'personnel', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'active', 'labor', '', 'particular', '', 'concern', 'viral', 'dissemination', 'patient', 'forcefully', 'exhale', '', '85', '', '', 'forceful', 'exhalation', 'reduce', 'effectiveness', 'mask', 'contain', 'respiratory', 'droplet', 'prevent', 'spread', 'virus', '', 'care', 'covid-19-positive', 'inpatient', '', 'ideally', '', 'pregnant', 'covid-19', 'inpatient', 'care', 'specially', 'equip', '', 'eg', '', 'negative-pressure', '', 'room', 'antepartum', '', 'intrapartum', '', 'postpartum', 'covid-19-only', 'unit', '', 'similar', 'adult', 'covid-19', 'inpatient', 'usually', 'place', 'dedicate', 'covid-19-only', 'unit', '', 'hall', '', 'hospital', '', 'patients', 'suspect', 'confirm', 'covid-19', 'normally', 'instruct', 'wear', 'face', 'mask', '', 'include', 'labor', 'delivery', '', 'difficult', 'active', 'push', '', '85', '', '', 'infection', 'control', 'precaution', 'regard', 'pregnant', 'patient', 'confirm', 'suspect', 'infection', 'similar', 'hospitalize', 'patient', 'review', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'support', 'person', 'labor', 'delivery', '', 'perhaps', 'controversial', 'issue', 'regard', 'infection', 'control', 'woman', 'labor', 'delivery', 'unit', 'whether', 'allow', 'support', 'person', '', 'facility', 'recognize', 'support', 'person', 'important', 'labor', 'woman', 'permit', 'one', 'support', 'person', 'must', 'remain', 'labor', 'woman', '', 'leave', 'room', 'return', '', '', 'doula', 'consider', 'type', 'health', 'care', 'personnel', 'facility', 'visitor', 'others', '', '', '', 'continuous', 'labor', 'support', 'doula', '', '', '', 'support', 'person', 'screen', 'fever', 'symptom', 'enter', 'build', 'accordance', 'hospital', 'policy', '', 'symptom', 'consistent', 'covid-19', '', 'exposure', 'confirm', 'case', 'within', '14', 'day', '', 'positive', 'test', 'covid-19', 'within', '14', 'day', 'allow', 'attend', 'labor', 'birth', '', 'screen', 'negative', '', 'require', 'support', 'person', 'wear', 'cloth', 'face', 'cover', '', 'minimum', '', 'consistent', 'cdc', 'guidance', '', '82', '', '', 'support', 'person', 'arrive', 'health', 'care', 'facility', 'without', 'cloth', 'face', 'cover', '', 'face', 'mask', 'issue', 'supply', 'availablea', 'support', 'person', 'screen', 'positive', 'permit', 'hospital', '', 'case', 'additional', 'support', 'person', 'desire', '', 'part', 'patient', 'labor', 'delivery', 'via', 'video', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'measures', 'patient', '', 'visitor', '', 'personnel', '', '', '', 'route', 'delivery', '', 'covid-19', 'indication', 'alter', 'route', 'delivery', '', '1654', '', '', 'cesarean', 'delivery', 'perform', 'standard', 'obstetric', 'indication', '', 'vertical', 'transmission', 'confirm', 'additional', 'data', 'report', '', 'indication', 'cesarean', 'delivery', 'since', 'increase', 'maternal', 'risk', 'unlikely', 'improve', 'newborn', 'outcome', '', 'reports', 'covid-19', 'infection', 'neonate', 'generally', 'describe', 'mild', 'disease', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', 'screening', 'patient', 'schedule', 'induction', 'cesarean', 'delivery', '', 'patients', 'screen', 'covid-19', 'undergo', 'pre-inductionpre-cesarean', 'laboratory', 'test', 'day', 'plan', 'induction', 'cesarean', 'delivery', '', 'evaluate', 'symptomatic', 'patient', 'determine', 'whether', 'feasible', 'reschedule', 'result', 'covid-19', 'test', 'available', '', 'require', 'balance', 'risk', 'continue', 'pregnancy', 'set', 'positive', 'negative', 'test', 'result', '', 'particular', '', 'result', 'positive', '', 'patient', 'become', 'severely', 'ill', 'time', 'since', 'symptom', 'often', 'severe', 'second', 'week', 'illnessin', 'asymptomatic', 'woman', '', 'induction', 'labor', 'cesarean', 'delivery', 'appropriate', 'medical', 'indication', 'postpone', 'reschedule', '', 'include', '39-week', 'induction', 'cesarean', 'delivery', 'patient', 'counsel', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'course', 'complication', '', '', '', 'analgesia', 'anesthesia', '', 'patient', 'suspect', 'covid-19', '', 'neuraxial', 'anesthetic', 'contraindicate', 'several', 'advantage', 'labor', 'patient', '', 'provide', 'analgesia', 'thus', 'reduce', 'cardiopulmonary', 'stress', 'pain', 'anxiety', '', 'turn', '', 'chance', 'viral', 'dissemination', '', 'available', 'case', 'emergency', 'cesarean', 'require', '', 'thus', 'obviate', 'general', 'anesthesia', '', 'society', 'obstetric', 'anesthesia', 'perinatology', 'suggest', 'consider', 'suspend', 'nitrous', 'oxide', 'labor', 'analgesia', 'patient', 'insufficient', 'data', 'clean', '', 'filter', '', 'potential', 'aerosolization', 'nitrous', 'oxide', 'system', '', '86', '', '', 'urge', 'consideration', 'limit', 'intravenous', '', 'patient-controlled', 'analgesia', 'risk', 'respiratory', 'depression', '', 'general', 'anesthesia', '', 'intubation', 'extubation', '', 'consider', 'aerosolize', 'procedure', '', 'special', 'ppe', '', 'ie', '', 'n-95', 'mask', '', 'etc', '', 'wear', 'involve', 'health', 'care', 'provider', 'cesarean', 'delivery', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', 'magnesium', 'sulfate', '', 'woman', 'respiratory', 'compromise', '', 'magnesium', 'sulfate', 'maternal', 'seizure', 'prophylaxis', 'andor', 'neonatal', 'neuroprotection', 'decide', 'case-by-case', 'basis', 'since', 'drug', 'depress', 'respiration', '', 'consultation', 'maternal-fetal', 'medicine', 'pulmonarycritical', 'care', 'specialist', 'advisedlabor', 'management', '', 'generally', '', 'management', 'labor', 'alter', 'woman', 'give', 'birth', 'covid-19', 'pandemic', 'woman', 'confirm', 'suspect', 'covid-19', 'asymptomatic', 'mild', '', '85', '', '', 'person-to-person', 'contact', 'time', 'labor', 'unit', 'hospital', 'limit', '', 'safely', 'feasible', '', 'patient', 'require', 'cervical', 'ripen', '', 'outpatient', 'mechanical', 'ripen', 'balloon', 'catheter', 'option', '', 'inpatient', 'cervical', 'ripen', '', 'two', 'method', '', 'eg', '', 'mechanical', 'misoprostol', 'mechanical', 'oxytocin', '', 'decrease', 'time', 'induction', 'delivery', '', 'compare', 'one', 'agent', '', '', '', 'techniques', 'ripen', 'unfavorable', 'cervix', 'prior', 'induction', '', '', 'section', 'outpatient', 'cervical', 'ripen', '', '', 'techniques', 'ripen', 'unfavorable', 'cervix', 'prior', 'induction', '', '', 'section', 'balloon', 'catheter', 'combine', 'prostaglandin', '', '', '', 'continuous', 'electronic', 'fetal', 'monitor', 'recommend', 'woman', 'suspect', 'confirm', 'covid-19', '', 'increase', 'frequency', 'nonreassuring', 'trace', 'report', '', 'case', 'series', 'typically', 'high', 'proportion', 'woman', 'pneumonia', '', 'intake', 'output', 'fluid', 'carefully', 'monitor', 'woman', '', 'aggressive', 'hydration', 'avoid', 'since', 'lead', 'pulmonary', 'edema', 'worsen', 'maternal', 'oxygenation', 'already', 'compromise', '', '79', '', '', 'nonpregnant', 'patient', 'severe', 'covid-19', '', 'conservative', 'fluid', 'management', 'recommend', '', 'long', 'hypotension', 'organ', 'hypoperfusion', 'avoid', '', '', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'supportive', 'care', 'oxygenation', 'adult', '', '', 'section', 'fluid', 'management', '', '', '', 'sars-cov-2', 'detect', 'vaginal', 'secretion', 'amniotic', 'fluid', '', 'rupture', 'fetal', 'membrane', 'internal', 'fetal', 'heart', 'rate', 'monitor', 'perform', 'usual', 'indication', '', 'data', 'limit', '', '19', '', '', 'note', 'labor', '', 'particularly', 'push', '', 'often', 'cause', 'loss', 'feces', '', 'contain', 'virus', 'spread', 'infection', '', '3987', '', 'believe', 'intervention', 'increase', 'risk', 'infection', 'prove', 'beneficial', '', 'example', 'birth', 'ball', 'peanut', 'ball', '', 'limit', '', 'intrapartum', 'oxygen', 'prove', 'fetal', 'benefit', '', 'practice', 'oxygen', 'therapy', 'fetal', 'resuscitation', 'abandon', '', 'nasal', 'cannula', 'face', 'mask', 'contact', 'maternal', 'respiratory', 'tract', 'secretion', '', 'handle', 'equipment', 'increase', 'contaminationexposure', 'patient', 'provider', '', 'lastly', '', 'advocate', 'delay', 'push', 'second', 'stage', '', 'although', 'others', 'suggest', 'minimize', 'duration', 'active', 'push', 'deep', 'breathe', 'maternal', 'expulsive', 'effort', 'increase', 'exposure', 'patient', 'respiratory', 'secretion', '', '79', '', '', '', '', 'intrapartum', 'category', '', 'ii', '', 'iii', 'fetal', 'heart', 'rate', 'trace', '', 'management', '', '', 'section', 'utero', 'resuscitation', '', '', 'nonpharmacologic', 'approach', 'management', 'labor', 'pain', '', '', 'section', 'birth', 'ball', '', '', 'management', 'normal', 'labor', 'delivery', '', '', 'section', 'pushing', 'position', 'technique', '', '', '', 'delivery', 'procedure', '', 'woman', 'suspect', 'infection', '', 'acog', 'state', 'delay', 'umbilical', 'cord', 'clamp', 'highly', 'unlikely', 'increase', 'risk', 'transmit', 'pathogen', 'infect', 'mother', 'fetus', '', '54', '', '', 'however', '', 'institution', 'choose', 'prohibit', 'practice', 'term', 'infant', '', 'benefit', 'modest', '', 'minimize', 'newborn', 'exposure', 'virus', 'immediate', 'environment', 'reduce', 'chance', 'newborn', 'require', 'phototherapy', 'jaundice', '', 'institution', 'prohibit', 'skin-to-skin', 'contact', 'case', '', '88', '', '', 'although', 'world', 'health', 'organization', 'american', 'academy', 'pediatrics', 'advise', '', '1689', '', '', 'one', 'expert', 'group', 'suggest', 'leave', 'vernix', 'caseosa', 'place', '24', 'hour', 'birth', 'since', 'contain', 'antimicrobial', 'peptide', '', '90', '', '', 'whereas', 'american', 'academy', 'pediatrics', 'advise', 'bath', 'newborn', 'soon', 'reasonably', 'possible', 'birth', 'remove', 'virus', 'potentially', 'present', 'skin', 'surface', '', '91', '', 'umbilical', 'cord', 'blood', 'bank', 'perform', 'plan', '', 'risk', 'covid-19', 'transmission', 'blood', 'product', 'document', 'unclear', 'present', '', '54', '', 'procedures', 'test', 'vertical', 'transmission', 'describe', '', '', 'vertical', 'transmission', '', '', '', 'intrapartum', 'postpartum', 'fever', '', 'covid-19', 'infection', 'part', 'differential', 'diagnosis', 'intrapartum', 'postpartum', 'fever', '', 'particularly', 'accompany', 'respiratory', 'symptom', 'reduce', 'oxygenation', '', 'patient', 'test', 'virus', '', 'along', 'evaluation', 'common', 'cause', 'intrapartum', 'postpartum', 'infection', '', 'eg', '', 'chorioamnionitis', '', 'endometritis', '', '', '14', '', '', '', '', 'intrapartum', 'fever', '', '', 'postpartum', 'endometritis', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'postpartum', 'carevenous', 'thromboembolism', 'prophylaxis', '', 'venous', 'thromboembolism', '', 'vte', '', 'prophylaxis', 'consider', 'postpartum', 'woman', 'covid-19', '', 'decision', 'base', 'individual', 'risk', 'assessment', '', 'wide', 'variation', 'practice', '', 'patient', 'receive', 'antepartum', 'pharmacologic', 'prophylaxis', 'covid-19', '', 'administer', 'postpartum', 'prophylaxis', 'remain', 'asymptomatic', 'mildly', 'symptomatic', 'uncomplicated', 'delivery', '', 'standard', 'indication', 'postpartum', 'vte', 'prophylaxis', '', 'patient', 'receive', 'antepartum', 'prophylaxis', 'covid-19', '', 'authority', 'recommend', 'discontinue', 'prophylaxis', 'upon', 'discharge', 'absence', 'ongoing', 'risk', 'factor', 'vte', '', 'eg', '', 'immobilization', '', 'recent', 'surgery', '', '', 'whereas', 'others', 'continue', 'prophylaxis', '7', '14', 'day', '', 'six', 'week', '', 'patient', 'moderateseverecritical', 'disease', 'mild', 'disease', 'vte', 'risk', 'factor', '', '507992', '', '', 'issue', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'inpatient', 'vte', 'prophylaxis', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'outpatient', 'thromboprophylaxis', '', '', 'anticoagulant', 'pregnancy', 'postpartum', '', '', '', 'maternal', 'monitoringfor', 'patient', 'suspect', 'covid-19', 'asymptomatic', '', 'postpartum', 'maternal', 'monitor', 'routine', '', 'patient', 'mild', 'illness', '', 'classification', 'disease', 'severity', '', '', '', 'check', 'vital', 'sign', 'monitor', 'intake', 'output', 'every', '4', 'hour', '24', 'hour', 'vaginal', 'delivery', '48', 'hour', 'cesarean', 'delivery', '', 'patient', 'moderate', 'illness', '', 'perform', 'continuous', 'pulse', 'oximetry', 'monitor', 'first', '24', 'hour', 'improvement', 'sign', 'symptom', '', 'whichever', 'longer', '', 'type', 'frequency', 'follow-up', 'laboratory', 'study', 'chest', 'image', '', 'initial', 'repeat', '', 'guide', 'patient', 'course', '', 'several', 'institutional', 'protocol', 'available', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'institutional', 'protocol', '', '', '', 'patient', 'severe', 'critical', 'illness', '', 'close', 'maternal', 'monitor', 'care', 'labor', 'delivery', 'unit', 'intensive', 'care', 'unit', 'indicate', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'infant', 'evaluation', '', 'infant', 'mother', 'covid-19', 'consider', 'covid-19', 'suspect', '', 'test', '', 'isolate', 'healthy', 'infant', '', 'care', 'accord', 'infection', 'control', 'precaution', 'patient', 'confirm', 'suspect', 'covid-19', '', '81', '', '', 'test', 'capacity', 'available', '', 'neonate', 'test', 'sars-cov-2', 'infection', 'soon', 'possible', 'within', 'first', '24', 'hour', 'age', 'available', 'molecular', 'assay', '', '91', '', '', 'repeat', 'test', 'perform', 'approximately', '48', 'hour', 'age', 'infant', 'still', 'birth', 'facility', '', 'throat', 'nasopharynx', 'sample', '', 'one', 'swab', 'conserve', 'swab', 'polymerase', 'chain', 'reaction', 'test', 'reagent', '', 'separate', 'rectal', 'swab', 'obtain', 'test', 'available', 'center', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'mother-baby', 'contact', '', 'temporary', 'separation', 'mother', 'suspect', 'covid-19', 'newborn', 'propose', 'reduce', 'risk', 'mother-baby', 'transmission', '', 'adverse', 'consequence', '', '93', '', '', 'example', '', 'rooming-in', 'avoid', 'skin-to-skin', 'contact', 'stressful', 'mother', '', 'disrupt', 'breastfeed', '', 'negative', 'effect', 'newborn', 'stress', '', 'feed', '', 'bondingthe', 'world', 'health', 'organization', '', '', 'opine', 'mother', 'suspect', '', 'probable', '', 'confirm', 'covid-19', 'virus', 'infection', 'enable', 'remain', 'together', 'practice', 'skin-to-skin', 'contact', '', '16', '', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'advise', 'determine', 'whether', 'separate', 'mother', 'suspect', 'covid-19', 'infant', 'case-by-case', 'basis', '', 'share', 'decision', 'mother', 'clinical', 'team', '', '81', '', '', 'factors', 'consider', 'include', '', 'mother', 'infant', 'clinical', 'conditionswhether', 'mother', 'infection', 'suspect', '', 'sars-cov-2', 'test', 'result', '', 'confirm', '', 'infant', 'sars-cov-2', 'test', 'result', '', 'separation', 'necessary', 'infant', 'positive', 'test', '', 'mother', 'desire', 'breastfeedthe', 'facility', 'ability', 'accommodate', 'mother-baby', 'separation', 'colocationthe', 'mother', 'ability', 'maintain', 'separation', 'home', '', 'meet', 'criterion', 'discontinue', 'temporary', 'separationother', 'risk', 'benefit', 'temporary', 'separation', 'mother', 'suspect', 'covid-19', 'infantif', 'mother-baby', 'separation', 'implement', '', 'follow', 'consider', '', 'infant', 'covid-19', 'suspect', 'isolate', 'healthy', 'infant', 'care', 'accord', 'interim', 'infection', 'prevention', 'control', 'recommendations', 'patients', 'suspected', 'confirmed', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'healthcare', 'settingsif', 'another', 'healthy', 'family', 'member', 'provide', 'infant', 'care', '', 'eg', '', 'diapering', '', 'bath', '', 'feed', '', '', 'appropriate', 'personal', 'protective', 'equipment', '', 'healthy', 'family', 'member', 'wear', 'gown', '', 'glove', '', 'face', 'mask', '', 'eye', 'protection', '', 'separation', 'indicate', '', 'mother', 'transmission-based', 'precaution', '', 'implement', '', 'measure', 'utilize', 'reduce', 'potential', 'mother-to-infant', 'transmission', 'include', '', 'physical', 'barrier', '', 'eg', '', 'curtain', 'mother', 'newborn', '', 'construct', '', 'newborn', 'keep', 'temperature', 'control', 'isolette', '6', 'foot', 'away', 'motherthe', 'mother', 'wear', 'face', 'mask', 'practice', 'hand', 'hygiene', 'close', 'contact', 'infant', '', 'particularly', 'feedingif', 'another', 'healthy', 'adult', 'room', '', 'care', 'newbornafter', 'hospital', 'discharge', '', 'hospital', 'discharge', '', '9194', '', '', 'mother', 'symptomatic', 'covid-19', 'infection', 'maintain', 'distance', 'least', 'six', 'foot', 'newborn', 'face', 'mask', 'hand', 'hygiene', 'newborn', 'care', '', '1', '', 'least', '3', 'day', '', '72', 'hour', '', 'pass', 'since', 'recovery', '', 'resolution', 'fever', 'without', 'fever-reducing', 'medication', 'plus', 'improvement', 'respiratory', 'symptom', '', 'cough', '', 'shortness', 'breath', '', '', '', '2', '', 'least', '10', 'day', 'pass', 'since', 'symptom', 'first', 'appearedfor', 'mother', 'laboratory-confirmed', 'covid-19', 'never', 'symptomatic', '', 'transmission', 'precaution', 'discontinue', 'least', '10', 'day', 'pass', 'since', 'date', 'first', 'positive', 'covid-19', 'diagnostic', 'testthese', 'symptom-', 'time-based', 'strategy', 'discontinue', 'transmission', 'precaution', '', 'test-based', 'strategy', 'exist', 'discuss', 'detail', 'separately', '', 'disadvantage', 'test-based', 'strategy', 'positive', 'sars-cov-2', 'reverse-transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'result', 'reflect', 'presence', 'viral', 'rna', 'necessarily', 'mean', 'viable', 'virus', 'present', 'transmit', '', '47', '', '', 'data', 'regard', 'postinfection', 'risk', 'transmission', 'personal', 'immunity', 'limit', '', '95', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'viral', 'shed', 'period', 'infectivity', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'transmission', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'discontinuation', 'precaution', '', '', '', 'breastfeeding', 'formula', 'feed', '', 'risk', 'sars-cov-2', 'transmission', 'ingestion', 'breast', 'milk', 'unclear', '', 'although', 'several', 'small', 'series', 'report', 'sample', 'breast', 'milk', 'mother', 'covid-19', 'test', 'negative', '', '1196', '', '', 'investigator', 'subsequently', 'report', 'identify', 'sample', 'breast', 'milk', 'positive', 'virus', '', '9798', '', '', 'data', 'ass', 'potential', 'risk', 'viral', 'transmission', 'ingest', 'breast', 'milkthere', 'general', 'consensus', 'breastfeed', 'encourage', 'maternal', 'infant', 'benefit', '', 'set', 'maternal', 'covid-19', 'infection', '', 'infant', 'receive', 'passive', 'antibody', 'protection', 'virus', 'since', 'breast', 'milk', 'source', 'antibody', 'anti-infective', 'factor', '', '', '', 'infant', 'benefit', 'breastfeed', '', '', 'maternal', 'economic', 'benefit', 'breastfeed', '', '', '', 'mother', 'baby', 'separation', 'implement', '', 'ideally', '', 'infant', 'feed', 'express', 'breast', 'milk', 'another', 'healthy', 'caregiver', 'mother', 'recover', 'prove', 'uninfected', '', 'provide', 'caregiver', 'healthy', 'follow', 'hygiene', 'precaution', '', '81', '', '', 'expressing', 'breast', 'milk', 'important', 'support', 'establishment', 'maternal', 'milk', 'supplybefore', 'pump', '', 'ideally', 'dedicate', 'breast', 'pump', '', 'mother', 'wear', 'mask', 'thoroughly', 'clean', 'hand', 'breast', 'soap', 'water', 'clean', 'pump', 'part', '', 'bottle', '', 'artificial', 'nipple', '', '99', '', '', 'cdc', 'issue', 'guidance', 'clean', 'breast', 'pump', 'breastfeed', '', 'possible', '', 'pump', 'equipment', 'thoroughly', 'clean', 'healthy', 'person', '', 'feed', 'healthy', 'caregiver', 'possible', '', 'mother', 'confirm', 'covid-19', 'symptomatic', 'mother', 'suspect', 'covid-19', 'precaution', 'prevent', 'transmission', 'infant', 'breastfeed', '', 'wear', 'mask', '', 'hand', 'breast', 'hygiene', '', 'disinfect', 'share', 'surface', 'symptomatic', 'mother', 'contact', '', '', 'however', '', 'note', 'value', 'precaution', '', 'cleanse', 'breast', 'prior', 'breastfeedingmilk', 'expression', 'disinfect', 'external', 'surface', 'milk', 'collection', 'device', '', 'eg', '', 'bottle', '', 'milk', 'bag', '', 'reduce', 'potential', 'transmission', 'sars-cov-2', '', 'formally', 'study', '', '100', '', 'ideally', '', 'woman', 'choose', 'formula', 'fee', 'another', 'healthy', 'caregiver', 'fee', 'infant', '', 'possible', 'desire', '', 'woman', 'must', 'appropriate', 'infection', 'control', 'precaution', '', 'describe', '', 'prevent', 'transmission', 'close', 'contact', 'feedinganalgesia', '', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'commonly', 'treatment', 'postpartum', 'pain', '', 'discuss', '', 'concern', 'possible', 'negative', 'effect', 'nsaids', 'patient', 'covid-19', 'raise', 'anecdotal', 'report', 'young', '', 'nonpregnant', 'patient', 'receive', 'nsaids', '', 'ibuprofen', '', 'early', 'course', 'infection', 'experience', 'severe', 'disease', '', '6869', '', '', 'however', '', 'clinical', 'population-based', 'data', 'directly', 'address', 'risk', 'nsaids', '', 'given', 'absence', 'data', '', 'european', 'medicines', 'agency', 'recommend', 'avoid', 'nsaids', 'clinically', 'indicate', '', '7071', '', '', 'given', 'uncertainty', '', 'suggest', 'acetaminophen', 'prefer', 'analgesic', 'agent', '', 'possible', '', 'nsaids', '', 'lowest', 'effective', 'dose', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'uncertainty', 'nsaid', '', '', '', 'permanent', 'reversible', 'contraception', '', 'permanent', 'contraception', '', 'tubal', 'sterilization', '', 'add', 'significant', 'additional', 'time', 'risk', 'perform', 'uncomplicated', 'cesarean', 'birth', 'thus', 'perform', 'plan', '', 'permanent', 'contraception', 'vaginal', 'birth', 'elective', 'procedure', '', 'decision', 'local', 'level', '', 'base', 'upon', 'available', 'resource', '', 'perform', 'reversible', 'contraceptive', 'method', 'desire', '', 'alternative', 'form', 'contraception', 'provide', '', 'eg', '', 'immediate', 'postpartum', 'long-acting', 'reversible', 'contraception', 'depot', 'medroxyprogesterone', 'acetate', '', 'long', 'patient', 'desire', 'one', 'method', '', 'avoid', 'additional', 'outpatient', 'postpartum', 'visit', '', '', '', 'overview', 'female', 'permanent', 'contraception', '', '', 'postpartum', 'permanent', 'contraception', '', 'procedures', '', '', 'postpartum', 'contraception', '', 'counseling', 'method', '', '', '', 'discharge', 'hospital', '', 'suggest', 'early', 'discharge', 'postpartum', '', 'one', 'day', 'vaginal', 'delivery', 'maximum', 'two', 'day', 'cesarean', 'delivery', '', 'limit', 'patient', 'personal', 'risk', 'hospital', 'environment', '', '85', '', 'candidates', 'mother-infant', 'separation', 'discharge', 'criterion', 'discontinuation', 'separation', 'discuss', '', '', 'hospital', 'discharge', '', '', '', 'postpartum', 'office', 'visit', '', 'modifying', 'reduce', 'postpartum', 'outpatient', 'care', 'appropriate', 'reduce', 'risk', 'inadvertent', 'exposure', '', 'example', '', 'possible', 'perform', 'early', 'postpartum', 'assessment', '', 'include', 'wind', 'blood', 'pressure', 'check', '', 'telehealth', '', 'comprehensive', 'postpartum', 'visit', 'still', 'important', '12', 'week', '', 'especially', 'patient', 'comorbidities', 'patient', 'lose', 'insurance', 'coverage', 'timeall', 'postpartum', 'patient', 'still', 'screen', 'postpartum', 'depression', 'four', 'eight', 'week', 'delivery', '', 'widely', 'instrument', 'self-report', '', '10-item', 'edinburgh', 'postnatal', 'depression', 'scale', '', 'figure', '1a-b', '', '', 'complete', 'le', 'five', 'minute', '', '101', '', '', 'alternative', 'available', '', 'discuss', '', 'psychological', 'impact', 'covid-19', '', 'include', 'moderate', 'severe', 'anxiety', '', 'recognize', 'support', 'offer', '', '', '', 'postpartum', 'unipolar', 'major', 'depression', '', 'epidemiology', '', 'clinical', 'feature', '', 'assessment', '', 'diagnosis', '', '', 'section', 'assessment', '', '', '', 'pregnancy', 'registries', '', 'registries', 'develop', 'collect', 'data', 'covid-19', 'affect', 'pregnancy', 'newborn', '', 'example', '', 'pregnancy', 'coronavirus', 'outcomes', 'registry', '', 'priority', '', 'official', 'united', 'states', 'registry', 'lead', 'university', 'california', '', 'san', 'franciscointernational', 'registry', 'coronavirus', 'exposure', 'pregnancy', '', 'ircep', '', 'another', 'registry', 'lead', 'international', 'group', 'investigatorsselected', 'resources', '', 'united', 'states', '', 'american', 'college', 'obstetricians', 'gynecologists', '', 'society', 'maternal-fetal', 'medicine', '', 'centers', 'disease', 'control', 'prevention', 'issue', 'guidance', 'regard', 'prenatal', '', 'intrapartum', '', 'postpartum', 'care', 'covid-19', 'pandemic', '', '5456', '', '', 'include', 'general', 'guidance', 'test', 'prevent', 'spread', 'covid-19', 'suggestion', 'modify', 'traditional', 'protocol', 'prenatal', 'visit', '', 'obstetric', 'ultrasound', 'examination', '', 'nonstress', 'test', 'biophysical', 'profile', '', 'plan', 'induction', 'cesarean', 'delivery', '', 'contact', 'infantamerican', 'college', 'obstetricians', 'gynecologists', 'covid-19', 'informationsociety', 'maternal-fetal', 'medicineworld', 'health', 'organizationcenters', 'disease', 'control', 'prevention', '', 'pregnancy', 'breastfeedinginterim', 'considerations', 'infection', 'prevention', 'control', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'inpatient', 'obstetric', 'healthcare', 'settingsinternational', 'society', 'infectious', 'disease', 'obstetrics', 'gynecology', 'recommendations', 'concerning', 'covid-19', 'pregnancy', '', '50', '', 'dedicate', 'website', '', 'wwwpregnancycovid19com', '', 'several', 'helpful', 'pregnancy-specific', 'link', 'information', '', 'include', 'information', 'patientspregnancy', 'registry', '', 'pregnancy', 'coronavirus', 'outcomes', 'registry', '', 'priority', '', 'nationwide', 'united', 'states', 'study', 'pregnant', 'recently', 'pregnant', 'woman', 'either', 'investigation', 'confirm', 'covid-19', 'infection', '', 'providers', 'patient', 'send', 'information', 'via', 'priorityucsfedusociety', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'summary', 'recommendationspregnant', 'woman', 'follow', 'recommendation', 'nonpregnant', 'person', 'avoid', 'exposure', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'virus', 'cause', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', '', 'prevention', '', '', '', 'clinical', 'manifestation', 'covid-19', 'pregnant', 'woman', 'similar', 'nonpregnant', 'individual', '', 'positive', 'test', 'sars-cov-2', 'generally', 'confirm', 'diagnosis', 'covid-19', '', 'although', 'false-positive', 'false-negative', 'test', 'possible', '', '', 'clinical', 'manifestation', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'feature', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'diagnosis', '', '', '', 'pregnancy', 'appear', 'increase', 'susceptibility', 'infection', 'worsen', 'clinical', 'course', '', 'infect', 'mother', 'recover', 'without', 'undergo', 'delivery', '', 'however', '', 'severe', 'disease', 'necessitate', 'maternal', 'intensive', 'care', 'unit', 'admission', 'extracorporeal', 'membrane', 'oxygenation', 'occur', '', 'maternal', 'death', 'report', '', '', 'maternal', 'course', '', '', '', 'infected', 'woman', '', 'especially', 'develop', 'pneumonia', '', 'appear', 'increase', 'frequency', 'preterm', 'birth', 'cesarean', 'delivery', '', 'complication', 'likely', 'relate', 'severe', 'maternal', 'illness', 'intrauterine', 'infection', 'appear', 'occur', '', 'still', 'investigation', '', 'possible', 'early', 'newborn', 'infection', 'one', 'possible', 'placental', 'infection', 'report', '', '', 'pregnancy', 'complication', '', 'vertical', 'transmission', '', '', '', 'american', 'college', 'obstetricians', 'gynecologists', '', 'acog', '', 'society', 'maternal-fetal', 'medicine', '', 'smfm', '', 'issue', 'guidance', 'regard', 'prenatal', 'care', 'covid-19', 'pandemic', '', 'available', 'acogorg', 'smfmorg', '', '', 'include', 'general', 'guidance', 'test', 'prevent', 'spread', 'covid-19', '', 'suggestion', 'modify', 'traditional', 'protocol', 'prenatal', 'postnatal', 'visit', 'hospital', 'discharge', '', 'algorithm', 'assessment', 'management', '', 'modification', 'tailor', 'low-', 'versus', 'high-risk', 'pregnancy', '', '', 'prenatal', 'care', '', 'discharge', 'hospital', '', 'postpartum', 'office', 'visit', '', '', '', 'general', 'population', '', 'centers', 'disease', 'control', 'prevention', 'recommend', 'avoid', 'glucocorticoid', 'covid-19-positive', 'person', 'potential', 'adverse', 'effect', 'course', 'disease', '', 'clear', 'benefit', 'antenatal', 'betamethasone', 'administration', '240', '336', 'week', 'gestation', 'patient', 'risk', 'preterm', 'birth', 'within', 'seven', 'day', '', 'acog', 'continue', 'recommend', 'standard', 'indication', 'pregnant', 'patient', 'suspect', 'confirm', 'covid-19', '', '', 'standard', 'medication', 'manage', 'pregnancy', 'complication', '', '', '', 'woman', 'preterm', 'covid-19', 'nonsevere', 'illness', 'medicalobstetric', 'indication', 'prompt', 'delivery', '', 'delivery', 'indicate', 'ideally', 'occur', 'sometime', 'negative', 'test', 'result', 'obtain', 'isolation', 'status', 'lift', '', 'thereby', 'minimize', 'risk', 'postnatal', 'transmission', 'neonate', '', 'severely', 'ill', 'patient', 'least', '32', '34', 'week', 'gestation', 'covid-19', 'pneumonia', 'benefit', 'early', 'delivery', '', '', 'timing', 'delivery', 'infect', 'woman', '', '', '', 'area', 'infection', 'active', '', 'believe', 'test', 'patient', 'upon', 'presentation', 'labor', 'delivery', '', 'day', 'schedule', 'admission', '', 'reasonable', '', 'test', 'available', '', 'city', 'high', 'infection', 'prevalence', '', 'high', 'proportion', 'asymptomatic', 'patient', '', '135', 'percent', 'one', 'study', '', 'admit', 'delivery', 'test', 'positive', '', 'clinical', 'implication', 'triage', '', 'staff', '', 'newborn', 'care', '', '', 'infection', 'control', 'precaution', '', '', '', 'generally', '', 'management', 'labor', 'alter', 'woman', 'give', 'birth', 'covid-19', 'pandemic', 'woman', 'confirm', 'suspect', 'covid-19', '', 'sars-cov-2', 'detect', 'vaginal', 'secretion', 'amniotic', 'fluid', '', 'rupture', 'fetal', 'membrane', 'internal', 'fetal', 'heart', 'rate', 'monitor', 'perform', 'usual', 'indication', '', 'data', 'limit', '', 'covid-19', 'indication', 'alter', 'route', 'delivery', '', 'partnersupport', 'person', 'screen', 'accordance', 'hospital', 'policy', 'symptom', 'consistent', 'covid-19', '', 'exposure', 'confirm', 'case', 'within', '14', 'day', '', 'positive', 'test', 'covid-19', 'within', '14', 'day', 'allow', 'attend', 'labor', 'birth', '', '', 'management', 'labor', 'delivery', '', '', '', 'patient', 'suspect', 'covid-19', '', 'neuraxial', 'anesthetic', 'contraindicate', 'several', 'advantage', 'labor', 'patient', '', 'society', 'obstetric', 'anesthesia', 'perinatology', 'suggest', 'suspend', 'nitrous', 'oxide', 'labor', 'analgesia', 'patient', 'insufficient', 'data', 'potential', 'aerosolization', 'nitrous', 'oxide', 'system', '', '', 'analgesia', 'anesthesia', '', '', '', 'delivery', 'patient', 'suspect', 'covid-19', '', 'institution', 'choose', 'avoid', 'delay', 'cord', 'clamp', 'term', 'infant', '', 'benefit', 'modest', '', 'minimize', 'newborn', 'exposure', 'virus', 'immediate', 'environment', 'reduce', 'chance', 'newborn', 'require', 'phototherapy', 'jaundice', '', '', 'delivery', 'procedure', '', '', '', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'commonly', 'treatment', 'postpartum', 'pain', '', 'however', '', 'anecdotal', 'report', 'possible', 'negative', 'effect', 'nsaids', 'patient', 'covid-19', '', 'given', 'uncertainty', '', 'acetaminophen', 'prefer', 'analgesic', 'agent', '', 'possible', '', 'nsaids', '', 'lowest', 'effective', 'dose', '', '', 'analgesia', 'anesthesia', '', '', '', 'infants', 'bear', 'mother', 'covid-19', 'covid-19', 'suspect', 'test', '', 'isolate', 'healthy', 'infant', '', 'care', 'accord', 'infection', 'control', 'precaution', 'patient', 'confirm', 'suspect', 'covid-19', '', '', 'infant', 'evaluation', '', '', '', 'whether', 'separate', 'mother', 'suspect', 'covid-19', 'infant', 'determine', 'case-by-case', 'basis', '', 'infant', 'test', 'positive', '', 'separation', 'unnecessary', '', 'separation', 'indicate', '', 'mother', 'transmission-based', 'precaution', '', 'implement', '', 'measure', 'utilize', 'reduce', 'potential', 'mother-to-infant', 'transmission', '', 'include', 'physical', 'barrier', '6', 'foot', 'separation', '', 'personal', 'protective', 'equipment', 'hand', 'hygiene', '', 'utilization', 'healthy', 'adult', 'infant', 'care', '', 'feed', '', 'diapering', '', 'bath', '', '', '', 'mother-baby', 'contact', '', '', '', 'virus', 'find', 'sample', 'breast', 'milk', '', 'data', 'limit', 'risk', 'transmission', 'infant', 'ingestion', 'breast', 'milk', 'unclear', '', 'droplet', 'transmission', 'newborn', 'occur', 'close', 'contact', 'feed', '', 'mother', 'confirm', 'covid-19', 'symptomatic', 'mother', 'suspect', 'covid-19', '', 'minimize', 'direct', 'contact', '', 'ideally', '', 'infant', 'feed', 'express', 'breast', 'milk', 'another', 'caregiver', 'mother', 'recover', 'prove', 'uninfected', '', 'provide', 'caregiver', 'healthy', 'follow', 'hygiene', 'precaution', '', 'case', '', 'mother', 'wear', 'mask', 'thoroughly', 'clean', 'hand', 'breast', 'pump', '', 'pump', 'part', '', 'bottle', '', 'artificial', 'nipple', 'clean', 'well', '', 'breastfeed', 'infant', 'directly', '', 'similar', 'personal', 'hygienic', 'precaution', '', '', 'breastfeeding', 'formula', 'feed', '', '', '', 'several', 'agent', 'evaluate', 'treatment', 'covid-19', '', 'remdesivir', 'promise', 'without', 'report', 'fetal', 'toxicity', 'severely', 'ill', 'pregnant', 'woman', '', '', 'safety', 'antiviral', 'drug', 'therapy', '', '', '']",8737,"{'': 2149, 'covid-19': 199, 'patient': 132, 'disease': 95, 'woman': 73, 'infection': 72, 'test': 71, 'delivery': 71, 'coronavirus': 66, 'care': 66, '2019': 60, 'pregnant': 55, 'risk': 50, 'maternal': 48, 'section': 47, 'management': 40, 'fetal': 40, 'suspect': 40, 'postpartum': 37, 'labor': 37}","{'hydroxychloroquine': 3, 'infection': 72, 'sars-cov-2': 29, 'vitro': 2, 'safety': 3}",109,-0.0772
ID:127759,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult']","['INTRODUCTION — At end 2019 , novel coronavirus identify cause cluster pneumonia case Wuhan , China .', 'Subsequently , infection rapidly spread throughout world , result global pandemic .', 'The coronavirus designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) illness cause coronavirus disease 2019 ( COVID-19 ) .', 'The spectrum COVID-19 adult range asymptomatic infection mild respiratory tract symptom severe pneumonia acute respiratory distress syndrome ( ARDS ) multiorgan dysfunction .', 'Our understand spectrum disease well optimal management strategy continue evolve.This topic address management adult patient COVID-19 ( presume confirm ) outpatient set , include self-care advice , telehealth , outpatient clinic management , emergency department ( ED ) referral .', ""It important note limit data inform outpatient management strategy , approach describe base upon clinical experience ; clinician take account individual patient 's clinical social circumstance well available resources.General management strategy , include infection control measure , care hospitalize patient , specific COVID-19 complication , discuss detail elsewhere , consideration special population : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Arrhythmias conduction system disease '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Anesthetic concern , include airway management infection control '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Intensive care ventilation anesthesia machine '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Cancer care pandemic '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Psychiatric symptom disorder '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate gastrointestinal disease adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Care patient systemic rheumatic disease pandemic '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' ."", ') ● ( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') GENERAL PRINCIPLESContinuum care — When possible , favor manage patient suspect confirm COVID-19 within outpatient continuum care management program include : ●Self-assessment tool .', ""( See 'Patient self-assessment tool ' ."", ') ●Initial telephone triage .', ""( See 'Initial telephone triage ' ."", ') ●Coordinated outreach management approach base upon individual patient risk , severity symptom , time course disease .', ""( See 'Risk stratification ' 'Determine in-person evaluation warrant ' 'Telehealth follow-up ' ."", ') ●Clinician telehealth ( telephone call video platform-based ) visit ( initial evaluation follow-up visit ) [ 1 ] .', ""( See 'Telehealth follow-up ' ."", ') ●COVID-19 test .', ""( See 'Suspicion COVID-19 role test ' ."", ') ●A separate outpatient respiratory clinic dedicate space within ambulatory clinic appropriate care patient COVID-19 respiratory problem .', 'Strategies reduce risk exposure severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) staff patient employ [ 2 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control health care set ' ."", ') In addition , outpatient clinic close , coordinate relationship local emergency department ( ED ) function partnership within continuum care program .', ""( See 'Rationale outpatient management remote care ' ."", ') ●A close work relationship local public health official community leaders.In system , patient could enter ambulatory COVID-19 care program contact primary health care provider follow discharge ED inpatient hospital stay.In addition , course illness recovery , patient would able transition different site care follow-up dictate clinical need ( eg , home self-care management , outpatient clinic ED evaluation , telehealth follow-up , back self-care management ) .Rationale outpatient management remote care — Outpatient management appropriate patient COVID-19 ; approximately 80 percent patient , illness mild warrant medical intervention hospitalization [ 3 ] .', 'In addition , remote ( telehealth ) management prefer majority patient follow reason : ●Remote management prevent unnecessary in-person medical visit , include visit urgent care facility EDs .', 'It thus avoid additional , unnecessary strain already overburden overwhelm health care system ( include utilization limit resource , especially personal protective equipment [ PPE ] ) .●In-person health care provider visit require patient leave home , travel via public , private , emergency transport potentially expose others SARS-CoV-2 .', 'In addition , upon arrival health care facility , patient may expose patient health care worker virus.Creating comprehensive , coordinate outpatient care program incorporate component may allow patient receive supportive care home , necessary , ambulatory clinic set , reduce ED hospital resource utilization.Telehealth use patient management previous disease outbreak , include SARS , Middle East respiratory syndrome ( MERS ) , influenza A H1N1 [ 4 ] .', ""However , remote evaluation study set global pandemic care patient COVID-19 ; thus , evidence demonstrate improve outcome home management COVID-19 lacking.Telehealth evaluation COVID-19 pandemic perform telephone call , video-based telemedicine platform , commercial video chat platform ; format choose compliant applicable patient privacy regulation [ 5 ] .Flexibility approach care — High-quality data support superiority single outpatient management strategy lack , treatment protocol develop modify understand disease evolves.Our approach base upon clinical experience treat patient COVID-19 place additional emphasis avoid infection transmission , preserve limit resource ( include test PPE ) , reduce burden overwhelm health care systems.The intensity ( frequency duration ) outpatient follow-up vary accord patient 's risk develop severe disease ( table 1 ) , vary institution , region , resource availability , likely change burden disease give location ."", 'As example , institution able establish dedicate respiratory clinic devote manage COVID-19 patient , available in-person remote management option ; many location , patient manage primary care clinician , often consultation team specially train clinicians.Additionally , institution may need revise protocol , even several-week period , response surge number patient suspect infection manage [ 6 ] .INITIAL EVALUATION — Most patient concern COVID-19 , even mild symptom , likely initiate contact health care system .', 'For patient , self-assessment tool , remote ( telehealth ) evaluation prefer initial management approach [ 7-9 ] .Patient self-assessment tool — Patient education material , include self-assessment tool , help patient determine medical evaluation necessary , proactive dissemination material may increase awareness encourage use .', 'Various online self-assessment tool publish medical institution governmental health agency guide patient question suggest seek medical care ; follow guidance , many patient mild illness may able recover home without need come direct contact health care provider .', 'Before recommend specific assessment tool , however , clinician vet option carefully , may exceed ability patient limit health literacy become quickly out-of-date base upon rapidly change guidelines.In one study , use self-assessment tool embed electronic health record allow 40 percent symptomatic patient appropriately triaged self-care [ 9 ] .', 'This study , however , conduct set relatively low community prevalence severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) might representative set widespread community transmission.Initial telephone triage — In addition self-assessment tool , initial triage call clinic staff often determine patient appropriate self-care home , patient warrant timely clinician telehealth visit ( televisit ) , patient warrant outpatient clinic visit urgent emergency department ( ED ) evaluation [ 10 ] .', ""( See 'Risk stratification ' . )"", '( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') Any patient symptom suggestive respiratory compromise hypoxia ( eg , significant dyspnea rest mental confusion ) refer urgent in-person evaluation ; appropriate site care depend upon severity symptom discuss elsewhere .', ""( See 'In-person evaluation moderate/severe dyspnea , hypoxia , concern higher acuity level ' ."", ') Suspicion COVID-19 role test — During pandemic , patient live region widespread community transmission compatible symptom generally manage presumptively COVID-19 , even test initial negative test result.Patients COVID-19 typically first experience viral-type illness symptom range mild upper respiratory tract infection ( eg , pharyngitis , rhinorrhea ) lower respiratory tract infection ( eg , cough , fever ) , influenza-like symptom ( eg , fever , chill , headache , myalgia ) , gastroenteritis ( eg , nausea , vomit , diarrhea ) ( table 2 ) [ 11,12 ] .', 'Loss smell taste may also occur , olfactory loss typically report early course illness [ 13 ] .', 'Dyspnea , develop , tend occur patient four eight day onset symptom , although occur 10 day [ 11 ] .', 'In patient le typical symptom isolate rhinorrhea headache , likelihood illness due COVID-19 take account local prevalence disease .', 'However , pandemic , COVID-19 rule base upon clinical history .', 'Further , even location high prevalence COVID-19 , possibility etiology symptom consider .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Initial presentation ' 'Managing potential cause symptom ' ."", ') Availability test SARS-CoV-2 vary widely across region .', 'If test capacity adequate personal protective equipment ( PPE ) supply allow , favor widespread use test , include drive-through test , important epidemiologic purpose .', 'However , resource limit , SARS-CoV-2 test outpatient mild disease may neither readily available appropriate ; United States , Centers Disease Control Prevention ( CDC ) Infectious Diseases Society America propose priority test ( table 3 ) .', 'Specific criterion test vary location , institution , change time .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'COVID-19 test readily available ' ."", ') In patient able undergo test , detection SARS-CoV-2 RNA reverse transcription polymerase chain reaction ( RT-PCR ) confirm COVID-19 .', 'However , give sample variability , viral load variation , potential false-negative result , single negative test exclude infection guide management [ 14,15 ] .', 'Antibody detection le utility diagnosis acute outpatient set use sole test exclude diagnose COVID-19 .', 'Laboratory test SARS-CoV-2 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Microbiologic diagnosis ' ."", ') Risk stratification — Our patient-centered continuum care management approach base stratification risk develop severe disease close monitor respiratory decompensation .', 'Patients without severe initial symptom , deem stable enough require immediate in-person evaluation , risk stratify determine intensity ( frequency duration ) follow-up.Assess risk severe disease — Older age certain chronic medical condition associate severe illness higher mortality COVID-19 ( table 1 ) .', 'We categorize patient high , moderate , low risk severe disease : ●High risk•Age ≥65 year •Residence nurse home long-term care facility•Immunocompromising condition•Chronic lung disease moderate severe asthma•Cardiovascular disease ( include hypertension ) •Severe obesity ( body mass index [ BMI ] ≥40 kg/m2 ) •Diabetes mellitus•Chronic kidney disease ( undergo dialysis ) •Cerebrovascular disease•Chronic liver disease•Tobacco use disorder●Moderate risk•Age 20 64 year , without specific comorbidities list above•Age < 20 year , underlie medical condition list above●Low risk•Age < 20 year , without underlie medical conditionsThese category base upon CDC guidance well data publish cohort study , older age many underlie condition associate severe disease death [ 16-19 ] .Additionally , United States , black Hispanic patient represent disproportionately high percentage hospitalization death [ 17,18,20 ] .', 'The reason find unclear may relate inequality social determinant health ( eg , access health care , economic stability , live environment , community experience , education ) predispose disease .', 'Risk factor severe COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ."", ') It important note although patient ≥65 year age poorly control chronic medical condition higher risk hospitalization death , infection SARS-CoV-2 may cause catastrophic illness patient , even among moderate-risk , le frequently , low-risk patient .', 'In addition , although vast majority child COVID-19 mild disease [ 21,22 ] , infant child underlie medical condition warrant close monitor ; severe disease likely occur child underlie medical condition [ 23 ] .', 'Multisystem inflammatory syndrome child ( MIS-C ) rare serious condition report child adolescent association current recent COVID-19 infection exposure [ 24-28 ] .', 'It share clinical feature Kawasaki disease ( KD ) , KD shock , toxic shock syndrome .', 'The evaluation management child COVID-19 exposure infection review detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' . )"", 'Assess symptom duration severityTime course development dyspnea — For patient suspect confirm COVID-19 , establish illness timeline : first day symptom begin , presence dyspnea , day dyspnea onset .', 'While mild dyspnea common , worsen dyspnea , particularly dyspnea rest , severe chest discomfort/tightness , concern symptom suggest development progression pulmonary involvement .', 'The trajectory dyspnea day follow onset particularly important , significant worsen acute respiratory distress syndrome ( ARDS ) manifest soon onset dyspnea ; study among patient develop ARDS , progression ARDS occur median 2.5 day onset dyspnea [ 29-33 ] .', 'In patient moderate high risk severe illness ( table 1 ) , outreach effort focus particularly day follow onset dyspnea ass worsen respiratory status.It unclear percentage patient COVID-19 develop dyspnea , available report likely representative patient SARS-CoV-2 infection .', 'However , patient symptomatic infection , dyspnea likely develop subgroup patient .', 'As example , dyspnea develop 19 percent approximately 1000 COVID-19 patient admit hospital Wuhan , China [ 34 ] .', 'However , CDC study laboratory-confirmed COVID-19 patient United States , 43 percent symptomatic adult 13 percent symptomatic child develop dyspnea [ 23 ] .', 'Among patient develop dyspnea , typically begin least several day onset illness .', 'In one study 41 hospitalize patient China , dyspnea develop , average , eight day onset symptom [ 35 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical manifestation ' ."", "") Dyspnea assessment — Remote assessment dyspnea focus patient 's subjective symptom , well objective assessment breathe , include deterioration respiratory function [ 36 ] ."", 'We begin ask patient develop difficulty breathe , associate cough .', ""If yes , ask patient describe difficulty word ass ease comfort speech ( eg , speak comfortably complete sentence ) .In addition , ask question provide objective assessment change respiratory status , include [ 36 ] : ● “ What activity could previously without difficulty cause breath ? ” ● '' Has get worse last one , two , three day ?"", ""`` ● “ Are breathe harder faster usual sit still ? ” ● “ Can longer usual household activity due shortness breath ? ” ● “ Does walk cause feel dizzy ? ” We use assessment categorize dyspnea severity : ●Mild dyspnea – Dyspnea interfere daily activity ( eg , mild shortness breath activity climb one two flight stair walk briskly ) .●Moderate dyspnea – Dyspnea create limitation activity daily live ( eg , shortness breath limit ability walk one flight stair without need rest , interfere meal preparation light housekeep task ) .●Severe dyspnea – Dyspnea cause shortness breath rest , render patient unable speak complete sentence , interfere basic activity toileting dressing.If available , telemedicine consultation video capability may allow even better evaluation respiratory status , allow clinician observe patient 's respiratory pattern , include use accessory muscle respiration [ 7 ] .The presence dyspnea , along risk factor develop severe disease ( table 1 ) , use guide clinician determine whether patient require in-person evaluation ."", ""( See 'Determine in-person evaluation warrant ' ."", ') Oxygenation assessment — If patient COVID-19 access reliable pulse oximeter home , adequately measure report result clinician , measurement oxygen saturation use additional piece information ass clinical status .', 'Patients advise use pulse oximeter warm finger , read obtain cold digit may accurate [ 37 ] .', 'In outpatient set , instruct patient check oximetry twice daily inform u value drop 95 percent.●For patient oxygen saturation ≤94 percent room air , in-person evaluation warrant .', ""( See 'In-person evaluation moderate/severe dyspnea , hypoxia , concern higher acuity level ' ."", ') ●For patient oxygen saturation ≥95 percent room air , decision in-person evaluation depend clinical feature severity dyspnea , risk severe disease , assessment overall acuity .', ""( See 'Determine in-person evaluation warrant ' ."", "") Oximetry consider within context patient 's overall clinical presentation ; normal oxygen saturation level use exclude clinically significant respiratory involvement patient concern symptom progressive severe dyspnea high overall acuity level ( see 'Assessment overall acuity level ' ) ."", ""In addition , although normal oximetry reassure , guarantee respiratory status deteriorate illness progresses.Of note , consider oxygen saturation read obtain application ( `` app '' ) mobile telephone accurate enough depend upon clinical use [ 38 ] .As dyspnea , availability telemedicine video capability may allow indirect assessment hypoxia observation cyanosis , present [ 7 ] .Assessment overall acuity level — In addition evaluation respiratory status , ass patient 's overall acuity level ask question regard orthostasis , dizziness , fall , hypotension ( home blood pressure measurement available ) , mental status change ( eg , lethargy , confusion , change behavior , difficulty rouse ) , observe cyanosis , urine output ."", 'While mild orthostasis symptom may address instruction increase fluid , mental status change , fall , cyanosis , hypotension , anuria , chest pain suggestive acute coronary syndrome concern warrant in-person evaluation .', ""( See 'In-person evaluation moderate/severe dyspnea , hypoxia , concern higher acuity level ' ."", ') Assess home set social factor — We ass ability patient monitor symptom understand importance seek medical guidance symptom progress .', ""Patients lack ability self-monitor self-report may need intensive staff outreach order adequately manage home.In addition , accordance interim CDC guideline home management , ass patient 's residential set appropriate home management recovery [ 39 ] ; patient manage home capable adhere appropriate infection control isolation precaution duration illness recovery ( include use separate bedroom live alone ) ."", 'Other important home resource include available caregiver , adequate access food , assistance activity daily live necessary .', 'Whether patient household member high risk severe disease another consideration ( table 1 ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control home set ' ."", ') DETERMINE IF IN-PERSON EVALUATION WARRANTED — Based upon assessment , particular risk develop severe disease , dyspnea oxygenation , overall acuity level , determine urgency appropriate set ( in-person evaluation versus schedule telehealth follow-up self-care ) management .', 'For patient warrant in-person evaluation , decide outpatient clinic emergency department ( ED ) evaluation appropriate .', '( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', "") While use follow general criterion determine appropriate clinical set in-person evaluation , criterion fix vary institution , region , even time change resource availability.In-person evaluation moderate/severe dyspnea , hypoxia , concern higher acuity level — All patient moderate severe dyspnea , initial oxygen saturation < 95 percent room air , symptom consistent higher acuity level warrant in-person evaluation , either ED outpatient clinic , depend upon severity findings.Criteria evaluation ED — We typically refer patient one follow feature ED management : ●Severe dyspnea ( dyspnea rest , interfere inability speak complete sentence ) ( see 'Dyspnea assessment ' ) ●Oxygen saturation room air ≤90 percent , regardless severity dyspnea ( see 'Oxygenation assessment ' ) ●Concerning alteration mentation ( eg , confusion , change behavior , difficulty rouse ) sign symptom hypoperfusion hypoxia ( eg , fall , hypotension , cyanosis , anuria , chest pain suggestive acute coronary syndrome ) ( see 'Assessment overall acuity level ' ) Patients meet criterion typically admit hospital inpatient evaluation management ."", 'However , fix criterion inpatient hospital admission COVID-19 ; criterion vary country region .', 'Further , area high infection prevalence , criterion may also vary availability hospital resource .', 'A lower threshold hospitalization may feasible set burden disease exceed resource availability ; United States , National Institutes Health ( NIH ) COVID-19 Treatment Guidelines Panel suggest hospitalization patient moderate severe disease ( eg , evidence lower respiratory tract infection without hypoxia ) [ 40 ] .', 'As inpatient hospital resource outpace patient volume set surge COVID-19 case , establish outpatient system closely follow-up monitor patient get admit .', 'However , approach may appropriate set limit outpatient resource .', ""( See 'Patients appropriate evaluation clinic ' ."", "") Patients appropriate evaluation clinic — Patients one follow feature typically appropriate evaluation outpatient clinic ( ideally dedicate respiratory/COVID-19 clinic available ) , provide meet criterion evaluation ED : ●Mild dyspnea patient oxygen saturation room air 91 94 percent ( see 'Dyspnea assessment ' ) ●Mild dyspnea patient high risk severe disease ( table 1 ) ( see 'Assess risk severe disease ' 'Dyspnea assessment ' ) ●Moderate dyspnea patient●Symptoms concern enough warrant in-person evaluation ( eg , mild orthostasis ) severe enough require ED referral ( see 'Assessment overall acuity level ' ) Clinic evaluation — For patient evaluate outpatient clinic ( feasible , respiratory/COVID-19 clinic ) , ass patient 's respiratory circulatory status , evaluate potentially treatable cause symptom [ 11 ] ."", ""( See 'Managing potential cause symptom ' ."", ') Based upon careful clinical history physical exam , include vital sign well measurement oxygen saturation rest ambulation , determine patient appropriate self-care , home management telehealth follow-up , transfer ED .', ""Of note , find chest image limit utility evaluation patient COVID-19 outpatient clinic ; patient 's clinical presentation important consideration management decision ."", ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Imaging find ' ."", ') The capability manage patient ambulatory set ( eg , ability administer intravenous fluid medication arrange outpatient follow-up ) vary institution region thus influence decision .', ""In addition , also consider patient 's home set social factor determine appropriateness continue outpatient ( clinic teleheath ) management.Home oxygen therapy oximetry patient — For patient COVID-19 , stable dyspnea , mild hypoxia , consider provide home oxygen therapy home oximetry monitor service available.In order consider patient home oxygen therapy home oximetry management COVID-19 , use follow criterion : ●The patient nonsevere ( mild moderate ) dyspnea , stable , nonprogressive symptom several days.●Oxygen saturation 91 93 percent increase ≥95 percent administration supplemental oxygen nasal cannula 2 liters/minute ; titrate saturation 96 percent.●The patient likely adherent therapy recommend follow-up.Initiation home oxygen therapy appropriate patient new onset dyspnea hypoxia early onset illness ."", 'Severe pulmonary involvement may develop even among patient low risk severe disease , need supplemental oxygen early course illness suggest need hospital admission close monitor .', 'In addition , patient increase oxygen requirement point course illness , hospitalization often indicated.Patients send home oxygen therapy require close follow-up ; daily clinician telehealth visit schedule , patient instruct check oximetry three time daily .', 'Patients receive home oxygen contact clinician : ●Oxygen saturation level decline establish flow rate .', 'In case , remote clinician evaluation perform determine in-person reevaluation warrant .', ""( See 'Determine in-person evaluation warrant ' ."", ') ●The oxygen saturation level drop 91 percent , case ED evaluation indicate .', ""( See 'Criteria evaluation ED ' ."", ') ●Worsening dyspnea develop , case in-person reevaluation warrant independent oximetry result .', ""( See 'In-person evaluation moderate/severe dyspnea , hypoxia , concern higher acuity level ' ."", ') Guidelines manage critically ill patient COVID-19 suggest initiate supplemental oxygen oxygenation saturation < 90 percent [ 41 ] .', 'However , data inform outcome use home oxygen oximetry monitor outpatient COVID-19 address optimal oxygen titration patient .', 'Additionally , guideline suggest COVID-19 patient oxygen saturation ≤93 percent room air admit hospital inpatient management [ 40 ] .', 'Nevertheless , approach base upon clinical experience manage patient COVID-19 set inpatient hospital resource limit due surge patient volume , establish system closely follow-up monitor patient outpatient set .', 'This approach may appropriate set limit outpatient resource .', 'Ideally , home oxygen therapy monitor evaluate set clinical trial rapid-cycle quality improvement project determine intervention decrease use health care facility ( eg , clinic visit , hospitalization ) without negatively impact health outcomes.In addition , health insurance coverage restriction may limit use home oxygen therapy patient , out-of-pocket cost may prohibitive patient without health insurance.Some patient warrant transfer clinic ED — After initial evaluation outpatient clinic , patient may require intensive management ED .', 'In particular , patient may require ED management increase work breathe history rapid decline respiratory function .', 'Additional criterion ED evaluation review elsewhere .', ""( See 'Criteria evaluation ED ' ."", ') Home management without in-person evaluation others — The majority patient without moderate severe dyspnea hypoxia remain home management without in-person evaluation , reliably report worsen symptom self-isolate anticipate duration illness.The component home management counsel patient suspect confirm COVID-19 discuss elsewhere .', ""( See 'Management counsel outpatient ' ."", ') Whether patient warrant telehealth follow-up depend upon risk severe disease extent dyspnea ( table 1 ) : ●Patients high risk severe disease , dyspnea discharge self-care home ; need in-person evaluation schedule follow-up telehealth visit .', 'They receive instruction contact clinician worsen symptoms.●Patients high risk severe disease , mild dyspnea , need in-person evaluation schedule telehealth follow-up visits.●Patients high risk severe disease , dyspnea , schedule telehealth follow-up visits.The frequency content follow-up telehealth evaluation discuss elsewhere .', ""( See 'Telehealth follow-up ' ."", ') Supervised residential care facilitate isolation — Patients would appropriate home care ( without telehealth follow-up ) unable adequately manage usual residential set candidate temporary shelter supervise residential care facility , available [ 42 ] .In particular , patient may unable adequately self-isolate ( eg , patient live multigenerational household , patient live high-risk individual ( table 1 ) , patient experience homelessness ) provide resource dedicate house unit , available .', 'Disruption family minimize much possible .', 'Every attempt make avoid hospitalization simply purpose facilitate self-isolation , option typically realistically available region widespread disease.Unfortunately , dedicate residential care facility COVID-19 patient widely available many country region , community-based solution self-isolation explored.MANAGEMENT AND COUNSELING FOR ALL OUTPATIENTS — When clinically appropriate , generally preferable manage patient suspect confirm COVID-19 remotely via telehealth visit .', ""( See 'Rationale outpatient management remote care ' ."", ') Interim recommendation outpatient management patient COVID-19 provide World Health Organization , Centers Disease Control Prevention ( CDC ) United States , several academic medical center [ 43-46 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Institutional protocol ' ."", ') Infection control — With patient , reinforce importance infection control self-isolation provide instruction anticipate duration isolation .', 'These review detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control home set ' ."", ') Symptom management — Symptomatic treatment include antipyretic analgesic myalgia headache maintenance oral fluid intake .', 'We generally prefer acetaminophen ; however , inform patient nonsteroidal antiinflammatory drug ( NSAID ) use acceptable symptom respond acetaminophen .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Uncertainty NSAID use ' ."", ') Some patient cough dyspnea may experience symptomatic improvement self-proning ( rest prone rather supine position ) [ 47 ] .', 'However , patient caution progressive respiratory symptom , particularly worsen dyspnea , prompt contact clinician evaluation .', ""( See 'Reevaluation worsen dyspnea ' ."", ') Managing potential cause symptom — Since symptom COVID-19 overlap many common condition , important consider possible etiology symptom include respiratory infection ( eg , influenza , streptococcal pharyngitis , community-acquired pneumonia [ CAP ] ) , congestive heart failure , asthma chronic obstructive pulmonary disease ( COPD ) exacerbation , even anxiety ( table 2 ) [ 11 ] .For condition treat remotely , possible streptococcal pharyngitis , mild asthma exacerbation , mild exacerbation chronic congestive heart failure ( CHF ) , often treat without in-person evaluation schedule daily follow-up telehealth visit .', 'Management specific medical condition discuss relevant UpToDate topic reviews.The prevalence disease also consider .', 'As example , region COVID-19 prevalent seasonal influenza activity remain high , patient symptom consistent condition treat empirically influenza.We also consider prevalence COVID-19 community determination whether evaluate patient in-person ; clinical judgement , however , remain important consideration decision .', 'As example , region COVID-19 prevalence high , effort make avoid minimize in-person evaluation possible ; remote evaluation management mild dyspnea , clinically appropriate , prefer .', ""( See 'Reevaluation worsen dyspnea ' 'Consider additional cause worsen dyspnea ' ."", ') Limited role COVID-19 specific therapy — A number therapy evaluate treatment COVID-19 , none prove efficacy .', 'Some , hydroxychloroquine , available indication remain investigational COVID-19 .', 'Medications COVID-19 specific therapy prescribe ambulatory set outside clinical trial [ 48 ] ; data extremely limit , concern potential toxicity unmonitored set [ 49 ] .A catalog clinical trial find covid-trials.org ; list trial filter set ( eg , outpatient versus inpatient ) .Therapies evaluation treatment COVID-19 discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'COVID-19-specific therapy ' ."", ') Medication management — In general , patient ’ usual home medication regimen adjust , although change may need .', 'We advise patient use nebulized medication avoid use presence others use meter dose inhaler preparation instead , possible , avoid potential aerosolization severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Avoiding nebulized medication ' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Nebulized medication ( spontaneously breathe patient ) ' ."", ') If patient already use continuous positive airway pressure ( CPAP ) bilevel positive airway pressure ( BPAP ) device management obstructive sleep apnea , may continue use machine ; nebulizer , advise use device isolate others.For patient take immunomodulating medication , consult prescribe clinician relative risk benefit temporarily discontinue , depend upon indication severity underlie condition .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' , section 'Adjusting immunosuppression ' `` Coronavirus disease 2019 ( COVID-19 ) : Care patient systemic rheumatic disease pandemic '' , section 'Medication management document presumptive COVID-19 ' ."", ') Thromboprophylaxis may appropriate certain patient , high risk venous thromboembolism .', 'This discuss greater detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Outpatient thromboprophylaxis ' ."", ') Management medication review detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Managing chronic medication ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Uncertainty NSAID use ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Avoiding nebulized medication ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Immunomodulatory agent ' `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate kidney disease hypertension '' , section 'Renin angiotensin system inhibitor ' `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' , section 'Outpatient thromboprophylaxis ' ."", ') Counseling warn symptom — We counsel patient warn symptom prompt reevaluation telehealth visit in-person , include emergency department ( ED ) evaluation .', 'These include new onset dyspnea , worsen dyspnea , dizziness , mental status change confusion .', 'Patients educate time course symptom possible development respiratory decline may occur , average , one week onset illness .', 'In addition , ass availability support home , ensure know call need assistance , reinforce access emergency medical services.Patients obstructive lung disease ( eg , COPD asthma ) specifically advise closely monitor respiratory status , caution presume worsen shortness breath due exacerbation underlie lung disease.Addressing goal care — Given potential severity COVID-19 , patient update health care proxy advance directive information electronic health record.For patient significant underlie medical comorbidities poor health status , COVID-19 may cause catastrophic illness include respiratory failure due acute respiratory distress syndrome ( ARDS ) .', 'Among patient , develop life-threatening complication likely poor outcome despite use aggressive measure mechanical ventilation .', 'For patient highest risk complication lowest likelihood survival , appropriateness hospitalization ventilator assistance discuss advance significant deterioration clinical condition .', 'For patient , may appropriate address home palliative care strategy anticipation need .', 'Many institution palliative care hospice program provide skilled nurse social work support patient family .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Surge capacity scarce resource allocation ' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'End life issue ' `` Advance care plan advance directive '' , section 'COVID-19 resource ' ."", ') Convalescent plasma donation — We encourage eligible patient donate convalescent plasma recovery COVID-19 .', 'To eligible plasma donation , patient must meet general criterion blood donation ( revise US Food Drug Administration [ FDA ] April , 2020 increase potential blood donor pool ) specific COVID-19 recovery guideline [ 50 ] .', ""( See `` Blood donor screen : Medical history '' , section 'COVID-19 pandemic revise deferral criterion ' `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Convalescent plasma ' ."", ') TELEHEALTH FOLLOW-UPFrequency follow-up — For patient COVID-19 determine appropriate home management telehealth follow-up , frequency telehealth visit determine risk severe disease ( table 1 ) , severity respiratory symptom , comfort level ability self-report worsen symptom .', ""( See 'Home management without in-person evaluation others ' ."", ') ●For patient , telehealth visit schedule day 4 , 7 , 10 ( follow onset clinical illness ) .●However , patient highest level concern , generally schedule first follow-up telehealth visit within 24 hour .', ""These include : •Patients age ≥65 year one additional risk factor severe disease ( table 1 ) •Any patient moderate dyspnea time initial evaluation•Patients feel may reliably report deterioration symptomsFor patient , frequency subsequent telehealth visit reduce every day patient remain clinically stable.Repeat assessment dyspnea hypoxia — At telehealth visit , evaluate patient 's respiratory status , focus assess new worsen dyspnea hypoxia , likely indication require in-person clinical reevaluation potential hospitalization ."", 'In addition , ass overall acuity level , ensure patient remain clinically stable enough remote management .', ""( See 'Dyspnea assessment ' 'Assessment overall acuity level ' ."", ') Reevaluation worsen dyspnea — All patient develop worsen severe dyspnea require evaluation management .', 'We use criterion determine whether patient need evaluate in-person initial evaluation .', ""( See 'Determine in-person evaluation warrant ' ."", ') For patient meet criterion in-person evaluation , potentially treatable cause dyspnea clinical history ( eg , anxiety , mild exacerbation congestive heart failure , mild asthma chronic obstructive pulmonary disease [ COPD ] exacerbation ) , typically treat condition remotely .', 'However , patient closely follow daily telehealth visit least next several day improve .', 'The frequency duration subsequent follow-up determine clinical course.Dyspnea severe enough interfere activity daily live cause difficulty speak require in-person evaluation .', 'Further , new dyspnea patient high risk severe disease prompt in-person evaluation ( table 1 ) .', 'The in-person evaluation occur appropriate clinical set , depend upon severity dyspnea , may vary health care system .', ""( See 'In-person evaluation moderate/severe dyspnea , hypoxia , concern higher acuity level ' ."", ') Consider additional cause worsen dyspnea — In addition , even though patient worsen symptom may manage remotely , perform in-person evaluation complaint suggestive serious condition complication amenable telehealth management , severe community-acquired pneumonia ( CAP ; eg , new productive cough , pleuritic chest discomfort ) , asthma COPD exacerbation ( eg , cough , increase wheeze ) , pulmonary embolism ( eg , worsen dyspnea , pleuritic chest pain , hemoptysis ) , heart failure ( increase dyspnea , edema , orthopnea ) acute pericarditis ( eg , chest pain ) .', 'This evaluation take place respiratory ( COVID-19 ) clinic appropriate clinical care set .', 'Discussion evaluation management condition find relevant UpToDate topics.In particular , patient suspect COVID-19 dyspnea underlie obstructive lung disease ( include COPD asthma ) present unique management challenge .', 'For patient , dyspnea may simply due exacerbation obstruction , possible differentiate clinically isolate exacerbation underlie pulmonary disease exacerbation relate COVID-19 .', 'In case , presumptive asthma COPD exacerbation treat short course oral corticosteroid increase use short-acting beta agonist .', 'Patients home oxygen baseline evaluate increase oxygen requirement .', ""( See `` An overview asthma management '' , section 'Advice relate COVID-19 pandemic ' `` Management exacerbation chronic obstructive pulmonary disease '' ."", ') OUTPATIENT MANAGEMENT FOLLOWING INPATIENT OR ED DISCHARGE — After discharge inpatient hospital set emergency department ( ED ) , clinician follow-up warrant , either outpatient clinic via telehealth visit .', 'At encounter hospital ED discharge , reinforce importance infection control provide counsel warn symptom prompt reevaluation .', ""( See 'Infection control ' 'Counseling warn symptom ' ."", ') In case , patient discharge home supervise residential care inpatient hospital set low flow oxygen therapy , oximetry monitor telehealth ( prefer available ) visit nurse .', 'The practice send patient home supplemental oxygen widely variable , however , do warrant close patient monitor .', ""( See 'Home oxygen therapy oximetry patient ' ."", ') Patients discharge home●Most patient discharge inpatient set require follow-up clinician visit within one two day follow discharge ; depend unique clinical social situation , telehealth visit in-person outpatient visit may appropriate.●For patient evaluate discharge ED felt need follow-up care , telehealth visit may also appropriate .', 'The time visit , however , would vary depend upon patient acuity indication.Patients discharge supervise residential care recovery — As part continuum care patient COVID-19 , temporary house supervise residential care facility may also appropriate manage patient discharge inpatient hospital set , well evaluate discharge ED .', ""( See 'Supervised residential care facilitate isolation ' ."", "") Depending upon type facility , patient 's medical acuity , available resource , telehealth follow-up may appropriate ; intensity telehealth follow-up vary depend upon indication house ( eg , solely need isolation versus isolation acute medical need ) .SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately ."", ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) pregnancy ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●Our understand spectrum coronavirus disease 2019 ( COVID-19 ) well optimal management strategy continue evolve ."", ""There limit data inform outpatient management strategy , approach describe base upon clinical experience ; clinician take account individual patient 's clinical social circumstance well available resource ."", ""( See 'Introduction ' ."", ') ●Outpatient management appropriate patient suspect confirm COVID-19 .', 'When possible , favor coordinate care management program include initial risk stratification , clinician telehealth visit ( telephone call video platform-based ) , dedicate outpatient respiratory clinic , close relationship local emergency department ( ED ) .', ""( See 'General principle ' ."", ') ●Patients live region widespread community transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) compatible symptom generally manage presumptively COVID-19 , even test initial negative test result ( table 2 ) .', ""( See 'Suspicion COVID-19 role test ' ."", ') ●On initial evaluation , ass risk factor severe disease ( table 1 ) , dyspnea severity duration ( oxygenation status dyspnea ) , overall level acuity , patient ’ home set determine warrant in-person evaluation outpatient clinic ED .', 'The additional criterion use make determination fix vary institution , region , time resource availability evolve .', ""( See 'Risk stratification ' . )"", '( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', "") We typically refer patient one follow feature ED management ( see 'Criteria evaluation ED ' ) : •Severe dyspnea ( dyspnea rest , interfere inability speak complete sentence ) •Oxygen saturation room air ≤90 percent , regardless severity dyspnea•Concerning alteration mentation ( eg , confusion , change behavior , difficulty rouse ) sign symptom hypoperfusion hypoxia ( eg , fall , hypotension , cyanosis , anuria , chest pain suggestive acute coronary syndrome ) We refer patient evaluation outpatient clinic one follow feature without precede feature ( see 'Patients appropriate evaluation clinic ' ) : •Mild dyspnea patient oxygen saturation room air 91 94 percent•Mild dyspnea patient high risk severe disease ( table 1 ) •Moderate dyspnea patient•Symptoms concern enough warrant in-person evaluation ( eg , mild orthostasis ) severe enough require ED referralOther patient generally remain home management without in-person evaluation reliably report worsen symptom self-isolate anticipate duration illness ."", 'Whether patient warrant telehealth follow-up depend upon risk severe disease extent dyspnea .', ""( See 'Home management without in-person evaluation others ' ."", "") ●When manage outpatient COVID-19 ( see 'Management counsel outpatient ' ) : •We reinforce importance infection control self-isolation ."", 'Instructions home isolation ( include duration ) discuss detail elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Infection control home set ' ."", ') •Symptoms COVID-19 overlap many common condition , important consider possible etiology symptom include respiratory infection , congestive heart failure , asthma chronic obstructive pulmonary disease ( COPD ) exacerbation , even anxiety .', 'For condition treat remotely , often treat without in-person evaluation schedule daily follow-up telehealth visit .', ""( See 'Managing potential cause symptom ' ."", ') •A number therapy evaluate treatment COVID-19 , none prove efficacy .', 'None treatment prescribe ambulatory set outside clinical trial ; data extremely limit , concern potential toxicity unmonitored set .', ""( See 'Limited role COVID-19 specific therapy ' ."", ') •In general , patient ’ usual home medication regimen adjust .', 'However , advise patient use nebulized medication avoid use presence others .', ""( See 'Medication management ' ."", ') •We counsel patient warn symptom prompt reevaluation telehealth visit in-person , include ED evaluation .', ""( See 'Counseling warn symptom ' ."", ') •All patient update health care proxy advance directive information electronic health record .', ""( See 'Addressing goal care ' ."", ') •We encourage eligible patient donate convalescent plasma recovery COVID-19 .', ""( See 'Convalescent plasma donation ' ."", "") ●On follow-up ( eg , telehealth visit ) , evaluate patient 's respiratory status , focus assess new worsen dyspnea ."", 'We use criterion determine whether patient need evaluate in-person initial evaluation .', ""( See 'Reevaluation worsen dyspnea ' 'Consider additional cause worsen dyspnea ' ."", ') ●Most patient discharge inpatient set warrant clinician follow-up within one two day follow discharge ; whether telehealth in-person outpatient visit appropriate depend unique clinical social situation .', 'Temporary house supervise residential care facility , available , may also appropriate patient discharge inpatient hospital set .', ""( See 'Outpatient management follow inpatient ED discharge ' . )""]","['', 'end', '2019', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'china', '', 'subsequently', '', 'infection', 'rapidly', 'spread', 'throughout', 'world', '', 'result', 'global', 'pandemic', '', 'coronavirus', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'illness', 'cause', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'spectrum', 'covid-19', 'adult', 'range', 'asymptomatic', 'infection', 'mild', 'respiratory', 'tract', 'symptom', 'severe', 'pneumonia', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'multiorgan', 'dysfunction', '', 'understand', 'spectrum', 'disease', 'well', 'optimal', 'management', 'strategy', 'continue', 'evolvethis', 'topic', 'address', 'management', 'adult', 'patient', 'covid-19', '', 'presume', 'confirm', '', 'outpatient', 'set', '', 'include', 'self-care', 'advice', '', 'telehealth', '', 'outpatient', 'clinic', 'management', '', 'emergency', 'department', '', 'ed', '', 'referral', '', 'important', 'note', 'limit', 'data', 'inform', 'outpatient', 'management', 'strategy', '', 'approach', 'describe', 'base', 'upon', 'clinical', 'experience', '', 'clinician', 'account', 'individual', 'patient', 'clinical', 'social', 'circumstance', 'well', 'available', 'resourcesgeneral', 'management', 'strategy', '', 'include', 'infection', 'control', 'measure', '', 'care', 'hospitalize', 'patient', '', 'specific', 'covid-19', 'complication', '', 'discuss', 'detail', 'elsewhere', '', 'consideration', 'special', 'population', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'anesthetic', 'concern', '', 'include', 'airway', 'management', 'infection', 'control', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'intensive', 'care', 'ventilation', 'anesthesia', 'machine', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'cancer', 'care', 'pandemic', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'psychiatric', 'symptom', 'disorder', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'gastrointestinal', 'disease', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'care', 'patient', 'systemic', 'rheumatic', 'disease', 'pandemic', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'general', 'principlescontinuum', 'care', '', 'possible', '', 'favor', 'manage', 'patient', 'suspect', 'confirm', 'covid-19', 'within', 'outpatient', 'continuum', 'care', 'management', 'program', 'include', '', 'self-assessment', 'tool', '', '', 'patient', 'self-assessment', 'tool', '', '', '', 'initial', 'telephone', 'triage', '', '', 'initial', 'telephone', 'triage', '', '', '', 'coordinated', 'outreach', 'management', 'approach', 'base', 'upon', 'individual', 'patient', 'risk', '', 'severity', 'symptom', '', 'time', 'course', 'disease', '', '', 'risk', 'stratification', '', 'determine', 'in-person', 'evaluation', 'warrant', '', 'telehealth', 'follow-up', '', '', '', 'clinician', 'telehealth', '', 'telephone', 'call', 'video', 'platform-based', '', 'visit', '', 'initial', 'evaluation', 'follow-up', 'visit', '', '', '1', '', '', '', 'telehealth', 'follow-up', '', '', '', 'covid-19', 'test', '', '', 'suspicion', 'covid-19', 'role', 'test', '', '', '', 'separate', 'outpatient', 'respiratory', 'clinic', 'dedicate', 'space', 'within', 'ambulatory', 'clinic', 'appropriate', 'care', 'patient', 'covid-19', 'respiratory', 'problem', '', 'strategies', 'reduce', 'risk', 'exposure', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'staff', 'patient', 'employ', '', '2', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'health', 'care', 'set', '', '', '', 'addition', '', 'outpatient', 'clinic', 'close', '', 'coordinate', 'relationship', 'local', 'emergency', 'department', '', 'ed', '', 'function', 'partnership', 'within', 'continuum', 'care', 'program', '', '', 'rationale', 'outpatient', 'management', 'remote', 'care', '', '', '', 'close', 'work', 'relationship', 'local', 'public', 'health', 'official', 'community', 'leadersin', 'system', '', 'patient', 'enter', 'ambulatory', 'covid-19', 'care', 'program', 'contact', 'primary', 'health', 'care', 'provider', 'follow', 'discharge', 'ed', 'inpatient', 'hospital', 'stayin', 'addition', '', 'course', 'illness', 'recovery', '', 'patient', 'able', 'transition', 'different', 'site', 'care', 'follow-up', 'dictate', 'clinical', '', 'eg', '', 'home', 'self-care', 'management', '', 'outpatient', 'clinic', 'ed', 'evaluation', '', 'telehealth', 'follow-up', '', 'back', 'self-care', 'management', '', 'rationale', 'outpatient', 'management', 'remote', 'care', '', 'outpatient', 'management', 'appropriate', 'patient', 'covid-19', '', 'approximately', '80', 'percent', 'patient', '', 'illness', 'mild', 'warrant', 'medical', 'intervention', 'hospitalization', '', '3', '', '', 'addition', '', 'remote', '', 'telehealth', '', 'management', 'prefer', 'majority', 'patient', 'follow', 'reason', '', 'remote', 'management', 'prevent', 'unnecessary', 'in-person', 'medical', 'visit', '', 'include', 'visit', 'urgent', 'care', 'facility', 'eds', '', 'thus', 'avoid', 'additional', '', 'unnecessary', 'strain', 'already', 'overburden', 'overwhelm', 'health', 'care', 'system', '', 'include', 'utilization', 'limit', 'resource', '', 'especially', 'personal', 'protective', 'equipment', '', 'ppe', '', '', 'in-person', 'health', 'care', 'provider', 'visit', 'require', 'patient', 'leave', 'home', '', 'travel', 'via', 'public', '', 'private', '', 'emergency', 'transport', 'potentially', 'expose', 'others', 'sars-cov-2', '', 'addition', '', 'upon', 'arrival', 'health', 'care', 'facility', '', 'patient', 'expose', 'patient', 'health', 'care', 'worker', 'viruscreating', 'comprehensive', '', 'coordinate', 'outpatient', 'care', 'program', 'incorporate', 'component', 'allow', 'patient', 'receive', 'supportive', 'care', 'home', '', 'necessary', '', 'ambulatory', 'clinic', 'set', '', 'reduce', 'ed', 'hospital', 'resource', 'utilizationtelehealth', 'patient', 'management', 'previous', 'disease', 'outbreak', '', 'include', 'sars', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', '', 'influenza', 'h1n1', '', '4', '', '', 'however', '', 'remote', 'evaluation', 'study', 'set', 'global', 'pandemic', 'care', 'patient', 'covid-19', '', 'thus', '', 'evidence', 'demonstrate', 'improve', 'outcome', 'home', 'management', 'covid-19', 'lackingtelehealth', 'evaluation', 'covid-19', 'pandemic', 'perform', 'telephone', 'call', '', 'video-based', 'telemedicine', 'platform', '', 'commercial', 'video', 'chat', 'platform', '', 'format', 'choose', 'compliant', 'applicable', 'patient', 'privacy', 'regulation', '', '5', '', 'flexibility', 'approach', 'care', '', 'high-quality', 'data', 'support', 'superiority', 'single', 'outpatient', 'management', 'strategy', '', 'treatment', 'protocol', 'develop', 'modify', 'understand', 'disease', 'evolvesour', 'approach', 'base', 'upon', 'clinical', 'experience', 'treat', 'patient', 'covid-19', 'place', 'additional', 'emphasis', 'avoid', 'infection', 'transmission', '', 'preserve', 'limit', 'resource', '', 'include', 'test', 'ppe', '', '', 'reduce', 'burden', 'overwhelm', 'health', 'care', 'systemsthe', 'intensity', '', 'frequency', 'duration', '', 'outpatient', 'follow-up', 'vary', 'accord', 'patient', 'risk', 'develop', 'severe', 'disease', '', 'table', '1', '', '', 'vary', 'institution', '', 'region', '', 'resource', 'availability', '', 'likely', 'change', 'burden', 'disease', 'give', 'location', '', 'example', '', 'institution', 'able', 'establish', 'dedicate', 'respiratory', 'clinic', 'devote', 'manage', 'covid-19', 'patient', '', 'available', 'in-person', 'remote', 'management', 'option', '', 'location', '', 'patient', 'manage', 'primary', 'care', 'clinician', '', 'often', 'consultation', 'team', 'specially', 'train', 'cliniciansadditionally', '', 'institution', 'revise', 'protocol', '', 'several-week', 'period', '', 'response', 'surge', 'number', 'patient', 'suspect', 'infection', 'manage', '', '6', '', 'initial', 'evaluation', '', 'patient', 'concern', 'covid-19', '', 'mild', 'symptom', '', 'likely', 'initiate', 'contact', 'health', 'care', 'system', '', 'patient', '', 'self-assessment', 'tool', '', 'remote', '', 'telehealth', '', 'evaluation', 'prefer', 'initial', 'management', 'approach', '', '7-9', '', 'patient', 'self-assessment', 'tool', '', 'patient', 'education', 'material', '', 'include', 'self-assessment', 'tool', '', 'help', 'patient', 'determine', 'medical', 'evaluation', 'necessary', '', 'proactive', 'dissemination', 'material', 'increase', 'awareness', 'encourage', '', 'various', 'online', 'self-assessment', 'tool', 'publish', 'medical', 'institution', 'governmental', 'health', 'agency', 'guide', 'patient', 'question', 'suggest', 'seek', 'medical', 'care', '', 'follow', 'guidance', '', 'patient', 'mild', 'illness', 'able', 'recover', 'home', 'without', 'direct', 'contact', 'health', 'care', 'provider', '', 'recommend', 'specific', 'assessment', 'tool', '', 'however', '', 'clinician', 'vet', 'option', 'carefully', '', 'exceed', 'ability', 'patient', 'limit', 'health', 'literacy', 'become', 'quickly', 'out-of-date', 'base', 'upon', 'rapidly', 'change', 'guidelinesin', 'one', 'study', '', 'self-assessment', 'tool', 'embed', 'electronic', 'health', 'record', 'allow', '40', 'percent', 'symptomatic', 'patient', 'appropriately', 'triaged', 'self-care', '', '9', '', '', 'study', '', 'however', '', 'conduct', 'set', 'relatively', 'low', 'community', 'prevalence', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'representative', 'set', 'widespread', 'community', 'transmissioninitial', 'telephone', 'triage', '', 'addition', 'self-assessment', 'tool', '', 'initial', 'triage', 'call', 'clinic', 'staff', 'often', 'determine', 'patient', 'appropriate', 'self-care', 'home', '', 'patient', 'warrant', 'timely', 'clinician', 'telehealth', 'visit', '', 'televisit', '', '', 'patient', 'warrant', 'outpatient', 'clinic', 'visit', 'urgent', 'emergency', 'department', '', 'ed', '', 'evaluation', '', '10', '', '', '', 'risk', 'stratification', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'patient', 'symptom', 'suggestive', 'respiratory', 'compromise', 'hypoxia', '', 'eg', '', 'significant', 'dyspnea', 'rest', 'mental', 'confusion', '', 'refer', 'urgent', 'in-person', 'evaluation', '', 'appropriate', 'site', 'care', 'depend', 'upon', 'severity', 'symptom', 'discuss', 'elsewhere', '', '', 'in-person', 'evaluation', 'moderatesevere', 'dyspnea', '', 'hypoxia', '', 'concern', 'higher', 'acuity', 'level', '', '', '', 'suspicion', 'covid-19', 'role', 'test', '', 'pandemic', '', 'patient', 'live', 'region', 'widespread', 'community', 'transmission', 'compatible', 'symptom', 'generally', 'manage', 'presumptively', 'covid-19', '', 'test', 'initial', 'negative', 'test', 'resultpatients', 'covid-19', 'typically', 'first', 'experience', 'viral-type', 'illness', 'symptom', 'range', 'mild', 'upper', 'respiratory', 'tract', 'infection', '', 'eg', '', 'pharyngitis', '', 'rhinorrhea', '', 'lower', 'respiratory', 'tract', 'infection', '', 'eg', '', 'cough', '', 'fever', '', '', 'influenza-like', 'symptom', '', 'eg', '', 'fever', '', 'chill', '', 'headache', '', 'myalgia', '', '', 'gastroenteritis', '', 'eg', '', 'nausea', '', 'vomit', '', 'diarrhea', '', '', 'table', '2', '', '', '1112', '', '', 'loss', 'smell', 'taste', 'occur', '', 'olfactory', 'loss', 'typically', 'report', 'early', 'course', 'illness', '', '13', '', '', 'dyspnea', '', 'develop', '', 'tend', 'occur', 'patient', 'four', 'eight', 'day', 'onset', 'symptom', '', 'although', 'occur', '10', 'day', '', '11', '', '', 'patient', 'le', 'typical', 'symptom', 'isolate', 'rhinorrhea', 'headache', '', 'likelihood', 'illness', 'due', 'covid-19', 'account', 'local', 'prevalence', 'disease', '', 'however', '', 'pandemic', '', 'covid-19', 'rule', 'base', 'upon', 'clinical', 'history', '', '', 'location', 'high', 'prevalence', 'covid-19', '', 'possibility', 'etiology', 'symptom', 'consider', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'initial', 'presentation', '', 'managing', 'potential', 'cause', 'symptom', '', '', '', 'availability', 'test', 'sars-cov-2', 'vary', 'widely', 'across', 'region', '', 'test', 'capacity', 'adequate', 'personal', 'protective', 'equipment', '', 'ppe', '', 'supply', 'allow', '', 'favor', 'widespread', 'test', '', 'include', 'drive-through', 'test', '', 'important', 'epidemiologic', 'purpose', '', 'however', '', 'resource', 'limit', '', 'sars-cov-2', 'test', 'outpatient', 'mild', 'disease', 'neither', 'readily', 'available', 'appropriate', '', 'united', 'states', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'infectious', 'diseases', 'society', 'america', 'propose', 'priority', 'test', '', 'table', '3', '', '', 'specific', 'criterion', 'test', 'vary', 'location', '', 'institution', '', 'change', 'time', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'covid-19', 'test', 'readily', 'available', '', '', '', 'patient', 'able', 'undergo', 'test', '', 'detection', 'sars-cov-2', 'rna', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'confirm', 'covid-19', '', 'however', '', 'give', 'sample', 'variability', '', 'viral', 'load', 'variation', '', 'potential', 'false-negative', 'result', '', 'single', 'negative', 'test', 'exclude', 'infection', 'guide', 'management', '', '1415', '', '', 'antibody', 'detection', 'le', 'utility', 'diagnosis', 'acute', 'outpatient', 'set', 'sole', 'test', 'exclude', 'diagnose', 'covid-19', '', 'laboratory', 'test', 'sars-cov-2', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'microbiologic', 'diagnosis', '', '', '', 'risk', 'stratification', '', 'patient-centered', 'continuum', 'care', 'management', 'approach', 'base', 'stratification', 'risk', 'develop', 'severe', 'disease', 'close', 'monitor', 'respiratory', 'decompensation', '', 'patients', 'without', 'severe', 'initial', 'symptom', '', 'deem', 'stable', 'enough', 'require', 'immediate', 'in-person', 'evaluation', '', 'risk', 'stratify', 'determine', 'intensity', '', 'frequency', 'duration', '', 'follow-upassess', 'risk', 'severe', 'disease', '', 'older', 'age', 'certain', 'chronic', 'medical', 'condition', 'associate', 'severe', 'illness', 'higher', 'mortality', 'covid-19', '', 'table', '1', '', '', 'categorize', 'patient', 'high', '', 'moderate', '', 'low', 'risk', 'severe', 'disease', '', 'high', 'riskage', '65', 'year', 'residence', 'nurse', 'home', 'long-term', 'care', 'facilityimmunocompromising', 'conditionchronic', 'lung', 'disease', 'moderate', 'severe', 'asthmacardiovascular', 'disease', '', 'include', 'hypertension', '', 'severe', 'obesity', '', 'body', 'mass', 'index', '', 'bmi', '', '40', 'kgm2', '', 'diabetes', 'mellituschronic', 'kidney', 'disease', '', 'undergo', 'dialysis', '', 'cerebrovascular', 'diseasechronic', 'liver', 'diseasetobacco', 'disordermoderate', 'riskage', '20', '64', 'year', '', 'without', 'specific', 'comorbidities', 'list', 'aboveage', '', '20', 'year', '', 'underlie', 'medical', 'condition', 'list', 'abovelow', 'riskage', '', '20', 'year', '', 'without', 'underlie', 'medical', 'conditionsthese', 'category', 'base', 'upon', 'cdc', 'guidance', 'well', 'data', 'publish', 'cohort', 'study', '', 'older', 'age', 'underlie', 'condition', 'associate', 'severe', 'disease', 'death', '', '16-19', '', 'additionally', '', 'united', 'states', '', 'black', 'hispanic', 'patient', 'represent', 'disproportionately', 'high', 'percentage', 'hospitalization', 'death', '', '171820', '', '', 'reason', 'find', 'unclear', 'relate', 'inequality', 'social', 'determinant', 'health', '', 'eg', '', 'access', 'health', 'care', '', 'economic', 'stability', '', 'live', 'environment', '', 'community', 'experience', '', 'education', '', 'predispose', 'disease', '', 'risk', 'factor', 'severe', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'important', 'note', 'although', 'patient', '65', 'year', 'age', 'poorly', 'control', 'chronic', 'medical', 'condition', 'higher', 'risk', 'hospitalization', 'death', '', 'infection', 'sars-cov-2', 'cause', 'catastrophic', 'illness', 'patient', '', 'among', 'moderate-risk', '', 'le', 'frequently', '', 'low-risk', 'patient', '', 'addition', '', 'although', 'vast', 'majority', 'child', 'covid-19', 'mild', 'disease', '', '2122', '', '', 'infant', 'child', 'underlie', 'medical', 'condition', 'warrant', 'close', 'monitor', '', 'severe', 'disease', 'likely', 'occur', 'child', 'underlie', 'medical', 'condition', '', '23', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'mis-c', '', 'rare', 'serious', 'condition', 'report', 'child', 'adolescent', 'association', 'current', 'recent', 'covid-19', 'infection', 'exposure', '', '24-28', '', '', 'share', 'clinical', 'feature', 'kawasaki', 'disease', '', 'kd', '', '', 'kd', 'shock', '', 'toxic', 'shock', 'syndrome', '', 'evaluation', 'management', 'child', 'covid-19', 'exposure', 'infection', 'review', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', 'assess', 'symptom', 'duration', 'severitytime', 'course', 'development', 'dyspnea', '', 'patient', 'suspect', 'confirm', 'covid-19', '', 'establish', 'illness', 'timeline', '', 'first', 'day', 'symptom', 'begin', '', 'presence', 'dyspnea', '', 'day', 'dyspnea', 'onset', '', 'mild', 'dyspnea', 'common', '', 'worsen', 'dyspnea', '', 'particularly', 'dyspnea', 'rest', '', 'severe', 'chest', 'discomforttightness', '', 'concern', 'symptom', 'suggest', 'development', 'progression', 'pulmonary', 'involvement', '', 'trajectory', 'dyspnea', 'day', 'follow', 'onset', 'particularly', 'important', '', 'significant', 'worsen', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', 'manifest', 'soon', 'onset', 'dyspnea', '', 'study', 'among', 'patient', 'develop', 'ards', '', 'progression', 'ards', 'occur', 'median', '25', 'day', 'onset', 'dyspnea', '', '29-33', '', '', 'patient', 'moderate', 'high', 'risk', 'severe', 'illness', '', 'table', '1', '', '', 'outreach', 'effort', 'focus', 'particularly', 'day', 'follow', 'onset', 'dyspnea', 'ass', 'worsen', 'respiratory', 'statusit', 'unclear', 'percentage', 'patient', 'covid-19', 'develop', 'dyspnea', '', 'available', 'report', 'likely', 'representative', 'patient', 'sars-cov-2', 'infection', '', 'however', '', 'patient', 'symptomatic', 'infection', '', 'dyspnea', 'likely', 'develop', 'subgroup', 'patient', '', 'example', '', 'dyspnea', 'develop', '19', 'percent', 'approximately', '1000', 'covid-19', 'patient', 'admit', 'hospital', 'wuhan', '', 'china', '', '34', '', '', 'however', '', 'cdc', 'study', 'laboratory-confirmed', 'covid-19', 'patient', 'united', 'states', '', '43', 'percent', 'symptomatic', 'adult', '13', 'percent', 'symptomatic', 'child', 'develop', 'dyspnea', '', '23', '', '', 'among', 'patient', 'develop', 'dyspnea', '', 'typically', 'begin', 'least', 'several', 'day', 'onset', 'illness', '', 'one', 'study', '41', 'hospitalize', 'patient', 'china', '', 'dyspnea', 'develop', '', 'average', '', 'eight', 'day', 'onset', 'symptom', '', '35', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'manifestation', '', '', '', 'dyspnea', 'assessment', '', 'remote', 'assessment', 'dyspnea', 'focus', 'patient', 'subjective', 'symptom', '', 'well', 'objective', 'assessment', 'breathe', '', 'include', 'deterioration', 'respiratory', 'function', '', '36', '', '', 'begin', 'ask', 'patient', 'develop', 'difficulty', 'breathe', '', 'associate', 'cough', '', 'yes', '', 'ask', 'patient', 'describe', 'difficulty', 'word', 'ass', 'ease', 'comfort', 'speech', '', 'eg', '', 'speak', 'comfortably', 'complete', 'sentence', '', 'addition', '', 'ask', 'question', 'provide', 'objective', 'assessment', 'change', 'respiratory', 'status', '', 'include', '', '36', '', '', '', '', 'activity', 'previously', 'without', 'difficulty', 'cause', 'breath', '', '', '', '', 'worse', 'last', 'one', '', 'two', '', 'three', 'day', '', '', '', '', 'breathe', 'harder', 'faster', 'usual', 'sit', 'still', '', '', '', '', 'longer', 'usual', 'household', 'activity', 'due', 'shortness', 'breath', '', '', '', '', 'walk', 'cause', 'feel', 'dizzy', '', '', 'assessment', 'categorize', 'dyspnea', 'severity', '', 'mild', 'dyspnea', '', 'dyspnea', 'interfere', 'daily', 'activity', '', 'eg', '', 'mild', 'shortness', 'breath', 'activity', 'climb', 'one', 'two', 'flight', 'stair', 'walk', 'briskly', '', 'moderate', 'dyspnea', '', 'dyspnea', 'create', 'limitation', 'activity', 'daily', 'live', '', 'eg', '', 'shortness', 'breath', 'limit', 'ability', 'walk', 'one', 'flight', 'stair', 'without', 'rest', '', 'interfere', 'meal', 'preparation', 'light', 'housekeep', 'task', '', 'severe', 'dyspnea', '', 'dyspnea', 'cause', 'shortness', 'breath', 'rest', '', 'render', 'patient', 'unable', 'speak', 'complete', 'sentence', '', 'interfere', 'basic', 'activity', 'toileting', 'dressingif', 'available', '', 'telemedicine', 'consultation', 'video', 'capability', 'allow', 'better', 'evaluation', 'respiratory', 'status', '', 'allow', 'clinician', 'observe', 'patient', 'respiratory', 'pattern', '', 'include', 'accessory', 'muscle', 'respiration', '', '7', '', 'presence', 'dyspnea', '', 'along', 'risk', 'factor', 'develop', 'severe', 'disease', '', 'table', '1', '', '', 'guide', 'clinician', 'determine', 'whether', 'patient', 'require', 'in-person', 'evaluation', '', '', 'determine', 'in-person', 'evaluation', 'warrant', '', '', '', 'oxygenation', 'assessment', '', 'patient', 'covid-19', 'access', 'reliable', 'pulse', 'oximeter', 'home', '', 'adequately', 'measure', 'report', 'result', 'clinician', '', 'measurement', 'oxygen', 'saturation', 'additional', 'piece', 'information', 'ass', 'clinical', 'status', '', 'patients', 'advise', 'pulse', 'oximeter', 'warm', 'finger', '', 'read', 'obtain', 'cold', 'digit', 'accurate', '', '37', '', '', 'outpatient', 'set', '', 'instruct', 'patient', 'check', 'oximetry', 'twice', 'daily', 'inform', 'u', 'value', 'drop', '95', 'percentfor', 'patient', 'oxygen', 'saturation', '94', 'percent', 'room', 'air', '', 'in-person', 'evaluation', 'warrant', '', '', 'in-person', 'evaluation', 'moderatesevere', 'dyspnea', '', 'hypoxia', '', 'concern', 'higher', 'acuity', 'level', '', '', '', 'patient', 'oxygen', 'saturation', '95', 'percent', 'room', 'air', '', 'decision', 'in-person', 'evaluation', 'depend', 'clinical', 'feature', 'severity', 'dyspnea', '', 'risk', 'severe', 'disease', '', 'assessment', 'overall', 'acuity', '', '', 'determine', 'in-person', 'evaluation', 'warrant', '', '', '', 'oximetry', 'consider', 'within', 'context', 'patient', 'overall', 'clinical', 'presentation', '', 'normal', 'oxygen', 'saturation', 'level', 'exclude', 'clinically', 'significant', 'respiratory', 'involvement', 'patient', 'concern', 'symptom', 'progressive', 'severe', 'dyspnea', 'high', 'overall', 'acuity', 'level', '', 'assessment', 'overall', 'acuity', 'level', '', '', '', 'addition', '', 'although', 'normal', 'oximetry', 'reassure', '', 'guarantee', 'respiratory', 'status', 'deteriorate', 'illness', 'progressesof', 'note', '', 'consider', 'oxygen', 'saturation', 'read', 'obtain', 'application', '', '', 'app', '', '', 'mobile', 'telephone', 'accurate', 'enough', 'depend', 'upon', 'clinical', '', '38', '', 'dyspnea', '', 'availability', 'telemedicine', 'video', 'capability', 'allow', 'indirect', 'assessment', 'hypoxia', 'observation', 'cyanosis', '', 'present', '', '7', '', 'assessment', 'overall', 'acuity', 'level', '', 'addition', 'evaluation', 'respiratory', 'status', '', 'ass', 'patient', 'overall', 'acuity', 'level', 'ask', 'question', 'regard', 'orthostasis', '', 'dizziness', '', 'fall', '', 'hypotension', '', 'home', 'blood', 'pressure', 'measurement', 'available', '', '', 'mental', 'status', 'change', '', 'eg', '', 'lethargy', '', 'confusion', '', 'change', 'behavior', '', 'difficulty', 'rouse', '', '', 'observe', 'cyanosis', '', 'urine', 'output', '', 'mild', 'orthostasis', 'symptom', 'address', 'instruction', 'increase', 'fluid', '', 'mental', 'status', 'change', '', 'fall', '', 'cyanosis', '', 'hypotension', '', 'anuria', '', 'chest', 'pain', 'suggestive', 'acute', 'coronary', 'syndrome', 'concern', 'warrant', 'in-person', 'evaluation', '', '', 'in-person', 'evaluation', 'moderatesevere', 'dyspnea', '', 'hypoxia', '', 'concern', 'higher', 'acuity', 'level', '', '', '', 'assess', 'home', 'set', 'social', 'factor', '', 'ass', 'ability', 'patient', 'monitor', 'symptom', 'understand', 'importance', 'seek', 'medical', 'guidance', 'symptom', 'progress', '', 'patients', 'ability', 'self-monitor', 'self-report', 'intensive', 'staff', 'outreach', 'order', 'adequately', 'manage', 'homein', 'addition', '', 'accordance', 'interim', 'cdc', 'guideline', 'home', 'management', '', 'ass', 'patient', 'residential', 'set', 'appropriate', 'home', 'management', 'recovery', '', '39', '', '', 'patient', 'manage', 'home', 'capable', 'adhere', 'appropriate', 'infection', 'control', 'isolation', 'precaution', 'duration', 'illness', 'recovery', '', 'include', 'separate', 'bedroom', 'live', 'alone', '', '', 'important', 'home', 'resource', 'include', 'available', 'caregiver', '', 'adequate', 'access', 'food', '', 'assistance', 'activity', 'daily', 'live', 'necessary', '', 'whether', 'patient', 'household', 'member', 'high', 'risk', 'severe', 'disease', 'another', 'consideration', '', 'table', '1', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'home', 'set', '', '', '', 'determine', 'in-person', 'evaluation', 'warranted', '', 'based', 'upon', 'assessment', '', 'particular', 'risk', 'develop', 'severe', 'disease', '', 'dyspnea', 'oxygenation', '', 'overall', 'acuity', 'level', '', 'determine', 'urgency', 'appropriate', 'set', '', 'in-person', 'evaluation', 'versus', 'schedule', 'telehealth', 'follow-up', 'self-care', '', 'management', '', 'patient', 'warrant', 'in-person', 'evaluation', '', 'decide', 'outpatient', 'clinic', 'emergency', 'department', '', 'ed', '', 'evaluation', 'appropriate', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'follow', 'general', 'criterion', 'determine', 'appropriate', 'clinical', 'set', 'in-person', 'evaluation', '', 'criterion', 'fix', 'vary', 'institution', '', 'region', '', 'time', 'change', 'resource', 'availabilityin-person', 'evaluation', 'moderatesevere', 'dyspnea', '', 'hypoxia', '', 'concern', 'higher', 'acuity', 'level', '', 'patient', 'moderate', 'severe', 'dyspnea', '', 'initial', 'oxygen', 'saturation', '', '95', 'percent', 'room', 'air', '', 'symptom', 'consistent', 'higher', 'acuity', 'level', 'warrant', 'in-person', 'evaluation', '', 'either', 'ed', 'outpatient', 'clinic', '', 'depend', 'upon', 'severity', 'findingscriteria', 'evaluation', 'ed', '', 'typically', 'refer', 'patient', 'one', 'follow', 'feature', 'ed', 'management', '', 'severe', 'dyspnea', '', 'dyspnea', 'rest', '', 'interfere', 'inability', 'speak', 'complete', 'sentence', '', '', 'dyspnea', 'assessment', '', '', 'oxygen', 'saturation', 'room', 'air', '90', 'percent', '', 'regardless', 'severity', 'dyspnea', '', 'oxygenation', 'assessment', '', '', 'concerning', 'alteration', 'mentation', '', 'eg', '', 'confusion', '', 'change', 'behavior', '', 'difficulty', 'rouse', '', 'sign', 'symptom', 'hypoperfusion', 'hypoxia', '', 'eg', '', 'fall', '', 'hypotension', '', 'cyanosis', '', 'anuria', '', 'chest', 'pain', 'suggestive', 'acute', 'coronary', 'syndrome', '', '', 'assessment', 'overall', 'acuity', 'level', '', '', 'patients', 'meet', 'criterion', 'typically', 'admit', 'hospital', 'inpatient', 'evaluation', 'management', '', 'however', '', 'fix', 'criterion', 'inpatient', 'hospital', 'admission', 'covid-19', '', 'criterion', 'vary', 'country', 'region', '', '', 'area', 'high', 'infection', 'prevalence', '', 'criterion', 'vary', 'availability', 'hospital', 'resource', '', 'lower', 'threshold', 'hospitalization', 'feasible', 'set', 'burden', 'disease', 'exceed', 'resource', 'availability', '', 'united', 'states', '', 'national', 'institutes', 'health', '', 'nih', '', 'covid-19', 'treatment', 'guidelines', 'panel', 'suggest', 'hospitalization', 'patient', 'moderate', 'severe', 'disease', '', 'eg', '', 'evidence', 'lower', 'respiratory', 'tract', 'infection', 'without', 'hypoxia', '', '', '40', '', '', 'inpatient', 'hospital', 'resource', 'outpace', 'patient', 'volume', 'set', 'surge', 'covid-19', 'case', '', 'establish', 'outpatient', 'system', 'closely', 'follow-up', 'monitor', 'patient', 'admit', '', 'however', '', 'approach', 'appropriate', 'set', 'limit', 'outpatient', 'resource', '', '', 'patients', 'appropriate', 'evaluation', 'clinic', '', '', '', 'patients', 'appropriate', 'evaluation', 'clinic', '', 'patients', 'one', 'follow', 'feature', 'typically', 'appropriate', 'evaluation', 'outpatient', 'clinic', '', 'ideally', 'dedicate', 'respiratorycovid-19', 'clinic', 'available', '', '', 'provide', 'meet', 'criterion', 'evaluation', 'ed', '', 'mild', 'dyspnea', 'patient', 'oxygen', 'saturation', 'room', 'air', '91', '94', 'percent', '', 'dyspnea', 'assessment', '', '', 'mild', 'dyspnea', 'patient', 'high', 'risk', 'severe', 'disease', '', 'table', '1', '', '', 'assess', 'risk', 'severe', 'disease', '', 'dyspnea', 'assessment', '', '', 'moderate', 'dyspnea', 'patientsymptoms', 'concern', 'enough', 'warrant', 'in-person', 'evaluation', '', 'eg', '', 'mild', 'orthostasis', '', 'severe', 'enough', 'require', 'ed', 'referral', '', 'assessment', 'overall', 'acuity', 'level', '', '', 'clinic', 'evaluation', '', 'patient', 'evaluate', 'outpatient', 'clinic', '', 'feasible', '', 'respiratorycovid-19', 'clinic', '', '', 'ass', 'patient', 'respiratory', 'circulatory', 'status', '', 'evaluate', 'potentially', 'treatable', 'cause', 'symptom', '', '11', '', '', '', 'managing', 'potential', 'cause', 'symptom', '', '', '', 'based', 'upon', 'careful', 'clinical', 'history', 'physical', 'exam', '', 'include', 'vital', 'sign', 'well', 'measurement', 'oxygen', 'saturation', 'rest', 'ambulation', '', 'determine', 'patient', 'appropriate', 'self-care', '', 'home', 'management', 'telehealth', 'follow-up', '', 'transfer', 'ed', '', 'note', '', 'find', 'chest', 'image', 'limit', 'utility', 'evaluation', 'patient', 'covid-19', 'outpatient', 'clinic', '', 'patient', 'clinical', 'presentation', 'important', 'consideration', 'management', 'decision', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'imaging', 'find', '', '', '', 'capability', 'manage', 'patient', 'ambulatory', 'set', '', 'eg', '', 'ability', 'administer', 'intravenous', 'fluid', 'medication', 'arrange', 'outpatient', 'follow-up', '', 'vary', 'institution', 'region', 'thus', 'influence', 'decision', '', 'addition', '', 'consider', 'patient', 'home', 'set', 'social', 'factor', 'determine', 'appropriateness', 'continue', 'outpatient', '', 'clinic', 'teleheath', '', 'managementhome', 'oxygen', 'therapy', 'oximetry', 'patient', '', 'patient', 'covid-19', '', 'stable', 'dyspnea', '', 'mild', 'hypoxia', '', 'consider', 'provide', 'home', 'oxygen', 'therapy', 'home', 'oximetry', 'monitor', 'service', 'availablein', 'order', 'consider', 'patient', 'home', 'oxygen', 'therapy', 'home', 'oximetry', 'management', 'covid-19', '', 'follow', 'criterion', '', 'patient', 'nonsevere', '', 'mild', 'moderate', '', 'dyspnea', '', 'stable', '', 'nonprogressive', 'symptom', 'several', 'daysoxygen', 'saturation', '91', '93', 'percent', 'increase', '95', 'percent', 'administration', 'supplemental', 'oxygen', 'nasal', 'cannula', '2', 'litersminute', '', 'titrate', 'saturation', '96', 'percentthe', 'patient', 'likely', 'adherent', 'therapy', 'recommend', 'follow-upinitiation', 'home', 'oxygen', 'therapy', 'appropriate', 'patient', 'new', 'onset', 'dyspnea', 'hypoxia', 'early', 'onset', 'illness', '', 'severe', 'pulmonary', 'involvement', 'develop', 'among', 'patient', 'low', 'risk', 'severe', 'disease', '', 'supplemental', 'oxygen', 'early', 'course', 'illness', 'suggest', 'hospital', 'admission', 'close', 'monitor', '', 'addition', '', 'patient', 'increase', 'oxygen', 'requirement', 'point', 'course', 'illness', '', 'hospitalization', 'often', 'indicatedpatients', 'send', 'home', 'oxygen', 'therapy', 'require', 'close', 'follow-up', '', 'daily', 'clinician', 'telehealth', 'visit', 'schedule', '', 'patient', 'instruct', 'check', 'oximetry', 'three', 'time', 'daily', '', 'patients', 'receive', 'home', 'oxygen', 'contact', 'clinician', '', 'oxygen', 'saturation', 'level', 'decline', 'establish', 'flow', 'rate', '', 'case', '', 'remote', 'clinician', 'evaluation', 'perform', 'determine', 'in-person', 'reevaluation', 'warrant', '', '', 'determine', 'in-person', 'evaluation', 'warrant', '', '', '', 'oxygen', 'saturation', 'level', 'drop', '91', 'percent', '', 'case', 'ed', 'evaluation', 'indicate', '', '', 'criteria', 'evaluation', 'ed', '', '', '', 'worsening', 'dyspnea', 'develop', '', 'case', 'in-person', 'reevaluation', 'warrant', 'independent', 'oximetry', 'result', '', '', 'in-person', 'evaluation', 'moderatesevere', 'dyspnea', '', 'hypoxia', '', 'concern', 'higher', 'acuity', 'level', '', '', '', 'guidelines', 'manage', 'critically', 'ill', 'patient', 'covid-19', 'suggest', 'initiate', 'supplemental', 'oxygen', 'oxygenation', 'saturation', '', '90', 'percent', '', '41', '', '', 'however', '', 'data', 'inform', 'outcome', 'home', 'oxygen', 'oximetry', 'monitor', 'outpatient', 'covid-19', 'address', 'optimal', 'oxygen', 'titration', 'patient', '', 'additionally', '', 'guideline', 'suggest', 'covid-19', 'patient', 'oxygen', 'saturation', '93', 'percent', 'room', 'air', 'admit', 'hospital', 'inpatient', 'management', '', '40', '', '', 'nevertheless', '', 'approach', 'base', 'upon', 'clinical', 'experience', 'manage', 'patient', 'covid-19', 'set', 'inpatient', 'hospital', 'resource', 'limit', 'due', 'surge', 'patient', 'volume', '', 'establish', 'system', 'closely', 'follow-up', 'monitor', 'patient', 'outpatient', 'set', '', 'approach', 'appropriate', 'set', 'limit', 'outpatient', 'resource', '', 'ideally', '', 'home', 'oxygen', 'therapy', 'monitor', 'evaluate', 'set', 'clinical', 'trial', 'rapid-cycle', 'quality', 'improvement', 'project', 'determine', 'intervention', 'decrease', 'health', 'care', 'facility', '', 'eg', '', 'clinic', 'visit', '', 'hospitalization', '', 'without', 'negatively', 'impact', 'health', 'outcomesin', 'addition', '', 'health', 'insurance', 'coverage', 'restriction', 'limit', 'home', 'oxygen', 'therapy', 'patient', '', 'out-of-pocket', 'cost', 'prohibitive', 'patient', 'without', 'health', 'insurancesome', 'patient', 'warrant', 'transfer', 'clinic', 'ed', '', 'initial', 'evaluation', 'outpatient', 'clinic', '', 'patient', 'require', 'intensive', 'management', 'ed', '', 'particular', '', 'patient', 'require', 'ed', 'management', 'increase', 'work', 'breathe', 'history', 'rapid', 'decline', 'respiratory', 'function', '', 'additional', 'criterion', 'ed', 'evaluation', 'review', 'elsewhere', '', '', 'criteria', 'evaluation', 'ed', '', '', '', 'home', 'management', 'without', 'in-person', 'evaluation', 'others', '', 'majority', 'patient', 'without', 'moderate', 'severe', 'dyspnea', 'hypoxia', 'remain', 'home', 'management', 'without', 'in-person', 'evaluation', '', 'reliably', 'report', 'worsen', 'symptom', 'self-isolate', 'anticipate', 'duration', 'illnessthe', 'component', 'home', 'management', 'counsel', 'patient', 'suspect', 'confirm', 'covid-19', 'discuss', 'elsewhere', '', '', 'management', 'counsel', 'outpatient', '', '', '', 'whether', 'patient', 'warrant', 'telehealth', 'follow-up', 'depend', 'upon', 'risk', 'severe', 'disease', 'extent', 'dyspnea', '', 'table', '1', '', '', 'patients', 'high', 'risk', 'severe', 'disease', '', 'dyspnea', 'discharge', 'self-care', 'home', '', 'in-person', 'evaluation', 'schedule', 'follow-up', 'telehealth', 'visit', '', 'receive', 'instruction', 'contact', 'clinician', 'worsen', 'symptomspatients', 'high', 'risk', 'severe', 'disease', '', 'mild', 'dyspnea', '', 'in-person', 'evaluation', 'schedule', 'telehealth', 'follow-up', 'visitspatients', 'high', 'risk', 'severe', 'disease', '', 'dyspnea', '', 'schedule', 'telehealth', 'follow-up', 'visitsthe', 'frequency', 'content', 'follow-up', 'telehealth', 'evaluation', 'discuss', 'elsewhere', '', '', 'telehealth', 'follow-up', '', '', '', 'supervised', 'residential', 'care', 'facilitate', 'isolation', '', 'patients', 'appropriate', 'home', 'care', '', 'without', 'telehealth', 'follow-up', '', 'unable', 'adequately', 'manage', 'usual', 'residential', 'set', 'candidate', 'temporary', 'shelter', 'supervise', 'residential', 'care', 'facility', '', 'available', '', '42', '', 'particular', '', 'patient', 'unable', 'adequately', 'self-isolate', '', 'eg', '', 'patient', 'live', 'multigenerational', 'household', '', 'patient', 'live', 'high-risk', 'individual', '', 'table', '1', '', '', 'patient', 'experience', 'homelessness', '', 'provide', 'resource', 'dedicate', 'house', 'unit', '', 'available', '', 'disruption', 'family', 'minimize', 'much', 'possible', '', 'every', 'attempt', 'avoid', 'hospitalization', 'simply', 'purpose', 'facilitate', 'self-isolation', '', 'option', 'typically', 'realistically', 'available', 'region', 'widespread', 'diseaseunfortunately', '', 'dedicate', 'residential', 'care', 'facility', 'covid-19', 'patient', 'widely', 'available', 'country', 'region', '', 'community-based', 'solution', 'self-isolation', 'exploredmanagement', 'counseling', 'outpatients', '', 'clinically', 'appropriate', '', 'generally', 'preferable', 'manage', 'patient', 'suspect', 'confirm', 'covid-19', 'remotely', 'via', 'telehealth', 'visit', '', '', 'rationale', 'outpatient', 'management', 'remote', 'care', '', '', '', 'interim', 'recommendation', 'outpatient', 'management', 'patient', 'covid-19', 'provide', 'world', 'health', 'organization', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'united', 'states', '', 'several', 'academic', 'medical', 'center', '', '43-46', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'institutional', 'protocol', '', '', '', 'infection', 'control', '', 'patient', '', 'reinforce', 'importance', 'infection', 'control', 'self-isolation', 'provide', 'instruction', 'anticipate', 'duration', 'isolation', '', 'review', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'home', 'set', '', '', '', 'symptom', 'management', '', 'symptomatic', 'treatment', 'include', 'antipyretic', 'analgesic', 'myalgia', 'headache', 'maintenance', 'oral', 'fluid', 'intake', '', 'generally', 'prefer', 'acetaminophen', '', 'however', '', 'inform', 'patient', 'nonsteroidal', 'antiinflammatory', 'drug', '', 'nsaid', '', 'acceptable', 'symptom', 'respond', 'acetaminophen', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'uncertainty', 'nsaid', '', '', '', 'patient', 'cough', 'dyspnea', 'experience', 'symptomatic', 'improvement', 'self-proning', '', 'rest', 'prone', 'supine', 'position', '', '', '47', '', '', 'however', '', 'patient', 'caution', 'progressive', 'respiratory', 'symptom', '', 'particularly', 'worsen', 'dyspnea', '', 'prompt', 'contact', 'clinician', 'evaluation', '', '', 'reevaluation', 'worsen', 'dyspnea', '', '', '', 'managing', 'potential', 'cause', 'symptom', '', 'since', 'symptom', 'covid-19', 'overlap', 'common', 'condition', '', 'important', 'consider', 'possible', 'etiology', 'symptom', 'include', 'respiratory', 'infection', '', 'eg', '', 'influenza', '', 'streptococcal', 'pharyngitis', '', 'community-acquired', 'pneumonia', '', 'cap', '', '', '', 'congestive', 'heart', 'failure', '', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', 'exacerbation', '', 'anxiety', '', 'table', '2', '', '', '11', '', 'condition', 'treat', 'remotely', '', 'possible', 'streptococcal', 'pharyngitis', '', 'mild', 'asthma', 'exacerbation', '', 'mild', 'exacerbation', 'chronic', 'congestive', 'heart', 'failure', '', 'chf', '', '', 'often', 'treat', 'without', 'in-person', 'evaluation', 'schedule', 'daily', 'follow-up', 'telehealth', 'visit', '', 'management', 'specific', 'medical', 'condition', 'discuss', 'relevant', 'uptodate', 'topic', 'reviewsthe', 'prevalence', 'disease', 'consider', '', 'example', '', 'region', 'covid-19', 'prevalent', 'seasonal', 'influenza', 'activity', 'remain', 'high', '', 'patient', 'symptom', 'consistent', 'condition', 'treat', 'empirically', 'influenzawe', 'consider', 'prevalence', 'covid-19', 'community', 'determination', 'whether', 'evaluate', 'patient', 'in-person', '', 'clinical', 'judgement', '', 'however', '', 'remain', 'important', 'consideration', 'decision', '', 'example', '', 'region', 'covid-19', 'prevalence', 'high', '', 'effort', 'avoid', 'minimize', 'in-person', 'evaluation', 'possible', '', 'remote', 'evaluation', 'management', 'mild', 'dyspnea', '', 'clinically', 'appropriate', '', 'prefer', '', '', 'reevaluation', 'worsen', 'dyspnea', '', 'consider', 'additional', 'cause', 'worsen', 'dyspnea', '', '', '', 'limited', 'role', 'covid-19', 'specific', 'therapy', '', 'number', 'therapy', 'evaluate', 'treatment', 'covid-19', '', 'none', 'prove', 'efficacy', '', '', 'hydroxychloroquine', '', 'available', 'indication', 'remain', 'investigational', 'covid-19', '', 'medications', 'covid-19', 'specific', 'therapy', 'prescribe', 'ambulatory', 'set', 'outside', 'clinical', 'trial', '', '48', '', '', 'data', 'extremely', 'limit', '', 'concern', 'potential', 'toxicity', 'unmonitored', 'set', '', '49', '', 'catalog', 'clinical', 'trial', 'find', 'covid-trialsorg', '', 'list', 'trial', 'filter', 'set', '', 'eg', '', 'outpatient', 'versus', 'inpatient', '', 'therapies', 'evaluation', 'treatment', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'covid-19-specific', 'therapy', '', '', '', 'medication', 'management', '', 'general', '', 'patient', '', 'usual', 'home', 'medication', 'regimen', 'adjust', '', 'although', 'change', '', 'advise', 'patient', 'nebulized', 'medication', 'avoid', 'presence', 'others', 'meter', 'dose', 'inhaler', 'preparation', 'instead', '', 'possible', '', 'avoid', 'potential', 'aerosolization', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'avoiding', 'nebulized', 'medication', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'nebulized', 'medication', '', 'spontaneously', 'breathe', 'patient', '', '', '', '', 'patient', 'already', 'continuous', 'positive', 'airway', 'pressure', '', 'cpap', '', 'bilevel', 'positive', 'airway', 'pressure', '', 'bpap', '', 'device', 'management', 'obstructive', 'sleep', 'apnea', '', 'continue', 'machine', '', 'nebulizer', '', 'advise', 'device', 'isolate', 'othersfor', 'patient', 'immunomodulating', 'medication', '', 'consult', 'prescribe', 'clinician', 'relative', 'risk', 'benefit', 'temporarily', 'discontinue', '', 'depend', 'upon', 'indication', 'severity', 'underlie', 'condition', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', 'section', 'adjusting', 'immunosuppression', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'care', 'patient', 'systemic', 'rheumatic', 'disease', 'pandemic', '', '', 'section', 'medication', 'management', 'document', 'presumptive', 'covid-19', '', '', '', 'thromboprophylaxis', 'appropriate', 'certain', 'patient', '', 'high', 'risk', 'venous', 'thromboembolism', '', 'discuss', 'greater', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'outpatient', 'thromboprophylaxis', '', '', '', 'management', 'medication', 'review', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'managing', 'chronic', 'medication', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'uncertainty', 'nsaid', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'avoiding', 'nebulized', 'medication', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'immunomodulatory', 'agent', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'kidney', 'disease', 'hypertension', '', '', 'section', 'renin', 'angiotensin', 'system', 'inhibitor', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', 'section', 'outpatient', 'thromboprophylaxis', '', '', '', 'counseling', 'warn', 'symptom', '', 'counsel', 'patient', 'warn', 'symptom', 'prompt', 'reevaluation', 'telehealth', 'visit', 'in-person', '', 'include', 'emergency', 'department', '', 'ed', '', 'evaluation', '', 'include', 'new', 'onset', 'dyspnea', '', 'worsen', 'dyspnea', '', 'dizziness', '', 'mental', 'status', 'change', 'confusion', '', 'patients', 'educate', 'time', 'course', 'symptom', 'possible', 'development', 'respiratory', 'decline', 'occur', '', 'average', '', 'one', 'week', 'onset', 'illness', '', 'addition', '', 'ass', 'availability', 'support', 'home', '', 'ensure', 'call', 'assistance', '', 'reinforce', 'access', 'emergency', 'medical', 'servicespatients', 'obstructive', 'lung', 'disease', '', 'eg', '', 'copd', 'asthma', '', 'specifically', 'advise', 'closely', 'monitor', 'respiratory', 'status', '', 'caution', 'presume', 'worsen', 'shortness', 'breath', 'due', 'exacerbation', 'underlie', 'lung', 'diseaseaddressing', 'goal', 'care', '', 'given', 'potential', 'severity', 'covid-19', '', 'patient', 'update', 'health', 'care', 'proxy', 'advance', 'directive', 'information', 'electronic', 'health', 'recordfor', 'patient', 'significant', 'underlie', 'medical', 'comorbidities', 'poor', 'health', 'status', '', 'covid-19', 'cause', 'catastrophic', 'illness', 'include', 'respiratory', 'failure', 'due', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', 'among', 'patient', '', 'develop', 'life-threatening', 'complication', 'likely', 'poor', 'outcome', 'despite', 'aggressive', 'measure', 'mechanical', 'ventilation', '', 'patient', 'highest', 'risk', 'complication', 'lowest', 'likelihood', 'survival', '', 'appropriateness', 'hospitalization', 'ventilator', 'assistance', 'discuss', 'advance', 'significant', 'deterioration', 'clinical', 'condition', '', 'patient', '', 'appropriate', 'address', 'home', 'palliative', 'care', 'strategy', 'anticipation', '', 'institution', 'palliative', 'care', 'hospice', 'program', 'provide', 'skilled', 'nurse', 'social', 'work', 'support', 'patient', 'family', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'surge', 'capacity', 'scarce', 'resource', 'allocation', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'end', 'life', 'issue', '', '', 'advance', 'care', 'plan', 'advance', 'directive', '', '', 'section', 'covid-19', 'resource', '', '', '', 'convalescent', 'plasma', 'donation', '', 'encourage', 'eligible', 'patient', 'donate', 'convalescent', 'plasma', 'recovery', 'covid-19', '', 'eligible', 'plasma', 'donation', '', 'patient', 'must', 'meet', 'general', 'criterion', 'blood', 'donation', '', 'revise', 'us', 'food', 'drug', 'administration', '', 'fda', '', 'april', '', '2020', 'increase', 'potential', 'blood', 'donor', 'pool', '', 'specific', 'covid-19', 'recovery', 'guideline', '', '50', '', '', '', '', 'blood', 'donor', 'screen', '', 'medical', 'history', '', '', 'section', 'covid-19', 'pandemic', 'revise', 'deferral', 'criterion', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'convalescent', 'plasma', '', '', '', 'telehealth', 'follow-upfrequency', 'follow-up', '', 'patient', 'covid-19', 'determine', 'appropriate', 'home', 'management', 'telehealth', 'follow-up', '', 'frequency', 'telehealth', 'visit', 'determine', 'risk', 'severe', 'disease', '', 'table', '1', '', '', 'severity', 'respiratory', 'symptom', '', 'comfort', 'level', 'ability', 'self-report', 'worsen', 'symptom', '', '', 'home', 'management', 'without', 'in-person', 'evaluation', 'others', '', '', '', 'patient', '', 'telehealth', 'visit', 'schedule', 'day', '4', '', '7', '', '10', '', 'follow', 'onset', 'clinical', 'illness', '', 'however', '', 'patient', 'highest', 'level', 'concern', '', 'generally', 'schedule', 'first', 'follow-up', 'telehealth', 'visit', 'within', '24', 'hour', '', 'include', '', 'patients', 'age', '65', 'year', 'one', 'additional', 'risk', 'factor', 'severe', 'disease', '', 'table', '1', '', 'patient', 'moderate', 'dyspnea', 'time', 'initial', 'evaluationpatients', 'feel', 'reliably', 'report', 'deterioration', 'symptomsfor', 'patient', '', 'frequency', 'subsequent', 'telehealth', 'visit', 'reduce', 'every', 'day', 'patient', 'remain', 'clinically', 'stablerepeat', 'assessment', 'dyspnea', 'hypoxia', '', 'telehealth', 'visit', '', 'evaluate', 'patient', 'respiratory', 'status', '', 'focus', 'assess', 'new', 'worsen', 'dyspnea', 'hypoxia', '', 'likely', 'indication', 'require', 'in-person', 'clinical', 'reevaluation', 'potential', 'hospitalization', '', 'addition', '', 'ass', 'overall', 'acuity', 'level', '', 'ensure', 'patient', 'remain', 'clinically', 'stable', 'enough', 'remote', 'management', '', '', 'dyspnea', 'assessment', '', 'assessment', 'overall', 'acuity', 'level', '', '', '', 'reevaluation', 'worsen', 'dyspnea', '', 'patient', 'develop', 'worsen', 'severe', 'dyspnea', 'require', 'evaluation', 'management', '', 'criterion', 'determine', 'whether', 'patient', 'evaluate', 'in-person', 'initial', 'evaluation', '', '', 'determine', 'in-person', 'evaluation', 'warrant', '', '', '', 'patient', 'meet', 'criterion', 'in-person', 'evaluation', '', 'potentially', 'treatable', 'cause', 'dyspnea', 'clinical', 'history', '', 'eg', '', 'anxiety', '', 'mild', 'exacerbation', 'congestive', 'heart', 'failure', '', 'mild', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', 'exacerbation', '', '', 'typically', 'treat', 'condition', 'remotely', '', 'however', '', 'patient', 'closely', 'follow', 'daily', 'telehealth', 'visit', 'least', 'next', 'several', 'day', 'improve', '', 'frequency', 'duration', 'subsequent', 'follow-up', 'determine', 'clinical', 'coursedyspnea', 'severe', 'enough', 'interfere', 'activity', 'daily', 'live', 'cause', 'difficulty', 'speak', 'require', 'in-person', 'evaluation', '', '', 'new', 'dyspnea', 'patient', 'high', 'risk', 'severe', 'disease', 'prompt', 'in-person', 'evaluation', '', 'table', '1', '', '', 'in-person', 'evaluation', 'occur', 'appropriate', 'clinical', 'set', '', 'depend', 'upon', 'severity', 'dyspnea', '', 'vary', 'health', 'care', 'system', '', '', 'in-person', 'evaluation', 'moderatesevere', 'dyspnea', '', 'hypoxia', '', 'concern', 'higher', 'acuity', 'level', '', '', '', 'consider', 'additional', 'cause', 'worsen', 'dyspnea', '', 'addition', '', 'though', 'patient', 'worsen', 'symptom', 'manage', 'remotely', '', 'perform', 'in-person', 'evaluation', 'complaint', 'suggestive', 'serious', 'condition', 'complication', 'amenable', 'telehealth', 'management', '', 'severe', 'community-acquired', 'pneumonia', '', 'cap', '', 'eg', '', 'new', 'productive', 'cough', '', 'pleuritic', 'chest', 'discomfort', '', '', 'asthma', 'copd', 'exacerbation', '', 'eg', '', 'cough', '', 'increase', 'wheeze', '', '', 'pulmonary', 'embolism', '', 'eg', '', 'worsen', 'dyspnea', '', 'pleuritic', 'chest', 'pain', '', 'hemoptysis', '', '', 'heart', 'failure', '', 'increase', 'dyspnea', '', 'edema', '', 'orthopnea', '', 'acute', 'pericarditis', '', 'eg', '', 'chest', 'pain', '', '', 'evaluation', 'place', 'respiratory', '', 'covid-19', '', 'clinic', 'appropriate', 'clinical', 'care', 'set', '', 'discussion', 'evaluation', 'management', 'condition', 'find', 'relevant', 'uptodate', 'topicsin', 'particular', '', 'patient', 'suspect', 'covid-19', 'dyspnea', 'underlie', 'obstructive', 'lung', 'disease', '', 'include', 'copd', 'asthma', '', 'present', 'unique', 'management', 'challenge', '', 'patient', '', 'dyspnea', 'simply', 'due', 'exacerbation', 'obstruction', '', 'possible', 'differentiate', 'clinically', 'isolate', 'exacerbation', 'underlie', 'pulmonary', 'disease', 'exacerbation', 'relate', 'covid-19', '', 'case', '', 'presumptive', 'asthma', 'copd', 'exacerbation', 'treat', 'short', 'course', 'oral', 'corticosteroid', 'increase', 'short-acting', 'beta', 'agonist', '', 'patients', 'home', 'oxygen', 'baseline', 'evaluate', 'increase', 'oxygen', 'requirement', '', '', '', 'overview', 'asthma', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', 'pandemic', '', '', 'management', 'exacerbation', 'chronic', 'obstructive', 'pulmonary', 'disease', '', '', '', 'outpatient', 'management', 'following', 'inpatient', 'ed', 'discharge', '', 'discharge', 'inpatient', 'hospital', 'set', 'emergency', 'department', '', 'ed', '', '', 'clinician', 'follow-up', 'warrant', '', 'either', 'outpatient', 'clinic', 'via', 'telehealth', 'visit', '', 'encounter', 'hospital', 'ed', 'discharge', '', 'reinforce', 'importance', 'infection', 'control', 'provide', 'counsel', 'warn', 'symptom', 'prompt', 'reevaluation', '', '', 'infection', 'control', '', 'counseling', 'warn', 'symptom', '', '', '', 'case', '', 'patient', 'discharge', 'home', 'supervise', 'residential', 'care', 'inpatient', 'hospital', 'set', 'low', 'flow', 'oxygen', 'therapy', '', 'oximetry', 'monitor', 'telehealth', '', 'prefer', 'available', '', 'visit', 'nurse', '', 'practice', 'send', 'patient', 'home', 'supplemental', 'oxygen', 'widely', 'variable', '', 'however', '', 'warrant', 'close', 'patient', 'monitor', '', '', 'home', 'oxygen', 'therapy', 'oximetry', 'patient', '', '', '', 'patients', 'discharge', 'homemost', 'patient', 'discharge', 'inpatient', 'set', 'require', 'follow-up', 'clinician', 'visit', 'within', 'one', 'two', 'day', 'follow', 'discharge', '', 'depend', 'unique', 'clinical', 'social', 'situation', '', 'telehealth', 'visit', 'in-person', 'outpatient', 'visit', 'appropriatefor', 'patient', 'evaluate', 'discharge', 'ed', 'felt', 'follow-up', 'care', '', 'telehealth', 'visit', 'appropriate', '', 'time', 'visit', '', 'however', '', 'vary', 'depend', 'upon', 'patient', 'acuity', 'indicationpatients', 'discharge', 'supervise', 'residential', 'care', 'recovery', '', 'part', 'continuum', 'care', 'patient', 'covid-19', '', 'temporary', 'house', 'supervise', 'residential', 'care', 'facility', 'appropriate', 'manage', 'patient', 'discharge', 'inpatient', 'hospital', 'set', '', 'well', 'evaluate', 'discharge', 'ed', '', '', 'supervised', 'residential', 'care', 'facilitate', 'isolation', '', '', '', 'depending', 'upon', 'type', 'facility', '', 'patient', 'medical', 'acuity', '', 'available', 'resource', '', 'telehealth', 'follow-up', 'appropriate', '', 'intensity', 'telehealth', 'follow-up', 'vary', 'depend', 'upon', 'indication', 'house', '', 'eg', '', 'solely', 'isolation', 'versus', 'isolation', 'acute', 'medical', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pregnancy', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', 'summary', 'recommendationsour', 'understand', 'spectrum', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'well', 'optimal', 'management', 'strategy', 'continue', 'evolve', '', 'limit', 'data', 'inform', 'outpatient', 'management', 'strategy', '', 'approach', 'describe', 'base', 'upon', 'clinical', 'experience', '', 'clinician', 'account', 'individual', 'patient', 'clinical', 'social', 'circumstance', 'well', 'available', 'resource', '', '', '', '', '', 'outpatient', 'management', 'appropriate', 'patient', 'suspect', 'confirm', 'covid-19', '', 'possible', '', 'favor', 'coordinate', 'care', 'management', 'program', 'include', 'initial', 'risk', 'stratification', '', 'clinician', 'telehealth', 'visit', '', 'telephone', 'call', 'video', 'platform-based', '', '', 'dedicate', 'outpatient', 'respiratory', 'clinic', '', 'close', 'relationship', 'local', 'emergency', 'department', '', 'ed', '', '', '', 'general', 'principle', '', '', '', 'patients', 'live', 'region', 'widespread', 'community', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'compatible', 'symptom', 'generally', 'manage', 'presumptively', 'covid-19', '', 'test', 'initial', 'negative', 'test', 'result', '', 'table', '2', '', '', '', 'suspicion', 'covid-19', 'role', 'test', '', '', '', 'initial', 'evaluation', '', 'ass', 'risk', 'factor', 'severe', 'disease', '', 'table', '1', '', '', 'dyspnea', 'severity', 'duration', '', 'oxygenation', 'status', 'dyspnea', '', '', 'overall', 'level', 'acuity', '', 'patient', '', 'home', 'set', 'determine', 'warrant', 'in-person', 'evaluation', 'outpatient', 'clinic', 'ed', '', 'additional', 'criterion', 'determination', 'fix', 'vary', 'institution', '', 'region', '', 'time', 'resource', 'availability', 'evolve', '', '', 'risk', 'stratification', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'typically', 'refer', 'patient', 'one', 'follow', 'feature', 'ed', 'management', '', 'criteria', 'evaluation', 'ed', '', '', '', 'severe', 'dyspnea', '', 'dyspnea', 'rest', '', 'interfere', 'inability', 'speak', 'complete', 'sentence', '', 'oxygen', 'saturation', 'room', 'air', '90', 'percent', '', 'regardless', 'severity', 'dyspneaconcerning', 'alteration', 'mentation', '', 'eg', '', 'confusion', '', 'change', 'behavior', '', 'difficulty', 'rouse', '', 'sign', 'symptom', 'hypoperfusion', 'hypoxia', '', 'eg', '', 'fall', '', 'hypotension', '', 'cyanosis', '', 'anuria', '', 'chest', 'pain', 'suggestive', 'acute', 'coronary', 'syndrome', '', 'refer', 'patient', 'evaluation', 'outpatient', 'clinic', 'one', 'follow', 'feature', 'without', 'precede', 'feature', '', 'patients', 'appropriate', 'evaluation', 'clinic', '', '', '', 'mild', 'dyspnea', 'patient', 'oxygen', 'saturation', 'room', 'air', '91', '94', 'percentmild', 'dyspnea', 'patient', 'high', 'risk', 'severe', 'disease', '', 'table', '1', '', 'moderate', 'dyspnea', 'patientsymptoms', 'concern', 'enough', 'warrant', 'in-person', 'evaluation', '', 'eg', '', 'mild', 'orthostasis', '', 'severe', 'enough', 'require', 'ed', 'referralother', 'patient', 'generally', 'remain', 'home', 'management', 'without', 'in-person', 'evaluation', 'reliably', 'report', 'worsen', 'symptom', 'self-isolate', 'anticipate', 'duration', 'illness', '', 'whether', 'patient', 'warrant', 'telehealth', 'follow-up', 'depend', 'upon', 'risk', 'severe', 'disease', 'extent', 'dyspnea', '', '', 'home', 'management', 'without', 'in-person', 'evaluation', 'others', '', '', '', 'manage', 'outpatient', 'covid-19', '', 'management', 'counsel', 'outpatient', '', '', '', 'reinforce', 'importance', 'infection', 'control', 'self-isolation', '', 'instructions', 'home', 'isolation', '', 'include', 'duration', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'infection', 'control', 'home', 'set', '', '', '', 'symptoms', 'covid-19', 'overlap', 'common', 'condition', '', 'important', 'consider', 'possible', 'etiology', 'symptom', 'include', 'respiratory', 'infection', '', 'congestive', 'heart', 'failure', '', 'asthma', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'copd', '', 'exacerbation', '', 'anxiety', '', 'condition', 'treat', 'remotely', '', 'often', 'treat', 'without', 'in-person', 'evaluation', 'schedule', 'daily', 'follow-up', 'telehealth', 'visit', '', '', 'managing', 'potential', 'cause', 'symptom', '', '', '', 'number', 'therapy', 'evaluate', 'treatment', 'covid-19', '', 'none', 'prove', 'efficacy', '', 'none', 'treatment', 'prescribe', 'ambulatory', 'set', 'outside', 'clinical', 'trial', '', 'data', 'extremely', 'limit', '', 'concern', 'potential', 'toxicity', 'unmonitored', 'set', '', '', 'limited', 'role', 'covid-19', 'specific', 'therapy', '', '', '', 'general', '', 'patient', '', 'usual', 'home', 'medication', 'regimen', 'adjust', '', 'however', '', 'advise', 'patient', 'nebulized', 'medication', 'avoid', 'presence', 'others', '', '', 'medication', 'management', '', '', '', 'counsel', 'patient', 'warn', 'symptom', 'prompt', 'reevaluation', 'telehealth', 'visit', 'in-person', '', 'include', 'ed', 'evaluation', '', '', 'counseling', 'warn', 'symptom', '', '', '', 'patient', 'update', 'health', 'care', 'proxy', 'advance', 'directive', 'information', 'electronic', 'health', 'record', '', '', 'addressing', 'goal', 'care', '', '', '', 'encourage', 'eligible', 'patient', 'donate', 'convalescent', 'plasma', 'recovery', 'covid-19', '', '', 'convalescent', 'plasma', 'donation', '', '', '', 'follow-up', '', 'eg', '', 'telehealth', 'visit', '', '', 'evaluate', 'patient', 'respiratory', 'status', '', 'focus', 'assess', 'new', 'worsen', 'dyspnea', '', 'criterion', 'determine', 'whether', 'patient', 'evaluate', 'in-person', 'initial', 'evaluation', '', '', 'reevaluation', 'worsen', 'dyspnea', '', 'consider', 'additional', 'cause', 'worsen', 'dyspnea', '', '', '', 'patient', 'discharge', 'inpatient', 'set', 'warrant', 'clinician', 'follow-up', 'within', 'one', 'two', 'day', 'follow', 'discharge', '', 'whether', 'telehealth', 'in-person', 'outpatient', 'visit', 'appropriate', 'depend', 'unique', 'clinical', 'social', 'situation', '', 'temporary', 'house', 'supervise', 'residential', 'care', 'facility', '', 'available', '', 'appropriate', 'patient', 'discharge', 'inpatient', 'hospital', 'set', '', '', 'outpatient', 'management', 'follow', 'inpatient', 'ed', 'discharge', '', '', '']",7208,"{'': 1863, 'patient': 201, 'covid-19': 137, 'disease': 113, 'dyspnea': 90, 'management': 81, 'evaluation': 81, 'care': 67, 'coronavirus': 66, '2019': 60, 'home': 53, 'outpatient': 52, 'in-person': 52, 'symptom': 51, 'severe': 50, 'set': 44, 'telehealth': 42, 'respiratory': 39, 'clinical': 38, 'risk': 36}","{'hydroxychloroquine': 1, 'infection': 33, 'sars-cov-2': 12}",46,-0.4588
ID:127488,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child']","['INTRODUCTION — Coronaviruses important human animal pathogen [ 1 ] .', 'At end 2019 , novel coronavirus identify cause cluster pneumonia case Wuhan , city Hubei province China .', 'It rapidly spread , result epidemic throughout China , follow increase number case country throughout world .', 'In February 2020 , World Health Organization ( WHO ) designate disease COVID-19 , stand coronavirus disease 2019 [ 2 ] .', 'The virus cause COVID-19 designate severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) ; previously , refer 2019-nCoV .', 'The WHO declare COVID-19 pandemic March 11 , 2020 [ 3 ] .Understanding COVID-19 evolve .', 'Interim guidance issue WHO United States Centers Disease Control Prevention [ 4,5 ] .', 'Links relate society guideline find elsewhere .', ""( See 'Society guideline link ' ."", ') This topic discus aspect COVID-19 specific child .', ""Multisystem inflammatory syndrome child ; general aspect epidemiology , clinical feature , diagnosis , prevention COVID-19 ; management COVID-19 adult ; coronaviruses discuss separately.● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Hypercoagulability '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Outpatient management adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", "") ● ( See `` Coronaviruses '' ."", "") ● ( See `` Severe acute respiratory syndrome ( SARS ) '' ."", "") ● ( See `` Middle East respiratory syndrome coronavirus : Virology , pathogenesis , epidemiology '' ."", ') EPIDEMIOLOGY — The epidemiology COVID-19 discuss detail separately .', 'This section focus epidemiology COVID-19 child .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Epidemiology ' . )"", 'Can child get COVID-19 ?', '— Children age get COVID-19 , although appear affect le commonly adult [ 6-11 ] .', 'In systematic literature review ( January 1 March 18 , 2020 ) , child account 1 5 percent diagnose COVID-19 case [ 12 ] .', 'Although surveillance definition criterion test change time geographically , proportion case occur child various country ( eg , China , South Korea , Italy , United States ) typically within range [ 9,13-16 ] .As April 2 , 2020 , among 149,760 laboratory-confirmed case report United States Centers Disease Control Prevention ( CDC ) , 1.7 percent child < 18 year ; approximately 70 percent case New York City , rest New York state , New Jersey [ 9 ] .', 'Approximately 90 percent case associate household community exposure , 10 percent associate travel.Although health care-associated outbreak report child [ 17,18 ] , case child result household exposure [ 9 ] .', 'In retrospective study transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) China , household secondary attack rate among pediatric contact range 4 7 percent [ 19,20 ] .', 'In review case New York state ( exclude New York City ) , secondary attack rate among child < 18 year 27 percent [ 21 ] .', 'Transmission SARS-CoV-2 discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Transmission ' ."", ') The age distribution case United States follow [ 9 ] : ● < 1 year – 15 percent●1 4 year – 11 percent●5 9 year – 15 percent●10 14 year – 27 percent●15 17 year – 32 percentAlthough infant < 1 year age account 15 percent confirm case , proportion case occur infant ( 0.27 percent ) le proportion United States population < 1 year age [ 9 ] .Among adult patient COVID-19 United States , emerge data suggest COVID-19 disproportionately affect racial ethnic minority group , perhaps relate underlie health condition economic social condition ( eg , poverty , multigenerational household , employment essential industry , lack pay sick leave , limit access medical care ) [ 22-25 ] .', ""The CDC 's COVID-NET provide race/ethnicity information COVID-19-associated hospitalization child [ 26 ] .Additional information relate COVID-19 activity United States ( eg , outpatient visit , hospitalization ) available CDC 's COVIDView ."", 'Can SARS-CoV-2 transmit breast milk infant feed ?', '— It unknown whether SARS-CoV-2 transmit breast milk .', 'The report test find virus maternal milk six patient [ 27 ] .', 'However , droplet transmission could occur close contact feed ( breastfeed bottle feed ) .', 'Strategies prevent transmission SARS-CoV-2 infant feed discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Breastfeeding formula feed ' ."", ') Can SARS-CoV-2 acquire utero ?', '— Issues relate COVID-19 pregnancy , include utero transmission , discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' ."", ') CLINICAL MANIFESTATIONSAre sign symptom COVID-19 different child adult ?', '— The symptom COVID-19 similar child adult , fewer child adult document infection report symptom [ 9,10 ] .', 'COVID-19 appear milder child adult , although severe case report [ 28 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Clinical manifestation ' 'Are child risk severe COVID-19 ? '"", '.', ') Among 2572 laboratory-confirmed case COVID-19 child < 18 year report United States Centers Disease Control Prevention ( CDC ) April 2 , 2020 , median age 11 year ( range 0 17 year ) ; 57 percent case boy [ 9 ] .', 'In case series China , median age affect child approximately 7 year ( range 1 day 18 year ) ; boy affect slightly often girl ( 57 60 percent case ) [ 6,7 ] .In young infant , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) cause fever without obvious source minimal respiratory symptom [ 29,30 ] .', 'In case series three infant single institution , infant present fever difficulty feed ; lymphopenia thrombocytosis consistent laboratory find [ 30 ] .', 'Fever cough common report symptom child [ 7,9,31,32 ] .', 'In case series United States , complete information symptom available 291 child ; 56 percent fever , 54 percent cough , 13 percent shortness breath ; 73 percent child least one symptom [ 9 ] .', ""In another series 1391 child evaluate COVID-19 Wuhan Children 's Hospital , 171 ( 12 percent ) confirm SARS-CoV-2 infection ( via identification RNA ) [ 7 ] ."", 'Approximately 16 percent child confirm infection asymptomatic , 19 percent upper respiratory infection , 65 percent pneumonia .', 'Fever occur point illness approximately 42 percent .', 'Other common symptom case series include cough ( 49 percent ) pharyngeal erythema ( 46 percent ) .', 'Less common symptom include fatigue , rhinorrhea/nasal congestion , diarrhea , vomit .', 'Similar clinical manifestation report smaller case series China Italy [ 31,33 ] .', 'Some child present gastrointestinal symptom [ 6 ] .', 'Additional symptom report adult include chill shake chill , myalgia , headache , new loss taste smell [ 34 ] .', 'Cutaneous find report infrequently well characterize ; include maculopapular , urticarial , vesicular eruption transient livedo reticularis [ 31,35-37 ] .', ""Reddish-purple nodule distal digit ( sometimes call `` COVID toe '' ) similar appearance pernio ( chilblain ) describe predominantly child young adult , although association COVID-19 clearly establish [ 35,38-41 ] .Laboratory find child confirm infection Wuhan variable ."", 'Approximately one-quarter white blood cell count < 5.5 x 109/L ( 5500/microL ) 3.5 percent lymphocyte count < 1.2 x 109/L ( 1200/microL ) [ 7 ] .', 'Procalcitonin elevate ( > 46 pg/mL ) 64 percent C-reactive protein ( CRP ) elevate ( > 10 mg/L ) 20 percent .', 'In adult patient , lymphopenia ( specifically CD4+ CD8+ T lymphocyte [ 42 ] ) , elevate liver enzyme , elevate lactate dehydrogenase ( LDH ) , elevate inflammatory marker ( eg , CRP , ferritin ) associate increase severity worse outcome .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Risk factor severe illness ' ."", ') Chest radiograph may unremarkable demonstrate bilateral consolidation [ 43,44 ] .', 'In series 171 child confirm SARS-CoV-2 infection , find chest compute tomography include grind glass opacity 33 percent , local patchy shadow 19 percent , bilateral patchy shadow 12 percent , interstitial abnormality 1 percent [ 7 ] .', 'Radiographic find may present symptom [ 45,46 ] .', 'In study eight Italian child hospitalize document COVID-19 , find lung ultrasonography include subpleural consolidation individual confluent B line [ 47 ] .', 'These find concordant radiographic find seven eight patient .', 'They similar find adult patient COVID-19 .', ""( See `` Bedside pleural ultrasonography : Equipment , technique , identification pleural effusion pneumothorax '' , section ' B line lung consolidation ' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'Clinical feature complication ' ."", ') Are child risk severe COVID-19 ? Frequency severe disease child — Although severe case COVID-19 child , include fatal case , report , child appear asymptomatic , mild , moderate disease recover within one two week disease onset [ 6-9,28,33,48-57 ] .In series 2135 child China include 728 child laboratory-confirmed COVID-19 disease , approximately 55 percent case mild asymptomatic , 40 percent case moderate ( eg , clinical radiographic evidence pneumonia without hypoxemia ) , 5 percent case severe ( eg , dyspnea , central cyanosis , hypoxemia ) , < 1 percent critical ( eg , acute respiratory distress syndrome , respiratory failure , shock ) [ 6 ] .', 'Among 376 infant < 1 year age available information , approximately 11 percent severe critical disease .', 'These find interpret caution ; many severe critical case laboratory confirm may cause respiratory infection .', 'Potential risk factor severe disease — Infants < 1 year age child certain serious underlie condition appear greater risk severe disease [ 9,58 ] .', ""The CDC 's COVID-NET provide information underlie medical condition accord age [ 26 ] , although robust evidence associate underlie condition severe illness child lack [ 59 ] ."", 'Among 345 child United States laboratory-confirmed COVID-19 complete information underlie condition , 23 percent underlie condition .', 'The commonly report underlie condition [ 9 ] : ●Chronic pulmonary disease ( include moderate severe asthma ) ●Cardiovascular disease●Immunosuppression ( eg , relate cancer , chemotherapy , radiation therapy , hematopoietic cell solid organ transplant , high do glucocorticoid ) In cross-sectional study 48 child admit pediatric intensive care unit North America , 40 child underlie condition [ 57 ] .', 'The common underlie condition medical complexity ( define dependence technological support association developmental delay and/or genetic anomaly ) 19 , immune suppression malignancy 11 , obesity 7 .', 'Although immunosuppression report underlie condition child severe COVID-19 disease case series , relationship immune compromise severe COVID-19 disease well establish .', 'In review 178 child cancer single institution New York City , 20 test positive SARS-CoV-2 , one require admission ( noncritical ) symptom relate COVID-19 [ 60 ] .', ""COVID-19 similarly mild small survey child develop COVID-19 receive immunosuppressive medication kidney disease inflammatory bowel disease [ 61,62 ] .Other medical condition may increase risk severe disease child base data adult include [ 55,58,63,64 ] : ●Chronic kidney disease undergo dialysis●Chronic liver disease ( eg , chronic hepatitis ) ●Endocrine disorder ( eg , diabetes mellitus ) ●Severe obesity ( body mass index ≥120 percent 95th percentile value ; ( figure 1A-B ) ) ( see `` Definition , epidemiology , etiology obesity child adolescent '' ) Why COVID-19 appear le common severe child adult unclear ."", 'Some consideration le intense immune response virus child versus adult ; cytokine release syndrome think important pathogenesis severe COVID-19 infection [ 65,66 ] .', 'Another explanation viral interference respiratory tract young child lead lower viral load child .', 'Finally , receptor SARS-CoV-2 virus angiotensin convert enzyme 2 receptor , may express differently respiratory tract child compare adult [ 6,12,67,68 ] .Multisystem inflammatory syndrome child — Multisystem inflammatory syndrome child ( MIS-C ) rare serious condition associate COVID-19 report child Europe North America .', 'The clinical feature MIS-C similar Kawasaki disease , Kawasaki disease shock syndrome , toxic shock syndrome .', 'They include persistent fever , hypotension , gastrointestinal symptom , rash , myocarditis , laboratory find associate increase inflammation ; respiratory symptom may lack ( table 1 ) .', 'MIS-C discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Multisystem inflammatory syndrome child '' ."", ') How often child COVID-19 require hospitalization ?', '— A minority child COVID-19 require hospitalization , require intensive care [ 7,9,69 ] .', 'In case series , hospitalization intensive care admission common among child underlie condition infant < 1 year age , although hospitalization infant may reflect severity illness .', ""( See 'Are child risk severe COVID-19 ? '"", '.', ') Among 2572 laboratory-confirmed case COVID-19 child < 18 year report CDC April 2 , 2020 , estimate rate hospitalization range 6 20 percent , estimate rate intensive care range 0.58 2 percent [ 9 ] .', 'In another series 171 child China confirm SARS-CoV-2 infection , three child require intensive care mechanical ventilation ; coexist condition ( one hydronephrosis , leukemia , intussusception ) [ 7 ] .', 'By March 8 , 2020 , 87 percent child discharge hospital , one child die four week admission ( 10-month old concomitant intussusception develop multiorgan failure ) .', 'In study Lombardy region Italy , 4 1591 patient ( < 1 percent ) admit intensive care unit COVID-19 younger 20 year [ 69 ] .', ""Additional information regard hospitalization child United States available CDC 's COVIDView.How I evaluate child pharyngitis pandemic ?"", '— Given concern SARS-CoV-2 may spread upper airway symptomatic asymptomatic child [ 70 ] , Royal College Paediatrics Child Health suggest avoidance examination oropharynx unless essential [ 71 ] .', 'When examination oropharynx necessary ( include obtain oropharyngeal swab ) , personal protective equipment wear , whether child symptom compatible COVID-19 .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Patients suspect confirm COVID-19 ' ."", ') APPROACH TO DIAGNOSISWhat criterion test COVID-19 child ?', '— Criteria test COVID-19 vary geographically .', 'In United States , guidance provide Centers Disease Control Prevention Infectious Diseases Society America ( table 2 ) may adapt state local health department depend upon test availability [ 72-74 ] .Testing criterion suggest World Health Organization find technical guidance online .', 'These criterion use European Centre Disease Prevention Control .', 'Guidance test country discuss separately .', ""( See 'Society guideline link ' ."", "") Outpatient test criterion — The approach test vary accord test availability resource ( eg , community begin offer COVID-19 test resident regardless symptom previous test ) .Given limit test resource , institution perform target test outpatient setting.For child evaluate symptom consistent COVID-19 ( eg , fever , persistent cough , shortness breath , vomit , diarrhea ) emergency department urgent care set , perform test severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) child : ●An underlie condition may increase risk severe disease ; example include : •An immune-compromising condition ( eg , recipient antineoplastic chemotherapy , recent hematopoietic cell transplantation , solid organ transplant recipient , primary immunodeficiency , HIV infection CD4 count < 15 percent ) •Chronic cardiac disease ( eg , cardiomyopathy , unrepaired cyanotic congenital heart disease , single ventricle physiology ) •Chronic pulmonary disease ( eg , requirement supplemental oxygenation noninvasive ventilation , severe persistent asthma ) •Former preterm infants•Neuromuscular disease impair airway clearance•Poorly control type I diabetes mellitus•Severe obesity ( body mass index ≥120 percent 95th percentile value ; ( figure 1A-B ) ) ●Known in-person exposure laboratory-confirmed case COVID-19 within previous 14 days●Presentation severe illness ( eg , new requirement supplemental oxygen increase requirement baseline , new increase need ventilation [ invasive noninvasive ] [ 59 ] ) One author ' institution institute `` drive-thru '' assessment center symptomatic patient ( eg , fever , persistent cough ) otherwise stable either : ●Underlying condition ( eg , immune compromise , chronic cardiac pulmonary disease ) ●Known in-person exposure laboratory-confirmed case COVID-19 within previous 14 daysThis assessment center also provide COVID-19 screen assessment schedule procedure ( eg , cardiac catheterization , endoscopy ) .Inpatient test criterion — Our institution perform universal test hospitalize patient time presentation , regardless clinical symptom sign COVID-19 ; infant bear institution mother test negative COVID-19 admit nursery neonatal intensive care unit ( NICU ) exception ."", 'This strategy implement reduce hospital-associated transmission , give prevalence asymptomatic infection children.For hospitalize child whose initial test result negative schedule procedure ( eg , endoscopy ) , retest within 48 hour schedule procedure.For patient suspect nosocomial acquisition respiratory virus , test common respiratory pathogen ( eg , via multiplex reverse transcriptase polymerase chain reaction ) well COVID-19.Laboratory test SARS-CoV-2 — Laboratory test COVID-19 discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Microbiologic diagnosis ' ."", ') Detection respiratory pathogen ( eg , influenza , respiratory syncytial virus , Mycoplasma pneumoniae ) nasopharyngeal specimen exclude COVID-19 [ 32,55,66,75-78 ] .', 'In one study , 8 20 child positive SARS-CoV-2 also positive common respiratory pathogen [ 79 ] .MANAGEMENTShould NSAIDs avoid ?', '— The uncertainty safety nonsteroidal anti-inflammatory drug ( NSAIDs ) patient COVID-19 discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Uncertainty NSAID use ' ."", ') Assessment severity — We use definition severity provide multicenter initial guidance use antiviral child COVID-19 [ 59 ] : ●Mild moderate disease – No new increase supplemental oxygen requirement●Severe disease – New requirement supplemental oxygen increase requirement baseline without new increase need ventilatory support ( noninvasive invasive ) ●Critical disease – New increase need noninvasive invasive mechanical ventilation , sepsis , multiorgan failure , rapidly worsen clinical trajectoryInpatient management child COVID-19 — Children COVID-19 severe critical lower respiratory tract disease generally require hospital admission .', 'Children nonsevere COVID-19 may require hospital admission risk severe disease due underlie condition ( eg , immune compromise ) .Supportive care patient — We provide supportive care pediatric patient COVID-19 recommend various national committee [ 59,80,81 ] .', 'Supportive care mainstay therapy child severe critical COVID-19 .', 'Most child COVID-19 improve supportive care , even severe disease [ 59,82 ] .', ""( See 'Society guideline link ' ."", ') Routine supportive care measure include : ●Provision respiratory support , include supplemental oxygen ventilatory support ( noninvasive invasive ) ; respiratory status may change suddenly approximately one week symptom [ 83 ] .●Provision fluid electrolyte support .', ""( See `` Fluid electrolyte therapy newborn '' `` Clinical assessment diagnosis hypovolemia ( dehydration ) child '' `` Treatment hypovolemia ( dehydration ) child '' ."", ') ●Provision empiric antibiotic indicate community-acquired health care-associated pneumonia ; continuation empiric antibiotic determine culture microbial test clinical condition .', 'Bacterial coinfections appear infrequent [ 84 ] .', ""( See `` Pneumonia child : Inpatient treatment '' ."", ') ●Monitoring cytokine release syndrome monitor blood pressure hypotension , oxygen saturation worsen hypoxemia , biomarkers .', 'We obtain baseline C-reactive protein ( CRP ) , D-dimer , ferritin , lactate dehydrogenase ( LDH ) , interleukin-6 ( IL-6 ) .', 'We monitor CRP , D-dimer , ferritin , LDH two three time per week concern worsen disease .', 'IL-6 perform offsite ; repeat twice per week elevate baseline concern worsen disease.For child receive immunosuppressive therapy , discus benefit risk reduce immunosuppressive therapy prescribe specialist ( eg , oncologist , transplant clinician , rheumatologist ) [ 85 ] .', 'Although relationship immune compromise severe COVID-19 disease well establish child [ 61,62 ] , management viral infection immunocompromised host typically include reduction baseline immunosuppression , reduction possible [ 86,87 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Issues relate solid organ transplantation '' , section 'Adjusting immunosuppression ' ."", ') Antiviral therapy select patient — Given lack data control trial support efficacy antiviral agent treatment COVID-19 child , agree recommendation multicenter initial guidance use antiviral agent child COVID-19 expert antiviral therapy COVID-19 occur context clinical trial [ 59,88 ] .', 'Information ongoing clinical trial available ClinicalTrials.gov.Antiviral therapy COVID-19 generally reserve child document severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection test available [ 59 ] .●Potential indication – Decisions use antiviral therapy individualize accord disease severity , clinical trajectory , underlie condition may increase risk progression .', 'Studies effectiveness safety antiviral therapy predominantly perform adult severe lower respiratory tract disease [ 89,90 ] ; study discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Specific treatment ' ."", ') Children COVID-19 risk unproven antiviral therapy may warrant include severe critical disease mild moderate disease underlie condition may increase risk severe disease.●Choice agent/regimen•Remdesivir – When decision make use antiviral therapy , agree multicenter panel remdesivir prefer agent .', 'Although data regard benefit remdesivir child COVID-19 lack , prefer antiviral agent emerge data comparative , randomize trial case series adult patient suggest may beneficial appear well tolerate [ 59,91,92 ] .', 'Studies remdesivir adult patient COVID-19 discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Remdesivir ' ."", ') Remdesivir dose accord weight follow : -≥3.5 < 40 kg : 5 mg/kg intravenous ( IV ) load dose day 1 , follow 2.5 mg/kg IV every 24 hour 5 10 day ( 5 day rapid clinical response ) -≥40 kg : 200 mg IV load dose day 1 , follow 100 mg IV every 24 hour 5 10 day ( 5 day rapid clinical response ) Remdesivir prodrug nucleotide analog inhibit RNA-dependent RNA polymerase activity coronaviruses [ 93-95 ] .', 'In United States , Food Drug Administration ( FDA ) issue emergency use authorization remdesivir hospitalize child adult severe COVID-19 ( ie , oxygen saturation ≤94 percent room air , require supplemental oxygen , mechanical ventilation , extracorporeal membrane oxygenation ) [ 96 ] .Reported adverse effect remdesivir include nausea , vomit , transaminase elevations.•Hydroxychloroquine chloroquine – The efficacy hydroxychloroquine treatment COVID-19 uncertain .', 'Although hydroxychloroquine investigate treatment COVID-19 , license indication [ 97 ] .', 'It ideally use hospitalize patient context clinical trial [ 98 ] .Hydroxychloroquine ( without azithromycin ) alternative remdesivir child warrant antiviral therapy candidate remdesivir remdesivir unavailable [ 59 ] .', 'Given lack prove benefit potential risk , use context clinical trial .', 'Hydroxychloroquine avoid child underlie QTc abnormality require medication potential serious drug interaction hydroxychloroquine .', 'Before initiate hydroxychloroquine , specific interaction medication check use drug interaction program , Lexicomp drug interaction tool provide UpToDate.The multicenter panel suggest either follow regimen hydroxychloroquine child [ 59 ] : -13 mg/kg ( maximum : 800 mg ) orally , follow 6.5 mg/kg ( maximum : 400 mg ) 6 , 24 , 48 hour initial dose ( duration extend five day case-by-case basis ) -6.5 mg/kg per dose ( maximum : 400 mg per dose ) orally twice per day day 1 , follow 3.25 mg/kg ( maximum : 200 mg/dose ) orally twice per day five daysHydroxychloroquine think alter endosomal lysosomal pH , inhibit viral replication propagation , although exact mechanism antiviral activity remain uncertain [ 99 ] .', 'In United States , FDA issue emergency use authorization allow use agent adolescent adult hospitalize COVID-19 participation clinical trial feasible [ 100 ] .Clinical study hydroxychloroquine limit small sample size include predominantly adult patient .', 'They discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Hydroxychloroquine/chloroquine ' ."", ') Given uncertain efficacy potential cardiac toxicity , avoid chloroquine combination hydroxychloroquine azithromycin treatment COVID-19 child [ 101 ] .•Lopinavir-ritonavir – We recommend routine use lopinavir-ritonavir give absence efficacy unfavorable pharmacodynamics [ 90 ] .Adjunctive therapy — We make decision use adjunctive therapy immune-mediated complication COVID-19 case-by-case basis accord disease severity .', 'We routinely use immune modulators ( eg , glucocorticoid , IL-6 inhibitor [ eg , tocilizumab ] , interferon-beta 1b , convalescent plasma recover COVID-19 patient ) treatment child COVID-19 , except context clinical trial .', 'The benefit risk uncertain [ 102 ] .Although available data use vitamin A treatment COVID-19 , vitamin A long use adjuvant treatment measles , use associate decrease morbidity mortality measles-associated pneumonia [ 103 ] .', 'Vitamin A deficiency may associate impairment humoral cell-mediated immunity , even mild vitamin A deficiency may lead increase morbidity measles viral respiratory infection [ 103 ] .', ""( See `` Measles : Clinical manifestation , diagnosis , treatment , prevention '' , section 'Vitamin A ' ."", ') Information ongoing clinical trial available ClinicalTrials.gov .', 'Outpatient management child COVID-19Telephone triage child — The United States Centers Disease Control Prevention ( CDC ) provide guidance telephone triage child possible COVID-19 .', 'How child manage home ?', '— Children document suspect COVID-19 mild symptom ( eg , fever , cough , pharyngitis , respiratory symptom ) generally manage home unless chronic condition increase risk severe disease.Management focus prevention transmission others ( ie , isolation ) , monitor clinical deterioration , supportive care .', 'Although role child transmission clear [ 104 ] , evidence report cluster case France suggest possibility child may transmit SARS-CoV-2 efficiently age group , perhaps relate viral interference [ 105 ] .', 'The CDC World Health Organization provide additional guidance ( child ) sick [ 106,107 ] .', ""( See 'Prevention transmission ' ."", ') ●Monitoring clinical deterioration – Caregivers child manage home counsel symptom clinical deterioration , may occur suddenly approximately one week symptom prompt urgent re-evaluation [ 83 ] .', ""These include [ 106-109 ] : •Severe respiratory distress , difficulty breathe ( infant : grunt , central cyanosis , inability breastfeed ) •Chest pain pressure•Blue lip face•Findings associate shock ( eg , cold , clammy , mottle skin ; new confusion ; difficulty arouse ; substantially reduce urine output ) ●Symptomatic supportive care – Symptomatic care COVID-19 outpatient set similar upper respiratory gastrointestinal clinical syndrome : •Upper respiratory tract infection ( see `` The common cold child : Management prevention '' , section 'Symptomatic therapy ' ) •Pharyngitis ( see `` Acute pharyngitis child adolescent : Symptomatic treatment '' , section 'Symptomatic treatment ' ) •Acute gastroenteritis ( see `` Acute viral gastroenteritis child resource-rich country : Management prevention '' , section 'Management ' ) The management fever child , include indication treatment , discuss separately ."", ""( See `` Fever infant child : Pathophysiology management '' , section 'Management fever ' ."", ') When home isolation discontinue ?', '— The optimal duration home isolation uncertain .', 'How long person remain infectious uncertain .', 'The duration viral shed variable ; appear wide range , may depend severity illness .', ""Among 110 child Wuhan Children 's Hospital , median duration viral shed 15 day onset illness ( interquartile range 11 20 day ) ; duration longer symptomatic asymptomatic child ( 17 versus 11 day ) [ 110 ] ."", ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Viral shed period infectivity ' ."", ') The CDC issue recommendation discontinuation home isolation , include test-based nontest-based strategy [ 111-113 ] .', 'The choice strategy depend upon patient population ( eg , immunocompromised versus nonimmunocompromised ) , availability test supply , access testing.Avoidance unproven intervention — Hydroxychloroquine investigational agent use supervision health care provider , describe ; misuse nonpharmaceutical form investigational agent ( eg , chloroquine phosphate , use home aquarium ; ivermectin intend animal ) may lead severe toxicity , include death [ 98,114,115 ] .', ""( See 'Inpatient management child COVID-19 ' ."", ') PREVENTION OF TRANSMISSIONFrom infect mother newborn — Prevention transmission infect mother newborn delivery discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Pregnancy issue '' , section 'Postpartum care ' ."", ') From child document suspect COVID-19During cardiopulmonary resuscitation — Modifications algorithm pediatric basic advance life support prevent transmit severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) discuss separately .', ""( See `` Pediatric basic life support health care provider '' , section 'COVID-19 patient ( suspect confirm ) ' `` Pediatric advance life support ( PALS ) '' , section 'COVID-19 patient ( suspect confirm ) ' ."", ') Hygiene social distance — Prevention transmission focus hygiene social distance .', 'This include [ 106,107,116 ] : ●Having friend family member bring necessary item home ( retrieve outside ) .●Having child ( sick family member ) wear mask leave home avoid .', 'At time discharge , supply allow , provide patient pair glove several mask may help prevent transmission household contact .', 'In addition , patient without access private transportation , arrange medical transportation , possible , preferable use public transportation ride-sharing service minimize exposure public .', '●As much possible , keep ill family member ≥6 foot away people , especially family member ≥65 year age serious medical conditions.If separation possible , ill family member wear face mask room vehicle people.●Keeping ill family member separate pet household.●Having family member fever cough sleep separate room use separate bathrooms.●Avoiding share item ( eg , pillow , blanket , utensil , cup ) .Additional information care people document , suspect , possible COVID-19 home available United States Centers Disease Control Prevention ( CDC ) World Health Organization [ 106,107 ] .Disinfection — Disinfection frequently touch surface also important , discuss separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' , section 'Environmental disinfection ' ."", ') For asymptomatic childrenShould routine health supervision appointment reschedule ?', '— During COVID-19 pandemic , benefit well-visits balance risk exposure COVID-19 communicable illness , within context patient population office environment [ 117-119 ] .', 'When clinician practice unable provide well-child visit patient practice , CDC American Academy Pediatrics ( AAP ) encourage prioritization newborn care vaccination child 24 month age [ 119,120 ] .', 'Disruption immunization service increase risk outbreak vaccine-preventable illness [ 121 ] .', 'Adherence recommendation infant bear woman hepatitis B surface antigen ( HBsAg ) positive whose HBsAg status unknown particularly important prevention mother-to-child transmission hepatitis B virus , especially delivery occur unplanned facility attend staff knowledgeable manage infant bear mother HBsAg positive [ 122 ] .', ""( See `` Standard immunization child adolescent : Overview '' , section 'Benefits vaccine ' `` Hepatitis B virus immunization infant , child , adolescent '' , section 'Routine infant immunization ' ."", ') Scheduling home visit , telemedicine , office space , and/or office location use keep well child child ill possibly ill separate ( eg , schedule well-visits morning sick visit afternoon , see child sick visit different part clinic , designate examination room , different office site [ practice ] child well-visits ) [ 117,123-125 ] .The AAP provide information resource telemedicine , include information state-by-state payer policies.Use cloth face mask — The CDC recommend individual ≥2 year age wear cloth face cover ( eg , homemade mask bandana ) public set social distance may difficult achieve ( eg , grocery store , clinician office ) , especially area substantial community transmission [ 126 ] .', 'Cloth mask recommend child < 2 year age , concern suffocation [ 127 ] .', 'The AAP provide additional information cloth mask child , include tip increase proper wear use .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Personal preventive measure ' ."", ') Should play date playground avoid ?', '— Given possibility transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) asymptomatic individual ( presymptomatic individual within incubation period ) [ 6,45,128-135 ] , CDC recommend child play date child household play outside , remain ≥6 foot people household [ 136 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Viral shed period infectivity ' ."", ') The CDC provide information safely remain physically active park recreational facility COVID-19 pandemic.Hand sanitizer safety — Although wash hand soap water , available , prefer hand hygiene , alcohol-based hand sanitizer safe use child sanitizer use accord information Drug Facts label ; cause concern child eat lick hand hand sanitizer fully dry [ 137 ] .', 'However , ingestion even small amount liquid hand sanitizer cause alcohol poison child ( include hypoglycemia ) , child younger six year supervise use alcohol-based hand sanitizers , alcohol-based hand sanitizers keep reach sight child [ 138 ] .', ""( See `` Ethanol intoxication child : Epidemiology , estimation toxicity , toxic effect '' `` Ethanol intoxication child : Clinical feature , evaluation , management '' ."", ') SPECIAL POPULATIONSChildren asthma — Considerations relate COVID-19 child asthma include safety glucocorticoid nebulized medication .', 'These consideration discuss separately .', ""( See `` An overview asthma management '' , section 'Advice relate COVID-19 pandemic ' ."", ') Children special health care need — The American Academy Pediatrics provide information keep child special health care need safe COVID-19 pandemic.Children attention deficit hyperactivity disorder — The European attention deficit hyperactivity disorder ( ADHD ) guideline group provide guidance management ADHD COVID-19 pandemic guidance start stimulant atomoxetine child in-person cardiovascular assessment pandemic [ 139,140 ] .OTHER ISSUES●What type infant formula substitute usual formula available ?', '– The American Academy Pediatrics ( AAP ) provide advice provider family infant formula available.●What effect prolong home confinement ?', ""– Although prolong home confinement may provide opportunity enhance parent-child relationship , may adversely affect child 's physical mental health [ 141-150 ] ."", 'They may le physically active , spend time electronic device , eat poorer quality diet .', 'Mental health stressor include fear infection , boredom , social isolation .', 'In survey primary school student Hubei province China restrict home mean 35 day , prevalence symptom depression anxiety ( approximately 20 percent ) greater survey [ 148 ] .', 'School closure relate health emergency associate increase risk violence vulnerability [ 144,151 ] .', 'Vulnerable child adolescent ( eg , homeless foster care , history maltreatment , sexual gender minority ) particular risk violence adverse mental health effect [ 149 ] .', 'Adverse mental physical health effect mitigate parent-child relation enhance parental role-modeling healthy behavior , involve child family activity , promotion self-discipline self-sufficiency skill , direct , developmentally appropriate conversation child pandemic [ 141,146,152-154 ] .Clinicians consider potential violence look sign parental stress , irritability , depression , and/or harsh response child behavior clinical encounter [ 151 ] .', 'They ask parent stress level , method manage stress , social support , substance use .', 'Clinicians offer cop strategy ( eg , deep breathe , call friend family member ) , resource , and/or referral mental health provider family may benefit intervention .', '•Resources relate child care prevention violence COVID-19 pandemic include : -Child Care Aware America-Global Partnership End Violence Against Children-The National Child Traumatic Stress Network•Resources talk child COVID-19 available multiple professional group others , include : -The American Academy Child Adolescent Psychiatry-The AAP : Talking child COVID-19-Coronavirus : A book child ( write Elizabeth Jenner , Kate Wilson , Nia Roberts ; illustrate Axel Scheffler ) -COVIBOOK child younger seven years-The United States Centers Disease Control Prevention-The National Association School Psychologists-The United Nations Office Coordination Humanitarian Affairs .', ""Inter-Agency Standing Committee ( child 's book child approximately 6 11 year age ) ●What resource available home school child keep occupy pandemic ?"", ""– Several national organization provide educational resource child , include , among others [ 123,144 ] : •AAP : -Working learn home COVID-19 outbreak-Getting child outside social distance COVID-19-Teens COVID-19 : Challenges opportunity outbreak•National Association Education Young Children•National Head Start Association Resources Parents•Opening Doors/Abriendo Puertas•Sesame Workshop•United Nations Children 's Fund ( UNICEF ) •The World Health Organization•Zero ThreeSOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately ."", ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print email topic patient .', ""( You also locate patient education article variety subject search `` patient education '' keyword [ ] interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) child ( The Basics ) '' `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●Coronavirus disease 2019 ( COVID-19 ) pandemic infectious disease cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) ."", 'Understanding COVID-19 evolve .', 'Interim guidance issue World Health Organization ( WHO ) United States Centers Disease Control Prevention ( CDC ) .', ""( See 'Introduction ' ."", ') ●Children age get COVID-19 , although appear affect le frequently adult .', ""( See 'Epidemiology ' ."", ') ●COVID-19 child usually mild , although severe case report , include case clinical feature similar toxic shock syndrome Kawasaki disease ( table 1 ) .', 'In case series child COVID-19 , common symptom child fever cough .', 'Other symptom include sore throat , fatigue , rhinorrhea/nasal congestion , diarrhea , vomit .', 'Additional symptom report adult include chill shake chill , myalgia , headache , new loss taste smell .', 'Laboratory find often normal may include leukopenia , lymphocytopenia , elevate procalcitonin C-reactive protein .', ""( See 'Clinical manifestation ' ."", ') ●Criteria test COVID-19 vary geographically .', 'In United States , guidance provide CDC Infectious Diseases Society America ( table 2 ) may adapt state local health department depend upon test availability .', ""( See 'What criterion test COVID-19 child ? '"", '.', ') •Given limit test resource , institution perform target test outpatient set .', 'For child evaluate symptom consistent COVID-19 emergency department urgent care set , perform test SARS-CoV-2 child underlie condition may increase risk severe disease , know in-person exposure laboratory-confirmed case COVID-19 within previous 14 day , presentation severe illness .', ""( See 'Outpatient test criterion ' ."", ') •We perform universal test hospitalize patient time presentation , regardless clinical symptom sign COVID-19 ; infant bear institution mother test negative COVID-19 admit nursery neonatal intensive care unit exception .', ""( See 'Inpatient test criterion ' . )"", '●Children COVID-19 severe critical lower respiratory tract disease generally require hospital admission .', 'Severe disease define new requirement supplemental oxygen increase requirement baseline without new increase need ventilatory support ( noninvasive invasive ) .', 'Critical disease define new increase need noninvasive invasive mechanical ventilation , sepsis , multiorgan failure , rapidly worsen clinical trajectory .', ""( See 'Assessment severity ' ."", ') ●Supportive care ( eg , respiratory support , fluid electrolyte support , monitor cytokine release syndrome ) mainstay therapy child severe critical COVID-19 .', ""( See 'Supportive care patient ' ."", ') ●We agree recommendation multicenter initial guidance use antiviral agent child COVID-19 expert antiviral therapy COVID-19 occur context clinical trial .', ""( See 'Antiviral therapy select patient ' ."", ') •Decisions regard antiviral therapy individualize accord disease severity , clinical trajectory , underlie condition may increase risk progression.•When decision make use antiviral therapy , prefer remdesivir agent .', 'Hydroxychloroquine ( without azithromycin ) alternative child candidate remdesivir remdesivir unavailable .', '●Children document suspect COVID-19 mild symptom ( eg , fever , cough , pharyngitis , respiratory symptom ) generally manage home unless chronic condition increase risk severe disease .', 'Management focus prevention transmission others ( ie , isolation ) , monitor clinical deterioration ( eg , difficulty breathe , cyanosis , symptom shock ) , supportive care .', ""( See 'How child manage home ? '"", '.', ') ●Symptomatic care COVID-19 outpatient set similar upper respiratory gastrointestinal clinical syndrome .', 'It discuss separately .', ""( See `` The common cold child : Management prevention '' , section 'Symptomatic therapy ' `` Acute pharyngitis child adolescent : Symptomatic treatment '' , section 'Symptomatic treatment ' `` Fever infant child : Pathophysiology management '' , section 'Management fever ' `` Acute viral gastroenteritis child resource-rich country : Management prevention '' , section 'Management ' ."", ') ●Prevention transmission focus hygiene social distance .', 'The CDC WHO provide guidance prevent transmission COVID-19 home outpatient set .', ""( See 'Prevention transmission ' . )""]","['', 'coronaviruses', 'important', 'human', 'animal', 'pathogen', '', '1', '', '', 'end', '2019', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'rapidly', 'spread', '', 'result', 'epidemic', 'throughout', 'china', '', 'follow', 'increase', 'number', 'case', 'country', 'throughout', 'world', '', 'february', '2020', '', 'world', 'health', 'organization', '', '', 'designate', 'disease', 'covid-19', '', 'stand', 'coronavirus', 'disease', '2019', '', '2', '', '', 'virus', 'cause', 'covid-19', 'designate', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'previously', '', 'refer', '2019-ncov', '', 'declare', 'covid-19', 'pandemic', 'march', '11', '', '2020', '', '3', '', 'understanding', 'covid-19', 'evolve', '', 'interim', 'guidance', 'issue', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', '45', '', '', 'links', 'relate', 'society', 'guideline', 'find', 'elsewhere', '', '', 'society', 'guideline', 'link', '', '', '', 'topic', 'discus', 'aspect', 'covid-19', 'specific', 'child', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'general', 'aspect', 'epidemiology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', 'covid-19', '', 'management', 'covid-19', 'adult', '', 'coronaviruses', 'discuss', 'separately', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'hypercoagulability', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'outpatient', 'management', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', '', '', '', 'coronaviruses', '', '', '', '', '', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', '', '', '', '', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'virology', '', 'pathogenesis', '', 'epidemiology', '', '', '', 'epidemiology', '', 'epidemiology', 'covid-19', 'discuss', 'detail', 'separately', '', 'section', 'focus', 'epidemiology', 'covid-19', 'child', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'epidemiology', '', '', '', 'child', 'covid-19', '', '', 'children', 'age', 'covid-19', '', 'although', 'appear', 'affect', 'le', 'commonly', 'adult', '', '6-11', '', '', 'systematic', 'literature', 'review', '', 'january', '1', 'march', '18', '', '2020', '', '', 'child', 'account', '1', '5', 'percent', 'diagnose', 'covid-19', 'case', '', '12', '', '', 'although', 'surveillance', 'definition', 'criterion', 'test', 'change', 'time', 'geographically', '', 'proportion', 'case', 'occur', 'child', 'various', 'country', '', 'eg', '', 'china', '', 'south', 'korea', '', 'italy', '', 'united', 'states', '', 'typically', 'within', 'range', '', '913-16', '', 'april', '2', '', '2020', '', 'among', '149760', 'laboratory-confirmed', 'case', 'report', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', '', '17', 'percent', 'child', '', '18', 'year', '', 'approximately', '70', 'percent', 'case', 'new', 'york', 'city', '', 'rest', 'new', 'york', 'state', '', 'new', 'jersey', '', '9', '', '', 'approximately', '90', 'percent', 'case', 'associate', 'household', 'community', 'exposure', '', '10', 'percent', 'associate', 'travelalthough', 'health', 'care-associated', 'outbreak', 'report', 'child', '', '1718', '', '', 'case', 'child', 'result', 'household', 'exposure', '', '9', '', '', 'retrospective', 'study', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'china', '', 'household', 'secondary', 'attack', 'rate', 'among', 'pediatric', 'contact', 'range', '4', '7', 'percent', '', '1920', '', '', 'review', 'case', 'new', 'york', 'state', '', 'exclude', 'new', 'york', 'city', '', '', 'secondary', 'attack', 'rate', 'among', 'child', '', '18', 'year', '27', 'percent', '', '21', '', '', 'transmission', 'sars-cov-2', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'transmission', '', '', '', 'age', 'distribution', 'case', 'united', 'states', 'follow', '', '9', '', '', '', '', '1', 'year', '', '15', 'percent1', '4', 'year', '', '11', 'percent5', '9', 'year', '', '15', 'percent10', '14', 'year', '', '27', 'percent15', '17', 'year', '', '32', 'percentalthough', 'infant', '', '1', 'year', 'age', 'account', '15', 'percent', 'confirm', 'case', '', 'proportion', 'case', 'occur', 'infant', '', '027', 'percent', '', 'le', 'proportion', 'united', 'states', 'population', '', '1', 'year', 'age', '', '9', '', 'among', 'adult', 'patient', 'covid-19', 'united', 'states', '', 'emerge', 'data', 'suggest', 'covid-19', 'disproportionately', 'affect', 'racial', 'ethnic', 'minority', 'group', '', 'perhaps', 'relate', 'underlie', 'health', 'condition', 'economic', 'social', 'condition', '', 'eg', '', 'poverty', '', 'multigenerational', 'household', '', 'employment', 'essential', 'industry', '', 'pay', 'sick', 'leave', '', 'limit', 'access', 'medical', 'care', '', '', '22-25', '', '', 'cdc', 'covid-net', 'provide', 'raceethnicity', 'information', 'covid-19-associated', 'hospitalization', 'child', '', '26', '', 'additional', 'information', 'relate', 'covid-19', 'activity', 'united', 'states', '', 'eg', '', 'outpatient', 'visit', '', 'hospitalization', '', 'available', 'cdc', 'covidview', '', 'sars-cov-2', 'transmit', 'breast', 'milk', 'infant', 'feed', '', '', 'unknown', 'whether', 'sars-cov-2', 'transmit', 'breast', 'milk', '', 'report', 'test', 'find', 'virus', 'maternal', 'milk', 'six', 'patient', '', '27', '', '', 'however', '', 'droplet', 'transmission', 'occur', 'close', 'contact', 'feed', '', 'breastfeed', 'bottle', 'feed', '', '', 'strategies', 'prevent', 'transmission', 'sars-cov-2', 'infant', 'feed', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'breastfeeding', 'formula', 'feed', '', '', '', 'sars-cov-2', 'acquire', 'utero', '', '', 'issues', 'relate', 'covid-19', 'pregnancy', '', 'include', 'utero', 'transmission', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', '', 'clinical', 'manifestationsare', 'sign', 'symptom', 'covid-19', 'different', 'child', 'adult', '', '', 'symptom', 'covid-19', 'similar', 'child', 'adult', '', 'fewer', 'child', 'adult', 'document', 'infection', 'report', 'symptom', '', '910', '', '', 'covid-19', 'appear', 'milder', 'child', 'adult', '', 'although', 'severe', 'case', 'report', '', '28', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'clinical', 'manifestation', '', 'child', 'risk', 'severe', 'covid-19', '', '', '', '', 'among', '2572', 'laboratory-confirmed', 'case', 'covid-19', 'child', '', '18', 'year', 'report', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'april', '2', '', '2020', '', 'median', 'age', '11', 'year', '', 'range', '0', '17', 'year', '', '', '57', 'percent', 'case', 'boy', '', '9', '', '', 'case', 'series', 'china', '', 'median', 'age', 'affect', 'child', 'approximately', '7', 'year', '', 'range', '1', 'day', '18', 'year', '', '', 'boy', 'affect', 'slightly', 'often', 'girl', '', '57', '60', 'percent', 'case', '', '', '67', '', 'young', 'infant', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'cause', 'fever', 'without', 'obvious', 'source', 'minimal', 'respiratory', 'symptom', '', '2930', '', '', 'case', 'series', 'three', 'infant', 'single', 'institution', '', 'infant', 'present', 'fever', 'difficulty', 'feed', '', 'lymphopenia', 'thrombocytosis', 'consistent', 'laboratory', 'find', '', '30', '', '', 'fever', 'cough', 'common', 'report', 'symptom', 'child', '', '793132', '', '', 'case', 'series', 'united', 'states', '', 'complete', 'information', 'symptom', 'available', '291', 'child', '', '56', 'percent', 'fever', '', '54', 'percent', 'cough', '', '13', 'percent', 'shortness', 'breath', '', '73', 'percent', 'child', 'least', 'one', 'symptom', '', '9', '', '', 'another', 'series', '1391', 'child', 'evaluate', 'covid-19', 'wuhan', 'children', 'hospital', '', '171', '', '12', 'percent', '', 'confirm', 'sars-cov-2', 'infection', '', 'via', 'identification', 'rna', '', '', '7', '', '', 'approximately', '16', 'percent', 'child', 'confirm', 'infection', 'asymptomatic', '', '19', 'percent', 'upper', 'respiratory', 'infection', '', '65', 'percent', 'pneumonia', '', 'fever', 'occur', 'point', 'illness', 'approximately', '42', 'percent', '', 'common', 'symptom', 'case', 'series', 'include', 'cough', '', '49', 'percent', '', 'pharyngeal', 'erythema', '', '46', 'percent', '', '', 'less', 'common', 'symptom', 'include', 'fatigue', '', 'rhinorrheanasal', 'congestion', '', 'diarrhea', '', 'vomit', '', 'similar', 'clinical', 'manifestation', 'report', 'smaller', 'case', 'series', 'china', 'italy', '', '3133', '', '', 'child', 'present', 'gastrointestinal', 'symptom', '', '6', '', '', 'additional', 'symptom', 'report', 'adult', 'include', 'chill', 'shake', 'chill', '', 'myalgia', '', 'headache', '', 'new', 'loss', 'taste', 'smell', '', '34', '', '', 'cutaneous', 'find', 'report', 'infrequently', 'well', 'characterize', '', 'include', 'maculopapular', '', 'urticarial', '', 'vesicular', 'eruption', 'transient', 'livedo', 'reticularis', '', '3135-37', '', '', 'reddish-purple', 'nodule', 'distal', 'digit', '', 'sometimes', 'call', '', 'covid', 'toe', '', '', 'similar', 'appearance', 'pernio', '', 'chilblain', '', 'describe', 'predominantly', 'child', 'young', 'adult', '', 'although', 'association', 'covid-19', 'clearly', 'establish', '', '3538-41', '', 'laboratory', 'find', 'child', 'confirm', 'infection', 'wuhan', 'variable', '', 'approximately', 'one-quarter', 'white', 'blood', 'cell', 'count', '', '55', 'x', '109l', '', '5500microl', '', '35', 'percent', 'lymphocyte', 'count', '', '12', 'x', '109l', '', '1200microl', '', '', '7', '', '', 'procalcitonin', 'elevate', '', '', '46', 'pgml', '', '64', 'percent', 'c-reactive', 'protein', '', 'crp', '', 'elevate', '', '', '10', 'mgl', '', '20', 'percent', '', 'adult', 'patient', '', 'lymphopenia', '', 'specifically', 'cd4', 'cd8', 'lymphocyte', '', '42', '', '', '', 'elevate', 'liver', 'enzyme', '', 'elevate', 'lactate', 'dehydrogenase', '', 'ldh', '', '', 'elevate', 'inflammatory', 'marker', '', 'eg', '', 'crp', '', 'ferritin', '', 'associate', 'increase', 'severity', 'worse', 'outcome', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'risk', 'factor', 'severe', 'illness', '', '', '', 'chest', 'radiograph', 'unremarkable', 'demonstrate', 'bilateral', 'consolidation', '', '4344', '', '', 'series', '171', 'child', 'confirm', 'sars-cov-2', 'infection', '', 'find', 'chest', 'compute', 'tomography', 'include', 'grind', 'glass', 'opacity', '33', 'percent', '', 'local', 'patchy', 'shadow', '19', 'percent', '', 'bilateral', 'patchy', 'shadow', '12', 'percent', '', 'interstitial', 'abnormality', '1', 'percent', '', '7', '', '', 'radiographic', 'find', 'present', 'symptom', '', '4546', '', '', 'study', 'eight', 'italian', 'child', 'hospitalize', 'document', 'covid-19', '', 'find', 'lung', 'ultrasonography', 'include', 'subpleural', 'consolidation', 'individual', 'confluent', 'b', '', '47', '', '', 'find', 'concordant', 'radiographic', 'find', 'seven', 'eight', 'patient', '', 'similar', 'find', 'adult', 'patient', 'covid-19', '', '', '', 'bedside', 'pleural', 'ultrasonography', '', 'equipment', '', 'technique', '', 'identification', 'pleural', 'effusion', 'pneumothorax', '', '', 'section', '', 'b', 'lung', 'consolidation', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'clinical', 'feature', 'complication', '', '', '', 'child', 'risk', 'severe', 'covid-19', '', 'frequency', 'severe', 'disease', 'child', '', 'although', 'severe', 'case', 'covid-19', 'child', '', 'include', 'fatal', 'case', '', 'report', '', 'child', 'appear', 'asymptomatic', '', 'mild', '', 'moderate', 'disease', 'recover', 'within', 'one', 'two', 'week', 'disease', 'onset', '', '6-9283348-57', '', 'series', '2135', 'child', 'china', 'include', '728', 'child', 'laboratory-confirmed', 'covid-19', 'disease', '', 'approximately', '55', 'percent', 'case', 'mild', 'asymptomatic', '', '40', 'percent', 'case', 'moderate', '', 'eg', '', 'clinical', 'radiographic', 'evidence', 'pneumonia', 'without', 'hypoxemia', '', '', '5', 'percent', 'case', 'severe', '', 'eg', '', 'dyspnea', '', 'central', 'cyanosis', '', 'hypoxemia', '', '', '', '1', 'percent', 'critical', '', 'eg', '', 'acute', 'respiratory', 'distress', 'syndrome', '', 'respiratory', 'failure', '', 'shock', '', '', '6', '', '', 'among', '376', 'infant', '', '1', 'year', 'age', 'available', 'information', '', 'approximately', '11', 'percent', 'severe', 'critical', 'disease', '', 'find', 'interpret', 'caution', '', 'severe', 'critical', 'case', 'laboratory', 'confirm', 'cause', 'respiratory', 'infection', '', 'potential', 'risk', 'factor', 'severe', 'disease', '', 'infants', '', '1', 'year', 'age', 'child', 'certain', 'serious', 'underlie', 'condition', 'appear', 'greater', 'risk', 'severe', 'disease', '', '958', '', '', 'cdc', 'covid-net', 'provide', 'information', 'underlie', 'medical', 'condition', 'accord', 'age', '', '26', '', '', 'although', 'robust', 'evidence', 'associate', 'underlie', 'condition', 'severe', 'illness', 'child', '', '59', '', '', 'among', '345', 'child', 'united', 'states', 'laboratory-confirmed', 'covid-19', 'complete', 'information', 'underlie', 'condition', '', '23', 'percent', 'underlie', 'condition', '', 'commonly', 'report', 'underlie', 'condition', '', '9', '', '', 'chronic', 'pulmonary', 'disease', '', 'include', 'moderate', 'severe', 'asthma', '', 'cardiovascular', 'diseaseimmunosuppression', '', 'eg', '', 'relate', 'cancer', '', 'chemotherapy', '', 'radiation', 'therapy', '', 'hematopoietic', 'cell', 'solid', 'organ', 'transplant', '', 'high', 'glucocorticoid', '', 'cross-sectional', 'study', '48', 'child', 'admit', 'pediatric', 'intensive', 'care', 'unit', 'north', 'america', '', '40', 'child', 'underlie', 'condition', '', '57', '', '', 'common', 'underlie', 'condition', 'medical', 'complexity', '', 'define', 'dependence', 'technological', 'support', 'association', 'developmental', 'delay', 'andor', 'genetic', 'anomaly', '', '19', '', 'immune', 'suppression', 'malignancy', '11', '', 'obesity', '7', '', 'although', 'immunosuppression', 'report', 'underlie', 'condition', 'child', 'severe', 'covid-19', 'disease', 'case', 'series', '', 'relationship', 'immune', 'compromise', 'severe', 'covid-19', 'disease', 'well', 'establish', '', 'review', '178', 'child', 'cancer', 'single', 'institution', 'new', 'york', 'city', '', '20', 'test', 'positive', 'sars-cov-2', '', 'one', 'require', 'admission', '', 'noncritical', '', 'symptom', 'relate', 'covid-19', '', '60', '', '', 'covid-19', 'similarly', 'mild', 'small', 'survey', 'child', 'develop', 'covid-19', 'receive', 'immunosuppressive', 'medication', 'kidney', 'disease', 'inflammatory', 'bowel', 'disease', '', '6162', '', 'medical', 'condition', 'increase', 'risk', 'severe', 'disease', 'child', 'base', 'data', 'adult', 'include', '', '55586364', '', '', 'chronic', 'kidney', 'disease', 'undergo', 'dialysischronic', 'liver', 'disease', '', 'eg', '', 'chronic', 'hepatitis', '', 'endocrine', 'disorder', '', 'eg', '', 'diabetes', 'mellitus', '', 'severe', 'obesity', '', 'body', 'mass', 'index', '120', 'percent', '95th', 'percentile', 'value', '', '', 'figure', '1a-b', '', '', '', '', 'definition', '', 'epidemiology', '', 'etiology', 'obesity', 'child', 'adolescent', '', '', 'covid-19', 'appear', 'le', 'common', 'severe', 'child', 'adult', 'unclear', '', 'consideration', 'le', 'intense', 'immune', 'response', 'virus', 'child', 'versus', 'adult', '', 'cytokine', 'release', 'syndrome', 'important', 'pathogenesis', 'severe', 'covid-19', 'infection', '', '6566', '', '', 'another', 'explanation', 'viral', 'interference', 'respiratory', 'tract', 'young', 'child', 'lead', 'lower', 'viral', 'load', 'child', '', 'finally', '', 'receptor', 'sars-cov-2', 'virus', 'angiotensin', 'convert', 'enzyme', '2', 'receptor', '', 'express', 'differently', 'respiratory', 'tract', 'child', 'compare', 'adult', '', '6126768', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', 'mis-c', '', 'rare', 'serious', 'condition', 'associate', 'covid-19', 'report', 'child', 'europe', 'north', 'america', '', 'clinical', 'feature', 'mis-c', 'similar', 'kawasaki', 'disease', '', 'kawasaki', 'disease', 'shock', 'syndrome', '', 'toxic', 'shock', 'syndrome', '', 'include', 'persistent', 'fever', '', 'hypotension', '', 'gastrointestinal', 'symptom', '', 'rash', '', 'myocarditis', '', 'laboratory', 'find', 'associate', 'increase', 'inflammation', '', 'respiratory', 'symptom', '', 'table', '1', '', '', 'mis-c', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'multisystem', 'inflammatory', 'syndrome', 'child', '', '', '', 'often', 'child', 'covid-19', 'require', 'hospitalization', '', '', 'minority', 'child', 'covid-19', 'require', 'hospitalization', '', 'require', 'intensive', 'care', '', '7969', '', '', 'case', 'series', '', 'hospitalization', 'intensive', 'care', 'admission', 'common', 'among', 'child', 'underlie', 'condition', 'infant', '', '1', 'year', 'age', '', 'although', 'hospitalization', 'infant', 'reflect', 'severity', 'illness', '', '', 'child', 'risk', 'severe', 'covid-19', '', '', '', '', 'among', '2572', 'laboratory-confirmed', 'case', 'covid-19', 'child', '', '18', 'year', 'report', 'cdc', 'april', '2', '', '2020', '', 'estimate', 'rate', 'hospitalization', 'range', '6', '20', 'percent', '', 'estimate', 'rate', 'intensive', 'care', 'range', '058', '2', 'percent', '', '9', '', '', 'another', 'series', '171', 'child', 'china', 'confirm', 'sars-cov-2', 'infection', '', 'three', 'child', 'require', 'intensive', 'care', 'mechanical', 'ventilation', '', 'coexist', 'condition', '', 'one', 'hydronephrosis', '', 'leukemia', '', 'intussusception', '', '', '7', '', '', 'march', '8', '', '2020', '', '87', 'percent', 'child', 'discharge', 'hospital', '', 'one', 'child', 'die', 'four', 'week', 'admission', '', '10-month', 'old', 'concomitant', 'intussusception', 'develop', 'multiorgan', 'failure', '', '', 'study', 'lombardy', 'region', 'italy', '', '4', '1591', 'patient', '', '', '1', 'percent', '', 'admit', 'intensive', 'care', 'unit', 'covid-19', 'younger', '20', 'year', '', '69', '', '', 'additional', 'information', 'regard', 'hospitalization', 'child', 'united', 'states', 'available', 'cdc', 'covidviewhow', 'evaluate', 'child', 'pharyngitis', 'pandemic', '', '', 'given', 'concern', 'sars-cov-2', 'spread', 'upper', 'airway', 'symptomatic', 'asymptomatic', 'child', '', '70', '', '', 'royal', 'college', 'paediatrics', 'child', 'health', 'suggest', 'avoidance', 'examination', 'oropharynx', 'unless', 'essential', '', '71', '', '', 'examination', 'oropharynx', 'necessary', '', 'include', 'obtain', 'oropharyngeal', 'swab', '', '', 'personal', 'protective', 'equipment', 'wear', '', 'whether', 'child', 'symptom', 'compatible', 'covid-19', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'patients', 'suspect', 'confirm', 'covid-19', '', '', '', 'approach', 'diagnosiswhat', 'criterion', 'test', 'covid-19', 'child', '', '', 'criteria', 'test', 'covid-19', 'vary', 'geographically', '', 'united', 'states', '', 'guidance', 'provide', 'centers', 'disease', 'control', 'prevention', 'infectious', 'diseases', 'society', 'america', '', 'table', '2', '', 'adapt', 'state', 'local', 'health', 'department', 'depend', 'upon', 'test', 'availability', '', '72-74', '', 'testing', 'criterion', 'suggest', 'world', 'health', 'organization', 'find', 'technical', 'guidance', 'online', '', 'criterion', 'european', 'centre', 'disease', 'prevention', 'control', '', 'guidance', 'test', 'country', 'discuss', 'separately', '', '', 'society', 'guideline', 'link', '', '', '', 'outpatient', 'test', 'criterion', '', 'approach', 'test', 'vary', 'accord', 'test', 'availability', 'resource', '', 'eg', '', 'community', 'begin', 'offer', 'covid-19', 'test', 'resident', 'regardless', 'symptom', 'previous', 'test', '', 'given', 'limit', 'test', 'resource', '', 'institution', 'perform', 'target', 'test', 'outpatient', 'settingfor', 'child', 'evaluate', 'symptom', 'consistent', 'covid-19', '', 'eg', '', 'fever', '', 'persistent', 'cough', '', 'shortness', 'breath', '', 'vomit', '', 'diarrhea', '', 'emergency', 'department', 'urgent', 'care', 'set', '', 'perform', 'test', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'child', '', 'underlie', 'condition', 'increase', 'risk', 'severe', 'disease', '', 'example', 'include', '', 'immune-compromising', 'condition', '', 'eg', '', 'recipient', 'antineoplastic', 'chemotherapy', '', 'recent', 'hematopoietic', 'cell', 'transplantation', '', 'solid', 'organ', 'transplant', 'recipient', '', 'primary', 'immunodeficiency', '', 'hiv', 'infection', 'cd4', 'count', '', '15', 'percent', '', 'chronic', 'cardiac', 'disease', '', 'eg', '', 'cardiomyopathy', '', 'unrepaired', 'cyanotic', 'congenital', 'heart', 'disease', '', 'single', 'ventricle', 'physiology', '', 'chronic', 'pulmonary', 'disease', '', 'eg', '', 'requirement', 'supplemental', 'oxygenation', 'noninvasive', 'ventilation', '', 'severe', 'persistent', 'asthma', '', 'former', 'preterm', 'infantsneuromuscular', 'disease', 'impair', 'airway', 'clearancepoorly', 'control', 'type', 'diabetes', 'mellitussevere', 'obesity', '', 'body', 'mass', 'index', '120', 'percent', '95th', 'percentile', 'value', '', '', 'figure', '1a-b', '', '', 'known', 'in-person', 'exposure', 'laboratory-confirmed', 'case', 'covid-19', 'within', 'previous', '14', 'dayspresentation', 'severe', 'illness', '', 'eg', '', 'new', 'requirement', 'supplemental', 'oxygen', 'increase', 'requirement', 'baseline', '', 'new', 'increase', 'ventilation', '', 'invasive', 'noninvasive', '', '', '59', '', '', 'one', 'author', '', 'institution', 'institute', '', 'drive-thru', '', 'assessment', 'center', 'symptomatic', 'patient', '', 'eg', '', 'fever', '', 'persistent', 'cough', '', 'otherwise', 'stable', 'either', '', 'underlying', 'condition', '', 'eg', '', 'immune', 'compromise', '', 'chronic', 'cardiac', 'pulmonary', 'disease', '', 'known', 'in-person', 'exposure', 'laboratory-confirmed', 'case', 'covid-19', 'within', 'previous', '14', 'daysthis', 'assessment', 'center', 'provide', 'covid-19', 'screen', 'assessment', 'schedule', 'procedure', '', 'eg', '', 'cardiac', 'catheterization', '', 'endoscopy', '', 'inpatient', 'test', 'criterion', '', 'institution', 'perform', 'universal', 'test', 'hospitalize', 'patient', 'time', 'presentation', '', 'regardless', 'clinical', 'symptom', 'sign', 'covid-19', '', 'infant', 'bear', 'institution', 'mother', 'test', 'negative', 'covid-19', 'admit', 'nursery', 'neonatal', 'intensive', 'care', 'unit', '', 'nicu', '', 'exception', '', 'strategy', 'implement', 'reduce', 'hospital-associated', 'transmission', '', 'give', 'prevalence', 'asymptomatic', 'infection', 'childrenfor', 'hospitalize', 'child', 'whose', 'initial', 'test', 'result', 'negative', 'schedule', 'procedure', '', 'eg', '', 'endoscopy', '', '', 'retest', 'within', '48', 'hour', 'schedule', 'procedurefor', 'patient', 'suspect', 'nosocomial', 'acquisition', 'respiratory', 'virus', '', 'test', 'common', 'respiratory', 'pathogen', '', 'eg', '', 'via', 'multiplex', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', '', 'well', 'covid-19laboratory', 'test', 'sars-cov-2', '', 'laboratory', 'test', 'covid-19', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'microbiologic', 'diagnosis', '', '', '', 'detection', 'respiratory', 'pathogen', '', 'eg', '', 'influenza', '', 'respiratory', 'syncytial', 'virus', '', 'mycoplasma', 'pneumoniae', '', 'nasopharyngeal', 'specimen', 'exclude', 'covid-19', '', '32556675-78', '', '', 'one', 'study', '', '8', '20', 'child', 'positive', 'sars-cov-2', 'positive', 'common', 'respiratory', 'pathogen', '', '79', '', 'managementshould', 'nsaids', 'avoid', '', '', 'uncertainty', 'safety', 'nonsteroidal', 'anti-inflammatory', 'drug', '', 'nsaids', '', 'patient', 'covid-19', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'uncertainty', 'nsaid', '', '', '', 'assessment', 'severity', '', 'definition', 'severity', 'provide', 'multicenter', 'initial', 'guidance', 'antiviral', 'child', 'covid-19', '', '59', '', '', 'mild', 'moderate', 'disease', '', 'new', 'increase', 'supplemental', 'oxygen', 'requirementsevere', 'disease', '', 'new', 'requirement', 'supplemental', 'oxygen', 'increase', 'requirement', 'baseline', 'without', 'new', 'increase', 'ventilatory', 'support', '', 'noninvasive', 'invasive', '', 'critical', 'disease', '', 'new', 'increase', 'noninvasive', 'invasive', 'mechanical', 'ventilation', '', 'sepsis', '', 'multiorgan', 'failure', '', 'rapidly', 'worsen', 'clinical', 'trajectoryinpatient', 'management', 'child', 'covid-19', '', 'children', 'covid-19', 'severe', 'critical', 'lower', 'respiratory', 'tract', 'disease', 'generally', 'require', 'hospital', 'admission', '', 'children', 'nonsevere', 'covid-19', 'require', 'hospital', 'admission', 'risk', 'severe', 'disease', 'due', 'underlie', 'condition', '', 'eg', '', 'immune', 'compromise', '', 'supportive', 'care', 'patient', '', 'provide', 'supportive', 'care', 'pediatric', 'patient', 'covid-19', 'recommend', 'various', 'national', 'committee', '', '598081', '', '', 'supportive', 'care', 'mainstay', 'therapy', 'child', 'severe', 'critical', 'covid-19', '', 'child', 'covid-19', 'improve', 'supportive', 'care', '', 'severe', 'disease', '', '5982', '', '', '', 'society', 'guideline', 'link', '', '', '', 'routine', 'supportive', 'care', 'measure', 'include', '', 'provision', 'respiratory', 'support', '', 'include', 'supplemental', 'oxygen', 'ventilatory', 'support', '', 'noninvasive', 'invasive', '', '', 'respiratory', 'status', 'change', 'suddenly', 'approximately', 'one', 'week', 'symptom', '', '83', '', 'provision', 'fluid', 'electrolyte', 'support', '', '', '', 'fluid', 'electrolyte', 'therapy', 'newborn', '', '', 'clinical', 'assessment', 'diagnosis', 'hypovolemia', '', 'dehydration', '', 'child', '', '', 'treatment', 'hypovolemia', '', 'dehydration', '', 'child', '', '', '', 'provision', 'empiric', 'antibiotic', 'indicate', 'community-acquired', 'health', 'care-associated', 'pneumonia', '', 'continuation', 'empiric', 'antibiotic', 'determine', 'culture', 'microbial', 'test', 'clinical', 'condition', '', 'bacterial', 'coinfections', 'appear', 'infrequent', '', '84', '', '', '', '', 'pneumonia', 'child', '', 'inpatient', 'treatment', '', '', '', 'monitoring', 'cytokine', 'release', 'syndrome', 'monitor', 'blood', 'pressure', 'hypotension', '', 'oxygen', 'saturation', 'worsen', 'hypoxemia', '', 'biomarkers', '', 'obtain', 'baseline', 'c-reactive', 'protein', '', 'crp', '', '', 'd-dimer', '', 'ferritin', '', 'lactate', 'dehydrogenase', '', 'ldh', '', '', 'interleukin-6', '', 'il-inhibitor', '', '', 'monitor', 'crp', '', 'd-dimer', '', 'ferritin', '', 'ldh', 'two', 'three', 'time', 'per', 'week', 'concern', 'worsen', 'disease', '', 'il-inhibitor', 'perform', 'offsite', '', 'repeat', 'twice', 'per', 'week', 'elevate', 'baseline', 'concern', 'worsen', 'diseasefor', 'child', 'receive', 'immunosuppressive', 'therapy', '', 'discus', 'benefit', 'risk', 'reduce', 'immunosuppressive', 'therapy', 'prescribe', 'specialist', '', 'eg', '', 'oncologist', '', 'transplant', 'clinician', '', 'rheumatologist', '', '', '85', '', '', 'although', 'relationship', 'immune', 'compromise', 'severe', 'covid-19', 'disease', 'well', 'establish', 'child', '', '6162', '', '', 'management', 'viral', 'infection', 'immunocompromised', 'host', 'typically', 'include', 'reduction', 'baseline', 'immunosuppression', '', 'reduction', 'possible', '', '8687', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'issues', 'relate', 'solid', 'organ', 'transplantation', '', '', 'section', 'adjusting', 'immunosuppression', '', '', '', 'antiviral', 'therapy', 'select', 'patient', '', 'given', 'data', 'control', 'trial', 'support', 'efficacy', 'antiviral', 'agent', 'treatment', 'covid-19', 'child', '', 'agree', 'recommendation', 'multicenter', 'initial', 'guidance', 'antiviral', 'agent', 'child', 'covid-19', 'expert', 'antiviral', 'therapy', 'covid-19', 'occur', 'context', 'clinical', 'trial', '', '5988', '', '', 'information', 'ongoing', 'clinical', 'trial', 'available', 'clinicaltrialsgovantiviral', 'therapy', 'covid-19', 'generally', 'reserve', 'child', 'document', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'infection', 'test', 'available', '', '59', '', 'potential', 'indication', '', 'decisions', 'antiviral', 'therapy', 'individualize', 'accord', 'disease', 'severity', '', 'clinical', 'trajectory', '', 'underlie', 'condition', 'increase', 'risk', 'progression', '', 'studies', 'effectiveness', 'safety', 'antiviral', 'therapy', 'predominantly', 'perform', 'adult', 'severe', 'lower', 'respiratory', 'tract', 'disease', '', '8990', '', '', 'study', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'specific', 'treatment', '', '', '', 'children', 'covid-19', 'risk', 'unproven', 'antiviral', 'therapy', 'warrant', 'include', 'severe', 'critical', 'disease', 'mild', 'moderate', 'disease', 'underlie', 'condition', 'increase', 'risk', 'severe', 'diseasechoice', 'agentregimenremdesivir', '', 'decision', 'antiviral', 'therapy', '', 'agree', 'multicenter', 'panel', 'remdesivir', 'prefer', 'agent', '', 'although', 'data', 'regard', 'benefit', 'remdesivir', 'child', 'covid-19', '', 'prefer', 'antiviral', 'agent', 'emerge', 'data', 'comparative', '', 'randomize', 'trial', 'case', 'series', 'adult', 'patient', 'suggest', 'beneficial', 'appear', 'well', 'tolerate', '', '599192', '', '', 'studies', 'remdesivir', 'adult', 'patient', 'covid-19', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'remdesivir', '', '', '', 'remdesivir', 'dose', 'accord', 'weight', 'follow', '', '-35', '', '40', 'kg', '', '5', 'mgkg', 'intravenous', '', 'iv', '', 'load', 'dose', 'day', '1', '', 'follow', '25', 'mgkg', 'iv', 'every', '24', 'hour', '5', '10', 'day', '', '5', 'day', 'rapid', 'clinical', 'response', '', '-40', 'kg', '', '200', 'mg', 'iv', 'load', 'dose', 'day', '1', '', 'follow', '100', 'mg', 'iv', 'every', '24', 'hour', '5', '10', 'day', '', '5', 'day', 'rapid', 'clinical', 'response', '', 'remdesivir', 'prodrug', 'nucleotide', 'analog', 'inhibit', 'rna-dependent', 'rna', 'polymerase', 'activity', 'coronaviruses', '', '93-95', '', '', 'united', 'states', '', 'food', 'drug', 'administration', '', 'fda', '', 'issue', 'emergency', 'authorization', 'remdesivir', 'hospitalize', 'child', 'adult', 'severe', 'covid-19', '', 'ie', '', 'oxygen', 'saturation', '94', 'percent', 'room', 'air', '', 'require', 'supplemental', 'oxygen', '', 'mechanical', 'ventilation', '', 'extracorporeal', 'membrane', 'oxygenation', '', '', '96', '', 'reported', 'adverse', 'effect', 'remdesivir', 'include', 'nausea', '', 'vomit', '', 'transaminase', 'elevationshydroxychloroquine', 'hydroxychloroquine', '', 'efficacy', 'hydroxychloroquine', 'treatment', 'covid-19', 'uncertain', '', 'although', 'hydroxychloroquine', 'investigate', 'treatment', 'covid-19', '', 'license', 'indication', '', '97', '', '', 'ideally', 'hospitalize', 'patient', 'context', 'clinical', 'trial', '', '98', '', 'hydroxychloroquine', '', 'without', 'azithromycin', '', 'alternative', 'remdesivir', 'child', 'warrant', 'antiviral', 'therapy', 'candidate', 'remdesivir', 'remdesivir', 'unavailable', '', '59', '', '', 'given', 'prove', 'benefit', 'potential', 'risk', '', 'context', 'clinical', 'trial', '', 'hydroxychloroquine', 'avoid', 'child', 'underlie', 'qtc', 'abnormality', 'require', 'medication', 'potential', 'serious', 'drug', 'interaction', 'hydroxychloroquine', '', 'initiate', 'hydroxychloroquine', '', 'specific', 'interaction', 'medication', 'check', 'drug', 'interaction', 'program', '', 'lexicomp', 'drug', 'interaction', 'tool', 'provide', 'uptodatethe', 'multicenter', 'panel', 'suggest', 'either', 'follow', 'regimen', 'hydroxychloroquine', 'child', '', '59', '', '', '-13', 'mgkg', '', 'maximum', '', '800', 'mg', '', 'orally', '', 'follow', '65', 'mgkg', '', 'maximum', '', '400', 'mg', '', '6', '', '24', '', '48', 'hour', 'initial', 'dose', '', 'duration', 'extend', 'five', 'day', 'case-by-case', 'basis', '', '-65', 'mgkg', 'per', 'dose', '', 'maximum', '', '400', 'mg', 'per', 'dose', '', 'orally', 'twice', 'per', 'day', 'day', '1', '', 'follow', '325', 'mgkg', '', 'maximum', '', '200', 'mgdose', '', 'orally', 'twice', 'per', 'day', 'five', 'dayshydroxychloroquine', 'alter', 'endosomal', 'lysosomal', 'ph', '', 'inhibit', 'viral', 'replication', 'propagation', '', 'although', 'exact', 'mechanism', 'antiviral', 'activity', 'remain', 'uncertain', '', '99', '', '', 'united', 'states', '', 'fda', 'issue', 'emergency', 'authorization', 'allow', 'agent', 'adolescent', 'adult', 'hospitalize', 'covid-19', 'participation', 'clinical', 'trial', 'feasible', '', '100', '', 'clinical', 'study', 'hydroxychloroquine', 'limit', 'small', 'sample', 'size', 'include', 'predominantly', 'adult', 'patient', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'hydroxychloroquinechloroquine', '', '', '', 'given', 'uncertain', 'efficacy', 'potential', 'cardiac', 'toxicity', '', 'avoid', 'hydroxychloroquine', 'combination', 'hydroxychloroquine', 'azithromycin', 'treatment', 'covid-19', 'child', '', '101', '', 'lopinavir-ritonavir', '', 'recommend', 'routine', 'lopinavir-ritonavir', 'give', 'absence', 'efficacy', 'unfavorable', 'pharmacodynamics', '', '90', '', 'adjunctive', 'therapy', '', 'decision', 'adjunctive', 'therapy', 'immune-mediated', 'complication', 'covid-19', 'case-by-case', 'basis', 'accord', 'disease', 'severity', '', 'routinely', 'immune', 'modulators', '', 'eg', '', 'glucocorticoid', '', 'il-inhibitor', 'inhibitor', '', 'eg', '', 'tocilizumab', '', '', 'interferon-beta', '1b', '', 'convalescent', 'plasma', 'recover', 'covid-19', 'patient', '', 'treatment', 'child', 'covid-19', '', 'except', 'context', 'clinical', 'trial', '', 'benefit', 'risk', 'uncertain', '', '102', '', 'although', 'available', 'data', 'vitamin', 'treatment', 'covid-19', '', 'vitamin', 'long', 'adjuvant', 'treatment', 'measles', '', 'associate', 'decrease', 'morbidity', 'mortality', 'measles-associated', 'pneumonia', '', '103', '', '', 'vitamin', 'deficiency', 'associate', 'impairment', 'humoral', 'cell-mediated', 'immunity', '', 'mild', 'vitamin', 'deficiency', 'lead', 'increase', 'morbidity', 'measles', 'viral', 'respiratory', 'infection', '', '103', '', '', '', '', 'measles', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'treatment', '', 'prevention', '', '', 'section', 'vitamin', '', '', '', 'information', 'ongoing', 'clinical', 'trial', 'available', 'clinicaltrialsgov', '', 'outpatient', 'management', 'child', 'covid-19telephone', 'triage', 'child', '', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'provide', 'guidance', 'telephone', 'triage', 'child', 'possible', 'covid-19', '', 'child', 'manage', 'home', '', '', 'children', 'document', 'suspect', 'covid-19', 'mild', 'symptom', '', 'eg', '', 'fever', '', 'cough', '', 'pharyngitis', '', 'respiratory', 'symptom', '', 'generally', 'manage', 'home', 'unless', 'chronic', 'condition', 'increase', 'risk', 'severe', 'diseasemanagement', 'focus', 'prevention', 'transmission', 'others', '', 'ie', '', 'isolation', '', '', 'monitor', 'clinical', 'deterioration', '', 'supportive', 'care', '', 'although', 'role', 'child', 'transmission', 'clear', '', '104', '', '', 'evidence', 'report', 'cluster', 'case', 'france', 'suggest', 'possibility', 'child', 'transmit', 'sars-cov-2', 'efficiently', 'age', 'group', '', 'perhaps', 'relate', 'viral', 'interference', '', '105', '', '', 'cdc', 'world', 'health', 'organization', 'provide', 'additional', 'guidance', '', 'child', '', 'sick', '', '106107', '', '', '', 'prevention', 'transmission', '', '', '', 'monitoring', 'clinical', 'deterioration', '', 'caregivers', 'child', 'manage', 'home', 'counsel', 'symptom', 'clinical', 'deterioration', '', 'occur', 'suddenly', 'approximately', 'one', 'week', 'symptom', 'prompt', 'urgent', 're-evaluation', '', '83', '', '', 'include', '', '106-109', '', '', 'severe', 'respiratory', 'distress', '', 'difficulty', 'breathe', '', 'infant', '', 'grunt', '', 'central', 'cyanosis', '', 'inability', 'breastfeed', '', 'chest', 'pain', 'pressureblue', 'lip', 'facefindings', 'associate', 'shock', '', 'eg', '', 'cold', '', 'clammy', '', 'mottle', 'skin', '', 'new', 'confusion', '', 'difficulty', 'arouse', '', 'substantially', 'reduce', 'urine', 'output', '', 'symptomatic', 'supportive', 'care', '', 'symptomatic', 'care', 'covid-19', 'outpatient', 'set', 'similar', 'upper', 'respiratory', 'gastrointestinal', 'clinical', 'syndrome', '', 'upper', 'respiratory', 'tract', 'infection', '', '', 'common', 'cold', 'child', '', 'management', 'prevention', '', '', 'section', 'symptomatic', 'therapy', '', '', 'pharyngitis', '', '', 'acute', 'pharyngitis', 'child', 'adolescent', '', 'symptomatic', 'treatment', '', '', 'section', 'symptomatic', 'treatment', '', '', 'acute', 'gastroenteritis', '', '', 'acute', 'viral', 'gastroenteritis', 'child', 'resource-rich', 'country', '', 'management', 'prevention', '', '', 'section', 'management', '', '', 'management', 'fever', 'child', '', 'include', 'indication', 'treatment', '', 'discuss', 'separately', '', '', '', 'fever', 'infant', 'child', '', 'pathophysiology', 'management', '', '', 'section', 'management', 'fever', '', '', '', 'home', 'isolation', 'discontinue', '', '', 'optimal', 'duration', 'home', 'isolation', 'uncertain', '', 'long', 'person', 'remain', 'infectious', 'uncertain', '', 'duration', 'viral', 'shed', 'variable', '', 'appear', 'wide', 'range', '', 'depend', 'severity', 'illness', '', 'among', '110', 'child', 'wuhan', 'children', 'hospital', '', 'median', 'duration', 'viral', 'shed', '15', 'day', 'onset', 'illness', '', 'interquartile', 'range', '11', '20', 'day', '', '', 'duration', 'longer', 'symptomatic', 'asymptomatic', 'child', '', '17', 'versus', '11', 'day', '', '', '110', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'viral', 'shed', 'period', 'infectivity', '', '', '', 'cdc', 'issue', 'recommendation', 'discontinuation', 'home', 'isolation', '', 'include', 'test-based', 'nontest-based', 'strategy', '', '111-113', '', '', 'choice', 'strategy', 'depend', 'upon', 'patient', 'population', '', 'eg', '', 'immunocompromised', 'versus', 'nonimmunocompromised', '', '', 'availability', 'test', 'supply', '', 'access', 'testingavoidance', 'unproven', 'intervention', '', 'hydroxychloroquine', 'investigational', 'agent', 'supervision', 'health', 'care', 'provider', '', 'describe', '', 'misuse', 'nonpharmaceutical', 'form', 'investigational', 'agent', '', 'eg', '', 'hydroxychloroquine', 'phosphate', '', 'home', 'aquarium', '', 'ivermectin', 'intend', 'animal', '', 'lead', 'severe', 'toxicity', '', 'include', 'death', '', '98114115', '', '', '', 'inpatient', 'management', 'child', 'covid-19', '', '', '', 'prevention', 'transmissionfrom', 'infect', 'mother', 'newborn', '', 'prevention', 'transmission', 'infect', 'mother', 'newborn', 'delivery', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'pregnancy', 'issue', '', '', 'section', 'postpartum', 'care', '', '', '', 'child', 'document', 'suspect', 'covid-19during', 'cardiopulmonary', 'resuscitation', '', 'modifications', 'algorithm', 'pediatric', 'basic', 'advance', 'life', 'support', 'prevent', 'transmit', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'discuss', 'separately', '', '', '', 'pediatric', 'basic', 'life', 'support', 'health', 'care', 'provider', '', '', 'section', 'covid-19', 'patient', '', 'suspect', 'confirm', '', '', '', 'pediatric', 'advance', 'life', 'support', '', 'pals', '', '', '', 'section', 'covid-19', 'patient', '', 'suspect', 'confirm', '', '', '', '', 'hygiene', 'social', 'distance', '', 'prevention', 'transmission', 'focus', 'hygiene', 'social', 'distance', '', 'include', '', '106107116', '', '', 'friend', 'family', 'member', 'bring', 'necessary', 'item', 'home', '', 'retrieve', 'outside', '', 'child', '', 'sick', 'family', 'member', '', 'wear', 'mask', 'leave', 'home', 'avoid', '', 'time', 'discharge', '', 'supply', 'allow', '', 'provide', 'patient', 'pair', 'glove', 'several', 'mask', 'help', 'prevent', 'transmission', 'household', 'contact', '', 'addition', '', 'patient', 'without', 'access', 'private', 'transportation', '', 'arrange', 'medical', 'transportation', '', 'possible', '', 'preferable', 'public', 'transportation', 'ride-sharing', 'service', 'minimize', 'exposure', 'public', '', 'much', 'possible', '', 'keep', 'ill', 'family', 'member', '6', 'foot', 'away', 'people', '', 'especially', 'family', 'member', '65', 'year', 'age', 'serious', 'medical', 'conditionsif', 'separation', 'possible', '', 'ill', 'family', 'member', 'wear', 'face', 'mask', 'room', 'vehicle', 'peoplekeeping', 'ill', 'family', 'member', 'separate', 'pet', 'householdhaving', 'family', 'member', 'fever', 'cough', 'sleep', 'separate', 'room', 'separate', 'bathroomsavoiding', 'share', 'item', '', 'eg', '', 'pillow', '', 'blanket', '', 'utensil', '', 'cup', '', 'additional', 'information', 'care', 'people', 'document', '', 'suspect', '', 'possible', 'covid-19', 'home', 'available', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'world', 'health', 'organization', '', '106107', '', 'disinfection', '', 'disinfection', 'frequently', 'touch', 'surface', 'important', '', 'discuss', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', 'section', 'environmental', 'disinfection', '', '', '', 'asymptomatic', 'childrenshould', 'routine', 'health', 'supervision', 'appointment', 'reschedule', '', '', 'covid-19', 'pandemic', '', 'benefit', 'well-visits', 'balance', 'risk', 'exposure', 'covid-19', 'communicable', 'illness', '', 'within', 'context', 'patient', 'population', 'office', 'environment', '', '117-119', '', '', 'clinician', 'practice', 'unable', 'provide', 'well-child', 'visit', 'patient', 'practice', '', 'cdc', 'american', 'academy', 'pediatrics', '', 'aap', '', 'encourage', 'prioritization', 'newborn', 'care', 'vaccination', 'child', '24', 'month', 'age', '', '119120', '', '', 'disruption', 'immunization', 'service', 'increase', 'risk', 'outbreak', 'vaccine-preventable', 'illness', '', '121', '', '', 'adherence', 'recommendation', 'infant', 'bear', 'woman', 'hepatitis', 'b', 'surface', 'antigen', '', 'hbsag', '', 'positive', 'whose', 'hbsag', 'status', 'unknown', 'particularly', 'important', 'prevention', 'mother-to-child', 'transmission', 'hepatitis', 'b', 'virus', '', 'especially', 'delivery', 'occur', 'unplanned', 'facility', 'attend', 'staff', 'knowledgeable', 'manage', 'infant', 'bear', 'mother', 'hbsag', 'positive', '', '122', '', '', '', '', 'standard', 'immunization', 'child', 'adolescent', '', 'overview', '', '', 'section', 'benefits', 'vaccine', '', '', 'hepatitis', 'b', 'virus', 'immunization', 'infant', '', 'child', '', 'adolescent', '', '', 'section', 'routine', 'infant', 'immunization', '', '', '', 'scheduling', 'home', 'visit', '', 'telemedicine', '', 'office', 'space', '', 'andor', 'office', 'location', 'keep', 'well', 'child', 'child', 'ill', 'possibly', 'ill', 'separate', '', 'eg', '', 'schedule', 'well-visits', 'morning', 'sick', 'visit', 'afternoon', '', 'child', 'sick', 'visit', 'different', 'part', 'clinic', '', 'designate', 'examination', 'room', '', 'different', 'office', 'site', '', 'practice', '', 'child', 'well-visits', '', '', '117123-125', '', 'aap', 'provide', 'information', 'resource', 'telemedicine', '', 'include', 'information', 'state-by-state', 'payer', 'policiesuse', 'cloth', 'face', 'mask', '', 'cdc', 'recommend', 'individual', '2', 'year', 'age', 'wear', 'cloth', 'face', 'cover', '', 'eg', '', 'homemade', 'mask', 'bandana', '', 'public', 'set', 'social', 'distance', 'difficult', 'achieve', '', 'eg', '', 'grocery', 'store', '', 'clinician', 'office', '', '', 'especially', 'area', 'substantial', 'community', 'transmission', '', '126', '', '', 'cloth', 'mask', 'recommend', 'child', '', '2', 'year', 'age', '', 'concern', 'suffocation', '', '127', '', '', 'aap', 'provide', 'additional', 'information', 'cloth', 'mask', 'child', '', 'include', 'tip', 'increase', 'proper', 'wear', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'personal', 'preventive', 'measure', '', '', '', 'play', 'date', 'playground', 'avoid', '', '', 'given', 'possibility', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'asymptomatic', 'individual', '', 'presymptomatic', 'individual', 'within', 'incubation', 'period', '', '', '645128-135', '', '', 'cdc', 'recommend', 'child', 'play', 'date', 'child', 'household', 'play', 'outside', '', 'remain', '6', 'foot', 'people', 'household', '', '136', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'viral', 'shed', 'period', 'infectivity', '', '', '', 'cdc', 'provide', 'information', 'safely', 'remain', 'physically', 'active', 'park', 'recreational', 'facility', 'covid-19', 'pandemichand', 'sanitizer', 'safety', '', 'although', 'wash', 'hand', 'soap', 'water', '', 'available', '', 'prefer', 'hand', 'hygiene', '', 'alcohol-based', 'hand', 'sanitizer', 'safe', 'child', 'sanitizer', 'accord', 'information', 'drug', 'facts', 'label', '', 'cause', 'concern', 'child', 'eat', 'lick', 'hand', 'hand', 'sanitizer', 'fully', 'dry', '', '137', '', '', 'however', '', 'ingestion', 'small', 'amount', 'liquid', 'hand', 'sanitizer', 'cause', 'alcohol', 'poison', 'child', '', 'include', 'hypoglycemia', '', '', 'child', 'younger', 'six', 'year', 'supervise', 'alcohol-based', 'hand', 'sanitizers', '', 'alcohol-based', 'hand', 'sanitizers', 'keep', 'reach', 'sight', 'child', '', '138', '', '', '', '', 'ethanol', 'intoxication', 'child', '', 'epidemiology', '', 'estimation', 'toxicity', '', 'toxic', 'effect', '', '', 'ethanol', 'intoxication', 'child', '', 'clinical', 'feature', '', 'evaluation', '', 'management', '', '', '', 'special', 'populationschildren', 'asthma', '', 'considerations', 'relate', 'covid-19', 'child', 'asthma', 'include', 'safety', 'glucocorticoid', 'nebulized', 'medication', '', 'consideration', 'discuss', 'separately', '', '', '', 'overview', 'asthma', 'management', '', '', 'section', 'advice', 'relate', 'covid-19', 'pandemic', '', '', '', 'children', 'special', 'health', 'care', '', 'american', 'academy', 'pediatrics', 'provide', 'information', 'keep', 'child', 'special', 'health', 'care', 'safe', 'covid-19', 'pandemicchildren', 'attention', 'deficit', 'hyperactivity', 'disorder', '', 'european', 'attention', 'deficit', 'hyperactivity', 'disorder', '', 'adhd', '', 'guideline', 'group', 'provide', 'guidance', 'management', 'adhd', 'covid-19', 'pandemic', 'guidance', 'start', 'stimulant', 'atomoxetine', 'child', 'in-person', 'cardiovascular', 'assessment', 'pandemic', '', '139140', '', 'issueswhat', 'type', 'infant', 'formula', 'substitute', 'usual', 'formula', 'available', '', '', 'american', 'academy', 'pediatrics', '', 'aap', '', 'provide', 'advice', 'provider', 'family', 'infant', 'formula', 'availablewhat', 'effect', 'prolong', 'home', 'confinement', '', '', 'although', 'prolong', 'home', 'confinement', 'provide', 'opportunity', 'enhance', 'parent-child', 'relationship', '', 'adversely', 'affect', 'child', 'physical', 'mental', 'health', '', '141-150', '', '', 'le', 'physically', 'active', '', 'spend', 'time', 'electronic', 'device', '', 'eat', 'poorer', 'quality', 'diet', '', 'mental', 'health', 'stressor', 'include', 'fear', 'infection', '', 'boredom', '', 'social', 'isolation', '', 'survey', 'primary', 'school', 'student', 'hubei', 'province', 'china', 'restrict', 'home', 'mean', '35', 'day', '', 'prevalence', 'symptom', 'depression', 'anxiety', '', 'approximately', '20', 'percent', '', 'greater', 'survey', '', '148', '', '', 'school', 'closure', 'relate', 'health', 'emergency', 'associate', 'increase', 'risk', 'violence', 'vulnerability', '', '144151', '', '', 'vulnerable', 'child', 'adolescent', '', 'eg', '', 'homeless', 'foster', 'care', '', 'history', 'maltreatment', '', 'sexual', 'gender', 'minority', '', 'particular', 'risk', 'violence', 'adverse', 'mental', 'health', 'effect', '', '149', '', '', 'adverse', 'mental', 'physical', 'health', 'effect', 'mitigate', 'parent-child', 'relation', 'enhance', 'parental', 'role-modeling', 'healthy', 'behavior', '', 'involve', 'child', 'family', 'activity', '', 'promotion', 'self-discipline', 'self-sufficiency', 'skill', '', 'direct', '', 'developmentally', 'appropriate', 'conversation', 'child', 'pandemic', '', '141146152-154', '', 'clinicians', 'consider', 'potential', 'violence', 'look', 'sign', 'parental', 'stress', '', 'irritability', '', 'depression', '', 'andor', 'harsh', 'response', 'child', 'behavior', 'clinical', 'encounter', '', '151', '', '', 'ask', 'parent', 'stress', 'level', '', 'method', 'manage', 'stress', '', 'social', 'support', '', 'substance', '', 'clinicians', 'offer', 'cop', 'strategy', '', 'eg', '', 'deep', 'breathe', '', 'call', 'friend', 'family', 'member', '', '', 'resource', '', 'andor', 'referral', 'mental', 'health', 'provider', 'family', 'benefit', 'intervention', '', 'resources', 'relate', 'child', 'care', 'prevention', 'violence', 'covid-19', 'pandemic', 'include', '', '-child', 'care', 'aware', 'america-global', 'partnership', 'end', 'violence', 'children-the', 'national', 'child', 'traumatic', 'stress', 'networkresources', 'talk', 'child', 'covid-19', 'available', 'multiple', 'professional', 'group', 'others', '', 'include', '', '-the', 'american', 'academy', 'child', 'adolescent', 'psychiatry-the', 'aap', '', 'talking', 'child', 'covid-19-coronavirus', '', 'book', 'child', '', 'write', 'elizabeth', 'jenner', '', 'kate', 'wilson', '', 'nia', 'roberts', '', 'illustrate', 'axel', 'scheffler', '', '-covibook', 'child', 'younger', 'seven', 'years-the', 'united', 'states', 'centers', 'disease', 'control', 'prevention-the', 'national', 'association', 'school', 'psychologists-the', 'united', 'nations', 'office', 'coordination', 'humanitarian', 'affairs', '', 'inter-agency', 'standing', 'committee', '', 'child', 'book', 'child', 'approximately', '6', '11', 'year', 'age', '', 'resource', 'available', 'home', 'school', 'child', 'keep', 'occupy', 'pandemic', '', '', 'several', 'national', 'organization', 'provide', 'educational', 'resource', 'child', '', 'include', '', 'among', 'others', '', '123144', '', '', 'aap', '', '-working', 'learn', 'home', 'covid-19', 'outbreak-getting', 'child', 'outside', 'social', 'distance', 'covid-19-teens', 'covid-19', '', 'challenges', 'opportunity', 'outbreaknational', 'association', 'education', 'young', 'childrennational', 'head', 'start', 'association', 'resources', 'parentsopening', 'doorsabriendo', 'puertassesame', 'workshopunited', 'nations', 'children', 'fund', '', 'unicef', '', 'world', 'health', 'organizationzero', 'threesociety', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'email', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'education', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'child', '', 'basics', '', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'summary', 'recommendationscoronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'infectious', 'disease', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'understanding', 'covid-19', 'evolve', '', 'interim', 'guidance', 'issue', 'world', 'health', 'organization', '', '', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', '', '', '', '', '', 'children', 'age', 'covid-19', '', 'although', 'appear', 'affect', 'le', 'frequently', 'adult', '', '', 'epidemiology', '', '', '', 'covid-19', 'child', 'usually', 'mild', '', 'although', 'severe', 'case', 'report', '', 'include', 'case', 'clinical', 'feature', 'similar', 'toxic', 'shock', 'syndrome', 'kawasaki', 'disease', '', 'table', '1', '', '', 'case', 'series', 'child', 'covid-19', '', 'common', 'symptom', 'child', 'fever', 'cough', '', 'symptom', 'include', 'sore', 'throat', '', 'fatigue', '', 'rhinorrheanasal', 'congestion', '', 'diarrhea', '', 'vomit', '', 'additional', 'symptom', 'report', 'adult', 'include', 'chill', 'shake', 'chill', '', 'myalgia', '', 'headache', '', 'new', 'loss', 'taste', 'smell', '', 'laboratory', 'find', 'often', 'normal', 'include', 'leukopenia', '', 'lymphocytopenia', '', 'elevate', 'procalcitonin', 'c-reactive', 'protein', '', '', 'clinical', 'manifestation', '', '', '', 'criteria', 'test', 'covid-19', 'vary', 'geographically', '', 'united', 'states', '', 'guidance', 'provide', 'cdc', 'infectious', 'diseases', 'society', 'america', '', 'table', '2', '', 'adapt', 'state', 'local', 'health', 'department', 'depend', 'upon', 'test', 'availability', '', '', 'criterion', 'test', 'covid-19', 'child', '', '', '', '', 'given', 'limit', 'test', 'resource', '', 'institution', 'perform', 'target', 'test', 'outpatient', 'set', '', 'child', 'evaluate', 'symptom', 'consistent', 'covid-19', 'emergency', 'department', 'urgent', 'care', 'set', '', 'perform', 'test', 'sars-cov-2', 'child', 'underlie', 'condition', 'increase', 'risk', 'severe', 'disease', '', 'in-person', 'exposure', 'laboratory-confirmed', 'case', 'covid-19', 'within', 'previous', '14', 'day', '', 'presentation', 'severe', 'illness', '', '', 'outpatient', 'test', 'criterion', '', '', '', 'perform', 'universal', 'test', 'hospitalize', 'patient', 'time', 'presentation', '', 'regardless', 'clinical', 'symptom', 'sign', 'covid-19', '', 'infant', 'bear', 'institution', 'mother', 'test', 'negative', 'covid-19', 'admit', 'nursery', 'neonatal', 'intensive', 'care', 'unit', 'exception', '', '', 'inpatient', 'test', 'criterion', '', '', '', 'children', 'covid-19', 'severe', 'critical', 'lower', 'respiratory', 'tract', 'disease', 'generally', 'require', 'hospital', 'admission', '', 'severe', 'disease', 'define', 'new', 'requirement', 'supplemental', 'oxygen', 'increase', 'requirement', 'baseline', 'without', 'new', 'increase', 'ventilatory', 'support', '', 'noninvasive', 'invasive', '', '', 'critical', 'disease', 'define', 'new', 'increase', 'noninvasive', 'invasive', 'mechanical', 'ventilation', '', 'sepsis', '', 'multiorgan', 'failure', '', 'rapidly', 'worsen', 'clinical', 'trajectory', '', '', 'assessment', 'severity', '', '', '', 'supportive', 'care', '', 'eg', '', 'respiratory', 'support', '', 'fluid', 'electrolyte', 'support', '', 'monitor', 'cytokine', 'release', 'syndrome', '', 'mainstay', 'therapy', 'child', 'severe', 'critical', 'covid-19', '', '', 'supportive', 'care', 'patient', '', '', '', 'agree', 'recommendation', 'multicenter', 'initial', 'guidance', 'antiviral', 'agent', 'child', 'covid-19', 'expert', 'antiviral', 'therapy', 'covid-19', 'occur', 'context', 'clinical', 'trial', '', '', 'antiviral', 'therapy', 'select', 'patient', '', '', '', 'decisions', 'regard', 'antiviral', 'therapy', 'individualize', 'accord', 'disease', 'severity', '', 'clinical', 'trajectory', '', 'underlie', 'condition', 'increase', 'risk', 'progressionwhen', 'decision', 'antiviral', 'therapy', '', 'prefer', 'remdesivir', 'agent', '', 'hydroxychloroquine', '', 'without', 'azithromycin', '', 'alternative', 'child', 'candidate', 'remdesivir', 'remdesivir', 'unavailable', '', 'children', 'document', 'suspect', 'covid-19', 'mild', 'symptom', '', 'eg', '', 'fever', '', 'cough', '', 'pharyngitis', '', 'respiratory', 'symptom', '', 'generally', 'manage', 'home', 'unless', 'chronic', 'condition', 'increase', 'risk', 'severe', 'disease', '', 'management', 'focus', 'prevention', 'transmission', 'others', '', 'ie', '', 'isolation', '', '', 'monitor', 'clinical', 'deterioration', '', 'eg', '', 'difficulty', 'breathe', '', 'cyanosis', '', 'symptom', 'shock', '', '', 'supportive', 'care', '', '', 'child', 'manage', 'home', '', '', '', '', 'symptomatic', 'care', 'covid-19', 'outpatient', 'set', 'similar', 'upper', 'respiratory', 'gastrointestinal', 'clinical', 'syndrome', '', 'discuss', 'separately', '', '', '', 'common', 'cold', 'child', '', 'management', 'prevention', '', '', 'section', 'symptomatic', 'therapy', '', '', 'acute', 'pharyngitis', 'child', 'adolescent', '', 'symptomatic', 'treatment', '', '', 'section', 'symptomatic', 'treatment', '', '', 'fever', 'infant', 'child', '', 'pathophysiology', 'management', '', '', 'section', 'management', 'fever', '', '', 'acute', 'viral', 'gastroenteritis', 'child', 'resource-rich', 'country', '', 'management', 'prevention', '', '', 'section', 'management', '', '', '', 'prevention', 'transmission', 'focus', 'hygiene', 'social', 'distance', '', 'cdc', 'provide', 'guidance', 'prevent', 'transmission', 'covid-19', 'home', 'outpatient', 'set', '', '', 'prevention', 'transmission', '', '', '']",6653,"{'': 1787, 'child': 163, 'covid-19': 148, 'disease': 88, 'severe': 51, 'clinical': 46, 'percent': 44, 'coronavirus': 43, 'patient': 41, 'care': 39, 'eg': 39, 'case': 38, 'include': 37, 'respiratory': 36, '2019': 35, 'test': 35, 'section': 34, 'prevention': 33, 'symptom': 33, 'adult': 29}","{'tocilizumab': 1, 'hydroxychloroquine': 14, 'infection': 19, 'sars-cov-2': 23, 'safety': 4, 'il-inhibitor': 3}",64,0.6908
ID:126613,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care']","['Introduction — This topic include link select international government-sponsored guideline several country region around world .', ""We update link periodically ; newer version guideline may available organization 's website.More detail guidance specialty care , include link individual society guideline resource patient , present separately ."", ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", ') The recommendation follow guideline may vary appear UpToDate topic review .', 'Readers look UpToDate topic review use UpToDate search box find relevant content.International●World Health Organization ( WHO ) : Country technical guidance – Coronavirus disease ( COVID-19 ) •Coronavirus disease ( COVID-19 ) travel advice•Coronavirus disease ( COVID-19 ) technical guidance – The Unity Studies : Early investigation protocols-Protocol assessment potential risk factor 2019-novel coronavirus ( 2019-nCoV ) infection among health care worker health care setting•Coronavirus disease ( COVID-19 ) technical guidance – Risk communication community engagement-Community-based health care , include outreach campaign , context COVID-19 pandemic•Coronavirus disease ( COVID-19 ) technical guidance – Surveillance case definitions-Interim guidance global surveillance ( case definition ) human infection coronavirus disease ( COVID-19 ) •Coronavirus disease ( COVID-19 ) technical guidance – Patient management-Interim guidance clinical management severe acute respiratory infection COVID-19 suspected-Clinical care severe acute respiratory infection – Tool kit-Technical documentation consideration quarantine individual context containment coronavirus disease ( COVID-19 ) -Interim guidance home care patient COVID-19 present mild symptom management contacts•Coronavirus disease ( COVID-19 ) technical guidance – Essential resource planning•Coronavirus disease ( COVID-19 ) technical guidance – Laboratory test 2019-nCoV humans-Interim guidance laboratory test 2019 novel coronavirus ( 2019-nCoV ) suspect human cases-Laboratory biosafety guidance relate coronavirus disease 2019 ( COVID-19 ) •Coronavirus disease ( COVID-19 ) technical guidance – Infection prevention control / WASH-Interim guidance infection prevention control health care novel coronavirus ( nCoV ) infection suspected-Interim guidance risk assessment management exposure health care worker context COVID-19-Interim guidance rational use personal protective equipment coronavirus disease ( COVID-19 ) consideration severe shortages-Advice use mask context COVID-19•Coronavirus disease ( COVID-19 ) technical guidance – Points entry mass gatherings•Guidance health workers•Coronavirus disease ( COVID-19 ) technical guidance – Maintaining essential health service systemsCanada●Public Health Agency Canada ( PHAC ) : Coronavirus infection – For health professionals•Interim guidance continuity immunization program COVID-19 pandemic•Infection prevention control COVID-19 – Interim guidance home care settings•COVID-19 technical brief – Masking face shield full duration shift acute healthcare settings•Infection prevention control coronavirus disease ( COVID-19 ) – Second interim guidance acute healthcare settings•COVID-19 pandemic guidance health care sector•Clinical management patient moderate severe COVID-19 – Interim guidance•Routine practice additional precaution prevent transmission infection healthcare settings•Interim national case definition – Coronavirus disease ( COVID-19 ) •Interim national surveillance guideline human infection coronavirus disease ( COVID-19 ) •Public health management case contact associate coronavirus disease 2019 ( COVID-19 ) •Coronavirus disease ( COVID-19 ) – Summary assumptions•SARS-CoV-2 ( severe acute respiratory syndrome-related coronavirus 2 ) – Biosafety advisoryUnited States●Centers Disease Control Prevention ( CDC ) : Coronavirus ( COVID-19 ) •Information healthcare professionals-Evaluating test person coronavirus disease 2019 ( COVID-19 ) -Interim clinical guidance management patient confirm coronavirus disease ( COVID-19 ) -Information clinician investigational therapeutic patient COVID-19-Discontinuation isolation person COVID-19 healthcare set ( interim guidance ) -Interim guidance implement home care people require hospitalization coronavirus disease 2019 ( COVID-19 ) -Discontinuation transmission-based precaution disposition patient COVID-19 healthcare set ( interim guidance ) -Interim infection prevention control recommendation patient suspect confirm coronavirus disease 2019 ( COVID-19 ) healthcare settings-Using personal protective equipment ( PPE ) -Hand hygiene recommendation – Guidance healthcare provider hand hygiene COVID-19-Outpatient ambulatory care set – Responding community transmission COVID-19 United States-Preparing COVID-19 – Long-term care facility , nurse homes-Strategies optimize supply PPE equipment-Interim US guidance risk assessment public health management healthcare personnel potential exposure healthcare set patient coronavirus disease 2019 ( COVID-19 ) -Return work healthcare personnel confirm suspect COVID-19-Preparedness tool healthcare professional facility respond coronavirus ( COVID-19 ) -Healthcare facility – Preparing community transmission-Prepare practice COVID-19•Health departments-Contact tracing-Public health guidance potential COVID-19 exposure associate international travel cruise travel-Public health recommendation community-related exposure-Interim guidance public health professional manage people COVID-19 home care isolation pet animals•Information laboratories-Interim guideline collect , handle , test clinical specimen person coronavirus disease 2019 ( COVID-19 ) -Interim laboratory biosafety guideline handle process specimen associate coronavirus disease 2019 ( COVID-19 ) •Communities , school , workplace , events-Interim guidance implement safety practice critical infrastructure worker may exposure person suspect confirm COVID-19-Cleaning disinfect facility-Resources support people experience homelessness-Interim guidance management coronavirus disease 2019 ( COVID-19 ) correctional detention facilities•Travel●Centers Medicare Medicaid Services ( CMS ) : Coronavirus – Clinical technical guidance●National Institutes Health ( NIH ) : Coronavirus disease 2019 ( COVID-19 ) treatment guidelines•Overview spectrum COVID-19•Care critically ill patient COVID-19•Potential antiviral drug evaluation treatment COVID-19•Immune-based therapy evaluation treatment COVID-19•Antithrombotic therapy patient COVID-19•Considerations certain concomitant medication patient COVID-19●US Food Drug Administration ( FDA ) : Coronavirus disease 2019 ( COVID-19 ) Europe●European Centre Disease Prevention Control ( ECDC ) : COVID-19•Risk assessment COVID-19•Preparedness COVID-19-Infection prevention control COVID-19 healthcare settings-Guidance health system contingency plan widespread transmission SARS-CoV-2 high impact healthcare services-Guidance discharge end isolation context widespread community transmission COVID-19-Guidelines use non-pharmaceutical measure delay mitigate impact 2019-nCoV-Personal protective equipment ( PPE ) need healthcare set care patient suspect confirm novel coronavirus ( 2019-nCoV ) •EU level surveillance COVID19-Case definition European surveillance COVID-19•Laboratory support COVID-19 EU/EEA-Contact trace – Public health management person , include healthcare worker , contact COVID-19 case European Union-Guidance wear remove personal protective equipment healthcare set care patient suspect confirm COVID-19-Disinfection environment healthcare non-healthcare set potentially contaminate SARS-CoV-2-Using face mask community – Reducing COVID-19 transmission potentially asymptomatic pre-symptomatic people use face mask ●World Health Organization ( WHO ) Europe : Interim guidance preparedness , prevention control COVID-19 prison place detentionUnited Kingdom●National Health Service ( NHS ) England : Coronavirus guidance clinician NHS managers•About coronavirus ( COVID-19 ) •Prevention•Infection control•Assessment•Management – Confirmed coronavirus ( COVID-19 ) •Discharge•Isolation●National Institute Health Care Excellence ( NICE ) : Coronavirus ( COVID-19 ) •COVID-19 rapid guideline – Antibiotics pneumonia adult hospital•COVID-19 rapid guideline – Managing suspect confirm pneumonia adult community•COVID-19 rapid guideline – Managing symptom ( include end life ) community●Public Health England ( PHE ) : COVID-19 – Guidance health professionals•Guidance COVID-19 – Investigation initial clinical management possible cases•Guidance COVID-19 – Management expose healthcare worker patient hospital settings•Guidance COVID-19 – Guidance stepdown infection control precaution within hospital discharge COVID-19 patient hospital home settings•Guidance COVID-19 – Infection prevention control ( IPC ) •Guidance COVID-19 – Personal protective equipment use aerosol generate procedures•Guidance COVID-19 – Personal protective equipment use non-aerosol generate procedures•Guidance COVID-19 – Guidance sample diagnostic laboratories•Guidance COVID-19 – Rapid test use community pharmacy home•Guidance travel advice – Coronavirus ( COVID-19 ) India●Advisory Committee Vaccines Immunization Practices ( ACVIP ) : Guidelines immunization COVID-19 pandemic●Government India Ministry Health Family Welfare ( MOHFW ) : Resources – Hospitals●Indian Council Medical Research ( ICMR ) : COVID-19 – Technical document advisoryAustralia●Australian Government Department Health ( DOH ) : Coronavirus ( COVID-19 ) resource health professional , include age care provider , pathology provider healthcare managers•Guidance use personal protective equipment ( PPE ) hospital COVID-19 outbreak •CDNA guidance symptom monitor health age care worker COVID-19 outbreak •PHLN guidance laboratory test SARS-CoV-2 ( virus cause COVID-19 ) •PHLN guidance microbiological laboratory infection control measure SARS-CoV-2 ( virus cause COVID-19 ) •PHLN recommendation non-PHLN laboratory undertake test SARS-CoV-2 ( virus cause COVID-19 ) ●New South Wales Department Health ( NSW Health ) : COVID-19 – Health professionals•COVID-19 – Updated advice health professionals•COVID-19 – Advice healthcare worker , staff , student volunteers•COVID-19 ( coronavirus ) – Guidance community-based outpatient health services•COVID-19 – Interim guidance elective surgery outpatient clinics•COVID-19 – Updated advice testing•Novel coronavirus 2019 ( COVID-19 ) – Control guideline public health units•Clinical guidance resources•Personal protective equipment ( PPE ) •COVID-19 test prioritisationJapan● [ In Japanese ] National Institute Infectious Diseases ( NIID ) : Novel coronavirus ( nCoV ) •Infection control new coronavirus infectious diseases•New coronavirus infection , health infection control home treatment•2019-nCoV ( new coronavirus ) infection sample suspect patient transportation manual•About discharge standard new coronavirus infectious disease']","['', 'topic', 'include', 'link', 'select', 'international', 'government-sponsored', 'guideline', 'several', 'country', 'region', 'around', 'world', '', 'update', 'link', 'periodically', '', 'newer', 'version', 'guideline', 'available', 'organization', 'websitemore', 'detail', 'guidance', 'specialty', 'care', '', 'include', 'link', 'individual', 'society', 'guideline', 'resource', 'patient', '', 'present', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'recommendation', 'follow', 'guideline', 'vary', 'appear', 'uptodate', 'topic', 'review', '', 'readers', 'look', 'uptodate', 'topic', 'review', 'uptodate', 'search', 'box', 'find', 'relevant', 'contentinternationalworld', 'health', 'organization', '', '', '', 'country', 'technical', 'guidance', '', 'coronavirus', 'disease', '', 'covid-19', '', 'coronavirus', 'disease', '', 'covid-19', '', 'travel', 'advicecoronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'unity', 'studies', '', 'early', 'investigation', 'protocols-protocol', 'assessment', 'potential', 'risk', 'factor', '2019-novel', 'coronavirus', '', '2019-ncov', '', 'infection', 'among', 'health', 'care', 'worker', 'health', 'care', 'settingcoronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'risk', 'communication', 'community', 'engagement-community-based', 'health', 'care', '', 'include', 'outreach', 'campaign', '', 'context', 'covid-19', 'pandemiccoronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'surveillance', 'case', 'definitions-interim', 'guidance', 'global', 'surveillance', '', 'case', 'definition', '', 'human', 'infection', 'coronavirus', 'disease', '', 'covid-19', '', 'coronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'patient', 'management-interim', 'guidance', 'clinical', 'management', 'severe', 'acute', 'respiratory', 'infection', 'covid-19', 'suspected-clinical', 'care', 'severe', 'acute', 'respiratory', 'infection', '', 'tool', 'kit-technical', 'documentation', 'consideration', 'quarantine', 'individual', 'context', 'containment', 'coronavirus', 'disease', '', 'covid-19', '', '-interim', 'guidance', 'home', 'care', 'patient', 'covid-19', 'present', 'mild', 'symptom', 'management', 'contactscoronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'essential', 'resource', 'planningcoronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'laboratory', 'test', '2019-ncov', 'humans-interim', 'guidance', 'laboratory', 'test', '2019', 'novel', 'coronavirus', '', '2019-ncov', '', 'suspect', 'human', 'cases-laboratory', 'biosafety', 'guidance', 'relate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'coronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'infection', 'prevention', 'control', '', 'wash-interim', 'guidance', 'infection', 'prevention', 'control', 'health', 'care', 'novel', 'coronavirus', '', 'ncov', '', 'infection', 'suspected-interim', 'guidance', 'risk', 'assessment', 'management', 'exposure', 'health', 'care', 'worker', 'context', 'covid-19-interim', 'guidance', 'rational', 'personal', 'protective', 'equipment', 'coronavirus', 'disease', '', 'covid-19', '', 'consideration', 'severe', 'shortages-advice', 'mask', 'context', 'covid-19coronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'points', 'entry', 'mass', 'gatheringsguidance', 'health', 'workerscoronavirus', 'disease', '', 'covid-19', '', 'technical', 'guidance', '', 'maintaining', 'essential', 'health', 'service', 'systemscanadapublic', 'health', 'agency', 'canada', '', 'phac', '', '', 'coronavirus', 'infection', '', 'health', 'professionalsinterim', 'guidance', 'continuity', 'immunization', 'program', 'covid-19', 'pandemicinfection', 'prevention', 'control', 'covid-19', '', 'interim', 'guidance', 'home', 'care', 'settingscovid-19', 'technical', 'brief', '', 'masking', 'face', 'shield', 'full', 'duration', 'shift', 'acute', 'healthcare', 'settingsinfection', 'prevention', 'control', 'coronavirus', 'disease', '', 'covid-19', '', '', 'second', 'interim', 'guidance', 'acute', 'healthcare', 'settingscovid-19', 'pandemic', 'guidance', 'health', 'care', 'sectorclinical', 'management', 'patient', 'moderate', 'severe', 'covid-19', '', 'interim', 'guidanceroutine', 'practice', 'additional', 'precaution', 'prevent', 'transmission', 'infection', 'healthcare', 'settingsinterim', 'national', 'case', 'definition', '', 'coronavirus', 'disease', '', 'covid-19', '', 'interim', 'national', 'surveillance', 'guideline', 'human', 'infection', 'coronavirus', 'disease', '', 'covid-19', '', 'public', 'health', 'management', 'case', 'contact', 'associate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'coronavirus', 'disease', '', 'covid-19', '', '', 'summary', 'assumptionssars-cov-2', '', 'severe', 'acute', 'respiratory', 'syndrome-related', 'coronavirus', '2', '', '', 'biosafety', 'advisoryunited', 'statescenters', 'disease', 'control', 'prevention', '', 'cdc', '', '', 'coronavirus', '', 'covid-19', '', 'information', 'healthcare', 'professionals-evaluating', 'test', 'person', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '-interim', 'clinical', 'guidance', 'management', 'patient', 'confirm', 'coronavirus', 'disease', '', 'covid-19', '', '-information', 'clinician', 'investigational', 'therapeutic', 'patient', 'covid-19-discontinuation', 'isolation', 'person', 'covid-19', 'healthcare', 'set', '', 'interim', 'guidance', '', '-interim', 'guidance', 'implement', 'home', 'care', 'people', 'require', 'hospitalization', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '-discontinuation', 'transmission-based', 'precaution', 'disposition', 'patient', 'covid-19', 'healthcare', 'set', '', 'interim', 'guidance', '', '-interim', 'infection', 'prevention', 'control', 'recommendation', 'patient', 'suspect', 'confirm', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'healthcare', 'settings-using', 'personal', 'protective', 'equipment', '', 'ppe', '', '-hand', 'hygiene', 'recommendation', '', 'guidance', 'healthcare', 'provider', 'hand', 'hygiene', 'covid-19-outpatient', 'ambulatory', 'care', 'set', '', 'responding', 'community', 'transmission', 'covid-19', 'united', 'states-preparing', 'covid-19', '', 'long-term', 'care', 'facility', '', 'nurse', 'homes-strategies', 'optimize', 'supply', 'ppe', 'equipment-interim', 'us', 'guidance', 'risk', 'assessment', 'public', 'health', 'management', 'healthcare', 'personnel', 'potential', 'exposure', 'healthcare', 'set', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '-return', 'work', 'healthcare', 'personnel', 'confirm', 'suspect', 'covid-19-preparedness', 'tool', 'healthcare', 'professional', 'facility', 'respond', 'coronavirus', '', 'covid-19', '', '-healthcare', 'facility', '', 'preparing', 'community', 'transmission-prepare', 'practice', 'covid-19health', 'departments-contact', 'tracing-public', 'health', 'guidance', 'potential', 'covid-19', 'exposure', 'associate', 'international', 'travel', 'cruise', 'travel-public', 'health', 'recommendation', 'community-related', 'exposure-interim', 'guidance', 'public', 'health', 'professional', 'manage', 'people', 'covid-19', 'home', 'care', 'isolation', 'pet', 'animalsinformation', 'laboratories-interim', 'guideline', 'collect', '', 'handle', '', 'test', 'clinical', 'specimen', 'person', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '-interim', 'laboratory', 'biosafety', 'guideline', 'handle', 'process', 'specimen', 'associate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'communities', '', 'school', '', 'workplace', '', 'events-interim', 'guidance', 'implement', 'safety', 'practice', 'critical', 'infrastructure', 'worker', 'exposure', 'person', 'suspect', 'confirm', 'covid-19-cleaning', 'disinfect', 'facility-resources', 'support', 'people', 'experience', 'homelessness-interim', 'guidance', 'management', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'correctional', 'detention', 'facilitiestravelcenters', 'medicare', 'medicaid', 'services', '', 'cms', '', '', 'coronavirus', '', 'clinical', 'technical', 'guidancenational', 'institutes', 'health', '', 'nih', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'treatment', 'guidelinesoverview', 'spectrum', 'covid-19care', 'critically', 'ill', 'patient', 'covid-19potential', 'antiviral', 'drug', 'evaluation', 'treatment', 'covid-19immune-based', 'therapy', 'evaluation', 'treatment', 'covid-19antithrombotic', 'therapy', 'patient', 'covid-19considerations', 'certain', 'concomitant', 'medication', 'patient', 'covid-19us', 'food', 'drug', 'administration', '', 'fda', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'europeeuropean', 'centre', 'disease', 'prevention', 'control', '', 'ecdc', '', '', 'covid-19risk', 'assessment', 'covid-19preparedness', 'covid-19-infection', 'prevention', 'control', 'covid-19', 'healthcare', 'settings-guidance', 'health', 'system', 'contingency', 'plan', 'widespread', 'transmission', 'sars-cov-2', 'high', 'impact', 'healthcare', 'services-guidance', 'discharge', 'end', 'isolation', 'context', 'widespread', 'community', 'transmission', 'covid-19-guidelines', 'non-pharmaceutical', 'measure', 'delay', 'mitigate', 'impact', '2019-ncov-personal', 'protective', 'equipment', '', 'ppe', '', 'healthcare', 'set', 'care', 'patient', 'suspect', 'confirm', 'novel', 'coronavirus', '', '2019-ncov', '', 'eu', 'level', 'surveillance', 'covid19-case', 'definition', 'european', 'surveillance', 'covid-19laboratory', 'support', 'covid-19', 'eueea-contact', 'trace', '', 'public', 'health', 'management', 'person', '', 'include', 'healthcare', 'worker', '', 'contact', 'covid-19', 'case', 'european', 'union-guidance', 'wear', 'remove', 'personal', 'protective', 'equipment', 'healthcare', 'set', 'care', 'patient', 'suspect', 'confirm', 'covid-19-disinfection', 'environment', 'healthcare', 'non-healthcare', 'set', 'potentially', 'contaminate', 'sars-cov-2-using', 'face', 'mask', 'community', '', 'reducing', 'covid-19', 'transmission', 'potentially', 'asymptomatic', 'pre-symptomatic', 'people', 'face', 'mask', 'world', 'health', 'organization', '', '', 'europe', '', 'interim', 'guidance', 'preparedness', '', 'prevention', 'control', 'covid-19', 'prison', 'place', 'detentionunited', 'kingdomnational', 'health', 'service', '', 'nhs', '', 'england', '', 'coronavirus', 'guidance', 'clinician', 'nhs', 'managersabout', 'coronavirus', '', 'covid-19', '', 'preventioninfection', 'controlassessmentmanagement', '', 'confirmed', 'coronavirus', '', 'covid-19', '', 'dischargeisolationnational', 'institute', 'health', 'care', 'excellence', '', '', '', 'coronavirus', '', 'covid-19', '', 'covid-19', 'rapid', 'guideline', '', 'antibiotics', 'pneumonia', 'adult', 'hospitalcovid-19', 'rapid', 'guideline', '', 'managing', 'suspect', 'confirm', 'pneumonia', 'adult', 'communitycovid-19', 'rapid', 'guideline', '', 'managing', 'symptom', '', 'include', 'end', 'life', '', 'communitypublic', 'health', 'england', '', 'phe', '', '', 'covid-19', '', 'guidance', 'health', 'professionalsguidance', 'covid-19', '', 'investigation', 'initial', 'clinical', 'management', 'possible', 'casesguidance', 'covid-19', '', 'management', 'expose', 'healthcare', 'worker', 'patient', 'hospital', 'settingsguidance', 'covid-19', '', 'guidance', 'stepdown', 'infection', 'control', 'precaution', 'within', 'hospital', 'discharge', 'covid-19', 'patient', 'hospital', 'home', 'settingsguidance', 'covid-19', '', 'infection', 'prevention', 'control', '', 'ipc', '', 'guidance', 'covid-19', '', 'personal', 'protective', 'equipment', 'aerosol', 'generate', 'proceduresguidance', 'covid-19', '', 'personal', 'protective', 'equipment', 'non-aerosol', 'generate', 'proceduresguidance', 'covid-19', '', 'guidance', 'sample', 'diagnostic', 'laboratoriesguidance', 'covid-19', '', 'rapid', 'test', 'community', 'pharmacy', 'homeguidance', 'travel', 'advice', '', 'coronavirus', '', 'covid-19', '', 'indiaadvisory', 'committee', 'vaccines', 'immunization', 'practices', '', 'acvip', '', '', 'guidelines', 'immunization', 'covid-19', 'pandemicgovernment', 'india', 'ministry', 'health', 'family', 'welfare', '', 'mohfw', '', '', 'resources', '', 'hospitalsindian', 'council', 'medical', 'research', '', 'icmr', '', '', 'covid-19', '', 'technical', 'document', 'advisoryaustraliaaustralian', 'government', 'department', 'health', '', 'doh', '', '', 'coronavirus', '', 'covid-19', '', 'resource', 'health', 'professional', '', 'include', 'age', 'care', 'provider', '', 'pathology', 'provider', 'healthcare', 'managersguidance', 'personal', 'protective', 'equipment', '', 'ppe', '', 'hospital', 'covid-19', 'outbreak', 'cdna', 'guidance', 'symptom', 'monitor', 'health', 'age', 'care', 'worker', 'covid-19', 'outbreak', 'phln', 'guidance', 'laboratory', 'test', 'sars-cov-2', '', 'virus', 'cause', 'covid-19', '', 'phln', 'guidance', 'microbiological', 'laboratory', 'infection', 'control', 'measure', 'sars-cov-2', '', 'virus', 'cause', 'covid-19', '', 'phln', 'recommendation', 'non-phln', 'laboratory', 'undertake', 'test', 'sars-cov-2', '', 'virus', 'cause', 'covid-19', '', 'new', 'south', 'wales', 'department', 'health', '', 'nsw', 'health', '', '', 'covid-19', '', 'health', 'professionalscovid-19', '', 'updated', 'advice', 'health', 'professionalscovid-19', '', 'advice', 'healthcare', 'worker', '', 'staff', '', 'student', 'volunteerscovid-19', '', 'coronavirus', '', '', 'guidance', 'community-based', 'outpatient', 'health', 'servicescovid-19', '', 'interim', 'guidance', 'elective', 'surgery', 'outpatient', 'clinicscovid-19', '', 'updated', 'advice', 'testingnovel', 'coronavirus', '2019', '', 'covid-19', '', '', 'control', 'guideline', 'public', 'health', 'unitsclinical', 'guidance', 'resourcespersonal', 'protective', 'equipment', '', 'ppe', '', 'covid-19', 'test', 'prioritisationjapan', '', 'japanese', '', 'national', 'institute', 'infectious', 'diseases', '', 'niid', '', '', 'novel', 'coronavirus', '', 'ncov', '', 'infection', 'control', 'new', 'coronavirus', 'infectious', 'diseasesnew', 'coronavirus', 'infection', '', 'health', 'infection', 'control', 'home', 'treatment2019-ncov', '', 'new', 'coronavirus', '', 'infection', 'sample', 'suspect', 'patient', 'transportation', 'manualabout', 'discharge', 'standard', 'new', 'coronavirus', 'infectious', 'disease']",1330,"{'': 258, 'covid-19': 77, 'coronavirus': 47, 'guidance': 45, 'disease': 35, 'health': 35, 'healthcare': 21, 'care': 20, 'patient': 18, 'infection': 18, '2019': 15, 'control': 15, 'guideline': 13, 'technical': 13, 'management': 11, 'prevention': 10, 'test': 8, 'suspect': 8, 'protective': 8, 'equipment': 8}","{'infection': 18, 'sars-cov-2': 4, 'safety': 1}",23,0.7506
ID:127828,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'psychiatric', 'symptom', 'disorder']","['INTRODUCTION — Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) highly transmissible disease cause , coronavirus disease 2019 ( COVID-19 ) , often lethal reach pandemic scale worldwide 2020 [ 1 ] .', 'The disease associate multiple psychiatric problem clinician care patient COVID-19 suspect illness [ 2,3 ] .', 'In addition , COVID-19 may precipitate anxiety , depression , sleep problem patient COVID-19 may adversely affect patient establish psychiatric disorder .', 'This topic address epidemiology , clinical feature , course illness , management psychiatric issue associate COVID-19 pandemic .', 'Other topic discus COVID-19 per se relate issue arise different specialty , cardiology , obstetrics gynecology , oncology.EPIDEMIOLOGY — A limit number study describe prevalence mental health sequela associate coronavirus disease 2019 ( COVID-19 ) .', 'Health care worker — Psychiatric symptom disorder occur clinician expose COVID-19 [ 3 ] .', 'As example , one cross-sectional study use self-report instrument ass hospital-based physician nurse ( total n > 1200 ) China January 29 February 3 , 2020 [ 2 ] .', 'The prevalence moderate severe psychiatric symptom follow : ●Anxiety – 12 percent●Depression – 15 percent●Insomnia – 8 percent●Traumatic distress – 35 percentIn addition , roughly one-quarter one-third clinician mild symptom .', 'Another cross-sectional study assess nearly 300 hospital-based physician nurse care patient COVID-19 Singapore February 19 March 13 , 2020 , use self-report screen instrument [ 4 ] .', 'Relatively clinician screen positive anxiety , depression , posttraumatic stress disorder ( PTSD ; approximately 5 10 percent ) , author attribute better preparedness clinician base upon previous experience 2003 severe acute respiratory system ( SARS ) epidemic.Risk factor protective factor — A review 59 study viral outbreak SARS epidemic COVID-19 pandemic identify multiple risk factor protective factor psychiatric problem health care worker [ 5 ] : ●Risk factor – The consistent risk factor across study increase contact affect patient .', 'Other consistent predictor prior history psychiatric symptoms/disorders and/or general medical illness , spend prolong time quarantine , perceive lack organizational support , perceive social stigma direct towards health care worker .', '●Protective factor – Across study , factor consistently decrease risk adverse psychological outcome health care worker access personal protective equipment .', 'Other consistent protective factor include supportive peer , access psychiatric intervention , trust institution ’ infection control measure , well receive clear communication supervisor adequate time work .', 'Patients COVID-19 — Few data available regard psychiatric problem patient COVID-19 .', 'However , base upon study conduct 2003 severe acute respiratory system ( SARS ) epidemic Hong Kong , anticipate many patient COVID-19 develop anxiety disorder , depressive disorder , PTSD , substance use disorder [ 6,7 ] .', 'As example , peak 2003 epidemic , prospective study enrol 79 patient SARS , include 30 infect health care worker ( primarily nurse ) , 145 healthy control [ 8 ] .', 'Self-reported stress greater among infect patient control , negative psychological effect dysphoria , impair sleep , poor concentration , impair judgment .', 'However , patient control also report positive psychological effect awareness hygiene , physical state , current affair .', 'In addition , COVID-19 appear affect central nervous system function , may indicate neuropsychiatric symptom likely occur patient .', ""( See 'Pathogenesis ' . )"", 'Patients pre-existing psychiatric illness — It appear psychological effect COVID-19 adversely affect many patient pre-existing mental disorder ( ie , onset disorder occur prior pandemic ) .', 'As example , approximately 20 25 percent think cop poorly deteriorate : ●A self-report , online survey outpatient pre-existing psychiatric disorder ( n > 1400 ) , conduct China February March 2020 , find deterioration relate pandemic report 21 percent [ 9 ] .', 'Mental health problem include anxiety , depression , insomnia , attribute fear infection , restriction transportation , isolate home.●In self-report , online survey individual self-identified mental illness anxiety disorder , unipolar major depression , bipolar disorder ( total n = 193 ) , approximately twice many cop poorly compare cop well ( 23 12 percent ) [ 10 ] .', 'The majority specific concern pandemic mental health , worsen illness ( 64 percent ) , inability receive treatment ( 39 percent ) , run medication ( 38 percent ) .', 'Patients serious mental illness schizophrenia individual homeless especially likely suffer pandemic , risk COVID-19 base upon social circumstance , also likely suffer chronic illness put risk poorer health outcome infect [ 11,12 ] .', 'In addition , cognitive difficulty marginalize social status may impair ability follow public health prescription intend minimize spread infection.General population — The COVID-19 pandemic may associate symptom anxiety , depression , distress , PTSD general population adult child , describe study immediately .', 'However , clear prevalence adverse psychiatric symptom pandemic exceed baseline prevalence : ●A cross-sectional study adult ( n = 1060 ) January February 2020 , use self-report measure , find clinically significant psychological distress present 12 percent [ 13 ] .', 'Distress greater age 50 year older , divorce widow , employ health care workers.●A cross-sectional , self-report internet survey adult ( n = 285 ) February 2020 find clinically significant symptom PTSD ( intrusion symptom , avoidance , negative alteration mood cognition , plus hyperarousal ) present 7 percent [ 14 ] .', 'Women individual sleep problem report symptom PTSD.●Chinese student grade 2 6 , quarantine home average 34 day , complete cross-sectional , online , self-report survey February March 2020 [ 15 ] .', 'Anxiety symptom depressive symptom report roughly 20 percent almost two-thirds worry become infect .', 'Older individual ( eg , ≥70 year ) , immunocompromised patient , patient chronic disease may also experience increase anxiety , depression , worry [ 16,17 ] .', 'PATHOGENESIS — The pathogenesis psychiatric symptom disorder arise coronavirus disease 2019 ( COVID-19 ) pandemic may include biologic psychosocial factors.COVID-19 may directly affect central nervous system function : ●A retrospective chart review hospitalize patient COVID-19 ( n = 214 ) find central nervous system manifestation ( eg , dizziness , headache , impair consciousness ) occur 25 percent [ 18 ] .', '●A retrospective study patient hospitalize acute respiratory distress syndrome due COVID-19 ( n = 58 ) find multiple neurologic psychiatric feature , agitation ( 69 percent ) , confusion ( 65 percent ) , corticospinal tract sign ( 67 percent ) [ 19 ] .', 'At time discharge , one-third patient impair neuropsychologic function , include inattention , disorientation , poorly organize movement command .', 'However , analysis cerebrospinal fluid seven patient negative virus , suggest neurologic find may result encephalopathy secondary critical illness , cytokine , medication , rather direct effect viral infection .', 'These find consistent literature review find past viral epidemic associate neuropsychiatric symptom demyelination , encephalopathy , neuromuscular dysfunction , well mood change psychosis [ 20 ] .', 'The symptom occur infection follow recovery infection ensue week , month , longer .', 'Immunologic find patient COVID-19 include elevate serum C-reactive protein pro-inflammatory cytokine ( eg , interleukin-6 ) decrease total blood lymphocyte count [ 20 ] .Critical illness resultant intensive care unit stay commonly expose patient extreme physiological psychological stressor life-threatening frequently precipitate posttraumatic stress disorder ( PTSD ) .', 'The estimate rate PTSD set vary widely , least-biased study estimate suggest rate 25 45 percent [ 21 ] .In addition , psychiatric illness occur pandemic may stem psychosocial factor [ 3,6,16,22,23 ] : ●Frequency extent exposure individual infect virus●Fear infect family members●Lack access test medical care COVID-19●Physical distance , home confinement , quarantining●Inconsistent message directive regard public health measure wear face masks●Increased workloads●Economic hardship insecurity●Shortages available resource ( eg , food , paper product , personal protective equipment ) ●Diminished personal freedoms●Continuous medium report pandemic uncertainty surround eventual outcomeAmong outpatient pre-existing psychiatric illness ( ie , onset prior pandemic ) , deterioration may occur routine visit clinician available [ 9 ] .', 'Consequently , patient unable obtain refill may force reduce dose medication stop altogether , patient may opportunity adjust dose switch medication ineffective cause adverse effects.CLINICAL FEATURES — The coronavirus disease 2019 ( COVID-19 ) pandemic may give rise psychiatric symptom disorder .', 'Overview — The COVID-19 pandemic may associate psychiatric symptom necessarily rise level psychiatric disorder , base upon study previous epidemic .', 'As example , review 24 study examine psychological impact quarantine 10 country infectious disease outbreak 2003 severe acute respiratory system epidemic 2014 Ebola outbreak [ 23 ] .', 'Adverse psychological outcome include anger , anxiety , boredom , confusion , fear , depression , emotional exhaustion , frustration , irritability , stress .', ""Other adverse outcome include avoidance behavior ( eg , avoid crowd public place ) , detachment others , subthreshold symptom alcohol use disorder posttraumatic stress disorder , excessive preoccupation distress somatic symptom , stigma , well domestic violence suicidal ideation behavior [ 16,23 ] .The COVID-19 pandemic may also lead full-blown anxiety disorder , depressive disorder , insomnia disorder , posttraumatic stress disorder ; disorder discuss separately : ● ( See `` Generalized anxiety disorder adult : Epidemiology , pathogenesis , clinical manifestation , course , assessment , diagnosis '' , section 'Clinical manifestation ' ."", "") ● ( See `` Panic disorder adult : Epidemiology , pathogenesis , clinical manifestation , course , assessment , diagnosis '' , section 'Clinical manifestation ' ."", "") ● ( See `` Unipolar depression adult : Clinical feature '' ."", "") ● ( See `` Evaluation diagnosis insomnia adult '' , section 'Clinical feature ' ."", "") ● ( See `` Posttraumatic stress disorder adult : Epidemiology , pathophysiology , clinical manifestation , course , assessment , diagnosis '' , section 'Clinical manifestation ' ."", ') In addition , COVID-19 pandemic may increase risk suicidal ideation behavior , base upon study find previous viral epidemic associate increase rate suicide death [ 24 ] , include suicide report adverse effect quarantine [ 25 ] .', 'Suicidality relate COVID-19 may due hardship impose pandemic , include economic privation , social isolation , reduce access general medical mental health care , stigma COVID-19 [ 9,16,22,24 ] .', 'Health care worker — Studies emerge viral outbreak suggest psychiatric symptom disorder likely occur health care worker relatively high risk exposure , compare worker low risk exposure .', 'As example , meta-analysis identify 25 study ( sample size report ) viral epidemic examine psychiatric problem health care worker direct contact affect patient health care worker little contact ( control ) [ 5 ] .', 'The analysis include 16 study 2003 severe acute respiratory system epidemic 5 COVID-19 pandemic .', 'The primary find include follow : ●Clinically significant psychological stress likely occur health care worker expose virus control ( odds ratio 1.7 , 95 % CI 1.5-2.0 ) .●Clinically significant acute and/or posttraumatic distress likely occur worker expose virus control ( odds ratio 1.7 , 95 % CI 1.3-2.3 ) .COURSE OF ILLNESS — Psychiatric problem relate coronavirus disease 2019 pandemic may persist least three year beyond pandemic , base upon retrospective study 2003 severe acute respiratory system ( SARS ) epidemic .', 'In study , individual expose survive SARS infection assess 2.5 3 year epidemic ; moderate severe symptom anxiety disorder , depressive disorder , posttraumatic stress disorder ( PTSD ) still present roughly 20 30 percent .', 'The risk persistent psychiatric symptom disorder higher health care worker individual quarantine : ●One year SARS epidemic , study enrol 96 individual survive SARS infection ( include 33 health care worker ) 112 healthy control [ 26 ] .', 'Self-reported stress greater among SARS survivor control , greater among health care worker SARS survivor non-health care worker survivor .', 'In addition , moderate severe symptom anxiety , depression , PTSD present approximately 33 percent survivor ; anxiety , depression , PTSD symptom greater female male , greater health care worker SARS survivor non-health care worker survivors.●In study hospital employee ( n = 549 ) expose SARS epidemic Beijing , self-report assessment three year later indicate moderate severe depressive symptom present 23 percent [ 27 ] .', 'Perceived risk relate SARS epidemic quarantine epidemic associate higher level depression follow-up.In addition , assessment three year later find among 549 health care worker , least one symptom alcohol use disorder present approximately 19 percent [ 28 ] .', 'Working high risk location ( eg , SARS ward ) epidemic quarantine epidemic associate symptom alcohol use disorder .', '●A study interview 90 survivor SARS infection approximately 2.5 year hospitalization illness ; history psychiatric disorder prior infection present 7 percent [ 29 ] .', 'At 2.5 year post-SARS , least one psychiatric disorder present 33 percent survivor , include PTSD 26 percent depressive disorder 16 percent .', 'In addition , social role function impair survivor .', ""ASSESSMENT AND DIAGNOSIS — Assessment diagnosis anxiety disorder , depressive disorder , insomnia disorder , posttraumatic stress disorder discuss separately : ● ( See `` Generalized anxiety disorder adult : Epidemiology , pathogenesis , clinical manifestation , course , assessment , diagnosis '' ."", "") ● ( See `` Panic disorder adult : Epidemiology , pathogenesis , clinical manifestation , course , assessment , diagnosis '' ."", "") ● ( See `` Unipolar depression adult : Assessment diagnosis '' ."", "") ● ( See `` Evaluation diagnosis insomnia adult '' ."", "") ● ( See `` Posttraumatic stress disorder adult : Epidemiology , pathophysiology , clinical manifestation , course , assessment , diagnosis '' ."", ') Individuals moderate severe distress , anxiety , depression screen suicidal think behavior ; one use screen tool directly ask .', ""( See `` Suicidal ideation behavior adult '' , section 'Screening ' ."", ') MANAGEMENT — Psychiatric issue relate coronavirus disease 2019 ( COVID-19 ) pandemic occur multiple population , include clinician treat patient COVID-19 suspect illness , patient COVID-19 , patient establish psychiatric disorder prior COVID-19 .', 'In addition , family member clinician patient may develop psychiatric symptom disorder .', 'General approach — For individual experience symptom anxiety , depression , insomnia , posttraumatic stress disorder ( PTSD ) COVID-19 pandemic , step care may efficacious cost-effective approach treatment [ 30 ] .', 'According approach , monitor mental health problem paramount .', 'Surveillance domestic violence child abuse , predict increase mandate stay-at-home order , also critical [ 30 ] .', 'Individuals low level symptom provide self-help material pertinent symptom concern eligible speak mental health professional additional persistent concern [ 9 ] .', 'Other intervention may help individual cope mild psychiatric symptom relate COVID-19 pandemic include limit one ’ intake print broadcast news pandemic , well maintain routine structure activity exercise , stay connect family friend via phone computer [ 16 ] .', 'Health care worker particular likely benefit private , on-demand access mental health professional address source anxiety , distress , emotion relate care patient [ 5,31,32 ] .', 'Individuals moderate severe symptom treat primary care provider refer mental health specialist.If feasible , psychiatric care administer computer telephone rather face-to-face [ 9,11,33 ] .', 'Patient contact voice voice plus video may superior text message email [ 6 ] .', 'Evidence support use remote care include small study outpatient psychiatrist ( n = 20 ) United States transition telemedicine video visit and/or phone visit March 2020 interview follow month [ 34 ] .', 'The study find transition relatively positive patient clinician .', 'Patient preference usually dictate whether visit conduct video phone .', 'Advantages telepsychiatry include improve access patient , patient feel relax thus forthcoming , opportunity see patient ’ home .', 'Disadvantages include difficulty observe nonverbal patient cue hear patient , technical disruption freeze screen , well patient lack privacy problem distraction .', 'Techniques improve visit include start visit ask whether patient enough privacy ; , suggestion offer use car reschedule visit .', 'For video visit , psychiatrist suggest use place office home provide consistency reassurance patients.In addition , US Food Drug Administration offer guidance April 14 , 2020 regard COVID-19 public health emergency use digital health device pose low risk treat psychiatric disorder generalize anxiety disorder , insomnia disorder , PTSD , unipolar major depression [ 35 ] .', 'The guideline recommend device use adjunctive treatment .', 'Functions device may perform include reminder physical activity , mindfulness activity , behavioral technique patient use experience increase anxiety .', 'When face-to-face visit necessary , personal protective equipment ( eg , mask ) use care ideally administer individual rather group .', 'In-person visit mask may experience le personal leave patient feel le connect clinician , compare voice plus video meetings.Psychiatrists may ask consult patient receive pharmacotherapy COVID-19 therefore familiar medication currently use .', 'As example , hydroxychloroquine , antimalarial drug use hospitalize COVID-19 patient ( undergo clinical trial ) , associate psychiatric side effect mood anxiety disturbance , insomnia , rarely , psychosis .', 'Patients ask prescribe medication supplement may take belief might reduce vulnerability COVID-19 infection .', 'Specific interaction psychiatric medication medication may determine use Lexicomp drug interaction tool ( Lexi-Interact Online ) include UpToDate .', 'Specific medication evaluate COVID-19 describe separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Specific treatment ' ."", ') Physical distance , widely encourage decelerate rate COVID-19 transmission within general public “ flatten curve ” COVID-19 case , result loneliness individual , particularly live alone , include elderly .', 'This likely exacerbate high rate loneliness already experience elderly , especially rely social service rather family human contact connection [ 17 ] .', 'Digital technology may serve bridge social connection encourage [ 6,36 ] .', 'However , many individual may lack access ability take advantage this.One resource provide example one respond patient family member different concern reaction COVID Ready Communication Playbook .', 'This document guide clinician range topic specific COVID-19 , include help patient family member cope dire situation , well clinician manage emotions.Family member COVID-19 patient — In context physical distance , inpatient facility restrict suspend visit family friend [ 37 ] .', 'Family member love one severely ill die respond grief .', 'The treatment team ask family think , feel , behavior relate loss , well provide grief counsel warrant .', ""( See `` Grief bereavement adult : Clinical feature '' `` Grief bereavement adult : Management '' . )"", 'Clinicians , patient COVID-19 , family discus end-of-life issue early course management , especially patient elderly suffer comorbidities .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' , section 'End life issue ' . )"", ""Health care worker — Health care worker directly treat patient COVID-19 risk psychiatric symptom disorder ( see 'Health care worker ' ) ."", 'In treat problem , mental health professional address potential source anxiety distress , include [ 5,24,31,32 ] : ●Access personal protective equipment●High transmissibility severe acute respiratory syndrome coronavirus 2 risk self-exposure infection●Risk expose family member others infection●Access test oneself family members●Enforcement infection control procedure workplace●Access up-to-date , accurate information COVID-19●Unclear communication supervisors●Access childcare school closures●Increased tax workloads●Moral dilemma moral injury arise situation decide allocate insufficient resource , inadvertently place others danger , implement clinical decision others one think contrary best practices●Loss control/vulnerability ●Availability use support colleague managers●Dying patient grief-stricken family membersBased upon study clinician ( n = 466 ) public hospital emergency department Hong Kong 2003 severe acute respiratory system ( SARS ) epidemic [ 38 ] , frequent cop strategy include accept reality stressor , take action circumvent stressor , view situation positive light attempt grow situation.A follow-up study hospital employee expose 2003 SARS epidemic Beijing ( n = 549 ) find higher level altruistic acceptance risk outbreak ( eg , “ I want help patient accept risk ” ) associate lower level self-reported depressive symptom three year later [ 27 ] .', ""Quarantine — A review 24 study examine adverse psychological impact quarantine suggest follow step mitigate negative effect [ 23 ] : ●Explain purpose quarantine implement it.●Voluntary quarantine associate le distress mandatory quarantine.●Emphasize altruistic benefit quarantine keep others safe.●Facilitate acquisition general ( eg , food house ) medical supply ( eg , prescription , thermometer , face mask ) .Suicidality — Interventions manage suicidal ideation behavior ( suicidality ) include follow [ 24 ] : ●Treatments specific suicidality ( see `` Suicidal ideation behavior adult '' , section 'Management ' ) ●Treating underlie psychiatric disorder telehealth in-person , depend upon severity suicidality●Encouraging patient maintain social contact telephone computer , well face-to-face encounter maintain physical distancing●Referring patient social work help access financial safety net ( eg , food , house , unemployment support , loan ) Specific disorder — Pharmacotherapy psychotherapy anxiety disorder , depressive disorder , insomnia disorder , PTSD associate COVID-19 follow recommendation treat general population patient disorder discuss separately : ● ( See `` Approach treat generalize anxiety disorder adult '' ."", "") ● ( See `` Approach treat panic disorder without agoraphobia adult '' ."", "") ● ( See `` Unipolar major depression adult : Choosing initial treatment '' ."", "") ● ( See `` Overview treatment insomnia adult '' ."", "") ● ( See `` Approach treat posttraumatic stress disorder adult '' ."", ') Schizophrenia — Pharmacotherapy psychosocial intervention acute symptom schizophrenia associate COVID-19 follow recommendation treat general population patient schizophrenia discuss separately .', ""( See `` Pharmacotherapy schizophrenia : Acute maintenance phase treatment '' `` Psychosocial intervention schizophrenia '' ."", ') Home visit — For patient schizophrenia acutely ill mild moderate symptom , daily home visit clinician 24-hour coverage may reasonable alternative inpatient hospitalization [ 33,39 ] .', 'This allow patient maintain physical distance home confinement , thus avoid exposure COVID-19 .', 'For patient schizophrenia stable , home visit may suitable promote adherence treatment prevent relapse.Clozapine bloodwork — Patients receive clozapine schizophrenia serious mental illness typically require blood test every one four week monitor absolute neutrophil count .', 'However , patient clinician need decide whether risk COVID-19 outweigh benefit obtain blood work .', ""( See `` Guidelines prescribe clozapine schizophrenia '' , section 'Required bloodwork coronavirus disease 2019 ' ."", "") SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately.●General guidance public health authority ( eg , World Health Organization United States Centers Disease Control Prevention ) – ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' ."", "") ●More detail guidance specialty care , include psychiatry – ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' , section 'Psychiatry ' . )"", ""●Resources psychiatric patient family – ( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' . )"", 'INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , “ The Basics ” “ Beyond Basics. ” The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', '( You also locate patient education article variety subject search “ patient info ” keyword ( ) interest . )', ""●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) Patient education material also available United States National Institute Mental Health United States Centers Disease Control Prevention.SUMMARY●In one study China , clinician treat patient coronavirus disease 2019 ( COVID-19 ) develop moderate severe psychiatric symptom , include : •Anxiety – 12 percent•Depression – 15 percent•Insomnia – 8 percent•Distress – 35 percent ( See 'Health care worker ' ."", ') ●The pathogenesis psychiatric symptom disorder arise COVID-19 pandemic may include biologic psychosocial factor .', ""( See 'Pathogenesis ' ."", ') ●The COVID-19 pandemic may associate psychiatric symptom necessarily rise level psychiatric disorder .', 'In addition , pandemic may lead full-blown psychiatric disorder , include anxiety disorder , depressive disorder , posttraumatic stress disorder ( PTSD ) .', 'During viral epidemic , psychiatric symptom disorder likely occur health care worker relatively high risk exposure , compare worker low risk exposure .', ""( See 'Clinical feature ' . )"", '●Psychiatric problem relate COVID-19 pandemic may persist least three year beyond pandemic .', 'In study prior epidemic assess individual 2.5 3 year epidemic , moderate severe symptom anxiety disorder , depressive disorder , PTSD present roughly 20 30 percent individual .', 'In addition , risk persistent psychiatric symptom disorder higher health care worker individual quarantine .', ""( See 'Course illness ' . )"", '●For individual experience symptom anxiety , depression , insomnia , PTSD , step care may efficacious cost-effective approach ; surveillance mental health problem paramount .', 'Those low level symptom provide self-help material eligible speak mental health professional additional persistent concern .', 'Individuals moderate severe symptom treat primary care provider mental health specialist .', ""( See 'General approach ' ."", ') ●Mental health professional work individual develop psychiatric issue relate COVID-19 address potential source anxiety distress , include access personal protective equipment , risk self-exposure infection , risk expose others infection , increase tax workload , moral dilemma , patient death .', ""( See 'Health care worker ' ."", ') ●The adverse psychological impact quarantine may mitigate take step explain purpose quarantine implement , well emphasize altruistic benefit quarantine keep others safe .', ""( See 'Quarantine ' ."", ') ●The hardship impose COVID-19 pandemic may give rise suicidal ideation behavior .', 'Individuals moderate severe distress , anxiety , depression screen suicidal think behavior .', 'Patients COVID-19 patient establish psychiatric disorder encourage maintain social contact access treatment telehealth in-person .', ""( See 'Suicidality ' . )""]","['', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'highly', 'transmissible', 'disease', 'cause', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'often', 'lethal', 'reach', 'pandemic', 'scale', 'worldwide', '2020', '', '1', '', '', 'disease', 'associate', 'multiple', 'psychiatric', 'problem', 'clinician', 'care', 'patient', 'covid-19', 'suspect', 'illness', '', '23', '', '', 'addition', '', 'covid-19', 'precipitate', 'anxiety', '', 'depression', '', 'sleep', 'problem', 'patient', 'covid-19', 'adversely', 'affect', 'patient', 'establish', 'psychiatric', 'disorder', '', 'topic', 'address', 'epidemiology', '', 'clinical', 'feature', '', 'course', 'illness', '', 'management', 'psychiatric', 'issue', 'associate', 'covid-19', 'pandemic', '', 'topic', 'discus', 'covid-19', 'per', 'se', 'relate', 'issue', 'arise', 'different', 'specialty', '', 'cardiology', '', 'obstetrics', 'gynecology', '', 'oncologyepidemiology', '', 'limit', 'number', 'study', 'describe', 'prevalence', 'mental', 'health', 'sequela', 'associate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'health', 'care', 'worker', '', 'psychiatric', 'symptom', 'disorder', 'occur', 'clinician', 'expose', 'covid-19', '', '3', '', '', 'example', '', 'one', 'cross-sectional', 'study', 'self-report', 'instrument', 'ass', 'hospital-based', 'physician', 'nurse', '', 'total', 'n', '', '1200', '', 'china', 'january', '29', 'february', '3', '', '2020', '', '2', '', '', 'prevalence', 'moderate', 'severe', 'psychiatric', 'symptom', 'follow', '', 'anxiety', '', '12', 'percentdepression', '', '15', 'percentinsomnia', '', '8', 'percenttraumatic', 'distress', '', '35', 'percentin', 'addition', '', 'roughly', 'one-quarter', 'one-third', 'clinician', 'mild', 'symptom', '', 'another', 'cross-sectional', 'study', 'assess', 'nearly', '300', 'hospital-based', 'physician', 'nurse', 'care', 'patient', 'covid-19', 'singapore', 'february', '19', 'march', '13', '', '2020', '', 'self-report', 'screen', 'instrument', '', '4', '', '', 'relatively', 'clinician', 'screen', 'positive', 'anxiety', '', 'depression', '', 'posttraumatic', 'stress', 'disorder', '', 'ptsd', '', 'approximately', '5', '10', 'percent', '', '', 'author', 'attribute', 'better', 'preparedness', 'clinician', 'base', 'upon', 'previous', 'experience', '2003', 'severe', 'acute', 'respiratory', 'system', '', 'sars', '', 'epidemicrisk', 'factor', 'protective', 'factor', '', 'review', '59', 'study', 'viral', 'outbreak', 'sars', 'epidemic', 'covid-19', 'pandemic', 'identify', 'multiple', 'risk', 'factor', 'protective', 'factor', 'psychiatric', 'problem', 'health', 'care', 'worker', '', '5', '', '', 'risk', 'factor', '', 'consistent', 'risk', 'factor', 'across', 'study', 'increase', 'contact', 'affect', 'patient', '', 'consistent', 'predictor', 'prior', 'history', 'psychiatric', 'symptomsdisorders', 'andor', 'general', 'medical', 'illness', '', 'spend', 'prolong', 'time', 'quarantine', '', 'perceive', 'organizational', 'support', '', 'perceive', 'social', 'stigma', 'direct', 'towards', 'health', 'care', 'worker', '', 'protective', 'factor', '', 'across', 'study', '', 'factor', 'consistently', 'decrease', 'risk', 'adverse', 'psychological', 'outcome', 'health', 'care', 'worker', 'access', 'personal', 'protective', 'equipment', '', 'consistent', 'protective', 'factor', 'include', 'supportive', 'peer', '', 'access', 'psychiatric', 'intervention', '', 'trust', 'institution', '', 'infection', 'control', 'measure', '', 'well', 'receive', 'clear', 'communication', 'supervisor', 'adequate', 'time', 'work', '', 'patients', 'covid-19', '', 'data', 'available', 'regard', 'psychiatric', 'problem', 'patient', 'covid-19', '', 'however', '', 'base', 'upon', 'study', 'conduct', '2003', 'severe', 'acute', 'respiratory', 'system', '', 'sars', '', 'epidemic', 'hong', 'kong', '', 'anticipate', 'patient', 'covid-19', 'develop', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'ptsd', '', 'substance', 'disorder', '', '67', '', '', 'example', '', 'peak', '2003', 'epidemic', '', 'prospective', 'study', 'enrol', '79', 'patient', 'sars', '', 'include', '30', 'infect', 'health', 'care', 'worker', '', 'primarily', 'nurse', '', '', '145', 'healthy', 'control', '', '8', '', '', 'self-reported', 'stress', 'greater', 'among', 'infect', 'patient', 'control', '', 'negative', 'psychological', 'effect', 'dysphoria', '', 'impair', 'sleep', '', 'poor', 'concentration', '', 'impair', 'judgment', '', 'however', '', 'patient', 'control', 'report', 'positive', 'psychological', 'effect', 'awareness', 'hygiene', '', 'physical', 'state', '', 'current', 'affair', '', 'addition', '', 'covid-19', 'appear', 'affect', 'central', 'nervous', 'system', 'function', '', 'indicate', 'neuropsychiatric', 'symptom', 'likely', 'occur', 'patient', '', '', 'pathogenesis', '', '', '', 'patients', 'pre-existing', 'psychiatric', 'illness', '', 'appear', 'psychological', 'effect', 'covid-19', 'adversely', 'affect', 'patient', 'pre-existing', 'mental', 'disorder', '', 'ie', '', 'onset', 'disorder', 'occur', 'prior', 'pandemic', '', '', 'example', '', 'approximately', '20', '25', 'percent', 'cop', 'poorly', 'deteriorate', '', 'self-report', '', 'online', 'survey', 'outpatient', 'pre-existing', 'psychiatric', 'disorder', '', 'n', '', '1400', '', '', 'conduct', 'china', 'february', 'march', '2020', '', 'find', 'deterioration', 'relate', 'pandemic', 'report', '21', 'percent', '', '9', '', '', 'mental', 'health', 'problem', 'include', 'anxiety', '', 'depression', '', 'insomnia', '', 'attribute', 'fear', 'infection', '', 'restriction', 'transportation', '', 'isolate', 'homein', 'self-report', '', 'online', 'survey', 'individual', 'self-identified', 'mental', 'illness', 'anxiety', 'disorder', '', 'unipolar', 'major', 'depression', '', 'bipolar', 'disorder', '', 'total', 'n', '', '193', '', '', 'approximately', 'twice', 'cop', 'poorly', 'compare', 'cop', 'well', '', '23', '12', 'percent', '', '', '10', '', '', 'majority', 'specific', 'concern', 'pandemic', 'mental', 'health', '', 'worsen', 'illness', '', '64', 'percent', '', '', 'inability', 'receive', 'treatment', '', '39', 'percent', '', '', 'medication', '', '38', 'percent', '', '', 'patients', 'serious', 'mental', 'illness', 'schizophrenia', 'individual', 'homeless', 'especially', 'likely', 'suffer', 'pandemic', '', 'risk', 'covid-19', 'base', 'upon', 'social', 'circumstance', '', 'likely', 'suffer', 'chronic', 'illness', 'put', 'risk', 'poorer', 'health', 'outcome', 'infect', '', '1112', '', '', 'addition', '', 'cognitive', 'difficulty', 'marginalize', 'social', 'status', 'impair', 'ability', 'follow', 'public', 'health', 'prescription', 'intend', 'minimize', 'spread', 'infectiongeneral', 'population', '', 'covid-19', 'pandemic', 'associate', 'symptom', 'anxiety', '', 'depression', '', 'distress', '', 'ptsd', 'general', 'population', 'adult', 'child', '', 'describe', 'study', 'immediately', '', 'however', '', 'clear', 'prevalence', 'adverse', 'psychiatric', 'symptom', 'pandemic', 'exceed', 'baseline', 'prevalence', '', 'cross-sectional', 'study', 'adult', '', 'n', '', '1060', '', 'january', 'february', '2020', '', 'self-report', 'measure', '', 'find', 'clinically', 'significant', 'psychological', 'distress', 'present', '12', 'percent', '', '13', '', '', 'distress', 'greater', 'age', '50', 'year', 'older', '', 'divorce', 'widow', '', 'employ', 'health', 'care', 'workersa', 'cross-sectional', '', 'self-report', 'internet', 'survey', 'adult', '', 'n', '', '285', '', 'february', '2020', 'find', 'clinically', 'significant', 'symptom', 'ptsd', '', 'intrusion', 'symptom', '', 'avoidance', '', 'negative', 'alteration', 'mood', 'cognition', '', 'plus', 'hyperarousal', '', 'present', '7', 'percent', '', '14', '', '', 'women', 'individual', 'sleep', 'problem', 'report', 'symptom', 'ptsdchinese', 'student', 'grade', '2', '6', '', 'quarantine', 'home', 'average', '34', 'day', '', 'complete', 'cross-sectional', '', 'online', '', 'self-report', 'survey', 'february', 'march', '2020', '', '15', '', '', 'anxiety', 'symptom', 'depressive', 'symptom', 'report', 'roughly', '20', 'percent', 'almost', 'two-thirds', 'worry', 'become', 'infect', '', 'older', 'individual', '', 'eg', '', '70', 'year', '', '', 'immunocompromised', 'patient', '', 'patient', 'chronic', 'disease', 'experience', 'increase', 'anxiety', '', 'depression', '', 'worry', '', '1617', '', '', 'pathogenesis', '', 'pathogenesis', 'psychiatric', 'symptom', 'disorder', 'arise', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'include', 'biologic', 'psychosocial', 'factorscovid-19', 'directly', 'affect', 'central', 'nervous', 'system', 'function', '', 'retrospective', 'chart', 'review', 'hospitalize', 'patient', 'covid-19', '', 'n', '', '214', '', 'find', 'central', 'nervous', 'system', 'manifestation', '', 'eg', '', 'dizziness', '', 'headache', '', 'impair', 'consciousness', '', 'occur', '25', 'percent', '', '18', '', '', 'retrospective', 'study', 'patient', 'hospitalize', 'acute', 'respiratory', 'distress', 'syndrome', 'due', 'covid-19', '', 'n', '', '58', '', 'find', 'multiple', 'neurologic', 'psychiatric', 'feature', '', 'agitation', '', '69', 'percent', '', '', 'confusion', '', '65', 'percent', '', '', 'corticospinal', 'tract', 'sign', '', '67', 'percent', '', '', '19', '', '', 'time', 'discharge', '', 'one-third', 'patient', 'impair', 'neuropsychologic', 'function', '', 'include', 'inattention', '', 'disorientation', '', 'poorly', 'organize', 'movement', 'command', '', 'however', '', 'analysis', 'cerebrospinal', 'fluid', 'seven', 'patient', 'negative', 'virus', '', 'suggest', 'neurologic', 'find', 'result', 'encephalopathy', 'secondary', 'critical', 'illness', '', 'cytokine', '', 'medication', '', 'direct', 'effect', 'viral', 'infection', '', 'find', 'consistent', 'literature', 'review', 'find', 'past', 'viral', 'epidemic', 'associate', 'neuropsychiatric', 'symptom', 'demyelination', '', 'encephalopathy', '', 'neuromuscular', 'dysfunction', '', 'well', 'mood', 'change', 'psychosis', '', '20', '', '', 'symptom', 'occur', 'infection', 'follow', 'recovery', 'infection', 'ensue', 'week', '', 'month', '', 'longer', '', 'immunologic', 'find', 'patient', 'covid-19', 'include', 'elevate', 'serum', 'c-reactive', 'protein', 'pro-inflammatory', 'cytokine', '', 'eg', '', 'interleukin-6', '', 'decrease', 'total', 'blood', 'lymphocyte', 'count', '', '20', '', 'critical', 'illness', 'resultant', 'intensive', 'care', 'unit', 'stay', 'commonly', 'expose', 'patient', 'extreme', 'physiological', 'psychological', 'stressor', 'life-threatening', 'frequently', 'precipitate', 'posttraumatic', 'stress', 'disorder', '', 'ptsd', '', '', 'estimate', 'rate', 'ptsd', 'set', 'vary', 'widely', '', 'least-biased', 'study', 'estimate', 'suggest', 'rate', '25', '45', 'percent', '', '21', '', 'addition', '', 'psychiatric', 'illness', 'occur', 'pandemic', 'stem', 'psychosocial', 'factor', '', '36162223', '', '', 'frequency', 'extent', 'exposure', 'individual', 'infect', 'virusfear', 'infect', 'family', 'memberslack', 'access', 'test', 'medical', 'care', 'covid-19physical', 'distance', '', 'home', 'confinement', '', 'quarantininginconsistent', 'message', 'directive', 'regard', 'public', 'health', 'measure', 'wear', 'face', 'masksincreased', 'workloadseconomic', 'hardship', 'insecurityshortages', 'available', 'resource', '', 'eg', '', 'food', '', 'paper', 'product', '', 'personal', 'protective', 'equipment', '', 'diminished', 'personal', 'freedomscontinuous', 'medium', 'report', 'pandemic', 'uncertainty', 'surround', 'eventual', 'outcomeamong', 'outpatient', 'pre-existing', 'psychiatric', 'illness', '', 'ie', '', 'onset', 'prior', 'pandemic', '', '', 'deterioration', 'occur', 'routine', 'visit', 'clinician', 'available', '', '9', '', '', 'consequently', '', 'patient', 'unable', 'obtain', 'refill', 'force', 'reduce', 'dose', 'medication', 'stop', 'altogether', '', 'patient', 'opportunity', 'adjust', 'dose', 'switch', 'medication', 'ineffective', 'cause', 'adverse', 'effectsclinical', 'features', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'give', 'rise', 'psychiatric', 'symptom', 'disorder', '', 'overview', '', 'covid-19', 'pandemic', 'associate', 'psychiatric', 'symptom', 'necessarily', 'rise', 'level', 'psychiatric', 'disorder', '', 'base', 'upon', 'study', 'previous', 'epidemic', '', 'example', '', 'review', '24', 'study', 'examine', 'psychological', 'impact', 'quarantine', '10', 'country', 'infectious', 'disease', 'outbreak', '2003', 'severe', 'acute', 'respiratory', 'system', 'epidemic', '2014', 'ebola', 'outbreak', '', '23', '', '', 'adverse', 'psychological', 'outcome', 'include', 'anger', '', 'anxiety', '', 'boredom', '', 'confusion', '', 'fear', '', 'depression', '', 'emotional', 'exhaustion', '', 'frustration', '', 'irritability', '', 'stress', '', 'adverse', 'outcome', 'include', 'avoidance', 'behavior', '', 'eg', '', 'avoid', 'crowd', 'public', 'place', '', '', 'detachment', 'others', '', 'subthreshold', 'symptom', 'alcohol', 'disorder', 'posttraumatic', 'stress', 'disorder', '', 'excessive', 'preoccupation', 'distress', 'somatic', 'symptom', '', 'stigma', '', 'well', 'domestic', 'violence', 'suicidal', 'ideation', 'behavior', '', '1623', '', 'covid-19', 'pandemic', 'lead', 'full-blown', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'insomnia', 'disorder', '', 'posttraumatic', 'stress', 'disorder', '', 'disorder', 'discuss', 'separately', '', '', '', '', 'generalized', 'anxiety', 'disorder', 'adult', '', 'epidemiology', '', 'pathogenesis', '', 'clinical', 'manifestation', '', 'course', '', 'assessment', '', 'diagnosis', '', '', 'section', 'clinical', 'manifestation', '', '', '', '', '', '', 'panic', 'disorder', 'adult', '', 'epidemiology', '', 'pathogenesis', '', 'clinical', 'manifestation', '', 'course', '', 'assessment', '', 'diagnosis', '', '', 'section', 'clinical', 'manifestation', '', '', '', '', '', '', 'unipolar', 'depression', 'adult', '', 'clinical', 'feature', '', '', '', '', '', '', 'evaluation', 'diagnosis', 'insomnia', 'adult', '', '', 'section', 'clinical', 'feature', '', '', '', '', '', '', 'posttraumatic', 'stress', 'disorder', 'adult', '', 'epidemiology', '', 'pathophysiology', '', 'clinical', 'manifestation', '', 'course', '', 'assessment', '', 'diagnosis', '', '', 'section', 'clinical', 'manifestation', '', '', '', 'addition', '', 'covid-19', 'pandemic', 'increase', 'risk', 'suicidal', 'ideation', 'behavior', '', 'base', 'upon', 'study', 'find', 'previous', 'viral', 'epidemic', 'associate', 'increase', 'rate', 'suicide', 'death', '', '24', '', '', 'include', 'suicide', 'report', 'adverse', 'effect', 'quarantine', '', '25', '', '', 'suicidality', 'relate', 'covid-19', 'due', 'hardship', 'impose', 'pandemic', '', 'include', 'economic', 'privation', '', 'social', 'isolation', '', 'reduce', 'access', 'general', 'medical', 'mental', 'health', 'care', '', 'stigma', 'covid-19', '', '9162224', '', '', 'health', 'care', 'worker', '', 'studies', 'emerge', 'viral', 'outbreak', 'suggest', 'psychiatric', 'symptom', 'disorder', 'likely', 'occur', 'health', 'care', 'worker', 'relatively', 'high', 'risk', 'exposure', '', 'compare', 'worker', 'low', 'risk', 'exposure', '', 'example', '', 'meta-analysis', 'identify', '25', 'study', '', 'sample', 'size', 'report', '', 'viral', 'epidemic', 'examine', 'psychiatric', 'problem', 'health', 'care', 'worker', 'direct', 'contact', 'affect', 'patient', 'health', 'care', 'worker', 'little', 'contact', '', 'control', '', '', '5', '', '', 'analysis', 'include', '16', 'study', '2003', 'severe', 'acute', 'respiratory', 'system', 'epidemic', '5', 'covid-19', 'pandemic', '', 'primary', 'find', 'include', 'follow', '', 'clinically', 'significant', 'psychological', 'stress', 'likely', 'occur', 'health', 'care', 'worker', 'expose', 'virus', 'control', '', 'odds', 'ratio', '17', '', '95', '', 'ci', '15-20', '', 'clinically', 'significant', 'acute', 'andor', 'posttraumatic', 'distress', 'likely', 'occur', 'worker', 'expose', 'virus', 'control', '', 'odds', 'ratio', '17', '', '95', '', 'ci', '13-23', '', 'course', 'illness', '', 'psychiatric', 'problem', 'relate', 'coronavirus', 'disease', '2019', 'pandemic', 'persist', 'least', 'three', 'year', 'beyond', 'pandemic', '', 'base', 'upon', 'retrospective', 'study', '2003', 'severe', 'acute', 'respiratory', 'system', '', 'sars', '', 'epidemic', '', 'study', '', 'individual', 'expose', 'survive', 'sars', 'infection', 'assess', '25', '3', 'year', 'epidemic', '', 'moderate', 'severe', 'symptom', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'posttraumatic', 'stress', 'disorder', '', 'ptsd', '', 'still', 'present', 'roughly', '20', '30', 'percent', '', 'risk', 'persistent', 'psychiatric', 'symptom', 'disorder', 'higher', 'health', 'care', 'worker', 'individual', 'quarantine', '', 'one', 'year', 'sars', 'epidemic', '', 'study', 'enrol', '96', 'individual', 'survive', 'sars', 'infection', '', 'include', '33', 'health', 'care', 'worker', '', '112', 'healthy', 'control', '', '26', '', '', 'self-reported', 'stress', 'greater', 'among', 'sars', 'survivor', 'control', '', 'greater', 'among', 'health', 'care', 'worker', 'sars', 'survivor', 'non-health', 'care', 'worker', 'survivor', '', 'addition', '', 'moderate', 'severe', 'symptom', 'anxiety', '', 'depression', '', 'ptsd', 'present', 'approximately', '33', 'percent', 'survivor', '', 'anxiety', '', 'depression', '', 'ptsd', 'symptom', 'greater', 'female', 'male', '', 'greater', 'health', 'care', 'worker', 'sars', 'survivor', 'non-health', 'care', 'worker', 'survivorsin', 'study', 'hospital', 'employee', '', 'n', '', '549', '', 'expose', 'sars', 'epidemic', 'beijing', '', 'self-report', 'assessment', 'three', 'year', 'later', 'indicate', 'moderate', 'severe', 'depressive', 'symptom', 'present', '23', 'percent', '', '27', '', '', 'perceived', 'risk', 'relate', 'sars', 'epidemic', 'quarantine', 'epidemic', 'associate', 'higher', 'level', 'depression', 'follow-upin', 'addition', '', 'assessment', 'three', 'year', 'later', 'find', 'among', '549', 'health', 'care', 'worker', '', 'least', 'one', 'symptom', 'alcohol', 'disorder', 'present', 'approximately', '19', 'percent', '', '28', '', '', 'working', 'high', 'risk', 'location', '', 'eg', '', 'sars', 'ward', '', 'epidemic', 'quarantine', 'epidemic', 'associate', 'symptom', 'alcohol', 'disorder', '', 'study', 'interview', '90', 'survivor', 'sars', 'infection', 'approximately', '25', 'year', 'hospitalization', 'illness', '', 'history', 'psychiatric', 'disorder', 'prior', 'infection', 'present', '7', 'percent', '', '29', '', '', '25', 'year', 'post-sars', '', 'least', 'one', 'psychiatric', 'disorder', 'present', '33', 'percent', 'survivor', '', 'include', 'ptsd', '26', 'percent', 'depressive', 'disorder', '16', 'percent', '', 'addition', '', 'social', 'role', 'function', 'impair', 'survivor', '', 'assessment', 'diagnosis', '', 'assessment', 'diagnosis', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'insomnia', 'disorder', '', 'posttraumatic', 'stress', 'disorder', 'discuss', 'separately', '', '', '', '', 'generalized', 'anxiety', 'disorder', 'adult', '', 'epidemiology', '', 'pathogenesis', '', 'clinical', 'manifestation', '', 'course', '', 'assessment', '', 'diagnosis', '', '', '', '', '', '', 'panic', 'disorder', 'adult', '', 'epidemiology', '', 'pathogenesis', '', 'clinical', 'manifestation', '', 'course', '', 'assessment', '', 'diagnosis', '', '', '', '', '', '', 'unipolar', 'depression', 'adult', '', 'assessment', 'diagnosis', '', '', '', '', '', '', 'evaluation', 'diagnosis', 'insomnia', 'adult', '', '', '', '', '', '', 'posttraumatic', 'stress', 'disorder', 'adult', '', 'epidemiology', '', 'pathophysiology', '', 'clinical', 'manifestation', '', 'course', '', 'assessment', '', 'diagnosis', '', '', '', 'individuals', 'moderate', 'severe', 'distress', '', 'anxiety', '', 'depression', 'screen', 'suicidal', 'behavior', '', 'one', 'screen', 'tool', 'directly', 'ask', '', '', '', 'suicidal', 'ideation', 'behavior', 'adult', '', '', 'section', 'screening', '', '', '', 'management', '', 'psychiatric', 'issue', 'relate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'occur', 'multiple', 'population', '', 'include', 'clinician', 'treat', 'patient', 'covid-19', 'suspect', 'illness', '', 'patient', 'covid-19', '', 'patient', 'establish', 'psychiatric', 'disorder', 'prior', 'covid-19', '', 'addition', '', 'family', 'member', 'clinician', 'patient', 'develop', 'psychiatric', 'symptom', 'disorder', '', 'general', 'approach', '', 'individual', 'experience', 'symptom', 'anxiety', '', 'depression', '', 'insomnia', '', 'posttraumatic', 'stress', 'disorder', '', 'ptsd', '', 'covid-19', 'pandemic', '', 'step', 'care', 'efficacious', 'cost-effective', 'approach', 'treatment', '', '30', '', '', 'according', 'approach', '', 'monitor', 'mental', 'health', 'problem', 'paramount', '', 'surveillance', 'domestic', 'violence', 'child', 'abuse', '', 'predict', 'increase', 'mandate', 'stay-at-home', 'order', '', 'critical', '', '30', '', '', 'individuals', 'low', 'level', 'symptom', 'provide', 'self-help', 'material', 'pertinent', 'symptom', 'concern', 'eligible', 'speak', 'mental', 'health', 'professional', 'additional', 'persistent', 'concern', '', '9', '', '', 'intervention', 'help', 'individual', 'cope', 'mild', 'psychiatric', 'symptom', 'relate', 'covid-19', 'pandemic', 'include', 'limit', 'one', '', 'intake', 'print', 'broadcast', 'news', 'pandemic', '', 'well', 'maintain', 'routine', 'structure', 'activity', 'exercise', '', 'stay', 'connect', 'family', 'friend', 'via', 'phone', 'computer', '', '16', '', '', 'health', 'care', 'worker', 'particular', 'likely', 'benefit', 'private', '', 'on-demand', 'access', 'mental', 'health', 'professional', 'address', 'source', 'anxiety', '', 'distress', '', 'emotion', 'relate', 'care', 'patient', '', '53132', '', '', 'individuals', 'moderate', 'severe', 'symptom', 'treat', 'primary', 'care', 'provider', 'refer', 'mental', 'health', 'specialistif', 'feasible', '', 'psychiatric', 'care', 'administer', 'computer', 'telephone', 'face-to-face', '', '91133', '', '', 'patient', 'contact', 'voice', 'voice', 'plus', 'video', 'superior', 'text', 'message', 'email', '', '6', '', '', 'evidence', 'support', 'remote', 'care', 'include', 'small', 'study', 'outpatient', 'psychiatrist', '', 'n', '', '20', '', 'united', 'states', 'transition', 'telemedicine', 'video', 'visit', 'andor', 'phone', 'visit', 'march', '2020', 'interview', 'follow', 'month', '', '34', '', '', 'study', 'find', 'transition', 'relatively', 'positive', 'patient', 'clinician', '', 'patient', 'preference', 'usually', 'dictate', 'whether', 'visit', 'conduct', 'video', 'phone', '', 'advantages', 'telepsychiatry', 'include', 'improve', 'access', 'patient', '', 'patient', 'feel', 'relax', 'thus', 'forthcoming', '', 'opportunity', 'patient', '', 'home', '', 'disadvantages', 'include', 'difficulty', 'observe', 'nonverbal', 'patient', 'cue', 'hear', 'patient', '', 'technical', 'disruption', 'freeze', 'screen', '', 'well', 'patient', 'privacy', 'problem', 'distraction', '', 'techniques', 'improve', 'visit', 'include', 'start', 'visit', 'ask', 'whether', 'patient', 'enough', 'privacy', '', '', 'suggestion', 'offer', 'car', 'reschedule', 'visit', '', 'video', 'visit', '', 'psychiatrist', 'suggest', 'place', 'office', 'home', 'provide', 'consistency', 'reassurance', 'patientsin', 'addition', '', 'us', 'food', 'drug', 'administration', 'offer', 'guidance', 'april', '14', '', '2020', 'regard', 'covid-19', 'public', 'health', 'emergency', 'digital', 'health', 'device', 'pose', 'low', 'risk', 'treat', 'psychiatric', 'disorder', 'generalize', 'anxiety', 'disorder', '', 'insomnia', 'disorder', '', 'ptsd', '', 'unipolar', 'major', 'depression', '', '35', '', '', 'guideline', 'recommend', 'device', 'adjunctive', 'treatment', '', 'functions', 'device', 'perform', 'include', 'reminder', 'physical', 'activity', '', 'mindfulness', 'activity', '', 'behavioral', 'technique', 'patient', 'experience', 'increase', 'anxiety', '', 'face-to-face', 'visit', 'necessary', '', 'personal', 'protective', 'equipment', '', 'eg', '', 'mask', '', 'care', 'ideally', 'administer', 'individual', 'group', '', 'in-person', 'visit', 'mask', 'experience', 'le', 'personal', 'leave', 'patient', 'feel', 'le', 'connect', 'clinician', '', 'compare', 'voice', 'plus', 'video', 'meetingspsychiatrists', 'ask', 'consult', 'patient', 'receive', 'pharmacotherapy', 'covid-19', 'therefore', 'familiar', 'medication', 'currently', '', 'example', '', 'hydroxychloroquine', '', 'antimalarial', 'drug', 'hospitalize', 'covid-19', 'patient', '', 'undergo', 'clinical', 'trial', '', '', 'associate', 'psychiatric', 'side', 'effect', 'mood', 'anxiety', 'disturbance', '', 'insomnia', '', 'rarely', '', 'psychosis', '', 'patients', 'ask', 'prescribe', 'medication', 'supplement', 'belief', 'reduce', 'vulnerability', 'covid-19', 'infection', '', 'specific', 'interaction', 'psychiatric', 'medication', 'medication', 'determine', 'lexicomp', 'drug', 'interaction', 'tool', '', 'lexi-interact', 'online', '', 'include', 'uptodate', '', 'specific', 'medication', 'evaluate', 'covid-19', 'describe', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'specific', 'treatment', '', '', '', 'physical', 'distance', '', 'widely', 'encourage', 'decelerate', 'rate', 'covid-19', 'transmission', 'within', 'general', 'public', '', 'flatten', 'curve', '', 'covid-19', 'case', '', 'result', 'loneliness', 'individual', '', 'particularly', 'live', 'alone', '', 'include', 'elderly', '', 'likely', 'exacerbate', 'high', 'rate', 'loneliness', 'already', 'experience', 'elderly', '', 'especially', 'rely', 'social', 'service', 'family', 'human', 'contact', 'connection', '', '17', '', '', 'digital', 'technology', 'serve', 'bridge', 'social', 'connection', 'encourage', '', '636', '', '', 'however', '', 'individual', 'access', 'ability', 'advantage', 'thisone', 'resource', 'provide', 'example', 'one', 'respond', 'patient', 'family', 'member', 'different', 'concern', 'reaction', 'covid', 'ready', 'communication', 'playbook', '', 'document', 'guide', 'clinician', 'range', 'topic', 'specific', 'covid-19', '', 'include', 'help', 'patient', 'family', 'member', 'cope', 'dire', 'situation', '', 'well', 'clinician', 'manage', 'emotionsfamily', 'member', 'covid-19', 'patient', '', 'context', 'physical', 'distance', '', 'inpatient', 'facility', 'restrict', 'suspend', 'visit', 'family', 'friend', '', '37', '', '', 'family', 'member', 'love', 'one', 'severely', 'ill', 'die', 'respond', 'grief', '', 'treatment', 'team', 'ask', 'family', '', 'feel', '', 'behavior', 'relate', 'loss', '', 'well', 'provide', 'grief', 'counsel', 'warrant', '', '', '', 'grief', 'bereavement', 'adult', '', 'clinical', 'feature', '', '', 'grief', 'bereavement', 'adult', '', 'management', '', '', '', 'clinicians', '', 'patient', 'covid-19', '', 'family', 'discus', 'end-of-life', 'issue', 'early', 'course', 'management', '', 'especially', 'patient', 'elderly', 'suffer', 'comorbidities', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', 'section', 'end', 'life', 'issue', '', '', '', 'health', 'care', 'worker', '', 'health', 'care', 'worker', 'directly', 'treat', 'patient', 'covid-19', 'risk', 'psychiatric', 'symptom', 'disorder', '', 'health', 'care', 'worker', '', '', '', 'treat', 'problem', '', 'mental', 'health', 'professional', 'address', 'potential', 'source', 'anxiety', 'distress', '', 'include', '', '5243132', '', '', 'access', 'personal', 'protective', 'equipmenthigh', 'transmissibility', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'risk', 'self-exposure', 'infectionrisk', 'expose', 'family', 'member', 'others', 'infectionaccess', 'test', 'oneself', 'family', 'membersenforcement', 'infection', 'control', 'procedure', 'workplaceaccess', 'up-to-date', '', 'accurate', 'information', 'covid-19unclear', 'communication', 'supervisorsaccess', 'childcare', 'school', 'closuresincreased', 'tax', 'workloadsmoral', 'dilemma', 'moral', 'injury', 'arise', 'situation', 'decide', 'allocate', 'insufficient', 'resource', '', 'inadvertently', 'place', 'others', 'danger', '', 'implement', 'clinical', 'decision', 'others', 'one', 'contrary', 'best', 'practicesloss', 'controlvulnerability', 'availability', 'support', 'colleague', 'managersdying', 'patient', 'grief-stricken', 'family', 'membersbased', 'upon', 'study', 'clinician', '', 'n', '', '466', '', 'public', 'hospital', 'emergency', 'department', 'hong', 'kong', '2003', 'severe', 'acute', 'respiratory', 'system', '', 'sars', '', 'epidemic', '', '38', '', '', 'frequent', 'cop', 'strategy', 'include', 'accept', 'reality', 'stressor', '', 'action', 'circumvent', 'stressor', '', 'view', 'situation', 'positive', 'light', 'attempt', 'grow', 'situationa', 'follow-up', 'study', 'hospital', 'employee', 'expose', '2003', 'sars', 'epidemic', 'beijing', '', 'n', '', '549', '', 'find', 'higher', 'level', 'altruistic', 'acceptance', 'risk', 'outbreak', '', 'eg', '', '', 'help', 'patient', 'accept', 'risk', '', '', 'associate', 'lower', 'level', 'self-reported', 'depressive', 'symptom', 'three', 'year', 'later', '', '27', '', '', 'quarantine', '', 'review', '24', 'study', 'examine', 'adverse', 'psychological', 'impact', 'quarantine', 'suggest', 'follow', 'step', 'mitigate', 'negative', 'effect', '', '23', '', '', 'explain', 'purpose', 'quarantine', 'implement', 'itvoluntary', 'quarantine', 'associate', 'le', 'distress', 'mandatory', 'quarantineemphasize', 'altruistic', 'benefit', 'quarantine', 'keep', 'others', 'safefacilitate', 'acquisition', 'general', '', 'eg', '', 'food', 'house', '', 'medical', 'supply', '', 'eg', '', 'prescription', '', 'thermometer', '', 'face', 'mask', '', 'suicidality', '', 'interventions', 'manage', 'suicidal', 'ideation', 'behavior', '', 'suicidality', '', 'include', 'follow', '', '24', '', '', 'treatments', 'specific', 'suicidality', '', '', 'suicidal', 'ideation', 'behavior', 'adult', '', '', 'section', 'management', '', '', 'treating', 'underlie', 'psychiatric', 'disorder', 'telehealth', 'in-person', '', 'depend', 'upon', 'severity', 'suicidalityencouraging', 'patient', 'maintain', 'social', 'contact', 'telephone', 'computer', '', 'well', 'face-to-face', 'encounter', 'maintain', 'physical', 'distancingreferring', 'patient', 'social', 'work', 'help', 'access', 'financial', 'safety', 'net', '', 'eg', '', 'food', '', 'house', '', 'unemployment', 'support', '', 'loan', '', 'specific', 'disorder', '', 'pharmacotherapy', 'psychotherapy', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'insomnia', 'disorder', '', 'ptsd', 'associate', 'covid-19', 'follow', 'recommendation', 'treat', 'general', 'population', 'patient', 'disorder', 'discuss', 'separately', '', '', '', '', 'approach', 'treat', 'generalize', 'anxiety', 'disorder', 'adult', '', '', '', '', '', '', 'approach', 'treat', 'panic', 'disorder', 'without', 'agoraphobia', 'adult', '', '', '', '', '', '', 'unipolar', 'major', 'depression', 'adult', '', 'choosing', 'initial', 'treatment', '', '', '', '', '', '', 'overview', 'treatment', 'insomnia', 'adult', '', '', '', '', '', '', 'approach', 'treat', 'posttraumatic', 'stress', 'disorder', 'adult', '', '', '', 'schizophrenia', '', 'pharmacotherapy', 'psychosocial', 'intervention', 'acute', 'symptom', 'schizophrenia', 'associate', 'covid-19', 'follow', 'recommendation', 'treat', 'general', 'population', 'patient', 'schizophrenia', 'discuss', 'separately', '', '', '', 'pharmacotherapy', 'schizophrenia', '', 'acute', 'maintenance', 'phase', 'treatment', '', '', 'psychosocial', 'intervention', 'schizophrenia', '', '', '', 'home', 'visit', '', 'patient', 'schizophrenia', 'acutely', 'ill', 'mild', 'moderate', 'symptom', '', 'daily', 'home', 'visit', 'clinician', '24-hour', 'coverage', 'reasonable', 'alternative', 'inpatient', 'hospitalization', '', '3339', '', '', 'allow', 'patient', 'maintain', 'physical', 'distance', 'home', 'confinement', '', 'thus', 'avoid', 'exposure', 'covid-19', '', 'patient', 'schizophrenia', 'stable', '', 'home', 'visit', 'suitable', 'promote', 'adherence', 'treatment', 'prevent', 'relapseclozapine', 'bloodwork', '', 'patients', 'receive', 'clozapine', 'schizophrenia', 'serious', 'mental', 'illness', 'typically', 'require', 'blood', 'test', 'every', 'one', 'four', 'week', 'monitor', 'absolute', 'neutrophil', 'count', '', 'however', '', 'patient', 'clinician', 'decide', 'whether', 'risk', 'covid-19', 'outweigh', 'benefit', 'obtain', 'blood', 'work', '', '', '', 'guidelines', 'prescribe', 'clozapine', 'schizophrenia', '', '', 'section', 'required', 'bloodwork', 'coronavirus', 'disease', '2019', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separatelygeneral', 'guidance', 'public', 'health', 'authority', '', 'eg', '', 'world', 'health', 'organization', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', '', 'detail', 'guidance', 'specialty', 'care', '', 'include', 'psychiatry', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'section', 'psychiatry', '', '', '', 'resources', 'psychiatric', 'patient', 'family', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'patient', 'education', 'material', 'available', 'united', 'states', 'national', 'institute', 'mental', 'health', 'united', 'states', 'centers', 'disease', 'control', 'preventionsummaryin', 'one', 'study', 'china', '', 'clinician', 'treat', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'develop', 'moderate', 'severe', 'psychiatric', 'symptom', '', 'include', '', 'anxiety', '', '12', 'percentdepression', '', '15', 'percentinsomnia', '', '8', 'percentdistress', '', '35', 'percent', '', 'health', 'care', 'worker', '', '', '', 'pathogenesis', 'psychiatric', 'symptom', 'disorder', 'arise', 'covid-19', 'pandemic', 'include', 'biologic', 'psychosocial', 'factor', '', '', 'pathogenesis', '', '', '', 'covid-19', 'pandemic', 'associate', 'psychiatric', 'symptom', 'necessarily', 'rise', 'level', 'psychiatric', 'disorder', '', 'addition', '', 'pandemic', 'lead', 'full-blown', 'psychiatric', 'disorder', '', 'include', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'posttraumatic', 'stress', 'disorder', '', 'ptsd', '', '', 'viral', 'epidemic', '', 'psychiatric', 'symptom', 'disorder', 'likely', 'occur', 'health', 'care', 'worker', 'relatively', 'high', 'risk', 'exposure', '', 'compare', 'worker', 'low', 'risk', 'exposure', '', '', 'clinical', 'feature', '', '', '', 'psychiatric', 'problem', 'relate', 'covid-19', 'pandemic', 'persist', 'least', 'three', 'year', 'beyond', 'pandemic', '', 'study', 'prior', 'epidemic', 'assess', 'individual', '25', '3', 'year', 'epidemic', '', 'moderate', 'severe', 'symptom', 'anxiety', 'disorder', '', 'depressive', 'disorder', '', 'ptsd', 'present', 'roughly', '20', '30', 'percent', 'individual', '', 'addition', '', 'risk', 'persistent', 'psychiatric', 'symptom', 'disorder', 'higher', 'health', 'care', 'worker', 'individual', 'quarantine', '', '', 'course', 'illness', '', '', '', 'individual', 'experience', 'symptom', 'anxiety', '', 'depression', '', 'insomnia', '', 'ptsd', '', 'step', 'care', 'efficacious', 'cost-effective', 'approach', '', 'surveillance', 'mental', 'health', 'problem', 'paramount', '', 'low', 'level', 'symptom', 'provide', 'self-help', 'material', 'eligible', 'speak', 'mental', 'health', 'professional', 'additional', 'persistent', 'concern', '', 'individuals', 'moderate', 'severe', 'symptom', 'treat', 'primary', 'care', 'provider', 'mental', 'health', 'specialist', '', '', 'general', 'approach', '', '', '', 'mental', 'health', 'professional', 'work', 'individual', 'develop', 'psychiatric', 'issue', 'relate', 'covid-19', 'address', 'potential', 'source', 'anxiety', 'distress', '', 'include', 'access', 'personal', 'protective', 'equipment', '', 'risk', 'self-exposure', 'infection', '', 'risk', 'expose', 'others', 'infection', '', 'increase', 'tax', 'workload', '', 'moral', 'dilemma', '', 'patient', 'death', '', '', 'health', 'care', 'worker', '', '', '', 'adverse', 'psychological', 'impact', 'quarantine', 'mitigate', 'step', 'explain', 'purpose', 'quarantine', 'implement', '', 'well', 'emphasize', 'altruistic', 'benefit', 'quarantine', 'keep', 'others', 'safe', '', '', 'quarantine', '', '', '', 'hardship', 'impose', 'covid-19', 'pandemic', 'give', 'rise', 'suicidal', 'ideation', 'behavior', '', 'individuals', 'moderate', 'severe', 'distress', '', 'anxiety', '', 'depression', 'screen', 'suicidal', 'behavior', '', 'patients', 'covid-19', 'patient', 'establish', 'psychiatric', 'disorder', 'encourage', 'maintain', 'social', 'contact', 'access', 'treatment', 'telehealth', 'in-person', '', '', 'suicidality', '', '', '']",4075,"{'': 983, 'patient': 75, 'disorder': 69, 'covid-19': 62, 'psychiatric': 46, 'health': 45, 'symptom': 45, 'care': 43, 'anxiety': 32, 'include': 32, 'pandemic': 31, 'study': 29, 'worker': 28, 'percent': 25, 'risk': 23, 'adult': 23, 'epidemic': 22, 'disease': 20, 'severe': 18, 'depression': 18}","{'hydroxychloroquine': 1, 'infection': 13, 'sars-cov-2': 1, 'safety': 1}",16,-0.9477
ID:16722,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['practice', 'changing', 'updates']","['INTRODUCTION — This section highlight select specific new recommendation and/or update anticipate may change usual clinical practice .', 'Practice Changing UpDates focus change may significant broad impact practice , therefore represent update affect practice .', 'These Practice Changing UpDates , reflect important change UpToDate past year , present chronologically , discuss greater detail identify topic reviews.INFECTIOUS DISEASES ( May 2020 ) Remdesivir COVID-19●For hospitalize patient severe COVID-19 , recommend remdesivir , available ( Grade 1C ) .Remdesivir investigational antiviral agent evaluation COVID-19 .', 'Emerging data randomize trial limit mix .', 'Interim analysis unpublished trial > 1000 patient confirm COVID-19 pulmonary involvement suggest remdesivir result faster time recovery ( median 11 versus 15 day placebo ) ; trend towards lower mortality statistically significant ( 8 versus 11.6 percent ) [ 1 ] .', 'In contrast , randomize trial China 237 patient severe COVID-19 , remdesivir placebo similar time clinical improvement ( median 21 versus 23 day ) mortality rate ( 14 versus 13 percent ) ; however , confidence find effect reduce use concomitant therapy , difference baseline comorbidities group , failure meet target enrollment [ 2 ] .', 'Overall , preliminary result larger trial confirm , remdesivir likely clinical benefit , although patient population likely benefit uncertain .', 'The United States Food Drug Administration grant emergency use authorization remdesivir hospitalize patient severe COVID-19 ; available , recommend remdesivir patient also refer trial agent , concurrent remdesivir use allow .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' , section 'Remdesivir ' ."", ') INFECTIOUS DISEASES ( March 2020 , Modified April 2020 ) One-time HCV screen adult ≥18 years●We suggest one-time screen hepatitis C virus infection adult age ≥18 year rather selective screen ( Grade 2C ) .In April 2020 , US Centers Disease Control Prevention ( CDC ) recommend adult ≥18 year screen least chronic hepatitis C virus ( HCV ) infection [ 3 ] .', 'The CDC recommendation differ US Preventive Services Task Force ( USPSTF ) recommendation issue March 2020 , include upper age limit 79 year universal screen [ 4 ] .', 'Previously , screen recommend patient certain risk factor bear certain decade , approach result many miss diagnosis .', 'The improve efficacy , tolerability , accessibility antiviral treatment HCV also support broader screen strategy .', 'We agree new CDC recommendation broad one-time screen adult , continue suggest repeat screen individual ongoing risk factor ( algorithm 1 ) .', ""( See `` Screening diagnosis chronic hepatitis C virus infection '' , section 'Routine one-time screen adult ' ."", ') ONCOLOGY ( March 2020 ) Hippocampal avoidance whole brain radiation treatment brain metastases●For patient undergo whole brain radiation therapy ( WBRT ) treatment brain metastasis , suggest use hippocampal avoidance intensity-modulated radiotherapy rather conventional WBRT ( Grade 2C ) .', 'Patients metastasis within 5 mm hippocampus receive conventional WBRT.For patient receive whole brain radiation ( WBRT ) brain metastasis , neurocognitive decline fear complication adversely impact quality life .', 'Lowering dose radiation deliver hippocampus intensity-modulated radiation therapy ( IMRT ) suggest way improve neurocognitive outcome compare conventional WBRT .', 'In randomize , unblinded trial 500 patient brain metastasis , use hippocampal avoidance IMRT ( HA-IMRT ) lead 26 percent relative reduction risk cognitive toxicity compare conventional WBRT [ 5 ] .', 'Patients HA-IMRT group report le difficulty remember thing , le difficulty speak , greater improvement fatigue six month .', 'Rates brain control overall survival similar group , although confidence interval wide .', 'All patient also receive memantine , N-methyl-D-aspartate antagonist show reduce risk neurotoxicity previous trial .', 'Based result , suggest HA-IMRT rather conventional WBRT patient require WBRT treatment brain metastasis , administer memantine concurrently .', ""( See `` Delayed complication cranial irradiation '' , section 'Prevention ' ."", ') HEMATOLOGY ( February 2020 ) Less chemoimmunotherapy limit stage diffuse large B cell non-Hodgkin lymphoma ( DLBCL ) adverse features●For patient limit stage ( stage I II ) diffuse large B cell non-Hodgkin lymphoma ( DLBCL ) adverse feature , suggest four cycle R-CHOP ( rituximab , cyclophosphamide , doxorubicin , vincristine , prednisone ) rather six cycle R-CHOP , radiation therapy ( RT ) alone , combine modality therapy ( R-CHOP plus RT ) ( Grade 2C ) .Limited stage ( stage I II ) diffuse large B cell non-Hodgkin lymphoma ( DLBCL ) without adverse risk factor ( ie , bulky disease , normal lactate dehydrogenase [ LDH ] , ECOG performance status 0-1 ) excellent prognosis treat current standard approach either six cycle R-CHOP ( rituximab , cyclophosphamide , doxorubicin , vincristine , prednisone ) three cycle R-CHOP follow radiation therapy ( RT ) .', 'To determine le chemoimmunotherapy could achieve comparable outcome le toxicity , almost 600 patient ≤60 year stage I-II DLBCL adverse risk factor randomly assign four versus six cycle R-CHOP [ 6 ] .', 'With median follow-up greater five year , le hematologic non-hematologic toxicity four cycle R-CHOP , three-year progression-free survival ( PFS ) estimate five-year PFS overall survival similar compare six cycle .', 'We suggest four cycle R-CHOP treatment adult age limit stage DLBCL adverse feature .', ""( See `` Initial treatment limit stage diffuse large B cell lymphoma '' , section 'No adverse feature ' ."", ') NEUROLOGY ( December 2019 ) Tranexamic acid adult acute traumatic brain injury●For patient moderate traumatic brain injury ( Glasgow Coma Scale greater 8 le 13 ) present within three hour injury , recommend immediate administration tranexamic acid ( Grade 1B ) .Whether antifibrolytic agent tranexamic acid benefit patient acute traumatic brain injury ( TBI ) previously uncertain .', 'In CRASH-3 trial , include 9000 adult present within three hour TBI Glasgow Coma Scale ( GCS ) < 13 evidence intracranial bleed CT scan , receive tranexamic acid nonsignificantly lower rate death relate head injury compare placebo ( 18.5 versus 19.8 percent ) [ 7 ] .', 'However , difference statistically significant patient unreactive pupil exclude ( 11.5 versus 13.2 percent ) subgroup patient mild moderate TBI ( 5.8 versus 7.5 percent ) .', 'Adverse event similar group , include rate vaso-occlusive event .', 'Based result , recommend tranexamic acid patient moderate TBI present within three hour injury .', 'Tranexamic acid may also reasonable patient group , severe TBI reactive pupil mild TBI ( GCS > 12 ) intracranial bleed , benefit le certain patient .', ""( See `` Management acute moderate severe traumatic brain injury '' , section 'Antifibrinolytic therapy ' ."", ') PEDIATRICS ( November 2019 ) Elexacaftor-tezacaftor-ivacaftor cystic fibrosis cause F508del variant●For patient age ≥12 year old cystic fibrosis homozygous F508del variant , suggest triple therapy regimen ( elexacaftor-tezacaftor-ivacaftor ) rather dual therapy ( tezacaftor-ivacaftor lumacaftor-ivacaftor ) ( Grade 2B ) .', 'For patient ≥12 year one F508del variant ( heterozygote ) , suggest triple therapy regimen rather dual therapy monotherapy ivacaftor ( Grade 2C ) .Elexacaftor-tezacaftor-ivacaftor combination cystic fibrosis transmembrane regulator ( CFTR ) modulator design improve production function defective CFTR protein individual cystic fibrosis ( CF ) cause F508del CFTR variant .', 'Two recent study evaluate combination drug differ population : •In randomize trial > 100 patient homozygous F508del variant , elexacaftor-tezacaftor-ivacaftor increase FEV1 four week improve respiratory symptom compare dual therapy ( tezacaftor-ivacaftor ) [ 8 ] .•In separate placebo-controlled randomize trial > 400 patient age ≥12 year heterozygous F508del variant second minimal function variant ( ie , produce CFTR protein protein unresponsive ivacaftor tezacaftor-ivacaftor ) , elexacaftor-tezacaftor-ivacaftor increase FEV1 four week treatment , decrease pulmonary exacerbation > 60 percent , improve respiratory symptom , reduce sweat chloride [ 9 ] .The study basis approval US Food Drug Administration combination drug patient ≥12 year F508del variant ( homozygote heterozygote 508del disease-causing CFTR variant ) .', 'We recommend CFTR modulator therapy patient CF suggest triple therapy patient homozygous heterozygous F508del CFTR variant , represent almost 90 percent patient cystic fibrosis United States .', ""( See `` Cystic fibrosis : Treatment CFTR modulators '' , section 'Efficacy ' . )"", 'HEMATOLOGY ( November 2019 ) Lenalidomide high-risk smolder multiple myeloma●For patient high-risk smolder multiple myeloma , recommend treatment single-agent lenalidomide lenalidomide plus dexamethasone rather observation ( Grade 1B ) .Until recently , standard care patient smolder multiple myeloma ( SMM ) observation systemic treatment defer progression symptomatic disease .', 'An earlier randomize trial demonstrate improve outcome lenalidomide plus dexamethasone ( Rd ) , concern study design make extrapolation result difficult .', 'In second multicenter randomize trial 182 patient SMM , single-agent lenalidomide improve progression-free survival ( PFS ) decrease end organ damage ( eg , renal failure , bone lesion ) compare observation [ 10 ] .', 'Serious ( grade 3/4 ) adverse event occur 41 percent patient treatment arm ; one treatment-related death phase II run-in none randomize phase .', 'On subgroup analysis , PFS benefit definitive high-risk SMM le clear intermediate-risk disease .', 'For patient high-risk SMM Mayo 2018 20/2/20 criterion , recommend treatment single-agent lenalidomide Rd rather observation ( algorithm 2 ) .', 'More intensive regimen , treatment lower-risk SMM , reserve patient enrol clinical trial .', ""( See `` Smoldering multiple myeloma '' , section 'Management high-risk SMM ' ."", ') CARDIOVASCULAR MEDICINE ( October 2019 ) Dapagliflozin heart failure reduce ejection fraction●For patient heart failure reduce ejection fraction ( HFrEF ) persistent symptom elevate serum natriuretic peptide level optimal pharmacologic device therapy , recommend addition dapagliflozin ( versus additional drug therapy ) ( Grade 1B ) .Sodium-glucose cotransporter 2 ( SGLT2 ) inhibitor reduce hospitalization heart failure ( HF ) patient type 2 diabetes mellitus ( DM ) , whether improve outcome nondiabetic patient HF know .', 'The DAPA-HF trial evaluate SGLT2 inhibitor dapagliflozin nearly 5000 patient symptomatic heart failure reduce ejection fraction ( HFrEF ) elevate natriuretic peptide level optimal drug device therapy [ 11 ] .', 'Compared placebo , all-cause mortality primary composite outcome ( worsen HF cardiovascular death ) reduce dapagliflozin , similar effect patient without type 2 DM .', 'The frequency adverse effect generally similar dapagliflozin placebo group .', 'Given find , recommend dapagliflozin patient HFrEF persistent symptom elevate serum natriuretic peptide level despite optimal drug device therapy ( include mineralocorticoid receptor antagonist and/or cardiac resynchronization therapy , indicate ) .', 'Dapagliflozin contraindicate patient symptomatic hypotension systolic blood pressure < 95 mmHg , estimate glomerular filtration rate ( eGFR ) < 30 mL per minute per 1.73 m2 , rapidly decline renal function .', ""( See `` Secondary pharmacologic therapy heart failure reduce ejection fraction ( HFrEF ) adult '' , section 'Evidence ' ."", "") OBSTETRICS , GYNECOLOGY AND WOMEN 'S HEALTH ( August 2019 ) New ACOG guideline prevent early-onset group B streptococcus infection newborns●Universal screen pregnant woman Group B streptococcal ( GBS ) colonization recommend 36 0/7 37 6/7 week gestation , rather previously recommend 35 37 week ."", 'Women GBS bacteriuria time pregnancy infant early-onset GBS infection previous pregnancy exclude culture-based screen routinely receive intrapartum antibiotic prophylaxis.The American College Obstetricians Gynecologists ( ACOG ) release guideline prevention early-onset group B streptococcus ( GBS ) infection newborn , update replace obstetric portion 2010 guideline Centers Disease Control Prevention ( CDC ) [ 12 ] .', 'Among revision , GBS rectovaginal screen culture recommend 36 0/7 37 6/7 week gestation rather 35 37 week .', 'Cultures obtain five week delivery predictive GBS status time birth , later screen window decrease number woman need recultured deliver due date .', 'In addition , select woman unknown GBS status history GBS colonization previous pregnancy , clinician may offer intrapartum prophylactic antibiotic part share decision-making process rather base decision initiate antibiotic intrapartum risk factor result rapid test .', ""( See `` Neonatal group B streptococcal disease : Prevention '' , section 'Culture-based approach ' ."", ') INFECTIOUS DISEASES ( June 2019 ) Screening US health care worker latent tuberculosis infection●In US region low incidence rate tuberculosis ( TB ) , health care worker facility tuberculin skin test conversion rate low need undergo routine serial TB test follow baseline TB test .', 'However , routine serial TB test may reasonable increase risk occupational exposure TB ( eg , pulmonologists , respiratory therapist , emergency department personnel ) , institutional policy individualized.Annual screen health care worker ( HCWs ) latent tuberculosis infection ( LTBI ) longstanding practice United States prevention tuberculosis ( TB ) transmission ; however , national incidence TB decline steadily past several decade , evidence annual screen reduce TB incidence , test number limitation .', 'Based factor , US Centers Disease Control Prevention ( CDC ) National Tuberculosis Controllers Association ( NTCA ) issue new guideline May 2019 state , follow baseline screen , health care worker undergo routine annual screen [ 13 ] .', 'We agree guidance , serf update prior 2005 guideline ( table 1 ) .', 'Annual screen may reasonable HCWs increase risk occupational TB exposure ( pulmonologists respiratory therapist ) HCWs certain set ( emergency department ) .', 'Institutional policy individualize incorporate factor .', ""( See `` Approach diagnosis latent tuberculosis infection ( tuberculosis screen ) adult '' , section 'Health care worker ' . )""]","['', 'section', 'highlight', 'select', 'specific', 'new', 'recommendation', 'andor', 'update', 'anticipate', 'change', 'usual', 'clinical', 'practice', '', 'practice', 'changing', 'updates', 'focus', 'change', 'significant', 'broad', 'impact', 'practice', '', 'therefore', 'represent', 'update', 'affect', 'practice', '', 'practice', 'changing', 'updates', '', 'reflect', 'important', 'change', 'uptodate', 'past', 'year', '', 'present', 'chronologically', '', 'discuss', 'greater', 'detail', 'identify', 'topic', 'reviewsinfectious', 'diseases', '', '2020', '', 'remdesivir', 'covid-19for', 'hospitalize', 'patient', 'severe', 'covid-19', '', 'recommend', 'remdesivir', '', 'available', '', 'grade', '1c', '', 'remdesivir', 'investigational', 'antiviral', 'agent', 'evaluation', 'covid-19', '', 'emerging', 'data', 'randomize', 'trial', 'limit', 'mix', '', 'interim', 'analysis', 'unpublished', 'trial', '', '1000', 'patient', 'confirm', 'covid-19', 'pulmonary', 'involvement', 'suggest', 'remdesivir', 'result', 'faster', 'time', 'recovery', '', 'median', '11', 'versus', '15', 'day', 'placebo', '', '', 'trend', 'towards', 'lower', 'mortality', 'statistically', 'significant', '', '8', 'versus', '116', 'percent', '', '', '1', '', '', 'contrast', '', 'randomize', 'trial', 'china', '237', 'patient', 'severe', 'covid-19', '', 'remdesivir', 'placebo', 'similar', 'time', 'clinical', 'improvement', '', 'median', '21', 'versus', '23', 'day', '', 'mortality', 'rate', '', '14', 'versus', '13', 'percent', '', '', 'however', '', 'confidence', 'find', 'effect', 'reduce', 'concomitant', 'therapy', '', 'difference', 'baseline', 'comorbidities', 'group', '', 'failure', 'meet', 'target', 'enrollment', '', '2', '', '', 'overall', '', 'preliminary', 'result', 'larger', 'trial', 'confirm', '', 'remdesivir', 'likely', 'clinical', 'benefit', '', 'although', 'patient', 'population', 'likely', 'benefit', 'uncertain', '', 'united', 'states', 'food', 'drug', 'administration', 'grant', 'emergency', 'authorization', 'remdesivir', 'hospitalize', 'patient', 'severe', 'covid-19', '', 'available', '', 'recommend', 'remdesivir', 'patient', 'refer', 'trial', 'agent', '', 'concurrent', 'remdesivir', 'allow', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', 'section', 'remdesivir', '', '', '', 'infectious', 'diseases', '', 'march', '2020', '', 'modified', 'april', '2020', '', 'one-time', 'hcv', 'screen', 'adult', '18', 'yearswe', 'suggest', 'one-time', 'screen', 'hepatitis', 'c', 'virus', 'infection', 'adult', 'age', '18', 'year', 'selective', 'screen', '', 'grade', '2c', '', 'april', '2020', '', 'us', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'recommend', 'adult', '18', 'year', 'screen', 'least', 'chronic', 'hepatitis', 'c', 'virus', '', 'hcv', '', 'infection', '', '3', '', '', 'cdc', 'recommendation', 'differ', 'us', 'preventive', 'services', 'task', 'force', '', 'uspstf', '', 'recommendation', 'issue', 'march', '2020', '', 'include', 'upper', 'age', 'limit', '79', 'year', 'universal', 'screen', '', '4', '', '', 'previously', '', 'screen', 'recommend', 'patient', 'certain', 'risk', 'factor', 'bear', 'certain', 'decade', '', 'approach', 'result', 'miss', 'diagnosis', '', 'improve', 'efficacy', '', 'tolerability', '', 'accessibility', 'antiviral', 'treatment', 'hcv', 'support', 'broader', 'screen', 'strategy', '', 'agree', 'new', 'cdc', 'recommendation', 'broad', 'one-time', 'screen', 'adult', '', 'continue', 'suggest', 'repeat', 'screen', 'individual', 'ongoing', 'risk', 'factor', '', 'algorithm', '1', '', '', '', '', 'screening', 'diagnosis', 'chronic', 'hepatitis', 'c', 'virus', 'infection', '', '', 'section', 'routine', 'one-time', 'screen', 'adult', '', '', '', 'oncology', '', 'march', '2020', '', 'hippocampal', 'avoidance', 'whole', 'brain', 'radiation', 'treatment', 'brain', 'metastasesfor', 'patient', 'undergo', 'whole', 'brain', 'radiation', 'therapy', '', 'wbrt', '', 'treatment', 'brain', 'metastasis', '', 'suggest', 'hippocampal', 'avoidance', 'intensity-modulated', 'radiotherapy', 'conventional', 'wbrt', '', 'grade', '2c', '', '', 'patients', 'metastasis', 'within', '5', 'mm', 'hippocampus', 'receive', 'conventional', 'wbrtfor', 'patient', 'receive', 'whole', 'brain', 'radiation', '', 'wbrt', '', 'brain', 'metastasis', '', 'neurocognitive', 'decline', 'fear', 'complication', 'adversely', 'impact', 'quality', 'life', '', 'lowering', 'dose', 'radiation', 'deliver', 'hippocampus', 'intensity-modulated', 'radiation', 'therapy', '', 'imrt', '', 'suggest', 'way', 'improve', 'neurocognitive', 'outcome', 'compare', 'conventional', 'wbrt', '', 'randomize', '', 'unblinded', 'trial', '500', 'patient', 'brain', 'metastasis', '', 'hippocampal', 'avoidance', 'imrt', '', 'ha-imrt', '', 'lead', '26', 'percent', 'relative', 'reduction', 'risk', 'cognitive', 'toxicity', 'compare', 'conventional', 'wbrt', '', '5', '', '', 'patients', 'ha-imrt', 'group', 'report', 'le', 'difficulty', 'remember', 'thing', '', 'le', 'difficulty', 'speak', '', 'greater', 'improvement', 'fatigue', 'six', 'month', '', 'rates', 'brain', 'control', 'overall', 'survival', 'similar', 'group', '', 'although', 'confidence', 'interval', 'wide', '', 'patient', 'receive', 'memantine', '', 'n-methyl-d-aspartate', 'antagonist', 'show', 'reduce', 'risk', 'neurotoxicity', 'previous', 'trial', '', 'based', 'result', '', 'suggest', 'ha-imrt', 'conventional', 'wbrt', 'patient', 'require', 'wbrt', 'treatment', 'brain', 'metastasis', '', 'administer', 'memantine', 'concurrently', '', '', '', 'delayed', 'complication', 'cranial', 'irradiation', '', '', 'section', 'prevention', '', '', '', 'hematology', '', 'february', '2020', '', 'less', 'chemoimmunotherapy', 'limit', 'stage', 'diffuse', 'large', 'b', 'cell', 'non-hodgkin', 'lymphoma', '', 'dlbcl', '', 'adverse', 'featuresfor', 'patient', 'limit', 'stage', '', 'stage', 'ii', '', 'diffuse', 'large', 'b', 'cell', 'non-hodgkin', 'lymphoma', '', 'dlbcl', '', 'adverse', 'feature', '', 'suggest', 'four', 'cycle', 'r-chop', '', 'rituximab', '', 'cyclophosphamide', '', 'doxorubicin', '', 'vincristine', '', 'prednisone', '', 'six', 'cycle', 'r-chop', '', 'radiation', 'therapy', '', 'rt', '', 'alone', '', 'combine', 'modality', 'therapy', '', 'r-chop', 'plus', 'rt', '', '', 'grade', '2c', '', 'limited', 'stage', '', 'stage', 'ii', '', 'diffuse', 'large', 'b', 'cell', 'non-hodgkin', 'lymphoma', '', 'dlbcl', '', 'without', 'adverse', 'risk', 'factor', '', 'ie', '', 'bulky', 'disease', '', 'normal', 'lactate', 'dehydrogenase', '', 'ldh', '', '', 'ecog', 'performance', 'status', '0-1', '', 'excellent', 'prognosis', 'treat', 'current', 'standard', 'approach', 'either', 'six', 'cycle', 'r-chop', '', 'rituximab', '', 'cyclophosphamide', '', 'doxorubicin', '', 'vincristine', '', 'prednisone', '', 'three', 'cycle', 'r-chop', 'follow', 'radiation', 'therapy', '', 'rt', '', '', 'determine', 'le', 'chemoimmunotherapy', 'achieve', 'comparable', 'outcome', 'le', 'toxicity', '', 'almost', '600', 'patient', '60', 'year', 'stage', 'i-ii', 'dlbcl', 'adverse', 'risk', 'factor', 'randomly', 'assign', 'four', 'versus', 'six', 'cycle', 'r-chop', '', '6', '', '', 'median', 'follow-up', 'greater', 'five', 'year', '', 'le', 'hematologic', 'non-hematologic', 'toxicity', 'four', 'cycle', 'r-chop', '', 'three-year', 'progression-free', 'survival', '', 'pfs', '', 'estimate', 'five-year', 'pfs', 'overall', 'survival', 'similar', 'compare', 'six', 'cycle', '', 'suggest', 'four', 'cycle', 'r-chop', 'treatment', 'adult', 'age', 'limit', 'stage', 'dlbcl', 'adverse', 'feature', '', '', '', 'initial', 'treatment', 'limit', 'stage', 'diffuse', 'large', 'b', 'cell', 'lymphoma', '', '', 'section', 'adverse', 'feature', '', '', '', 'neurology', '', 'december', '2019', '', 'tranexamic', 'acid', 'adult', 'acute', 'traumatic', 'brain', 'injuryfor', 'patient', 'moderate', 'traumatic', 'brain', 'injury', '', 'glasgow', 'coma', 'scale', 'greater', '8', 'le', '13', '', 'present', 'within', 'three', 'hour', 'injury', '', 'recommend', 'immediate', 'administration', 'tranexamic', 'acid', '', 'grade', '1b', '', 'whether', 'antifibrolytic', 'agent', 'tranexamic', 'acid', 'benefit', 'patient', 'acute', 'traumatic', 'brain', 'injury', '', 'tbi', '', 'previously', 'uncertain', '', 'crash-3', 'trial', '', 'include', '9000', 'adult', 'present', 'within', 'three', 'hour', 'tbi', 'glasgow', 'coma', 'scale', '', 'gcs', '', '', '13', 'evidence', 'intracranial', 'bleed', 'ct', 'scan', '', 'receive', 'tranexamic', 'acid', 'nonsignificantly', 'lower', 'rate', 'death', 'relate', 'head', 'injury', 'compare', 'placebo', '', '185', 'versus', '198', 'percent', '', '', '7', '', '', 'however', '', 'difference', 'statistically', 'significant', 'patient', 'unreactive', 'pupil', 'exclude', '', '115', 'versus', '132', 'percent', '', 'subgroup', 'patient', 'mild', 'moderate', 'tbi', '', '58', 'versus', '75', 'percent', '', '', 'adverse', 'event', 'similar', 'group', '', 'include', 'rate', 'vaso-occlusive', 'event', '', 'based', 'result', '', 'recommend', 'tranexamic', 'acid', 'patient', 'moderate', 'tbi', 'present', 'within', 'three', 'hour', 'injury', '', 'tranexamic', 'acid', 'reasonable', 'patient', 'group', '', 'severe', 'tbi', 'reactive', 'pupil', 'mild', 'tbi', '', 'gcs', '', '12', '', 'intracranial', 'bleed', '', 'benefit', 'le', 'certain', 'patient', '', '', '', 'management', 'acute', 'moderate', 'severe', 'traumatic', 'brain', 'injury', '', '', 'section', 'antifibrinolytic', 'therapy', '', '', '', 'pediatrics', '', 'november', '2019', '', 'elexacaftor-tezacaftor-ivacaftor', 'cystic', 'fibrosis', 'cause', 'f508del', 'variantfor', 'patient', 'age', '12', 'year', 'old', 'cystic', 'fibrosis', 'homozygous', 'f508del', 'variant', '', 'suggest', 'triple', 'therapy', 'regimen', '', 'elexacaftor-tezacaftor-ivacaftor', '', 'dual', 'therapy', '', 'tezacaftor-ivacaftor', 'lumacaftor-ivacaftor', '', '', 'grade', '2b', '', '', 'patient', '12', 'year', 'one', 'f508del', 'variant', '', 'heterozygote', '', '', 'suggest', 'triple', 'therapy', 'regimen', 'dual', 'therapy', 'monotherapy', 'ivacaftor', '', 'grade', '2c', '', 'elexacaftor-tezacaftor-ivacaftor', 'combination', 'cystic', 'fibrosis', 'transmembrane', 'regulator', '', 'cftr', '', 'modulator', 'design', 'improve', 'production', 'function', 'defective', 'cftr', 'protein', 'individual', 'cystic', 'fibrosis', '', 'cf', '', 'cause', 'f508del', 'cftr', 'variant', '', 'two', 'recent', 'study', 'evaluate', 'combination', 'drug', 'differ', 'population', '', 'randomize', 'trial', '', '100', 'patient', 'homozygous', 'f508del', 'variant', '', 'elexacaftor-tezacaftor-ivacaftor', 'increase', 'fev1', 'four', 'week', 'improve', 'respiratory', 'symptom', 'compare', 'dual', 'therapy', '', 'tezacaftor-ivacaftor', '', '', '8', '', 'separate', 'placebo-controlled', 'randomize', 'trial', '', '400', 'patient', 'age', '12', 'year', 'heterozygous', 'f508del', 'variant', 'second', 'minimal', 'function', 'variant', '', 'ie', '', 'produce', 'cftr', 'protein', 'protein', 'unresponsive', 'ivacaftor', 'tezacaftor-ivacaftor', '', '', 'elexacaftor-tezacaftor-ivacaftor', 'increase', 'fev1', 'four', 'week', 'treatment', '', 'decrease', 'pulmonary', 'exacerbation', '', '60', 'percent', '', 'improve', 'respiratory', 'symptom', '', 'reduce', 'sweat', 'chloride', '', '9', '', 'study', 'basis', 'approval', 'us', 'food', 'drug', 'administration', 'combination', 'drug', 'patient', '12', 'year', 'f508del', 'variant', '', 'homozygote', 'heterozygote', '508del', 'disease-causing', 'cftr', 'variant', '', '', 'recommend', 'cftr', 'modulator', 'therapy', 'patient', 'cf', 'suggest', 'triple', 'therapy', 'patient', 'homozygous', 'heterozygous', 'f508del', 'cftr', 'variant', '', 'represent', 'almost', '90', 'percent', 'patient', 'cystic', 'fibrosis', 'united', 'states', '', '', '', 'cystic', 'fibrosis', '', 'treatment', 'cftr', 'modulators', '', '', 'section', 'efficacy', '', '', '', 'hematology', '', 'november', '2019', '', 'lenalidomide', 'high-risk', 'smolder', 'multiple', 'myelomafor', 'patient', 'high-risk', 'smolder', 'multiple', 'myeloma', '', 'recommend', 'treatment', 'single-agent', 'lenalidomide', 'lenalidomide', 'plus', 'dexamethasone', 'observation', '', 'grade', '1b', '', 'recently', '', 'standard', 'care', 'patient', 'smolder', 'multiple', 'myeloma', '', 'smm', '', 'observation', 'systemic', 'treatment', 'defer', 'progression', 'symptomatic', 'disease', '', 'earlier', 'randomize', 'trial', 'demonstrate', 'improve', 'outcome', 'lenalidomide', 'plus', 'dexamethasone', '', 'rd', '', '', 'concern', 'study', 'design', 'extrapolation', 'result', 'difficult', '', 'second', 'multicenter', 'randomize', 'trial', '182', 'patient', 'smm', '', 'single-agent', 'lenalidomide', 'improve', 'progression-free', 'survival', '', 'pfs', '', 'decrease', 'end', 'organ', 'damage', '', 'eg', '', 'renal', 'failure', '', 'bone', 'lesion', '', 'compare', 'observation', '', '10', '', '', 'serious', '', 'grade', '34', '', 'adverse', 'event', 'occur', '41', 'percent', 'patient', 'treatment', 'arm', '', 'one', 'treatment-related', 'death', 'phase', 'ii', 'run-in', 'none', 'randomize', 'phase', '', 'subgroup', 'analysis', '', 'pfs', 'benefit', 'definitive', 'high-risk', 'smm', 'le', 'clear', 'intermediate-risk', 'disease', '', 'patient', 'high-risk', 'smm', 'mayo', '2018', '20220', 'criterion', '', 'recommend', 'treatment', 'single-agent', 'lenalidomide', 'rd', 'observation', '', 'algorithm', '2', '', '', 'intensive', 'regimen', '', 'treatment', 'lower-risk', 'smm', '', 'reserve', 'patient', 'enrol', 'clinical', 'trial', '', '', '', 'smoldering', 'multiple', 'myeloma', '', '', 'section', 'management', 'high-risk', 'smm', '', '', '', 'cardiovascular', 'medicine', '', 'october', '2019', '', 'dapagliflozin', 'heart', 'failure', 'reduce', 'ejection', 'fractionfor', 'patient', 'heart', 'failure', 'reduce', 'ejection', 'fraction', '', 'hfref', '', 'persistent', 'symptom', 'elevate', 'serum', 'natriuretic', 'peptide', 'level', 'optimal', 'pharmacologic', 'device', 'therapy', '', 'recommend', 'addition', 'dapagliflozin', '', 'versus', 'additional', 'drug', 'therapy', '', '', 'grade', '1b', '', 'sodium-glucose', 'cotransporter', '2', '', 'sglt2', '', 'inhibitor', 'reduce', 'hospitalization', 'heart', 'failure', '', 'hf', '', 'patient', 'type', '2', 'diabetes', 'mellitus', '', 'dm', '', '', 'whether', 'improve', 'outcome', 'nondiabetic', 'patient', 'hf', '', 'dapa-hf', 'trial', 'evaluate', 'sglt2', 'inhibitor', 'dapagliflozin', 'nearly', '5000', 'patient', 'symptomatic', 'heart', 'failure', 'reduce', 'ejection', 'fraction', '', 'hfref', '', 'elevate', 'natriuretic', 'peptide', 'level', 'optimal', 'drug', 'device', 'therapy', '', '11', '', '', 'compared', 'placebo', '', 'all-cause', 'mortality', 'primary', 'composite', 'outcome', '', 'worsen', 'hf', 'cardiovascular', 'death', '', 'reduce', 'dapagliflozin', '', 'similar', 'effect', 'patient', 'without', 'type', '2', 'dm', '', 'frequency', 'adverse', 'effect', 'generally', 'similar', 'dapagliflozin', 'placebo', 'group', '', 'given', 'find', '', 'recommend', 'dapagliflozin', 'patient', 'hfref', 'persistent', 'symptom', 'elevate', 'serum', 'natriuretic', 'peptide', 'level', 'despite', 'optimal', 'drug', 'device', 'therapy', '', 'include', 'mineralocorticoid', 'receptor', 'antagonist', 'andor', 'cardiac', 'resynchronization', 'therapy', '', 'indicate', '', '', 'dapagliflozin', 'contraindicate', 'patient', 'symptomatic', 'hypotension', 'systolic', 'blood', 'pressure', '', '95', 'mmhg', '', 'estimate', 'glomerular', 'filtration', 'rate', '', 'egfr', '', '', '30', 'ml', 'per', 'minute', 'per', '173', 'm2', '', 'rapidly', 'decline', 'renal', 'function', '', '', '', 'secondary', 'pharmacologic', 'therapy', 'heart', 'failure', 'reduce', 'ejection', 'fraction', '', 'hfref', '', 'adult', '', '', 'section', 'evidence', '', '', '', 'obstetrics', '', 'gynecology', 'women', 'health', '', 'august', '2019', '', 'new', 'acog', 'guideline', 'prevent', 'early-onset', 'group', 'b', 'streptococcus', 'infection', 'newbornsuniversal', 'screen', 'pregnant', 'woman', 'group', 'b', 'streptococcal', '', 'gbs', '', 'colonization', 'recommend', '36', '07', '37', '67', 'week', 'gestation', '', 'previously', 'recommend', '35', '37', 'week', '', 'women', 'gbs', 'bacteriuria', 'time', 'pregnancy', 'infant', 'early-onset', 'gbs', 'infection', 'previous', 'pregnancy', 'exclude', 'culture-based', 'screen', 'routinely', 'receive', 'intrapartum', 'antibiotic', 'prophylaxisthe', 'american', 'college', 'obstetricians', 'gynecologists', '', 'acog', '', 'release', 'guideline', 'prevention', 'early-onset', 'group', 'b', 'streptococcus', '', 'gbs', '', 'infection', 'newborn', '', 'update', 'replace', 'obstetric', 'portion', '2010', 'guideline', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', '', '12', '', '', 'among', 'revision', '', 'gbs', 'rectovaginal', 'screen', 'culture', 'recommend', '36', '07', '37', '67', 'week', 'gestation', '35', '37', 'week', '', 'cultures', 'obtain', 'five', 'week', 'delivery', 'predictive', 'gbs', 'status', 'time', 'birth', '', 'later', 'screen', 'window', 'decrease', 'number', 'woman', 'recultured', 'deliver', 'due', 'date', '', 'addition', '', 'select', 'woman', 'unknown', 'gbs', 'status', 'history', 'gbs', 'colonization', 'previous', 'pregnancy', '', 'clinician', 'offer', 'intrapartum', 'prophylactic', 'antibiotic', 'part', 'share', 'decision-making', 'process', 'base', 'decision', 'initiate', 'antibiotic', 'intrapartum', 'risk', 'factor', 'result', 'rapid', 'test', '', '', '', 'neonatal', 'group', 'b', 'streptococcal', 'disease', '', 'prevention', '', '', 'section', 'culture-based', 'approach', '', '', '', 'infectious', 'diseases', '', 'june', '2019', '', 'screening', 'us', 'health', 'care', 'worker', 'latent', 'tuberculosis', 'infectionin', 'us', 'region', 'low', 'incidence', 'rate', 'tuberculosis', '', 'tb', '', '', 'health', 'care', 'worker', 'facility', 'tuberculin', 'skin', 'test', 'conversion', 'rate', 'low', 'undergo', 'routine', 'serial', 'tb', 'test', 'follow', 'baseline', 'tb', 'test', '', 'however', '', 'routine', 'serial', 'tb', 'test', 'reasonable', 'increase', 'risk', 'occupational', 'exposure', 'tb', '', 'eg', '', 'pulmonologists', '', 'respiratory', 'therapist', '', 'emergency', 'department', 'personnel', '', '', 'institutional', 'policy', 'individualizedannual', 'screen', 'health', 'care', 'worker', '', 'hcws', '', 'latent', 'tuberculosis', 'infection', '', 'ltbi', '', 'longstanding', 'practice', 'united', 'states', 'prevention', 'tuberculosis', '', 'tb', '', 'transmission', '', 'however', '', 'national', 'incidence', 'tb', 'decline', 'steadily', 'past', 'several', 'decade', '', 'evidence', 'annual', 'screen', 'reduce', 'tb', 'incidence', '', 'test', 'number', 'limitation', '', 'based', 'factor', '', 'us', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'national', 'tuberculosis', 'controllers', 'association', '', 'ntca', '', 'issue', 'new', 'guideline', '2019', 'state', '', 'follow', 'baseline', 'screen', '', 'health', 'care', 'worker', 'undergo', 'routine', 'annual', 'screen', '', '13', '', '', 'agree', 'guidance', '', 'serf', 'update', 'prior', '2005', 'guideline', '', 'table', '1', '', '', 'annual', 'screen', 'reasonable', 'hcws', 'increase', 'risk', 'occupational', 'tb', 'exposure', '', 'pulmonologists', 'respiratory', 'therapist', '', 'hcws', 'certain', 'set', '', 'emergency', 'department', '', '', 'institutional', 'policy', 'individualize', 'incorporate', 'factor', '', '', '', 'approach', 'diagnosis', 'latent', 'tuberculosis', 'infection', '', 'tuberculosis', 'screen', '', 'adult', '', '', 'section', 'health', 'care', 'worker', '', '', '']",2099,"{'': 461, 'patient': 42, 'therapy': 20, 'screen': 20, 'recommend': 14, 'trial': 14, 'treatment': 13, 'brain': 13, 'section': 11, 'suggest': 11, 'adult': 11, 'year': 10, 'remdesivir': 10, 'grade': 10, 'reduce': 10, 'group': 10, 'versus': 9, 'percent': 9, 'risk': 9, 'adverse': 9}","{'rituximab': 2, 'cyclophosphamide': 2, 'infection': 8}",12,0.7506
ID:127094,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['second-line', 'systemic', 'therapy', 'advance', 'exocrine', 'pancreatic', 'cancer']","['INTRODUCTIONFor patient locally advance unresectable metastatic exocrine pancreatic cancer , palliative systemic chemotherapy improve disease-related symptom prolong survival .', 'Options second-line systemic therapy progression first-line regimen review .', 'Initial palliative systemic chemotherapy , specific method symptom palliation , management patient metastatic well-differentiated neuroendocrine ( islet cell ) tumor discuss separately .', ""( See `` Initial systemic chemotherapy advance exocrine pancreatic cancer '' `` Supportive care patient locally advance metastatic exocrine pancreatic cancer '' `` Endoscopic ultrasound-guided celiac plexus ganglion intervention '' `` Metastatic well-differentiated pancreatic neuroendocrine tumor : Systemic therapy option control tumor growth symptom hormone hypersecretion '' . )""]","['introductionfor', 'patient', 'locally', 'advance', 'unresectable', 'metastatic', 'exocrine', 'pancreatic', 'cancer', '', 'palliative', 'systemic', 'chemotherapy', 'improve', 'disease-related', 'symptom', 'prolong', 'survival', '', 'options', 'second-line', 'systemic', 'therapy', 'progression', 'first-line', 'regimen', 'review', '', 'initial', 'palliative', 'systemic', 'chemotherapy', '', 'specific', 'method', 'symptom', 'palliation', '', 'management', 'patient', 'metastatic', 'well-differentiated', 'neuroendocrine', '', 'islet', 'cell', '', 'tumor', 'discuss', 'separately', '', '', '', 'initial', 'systemic', 'chemotherapy', 'advance', 'exocrine', 'pancreatic', 'cancer', '', '', 'supportive', 'care', 'patient', 'locally', 'advance', 'metastatic', 'exocrine', 'pancreatic', 'cancer', '', '', 'endoscopic', 'ultrasound-guided', 'celiac', 'plexus', 'ganglion', 'intervention', '', '', 'metastatic', 'well-differentiated', 'pancreatic', 'neuroendocrine', 'tumor', '', 'systemic', 'therapy', 'option', 'control', 'tumor', 'growth', 'symptom', 'hormone', 'hypersecretion', '', '', '']",99,"{'': 20, 'systemic': 5, 'metastatic': 4, 'pancreatic': 4, 'patient': 3, 'advance': 3, 'exocrine': 3, 'cancer': 3, 'chemotherapy': 3, 'symptom': 3, 'tumor': 3, 'locally': 2, 'palliative': 2, 'therapy': 2, 'initial': 2, 'well-differentiated': 2, 'neuroendocrine': 2, 'introductionfor': 1, 'unresectable': 1, 'improve': 1}",{},0,-0.6249
ID:127551,,medical,2020-05-22 02:00:00,UPTODATE,2020-05-23 22:13:35.057884,"['coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'arrhythmias', 'conduction', 'system', 'disease']","['INTRODUCTION — Coronaviruses important human animal pathogen .', 'At end 2019 , novel coronavirus identify cause cluster pneumonia case Wuhan , city Hubei Province China .', 'It rapidly spread , result global pandemic .', ""The disease designate COVID-19 , stand `` coronavirus disease 2019 '' [ 1 ] ."", ""The virus cause COVID-19 designate `` severe acute respiratory syndrome coronavirus 2 '' ( SARS-CoV-2 ) ; previously , refer 2019-nCoV.Understanding COVID-19 evolve rapidly ."", 'Interim guidance issue World Health Organization United States Centers Disease Control Prevention [ 2,3 ] .', 'Links relate society guideline find elsewhere .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' , section 'Society guideline link ' ."", ') This topic discus epidemiology , clinical feature , diagnosis , management arrhythmia conduction system disease patient COVID-19 .', ""Clinical presentation , diagnosis , management cardiac presentation ( eg , acute coronary syndrome , heart failure , etc ) noncardiac symptom COVID-19 discuss detail elsewhere : ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Management hospitalize adult '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial infarction coronary artery disease issue '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Considerations child '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Infection control health care home set '' ."", "") ● ( See `` Coronavirus disease 2019 ( COVID-19 ) : Questions answer '' ."", ') ● ( Related Pathway ( ) : Coronavirus disease 2019 ( COVID-19 ) : Initial telephone triage adult outpatient .', ') Community-acquired coronaviruses , severe acute respiratory syndrome ( SARS ) coronavirus , Middle East respiratory syndrome ( MERS ) coronavirus discuss separately .', ""( See `` Coronaviruses '' `` Severe acute respiratory syndrome ( SARS ) '' `` Middle East respiratory syndrome coronavirus : Virology , pathogenesis , epidemiology '' ."", ') EPIDEMIOLOGY — The prevalence arrhythmia conduction system disease ( cardiovascular disease general ) patient COVID-19 vary population population .', 'In available report , specific cause palpitation type arrhythmia specify .', 'Hypoxia electrolyte abnormality , know contribute development acute arrhythmia , frequently report acute phase severe COVID-19 illness ; therefore , exact contribution COVID-19 infection development arrhythmia asymptomatic , mildly ill , critically ill , recover patient know [ 4 ] .', '●In multinational cohort 8910 patient Asia , Europe , North America , 304 patient ( 3.4 percent ) history arrhythmia [ 5 ] .', 'A history arrhythmia twice common patient die COVID-19 ( 6.8 versus 3.2 percent among survivor ) .', '●In 137 subject Hubei province , 10 patient ( 7.3 percent ) note palpitation one initial symptom [ 6 ] .', '●In study 138 patient Wuhan hospitalize COVID-19-related pneumonia , arrhythmia report 17 percent general cohort 44 percent patient admit intensive care unit [ 7 ] .', 'CLINICAL MANIFESTATIONSSigns symptom — Pneumonia appear frequent serious manifestation infection , characterize primarily fever , cough , dyspnea , bilateral infiltrate chest image .', 'The common clinical feature report onset illness include fever ( 99 percent ) , fatigue ( 70 percent ) , dry cough ( 59 percent ) , anorexia ( 40 percent ) , myalgia ( 35 percent ) , dyspnea ( 31 percent ) , sputum production ( 27 percent ) [ 7 ] .', 'Noncardiac manifestation COVID-19 discuss detail separately .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Epidemiology , virology , clinical feature , diagnosis , prevention '' `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') The vast majority patient present systemic illness consistent COVID-19 symptom sign arrhythmia conduction system disease .', 'Patients may tachycardic ( without palpitation ) set illness-related symptom ( eg , fever , shortness breath , pain , etc ) .', 'The follow observation report various cohort : ●In cohort Hubei province , 7.3 percent report palpitation present symptom [ 6,8 ] .', '●Among 4250 patient COVID-19 multicenter New York cohort , 260 ( 6.1 percent ) QTc > 500 millisecond time admission [ 9 ] .', 'However , another study 84 patient receive hydroxychloroquine azithromycin , baseline QTc 435 millisecond take medication [ 10 ] .', '●Among 393 patient COVID-19 different New York cohort , atrial arrhythmia common among patient require mechanical ventilation ( 17.7 versus 1.9 percent ) [ 11 ] .●Among 187 patient COVID-19 Chinese cohort , 11 patient ( 5.9 percent ) ventricular tachyarrhythmias hospitalize [ 12 ] .', '●Epidemiologic data Lombardi region Italy show nearly 60 percent increase rate out-of-hospital cardiac arrest peak 2020 COVID-19 pandemic ( compare time frame 2019 ) [ 13 ] .', 'This could relate COVID-19 infection , stress relate pandemic , delay seek medical attention cardiac symptom .', 'It appear increase shockable rhythm , even suspect diagnose COVID-19 .', 'Other patient arrhythmia may see include : ●Patients present cardiovascular complication set COVID-19 infection , myocardial injury myocardial ischemia .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial infarction coronary artery disease issue '' `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' . )"", '●Patients hypoxia , shock ( septic cardiogenic ) , evidence widespread systemic inflammation [ 14 ] .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Critical care airway management issue '' ."", ') ●Patients electrolyte disturbance ( eg , hypokalemia ) predispose development arrhythmia .', ""( See `` Clinical manifestation treatment hypokalemia adult '' , section 'Cardiac arrhythmia ECG abnormality ' `` Hypomagnesemia : Clinical manifestation magnesium depletion '' , section 'Cardiovascular ' ."", ') ●Patients receive QT-prolonging therapy may develop polymorphic ventricular tachycardia ( VT ) .', ""( See 'Patients polymorphic ventricular tachycardia ( torsades de point ) ' . )"", '●Patients fever , unmask case cardiac channelopathies Brugada syndrome long QT syndrome [ 15,16 ] .', ""( See 'Brugada syndrome ' `` Brugada syndrome : Clinical presentation , diagnosis , evaluation '' `` Congenital long QT syndrome : Epidemiology clinical manifestation '' ."", ') Cardiovascular testingECG — Most patient COVID-19 suspect , particular patient severe disease QT-prolonging medication use , baseline electrocardiogram ( ECG ) perform time entry health care system [ 17 ] .', 'Ideally , would 12-lead ECG , single- multi-lead ECG telemetry monitor multiple lead position hand-held ECG device may adequate situation minimize staff exposure patient [ 18 ] .', 'This allow document baseline QRS-T morphology patient develop signs/symptoms suggestive myocardial injury acute coronary syndrome .', 'Additionally , baseline ECG allow documentation QT ( correct QTc ) interval .', 'Importantly , QTc need monitor QT-prolonging therapy initiate ( eg , azithromycin , chloroquine , etc ) reduce risk acquire LQTS .', ""( See `` Acquired long QT syndrome : Clinical manifestation , diagnosis , management '' 'Patients receive QT-prolonging treatment ( eg , hydroxychloroquine , chloroquine , azithromycin , etc ) ' ."", ') Continuous ECG monitor — In absence document cardiac arrhythmia , suspect myocardial ischemia , standard indication , continuous ECG monitor require .', 'However , part infection control mechanism patient establish suspect COVID-19 infection , many hospital utilize continuous ECG monitor ( conjunction automate blood pressure read oxygen saturation monitor ) lieu standard vital sign check nurse staff .', 'This practice reduce number clinical staff interact patient , thereby reduce risk health care worker preserve personal protective equipment .', 'Transthoracic echocardiography — While patient may develop cardiac manifestation , include myocardial injury , initial transthoracic echocardiogram necessary patient .', 'Providers may consider use point-of-care ultrasound focus exam .', ""( See `` Coronavirus disease 2019 ( COVID-19 ) : Myocardial injury '' ."", ') DIAGNOSIS OF ARRHYTHMIAS — Arrhythmias commonly diagnose combination vital sign review ECG , ideally 12-lead ECG , rhythm strip also use .', 'Tachycardias present pulse greater 100 beat per minute , bradyarrhythmias present pulse le 50 60 beat per minute .', '●The common arrhythmia overall patient COVID-19 sinus tachycardia , likely pathologic arrhythmia include atrial fibrillation , atrial flutter , monomorphic polymorphic VT.●The differentiation various tachycardia base regularity ( ie , regular irregular ) QRS width ( ie , narrow wide QRS complex ) require surface ECG .', ""( See `` Narrow QRS complex tachycardia : Clinical manifestation , diagnosis , evaluation '' `` Wide QRS complex tachycardia : Approach diagnosis '' ."", ') ●Bradyarrhythmias , include sinus pause high-grade heart block slow escape rhythm , typically see identify use surface ECG present .', ""( See `` Sinus node dysfunction : Clinical manifestation , diagnosis , evaluation '' `` Second degree atrioventricular block : Mobitz type II '' `` Third degree ( complete ) atrioventricular block '' ."", ') The diagnosis acquire LQTS make patient sufficient QT prolongation surface ECG association medication clinical scenario ( ie , hypokalemia hypomagnesemia ) know cause QT prolongation .', 'Ideally , diagnosis make follow review full 12-lead ECG , sometimes single-lead rhythm strip adequate full 12-lead ECG obtain .', 'Acquired QT prolongation typically reversible upon removal underlie etiology , discontinuation offend medication correction electrolyte derangement .', ""( See 'Management ' ."", ') Overall , average QTc healthy person puberty 420±20 millisecond .', 'In general , 99th percentile QTc value 470 millisecond postpubertal male 480 millisecond postpubertal female [ 19 ] .', 'A QTc > 500 millisecond consider highly abnormal men women.MANAGEMENTPatients polymorphic ventricular tachycardia ( torsades de point ) — All patient torsades de point ( TdP ) immediate assessment symptom , vital sign , level consciousness determine hemodynamically stable unstable .', 'Unstable patient — Patients sustain TdP usually become hemodynamically unstable , severely symptomatic , pulseless treat accord standard resuscitation algorithm [ 20 ] , include cardioversion/defibrillation ( algorithm 1 ) .', 'Initial treatment antiarrhythmic medication , exception intravenous ( IV ) magnesium , indicate hemodynamically unstable pulseless patient .', 'A full discussion standard approach basic life support advance cardiac life support present separately .', ""( See `` Basic life support ( BLS ) adult '' `` Advanced cardiac life support ( ACLS ) adult '' ."", ') Stable patient — Patients TdP hemodynamically stable presentation may remain stable may become unstable rapidly without warn .', 'As , therapy promptly provide patient .', 'A stable patient one typically show evidence hemodynamic compromise may frequent , repetitive burst TdP .', 'This patient continuous monitor frequent reevaluation due potential rapid deterioration long TdP persist .', '●For patient single episode TdP , treatment IV magnesium along correction metabolic/electrolyte derangement and/or removal incite medication may sufficient .', 'The patient carefully monitor electrolyte normalize QT interval nearly normalizes.●For patient multiple self-terminating episode TdP , therapy utilize patient single episode ( ie , IV magnesium , correction metabolic/electrolyte derangement , and/or removal incite medication ) , along additional intervention increase heart rate , include overdrive pace and/or IV isoproterenol infusion.Patients arrhythmia — The management arrhythmia set COVID-19 infection different routine management condition without COVID-19 infection .', ""Please refer follow topic management : Atrial fibrillation supraventricular tachycardia : ● ( See `` Overview acute management tachyarrhythmias '' ."", "") ● ( See `` Overview atrial fibrillation '' ."", "") ● ( See `` Overview atrial flutter '' ."", "") ● ( See `` Atrioventricular nodal reentrant tachycardia '' ."", "") ● ( See `` Treatment symptomatic arrhythmia associate Wolff-Parkinson-White syndrome '' ."", "") ● ( See `` Focal atrial tachycardia '' . )"", ""Monomorphic VT : ● ( See `` Wide QRS complex tachycardia : Approach management '' ."", "") ● ( See `` Sustained monomorphic ventricular tachycardia patient structural heart disease : Treatment prognosis '' ."", "") ● ( See `` Ventricular tachycardia absence apparent structural heart disease '' . )"", ""Conduction system disease : ● ( See `` Sinus node dysfunction : Treatment '' ."", "") ● ( See `` Third degree ( complete ) atrioventricular block '' ."", "") ● ( See `` Second degree atrioventricular block : Mobitz type II '' ."", "") ● ( See `` Temporary cardiac pace '' ."", ') Patients receive QT-prolonging treatment ( eg , hydroxychloroquine , chloroquine , azithromycin , etc ) — While data limit , many patient treat chloroquine hydroxychloroquine , structurally similar quinidine QT-prolonging effect block activation potassium channel IKr ( hERG/Kv11.1 ) [ 4,21,22 ] .', 'Other medication QT-prolonging effect may try COVID-19 ( table 1 ) .', 'In addition , chloroquine hydroxychloroquine metabolize CYP3A4 , medication inhibit cytochrome could raise plasma level [ 21 ] .', 'Limited data hydroxychloroquine suggest low risk cause TdP , base use rheumatoid arthritis , systemic lupus erythematosus , antimalarial therapy [ 23,24 ] .', 'There in-vitro data suggest safety azithromycin chloroquine action potential duration alternans [ 25 ] , clinical data TdP risk .', 'For medication , time window use short duration , another reason risk TdP may lower .', 'However , greater QT-prolonging effect electrolyte abnormality , take QT-prolonging medication , chronic renal insufficiency , congenital long QT syndrome .', '●In one study 84 patient COVID-19 receive hydroxychloroquine azithromycin , QTc increase 435 millisecond maximum 463 millisecond , peak day 3 4 [ 10 ] .', 'There high-risk group nine patient ( 11 percent ) whose baseline QTc 447 millisecond increase 527 millisecond .', 'Importantly , TdP seen.●In study 81 severely ill patient admit suspicion COVID-19 treat azithromycin randomize receive chloroquine high dose ( 600 mg twice daily 10 day ) low dose ( 450 mg twice daily one day , 450 mg daily four day ) , baseline QTc ( Fridericia method ) average 425 millisecond significantly different high- low-dose patient [ 26 ] .', 'QTc increase > 500 millisecond 7 37 ( 18.9 percent ) high-dose recipient 4 36 ( 11.1 percent ) low-dose recipient .', ""Two high-dose chloroquine recipient develop VT , TdP reported.Monitoring QT prolongation — The patient 's baseline QTc value obtain prior administer drug potential prolong QT interval [ 27 ] ."", 'The best method obtain QT interval 12-lead ECG , reduce exposure staff , may always feasible .', 'A single-lead ECG may underestimate QT interval , attempt use multiple-lead telemetry system monitor QT interval .', 'There outpatient use hydroxychloroquine also , clear guidance regard monitor patient .', 'Ambulatory ECG monitor technology , include use mobile wearable technology ( eg , mobile cardiac outpatient telemetry ) , report reliable alternative demand exceed capacity standard telemetry monitor [ 28 ] .', 'It also important patient treat QT-prolonging drug report promptly new symptom include palpitation , syncope , near-syncope .', 'They also report clinical change could lead hypokalemia , gastroenteritis initiation diuretic therapy .', 'In general , patient follow QTc interval low risk significant QT prolongation polymorphic VT : ●QTc < 460 millisecond prepubertal males/females●QTc < 470 millisecond postpubertal males●QTc < 480 millisecond postpubertal femalesPatients baseline QTc interval ≥500 millisecond ( QRS ≤120 millisecond ) increase risk significant QT prolongation polymorphic VT [ 29 ] .', 'In patient , effort make correct contribute electrolyte abnormality ( eg , hypocalcemia , hypokalemia , and/or hypomagnesemia ) , goal potassium close 5 mEq/L .', 'Even normal QT interval , review discontinuation QT-prolonging medication may essential immediate care patient ( eg , proton pump inhibitor , etc ) ( table 1 ) [ 30 ] .', 'In particular , one QT-prolonging agent use simultaneously , recommend one follow approach : ●One protocol publish Mayo Clinic , use QTc cutoff [ 31 ] .', 'If two three hour dose hydroxychloroquine QT-prolonging agent , QTc increase ≥500 millisecond change QT interval ≥60 millisecond , reevaluation risk TdP versus benefit medication , follow step take : •Recognition increase risk TdP.•Discontinuation QT-prolonging medications.•Correction electrolyte abnormalities.•Place patient continuous telemetry , consideration wearable defibrillator placement external defibrillator patches.•If TdP develop , hydroxychloroquine , chloroquine , azithromycin medication stopped.●Another protocol propose ECG baseline four hour hydroxychloroquine antiviral medication administration congenital acquire long QT syndrome , patient already take QT-prolonging medication , patient structural heart disease bradycardia [ 21 ] .', 'Another ECG complete one three day later .', 'For others , ECG QTc interval-monitoring method do 24 hour start medication .', 'If QTc increase ≥500 millisecond , change QT interval ≥60 millisecond , ventricular ectopy develop , protocol recommend cardiology consultation .', '●There risk score develop hospitalize patient prediction QT interval prolongation , though necessarily use hydroxychloroquine [ 32,33 ] .', 'It classify patient low , moderate , high risk TdP , may allow triaging whether continuous telemetry need use QT-prolonging medication , especially limit resource patient could otherwise follow outpatient .', 'Signs toxicity — There also anecdotal report toxicity associate chloroquine hydroxychloroquine .', 'Doses 5 gm chloroquine usually lead death [ 34 ] .', 'Symptoms typically occur first hour ingestion , seizure cardiac arrest , medication similar quinidine , sodium channel blocker .', 'Cardiovascular toxicity include widen QRS , prolong QT interval , ventricular arrhythmia , cardiac dysfunction , hypotension .', 'If ingestion acute , activate charcoal may use .', 'In general , treatment involve epinephrine , high-dose diazepam , repletion potassium [ 35 ] .', 'However , much potassium give , rebound hyperkalemia intracellular shift cell .', 'A bicarbonate IV infusion may give , care may lead worsen hypokalemia .', 'IV lipid emulsion also attempt limit report [ 36 ] .', 'A local poison control center may contact additional help .', 'Brugada syndrome — Because increase risk ventricular arrhythmia set fever Brugada syndrome , aggressive fever reduction acetaminophen imperative .', 'High-risk patient , spontaneous type 1 pattern ECG prior syncope , might consider go emergency department fever promptly lower acetaminophen [ 21 ] .', ""( See `` Brugada syndrome : Prognosis , management , approach screen '' , section 'Treatment ' ."", ') PROGNOSIS — Mortality rate appear increase significantly increase age ; case fatality rate < 1 percent report 50 year age , rate approach 15 percent patient 80 year age older [ 37 ] .', 'Similarly , mortality increase disease severity , death report among mild severe case Chinese cohort , mortality approach 50 percent among critically ill patient [ 37 ] .', 'Underlying medical comorbidities appear significantly impact COVID-19 severity mortality .', 'Patients underlie cardiovascular disease hypertension report significantly high-case fatality rate compare patient without underlie comorbidities ( 10.5 6 percent mortality , respectively , compare 0.9 percent mortality without underlie comorbidities ) [ 37,38 ] .', 'Similarly , patient multinational cohort die COVID-19 twice likely history cardiac arrhythmia [ 5 ] .IMPORTANT INFORMATION FOR PROVIDERS CARING FOR COVID-19 PATIENTS — In addition provide best possible care patient , infection control limit transmission essential component care patient suspect document COVID-19 [ 4,39-43 ] .Inpatient care consultation — The approach care hospitalize patient document suspect COVID-19 differ slightly , intent reduce exposure ( spread ) COVID-19 health care provider .', 'In general , number person interact directly patient time spend room minimize .', 'Social distance maintain , patient member health care team .', ""The follow step , possible , minimize exposure personnel limit use PPE : ●For stable new admission , patient see person attend physician one house officer advance practitioner ( applicable ) .●For stable patient daily round , one person primary care team enter room conduct need physical exam , rest team participate outside room via video chat telephone.●Routine arrhythmia consultation , particularly stable patient ECG evidence document specific arrhythmia conduction disorder , complete without enter patient 's room review available record ECG monitor data ."", '●Consider place patient telemetry concern arrhythmia , thereby reduce need in-room vital signs.●Utilize room window door assist monitor patient outside room .', 'Patients contact telephone routine matter without require entry room.Arrhythmia-related procedure — In order maximize available health care system resource treat COVID-19 patient pandemic , also minimize potential exposure health care personnel asymptomatic carrier virus , elective nonurgent procedure postpone later date .', 'A discussion reason behind decision postpone procedure communicate patient document medical record .', 'Conversely , urgent semiurgent procedure perform perceive benefit procedure patient outweigh risk resource utilization health care personnel exposure .', 'Examples type procedure category follow [ 4,39 ] : Urgent ( substantial risk decompensation , hospitalization , death procedure delay ) : ●VT ablation medically uncontrolled electrical storm hemodynamically compromise patient.●Catheter ablation incessant , hemodynamically significant , severely symptomatic tachycardia ( supraventricular VT [ SVT ] /atrial fibrillation [ AF ] /atrial flutter ) respond antiarrhythmic drug , rate control , and/or cardioversion.●Catheter ablation Wolff-Parkinson-White syndrome preexcited AF syncope cardiac arrest.●Lead revision malfunction pacemaker-dependent patient implantable cardioverter-defibrillator ( ICD ) patient receive inappropriate therapy.●Generator change pacemaker-dependent patient elective replacement indicator ( ERI ) device end life .', '●Pacemaker ICD generator change minimal battery remain , depend specific clinical situations.●Secondary prevention ICD.●Pacemaker implant complete heart block , Mobitz II atrioventricular ( AV ) block , high-grade AV block symptom severe symptomatic sinus node dysfunction long pauses.●Lead/device extraction infection , include patient respond antibiotic endocarditis , bacteremia , pocket infection.●Cardiac resynchronization therapy set severe refractory heart failure guideline-indicated patients.●Cardioversion highly symptomatic atrial arrhythmia rapid ventricular rate control medications.●Transesophageal echocardiogram patient need urgent cardioversion.Semiurgent ( procedure deem urgent perform timely manner due clinical scenario ) : ●VT ablation medically refractory recurrent VT. ●SVT ablation patient medically refractory SVT , result emergency department visit .', '●Cardiac implantable electrical device ( CIED ) generator replacement ERI battery status urgent .', '●Primary prevention ICD patient particularly high risk life-threating ventricular arrhythmia .', 'Nonurgent ( procedure may delay week month ) : ●Premature ventricular complex ablation .', '●SVT ablation .', '●AF atrial flutter ablation stable patient without heart failure , significant risk get hospitalize delay procedure , high risk procedure-related complication due comorbidities .', '●Electrophysiology test evaluate stable tachyarrhythmias bradycardia .', '●Primary prevention ICD semiurgent .', '●Cardiac resynchronization therapy stable patients.●CIED upgrade .', '●Pacemaker implant sinus node dysfunction , Mobitz I AV block , stable non-high-degree AV block , tachy-brady syndrome mildly symptomatic patient .', '●Pacemaker ICD generator replacement patient > 6 week battery remain .', '●Extraction noninfected devices/leads unless device function dependent lead extraction reimplant .', '●Cardioversion stable arrhythmia well-tolerated symptom .', '●Left atrial appendage ( LAA ) closure patient anticoagulation.●Transesophageal echocardiogram routine assessment valve LAA closure device cardioversions do appropriate period anticoagulation.●Implantable loop recorder implants.●Tilt-table testing.Perioperative cardiac implantable electrical device management — For patient CIED undergo surgery endoscopic procedure , important know patient pacemaker dependent , patient ICD therapy activate , likelihood electromagnetic interference ( EMI ) procedure ( eg , due electrocautery , etc ) .', 'In patient document suspect COVID-19 undergo procedure high likelihood EMI could result pacemaker ICD malfunction , application magnet may use suspend antitachyarrhythmia therapy ICD produce asynchronous pace pacemaker [ 40 ] .', 'This allow patient safely proceed necessary procedure without reprogramming CIED procedure , thereby reduce risk health care personnel preserve personal protective equipment ( PPE ) .The standard approach CIED management , include in-person reprogramming CIED procedure , discuss detail elsewhere .', ""( See `` Perioperative management patient pacemaker implantable cardioverter-defibrillator '' ."", ') Cardiac implantable electrical device interrogation — For patient , majority CIED follow-up device interrogation modern-era device do either person remotely .', 'To maintain social distance COVID-19 pandemic , recommend remote CIED interrogation vast majority stable patient [ 40 ] .Certain situation remain , however , in-person CIED interrogation may prefer option , include [ 4,40 ] : ●Suspected CIED malfunction , include : •Inappropriate pacemaker pace sense note ECG telemetry monitoring.•Failure ICD deliver therapy document sustain ventricular tachyarrhythmia.●Clinically actionable abnormality CIED suspicion device near end battery life , note remote monitor , telemetry , ambulatory monitoring.●ICD shock , presyncope , syncope concern arrhythmic event perform program changes.●Untreated sustain ventricular arrhythmia patient ICD.●Evaluation symptom suspicious arrhythmia abnormal device function patient enrol remote monitoring.●Identified need reprogramming CIED , ICD patient whose device deliver auditory vibratory alerts.●Assessment atrial fibrillation ( AF ) patient stroke clear documentation AF ECG telemetry monitoring.●For CIED patient require urgent emergent magnetic resonance image ( MRI ) scan , consider perform compute tomography scan instead possible ( minimize need additional health care provider device manufacturer representative contact ) ; urgent , delay MRI .', '●Patients emergency department ( set ) remote monitor available .', ""Remote monitor use wherever possible , include option ask family bring patient 's home monitor equipment hospital ."", 'After in-person CIED interrogation perform , important disinfect part programmer ( eg , program wand cord ) contact patient .', 'If available , disposable plastic wand cover may use minimize contamination , consideration also give use dedicate interrogation device set know suspect COVID-19-positive patient .', 'To reduce exposure health care personnel CIED patient , doughnut magnet use alternative complete CIED interrogation reprogramming [ 41 ] .', 'When hospitalize patient pacemaker remote monitor capability , proper function pacemaker question , temporary application doughnut magnet pacemaker safe quickly determine whether pacemaker capable deliver pace stimulus capture heart .', 'Magnet application place pacemaker asynchronous pace mode .', 'Depending manufacturer program set , may include change pace rate , give evidence battery status ( ie , elective replacement indicator ) whether pacemaker capture .', 'In addition , demonstration ventricular capture provide basic reassurance pacemaker functional avoid need complete pacemaker interrogation .', ""( See `` Perioperative management patient pacemaker implantable cardioverter-defibrillator '' ."", "") Patients require cardiopulmonary resuscitation ( CPR ) — In general , basic life support advance cardiac life support patient COVID-19 administer standard fashion , similar patient without COVID-19 , follow exception [ 4,42 ] ( see `` Basic life support ( BLS ) adult '' , section 'Resuscitation patient COVID-19 ' ) : ●Any personnel care patient suspect confirm COVID-19 wear appropriate PPE enter room : gown , glove , eye protection , respirator ( eg , N95 respirator ) ."", 'If supply respirator limit , United States Centers Disease Control Prevention acknowledge facemasks acceptable alternative ( addition contact precaution eye protection ) , respirator wear aerosol-generating procedure , include intubation .', 'The appropriate PPE don prior interact patient , even lead delay provision resuscitative care.●The number people involve resuscitation keep minimum .', 'This typically include team leader , anesthesiologist manage airway ( patient already intubate ) , recorder/scribe , person perform chest compression , defibrillation , administration medication ( often , participant rotate allow period rest perform chest compression ) .●In COVID-19 patient yet intubate time cardiac arrest , early intubation perform provider likely achieve success first pas , utilize readily available technology ( eg , video laryngoscopy ) optimize first-pass success .', 'Chest compression stop intubation , intubation ( cuff endotracheal tube ) perform prior standard two minute chest compression early defibrillation mean control potential spread airborne droplets.●If available , mechanical chest compression device may use place manual compression adult adolescent meet minimum height weight requirements.●For critically ill patient already intubate prone position time arrest , CPR may attempt patient prone perform compression hand T7/10 vertebral body .', 'Defibrillation may perform pad anterior-posterior position .', 'The patient turn supine position resuscitation able without equipment disconnection may lead aerosolization viral particles.●For out-of-hospital resuscitation effort , lay rescuer perform chest compression-only CPR wear face mask cloth cover .', 'When available , automate external defibrillator apply use accord usual protocol .', ""( See `` Automated external defibrillator '' `` Basic life support ( BLS ) adult '' , section 'Defibrillation ' ."", ') Initial treatment antiarrhythmic medication , exception IV magnesium , indicate hemodynamically unstable pulseless patient .', 'A full discussion standard approach basic life support advance cardiac life support present separately .', ""( See `` Basic life support ( BLS ) adult '' `` Advanced cardiac life support ( ACLS ) adult '' ."", ') SOCIETY GUIDELINE LINKS — Links society government-sponsored guideline select country region around world provide separately .', ""( See `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – International government guideline general care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Guidelines specialty care '' `` Society guideline link : Coronavirus disease 2019 ( COVID-19 ) – Resources patient '' ."", "") INFORMATION FOR PATIENTS — UpToDate offer two type patient education material , `` The Basics '' `` Beyond Basics . ''"", 'The Basics patient education piece write plain language , 5th 6th grade read level , answer four five key question patient might give condition .', 'These article best patient want general overview prefer short , easy-to-read material .', 'Beyond Basics patient education piece longer , sophisticate , detail .', 'These article write 10th 12th grade read level best patient want in-depth information comfortable medical jargon.Here patient education article relevant topic .', 'We encourage print e-mail topic patient .', ""( You also locate patient education article variety subject search `` patient info '' keyword ( ) interest ."", "") ●Basics topic ( see `` Patient education : Coronavirus disease 2019 ( COVID-19 ) overview ( The Basics ) '' ) SUMMARY AND RECOMMENDATIONS●The vast majority patient present systemic illness consistent COVID-19 symptom sign arrhythmia conduction system disease ."", 'However , patient arrhythmia may see include patient myocardial injury , myocardial ischemia , hypoxia , shock , electrolyte disturbance , receive medication know prolong QT interval .', ""( See 'Signs symptom ' ."", ') ●All patient COVID-19 suspect baseline electrocardiogram ( ECG ) perform time entry health care system .', 'Ideally , would 12-lead ECG , single-lead multi-lead ECG telemetry monitor may adequate situation minimize staff exposure patient .', 'Continuous ECG monitor echocardiography require patient use select situation .', ""( See 'Cardiovascular test ' ."", ') ●Patients sustain torsades de point ( TdP ) usually become hemodynamically unstable , severely symptomatic , pulseless treat accord standard resuscitation algorithm , include cardioversion/defibrillation ( algorithm 1 ) .', 'Patients TdP hemodynamically stable presentation may remain stable may become unstable rapidly without warn .', 'Treatment intravenous ( IV ) magnesium along correction metabolic/electrolyte derangement and/or removal incite medication may sufficient , although patient frequent recurrent episode may require additional intervention .', ""( See 'Patients polymorphic ventricular tachycardia ( torsades de point ) ' ."", ') ●Patients receive QT-prolonging medication baseline QTc value obtain prior administer drug .', 'If QTc subsequently increase ≥500 millisecond change QT interval ≥60 millisecond baseline ECG , risk versus benefit continue treatment QT-prolonging medication reassess , consideration dose adjustment additional intervention .', ""( See 'Patients receive QT-prolonging treatment ( eg , hydroxychloroquine , chloroquine , azithromycin , etc ) ' ."", ') ●The approach care hospitalize patient document suspect COVID-19 differ slightly , intent reduce exposure ( spread ) COVID-19 health care provider .', 'In general , number person interact directly patient time spend room minimize .', 'Social distance maintain , patient member health care team .', ""( See 'Inpatient care consultation ' 'Arrhythmia-related procedure ' ."", ') ●The approach cardiac implantable electrical device ( CIED ) interrogation perioperative CIED management summarize text .', 'Strategies avoid in-person device interrogation deploy .', ""( See 'Cardiac implantable electrical device interrogation ' 'Perioperative cardiac implantable electrical device management ' ."", ') ●In general , basic life support advance cardiac life support patient COVID-19 administer standard fashion patient without COVID-19 .', 'However , personnel care patient suspect confirm COVID-19 wear appropriate personal protective equipment ( include gown , glove , eye protection , respirator face mask ) enter room , number people involve resuscitation keep minimum , early intubation perform patient yet intubate time cardiac arrest .', ""( See 'Patients require cardiopulmonary resuscitation ( CPR ) ' . )""]","['', 'coronaviruses', 'important', 'human', 'animal', 'pathogen', '', 'end', '2019', '', 'novel', 'coronavirus', 'identify', 'cause', 'cluster', 'pneumonia', 'case', 'wuhan', '', 'city', 'hubei', 'province', 'china', '', 'rapidly', 'spread', '', 'result', 'global', 'pandemic', '', 'disease', 'designate', 'covid-19', '', 'stand', '', 'coronavirus', 'disease', '2019', '', '', '1', '', '', 'virus', 'cause', 'covid-19', 'designate', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', '', 'sars-cov-2', '', '', 'previously', '', 'refer', '2019-ncovunderstanding', 'covid-19', 'evolve', 'rapidly', '', 'interim', 'guidance', 'issue', 'world', 'health', 'organization', 'united', 'states', 'centers', 'disease', 'control', 'prevention', '', '23', '', '', 'links', 'relate', 'society', 'guideline', 'find', 'elsewhere', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'section', 'society', 'guideline', 'link', '', '', '', 'topic', 'discus', 'epidemiology', '', 'clinical', 'feature', '', 'diagnosis', '', 'management', 'arrhythmia', 'conduction', 'system', 'disease', 'patient', 'covid-19', '', 'clinical', 'presentation', '', 'diagnosis', '', 'management', 'cardiac', 'presentation', '', 'eg', '', 'acute', 'coronary', 'syndrome', '', 'heart', 'failure', '', 'etc', '', 'noncardiac', 'symptom', 'covid-19', 'discuss', 'detail', 'elsewhere', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'management', 'hospitalize', 'adult', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'infarction', 'coronary', 'artery', 'disease', 'issue', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'considerations', 'child', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'infection', 'control', 'health', 'care', 'home', 'set', '', '', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'questions', 'answer', '', '', '', '', '', 'related', 'pathway', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'initial', 'telephone', 'triage', 'adult', 'outpatient', '', '', 'community-acquired', 'coronaviruses', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', 'coronavirus', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'mers', '', 'coronavirus', 'discuss', 'separately', '', '', '', 'coronaviruses', '', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'sars', '', '', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'virology', '', 'pathogenesis', '', 'epidemiology', '', '', '', 'epidemiology', '', 'prevalence', 'arrhythmia', 'conduction', 'system', 'disease', '', 'cardiovascular', 'disease', 'general', '', 'patient', 'covid-19', 'vary', 'population', 'population', '', 'available', 'report', '', 'specific', 'cause', 'palpitation', 'type', 'arrhythmia', 'specify', '', 'hypoxia', 'electrolyte', 'abnormality', '', 'contribute', 'development', 'acute', 'arrhythmia', '', 'frequently', 'report', 'acute', 'phase', 'severe', 'covid-19', 'illness', '', 'therefore', '', 'exact', 'contribution', 'covid-19', 'infection', 'development', 'arrhythmia', 'asymptomatic', '', 'mildly', 'ill', '', 'critically', 'ill', '', 'recover', 'patient', '', '4', '', '', 'multinational', 'cohort', '8910', 'patient', 'asia', '', 'europe', '', 'north', 'america', '', '304', 'patient', '', '34', 'percent', '', 'history', 'arrhythmia', '', '5', '', '', 'history', 'arrhythmia', 'twice', 'common', 'patient', 'die', 'covid-19', '', '68', 'versus', '32', 'percent', 'among', 'survivor', '', '', '137', 'hubei', 'province', '', '10', 'patient', '', '73', 'percent', '', 'note', 'palpitation', 'one', 'initial', 'symptom', '', '6', '', '', 'study', '138', 'patient', 'wuhan', 'hospitalize', 'covid-19-related', 'pneumonia', '', 'arrhythmia', 'report', '17', 'percent', 'general', 'cohort', '44', 'percent', 'patient', 'admit', 'intensive', 'care', 'unit', '', '7', '', '', 'clinical', 'manifestationssigns', 'symptom', '', 'pneumonia', 'appear', 'frequent', 'serious', 'manifestation', 'infection', '', 'characterize', 'primarily', 'fever', '', 'cough', '', 'dyspnea', '', 'bilateral', 'infiltrate', 'chest', 'image', '', 'common', 'clinical', 'feature', 'report', 'onset', 'illness', 'include', 'fever', '', '99', 'percent', '', '', 'fatigue', '', '70', 'percent', '', '', 'dry', 'cough', '', '59', 'percent', '', '', 'anorexia', '', '40', 'percent', '', '', 'myalgia', '', '35', 'percent', '', '', 'dyspnea', '', '31', 'percent', '', '', 'sputum', 'production', '', '27', 'percent', '', '', '7', '', '', 'noncardiac', 'manifestation', 'covid-19', 'discuss', 'detail', 'separately', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'epidemiology', '', 'virology', '', 'clinical', 'feature', '', 'diagnosis', '', 'prevention', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'vast', 'majority', 'patient', 'present', 'systemic', 'illness', 'consistent', 'covid-19', 'symptom', 'sign', 'arrhythmia', 'conduction', 'system', 'disease', '', 'patients', 'tachycardic', '', 'without', 'palpitation', '', 'set', 'illness-related', 'symptom', '', 'eg', '', 'fever', '', 'shortness', 'breath', '', 'pain', '', 'etc', '', '', 'follow', 'observation', 'report', 'various', 'cohort', '', 'cohort', 'hubei', 'province', '', '73', 'percent', 'report', 'palpitation', 'present', 'symptom', '', '68', '', '', 'among', '4250', 'patient', 'covid-19', 'multicenter', 'new', 'york', 'cohort', '', '260', '', '61', 'percent', '', 'qtc', '', '500', 'millisecond', 'time', 'admission', '', '9', '', '', 'however', '', 'another', 'study', '84', 'patient', 'receive', 'hydroxychloroquine', 'azithromycin', '', 'baseline', 'qtc', '435', 'millisecond', 'medication', '', '10', '', '', 'among', '393', 'patient', 'covid-19', 'different', 'new', 'york', 'cohort', '', 'atrial', 'arrhythmia', 'common', 'among', 'patient', 'require', 'mechanical', 'ventilation', '', '177', 'versus', '19', 'percent', '', '', '11', '', 'among', '187', 'patient', 'covid-19', 'chinese', 'cohort', '', '11', 'patient', '', '59', 'percent', '', 'ventricular', 'tachyarrhythmias', 'hospitalize', '', '12', '', '', 'epidemiologic', 'data', 'lombardi', 'region', 'italy', 'show', 'nearly', '60', 'percent', 'increase', 'rate', 'out-of-hospital', 'cardiac', 'arrest', 'peak', '2020', 'covid-19', 'pandemic', '', 'compare', 'time', 'frame', '2019', '', '', '13', '', '', 'relate', 'covid-19', 'infection', '', 'stress', 'relate', 'pandemic', '', 'delay', 'seek', 'medical', 'attention', 'cardiac', 'symptom', '', 'appear', 'increase', 'shockable', 'rhythm', '', 'suspect', 'diagnose', 'covid-19', '', 'patient', 'arrhythmia', 'include', '', 'patients', 'present', 'cardiovascular', 'complication', 'set', 'covid-19', 'infection', '', 'myocardial', 'injury', 'myocardial', 'ischemia', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'infarction', 'coronary', 'artery', 'disease', 'issue', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', 'patients', 'hypoxia', '', 'shock', '', 'septic', 'cardiogenic', '', '', 'evidence', 'widespread', 'systemic', 'inflammation', '', '14', '', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'critical', 'care', 'airway', 'management', 'issue', '', '', '', 'patients', 'electrolyte', 'disturbance', '', 'eg', '', 'hypokalemia', '', 'predispose', 'development', 'arrhythmia', '', '', '', 'clinical', 'manifestation', 'treatment', 'hypokalemia', 'adult', '', '', 'section', 'cardiac', 'arrhythmia', 'ecg', 'abnormality', '', '', 'hypomagnesemia', '', 'clinical', 'manifestation', 'magnesium', 'depletion', '', '', 'section', 'cardiovascular', '', '', '', 'patients', 'receive', 'qt-prolonging', 'therapy', 'develop', 'polymorphic', 'ventricular', 'tachycardia', '', 'vt', '', '', '', 'patients', 'polymorphic', 'ventricular', 'tachycardia', '', 'torsades', 'de', 'point', '', '', '', '', 'patients', 'fever', '', 'unmask', 'case', 'cardiac', 'channelopathies', 'brugada', 'syndrome', 'long', 'qt', 'syndrome', '', '1516', '', '', '', 'brugada', 'syndrome', '', '', 'brugada', 'syndrome', '', 'clinical', 'presentation', '', 'diagnosis', '', 'evaluation', '', '', 'congenital', 'long', 'qt', 'syndrome', '', 'epidemiology', 'clinical', 'manifestation', '', '', '', 'cardiovascular', 'testingecg', '', 'patient', 'covid-19', 'suspect', '', 'particular', 'patient', 'severe', 'disease', 'qt-prolonging', 'medication', '', 'baseline', 'electrocardiogram', '', 'ecg', '', 'perform', 'time', 'entry', 'health', 'care', 'system', '', '17', '', '', 'ideally', '', '12-lead', 'ecg', '', 'single-', 'multi-lead', 'ecg', 'telemetry', 'monitor', 'multiple', 'lead', 'position', 'hand-held', 'ecg', 'device', 'adequate', 'situation', 'minimize', 'staff', 'exposure', 'patient', '', '18', '', '', 'allow', 'document', 'baseline', 'qrs-t', 'morphology', 'patient', 'develop', 'signssymptoms', 'suggestive', 'myocardial', 'injury', 'acute', 'coronary', 'syndrome', '', 'additionally', '', 'baseline', 'ecg', 'allow', 'documentation', 'qt', '', 'correct', 'qtc', '', 'interval', '', 'importantly', '', 'qtc', 'monitor', 'qt-prolonging', 'therapy', 'initiate', '', 'eg', '', 'azithromycin', '', 'hydroxychloroquine', '', 'etc', '', 'reduce', 'risk', 'acquire', 'lqts', '', '', '', 'acquired', 'long', 'qt', 'syndrome', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'management', '', 'patients', 'receive', 'qt-prolonging', 'treatment', '', 'eg', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'azithromycin', '', 'etc', '', '', '', '', 'continuous', 'ecg', 'monitor', '', 'absence', 'document', 'cardiac', 'arrhythmia', '', 'suspect', 'myocardial', 'ischemia', '', 'standard', 'indication', '', 'continuous', 'ecg', 'monitor', 'require', '', 'however', '', 'part', 'infection', 'control', 'mechanism', 'patient', 'establish', 'suspect', 'covid-19', 'infection', '', 'hospital', 'utilize', 'continuous', 'ecg', 'monitor', '', 'conjunction', 'automate', 'blood', 'pressure', 'read', 'oxygen', 'saturation', 'monitor', '', 'lieu', 'standard', 'vital', 'sign', 'check', 'nurse', 'staff', '', 'practice', 'reduce', 'number', 'clinical', 'staff', 'interact', 'patient', '', 'thereby', 'reduce', 'risk', 'health', 'care', 'worker', 'preserve', 'personal', 'protective', 'equipment', '', 'transthoracic', 'echocardiography', '', 'patient', 'develop', 'cardiac', 'manifestation', '', 'include', 'myocardial', 'injury', '', 'initial', 'transthoracic', 'echocardiogram', 'necessary', 'patient', '', 'providers', 'consider', 'point-of-care', 'ultrasound', 'focus', 'exam', '', '', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'myocardial', 'injury', '', '', '', 'diagnosis', 'arrhythmias', '', 'arrhythmias', 'commonly', 'diagnose', 'combination', 'vital', 'sign', 'review', 'ecg', '', 'ideally', '12-lead', 'ecg', '', 'rhythm', 'strip', '', 'tachycardias', 'present', 'pulse', 'greater', '100', 'beat', 'per', 'minute', '', 'bradyarrhythmias', 'present', 'pulse', 'le', '50', '60', 'beat', 'per', 'minute', '', 'common', 'arrhythmia', 'overall', 'patient', 'covid-19', 'sinus', 'tachycardia', '', 'likely', 'pathologic', 'arrhythmia', 'include', 'atrial', 'fibrillation', '', 'atrial', 'flutter', '', 'monomorphic', 'polymorphic', 'vtthe', 'differentiation', 'various', 'tachycardia', 'base', 'regularity', '', 'ie', '', 'regular', 'irregular', '', 'qrs', 'width', '', 'ie', '', 'narrow', 'wide', 'qrs', 'complex', '', 'require', 'surface', 'ecg', '', '', '', 'narrow', 'qrs', 'complex', 'tachycardia', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'evaluation', '', '', 'wide', 'qrs', 'complex', 'tachycardia', '', 'approach', 'diagnosis', '', '', '', 'bradyarrhythmias', '', 'include', 'sinus', 'pause', 'high-grade', 'heart', 'block', 'slow', 'escape', 'rhythm', '', 'typically', 'identify', 'surface', 'ecg', 'present', '', '', '', 'sinus', 'node', 'dysfunction', '', 'clinical', 'manifestation', '', 'diagnosis', '', 'evaluation', '', '', 'second', 'degree', 'atrioventricular', 'block', '', 'mobitz', 'type', 'ii', '', '', 'third', 'degree', '', 'complete', '', 'atrioventricular', 'block', '', '', '', 'diagnosis', 'acquire', 'lqts', 'patient', 'sufficient', 'qt', 'prolongation', 'surface', 'ecg', 'association', 'medication', 'clinical', 'scenario', '', 'ie', '', 'hypokalemia', 'hypomagnesemia', '', 'cause', 'qt', 'prolongation', '', 'ideally', '', 'diagnosis', 'follow', 'review', 'full', '12-lead', 'ecg', '', 'sometimes', 'single-lead', 'rhythm', 'strip', 'adequate', 'full', '12-lead', 'ecg', 'obtain', '', 'acquired', 'qt', 'prolongation', 'typically', 'reversible', 'upon', 'removal', 'underlie', 'etiology', '', 'discontinuation', 'offend', 'medication', 'correction', 'electrolyte', 'derangement', '', '', 'management', '', '', '', 'overall', '', 'average', 'qtc', 'healthy', 'person', 'puberty', '42020', 'millisecond', '', 'general', '', '99th', 'percentile', 'qtc', 'value', '470', 'millisecond', 'postpubertal', 'male', '480', 'millisecond', 'postpubertal', 'female', '', '19', '', '', 'qtc', '', '500', 'millisecond', 'consider', 'highly', 'abnormal', 'men', 'womenmanagementpatients', 'polymorphic', 'ventricular', 'tachycardia', '', 'torsades', 'de', 'point', '', '', 'patient', 'torsades', 'de', 'point', '', 'tdp', '', 'immediate', 'assessment', 'symptom', '', 'vital', 'sign', '', 'level', 'consciousness', 'determine', 'hemodynamically', 'stable', 'unstable', '', 'unstable', 'patient', '', 'patients', 'sustain', 'tdp', 'usually', 'become', 'hemodynamically', 'unstable', '', 'severely', 'symptomatic', '', 'pulseless', 'treat', 'accord', 'standard', 'resuscitation', 'algorithm', '', '20', '', '', 'include', 'cardioversiondefibrillation', '', 'algorithm', '1', '', '', 'initial', 'treatment', 'antiarrhythmic', 'medication', '', 'exception', 'intravenous', '', 'iv', '', 'magnesium', '', 'indicate', 'hemodynamically', 'unstable', 'pulseless', 'patient', '', 'full', 'discussion', 'standard', 'approach', 'basic', 'life', 'support', 'advance', 'cardiac', 'life', 'support', 'present', 'separately', '', '', '', 'basic', 'life', 'support', '', 'bls', '', 'adult', '', '', 'advanced', 'cardiac', 'life', 'support', '', 'acls', '', 'adult', '', '', '', 'stable', 'patient', '', 'patients', 'tdp', 'hemodynamically', 'stable', 'presentation', 'remain', 'stable', 'become', 'unstable', 'rapidly', 'without', 'warn', '', '', 'therapy', 'promptly', 'provide', 'patient', '', 'stable', 'patient', 'one', 'typically', 'show', 'evidence', 'hemodynamic', 'compromise', 'frequent', '', 'repetitive', 'burst', 'tdp', '', 'patient', 'continuous', 'monitor', 'frequent', 'reevaluation', 'due', 'potential', 'rapid', 'deterioration', 'long', 'tdp', 'persist', '', 'patient', 'single', 'episode', 'tdp', '', 'treatment', 'iv', 'magnesium', 'along', 'correction', 'metabolicelectrolyte', 'derangement', 'andor', 'removal', 'incite', 'medication', 'sufficient', '', 'patient', 'carefully', 'monitor', 'electrolyte', 'normalize', 'qt', 'interval', 'nearly', 'normalizesfor', 'patient', 'multiple', 'self-terminating', 'episode', 'tdp', '', 'therapy', 'utilize', 'patient', 'single', 'episode', '', 'ie', '', 'iv', 'magnesium', '', 'correction', 'metabolicelectrolyte', 'derangement', '', 'andor', 'removal', 'incite', 'medication', '', '', 'along', 'additional', 'intervention', 'increase', 'heart', 'rate', '', 'include', 'overdrive', 'pace', 'andor', 'iv', 'isoproterenol', 'infusionpatients', 'arrhythmia', '', 'management', 'arrhythmia', 'set', 'covid-19', 'infection', 'different', 'routine', 'management', 'condition', 'without', 'covid-19', 'infection', '', 'please', 'refer', 'follow', 'topic', 'management', '', 'atrial', 'fibrillation', 'supraventricular', 'tachycardia', '', '', '', '', 'overview', 'acute', 'management', 'tachyarrhythmias', '', '', '', '', '', '', 'overview', 'atrial', 'fibrillation', '', '', '', '', '', '', 'overview', 'atrial', 'flutter', '', '', '', '', '', '', 'atrioventricular', 'nodal', 'reentrant', 'tachycardia', '', '', '', '', '', '', 'treatment', 'symptomatic', 'arrhythmia', 'associate', 'wolff-parkinson-white', 'syndrome', '', '', '', '', '', '', 'focal', 'atrial', 'tachycardia', '', '', '', 'monomorphic', 'vt', '', '', '', '', 'wide', 'qrs', 'complex', 'tachycardia', '', 'approach', 'management', '', '', '', '', '', '', 'sustained', 'monomorphic', 'ventricular', 'tachycardia', 'patient', 'structural', 'heart', 'disease', '', 'treatment', 'prognosis', '', '', '', '', '', '', 'ventricular', 'tachycardia', 'absence', 'apparent', 'structural', 'heart', 'disease', '', '', '', 'conduction', 'system', 'disease', '', '', '', '', 'sinus', 'node', 'dysfunction', '', 'treatment', '', '', '', '', '', '', 'third', 'degree', '', 'complete', '', 'atrioventricular', 'block', '', '', '', '', '', '', 'second', 'degree', 'atrioventricular', 'block', '', 'mobitz', 'type', 'ii', '', '', '', '', '', '', 'temporary', 'cardiac', 'pace', '', '', '', 'patients', 'receive', 'qt-prolonging', 'treatment', '', 'eg', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'azithromycin', '', 'etc', '', '', 'data', 'limit', '', 'patient', 'treat', 'hydroxychloroquine', 'hydroxychloroquine', '', 'structurally', 'similar', 'quinidine', 'qt-prolonging', 'effect', 'block', 'activation', 'potassium', 'channel', 'ikr', '', 'hergkv111', '', '', '42122', '', '', 'medication', 'qt-prolonging', 'effect', 'covid-19', '', 'table', '1', '', '', 'addition', '', 'hydroxychloroquine', 'hydroxychloroquine', 'metabolize', 'cyp3a4', '', 'medication', 'inhibit', 'cytochrome', 'raise', 'plasma', 'level', '', '21', '', '', 'limited', 'data', 'hydroxychloroquine', 'suggest', 'low', 'risk', 'cause', 'tdp', '', 'base', 'arthritis', 'arthritis', '', 'systemic', 'lupus', 'erythematosus', '', 'antimalarial', 'therapy', '', '2324', '', '', 'in-vitro', 'data', 'suggest', 'safety', 'azithromycin', 'hydroxychloroquine', 'action', 'potential', 'duration', 'alternans', '', '25', '', '', 'clinical', 'data', 'tdp', 'risk', '', 'medication', '', 'time', 'window', 'short', 'duration', '', 'another', 'reason', 'risk', 'tdp', 'lower', '', 'however', '', 'greater', 'qt-prolonging', 'effect', 'electrolyte', 'abnormality', '', 'qt-prolonging', 'medication', '', 'chronic', 'renal', 'insufficiency', '', 'congenital', 'long', 'qt', 'syndrome', '', 'one', 'study', '84', 'patient', 'covid-19', 'receive', 'hydroxychloroquine', 'azithromycin', '', 'qtc', 'increase', '435', 'millisecond', 'maximum', '463', 'millisecond', '', 'peak', 'day', '3', '4', '', '10', '', '', 'high-risk', 'group', 'nine', 'patient', '', '11', 'percent', '', 'whose', 'baseline', 'qtc', '447', 'millisecond', 'increase', '527', 'millisecond', '', 'importantly', '', 'tdp', 'seenin', 'study', '81', 'severely', 'ill', 'patient', 'admit', 'suspicion', 'covid-19', 'treat', 'azithromycin', 'randomize', 'receive', 'hydroxychloroquine', 'high', 'dose', '', '600', 'mg', 'twice', 'daily', '10', 'day', '', 'low', 'dose', '', '450', 'mg', 'twice', 'daily', 'one', 'day', '', '450', 'mg', 'daily', 'four', 'day', '', '', 'baseline', 'qtc', '', 'fridericia', 'method', '', 'average', '425', 'millisecond', 'significantly', 'different', 'high-', 'low-dose', 'patient', '', '26', '', '', 'qtc', 'increase', '', '500', 'millisecond', '7', '37', '', '189', 'percent', '', 'high-dose', 'recipient', '4', '36', '', '111', 'percent', '', 'low-dose', 'recipient', '', 'two', 'high-dose', 'hydroxychloroquine', 'recipient', 'develop', 'vt', '', 'tdp', 'reportedmonitoring', 'qt', 'prolongation', '', 'patient', 'baseline', 'qtc', 'value', 'obtain', 'prior', 'administer', 'drug', 'potential', 'prolong', 'qt', 'interval', '', '27', '', '', 'best', 'method', 'obtain', 'qt', 'interval', '12-lead', 'ecg', '', 'reduce', 'exposure', 'staff', '', 'always', 'feasible', '', 'single-lead', 'ecg', 'underestimate', 'qt', 'interval', '', 'attempt', 'multiple-lead', 'telemetry', 'system', 'monitor', 'qt', 'interval', '', 'outpatient', 'hydroxychloroquine', '', 'clear', 'guidance', 'regard', 'monitor', 'patient', '', 'ambulatory', 'ecg', 'monitor', 'technology', '', 'include', 'mobile', 'wearable', 'technology', '', 'eg', '', 'mobile', 'cardiac', 'outpatient', 'telemetry', '', '', 'report', 'reliable', 'alternative', 'demand', 'exceed', 'capacity', 'standard', 'telemetry', 'monitor', '', '28', '', '', 'important', 'patient', 'treat', 'qt-prolonging', 'drug', 'report', 'promptly', 'new', 'symptom', 'include', 'palpitation', '', 'syncope', '', 'near-syncope', '', 'report', 'clinical', 'change', 'lead', 'hypokalemia', '', 'gastroenteritis', 'initiation', 'diuretic', 'therapy', '', 'general', '', 'patient', 'follow', 'qtc', 'interval', 'low', 'risk', 'significant', 'qt', 'prolongation', 'polymorphic', 'vt', '', 'qtc', '', '460', 'millisecond', 'prepubertal', 'malesfemalesqtc', '', '470', 'millisecond', 'postpubertal', 'malesqtc', '', '480', 'millisecond', 'postpubertal', 'femalespatients', 'baseline', 'qtc', 'interval', '500', 'millisecond', '', 'qrs', '120', 'millisecond', '', 'increase', 'risk', 'significant', 'qt', 'prolongation', 'polymorphic', 'vt', '', '29', '', '', 'patient', '', 'effort', 'correct', 'contribute', 'electrolyte', 'abnormality', '', 'eg', '', 'hypocalcemia', '', 'hypokalemia', '', 'andor', 'hypomagnesemia', '', '', 'goal', 'potassium', 'close', '5', 'meql', '', 'normal', 'qt', 'interval', '', 'review', 'discontinuation', 'qt-prolonging', 'medication', 'essential', 'immediate', 'care', 'patient', '', 'eg', '', 'proton', 'pump', 'inhibitor', '', 'etc', '', '', 'table', '1', '', '', '30', '', '', 'particular', '', 'one', 'qt-prolonging', 'agent', 'simultaneously', '', 'recommend', 'one', 'follow', 'approach', '', 'one', 'protocol', 'publish', 'mayo', 'clinic', '', 'qtc', 'cutoff', '', '31', '', '', 'two', 'three', 'hour', 'dose', 'hydroxychloroquine', 'qt-prolonging', 'agent', '', 'qtc', 'increase', '500', 'millisecond', 'change', 'qt', 'interval', '60', 'millisecond', '', 'reevaluation', 'risk', 'tdp', 'versus', 'benefit', 'medication', '', 'follow', 'step', '', 'recognition', 'increase', 'risk', 'tdpdiscontinuation', 'qt-prolonging', 'medicationscorrection', 'electrolyte', 'abnormalitiesplace', 'patient', 'continuous', 'telemetry', '', 'consideration', 'wearable', 'defibrillator', 'placement', 'external', 'defibrillator', 'patchesif', 'tdp', 'develop', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'azithromycin', 'medication', 'stoppedanother', 'protocol', 'propose', 'ecg', 'baseline', 'four', 'hour', 'hydroxychloroquine', 'antiviral', 'medication', 'administration', 'congenital', 'acquire', 'long', 'qt', 'syndrome', '', 'patient', 'already', 'qt-prolonging', 'medication', '', 'patient', 'structural', 'heart', 'disease', 'bradycardia', '', '21', '', '', 'another', 'ecg', 'complete', 'one', 'three', 'day', 'later', '', 'others', '', 'ecg', 'qtc', 'interval-monitoring', 'method', '24', 'hour', 'start', 'medication', '', 'qtc', 'increase', '500', 'millisecond', '', 'change', 'qt', 'interval', '60', 'millisecond', '', 'ventricular', 'ectopy', 'develop', '', 'protocol', 'recommend', 'cardiology', 'consultation', '', 'risk', 'score', 'develop', 'hospitalize', 'patient', 'prediction', 'qt', 'interval', 'prolongation', '', 'though', 'necessarily', 'hydroxychloroquine', '', '3233', '', '', 'classify', 'patient', 'low', '', 'moderate', '', 'high', 'risk', 'tdp', '', 'allow', 'triaging', 'whether', 'continuous', 'telemetry', 'qt-prolonging', 'medication', '', 'especially', 'limit', 'resource', 'patient', 'otherwise', 'follow', 'outpatient', '', 'signs', 'toxicity', '', 'anecdotal', 'report', 'toxicity', 'associate', 'hydroxychloroquine', 'hydroxychloroquine', '', 'doses', '5', 'gm', 'hydroxychloroquine', 'usually', 'lead', 'death', '', '34', '', '', 'symptoms', 'typically', 'occur', 'first', 'hour', 'ingestion', '', 'seizure', 'cardiac', 'arrest', '', 'medication', 'similar', 'quinidine', '', 'sodium', 'channel', 'blocker', '', 'cardiovascular', 'toxicity', 'include', 'widen', 'qrs', '', 'prolong', 'qt', 'interval', '', 'ventricular', 'arrhythmia', '', 'cardiac', 'dysfunction', '', 'hypotension', '', 'ingestion', 'acute', '', 'activate', 'charcoal', '', 'general', '', 'treatment', 'involve', 'epinephrine', '', 'high-dose', 'diazepam', '', 'repletion', 'potassium', '', '35', '', '', 'however', '', 'much', 'potassium', 'give', '', 'rebound', 'hyperkalemia', 'intracellular', 'shift', 'cell', '', 'bicarbonate', 'iv', 'infusion', 'give', '', 'care', 'lead', 'worsen', 'hypokalemia', '', 'iv', 'lipid', 'emulsion', 'attempt', 'limit', 'report', '', '36', '', '', 'local', 'poison', 'control', 'center', 'contact', 'additional', 'help', '', 'brugada', 'syndrome', '', 'increase', 'risk', 'ventricular', 'arrhythmia', 'set', 'fever', 'brugada', 'syndrome', '', 'aggressive', 'fever', 'reduction', 'acetaminophen', 'imperative', '', 'high-risk', 'patient', '', 'spontaneous', 'type', '1', 'pattern', 'ecg', 'prior', 'syncope', '', 'consider', 'emergency', 'department', 'fever', 'promptly', 'lower', 'acetaminophen', '', '21', '', '', '', '', 'brugada', 'syndrome', '', 'prognosis', '', 'management', '', 'approach', 'screen', '', '', 'section', 'treatment', '', '', '', 'prognosis', '', 'mortality', 'rate', 'appear', 'increase', 'significantly', 'increase', 'age', '', 'case', 'fatality', 'rate', '', '1', 'percent', 'report', '50', 'year', 'age', '', 'rate', 'approach', '15', 'percent', 'patient', '80', 'year', 'age', 'older', '', '37', '', '', 'similarly', '', 'mortality', 'increase', 'disease', 'severity', '', 'death', 'report', 'among', 'mild', 'severe', 'case', 'chinese', 'cohort', '', 'mortality', 'approach', '50', 'percent', 'among', 'critically', 'ill', 'patient', '', '37', '', '', 'underlying', 'medical', 'comorbidities', 'appear', 'significantly', 'impact', 'covid-19', 'severity', 'mortality', '', 'patients', 'underlie', 'cardiovascular', 'disease', 'hypertension', 'report', 'significantly', 'high-case', 'fatality', 'rate', 'compare', 'patient', 'without', 'underlie', 'comorbidities', '', '105', '6', 'percent', 'mortality', '', 'respectively', '', 'compare', '09', 'percent', 'mortality', 'without', 'underlie', 'comorbidities', '', '', '3738', '', '', 'similarly', '', 'patient', 'multinational', 'cohort', 'die', 'covid-19', 'twice', 'likely', 'history', 'cardiac', 'arrhythmia', '', '5', '', 'important', 'information', 'providers', 'caring', 'covid-19', 'patients', '', 'addition', 'provide', 'best', 'possible', 'care', 'patient', '', 'infection', 'control', 'limit', 'transmission', 'essential', 'component', 'care', 'patient', 'suspect', 'document', 'covid-19', '', '439-43', '', 'inpatient', 'care', 'consultation', '', 'approach', 'care', 'hospitalize', 'patient', 'document', 'suspect', 'covid-19', 'differ', 'slightly', '', 'intent', 'reduce', 'exposure', '', 'spread', '', 'covid-19', 'health', 'care', 'provider', '', 'general', '', 'number', 'person', 'interact', 'directly', 'patient', 'time', 'spend', 'room', 'minimize', '', 'social', 'distance', 'maintain', '', 'patient', 'member', 'health', 'care', 'team', '', 'follow', 'step', '', 'possible', '', 'minimize', 'exposure', 'personnel', 'limit', 'ppe', '', 'stable', 'new', 'admission', '', 'patient', 'person', 'attend', 'physician', 'one', 'house', 'officer', 'advance', 'practitioner', '', 'applicable', '', 'stable', 'patient', 'daily', 'round', '', 'one', 'person', 'primary', 'care', 'team', 'enter', 'room', 'conduct', 'physical', 'exam', '', 'rest', 'team', 'participate', 'outside', 'room', 'via', 'video', 'chat', 'telephoneroutine', 'arrhythmia', 'consultation', '', 'particularly', 'stable', 'patient', 'ecg', 'evidence', 'document', 'specific', 'arrhythmia', 'conduction', 'disorder', '', 'complete', 'without', 'enter', 'patient', 'room', 'review', 'available', 'record', 'ecg', 'monitor', 'data', '', 'consider', 'place', 'patient', 'telemetry', 'concern', 'arrhythmia', '', 'thereby', 'reduce', 'in-room', 'vital', 'signsutilize', 'room', 'window', 'door', 'assist', 'monitor', 'patient', 'outside', 'room', '', 'patients', 'contact', 'telephone', 'routine', 'matter', 'without', 'require', 'entry', 'roomarrhythmia-related', 'procedure', '', 'order', 'maximize', 'available', 'health', 'care', 'system', 'resource', 'treat', 'covid-19', 'patient', 'pandemic', '', 'minimize', 'potential', 'exposure', 'health', 'care', 'personnel', 'asymptomatic', 'carrier', 'virus', '', 'elective', 'nonurgent', 'procedure', 'postpone', 'later', 'date', '', 'discussion', 'reason', 'behind', 'decision', 'postpone', 'procedure', 'communicate', 'patient', 'document', 'medical', 'record', '', 'conversely', '', 'urgent', 'semiurgent', 'procedure', 'perform', 'perceive', 'benefit', 'procedure', 'patient', 'outweigh', 'risk', 'resource', 'utilization', 'health', 'care', 'personnel', 'exposure', '', 'examples', 'type', 'procedure', 'category', 'follow', '', '439', '', '', 'urgent', '', 'substantial', 'risk', 'decompensation', '', 'hospitalization', '', 'death', 'procedure', 'delay', '', '', 'vt', 'ablation', 'medically', 'uncontrolled', 'electrical', 'storm', 'hemodynamically', 'compromise', 'patientcatheter', 'ablation', 'incessant', '', 'hemodynamically', 'significant', '', 'severely', 'symptomatic', 'tachycardia', '', 'supraventricular', 'vt', '', 'svt', '', 'atrial', 'fibrillation', '', 'af', '', 'atrial', 'flutter', '', 'respond', 'antiarrhythmic', 'drug', '', 'rate', 'control', '', 'andor', 'cardioversioncatheter', 'ablation', 'wolff-parkinson-white', 'syndrome', 'preexcited', 'af', 'syncope', 'cardiac', 'arrestlead', 'revision', 'malfunction', 'pacemaker-dependent', 'patient', 'implantable', 'cardioverter-defibrillator', '', 'icd', '', 'patient', 'receive', 'inappropriate', 'therapygenerator', 'change', 'pacemaker-dependent', 'patient', 'elective', 'replacement', 'indicator', '', 'eri', '', 'device', 'end', 'life', '', 'pacemaker', 'icd', 'generator', 'change', 'minimal', 'battery', 'remain', '', 'depend', 'specific', 'clinical', 'situationssecondary', 'prevention', 'icdpacemaker', 'implant', 'complete', 'heart', 'block', '', 'mobitz', 'ii', 'atrioventricular', '', 'av', '', 'block', '', 'high-grade', 'av', 'block', 'symptom', 'severe', 'symptomatic', 'sinus', 'node', 'dysfunction', 'long', 'pausesleaddevice', 'extraction', 'infection', '', 'include', 'patient', 'respond', 'antibiotic', 'endocarditis', '', 'bacteremia', '', 'pocket', 'infectioncardiac', 'resynchronization', 'therapy', 'set', 'severe', 'refractory', 'heart', 'failure', 'guideline-indicated', 'patientscardioversion', 'highly', 'symptomatic', 'atrial', 'arrhythmia', 'rapid', 'ventricular', 'rate', 'control', 'medicationstransesophageal', 'echocardiogram', 'patient', 'urgent', 'cardioversionsemiurgent', '', 'procedure', 'deem', 'urgent', 'perform', 'timely', 'manner', 'due', 'clinical', 'scenario', '', '', 'vt', 'ablation', 'medically', 'refractory', 'recurrent', 'vt', 'svt', 'ablation', 'patient', 'medically', 'refractory', 'svt', '', 'result', 'emergency', 'department', 'visit', '', 'cardiac', 'implantable', 'electrical', 'device', '', 'cied', '', 'generator', 'replacement', 'eri', 'battery', 'status', 'urgent', '', 'primary', 'prevention', 'icd', 'patient', 'particularly', 'high', 'risk', 'life-threating', 'ventricular', 'arrhythmia', '', 'nonurgent', '', 'procedure', 'delay', 'week', 'month', '', '', 'premature', 'ventricular', 'complex', 'ablation', '', 'svt', 'ablation', '', 'af', 'atrial', 'flutter', 'ablation', 'stable', 'patient', 'without', 'heart', 'failure', '', 'significant', 'risk', 'hospitalize', 'delay', 'procedure', '', 'high', 'risk', 'procedure-related', 'complication', 'due', 'comorbidities', '', 'electrophysiology', 'test', 'evaluate', 'stable', 'tachyarrhythmias', 'bradycardia', '', 'primary', 'prevention', 'icd', 'semiurgent', '', 'cardiac', 'resynchronization', 'therapy', 'stable', 'patientscied', 'upgrade', '', 'pacemaker', 'implant', 'sinus', 'node', 'dysfunction', '', 'mobitz', 'av', 'block', '', 'stable', 'non-high-degree', 'av', 'block', '', 'tachy-brady', 'syndrome', 'mildly', 'symptomatic', 'patient', '', 'pacemaker', 'icd', 'generator', 'replacement', 'patient', '', '6', 'week', 'battery', 'remain', '', 'extraction', 'noninfected', 'devicesleads', 'unless', 'device', 'function', 'dependent', 'lead', 'extraction', 'reimplant', '', 'cardioversion', 'stable', 'arrhythmia', 'well-tolerated', 'symptom', '', 'left', 'atrial', 'appendage', '', 'laa', '', 'closure', 'patient', 'anticoagulationtransesophageal', 'echocardiogram', 'routine', 'assessment', 'valve', 'laa', 'closure', 'device', 'cardioversions', 'appropriate', 'period', 'anticoagulationimplantable', 'loop', 'recorder', 'implantstilt-table', 'testingperioperative', 'cardiac', 'implantable', 'electrical', 'device', 'management', '', 'patient', 'cied', 'undergo', 'surgery', 'endoscopic', 'procedure', '', 'important', 'patient', 'pacemaker', 'dependent', '', 'patient', 'icd', 'therapy', 'activate', '', 'likelihood', 'electromagnetic', 'interference', '', 'emi', '', 'procedure', '', 'eg', '', 'due', 'electrocautery', '', 'etc', '', '', 'patient', 'document', 'suspect', 'covid-19', 'undergo', 'procedure', 'high', 'likelihood', 'emi', 'result', 'pacemaker', 'icd', 'malfunction', '', 'application', 'magnet', 'suspend', 'antitachyarrhythmia', 'therapy', 'icd', 'produce', 'asynchronous', 'pace', 'pacemaker', '', '40', '', '', 'allow', 'patient', 'safely', 'proceed', 'necessary', 'procedure', 'without', 'reprogramming', 'cied', 'procedure', '', 'thereby', 'reduce', 'risk', 'health', 'care', 'personnel', 'preserve', 'personal', 'protective', 'equipment', '', 'ppe', '', 'standard', 'approach', 'cied', 'management', '', 'include', 'in-person', 'reprogramming', 'cied', 'procedure', '', 'discuss', 'detail', 'elsewhere', '', '', '', 'perioperative', 'management', 'patient', 'pacemaker', 'implantable', 'cardioverter-defibrillator', '', '', '', 'cardiac', 'implantable', 'electrical', 'device', 'interrogation', '', 'patient', '', 'majority', 'cied', 'follow-up', 'device', 'interrogation', 'modern-era', 'device', 'either', 'person', 'remotely', '', 'maintain', 'social', 'distance', 'covid-19', 'pandemic', '', 'recommend', 'remote', 'cied', 'interrogation', 'vast', 'majority', 'stable', 'patient', '', '40', '', 'certain', 'situation', 'remain', '', 'however', '', 'in-person', 'cied', 'interrogation', 'prefer', 'option', '', 'include', '', '440', '', '', 'suspected', 'cied', 'malfunction', '', 'include', '', 'inappropriate', 'pacemaker', 'pace', 'sense', 'note', 'ecg', 'telemetry', 'monitoringfailure', 'icd', 'deliver', 'therapy', 'document', 'sustain', 'ventricular', 'tachyarrhythmiaclinically', 'actionable', 'abnormality', 'cied', 'suspicion', 'device', 'near', 'end', 'battery', 'life', '', 'note', 'remote', 'monitor', '', 'telemetry', '', 'ambulatory', 'monitoringicd', 'shock', '', 'presyncope', '', 'syncope', 'concern', 'arrhythmic', 'event', 'perform', 'program', 'changesuntreated', 'sustain', 'ventricular', 'arrhythmia', 'patient', 'icdevaluation', 'symptom', 'suspicious', 'arrhythmia', 'abnormal', 'device', 'function', 'patient', 'enrol', 'remote', 'monitoringidentified', 'reprogramming', 'cied', '', 'icd', 'patient', 'whose', 'device', 'deliver', 'auditory', 'vibratory', 'alertsassessment', 'atrial', 'fibrillation', '', 'af', '', 'patient', 'stroke', 'clear', 'documentation', 'af', 'ecg', 'telemetry', 'monitoringfor', 'cied', 'patient', 'require', 'urgent', 'emergent', 'magnetic', 'resonance', 'image', '', 'mri', '', 'scan', '', 'consider', 'perform', 'compute', 'tomography', 'scan', 'instead', 'possible', '', 'minimize', 'additional', 'health', 'care', 'provider', 'device', 'manufacturer', 'representative', 'contact', '', '', 'urgent', '', 'delay', 'mri', '', 'patients', 'emergency', 'department', '', 'set', '', 'remote', 'monitor', 'available', '', 'remote', 'monitor', 'wherever', 'possible', '', 'include', 'option', 'ask', 'family', 'bring', 'patient', 'home', 'monitor', 'equipment', 'hospital', '', 'in-person', 'cied', 'interrogation', 'perform', '', 'important', 'disinfect', 'part', 'programmer', '', 'eg', '', 'program', 'wand', 'cord', '', 'contact', 'patient', '', 'available', '', 'disposable', 'plastic', 'wand', 'cover', 'minimize', 'contamination', '', 'consideration', 'give', 'dedicate', 'interrogation', 'device', 'set', 'suspect', 'covid-19-positive', 'patient', '', 'reduce', 'exposure', 'health', 'care', 'personnel', 'cied', 'patient', '', 'doughnut', 'magnet', 'alternative', 'complete', 'cied', 'interrogation', 'reprogramming', '', '41', '', '', 'hospitalize', 'patient', 'pacemaker', 'remote', 'monitor', 'capability', '', 'proper', 'function', 'pacemaker', 'question', '', 'temporary', 'application', 'doughnut', 'magnet', 'pacemaker', 'safe', 'quickly', 'determine', 'whether', 'pacemaker', 'capable', 'deliver', 'pace', 'stimulus', 'capture', 'heart', '', 'magnet', 'application', 'place', 'pacemaker', 'asynchronous', 'pace', 'mode', '', 'depending', 'manufacturer', 'program', 'set', '', 'include', 'change', 'pace', 'rate', '', 'give', 'evidence', 'battery', 'status', '', 'ie', '', 'elective', 'replacement', 'indicator', '', 'whether', 'pacemaker', 'capture', '', 'addition', '', 'demonstration', 'ventricular', 'capture', 'provide', 'basic', 'reassurance', 'pacemaker', 'functional', 'avoid', 'complete', 'pacemaker', 'interrogation', '', '', '', 'perioperative', 'management', 'patient', 'pacemaker', 'implantable', 'cardioverter-defibrillator', '', '', '', 'patients', 'require', 'cardiopulmonary', 'resuscitation', '', 'cpr', '', '', 'general', '', 'basic', 'life', 'support', 'advance', 'cardiac', 'life', 'support', 'patient', 'covid-19', 'administer', 'standard', 'fashion', '', 'similar', 'patient', 'without', 'covid-19', '', 'follow', 'exception', '', '442', '', '', '', 'basic', 'life', 'support', '', 'bls', '', 'adult', '', '', 'section', 'resuscitation', 'patient', 'covid-19', '', '', '', 'personnel', 'care', 'patient', 'suspect', 'confirm', 'covid-19', 'wear', 'appropriate', 'ppe', 'enter', 'room', '', 'gown', '', 'glove', '', 'eye', 'protection', '', 'respirator', '', 'eg', '', 'n95', 'respirator', '', '', 'supply', 'respirator', 'limit', '', 'united', 'states', 'centers', 'disease', 'control', 'prevention', 'acknowledge', 'facemasks', 'acceptable', 'alternative', '', 'addition', 'contact', 'precaution', 'eye', 'protection', '', '', 'respirator', 'wear', 'aerosol-generating', 'procedure', '', 'include', 'intubation', '', 'appropriate', 'ppe', 'prior', 'interact', 'patient', '', 'lead', 'delay', 'provision', 'resuscitative', 'carethe', 'number', 'people', 'involve', 'resuscitation', 'keep', 'minimum', '', 'typically', 'include', 'team', 'leader', '', 'anesthesiologist', 'manage', 'airway', '', 'patient', 'already', 'intubate', '', '', 'recorderscribe', '', 'person', 'perform', 'chest', 'compression', '', 'defibrillation', '', 'administration', 'medication', '', 'often', '', 'participant', 'rotate', 'allow', 'period', 'rest', 'perform', 'chest', 'compression', '', 'covid-19', 'patient', 'yet', 'intubate', 'time', 'cardiac', 'arrest', '', 'early', 'intubation', 'perform', 'provider', 'likely', 'achieve', 'success', 'first', 'pas', '', 'utilize', 'readily', 'available', 'technology', '', 'eg', '', 'video', 'laryngoscopy', '', 'optimize', 'first-pass', 'success', '', 'chest', 'compression', 'stop', 'intubation', '', 'intubation', '', 'cuff', 'endotracheal', 'tube', '', 'perform', 'prior', 'standard', 'two', 'minute', 'chest', 'compression', 'early', 'defibrillation', 'mean', 'control', 'potential', 'spread', 'airborne', 'dropletsif', 'available', '', 'mechanical', 'chest', 'compression', 'device', 'place', 'manual', 'compression', 'adult', 'adolescent', 'meet', 'minimum', 'height', 'weight', 'requirementsfor', 'critically', 'ill', 'patient', 'already', 'intubate', 'prone', 'position', 'time', 'arrest', '', 'cpr', 'attempt', 'patient', 'prone', 'perform', 'compression', 'hand', 't710', 'vertebral', 'body', '', 'defibrillation', 'perform', 'pad', 'anterior-posterior', 'position', '', 'patient', 'turn', 'supine', 'position', 'resuscitation', 'able', 'without', 'equipment', 'disconnection', 'lead', 'aerosolization', 'viral', 'particlesfor', 'out-of-hospital', 'resuscitation', 'effort', '', 'lay', 'rescuer', 'perform', 'chest', 'compression-only', 'cpr', 'wear', 'face', 'mask', 'cloth', 'cover', '', 'available', '', 'automate', 'external', 'defibrillator', 'apply', 'accord', 'usual', 'protocol', '', '', '', 'automated', 'external', 'defibrillator', '', '', 'basic', 'life', 'support', '', 'bls', '', 'adult', '', '', 'section', 'defibrillation', '', '', '', 'initial', 'treatment', 'antiarrhythmic', 'medication', '', 'exception', 'iv', 'magnesium', '', 'indicate', 'hemodynamically', 'unstable', 'pulseless', 'patient', '', 'full', 'discussion', 'standard', 'approach', 'basic', 'life', 'support', 'advance', 'cardiac', 'life', 'support', 'present', 'separately', '', '', '', 'basic', 'life', 'support', '', 'bls', '', 'adult', '', '', 'advanced', 'cardiac', 'life', 'support', '', 'acls', '', 'adult', '', '', '', 'society', 'guideline', 'links', '', 'links', 'society', 'government-sponsored', 'guideline', 'select', 'country', 'region', 'around', 'world', 'provide', 'separately', '', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'international', 'government', 'guideline', 'general', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'guidelines', 'specialty', 'care', '', '', 'society', 'guideline', 'link', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'resources', 'patient', '', '', '', 'information', 'patients', '', 'uptodate', 'offer', 'two', 'type', 'patient', 'education', 'material', '', '', 'basics', '', '', 'beyond', 'basics', '', '', 'basics', 'patient', 'education', 'piece', 'write', 'plain', 'language', '', '5th', '6th', 'grade', 'read', 'level', '', 'answer', 'four', 'five', 'key', 'question', 'patient', 'give', 'condition', '', 'article', 'best', 'patient', 'general', 'overview', 'prefer', 'short', '', 'easy-to-read', 'material', '', 'beyond', 'basics', 'patient', 'education', 'piece', 'longer', '', 'sophisticate', '', 'detail', '', 'article', 'write', '10th', '12th', 'grade', 'read', 'level', 'best', 'patient', 'in-depth', 'information', 'comfortable', 'medical', 'jargonhere', 'patient', 'education', 'article', 'relevant', 'topic', '', 'encourage', 'print', 'e-mail', 'topic', 'patient', '', '', 'locate', 'patient', 'education', 'article', 'variety', 'search', '', 'patient', 'info', '', 'keyword', '', '', 'interest', '', '', 'basics', 'topic', '', '', 'patient', 'education', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'overview', '', 'basics', '', '', '', 'summary', 'recommendationsthe', 'vast', 'majority', 'patient', 'present', 'systemic', 'illness', 'consistent', 'covid-19', 'symptom', 'sign', 'arrhythmia', 'conduction', 'system', 'disease', '', 'however', '', 'patient', 'arrhythmia', 'include', 'patient', 'myocardial', 'injury', '', 'myocardial', 'ischemia', '', 'hypoxia', '', 'shock', '', 'electrolyte', 'disturbance', '', 'receive', 'medication', 'prolong', 'qt', 'interval', '', '', 'signs', 'symptom', '', '', '', 'patient', 'covid-19', 'suspect', 'baseline', 'electrocardiogram', '', 'ecg', '', 'perform', 'time', 'entry', 'health', 'care', 'system', '', 'ideally', '', '12-lead', 'ecg', '', 'single-lead', 'multi-lead', 'ecg', 'telemetry', 'monitor', 'adequate', 'situation', 'minimize', 'staff', 'exposure', 'patient', '', 'continuous', 'ecg', 'monitor', 'echocardiography', 'require', 'patient', 'select', 'situation', '', '', 'cardiovascular', 'test', '', '', '', 'patients', 'sustain', 'torsades', 'de', 'point', '', 'tdp', '', 'usually', 'become', 'hemodynamically', 'unstable', '', 'severely', 'symptomatic', '', 'pulseless', 'treat', 'accord', 'standard', 'resuscitation', 'algorithm', '', 'include', 'cardioversiondefibrillation', '', 'algorithm', '1', '', '', 'patients', 'tdp', 'hemodynamically', 'stable', 'presentation', 'remain', 'stable', 'become', 'unstable', 'rapidly', 'without', 'warn', '', 'treatment', 'intravenous', '', 'iv', '', 'magnesium', 'along', 'correction', 'metabolicelectrolyte', 'derangement', 'andor', 'removal', 'incite', 'medication', 'sufficient', '', 'although', 'patient', 'frequent', 'recurrent', 'episode', 'require', 'additional', 'intervention', '', '', 'patients', 'polymorphic', 'ventricular', 'tachycardia', '', 'torsades', 'de', 'point', '', '', '', '', 'patients', 'receive', 'qt-prolonging', 'medication', 'baseline', 'qtc', 'value', 'obtain', 'prior', 'administer', 'drug', '', 'qtc', 'subsequently', 'increase', '500', 'millisecond', 'change', 'qt', 'interval', '60', 'millisecond', 'baseline', 'ecg', '', 'risk', 'versus', 'benefit', 'continue', 'treatment', 'qt-prolonging', 'medication', 'reassess', '', 'consideration', 'dose', 'adjustment', 'additional', 'intervention', '', '', 'patients', 'receive', 'qt-prolonging', 'treatment', '', 'eg', '', 'hydroxychloroquine', '', 'hydroxychloroquine', '', 'azithromycin', '', 'etc', '', '', '', '', 'approach', 'care', 'hospitalize', 'patient', 'document', 'suspect', 'covid-19', 'differ', 'slightly', '', 'intent', 'reduce', 'exposure', '', 'spread', '', 'covid-19', 'health', 'care', 'provider', '', 'general', '', 'number', 'person', 'interact', 'directly', 'patient', 'time', 'spend', 'room', 'minimize', '', 'social', 'distance', 'maintain', '', 'patient', 'member', 'health', 'care', 'team', '', '', 'inpatient', 'care', 'consultation', '', 'arrhythmia-related', 'procedure', '', '', '', 'approach', 'cardiac', 'implantable', 'electrical', 'device', '', 'cied', '', 'interrogation', 'perioperative', 'cied', 'management', 'summarize', 'text', '', 'strategies', 'avoid', 'in-person', 'device', 'interrogation', 'deploy', '', '', 'cardiac', 'implantable', 'electrical', 'device', 'interrogation', '', 'perioperative', 'cardiac', 'implantable', 'electrical', 'device', 'management', '', '', '', 'general', '', 'basic', 'life', 'support', 'advance', 'cardiac', 'life', 'support', 'patient', 'covid-19', 'administer', 'standard', 'fashion', 'patient', 'without', 'covid-19', '', 'however', '', 'personnel', 'care', 'patient', 'suspect', 'confirm', 'covid-19', 'wear', 'appropriate', 'personal', 'protective', 'equipment', '', 'include', 'gown', '', 'glove', '', 'eye', 'protection', '', 'respirator', 'face', 'mask', '', 'enter', 'room', '', 'number', 'people', 'involve', 'resuscitation', 'keep', 'minimum', '', 'early', 'intubation', 'perform', 'patient', 'yet', 'intubate', 'time', 'cardiac', 'arrest', '', '', 'patients', 'require', 'cardiopulmonary', 'resuscitation', '', 'cpr', '', '', '', '']",4986,"{'': 1281, 'patient': 142, 'covid-19': 67, 'disease': 38, 'arrhythmia': 32, 'ecg': 32, 'care': 31, 'cardiac': 28, 'coronavirus': 26, 'hydroxychloroquine': 26, 'percent': 25, 'medication': 25, 'qt': 24, '2019': 23, 'patients': 23, 'millisecond': 23, 'syndrome': 21, 'include': 21, 'qtc': 21, 'monitor': 21}","{'hydroxychloroquine': 26, 'infection': 11, 'sars-cov-2': 1, 'safety': 1, 'arthritis': 2}",41,0.4767
DOI:10.1038/s41421-020-0168-9,10.1038/s41421-020-0168-9,Research,2020-05-04 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['immune', 'cell', 'profile', 'covid-19', 'patient', 'recovery', 'stage', 'single-cell', 'sequence']","['COVID-19 , cause SARS-CoV-2 , recently affect 1,200,000 people kill 60,000 .', 'The key immune cell subset change state course COVID-19 remain unclear .', 'We seek comprehensively characterize transcriptional change peripheral blood mononuclear cell recovery stage COVID-19 single-cell RNA sequence technique .', 'It find T cell decrease remarkably , whereas monocyte increase patient early recovery stage ( ERS ) COVID-19 .', 'There increase ratio classical CD14++ monocyte high inflammatory gene expression well greater abundance CD14++IL1β+ monocyte ERS .', 'CD4+ T cell CD8+ T cell decrease significantly express high level inflammatory gene ERS .', 'Among B cell , plasma cell increase remarkably , whereas naïve B cell decrease .', 'Several novel B cell-receptor ( BCR ) change identify , IGHV3-23 IGHV3-7 , isotypes ( IGHV3-15 , IGHV3-30 , IGKV3-11 ) previously use virus vaccine development confirm .', 'The strongest pair frequency , IGHV3-23-IGHJ4 , indicate monoclonal state associate SARS-CoV-2 specificity , report yet .', 'Furthermore , integrate analysis predict IL-1β M-CSF may novel candidate target gene inflammatory storm TNFSF13 , IL-18 , IL-2 , IL-4 may beneficial recovery COVID-19 patient .', 'Our study provide first evidence inflammatory immune signature ERS , suggest COVID-19 patient still vulnerable hospital discharge .', 'Identification novel BCR signal may lead development vaccine antibody treatment COVID-19 .']","['covid-19', '', 'cause', 'sars-cov-2', '', 'recently', 'affect', '1200000', 'people', 'kill', '60000', '', 'key', 'immune', 'cell', 'subset', 'change', 'state', 'course', 'covid-19', 'remain', 'unclear', '', 'seek', 'comprehensively', 'characterize', 'transcriptional', 'change', 'peripheral', 'blood', 'mononuclear', 'cell', 'recovery', 'stage', 'covid-19', 'single-cell', 'rna', 'sequence', 'technique', '', 'find', 'cell', 'decrease', 'remarkably', '', 'whereas', 'monocyte', 'increase', 'patient', 'early', 'recovery', 'stage', '', 'ers', '', 'covid-19', '', 'increase', 'ratio', 'classical', 'cd14', 'monocyte', 'high', 'inflammatory', 'gene', 'expression', 'well', 'greater', 'abundance', 'cd14il1', 'monocyte', 'ers', '', 'cd4', 'cell', 'cd8', 'cell', 'decrease', 'significantly', 'express', 'high', 'level', 'inflammatory', 'gene', 'ers', '', 'among', 'b', 'cell', '', 'plasma', 'cell', 'increase', 'remarkably', '', 'whereas', 'nave', 'b', 'cell', 'decrease', '', 'several', 'novel', 'b', 'cell-receptor', '', 'bcr', '', 'change', 'identify', '', 'ighv3-23', 'ighv3-7', '', 'isotypes', '', 'ighv3-15', '', 'ighv3-30', '', 'igkv3-11', '', 'previously', 'virus', 'vaccine', 'development', 'confirm', '', 'strongest', 'pair', 'frequency', '', 'ighv3-23-ighj4', '', 'indicate', 'monoclonal', 'state', 'associate', 'sars-cov-2', 'specificity', '', 'report', 'yet', '', 'furthermore', '', 'integrate', 'analysis', 'predict', 'il-inhibitor', 'm-csf', 'novel', 'candidate', 'target', 'gene', 'inflammatory', 'storm', 'tnfsf13', '', 'il-18', '', 'il-2', '', 'il-4', 'beneficial', 'recovery', 'covid-19', 'patient', '', 'study', 'provide', 'first', 'evidence', 'inflammatory', 'immune', 'signature', 'ers', '', 'suggest', 'covid-19', 'patient', 'still', 'vulnerable', 'hospital', 'discharge', '', 'identification', 'novel', 'bcr', 'signal', 'lead', 'development', 'vaccine', 'antibody', 'treatment', 'covid-19', '']",197,"{'': 35, 'cell': 8, 'covid-19': 7, 'ers': 4, 'inflammatory': 4, 'change': 3, 'recovery': 3, 'decrease': 3, 'monocyte': 3, 'increase': 3, 'patient': 3, 'gene': 3, 'b': 3, 'novel': 3, 'sars-cov-2': 2, 'immune': 2, 'state': 2, 'stage': 2, 'remarkably': 2, 'whereas': 2}","{'sars-cov-2': 2, 'il-inhibitor': 1}",3,-0.6705
DOI:10.1038/s41375-020-0876-z,10.1038/s41375-020-0876-z,Reviews,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['management', 'patient', 'multiple', 'myeloma', 'era', 'covid-19', 'pandemic', '', 'consensus', 'paper', 'european', 'myeloma', 'network', '', 'emn', '']","['Patients multiple myeloma ( MM ) seem increase risk severe COVID-19 infection associate complication due immunocompromised state , older age comorbidities .', 'The European Myeloma Network provide expert consensus statement order guide therapeutic decision era COVID-19 pandemic .', 'Patient education personal hygiene social distance measure , along treatment individualization , telemedicine continuous surveillance early diagnosis COVID-19 essential .', 'In country local community COVID-19 infection widely spread , MM patient PCR test nasopharyngeal swab SARS-CoV-2 hospital admission , start new treatment line , cell apheresis ASCT order avoid ward community spread infection .', 'Oral agent-based regimen consider , especially elderly frail patient standard risk disease , whereas de-intensified regimen dexamethasone , bortezomib , carfilzomib daratumumab use base patient risk response .', 'Treatment initiation postpone patient end organ damage , myeloma emergency aggressive relapse .', 'Autologous ( especially allogeneic ) transplantation delay extend induction administer , especially standard risk patient adequate MM response induction .', 'Watchful wait consider standard risk relapse patient low tumor burden , slow biochemical relapse .', 'The conduction clinical trial continue appropriate adaptation current circumstance .', 'Patients MM symptomatic COVID-19 disease interrupt anti-myeloma treatment recovery .', 'For patient positive PCR test SARS-CoV-2 , symptom COVID-19 , 14-day quarantine consider myeloma-related event allow delay treatment .', 'The need surveillance drug interaction due polypharmacy highlight .', 'The participation international COVID-19 cancer registry greatly encourage .']","['patients', 'multiple', 'myeloma', '', 'mm', '', 'increase', 'risk', 'severe', 'covid-19', 'infection', 'associate', 'complication', 'due', 'immunocompromised', 'state', '', 'older', 'age', 'comorbidities', '', 'european', 'myeloma', 'network', 'provide', 'expert', 'consensus', 'statement', 'order', 'guide', 'therapeutic', 'decision', 'era', 'covid-19', 'pandemic', '', 'patient', 'education', 'personal', 'hygiene', 'social', 'distance', 'measure', '', 'along', 'treatment', 'individualization', '', 'telemedicine', 'continuous', 'surveillance', 'early', 'diagnosis', 'covid-19', 'essential', '', 'country', 'local', 'community', 'covid-19', 'infection', 'widely', 'spread', '', 'mm', 'patient', 'pcr', 'test', 'nasopharyngeal', 'swab', 'sars-cov-2', 'hospital', 'admission', '', 'start', 'new', 'treatment', '', 'cell', 'apheresis', 'asct', 'order', 'avoid', 'ward', 'community', 'spread', 'infection', '', 'oral', 'agent-based', 'regimen', 'consider', '', 'especially', 'elderly', 'frail', 'patient', 'standard', 'risk', 'disease', '', 'whereas', 'de-intensified', 'regimen', 'dexamethasone', '', 'bortezomib', '', 'carfilzomib', 'daratumumab', 'base', 'patient', 'risk', 'response', '', 'treatment', 'initiation', 'postpone', 'patient', 'end', 'organ', 'damage', '', 'myeloma', 'emergency', 'aggressive', 'relapse', '', 'autologous', '', 'especially', 'allogeneic', '', 'transplantation', 'delay', 'extend', 'induction', 'administer', '', 'especially', 'standard', 'risk', 'patient', 'adequate', 'mm', 'response', 'induction', '', 'watchful', 'wait', 'consider', 'standard', 'risk', 'relapse', 'patient', 'low', 'tumor', 'burden', '', 'slow', 'biochemical', 'relapse', '', 'conduction', 'clinical', 'trial', 'continue', 'appropriate', 'adaptation', 'current', 'circumstance', '', 'patients', 'mm', 'symptomatic', 'covid-19', 'disease', 'interrupt', 'anti-myeloma', 'treatment', 'recovery', '', 'patient', 'positive', 'pcr', 'test', 'sars-cov-2', '', 'symptom', 'covid-19', '', '14-day', 'quarantine', 'consider', 'myeloma-related', 'event', 'allow', 'delay', 'treatment', '', 'surveillance', 'drug', 'interaction', 'due', 'polypharmacy', 'highlight', '', 'participation', 'international', 'covid-19', 'cancer', 'registry', 'greatly', 'encourage', '']",215,"{'': 32, 'patient': 8, 'covid-19': 7, 'risk': 5, 'treatment': 5, 'mm': 4, 'myeloma': 3, 'infection': 3, 'consider': 3, 'especially': 3, 'standard': 3, 'relapse': 3, 'patients': 2, 'due': 2, 'order': 2, 'surveillance': 2, 'community': 2, 'spread': 2, 'pcr': 2, 'test': 2}","{'infection': 3, 'sars-cov-2': 2}",5,-0.34
DOI:10.1038/s41591-020-0931-3,10.1038/s41591-020-0931-3,Research,2020-05-19 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['artificial', 'intelligenceenabled', 'rapid', 'diagnosis', 'patient', 'covid-19']","['For diagnosis coronavirus disease 2019 ( COVID-19 ) , SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction ( RT–PCR ) test routinely use .', 'However , test take 2 complete , serial test may require rule possibility false negative result currently shortage RT–PCR test kit , underscore urgent need alternative method rapid accurate diagnosis patient COVID-19 .', 'Chest compute tomography ( CT ) valuable component evaluation patient suspect SARS-CoV-2 infection .', 'Nevertheless , CT alone may limit negative predictive value rule SARS-CoV-2 infection , patient may normal radiological find early stage disease .', 'In study , use artificial intelligence ( AI ) algorithm integrate chest CT find clinical symptom , exposure history laboratory test rapidly diagnose patient positive COVID-19 .', 'Among total 905 patient test real-time RT–PCR assay next-generation sequence RT–PCR , 419 ( 46.3 % ) test positive SARS-CoV-2 .', 'In test set 279 patient , AI system achieve area curve 0.92 equal sensitivity compare senior thoracic radiologist .', 'The AI system also improve detection patient positive COVID-19 via RT–PCR present normal CT scan , correctly identify 17 25 ( 68 % ) patient , whereas radiologist classify patient COVID-19 negative .', 'When CT scan associate clinical history available , propose AI system help rapidly diagnose COVID-19 patient .']","['diagnosis', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'sars-cov-2', 'virus-specific', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', '', 'rtpcr', '', 'test', 'routinely', '', 'however', '', 'test', '2', 'complete', '', 'serial', 'test', 'require', 'rule', 'possibility', 'false', 'negative', 'result', 'currently', 'shortage', 'rtpcr', 'test', 'kit', '', 'underscore', 'urgent', 'alternative', 'method', 'rapid', 'accurate', 'diagnosis', 'patient', 'covid-19', '', 'chest', 'compute', 'tomography', '', 'ct', '', 'valuable', 'component', 'evaluation', 'patient', 'suspect', 'sars-cov-2', 'infection', '', 'nevertheless', '', 'ct', 'alone', 'limit', 'negative', 'predictive', 'value', 'rule', 'sars-cov-2', 'infection', '', 'patient', 'normal', 'radiological', 'find', 'early', 'stage', 'disease', '', 'study', '', 'artificial', 'intelligence', '', 'ai', '', 'algorithm', 'integrate', 'chest', 'ct', 'find', 'clinical', 'symptom', '', 'exposure', 'history', 'laboratory', 'test', 'rapidly', 'diagnose', 'patient', 'positive', 'covid-19', '', 'among', 'total', '905', 'patient', 'test', 'real-time', 'rtpcr', 'assay', 'next-generation', 'sequence', 'rtpcr', '', '419', '', '463', '', '', 'test', 'positive', 'sars-cov-2', '', 'test', 'set', '279', 'patient', '', 'ai', 'system', 'achieve', 'area', 'curve', '092', 'equal', 'sensitivity', 'compare', 'senior', 'thoracic', 'radiologist', '', 'ai', 'system', 'improve', 'detection', 'patient', 'positive', 'covid-19', 'via', 'rtpcr', 'present', 'normal', 'ct', 'scan', '', 'correctly', 'identify', '17', '25', '', '68', '', '', 'patient', '', 'whereas', 'radiologist', 'classify', 'patient', 'covid-19', 'negative', '', 'ct', 'scan', 'associate', 'clinical', 'history', 'available', '', 'propose', 'ai', 'system', 'help', 'rapidly', 'diagnose', 'covid-19', 'patient', '']",196,"{'': 36, 'patient': 10, 'test': 8, 'covid-19': 6, 'rtpcr': 5, 'ct': 5, 'sars-cov-2': 4, 'ai': 4, 'negative': 3, 'positive': 3, 'system': 3, 'diagnosis': 2, 'disease': 2, 'rule': 2, 'chest': 2, 'infection': 2, 'normal': 2, 'find': 2, 'clinical': 2, 'history': 2}","{'infection': 2, 'sars-cov-2': 4}",6,-0.4588
DOI:10.1038/s41431-020-0637-5,10.1038/s41431-020-0637-5,Reviews,2020-05-15 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['connecting', 'data', '', 'tool', 'people', 'across', 'europe', '', 'elixir', '', 'response', 'covid-19', 'pandemic']","['ELIXIR , European research infrastructure life science data , provide open access data , tool workflow response COVID-19 pandemic .', 'ELIXIR ’ 23 node react swiftly support researcher combine effort pandemic set three joint priority : 1 .', 'Connecting national COVID-19 data platform create federate European COVID-19 Data Spaces ; 2 .', 'Fostering good data management make COVID-19 data open , FAIR reusable long term ; 3 .', 'Providing open tool , workflow computational resource drive reproducible collaborative science .', 'ELIXIR ’ strategy base support give national node - collectively span 200 institute - research project partner community initiative drive development adoption good data practice community drive standard .', 'ELIXIR Nodes provide support activity locally internationally , provision compute capability help collect viral sequence data hospital .', 'Some Nodes prioritise access national cloud compute facility COVID-19 research project , others develop tool search , access share data relate pandemic national healthcare set .']","['elixir', '', 'european', 'research', 'infrastructure', 'life', 'science', 'data', '', 'provide', 'open', 'access', 'data', '', 'tool', 'workflow', 'response', 'covid-19', 'pandemic', '', 'elixir', '', '23', 'node', 'react', 'swiftly', 'support', 'researcher', 'combine', 'effort', 'pandemic', 'set', 'three', 'joint', 'priority', '', '1', '', 'connecting', 'national', 'covid-19', 'data', 'platform', 'create', 'federate', 'european', 'covid-19', 'data', 'spaces', '', '2', '', 'fostering', 'data', 'management', 'covid-19', 'data', 'open', '', 'fair', 'reusable', 'long', 'term', '', '3', '', 'providing', 'open', 'tool', '', 'workflow', 'computational', 'resource', 'drive', 'reproducible', 'collaborative', 'science', '', 'elixir', '', 'strategy', 'base', 'support', 'give', 'national', 'node', '-', 'collectively', 'span', '200', 'institute', '-', 'research', 'project', 'partner', 'community', 'initiative', 'drive', 'development', 'adoption', 'data', 'practice', 'community', 'drive', 'standard', '', 'elixir', 'nodes', 'provide', 'support', 'activity', 'locally', 'internationally', '', 'provision', 'compute', 'capability', 'help', 'collect', 'viral', 'sequence', 'data', 'hospital', '', 'nodes', 'prioritise', 'access', 'national', 'cloud', 'compute', 'facility', 'covid-19', 'research', 'project', '', 'others', 'develop', 'tool', 'search', '', 'access', 'share', 'data', 'relate', 'pandemic', 'national', 'healthcare', 'set', '']",149,"{'': 21, 'data': 9, 'covid-19': 5, 'elixir': 4, 'national': 4, 'research': 3, 'open': 3, 'access': 3, 'tool': 3, 'pandemic': 3, 'support': 3, 'drive': 3, 'european': 2, 'science': 2, 'provide': 2, 'workflow': 2, 'node': 2, 'set': 2, '-': 2, 'project': 2}",{},0,0.7184
DOI:10.1038/s41375-020-0836-7,10.1038/s41375-020-0836-7,Research,2020-04-24 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', 'person', 'haematological', 'cancer']","['Infection SARS-CoV-2 , cause coronavirus infectious disease–19 ( COVID-19 ) , cause pandemic > 850,000 case worldwide increase .', 'Several study report outcome COVID-19 predominately well person .', 'There also data COVID-19 person predominately solid cancer controversy whether person outcome .', 'We conduct cohort study two centre Wuhan , China , 128 hospitalise subject haematological cancer , 13 ( 10 % ) develop COVID-19 .', 'We also study 226 health care provider , 16 develop COVID-19 11 hospitalise .', 'Co-variates compare 115 subject haematological cancer without COVID-19 11 hospitalise health care provider COVID-19 .', 'There significant difference baseline co-variates subject haematological cancer develop develop COVID-19 .', 'Case rate COVID-19 hospitalise subject haematological cancer 10 % ( 95 % Confidence Interval [ CI ] , 6 , 17 % ) compare 7 % ( 4 , 12 % ; P = 0.322 ) health care provider .', 'However , 13 subject haematological cancer severe COVID-19 death compare hospitalise health care provider COVID-19 .', 'Case fatality rate 62 % ( 32 , 85 % ) 0 ( 0 , 32 % ; P = 0.002 ) .', 'Hospitalised person haematological cancer similar case rate COVID-19 compare normal health care provider severe disease higher case fatality rate .', 'Because unable identify specific risk factor COVID-19 hospitalise person haematological cancer , suggest increase surveillance possible protective isolation .']","['infection', 'sars-cov-2', '', 'cause', 'coronavirus', 'infectious', 'disease19', '', 'covid-19', '', '', 'cause', 'pandemic', '', '850000', 'case', 'worldwide', 'increase', '', 'several', 'study', 'report', 'outcome', 'covid-19', 'predominately', 'well', 'person', '', 'data', 'covid-19', 'person', 'predominately', 'solid', 'cancer', 'controversy', 'whether', 'person', 'outcome', '', 'conduct', 'cohort', 'study', 'two', 'centre', 'wuhan', '', 'china', '', '128', 'hospitalise', 'haematological', 'cancer', '', '13', '', '10', '', '', 'develop', 'covid-19', '', 'study', '226', 'health', 'care', 'provider', '', '16', 'develop', 'covid-19', '11', 'hospitalise', '', 'co-variates', 'compare', '115', 'haematological', 'cancer', 'without', 'covid-19', '11', 'hospitalise', 'health', 'care', 'provider', 'covid-19', '', 'significant', 'difference', 'baseline', 'co-variates', 'haematological', 'cancer', 'develop', 'develop', 'covid-19', '', 'case', 'rate', 'covid-19', 'hospitalise', 'haematological', 'cancer', '10', '', '', '95', '', 'confidence', 'interval', '', 'ci', '', '', '6', '', '17', '', '', 'compare', '7', '', '', '4', '', '12', '', '', 'p', '', '0322', '', 'health', 'care', 'provider', '', 'however', '', '13', 'haematological', 'cancer', 'severe', 'covid-19', 'death', 'compare', 'hospitalise', 'health', 'care', 'provider', 'covid-19', '', 'case', 'fatality', 'rate', '62', '', '', '32', '', '85', '', '', '0', '', '0', '', '32', '', '', 'p', '', '0002', '', '', 'hospitalised', 'person', 'haematological', 'cancer', 'similar', 'case', 'rate', 'covid-19', 'compare', 'normal', 'health', 'care', 'provider', 'severe', 'disease', 'higher', 'case', 'fatality', 'rate', '', 'unable', 'identify', 'specific', 'risk', 'factor', 'covid-19', 'hospitalise', 'person', 'haematological', 'cancer', '', 'suggest', 'increase', 'surveillance', 'possible', 'protective', 'isolation', '']",212,"{'': 53, 'covid-19': 13, 'cancer': 8, 'haematological': 7, 'hospitalise': 6, 'case': 5, 'person': 5, 'health': 5, 'care': 5, 'provider': 5, 'develop': 4, 'compare': 4, 'rate': 4, 'study': 3, 'cause': 2, 'increase': 2, 'outcome': 2, 'predominately': 2, '13': 2, '10': 2}","{'infection': 1, 'sars-cov-2': 1}",2,-0.1027
DOI:10.1038/s41372-020-0695-0,10.1038/s41372-020-0695-0,Reviews,2020-05-21 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['management', 'newborn', 'expose', 'mother', 'confirm', 'suspect', 'covid-19']","['There limit information newborn confirm suspect COVID-19 .', 'Particularly hospital delivery , clinician refine practice order prevent secondary infection .', 'While guidance international association continuously update , facet care neonate bear woman confirm suspect COVID-19 center-specific , give local custom , build infrastructure constraint , availability protective equipment .', 'Based anecdotal report institution epicenter COVID-19 pandemic close hospital , together limit experience , anticipation increase number expose newborn , develop triage algorithm Penn State Hospital Milton S. Hershey Medical Center may useful center anticipate similar surge .', 'We discus several care practice change COVID-19 era include use antenatal steroid , delay cord clamp ( DCC ) , mother–newborn separation , breastfeed .', 'Moreover , paper provide comprehensive guidance suitable respiratory support newborn COVID-19 pandemic .', 'We also present detail recommendation discharge process beyond , include provide scale home phototherapy family , parental teach via telehealth in-person education door hospital , telehealth newborn follow-up .']","['limit', 'information', 'newborn', 'confirm', 'suspect', 'covid-19', '', 'particularly', 'hospital', 'delivery', '', 'clinician', 'refine', 'practice', 'order', 'prevent', 'secondary', 'infection', '', 'guidance', 'international', 'association', 'continuously', 'update', '', 'facet', 'care', 'neonate', 'bear', 'woman', 'confirm', 'suspect', 'covid-19', 'center-specific', '', 'give', 'local', 'custom', '', 'build', 'infrastructure', 'constraint', '', 'availability', 'protective', 'equipment', '', 'based', 'anecdotal', 'report', 'institution', 'epicenter', 'covid-19', 'pandemic', 'close', 'hospital', '', 'together', 'limit', 'experience', '', 'anticipation', 'increase', 'number', 'expose', 'newborn', '', 'develop', 'triage', 'algorithm', 'penn', 'state', 'hospital', 'milton', 'hershey', 'medical', 'center', 'useful', 'center', 'anticipate', 'similar', 'surge', '', 'discus', 'several', 'care', 'practice', 'change', 'covid-19', 'era', 'include', 'antenatal', 'steroid', '', 'delay', 'cord', 'clamp', '', 'dcc', '', '', 'mothernewborn', 'separation', '', 'breastfeed', '', 'moreover', '', 'paper', 'provide', 'comprehensive', 'guidance', 'suitable', 'respiratory', 'support', 'newborn', 'covid-19', 'pandemic', '', 'present', 'detail', 'recommendation', 'discharge', 'process', 'beyond', '', 'include', 'provide', 'scale', 'home', 'phototherapy', 'family', '', 'parental', 'teach', 'via', 'telehealth', 'in-person', 'education', 'door', 'hospital', '', 'telehealth', 'newborn', 'follow-up', '']",146,"{'': 24, 'covid-19': 5, 'newborn': 4, 'hospital': 4, 'limit': 2, 'confirm': 2, 'suspect': 2, 'practice': 2, 'guidance': 2, 'care': 2, 'pandemic': 2, 'center': 2, 'include': 2, 'provide': 2, 'telehealth': 2, 'information': 1, 'particularly': 1, 'delivery': 1, 'clinician': 1, 'refine': 1}",{'infection': 1},1,-0.0258
DOI:10.1038/s41577-020-0331-4,10.1038/s41577-020-0331-4,Reviews,2020-05-06 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['pathological', 'inflammation', 'patient', 'covid-19', '', 'key', 'role', 'monocyte', 'macrophage']","['The COVID-19 pandemic cause infection SARS-CoV-2 lead 200,000 death worldwide .', 'Several study establish hyperinflammatory response induce SARS-CoV-2 major cause disease severity death infect patient .', 'Macrophages population innate immune cell sense respond microbial threat produce inflammatory molecule eliminate pathogen promote tissue repair .', 'However , dysregulated macrophage response damage host , see macrophage activation syndrome induce severe infection , include infection relate virus SARS-CoV .', 'Here describe potentially pathological role macrophage SARS-CoV-2 infection discus ongoing prospective therapeutic strategy modulate macrophage activation patient COVID-19 .']","['covid-19', 'pandemic', 'cause', 'infection', 'sars-cov-2', 'lead', '200000', 'death', 'worldwide', '', 'several', 'study', 'establish', 'hyperinflammatory', 'response', 'induce', 'sars-cov-2', 'major', 'cause', 'disease', 'severity', 'death', 'infect', 'patient', '', 'macrophages', 'population', 'innate', 'immune', 'cell', 'sense', 'respond', 'microbial', 'threat', 'produce', 'inflammatory', 'molecule', 'eliminate', 'pathogen', 'promote', 'tissue', 'repair', '', 'however', '', 'dysregulated', 'macrophage', 'response', 'damage', 'host', '', 'macrophage', 'activation', 'syndrome', 'induce', 'severe', 'infection', '', 'include', 'infection', 'relate', 'virus', 'sars-cov', '', 'describe', 'potentially', 'pathological', 'role', 'macrophage', 'sars-cov-2', 'infection', 'discus', 'ongoing', 'prospective', 'therapeutic', 'strategy', 'modulate', 'macrophage', 'activation', 'patient', 'covid-19', '']",82,"{'': 8, 'infection': 4, 'macrophage': 4, 'sars-cov-2': 3, 'covid-19': 2, 'cause': 2, 'death': 2, 'response': 2, 'induce': 2, 'patient': 2, 'activation': 2, 'pandemic': 1, 'lead': 1, '200000': 1, 'worldwide': 1, 'several': 1, 'study': 1, 'establish': 1, 'hyperinflammatory': 1, 'major': 1}","{'infection': 4, 'sars-cov-2': 3}",7,-0.8126
DOI:10.1038/s41375-020-0853-6,10.1038/s41375-020-0853-6,Research,2020-05-18 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', 'person', 'chronic', 'myeloid', 'leukaemia']","['We study questionnaire 530 subject chronic myeloid leukaemia ( CML ) Hubei Province recent SARS-CoV-2 epidemic .', 'Five develop confirm ( N = 4 ) probable COVID-19 ( N = 1 ) .', 'Prevalence COVID-19 subject , 0.9 % ( 95 % Confidence Interval , 0.1 , 1.8 % ) ninefold higher 0.1 % ( 0 , 0.12 % ) report normal lower 10 % ( 6 , 17 % ) report hospitalise person haematological cancer normal health-care provider , 7 % ( 4 , 12 % ) .', 'Co-variates associate increase risk develop COVID-19 amongst person CML exposure someone infect SARS-CoV-2 ( P = 0.037 ) , complete haematologic response ( P = 0.003 ) co-morbidity ( y ) ( P = 0.024 ) .', 'There also increase risk develop COVID-19 subject advance phase CML ( P = 0.004 ) even achieve complete cytogenetic response major molecular response time exposure SARS-CoV-2 .', '1 21 subject receive 3rd generation tyrosine kinase-inhibitor ( TKI ) develop COVID-19 versus 3 346 subject receive imatinib versus 0 162 subject receive 2nd generation TKIs ( P = 0.096 ) .', 'Other co-variates age TKI-therapy duration significantly associate increase risk develop COVID-19 .', 'Persons risk factor may benefit increase surveillance SARS-CoV-2 infection possible protective isolation .']","['study', 'questionnaire', '530', 'chronic', 'myeloid', 'leukaemia', '', 'cml', '', 'hubei', 'province', 'recent', 'sars-cov-2', 'epidemic', '', 'five', 'develop', 'confirm', '', 'n', '', '4', '', 'probable', 'covid-19', '', 'n', '', '1', '', '', 'prevalence', 'covid-19', '', '09', '', '', '95', '', 'confidence', 'interval', '', '01', '', '18', '', '', 'ninefold', 'higher', '01', '', '', '0', '', '012', '', '', 'report', 'normal', 'lower', '10', '', '', '6', '', '17', '', '', 'report', 'hospitalise', 'person', 'haematological', 'cancer', 'normal', 'health-care', 'provider', '', '7', '', '', '4', '', '12', '', '', '', 'co-variates', 'associate', 'increase', 'risk', 'develop', 'covid-19', 'amongst', 'person', 'cml', 'exposure', 'someone', 'infect', 'sars-cov-2', '', 'p', '', '0037', '', '', 'complete', 'haematologic', 'response', '', 'p', '', '0003', '', 'co-morbidity', '', '', '', 'p', '', '0024', '', '', 'increase', 'risk', 'develop', 'covid-19', 'advance', 'phase', 'cml', '', 'p', '', '0004', '', 'achieve', 'complete', 'cytogenetic', 'response', 'major', 'molecular', 'response', 'time', 'exposure', 'sars-cov-2', '', '1', '21', 'receive', '3rd', 'generation', 'tyrosine', 'kinase-inhibitor', '', 'tki', '', 'develop', 'covid-19', 'versus', '3', '346', 'receive', 'imatinib', 'versus', '0', '162', 'receive', '2nd', 'generation', 'tkis', '', 'p', '', '0096', '', '', 'co-variates', 'age', 'tki-therapy', 'duration', 'significantly', 'associate', 'increase', 'risk', 'develop', 'covid-19', '', 'persons', 'risk', 'factor', 'benefit', 'increase', 'surveillance', 'sars-cov-2', 'infection', 'possible', 'protective', 'isolation', '']",198,"{'': 60, 'covid-19': 6, 'develop': 5, 'p': 5, 'sars-cov-2': 4, 'increase': 4, 'risk': 4, 'cml': 3, 'response': 3, 'receive': 3, 'n': 2, '4': 2, '1': 2, '01': 2, '0': 2, 'report': 2, 'normal': 2, 'person': 2, 'co-variates': 2, 'associate': 2}","{'infection': 1, 'sars-cov-2': 4}",5,-0.5106
DOI:10.1038/s41394-020-0288-3,10.1038/s41394-020-0288-3,Research,2020-05-13 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['clinical', 'feature', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'cohort', 'patient', 'disability', 'due', 'spinal', 'cord', 'injury']","['Study designCohort study patient spinal cord injury ( SCI ) .ObjectivesTo describe clinical analytical feature coronavirus disease 2019 ( Covid-19 ) infect cohort SCI enable accurate diagnosis outline prevention measures.SettingThis study conduct National Hospital Paraplegics ( Toledo , Spain ) .MethodsA cohort analysis seven patient SCI infect Covid-19 perform .', 'Diagnosis confirm reverse transcriptase polymerase chain reaction ( RT-PCR ) nasal exudate sputum sample .', 'Clinical , analytical , radiographic find registered.ResultsRT-PCR detect COVID-19 infection patient , affect male people cervical level injury often ( five seven ) .', 'The average delay diagnostic confirmation 4 day ( interquartile range , 1–10 ) .', 'Fever frequent symptom ( six seven ) .', 'The second common symptom asthenia ( four seven ) , follow dyspnea , cough , expectoration ( three seven symptom ) .', 'The Modified Early Warning System score Covid-19 severity rat classify severe five seven case .', 'All one patient show radiological alteration evident chest X-rays time diagnosis .', 'All patient recover gradually.ConclusionOur patient SCI Covid-19 infection exhibit fewer symptom general population .', 'Furthermore , present similar greater clinical severity .', 'The clinical evolution pronounce expect .', 'This study recommend close supervision SCI population detect early compatible sign symptom Covid-19 infection .']","['study', 'designcohort', 'study', 'patient', 'spinal', 'cord', 'injury', '', 'sci', '', 'objectivesto', 'describe', 'clinical', 'analytical', 'feature', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'infect', 'cohort', 'sci', 'enable', 'accurate', 'diagnosis', 'outline', 'prevention', 'measuressettingthis', 'study', 'conduct', 'national', 'hospital', 'paraplegics', '', 'toledo', '', 'spain', '', 'methodsa', 'cohort', 'analysis', 'seven', 'patient', 'sci', 'infect', 'covid-19', 'perform', '', 'diagnosis', 'confirm', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'nasal', 'exudate', 'sputum', 'sample', '', 'clinical', '', 'analytical', '', 'radiographic', 'find', 'registeredresultsrt-pcr', 'detect', 'covid-19', 'infection', 'patient', '', 'affect', 'male', 'people', 'cervical', 'level', 'injury', 'often', '', 'five', 'seven', '', '', 'average', 'delay', 'diagnostic', 'confirmation', '4', 'day', '', 'interquartile', 'range', '', '110', '', '', 'fever', 'frequent', 'symptom', '', 'six', 'seven', '', '', 'second', 'common', 'symptom', 'asthenia', '', 'four', 'seven', '', '', 'follow', 'dyspnea', '', 'cough', '', 'expectoration', '', 'three', 'seven', 'symptom', '', '', 'modified', 'early', 'warning', 'system', 'score', 'covid-19', 'severity', 'rat', 'classify', 'severe', 'five', 'seven', 'case', '', 'one', 'patient', 'show', 'radiological', 'alteration', 'evident', 'chest', 'x-rays', 'time', 'diagnosis', '', 'patient', 'recover', 'graduallyconclusionour', 'patient', 'sci', 'covid-19', 'infection', 'exhibit', 'fewer', 'symptom', 'general', 'population', '', 'furthermore', '', 'present', 'similar', 'greater', 'clinical', 'severity', '', 'clinical', 'evolution', 'pronounce', 'expect', '', 'study', 'recommend', 'close', 'supervision', 'sci', 'population', 'detect', 'early', 'compatible', 'sign', 'symptom', 'covid-19', 'infection', '']",196,"{'': 39, 'patient': 6, 'covid-19': 6, 'seven': 6, 'sci': 5, 'symptom': 5, 'study': 4, 'clinical': 4, 'diagnosis': 3, 'infection': 3, 'injury': 2, 'analytical': 2, 'infect': 2, 'cohort': 2, 'detect': 2, 'five': 2, 'early': 2, 'severity': 2, 'population': 2, 'designcohort': 1}",{'infection': 3},3,-0.6808
DOI:10.1038/s41430-020-0652-1,10.1038/s41430-020-0652-1,Reviews,2020-05-13 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['diabetes', 'covid-19', '', 'evidence', '', 'current', 'status', 'unanswered', 'research', 'question']","['Patients diabetes get coronavirus disease 2019 ( COVID-19 ) risk severe disease course mortality .', 'Several factor especially impair immune response , heighten inflammatory response hypercoagulable state contribute increase disease severity .', 'However , many contentious issue evidence rather limit .', 'There theoretical concern effect different anti-hyperglycaemic drug .', 'Similarly , despite recognition angiotensin convert enzyme 2 ( ACE2 ) receptor severe acute respiratory syndrome coronavirus 2 ( SARS CoV-2 ) , role ACE2 lung injury ; conflict result use angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) patient .', 'Management patient diabetes time restriction mobility pose challenge novel approach like telemedicine useful .', 'There need study natural course COVID-19 patient diabetes understand individual , regional ethnic variation disease prevalence course .']","['patients', 'diabetes', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'risk', 'severe', 'disease', 'course', 'mortality', '', 'several', 'factor', 'especially', 'impair', 'immune', 'response', '', 'heighten', 'inflammatory', 'response', 'hypercoagulable', 'state', 'contribute', 'increase', 'disease', 'severity', '', 'however', '', 'contentious', 'issue', 'evidence', 'limit', '', 'theoretical', 'concern', 'effect', 'different', 'anti-hyperglycaemic', 'drug', '', 'similarly', '', 'despite', 'recognition', 'angiotensin', 'convert', 'enzyme', '2', '', 'ace2', '', 'receptor', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars', 'cov-2', '', '', 'role', 'ace2', 'lung', 'injury', '', 'conflict', 'result', 'angiotensin', 'convert', 'enzyme', '', 'ace', '', 'inhibitor', 'angiotensin', 'receptor', 'blocker', '', 'arb', '', 'patient', '', 'management', 'patient', 'diabetes', 'time', 'restriction', 'mobility', 'pose', 'challenge', 'novel', 'approach', 'like', 'telemedicine', 'useful', '', 'study', 'natural', 'course', 'covid-19', 'patient', 'diabetes', 'understand', 'individual', '', 'regional', 'ethnic', 'variation', 'disease', 'prevalence', 'course', '']",120,"{'': 23, 'disease': 4, 'diabetes': 3, 'course': 3, 'angiotensin': 3, 'patient': 3, 'coronavirus': 2, 'covid-19': 2, 'severe': 2, 'response': 2, 'convert': 2, 'enzyme': 2, '2': 2, 'ace2': 2, 'receptor': 2, 'patients': 1, '2019': 1, 'risk': 1, 'mortality': 1, 'several': 1}",{},0,-0.2782
DOI:10.1038/s41591-020-0901-9,10.1038/s41591-020-0901-9,Research,2020-05-12 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['single-cell', 'landscape', 'bronchoalveolar', 'immune', 'cell', 'patient', 'covid-19']","['Respiratory immune characteristic associate Coronavirus Disease 2019 ( COVID-19 ) severity currently unclear .', 'We characterize bronchoalveolar lavage fluid immune cell patient vary severity COVID-19 healthy people use single-cell RNA sequence .', 'Proinflammatory monocyte-derived macrophage abundant bronchoalveolar lavage fluid patient severe COVID-9 .', 'Moderate case characterize presence highly clonally expand CD8+ T cell .', 'This atlas bronchoalveolar immune microenvironment suggest potential mechanism underlie pathogenesis recovery COVID-19 .']","['respiratory', 'immune', 'characteristic', 'associate', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'severity', 'currently', 'unclear', '', 'characterize', 'bronchoalveolar', 'lavage', 'fluid', 'immune', 'cell', 'patient', 'vary', 'severity', 'covid-19', 'healthy', 'people', 'single-cell', 'rna', 'sequence', '', 'proinflammatory', 'monocyte-derived', 'macrophage', 'abundant', 'bronchoalveolar', 'lavage', 'fluid', 'patient', 'severe', 'covid-9', '', 'moderate', 'case', 'characterize', 'presence', 'highly', 'clonally', 'expand', 'cd8', 'cell', '', 'atlas', 'bronchoalveolar', 'immune', 'microenvironment', 'suggest', 'potential', 'mechanism', 'underlie', 'pathogenesis', 'recovery', 'covid-19', '']",63,"{'': 7, 'immune': 3, 'covid-19': 3, 'bronchoalveolar': 3, 'severity': 2, 'characterize': 2, 'lavage': 2, 'fluid': 2, 'cell': 2, 'patient': 2, 'respiratory': 1, 'characteristic': 1, 'associate': 1, 'coronavirus': 1, 'disease': 1, '2019': 1, 'currently': 1, 'unclear': 1, 'vary': 1, 'healthy': 1}",{},0,0.3612
DOI:10.1038/s41431-020-0634-8,10.1038/s41431-020-0634-8,Reviews,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['bbmri-eric', '', 'contribution', 'research', 'knowledge', 'exchange', 'covid-19']","['During COVID-19 pandemic , European biobanking infrastructure unique position preserve valuable biological material complement detail data future research purpose .', 'Biobanks either integrate healthcare , preservation biological material fork clinical routine diagnostics medical treatment process also host prospective cohort material relate clinical trial .', 'The paper discuss objective BBMRI-ERIC , European research infrastructure establish facilitate access quality-defined biological material data research purpose , respect COVID-19 crisis : ( ) collect information available European well non-European COVID-19-relevant biobanking resource BBMRI-ERIC Directory facilitate access via BBMRI-ERIC Negotiator platform ; ( b ) help harmonize guideline data biological material collect maximize utility future research , include large-scale data process artificial intelligence , participate activity COVID-19 Host Genetics Initiative ; ( c ) minimize risk involve party deal ( potentially ) infectious material develop recommendation guideline ; ( ) provide European-wide platform exchange relation ethical , legal , societal issue ( ELSI ) specific collection biological material data COVID-19 pandemic .']","['covid-19', 'pandemic', '', 'european', 'biobanking', 'infrastructure', 'unique', 'position', 'preserve', 'valuable', 'biological', 'material', 'complement', 'detail', 'data', 'future', 'research', 'purpose', '', 'biobanks', 'either', 'integrate', 'healthcare', '', 'preservation', 'biological', 'material', 'fork', 'clinical', 'routine', 'diagnostics', 'medical', 'treatment', 'process', 'host', 'prospective', 'cohort', 'material', 'relate', 'clinical', 'trial', '', 'paper', 'discuss', 'objective', 'bbmri-eric', '', 'european', 'research', 'infrastructure', 'establish', 'facilitate', 'access', 'quality-defined', 'biological', 'material', 'data', 'research', 'purpose', '', 'respect', 'covid-19', 'crisis', '', '', '', 'collect', 'information', 'available', 'european', 'well', 'non-european', 'covid-19-relevant', 'biobanking', 'resource', 'bbmri-eric', 'directory', 'facilitate', 'access', 'via', 'bbmri-eric', 'negotiator', 'platform', '', '', 'b', '', 'help', 'harmonize', 'guideline', 'data', 'biological', 'material', 'collect', 'maximize', 'utility', 'future', 'research', '', 'include', 'large-scale', 'data', 'process', 'artificial', 'intelligence', '', 'participate', 'activity', 'covid-19', 'host', 'genetics', 'initiative', '', '', 'c', '', 'minimize', 'risk', 'involve', 'party', 'deal', '', 'potentially', '', 'infectious', 'material', 'develop', 'recommendation', 'guideline', '', '', '', 'provide', 'european-wide', 'platform', 'exchange', 'relation', 'ethical', '', 'legal', '', 'societal', 'issue', '', 'elsi', '', 'specific', 'collection', 'biological', 'material', 'data', 'covid-19', 'pandemic', '']",154,"{'': 27, 'material': 7, 'biological': 5, 'data': 5, 'covid-19': 4, 'research': 4, 'european': 3, 'bbmri-eric': 3, 'pandemic': 2, 'biobanking': 2, 'infrastructure': 2, 'future': 2, 'purpose': 2, 'clinical': 2, 'process': 2, 'host': 2, 'facilitate': 2, 'access': 2, 'collect': 2, 'platform': 2}",{},0,0.9442
DOI:10.1038/s41571-020-0394-y,10.1038/s41571-020-0394-y,Comments and Opinion,2020-05-18 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', 'cancer', '', 'really', '']",[],[],0,{},{},0,0.0
DOI:10.1038/s41391-020-0240-4,10.1038/s41391-020-0240-4,Reviews,2020-05-18 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['elective', 'procedure', 'prostate', 'cancer', 'time', 'covid-19', '', 'multidisciplinary', 'team', 'experience']","['On March 29th 2020 , 97,689 case COVID-19 diagnose Italy , 73,880 actually positive case , daily increase 3815 case , 27,386 hospitalize 3906 patient intensive care unit , cause total 10,779 know death .', 'In urological department , quickly inpatient outpatient service significantly reduce .', 'Even COVID-19 situation , urological neoplasm care must go , significant change need make way care deliver .', 'We compare diagnostic therapeutic elective procedure request perform PC management multidisciplinary team ( MDT ) 1 month activity highest national level COVID-19 infection ( March 2020 ) restriction population , management perform no-COVID-19 month ( March 2019 ) 1 year ago .', 'The management receive significant reduction medical therapy advance hormone sensitive ( HS ) castration resistant ( CR ) PC .', 'We describe MDT identification elective undeferrable PC management COVID-19 time .', 'These suggestion consider country ( ITALY ) rapid increase COVID-19 case complication , region actual lower impact ( 2914 actual positive 1079 hospitalize case ) infection hospital completely convert COVID-19 management .', 'Indications different restrict emergency basis COVID-19 pandemic situation hospital involvement .']","['march', '29th', '2020', '', '97689', 'case', 'covid-19', 'diagnose', 'italy', '', '73880', 'actually', 'positive', 'case', '', 'daily', 'increase', '3815', 'case', '', '27386', 'hospitalize', '3906', 'patient', 'intensive', 'care', 'unit', '', 'cause', 'total', '10779', 'death', '', 'urological', 'department', '', 'quickly', 'inpatient', 'outpatient', 'service', 'significantly', 'reduce', '', 'covid-19', 'situation', '', 'urological', 'neoplasm', 'care', 'must', '', 'significant', 'change', 'way', 'care', 'deliver', '', 'compare', 'diagnostic', 'therapeutic', 'elective', 'procedure', 'request', 'perform', 'pc', 'management', 'multidisciplinary', 'team', '', 'mdt', '', '1', 'month', 'activity', 'highest', 'national', 'level', 'covid-19', 'infection', '', 'march', '2020', '', 'restriction', 'population', '', 'management', 'perform', 'no-covid-19', 'month', '', 'march', '2019', '', '1', 'year', 'ago', '', 'management', 'receive', 'significant', 'reduction', 'medical', 'therapy', 'advance', 'hormone', 'sensitive', '', 'hs', '', 'castration', 'resistant', '', 'cr', '', 'pc', '', 'describe', 'mdt', 'identification', 'elective', 'undeferrable', 'pc', 'management', 'covid-19', 'time', '', 'suggestion', 'consider', 'country', '', 'italy', '', 'rapid', 'increase', 'covid-19', 'case', 'complication', '', 'region', 'actual', 'lower', 'impact', '', '2914', 'actual', 'positive', '1079', 'hospitalize', 'case', '', 'infection', 'hospital', 'completely', 'convert', 'covid-19', 'management', '', 'indications', 'different', 'restrict', 'emergency', 'basis', 'covid-19', 'pandemic', 'situation', 'hospital', 'involvement', '']",169,"{'': 32, 'covid-19': 7, 'case': 5, 'management': 5, 'march': 3, 'care': 3, 'pc': 3, '2020': 2, 'italy': 2, 'positive': 2, 'increase': 2, 'hospitalize': 2, 'urological': 2, 'situation': 2, 'significant': 2, 'elective': 2, 'perform': 2, 'mdt': 2, '1': 2, 'month': 2}",{'infection': 2},2,0.9081
DOI:10.1038/s41591-020-0874-8,10.1038/s41591-020-0874-8,Reviews,2020-04-16 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['caring', 'patient', 'cancer', 'covid-19', 'era']","['The current COVID-19 pandemic challenge oncologist profoundly re-organize oncological care order dramatically reduce hospital visit admission therapy-induced immune-related complication without compromise cancer outcome .', 'Since COVID-19 novel disease , guidance scientific evidence often unavailable , impactful decision inevitably make basis expert opinion .', 'Here report seven comprehensive cancer center Cancer Core Europe organize healthcare system unprecedented scale pace make operation ‘ pandemic proof ’ .', 'We identify discus many commonality , also important local difference , pinpoint critical research priority enable evidence-based remodel cancer care COVID-19 pandemic .', 'Also , discus current situation offer unique window opportunity assess effect de-escalate anticancer regimen , may fast-forward development more-refined less-toxic treatment .', 'By share joint experience , offer roadmap proceed aim mobilize global research community generate data critically need offer best possible care patient .']","['current', 'covid-19', 'pandemic', 'challenge', 'oncologist', 'profoundly', 're-organize', 'oncological', 'care', 'order', 'dramatically', 'reduce', 'hospital', 'visit', 'admission', 'therapy-induced', 'immune-related', 'complication', 'without', 'compromise', 'cancer', 'outcome', '', 'since', 'covid-19', 'novel', 'disease', '', 'guidance', 'scientific', 'evidence', 'often', 'unavailable', '', 'impactful', 'decision', 'inevitably', 'basis', 'expert', 'opinion', '', 'report', 'seven', 'comprehensive', 'cancer', 'center', 'cancer', 'core', 'europe', 'organize', 'healthcare', 'system', 'unprecedented', 'scale', 'pace', 'operation', '', 'pandemic', 'proof', '', '', 'identify', 'discus', 'commonality', '', 'important', 'local', 'difference', '', 'pinpoint', 'critical', 'research', 'priority', 'enable', 'evidence-based', 'remodel', 'cancer', 'care', 'covid-19', 'pandemic', '', '', 'discus', 'current', 'situation', 'offer', 'unique', 'window', 'opportunity', 'assess', 'effect', 'de-escalate', 'anticancer', 'regimen', '', 'fast-forward', 'development', 'more-refined', 'less-toxic', 'treatment', '', 'share', 'joint', 'experience', '', 'offer', 'roadmap', 'proceed', 'aim', 'mobilize', 'global', 'research', 'community', 'generate', 'data', 'critically', 'offer', 'best', 'possible', 'care', 'patient', '']",122,"{'': 15, 'cancer': 4, 'covid-19': 3, 'pandemic': 3, 'care': 3, 'offer': 3, 'current': 2, 'discus': 2, 'research': 2, 'challenge': 1, 'oncologist': 1, 'profoundly': 1, 're-organize': 1, 'oncological': 1, 'order': 1, 'dramatically': 1, 'reduce': 1, 'hospital': 1, 'visit': 1, 'admission': 1}",{},0,0.8567
DOI:10.1038/s41430-020-0659-7,10.1038/s41430-020-0659-7,Research,2020-05-13 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['clinical', 'significance', 'nutritional', 'risk', 'screen', 'older', 'adult', 'patient', 'covid-19']","['ObjectivesThe aim study ass nutritional risk among older patient COVID-19 associate clinical outcome use four nutritional risk screen ( NRS ) tool : Nutrition Risk Screening 2002 ( NRS 2002 ) , Malnutrition Universal Screening Tool ( MUST ) , Mini Nutrition Assessment Shortcut ( MNA-sf ) , Nutrition Risk Index ( NRI ) .MethodsWe retrospectively analyze data patient COVID-19 older 65 year treat hospital January 28 , 2020 March 5 , 2020 , explore relationship nutritional risk clinical outcomes.ResultsA total 141 patient COVID-19 ( 46 common COVID-19 , 73 severe COVID-19 , 22 extremely severe COVID-19 ) enrol study .', 'NRS 2002 identify 85.8 % patient risk , identify 41.1 % MUST , 77.3 % MNA-sf , 71.6 % NRI .', 'The agreement strength moderate NRS 2002 MNA-sf , NRI , fair MUST MNA-sf , NRI , fair MNA-sf NRI , poor NRS 2002 MUST ( P < 0.01 ) .', 'After adjustment confound factor multivariate regression analysis , patient risk group significantly longer LOS , higher hospital expense ( except MNA-sf ) , poor appetite , heavier disease severity , weight change ( kg ) normal patient use NRS 2002 , MNA-sf , NRI ( P < 0.05 ) .ConclusionsThe NRS 2002 , MNA-sf , NRI useful practical tool respect screen patient COVID-19 nutritional risk , well need additional nutritional intervention .']","['objectivesthe', 'aim', 'study', 'ass', 'nutritional', 'risk', 'among', 'older', 'patient', 'covid-19', 'associate', 'clinical', 'outcome', 'four', 'nutritional', 'risk', 'screen', '', 'nrs', '', 'tool', '', 'nutrition', 'risk', 'screening', '2002', '', 'nrs', '2002', '', '', 'malnutrition', 'universal', 'screening', 'tool', '', 'must', '', '', 'mini', 'nutrition', 'assessment', 'shortcut', '', 'mna-sf', '', '', 'nutrition', 'risk', 'index', '', 'nri', '', 'methodswe', 'retrospectively', 'analyze', 'data', 'patient', 'covid-19', 'older', '65', 'year', 'treat', 'hospital', 'january', '28', '', '2020', 'march', '5', '', '2020', '', 'explore', 'relationship', 'nutritional', 'risk', 'clinical', 'outcomesresultsa', 'total', '141', 'patient', 'covid-19', '', '46', 'common', 'covid-19', '', '73', 'severe', 'covid-19', '', '22', 'extremely', 'severe', 'covid-19', '', 'enrol', 'study', '', 'nrs', '2002', 'identify', '858', '', 'patient', 'risk', '', 'identify', '411', '', 'must', '', '773', '', 'mna-sf', '', '716', '', 'nri', '', 'agreement', 'strength', 'moderate', 'nrs', '2002', 'mna-sf', '', 'nri', '', 'fair', 'must', 'mna-sf', '', 'nri', '', 'fair', 'mna-sf', 'nri', '', 'poor', 'nrs', '2002', 'must', '', 'p', '', '001', '', '', 'adjustment', 'confound', 'factor', 'multivariate', 'regression', 'analysis', '', 'patient', 'risk', 'group', 'significantly', 'longer', 'los', '', 'higher', 'hospital', 'expense', '', 'except', 'mna-sf', '', '', 'poor', 'appetite', '', 'heavier', 'disease', 'severity', '', 'weight', 'change', '', 'kg', '', 'normal', 'patient', 'nrs', '2002', '', 'mna-sf', '', 'nri', '', 'p', '', '005', '', 'conclusionsthe', 'nrs', '2002', '', 'mna-sf', '', 'nri', 'useful', 'practical', 'tool', 'respect', 'screen', 'patient', 'covid-19', 'nutritional', 'risk', '', 'well', 'additional', 'nutritional', 'intervention', '']",219,"{'': 57, 'risk': 8, 'mna-sf': 8, 'patient': 7, 'covid-19': 7, 'nrs': 7, '2002': 7, 'nri': 7, 'nutritional': 5, 'must': 4, 'tool': 3, 'nutrition': 3, 'study': 2, 'older': 2, 'clinical': 2, 'screen': 2, 'screening': 2, 'hospital': 2, '2020': 2, 'severe': 2}",{},0,-0.8271
DOI:10.1038/s41577-020-0311-8,10.1038/s41577-020-0311-8,Reviews,2020-04-28 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['trinity', 'covid-19', '', 'immunity', '', 'inflammation', 'intervention']","['Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) causative agent ongoing coronavirus disease 2019 ( COVID-19 ) pandemic .', 'Alongside investigation virology SARS-CoV-2 , understand fundamental physiological immunological process underlie clinical manifestation COVID-19 vital identification rational design effective therapy .', 'Here , provide overview pathophysiology SARS-CoV-2 infection .', 'We describe interaction SARS-CoV-2 immune system subsequent contribution dysfunctional immune response disease progression .', 'From nascent report describe SARS-CoV-2 , make inference basis parallel pathophysiological immunological feature human coronaviruses target lower respiratory tract — severe acute respiratory syndrome coronavirus ( SARS-CoV ) Middle East respiratory syndrome coronavirus ( MERS-CoV ) .', 'Finally , highlight implication approach potential therapeutic intervention target viral infection and/or immunoregulation .']","['severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'causative', 'agent', 'ongoing', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', '', 'alongside', 'investigation', 'virology', 'sars-cov-2', '', 'understand', 'fundamental', 'physiological', 'immunological', 'process', 'underlie', 'clinical', 'manifestation', 'covid-19', 'vital', 'identification', 'rational', 'design', 'effective', 'therapy', '', '', 'provide', 'overview', 'pathophysiology', 'sars-cov-2', 'infection', '', 'describe', 'interaction', 'sars-cov-2', 'immune', 'system', 'subsequent', 'contribution', 'dysfunctional', 'immune', 'response', 'disease', 'progression', '', 'nascent', 'report', 'describe', 'sars-cov-2', '', 'inference', 'basis', 'parallel', 'pathophysiological', 'immunological', 'feature', 'human', 'coronaviruses', 'target', 'lower', 'respiratory', 'tract', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '', 'sars-cov', '', 'middle', 'east', 'respiratory', 'syndrome', 'coronavirus', '', 'mers-cov', '', '', 'finally', '', 'highlight', 'implication', 'approach', 'potential', 'therapeutic', 'intervention', 'target', 'viral', 'infection', 'andor', 'immunoregulation', '']",110,"{'': 19, 'sars-cov-2': 5, 'respiratory': 4, 'coronavirus': 4, 'syndrome': 3, 'severe': 2, 'acute': 2, 'disease': 2, 'covid-19': 2, 'immunological': 2, 'infection': 2, 'describe': 2, 'immune': 2, 'target': 2, '2': 1, 'causative': 1, 'agent': 1, 'ongoing': 1, '2019': 1, 'pandemic': 1}","{'infection': 2, 'sars-cov-2': 5}",7,0.4019
DOI:10.1038/s41582-020-0368-9,10.1038/s41582-020-0368-9,Comments and Opinion,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', 'management', 'neuroimmunological', 'disorder']",[],[],0,{},{},0,0.0
DOI:10.1038/s43018-020-0074-y,10.1038/s43018-020-0074-y,Comments and Opinion,2020-05-20 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['impact', 'covid-19', 'pandemic', 'cancer', 'care']",[],[],0,{},{},0,0.0
DOI:10.1038/s41577-020-0343-0,10.1038/s41577-020-0343-0,Comments and Opinion,2020-05-21 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', '', 'vasculature', 'unleash']",[],[],0,{},{},0,0.0
DOI:10.1038/s41372-020-0665-6,10.1038/s41372-020-0665-6,Reviews,2020-04-10 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['perinatal', 'aspect', 'covid-19', 'pandemic', '', 'practical', 'resource', 'perinatalneonatal', 'specialist']","['BackgroundLittle know perinatal aspect COVID-19.ObjectiveTo summarize available evidence provide perinatologists/neonatologists tool manage patients.MethodsAnalysis available literature COVID-19 use Medline Google scholar.ResultsFrom scant data : vertical transmission maternal infection third trimester probably occur likely occur rarely .', 'Consequences COVID-19 infection among woman early pregnancy remain unknown .', 'We conclude pregnancy risk factor severe disease woman COVID-19 .', 'Little know disease severity neonate , sample , presence SARS-CoV-2 document human milk .', 'Links website organization update COVID-19 information provide .', 'Infographics summarize approach pregnant woman neonate suspect confirm COVID-19.ConclusionsAs pandemic continue , data available could lead change current knowledge recommendation .']","['backgroundlittle', 'perinatal', 'aspect', 'covid-19objectiveto', 'summarize', 'available', 'evidence', 'provide', 'perinatologistsneonatologists', 'tool', 'manage', 'patientsmethodsanalysis', 'available', 'literature', 'covid-19', 'medline', 'scholarresultsfrom', 'scant', 'data', '', 'vertical', 'transmission', 'maternal', 'infection', 'third', 'trimester', 'probably', 'occur', 'likely', 'occur', 'rarely', '', 'consequences', 'covid-19', 'infection', 'among', 'woman', 'early', 'pregnancy', 'remain', 'unknown', '', 'conclude', 'pregnancy', 'risk', 'factor', 'severe', 'disease', 'woman', 'covid-19', '', 'little', 'disease', 'severity', 'neonate', '', 'sample', '', 'presence', 'sars-cov-2', 'document', 'human', 'milk', '', 'links', 'website', 'organization', 'update', 'covid-19', 'information', 'provide', '', 'infographics', 'summarize', 'approach', 'pregnant', 'woman', 'neonate', 'suspect', 'confirm', 'covid-19conclusionsas', 'pandemic', 'continue', '', 'data', 'available', 'lead', 'change', 'current', 'knowledge', 'recommendation', '']",92,"{'': 10, 'covid-19': 4, 'available': 3, 'woman': 3, 'summarize': 2, 'provide': 2, 'data': 2, 'infection': 2, 'occur': 2, 'pregnancy': 2, 'disease': 2, 'neonate': 2, 'backgroundlittle': 1, 'perinatal': 1, 'aspect': 1, 'covid-19objectiveto': 1, 'evidence': 1, 'perinatologistsneonatologists': 1, 'tool': 1, 'manage': 1}","{'infection': 2, 'sars-cov-2': 1}",3,-0.5719
DOI:10.1038/s41409-020-0919-0,10.1038/s41409-020-0919-0,Reviews,2020-05-13 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['challenge', 'covid-19', 'hematopoietic', 'cell', 'transplantation', '', 'ebmt', 'recommendation', 'management', 'hematopoietic', 'cell', 'transplant', 'recipient', '', 'donor', '', 'patient', 'undergo', 'car', 't-cell', 'therapy']","['The new coronavirus SARS-CoV-2 rapidly spread world cause disease WHO call COVID-19 .', 'This pandemic pose unprecedented stress health care system include program perform allogeneic autologous hematopoietic cell transplantation ( HCT ) cellular therapy CAR T cell .', 'Risk factor severe disease include age predispose condition cancer .', 'The true impact stem cell transplant CAR T-cell recipient unknown .', 'The European Society Blood Marrow Transplantation ( EBMT ) therefore develop recommendation transplant program physician care patient .', 'These guideline develop expert Infectious Diseases Working Party endorse EBMT ’ scientific council board .', 'This work intend provide guideline transplant center , management transplant candidate recipient , donor issue COVID-19 pandemic pass .']","['new', 'coronavirus', 'sars-cov-2', 'rapidly', 'spread', 'world', 'cause', 'disease', 'call', 'covid-19', '', 'pandemic', 'pose', 'unprecedented', 'stress', 'health', 'care', 'system', 'include', 'program', 'perform', 'allogeneic', 'autologous', 'hematopoietic', 'cell', 'transplantation', '', 'hct', '', 'cellular', 'therapy', 'car', 'cell', '', 'risk', 'factor', 'severe', 'disease', 'include', 'age', 'predispose', 'condition', 'cancer', '', 'true', 'impact', 'stem', 'cell', 'transplant', 'car', 't-cell', 'recipient', 'unknown', '', 'european', 'society', 'blood', 'marrow', 'transplantation', '', 'ebmt', '', 'therefore', 'develop', 'recommendation', 'transplant', 'program', 'physician', 'care', 'patient', '', 'guideline', 'develop', 'expert', 'infectious', 'diseases', 'working', 'party', 'endorse', 'ebmt', '', 'scientific', 'council', 'board', '', 'work', 'intend', 'provide', 'guideline', 'transplant', 'center', '', 'management', 'transplant', 'candidate', 'recipient', '', 'donor', 'issue', 'covid-19', 'pandemic', 'pass', '']",103,"{'': 14, 'transplant': 4, 'cell': 3, 'disease': 2, 'covid-19': 2, 'pandemic': 2, 'care': 2, 'include': 2, 'program': 2, 'transplantation': 2, 'car': 2, 'recipient': 2, 'ebmt': 2, 'develop': 2, 'guideline': 2, 'new': 1, 'coronavirus': 1, 'sars-cov-2': 1, 'rapidly': 1, 'spread': 1}",{'sars-cov-2': 1},1,-0.8271
DOI:10.1038/s41591-020-0897-1,10.1038/s41591-020-0897-1,Research,2020-04-29 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['antibody', 'response', 'sars-cov-2', 'patient', 'covid-19']","['We report acute antibody response SARS-CoV-2 285 patient COVID-19 .', 'Within 19 day symptom onset , 100 % patient test positive antiviral immunoglobulin-G ( IgG ) .', 'Seroconversion IgG IgM occur simultaneously sequentially .', 'Both IgG IgM titer plateaued within 6 day seroconversion .', 'Serological test may helpful diagnosis suspect patient negative RT–PCR result identification asymptomatic infection .']","['report', 'acute', 'antibody', 'response', 'sars-cov-2', '285', 'patient', 'covid-19', '', 'within', '19', 'day', 'symptom', 'onset', '', '100', '', 'patient', 'test', 'positive', 'antiviral', 'immunoglobulin-g', '', 'igg', '', '', 'seroconversion', 'igg', 'igm', 'occur', 'simultaneously', 'sequentially', '', 'igg', 'igm', 'titer', 'plateaued', 'within', '6', 'day', 'seroconversion', '', 'serological', 'test', 'helpful', 'diagnosis', 'suspect', 'patient', 'negative', 'rtpcr', 'result', 'identification', 'asymptomatic', 'infection', '']",55,"{'': 9, 'patient': 3, 'igg': 3, 'within': 2, 'day': 2, 'test': 2, 'seroconversion': 2, 'igm': 2, 'report': 1, 'acute': 1, 'antibody': 1, 'response': 1, 'sars-cov-2': 1, '285': 1, 'covid-19': 1, '19': 1, 'symptom': 1, 'onset': 1, '100': 1, 'positive': 1}","{'infection': 1, 'sars-cov-2': 1}",2,0.5574
DOI:10.1038/s41436-020-0832-3,10.1038/s41436-020-0832-3,Comments and Opinion,2020-05-12 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', 'outcome', 'human', 'genome']",[],[],0,{},{},0,0.0
DOI:10.1038/s41440-020-0455-8,10.1038/s41440-020-0455-8,Reviews,2020-04-27 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['interactions', 'coronaviruses', 'ace2', '', 'angiotensin', 'ii', '', 'ras', 'inhibitorslessons', 'available', 'evidence', 'insight', 'covid-19']","['The rapid spread novel coronavirus , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) , lead ongoing pandemic coronavirus disease 2019 ( COVID-19 ) .', 'Recently , angiotensin-converting enzyme 2 ( ACE2 ) show functional receptor SARS-CoV-2 enter host target cell .', 'Given angiotensin receptor blocker ( ARBs ) ACE inhibitor ( ACEI ) upregulated ACE2 expression animal study , concern might arise regard whether ARBs ACEIs would increase morbidity mortality COVID-19 .', 'On hand , animal data suggest potential protective effect ARBs COVID-19 pneumonia ARB prevent aggravation acute lung injury mouse infect SARS-CoV , closely relate SARS-CoV-2 .', 'Importantly , however , clinical experimental evidence support ARBs ACEIs either augment susceptibility SARS-CoV-2 aggravate severity outcome COVID-19 present .', 'Until data available , recommend ARB ACEI medication continue treatment patient cardiovascular disease hypertension , especially high risk , accord guideline-directed medical therapy base currently available evidence .']","['rapid', 'spread', 'novel', 'coronavirus', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'lead', 'ongoing', 'pandemic', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'recently', '', 'angiotensin-converting', 'enzyme', '2', '', 'ace2', '', 'show', 'functional', 'receptor', 'sars-cov-2', 'enter', 'host', 'target', 'cell', '', 'given', 'angiotensin', 'receptor', 'blocker', '', 'arbs', '', 'ace', 'inhibitor', '', 'acei', '', 'upregulated', 'ace2', 'expression', 'animal', 'study', '', 'concern', 'arise', 'regard', 'whether', 'arbs', 'aceis', 'increase', 'morbidity', 'mortality', 'covid-19', '', 'hand', '', 'animal', 'data', 'suggest', 'potential', 'protective', 'effect', 'arbs', 'covid-19', 'pneumonia', 'arb', 'prevent', 'aggravation', 'acute', 'lung', 'injury', 'mouse', 'infect', 'sars-cov', '', 'closely', 'relate', 'sars-cov-2', '', 'importantly', '', 'however', '', 'clinical', 'experimental', 'evidence', 'support', 'arbs', 'aceis', 'either', 'augment', 'susceptibility', 'sars-cov-2', 'aggravate', 'severity', 'outcome', 'covid-19', 'present', '', 'data', 'available', '', 'recommend', 'arb', 'acei', 'medication', 'continue', 'treatment', 'patient', 'cardiovascular', 'disease', 'hypertension', '', 'especially', 'high', 'risk', '', 'accord', 'guideline-directed', 'medical', 'therapy', 'base', 'currently', 'available', 'evidence', '']",143,"{'': 27, 'sars-cov-2': 4, 'covid-19': 4, 'arbs': 4, 'coronavirus': 3, 'acute': 2, '2': 2, 'disease': 2, 'ace2': 2, 'receptor': 2, 'acei': 2, 'animal': 2, 'aceis': 2, 'data': 2, 'arb': 2, 'evidence': 2, 'available': 2, 'rapid': 1, 'spread': 1, 'novel': 1}",{'sars-cov-2': 4},4,0.1779
DOI:10.1038/s41591-020-0916-2,10.1038/s41591-020-0916-2,Research,2020-05-11 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['real-time', 'track', 'self-reported', 'symptom', 'predict', 'potential', 'covid-19']","['A total 2,618,862 participant report potential symptom COVID-19 smartphone-based app .', 'Among 18,401 undergo SARS-CoV-2 test , proportion participant report loss smell taste higher positive test result ( 4,668 7,178 individual ; 65.03 % ) negative test result ( 2,436 11,223 participant ; 21.71 % ) ( odds ratio = 6.74 ; 95 % confidence interval = 6.31–7.21 ) .', 'A model combine symptom predict probable infection apply data app user report symptom ( 805,753 ) predict 140,312 ( 17.42 % ) participant likely COVID-19 .']","['total', '2618862', 'participant', 'report', 'potential', 'symptom', 'covid-19', 'smartphone-based', 'app', '', 'among', '18401', 'undergo', 'sars-cov-2', 'test', '', 'proportion', 'participant', 'report', 'loss', 'smell', 'taste', 'higher', 'positive', 'test', 'result', '', '4668', '7178', 'individual', '', '6503', '', '', 'negative', 'test', 'result', '', '2436', '11223', 'participant', '', '2171', '', '', '', 'odds', 'ratio', '', '674', '', '95', '', 'confidence', 'interval', '', '631721', '', '', 'model', 'combine', 'symptom', 'predict', 'probable', 'infection', 'apply', 'data', 'app', 'user', 'report', 'symptom', '', '805753', '', 'predict', '140312', '', '1742', '', '', 'participant', 'likely', 'covid-19', '']",84,"{'': 23, 'participant': 4, 'report': 3, 'symptom': 3, 'test': 3, 'covid-19': 2, 'app': 2, 'result': 2, 'predict': 2, 'total': 1, '2618862': 1, 'potential': 1, 'smartphone-based': 1, 'among': 1, '18401': 1, 'undergo': 1, 'sars-cov-2': 1, 'proportion': 1, 'loss': 1, 'smell': 1}","{'infection': 1, 'sars-cov-2': 1}",2,0.2263
DOI:10.1038/s41394-020-0284-7,10.1038/s41394-020-0284-7,Reviews,2020-05-11 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', '', 'screening', 'triage', 'challenge', 'people', 'disability', 'due', 'spinal', 'cord', 'injury']","['An outbreak novel coronavirus disease ( COVID-19 ) emerge Chinese city Wuhan rapidly become global public health pandemic .', 'As March 2020 , Centers Disease Control Prevention ( CDC ) describe priority level test patient suspect COVID-19 information seek medical attention .', 'However , paucity guidance people spinal cord injury ( SCI ) may present typical symptom COVID-19 due alter physiology .', 'This may pose challenge surveillance , risk stratification , initial management vulnerable population .', 'In point-counterpoint discussion , outline important difference presentation along COVID-19 case co-morbid SCI .']","['outbreak', 'novel', 'coronavirus', 'disease', '', 'covid-19', '', 'emerge', 'chinese', 'city', 'wuhan', 'rapidly', 'become', 'global', 'public', 'health', 'pandemic', '', 'march', '2020', '', 'centers', 'disease', 'control', 'prevention', '', 'cdc', '', 'describe', 'priority', 'level', 'test', 'patient', 'suspect', 'covid-19', 'information', 'seek', 'medical', 'attention', '', 'however', '', 'paucity', 'guidance', 'people', 'spinal', 'cord', 'injury', '', 'sci', '', 'present', 'typical', 'symptom', 'covid-19', 'due', 'alter', 'physiology', '', 'pose', 'challenge', 'surveillance', '', 'risk', 'stratification', '', 'initial', 'management', 'vulnerable', 'population', '', 'point-counterpoint', 'discussion', '', 'outline', 'important', 'difference', 'presentation', 'along', 'covid-19', 'case', 'co-morbid', 'sci', '']",84,"{'': 16, 'covid-19': 4, 'disease': 2, 'sci': 2, 'outbreak': 1, 'novel': 1, 'coronavirus': 1, 'emerge': 1, 'chinese': 1, 'city': 1, 'wuhan': 1, 'rapidly': 1, 'become': 1, 'global': 1, 'public': 1, 'health': 1, 'pandemic': 1, 'march': 1, '2020': 1, 'centers': 1}",{},0,-0.4019
DOI:10.1038/s43018-020-0065-z,10.1038/s43018-020-0065-z,Comments and Opinion,2020-04-21 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['crowdsourcing', 'crisis', 'response', 'covid-19', 'oncology']",[],[],0,{},{},0,0.0
DOI:10.1038/s41585-020-0331-y,10.1038/s41585-020-0331-y,Comments and Opinion,2020-05-06 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['multifaceted', 'long-term', 'effect', 'covid-19', 'pandemic', 'urology']",[],[],0,{},{},0,0.0
DOI:10.1038/s41433-020-0965-2,10.1038/s41433-020-0965-2,Research,2020-05-18 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['detection', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus-2', 'tear', 'patient', 'coronavirus', 'disease', '2019']","['ObjectivesSince report ocular involvement coronavirus disease 2019 ( COVID-19 ) patient , study aim ass presence severe acute respiratory syndrome Coronavirus-2 ( SARS-CoV-2 ) tear patient COVID-19.MethodsIn prospective case series , nasopharyngeal tear sample 43 patient severe COVID-19 perform .', 'The quantitative reverse transcription polymerase chain reaction ( RT-PCR ) conduct detect SARS-CoV-2 .', 'Ocular systemic sign symptom record medical history.ResultsThe mean age patient 56 ± 13 year .', 'The average disease time initiation symptom 3.27 day , range : 1–7 day .', 'Forty-one patient ( 95.3 % ) fever time sample .', 'Only one patient conjunctivitis .', 'Thirty ( 69.8 % ) nasopharyngeal three ( 7 % ) tear sample positive SARS-CoV-2 .', 'The result tear sample positive patient conjunctivitis .', 'All patient positive tear RT-PCR result positive nasopharyngeal RT-PCR results.ConclusionsOcular manifestation rare series severe COVID-19 patient , however , 7 % patient viral RNA conjunctival secretion .', 'Therefore , possibility ocular transmission consider even absence ocular manifestation .']","['objectivessince', 'report', 'ocular', 'involvement', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'patient', '', 'study', 'aim', 'ass', 'presence', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus-2', '', 'sars-cov-2', '', 'tear', 'patient', 'covid-19methodsin', 'prospective', 'case', 'series', '', 'nasopharyngeal', 'tear', 'sample', '43', 'patient', 'severe', 'covid-19', 'perform', '', 'quantitative', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'conduct', 'detect', 'sars-cov-2', '', 'ocular', 'systemic', 'sign', 'symptom', 'record', 'medical', 'historyresultsthe', 'mean', 'age', 'patient', '56', '', '13', 'year', '', 'average', 'disease', 'time', 'initiation', 'symptom', '327', 'day', '', 'range', '', '17', 'day', '', 'forty-one', 'patient', '', '953', '', '', 'fever', 'time', 'sample', '', 'one', 'patient', 'conjunctivitis', '', 'thirty', '', '698', '', '', 'nasopharyngeal', 'three', '', '7', '', '', 'tear', 'sample', 'positive', 'sars-cov-2', '', 'result', 'tear', 'sample', 'positive', 'patient', 'conjunctivitis', '', 'patient', 'positive', 'tear', 'rt-pcr', 'result', 'positive', 'nasopharyngeal', 'rt-pcr', 'resultsconclusionsocular', 'manifestation', 'rare', 'series', 'severe', 'covid-19', 'patient', '', 'however', '', '7', '', 'patient', 'viral', 'rna', 'conjunctival', 'secretion', '', 'therefore', '', 'possibility', 'ocular', 'transmission', 'consider', 'absence', 'ocular', 'manifestation', '']",154,"{'': 34, 'patient': 10, 'tear': 5, 'ocular': 4, 'sample': 4, 'positive': 4, 'covid-19': 3, 'severe': 3, 'sars-cov-2': 3, 'nasopharyngeal': 3, 'rt-pcr': 3, 'disease': 2, 'series': 2, 'symptom': 2, 'time': 2, 'day': 2, 'conjunctivitis': 2, '7': 2, 'result': 2, 'manifestation': 2}",{'sars-cov-2': 3},3,-0.8271
DOI:10.1038/s41409-020-0913-6,10.1038/s41409-020-0913-6,Correspondence,2020-05-04 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', 'pandemic', 'impact', 'hematopoietic', 'stem', 'cell', 'transplantation']",[],[],0,{},{},0,0.0
DOI:10.1038/s41390-020-0962-y,10.1038/s41390-020-0962-y,Comments and Opinion,2020-05-15 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['key', 'clinical', 'research', 'priority', 'pediatric', 'community', 'covid-19', 'pandemic']",[],[],0,{},{},0,0.0
DOI:10.1038/s41558-020-0804-2,10.1038/s41558-020-0804-2,Comments and Opinion,2020-05-15 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['compound', 'climate', 'risk', 'covid-19', 'pandemic']",[],[],0,{},{},0,0.0
DOI:10.1038/s41581-020-0305-6,10.1038/s41581-020-0305-6,Comments and Opinion,2020-05-14 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', '', 'implication', 'immunosuppression', 'kidney', 'disease', 'transplantation']",[],[],0,{},{},0,0.0
DOI:10.1038/s41422-020-0327-4,10.1038/s41422-020-0327-4,Research Highlights,2020-04-28 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['covid-19', '', 'towards', 'understand', 'pathogenesis']",[],[],0,{},{},0,0.0
DOI:10.1038/s41415-020-1646-z,10.1038/s41415-020-1646-z,Comments and Opinion,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['re-invent', 'wheel', 'road', '']","[""The COVID-19 disruption 'business usual ' present opportunity profound change oral healthcare experience patient profession ."", 'While prospect change dominate professional dialogue year , post-COVID-19 era offer choice respect pace , proximity , preparedness , protection equity .', 'There potential determine revision current activity-driven clinical approach , adoption minimally invasive oral care philosophy routine practice use technology remotely support patient .', 'Throughout COVID-19 , whole dental profession demonstrate adaptability redeployment compassion deliver care variety set .', 'These vital trait bold clinical leadership , prepare make timely choice act fast , underpin successful transition towards safe resumption routine dental service .', 'In make right choice , hand future integrate dental team care model time concentrate personalise prevention advice , well provision effective , highly skilled treatment .']","['covid-19', 'disruption', 'business', 'usual', '', 'present', 'opportunity', 'profound', 'change', 'oral', 'healthcare', 'experience', 'patient', 'profession', '', 'prospect', 'change', 'dominate', 'professional', 'dialogue', 'year', '', 'post-covid-19', 'era', 'offer', 'choice', 'respect', 'pace', '', 'proximity', '', 'preparedness', '', 'protection', 'equity', '', 'potential', 'determine', 'revision', 'current', 'activity-driven', 'clinical', 'approach', '', 'adoption', 'minimally', 'invasive', 'oral', 'care', 'philosophy', 'routine', 'practice', 'technology', 'remotely', 'support', 'patient', '', 'throughout', 'covid-19', '', 'whole', 'dental', 'profession', 'demonstrate', 'adaptability', 'redeployment', 'compassion', 'deliver', 'care', 'variety', 'set', '', 'vital', 'trait', 'bold', 'clinical', 'leadership', '', 'prepare', 'timely', 'choice', 'act', 'fast', '', 'underpin', 'successful', 'transition', 'towards', 'safe', 'resumption', 'routine', 'dental', 'service', '', 'choice', '', 'hand', 'future', 'integrate', 'dental', 'team', 'care', 'model', 'time', 'concentrate', 'personalise', 'prevention', 'advice', '', 'well', 'provision', 'effective', '', 'highly', 'skilled', 'treatment', '']",117,"{'': 18, 'choice': 3, 'care': 3, 'dental': 3, 'covid-19': 2, 'change': 2, 'oral': 2, 'patient': 2, 'profession': 2, 'clinical': 2, 'routine': 2, 'disruption': 1, 'business': 1, 'usual': 1, 'present': 1, 'opportunity': 1, 'profound': 1, 'healthcare': 1, 'experience': 1, 'prospect': 1}",{},0,0.875
DOI:10.1038/s42256-020-0181-6,10.1038/s42256-020-0181-6,Comments and Opinion,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['machine', 'learning', 'covid-19', 'global', 'collaboration', 'data-sharing']",[],[],0,{},{},0,0.0
DOI:10.1038/s41569-020-0401-0,10.1038/s41569-020-0401-0,Research Highlights,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['raas', 'inhibitor', 'increase', 'risk', 'covid-19']",[],[],0,{},{},0,0.0
DOI:10.1038/s42256-020-0185-2,10.1038/s42256-020-0185-2,Comments and Opinion,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['challenge', 'deploy', 'artificial', 'intelligence', 'model', 'rapidly', 'evolve', 'pandemic']",[],[],0,{},{},0,0.0
DOI:10.1038/s41366-020-0602-y,10.1038/s41366-020-0602-y,Editorial,2020-05-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['insight', 'relationship', 'obesity-induced', 'low-level', 'chronic', 'inflammation', 'covid-19', 'infection']",[],[],0,{},{},0,0.0
DOI:10.1038/s41591-020-0883-7,10.1038/s41591-020-0883-7,Research,2020-04-22 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['modelling', 'covid-19', 'epidemic', 'implementation', 'population-wide', 'intervention', 'italy']","['In Italy , 128,948 confirm case 15,887 death people test positive SARS-CoV-2 register 5 April 2020 .', 'Ending global SARS-CoV-2 pandemic require implementation multiple population-wide strategy , include social distance , test contact trace .', 'We propose new model predict course epidemic help plan effective control strategy .', 'The model consider eight stage infection : susceptible ( S ) , infect ( I ) , diagnose ( D ) , ail ( A ) , recognize ( R ) , threaten ( T ) , heal ( H ) extinct ( E ) , collectively term SIDARTHE .', 'Our SIDARTHE model discriminate infect individual depend whether diagnose severity symptom .', 'The distinction diagnose non-diagnosed individual important former typically isolate hence le likely spread infection .', 'This delineation also help explain misperceptions case fatality rate epidemic spread .', 'We compare simulation result real data COVID-19 epidemic Italy , model possible scenario implementation countermeasure .', 'Our result demonstrate restrictive social-distancing measure need combine widespread test contact trace end ongoing COVID-19 pandemic .']","['italy', '', '128948', 'confirm', 'case', '15887', 'death', 'people', 'test', 'positive', 'sars-cov-2', 'register', '5', 'april', '2020', '', 'ending', 'global', 'sars-cov-2', 'pandemic', 'require', 'implementation', 'multiple', 'population-wide', 'strategy', '', 'include', 'social', 'distance', '', 'test', 'contact', 'trace', '', 'propose', 'new', 'model', 'predict', 'course', 'epidemic', 'help', 'plan', 'effective', 'control', 'strategy', '', 'model', 'consider', 'eight', 'stage', 'infection', '', 'susceptible', '', '', '', 'infect', '', '', '', 'diagnose', '', '', '', 'ail', '', '', '', 'recognize', '', 'r', '', '', 'threaten', '', '', '', 'heal', '', 'h', '', 'extinct', '', 'e', '', '', 'collectively', 'term', 'sidarthe', '', 'sidarthe', 'model', 'discriminate', 'infect', 'individual', 'depend', 'whether', 'diagnose', 'severity', 'symptom', '', 'distinction', 'diagnose', 'non-diagnosed', 'individual', 'important', 'former', 'typically', 'isolate', 'hence', 'le', 'likely', 'spread', 'infection', '', 'delineation', 'help', 'explain', 'misperceptions', 'case', 'fatality', 'rate', 'epidemic', 'spread', '', 'compare', 'simulation', 'result', 'real', 'data', 'covid-19', 'epidemic', 'italy', '', 'model', 'possible', 'scenario', 'implementation', 'countermeasure', '', 'result', 'demonstrate', 'restrictive', 'social-distancing', 'measure', 'combine', 'widespread', 'test', 'contact', 'trace', 'end', 'ongoing', 'covid-19', 'pandemic', '']",155,"{'': 37, 'model': 4, 'test': 3, 'epidemic': 3, 'diagnose': 3, 'italy': 2, 'case': 2, 'sars-cov-2': 2, 'pandemic': 2, 'implementation': 2, 'strategy': 2, 'contact': 2, 'trace': 2, 'help': 2, 'infection': 2, 'infect': 2, 'sidarthe': 2, 'individual': 2, 'spread': 2, 'result': 2}","{'infection': 2, 'sars-cov-2': 2}",4,0.6705
DOI:10.1038/s41467-020-16505-0,10.1038/s41467-020-16505-0,Research,2020-05-20 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['immunogenicity', 'dna', 'vaccine', 'candidate', 'covid-19']","['The coronavirus family member , SARS-CoV-2 identify causal agent pandemic viral pneumonia disease , COVID-19 .', 'At time , vaccine available control dissemination disease .', 'We previously engineer synthetic DNA vaccine target MERS coronavirus Spike ( S ) protein , major surface antigen coronaviruses , currently clinical study .', 'Here build prior experience generate synthetic DNA-based vaccine candidate target SARS-CoV-2 S protein .', 'The engineer construct , INO-4800 , result robust expression S protein vitro .', 'Following immunization mouse guinea pig INO-4800 measure antigen-specific T cell response , functional antibody neutralize SARS-CoV-2 infection block Spike protein bind ACE2 receptor , biodistribution SARS-CoV-2 target antibody lung .', 'This preliminary dataset identify INO-4800 potential COVID-19 vaccine candidate , support translational study .']","['coronavirus', 'family', 'member', '', 'sars-cov-2', 'identify', 'causal', 'agent', 'pandemic', 'viral', 'pneumonia', 'disease', '', 'covid-19', '', 'time', '', 'vaccine', 'available', 'control', 'dissemination', 'disease', '', 'previously', 'engineer', 'synthetic', 'dna', 'vaccine', 'target', 'mers', 'coronavirus', 'spike', '', '', 'protein', '', 'major', 'surface', 'antigen', 'coronaviruses', '', 'currently', 'clinical', 'study', '', 'build', 'prior', 'experience', 'generate', 'synthetic', 'dna-based', 'vaccine', 'candidate', 'target', 'sars-cov-2', 'protein', '', 'engineer', 'construct', '', 'ino-4800', '', 'result', 'robust', 'expression', 'protein', 'vitro', '', 'following', 'immunization', 'mouse', 'guinea', 'pig', 'ino-4800', 'measure', 'antigen-specific', 'cell', 'response', '', 'functional', 'antibody', 'neutralize', 'sars-cov-2', 'infection', 'block', 'spike', 'protein', 'bind', 'ace2', 'receptor', '', 'biodistribution', 'sars-cov-2', 'target', 'antibody', 'lung', '', 'preliminary', 'dataset', 'identify', 'ino-4800', 'potential', 'covid-19', 'vaccine', 'candidate', '', 'support', 'translational', 'study', '']",110,"{'': 19, 'sars-cov-2': 4, 'vaccine': 4, 'protein': 4, 'target': 3, 'ino-4800': 3, 'coronavirus': 2, 'identify': 2, 'disease': 2, 'covid-19': 2, 'engineer': 2, 'synthetic': 2, 'spike': 2, 'study': 2, 'candidate': 2, 'antibody': 2, 'family': 1, 'member': 1, 'causal': 1, 'agent': 1}","{'infection': 1, 'sars-cov-2': 4, 'vitro': 1}",6,0.0
DOI:10.1038/s41430-020-0664-x,10.1038/s41430-020-0664-x,Reviews,2020-05-20 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['nutritional', 'management', 'covid-19', 'patient', 'rehabilitation', 'unit']",[],[],0,{},{},0,0.0
DOI:10.1038/s41423-020-0450-7,10.1038/s41423-020-0450-7,Comments and Opinion,2020-05-07 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['nkg2a', 'covid-19', '', 'another', 'brick', 'wall']",[],[],0,{},{},0,0.0
DOI:10.1038/s41390-020-0937-z,10.1038/s41390-020-0937-z,Correspondence,2020-05-07 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['neonatal', 'emergency', 'transport', 'system', 'covid-19', 'pandemic', 'veneto', 'region', '', 'proposal', 'standard', 'operate', 'procedure']",[],[],0,{},{},0,0.0
DOI:10.1038/s41409-020-0895-4,10.1038/s41409-020-0895-4,Reviews,2020-04-20 00:00:00,NATURE,2020-05-23 22:13:35.057884,"['lessons', 'early', 'management', 'covid-19', 'outbreak', 'pediatric', 'transplant', 'hemato-oncology', 'center', 'embed', 'within', 'covid-19', 'dedicate', 'hospital', 'lombardia', '', 'italy', '', 'estote', 'parati']","['Italy second expose country worldwide , China , Lombardia affect region Italy , half national case , 13 % healthcare professional .', 'The Clinica Pediatrica Università degli Studi di Milano Bicocca general pediatric hematology oncology transplant center embed within designate COVID-19 general Hospital San Gerardo Monza , locate Lombardia , Italy .', 'Preventive control measure specifically undertake cope emergency within hemato-oncology , transplant , outpatient unit pediatric department describe .', 'Preliminary COVID-19 experience first Italian pediatric hemato-oncology patient report .', 'The available data regard pediatrics specifically hemato-oncological patient discuss .', 'The purpose report share pediatric hemato-oncology issue encounter first week COVID-19 outbreak Italy alert healthcare professional worldwide prepare accordingly .']","['italy', 'second', 'expose', 'country', 'worldwide', '', 'china', '', 'lombardia', 'affect', 'region', 'italy', '', 'half', 'national', 'case', '', '13', '', 'healthcare', 'professional', '', 'clinica', 'pediatrica', 'universit', 'degli', 'studi', 'di', 'milano', 'bicocca', 'general', 'pediatric', 'hematology', 'oncology', 'transplant', 'center', 'embed', 'within', 'designate', 'covid-19', 'general', 'hospital', 'san', 'gerardo', 'monza', '', 'locate', 'lombardia', '', 'italy', '', 'preventive', 'control', 'measure', 'specifically', 'undertake', 'cope', 'emergency', 'within', 'hemato-oncology', '', 'transplant', '', 'outpatient', 'unit', 'pediatric', 'department', 'describe', '', 'preliminary', 'covid-19', 'experience', 'first', 'italian', 'pediatric', 'hemato-oncology', 'patient', 'report', '', 'available', 'data', 'regard', 'pediatrics', 'specifically', 'hemato-oncological', 'patient', 'discuss', '', 'purpose', 'report', 'share', 'pediatric', 'hemato-oncology', 'issue', 'encounter', 'first', 'week', 'covid-19', 'outbreak', 'italy', 'alert', 'healthcare', 'professional', 'worldwide', 'prepare', 'accordingly', '']",107,"{'': 15, 'italy': 4, 'pediatric': 4, 'covid-19': 3, 'hemato-oncology': 3, 'worldwide': 2, 'lombardia': 2, 'healthcare': 2, 'professional': 2, 'general': 2, 'transplant': 2, 'within': 2, 'specifically': 2, 'first': 2, 'patient': 2, 'report': 2, 'second': 1, 'expose': 1, 'country': 1, 'china': 1}",{},0,-0.4939
DOI:10.7326/M20-1998,10.7326/M20-1998,Special Article,2020-05-13 00:00:00,ACP,2020-05-23 22:13:35.057884,"['clinicians', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'azithromycin', 'prophylaxis', 'treatment', 'covid-19', '', '', 'living', 'practice', 'points', 'american', 'college', 'physicians', '', 'version', '1', '']","['Should Clinicians Use Chloroquine Hydroxychloroquine Alone Combination With Azithromycin Prophylaxis Against COVID-19 ?', 'Should Clinicians Use Chloroquine Hydroxychloroquine Alone Combination With Azithromycin Treatment COVID-19 ?', 'Using chloroquine hydroxychloroquine , without azithromycin , prevent coronavirus disease ( COVID-19 ) infection novel coronavirus ( SARS-CoV-2 ) treat COVID-19 begin receive attention follow preliminary report vitro ( 1 ) human ( 2 ) study .', 'While multiple study plan way ( 3 , 4 ) , imperative continually synthesize result best available evidence inform point-of-care decision use chloroquine hydroxychloroquine .', 'These practice point base rapid live systematic evidence review conduct University Connecticut Health Outcomes , Policy , Evidence Synthesis Group update new evidence become available .', 'The practice point development update method include Appendix .', 'This version practice point , base evidence review conduct 17 April 2020 , approve American College Physicians Board Regents 4 May 2020 submit Annals Internal Medicine 6 May 2020 .', 'Do use chloroquine hydroxychloroquine alone combination azithromycin prophylaxis COVID-19 due know harm available evidence benefit general population .', 'Do use chloroquine hydroxychloroquine alone combination azithromycin treatment patient COVID-19 due know harm available evidence benefit patient COVID-19 .']","['clinicians', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'azithromycin', 'prophylaxis', 'covid-19', '', 'clinicians', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'azithromycin', 'treatment', 'covid-19', '', 'using', 'hydroxychloroquine', 'hydroxychloroquine', '', 'without', 'azithromycin', '', 'prevent', 'coronavirus', 'disease', '', 'covid-19', '', 'infection', 'novel', 'coronavirus', '', 'sars-cov-2', '', 'treat', 'covid-19', 'begin', 'receive', 'attention', 'follow', 'preliminary', 'report', 'vitro', '', '1', '', 'human', '', '2', '', 'study', '', 'multiple', 'study', 'plan', 'way', '', '3', '', '4', '', '', 'imperative', 'continually', 'synthesize', 'result', 'best', 'available', 'evidence', 'inform', 'point-of-care', 'decision', 'hydroxychloroquine', 'hydroxychloroquine', '', 'practice', 'point', 'base', 'rapid', 'live', 'systematic', 'evidence', 'review', 'conduct', 'university', 'connecticut', 'health', 'outcomes', '', 'policy', '', 'evidence', 'synthesis', 'group', 'update', 'new', 'evidence', 'become', 'available', '', 'practice', 'point', 'development', 'update', 'method', 'include', 'appendix', '', 'version', 'practice', 'point', '', 'base', 'evidence', 'review', 'conduct', '17', 'april', '2020', '', 'approve', 'american', 'college', 'physicians', 'board', 'regents', '4', '2020', 'submit', 'annals', 'internal', 'medicine', '6', '2020', '', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'azithromycin', 'prophylaxis', 'covid-19', 'due', 'harm', 'available', 'evidence', 'benefit', 'general', 'population', '', 'hydroxychloroquine', 'hydroxychloroquine', 'alone', 'combination', 'azithromycin', 'treatment', 'patient', 'covid-19', 'due', 'harm', 'available', 'evidence', 'benefit', 'patient', 'covid-19', '']",169,"{'': 27, 'hydroxychloroquine': 12, 'covid-19': 7, 'evidence': 7, 'azithromycin': 5, 'alone': 4, 'combination': 4, 'available': 4, 'practice': 3, 'point': 3, '2020': 3, 'clinicians': 2, 'prophylaxis': 2, 'treatment': 2, 'coronavirus': 2, 'study': 2, '4': 2, 'base': 2, 'review': 2, 'conduct': 2}","{'hydroxychloroquine': 12, 'infection': 1, 'sars-cov-2': 1, 'vitro': 1}",15,0.3151
DOI:10.7326/M20-2306,10.7326/M20-2306,Reviews,2020-05-22 00:00:00,ACP,2020-05-23 22:13:35.057884,"['ventilation', 'techniques', 'risk', 'transmission', 'coronavirus', 'disease', '', 'including', 'covid-19', '', 'living', 'systematic', 'review', 'multiple', 'streams', 'evidence']","['As 18 May 2020 , ongoing pandemic cause severe acute respiratory syndrome-coronavirus-2 ( SARS-CoV-2 ) affect 4.8 million individual worldwide cause 300 000 death ( 1 ) .', 'SARS-CoV-2 spread person person close contact cause coronavirus disease 2019 ( COVID-19 ) ; death cause development hypoxemic respiratory failure severe acute respiratory distress syndrome ( ARDS ) .', 'Noninvasive ventilation ( NIV ) , invasive mechanical ventilation ( IMV ) , supportive therapy mainstay treatment ARDS .', 'Noninvasive ventilation associate fewer adverse outcome patient IMV .', 'However , NIV create risk health care worker ( HCWs ) care patient , SARS-CoV-2 transmission via aerosol ( 2 ) .', 'The magnitude risk well explore COVID-19 .', 'In contrast , IMV typically us close system thus carry much lower risk transmission via aerosol .', 'Countries large number patient COVID-19 require mechanical ventilation experience shortage ventilator rely NIV , include continuous positive airway pressure ( CPAP ) , bilevel positive airway pressure ( BiPAP ) , high-flow oxygen nasal cannula ( HFNC ) .', 'Guidelines vary considerably recommendation role optimal method NIV , reflect difference assume effectiveness balance risk infection HCWs aerosol .', 'Hypoxemic respiratory failure ARDS common COVID-19 , ideal way provide ventilation effect NIV HCWs uncertain .', 'Although different cause ARDS , severe acute respiratory syndrome ( cause SARS-CoV-1 ) Middle East respiratory syndrome ( cause MERS-CoV ) may resemble ARDS COVID-19 ( 3 , 4 ) .', 'Thus , evidence SARS MERS may useful explore effect NIV .', 'Commissioned World Health Organization ( WHO ) inform guidance document , urgently systematically review evidence ass benefit harm alternate noninvasive invasive ventilation strategy acute hypoxemic respiratory failure patient COVID-19 .', 'This include search indirect evidence ( example , relate SARS MERS ) evidence effect virus transmission HCWs .', 'By agreement WHO 3 April 2020 , perform urgent systematic review compare effect different ventilation technique important patient outcome risk transmission coronavirus disease , include COVID-19 .', 'We adhere Cochrane systematic review method , rat certainty evidence follow GRADE ( Grading Recommendations Assessment , Development Evaluation ) approach , prospectively register review PROSPERO ( registration number CRD42020178187 ) ( Supplement 1 ) , follow PRISMA ( Preferred Reporting Items Systematic review Meta-Analyses ) report guideline ( 5–9 ) .', 'We assemble large international collaborative team researcher , frontline specialist clinician , epidemiologist , patient , public health expert , health policy expert expertise systematic review .', 'The review address follow 4 stream evidence : 1 ) study design address NIV individual acute hypoxic respiratory failure cause coronavirus ( COVID-19 , MERS , SARS ) ; 2 ) systematic review randomize trial assess efficacy NIV approach patient hypoxemic respiratory failure due coronavirus infection ; 3 ) animal , mechanistic , laboratory , preclinical evidence regard aerosol dispersion coronavirus ; 4 ) study adult evaluate risk virus transmission HCWs aerosol-generating procedure ( AGPs ) .', 'When possible , result focus information relevant SARS-CoV-2 COVID-19 .', 'Information relate first stream evidence continually update maintain live systematic review least 1 year .']","['18', '2020', '', 'ongoing', 'pandemic', 'cause', 'severe', 'acute', 'respiratory', 'syndrome-coronavirus-2', '', 'sars-cov-2', '', 'affect', '48', 'million', 'individual', 'worldwide', 'cause', '300', '000', 'death', '', '1', '', '', 'sars-cov-2', 'spread', 'person', 'person', 'close', 'contact', 'cause', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'death', 'cause', 'development', 'hypoxemic', 'respiratory', 'failure', 'severe', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', 'noninvasive', 'ventilation', '', 'niv', '', '', 'invasive', 'mechanical', 'ventilation', '', 'imv', '', '', 'supportive', 'therapy', 'mainstay', 'treatment', 'ards', '', 'noninvasive', 'ventilation', 'associate', 'fewer', 'adverse', 'outcome', 'patient', 'imv', '', 'however', '', 'niv', 'create', 'risk', 'health', 'care', 'worker', '', 'hcws', '', 'care', 'patient', '', 'sars-cov-2', 'transmission', 'via', 'aerosol', '', '2', '', '', 'magnitude', 'risk', 'well', 'explore', 'covid-19', '', 'contrast', '', 'imv', 'typically', 'us', 'close', 'system', 'thus', 'carry', 'much', 'lower', 'risk', 'transmission', 'via', 'aerosol', '', 'countries', 'large', 'number', 'patient', 'covid-19', 'require', 'mechanical', 'ventilation', 'experience', 'shortage', 'ventilator', 'rely', 'niv', '', 'include', 'continuous', 'positive', 'airway', 'pressure', '', 'cpap', '', '', 'bilevel', 'positive', 'airway', 'pressure', '', 'bipap', '', '', 'high-flow', 'oxygen', 'nasal', 'cannula', '', 'hfnc', '', '', 'guidelines', 'vary', 'considerably', 'recommendation', 'role', 'optimal', 'method', 'niv', '', 'reflect', 'difference', 'assume', 'effectiveness', 'balance', 'risk', 'infection', 'hcws', 'aerosol', '', 'hypoxemic', 'respiratory', 'failure', 'ards', 'common', 'covid-19', '', 'ideal', 'way', 'provide', 'ventilation', 'effect', 'niv', 'hcws', 'uncertain', '', 'although', 'different', 'cause', 'ards', '', 'severe', 'acute', 'respiratory', 'syndrome', '', 'cause', 'sars-cov-1', '', 'middle', 'east', 'respiratory', 'syndrome', '', 'cause', 'mers-cov', '', 'resemble', 'ards', 'covid-19', '', '3', '', '4', '', '', 'thus', '', 'evidence', 'sars', 'mers', 'useful', 'explore', 'effect', 'niv', '', 'commissioned', 'world', 'health', 'organization', '', '', 'inform', 'guidance', 'document', '', 'urgently', 'systematically', 'review', 'evidence', 'ass', 'benefit', 'harm', 'alternate', 'noninvasive', 'invasive', 'ventilation', 'strategy', 'acute', 'hypoxemic', 'respiratory', 'failure', 'patient', 'covid-19', '', 'include', 'search', 'indirect', 'evidence', '', 'example', '', 'relate', 'sars', 'mers', '', 'evidence', 'effect', 'virus', 'transmission', 'hcws', '', 'agreement', '3', 'april', '2020', '', 'perform', 'urgent', 'systematic', 'review', 'compare', 'effect', 'different', 'ventilation', 'technique', 'important', 'patient', 'outcome', 'risk', 'transmission', 'coronavirus', 'disease', '', 'include', 'covid-19', '', 'adhere', 'cochrane', 'systematic', 'review', 'method', '', 'rat', 'certainty', 'evidence', 'follow', 'grade', '', 'grading', 'recommendations', 'assessment', '', 'development', 'evaluation', '', 'approach', '', 'prospectively', 'register', 'review', 'prospero', '', 'registration', 'number', 'crd42020178187', '', '', 'supplement', '1', '', '', 'follow', 'prisma', '', 'preferred', 'reporting', 'items', 'systematic', 'review', 'meta-analyses', '', 'report', 'guideline', '', '59', '', '', 'assemble', 'large', 'international', 'collaborative', 'team', 'researcher', '', 'frontline', 'specialist', 'clinician', '', 'epidemiologist', '', 'patient', '', 'public', 'health', 'expert', '', 'health', 'policy', 'expert', 'expertise', 'systematic', 'review', '', 'review', 'address', 'follow', '4', 'stream', 'evidence', '', '1', '', 'study', 'design', 'address', 'niv', 'individual', 'acute', 'hypoxic', 'respiratory', 'failure', 'cause', 'coronavirus', '', 'covid-19', '', 'mers', '', 'sars', '', '', '2', '', 'systematic', 'review', 'randomize', 'trial', 'assess', 'efficacy', 'niv', 'approach', 'patient', 'hypoxemic', 'respiratory', 'failure', 'due', 'coronavirus', 'infection', '', '3', '', 'animal', '', 'mechanistic', '', 'laboratory', '', 'preclinical', 'evidence', 'regard', 'aerosol', 'dispersion', 'coronavirus', '', '4', '', 'study', 'adult', 'evaluate', 'risk', 'virus', 'transmission', 'hcws', 'aerosol-generating', 'procedure', '', 'agps', '', '', 'possible', '', 'result', 'focus', 'information', 'relevant', 'sars-cov-2', 'covid-19', '', 'information', 'relate', 'first', 'stream', 'evidence', 'continually', 'update', 'maintain', 'live', 'systematic', 'review', 'least', '1', 'year', '']",489,"{'': 108, 'respiratory': 9, 'covid-19': 9, 'review': 9, 'cause': 8, 'niv': 8, 'evidence': 8, 'ventilation': 7, 'patient': 7, 'risk': 6, 'systematic': 6, 'acute': 5, 'coronavirus': 5, 'failure': 5, 'ards': 5, 'hcws': 5, 'transmission': 5, 'sars-cov-2': 4, '1': 4, 'hypoxemic': 4}","{'infection': 2, 'sars-cov-2': 4}",6,-0.9552
DOI:10.7326/M20-2567,10.7326/M20-2567,Ideas and Opinions,2020-05-22 00:00:00,ACP,2020-05-23 22:13:35.057884,"['cloth', 'masks', 'prevent', 'transmission', 'covid-19', '', 'evidence-based', '', 'risk-based', 'approach']","['Physical distance , hand hygiene , disinfection surface cornerstone infection control coronavirus disease 2019 ( COVID-19 ) pandemic .', 'At time , government , international agency , policymakers , public health official debate validity recommend use nonmedical mask general public reduce transmission severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'We believe decision inform evidence .', 'Although direct evidence indicate cloth mask effective reduce transmission SARS-CoV-2 , evidence reduce contamination air surface convince suffice inform policy decision use pandemic pending research .', 'Cloth stop isolate virion .', 'However , virus transmission occur via larger particle secretion , whether aerosol ( < 5 µm ) droplet ( > 5 µm ) , generate directly speak , eat , cough , sneeze ; aerosol also create water evaporate smaller droplet , become aerosol-sized droplet nucleus .', 'The point particle penetrate particle stop , particularly outward direction .', 'Every virus-laden particle retain mask available hang air aerosol fall surface later pick touch .', 'Filtration efficiency ability material block transmission ; express percentage ( Figure ) assess use surrogate marker , include biological aerosol .', 'Mask standard set ASTM International require test latex sphere aerosolize Staphylococcus aureus ( 1 ) , mask assess separately every pathogen : Filtration efficiency depend physical retention particle different size , regardless pathogen particle contain .', 'For consistency , calculate FE data provide original work rather present data unit choose author .', 'PF fit factor synonym .', 'FE = filtration efficiency ; PF = protection factor ; TIL = total inward leakage .', 'Cloth block droplet aerosol , layer add efficiency .', 'Filtration efficiency single layer different type cotton cloth bioaerosol ( 0.2 µm ) experiment 43 % 94 % , compare 98 % 99 % fabric disposable medical mask ( 2 ) .', 'In summary similar observation , single layer scarf , sweatshirt , T-shirts , towel associate filtration efficiency 10 % 40 % experiment use NaCl aerosol ( 0.075 µm ) ( 3 ) .', 'For tea towel fabric , study aerosol-sized particle , filtration efficiency experiment use bacterial marker 83 % 1 layer 97 % 2 layer , compare 96 % medical mask ( 4 ) .', 'In experiment use virus , 1 layer tea towel 72 % efficiency 1 layer T-shirt fabric 51 % , compare 90 % medical mask ( 4 ) .', 'A 2020 study confirm fabric block clinically useful percentage transmission , even aerosol even single layer ; multiple layer improve efficiency ( 5 ) .']","['physical', 'distance', '', 'hand', 'hygiene', '', 'disinfection', 'surface', 'cornerstone', 'infection', 'control', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', '', 'time', '', 'government', '', 'international', 'agency', '', 'policymakers', '', 'public', 'health', 'official', 'debate', 'validity', 'recommend', 'nonmedical', 'mask', 'general', 'public', 'reduce', 'transmission', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', 'believe', 'decision', 'inform', 'evidence', '', 'although', 'direct', 'evidence', 'indicate', 'cloth', 'mask', 'effective', 'reduce', 'transmission', 'sars-cov-2', '', 'evidence', 'reduce', 'contamination', 'air', 'surface', 'convince', 'suffice', 'inform', 'policy', 'decision', 'pandemic', 'pending', 'research', '', 'cloth', 'stop', 'isolate', 'virion', '', 'however', '', 'virus', 'transmission', 'occur', 'via', 'larger', 'particle', 'secretion', '', 'whether', 'aerosol', '', '', '5', '', 'droplet', '', '', '5', '', '', 'generate', 'directly', 'speak', '', 'eat', '', 'cough', '', 'sneeze', '', 'aerosol', 'create', 'water', 'evaporate', 'smaller', 'droplet', '', 'become', 'aerosol-sized', 'droplet', 'nucleus', '', 'point', 'particle', 'penetrate', 'particle', 'stop', '', 'particularly', 'outward', 'direction', '', 'every', 'virus-laden', 'particle', 'retain', 'mask', 'available', 'hang', 'air', 'aerosol', 'fall', 'surface', 'later', 'pick', 'touch', '', 'filtration', 'efficiency', 'ability', 'material', 'block', 'transmission', '', 'express', 'percentage', '', 'figure', '', 'assess', 'surrogate', 'marker', '', 'include', 'biological', 'aerosol', '', 'mask', 'standard', 'set', 'astm', 'international', 'require', 'test', 'latex', 'sphere', 'aerosolize', 'staphylococcus', 'aureus', '', '1', '', '', 'mask', 'assess', 'separately', 'every', 'pathogen', '', 'filtration', 'efficiency', 'depend', 'physical', 'retention', 'particle', 'different', 'size', '', 'regardless', 'pathogen', 'particle', 'contain', '', 'consistency', '', 'calculate', 'fe', 'data', 'provide', 'original', 'work', 'present', 'data', 'unit', 'choose', 'author', '', 'pf', 'fit', 'factor', 'synonym', '', 'fe', '', 'filtration', 'efficiency', '', 'pf', '', 'protection', 'factor', '', 'til', '', 'total', 'inward', 'leakage', '', 'cloth', 'block', 'droplet', 'aerosol', '', 'layer', 'add', 'efficiency', '', 'filtration', 'efficiency', 'single', 'layer', 'different', 'type', 'cotton', 'cloth', 'bioaerosol', '', '02', '', 'experiment', '43', '', '94', '', '', 'compare', '98', '', '99', '', 'fabric', 'disposable', 'medical', 'mask', '', '2', '', '', 'summary', 'similar', 'observation', '', 'single', 'layer', 'scarf', '', 'sweatshirt', '', 't-shirts', '', 'towel', 'associate', 'filtration', 'efficiency', '10', '', '40', '', 'experiment', 'nacl', 'aerosol', '', '0075', '', '', '3', '', '', 'tea', 'towel', 'fabric', '', 'study', 'aerosol-sized', 'particle', '', 'filtration', 'efficiency', 'experiment', 'bacterial', 'marker', '83', '', '1', 'layer', '97', '', '2', 'layer', '', 'compare', '96', '', 'medical', 'mask', '', '4', '', '', 'experiment', 'virus', '', '1', 'layer', 'tea', 'towel', '72', '', 'efficiency', '1', 'layer', 't-shirt', 'fabric', '51', '', '', 'compare', '90', '', 'medical', 'mask', '', '4', '', '', '2020', 'study', 'confirm', 'fabric', 'block', 'clinically', 'useful', 'percentage', 'transmission', '', 'aerosol', 'single', 'layer', '', 'multiple', 'layer', 'improve', 'efficiency', '', '5', '', '']",394,"{'': 99, 'efficiency': 9, 'layer': 9, 'mask': 8, 'particle': 7, 'aerosol': 7, 'filtration': 6, 'transmission': 5, 'cloth': 4, 'droplet': 4, '1': 4, 'experiment': 4, 'fabric': 4, 'surface': 3, 'reduce': 3, '2': 3, 'evidence': 3, '5': 3, 'block': 3, 'single': 3}","{'infection': 1, 'sars-cov-2': 2}",3,0.4767
DOI:10.7326/M20-2347,10.7326/M20-2347,On Being a Doctor,2020-05-19 00:00:00,ACP,2020-05-23 22:13:35.057884,"['seven', 'oclock']","['Every night , 7:00 , begin .', 'It start slowly , herald arrival sound single clap cheer .', 'On street devoid typical pedestrian vehicular traffic , noise carry far , attract attention million New Yorkers shelter place .', 'Enticed allure , others soon join .', 'As volume rise , constant daytime blare ambulance siren temporarily forget .', 'Everyone different role play : bang pot pan outside window , others play music balcony .', 'Drivers honk car horn .', 'Everybody cheer .', 'The melody harmonize , begin scatter cacophony soon become orchestra .', 'The sky fill encouragement tenant townhouses residential tower alike join .', 'The energy electric .', 'For minute , gloom overtake city cast aside .', 'Yet , peak soon pass succeed dishearten decrescendo .', 'Cookware disappear , song end , car scatter .', 'Cheers die , replace eerie silence city lay low black swan .', 'Neighbors retreat safety apartment .', 'New York return surreal status quo .']","['every', 'night', '', '700', '', 'begin', '', 'start', 'slowly', '', 'herald', 'arrival', 'sound', 'single', 'clap', 'cheer', '', 'street', 'devoid', 'typical', 'pedestrian', 'vehicular', 'traffic', '', 'noise', 'carry', 'far', '', 'attract', 'attention', 'million', 'new', 'yorkers', 'shelter', 'place', '', 'enticed', 'allure', '', 'others', 'soon', 'join', '', 'volume', 'rise', '', 'constant', 'daytime', 'blare', 'ambulance', 'siren', 'temporarily', 'forget', '', 'everyone', 'different', 'role', 'play', '', 'bang', 'pot', 'pan', 'outside', 'window', '', 'others', 'play', 'music', 'balcony', '', 'drivers', 'honk', 'car', 'horn', '', 'everybody', 'cheer', '', 'melody', 'harmonize', '', 'begin', 'scatter', 'cacophony', 'soon', 'become', 'orchestra', '', 'sky', 'fill', 'encouragement', 'tenant', 'townhouses', 'residential', 'tower', 'alike', 'join', '', 'energy', 'electric', '', 'minute', '', 'gloom', 'overtake', 'city', 'cast', 'aside', '', 'yet', '', 'peak', 'soon', 'pass', 'succeed', 'dishearten', 'decrescendo', '', 'cookware', 'disappear', '', 'song', 'end', '', 'car', 'scatter', '', 'cheers', 'die', '', 'replace', 'eerie', 'silence', 'city', 'lay', 'low', 'black', 'swan', '', 'neighbors', 'retreat', 'safety', 'apartment', '', 'new', 'york', 'return', 'surreal', 'status', 'quo', '']",151,"{'': 32, 'soon': 3, 'begin': 2, 'cheer': 2, 'new': 2, 'others': 2, 'join': 2, 'play': 2, 'car': 2, 'scatter': 2, 'city': 2, 'every': 1, 'night': 1, '700': 1, 'start': 1, 'slowly': 1, 'herald': 1, 'arrival': 1, 'sound': 1, 'single': 1}",{'safety': 1},1,0.7003
DOI:10.7326/M20-2383,10.7326/M20-2383,Ad Libitum,2020-05-19 00:00:00,ACP,2020-05-23 22:13:35.057884,"['required', 'covid', 'mandatories']",['This article publish Annals.org 19 May 2020 .'],"['article', 'publish', 'annalsorg', '19', '2020', '']",6,"{'article': 1, 'publish': 1, 'annalsorg': 1, '19': 1, '2020': 1, '': 1}",{},0,0.0
DOI:10.7326/M20-2883,10.7326/M20-2883,Ad Libitum,2020-05-19 00:00:00,ACP,2020-05-23 22:13:35.057884,"['view', 'covid', 'palliative', 'care', 'unit']",['This article publish Annals.org 19 May 2020 .'],"['article', 'publish', 'annalsorg', '19', '2020', '']",6,"{'article': 1, 'publish': 1, 'annalsorg': 1, '19': 1, '2020': 1, '': 1}",{},0,0.0
DOI:10.7326/A19-0030,10.7326/A19-0030,Web Exclusives,2020-04-30 00:00:00,ACP,2020-05-23 22:13:35.057884,"['annals', 'call', '-', 'surge', 'modeling', 'covid-19']","['In episode Annals On Call , Dr. Centor discus COVID-19 pandemic surge model Dr. John Wong Tufts University .', 'Annals article discuss include ... Pandemic Surge Models Time Severe Acute Respiratory Syndrome Coronavirus-2 : Wrong Useful ?', "": urlplaceholder Estimating Maximum Capacity COVID-19 Cases Manageable per Day Given Health Care System 's Constrained Resources : urlplaceholder""]","['episode', 'annals', 'call', '', 'dr', 'centor', 'discus', 'covid-19', 'pandemic', 'surge', 'model', 'dr', 'john', 'wong', 'tufts', 'university', '', 'annals', 'article', 'discuss', 'include', '', 'pandemic', 'surge', 'models', 'time', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus-2', '', 'wrong', 'useful', '', '', 'urlplaceholder', 'estimating', 'maximum', 'capacity', 'covid-19', 'cases', 'manageable', 'per', 'day', 'given', 'health', 'care', 'system', 'constrained', 'resources', '', 'urlplaceholder']",53,"{'': 7, 'annals': 2, 'dr': 2, 'covid-19': 2, 'pandemic': 2, 'surge': 2, 'urlplaceholder': 2, 'episode': 1, 'call': 1, 'centor': 1, 'discus': 1, 'model': 1, 'john': 1, 'wong': 1, 'tufts': 1, 'university': 1, 'article': 1, 'discuss': 1, 'include': 1, 'models': 1}",{},0,-0.0
DOI:10.7326/M20-1897,10.7326/M20-1897,Web Exclusives,2020-04-21 00:00:00,ACP,2020-05-23 22:13:35.057884,"['annals', 'hospitalists', 'inpatient', 'notes', '-', 'preparing', 'battle', '', 'hospitalists', 'manage', 'stress', 'covid-19']","['We war .', 'An invisible enemy break rank global society wag aggressive campaign .', 'Hospitalists front line defend health safety .', 'As pandemic , coronavirus disease 2019 present challenge well-being citizen around globe , result fear illness , social distance measure , isolation quarantine , protract uncertainty ( 1 ) .', 'Hospitalists health care worker face additional unique challenge .', 'A transition crisis standard care require allocation scarce resource , proximity infect patient , concern bring infection home family member , societal stigma , change procedure create unprecedented strain .', 'China , outbreak epicenter , already see adverse mental health effect health care professional , high rate depression , anxiety , insomnia , general distress report ( 2 ) .', 'Ensuring well-being hospitalists lead edge health care response require action organizational leader , health care personnel alike , preserve important asset global battle .', 'Interventions enhance well-being function hospitalists health care worker extreme time stress use principle psychological first aid , evidence-based framework enhance sense safety , calm , hope , self- organizational efficacy , social connectedness ( 3 ) .', 'During crisis , leadership decision behavior profound effect function psychological well-being personnel ( 4 ) .', 'Throughout health care practice , leader clinical administrative team service well higher level facility organization .', 'All leader potential make critical contribution well-being personnel crisis subsequent recovery .', 'Leaders prioritize wellness sustainment health care professional prevention effort reduce psychological morbidity outbreak use psychological first aid principle ( 5 ) .', 'The follow step leader take support workforce sustain patient care : Be present .', 'This provide reassurance “ 1 team , 1 fight ” approach .', 'Take time connect communicate personnel .', 'Communicate effectively .', 'Information treat anxiety crisis .', ""Share know n't know ."", 'Commit find answer share team .', 'Ensure train equipment .', 'Obtain need equipment ensure train use .', 'Address anticipate exposure .', 'Speak take action personnel safety risk .']","['war', '', 'invisible', 'enemy', 'break', 'rank', 'global', 'society', 'wag', 'aggressive', 'campaign', '', 'hospitalists', 'front', 'defend', 'health', 'safety', '', 'pandemic', '', 'coronavirus', 'disease', '2019', 'present', 'challenge', 'well-being', 'citizen', 'around', 'globe', '', 'result', 'fear', 'illness', '', 'social', 'distance', 'measure', '', 'isolation', 'quarantine', '', 'protract', 'uncertainty', '', '1', '', '', 'hospitalists', 'health', 'care', 'worker', 'face', 'additional', 'unique', 'challenge', '', 'transition', 'crisis', 'standard', 'care', 'require', 'allocation', 'scarce', 'resource', '', 'proximity', 'infect', 'patient', '', 'concern', 'bring', 'infection', 'home', 'family', 'member', '', 'societal', 'stigma', '', 'change', 'procedure', 'create', 'unprecedented', 'strain', '', 'china', '', 'outbreak', 'epicenter', '', 'already', 'adverse', 'mental', 'health', 'effect', 'health', 'care', 'professional', '', 'high', 'rate', 'depression', '', 'anxiety', '', 'insomnia', '', 'general', 'distress', 'report', '', '2', '', '', 'ensuring', 'well-being', 'hospitalists', 'lead', 'edge', 'health', 'care', 'response', 'require', 'action', 'organizational', 'leader', '', 'health', 'care', 'personnel', 'alike', '', 'preserve', 'important', 'asset', 'global', 'battle', '', 'interventions', 'enhance', 'well-being', 'function', 'hospitalists', 'health', 'care', 'worker', 'extreme', 'time', 'stress', 'principle', 'psychological', 'first', 'aid', '', 'evidence-based', 'framework', 'enhance', 'sense', 'safety', '', 'calm', '', 'hope', '', 'self-', 'organizational', 'efficacy', '', 'social', 'connectedness', '', '3', '', '', 'crisis', '', 'leadership', 'decision', 'behavior', 'profound', 'effect', 'function', 'psychological', 'well-being', 'personnel', '', '4', '', '', 'throughout', 'health', 'care', 'practice', '', 'leader', 'clinical', 'administrative', 'team', 'service', 'well', 'higher', 'level', 'facility', 'organization', '', 'leader', 'potential', 'critical', 'contribution', 'well-being', 'personnel', 'crisis', 'subsequent', 'recovery', '', 'leaders', 'prioritize', 'wellness', 'sustainment', 'health', 'care', 'professional', 'prevention', 'effort', 'reduce', 'psychological', 'morbidity', 'outbreak', 'psychological', 'first', 'aid', 'principle', '', '5', '', '', 'follow', 'step', 'leader', 'support', 'workforce', 'sustain', 'patient', 'care', '', 'present', '', 'provide', 'reassurance', '', '1', 'team', '', '1', 'fight', '', 'approach', '', 'time', 'connect', 'communicate', 'personnel', '', 'communicate', 'effectively', '', 'information', 'treat', 'anxiety', 'crisis', '', 'share', 'nt', '', 'commit', 'find', 'answer', 'share', 'team', '', 'ensure', 'train', 'equipment', '', 'obtain', 'equipment', 'ensure', 'train', '', 'address', 'anticipate', 'exposure', '', 'speak', 'action', 'personnel', 'safety', 'risk', '']",299,"{'': 62, 'health': 9, 'care': 9, 'well-being': 5, 'personnel': 5, 'hospitalists': 4, 'crisis': 4, 'leader': 4, 'psychological': 4, 'safety': 3, '1': 3, 'team': 3, 'global': 2, 'present': 2, 'challenge': 2, 'social': 2, 'worker': 2, 'require': 2, 'patient': 2, 'outbreak': 2}","{'infection': 1, 'safety': 3}",4,-0.7506
DOI:10.7326/L20-0419,10.7326/L20-0419,Letters,2020-05-18 00:00:00,ACP,2020-05-23 22:13:35.057884,"['tocilizumab', 'hemophagocytic', 'syndrome', 'kidney', 'transplant', 'recipient', 'covid-19']","['Background : A subset patient coronavirus disease 2019 ( COVID-19 ) develop acute respiratory distress syndrome require mechanical ventilation .', 'Studies suggest many patient COVID-19 acute respiratory distress syndrome experience cytokine storm characterize fever ; hyperferritinemia ; massive release inflammatory cytokine , include interleukin-6 , tumor necrosis factor-α , monocyte chemoattractant protein ( 1 ) .', 'These find lead hypothesis biological agent target specific cytokine inflammatory pathway may improve respiratory outcome patient severe form COVID-19 ( 2 ) .', 'Objective : To describe patient COVID-19 overt hemophagocytic syndrome whose response treatment consistent hypothesis .', 'Case Report : A 51-year-old man receive kidney transplant refer intensive care unit cough , fever , shortness breath lead presumptive diagnosis COVID-19 .', 'On day 1 , acute respiratory failure require mechanical ventilation prone position .', 'Therapy dexamethasone ( 5 mg twice daily ) , ceftriaxone ( 2 g/d ) , spiramycin ( 1.5 million unit 3 time daily ) initiate .', 'Tacrolimus mycophenolate mofetil withdraw .', 'On day 2 , patient develop refractory multiorgan failure characterize inflammatory state , heart failure , stage 3 acute-on-chronic kidney injury , acute liver failure , nonregenerative anemia , thrombocytopenia , lactic acidosis .', 'The C-reactive protein level 262 mg/L , ferritin level 52 005 μg/L .', 'We consider diagnosis hemophagocytic syndrome patient underlie immunosuppression ; fever 39 °C ; serum ferritin level 6000 μg/L ; hemoglobin level 92 g/L ; platelet count 110 × 109 cells/L ; high level serum triglyceride ; aspartate aminotransferase HScore 253 , indicate probability hemophagocytic syndrome 99.5 % ( 3 ) .', 'Bone marrow aspiration liver biopsy confirm presence hemophagocytosis ( Figure ) .', 'Polymerase chain reaction identify severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) bronchoalveolar fluid ( cycle threshold 21 ) blood .', 'COVID-19 = coronavirus disease 2019 .', 'A. Hemophagocytosis polymorphonuclear neutrophil ( yellow arrow ) , erythrocyte ( green arrow ) , platelet ( red arrow ) activate macrophage bone marrow aspirate .', 'May–Grünwald–Giemsa stain , original magnification × 1000 .', 'B. Kupffer cell hypertrophy hyperplasia hemophagocytosis polymorphonuclear neutrophil ( yellow arrow ) lymphocyte ( red arrow ) liver ( hematoxylin–eosin stain ) .', 'C. CD68 immunostaining liver biopsy ( brown stain : activate macrophage hemophagocytosis erythrocyte [ green arrow ] ) .']","['background', '', 'subset', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'develop', 'acute', 'respiratory', 'distress', 'syndrome', 'require', 'mechanical', 'ventilation', '', 'studies', 'suggest', 'patient', 'covid-19', 'acute', 'respiratory', 'distress', 'syndrome', 'experience', 'cytokine', 'storm', 'characterize', 'fever', '', 'hyperferritinemia', '', 'massive', 'release', 'inflammatory', 'cytokine', '', 'include', 'interleukin-6', '', 'tumor', 'necrosis', 'factor-', '', 'monocyte', 'chemoattractant', 'protein', '', '1', '', '', 'find', 'lead', 'hypothesis', 'biological', 'agent', 'target', 'specific', 'cytokine', 'inflammatory', 'pathway', 'improve', 'respiratory', 'outcome', 'patient', 'severe', 'form', 'covid-19', '', '2', '', '', 'objective', '', 'describe', 'patient', 'covid-19', 'overt', 'hemophagocytic', 'syndrome', 'whose', 'response', 'treatment', 'consistent', 'hypothesis', '', 'case', 'report', '', '51-year-old', 'man', 'receive', 'kidney', 'transplant', 'refer', 'intensive', 'care', 'unit', 'cough', '', 'fever', '', 'shortness', 'breath', 'lead', 'presumptive', 'diagnosis', 'covid-19', '', 'day', '1', '', 'acute', 'respiratory', 'failure', 'require', 'mechanical', 'ventilation', 'prone', 'position', '', 'therapy', 'dexamethasone', '', '5', 'mg', 'twice', 'daily', '', '', 'ceftriaxone', '', '2', 'gd', '', '', 'spiramycin', '', '15', 'million', 'unit', '3', 'time', 'daily', '', 'initiate', '', 'tacrolimus', 'mofetil', 'mofetil', 'withdraw', '', 'day', '2', '', 'patient', 'develop', 'refractory', 'multiorgan', 'failure', 'characterize', 'inflammatory', 'state', '', 'heart', 'failure', '', 'stage', '3', 'acute-on-chronic', 'kidney', 'injury', '', 'acute', 'liver', 'failure', '', 'nonregenerative', 'anemia', '', 'thrombocytopenia', '', 'lactic', 'acidosis', '', 'c-reactive', 'protein', 'level', '262', 'mgl', '', 'ferritin', 'level', '52', '005', 'gl', '', 'consider', 'diagnosis', 'hemophagocytic', 'syndrome', 'patient', 'underlie', 'immunosuppression', '', 'fever', '39', 'c', '', 'serum', 'ferritin', 'level', '6000', 'gl', '', 'hemoglobin', 'level', '92', 'gl', '', 'platelet', 'count', '110', '', '109', 'cellsl', '', 'high', 'level', 'serum', 'triglyceride', '', 'aspartate', 'aminotransferase', 'hscore', '253', '', 'indicate', 'probability', 'hemophagocytic', 'syndrome', '995', '', '', '3', '', '', 'bone', 'marrow', 'aspiration', 'liver', 'biopsy', 'confirm', 'presence', 'hemophagocytosis', '', 'figure', '', '', 'polymerase', 'chain', 'reaction', 'identify', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'bronchoalveolar', 'fluid', '', 'cycle', 'threshold', '21', '', 'blood', '', 'covid-19', '', 'coronavirus', 'disease', '2019', '', 'hemophagocytosis', 'polymorphonuclear', 'neutrophil', '', 'yellow', 'arrow', '', '', 'erythrocyte', '', 'green', 'arrow', '', '', 'platelet', '', 'red', 'arrow', '', 'activate', 'macrophage', 'bone', 'marrow', 'aspirate', '', 'maygrnwaldgiemsa', 'stain', '', 'original', 'magnification', '', '1000', '', 'b', 'kupffer', 'cell', 'hypertrophy', 'hyperplasia', 'hemophagocytosis', 'polymorphonuclear', 'neutrophil', '', 'yellow', 'arrow', '', 'lymphocyte', '', 'red', 'arrow', '', 'liver', '', 'hematoxylineosin', 'stain', '', '', 'c', 'cd68', 'immunostaining', 'liver', 'biopsy', '', 'brown', 'stain', '', 'activate', 'macrophage', 'hemophagocytosis', 'erythrocyte', '', 'green', 'arrow', '', '', '']",365,"{'': 90, 'patient': 6, 'covid-19': 6, 'syndrome': 6, 'arrow': 6, 'acute': 5, 'respiratory': 5, 'level': 5, '2': 4, 'failure': 4, 'liver': 4, 'hemophagocytosis': 4, 'coronavirus': 3, 'cytokine': 3, 'fever': 3, 'inflammatory': 3, 'hemophagocytic': 3, '3': 3, 'gl': 3, 'stain': 3}","{'mofetil': 2, 'tacrolimus': 1, 'sars-cov-2': 1}",4,-0.8442
DOI:10.7326/M20-1515,10.7326/M20-1515,Reviews,2020-05-15 00:00:00,ACP,2020-05-23 22:13:35.057884,"['risks', 'impact', 'angiotensin-converting', 'enzyme', 'inhibitors', 'angiotensin-receptor', 'blockers', 'sars-cov-2', 'infection', 'adults', '', 'living', 'systematic', 'review']","['Concerns exist angiotensin-converting enzyme inhibitor ( ACEIs ) angiotensin-receptor blocker ( ARBs ) increase susceptibility severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 , viral agent cause disease COVID-19 ) likelihood severe COVID-19 illness ( 1 ) .', 'Early report Wuhan , China , show hypertension diabetes common among patient COVID-19 associate worse outcome ( 2 ) .', 'Although early study specify whether patient use ACEIs ARBs become infect , medication widely use treat hypertension diabetes ( 3 , 4 ) .', 'The propose mechanism ACEIs ARBs may play role COVID-19 upregulation angiotensin-converting enzyme 2 ( ACE2 ) , presume act functional receptor SARS-CoV-2 gain entry host cell ( 5 ) ( Figure 1 ) .', 'Angiotensin-converting enzyme 2 exist primarily membrane-bound monocarboxypeptidase robust expression tissue lung , vasculature , intestine , kidney ( 5 ) .', 'A soluble circulate form ACE2 ( sACE2 ) cardiovascular effect renin–angiotensin system ( 6–8 ) .', 'Related viral pathogenesis , sACE2 show block SARS viral entry cell ( 9 ) consider potential therapy ( 10 ) .', 'As part RAS , ACE2 ( green ) regulate level angiotensin II .', 'As functional receptor SARS-CoV-2 , ACE2 may facilitate viral entry cell .', 'This figure illustrate role ACE2 RAS pharmacologic RAS blockade ACEIs ARBs ( red ) could theoretically increase amount ACE2 available viral bind .', 'ACE2 = angiotensin-converting enzyme 2 ; ACEI = angiotensin-converting enzyme inhibitor ; ARB = angiotensin-receptor blocker ; AT1 = type 1 angiotensin receptor ; RAS = renin–angiotensin system ; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2 .', 'Angiotensin-converting enzyme 2 distinct directly relate clinical use ACEIs ARBs , mechanism action .', 'Angiotensin-converting enzyme inhibitor target angiotensin-converting enzyme 1 ( ACE ) inhibit conversion angiotensin I angiotensin II , thereby reduce level angiotensin II available bind activate type 1 angiotensin receptor ( AT1 ) , mediate vasopressor effect angiotensin II ( 11 ) .', 'Angiotensin-receptor blocker work bind AT1 receptor directly block action angiotensin II .', 'In contrast ACE , act generate angiotensin II , ACE2 degrade angiotensin II angiotensin ( 1-7 ) thus negative regulator renin–angiotensin system ( Figure 1 ) ( 12 ) .']","['concerns', 'exist', 'angiotensin-converting', 'enzyme', 'inhibitor', '', 'aceis', '', 'angiotensin-receptor', 'blocker', '', 'arbs', '', 'increase', 'susceptibility', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'viral', 'agent', 'cause', 'disease', 'covid-19', '', 'likelihood', 'severe', 'covid-19', 'illness', '', '1', '', '', 'early', 'report', 'wuhan', '', 'china', '', 'show', 'hypertension', 'diabetes', 'common', 'among', 'patient', 'covid-19', 'associate', 'worse', 'outcome', '', '2', '', '', 'although', 'early', 'study', 'specify', 'whether', 'patient', 'aceis', 'arbs', 'become', 'infect', '', 'medication', 'widely', 'treat', 'hypertension', 'diabetes', '', '3', '', '4', '', '', 'propose', 'mechanism', 'aceis', 'arbs', 'play', 'role', 'covid-19', 'upregulation', 'angiotensin-converting', 'enzyme', '2', '', 'ace2', '', '', 'presume', 'act', 'functional', 'receptor', 'sars-cov-2', 'gain', 'entry', 'host', 'cell', '', '5', '', '', 'figure', '1', '', '', 'angiotensin-converting', 'enzyme', '2', 'exist', 'primarily', 'membrane-bound', 'monocarboxypeptidase', 'robust', 'expression', 'tissue', 'lung', '', 'vasculature', '', 'intestine', '', 'kidney', '', '5', '', '', 'soluble', 'circulate', 'form', 'ace2', '', 'sace2', '', 'cardiovascular', 'effect', 'reninangiotensin', 'system', '', '68', '', '', 'related', 'viral', 'pathogenesis', '', 'sace2', 'show', 'block', 'sars', 'viral', 'entry', 'cell', '', '9', '', 'consider', 'potential', 'therapy', '', '10', '', '', 'part', 'ras', '', 'ace2', '', 'green', '', 'regulate', 'level', 'angiotensin', 'ii', '', 'functional', 'receptor', 'sars-cov-2', '', 'ace2', 'facilitate', 'viral', 'entry', 'cell', '', 'figure', 'illustrate', 'role', 'ace2', 'ras', 'pharmacologic', 'ras', 'blockade', 'aceis', 'arbs', '', 'red', '', 'theoretically', 'increase', 'amount', 'ace2', 'available', 'viral', 'bind', '', 'ace2', '', 'angiotensin-converting', 'enzyme', '2', '', 'acei', '', 'angiotensin-converting', 'enzyme', 'inhibitor', '', 'arb', '', 'angiotensin-receptor', 'blocker', '', 'at1', '', 'type', '1', 'angiotensin', 'receptor', '', 'ras', '', 'reninangiotensin', 'system', '', 'sars-cov-2', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'angiotensin-converting', 'enzyme', '2', 'distinct', 'directly', 'relate', 'clinical', 'aceis', 'arbs', '', 'mechanism', 'action', '', 'angiotensin-converting', 'enzyme', 'inhibitor', 'target', 'angiotensin-converting', 'enzyme', '1', '', 'ace', '', 'inhibit', 'conversion', 'angiotensin', 'angiotensin', 'ii', '', 'thereby', 'reduce', 'level', 'angiotensin', 'ii', 'available', 'bind', 'activate', 'type', '1', 'angiotensin', 'receptor', '', 'at1', '', '', 'mediate', 'vasopressor', 'effect', 'angiotensin', 'ii', '', '11', '', '', 'angiotensin-receptor', 'blocker', 'work', 'bind', 'at1', 'receptor', 'directly', 'block', 'action', 'angiotensin', 'ii', '', 'contrast', 'ace', '', 'act', 'generate', 'angiotensin', 'ii', '', 'ace2', 'degrade', 'angiotensin', 'ii', 'angiotensin', '', '1-7', '', 'thus', 'negative', 'regulator', 'reninangiotensin', 'system', '', 'figure', '1', '', '', '12', '', '']",345,"{'': 87, 'angiotensin': 11, 'angiotensin-converting': 8, 'enzyme': 8, 'ace2': 8, '2': 7, 'ii': 7, '1': 6, 'aceis': 5, 'arbs': 5, 'viral': 5, 'receptor': 5, 'sars-cov-2': 4, 'covid-19': 4, 'ras': 4, 'inhibitor': 3, 'angiotensin-receptor': 3, 'blocker': 3, 'severe': 3, 'entry': 3}",{'sars-cov-2': 4},4,-0.743
DOI:10.7326/M20-3047,10.7326/M20-3047,Editorials,2020-05-15 00:00:00,ACP,2020-05-23 22:13:35.057884,"['covid-19', 'angiotensin-converting', 'enzyme', 'inhibitorangiotensin-receptor', 'blocker', 'therapy']","['Coronavirus disease 2019 ( COVID-19 ) –related concern angiotensin-converting enzyme inhibitor ( ACEIs ) angiotensin-receptor blocker ( ARBs ) seem develop approximately follow : • The epidemic break widely January February .', '• Early report show common comorbid condition , include hypertension , statistically link worse illness severity .', '• Many hypertensive person take ACEIs ARBs .', '• Previous study relate coronavirus , causal agent 2003–2004 severe acute respiratory syndrome epidemic , show ACE-2 membrane receptor key ability virus infect cell .']","['coronavirus', 'disease', '2019', '', 'covid-19', '', 'related', 'concern', 'angiotensin-converting', 'enzyme', 'inhibitor', '', 'aceis', '', 'angiotensin-receptor', 'blocker', '', 'arbs', '', 'develop', 'approximately', 'follow', '', '', 'epidemic', 'break', 'widely', 'january', 'february', '', '', 'early', 'report', 'show', 'common', 'comorbid', 'condition', '', 'include', 'hypertension', '', 'statistically', 'link', 'worse', 'illness', 'severity', '', '', 'hypertensive', 'person', 'aceis', 'arbs', '', '', 'previous', 'study', 'relate', 'coronavirus', '', 'causal', 'agent', '20032004', 'severe', 'acute', 'respiratory', 'syndrome', 'epidemic', '', 'show', 'ace-2', 'membrane', 'receptor', 'key', 'ability', 'virus', 'infect', 'cell', '']",78,"{'': 19, 'coronavirus': 2, 'aceis': 2, 'arbs': 2, 'epidemic': 2, 'show': 2, 'disease': 1, '2019': 1, 'covid-19': 1, 'related': 1, 'concern': 1, 'angiotensin-converting': 1, 'enzyme': 1, 'inhibitor': 1, 'angiotensin-receptor': 1, 'blocker': 1, 'develop': 1, 'approximately': 1, 'follow': 1, 'break': 1}",{},0,-0.7269
DOI:10.7326/M20-3255,10.7326/M20-3255,Editorials,2020-05-15 00:00:00,ACP,2020-05-23 22:13:35.057884,"['thromboembolic', 'findings', 'covid-19', 'autopsies', '', 'pulmonary', 'thrombosis', 'embolism', '']","['The coronavirus disease 2019 ( COVID-19 ) pandemic cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) initially present pneumonia unknown cause Wuhan , China , December 2019 , SARS-CoV-2 identify causative agent January 2020 ( 1 ) .', 'Since COVID-19 , pulmonary systemic manifestation , spread globally—with 4.2 million case 291 000 death 187 country report ( 2 ) .', 'With spread disease , abnormal coagulation variable high incidence venous thromboembolic ( VTE ) complication note , raise need develop specific VTE diagnostic therapeutic strategy ( 3 ) .', 'Complete autopsy study almost nonexistent initial phase outbreak ; reasonably , due concern relate infectivity , transmission rate , biosafety .', 'The report initially publish limit postmortem biopsy COVID-19–positive patient ( 4–6 ) lobectomy specimen initially resect lung adenocarcinoma , patient later find COVID-19–positive ( 7 ) .', 'Pathologic feature exudative proliferative phase diffuse alveolar damage ( DAD ) note initial report overlap feature SARS also note .', 'Later complete autopsy perform United States support presence DAD ( 8 , 9 ) .', 'More recently , Wichmann colleague ( 10 ) report find 12 consecutive , legally mandate autopsy patient COVID-19 .', 'The author note high incidence pulmonary embolism without underlie deep venous thrombosis , despite absence history VTE .', 'Massive pulmonary embolism cause death one third case , additional one fourth recent deep venous thrombosis without pulmonary embolism .', 'Seventy-five percent men two third note recent thrombosis prostatic venous plexus .', 'Preexisting coronary heart disease ( 50 % ) , respiratory tract , obesity , type 2 diabetes mellitus note absence antemortem VTEs .', 'Histologically exudative phase DAD note two third presence pulmonary thrombus 5 8 case DAD .', 'Similar histologic find DAD microthrombi 45 % case also recently report Menter associate series 21 COVID-19–positive autopsy , 4 prominent central pulmonary embolism ( 11 ) .', 'In issue , Lax colleague ( 12 ) report find autopsy perform 11 patient randomly select among 48 hospitalize COVID-19–positive decedent .', 'Significant preexist comorbid condition include hypertension , type 2 diabetes mellitus , obesity , chronic obstructive pulmonary disease , coronary heart disease , cancer , well history cerebrovascular disease ( ischemic stroke 4 patient ) pulmonary embolism ( 1 patient ) .', 'After autopsy tissue fixation , grossly visible pulmonary thrombus note case associate infarct 9 11 ( 81 % ) autopsy .', 'During hospital stay , 10 11 decease patient receive prophylactic dose anticoagulant therapy , 2 receive therapy even admission ; thus suggest pulmonary thrombus form despite anticoagulant therapy .', 'Apart DAD , histologic evaluation highlight presence multiple thrombus small mid-sized pulmonary artery adjacent lung parenchymal infarct .', 'These autopsy study highlight importance thromboembolic event COVID-19 .', 'Wichmann colleague highlight high incidence pulmonary embolism without deep venous thrombosis , well presence recent thrombus prostatic venous plexus , patient history VTE , suggest de novo coagulopathy patient COVID-19 .', 'In contrast , Lax colleague highlight change consistent thrombosis occur within pulmonary arterial circulation , absence apparent embolism .']","['coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'initially', 'present', 'pneumonia', 'unknown', 'cause', 'wuhan', '', 'china', '', 'december', '2019', '', 'sars-cov-2', 'identify', 'causative', 'agent', 'january', '2020', '', '1', '', '', 'since', 'covid-19', '', 'pulmonary', 'systemic', 'manifestation', '', 'spread', 'globallywith', '42', 'million', 'case', '291', '000', 'death', '187', 'country', 'report', '', '2', '', '', 'spread', 'disease', '', 'abnormal', 'coagulation', 'variable', 'high', 'incidence', 'venous', 'thromboembolic', '', 'vte', '', 'complication', 'note', '', 'raise', 'develop', 'specific', 'vte', 'diagnostic', 'therapeutic', 'strategy', '', '3', '', '', 'complete', 'autopsy', 'study', 'almost', 'nonexistent', 'initial', 'phase', 'outbreak', '', 'reasonably', '', 'due', 'concern', 'relate', 'infectivity', '', 'transmission', 'rate', '', 'biosafety', '', 'report', 'initially', 'publish', 'limit', 'postmortem', 'biopsy', 'covid-19positive', 'patient', '', '46', '', 'lobectomy', 'specimen', 'initially', 'resect', 'lung', 'adenocarcinoma', '', 'patient', 'later', 'find', 'covid-19positive', '', '7', '', '', 'pathologic', 'feature', 'exudative', 'proliferative', 'phase', 'diffuse', 'alveolar', 'damage', '', 'dad', '', 'note', 'initial', 'report', 'overlap', 'feature', 'sars', 'note', '', 'later', 'complete', 'autopsy', 'perform', 'united', 'states', 'support', 'presence', 'dad', '', '8', '', '9', '', '', 'recently', '', 'wichmann', 'colleague', '', '10', '', 'report', 'find', '12', 'consecutive', '', 'legally', 'mandate', 'autopsy', 'patient', 'covid-19', '', 'author', 'note', 'high', 'incidence', 'pulmonary', 'embolism', 'without', 'underlie', 'deep', 'venous', 'thrombosis', '', 'despite', 'absence', 'history', 'vte', '', 'massive', 'pulmonary', 'embolism', 'cause', 'death', 'one', 'third', 'case', '', 'additional', 'one', 'fourth', 'recent', 'deep', 'venous', 'thrombosis', 'without', 'pulmonary', 'embolism', '', 'seventy-five', 'percent', 'men', 'two', 'third', 'note', 'recent', 'thrombosis', 'prostatic', 'venous', 'plexus', '', 'preexisting', 'coronary', 'heart', 'disease', '', '50', '', '', '', 'respiratory', 'tract', '', 'obesity', '', 'type', '2', 'diabetes', 'mellitus', 'note', 'absence', 'antemortem', 'vtes', '', 'histologically', 'exudative', 'phase', 'dad', 'note', 'two', 'third', 'presence', 'pulmonary', 'thrombus', '5', '8', 'case', 'dad', '', 'similar', 'histologic', 'find', 'dad', 'microthrombi', '45', '', 'case', 'recently', 'report', 'menter', 'associate', 'series', '21', 'covid-19positive', 'autopsy', '', '4', 'prominent', 'central', 'pulmonary', 'embolism', '', '11', '', '', 'issue', '', 'lax', 'colleague', '', '12', '', 'report', 'find', 'autopsy', 'perform', '11', 'patient', 'randomly', 'select', 'among', '48', 'hospitalize', 'covid-19positive', 'decedent', '', 'significant', 'preexist', 'comorbid', 'condition', 'include', 'hypertension', '', 'type', '2', 'diabetes', 'mellitus', '', 'obesity', '', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'coronary', 'heart', 'disease', '', 'cancer', '', 'well', 'history', 'cerebrovascular', 'disease', '', 'ischemic', 'stroke', '4', 'patient', '', 'pulmonary', 'embolism', '', '1', 'patient', '', '', 'autopsy', 'tissue', 'fixation', '', 'grossly', 'visible', 'pulmonary', 'thrombus', 'note', 'case', 'associate', 'infarct', '9', '11', '', '81', '', '', 'autopsy', '', 'hospital', 'stay', '', '10', '11', 'decease', 'patient', 'receive', 'prophylactic', 'dose', 'anticoagulant', 'therapy', '', '2', 'receive', 'therapy', 'admission', '', 'thus', 'suggest', 'pulmonary', 'thrombus', 'form', 'despite', 'anticoagulant', 'therapy', '', 'apart', 'dad', '', 'histologic', 'evaluation', 'highlight', 'presence', 'multiple', 'thrombus', 'small', 'mid-sized', 'pulmonary', 'artery', 'adjacent', 'lung', 'parenchymal', 'infarct', '', 'autopsy', 'study', 'highlight', 'importance', 'thromboembolic', 'event', 'covid-19', '', 'wichmann', 'colleague', 'highlight', 'high', 'incidence', 'pulmonary', 'embolism', 'without', 'deep', 'venous', 'thrombosis', '', 'well', 'presence', 'recent', 'thrombus', 'prostatic', 'venous', 'plexus', '', 'patient', 'history', 'vte', '', 'suggest', 'de', 'novo', 'coagulopathy', 'patient', 'covid-19', '', 'contrast', '', 'lax', 'colleague', 'highlight', 'change', 'consistent', 'thrombosis', 'occur', 'within', 'pulmonary', 'arterial', 'circulation', '', 'absence', 'apparent', 'embolism', '']",485,"{'': 97, 'pulmonary': 13, 'patient': 9, 'note': 8, 'autopsy': 8, 'embolism': 7, 'disease': 6, 'report': 6, 'venous': 6, 'dad': 6, 'covid-19': 5, '2': 5, 'case': 5, 'thrombosis': 5, 'thrombus': 5, 'vte': 4, 'covid-19positive': 4, 'find': 4, 'presence': 4, 'colleague': 4}",{'sars-cov-2': 2},2,-0.891
DOI:10.7326/M20-1982,10.7326/M20-1982,Ideas and Opinions,2020-05-14 00:00:00,ACP,2020-05-23 22:13:35.057884,"['new', 'normal', '', 'key', 'considerations', 'effective', 'serious', 'illness', 'communication', 'video', 'telephone', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic']","['On 4 March 2019 , year coronavirus disease 2019 ( COVID-19 ) pandemic descend United States , doctor deliver difficult news 78-year-old man intensive care unit advance chronic obstructive pulmonary disease ( 1 ) .', 'His granddaughter , sit beside , record interaction cellphone .', 'First , see nurse roll piece equipment screen .', ""She attend task patient 's room man screen—the doctor—begins speak ."", ""We hear part say : damage man 's lung fix ; morphine may help feel better ."", 'The granddaughter ask grandfather understand ; hear response .', 'The clip end .', 'The man die next day .', 'His family , deeply dissatisfy interaction , release video press , article title like “ Doctor deliver end-of-life news via robot ” broadly disseminate .', 'Fast forward .', 'Across country , clinician use telecommunication ( video telephone ) serious illness communication hospitalize patient COVID-19 love one , together separately .', 'The term serious illness communication refer communication clinician patient prognosis , goal , value , priority , recommendation goal-concordant treatment plan ( 2 ) .', 'The pandemic bring new barrier effective serious illness communication : widespread fear uncertainty , surge work demand clinician , clinically appropriate unfamiliar use telecommunication reduce exposure virus preserve personal protective equipment .', 'Here , discus frontline clinician meaningful conversation patient seriously ill love one use telecommunication extraordinary time ( Table ) .', 'Serious illness communication , whether person telecommunication , require careful preparation .', ""Clinicians ass patient 's ability participate , need translator , preference include love one ."", 'An advantage telecommunication love one include distance .', 'A review prior advance care plan documentation identify legal decision maker guide decision make patient participate .', 'If use video , clinician ensure patient use equipment ; hospital engage volunteer help .', ""If possible , clinician conduct visit private space remove mask preserve patient 's privacy ."", 'Clinicians identify hear vision impairment adjust environment communication accordingly ( Table ) .', 'Finally , clinician start actual conversation check first—especially distraction pandemic .', 'A deep breath bring one present focus need patient family .', 'Serious illness communication require rapid establishment rapport trust , challenge video telephone ( 8 ) , especially context shift work rotate clinician .', 'Clinicians foster continuity include nurse staff member regularly work patient establish primary care provider .', 'Some clinician redeploy family liaison provide regular medical update hospital stay ; liaison include ( 9 ) .', 'Whenever possible , suggest several brief conversation rather 1 prolong meet .', 'An initial conversation without urgent decision make allow participant adjust telecommunication , troubleshoot technologic glitch , begin build rapport .', ""Even urgent conversation , minute spend chat patient 's interest background quickly build rapport ."", 'To build trust , clinician acknowledge telecommunication optimal .', 'If patient family member express disappointment , clinician use “ I wish ” statement ( example , “ I wish I could person support you. ” ) .', 'Clinicians mindful demonstrate listen make eye contact camera , device screen , give brief verbal response ( “ yes… ” “ go on… ” ) .', 'Before conversation , clinician consider agenda : Is communication task information share , provide emotional support , identify goal value , decision make ?', 'Many open-source , step-by-step framework , specific COVID-19 , disseminate , include guide break bad news , identify goal care , advance care plan ( 3–6 ) .', 'An advantage telecommunication clinician framework screen cheat sheet ongoing conversation , may especially helpful clinician new serious illness communication .', 'However , caution clinician avoid strict adherence algorithm remain flexible .', 'Asking permission regular point conversation provide natural transition , build psychological safety , allow patient family control .', 'For example , clinician ask , “ May I tell I understand father today ? ” Likewise , clinician regularly check understand , use summarize statement , orient back patient love one also conversation .']","['4', 'march', '2019', '', 'year', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'descend', 'united', 'states', '', 'doctor', 'deliver', 'difficult', 'news', '78-year-old', 'man', 'intensive', 'care', 'unit', 'advance', 'chronic', 'obstructive', 'pulmonary', 'disease', '', '1', '', '', 'granddaughter', '', 'sit', 'beside', '', 'record', 'interaction', 'cellphone', '', 'first', '', 'nurse', 'roll', 'piece', 'equipment', 'screen', '', 'attend', 'task', 'patient', 'room', 'man', 'screenthe', 'doctorbegins', 'speak', '', 'hear', 'part', '', 'damage', 'man', 'lung', 'fix', '', 'morphine', 'help', 'feel', 'better', '', 'granddaughter', 'ask', 'grandfather', 'understand', '', 'hear', 'response', '', 'clip', 'end', '', 'man', 'die', 'next', 'day', '', 'family', '', 'deeply', 'dissatisfy', 'interaction', '', 'release', 'video', 'press', '', 'article', 'title', 'like', '', 'doctor', 'deliver', 'end-of-life', 'news', 'via', 'robot', '', 'broadly', 'disseminate', '', 'fast', 'forward', '', 'across', 'country', '', 'clinician', 'telecommunication', '', 'video', 'telephone', '', 'serious', 'illness', 'communication', 'hospitalize', 'patient', 'covid-19', 'love', 'one', '', 'together', 'separately', '', 'term', 'serious', 'illness', 'communication', 'refer', 'communication', 'clinician', 'patient', 'prognosis', '', 'goal', '', 'value', '', 'priority', '', 'recommendation', 'goal-concordant', 'treatment', 'plan', '', '2', '', '', 'pandemic', 'bring', 'new', 'barrier', 'effective', 'serious', 'illness', 'communication', '', 'widespread', 'fear', 'uncertainty', '', 'surge', 'work', 'demand', 'clinician', '', 'clinically', 'appropriate', 'unfamiliar', 'telecommunication', 'reduce', 'exposure', 'virus', 'preserve', 'personal', 'protective', 'equipment', '', '', 'discus', 'frontline', 'clinician', 'meaningful', 'conversation', 'patient', 'seriously', 'ill', 'love', 'one', 'telecommunication', 'extraordinary', 'time', '', 'table', '', '', 'serious', 'illness', 'communication', '', 'whether', 'person', 'telecommunication', '', 'require', 'careful', 'preparation', '', 'clinicians', 'ass', 'patient', 'ability', 'participate', '', 'translator', '', 'preference', 'include', 'love', 'one', '', 'advantage', 'telecommunication', 'love', 'one', 'include', 'distance', '', 'review', 'prior', 'advance', 'care', 'plan', 'documentation', 'identify', 'legal', 'decision', 'maker', 'guide', 'decision', 'patient', 'participate', '', 'video', '', 'clinician', 'ensure', 'patient', 'equipment', '', 'hospital', 'engage', 'volunteer', 'help', '', 'possible', '', 'clinician', 'conduct', 'visit', 'private', 'space', 'remove', 'mask', 'preserve', 'patient', 'privacy', '', 'clinicians', 'identify', 'hear', 'vision', 'impairment', 'adjust', 'environment', 'communication', 'accordingly', '', 'table', '', '', 'finally', '', 'clinician', 'start', 'actual', 'conversation', 'check', 'firstespecially', 'distraction', 'pandemic', '', 'deep', 'breath', 'bring', 'one', 'present', 'focus', 'patient', 'family', '', 'serious', 'illness', 'communication', 'require', 'rapid', 'establishment', 'rapport', 'trust', '', 'challenge', 'video', 'telephone', '', '8', '', '', 'especially', 'context', 'shift', 'work', 'rotate', 'clinician', '', 'clinicians', 'foster', 'continuity', 'include', 'nurse', 'staff', 'member', 'regularly', 'work', 'patient', 'establish', 'primary', 'care', 'provider', '', 'clinician', 'redeploy', 'family', 'liaison', 'provide', 'regular', 'medical', 'update', 'hospital', 'stay', '', 'liaison', 'include', '', '9', '', '', 'whenever', 'possible', '', 'suggest', 'several', 'brief', 'conversation', '1', 'prolong', 'meet', '', 'initial', 'conversation', 'without', 'urgent', 'decision', 'allow', 'participant', 'adjust', 'telecommunication', '', 'troubleshoot', 'technologic', 'glitch', '', 'begin', 'build', 'rapport', '', 'urgent', 'conversation', '', 'minute', 'spend', 'chat', 'patient', 'interest', 'background', 'quickly', 'build', 'rapport', '', 'build', 'trust', '', 'clinician', 'acknowledge', 'telecommunication', 'optimal', '', 'patient', 'family', 'member', 'express', 'disappointment', '', 'clinician', '', 'wish', '', 'statement', '', 'example', '', '', 'wish', 'person', 'support', '', '', '', 'clinicians', 'mindful', 'demonstrate', 'listen', 'eye', 'contact', 'camera', '', 'device', 'screen', '', 'give', 'brief', 'verbal', 'response', '', '', 'yes', '', '', '', '', '', 'conversation', '', 'clinician', 'consider', 'agenda', '', 'communication', 'task', 'information', 'share', '', 'provide', 'emotional', 'support', '', 'identify', 'goal', 'value', '', 'decision', '', 'open-source', '', 'step-by-step', 'framework', '', 'specific', 'covid-19', '', 'disseminate', '', 'include', 'guide', 'break', 'bad', 'news', '', 'identify', 'goal', 'care', '', 'advance', 'care', 'plan', '', '36', '', '', 'advantage', 'telecommunication', 'clinician', 'framework', 'screen', 'cheat', 'sheet', 'ongoing', 'conversation', '', 'especially', 'helpful', 'clinician', 'new', 'serious', 'illness', 'communication', '', 'however', '', 'caution', 'clinician', 'avoid', 'strict', 'adherence', 'algorithm', 'remain', 'flexible', '', 'asking', 'permission', 'regular', 'point', 'conversation', 'provide', 'natural', 'transition', '', 'build', 'psychological', 'safety', '', 'allow', 'patient', 'family', 'control', '', 'example', '', 'clinician', 'ask', '', '', 'tell', 'understand', 'father', 'today', '', '', 'likewise', '', 'clinician', 'regularly', 'check', 'understand', '', 'summarize', 'statement', '', 'orient', 'back', 'patient', 'love', 'one', 'conversation', '']",587,"{'': 134, 'clinician': 17, 'patient': 14, 'communication': 9, 'conversation': 9, 'telecommunication': 8, 'serious': 6, 'illness': 6, 'one': 6, 'care': 5, 'family': 5, 'love': 5, 'include': 5, 'man': 4, 'video': 4, 'clinicians': 4, 'identify': 4, 'decision': 4, 'build': 4, 'covid-19': 3}",{'safety': 1},1,0.5423
DOI:10.7326/M20-2566,10.7326/M20-2566,Original Research,2020-05-14 00:00:00,ACP,2020-05-23 22:13:35.057884,"['pulmonary', 'arterial', 'thrombosis', 'covid-19', 'fatal', 'outcome', '', 'results', 'prospective', '', 'single-center', '', 'clinicopathologic', 'case', 'series']","['The pandemic spread severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) cause coronavirus disease 2019 ( COVID-19 ) , within month , lead global health economic crisis ( 1–3 ) .', 'COVID-19 usually characterize symptom acute respiratory infection , fever , headache , dry cough , shortness breath , may show symptom involve gastrointestinal tract ( gastroenteritis-like , vomit diarrhea , hepatitis-like picture ) central nervous system ( notably anosmia ) ( 4–8 ) .', 'Only small subset infect individual become severely ill , require intensive care risk death , number may increase dramatically high transmission rate virus ( 8–10 ) .', 'Although advance age certain comorbid condition , diabetes mellitus cardiovascular disease , identify risk factor adverse outcome death , individual clinical course highly unpredictable dynamic , rapid deterioration respiratory hemodynamic condition ( 10–14 ) .', 'So far , little know pathologic find underlie clinical presentation severe COVID-19 .', 'Only report surgical specimen autopsy case publish past month , detail information still limit ( 15–17 ) part obtain postmortem core biopsy ( 18 , 19 ) .', 'More insight autopsy become available 2003 SARS-CoV-1 epidemic , show patient fatal outcome predominantly diffuse alveolar damage characterize edema , hyaline membrane , proliferation pneumocytes fibroblast ( 20 ) .', 'Nevertheless , pattern organ damage cause SARS-CoV-2 occur patient COVID-19 still incompletely understand .', 'In light currently limit option effective antiviral treatment , may critical better understand morphologic basis severe fatal COVID-19 outcome ( 21 ) .', 'The aim detail autopsy study unravel clinicopathologic basis adverse outcome patient fatal course COVID-19 evaluate gross microscopic find correlation clinical phenotype .', 'We use prospectively design systematic approach perform autopsy study organ change macro- microscopically relate key clinical feature .', 'Moreover , provide comprehensive systematic clinicopathologic evaluation key multiorgan involvement failure COVID-19 .', 'The study prospectively design , autopsy patient COVID-19 hospital do accord protocol .', 'The Hospital Graz II second largest public academic teach hospital region Styria , Austria ( 1.2 million inhabitant ) designate COVID-19 center region begin outbreak pandemic .', 'From 28 February 14 April 2020 , 242 patient COVID-19 treat hospital , 48 die .', 'Autopsy perform 11 48 decease patient ( 23 % ) , 10 select random ; 1 case , treat intensive care specialist request autopsy .', 'The number patient randomly select autopsy influence daily number decease patient , together infrastructural , time , personnel constraint .', 'There medical exclusion criterion .', 'According federal Austrian hospital law , autopsy public hospital mandatory without requirement inform consent relative cause death unclear , scientific public interest present , health authority court order autopsy .', ""Nevertheless , religious reason explicit wish patient ' relative abstain autopsy would respect , possible ."", 'In study , autopsy perform accordance law owe unknown cause death , scientific public interest novel disease .', 'No inform consent obtain family .', 'All perform procedure investigation accordance ethical standard institutional research committee 1964 Declaration Helsinki later amendment .']","['pandemic', 'spread', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'cause', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'within', 'month', '', 'lead', 'global', 'health', 'economic', 'crisis', '', '13', '', '', 'covid-19', 'usually', 'characterize', 'symptom', 'acute', 'respiratory', 'infection', '', 'fever', '', 'headache', '', 'dry', 'cough', '', 'shortness', 'breath', '', 'show', 'symptom', 'involve', 'gastrointestinal', 'tract', '', 'gastroenteritis-like', '', 'vomit', 'diarrhea', '', 'hepatitis-like', 'picture', '', 'central', 'nervous', 'system', '', 'notably', 'anosmia', '', '', '48', '', '', 'small', 'subset', 'infect', 'individual', 'become', 'severely', 'ill', '', 'require', 'intensive', 'care', 'risk', 'death', '', 'number', 'increase', 'dramatically', 'high', 'transmission', 'rate', 'virus', '', '810', '', '', 'although', 'advance', 'age', 'certain', 'comorbid', 'condition', '', 'diabetes', 'mellitus', 'cardiovascular', 'disease', '', 'identify', 'risk', 'factor', 'adverse', 'outcome', 'death', '', 'individual', 'clinical', 'course', 'highly', 'unpredictable', 'dynamic', '', 'rapid', 'deterioration', 'respiratory', 'hemodynamic', 'condition', '', '1014', '', '', 'far', '', 'little', 'pathologic', 'find', 'underlie', 'clinical', 'presentation', 'severe', 'covid-19', '', 'report', 'surgical', 'specimen', 'autopsy', 'case', 'publish', 'past', 'month', '', 'detail', 'information', 'still', 'limit', '', '1517', '', 'part', 'obtain', 'postmortem', 'core', 'biopsy', '', '18', '', '19', '', '', 'insight', 'autopsy', 'become', 'available', '2003', 'sars-cov-1', 'epidemic', '', 'show', 'patient', 'fatal', 'outcome', 'predominantly', 'diffuse', 'alveolar', 'damage', 'characterize', 'edema', '', 'hyaline', 'membrane', '', 'proliferation', 'pneumocytes', 'fibroblast', '', '20', '', '', 'nevertheless', '', 'pattern', 'organ', 'damage', 'cause', 'sars-cov-2', 'occur', 'patient', 'covid-19', 'still', 'incompletely', 'understand', '', 'light', 'currently', 'limit', 'option', 'effective', 'antiviral', 'treatment', '', 'critical', 'better', 'understand', 'morphologic', 'basis', 'severe', 'fatal', 'covid-19', 'outcome', '', '21', '', '', 'aim', 'detail', 'autopsy', 'study', 'unravel', 'clinicopathologic', 'basis', 'adverse', 'outcome', 'patient', 'fatal', 'course', 'covid-19', 'evaluate', 'gross', 'microscopic', 'find', 'correlation', 'clinical', 'phenotype', '', 'prospectively', 'design', 'systematic', 'approach', 'perform', 'autopsy', 'study', 'organ', 'change', 'macro-', 'microscopically', 'relate', 'key', 'clinical', 'feature', '', 'moreover', '', 'provide', 'comprehensive', 'systematic', 'clinicopathologic', 'evaluation', 'key', 'multiorgan', 'involvement', 'failure', 'covid-19', '', 'study', 'prospectively', 'design', '', 'autopsy', 'patient', 'covid-19', 'hospital', 'accord', 'protocol', '', 'hospital', 'graz', 'ii', 'second', 'largest', 'public', 'academic', 'teach', 'hospital', 'region', 'styria', '', 'austria', '', '12', 'million', 'inhabitant', '', 'designate', 'covid-19', 'center', 'region', 'begin', 'outbreak', 'pandemic', '', '28', 'february', '14', 'april', '2020', '', '242', 'patient', 'covid-19', 'treat', 'hospital', '', '48', 'die', '', 'autopsy', 'perform', '11', '48', 'decease', 'patient', '', '23', '', '', '', '10', 'select', 'random', '', '1', 'case', '', 'treat', 'intensive', 'care', 'specialist', 'request', 'autopsy', '', 'number', 'patient', 'randomly', 'select', 'autopsy', 'influence', 'daily', 'number', 'decease', 'patient', '', 'together', 'infrastructural', '', 'time', '', 'personnel', 'constraint', '', 'medical', 'exclusion', 'criterion', '', 'according', 'federal', 'austrian', 'hospital', 'law', '', 'autopsy', 'public', 'hospital', 'mandatory', 'without', 'requirement', 'inform', 'consent', 'relative', 'cause', 'death', 'unclear', '', 'scientific', 'public', 'interest', 'present', '', 'health', 'authority', 'court', 'order', 'autopsy', '', 'nevertheless', '', 'religious', 'reason', 'explicit', 'wish', 'patient', '', 'relative', 'abstain', 'autopsy', 'respect', '', 'possible', '', 'study', '', 'autopsy', 'perform', 'accordance', 'law', 'owe', 'unknown', 'cause', 'death', '', 'scientific', 'public', 'interest', 'novel', 'disease', '', 'inform', 'consent', 'obtain', 'family', '', 'perform', 'procedure', 'investigation', 'accordance', 'ethical', 'standard', 'institutional', 'research', 'committee', '1964', 'declaration', 'helsinki', 'later', 'amendment', '']",468,"{'': 94, 'autopsy': 12, 'covid-19': 10, 'patient': 9, 'hospital': 6, 'cause': 4, 'death': 4, 'outcome': 4, 'clinical': 4, 'study': 4, 'perform': 4, 'public': 4, 'severe': 3, 'respiratory': 3, 'disease': 3, '48': 3, 'number': 3, 'fatal': 3, 'pandemic': 2, 'acute': 2}","{'infection': 1, 'sars-cov-2': 2}",3,-0.93
DOI:10.7326/M20-1495,10.7326/M20-1495,Original Research,2020-05-13 00:00:00,ACP,2020-05-23 22:13:35.057884,"['variation', 'false-negative', 'rate', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reactionbased', 'sars-cov-2', 'tests', 'time', 'since', 'exposure']","['Tests severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) base reverse transcriptase polymerase chain reaction ( RT-PCR ) often use “ rule ” infection among high-risk person , expose inpatient health care worker .', 'Hence , critical understand predictive value change relation time since exposure symptom , especially use result test make decision whether stop use personal protective equipment allow expose health care worker return work .', 'The sensitivity specificity PCR-based test SARS-CoV-2 poorly characterize , “ window period ” acquisition test likely produce false-negative result well know .', 'Accurate test SARS-CoV-2 , follow appropriate preventive measure , paramount health care set prevent nosocomial community transmission .', 'However , hospital face critical shortage SARS-CoV-2 test capacity , personal protective equipment , health care personnel ( 1 ) .', 'As epidemic progress , hospital increasingly decide respond patient health care worker know exposure SARS-CoV-2 .', 'Although 14 day airborne precaution quarantine would conservative approach minimize transmission per guideline Centers Disease Control Prevention ( 2 ) , feasible many hospital give starkly limit resource .', 'As RT-PCR–based test SARS-CoV-2 become available , increasingly use “ rule ” infection conserve scarce personal protective equipment preserve workforce .', 'When expose health care worker test negative , may clear return work ; similarly , expose patient test negative , airborne droplet precaution may remove .', 'If negative result test do window period treat strong evidence expose person SARS-CoV-2–negative , preventable transmission could occur .', 'It critical understand predictive value test vary time exposure symptom onset avoid falsely reassure negative result test do early course infection .', 'The goal study estimate false-negative rate day since infection .', 'As part broader effort provide critical evaluation emerge evidence , Novel Coronavirus Research Compendium Johns Hopkins School Public Health literature review identify preprint peer-reviewed article SARS-CoV-2 diagnostics ( 3 ) .', 'Investigators search PubMed , bioRxiv , medRxiv use strategy detail Supplement Table 1 .', 'The search last update 15 April 2020 .', 'From broader search , identify article provide data RT-PCR performance time since symptom onset exposure use sample derive nasal throat swab among patient test SARS-CoV-2 .', 'Inclusion criterion use RT-PCR–based test , sample collection upper respiratory tract , report time since symptom onset exposure .', 'We exclude article clearly define time test symptom onset exposure .', 'We identify 7 study ( 2 preprints 5 peer-reviewed article ) ( 4–10 ) total 1330 respiratory sample analyze RT-PCR .', 'Figure 1 summarize source data .', 'One study Kujawski colleague ( 10 ) provide nasal throat sample patient ; use nasal sample analysis .']","['tests', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'base', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', '', 'rt-pcr', '', 'often', '', 'rule', '', 'infection', 'among', 'high-risk', 'person', '', 'expose', 'inpatient', 'health', 'care', 'worker', '', 'hence', '', 'critical', 'understand', 'predictive', 'value', 'change', 'relation', 'time', 'since', 'exposure', 'symptom', '', 'especially', 'result', 'test', 'decision', 'whether', 'stop', 'personal', 'protective', 'equipment', 'allow', 'expose', 'health', 'care', 'worker', 'return', 'work', '', 'sensitivity', 'specificity', 'pcr-based', 'test', 'sars-cov-2', 'poorly', 'characterize', '', '', 'window', 'period', '', 'acquisition', 'test', 'likely', 'produce', 'false-negative', 'result', 'well', '', 'accurate', 'test', 'sars-cov-2', '', 'follow', 'appropriate', 'preventive', 'measure', '', 'paramount', 'health', 'care', 'set', 'prevent', 'nosocomial', 'community', 'transmission', '', 'however', '', 'hospital', 'face', 'critical', 'shortage', 'sars-cov-2', 'test', 'capacity', '', 'personal', 'protective', 'equipment', '', 'health', 'care', 'personnel', '', '1', '', '', 'epidemic', 'progress', '', 'hospital', 'increasingly', 'decide', 'respond', 'patient', 'health', 'care', 'worker', 'exposure', 'sars-cov-2', '', 'although', '14', 'day', 'airborne', 'precaution', 'quarantine', 'conservative', 'approach', 'minimize', 'transmission', 'per', 'guideline', 'centers', 'disease', 'control', 'prevention', '', '2', '', '', 'feasible', 'hospital', 'give', 'starkly', 'limit', 'resource', '', 'rt-pcrbased', 'test', 'sars-cov-2', 'become', 'available', '', 'increasingly', '', 'rule', '', 'infection', 'conserve', 'scarce', 'personal', 'protective', 'equipment', 'preserve', 'workforce', '', 'expose', 'health', 'care', 'worker', 'test', 'negative', '', 'clear', 'return', 'work', '', 'similarly', '', 'expose', 'patient', 'test', 'negative', '', 'airborne', 'droplet', 'precaution', 'remove', '', 'negative', 'result', 'test', 'window', 'period', 'treat', 'strong', 'evidence', 'expose', 'person', 'sars-cov-2negative', '', 'preventable', 'transmission', 'occur', '', 'critical', 'understand', 'predictive', 'value', 'test', 'vary', 'time', 'exposure', 'symptom', 'onset', 'avoid', 'falsely', 'reassure', 'negative', 'result', 'test', 'early', 'course', 'infection', '', 'goal', 'study', 'estimate', 'false-negative', 'rate', 'day', 'since', 'infection', '', 'part', 'broader', 'effort', 'provide', 'critical', 'evaluation', 'emerge', 'evidence', '', 'novel', 'coronavirus', 'research', 'compendium', 'johns', 'hopkins', 'school', 'public', 'health', 'literature', 'review', 'identify', 'preprint', 'peer-reviewed', 'article', 'sars-cov-2', 'diagnostics', '', '3', '', '', 'investigators', 'search', '', 'biorxiv', '', 'medrxiv', 'strategy', 'detail', 'supplement', 'table', '1', '', 'search', 'last', 'update', '15', 'april', '2020', '', 'broader', 'search', '', 'identify', 'article', 'provide', 'data', 'rt-pcr', 'performance', 'time', 'since', 'symptom', 'onset', 'exposure', 'sample', 'derive', 'nasal', 'throat', 'swab', 'among', 'patient', 'test', 'sars-cov-2', '', 'inclusion', 'criterion', 'rt-pcrbased', 'test', '', 'sample', 'collection', 'upper', 'respiratory', 'tract', '', 'report', 'time', 'since', 'symptom', 'onset', 'exposure', '', 'exclude', 'article', 'clearly', 'define', 'time', 'test', 'symptom', 'onset', 'exposure', '', 'identify', '7', 'study', '', '2', 'preprints', '5', 'peer-reviewed', 'article', '', '', '410', '', 'total', '1330', 'respiratory', 'sample', 'analyze', 'rt-pcr', '', 'figure', '1', 'summarize', 'source', 'data', '', 'one', 'study', 'kujawski', 'colleague', '', '10', '', 'provide', 'nasal', 'throat', 'sample', 'patient', '', 'nasal', 'sample', 'analysis', '']",395,"{'': 67, 'test': 14, 'sars-cov-2': 8, 'health': 7, 'care': 6, 'exposure': 6, 'expose': 5, 'time': 5, 'symptom': 5, 'sample': 5, 'infection': 4, 'worker': 4, 'critical': 4, 'since': 4, 'result': 4, 'patient': 4, 'negative': 4, 'onset': 4, 'article': 4, 'respiratory': 3}","{'infection': 4, 'sars-cov-2': 8}",12,0.5423
DOI:10.7326/M20-1774,10.7326/M20-1774,Ideas and Opinions,2020-05-13 00:00:00,ACP,2020-05-23 22:13:35.057884,"['covid-19', 'outpatient', 'parenteral', 'antimicrobial', 'therapy', '', 'protect', 'vulnerable', 'medicare', 'beneficiaries']","['In December 2019 , severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) start epidemic Wuhan , China , since spread throughout world .', 'Now call coronavirus disease 2019 ( COVID-19 ) , illness cause SARS-CoV-2 declare pandemic World Health Organization 11 March 2020 .', 'Reports China show older age significant risk factor morbidity mortality among patient infect SARS-CoV-2 ( 1 ) .', ""In Washington state , initial epicenter COVID-19 United States , nurse home resident one heavily affect population high mortality rate , highlight COVID-19 's ability spread rapidly set ( 2 ) ."", 'Other risk factor worse outcome include immunocompromised state , underlie structural lung disease , cardiac disease , obesity , hypertension , diabetes ( 3 ) .', 'Each comorbid condition common person receive outpatient parenteral antimicrobial therapy ( OPAT ) , make group high-risk population .', 'However , current payment policy Medicare could lead unintended consequence patient receive OPAT , include exposure COVID-19 .', 'Home infusion involve intravenous administration medication home .', 'For patient receive home infusion , several component need cover : medication , supply equipment , service home visit nurse .', 'Many condition require intravenous administration medication home , include total parenteral nutrition , intravenous antibiotic , intravenous immunoglobulin .', 'Outpatient parenteral antimicrobial therapy one common home infusion service use 4 decade ( 4 ) .', 'It show convenient cost-effective way complete prolong course intravenous antibiotic outside hospital ( 5 ) .', 'It outpatient intravenous medication give various set , include home assistance home health , outpatient infusion center , skilled-nursing facility .', 'Most private insurance Medicare Advantage plan , Tricare , many state Medicaid program cover home infusion service , commonly use model among beneficiary group result ( 6 ) .', ""However , Medicare fee-for-service program adequately cover infusion service provide patient ' home ."", 'Although Medicare Part A cover home nurse , patient homebound , many patient need home infusion service .', 'Medicare Part B cover intravenous medication payment rule durable medical equipment , represent fewer 10 % antimicrobial prescribe OPAT ( Table ) ( 7 ) .', 'Medicare Part D , use 70 % Medicare beneficiary , cover drug medically necessary supplies—tubing , bag , needle , pumps—or administrative , pharmacy , nurse service need deliver medication ( 8 ) .']","['december', '2019', '', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'start', 'epidemic', 'wuhan', '', 'china', '', 'since', 'spread', 'throughout', 'world', '', 'call', 'coronavirus', 'disease', '2019', '', 'covid-19', '', '', 'illness', 'cause', 'sars-cov-2', 'declare', 'pandemic', 'world', 'health', 'organization', '11', 'march', '2020', '', 'reports', 'china', 'show', 'older', 'age', 'significant', 'risk', 'factor', 'morbidity', 'mortality', 'among', 'patient', 'infect', 'sars-cov-2', '', '1', '', '', 'washington', 'state', '', 'initial', 'epicenter', 'covid-19', 'united', 'states', '', 'nurse', 'home', 'resident', 'one', 'heavily', 'affect', 'population', 'high', 'mortality', 'rate', '', 'highlight', 'covid-19', 'ability', 'spread', 'rapidly', 'set', '', '2', '', '', 'risk', 'factor', 'worse', 'outcome', 'include', 'immunocompromised', 'state', '', 'underlie', 'structural', 'lung', 'disease', '', 'cardiac', 'disease', '', 'obesity', '', 'hypertension', '', 'diabetes', '', '3', '', '', 'comorbid', 'condition', 'common', 'person', 'receive', 'outpatient', 'parenteral', 'antimicrobial', 'therapy', '', 'opat', '', '', 'group', 'high-risk', 'population', '', 'however', '', 'current', 'payment', 'policy', 'medicare', 'lead', 'unintended', 'consequence', 'patient', 'receive', 'opat', '', 'include', 'exposure', 'covid-19', '', 'home', 'infusion', 'involve', 'intravenous', 'administration', 'medication', 'home', '', 'patient', 'receive', 'home', 'infusion', '', 'several', 'component', 'cover', '', 'medication', '', 'supply', 'equipment', '', 'service', 'home', 'visit', 'nurse', '', 'condition', 'require', 'intravenous', 'administration', 'medication', 'home', '', 'include', 'total', 'parenteral', 'nutrition', '', 'intravenous', 'antibiotic', '', 'intravenous', 'immunoglobulin', '', 'outpatient', 'parenteral', 'antimicrobial', 'therapy', 'one', 'common', 'home', 'infusion', 'service', '4', 'decade', '', '4', '', '', 'show', 'convenient', 'cost-effective', 'way', 'complete', 'prolong', 'course', 'intravenous', 'antibiotic', 'outside', 'hospital', '', '5', '', '', 'outpatient', 'intravenous', 'medication', 'give', 'various', 'set', '', 'include', 'home', 'assistance', 'home', 'health', '', 'outpatient', 'infusion', 'center', '', 'skilled-nursing', 'facility', '', 'private', 'insurance', 'medicare', 'advantage', 'plan', '', 'tricare', '', 'state', 'medicaid', 'program', 'cover', 'home', 'infusion', 'service', '', 'commonly', 'model', 'among', 'beneficiary', 'group', 'result', '', '6', '', '', 'however', '', 'medicare', 'fee-for-service', 'program', 'adequately', 'cover', 'infusion', 'service', 'provide', 'patient', '', 'home', '', 'although', 'medicare', 'part', 'cover', 'home', 'nurse', '', 'patient', 'homebound', '', 'patient', 'home', 'infusion', 'service', '', 'medicare', 'part', 'b', 'cover', 'intravenous', 'medication', 'payment', 'rule', 'durable', 'medical', 'equipment', '', 'represent', 'fewer', '10', '', 'antimicrobial', 'prescribe', 'opat', '', 'table', '', '', '7', '', '', 'medicare', 'part', '', '70', '', 'medicare', 'beneficiary', '', 'cover', 'drug', 'medically', 'necessary', 'suppliestubing', '', 'bag', '', 'needle', '', 'pumpsor', 'administrative', '', 'pharmacy', '', 'nurse', 'service', 'deliver', 'medication', '', '8', '', '']",357,"{'': 84, 'home': 13, 'medicare': 7, 'infusion': 7, 'intravenous': 7, 'patient': 6, 'medication': 6, 'cover': 6, 'service': 6, 'covid-19': 4, 'nurse': 4, 'include': 4, 'outpatient': 4, 'sars-cov-2': 3, 'disease': 3, 'state': 3, 'receive': 3, 'parenteral': 3, 'antimicrobial': 3, 'opat': 3}",{'sars-cov-2': 3},3,-0.6808
DOI:10.7326/A19-0031,10.7326/A19-0031,Web Exclusives,2020-05-12 00:00:00,ACP,2020-05-23 22:13:35.057884,"['annals', 'call', '-', 'clinical', 'reasoning', 'testing', 'covid-19']","['In episode Annals On Call , Dr. Centor discus test COVID-19 Drs .', 'Rabih Geha Reza Manesh .', 'Annals article discuss include ...', 'Diagnostic Testing Severe Acute Respiratory Syndrome–Related Coronavirus-2 .', 'A Narrative Review : www.acpjournals.org/doi/10.7326/M20-1301 Annals On Call focus clinically influential article publish Annals Internal Medicine .', 'Dr. Robert Centor share perspective material interview topic area expert discus , debate , share diverse insight patient care health care delivery .']","['episode', 'annals', 'call', '', 'dr', 'centor', 'discus', 'test', 'covid-19', 'drs', '', 'rabih', 'geha', 'reza', 'manesh', '', 'annals', 'article', 'discuss', 'include', '', 'diagnostic', 'testing', 'severe', 'acute', 'respiratory', 'syndromerelated', 'coronavirus-2', '', 'narrative', 'review', '', 'wwwacpjournalsorgdoi107326m20-1301', 'annals', 'call', 'focus', 'clinically', 'influential', 'article', 'publish', 'annals', 'internal', 'medicine', '', 'dr', 'robert', 'centor', 'share', 'perspective', 'material', 'interview', 'topic', 'area', 'expert', 'discus', '', 'debate', '', 'share', 'diverse', 'insight', 'patient', 'care', 'health', 'care', 'delivery', '']",67,"{'': 10, 'annals': 4, 'call': 2, 'dr': 2, 'centor': 2, 'discus': 2, 'article': 2, 'share': 2, 'care': 2, 'episode': 1, 'test': 1, 'covid-19': 1, 'drs': 1, 'rabih': 1, 'geha': 1, 'reza': 1, 'manesh': 1, 'discuss': 1, 'include': 1, 'diagnostic': 1}",{},0,0.0
DOI:10.7326/G20-0045,10.7326/G20-0045,Web Exclusives,2020-05-12 00:00:00,ACP,2020-05-23 22:13:35.057884,"['annals', 'graphic', 'medicine', '-', 'learned', 'covid-19', '', '']","['This article publish Annals.org 12 May 2020 .', 'Written Lucia Briatore , MD , PhD , illustrate Ilaria Pozzi .']","['article', 'publish', 'annalsorg', '12', '2020', '', 'written', 'lucia', 'briatore', '', 'md', '', 'phd', '', 'illustrate', 'ilaria', 'pozzi', '']",18,"{'': 5, 'article': 1, 'publish': 1, 'annalsorg': 1, '12': 1, '2020': 1, 'written': 1, 'lucia': 1, 'briatore': 1, 'md': 1, 'phd': 1, 'illustrate': 1, 'ilaria': 1, 'pozzi': 1}",{},0,0.0
DOI:10.7326/L20-0354,10.7326/L20-0354,Letters,2020-05-12 00:00:00,ACP,2020-05-23 22:13:35.057884,"['cytokine', 'levels', 'body', 'fluids', 'patient', 'covid-19', 'acute', 'respiratory', 'distress', 'syndrome', '', 'case', 'report']","['Background : Some patient coronavirus disease 2019 ( COVID-19 ) progress rapidly acute respiratory distress syndrome ( ARDS ) , septic shock , multiple organ failure ( 1 ) .', 'Some expert attribute sequence event large increase cytokine ( cytokine storm ) cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) secondary infection another organism .', 'Objective : To report cytokine level multiple body fluid patient COVID-19 ARDS , septic shock , multiple organ failure .', 'Case Report : On 20 January 2020 , 66-year-old man expose patient COVID-19 develop cough fever treat home .', 'On 2 February , cough fever gradually worsen , body temperature reach 38.7 °C , develop diarrhea vomit .', 'He treat local hospital , medical history include vitiligo , gastric ulcer , coronary heart disease , chronic obstructive pulmonary disease .', 'He develop dyspnea 2 day later , COVID-19 diagnose throat swab test nucleic acid .', 'He receive antiviral drug abidol supportive care .', 'When dyspnea worsen , transfer intensive care unit noninvasive mechanical ventilation .', 'On 11 February , mechanical ventilation start progressive decrease blood oxygen saturation , blood lactate level 4 mmol/L , PaO2–FiO2 ratio 186 mm Hg .', 'On 17 February , patient transfer Severe COVID-19 Intensive Treatment Center Heilongjiang Province .', 'His COVID-19 status confirm critical type , accord guideline National Health Commission ( trial version 7 ) .', 'We treat antiviral drug , immunoglobulin infusion , lung-protective ventilation , lung recruitment prone position ventilation .', 'In addition , start measure level cytokine IL-6 IL-10 blood daily bronchoalveolar lavage fluid pleural fluid intermittently , find high level ( Figure ) .', 'On 23 February , start continuous renal replacement therapy Oxiris filter ( Baxter International ) , design adsorb uremic toxin , endotoxin , cytokine .', 'Computed tomography 24 February show worsen pulmonary inflammation .', ""On 1 March , start extracorporeal membrane oxygenation could maintain patient 's oxygenation intermittent prone position ventilation ."", 'On 2 March , patient develop septic shock cardiac insufficiency , introduce intra-aortic balloon pump .', 'On 6 March , every-other-day plasmapheresis start another attempt decrease cytokine level .', ""Computed tomography 9 March show patient 's lung consolidation worsen ."", 'Unfortunately , patient die 14 March .']","['background', '', 'patient', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'progress', 'rapidly', 'acute', 'respiratory', 'distress', 'syndrome', '', 'ards', '', '', 'septic', 'shock', '', 'multiple', 'organ', 'failure', '', '1', '', '', 'expert', 'attribute', 'sequence', 'event', 'large', 'increase', 'cytokine', '', 'cytokine', 'storm', '', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', 'secondary', 'infection', 'another', 'organism', '', 'objective', '', 'report', 'cytokine', 'level', 'multiple', 'body', 'fluid', 'patient', 'covid-19', 'ards', '', 'septic', 'shock', '', 'multiple', 'organ', 'failure', '', 'case', 'report', '', '20', 'january', '2020', '', '66-year-old', 'man', 'expose', 'patient', 'covid-19', 'develop', 'cough', 'fever', 'treat', 'home', '', '2', 'february', '', 'cough', 'fever', 'gradually', 'worsen', '', 'body', 'temperature', 'reach', '387', 'c', '', 'develop', 'diarrhea', 'vomit', '', 'treat', 'local', 'hospital', '', 'medical', 'history', 'include', 'vitiligo', '', 'gastric', 'ulcer', '', 'coronary', 'heart', 'disease', '', 'chronic', 'obstructive', 'pulmonary', 'disease', '', 'develop', 'dyspnea', '2', 'day', 'later', '', 'covid-19', 'diagnose', 'throat', 'swab', 'test', 'nucleic', 'acid', '', 'receive', 'antiviral', 'drug', 'abidol', 'supportive', 'care', '', 'dyspnea', 'worsen', '', 'transfer', 'intensive', 'care', 'unit', 'noninvasive', 'mechanical', 'ventilation', '', '11', 'february', '', 'mechanical', 'ventilation', 'start', 'progressive', 'decrease', 'blood', 'oxygen', 'saturation', '', 'blood', 'lactate', 'level', '4', 'mmoll', '', 'pao2fio2', 'ratio', '186', 'mm', 'hg', '', '17', 'february', '', 'patient', 'transfer', 'severe', 'covid-19', 'intensive', 'treatment', 'center', 'heilongjiang', 'province', '', 'covid-19', 'status', 'confirm', 'critical', 'type', '', 'accord', 'guideline', 'national', 'health', 'commission', '', 'trial', 'version', '7', '', '', 'treat', 'antiviral', 'drug', '', 'immunoglobulin', 'infusion', '', 'lung-protective', 'ventilation', '', 'lung', 'recruitment', 'prone', 'position', 'ventilation', '', 'addition', '', 'start', 'measure', 'level', 'cytokine', 'il-inhibitor', 'il-10', 'blood', 'daily', 'bronchoalveolar', 'lavage', 'fluid', 'pleural', 'fluid', 'intermittently', '', 'find', 'high', 'level', '', 'figure', '', '', '23', 'february', '', 'start', 'continuous', 'renal', 'replacement', 'therapy', 'oxiris', 'filter', '', 'baxter', 'international', '', '', 'design', 'adsorb', 'uremic', 'toxin', '', 'endotoxin', '', 'cytokine', '', 'computed', 'tomography', '24', 'february', 'show', 'worsen', 'pulmonary', 'inflammation', '', '1', 'march', '', 'start', 'extracorporeal', 'membrane', 'oxygenation', 'maintain', 'patient', 'oxygenation', 'intermittent', 'prone', 'position', 'ventilation', '', '2', 'march', '', 'patient', 'develop', 'septic', 'shock', 'cardiac', 'insufficiency', '', 'introduce', 'intra-aortic', 'balloon', 'pump', '', '6', 'march', '', 'every-other-day', 'plasmapheresis', 'start', 'another', 'attempt', 'decrease', 'cytokine', 'level', '', 'computed', 'tomography', '9', 'march', 'show', 'patient', 'lung', 'consolidation', 'worsen', '', 'unfortunately', '', 'patient', 'die', '14', 'march', '']",349,"{'': 73, 'patient': 8, 'covid-19': 6, 'cytokine': 6, 'level': 5, 'february': 5, 'ventilation': 5, 'start': 5, 'march': 5, '2': 4, 'develop': 4, 'worsen': 4, 'disease': 3, 'septic': 3, 'shock': 3, 'multiple': 3, 'fluid': 3, 'treat': 3, 'blood': 3, 'coronavirus': 2}","{'infection': 1, 'sars-cov-2': 1, 'il-inhibitor': 1}",3,-0.9136
DOI:10.7326/M20-1550,10.7326/M20-1550,Letters,2020-05-12 00:00:00,ACP,2020-05-23 22:13:35.057884,"['pharmacokinetics', 'lopinavir', 'ritonavir', 'patients', 'hospitalized', 'coronavirus', 'disease', '2019', '', 'covid-19', '']","['Background : The coronavirus disease 2019 ( COVID-19 ) pandemic rapidly spread around world , lack effective treatment fuel global search “ magic bullet ” disease cause severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) .', 'As 29 April 2020 , total 997 COVID-19 trial register ClinicalTrials.gov , 30 investigate effect lopinavir ritonavir .', 'Lopinavir main antiviral agent , whereas ritonavir act pharmacokinetic “ booster ” increase lopinavir plasma concentration inhibit cytochrome 3A4 enzyme ( 1 ) .', 'The combination approve antiretroviral therapy adult HIV-1 infection .', 'However , vitro data also suggest antiviral activity lopinavir SARS-CoV-1 , half-maximal effective concentration ( EC50 ) 4.1 µg/mL ; Middle East respiratory syndrome-CoV , EC50 10.8 µg/mL ; , recently , SARS-CoV-2 , EC50 16.4 µg/mL ( 2 ) .', 'Importantly , EC50 HIV-1 0.07 µg/mL , 200-fold lower SARS-CoV-2 ( 1 ) .', 'Recently , Cao colleague publish negative result placebo-controlled trial patient hospitalize COVID-19 lopinavir treatment affect mortality , clinical performance , viral load ( 3 ) .', 'Objective : To measure trough level lopinavir ritonavir patient COVID-19 .', 'Methods Findings : In series 8 patient admit “ normal care ” ward COVID-19 , quantify trough plasma concentration lopinavir ritonavir liquid chromatography–tandem mass spectrometry .', 'Patients concomitant intake relevant CYP3A4 inducer inhibitor exclude .', 'Patients hospitalize receive 400 mg lopinavir 100 mg ritonavir twice daily 3 10 day analysis , do morning shortly next dose .', 'Assuming half-life 4 6 hour lopinavir , steady-state condition may assume patient .', 'Analysis trough level choose provide robust pharmacokinetic information single time–point assessment frequently investigate HIV trial , make data comparable .', 'Trough concentration lopinavir range 6.2 24.3 µg/mL ( median , 13.6 µg/mL ) ( Table ) .', 'Interestingly , small sample , trough concentration seem associate C-reactive protein ( Spearman correlation coefficient rS = 0.81 ) .', 'All patient unremarkable disease course discharge normal care ward .', 'Specific adverse effect lopinavir ritonavir observe .']","['background', '', 'coronavirus', 'disease', '2019', '', 'covid-19', '', 'pandemic', 'rapidly', 'spread', 'around', 'world', '', 'effective', 'treatment', 'fuel', 'global', 'search', '', 'magic', 'bullet', '', 'disease', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '', 'sars-cov-2', '', '', '29', 'april', '2020', '', 'total', '997', 'covid-19', 'trial', 'register', 'clinicaltrialsgov', '', '30', 'investigate', 'effect', 'lopinavir', 'ritonavir', '', 'lopinavir', 'main', 'antiviral', 'agent', '', 'whereas', 'ritonavir', 'act', 'pharmacokinetic', '', 'booster', '', 'increase', 'lopinavir', 'plasma', 'concentration', 'inhibit', 'cytochrome', '3a4', 'enzyme', '', '1', '', '', 'combination', 'approve', 'antiretroviral', 'therapy', 'adult', 'hiv-1', 'infection', '', 'however', '', 'vitro', 'data', 'suggest', 'antiviral', 'activity', 'lopinavir', 'sars-cov-1', '', 'half-maximal', 'effective', 'concentration', '', 'ec50', '', '41', 'gml', '', 'middle', 'east', 'respiratory', 'syndrome-cov', '', 'ec50', '108', 'gml', '', '', 'recently', '', 'sars-cov-2', '', 'ec50', '164', 'gml', '', '2', '', '', 'importantly', '', 'ec50', 'hiv-1', '007', 'gml', '', '200-fold', 'lower', 'sars-cov-2', '', '1', '', '', 'recently', '', 'cao', 'colleague', 'publish', 'negative', 'result', 'placebo-controlled', 'trial', 'patient', 'hospitalize', 'covid-19', 'lopinavir', 'treatment', 'affect', 'mortality', '', 'clinical', 'performance', '', 'viral', 'load', '', '3', '', '', 'objective', '', 'measure', 'trough', 'level', 'lopinavir', 'ritonavir', 'patient', 'covid-19', '', 'methods', 'findings', '', 'series', '8', 'patient', 'admit', '', 'normal', 'care', '', 'ward', 'covid-19', '', 'quantify', 'trough', 'plasma', 'concentration', 'lopinavir', 'ritonavir', 'liquid', 'chromatographytandem', 'mass', 'spectrometry', '', 'patients', 'concomitant', 'intake', 'relevant', 'cyp3a4', 'inducer', 'inhibitor', 'exclude', '', 'patients', 'hospitalize', 'receive', '400', 'mg', 'lopinavir', '100', 'mg', 'ritonavir', 'twice', 'daily', '3', '10', 'day', 'analysis', '', 'morning', 'shortly', 'next', 'dose', '', 'assuming', 'half-life', '4', '6', 'hour', 'lopinavir', '', 'steady-state', 'condition', 'assume', 'patient', '', 'analysis', 'trough', 'level', 'choose', 'provide', 'robust', 'pharmacokinetic', 'information', 'single', 'timepoint', 'assessment', 'frequently', 'investigate', 'hiv', 'trial', '', 'data', 'comparable', '', 'trough', 'concentration', 'lopinavir', 'range', '62', '243', 'gml', '', 'median', '', '136', 'gml', '', '', 'table', '', '', 'interestingly', '', 'small', 'sample', '', 'trough', 'concentration', 'associate', 'c-reactive', 'protein', '', 'spearman', 'correlation', 'coefficient', 'rs', '', '081', '', '', 'patient', 'unremarkable', 'disease', 'course', 'discharge', 'normal', 'care', 'ward', '', 'specific', 'adverse', 'effect', 'lopinavir', 'ritonavir', 'observe', '']",312,"{'': 71, 'lopinavir': 11, 'ritonavir': 6, 'gml': 6, 'covid-19': 5, 'concentration': 5, 'patient': 5, 'trough': 5, 'ec50': 4, 'disease': 3, 'sars-cov-2': 3, 'trial': 3, 'coronavirus': 2, 'effective': 2, 'treatment': 2, 'respiratory': 2, '2': 2, 'investigate': 2, 'effect': 2, 'antiviral': 2}","{'infection': 1, 'sars-cov-2': 3, 'vitro': 1}",5,-0.2732
